id|nct_id|result_group_id|ctgov_group_code|period|reason|count
1|NCT02882152|53|P2|Overall Study|Lost to Follow-up|0
2|NCT02882152|54|P1|Overall Study|Lost to Follow-up|1
3|NCT02862106|68|P2|Overall Study|Subjects moved to other city|0
4|NCT02862106|69|P1|Overall Study|Subjects moved to other city|1
5|NCT02862106|68|P2|Overall Study|Withdrawal by Subject|0
6|NCT02862106|69|P1|Overall Study|Withdrawal by Subject|2
7|NCT02862106|68|P2|Overall Study|Lost to Follow-up|5
8|NCT02862106|69|P1|Overall Study|Lost to Follow-up|15
9|NCT02862106|68|P2|Overall Study|Protocol Violation|1
10|NCT02862106|69|P1|Overall Study|Protocol Violation|16
11|NCT02862106|68|P2|Overall Study|Adverse Event|0
12|NCT02862106|69|P1|Overall Study|Adverse Event|4
13|NCT02829775|180|P1|Overall Study|Disease remission|1
14|NCT02829775|180|P1|Overall Study|Withdrawal by Subject|3
15|NCT02829775|180|P1|Overall Study|Death|1
16|NCT02809833|249|P1|Overall Study|Missing Information|52
17|NCT02809833|249|P1|Overall Study|Not Specified|5
18|NCT02809833|249|P1|Overall Study|Adverse Event (AE)|24
19|NCT02809833|249|P1|Overall Study|Lost to Follow-up|35
20|NCT02809833|249|P1|Overall Study|Withdrawal by Subject|34
21|NCT02809833|249|P1|Overall Study|Noncompliance|1
22|NCT02809833|249|P1|Overall Study|Remission/Treatment No Longer Needed|3
23|NCT02809833|249|P1|Overall Study|Lack of Efficacy|89
24|NCT02809833|249|P1|Overall Study|Intolerance|54
25|NCT02809833|249|P1|Overall Study|Death|3
26|NCT02806505|371|P2|Overall Study|Insufficient therapeutic response|4
27|NCT02806505|372|P1|Overall Study|Insufficient therapeutic response|2
28|NCT02806505|371|P2|Overall Study|Failure to return|1
29|NCT02806505|372|P1|Overall Study|Failure to return|0
30|NCT02806505|371|P2|Overall Study|Did not cooperate/refused treatment|3
31|NCT02806505|372|P1|Overall Study|Did not cooperate/refused treatment|3
32|NCT02806505|371|P2|Overall Study|Death|0
33|NCT02806505|372|P1|Overall Study|Death|4
34|NCT02806505|371|P2|Overall Study|Adverse event/intercurrent illness|3
35|NCT02806505|372|P1|Overall Study|Adverse event/intercurrent illness|1
36|NCT02791269|436|P2|Overall Study|Lost to Follow-up|1
37|NCT02791269|437|P1|Overall Study|Lost to Follow-up|0
38|NCT02774278|499|P1|Overall Study|Protocol Violation|2
39|NCT02774278|499|P1|Overall Study|Withdrawal by Subject|3
40|NCT02774278|499|P1|Overall Study|Administrative reasons|6
41|NCT02774278|499|P1|Overall Study|Refused treatment/did not cooperate|9
42|NCT02774278|499|P1|Overall Study|Adverse event/intercurrent illness|16
43|NCT02774278|499|P1|Overall Study|Death|29
44|NCT02774278|499|P1|Overall Study|Lack of Efficacy|199
45|NCT02766400|527|P2|Overall Study|Withdrawal by Subject|0
46|NCT02766400|528|P1|Overall Study|Withdrawal by Subject|1
47|NCT02766400|527|P2|Overall Study|Death|2
48|NCT02766400|528|P1|Overall Study|Death|1
49|NCT02761629|560|P2|Overall Study|Randomized But Not Treated|4
50|NCT02761629|561|P1|Overall Study|Randomized But Not Treated|8
51|NCT02761629|560|P2|Overall Study|Lost to Follow-up|1
52|NCT02761629|561|P1|Overall Study|Lost to Follow-up|4
53|NCT02761629|560|P2|Overall Study|Unspecified|2
54|NCT02761629|561|P1|Overall Study|Unspecified|0
55|NCT02761629|560|P2|Overall Study|Withdrawal by Subject|3
56|NCT02761629|561|P1|Overall Study|Withdrawal by Subject|0
57|NCT02761629|560|P2|Overall Study|Protocol Violation|2
58|NCT02761629|561|P1|Overall Study|Protocol Violation|2
59|NCT02761629|560|P2|Overall Study|Did not Cooperate/Refused Treatment|4
60|NCT02761629|561|P1|Overall Study|Did not Cooperate/Refused Treatment|2
61|NCT02761629|560|P2|Overall Study|Failure to Return|4
62|NCT02761629|561|P1|Overall Study|Failure to Return|2
63|NCT02761629|560|P2|Overall Study|Insufficient Therapeutic Response|7
64|NCT02761629|561|P1|Overall Study|Insufficient Therapeutic Response|2
65|NCT02761629|560|P2|Overall Study|Adverse Event/Intercurrent Illness|5
66|NCT02761629|561|P1|Overall Study|Adverse Event/Intercurrent Illness|7
67|NCT02755805|594|P2|Overall Study|Withdrawal by Subject|2
68|NCT02755805|595|P1|Overall Study|Withdrawal by Subject|0
69|NCT02755805|594|P2|Overall Study|Refused assessments|0
70|NCT02755805|595|P1|Overall Study|Refused assessments|1
71|NCT02755805|594|P2|Overall Study|Lost to Follow-up|2
72|NCT02755805|595|P1|Overall Study|Lost to Follow-up|1
73|NCT02750943|628|P2|Overall Study|Withdrawal by Subject|7
74|NCT02750943|629|P1|Overall Study|Withdrawal by Subject|5
75|NCT02750943|628|P2|Overall Study|Lost to Follow-up|2
76|NCT02750943|629|P1|Overall Study|Lost to Follow-up|1
77|NCT02750709|643|P6|Treatment Period 1|Adverse Event|1
78|NCT02750709|644|P5|Treatment Period 1|Adverse Event|0
79|NCT02750709|645|P4|Treatment Period 1|Adverse Event|0
80|NCT02750709|646|P3|Treatment Period 1|Adverse Event|0
81|NCT02750709|647|P2|Treatment Period 1|Adverse Event|0
82|NCT02750709|648|P1|Treatment Period 1|Adverse Event|0
83|NCT02750345|674|P6|Intervention 1|Adverse Event|0
84|NCT02750345|675|P5|Intervention 1|Adverse Event|1
85|NCT02750345|676|P4|Intervention 1|Adverse Event|0
86|NCT02750345|677|P3|Intervention 1|Adverse Event|0
87|NCT02750345|678|P2|Intervention 1|Adverse Event|0
88|NCT02750345|679|P1|Intervention 1|Adverse Event|0
89|NCT02750332|705|P2|Treatment Period 1|Withdrawal by Subject|1
90|NCT02750332|706|P1|Treatment Period 1|Withdrawal by Subject|0
91|NCT02748213|726|P2|Overall Study|Not Specified|29
92|NCT02748213|727|P1|Overall Study|Not Specified|30
93|NCT02748213|726|P2|Overall Study|Failure to Return|0
94|NCT02748213|727|P1|Overall Study|Failure to Return|1
95|NCT02748213|726|P2|Overall Study|Refused Treatment*|6
96|NCT02748213|727|P1|Overall Study|Refused Treatment*|6
97|NCT02748213|726|P2|Overall Study|Protocol Violation|4
98|NCT02748213|727|P1|Overall Study|Protocol Violation|6
99|NCT02748213|726|P2|Overall Study|Violation of Selection Criteria|0
100|NCT02748213|727|P1|Overall Study|Violation of Selection Criteria|2
101|NCT02748213|726|P2|Overall Study|Insufficient Therapeutic Response|57
102|NCT02748213|727|P1|Overall Study|Insufficient Therapeutic Response|56
103|NCT02748213|726|P2|Overall Study|Death|3
104|NCT02748213|727|P1|Overall Study|Death|5
105|NCT02748213|726|P2|Overall Study|Adverse Event or Intercurrent Illness|11
106|NCT02748213|727|P1|Overall Study|Adverse Event or Intercurrent Illness|5
107|NCT02748213|726|P2|Overall Study|Abnormal Laboratory Test|0
108|NCT02748213|727|P1|Overall Study|Abnormal Laboratory Test|1
109|NCT02748213|726|P2|Overall Study|Withdrawal Prior to Treatment|2
110|NCT02748213|727|P1|Overall Study|Withdrawal Prior to Treatment|1
111|NCT02746679|745|P2|Overall Study|Lost to Follow-up|6
112|NCT02746679|746|P1|Overall Study|Lost to Follow-up|4
113|NCT02739594|817|P2|Overall Study|Not Specified|2
114|NCT02739594|818|P1|Overall Study|Not Specified|6
115|NCT02739594|817|P2|Overall Study|Elevated Serum Creatinine|1
116|NCT02739594|818|P1|Overall Study|Elevated Serum Creatinine|0
117|NCT02739594|817|P2|Overall Study|Lost to Follow-up|1
118|NCT02739594|818|P1|Overall Study|Lost to Follow-up|0
119|NCT02739594|817|P2|Overall Study|Withdrawal by Subject|1
120|NCT02739594|818|P1|Overall Study|Withdrawal by Subject|1
121|NCT02739594|817|P2|Overall Study|Administrative Reasons|3
122|NCT02739594|818|P1|Overall Study|Administrative Reasons|1
123|NCT02739594|817|P2|Overall Study|Renal Insufficiency|6
124|NCT02739594|818|P1|Overall Study|Renal Insufficiency|4
125|NCT02739594|817|P2|Overall Study|Death|2
126|NCT02739594|818|P1|Overall Study|Death|4
127|NCT02739594|817|P2|Overall Study|Protocol Violation|6
128|NCT02739594|818|P1|Overall Study|Protocol Violation|5
129|NCT02739594|817|P2|Overall Study|Violation of Eligibility Criteria|2
130|NCT02739594|818|P1|Overall Study|Violation of Eligibility Criteria|1
131|NCT02739594|817|P2|Overall Study|Undesired Event|4
132|NCT02739594|818|P1|Overall Study|Undesired Event|3
133|NCT02736721|848|P1|Overall Study|Unspecified|5
134|NCT02736721|848|P1|Overall Study|Lost to Follow-up|3
135|NCT02736721|848|P1|Overall Study|Adverse Event|8
136|NCT02732639|857|P1|Overall Study|Lost to Follow-up|1
137|NCT02732210|870|P2|Overall Study|Missing|8
138|NCT02732210|871|P1|Overall Study|Missing|0
139|NCT02732210|870|P2|Overall Study|Other|103
140|NCT02732210|871|P1|Overall Study|Other|35
141|NCT02732210|870|P2|Overall Study|Death|15
142|NCT02732210|871|P1|Overall Study|Death|4
143|NCT02732210|870|P2|Overall Study|Lost to Follow-up|57
144|NCT02732210|871|P1|Overall Study|Lost to Follow-up|5
145|NCT02732210|870|P2|Overall Study|Withdrawal by Subject|87
146|NCT02732210|871|P1|Overall Study|Withdrawal by Subject|28
147|NCT02732210|870|P2|Overall Study|Study Ended|13
148|NCT02732210|871|P1|Overall Study|Study Ended|13
149|NCT02732210|870|P2|Overall Study|Site Closed|11
150|NCT02732210|871|P1|Overall Study|Site Closed|0
151|NCT02731131|908|P2|Overall Study|Refused Therapy|1
152|NCT02731131|909|P1|Overall Study|Refused Therapy|0
153|NCT02731131|908|P2|Overall Study|Psychiatric Disorder|1
154|NCT02731131|909|P1|Overall Study|Psychiatric Disorder|0
155|NCT02726022|934|P1|Overall Study|Treatment Failure and Poor Compliance|1
156|NCT02726022|934|P1|Overall Study|Poor Compliance|13
157|NCT02726022|934|P1|Overall Study|Treatment Failure|8
158|NCT02726022|934|P1|Overall Study|Adverse Event|14
159|NCT02717754|949|P6|Overall Study|Incorrect Infusion Duration|20
160|NCT02717754|950|P5|Overall Study|Incorrect Infusion Duration|20
161|NCT02717754|951|P4|Overall Study|Incorrect Infusion Duration|10
162|NCT02717754|952|P3|Overall Study|Incorrect Infusion Duration|0
163|NCT02717754|953|P2|Overall Study|Incorrect Infusion Duration|0
164|NCT02717754|954|P1|Overall Study|Incorrect Infusion Duration|0
165|NCT02716779|985|P3|Combination Therapy|Adverse Event|1
166|NCT02716779|986|P2|Combination Therapy|Adverse Event|2
167|NCT02716779|987|P1|Combination Therapy|Adverse Event|0
168|NCT02716779|985|P3|Monotherapy|Adverse Event|1
169|NCT02716779|986|P2|Monotherapy|Adverse Event|1
170|NCT02716779|987|P1|Monotherapy|Adverse Event|0
171|NCT02709577|1033|P4|Overall Study|Withdrawal by Subject|0
172|NCT02709577|1034|P3|Overall Study|Withdrawal by Subject|2
173|NCT02709577|1035|P2|Overall Study|Withdrawal by Subject|3
174|NCT02709577|1036|P1|Overall Study|Withdrawal by Subject|2
175|NCT02709577|1033|P4|Overall Study|procedural complication|0
176|NCT02709577|1034|P3|Overall Study|procedural complication|0
177|NCT02709577|1035|P2|Overall Study|procedural complication|1
178|NCT02709577|1036|P1|Overall Study|procedural complication|0
179|NCT02709577|1033|P4|Overall Study|non-accommodating anatomy|0
180|NCT02709577|1034|P3|Overall Study|non-accommodating anatomy|0
181|NCT02709577|1035|P2|Overall Study|non-accommodating anatomy|1
182|NCT02709577|1036|P1|Overall Study|non-accommodating anatomy|0
183|NCT02708524|1052|P4|Overall Study|Subject lost study lens|0
184|NCT02708524|1053|P3|Overall Study|Subject lost study lens|0
185|NCT02708524|1054|P2|Overall Study|Subject lost study lens|0
186|NCT02708524|1055|P1|Overall Study|Subject lost study lens|1
187|NCT02708524|1052|P4|Overall Study|Did not wear lens at final visit|0
188|NCT02708524|1053|P3|Overall Study|Did not wear lens at final visit|0
189|NCT02708524|1054|P2|Overall Study|Did not wear lens at final visit|1
190|NCT02708524|1055|P1|Overall Study|Did not wear lens at final visit|0
191|NCT02708524|1052|P4|Overall Study|Dispensed incorrect study lens|0
192|NCT02708524|1053|P3|Overall Study|Dispensed incorrect study lens|1
193|NCT02708524|1054|P2|Overall Study|Dispensed incorrect study lens|1
194|NCT02708524|1055|P1|Overall Study|Dispensed incorrect study lens|0
195|NCT02708524|1052|P4|Overall Study|Withdrawal by Subject|0
196|NCT02708524|1053|P3|Overall Study|Withdrawal by Subject|0
197|NCT02708524|1054|P2|Overall Study|Withdrawal by Subject|1
198|NCT02708524|1055|P1|Overall Study|Withdrawal by Subject|1
199|NCT02708524|1052|P4|Overall Study|Protocol Violation|0
200|NCT02708524|1053|P3|Overall Study|Protocol Violation|0
201|NCT02708524|1054|P2|Overall Study|Protocol Violation|1
202|NCT02708524|1055|P1|Overall Study|Protocol Violation|0
203|NCT02708524|1052|P4|Overall Study|Lost to Follow-up|0
204|NCT02708524|1053|P3|Overall Study|Lost to Follow-up|1
205|NCT02708524|1054|P2|Overall Study|Lost to Follow-up|1
206|NCT02708524|1055|P1|Overall Study|Lost to Follow-up|1
207|NCT02708524|1052|P4|Overall Study|Lens Discomfort|0
208|NCT02708524|1053|P3|Overall Study|Lens Discomfort|1
209|NCT02708524|1054|P2|Overall Study|Lens Discomfort|0
210|NCT02708524|1055|P1|Overall Study|Lens Discomfort|1
211|NCT02708524|1052|P4|Overall Study|Adverse Event|0
212|NCT02708524|1053|P3|Overall Study|Adverse Event|0
213|NCT02708524|1054|P2|Overall Study|Adverse Event|1
214|NCT02708524|1055|P1|Overall Study|Adverse Event|0
215|NCT02708277|1103|P2|Overall Study|Lost to Follow-up|4
216|NCT02708277|1104|P1|Overall Study|Lost to Follow-up|7
217|NCT02707640|1147|P2|Overall Study|Sponsor Discretion|0
218|NCT02707640|1148|P1|Overall Study|Sponsor Discretion|1
219|NCT02707640|1147|P2|Overall Study|Participant's Personal Decision|2
220|NCT02707640|1148|P1|Overall Study|Participant's Personal Decision|1
221|NCT02707640|1147|P2|Overall Study|Withdrawal by Subject|1
222|NCT02707640|1148|P1|Overall Study|Withdrawal by Subject|0
223|NCT02707640|1147|P2|Overall Study|Physician Decision|0
224|NCT02707640|1148|P1|Overall Study|Physician Decision|2
225|NCT02707640|1147|P2|Overall Study|Death|2
226|NCT02707640|1148|P1|Overall Study|Death|1
227|NCT02707640|1147|P2|Overall Study|Adverse Event|2
228|NCT02707640|1148|P1|Overall Study|Adverse Event|4
229|NCT02699892|1188|P1|Overall Study|Unspecified|36
230|NCT02694718|1193|P1|Overall Study|Withdrawal by Subject|1
231|NCT02694718|1193|P1|Overall Study|Death|1
232|NCT02694536|1203|P1|Overall Study|Not Specified|22
233|NCT02694536|1203|P1|Overall Study|Death|8
234|NCT02694536|1203|P1|Overall Study|Withdrawal by Subject|8
235|NCT02694536|1203|P1|Overall Study|Study Drug-Related Adverse Event|1
236|NCT02694536|1203|P1|Overall Study|Lost to Follow-up|1
237|NCT02694536|1203|P1|Overall Study|Progressive Disease|40
238|NCT02678676|1384|P2|Overall Study|Unconfirmed for lost to follow-up|67
239|NCT02678676|1385|P1|Overall Study|Unconfirmed for lost to follow-up|85
240|NCT02678676|1384|P2|Overall Study|Lost to Follow-up|151
241|NCT02678676|1385|P1|Overall Study|Lost to Follow-up|171
242|NCT02678676|1384|P2|Overall Study|Withdrawal by Subject|5
243|NCT02678676|1385|P1|Overall Study|Withdrawal by Subject|13
244|NCT02678676|1384|P2|Overall Study|Death|649
245|NCT02678676|1385|P1|Overall Study|Death|619
246|NCT02666222|1467|P1|Overall Study|Death|2
247|NCT02644109|1623|P2|Overall Study|Adverse Event|4
248|NCT02644109|1624|P1|Overall Study|Adverse Event|0
249|NCT02644096|1632|P2|Overall Study|Withdrawal by Subject|25
250|NCT02644096|1633|P1|Overall Study|Withdrawal by Subject|28
251|NCT02641379|1736|P11|Overall Study|PCR positive|0
252|NCT02641379|1737|P10|Overall Study|PCR positive|0
253|NCT02641379|1738|P9|Overall Study|PCR positive|0
254|NCT02641379|1739|P8|Overall Study|PCR positive|0
255|NCT02641379|1740|P7|Overall Study|PCR positive|1
256|NCT02641379|1741|P6|Overall Study|PCR positive|0
257|NCT02641379|1742|P5|Overall Study|PCR positive|0
258|NCT02641379|1743|P4|Overall Study|PCR positive|0
259|NCT02641379|1744|P3|Overall Study|PCR positive|0
260|NCT02641379|1745|P2|Overall Study|PCR positive|0
261|NCT02641379|1746|P1|Overall Study|PCR positive|0
262|NCT02641379|1736|P11|Overall Study|Missing PCR result at Week 8|0
263|NCT02641379|1737|P10|Overall Study|Missing PCR result at Week 8|1
264|NCT02641379|1738|P9|Overall Study|Missing PCR result at Week 8|0
265|NCT02641379|1739|P8|Overall Study|Missing PCR result at Week 8|0
266|NCT02641379|1740|P7|Overall Study|Missing PCR result at Week 8|0
267|NCT02641379|1741|P6|Overall Study|Missing PCR result at Week 8|0
268|NCT02641379|1742|P5|Overall Study|Missing PCR result at Week 8|0
269|NCT02641379|1743|P4|Overall Study|Missing PCR result at Week 8|0
270|NCT02641379|1744|P3|Overall Study|Missing PCR result at Week 8|0
271|NCT02641379|1745|P2|Overall Study|Missing PCR result at Week 8|0
272|NCT02641379|1746|P1|Overall Study|Missing PCR result at Week 8|0
273|NCT02641379|1736|P11|Overall Study|Participant treated after Week 24|0
274|NCT02641379|1737|P10|Overall Study|Participant treated after Week 24|0
275|NCT02641379|1738|P9|Overall Study|Participant treated after Week 24|1
276|NCT02641379|1739|P8|Overall Study|Participant treated after Week 24|0
277|NCT02641379|1740|P7|Overall Study|Participant treated after Week 24|0
278|NCT02641379|1741|P6|Overall Study|Participant treated after Week 24|0
279|NCT02641379|1742|P5|Overall Study|Participant treated after Week 24|0
280|NCT02641379|1743|P4|Overall Study|Participant treated after Week 24|0
281|NCT02641379|1744|P3|Overall Study|Participant treated after Week 24|0
282|NCT02641379|1745|P2|Overall Study|Participant treated after Week 24|0
283|NCT02641379|1746|P1|Overall Study|Participant treated after Week 24|0
284|NCT02641379|1736|P11|Overall Study|Participant’s PCR high|0
285|NCT02641379|1737|P10|Overall Study|Participant’s PCR high|0
286|NCT02641379|1738|P9|Overall Study|Participant’s PCR high|0
287|NCT02641379|1739|P8|Overall Study|Participant’s PCR high|1
288|NCT02641379|1740|P7|Overall Study|Participant’s PCR high|0
289|NCT02641379|1741|P6|Overall Study|Participant’s PCR high|0
290|NCT02641379|1742|P5|Overall Study|Participant’s PCR high|0
291|NCT02641379|1743|P4|Overall Study|Participant’s PCR high|0
292|NCT02641379|1744|P3|Overall Study|Participant’s PCR high|0
293|NCT02641379|1745|P2|Overall Study|Participant’s PCR high|0
294|NCT02641379|1746|P1|Overall Study|Participant’s PCR high|0
295|NCT02641379|1736|P11|Overall Study|Negative PCR result|0
296|NCT02641379|1737|P10|Overall Study|Negative PCR result|1
297|NCT02641379|1738|P9|Overall Study|Negative PCR result|0
298|NCT02641379|1739|P8|Overall Study|Negative PCR result|0
299|NCT02641379|1740|P7|Overall Study|Negative PCR result|0
300|NCT02641379|1741|P6|Overall Study|Negative PCR result|0
301|NCT02641379|1742|P5|Overall Study|Negative PCR result|0
302|NCT02641379|1743|P4|Overall Study|Negative PCR result|0
303|NCT02641379|1744|P3|Overall Study|Negative PCR result|0
304|NCT02641379|1745|P2|Overall Study|Negative PCR result|0
305|NCT02641379|1746|P1|Overall Study|Negative PCR result|0
306|NCT02641379|1736|P11|Overall Study|No 2 Log drop at Week 12|1
307|NCT02641379|1737|P10|Overall Study|No 2 Log drop at Week 12|0
308|NCT02641379|1738|P9|Overall Study|No 2 Log drop at Week 12|0
309|NCT02641379|1739|P8|Overall Study|No 2 Log drop at Week 12|0
310|NCT02641379|1740|P7|Overall Study|No 2 Log drop at Week 12|0
311|NCT02641379|1741|P6|Overall Study|No 2 Log drop at Week 12|0
312|NCT02641379|1742|P5|Overall Study|No 2 Log drop at Week 12|0
313|NCT02641379|1743|P4|Overall Study|No 2 Log drop at Week 12|0
314|NCT02641379|1744|P3|Overall Study|No 2 Log drop at Week 12|0
315|NCT02641379|1745|P2|Overall Study|No 2 Log drop at Week 12|0
316|NCT02641379|1746|P1|Overall Study|No 2 Log drop at Week 12|0
317|NCT02641379|1736|P11|Overall Study|Non-response Week 12|0
318|NCT02641379|1737|P10|Overall Study|Non-response Week 12|0
319|NCT02641379|1738|P9|Overall Study|Non-response Week 12|0
320|NCT02641379|1739|P8|Overall Study|Non-response Week 12|1
321|NCT02641379|1740|P7|Overall Study|Non-response Week 12|0
322|NCT02641379|1741|P6|Overall Study|Non-response Week 12|0
323|NCT02641379|1742|P5|Overall Study|Non-response Week 12|0
324|NCT02641379|1743|P4|Overall Study|Non-response Week 12|0
325|NCT02641379|1744|P3|Overall Study|Non-response Week 12|0
326|NCT02641379|1745|P2|Overall Study|Non-response Week 12|0
327|NCT02641379|1746|P1|Overall Study|Non-response Week 12|0
328|NCT02641379|1736|P11|Overall Study|Participant showed weight reduction|0
329|NCT02641379|1737|P10|Overall Study|Participant showed weight reduction|0
330|NCT02641379|1738|P9|Overall Study|Participant showed weight reduction|0
331|NCT02641379|1739|P8|Overall Study|Participant showed weight reduction|1
332|NCT02641379|1740|P7|Overall Study|Participant showed weight reduction|0
333|NCT02641379|1741|P6|Overall Study|Participant showed weight reduction|0
334|NCT02641379|1742|P5|Overall Study|Participant showed weight reduction|0
335|NCT02641379|1743|P4|Overall Study|Participant showed weight reduction|0
336|NCT02641379|1744|P3|Overall Study|Participant showed weight reduction|0
337|NCT02641379|1745|P2|Overall Study|Participant showed weight reduction|0
338|NCT02641379|1746|P1|Overall Study|Participant showed weight reduction|0
339|NCT02641379|1736|P11|Overall Study|Source data not found|0
340|NCT02641379|1737|P10|Overall Study|Source data not found|0
341|NCT02641379|1738|P9|Overall Study|Source data not found|0
342|NCT02641379|1739|P8|Overall Study|Source data not found|0
343|NCT02641379|1740|P7|Overall Study|Source data not found|0
344|NCT02641379|1741|P6|Overall Study|Source data not found|1
345|NCT02641379|1742|P5|Overall Study|Source data not found|0
346|NCT02641379|1743|P4|Overall Study|Source data not found|0
347|NCT02641379|1744|P3|Overall Study|Source data not found|0
348|NCT02641379|1745|P2|Overall Study|Source data not found|0
349|NCT02641379|1746|P1|Overall Study|Source data not found|0
350|NCT02641379|1736|P11|Overall Study|Lost to Follow-up|0
351|NCT02641379|1737|P10|Overall Study|Lost to Follow-up|0
352|NCT02641379|1738|P9|Overall Study|Lost to Follow-up|1
353|NCT02641379|1739|P8|Overall Study|Lost to Follow-up|0
354|NCT02641379|1740|P7|Overall Study|Lost to Follow-up|0
355|NCT02641379|1741|P6|Overall Study|Lost to Follow-up|0
356|NCT02641379|1742|P5|Overall Study|Lost to Follow-up|0
357|NCT02641379|1743|P4|Overall Study|Lost to Follow-up|0
358|NCT02641379|1744|P3|Overall Study|Lost to Follow-up|0
359|NCT02641379|1745|P2|Overall Study|Lost to Follow-up|0
360|NCT02641379|1746|P1|Overall Study|Lost to Follow-up|0
361|NCT02641379|1736|P11|Overall Study|Participation in sili rescue study|0
362|NCT02641379|1737|P10|Overall Study|Participation in sili rescue study|0
363|NCT02641379|1738|P9|Overall Study|Participation in sili rescue study|0
364|NCT02641379|1739|P8|Overall Study|Participation in sili rescue study|0
365|NCT02641379|1740|P7|Overall Study|Participation in sili rescue study|0
366|NCT02641379|1741|P6|Overall Study|Participation in sili rescue study|1
367|NCT02641379|1742|P5|Overall Study|Participation in sili rescue study|0
368|NCT02641379|1743|P4|Overall Study|Participation in sili rescue study|0
369|NCT02641379|1744|P3|Overall Study|Participation in sili rescue study|0
370|NCT02641379|1745|P2|Overall Study|Participation in sili rescue study|0
371|NCT02641379|1746|P1|Overall Study|Participation in sili rescue study|0
372|NCT02641379|1736|P11|Overall Study|Protocol Violation|0
373|NCT02641379|1737|P10|Overall Study|Protocol Violation|0
374|NCT02641379|1738|P9|Overall Study|Protocol Violation|1
375|NCT02641379|1739|P8|Overall Study|Protocol Violation|0
376|NCT02641379|1740|P7|Overall Study|Protocol Violation|0
377|NCT02641379|1741|P6|Overall Study|Protocol Violation|0
378|NCT02641379|1742|P5|Overall Study|Protocol Violation|2
379|NCT02641379|1743|P4|Overall Study|Protocol Violation|0
380|NCT02641379|1744|P3|Overall Study|Protocol Violation|0
381|NCT02641379|1745|P2|Overall Study|Protocol Violation|0
382|NCT02641379|1746|P1|Overall Study|Protocol Violation|0
383|NCT02641379|1736|P11|Overall Study|Blood could not be drawn|0
384|NCT02641379|1737|P10|Overall Study|Blood could not be drawn|0
385|NCT02641379|1738|P9|Overall Study|Blood could not be drawn|0
386|NCT02641379|1739|P8|Overall Study|Blood could not be drawn|0
387|NCT02641379|1740|P7|Overall Study|Blood could not be drawn|0
388|NCT02641379|1741|P6|Overall Study|Blood could not be drawn|0
389|NCT02641379|1742|P5|Overall Study|Blood could not be drawn|1
390|NCT02641379|1743|P4|Overall Study|Blood could not be drawn|0
391|NCT02641379|1744|P3|Overall Study|Blood could not be drawn|0
392|NCT02641379|1745|P2|Overall Study|Blood could not be drawn|0
393|NCT02641379|1746|P1|Overall Study|Blood could not be drawn|0
394|NCT02641379|1736|P11|Overall Study|Baseline viral load unavailable|0
395|NCT02641379|1737|P10|Overall Study|Baseline viral load unavailable|0
396|NCT02641379|1738|P9|Overall Study|Baseline viral load unavailable|0
397|NCT02641379|1739|P8|Overall Study|Baseline viral load unavailable|0
398|NCT02641379|1740|P7|Overall Study|Baseline viral load unavailable|0
399|NCT02641379|1741|P6|Overall Study|Baseline viral load unavailable|0
400|NCT02641379|1742|P5|Overall Study|Baseline viral load unavailable|0
401|NCT02641379|1743|P4|Overall Study|Baseline viral load unavailable|1
402|NCT02641379|1744|P3|Overall Study|Baseline viral load unavailable|0
403|NCT02641379|1745|P2|Overall Study|Baseline viral load unavailable|0
404|NCT02641379|1746|P1|Overall Study|Baseline viral load unavailable|0
405|NCT02641379|1736|P11|Overall Study|Inclusion criteria not fulfilled|0
406|NCT02641379|1737|P10|Overall Study|Inclusion criteria not fulfilled|0
407|NCT02641379|1738|P9|Overall Study|Inclusion criteria not fulfilled|0
408|NCT02641379|1739|P8|Overall Study|Inclusion criteria not fulfilled|0
409|NCT02641379|1740|P7|Overall Study|Inclusion criteria not fulfilled|0
410|NCT02641379|1741|P6|Overall Study|Inclusion criteria not fulfilled|0
411|NCT02641379|1742|P5|Overall Study|Inclusion criteria not fulfilled|0
412|NCT02641379|1743|P4|Overall Study|Inclusion criteria not fulfilled|1
413|NCT02641379|1744|P3|Overall Study|Inclusion criteria not fulfilled|0
414|NCT02641379|1745|P2|Overall Study|Inclusion criteria not fulfilled|0
415|NCT02641379|1746|P1|Overall Study|Inclusion criteria not fulfilled|0
416|NCT02641379|1736|P11|Overall Study|PCR sample for Week 4 not drawn|0
417|NCT02641379|1737|P10|Overall Study|PCR sample for Week 4 not drawn|0
418|NCT02641379|1738|P9|Overall Study|PCR sample for Week 4 not drawn|0
419|NCT02641379|1739|P8|Overall Study|PCR sample for Week 4 not drawn|0
420|NCT02641379|1740|P7|Overall Study|PCR sample for Week 4 not drawn|0
421|NCT02641379|1741|P6|Overall Study|PCR sample for Week 4 not drawn|0
422|NCT02641379|1742|P5|Overall Study|PCR sample for Week 4 not drawn|0
423|NCT02641379|1743|P4|Overall Study|PCR sample for Week 4 not drawn|1
424|NCT02641379|1744|P3|Overall Study|PCR sample for Week 4 not drawn|0
425|NCT02641379|1745|P2|Overall Study|PCR sample for Week 4 not drawn|0
426|NCT02641379|1746|P1|Overall Study|PCR sample for Week 4 not drawn|0
427|NCT02641379|1736|P11|Overall Study|PCR positive at Week 28|0
428|NCT02641379|1737|P10|Overall Study|PCR positive at Week 28|0
429|NCT02641379|1738|P9|Overall Study|PCR positive at Week 28|0
430|NCT02641379|1739|P8|Overall Study|PCR positive at Week 28|0
431|NCT02641379|1740|P7|Overall Study|PCR positive at Week 28|0
432|NCT02641379|1741|P6|Overall Study|PCR positive at Week 28|0
433|NCT02641379|1742|P5|Overall Study|PCR positive at Week 28|0
434|NCT02641379|1743|P4|Overall Study|PCR positive at Week 28|0
435|NCT02641379|1744|P3|Overall Study|PCR positive at Week 28|1
436|NCT02641379|1745|P2|Overall Study|PCR positive at Week 28|0
437|NCT02641379|1746|P1|Overall Study|PCR positive at Week 28|0
438|NCT02641379|1736|P11|Overall Study|No PCR at baseline|0
439|NCT02641379|1737|P10|Overall Study|No PCR at baseline|0
440|NCT02641379|1738|P9|Overall Study|No PCR at baseline|0
441|NCT02641379|1739|P8|Overall Study|No PCR at baseline|0
442|NCT02641379|1740|P7|Overall Study|No PCR at baseline|0
443|NCT02641379|1741|P6|Overall Study|No PCR at baseline|0
444|NCT02641379|1742|P5|Overall Study|No PCR at baseline|0
445|NCT02641379|1743|P4|Overall Study|No PCR at baseline|0
446|NCT02641379|1744|P3|Overall Study|No PCR at baseline|1
447|NCT02641379|1745|P2|Overall Study|No PCR at baseline|0
448|NCT02641379|1746|P1|Overall Study|No PCR at baseline|0
449|NCT02641379|1736|P11|Overall Study|PCR not performed at Week 12|0
450|NCT02641379|1737|P10|Overall Study|PCR not performed at Week 12|0
451|NCT02641379|1738|P9|Overall Study|PCR not performed at Week 12|0
452|NCT02641379|1739|P8|Overall Study|PCR not performed at Week 12|0
453|NCT02641379|1740|P7|Overall Study|PCR not performed at Week 12|0
454|NCT02641379|1741|P6|Overall Study|PCR not performed at Week 12|0
455|NCT02641379|1742|P5|Overall Study|PCR not performed at Week 12|0
456|NCT02641379|1743|P4|Overall Study|PCR not performed at Week 12|0
457|NCT02641379|1744|P3|Overall Study|PCR not performed at Week 12|1
458|NCT02641379|1745|P2|Overall Study|PCR not performed at Week 12|0
459|NCT02641379|1746|P1|Overall Study|PCR not performed at Week 12|0
460|NCT02641379|1736|P11|Overall Study|PCR positive at Week 48|0
461|NCT02641379|1737|P10|Overall Study|PCR positive at Week 48|0
462|NCT02641379|1738|P9|Overall Study|PCR positive at Week 48|0
463|NCT02641379|1739|P8|Overall Study|PCR positive at Week 48|0
464|NCT02641379|1740|P7|Overall Study|PCR positive at Week 48|0
465|NCT02641379|1741|P6|Overall Study|PCR positive at Week 48|0
466|NCT02641379|1742|P5|Overall Study|PCR positive at Week 48|0
467|NCT02641379|1743|P4|Overall Study|PCR positive at Week 48|0
468|NCT02641379|1744|P3|Overall Study|PCR positive at Week 48|0
469|NCT02641379|1745|P2|Overall Study|PCR positive at Week 48|1
470|NCT02641379|1746|P1|Overall Study|PCR positive at Week 48|0
471|NCT02641379|1736|P11|Overall Study|PCR positive at Week 68|0
472|NCT02641379|1737|P10|Overall Study|PCR positive at Week 68|0
473|NCT02641379|1738|P9|Overall Study|PCR positive at Week 68|0
474|NCT02641379|1739|P8|Overall Study|PCR positive at Week 68|0
475|NCT02641379|1740|P7|Overall Study|PCR positive at Week 68|0
476|NCT02641379|1741|P6|Overall Study|PCR positive at Week 68|0
477|NCT02641379|1742|P5|Overall Study|PCR positive at Week 68|0
478|NCT02641379|1743|P4|Overall Study|PCR positive at Week 68|0
479|NCT02641379|1744|P3|Overall Study|PCR positive at Week 68|0
480|NCT02641379|1745|P2|Overall Study|PCR positive at Week 68|1
481|NCT02641379|1746|P1|Overall Study|PCR positive at Week 68|0
482|NCT02641379|1736|P11|Overall Study|Financial problems|0
483|NCT02641379|1737|P10|Overall Study|Financial problems|0
484|NCT02641379|1738|P9|Overall Study|Financial problems|0
485|NCT02641379|1739|P8|Overall Study|Financial problems|0
486|NCT02641379|1740|P7|Overall Study|Financial problems|0
487|NCT02641379|1741|P6|Overall Study|Financial problems|0
488|NCT02641379|1742|P5|Overall Study|Financial problems|0
489|NCT02641379|1743|P4|Overall Study|Financial problems|0
490|NCT02641379|1744|P3|Overall Study|Financial problems|0
491|NCT02641379|1745|P2|Overall Study|Financial problems|1
492|NCT02641379|1746|P1|Overall Study|Financial problems|0
493|NCT02641379|1736|P11|Overall Study|Therapy stopped due to misunderstanding|0
494|NCT02641379|1737|P10|Overall Study|Therapy stopped due to misunderstanding|0
495|NCT02641379|1738|P9|Overall Study|Therapy stopped due to misunderstanding|0
496|NCT02641379|1739|P8|Overall Study|Therapy stopped due to misunderstanding|0
497|NCT02641379|1740|P7|Overall Study|Therapy stopped due to misunderstanding|0
498|NCT02641379|1741|P6|Overall Study|Therapy stopped due to misunderstanding|0
499|NCT02641379|1742|P5|Overall Study|Therapy stopped due to misunderstanding|0
500|NCT02641379|1743|P4|Overall Study|Therapy stopped due to misunderstanding|0
501|NCT02641379|1744|P3|Overall Study|Therapy stopped due to misunderstanding|0
502|NCT02641379|1745|P2|Overall Study|Therapy stopped due to misunderstanding|0
503|NCT02641379|1746|P1|Overall Study|Therapy stopped due to misunderstanding|1
504|NCT02641379|1736|P11|Overall Study|Participant stopped study/treatment|0
505|NCT02641379|1737|P10|Overall Study|Participant stopped study/treatment|0
506|NCT02641379|1738|P9|Overall Study|Participant stopped study/treatment|1
507|NCT02641379|1739|P8|Overall Study|Participant stopped study/treatment|0
508|NCT02641379|1740|P7|Overall Study|Participant stopped study/treatment|2
509|NCT02641379|1741|P6|Overall Study|Participant stopped study/treatment|1
510|NCT02641379|1742|P5|Overall Study|Participant stopped study/treatment|0
511|NCT02641379|1743|P4|Overall Study|Participant stopped study/treatment|0
512|NCT02641379|1744|P3|Overall Study|Participant stopped study/treatment|1
513|NCT02641379|1745|P2|Overall Study|Participant stopped study/treatment|3
514|NCT02641379|1746|P1|Overall Study|Participant stopped study/treatment|1
515|NCT02641379|1736|P11|Overall Study|Participant showed relapse|0
516|NCT02641379|1737|P10|Overall Study|Participant showed relapse|0
517|NCT02641379|1738|P9|Overall Study|Participant showed relapse|0
518|NCT02641379|1739|P8|Overall Study|Participant showed relapse|0
519|NCT02641379|1740|P7|Overall Study|Participant showed relapse|1
520|NCT02641379|1741|P6|Overall Study|Participant showed relapse|0
521|NCT02641379|1742|P5|Overall Study|Participant showed relapse|0
522|NCT02641379|1743|P4|Overall Study|Participant showed relapse|0
523|NCT02641379|1744|P3|Overall Study|Participant showed relapse|0
524|NCT02641379|1745|P2|Overall Study|Participant showed relapse|0
525|NCT02641379|1746|P1|Overall Study|Participant showed relapse|1
526|NCT02641379|1736|P11|Overall Study|PCR positive at follow up 2|0
527|NCT02641379|1737|P10|Overall Study|PCR positive at follow up 2|0
528|NCT02641379|1738|P9|Overall Study|PCR positive at follow up 2|0
529|NCT02641379|1739|P8|Overall Study|PCR positive at follow up 2|0
530|NCT02641379|1740|P7|Overall Study|PCR positive at follow up 2|0
531|NCT02641379|1741|P6|Overall Study|PCR positive at follow up 2|0
532|NCT02641379|1742|P5|Overall Study|PCR positive at follow up 2|0
533|NCT02641379|1743|P4|Overall Study|PCR positive at follow up 2|0
534|NCT02641379|1744|P3|Overall Study|PCR positive at follow up 2|0
535|NCT02641379|1745|P2|Overall Study|PCR positive at follow up 2|0
536|NCT02641379|1746|P1|Overall Study|PCR positive at follow up 2|1
537|NCT02641379|1736|P11|Overall Study|PCR positive at Week 24|0
538|NCT02641379|1737|P10|Overall Study|PCR positive at Week 24|1
539|NCT02641379|1738|P9|Overall Study|PCR positive at Week 24|0
540|NCT02641379|1739|P8|Overall Study|PCR positive at Week 24|8
541|NCT02641379|1740|P7|Overall Study|PCR positive at Week 24|3
542|NCT02641379|1741|P6|Overall Study|PCR positive at Week 24|6
543|NCT02641379|1742|P5|Overall Study|PCR positive at Week 24|0
544|NCT02641379|1743|P4|Overall Study|PCR positive at Week 24|0
545|NCT02641379|1744|P3|Overall Study|PCR positive at Week 24|62
546|NCT02641379|1745|P2|Overall Study|PCR positive at Week 24|21
547|NCT02641379|1746|P1|Overall Study|PCR positive at Week 24|15
548|NCT02641379|1736|P11|Overall Study|Participant cannot be reached|1
549|NCT02641379|1737|P10|Overall Study|Participant cannot be reached|2
550|NCT02641379|1738|P9|Overall Study|Participant cannot be reached|0
551|NCT02641379|1739|P8|Overall Study|Participant cannot be reached|1
552|NCT02641379|1740|P7|Overall Study|Participant cannot be reached|0
553|NCT02641379|1741|P6|Overall Study|Participant cannot be reached|1
554|NCT02641379|1742|P5|Overall Study|Participant cannot be reached|2
555|NCT02641379|1743|P4|Overall Study|Participant cannot be reached|8
556|NCT02641379|1744|P3|Overall Study|Participant cannot be reached|0
557|NCT02641379|1745|P2|Overall Study|Participant cannot be reached|4
558|NCT02641379|1746|P1|Overall Study|Participant cannot be reached|4
559|NCT02641379|1736|P11|Overall Study|Participant’s compliance|1
560|NCT02641379|1737|P10|Overall Study|Participant’s compliance|1
561|NCT02641379|1738|P9|Overall Study|Participant’s compliance|1
562|NCT02641379|1739|P8|Overall Study|Participant’s compliance|0
563|NCT02641379|1740|P7|Overall Study|Participant’s compliance|0
564|NCT02641379|1741|P6|Overall Study|Participant’s compliance|2
565|NCT02641379|1742|P5|Overall Study|Participant’s compliance|0
566|NCT02641379|1743|P4|Overall Study|Participant’s compliance|1
567|NCT02641379|1744|P3|Overall Study|Participant’s compliance|0
568|NCT02641379|1745|P2|Overall Study|Participant’s compliance|1
569|NCT02641379|1746|P1|Overall Study|Participant’s compliance|0
570|NCT02641379|1736|P11|Overall Study|Participant unable to attend study visit|0
571|NCT02641379|1737|P10|Overall Study|Participant unable to attend study visit|2
572|NCT02641379|1738|P9|Overall Study|Participant unable to attend study visit|0
573|NCT02641379|1739|P8|Overall Study|Participant unable to attend study visit|1
574|NCT02641379|1740|P7|Overall Study|Participant unable to attend study visit|1
575|NCT02641379|1741|P6|Overall Study|Participant unable to attend study visit|1
576|NCT02641379|1742|P5|Overall Study|Participant unable to attend study visit|5
577|NCT02641379|1743|P4|Overall Study|Participant unable to attend study visit|2
578|NCT02641379|1744|P3|Overall Study|Participant unable to attend study visit|1
579|NCT02641379|1745|P2|Overall Study|Participant unable to attend study visit|10
580|NCT02641379|1746|P1|Overall Study|Participant unable to attend study visit|4
581|NCT02641379|1736|P11|Overall Study|Lack of Efficacy|0
582|NCT02641379|1737|P10|Overall Study|Lack of Efficacy|0
583|NCT02641379|1738|P9|Overall Study|Lack of Efficacy|0
584|NCT02641379|1739|P8|Overall Study|Lack of Efficacy|5
585|NCT02641379|1740|P7|Overall Study|Lack of Efficacy|0
586|NCT02641379|1741|P6|Overall Study|Lack of Efficacy|2
587|NCT02641379|1742|P5|Overall Study|Lack of Efficacy|0
588|NCT02641379|1743|P4|Overall Study|Lack of Efficacy|0
589|NCT02641379|1744|P3|Overall Study|Lack of Efficacy|2
590|NCT02641379|1745|P2|Overall Study|Lack of Efficacy|0
591|NCT02641379|1746|P1|Overall Study|Lack of Efficacy|0
592|NCT02641379|1736|P11|Overall Study|Adverse Event|5
593|NCT02641379|1737|P10|Overall Study|Adverse Event|1
594|NCT02641379|1738|P9|Overall Study|Adverse Event|1
595|NCT02641379|1739|P8|Overall Study|Adverse Event|0
596|NCT02641379|1740|P7|Overall Study|Adverse Event|5
597|NCT02641379|1741|P6|Overall Study|Adverse Event|1
598|NCT02641379|1742|P5|Overall Study|Adverse Event|5
599|NCT02641379|1743|P4|Overall Study|Adverse Event|2
600|NCT02641379|1744|P3|Overall Study|Adverse Event|2
601|NCT02641379|1745|P2|Overall Study|Adverse Event|8
602|NCT02641379|1746|P1|Overall Study|Adverse Event|7
603|NCT02641379|1736|P11|Overall Study|Withdrawal of informed consent|0
604|NCT02641379|1737|P10|Overall Study|Withdrawal of informed consent|0
605|NCT02641379|1738|P9|Overall Study|Withdrawal of informed consent|0
606|NCT02641379|1739|P8|Overall Study|Withdrawal of informed consent|1
607|NCT02641379|1740|P7|Overall Study|Withdrawal of informed consent|0
608|NCT02641379|1741|P6|Overall Study|Withdrawal of informed consent|0
609|NCT02641379|1742|P5|Overall Study|Withdrawal of informed consent|0
610|NCT02641379|1743|P4|Overall Study|Withdrawal of informed consent|0
611|NCT02641379|1744|P3|Overall Study|Withdrawal of informed consent|0
612|NCT02641379|1745|P2|Overall Study|Withdrawal of informed consent|1
613|NCT02641379|1746|P1|Overall Study|Withdrawal of informed consent|0
614|NCT02641379|1736|P11|Overall Study|Exclusion criterion during screening|0
615|NCT02641379|1737|P10|Overall Study|Exclusion criterion during screening|0
616|NCT02641379|1738|P9|Overall Study|Exclusion criterion during screening|0
617|NCT02641379|1739|P8|Overall Study|Exclusion criterion during screening|0
618|NCT02641379|1740|P7|Overall Study|Exclusion criterion during screening|0
619|NCT02641379|1741|P6|Overall Study|Exclusion criterion during screening|0
620|NCT02641379|1742|P5|Overall Study|Exclusion criterion during screening|2
621|NCT02641379|1743|P4|Overall Study|Exclusion criterion during screening|1
622|NCT02641379|1744|P3|Overall Study|Exclusion criterion during screening|0
623|NCT02641379|1745|P2|Overall Study|Exclusion criterion during screening|0
624|NCT02641379|1746|P1|Overall Study|Exclusion criterion during screening|1
625|NCT02633787|1833|P1|Overall Study|Withdrawal by Subject|1
626|NCT02630563|1839|P1|Overall Study|Administrative|1
627|NCT02628418|1850|P2|Overall Study|Lost to Follow-up|2
628|NCT02628418|1851|P1|Overall Study|Lost to Follow-up|1
629|NCT02628938|1875|P3|Overall Study|Failure to comply with the instructions|3
630|NCT02628938|1876|P2|Overall Study|Failure to comply with the instructions|0
631|NCT02628938|1877|P1|Overall Study|Failure to comply with the instructions|3
632|NCT02628938|1875|P3|Overall Study|Did not attend the follow up recall|1
633|NCT02628938|1876|P2|Overall Study|Did not attend the follow up recall|2
634|NCT02628938|1877|P1|Overall Study|Did not attend the follow up recall|2
635|NCT02627144|1895|P1|Overall Study|Unspecified|17
636|NCT02627144|1895|P1|Overall Study|Enrolled, not treated|6
637|NCT02627144|1895|P1|Overall Study|Lost to Follow-up|8
638|NCT02627144|1895|P1|Overall Study|Administrative reasons|65
639|NCT02627144|1895|P1|Overall Study|Refusal of treatment / poor cooperation|38
640|NCT02627144|1895|P1|Overall Study|Death from other cause|8
641|NCT02627144|1895|P1|Overall Study|Death from cancer|20
642|NCT02627144|1895|P1|Overall Study|Cancer progression|171
643|NCT02627144|1895|P1|Overall Study|Serious adverse event|32
644|NCT02621034|1919|P3|Overall Study|Lost to Follow-up|5
645|NCT02621034|1920|P2|Overall Study|Lost to Follow-up|2
646|NCT02621034|1921|P1|Overall Study|Lost to Follow-up|3
647|NCT02612077|2101|P1|Overall Study|Unknown reason|2
648|NCT02612077|2101|P1|Overall Study|Disease Progression|3
649|NCT02612077|2101|P1|Overall Study|Enrollment in a Clinical Trial|1
650|NCT02612077|2101|P1|Overall Study|Moved or Changed Medical Team|23
651|NCT02612077|2101|P1|Overall Study|Death|377
652|NCT02612077|2101|P1|Overall Study|Lost to Follow-up|20
653|NCT02612077|2101|P1|Overall Study|Protocol Violation|28
654|NCT02612077|2101|P1|Overall Study|Withdrawal by Subject|9
655|NCT02612077|2101|P1|Overall Study|Adverse Event|3
656|NCT02609178|2129|P6|First Crown|Withdrawal by Subject|0
657|NCT02609178|2130|P5|First Crown|Withdrawal by Subject|0
658|NCT02609178|2131|P4|First Crown|Withdrawal by Subject|1
659|NCT02609178|2132|P3|First Crown|Withdrawal by Subject|1
660|NCT02609178|2133|P2|First Crown|Withdrawal by Subject|0
661|NCT02609178|2134|P1|First Crown|Withdrawal by Subject|0
662|NCT02598934|2198|P2|Overall Study|Protocol Violation|2
663|NCT02598934|2199|P1|Overall Study|Protocol Violation|1
664|NCT02598934|2198|P2|Overall Study|Administrative|1
665|NCT02598934|2199|P1|Overall Study|Administrative|2
666|NCT02598934|2198|P2|Overall Study|Withdrawal by Subject|3
667|NCT02598934|2199|P1|Overall Study|Withdrawal by Subject|2
668|NCT02598934|2198|P2|Overall Study|Failure to Return|3
669|NCT02598934|2199|P1|Overall Study|Failure to Return|3
670|NCT02598934|2198|P2|Overall Study|Adverse Event|13
671|NCT02598934|2199|P1|Overall Study|Adverse Event|11
672|NCT02598622|2211|P2|Overall Study|Physician Decision|0
673|NCT02598622|2212|P1|Overall Study|Physician Decision|3
674|NCT02598622|2211|P2|Overall Study|Withdrawal by Subject|0
675|NCT02598622|2212|P1|Overall Study|Withdrawal by Subject|3
676|NCT02598128|2218|P4|Period A: Days -7 to -1|Adverse Event|0
677|NCT02598128|2219|P3|Period A: Days -7 to -1|Adverse Event|0
678|NCT02598128|2220|P2|Period A: Days -7 to -1|Adverse Event|0
679|NCT02598128|2221|P1|Period A: Days -7 to -1|Adverse Event|1
680|NCT02597855|2235|P2|Overall Study|Lost to Follow-up|1
681|NCT02597855|2236|P1|Overall Study|Lost to Follow-up|2
682|NCT02596958|2263|P1|Overall Study|Excluded Due to Second Line Treatment|9
683|NCT02596958|2263|P1|Overall Study|Missing|32
684|NCT02596958|2263|P1|Overall Study|Lost to Follow-up|33
685|NCT02596958|2263|P1|Overall Study|Administrative Reasons/Other|231
686|NCT02596958|2263|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
687|NCT02596958|2263|P1|Overall Study|Death From Other Cause|33
688|NCT02596958|2263|P1|Overall Study|Death From Cancer|112
689|NCT02596958|2263|P1|Overall Study|Cancer Progression|441
690|NCT02596958|2263|P1|Overall Study|Serious Adverse Drug Reactions|44
691|NCT02596945|2275|P1|Overall Study|Missing|1
692|NCT02596945|2275|P1|Overall Study|Withdrawal by Subject|1
693|NCT02596945|2275|P1|Overall Study|Other Erythropoietin stimulating agent|4
694|NCT02596945|2275|P1|Overall Study|Change to hemodialysis|15
695|NCT02596945|2275|P1|Overall Study|Unspecified|32
696|NCT02596945|2275|P1|Overall Study|No documentation of study drug dosing|3
697|NCT02596620|2283|P2|Overall Study|Lost to Follow-up|1
698|NCT02596620|2284|P1|Overall Study|Lost to Follow-up|1
699|NCT02595502|2290|P2|Period 3|Received Incorrect Treatment at period 3|1
700|NCT02595502|2291|P1|Period 3|Received Incorrect Treatment at period 3|0
701|NCT02595502|2290|P2|Period 3|Lost to Follow-up|0
702|NCT02595502|2291|P1|Period 3|Lost to Follow-up|1
703|NCT02595502|2290|P2|Period 3|Protocol Violation|1
704|NCT02595502|2291|P1|Period 3|Protocol Violation|0
705|NCT02595502|2290|P2|Period 2|Received incorrect lens at Period 1|1
706|NCT02595502|2291|P1|Period 2|Received incorrect lens at Period 1|0
707|NCT02595502|2290|P2|Period 2|Adverse Event|1
708|NCT02595502|2291|P1|Period 2|Adverse Event|1
709|NCT02595502|2290|P2|Period 1|Lost to Follow-up|1
710|NCT02595502|2291|P1|Period 1|Lost to Follow-up|0
711|NCT02595502|2290|P2|Period 1|Withdrawal by Subject|0
712|NCT02595502|2291|P1|Period 1|Withdrawal by Subject|1
713|NCT02595502|2290|P2|Period 1|Adverse Event|1
714|NCT02595502|2291|P1|Period 1|Adverse Event|0
715|NCT02595450|2297|P1|Overall Study|Enrolled, but not treated|8
716|NCT02595450|2297|P1|Overall Study|Unspecified (only completed 1 cycle)|73
717|NCT02591238|2316|P4|Overall Study|personal circumstances|0
718|NCT02591238|2317|P3|Overall Study|personal circumstances|0
719|NCT02591238|2318|P2|Overall Study|personal circumstances|1
720|NCT02591238|2319|P1|Overall Study|personal circumstances|0
721|NCT02591238|2316|P4|Overall Study|personal circumstances|1
722|NCT02591238|2317|P3|Overall Study|personal circumstances|0
723|NCT02591238|2318|P2|Overall Study|personal circumstances|0
724|NCT02591238|2319|P1|Overall Study|personal circumstances|0
725|NCT02591238|2316|P4|Overall Study|influenza|1
726|NCT02591238|2317|P3|Overall Study|influenza|0
727|NCT02591238|2318|P2|Overall Study|influenza|0
728|NCT02591238|2319|P1|Overall Study|influenza|0
729|NCT02591238|2316|P4|Overall Study|Withdrawal by Subject|1
730|NCT02591238|2317|P3|Overall Study|Withdrawal by Subject|0
731|NCT02591238|2318|P2|Overall Study|Withdrawal by Subject|0
732|NCT02591238|2319|P1|Overall Study|Withdrawal by Subject|0
733|NCT02591238|2316|P4|Overall Study|Pregnancy|0
734|NCT02591238|2317|P3|Overall Study|Pregnancy|0
735|NCT02591238|2318|P2|Overall Study|Pregnancy|0
736|NCT02591238|2319|P1|Overall Study|Pregnancy|1
737|NCT02590562|2353|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
738|NCT02587819|2415|P1|Overall Study|Lost to Follow-up|1
739|NCT02587819|2415|P1|Overall Study|Adverse Event|1
740|NCT02586506|2433|P1|Overall Study|Other Reason|2
741|NCT02586506|2433|P1|Overall Study|Lost to Follow-up|1
742|NCT02586506|2433|P1|Overall Study|Protocol Violation|6
743|NCT02586493|2439|P1|Overall Study|Withdrawal by Subject|1
744|NCT02586493|2439|P1|Overall Study|Lost to Follow-up|1
745|NCT02586493|2439|P1|Overall Study|Protocol Violation|6
746|NCT02586493|2439|P1|Overall Study|Adverse Event|4
747|NCT02582983|2474|P1|Overall Study|Adverse Event|1
748|NCT02582983|2474|P1|Overall Study|Withdrawal by Subject|2
749|NCT02582983|2474|P1|Overall Study|Death|3
750|NCT02578992|2518|P2|Overall Study|equipment not available or malfunction|3
751|NCT02578992|2519|P1|Overall Study|equipment not available or malfunction|3
752|NCT02577315|2533|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
753|NCT02577315|2534|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
754|NCT02576535|2550|P1|Overall Study|Withdrawal by Subject|2
755|NCT02576145|2561|P2|Overall Study|Tetanus Titers Decreased|1
756|NCT02576145|2562|P1|Overall Study|Tetanus Titers Decreased|0
757|NCT02576145|2561|P2|Overall Study|Acute rejection|0
758|NCT02576145|2562|P1|Overall Study|Acute rejection|1
759|NCT02576145|2561|P2|Overall Study|Withdrawal by Subject|0
760|NCT02576145|2562|P1|Overall Study|Withdrawal by Subject|1
761|NCT02576145|2561|P2|Overall Study|Adverse Event|0
762|NCT02576145|2562|P1|Overall Study|Adverse Event|1
763|NCT02574845|2610|P6|Overall Study|Adverse Event|1
764|NCT02574845|2611|P5|Overall Study|Adverse Event|0
765|NCT02574845|2612|P4|Overall Study|Adverse Event|0
766|NCT02574845|2613|P3|Overall Study|Adverse Event|0
767|NCT02574845|2614|P2|Overall Study|Adverse Event|1
768|NCT02574845|2615|P1|Overall Study|Adverse Event|0
769|NCT02574845|2610|P6|Overall Study|Consent withdrawn further participation|0
770|NCT02574845|2611|P5|Overall Study|Consent withdrawn further participation|1
771|NCT02574845|2612|P4|Overall Study|Consent withdrawn further participation|0
772|NCT02574845|2613|P3|Overall Study|Consent withdrawn further participation|0
773|NCT02574845|2614|P2|Overall Study|Consent withdrawn further participation|0
774|NCT02574845|2615|P1|Overall Study|Consent withdrawn further participation|0
775|NCT02574260|2641|P1|Overall Study|Disease Progression|1
776|NCT02569996|2756|P1|Overall Study|Unknown reason|1
777|NCT02569996|2756|P1|Overall Study|Complete remission|7
778|NCT02569996|2756|P1|Overall Study|Lost to Follow-up|5
779|NCT02569996|2756|P1|Overall Study|Withdrawal by Subject|5
780|NCT02569996|2756|P1|Overall Study|Non-compliance|9
781|NCT02569996|2756|P1|Overall Study|New anti-lymphoma treatment|1
782|NCT02569996|2756|P1|Overall Study|Progression of the disease|18
783|NCT02569996|2756|P1|Overall Study|Physician Decision|3
784|NCT02569996|2756|P1|Overall Study|Adverse Event|6
785|NCT02567188|2809|P1|Overall Study|Protocol Violation|5
786|NCT02567188|2809|P1|Overall Study|Started Hemodialysis|2
787|NCT02567188|2809|P1|Overall Study|Moved and Changed Clinic|1
788|NCT02567188|2809|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
789|NCT02567188|2809|P1|Overall Study|Withdrawal by Subject|1
790|NCT02567188|2809|P1|Overall Study|Adverse Event|1
791|NCT02567188|2809|P1|Overall Study|Lost to Follow-up|5
792|NCT02567188|2809|P1|Overall Study|Terminated Mircera Treatment|9
793|NCT02567188|2809|P1|Overall Study|Death|10
794|NCT02561572|2892|P2|Overall Study|Protocol Violation|1
795|NCT02561572|2893|P1|Overall Study|Protocol Violation|0
796|NCT02561572|2892|P2|Overall Study|Inadequate time before surgery|1
797|NCT02561572|2893|P1|Overall Study|Inadequate time before surgery|2
798|NCT02557646|2909|P1|Overall Study|Unspecified|14
799|NCT02557646|2909|P1|Overall Study|Lost to Follow-up|17
800|NCT02557646|2909|P1|Overall Study|Withdrawal by Subject|18
801|NCT02557646|2909|P1|Overall Study|Lack of Efficacy|186
802|NCT02557646|2909|P1|Overall Study|Death|1
803|NCT02557646|2909|P1|Overall Study|Adverse Event|40
804|NCT02556307|2927|P1|Overall Study|Enrolled but not treated|2
805|NCT02556307|2927|P1|Overall Study|Change to triple therapy|4
806|NCT02556307|2927|P1|Overall Study|Lost to Follow-up|36
807|NCT02556307|2927|P1|Overall Study|Premature treatment interruption|11
808|NCT02555618|2939|P2|Overall Study|Sponsor's Circumstances|0
809|NCT02555618|2940|P1|Overall Study|Sponsor's Circumstances|1
810|NCT02553629|2999|P2|Overall Study|Logistic reasons|6
811|NCT02553629|3000|P1|Overall Study|Logistic reasons|3
812|NCT02553421|3016|P2|Overall Study|Improper Device Placement|0
813|NCT02553421|3017|P1|Overall Study|Improper Device Placement|3
814|NCT02553421|3016|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
815|NCT02553421|3017|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
816|NCT02553421|3016|P2|Overall Study|Lost to Follow-up|1
817|NCT02553421|3017|P1|Overall Study|Lost to Follow-up|21
818|NCT02549027|3112|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
819|NCT02549027|3113|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
820|NCT02549027|3114|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
821|NCT02549027|3115|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
822|NCT02549027|3116|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
823|NCT02549027|3117|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
824|NCT02549027|3112|P6|Washout After Period 4|Withdrawal by Subject|0
825|NCT02549027|3113|P5|Washout After Period 4|Withdrawal by Subject|0
826|NCT02549027|3114|P4|Washout After Period 4|Withdrawal by Subject|1
827|NCT02549027|3115|P3|Washout After Period 4|Withdrawal by Subject|1
828|NCT02549027|3116|P2|Washout After Period 4|Withdrawal by Subject|1
829|NCT02549027|3117|P1|Washout After Period 4|Withdrawal by Subject|0
830|NCT02548156|3245|P6|Washout Period 1|Lost to Follow-up|0
831|NCT02548156|3246|P5|Washout Period 1|Lost to Follow-up|1
832|NCT02548156|3247|P4|Washout Period 1|Lost to Follow-up|0
833|NCT02548156|3248|P3|Washout Period 1|Lost to Follow-up|0
834|NCT02548156|3249|P2|Washout Period 1|Lost to Follow-up|0
835|NCT02548156|3250|P1|Washout Period 1|Lost to Follow-up|0
836|NCT02547454|3267|P1|Overall Study|No data|11
837|NCT02547454|3267|P1|Overall Study|Unspecified|39
838|NCT02547454|3267|P1|Overall Study|Lost to Follow-up|26
839|NCT02547454|3267|P1|Overall Study|Death|38
840|NCT02547454|3267|P1|Overall Study|Due to no further need to treat|4
841|NCT02547454|3267|P1|Overall Study|Due to transplantation|1
842|NCT02547454|3267|P1|Overall Study|Due to hemodialysis|53
843|NCT02543918|3297|P2|Overall Study|Adverse Event|1
844|NCT02543918|3298|P1|Overall Study|Adverse Event|1
845|NCT02543918|3297|P2|Overall Study|Withdrawal by Subject|1
846|NCT02543918|3298|P1|Overall Study|Withdrawal by Subject|1
847|NCT02543918|3297|P2|Overall Study|Lost to Follow-up|1
848|NCT02543918|3298|P1|Overall Study|Lost to Follow-up|1
849|NCT02543918|3297|P2|Overall Study|Never treated|1
850|NCT02543918|3298|P1|Overall Study|Never treated|0
851|NCT02540850|3323|P3|Overall Study|Lost to Follow-up|34
852|NCT02540850|3324|P2|Overall Study|Lost to Follow-up|66
853|NCT02540850|3325|P1|Overall Study|Lost to Follow-up|69
854|NCT02540213|3383|P1|Overall Study|Enrolled but not treated|2
855|NCT02540213|3383|P1|Overall Study|Consent withdrawn|7
856|NCT02540213|3383|P1|Overall Study|Lack of Efficacy|6
857|NCT02540213|3383|P1|Overall Study|Kidney transplant|3
858|NCT02540213|3383|P1|Overall Study|Administrative reasons|3
859|NCT02540213|3383|P1|Overall Study|Death/adverse event|18
860|NCT02538107|3452|P1|Overall Study|Not recorded|7
861|NCT02538107|3452|P1|Overall Study|Unspecified|7
862|NCT02538107|3452|P1|Overall Study|Surgery|1
863|NCT02538107|3452|P1|Overall Study|Adverse Event|4
864|NCT02538107|3452|P1|Overall Study|Administrative reason|5
865|NCT02538107|3452|P1|Overall Study|Death|4
866|NCT02538107|3452|P1|Overall Study|Withdrawal by Subject|17
867|NCT02538107|3452|P1|Overall Study|No further treatment necessary|18
868|NCT02538107|3452|P1|Overall Study|Administration of other ESA|11
869|NCT02538107|3452|P1|Overall Study|Necessity of dialysis|20
870|NCT02538107|3452|P1|Overall Study|Missing|5
871|NCT02538107|3452|P1|Overall Study|Did not receive any Mircera dose|11
872|NCT02537522|3485|P4|Phase II - Period 1 Bilateral|Adverse Event|1
873|NCT02537522|3486|P3|Phase II - Period 1 Bilateral|Adverse Event|0
874|NCT02537522|3487|P2|Phase II - Period 1 Bilateral|Adverse Event|0
875|NCT02537522|3488|P1|Phase II - Period 1 Bilateral|Adverse Event|0
876|NCT02537522|3485|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
877|NCT02537522|3486|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
878|NCT02537522|3487|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
879|NCT02537522|3488|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
880|NCT02537522|3485|P4|Phase I - Contralateral|incorrect randomization|0
881|NCT02537522|3486|P3|Phase I - Contralateral|incorrect randomization|0
882|NCT02537522|3487|P2|Phase I - Contralateral|incorrect randomization|1
883|NCT02537522|3488|P1|Phase I - Contralateral|incorrect randomization|0
884|NCT02537522|3485|P4|Phase I - Contralateral|Withdrawal by Subject|0
885|NCT02537522|3486|P3|Phase I - Contralateral|Withdrawal by Subject|0
886|NCT02537522|3487|P2|Phase I - Contralateral|Withdrawal by Subject|1
887|NCT02537522|3488|P1|Phase I - Contralateral|Withdrawal by Subject|0
888|NCT02537522|3485|P4|Phase I - Contralateral|Subject no longer eligible|0
889|NCT02537522|3486|P3|Phase I - Contralateral|Subject no longer eligible|0
890|NCT02537522|3487|P2|Phase I - Contralateral|Subject no longer eligible|7
891|NCT02537522|3488|P1|Phase I - Contralateral|Subject no longer eligible|15
892|NCT02536664|3498|P2|Overall Study|Missing|20
893|NCT02536664|3499|P1|Overall Study|Missing|53
894|NCT02536664|3498|P2|Overall Study|Unspecified|24
895|NCT02536664|3499|P1|Overall Study|Unspecified|18
896|NCT02536664|3498|P2|Overall Study|Withdrawal by Subject|5
897|NCT02536664|3499|P1|Overall Study|Withdrawal by Subject|8
898|NCT02536664|3498|P2|Overall Study|Intolerability|6
899|NCT02536664|3499|P1|Overall Study|Intolerability|8
900|NCT02536664|3498|P2|Overall Study|Death due to other reason|2
901|NCT02536664|3499|P1|Overall Study|Death due to other reason|3
902|NCT02536664|3498|P2|Overall Study|Death due to lymphoma|1
903|NCT02536664|3499|P1|Overall Study|Death due to lymphoma|2
904|NCT02536664|3498|P2|Overall Study|Progression|18
905|NCT02536664|3499|P1|Overall Study|Progression|13
906|NCT02536664|3498|P2|Overall Study|Inadequate completion of documentation|4
907|NCT02536664|3499|P1|Overall Study|Inadequate completion of documentation|2
908|NCT02535741|3517|P1|Overall Study|Missing data|6
909|NCT02535741|3517|P1|Overall Study|Exclusion criteria: Bilateral implant|4
910|NCT02535741|3517|P1|Overall Study|Lost to Follow-up|10
911|NCT02535741|3517|P1|Overall Study|Withdrawal by Subject|9
912|NCT02535741|3517|P1|Overall Study|Adverse Event|3
913|NCT02534324|3523|P2|Overall Study|Adverse Event|0
914|NCT02534324|3524|P1|Overall Study|Adverse Event|1
915|NCT02534324|3523|P2|Overall Study|Lost to Follow-up|7
916|NCT02534324|3524|P1|Overall Study|Lost to Follow-up|20
917|NCT02534324|3523|P2|Overall Study|Protocol Violation|1
918|NCT02534324|3524|P1|Overall Study|Protocol Violation|4
919|NCT02533401|3534|P1|Overall Study|Violation of Selection Criteria|1
920|NCT02533401|3534|P1|Overall Study|Lost to Follow-up|1
921|NCT02533401|3534|P1|Overall Study|Insufficient Response/Progressed Disease|1
922|NCT02533401|3534|P1|Overall Study|Death|5
923|NCT02533401|3534|P1|Overall Study|Adverse Event/Intercurrent Disease|3
924|NCT02531646|3545|P3|Overall Study|equip. image processing issue|0
925|NCT02531646|3546|P2|Overall Study|equip. image processing issue|1
926|NCT02531646|3547|P1|Overall Study|equip. image processing issue|5
927|NCT02530671|3567|P2|Overall Study|Withdrawal by Subject|0
928|NCT02530671|3568|P1|Overall Study|Withdrawal by Subject|1
929|NCT02530671|3567|P2|Overall Study|Lost to Follow-up|0
930|NCT02530671|3568|P1|Overall Study|Lost to Follow-up|2
931|NCT02528331|3593|P1|Overall Study|Withdrawal by Subject|2
932|NCT02527161|3611|P1|Overall Study|Consent violation|4
933|NCT02527161|3611|P1|Overall Study|MRI contraindication|2
934|NCT02527161|3611|P1|Overall Study|Delay in or unfit for surgery|5
935|NCT02527161|3611|P1|Overall Study|Exclusion RA diagnosis|1
936|NCT02527161|3611|P1|Overall Study|Exclusion for excessive deformity|1
937|NCT02527161|3611|P1|Overall Study|Exclusion for BMI|2
938|NCT02527161|3611|P1|Overall Study|Shape Match not used in surgery|2
939|NCT02527161|3611|P1|Overall Study|Withdrawal by Subject|6
940|NCT02527161|3611|P1|Overall Study|Failed MRI|39
941|NCT02527148|3630|P2|Overall Study|Did not receive study intervention|0
942|NCT02527148|3631|P1|Overall Study|Did not receive study intervention|1
943|NCT02526550|3649|P1|Overall Study|Lost to Follow-up|1
944|NCT02522624|3733|P2|Overall Study|Technical failure|0
945|NCT02522624|3734|P1|Overall Study|Technical failure|1
946|NCT02519855|3752|P2|Overall Study|Lost to Follow-up|3
947|NCT02519855|3753|P1|Overall Study|Lost to Follow-up|3
948|NCT02519855|3752|P2|Overall Study|Adverse Event|1
949|NCT02519855|3753|P1|Overall Study|Adverse Event|0
950|NCT02519595|3772|P3|Overall Study|Protocol Violation|16
951|NCT02519595|3773|P2|Overall Study|Protocol Violation|22
952|NCT02519595|3774|P1|Overall Study|Protocol Violation|8
953|NCT02516163|3805|P1|Overall Study|MRI contraindication exclusion|6
954|NCT02516163|3805|P1|Overall Study|Data not recorded|2
955|NCT02516163|3805|P1|Overall Study|Use of incorrect measurement technique|5
956|NCT02516163|3805|P1|Overall Study|Unfit/delay in surgery|3
957|NCT02516163|3805|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
958|NCT02516163|3805|P1|Overall Study|Withdrawal by Subject|1
959|NCT02516098|3811|P2|Period 2|Withdrawal by Subject|1
960|NCT02516098|3812|P1|Period 2|Withdrawal by Subject|0
961|NCT02516098|3811|P2|Washout After Period 1|Adverse Event|1
962|NCT02516098|3812|P1|Washout After Period 1|Adverse Event|0
963|NCT02516098|3811|P2|Period 1|Protocol Violation|0
964|NCT02516098|3812|P1|Period 1|Protocol Violation|1
965|NCT02515994|3826|P2|Overall Study|Withdrawal by Subject|0
966|NCT02515994|3827|P1|Overall Study|Withdrawal by Subject|2
967|NCT02515994|3826|P2|Overall Study|Adverse Event|1
968|NCT02515994|3827|P1|Overall Study|Adverse Event|3
969|NCT02515994|3826|P2|Overall Study|No Longer Meets Eligibility Criteria|1
970|NCT02515994|3827|P1|Overall Study|No Longer Meets Eligibility Criteria|2
971|NCT02515994|3826|P2|Overall Study|Protocol Violation|5
972|NCT02515994|3827|P1|Overall Study|Protocol Violation|3
973|NCT02515279|3839|P1|Overall Study|Unspecified|22
974|NCT02515279|3839|P1|Overall Study|End-of-treatment visit not attended|17
975|NCT02515279|3839|P1|Overall Study|Withdrawal by Subject|18
976|NCT02515279|3839|P1|Overall Study|Lost to Follow-up|9
977|NCT02515279|3839|P1|Overall Study|Lack of Efficacy|31
978|NCT02515279|3839|P1|Overall Study|Adverse Event|7
979|NCT02510820|3884|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
980|NCT02510820|3885|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
981|NCT02510820|3884|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
982|NCT02510820|3885|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
983|NCT02507752|3923|P1|Overall Study|Participant didn't perform visit Week 24|1
984|NCT02507752|3923|P1|Overall Study|Participant didn't perform visit Week 12|1
985|NCT02507752|3923|P1|Overall Study|Infusion reaction at first infusion|1
986|NCT02507752|3923|P1|Overall Study|Lost to Follow-up|7
987|NCT02507752|3923|P1|Overall Study|Protocol Violation|6
988|NCT02507752|3923|P1|Overall Study|Adverse Event|1
989|NCT02507375|3943|P2|Overall Study|Adverse Event|1
990|NCT02507375|3944|P1|Overall Study|Adverse Event|0
991|NCT02507375|3943|P2|Overall Study|Refused treatment|1
992|NCT02507375|3944|P1|Overall Study|Refused treatment|0
993|NCT02507375|3943|P2|Overall Study|Death|1
994|NCT02507375|3944|P1|Overall Study|Death|0
995|NCT02507375|3943|P2|Overall Study|Progressive Disease|5
996|NCT02507375|3944|P1|Overall Study|Progressive Disease|4
997|NCT02506881|3965|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
998|NCT02506881|3966|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
999|NCT02506881|3967|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
1000|NCT02506881|3968|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
1001|NCT02506881|3965|P4|First Intervention (Day 1)|Withdrawal by Subject|0
1002|NCT02506881|3966|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1003|NCT02506881|3967|P2|First Intervention (Day 1)|Withdrawal by Subject|0
1004|NCT02506881|3968|P1|First Intervention (Day 1)|Withdrawal by Subject|1
1005|NCT02506881|3965|P4|First Intervention (Day 1)|Protocol Violation|0
1006|NCT02506881|3966|P3|First Intervention (Day 1)|Protocol Violation|1
1007|NCT02506881|3967|P2|First Intervention (Day 1)|Protocol Violation|0
1008|NCT02506881|3968|P1|First Intervention (Day 1)|Protocol Violation|0
1009|NCT02506257|4006|P4|Overall Study|Protocol Violation|0
1010|NCT02506257|4007|P3|Overall Study|Protocol Violation|1
1011|NCT02506257|4008|P2|Overall Study|Protocol Violation|0
1012|NCT02506257|4009|P1|Overall Study|Protocol Violation|0
1013|NCT02506257|4006|P4|Overall Study|Adverse Event|0
1014|NCT02506257|4007|P3|Overall Study|Adverse Event|3
1015|NCT02506257|4008|P2|Overall Study|Adverse Event|2
1016|NCT02506257|4009|P1|Overall Study|Adverse Event|0
1017|NCT02504320|4056|P4|Treatment Period 3|Adverse Event|0
1018|NCT02504320|4057|P3|Treatment Period 3|Adverse Event|1
1019|NCT02504320|4058|P2|Treatment Period 3|Adverse Event|0
1020|NCT02504320|4059|P1|Treatment Period 3|Adverse Event|0
1021|NCT02504320|4056|P4|Treatment Period 3|Positive Drug Screen|1
1022|NCT02504320|4057|P3|Treatment Period 3|Positive Drug Screen|0
1023|NCT02504320|4058|P2|Treatment Period 3|Positive Drug Screen|0
1024|NCT02504320|4059|P1|Treatment Period 3|Positive Drug Screen|0
1025|NCT02504320|4056|P4|Treatment Period 2|Positive Drug Screen|0
1026|NCT02504320|4057|P3|Treatment Period 2|Positive Drug Screen|0
1027|NCT02504320|4058|P2|Treatment Period 2|Positive Drug Screen|1
1028|NCT02504320|4059|P1|Treatment Period 2|Positive Drug Screen|0
1029|NCT02504320|4056|P4|Treatment Period 1|Positive Drug Screen|0
1030|NCT02504320|4057|P3|Treatment Period 1|Positive Drug Screen|1
1031|NCT02504320|4058|P2|Treatment Period 1|Positive Drug Screen|0
1032|NCT02504320|4059|P1|Treatment Period 1|Positive Drug Screen|0
1033|NCT02503865|4084|P3|Overall Study|Refused treatment|2
1034|NCT02503865|4085|P2|Overall Study|Refused treatment|39
1035|NCT02503865|4086|P1|Overall Study|Refused treatment|4
1036|NCT02503865|4084|P3|Overall Study|Moved out of area|0
1037|NCT02503865|4085|P2|Overall Study|Moved out of area|8
1038|NCT02503865|4086|P1|Overall Study|Moved out of area|1
1039|NCT02503215|4106|P1|Overall Study|Unable to use positive airway pressure|2
1040|NCT02503215|4106|P1|Overall Study|Unable to wear compression stockings|1
1041|NCT02502734|4185|P2|Washout Period|Adverse Event|0
1042|NCT02502734|4186|P1|Washout Period|Adverse Event|1
1043|NCT02502734|4185|P2|Double-blind Treatment Period 1|Adverse Event|0
1044|NCT02502734|4186|P1|Double-blind Treatment Period 1|Adverse Event|1
1045|NCT02498678|4254|P2|Overall Study|interference from the surgical team|2
1046|NCT02498678|4255|P1|Overall Study|interference from the surgical team|0
1047|NCT02496533|4280|P2|Overall Study|Late for radiologic testing|2
1048|NCT02496533|4281|P1|Overall Study|Late for radiologic testing|0
1049|NCT02496533|4280|P2|Overall Study|Patient did not complete all measures|4
1050|NCT02496533|4281|P1|Overall Study|Patient did not complete all measures|0
1051|NCT02496533|4280|P2|Overall Study|Lack of data on outcome|0
1052|NCT02496533|4281|P1|Overall Study|Lack of data on outcome|3
1053|NCT02496221|4293|P2|Treatment Period 2 - 4 Days|Physician Decision|0
1054|NCT02496221|4294|P1|Treatment Period 2 - 4 Days|Physician Decision|1
1055|NCT02496221|4293|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
1056|NCT02496221|4294|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
1057|NCT02496221|4293|P2|Treatment Period 2 - 4 Days|Adverse Event|1
1058|NCT02496221|4294|P1|Treatment Period 2 - 4 Days|Adverse Event|0
1059|NCT02496000|4331|P3|Overall Study|undetermined|0
1060|NCT02496000|4332|P2|Overall Study|undetermined|1
1061|NCT02496000|4333|P1|Overall Study|undetermined|0
1062|NCT02496000|4331|P3|Overall Study|Non-compliance or lack of cooperation|0
1063|NCT02496000|4332|P2|Overall Study|Non-compliance or lack of cooperation|2
1064|NCT02496000|4333|P1|Overall Study|Non-compliance or lack of cooperation|0
1065|NCT02496000|4331|P3|Overall Study|Protocol Violation|1
1066|NCT02496000|4332|P2|Overall Study|Protocol Violation|0
1067|NCT02496000|4333|P1|Overall Study|Protocol Violation|0
1068|NCT02496000|4331|P3|Overall Study|Lost to Follow-up|1
1069|NCT02496000|4332|P2|Overall Study|Lost to Follow-up|0
1070|NCT02496000|4333|P1|Overall Study|Lost to Follow-up|1
1071|NCT02496000|4331|P3|Overall Study|Withdrawal by Subject|0
1072|NCT02496000|4332|P2|Overall Study|Withdrawal by Subject|2
1073|NCT02496000|4333|P1|Overall Study|Withdrawal by Subject|1
1074|NCT02495948|4342|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
1075|NCT02495948|4343|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
1076|NCT02495948|4342|P2|Period 1, First 30 Days of Wear|Adverse Event|1
1077|NCT02495948|4343|P1|Period 1, First 30 Days of Wear|Adverse Event|0
1078|NCT02494596|4365|P3|Overall Study|Refused Treatment|0
1079|NCT02494596|4366|P2|Overall Study|Refused Treatment|1
1080|NCT02494596|4367|P1|Overall Study|Refused Treatment|0
1081|NCT02494596|4365|P3|Overall Study|Adverse Event|0
1082|NCT02494596|4366|P2|Overall Study|Adverse Event|1
1083|NCT02494596|4367|P1|Overall Study|Adverse Event|0
1084|NCT02494596|4365|P3|Overall Study|Insufficient Therapeutic Response|1
1085|NCT02494596|4366|P2|Overall Study|Insufficient Therapeutic Response|3
1086|NCT02494596|4367|P1|Overall Study|Insufficient Therapeutic Response|3
1087|NCT02492165|4420|P4|Overall Study|Withdrawal by Subject|0
1088|NCT02492165|4421|P3|Overall Study|Withdrawal by Subject|0
1089|NCT02492165|4422|P2|Overall Study|Withdrawal by Subject|1
1090|NCT02492165|4423|P1|Overall Study|Withdrawal by Subject|0
1091|NCT02491892|4467|P2|Overall Study|Lost to Follow-up|0
1092|NCT02491892|4468|P1|Overall Study|Lost to Follow-up|1
1093|NCT02491892|4467|P2|Overall Study|Refused Treatment|0
1094|NCT02491892|4468|P1|Overall Study|Refused Treatment|1
1095|NCT02491892|4467|P2|Overall Study|Lack of Efficacy|36
1096|NCT02491892|4468|P1|Overall Study|Lack of Efficacy|37
1097|NCT02491892|4467|P2|Overall Study|Death|1
1098|NCT02491892|4468|P1|Overall Study|Death|1
1099|NCT02491892|4467|P2|Overall Study|Adverse Event|1
1100|NCT02491892|4468|P1|Overall Study|Adverse Event|1
1101|NCT02490475|4527|P4|Period 2: Extension Phase|Adverse Event|0
1102|NCT02490475|4528|P3|Period 2: Extension Phase|Adverse Event|1
1103|NCT02490475|4529|P2|Period 2: Extension Phase|Adverse Event|0
1104|NCT02490475|4530|P1|Period 2: Extension Phase|Adverse Event|0
1105|NCT02490475|4527|P4|Period 2: Extension Phase|Refused Treatment|1
1106|NCT02490475|4528|P3|Period 2: Extension Phase|Refused Treatment|0
1107|NCT02490475|4529|P2|Period 2: Extension Phase|Refused Treatment|0
1108|NCT02490475|4530|P1|Period 2: Extension Phase|Refused Treatment|0
1109|NCT02490475|4527|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
1110|NCT02490475|4528|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
1111|NCT02490475|4529|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
1112|NCT02490475|4530|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
1113|NCT02490475|4527|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
1114|NCT02490475|4528|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
1115|NCT02490475|4529|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
1116|NCT02490475|4530|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
1117|NCT02490475|4527|P4|Period 1: First 6 Cycles|Refused Treatment|0
1118|NCT02490475|4528|P3|Period 1: First 6 Cycles|Refused Treatment|0
1119|NCT02490475|4529|P2|Period 1: First 6 Cycles|Refused Treatment|0
1120|NCT02490475|4530|P1|Period 1: First 6 Cycles|Refused Treatment|1
1121|NCT02490475|4527|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1122|NCT02490475|4528|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1123|NCT02490475|4529|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
1124|NCT02490475|4530|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1125|NCT02490475|4527|P4|Period 1: First 6 Cycles|Adverse Event|1
1126|NCT02490475|4528|P3|Period 1: First 6 Cycles|Adverse Event|0
1127|NCT02490475|4529|P2|Period 1: First 6 Cycles|Adverse Event|1
1128|NCT02490475|4530|P1|Period 1: First 6 Cycles|Adverse Event|2
1129|NCT02486952|4627|P1|Overall Study|Unspecified|2
1130|NCT02486952|4627|P1|Overall Study|Lost to Follow-up|26
1131|NCT02486952|4627|P1|Overall Study|Lack of Efficacy|3
1132|NCT02486952|4627|P1|Overall Study|Death|15
1133|NCT02486952|4627|P1|Overall Study|Adverse Event|1
1134|NCT02486952|4627|P1|Overall Study|Not Started Induction Therapy|3
1135|NCT02485483|4634|P2|Overall Study|Discontinued after baseline|0
1136|NCT02485483|4635|P1|Overall Study|Discontinued after baseline|39
1137|NCT02485483|4634|P2|Overall Study|Depression at baseline|0
1138|NCT02485483|4635|P1|Overall Study|Depression at baseline|15
1139|NCT02485158|4650|P1|Overall Study|expected drug side effect|1
1140|NCT02485158|4650|P1|Overall Study|Withdrawal by Subject|3
1141|NCT02483611|4744|P3|Overall Study|Protocol Violation|1
1142|NCT02483611|4745|P2|Overall Study|Protocol Violation|0
1143|NCT02483611|4746|P1|Overall Study|Protocol Violation|0
1144|NCT02481934|4841|P1|Overall Study|Death|2
1145|NCT02480010|4895|P2|Overall Study|Refused Treatment|3
1146|NCT02480010|4896|P1|Overall Study|Refused Treatment|0
1147|NCT02480010|4895|P2|Overall Study|Insufficient therapeutic response|29
1148|NCT02480010|4896|P1|Overall Study|Insufficient therapeutic response|31
1149|NCT02480010|4895|P2|Overall Study|Death|0
1150|NCT02480010|4896|P1|Overall Study|Death|1
1151|NCT02480010|4895|P2|Overall Study|Adverse Event|1
1152|NCT02480010|4896|P1|Overall Study|Adverse Event|3
1153|NCT02478372|4965|P2|Overall Study|Death|2
1154|NCT02478372|4966|P1|Overall Study|Death|0
1155|NCT02478372|4965|P2|Overall Study|Lost to Follow-up|4
1156|NCT02478372|4966|P1|Overall Study|Lost to Follow-up|1
1157|NCT02478372|4965|P2|Overall Study|Protocol Violation|8
1158|NCT02478372|4966|P1|Overall Study|Protocol Violation|12
1159|NCT02476422|4990|P2|Overall Study|Subject/guardian decision|1
1160|NCT02476422|4991|P1|Overall Study|Subject/guardian decision|0
1161|NCT02475980|5021|P1|Overall Study|Withdrawal by Subject|1
1162|NCT02475980|5021|P1|Overall Study|Lost to Follow-up|4
1163|NCT02475564|5032|P2|Overall Study|Intense Menstrual bleeding|0
1164|NCT02475564|5033|P1|Overall Study|Intense Menstrual bleeding|1
1165|NCT02475564|5032|P2|Overall Study|Lost to Follow-up|1
1166|NCT02475564|5033|P1|Overall Study|Lost to Follow-up|2
1167|NCT02475564|5032|P2|Overall Study|Withdrawal by Subject|0
1168|NCT02475564|5033|P1|Overall Study|Withdrawal by Subject|1
1169|NCT02475278|5043|P1|Overall Study|Reason Not Specified|1
1170|NCT02475278|5043|P1|Overall Study|Lost to Follow-up|1
1171|NCT02473510|5056|P2|Overall Study|Lost to Follow-up|2
1172|NCT02473510|5057|P1|Overall Study|Lost to Follow-up|1
1173|NCT02473367|5071|P1|Period 4|Lost to Follow-up|1
1174|NCT02473367|5071|P1|Wait 1|Withdrawal by Subject|1
1175|NCT02472847|5091|P2|Overall Study|Withdrawal by Subject|5
1176|NCT02472847|5092|P1|Overall Study|Withdrawal by Subject|1
1177|NCT02472756|5098|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
1178|NCT02472756|5098|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
1179|NCT02472756|5098|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
1180|NCT02472756|5098|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
1181|NCT02472756|5098|P1|Induction (Approximately 6 Months)|Adverse Event|1
1182|NCT02472366|5139|P2|Overall Study|Lost to Follow-up|0
1183|NCT02472366|5140|P1|Overall Study|Lost to Follow-up|1
1184|NCT02471755|5156|P2|Overall Study|Lost to Follow-up|1
1185|NCT02471755|5157|P1|Overall Study|Lost to Follow-up|0
1186|NCT02471755|5156|P2|Overall Study|Withdrawal by Subject|0
1187|NCT02471755|5157|P1|Overall Study|Withdrawal by Subject|1
1188|NCT02471612|5173|P1|Overall Study|Lost to Follow-up|2
1189|NCT02469961|5203|P2|Overall Study|Physician Decision|1
1190|NCT02469961|5204|P1|Overall Study|Physician Decision|4
1191|NCT02465489|5269|P1|Overall Study|Adverse Event|5
1192|NCT02463331|5311|P2|Overall Study|Physician Decision|0
1193|NCT02463331|5312|P1|Overall Study|Physician Decision|3
1194|NCT02463331|5311|P2|Overall Study|Lack of Efficacy|0
1195|NCT02463331|5312|P1|Overall Study|Lack of Efficacy|6
1196|NCT02463331|5311|P2|Overall Study|Pregnancy|3
1197|NCT02463331|5312|P1|Overall Study|Pregnancy|2
1198|NCT02463331|5311|P2|Overall Study|Lost to Follow-up|1
1199|NCT02463331|5312|P1|Overall Study|Lost to Follow-up|1
1200|NCT02463331|5311|P2|Overall Study|Adverse Event|2
1201|NCT02463331|5312|P1|Overall Study|Adverse Event|4
1202|NCT02461290|5378|P1|Overall Study|Lost to Follow-up|3
1203|NCT02461290|5378|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
1204|NCT02457247|5431|P4|Period 2|Voluntary Withdrawal|0
1205|NCT02457247|5432|P3|Period 2|Voluntary Withdrawal|0
1206|NCT02457247|5433|P2|Period 2|Voluntary Withdrawal|1
1207|NCT02457247|5434|P1|Period 2|Voluntary Withdrawal|1
1208|NCT02457247|5431|P4|Period 2|Lost to Follow-up|0
1209|NCT02457247|5432|P3|Period 2|Lost to Follow-up|0
1210|NCT02457247|5433|P2|Period 2|Lost to Follow-up|1
1211|NCT02457247|5434|P1|Period 2|Lost to Follow-up|0
1212|NCT02457247|5431|P4|Period 2|Significant Protocol Deviation|0
1213|NCT02457247|5432|P3|Period 2|Significant Protocol Deviation|0
1214|NCT02457247|5433|P2|Period 2|Significant Protocol Deviation|0
1215|NCT02457247|5434|P1|Period 2|Significant Protocol Deviation|1
1216|NCT02457247|5431|P4|Period 2|Pretreatment Event/Adverse Event|0
1217|NCT02457247|5432|P3|Period 2|Pretreatment Event/Adverse Event|0
1218|NCT02457247|5433|P2|Period 2|Pretreatment Event/Adverse Event|1
1219|NCT02457247|5434|P1|Period 2|Pretreatment Event/Adverse Event|0
1220|NCT02457247|5431|P4|Period 1|Voluntary Withdrawal|0
1221|NCT02457247|5432|P3|Period 1|Voluntary Withdrawal|0
1222|NCT02457247|5433|P2|Period 1|Voluntary Withdrawal|0
1223|NCT02457247|5434|P1|Period 1|Voluntary Withdrawal|1
1224|NCT02457247|5431|P4|Period 1|Significant Protocol Deviation|0
1225|NCT02457247|5432|P3|Period 1|Significant Protocol Deviation|0
1226|NCT02457247|5433|P2|Period 1|Significant Protocol Deviation|1
1227|NCT02457247|5434|P1|Period 1|Significant Protocol Deviation|1
1228|NCT02457247|5431|P4|Period 1|Pretreatment Event/Adverse Event|0
1229|NCT02457247|5432|P3|Period 1|Pretreatment Event/Adverse Event|0
1230|NCT02457247|5433|P2|Period 1|Pretreatment Event/Adverse Event|1
1231|NCT02457247|5434|P1|Period 1|Pretreatment Event/Adverse Event|0
1232|NCT02455050|5458|P4|Treatment Period 2|Lost to Follow-up|1
1233|NCT02455050|5459|P3|Treatment Period 2|Lost to Follow-up|2
1234|NCT02455050|5460|P2|Treatment Period 2|Lost to Follow-up|0
1235|NCT02455050|5461|P1|Treatment Period 2|Lost to Follow-up|1
1236|NCT02455050|5458|P4|Treatment Period 1|Lost to Follow-up|2
1237|NCT02455050|5459|P3|Treatment Period 1|Lost to Follow-up|1
1238|NCT02455050|5460|P2|Treatment Period 1|Lost to Follow-up|1
1239|NCT02455050|5461|P1|Treatment Period 1|Lost to Follow-up|1
1240|NCT02454608|5527|P2|Overall Study|Lack of Efficacy|2
1241|NCT02454608|5528|P1|Overall Study|Lack of Efficacy|0
1242|NCT02454101|5604|P2|Overall Study|Lost to Follow-up|4
1243|NCT02454101|5605|P1|Overall Study|Lost to Follow-up|3
1244|NCT02454101|5604|P2|Overall Study|Adverse Event|3
1245|NCT02454101|5605|P1|Overall Study|Adverse Event|2
1246|NCT02449902|5740|P2|Overall Study|Withdrawal by Subject|1
1247|NCT02449902|5741|P1|Overall Study|Withdrawal by Subject|0
1248|NCT02449902|5740|P2|Overall Study|Adverse Event|1
1249|NCT02449902|5741|P1|Overall Study|Adverse Event|0
1250|NCT02449044|5765|P1|Overall Study|Sponsor Discontinued Trial|3
1251|NCT02449044|5765|P1|Overall Study|Physician Decision|9
1252|NCT02449044|5765|P1|Overall Study|Met Withdrawal Criteria|7
1253|NCT02449044|5765|P1|Overall Study|Adverse Event|30
1254|NCT02449044|5765|P1|Overall Study|Withdrawal by Subject|13
1255|NCT02449044|5765|P1|Overall Study|Lost to Follow-up|2
1256|NCT02447458|5824|P6|Overall Study|Other|0
1257|NCT02447458|5825|P5|Overall Study|Other|0
1258|NCT02447458|5826|P4|Overall Study|Other|0
1259|NCT02447458|5827|P3|Overall Study|Other|1
1260|NCT02447458|5828|P2|Overall Study|Other|0
1261|NCT02447458|5829|P1|Overall Study|Other|0
1262|NCT02446990|5933|P2|Overall Study|Withdrawal by Subject|199
1263|NCT02446990|5934|P1|Overall Study|Withdrawal by Subject|231
1264|NCT02446990|5933|P2|Overall Study|Physician Decision|0
1265|NCT02446990|5934|P1|Overall Study|Physician Decision|1
1266|NCT02446990|5933|P2|Overall Study|Lost to Follow-up|1
1267|NCT02446990|5934|P1|Overall Study|Lost to Follow-up|3
1268|NCT02446990|5933|P2|Overall Study|Death|458
1269|NCT02446990|5934|P1|Overall Study|Death|485
1270|NCT02446171|5970|P4|Overall Study|Withdrawal by Subject|0
1271|NCT02446171|5971|P3|Overall Study|Withdrawal by Subject|2
1272|NCT02446171|5972|P2|Overall Study|Withdrawal by Subject|0
1273|NCT02446171|5973|P1|Overall Study|Withdrawal by Subject|0
1274|NCT02445755|6042|P1|Overall Study|Screen Failure|5
1275|NCT02445755|6042|P1|Overall Study|Protocol Violation|6
1276|NCT02445755|6042|P1|Overall Study|Withdrawal by Subject|2
1277|NCT02445573|6051|P2|Overall Study|Lost to Follow-up|1
1278|NCT02445573|6052|P1|Overall Study|Lost to Follow-up|0
1279|NCT02445573|6051|P2|Overall Study|Withdrawal by Subject|1
1280|NCT02445573|6052|P1|Overall Study|Withdrawal by Subject|1
1281|NCT02444182|6116|P2|Overall Study|Lost to Follow-up|4
1282|NCT02444182|6117|P1|Overall Study|Lost to Follow-up|0
1283|NCT02444182|6116|P2|Overall Study|non-compliance|1
1284|NCT02444182|6117|P1|Overall Study|non-compliance|2
1285|NCT02442310|6153|P1|Overall Study|Withdrawal by Subject|1
1286|NCT02442310|6153|P1|Overall Study|Adverse Event|2
1287|NCT02441218|6177|P2|Overall Study|Lost to Follow-up|1
1288|NCT02441218|6178|P1|Overall Study|Lost to Follow-up|2
1289|NCT02441218|6177|P2|Overall Study|Withdrawal by Subject|58
1290|NCT02441218|6178|P1|Overall Study|Withdrawal by Subject|73
1291|NCT02441218|6177|P2|Overall Study|Death|553
1292|NCT02441218|6178|P1|Overall Study|Death|503
1293|NCT02441179|6204|P2|Overall Study|Withdrawal by Subject|1
1294|NCT02441179|6205|P1|Overall Study|Withdrawal by Subject|1
1295|NCT02441114|6223|P1|Washout2|Withdrawal by Subject|4
1296|NCT02439138|6256|P1|Overall Study|PI decision to terminate the study|2
1297|NCT02439138|6256|P1|Overall Study|Adverse Event|1
1298|NCT02437409|6310|P1|Overall Study|Screening failure|9
1299|NCT02437409|6310|P1|Overall Study|Withdrawal by Subject|3
1300|NCT02437409|6310|P1|Overall Study|Protocol Violation|3
1301|NCT02437305|6323|P2|Overall Study|Lost to Follow-up|12
1302|NCT02437305|6324|P1|Overall Study|Lost to Follow-up|18
1303|NCT02436811|6335|P3|Overall Study|Lost to Follow-up|7
1304|NCT02436811|6336|P2|Overall Study|Lost to Follow-up|9
1305|NCT02436811|6337|P1|Overall Study|Lost to Follow-up|2
1306|NCT02436577|6351|P6|Overall Study|Protocol Deviation|0
1307|NCT02436577|6352|P5|Overall Study|Protocol Deviation|0
1308|NCT02436577|6353|P4|Overall Study|Protocol Deviation|0
1309|NCT02436577|6354|P3|Overall Study|Protocol Deviation|0
1310|NCT02436577|6355|P2|Overall Study|Protocol Deviation|1
1311|NCT02436577|6356|P1|Overall Study|Protocol Deviation|0
1312|NCT02436330|6411|P2|Cohort 6|Withdrawal by Subject|1
1313|NCT02436330|6412|P1|Cohort 6|Withdrawal by Subject|1
1314|NCT02436330|6411|P2|Cohort 6|Lost to Follow-up|0
1315|NCT02436330|6412|P1|Cohort 6|Lost to Follow-up|2
1316|NCT02436330|6411|P2|Cohort 5|Withdrawal by Subject|2
1317|NCT02436330|6412|P1|Cohort 5|Withdrawal by Subject|3
1318|NCT02436330|6411|P2|Cohort 5|Lost to Follow-up|2
1319|NCT02436330|6412|P1|Cohort 5|Lost to Follow-up|3
1320|NCT02436330|6411|P2|Cohort 4|Withdrawal by Subject|0
1321|NCT02436330|6412|P1|Cohort 4|Withdrawal by Subject|1
1322|NCT02436330|6411|P2|Cohort 4|Lost to Follow-up|0
1323|NCT02436330|6412|P1|Cohort 4|Lost to Follow-up|1
1324|NCT02436330|6411|P2|Cohort 3|Withdrawal by Subject|0
1325|NCT02436330|6412|P1|Cohort 3|Withdrawal by Subject|4
1326|NCT02436330|6411|P2|Cohort 3|Lost to Follow-up|0
1327|NCT02436330|6412|P1|Cohort 3|Lost to Follow-up|1
1328|NCT02436330|6411|P2|Cohort 2|Withdrawal by Subject|3
1329|NCT02436330|6412|P1|Cohort 2|Withdrawal by Subject|2
1330|NCT02436330|6411|P2|Cohort 2|Lost to Follow-up|0
1331|NCT02436330|6412|P1|Cohort 2|Lost to Follow-up|2
1332|NCT02436330|6411|P2|Cohort 1|Withdrawal by Subject|1
1333|NCT02436330|6412|P1|Cohort 1|Withdrawal by Subject|0
1334|NCT02436330|6411|P2|Cohort 1|Lost to Follow-up|2
1335|NCT02436330|6412|P1|Cohort 1|Lost to Follow-up|5
1336|NCT02435966|6457|P3|Overall Study|Withdrawal by Subject|0
1337|NCT02435966|6458|P2|Overall Study|Withdrawal by Subject|1
1338|NCT02435966|6459|P1|Overall Study|Withdrawal by Subject|0
1339|NCT02435836|6467|P1|Overall Study|AE of Worsening Schizophrenia|96
1340|NCT02435836|6467|P1|Overall Study|Met Withdrawal Criteria|7
1341|NCT02435836|6467|P1|Overall Study|Protocol Violation|6
1342|NCT02435836|6467|P1|Overall Study|Noncompliance|27
1343|NCT02435836|6467|P1|Overall Study|Sponsor discontinued trial|167
1344|NCT02435836|6467|P1|Overall Study|Adverse Event|44
1345|NCT02435836|6467|P1|Overall Study|Insufficient Clinical Response|26
1346|NCT02435836|6467|P1|Overall Study|Withdrawal by Subject|236
1347|NCT02435836|6467|P1|Overall Study|Lack of Efficacy|1
1348|NCT02435836|6467|P1|Overall Study|Lost to Follow-up|21
1349|NCT02434939|6485|P2|Overall Study|Adverse Event|1
1350|NCT02434939|6486|P1|Overall Study|Adverse Event|0
1351|NCT02434939|6485|P2|Overall Study|Withdrawal by Subject|0
1352|NCT02434939|6486|P1|Overall Study|Withdrawal by Subject|3
1353|NCT02434939|6485|P2|Overall Study|Lack of Efficacy|48
1354|NCT02434939|6486|P1|Overall Study|Lack of Efficacy|34
1355|NCT02432040|6526|P2|Overall Study|Physician Decision|1
1356|NCT02432040|6527|P1|Overall Study|Physician Decision|1
1357|NCT02432040|6526|P2|Overall Study|Lost to Follow-up|5
1358|NCT02432040|6527|P1|Overall Study|Lost to Follow-up|4
1359|NCT02432040|6526|P2|Overall Study|Lack of Efficacy|0
1360|NCT02432040|6527|P1|Overall Study|Lack of Efficacy|3
1361|NCT02430870|6590|P8|Part 2|Other Reason Not Specified|1
1362|NCT02430870|6591|P7|Part 2|Other Reason Not Specified|0
1363|NCT02430870|6592|P6|Part 2|Other Reason Not Specified|0
1364|NCT02430870|6593|P5|Part 2|Other Reason Not Specified|0
1365|NCT02430870|6594|P4|Part 2|Other Reason Not Specified|0
1366|NCT02430870|6595|P3|Part 2|Other Reason Not Specified|0
1367|NCT02430870|6596|P2|Part 2|Other Reason Not Specified|0
1368|NCT02430870|6597|P1|Part 2|Other Reason Not Specified|0
1369|NCT02430870|6590|P8|Part 2|Voluntary Withdrawal|0
1370|NCT02430870|6591|P7|Part 2|Voluntary Withdrawal|1
1371|NCT02430870|6592|P6|Part 2|Voluntary Withdrawal|0
1372|NCT02430870|6593|P5|Part 2|Voluntary Withdrawal|0
1373|NCT02430870|6594|P4|Part 2|Voluntary Withdrawal|0
1374|NCT02430870|6595|P3|Part 2|Voluntary Withdrawal|0
1375|NCT02430870|6596|P2|Part 2|Voluntary Withdrawal|0
1376|NCT02430870|6597|P1|Part 2|Voluntary Withdrawal|0
1377|NCT02428413|6695|P2|Overall Study|Nurse Refusal|0
1378|NCT02428413|6696|P1|Overall Study|Nurse Refusal|1
1379|NCT02428413|6695|P2|Overall Study|Missed Cases|2
1380|NCT02428413|6696|P1|Overall Study|Missed Cases|1
1381|NCT02428413|6695|P2|Overall Study|Case Cancelled|0
1382|NCT02428413|6696|P1|Overall Study|Case Cancelled|2
1383|NCT02428413|6695|P2|Overall Study|Protocol Violation|2
1384|NCT02428413|6696|P1|Overall Study|Protocol Violation|1
1385|NCT02428413|6695|P2|Overall Study|Device to measure WAG malfunctioned|5
1386|NCT02428413|6696|P1|Overall Study|Device to measure WAG malfunctioned|3
1387|NCT02427984|6711|P3|Overall Study|Lost to Follow-up|18
1388|NCT02427984|6712|P2|Overall Study|Lost to Follow-up|5
1389|NCT02427984|6713|P1|Overall Study|Lost to Follow-up|13
1390|NCT02427477|6755|P2|Period 1|Adverse Event|0
1391|NCT02427477|6756|P1|Period 1|Adverse Event|1
1392|NCT02424565|6764|P2|Period 1 (D0)|Protocol Violation|1
1393|NCT02424565|6765|P1|Period 1 (D0)|Protocol Violation|0
1394|NCT02424149|6773|P2|Overall Study|Withdrawal by Subject|1
1395|NCT02424149|6774|P1|Overall Study|Withdrawal by Subject|0
1396|NCT02424149|6773|P2|Overall Study|surgery cancelled|0
1397|NCT02424149|6774|P1|Overall Study|surgery cancelled|2
1398|NCT02420093|6925|P2|Overall Study|Withdrawal by Subject|1
1399|NCT02420093|6926|P1|Overall Study|Withdrawal by Subject|1
1400|NCT02419313|6967|P2|Second Intervention|Lost to Follow-up|0
1401|NCT02419313|6968|P1|Second Intervention|Lost to Follow-up|1
1402|NCT02419313|6967|P2|First Intervention|Lost to Follow-up|0
1403|NCT02419313|6968|P1|First Intervention|Lost to Follow-up|2
1404|NCT02419001|6980|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
1405|NCT02419001|6981|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
1406|NCT02417532|7018|P1|Overall Study|unable to complete exercises|4
1407|NCT02416180|7053|P1|Overall Study|Withdrawal by Subject|1
1408|NCT02415959|7065|P5|Overall Study|Protocol Violation|0
1409|NCT02415959|7066|P4|Overall Study|Protocol Violation|1
1410|NCT02415959|7067|P3|Overall Study|Protocol Violation|0
1411|NCT02415959|7068|P2|Overall Study|Protocol Violation|0
1412|NCT02415959|7069|P1|Overall Study|Protocol Violation|0
1413|NCT02415959|7065|P5|Overall Study|Adverse Event|0
1414|NCT02415959|7066|P4|Overall Study|Adverse Event|0
1415|NCT02415959|7067|P3|Overall Study|Adverse Event|0
1416|NCT02415959|7068|P2|Overall Study|Adverse Event|1
1417|NCT02415959|7069|P1|Overall Study|Adverse Event|0
1418|NCT02414828|7184|P4|Overall Study|Lost to Follow-up|2
1419|NCT02414828|7185|P3|Overall Study|Lost to Follow-up|1
1420|NCT02414828|7186|P2|Overall Study|Lost to Follow-up|1
1421|NCT02414828|7187|P1|Overall Study|Lost to Follow-up|0
1422|NCT02414152|7225|P1|Overall Study|Lack of Efficacy|1
1423|NCT02414152|7225|P1|Overall Study|Withdrawal by Subject|1
1424|NCT02413593|7229|P1|Overall Study|Adverse Event|1
1425|NCT02413593|7229|P1|Overall Study|Lost to Follow-up|3
1426|NCT02413333|7242|P2|Period 2|Protocol Deviation|0
1427|NCT02413333|7243|P1|Period 2|Protocol Deviation|1
1428|NCT02413333|7242|P2|Period 1|Reason Not Specified|1
1429|NCT02413333|7243|P1|Period 1|Reason Not Specified|0
1430|NCT02413333|7242|P2|Period 1|Adverse Event|0
1431|NCT02413333|7243|P1|Period 1|Adverse Event|1
1432|NCT02412657|7265|P3|Overall Study|Protocol Violation|3
1433|NCT02412657|7266|P2|Overall Study|Protocol Violation|2
1434|NCT02412657|7267|P1|Overall Study|Protocol Violation|0
1435|NCT02412657|7265|P3|Overall Study|Lost to Follow-up|0
1436|NCT02412657|7266|P2|Overall Study|Lost to Follow-up|0
1437|NCT02412657|7267|P1|Overall Study|Lost to Follow-up|1
1438|NCT02411747|7307|P2|Overall Study|Protocol Violation|4
1439|NCT02411747|7308|P1|Overall Study|Protocol Violation|2
1440|NCT02411747|7307|P2|Overall Study|Withdrawal by Subject|0
1441|NCT02411747|7308|P1|Overall Study|Withdrawal by Subject|1
1442|NCT02406586|7378|P3|Overall Study|Withdrawal by Subject|0
1443|NCT02406586|7379|P2|Overall Study|Withdrawal by Subject|0
1444|NCT02406586|7380|P1|Overall Study|Withdrawal by Subject|1
1445|NCT02406586|7378|P3|Overall Study|Lost to Follow-up|2
1446|NCT02406586|7379|P2|Overall Study|Lost to Follow-up|4
1447|NCT02406586|7380|P1|Overall Study|Lost to Follow-up|0
1448|NCT02404649|7474|P2|Overall Study|Adverse Event|2
1449|NCT02404649|7475|P1|Overall Study|Adverse Event|1
1450|NCT02403180|7483|P2|Period 2 (5 Days)|Withdrawal by Subject|1
1451|NCT02403180|7484|P1|Period 2 (5 Days)|Withdrawal by Subject|0
1452|NCT02403180|7483|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
1453|NCT02403180|7484|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
1454|NCT02402322|7495|P3|Follow-up|Withdrawal by Subject|24
1455|NCT02402322|7496|P2|Follow-up|Withdrawal by Subject|3
1456|NCT02402322|7497|P1|Follow-up|Withdrawal by Subject|6
1457|NCT02402322|7495|P3|Pretreatment|Withdrawal by Subject|1
1458|NCT02402322|7496|P2|Pretreatment|Withdrawal by Subject|1
1459|NCT02402322|7497|P1|Pretreatment|Withdrawal by Subject|3
1460|NCT02401529|7568|P2|Overall Study|Protocol Violation|0
1461|NCT02401529|7569|P1|Overall Study|Protocol Violation|5
1462|NCT02401529|7568|P2|Overall Study|Physician Decision|6
1463|NCT02401529|7569|P1|Overall Study|Physician Decision|2
1464|NCT02401529|7568|P2|Overall Study|Lost to Follow-up|1
1465|NCT02401529|7569|P1|Overall Study|Lost to Follow-up|2
1466|NCT02400333|7653|P4|Overall Study|Protocol Violation|1
1467|NCT02400333|7654|P3|Overall Study|Protocol Violation|2
1468|NCT02400333|7655|P2|Overall Study|Protocol Violation|0
1469|NCT02400333|7656|P1|Overall Study|Protocol Violation|1
1470|NCT02400333|7653|P4|Overall Study|Withdrawal by Subject|1
1471|NCT02400333|7654|P3|Overall Study|Withdrawal by Subject|0
1472|NCT02400333|7655|P2|Overall Study|Withdrawal by Subject|1
1473|NCT02400333|7656|P1|Overall Study|Withdrawal by Subject|0
1474|NCT02399163|7720|P1|Overall Study|Withdrawal by Participant|5
1475|NCT02399163|7720|P1|Overall Study|Protocol Deviation|2
1476|NCT02399163|7720|P1|Overall Study|Adverse Event|2
1477|NCT02397915|7765|P4|Period 1|Physician Decision|0
1478|NCT02397915|7766|P3|Period 1|Physician Decision|0
1479|NCT02397915|7767|P2|Period 1|Physician Decision|0
1480|NCT02397915|7768|P1|Period 1|Physician Decision|1
1481|NCT02397915|7765|P4|Period 1|Protocol Violation|0
1482|NCT02397915|7766|P3|Period 1|Protocol Violation|0
1483|NCT02397915|7767|P2|Period 1|Protocol Violation|1
1484|NCT02397915|7768|P1|Period 1|Protocol Violation|0
1485|NCT02397655|7818|P1|Overall Study|data not completed|1301
1486|NCT02395055|7912|P2|Overall Study|Withdrawal by Subject|3
1487|NCT02395055|7913|P1|Overall Study|Withdrawal by Subject|7
1488|NCT02394665|7926|P3|Overall Study|Physician Decision|0
1489|NCT02394665|7927|P2|Overall Study|Physician Decision|0
1490|NCT02394665|7928|P1|Overall Study|Physician Decision|1
1491|NCT02393950|7969|P2|Overall Study|Withdrawal by Subject|1
1492|NCT02393950|7970|P1|Overall Study|Withdrawal by Subject|0
1493|NCT02393950|7969|P2|Overall Study|Adverse Event|0
1494|NCT02393950|7970|P1|Overall Study|Adverse Event|1
1495|NCT02392247|8063|P1|Overall Study|Surgery cancelled; no data|1
1496|NCT02392247|8063|P1|Overall Study|Withdrawal by Subject|1
1497|NCT02389452|8081|P1|Overall Study|Enrolled but Not Eligible for Study|6
1498|NCT02389452|8081|P1|Overall Study|Withdrawal by Subject|5
1499|NCT02389452|8081|P1|Overall Study|Adverse Event|1
1500|NCT02389452|8081|P1|Overall Study|Lost to Follow-up|13
1501|NCT02388763|8156|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
1502|NCT02388763|8157|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
1503|NCT02388763|8156|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
1504|NCT02388763|8157|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
1505|NCT02388074|8168|P1|Overall Study|Sample Not Returned|1
1506|NCT02388074|8168|P1|Overall Study|Lost in Transit|2
1507|NCT02387580|8197|P6|Overall Study|Withdrawal by Subject|0
1508|NCT02387580|8198|P5|Overall Study|Withdrawal by Subject|0
1509|NCT02387580|8199|P4|Overall Study|Withdrawal by Subject|1
1510|NCT02387580|8200|P3|Overall Study|Withdrawal by Subject|0
1511|NCT02387580|8201|P2|Overall Study|Withdrawal by Subject|0
1512|NCT02387580|8202|P1|Overall Study|Withdrawal by Subject|0
1513|NCT02382640|8364|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1514|NCT02382640|8365|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1515|NCT02382640|8366|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
1516|NCT02382640|8367|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
1517|NCT02380287|8427|P8|Overall Study|Adverse Event|0
1518|NCT02380287|8428|P7|Overall Study|Adverse Event|0
1519|NCT02380287|8429|P6|Overall Study|Adverse Event|0
1520|NCT02380287|8430|P5|Overall Study|Adverse Event|0
1521|NCT02380287|8431|P4|Overall Study|Adverse Event|0
1522|NCT02380287|8432|P3|Overall Study|Adverse Event|1
1523|NCT02380287|8433|P2|Overall Study|Adverse Event|0
1524|NCT02380287|8434|P1|Overall Study|Adverse Event|0
1525|NCT02379637|8452|P2|Overall Study|Withdrawal by Subject|0
1526|NCT02379637|8453|P1|Overall Study|Withdrawal by Subject|1
1527|NCT02379637|8452|P2|Overall Study|Adverse Event|0
1528|NCT02379637|8453|P1|Overall Study|Adverse Event|1
1529|NCT02379637|8452|P2|Overall Study|Protocol Violation|1
1530|NCT02379637|8453|P1|Overall Study|Protocol Violation|0
1531|NCT02375373|8465|P1|Overall Study|Withdrawal by Subject|11
1532|NCT02375347|8469|P1|Overall Study|Protocol Violation|1
1533|NCT02374346|8506|P1|Overall Study|operated or discharged during weekend|48
1534|NCT02372071|8579|P1|Overall Study|Protocol Violation|18
1535|NCT02372058|8584|P1|Overall Study|Withdrawal by Subject|3
1536|NCT02370121|8602|P2|Overall Study|Lost to Follow-up|1
1537|NCT02370121|8603|P1|Overall Study|Lost to Follow-up|1
1538|NCT02370615|8643|P2|Overall Study|Adverse Event|0
1539|NCT02370615|8644|P1|Overall Study|Adverse Event|1
1540|NCT02370602|8687|P6|Overall Study|Pretreatment Event/Adverse Event|0
1541|NCT02370602|8688|P5|Overall Study|Pretreatment Event/Adverse Event|0
1542|NCT02370602|8689|P4|Overall Study|Pretreatment Event/Adverse Event|0
1543|NCT02370602|8690|P3|Overall Study|Pretreatment Event/Adverse Event|0
1544|NCT02370602|8691|P2|Overall Study|Pretreatment Event/Adverse Event|0
1545|NCT02370602|8692|P1|Overall Study|Pretreatment Event/Adverse Event|1
1546|NCT02370537|8786|P3|Part B|Withdrawal by Subject|0
1547|NCT02370537|8787|P2|Part B|Withdrawal by Subject|1
1548|NCT02370537|8788|P1|Part B|Withdrawal by Subject|0
1549|NCT02370537|8786|P3|Part B|Not randomised to receive treatment|259
1550|NCT02370537|8787|P2|Part B|Not randomised to receive treatment|2
1551|NCT02370537|8788|P1|Part B|Not randomised to receive treatment|1
1552|NCT02370537|8786|P3|Part A (Open-label Recruitment)|Adverse Event|1
1553|NCT02370537|8787|P2|Part A (Open-label Recruitment)|Adverse Event|0
1554|NCT02370537|8788|P1|Part A (Open-label Recruitment)|Adverse Event|0
1555|NCT02370537|8786|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
1556|NCT02370537|8787|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
1557|NCT02370537|8788|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
1558|NCT02369341|8837|P2|Overall Study|Migrated/moved from study area|0
1559|NCT02369341|8838|P1|Overall Study|Migrated/moved from study area|1
1560|NCT02368314|8905|P2|Overall Study|Adverse Event|2
1561|NCT02368314|8906|P1|Overall Study|Adverse Event|1
1562|NCT02368314|8905|P2|Overall Study|Withdrawal by Subject|1
1563|NCT02368314|8906|P1|Overall Study|Withdrawal by Subject|2
1564|NCT02367885|8928|P3|Overall Study|Withdrawal by Subject|0
1565|NCT02367885|8929|P2|Overall Study|Withdrawal by Subject|0
1566|NCT02367885|8930|P1|Overall Study|Withdrawal by Subject|1
1567|NCT02367885|8928|P3|Overall Study|Lost to Follow-up|0
1568|NCT02367885|8929|P2|Overall Study|Lost to Follow-up|0
1569|NCT02367885|8930|P1|Overall Study|Lost to Follow-up|1
1570|NCT02366923|9069|P1|Overall Study|High Astigmatism|3
1571|NCT02366923|9069|P1|Overall Study|Positive Slit Lamp Findings|2
1572|NCT02366923|9069|P1|Overall Study|Withdrawal by Subject|1
1573|NCT02366910|9082|P1|Overall Study|Screen Failure|3
1574|NCT02366910|9082|P1|Overall Study|Withdrawal by Subject|2
1575|NCT02366767|9096|P2|Overall Study|left for home after 1 day at camp|0
1576|NCT02366767|9097|P1|Overall Study|left for home after 1 day at camp|1
1577|NCT02366689|9110|P3|Overall Study|Pregnancy|1
1578|NCT02366689|9111|P2|Overall Study|Pregnancy|1
1579|NCT02366689|9112|P1|Overall Study|Pregnancy|0
1580|NCT02366689|9110|P3|Overall Study|Lost to Follow-up|0
1581|NCT02366689|9111|P2|Overall Study|Lost to Follow-up|2
1582|NCT02366689|9112|P1|Overall Study|Lost to Follow-up|3
1583|NCT02366689|9110|P3|Overall Study|Withdrawal by Subject|1
1584|NCT02366689|9111|P2|Overall Study|Withdrawal by Subject|0
1585|NCT02366689|9112|P1|Overall Study|Withdrawal by Subject|1
1586|NCT02366637|9135|P2|Second Intervention Period|Study Terminated by Sponsor|1
1587|NCT02366637|9136|P1|Second Intervention Period|Study Terminated by Sponsor|1
1588|NCT02366637|9135|P2|First Intervention Period|Study Terminated by Sponsor|4
1589|NCT02366637|9136|P1|First Intervention Period|Study Terminated by Sponsor|6
1590|NCT02366637|9135|P2|First Intervention Period|Adverse Event|1
1591|NCT02366637|9136|P1|First Intervention Period|Adverse Event|0
1592|NCT02363478|9191|P1|Overall Study|Adverse Event|4
1593|NCT02363478|9191|P1|Overall Study|Lost to Follow-up|4
1594|NCT02362360|9206|P2|Period 1|Withdrawal by Subject|1
1595|NCT02362360|9207|P1|Period 1|Withdrawal by Subject|2
1596|NCT02362360|9206|P2|Period 1|Lack of Efficacy|0
1597|NCT02362360|9207|P1|Period 1|Lack of Efficacy|1
1598|NCT02360995|9246|P3|Overall Study|Withdrawal by Subject|0
1599|NCT02360995|9247|P2|Overall Study|Withdrawal by Subject|1
1600|NCT02360995|9248|P1|Overall Study|Withdrawal by Subject|0
1601|NCT02360995|9246|P3|Overall Study|Lost to Follow-up|2
1602|NCT02360995|9247|P2|Overall Study|Lost to Follow-up|0
1603|NCT02360995|9248|P1|Overall Study|Lost to Follow-up|2
1604|NCT02359903|9308|P2|Overall Study|Adverse Event|2
1605|NCT02359903|9309|P1|Overall Study|Adverse Event|0
1606|NCT02359877|9320|P3|Stage 2|Withdrawal by Subject|0
1607|NCT02359877|9321|P2|Stage 2|Withdrawal by Subject|0
1608|NCT02359877|9322|P1|Stage 2|Withdrawal by Subject|2
1609|NCT02359877|9320|P3|Stage 2|Adverse Event|0
1610|NCT02359877|9321|P2|Stage 2|Adverse Event|0
1611|NCT02359877|9322|P1|Stage 2|Adverse Event|1
1612|NCT02359877|9320|P3|Stage 1|Withdrawal by Subject|0
1613|NCT02359877|9321|P2|Stage 1|Withdrawal by Subject|0
1614|NCT02359877|9322|P1|Stage 1|Withdrawal by Subject|1
1615|NCT02359435|9374|P2|Overall Study|Lost to Follow-up|4
1616|NCT02359435|9375|P1|Overall Study|Lost to Follow-up|4
1617|NCT02358044|9387|P2|Overall Study|Ongoing on Study|69
1618|NCT02358044|9388|P1|Overall Study|Ongoing on Study|75
1619|NCT02358044|9387|P2|Overall Study|Withdrawal by Subject|3
1620|NCT02358044|9388|P1|Overall Study|Withdrawal by Subject|0
1621|NCT02358044|9387|P2|Overall Study|Physician Decision|1
1622|NCT02358044|9388|P1|Overall Study|Physician Decision|0
1623|NCT02358044|9387|P2|Overall Study|Lost to Follow-up|0
1624|NCT02358044|9388|P1|Overall Study|Lost to Follow-up|1
1625|NCT02358044|9387|P2|Overall Study|Adverse Event|1
1626|NCT02358044|9388|P1|Overall Study|Adverse Event|0
1627|NCT02357940|9404|P2|Overall Study|Investigator's judgement|1
1628|NCT02357940|9405|P1|Overall Study|Investigator's judgement|0
1629|NCT02357940|9404|P2|Overall Study|Adverse Event|1
1630|NCT02357940|9405|P1|Overall Study|Adverse Event|0
1631|NCT02356588|9539|P2|Overall Study|Protocol Violation|1
1632|NCT02356588|9540|P1|Overall Study|Protocol Violation|0
1633|NCT02356588|9539|P2|Overall Study|Withdrawal by Subject|0
1634|NCT02356588|9540|P1|Overall Study|Withdrawal by Subject|1
1635|NCT02356588|9539|P2|Overall Study|Adverse Event|2
1636|NCT02356588|9540|P1|Overall Study|Adverse Event|0
1637|NCT02356588|9539|P2|Overall Study|Lack of Efficacy|10
1638|NCT02356588|9540|P1|Overall Study|Lack of Efficacy|4
1639|NCT02354599|9617|P6|Overall Study|Withdrawal by Subject|0
1640|NCT02354599|9618|P5|Overall Study|Withdrawal by Subject|0
1641|NCT02354599|9619|P4|Overall Study|Withdrawal by Subject|0
1642|NCT02354599|9620|P3|Overall Study|Withdrawal by Subject|0
1643|NCT02354599|9621|P2|Overall Study|Withdrawal by Subject|1
1644|NCT02354599|9622|P1|Overall Study|Withdrawal by Subject|1
1645|NCT02354599|9617|P6|Overall Study|Pretreatment Event/Adverse Event|1
1646|NCT02354599|9618|P5|Overall Study|Pretreatment Event/Adverse Event|0
1647|NCT02354599|9619|P4|Overall Study|Pretreatment Event/Adverse Event|0
1648|NCT02354599|9620|P3|Overall Study|Pretreatment Event/Adverse Event|0
1649|NCT02354599|9621|P2|Overall Study|Pretreatment Event/Adverse Event|0
1650|NCT02354599|9622|P1|Overall Study|Pretreatment Event/Adverse Event|0
1651|NCT02353572|9705|P1|Overall Study|Study terminated|2
1652|NCT02353572|9705|P1|Overall Study|Withdrawal by Subject|1
1653|NCT02353468|9709|P1|Overall Study|Study terminated|3
1654|NCT02353442|9715|P2|Overall Study|Withdrawal by Subject|4
1655|NCT02353442|9716|P1|Overall Study|Withdrawal by Subject|3
1656|NCT02351817|9730|P2|Period 2|Protocol Violation|0
1657|NCT02351817|9731|P1|Period 2|Protocol Violation|1
1658|NCT02351817|9730|P2|Period 2|Adverse Event|2
1659|NCT02351817|9731|P1|Period 2|Adverse Event|0
1660|NCT02351817|9730|P2|Period 1|Lack of Efficacy|1
1661|NCT02351817|9731|P1|Period 1|Lack of Efficacy|0
1662|NCT02351817|9730|P2|Period 1|Adverse Event|2
1663|NCT02351817|9731|P1|Period 1|Adverse Event|1
1664|NCT02349711|9779|P2|Overall Study|Lost to Follow-up|1
1665|NCT02349711|9780|P1|Overall Study|Lost to Follow-up|1
1666|NCT02349711|9779|P2|Overall Study|Withdrawal by Subject|1
1667|NCT02349711|9780|P1|Overall Study|Withdrawal by Subject|2
1668|NCT02344745|9872|P2|Overall Study|Data collection sheets were lost|0
1669|NCT02344745|9873|P1|Overall Study|Data collection sheets were lost|2
1670|NCT02342288|9925|P2|Overall Study|coordinator not available|2
1671|NCT02342288|9926|P1|Overall Study|coordinator not available|0
1672|NCT02342288|9925|P2|Overall Study|subject cannot tolerate numbing drops|1
1673|NCT02342288|9926|P1|Overall Study|subject cannot tolerate numbing drops|0
1674|NCT02342288|9925|P2|Overall Study|coordinator contaminated with blood|1
1675|NCT02342288|9926|P1|Overall Study|coordinator contaminated with blood|0
1676|NCT02342288|9925|P2|Overall Study|Withdrawal by Subject|0
1677|NCT02342288|9926|P1|Overall Study|Withdrawal by Subject|1
1678|NCT02342288|9925|P2|Overall Study|anesthesia leak in system|0
1679|NCT02342288|9926|P1|Overall Study|anesthesia leak in system|1
1680|NCT02342288|9925|P2|Overall Study|no protocol anesthesiologist available|2
1681|NCT02342288|9926|P1|Overall Study|no protocol anesthesiologist available|3
1682|NCT02342223|9932|P1|Overall Study|Lost to Follow-up|1
1683|NCT02341482|10104|P1|Overall Study|Adverse Event|1
1684|NCT02336607|10235|P4|Overall Study|Withdrawal by Subject|20
1685|NCT02336607|10236|P3|Overall Study|Withdrawal by Subject|0
1686|NCT02336607|10237|P2|Overall Study|Withdrawal by Subject|2
1687|NCT02336607|10238|P1|Overall Study|Withdrawal by Subject|0
1688|NCT02336607|10235|P4|Overall Study|Adverse Event|26
1689|NCT02336607|10236|P3|Overall Study|Adverse Event|2
1690|NCT02336607|10237|P2|Overall Study|Adverse Event|2
1691|NCT02336607|10238|P1|Overall Study|Adverse Event|0
1692|NCT02336607|10235|P4|Overall Study|Protocol Violation|3
1693|NCT02336607|10236|P3|Overall Study|Protocol Violation|1
1694|NCT02336607|10237|P2|Overall Study|Protocol Violation|1
1695|NCT02336607|10238|P1|Overall Study|Protocol Violation|0
1696|NCT02336607|10235|P4|Overall Study|Lost to Follow-up|21
1697|NCT02336607|10236|P3|Overall Study|Lost to Follow-up|0
1698|NCT02336607|10237|P2|Overall Study|Lost to Follow-up|1
1699|NCT02336607|10238|P1|Overall Study|Lost to Follow-up|2
1700|NCT02336607|10235|P4|Overall Study|Lack of Efficacy|2
1701|NCT02336607|10236|P3|Overall Study|Lack of Efficacy|0
1702|NCT02336607|10237|P2|Overall Study|Lack of Efficacy|0
1703|NCT02336607|10238|P1|Overall Study|Lack of Efficacy|1
1704|NCT02336607|10235|P4|Overall Study|Physician Decision|15
1705|NCT02336607|10236|P3|Overall Study|Physician Decision|3
1706|NCT02336607|10237|P2|Overall Study|Physician Decision|4
1707|NCT02336607|10238|P1|Overall Study|Physician Decision|1
1708|NCT02332798|10473|P3|Overall Study|Abnormal laboratory findings|0
1709|NCT02332798|10474|P2|Overall Study|Abnormal laboratory findings|0
1710|NCT02332798|10475|P1|Overall Study|Abnormal laboratory findings|1
1711|NCT02332798|10473|P3|Overall Study|Positive urine drug test|0
1712|NCT02332798|10474|P2|Overall Study|Positive urine drug test|1
1713|NCT02332798|10475|P1|Overall Study|Positive urine drug test|0
1714|NCT02332798|10473|P3|Overall Study|Unwilling to participate in study|1
1715|NCT02332798|10474|P2|Overall Study|Unwilling to participate in study|1
1716|NCT02332798|10475|P1|Overall Study|Unwilling to participate in study|0
1717|NCT02331446|10544|P4|Overall Study|Lost before baseline analysis|0
1718|NCT02331446|10545|P3|Overall Study|Lost before baseline analysis|1
1719|NCT02331446|10546|P2|Overall Study|Lost before baseline analysis|1
1720|NCT02331446|10547|P1|Overall Study|Lost before baseline analysis|0
1721|NCT02331446|10544|P4|Overall Study|Physician Decision|1
1722|NCT02331446|10545|P3|Overall Study|Physician Decision|0
1723|NCT02331446|10546|P2|Overall Study|Physician Decision|1
1724|NCT02331446|10547|P1|Overall Study|Physician Decision|0
1725|NCT02331446|10544|P4|Overall Study|Disease|1
1726|NCT02331446|10545|P3|Overall Study|Disease|2
1727|NCT02331446|10546|P2|Overall Study|Disease|2
1728|NCT02331446|10547|P1|Overall Study|Disease|0
1729|NCT02331446|10544|P4|Overall Study|Personal Problem|0
1730|NCT02331446|10545|P3|Overall Study|Personal Problem|0
1731|NCT02331446|10546|P2|Overall Study|Personal Problem|0
1732|NCT02331446|10547|P1|Overall Study|Personal Problem|2
1733|NCT02331446|10544|P4|Overall Study|Lost to Follow-up|1
1734|NCT02331446|10545|P3|Overall Study|Lost to Follow-up|0
1735|NCT02331446|10546|P2|Overall Study|Lost to Follow-up|1
1736|NCT02331446|10547|P1|Overall Study|Lost to Follow-up|2
1737|NCT02329730|10659|P12|Overall Study|Withdrawal by Subject|0
1738|NCT02329730|10660|P11|Overall Study|Withdrawal by Subject|0
1739|NCT02329730|10661|P10|Overall Study|Withdrawal by Subject|1
1740|NCT02329730|10662|P9|Overall Study|Withdrawal by Subject|1
1741|NCT02329730|10663|P8|Overall Study|Withdrawal by Subject|1
1742|NCT02329730|10664|P7|Overall Study|Withdrawal by Subject|1
1743|NCT02329730|10665|P6|Overall Study|Withdrawal by Subject|0
1744|NCT02329730|10666|P5|Overall Study|Withdrawal by Subject|1
1745|NCT02329730|10667|P4|Overall Study|Withdrawal by Subject|0
1746|NCT02329730|10668|P3|Overall Study|Withdrawal by Subject|0
1747|NCT02329730|10669|P2|Overall Study|Withdrawal by Subject|0
1748|NCT02329730|10670|P1|Overall Study|Withdrawal by Subject|0
1749|NCT02329730|10659|P12|Overall Study|Protocol Violation|0
1750|NCT02329730|10660|P11|Overall Study|Protocol Violation|0
1751|NCT02329730|10661|P10|Overall Study|Protocol Violation|0
1752|NCT02329730|10662|P9|Overall Study|Protocol Violation|0
1753|NCT02329730|10663|P8|Overall Study|Protocol Violation|0
1754|NCT02329730|10664|P7|Overall Study|Protocol Violation|0
1755|NCT02329730|10665|P6|Overall Study|Protocol Violation|2
1756|NCT02329730|10666|P5|Overall Study|Protocol Violation|2
1757|NCT02329730|10667|P4|Overall Study|Protocol Violation|0
1758|NCT02329730|10668|P3|Overall Study|Protocol Violation|0
1759|NCT02329730|10669|P2|Overall Study|Protocol Violation|0
1760|NCT02329730|10670|P1|Overall Study|Protocol Violation|0
1761|NCT02329223|10763|P3|Overall Study|Adverse Event|0
1762|NCT02329223|10764|P2|Overall Study|Adverse Event|1
1763|NCT02329223|10765|P1|Overall Study|Adverse Event|0
1764|NCT02329223|10763|P3|Overall Study|Physician Decision|1
1765|NCT02329223|10764|P2|Overall Study|Physician Decision|0
1766|NCT02329223|10765|P1|Overall Study|Physician Decision|0
1767|NCT02329223|10763|P3|Overall Study|Withdrawal by Subject|5
1768|NCT02329223|10764|P2|Overall Study|Withdrawal by Subject|2
1769|NCT02329223|10765|P1|Overall Study|Withdrawal by Subject|1
1770|NCT02328937|10815|P6|Period 2|Adverse Event|0
1771|NCT02328937|10816|P5|Period 2|Adverse Event|0
1772|NCT02328937|10817|P4|Period 2|Adverse Event|0
1773|NCT02328937|10818|P3|Period 2|Adverse Event|1
1774|NCT02328937|10819|P2|Period 2|Adverse Event|0
1775|NCT02328937|10820|P1|Period 2|Adverse Event|0
1776|NCT02328937|10815|P6|Period 1|Lost to Follow-up|0
1777|NCT02328937|10816|P5|Period 1|Lost to Follow-up|0
1778|NCT02328937|10817|P4|Period 1|Lost to Follow-up|1
1779|NCT02328937|10818|P3|Period 1|Lost to Follow-up|0
1780|NCT02328937|10819|P2|Period 1|Lost to Follow-up|0
1781|NCT02328937|10820|P1|Period 1|Lost to Follow-up|0
1782|NCT02325518|10890|P2|Overall Study|Withdrawal by Subject|1
1783|NCT02325518|10891|P1|Overall Study|Withdrawal by Subject|0
1784|NCT02325518|10890|P2|Overall Study|Physician Decision|1
1785|NCT02325518|10891|P1|Overall Study|Physician Decision|0
1786|NCT02325518|10890|P2|Overall Study|Adverse Event|1
1787|NCT02325518|10891|P1|Overall Study|Adverse Event|4
1788|NCT02322775|10915|P2|Overall Study|Not willing to perform all FU visits|1
1789|NCT02322775|10916|P1|Overall Study|Not willing to perform all FU visits|0
1790|NCT02322775|10915|P2|Overall Study|Withdrawal by Subject|4
1791|NCT02322775|10916|P1|Overall Study|Withdrawal by Subject|3
1792|NCT02322775|10915|P2|Overall Study|Protocol Violation|0
1793|NCT02322775|10916|P1|Overall Study|Protocol Violation|1
1794|NCT02322775|10915|P2|Overall Study|Lost to Follow-up|1
1795|NCT02322775|10916|P1|Overall Study|Lost to Follow-up|0
1796|NCT02322775|10915|P2|Overall Study|Adverse Event|0
1797|NCT02322775|10916|P1|Overall Study|Adverse Event|1
1798|NCT02322749|10942|P6|Period 3|Withdrawal by Subject|0
1799|NCT02322749|10943|P5|Period 3|Withdrawal by Subject|0
1800|NCT02322749|10944|P4|Period 3|Withdrawal by Subject|0
1801|NCT02322749|10945|P3|Period 3|Withdrawal by Subject|1
1802|NCT02322749|10946|P2|Period 3|Withdrawal by Subject|0
1803|NCT02322749|10947|P1|Period 3|Withdrawal by Subject|0
1804|NCT02322749|10942|P6|Period 2|Withdrawal by Subject|0
1805|NCT02322749|10943|P5|Period 2|Withdrawal by Subject|0
1806|NCT02322749|10944|P4|Period 2|Withdrawal by Subject|1
1807|NCT02322749|10945|P3|Period 2|Withdrawal by Subject|0
1808|NCT02322749|10946|P2|Period 2|Withdrawal by Subject|0
1809|NCT02322749|10947|P1|Period 2|Withdrawal by Subject|0
1810|NCT02322749|10942|P6|Period 2|Adverse Event|0
1811|NCT02322749|10943|P5|Period 2|Adverse Event|0
1812|NCT02322749|10944|P4|Period 2|Adverse Event|1
1813|NCT02322749|10945|P3|Period 2|Adverse Event|0
1814|NCT02322749|10946|P2|Period 2|Adverse Event|0
1815|NCT02322749|10947|P1|Period 2|Adverse Event|0
1816|NCT02322216|10977|P2|Overall Study|Withdrawal by Subject|4
1817|NCT02322216|10978|P1|Overall Study|Withdrawal by Subject|1
1818|NCT02322216|10977|P2|Overall Study|Adverse Event|0
1819|NCT02322216|10978|P1|Overall Study|Adverse Event|1
1820|NCT02320396|11014|P2|Overall Study|Withdrawal by Subject|0
1821|NCT02320396|11015|P1|Overall Study|Withdrawal by Subject|2
1822|NCT02320396|11014|P2|Overall Study|Protocol Violation|1
1823|NCT02320396|11015|P1|Overall Study|Protocol Violation|0
1824|NCT02320396|11014|P2|Overall Study|Pregnancy|1
1825|NCT02320396|11015|P1|Overall Study|Pregnancy|0
1826|NCT02320396|11014|P2|Overall Study|Adverse Event|2
1827|NCT02320396|11015|P1|Overall Study|Adverse Event|2
1828|NCT02319525|11057|P2|Overall Study|Withdrawal by Subject|1
1829|NCT02319525|11058|P1|Overall Study|Withdrawal by Subject|2
1830|NCT02319148|11081|P4|Second Intervention Period|Unspecified|1
1831|NCT02319148|11082|P3|Second Intervention Period|Unspecified|0
1832|NCT02319148|11083|P2|Second Intervention Period|Unspecified|0
1833|NCT02319148|11084|P1|Second Intervention Period|Unspecified|0
1834|NCT02319148|11081|P4|Second Intervention Period|No longer willing to participate|0
1835|NCT02319148|11082|P3|Second Intervention Period|No longer willing to participate|0
1836|NCT02319148|11083|P2|Second Intervention Period|No longer willing to participate|1
1837|NCT02319148|11084|P1|Second Intervention Period|No longer willing to participate|0
1838|NCT02319148|11081|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
1839|NCT02319148|11082|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
1840|NCT02319148|11083|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
1841|NCT02319148|11084|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
1842|NCT02319031|11146|P2|Treatment Period|Death|0
1843|NCT02319031|11147|P1|Treatment Period|Death|1
1844|NCT02318693|11172|P2|Overall Study|Protocol Violation|1
1845|NCT02318693|11173|P1|Overall Study|Protocol Violation|0
1846|NCT02317809|11187|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
1847|NCT02317809|11188|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
1848|NCT02317809|11187|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
1849|NCT02317809|11188|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
1850|NCT02317510|11232|P2|Overall Study|Adverse Event|1
1851|NCT02317510|11233|P1|Overall Study|Adverse Event|0
1852|NCT02317016|11261|P1|Period 3|Death|1
1853|NCT02317016|11261|P1|Period 3|Condition under investigation worsened|1
1854|NCT02317016|11261|P1|Period 2|Adverse Event|1
1855|NCT02316769|11287|P2|Overall Study|Withdrawal by Subject|0
1856|NCT02316769|11288|P1|Overall Study|Withdrawal by Subject|1
1857|NCT02316769|11287|P2|Overall Study|Physician Decision|0
1858|NCT02316769|11288|P1|Overall Study|Physician Decision|1
1859|NCT02316613|11296|P1|Overall Study|Did not met selection criteria|14
1860|NCT02316613|11296|P1|Overall Study|No data and duplicate cases|5
1861|NCT02316613|11296|P1|Overall Study|Participant moved/changed medical team|11
1862|NCT02316613|11296|P1|Overall Study|Lymphoma transformation|2
1863|NCT02316613|11296|P1|Overall Study|Lost to Follow-up|9
1864|NCT02316613|11296|P1|Overall Study|Death|63
1865|NCT02314637|11360|P2|Overall Study|Other Reason|0
1866|NCT02314637|11361|P1|Overall Study|Other Reason|1
1867|NCT02314637|11360|P2|Overall Study|Withdrawal by Subject|4
1868|NCT02314637|11361|P1|Overall Study|Withdrawal by Subject|5
1869|NCT02314637|11360|P2|Overall Study|Physician Decision|2
1870|NCT02314637|11361|P1|Overall Study|Physician Decision|5
1871|NCT02314637|11360|P2|Overall Study|Lack of Efficacy|0
1872|NCT02314637|11361|P1|Overall Study|Lack of Efficacy|1
1873|NCT02314637|11360|P2|Overall Study|Adverse Event|8
1874|NCT02314637|11361|P1|Overall Study|Adverse Event|4
1875|NCT02313766|11437|P3|Overall Study|Adverse Event|0
1876|NCT02313766|11438|P2|Overall Study|Adverse Event|1
1877|NCT02313766|11439|P1|Overall Study|Adverse Event|0
1878|NCT02313766|11437|P3|Overall Study|Lost to Follow-up|0
1879|NCT02313766|11438|P2|Overall Study|Lost to Follow-up|2
1880|NCT02313766|11439|P1|Overall Study|Lost to Follow-up|0
1881|NCT02313766|11437|P3|Overall Study|surgery cancelled|0
1882|NCT02313766|11438|P2|Overall Study|surgery cancelled|0
1883|NCT02313766|11439|P1|Overall Study|surgery cancelled|1
1884|NCT02313558|11455|P2|Overall Study|Lost to Follow-up|4
1885|NCT02313558|11456|P1|Overall Study|Lost to Follow-up|4
1886|NCT02313558|11455|P2|Overall Study|Withdrawal by Subject|0
1887|NCT02313558|11456|P1|Overall Study|Withdrawal by Subject|2
1888|NCT02313233|11470|P2|Overall Study|Administrative reason|1
1889|NCT02313233|11471|P1|Overall Study|Administrative reason|1
1890|NCT02313233|11470|P2|Overall Study|Withdrawal by Subject|2
1891|NCT02313233|11471|P1|Overall Study|Withdrawal by Subject|1
1892|NCT02313155|11493|P2|Overall Study|Lost to Follow-up|1
1893|NCT02313155|11494|P1|Overall Study|Lost to Follow-up|0
1894|NCT02310646|11610|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
1895|NCT02310646|11611|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
1896|NCT02310646|11610|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
1897|NCT02310646|11611|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
1898|NCT02310568|11640|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
1899|NCT02310568|11641|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
1900|NCT02310568|11642|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
1901|NCT02310568|11643|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
1902|NCT02310568|11644|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
1903|NCT02310568|11640|P5|Stage 2 (4 Weeks)|Protocol Violation|0
1904|NCT02310568|11641|P4|Stage 2 (4 Weeks)|Protocol Violation|1
1905|NCT02310568|11642|P3|Stage 2 (4 Weeks)|Protocol Violation|0
1906|NCT02310568|11643|P2|Stage 2 (4 Weeks)|Protocol Violation|0
1907|NCT02310568|11644|P1|Stage 2 (4 Weeks)|Protocol Violation|0
1908|NCT02310568|11640|P5|Stage 2 (4 Weeks)|Adverse Event|1
1909|NCT02310568|11641|P4|Stage 2 (4 Weeks)|Adverse Event|1
1910|NCT02310568|11642|P3|Stage 2 (4 Weeks)|Adverse Event|0
1911|NCT02310568|11643|P2|Stage 2 (4 Weeks)|Adverse Event|0
1912|NCT02310568|11644|P1|Stage 2 (4 Weeks)|Adverse Event|0
1913|NCT02310568|11640|P5|Stage 2 (4 Weeks)|Unspecified|0
1914|NCT02310568|11641|P4|Stage 2 (4 Weeks)|Unspecified|0
1915|NCT02310568|11642|P3|Stage 2 (4 Weeks)|Unspecified|1
1916|NCT02310568|11643|P2|Stage 2 (4 Weeks)|Unspecified|1
1917|NCT02310568|11644|P1|Stage 2 (4 Weeks)|Unspecified|0
1918|NCT02310568|11640|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1919|NCT02310568|11641|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
1920|NCT02310568|11642|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1921|NCT02310568|11643|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
1922|NCT02310568|11644|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
1923|NCT02310568|11640|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1924|NCT02310568|11641|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
1925|NCT02310568|11642|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1926|NCT02310568|11643|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1927|NCT02310568|11644|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
1928|NCT02310568|11640|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1929|NCT02310568|11641|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
1930|NCT02310568|11642|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1931|NCT02310568|11643|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1932|NCT02310568|11644|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
1933|NCT02310568|11640|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
1934|NCT02310568|11641|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
1935|NCT02310568|11642|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
1936|NCT02310568|11643|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
1937|NCT02310568|11644|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
1938|NCT02310568|11640|P5|Stage 1 ( 4 Weeks)|Unspecified|0
1939|NCT02310568|11641|P4|Stage 1 ( 4 Weeks)|Unspecified|0
1940|NCT02310568|11642|P3|Stage 1 ( 4 Weeks)|Unspecified|0
1941|NCT02310568|11643|P2|Stage 1 ( 4 Weeks)|Unspecified|1
1942|NCT02310568|11644|P1|Stage 1 ( 4 Weeks)|Unspecified|1
1943|NCT02310568|11640|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1944|NCT02310568|11641|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1945|NCT02310568|11642|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1946|NCT02310568|11643|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
1947|NCT02310568|11644|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
1948|NCT02310568|11640|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
1949|NCT02310568|11641|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1950|NCT02310568|11642|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1951|NCT02310568|11643|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1952|NCT02310568|11644|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
1953|NCT02310126|11724|P2|Period 1|Protocol Violation|1
1954|NCT02310126|11725|P1|Period 1|Protocol Violation|0
1955|NCT02310126|11724|P2|Period 1|Lost to Follow-up|1
1956|NCT02310126|11725|P1|Period 1|Lost to Follow-up|0
1957|NCT02309294|11731|P1|Overall Study|Withdrawal by Subject|2
1958|NCT02309112|11738|P3|Overall Study|Lost to Follow-up|0
1959|NCT02309112|11739|P2|Overall Study|Lost to Follow-up|1
1960|NCT02309112|11740|P1|Overall Study|Lost to Follow-up|0
1961|NCT02309112|11738|P3|Overall Study|Withdrawal by Subject|1
1962|NCT02309112|11739|P2|Overall Study|Withdrawal by Subject|0
1963|NCT02309112|11740|P1|Overall Study|Withdrawal by Subject|1
1964|NCT02308748|11776|P10|Period 5|Adverse Event|0
1965|NCT02308748|11777|P9|Period 5|Adverse Event|1
1966|NCT02308748|11778|P8|Period 5|Adverse Event|0
1967|NCT02308748|11779|P7|Period 5|Adverse Event|0
1968|NCT02308748|11780|P6|Period 5|Adverse Event|0
1969|NCT02308748|11781|P5|Period 5|Adverse Event|0
1970|NCT02308748|11782|P4|Period 5|Adverse Event|0
1971|NCT02308748|11783|P3|Period 5|Adverse Event|0
1972|NCT02308748|11784|P2|Period 5|Adverse Event|0
1973|NCT02308748|11785|P1|Period 5|Adverse Event|1
1974|NCT02308748|11776|P10|Period 3|Protocol Violation|1
1975|NCT02308748|11777|P9|Period 3|Protocol Violation|0
1976|NCT02308748|11778|P8|Period 3|Protocol Violation|0
1977|NCT02308748|11779|P7|Period 3|Protocol Violation|0
1978|NCT02308748|11780|P6|Period 3|Protocol Violation|0
1979|NCT02308748|11781|P5|Period 3|Protocol Violation|0
1980|NCT02308748|11782|P4|Period 3|Protocol Violation|0
1981|NCT02308748|11783|P3|Period 3|Protocol Violation|0
1982|NCT02308748|11784|P2|Period 3|Protocol Violation|0
1983|NCT02308748|11785|P1|Period 3|Protocol Violation|0
1984|NCT02308748|11776|P10|Period 2|Adverse Event|0
1985|NCT02308748|11777|P9|Period 2|Adverse Event|0
1986|NCT02308748|11778|P8|Period 2|Adverse Event|1
1987|NCT02308748|11779|P7|Period 2|Adverse Event|0
1988|NCT02308748|11780|P6|Period 2|Adverse Event|0
1989|NCT02308748|11781|P5|Period 2|Adverse Event|0
1990|NCT02308748|11782|P4|Period 2|Adverse Event|0
1991|NCT02308748|11783|P3|Period 2|Adverse Event|0
1992|NCT02308748|11784|P2|Period 2|Adverse Event|0
1993|NCT02308748|11785|P1|Period 2|Adverse Event|0
1994|NCT02308748|11776|P10|Period 1|Withdrawal by Subject|0
1995|NCT02308748|11777|P9|Period 1|Withdrawal by Subject|0
1996|NCT02308748|11778|P8|Period 1|Withdrawal by Subject|0
1997|NCT02308748|11779|P7|Period 1|Withdrawal by Subject|0
1998|NCT02308748|11780|P6|Period 1|Withdrawal by Subject|0
1999|NCT02308748|11781|P5|Period 1|Withdrawal by Subject|0
2000|NCT02308748|11782|P4|Period 1|Withdrawal by Subject|0
2001|NCT02308748|11783|P3|Period 1|Withdrawal by Subject|1
2002|NCT02308748|11784|P2|Period 1|Withdrawal by Subject|0
2003|NCT02308748|11785|P1|Period 1|Withdrawal by Subject|0
2004|NCT02307266|11824|P3|Overall Study|Lost to Follow-up|0
2005|NCT02307266|11825|P2|Overall Study|Lost to Follow-up|0
2006|NCT02307266|11826|P1|Overall Study|Lost to Follow-up|3
2007|NCT02307266|11824|P3|Overall Study|Withdrawal by Subject|1
2008|NCT02307266|11825|P2|Overall Study|Withdrawal by Subject|0
2009|NCT02307266|11826|P1|Overall Study|Withdrawal by Subject|2
2010|NCT02307266|11824|P3|Overall Study|Adverse Event|5
2011|NCT02307266|11825|P2|Overall Study|Adverse Event|1
2012|NCT02307266|11826|P1|Overall Study|Adverse Event|3
2013|NCT02305446|11851|P1|Overall Study|Adverse Event|1
2014|NCT02304926|11954|P2|Overall Study|Lost to Follow-up|1
2015|NCT02304926|11955|P1|Overall Study|Lost to Follow-up|2
2016|NCT02303704|12012|P2|Overall Study|Protocol Violation|9
2017|NCT02303704|12013|P1|Overall Study|Protocol Violation|5
2018|NCT02301429|12045|P1|Overall Study|not acceptable vascular anatomy|3
2019|NCT02301169|12064|P2|Overall Study|Adverse Event|0
2020|NCT02301169|12065|P1|Overall Study|Adverse Event|1
2021|NCT02300311|12081|P2|Overall Study|Refused to continue taking medication|0
2022|NCT02300311|12082|P1|Overall Study|Refused to continue taking medication|18
2023|NCT02300311|12081|P2|Overall Study|Other than the reason specified|0
2024|NCT02300311|12082|P1|Overall Study|Other than the reason specified|1
2025|NCT02300129|12094|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
2026|NCT02300129|12095|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
2027|NCT02300129|12096|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
2028|NCT02300129|12097|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
2029|NCT02300129|12094|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
2030|NCT02300129|12095|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
2031|NCT02300129|12096|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
2032|NCT02300129|12097|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
2033|NCT02300129|12094|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
2034|NCT02300129|12095|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
2035|NCT02300129|12096|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
2036|NCT02300129|12097|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
2037|NCT02299635|12186|P1|Overall Study|Unspecified|3
2038|NCT02299635|12186|P1|Overall Study|Withdrawal by Subject|2
2039|NCT02299635|12186|P1|Overall Study|Objective progression or relapse|10
2040|NCT02299635|12186|P1|Overall Study|Global deterioration of health status|1
2041|NCT02299635|12186|P1|Overall Study|Death|1
2042|NCT02299635|12186|P1|Overall Study|Adverse Event|2
2043|NCT02299427|12207|P2|Overall Study|not adherent to dog website use|0
2044|NCT02299427|12208|P1|Overall Study|not adherent to dog website use|21
2045|NCT02299427|12207|P2|Overall Study|Lost to Follow-up|3
2046|NCT02299427|12208|P1|Overall Study|Lost to Follow-up|1
2047|NCT02299427|12207|P2|Overall Study|Withdrawal by Subject|0
2048|NCT02299427|12208|P1|Overall Study|Withdrawal by Subject|1
2049|NCT02298868|12238|P1|Overall Study|Patient underwent transplant|1
2050|NCT02298868|12238|P1|Overall Study|Death|1
2051|NCT02298868|12238|P1|Overall Study|Adverse Event|1
2052|NCT02297841|12269|P1|Overall Study|Protocol Violation|7
2053|NCT02297841|12269|P1|Overall Study|Withdrawal by Subject|1
2054|NCT02296931|12280|P2|Overall Study|Protocol Violation|2
2055|NCT02296931|12281|P1|Overall Study|Protocol Violation|0
2056|NCT02295774|12287|P1|Overall Study|Withdrawal by Subject|2
2057|NCT02295774|12287|P1|Overall Study|Lost to Follow-up|1
2058|NCT02295020|12318|P2|Overall Study|Withdrawal by Subject|2
2059|NCT02295020|12319|P1|Overall Study|Withdrawal by Subject|3
2060|NCT02295020|12318|P2|Overall Study|Adverse Event|1
2061|NCT02295020|12319|P1|Overall Study|Adverse Event|0
2062|NCT02294773|12351|P2|Overall Study|Withdrawal by Subject|2
2063|NCT02294773|12352|P1|Overall Study|Withdrawal by Subject|0
2064|NCT02294604|12369|P3|Overall Study|Culture contamination|2
2065|NCT02294604|12370|P2|Overall Study|Culture contamination|0
2066|NCT02294604|12371|P1|Overall Study|Culture contamination|1
2067|NCT02294604|12369|P3|Overall Study|Did not provide samples for culture|1
2068|NCT02294604|12370|P2|Overall Study|Did not provide samples for culture|0
2069|NCT02294604|12371|P1|Overall Study|Did not provide samples for culture|0
2070|NCT02294019|12388|P1|Overall Study|Withdrawal by Subject|1
2071|NCT02294019|12388|P1|Overall Study|Unspecified|1
2072|NCT02294019|12388|P1|Overall Study|Lost to Follow-up|31
2073|NCT02294019|12388|P1|Overall Study|Protocol Violation|68
2074|NCT02294019|12388|P1|Overall Study|Adverse Event|2
2075|NCT02293538|12395|P2|Overall Study|Withdrawal by Subject|1
2076|NCT02293538|12396|P1|Overall Study|Withdrawal by Subject|0
2077|NCT02293538|12395|P2|Overall Study|Lost to Follow-up|0
2078|NCT02293538|12396|P1|Overall Study|Lost to Follow-up|1
2079|NCT02293538|12395|P2|Overall Study|Adverse Event|1
2080|NCT02293538|12396|P1|Overall Study|Adverse Event|0
2081|NCT02291510|12489|P4|Overall Study|Adverse Event|1
2082|NCT02291510|12490|P3|Overall Study|Adverse Event|0
2083|NCT02291510|12491|P2|Overall Study|Adverse Event|0
2084|NCT02291510|12492|P1|Overall Study|Adverse Event|0
2085|NCT02291419|12508|P2|Overall Study|Early study termination|5
2086|NCT02291419|12509|P1|Overall Study|Early study termination|1
2087|NCT02289742|12547|P4|Third Wear Period|Reason not given|1
2088|NCT02289742|12548|P3|Third Wear Period|Reason not given|0
2089|NCT02289742|12549|P2|Third Wear Period|Reason not given|0
2090|NCT02289742|12550|P1|Third Wear Period|Reason not given|0
2091|NCT02289742|12547|P4|Third Wear Period|Adverse Event|0
2092|NCT02289742|12548|P3|Third Wear Period|Adverse Event|0
2093|NCT02289742|12549|P2|Third Wear Period|Adverse Event|1
2094|NCT02289742|12550|P1|Third Wear Period|Adverse Event|0
2095|NCT02289742|12547|P4|First Wear Period|Other prior to treatment|1
2096|NCT02289742|12548|P3|First Wear Period|Other prior to treatment|0
2097|NCT02289742|12549|P2|First Wear Period|Other prior to treatment|0
2098|NCT02289742|12550|P1|First Wear Period|Other prior to treatment|0
2099|NCT02289742|12547|P4|First Wear Period|Adverse Event|0
2100|NCT02289742|12548|P3|First Wear Period|Adverse Event|1
2101|NCT02289742|12549|P2|First Wear Period|Adverse Event|0
2102|NCT02289742|12550|P1|First Wear Period|Adverse Event|0
2103|NCT02289742|12547|P4|First Wear Period|Adverse event prior to treatment|0
2104|NCT02289742|12548|P3|First Wear Period|Adverse event prior to treatment|0
2105|NCT02289742|12549|P2|First Wear Period|Adverse event prior to treatment|1
2106|NCT02289742|12550|P1|First Wear Period|Adverse event prior to treatment|0
2107|NCT02289079|12582|P2|Overall Study|Lost to Follow-up|1
2108|NCT02289079|12583|P1|Overall Study|Lost to Follow-up|0
2109|NCT02289079|12582|P2|Overall Study|Physician Decision|0
2110|NCT02289079|12583|P1|Overall Study|Physician Decision|2
2111|NCT02288312|12625|P3|Overall Study|Pregnancy|0
2112|NCT02288312|12626|P2|Overall Study|Pregnancy|0
2113|NCT02288312|12627|P1|Overall Study|Pregnancy|1
2114|NCT02287623|12820|P2|Overall Study|Protocol Violation|1
2115|NCT02287623|12821|P1|Overall Study|Protocol Violation|0
2116|NCT02287610|12837|P1|Overall Study|Excluded-investigator non-responsiveness|5
2117|NCT02287610|12837|P1|Overall Study|Withdrawal by Subject|8
2118|NCT02287610|12837|P1|Overall Study|Lost to Follow-up|3
2119|NCT02287402|12876|P1|Follow-up|Voluntary Withdrawal|2
2120|NCT02287402|12876|P1|Follow-up|Lost to Follow-up|1
2121|NCT02287402|12876|P1|Treatment Period|Voluntary Withdrawal|10
2122|NCT02287402|12876|P1|Treatment Period|Adverse Event|17
2123|NCT02286193|13058|P1|Overall Study|Referred: Declined service|38
2124|NCT02286193|13058|P1|Overall Study|Referred: unable to reach/resource sent|104
2125|NCT02286193|13058|P1|Overall Study|Referred: CRS unable to make contact|62
2126|NCT02285998|13065|P2|Overall Study|Other Reasons|10
2127|NCT02285998|13066|P1|Overall Study|Other Reasons|7
2128|NCT02285998|13065|P2|Overall Study|Withdrawal by Subject|61
2129|NCT02285998|13066|P1|Overall Study|Withdrawal by Subject|53
2130|NCT02285998|13065|P2|Overall Study|Lost to Follow-up|172
2131|NCT02285998|13066|P1|Overall Study|Lost to Follow-up|176
2132|NCT02285998|13065|P2|Overall Study|Physician Decision|2
2133|NCT02285998|13066|P1|Overall Study|Physician Decision|1
2134|NCT02285998|13065|P2|Overall Study|Adverse Event|8
2135|NCT02285998|13066|P1|Overall Study|Adverse Event|9
2136|NCT02285270|13090|P1|Overall Study|Determined to be ineligible|1
2137|NCT02285270|13090|P1|Overall Study|Physician Decision|3
2138|NCT02285270|13090|P1|Overall Study|Lost to Follow-up|1
2139|NCT02284347|13172|P1|Overall Study|Withdrawn prior to treatment|1
2140|NCT02284347|13172|P1|Overall Study|Lost to Follow-up|2
2141|NCT02283788|13256|P4|Overall Study|Withdrawal by Subject|1
2142|NCT02283788|13257|P3|Overall Study|Withdrawal by Subject|0
2143|NCT02283788|13258|P2|Overall Study|Withdrawal by Subject|1
2144|NCT02283788|13259|P1|Overall Study|Withdrawal by Subject|0
2145|NCT02283788|13256|P4|Overall Study|Adverse Event|1
2146|NCT02283788|13257|P3|Overall Study|Adverse Event|5
2147|NCT02283788|13258|P2|Overall Study|Adverse Event|3
2148|NCT02283788|13259|P1|Overall Study|Adverse Event|1
2149|NCT02282982|13269|P1|Overall Study|Other, not specified|18
2150|NCT02282982|13269|P1|Overall Study|Palivizumab is ended|11
2151|NCT02282982|13269|P1|Overall Study|Lack of product|156
2152|NCT02282982|13269|P1|Overall Study|Death|4
2153|NCT02282982|13269|P1|Overall Study|Withdrew consent|2
2154|NCT02282982|13269|P1|Overall Study|Lost to Follow-up|15
2155|NCT02282813|13287|P3|Overall Study|Administrative reasons|0
2156|NCT02282813|13288|P2|Overall Study|Administrative reasons|1
2157|NCT02282813|13289|P1|Overall Study|Administrative reasons|0
2158|NCT02282813|13287|P3|Overall Study|Lack of Efficacy|0
2159|NCT02282813|13288|P2|Overall Study|Lack of Efficacy|0
2160|NCT02282813|13289|P1|Overall Study|Lack of Efficacy|1
2161|NCT02282813|13287|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
2162|NCT02282813|13288|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
2163|NCT02282813|13289|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
2164|NCT02282813|13287|P3|Overall Study|Lost to Follow-up|1
2165|NCT02282813|13288|P2|Overall Study|Lost to Follow-up|0
2166|NCT02282813|13289|P1|Overall Study|Lost to Follow-up|2
2167|NCT02282813|13287|P3|Overall Study|Physician Decision|1
2168|NCT02282813|13288|P2|Overall Study|Physician Decision|3
2169|NCT02282813|13289|P1|Overall Study|Physician Decision|0
2170|NCT02282813|13287|P3|Overall Study|Subject non-compliance|0
2171|NCT02282813|13288|P2|Overall Study|Subject non-compliance|4
2172|NCT02282813|13289|P1|Overall Study|Subject non-compliance|1
2173|NCT02282813|13287|P3|Overall Study|Adverse Event|1
2174|NCT02282813|13288|P2|Overall Study|Adverse Event|10
2175|NCT02282813|13289|P1|Overall Study|Adverse Event|3
2176|NCT02282813|13287|P3|Overall Study|Withdrawal by Subject|0
2177|NCT02282813|13288|P2|Overall Study|Withdrawal by Subject|5
2178|NCT02282813|13289|P1|Overall Study|Withdrawal by Subject|4
2179|NCT02282605|13309|P3|Overall Study|negative SA result on Day -1|0
2180|NCT02282605|13310|P2|Overall Study|negative SA result on Day -1|0
2181|NCT02282605|13311|P1|Overall Study|negative SA result on Day -1|3
2182|NCT02280499|13456|P1|Overall Study|Adverse Event|5
2183|NCT02280499|13456|P1|Overall Study|Lost to Follow-up|42
2184|NCT02280499|13456|P1|Overall Study|Death|14
2185|NCT02280187|13462|P1|Overall Study|Lost to Follow-up|218
2186|NCT02279407|13515|P4|Overall Study|Adverse Event|0
2187|NCT02279407|13516|P3|Overall Study|Adverse Event|2
2188|NCT02279407|13517|P2|Overall Study|Adverse Event|1
2189|NCT02279407|13518|P1|Overall Study|Adverse Event|1
2190|NCT02279407|13515|P4|Overall Study|Withdrawal by Subject|1
2191|NCT02279407|13516|P3|Overall Study|Withdrawal by Subject|1
2192|NCT02279407|13517|P2|Overall Study|Withdrawal by Subject|0
2193|NCT02279407|13518|P1|Overall Study|Withdrawal by Subject|1
2194|NCT02279407|13515|P4|Overall Study|Couldn't swallow IP; noncompliance|0
2195|NCT02279407|13516|P3|Overall Study|Couldn't swallow IP; noncompliance|2
2196|NCT02279407|13517|P2|Overall Study|Couldn't swallow IP; noncompliance|0
2197|NCT02279407|13518|P1|Overall Study|Couldn't swallow IP; noncompliance|0
2198|NCT02278614|13545|P2|Overall Study|left eye was not eligible|0
2199|NCT02278614|13546|P1|Overall Study|left eye was not eligible|1
2200|NCT02278614|13545|P2|Overall Study|Adverse Event|0
2201|NCT02278614|13546|P1|Overall Study|Adverse Event|1
2202|NCT02278614|13545|P2|Overall Study|Withdrawal by Subject|5
2203|NCT02278614|13546|P1|Overall Study|Withdrawal by Subject|3
2204|NCT02277119|13599|P3|Overall Study|Protocol Violation|7
2205|NCT02277119|13600|P2|Overall Study|Protocol Violation|3
2206|NCT02277119|13601|P1|Overall Study|Protocol Violation|2
2207|NCT02277119|13599|P3|Overall Study|Lack of Efficacy|1
2208|NCT02277119|13600|P2|Overall Study|Lack of Efficacy|1
2209|NCT02277119|13601|P1|Overall Study|Lack of Efficacy|1
2210|NCT02275546|13745|P2|Treatment Period 2|Protocol Violation|1
2211|NCT02275546|13746|P1|Treatment Period 2|Protocol Violation|0
2212|NCT02275546|13745|P2|Treatment Period 2|Withdrawal by Subject|1
2213|NCT02275546|13746|P1|Treatment Period 2|Withdrawal by Subject|2
2214|NCT02275364|13754|P2|Period 1|Other reason|0
2215|NCT02275364|13755|P1|Period 1|Other reason|1
2216|NCT02275364|13754|P2|Period 1|Withdrawal by Subject|0
2217|NCT02275364|13755|P1|Period 1|Withdrawal by Subject|1
2218|NCT02274948|13818|P2|Overall Study|Left the area|3
2219|NCT02274948|13819|P1|Overall Study|Left the area|4
2220|NCT02274948|13818|P2|Overall Study|Stopped on family Practitioner advice|5
2221|NCT02274948|13819|P1|Overall Study|Stopped on family Practitioner advice|2
2222|NCT02274948|13818|P2|Overall Study|Withdrawal by Subject|58
2223|NCT02274948|13819|P1|Overall Study|Withdrawal by Subject|64
2224|NCT02274948|13818|P2|Overall Study|Lost to Follow-up|25
2225|NCT02274948|13819|P1|Overall Study|Lost to Follow-up|28
2226|NCT02274792|13833|P1|Overall Study|Sponsor Decision|2
2227|NCT02274792|13833|P1|Overall Study|Protocol Specified Criteria|2
2228|NCT02274792|13833|P1|Overall Study|Lost to Follow-up|8
2229|NCT02274792|13833|P1|Overall Study|Withdrawal by Subject|13
2230|NCT02273908|13853|P2|Overall Study|Withdrawal by Subject|2
2231|NCT02273908|13854|P1|Overall Study|Withdrawal by Subject|4
2232|NCT02273908|13853|P2|Overall Study|Did not meet entrance criteria|2
2233|NCT02273908|13854|P1|Overall Study|Did not meet entrance criteria|3
2234|NCT02273908|13853|P2|Overall Study|Lost to Follow-up|1
2235|NCT02273908|13854|P1|Overall Study|Lost to Follow-up|10
2236|NCT02273908|13853|P2|Overall Study|Adverse Event|0
2237|NCT02273908|13854|P1|Overall Study|Adverse Event|16
2238|NCT02273752|13876|P1|Overall Study|Trial was terminated early|2
2239|NCT02271854|13918|P1|Overall Study|Lost to Follow-up|1
2240|NCT02271854|13918|P1|Overall Study|Unable or unwilling to cooperate with st|1
2241|NCT02271854|13918|P1|Overall Study|Withdrawal by Subject|2
2242|NCT02271529|13925|P1|Overall Study|Withdrawal by Subject|1
2243|NCT02269657|13944|P1|Overall Study|Protocol Violation|3
2244|NCT02269475|13964|P2|Overall Study|Withdrawal by Subject|1
2245|NCT02269475|13965|P1|Overall Study|Withdrawal by Subject|0
2246|NCT02269475|13964|P2|Overall Study|Meet Exclusion Criteria No. 17|0
2247|NCT02269475|13965|P1|Overall Study|Meet Exclusion Criteria No. 17|3
2248|NCT02269098|13978|P2|Overall Study|Lost to Follow-up|9
2249|NCT02269098|13979|P1|Overall Study|Lost to Follow-up|14
2250|NCT02268864|13996|P3|Overall Study|Death|0
2251|NCT02268864|13997|P2|Overall Study|Death|1
2252|NCT02268864|13998|P1|Overall Study|Death|0
2253|NCT02268864|13996|P3|Overall Study|Withdrawal by Subject|0
2254|NCT02268864|13997|P2|Overall Study|Withdrawal by Subject|0
2255|NCT02268864|13998|P1|Overall Study|Withdrawal by Subject|2
2256|NCT02268396|14020|P1|Overall Study|2 Subjects no Day 29 Assessment|2
2257|NCT02268396|14020|P1|Overall Study|Protocol-Specified Criteria|2
2258|NCT02268396|14020|P1|Overall Study|Lost to Follow-up|2
2259|NCT02268396|14020|P1|Overall Study|Withdrawal by Subject|1
2260|NCT02268396|14020|P1|Overall Study|Administrative|2
2261|NCT02268396|14020|P1|Overall Study|Adverse Event|3
2262|NCT02268058|14033|P4|Overall Study|Protocol Violation|0
2263|NCT02268058|14034|P3|Overall Study|Protocol Violation|0
2264|NCT02268058|14035|P2|Overall Study|Protocol Violation|0
2265|NCT02268058|14036|P1|Overall Study|Protocol Violation|1
2266|NCT02267824|14069|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
2267|NCT02267824|14070|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
2268|NCT02267824|14069|P2|Overall Study|Protocol Violation|0
2269|NCT02267824|14070|P1|Overall Study|Protocol Violation|3
2270|NCT02267824|14069|P2|Overall Study|Lost to Follow-up|0
2271|NCT02267824|14070|P1|Overall Study|Lost to Follow-up|4
2272|NCT02267824|14069|P2|Overall Study|Pregnancy|1
2273|NCT02267824|14070|P1|Overall Study|Pregnancy|1
2274|NCT02266381|14098|P3|Overall Study|Physician Decision|4
2275|NCT02266381|14099|P2|Overall Study|Physician Decision|5
2276|NCT02266381|14100|P1|Overall Study|Physician Decision|3
2277|NCT02264821|14135|P3|Overall Study|Protocol Violation|6
2278|NCT02264821|14136|P2|Overall Study|Protocol Violation|3
2279|NCT02264821|14137|P1|Overall Study|Protocol Violation|1
2280|NCT02262754|14215|P3|Overall Study|Unspecified|2
2281|NCT02262754|14216|P2|Overall Study|Unspecified|0
2282|NCT02262754|14217|P1|Overall Study|Unspecified|4
2283|NCT02262754|14215|P3|Overall Study|Withdrawal by Subject|1
2284|NCT02262754|14216|P2|Overall Study|Withdrawal by Subject|0
2285|NCT02262754|14217|P1|Overall Study|Withdrawal by Subject|1
2286|NCT02262754|14215|P3|Overall Study|Protocol Violation|0
2287|NCT02262754|14216|P2|Overall Study|Protocol Violation|0
2288|NCT02262754|14217|P1|Overall Study|Protocol Violation|1
2289|NCT02262754|14215|P3|Overall Study|Study terminated by sponsor|4
2290|NCT02262754|14216|P2|Overall Study|Study terminated by sponsor|4
2291|NCT02262754|14217|P1|Overall Study|Study terminated by sponsor|5
2292|NCT02262754|14215|P3|Overall Study|No longer meets eligibility criteria|0
2293|NCT02262754|14216|P2|Overall Study|No longer meets eligibility criteria|1
2294|NCT02262754|14217|P1|Overall Study|No longer meets eligibility criteria|0
2295|NCT02262754|14215|P3|Overall Study|Lost to Follow-up|1
2296|NCT02262754|14216|P2|Overall Study|Lost to Follow-up|0
2297|NCT02262754|14217|P1|Overall Study|Lost to Follow-up|0
2298|NCT02262754|14215|P3|Overall Study|Lack of Efficacy|1
2299|NCT02262754|14216|P2|Overall Study|Lack of Efficacy|0
2300|NCT02262754|14217|P1|Overall Study|Lack of Efficacy|2
2301|NCT02262754|14215|P3|Overall Study|Adverse Event|0
2302|NCT02262754|14216|P2|Overall Study|Adverse Event|4
2303|NCT02262754|14217|P1|Overall Study|Adverse Event|3
2304|NCT02260882|14387|P2|Overall Study|Protocol Violation|1
2305|NCT02260882|14388|P1|Overall Study|Protocol Violation|0
2306|NCT02259400|14417|P2|Overall Study|Death|2
2307|NCT02259400|14418|P1|Overall Study|Death|0
2308|NCT02259348|14450|P1|Overall Study|Death|4
2309|NCT02259348|14450|P1|Overall Study|Donors|6
2310|NCT02258334|14484|P4|Overall Study|Adverse Event|0
2311|NCT02258334|14485|P3|Overall Study|Adverse Event|0
2312|NCT02258334|14486|P2|Overall Study|Adverse Event|0
2313|NCT02258334|14487|P1|Overall Study|Adverse Event|1
2314|NCT02257918|14516|P3|Overall Study|Pregnancy|1
2315|NCT02257918|14517|P2|Overall Study|Pregnancy|0
2316|NCT02257918|14518|P1|Overall Study|Pregnancy|0
2317|NCT02257918|14516|P3|Overall Study|Withdrawal by Subject|1
2318|NCT02257918|14517|P2|Overall Study|Withdrawal by Subject|0
2319|NCT02257918|14518|P1|Overall Study|Withdrawal by Subject|0
2320|NCT02257918|14516|P3|Overall Study|Lost to Follow-up|0
2321|NCT02257918|14517|P2|Overall Study|Lost to Follow-up|1
2322|NCT02257918|14518|P1|Overall Study|Lost to Follow-up|4
2323|NCT02257385|14570|P2|Overall Study|Withdrawal by Subject|4
2324|NCT02257385|14571|P1|Overall Study|Withdrawal by Subject|4
2325|NCT02257385|14570|P2|Overall Study|Lost to Follow-up|1
2326|NCT02257385|14571|P1|Overall Study|Lost to Follow-up|0
2327|NCT02257385|14570|P2|Overall Study|Protocol Violation|7
2328|NCT02257385|14571|P1|Overall Study|Protocol Violation|5
2329|NCT02257385|14570|P2|Overall Study|Lack of Efficacy|2
2330|NCT02257385|14571|P1|Overall Study|Lack of Efficacy|1
2331|NCT02257385|14570|P2|Overall Study|Adverse Event|8
2332|NCT02257385|14571|P1|Overall Study|Adverse Event|12
2333|NCT02257372|14581|P2|Overall Study|Withdrew consent|0
2334|NCT02257372|14582|P1|Overall Study|Withdrew consent|1
2335|NCT02257372|14581|P2|Overall Study|Lost to Follow-up|1
2336|NCT02257372|14582|P1|Overall Study|Lost to Follow-up|0
2337|NCT02257372|14581|P2|Overall Study|Protocol Violation|1
2338|NCT02257372|14582|P1|Overall Study|Protocol Violation|1
2339|NCT02257372|14581|P2|Overall Study|Lack of Efficacy|1
2340|NCT02257372|14582|P1|Overall Study|Lack of Efficacy|2
2341|NCT02257372|14581|P2|Overall Study|Adverse Event|7
2342|NCT02257372|14582|P1|Overall Study|Adverse Event|3
2343|NCT02256982|14592|P2|Overall Study|Disease Progression|1
2344|NCT02256982|14593|P1|Overall Study|Disease Progression|0
2345|NCT02256553|14599|P1|Period III|Adverse Event|3
2346|NCT02256553|14599|P1|Period II|Subject Moved|1
2347|NCT02256553|14599|P1|Period II|Adverse Event|1
2348|NCT02256553|14599|P1|Period I|Protocol Violation|1
2349|NCT02256553|14599|P1|Period I|Adverse Event|5
2350|NCT02256488|14612|P4|Overall Study|Withdrawal by Subject|2
2351|NCT02256488|14613|P3|Overall Study|Withdrawal by Subject|0
2352|NCT02256488|14614|P2|Overall Study|Withdrawal by Subject|0
2353|NCT02256488|14615|P1|Overall Study|Withdrawal by Subject|1
2354|NCT02256488|14612|P4|Overall Study|OTHER|1
2355|NCT02256488|14613|P3|Overall Study|OTHER|1
2356|NCT02256488|14614|P2|Overall Study|OTHER|0
2357|NCT02256488|14615|P1|Overall Study|OTHER|1
2358|NCT02256488|14612|P4|Overall Study|Lost to Follow-up|3
2359|NCT02256488|14613|P3|Overall Study|Lost to Follow-up|9
2360|NCT02256488|14614|P2|Overall Study|Lost to Follow-up|6
2361|NCT02256488|14615|P1|Overall Study|Lost to Follow-up|6
2362|NCT02255279|14657|P2|Overall Study|Withdrawal by Subject|6
2363|NCT02255279|14658|P1|Overall Study|Withdrawal by Subject|3
2364|NCT02255279|14657|P2|Overall Study|Protocol Violation|1
2365|NCT02255279|14658|P1|Overall Study|Protocol Violation|0
2366|NCT02255279|14657|P2|Overall Study|Lost to Follow-up|2
2367|NCT02255279|14658|P1|Overall Study|Lost to Follow-up|2
2368|NCT02255149|14684|P1|Overall Study|Implant Failure|1
2369|NCT02255149|14684|P1|Overall Study|Withdrawal by PI|1
2370|NCT02255149|14684|P1|Overall Study|Withdrawal by Subject|1
2371|NCT02255149|14684|P1|Overall Study|Lost to Follow-up|2
2372|NCT02254551|14688|P1|Dose Escalation|Dose-limiting toxicity|2
2373|NCT02254551|14688|P1|Dose Escalation|Physician Decision|1
2374|NCT02252965|14752|P2|Overall Study|Unspecified|5
2375|NCT02252965|14753|P1|Overall Study|Unspecified|4
2376|NCT02252965|14752|P2|Overall Study|Withdrawal by Subject|9
2377|NCT02252965|14753|P1|Overall Study|Withdrawal by Subject|7
2378|NCT02252965|14752|P2|Overall Study|Lack of Efficacy|2
2379|NCT02252965|14753|P1|Overall Study|Lack of Efficacy|0
2380|NCT02252965|14752|P2|Overall Study|Protocol Violation|5
2381|NCT02252965|14753|P1|Overall Study|Protocol Violation|4
2382|NCT02252965|14752|P2|Overall Study|Lost to Follow-up|8
2383|NCT02252965|14753|P1|Overall Study|Lost to Follow-up|16
2384|NCT02252965|14752|P2|Overall Study|Adverse Event|14
2385|NCT02252965|14753|P1|Overall Study|Adverse Event|9
2386|NCT02252016|14868|P2|Safety Follow-Up|Ongoing in follow-up|50
2387|NCT02252016|14869|P1|Safety Follow-Up|Ongoing in follow-up|106
2388|NCT02252016|14868|P2|Treatment|Adverse Event|1
2389|NCT02252016|14869|P1|Treatment|Adverse Event|0
2390|NCT02252016|14868|P2|Treatment|Protocol Violation|0
2391|NCT02252016|14869|P1|Treatment|Protocol Violation|1
2392|NCT02252016|14868|P2|Treatment|Withdrawal by Subject|1
2393|NCT02252016|14869|P1|Treatment|Withdrawal by Subject|0
2394|NCT02250274|14926|P2|Overall Study|Insufficient blood draw amount|6
2395|NCT02250274|14927|P1|Overall Study|Insufficient blood draw amount|7
2396|NCT02248818|14980|P9|Randomised Study|Administrative - randomization error|0
2397|NCT02248818|14981|P8|Randomised Study|Administrative - randomization error|0
2398|NCT02248818|14982|P7|Randomised Study|Administrative - randomization error|0
2399|NCT02248818|14983|P6|Randomised Study|Administrative - randomization error|8
2400|NCT02248818|14984|P5|Randomised Study|Administrative - randomization error|0
2401|NCT02248818|14985|P4|Randomised Study|Administrative - randomization error|0
2402|NCT02248818|14986|P3|Randomised Study|Administrative - randomization error|0
2403|NCT02248818|14987|P2|Randomised Study|Administrative - randomization error|0
2404|NCT02248818|14988|P1|Randomised Study|Administrative - randomization error|0
2405|NCT02248818|14980|P9|Screening|Lost to Follow-up|7
2406|NCT02248818|14981|P8|Screening|Lost to Follow-up|0
2407|NCT02248818|14982|P7|Screening|Lost to Follow-up|0
2408|NCT02248818|14983|P6|Screening|Lost to Follow-up|0
2409|NCT02248818|14984|P5|Screening|Lost to Follow-up|0
2410|NCT02248818|14985|P4|Screening|Lost to Follow-up|0
2411|NCT02248818|14986|P3|Screening|Lost to Follow-up|0
2412|NCT02248818|14987|P2|Screening|Lost to Follow-up|0
2413|NCT02248818|14988|P1|Screening|Lost to Follow-up|0
2414|NCT02248818|14980|P9|Screening|Withdrawal by Subject|6
2415|NCT02248818|14981|P8|Screening|Withdrawal by Subject|0
2416|NCT02248818|14982|P7|Screening|Withdrawal by Subject|0
2417|NCT02248818|14983|P6|Screening|Withdrawal by Subject|0
2418|NCT02248818|14984|P5|Screening|Withdrawal by Subject|0
2419|NCT02248818|14985|P4|Screening|Withdrawal by Subject|0
2420|NCT02248818|14986|P3|Screening|Withdrawal by Subject|0
2421|NCT02248818|14987|P2|Screening|Withdrawal by Subject|0
2422|NCT02248818|14988|P1|Screening|Withdrawal by Subject|0
2423|NCT02248818|14980|P9|Screening|Physician Decision|73
2424|NCT02248818|14981|P8|Screening|Physician Decision|0
2425|NCT02248818|14982|P7|Screening|Physician Decision|0
2426|NCT02248818|14983|P6|Screening|Physician Decision|0
2427|NCT02248818|14984|P5|Screening|Physician Decision|0
2428|NCT02248818|14985|P4|Screening|Physician Decision|0
2429|NCT02248818|14986|P3|Screening|Physician Decision|0
2430|NCT02248818|14987|P2|Screening|Physician Decision|0
2431|NCT02248818|14988|P1|Screening|Physician Decision|0
2432|NCT02248818|14980|P9|Screening|Study fully enrolled|14
2433|NCT02248818|14981|P8|Screening|Study fully enrolled|0
2434|NCT02248818|14982|P7|Screening|Study fully enrolled|0
2435|NCT02248818|14983|P6|Screening|Study fully enrolled|0
2436|NCT02248818|14984|P5|Screening|Study fully enrolled|0
2437|NCT02248818|14985|P4|Screening|Study fully enrolled|0
2438|NCT02248818|14986|P3|Screening|Study fully enrolled|0
2439|NCT02248818|14987|P2|Screening|Study fully enrolled|0
2440|NCT02248818|14988|P1|Screening|Study fully enrolled|0
2441|NCT02248818|14980|P9|Screening|Protocol Violation|7
2442|NCT02248818|14981|P8|Screening|Protocol Violation|0
2443|NCT02248818|14982|P7|Screening|Protocol Violation|0
2444|NCT02248818|14983|P6|Screening|Protocol Violation|0
2445|NCT02248818|14984|P5|Screening|Protocol Violation|0
2446|NCT02248818|14985|P4|Screening|Protocol Violation|0
2447|NCT02248818|14986|P3|Screening|Protocol Violation|0
2448|NCT02248818|14987|P2|Screening|Protocol Violation|0
2449|NCT02248818|14988|P1|Screening|Protocol Violation|0
2450|NCT02248480|15164|P2|Overall Study|Other:Physician Decision|1
2451|NCT02248480|15165|P1|Overall Study|Other:Physician Decision|0
2452|NCT02248480|15164|P2|Overall Study|Entry Criteria Not Met|1
2453|NCT02248480|15165|P1|Overall Study|Entry Criteria Not Met|0
2454|NCT02248480|15164|P2|Overall Study|Withdrawal by Subject|4
2455|NCT02248480|15165|P1|Overall Study|Withdrawal by Subject|2
2456|NCT02248480|15164|P2|Overall Study|Adverse Event|2
2457|NCT02248480|15165|P1|Overall Study|Adverse Event|11
2458|NCT02248480|15164|P2|Overall Study|Lack of Efficacy|6
2459|NCT02248480|15165|P1|Overall Study|Lack of Efficacy|4
2460|NCT02247011|15223|P1|Overall Study|Poor quality of radiological results|125
2461|NCT02246582|15240|P2|Overall Study|Withdrawal by Subject|4
2462|NCT02246582|15241|P1|Overall Study|Withdrawal by Subject|3
2463|NCT02246166|15249|P2|Overall Study|Protocol Violation|0
2464|NCT02246166|15250|P1|Overall Study|Protocol Violation|1
2465|NCT02246114|15286|P2|Overall Study|miscarriage|0
2466|NCT02246114|15287|P1|Overall Study|miscarriage|1
2467|NCT02244580|15333|P1|Overall Study|No cancer tissues available|241
2468|NCT02243202|15358|P4|Overall Study|Randomized but not received treatment|1
2469|NCT02243202|15359|P3|Overall Study|Randomized but not received treatment|0
2470|NCT02243202|15360|P2|Overall Study|Randomized but not received treatment|0
2471|NCT02243202|15361|P1|Overall Study|Randomized but not received treatment|0
2472|NCT02243202|15358|P4|Overall Study|Unspecified|2
2473|NCT02243202|15359|P3|Overall Study|Unspecified|1
2474|NCT02243202|15360|P2|Overall Study|Unspecified|3
2475|NCT02243202|15361|P1|Overall Study|Unspecified|1
2476|NCT02243202|15358|P4|Overall Study|Withdrawal by Subject|4
2477|NCT02243202|15359|P3|Overall Study|Withdrawal by Subject|4
2478|NCT02243202|15360|P2|Overall Study|Withdrawal by Subject|6
2479|NCT02243202|15361|P1|Overall Study|Withdrawal by Subject|7
2480|NCT02243202|15358|P4|Overall Study|Protocol Violation|1
2481|NCT02243202|15359|P3|Overall Study|Protocol Violation|2
2482|NCT02243202|15360|P2|Overall Study|Protocol Violation|1
2483|NCT02243202|15361|P1|Overall Study|Protocol Violation|3
2484|NCT02243202|15358|P4|Overall Study|Lost to Follow-up|11
2485|NCT02243202|15359|P3|Overall Study|Lost to Follow-up|14
2486|NCT02243202|15360|P2|Overall Study|Lost to Follow-up|9
2487|NCT02243202|15361|P1|Overall Study|Lost to Follow-up|9
2488|NCT02243202|15358|P4|Overall Study|Adverse Event|4
2489|NCT02243202|15359|P3|Overall Study|Adverse Event|10
2490|NCT02243202|15360|P2|Overall Study|Adverse Event|6
2491|NCT02243202|15361|P1|Overall Study|Adverse Event|5
2492|NCT02243046|15398|P3|Overall Study|Lost to Follow-up|4
2493|NCT02243046|15399|P2|Overall Study|Lost to Follow-up|1
2494|NCT02243046|15400|P1|Overall Study|Lost to Follow-up|1
2495|NCT02242643|15430|P2|Overall Study|Withdrawal by subject at Visit 2|1
2496|NCT02242643|15431|P1|Overall Study|Withdrawal by subject at Visit 2|0
2497|NCT02242643|15430|P2|Overall Study|Language barrier|0
2498|NCT02242643|15431|P1|Overall Study|Language barrier|1
2499|NCT02242643|15430|P2|Overall Study|Protocol requirements not followed|0
2500|NCT02242643|15431|P1|Overall Study|Protocol requirements not followed|1
2501|NCT02242643|15430|P2|Overall Study|Consent withdrawal by parent|0
2502|NCT02242643|15431|P1|Overall Study|Consent withdrawal by parent|1
2503|NCT02242643|15430|P2|Overall Study|Non-compliance|0
2504|NCT02242643|15431|P1|Overall Study|Non-compliance|1
2505|NCT02242643|15430|P2|Overall Study|Child placed in foster care by family|1
2506|NCT02242643|15431|P1|Overall Study|Child placed in foster care by family|0
2507|NCT02242643|15430|P2|Overall Study|Lost to Follow-up|61
2508|NCT02242643|15431|P1|Overall Study|Lost to Follow-up|54
2509|NCT02242643|15430|P2|Overall Study|Migrated/moved from study area|3
2510|NCT02242643|15431|P1|Overall Study|Migrated/moved from study area|1
2511|NCT02242643|15430|P2|Overall Study|Withdrawal by Subject|10
2512|NCT02242643|15431|P1|Overall Study|Withdrawal by Subject|15
2513|NCT02242643|15430|P2|Overall Study|Protocol Violation|2
2514|NCT02242643|15431|P1|Overall Study|Protocol Violation|1
2515|NCT02240628|15492|P2|Overall Study|Physician Decision|5
2516|NCT02240628|15493|P1|Overall Study|Physician Decision|6
2517|NCT02240368|15504|P3|Overall Study|Entropy failed to detect more than 50%|1
2518|NCT02240368|15505|P2|Overall Study|Entropy failed to detect more than 50%|0
2519|NCT02240368|15506|P1|Overall Study|Entropy failed to detect more than 50%|0
2520|NCT02240368|15504|P3|Overall Study|Surgery lasted less then 20 minutes|0
2521|NCT02240368|15505|P2|Overall Study|Surgery lasted less then 20 minutes|0
2522|NCT02240368|15506|P1|Overall Study|Surgery lasted less then 20 minutes|1
2523|NCT02239926|15530|P2|Overall Study|Withdrawal by Subject|1
2524|NCT02239926|15531|P1|Overall Study|Withdrawal by Subject|0
2525|NCT02239692|15556|P2|Overall Study|Other reason|0
2526|NCT02239692|15557|P1|Overall Study|Other reason|1
2527|NCT02239692|15556|P2|Overall Study|Withdrawal by Subject|5
2528|NCT02239692|15557|P1|Overall Study|Withdrawal by Subject|3
2529|NCT02239692|15556|P2|Overall Study|Lost to Follow-up|4
2530|NCT02239692|15557|P1|Overall Study|Lost to Follow-up|1
2531|NCT02239692|15556|P2|Overall Study|Physician Decision|1
2532|NCT02239692|15557|P1|Overall Study|Physician Decision|0
2533|NCT02239692|15556|P2|Overall Study|Adverse Event|1
2534|NCT02239692|15557|P1|Overall Study|Adverse Event|0
2535|NCT02239692|15556|P2|Overall Study|Incomplete colonoscopy|2
2536|NCT02239692|15557|P1|Overall Study|Incomplete colonoscopy|1
2537|NCT02238067|15596|P1|Overall Study|Not completed survey at Month 6|45
2538|NCT02236611|15662|P2|Overall Study|Withdrew consent|4
2539|NCT02236611|15663|P1|Overall Study|Withdrew consent|9
2540|NCT02236611|15662|P2|Overall Study|Protocol deviation|5
2541|NCT02236611|15663|P1|Overall Study|Protocol deviation|3
2542|NCT02236611|15662|P2|Overall Study|Lost to Follow-up|2
2543|NCT02236611|15663|P1|Overall Study|Lost to Follow-up|0
2544|NCT02236611|15662|P2|Overall Study|Lack of Efficacy|7
2545|NCT02236611|15663|P1|Overall Study|Lack of Efficacy|4
2546|NCT02236611|15662|P2|Overall Study|Adverse Event|16
2547|NCT02236611|15663|P1|Overall Study|Adverse Event|10
2548|NCT02236130|15671|P2|Overall Study|Lost to Follow-up|12
2549|NCT02236130|15672|P1|Overall Study|Lost to Follow-up|7
2550|NCT02234479|15703|P2|Overall Study|Withdrawal by Subject|3
2551|NCT02234479|15704|P1|Overall Study|Withdrawal by Subject|1
2552|NCT02233647|15758|P1|Overall Study|Adverse Event|1
2553|NCT02233309|15787|P1|Overall Study|Physician Decision|5
2554|NCT02232880|15810|P1|Overall Study|study stopped prior to randomization|1
2555|NCT02231918|15831|P3|Overall Study|Adverse Event|1
2556|NCT02231918|15832|P2|Overall Study|Adverse Event|0
2557|NCT02231918|15833|P1|Overall Study|Adverse Event|0
2558|NCT02231918|15831|P3|Overall Study|Withdrawal by Subject|0
2559|NCT02231918|15832|P2|Overall Study|Withdrawal by Subject|1
2560|NCT02231918|15833|P1|Overall Study|Withdrawal by Subject|0
2561|NCT02231164|15956|P2|Overall Study|Withdrawal by Subject|2
2562|NCT02231164|15957|P1|Overall Study|Withdrawal by Subject|1
2563|NCT02231164|15956|P2|Overall Study|Lack of Efficacy|3
2564|NCT02231164|15957|P1|Overall Study|Lack of Efficacy|4
2565|NCT02231164|15956|P2|Overall Study|Adverse Event|1
2566|NCT02231164|15957|P1|Overall Study|Adverse Event|1
2567|NCT02230904|15965|P2|Overall Study|Safety follow up could not take place|1
2568|NCT02230904|15966|P1|Overall Study|Safety follow up could not take place|0
2569|NCT02230683|15999|P1|Overall Study|Adverse Event|1
2570|NCT02229864|16023|P1|1 - Year Visit|Missed Visits|1
2571|NCT02229214|16150|P2|Overall Study|Withdrawal by Subject|0
2572|NCT02229214|16151|P1|Overall Study|Withdrawal by Subject|4
2573|NCT02229214|16150|P2|Overall Study|Adverse Event|0
2574|NCT02229214|16151|P1|Overall Study|Adverse Event|2
2575|NCT02228980|16175|P4|Overall Study|Withdrawal by Subject|3
2576|NCT02228980|16176|P3|Overall Study|Withdrawal by Subject|2
2577|NCT02228980|16177|P2|Overall Study|Withdrawal by Subject|3
2578|NCT02228980|16178|P1|Overall Study|Withdrawal by Subject|3
2579|NCT02228980|16175|P4|Overall Study|Protocol Violation|0
2580|NCT02228980|16176|P3|Overall Study|Protocol Violation|0
2581|NCT02228980|16177|P2|Overall Study|Protocol Violation|0
2582|NCT02228980|16178|P1|Overall Study|Protocol Violation|7
2583|NCT02228980|16175|P4|Overall Study|Adverse Event|0
2584|NCT02228980|16176|P3|Overall Study|Adverse Event|0
2585|NCT02228980|16177|P2|Overall Study|Adverse Event|0
2586|NCT02228980|16178|P1|Overall Study|Adverse Event|14
2671|NCT02220764|16695|P2|Overall Study|Death|0
2587|NCT02228395|16200|P3|First Intervention Period|Unable to comply with study dates|1
2588|NCT02228395|16201|P2|First Intervention Period|Unable to comply with study dates|1
2589|NCT02228395|16202|P1|First Intervention Period|Unable to comply with study dates|0
2590|NCT02228395|16200|P3|First Intervention Period|No longer willing to participate|0
2591|NCT02228395|16201|P2|First Intervention Period|No longer willing to participate|0
2592|NCT02228395|16202|P1|First Intervention Period|No longer willing to participate|1
2593|NCT02226562|16291|P2|Overall Study|Lost to Follow-up|1
2594|NCT02226562|16292|P1|Overall Study|Lost to Follow-up|0
2595|NCT02226549|16310|P2|Overall Study|Lost to Follow-up|1
2596|NCT02226549|16311|P1|Overall Study|Lost to Follow-up|0
2597|NCT02226549|16310|P2|Overall Study|Randomized but Never Treated|0
2598|NCT02226549|16311|P1|Overall Study|Randomized but Never Treated|1
2599|NCT02226198|16321|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
2600|NCT02226198|16322|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
2601|NCT02226198|16323|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
2602|NCT02226198|16321|P3|Lead-in Phase|Protocol Violation|0
2603|NCT02226198|16322|P2|Lead-in Phase|Protocol Violation|0
2604|NCT02226198|16323|P1|Lead-in Phase|Protocol Violation|1
2605|NCT02224625|16404|P1|Sensitization|Adverse Event|55
2606|NCT02224625|16404|P1|Irritation|Adverse Event|6
2607|NCT02224053|16421|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
2608|NCT02224053|16421|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
2609|NCT02224053|16421|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
2610|NCT02224053|16421|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
2611|NCT02224053|16421|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
2612|NCT02223754|16467|P2|Period 2|Test Article No Longer Available|1
2613|NCT02223754|16468|P1|Period 2|Test Article No Longer Available|0
2614|NCT02223754|16467|P2|Period 2|Lost to Follow-up|0
2615|NCT02223754|16468|P1|Period 2|Lost to Follow-up|1
2616|NCT02223754|16467|P2|Period 2|Lens Discomfort|1
2617|NCT02223754|16468|P1|Period 2|Lens Discomfort|1
2618|NCT02223754|16467|P2|Period 2|Protocol Violation|0
2619|NCT02223754|16468|P1|Period 2|Protocol Violation|1
2620|NCT02223754|16467|P2|Period 2|Adverse Event|1
2621|NCT02223754|16468|P1|Period 2|Adverse Event|0
2622|NCT02223754|16467|P2|Period 1|Unsatisfactory Visual Response|1
2623|NCT02223754|16468|P1|Period 1|Unsatisfactory Visual Response|0
2624|NCT02223754|16467|P2|Period 1|Test Article No Longer Available|5
2625|NCT02223754|16468|P1|Period 1|Test Article No Longer Available|1
2626|NCT02223754|16467|P2|Period 1|Withdrawal by Subject|4
2627|NCT02223754|16468|P1|Period 1|Withdrawal by Subject|0
2628|NCT02223754|16467|P2|Period 1|Protocol Violation|4
2629|NCT02223754|16468|P1|Period 1|Protocol Violation|2
2630|NCT02223754|16467|P2|Period 1|Lost to Follow-up|1
2631|NCT02223754|16468|P1|Period 1|Lost to Follow-up|0
2632|NCT02223754|16467|P2|Period 1|Adverse Event|0
2633|NCT02223754|16468|P1|Period 1|Adverse Event|1
2634|NCT02223715|16488|P1|Overall Study|Lost to Follow-up|73
2635|NCT02223715|16488|P1|Overall Study|Death|31
2636|NCT02222818|16582|P2|Period 1|Eligibility criteria not met|3
2637|NCT02222818|16583|P1|Period 1|Eligibility criteria not met|0
2638|NCT02222558|16590|P6|Period 3|Withdrawal by Subject|1
2639|NCT02222558|16591|P5|Period 3|Withdrawal by Subject|0
2640|NCT02222558|16592|P4|Period 3|Withdrawal by Subject|0
2641|NCT02222558|16593|P3|Period 3|Withdrawal by Subject|0
2642|NCT02222558|16594|P2|Period 3|Withdrawal by Subject|0
2643|NCT02222558|16595|P1|Period 3|Withdrawal by Subject|0
2644|NCT02222558|16590|P6|Period 1: Single Dose|Withdrawal by Subject|0
2645|NCT02222558|16591|P5|Period 1: Single Dose|Withdrawal by Subject|0
2646|NCT02222558|16592|P4|Period 1: Single Dose|Withdrawal by Subject|0
2647|NCT02222558|16593|P3|Period 1: Single Dose|Withdrawal by Subject|0
2648|NCT02222558|16594|P2|Period 1: Single Dose|Withdrawal by Subject|0
2649|NCT02222558|16595|P1|Period 1: Single Dose|Withdrawal by Subject|4
2650|NCT02222207|16609|P1|Overall Study|Adverse Event|1
2651|NCT02222207|16609|P1|Overall Study|Other reasons|2
2652|NCT02222207|16609|P1|Overall Study|Death|1
2653|NCT02221648|16646|P2|Overall Study|Withdrawal by Subject|3
2654|NCT02221648|16647|P1|Overall Study|Withdrawal by Subject|3
2655|NCT02220998|16659|P2|Overall Study|Lost to Follow-up|4
2656|NCT02220998|16660|P1|Overall Study|Lost to Follow-up|4
2657|NCT02220998|16659|P2|Overall Study|Lack of Efficacy|5
2658|NCT02220998|16660|P1|Overall Study|Lack of Efficacy|0
2659|NCT02220998|16659|P2|Overall Study|Death|0
2660|NCT02220998|16660|P1|Overall Study|Death|2
2661|NCT02220998|16659|P2|Overall Study|Randomized but Never Treated|2
2662|NCT02220998|16660|P1|Overall Study|Randomized but Never Treated|1
2663|NCT02220920|16678|P2|Overall Study|Conflict with the stopping criteria|2
2664|NCT02220920|16679|P1|Overall Study|Conflict with the stopping criteria|1
2665|NCT02220920|16678|P2|Overall Study|Withdrawal by Subject|0
2666|NCT02220920|16679|P1|Overall Study|Withdrawal by Subject|1
2667|NCT02220920|16678|P2|Overall Study|Lack of Efficacy|1
2668|NCT02220920|16679|P1|Overall Study|Lack of Efficacy|0
2669|NCT02220920|16678|P2|Overall Study|Adverse Event|0
2670|NCT02220920|16679|P1|Overall Study|Adverse Event|1
2672|NCT02220764|16696|P1|Overall Study|Death|1
2673|NCT02220764|16695|P2|Overall Study|Lost to Follow-up|1
2674|NCT02220764|16696|P1|Overall Study|Lost to Follow-up|3
2675|NCT02219685|16723|P2|Blinded Treatment Phase|Withdrew Consent|0
2676|NCT02219685|16724|P1|Blinded Treatment Phase|Withdrew Consent|1
2677|NCT02219685|16723|P2|Blinded Treatment Phase|Lost to Follow-up|0
2678|NCT02219685|16724|P1|Blinded Treatment Phase|Lost to Follow-up|1
2679|NCT02218268|16774|P2|24 Hour Washout|Physician Decision|9
2680|NCT02218268|16775|P1|24 Hour Washout|Physician Decision|11
2681|NCT02217982|16783|P2|Overall Study|Adverse Event|1
2682|NCT02217982|16784|P1|Overall Study|Adverse Event|0
2683|NCT02217982|16783|P2|Overall Study|Trial discontinued|0
2684|NCT02217982|16784|P1|Overall Study|Trial discontinued|1
2685|NCT02217878|16792|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
2686|NCT02217878|16793|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
2687|NCT02217878|16792|P2|Overall Study|required morphine due to chest pain|2
2688|NCT02217878|16793|P1|Overall Study|required morphine due to chest pain|1
2689|NCT02214225|16842|P3|Overall Study|randomized in error, not vaccinated|1
2690|NCT02214225|16843|P2|Overall Study|randomized in error, not vaccinated|1
2691|NCT02214225|16844|P1|Overall Study|randomized in error, not vaccinated|2
2692|NCT02214225|16842|P3|Overall Study|Death|1
2693|NCT02214225|16843|P2|Overall Study|Death|0
2694|NCT02214225|16844|P1|Overall Study|Death|5
2695|NCT02214225|16842|P3|Overall Study|Withdrawal by Subject|2
2696|NCT02214225|16843|P2|Overall Study|Withdrawal by Subject|0
2697|NCT02214225|16844|P1|Overall Study|Withdrawal by Subject|2
2698|NCT02214225|16842|P3|Overall Study|Lost to Follow-up|18
2699|NCT02214225|16843|P2|Overall Study|Lost to Follow-up|18
2700|NCT02214225|16844|P1|Overall Study|Lost to Follow-up|46
2701|NCT02214186|16903|P2|Overall Study|Protocol Violation|1
2702|NCT02214186|16904|P1|Overall Study|Protocol Violation|1
2703|NCT02214186|16903|P2|Overall Study|Lost to Follow-up|1
2704|NCT02214186|16904|P1|Overall Study|Lost to Follow-up|1
2705|NCT02213510|16928|P2|Overall Study|Lost to Follow-up|0
2706|NCT02213510|16929|P1|Overall Study|Lost to Follow-up|1
2707|NCT02213510|16928|P2|Overall Study|Death|1
2708|NCT02213510|16929|P1|Overall Study|Death|0
2709|NCT02213055|16987|P2|Overall Study|Did not Return to School|0
2710|NCT02213055|16988|P1|Overall Study|Did not Return to School|5
2711|NCT02213055|16987|P2|Overall Study|Did not meet Inclusion Criteria|0
2712|NCT02213055|16988|P1|Overall Study|Did not meet Inclusion Criteria|6
2713|NCT02213055|16987|P2|Overall Study|Had another Treatment during the Study|0
2714|NCT02213055|16988|P1|Overall Study|Had another Treatment during the Study|3
2715|NCT02213055|16987|P2|Overall Study|Did not have Live Lice|0
2716|NCT02213055|16988|P1|Overall Study|Did not have Live Lice|8
2717|NCT02213055|16987|P2|Overall Study|Documentation Issue during Study|0
2718|NCT02213055|16988|P1|Overall Study|Documentation Issue during Study|10
2719|NCT02213055|16987|P2|Overall Study|Documentation Issue at Enrollment|0
2720|NCT02213055|16988|P1|Overall Study|Documentation Issue at Enrollment|1
2721|NCT02213055|16987|P2|Overall Study|Protocol was not Followed during Study|0
2722|NCT02213055|16988|P1|Overall Study|Protocol was not Followed during Study|1
2723|NCT02213055|16987|P2|Overall Study|Protocol was not Followed at Enrollment|0
2724|NCT02213055|16988|P1|Overall Study|Protocol was not Followed at Enrollment|5
2725|NCT02212301|17020|P2|Period 1|Lost to Follow-up|1
2726|NCT02212301|17021|P1|Period 1|Lost to Follow-up|0
2727|NCT02212197|17032|P3|Overall Study|Need for radiotherapy|0
2728|NCT02212197|17033|P2|Overall Study|Need for radiotherapy|0
2729|NCT02212197|17034|P1|Overall Study|Need for radiotherapy|1
2730|NCT02210091|17089|P2|Overall Study|Withdrawal by Sponsor|1
2731|NCT02210091|17090|P1|Overall Study|Withdrawal by Sponsor|0
2732|NCT02210091|17089|P2|Overall Study|Physician Decision|1
2733|NCT02210091|17090|P1|Overall Study|Physician Decision|0
2734|NCT02209766|17166|P5|Overall Study|Withdrawal by Subject|0
2735|NCT02209766|17167|P4|Overall Study|Withdrawal by Subject|1
2736|NCT02209766|17168|P3|Overall Study|Withdrawal by Subject|0
2737|NCT02209766|17169|P2|Overall Study|Withdrawal by Subject|0
2738|NCT02209766|17170|P1|Overall Study|Withdrawal by Subject|0
2739|NCT02209506|17221|P5|Overall Study|Withdrawal by Subject|1
2740|NCT02209506|17222|P4|Overall Study|Withdrawal by Subject|0
2741|NCT02209506|17223|P3|Overall Study|Withdrawal by Subject|0
2742|NCT02209506|17224|P2|Overall Study|Withdrawal by Subject|0
2743|NCT02209506|17225|P1|Overall Study|Withdrawal by Subject|0
2744|NCT02209454|17300|P2|Second Period|Adverse Event|0
2745|NCT02209454|17301|P1|Second Period|Adverse Event|1
2746|NCT02209181|17319|P4|Overall Study|Withdrawal by Subject|0
2747|NCT02209181|17320|P3|Overall Study|Withdrawal by Subject|0
2748|NCT02209181|17321|P2|Overall Study|Withdrawal by Subject|1
2749|NCT02209181|17322|P1|Overall Study|Withdrawal by Subject|0
2750|NCT02209181|17319|P4|Overall Study|Adverse Event|0
2751|NCT02209181|17320|P3|Overall Study|Adverse Event|1
2752|NCT02209181|17321|P2|Overall Study|Adverse Event|0
2753|NCT02209181|17322|P1|Overall Study|Adverse Event|1
2754|NCT02207907|17493|P2|Overall Study|Pregnancy|1
2755|NCT02207907|17494|P1|Overall Study|Pregnancy|0
2756|NCT02207907|17493|P2|Overall Study|Did not meet study criteria|0
2757|NCT02207907|17494|P1|Overall Study|Did not meet study criteria|3
2758|NCT02207907|17493|P2|Overall Study|Withdrawal by Subject|6
2759|NCT02207907|17494|P1|Overall Study|Withdrawal by Subject|5
2760|NCT02207907|17493|P2|Overall Study|Lost to Follow-up|1
2761|NCT02207907|17494|P1|Overall Study|Lost to Follow-up|3
2762|NCT02207829|17512|P2|Overall Study|Withdrew consent|14
2763|NCT02207829|17513|P1|Overall Study|Withdrew consent|18
2764|NCT02207829|17512|P2|Overall Study|Protocol deviation|4
2765|NCT02207829|17513|P1|Overall Study|Protocol deviation|5
2766|NCT02207829|17512|P2|Overall Study|Lost to Follow-up|2
2767|NCT02207829|17513|P1|Overall Study|Lost to Follow-up|2
2768|NCT02207829|17512|P2|Overall Study|Lack of Efficacy|5
2769|NCT02207829|17513|P1|Overall Study|Lack of Efficacy|7
2770|NCT02207829|17512|P2|Overall Study|Adverse Event|9
2771|NCT02207829|17513|P1|Overall Study|Adverse Event|10
2772|NCT02207608|17521|P2|Overall Study|Adverse Event|0
2773|NCT02207608|17522|P1|Overall Study|Adverse Event|1
2774|NCT02207413|17545|P6|Overall Study|Migrated/moved from study area|0
2775|NCT02207413|17546|P5|Overall Study|Migrated/moved from study area|1
2776|NCT02207413|17547|P4|Overall Study|Migrated/moved from study area|0
2777|NCT02207413|17548|P3|Overall Study|Migrated/moved from study area|0
2778|NCT02207413|17549|P2|Overall Study|Migrated/moved from study area|0
2779|NCT02207413|17550|P1|Overall Study|Migrated/moved from study area|0
2780|NCT02207413|17545|P6|Overall Study|Adverse Event|1
2781|NCT02207413|17546|P5|Overall Study|Adverse Event|2
2782|NCT02207413|17547|P4|Overall Study|Adverse Event|0
2783|NCT02207413|17548|P3|Overall Study|Adverse Event|0
2784|NCT02207413|17549|P2|Overall Study|Adverse Event|0
2785|NCT02207413|17550|P1|Overall Study|Adverse Event|0
2786|NCT02207413|17545|P6|Overall Study|Lost to Follow-up|5
2787|NCT02207413|17546|P5|Overall Study|Lost to Follow-up|1
2788|NCT02207413|17547|P4|Overall Study|Lost to Follow-up|1
2789|NCT02207413|17548|P3|Overall Study|Lost to Follow-up|0
2790|NCT02207413|17549|P2|Overall Study|Lost to Follow-up|0
2791|NCT02207413|17550|P1|Overall Study|Lost to Follow-up|0
2792|NCT02207413|17545|P6|Overall Study|Withdrawal by Subject|7
2793|NCT02207413|17546|P5|Overall Study|Withdrawal by Subject|3
2794|NCT02207413|17547|P4|Overall Study|Withdrawal by Subject|0
2795|NCT02207413|17548|P3|Overall Study|Withdrawal by Subject|0
2796|NCT02207413|17549|P2|Overall Study|Withdrawal by Subject|0
2797|NCT02207413|17550|P1|Overall Study|Withdrawal by Subject|1
2798|NCT02207400|17646|P2|Overall Study|Positive Urine Pregnancy Test|1
2799|NCT02207400|17647|P1|Overall Study|Positive Urine Pregnancy Test|0
2800|NCT02207400|17646|P2|Overall Study|Withdrawal by Subject|4
2801|NCT02207400|17647|P1|Overall Study|Withdrawal by Subject|8
2802|NCT02207400|17646|P2|Overall Study|Protocol Violation|1
2803|NCT02207400|17647|P1|Overall Study|Protocol Violation|1
2804|NCT02207400|17646|P2|Overall Study|Lost to Follow-up|7
2805|NCT02207400|17647|P1|Overall Study|Lost to Follow-up|6
2806|NCT02207400|17646|P2|Overall Study|Adverse Event|1
2807|NCT02207400|17647|P1|Overall Study|Adverse Event|1
2808|NCT02206607|17665|P5|Second Intervention Period|Insufficient Clinical Response|0
2809|NCT02206607|17666|P4|Second Intervention Period|Insufficient Clinical Response|1
2810|NCT02206607|17667|P3|Second Intervention Period|Insufficient Clinical Response|0
2811|NCT02206607|17668|P2|Second Intervention Period|Insufficient Clinical Response|0
2812|NCT02206607|17669|P1|Second Intervention Period|Insufficient Clinical Response|0
2813|NCT02206607|17665|P5|Open-Label Run-In|Withdrawal by Subject|0
2814|NCT02206607|17666|P4|Open-Label Run-In|Withdrawal by Subject|0
2815|NCT02206607|17667|P3|Open-Label Run-In|Withdrawal by Subject|0
2816|NCT02206607|17668|P2|Open-Label Run-In|Withdrawal by Subject|0
2817|NCT02206607|17669|P1|Open-Label Run-In|Withdrawal by Subject|3
2818|NCT02205814|17725|P4|Overall Study|not compliant with study procedures|0
2819|NCT02205814|17726|P3|Overall Study|not compliant with study procedures|1
2820|NCT02205814|17727|P2|Overall Study|not compliant with study procedures|0
2821|NCT02205814|17728|P1|Overall Study|not compliant with study procedures|0
2822|NCT02205814|17725|P4|Overall Study|Withdrawal by Subject|1
2823|NCT02205814|17726|P3|Overall Study|Withdrawal by Subject|2
2824|NCT02205814|17727|P2|Overall Study|Withdrawal by Subject|1
2825|NCT02205814|17728|P1|Overall Study|Withdrawal by Subject|0
2826|NCT02205814|17725|P4|Overall Study|Protocol Violation|1
2827|NCT02205814|17726|P3|Overall Study|Protocol Violation|0
2828|NCT02205814|17727|P2|Overall Study|Protocol Violation|0
2829|NCT02205814|17728|P1|Overall Study|Protocol Violation|1
2830|NCT02205814|17725|P4|Overall Study|Physician Decision|0
2831|NCT02205814|17726|P3|Overall Study|Physician Decision|1
2832|NCT02205814|17727|P2|Overall Study|Physician Decision|0
2833|NCT02205814|17728|P1|Overall Study|Physician Decision|0
2834|NCT02205814|17725|P4|Overall Study|Lack of Efficacy|1
2835|NCT02205814|17726|P3|Overall Study|Lack of Efficacy|1
2836|NCT02205814|17727|P2|Overall Study|Lack of Efficacy|0
2837|NCT02205814|17728|P1|Overall Study|Lack of Efficacy|1
2838|NCT02205814|17725|P4|Overall Study|Lost to Follow-up|1
2839|NCT02205814|17726|P3|Overall Study|Lost to Follow-up|0
2840|NCT02205814|17727|P2|Overall Study|Lost to Follow-up|0
2841|NCT02205814|17728|P1|Overall Study|Lost to Follow-up|0
2842|NCT02205476|17752|P2|Overall Study|Study termination by Sponsor|3
2843|NCT02205476|17753|P1|Overall Study|Study termination by Sponsor|7
2844|NCT02204579|17806|P1|Overall Study|Screen failures|2
2845|NCT02204449|17860|P2|Overall Study|Withdrawal by Subject|1
2846|NCT02204449|17861|P1|Overall Study|Withdrawal by Subject|0
2847|NCT02204449|17860|P2|Overall Study|Death|1
2848|NCT02204449|17861|P1|Overall Study|Death|0
2849|NCT02204449|17860|P2|Overall Study|Lost to Follow-up|9
2850|NCT02204449|17861|P1|Overall Study|Lost to Follow-up|7
2851|NCT02203916|17874|P3|Overall Study|Reason Not Specified|1
2852|NCT02203916|17875|P2|Overall Study|Reason Not Specified|2
2853|NCT02203916|17876|P1|Overall Study|Reason Not Specified|0
2854|NCT02203916|17874|P3|Overall Study|Lack of Efficacy|0
2855|NCT02203916|17875|P2|Overall Study|Lack of Efficacy|0
2856|NCT02203916|17876|P1|Overall Study|Lack of Efficacy|3
2857|NCT02203916|17874|P3|Overall Study|Voluntary Withdrawal|8
2858|NCT02203916|17875|P2|Overall Study|Voluntary Withdrawal|3
2859|NCT02203916|17876|P1|Overall Study|Voluntary Withdrawal|3
2860|NCT02203916|17874|P3|Overall Study|Lost to Follow-up|0
2861|NCT02203916|17875|P2|Overall Study|Lost to Follow-up|1
2862|NCT02203916|17876|P1|Overall Study|Lost to Follow-up|0
2863|NCT02203916|17874|P3|Overall Study|Major Protocol Deviation|0
2864|NCT02203916|17875|P2|Overall Study|Major Protocol Deviation|1
2865|NCT02203916|17876|P1|Overall Study|Major Protocol Deviation|1
2866|NCT02203916|17874|P3|Overall Study|Pretreatment Event/Adverse Event|2
2867|NCT02203916|17875|P2|Overall Study|Pretreatment Event/Adverse Event|3
2868|NCT02203916|17876|P1|Overall Study|Pretreatment Event/Adverse Event|1
2869|NCT02203721|17946|P2|Overall Study|Illness|1
2870|NCT02203721|17947|P1|Overall Study|Illness|0
2871|NCT02203721|17946|P2|Overall Study|Death|2
2872|NCT02203721|17947|P1|Overall Study|Death|0
2873|NCT02203721|17946|P2|Overall Study|Lost to Follow-up|0
2874|NCT02203721|17947|P1|Overall Study|Lost to Follow-up|1
2875|NCT02203149|17964|P5|Part 2|Adverse Event|1
2876|NCT02203149|17965|P4|Part 2|Adverse Event|1
2877|NCT02203149|17966|P3|Part 2|Adverse Event|0
2878|NCT02203149|17967|P2|Part 2|Adverse Event|0
2879|NCT02203149|17968|P1|Part 2|Adverse Event|0
2880|NCT02203149|17964|P5|Part 2|Withdrawal by Subject|0
2881|NCT02203149|17965|P4|Part 2|Withdrawal by Subject|1
2882|NCT02203149|17966|P3|Part 2|Withdrawal by Subject|0
2883|NCT02203149|17967|P2|Part 2|Withdrawal by Subject|0
2884|NCT02203149|17968|P1|Part 2|Withdrawal by Subject|0
2885|NCT02203149|17964|P5|Part 2|Death|0
2886|NCT02203149|17965|P4|Part 2|Death|1
2887|NCT02203149|17966|P3|Part 2|Death|1
2888|NCT02203149|17967|P2|Part 2|Death|0
2889|NCT02203149|17968|P1|Part 2|Death|0
2890|NCT02203149|17964|P5|Part 1|Adverse Event|0
2891|NCT02203149|17965|P4|Part 1|Adverse Event|0
2892|NCT02203149|17966|P3|Part 1|Adverse Event|0
2893|NCT02203149|17967|P2|Part 1|Adverse Event|1
2894|NCT02203149|17968|P1|Part 1|Adverse Event|0
2895|NCT02202538|18001|P1|Overall Study|Investigator Decision|1
2896|NCT02202538|18001|P1|Overall Study|Did not meet all inclusion criteria|2
2897|NCT02202538|18001|P1|Overall Study|Withdrawal by Subject|5
2898|NCT02201953|18031|P2|Overall Study|Death|3
2899|NCT02201953|18032|P1|Overall Study|Death|0
2900|NCT02201953|18031|P2|Overall Study|Adverse Event|5
2901|NCT02201953|18032|P1|Overall Study|Adverse Event|0
2902|NCT02201953|18031|P2|Overall Study|Withdrew Consent|5
2903|NCT02201953|18032|P1|Overall Study|Withdrew Consent|2
2904|NCT02201953|18031|P2|Overall Study|Lost to Follow-up|8
2905|NCT02201953|18032|P1|Overall Study|Lost to Follow-up|8
2906|NCT02201953|18031|P2|Overall Study|Lack of Efficacy|30
2907|NCT02201953|18032|P1|Overall Study|Lack of Efficacy|9
2908|NCT02201953|18031|P2|Overall Study|Randomized but Never Treated|5
2909|NCT02201953|18032|P1|Overall Study|Randomized but Never Treated|1
2910|NCT02201940|18050|P2|Overall Study|Adverse Event|1
2911|NCT02201940|18051|P1|Overall Study|Adverse Event|0
2912|NCT02201940|18050|P2|Overall Study|Death|0
2913|NCT02201940|18051|P1|Overall Study|Death|1
2914|NCT02201940|18050|P2|Overall Study|Investigator's Discretion|1
2915|NCT02201940|18051|P1|Overall Study|Investigator's Discretion|1
2916|NCT02201940|18050|P2|Overall Study|Withdrew Consent|1
2917|NCT02201940|18051|P1|Overall Study|Withdrew Consent|2
2918|NCT02201940|18050|P2|Overall Study|Lost to Follow-up|0
2919|NCT02201940|18051|P1|Overall Study|Lost to Follow-up|5
2920|NCT02201940|18050|P2|Overall Study|Lack of Efficacy|113
2921|NCT02201940|18051|P1|Overall Study|Lack of Efficacy|2
2922|NCT02201940|18050|P2|Overall Study|Randomized/Enrolled but Never Treated|0
2923|NCT02201940|18051|P1|Overall Study|Randomized/Enrolled but Never Treated|1
2924|NCT02201901|18070|P3|Overall Study|Adverse Event|0
2925|NCT02201901|18071|P2|Overall Study|Adverse Event|1
2926|NCT02201901|18072|P1|Overall Study|Adverse Event|1
2927|NCT02201901|18070|P3|Overall Study|Withdrew Consent|2
2928|NCT02201901|18071|P2|Overall Study|Withdrew Consent|0
2929|NCT02201901|18072|P1|Overall Study|Withdrew Consent|2
2930|NCT02201901|18070|P3|Overall Study|Lost to Follow-up|2
2931|NCT02201901|18071|P2|Overall Study|Lost to Follow-up|3
2932|NCT02201901|18072|P1|Overall Study|Lost to Follow-up|2
2933|NCT02201901|18070|P3|Overall Study|Death|3
2934|NCT02201901|18071|P2|Overall Study|Death|3
2935|NCT02201901|18072|P1|Overall Study|Death|3
2936|NCT02201901|18070|P3|Overall Study|Lack of Efficacy|6
2937|NCT02201901|18071|P2|Overall Study|Lack of Efficacy|1
2938|NCT02201901|18072|P1|Overall Study|Lack of Efficacy|7
2939|NCT02201901|18070|P3|Overall Study|Randomized but never treated|0
2940|NCT02201901|18071|P2|Overall Study|Randomized but never treated|1
2941|NCT02201901|18072|P1|Overall Study|Randomized but never treated|0
2942|NCT02201784|18103|P2|Overall Study|Failure to achieve adequate block|0
2943|NCT02201784|18104|P1|Overall Study|Failure to achieve adequate block|2
2944|NCT02201524|18122|P4|Overall Study|Unspecified|0
2945|NCT02201524|18123|P3|Overall Study|Unspecified|0
2946|NCT02201524|18124|P2|Overall Study|Unspecified|1
2947|NCT02201524|18125|P1|Overall Study|Unspecified|1
2948|NCT02201524|18122|P4|Overall Study|Withdrawal by Subject|1
2949|NCT02201524|18123|P3|Overall Study|Withdrawal by Subject|1
2950|NCT02201524|18124|P2|Overall Study|Withdrawal by Subject|0
2951|NCT02201524|18125|P1|Overall Study|Withdrawal by Subject|0
2952|NCT02201524|18122|P4|Overall Study|Protocol Violation|1
2953|NCT02201524|18123|P3|Overall Study|Protocol Violation|0
2954|NCT02201524|18124|P2|Overall Study|Protocol Violation|0
2955|NCT02201524|18125|P1|Overall Study|Protocol Violation|0
2956|NCT02201524|18122|P4|Overall Study|No longer meets eligibility criteria|2
2957|NCT02201524|18123|P3|Overall Study|No longer meets eligibility criteria|0
2958|NCT02201524|18124|P2|Overall Study|No longer meets eligibility criteria|0
2959|NCT02201524|18125|P1|Overall Study|No longer meets eligibility criteria|0
2960|NCT02201524|18122|P4|Overall Study|Lost to Follow-up|0
2961|NCT02201524|18123|P3|Overall Study|Lost to Follow-up|2
2962|NCT02201524|18124|P2|Overall Study|Lost to Follow-up|0
2963|NCT02201524|18125|P1|Overall Study|Lost to Follow-up|0
2964|NCT02201524|18122|P4|Overall Study|Insufficient clinical response|0
2965|NCT02201524|18123|P3|Overall Study|Insufficient clinical response|0
2966|NCT02201524|18124|P2|Overall Study|Insufficient clinical response|0
2967|NCT02201524|18125|P1|Overall Study|Insufficient clinical response|1
2968|NCT02201524|18122|P4|Overall Study|Adverse Event|0
2969|NCT02201524|18123|P3|Overall Study|Adverse Event|1
2970|NCT02201524|18124|P2|Overall Study|Adverse Event|2
2971|NCT02201524|18125|P1|Overall Study|Adverse Event|0
2972|NCT02198963|18358|P1|Overall Study|Withdrawal by Subject|6
2973|NCT02198963|18358|P1|Overall Study|Adverse Event|1
2974|NCT02198235|18385|P3|Overall Study|Lost to Follow-up|2
2975|NCT02198235|18386|P2|Overall Study|Lost to Follow-up|2
2976|NCT02198235|18387|P1|Overall Study|Lost to Follow-up|3
2977|NCT02197806|18408|P4|Overall Study|Adverse Event|1
2978|NCT02197806|18409|P3|Overall Study|Adverse Event|0
2979|NCT02197806|18410|P2|Overall Study|Adverse Event|1
2980|NCT02197806|18411|P1|Overall Study|Adverse Event|0
2981|NCT02197247|18434|P1|Period 3|Condition under investigation worsened|5
2982|NCT02197247|18434|P1|Period 2|Condition under investigation worsened|2
2983|NCT02197247|18434|P1|Period 2|Adverse Event|2
2984|NCT02197234|18477|P1|Overall Study|Withdrawal by Subject|1
2985|NCT02197234|18477|P1|Overall Study|Adverse Event|1
2986|NCT02197234|18477|P1|Overall Study|Condition under investigation worsened|1
2987|NCT02196675|18517|P3|Overall Study|Death|1
2988|NCT02196675|18518|P2|Overall Study|Death|0
2989|NCT02196675|18519|P1|Overall Study|Death|0
2990|NCT02196675|18517|P3|Overall Study|Protocol Violation|0
2991|NCT02196675|18518|P2|Overall Study|Protocol Violation|1
2992|NCT02196675|18519|P1|Overall Study|Protocol Violation|0
2993|NCT02196675|18517|P3|Overall Study|Intra-operative surgical exclusion|0
2994|NCT02196675|18518|P2|Overall Study|Intra-operative surgical exclusion|1
2995|NCT02196675|18519|P1|Overall Study|Intra-operative surgical exclusion|1
2996|NCT02196675|18517|P3|Overall Study|Withdrawal by Subject|0
2997|NCT02196675|18518|P2|Overall Study|Withdrawal by Subject|0
2998|NCT02196675|18519|P1|Overall Study|Withdrawal by Subject|1
2999|NCT02195687|18550|P2|Overall Study|Lost to Follow-up|1
3000|NCT02195687|18551|P1|Overall Study|Lost to Follow-up|4
3001|NCT02195687|18550|P2|Overall Study|Personal Reasons|1
3002|NCT02195687|18551|P1|Overall Study|Personal Reasons|1
3003|NCT02195583|18567|P1|Overall Study|Other Reason|2
3004|NCT02195583|18567|P1|Overall Study|Adverse Event|2
3005|NCT02195583|18567|P1|Overall Study|Withdrawal by Subject|4
3006|NCT02195583|18567|P1|Overall Study|Lost to Follow-up|1
3007|NCT02194621|18609|P3|Overall Study|Withdrawal by Subject|7
3008|NCT02194621|18610|P2|Overall Study|Withdrawal by Subject|4
3009|NCT02194621|18611|P1|Overall Study|Withdrawal by Subject|4
3010|NCT02194621|18609|P3|Overall Study|6 withdrew prior to randomization|2
3011|NCT02194621|18610|P2|Overall Study|6 withdrew prior to randomization|2
3012|NCT02194621|18611|P1|Overall Study|6 withdrew prior to randomization|2
3013|NCT02193828|18632|P4|Overall Study|Withdrawal by Subject|1
3014|NCT02193828|18633|P3|Overall Study|Withdrawal by Subject|1
3015|NCT02193828|18634|P2|Overall Study|Withdrawal by Subject|0
3016|NCT02193828|18635|P1|Overall Study|Withdrawal by Subject|0
3017|NCT02193178|18708|P1|Overall Study|Dry eyes|1
3018|NCT02193178|18708|P1|Overall Study|Lost to Follow-up|1
3019|NCT02193165|18758|P3|6 Week Product Use|Lost to Follow-up|0
3020|NCT02193165|18759|P2|6 Week Product Use|Lost to Follow-up|1
3021|NCT02193165|18760|P1|6 Week Product Use|Lost to Follow-up|0
3022|NCT02193165|18758|P3|4 Week Product Use|Lost to Follow-up|1
3023|NCT02193165|18759|P2|4 Week Product Use|Lost to Follow-up|1
3024|NCT02193165|18760|P1|4 Week Product Use|Lost to Follow-up|1
3025|NCT02193087|18787|P4|Overall Study|Did Not Receive Any Vaccination|1
3026|NCT02193087|18788|P3|Overall Study|Did Not Receive Any Vaccination|0
3027|NCT02193087|18789|P2|Overall Study|Did Not Receive Any Vaccination|3
3028|NCT02193087|18790|P1|Overall Study|Did Not Receive Any Vaccination|2
3029|NCT02193087|18787|P4|Overall Study|Other Reason Not Specified|9
3030|NCT02193087|18788|P3|Overall Study|Other Reason Not Specified|1
3031|NCT02193087|18789|P2|Overall Study|Other Reason Not Specified|2
3032|NCT02193087|18790|P1|Overall Study|Other Reason Not Specified|7
3033|NCT02193087|18787|P4|Overall Study|Withdrawal by Subject|19
3034|NCT02193087|18788|P3|Overall Study|Withdrawal by Subject|1
3035|NCT02193087|18789|P2|Overall Study|Withdrawal by Subject|3
3036|NCT02193087|18790|P1|Overall Study|Withdrawal by Subject|10
3037|NCT02193087|18787|P4|Overall Study|Protocol Violation|2
3038|NCT02193087|18788|P3|Overall Study|Protocol Violation|1
3039|NCT02193087|18789|P2|Overall Study|Protocol Violation|0
3040|NCT02193087|18790|P1|Overall Study|Protocol Violation|2
3041|NCT02193087|18787|P4|Overall Study|Lost to Follow-up|37
3042|NCT02193087|18788|P3|Overall Study|Lost to Follow-up|4
3043|NCT02193087|18789|P2|Overall Study|Lost to Follow-up|6
3044|NCT02193087|18790|P1|Overall Study|Lost to Follow-up|14
3045|NCT02193087|18787|P4|Overall Study|Adverse Event|11
3046|NCT02193087|18788|P3|Overall Study|Adverse Event|0
3047|NCT02193087|18789|P2|Overall Study|Adverse Event|0
3048|NCT02193087|18790|P1|Overall Study|Adverse Event|2
3049|NCT02191046|18902|P2|Overall Study|low compliance|1
3050|NCT02191046|18903|P1|Overall Study|low compliance|5
3051|NCT02189941|18933|P3|Overall Study|Non-compliance|1
3052|NCT02189941|18934|P2|Overall Study|Non-compliance|0
3053|NCT02189941|18935|P1|Overall Study|Non-compliance|0
3054|NCT02189863|18963|P2|First 2 Weeks|Motion Sickness|2
3055|NCT02189863|18964|P1|First 2 Weeks|Motion Sickness|4
3056|NCT02189837|18979|P4|Overall Study|Sponsor Decision|1
3057|NCT02189837|18980|P3|Overall Study|Sponsor Decision|0
3058|NCT02189837|18981|P2|Overall Study|Sponsor Decision|0
3059|NCT02189837|18982|P1|Overall Study|Sponsor Decision|0
3060|NCT02189837|18979|P4|Overall Study|Withdrawal by Subject|1
3061|NCT02189837|18980|P3|Overall Study|Withdrawal by Subject|3
3062|NCT02189837|18981|P2|Overall Study|Withdrawal by Subject|1
3063|NCT02189837|18982|P1|Overall Study|Withdrawal by Subject|2
3064|NCT02189252|19017|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
3065|NCT02189252|19018|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
3066|NCT02189252|19019|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
3067|NCT02189252|19020|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
3068|NCT02189252|19017|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
3069|NCT02189252|19018|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
3070|NCT02189252|19019|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
3071|NCT02189252|19020|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
3072|NCT02188849|19079|P2|Overall Study|Lost to Follow-up|8
3073|NCT02188849|19080|P1|Overall Study|Lost to Follow-up|3
3074|NCT02187809|19097|P1|Overall Study|The study was terminated|3
3075|NCT02187029|19111|P4|Overall Study|Withdrawal by Subject|0
3076|NCT02187029|19112|P3|Overall Study|Withdrawal by Subject|0
3077|NCT02187029|19113|P2|Overall Study|Withdrawal by Subject|0
3078|NCT02187029|19114|P1|Overall Study|Withdrawal by Subject|1
3079|NCT02187029|19111|P4|Overall Study|Study Terminated by Sponsor|3
3080|NCT02187029|19112|P3|Overall Study|Study Terminated by Sponsor|10
3081|NCT02187029|19113|P2|Overall Study|Study Terminated by Sponsor|0
3082|NCT02187029|19114|P1|Overall Study|Study Terminated by Sponsor|0
3083|NCT02187029|19111|P4|Overall Study|Adverse Event|0
3084|NCT02187029|19112|P3|Overall Study|Adverse Event|1
3085|NCT02187029|19113|P2|Overall Study|Adverse Event|1
3086|NCT02187029|19114|P1|Overall Study|Adverse Event|0
3087|NCT02185534|19257|P6|First Washout Period|Protocol Violation|1
3088|NCT02185534|19258|P5|First Washout Period|Protocol Violation|0
3089|NCT02185534|19259|P4|First Washout Period|Protocol Violation|0
3090|NCT02185534|19260|P3|First Washout Period|Protocol Violation|0
3091|NCT02185534|19261|P2|First Washout Period|Protocol Violation|0
3092|NCT02185534|19262|P1|First Washout Period|Protocol Violation|0
3093|NCT02185534|19257|P6|First Washout Period|Withdrawal by Subject|0
3094|NCT02185534|19258|P5|First Washout Period|Withdrawal by Subject|1
3095|NCT02185534|19259|P4|First Washout Period|Withdrawal by Subject|0
3096|NCT02185534|19260|P3|First Washout Period|Withdrawal by Subject|0
3097|NCT02185534|19261|P2|First Washout Period|Withdrawal by Subject|0
3098|NCT02185534|19262|P1|First Washout Period|Withdrawal by Subject|1
3099|NCT02185534|19257|P6|First Period|Withdrawal by Subject|0
3100|NCT02185534|19258|P5|First Period|Withdrawal by Subject|0
3101|NCT02185534|19259|P4|First Period|Withdrawal by Subject|1
3102|NCT02185534|19260|P3|First Period|Withdrawal by Subject|0
3103|NCT02185534|19261|P2|First Period|Withdrawal by Subject|0
3104|NCT02185534|19262|P1|First Period|Withdrawal by Subject|0
3105|NCT02183675|19376|P6|Treatment Period 2 (10 Days)|Adverse Event|2
3106|NCT02183675|19377|P5|Treatment Period 2 (10 Days)|Adverse Event|0
3107|NCT02183675|19378|P4|Treatment Period 2 (10 Days)|Adverse Event|0
3108|NCT02183675|19379|P3|Treatment Period 2 (10 Days)|Adverse Event|0
3109|NCT02183675|19380|P2|Treatment Period 2 (10 Days)|Adverse Event|0
3110|NCT02183675|19381|P1|Treatment Period 2 (10 Days)|Adverse Event|0
3111|NCT02180061|19509|P2|Overall Study|Continuing in Study|2
3112|NCT02180061|19510|P1|Overall Study|Continuing in Study|19
3113|NCT02180061|19509|P2|Overall Study|Progressive Disease|4
3114|NCT02180061|19510|P1|Overall Study|Progressive Disease|9
3115|NCT02180061|19509|P2|Overall Study|Clinical Progression|0
3116|NCT02180061|19510|P1|Overall Study|Clinical Progression|3
3117|NCT02180061|19509|P2|Overall Study|Adverse Event|2
3118|NCT02180061|19510|P1|Overall Study|Adverse Event|3
3119|NCT02179398|19548|P2|Overall Study|Lost to Follow-up|1
3120|NCT02179398|19549|P1|Overall Study|Lost to Follow-up|0
3121|NCT02179398|19548|P2|Overall Study|Lack of obligatory data|3
3122|NCT02179398|19549|P1|Overall Study|Lack of obligatory data|3
3123|NCT02178995|19569|P9|Open Label|Adverse Event|0
3124|NCT02178995|19570|P8|Open Label|Adverse Event|0
3125|NCT02178995|19571|P7|Open Label|Adverse Event|0
3126|NCT02178995|19572|P6|Open Label|Adverse Event|0
3127|NCT02178995|19573|P5|Open Label|Adverse Event|0
3128|NCT02178995|19574|P4|Open Label|Adverse Event|0
3129|NCT02178995|19575|P3|Open Label|Adverse Event|0
3130|NCT02178995|19576|P2|Open Label|Adverse Event|0
3131|NCT02178995|19577|P1|Open Label|Adverse Event|2
3132|NCT02178995|19569|P9|Double Blind|Lost to Follow-up|0
3133|NCT02178995|19570|P8|Double Blind|Lost to Follow-up|1
3134|NCT02178995|19571|P7|Double Blind|Lost to Follow-up|0
3135|NCT02178995|19572|P6|Double Blind|Lost to Follow-up|0
3136|NCT02178995|19573|P5|Double Blind|Lost to Follow-up|0
3137|NCT02178995|19574|P4|Double Blind|Lost to Follow-up|0
3138|NCT02178995|19575|P3|Double Blind|Lost to Follow-up|0
3139|NCT02178995|19576|P2|Double Blind|Lost to Follow-up|1
3140|NCT02178995|19577|P1|Double Blind|Lost to Follow-up|0
3141|NCT02178995|19569|P9|Double Blind|Adverse Event|1
3142|NCT02178995|19570|P8|Double Blind|Adverse Event|1
3143|NCT02178995|19571|P7|Double Blind|Adverse Event|0
3144|NCT02178995|19572|P6|Double Blind|Adverse Event|1
3145|NCT02178995|19573|P5|Double Blind|Adverse Event|0
3146|NCT02178995|19574|P4|Double Blind|Adverse Event|0
3147|NCT02178995|19575|P3|Double Blind|Adverse Event|0
3148|NCT02178995|19576|P2|Double Blind|Adverse Event|0
3149|NCT02178995|19577|P1|Double Blind|Adverse Event|0
3150|NCT02178059|19648|P2|Washout|Physician Decision|0
3151|NCT02178059|19649|P1|Washout|Physician Decision|1
3152|NCT02176525|19682|P8|Overall Study|not treated|0
3153|NCT02176525|19683|P7|Overall Study|not treated|0
3154|NCT02176525|19684|P6|Overall Study|not treated|1
3155|NCT02176525|19685|P5|Overall Study|not treated|0
3156|NCT02176525|19686|P4|Overall Study|not treated|0
3157|NCT02176525|19687|P3|Overall Study|not treated|0
3158|NCT02176525|19688|P2|Overall Study|not treated|0
3159|NCT02176525|19689|P1|Overall Study|not treated|1
3160|NCT02176525|19682|P8|Overall Study|Adverse Event|0
3161|NCT02176525|19683|P7|Overall Study|Adverse Event|1
3162|NCT02176525|19684|P6|Overall Study|Adverse Event|0
3163|NCT02176525|19685|P5|Overall Study|Adverse Event|1
3164|NCT02176525|19686|P4|Overall Study|Adverse Event|1
3165|NCT02176525|19687|P3|Overall Study|Adverse Event|0
3166|NCT02176525|19688|P2|Overall Study|Adverse Event|0
3167|NCT02176525|19689|P1|Overall Study|Adverse Event|0
3168|NCT02176421|19866|P1|Overall Study|Adverse Event|1
3169|NCT02176421|19866|P1|Overall Study|Lost to Follow-up|4
3170|NCT02176356|19875|P1|Overall Study|Other Miscellaneous Reasons|2
3171|NCT02176356|19875|P1|Overall Study|Personal Reasons|3
3172|NCT02176356|19875|P1|Overall Study|Lost to Follow-up|4
3173|NCT02176356|19875|P1|Overall Study|Screen Failure|14
3174|NCT02175199|19911|P2|Overall Study|Sponsor Decision|0
3175|NCT02175199|19912|P1|Overall Study|Sponsor Decision|1
3176|NCT02175199|19911|P2|Overall Study|Randomized in Error|0
3177|NCT02175199|19912|P1|Overall Study|Randomized in Error|1
3178|NCT02175199|19911|P2|Overall Study|Withdrawal by Subject|5
3179|NCT02175199|19912|P1|Overall Study|Withdrawal by Subject|1
3180|NCT02175121|19926|P5|Overall Study|Time issues|0
3181|NCT02175121|19927|P4|Overall Study|Time issues|0
3182|NCT02175121|19928|P3|Overall Study|Time issues|1
3183|NCT02175121|19929|P2|Overall Study|Time issues|0
3184|NCT02175121|19930|P1|Overall Study|Time issues|0
3185|NCT02175121|19926|P5|Overall Study|Schedule conflict|0
3186|NCT02175121|19927|P4|Overall Study|Schedule conflict|0
3187|NCT02175121|19928|P3|Overall Study|Schedule conflict|1
3188|NCT02175121|19929|P2|Overall Study|Schedule conflict|0
3189|NCT02175121|19930|P1|Overall Study|Schedule conflict|0
3190|NCT02175121|19926|P5|Overall Study|Personal emergency|1
3191|NCT02175121|19927|P4|Overall Study|Personal emergency|0
3192|NCT02175121|19928|P3|Overall Study|Personal emergency|0
3193|NCT02175121|19929|P2|Overall Study|Personal emergency|0
3194|NCT02175121|19930|P1|Overall Study|Personal emergency|0
3195|NCT02175121|19926|P5|Overall Study|Lost to Follow-up|0
3196|NCT02175121|19927|P4|Overall Study|Lost to Follow-up|1
3197|NCT02175121|19928|P3|Overall Study|Lost to Follow-up|0
3198|NCT02175121|19929|P2|Overall Study|Lost to Follow-up|1
3199|NCT02175121|19930|P1|Overall Study|Lost to Follow-up|0
3200|NCT02175121|19926|P5|Overall Study|Lack of Efficacy|0
3201|NCT02175121|19927|P4|Overall Study|Lack of Efficacy|0
3202|NCT02175121|19928|P3|Overall Study|Lack of Efficacy|0
3203|NCT02175121|19929|P2|Overall Study|Lack of Efficacy|0
3204|NCT02175121|19930|P1|Overall Study|Lack of Efficacy|1
3205|NCT02173769|20057|P1|Overall Study|Protocol Violation|4
3206|NCT02173054|20071|P3|Overall Study|Withdrawal by Subject|1
3207|NCT02173054|20072|P2|Overall Study|Withdrawal by Subject|0
3208|NCT02173054|20073|P1|Overall Study|Withdrawal by Subject|0
3209|NCT02173054|20071|P3|Overall Study|lack of compliance|0
3210|NCT02173054|20072|P2|Overall Study|lack of compliance|0
3211|NCT02173054|20073|P1|Overall Study|lack of compliance|1
3212|NCT02172625|20118|P2|Overall Study|car accident|1
3213|NCT02172625|20119|P1|Overall Study|car accident|0
3214|NCT02172625|20118|P2|Overall Study|Pregnancy|1
3215|NCT02172625|20119|P1|Overall Study|Pregnancy|0
3216|NCT02172625|20118|P2|Overall Study|Adverse Event|1
3217|NCT02172625|20119|P1|Overall Study|Adverse Event|0
3218|NCT02170688|20223|P5|Overall Study|Physician Decision|0
3219|NCT02170688|20224|P4|Overall Study|Physician Decision|0
3220|NCT02170688|20225|P3|Overall Study|Physician Decision|1
3221|NCT02170688|20226|P2|Overall Study|Physician Decision|0
3222|NCT02170688|20227|P1|Overall Study|Physician Decision|0
3223|NCT02170688|20223|P5|Overall Study|Full dose not received|0
3224|NCT02170688|20224|P4|Overall Study|Full dose not received|0
3225|NCT02170688|20225|P3|Overall Study|Full dose not received|0
3226|NCT02170688|20226|P2|Overall Study|Full dose not received|1
3227|NCT02170688|20227|P1|Overall Study|Full dose not received|0
3228|NCT02170688|20223|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
3229|NCT02170688|20224|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
3230|NCT02170688|20225|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
3231|NCT02170688|20226|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
3232|NCT02170688|20227|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
3233|NCT02170207|20388|P1|Overall Study|Case report forms unavailable|5
3234|NCT02170077|20399|P3|Overall Study|Exacerbation of seizures|1
3235|NCT02170077|20400|P2|Overall Study|Exacerbation of seizures|2
3236|NCT02170077|20401|P1|Overall Study|Exacerbation of seizures|0
3237|NCT02170077|20399|P3|Overall Study|Exclusion criteria|5
3238|NCT02170077|20400|P2|Overall Study|Exclusion criteria|2
3239|NCT02170077|20401|P1|Overall Study|Exclusion criteria|2
3240|NCT02170077|20399|P3|Overall Study|Lost to Follow-up|0
3241|NCT02170077|20400|P2|Overall Study|Lost to Follow-up|1
3242|NCT02170077|20401|P1|Overall Study|Lost to Follow-up|0
3243|NCT02170077|20399|P3|Overall Study|Adverse Event|4
3244|NCT02170077|20400|P2|Overall Study|Adverse Event|4
3245|NCT02170077|20401|P1|Overall Study|Adverse Event|4
3246|NCT02170077|20399|P3|Overall Study|Withdrawal by Subject|2
3247|NCT02170077|20400|P2|Overall Study|Withdrawal by Subject|4
3248|NCT02170077|20401|P1|Overall Study|Withdrawal by Subject|3
3249|NCT02170064|20412|P3|Overall Study|Physician Decision|0
3250|NCT02170064|20413|P2|Overall Study|Physician Decision|1
3251|NCT02170064|20414|P1|Overall Study|Physician Decision|1
3252|NCT02170064|20412|P3|Overall Study|Withdrawal by Subject|1
3253|NCT02170064|20413|P2|Overall Study|Withdrawal by Subject|1
3254|NCT02170064|20414|P1|Overall Study|Withdrawal by Subject|5
3255|NCT02169414|20570|P4|Overall Study|Adverse Event|0
3256|NCT02169414|20571|P3|Overall Study|Adverse Event|0
3257|NCT02169414|20572|P2|Overall Study|Adverse Event|1
3258|NCT02169414|20573|P1|Overall Study|Adverse Event|0
3259|NCT02169414|20570|P4|Overall Study|Withdrawal by Subject|0
3260|NCT02169414|20571|P3|Overall Study|Withdrawal by Subject|0
3261|NCT02169414|20572|P2|Overall Study|Withdrawal by Subject|0
3262|NCT02169414|20573|P1|Overall Study|Withdrawal by Subject|1
3263|NCT02169336|20614|P3|Overall Study|Subject declined to continue dosing|1
3264|NCT02169336|20615|P2|Overall Study|Subject declined to continue dosing|0
3265|NCT02169336|20616|P1|Overall Study|Subject declined to continue dosing|0
3266|NCT02169336|20614|P3|Overall Study|Physician Decision|1
3267|NCT02169336|20615|P2|Overall Study|Physician Decision|0
3268|NCT02169336|20616|P1|Overall Study|Physician Decision|0
3269|NCT02169336|20614|P3|Overall Study|Withdrawal by Subject|0
3270|NCT02169336|20615|P2|Overall Study|Withdrawal by Subject|0
3271|NCT02169336|20616|P1|Overall Study|Withdrawal by Subject|1
3272|NCT02169336|20614|P3|Overall Study|Adverse Event|1
3273|NCT02169336|20615|P2|Overall Study|Adverse Event|3
3274|NCT02169336|20616|P1|Overall Study|Adverse Event|2
3275|NCT02169336|20614|P3|Overall Study|Lack of Efficacy|0
3276|NCT02169336|20615|P2|Overall Study|Lack of Efficacy|1
3277|NCT02169336|20616|P1|Overall Study|Lack of Efficacy|1
3278|NCT02168478|20637|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
3279|NCT02168478|20637|P1|Overall Study|Did Not Consent to Participation|2
3280|NCT02168478|20637|P1|Overall Study|Withdrawal by Subject|1
3281|NCT02168387|20643|P2|Overall Study|Death|0
3282|NCT02168387|20644|P1|Overall Study|Death|1
3283|NCT02168387|20643|P2|Overall Study|Planned exubation|3
3284|NCT02168387|20644|P1|Overall Study|Planned exubation|6
3285|NCT02167139|20690|P4|Transition-extension|Lost to Follow-up|0
3286|NCT02167139|20691|P3|Transition-extension|Lost to Follow-up|0
3287|NCT02167139|20692|P2|Transition-extension|Lost to Follow-up|0
3288|NCT02167139|20693|P1|Transition-extension|Lost to Follow-up|1
3289|NCT02167139|20690|P4|Transition-extension|Other|0
3290|NCT02167139|20691|P3|Transition-extension|Other|1
3291|NCT02167139|20692|P2|Transition-extension|Other|0
3292|NCT02167139|20693|P1|Transition-extension|Other|1
3293|NCT02167139|20690|P4|Transition-extension|Lack of Efficacy|1
3294|NCT02167139|20691|P3|Transition-extension|Lack of Efficacy|1
3295|NCT02167139|20692|P2|Transition-extension|Lack of Efficacy|0
3296|NCT02167139|20693|P1|Transition-extension|Lack of Efficacy|0
3297|NCT02167139|20690|P4|Transition-extension|Withdrawal by Subject|1
3298|NCT02167139|20691|P3|Transition-extension|Withdrawal by Subject|4
3299|NCT02167139|20692|P2|Transition-extension|Withdrawal by Subject|0
3300|NCT02167139|20693|P1|Transition-extension|Withdrawal by Subject|2
3301|NCT02167139|20690|P4|Transition-extension|Adverse Event|3
3302|NCT02167139|20691|P3|Transition-extension|Adverse Event|2
3303|NCT02167139|20692|P2|Transition-extension|Adverse Event|0
3304|NCT02167139|20693|P1|Transition-extension|Adverse Event|2
3305|NCT02167139|20690|P4|Randomised, Double-blind|Other|0
3306|NCT02167139|20691|P3|Randomised, Double-blind|Other|0
3307|NCT02167139|20692|P2|Randomised, Double-blind|Other|0
3308|NCT02167139|20693|P1|Randomised, Double-blind|Other|3
3309|NCT02167139|20690|P4|Randomised, Double-blind|Lack of Efficacy|0
3310|NCT02167139|20691|P3|Randomised, Double-blind|Lack of Efficacy|0
3311|NCT02167139|20692|P2|Randomised, Double-blind|Lack of Efficacy|2
3312|NCT02167139|20693|P1|Randomised, Double-blind|Lack of Efficacy|1
3313|NCT02167139|20690|P4|Randomised, Double-blind|Adverse Event|0
3314|NCT02167139|20691|P3|Randomised, Double-blind|Adverse Event|0
3315|NCT02167139|20692|P2|Randomised, Double-blind|Adverse Event|9
3316|NCT02167139|20693|P1|Randomised, Double-blind|Adverse Event|2
3317|NCT02167139|20690|P4|Randomised, Double-blind|Withdrawal by Subject|0
3318|NCT02167139|20691|P3|Randomised, Double-blind|Withdrawal by Subject|0
3319|NCT02167139|20692|P2|Randomised, Double-blind|Withdrawal by Subject|8
3320|NCT02167139|20693|P1|Randomised, Double-blind|Withdrawal by Subject|11
3321|NCT02166697|20707|P1|Overall Study|Protocol Violation|347
3322|NCT02164539|20763|P7|Treatment Phase C (1 Week)|Physician Decision|1
3323|NCT02164539|20764|P6|Treatment Phase C (1 Week)|Physician Decision|0
3324|NCT02164539|20765|P5|Treatment Phase C (1 Week)|Physician Decision|0
3325|NCT02164539|20766|P4|Treatment Phase C (1 Week)|Physician Decision|0
3326|NCT02164539|20767|P3|Treatment Phase C (1 Week)|Physician Decision|0
3327|NCT02164539|20768|P2|Treatment Phase C (1 Week)|Physician Decision|0
3328|NCT02164539|20769|P1|Treatment Phase C (1 Week)|Physician Decision|0
3329|NCT02164539|20763|P7|Treatment Phase C (1 Week)|Adverse Event|1
3330|NCT02164539|20764|P6|Treatment Phase C (1 Week)|Adverse Event|0
3331|NCT02164539|20765|P5|Treatment Phase C (1 Week)|Adverse Event|0
3332|NCT02164539|20766|P4|Treatment Phase C (1 Week)|Adverse Event|0
3333|NCT02164539|20767|P3|Treatment Phase C (1 Week)|Adverse Event|0
3334|NCT02164539|20768|P2|Treatment Phase C (1 Week)|Adverse Event|0
3335|NCT02164539|20769|P1|Treatment Phase C (1 Week)|Adverse Event|0
3336|NCT02164539|20763|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
3337|NCT02164539|20764|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
3338|NCT02164539|20765|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
3339|NCT02164539|20766|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
3340|NCT02164539|20767|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
3341|NCT02164539|20768|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
3342|NCT02164539|20769|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
3343|NCT02164539|20763|P7|Treatment Phase B (1 Week)|Physician Decision|1
3344|NCT02164539|20764|P6|Treatment Phase B (1 Week)|Physician Decision|0
3345|NCT02164539|20765|P5|Treatment Phase B (1 Week)|Physician Decision|1
3346|NCT02164539|20766|P4|Treatment Phase B (1 Week)|Physician Decision|0
3347|NCT02164539|20767|P3|Treatment Phase B (1 Week)|Physician Decision|0
3348|NCT02164539|20768|P2|Treatment Phase B (1 Week)|Physician Decision|0
3349|NCT02164539|20769|P1|Treatment Phase B (1 Week)|Physician Decision|0
3350|NCT02164539|20763|P7|Treatment Phase B (1 Week)|Adverse Event|0
3351|NCT02164539|20764|P6|Treatment Phase B (1 Week)|Adverse Event|0
3352|NCT02164539|20765|P5|Treatment Phase B (1 Week)|Adverse Event|2
3353|NCT02164539|20766|P4|Treatment Phase B (1 Week)|Adverse Event|0
3354|NCT02164539|20767|P3|Treatment Phase B (1 Week)|Adverse Event|0
3355|NCT02164539|20768|P2|Treatment Phase B (1 Week)|Adverse Event|0
3356|NCT02164539|20769|P1|Treatment Phase B (1 Week)|Adverse Event|0
3357|NCT02164539|20763|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
3358|NCT02164539|20764|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
3359|NCT02164539|20765|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
3360|NCT02164539|20766|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
3361|NCT02164539|20767|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
3362|NCT02164539|20768|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
3363|NCT02164539|20769|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
3364|NCT02163915|20832|P5|Overall Study|Physician Decision|0
3365|NCT02163915|20833|P4|Overall Study|Physician Decision|1
3366|NCT02163915|20834|P3|Overall Study|Physician Decision|0
3367|NCT02163915|20835|P2|Overall Study|Physician Decision|0
3368|NCT02163915|20836|P1|Overall Study|Physician Decision|0
3369|NCT02163915|20832|P5|Overall Study|Study termination|2
3370|NCT02163915|20833|P4|Overall Study|Study termination|0
3371|NCT02163915|20834|P3|Overall Study|Study termination|0
3372|NCT02163915|20835|P2|Overall Study|Study termination|0
3373|NCT02163915|20836|P1|Overall Study|Study termination|1
3374|NCT02163915|20832|P5|Overall Study|Withdrawal by Subject|2
3375|NCT02163915|20833|P4|Overall Study|Withdrawal by Subject|2
3376|NCT02163915|20834|P3|Overall Study|Withdrawal by Subject|2
3377|NCT02163915|20835|P2|Overall Study|Withdrawal by Subject|0
3378|NCT02163915|20836|P1|Overall Study|Withdrawal by Subject|2
3379|NCT02163395|20941|P1|Overall Study|Adverse Event|1
3380|NCT02163395|20941|P1|Overall Study|Lost to Follow-up|3
3381|NCT02163395|20941|P1|Overall Study|Withdrawal by Subject|1
3382|NCT02161146|20975|P5|Overall Study|Other Miscellaneous Reasons|0
3383|NCT02161146|20976|P4|Overall Study|Other Miscellaneous Reasons|0
3384|NCT02161146|20977|P3|Overall Study|Other Miscellaneous Reasons|0
3385|NCT02161146|20978|P2|Overall Study|Other Miscellaneous Reasons|1
3386|NCT02161146|20979|P1|Overall Study|Other Miscellaneous Reasons|0
3387|NCT02161146|20975|P5|Overall Study|Personal Reasons|1
3388|NCT02161146|20976|P4|Overall Study|Personal Reasons|2
3389|NCT02161146|20977|P3|Overall Study|Personal Reasons|0
3390|NCT02161146|20978|P2|Overall Study|Personal Reasons|1
3391|NCT02161146|20979|P1|Overall Study|Personal Reasons|0
3392|NCT02161146|20975|P5|Overall Study|Lost to Follow-up|0
3393|NCT02161146|20976|P4|Overall Study|Lost to Follow-up|0
3394|NCT02161146|20977|P3|Overall Study|Lost to Follow-up|0
3395|NCT02161146|20978|P2|Overall Study|Lost to Follow-up|1
3396|NCT02161146|20979|P1|Overall Study|Lost to Follow-up|0
3397|NCT02161146|20975|P5|Overall Study|Adverse Event|0
3398|NCT02161146|20976|P4|Overall Study|Adverse Event|1
3399|NCT02161146|20977|P3|Overall Study|Adverse Event|0
3400|NCT02161146|20978|P2|Overall Study|Adverse Event|1
3401|NCT02161146|20979|P1|Overall Study|Adverse Event|1
3402|NCT02161016|20992|P1|Overall Study|withdrawn by IRB|1
3403|NCT02160977|21023|P2|Six Months After Surgery|Lost to Follow-up|1
3404|NCT02160977|21024|P1|Six Months After Surgery|Lost to Follow-up|2
3405|NCT02160977|21023|P2|Three Months After Surgery|Lost to Follow-up|2
3406|NCT02160977|21024|P1|Three Months After Surgery|Lost to Follow-up|0
3407|NCT02160977|21023|P2|Six Weeks After Surgery|Lost to Follow-up|0
3408|NCT02160977|21024|P1|Six Weeks After Surgery|Lost to Follow-up|1
3409|NCT02160314|21036|P2|Overall Study|Lost to Follow-up|1
3410|NCT02160314|21037|P1|Overall Study|Lost to Follow-up|0
3411|NCT02160314|21036|P2|Overall Study|Withdrawal by Subject|2
3412|NCT02160314|21037|P1|Overall Study|Withdrawal by Subject|1
3413|NCT02160314|21036|P2|Overall Study|Protocol Violation|4
3414|NCT02160314|21037|P1|Overall Study|Protocol Violation|0
3415|NCT02160314|21036|P2|Overall Study|Adverse Event|6
3416|NCT02160314|21037|P1|Overall Study|Adverse Event|0
3417|NCT02159950|21045|P2|Overall Study|Progression|1
3418|NCT02159950|21046|P1|Overall Study|Progression|0
3419|NCT02159950|21045|P2|Overall Study|Adverse Event|1
3420|NCT02159950|21046|P1|Overall Study|Adverse Event|0
3421|NCT02159482|21094|P1|Overall Study|Physician Decision|3
3422|NCT02159482|21094|P1|Overall Study|Withdrawal by Subject|2
3423|NCT02159365|21099|P1|Overall Study|Unspecified|1
3424|NCT02159365|21099|P1|Overall Study|Subject Withdrew Consent|1
3425|NCT02159365|21099|P1|Overall Study|Subject Request to Discontinue Treatment|1
3426|NCT02159365|21099|P1|Overall Study|Study Drug Toxicity|1
3427|NCT02159365|21099|P1|Overall Study|Lost to Follow-up|1
3428|NCT02159365|21099|P1|Overall Study|Adverse Event Unrelated to Study Drug|6
3429|NCT02159365|21099|P1|Overall Study|Disease Progression|11
3430|NCT02159352|21105|P2|Overall Study|Withdrawal by Subject|1
3431|NCT02159352|21106|P1|Overall Study|Withdrawal by Subject|0
3432|NCT02159352|21105|P2|Overall Study|Adverse Event|1
3433|NCT02159352|21106|P1|Overall Study|Adverse Event|3
3434|NCT02159040|21181|P1|Overall Study|Death|1
3435|NCT02158442|21196|P2|Overall Study|Perfusion staff not available|0
3436|NCT02158442|21197|P1|Overall Study|Perfusion staff not available|1
3437|NCT02158442|21196|P2|Overall Study|Withdrawal by Subject|0
3438|NCT02158442|21197|P1|Overall Study|Withdrawal by Subject|1
3439|NCT02158247|21205|P1|Overall Study|Invisible vocal cords|5
3440|NCT02158039|21221|P1|Overall Study|Screen Failure|9
3441|NCT02158039|21221|P1|Overall Study|Withdrawal by Subject|1
3442|NCT02157883|21236|P1|2: AZD9291+Itraconozole|Adverse Event|1
3443|NCT02157376|21267|P2|Overall Study|Investigator's misjudgement|2
3444|NCT02157376|21268|P1|Overall Study|Investigator's misjudgement|1
3445|NCT02157376|21267|P2|Overall Study|Not treated|3
3446|NCT02157376|21268|P1|Overall Study|Not treated|8
3447|NCT02157376|21267|P2|Overall Study|Withdrawal by Subject|8
3448|NCT02157376|21268|P1|Overall Study|Withdrawal by Subject|3
3449|NCT02157376|21267|P2|Overall Study|Eligibility criteria not fulfilled|1
3450|NCT02157376|21268|P1|Overall Study|Eligibility criteria not fulfilled|0
3451|NCT02157376|21267|P2|Overall Study|Death|4
3452|NCT02157376|21268|P1|Overall Study|Death|10
3453|NCT02157298|21278|P2|Overall Study|Withdrawal by Subject|0
3454|NCT02157298|21279|P1|Overall Study|Withdrawal by Subject|1
3455|NCT02157298|21278|P2|Overall Study|Poor/Non-compliance|0
3456|NCT02157298|21279|P1|Overall Study|Poor/Non-compliance|1
3457|NCT02157298|21278|P2|Overall Study|Subject no longer meets study criteria|2
3458|NCT02157298|21279|P1|Overall Study|Subject no longer meets study criteria|1
3459|NCT02157298|21278|P2|Overall Study|Adverse Event|0
3460|NCT02157298|21279|P1|Overall Study|Adverse Event|1
3461|NCT02157116|21293|P1|Overall Study|Failed Screening|2
3462|NCT02157116|21293|P1|Overall Study|Physician Decision|3
3463|NCT02157116|21293|P1|Overall Study|Withdrawal by Subject|4
3464|NCT02156466|21307|P5|Overall Study|Quantiferon Positivity|0
3465|NCT02156466|21308|P4|Overall Study|Quantiferon Positivity|1
3466|NCT02156466|21309|P3|Overall Study|Quantiferon Positivity|0
3467|NCT02156466|21310|P2|Overall Study|Quantiferon Positivity|0
3468|NCT02156466|21311|P1|Overall Study|Quantiferon Positivity|0
3469|NCT02156466|21307|P5|Overall Study|Adverse Event|0
3470|NCT02156466|21308|P4|Overall Study|Adverse Event|1
3471|NCT02156466|21309|P3|Overall Study|Adverse Event|1
3472|NCT02156466|21310|P2|Overall Study|Adverse Event|0
3473|NCT02156466|21311|P1|Overall Study|Adverse Event|0
3474|NCT02156271|21492|P2|Overall Study|Physician Decision|3
3475|NCT02156271|21493|P1|Overall Study|Physician Decision|4
3476|NCT02155985|21532|P3|Overall Study|Lost to Follow-up|0
3477|NCT02155985|21533|P2|Overall Study|Lost to Follow-up|0
3478|NCT02155985|21534|P1|Overall Study|Lost to Follow-up|1
3479|NCT02155985|21532|P3|Overall Study|Withdrawal by Subject|1
3480|NCT02155985|21533|P2|Overall Study|Withdrawal by Subject|0
3481|NCT02155985|21534|P1|Overall Study|Withdrawal by Subject|0
3482|NCT02155881|21544|P2|Overall Study|Inappropriately randomized|2
3483|NCT02155881|21545|P1|Overall Study|Inappropriately randomized|2
3484|NCT02155881|21544|P2|Overall Study|Withdrawal by Subject|2
3485|NCT02155881|21545|P1|Overall Study|Withdrawal by Subject|0
3486|NCT02155283|21597|P1|Overall Study|Protocol Violation|3
3487|NCT02155283|21597|P1|Overall Study|Withdrawal by Subject|1
3488|NCT02155283|21597|P1|Overall Study|Lost to Follow-up|3
3489|NCT02154425|21624|P1|Screening Period|Adverse Event|1
3490|NCT02154139|21667|P1|Overall Study|Investigator transferred|3
3491|NCT02154139|21667|P1|Overall Study|Other|2
3492|NCT02154139|21667|P1|Overall Study|Injection not administered|2
3493|NCT02154087|21675|P1|Overall Study|Study Termination|1
3494|NCT02153827|21694|P2|Overall Study|Lost to Follow-up|9
3495|NCT02153827|21695|P1|Overall Study|Lost to Follow-up|3
3496|NCT02153788|21711|P2|Overall Study|Physician Decision|1
3497|NCT02153788|21712|P1|Overall Study|Physician Decision|2
3498|NCT02153398|21774|P5|Overall Study|Adverse Event|0
3499|NCT02153398|21775|P4|Overall Study|Adverse Event|1
3500|NCT02153398|21776|P3|Overall Study|Adverse Event|1
3501|NCT02153398|21777|P2|Overall Study|Adverse Event|0
3502|NCT02153398|21778|P1|Overall Study|Adverse Event|0
3503|NCT02153398|21774|P5|Overall Study|Withdrawal by Subject|0
3504|NCT02153398|21775|P4|Overall Study|Withdrawal by Subject|0
3505|NCT02153398|21776|P3|Overall Study|Withdrawal by Subject|0
3506|NCT02153398|21777|P2|Overall Study|Withdrawal by Subject|0
3507|NCT02153398|21778|P1|Overall Study|Withdrawal by Subject|1
3508|NCT02153086|21967|P1|Overall Study|Other|2
3509|NCT02153086|21967|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
3510|NCT02152605|21983|P2|Overall Study|Withdrew consent|2
3511|NCT02152605|21984|P1|Overall Study|Withdrew consent|4
3512|NCT02152605|21983|P2|Overall Study|Lost to Follow-up|0
3513|NCT02152605|21984|P1|Overall Study|Lost to Follow-up|1
3514|NCT02152605|21983|P2|Overall Study|Protocol deviation|4
3515|NCT02152605|21984|P1|Overall Study|Protocol deviation|1
3516|NCT02152605|21983|P2|Overall Study|Lack of Efficacy|4
3517|NCT02152605|21984|P1|Overall Study|Lack of Efficacy|7
3518|NCT02152605|21983|P2|Overall Study|Adverse Event|8
3519|NCT02152605|21984|P1|Overall Study|Adverse Event|6
3520|NCT02152566|21994|P1|Overall Study|Withdrawal by Subject|2
3521|NCT02152566|21994|P1|Overall Study|Lost to Follow-up|1
3522|NCT02152371|22000|P2|Overall Study|Reason Not Given|1
3523|NCT02152371|22001|P1|Overall Study|Reason Not Given|0
3524|NCT02152371|22000|P2|Overall Study|Physician Decision|2
3525|NCT02152371|22001|P1|Overall Study|Physician Decision|0
3526|NCT02152371|22000|P2|Overall Study|Lack of Efficacy|1
3527|NCT02152371|22001|P1|Overall Study|Lack of Efficacy|0
3528|NCT02152371|22000|P2|Overall Study|Lost to Follow-up|0
3529|NCT02152371|22001|P1|Overall Study|Lost to Follow-up|1
3530|NCT02152371|22000|P2|Overall Study|Protocol Violation|3
3531|NCT02152371|22001|P1|Overall Study|Protocol Violation|2
3532|NCT02152371|22000|P2|Overall Study|Withdrawal by Subject|7
3533|NCT02152371|22001|P1|Overall Study|Withdrawal by Subject|3
3534|NCT02152371|22000|P2|Overall Study|Adverse Event|2
3535|NCT02152371|22001|P1|Overall Study|Adverse Event|6
3536|NCT02152007|22037|P1|Overall Study|Withdrawal by Subject|1
3537|NCT02151786|22096|P1|Overall Study|Unavailability of Information|8
3538|NCT02151786|22096|P1|Overall Study|Randomized, not Treated|1
3539|NCT02151786|22096|P1|Overall Study|Outside the Contract Period|1
3540|NCT02151786|22096|P1|Overall Study|Unavailability of Case Report Form|26
3541|NCT02151773|22107|P1|Overall Study|Protocol Deviation|64
3542|NCT02151058|22115|P3|Overall Study|Lost to Follow-up|2
3543|NCT02151058|22116|P2|Overall Study|Lost to Follow-up|0
3544|NCT02151058|22117|P1|Overall Study|Lost to Follow-up|1
3545|NCT02151058|22115|P3|Overall Study|Withdrawal by Subject|3
3546|NCT02151058|22116|P2|Overall Study|Withdrawal by Subject|1
3547|NCT02151058|22117|P1|Overall Study|Withdrawal by Subject|1
3548|NCT02150954|22151|P2|Overall Study|Protocol Violation|0
3549|NCT02150954|22152|P1|Overall Study|Protocol Violation|1
3550|NCT02150213|22224|P1|Overall Study|Withdrawal by Subject|1
3551|NCT02150213|22224|P1|Overall Study|Lost to Follow-up|1
3552|NCT02149875|22250|P3|Overall Study|Physician Decision|2
3553|NCT02149875|22251|P2|Overall Study|Physician Decision|2
3554|NCT02149875|22252|P1|Overall Study|Physician Decision|1
3555|NCT02149875|22250|P3|Overall Study|Withdrawal by Subject|2
3556|NCT02149875|22251|P2|Overall Study|Withdrawal by Subject|2
3557|NCT02149875|22252|P1|Overall Study|Withdrawal by Subject|3
3558|NCT02149875|22250|P3|Overall Study|Lost to Follow-up|5
3559|NCT02149875|22251|P2|Overall Study|Lost to Follow-up|4
3560|NCT02149875|22252|P1|Overall Study|Lost to Follow-up|3
3561|NCT02147691|22304|P2|Overall Study|Lost to Follow-up|1
3562|NCT02147691|22305|P1|Overall Study|Lost to Follow-up|0
3563|NCT02147691|22304|P2|Overall Study|Adverse Event|0
3564|NCT02147691|22305|P1|Overall Study|Adverse Event|2
3565|NCT02147691|22304|P2|Overall Study|Withdrawal by Subject|0
3566|NCT02147691|22305|P1|Overall Study|Withdrawal by Subject|2
3567|NCT02147561|22349|P1|Overall Study|Subjects who didn’t receive BOTOX|1
3568|NCT02147561|22349|P1|Overall Study|Lost to Follow-up|3
3569|NCT02147288|22357|P10|Overall Study|complications from concurrent hernia rep|0
3570|NCT02147288|22358|P9|Overall Study|complications from concurrent hernia rep|0
3571|NCT02147288|22359|P8|Overall Study|complications from concurrent hernia rep|0
3572|NCT02147288|22360|P7|Overall Study|complications from concurrent hernia rep|0
3573|NCT02147288|22361|P6|Overall Study|complications from concurrent hernia rep|0
3574|NCT02147288|22362|P5|Overall Study|complications from concurrent hernia rep|0
3575|NCT02147288|22363|P4|Overall Study|complications from concurrent hernia rep|0
3576|NCT02147288|22364|P3|Overall Study|complications from concurrent hernia rep|0
3577|NCT02147288|22365|P2|Overall Study|complications from concurrent hernia rep|1
3578|NCT02147288|22366|P1|Overall Study|complications from concurrent hernia rep|0
3579|NCT02147288|22357|P10|Overall Study|post-operative hematoma|0
3580|NCT02147288|22358|P9|Overall Study|post-operative hematoma|0
3581|NCT02147288|22359|P8|Overall Study|post-operative hematoma|0
3582|NCT02147288|22360|P7|Overall Study|post-operative hematoma|0
3583|NCT02147288|22361|P6|Overall Study|post-operative hematoma|0
3584|NCT02147288|22362|P5|Overall Study|post-operative hematoma|0
3585|NCT02147288|22363|P4|Overall Study|post-operative hematoma|0
3586|NCT02147288|22364|P3|Overall Study|post-operative hematoma|0
3587|NCT02147288|22365|P2|Overall Study|post-operative hematoma|1
3588|NCT02147288|22366|P1|Overall Study|post-operative hematoma|1
3589|NCT02147093|22374|P2|Period 2|Protocol Violation|0
3590|NCT02147093|22375|P1|Period 2|Protocol Violation|2
3591|NCT02147093|22374|P2|Period 1|Lost to Follow-up|1
3592|NCT02147093|22375|P1|Period 1|Lost to Follow-up|0
3593|NCT02146599|22383|P1|Overall Study|Failed to meet inclusion criteria|5
3594|NCT02146352|22396|P1|Overall Study|Patient entered hospice care|1
3595|NCT02146352|22396|P1|Overall Study|Death|1
3596|NCT02146105|22410|P1|Overall Study|Withdrawal by Subject|5
3597|NCT02146105|22410|P1|Overall Study|Adverse Event|1
3598|NCT02145156|22491|P3|Overall Study|No match to vaccination records|37
3599|NCT02145156|22492|P2|Overall Study|No match to vaccination records|59
3600|NCT02145156|22493|P1|Overall Study|No match to vaccination records|52
3601|NCT02145156|22491|P3|Overall Study|Received all vaccines prior to baseline|45
3602|NCT02145156|22492|P2|Overall Study|Received all vaccines prior to baseline|61
3603|NCT02145156|22493|P1|Overall Study|Received all vaccines prior to baseline|41
3604|NCT02144337|22536|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
3605|NCT02144337|22537|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
3606|NCT02144337|22536|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
3607|NCT02144337|22537|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
3608|NCT02144337|22536|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
3609|NCT02144337|22537|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
3610|NCT02144337|22536|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
3611|NCT02144337|22537|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
3612|NCT02144337|22536|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
3613|NCT02144337|22537|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
3614|NCT02144220|22566|P1|Overall Study|Protocol Violation|1
3615|NCT02144220|22566|P1|Overall Study|Withdrawal by Subject|2
3616|NCT02144220|22566|P1|Overall Study|Physician Decision|3
3617|NCT02144220|22566|P1|Overall Study|Lack of Efficacy|4
3618|NCT02144220|22566|P1|Overall Study|technology incompatibility|9
3619|NCT02143947|22576|P2|Overall Study|Lost to Follow-up|2
3620|NCT02143947|22577|P1|Overall Study|Lost to Follow-up|4
3621|NCT02143583|22592|P3|Overall Study|husband illness|1
3622|NCT02143583|22593|P2|Overall Study|husband illness|0
3623|NCT02143583|22594|P1|Overall Study|husband illness|0
3624|NCT02143583|22592|P3|Overall Study|Withdrawal by Subject|1
3625|NCT02143583|22593|P2|Overall Study|Withdrawal by Subject|0
3626|NCT02143583|22594|P1|Overall Study|Withdrawal by Subject|1
3627|NCT02142712|22608|P4|Overall Study|Lost to Follow-up|0
3628|NCT02142712|22609|P3|Overall Study|Lost to Follow-up|1
3629|NCT02142712|22610|P2|Overall Study|Lost to Follow-up|1
3630|NCT02142712|22611|P1|Overall Study|Lost to Follow-up|1
3631|NCT02141997|22794|P4|Overall Study|Not specified|0
3632|NCT02141997|22795|P3|Overall Study|Not specified|0
3633|NCT02141997|22796|P2|Overall Study|Not specified|4
3634|NCT02141997|22797|P1|Overall Study|Not specified|1
3635|NCT02141997|22794|P4|Overall Study|Withdrew consent|0
3636|NCT02141997|22795|P3|Overall Study|Withdrew consent|3
3637|NCT02141997|22796|P2|Overall Study|Withdrew consent|0
3638|NCT02141997|22797|P1|Overall Study|Withdrew consent|1
3639|NCT02141997|22794|P4|Overall Study|Participant noncompliance|0
3640|NCT02141997|22795|P3|Overall Study|Participant noncompliance|0
3641|NCT02141997|22796|P2|Overall Study|Participant noncompliance|0
3642|NCT02141997|22797|P1|Overall Study|Participant noncompliance|1
3643|NCT02141997|22794|P4|Overall Study|Adverse Event|1
3644|NCT02141997|22795|P3|Overall Study|Adverse Event|0
3645|NCT02141997|22796|P2|Overall Study|Adverse Event|2
3646|NCT02141997|22797|P1|Overall Study|Adverse Event|0
3647|NCT02141633|22837|P2|Overall Study|Physician Decision|0
3648|NCT02141633|22838|P1|Overall Study|Physician Decision|1
3649|NCT02141620|22846|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
3650|NCT02141620|22847|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
3651|NCT02141516|22908|P3|Overall Study|Other|0
3652|NCT02141516|22909|P2|Overall Study|Other|3
3653|NCT02141516|22910|P1|Overall Study|Other|0
3654|NCT02141516|22908|P3|Overall Study|Lost to Follow-up|0
3655|NCT02141516|22909|P2|Overall Study|Lost to Follow-up|1
3656|NCT02141516|22910|P1|Overall Study|Lost to Follow-up|0
3657|NCT02141516|22908|P3|Overall Study|Adverse Event|0
3658|NCT02141516|22909|P2|Overall Study|Adverse Event|1
3659|NCT02141516|22910|P1|Overall Study|Adverse Event|0
3660|NCT02141217|22960|P2|Overall Study|Surgical Intervention|1
3661|NCT02141217|22961|P1|Overall Study|Surgical Intervention|1
3662|NCT02141217|22960|P2|Overall Study|Physician Decision|0
3663|NCT02141217|22961|P1|Overall Study|Physician Decision|1
3664|NCT02141217|22960|P2|Overall Study|Lost to Follow-up|1
3665|NCT02141217|22961|P1|Overall Study|Lost to Follow-up|1
3666|NCT02141217|22960|P2|Overall Study|Withdrawal by Subject|0
3667|NCT02141217|22961|P1|Overall Study|Withdrawal by Subject|6
3668|NCT02141217|22960|P2|Overall Study|Protocol Violation|4
3669|NCT02141217|22961|P1|Overall Study|Protocol Violation|1
3670|NCT02141217|22960|P2|Overall Study|Adverse Event|2
3671|NCT02141217|22961|P1|Overall Study|Adverse Event|1
3672|NCT02140645|23027|P6|Overall Study|Not linked|70896
3673|NCT02140645|23028|P5|Overall Study|Not linked|3286
3674|NCT02140645|23029|P4|Overall Study|Not linked|13833
3675|NCT02140645|23030|P3|Overall Study|Not linked|4236
3676|NCT02140645|23031|P2|Overall Study|Not linked|61654
3677|NCT02140645|23032|P1|Overall Study|Not linked|5489
3678|NCT02140164|23130|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
3679|NCT02140060|23145|P6|Overall Study|Lack of Efficacy|0
3680|NCT02140060|23146|P5|Overall Study|Lack of Efficacy|0
3681|NCT02140060|23147|P4|Overall Study|Lack of Efficacy|1
3682|NCT02140060|23148|P3|Overall Study|Lack of Efficacy|0
3683|NCT02140060|23149|P2|Overall Study|Lack of Efficacy|0
3684|NCT02140060|23150|P1|Overall Study|Lack of Efficacy|0
3685|NCT02140060|23145|P6|Overall Study|Adverse Event|1
3686|NCT02140060|23146|P5|Overall Study|Adverse Event|1
3687|NCT02140060|23147|P4|Overall Study|Adverse Event|1
3688|NCT02140060|23148|P3|Overall Study|Adverse Event|0
3689|NCT02140060|23149|P2|Overall Study|Adverse Event|0
3690|NCT02140060|23150|P1|Overall Study|Adverse Event|0
3691|NCT02139982|23175|P10|Overall Study|Lack of Efficacy|0
3692|NCT02139982|23176|P9|Overall Study|Lack of Efficacy|0
3693|NCT02139982|23177|P8|Overall Study|Lack of Efficacy|0
3694|NCT02139982|23178|P7|Overall Study|Lack of Efficacy|0
3695|NCT02139982|23179|P6|Overall Study|Lack of Efficacy|0
3696|NCT02139982|23180|P5|Overall Study|Lack of Efficacy|0
3697|NCT02139982|23181|P4|Overall Study|Lack of Efficacy|1
3698|NCT02139982|23182|P3|Overall Study|Lack of Efficacy|0
3699|NCT02139982|23183|P2|Overall Study|Lack of Efficacy|1
3700|NCT02139982|23184|P1|Overall Study|Lack of Efficacy|0
3701|NCT02139943|23229|P3|Overall Study|eGFR Withdrawal Criteria|1
3702|NCT02139943|23230|P2|Overall Study|eGFR Withdrawal Criteria|0
3703|NCT02139943|23231|P1|Overall Study|eGFR Withdrawal Criteria|0
3704|NCT02139943|23229|P3|Overall Study|Participant in Poor Compliance|1
3705|NCT02139943|23230|P2|Overall Study|Participant in Poor Compliance|0
3706|NCT02139943|23231|P1|Overall Study|Participant in Poor Compliance|1
3707|NCT02139943|23229|P3|Overall Study|Participant wishes to discontinue|0
3708|NCT02139943|23230|P2|Overall Study|Participant wishes to discontinue|0
3709|NCT02139943|23231|P1|Overall Study|Participant wishes to discontinue|2
3710|NCT02139943|23229|P3|Overall Study|Unspecified|1
3711|NCT02139943|23230|P2|Overall Study|Unspecified|0
3712|NCT02139943|23231|P1|Overall Study|Unspecified|0
3713|NCT02139943|23229|P3|Overall Study|Withdrawal by Subject|0
3714|NCT02139943|23230|P2|Overall Study|Withdrawal by Subject|3
3715|NCT02139943|23231|P1|Overall Study|Withdrawal by Subject|4
3716|NCT02139943|23229|P3|Overall Study|Lost to Follow-up|2
3717|NCT02139943|23230|P2|Overall Study|Lost to Follow-up|2
3718|NCT02139943|23231|P1|Overall Study|Lost to Follow-up|3
3719|NCT02139943|23229|P3|Overall Study|Adverse Event|2
3720|NCT02139943|23230|P2|Overall Study|Adverse Event|1
3721|NCT02139943|23231|P1|Overall Study|Adverse Event|0
3722|NCT02139046|23267|P5|Overall Study|Other Miscellaneous Reasons|12
3723|NCT02139046|23268|P4|Overall Study|Other Miscellaneous Reasons|9
3724|NCT02139046|23269|P3|Overall Study|Other Miscellaneous Reasons|4
3725|NCT02139046|23270|P2|Overall Study|Other Miscellaneous Reasons|9
3726|NCT02139046|23271|P1|Overall Study|Other Miscellaneous Reasons|10
3727|NCT02139046|23267|P5|Overall Study|Withdrawal due to a Gout Flare|1
3728|NCT02139046|23268|P4|Overall Study|Withdrawal due to a Gout Flare|0
3729|NCT02139046|23269|P3|Overall Study|Withdrawal due to a Gout Flare|1
3730|NCT02139046|23270|P2|Overall Study|Withdrawal due to a Gout Flare|1
3731|NCT02139046|23271|P1|Overall Study|Withdrawal due to a Gout Flare|1
3732|NCT02139046|23267|P5|Overall Study|Lack of Efficacy|2
3733|NCT02139046|23268|P4|Overall Study|Lack of Efficacy|1
3734|NCT02139046|23269|P3|Overall Study|Lack of Efficacy|2
3735|NCT02139046|23270|P2|Overall Study|Lack of Efficacy|1
3736|NCT02139046|23271|P1|Overall Study|Lack of Efficacy|0
3737|NCT02139046|23267|P5|Overall Study|Voluntary Withdrawal|16
3738|NCT02139046|23268|P4|Overall Study|Voluntary Withdrawal|15
3739|NCT02139046|23269|P3|Overall Study|Voluntary Withdrawal|10
3740|NCT02139046|23270|P2|Overall Study|Voluntary Withdrawal|8
3741|NCT02139046|23271|P1|Overall Study|Voluntary Withdrawal|20
3742|NCT02139046|23267|P5|Overall Study|Lost to Follow-up|13
3743|NCT02139046|23268|P4|Overall Study|Lost to Follow-up|18
3744|NCT02139046|23269|P3|Overall Study|Lost to Follow-up|16
3745|NCT02139046|23270|P2|Overall Study|Lost to Follow-up|16
3746|NCT02139046|23271|P1|Overall Study|Lost to Follow-up|13
3747|NCT02139046|23267|P5|Overall Study|Major Protocol Deviation|6
3748|NCT02139046|23268|P4|Overall Study|Major Protocol Deviation|12
3749|NCT02139046|23269|P3|Overall Study|Major Protocol Deviation|16
3750|NCT02139046|23270|P2|Overall Study|Major Protocol Deviation|10
3751|NCT02139046|23271|P1|Overall Study|Major Protocol Deviation|9
3752|NCT02139046|23267|P5|Overall Study|Pretreatment Event/Adverse Event|7
3753|NCT02139046|23268|P4|Overall Study|Pretreatment Event/Adverse Event|13
3754|NCT02139046|23269|P3|Overall Study|Pretreatment Event/Adverse Event|10
3755|NCT02139046|23270|P2|Overall Study|Pretreatment Event/Adverse Event|9
3756|NCT02139046|23271|P1|Overall Study|Pretreatment Event/Adverse Event|9
3757|NCT02138747|23297|P4|Treatment Period 2|Other - Miscellaneous|0
3758|NCT02138747|23298|P3|Treatment Period 2|Other - Miscellaneous|0
3759|NCT02138747|23299|P2|Treatment Period 2|Other - Miscellaneous|0
3760|NCT02138747|23300|P1|Treatment Period 2|Other - Miscellaneous|3
3761|NCT02138747|23297|P4|Treatment Period 2|Withdrawal by Subject|2
3762|NCT02138747|23298|P3|Treatment Period 2|Withdrawal by Subject|1
3763|NCT02138747|23299|P2|Treatment Period 2|Withdrawal by Subject|4
3764|NCT02138747|23300|P1|Treatment Period 2|Withdrawal by Subject|5
3765|NCT02138747|23297|P4|Treatment Period 2|Protocol Violation|0
3766|NCT02138747|23298|P3|Treatment Period 2|Protocol Violation|0
3767|NCT02138747|23299|P2|Treatment Period 2|Protocol Violation|0
3768|NCT02138747|23300|P1|Treatment Period 2|Protocol Violation|1
3769|NCT02138747|23297|P4|Treatment Period 2|Lost to Follow-up|0
3770|NCT02138747|23298|P3|Treatment Period 2|Lost to Follow-up|0
3771|NCT02138747|23299|P2|Treatment Period 2|Lost to Follow-up|0
3772|NCT02138747|23300|P1|Treatment Period 2|Lost to Follow-up|2
3773|NCT02138747|23297|P4|Treatment Period 2|Adverse Event|1
3774|NCT02138747|23298|P3|Treatment Period 2|Adverse Event|1
3775|NCT02138747|23299|P2|Treatment Period 2|Adverse Event|3
3776|NCT02138747|23300|P1|Treatment Period 2|Adverse Event|6
3777|NCT02138747|23297|P4|Treatment Period 1|Other - Miscellaneous|0
3778|NCT02138747|23298|P3|Treatment Period 1|Other - Miscellaneous|0
3779|NCT02138747|23299|P2|Treatment Period 1|Other - Miscellaneous|4
3780|NCT02138747|23300|P1|Treatment Period 1|Other - Miscellaneous|2
3781|NCT02138747|23297|P4|Treatment Period 1|Withdrawal by Subject|3
3782|NCT02138747|23298|P3|Treatment Period 1|Withdrawal by Subject|1
3783|NCT02138747|23299|P2|Treatment Period 1|Withdrawal by Subject|4
3784|NCT02138747|23300|P1|Treatment Period 1|Withdrawal by Subject|8
3785|NCT02138747|23297|P4|Treatment Period 1|Protocol Violation|0
3786|NCT02138747|23298|P3|Treatment Period 1|Protocol Violation|0
3787|NCT02138747|23299|P2|Treatment Period 1|Protocol Violation|2
3788|NCT02138747|23300|P1|Treatment Period 1|Protocol Violation|0
3789|NCT02138747|23297|P4|Treatment Period 1|Lost to Follow-up|0
3790|NCT02138747|23298|P3|Treatment Period 1|Lost to Follow-up|1
3791|NCT02138747|23299|P2|Treatment Period 1|Lost to Follow-up|1
3792|NCT02138747|23300|P1|Treatment Period 1|Lost to Follow-up|0
3793|NCT02138747|23297|P4|Treatment Period 1|Adverse Event|1
3794|NCT02138747|23298|P3|Treatment Period 1|Adverse Event|2
3795|NCT02138747|23299|P2|Treatment Period 1|Adverse Event|14
3796|NCT02138747|23300|P1|Treatment Period 1|Adverse Event|10
3797|NCT02137785|23563|P2|Overall Study|subject moved out of state|0
3798|NCT02137785|23564|P1|Overall Study|subject moved out of state|1
3799|NCT02137785|23563|P2|Overall Study|Withdrawal by Subject|4
3800|NCT02137785|23564|P1|Overall Study|Withdrawal by Subject|1
3801|NCT02137785|23563|P2|Overall Study|Lost to Follow-up|0
3802|NCT02137785|23564|P1|Overall Study|Lost to Follow-up|1
3803|NCT02136134|23744|P2|Overall Study|Subjects randomized but not treated|8
3804|NCT02136134|23745|P1|Overall Study|Subjects randomized but not treated|10
3805|NCT02136134|23744|P2|Overall Study|Ongoing|207
3806|NCT02136134|23745|P1|Overall Study|Ongoing|185
3807|NCT02136134|23744|P2|Overall Study|Unspecified|3
3808|NCT02136134|23745|P1|Overall Study|Unspecified|3
3809|NCT02136134|23744|P2|Overall Study|Withdrawal by Subject|4
3810|NCT02136134|23745|P1|Overall Study|Withdrawal by Subject|14
3811|NCT02136134|23744|P2|Overall Study|Death|29
3812|NCT02136134|23745|P1|Overall Study|Death|35
3813|NCT02134977|23806|P1|Overall Study|Protocol Deviation|102
3814|NCT02134587|23827|P1|Overall Study|Did not completed all meetings|30
3815|NCT02133131|23919|P7|Overall Study|Protocol Violation|1
3816|NCT02133131|23920|P6|Overall Study|Protocol Violation|0
3817|NCT02133131|23921|P5|Overall Study|Protocol Violation|0
3818|NCT02133131|23922|P4|Overall Study|Protocol Violation|0
3819|NCT02133131|23923|P3|Overall Study|Protocol Violation|0
3820|NCT02133131|23924|P2|Overall Study|Protocol Violation|0
3821|NCT02133131|23925|P1|Overall Study|Protocol Violation|0
3822|NCT02133131|23919|P7|Overall Study|Ongoing in study|11
3823|NCT02133131|23920|P6|Overall Study|Ongoing in study|14
3824|NCT02133131|23921|P5|Overall Study|Ongoing in study|15
3825|NCT02133131|23922|P4|Overall Study|Ongoing in study|0
3826|NCT02133131|23923|P3|Overall Study|Ongoing in study|0
3827|NCT02133131|23924|P2|Overall Study|Ongoing in study|0
3828|NCT02133131|23925|P1|Overall Study|Ongoing in study|0
3829|NCT02133131|23919|P7|Overall Study|Status not recorded|0
3830|NCT02133131|23920|P6|Overall Study|Status not recorded|0
3831|NCT02133131|23921|P5|Overall Study|Status not recorded|0
3832|NCT02133131|23922|P4|Overall Study|Status not recorded|4
3833|NCT02133131|23923|P3|Overall Study|Status not recorded|1
3834|NCT02133131|23924|P2|Overall Study|Status not recorded|5
3835|NCT02133131|23925|P1|Overall Study|Status not recorded|4
3836|NCT02133131|23919|P7|Overall Study|Lost to Follow-up|0
3837|NCT02133131|23920|P6|Overall Study|Lost to Follow-up|0
3838|NCT02133131|23921|P5|Overall Study|Lost to Follow-up|0
3839|NCT02133131|23922|P4|Overall Study|Lost to Follow-up|1
3840|NCT02133131|23923|P3|Overall Study|Lost to Follow-up|0
3841|NCT02133131|23924|P2|Overall Study|Lost to Follow-up|0
3842|NCT02133131|23925|P1|Overall Study|Lost to Follow-up|1
3843|NCT02133131|23919|P7|Overall Study|Adverse Event|0
3844|NCT02133131|23920|P6|Overall Study|Adverse Event|0
3845|NCT02133131|23921|P5|Overall Study|Adverse Event|0
3846|NCT02133131|23922|P4|Overall Study|Adverse Event|1
3847|NCT02133131|23923|P3|Overall Study|Adverse Event|0
3848|NCT02133131|23924|P2|Overall Study|Adverse Event|0
3849|NCT02133131|23925|P1|Overall Study|Adverse Event|0
3850|NCT02132767|23987|P2|Overall Study|Lost to Follow-up|4
3851|NCT02132767|23988|P1|Overall Study|Lost to Follow-up|4
3852|NCT02132767|23987|P2|Overall Study|Withdrawal by Subject|9
3853|NCT02132767|23988|P1|Overall Study|Withdrawal by Subject|10
3854|NCT02132767|23987|P2|Overall Study|Death|2
3855|NCT02132767|23988|P1|Overall Study|Death|3
3856|NCT02132611|24008|P1|Overall Study|Death|2
3857|NCT02132117|24019|P2|Overall Study|Other Miscellaneous Reasons|0
3858|NCT02132117|24020|P1|Overall Study|Other Miscellaneous Reasons|2
3859|NCT02132117|24019|P2|Overall Study|Personal Reasons|2
3860|NCT02132117|24020|P1|Overall Study|Personal Reasons|1
3861|NCT02132117|24019|P2|Overall Study|Lost to Follow-up|2
3862|NCT02132117|24020|P1|Overall Study|Lost to Follow-up|2
3863|NCT02132117|24019|P2|Overall Study|Adverse Event|1
3864|NCT02132117|24020|P1|Overall Study|Adverse Event|6
3865|NCT02131636|24038|P2|Overall Study|Adverse Event|1
3866|NCT02131636|24039|P1|Overall Study|Adverse Event|4
3867|NCT02131636|24038|P2|Overall Study|Lost to Follow-up|0
3868|NCT02131636|24039|P1|Overall Study|Lost to Follow-up|4
3869|NCT02131636|24038|P2|Overall Study|Personal Reasons|4
3870|NCT02131636|24039|P1|Overall Study|Personal Reasons|4
3871|NCT02131532|24055|P1|Overall Study|Other health conditions|2
3872|NCT02131532|24055|P1|Overall Study|Physician Decision|1
3873|NCT02131532|24055|P1|Overall Study|Withdrawal by Subject|1
3874|NCT02131311|24145|P1|Overall Study|Lost to Follow-up|1
3875|NCT02131311|24145|P1|Overall Study|Protocol Violation|1
3876|NCT02131311|24145|P1|Overall Study|Adverse Event|2
3877|NCT02131233|24157|P2|Overall Study|Withdrawal by Subject|8
3878|NCT02131233|24158|P1|Overall Study|Withdrawal by Subject|12
3879|NCT02131233|24157|P2|Overall Study|Pregnancy|0
3880|NCT02131233|24158|P1|Overall Study|Pregnancy|2
3881|NCT02131233|24157|P2|Overall Study|Physician Decision|0
3882|NCT02131233|24158|P1|Overall Study|Physician Decision|4
3883|NCT02131233|24157|P2|Overall Study|Non-Compliance With Study Drug|4
3884|NCT02131233|24158|P1|Overall Study|Non-Compliance With Study Drug|5
3885|NCT02131233|24157|P2|Overall Study|Lost to Follow-up|4
3886|NCT02131233|24158|P1|Overall Study|Lost to Follow-up|8
3887|NCT02131233|24157|P2|Overall Study|Lack of Efficacy|1
3888|NCT02131233|24158|P1|Overall Study|Lack of Efficacy|4
3889|NCT02131233|24157|P2|Overall Study|Death|1
3890|NCT02131233|24158|P1|Overall Study|Death|0
3891|NCT02131233|24157|P2|Overall Study|Adverse Event|6
3892|NCT02131233|24158|P1|Overall Study|Adverse Event|6
3893|NCT02131233|24157|P2|Overall Study|Not Treated|3
3894|NCT02131233|24158|P1|Overall Study|Not Treated|2
3895|NCT02129608|24206|P3|Overall Study|Withdrawal by Subject|2
3896|NCT02129608|24207|P2|Overall Study|Withdrawal by Subject|0
3897|NCT02129608|24208|P1|Overall Study|Withdrawal by Subject|0
3898|NCT02129608|24206|P3|Overall Study|Lost to Follow-up|1
3899|NCT02129608|24207|P2|Overall Study|Lost to Follow-up|1
3900|NCT02129608|24208|P1|Overall Study|Lost to Follow-up|0
3901|NCT02129062|24219|P1|Overall Study|Disease Progression|2
3902|NCT02129062|24219|P1|Overall Study|Death|1
3903|NCT02128542|24239|P2|Overall Study|Withdrew Consent|0
3904|NCT02128542|24240|P1|Overall Study|Withdrew Consent|1
3905|NCT02128542|24239|P2|Overall Study|Lost to Follow-up|0
3906|NCT02128542|24240|P1|Overall Study|Lost to Follow-up|3
3907|NCT02128490|24258|P5|Overall Study|Other Miscellaneous Reasons|1
3908|NCT02128490|24259|P4|Overall Study|Other Miscellaneous Reasons|1
3909|NCT02128490|24260|P3|Overall Study|Other Miscellaneous Reasons|2
3910|NCT02128490|24261|P2|Overall Study|Other Miscellaneous Reasons|0
3911|NCT02128490|24262|P1|Overall Study|Other Miscellaneous Reasons|0
3912|NCT02128490|24258|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
3913|NCT02128490|24259|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
3914|NCT02128490|24260|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
3915|NCT02128490|24261|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
3916|NCT02128490|24262|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
3917|NCT02128490|24258|P5|Overall Study|Lack of Efficacy|0
3918|NCT02128490|24259|P4|Overall Study|Lack of Efficacy|0
3919|NCT02128490|24260|P3|Overall Study|Lack of Efficacy|0
3920|NCT02128490|24261|P2|Overall Study|Lack of Efficacy|1
3921|NCT02128490|24262|P1|Overall Study|Lack of Efficacy|0
3922|NCT02128490|24258|P5|Overall Study|Voluntary Withdrawal|2
3923|NCT02128490|24259|P4|Overall Study|Voluntary Withdrawal|1
3924|NCT02128490|24260|P3|Overall Study|Voluntary Withdrawal|1
3925|NCT02128490|24261|P2|Overall Study|Voluntary Withdrawal|3
3926|NCT02128490|24262|P1|Overall Study|Voluntary Withdrawal|3
3927|NCT02128490|24258|P5|Overall Study|Lost to Follow-up|1
3928|NCT02128490|24259|P4|Overall Study|Lost to Follow-up|1
3929|NCT02128490|24260|P3|Overall Study|Lost to Follow-up|1
3930|NCT02128490|24261|P2|Overall Study|Lost to Follow-up|0
3931|NCT02128490|24262|P1|Overall Study|Lost to Follow-up|0
3932|NCT02128490|24258|P5|Overall Study|Major Protocol Deviation|2
3933|NCT02128490|24259|P4|Overall Study|Major Protocol Deviation|2
3934|NCT02128490|24260|P3|Overall Study|Major Protocol Deviation|0
3935|NCT02128490|24261|P2|Overall Study|Major Protocol Deviation|2
3936|NCT02128490|24262|P1|Overall Study|Major Protocol Deviation|1
3937|NCT02128490|24258|P5|Overall Study|Pretreatment Event/Adverse Event|0
3938|NCT02128490|24259|P4|Overall Study|Pretreatment Event/Adverse Event|1
3939|NCT02128490|24260|P3|Overall Study|Pretreatment Event/Adverse Event|1
3940|NCT02128490|24261|P2|Overall Study|Pretreatment Event/Adverse Event|0
3941|NCT02128490|24262|P1|Overall Study|Pretreatment Event/Adverse Event|1
3942|NCT02127372|24306|P2|Overall Study|Withdrawal by Subject|0
3943|NCT02127372|24307|P1|Overall Study|Withdrawal by Subject|1
3944|NCT02126839|24319|P2|Overall Study|Not specified|5
3945|NCT02126839|24320|P1|Overall Study|Not specified|5
3946|NCT02126839|24319|P2|Overall Study|Lost to Follow-up|4
3947|NCT02126839|24320|P1|Overall Study|Lost to Follow-up|1
3948|NCT02126839|24319|P2|Overall Study|Sponsor request|1
3949|NCT02126839|24320|P1|Overall Study|Sponsor request|0
3950|NCT02126839|24319|P2|Overall Study|Protocol Violation|3
3951|NCT02126839|24320|P1|Overall Study|Protocol Violation|2
3952|NCT02126839|24319|P2|Overall Study|Withdrawal by parent/guardian|0
3953|NCT02126839|24320|P1|Overall Study|Withdrawal by parent/guardian|1
3954|NCT02126839|24319|P2|Overall Study|Withdrawal by Subject|0
3955|NCT02126839|24320|P1|Overall Study|Withdrawal by Subject|1
3956|NCT02126839|24319|P2|Overall Study|Adverse Event|1
3957|NCT02126839|24320|P1|Overall Study|Adverse Event|0
3958|NCT02126670|24347|P4|Overall Study|Withdrawal by Subject|1
3959|NCT02126670|24348|P3|Overall Study|Withdrawal by Subject|0
3960|NCT02126670|24349|P2|Overall Study|Withdrawal by Subject|0
3961|NCT02126670|24350|P1|Overall Study|Withdrawal by Subject|1
3962|NCT02125877|24375|P2|Overall Study|Adverse Event|4
3963|NCT02125877|24376|P1|Overall Study|Adverse Event|6
3964|NCT02125877|24375|P2|Overall Study|Protocol deviation|1
3965|NCT02125877|24376|P1|Overall Study|Protocol deviation|4
3966|NCT02125877|24375|P2|Overall Study|Withdrawal by Subject|1
3967|NCT02125877|24376|P1|Overall Study|Withdrawal by Subject|2
3968|NCT02125877|24375|P2|Overall Study|Participant/guardian decision|2
3969|NCT02125877|24376|P1|Overall Study|Participant/guardian decision|0
3970|NCT02125877|24375|P2|Overall Study|Administrative problems|1
3971|NCT02125877|24376|P1|Overall Study|Administrative problems|0
3972|NCT02125877|24375|P2|Overall Study|Death|1
3973|NCT02125877|24376|P1|Overall Study|Death|0
3974|NCT02125877|24375|P2|Overall Study|Physician Decision|0
3975|NCT02125877|24376|P1|Overall Study|Physician Decision|1
3976|NCT02125734|24406|P2|Overall Study|Adverse Event|1
3977|NCT02125734|24407|P1|Overall Study|Adverse Event|0
3978|NCT02123472|24455|P2|Period 2 (7 Days)|Withdrawal by Subject|1
3979|NCT02123472|24456|P1|Period 2 (7 Days)|Withdrawal by Subject|0
3980|NCT02123459|24466|P2|Washout Period (1 Day)|Adverse Event|0
3981|NCT02123459|24467|P1|Washout Period (1 Day)|Adverse Event|1
3982|NCT02123446|24477|P2|Washout Period (1 Day)|Physician Decision|0
3983|NCT02123446|24478|P1|Washout Period (1 Day)|Physician Decision|1
3984|NCT02124161|24501|P2|Overall Study|Lost to Follow-up|4
3985|NCT02124161|24502|P1|Overall Study|Lost to Follow-up|3
3986|NCT02124161|24501|P2|Overall Study|No longer meets eligibility criteria|4
3987|NCT02124161|24502|P1|Overall Study|No longer meets eligibility criteria|5
3988|NCT02124161|24501|P2|Overall Study|Does not meet entrance criteria|3
3989|NCT02124161|24502|P1|Overall Study|Does not meet entrance criteria|2
3990|NCT02124161|24501|P2|Overall Study|Adverse Event|0
3991|NCT02124161|24502|P1|Overall Study|Adverse Event|2
3992|NCT02124161|24501|P2|Overall Study|Withdrawal by Subject|2
3993|NCT02124161|24502|P1|Overall Study|Withdrawal by Subject|1
3994|NCT02124161|24501|P2|Overall Study|Protocol Violation|1
3995|NCT02124161|24502|P1|Overall Study|Protocol Violation|2
3996|NCT02124161|24501|P2|Overall Study|Death|0
3997|NCT02124161|24502|P1|Overall Study|Death|1
3998|NCT02124161|24501|P2|Overall Study|Other unspecified|1
3999|NCT02124161|24502|P1|Overall Study|Other unspecified|0
4000|NCT02121847|24597|P1|Overall Study|Adverse Event|2
4001|NCT02121847|24597|P1|Overall Study|Administrative Reasons|1
4002|NCT02121795|24618|P2|Overall Study|Still in Study up to the Data Cut Date|316
4003|NCT02121795|24619|P1|Overall Study|Still in Study up to the Data Cut Date|315
4004|NCT02121795|24618|P2|Overall Study|Lost to Follow-up|1
4005|NCT02121795|24619|P1|Overall Study|Lost to Follow-up|2
4006|NCT02121795|24618|P2|Overall Study|Withdrew Consent|10
4007|NCT02121795|24619|P1|Overall Study|Withdrew Consent|10
4008|NCT02121795|24618|P2|Overall Study|Protocol Violation|2
4009|NCT02121795|24619|P1|Overall Study|Protocol Violation|0
4010|NCT02121795|24618|P2|Overall Study|Non-Compliance with Study Drug|1
4011|NCT02121795|24619|P1|Overall Study|Non-Compliance with Study Drug|1
4012|NCT02121795|24618|P2|Overall Study|Investigator's Discretion|0
4013|NCT02121795|24619|P1|Overall Study|Investigator's Discretion|1
4014|NCT02121795|24618|P2|Overall Study|Adverse Event|0
4015|NCT02121795|24619|P1|Overall Study|Adverse Event|4
4016|NCT02121795|24618|P2|Overall Study|Randomized but Never Treated|4
4017|NCT02121795|24619|P1|Overall Study|Randomized but Never Treated|1
4018|NCT02121522|24633|P1|Overall Study|Adverse Event|1
4019|NCT02121509|24640|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
4020|NCT02121509|24641|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
4021|NCT02121509|24642|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
4022|NCT02121509|24643|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
4023|NCT02121509|24640|P4|Washout Period (35 Days)|Withdrawal by Subject|0
4024|NCT02121509|24641|P3|Washout Period (35 Days)|Withdrawal by Subject|0
4025|NCT02121509|24642|P2|Washout Period (35 Days)|Withdrawal by Subject|3
4026|NCT02121509|24643|P1|Washout Period (35 Days)|Withdrawal by Subject|0
4027|NCT02121509|24640|P4|Washout Period (35 Days)|Adverse Event|0
4028|NCT02121509|24641|P3|Washout Period (35 Days)|Adverse Event|0
4029|NCT02121509|24642|P2|Washout Period (35 Days)|Adverse Event|1
4030|NCT02121509|24643|P1|Washout Period (35 Days)|Adverse Event|1
4031|NCT02120833|24718|P2|Overall Study|Lost to Follow-up|1
4032|NCT02120833|24719|P1|Overall Study|Lost to Follow-up|1
4033|NCT02120833|24718|P2|Overall Study|Withdrawal by Subject|0
4034|NCT02120833|24719|P1|Overall Study|Withdrawal by Subject|2
4035|NCT02120833|24718|P2|Overall Study|Adverse Event|0
4036|NCT02120833|24719|P1|Overall Study|Adverse Event|1
4037|NCT02120300|24883|P4|Overall Study|Lost to Follow-up|0
4038|NCT02120300|24884|P3|Overall Study|Lost to Follow-up|0
4039|NCT02120300|24885|P2|Overall Study|Lost to Follow-up|0
4040|NCT02120300|24886|P1|Overall Study|Lost to Follow-up|1
4041|NCT02120300|24883|P4|Overall Study|Lack of Efficacy|1
4042|NCT02120300|24884|P3|Overall Study|Lack of Efficacy|0
4043|NCT02120300|24885|P2|Overall Study|Lack of Efficacy|0
4044|NCT02120300|24886|P1|Overall Study|Lack of Efficacy|0
4045|NCT02120300|24883|P4|Overall Study|Enrolled but Never Treated|0
4046|NCT02120300|24884|P3|Overall Study|Enrolled but Never Treated|0
4047|NCT02120300|24885|P2|Overall Study|Enrolled but Never Treated|0
4048|NCT02120300|24886|P1|Overall Study|Enrolled but Never Treated|2
4049|NCT02120027|24924|P2|Overall Study|Withdrawal by Subject|25
4050|NCT02120027|24925|P1|Overall Study|Withdrawal by Subject|33
4051|NCT02120027|24924|P2|Overall Study|Study terminated by Sponsor|47
4052|NCT02120027|24925|P1|Overall Study|Study terminated by Sponsor|45
4053|NCT02120027|24924|P2|Overall Study|Protocol Violation|21
4054|NCT02120027|24925|P1|Overall Study|Protocol Violation|18
4055|NCT02120027|24924|P2|Overall Study|Physician Decision|3
4056|NCT02120027|24925|P1|Overall Study|Physician Decision|4
4057|NCT02120027|24924|P2|Overall Study|Other|0
4058|NCT02120027|24925|P1|Overall Study|Other|4
4059|NCT02120027|24924|P2|Overall Study|Lost to Follow-up|13
4060|NCT02120027|24925|P1|Overall Study|Lost to Follow-up|5
4061|NCT02120027|24924|P2|Overall Study|Lack of Efficacy|5
4062|NCT02120027|24925|P1|Overall Study|Lack of Efficacy|3
4063|NCT02120027|24924|P2|Overall Study|Adverse Event|5
4064|NCT02120027|24925|P1|Overall Study|Adverse Event|4
4065|NCT02119325|24939|P2|Washout Period 1|Adverse Event|1
4066|NCT02119325|24940|P1|Washout Period 1|Adverse Event|0
4067|NCT02119286|24987|P3|Overall Study|Withdrawal by Subject|0
4068|NCT02119286|24988|P2|Overall Study|Withdrawal by Subject|1
4069|NCT02119286|24989|P1|Overall Study|Withdrawal by Subject|4
4070|NCT02119286|24987|P3|Overall Study|Lost to Follow-up|1
4071|NCT02119286|24988|P2|Overall Study|Lost to Follow-up|0
4072|NCT02119286|24989|P1|Overall Study|Lost to Follow-up|2
4073|NCT02119286|24987|P3|Overall Study|Lack of Efficacy|4
4074|NCT02119286|24988|P2|Overall Study|Lack of Efficacy|3
4075|NCT02119286|24989|P1|Overall Study|Lack of Efficacy|11
4076|NCT02119286|24987|P3|Overall Study|Adverse Event|2
4077|NCT02119286|24988|P2|Overall Study|Adverse Event|7
4078|NCT02119286|24989|P1|Overall Study|Adverse Event|9
4079|NCT02118961|25002|P2|Overall Study|Withdrawal by Subject|0
4080|NCT02118961|25003|P1|Overall Study|Withdrawal by Subject|1
4081|NCT02118896|25031|P10|Overall Study|Miscellaneous|0
4082|NCT02118896|25032|P9|Overall Study|Miscellaneous|0
4083|NCT02118896|25033|P8|Overall Study|Miscellaneous|0
4084|NCT02118896|25034|P7|Overall Study|Miscellaneous|0
4085|NCT02118896|25035|P6|Overall Study|Miscellaneous|4
4086|NCT02118896|25036|P5|Overall Study|Miscellaneous|0
4087|NCT02118896|25037|P4|Overall Study|Miscellaneous|2
4088|NCT02118896|25038|P3|Overall Study|Miscellaneous|0
4089|NCT02118896|25039|P2|Overall Study|Miscellaneous|2
4090|NCT02118896|25040|P1|Overall Study|Miscellaneous|1
4091|NCT02118896|25031|P10|Overall Study|Prohibited medication|0
4092|NCT02118896|25032|P9|Overall Study|Prohibited medication|0
4093|NCT02118896|25033|P8|Overall Study|Prohibited medication|0
4094|NCT02118896|25034|P7|Overall Study|Prohibited medication|0
4095|NCT02118896|25035|P6|Overall Study|Prohibited medication|3
4096|NCT02118896|25036|P5|Overall Study|Prohibited medication|1
4097|NCT02118896|25037|P4|Overall Study|Prohibited medication|0
4098|NCT02118896|25038|P3|Overall Study|Prohibited medication|0
4099|NCT02118896|25039|P2|Overall Study|Prohibited medication|0
4100|NCT02118896|25040|P1|Overall Study|Prohibited medication|0
4101|NCT02118896|25031|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
4102|NCT02118896|25032|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
4103|NCT02118896|25033|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
4104|NCT02118896|25034|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
4105|NCT02118896|25035|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
4106|NCT02118896|25036|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
4107|NCT02118896|25037|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
4108|NCT02118896|25038|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
4109|NCT02118896|25039|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
4110|NCT02118896|25040|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
4111|NCT02118896|25031|P10|Overall Study|Lost to Follow-up|0
4112|NCT02118896|25032|P9|Overall Study|Lost to Follow-up|0
4113|NCT02118896|25033|P8|Overall Study|Lost to Follow-up|0
4114|NCT02118896|25034|P7|Overall Study|Lost to Follow-up|0
4115|NCT02118896|25035|P6|Overall Study|Lost to Follow-up|1
4116|NCT02118896|25036|P5|Overall Study|Lost to Follow-up|2
4117|NCT02118896|25037|P4|Overall Study|Lost to Follow-up|0
4118|NCT02118896|25038|P3|Overall Study|Lost to Follow-up|1
4119|NCT02118896|25039|P2|Overall Study|Lost to Follow-up|2
4120|NCT02118896|25040|P1|Overall Study|Lost to Follow-up|1
4121|NCT02118896|25031|P10|Overall Study|Pregnancy|0
4122|NCT02118896|25032|P9|Overall Study|Pregnancy|0
4123|NCT02118896|25033|P8|Overall Study|Pregnancy|0
4124|NCT02118896|25034|P7|Overall Study|Pregnancy|1
4125|NCT02118896|25035|P6|Overall Study|Pregnancy|3
4126|NCT02118896|25036|P5|Overall Study|Pregnancy|1
4127|NCT02118896|25037|P4|Overall Study|Pregnancy|0
4128|NCT02118896|25038|P3|Overall Study|Pregnancy|0
4129|NCT02118896|25039|P2|Overall Study|Pregnancy|1
4130|NCT02118896|25040|P1|Overall Study|Pregnancy|1
4131|NCT02118896|25031|P10|Overall Study|Non-compliance|0
4132|NCT02118896|25032|P9|Overall Study|Non-compliance|0
4133|NCT02118896|25033|P8|Overall Study|Non-compliance|1
4134|NCT02118896|25034|P7|Overall Study|Non-compliance|0
4135|NCT02118896|25035|P6|Overall Study|Non-compliance|1
4136|NCT02118896|25036|P5|Overall Study|Non-compliance|0
4137|NCT02118896|25037|P4|Overall Study|Non-compliance|5
4138|NCT02118896|25038|P3|Overall Study|Non-compliance|1
4139|NCT02118896|25039|P2|Overall Study|Non-compliance|1
4140|NCT02118896|25040|P1|Overall Study|Non-compliance|2
4141|NCT02118896|25031|P10|Overall Study|Consent withdrawn|0
4142|NCT02118896|25032|P9|Overall Study|Consent withdrawn|0
4143|NCT02118896|25033|P8|Overall Study|Consent withdrawn|0
4144|NCT02118896|25034|P7|Overall Study|Consent withdrawn|0
4145|NCT02118896|25035|P6|Overall Study|Consent withdrawn|4
4146|NCT02118896|25036|P5|Overall Study|Consent withdrawn|1
4147|NCT02118896|25037|P4|Overall Study|Consent withdrawn|4
4148|NCT02118896|25038|P3|Overall Study|Consent withdrawn|3
4149|NCT02118896|25039|P2|Overall Study|Consent withdrawn|0
4150|NCT02118896|25040|P1|Overall Study|Consent withdrawn|2
4151|NCT02118896|25031|P10|Overall Study|Adverse Event|0
4152|NCT02118896|25032|P9|Overall Study|Adverse Event|4
4153|NCT02118896|25033|P8|Overall Study|Adverse Event|1
4154|NCT02118896|25034|P7|Overall Study|Adverse Event|1
4155|NCT02118896|25035|P6|Overall Study|Adverse Event|9
4156|NCT02118896|25036|P5|Overall Study|Adverse Event|5
4157|NCT02118896|25037|P4|Overall Study|Adverse Event|5
4158|NCT02118896|25038|P3|Overall Study|Adverse Event|4
4159|NCT02118896|25039|P2|Overall Study|Adverse Event|4
4160|NCT02118896|25040|P1|Overall Study|Adverse Event|5
4161|NCT02118896|25031|P10|Overall Study|Death|0
4162|NCT02118896|25032|P9|Overall Study|Death|0
4163|NCT02118896|25033|P8|Overall Study|Death|0
4164|NCT02118896|25034|P7|Overall Study|Death|0
4165|NCT02118896|25035|P6|Overall Study|Death|1
4166|NCT02118896|25036|P5|Overall Study|Death|3
4167|NCT02118896|25037|P4|Overall Study|Death|6
4168|NCT02118896|25038|P3|Overall Study|Death|4
4169|NCT02118896|25039|P2|Overall Study|Death|0
4170|NCT02118896|25040|P1|Overall Study|Death|4
4171|NCT02118597|25128|P1|Overall Study|Investigator's decision|1
4172|NCT02118597|25128|P1|Overall Study|Serious Adverse Event|1
4173|NCT02118597|25128|P1|Overall Study|Sponsor terminated the study|14
4174|NCT02117687|25159|P2|Overall Study|Other Reasons|1
4175|NCT02117687|25160|P1|Overall Study|Other Reasons|1
4176|NCT02117687|25159|P2|Overall Study|Adverse Event|2
4177|NCT02117687|25160|P1|Overall Study|Adverse Event|0
4178|NCT02117687|25159|P2|Overall Study|Lost to Follow-up|1
4179|NCT02117687|25160|P1|Overall Study|Lost to Follow-up|0
4180|NCT02117570|25195|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
4181|NCT02117570|25196|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
4182|NCT02117570|25197|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
4183|NCT02117570|25195|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
4184|NCT02117570|25196|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
4185|NCT02117570|25197|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
4186|NCT02117570|25195|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
4187|NCT02117570|25196|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
4188|NCT02117570|25197|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
4189|NCT02117570|25195|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
4190|NCT02117570|25196|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
4191|NCT02117570|25197|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
4192|NCT02117570|25195|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
4193|NCT02117570|25196|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
4194|NCT02117570|25197|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
4195|NCT02117570|25195|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
4196|NCT02117570|25196|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
4197|NCT02117570|25197|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
4198|NCT02117570|25195|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
4199|NCT02117570|25196|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
4200|NCT02117570|25197|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
4201|NCT02117544|25247|P2|Period 1|Lost to follow-up (prior to treatment)|0
4202|NCT02117544|25248|P1|Period 1|Lost to follow-up (prior to treatment)|2
4203|NCT02117414|25263|P2|Overall Study|Withdrawal by Subject|4
4204|NCT02117414|25264|P1|Overall Study|Withdrawal by Subject|10
4205|NCT02117414|25263|P2|Overall Study|Death|2
4206|NCT02117414|25264|P1|Overall Study|Death|5
4207|NCT02117050|25304|P1|Overall Study|Subject Enrolled but not Dosed|1
4208|NCT02115815|25332|P7|Overall Study|Missed appointment, randomized in error|0
4209|NCT02115815|25333|P6|Overall Study|Missed appointment, randomized in error|1
4210|NCT02115815|25334|P5|Overall Study|Missed appointment, randomized in error|0
4211|NCT02115815|25335|P4|Overall Study|Missed appointment, randomized in error|0
4212|NCT02115815|25336|P3|Overall Study|Missed appointment, randomized in error|0
4213|NCT02115815|25337|P2|Overall Study|Missed appointment, randomized in error|0
4214|NCT02115815|25338|P1|Overall Study|Missed appointment, randomized in error|0
4215|NCT02115815|25332|P7|Overall Study|Not enough drug to dose participant|0
4216|NCT02115815|25333|P6|Overall Study|Not enough drug to dose participant|1
4217|NCT02115815|25334|P5|Overall Study|Not enough drug to dose participant|0
4218|NCT02115815|25335|P4|Overall Study|Not enough drug to dose participant|0
4219|NCT02115815|25336|P3|Overall Study|Not enough drug to dose participant|0
4220|NCT02115815|25337|P2|Overall Study|Not enough drug to dose participant|0
4221|NCT02115815|25338|P1|Overall Study|Not enough drug to dose participant|0
4222|NCT02115815|25332|P7|Overall Study|Withdrawal by Subject|0
4223|NCT02115815|25333|P6|Overall Study|Withdrawal by Subject|0
4224|NCT02115815|25334|P5|Overall Study|Withdrawal by Subject|0
4225|NCT02115815|25335|P4|Overall Study|Withdrawal by Subject|0
4226|NCT02115815|25336|P3|Overall Study|Withdrawal by Subject|0
4227|NCT02115815|25337|P2|Overall Study|Withdrawal by Subject|0
4228|NCT02115815|25338|P1|Overall Study|Withdrawal by Subject|2
4229|NCT02115321|25446|P2|Overall Study|Death|0
4230|NCT02115321|25447|P1|Overall Study|Death|1
4231|NCT02114892|25469|P2|Overall Study|Lost to Follow-up|2
4232|NCT02114892|25470|P1|Overall Study|Lost to Follow-up|1
4233|NCT02114268|25510|P6|Overall Study|Withdrawn by site due to noncompliance|0
4234|NCT02114268|25511|P5|Overall Study|Withdrawn by site due to noncompliance|0
4235|NCT02114268|25512|P4|Overall Study|Withdrawn by site due to noncompliance|0
4236|NCT02114268|25513|P3|Overall Study|Withdrawn by site due to noncompliance|0
4237|NCT02114268|25514|P2|Overall Study|Withdrawn by site due to noncompliance|0
4238|NCT02114268|25515|P1|Overall Study|Withdrawn by site due to noncompliance|1
4239|NCT02114268|25510|P6|Overall Study|Withdrawal by Subject|1
4240|NCT02114268|25511|P5|Overall Study|Withdrawal by Subject|0
4241|NCT02114268|25512|P4|Overall Study|Withdrawal by Subject|0
4242|NCT02114268|25513|P3|Overall Study|Withdrawal by Subject|0
4243|NCT02114268|25514|P2|Overall Study|Withdrawal by Subject|0
4244|NCT02114268|25515|P1|Overall Study|Withdrawal by Subject|1
4245|NCT02114268|25510|P6|Overall Study|Lost to Follow-up|2
4246|NCT02114268|25511|P5|Overall Study|Lost to Follow-up|0
4247|NCT02114268|25512|P4|Overall Study|Lost to Follow-up|0
4248|NCT02114268|25513|P3|Overall Study|Lost to Follow-up|1
4249|NCT02114268|25514|P2|Overall Study|Lost to Follow-up|1
4250|NCT02114268|25515|P1|Overall Study|Lost to Follow-up|4
4251|NCT02114177|25583|P2|Overall Study|Unspecified|1
4252|NCT02114177|25584|P1|Overall Study|Unspecified|2
4253|NCT02114177|25583|P2|Overall Study|Withdrawal by Subject|1
4254|NCT02114177|25584|P1|Overall Study|Withdrawal by Subject|6
4255|NCT02114177|25583|P2|Overall Study|Lost to Follow-up|2
4256|NCT02114177|25584|P1|Overall Study|Lost to Follow-up|1
4257|NCT02114151|25608|P1|Overall Study|Withdrawal by Subject|5
4258|NCT02114151|25608|P1|Overall Study|Lost to Follow-up|1
4259|NCT02114151|25608|P1|Overall Study|Death|1
4260|NCT02113579|25625|P2|Overall Study|Lost to Follow-up|2
4261|NCT02113579|25626|P1|Overall Study|Lost to Follow-up|6
4262|NCT02113579|25625|P2|Overall Study|Withdrawal by Subject|2
4263|NCT02113579|25626|P1|Overall Study|Withdrawal by Subject|3
4264|NCT02113579|25625|P2|Overall Study|Adverse Event|0
4265|NCT02113579|25626|P1|Overall Study|Adverse Event|1
4266|NCT02113449|25650|P1|Overall Study|Adverse Event|4
4267|NCT02113124|25666|P2|Overall Study|Unable to retrieve blood sample|1
4268|NCT02113124|25667|P1|Overall Study|Unable to retrieve blood sample|1
4269|NCT02113007|25673|P1|Overall Study|Progressive disease|2
4270|NCT02111603|25679|P1|Overall Study|Withdrawal by Subject|1
4271|NCT02111369|25688|P1|Overall Study|Withdrawal by Subject|1
4272|NCT02111369|25688|P1|Overall Study|Lost to Follow-up|2
4273|NCT02111083|25712|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
4274|NCT02111083|25713|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
4275|NCT02110238|25733|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
4276|NCT02110238|25734|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
4277|NCT02110238|25733|P2|14 Week Blinded Extension Phase|Protocol Violation|3
4278|NCT02110238|25734|P1|14 Week Blinded Extension Phase|Protocol Violation|2
4279|NCT02110238|25733|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
4280|NCT02110238|25734|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
4281|NCT02110238|25733|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
4282|NCT02110238|25734|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
4283|NCT02110238|25733|P2|14 Week Blinded Extension Phase|Adverse Event|1
4284|NCT02110238|25734|P1|14 Week Blinded Extension Phase|Adverse Event|1
4285|NCT02110238|25733|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
4286|NCT02110238|25734|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
4287|NCT02110238|25733|P2|12 Week Pivotal Phase|Protocol Violation|1
4288|NCT02110238|25734|P1|12 Week Pivotal Phase|Protocol Violation|0
4289|NCT02110238|25733|P2|12 Week Pivotal Phase|Physician Decision|2
4290|NCT02110238|25734|P1|12 Week Pivotal Phase|Physician Decision|0
4291|NCT02110238|25733|P2|12 Week Pivotal Phase|Lost to Follow-up|0
4292|NCT02110238|25734|P1|12 Week Pivotal Phase|Lost to Follow-up|2
4293|NCT02110238|25733|P2|12 Week Pivotal Phase|Lack of Efficacy|3
4294|NCT02110238|25734|P1|12 Week Pivotal Phase|Lack of Efficacy|2
4295|NCT02110238|25733|P2|12 Week Pivotal Phase|Adverse Event|0
4296|NCT02110238|25734|P1|12 Week Pivotal Phase|Adverse Event|3
4297|NCT02109172|25749|P6|Overall Study|Death|0
4298|NCT02109172|25750|P5|Overall Study|Death|1
4299|NCT02109172|25751|P4|Overall Study|Death|0
4300|NCT02109172|25752|P3|Overall Study|Death|0
4301|NCT02109172|25753|P2|Overall Study|Death|0
4302|NCT02109172|25754|P1|Overall Study|Death|0
4303|NCT02109172|25749|P6|Overall Study|Adverse Event|1
4304|NCT02109172|25750|P5|Overall Study|Adverse Event|0
4305|NCT02109172|25751|P4|Overall Study|Adverse Event|0
4306|NCT02109172|25752|P3|Overall Study|Adverse Event|1
4307|NCT02109172|25753|P2|Overall Study|Adverse Event|0
4308|NCT02109172|25754|P1|Overall Study|Adverse Event|0
4309|NCT02109172|25749|P6|Overall Study|Withdrawal by Subject|0
4310|NCT02109172|25750|P5|Overall Study|Withdrawal by Subject|0
4311|NCT02109172|25751|P4|Overall Study|Withdrawal by Subject|1
4312|NCT02109172|25752|P3|Overall Study|Withdrawal by Subject|0
4313|NCT02109172|25753|P2|Overall Study|Withdrawal by Subject|0
4314|NCT02109172|25754|P1|Overall Study|Withdrawal by Subject|1
4315|NCT02109133|25775|P2|Overall Study|Lost to Follow-up|0
4316|NCT02109133|25776|P1|Overall Study|Lost to Follow-up|1
4317|NCT02109107|25788|P1|Overall Study|Lost to Follow-up|2
4318|NCT02108652|25831|P1|Overall Study|Ongoing at data cutoff 14 September 2015|108
4319|NCT02108652|25831|P1|Overall Study|Withdrawal by Subject|8
4320|NCT02108652|25831|P1|Overall Study|Unspecified|1
4321|NCT02108652|25831|P1|Overall Study|Death|193
4322|NCT02107898|26000|P2|Overall Study|Randomized but not treated|1
4323|NCT02107898|26001|P1|Overall Study|Randomized but not treated|0
4324|NCT02107898|26000|P2|Overall Study|Consent withdrawn by participant|1
4325|NCT02107898|26001|P1|Overall Study|Consent withdrawn by participant|2
4326|NCT02107898|26000|P2|Overall Study|Participant moved|2
4327|NCT02107898|26001|P1|Overall Study|Participant moved|0
4328|NCT02107898|26000|P2|Overall Study|Poor compliance to protocol|1
4329|NCT02107898|26001|P1|Overall Study|Poor compliance to protocol|0
4330|NCT02107898|26000|P2|Overall Study|Adverse Event|7
4331|NCT02107898|26001|P1|Overall Study|Adverse Event|4
4332|NCT02107313|26091|P2|Overall Study|One participant did not do the FED cohor|1
4333|NCT02107313|26092|P1|Overall Study|One participant did not do the FED cohor|0
4334|NCT02107274|26102|P2|Control Phase|Adverse Event|1
4335|NCT02107274|26103|P1|Control Phase|Adverse Event|0
4336|NCT02107274|26102|P2|Control Phase|Death|0
4337|NCT02107274|26103|P1|Control Phase|Death|2
4338|NCT02107274|26102|P2|Control Phase|Lost to Follow-up|1
4339|NCT02107274|26103|P1|Control Phase|Lost to Follow-up|1
4340|NCT02107274|26102|P2|Treatment vs. Placebo|Lost to Follow-up|2
4341|NCT02107274|26103|P1|Treatment vs. Placebo|Lost to Follow-up|0
4342|NCT02107274|26102|P2|Treatment vs. Placebo|Adverse Event|0
4343|NCT02107274|26103|P1|Treatment vs. Placebo|Adverse Event|3
4344|NCT02107196|26117|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
4345|NCT02107196|26118|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
4346|NCT02107196|26117|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
4347|NCT02107196|26118|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
4348|NCT02107196|26117|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
4349|NCT02107196|26118|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
4350|NCT02107196|26117|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
4351|NCT02107196|26118|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
4352|NCT02107196|26117|P2|12-week Treatment Period|Reason Missing|8
4353|NCT02107196|26118|P1|12-week Treatment Period|Reason Missing|11
4354|NCT02107196|26117|P2|12-week Treatment Period|Protocol Violation|8
4355|NCT02107196|26118|P1|12-week Treatment Period|Protocol Violation|7
4356|NCT02107196|26117|P2|12-week Treatment Period|Withdrawal by Subject|12
4357|NCT02107196|26118|P1|12-week Treatment Period|Withdrawal by Subject|15
4358|NCT02107196|26117|P2|12-week Treatment Period|Physician Decision|1
4359|NCT02107196|26118|P1|12-week Treatment Period|Physician Decision|0
4360|NCT02107196|26117|P2|12-week Treatment Period|Lost to Follow-up|6
4361|NCT02107196|26118|P1|12-week Treatment Period|Lost to Follow-up|3
4362|NCT02107196|26117|P2|12-week Treatment Period|Lack of Efficacy|1
4363|NCT02107196|26118|P1|12-week Treatment Period|Lack of Efficacy|2
4364|NCT02107196|26117|P2|12-week Treatment Period|Adverse Event|3
4365|NCT02107196|26118|P1|12-week Treatment Period|Adverse Event|6
4366|NCT02106403|26165|P6|Follow-Up Visit 3|Other Reason|1
4367|NCT02106403|26166|P5|Follow-Up Visit 3|Other Reason|0
4368|NCT02106403|26167|P4|Follow-Up Visit 3|Other Reason|0
4369|NCT02106403|26168|P3|Follow-Up Visit 3|Other Reason|0
4370|NCT02106403|26169|P2|Follow-Up Visit 3|Other Reason|0
4371|NCT02106403|26170|P1|Follow-Up Visit 3|Other Reason|0
4372|NCT02106156|26193|P3|Overall Study|Relocation/Change of Physician|0
4373|NCT02106156|26194|P2|Overall Study|Relocation/Change of Physician|1
4374|NCT02106156|26195|P1|Overall Study|Relocation/Change of Physician|40
4375|NCT02106156|26193|P3|Overall Study|Hospitalization/Surgical Intervention|0
4376|NCT02106156|26194|P2|Overall Study|Hospitalization/Surgical Intervention|0
4377|NCT02106156|26195|P1|Overall Study|Hospitalization/Surgical Intervention|6
4378|NCT02106156|26193|P3|Overall Study|Change of Laboratory Parameter|0
4379|NCT02106156|26194|P2|Overall Study|Change of Laboratory Parameter|0
4380|NCT02106156|26195|P1|Overall Study|Change of Laboratory Parameter|10
4381|NCT02106156|26193|P3|Overall Study|Unplanned Event|0
4382|NCT02106156|26194|P2|Overall Study|Unplanned Event|2
4383|NCT02106156|26195|P1|Overall Study|Unplanned Event|82
4384|NCT02106156|26193|P3|Overall Study|Lost to Follow-up|0
4385|NCT02106156|26194|P2|Overall Study|Lost to Follow-up|8
4386|NCT02106156|26195|P1|Overall Study|Lost to Follow-up|451
4387|NCT02106156|26193|P3|Overall Study|Patients Request|0
4388|NCT02106156|26194|P2|Overall Study|Patients Request|9
4389|NCT02106156|26195|P1|Overall Study|Patients Request|307
4390|NCT02106156|26193|P3|Overall Study|Lack of Compliance|0
4391|NCT02106156|26194|P2|Overall Study|Lack of Compliance|7
4392|NCT02106156|26195|P1|Overall Study|Lack of Compliance|211
4393|NCT02106156|26193|P3|Overall Study|Concomitant Disease|0
4394|NCT02106156|26194|P2|Overall Study|Concomitant Disease|2
4395|NCT02106156|26195|P1|Overall Study|Concomitant Disease|74
4396|NCT02106156|26193|P3|Overall Study|Lack of Virological Response|0
4397|NCT02106156|26194|P2|Overall Study|Lack of Virological Response|8
4398|NCT02106156|26195|P1|Overall Study|Lack of Virological Response|1044
4399|NCT02106156|26193|P3|Overall Study|Lack of Tolerability|0
4400|NCT02106156|26194|P2|Overall Study|Lack of Tolerability|3
4401|NCT02106156|26195|P1|Overall Study|Lack of Tolerability|305
4402|NCT02106156|26193|P3|Overall Study|Patient Died|0
4403|NCT02106156|26194|P2|Overall Study|Patient Died|0
4404|NCT02106156|26195|P1|Overall Study|Patient Died|19
4405|NCT02105987|26219|P6|Continuation Phase|Protocol Violation|0
4406|NCT02105987|26220|P5|Continuation Phase|Protocol Violation|1
4407|NCT02105987|26221|P4|Continuation Phase|Protocol Violation|0
4408|NCT02105987|26222|P3|Continuation Phase|Protocol Violation|0
4409|NCT02105987|26223|P2|Continuation Phase|Protocol Violation|0
4410|NCT02105987|26224|P1|Continuation Phase|Protocol Violation|0
4411|NCT02105987|26219|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
4412|NCT02105987|26220|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
4413|NCT02105987|26221|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
4414|NCT02105987|26222|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
4415|NCT02105987|26223|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
4416|NCT02105987|26224|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
4417|NCT02105987|26219|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4418|NCT02105987|26220|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4419|NCT02105987|26221|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
4420|NCT02105987|26222|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4421|NCT02105987|26223|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4422|NCT02105987|26224|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4423|NCT02105987|26219|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
4424|NCT02105987|26220|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
4425|NCT02105987|26221|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
4426|NCT02105987|26222|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
4427|NCT02105987|26223|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
4428|NCT02105987|26224|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
4429|NCT02105987|26219|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
4430|NCT02105987|26220|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
4431|NCT02105987|26221|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
4432|NCT02105987|26222|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
4433|NCT02105987|26223|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
4434|NCT02105987|26224|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
4435|NCT02105987|26219|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
4436|NCT02105987|26220|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
4437|NCT02105987|26221|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
4438|NCT02105987|26222|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
4439|NCT02105987|26223|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
4440|NCT02105987|26224|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
4441|NCT02105987|26219|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
4442|NCT02105987|26220|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
4443|NCT02105987|26221|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
4444|NCT02105987|26222|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
4445|NCT02105987|26223|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
4446|NCT02105987|26224|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
4447|NCT02105987|26219|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
4448|NCT02105987|26220|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
4449|NCT02105987|26221|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
4450|NCT02105987|26222|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
4451|NCT02105987|26223|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
4452|NCT02105987|26224|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
4453|NCT02105987|26219|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4454|NCT02105987|26220|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4455|NCT02105987|26221|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4456|NCT02105987|26222|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4457|NCT02105987|26223|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
4458|NCT02105987|26224|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4459|NCT02105987|26219|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
4460|NCT02105987|26220|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
4461|NCT02105987|26221|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
4462|NCT02105987|26222|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
4463|NCT02105987|26223|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
4464|NCT02105987|26224|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
4465|NCT02105987|26219|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
4466|NCT02105987|26220|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
4467|NCT02105987|26221|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
4468|NCT02105987|26222|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
4469|NCT02105987|26223|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
4470|NCT02105987|26224|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
4471|NCT02105987|26219|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
4472|NCT02105987|26220|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
4473|NCT02105987|26221|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
4474|NCT02105987|26222|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
4475|NCT02105987|26223|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
4476|NCT02105987|26224|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
4477|NCT02105987|26219|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
4478|NCT02105987|26220|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
4479|NCT02105987|26221|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
4480|NCT02105987|26222|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
4481|NCT02105987|26223|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
4482|NCT02105987|26224|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
4483|NCT02105987|26219|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
4484|NCT02105987|26220|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
4485|NCT02105987|26221|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
4486|NCT02105987|26222|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
4487|NCT02105987|26223|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
4488|NCT02105987|26224|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
4489|NCT02105974|26278|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
4490|NCT02105974|26279|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
4491|NCT02105974|26280|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
4492|NCT02105974|26278|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
4493|NCT02105974|26279|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
4494|NCT02105974|26280|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
4495|NCT02105974|26278|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
4496|NCT02105974|26279|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
4497|NCT02105974|26280|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
4498|NCT02105974|26278|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
4499|NCT02105974|26279|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
4500|NCT02105974|26280|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
4501|NCT02105974|26278|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
4502|NCT02105974|26279|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
4503|NCT02105974|26280|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
4504|NCT02105974|26278|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
4505|NCT02105974|26279|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
4506|NCT02105974|26280|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
4507|NCT02105974|26278|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
4508|NCT02105974|26279|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
4509|NCT02105974|26280|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
4510|NCT02105974|26278|P3|2 Week Run-in Period|Investigator discretion|0
4511|NCT02105974|26279|P2|2 Week Run-in Period|Investigator discretion|0
4512|NCT02105974|26280|P1|2 Week Run-in Period|Investigator discretion|8
4513|NCT02105974|26278|P3|2 Week Run-in Period|Withdrew consent|0
4514|NCT02105974|26279|P2|2 Week Run-in Period|Withdrew consent|0
4515|NCT02105974|26280|P1|2 Week Run-in Period|Withdrew consent|23
4516|NCT02105974|26278|P3|2 Week Run-in Period|Lost to Follow-up|0
4517|NCT02105974|26279|P2|2 Week Run-in Period|Lost to Follow-up|0
4518|NCT02105974|26280|P1|2 Week Run-in Period|Lost to Follow-up|2
4519|NCT02105974|26278|P3|2 Week Run-in Period|Study closed/terminated|0
4520|NCT02105974|26279|P2|2 Week Run-in Period|Study closed/terminated|0
4521|NCT02105974|26280|P1|2 Week Run-in Period|Study closed/terminated|1
4522|NCT02105974|26278|P3|2 Week Run-in Period|Adverse Event|0
4523|NCT02105974|26279|P2|2 Week Run-in Period|Adverse Event|0
4524|NCT02105974|26280|P1|2 Week Run-in Period|Adverse Event|6
4525|NCT02105974|26278|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
4526|NCT02105974|26279|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
4527|NCT02105974|26280|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
4528|NCT02105974|26278|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
4529|NCT02105974|26279|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
4530|NCT02105974|26280|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
4531|NCT02105701|26294|P4|Overall Study|Death|0
4532|NCT02105701|26295|P3|Overall Study|Death|0
4533|NCT02105701|26296|P2|Overall Study|Death|0
4534|NCT02105701|26297|P1|Overall Study|Death|1
4535|NCT02105701|26294|P4|Overall Study|Withdrawal by Subject|1
4536|NCT02105701|26295|P3|Overall Study|Withdrawal by Subject|0
4537|NCT02105701|26296|P2|Overall Study|Withdrawal by Subject|1
4538|NCT02105701|26297|P1|Overall Study|Withdrawal by Subject|2
4539|NCT02105701|26294|P4|Overall Study|Protocol Violation|0
4540|NCT02105701|26295|P3|Overall Study|Protocol Violation|1
4541|NCT02105701|26296|P2|Overall Study|Protocol Violation|0
4542|NCT02105701|26297|P1|Overall Study|Protocol Violation|0
4543|NCT02105701|26294|P4|Overall Study|Lost to Follow-up|1
4544|NCT02105701|26295|P3|Overall Study|Lost to Follow-up|2
4545|NCT02105701|26296|P2|Overall Study|Lost to Follow-up|0
4546|NCT02105701|26297|P1|Overall Study|Lost to Follow-up|1
4547|NCT02105688|26321|P2|Overall Study|Withdrawal by Subject|2
4548|NCT02105688|26322|P1|Overall Study|Withdrawal by Subject|4
4549|NCT02105688|26321|P2|Overall Study|Protocol Violation|1
4550|NCT02105688|26322|P1|Overall Study|Protocol Violation|0
4551|NCT02105688|26321|P2|Overall Study|Physician Decision|1
4552|NCT02105688|26322|P1|Overall Study|Physician Decision|0
4553|NCT02105688|26321|P2|Overall Study|Lost to Follow-up|4
4554|NCT02105688|26322|P1|Overall Study|Lost to Follow-up|9
4555|NCT02105688|26321|P2|Overall Study|Adverse Event|1
4556|NCT02105688|26322|P1|Overall Study|Adverse Event|1
4557|NCT02105688|26321|P2|Overall Study|Ongoing|90
4558|NCT02105688|26322|P1|Overall Study|Ongoing|12
4559|NCT02105662|26332|P1|Overall Study|Withdrawal by Subject|1
4560|NCT02105662|26332|P1|Overall Study|Lost to Follow-up|5
4561|NCT02105636|26341|P2|Overall Study|Not Reported|0
4562|NCT02105636|26342|P1|Overall Study|Not Reported|3
4563|NCT02105636|26341|P2|Overall Study|Reason Not Specified|2
4564|NCT02105636|26342|P1|Overall Study|Reason Not Specified|0
4565|NCT02105636|26341|P2|Overall Study|Poor/Non-compliance|1
4566|NCT02105636|26342|P1|Overall Study|Poor/Non-compliance|0
4567|NCT02105636|26341|P2|Overall Study|Maximum Clinical Benefit|1
4568|NCT02105636|26342|P1|Overall Study|Maximum Clinical Benefit|1
4569|NCT02105636|26341|P2|Overall Study|Subject Withdrew Consent|1
4570|NCT02105636|26342|P1|Overall Study|Subject Withdrew Consent|4
4571|NCT02105636|26341|P2|Overall Study|Subject Request to Discontinue Treatment|6
4572|NCT02105636|26342|P1|Overall Study|Subject Request to Discontinue Treatment|4
4573|NCT02105636|26341|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
4574|NCT02105636|26342|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
4575|NCT02105636|26341|P2|Overall Study|Study Drug Toxicity|11
4576|NCT02105636|26342|P1|Overall Study|Study Drug Toxicity|9
4577|NCT02105636|26341|P2|Overall Study|Disease Progression|83
4578|NCT02105636|26342|P1|Overall Study|Disease Progression|162
4579|NCT02105467|26354|P2|Period 3|Lost to Follow-up|1
4580|NCT02105467|26355|P1|Period 3|Lost to Follow-up|0
4581|NCT02105467|26354|P2|Period 2|Withdrawal by Subject|2
4582|NCT02105467|26355|P1|Period 2|Withdrawal by Subject|0
4583|NCT02105467|26354|P2|Period 2|Death|0
4584|NCT02105467|26355|P1|Period 2|Death|1
4585|NCT02105467|26354|P2|Period 2|Lost to Follow-up|0
4586|NCT02105467|26355|P1|Period 2|Lost to Follow-up|1
4587|NCT02105467|26354|P2|Period 1|Death|0
4588|NCT02105467|26355|P1|Period 1|Death|1
4589|NCT02105467|26354|P2|Period 1|Lost to Follow-up|0
4590|NCT02105467|26355|P1|Period 1|Lost to Follow-up|1
4591|NCT02105454|26367|P1|Overall Study|Withdrawal by Subject|1
4592|NCT02105285|26377|P3|Overall Study|Withdrawal by Subject|0
4593|NCT02105285|26378|P2|Overall Study|Withdrawal by Subject|0
4594|NCT02105285|26379|P1|Overall Study|Withdrawal by Subject|1
4595|NCT02105285|26377|P3|Overall Study|Protocol Violation|0
4596|NCT02105285|26378|P2|Overall Study|Protocol Violation|1
4597|NCT02105285|26379|P1|Overall Study|Protocol Violation|0
4598|NCT02105285|26377|P3|Overall Study|Adverse Event|0
4599|NCT02105285|26378|P2|Overall Study|Adverse Event|1
4600|NCT02105285|26379|P1|Overall Study|Adverse Event|1
4601|NCT02105272|26398|P2|Overall Study|Withdrawal by Subject|0
4602|NCT02105272|26399|P1|Overall Study|Withdrawal by Subject|2
4603|NCT02105272|26398|P2|Overall Study|Protocol Violation|0
4604|NCT02105272|26399|P1|Overall Study|Protocol Violation|2
4605|NCT02105272|26398|P2|Overall Study|Physician Decision|1
4606|NCT02105272|26399|P1|Overall Study|Physician Decision|0
4607|NCT02105272|26398|P2|Overall Study|Adverse Event|2
4608|NCT02105272|26399|P1|Overall Study|Adverse Event|1
4609|NCT02104895|26417|P2|Overall Study|Withdrawal by Subject|14
4610|NCT02104895|26418|P1|Overall Study|Withdrawal by Subject|0
4611|NCT02103439|26465|P2|Overall Study|Withdrawal by Subject|1
4612|NCT02103439|26466|P1|Overall Study|Withdrawal by Subject|3
4613|NCT02103439|26465|P2|Overall Study|Adverse Event|2
4614|NCT02103439|26466|P1|Overall Study|Adverse Event|0
4615|NCT02103062|26501|P2|Overall Study|Death|1
4616|NCT02103062|26502|P1|Overall Study|Death|0
4617|NCT02103062|26501|P2|Overall Study|Progressive Disease|20
4618|NCT02103062|26502|P1|Overall Study|Progressive Disease|17
4619|NCT02103062|26501|P2|Overall Study|Adverse Event|2
4620|NCT02103062|26502|P1|Overall Study|Adverse Event|1
4621|NCT02102399|26595|P2|Overall Study|Withdrawal by Subject|4
4622|NCT02102399|26596|P1|Overall Study|Withdrawal by Subject|6
4623|NCT02101359|26646|P2|Overall Study|Protocol Violation|2
4624|NCT02101359|26647|P1|Overall Study|Protocol Violation|0
4625|NCT02101359|26646|P2|Overall Study|Lost to Follow-up|0
4626|NCT02101359|26647|P1|Overall Study|Lost to Follow-up|1
4627|NCT02101359|26646|P2|Overall Study|Withdrawal by Subject|4
4628|NCT02101359|26647|P1|Overall Study|Withdrawal by Subject|5
4629|NCT02101359|26646|P2|Overall Study|Not included|13
4630|NCT02101359|26647|P1|Overall Study|Not included|23
4631|NCT02101294|26653|P1|Overall Study|Lost to Follow-up|6
4632|NCT02101294|26653|P1|Overall Study|Withdrawal by Subject|5
4633|NCT02101112|26673|P6|Overall Study|Withdrawal by Subject|0
4634|NCT02101112|26674|P5|Overall Study|Withdrawal by Subject|1
4635|NCT02101112|26675|P4|Overall Study|Withdrawal by Subject|0
4636|NCT02101112|26676|P3|Overall Study|Withdrawal by Subject|0
4637|NCT02101112|26677|P2|Overall Study|Withdrawal by Subject|0
4638|NCT02101112|26678|P1|Overall Study|Withdrawal by Subject|0
4639|NCT02101112|26673|P6|Overall Study|Adverse Event|0
4640|NCT02101112|26674|P5|Overall Study|Adverse Event|0
4641|NCT02101112|26675|P4|Overall Study|Adverse Event|0
4642|NCT02101112|26676|P3|Overall Study|Adverse Event|1
4643|NCT02101112|26677|P2|Overall Study|Adverse Event|0
4644|NCT02101112|26678|P1|Overall Study|Adverse Event|0
4645|NCT02100839|26710|P2|Multiple Ascending Dose|Withdrawal by Subject|0
4646|NCT02100839|26711|P1|Multiple Ascending Dose|Withdrawal by Subject|2
4647|NCT02100839|26710|P2|Multiple Ascending Dose|Adverse Event|0
4648|NCT02100839|26711|P1|Multiple Ascending Dose|Adverse Event|2
4649|NCT02100644|26734|P3|LTG Escalation Phase|Withdrawal by Subject|0
4650|NCT02100644|26735|P2|LTG Escalation Phase|Withdrawal by Subject|0
4651|NCT02100644|26736|P1|LTG Escalation Phase|Withdrawal by Subject|3
4652|NCT02100644|26734|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
4653|NCT02100644|26735|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
4654|NCT02100644|26736|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
4655|NCT02100644|26734|P3|LTG Escalation Phase|Adverse Event|0
4656|NCT02100644|26735|P2|LTG Escalation Phase|Adverse Event|0
4657|NCT02100644|26736|P1|LTG Escalation Phase|Adverse Event|9
4658|NCT02100475|26761|P2|Overall Study|Withdrawal criteria|0
4659|NCT02100475|26762|P1|Overall Study|Withdrawal criteria|1
4660|NCT02100475|26761|P2|Overall Study|Unclassified|2
4661|NCT02100475|26762|P1|Overall Study|Unclassified|1
4662|NCT02099838|26795|P2|Overall Study|Withdrawal by Subject|1
4663|NCT02099838|26796|P1|Overall Study|Withdrawal by Subject|0
4664|NCT02099838|26795|P2|Overall Study|Lost to Follow-up|1
4665|NCT02099838|26796|P1|Overall Study|Lost to Follow-up|3
4666|NCT02099838|26795|P2|Overall Study|Death|0
4667|NCT02099838|26796|P1|Overall Study|Death|1
4668|NCT02099708|26826|P1|Overall Study|Other|29
4669|NCT02099708|26826|P1|Overall Study|Lost to Follow-up|141
4670|NCT02099708|26826|P1|Overall Study|Data Not Available|30
4671|NCT02099682|26837|P1|Overall Study|Other|29
4672|NCT02099682|26837|P1|Overall Study|Lost to Follow-up|31
4673|NCT02099682|26837|P1|Overall Study|Data Not Available|51
4674|NCT02099344|26863|P2|Overall Study|Physician Decision|0
4675|NCT02099344|26864|P1|Overall Study|Physician Decision|1
4676|NCT02098746|26897|P1|Overall Study|Data Not Available After Treatment|1
4677|NCT02098746|26897|P1|Overall Study|Enrolled 15 Days After the First Dose|1
4678|NCT02098746|26897|P1|Overall Study|Other Miscellaneous Reasons|1
4679|NCT02098746|26897|P1|Overall Study|Changes of Investigator|2
4680|NCT02098733|26905|P1|Overall Study|Lost to Follow-up|5
4681|NCT02098733|26905|P1|Overall Study|Data Not Available|5
4682|NCT02098395|26919|P4|Overall Study|Unclassified|2
4683|NCT02098395|26920|P3|Overall Study|Unclassified|3
4684|NCT02098395|26921|P2|Overall Study|Unclassified|0
4685|NCT02098395|26922|P1|Overall Study|Unclassified|0
4686|NCT02098395|26919|P4|Overall Study|Lost to Follow-up|3
4687|NCT02098395|26920|P3|Overall Study|Lost to Follow-up|0
4688|NCT02098395|26921|P2|Overall Study|Lost to Follow-up|1
4689|NCT02098395|26922|P1|Overall Study|Lost to Follow-up|2
4690|NCT02098395|26919|P4|Overall Study|Adverse Event|2
4691|NCT02098395|26920|P3|Overall Study|Adverse Event|34
4692|NCT02098395|26921|P2|Overall Study|Adverse Event|19
4693|NCT02098395|26922|P1|Overall Study|Adverse Event|12
4694|NCT02098395|26919|P4|Overall Study|Withdrawal by Subject|13
4695|NCT02098395|26920|P3|Overall Study|Withdrawal by Subject|5
4696|NCT02098395|26921|P2|Overall Study|Withdrawal by Subject|10
4697|NCT02098395|26922|P1|Overall Study|Withdrawal by Subject|10
4698|NCT02098395|26919|P4|Overall Study|Protocol Violation|7
4699|NCT02098395|26920|P3|Overall Study|Protocol Violation|0
4700|NCT02098395|26921|P2|Overall Study|Protocol Violation|2
4701|NCT02098395|26922|P1|Overall Study|Protocol Violation|2
4702|NCT02097745|26947|P1|Overall Study|Reason Not Specified|96
4703|NCT02097745|26947|P1|Overall Study|Administrative/Other|27
4704|NCT02097745|26947|P1|Overall Study|Failure to Return|14
4705|NCT02097745|26947|P1|Overall Study|Death|16
4706|NCT02097745|26947|P1|Overall Study|Adverse Event|25
4707|NCT02097719|26971|P2|Overall Study|Adverse Event|0
4708|NCT02097719|26972|P1|Overall Study|Adverse Event|2
4709|NCT02097719|26971|P2|Overall Study|Lost to Follow-up|1
4710|NCT02097719|26972|P1|Overall Study|Lost to Follow-up|0
4711|NCT02097719|26971|P2|Overall Study|Subject Withdrew Consent|0
4712|NCT02097719|26972|P1|Overall Study|Subject Withdrew Consent|1
4713|NCT02097108|26984|P1|Overall Study|patient was abroad for 6 months|1
4714|NCT02097108|26984|P1|Overall Study|Adverse Event|1
4715|NCT02097056|26991|P1|Overall Study|Not specified|2
4716|NCT02097056|26991|P1|Overall Study|Adverse Event|37
4717|NCT02097056|26991|P1|Overall Study|Lost to Follow-up|2
4718|NCT02097056|26991|P1|Overall Study|Withdrawal by Subject|15
4719|NCT02097056|26991|P1|Overall Study|Protocol Violation|2
4720|NCT02097030|26999|P2|First Intervention (3 Days)|Visual Acuity|1
4721|NCT02097030|27000|P1|First Intervention (3 Days)|Visual Acuity|0
4722|NCT02097030|26999|P2|First Intervention (3 Days)|Lost to Follow-up|0
4723|NCT02097030|27000|P1|First Intervention (3 Days)|Lost to Follow-up|1
4724|NCT02096835|27064|P3|Overall Study|Lost to Follow-up|1
4725|NCT02096835|27065|P2|Overall Study|Lost to Follow-up|0
4726|NCT02096835|27066|P1|Overall Study|Lost to Follow-up|1
4727|NCT02096835|27064|P3|Overall Study|converted to open procedures|0
4728|NCT02096835|27065|P2|Overall Study|converted to open procedures|0
4729|NCT02096835|27066|P1|Overall Study|converted to open procedures|1
4730|NCT02096835|27064|P3|Overall Study|Withdrawal by Subject|0
4731|NCT02096835|27065|P2|Overall Study|Withdrawal by Subject|0
4732|NCT02096835|27066|P1|Overall Study|Withdrawal by Subject|1
4733|NCT02096744|27083|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
4734|NCT02096744|27084|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
4735|NCT02096744|27083|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
4736|NCT02096744|27084|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
4737|NCT02096744|27083|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
4738|NCT02096744|27084|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
4739|NCT02095691|27187|P1|Overall Study|Physician Decision|1
4740|NCT02095223|27221|P2|Overall Study|Withdrawal by Subject|0
4741|NCT02095223|27222|P1|Overall Study|Withdrawal by Subject|1
4742|NCT02095158|27230|P1|Overall Study|Other Miscellaneous Reasons|1
4743|NCT02095158|27230|P1|Overall Study|Protocol Violation|1
4744|NCT02095158|27230|P1|Overall Study|Personal Reasons|35
4745|NCT02095158|27230|P1|Overall Study|Lost to Follow-up|20
4746|NCT02095158|27230|P1|Overall Study|Pregnancy|1
4747|NCT02095158|27230|P1|Overall Study|Lack of Efficacy|3
4748|NCT02095158|27230|P1|Overall Study|Adverse Event|14
4749|NCT02094937|27235|P4|12 Weeks in Period 2|Randomized incorrectly|0
4750|NCT02094937|27236|P3|12 Weeks in Period 2|Randomized incorrectly|0
4751|NCT02094937|27237|P2|12 Weeks in Period 2|Randomized incorrectly|1
4752|NCT02094937|27238|P1|12 Weeks in Period 2|Randomized incorrectly|0
4753|NCT02094937|27235|P4|12 Weeks in Period 2|Withdrawal by Subject|0
4754|NCT02094937|27236|P3|12 Weeks in Period 2|Withdrawal by Subject|2
4755|NCT02094937|27237|P2|12 Weeks in Period 2|Withdrawal by Subject|2
4756|NCT02094937|27238|P1|12 Weeks in Period 2|Withdrawal by Subject|0
4757|NCT02094937|27235|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
4758|NCT02094937|27236|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
4759|NCT02094937|27237|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
4760|NCT02094937|27238|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
4761|NCT02094937|27235|P4|12 Weeks in Period 2|Lack of Efficacy|0
4762|NCT02094937|27236|P3|12 Weeks in Period 2|Lack of Efficacy|0
4763|NCT02094937|27237|P2|12 Weeks in Period 2|Lack of Efficacy|1
4764|NCT02094937|27238|P1|12 Weeks in Period 2|Lack of Efficacy|0
4765|NCT02094937|27235|P4|12 Weeks in Period 2|Adverse Event|1
4766|NCT02094937|27236|P3|12 Weeks in Period 2|Adverse Event|4
4767|NCT02094937|27237|P2|12 Weeks in Period 2|Adverse Event|2
4768|NCT02094937|27238|P1|12 Weeks in Period 2|Adverse Event|0
4769|NCT02094937|27235|P4|8 Weeks in Period 1|Withdrawal by Subject|0
4770|NCT02094937|27236|P3|8 Weeks in Period 1|Withdrawal by Subject|0
4771|NCT02094937|27237|P2|8 Weeks in Period 1|Withdrawal by Subject|0
4772|NCT02094937|27238|P1|8 Weeks in Period 1|Withdrawal by Subject|4
4773|NCT02094937|27235|P4|8 Weeks in Period 1|Physician Decision|0
4774|NCT02094937|27236|P3|8 Weeks in Period 1|Physician Decision|0
4775|NCT02094937|27237|P2|8 Weeks in Period 1|Physician Decision|0
4776|NCT02094937|27238|P1|8 Weeks in Period 1|Physician Decision|1
4777|NCT02094937|27235|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
4778|NCT02094937|27236|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
4779|NCT02094937|27237|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
4780|NCT02094937|27238|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
4781|NCT02094937|27235|P4|8 Weeks in Period 1|Protocol Violation|0
4782|NCT02094937|27236|P3|8 Weeks in Period 1|Protocol Violation|0
4783|NCT02094937|27237|P2|8 Weeks in Period 1|Protocol Violation|0
4784|NCT02094937|27238|P1|8 Weeks in Period 1|Protocol Violation|2
4785|NCT02094937|27235|P4|8 Weeks in Period 1|Lack of Efficacy|0
4786|NCT02094937|27236|P3|8 Weeks in Period 1|Lack of Efficacy|0
4787|NCT02094937|27237|P2|8 Weeks in Period 1|Lack of Efficacy|0
4788|NCT02094937|27238|P1|8 Weeks in Period 1|Lack of Efficacy|3
4789|NCT02094937|27235|P4|8 Weeks in Period 1|Adverse Event|0
4790|NCT02094937|27236|P3|8 Weeks in Period 1|Adverse Event|0
4791|NCT02094937|27237|P2|8 Weeks in Period 1|Adverse Event|0
4792|NCT02094937|27238|P1|8 Weeks in Period 1|Adverse Event|9
4793|NCT02094885|27270|P2|Overall Study|Withdrawn due to age|0
4794|NCT02094885|27271|P1|Overall Study|Withdrawn due to age|1
4795|NCT02094885|27270|P2|Overall Study|Death|5
4796|NCT02094885|27271|P1|Overall Study|Death|1
4797|NCT02094677|27285|P2|Overall Study|Screening|1
4798|NCT02094677|27286|P1|Overall Study|Screening|3
4799|NCT02094300|27378|P1|Overall Study|Still be eligible for follow-up|3
4800|NCT02094300|27378|P1|Overall Study|Lost to Follow-up|10
4801|NCT02094300|27378|P1|Overall Study|Death|7
4802|NCT02094261|27382|P1|Overall Study|Ongoing Study at Data Cut-off|181
4803|NCT02094261|27382|P1|Overall Study|Withdrawal by Subject|4
4804|NCT02094261|27382|P1|Overall Study|Lost to Follow-up|1
4805|NCT02094261|27382|P1|Overall Study|Death|24
4806|NCT02093923|27394|P5|Overall Study|Screen failure after randomization|0
4807|NCT02093923|27395|P4|Overall Study|Screen failure after randomization|1
4808|NCT02093923|27396|P3|Overall Study|Screen failure after randomization|0
4809|NCT02093923|27397|P2|Overall Study|Screen failure after randomization|0
4810|NCT02093923|27398|P1|Overall Study|Screen failure after randomization|0
4811|NCT02093923|27394|P5|Overall Study|Lost to Follow-up|0
4812|NCT02093923|27395|P4|Overall Study|Lost to Follow-up|1
4813|NCT02093923|27396|P3|Overall Study|Lost to Follow-up|0
4814|NCT02093923|27397|P2|Overall Study|Lost to Follow-up|0
4815|NCT02093923|27398|P1|Overall Study|Lost to Follow-up|0
4816|NCT02093897|27453|P1|Overall Study|Adverse event, non-fatal|1
4817|NCT02093897|27453|P1|Overall Study|Planned age group closure - no's reached|17
4818|NCT02093897|27453|P1|Overall Study|Physician Decision|1
4819|NCT02093390|27555|P2|Overall Study|Withdrawal by Subject|1
4820|NCT02093390|27556|P1|Overall Study|Withdrawal by Subject|0
4821|NCT02093351|27595|P3|Overall Study|Death|0
4822|NCT02093351|27596|P2|Overall Study|Death|1
4823|NCT02093351|27597|P1|Overall Study|Death|0
4824|NCT02093351|27595|P3|Overall Study|Condition under investigation worsened|2
4825|NCT02093351|27596|P2|Overall Study|Condition under investigation worsened|0
4826|NCT02093351|27597|P1|Overall Study|Condition under investigation worsened|2
4827|NCT02093351|27595|P3|Overall Study|Adverse Event|1
4828|NCT02093351|27596|P2|Overall Study|Adverse Event|1
4829|NCT02093351|27597|P1|Overall Study|Adverse Event|0
4830|NCT02092961|27629|P3|Overall Study|Adverse Event|0
4831|NCT02092961|27630|P2|Overall Study|Adverse Event|4
4832|NCT02092961|27631|P1|Overall Study|Adverse Event|2
4833|NCT02092961|27629|P3|Overall Study|Dev. of study specific discont. criteria|0
4834|NCT02092961|27630|P2|Overall Study|Dev. of study specific discont. criteria|0
4835|NCT02092961|27631|P1|Overall Study|Dev. of study specific discont. criteria|3
4836|NCT02092961|27629|P3|Overall Study|Lack of therapeutic response|3
4837|NCT02092961|27630|P2|Overall Study|Lack of therapeutic response|1
4838|NCT02092961|27631|P1|Overall Study|Lack of therapeutic response|2
4839|NCT02092961|27629|P3|Overall Study|Study stopped|12
4840|NCT02092961|27630|P2|Overall Study|Study stopped|9
4841|NCT02092961|27631|P1|Overall Study|Study stopped|13
4842|NCT02092961|27629|P3|Overall Study|Not reported|1
4843|NCT02092961|27630|P2|Overall Study|Not reported|0
4844|NCT02092961|27631|P1|Overall Study|Not reported|1
4845|NCT02092662|27667|P2|Overall Study|Lost to Follow-up|0
4846|NCT02092662|27668|P1|Overall Study|Lost to Follow-up|13
4847|NCT02092350|27729|P2|Overall Study|Withdrawal by Subject|2
4848|NCT02092350|27730|P1|Overall Study|Withdrawal by Subject|2
4849|NCT02092350|27729|P2|Overall Study|Screen Failure|0
4850|NCT02092350|27730|P1|Overall Study|Screen Failure|1
4851|NCT02092350|27729|P2|Overall Study|Physician Decision|1
4852|NCT02092350|27730|P1|Overall Study|Physician Decision|1
4853|NCT02092350|27729|P2|Overall Study|Protocol Violation|0
4854|NCT02092350|27730|P1|Overall Study|Protocol Violation|1
4855|NCT02092350|27729|P2|Overall Study|Lost to Follow-up|1
4856|NCT02092350|27730|P1|Overall Study|Lost to Follow-up|3
4857|NCT02092350|27729|P2|Overall Study|Death|5
4858|NCT02092350|27730|P1|Overall Study|Death|2
4859|NCT02092350|27729|P2|Overall Study|Adverse Event|3
4860|NCT02092350|27730|P1|Overall Study|Adverse Event|0
4861|NCT02091752|27800|P1|Overall Study|Adverse Event|1
4862|NCT02091752|27800|P1|Overall Study|Study terminated by Sponsor|2
4863|NCT02091726|27811|P1|Overall Study|Lost to Follow-up|6
4864|NCT02091414|27828|P1|Overall Study|Death|2
4865|NCT02091414|27828|P1|Overall Study|Withdrawal by Subject|2
4866|NCT02090855|27840|P1|Overall Study|no evaluable Standard of Truth results|2
4867|NCT02090764|27853|P2|Overall Study|Lost to Follow-up|2
4868|NCT02090764|27854|P1|Overall Study|Lost to Follow-up|2
4869|NCT02090764|27853|P2|Overall Study|Intercurrent illness and other|1
4870|NCT02090764|27854|P1|Overall Study|Intercurrent illness and other|1
4871|NCT02090764|27853|P2|Overall Study|Withdrawal by Subject|1
4872|NCT02090764|27854|P1|Overall Study|Withdrawal by Subject|2
4873|NCT02090764|27853|P2|Overall Study|Lack of Efficacy|13
4874|NCT02090764|27854|P1|Overall Study|Lack of Efficacy|0
4875|NCT02090764|27853|P2|Overall Study|Adverse Event|3
4876|NCT02090764|27854|P1|Overall Study|Adverse Event|1
4877|NCT02090413|27863|P3|Overall Study|Lost to Follow-up|0
4878|NCT02090413|27864|P2|Overall Study|Lost to Follow-up|1
4879|NCT02090413|27865|P1|Overall Study|Lost to Follow-up|1
4880|NCT02090413|27863|P3|Overall Study|Not Specified|0
4881|NCT02090413|27864|P2|Overall Study|Not Specified|1
4882|NCT02090413|27865|P1|Overall Study|Not Specified|2
4883|NCT02090413|27863|P3|Overall Study|Investigator Decision|0
4884|NCT02090413|27864|P2|Overall Study|Investigator Decision|1
4885|NCT02090413|27865|P1|Overall Study|Investigator Decision|1
4886|NCT02090413|27863|P3|Overall Study|Withdrawal by Subject|2
4887|NCT02090413|27864|P2|Overall Study|Withdrawal by Subject|2
4888|NCT02090413|27865|P1|Overall Study|Withdrawal by Subject|2
4889|NCT02090413|27863|P3|Overall Study|Flushing event|1
4890|NCT02090413|27864|P2|Overall Study|Flushing event|0
4891|NCT02090413|27865|P1|Overall Study|Flushing event|2
4892|NCT02090413|27863|P3|Overall Study|Adverse Event|20
4893|NCT02090413|27864|P2|Overall Study|Adverse Event|15
4894|NCT02090413|27865|P1|Overall Study|Adverse Event|11
4895|NCT02089347|27953|P2|Overall Study|Protocol Violation|0
4896|NCT02089347|27954|P1|Overall Study|Protocol Violation|1
4897|NCT02088957|27994|P2|Overall Study|Lack of Efficacy|0
4898|NCT02088957|27995|P1|Overall Study|Lack of Efficacy|1
4899|NCT02087943|28014|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
4900|NCT02087943|28015|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
4901|NCT02087943|28016|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
4902|NCT02087943|28017|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
4903|NCT02087943|28018|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
4904|NCT02087943|28014|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
4905|NCT02087943|28015|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
4906|NCT02087943|28016|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
4907|NCT02087943|28017|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
4908|NCT02087943|28018|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
4909|NCT02087943|28014|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
4910|NCT02087943|28015|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
4911|NCT02087943|28016|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
4912|NCT02087943|28017|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
4913|NCT02087943|28018|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
4914|NCT02087943|28014|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
4915|NCT02087943|28015|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
4916|NCT02087943|28016|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
4917|NCT02087943|28017|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
4918|NCT02087943|28018|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
4919|NCT02087943|28014|P5|Active Treatment Phase Week 12-24|Adverse Event|1
4920|NCT02087943|28015|P4|Active Treatment Phase Week 12-24|Adverse Event|0
4921|NCT02087943|28016|P3|Active Treatment Phase Week 12-24|Adverse Event|2
4922|NCT02087943|28017|P2|Active Treatment Phase Week 12-24|Adverse Event|1
4923|NCT02087943|28018|P1|Active Treatment Phase Week 12-24|Adverse Event|0
4924|NCT02087943|28014|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
4925|NCT02087943|28015|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
4926|NCT02087943|28016|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
4927|NCT02087943|28017|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
4928|NCT02087943|28018|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
4929|NCT02087943|28014|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
4930|NCT02087943|28015|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
4931|NCT02087943|28016|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
4932|NCT02087943|28017|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
4933|NCT02087943|28018|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
4934|NCT02087943|28014|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
4935|NCT02087943|28015|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
4936|NCT02087943|28016|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
4937|NCT02087943|28017|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
4938|NCT02087943|28018|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
4939|NCT02087943|28014|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
4940|NCT02087943|28015|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
4941|NCT02087943|28016|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
4942|NCT02087943|28017|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
4943|NCT02087943|28018|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
4944|NCT02087943|28014|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
4945|NCT02087943|28015|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
4946|NCT02087943|28016|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
4947|NCT02087943|28017|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
4948|NCT02087943|28018|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
4949|NCT02087774|28044|P2|Overall Study|Were absent day of data collection|20
4950|NCT02087774|28045|P1|Overall Study|Were absent day of data collection|8
4951|NCT02087670|28065|P2|Overall Study|Withdrawal by Subject|2
4952|NCT02087670|28066|P1|Overall Study|Withdrawal by Subject|3
4953|NCT02087176|28074|P1|Overall Study|Study Terminated by Sponsor|2
4954|NCT02087176|28074|P1|Overall Study|Censored|19
4955|NCT02087176|28074|P1|Overall Study|Death|10
4956|NCT02087176|28074|P1|Overall Study|Withdrawal by Subject|1
4957|NCT02087059|28079|P1|Overall Study|Lost to Follow-up|1
4958|NCT02087059|28079|P1|Overall Study|Adverse Event|5
4959|NCT02087059|28079|P1|Overall Study|Disease Progression|1
4960|NCT02086591|28099|P1|Overall Study|protocol terminated|3
4961|NCT02086591|28099|P1|Overall Study|Withdrawal by Subject|1
4962|NCT02086591|28099|P1|Overall Study|Adverse Event|1
4963|NCT02085161|28117|P4|Overall Study|Other Reason|1
4964|NCT02085161|28118|P3|Overall Study|Other Reason|1
4965|NCT02085161|28119|P2|Overall Study|Other Reason|0
4966|NCT02085161|28120|P1|Overall Study|Other Reason|1
4967|NCT02085161|28117|P4|Overall Study|Withdrawal by Subject|3
4968|NCT02085161|28118|P3|Overall Study|Withdrawal by Subject|0
4969|NCT02085161|28119|P2|Overall Study|Withdrawal by Subject|4
4970|NCT02085161|28120|P1|Overall Study|Withdrawal by Subject|2
4971|NCT02085161|28117|P4|Overall Study|Protocol Violation|1
4972|NCT02085161|28118|P3|Overall Study|Protocol Violation|0
4973|NCT02085161|28119|P2|Overall Study|Protocol Violation|1
4974|NCT02085161|28120|P1|Overall Study|Protocol Violation|0
4975|NCT02085161|28117|P4|Overall Study|Adverse Event|5
4976|NCT02085161|28118|P3|Overall Study|Adverse Event|4
4977|NCT02085161|28119|P2|Overall Study|Adverse Event|5
4978|NCT02085161|28120|P1|Overall Study|Adverse Event|8
4979|NCT02085161|28117|P4|Overall Study|Not Treated|0
4980|NCT02085161|28118|P3|Overall Study|Not Treated|0
4981|NCT02085161|28119|P2|Overall Study|Not Treated|0
4982|NCT02085161|28120|P1|Overall Study|Not Treated|1
4983|NCT02084238|28188|P1|Overall Study|Lost to Follow-up|2
4984|NCT02084082|28201|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
4985|NCT02084082|28202|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4986|NCT02084082|28203|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4987|NCT02084082|28204|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4988|NCT02084082|28201|P4|Washout Period 1 (35 Days)|Adverse Event|1
4989|NCT02084082|28202|P3|Washout Period 1 (35 Days)|Adverse Event|1
4990|NCT02084082|28203|P2|Washout Period 1 (35 Days)|Adverse Event|0
4991|NCT02084082|28204|P1|Washout Period 1 (35 Days)|Adverse Event|0
4992|NCT02084056|28245|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4993|NCT02084056|28246|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4994|NCT02084056|28247|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4995|NCT02084056|28248|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
4996|NCT02084056|28245|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4997|NCT02084056|28246|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4998|NCT02084056|28247|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4999|NCT02084056|28248|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
5000|NCT02083965|28280|P2|Overall Study|Not specified|0
5001|NCT02083965|28281|P1|Overall Study|Not specified|1
5002|NCT02083965|28280|P2|Overall Study|Withdrawal by Subject|1
5003|NCT02083965|28281|P1|Overall Study|Withdrawal by Subject|0
5004|NCT02083380|28383|P3|Overall Study|Other|6
5005|NCT02083380|28384|P2|Overall Study|Other|4
5006|NCT02083380|28385|P1|Overall Study|Other|8
5007|NCT02083380|28383|P3|Overall Study|Lost to Follow-up|3
5008|NCT02083380|28384|P2|Overall Study|Lost to Follow-up|3
5009|NCT02083380|28385|P1|Overall Study|Lost to Follow-up|5
5010|NCT02083380|28383|P3|Overall Study|Adverse Event|1
5011|NCT02083380|28384|P2|Overall Study|Adverse Event|0
5012|NCT02083380|28385|P1|Overall Study|Adverse Event|0
5013|NCT02083380|28383|P3|Overall Study|Physician Decision|3
5014|NCT02083380|28384|P2|Overall Study|Physician Decision|6
5015|NCT02083380|28385|P1|Overall Study|Physician Decision|1
5016|NCT02083380|28383|P3|Overall Study|Withdrawal by Subject|7
5017|NCT02083380|28384|P2|Overall Study|Withdrawal by Subject|3
5018|NCT02083380|28385|P1|Overall Study|Withdrawal by Subject|9
5019|NCT02083380|28383|P3|Overall Study|Lack of Efficacy|64
5020|NCT02083380|28384|P2|Overall Study|Lack of Efficacy|79
5021|NCT02083380|28385|P1|Overall Study|Lack of Efficacy|68
5022|NCT02082912|28529|P2|Overall Study|Physician Decision|1
5023|NCT02082912|28530|P1|Overall Study|Physician Decision|0
5024|NCT02082262|28559|P1|Overall Study|Adverse Event|48
5025|NCT02082262|28559|P1|Overall Study|Withdrawal by Subject|3
5026|NCT02082158|28569|P6|Overall Study|Failed Fit-testing|7
5027|NCT02082158|28570|P5|Overall Study|Failed Fit-testing|3
5028|NCT02082158|28571|P4|Overall Study|Failed Fit-testing|4
5029|NCT02082158|28572|P3|Overall Study|Failed Fit-testing|14
5030|NCT02082158|28573|P2|Overall Study|Failed Fit-testing|8
5031|NCT02082158|28574|P1|Overall Study|Failed Fit-testing|8
5032|NCT02082158|28569|P6|Overall Study|Withdrawal by Subject|0
5033|NCT02082158|28570|P5|Overall Study|Withdrawal by Subject|1
5034|NCT02082158|28571|P4|Overall Study|Withdrawal by Subject|0
5035|NCT02082158|28572|P3|Overall Study|Withdrawal by Subject|0
5036|NCT02082158|28573|P2|Overall Study|Withdrawal by Subject|0
5037|NCT02082158|28574|P1|Overall Study|Withdrawal by Subject|0
5038|NCT02081599|28596|P2|Period 2：Open-label Period|Withdrawal by Subject|0
5039|NCT02081599|28597|P1|Period 2：Open-label Period|Withdrawal by Subject|2
5040|NCT02081599|28596|P2|Period 2：Open-label Period|Physician Decision|0
5041|NCT02081599|28597|P1|Period 2：Open-label Period|Physician Decision|1
5042|NCT02081599|28596|P2|Period 2：Open-label Period|Lack of Efficacy|4
5043|NCT02081599|28597|P1|Period 2：Open-label Period|Lack of Efficacy|2
5044|NCT02081599|28596|P2|Period 2：Open-label Period|Adverse Event|0
5045|NCT02081599|28597|P1|Period 2：Open-label Period|Adverse Event|1
5046|NCT02081599|28596|P2|Period 1：Double-blind Period|stopping criteria|0
5047|NCT02081599|28597|P1|Period 1：Double-blind Period|stopping criteria|1
5048|NCT02081599|28596|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
5049|NCT02081599|28597|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
5050|NCT02081599|28596|P2|Period 1：Double-blind Period|Protocol Violation|1
5051|NCT02081599|28597|P1|Period 1：Double-blind Period|Protocol Violation|0
5052|NCT02081599|28596|P2|Period 1：Double-blind Period|Physician Decision|0
5053|NCT02081599|28597|P1|Period 1：Double-blind Period|Physician Decision|1
5054|NCT02081599|28596|P2|Period 1：Double-blind Period|Lack of Efficacy|1
5055|NCT02081599|28597|P1|Period 1：Double-blind Period|Lack of Efficacy|2
5056|NCT02081599|28596|P2|Period 1：Double-blind Period|Adverse Event|0
5057|NCT02081599|28597|P1|Period 1：Double-blind Period|Adverse Event|3
5058|NCT02081183|28628|P2|Overall Study|Not specified|3
5059|NCT02081183|28629|P1|Overall Study|Not specified|3
5060|NCT02081183|28628|P2|Overall Study|Protocol Violation|0
5061|NCT02081183|28629|P1|Overall Study|Protocol Violation|1
5062|NCT02081183|28628|P2|Overall Study|Lost to Follow-up|1
5063|NCT02081183|28629|P1|Overall Study|Lost to Follow-up|0
5064|NCT02081079|28645|P2|Overall Study|Lost to Follow-up|0
5065|NCT02081079|28646|P1|Overall Study|Lost to Follow-up|1
5066|NCT02081079|28645|P2|Overall Study|Lack of Efficacy|2
5067|NCT02081079|28646|P1|Overall Study|Lack of Efficacy|3
5068|NCT02081001|28719|P12|Overall Study|Adverse Event|0
5069|NCT02081001|28720|P11|Overall Study|Adverse Event|0
5070|NCT02081001|28721|P10|Overall Study|Adverse Event|0
5071|NCT02081001|28722|P9|Overall Study|Adverse Event|0
5072|NCT02081001|28723|P8|Overall Study|Adverse Event|0
5073|NCT02081001|28724|P7|Overall Study|Adverse Event|0
5074|NCT02081001|28725|P6|Overall Study|Adverse Event|0
5075|NCT02081001|28726|P5|Overall Study|Adverse Event|1
5076|NCT02081001|28727|P4|Overall Study|Adverse Event|0
5077|NCT02081001|28728|P3|Overall Study|Adverse Event|0
5078|NCT02081001|28729|P2|Overall Study|Adverse Event|0
5079|NCT02081001|28730|P1|Overall Study|Adverse Event|0
5080|NCT02080091|28818|P1|Overall Study|Other|1
5081|NCT02080091|28818|P1|Overall Study|Withdrawal by Subject|1
5082|NCT02080091|28818|P1|Overall Study|Death|1
5083|NCT02080091|28818|P1|Overall Study|Study Terminated|22
5084|NCT02079844|28827|P3|Treatment Period 2|Voluntary Withdrawal|0
5085|NCT02079844|28828|P2|Treatment Period 2|Voluntary Withdrawal|1
5086|NCT02079844|28829|P1|Treatment Period 2|Voluntary Withdrawal|0
5087|NCT02079844|28827|P3|Treatment Period 1|Voluntary Withdrawal|2
5088|NCT02079844|28828|P2|Treatment Period 1|Voluntary Withdrawal|0
5089|NCT02079844|28829|P1|Treatment Period 1|Voluntary Withdrawal|0
5090|NCT02079649|28889|P4|Overall Study|Randomization error (prior to treatment)|0
5091|NCT02079649|28890|P3|Overall Study|Randomization error (prior to treatment)|1
5092|NCT02079649|28891|P2|Overall Study|Randomization error (prior to treatment)|0
5093|NCT02079649|28892|P1|Overall Study|Randomization error (prior to treatment)|1
5094|NCT02079649|28889|P4|Overall Study|Withdrawal by Subject|1
5095|NCT02079649|28890|P3|Overall Study|Withdrawal by Subject|0
5096|NCT02079649|28891|P2|Overall Study|Withdrawal by Subject|0
5097|NCT02079649|28892|P1|Overall Study|Withdrawal by Subject|0
5098|NCT02079649|28889|P4|Overall Study|Lost to Follow-up|1
5099|NCT02079649|28890|P3|Overall Study|Lost to Follow-up|0
5100|NCT02079649|28891|P2|Overall Study|Lost to Follow-up|0
5101|NCT02079649|28892|P1|Overall Study|Lost to Follow-up|0
5102|NCT02079532|28907|P1|Overall Study|Not specified|3
5103|NCT02079532|28907|P1|Overall Study|Inclusion into ReFIRST|3
5104|NCT02079532|28907|P1|Overall Study|Administrative problems|1
5105|NCT02079532|28907|P1|Overall Study|Withdrawal by Subject|1
5106|NCT02079532|28907|P1|Overall Study|Protocol Violation|3
5107|NCT02079532|28907|P1|Overall Study|Lack of Efficacy|9
5108|NCT02079532|28907|P1|Overall Study|Additional or changed therapy|2
5109|NCT02079532|28907|P1|Overall Study|Adverse Event|7
5110|NCT02079519|28929|P1|Overall Study|Adverse Event|1
5111|NCT02079519|28929|P1|Overall Study|Disease Progression|9
5112|NCT02077374|28944|P2|Overall Study|Protocol Violation|1
5113|NCT02077374|28945|P1|Overall Study|Protocol Violation|0
5114|NCT02077374|28944|P2|Overall Study|Withdrawal by Subject|1
5115|NCT02077374|28945|P1|Overall Study|Withdrawal by Subject|0
5116|NCT02076009|29076|P2|Overall Study|Subjects randomized but not treated|3
5117|NCT02076009|29077|P1|Overall Study|Subjects randomized but not treated|2
5118|NCT02076009|29076|P2|Overall Study|Ongoing|249
5119|NCT02076009|29077|P1|Overall Study|Ongoing|226
5120|NCT02076009|29076|P2|Overall Study|Progressive disease|0
5121|NCT02076009|29077|P1|Overall Study|Progressive disease|1
5122|NCT02076009|29076|P2|Overall Study|Lost to Follow-up|1
5123|NCT02076009|29077|P1|Overall Study|Lost to Follow-up|1
5124|NCT02076009|29076|P2|Overall Study|Withdrawal by Subject|3
5125|NCT02076009|29077|P1|Overall Study|Withdrawal by Subject|9
5126|NCT02076009|29076|P2|Overall Study|Death|30
5127|NCT02076009|29077|P1|Overall Study|Death|44
5128|NCT02075632|29099|P2|Overall Study|Withdrawal by Subject|1
5129|NCT02075632|29100|P1|Overall Study|Withdrawal by Subject|0
5130|NCT02075632|29099|P2|Overall Study|Lost to Follow-up|3
5131|NCT02075632|29100|P1|Overall Study|Lost to Follow-up|0
5132|NCT02075632|29099|P2|Overall Study|Adverse Event|1
5133|NCT02075632|29100|P1|Overall Study|Adverse Event|1
5134|NCT02075073|29159|P3|Overall Study|Withdrawal by Subject|0
5135|NCT02075073|29160|P2|Overall Study|Withdrawal by Subject|1
5136|NCT02075073|29161|P1|Overall Study|Withdrawal by Subject|0
5137|NCT02074553|29206|P8|Washout Period 3|Physician Decision|1
5138|NCT02074553|29207|P7|Washout Period 3|Physician Decision|0
5139|NCT02074553|29208|P6|Washout Period 3|Physician Decision|0
5140|NCT02074553|29209|P5|Washout Period 3|Physician Decision|0
5141|NCT02074553|29210|P4|Washout Period 3|Physician Decision|0
5142|NCT02074553|29211|P3|Washout Period 3|Physician Decision|0
5143|NCT02074553|29212|P2|Washout Period 3|Physician Decision|0
5144|NCT02074553|29213|P1|Washout Period 3|Physician Decision|0
5145|NCT02074553|29206|P8|Washout Period 2|Lost to Follow-up|0
5146|NCT02074553|29207|P7|Washout Period 2|Lost to Follow-up|0
5147|NCT02074553|29208|P6|Washout Period 2|Lost to Follow-up|0
5148|NCT02074553|29209|P5|Washout Period 2|Lost to Follow-up|0
5149|NCT02074553|29210|P4|Washout Period 2|Lost to Follow-up|0
5150|NCT02074553|29211|P3|Washout Period 2|Lost to Follow-up|1
5151|NCT02074553|29212|P2|Washout Period 2|Lost to Follow-up|0
5152|NCT02074553|29213|P1|Washout Period 2|Lost to Follow-up|0
5153|NCT02074553|29206|P8|Washout Period 2|Physician Decision|0
5154|NCT02074553|29207|P7|Washout Period 2|Physician Decision|0
5155|NCT02074553|29208|P6|Washout Period 2|Physician Decision|1
5156|NCT02074553|29209|P5|Washout Period 2|Physician Decision|0
5157|NCT02074553|29210|P4|Washout Period 2|Physician Decision|0
5158|NCT02074553|29211|P3|Washout Period 2|Physician Decision|0
5159|NCT02074553|29212|P2|Washout Period 2|Physician Decision|0
5160|NCT02074553|29213|P1|Washout Period 2|Physician Decision|0
5161|NCT02074553|29206|P8|Washout Period 2|Adverse Event|0
5162|NCT02074553|29207|P7|Washout Period 2|Adverse Event|1
5163|NCT02074553|29208|P6|Washout Period 2|Adverse Event|0
5164|NCT02074553|29209|P5|Washout Period 2|Adverse Event|0
5165|NCT02074553|29210|P4|Washout Period 2|Adverse Event|0
5166|NCT02074553|29211|P3|Washout Period 2|Adverse Event|0
5167|NCT02074553|29212|P2|Washout Period 2|Adverse Event|0
5168|NCT02074553|29213|P1|Washout Period 2|Adverse Event|0
5169|NCT02074553|29206|P8|Washout Period 1|Unspecified|0
5170|NCT02074553|29207|P7|Washout Period 1|Unspecified|0
5171|NCT02074553|29208|P6|Washout Period 1|Unspecified|1
5172|NCT02074553|29209|P5|Washout Period 1|Unspecified|0
5173|NCT02074553|29210|P4|Washout Period 1|Unspecified|0
5174|NCT02074553|29211|P3|Washout Period 1|Unspecified|0
5175|NCT02074553|29212|P2|Washout Period 1|Unspecified|0
5176|NCT02074553|29213|P1|Washout Period 1|Unspecified|0
5177|NCT02074553|29206|P8|Washout Period 1|Physician Decision|0
5178|NCT02074553|29207|P7|Washout Period 1|Physician Decision|0
5179|NCT02074553|29208|P6|Washout Period 1|Physician Decision|0
5180|NCT02074553|29209|P5|Washout Period 1|Physician Decision|0
5181|NCT02074553|29210|P4|Washout Period 1|Physician Decision|1
5182|NCT02074553|29211|P3|Washout Period 1|Physician Decision|0
5183|NCT02074553|29212|P2|Washout Period 1|Physician Decision|0
5184|NCT02074553|29213|P1|Washout Period 1|Physician Decision|0
5185|NCT02074553|29206|P8|Washout Period 1|Adverse Event|0
5186|NCT02074553|29207|P7|Washout Period 1|Adverse Event|0
5187|NCT02074553|29208|P6|Washout Period 1|Adverse Event|0
5188|NCT02074553|29209|P5|Washout Period 1|Adverse Event|0
5189|NCT02074553|29210|P4|Washout Period 1|Adverse Event|0
5190|NCT02074553|29211|P3|Washout Period 1|Adverse Event|0
5191|NCT02074553|29212|P2|Washout Period 1|Adverse Event|0
5192|NCT02074553|29213|P1|Washout Period 1|Adverse Event|1
5193|NCT02074553|29206|P8|Intervention Period 1|Family Emergency|0
5194|NCT02074553|29207|P7|Intervention Period 1|Family Emergency|0
5195|NCT02074553|29208|P6|Intervention Period 1|Family Emergency|0
5196|NCT02074553|29209|P5|Intervention Period 1|Family Emergency|0
5197|NCT02074553|29210|P4|Intervention Period 1|Family Emergency|1
5198|NCT02074553|29211|P3|Intervention Period 1|Family Emergency|0
5199|NCT02074553|29212|P2|Intervention Period 1|Family Emergency|0
5200|NCT02074553|29213|P1|Intervention Period 1|Family Emergency|0
5201|NCT02074514|29395|P2|Overall Study|Withdrew Consent|1
5202|NCT02074514|29396|P1|Overall Study|Withdrew Consent|0
5203|NCT02074514|29395|P2|Overall Study|Lost to Follow-up|1
5204|NCT02074514|29396|P1|Overall Study|Lost to Follow-up|0
5205|NCT02074514|29395|P2|Overall Study|Lack of Efficacy|2
5206|NCT02074514|29396|P1|Overall Study|Lack of Efficacy|3
5207|NCT02073656|29531|P1|Primary Study|Withdrew Consent|1
5208|NCT02073656|29531|P1|Primary Study|Death|1
5209|NCT02073656|29531|P1|Primary Study|Lost to Follow-up|6
5210|NCT02072980|29609|P2|Period 2, Second Wear|Adverse Event|1
5211|NCT02072980|29610|P1|Period 2, Second Wear|Adverse Event|0
5212|NCT02072096|29632|P2|Overall Study|Lost to Follow-up|0
5213|NCT02072096|29633|P1|Overall Study|Lost to Follow-up|1
5214|NCT02072096|29632|P2|Overall Study|Study Terminated by Sponsor|30
5215|NCT02072096|29633|P1|Overall Study|Study Terminated by Sponsor|43
5216|NCT02072096|29632|P2|Overall Study|Physician Decision|1
5217|NCT02072096|29633|P1|Overall Study|Physician Decision|0
5218|NCT02072096|29632|P2|Overall Study|Death|0
5219|NCT02072096|29633|P1|Overall Study|Death|2
5220|NCT02072096|29632|P2|Overall Study|No Reason Provided|2
5221|NCT02072096|29633|P1|Overall Study|No Reason Provided|4
5222|NCT02072096|29632|P2|Overall Study|Adverse Event|2
5223|NCT02072096|29633|P1|Overall Study|Adverse Event|5
5224|NCT02072096|29632|P2|Overall Study|Withdrawal by Subject|7
5225|NCT02072096|29633|P1|Overall Study|Withdrawal by Subject|5
5226|NCT02072096|29632|P2|Overall Study|Protocol Violation|7
5227|NCT02072096|29633|P1|Overall Study|Protocol Violation|7
5228|NCT02072096|29632|P2|Overall Study|Lack of Efficacy|29
5229|NCT02072096|29633|P1|Overall Study|Lack of Efficacy|18
5230|NCT02071771|29689|P2|Period 1: First 10 Days|Unavailable lens power|0
5231|NCT02071771|29690|P1|Period 1: First 10 Days|Unavailable lens power|1
5232|NCT02071771|29689|P2|Period 1: First 10 Days|Unacceptable lens fit|0
5233|NCT02071771|29690|P1|Period 1: First 10 Days|Unacceptable lens fit|1
5234|NCT02071082|29719|P2|Overall Study|Participants Still on Study|68
5235|NCT02071082|29720|P1|Overall Study|Participants Still on Study|3
5236|NCT02071082|29719|P2|Overall Study|Lost to Follow-up|1
5237|NCT02071082|29720|P1|Overall Study|Lost to Follow-up|0
5238|NCT02071082|29719|P2|Overall Study|Withdrew Consent|3
5239|NCT02071082|29720|P1|Overall Study|Withdrew Consent|0
5240|NCT02071082|29719|P2|Overall Study|Non-Compliance with Study Drug|1
5241|NCT02071082|29720|P1|Overall Study|Non-Compliance with Study Drug|0
5242|NCT02071082|29719|P2|Overall Study|Adverse Event|1
5243|NCT02071082|29720|P1|Overall Study|Adverse Event|0
5244|NCT02071082|29719|P2|Overall Study|Enrolled and Never Treated|1
5245|NCT02071082|29720|P1|Overall Study|Enrolled and Never Treated|1
5246|NCT02070380|29765|P4|Second Injection|Protocol Violation|5
5247|NCT02070380|29766|P3|Second Injection|Protocol Violation|1
5248|NCT02070380|29767|P2|Second Injection|Protocol Violation|1
5249|NCT02070380|29768|P1|Second Injection|Protocol Violation|0
5250|NCT02070380|29765|P4|Second Injection|Image sets missing or technically inadeq|0
5251|NCT02070380|29766|P3|Second Injection|Image sets missing or technically inadeq|0
5252|NCT02070380|29767|P2|Second Injection|Image sets missing or technically inadeq|1
5253|NCT02070380|29768|P1|Second Injection|Image sets missing or technically inadeq|0
5254|NCT02070380|29765|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
5255|NCT02070380|29766|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
5256|NCT02070380|29767|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
5257|NCT02070380|29768|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
5258|NCT02069093|29827|P1|Overall Study|Adverse Event|10
5259|NCT02069093|29827|P1|Overall Study|Abnormal laboratory values|1
5260|NCT02069093|29827|P1|Overall Study|Withdrawal by Subject|2
5261|NCT02069093|29827|P1|Overall Study|Administrative problems|1
5262|NCT02069093|29827|P1|Overall Study|Death|1
5263|NCT02069093|29827|P1|Overall Study|New cancer therapy|1
5264|NCT02069093|29827|P1|Overall Study|Disease progression|14
5265|NCT02068443|29839|P3|Overall Study|Other Reason Not Specified|0
5266|NCT02068443|29840|P2|Overall Study|Other Reason Not Specified|0
5267|NCT02068443|29841|P1|Overall Study|Other Reason Not Specified|1
5268|NCT02068443|29839|P3|Overall Study|Lack of Efficacy|0
5269|NCT02068443|29840|P2|Overall Study|Lack of Efficacy|1
5270|NCT02068443|29841|P1|Overall Study|Lack of Efficacy|2
5271|NCT02068443|29839|P3|Overall Study|Voluntary Withdrawal|1
5272|NCT02068443|29840|P2|Overall Study|Voluntary Withdrawal|0
5273|NCT02068443|29841|P1|Overall Study|Voluntary Withdrawal|4
5274|NCT02068443|29839|P3|Overall Study|Pretreatment Event/Adverse Event|2
5275|NCT02068443|29840|P2|Overall Study|Pretreatment Event/Adverse Event|5
5276|NCT02068443|29841|P1|Overall Study|Pretreatment Event/Adverse Event|0
5277|NCT02068222|29876|P1|Overall Study|Lost to Follow-up|1
5278|NCT02067728|29885|P2|6 Month Measurements|Unable to attend|97
5279|NCT02067728|29886|P1|6 Month Measurements|Unable to attend|114
5280|NCT02067728|29885|P2|6 Month Follow up Survey|Lost to Follow-up|60
5281|NCT02067728|29886|P1|6 Month Follow up Survey|Lost to Follow-up|48
5282|NCT02067728|29885|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
5283|NCT02067728|29886|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
5284|NCT02067533|29916|P2|Overall Study|Lost to Follow-up|2
5285|NCT02067533|29917|P1|Overall Study|Lost to Follow-up|4
5286|NCT02066922|29923|P1|Overall Study|Adverse Event|1
5287|NCT02066051|29945|P1|Overall Study|Subject developed active GVHD|1
5288|NCT02064231|30135|P2|Second Test Period (Test B or Test D)|Adverse Event|1
5289|NCT02064231|30136|P1|Second Test Period (Test B or Test D)|Adverse Event|0
5290|NCT02064231|30135|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
5291|NCT02064231|30136|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|2
5292|NCT02064231|30135|P2|First Test Period (Test A or Test C)|Adverse Event|0
5293|NCT02064231|30136|P1|First Test Period (Test A or Test C)|Adverse Event|1
5294|NCT02064231|30135|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
5295|NCT02064231|30136|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
5296|NCT02064231|30135|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
5297|NCT02064231|30136|P1|First Test Period (Test A or Test C)|Lack of Efficacy|4
5298|NCT02064205|30148|P1|Overall Study|Withdrawal by Subject|1
5299|NCT02063737|30166|P2|Overall Study|Lost to Follow-up|4
5300|NCT02063737|30167|P1|Overall Study|Lost to Follow-up|11
5301|NCT02062658|30286|P1|Overall Study|Lack of Efficacy|1
5302|NCT02062658|30286|P1|Overall Study|Withdrawal by Subject|1
5303|NCT02062450|30313|P1|Overall Study|No follow-up visit|124
5304|NCT02062437|30327|P1|Overall Study|Pt. couldn't come due to med. condition|1
5305|NCT02062437|30327|P1|Overall Study|Death|2
5306|NCT02062437|30327|P1|Overall Study|Patient not available for the 2y visit|18
5307|NCT02062437|30327|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
5308|NCT02062385|30340|P4|Overall Study|Lost to Follow-up|0
5309|NCT02062385|30341|P3|Overall Study|Lost to Follow-up|1
5310|NCT02062385|30342|P2|Overall Study|Lost to Follow-up|0
5311|NCT02062385|30343|P1|Overall Study|Lost to Follow-up|0
5312|NCT02062385|30340|P4|Overall Study|Death|1
5313|NCT02062385|30341|P3|Overall Study|Death|0
5314|NCT02062385|30342|P2|Overall Study|Death|0
5315|NCT02062385|30343|P1|Overall Study|Death|0
5316|NCT02062385|30340|P4|Overall Study|Withdrawn by parent/guardian|8
5317|NCT02062385|30341|P3|Overall Study|Withdrawn by parent/guardian|9
5318|NCT02062385|30342|P2|Overall Study|Withdrawn by parent/guardian|41
5319|NCT02062385|30343|P1|Overall Study|Withdrawn by parent/guardian|46
5320|NCT02062385|30340|P4|Overall Study|Moved|0
5321|NCT02062385|30341|P3|Overall Study|Moved|1
5322|NCT02062385|30342|P2|Overall Study|Moved|11
5323|NCT02062385|30343|P1|Overall Study|Moved|10
5324|NCT02062385|30340|P4|Overall Study|Incomplete EPI by database lock|0
5325|NCT02062385|30341|P3|Overall Study|Incomplete EPI by database lock|0
5326|NCT02062385|30342|P2|Overall Study|Incomplete EPI by database lock|0
5327|NCT02062385|30343|P1|Overall Study|Incomplete EPI by database lock|2
5328|NCT02062385|30340|P4|Overall Study|Protocol Violation|0
5329|NCT02062385|30341|P3|Overall Study|Protocol Violation|0
5330|NCT02062385|30342|P2|Overall Study|Protocol Violation|0
5331|NCT02062385|30343|P1|Overall Study|Protocol Violation|1
5332|NCT02062385|30340|P4|Overall Study|Adverse Event|0
5333|NCT02062385|30341|P3|Overall Study|Adverse Event|1
5334|NCT02062385|30342|P2|Overall Study|Adverse Event|13
5335|NCT02062385|30343|P1|Overall Study|Adverse Event|19
5336|NCT02061592|30394|P2|Period 2|Lost to Follow-up|1
5337|NCT02061592|30395|P1|Period 2|Lost to Follow-up|0
5338|NCT02061592|30394|P2|Period 1|Protocol Violation|0
5339|NCT02061592|30395|P1|Period 1|Protocol Violation|1
5340|NCT02061592|30394|P2|Period 1|Withdrawal by Subject|0
5341|NCT02061592|30395|P1|Period 1|Withdrawal by Subject|1
5342|NCT02058992|30629|P1|Overall Study|CRF Uncollected|20
5343|NCT02058992|30629|P1|Overall Study|Protocol Violation|92
5344|NCT02058992|30629|P1|Overall Study|Lost to Follow-up|4
5345|NCT02058537|30638|P1|Overall Study|Withdrawal by Subject|1
5346|NCT02058498|30644|P1|Overall Study|Withdrawal by Subject|4
5347|NCT02058290|30652|P2|Overall Study|Withdrawal by Subject|1
5348|NCT02058290|30653|P1|Overall Study|Withdrawal by Subject|0
5349|NCT02058290|30652|P2|Overall Study|Didn't meet intraoperative criteria|7
5350|NCT02058290|30653|P1|Overall Study|Didn't meet intraoperative criteria|8
5351|NCT02058290|30652|P2|Overall Study|Physician Decision|0
5352|NCT02058290|30653|P1|Overall Study|Physician Decision|1
5353|NCT02058290|30652|P2|Overall Study|Protocol Violation|1
5354|NCT02058290|30653|P1|Overall Study|Protocol Violation|2
5355|NCT02058160|30669|P2|Overall Study|Other than specified above|6
5356|NCT02058160|30670|P1|Overall Study|Other than specified above|12
5357|NCT02058160|30669|P2|Overall Study|Lost to Follow-up|0
5358|NCT02058160|30670|P1|Overall Study|Lost to Follow-up|1
5359|NCT02058160|30669|P2|Overall Study|Adverse Event|3
5360|NCT02058160|30670|P1|Overall Study|Adverse Event|12
5361|NCT02058160|30669|P2|Overall Study|Poor compliance to protocol|1
5362|NCT02058160|30670|P1|Overall Study|Poor compliance to protocol|4
5363|NCT02058160|30669|P2|Overall Study|Randomized but not treated|4
5364|NCT02058160|30670|P1|Overall Study|Randomized but not treated|2
5365|NCT02058147|30707|P3|Overall Study|Other than specified|0
5366|NCT02058147|30708|P2|Overall Study|Other than specified|9
5367|NCT02058147|30709|P1|Overall Study|Other than specified|8
5368|NCT02058147|30707|P3|Overall Study|Poor compliance to protocol|4
5369|NCT02058147|30708|P2|Overall Study|Poor compliance to protocol|9
5370|NCT02058147|30709|P1|Overall Study|Poor compliance to protocol|8
5371|NCT02058147|30707|P3|Overall Study|Lack of Efficacy|3
5372|NCT02058147|30708|P2|Overall Study|Lack of Efficacy|0
5373|NCT02058147|30709|P1|Overall Study|Lack of Efficacy|1
5374|NCT02058147|30707|P3|Overall Study|Adverse Event|21
5375|NCT02058147|30708|P2|Overall Study|Adverse Event|9
5376|NCT02058147|30709|P1|Overall Study|Adverse Event|12
5377|NCT02058147|30707|P3|Overall Study|Randomized but not treated|1
5378|NCT02058147|30708|P2|Overall Study|Randomized but not treated|0
5379|NCT02058147|30709|P1|Overall Study|Randomized but not treated|0
5380|NCT02058069|30758|P1|Overall Study|Withdrawal by Subject|6
5381|NCT02058069|30758|P1|Overall Study|Exclusion due to implant size|5
5382|NCT02057835|30776|P10|Overall Study|Withdrawal by Subject|0
5383|NCT02057835|30777|P9|Overall Study|Withdrawal by Subject|0
5384|NCT02057835|30778|P8|Overall Study|Withdrawal by Subject|0
5385|NCT02057835|30779|P7|Overall Study|Withdrawal by Subject|0
5386|NCT02057835|30780|P6|Overall Study|Withdrawal by Subject|0
5387|NCT02057835|30781|P5|Overall Study|Withdrawal by Subject|0
5388|NCT02057835|30782|P4|Overall Study|Withdrawal by Subject|0
5389|NCT02057835|30783|P3|Overall Study|Withdrawal by Subject|0
5390|NCT02057835|30784|P2|Overall Study|Withdrawal by Subject|2
5391|NCT02057835|30785|P1|Overall Study|Withdrawal by Subject|0
5392|NCT02056834|30880|P1|Overall Study|Lost to Follow-up|7
5393|NCT02056392|30905|P6|Overall Study|Withdrawal by Subject|0
5394|NCT02056392|30906|P5|Overall Study|Withdrawal by Subject|1
5395|NCT02056392|30907|P4|Overall Study|Withdrawal by Subject|0
5396|NCT02056392|30908|P3|Overall Study|Withdrawal by Subject|0
5397|NCT02056392|30909|P2|Overall Study|Withdrawal by Subject|0
5398|NCT02056392|30910|P1|Overall Study|Withdrawal by Subject|1
5399|NCT02056392|30905|P6|Overall Study|Protocol Violation|0
5400|NCT02056392|30906|P5|Overall Study|Protocol Violation|0
5401|NCT02056392|30907|P4|Overall Study|Protocol Violation|0
5402|NCT02056392|30908|P3|Overall Study|Protocol Violation|1
5403|NCT02056392|30909|P2|Overall Study|Protocol Violation|0
5404|NCT02056392|30910|P1|Overall Study|Protocol Violation|1
5405|NCT02056392|30905|P6|Overall Study|Lost to Follow-up|0
5406|NCT02056392|30906|P5|Overall Study|Lost to Follow-up|0
5407|NCT02056392|30907|P4|Overall Study|Lost to Follow-up|0
5408|NCT02056392|30908|P3|Overall Study|Lost to Follow-up|2
5409|NCT02056392|30909|P2|Overall Study|Lost to Follow-up|1
5410|NCT02056392|30910|P1|Overall Study|Lost to Follow-up|0
5411|NCT02054702|30991|P2|Overall Study|Withdrawal by Subject|4
5412|NCT02054702|30992|P1|Overall Study|Withdrawal by Subject|14
5413|NCT02054702|30991|P2|Overall Study|Physician Decision|1
5414|NCT02054702|30992|P1|Overall Study|Physician Decision|0
5415|NCT02054702|30991|P2|Overall Study|Met Withdrawal Criteria|1
5416|NCT02054702|30992|P1|Overall Study|Met Withdrawal Criteria|4
5417|NCT02054702|30991|P2|Overall Study|Adverse Event|1
5418|NCT02054702|30992|P1|Overall Study|Adverse Event|3
5419|NCT02054702|30991|P2|Overall Study|Lost to Follow-up|5
5420|NCT02054702|30992|P1|Overall Study|Lost to Follow-up|3
5421|NCT02054481|31024|P4|Overall Study|Other reason|0
5422|NCT02054481|31025|P3|Overall Study|Other reason|2
5423|NCT02054481|31026|P2|Overall Study|Other reason|1
5424|NCT02054481|31027|P1|Overall Study|Other reason|2
5425|NCT02054481|31024|P4|Overall Study|Lost to Follow-up|0
5426|NCT02054481|31025|P3|Overall Study|Lost to Follow-up|0
5427|NCT02054481|31026|P2|Overall Study|Lost to Follow-up|0
5428|NCT02054481|31027|P1|Overall Study|Lost to Follow-up|1
5429|NCT02054481|31024|P4|Overall Study|Adverse Event|1
5430|NCT02054481|31025|P3|Overall Study|Adverse Event|0
5431|NCT02054481|31026|P2|Overall Study|Adverse Event|1
5432|NCT02054481|31027|P1|Overall Study|Adverse Event|1
5433|NCT02054325|31075|P2|Overall Study|Lost to Follow-up|5
5434|NCT02054325|31076|P1|Overall Study|Lost to Follow-up|8
5435|NCT02053610|31086|P2|Overall Study|Failure to Return|3
5436|NCT02053610|31087|P1|Overall Study|Failure to Return|4
5437|NCT02053610|31086|P2|Overall Study|Did not Receive Treatment|2
5438|NCT02053610|31087|P1|Overall Study|Did not Receive Treatment|0
5439|NCT02053610|31086|P2|Overall Study|Refused treatment/Did not cooperate|0
5440|NCT02053610|31087|P1|Overall Study|Refused treatment/Did not cooperate|3
5441|NCT02053610|31086|P2|Overall Study|Disease Progression|94
5442|NCT02053610|31087|P1|Overall Study|Disease Progression|148
5443|NCT02053610|31086|P2|Overall Study|Administrative/Other|27
5444|NCT02053610|31087|P1|Overall Study|Administrative/Other|34
5445|NCT02053610|31086|P2|Overall Study|Death|25
5446|NCT02053610|31087|P1|Overall Study|Death|31
5447|NCT02053610|31086|P2|Overall Study|Withdrew Consent|14
5448|NCT02053610|31087|P1|Overall Study|Withdrew Consent|12
5449|NCT02053610|31086|P2|Overall Study|Adverse Event/Intercurrent Illness|9
5450|NCT02053610|31087|P1|Overall Study|Adverse Event/Intercurrent Illness|3
5451|NCT02053493|31119|P2|Overall Study|Withdrawal by Subject|1
5452|NCT02053493|31120|P1|Overall Study|Withdrawal by Subject|1
5453|NCT02052414|31226|P1|Overall Study|Withdrawal by Subject|3
5454|NCT02052414|31226|P1|Overall Study|Lack of Efficacy|2
5455|NCT02052414|31226|P1|Overall Study|Adverse Event|12
5456|NCT02050048|31325|P2|Overall Study|Ineligible after ERCP|1
5457|NCT02050048|31326|P1|Overall Study|Ineligible after ERCP|4
5458|NCT02050048|31325|P2|Overall Study|Death|0
5459|NCT02050048|31326|P1|Overall Study|Death|1
5460|NCT02050048|31325|P2|Overall Study|Lost to Follow-up|1
5461|NCT02050048|31326|P1|Overall Study|Lost to Follow-up|0
5462|NCT02048072|31354|P1|Overall Study|Lost to Follow-up|1
5463|NCT02048072|31354|P1|Overall Study|Adverse Event|3
5464|NCT02047227|31365|P2|Overall Study|Unspecified|9
5465|NCT02047227|31366|P1|Overall Study|Unspecified|10
5466|NCT02047227|31365|P2|Overall Study|All embryos discarded|11
5467|NCT02047227|31366|P1|Overall Study|All embryos discarded|12
5468|NCT02047227|31365|P2|Overall Study|Intention to freeze all embryos|0
5469|NCT02047227|31366|P1|Overall Study|Intention to freeze all embryos|1
5470|NCT02047227|31365|P2|Overall Study|No fertilization|51
5471|NCT02047227|31366|P1|Overall Study|No fertilization|61
5472|NCT02047227|31365|P2|Overall Study|No oocytes retrieved|20
5473|NCT02047227|31366|P1|Overall Study|No oocytes retrieved|21
5474|NCT02047227|31365|P2|Overall Study|Lack of ovarian response to stimulation|32
5475|NCT02047227|31366|P1|Overall Study|Lack of ovarian response to stimulation|35
5476|NCT02047227|31365|P2|Overall Study|Spontaneous pregnancy|0
5477|NCT02047227|31366|P1|Overall Study|Spontaneous pregnancy|1
5478|NCT02047227|31365|P2|Overall Study|Protocol Violation|0
5479|NCT02047227|31366|P1|Overall Study|Protocol Violation|1
5480|NCT02047227|31365|P2|Overall Study|Lost to Follow-up|3
5481|NCT02047227|31366|P1|Overall Study|Lost to Follow-up|0
5482|NCT02047227|31365|P2|Overall Study|Adverse Event|4
5483|NCT02047227|31366|P1|Overall Study|Adverse Event|2
5484|NCT02046993|31384|P2|Overall Study|Lost to Follow-up|1
5485|NCT02046993|31385|P1|Overall Study|Lost to Follow-up|1
5486|NCT02046993|31384|P2|Overall Study|Withdrawal by Subject|10
5487|NCT02046993|31385|P1|Overall Study|Withdrawal by Subject|2
5488|NCT02046226|31435|P1|Overall Study|Lost to Follow-up|7
5489|NCT02045732|31444|P2|Overall Study|At the discretion of the investigator|1
5490|NCT02045732|31445|P1|Overall Study|At the discretion of the investigator|1
5491|NCT02044848|31491|P2|Overall Study|Administrative Problems|3
5492|NCT02044848|31492|P1|Overall Study|Administrative Problems|2
5493|NCT02044458|31500|P2|Overall Study|Protocol Violation|8
5494|NCT02044458|31501|P1|Overall Study|Protocol Violation|3
5495|NCT02043782|31594|P6|Period 1|Adverse Event|0
5496|NCT02043782|31595|P5|Period 1|Adverse Event|0
5497|NCT02043782|31596|P4|Period 1|Adverse Event|0
5498|NCT02043782|31597|P3|Period 1|Adverse Event|1
5499|NCT02043782|31598|P2|Period 1|Adverse Event|0
5500|NCT02043782|31599|P1|Period 1|Adverse Event|0
5501|NCT02043366|31613|P6|Overall Study|Lost to Follow-up|2
5502|NCT02043366|31614|P5|Overall Study|Lost to Follow-up|2
5503|NCT02043366|31615|P4|Overall Study|Lost to Follow-up|2
5504|NCT02043366|31616|P3|Overall Study|Lost to Follow-up|2
5505|NCT02043366|31617|P2|Overall Study|Lost to Follow-up|2
5506|NCT02043366|31618|P1|Overall Study|Lost to Follow-up|2
5507|NCT02042404|31694|P2|Overall Study|Inability to meet time requirements|0
5508|NCT02042404|31695|P1|Overall Study|Inability to meet time requirements|1
5509|NCT02042404|31694|P2|Overall Study|Unrelated Adverse Event|0
5510|NCT02042404|31695|P1|Overall Study|Unrelated Adverse Event|3
5511|NCT02042404|31694|P2|Overall Study|Death|0
5512|NCT02042404|31695|P1|Overall Study|Death|1
5513|NCT02041520|31708|P2|Overall Study|Hypothiroidism identified during follow-|1
5514|NCT02041520|31709|P1|Overall Study|Hypothiroidism identified during follow-|0
5515|NCT02041520|31708|P2|Overall Study|Lost to Follow-up|1
5516|NCT02041520|31709|P1|Overall Study|Lost to Follow-up|0
5517|NCT02041520|31708|P2|Overall Study|Protocol Violation|0
5518|NCT02041520|31709|P1|Overall Study|Protocol Violation|1
5519|NCT02041520|31708|P2|Overall Study|Withdrawal by Subject|4
5520|NCT02041520|31709|P1|Overall Study|Withdrawal by Subject|3
5521|NCT02041520|31708|P2|Overall Study|Adverse Event|1
5522|NCT02041520|31709|P1|Overall Study|Adverse Event|2
5523|NCT02041286|31752|P1|Overall Study|Adverse Event|1
5524|NCT02039687|31835|P4|Overall Study|Withdrawal by Subject|0
5525|NCT02039687|31836|P3|Overall Study|Withdrawal by Subject|0
5526|NCT02039687|31837|P2|Overall Study|Withdrawal by Subject|1
5527|NCT02039687|31838|P1|Overall Study|Withdrawal by Subject|0
5528|NCT02039687|31835|P4|Overall Study|Adverse Event|0
5529|NCT02039687|31836|P3|Overall Study|Adverse Event|1
5530|NCT02039687|31837|P2|Overall Study|Adverse Event|0
5531|NCT02039687|31838|P1|Overall Study|Adverse Event|0
5532|NCT02039414|31858|P2|Overall Study|Protocol Violation|1
5533|NCT02039414|31859|P1|Overall Study|Protocol Violation|3
5534|NCT02039414|31858|P2|Overall Study|Lost to Follow-up|0
5535|NCT02039414|31859|P1|Overall Study|Lost to Follow-up|2
5536|NCT02039414|31858|P2|Overall Study|Delivered|1
5537|NCT02039414|31859|P1|Overall Study|Delivered|1
5538|NCT02038959|31873|P2|Overall Study|Withdrawal by Subject|8
5539|NCT02038959|31874|P1|Overall Study|Withdrawal by Subject|6
5540|NCT02038907|31914|P14|Overall Study|Withdrawal by Subject|0
5541|NCT02038907|31915|P13|Overall Study|Withdrawal by Subject|0
5542|NCT02038907|31916|P12|Overall Study|Withdrawal by Subject|0
5543|NCT02038907|31917|P11|Overall Study|Withdrawal by Subject|1
5544|NCT02038907|31918|P10|Overall Study|Withdrawal by Subject|0
5545|NCT02038907|31919|P9|Overall Study|Withdrawal by Subject|0
5546|NCT02038907|31920|P8|Overall Study|Withdrawal by Subject|0
5547|NCT02038907|31921|P7|Overall Study|Withdrawal by Subject|0
5548|NCT02038907|31922|P6|Overall Study|Withdrawal by Subject|0
5549|NCT02038907|31923|P5|Overall Study|Withdrawal by Subject|0
5550|NCT02038907|31924|P4|Overall Study|Withdrawal by Subject|0
5551|NCT02038907|31925|P3|Overall Study|Withdrawal by Subject|0
5552|NCT02038907|31926|P2|Overall Study|Withdrawal by Subject|0
5553|NCT02038907|31927|P1|Overall Study|Withdrawal by Subject|0
5554|NCT02038907|31914|P14|Overall Study|Protocol Violation|0
5555|NCT02038907|31915|P13|Overall Study|Protocol Violation|0
5556|NCT02038907|31916|P12|Overall Study|Protocol Violation|0
5557|NCT02038907|31917|P11|Overall Study|Protocol Violation|1
5558|NCT02038907|31918|P10|Overall Study|Protocol Violation|0
5559|NCT02038907|31919|P9|Overall Study|Protocol Violation|0
5560|NCT02038907|31920|P8|Overall Study|Protocol Violation|0
5561|NCT02038907|31921|P7|Overall Study|Protocol Violation|0
5562|NCT02038907|31922|P6|Overall Study|Protocol Violation|0
5563|NCT02038907|31923|P5|Overall Study|Protocol Violation|0
5564|NCT02038907|31924|P4|Overall Study|Protocol Violation|0
5565|NCT02038907|31925|P3|Overall Study|Protocol Violation|0
5566|NCT02038907|31926|P2|Overall Study|Protocol Violation|0
5567|NCT02038907|31927|P1|Overall Study|Protocol Violation|0
5568|NCT02038075|32457|P2|Overall Study|Withdrawal by Subject|0
5569|NCT02038075|32458|P1|Overall Study|Withdrawal by Subject|3
5570|NCT02037477|32468|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
5571|NCT02037477|32469|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
5572|NCT02037477|32470|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
5573|NCT02037477|32471|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
5574|NCT02036775|32549|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
5575|NCT02036775|32550|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5576|NCT02036775|32551|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5577|NCT02036775|32552|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5578|NCT02036775|32553|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5579|NCT02036775|32554|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
5580|NCT02035332|32603|P1|Overall Study|Procedure Aborted due to Uterine Width|1
5581|NCT02035748|32620|P1|Overall Study|Progressive Disease|1
5582|NCT02035748|32620|P1|Overall Study|Withdrawal by Subject|6
5583|NCT02035748|32620|P1|Overall Study|Physician Decision|3
5584|NCT02035748|32620|P1|Overall Study|Lost to Follow-up|2
5585|NCT02035748|32620|P1|Overall Study|Death|3
5586|NCT02035748|32620|P1|Overall Study|Adverse Event|5
5587|NCT02035475|32630|P1|Overall Study|Equipment Error|1
5588|NCT02035475|32630|P1|Overall Study|Physician Decision|1
5589|NCT02035475|32630|P1|Overall Study|Withdrawal by Subject|4
5590|NCT02034877|32643|P2|Overall Study|No Longer Willing to Participate|3
5591|NCT02034877|32644|P1|Overall Study|No Longer Willing to Participate|0
5592|NCT02034877|32643|P2|Overall Study|Lost to Follow-up|3
5593|NCT02034877|32644|P1|Overall Study|Lost to Follow-up|0
5594|NCT02034708|32662|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
5595|NCT02034708|32663|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
5596|NCT02034708|32662|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
5597|NCT02034708|32663|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
5598|NCT02034708|32662|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
5599|NCT02034708|32663|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
5600|NCT02034708|32662|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
5601|NCT02034708|32663|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
5602|NCT02034591|32674|P6|Overall Study|Withdrawal by Subject|0
5603|NCT02034591|32675|P5|Overall Study|Withdrawal by Subject|1
5604|NCT02034591|32676|P4|Overall Study|Withdrawal by Subject|0
5605|NCT02034591|32677|P3|Overall Study|Withdrawal by Subject|0
5606|NCT02034591|32678|P2|Overall Study|Withdrawal by Subject|0
5607|NCT02034591|32679|P1|Overall Study|Withdrawal by Subject|0
5608|NCT02034565|32734|P2|Overall Study|Adverse Event|0
5609|NCT02034565|32735|P1|Overall Study|Adverse Event|1
5610|NCT02034162|32751|P3|Double-blind|Withdrawal by Subject|0
5611|NCT02034162|32752|P2|Double-blind|Withdrawal by Subject|7
5612|NCT02034162|32753|P1|Double-blind|Withdrawal by Subject|5
5613|NCT02034162|32751|P3|Double-blind|Protocol Violation|0
5614|NCT02034162|32752|P2|Double-blind|Protocol Violation|1
5615|NCT02034162|32753|P1|Double-blind|Protocol Violation|0
5616|NCT02034162|32751|P3|Double-blind|Physician Decision|0
5617|NCT02034162|32752|P2|Double-blind|Physician Decision|0
5618|NCT02034162|32753|P1|Double-blind|Physician Decision|1
5619|NCT02034162|32751|P3|Double-blind|Lost to Follow-up|0
5620|NCT02034162|32752|P2|Double-blind|Lost to Follow-up|0
5621|NCT02034162|32753|P1|Double-blind|Lost to Follow-up|3
5622|NCT02032901|32836|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
5623|NCT02032901|32837|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
5624|NCT02032901|32836|P2|Treatment Period (12 Weeks)|Pregnancy|0
5625|NCT02032901|32837|P1|Treatment Period (12 Weeks)|Pregnancy|1
5626|NCT02032888|32861|P3|Follow-up Period|Not specified|0
5627|NCT02032888|32862|P2|Follow-up Period|Not specified|0
5628|NCT02032888|32863|P1|Follow-up Period|Not specified|1
5629|NCT02032888|32861|P3|Follow-up Period|Death|0
5630|NCT02032888|32862|P2|Follow-up Period|Death|1
5631|NCT02032888|32863|P1|Follow-up Period|Death|1
5632|NCT02032888|32861|P3|Follow-up Period|Lost to Follow-up|0
5633|NCT02032888|32862|P2|Follow-up Period|Lost to Follow-up|1
5634|NCT02032888|32863|P1|Follow-up Period|Lost to Follow-up|1
5635|NCT02032888|32861|P3|Treatment Period|Not specified|0
5636|NCT02032888|32862|P2|Treatment Period|Not specified|1
5637|NCT02032888|32863|P1|Treatment Period|Not specified|1
5638|NCT02032888|32861|P3|Treatment Period|Poor compliance/noncompliance|0
5639|NCT02032888|32862|P2|Treatment Period|Poor compliance/noncompliance|1
5640|NCT02032888|32863|P1|Treatment Period|Poor compliance/noncompliance|1
5641|NCT02032875|32894|P2|Follow-up Period|Virologic Relapse|10
5642|NCT02032875|32895|P1|Follow-up Period|Virologic Relapse|3
5643|NCT02032875|32894|P2|Follow-up Period|Death|1
5644|NCT02032875|32895|P1|Follow-up Period|Death|0
5645|NCT02032875|32894|P2|Treatment Period|Liver transplant, Treatment extension|3
5646|NCT02032875|32895|P1|Treatment Period|Liver transplant, Treatment extension|0
5647|NCT02032875|32894|P2|Treatment Period|Liver transplant, No extension needed|1
5648|NCT02032875|32895|P1|Treatment Period|Liver transplant, No extension needed|0
5649|NCT02032875|32894|P2|Treatment Period|Adverse Event|0
5650|NCT02032875|32895|P1|Treatment Period|Adverse Event|1
5651|NCT02032706|32924|P1|Overall Study|Protocol Violation|1
5652|NCT02032706|32924|P1|Overall Study|Did not qualify|5
5653|NCT02032407|32962|P1|Overall Study|Other Miscellaneous Reasons|2
5654|NCT02032407|32962|P1|Overall Study|Pregnancy|1
5655|NCT02032407|32962|P1|Overall Study|Lost to Follow-up|2
5656|NCT02031471|33006|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
5657|NCT02031471|33006|P1|Long Term Extension (LTE) Period|Adverse Event|1
5658|NCT02031471|33006|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
5659|NCT02031471|33006|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
5660|NCT02031471|33006|P1|24 Week Treatment Period|Protocol Violation|1
5661|NCT02031471|33006|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
5662|NCT02031471|33006|P1|24 Week Treatment Period|Adverse Event|6
5663|NCT02030600|33038|P2|Overall Study|Unclassified|0
5664|NCT02030600|33039|P1|Overall Study|Unclassified|2
5665|NCT02030600|33038|P2|Overall Study|Casebook unsigned|0
5666|NCT02030600|33039|P1|Overall Study|Casebook unsigned|1
5667|NCT02030600|33038|P2|Overall Study|Withdrawal by Subject|26
5668|NCT02030600|33039|P1|Overall Study|Withdrawal by Subject|26
5669|NCT02030600|33038|P2|Overall Study|Protocol Violation|19
5670|NCT02030600|33039|P1|Overall Study|Protocol Violation|23
5671|NCT02030600|33038|P2|Overall Study|Lost to Follow-up|5
5672|NCT02030600|33039|P1|Overall Study|Lost to Follow-up|15
5673|NCT02030600|33038|P2|Overall Study|Lack of Efficacy|2
5674|NCT02030600|33039|P1|Overall Study|Lack of Efficacy|2
5675|NCT02030600|33038|P2|Overall Study|Adverse Event|11
5676|NCT02030600|33039|P1|Overall Study|Adverse Event|9
5677|NCT02030535|33060|P1|Washout Period 1 (21 Days)|Adverse Event|1
5678|NCT02029989|33130|P2|Overall Study|Protocol Violation|0
5679|NCT02029989|33131|P1|Overall Study|Protocol Violation|1
5680|NCT02029989|33130|P2|Overall Study|Death|1
5681|NCT02029989|33131|P1|Overall Study|Death|0
5682|NCT02029989|33130|P2|Overall Study|Lost to Follow-up|7
5683|NCT02029989|33131|P1|Overall Study|Lost to Follow-up|9
5684|NCT02029989|33130|P2|Overall Study|Physician Decision|0
5685|NCT02029989|33131|P1|Overall Study|Physician Decision|2
5686|NCT02029989|33130|P2|Overall Study|Change of location|3
5687|NCT02029989|33131|P1|Overall Study|Change of location|2
5688|NCT02029989|33130|P2|Overall Study|Withdrawal: Fear of needles|0
5689|NCT02029989|33131|P1|Overall Study|Withdrawal: Fear of needles|1
5690|NCT02029989|33130|P2|Overall Study|Withdrawal by Subject|0
5691|NCT02029989|33131|P1|Overall Study|Withdrawal by Subject|1
5692|NCT02029521|33161|P2|Overall Study|Withdrawal by Subject|1
5693|NCT02029521|33162|P1|Overall Study|Withdrawal by Subject|1
5694|NCT02029521|33161|P2|Overall Study|Protocol Violation|0
5695|NCT02029521|33162|P1|Overall Study|Protocol Violation|1
5696|NCT02029417|33244|P1|Overall Study|Adverse Event|1
5697|NCT02029417|33244|P1|Overall Study|Death|1
5698|NCT02028767|33337|P2|Treatment Period 2|Reason other than those specified above|0
5699|NCT02028767|33338|P1|Treatment Period 2|Reason other than those specified above|1
5700|NCT02028767|33337|P2|Treatment Period 2|Non compliant with protocol|0
5701|NCT02028767|33338|P1|Treatment Period 2|Non compliant with protocol|1
5702|NCT02028065|33566|P3|Treatment Through Study Completion|Adverse Event|5
5703|NCT02028065|33567|P2|Treatment Through Study Completion|Adverse Event|3
5704|NCT02028065|33568|P1|Treatment Through Study Completion|Adverse Event|3
5705|NCT02028065|33566|P3|Treatment Through Study Completion|Withdrawal by Subject|3
5706|NCT02028065|33567|P2|Treatment Through Study Completion|Withdrawal by Subject|4
5707|NCT02028065|33568|P1|Treatment Through Study Completion|Withdrawal by Subject|5
5708|NCT02028065|33566|P3|Treatment Through Study Completion|Protocol Violation|0
5709|NCT02028065|33567|P2|Treatment Through Study Completion|Protocol Violation|4
5710|NCT02028065|33568|P1|Treatment Through Study Completion|Protocol Violation|1
5711|NCT02028065|33566|P3|Treatment Through Study Completion|Physician Decision|0
5712|NCT02028065|33567|P2|Treatment Through Study Completion|Physician Decision|0
5713|NCT02028065|33568|P1|Treatment Through Study Completion|Physician Decision|1
5714|NCT02028065|33566|P3|Treatment Through Study Completion|Lost to Follow-up|6
5715|NCT02028065|33567|P2|Treatment Through Study Completion|Lost to Follow-up|4
5716|NCT02028065|33568|P1|Treatment Through Study Completion|Lost to Follow-up|2
5717|NCT02028065|33566|P3|Randomization Through Start Treatment|Not treated|3
5718|NCT02028065|33567|P2|Randomization Through Start Treatment|Not treated|3
5719|NCT02028065|33568|P1|Randomization Through Start Treatment|Not treated|1
5720|NCT02027844|33595|P3|Overall Study|Incomlete data|0
5721|NCT02027844|33596|P2|Overall Study|Incomlete data|0
5722|NCT02027844|33597|P1|Overall Study|Incomlete data|2
5723|NCT02027844|33595|P3|Overall Study|Protocol Violation|0
5724|NCT02027844|33596|P2|Overall Study|Protocol Violation|2
5725|NCT02027844|33597|P1|Overall Study|Protocol Violation|0
5726|NCT02027844|33595|P3|Overall Study|Lost to Follow-up|1
5727|NCT02027844|33596|P2|Overall Study|Lost to Follow-up|2
5728|NCT02027844|33597|P1|Overall Study|Lost to Follow-up|0
5729|NCT02027844|33595|P3|Overall Study|Withdrawal by Subject|1
5730|NCT02027844|33596|P2|Overall Study|Withdrawal by Subject|2
5731|NCT02027844|33597|P1|Overall Study|Withdrawal by Subject|3
5732|NCT02027402|33616|P2|Overall Study|Withdrawal by Subject|1
5733|NCT02027402|33617|P1|Overall Study|Withdrawal by Subject|4
5734|NCT02027311|33631|P2|Overall Study|Protocol Violation|2
5735|NCT02027311|33632|P1|Overall Study|Protocol Violation|3
5736|NCT02026141|33671|P2|Overall Study|Protocol Violation|1
5737|NCT02026141|33672|P1|Overall Study|Protocol Violation|0
5738|NCT02025907|33680|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
5739|NCT02025907|33681|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
5740|NCT02025907|33680|P2|Overall Study|Adverse Event|1
5741|NCT02025907|33681|P1|Overall Study|Adverse Event|3
5742|NCT02025907|33680|P2|Overall Study|Lost to Follow-up|2
5743|NCT02025907|33681|P1|Overall Study|Lost to Follow-up|2
5744|NCT02025907|33680|P2|Overall Study|Physician Decision|0
5745|NCT02025907|33681|P1|Overall Study|Physician Decision|2
5746|NCT02025907|33680|P2|Overall Study|Protocol Violation|0
5747|NCT02025907|33681|P1|Overall Study|Protocol Violation|2
5748|NCT02025907|33680|P2|Overall Study|Withdrawal by Subject|8
5749|NCT02025907|33681|P1|Overall Study|Withdrawal by Subject|15
5750|NCT02025907|33680|P2|Overall Study|Lack of Efficacy|0
5751|NCT02025907|33681|P1|Overall Study|Lack of Efficacy|1
5752|NCT02024971|33724|P1|Overall Study|Lost to Follow-up|6
5753|NCT02024971|33724|P1|Overall Study|Data Not Available|30
5754|NCT02024867|33733|P2|Overall Study|Lost to Follow-up|4
5755|NCT02024867|33734|P1|Overall Study|Lost to Follow-up|6
5756|NCT02024867|33733|P2|Overall Study|Protocol Violation|3
5757|NCT02024867|33734|P1|Overall Study|Protocol Violation|3
5758|NCT02024698|33750|P2|First Intervention (7 Days)|Withdrawal by Subject|1
5759|NCT02024698|33751|P1|First Intervention (7 Days)|Withdrawal by Subject|0
5760|NCT02023268|33790|P2|Overall Study|Withdrawal by Subject|1
5761|NCT02023268|33791|P1|Overall Study|Withdrawal by Subject|0
5762|NCT02023268|33790|P2|Overall Study|Adverse Event|2
5763|NCT02023268|33791|P1|Overall Study|Adverse Event|0
5764|NCT02023268|33790|P2|Overall Study|Lack of Efficacy|1
5765|NCT02023268|33791|P1|Overall Study|Lack of Efficacy|0
5766|NCT02023112|33862|P2|Overall Study|Withdrawal by Subject|1
5767|NCT02023112|33863|P1|Overall Study|Withdrawal by Subject|2
5768|NCT02023099|33884|P3|Overall Study|Non-treatment-emergent Fatal AE|1
5769|NCT02023099|33885|P2|Overall Study|Non-treatment-emergent Fatal AE|0
5770|NCT02023099|33886|P1|Overall Study|Non-treatment-emergent Fatal AE|0
5771|NCT02023099|33884|P3|Overall Study|Withdrawn Consent|1
5772|NCT02023099|33885|P2|Overall Study|Withdrawn Consent|0
5773|NCT02023099|33886|P1|Overall Study|Withdrawn Consent|3
5774|NCT02023099|33884|P3|Overall Study|Non-fatal Adverse Event (AE)|1
5775|NCT02023099|33885|P2|Overall Study|Non-fatal Adverse Event (AE)|0
5776|NCT02023099|33886|P1|Overall Study|Non-fatal Adverse Event (AE)|0
5777|NCT02022670|33905|P3|Overall Study|Adverse Event|1
5778|NCT02022670|33906|P2|Overall Study|Adverse Event|0
5779|NCT02022670|33907|P1|Overall Study|Adverse Event|1
5780|NCT02020941|33964|P1|Overall Study|Disease Progression|4
5781|NCT02020941|33964|P1|Overall Study|Withdrawal by Subject|1
5782|NCT02020941|33964|P1|Overall Study|Physician Decision|2
5783|NCT02020941|33964|P1|Overall Study|Adverse Event|1
5784|NCT02020863|33973|P1|Overall Study|Team chose not to place an a line|1
5785|NCT02020863|33973|P1|Overall Study|Discovery of Metastatic disease|4
5786|NCT02020577|33979|P2|Overall Study|Withdrawal by Subject|1
5787|NCT02020577|33980|P1|Overall Study|Withdrawal by Subject|0
5788|NCT02020577|33979|P2|Overall Study|Other AE or clinical progression|15
5789|NCT02020577|33980|P1|Overall Study|Other AE or clinical progression|0
5790|NCT02020577|33979|P2|Overall Study|Progressive disease|36
5791|NCT02020577|33980|P1|Overall Study|Progressive disease|3
5792|NCT02020512|33990|P1|Overall Study|Protocol Violation|4
5793|NCT02020512|33990|P1|Overall Study|Lost to Follow-up|3
5794|NCT02020512|33990|P1|Overall Study|Adverse Event|1
5795|NCT02020031|33996|P2|Overall Study|Physician Decision|1
5796|NCT02020031|33997|P1|Overall Study|Physician Decision|1
5797|NCT02017015|34044|P1|Overall Study|Physician Decision|2
5798|NCT02017015|34044|P1|Overall Study|Non-compliance with study drug|2
5799|NCT02017015|34044|P1|Overall Study|Progressive Disease|31
5800|NCT02017015|34044|P1|Overall Study|Death|4
5801|NCT02017015|34044|P1|Overall Study|Withdrawal by Subject|21
5802|NCT02017015|34044|P1|Overall Study|Adverse Event|9
5803|NCT02016690|34067|P1|Overall Study|Hospitalized for RSV at study start|3
5804|NCT02016690|34067|P1|Overall Study|Did not meet inclusion criteria|13
5805|NCT02016690|34067|P1|Overall Study|Excluded from SAS: Ineligible for study|2
5806|NCT02016690|34067|P1|Overall Study|Excluded from SAS: Early treatment|2
5807|NCT02016690|34067|P1|Overall Study|Excluded from SAS: Duplication|2
5808|NCT02016690|34067|P1|Overall Study|Excluded from SAS: Enrollment violation|2
5809|NCT02016625|34080|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
5810|NCT02016625|34081|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
5811|NCT02016625|34080|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
5812|NCT02016625|34081|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
5813|NCT02016625|34080|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
5814|NCT02016625|34081|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
5815|NCT02016482|34115|P2|Period B|Missing|1
5816|NCT02016482|34116|P1|Period B|Missing|0
5817|NCT02016482|34115|P2|Period B|Required Alternative/Prohibited Therapy|2
5818|NCT02016482|34116|P1|Period B|Required Alternative/Prohibited Therapy|0
5819|NCT02016482|34115|P2|Period B|Not Specified|0
5820|NCT02016482|34116|P1|Period B|Not Specified|3
5821|NCT02016482|34115|P2|Period B|Lack of Efficacy|3
5822|NCT02016482|34116|P1|Period B|Lack of Efficacy|4
5823|NCT02016482|34115|P2|Period B|Lost to Follow-up|0
5824|NCT02016482|34116|P1|Period B|Lost to Follow-up|1
5825|NCT02016482|34115|P2|Period B|Withdrawal by Subject|1
5826|NCT02016482|34116|P1|Period B|Withdrawal by Subject|1
5827|NCT02016482|34115|P2|Period A|Required Alternative/Prohibited Therapy|1
5828|NCT02016482|34116|P1|Period A|Required Alternative/Prohibited Therapy|0
5829|NCT02016482|34115|P2|Period A|Protocol Violation|1
5830|NCT02016482|34116|P1|Period A|Protocol Violation|0
5831|NCT02016482|34115|P2|Period A|Not Specified|0
5832|NCT02016482|34116|P1|Period A|Not Specified|3
5833|NCT02016482|34115|P2|Period A|Lack of Efficacy|1
5834|NCT02016482|34116|P1|Period A|Lack of Efficacy|2
5835|NCT02016482|34115|P2|Period A|Lost to Follow-up|3
5836|NCT02016482|34116|P1|Period A|Lost to Follow-up|3
5837|NCT02016482|34115|P2|Period A|Withdrawal by Subject|4
5838|NCT02016482|34116|P1|Period A|Withdrawal by Subject|3
5839|NCT02016482|34115|P2|Period A|Adverse Event|5
5840|NCT02016482|34116|P1|Period A|Adverse Event|3
5841|NCT02016170|34207|P3|Overall Study|Protocol Violation|0
5842|NCT02016170|34208|P2|Overall Study|Protocol Violation|0
5843|NCT02016170|34209|P1|Overall Study|Protocol Violation|1
5844|NCT02016170|34207|P3|Overall Study|Adverse Event|0
5845|NCT02016170|34208|P2|Overall Study|Adverse Event|1
5846|NCT02016170|34209|P1|Overall Study|Adverse Event|1
5847|NCT02015793|34229|P2|Overall Study|Withdrawal by Subject|1
5848|NCT02015793|34230|P1|Overall Study|Withdrawal by Subject|1
5849|NCT02015793|34229|P2|Overall Study|Adverse Event|3
5850|NCT02015793|34230|P1|Overall Study|Adverse Event|3
5851|NCT02015676|34263|P3|Overall Study|Disease progression|1
5852|NCT02015676|34264|P2|Overall Study|Disease progression|1
5853|NCT02015676|34265|P1|Overall Study|Disease progression|3
5854|NCT02015676|34263|P3|Overall Study|Death|0
5855|NCT02015676|34264|P2|Overall Study|Death|1
5856|NCT02015676|34265|P1|Overall Study|Death|0
5857|NCT02015676|34263|P3|Overall Study|Administrative reasons|1
5858|NCT02015676|34264|P2|Overall Study|Administrative reasons|3
5859|NCT02015676|34265|P1|Overall Study|Administrative reasons|0
5860|NCT02015676|34263|P3|Overall Study|Withdrawal by Subject|1
5861|NCT02015676|34264|P2|Overall Study|Withdrawal by Subject|7
5862|NCT02015676|34265|P1|Overall Study|Withdrawal by Subject|1
5863|NCT02015676|34263|P3|Overall Study|Protocol Violation|0
5864|NCT02015676|34264|P2|Overall Study|Protocol Violation|0
5865|NCT02015676|34265|P1|Overall Study|Protocol Violation|1
5866|NCT02015676|34263|P3|Overall Study|Lack of Efficacy|0
5867|NCT02015676|34264|P2|Overall Study|Lack of Efficacy|4
5868|NCT02015676|34265|P1|Overall Study|Lack of Efficacy|2
5869|NCT02015676|34263|P3|Overall Study|Adverse Event|0
5870|NCT02015676|34264|P2|Overall Study|Adverse Event|18
5871|NCT02015676|34265|P1|Overall Study|Adverse Event|2
5872|NCT02015546|34282|P3|Overall Study|Screem Failure|3
5873|NCT02015546|34283|P2|Overall Study|Screem Failure|1
5874|NCT02015546|34284|P1|Overall Study|Screem Failure|2
5875|NCT02015546|34282|P3|Overall Study|Withdrawal by Subject|1
5876|NCT02015546|34283|P2|Overall Study|Withdrawal by Subject|1
5877|NCT02015546|34284|P1|Overall Study|Withdrawal by Subject|1
5878|NCT02015221|34318|P2|Overall Study|Lost to Follow-up|0
5879|NCT02015221|34319|P1|Overall Study|Lost to Follow-up|1
5880|NCT02015221|34318|P2|Overall Study|Withdrawal by Subject|6
5881|NCT02015221|34319|P1|Overall Study|Withdrawal by Subject|8
5882|NCT02015195|34332|P7|Overall Study|Adverse Event|0
5883|NCT02015195|34333|P6|Overall Study|Adverse Event|0
5884|NCT02015195|34334|P5|Overall Study|Adverse Event|0
5885|NCT02015195|34335|P4|Overall Study|Adverse Event|1
5886|NCT02015195|34336|P3|Overall Study|Adverse Event|0
5887|NCT02015195|34337|P2|Overall Study|Adverse Event|0
5888|NCT02015195|34338|P1|Overall Study|Adverse Event|0
5889|NCT02014480|34359|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
5890|NCT02014480|34360|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5891|NCT02014480|34361|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5892|NCT02014480|34362|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5893|NCT02014480|34363|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5894|NCT02014480|34364|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
5895|NCT02014480|34359|P6|Treatment Period 3 (14 Days)|Adverse Event|1
5896|NCT02014480|34360|P5|Treatment Period 3 (14 Days)|Adverse Event|0
5897|NCT02014480|34361|P4|Treatment Period 3 (14 Days)|Adverse Event|0
5898|NCT02014480|34362|P3|Treatment Period 3 (14 Days)|Adverse Event|1
5899|NCT02014480|34363|P2|Treatment Period 3 (14 Days)|Adverse Event|0
5900|NCT02014480|34364|P1|Treatment Period 3 (14 Days)|Adverse Event|0
5901|NCT02014480|34359|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5902|NCT02014480|34360|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5903|NCT02014480|34361|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5904|NCT02014480|34362|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5905|NCT02014480|34363|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
5906|NCT02014480|34364|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
5907|NCT02014480|34359|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
5908|NCT02014480|34360|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
5909|NCT02014480|34361|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
5910|NCT02014480|34362|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
5911|NCT02014480|34363|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
5912|NCT02014480|34364|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
5913|NCT02014480|34359|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5914|NCT02014480|34360|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5915|NCT02014480|34361|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5916|NCT02014480|34362|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
5917|NCT02014480|34363|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5918|NCT02014480|34364|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
5919|NCT02014480|34359|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5920|NCT02014480|34360|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5921|NCT02014480|34361|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
5922|NCT02014480|34362|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5923|NCT02014480|34363|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
5924|NCT02014480|34364|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
5925|NCT02014480|34359|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5926|NCT02014480|34360|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5927|NCT02014480|34361|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5928|NCT02014480|34362|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
5929|NCT02014480|34363|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5930|NCT02014480|34364|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
5931|NCT02014467|34383|P2|Overall Study|Withdrawal by Subject|4
5932|NCT02014467|34384|P1|Overall Study|Withdrawal by Subject|16
5933|NCT02014467|34383|P2|Overall Study|Physician Decision|3
5934|NCT02014467|34384|P1|Overall Study|Physician Decision|2
5935|NCT02014467|34383|P2|Overall Study|Protocol Violation|0
5936|NCT02014467|34384|P1|Overall Study|Protocol Violation|3
5937|NCT02014467|34383|P2|Overall Study|Adverse Event|0
5938|NCT02014467|34384|P1|Overall Study|Adverse Event|4
5939|NCT02014441|34444|P1|Overall Study|Continuing in Study|21
5940|NCT02014441|34444|P1|Overall Study|Withdrawal by Subject|9
5941|NCT02014272|34549|P2|Intervention Period 1|Adverse Event|1
5942|NCT02014272|34550|P1|Intervention Period 1|Adverse Event|0
5943|NCT02014272|34549|P2|Intervention Period 1|Withdrawal by Subject|0
5944|NCT02014272|34550|P1|Intervention Period 1|Withdrawal by Subject|1
5945|NCT02013830|34582|P1|Overall Study|Refused treatment|1
5946|NCT02013830|34582|P1|Overall Study|Insufficient therapeutic response|25
5947|NCT02013830|34582|P1|Overall Study|Death|1
5948|NCT02013830|34582|P1|Overall Study|Adverse Event|3
5949|NCT02013817|34593|P1|Overall Study|Not specified|9
5950|NCT02013817|34593|P1|Overall Study|Death|2
5951|NCT02013817|34593|P1|Overall Study|Withdrawal by Subject|4
5952|NCT02013817|34593|P1|Overall Study|Adverse Event|12
5953|NCT02013765|34602|P1|Overall Study|Trial was terminated by sponsor|1
5954|NCT02013687|34616|P4|Overall Study|Missed visits due to patient travel|0
5955|NCT02013687|34617|P3|Overall Study|Missed visits due to patient travel|1
5956|NCT02013687|34618|P2|Overall Study|Missed visits due to patient travel|0
5957|NCT02013687|34619|P1|Overall Study|Missed visits due to patient travel|0
5958|NCT02013687|34616|P4|Overall Study|Withdrawal by Subject|1
5959|NCT02013687|34617|P3|Overall Study|Withdrawal by Subject|0
5960|NCT02013687|34618|P2|Overall Study|Withdrawal by Subject|0
5961|NCT02013687|34619|P1|Overall Study|Withdrawal by Subject|0
5962|NCT02013687|34616|P4|Overall Study|Protocol Violation|1
5963|NCT02013687|34617|P3|Overall Study|Protocol Violation|0
5964|NCT02013687|34618|P2|Overall Study|Protocol Violation|0
5965|NCT02013687|34619|P1|Overall Study|Protocol Violation|0
5966|NCT02013687|34616|P4|Overall Study|Lost to Follow-up|0
5967|NCT02013687|34617|P3|Overall Study|Lost to Follow-up|1
5968|NCT02013687|34618|P2|Overall Study|Lost to Follow-up|0
5969|NCT02013687|34619|P1|Overall Study|Lost to Follow-up|0
5970|NCT02013622|34649|P1|Overall Study|Lack of Efficacy|1
5971|NCT02013622|34649|P1|Overall Study|Protocol Deviation|1
5972|NCT02013622|34649|P1|Overall Study|Withdrawal by Subject|6
5973|NCT02013622|34649|P1|Overall Study|Met Withdrawal Criteria|3
5974|NCT02013622|34649|P1|Overall Study|Adverse Event|3
5975|NCT02013622|34649|P1|Overall Study|Lost to Follow-up|10
5976|NCT02013609|34669|P1|Overall Study|Met Withdrawal Criteria|3
5977|NCT02013609|34669|P1|Overall Study|Adverse Event|3
5978|NCT02013609|34669|P1|Overall Study|Lost to Follow-up|3
5979|NCT02013609|34669|P1|Overall Study|Withdrawal by Subject|9
5980|NCT02013531|34692|P1|Overall Study|Withdrawal by Subject|1
5981|NCT02013531|34692|P1|Overall Study|Met Withdrawal Criteria|1
5982|NCT02013531|34692|P1|Overall Study|Lost to Follow-up|3
5983|NCT02013388|34722|P8|Overall Study|work emergency|0
5984|NCT02013388|34723|P7|Overall Study|work emergency|0
5985|NCT02013388|34724|P6|Overall Study|work emergency|0
5986|NCT02013388|34725|P5|Overall Study|work emergency|1
5987|NCT02013388|34726|P4|Overall Study|work emergency|0
5988|NCT02013388|34727|P3|Overall Study|work emergency|0
5989|NCT02013388|34728|P2|Overall Study|work emergency|0
5990|NCT02013388|34729|P1|Overall Study|work emergency|1
5991|NCT02013206|34765|P2|Overall Study|Other reasons off treatment|2
5992|NCT02013206|34766|P1|Overall Study|Other reasons off treatment|5
5993|NCT02013206|34765|P2|Overall Study|Death|2
5994|NCT02013206|34766|P1|Overall Study|Death|1
5995|NCT02013206|34765|P2|Overall Study|Patient non-compliance|0
5996|NCT02013206|34766|P1|Overall Study|Patient non-compliance|1
5997|NCT02013206|34765|P2|Overall Study|Patient refusal|0
5998|NCT02013206|34766|P1|Overall Study|Patient refusal|2
5999|NCT02013206|34765|P2|Overall Study|Adverse Event|0
6000|NCT02013206|34766|P1|Overall Study|Adverse Event|1
6001|NCT02013206|34765|P2|Overall Study|Symptomatic deterioration|1
6002|NCT02013206|34766|P1|Overall Study|Symptomatic deterioration|3
6003|NCT02013206|34765|P2|Overall Study|Progressive disease (PD)|17
6004|NCT02013206|34766|P1|Overall Study|Progressive disease (PD)|14
6005|NCT02012686|34788|P2|Overall Study|electrocardiography monitoring noise|1
6006|NCT02012686|34789|P1|Overall Study|electrocardiography monitoring noise|0
6007|NCT02012686|34788|P2|Overall Study|muscle contraction|1
6008|NCT02012686|34789|P1|Overall Study|muscle contraction|0
6009|NCT02012452|34836|P2|Overall Study|Withdrawal by Subject|0
6010|NCT02012452|34837|P1|Overall Study|Withdrawal by Subject|4
6011|NCT02012452|34836|P2|Overall Study|Lost to Follow-up|1
6012|NCT02012452|34837|P1|Overall Study|Lost to Follow-up|2
6013|NCT02012218|34850|P5|Overall Study|Protocol Deviation|0
6014|NCT02012218|34851|P4|Overall Study|Protocol Deviation|0
6015|NCT02012218|34852|P3|Overall Study|Protocol Deviation|0
6016|NCT02012218|34853|P2|Overall Study|Protocol Deviation|0
6017|NCT02012218|34854|P1|Overall Study|Protocol Deviation|1
6018|NCT02012218|34850|P5|Overall Study|Protocol Specified|0
6019|NCT02012218|34851|P4|Overall Study|Protocol Specified|0
6020|NCT02012218|34852|P3|Overall Study|Protocol Specified|0
6021|NCT02012218|34853|P2|Overall Study|Protocol Specified|0
6022|NCT02012218|34854|P1|Overall Study|Protocol Specified|1
6023|NCT02012218|34850|P5|Overall Study|Lost to Follow-up|0
6024|NCT02012218|34851|P4|Overall Study|Lost to Follow-up|0
6025|NCT02012218|34852|P3|Overall Study|Lost to Follow-up|1
6026|NCT02012218|34853|P2|Overall Study|Lost to Follow-up|1
6027|NCT02012218|34854|P1|Overall Study|Lost to Follow-up|0
6028|NCT02012218|34850|P5|Overall Study|Adverse Event|0
6029|NCT02012218|34851|P4|Overall Study|Adverse Event|1
6030|NCT02012218|34852|P3|Overall Study|Adverse Event|0
6031|NCT02012218|34853|P2|Overall Study|Adverse Event|0
6032|NCT02012218|34854|P1|Overall Study|Adverse Event|1
6033|NCT02012218|34850|P5|Overall Study|Withdrawal by Subject|1
6034|NCT02012218|34851|P4|Overall Study|Withdrawal by Subject|1
6035|NCT02012218|34852|P3|Overall Study|Withdrawal by Subject|1
6036|NCT02012218|34853|P2|Overall Study|Withdrawal by Subject|0
6037|NCT02012218|34854|P1|Overall Study|Withdrawal by Subject|1
6038|NCT02011113|34960|P1|Overall Study|Study terminated by sponsor|11
6039|NCT02011113|34960|P1|Overall Study|Investigator's judgement- DP|3
6040|NCT02011113|34960|P1|Overall Study|Insufficient effect of Pomalidomide|1
6041|NCT02011113|34960|P1|Overall Study|Death|1
6042|NCT02011113|34960|P1|Overall Study|Disease Progression (DP)|16
6043|NCT02011113|34960|P1|Overall Study|Adverse Event|4
6044|NCT02010684|34989|P2|Overall Study|Withdrawal by Subject|5
6045|NCT02010684|34990|P1|Overall Study|Withdrawal by Subject|4
6046|NCT02010684|34989|P2|Overall Study|Lost to Follow-up|18
6047|NCT02010684|34990|P1|Overall Study|Lost to Follow-up|8
6048|NCT02010632|35008|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
6049|NCT02010632|35009|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
6050|NCT02010255|35029|P14|Overall Study|Randomized but Not Treated|1
6051|NCT02010255|35030|P13|Overall Study|Randomized but Not Treated|0
6052|NCT02010255|35031|P12|Overall Study|Randomized but Not Treated|0
6053|NCT02010255|35032|P11|Overall Study|Randomized but Not Treated|0
6054|NCT02010255|35033|P10|Overall Study|Randomized but Not Treated|0
6055|NCT02010255|35034|P9|Overall Study|Randomized but Not Treated|0
6056|NCT02010255|35035|P8|Overall Study|Randomized but Not Treated|0
6057|NCT02010255|35036|P7|Overall Study|Randomized but Not Treated|0
6058|NCT02010255|35037|P6|Overall Study|Randomized but Not Treated|0
6059|NCT02010255|35038|P5|Overall Study|Randomized but Not Treated|0
6060|NCT02010255|35039|P4|Overall Study|Randomized but Not Treated|0
6061|NCT02010255|35040|P3|Overall Study|Randomized but Not Treated|0
6062|NCT02010255|35041|P2|Overall Study|Randomized but Not Treated|0
6063|NCT02010255|35042|P1|Overall Study|Randomized but Not Treated|0
6064|NCT02010255|35029|P14|Overall Study|Lost to Follow-up|0
6065|NCT02010255|35030|P13|Overall Study|Lost to Follow-up|0
6066|NCT02010255|35031|P12|Overall Study|Lost to Follow-up|0
6067|NCT02010255|35032|P11|Overall Study|Lost to Follow-up|0
6068|NCT02010255|35033|P10|Overall Study|Lost to Follow-up|0
6069|NCT02010255|35034|P9|Overall Study|Lost to Follow-up|0
6070|NCT02010255|35035|P8|Overall Study|Lost to Follow-up|0
6071|NCT02010255|35036|P7|Overall Study|Lost to Follow-up|0
6072|NCT02010255|35037|P6|Overall Study|Lost to Follow-up|0
6073|NCT02010255|35038|P5|Overall Study|Lost to Follow-up|1
6074|NCT02010255|35039|P4|Overall Study|Lost to Follow-up|0
6075|NCT02010255|35040|P3|Overall Study|Lost to Follow-up|1
6076|NCT02010255|35041|P2|Overall Study|Lost to Follow-up|0
6077|NCT02010255|35042|P1|Overall Study|Lost to Follow-up|0
6078|NCT02010255|35029|P14|Overall Study|Adverse Event|0
6079|NCT02010255|35030|P13|Overall Study|Adverse Event|0
6080|NCT02010255|35031|P12|Overall Study|Adverse Event|0
6081|NCT02010255|35032|P11|Overall Study|Adverse Event|0
6082|NCT02010255|35033|P10|Overall Study|Adverse Event|0
6083|NCT02010255|35034|P9|Overall Study|Adverse Event|0
6084|NCT02010255|35035|P8|Overall Study|Adverse Event|0
6085|NCT02010255|35036|P7|Overall Study|Adverse Event|0
6086|NCT02010255|35037|P6|Overall Study|Adverse Event|0
6087|NCT02010255|35038|P5|Overall Study|Adverse Event|0
6088|NCT02010255|35039|P4|Overall Study|Adverse Event|0
6089|NCT02010255|35040|P3|Overall Study|Adverse Event|0
6090|NCT02010255|35041|P2|Overall Study|Adverse Event|0
6091|NCT02010255|35042|P1|Overall Study|Adverse Event|1
6092|NCT02010255|35029|P14|Overall Study|Withdrew Consent|0
6093|NCT02010255|35030|P13|Overall Study|Withdrew Consent|0
6094|NCT02010255|35031|P12|Overall Study|Withdrew Consent|0
6095|NCT02010255|35032|P11|Overall Study|Withdrew Consent|0
6096|NCT02010255|35033|P10|Overall Study|Withdrew Consent|0
6097|NCT02010255|35034|P9|Overall Study|Withdrew Consent|0
6098|NCT02010255|35035|P8|Overall Study|Withdrew Consent|0
6099|NCT02010255|35036|P7|Overall Study|Withdrew Consent|0
6100|NCT02010255|35037|P6|Overall Study|Withdrew Consent|0
6101|NCT02010255|35038|P5|Overall Study|Withdrew Consent|0
6102|NCT02010255|35039|P4|Overall Study|Withdrew Consent|1
6103|NCT02010255|35040|P3|Overall Study|Withdrew Consent|0
6104|NCT02010255|35041|P2|Overall Study|Withdrew Consent|0
6105|NCT02010255|35042|P1|Overall Study|Withdrew Consent|1
6106|NCT02010255|35029|P14|Overall Study|Lack of Efficacy|0
6107|NCT02010255|35030|P13|Overall Study|Lack of Efficacy|0
6108|NCT02010255|35031|P12|Overall Study|Lack of Efficacy|0
6109|NCT02010255|35032|P11|Overall Study|Lack of Efficacy|1
6110|NCT02010255|35033|P10|Overall Study|Lack of Efficacy|0
6111|NCT02010255|35034|P9|Overall Study|Lack of Efficacy|0
6112|NCT02010255|35035|P8|Overall Study|Lack of Efficacy|0
6113|NCT02010255|35036|P7|Overall Study|Lack of Efficacy|0
6114|NCT02010255|35037|P6|Overall Study|Lack of Efficacy|0
6115|NCT02010255|35038|P5|Overall Study|Lack of Efficacy|1
6116|NCT02010255|35039|P4|Overall Study|Lack of Efficacy|1
6117|NCT02010255|35040|P3|Overall Study|Lack of Efficacy|2
6118|NCT02010255|35041|P2|Overall Study|Lack of Efficacy|1
6119|NCT02010255|35042|P1|Overall Study|Lack of Efficacy|4
6120|NCT02010255|35029|P14|Overall Study|Death|0
6121|NCT02010255|35030|P13|Overall Study|Death|0
6122|NCT02010255|35031|P12|Overall Study|Death|1
6123|NCT02010255|35032|P11|Overall Study|Death|1
6124|NCT02010255|35033|P10|Overall Study|Death|0
6125|NCT02010255|35034|P9|Overall Study|Death|1
6126|NCT02010255|35035|P8|Overall Study|Death|1
6127|NCT02010255|35036|P7|Overall Study|Death|1
6128|NCT02010255|35037|P6|Overall Study|Death|0
6129|NCT02010255|35038|P5|Overall Study|Death|2
6130|NCT02010255|35039|P4|Overall Study|Death|4
6131|NCT02010255|35040|P3|Overall Study|Death|4
6132|NCT02010255|35041|P2|Overall Study|Death|1
6133|NCT02010255|35042|P1|Overall Study|Death|0
6134|NCT02009878|35386|P3|Overall Study|Participant Met Withdrawal Criteria|0
6135|NCT02009878|35387|P2|Overall Study|Participant Met Withdrawal Criteria|1
6136|NCT02009878|35388|P1|Overall Study|Participant Met Withdrawal Criteria|0
6137|NCT02009865|35422|P2|Overall Study|Withdrawal by Subject|1
6138|NCT02009865|35423|P1|Overall Study|Withdrawal by Subject|1
6139|NCT02009865|35422|P2|Overall Study|Protocol Violation|2
6140|NCT02009865|35423|P1|Overall Study|Protocol Violation|0
6141|NCT02009865|35422|P2|Overall Study|Adverse Event|2
6142|NCT02009865|35423|P1|Overall Study|Adverse Event|0
6143|NCT02009722|35439|P2|Overall Study|Did not receive intervention|1
6144|NCT02009722|35440|P1|Overall Study|Did not receive intervention|0
6145|NCT02009722|35439|P2|Overall Study|Protocol Violation|2
6146|NCT02009722|35440|P1|Overall Study|Protocol Violation|1
6147|NCT02009696|35464|P1|Overall Study|Withdrawal by Subject|2
6148|NCT02009163|35472|P3|Randomized-withdrawal Period|Not specified|5
6149|NCT02009163|35473|P2|Randomized-withdrawal Period|Not specified|9
6150|NCT02009163|35474|P1|Randomized-withdrawal Period|Not specified|0
6151|NCT02009163|35472|P3|Randomized-withdrawal Period|Pregnancy|2
6152|NCT02009163|35473|P2|Randomized-withdrawal Period|Pregnancy|0
6153|NCT02009163|35474|P1|Randomized-withdrawal Period|Pregnancy|0
6154|NCT02009163|35472|P3|Randomized-withdrawal Period|Protocol Violation|2
6155|NCT02009163|35473|P2|Randomized-withdrawal Period|Protocol Violation|1
6156|NCT02009163|35474|P1|Randomized-withdrawal Period|Protocol Violation|0
6157|NCT02009163|35472|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
6158|NCT02009163|35473|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
6159|NCT02009163|35474|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
6160|NCT02009163|35472|P3|Randomized-withdrawal Period|Adverse Event|6
6161|NCT02009163|35473|P2|Randomized-withdrawal Period|Adverse Event|0
6162|NCT02009163|35474|P1|Randomized-withdrawal Period|Adverse Event|0
6163|NCT02009163|35472|P3|Randomized-withdrawal Period|Lost to Follow-up|6
6164|NCT02009163|35473|P2|Randomized-withdrawal Period|Lost to Follow-up|13
6165|NCT02009163|35474|P1|Randomized-withdrawal Period|Lost to Follow-up|0
6166|NCT02009163|35472|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
6167|NCT02009163|35473|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
6168|NCT02009163|35474|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
6169|NCT02009163|35472|P3|Open-label Period (Non-randomized)|Not specified|0
6170|NCT02009163|35473|P2|Open-label Period (Non-randomized)|Not specified|0
6171|NCT02009163|35474|P1|Open-label Period (Non-randomized)|Not specified|13
6172|NCT02009163|35472|P3|Open-label Period (Non-randomized)|Pregnancy|0
6173|NCT02009163|35473|P2|Open-label Period (Non-randomized)|Pregnancy|0
6174|NCT02009163|35474|P1|Open-label Period (Non-randomized)|Pregnancy|1
6175|NCT02009163|35472|P3|Open-label Period (Non-randomized)|Protocol Violation|0
6176|NCT02009163|35473|P2|Open-label Period (Non-randomized)|Protocol Violation|0
6177|NCT02009163|35474|P1|Open-label Period (Non-randomized)|Protocol Violation|10
6178|NCT02009163|35472|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
6179|NCT02009163|35473|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
6180|NCT02009163|35474|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
6181|NCT02009163|35472|P3|Open-label Period (Non-randomized)|Adverse Event|0
6182|NCT02009163|35473|P2|Open-label Period (Non-randomized)|Adverse Event|0
6183|NCT02009163|35474|P1|Open-label Period (Non-randomized)|Adverse Event|22
6184|NCT02009163|35472|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
6185|NCT02009163|35473|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
6186|NCT02009163|35474|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
6187|NCT02009163|35472|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
6188|NCT02009163|35473|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
6189|NCT02009163|35474|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
6190|NCT02007577|35539|P2|Overall Study|Withdrawal by Subject|1
6191|NCT02007577|35540|P1|Overall Study|Withdrawal by Subject|0
6192|NCT02007577|35539|P2|Overall Study|Adverse Event|0
6193|NCT02007577|35540|P1|Overall Study|Adverse Event|1
6194|NCT02007434|35556|P8|Overall Study|Non-compliance|0
6195|NCT02007434|35557|P7|Overall Study|Non-compliance|0
6196|NCT02007434|35558|P6|Overall Study|Non-compliance|0
6197|NCT02007434|35559|P5|Overall Study|Non-compliance|0
6198|NCT02007434|35560|P4|Overall Study|Non-compliance|0
6199|NCT02007434|35561|P3|Overall Study|Non-compliance|1
6200|NCT02007434|35562|P2|Overall Study|Non-compliance|0
6201|NCT02007434|35563|P1|Overall Study|Non-compliance|1
6202|NCT02007434|35556|P8|Overall Study|Lost to Follow-up|0
6203|NCT02007434|35557|P7|Overall Study|Lost to Follow-up|0
6204|NCT02007434|35558|P6|Overall Study|Lost to Follow-up|0
6205|NCT02007434|35559|P5|Overall Study|Lost to Follow-up|0
6206|NCT02007434|35560|P4|Overall Study|Lost to Follow-up|0
6207|NCT02007434|35561|P3|Overall Study|Lost to Follow-up|0
6208|NCT02007434|35562|P2|Overall Study|Lost to Follow-up|1
6209|NCT02007434|35563|P1|Overall Study|Lost to Follow-up|0
6210|NCT02007252|35685|P2|Overall Study|Adverse Event|4
6211|NCT02007252|35686|P1|Overall Study|Adverse Event|7
6212|NCT02007252|35685|P2|Overall Study|Abnormal laboratory value(s)|0
6213|NCT02007252|35686|P1|Overall Study|Abnormal laboratory value(s)|1
6214|NCT02007252|35685|P2|Overall Study|Administrative problems|7
6215|NCT02007252|35686|P1|Overall Study|Administrative problems|3
6216|NCT02007070|35699|P1|Overall Study|Continuing|9
6217|NCT02007070|35699|P1|Overall Study|Progressive Disease|18
6218|NCT02007070|35699|P1|Overall Study|Physician Decision|1
6219|NCT02007070|35699|P1|Overall Study|Protocol Violation|2
6220|NCT02007070|35699|P1|Overall Study|Death|1
6221|NCT02007070|35699|P1|Overall Study|Clinical Progression|4
6222|NCT02007070|35699|P1|Overall Study|Adverse Event|3
6223|NCT02006732|35733|P4|Overall Study|Withdrawal by Subject|1
6224|NCT02006732|35734|P3|Overall Study|Withdrawal by Subject|4
6225|NCT02006732|35735|P2|Overall Study|Withdrawal by Subject|0
6226|NCT02006732|35736|P1|Overall Study|Withdrawal by Subject|3
6227|NCT02006732|35733|P4|Overall Study|Lost to Follow-up|0
6228|NCT02006732|35734|P3|Overall Study|Lost to Follow-up|0
6229|NCT02006732|35735|P2|Overall Study|Lost to Follow-up|1
6230|NCT02006732|35736|P1|Overall Study|Lost to Follow-up|0
6231|NCT02006732|35733|P4|Overall Study|Protocol Violation|0
6232|NCT02006732|35734|P3|Overall Study|Protocol Violation|0
6233|NCT02006732|35735|P2|Overall Study|Protocol Violation|1
6234|NCT02006732|35736|P1|Overall Study|Protocol Violation|1
6235|NCT02006732|35733|P4|Overall Study|Lack of Efficacy|1
6236|NCT02006732|35734|P3|Overall Study|Lack of Efficacy|1
6237|NCT02006732|35735|P2|Overall Study|Lack of Efficacy|3
6238|NCT02006732|35736|P1|Overall Study|Lack of Efficacy|6
6239|NCT02006732|35733|P4|Overall Study|Adverse Event|2
6240|NCT02006732|35734|P3|Overall Study|Adverse Event|4
6241|NCT02006732|35735|P2|Overall Study|Adverse Event|7
6242|NCT02006732|35736|P1|Overall Study|Adverse Event|10
6243|NCT02006706|35774|P1|Overall Study|Lost to Follow-up|1
6244|NCT02006667|35779|P1|Overall Study|Withdrawal by Subject|1
6245|NCT02006667|35779|P1|Overall Study|Death|2
6246|NCT02006667|35779|P1|Overall Study|Adverse Event|3
6247|NCT02005692|35795|P1|Overall Study|Discharged earlier than anticipated|5
6248|NCT02005692|35795|P1|Overall Study|Withdrawal by Subject|1
6249|NCT02005692|35795|P1|Overall Study|Protocol Violation|1
6250|NCT02005562|35802|P2|Overall Study|Physician Decision|1
6251|NCT02005562|35803|P1|Overall Study|Physician Decision|0
6252|NCT02005562|35802|P2|Overall Study|No transplant|4
6253|NCT02005562|35803|P1|Overall Study|No transplant|1
6254|NCT02005562|35802|P2|Overall Study|Withdrawal by Subject|2
6255|NCT02005562|35803|P1|Overall Study|Withdrawal by Subject|2
6256|NCT02005562|35802|P2|Overall Study|Graft loss|6
6257|NCT02005562|35803|P1|Overall Study|Graft loss|7
6258|NCT02005562|35802|P2|Overall Study|Death|2
6259|NCT02005562|35803|P1|Overall Study|Death|2
6260|NCT02005484|35845|P1|Overall Study|Sponsor decision|1
6261|NCT02005484|35845|P1|Overall Study|Changed to a Different Study|1
6262|NCT02005484|35845|P1|Overall Study|Disease progression|1
6263|NCT02005484|35845|P1|Overall Study|Death|1
6264|NCT02005211|35862|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
6265|NCT02005211|35863|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
6266|NCT02005211|35864|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
6267|NCT02005211|35865|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
6268|NCT02005211|35866|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
6269|NCT02005211|35867|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
6270|NCT02005211|35868|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
6271|NCT02005029|35903|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
6272|NCT02005029|35904|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
6273|NCT02004886|35939|P4|Overall Study|Unable to attend future visits|0
6274|NCT02004886|35940|P3|Overall Study|Unable to attend future visits|0
6275|NCT02004886|35941|P2|Overall Study|Unable to attend future visits|0
6276|NCT02004886|35942|P1|Overall Study|Unable to attend future visits|1
6277|NCT02004886|35939|P4|Overall Study|Adverse Event|0
6278|NCT02004886|35940|P3|Overall Study|Adverse Event|0
6279|NCT02004886|35941|P2|Overall Study|Adverse Event|1
6280|NCT02004886|35942|P1|Overall Study|Adverse Event|0
6281|NCT02004873|35992|P1|Overall Study|Withdrawal by Subject|1
6282|NCT02004873|35992|P1|Overall Study|Death|23
6283|NCT02004873|35992|P1|Overall Study|Missed 6-month visit|4
6284|NCT02004873|35992|P1|Overall Study|Awaiting 6-month visit|390
6285|NCT02004873|35992|P1|Overall Study|Implant unsuccessful|6
6286|NCT02004847|36001|P2|Overall Study|Protocol Violation|1
6287|NCT02004847|36002|P1|Overall Study|Protocol Violation|1
6288|NCT02004236|36049|P3|Overall Study|Lack of Efficacy|16
6289|NCT02004236|36050|P2|Overall Study|Lack of Efficacy|0
6290|NCT02004236|36051|P1|Overall Study|Lack of Efficacy|0
6291|NCT02004093|36103|P2|Overall Study|Not specified|1
6292|NCT02004093|36104|P1|Overall Study|Not specified|3
6293|NCT02004093|36103|P2|Overall Study|Withdrawal by Subject|7
6294|NCT02004093|36104|P1|Overall Study|Withdrawal by Subject|3
6295|NCT02004093|36103|P2|Overall Study|Lost to Follow-up|1
6296|NCT02004093|36104|P1|Overall Study|Lost to Follow-up|0
6297|NCT02004093|36103|P2|Overall Study|Protocol Violation|1
6298|NCT02004093|36104|P1|Overall Study|Protocol Violation|0
6299|NCT02004093|36103|P2|Overall Study|Lack of Efficacy|62
6300|NCT02004093|36104|P1|Overall Study|Lack of Efficacy|66
6301|NCT02004093|36103|P2|Overall Study|Death|1
6302|NCT02004093|36104|P1|Overall Study|Death|2
6303|NCT02003638|36136|P2|Overall Study|Withdrawal by Subject|0
6304|NCT02003638|36137|P1|Overall Study|Withdrawal by Subject|1
6305|NCT02003534|36143|P1|Overall Study|Lost to Follow-up|47
6306|NCT02003391|36155|P2|Overall Study|Adverse Event|0
6307|NCT02003391|36156|P1|Overall Study|Adverse Event|1
6308|NCT02003391|36155|P2|Overall Study|Protocol Violation|1
6309|NCT02003391|36156|P1|Overall Study|Protocol Violation|0
6310|NCT02003391|36155|P2|Overall Study|Withdrawal by Subject|1
6311|NCT02003391|36156|P1|Overall Study|Withdrawal by Subject|2
6312|NCT02003014|36166|P1|Overall Study|Investigator's transfer|4
6313|NCT02003014|36166|P1|Overall Study|Patient did not visit the study site|5
6314|NCT02003014|36166|P1|Overall Study|Treatment started after contract period|1
6315|NCT02003014|36166|P1|Overall Study|Case report forms uncollected|9
6316|NCT02002689|36246|P1|Overall Study|Adverse Event|3
6317|NCT02002689|36246|P1|Overall Study|Disease Progression|7
6318|NCT02002221|36265|P2|Overall Study|Patient withdrew consent|1
6319|NCT02002221|36266|P1|Overall Study|Patient withdrew consent|0
6320|NCT02002221|36265|P2|Overall Study|Unsatisfactory therapeutic effect|1
6321|NCT02002221|36266|P1|Overall Study|Unsatisfactory therapeutic effect|0
6322|NCT02002221|36265|P2|Overall Study|Adverse Event|1
6323|NCT02002221|36266|P1|Overall Study|Adverse Event|2
6324|NCT02001181|36293|P2|Overall Study|Withdrawal by Subject|1
6325|NCT02001181|36294|P1|Overall Study|Withdrawal by Subject|0
6326|NCT02001181|36293|P2|Overall Study|Lost to Follow-up|0
6327|NCT02001181|36294|P1|Overall Study|Lost to Follow-up|1
6328|NCT02001181|36293|P2|Overall Study|Adverse Event|2
6329|NCT02001181|36294|P1|Overall Study|Adverse Event|0
6330|NCT02000752|36339|P2|Overall Study|Shift Changes|5
6331|NCT02000752|36340|P1|Overall Study|Shift Changes|12
6332|NCT02000752|36339|P2|Overall Study|Dystocic delivery|8
6333|NCT02000752|36340|P1|Overall Study|Dystocic delivery|19
6334|NCT02000531|36354|P2|Overall Study|Discontinued due to data cut-off|8
6335|NCT02000531|36355|P1|Overall Study|Discontinued due to data cut-off|3
6336|NCT02000531|36354|P2|Overall Study|Lost to Follow-up|0
6337|NCT02000531|36355|P1|Overall Study|Lost to Follow-up|1
6338|NCT01999894|36363|P1|Overall Study|Inclusion/exclusion criteria not met|1
6339|NCT01999894|36363|P1|Overall Study|Other Reason|3
6340|NCT01999894|36363|P1|Overall Study|Lost to Follow-up|10
6341|NCT01999894|36363|P1|Overall Study|Withdrawal by Subject|7
6342|NCT01999894|36363|P1|Overall Study|Protocol Violation|1
6343|NCT01999894|36363|P1|Overall Study|Lack of Efficacy|5
6344|NCT01999894|36363|P1|Overall Study|Adverse Event|9
6345|NCT01998919|36417|P2|Overall Study|Not specified|2
6346|NCT01998919|36418|P1|Overall Study|Not specified|5
6347|NCT01998919|36417|P2|Overall Study|Lost to Follow-up|0
6348|NCT01998919|36418|P1|Overall Study|Lost to Follow-up|2
6349|NCT01998919|36417|P2|Overall Study|Withdrawal by Subject|4
6350|NCT01998919|36418|P1|Overall Study|Withdrawal by Subject|2
6351|NCT01998919|36417|P2|Overall Study|Disease progression|22
6352|NCT01998919|36418|P1|Overall Study|Disease progression|31
6353|NCT01998919|36417|P2|Overall Study|Adverse Event|5
6354|NCT01998919|36418|P1|Overall Study|Adverse Event|0
6355|NCT01998919|36417|P2|Overall Study|Death|2
6356|NCT01998919|36418|P1|Overall Study|Death|2
6357|NCT01998906|36439|P3|Overall Study|Not specified|4
6358|NCT01998906|36440|P2|Overall Study|Not specified|8
6359|NCT01998906|36441|P1|Overall Study|Not specified|3
6360|NCT01998906|36439|P3|Overall Study|Administrative/Other|3
6361|NCT01998906|36440|P2|Overall Study|Administrative/Other|1
6362|NCT01998906|36441|P1|Overall Study|Administrative/Other|2
6363|NCT01998906|36439|P3|Overall Study|Withdrawal by Subject|3
6364|NCT01998906|36440|P2|Overall Study|Withdrawal by Subject|4
6365|NCT01998906|36441|P1|Overall Study|Withdrawal by Subject|1
6366|NCT01998906|36439|P3|Overall Study|Violation of Selection Criteria|1
6367|NCT01998906|36440|P2|Overall Study|Violation of Selection Criteria|0
6368|NCT01998906|36441|P1|Overall Study|Violation of Selection Criteria|0
6369|NCT01998906|36439|P3|Overall Study|Failure to return|4
6370|NCT01998906|36440|P2|Overall Study|Failure to return|2
6371|NCT01998906|36441|P1|Overall Study|Failure to return|0
6372|NCT01998906|36439|P3|Overall Study|Lack of Efficacy|8
6373|NCT01998906|36440|P2|Overall Study|Lack of Efficacy|9
6374|NCT01998906|36441|P1|Overall Study|Lack of Efficacy|10
6375|NCT01998906|36439|P3|Overall Study|Death|17
6376|NCT01998906|36440|P2|Overall Study|Death|30
6377|NCT01998906|36441|P1|Overall Study|Death|21
6378|NCT01998906|36439|P3|Overall Study|Participants ongoing in follow−up|58
6379|NCT01998906|36440|P2|Overall Study|Participants ongoing in follow−up|60
6380|NCT01998906|36441|P1|Overall Study|Participants ongoing in follow−up|77
6381|NCT01998893|36485|P1|Overall Study|Transformation to high-grade lymphoma|1
6382|NCT01998893|36485|P1|Overall Study|Withdrawal by Subject|1
6383|NCT01998893|36485|P1|Overall Study|Protocol Violation|2
6384|NCT01998893|36485|P1|Overall Study|Physician Decision|2
6385|NCT01998893|36485|P1|Overall Study|Lost to Follow-up|8
6386|NCT01998893|36485|P1|Overall Study|Death|1
6387|NCT01998893|36485|P1|Overall Study|Adverse Event|2
6388|NCT01998880|36497|P2|Overall Study|Violation of Selection Criteria at Entry|1
6389|NCT01998880|36498|P1|Overall Study|Violation of Selection Criteria at Entry|1
6390|NCT01998880|36497|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
6391|NCT01998880|36498|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
6392|NCT01998880|36497|P2|Overall Study|Other Protocol Violation|1
6393|NCT01998880|36498|P1|Overall Study|Other Protocol Violation|0
6394|NCT01998880|36497|P2|Overall Study|Administrative/Other|1
6395|NCT01998880|36498|P1|Overall Study|Administrative/Other|3
6396|NCT01998880|36497|P2|Overall Study|Insufficient Therapeutic Response|5
6397|NCT01998880|36498|P1|Overall Study|Insufficient Therapeutic Response|1
6398|NCT01998880|36497|P2|Overall Study|Death|6
6399|NCT01998880|36498|P1|Overall Study|Death|3
6400|NCT01998880|36497|P2|Overall Study|Withdrew Consent|2
6401|NCT01998880|36498|P1|Overall Study|Withdrew Consent|2
6402|NCT01998880|36497|P2|Overall Study|Progression of Disease|8
6403|NCT01998880|36498|P1|Overall Study|Progression of Disease|2
6404|NCT01998880|36497|P2|Overall Study|Adverse Events or Intercurrent Illness|16
6405|NCT01998880|36498|P1|Overall Study|Adverse Events or Intercurrent Illness|16
6406|NCT01998581|36516|P2|Overall Study|Randomized but withdrew before treatment|0
6407|NCT01998581|36517|P1|Overall Study|Randomized but withdrew before treatment|1
6408|NCT01998581|36516|P2|Overall Study|Other reasons|2
6409|NCT01998581|36517|P1|Overall Study|Other reasons|3
6410|NCT01998581|36516|P2|Overall Study|Adverse Event|1
6411|NCT01998581|36517|P1|Overall Study|Adverse Event|1
6412|NCT01998581|36516|P2|Overall Study|Lost to Follow-up|4
6413|NCT01998581|36517|P1|Overall Study|Lost to Follow-up|12
6414|NCT01998581|36516|P2|Overall Study|Withdrawal by Subject|1
6415|NCT01998581|36517|P1|Overall Study|Withdrawal by Subject|8
6416|NCT01998581|36516|P2|Overall Study|Protocol Violation|0
6417|NCT01998581|36517|P1|Overall Study|Protocol Violation|1
6418|NCT01998581|36516|P2|Overall Study|Refused repeat treatment|4
6419|NCT01998581|36517|P1|Overall Study|Refused repeat treatment|20
6420|NCT01998399|36542|P2|Overall Study|Withdrawal by Subject|1
6421|NCT01998399|36543|P1|Overall Study|Withdrawal by Subject|0
6422|NCT01998399|36542|P2|Overall Study|Study stopped before dosing completed|3
6423|NCT01998399|36543|P1|Overall Study|Study stopped before dosing completed|3
6424|NCT01998399|36542|P2|Overall Study|Death|2
6425|NCT01998399|36543|P1|Overall Study|Death|4
6426|NCT01998399|36542|P2|Overall Study|Lost to Follow-up|3
6427|NCT01998399|36543|P1|Overall Study|Lost to Follow-up|1
6428|NCT01997892|36579|P1|Overall Study|Study completion data not recorded|35
6429|NCT01997892|36579|P1|Overall Study|Other|3
6430|NCT01997892|36579|P1|Overall Study|Renal transplant|8
6431|NCT01997892|36579|P1|Overall Study|Death|14
6432|NCT01997892|36579|P1|Overall Study|Lost to Follow-up|6
6433|NCT01997892|36579|P1|Overall Study|Physician Decision|2
6434|NCT01996904|36635|P2|Overall Study|Lost to Follow-up|27
6435|NCT01996904|36636|P1|Overall Study|Lost to Follow-up|38
6436|NCT01996709|36649|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
6437|NCT01996709|36650|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
6438|NCT01996709|36649|P2|Overall Study|Subject Non-Compliant|0
6439|NCT01996709|36650|P1|Overall Study|Subject Non-Compliant|1
6440|NCT01996709|36649|P2|Overall Study|Lost to Follow-up|0
6441|NCT01996709|36650|P1|Overall Study|Lost to Follow-up|3
6442|NCT01996709|36649|P2|Overall Study|Withdrawal by Subject|0
6443|NCT01996709|36650|P1|Overall Study|Withdrawal by Subject|1
6444|NCT01996332|36691|P1|Overall Study|Lost to Follow-up|34
6445|NCT01996332|36691|P1|Overall Study|Physician Decision|17
6446|NCT01996332|36691|P1|Overall Study|Clinical Deterioration|28
6447|NCT01996332|36691|P1|Overall Study|Other|20
6448|NCT01996332|36691|P1|Overall Study|Withdrawal by Subject|71
6449|NCT01996332|36691|P1|Overall Study|Protocol Violation|9
6450|NCT01996332|36691|P1|Overall Study|Death|264
6451|NCT01996332|36691|P1|Overall Study|Lack of Efficacy|1245
6452|NCT01996332|36691|P1|Overall Study|Adverse Event|117
6453|NCT01996319|36699|P2|Overall Study|Adverse Event|2
6454|NCT01996319|36700|P1|Overall Study|Adverse Event|2
6455|NCT01996319|36699|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
6456|NCT01996319|36700|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
6457|NCT01996319|36699|P2|Overall Study|Protocol Violation|0
6458|NCT01996319|36700|P1|Overall Study|Protocol Violation|1
6459|NCT01995461|36720|P1|Overall Study|Withdrawal by Subject|2
6460|NCT01995461|36720|P1|Overall Study|Lost to Follow-up|2
6461|NCT01995461|36720|P1|Overall Study|Death|1
6462|NCT01995357|36726|P6|Period 5|Adverse Event|0
6463|NCT01995357|36727|P5|Period 5|Adverse Event|0
6464|NCT01995357|36728|P4|Period 5|Adverse Event|0
6465|NCT01995357|36729|P3|Period 5|Adverse Event|1
6466|NCT01995357|36730|P2|Period 5|Adverse Event|0
6467|NCT01995357|36731|P1|Period 5|Adverse Event|1
6468|NCT01995357|36726|P6|Period 5|Lack of Efficacy|0
6469|NCT01995357|36727|P5|Period 5|Lack of Efficacy|0
6470|NCT01995357|36728|P4|Period 5|Lack of Efficacy|0
6471|NCT01995357|36729|P3|Period 5|Lack of Efficacy|0
6472|NCT01995357|36730|P2|Period 5|Lack of Efficacy|0
6473|NCT01995357|36731|P1|Period 5|Lack of Efficacy|1
6474|NCT01995136|36747|P1|Overall Study|Change in residence|1
6475|NCT01994902|36766|P2|Test Period 2|not known|3
6476|NCT01994902|36767|P1|Test Period 2|not known|0
6477|NCT01994902|36766|P2|Test Period 2|Lack of Efficacy|1
6478|NCT01994902|36767|P1|Test Period 2|Lack of Efficacy|0
6479|NCT01994902|36766|P2|Test Period 2|Withdrawal by Subject|2
6480|NCT01994902|36767|P1|Test Period 2|Withdrawal by Subject|0
6481|NCT01994902|36766|P2|Test Period 1|bag too small|0
6482|NCT01994902|36767|P1|Test Period 1|bag too small|1
6483|NCT01994902|36766|P2|Test Period 1|Lack of Efficacy|1
6484|NCT01994902|36767|P1|Test Period 1|Lack of Efficacy|0
6485|NCT01994902|36766|P2|Test Period 1|Adverse Event|1
6486|NCT01994902|36767|P1|Test Period 1|Adverse Event|2
6487|NCT01994902|36766|P2|Test Period 1|device deficiency with adverse event|1
6488|NCT01994902|36767|P1|Test Period 1|device deficiency with adverse event|0
6489|NCT01994902|36766|P2|Test Period 1|Withdrawal by Subject|0
6490|NCT01994902|36767|P1|Test Period 1|Withdrawal by Subject|3
6491|NCT01994876|36773|P2|Test Period 2|Protocol Violation|1
6492|NCT01994876|36774|P1|Test Period 2|Protocol Violation|0
6493|NCT01994876|36773|P2|Test Period 2|Adverse Event|0
6494|NCT01994876|36774|P1|Test Period 2|Adverse Event|1
6495|NCT01994876|36773|P2|Test Period 1|Adverse Event|1
6496|NCT01994876|36774|P1|Test Period 1|Adverse Event|0
6497|NCT01994876|36773|P2|Test Period 1|Withdrawal by Subject|1
6498|NCT01994876|36774|P1|Test Period 1|Withdrawal by Subject|0
6499|NCT01994863|36782|P2|Period 2|Withdrawal by Subject|1
6500|NCT01994863|36783|P1|Period 2|Withdrawal by Subject|1
6501|NCT01994863|36782|P2|Period 2|Lack of Efficacy|2
6502|NCT01994863|36783|P1|Period 2|Lack of Efficacy|0
6503|NCT01994863|36782|P2|Period 2|Adverse Event|1
6504|NCT01994863|36783|P1|Period 2|Adverse Event|0
6505|NCT01994863|36782|P2|Period 1|Lack of Efficacy|0
6506|NCT01994863|36783|P1|Period 1|Lack of Efficacy|1
6507|NCT01994863|36782|P2|Period 1|Trial stopped by sponsor|3
6508|NCT01994863|36783|P1|Period 1|Trial stopped by sponsor|1
6509|NCT01994863|36782|P2|Period 1|Withdrawal by Subject|0
6510|NCT01994863|36783|P1|Period 1|Withdrawal by Subject|1
6511|NCT01994863|36782|P2|Period 1|Adverse Event|0
6512|NCT01994863|36783|P1|Period 1|Adverse Event|4
6513|NCT01994629|36798|P2|Overall Study|Lost to Follow-up|3
6514|NCT01994629|36799|P1|Overall Study|Lost to Follow-up|0
6515|NCT01994629|36798|P2|Overall Study|Withdrawal by Subject|0
6516|NCT01994629|36799|P1|Overall Study|Withdrawal by Subject|1
6517|NCT01994291|36835|P3|Overall Study|Unspecified|0
6518|NCT01994291|36836|P2|Overall Study|Unspecified|2
6519|NCT01994291|36837|P1|Overall Study|Unspecified|1
6520|NCT01994291|36835|P3|Overall Study|Withdrawal by Subject|5
6521|NCT01994291|36836|P2|Overall Study|Withdrawal by Subject|3
6522|NCT01994291|36837|P1|Overall Study|Withdrawal by Subject|6
6523|NCT01994291|36835|P3|Overall Study|Protocol Violation|0
6524|NCT01994291|36836|P2|Overall Study|Protocol Violation|0
6525|NCT01994291|36837|P1|Overall Study|Protocol Violation|1
6526|NCT01994291|36835|P3|Overall Study|Medication error without associated AE|1
6527|NCT01994291|36836|P2|Overall Study|Medication error without associated AE|0
6528|NCT01994291|36837|P1|Overall Study|Medication error without associated AE|1
6529|NCT01994291|36835|P3|Overall Study|Does not meet entrance criteria|0
6530|NCT01994291|36836|P2|Overall Study|Does not meet entrance criteria|0
6531|NCT01994291|36837|P1|Overall Study|Does not meet entrance criteria|1
6532|NCT01994291|36835|P3|Overall Study|Lost to Follow-up|0
6533|NCT01994291|36836|P2|Overall Study|Lost to Follow-up|1
6534|NCT01994291|36837|P1|Overall Study|Lost to Follow-up|1
6535|NCT01994291|36835|P3|Overall Study|Adverse Event|3
6536|NCT01994291|36836|P2|Overall Study|Adverse Event|1
6537|NCT01994291|36837|P1|Overall Study|Adverse Event|4
6538|NCT01993888|36893|P2|Overall Study|Withdrawal by Subject|1
6539|NCT01993888|36894|P1|Overall Study|Withdrawal by Subject|0
6540|NCT01993888|36893|P2|Overall Study|Lost to Follow-up|1
6541|NCT01993888|36894|P1|Overall Study|Lost to Follow-up|1
6542|NCT01993888|36893|P2|Overall Study|Death|1
6543|NCT01993888|36894|P1|Overall Study|Death|1
6544|NCT01993823|36912|P2|Overall Study|Lost to Follow-up|4
6545|NCT01993823|36913|P1|Overall Study|Lost to Follow-up|1
6546|NCT01993823|36912|P2|Overall Study|Protocol Violation|1
6547|NCT01993823|36913|P1|Overall Study|Protocol Violation|0
6548|NCT01993823|36912|P2|Overall Study|Requested by the patient|11
6549|NCT01993823|36913|P1|Overall Study|Requested by the patient|6
6550|NCT01993030|36928|P2|Overall Study|Adverse Event|4
6551|NCT01993030|36929|P1|Overall Study|Adverse Event|0
6552|NCT01992536|36983|P10|Overall Study|Withdrawal by Subject|0
6553|NCT01992536|36984|P9|Overall Study|Withdrawal by Subject|0
6554|NCT01992536|36985|P8|Overall Study|Withdrawal by Subject|0
6555|NCT01992536|36986|P7|Overall Study|Withdrawal by Subject|0
6556|NCT01992536|36987|P6|Overall Study|Withdrawal by Subject|0
6557|NCT01992536|36988|P5|Overall Study|Withdrawal by Subject|0
6558|NCT01992536|36989|P4|Overall Study|Withdrawal by Subject|2
6559|NCT01992536|36990|P3|Overall Study|Withdrawal by Subject|0
6560|NCT01992536|36991|P2|Overall Study|Withdrawal by Subject|1
6561|NCT01992536|36992|P1|Overall Study|Withdrawal by Subject|0
6562|NCT01992536|36983|P10|Overall Study|Lost to Follow-up|1
6563|NCT01992536|36984|P9|Overall Study|Lost to Follow-up|1
6564|NCT01992536|36985|P8|Overall Study|Lost to Follow-up|0
6565|NCT01992536|36986|P7|Overall Study|Lost to Follow-up|0
6566|NCT01992536|36987|P6|Overall Study|Lost to Follow-up|1
6567|NCT01992536|36988|P5|Overall Study|Lost to Follow-up|0
6568|NCT01992536|36989|P4|Overall Study|Lost to Follow-up|0
6569|NCT01992536|36990|P3|Overall Study|Lost to Follow-up|1
6570|NCT01992536|36991|P2|Overall Study|Lost to Follow-up|2
6571|NCT01992536|36992|P1|Overall Study|Lost to Follow-up|4
6572|NCT01992536|36983|P10|Overall Study|Administrative Reason|0
6573|NCT01992536|36984|P9|Overall Study|Administrative Reason|0
6574|NCT01992536|36985|P8|Overall Study|Administrative Reason|0
6575|NCT01992536|36986|P7|Overall Study|Administrative Reason|7
6576|NCT01992536|36987|P6|Overall Study|Administrative Reason|0
6577|NCT01992536|36988|P5|Overall Study|Administrative Reason|0
6578|NCT01992536|36989|P4|Overall Study|Administrative Reason|0
6579|NCT01992536|36990|P3|Overall Study|Administrative Reason|0
6580|NCT01992536|36991|P2|Overall Study|Administrative Reason|0
6581|NCT01992536|36992|P1|Overall Study|Administrative Reason|0
6582|NCT01992107|37243|P3|Overall Study|Withdrawal by Subject|8
6583|NCT01992107|37244|P2|Overall Study|Withdrawal by Subject|7
6584|NCT01992107|37245|P1|Overall Study|Withdrawal by Subject|13
6585|NCT01992107|37243|P3|Overall Study|noncompliance and were unavailable|2
6586|NCT01992107|37244|P2|Overall Study|noncompliance and were unavailable|3
6587|NCT01992107|37245|P1|Overall Study|noncompliance and were unavailable|7
6588|NCT01992107|37243|P3|Overall Study|Lost to Follow-up|26
6589|NCT01992107|37244|P2|Overall Study|Lost to Follow-up|22
6590|NCT01992107|37245|P1|Overall Study|Lost to Follow-up|46
6591|NCT01992107|37243|P3|Overall Study|Adverse Event|0
6592|NCT01992107|37244|P2|Overall Study|Adverse Event|1
6593|NCT01992107|37245|P1|Overall Study|Adverse Event|0
6594|NCT01992107|37243|P3|Overall Study|Administrative reasons|0
6595|NCT01992107|37244|P2|Overall Study|Administrative reasons|0
6596|NCT01992107|37245|P1|Overall Study|Administrative reasons|2
6597|NCT01992094|37301|P3|Overall Study|Withdrawal by Subject|4
6598|NCT01992094|37302|P2|Overall Study|Withdrawal by Subject|3
6599|NCT01992094|37303|P1|Overall Study|Withdrawal by Subject|7
6600|NCT01992094|37301|P3|Overall Study|Protocol Violation|1
6601|NCT01992094|37302|P2|Overall Study|Protocol Violation|0
6602|NCT01992094|37303|P1|Overall Study|Protocol Violation|1
6603|NCT01992094|37301|P3|Overall Study|OTHER|0
6604|NCT01992094|37302|P2|Overall Study|OTHER|0
6605|NCT01992094|37303|P1|Overall Study|OTHER|4
6606|NCT01992094|37301|P3|Overall Study|Lost to Follow-up|13
6607|NCT01992094|37302|P2|Overall Study|Lost to Follow-up|9
6608|NCT01992094|37303|P1|Overall Study|Lost to Follow-up|26
6609|NCT01992094|37301|P3|Overall Study|Death|2
6610|NCT01992094|37302|P2|Overall Study|Death|5
6611|NCT01992094|37303|P1|Overall Study|Death|5
6612|NCT01992094|37301|P3|Overall Study|Adverse Event|0
6613|NCT01992094|37302|P2|Overall Study|Adverse Event|0
6614|NCT01992094|37303|P1|Overall Study|Adverse Event|1
6615|NCT01992094|37301|P3|Overall Study|ADMINISTRATIVE REASON|1
6616|NCT01992094|37302|P2|Overall Study|ADMINISTRATIVE REASON|7
6617|NCT01992094|37303|P1|Overall Study|ADMINISTRATIVE REASON|6
6618|NCT01990859|37402|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
6619|NCT01990859|37402|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
6620|NCT01990664|37527|P2|Overall Study|Unsatisfactory Visual Response|1
6621|NCT01990664|37528|P1|Overall Study|Unsatisfactory Visual Response|0
6622|NCT01990664|37527|P2|Overall Study|Lens Handling Difficulties|0
6623|NCT01990664|37528|P1|Overall Study|Lens Handling Difficulties|1
6624|NCT01990664|37527|P2|Overall Study|Lens Discomfort|1
6625|NCT01990664|37528|P1|Overall Study|Lens Discomfort|1
6626|NCT01990664|37527|P2|Overall Study|Protocol Violation|0
6627|NCT01990664|37528|P1|Overall Study|Protocol Violation|1
6628|NCT01990664|37527|P2|Overall Study|Withdrawal by Subject|3
6629|NCT01990664|37528|P1|Overall Study|Withdrawal by Subject|2
6630|NCT01990664|37527|P2|Overall Study|Lost to Follow-up|6
6631|NCT01990664|37528|P1|Overall Study|Lost to Follow-up|2
6632|NCT01990339|37534|P1|Overall Study|Lost to Follow-up|861
6633|NCT01990339|37534|P1|Overall Study|Voluntary Withdrawal|1402
6634|NCT01990339|37534|P1|Overall Study|Data Not Available|49
6635|NCT01990261|37539|P1|Overall Study|Lost to Follow-up|2
6636|NCT01990261|37539|P1|Overall Study|Dossier not Approved|1
6637|NCT01990261|37539|P1|Overall Study|PD Before Treatment Start|1
6638|NCT01990261|37539|P1|Overall Study|Disease Progression (PD)|8
6639|NCT01990261|37539|P1|Overall Study|Death From other Causes|1
6640|NCT01990261|37539|P1|Overall Study|Death due to Disease Progression (PD)|10
6641|NCT01990261|37539|P1|Overall Study|Death Before Treatment Start|2
6642|NCT01989689|37551|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
6643|NCT01989689|37552|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
6644|NCT01989689|37551|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
6645|NCT01989689|37552|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
6646|NCT01989572|37568|P6|Overall Study|alternative therapy|3
6647|NCT01989572|37569|P5|Overall Study|alternative therapy|1
6648|NCT01989572|37570|P4|Overall Study|alternative therapy|0
6649|NCT01989572|37571|P3|Overall Study|alternative therapy|0
6650|NCT01989572|37572|P2|Overall Study|alternative therapy|0
6651|NCT01989572|37573|P1|Overall Study|alternative therapy|3
6652|NCT01989572|37568|P6|Overall Study|not start protocol therapy|18
6653|NCT01989572|37569|P5|Overall Study|not start protocol therapy|4
6654|NCT01989572|37570|P4|Overall Study|not start protocol therapy|3
6655|NCT01989572|37571|P3|Overall Study|not start protocol therapy|2
6656|NCT01989572|37572|P2|Overall Study|not start protocol therapy|1
6657|NCT01989572|37573|P1|Overall Study|not start protocol therapy|5
6658|NCT01989572|37568|P6|Overall Study|unknown/not specify|5
6659|NCT01989572|37569|P5|Overall Study|unknown/not specify|3
6660|NCT01989572|37570|P4|Overall Study|unknown/not specify|3
6661|NCT01989572|37571|P3|Overall Study|unknown/not specify|1
6662|NCT01989572|37572|P2|Overall Study|unknown/not specify|4
6663|NCT01989572|37573|P1|Overall Study|unknown/not specify|3
6664|NCT01989572|37568|P6|Overall Study|maximum dose reached|0
6665|NCT01989572|37569|P5|Overall Study|maximum dose reached|1
6666|NCT01989572|37570|P4|Overall Study|maximum dose reached|0
6667|NCT01989572|37571|P3|Overall Study|maximum dose reached|0
6668|NCT01989572|37572|P2|Overall Study|maximum dose reached|1
6669|NCT01989572|37573|P1|Overall Study|maximum dose reached|0
6670|NCT01989572|37568|P6|Overall Study|error|1
6671|NCT01989572|37569|P5|Overall Study|error|1
6672|NCT01989572|37570|P4|Overall Study|error|1
6673|NCT01989572|37571|P3|Overall Study|error|1
6674|NCT01989572|37572|P2|Overall Study|error|1
6675|NCT01989572|37573|P1|Overall Study|error|2
6676|NCT01989572|37568|P6|Overall Study|complicating disease|0
6677|NCT01989572|37569|P5|Overall Study|complicating disease|1
6678|NCT01989572|37570|P4|Overall Study|complicating disease|0
6679|NCT01989572|37571|P3|Overall Study|complicating disease|2
6680|NCT01989572|37572|P2|Overall Study|complicating disease|1
6681|NCT01989572|37573|P1|Overall Study|complicating disease|1
6682|NCT01989572|37568|P6|Overall Study|Withdrawal by Subject|4
6683|NCT01989572|37569|P5|Overall Study|Withdrawal by Subject|12
6684|NCT01989572|37570|P4|Overall Study|Withdrawal by Subject|1
6685|NCT01989572|37571|P3|Overall Study|Withdrawal by Subject|5
6686|NCT01989572|37572|P2|Overall Study|Withdrawal by Subject|1
6687|NCT01989572|37573|P1|Overall Study|Withdrawal by Subject|4
6688|NCT01989572|37568|P6|Overall Study|Death|0
6689|NCT01989572|37569|P5|Overall Study|Death|1
6690|NCT01989572|37570|P4|Overall Study|Death|0
6691|NCT01989572|37571|P3|Overall Study|Death|0
6692|NCT01989572|37572|P2|Overall Study|Death|0
6693|NCT01989572|37573|P1|Overall Study|Death|0
6694|NCT01989572|37568|P6|Overall Study|Adverse Event|0
6695|NCT01989572|37569|P5|Overall Study|Adverse Event|3
6696|NCT01989572|37570|P4|Overall Study|Adverse Event|0
6697|NCT01989572|37571|P3|Overall Study|Adverse Event|3
6698|NCT01989572|37572|P2|Overall Study|Adverse Event|1
6699|NCT01989572|37573|P1|Overall Study|Adverse Event|2
6700|NCT01989572|37568|P6|Overall Study|Lack of Efficacy|79
6701|NCT01989572|37569|P5|Overall Study|Lack of Efficacy|71
6702|NCT01989572|37570|P4|Overall Study|Lack of Efficacy|43
6703|NCT01989572|37571|P3|Overall Study|Lack of Efficacy|48
6704|NCT01989572|37572|P2|Overall Study|Lack of Efficacy|48
6705|NCT01989572|37573|P1|Overall Study|Lack of Efficacy|35
6706|NCT01989455|37606|P5|Overall Study|Technical problems with infusion|1
6707|NCT01989455|37607|P4|Overall Study|Technical problems with infusion|0
6708|NCT01989455|37608|P3|Overall Study|Technical problems with infusion|1
6709|NCT01989455|37609|P2|Overall Study|Technical problems with infusion|0
6710|NCT01989455|37610|P1|Overall Study|Technical problems with infusion|0
6711|NCT01989455|37606|P5|Overall Study|Withdrawal by Subject|0
6712|NCT01989455|37607|P4|Overall Study|Withdrawal by Subject|0
6713|NCT01989455|37608|P3|Overall Study|Withdrawal by Subject|0
6714|NCT01989455|37609|P2|Overall Study|Withdrawal by Subject|1
6715|NCT01989455|37610|P1|Overall Study|Withdrawal by Subject|0
6716|NCT01989455|37606|P5|Overall Study|Adverse Event|0
6717|NCT01989455|37607|P4|Overall Study|Adverse Event|0
6718|NCT01989455|37608|P3|Overall Study|Adverse Event|0
6719|NCT01989455|37609|P2|Overall Study|Adverse Event|1
6720|NCT01989455|37610|P1|Overall Study|Adverse Event|0
6721|NCT01989169|37654|P2|Period 2|Adverse Event|1
6722|NCT01989169|37655|P1|Period 2|Adverse Event|0
6723|NCT01988402|37682|P2|Overall Study|Withdrawal by Subject|0
6724|NCT01988402|37683|P1|Overall Study|Withdrawal by Subject|1
6725|NCT01988402|37682|P2|Overall Study|Adverse Event|2
6726|NCT01988402|37683|P1|Overall Study|Adverse Event|1
6727|NCT01987765|37721|P1|Overall Study|Lost to Follow-up|37
6728|NCT01987765|37721|P1|Overall Study|Protocol Violation|65
6729|NCT01987557|37745|P3|Overall Study|Adverse Event|0
6730|NCT01987557|37746|P2|Overall Study|Adverse Event|2
6731|NCT01987557|37747|P1|Overall Study|Adverse Event|0
6732|NCT01987557|37745|P3|Overall Study|Withdrawal by Subject|2
6733|NCT01987557|37746|P2|Overall Study|Withdrawal by Subject|1
6734|NCT01987557|37747|P1|Overall Study|Withdrawal by Subject|2
6735|NCT01987557|37745|P3|Overall Study|Protocol Violation|1
6736|NCT01987557|37746|P2|Overall Study|Protocol Violation|0
6737|NCT01987557|37747|P1|Overall Study|Protocol Violation|1
6738|NCT01987453|37758|P3|Overall Study|Lack of Efficacy|0
6739|NCT01987453|37759|P2|Overall Study|Lack of Efficacy|12
6740|NCT01987453|37760|P1|Overall Study|Lack of Efficacy|1
6741|NCT01987453|37758|P3|Overall Study|Death|1
6742|NCT01987453|37759|P2|Overall Study|Death|0
6743|NCT01987453|37760|P1|Overall Study|Death|0
6744|NCT01986985|37811|P1|Overall Study|Scan not completed due to malfunction|3
6745|NCT01986985|37811|P1|Overall Study|Withdrawal by Subject|4
6746|NCT01986751|37869|P2|Overall Study|improperly consented|2
6747|NCT01986751|37870|P1|Overall Study|improperly consented|10
6748|NCT01986231|37890|P1|Overall Study|Adverse Event|1
6749|NCT01986062|37897|P2|Overall Study|Lost to Follow-up|1
6750|NCT01986062|37898|P1|Overall Study|Lost to Follow-up|1
6751|NCT01985321|37958|P2|Overall Study|Subject treated wrong type of sore|0
6752|NCT01985321|37959|P1|Overall Study|Subject treated wrong type of sore|1
6753|NCT01985321|37958|P2|Overall Study|Lost to Follow-up|2
6754|NCT01985321|37959|P1|Overall Study|Lost to Follow-up|5
6755|NCT01985321|37958|P2|Overall Study|Withdrawal by Subject|0
6756|NCT01985321|37959|P1|Overall Study|Withdrawal by Subject|1
6757|NCT01985321|37958|P2|Overall Study|Protocol Violation|3
6758|NCT01985321|37959|P1|Overall Study|Protocol Violation|4
6759|NCT01985126|37969|P2|Overall Study|Ongoing|67
6760|NCT01985126|37970|P1|Overall Study|Ongoing|9
6761|NCT01985126|37969|P2|Overall Study|Lost to Follow-up|3
6762|NCT01985126|37970|P1|Overall Study|Lost to Follow-up|0
6763|NCT01985126|37969|P2|Overall Study|Withdrawal by Subject|5
6764|NCT01985126|37970|P1|Overall Study|Withdrawal by Subject|2
6765|NCT01985126|37969|P2|Overall Study|Death|31
6766|NCT01985126|37970|P1|Overall Study|Death|7
6767|NCT01984697|37993|P5|Overall Study|Follow-up continues|308
6768|NCT01984697|37994|P4|Overall Study|Follow-up continues|290
6769|NCT01984697|37995|P3|Overall Study|Follow-up continues|292
6770|NCT01984697|37996|P2|Overall Study|Follow-up continues|294
6771|NCT01984697|37997|P1|Overall Study|Follow-up continues|290
6772|NCT01984697|37993|P5|Overall Study|Withdrawal by Subject|2
6773|NCT01984697|37994|P4|Overall Study|Withdrawal by Subject|7
6774|NCT01984697|37995|P3|Overall Study|Withdrawal by Subject|4
6775|NCT01984697|37996|P2|Overall Study|Withdrawal by Subject|5
6776|NCT01984697|37997|P1|Overall Study|Withdrawal by Subject|3
6777|NCT01984697|37993|P5|Overall Study|Protocol Violation|0
6778|NCT01984697|37994|P4|Overall Study|Protocol Violation|1
6779|NCT01984697|37995|P3|Overall Study|Protocol Violation|0
6780|NCT01984697|37996|P2|Overall Study|Protocol Violation|0
6781|NCT01984697|37997|P1|Overall Study|Protocol Violation|0
6782|NCT01984697|37993|P5|Overall Study|Physician Decision|0
6783|NCT01984697|37994|P4|Overall Study|Physician Decision|0
6784|NCT01984697|37995|P3|Overall Study|Physician Decision|0
6785|NCT01984697|37996|P2|Overall Study|Physician Decision|0
6786|NCT01984697|37997|P1|Overall Study|Physician Decision|1
6787|NCT01984697|37993|P5|Overall Study|Lost to Follow-up|4
6788|NCT01984697|37994|P4|Overall Study|Lost to Follow-up|3
6789|NCT01984697|37995|P3|Overall Study|Lost to Follow-up|4
6790|NCT01984697|37996|P2|Overall Study|Lost to Follow-up|2
6791|NCT01984697|37997|P1|Overall Study|Lost to Follow-up|7
6792|NCT01984697|37993|P5|Overall Study|Adverse Event|0
6793|NCT01984697|37994|P4|Overall Study|Adverse Event|0
6794|NCT01984697|37995|P3|Overall Study|Adverse Event|1
6795|NCT01984697|37996|P2|Overall Study|Adverse Event|0
6796|NCT01984697|37997|P1|Overall Study|Adverse Event|0
6797|NCT01984294|38103|P3|Overall Study|Adverse Event|0
6798|NCT01984294|38104|P2|Overall Study|Adverse Event|1
6799|NCT01984294|38105|P1|Overall Study|Adverse Event|0
6800|NCT01984294|38103|P3|Overall Study|Lack of Efficacy|6
6801|NCT01984294|38104|P2|Overall Study|Lack of Efficacy|2
6802|NCT01984294|38105|P1|Overall Study|Lack of Efficacy|4
6803|NCT01984294|38103|P3|Overall Study|Randomized but Never Treated|1
6804|NCT01984294|38104|P2|Overall Study|Randomized but Never Treated|0
6805|NCT01984294|38105|P1|Overall Study|Randomized but Never Treated|0
6806|NCT01984229|38127|P2|Safety Follow-up Period|Lost to Follow-up|0
6807|NCT01984229|38128|P1|Safety Follow-up Period|Lost to Follow-up|1
6808|NCT01984229|38127|P2|Safety Follow-up Period|Adverse Event|1
6809|NCT01984229|38128|P1|Safety Follow-up Period|Adverse Event|1
6810|NCT01983878|38178|P1|Overall Study|Still Receiving Treatment|3
6811|NCT01983111|38244|P2|Overall Study|Protocol Violation|1
6812|NCT01983111|38245|P1|Overall Study|Protocol Violation|0
6813|NCT01983111|38244|P2|Overall Study|Adverse Event|0
6814|NCT01983111|38245|P1|Overall Study|Adverse Event|4
6815|NCT01983111|38244|P2|Overall Study|Withdrawal by Subject|6
6816|NCT01983111|38245|P1|Overall Study|Withdrawal by Subject|8
6817|NCT01982812|38263|P2|Overall Study|Adverse Event|5
6818|NCT01982812|38264|P1|Overall Study|Adverse Event|0
6819|NCT01982812|38263|P2|Overall Study|Death|5
6820|NCT01982812|38264|P1|Overall Study|Death|1
6821|NCT01982292|38282|P2|Overall Study|Technical Problems|0
6822|NCT01982292|38283|P1|Overall Study|Technical Problems|2
6823|NCT01982292|38282|P2|Overall Study|Patient/Guardian Decision|1
6824|NCT01982292|38283|P1|Overall Study|Patient/Guardian Decision|3
6825|NCT01982292|38282|P2|Overall Study|Protocol Deviation|0
6826|NCT01982292|38283|P1|Overall Study|Protocol Deviation|1
6827|NCT01982292|38282|P2|Overall Study|Non-Compliance With Study Treatment|0
6828|NCT01982292|38283|P1|Overall Study|Non-Compliance With Study Treatment|1
6829|NCT01982292|38282|P2|Overall Study|Lost to Follow-up|0
6830|NCT01982292|38283|P1|Overall Study|Lost to Follow-up|2
6831|NCT01982292|38282|P2|Overall Study|Death|0
6832|NCT01982292|38283|P1|Overall Study|Death|1
6833|NCT01982292|38282|P2|Overall Study|Adverse Event|0
6834|NCT01982292|38283|P1|Overall Study|Adverse Event|2
6835|NCT01982253|38304|P3|Overall Study|Study terminated by sponsor|4
6836|NCT01982253|38305|P2|Overall Study|Study terminated by sponsor|4
6837|NCT01982253|38306|P1|Overall Study|Study terminated by sponsor|1
6838|NCT01982253|38304|P3|Overall Study|Withdrawal by Subject|0
6839|NCT01982253|38305|P2|Overall Study|Withdrawal by Subject|0
6840|NCT01982253|38306|P1|Overall Study|Withdrawal by Subject|1
6841|NCT01981616|38345|P2|Overall Study|Protocol Violation|0
6842|NCT01981616|38346|P1|Overall Study|Protocol Violation|1
6843|NCT01981616|38345|P2|Overall Study|Adverse Event|1
6844|NCT01981616|38346|P1|Overall Study|Adverse Event|0
6845|NCT01981473|38361|P3|Overall Study|Received treatment for >24 months|6
6846|NCT01981473|38362|P2|Overall Study|Received treatment for >24 months|0
6847|NCT01981473|38363|P1|Overall Study|Received treatment for >24 months|2
6848|NCT01981473|38361|P3|Overall Study|Received treatment for < 6 months|1
6849|NCT01981473|38362|P2|Overall Study|Received treatment for < 6 months|0
6850|NCT01981473|38363|P1|Overall Study|Received treatment for < 6 months|0
6851|NCT01981473|38361|P3|Overall Study|Incorrect diagnosis of RA|1
6852|NCT01981473|38362|P2|Overall Study|Incorrect diagnosis of RA|0
6853|NCT01981473|38363|P1|Overall Study|Incorrect diagnosis of RA|0
6854|NCT01981356|38404|P2|Overall Study|Protocol Violation|0
6855|NCT01981356|38405|P1|Overall Study|Protocol Violation|2
6856|NCT01981356|38404|P2|Overall Study|Withdrawal by Subject|1
6857|NCT01981356|38405|P1|Overall Study|Withdrawal by Subject|1
6858|NCT01981356|38404|P2|Overall Study|Lost to Follow-up|1
6859|NCT01981356|38405|P1|Overall Study|Lost to Follow-up|4
6860|NCT01980940|38447|P8|Overall Study|Protocol Violation|0
6861|NCT01980940|38448|P7|Overall Study|Protocol Violation|0
6862|NCT01980940|38449|P6|Overall Study|Protocol Violation|2
6863|NCT01980940|38450|P5|Overall Study|Protocol Violation|0
6864|NCT01980940|38451|P4|Overall Study|Protocol Violation|0
6865|NCT01980940|38452|P3|Overall Study|Protocol Violation|0
6866|NCT01980940|38453|P2|Overall Study|Protocol Violation|0
6867|NCT01980940|38454|P1|Overall Study|Protocol Violation|0
6868|NCT01980095|38535|P2|Overall Study|Study drug discontinued|0
6869|NCT01980095|38536|P1|Overall Study|Study drug discontinued|1
6870|NCT01980095|38535|P2|Overall Study|Safety issue|1
6871|NCT01980095|38536|P1|Overall Study|Safety issue|0
6872|NCT01980095|38535|P2|Overall Study|Poor compliance|0
6873|NCT01980095|38536|P1|Overall Study|Poor compliance|5
6874|NCT01980095|38535|P2|Overall Study|Withdrawal by Subject|3
6875|NCT01980095|38536|P1|Overall Study|Withdrawal by Subject|2
6876|NCT01980095|38535|P2|Overall Study|Lost to Follow-up|7
6877|NCT01980095|38536|P1|Overall Study|Lost to Follow-up|6
6878|NCT01979185|38546|P2|Period 2|Not specified|1
6879|NCT01979185|38547|P1|Period 2|Not specified|0
6880|NCT01978145|38583|P2|Treatment Period 2|Par. reached defined stopping criteria|5
6881|NCT01978145|38584|P1|Treatment Period 2|Par. reached defined stopping criteria|8
6882|NCT01978145|38583|P2|Treatment Period 2|Withdrawal by Subject|4
6883|NCT01978145|38584|P1|Treatment Period 2|Withdrawal by Subject|7
6884|NCT01978145|38583|P2|Treatment Period 2|Lost to Follow-up|1
6885|NCT01978145|38584|P1|Treatment Period 2|Lost to Follow-up|1
6886|NCT01978145|38583|P2|Treatment Period 2|Protocol Violation|1
6887|NCT01978145|38584|P1|Treatment Period 2|Protocol Violation|0
6888|NCT01978145|38583|P2|Treatment Period 2|Adverse Event|3
6889|NCT01978145|38584|P1|Treatment Period 2|Adverse Event|3
6890|NCT01978145|38583|P2|Washout Period 1|Par. reached defined stopping criteria|1
6891|NCT01978145|38584|P1|Washout Period 1|Par. reached defined stopping criteria|0
6892|NCT01978145|38583|P2|Washout Period 1|Withdrawal by Subject|1
6893|NCT01978145|38584|P1|Washout Period 1|Withdrawal by Subject|1
6894|NCT01978145|38583|P2|Washout Period 1|Adverse Event|1
6895|NCT01978145|38584|P1|Washout Period 1|Adverse Event|0
6896|NCT01978145|38583|P2|Treatment Period 1|Par. reached defined stopping criteria|3
6897|NCT01978145|38584|P1|Treatment Period 1|Par. reached defined stopping criteria|2
6898|NCT01978145|38583|P2|Treatment Period 1|Withdrawal by Subject|4
6899|NCT01978145|38584|P1|Treatment Period 1|Withdrawal by Subject|5
6900|NCT01978145|38583|P2|Treatment Period 1|Physician Decision|0
6901|NCT01978145|38584|P1|Treatment Period 1|Physician Decision|1
6902|NCT01978145|38583|P2|Treatment Period 1|Adverse Event|9
6903|NCT01978145|38584|P1|Treatment Period 1|Adverse Event|1
6904|NCT01978119|38600|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
6905|NCT01978119|38601|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
6906|NCT01978119|38600|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
6907|NCT01978119|38601|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
6908|NCT01978119|38600|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
6909|NCT01978119|38601|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
6910|NCT01977820|38627|P2|Overall Study|Sponsor terminated the study|1
6911|NCT01977820|38628|P1|Overall Study|Sponsor terminated the study|1
6912|NCT01977794|38636|P2|Overall Study|Unspecified|1
6913|NCT01977794|38637|P1|Overall Study|Unspecified|0
6914|NCT01977794|38636|P2|Overall Study|Withdrew consent|1
6915|NCT01977794|38637|P1|Overall Study|Withdrew consent|2
6916|NCT01977794|38636|P2|Overall Study|Death|1
6917|NCT01977794|38637|P1|Overall Study|Death|1
6918|NCT01977794|38636|P2|Overall Study|Protocol Violation|0
6919|NCT01977794|38637|P1|Overall Study|Protocol Violation|1
6920|NCT01977794|38636|P2|Overall Study|Lost to Follow-up|1
6921|NCT01977794|38637|P1|Overall Study|Lost to Follow-up|2
6922|NCT01977794|38636|P2|Overall Study|Adverse Event|2
6923|NCT01977794|38637|P1|Overall Study|Adverse Event|2
6924|NCT01977729|38651|P1|Overall Study|Study terminated|1
6925|NCT01977573|38665|P4|Overall Study|Withdrawal by Subject|1
6926|NCT01977573|38666|P3|Overall Study|Withdrawal by Subject|1
6927|NCT01977573|38667|P2|Overall Study|Withdrawal by Subject|1
6928|NCT01977573|38668|P1|Overall Study|Withdrawal by Subject|6
6929|NCT01977573|38665|P4|Overall Study|Reached Defined Stopping Criteria|0
6930|NCT01977573|38666|P3|Overall Study|Reached Defined Stopping Criteria|1
6931|NCT01977573|38667|P2|Overall Study|Reached Defined Stopping Criteria|1
6932|NCT01977573|38668|P1|Overall Study|Reached Defined Stopping Criteria|2
6933|NCT01977573|38665|P4|Overall Study|Protocol Violation|0
6934|NCT01977573|38666|P3|Overall Study|Protocol Violation|0
6935|NCT01977573|38667|P2|Overall Study|Protocol Violation|1
6936|NCT01977573|38668|P1|Overall Study|Protocol Violation|3
6937|NCT01977573|38665|P4|Overall Study|Physician Decision|0
6938|NCT01977573|38666|P3|Overall Study|Physician Decision|0
6939|NCT01977573|38667|P2|Overall Study|Physician Decision|0
6940|NCT01977573|38668|P1|Overall Study|Physician Decision|1
6941|NCT01977573|38665|P4|Overall Study|Lost to Follow-up|1
6942|NCT01977573|38666|P3|Overall Study|Lost to Follow-up|0
6943|NCT01977573|38667|P2|Overall Study|Lost to Follow-up|0
6944|NCT01977573|38668|P1|Overall Study|Lost to Follow-up|1
6945|NCT01977573|38665|P4|Overall Study|Adverse Event|1
6946|NCT01977573|38666|P3|Overall Study|Adverse Event|2
6947|NCT01977573|38667|P2|Overall Study|Adverse Event|0
6948|NCT01977573|38668|P1|Overall Study|Adverse Event|7
6949|NCT01977482|38782|P6|Overall Study|Withdrawal by Subject|5
6950|NCT01977482|38783|P5|Overall Study|Withdrawal by Subject|1
6951|NCT01977482|38784|P4|Overall Study|Withdrawal by Subject|3
6952|NCT01977482|38785|P3|Overall Study|Withdrawal by Subject|1
6953|NCT01977482|38786|P2|Overall Study|Withdrawal by Subject|4
6954|NCT01977482|38787|P1|Overall Study|Withdrawal by Subject|2
6955|NCT01977482|38782|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
6956|NCT01977482|38783|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
6957|NCT01977482|38784|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
6958|NCT01977482|38785|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
6959|NCT01977482|38786|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
6960|NCT01977482|38787|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
6961|NCT01977482|38782|P6|Overall Study|Protocol Violation|0
6962|NCT01977482|38783|P5|Overall Study|Protocol Violation|0
6963|NCT01977482|38784|P4|Overall Study|Protocol Violation|0
6964|NCT01977482|38785|P3|Overall Study|Protocol Violation|1
6965|NCT01977482|38786|P2|Overall Study|Protocol Violation|0
6966|NCT01977482|38787|P1|Overall Study|Protocol Violation|0
6967|NCT01977482|38782|P6|Overall Study|Physician Decision|0
6968|NCT01977482|38783|P5|Overall Study|Physician Decision|0
6969|NCT01977482|38784|P4|Overall Study|Physician Decision|0
6970|NCT01977482|38785|P3|Overall Study|Physician Decision|0
6971|NCT01977482|38786|P2|Overall Study|Physician Decision|1
6972|NCT01977482|38787|P1|Overall Study|Physician Decision|0
6973|NCT01977482|38782|P6|Overall Study|Lost to Follow-up|0
6974|NCT01977482|38783|P5|Overall Study|Lost to Follow-up|0
6975|NCT01977482|38784|P4|Overall Study|Lost to Follow-up|0
6976|NCT01977482|38785|P3|Overall Study|Lost to Follow-up|0
6977|NCT01977482|38786|P2|Overall Study|Lost to Follow-up|0
6978|NCT01977482|38787|P1|Overall Study|Lost to Follow-up|1
6979|NCT01977482|38782|P6|Overall Study|Adverse Event|0
6980|NCT01977482|38783|P5|Overall Study|Adverse Event|2
6981|NCT01977482|38784|P4|Overall Study|Adverse Event|0
6982|NCT01977482|38785|P3|Overall Study|Adverse Event|1
6983|NCT01977482|38786|P2|Overall Study|Adverse Event|1
6984|NCT01977482|38787|P1|Overall Study|Adverse Event|0
6985|NCT01977456|38902|P1|Overall Study|Death|5
6986|NCT01976845|38940|P3|Overall Study|Physician Decision|3
6987|NCT01976845|38941|P2|Overall Study|Physician Decision|8
6988|NCT01976845|38942|P1|Overall Study|Physician Decision|8
6989|NCT01976806|38958|P2|Overall Study|Withdrawal by Subject|1
6990|NCT01976806|38959|P1|Overall Study|Withdrawal by Subject|1
6991|NCT01976806|38958|P2|Overall Study|Adverse Event|1
6992|NCT01976806|38959|P1|Overall Study|Adverse Event|1
6993|NCT01976806|38958|P2|Overall Study|Lost to Follow-up|4
6994|NCT01976806|38959|P1|Overall Study|Lost to Follow-up|1
6995|NCT01976624|38970|P1|Overall Study|Participants age less than 19 years|12
6996|NCT01976624|38970|P1|Overall Study|Participants contraindicated|2
6997|NCT01976299|38992|P2|Overall Study|See clarification above in comments|2
6998|NCT01976299|38993|P1|Overall Study|See clarification above in comments|9
6999|NCT01976299|38992|P2|Overall Study|Lost to Follow-up|1
7000|NCT01976299|38993|P1|Overall Study|Lost to Follow-up|7
7001|NCT01976299|38992|P2|Overall Study|Death|2
7002|NCT01976299|38993|P1|Overall Study|Death|4
7003|NCT01976299|38992|P2|Overall Study|Withdrawal by Subject|1
7004|NCT01976299|38993|P1|Overall Study|Withdrawal by Subject|3
7005|NCT01975675|39015|P4|Overall Study|Death|0
7006|NCT01975675|39016|P3|Overall Study|Death|0
7007|NCT01975675|39017|P2|Overall Study|Death|1
7008|NCT01975675|39018|P1|Overall Study|Death|0
7009|NCT01975285|39051|P2|Overall Study|Failed Block and follow up|2
7010|NCT01975285|39052|P1|Overall Study|Failed Block and follow up|2
7011|NCT01975246|39068|P2|Overall Study|Other than stated|1
7012|NCT01975246|39069|P1|Overall Study|Other than stated|0
7013|NCT01975246|39068|P2|Overall Study|Protocol Violation|0
7014|NCT01975246|39069|P1|Overall Study|Protocol Violation|1
7015|NCT01975246|39068|P2|Overall Study|Lack of Efficacy|0
7016|NCT01975246|39069|P1|Overall Study|Lack of Efficacy|1
7017|NCT01975246|39068|P2|Overall Study|Adverse Event|1
7018|NCT01975246|39069|P1|Overall Study|Adverse Event|2
7019|NCT01974895|39081|P2|Overall Study|Other (Reason unknown)|8
7020|NCT01974895|39082|P1|Overall Study|Other (Reason unknown)|9
7021|NCT01974895|39081|P2|Overall Study|Other (Missed Visit)|0
7022|NCT01974895|39082|P1|Overall Study|Other (Missed Visit)|1
7023|NCT01974895|39081|P2|Overall Study|Withdrawal by Subject|1
7024|NCT01974895|39082|P1|Overall Study|Withdrawal by Subject|0
7025|NCT01974895|39081|P2|Overall Study|Lost to Follow-up|6
7026|NCT01974895|39082|P1|Overall Study|Lost to Follow-up|4
7027|NCT01974895|39081|P2|Overall Study|Protocol Violation|0
7028|NCT01974895|39082|P1|Overall Study|Protocol Violation|1
7029|NCT01974817|39112|P1|Overall Study|Protocol Violation|2
7030|NCT01974817|39112|P1|Overall Study|Lost to Follow-up|2
7031|NCT01974817|39112|P1|Overall Study|Death|4
7032|NCT01974752|39118|P2|Overall Study|Other Eligibility Criteria|1
7033|NCT01974752|39119|P1|Overall Study|Other Eligibility Criteria|0
7034|NCT01974752|39118|P2|Overall Study|Withdrawal by Subject|3
7035|NCT01974752|39119|P1|Overall Study|Withdrawal by Subject|2
7036|NCT01974752|39118|P2|Overall Study|Lost to Follow-up|0
7037|NCT01974752|39119|P1|Overall Study|Lost to Follow-up|2
7038|NCT01974752|39118|P2|Overall Study|Death|11
7039|NCT01974752|39119|P1|Overall Study|Death|33
7040|NCT01974323|39146|P2|Overall Study|Adverse Event|2
7041|NCT01974323|39147|P1|Overall Study|Adverse Event|2
7042|NCT01974323|39146|P2|Overall Study|Lack of Efficacy|1
7043|NCT01974323|39147|P1|Overall Study|Lack of Efficacy|1
7044|NCT01974323|39146|P2|Overall Study|Pregnancy|1
7045|NCT01974323|39147|P1|Overall Study|Pregnancy|2
7046|NCT01974323|39146|P2|Overall Study|Lost to Follow-up|40
7047|NCT01974323|39147|P1|Overall Study|Lost to Follow-up|45
7048|NCT01974323|39146|P2|Overall Study|Personal Reasons|19
7049|NCT01974323|39147|P1|Overall Study|Personal Reasons|15
7050|NCT01974323|39146|P2|Overall Study|Protocol Violation|2
7051|NCT01974323|39147|P1|Overall Study|Protocol Violation|2
7052|NCT01974323|39146|P2|Overall Study|Other Reasons|28
7053|NCT01974323|39147|P1|Overall Study|Other Reasons|25
7054|NCT01974141|39180|P2|Overall Study|Adverse Event|5
7055|NCT01974141|39181|P1|Overall Study|Adverse Event|4
7056|NCT01974141|39180|P2|Overall Study|Lack of Efficacy|1
7057|NCT01974141|39181|P1|Overall Study|Lack of Efficacy|0
7058|NCT01974141|39180|P2|Overall Study|Pregnancy|3
7059|NCT01974141|39181|P1|Overall Study|Pregnancy|3
7060|NCT01974141|39180|P2|Overall Study|Lost to Follow-up|29
7061|NCT01974141|39181|P1|Overall Study|Lost to Follow-up|38
7062|NCT01974141|39180|P2|Overall Study|Personal Reasons|20
7063|NCT01974141|39181|P1|Overall Study|Personal Reasons|21
7064|NCT01974141|39180|P2|Overall Study|Protocol Violation|6
7065|NCT01974141|39181|P1|Overall Study|Protocol Violation|2
7066|NCT01974141|39180|P2|Overall Study|Other Reasons|18
7067|NCT01974141|39181|P1|Overall Study|Other Reasons|28
7068|NCT01973595|39238|P4|Washout|Withdrawal by Subject|0
7069|NCT01973595|39239|P3|Washout|Withdrawal by Subject|1
7070|NCT01973595|39240|P2|Washout|Withdrawal by Subject|0
7071|NCT01973595|39241|P1|Washout|Withdrawal by Subject|1
7072|NCT01973439|39255|P1|Overall Study|PK curve incomplete|2
7073|NCT01973439|39255|P1|Overall Study|Vomiting after commencing once daily|1
7074|NCT01973439|39255|P1|Overall Study|Lost samples from one PK Day|2
7075|NCT01973231|39277|P2|Overall Study|Withdrawal by Subject|9
7076|NCT01973231|39278|P1|Overall Study|Withdrawal by Subject|7
7077|NCT01973231|39277|P2|Overall Study|unclassified|1
7078|NCT01973231|39278|P1|Overall Study|unclassified|2
7079|NCT01973231|39277|P2|Overall Study|Lost to Follow-up|1
7080|NCT01973231|39278|P1|Overall Study|Lost to Follow-up|1
7081|NCT01973231|39277|P2|Overall Study|Protocol Violation|1
7082|NCT01973231|39278|P1|Overall Study|Protocol Violation|1
7083|NCT01973218|39298|P2|Overall Study|Withdrawal by Subject|0
7084|NCT01973218|39299|P1|Overall Study|Withdrawal by Subject|1
7085|NCT01973218|39298|P2|Overall Study|Adverse Event|0
7086|NCT01973218|39299|P1|Overall Study|Adverse Event|1
7087|NCT01972776|39341|P6|Part 2|Administrative problems|7
7088|NCT01972776|39342|P5|Part 2|Administrative problems|10
7089|NCT01972776|39343|P4|Part 2|Administrative problems|0
7090|NCT01972776|39344|P3|Part 2|Administrative problems|0
7091|NCT01972776|39345|P2|Part 2|Administrative problems|0
7092|NCT01972776|39346|P1|Part 2|Administrative problems|0
7093|NCT01972776|39341|P6|Part 2|Adverse Event|0
7094|NCT01972776|39342|P5|Part 2|Adverse Event|3
7095|NCT01972776|39343|P4|Part 2|Adverse Event|0
7096|NCT01972776|39344|P3|Part 2|Adverse Event|0
7097|NCT01972776|39345|P2|Part 2|Adverse Event|0
7098|NCT01972776|39346|P1|Part 2|Adverse Event|0
7099|NCT01972776|39341|P6|Part 1|Adverse Event|0
7100|NCT01972776|39342|P5|Part 1|Adverse Event|0
7101|NCT01972776|39343|P4|Part 1|Adverse Event|1
7102|NCT01972776|39344|P3|Part 1|Adverse Event|1
7103|NCT01972776|39345|P2|Part 1|Adverse Event|0
7104|NCT01972776|39346|P1|Part 1|Adverse Event|0
7105|NCT01972776|39341|P6|Part 1|Withdrawal by Subject|0
7106|NCT01972776|39342|P5|Part 1|Withdrawal by Subject|0
7107|NCT01972776|39343|P4|Part 1|Withdrawal by Subject|0
7108|NCT01972776|39344|P3|Part 1|Withdrawal by Subject|1
7109|NCT01972776|39345|P2|Part 1|Withdrawal by Subject|0
7110|NCT01972776|39346|P1|Part 1|Withdrawal by Subject|0
7111|NCT01972659|39416|P2|Overall Study|problems realted to acceleromyograph|1
7112|NCT01972659|39417|P1|Overall Study|problems realted to acceleromyograph|2
7113|NCT01972659|39416|P2|Overall Study|Protocol Violation|2
7114|NCT01972659|39417|P1|Overall Study|Protocol Violation|2
7115|NCT01972438|39442|P2|Post Month 12 Study Period|Early Study Closure|4
7116|NCT01972438|39443|P1|Post Month 12 Study Period|Early Study Closure|3
7117|NCT01972438|39442|P2|Months 6-12 Study Period|Early Study Closure|2
7118|NCT01972438|39443|P1|Months 6-12 Study Period|Early Study Closure|2
7119|NCT01972438|39442|P2|Months 6-12 Study Period|Death|0
7120|NCT01972438|39443|P1|Months 6-12 Study Period|Death|1
7121|NCT01972438|39442|P2|Months 3-6 Crossover Period|Early Study Closure|1
7122|NCT01972438|39443|P1|Months 3-6 Crossover Period|Early Study Closure|0
7123|NCT01972438|39442|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
7124|NCT01972438|39443|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
7125|NCT01972438|39442|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
7126|NCT01972438|39443|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
7127|NCT01972438|39442|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
7128|NCT01972438|39443|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
7129|NCT01972438|39442|P2|Baseline-Month 3 Crossover Period|Death|0
7130|NCT01972438|39443|P1|Baseline-Month 3 Crossover Period|Death|1
7131|NCT01972152|39495|P6|Second Treatment Visit|Protocol Violation|0
7132|NCT01972152|39496|P5|Second Treatment Visit|Protocol Violation|0
7133|NCT01972152|39497|P4|Second Treatment Visit|Protocol Violation|0
7134|NCT01972152|39498|P3|Second Treatment Visit|Protocol Violation|0
7135|NCT01972152|39499|P2|Second Treatment Visit|Protocol Violation|1
7136|NCT01972152|39500|P1|Second Treatment Visit|Protocol Violation|0
7137|NCT01972152|39495|P6|First Treatment Visit|Lost to Follow-up|0
7138|NCT01972152|39496|P5|First Treatment Visit|Lost to Follow-up|0
7139|NCT01972152|39497|P4|First Treatment Visit|Lost to Follow-up|0
7140|NCT01972152|39498|P3|First Treatment Visit|Lost to Follow-up|0
7141|NCT01972152|39499|P2|First Treatment Visit|Lost to Follow-up|1
7142|NCT01972152|39500|P1|First Treatment Visit|Lost to Follow-up|0
7143|NCT01971723|39537|P2|Overall Study|Protocol Violation|2
7144|NCT01971723|39538|P1|Overall Study|Protocol Violation|1
7145|NCT01971723|39537|P2|Overall Study|Withdrawal by Subject|1
7146|NCT01971723|39538|P1|Overall Study|Withdrawal by Subject|1
7147|NCT01971554|39572|P4|Overall Study|Lost to Follow-up|0
7148|NCT01971554|39573|P3|Overall Study|Lost to Follow-up|0
7149|NCT01971554|39574|P2|Overall Study|Lost to Follow-up|0
7150|NCT01971554|39575|P1|Overall Study|Lost to Follow-up|1
7151|NCT01970995|39624|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
7152|NCT01970995|39625|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
7153|NCT01970995|39626|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
7154|NCT01970995|39624|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7155|NCT01970995|39625|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7156|NCT01970995|39626|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
7157|NCT01970982|39649|P3|Overall Study|Withdrawal by Subject|2
7158|NCT01970982|39650|P2|Overall Study|Withdrawal by Subject|0
7159|NCT01970982|39651|P1|Overall Study|Withdrawal by Subject|0
7160|NCT01970878|39673|P4|Overall Study|No Completion Status|0
7161|NCT01970878|39674|P3|Overall Study|No Completion Status|0
7162|NCT01970878|39675|P2|Overall Study|No Completion Status|1
7163|NCT01970878|39676|P1|Overall Study|No Completion Status|0
7164|NCT01970878|39673|P4|Overall Study|Physician Decision|0
7165|NCT01970878|39674|P3|Overall Study|Physician Decision|1
7166|NCT01970878|39675|P2|Overall Study|Physician Decision|1
7167|NCT01970878|39676|P1|Overall Study|Physician Decision|0
7168|NCT01970878|39673|P4|Overall Study|Protocol Specified Criteria|6
7169|NCT01970878|39674|P3|Overall Study|Protocol Specified Criteria|3
7170|NCT01970878|39675|P2|Overall Study|Protocol Specified Criteria|4
7171|NCT01970878|39676|P1|Overall Study|Protocol Specified Criteria|10
7172|NCT01970878|39673|P4|Overall Study|Adverse Event|3
7173|NCT01970878|39674|P3|Overall Study|Adverse Event|4
7174|NCT01970878|39675|P2|Overall Study|Adverse Event|7
7175|NCT01970878|39676|P1|Overall Study|Adverse Event|12
7176|NCT01970878|39673|P4|Overall Study|Lack of Efficacy|0
7177|NCT01970878|39674|P3|Overall Study|Lack of Efficacy|2
7178|NCT01970878|39675|P2|Overall Study|Lack of Efficacy|1
7179|NCT01970878|39676|P1|Overall Study|Lack of Efficacy|2
7180|NCT01970878|39673|P4|Overall Study|Administrative Reasons|4
7181|NCT01970878|39674|P3|Overall Study|Administrative Reasons|0
7182|NCT01970878|39675|P2|Overall Study|Administrative Reasons|0
7183|NCT01970878|39676|P1|Overall Study|Administrative Reasons|1
7184|NCT01970878|39673|P4|Overall Study|Lost to Follow-up|4
7185|NCT01970878|39674|P3|Overall Study|Lost to Follow-up|2
7186|NCT01970878|39675|P2|Overall Study|Lost to Follow-up|3
7187|NCT01970878|39676|P1|Overall Study|Lost to Follow-up|1
7188|NCT01970878|39673|P4|Overall Study|Withdrawal by Subject|7
7189|NCT01970878|39674|P3|Overall Study|Withdrawal by Subject|14
7190|NCT01970878|39675|P2|Overall Study|Withdrawal by Subject|10
7191|NCT01970878|39676|P1|Overall Study|Withdrawal by Subject|11
7192|NCT01970488|39712|P5|Part 2: Post Week 16|Lost to Follow-up|2
7193|NCT01970488|39713|P4|Part 2: Post Week 16|Lost to Follow-up|1
7194|NCT01970488|39714|P3|Part 2: Post Week 16|Lost to Follow-up|1
7195|NCT01970488|39715|P2|Part 2: Post Week 16|Lost to Follow-up|0
7196|NCT01970488|39716|P1|Part 2: Post Week 16|Lost to Follow-up|0
7197|NCT01970488|39712|P5|Part 2: Post Week 16|Withdrawal by Subject|3
7198|NCT01970488|39713|P4|Part 2: Post Week 16|Withdrawal by Subject|3
7199|NCT01970488|39714|P3|Part 2: Post Week 16|Withdrawal by Subject|8
7200|NCT01970488|39715|P2|Part 2: Post Week 16|Withdrawal by Subject|0
7201|NCT01970488|39716|P1|Part 2: Post Week 16|Withdrawal by Subject|0
7202|NCT01970488|39712|P5|Part 2: Post Week 16|Adverse Event|1
7203|NCT01970488|39713|P4|Part 2: Post Week 16|Adverse Event|1
7204|NCT01970488|39714|P3|Part 2: Post Week 16|Adverse Event|5
7205|NCT01970488|39715|P2|Part 2: Post Week 16|Adverse Event|0
7206|NCT01970488|39716|P1|Part 2: Post Week 16|Adverse Event|0
7207|NCT01970488|39712|P5|Part 2: Post Week 16|Lack of Efficacy|1
7208|NCT01970488|39713|P4|Part 2: Post Week 16|Lack of Efficacy|3
7209|NCT01970488|39714|P3|Part 2: Post Week 16|Lack of Efficacy|2
7210|NCT01970488|39715|P2|Part 2: Post Week 16|Lack of Efficacy|0
7211|NCT01970488|39716|P1|Part 2: Post Week 16|Lack of Efficacy|0
7212|NCT01970488|39712|P5|Part 2: Post Week 16|Non-compliance|0
7213|NCT01970488|39713|P4|Part 2: Post Week 16|Non-compliance|0
7214|NCT01970488|39714|P3|Part 2: Post Week 16|Non-compliance|1
7215|NCT01970488|39715|P2|Part 2: Post Week 16|Non-compliance|0
7216|NCT01970488|39716|P1|Part 2: Post Week 16|Non-compliance|0
7217|NCT01970488|39712|P5|Part 2: Post Week 16|Physician Decision|1
7218|NCT01970488|39713|P4|Part 2: Post Week 16|Physician Decision|0
7219|NCT01970488|39714|P3|Part 2: Post Week 16|Physician Decision|0
7220|NCT01970488|39715|P2|Part 2: Post Week 16|Physician Decision|0
7221|NCT01970488|39716|P1|Part 2: Post Week 16|Physician Decision|0
7222|NCT01970488|39712|P5|Part 1: Through Week 16|Lost to Follow-up|0
7223|NCT01970488|39713|P4|Part 1: Through Week 16|Lost to Follow-up|0
7224|NCT01970488|39714|P3|Part 1: Through Week 16|Lost to Follow-up|0
7225|NCT01970488|39715|P2|Part 1: Through Week 16|Lost to Follow-up|2
7226|NCT01970488|39716|P1|Part 1: Through Week 16|Lost to Follow-up|0
7227|NCT01970488|39712|P5|Part 1: Through Week 16|Withdrawal by Subject|0
7228|NCT01970488|39713|P4|Part 1: Through Week 16|Withdrawal by Subject|0
7229|NCT01970488|39714|P3|Part 1: Through Week 16|Withdrawal by Subject|0
7230|NCT01970488|39715|P2|Part 1: Through Week 16|Withdrawal by Subject|2
7231|NCT01970488|39716|P1|Part 1: Through Week 16|Withdrawal by Subject|3
7232|NCT01970488|39712|P5|Part 1: Through Week 16|Adverse Event|0
7233|NCT01970488|39713|P4|Part 1: Through Week 16|Adverse Event|0
7234|NCT01970488|39714|P3|Part 1: Through Week 16|Adverse Event|0
7235|NCT01970488|39715|P2|Part 1: Through Week 16|Adverse Event|5
7236|NCT01970488|39716|P1|Part 1: Through Week 16|Adverse Event|6
7237|NCT01970488|39712|P5|Part 1: Through Week 16|Protocol Violation|0
7238|NCT01970488|39713|P4|Part 1: Through Week 16|Protocol Violation|0
7239|NCT01970488|39714|P3|Part 1: Through Week 16|Protocol Violation|0
7240|NCT01970488|39715|P2|Part 1: Through Week 16|Protocol Violation|2
7241|NCT01970488|39716|P1|Part 1: Through Week 16|Protocol Violation|1
7242|NCT01970488|39712|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
7243|NCT01970488|39713|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
7244|NCT01970488|39714|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
7245|NCT01970488|39715|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
7246|NCT01970488|39716|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
7247|NCT01970475|39783|P2|Overall Study|Protocol Violation|0
7248|NCT01970475|39784|P1|Overall Study|Protocol Violation|1
7249|NCT01970475|39783|P2|Overall Study|Lost to Follow-up|2
7250|NCT01970475|39784|P1|Overall Study|Lost to Follow-up|2
7251|NCT01970475|39783|P2|Overall Study|Adverse Event|3
7252|NCT01970475|39784|P1|Overall Study|Adverse Event|7
7253|NCT01970475|39783|P2|Overall Study|Withdrawal by Subject|6
7254|NCT01970475|39784|P1|Overall Study|Withdrawal by Subject|11
7255|NCT01970397|39804|P2|Overall Study|Protocol Violation|1
7256|NCT01970397|39805|P1|Overall Study|Protocol Violation|1
7257|NCT01970397|39804|P2|Overall Study|Personal Reasons|2
7258|NCT01970397|39805|P1|Overall Study|Personal Reasons|1
7259|NCT01970397|39804|P2|Overall Study|Lost to Follow-up|1
7260|NCT01970397|39805|P1|Overall Study|Lost to Follow-up|0
7261|NCT01970397|39804|P2|Overall Study|Adverse Event|1
7262|NCT01970397|39805|P1|Overall Study|Adverse Event|0
7263|NCT01969721|39832|P4|Overall Study|Discontinued during washout periods.|2
7264|NCT01969721|39833|P3|Overall Study|Discontinued during washout periods.|1
7265|NCT01969721|39834|P2|Overall Study|Discontinued during washout periods.|1
7266|NCT01969721|39835|P1|Overall Study|Discontinued during washout periods.|0
7267|NCT01969721|39832|P4|Overall Study|Other not defined above|0
7268|NCT01969721|39833|P3|Overall Study|Other not defined above|0
7269|NCT01969721|39834|P2|Overall Study|Other not defined above|2
7270|NCT01969721|39835|P1|Overall Study|Other not defined above|0
7271|NCT01969721|39832|P4|Overall Study|Non compliant with protocol|2
7272|NCT01969721|39833|P3|Overall Study|Non compliant with protocol|0
7273|NCT01969721|39834|P2|Overall Study|Non compliant with protocol|1
7274|NCT01969721|39835|P1|Overall Study|Non compliant with protocol|1
7275|NCT01969721|39832|P4|Overall Study|Lack of Efficacy|0
7276|NCT01969721|39833|P3|Overall Study|Lack of Efficacy|1
7277|NCT01969721|39834|P2|Overall Study|Lack of Efficacy|0
7278|NCT01969721|39835|P1|Overall Study|Lack of Efficacy|0
7279|NCT01969721|39832|P4|Overall Study|Adverse Event|2
7280|NCT01969721|39833|P3|Overall Study|Adverse Event|3
7281|NCT01969721|39834|P2|Overall Study|Adverse Event|8
7282|NCT01969721|39835|P1|Overall Study|Adverse Event|3
7283|NCT01969565|39861|P1|Overall Study|Withdrawal by Subject|1
7284|NCT01969084|39890|P2|Overall Study|Adverse Event|1
7285|NCT01969084|39891|P1|Overall Study|Adverse Event|0
7286|NCT01968811|39905|P1|Overall Study|post op.ref. of subject to other hospita|1
7287|NCT01968811|39905|P1|Overall Study|Protocol Violation|4
7288|NCT01968551|39913|P3|Extension Phase|Still on study|32
7289|NCT01968551|39914|P2|Extension Phase|Still on study|87
7290|NCT01968551|39915|P1|Extension Phase|Still on study|20
7291|NCT01968551|39913|P3|Extension Phase|Adverse Event|2
7292|NCT01968551|39914|P2|Extension Phase|Adverse Event|0
7293|NCT01968551|39915|P1|Extension Phase|Adverse Event|0
7294|NCT01968551|39913|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
7295|NCT01968551|39914|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
7296|NCT01968551|39915|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
7297|NCT01968551|39913|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
7298|NCT01968551|39914|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
7299|NCT01968551|39915|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
7300|NCT01968551|39913|P3|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
7301|NCT01968551|39914|P2|Open Label Phase (48 Weeks)|Investigator’s Discretion|1
7302|NCT01968551|39915|P1|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
7303|NCT01968551|39913|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
7304|NCT01968551|39914|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
7305|NCT01968551|39915|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
7306|NCT01968434|39931|P2|Overall Study|Lost to Follow-up|6
7307|NCT01968434|39932|P1|Overall Study|Lost to Follow-up|3
7308|NCT01967732|39967|P4|First Intervention (Day 1)|Poor venous access|0
7309|NCT01967732|39968|P3|First Intervention (Day 1)|Poor venous access|0
7310|NCT01967732|39969|P2|First Intervention (Day 1)|Poor venous access|1
7311|NCT01967732|39970|P1|First Intervention (Day 1)|Poor venous access|0
7312|NCT01967732|39967|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7313|NCT01967732|39968|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7314|NCT01967732|39969|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
7315|NCT01967732|39970|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
7316|NCT01967719|39984|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
7317|NCT01967719|39985|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
7318|NCT01967719|39986|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
7319|NCT01967719|39987|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
7320|NCT01967719|39984|P4|First Intervention (Day 1)|Withdrawal by Subject|1
7321|NCT01967719|39985|P3|First Intervention (Day 1)|Withdrawal by Subject|0
7322|NCT01967719|39986|P2|First Intervention (Day 1)|Withdrawal by Subject|1
7323|NCT01967719|39987|P1|First Intervention (Day 1)|Withdrawal by Subject|0
7324|NCT01967706|40002|P4|First Intervention (Day 1)|Withdrawal by Subject|0
7325|NCT01967706|40003|P3|First Intervention (Day 1)|Withdrawal by Subject|0
7326|NCT01967706|40004|P2|First Intervention (Day 1)|Withdrawal by Subject|0
7327|NCT01967706|40005|P1|First Intervention (Day 1)|Withdrawal by Subject|1
7328|NCT01967550|40016|P2|Overall Study|Non Compliance|1
7329|NCT01967550|40017|P1|Overall Study|Non Compliance|0
7330|NCT01967550|40016|P2|Overall Study|Protocol Violation|1
7331|NCT01967550|40017|P1|Overall Study|Protocol Violation|2
7332|NCT01967550|40016|P2|Overall Study|Adverse Event|0
7333|NCT01967550|40017|P1|Overall Study|Adverse Event|2
7334|NCT01967550|40016|P2|Overall Study|Withdrawal by Subject|0
7335|NCT01967550|40017|P1|Overall Study|Withdrawal by Subject|1
7336|NCT01967277|40025|P2|Overall Study|Unrelated illness|1
7337|NCT01967277|40026|P1|Overall Study|Unrelated illness|0
7338|NCT01967277|40025|P2|Overall Study|Lost to Follow-up|2
7339|NCT01967277|40026|P1|Overall Study|Lost to Follow-up|1
7340|NCT01967147|40036|P2|Overall Study|Other|5
7341|NCT01967147|40037|P1|Overall Study|Other|4
7342|NCT01967147|40036|P2|Overall Study|Non-compliance with Study Drug|3
7343|NCT01967147|40037|P1|Overall Study|Non-compliance with Study Drug|0
7344|NCT01967147|40036|P2|Overall Study|Withdrawal by Subject|4
7345|NCT01967147|40037|P1|Overall Study|Withdrawal by Subject|2
7346|NCT01967147|40036|P2|Overall Study|Lost to Follow-up|2
7347|NCT01967147|40037|P1|Overall Study|Lost to Follow-up|1
7348|NCT01967147|40036|P2|Overall Study|Lack of Efficacy|4
7349|NCT01967147|40037|P1|Overall Study|Lack of Efficacy|1
7350|NCT01967147|40036|P2|Overall Study|Adverse Event|2
7351|NCT01967147|40037|P1|Overall Study|Adverse Event|5
7352|NCT01966120|40251|P2|Overall Study|Lost to Follow-up|1
7353|NCT01966120|40252|P1|Overall Study|Lost to Follow-up|1
7354|NCT01966120|40251|P2|Overall Study|Withdrawal by Subject|5
7355|NCT01966120|40252|P1|Overall Study|Withdrawal by Subject|0
7356|NCT01966068|40276|P1|Overall Study|Lost to Follow-up|81
7357|NCT01966068|40276|P1|Overall Study|Withdrawal by Subject|57
7358|NCT01966042|40281|P1|Overall Study|Death|2
7359|NCT01965938|40290|P2|Overall Study|Withdrawal by Subject|0
7360|NCT01965938|40291|P1|Overall Study|Withdrawal by Subject|1
7361|NCT01965600|40328|P4|Second Intervention|Study terminated by Sponsor|2
7362|NCT01965600|40329|P3|Second Intervention|Study terminated by Sponsor|2
7363|NCT01965600|40330|P2|Second Intervention|Study terminated by Sponsor|0
7364|NCT01965600|40331|P1|Second Intervention|Study terminated by Sponsor|0
7365|NCT01965600|40328|P4|Washout Period of Approximately 15 Days|Adverse Event|1
7366|NCT01965600|40329|P3|Washout Period of Approximately 15 Days|Adverse Event|0
7367|NCT01965600|40330|P2|Washout Period of Approximately 15 Days|Adverse Event|0
7368|NCT01965600|40331|P1|Washout Period of Approximately 15 Days|Adverse Event|0
7369|NCT01965600|40328|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7370|NCT01965600|40329|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7371|NCT01965600|40330|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
7372|NCT01965600|40331|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
7373|NCT01965600|40328|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7374|NCT01965600|40329|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7375|NCT01965600|40330|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
7376|NCT01965600|40331|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
7377|NCT01965600|40328|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
7378|NCT01965600|40329|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
7379|NCT01965600|40330|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
7380|NCT01965600|40331|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
7381|NCT01965535|40388|P2|Overall Study|Lack of Efficacy|1
7382|NCT01965535|40389|P1|Overall Study|Lack of Efficacy|2
7383|NCT01965431|40403|P6|Overall Study|Other than stated above|6
7384|NCT01965431|40404|P5|Overall Study|Other than stated above|6
7385|NCT01965431|40405|P4|Overall Study|Other than stated above|6
7386|NCT01965431|40406|P3|Overall Study|Other than stated above|6
7387|NCT01965431|40407|P2|Overall Study|Other than stated above|5
7388|NCT01965431|40408|P1|Overall Study|Other than stated above|6
7389|NCT01965431|40403|P6|Overall Study|Adverse Event|0
7390|NCT01965431|40404|P5|Overall Study|Adverse Event|0
7391|NCT01965431|40405|P4|Overall Study|Adverse Event|0
7392|NCT01965431|40406|P3|Overall Study|Adverse Event|0
7393|NCT01965431|40407|P2|Overall Study|Adverse Event|1
7394|NCT01965431|40408|P1|Overall Study|Adverse Event|0
7395|NCT01965327|40421|P1|Overall Study|Physician Decision|2
7396|NCT01965262|40635|P2|Second Intervention (7 Days)|Poor visual acuity|0
7397|NCT01965262|40636|P1|Second Intervention (7 Days)|Poor visual acuity|1
7398|NCT01965262|40635|P2|Second Intervention (7 Days)|Poor lens fit|9
7399|NCT01965262|40636|P1|Second Intervention (7 Days)|Poor lens fit|0
7400|NCT01965262|40635|P2|Second Intervention (7 Days)|Discontinued|1
7401|NCT01965262|40636|P1|Second Intervention (7 Days)|Discontinued|0
7402|NCT01964898|40719|P2|Overall Study|Withdrawal by Subject|0
7403|NCT01964898|40720|P1|Overall Study|Withdrawal by Subject|1
7404|NCT01964898|40719|P2|Overall Study|Lost to Follow-up|5
7405|NCT01964898|40720|P1|Overall Study|Lost to Follow-up|3
7406|NCT01964898|40719|P2|Overall Study|did not receive the allocated interventi|1
7407|NCT01964898|40720|P1|Overall Study|did not receive the allocated interventi|2
7408|NCT01964898|40719|P2|Overall Study|ineligible post-randomization|1
7409|NCT01964898|40720|P1|Overall Study|ineligible post-randomization|1
7410|NCT01964716|40742|P2|Overall Study|Death|0
7411|NCT01964716|40743|P1|Overall Study|Death|1
7412|NCT01964716|40742|P2|Overall Study|No longer met eligibility criteria|1
7413|NCT01964716|40743|P1|Overall Study|No longer met eligibility criteria|1
7414|NCT01964716|40742|P2|Overall Study|Lost to Follow-up|2
7415|NCT01964716|40743|P1|Overall Study|Lost to Follow-up|1
7416|NCT01964716|40742|P2|Overall Study|Withdrawal by Subject|3
7417|NCT01964716|40743|P1|Overall Study|Withdrawal by Subject|2
7418|NCT01964547|40781|P2|Overall Study|Withdrawal by Investigator|1
7419|NCT01964547|40782|P1|Overall Study|Withdrawal by Investigator|0
7420|NCT01964547|40781|P2|Overall Study|Lost to Follow-up|1
7421|NCT01964547|40782|P1|Overall Study|Lost to Follow-up|0
7422|NCT01964547|40781|P2|Overall Study|Withdrawal by Subject|7
7423|NCT01964547|40782|P1|Overall Study|Withdrawal by Subject|4
7424|NCT01964547|40781|P2|Overall Study|Adverse Event|2
7425|NCT01964547|40782|P1|Overall Study|Adverse Event|8
7426|NCT01964352|40810|P4|Overall Study|Other than stated above|2
7427|NCT01964352|40811|P3|Overall Study|Other than stated above|1
7428|NCT01964352|40812|P2|Overall Study|Other than stated above|2
7429|NCT01964352|40813|P1|Overall Study|Other than stated above|0
7430|NCT01964352|40810|P4|Overall Study|Withdrawal by Subject|0
7431|NCT01964352|40811|P3|Overall Study|Withdrawal by Subject|1
7432|NCT01964352|40812|P2|Overall Study|Withdrawal by Subject|2
7433|NCT01964352|40813|P1|Overall Study|Withdrawal by Subject|4
7434|NCT01964352|40810|P4|Overall Study|Lost to Follow-up|1
7435|NCT01964352|40811|P3|Overall Study|Lost to Follow-up|0
7436|NCT01964352|40812|P2|Overall Study|Lost to Follow-up|0
7437|NCT01964352|40813|P1|Overall Study|Lost to Follow-up|1
7438|NCT01964352|40810|P4|Overall Study|Protocol Violation|2
7439|NCT01964352|40811|P3|Overall Study|Protocol Violation|0
7440|NCT01964352|40812|P2|Overall Study|Protocol Violation|4
7441|NCT01964352|40813|P1|Overall Study|Protocol Violation|2
7442|NCT01964352|40810|P4|Overall Study|Lack of Efficacy|0
7443|NCT01964352|40811|P3|Overall Study|Lack of Efficacy|0
7444|NCT01964352|40812|P2|Overall Study|Lack of Efficacy|0
7445|NCT01964352|40813|P1|Overall Study|Lack of Efficacy|6
7446|NCT01964352|40810|P4|Overall Study|Adverse Event|3
7447|NCT01964352|40811|P3|Overall Study|Adverse Event|4
7448|NCT01964352|40812|P2|Overall Study|Adverse Event|3
7449|NCT01964352|40813|P1|Overall Study|Adverse Event|13
7450|NCT01964326|40843|P1|Overall Study|Did not meet eligibility criteria|1
7451|NCT01964326|40843|P1|Overall Study|Unspecified|9
7452|NCT01964326|40843|P1|Overall Study|Investigator Discretion|1
7453|NCT01964326|40843|P1|Overall Study|Physician Decision|55
7454|NCT01964326|40843|P1|Overall Study|No Longer Meets Eligibility Criteria|1
7455|NCT01964326|40843|P1|Overall Study|Pregnancy|1
7456|NCT01964326|40843|P1|Overall Study|Withdrawal by Subject|87
7457|NCT01964326|40843|P1|Overall Study|Lost to Follow-up|88
7458|NCT01964326|40843|P1|Overall Study|Protocol Violation|4
7459|NCT01964326|40843|P1|Overall Study|Death|2
7460|NCT01964326|40843|P1|Overall Study|Adverse Event|48
7461|NCT01964222|40852|P2|Overall Study|Screening Failure|0
7462|NCT01964222|40853|P1|Overall Study|Screening Failure|2
7463|NCT01964222|40852|P2|Overall Study|Withdrawal by Subject|6
7464|NCT01964222|40853|P1|Overall Study|Withdrawal by Subject|6
7465|NCT01964222|40852|P2|Overall Study|Lost to Follow-up|5
7466|NCT01964222|40853|P1|Overall Study|Lost to Follow-up|7
7467|NCT01963767|40886|P2|Overall Study|Adverse Event|0
7468|NCT01963767|40887|P1|Overall Study|Adverse Event|2
7469|NCT01963767|40886|P2|Overall Study|Withdrawal by Subject|2
7470|NCT01963767|40887|P1|Overall Study|Withdrawal by Subject|4
7471|NCT01963676|40897|P2|Overall Study|Withdrawal by Subject|0
7472|NCT01963676|40898|P1|Overall Study|Withdrawal by Subject|1
7473|NCT01963611|40911|P5|Overall Study|Unspecified|45
7474|NCT01963611|40912|P4|Overall Study|Unspecified|45
7475|NCT01963611|40913|P3|Overall Study|Unspecified|48
7476|NCT01963611|40914|P2|Overall Study|Unspecified|46
7477|NCT01963611|40915|P1|Overall Study|Unspecified|47
7478|NCT01963611|40911|P5|Overall Study|Withdrawal by Subject|3
7479|NCT01963611|40912|P4|Overall Study|Withdrawal by Subject|1
7480|NCT01963611|40913|P3|Overall Study|Withdrawal by Subject|1
7481|NCT01963611|40914|P2|Overall Study|Withdrawal by Subject|2
7482|NCT01963611|40915|P1|Overall Study|Withdrawal by Subject|3
7483|NCT01963611|40911|P5|Overall Study|Lack of Efficacy|0
7484|NCT01963611|40912|P4|Overall Study|Lack of Efficacy|1
7485|NCT01963611|40913|P3|Overall Study|Lack of Efficacy|0
7486|NCT01963611|40914|P2|Overall Study|Lack of Efficacy|0
7487|NCT01963611|40915|P1|Overall Study|Lack of Efficacy|0
7488|NCT01963611|40911|P5|Overall Study|Protocol Violation|0
7489|NCT01963611|40912|P4|Overall Study|Protocol Violation|1
7490|NCT01963611|40913|P3|Overall Study|Protocol Violation|0
7491|NCT01963611|40914|P2|Overall Study|Protocol Violation|0
7492|NCT01963611|40915|P1|Overall Study|Protocol Violation|0
7493|NCT01963611|40911|P5|Overall Study|Adverse Event|3
7494|NCT01963611|40912|P4|Overall Study|Adverse Event|4
7495|NCT01963611|40913|P3|Overall Study|Adverse Event|3
7496|NCT01963611|40914|P2|Overall Study|Adverse Event|1
7497|NCT01963611|40915|P1|Overall Study|Adverse Event|1
7498|NCT01962922|41006|P2|Extendion Portion (up to Month 6)|Physician Decision|0
7499|NCT01962922|41007|P1|Extendion Portion (up to Month 6)|Physician Decision|1
7500|NCT01962922|41006|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
7501|NCT01962922|41007|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
7502|NCT01962922|41006|P2|PK Portion Day 7|non-compliance|0
7503|NCT01962922|41007|P1|PK Portion Day 7|non-compliance|1
7504|NCT01962922|41006|P2|PK Portion Day 7|Withdrawal by Subject|0
7505|NCT01962922|41007|P1|PK Portion Day 7|Withdrawal by Subject|3
7506|NCT01962493|41046|P2|Overall Study|Withdrawal by Subject|2
7507|NCT01962493|41047|P1|Overall Study|Withdrawal by Subject|4
7508|NCT01962493|41046|P2|Overall Study|Protocol Violation|1
7509|NCT01962493|41047|P1|Overall Study|Protocol Violation|0
7510|NCT01962493|41046|P2|Overall Study|Adverse Event|2
7511|NCT01962493|41047|P1|Overall Study|Adverse Event|1
7512|NCT01962441|41070|P3|Retreatment Substudy|Participant Still on Study|0
7513|NCT01962441|41071|P2|Retreatment Substudy|Participant Still on Study|10
7514|NCT01962441|41072|P1|Retreatment Substudy|Participant Still on Study|20
7515|NCT01962441|41070|P3|Randomized Period|Protocol Violation|0
7516|NCT01962441|41071|P2|Randomized Period|Protocol Violation|1
7517|NCT01962441|41072|P1|Randomized Period|Protocol Violation|0
7518|NCT01962441|41070|P3|Randomized Period|Death|2
7519|NCT01962441|41071|P2|Randomized Period|Death|0
7520|NCT01962441|41072|P1|Randomized Period|Death|0
7521|NCT01962441|41070|P3|Randomized Period|Adverse Event|0
7522|NCT01962441|41071|P2|Randomized Period|Adverse Event|1
7523|NCT01962441|41072|P1|Randomized Period|Adverse Event|1
7524|NCT01962441|41070|P3|Randomized Period|Withdrew Consent|2
7525|NCT01962441|41071|P2|Randomized Period|Withdrew Consent|3
7526|NCT01962441|41072|P1|Randomized Period|Withdrew Consent|3
7527|NCT01962441|41070|P3|Randomized Period|Lost to Follow-up|4
7528|NCT01962441|41071|P2|Randomized Period|Lost to Follow-up|4
7529|NCT01962441|41072|P1|Randomized Period|Lost to Follow-up|2
7530|NCT01962441|41070|P3|Randomized Period|Randomized but Never Treated|3
7531|NCT01962441|41071|P2|Randomized Period|Randomized but Never Treated|2
7532|NCT01962441|41072|P1|Randomized Period|Randomized but Never Treated|4
7533|NCT01961544|41110|P1|Overall Study|Aggravation of Steral Pain|1
7534|NCT01961544|41110|P1|Overall Study|Poor Tolerance|1
7535|NCT01961544|41110|P1|Overall Study|Physician Decision|2
7536|NCT01961544|41110|P1|Overall Study|Adverse Event|1
7537|NCT01961544|41110|P1|Overall Study|Withdrawal by Subject|7
7538|NCT01961544|41110|P1|Overall Study|Protocol Violation|1
7539|NCT01961349|41118|P3|Overall Study|registration error, personal reason etc|1
7540|NCT01961349|41119|P2|Overall Study|registration error, personal reason etc|2
7541|NCT01961349|41120|P1|Overall Study|registration error, personal reason etc|2
7542|NCT01961349|41118|P3|Overall Study|Adverse Event|1
7543|NCT01961349|41119|P2|Overall Study|Adverse Event|0
7544|NCT01961349|41120|P1|Overall Study|Adverse Event|0
7545|NCT01961349|41118|P3|Overall Study|Withdrawal by Subject|0
7546|NCT01961349|41119|P2|Overall Study|Withdrawal by Subject|4
7547|NCT01961349|41120|P1|Overall Study|Withdrawal by Subject|1
7548|NCT01960907|41142|P2|Overall Study|Withdrawal by Subject|42
7549|NCT01960907|41143|P1|Overall Study|Withdrawal by Subject|32
7550|NCT01960907|41142|P2|Overall Study|Death|3
7551|NCT01960907|41143|P1|Overall Study|Death|4
7552|NCT01960842|41153|P1|Overall Study|Withdrawal by Subject|2
7553|NCT01960842|41153|P1|Overall Study|Adverse Event|1
7554|NCT01960816|41176|P1|Overall Study|Lost to Follow-up|1
7555|NCT01960114|41206|P2|Overall Study|Could not swallow study medication|1
7556|NCT01960114|41207|P1|Overall Study|Could not swallow study medication|0
7557|NCT01960114|41206|P2|Overall Study|Adverse Event|0
7558|NCT01960114|41207|P1|Overall Study|Adverse Event|1
7559|NCT01959932|41253|P3|Overall Study|Withdrawal by Subject|0
7560|NCT01959932|41254|P2|Overall Study|Withdrawal by Subject|0
7561|NCT01959932|41255|P1|Overall Study|Withdrawal by Subject|1
7562|NCT01959880|41277|P4|Overall Study|Study completed early-FDA approved|152
7563|NCT01959880|41278|P3|Overall Study|Study completed early-FDA approved|179
7564|NCT01959880|41279|P2|Overall Study|Study completed early-FDA approved|311
7565|NCT01959880|41280|P1|Overall Study|Study completed early-FDA approved|1003
7566|NCT01959880|41277|P4|Overall Study|Explantation w/o study device reimplant.|12
7567|NCT01959880|41278|P3|Overall Study|Explantation w/o study device reimplant.|5
7568|NCT01959880|41279|P2|Overall Study|Explantation w/o study device reimplant.|17
7569|NCT01959880|41280|P1|Overall Study|Explantation w/o study device reimplant.|22
7570|NCT01959880|41277|P4|Overall Study|Lost to Follow-up|8
7571|NCT01959880|41278|P3|Overall Study|Lost to Follow-up|15
7572|NCT01959880|41279|P2|Overall Study|Lost to Follow-up|18
7573|NCT01959880|41280|P1|Overall Study|Lost to Follow-up|95
7574|NCT01959880|41277|P4|Overall Study|Death|2
7575|NCT01959880|41278|P3|Overall Study|Death|1
7576|NCT01959880|41279|P2|Overall Study|Death|10
7577|NCT01959880|41280|P1|Overall Study|Death|1
7578|NCT01959880|41277|P4|Overall Study|Withdrawal by Subject|7
7579|NCT01959880|41278|P3|Overall Study|Withdrawal by Subject|8
7580|NCT01959880|41279|P2|Overall Study|Withdrawal by Subject|13
7581|NCT01959880|41280|P1|Overall Study|Withdrawal by Subject|11
7582|NCT01959607|41309|P4|First Intervention (Day 1)|Withdrawal by Subject|0
7583|NCT01959607|41310|P3|First Intervention (Day 1)|Withdrawal by Subject|0
7584|NCT01959607|41311|P2|First Intervention (Day 1)|Withdrawal by Subject|1
7585|NCT01959607|41312|P1|First Intervention (Day 1)|Withdrawal by Subject|1
7586|NCT01959516|41319|P2|Epoch 2|Moderate or severe COPD exacerbation|1
7587|NCT01959516|41320|P1|Epoch 2|Moderate or severe COPD exacerbation|0
7588|NCT01959516|41319|P2|Epoch 2|Subject withdrew consent|0
7589|NCT01959516|41320|P1|Epoch 2|Subject withdrew consent|1
7590|NCT01959516|41319|P2|Epoch 2|unsatisfactory therapeutic effect|0
7591|NCT01959516|41320|P1|Epoch 2|unsatisfactory therapeutic effect|1
7592|NCT01959516|41319|P2|Epoch 1|Protocol deviation|1
7593|NCT01959516|41320|P1|Epoch 1|Protocol deviation|0
7594|NCT01959516|41319|P2|Epoch 1|Moderate or severe COPD exacerbation|1
7595|NCT01959516|41320|P1|Epoch 1|Moderate or severe COPD exacerbation|0
7596|NCT01959516|41319|P2|Epoch 1|Use of prohibited treatment|0
7597|NCT01959516|41320|P1|Epoch 1|Use of prohibited treatment|1
7598|NCT01959516|41319|P2|Epoch 1|Administrative problems|0
7599|NCT01959516|41320|P1|Epoch 1|Administrative problems|1
7600|NCT01959516|41319|P2|Epoch 1|Subject withdrew consent|2
7601|NCT01959516|41320|P1|Epoch 1|Subject withdrew consent|3
7602|NCT01959516|41319|P2|Epoch 1|unsatisfactory therapeutic effect|0
7603|NCT01959516|41320|P1|Epoch 1|unsatisfactory therapeutic effect|1
7604|NCT01959516|41319|P2|Epoch 1|Adverse Event|1
7605|NCT01959516|41320|P1|Epoch 1|Adverse Event|4
7606|NCT01959503|41330|P2|Overall Study|Randomized but not treated|1
7607|NCT01959503|41331|P1|Overall Study|Randomized but not treated|1
7608|NCT01959503|41330|P2|Overall Study|Death|1
7609|NCT01959503|41331|P1|Overall Study|Death|2
7610|NCT01959412|41351|P6|Overall Study|Adverse Event|0
7611|NCT01959412|41352|P5|Overall Study|Adverse Event|0
7612|NCT01959412|41353|P4|Overall Study|Adverse Event|1
7613|NCT01959412|41354|P3|Overall Study|Adverse Event|0
7614|NCT01959412|41355|P2|Overall Study|Adverse Event|0
7615|NCT01959412|41356|P1|Overall Study|Adverse Event|0
7616|NCT01959412|41351|P6|Overall Study|Protocol deviation|0
7617|NCT01959412|41352|P5|Overall Study|Protocol deviation|3
7618|NCT01959412|41353|P4|Overall Study|Protocol deviation|1
7619|NCT01959412|41354|P3|Overall Study|Protocol deviation|0
7620|NCT01959412|41355|P2|Overall Study|Protocol deviation|1
7621|NCT01959412|41356|P1|Overall Study|Protocol deviation|1
7622|NCT01959035|41394|P1|Overall Study|Other (no primary reason given)|1
7623|NCT01959035|41394|P1|Overall Study|Lost to Follow-up|1
7624|NCT01959035|41394|P1|Overall Study|Withdrawal by Subject|4
7625|NCT01959035|41394|P1|Overall Study|Adverse Event|5
7626|NCT01958827|41420|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
7627|NCT01958827|41420|P1|Overall Study|Lack of Efficacy|6
7628|NCT01958827|41420|P1|Overall Study|Adverse Event|3
7629|NCT01958619|41481|P4|Overall Study|Protocol Violation|0
7630|NCT01958619|41482|P3|Overall Study|Protocol Violation|1
7631|NCT01958619|41483|P2|Overall Study|Protocol Violation|0
7632|NCT01958619|41484|P1|Overall Study|Protocol Violation|2
7633|NCT01958164|41517|P2|Overall Study|Lost to Follow-up|3
7634|NCT01958164|41518|P1|Overall Study|Lost to Follow-up|2
7635|NCT01958164|41517|P2|Overall Study|Adverse Event|2
7636|NCT01958164|41518|P1|Overall Study|Adverse Event|0
7637|NCT01958060|41537|P6|Overall Study|Not treated|0
7638|NCT01958060|41538|P5|Overall Study|Not treated|1
7639|NCT01958060|41539|P4|Overall Study|Not treated|0
7640|NCT01958060|41540|P3|Overall Study|Not treated|0
7641|NCT01958060|41541|P2|Overall Study|Not treated|0
7642|NCT01958060|41542|P1|Overall Study|Not treated|2
7643|NCT01958008|41569|P4|Overall Study|Other adverse event|0
7644|NCT01958008|41570|P3|Overall Study|Other adverse event|0
7645|NCT01958008|41571|P2|Overall Study|Other adverse event|0
7646|NCT01958008|41572|P1|Overall Study|Other adverse event|1
7647|NCT01958008|41569|P4|Overall Study|Worsening of disease under study|0
7648|NCT01958008|41570|P3|Overall Study|Worsening of disease under study|1
7649|NCT01958008|41571|P2|Overall Study|Worsening of disease under study|0
7650|NCT01958008|41572|P1|Overall Study|Worsening of disease under study|0
7651|NCT01957553|41643|P2|Test Period 2 (21 +- 1 Days)|Other|0
7652|NCT01957553|41644|P1|Test Period 2 (21 +- 1 Days)|Other|1
7653|NCT01957553|41643|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
7654|NCT01957553|41644|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
7655|NCT01957553|41643|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
7656|NCT01957553|41644|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
7657|NCT01957553|41643|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
7658|NCT01957553|41644|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
7659|NCT01957553|41643|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
7660|NCT01957553|41644|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
7661|NCT01957553|41643|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
7662|NCT01957553|41644|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
7663|NCT01957553|41643|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
7664|NCT01957553|41644|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
7665|NCT01957553|41643|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
7666|NCT01957553|41644|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
7667|NCT01957553|41643|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
7668|NCT01957553|41644|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
7669|NCT01957488|41650|P6|Test Period 3|Lack of Efficacy|0
7670|NCT01957488|41651|P5|Test Period 3|Lack of Efficacy|0
7671|NCT01957488|41652|P4|Test Period 3|Lack of Efficacy|0
7672|NCT01957488|41653|P3|Test Period 3|Lack of Efficacy|0
7673|NCT01957488|41654|P2|Test Period 3|Lack of Efficacy|1
7674|NCT01957488|41655|P1|Test Period 3|Lack of Efficacy|0
7675|NCT01957488|41650|P6|Test Period 3|Withdrawal by Subject|0
7676|NCT01957488|41651|P5|Test Period 3|Withdrawal by Subject|0
7677|NCT01957488|41652|P4|Test Period 3|Withdrawal by Subject|0
7678|NCT01957488|41653|P3|Test Period 3|Withdrawal by Subject|0
7679|NCT01957488|41654|P2|Test Period 3|Withdrawal by Subject|0
7680|NCT01957488|41655|P1|Test Period 3|Withdrawal by Subject|1
7681|NCT01957488|41650|P6|Test Period 2|Discontinue due to personal problems|1
7682|NCT01957488|41651|P5|Test Period 2|Discontinue due to personal problems|0
7683|NCT01957488|41652|P4|Test Period 2|Discontinue due to personal problems|0
7684|NCT01957488|41653|P3|Test Period 2|Discontinue due to personal problems|0
7685|NCT01957488|41654|P2|Test Period 2|Discontinue due to personal problems|0
7686|NCT01957488|41655|P1|Test Period 2|Discontinue due to personal problems|0
7687|NCT01957488|41650|P6|Test Period 2|Adverse Event|0
7688|NCT01957488|41651|P5|Test Period 2|Adverse Event|2
7689|NCT01957488|41652|P4|Test Period 2|Adverse Event|0
7690|NCT01957488|41653|P3|Test Period 2|Adverse Event|0
7691|NCT01957488|41654|P2|Test Period 2|Adverse Event|0
7692|NCT01957488|41655|P1|Test Period 2|Adverse Event|0
7693|NCT01957488|41650|P6|Test Period 2|Withdrawal by Subject|0
7694|NCT01957488|41651|P5|Test Period 2|Withdrawal by Subject|0
7695|NCT01957488|41652|P4|Test Period 2|Withdrawal by Subject|0
7696|NCT01957488|41653|P3|Test Period 2|Withdrawal by Subject|0
7697|NCT01957488|41654|P2|Test Period 2|Withdrawal by Subject|1
7698|NCT01957488|41655|P1|Test Period 2|Withdrawal by Subject|0
7699|NCT01957488|41650|P6|Test Period 2|not known|0
7700|NCT01957488|41651|P5|Test Period 2|not known|0
7701|NCT01957488|41652|P4|Test Period 2|not known|0
7702|NCT01957488|41653|P3|Test Period 2|not known|0
7703|NCT01957488|41654|P2|Test Period 2|not known|0
7704|NCT01957488|41655|P1|Test Period 2|not known|1
7705|NCT01957488|41650|P6|Test Period 2|Protocol Violation|0
7706|NCT01957488|41651|P5|Test Period 2|Protocol Violation|0
7707|NCT01957488|41652|P4|Test Period 2|Protocol Violation|1
7708|NCT01957488|41653|P3|Test Period 2|Protocol Violation|1
7709|NCT01957488|41654|P2|Test Period 2|Protocol Violation|0
7710|NCT01957488|41655|P1|Test Period 2|Protocol Violation|2
7711|NCT01957488|41650|P6|Test Period 1|screen failure|1
7712|NCT01957488|41651|P5|Test Period 1|screen failure|0
7713|NCT01957488|41652|P4|Test Period 1|screen failure|0
7714|NCT01957488|41653|P3|Test Period 1|screen failure|0
7715|NCT01957488|41654|P2|Test Period 1|screen failure|0
7716|NCT01957488|41655|P1|Test Period 1|screen failure|0
7717|NCT01957488|41650|P6|Test Period 1|subject did not want to wait for cut bag|0
7718|NCT01957488|41651|P5|Test Period 1|subject did not want to wait for cut bag|1
7719|NCT01957488|41652|P4|Test Period 1|subject did not want to wait for cut bag|0
7720|NCT01957488|41653|P3|Test Period 1|subject did not want to wait for cut bag|0
7721|NCT01957488|41654|P2|Test Period 1|subject did not want to wait for cut bag|0
7722|NCT01957488|41655|P1|Test Period 1|subject did not want to wait for cut bag|0
7723|NCT01957488|41650|P6|Test Period 1|Withdrawal by Subject|2
7724|NCT01957488|41651|P5|Test Period 1|Withdrawal by Subject|1
7725|NCT01957488|41652|P4|Test Period 1|Withdrawal by Subject|1
7726|NCT01957488|41653|P3|Test Period 1|Withdrawal by Subject|0
7727|NCT01957488|41654|P2|Test Period 1|Withdrawal by Subject|0
7728|NCT01957488|41655|P1|Test Period 1|Withdrawal by Subject|0
7729|NCT01957488|41650|P6|Test Period 1|Adverse Event|0
7730|NCT01957488|41651|P5|Test Period 1|Adverse Event|1
7731|NCT01957488|41652|P4|Test Period 1|Adverse Event|0
7732|NCT01957488|41653|P3|Test Period 1|Adverse Event|1
7733|NCT01957488|41654|P2|Test Period 1|Adverse Event|1
7734|NCT01957488|41655|P1|Test Period 1|Adverse Event|0
7735|NCT01957488|41650|P6|Test Period 1|Protocol Violation|3
7736|NCT01957488|41651|P5|Test Period 1|Protocol Violation|0
7737|NCT01957488|41652|P4|Test Period 1|Protocol Violation|1
7738|NCT01957488|41653|P3|Test Period 1|Protocol Violation|2
7739|NCT01957488|41654|P2|Test Period 1|Protocol Violation|2
7740|NCT01957488|41655|P1|Test Period 1|Protocol Violation|1
7741|NCT01957488|41650|P6|Test Period 1|Lost to Follow-up|0
7742|NCT01957488|41651|P5|Test Period 1|Lost to Follow-up|0
7743|NCT01957488|41652|P4|Test Period 1|Lost to Follow-up|1
7744|NCT01957488|41653|P3|Test Period 1|Lost to Follow-up|1
7745|NCT01957488|41654|P2|Test Period 1|Lost to Follow-up|0
7746|NCT01957488|41655|P1|Test Period 1|Lost to Follow-up|2
7747|NCT01957475|41663|P2|Test Period 2|Adverse Event|0
7748|NCT01957475|41664|P1|Test Period 2|Adverse Event|1
7749|NCT01957475|41663|P2|Test Period 1|Lack of Efficacy|1
7750|NCT01957475|41664|P1|Test Period 1|Lack of Efficacy|0
7751|NCT01957475|41663|P2|Test Period 1|Other|0
7752|NCT01957475|41664|P1|Test Period 1|Other|1
7753|NCT01957475|41663|P2|Test Period 1|Withdrawal by Subject|0
7754|NCT01957475|41664|P1|Test Period 1|Withdrawal by Subject|1
7755|NCT01957462|41670|P2|Test Period 1|Adverse Event|0
7756|NCT01957462|41671|P1|Test Period 1|Adverse Event|1
7757|NCT01957462|41670|P2|Test Period 1|Withdrawal by Subject|0
7758|NCT01957462|41671|P1|Test Period 1|Withdrawal by Subject|1
7759|NCT01957397|41682|P2|Test Period 3|the adhesive did not work|0
7760|NCT01957397|41683|P1|Test Period 3|the adhesive did not work|1
7761|NCT01957397|41682|P2|Test Period 3|Adverse Event|2
7762|NCT01957397|41683|P1|Test Period 3|Adverse Event|1
7763|NCT01957397|41682|P2|Test Period 2|Adverse Event|1
7764|NCT01957397|41683|P1|Test Period 2|Adverse Event|0
7765|NCT01957397|41682|P2|Test Period 1|Withdrawal by Subject|0
7766|NCT01957397|41683|P1|Test Period 1|Withdrawal by Subject|1
7767|NCT01957397|41682|P2|Test Period 1|sudden leakage/small bag|1
7768|NCT01957397|41683|P1|Test Period 1|sudden leakage/small bag|1
7769|NCT01957215|41708|P2|Overall Study|Withdrawal by Subject|5
7770|NCT01957215|41709|P1|Overall Study|Withdrawal by Subject|7
7771|NCT01957215|41708|P2|Overall Study|Protocol Violation|2
7772|NCT01957215|41709|P1|Overall Study|Protocol Violation|1
7773|NCT01957215|41708|P2|Overall Study|Lost to Follow-up|3
7774|NCT01957215|41709|P1|Overall Study|Lost to Follow-up|3
7775|NCT01957215|41708|P2|Overall Study|Adverse Event|2
7776|NCT01957215|41709|P1|Overall Study|Adverse Event|2
7777|NCT01957202|41737|P18|Treatment Period 3 (8 Days)|Adverse Event|0
7778|NCT01957202|41738|P17|Treatment Period 3 (8 Days)|Adverse Event|1
7779|NCT01957202|41739|P16|Treatment Period 3 (8 Days)|Adverse Event|0
7780|NCT01957202|41740|P15|Treatment Period 3 (8 Days)|Adverse Event|0
7781|NCT01957202|41741|P14|Treatment Period 3 (8 Days)|Adverse Event|0
7782|NCT01957202|41742|P13|Treatment Period 3 (8 Days)|Adverse Event|0
7783|NCT01957202|41743|P12|Treatment Period 3 (8 Days)|Adverse Event|0
7784|NCT01957202|41744|P11|Treatment Period 3 (8 Days)|Adverse Event|0
7785|NCT01957202|41745|P10|Treatment Period 3 (8 Days)|Adverse Event|0
7786|NCT01957202|41746|P9|Treatment Period 3 (8 Days)|Adverse Event|0
7787|NCT01957202|41747|P8|Treatment Period 3 (8 Days)|Adverse Event|0
7788|NCT01957202|41748|P7|Treatment Period 3 (8 Days)|Adverse Event|0
7789|NCT01957202|41749|P6|Treatment Period 3 (8 Days)|Adverse Event|0
7790|NCT01957202|41750|P5|Treatment Period 3 (8 Days)|Adverse Event|0
7791|NCT01957202|41751|P4|Treatment Period 3 (8 Days)|Adverse Event|0
7792|NCT01957202|41752|P3|Treatment Period 3 (8 Days)|Adverse Event|0
7793|NCT01957202|41753|P2|Treatment Period 3 (8 Days)|Adverse Event|0
7794|NCT01957202|41754|P1|Treatment Period 3 (8 Days)|Adverse Event|0
7795|NCT01957202|41737|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7796|NCT01957202|41738|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
7797|NCT01957202|41739|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7798|NCT01957202|41740|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7799|NCT01957202|41741|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7800|NCT01957202|41742|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7801|NCT01957202|41743|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7802|NCT01957202|41744|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7803|NCT01957202|41745|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7804|NCT01957202|41746|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7805|NCT01957202|41747|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7806|NCT01957202|41748|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7807|NCT01957202|41749|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7808|NCT01957202|41750|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7809|NCT01957202|41751|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7810|NCT01957202|41752|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7811|NCT01957202|41753|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
7812|NCT01957202|41754|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
7813|NCT01957163|41779|P3|Overall Study|Withdrawal by Subject|4
7814|NCT01957163|41780|P2|Overall Study|Withdrawal by Subject|2
7815|NCT01957163|41781|P1|Overall Study|Withdrawal by Subject|4
7816|NCT01957163|41779|P3|Overall Study|Lost to Follow-up|0
7817|NCT01957163|41780|P2|Overall Study|Lost to Follow-up|1
7818|NCT01957163|41781|P1|Overall Study|Lost to Follow-up|0
7819|NCT01957163|41779|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
7820|NCT01957163|41780|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
7821|NCT01957163|41781|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
7822|NCT01957163|41779|P3|Overall Study|Protocol Violation|0
7823|NCT01957163|41780|P2|Overall Study|Protocol Violation|2
7824|NCT01957163|41781|P1|Overall Study|Protocol Violation|1
7825|NCT01957163|41779|P3|Overall Study|Lack of Efficacy|9
7826|NCT01957163|41780|P2|Overall Study|Lack of Efficacy|4
7827|NCT01957163|41781|P1|Overall Study|Lack of Efficacy|5
7828|NCT01957163|41779|P3|Overall Study|Adverse Event|4
7829|NCT01957163|41780|P2|Overall Study|Adverse Event|2
7830|NCT01957163|41781|P1|Overall Study|Adverse Event|5
7831|NCT01957111|41794|P2|Overall Study|Withdrawal by Subject|1
7832|NCT01957111|41795|P1|Overall Study|Withdrawal by Subject|1
7833|NCT01956240|41805|P2|Overall Study|Adverse Event|4
7834|NCT01956240|41806|P1|Overall Study|Adverse Event|17
7835|NCT01956240|41805|P2|Overall Study|Lost to Follow-up|20
7836|NCT01956240|41806|P1|Overall Study|Lost to Follow-up|6
7837|NCT01955707|41956|P2|Overall Study|Not Specified|2
7838|NCT01955707|41957|P1|Overall Study|Not Specified|4
7839|NCT01955707|41956|P2|Overall Study|Death|14
7840|NCT01955707|41957|P1|Overall Study|Death|13
7841|NCT01955707|41956|P2|Overall Study|Withdrawal by Subject|3
7842|NCT01955707|41957|P1|Overall Study|Withdrawal by Subject|0
7843|NCT01955707|41956|P2|Overall Study|Lost to Follow-up|1
7844|NCT01955707|41957|P1|Overall Study|Lost to Follow-up|2
7845|NCT01955707|41956|P2|Overall Study|Adverse Event|2
7846|NCT01955707|41957|P1|Overall Study|Adverse Event|1
7847|NCT01955083|42001|P2|Overall Study|Lost to Follow-up|1
7848|NCT01955083|42002|P1|Overall Study|Lost to Follow-up|1
7849|NCT01955044|42035|P3|Overall Study|Death|0
7850|NCT01955044|42036|P2|Overall Study|Death|1
7851|NCT01955044|42037|P1|Overall Study|Death|1
7852|NCT01955005|42050|P2|Overall Study|Withdrawal by Subject|5
7853|NCT01955005|42051|P1|Overall Study|Withdrawal by Subject|3
7854|NCT01954745|42061|P1|Overall Study|Death|1
7855|NCT01954745|42061|P1|Overall Study|Adverse Event|2
7856|NCT01954745|42061|P1|Overall Study|Clinical Progression|5
7857|NCT01954745|42061|P1|Overall Study|Radiological Progression|11
7858|NCT01954251|42070|P2|Overall Study|Withdrawal by Subject|6
7859|NCT01954251|42071|P1|Overall Study|Withdrawal by Subject|2
7860|NCT01954251|42070|P2|Overall Study|Lost to Follow-up|6
7861|NCT01954251|42071|P1|Overall Study|Lost to Follow-up|6
7862|NCT01954251|42070|P2|Overall Study|Adverse Event|7
7863|NCT01954251|42071|P1|Overall Study|Adverse Event|5
7864|NCT01954121|42168|P2|Overall Study|Subject did not follow instructions|2
7865|NCT01954121|42169|P1|Overall Study|Subject did not follow instructions|0
7866|NCT01954121|42168|P2|Overall Study|Non-compliant patient|1
7867|NCT01954121|42169|P1|Overall Study|Non-compliant patient|1
7868|NCT01954121|42168|P2|Overall Study|Non-compliant with study procedures|0
7869|NCT01954121|42169|P1|Overall Study|Non-compliant with study procedures|1
7870|NCT01954121|42168|P2|Overall Study|SAE, non-fatal|4
7871|NCT01954121|42169|P1|Overall Study|SAE, non-fatal|1
7872|NCT01954121|42168|P2|Overall Study|AE, non-serious non-fatal|22
7873|NCT01954121|42169|P1|Overall Study|AE, non-serious non-fatal|5
7874|NCT01954121|42168|P2|Overall Study|AE, serious fatal|0
7875|NCT01954121|42169|P1|Overall Study|AE, serious fatal|1
7876|NCT01954121|42168|P2|Overall Study|Pregnancy|1
7877|NCT01954121|42169|P1|Overall Study|Pregnancy|1
7878|NCT01954121|42168|P2|Overall Study|Withdrawal by Subject|12
7879|NCT01954121|42169|P1|Overall Study|Withdrawal by Subject|18
7880|NCT01954121|42168|P2|Overall Study|Lost to Follow-up|6
7881|NCT01954121|42169|P1|Overall Study|Lost to Follow-up|5
7882|NCT01954121|42168|P2|Overall Study|Protocol Violation|2
7883|NCT01954121|42169|P1|Overall Study|Protocol Violation|0
7884|NCT01954121|42168|P2|Overall Study|Lack of Efficacy|41
7885|NCT01954121|42169|P1|Overall Study|Lack of Efficacy|94
7886|NCT01953354|42185|P2|Overall Study|Disease Exacerbation|0
7887|NCT01953354|42186|P1|Overall Study|Disease Exacerbation|1
7888|NCT01953354|42185|P2|Overall Study|Decision of Sponsor|1
7889|NCT01953354|42186|P1|Overall Study|Decision of Sponsor|0
7890|NCT01953354|42185|P2|Overall Study|Withdrawal by Subject|1
7891|NCT01953354|42186|P1|Overall Study|Withdrawal by Subject|0
7892|NCT01953328|42214|P8|Overall Study|Lost to Follow-up|0
7893|NCT01953328|42215|P7|Overall Study|Lost to Follow-up|0
7894|NCT01953328|42216|P6|Overall Study|Lost to Follow-up|0
7895|NCT01953328|42217|P5|Overall Study|Lost to Follow-up|1
7896|NCT01953328|42218|P4|Overall Study|Lost to Follow-up|0
7897|NCT01953328|42219|P3|Overall Study|Lost to Follow-up|0
7898|NCT01953328|42220|P2|Overall Study|Lost to Follow-up|0
7899|NCT01953328|42221|P1|Overall Study|Lost to Follow-up|0
7900|NCT01953328|42214|P8|Overall Study|Withdrawal by Subject|0
7901|NCT01953328|42215|P7|Overall Study|Withdrawal by Subject|0
7902|NCT01953328|42216|P6|Overall Study|Withdrawal by Subject|0
7903|NCT01953328|42217|P5|Overall Study|Withdrawal by Subject|1
7904|NCT01953328|42218|P4|Overall Study|Withdrawal by Subject|0
7905|NCT01953328|42219|P3|Overall Study|Withdrawal by Subject|0
7906|NCT01953328|42220|P2|Overall Study|Withdrawal by Subject|0
7907|NCT01953328|42221|P1|Overall Study|Withdrawal by Subject|0
7908|NCT01952834|42432|P1|Overall Study|Adverse Event|1
7909|NCT01952691|42439|P1|Overall Study|Lost to Follow-up|2
7910|NCT01952665|42447|P2|Overall Study|Protocol Violation|1
7911|NCT01952665|42448|P1|Overall Study|Protocol Violation|0
7912|NCT01952665|42447|P2|Overall Study|Adverse Event|1
7913|NCT01952665|42448|P1|Overall Study|Adverse Event|2
7914|NCT01952665|42447|P2|Overall Study|Lost to Follow-up|2
7915|NCT01952665|42448|P1|Overall Study|Lost to Follow-up|1
7916|NCT01952665|42447|P2|Overall Study|Physician Decision|2
7917|NCT01952665|42448|P1|Overall Study|Physician Decision|3
7918|NCT01952366|42599|P1|Overall Study|Withdrawal by Subject|9
7919|NCT01952366|42599|P1|Overall Study|Death|22
7920|NCT01952145|42613|P2|Overall Study|Unclassified|1
7921|NCT01952145|42614|P1|Overall Study|Unclassified|1
7922|NCT01952145|42613|P2|Overall Study|Withdrawal Criteria|11
7923|NCT01952145|42614|P1|Overall Study|Withdrawal Criteria|16
7924|NCT01952145|42613|P2|Overall Study|Adverse Event|0
7925|NCT01952145|42614|P1|Overall Study|Adverse Event|9
7926|NCT01952145|42613|P2|Overall Study|Death|1
7927|NCT01952145|42614|P1|Overall Study|Death|0
7928|NCT01952145|42613|P2|Overall Study|Protocol Violation|1
7929|NCT01952145|42614|P1|Overall Study|Protocol Violation|2
7930|NCT01952080|42628|P4|Overall Study|Protocol Non-compliance|0
7931|NCT01952080|42629|P3|Overall Study|Protocol Non-compliance|0
7932|NCT01952080|42630|P2|Overall Study|Protocol Non-compliance|1
7933|NCT01952080|42631|P1|Overall Study|Protocol Non-compliance|0
7934|NCT01952080|42628|P4|Overall Study|Withdrawal by Subject|1
7935|NCT01952080|42629|P3|Overall Study|Withdrawal by Subject|0
7936|NCT01952080|42630|P2|Overall Study|Withdrawal by Subject|0
7937|NCT01952080|42631|P1|Overall Study|Withdrawal by Subject|0
7938|NCT01951703|42697|P2|Second Intervention|Unsatisfactory Lens fitting|1
7939|NCT01951703|42698|P1|Second Intervention|Unsatisfactory Lens fitting|0
7940|NCT01951703|42697|P2|Second Intervention|Protocol Violation|1
7941|NCT01951703|42698|P1|Second Intervention|Protocol Violation|0
7942|NCT01951703|42697|P2|First Intervention|Physician Decision|0
7943|NCT01951703|42698|P1|First Intervention|Physician Decision|1
7944|NCT01951703|42697|P2|First Intervention|Subject was not compliant|1
7945|NCT01951703|42698|P1|First Intervention|Subject was not compliant|1
7946|NCT01951703|42697|P2|First Intervention|Withdrawal by Subject|0
7947|NCT01951703|42698|P1|First Intervention|Withdrawal by Subject|1
7948|NCT01951573|42721|P2|Washout Period|Adverse Event|1
7949|NCT01951573|42722|P1|Washout Period|Adverse Event|0
7950|NCT01951417|42732|P1|Overall Study|Lost to Follow-up|6
7951|NCT01951417|42732|P1|Overall Study|Protocol Violation|2
7952|NCT01951417|42732|P1|Overall Study|Withdrawal by Subject|1
7953|NCT01951170|42755|P1|Overall Study|Investigator decision|1
7954|NCT01951092|42778|P1|Overall Study|Transfer of Care|1
7955|NCT01951092|42778|P1|Overall Study|Incarceration|1
7956|NCT01951092|42778|P1|Overall Study|Lost to Follow-up|10
7957|NCT01950741|42789|P1|Overall Study|Withdrawal by Subject|1
7958|NCT01950741|42789|P1|Overall Study|Death|1
7959|NCT01950741|42789|P1|Overall Study|Lost to Follow-up|1
7960|NCT01950364|42800|P2|Overall Study|Protocol Violation|1
7961|NCT01950364|42801|P1|Overall Study|Protocol Violation|0
7962|NCT01950364|42800|P2|Overall Study|Withdrawal by Subject|1
7963|NCT01950364|42801|P1|Overall Study|Withdrawal by Subject|0
7964|NCT01950364|42800|P2|Overall Study|Disease Progression|2
7965|NCT01950364|42801|P1|Overall Study|Disease Progression|5
7966|NCT01950364|42800|P2|Overall Study|Stem Cell Transplant|6
7967|NCT01950364|42801|P1|Overall Study|Stem Cell Transplant|2
7968|NCT01950364|42800|P2|Overall Study|Adverse Event|0
7969|NCT01950364|42801|P1|Overall Study|Adverse Event|3
7970|NCT01949870|42910|P1|Overall Study|Eligibility requirements not fulfilled|2
7971|NCT01949870|42910|P1|Overall Study|Study termination|1
7972|NCT01949870|42910|P1|Overall Study|Adverse Event|1
7973|NCT01949870|42910|P1|Overall Study|Lack of Efficacy|2
7974|NCT01949532|43069|P2|Overall Study|On-study at the Data Cut-off Date|3
7975|NCT01949532|43070|P1|Overall Study|On-study at the Data Cut-off Date|3
7976|NCT01949155|43145|P2|Overall Study|Protocol Violation|0
7977|NCT01949155|43146|P1|Overall Study|Protocol Violation|1
7978|NCT01949155|43145|P2|Overall Study|Lost to Follow-up|0
7979|NCT01949155|43146|P1|Overall Study|Lost to Follow-up|1
7980|NCT01949142|43158|P2|Overall Study|Parent changed their mind|0
7981|NCT01949142|43159|P1|Overall Study|Parent changed their mind|1
7982|NCT01949142|43158|P2|Overall Study|Lost to Follow-up|1
7983|NCT01949142|43159|P1|Overall Study|Lost to Follow-up|1
7984|NCT01949142|43158|P2|Overall Study|Withdrawal of consent|0
7985|NCT01949142|43159|P1|Overall Study|Withdrawal of consent|1
7986|NCT01949051|43169|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7987|NCT01949051|43170|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7988|NCT01949051|43171|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7989|NCT01949051|43172|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
7990|NCT01949051|43173|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7991|NCT01949051|43174|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
7992|NCT01949051|43169|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7993|NCT01949051|43170|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7994|NCT01949051|43171|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7995|NCT01949051|43172|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7996|NCT01949051|43173|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
7997|NCT01949051|43174|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
7998|NCT01949051|43169|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
7999|NCT01949051|43170|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
8000|NCT01949051|43171|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
8001|NCT01949051|43172|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
8002|NCT01949051|43173|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
8003|NCT01949051|43174|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
8004|NCT01949051|43169|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
8005|NCT01949051|43170|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
8006|NCT01949051|43171|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
8007|NCT01949051|43172|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
8008|NCT01949051|43173|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
8009|NCT01949051|43174|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
8010|NCT01949051|43169|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
8011|NCT01949051|43170|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
8012|NCT01949051|43171|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
8013|NCT01949051|43172|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
8014|NCT01949051|43173|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
8015|NCT01949051|43174|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
8016|NCT01948908|43188|P3|Overall Study|Protocol Violation|2
8017|NCT01948908|43189|P2|Overall Study|Protocol Violation|0
8018|NCT01948908|43190|P1|Overall Study|Protocol Violation|1
8019|NCT01948830|43206|P2|Overall Study|Death|4
8020|NCT01948830|43207|P1|Overall Study|Death|3
8021|NCT01948830|43206|P2|Overall Study|Adverse Event|2
8022|NCT01948830|43207|P1|Overall Study|Adverse Event|9
8023|NCT01948830|43206|P2|Overall Study|Withdrawal by Subject|17
8024|NCT01948830|43207|P1|Overall Study|Withdrawal by Subject|14
8025|NCT01948830|43206|P2|Overall Study|Lost to Follow-up|4
8026|NCT01948830|43207|P1|Overall Study|Lost to Follow-up|5
8027|NCT01948830|43206|P2|Overall Study|Protocol deviation|2
8028|NCT01948830|43207|P1|Overall Study|Protocol deviation|1
8029|NCT01948830|43206|P2|Overall Study|Physician Decision|3
8030|NCT01948830|43207|P1|Overall Study|Physician Decision|1
8031|NCT01948791|43239|P1|Overall Study|Screening failure|35
8032|NCT01948791|43239|P1|Overall Study|Others|7
8033|NCT01948791|43239|P1|Overall Study|Management issues|1
8034|NCT01948791|43239|P1|Overall Study|Lost to Follow-up|6
8035|NCT01948791|43239|P1|Overall Study|Withdrawal by Subject|5
8036|NCT01948791|43239|P1|Overall Study|Protocol Violation|2
8037|NCT01948791|43239|P1|Overall Study|Lack of Efficacy|3
8038|NCT01948791|43239|P1|Overall Study|Adverse Event|12
8039|NCT01948193|43269|P1|Overall Study|Lost to Follow-up|7
8040|NCT01948193|43269|P1|Overall Study|Serious event|2
8041|NCT01948076|43280|P2|Overall Study|Withdrawal by Subject|1
8042|NCT01948076|43281|P1|Overall Study|Withdrawal by Subject|0
8043|NCT01948050|43291|P2|Overall Study|Withdrawal by Subject|1
8044|NCT01948050|43292|P1|Overall Study|Withdrawal by Subject|0
8045|NCT01947855|43360|P3|Overall Study|Withdrawal by Subject|0
8046|NCT01947855|43361|P2|Overall Study|Withdrawal by Subject|0
8047|NCT01947855|43362|P1|Overall Study|Withdrawal by Subject|1
8048|NCT01947582|43370|P1|Overall Study|Withdrawal by Subject|1
8049|NCT01947491|43381|P4|Overall Study|Adverse Event|2
8050|NCT01947491|43382|P3|Overall Study|Adverse Event|0
8051|NCT01947491|43383|P2|Overall Study|Adverse Event|1
8052|NCT01947491|43384|P1|Overall Study|Adverse Event|0
8053|NCT01947491|43381|P4|Overall Study|Worsening of condition|0
8054|NCT01947491|43382|P3|Overall Study|Worsening of condition|0
8055|NCT01947491|43383|P2|Overall Study|Worsening of condition|1
8056|NCT01947491|43384|P1|Overall Study|Worsening of condition|0
8057|NCT01947491|43381|P4|Overall Study|Withdrawal by Subject|0
8058|NCT01947491|43382|P3|Overall Study|Withdrawal by Subject|1
8059|NCT01947491|43383|P2|Overall Study|Withdrawal by Subject|1
8060|NCT01947491|43384|P1|Overall Study|Withdrawal by Subject|1
8061|NCT01947491|43381|P4|Overall Study|Protocol Violation|0
8062|NCT01947491|43382|P3|Overall Study|Protocol Violation|0
8063|NCT01947491|43383|P2|Overall Study|Protocol Violation|0
8064|NCT01947491|43384|P1|Overall Study|Protocol Violation|1
8065|NCT01947491|43381|P4|Overall Study|Lack of Efficacy|1
8066|NCT01947491|43382|P3|Overall Study|Lack of Efficacy|0
8067|NCT01947491|43383|P2|Overall Study|Lack of Efficacy|0
8068|NCT01947491|43384|P1|Overall Study|Lack of Efficacy|1
8069|NCT01947491|43381|P4|Overall Study|Lost to Follow-up|2
8070|NCT01947491|43382|P3|Overall Study|Lost to Follow-up|1
8071|NCT01947491|43383|P2|Overall Study|Lost to Follow-up|3
8072|NCT01947491|43384|P1|Overall Study|Lost to Follow-up|5
8073|NCT01947127|43428|P2|Overall Study|Data loss|4
8074|NCT01947127|43429|P1|Overall Study|Data loss|4
8075|NCT01947127|43428|P2|Overall Study|Withdrawal by Subject|1
8076|NCT01947127|43429|P1|Overall Study|Withdrawal by Subject|1
8077|NCT01947127|43428|P2|Overall Study|Protocol Violation|38
8078|NCT01947127|43429|P1|Overall Study|Protocol Violation|18
8079|NCT01946529|43453|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
8080|NCT01946529|43454|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
8081|NCT01946529|43455|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
8082|NCT01946529|43453|P3|End of Window Therapy (2 Courses)|Physician Decision|0
8083|NCT01946529|43454|P2|End of Window Therapy (2 Courses)|Physician Decision|1
8084|NCT01946529|43455|P1|End of Window Therapy (2 Courses)|Physician Decision|0
8085|NCT01946438|43466|P4|Overall Study|Withdrawal by Subject|0
8086|NCT01946438|43467|P3|Overall Study|Withdrawal by Subject|0
8087|NCT01946438|43468|P2|Overall Study|Withdrawal by Subject|0
8088|NCT01946438|43469|P1|Overall Study|Withdrawal by Subject|1
8089|NCT01946438|43466|P4|Overall Study|Protocol Violation|0
8090|NCT01946438|43467|P3|Overall Study|Protocol Violation|1
8091|NCT01946438|43468|P2|Overall Study|Protocol Violation|0
8092|NCT01946438|43469|P1|Overall Study|Protocol Violation|0
8093|NCT01946438|43466|P4|Overall Study|Serious Adverse event|0
8094|NCT01946438|43467|P3|Overall Study|Serious Adverse event|0
8095|NCT01946438|43468|P2|Overall Study|Serious Adverse event|0
8096|NCT01946438|43469|P1|Overall Study|Serious Adverse event|1
8097|NCT01946438|43466|P4|Overall Study|Adverse Event|1
8098|NCT01946438|43467|P3|Overall Study|Adverse Event|0
8099|NCT01946438|43468|P2|Overall Study|Adverse Event|0
8100|NCT01946438|43469|P1|Overall Study|Adverse Event|0
8101|NCT01946425|43497|P2|Overall Study|Withdrawal by Subject|0
8102|NCT01946425|43498|P1|Overall Study|Withdrawal by Subject|1
8103|NCT01946425|43497|P2|Overall Study|Protocol Violation|0
8104|NCT01946425|43498|P1|Overall Study|Protocol Violation|1
8105|NCT01946412|43512|P1|Overall Study|Difficulty in swallowing|1
8106|NCT01946412|43512|P1|Overall Study|Continued with commercial Kalydeco|2
8107|NCT01946412|43512|P1|Overall Study|Non-Compliance|1
8108|NCT01946412|43512|P1|Overall Study|Adverse Event|1
8109|NCT01946178|43555|P1|Overall Study|Lost to Follow-up|1
8110|NCT01946178|43555|P1|Overall Study|Pregnancy|1
8111|NCT01945944|43624|P2|Overall Study|Withdrawal by Subject|1
8112|NCT01945944|43625|P1|Overall Study|Withdrawal by Subject|0
8113|NCT01945944|43624|P2|Overall Study|Physician Decision|0
8114|NCT01945944|43625|P1|Overall Study|Physician Decision|1
8115|NCT01945944|43624|P2|Overall Study|Adverse Event|2
8116|NCT01945944|43625|P1|Overall Study|Adverse Event|0
8117|NCT01945242|43684|P2|Overall Study|Physician Decision|3
8118|NCT01945242|43685|P1|Overall Study|Physician Decision|3
8119|NCT01945086|43737|P3|Overall Study|Adverse Event|1
8120|NCT01945086|43738|P2|Overall Study|Adverse Event|0
8121|NCT01945086|43739|P1|Overall Study|Adverse Event|0
8122|NCT01945086|43737|P3|Overall Study|Withdrawal by Subject|1
8123|NCT01945086|43738|P2|Overall Study|Withdrawal by Subject|0
8124|NCT01945086|43739|P1|Overall Study|Withdrawal by Subject|1
8125|NCT01945034|43783|P3|Overall Study|Protocol Violation|1
8126|NCT01945034|43784|P2|Overall Study|Protocol Violation|0
8127|NCT01945034|43785|P1|Overall Study|Protocol Violation|1
8128|NCT01945034|43783|P3|Overall Study|Lost to Follow-up|2
8129|NCT01945034|43784|P2|Overall Study|Lost to Follow-up|0
8130|NCT01945034|43785|P1|Overall Study|Lost to Follow-up|0
8131|NCT01945034|43783|P3|Overall Study|Unspecified|3
8132|NCT01945034|43784|P2|Overall Study|Unspecified|1
8133|NCT01945034|43785|P1|Overall Study|Unspecified|0
8134|NCT01945034|43783|P3|Overall Study|Withdrawal by Subject|1
8135|NCT01945034|43784|P2|Overall Study|Withdrawal by Subject|3
8136|NCT01945034|43785|P1|Overall Study|Withdrawal by Subject|0
8137|NCT01945034|43783|P3|Overall Study|Medication Error|0
8138|NCT01945034|43784|P2|Overall Study|Medication Error|1
8139|NCT01945034|43785|P1|Overall Study|Medication Error|0
8140|NCT01945021|43835|P1|Overall Study|Non-RECIST disease progression|1
8141|NCT01945021|43835|P1|Overall Study|Withdrawal of consent|3
8142|NCT01945021|43835|P1|Overall Study|Withdrawal by Subject|2
8143|NCT01945021|43835|P1|Overall Study|Global deterioration of health-related s|1
8144|NCT01945021|43835|P1|Overall Study|Disease progression by RECIST v1.1|30
8145|NCT01945021|43835|P1|Overall Study|Pregnancy|1
8146|NCT01945021|43835|P1|Overall Study|Death|1
8147|NCT01945021|43835|P1|Overall Study|Adverse Event|8
8148|NCT01944969|43849|P1|Overall Study|Administrative or other reasons|23
8149|NCT01944969|43849|P1|Overall Study|Non-compliance with IMP|1
8150|NCT01944969|43849|P1|Overall Study|Lack of Efficacy|1
8151|NCT01944969|43849|P1|Overall Study|Adverse Event|1
8152|NCT01944774|43874|P3|Overall Study|Lost to Follow-up|0
8153|NCT01944774|43875|P2|Overall Study|Lost to Follow-up|1
8154|NCT01944774|43876|P1|Overall Study|Lost to Follow-up|0
8155|NCT01944774|43874|P3|Overall Study|Lack of Efficacy|2
8156|NCT01944774|43875|P2|Overall Study|Lack of Efficacy|2
8157|NCT01944774|43876|P1|Overall Study|Lack of Efficacy|1
8158|NCT01944774|43874|P3|Overall Study|Adverse Event|3
8159|NCT01944774|43875|P2|Overall Study|Adverse Event|2
8160|NCT01944774|43876|P1|Overall Study|Adverse Event|3
8161|NCT01944774|43874|P3|Overall Study|Withdrawal by Subject|3
8162|NCT01944774|43875|P2|Overall Study|Withdrawal by Subject|3
8163|NCT01944774|43876|P1|Overall Study|Withdrawal by Subject|2
8164|NCT01944631|43919|P2|Overall Study|Withdrawal by Subject|1
8165|NCT01944631|43920|P1|Overall Study|Withdrawal by Subject|0
8166|NCT01944631|43919|P2|Overall Study|Lost to Follow-up|1
8167|NCT01944631|43920|P1|Overall Study|Lost to Follow-up|3
8168|NCT01944631|43919|P2|Overall Study|Adverse Event|0
8169|NCT01944631|43920|P1|Overall Study|Adverse Event|1
8170|NCT01944059|43955|P1|Overall Study|Adverse Event|2
8171|NCT01944059|43955|P1|Overall Study|Withdrawal by Subject|1
8172|NCT01944059|43955|P1|Overall Study|Physician Decision|3
8173|NCT01944059|43955|P1|Overall Study|Lost to Follow-up|1
8174|NCT01943552|43994|P2|Overall Study|Other Reasons|17
8175|NCT01943552|43995|P1|Overall Study|Other Reasons|16
8176|NCT01943552|43994|P2|Overall Study|Withdrawal by Subject|6
8177|NCT01943552|43995|P1|Overall Study|Withdrawal by Subject|6
8178|NCT01943552|43994|P2|Overall Study|Adverse Event|2
8179|NCT01943552|43995|P1|Overall Study|Adverse Event|3
8180|NCT01943292|44018|P3|Overall Study|Withdrawal by Subject|0
8181|NCT01943292|44019|P2|Overall Study|Withdrawal by Subject|0
8182|NCT01943292|44020|P1|Overall Study|Withdrawal by Subject|1
8183|NCT01942785|44047|P1|Overall Study|Protocol Violation|1
8184|NCT01942785|44047|P1|Overall Study|Withdrawal by Subject|1
8185|NCT01942785|44047|P1|Overall Study|Adverse Event|2
8186|NCT01942733|44076|P1|Overall Study|Administrative|1
8187|NCT01942733|44076|P1|Overall Study|Non-compliance with IMP|1
8188|NCT01942733|44076|P1|Overall Study|Lost to Follow-up|1
8189|NCT01942135|44107|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
8190|NCT01942135|44108|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
8191|NCT01942135|44107|P2|Overall Study|Withdrawal by Subject|2
8192|NCT01942135|44108|P1|Overall Study|Withdrawal by Subject|4
8193|NCT01942135|44107|P2|Overall Study|Participant Refused toContinue Treatment|1
8194|NCT01942135|44108|P1|Overall Study|Participant Refused toContinue Treatment|1
8195|NCT01942135|44107|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
8196|NCT01942135|44108|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
8197|NCT01942135|44107|P2|Overall Study|Death|1
8198|NCT01942135|44108|P1|Overall Study|Death|0
8199|NCT01942135|44107|P2|Overall Study|Randomized Not Treated|2
8200|NCT01942135|44108|P1|Overall Study|Randomized Not Treated|2
8201|NCT01942135|44107|P2|Overall Study|Global deterioration of health status|3
8202|NCT01942135|44108|P1|Overall Study|Global deterioration of health status|8
8203|NCT01942135|44107|P2|Overall Study|Adverse Event|3
8204|NCT01942135|44108|P1|Overall Study|Adverse Event|9
8205|NCT01941940|44145|P1|Overall Study|Unspecified|6
8206|NCT01941940|44145|P1|Overall Study|Protocol Violation|1
8207|NCT01941940|44145|P1|Overall Study|Withdrawal by Subject|15
8208|NCT01941940|44145|P1|Overall Study|Physician Decision|8
8209|NCT01941940|44145|P1|Overall Study|Lost to Follow-up|1
8210|NCT01941940|44145|P1|Overall Study|Adverse Event|19
8211|NCT01941498|44164|P1|Overall Study|Relocated out of state|1
8212|NCT01941186|44278|P2|Follow-up|Lost to Follow-up|0
8213|NCT01941186|44279|P1|Follow-up|Lost to Follow-up|1
8214|NCT01940484|44336|P1|Overall Study|Adverse Event|1
8215|NCT01940484|44336|P1|Overall Study|Death|2
8216|NCT01940484|44336|P1|Overall Study|Underwent transplantation|4
8217|NCT01940484|44336|P1|Overall Study|Withdrawal by Subject|3
8218|NCT01940120|44371|P1|Overall Study|Lost to Follow-up|4
8219|NCT01940120|44371|P1|Overall Study|Withdrawal by Subject|7
8220|NCT01940120|44371|P1|Overall Study|Death|33
8221|NCT01939548|44495|P3|Overall Study|Did not complete follow-up|0
8222|NCT01939548|44496|P2|Overall Study|Did not complete follow-up|1
8223|NCT01939548|44497|P1|Overall Study|Did not complete follow-up|0
8224|NCT01939548|44495|P3|Overall Study|Participant withdrew consent|0
8225|NCT01939548|44496|P2|Overall Study|Participant withdrew consent|2
8226|NCT01939548|44497|P1|Overall Study|Participant withdrew consent|0
8227|NCT01939548|44495|P3|Overall Study|Participant unwilling to continue|0
8228|NCT01939548|44496|P2|Overall Study|Participant unwilling to continue|1
8229|NCT01939548|44497|P1|Overall Study|Participant unwilling to continue|0
8230|NCT01939548|44495|P3|Overall Study|Participant dropped|1
8231|NCT01939548|44496|P2|Overall Study|Participant dropped|0
8232|NCT01939548|44497|P1|Overall Study|Participant dropped|0
8233|NCT01939548|44495|P3|Overall Study|Death|1
8234|NCT01939548|44496|P2|Overall Study|Death|0
8235|NCT01939548|44497|P1|Overall Study|Death|0
8236|NCT01939548|44495|P3|Overall Study|Adverse Event|7
8237|NCT01939548|44496|P2|Overall Study|Adverse Event|9
8238|NCT01939548|44497|P1|Overall Study|Adverse Event|2
8239|NCT01939548|44495|P3|Overall Study|Lost to Follow-up|3
8240|NCT01939548|44496|P2|Overall Study|Lost to Follow-up|5
8241|NCT01939548|44497|P1|Overall Study|Lost to Follow-up|5
8242|NCT01939548|44495|P3|Overall Study|Protocol Violation|5
8243|NCT01939548|44496|P2|Overall Study|Protocol Violation|6
8244|NCT01939548|44497|P1|Overall Study|Protocol Violation|7
8245|NCT01939548|44495|P3|Overall Study|Withdrawal by Subject|1
8246|NCT01939548|44496|P2|Overall Study|Withdrawal by Subject|4
8247|NCT01939548|44497|P1|Overall Study|Withdrawal by Subject|4
8248|NCT01939548|44495|P3|Overall Study|Did Not Meet Entrance Criteria|0
8249|NCT01939548|44496|P2|Overall Study|Did Not Meet Entrance Criteria|0
8250|NCT01939548|44497|P1|Overall Study|Did Not Meet Entrance Criteria|1
8251|NCT01939548|44495|P3|Overall Study|Insufficient Clinical Response|0
8252|NCT01939548|44496|P2|Overall Study|Insufficient Clinical Response|0
8253|NCT01939548|44497|P1|Overall Study|Insufficient Clinical Response|1
8254|NCT01939548|44495|P3|Overall Study|Study Terminated by Sponsor|12
8255|NCT01939548|44496|P2|Overall Study|Study Terminated by Sponsor|19
8256|NCT01939548|44497|P1|Overall Study|Study Terminated by Sponsor|17
8257|NCT01939548|44495|P3|Overall Study|Non compliance|0
8258|NCT01939548|44496|P2|Overall Study|Non compliance|2
8259|NCT01939548|44497|P1|Overall Study|Non compliance|0
8260|NCT01939496|44571|P3|Overall Study|Unspecified|1
8261|NCT01939496|44572|P2|Overall Study|Unspecified|0
8262|NCT01939496|44573|P1|Overall Study|Unspecified|2
8263|NCT01939496|44571|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
8264|NCT01939496|44572|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
8265|NCT01939496|44573|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
8266|NCT01939496|44571|P3|Overall Study|Withdrawal by Subject|1
8267|NCT01939496|44572|P2|Overall Study|Withdrawal by Subject|1
8268|NCT01939496|44573|P1|Overall Study|Withdrawal by Subject|0
8269|NCT01939496|44571|P3|Overall Study|Protocol Violation|0
8270|NCT01939496|44572|P2|Overall Study|Protocol Violation|0
8271|NCT01939496|44573|P1|Overall Study|Protocol Violation|3
8272|NCT01939496|44571|P3|Overall Study|Physician Decision|0
8273|NCT01939496|44572|P2|Overall Study|Physician Decision|0
8274|NCT01939496|44573|P1|Overall Study|Physician Decision|1
8275|NCT01939496|44571|P3|Overall Study|Lost to Follow-up|0
8276|NCT01939496|44572|P2|Overall Study|Lost to Follow-up|1
8277|NCT01939496|44573|P1|Overall Study|Lost to Follow-up|1
8278|NCT01939496|44571|P3|Overall Study|Adverse Event|0
8279|NCT01939496|44572|P2|Overall Study|Adverse Event|0
8280|NCT01939496|44573|P1|Overall Study|Adverse Event|2
8281|NCT01939314|44625|P2|Overall Study|Lost to Follow-up|6
8282|NCT01939314|44626|P1|Overall Study|Lost to Follow-up|5
8283|NCT01939314|44625|P2|Overall Study|Pregnancy|1
8284|NCT01939314|44626|P1|Overall Study|Pregnancy|0
8285|NCT01939314|44625|P2|Overall Study|Protocol Violation|0
8286|NCT01939314|44626|P1|Overall Study|Protocol Violation|1
8287|NCT01939314|44625|P2|Overall Study|Withdrawal by Subject|1
8288|NCT01939314|44626|P1|Overall Study|Withdrawal by Subject|3
8289|NCT01939002|44649|P2|Overall Study|Not Specified|2
8290|NCT01939002|44650|P1|Overall Study|Not Specified|1
8291|NCT01939002|44649|P2|Overall Study|Withdrawal by Subject|3
8292|NCT01939002|44650|P1|Overall Study|Withdrawal by Subject|5
8293|NCT01939002|44649|P2|Overall Study|Adverse Event|13
8294|NCT01939002|44650|P1|Overall Study|Adverse Event|13
8295|NCT01938430|44737|P14|Overall Study|Withdrew Consent|0
8296|NCT01938430|44738|P13|Overall Study|Withdrew Consent|0
8297|NCT01938430|44739|P12|Overall Study|Withdrew Consent|0
8298|NCT01938430|44740|P11|Overall Study|Withdrew Consent|0
8299|NCT01938430|44741|P10|Overall Study|Withdrew Consent|0
8300|NCT01938430|44742|P9|Overall Study|Withdrew Consent|1
8301|NCT01938430|44743|P8|Overall Study|Withdrew Consent|0
8302|NCT01938430|44744|P7|Overall Study|Withdrew Consent|0
8303|NCT01938430|44745|P6|Overall Study|Withdrew Consent|0
8304|NCT01938430|44746|P5|Overall Study|Withdrew Consent|0
8305|NCT01938430|44747|P4|Overall Study|Withdrew Consent|0
8306|NCT01938430|44748|P3|Overall Study|Withdrew Consent|0
8307|NCT01938430|44749|P2|Overall Study|Withdrew Consent|0
8308|NCT01938430|44750|P1|Overall Study|Withdrew Consent|0
8309|NCT01938430|44737|P14|Overall Study|Lost to Follow-up|0
8310|NCT01938430|44738|P13|Overall Study|Lost to Follow-up|0
8311|NCT01938430|44739|P12|Overall Study|Lost to Follow-up|0
8312|NCT01938430|44740|P11|Overall Study|Lost to Follow-up|0
8313|NCT01938430|44741|P10|Overall Study|Lost to Follow-up|0
8314|NCT01938430|44742|P9|Overall Study|Lost to Follow-up|0
8315|NCT01938430|44743|P8|Overall Study|Lost to Follow-up|0
8316|NCT01938430|44744|P7|Overall Study|Lost to Follow-up|0
8317|NCT01938430|44745|P6|Overall Study|Lost to Follow-up|1
8318|NCT01938430|44746|P5|Overall Study|Lost to Follow-up|0
8319|NCT01938430|44747|P4|Overall Study|Lost to Follow-up|0
8320|NCT01938430|44748|P3|Overall Study|Lost to Follow-up|1
8321|NCT01938430|44749|P2|Overall Study|Lost to Follow-up|0
8322|NCT01938430|44750|P1|Overall Study|Lost to Follow-up|0
8323|NCT01938430|44737|P14|Overall Study|Lack of Efficacy|0
8324|NCT01938430|44738|P13|Overall Study|Lack of Efficacy|0
8325|NCT01938430|44739|P12|Overall Study|Lack of Efficacy|1
8326|NCT01938430|44740|P11|Overall Study|Lack of Efficacy|2
8327|NCT01938430|44741|P10|Overall Study|Lack of Efficacy|0
8328|NCT01938430|44742|P9|Overall Study|Lack of Efficacy|1
8329|NCT01938430|44743|P8|Overall Study|Lack of Efficacy|0
8330|NCT01938430|44744|P7|Overall Study|Lack of Efficacy|0
8331|NCT01938430|44745|P6|Overall Study|Lack of Efficacy|0
8332|NCT01938430|44746|P5|Overall Study|Lack of Efficacy|0
8333|NCT01938430|44747|P4|Overall Study|Lack of Efficacy|1
8334|NCT01938430|44748|P3|Overall Study|Lack of Efficacy|1
8335|NCT01938430|44749|P2|Overall Study|Lack of Efficacy|1
8336|NCT01938430|44750|P1|Overall Study|Lack of Efficacy|3
8337|NCT01938430|44737|P14|Overall Study|Investigator's Discretion|0
8338|NCT01938430|44738|P13|Overall Study|Investigator's Discretion|0
8339|NCT01938430|44739|P12|Overall Study|Investigator's Discretion|0
8340|NCT01938430|44740|P11|Overall Study|Investigator's Discretion|0
8341|NCT01938430|44741|P10|Overall Study|Investigator's Discretion|0
8342|NCT01938430|44742|P9|Overall Study|Investigator's Discretion|0
8343|NCT01938430|44743|P8|Overall Study|Investigator's Discretion|0
8344|NCT01938430|44744|P7|Overall Study|Investigator's Discretion|0
8345|NCT01938430|44745|P6|Overall Study|Investigator's Discretion|0
8346|NCT01938430|44746|P5|Overall Study|Investigator's Discretion|0
8347|NCT01938430|44747|P4|Overall Study|Investigator's Discretion|0
8348|NCT01938430|44748|P3|Overall Study|Investigator's Discretion|1
8349|NCT01938430|44749|P2|Overall Study|Investigator's Discretion|0
8350|NCT01938430|44750|P1|Overall Study|Investigator's Discretion|0
8351|NCT01938430|44737|P14|Overall Study|Death|0
8352|NCT01938430|44738|P13|Overall Study|Death|0
8353|NCT01938430|44739|P12|Overall Study|Death|0
8354|NCT01938430|44740|P11|Overall Study|Death|0
8355|NCT01938430|44741|P10|Overall Study|Death|3
8356|NCT01938430|44742|P9|Overall Study|Death|2
8357|NCT01938430|44743|P8|Overall Study|Death|1
8358|NCT01938430|44744|P7|Overall Study|Death|1
8359|NCT01938430|44745|P6|Overall Study|Death|0
8360|NCT01938430|44746|P5|Overall Study|Death|0
8361|NCT01938430|44747|P4|Overall Study|Death|1
8362|NCT01938430|44748|P3|Overall Study|Death|2
8363|NCT01938430|44749|P2|Overall Study|Death|2
8364|NCT01938430|44750|P1|Overall Study|Death|1
8365|NCT01938430|44737|P14|Overall Study|Adverse Event|0
8366|NCT01938430|44738|P13|Overall Study|Adverse Event|0
8367|NCT01938430|44739|P12|Overall Study|Adverse Event|0
8368|NCT01938430|44740|P11|Overall Study|Adverse Event|0
8369|NCT01938430|44741|P10|Overall Study|Adverse Event|0
8370|NCT01938430|44742|P9|Overall Study|Adverse Event|0
8371|NCT01938430|44743|P8|Overall Study|Adverse Event|0
8372|NCT01938430|44744|P7|Overall Study|Adverse Event|1
8373|NCT01938430|44745|P6|Overall Study|Adverse Event|0
8374|NCT01938430|44746|P5|Overall Study|Adverse Event|0
8375|NCT01938430|44747|P4|Overall Study|Adverse Event|0
8376|NCT01938430|44748|P3|Overall Study|Adverse Event|0
8377|NCT01938430|44749|P2|Overall Study|Adverse Event|0
8378|NCT01938430|44750|P1|Overall Study|Adverse Event|0
8379|NCT01938430|44737|P14|Overall Study|Randomized but Not Treated|1
8380|NCT01938430|44738|P13|Overall Study|Randomized but Not Treated|0
8381|NCT01938430|44739|P12|Overall Study|Randomized but Not Treated|0
8382|NCT01938430|44740|P11|Overall Study|Randomized but Not Treated|1
8383|NCT01938430|44741|P10|Overall Study|Randomized but Not Treated|0
8384|NCT01938430|44742|P9|Overall Study|Randomized but Not Treated|0
8385|NCT01938430|44743|P8|Overall Study|Randomized but Not Treated|0
8386|NCT01938430|44744|P7|Overall Study|Randomized but Not Treated|0
8387|NCT01938430|44745|P6|Overall Study|Randomized but Not Treated|0
8388|NCT01938430|44746|P5|Overall Study|Randomized but Not Treated|0
8389|NCT01938430|44747|P4|Overall Study|Randomized but Not Treated|0
8390|NCT01938430|44748|P3|Overall Study|Randomized but Not Treated|0
8391|NCT01938430|44749|P2|Overall Study|Randomized but Not Treated|0
8392|NCT01938430|44750|P1|Overall Study|Randomized but Not Treated|0
8393|NCT01937871|45184|P3|Overall Study|Entry Criteria Not Met|1
8394|NCT01937871|45185|P2|Overall Study|Entry Criteria Not Met|2
8395|NCT01937871|45186|P1|Overall Study|Entry Criteria Not Met|1
8396|NCT01937871|45184|P3|Overall Study|Physician Decision|0
8397|NCT01937871|45185|P2|Overall Study|Physician Decision|1
8398|NCT01937871|45186|P1|Overall Study|Physician Decision|0
8399|NCT01937871|45184|P3|Overall Study|Withdrawal by Subject|4
8400|NCT01937871|45185|P2|Overall Study|Withdrawal by Subject|6
8401|NCT01937871|45186|P1|Overall Study|Withdrawal by Subject|9
8402|NCT01937871|45184|P3|Overall Study|Lost to Follow-up|4
8403|NCT01937871|45185|P2|Overall Study|Lost to Follow-up|2
8404|NCT01937871|45186|P1|Overall Study|Lost to Follow-up|8
8405|NCT01937871|45184|P3|Overall Study|Adverse Event|2
8406|NCT01937871|45185|P2|Overall Study|Adverse Event|6
8407|NCT01937871|45186|P1|Overall Study|Adverse Event|6
8408|NCT01937715|45262|P5|Overall Study|Unspecified|0
8409|NCT01937715|45263|P4|Overall Study|Unspecified|3
8410|NCT01937715|45264|P3|Overall Study|Unspecified|0
8411|NCT01937715|45265|P2|Overall Study|Unspecified|0
8412|NCT01937715|45266|P1|Overall Study|Unspecified|0
8413|NCT01937715|45262|P5|Overall Study|Withdrawal by Subject|2
8414|NCT01937715|45263|P4|Overall Study|Withdrawal by Subject|0
8415|NCT01937715|45264|P3|Overall Study|Withdrawal by Subject|0
8416|NCT01937715|45265|P2|Overall Study|Withdrawal by Subject|1
8417|NCT01937715|45266|P1|Overall Study|Withdrawal by Subject|0
8418|NCT01937715|45262|P5|Overall Study|Death|0
8419|NCT01937715|45263|P4|Overall Study|Death|1
8420|NCT01937715|45264|P3|Overall Study|Death|0
8421|NCT01937715|45265|P2|Overall Study|Death|0
8422|NCT01937715|45266|P1|Overall Study|Death|0
8423|NCT01937312|45452|P2|Overall Study|Withdrawal of subject prior to treatment|1
8424|NCT01937312|45453|P1|Overall Study|Withdrawal of subject prior to treatment|1
8425|NCT01937312|45452|P2|Overall Study|Lack of Efficacy|1
8426|NCT01937312|45453|P1|Overall Study|Lack of Efficacy|0
8427|NCT01937312|45452|P2|Overall Study|Adverse Event|1
8428|NCT01937312|45453|P1|Overall Study|Adverse Event|10
8429|NCT01937299|45468|P2|Overall Study|Withdrawal by Subject|0
8430|NCT01937299|45469|P1|Overall Study|Withdrawal by Subject|1
8431|NCT01937299|45468|P2|Overall Study|Lack of Efficacy|4
8432|NCT01937299|45469|P1|Overall Study|Lack of Efficacy|0
8433|NCT01937299|45468|P2|Overall Study|Adverse Event|0
8434|NCT01937299|45469|P1|Overall Study|Adverse Event|13
8435|NCT01937130|45484|P4|Overall Study|Patient lost to FU due to death|0
8436|NCT01937130|45485|P3|Overall Study|Patient lost to FU due to death|0
8437|NCT01937130|45486|P2|Overall Study|Patient lost to FU due to death|0
8438|NCT01937130|45487|P1|Overall Study|Patient lost to FU due to death|2
8439|NCT01937130|45484|P4|Overall Study|Patients unable to swallow|0
8440|NCT01937130|45485|P3|Overall Study|Patients unable to swallow|0
8441|NCT01937130|45486|P2|Overall Study|Patients unable to swallow|1
8442|NCT01937130|45487|P1|Overall Study|Patients unable to swallow|0
8443|NCT01937130|45484|P4|Overall Study|Physician Decision|0
8444|NCT01937130|45485|P3|Overall Study|Physician Decision|0
8445|NCT01937130|45486|P2|Overall Study|Physician Decision|1
8446|NCT01937130|45487|P1|Overall Study|Physician Decision|0
8447|NCT01937130|45484|P4|Overall Study|Lost to Follow-up|0
8448|NCT01937130|45485|P3|Overall Study|Lost to Follow-up|2
8449|NCT01937130|45486|P2|Overall Study|Lost to Follow-up|0
8450|NCT01937130|45487|P1|Overall Study|Lost to Follow-up|2
8451|NCT01937130|45484|P4|Overall Study|Death|0
8452|NCT01937130|45485|P3|Overall Study|Death|1
8453|NCT01937130|45486|P2|Overall Study|Death|1
8454|NCT01937130|45487|P1|Overall Study|Death|1
8455|NCT01937130|45484|P4|Overall Study|Adverse Event|1
8456|NCT01937130|45485|P3|Overall Study|Adverse Event|0
8457|NCT01937130|45486|P2|Overall Study|Adverse Event|1
8458|NCT01937130|45487|P1|Overall Study|Adverse Event|0
8459|NCT01937130|45484|P4|Overall Study|Withdrawal by Subject|1
8460|NCT01937130|45485|P3|Overall Study|Withdrawal by Subject|0
8461|NCT01937130|45486|P2|Overall Study|Withdrawal by Subject|0
8462|NCT01937130|45487|P1|Overall Study|Withdrawal by Subject|0
8463|NCT01936181|45516|P4|Transition-extension|Withdrawal by Subject|1
8464|NCT01936181|45517|P3|Transition-extension|Withdrawal by Subject|2
8465|NCT01936181|45518|P2|Transition-extension|Withdrawal by Subject|0
8466|NCT01936181|45519|P1|Transition-extension|Withdrawal by Subject|7
8467|NCT01936181|45516|P4|Transition-extension|Physician Decision|1
8468|NCT01936181|45517|P3|Transition-extension|Physician Decision|0
8469|NCT01936181|45518|P2|Transition-extension|Physician Decision|0
8470|NCT01936181|45519|P1|Transition-extension|Physician Decision|2
8471|NCT01936181|45516|P4|Transition-extension|Lost to Follow-up|2
8472|NCT01936181|45517|P3|Transition-extension|Lost to Follow-up|1
8473|NCT01936181|45518|P2|Transition-extension|Lost to Follow-up|0
8474|NCT01936181|45519|P1|Transition-extension|Lost to Follow-up|3
8475|NCT01936181|45516|P4|Transition-extension|Adverse Event|1
8476|NCT01936181|45517|P3|Transition-extension|Adverse Event|3
8477|NCT01936181|45518|P2|Transition-extension|Adverse Event|0
8478|NCT01936181|45519|P1|Transition-extension|Adverse Event|3
8479|NCT01936181|45516|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
8480|NCT01936181|45517|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
8481|NCT01936181|45518|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
8482|NCT01936181|45519|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
8483|NCT01936181|45516|P4|Randomised, Double-blind|Withdrawal by Subject|0
8484|NCT01936181|45517|P3|Randomised, Double-blind|Withdrawal by Subject|0
8485|NCT01936181|45518|P2|Randomised, Double-blind|Withdrawal by Subject|26
8486|NCT01936181|45519|P1|Randomised, Double-blind|Withdrawal by Subject|23
8487|NCT01936181|45516|P4|Randomised, Double-blind|Physician Decision|0
8488|NCT01936181|45517|P3|Randomised, Double-blind|Physician Decision|0
8489|NCT01936181|45518|P2|Randomised, Double-blind|Physician Decision|4
8490|NCT01936181|45519|P1|Randomised, Double-blind|Physician Decision|4
8491|NCT01936181|45516|P4|Randomised, Double-blind|Pregnancy|0
8492|NCT01936181|45517|P3|Randomised, Double-blind|Pregnancy|0
8493|NCT01936181|45518|P2|Randomised, Double-blind|Pregnancy|1
8494|NCT01936181|45519|P1|Randomised, Double-blind|Pregnancy|0
8495|NCT01936181|45516|P4|Randomised, Double-blind|Lost to Follow-up|0
8496|NCT01936181|45517|P3|Randomised, Double-blind|Lost to Follow-up|0
8497|NCT01936181|45518|P2|Randomised, Double-blind|Lost to Follow-up|1
8498|NCT01936181|45519|P1|Randomised, Double-blind|Lost to Follow-up|0
8499|NCT01936181|45516|P4|Randomised, Double-blind|Lack of Efficacy|0
8500|NCT01936181|45517|P3|Randomised, Double-blind|Lack of Efficacy|0
8501|NCT01936181|45518|P2|Randomised, Double-blind|Lack of Efficacy|6
8502|NCT01936181|45519|P1|Randomised, Double-blind|Lack of Efficacy|5
8503|NCT01936181|45516|P4|Randomised, Double-blind|Protocol Violation|0
8504|NCT01936181|45517|P3|Randomised, Double-blind|Protocol Violation|0
8505|NCT01936181|45518|P2|Randomised, Double-blind|Protocol Violation|5
8506|NCT01936181|45519|P1|Randomised, Double-blind|Protocol Violation|1
8507|NCT01936181|45516|P4|Randomised, Double-blind|Adverse Event|0
8508|NCT01936181|45517|P3|Randomised, Double-blind|Adverse Event|0
8509|NCT01936181|45518|P2|Randomised, Double-blind|Adverse Event|21
8510|NCT01936181|45519|P1|Randomised, Double-blind|Adverse Event|27
8511|NCT01936649|45559|P1|Overall Study|Other than specified above|5
8512|NCT01936649|45559|P1|Overall Study|Protocol Violation|2
8513|NCT01936649|45559|P1|Overall Study|Physician Decision|2
8514|NCT01936649|45559|P1|Overall Study|Withdrawal by Subject|4
8515|NCT01934790|45586|P1|Overall Study|Study drug never administered|1
8516|NCT01934790|45586|P1|Overall Study|Withdrawal by Subject|2
8517|NCT01934790|45586|P1|Overall Study|Radiological progression|4
8518|NCT01934790|45586|P1|Overall Study|Clinical progression|6
8519|NCT01934790|45586|P1|Overall Study|Adverse Event|3
8520|NCT01934504|45632|P4|Overall Study|Study Terminated by Sponsor|5
8521|NCT01934504|45633|P3|Overall Study|Study Terminated by Sponsor|5
8522|NCT01934504|45634|P2|Overall Study|Study Terminated by Sponsor|0
8523|NCT01934504|45635|P1|Overall Study|Study Terminated by Sponsor|1
8524|NCT01934504|45632|P4|Overall Study|Protocol Deviation|2
8525|NCT01934504|45633|P3|Overall Study|Protocol Deviation|0
8526|NCT01934504|45634|P2|Overall Study|Protocol Deviation|0
8527|NCT01934504|45635|P1|Overall Study|Protocol Deviation|0
8528|NCT01933880|45668|P2|Overall Study|Protocol Violation|0
8529|NCT01933880|45669|P1|Overall Study|Protocol Violation|1
8530|NCT01933880|45668|P2|Overall Study|Unspecified|0
8531|NCT01933880|45669|P1|Overall Study|Unspecified|4
8532|NCT01933880|45668|P2|Overall Study|Followup exceeded 4 days to visit window|0
8533|NCT01933880|45669|P1|Overall Study|Followup exceeded 4 days to visit window|19
8534|NCT01933880|45668|P2|Overall Study|Concomitant medication Interference|1
8535|NCT01933880|45669|P1|Overall Study|Concomitant medication Interference|0
8536|NCT01933880|45668|P2|Overall Study|Lack of Efficacy|0
8537|NCT01933880|45669|P1|Overall Study|Lack of Efficacy|1
8538|NCT01933880|45668|P2|Overall Study|Withdrawal by Subject|0
8539|NCT01933880|45669|P1|Overall Study|Withdrawal by Subject|5
8540|NCT01933672|45745|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
8541|NCT01933672|45746|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
8542|NCT01933672|45747|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
8543|NCT01933672|45748|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
8544|NCT01933672|45749|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
8545|NCT01933672|45750|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
8546|NCT01933672|45751|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
8547|NCT01933672|45745|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
8548|NCT01933672|45746|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
8549|NCT01933672|45747|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
8550|NCT01933672|45748|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
8551|NCT01933672|45749|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
8552|NCT01933672|45750|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
8553|NCT01933672|45751|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
8554|NCT01933672|45745|P7|Second Intervention Period (12-16 Days)|Unspecified|0
8555|NCT01933672|45746|P6|Second Intervention Period (12-16 Days)|Unspecified|0
8556|NCT01933672|45747|P5|Second Intervention Period (12-16 Days)|Unspecified|0
8557|NCT01933672|45748|P4|Second Intervention Period (12-16 Days)|Unspecified|0
8558|NCT01933672|45749|P3|Second Intervention Period (12-16 Days)|Unspecified|1
8559|NCT01933672|45750|P2|Second Intervention Period (12-16 Days)|Unspecified|1
8560|NCT01933672|45751|P1|Second Intervention Period (12-16 Days)|Unspecified|0
8561|NCT01933672|45745|P7|First Intervention Period (12-16 Days)|Unspecified|0
8562|NCT01933672|45746|P6|First Intervention Period (12-16 Days)|Unspecified|1
8563|NCT01933672|45747|P5|First Intervention Period (12-16 Days)|Unspecified|0
8564|NCT01933672|45748|P4|First Intervention Period (12-16 Days)|Unspecified|0
8565|NCT01933672|45749|P3|First Intervention Period (12-16 Days)|Unspecified|1
8566|NCT01933672|45750|P2|First Intervention Period (12-16 Days)|Unspecified|0
8567|NCT01933672|45751|P1|First Intervention Period (12-16 Days)|Unspecified|0
8568|NCT01933672|45745|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
8569|NCT01933672|45746|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
8570|NCT01933672|45747|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
8571|NCT01933672|45748|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
8572|NCT01933672|45749|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
8573|NCT01933672|45750|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
8574|NCT01933672|45751|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
8575|NCT01933672|45745|P7|Metformin Run-in Period|Unspecified|0
8576|NCT01933672|45746|P6|Metformin Run-in Period|Unspecified|0
8577|NCT01933672|45747|P5|Metformin Run-in Period|Unspecified|0
8578|NCT01933672|45748|P4|Metformin Run-in Period|Unspecified|0
8579|NCT01933672|45749|P3|Metformin Run-in Period|Unspecified|0
8580|NCT01933672|45750|P2|Metformin Run-in Period|Unspecified|0
8581|NCT01933672|45751|P1|Metformin Run-in Period|Unspecified|5
8582|NCT01933672|45745|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
8583|NCT01933672|45746|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
8584|NCT01933672|45747|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
8585|NCT01933672|45748|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
8586|NCT01933672|45749|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
8587|NCT01933672|45750|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
8588|NCT01933672|45751|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
8589|NCT01933672|45745|P7|Metformin Run-in Period|Adverse Event|0
8590|NCT01933672|45746|P6|Metformin Run-in Period|Adverse Event|0
8591|NCT01933672|45747|P5|Metformin Run-in Period|Adverse Event|0
8592|NCT01933672|45748|P4|Metformin Run-in Period|Adverse Event|0
8593|NCT01933672|45749|P3|Metformin Run-in Period|Adverse Event|0
8594|NCT01933672|45750|P2|Metformin Run-in Period|Adverse Event|0
8595|NCT01933672|45751|P1|Metformin Run-in Period|Adverse Event|1
8596|NCT01933334|45826|P2|Overall Study|Withdrawal by Subject|1
8597|NCT01933334|45827|P1|Overall Study|Withdrawal by Subject|0
8598|NCT01933334|45826|P2|Overall Study|Adverse Event|1
8599|NCT01933334|45827|P1|Overall Study|Adverse Event|5
8600|NCT01932762|45845|P4|Overall Study|Physician Decision|0
8601|NCT01932762|45846|P3|Overall Study|Physician Decision|0
8602|NCT01932762|45847|P2|Overall Study|Physician Decision|0
8603|NCT01932762|45848|P1|Overall Study|Physician Decision|1
8604|NCT01932762|45845|P4|Overall Study|Lost to Follow-up|1
8605|NCT01932762|45846|P3|Overall Study|Lost to Follow-up|0
8606|NCT01932762|45847|P2|Overall Study|Lost to Follow-up|0
8607|NCT01932762|45848|P1|Overall Study|Lost to Follow-up|4
8608|NCT01932762|45845|P4|Overall Study|Withdrawal by Subject|0
8609|NCT01932762|45846|P3|Overall Study|Withdrawal by Subject|0
8610|NCT01932762|45847|P2|Overall Study|Withdrawal by Subject|2
8611|NCT01932762|45848|P1|Overall Study|Withdrawal by Subject|1
8612|NCT01931865|45965|P1|Overall Study|Withdrawal by Subject|2
8613|NCT01931865|45965|P1|Overall Study|Lost to Follow-up|2
8614|NCT01931475|45984|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
8615|NCT01931475|45985|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
8616|NCT01931475|45984|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
8617|NCT01931475|45985|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
8618|NCT01931475|45984|P2|Period 2: Extension Treatment Phase|Physician Decision|1
8619|NCT01931475|45985|P1|Period 2: Extension Treatment Phase|Physician Decision|1
8620|NCT01931475|45984|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
8621|NCT01931475|45985|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
8622|NCT01931475|45984|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
8623|NCT01931475|45985|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
8624|NCT01931475|45984|P2|Period 2: Extension Treatment Phase|Adverse Event|8
8625|NCT01931475|45985|P1|Period 2: Extension Treatment Phase|Adverse Event|0
8626|NCT01931475|45984|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
8627|NCT01931475|45985|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
8628|NCT01931475|45984|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
8629|NCT01931475|45985|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
8630|NCT01931475|45984|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
8631|NCT01931475|45985|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
8632|NCT01931475|45984|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
8633|NCT01931475|45985|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
8634|NCT01931475|45984|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
8635|NCT01931475|45985|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
8636|NCT01931150|46014|P2|Overall Study|Withdrawal by Subject|2
8637|NCT01931150|46015|P1|Overall Study|Withdrawal by Subject|1
8638|NCT01930890|46025|P4|Overall Study|Adverse Event|0
8639|NCT01930890|46026|P3|Overall Study|Adverse Event|0
8640|NCT01930890|46027|P2|Overall Study|Adverse Event|1
8641|NCT01930890|46028|P1|Overall Study|Adverse Event|0
8642|NCT01930890|46025|P4|Overall Study|Consent Withdrawn|1
8643|NCT01930890|46026|P3|Overall Study|Consent Withdrawn|0
8644|NCT01930890|46027|P2|Overall Study|Consent Withdrawn|3
8645|NCT01930890|46028|P1|Overall Study|Consent Withdrawn|0
8646|NCT01930890|46025|P4|Overall Study|Investigator Decision|0
8647|NCT01930890|46026|P3|Overall Study|Investigator Decision|0
8648|NCT01930890|46027|P2|Overall Study|Investigator Decision|1
8649|NCT01930890|46028|P1|Overall Study|Investigator Decision|0
8650|NCT01930890|46025|P4|Overall Study|Death|1
8651|NCT01930890|46026|P3|Overall Study|Death|0
8652|NCT01930890|46027|P2|Overall Study|Death|0
8653|NCT01930890|46028|P1|Overall Study|Death|0
8654|NCT01930890|46025|P4|Overall Study|Study Termination|25
8655|NCT01930890|46026|P3|Overall Study|Study Termination|13
8656|NCT01930890|46027|P2|Overall Study|Study Termination|28
8657|NCT01930890|46028|P1|Overall Study|Study Termination|14
8658|NCT01930799|46042|P1|Overall Study|Lost to Follow-up|5
8659|NCT01930799|46042|P1|Overall Study|Withdrawal by Subject|3
8660|NCT01929031|46154|P6|Overall Study|Reason other than specified above|0
8661|NCT01929031|46155|P5|Overall Study|Reason other than specified above|1
8662|NCT01929031|46156|P4|Overall Study|Reason other than specified above|0
8663|NCT01929031|46157|P3|Overall Study|Reason other than specified above|0
8664|NCT01929031|46158|P2|Overall Study|Reason other than specified above|1
8665|NCT01929031|46159|P1|Overall Study|Reason other than specified above|0
8666|NCT01929031|46154|P6|Overall Study|Protocol Violation|1
8667|NCT01929031|46155|P5|Overall Study|Protocol Violation|0
8668|NCT01929031|46156|P4|Overall Study|Protocol Violation|0
8669|NCT01929031|46157|P3|Overall Study|Protocol Violation|0
8670|NCT01929031|46158|P2|Overall Study|Protocol Violation|0
8671|NCT01929031|46159|P1|Overall Study|Protocol Violation|1
8672|NCT01929031|46154|P6|Overall Study|Adverse Event|0
8673|NCT01929031|46155|P5|Overall Study|Adverse Event|0
8674|NCT01929031|46156|P4|Overall Study|Adverse Event|0
8675|NCT01929031|46157|P3|Overall Study|Adverse Event|1
8676|NCT01929031|46158|P2|Overall Study|Adverse Event|1
8677|NCT01929031|46159|P1|Overall Study|Adverse Event|3
8678|NCT01928940|46183|P2|Overall Study|Ongoing|5
8679|NCT01928940|46184|P1|Overall Study|Ongoing|4
8680|NCT01928940|46183|P2|Overall Study|Adverse Event|1
8681|NCT01928940|46184|P1|Overall Study|Adverse Event|0
8682|NCT01930045|46252|P6|Pause (up to 37 Days)|Protocol Violation|1
8683|NCT01930045|46253|P5|Pause (up to 37 Days)|Protocol Violation|0
8684|NCT01930045|46254|P4|Pause (up to 37 Days)|Protocol Violation|0
8685|NCT01930045|46255|P3|Pause (up to 37 Days)|Protocol Violation|0
8686|NCT01930045|46256|P2|Pause (up to 37 Days)|Protocol Violation|0
8687|NCT01930045|46257|P1|Pause (up to 37 Days)|Protocol Violation|0
8688|NCT01930045|46252|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
8689|NCT01930045|46253|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
8690|NCT01930045|46254|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
8691|NCT01930045|46255|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
8692|NCT01930045|46256|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
8693|NCT01930045|46257|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
8849|NCT01928381|46603|P2|Part 1 - Pain Training|Withdrawal by Subject|0
8694|NCT01929993|46284|P2|Overall Study|Absent CIN, invasion present or artifact|22
8695|NCT01929993|46285|P1|Overall Study|Absent CIN, invasion present or artifact|26
8696|NCT01929993|46284|P2|Overall Study|Protocol Violation|6
8697|NCT01929993|46285|P1|Overall Study|Protocol Violation|4
8698|NCT01929980|46291|P1|Overall Study|Physician Decision|1
8699|NCT01929876|46299|P1|Period 2|Non-Compliance|1
8700|NCT01929317|46343|P2|Long-term Phase|Study Closed/Terminated|3
8701|NCT01929317|46344|P1|Long-term Phase|Study Closed/Terminated|5
8702|NCT01929317|46343|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
8703|NCT01929317|46344|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
8704|NCT01929317|46343|P2|Long-term Phase|Protocol Violation|0
8705|NCT01929317|46344|P1|Long-term Phase|Protocol Violation|1
8706|NCT01929317|46343|P2|Long-term Phase|Withdrawal by Subject|0
8707|NCT01929317|46344|P1|Long-term Phase|Withdrawal by Subject|4
8708|NCT01929317|46343|P2|Long-term Phase|Physician Decision|0
8709|NCT01929317|46344|P1|Long-term Phase|Physician Decision|3
8710|NCT01929317|46343|P2|Long-term Phase|Adverse Event|1
8711|NCT01929317|46344|P1|Long-term Phase|Adverse Event|5
8712|NCT01929317|46343|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
8713|NCT01929317|46344|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
8714|NCT01929317|46343|P2|Dose Increase Effect Verification Phase|Physician Decision|0
8715|NCT01929317|46344|P1|Dose Increase Effect Verification Phase|Physician Decision|1
8716|NCT01929317|46343|P2|Dose Increase Effect Verification Phase|Adverse Event|1
8717|NCT01929317|46344|P1|Dose Increase Effect Verification Phase|Adverse Event|5
8718|NCT01929135|46413|P2|Overall Study|Lost to Follow-up|1
8719|NCT01929135|46414|P1|Overall Study|Lost to Follow-up|1
8720|NCT01929083|46428|P2|Intervention 2|Adverse Event|1
8721|NCT01929083|46429|P1|Intervention 2|Adverse Event|0
8722|NCT01929083|46428|P2|Intervention 1|Nonadherent to study medications|0
8723|NCT01929083|46429|P1|Intervention 1|Nonadherent to study medications|1
8724|NCT01929083|46428|P2|Intervention 1|Lost to Follow-up|0
8725|NCT01929083|46429|P1|Intervention 1|Lost to Follow-up|2
8726|NCT01929044|46455|P2|Overall Study|Not Treated|3
8727|NCT01929044|46456|P1|Overall Study|Not Treated|1
8728|NCT01929044|46455|P2|Overall Study|Protocol Violation|14
8729|NCT01929044|46456|P1|Overall Study|Protocol Violation|9
8730|NCT01929044|46455|P2|Overall Study|Adverse Event|0
8731|NCT01929044|46456|P1|Overall Study|Adverse Event|1
8732|NCT01928615|46509|P1|Overall Study|Study Terminated by Sponsor|2
8733|NCT01928472|46528|P4|Overall Study|Unclassified|0
8734|NCT01928472|46529|P3|Overall Study|Unclassified|1
8735|NCT01928472|46530|P2|Overall Study|Unclassified|0
8736|NCT01928472|46531|P1|Overall Study|Unclassified|0
8737|NCT01928472|46528|P4|Overall Study|Administrative Reason|0
8738|NCT01928472|46529|P3|Overall Study|Administrative Reason|0
8739|NCT01928472|46530|P2|Overall Study|Administrative Reason|1
8740|NCT01928472|46531|P1|Overall Study|Administrative Reason|2
8741|NCT01928472|46528|P4|Overall Study|Lost to Follow-up|0
8742|NCT01928472|46529|P3|Overall Study|Lost to Follow-up|4
8743|NCT01928472|46530|P2|Overall Study|Lost to Follow-up|3
8744|NCT01928472|46531|P1|Overall Study|Lost to Follow-up|2
8745|NCT01928472|46528|P4|Overall Study|Withdrawal by Subject|2
8746|NCT01928472|46529|P3|Overall Study|Withdrawal by Subject|1
8747|NCT01928472|46530|P2|Overall Study|Withdrawal by Subject|4
8748|NCT01928472|46531|P1|Overall Study|Withdrawal by Subject|4
8749|NCT01928472|46528|P4|Overall Study|Death|0
8750|NCT01928472|46529|P3|Overall Study|Death|1
8751|NCT01928472|46530|P2|Overall Study|Death|0
8752|NCT01928472|46531|P1|Overall Study|Death|0
8753|NCT01928381|46598|P7|Part 2 - Post Third Intervention|Protocol Violation|0
8754|NCT01928381|46599|P6|Part 2 - Post Third Intervention|Protocol Violation|0
8755|NCT01928381|46600|P5|Part 2 - Post Third Intervention|Protocol Violation|0
8756|NCT01928381|46601|P4|Part 2 - Post Third Intervention|Protocol Violation|0
8757|NCT01928381|46602|P3|Part 2 - Post Third Intervention|Protocol Violation|1
8758|NCT01928381|46603|P2|Part 2 - Post Third Intervention|Protocol Violation|0
8759|NCT01928381|46604|P1|Part 2 - Post Third Intervention|Protocol Violation|0
8760|NCT01928381|46598|P7|Part 2 - Second Intervention|Lost to Follow-up|0
8761|NCT01928381|46599|P6|Part 2 - Second Intervention|Lost to Follow-up|0
8762|NCT01928381|46600|P5|Part 2 - Second Intervention|Lost to Follow-up|0
8763|NCT01928381|46601|P4|Part 2 - Second Intervention|Lost to Follow-up|1
8764|NCT01928381|46602|P3|Part 2 - Second Intervention|Lost to Follow-up|0
8765|NCT01928381|46603|P2|Part 2 - Second Intervention|Lost to Follow-up|1
8766|NCT01928381|46604|P1|Part 2 - Second Intervention|Lost to Follow-up|0
8767|NCT01928381|46598|P7|Washout First Intervention|Protocol Violation|0
8768|NCT01928381|46599|P6|Washout First Intervention|Protocol Violation|0
8769|NCT01928381|46600|P5|Washout First Intervention|Protocol Violation|1
8770|NCT01928381|46601|P4|Washout First Intervention|Protocol Violation|0
8771|NCT01928381|46602|P3|Washout First Intervention|Protocol Violation|0
8772|NCT01928381|46603|P2|Washout First Intervention|Protocol Violation|0
8773|NCT01928381|46604|P1|Washout First Intervention|Protocol Violation|0
8774|NCT01928381|46598|P7|Part 2 - First Intervention|Lost to Follow-up|0
8775|NCT01928381|46599|P6|Part 2 - First Intervention|Lost to Follow-up|0
8776|NCT01928381|46600|P5|Part 2 - First Intervention|Lost to Follow-up|0
8777|NCT01928381|46601|P4|Part 2 - First Intervention|Lost to Follow-up|1
8778|NCT01928381|46602|P3|Part 2 - First Intervention|Lost to Follow-up|0
8779|NCT01928381|46603|P2|Part 2 - First Intervention|Lost to Follow-up|0
8780|NCT01928381|46604|P1|Part 2 - First Intervention|Lost to Follow-up|0
8781|NCT01928381|46598|P7|Part 2 - First Intervention|Eligibility criterion not met|1
8782|NCT01928381|46599|P6|Part 2 - First Intervention|Eligibility criterion not met|1
8783|NCT01928381|46600|P5|Part 2 - First Intervention|Eligibility criterion not met|0
8784|NCT01928381|46601|P4|Part 2 - First Intervention|Eligibility criterion not met|0
8785|NCT01928381|46602|P3|Part 2 - First Intervention|Eligibility criterion not met|0
8786|NCT01928381|46603|P2|Part 2 - First Intervention|Eligibility criterion not met|0
8787|NCT01928381|46604|P1|Part 2 - First Intervention|Eligibility criterion not met|0
8788|NCT01928381|46598|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
8789|NCT01928381|46599|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
8790|NCT01928381|46600|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
8791|NCT01928381|46601|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
8792|NCT01928381|46602|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
8793|NCT01928381|46603|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
8794|NCT01928381|46604|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
8795|NCT01928381|46598|P7|Part 2 - First Intervention|Withdrawal by Subject|0
8796|NCT01928381|46599|P6|Part 2 - First Intervention|Withdrawal by Subject|0
8797|NCT01928381|46600|P5|Part 2 - First Intervention|Withdrawal by Subject|0
8798|NCT01928381|46601|P4|Part 2 - First Intervention|Withdrawal by Subject|0
8799|NCT01928381|46602|P3|Part 2 - First Intervention|Withdrawal by Subject|1
8800|NCT01928381|46603|P2|Part 2 - First Intervention|Withdrawal by Subject|0
8801|NCT01928381|46604|P1|Part 2 - First Intervention|Withdrawal by Subject|0
8802|NCT01928381|46598|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
8803|NCT01928381|46599|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
8804|NCT01928381|46600|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
8805|NCT01928381|46601|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
8806|NCT01928381|46602|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
8807|NCT01928381|46603|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
8808|NCT01928381|46604|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
8809|NCT01928381|46598|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
8810|NCT01928381|46599|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
8811|NCT01928381|46600|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
8812|NCT01928381|46601|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
8813|NCT01928381|46602|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
8814|NCT01928381|46603|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
8815|NCT01928381|46604|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
8816|NCT01928381|46598|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
8817|NCT01928381|46599|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
8818|NCT01928381|46600|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
8819|NCT01928381|46601|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
8820|NCT01928381|46602|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
8821|NCT01928381|46603|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
8822|NCT01928381|46604|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
8823|NCT01928381|46598|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
8824|NCT01928381|46599|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
8825|NCT01928381|46600|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
8826|NCT01928381|46601|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
8827|NCT01928381|46602|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
8828|NCT01928381|46603|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
8829|NCT01928381|46604|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
8830|NCT01928381|46598|P7|Part 1 - Pain Training|Protocol Violation|0
8831|NCT01928381|46599|P6|Part 1 - Pain Training|Protocol Violation|0
8832|NCT01928381|46600|P5|Part 1 - Pain Training|Protocol Violation|0
8833|NCT01928381|46601|P4|Part 1 - Pain Training|Protocol Violation|0
8834|NCT01928381|46602|P3|Part 1 - Pain Training|Protocol Violation|0
8835|NCT01928381|46603|P2|Part 1 - Pain Training|Protocol Violation|0
8836|NCT01928381|46604|P1|Part 1 - Pain Training|Protocol Violation|1
8837|NCT01928381|46598|P7|Part 1 - Pain Training|Lost to Follow-up|0
8838|NCT01928381|46599|P6|Part 1 - Pain Training|Lost to Follow-up|0
8839|NCT01928381|46600|P5|Part 1 - Pain Training|Lost to Follow-up|0
8840|NCT01928381|46601|P4|Part 1 - Pain Training|Lost to Follow-up|0
8841|NCT01928381|46602|P3|Part 1 - Pain Training|Lost to Follow-up|0
8842|NCT01928381|46603|P2|Part 1 - Pain Training|Lost to Follow-up|0
8843|NCT01928381|46604|P1|Part 1 - Pain Training|Lost to Follow-up|4
8844|NCT01928381|46598|P7|Part 1 - Pain Training|Withdrawal by Subject|0
8845|NCT01928381|46599|P6|Part 1 - Pain Training|Withdrawal by Subject|0
8846|NCT01928381|46600|P5|Part 1 - Pain Training|Withdrawal by Subject|0
8847|NCT01928381|46601|P4|Part 1 - Pain Training|Withdrawal by Subject|0
8848|NCT01928381|46602|P3|Part 1 - Pain Training|Withdrawal by Subject|0
8850|NCT01928381|46604|P1|Part 1 - Pain Training|Withdrawal by Subject|1
8851|NCT01928381|46598|P7|Part 1 - Pain Training|Pain training criteria not met|0
8852|NCT01928381|46599|P6|Part 1 - Pain Training|Pain training criteria not met|0
8853|NCT01928381|46600|P5|Part 1 - Pain Training|Pain training criteria not met|0
8854|NCT01928381|46601|P4|Part 1 - Pain Training|Pain training criteria not met|0
8855|NCT01928381|46602|P3|Part 1 - Pain Training|Pain training criteria not met|0
8856|NCT01928381|46603|P2|Part 1 - Pain Training|Pain training criteria not met|0
8857|NCT01928381|46604|P1|Part 1 - Pain Training|Pain training criteria not met|29
8858|NCT01928381|46598|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
8859|NCT01928381|46599|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
8860|NCT01928381|46600|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
8861|NCT01928381|46601|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
8862|NCT01928381|46602|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
8863|NCT01928381|46603|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
8864|NCT01928381|46604|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
8865|NCT01927757|46626|P1|Overall Study|Ethical Reasons|4
8866|NCT01927757|46626|P1|Overall Study|Other|1
8867|NCT01927757|46626|P1|Overall Study|Decision by Sponsor|2
8868|NCT01927757|46626|P1|Overall Study|Lost to Follow-up|2
8869|NCT01927757|46626|P1|Overall Study|Withdrawal by Subject|14
8870|NCT01927419|46646|P2|Overall Study|Not reported|0
8871|NCT01927419|46647|P1|Overall Study|Not reported|1
8872|NCT01927419|46646|P2|Overall Study|Not specified|1
8873|NCT01927419|46647|P1|Overall Study|Not specified|2
8874|NCT01927419|46646|P2|Overall Study|Withdrawal by Subject|1
8875|NCT01927419|46647|P1|Overall Study|Withdrawal by Subject|3
8876|NCT01927419|46646|P2|Overall Study|Adverse event unrelated to study drug|1
8877|NCT01927419|46647|P1|Overall Study|Adverse event unrelated to study drug|6
8878|NCT01927419|46646|P2|Overall Study|Death|1
8879|NCT01927419|46647|P1|Overall Study|Death|0
8880|NCT01927419|46646|P2|Overall Study|Study drug toxicity|7
8881|NCT01927419|46647|P1|Overall Study|Study drug toxicity|43
8882|NCT01927419|46646|P2|Overall Study|Disease progression|17
8883|NCT01927419|46647|P1|Overall Study|Disease progression|15
8884|NCT01927055|46666|P3|Double-Blind|Extended Vacation|0
8885|NCT01927055|46667|P2|Double-Blind|Extended Vacation|1
8886|NCT01927055|46668|P1|Double-Blind|Extended Vacation|0
8887|NCT01927055|46666|P3|Double-Blind|Supine Hypertension|1
8888|NCT01927055|46667|P2|Double-Blind|Supine Hypertension|0
8889|NCT01927055|46668|P1|Double-Blind|Supine Hypertension|0
8890|NCT01927055|46666|P3|Double-Blind|Study Stopped|7
8891|NCT01927055|46667|P2|Double-Blind|Study Stopped|7
8892|NCT01927055|46668|P1|Double-Blind|Study Stopped|0
8893|NCT01927055|46666|P3|Double-Blind|Withdrawal by Subject|3
8894|NCT01927055|46667|P2|Double-Blind|Withdrawal by Subject|2
8895|NCT01927055|46668|P1|Double-Blind|Withdrawal by Subject|0
8896|NCT01927055|46666|P3|Double-Blind|Protocol Violation|1
8897|NCT01927055|46667|P2|Double-Blind|Protocol Violation|0
8898|NCT01927055|46668|P1|Double-Blind|Protocol Violation|0
8899|NCT01927055|46666|P3|Double-Blind|Adverse Event|1
8900|NCT01927055|46667|P2|Double-Blind|Adverse Event|1
8901|NCT01927055|46668|P1|Double-Blind|Adverse Event|0
8902|NCT01927055|46666|P3|Open-label|Difficulty attending study visits|0
8903|NCT01927055|46667|P2|Open-label|Difficulty attending study visits|0
8904|NCT01927055|46668|P1|Open-label|Difficulty attending study visits|1
8905|NCT01927055|46666|P3|Open-label|Supine Hypertension|0
8906|NCT01927055|46667|P2|Open-label|Supine Hypertension|0
8907|NCT01927055|46668|P1|Open-label|Supine Hypertension|4
8908|NCT01927055|46666|P3|Open-label|Study Stopped|0
8909|NCT01927055|46667|P2|Open-label|Study Stopped|0
8910|NCT01927055|46668|P1|Open-label|Study Stopped|4
8911|NCT01927055|46666|P3|Open-label|Withdrawal by Subject|0
8912|NCT01927055|46667|P2|Open-label|Withdrawal by Subject|0
8913|NCT01927055|46668|P1|Open-label|Withdrawal by Subject|1
8914|NCT01927055|46666|P3|Open-label|Adverse Event|0
8915|NCT01927055|46667|P2|Open-label|Adverse Event|0
8916|NCT01927055|46668|P1|Open-label|Adverse Event|6
8917|NCT01926626|46686|P1|Overall Study|Lost to Follow-up|7
8918|NCT01926626|46686|P1|Overall Study|Withdrawal by Subject|15
8919|NCT01926015|46698|P2|Overall Study|Randomized not treated|0
8920|NCT01926015|46699|P1|Overall Study|Randomized not treated|2
8921|NCT01926015|46698|P2|Overall Study|Withdrawal by parent/guardian|1
8922|NCT01926015|46699|P1|Overall Study|Withdrawal by parent/guardian|0
8923|NCT01925768|46742|P2|Overall Study|Non-compliance with study drug|1
8924|NCT01925768|46743|P1|Overall Study|Non-compliance with study drug|0
8925|NCT01925768|46742|P2|Overall Study|Withdrawal by Subject|4
8926|NCT01925768|46743|P1|Overall Study|Withdrawal by Subject|1
8927|NCT01925768|46742|P2|Overall Study|Lack of Efficacy|6
8928|NCT01925768|46743|P1|Overall Study|Lack of Efficacy|3
8929|NCT01925768|46742|P2|Overall Study|Adverse Event|10
8930|NCT01925768|46743|P1|Overall Study|Adverse Event|5
8931|NCT01925768|46742|P2|Overall Study|Protocol Violation|2
8932|NCT01925768|46743|P1|Overall Study|Protocol Violation|1
8933|NCT01925768|46742|P2|Overall Study|Lost to Follow-up|0
8934|NCT01925768|46743|P1|Overall Study|Lost to Follow-up|1
8935|NCT01925703|46751|P1|Overall Study|Discharge prior to full iron repletion|1
8936|NCT01925703|46751|P1|Overall Study|Lost to Follow-up|2
8937|NCT01925703|46751|P1|Overall Study|Physician Decision|1
8938|NCT01925417|46757|P1|Overall Study|Death|1
8939|NCT01925417|46757|P1|Overall Study|Withdrawal by Subject|2
8940|NCT01925183|46766|P2|Overall Study|Adverse Event|0
8941|NCT01925183|46767|P1|Overall Study|Adverse Event|1
8942|NCT01925170|46775|P1|Overall Study|Unverified cancer status|53
8943|NCT01924767|46825|P5|Overall Study|Adverse Event|0
8944|NCT01924767|46826|P4|Overall Study|Adverse Event|0
8945|NCT01924767|46827|P3|Overall Study|Adverse Event|1
8946|NCT01924767|46828|P2|Overall Study|Adverse Event|0
8947|NCT01924767|46829|P1|Overall Study|Adverse Event|1
8948|NCT01924182|46958|P2|Overall Study|Withdrawal by Subject|0
8949|NCT01924182|46959|P1|Overall Study|Withdrawal by Subject|1
8950|NCT01923896|46967|P2|Overall Study|Adverse Event|0
8951|NCT01923896|46968|P1|Overall Study|Adverse Event|1
8952|NCT01923467|46980|P1|Overall Study|Subject non-interest|479
8953|NCT01923467|46980|P1|Overall Study|Lost to Follow-up|62
8954|NCT01923389|46986|P2|Overall Study|Protocol Violation|0
8955|NCT01923389|46987|P1|Overall Study|Protocol Violation|1
8956|NCT01922349|47013|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
8957|NCT01922349|47014|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
8958|NCT01922349|47015|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
8959|NCT01922349|47016|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
8960|NCT01922271|47123|P2|WASHOUT Period|Withdrawal by Subject|0
8961|NCT01922271|47124|P1|WASHOUT Period|Withdrawal by Subject|1
8962|NCT01922089|47159|P2|Overall Study|Lost to Follow-up|1
8963|NCT01922089|47160|P1|Overall Study|Lost to Follow-up|0
8964|NCT01922089|47159|P2|Overall Study|Death|1
8965|NCT01922089|47160|P1|Overall Study|Death|2
8966|NCT01922089|47159|P2|Overall Study|Physician Decision|3
8967|NCT01922089|47160|P1|Overall Study|Physician Decision|2
8968|NCT01922089|47159|P2|Overall Study|administrative problems|1
8969|NCT01922089|47160|P1|Overall Study|administrative problems|4
8970|NCT01922089|47159|P2|Overall Study|Withdrawal by Subject|4
8971|NCT01922089|47160|P1|Overall Study|Withdrawal by Subject|3
8972|NCT01922089|47159|P2|Overall Study|Protocol Deviation|7
8973|NCT01922089|47160|P1|Overall Study|Protocol Deviation|10
8974|NCT01922089|47159|P2|Overall Study|Adverse Event|13
8975|NCT01922089|47160|P1|Overall Study|Adverse Event|18
8976|NCT01920568|47172|P2|Overall Study|Death due to disease progression|12
8977|NCT01920568|47173|P1|Overall Study|Death due to disease progression|25
8978|NCT01920568|47172|P2|Overall Study|Withdrawal by Subject|55
8979|NCT01920568|47173|P1|Overall Study|Withdrawal by Subject|79
8980|NCT01920568|47172|P2|Overall Study|Physician Decision|4
8981|NCT01920568|47173|P1|Overall Study|Physician Decision|13
8982|NCT01920568|47172|P2|Overall Study|Lost to Follow-up|2
8983|NCT01920568|47173|P1|Overall Study|Lost to Follow-up|2
8984|NCT01920568|47172|P2|Overall Study|Protocol Violation|3
8985|NCT01920568|47173|P1|Overall Study|Protocol Violation|5
8986|NCT01920568|47172|P2|Overall Study|Adverse Event|8
8987|NCT01920568|47173|P1|Overall Study|Adverse Event|27
8988|NCT01921101|47209|P2|Overall Study|Death|6
8989|NCT01921101|47210|P1|Overall Study|Death|16
8990|NCT01920958|47218|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
8991|NCT01920854|47241|P7|Overall Study|Withdrawal by Subject|1
8992|NCT01920854|47242|P6|Overall Study|Withdrawal by Subject|0
8993|NCT01920854|47243|P5|Overall Study|Withdrawal by Subject|1
8994|NCT01920854|47244|P4|Overall Study|Withdrawal by Subject|0
8995|NCT01920854|47245|P3|Overall Study|Withdrawal by Subject|0
8996|NCT01920854|47246|P2|Overall Study|Withdrawal by Subject|0
8997|NCT01920854|47247|P1|Overall Study|Withdrawal by Subject|1
8998|NCT01919801|47395|P2|Overall Study|Unspecified|1
8999|NCT01919801|47396|P1|Overall Study|Unspecified|0
9000|NCT01919801|47395|P2|Overall Study|Lost to Follow-up|1
9001|NCT01919801|47396|P1|Overall Study|Lost to Follow-up|0
9002|NCT01919801|47395|P2|Overall Study|Physician Decision|1
9003|NCT01919801|47396|P1|Overall Study|Physician Decision|0
9004|NCT01919801|47395|P2|Overall Study|Withdrawal by Subject|0
9005|NCT01919801|47396|P1|Overall Study|Withdrawal by Subject|1
9006|NCT01919229|47434|P3|Overall Study|Subject/guardian decision|1
9007|NCT01919229|47435|P2|Overall Study|Subject/guardian decision|0
9008|NCT01919229|47436|P1|Overall Study|Subject/guardian decision|0
9009|NCT01918371|47467|P2|Overall Study|Missing Data|1
9010|NCT01918371|47468|P1|Overall Study|Missing Data|1
9011|NCT01918332|47546|P4|Overall Study|lipid result by central lab did not meet|0
9012|NCT01918332|47547|P3|Overall Study|lipid result by central lab did not meet|1
9013|NCT01918332|47548|P2|Overall Study|lipid result by central lab did not meet|0
9014|NCT01918332|47549|P1|Overall Study|lipid result by central lab did not meet|0
9015|NCT01918332|47546|P4|Overall Study|Protocol Violation|3
9016|NCT01918332|47547|P3|Overall Study|Protocol Violation|6
9017|NCT01918332|47548|P2|Overall Study|Protocol Violation|2
9018|NCT01918332|47549|P1|Overall Study|Protocol Violation|6
9019|NCT01918332|47546|P4|Overall Study|Withdrawal by Subject|3
9020|NCT01918332|47547|P3|Overall Study|Withdrawal by Subject|2
9021|NCT01918332|47548|P2|Overall Study|Withdrawal by Subject|3
9022|NCT01918332|47549|P1|Overall Study|Withdrawal by Subject|2
9023|NCT01918332|47546|P4|Overall Study|Adverse Event|1
9024|NCT01918332|47547|P3|Overall Study|Adverse Event|0
9025|NCT01918332|47548|P2|Overall Study|Adverse Event|0
9026|NCT01918332|47549|P1|Overall Study|Adverse Event|0
9027|NCT01918085|47561|P2|Test Period 1: Strata Strip|Adverse Event|1
9028|NCT01918085|47562|P1|Test Period 1: Strata Strip|Adverse Event|0
9029|NCT01918033|47573|P3|Overall Study|Withdrawal by Subject|0
9030|NCT01918033|47574|P2|Overall Study|Withdrawal by Subject|1
9031|NCT01918033|47575|P1|Overall Study|Withdrawal by Subject|2
9032|NCT01918033|47573|P3|Overall Study|Protocol Violation|1
9033|NCT01918033|47574|P2|Overall Study|Protocol Violation|0
9034|NCT01918033|47575|P1|Overall Study|Protocol Violation|2
9035|NCT01918033|47573|P3|Overall Study|Lost to Follow-up|0
9036|NCT01918033|47574|P2|Overall Study|Lost to Follow-up|1
9037|NCT01918033|47575|P1|Overall Study|Lost to Follow-up|0
9038|NCT01918033|47573|P3|Overall Study|Adverse Event|2
9039|NCT01918033|47574|P2|Overall Study|Adverse Event|0
9040|NCT01918033|47575|P1|Overall Study|Adverse Event|1
9041|NCT01917656|47646|P2|Overall Study|Lost to Follow-up|4
9042|NCT01917656|47647|P1|Overall Study|Lost to Follow-up|3
9043|NCT01917656|47646|P2|Overall Study|Withdrawal by Subject|3
9044|NCT01917656|47647|P1|Overall Study|Withdrawal by Subject|4
9045|NCT01917656|47646|P2|Overall Study|Unclassified|3
9046|NCT01917656|47647|P1|Overall Study|Unclassified|0
9047|NCT01917656|47646|P2|Overall Study|Withdrawal criteria|14
9048|NCT01917656|47647|P1|Overall Study|Withdrawal criteria|8
9049|NCT01917656|47646|P2|Overall Study|Adverse Event|0
9050|NCT01917656|47647|P1|Overall Study|Adverse Event|11
9051|NCT01917526|47673|P2|Overall Study|Protocol Violation|1
9052|NCT01917526|47674|P1|Overall Study|Protocol Violation|1
9053|NCT01917344|47682|P1|Overall Study|Withdrawal by Subject|1
9054|NCT01916980|47697|P2|Overall Study|Withdrawal by Subject|0
9055|NCT01916980|47698|P1|Overall Study|Withdrawal by Subject|1
9056|NCT01916980|47697|P2|Overall Study|Lack of Efficacy|2
9057|NCT01916980|47698|P1|Overall Study|Lack of Efficacy|2
9058|NCT01916980|47697|P2|Overall Study|Adverse Event|2
9059|NCT01916980|47698|P1|Overall Study|Adverse Event|4
9060|NCT01916967|47717|P3|Overall Study|Protocol Violation|0
9061|NCT01916967|47718|P2|Overall Study|Protocol Violation|1
9062|NCT01916967|47719|P1|Overall Study|Protocol Violation|0
9063|NCT01916967|47717|P3|Overall Study|Physician Decision|1
9064|NCT01916967|47718|P2|Overall Study|Physician Decision|0
9065|NCT01916967|47719|P1|Overall Study|Physician Decision|0
9066|NCT01916967|47717|P3|Overall Study|Lack of Efficacy|6
9067|NCT01916967|47718|P2|Overall Study|Lack of Efficacy|0
9068|NCT01916967|47719|P1|Overall Study|Lack of Efficacy|0
9069|NCT01916967|47717|P3|Overall Study|Adverse Event|2
9070|NCT01916967|47718|P2|Overall Study|Adverse Event|0
9071|NCT01916967|47719|P1|Overall Study|Adverse Event|0
9072|NCT01916304|47827|P1|Overall Study|Screening failure|17
9073|NCT01916226|47839|P4|Overall Study|Physician Decision|1
9074|NCT01916226|47840|P3|Overall Study|Physician Decision|0
9075|NCT01916226|47841|P2|Overall Study|Physician Decision|0
9076|NCT01916226|47842|P1|Overall Study|Physician Decision|0
9077|NCT01916226|47839|P4|Overall Study|Protocol Violation|1
9078|NCT01916226|47840|P3|Overall Study|Protocol Violation|0
9079|NCT01916226|47841|P2|Overall Study|Protocol Violation|1
9080|NCT01916226|47842|P1|Overall Study|Protocol Violation|0
9081|NCT01916226|47839|P4|Overall Study|Lack of Efficacy|1
9082|NCT01916226|47840|P3|Overall Study|Lack of Efficacy|2
9083|NCT01916226|47841|P2|Overall Study|Lack of Efficacy|0
9084|NCT01916226|47842|P1|Overall Study|Lack of Efficacy|0
9085|NCT01916226|47839|P4|Overall Study|Adverse Event|1
9086|NCT01916226|47840|P3|Overall Study|Adverse Event|1
9087|NCT01916226|47841|P2|Overall Study|Adverse Event|0
9088|NCT01916226|47842|P1|Overall Study|Adverse Event|1
9089|NCT01916109|47876|P1|Overall Study|Withdrawal by Subject|1
9090|NCT01915914|47880|P4|Follow-up Phase|Physician Decision|1
9091|NCT01915914|47881|P3|Follow-up Phase|Physician Decision|0
9092|NCT01915914|47882|P2|Follow-up Phase|Physician Decision|0
9093|NCT01915914|47883|P1|Follow-up Phase|Physician Decision|0
9094|NCT01915914|47880|P4|Follow-up Phase|Withdrawal by Subject|1
9095|NCT01915914|47881|P3|Follow-up Phase|Withdrawal by Subject|0
9096|NCT01915914|47882|P2|Follow-up Phase|Withdrawal by Subject|0
9097|NCT01915914|47883|P1|Follow-up Phase|Withdrawal by Subject|0
9098|NCT01915914|47880|P4|Maintenance Phase|Missing|0
9099|NCT01915914|47881|P3|Maintenance Phase|Missing|0
9100|NCT01915914|47882|P2|Maintenance Phase|Missing|1
9101|NCT01915914|47883|P1|Maintenance Phase|Missing|0
9102|NCT01915914|47880|P4|Maintenance Phase|Lost to Follow-up|0
9103|NCT01915914|47881|P3|Maintenance Phase|Lost to Follow-up|1
9104|NCT01915914|47882|P2|Maintenance Phase|Lost to Follow-up|4
9105|NCT01915914|47883|P1|Maintenance Phase|Lost to Follow-up|0
9106|NCT01915914|47880|P4|Maintenance Phase|Withdrawal by Subject|0
9107|NCT01915914|47881|P3|Maintenance Phase|Withdrawal by Subject|1
9108|NCT01915914|47882|P2|Maintenance Phase|Withdrawal by Subject|1
9109|NCT01915914|47883|P1|Maintenance Phase|Withdrawal by Subject|0
9110|NCT01915914|47880|P4|Acute Phase|Missing|0
9111|NCT01915914|47881|P3|Acute Phase|Missing|0
9112|NCT01915914|47882|P2|Acute Phase|Missing|0
9113|NCT01915914|47883|P1|Acute Phase|Missing|1
9114|NCT01915914|47880|P4|Acute Phase|"Not Achieved treatment success"|0
9115|NCT01915914|47881|P3|Acute Phase|"Not Achieved treatment success"|0
9116|NCT01915914|47882|P2|Acute Phase|"Not Achieved treatment success"|0
9117|NCT01915914|47883|P1|Acute Phase|"Not Achieved treatment success"|1
9118|NCT01915914|47880|P4|Acute Phase|Accepted Other Topic Therapies|0
9119|NCT01915914|47881|P3|Acute Phase|Accepted Other Topic Therapies|0
9120|NCT01915914|47882|P2|Acute Phase|Accepted Other Topic Therapies|0
9121|NCT01915914|47883|P1|Acute Phase|Accepted Other Topic Therapies|1
9122|NCT01915914|47880|P4|Acute Phase|Physician Decision|0
9123|NCT01915914|47881|P3|Acute Phase|Physician Decision|0
9124|NCT01915914|47882|P2|Acute Phase|Physician Decision|0
9125|NCT01915914|47883|P1|Acute Phase|Physician Decision|1
9126|NCT01915914|47880|P4|Acute Phase|Lost to Follow-up|0
9127|NCT01915914|47881|P3|Acute Phase|Lost to Follow-up|0
9128|NCT01915914|47882|P2|Acute Phase|Lost to Follow-up|0
9129|NCT01915914|47883|P1|Acute Phase|Lost to Follow-up|4
9130|NCT01915914|47880|P4|Acute Phase|Withdrawal by Subject|0
9131|NCT01915914|47881|P3|Acute Phase|Withdrawal by Subject|0
9132|NCT01915914|47882|P2|Acute Phase|Withdrawal by Subject|0
9133|NCT01915914|47883|P1|Acute Phase|Withdrawal by Subject|4
9134|NCT01915849|47915|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
9135|NCT01915849|47916|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
9136|NCT01915849|47917|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
9137|NCT01915849|47918|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
9138|NCT01915849|47915|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
9139|NCT01915849|47916|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
9140|NCT01915849|47917|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
9141|NCT01915849|47918|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
9142|NCT01915732|47943|P2|Overall Study|Poor Conscious Effect|1
9143|NCT01915732|47944|P1|Overall Study|Poor Conscious Effect|0
9144|NCT01915732|47943|P2|Overall Study|Improper Facial Procedure|1
9145|NCT01915732|47944|P1|Overall Study|Improper Facial Procedure|0
9146|NCT01915732|47943|P2|Overall Study|Job Transfer|1
9147|NCT01915732|47944|P1|Overall Study|Job Transfer|0
9148|NCT01915732|47943|P2|Overall Study|Par. Refused to Hospital Visits|1
9149|NCT01915732|47944|P1|Overall Study|Par. Refused to Hospital Visits|0
9150|NCT01915732|47943|P2|Overall Study|Par. not Willing to Continue Treatment|1
9151|NCT01915732|47944|P1|Overall Study|Par. not Willing to Continue Treatment|0
9152|NCT01915732|47943|P2|Overall Study|Got Well|1
9153|NCT01915732|47944|P1|Overall Study|Got Well|0
9154|NCT01915732|47943|P2|Overall Study|Par. Unable to Come to the Hospital|1
9155|NCT01915732|47944|P1|Overall Study|Par. Unable to Come to the Hospital|0
9156|NCT01915732|47943|P2|Overall Study|Poor Perceived Efficacy|0
9157|NCT01915732|47944|P1|Overall Study|Poor Perceived Efficacy|1
9158|NCT01915732|47943|P2|Overall Study|Pregnancy|0
9159|NCT01915732|47944|P1|Overall Study|Pregnancy|1
9160|NCT01915732|47943|P2|Overall Study|Recovered|0
9161|NCT01915732|47944|P1|Overall Study|Recovered|1
9162|NCT01915732|47943|P2|Overall Study|Drug Release Error|0
9163|NCT01915732|47944|P1|Overall Study|Drug Release Error|1
9164|NCT01915732|47943|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
9165|NCT01915732|47944|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
9166|NCT01915732|47943|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
9167|NCT01915732|47944|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
9168|NCT01915732|47943|P2|Overall Study|Lost to Follow-up|26
9169|NCT01915732|47944|P1|Overall Study|Lost to Follow-up|22
9170|NCT01915732|47943|P2|Overall Study|Lack of Efficacy|11
9171|NCT01915732|47944|P1|Overall Study|Lack of Efficacy|6
9172|NCT01915732|47943|P2|Overall Study|Protocol Violation|5
9173|NCT01915732|47944|P1|Overall Study|Protocol Violation|5
9174|NCT01915732|47943|P2|Overall Study|Adverse Event|4
9175|NCT01915732|47944|P1|Overall Study|Adverse Event|12
9176|NCT01915732|47943|P2|Overall Study|Failure to Meet Randomization Criteria|0
9177|NCT01915732|47944|P1|Overall Study|Failure to Meet Randomization Criteria|1
9178|NCT01915732|47943|P2|Overall Study|Withdrawal by Subject|18
9179|NCT01915732|47944|P1|Overall Study|Withdrawal by Subject|18
9180|NCT01914926|47987|P2|Overall Study|uncooperative, agitated and removed|1
9181|NCT01914926|47988|P1|Overall Study|uncooperative, agitated and removed|0
9182|NCT01914926|47987|P2|Overall Study|Adverse Event|0
9183|NCT01914926|47988|P1|Overall Study|Adverse Event|1
9184|NCT01914757|47997|P3|Overall Study|Other reasons|4
9185|NCT01914757|47998|P2|Overall Study|Other reasons|9
9186|NCT01914757|47999|P1|Overall Study|Other reasons|5
9187|NCT01914757|47997|P3|Overall Study|Eligibility criteria not fulfilled|2
9188|NCT01914757|47998|P2|Overall Study|Eligibility criteria not fulfilled|0
9189|NCT01914757|47999|P1|Overall Study|Eligibility criteria not fulfilled|2
9190|NCT01914757|47997|P3|Overall Study|Study specific withdrawal criteria|0
9191|NCT01914757|47998|P2|Overall Study|Study specific withdrawal criteria|1
9192|NCT01914757|47999|P1|Overall Study|Study specific withdrawal criteria|0
9193|NCT01914757|47997|P3|Overall Study|Adverse Event|4
9194|NCT01914757|47998|P2|Overall Study|Adverse Event|3
9195|NCT01914757|47999|P1|Overall Study|Adverse Event|4
9196|NCT01914757|47997|P3|Overall Study|Death|1
9197|NCT01914757|47998|P2|Overall Study|Death|2
9198|NCT01914757|47999|P1|Overall Study|Death|2
9199|NCT01914757|47997|P3|Overall Study|Withdrawal by Subject|19
9200|NCT01914757|47998|P2|Overall Study|Withdrawal by Subject|27
9201|NCT01914757|47999|P1|Overall Study|Withdrawal by Subject|15
9202|NCT01914757|47997|P3|Overall Study|Lost to Follow-up|6
9203|NCT01914757|47998|P2|Overall Study|Lost to Follow-up|8
9204|NCT01914757|47999|P1|Overall Study|Lost to Follow-up|5
9205|NCT01914757|47997|P3|Overall Study|Severe non-compliance to protocol|2
9206|NCT01914757|47998|P2|Overall Study|Severe non-compliance to protocol|1
9207|NCT01914757|47999|P1|Overall Study|Severe non-compliance to protocol|3
9208|NCT01914666|48076|P3|Treatment Period|Physician Decision|2
9209|NCT01914666|48077|P2|Treatment Period|Physician Decision|0
9210|NCT01914666|48078|P1|Treatment Period|Physician Decision|0
9211|NCT01914666|48076|P3|Treatment Period|Withdrawal by Subject|2
9212|NCT01914666|48077|P2|Treatment Period|Withdrawal by Subject|2
9213|NCT01914666|48078|P1|Treatment Period|Withdrawal by Subject|3
9214|NCT01914666|48076|P3|Treatment Period|Adverse Event|2
9215|NCT01914666|48077|P2|Treatment Period|Adverse Event|4
9216|NCT01914666|48078|P1|Treatment Period|Adverse Event|10
9217|NCT01914666|48076|P3|Treatment Period|Lack of Efficacy|2
9218|NCT01914666|48077|P2|Treatment Period|Lack of Efficacy|0
9219|NCT01914666|48078|P1|Treatment Period|Lack of Efficacy|0
9220|NCT01913041|48141|P1|Overall Study|Physician Decision|1
9221|NCT01913041|48141|P1|Overall Study|Withdrawal by Subject|3
9222|NCT01913041|48141|P1|Overall Study|Protocol Violation|35
9223|NCT01912781|48147|P2|Overall Study|Withdrawal by Subject|0
9224|NCT01912781|48148|P1|Overall Study|Withdrawal by Subject|2
9225|NCT01912768|48179|P2|Overall Study|Randomized in error|0
9226|NCT01912768|48180|P1|Overall Study|Randomized in error|1
9227|NCT01912768|48179|P2|Overall Study|Withdrawal by Subject|3
9228|NCT01912768|48180|P1|Overall Study|Withdrawal by Subject|5
9229|NCT01912768|48179|P2|Overall Study|Lost to Follow-up|1
9230|NCT01912768|48180|P1|Overall Study|Lost to Follow-up|2
9231|NCT01912768|48179|P2|Overall Study|Adverse Event|0
9232|NCT01912768|48180|P1|Overall Study|Adverse Event|2
9233|NCT01912599|48211|P2|Overall Study|Withdrawal by Subject|1
9234|NCT01912599|48212|P1|Overall Study|Withdrawal by Subject|0
9235|NCT01912404|48237|P2|Overall Study|Due to personal reasons|0
9236|NCT01912404|48238|P1|Overall Study|Due to personal reasons|1
9237|NCT01912222|48252|P3|Part B: Treatment Period|Withdrawal by Subject|2
9238|NCT01912222|48253|P2|Part B: Treatment Period|Withdrawal by Subject|1
9239|NCT01912222|48254|P1|Part B: Treatment Period|Withdrawal by Subject|2
9240|NCT01912222|48252|P3|Part B: Treatment Period|Adverse Event|3
9241|NCT01912222|48253|P2|Part B: Treatment Period|Adverse Event|2
9242|NCT01912222|48254|P1|Part B: Treatment Period|Adverse Event|1
9243|NCT01912222|48252|P3|Part B: Treatment Period|Progressive disease|15
9244|NCT01912222|48253|P2|Part B: Treatment Period|Progressive disease|12
9245|NCT01912222|48254|P1|Part B: Treatment Period|Progressive disease|10
9246|NCT01912222|48252|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
9247|NCT01912222|48253|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
9248|NCT01912222|48254|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
9249|NCT01911845|48277|P1|Overall Study|Other (not specified)|3
9250|NCT01911845|48277|P1|Overall Study|Lost to Follow-up|1
9251|NCT01911845|48277|P1|Overall Study|Adverse Event|2
9252|NCT01911780|48293|P2|Extension Period (52 Weeks)|Personal reason|1
9253|NCT01911780|48294|P1|Extension Period (52 Weeks)|Personal reason|1
9254|NCT01911780|48293|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
9255|NCT01911780|48294|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
9256|NCT01911780|48293|P2|Extension Period (52 Weeks)|Adverse Event|0
9257|NCT01911780|48294|P1|Extension Period (52 Weeks)|Adverse Event|3
9258|NCT01911780|48293|P2|Double-blind Period (8 Weeks)|Personal reason|0
9259|NCT01911780|48294|P1|Double-blind Period (8 Weeks)|Personal reason|1
9260|NCT01911780|48293|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
9261|NCT01911780|48294|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
9262|NCT01911780|48293|P2|Double-blind Period (8 Weeks)|Adverse Event|2
9263|NCT01911780|48294|P1|Double-blind Period (8 Weeks)|Adverse Event|1
9264|NCT01911442|48331|P3|Overall Study|Mother's Work Schedule|0
9265|NCT01911442|48332|P2|Overall Study|Mother's Work Schedule|1
9266|NCT01911442|48333|P1|Overall Study|Mother's Work Schedule|0
9267|NCT01911442|48331|P3|Overall Study|Withdrawal by Subject|6
9268|NCT01911442|48332|P2|Overall Study|Withdrawal by Subject|0
9269|NCT01911442|48333|P1|Overall Study|Withdrawal by Subject|1
9270|NCT01911442|48331|P3|Overall Study|Lost to Follow-up|1
9271|NCT01911442|48332|P2|Overall Study|Lost to Follow-up|0
9272|NCT01911442|48333|P1|Overall Study|Lost to Follow-up|2
9273|NCT01911442|48331|P3|Overall Study|Lack of Efficacy|1
9274|NCT01911442|48332|P2|Overall Study|Lack of Efficacy|1
9275|NCT01911442|48333|P1|Overall Study|Lack of Efficacy|1
9276|NCT01911442|48331|P3|Overall Study|Adverse Event|4
9277|NCT01911442|48332|P2|Overall Study|Adverse Event|2
9278|NCT01911442|48333|P1|Overall Study|Adverse Event|2
9279|NCT01911273|48398|P2|Overall Study|Withdrawal by Subject|2
9280|NCT01911273|48399|P1|Overall Study|Withdrawal by Subject|0
9281|NCT01911273|48398|P2|Overall Study|Progression of Disease|0
9282|NCT01911273|48399|P1|Overall Study|Progression of Disease|1
9283|NCT01911260|48433|P4|Follow-up Period|transference or evasion of school|12
9284|NCT01911260|48434|P3|Follow-up Period|transference or evasion of school|15
9285|NCT01911260|48435|P2|Follow-up Period|transference or evasion of school|20
9286|NCT01911260|48436|P1|Follow-up Period|transference or evasion of school|13
9287|NCT01911260|48433|P4|Supplementation Period|less than 12 weeks supplementation|2
9288|NCT01911260|48434|P3|Supplementation Period|less than 12 weeks supplementation|1
9289|NCT01911260|48435|P2|Supplementation Period|less than 12 weeks supplementation|3
9290|NCT01911260|48436|P1|Supplementation Period|less than 12 weeks supplementation|0
9291|NCT01911260|48433|P4|Supplementation Period|refused to receive supplement|0
9292|NCT01911260|48434|P3|Supplementation Period|refused to receive supplement|1
9293|NCT01911260|48435|P2|Supplementation Period|refused to receive supplement|0
9294|NCT01911260|48436|P1|Supplementation Period|refused to receive supplement|1
9295|NCT01911260|48433|P4|Supplementation Period|Adverse Event|0
9296|NCT01911260|48434|P3|Supplementation Period|Adverse Event|1
9297|NCT01911260|48435|P2|Supplementation Period|Adverse Event|0
9298|NCT01911260|48436|P1|Supplementation Period|Adverse Event|2
9299|NCT01911260|48433|P4|Supplementation Period|transference or evasion of school|6
9300|NCT01911260|48434|P3|Supplementation Period|transference or evasion of school|7
9301|NCT01911260|48435|P2|Supplementation Period|transference or evasion of school|9
9302|NCT01911260|48436|P1|Supplementation Period|transference or evasion of school|7
9303|NCT01910441|48491|P2|Overall Study|Physician Decision|1
9304|NCT01910441|48492|P1|Overall Study|Physician Decision|0
9305|NCT01910441|48491|P2|Overall Study|Adverse Event|0
9306|NCT01910441|48492|P1|Overall Study|Adverse Event|1
9307|NCT01910441|48491|P2|Overall Study|Non-compliance|1
9308|NCT01910441|48492|P1|Overall Study|Non-compliance|0
9309|NCT01910441|48491|P2|Overall Study|Withdrawal by Subject|1
9310|NCT01910441|48492|P1|Overall Study|Withdrawal by Subject|0
9311|NCT01910441|48491|P2|Overall Study|Lost to Follow-up|5
9312|NCT01910441|48492|P1|Overall Study|Lost to Follow-up|6
9313|NCT01910441|48491|P2|Overall Study|Sponsor decision|2
9314|NCT01910441|48492|P1|Overall Study|Sponsor decision|0
9315|NCT01910402|48500|P2|Continuation Phase|Withdrawal by Subject|0
9316|NCT01910402|48501|P1|Continuation Phase|Withdrawal by Subject|2
9317|NCT01910402|48500|P2|Continuation Phase|Protocol Violation|0
9318|NCT01910402|48501|P1|Continuation Phase|Protocol Violation|3
9319|NCT01910402|48500|P2|Continuation Phase|Adverse Event|0
9320|NCT01910402|48501|P1|Continuation Phase|Adverse Event|1
9321|NCT01910402|48500|P2|Continuation Phase|Ongoing|0
9322|NCT01910402|48501|P1|Continuation Phase|Ongoing|84
9323|NCT01910402|48500|P2|Randomized Phase|Withdrawal by Subject|7
9324|NCT01910402|48501|P1|Randomized Phase|Withdrawal by Subject|5
9325|NCT01910402|48500|P2|Randomized Phase|Protocol Violation|13
9326|NCT01910402|48501|P1|Randomized Phase|Protocol Violation|10
9327|NCT01910402|48500|P2|Randomized Phase|Lost to Follow-up|13
9328|NCT01910402|48501|P1|Randomized Phase|Lost to Follow-up|11
9329|NCT01910402|48500|P2|Randomized Phase|Lack of Efficacy|4
9330|NCT01910402|48501|P1|Randomized Phase|Lack of Efficacy|5
9331|NCT01910402|48500|P2|Randomized Phase|Physician Decision|0
9332|NCT01910402|48501|P1|Randomized Phase|Physician Decision|1
9333|NCT01910402|48500|P2|Randomized Phase|Adverse Event|18
9334|NCT01910402|48501|P1|Randomized Phase|Adverse Event|10
9335|NCT01910389|48571|P2|Overall Study|Study Closed|8
9336|NCT01910389|48572|P1|Overall Study|Study Closed|13
9337|NCT01910389|48571|P2|Overall Study|Withdrawal by Subject|0
9338|NCT01910389|48572|P1|Overall Study|Withdrawal by Subject|2
9339|NCT01910181|48602|P1|Overall Study|Alive in Follow-Up|12
9340|NCT01910181|48602|P1|Overall Study|Alive on Treatment|14
9341|NCT01910181|48602|P1|Overall Study|Death|20
9342|NCT01910116|48629|P2|Overall Study|incomplete data|1
9343|NCT01910116|48630|P1|Overall Study|incomplete data|0
9344|NCT01910116|48629|P2|Overall Study|uncertain allocation|3
9345|NCT01910116|48630|P1|Overall Study|uncertain allocation|1
9346|NCT01910116|48629|P2|Overall Study|Withdrawal by Subject|3
9347|NCT01910116|48630|P1|Overall Study|Withdrawal by Subject|8
9348|NCT01910116|48629|P2|Overall Study|Protocol Violation|2
9349|NCT01910116|48630|P1|Overall Study|Protocol Violation|1
9350|NCT01910116|48629|P2|Overall Study|Lost to Follow-up|0
9351|NCT01910116|48630|P1|Overall Study|Lost to Follow-up|1
9352|NCT01910116|48629|P2|Overall Study|Lack of Efficacy|4
9353|NCT01910116|48630|P1|Overall Study|Lack of Efficacy|3
9354|NCT01910116|48629|P2|Overall Study|Adverse Event|3
9355|NCT01910116|48630|P1|Overall Study|Adverse Event|0
9356|NCT01909804|48727|P12|Overall Study|Protocol Violation|1
9357|NCT01909804|48728|P11|Overall Study|Protocol Violation|0
9358|NCT01909804|48729|P10|Overall Study|Protocol Violation|0
9359|NCT01909804|48730|P9|Overall Study|Protocol Violation|0
9360|NCT01909804|48731|P8|Overall Study|Protocol Violation|0
9361|NCT01909804|48732|P7|Overall Study|Protocol Violation|0
9362|NCT01909804|48733|P6|Overall Study|Protocol Violation|0
9363|NCT01909804|48734|P5|Overall Study|Protocol Violation|0
9364|NCT01909804|48735|P4|Overall Study|Protocol Violation|0
9365|NCT01909804|48736|P3|Overall Study|Protocol Violation|0
9366|NCT01909804|48737|P2|Overall Study|Protocol Violation|0
9367|NCT01909804|48738|P1|Overall Study|Protocol Violation|0
9368|NCT01909804|48727|P12|Overall Study|Withdrew Consent|0
9369|NCT01909804|48728|P11|Overall Study|Withdrew Consent|0
9370|NCT01909804|48729|P10|Overall Study|Withdrew Consent|0
9371|NCT01909804|48730|P9|Overall Study|Withdrew Consent|0
9372|NCT01909804|48731|P8|Overall Study|Withdrew Consent|0
9373|NCT01909804|48732|P7|Overall Study|Withdrew Consent|0
9374|NCT01909804|48733|P6|Overall Study|Withdrew Consent|1
9375|NCT01909804|48734|P5|Overall Study|Withdrew Consent|1
9376|NCT01909804|48735|P4|Overall Study|Withdrew Consent|0
9377|NCT01909804|48736|P3|Overall Study|Withdrew Consent|0
9378|NCT01909804|48737|P2|Overall Study|Withdrew Consent|0
9379|NCT01909804|48738|P1|Overall Study|Withdrew Consent|0
9380|NCT01909804|48727|P12|Overall Study|Lack of Efficacy|1
9381|NCT01909804|48728|P11|Overall Study|Lack of Efficacy|0
9382|NCT01909804|48729|P10|Overall Study|Lack of Efficacy|1
9383|NCT01909804|48730|P9|Overall Study|Lack of Efficacy|0
9384|NCT01909804|48731|P8|Overall Study|Lack of Efficacy|1
9385|NCT01909804|48732|P7|Overall Study|Lack of Efficacy|1
9386|NCT01909804|48733|P6|Overall Study|Lack of Efficacy|3
9387|NCT01909804|48734|P5|Overall Study|Lack of Efficacy|7
9388|NCT01909804|48735|P4|Overall Study|Lack of Efficacy|0
9389|NCT01909804|48736|P3|Overall Study|Lack of Efficacy|0
9390|NCT01909804|48737|P2|Overall Study|Lack of Efficacy|1
9391|NCT01909804|48738|P1|Overall Study|Lack of Efficacy|4
9392|NCT01909804|48727|P12|Overall Study|Death|0
9393|NCT01909804|48728|P11|Overall Study|Death|1
9394|NCT01909804|48729|P10|Overall Study|Death|0
9395|NCT01909804|48730|P9|Overall Study|Death|0
9396|NCT01909804|48731|P8|Overall Study|Death|0
9397|NCT01909804|48732|P7|Overall Study|Death|0
9398|NCT01909804|48733|P6|Overall Study|Death|0
9399|NCT01909804|48734|P5|Overall Study|Death|0
9400|NCT01909804|48735|P4|Overall Study|Death|0
9401|NCT01909804|48736|P3|Overall Study|Death|0
9402|NCT01909804|48737|P2|Overall Study|Death|0
9403|NCT01909804|48738|P1|Overall Study|Death|0
9404|NCT01909804|48727|P12|Overall Study|Randomized but Never Treated|1
9405|NCT01909804|48728|P11|Overall Study|Randomized but Never Treated|0
9406|NCT01909804|48729|P10|Overall Study|Randomized but Never Treated|0
9407|NCT01909804|48730|P9|Overall Study|Randomized but Never Treated|0
9408|NCT01909804|48731|P8|Overall Study|Randomized but Never Treated|0
9409|NCT01909804|48732|P7|Overall Study|Randomized but Never Treated|1
9410|NCT01909804|48733|P6|Overall Study|Randomized but Never Treated|0
9411|NCT01909804|48734|P5|Overall Study|Randomized but Never Treated|0
9412|NCT01909804|48735|P4|Overall Study|Randomized but Never Treated|0
9413|NCT01909804|48736|P3|Overall Study|Randomized but Never Treated|0
9414|NCT01909804|48737|P2|Overall Study|Randomized but Never Treated|0
9415|NCT01909804|48738|P1|Overall Study|Randomized but Never Treated|0
9416|NCT01909778|48784|P1|Overall Study|failed screening|1
9417|NCT01909466|48874|P2|Overall Study|Lack of Efficacy|0
9418|NCT01909466|48875|P1|Overall Study|Lack of Efficacy|1
9419|NCT01909466|48874|P2|Overall Study|Withdrawal by Subject|9
9420|NCT01909466|48875|P1|Overall Study|Withdrawal by Subject|11
9421|NCT01909466|48874|P2|Overall Study|Physician Decision|0
9422|NCT01909466|48875|P1|Overall Study|Physician Decision|2
9423|NCT01909466|48874|P2|Overall Study|Met Withdrawal Criteria|3
9424|NCT01909466|48875|P1|Overall Study|Met Withdrawal Criteria|0
9425|NCT01909466|48874|P2|Overall Study|Adverse Event|4
9426|NCT01909466|48875|P1|Overall Study|Adverse Event|3
9427|NCT01909466|48874|P2|Overall Study|Lost to Follow-up|7
9428|NCT01909466|48875|P1|Overall Study|Lost to Follow-up|5
9429|NCT01909336|48898|P3|Overall Study|Physician Decision|1
9430|NCT01909336|48899|P2|Overall Study|Physician Decision|1
9431|NCT01909336|48900|P1|Overall Study|Physician Decision|0
9432|NCT01909336|48898|P3|Overall Study|Lost to Follow-up|2
9433|NCT01909336|48899|P2|Overall Study|Lost to Follow-up|2
9434|NCT01909336|48900|P1|Overall Study|Lost to Follow-up|4
9435|NCT01908803|48973|P2|Overall Study|Adverse Event (pre-treatment)|0
9436|NCT01908803|48974|P1|Overall Study|Adverse Event (pre-treatment)|1
9437|NCT01908803|48973|P2|Overall Study|Randomization Error|0
9438|NCT01908803|48974|P1|Overall Study|Randomization Error|1
9439|NCT01908803|48973|P2|Overall Study|Withdrawal by Subject|0
9440|NCT01908803|48974|P1|Overall Study|Withdrawal by Subject|1
9441|NCT01908803|48973|P2|Overall Study|Physician Decision|1
9442|NCT01908803|48974|P1|Overall Study|Physician Decision|0
9443|NCT01908803|48973|P2|Overall Study|Adverse Event|0
9444|NCT01908803|48974|P1|Overall Study|Adverse Event|1
9445|NCT01908140|48987|P2|Overall Study|Adverse Event|23
9446|NCT01908140|48988|P1|Overall Study|Adverse Event|22
9447|NCT01908140|48987|P2|Overall Study|Protocol Violation|9
9448|NCT01908140|48988|P1|Overall Study|Protocol Violation|8
9449|NCT01908140|48987|P2|Overall Study|Lost to Follow-up|6
9450|NCT01908140|48988|P1|Overall Study|Lost to Follow-up|1
9451|NCT01908140|48987|P2|Overall Study|Withdrawal by Subject|24
9452|NCT01908140|48988|P1|Overall Study|Withdrawal by Subject|23
9453|NCT01908140|48987|P2|Overall Study|Lack of Efficacy|5
9454|NCT01908140|48988|P1|Overall Study|Lack of Efficacy|7
9455|NCT01908140|48987|P2|Overall Study|Other or Progressive Disease|12
9456|NCT01908140|48988|P1|Overall Study|Other or Progressive Disease|5
9457|NCT01907906|49009|P2|Overall Study|Physician Decision|1
9458|NCT01907906|49010|P1|Overall Study|Physician Decision|3
9459|NCT01907906|49009|P2|Overall Study|Withdrawal by Subject|0
9460|NCT01907906|49010|P1|Overall Study|Withdrawal by Subject|1
9461|NCT01907854|49090|P2|Overall Study|Unclassified|3
9462|NCT01907854|49091|P1|Overall Study|Unclassified|4
9463|NCT01907854|49090|P2|Overall Study|Lost to Follow-up|2
9464|NCT01907854|49091|P1|Overall Study|Lost to Follow-up|2
9465|NCT01907854|49090|P2|Overall Study|Withdrawal by Subject|7
9466|NCT01907854|49091|P1|Overall Study|Withdrawal by Subject|9
9467|NCT01907854|49090|P2|Overall Study|Protocol Violation|1
9468|NCT01907854|49091|P1|Overall Study|Protocol Violation|1
9469|NCT01907516|49111|P2|First Intervention (3 Weeks)|Developed DKA during study|0
9470|NCT01907516|49112|P1|First Intervention (3 Weeks)|Developed DKA during study|1
9471|NCT01907516|49111|P2|First Intervention (3 Weeks)|Delivered before second arm|4
9472|NCT01907516|49112|P1|First Intervention (3 Weeks)|Delivered before second arm|3
9473|NCT01907516|49111|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
9474|NCT01907516|49112|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
9475|NCT01907516|49111|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
9476|NCT01907516|49112|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
9477|NCT01905657|49298|P3|Overall Study|Excluded from Efficacy Analysis|0
9478|NCT01905657|49299|P2|Overall Study|Excluded from Efficacy Analysis|0
9479|NCT01905657|49300|P1|Overall Study|Excluded from Efficacy Analysis|1
9480|NCT01905657|49298|P3|Overall Study|Continuing in Study|11
9481|NCT01905657|49299|P2|Overall Study|Continuing in Study|74
9482|NCT01905657|49300|P1|Overall Study|Continuing in Study|74
9483|NCT01905657|49298|P3|Overall Study|Withdrawal by Subject|45
9484|NCT01905657|49299|P2|Overall Study|Withdrawal by Subject|10
9485|NCT01905657|49300|P1|Overall Study|Withdrawal by Subject|5
9486|NCT01905657|49298|P3|Overall Study|Protocol Violation|1
9487|NCT01905657|49299|P2|Overall Study|Protocol Violation|1
9488|NCT01905657|49300|P1|Overall Study|Protocol Violation|2
9489|NCT01905657|49298|P3|Overall Study|Progressive Disease|89
9490|NCT01905657|49299|P2|Overall Study|Progressive Disease|126
9491|NCT01905657|49300|P1|Overall Study|Progressive Disease|124
9492|NCT01905657|49298|P3|Overall Study|Physician Decision|113
9493|NCT01905657|49299|P2|Overall Study|Physician Decision|74
9494|NCT01905657|49300|P1|Overall Study|Physician Decision|82
9495|NCT01905657|49298|P3|Overall Study|Unspecified|1
9496|NCT01905657|49299|P2|Overall Study|Unspecified|7
9497|NCT01905657|49300|P1|Overall Study|Unspecified|3
9498|NCT01905657|49298|P3|Overall Study|Death|21
9499|NCT01905657|49299|P2|Overall Study|Death|21
9500|NCT01905657|49300|P1|Overall Study|Death|21
9501|NCT01905657|49298|P3|Overall Study|Adverse Event|47
9502|NCT01905657|49299|P2|Overall Study|Adverse Event|32
9503|NCT01905657|49300|P1|Overall Study|Adverse Event|33
9504|NCT01905657|49298|P3|Overall Study|Not Treated|0
9505|NCT01905657|49299|P2|Overall Study|Not Treated|1
9506|NCT01905657|49300|P1|Overall Study|Not Treated|0
9507|NCT01905553|49325|P2|Period 2|Adverse Event|0
9508|NCT01905553|49326|P1|Period 2|Adverse Event|1
9509|NCT01905540|49340|P4|Period 3|Not specified|1
9510|NCT01905540|49341|P3|Period 3|Not specified|1
9511|NCT01905540|49342|P2|Period 3|Not specified|0
9512|NCT01905540|49343|P1|Period 3|Not specified|1
9513|NCT01904773|49365|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
9514|NCT01904773|49366|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
9515|NCT01904773|49367|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
9516|NCT01904773|49368|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
9517|NCT01904773|49369|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
9518|NCT01904773|49370|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
9519|NCT01904773|49371|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
9520|NCT01904773|49372|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
9521|NCT01904773|49373|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
9522|NCT01904773|49365|P9|Fifth Intervention|Adverse Event|0
9523|NCT01904773|49366|P8|Fifth Intervention|Adverse Event|1
9524|NCT01904773|49367|P7|Fifth Intervention|Adverse Event|0
9525|NCT01904773|49368|P6|Fifth Intervention|Adverse Event|0
9526|NCT01904773|49369|P5|Fifth Intervention|Adverse Event|0
9527|NCT01904773|49370|P4|Fifth Intervention|Adverse Event|0
9528|NCT01904773|49371|P3|Fifth Intervention|Adverse Event|0
9529|NCT01904773|49372|P2|Fifth Intervention|Adverse Event|0
9530|NCT01904773|49373|P1|Fifth Intervention|Adverse Event|0
9531|NCT01904773|49365|P9|Placebo Washout First Intervention|Condition worsened|0
9532|NCT01904773|49366|P8|Placebo Washout First Intervention|Condition worsened|0
9533|NCT01904773|49367|P7|Placebo Washout First Intervention|Condition worsened|0
9534|NCT01904773|49368|P6|Placebo Washout First Intervention|Condition worsened|0
9535|NCT01904773|49369|P5|Placebo Washout First Intervention|Condition worsened|0
9536|NCT01904773|49370|P4|Placebo Washout First Intervention|Condition worsened|0
9537|NCT01904773|49371|P3|Placebo Washout First Intervention|Condition worsened|0
9538|NCT01904773|49372|P2|Placebo Washout First Intervention|Condition worsened|1
9539|NCT01904773|49373|P1|Placebo Washout First Intervention|Condition worsened|0
9540|NCT01904773|49365|P9|First Intervention|Adverse Event|0
9541|NCT01904773|49366|P8|First Intervention|Adverse Event|0
9542|NCT01904773|49367|P7|First Intervention|Adverse Event|1
9543|NCT01904773|49368|P6|First Intervention|Adverse Event|0
9544|NCT01904773|49369|P5|First Intervention|Adverse Event|0
9545|NCT01904773|49370|P4|First Intervention|Adverse Event|0
9546|NCT01904773|49371|P3|First Intervention|Adverse Event|0
9547|NCT01904773|49372|P2|First Intervention|Adverse Event|0
9548|NCT01904773|49373|P1|First Intervention|Adverse Event|0
9549|NCT01904773|49365|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
9550|NCT01904773|49366|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
9551|NCT01904773|49367|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
9552|NCT01904773|49368|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
9553|NCT01904773|49369|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
9554|NCT01904773|49370|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
9555|NCT01904773|49371|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
9556|NCT01904773|49372|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
9557|NCT01904773|49373|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
9558|NCT01904773|49365|P9|Screen|Withdrawal by Subject|0
9559|NCT01904773|49366|P8|Screen|Withdrawal by Subject|0
9560|NCT01904773|49367|P7|Screen|Withdrawal by Subject|0
9561|NCT01904773|49368|P6|Screen|Withdrawal by Subject|0
9562|NCT01904773|49369|P5|Screen|Withdrawal by Subject|0
9563|NCT01904773|49370|P4|Screen|Withdrawal by Subject|0
9564|NCT01904773|49371|P3|Screen|Withdrawal by Subject|0
9565|NCT01904773|49372|P2|Screen|Withdrawal by Subject|0
9566|NCT01904773|49373|P1|Screen|Withdrawal by Subject|1
9567|NCT01904773|49365|P9|Screen|Screen failure|0
9568|NCT01904773|49366|P8|Screen|Screen failure|0
9569|NCT01904773|49367|P7|Screen|Screen failure|0
9570|NCT01904773|49368|P6|Screen|Screen failure|0
9571|NCT01904773|49369|P5|Screen|Screen failure|0
9572|NCT01904773|49370|P4|Screen|Screen failure|0
9573|NCT01904773|49371|P3|Screen|Screen failure|0
9574|NCT01904773|49372|P2|Screen|Screen failure|0
9575|NCT01904773|49373|P1|Screen|Screen failure|3
9576|NCT01904760|49390|P2|Overall Study|Protocol Violation|0
9577|NCT01904760|49391|P1|Overall Study|Protocol Violation|1
9578|NCT01904721|49406|P7|Overall Study|Adverse Event|0
9579|NCT01904721|49407|P6|Overall Study|Adverse Event|1
9580|NCT01904721|49408|P5|Overall Study|Adverse Event|3
9581|NCT01904721|49409|P4|Overall Study|Adverse Event|0
9582|NCT01904721|49410|P3|Overall Study|Adverse Event|0
9583|NCT01904721|49411|P2|Overall Study|Adverse Event|0
9584|NCT01904721|49412|P1|Overall Study|Adverse Event|0
9585|NCT01904721|49406|P7|Overall Study|Lack of Efficacy|1
9586|NCT01904721|49407|P6|Overall Study|Lack of Efficacy|0
9587|NCT01904721|49408|P5|Overall Study|Lack of Efficacy|0
9588|NCT01904721|49409|P4|Overall Study|Lack of Efficacy|0
9589|NCT01904721|49410|P3|Overall Study|Lack of Efficacy|0
9590|NCT01904721|49411|P2|Overall Study|Lack of Efficacy|0
9591|NCT01904721|49412|P1|Overall Study|Lack of Efficacy|0
9592|NCT01904721|49406|P7|Overall Study|Lost to Follow-up|1
9593|NCT01904721|49407|P6|Overall Study|Lost to Follow-up|3
9594|NCT01904721|49408|P5|Overall Study|Lost to Follow-up|1
9595|NCT01904721|49409|P4|Overall Study|Lost to Follow-up|0
9596|NCT01904721|49410|P3|Overall Study|Lost to Follow-up|0
9597|NCT01904721|49411|P2|Overall Study|Lost to Follow-up|0
9598|NCT01904721|49412|P1|Overall Study|Lost to Follow-up|0
9599|NCT01904721|49406|P7|Overall Study|Personal Reasons|3
9600|NCT01904721|49407|P6|Overall Study|Personal Reasons|3
9601|NCT01904721|49408|P5|Overall Study|Personal Reasons|2
9602|NCT01904721|49409|P4|Overall Study|Personal Reasons|0
9603|NCT01904721|49410|P3|Overall Study|Personal Reasons|0
9604|NCT01904721|49411|P2|Overall Study|Personal Reasons|0
9605|NCT01904721|49412|P1|Overall Study|Personal Reasons|0
9606|NCT01904721|49406|P7|Overall Study|Other Reasons|2
9607|NCT01904721|49407|P6|Overall Study|Other Reasons|2
9608|NCT01904721|49408|P5|Overall Study|Other Reasons|2
9609|NCT01904721|49409|P4|Overall Study|Other Reasons|1
9610|NCT01904721|49410|P3|Overall Study|Other Reasons|1
9611|NCT01904721|49411|P2|Overall Study|Other Reasons|0
9612|NCT01904721|49412|P1|Overall Study|Other Reasons|0
9613|NCT01904604|49442|P3|Overall Study|Unrelated illness|0
9614|NCT01904604|49443|P2|Overall Study|Unrelated illness|1
9615|NCT01904604|49444|P1|Overall Study|Unrelated illness|0
9616|NCT01904604|49442|P3|Overall Study|Increased syncope|0
9617|NCT01904604|49443|P2|Overall Study|Increased syncope|1
9618|NCT01904604|49444|P1|Overall Study|Increased syncope|0
9619|NCT01904604|49442|P3|Overall Study|Patch site reactions|0
9620|NCT01904604|49443|P2|Overall Study|Patch site reactions|1
9621|NCT01904604|49444|P1|Overall Study|Patch site reactions|0
9622|NCT01904604|49442|P3|Overall Study|Anxiety about OFC/Refused OFC|0
9623|NCT01904604|49443|P2|Overall Study|Anxiety about OFC/Refused OFC|0
9624|NCT01904604|49444|P1|Overall Study|Anxiety about OFC/Refused OFC|2
9625|NCT01904604|49442|P3|Overall Study|Non-compliance|0
9626|NCT01904604|49443|P2|Overall Study|Non-compliance|0
9627|NCT01904604|49444|P1|Overall Study|Non-compliance|1
9628|NCT01904604|49442|P3|Overall Study|Withdrew before receiving dosing|0
9629|NCT01904604|49443|P2|Overall Study|Withdrew before receiving dosing|1
9630|NCT01904604|49444|P1|Overall Study|Withdrew before receiving dosing|0
9631|NCT01904149|49466|P6|Overall Study|non compliance with study drug|0
9632|NCT01904149|49467|P5|Overall Study|non compliance with study drug|0
9633|NCT01904149|49468|P4|Overall Study|non compliance with study drug|0
9634|NCT01904149|49469|P3|Overall Study|non compliance with study drug|0
9635|NCT01904149|49470|P2|Overall Study|non compliance with study drug|0
9636|NCT01904149|49471|P1|Overall Study|non compliance with study drug|1
9637|NCT01904149|49466|P6|Overall Study|Protocol Violation|0
9638|NCT01904149|49467|P5|Overall Study|Protocol Violation|0
9639|NCT01904149|49468|P4|Overall Study|Protocol Violation|0
9640|NCT01904149|49469|P3|Overall Study|Protocol Violation|0
9641|NCT01904149|49470|P2|Overall Study|Protocol Violation|1
9642|NCT01904149|49471|P1|Overall Study|Protocol Violation|0
9643|NCT01904149|49466|P6|Overall Study|Withdrawal by Subject|0
9644|NCT01904149|49467|P5|Overall Study|Withdrawal by Subject|1
9645|NCT01904149|49468|P4|Overall Study|Withdrawal by Subject|0
9646|NCT01904149|49469|P3|Overall Study|Withdrawal by Subject|1
9647|NCT01904149|49470|P2|Overall Study|Withdrawal by Subject|3
9648|NCT01904149|49471|P1|Overall Study|Withdrawal by Subject|1
9649|NCT01904149|49466|P6|Overall Study|Lack of Efficacy|1
9650|NCT01904149|49467|P5|Overall Study|Lack of Efficacy|3
9651|NCT01904149|49468|P4|Overall Study|Lack of Efficacy|3
9652|NCT01904149|49469|P3|Overall Study|Lack of Efficacy|1
9653|NCT01904149|49470|P2|Overall Study|Lack of Efficacy|3
9654|NCT01904149|49471|P1|Overall Study|Lack of Efficacy|0
9655|NCT01904149|49466|P6|Overall Study|Adverse Event|2
9656|NCT01904149|49467|P5|Overall Study|Adverse Event|1
9657|NCT01904149|49468|P4|Overall Study|Adverse Event|1
9658|NCT01904149|49469|P3|Overall Study|Adverse Event|0
9659|NCT01904149|49470|P2|Overall Study|Adverse Event|4
9660|NCT01904149|49471|P1|Overall Study|Adverse Event|3
9661|NCT01904058|49522|P4|Overall Study|Pregnancy|1
9662|NCT01904058|49523|P3|Overall Study|Pregnancy|0
9663|NCT01904058|49524|P2|Overall Study|Pregnancy|0
9664|NCT01904058|49525|P1|Overall Study|Pregnancy|0
9665|NCT01904058|49522|P4|Overall Study|Withdrawal by Subject|0
9666|NCT01904058|49523|P3|Overall Study|Withdrawal by Subject|1
9667|NCT01904058|49524|P2|Overall Study|Withdrawal by Subject|0
9668|NCT01904058|49525|P1|Overall Study|Withdrawal by Subject|1
9669|NCT01904058|49522|P4|Overall Study|Adverse Event|0
9670|NCT01904058|49523|P3|Overall Study|Adverse Event|0
9671|NCT01904058|49524|P2|Overall Study|Adverse Event|0
9672|NCT01904058|49525|P1|Overall Study|Adverse Event|2
9673|NCT01903876|49565|P2|Six-Month Follow-up Period|Lost to Follow-up|145
9674|NCT01903876|49566|P1|Six-Month Follow-up Period|Lost to Follow-up|91
9675|NCT01903876|49565|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
9676|NCT01903876|49566|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
9677|NCT01903720|49574|P1|Overall Study|Treatment with alternative drug|1
9678|NCT01903720|49574|P1|Overall Study|Lost to Follow-up|2
9679|NCT01903720|49574|P1|Overall Study|Rescinding of informed consent|2
9680|NCT01903720|49574|P1|Overall Study|Adverse Event|1
9681|NCT01903720|49574|P1|Overall Study|Inclusion / exclusion criteria not met|6
9682|NCT01903460|49593|P4|Overall Study|Adverse Event|1
9683|NCT01903460|49594|P3|Overall Study|Adverse Event|0
9684|NCT01903460|49595|P2|Overall Study|Adverse Event|0
9685|NCT01903460|49596|P1|Overall Study|Adverse Event|0
9686|NCT01902888|49678|P1|Overall Study|Study Terminated|3
9687|NCT01902303|49694|P2|Overall Study|Did not develop a cold sore|19
9688|NCT01902303|49695|P1|Overall Study|Did not develop a cold sore|21
9689|NCT01902303|49694|P2|Overall Study|subject lost investigational product|1
9690|NCT01902303|49695|P1|Overall Study|subject lost investigational product|0
9691|NCT01902303|49694|P2|Overall Study|Protocol Violation|2
9692|NCT01902303|49695|P1|Overall Study|Protocol Violation|2
9693|NCT01902303|49694|P2|Overall Study|Lost to Follow-up|1
9694|NCT01902303|49695|P1|Overall Study|Lost to Follow-up|0
9695|NCT01902303|49694|P2|Overall Study|Adverse Event|1
9696|NCT01902303|49695|P1|Overall Study|Adverse Event|0
9697|NCT01902134|49709|P6|Overall Study|not specified|0
9698|NCT01902134|49710|P5|Overall Study|not specified|1
9699|NCT01902134|49711|P4|Overall Study|not specified|0
9700|NCT01902134|49712|P3|Overall Study|not specified|2
9701|NCT01902134|49713|P2|Overall Study|not specified|1
9702|NCT01902134|49714|P1|Overall Study|not specified|0
9703|NCT01902134|49709|P6|Overall Study|no compliance|0
9704|NCT01902134|49710|P5|Overall Study|no compliance|0
9705|NCT01902134|49711|P4|Overall Study|no compliance|0
9706|NCT01902134|49712|P3|Overall Study|no compliance|0
9707|NCT01902134|49713|P2|Overall Study|no compliance|0
9708|NCT01902134|49714|P1|Overall Study|no compliance|1
9709|NCT01902134|49709|P6|Overall Study|Withdrawal by Subject|4
9710|NCT01902134|49710|P5|Overall Study|Withdrawal by Subject|5
9711|NCT01902134|49711|P4|Overall Study|Withdrawal by Subject|1
9712|NCT01902134|49712|P3|Overall Study|Withdrawal by Subject|9
9713|NCT01902134|49713|P2|Overall Study|Withdrawal by Subject|8
9714|NCT01902134|49714|P1|Overall Study|Withdrawal by Subject|4
9715|NCT01902134|49709|P6|Overall Study|Protocol Violation|1
9716|NCT01902134|49710|P5|Overall Study|Protocol Violation|0
9717|NCT01902134|49711|P4|Overall Study|Protocol Violation|0
9718|NCT01902134|49712|P3|Overall Study|Protocol Violation|0
9719|NCT01902134|49713|P2|Overall Study|Protocol Violation|0
9720|NCT01902134|49714|P1|Overall Study|Protocol Violation|0
9721|NCT01902134|49709|P6|Overall Study|Physician Decision|0
9722|NCT01902134|49710|P5|Overall Study|Physician Decision|0
9723|NCT01902134|49711|P4|Overall Study|Physician Decision|0
9724|NCT01902134|49712|P3|Overall Study|Physician Decision|0
9725|NCT01902134|49713|P2|Overall Study|Physician Decision|1
9726|NCT01902134|49714|P1|Overall Study|Physician Decision|0
9727|NCT01902134|49709|P6|Overall Study|Lack of Efficacy|1
9728|NCT01902134|49710|P5|Overall Study|Lack of Efficacy|0
9729|NCT01902134|49711|P4|Overall Study|Lack of Efficacy|0
9730|NCT01902134|49712|P3|Overall Study|Lack of Efficacy|2
9731|NCT01902134|49713|P2|Overall Study|Lack of Efficacy|0
9732|NCT01902134|49714|P1|Overall Study|Lack of Efficacy|0
9733|NCT01902134|49709|P6|Overall Study|Adverse Event|3
9734|NCT01902134|49710|P5|Overall Study|Adverse Event|1
9735|NCT01902134|49711|P4|Overall Study|Adverse Event|1
9736|NCT01902134|49712|P3|Overall Study|Adverse Event|2
9737|NCT01902134|49713|P2|Overall Study|Adverse Event|1
9738|NCT01902134|49714|P1|Overall Study|Adverse Event|3
9739|NCT01901393|49761|P2|Overall Study|Adverse Event|0
9740|NCT01901393|49762|P1|Overall Study|Adverse Event|1
9741|NCT01901341|49780|P2|Overall Study|Withdrawal by Subject|1
9742|NCT01901341|49781|P1|Overall Study|Withdrawal by Subject|1
9743|NCT01901341|49780|P2|Overall Study|Study Terminated by Sponsor|15
9744|NCT01901341|49781|P1|Overall Study|Study Terminated by Sponsor|13
9745|NCT01901341|49780|P2|Overall Study|Protocol Violation|0
9746|NCT01901341|49781|P1|Overall Study|Protocol Violation|2
9747|NCT01901341|49780|P2|Overall Study|Lost to Follow-up|1
9748|NCT01901341|49781|P1|Overall Study|Lost to Follow-up|0
9749|NCT01901341|49780|P2|Overall Study|Lack of Efficacy|2
9750|NCT01901341|49781|P1|Overall Study|Lack of Efficacy|0
9751|NCT01901341|49780|P2|Overall Study|Adverse Event|2
9752|NCT01901341|49781|P1|Overall Study|Adverse Event|4
9753|NCT01901328|49795|P2|Overall Study|Lack of Efficacy|1
9754|NCT01901328|49796|P1|Overall Study|Lack of Efficacy|0
9755|NCT01901328|49795|P2|Overall Study|Withdrawal by Subject|2
9756|NCT01901328|49796|P1|Overall Study|Withdrawal by Subject|1
9757|NCT01901328|49795|P2|Overall Study|Study Terminated by Sponsor|16
9758|NCT01901328|49796|P1|Overall Study|Study Terminated by Sponsor|19
9759|NCT01901328|49795|P2|Overall Study|Protocol Violation|1
9760|NCT01901328|49796|P1|Overall Study|Protocol Violation|1
9761|NCT01901328|49795|P2|Overall Study|Physician Decision|1
9762|NCT01901328|49796|P1|Overall Study|Physician Decision|0
9763|NCT01901328|49795|P2|Overall Study|Lost to Follow-up|0
9764|NCT01901328|49796|P1|Overall Study|Lost to Follow-up|1
9765|NCT01901302|49810|P2|Overall Study|Withdrawal by Subject|0
9766|NCT01901302|49811|P1|Overall Study|Withdrawal by Subject|2
9767|NCT01901302|49810|P2|Overall Study|Study Terminated by Sponsor|20
9768|NCT01901302|49811|P1|Overall Study|Study Terminated by Sponsor|23
9769|NCT01901302|49810|P2|Overall Study|Lack of Efficacy|2
9770|NCT01901302|49811|P1|Overall Study|Lack of Efficacy|0
9771|NCT01901302|49810|P2|Overall Study|Adverse Event|1
9772|NCT01901302|49811|P1|Overall Study|Adverse Event|2
9773|NCT01901185|49832|P1|Overall Study|Withdrawal by Subject|2
9774|NCT01900054|49861|P1|Overall Study|Withdrawal by Subject|1
9775|NCT01900054|49861|P1|Overall Study|Physician Decision|1
9776|NCT01899742|49872|P2|Overall Study|Withdrawal by Subject|5
9777|NCT01899742|49873|P1|Overall Study|Withdrawal by Subject|9
9778|NCT01899742|49872|P2|Overall Study|Protocol Violation|2
9779|NCT01899742|49873|P1|Overall Study|Protocol Violation|2
9780|NCT01899742|49872|P2|Overall Study|Lack of Efficacy|5
9781|NCT01899742|49873|P1|Overall Study|Lack of Efficacy|1
9782|NCT01899742|49872|P2|Overall Study|Adverse Event|4
9783|NCT01899742|49873|P1|Overall Study|Adverse Event|5
9784|NCT01899144|49912|P1|Treatment Period 5|Not specified|1
9785|NCT01899144|49912|P1|Treatment Period 3|Not specified|2
9786|NCT01899144|49912|P1|Treatment Period 2|Not specified|1
9787|NCT01898884|49939|P9|Multiple Dose Period|Randomized Not Treated|1
9788|NCT01898884|49940|P8|Multiple Dose Period|Randomized Not Treated|0
9789|NCT01898884|49941|P7|Multiple Dose Period|Randomized Not Treated|0
9790|NCT01898884|49942|P6|Multiple Dose Period|Randomized Not Treated|0
9791|NCT01898884|49943|P5|Multiple Dose Period|Randomized Not Treated|0
9792|NCT01898884|49944|P4|Multiple Dose Period|Randomized Not Treated|0
9793|NCT01898884|49945|P3|Multiple Dose Period|Randomized Not Treated|0
9794|NCT01898884|49946|P2|Multiple Dose Period|Randomized Not Treated|0
9795|NCT01898884|49947|P1|Multiple Dose Period|Randomized Not Treated|0
9796|NCT01898884|49939|P9|Multiple Dose Period|Adverse Event|0
9797|NCT01898884|49940|P8|Multiple Dose Period|Adverse Event|0
9798|NCT01898884|49941|P7|Multiple Dose Period|Adverse Event|1
9799|NCT01898884|49942|P6|Multiple Dose Period|Adverse Event|0
9800|NCT01898884|49943|P5|Multiple Dose Period|Adverse Event|0
9801|NCT01898884|49944|P4|Multiple Dose Period|Adverse Event|0
9802|NCT01898884|49945|P3|Multiple Dose Period|Adverse Event|0
9803|NCT01898884|49946|P2|Multiple Dose Period|Adverse Event|0
9804|NCT01898884|49947|P1|Multiple Dose Period|Adverse Event|0
9805|NCT01898442|50100|P3|Overall Study|Patient vomited pills|1
9806|NCT01898442|50101|P2|Overall Study|Patient vomited pills|0
9807|NCT01898442|50102|P1|Overall Study|Patient vomited pills|0
9808|NCT01898442|50100|P3|Overall Study|Hemolysis/technical problems|2
9809|NCT01898442|50101|P2|Overall Study|Hemolysis/technical problems|2
9810|NCT01898442|50102|P1|Overall Study|Hemolysis/technical problems|1
9811|NCT01898286|50125|P1|Overall Study|Lost to Follow-up|1
9812|NCT01898286|50125|P1|Overall Study|Protocol Violation|1
9813|NCT01898286|50125|P1|Overall Study|Withdrawal by Subject|1
9814|NCT01898208|50135|P3|Overall Study|Lost to Follow-up|1
9815|NCT01898208|50136|P2|Overall Study|Lost to Follow-up|1
9816|NCT01898208|50137|P1|Overall Study|Lost to Follow-up|3
9817|NCT01898208|50135|P3|Overall Study|System/Technical Error|3
9818|NCT01898208|50136|P2|Overall Study|System/Technical Error|2
9819|NCT01898208|50137|P1|Overall Study|System/Technical Error|1
9820|NCT01898208|50135|P3|Overall Study|Non-Blood Specimens in Bottles|4
9821|NCT01898208|50136|P2|Overall Study|Non-Blood Specimens in Bottles|5
9822|NCT01898208|50137|P1|Overall Study|Non-Blood Specimens in Bottles|3
9823|NCT01898208|50135|P3|Overall Study|Negative Gram Stain|6
9824|NCT01898208|50136|P2|Overall Study|Negative Gram Stain|9
9825|NCT01898208|50137|P1|Overall Study|Negative Gram Stain|6
9826|NCT01898208|50135|P3|Overall Study|Death/comfort care within 24 hours|8
9827|NCT01898208|50136|P2|Overall Study|Death/comfort care within 24 hours|9
9828|NCT01898208|50137|P1|Overall Study|Death/comfort care within 24 hours|10
9829|NCT01898208|50135|P3|Overall Study|Positive blood culture|15
9830|NCT01898208|50136|P2|Overall Study|Positive blood culture|23
9831|NCT01898208|50137|P1|Overall Study|Positive blood culture|17
9832|NCT01897727|50183|P2|Overall Study|Exclusion: central sleep apnea|1
9833|NCT01897727|50184|P1|Overall Study|Exclusion: central sleep apnea|0
9834|NCT01897233|50213|P1|Part B (24 Weeks)|Physician Decision|1
9835|NCT01897233|50213|P1|Part B (24 Weeks)|Withdrawal by Subject|2
9836|NCT01897233|50213|P1|Part B (24 Weeks)|Adverse Event|1
9837|NCT01896557|50255|P2|Clopidogrel + GI Protector|Reading error|3
9838|NCT01896557|50256|P1|Clopidogrel + GI Protector|Reading error|1
9839|NCT01896557|50255|P2|Clopidogrel + GI Protector|low adherence|1
9840|NCT01896557|50256|P1|Clopidogrel + GI Protector|low adherence|1
9841|NCT01896557|50255|P2|Clopidogrel Alone|Adverse Event|0
9842|NCT01896557|50256|P1|Clopidogrel Alone|Adverse Event|1
9843|NCT01896297|50289|P1|Overall Study|Died in post treatment phase|1
9844|NCT01896193|50302|P2|Overall Study|Withdrew Consent|0
9845|NCT01896193|50303|P1|Overall Study|Withdrew Consent|1
9846|NCT01896193|50302|P2|Overall Study|Protocol Violation|1
9847|NCT01896193|50303|P1|Overall Study|Protocol Violation|0
9848|NCT01896193|50302|P2|Overall Study|Lack of Efficacy|11
9849|NCT01896193|50303|P1|Overall Study|Lack of Efficacy|20
9850|NCT01895101|50330|P3|Overall Study|coagulation disorder|0
9851|NCT01895101|50331|P2|Overall Study|coagulation disorder|1
9852|NCT01895101|50332|P1|Overall Study|coagulation disorder|0
9853|NCT01895101|50330|P3|Overall Study|Death|0
9854|NCT01895101|50331|P2|Overall Study|Death|1
9855|NCT01895101|50332|P1|Overall Study|Death|0
9856|NCT01895101|50330|P3|Overall Study|another study, enrolled in other study|0
9857|NCT01895101|50331|P2|Overall Study|another study, enrolled in other study|1
9858|NCT01895101|50332|P1|Overall Study|another study, enrolled in other study|0
9859|NCT01895101|50330|P3|Overall Study|Withdrawal by Subject|2
9860|NCT01895101|50331|P2|Overall Study|Withdrawal by Subject|1
9861|NCT01895101|50332|P1|Overall Study|Withdrawal by Subject|0
9862|NCT01895101|50330|P3|Overall Study|OPCAB procedure|3
9863|NCT01895101|50331|P2|Overall Study|OPCAB procedure|1
9864|NCT01895101|50332|P1|Overall Study|OPCAB procedure|1
9865|NCT01894984|50359|P2|Overall Study|Unspecified|175
9866|NCT01894984|50360|P1|Overall Study|Unspecified|314
9867|NCT01896050|50434|P2|Overall Study|Death|0
9868|NCT01896050|50435|P1|Overall Study|Death|1
9869|NCT01896050|50434|P2|Overall Study|Adverse Event|2
9870|NCT01896050|50435|P1|Overall Study|Adverse Event|37
9871|NCT01895543|50474|P1|Overall Study|Other (Not fulfilling above criteria)|24
9872|NCT01895543|50474|P1|Overall Study|Physician Decision|2
9873|NCT01895543|50474|P1|Overall Study|Protocol Violation|1
9874|NCT01895543|50474|P1|Overall Study|Subject's substantial non-compliance|6
9875|NCT01895543|50474|P1|Overall Study|Adverse Event|28
9876|NCT01895543|50474|P1|Overall Study|Lost to Follow-up|25
9877|NCT01895543|50474|P1|Overall Study|Withdrawal by Subject|43
9878|NCT01895335|50488|P1|Overall Study|Other than Specified Above|44
9879|NCT01895335|50488|P1|Overall Study|Included But Not treated|1
9880|NCT01895335|50488|P1|Overall Study|Poor Compliance to Protocol|11
9881|NCT01895335|50488|P1|Overall Study|Lack of Efficacy|53
9882|NCT01895335|50488|P1|Overall Study|Adverse Event|106
9883|NCT01895322|50505|P1|Overall Study|Protocol Violation|10
9884|NCT01895322|50505|P1|Overall Study|Withdrawal by Subject|2
9885|NCT01895322|50505|P1|Overall Study|Adverse Event|1
9886|NCT01895309|50514|P2|Overall Study|Withdrawal by Subject|18
9887|NCT01895309|50515|P1|Overall Study|Withdrawal by Subject|9
9888|NCT01895309|50514|P2|Overall Study|Physician Decision|10
9889|NCT01895309|50515|P1|Overall Study|Physician Decision|15
9890|NCT01895309|50514|P2|Overall Study|Lost to Follow-up|3
9891|NCT01895309|50515|P1|Overall Study|Lost to Follow-up|1
9892|NCT01895309|50514|P2|Overall Study|Lack of Efficacy|3
9893|NCT01895309|50515|P1|Overall Study|Lack of Efficacy|1
9894|NCT01895309|50514|P2|Overall Study|Protocol Violation|0
9895|NCT01895309|50515|P1|Overall Study|Protocol Violation|1
9896|NCT01895309|50514|P2|Overall Study|Adverse Event|17
9897|NCT01895309|50515|P1|Overall Study|Adverse Event|13
9898|NCT01894607|50527|P1|Overall Study|Ineligible|1
9899|NCT01894581|50534|P2|Overall Study|Screen Failure|4
9900|NCT01894581|50535|P1|Overall Study|Screen Failure|3
9901|NCT01894581|50534|P2|Overall Study|Withdrawal by Subject|3
9902|NCT01894581|50535|P1|Overall Study|Withdrawal by Subject|2
9903|NCT01894256|50548|P3|Part B|Lack of Efficacy|13
9904|NCT01894256|50549|P2|Part B|Lack of Efficacy|12
9905|NCT01894256|50550|P1|Part B|Lack of Efficacy|15
9906|NCT01894256|50548|P3|Part B|Withdrawal by Subject|0
9907|NCT01894256|50549|P2|Part B|Withdrawal by Subject|1
9908|NCT01894256|50550|P1|Part B|Withdrawal by Subject|0
9909|NCT01894256|50548|P3|Part B|Death|1
9910|NCT01894256|50549|P2|Part B|Death|1
9911|NCT01894256|50550|P1|Part B|Death|0
9912|NCT01894256|50548|P3|Part A|Adverse Event|0
9913|NCT01894256|50549|P2|Part A|Adverse Event|1
9914|NCT01894256|50550|P1|Part A|Adverse Event|0
9915|NCT01894100|50596|P2|Overall Study|Withdrawal by Subject|0
9916|NCT01894100|50597|P1|Overall Study|Withdrawal by Subject|3
9917|NCT01894100|50596|P2|Overall Study|Lost to Follow-up|1
9918|NCT01894100|50597|P1|Overall Study|Lost to Follow-up|0
9919|NCT01893346|50629|P4|Overall Study|Withdrawal by Subject|0
9920|NCT01893346|50630|P3|Overall Study|Withdrawal by Subject|0
9921|NCT01893346|50631|P2|Overall Study|Withdrawal by Subject|0
9922|NCT01893346|50632|P1|Overall Study|Withdrawal by Subject|2
9923|NCT01893346|50629|P4|Overall Study|Protocol Violation|0
9924|NCT01893346|50630|P3|Overall Study|Protocol Violation|0
9925|NCT01893346|50631|P2|Overall Study|Protocol Violation|0
9926|NCT01893346|50632|P1|Overall Study|Protocol Violation|1
9927|NCT01893346|50629|P4|Overall Study|Lost to Follow-up|0
9928|NCT01893346|50630|P3|Overall Study|Lost to Follow-up|0
9929|NCT01893346|50631|P2|Overall Study|Lost to Follow-up|1
9930|NCT01893346|50632|P1|Overall Study|Lost to Follow-up|0
9931|NCT01893281|50646|P1|Overall Study|Withdrawal by Subject|1
9932|NCT01893281|50646|P1|Overall Study|Protocol Violation|1
9933|NCT01893281|50646|P1|Overall Study|Adverse Event|1
9934|NCT01893203|50653|P1|Overall Study|Withdrawal by Subject|1
9935|NCT01892657|50660|P1|Overall Study|Protocol Violation|12
9936|NCT01892657|50660|P1|Overall Study|Withdrawal by Subject|6
9937|NCT01892189|50685|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
9938|NCT01892189|50686|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
9939|NCT01892189|50687|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
9940|NCT01892189|50688|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
9941|NCT01892189|50689|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
9942|NCT01892189|50690|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
9943|NCT01892189|50691|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
9944|NCT01892189|50692|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
9945|NCT01892189|50693|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
9946|NCT01892189|50685|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
9947|NCT01892189|50686|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
9948|NCT01892189|50687|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
9949|NCT01892189|50688|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
9950|NCT01892189|50689|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
9951|NCT01892189|50690|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
9952|NCT01892189|50691|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
9953|NCT01892189|50692|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
9954|NCT01892189|50693|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
9955|NCT01892189|50685|P9|Washout Period 1 (7 Days)|Adverse Event|1
9956|NCT01892189|50686|P8|Washout Period 1 (7 Days)|Adverse Event|0
9957|NCT01892189|50687|P7|Washout Period 1 (7 Days)|Adverse Event|0
9958|NCT01892189|50688|P6|Washout Period 1 (7 Days)|Adverse Event|0
9959|NCT01892189|50689|P5|Washout Period 1 (7 Days)|Adverse Event|0
9960|NCT01892189|50690|P4|Washout Period 1 (7 Days)|Adverse Event|0
9961|NCT01892189|50691|P3|Washout Period 1 (7 Days)|Adverse Event|0
9962|NCT01892189|50692|P2|Washout Period 1 (7 Days)|Adverse Event|0
9963|NCT01892189|50693|P1|Washout Period 1 (7 Days)|Adverse Event|0
9964|NCT01892020|50733|P2|Period 2|Protocol Violation|0
9965|NCT01892020|50734|P1|Period 2|Protocol Violation|1
9966|NCT01892020|50733|P2|Period 1|Unclassified|1
9967|NCT01892020|50734|P1|Period 1|Unclassified|0
9968|NCT01892020|50733|P2|Period 1|Protocol Violation|4
9969|NCT01892020|50734|P1|Period 1|Protocol Violation|2
9970|NCT01892020|50733|P2|Period 1|Adverse Event|1
9971|NCT01892020|50734|P1|Period 1|Adverse Event|1
9972|NCT01891669|50775|P10|Overall Study|Unspecified|0
9973|NCT01891669|50776|P9|Overall Study|Unspecified|0
9974|NCT01891669|50777|P8|Overall Study|Unspecified|1
9975|NCT01891669|50778|P7|Overall Study|Unspecified|0
9976|NCT01891669|50779|P6|Overall Study|Unspecified|0
9977|NCT01891669|50780|P5|Overall Study|Unspecified|0
9978|NCT01891669|50781|P4|Overall Study|Unspecified|0
9979|NCT01891669|50782|P3|Overall Study|Unspecified|0
9980|NCT01891669|50783|P2|Overall Study|Unspecified|0
9981|NCT01891669|50784|P1|Overall Study|Unspecified|1
9982|NCT01891669|50775|P10|Overall Study|Withdrawal by Subject|1
9983|NCT01891669|50776|P9|Overall Study|Withdrawal by Subject|1
9984|NCT01891669|50777|P8|Overall Study|Withdrawal by Subject|2
9985|NCT01891669|50778|P7|Overall Study|Withdrawal by Subject|1
9986|NCT01891669|50779|P6|Overall Study|Withdrawal by Subject|0
9987|NCT01891669|50780|P5|Overall Study|Withdrawal by Subject|0
9988|NCT01891669|50781|P4|Overall Study|Withdrawal by Subject|0
9989|NCT01891669|50782|P3|Overall Study|Withdrawal by Subject|0
9990|NCT01891669|50783|P2|Overall Study|Withdrawal by Subject|1
9991|NCT01891669|50784|P1|Overall Study|Withdrawal by Subject|1
9992|NCT01891669|50775|P10|Overall Study|Death|1
9993|NCT01891669|50776|P9|Overall Study|Death|0
9994|NCT01891669|50777|P8|Overall Study|Death|1
9995|NCT01891669|50778|P7|Overall Study|Death|0
9996|NCT01891669|50779|P6|Overall Study|Death|0
9997|NCT01891669|50780|P5|Overall Study|Death|0
9998|NCT01891669|50781|P4|Overall Study|Death|0
9999|NCT01891669|50782|P3|Overall Study|Death|0
10000|NCT01891669|50783|P2|Overall Study|Death|0
10001|NCT01891669|50784|P1|Overall Study|Death|0
10002|NCT01890915|50946|P2|Overall Study|Equipment Malfunction|1
10003|NCT01890915|50947|P1|Overall Study|Equipment Malfunction|0
10004|NCT01890915|50946|P2|Overall Study|Protocol Violation|0
10005|NCT01890915|50947|P1|Overall Study|Protocol Violation|2
10006|NCT01890915|50946|P2|Overall Study|Adverse Event|0
10007|NCT01890915|50947|P1|Overall Study|Adverse Event|1
10008|NCT01890785|50963|P6|Third Intervention|Withdrawal by Subject|0
10009|NCT01890785|50964|P5|Third Intervention|Withdrawal by Subject|0
10010|NCT01890785|50965|P4|Third Intervention|Withdrawal by Subject|0
10011|NCT01890785|50966|P3|Third Intervention|Withdrawal by Subject|0
10012|NCT01890785|50967|P2|Third Intervention|Withdrawal by Subject|1
10013|NCT01890785|50968|P1|Third Intervention|Withdrawal by Subject|0
10014|NCT01890746|50987|P2|Overall Study|Ongoing|50
10015|NCT01890746|50988|P1|Overall Study|Ongoing|44
10016|NCT01890746|50987|P2|Overall Study|Death|14
10017|NCT01890746|50988|P1|Overall Study|Death|23
10018|NCT01890746|50987|P2|Overall Study|Withdrawal by Subject|8
10019|NCT01890746|50988|P1|Overall Study|Withdrawal by Subject|4
10020|NCT01890746|50987|P2|Overall Study|Physician Decision|2
10021|NCT01890746|50988|P1|Overall Study|Physician Decision|2
10022|NCT01890746|50987|P2|Overall Study|Adverse Event|0
10023|NCT01890746|50988|P1|Overall Study|Adverse Event|1
10024|NCT01890512|51060|P1|Overall Study|Protocol Violation|1
10025|NCT01890512|51060|P1|Overall Study|Withdrawal by Subject|1
10026|NCT01890512|51060|P1|Overall Study|Physician Decision|1
10027|NCT01890473|51066|P2|Overall Study|Poor/non-compliance|0
10028|NCT01890473|51067|P1|Overall Study|Poor/non-compliance|1
10029|NCT01890473|51066|P2|Overall Study|Lost to Follow-up|0
10030|NCT01890473|51067|P1|Overall Study|Lost to Follow-up|1
10031|NCT01890148|51109|P1|Overall Study|Adverse Event|1
10032|NCT01890122|51129|P4|Overall Study|Randomized but not Treated|0
10033|NCT01890122|51130|P3|Overall Study|Randomized but not Treated|0
10034|NCT01890122|51131|P2|Overall Study|Randomized but not Treated|1
10035|NCT01890122|51132|P1|Overall Study|Randomized but not Treated|1
10036|NCT01890122|51129|P4|Overall Study|Reason not Specified|2
10037|NCT01890122|51130|P3|Overall Study|Reason not Specified|1
10038|NCT01890122|51131|P2|Overall Study|Reason not Specified|1
10039|NCT01890122|51132|P1|Overall Study|Reason not Specified|0
10040|NCT01890122|51129|P4|Overall Study|Lack of Efficacy|41
10041|NCT01890122|51130|P3|Overall Study|Lack of Efficacy|7
10042|NCT01890122|51131|P2|Overall Study|Lack of Efficacy|24
10043|NCT01890122|51132|P1|Overall Study|Lack of Efficacy|14
10044|NCT01890122|51129|P4|Overall Study|Voluntary Withdrawal|11
10045|NCT01890122|51130|P3|Overall Study|Voluntary Withdrawal|2
10046|NCT01890122|51131|P2|Overall Study|Voluntary Withdrawal|8
10047|NCT01890122|51132|P1|Overall Study|Voluntary Withdrawal|8
10048|NCT01890122|51129|P4|Overall Study|Lost to Follow-up|2
10049|NCT01890122|51130|P3|Overall Study|Lost to Follow-up|2
10050|NCT01890122|51131|P2|Overall Study|Lost to Follow-up|1
10051|NCT01890122|51132|P1|Overall Study|Lost to Follow-up|0
10052|NCT01890122|51129|P4|Overall Study|Major Protocol Deviation|1
10053|NCT01890122|51130|P3|Overall Study|Major Protocol Deviation|0
10054|NCT01890122|51131|P2|Overall Study|Major Protocol Deviation|1
10055|NCT01890122|51132|P1|Overall Study|Major Protocol Deviation|3
10056|NCT01890122|51129|P4|Overall Study|Adverse Event|2
10057|NCT01890122|51130|P3|Overall Study|Adverse Event|1
10058|NCT01890122|51131|P2|Overall Study|Adverse Event|1
10059|NCT01890122|51132|P1|Overall Study|Adverse Event|1
10060|NCT01889251|51264|P2|Overall Study|Adverse Event|0
10061|NCT01889251|51265|P1|Overall Study|Adverse Event|1
10062|NCT01888965|51271|P1|Overall Study|Lack of Efficacy|4
10063|NCT01888965|51271|P1|Overall Study|Adverse Event|5
10064|NCT01888900|51279|P2|Overall Study|failed treatment|2
10065|NCT01888900|51280|P1|Overall Study|failed treatment|0
10066|NCT01888367|51303|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
10156|NCT01884675|51646|P1|Overall Study|Study closed/terminated|3
10067|NCT01888367|51304|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
10068|NCT01888367|51305|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
10069|NCT01888367|51303|P3|Overall Study|Protocol Violation|1
10070|NCT01888367|51304|P2|Overall Study|Protocol Violation|0
10071|NCT01888367|51305|P1|Overall Study|Protocol Violation|0
10072|NCT01888367|51303|P3|Overall Study|Lost to Follow-up|0
10073|NCT01888367|51304|P2|Overall Study|Lost to Follow-up|1
10074|NCT01888367|51305|P1|Overall Study|Lost to Follow-up|1
10075|NCT01888367|51303|P3|Overall Study|Withdrawal by Subject|1
10076|NCT01888367|51304|P2|Overall Study|Withdrawal by Subject|0
10077|NCT01888367|51305|P1|Overall Study|Withdrawal by Subject|1
10078|NCT01888367|51303|P3|Overall Study|Death|1
10079|NCT01888367|51304|P2|Overall Study|Death|0
10080|NCT01888367|51305|P1|Overall Study|Death|2
10081|NCT01888367|51303|P3|Overall Study|Physician Decision|2
10082|NCT01888367|51304|P2|Overall Study|Physician Decision|4
10083|NCT01888367|51305|P1|Overall Study|Physician Decision|3
10084|NCT01888003|51325|P3|Overall Study|Study Terminated|40
10085|NCT01888003|51326|P2|Overall Study|Study Terminated|6
10086|NCT01888003|51327|P1|Overall Study|Study Terminated|5
10087|NCT01887678|51367|P2|Overall Study|Specified|2
10088|NCT01887678|51368|P1|Overall Study|Specified|1
10089|NCT01887678|51367|P2|Overall Study|Non-compliance|3
10090|NCT01887678|51368|P1|Overall Study|Non-compliance|0
10091|NCT01887678|51367|P2|Overall Study|Lack of Efficacy|2
10092|NCT01887678|51368|P1|Overall Study|Lack of Efficacy|1
10093|NCT01887678|51367|P2|Overall Study|Deterioration of clinical condition|4
10094|NCT01887678|51368|P1|Overall Study|Deterioration of clinical condition|0
10095|NCT01887678|51367|P2|Overall Study|Lost to Follow-up|2
10096|NCT01887678|51368|P1|Overall Study|Lost to Follow-up|4
10097|NCT01887678|51367|P2|Overall Study|Withdrawal of consent|4
10098|NCT01887678|51368|P1|Overall Study|Withdrawal of consent|3
10099|NCT01887678|51367|P2|Overall Study|Exceeded rescue medication dosage|5
10100|NCT01887678|51368|P1|Overall Study|Exceeded rescue medication dosage|4
10101|NCT01887678|51367|P2|Overall Study|Adverse Event|6
10102|NCT01887678|51368|P1|Overall Study|Adverse Event|4
10103|NCT01887418|51436|P3|Overall Study|Travelling difficulties|1
10104|NCT01887418|51437|P2|Overall Study|Travelling difficulties|0
10105|NCT01887418|51438|P1|Overall Study|Travelling difficulties|0
10106|NCT01887353|51457|P2|Overall Study|Study stopped early|3
10107|NCT01887353|51458|P1|Overall Study|Study stopped early|4
10108|NCT01886781|51488|P2|Overall Study|Worsening of symptoms|1
10109|NCT01886781|51489|P1|Overall Study|Worsening of symptoms|1
10110|NCT01886781|51488|P2|Overall Study|Withdrawal by Subject|1
10111|NCT01886781|51489|P1|Overall Study|Withdrawal by Subject|2
10112|NCT01886781|51488|P2|Overall Study|Lost to Follow-up|0
10113|NCT01886781|51489|P1|Overall Study|Lost to Follow-up|5
10114|NCT01886781|51488|P2|Overall Study|Adverse Event|0
10115|NCT01886781|51489|P1|Overall Study|Adverse Event|1
10116|NCT01886781|51488|P2|Overall Study|Protocol Violation|0
10117|NCT01886781|51489|P1|Overall Study|Protocol Violation|5
10118|NCT01886716|51499|P4|Week 3|Lost to Follow-up|1
10119|NCT01886716|51500|P3|Week 3|Lost to Follow-up|0
10120|NCT01886716|51501|P2|Week 3|Lost to Follow-up|1
10121|NCT01886716|51502|P1|Week 3|Lost to Follow-up|1
10122|NCT01886716|51499|P4|Week 2|Lost to Follow-up|3
10123|NCT01886716|51500|P3|Week 2|Lost to Follow-up|1
10124|NCT01886716|51501|P2|Week 2|Lost to Follow-up|2
10125|NCT01886716|51502|P1|Week 2|Lost to Follow-up|3
10126|NCT01886716|51499|P4|Week 1|Lost to Follow-up|2
10127|NCT01886716|51500|P3|Week 1|Lost to Follow-up|2
10128|NCT01886716|51501|P2|Week 1|Lost to Follow-up|0
10129|NCT01886716|51502|P1|Week 1|Lost to Follow-up|0
10130|NCT01886690|51518|P2|Overall Study|Personal Reasons|1
10131|NCT01886690|51519|P1|Overall Study|Personal Reasons|0
10132|NCT01886690|51518|P2|Overall Study|Protocol Violation|1
10133|NCT01886690|51519|P1|Overall Study|Protocol Violation|0
10134|NCT01886300|51533|P1|Overall Study|Trial terminated by sponsor|16
10135|NCT01886287|51544|P1|Overall Study|Clinical progression due to disease|1
10136|NCT01886287|51544|P1|Overall Study|Radiographic disease progression|1
10137|NCT01885559|51573|P2|Overall Study|Protocol Violation|1
10138|NCT01885559|51574|P1|Overall Study|Protocol Violation|0
10139|NCT01885559|51573|P2|Overall Study|Less than full participation|19
10140|NCT01885559|51574|P1|Overall Study|Less than full participation|9
10141|NCT01885559|51573|P2|Overall Study|Lost to Follow-up|16
10142|NCT01885559|51574|P1|Overall Study|Lost to Follow-up|15
10143|NCT01885104|51619|P2|Overall Study|Physician Decision|0
10144|NCT01885104|51620|P1|Overall Study|Physician Decision|1
10145|NCT01885104|51619|P2|Overall Study|Lost to Follow-up|1
10146|NCT01885104|51620|P1|Overall Study|Lost to Follow-up|0
10147|NCT01885104|51619|P2|Overall Study|Withdrawal of Consent|0
10148|NCT01885104|51620|P1|Overall Study|Withdrawal of Consent|1
10149|NCT01885000|51630|P2|Overall Study|Protocol Violation|1
10150|NCT01885000|51631|P1|Overall Study|Protocol Violation|0
10151|NCT01885000|51630|P2|Overall Study|Withdrawal by Subject|1
10152|NCT01885000|51631|P1|Overall Study|Withdrawal by Subject|1
10153|NCT01885000|51630|P2|Overall Study|Adverse Event|0
10154|NCT01885000|51631|P1|Overall Study|Adverse Event|1
10155|NCT01884675|51645|P2|Overall Study|Study closed/terminated|2
10157|NCT01883635|51774|P2|Overall Study|Withdrawal by Subject|0
10158|NCT01883635|51775|P1|Overall Study|Withdrawal by Subject|4
10159|NCT01883453|51789|P2|Overall Study|No episode of common cold|23
10160|NCT01883453|51790|P1|Overall Study|No episode of common cold|25
10161|NCT01882907|51818|P2|Overall Study|Withdrawal by Subject|6
10162|NCT01882907|51819|P1|Overall Study|Withdrawal by Subject|0
10163|NCT01882907|51818|P2|Overall Study|Protocol Violation|14
10164|NCT01882907|51819|P1|Overall Study|Protocol Violation|10
10165|NCT01882907|51818|P2|Overall Study|Lost to Follow-up|4
10166|NCT01882907|51819|P1|Overall Study|Lost to Follow-up|1
10167|NCT01882907|51818|P2|Overall Study|Lack of Efficacy|3
10168|NCT01882907|51819|P1|Overall Study|Lack of Efficacy|0
10169|NCT01882907|51818|P2|Overall Study|Adverse Event|1
10170|NCT01882907|51819|P1|Overall Study|Adverse Event|3
10171|NCT01882647|51832|P2|Overall Study|Withdrawal by Subject|4
10172|NCT01882647|51833|P1|Overall Study|Withdrawal by Subject|0
10173|NCT01882647|51832|P2|Overall Study|Lost to Follow-up|2
10174|NCT01882647|51833|P1|Overall Study|Lost to Follow-up|2
10175|NCT01882465|51849|P7|Period 2|Protocol Violation|0
10176|NCT01882465|51850|P6|Period 2|Protocol Violation|0
10177|NCT01882465|51851|P5|Period 2|Protocol Violation|1
10178|NCT01882465|51852|P4|Period 2|Protocol Violation|0
10179|NCT01882465|51853|P3|Period 2|Protocol Violation|0
10180|NCT01882465|51854|P2|Period 2|Protocol Violation|0
10181|NCT01882465|51855|P1|Period 2|Protocol Violation|0
10182|NCT01882465|51849|P7|Period 1|Withdrawal by Subject|1
10183|NCT01882465|51850|P6|Period 1|Withdrawal by Subject|0
10184|NCT01882465|51851|P5|Period 1|Withdrawal by Subject|0
10185|NCT01882465|51852|P4|Period 1|Withdrawal by Subject|0
10186|NCT01882465|51853|P3|Period 1|Withdrawal by Subject|0
10187|NCT01882465|51854|P2|Period 1|Withdrawal by Subject|0
10188|NCT01882465|51855|P1|Period 1|Withdrawal by Subject|0
10189|NCT01882465|51849|P7|Period 1|Lens Discomfort|0
10190|NCT01882465|51850|P6|Period 1|Lens Discomfort|0
10191|NCT01882465|51851|P5|Period 1|Lens Discomfort|0
10192|NCT01882465|51852|P4|Period 1|Lens Discomfort|1
10193|NCT01882465|51853|P3|Period 1|Lens Discomfort|0
10194|NCT01882465|51854|P2|Period 1|Lens Discomfort|0
10195|NCT01882465|51855|P1|Period 1|Lens Discomfort|0
10196|NCT01882257|51880|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
10197|NCT01882257|51881|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
10198|NCT01882257|51882|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
10199|NCT01882257|51880|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
10200|NCT01882257|51881|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
10201|NCT01882257|51882|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
10202|NCT01881776|51909|P3|Overall Study|Protocol Violation|1
10203|NCT01881776|51910|P2|Overall Study|Protocol Violation|2
10204|NCT01881776|51911|P1|Overall Study|Protocol Violation|0
10205|NCT01881776|51909|P3|Overall Study|Lost to Follow-up|1
10206|NCT01881776|51910|P2|Overall Study|Lost to Follow-up|2
10207|NCT01881776|51911|P1|Overall Study|Lost to Follow-up|1
10208|NCT01881126|51939|P2|Overall Study|Adverse Event|1
10209|NCT01881126|51940|P1|Overall Study|Adverse Event|0
10210|NCT01881126|51939|P2|Overall Study|Non-compliance|1
10211|NCT01881126|51940|P1|Overall Study|Non-compliance|1
10212|NCT01880736|51959|P4|Overall Study|Withdrawal Criteria|5
10213|NCT01880736|51960|P3|Overall Study|Withdrawal Criteria|1
10214|NCT01880736|51961|P2|Overall Study|Withdrawal Criteria|2
10215|NCT01880736|51962|P1|Overall Study|Withdrawal Criteria|1
10216|NCT01880736|51959|P4|Overall Study|Adverse Event|1
10217|NCT01880736|51960|P3|Overall Study|Adverse Event|0
10218|NCT01880736|51961|P2|Overall Study|Adverse Event|0
10219|NCT01880736|51962|P1|Overall Study|Adverse Event|0
10220|NCT01880437|52047|P3|Overall Study|Study terminated by Sponsor|2
10221|NCT01880437|52048|P2|Overall Study|Study terminated by Sponsor|0
10222|NCT01880437|52049|P1|Overall Study|Study terminated by Sponsor|3
10223|NCT01880437|52047|P3|Overall Study|Death|17
10224|NCT01880437|52048|P2|Overall Study|Death|4
10225|NCT01880437|52049|P1|Overall Study|Death|12
10226|NCT01880424|52075|P2|Overall Study|Not specified|0
10227|NCT01880424|52076|P1|Overall Study|Not specified|1
10228|NCT01880424|52075|P2|Overall Study|Withdrawal by Subject|30
10229|NCT01880424|52076|P1|Overall Study|Withdrawal by Subject|10
10230|NCT01880424|52075|P2|Overall Study|Protocol Violation|13
10231|NCT01880424|52076|P1|Overall Study|Protocol Violation|11
10232|NCT01880424|52075|P2|Overall Study|Lost to Follow-up|2
10233|NCT01880424|52076|P1|Overall Study|Lost to Follow-up|3
10234|NCT01880424|52075|P2|Overall Study|Lack of Efficacy|4
10235|NCT01880424|52076|P1|Overall Study|Lack of Efficacy|1
10236|NCT01880424|52075|P2|Overall Study|Adverse Event|6
10237|NCT01880424|52076|P1|Overall Study|Adverse Event|7
10238|NCT01879852|52119|P2|Overall Study|Withdrawal by Subject|0
10239|NCT01879852|52120|P1|Overall Study|Withdrawal by Subject|2
10240|NCT01879722|52164|P10|Overall Study|Voluntary Withdrawal|0
10241|NCT01879722|52165|P9|Overall Study|Voluntary Withdrawal|1
10242|NCT01879722|52166|P8|Overall Study|Voluntary Withdrawal|0
10243|NCT01879722|52167|P7|Overall Study|Voluntary Withdrawal|0
10244|NCT01879722|52168|P6|Overall Study|Voluntary Withdrawal|0
10245|NCT01879722|52169|P5|Overall Study|Voluntary Withdrawal|0
10246|NCT01879722|52170|P4|Overall Study|Voluntary Withdrawal|0
10247|NCT01879722|52171|P3|Overall Study|Voluntary Withdrawal|0
10248|NCT01879722|52172|P2|Overall Study|Voluntary Withdrawal|0
10249|NCT01879722|52173|P1|Overall Study|Voluntary Withdrawal|0
10250|NCT01879722|52164|P10|Overall Study|Pretreatment Event/Adverse Event|0
10251|NCT01879722|52165|P9|Overall Study|Pretreatment Event/Adverse Event|1
10252|NCT01879722|52166|P8|Overall Study|Pretreatment Event/Adverse Event|1
10253|NCT01879722|52167|P7|Overall Study|Pretreatment Event/Adverse Event|0
10254|NCT01879722|52168|P6|Overall Study|Pretreatment Event/Adverse Event|0
10255|NCT01879722|52169|P5|Overall Study|Pretreatment Event/Adverse Event|1
10256|NCT01879722|52170|P4|Overall Study|Pretreatment Event/Adverse Event|1
10257|NCT01879722|52171|P3|Overall Study|Pretreatment Event/Adverse Event|0
10258|NCT01879722|52172|P2|Overall Study|Pretreatment Event/Adverse Event|1
10259|NCT01879722|52173|P1|Overall Study|Pretreatment Event/Adverse Event|0
10260|NCT01879683|52321|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
10261|NCT01879618|52328|P1|Overall Study|Adverse Event|5
10262|NCT01879618|52328|P1|Overall Study|Protocol Violation|6
10263|NCT01879618|52328|P1|Overall Study|Surgery;changed schedule; not available|8
10264|NCT01879618|52328|P1|Overall Study|Withdrawal by Subject|1
10265|NCT01879618|52328|P1|Overall Study|Does not meet entrance criteria|1
10266|NCT01879579|52335|P2|Overall Study|Discontinued insulin - possible allergy|1
10267|NCT01879579|52336|P1|Overall Study|Discontinued insulin - possible allergy|0
10268|NCT01879579|52335|P2|Overall Study|Phenotypic type 1 diabetes|1
10269|NCT01879579|52336|P1|Overall Study|Phenotypic type 1 diabetes|0
10270|NCT01879579|52335|P2|Overall Study|Did not initiate insulin treatment|0
10271|NCT01879579|52336|P1|Overall Study|Did not initiate insulin treatment|1
10272|NCT01879579|52335|P2|Overall Study|Did not enroll in texting platform|0
10273|NCT01879579|52336|P1|Overall Study|Did not enroll in texting platform|1
10274|NCT01879579|52335|P2|Overall Study|Phone incompatible with texting platform|0
10275|NCT01879579|52336|P1|Overall Study|Phone incompatible with texting platform|3
10276|NCT01879553|52366|P2|Overall Study|Withdrawal by Subject|0
10277|NCT01879553|52367|P1|Overall Study|Withdrawal by Subject|1
10278|NCT01879410|52401|P2|Overall Study|Randomised in Error|2
10279|NCT01879410|52402|P1|Overall Study|Randomised in Error|1
10280|NCT01879410|52401|P2|Overall Study|Withdrawal by Subject|8
10281|NCT01879410|52402|P1|Overall Study|Withdrawal by Subject|7
10282|NCT01879410|52401|P2|Overall Study|Lost to Follow-up|1
10283|NCT01879410|52402|P1|Overall Study|Lost to Follow-up|2
10284|NCT01879410|52401|P2|Overall Study|Protocol Violation|7
10285|NCT01879410|52402|P1|Overall Study|Protocol Violation|1
10286|NCT01879410|52401|P2|Overall Study|Lack of Efficacy|6
10287|NCT01879410|52402|P1|Overall Study|Lack of Efficacy|4
10288|NCT01879410|52401|P2|Overall Study|Adverse Event|14
10289|NCT01879410|52402|P1|Overall Study|Adverse Event|9
10290|NCT01879319|52469|P2|Overall Study|Lost to Follow-up|5
10291|NCT01879319|52470|P1|Overall Study|Lost to Follow-up|1
10292|NCT01879319|52469|P2|Overall Study|Withdrawal by Subject|0
10293|NCT01879319|52470|P1|Overall Study|Withdrawal by Subject|1
10294|NCT01878214|52587|P2|Overall Study|Lost to Follow-up|36
10295|NCT01878214|52588|P1|Overall Study|Lost to Follow-up|35
10296|NCT01878214|52587|P2|Overall Study|Death|1
10297|NCT01878214|52588|P1|Overall Study|Death|0
10298|NCT01878214|52587|P2|Overall Study|Withdrawal by Subject|7
10299|NCT01878214|52588|P1|Overall Study|Withdrawal by Subject|18
10300|NCT01878149|52604|P2|Overall Study|Did Not Meet Eligibility Criteria|2
10301|NCT01878149|52605|P1|Overall Study|Did Not Meet Eligibility Criteria|2
10302|NCT01877720|52617|P2|Overall Study|Adverse Event|0
10303|NCT01877720|52618|P1|Overall Study|Adverse Event|1
10304|NCT01877408|52649|P2|Overall Study|Lost to Follow-up|2
10305|NCT01877408|52650|P1|Overall Study|Lost to Follow-up|0
10306|NCT01877278|52683|P2|Overall Study|Lost to Follow-up|3
10307|NCT01877278|52684|P1|Overall Study|Lost to Follow-up|3
10308|NCT01876823|52715|P1|Overall Study|Patients moved|2
10309|NCT01876823|52715|P1|Overall Study|Physician Decision|2
10310|NCT01876823|52715|P1|Overall Study|Withdrawal by Subject|5
10311|NCT01876732|52728|P1|Overall Study|MMA was not over 800mg/dL|75
10312|NCT01876706|52733|P1|Overall Study|Lost to Follow-up|2
10313|NCT01876706|52733|P1|Overall Study|BPH Intervention|2
10314|NCT01876368|52752|P2|Overall Study|Subject/guardian decision|1
10315|NCT01876368|52753|P1|Overall Study|Subject/guardian decision|3
10316|NCT01876368|52752|P2|Overall Study|Protocol deviation|3
10317|NCT01876368|52753|P1|Overall Study|Protocol deviation|3
10318|NCT01876368|52752|P2|Overall Study|Physician Decision|2
10319|NCT01876368|52753|P1|Overall Study|Physician Decision|0
10320|NCT01876368|52752|P2|Overall Study|Non-compliance with study treatment|1
10321|NCT01876368|52753|P1|Overall Study|Non-compliance with study treatment|0
10322|NCT01876368|52752|P2|Overall Study|Lost to Follow-up|1
10323|NCT01876368|52753|P1|Overall Study|Lost to Follow-up|0
10324|NCT01876368|52752|P2|Overall Study|Lack of Efficacy|0
10325|NCT01876368|52753|P1|Overall Study|Lack of Efficacy|1
10326|NCT01876368|52752|P2|Overall Study|Adverse Event|5
10327|NCT01876368|52753|P1|Overall Study|Adverse Event|2
10328|NCT01875991|52797|P2|Overall Study|Sponsor Decision|0
10329|NCT01875991|52798|P1|Overall Study|Sponsor Decision|1
10330|NCT01875991|52797|P2|Overall Study|Withdrawal by Subject|6
10331|NCT01875991|52798|P1|Overall Study|Withdrawal by Subject|6
10332|NCT01875848|52836|P2|Overall Study|Withdrawal by Subject|0
10333|NCT01875848|52837|P1|Overall Study|Withdrawal by Subject|2
10334|NCT01875731|52847|P2|Overall Study|Fail to obtain lab sample|0
10335|NCT01875731|52848|P1|Overall Study|Fail to obtain lab sample|1
10336|NCT01874665|52858|P2|Overall Study|Treatment Ongoing|2
10337|NCT01874665|52859|P1|Overall Study|Treatment Ongoing|4
10338|NCT01875471|52875|P2|Overall Study|Unsatisfactory Lens Fitting|0
10339|NCT01875471|52876|P1|Overall Study|Unsatisfactory Lens Fitting|1
10340|NCT01875471|52875|P2|Overall Study|Adverse Event|1
10341|NCT01875471|52876|P1|Overall Study|Adverse Event|0
10342|NCT01874340|52897|P4|Overall Study|Withdrawal by Subject|1
10343|NCT01874340|52898|P3|Overall Study|Withdrawal by Subject|0
10344|NCT01874340|52899|P2|Overall Study|Withdrawal by Subject|0
10345|NCT01874340|52900|P1|Overall Study|Withdrawal by Subject|0
10346|NCT01874340|52897|P4|Overall Study|Study terminated by Sponsor|4
10347|NCT01874340|52898|P3|Overall Study|Study terminated by Sponsor|8
10348|NCT01874340|52899|P2|Overall Study|Study terminated by Sponsor|8
10349|NCT01874340|52900|P1|Overall Study|Study terminated by Sponsor|6
10350|NCT01874275|52928|P2|Overall Study|Lost to Follow-up|0
10351|NCT01874275|52929|P1|Overall Study|Lost to Follow-up|1
10352|NCT01874145|52952|P2|Extension Period|Lost to Follow-up|1
10353|NCT01874145|52953|P1|Extension Period|Lost to Follow-up|1
10354|NCT01874145|52952|P2|Extension Period|Withdrawal by Subject|1
10355|NCT01874145|52953|P1|Extension Period|Withdrawal by Subject|2
10356|NCT01874145|52952|P2|Extension Period|Adverse Event|2
10357|NCT01874145|52953|P1|Extension Period|Adverse Event|3
10358|NCT01874145|52952|P2|Core Period|Withdrawal by Subject|4
10359|NCT01874145|52953|P1|Core Period|Withdrawal by Subject|0
10360|NCT01874145|52952|P2|Core Period|Adverse Event|1
10361|NCT01874145|52953|P1|Core Period|Adverse Event|0
10362|NCT01874145|52952|P2|Core Period|Physician Decision|1
10363|NCT01874145|52953|P1|Core Period|Physician Decision|1
10364|NCT01874145|52952|P2|Core Period|Protocol Violation|1
10365|NCT01874145|52953|P1|Core Period|Protocol Violation|1
10366|NCT01874145|52952|P2|Core Period|Non-compliance|0
10367|NCT01874145|52953|P1|Core Period|Non-compliance|1
10368|NCT01873950|53002|P5|Period 5|Withdrawal by Subject|0
10369|NCT01873950|53003|P4|Period 5|Withdrawal by Subject|1
10370|NCT01873950|53004|P3|Period 5|Withdrawal by Subject|0
10371|NCT01873950|53005|P2|Period 5|Withdrawal by Subject|0
10372|NCT01873950|53006|P1|Period 5|Withdrawal by Subject|0
10373|NCT01873859|53027|P2|Overall Study|Withdrawal by Subject|4
10374|NCT01873859|53028|P1|Overall Study|Withdrawal by Subject|0
10375|NCT01873729|53036|P1|Overall Study|Withdrawal by Subject|1
10376|NCT01873417|53041|P1|Overall Study|Physician Decision|3
10377|NCT01873417|53041|P1|Overall Study|Withdrawal by Subject|2
10378|NCT01873417|53041|P1|Overall Study|Lost to Follow-up|2
10379|NCT01873417|53041|P1|Overall Study|Adverse Event|24
10380|NCT01873417|53041|P1|Overall Study|Did Not Receive Any Study Drug|4
10381|NCT01872715|53052|P1|Overall Study|Withdrawal by Subject|2
10382|NCT01872715|53052|P1|Overall Study|Protocol Violation|1
10383|NCT01872715|53052|P1|Overall Study|Adverse Event|1
10384|NCT01872611|53069|P2|Overall Study|Reason not provided|6
10385|NCT01872611|53070|P1|Overall Study|Reason not provided|6
10386|NCT01872611|53069|P2|Overall Study|Withdrawal by Subject|1
10387|NCT01872611|53070|P1|Overall Study|Withdrawal by Subject|6
10388|NCT01872611|53069|P2|Overall Study|Physician Decision|0
10389|NCT01872611|53070|P1|Overall Study|Physician Decision|1
10390|NCT01872611|53069|P2|Overall Study|Lost to Follow-up|1
10391|NCT01872611|53070|P1|Overall Study|Lost to Follow-up|8
10392|NCT01872611|53069|P2|Overall Study|Death, prior to treatment|1
10393|NCT01872611|53070|P1|Overall Study|Death, prior to treatment|0
10394|NCT01872611|53069|P2|Overall Study|Death|1
10395|NCT01872611|53070|P1|Overall Study|Death|0
10396|NCT01872611|53069|P2|Overall Study|Adverse Event, prior to treatment|1
10397|NCT01872611|53070|P1|Overall Study|Adverse Event, prior to treatment|0
10398|NCT01872611|53069|P2|Overall Study|Adverse Event|1
10399|NCT01872611|53070|P1|Overall Study|Adverse Event|3
10400|NCT01872078|53092|P4|Overall Study|Patient met exclusion criterion 16.|1
10401|NCT01872078|53093|P3|Overall Study|Patient met exclusion criterion 16.|0
10402|NCT01872078|53094|P2|Overall Study|Patient met exclusion criterion 16.|0
10403|NCT01872078|53095|P1|Overall Study|Patient met exclusion criterion 16.|0
10404|NCT01872078|53092|P4|Overall Study|Withdrawal by Subject|0
10405|NCT01872078|53093|P3|Overall Study|Withdrawal by Subject|1
10406|NCT01872078|53094|P2|Overall Study|Withdrawal by Subject|0
10407|NCT01872078|53095|P1|Overall Study|Withdrawal by Subject|0
10408|NCT01872078|53092|P4|Overall Study|Protocol Violation|0
10409|NCT01872078|53093|P3|Overall Study|Protocol Violation|1
10410|NCT01872078|53094|P2|Overall Study|Protocol Violation|0
10411|NCT01872078|53095|P1|Overall Study|Protocol Violation|0
10412|NCT01872078|53092|P4|Overall Study|Dose administration non-compliance|1
10413|NCT01872078|53093|P3|Overall Study|Dose administration non-compliance|0
10414|NCT01872078|53094|P2|Overall Study|Dose administration non-compliance|0
10415|NCT01872078|53095|P1|Overall Study|Dose administration non-compliance|0
10416|NCT01872078|53092|P4|Overall Study|Adverse Event|0
10417|NCT01872078|53093|P3|Overall Study|Adverse Event|1
10418|NCT01872078|53094|P2|Overall Study|Adverse Event|0
10419|NCT01872078|53095|P1|Overall Study|Adverse Event|0
10420|NCT01871870|53105|P1|Overall Study|hyperglycemia|2
10421|NCT01871870|53105|P1|Overall Study|Hardware issues|7
10422|NCT01871805|53116|P6|Phase II|Lost to Follow-up|2
10423|NCT01871805|53117|P5|Phase II|Lost to Follow-up|0
10424|NCT01871805|53118|P4|Phase II|Lost to Follow-up|0
10425|NCT01871805|53119|P3|Phase II|Lost to Follow-up|0
10426|NCT01871805|53120|P2|Phase II|Lost to Follow-up|0
10427|NCT01871805|53121|P1|Phase II|Lost to Follow-up|0
10428|NCT01871805|53116|P6|Phase II|Alive in Survival Follow-up|17
10429|NCT01871805|53117|P5|Phase II|Alive in Survival Follow-up|0
10430|NCT01871805|53118|P4|Phase II|Alive in Survival Follow-up|0
10431|NCT01871805|53119|P3|Phase II|Alive in Survival Follow-up|0
10432|NCT01871805|53120|P2|Phase II|Alive in Survival Follow-up|0
10433|NCT01871805|53121|P1|Phase II|Alive in Survival Follow-up|0
10434|NCT01871805|53116|P6|Phase II|Alive on Treatment|56
10435|NCT01871805|53117|P5|Phase II|Alive on Treatment|0
10436|NCT01871805|53118|P4|Phase II|Alive on Treatment|0
10437|NCT01871805|53119|P3|Phase II|Alive on Treatment|0
10438|NCT01871805|53120|P2|Phase II|Alive on Treatment|0
10439|NCT01871805|53121|P1|Phase II|Alive on Treatment|0
10440|NCT01871805|53116|P6|Phase II|Death|12
10441|NCT01871805|53117|P5|Phase II|Death|0
10442|NCT01871805|53118|P4|Phase II|Death|0
10443|NCT01871805|53119|P3|Phase II|Death|0
10444|NCT01871805|53120|P2|Phase II|Death|0
10445|NCT01871805|53121|P1|Phase II|Death|0
10446|NCT01871805|53116|P6|Phase I|Lost to Follow-up|0
10447|NCT01871805|53117|P5|Phase I|Lost to Follow-up|0
10448|NCT01871805|53118|P4|Phase I|Lost to Follow-up|0
10449|NCT01871805|53119|P3|Phase I|Lost to Follow-up|0
10450|NCT01871805|53120|P2|Phase I|Lost to Follow-up|1
10451|NCT01871805|53121|P1|Phase I|Lost to Follow-up|0
10452|NCT01871805|53116|P6|Phase I|Alive in Survival Follow-up|0
10453|NCT01871805|53117|P5|Phase I|Alive in Survival Follow-up|4
10454|NCT01871805|53118|P4|Phase I|Alive in Survival Follow-up|1
10455|NCT01871805|53119|P3|Phase I|Alive in Survival Follow-up|3
10456|NCT01871805|53120|P2|Phase I|Alive in Survival Follow-up|0
10457|NCT01871805|53121|P1|Phase I|Alive in Survival Follow-up|1
10458|NCT01871805|53116|P6|Phase I|Alive on Treatment|0
10459|NCT01871805|53117|P5|Phase I|Alive on Treatment|3
10460|NCT01871805|53118|P4|Phase I|Alive on Treatment|4
10461|NCT01871805|53119|P3|Phase I|Alive on Treatment|5
10462|NCT01871805|53120|P2|Phase I|Alive on Treatment|3
10463|NCT01871805|53121|P1|Phase I|Alive on Treatment|0
10464|NCT01871805|53116|P6|Phase I|Death|0
10465|NCT01871805|53117|P5|Phase I|Death|6
10466|NCT01871805|53118|P4|Phase I|Death|2
10467|NCT01871805|53119|P3|Phase I|Death|5
10468|NCT01871805|53120|P2|Phase I|Death|3
10469|NCT01871805|53121|P1|Phase I|Death|6
10470|NCT01871558|53189|P2|Overall Study|Withdrawal by Subject|0
10471|NCT01871558|53190|P1|Overall Study|Withdrawal by Subject|2
10472|NCT01871558|53189|P2|Overall Study|antidiabetic drug prematurely stopped|1
10473|NCT01871558|53190|P1|Overall Study|antidiabetic drug prematurely stopped|1
10474|NCT01871558|53189|P2|Overall Study|Other reason|1
10475|NCT01871558|53190|P1|Overall Study|Other reason|0
10476|NCT01871532|53210|P2|Overall Study|Withdrawal by Subject|2
10477|NCT01871532|53211|P1|Overall Study|Withdrawal by Subject|1
10478|NCT01871519|53245|P1|Overall Study|Withdrawal by Subject|49
10479|NCT01871519|53245|P1|Overall Study|Lost to Follow-up|15
10480|NCT01871519|53245|P1|Overall Study|Death|26
10481|NCT01871402|53268|P2|Overall Study|Non-compliance|1
10482|NCT01871402|53269|P1|Overall Study|Non-compliance|0
10483|NCT01871402|53268|P2|Overall Study|Withdrawal by Subject|2
10484|NCT01871402|53269|P1|Overall Study|Withdrawal by Subject|0
10485|NCT01871402|53268|P2|Overall Study|Lost to Follow-up|0
10486|NCT01871402|53269|P1|Overall Study|Lost to Follow-up|1
10487|NCT01871285|53287|P4|First Intervention (1 Day)|Lost to Follow-up|0
10488|NCT01871285|53288|P3|First Intervention (1 Day)|Lost to Follow-up|1
10489|NCT01871285|53289|P2|First Intervention (1 Day)|Lost to Follow-up|1
10490|NCT01871285|53290|P1|First Intervention (1 Day)|Lost to Follow-up|0
10491|NCT01871285|53287|P4|First Intervention (1 Day)|Adverse Event|0
10492|NCT01871285|53288|P3|First Intervention (1 Day)|Adverse Event|0
10493|NCT01871285|53289|P2|First Intervention (1 Day)|Adverse Event|0
10494|NCT01871285|53290|P1|First Intervention (1 Day)|Adverse Event|1
10495|NCT01871142|53316|P1|Overall Study|Adverse Event|1
10496|NCT01871090|53332|P2|Overall Study|Subject Non-Compliance|1
10497|NCT01871090|53333|P1|Overall Study|Subject Non-Compliance|0
10498|NCT01871090|53332|P2|Overall Study|Interrogation not completed correctly|0
10499|NCT01871090|53333|P1|Overall Study|Interrogation not completed correctly|1
10500|NCT01871090|53332|P2|Overall Study|Interrogation not done in Emergency Room|22
10501|NCT01871090|53333|P1|Overall Study|Interrogation not done in Emergency Room|1
10502|NCT01870999|53346|P3|Overall Study|Protocol Violation|1
10503|NCT01870999|53347|P2|Overall Study|Protocol Violation|0
10504|NCT01870999|53348|P1|Overall Study|Protocol Violation|0
10505|NCT01870999|53346|P3|Overall Study|Withdrawal by Subject|5
10506|NCT01870999|53347|P2|Overall Study|Withdrawal by Subject|2
10507|NCT01870999|53348|P1|Overall Study|Withdrawal by Subject|0
10508|NCT01870999|53346|P3|Overall Study|Subject withdrawn by Investigator|0
10509|NCT01870999|53347|P2|Overall Study|Subject withdrawn by Investigator|0
10510|NCT01870999|53348|P1|Overall Study|Subject withdrawn by Investigator|1
10511|NCT01870999|53346|P3|Overall Study|Subject met withdrawal criteria|0
10512|NCT01870999|53347|P2|Overall Study|Subject met withdrawal criteria|2
10513|NCT01870999|53348|P1|Overall Study|Subject met withdrawal criteria|3
10514|NCT01870999|53346|P3|Overall Study|Adverse Event|1
10515|NCT01870999|53347|P2|Overall Study|Adverse Event|4
10516|NCT01870999|53348|P1|Overall Study|Adverse Event|0
10517|NCT01870973|53406|P2|Overall Study|Lost to Follow-up|3
10518|NCT01870973|53407|P1|Overall Study|Lost to Follow-up|10
10519|NCT01870921|53413|P1|Overall Study|Other|1
10520|NCT01870921|53413|P1|Overall Study|Subject Lost to Follow up|2
10521|NCT01870921|53413|P1|Overall Study|Severe non-compliance to protocol|7
10522|NCT01870921|53413|P1|Overall Study|Subject decision|80
10523|NCT01870843|53432|P1|Overall Study|Withdrawal by Subject|18
10524|NCT01870843|53432|P1|Overall Study|Death|1
10525|NCT01870843|53432|P1|Overall Study|Lost to Follow-up|24
10526|NCT01870843|53432|P1|Overall Study|Adverse Event|10
10527|NCT01870739|53447|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
10528|NCT01870739|53448|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
10529|NCT01870739|53447|P2|Add-on Period (40 Weeks)|Protocol deviation|1
10530|NCT01870739|53448|P1|Add-on Period (40 Weeks)|Protocol deviation|1
10531|NCT01870739|53447|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
10532|NCT01870739|53448|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
10533|NCT01870739|53447|P2|Add-on Period (40 Weeks)|Adverse Event|1
10534|NCT01870739|53448|P1|Add-on Period (40 Weeks)|Adverse Event|0
10535|NCT01870739|53447|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
10536|NCT01870739|53448|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
10537|NCT01870739|53447|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
10538|NCT01870739|53448|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
10539|NCT01870739|53447|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
10540|NCT01870739|53448|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
10541|NCT01868893|53553|P1|Overall Study|Neutropenia|1
10542|NCT01868893|53553|P1|Overall Study|Commercial availability of study drug|17
10543|NCT01868893|53553|P1|Overall Study|Adverse Event|2
10544|NCT01868542|53571|P2|Overall Study|Unclassified|1
10545|NCT01868542|53572|P1|Overall Study|Unclassified|0
10546|NCT01868542|53571|P2|Overall Study|Protocol Violation|1
10547|NCT01868542|53572|P1|Overall Study|Protocol Violation|0
10548|NCT01868503|53590|P1|Overall Study|Protocol Violation|1
10549|NCT01868503|53590|P1|Overall Study|Withdrawal by Subject|1
10550|NCT01868243|53596|P2|Overall Study|Death|1
10551|NCT01868243|53597|P1|Overall Study|Death|0
10552|NCT01868074|53607|P2|Overall Study|Withdrawal by Subject|2
10553|NCT01868074|53608|P1|Overall Study|Withdrawal by Subject|4
10554|NCT01868074|53607|P2|Overall Study|Lost to Follow-up|2
10555|NCT01868074|53608|P1|Overall Study|Lost to Follow-up|3
10556|NCT01868035|53618|P1|Overall Study|Non-compliance|1
10557|NCT01868035|53618|P1|Overall Study|Progressive Disease|2
10558|NCT01868035|53618|P1|Overall Study|Withdrawal by Subject|1
10559|NCT01868035|53618|P1|Overall Study|Lost to Follow-up|3
10560|NCT01868009|53634|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
10561|NCT01868009|53635|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
10562|NCT01868009|53634|P2|Period 2 (5-9 Days)|Adverse Event|0
10563|NCT01868009|53635|P1|Period 2 (5-9 Days)|Adverse Event|1
10564|NCT01868009|53634|P2|Period 1 (5-9 Days)|Adverse Event|2
10565|NCT01868009|53635|P1|Period 1 (5-9 Days)|Adverse Event|0
10566|NCT01867710|53649|P4|Overall Study|Unspecified|0
10567|NCT01867710|53650|P3|Overall Study|Unspecified|0
10568|NCT01867710|53651|P2|Overall Study|Unspecified|1
10569|NCT01867710|53652|P1|Overall Study|Unspecified|0
10570|NCT01867710|53649|P4|Overall Study|Eligible Criteria Not Met|0
10571|NCT01867710|53650|P3|Overall Study|Eligible Criteria Not Met|1
10572|NCT01867710|53651|P2|Overall Study|Eligible Criteria Not Met|0
10573|NCT01867710|53652|P1|Overall Study|Eligible Criteria Not Met|0
10574|NCT01867710|53649|P4|Overall Study|Withdrawal by Subject|0
10575|NCT01867710|53650|P3|Overall Study|Withdrawal by Subject|0
10576|NCT01867710|53651|P2|Overall Study|Withdrawal by Subject|1
10577|NCT01867710|53652|P1|Overall Study|Withdrawal by Subject|0
10578|NCT01867710|53649|P4|Overall Study|Protocol Violation|1
10579|NCT01867710|53650|P3|Overall Study|Protocol Violation|0
10580|NCT01867710|53651|P2|Overall Study|Protocol Violation|0
10581|NCT01867710|53652|P1|Overall Study|Protocol Violation|1
10582|NCT01867710|53649|P4|Overall Study|Physician Decision|0
10583|NCT01867710|53650|P3|Overall Study|Physician Decision|1
10584|NCT01867710|53651|P2|Overall Study|Physician Decision|0
10585|NCT01867710|53652|P1|Overall Study|Physician Decision|0
10586|NCT01867710|53649|P4|Overall Study|Death|0
10587|NCT01867710|53650|P3|Overall Study|Death|1
10588|NCT01867710|53651|P2|Overall Study|Death|1
10589|NCT01867710|53652|P1|Overall Study|Death|0
10590|NCT01867710|53649|P4|Overall Study|Other Adverse Events|3
10591|NCT01867710|53650|P3|Overall Study|Other Adverse Events|1
10592|NCT01867710|53651|P2|Overall Study|Other Adverse Events|0
10593|NCT01867710|53652|P1|Overall Study|Other Adverse Events|1
10594|NCT01867710|53649|P4|Overall Study|Palliative Radiation Required|1
10595|NCT01867710|53650|P3|Overall Study|Palliative Radiation Required|1
10596|NCT01867710|53651|P2|Overall Study|Palliative Radiation Required|0
10597|NCT01867710|53652|P1|Overall Study|Palliative Radiation Required|0
10598|NCT01867710|53649|P4|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
10599|NCT01867710|53650|P3|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
10600|NCT01867710|53651|P2|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
10601|NCT01867710|53652|P1|Overall Study|Adverse Event Sustained Toxicity>Grade 1|1
10602|NCT01867710|53649|P4|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
10603|NCT01867710|53650|P3|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
10604|NCT01867710|53651|P2|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|2
10605|NCT01867710|53652|P1|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
10606|NCT01867710|53649|P4|Overall Study|Disease Progression|2
10607|NCT01867710|53650|P3|Overall Study|Disease Progression|4
10608|NCT01867710|53651|P2|Overall Study|Disease Progression|2
10609|NCT01867710|53652|P1|Overall Study|Disease Progression|5
10610|NCT01867658|53666|P1|Overall Study|Subject could not be contacted|1
10611|NCT01867658|53666|P1|Overall Study|Death|2
10612|NCT01867658|53666|P1|Overall Study|Withdrawal by Subject|6
10613|NCT01867021|53696|P2|Overall Study|Withdrawal by Subject|6
10614|NCT01867021|53697|P1|Overall Study|Withdrawal by Subject|1
10615|NCT01867021|53696|P2|Overall Study|Lost to Follow-up|2
10616|NCT01867021|53697|P1|Overall Study|Lost to Follow-up|0
10617|NCT01867021|53696|P2|Overall Study|Death|0
10618|NCT01867021|53697|P1|Overall Study|Death|1
10619|NCT01867021|53696|P2|Overall Study|Not Eligible|1
10620|NCT01867021|53697|P1|Overall Study|Not Eligible|0
10621|NCT01867021|53696|P2|Overall Study|Adverse Event|1
10622|NCT01867021|53697|P1|Overall Study|Adverse Event|0
10623|NCT01865812|53716|P1|Overall Study|Adverse Event|2
10624|NCT01866709|53724|P2|Overall Study|Adverse Event|0
10625|NCT01866709|53725|P1|Overall Study|Adverse Event|1
10626|NCT01866319|53736|P3|Overall Study|Remain on study|176
10627|NCT01866319|53737|P2|Overall Study|Remain on study|190
10628|NCT01866319|53738|P1|Overall Study|Remain on study|131
10629|NCT01866319|53736|P3|Overall Study|Withdrawal by Subject|6
10630|NCT01866319|53737|P2|Overall Study|Withdrawal by Subject|9
10631|NCT01866319|53738|P1|Overall Study|Withdrawal by Subject|31
10632|NCT01866319|53736|P3|Overall Study|Physician Decision|0
10633|NCT01866319|53737|P2|Overall Study|Physician Decision|0
10634|NCT01866319|53738|P1|Overall Study|Physician Decision|1
10635|NCT01866319|53736|P3|Overall Study|Lost to Follow-up|6
10636|NCT01866319|53737|P2|Overall Study|Lost to Follow-up|0
10637|NCT01866319|53738|P1|Overall Study|Lost to Follow-up|3
10638|NCT01866319|53736|P3|Overall Study|Death|77
10639|NCT01866319|53737|P2|Overall Study|Death|74
10640|NCT01866319|53738|P1|Overall Study|Death|97
10641|NCT01866319|53736|P3|Overall Study|Clinical progression|0
10642|NCT01866319|53737|P2|Overall Study|Clinical progression|0
10643|NCT01866319|53738|P1|Overall Study|Clinical progression|1
10644|NCT01866319|53736|P3|Overall Study|Adverse Event|12
10645|NCT01866319|53737|P2|Overall Study|Adverse Event|6
10646|NCT01866319|53738|P1|Overall Study|Adverse Event|13
10647|NCT01864005|53801|P2|Overall Study|Need GP IIb/IIIa|3
10648|NCT01864005|53802|P1|Overall Study|Need GP IIb/IIIa|1
10649|NCT01864005|53801|P2|Overall Study|Disease need|1
10650|NCT01864005|53802|P1|Overall Study|Disease need|1
10651|NCT01864005|53801|P2|Overall Study|Incorrect enrolment|0
10652|NCT01864005|53802|P1|Overall Study|Incorrect enrolment|1
10653|NCT01864005|53801|P2|Overall Study|Withdrawal by Subject|1
10654|NCT01864005|53802|P1|Overall Study|Withdrawal by Subject|0
10655|NCT01864005|53801|P2|Overall Study|Protocol Violation|1
10656|NCT01864005|53802|P1|Overall Study|Protocol Violation|0
10657|NCT01863953|53819|P3|Overall Study|Adverse Event|1
10658|NCT01863953|53820|P2|Overall Study|Adverse Event|0
10659|NCT01863953|53821|P1|Overall Study|Adverse Event|0
10660|NCT01863771|53835|P4|Maintenance Phase|Withdrawal by Subject|3
10661|NCT01863771|53836|P3|Maintenance Phase|Withdrawal by Subject|2
10662|NCT01863771|53837|P2|Maintenance Phase|Withdrawal by Subject|1
10663|NCT01863771|53838|P1|Maintenance Phase|Withdrawal by Subject|0
10664|NCT01863771|53835|P4|Maintenance Phase|Pregnancy|0
10665|NCT01863771|53836|P3|Maintenance Phase|Pregnancy|0
10666|NCT01863771|53837|P2|Maintenance Phase|Pregnancy|1
10667|NCT01863771|53838|P1|Maintenance Phase|Pregnancy|0
10668|NCT01863771|53835|P4|Maintenance Phase|Physician Decision|1
10669|NCT01863771|53836|P3|Maintenance Phase|Physician Decision|2
10670|NCT01863771|53837|P2|Maintenance Phase|Physician Decision|0
10671|NCT01863771|53838|P1|Maintenance Phase|Physician Decision|0
10672|NCT01863771|53835|P4|Maintenance Phase|Lack of Efficacy|38
10673|NCT01863771|53836|P3|Maintenance Phase|Lack of Efficacy|7
10674|NCT01863771|53837|P2|Maintenance Phase|Lack of Efficacy|3
10675|NCT01863771|53838|P1|Maintenance Phase|Lack of Efficacy|0
10676|NCT01863771|53835|P4|Maintenance Phase|Adverse Event|1
10677|NCT01863771|53836|P3|Maintenance Phase|Adverse Event|1
10678|NCT01863771|53837|P2|Maintenance Phase|Adverse Event|0
10679|NCT01863771|53838|P1|Maintenance Phase|Adverse Event|0
10680|NCT01863771|53835|P4|Induction Phase|Withdrawal by Subject|0
10681|NCT01863771|53836|P3|Induction Phase|Withdrawal by Subject|0
10682|NCT01863771|53837|P2|Induction Phase|Withdrawal by Subject|0
10683|NCT01863771|53838|P1|Induction Phase|Withdrawal by Subject|2
10684|NCT01863771|53835|P4|Induction Phase|Lack of Efficacy|0
10685|NCT01863771|53836|P3|Induction Phase|Lack of Efficacy|0
10686|NCT01863771|53837|P2|Induction Phase|Lack of Efficacy|0
10687|NCT01863771|53838|P1|Induction Phase|Lack of Efficacy|10
10688|NCT01863771|53835|P4|Induction Phase|Adverse Event|0
10689|NCT01863771|53836|P3|Induction Phase|Adverse Event|0
10690|NCT01863771|53837|P2|Induction Phase|Adverse Event|0
10691|NCT01863771|53838|P1|Induction Phase|Adverse Event|9
10692|NCT01863680|53850|P1|Overall Study|Unspecified|6
10693|NCT01863680|53850|P1|Overall Study|Did not undergo IVF/ET|14
10694|NCT01863680|53850|P1|Overall Study|Withdrawal by Subject|1
10695|NCT01863680|53850|P1|Overall Study|Spontaneous pregnancy|2
10696|NCT01863680|53850|P1|Overall Study|Risk of OHSS|17
10697|NCT01863680|53850|P1|Overall Study|Adverse Event|17
10698|NCT01863667|53858|P2|Overall Study|Withdrawal by Subject|2
10699|NCT01863667|53859|P1|Overall Study|Withdrawal by Subject|2
10700|NCT01863667|53858|P2|Overall Study|Study terminated by Sponsor|30
10701|NCT01863667|53859|P1|Overall Study|Study terminated by Sponsor|30
10702|NCT01863667|53858|P2|Overall Study|Adverse Event|0
10703|NCT01863667|53859|P1|Overall Study|Adverse Event|1
10704|NCT01863433|53879|P1|Overall Study|Protocol Violation|1
10705|NCT01863368|53889|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
10706|NCT01863368|53890|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
10707|NCT01863368|53889|P2|Phase II, Day 35 to Day 90|Adverse Event|0
10708|NCT01863368|53890|P1|Phase II, Day 35 to Day 90|Adverse Event|1
10709|NCT01863368|53889|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
10710|NCT01863368|53890|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
10711|NCT01863368|53889|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
10712|NCT01863368|53890|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
10713|NCT01863368|53889|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
10714|NCT01863368|53890|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
10715|NCT01863368|53889|P2|Phase I, Day 0 to Day 35|Adverse Event|4
10716|NCT01863368|53890|P1|Phase I, Day 0 to Day 35|Adverse Event|2
10717|NCT01862484|53914|P2|Overall Study|Withdrawal by Subject|3
10718|NCT01862484|53915|P1|Overall Study|Withdrawal by Subject|0
10719|NCT01862484|53914|P2|Overall Study|Protocol Violation|2
10720|NCT01862484|53915|P1|Overall Study|Protocol Violation|0
10721|NCT01862484|53914|P2|Overall Study|Lost to Follow-up|2
10722|NCT01862484|53915|P1|Overall Study|Lost to Follow-up|1
10723|NCT01862484|53914|P2|Overall Study|Lack of Efficacy|1
10724|NCT01862484|53915|P1|Overall Study|Lack of Efficacy|1
10725|NCT01861522|53978|P2|Overall Study|Withdrawal by Subject|0
10726|NCT01861522|53979|P1|Overall Study|Withdrawal by Subject|2
10727|NCT01861522|53978|P2|Overall Study|Adverse Event|0
10728|NCT01861522|53979|P1|Overall Study|Adverse Event|1
10729|NCT01860989|54003|P1|Overall Study|Unsatisfactory therapeutic|5
10730|NCT01860703|54007|P4|Overall Study|Personal reason|0
10731|NCT01860703|54008|P3|Overall Study|Personal reason|1
10732|NCT01860703|54009|P2|Overall Study|Personal reason|0
10733|NCT01860703|54010|P1|Overall Study|Personal reason|1
10734|NCT01860703|54007|P4|Overall Study|Withdrawal by Subject|0
10735|NCT01860703|54008|P3|Overall Study|Withdrawal by Subject|0
10736|NCT01860703|54009|P2|Overall Study|Withdrawal by Subject|1
10737|NCT01860703|54010|P1|Overall Study|Withdrawal by Subject|0
10738|NCT01860703|54007|P4|Overall Study|Adverse Event|2
10739|NCT01860703|54008|P3|Overall Study|Adverse Event|0
10740|NCT01860703|54009|P2|Overall Study|Adverse Event|4
10741|NCT01860703|54010|P1|Overall Study|Adverse Event|1
10742|NCT01860534|54044|P2|ROP #2|discharged prior to ROP #2|0
10743|NCT01860534|54045|P1|ROP #2|discharged prior to ROP #2|1
10744|NCT01860534|54044|P2|ROP #1|Needed treatment for ROP|1
10745|NCT01860534|54045|P1|ROP #1|Needed treatment for ROP|0
10746|NCT01860079|54074|P2|Overall Study|Physician Decision|22
10747|NCT01860079|54075|P1|Overall Study|Physician Decision|14
10748|NCT01859949|54083|P2|Overall Study|Adverse Event|1
10749|NCT01859949|54084|P1|Overall Study|Adverse Event|0
10750|NCT01859949|54083|P2|Overall Study|Protocol Violation|1
10751|NCT01859949|54084|P1|Overall Study|Protocol Violation|1
10752|NCT01859949|54083|P2|Overall Study|Withdrawal by Subject|10
10753|NCT01859949|54084|P1|Overall Study|Withdrawal by Subject|11
10754|NCT01859949|54083|P2|Overall Study|Physician Decision|4
10755|NCT01859949|54084|P1|Overall Study|Physician Decision|2
10756|NCT01859949|54083|P2|Overall Study|Family Matters|1
10757|NCT01859949|54084|P1|Overall Study|Family Matters|0
10758|NCT01859793|54102|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
10759|NCT01859793|54103|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
10760|NCT01859793|54102|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
10761|NCT01859793|54103|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
10762|NCT01859793|54102|P2|First Intervention (8 Weeks)|Adverse Event|0
10763|NCT01859793|54103|P1|First Intervention (8 Weeks)|Adverse Event|1
10764|NCT01859793|54102|P2|First Intervention (8 Weeks)|Protocol Violation|0
10765|NCT01859793|54103|P1|First Intervention (8 Weeks)|Protocol Violation|2
10766|NCT01859715|54116|P3|Overall Study|No 2nd VAS|23
10767|NCT01859715|54117|P2|Overall Study|No 2nd VAS|8
10768|NCT01859715|54118|P1|Overall Study|No 2nd VAS|16
10769|NCT01859702|54129|P1|Overall Study|Adverse Event|2
10770|NCT01859702|54129|P1|Overall Study|Protocol deviation|3
10771|NCT01859598|54143|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
10772|NCT01859507|54151|P1|Overall Study|left the country|4
10773|NCT01859494|54156|P1|Overall Study|Adverse Event|1
10774|NCT01859143|54207|P2|Overall Study|Lost to Follow-up|0
10775|NCT01859143|54208|P1|Overall Study|Lost to Follow-up|2
10776|NCT01858766|54241|P19|Overall Study|Withdrew Consent|0
10777|NCT01858766|54242|P18|Overall Study|Withdrew Consent|0
10778|NCT01858766|54243|P17|Overall Study|Withdrew Consent|0
10779|NCT01858766|54244|P16|Overall Study|Withdrew Consent|0
10780|NCT01858766|54245|P15|Overall Study|Withdrew Consent|0
10781|NCT01858766|54246|P14|Overall Study|Withdrew Consent|0
10782|NCT01858766|54247|P13|Overall Study|Withdrew Consent|0
10783|NCT01858766|54248|P12|Overall Study|Withdrew Consent|1
10784|NCT01858766|54249|P11|Overall Study|Withdrew Consent|0
10785|NCT01858766|54250|P10|Overall Study|Withdrew Consent|0
10786|NCT01858766|54251|P9|Overall Study|Withdrew Consent|0
10787|NCT01858766|54252|P8|Overall Study|Withdrew Consent|0
10788|NCT01858766|54253|P7|Overall Study|Withdrew Consent|0
10789|NCT01858766|54254|P6|Overall Study|Withdrew Consent|0
10790|NCT01858766|54255|P5|Overall Study|Withdrew Consent|0
10791|NCT01858766|54256|P4|Overall Study|Withdrew Consent|0
10792|NCT01858766|54257|P3|Overall Study|Withdrew Consent|0
10793|NCT01858766|54258|P2|Overall Study|Withdrew Consent|0
10794|NCT01858766|54259|P1|Overall Study|Withdrew Consent|0
10795|NCT01858766|54241|P19|Overall Study|Lost to Follow-up|1
10796|NCT01858766|54242|P18|Overall Study|Lost to Follow-up|0
10797|NCT01858766|54243|P17|Overall Study|Lost to Follow-up|1
10798|NCT01858766|54244|P16|Overall Study|Lost to Follow-up|1
10799|NCT01858766|54245|P15|Overall Study|Lost to Follow-up|3
10800|NCT01858766|54246|P14|Overall Study|Lost to Follow-up|0
10801|NCT01858766|54247|P13|Overall Study|Lost to Follow-up|0
10802|NCT01858766|54248|P12|Overall Study|Lost to Follow-up|1
10803|NCT01858766|54249|P11|Overall Study|Lost to Follow-up|0
10804|NCT01858766|54250|P10|Overall Study|Lost to Follow-up|0
10805|NCT01858766|54251|P9|Overall Study|Lost to Follow-up|0
10806|NCT01858766|54252|P8|Overall Study|Lost to Follow-up|2
10807|NCT01858766|54253|P7|Overall Study|Lost to Follow-up|0
10808|NCT01858766|54254|P6|Overall Study|Lost to Follow-up|1
10809|NCT01858766|54255|P5|Overall Study|Lost to Follow-up|0
10810|NCT01858766|54256|P4|Overall Study|Lost to Follow-up|0
10811|NCT01858766|54257|P3|Overall Study|Lost to Follow-up|0
10812|NCT01858766|54258|P2|Overall Study|Lost to Follow-up|0
10813|NCT01858766|54259|P1|Overall Study|Lost to Follow-up|0
10814|NCT01858766|54241|P19|Overall Study|Lack of Efficacy|3
10815|NCT01858766|54242|P18|Overall Study|Lack of Efficacy|3
10816|NCT01858766|54243|P17|Overall Study|Lack of Efficacy|2
10817|NCT01858766|54244|P16|Overall Study|Lack of Efficacy|5
10818|NCT01858766|54245|P15|Overall Study|Lack of Efficacy|5
10819|NCT01858766|54246|P14|Overall Study|Lack of Efficacy|3
10820|NCT01858766|54247|P13|Overall Study|Lack of Efficacy|5
10821|NCT01858766|54248|P12|Overall Study|Lack of Efficacy|3
10822|NCT01858766|54249|P11|Overall Study|Lack of Efficacy|0
10823|NCT01858766|54250|P10|Overall Study|Lack of Efficacy|0
10824|NCT01858766|54251|P9|Overall Study|Lack of Efficacy|0
10825|NCT01858766|54252|P8|Overall Study|Lack of Efficacy|0
10826|NCT01858766|54253|P7|Overall Study|Lack of Efficacy|0
10827|NCT01858766|54254|P6|Overall Study|Lack of Efficacy|2
10828|NCT01858766|54255|P5|Overall Study|Lack of Efficacy|1
10829|NCT01858766|54256|P4|Overall Study|Lack of Efficacy|0
10830|NCT01858766|54257|P3|Overall Study|Lack of Efficacy|0
10831|NCT01858766|54258|P2|Overall Study|Lack of Efficacy|0
10832|NCT01858766|54259|P1|Overall Study|Lack of Efficacy|1
10833|NCT01858766|54241|P19|Overall Study|Death|0
10834|NCT01858766|54242|P18|Overall Study|Death|0
10835|NCT01858766|54243|P17|Overall Study|Death|0
10836|NCT01858766|54244|P16|Overall Study|Death|0
10837|NCT01858766|54245|P15|Overall Study|Death|0
10838|NCT01858766|54246|P14|Overall Study|Death|0
10839|NCT01858766|54247|P13|Overall Study|Death|0
10840|NCT01858766|54248|P12|Overall Study|Death|0
10841|NCT01858766|54249|P11|Overall Study|Death|0
10842|NCT01858766|54250|P10|Overall Study|Death|0
10843|NCT01858766|54251|P9|Overall Study|Death|0
10844|NCT01858766|54252|P8|Overall Study|Death|0
10845|NCT01858766|54253|P7|Overall Study|Death|0
10846|NCT01858766|54254|P6|Overall Study|Death|0
10847|NCT01858766|54255|P5|Overall Study|Death|0
10848|NCT01858766|54256|P4|Overall Study|Death|0
10849|NCT01858766|54257|P3|Overall Study|Death|1
10850|NCT01858766|54258|P2|Overall Study|Death|0
10851|NCT01858766|54259|P1|Overall Study|Death|0
10852|NCT01858766|54241|P19|Overall Study|Randomized but Never Treated|0
10853|NCT01858766|54242|P18|Overall Study|Randomized but Never Treated|1
10854|NCT01858766|54243|P17|Overall Study|Randomized but Never Treated|0
10855|NCT01858766|54244|P16|Overall Study|Randomized but Never Treated|0
10856|NCT01858766|54245|P15|Overall Study|Randomized but Never Treated|0
10857|NCT01858766|54246|P14|Overall Study|Randomized but Never Treated|0
10858|NCT01858766|54247|P13|Overall Study|Randomized but Never Treated|0
10859|NCT01858766|54248|P12|Overall Study|Randomized but Never Treated|0
10860|NCT01858766|54249|P11|Overall Study|Randomized but Never Treated|0
10861|NCT01858766|54250|P10|Overall Study|Randomized but Never Treated|0
10862|NCT01858766|54251|P9|Overall Study|Randomized but Never Treated|0
10863|NCT01858766|54252|P8|Overall Study|Randomized but Never Treated|0
10864|NCT01858766|54253|P7|Overall Study|Randomized but Never Treated|0
10865|NCT01858766|54254|P6|Overall Study|Randomized but Never Treated|1
10866|NCT01858766|54255|P5|Overall Study|Randomized but Never Treated|0
10867|NCT01858766|54256|P4|Overall Study|Randomized but Never Treated|0
10868|NCT01858766|54257|P3|Overall Study|Randomized but Never Treated|0
10869|NCT01858766|54258|P2|Overall Study|Randomized but Never Treated|0
10870|NCT01858766|54259|P1|Overall Study|Randomized but Never Treated|0
10871|NCT01858701|54330|P2|Period 2, Second 30 Days of Wear|Comfort|1
10872|NCT01858701|54331|P1|Period 2, Second 30 Days of Wear|Comfort|0
10873|NCT01858701|54330|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
10874|NCT01858701|54331|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
10875|NCT01858701|54330|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
10876|NCT01858701|54331|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
10877|NCT01858701|54330|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
10878|NCT01858701|54331|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
10879|NCT01858636|54337|P1|Overall Study|Withdrawal by Subject|1
10880|NCT01858636|54337|P1|Overall Study|Lost to Follow-up|1
10881|NCT01858636|54337|P1|Overall Study|Death|1
10882|NCT01858636|54337|P1|Overall Study|Physician Decision|1
10883|NCT01858636|54337|P1|Overall Study|No Device Deployment Attempted|24
10884|NCT01858376|54342|P1|Overall Study|Dropped d/t lab work not fitting criter|4
10885|NCT01857622|54367|P3|Overall Study|Withdrawal by Subject|0
10886|NCT01857622|54368|P2|Overall Study|Withdrawal by Subject|0
10887|NCT01857622|54369|P1|Overall Study|Withdrawal by Subject|1
10888|NCT01857622|54367|P3|Overall Study|Protocol Violation|0
10889|NCT01857622|54368|P2|Overall Study|Protocol Violation|1
10890|NCT01857622|54369|P1|Overall Study|Protocol Violation|4
10891|NCT01857622|54367|P3|Overall Study|Physician Decision|0
10892|NCT01857622|54368|P2|Overall Study|Physician Decision|0
10893|NCT01857622|54369|P1|Overall Study|Physician Decision|1
10894|NCT01857622|54367|P3|Overall Study|Adverse Event|2
10895|NCT01857622|54368|P2|Overall Study|Adverse Event|0
10896|NCT01857622|54369|P1|Overall Study|Adverse Event|5
10897|NCT01857583|54381|P4|Overall Study|Withdrawal by Subject|2
10898|NCT01857583|54382|P3|Overall Study|Withdrawal by Subject|1
10899|NCT01857583|54383|P2|Overall Study|Withdrawal by Subject|0
10900|NCT01857583|54384|P1|Overall Study|Withdrawal by Subject|1
10901|NCT01857583|54381|P4|Overall Study|Physician Decision|1
10902|NCT01857583|54382|P3|Overall Study|Physician Decision|0
10903|NCT01857583|54383|P2|Overall Study|Physician Decision|0
10904|NCT01857583|54384|P1|Overall Study|Physician Decision|0
10905|NCT01857583|54381|P4|Overall Study|Death|0
10906|NCT01857583|54382|P3|Overall Study|Death|1
10907|NCT01857583|54383|P2|Overall Study|Death|1
10908|NCT01857583|54384|P1|Overall Study|Death|0
10909|NCT01857583|54381|P4|Overall Study|Adverse Event|1
10910|NCT01857583|54382|P3|Overall Study|Adverse Event|1
10911|NCT01857583|54383|P2|Overall Study|Adverse Event|0
10912|NCT01857583|54384|P1|Overall Study|Adverse Event|0
10913|NCT01857531|54394|P1|Overall Study|Withdrawal by Subject|4
10914|NCT01857323|54412|P1|Overall Study|Did not complete 180 doses|48
10915|NCT01857323|54412|P1|Overall Study|Not specified|4
10916|NCT01857323|54412|P1|Overall Study|Lost to Follow-up|1
10917|NCT01857323|54412|P1|Overall Study|Protocol Violation|6
10918|NCT01857323|54412|P1|Overall Study|Non-compliance|1
10919|NCT01857323|54412|P1|Overall Study|Withdrawal by Subject|3
10920|NCT01857323|54412|P1|Overall Study|Adverse Event|1
10921|NCT01857206|54461|P2|Overall Study|Withdrawal by Subject|0
10922|NCT01857206|54462|P1|Overall Study|Withdrawal by Subject|1
10923|NCT01857206|54461|P2|Overall Study|Unclassified|3
10924|NCT01857206|54462|P1|Overall Study|Unclassified|3
10925|NCT01857206|54461|P2|Overall Study|Lost to Follow-up|6
10926|NCT01857206|54462|P1|Overall Study|Lost to Follow-up|9
10927|NCT01857206|54461|P2|Overall Study|ADMINISTRATIVE REASON|1
10928|NCT01857206|54462|P1|Overall Study|ADMINISTRATIVE REASON|0
10929|NCT01857063|54482|P2|Period 2 (7 Days)|Withdrawal by Subject|0
10930|NCT01857063|54483|P1|Period 2 (7 Days)|Withdrawal by Subject|1
10931|NCT01857063|54482|P2|Period 2 (7 Days)|Physician Decision|1
10932|NCT01857063|54483|P1|Period 2 (7 Days)|Physician Decision|1
10933|NCT01857063|54482|P2|Period 2 (7 Days)|Adverse Event|1
10934|NCT01857063|54483|P1|Period 2 (7 Days)|Adverse Event|2
10935|NCT01857063|54482|P2|Period 1 (7 Days)|Withdrawal by Subject|3
10936|NCT01857063|54483|P1|Period 1 (7 Days)|Withdrawal by Subject|1
10937|NCT01857063|54482|P2|Period 1 (7 Days)|Physician Decision|0
10938|NCT01857063|54483|P1|Period 1 (7 Days)|Physician Decision|1
10939|NCT01857063|54482|P2|Period 1 (7 Days)|Adverse Event|1
10940|NCT01857063|54483|P1|Period 1 (7 Days)|Adverse Event|0
10941|NCT01856686|54528|P2|Overall Study|Lost to Follow-up|11
10942|NCT01856686|54529|P1|Overall Study|Lost to Follow-up|5
10943|NCT01856673|54572|P3|Overall Study|Protocol Violation|1
10944|NCT01856673|54573|P2|Overall Study|Protocol Violation|0
10945|NCT01856673|54574|P1|Overall Study|Protocol Violation|1
10946|NCT01856673|54572|P3|Overall Study|Death|0
10947|NCT01856673|54573|P2|Overall Study|Death|1
10948|NCT01856673|54574|P1|Overall Study|Death|2
10949|NCT01856673|54572|P3|Overall Study|Paperwork errors|0
10950|NCT01856673|54573|P2|Overall Study|Paperwork errors|0
10951|NCT01856673|54574|P1|Overall Study|Paperwork errors|4
10952|NCT01856673|54572|P3|Overall Study|Psychologist decision|0
10953|NCT01856673|54573|P2|Overall Study|Psychologist decision|0
10954|NCT01856673|54574|P1|Overall Study|Psychologist decision|3
10955|NCT01856673|54572|P3|Overall Study|Unknown reasons|0
10956|NCT01856673|54573|P2|Overall Study|Unknown reasons|0
10957|NCT01856673|54574|P1|Overall Study|Unknown reasons|20
10958|NCT01856673|54572|P3|Overall Study|Lost to Follow-up|0
10959|NCT01856673|54573|P2|Overall Study|Lost to Follow-up|34
10960|NCT01856673|54574|P1|Overall Study|Lost to Follow-up|22
10961|NCT01856673|54572|P3|Overall Study|Withdrawal by Subject|33
10962|NCT01856673|54573|P2|Overall Study|Withdrawal by Subject|50
10963|NCT01856673|54574|P1|Overall Study|Withdrawal by Subject|46
10964|NCT01856322|54607|P3|Overall Study|off study due to lack of accrual|3
10965|NCT01856322|54608|P2|Overall Study|off study due to lack of accrual|0
10966|NCT01856322|54609|P1|Overall Study|off study due to lack of accrual|0
10967|NCT01855958|54671|P2|Overall Study|Withdrawal by Subject|0
10968|NCT01855958|54672|P1|Overall Study|Withdrawal by Subject|1
10969|NCT01855945|54702|P12|Overall Study|Withdrawal by Subject|1
10970|NCT01855945|54703|P11|Overall Study|Withdrawal by Subject|4
10971|NCT01855945|54704|P10|Overall Study|Withdrawal by Subject|2
10972|NCT01855945|54705|P9|Overall Study|Withdrawal by Subject|0
10973|NCT01855945|54706|P8|Overall Study|Withdrawal by Subject|0
10974|NCT01855945|54707|P7|Overall Study|Withdrawal by Subject|1
10975|NCT01855945|54708|P6|Overall Study|Withdrawal by Subject|0
10976|NCT01855945|54709|P5|Overall Study|Withdrawal by Subject|1
10977|NCT01855945|54710|P4|Overall Study|Withdrawal by Subject|1
10978|NCT01855945|54711|P3|Overall Study|Withdrawal by Subject|4
10979|NCT01855945|54712|P2|Overall Study|Withdrawal by Subject|0
10980|NCT01855945|54713|P1|Overall Study|Withdrawal by Subject|4
10981|NCT01855945|54702|P12|Overall Study|Other - Unclassified|0
10982|NCT01855945|54703|P11|Overall Study|Other - Unclassified|1
10983|NCT01855945|54704|P10|Overall Study|Other - Unclassified|0
10984|NCT01855945|54705|P9|Overall Study|Other - Unclassified|0
10985|NCT01855945|54706|P8|Overall Study|Other - Unclassified|1
10986|NCT01855945|54707|P7|Overall Study|Other - Unclassified|2
10987|NCT01855945|54708|P6|Overall Study|Other - Unclassified|0
10988|NCT01855945|54709|P5|Overall Study|Other - Unclassified|0
10989|NCT01855945|54710|P4|Overall Study|Other - Unclassified|0
10990|NCT01855945|54711|P3|Overall Study|Other - Unclassified|1
10991|NCT01855945|54712|P2|Overall Study|Other - Unclassified|1
10992|NCT01855945|54713|P1|Overall Study|Other - Unclassified|1
10993|NCT01855945|54702|P12|Overall Study|Lost to Follow-up|2
10994|NCT01855945|54703|P11|Overall Study|Lost to Follow-up|0
10995|NCT01855945|54704|P10|Overall Study|Lost to Follow-up|0
10996|NCT01855945|54705|P9|Overall Study|Lost to Follow-up|2
10997|NCT01855945|54706|P8|Overall Study|Lost to Follow-up|7
10998|NCT01855945|54707|P7|Overall Study|Lost to Follow-up|4
10999|NCT01855945|54708|P6|Overall Study|Lost to Follow-up|3
11000|NCT01855945|54709|P5|Overall Study|Lost to Follow-up|0
11001|NCT01855945|54710|P4|Overall Study|Lost to Follow-up|3
11002|NCT01855945|54711|P3|Overall Study|Lost to Follow-up|7
11003|NCT01855945|54712|P2|Overall Study|Lost to Follow-up|10
11004|NCT01855945|54713|P1|Overall Study|Lost to Follow-up|11
11005|NCT01855945|54702|P12|Overall Study|Death|0
11006|NCT01855945|54703|P11|Overall Study|Death|0
11007|NCT01855945|54704|P10|Overall Study|Death|0
11008|NCT01855945|54705|P9|Overall Study|Death|0
11009|NCT01855945|54706|P8|Overall Study|Death|0
11010|NCT01855945|54707|P7|Overall Study|Death|2
11011|NCT01855945|54708|P6|Overall Study|Death|0
11012|NCT01855945|54709|P5|Overall Study|Death|0
11013|NCT01855945|54710|P4|Overall Study|Death|0
11014|NCT01855945|54711|P3|Overall Study|Death|0
11015|NCT01855945|54712|P2|Overall Study|Death|0
11016|NCT01855945|54713|P1|Overall Study|Death|0
11017|NCT01855945|54702|P12|Overall Study|Adverse Event|0
11018|NCT01855945|54703|P11|Overall Study|Adverse Event|0
11019|NCT01855945|54704|P10|Overall Study|Adverse Event|0
11020|NCT01855945|54705|P9|Overall Study|Adverse Event|0
11021|NCT01855945|54706|P8|Overall Study|Adverse Event|0
11022|NCT01855945|54707|P7|Overall Study|Adverse Event|1
11023|NCT01855945|54708|P6|Overall Study|Adverse Event|0
11024|NCT01855945|54709|P5|Overall Study|Adverse Event|0
11025|NCT01855945|54710|P4|Overall Study|Adverse Event|0
11026|NCT01855945|54711|P3|Overall Study|Adverse Event|0
11027|NCT01855945|54712|P2|Overall Study|Adverse Event|0
11028|NCT01855945|54713|P1|Overall Study|Adverse Event|0
11029|NCT01855919|54849|P2|Overall Study|Protocol Violation|4
11030|NCT01855919|54850|P1|Overall Study|Protocol Violation|1
11031|NCT01855919|54849|P2|Overall Study|Entry Criteria Not Met|1
11032|NCT01855919|54850|P1|Overall Study|Entry Criteria Not Met|1
11033|NCT01855919|54849|P2|Overall Study|Withdrawal by Subject|10
11034|NCT01855919|54850|P1|Overall Study|Withdrawal by Subject|4
11035|NCT01855919|54849|P2|Overall Study|Lack of Efficacy|3
11036|NCT01855919|54850|P1|Overall Study|Lack of Efficacy|1
11037|NCT01855919|54849|P2|Overall Study|Adverse Event|8
11038|NCT01855919|54850|P1|Overall Study|Adverse Event|16
11039|NCT01855074|54882|P1|Overall Study|Started but not treated|1
11040|NCT01855074|54882|P1|Overall Study|Withdrawal by Subject|8
11041|NCT01855074|54882|P1|Overall Study|Lost to Follow-up|4
11042|NCT01855074|54882|P1|Overall Study|Adverse Event|1
11043|NCT01854944|54894|P3|Overall Study|Withdrawal by Subject|1
11044|NCT01854944|54895|P2|Overall Study|Withdrawal by Subject|0
11045|NCT01854944|54896|P1|Overall Study|Withdrawal by Subject|0
11046|NCT01854697|54955|P5|Overall Study|Not Specified|0
11047|NCT01854697|54956|P4|Overall Study|Not Specified|0
11048|NCT01854697|54957|P3|Overall Study|Not Specified|1
11049|NCT01854697|54958|P2|Overall Study|Not Specified|1
11050|NCT01854697|54959|P1|Overall Study|Not Specified|0
11051|NCT01854697|54955|P5|Overall Study|Withdrew Consent|0
11052|NCT01854697|54956|P4|Overall Study|Withdrew Consent|1
11053|NCT01854697|54957|P3|Overall Study|Withdrew Consent|0
11054|NCT01854697|54958|P2|Overall Study|Withdrew Consent|1
11055|NCT01854697|54959|P1|Overall Study|Withdrew Consent|0
11056|NCT01854697|54955|P5|Overall Study|To enter another AbbVie study|1
11057|NCT01854697|54956|P4|Overall Study|To enter another AbbVie study|0
11058|NCT01854697|54957|P3|Overall Study|To enter another AbbVie study|0
11059|NCT01854697|54958|P2|Overall Study|To enter another AbbVie study|0
11060|NCT01854697|54959|P1|Overall Study|To enter another AbbVie study|1
11061|NCT01854697|54955|P5|Overall Study|Lost to Follow-up|0
11062|NCT01854697|54956|P4|Overall Study|Lost to Follow-up|2
11063|NCT01854697|54957|P3|Overall Study|Lost to Follow-up|1
11064|NCT01854697|54958|P2|Overall Study|Lost to Follow-up|1
11065|NCT01854697|54959|P1|Overall Study|Lost to Follow-up|4
11066|NCT01854697|54955|P5|Overall Study|Adverse Event|1
11067|NCT01854697|54956|P4|Overall Study|Adverse Event|0
11068|NCT01854697|54957|P3|Overall Study|Adverse Event|0
11069|NCT01854697|54958|P2|Overall Study|Adverse Event|0
11070|NCT01854697|54959|P1|Overall Study|Adverse Event|1
11071|NCT01854528|55043|P2|Overall Study|Virologic Failure|9
11072|NCT01854528|55044|P1|Overall Study|Virologic Failure|0
11073|NCT01854528|55043|P2|Overall Study|Withdrawal by Subject|2
11074|NCT01854528|55044|P1|Overall Study|Withdrawal by Subject|0
11075|NCT01854528|55043|P2|Overall Study|Adverse Event|4
11076|NCT01854528|55044|P1|Overall Study|Adverse Event|0
11077|NCT01853982|55089|P2|Overall Study|Lost to Follow-up|1
11078|NCT01853982|55090|P1|Overall Study|Lost to Follow-up|0
11079|NCT01853982|55089|P2|Overall Study|Death|0
11080|NCT01853982|55090|P1|Overall Study|Death|1
11081|NCT01853982|55089|P2|Overall Study|Withdrawal by Subject|0
11082|NCT01853982|55090|P1|Overall Study|Withdrawal by Subject|1
11083|NCT01853839|55096|P1|Overall Study|Lost to follow-up or no valid BP measure|336
11084|NCT01853839|55096|P1|Overall Study|End of treatment visit too early|33
11085|NCT01853839|55096|P1|Overall Study|Not meet ITT population definition|58
11086|NCT01853839|55096|P1|Overall Study|Violated inclusion criteria|2
11087|NCT01853696|55118|P2|Overall Study|Lost to Follow-up|4
11088|NCT01853696|55119|P1|Overall Study|Lost to Follow-up|5
11089|NCT01853696|55118|P2|Overall Study|Withdrawal by Subject|1
11090|NCT01853696|55119|P1|Overall Study|Withdrawal by Subject|1
11091|NCT01853475|55155|P3|Overall Study|Withdrawal by Subject|0
11092|NCT01853475|55156|P2|Overall Study|Withdrawal by Subject|1
11093|NCT01853475|55157|P1|Overall Study|Withdrawal by Subject|0
11094|NCT01853397|55178|P4|Overall Study|Subject Noncompliance|1
11095|NCT01853397|55179|P3|Overall Study|Subject Noncompliance|0
11096|NCT01853397|55180|P2|Overall Study|Subject Noncompliance|0
11097|NCT01853397|55181|P1|Overall Study|Subject Noncompliance|0
11098|NCT01853397|55178|P4|Overall Study|Withdrawal by Subject|1
11099|NCT01853397|55179|P3|Overall Study|Withdrawal by Subject|0
11100|NCT01853397|55180|P2|Overall Study|Withdrawal by Subject|0
11101|NCT01853397|55181|P1|Overall Study|Withdrawal by Subject|0
11102|NCT01853384|55209|P2|Completed Follow up Visit 2|Lost to Follow-up|1
11103|NCT01853384|55210|P1|Completed Follow up Visit 2|Lost to Follow-up|0
11104|NCT01853384|55209|P2|Completed Follow up Visit 2|Death|0
11105|NCT01853384|55210|P1|Completed Follow up Visit 2|Death|1
11106|NCT01853384|55209|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
11107|NCT01853384|55210|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
11108|NCT01853384|55209|P2|Completed Follow up Visit 2|Adverse Event|0
11109|NCT01853384|55210|P1|Completed Follow up Visit 2|Adverse Event|1
11110|NCT01853384|55209|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
11111|NCT01853384|55210|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
11112|NCT01853384|55209|P2|Completed Follow up Visit 1|Early Termination|9
11113|NCT01853384|55210|P1|Completed Follow up Visit 1|Early Termination|13
11114|NCT01853384|55209|P2|Randomized|Other|3
11115|NCT01853384|55210|P1|Randomized|Other|3
11116|NCT01853384|55209|P2|Randomized|Sponsor Decision|34
11117|NCT01853384|55210|P1|Randomized|Sponsor Decision|47
11118|NCT01853384|55209|P2|Randomized|Withdrawal by Subject|3
11119|NCT01853384|55210|P1|Randomized|Withdrawal by Subject|5
11120|NCT01853384|55209|P2|Randomized|Lost to Follow-up|1
11121|NCT01853384|55210|P1|Randomized|Lost to Follow-up|1
11122|NCT01853384|55209|P2|Randomized|Death|2
11123|NCT01853384|55210|P1|Randomized|Death|1
11124|NCT01853384|55209|P2|Randomized|Adverse Event|3
11125|NCT01853384|55210|P1|Randomized|Adverse Event|5
11126|NCT01853254|55239|P1|Overall Study|Administrative/Other|16
11127|NCT01853254|55239|P1|Overall Study|Withdrawal of Consent|16
11128|NCT01853254|55239|P1|Overall Study|Other Protocol Violation|1
11129|NCT01853254|55239|P1|Overall Study|Refusal of Treatment|1
11130|NCT01853254|55239|P1|Overall Study|Insufficient Therapeutic Response|22
11131|NCT01853254|55239|P1|Overall Study|Failure to Return|43
11132|NCT01853254|55239|P1|Overall Study|Death|1
11133|NCT01853254|55239|P1|Overall Study|Adverse Event/Intercurrent Illness|3
11134|NCT01853254|55239|P1|Overall Study|Abnormal Laboratory Test|1
11135|NCT01853176|55256|P2|Overall Study|Study terminated|0
11136|NCT01853176|55257|P1|Overall Study|Study terminated|4
11137|NCT01853072|55276|P2|Overall Study|Reason not specified|6
11138|NCT01853072|55277|P1|Overall Study|Reason not specified|9
11139|NCT01853072|55276|P2|Overall Study|Withdrawal by Subject|2
11140|NCT01853072|55277|P1|Overall Study|Withdrawal by Subject|1
11141|NCT01853072|55276|P2|Overall Study|Physician Decision|1
11142|NCT01853072|55277|P1|Overall Study|Physician Decision|1
11143|NCT01853072|55276|P2|Overall Study|Non-compliance with study drug|1
11144|NCT01853072|55277|P1|Overall Study|Non-compliance with study drug|0
11145|NCT01853072|55276|P2|Overall Study|Lost to Follow-up|3
11146|NCT01853072|55277|P1|Overall Study|Lost to Follow-up|0
11147|NCT01853072|55276|P2|Overall Study|Death|4
11148|NCT01853072|55277|P1|Overall Study|Death|1
11149|NCT01853072|55276|P2|Overall Study|Adverse Event|3
11150|NCT01853072|55277|P1|Overall Study|Adverse Event|0
11151|NCT01853072|55276|P2|Overall Study|Adverse event prior to treatment|1
11152|NCT01853072|55277|P1|Overall Study|Adverse event prior to treatment|0
11153|NCT01852825|55311|P3|Overall Study|Withdrawal by Subject|0
11154|NCT01852825|55312|P2|Overall Study|Withdrawal by Subject|0
11155|NCT01852825|55313|P1|Overall Study|Withdrawal by Subject|2
11156|NCT01852812|55339|P3|Overall Study|Non-compliance With Study Drug|0
11157|NCT01852812|55340|P2|Overall Study|Non-compliance With Study Drug|1
11158|NCT01852812|55341|P1|Overall Study|Non-compliance With Study Drug|0
11159|NCT01852812|55339|P3|Overall Study|Adverse Event|1
11160|NCT01852812|55340|P2|Overall Study|Adverse Event|0
11161|NCT01852812|55341|P1|Overall Study|Adverse Event|0
11162|NCT01852591|55370|P1|Overall Study|Not Evaluable at Time of Analysis|1
11163|NCT01852591|55370|P1|Overall Study|Withdrawal by Subject|2
11164|NCT01852214|55384|P2|Washout Period|Withdrawal by Subject|1
11165|NCT01852214|55385|P1|Washout Period|Withdrawal by Subject|0
11166|NCT01852214|55384|P2|Period 1|Withdrawal by Subject|1
11167|NCT01852214|55385|P1|Period 1|Withdrawal by Subject|0
11168|NCT01852214|55384|P2|Period 1|Adverse Event|2
11169|NCT01852214|55385|P1|Period 1|Adverse Event|1
11170|NCT01852162|55412|P2|Overall Study|Withdrawal by Subject|1
11171|NCT01852162|55413|P1|Overall Study|Withdrawal by Subject|3
11172|NCT01852162|55412|P2|Overall Study|Adverse Event|0
11173|NCT01852162|55413|P1|Overall Study|Adverse Event|1
11174|NCT01851863|55465|P4|Overall Study|Lost to Follow-up|3
11175|NCT01851863|55466|P3|Overall Study|Lost to Follow-up|2
11176|NCT01851863|55467|P2|Overall Study|Lost to Follow-up|4
11177|NCT01851863|55468|P1|Overall Study|Lost to Follow-up|3
11178|NCT01851863|55465|P4|Overall Study|Did not receive study medication|0
11179|NCT01851863|55466|P3|Overall Study|Did not receive study medication|3
11180|NCT01851863|55467|P2|Overall Study|Did not receive study medication|5
11181|NCT01851863|55468|P1|Overall Study|Did not receive study medication|2
11182|NCT01851590|55519|P3|Overall Study|Lack of Efficacy|0
11183|NCT01851590|55520|P2|Overall Study|Lack of Efficacy|1
11184|NCT01851590|55521|P1|Overall Study|Lack of Efficacy|0
11185|NCT01851590|55519|P3|Overall Study|Adverse Event|2
11186|NCT01851590|55520|P2|Overall Study|Adverse Event|0
11187|NCT01851590|55521|P1|Overall Study|Adverse Event|0
11188|NCT01851590|55519|P3|Overall Study|Withdrawal by Subject|1
11189|NCT01851590|55520|P2|Overall Study|Withdrawal by Subject|0
11190|NCT01851590|55521|P1|Overall Study|Withdrawal by Subject|0
11191|NCT01851330|55544|P3|Overall Study|Investigator’s Discretion|1
11192|NCT01851330|55545|P2|Overall Study|Investigator’s Discretion|0
11193|NCT01851330|55546|P1|Overall Study|Investigator’s Discretion|0
11194|NCT01851330|55544|P3|Overall Study|Withdrew Consent|0
11195|NCT01851330|55545|P2|Overall Study|Withdrew Consent|1
11196|NCT01851330|55546|P1|Overall Study|Withdrew Consent|2
11197|NCT01851330|55544|P3|Overall Study|Lost to Follow-up|9
11198|NCT01851330|55545|P2|Overall Study|Lost to Follow-up|6
11199|NCT01851330|55546|P1|Overall Study|Lost to Follow-up|1
11200|NCT01851330|55544|P3|Overall Study|Lack of Efficacy|2
11201|NCT01851330|55545|P2|Overall Study|Lack of Efficacy|9
11202|NCT01851330|55546|P1|Overall Study|Lack of Efficacy|10
11203|NCT01849562|55584|P3|Overall Study|Non-compliance with Study Drug|0
11204|NCT01849562|55585|P2|Overall Study|Non-compliance with Study Drug|0
11205|NCT01849562|55586|P1|Overall Study|Non-compliance with Study Drug|1
11206|NCT01849562|55584|P3|Overall Study|Lost to Follow-up|0
11207|NCT01849562|55585|P2|Overall Study|Lost to Follow-up|0
11208|NCT01849562|55586|P1|Overall Study|Lost to Follow-up|1
11209|NCT01850589|55599|P2|Overall Study|Withdrawal by Subject|0
11210|NCT01850589|55600|P1|Overall Study|Withdrawal by Subject|8
11211|NCT01849848|55663|P1|Overall Study|Progression of the primary disease|3
11212|NCT01849848|55663|P1|Overall Study|Physician Decision|1
11213|NCT01849497|55763|P2|Overall Study|Lost to Follow-up|1
11214|NCT01849497|55764|P1|Overall Study|Lost to Follow-up|0
11215|NCT01849497|55763|P2|Overall Study|Sponsor Decision|1
11216|NCT01849497|55764|P1|Overall Study|Sponsor Decision|0
11217|NCT01849497|55763|P2|Overall Study|Withdrawal by Subject|2
11218|NCT01849497|55764|P1|Overall Study|Withdrawal by Subject|1
11219|NCT01849289|55801|P2|Overall Study|Unclassified|18
11220|NCT01849289|55802|P1|Overall Study|Unclassified|25
11221|NCT01849289|55801|P2|Overall Study|Withdrawal criteria|0
11222|NCT01849289|55802|P1|Overall Study|Withdrawal criteria|1
11223|NCT01849289|55801|P2|Overall Study|Protocol Violation|3
11224|NCT01849289|55802|P1|Overall Study|Protocol Violation|3
11225|NCT01849289|55801|P2|Overall Study|Adverse Event|3
11226|NCT01849289|55802|P1|Overall Study|Adverse Event|3
11227|NCT01848990|55836|P3|Overall Study|Death|0
11228|NCT01848990|55837|P2|Overall Study|Death|0
11229|NCT01848990|55838|P1|Overall Study|Death|1
11230|NCT01848990|55836|P3|Overall Study|Non Compliance|0
11231|NCT01848990|55837|P2|Overall Study|Non Compliance|0
11232|NCT01848990|55838|P1|Overall Study|Non Compliance|1
11233|NCT01848990|55836|P3|Overall Study|Physician Decision|0
11234|NCT01848990|55837|P2|Overall Study|Physician Decision|0
11235|NCT01848990|55838|P1|Overall Study|Physician Decision|1
11236|NCT01848990|55836|P3|Overall Study|Withdrawal by Subject|9
11237|NCT01848990|55837|P2|Overall Study|Withdrawal by Subject|6
11238|NCT01848990|55838|P1|Overall Study|Withdrawal by Subject|20
11239|NCT01848990|55836|P3|Overall Study|Protocol Violation|0
11240|NCT01848990|55837|P2|Overall Study|Protocol Violation|1
11241|NCT01848990|55838|P1|Overall Study|Protocol Violation|0
11242|NCT01848990|55836|P3|Overall Study|Lost to Follow-up|2
11243|NCT01848990|55837|P2|Overall Study|Lost to Follow-up|1
11244|NCT01848990|55838|P1|Overall Study|Lost to Follow-up|6
11245|NCT01848990|55836|P3|Overall Study|Adverse Event|0
11246|NCT01848990|55837|P2|Overall Study|Adverse Event|1
11247|NCT01848990|55838|P1|Overall Study|Adverse Event|4
11248|NCT01848938|55864|P2|Overall Study|Lost to Follow-up|1
11249|NCT01848938|55865|P1|Overall Study|Lost to Follow-up|1
11250|NCT01848756|55909|P1|Overall Study|Enrolled in Error|1
11251|NCT01848756|55909|P1|Overall Study|Withdrawal by Subject|1
11252|NCT01848756|55909|P1|Overall Study|Adverse Event|1
11253|NCT01848288|55923|P1|Overall Study|Withdrawal by Subject|1
11254|NCT01848288|55923|P1|Overall Study|Protocol Violation|1
11255|NCT01848288|55923|P1|Overall Study|Death|1
11256|NCT01848210|55934|P2|Overall Study|Administrative|0
11257|NCT01848210|55935|P1|Overall Study|Administrative|1
11258|NCT01848210|55934|P2|Overall Study|Chronic Venous Insufficiency Course|2
11259|NCT01848210|55935|P1|Overall Study|Chronic Venous Insufficiency Course|1
11260|NCT01848210|55934|P2|Overall Study|Hepatic Function Alteration|0
11261|NCT01848210|55935|P1|Overall Study|Hepatic Function Alteration|4
11262|NCT01848210|55934|P2|Overall Study|Hypesensitivity|0
11263|NCT01848210|55935|P1|Overall Study|Hypesensitivity|1
11264|NCT01848210|55934|P2|Overall Study|Discontinuation Criterion|7
11265|NCT01848210|55935|P1|Overall Study|Discontinuation Criterion|5
11266|NCT01848210|55934|P2|Overall Study|Adverse Event|9
11267|NCT01848210|55935|P1|Overall Study|Adverse Event|7
11268|NCT01848210|55934|P2|Overall Study|Impedition Condition|9
11269|NCT01848210|55935|P1|Overall Study|Impedition Condition|5
11270|NCT01848210|55934|P2|Overall Study|Use of Forbidden Drugs|10
11271|NCT01848210|55935|P1|Overall Study|Use of Forbidden Drugs|9
11272|NCT01848210|55934|P2|Overall Study|Protocol Violation|5
11273|NCT01848210|55935|P1|Overall Study|Protocol Violation|3
11274|NCT01848210|55934|P2|Overall Study|Lost to Follow-up|12
11275|NCT01848210|55935|P1|Overall Study|Lost to Follow-up|24
11276|NCT01848210|55934|P2|Overall Study|Informed Consent Form Withdrawal|24
11277|NCT01848210|55935|P1|Overall Study|Informed Consent Form Withdrawal|28
11278|NCT01847443|56015|P4|Washout Period Before Study Period 4|Positive alcohol test|0
11279|NCT01847443|56016|P3|Washout Period Before Study Period 4|Positive alcohol test|0
11280|NCT01847443|56017|P2|Washout Period Before Study Period 4|Positive alcohol test|0
11281|NCT01847443|56018|P1|Washout Period Before Study Period 4|Positive alcohol test|1
11282|NCT01847443|56015|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
11283|NCT01847443|56016|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
11284|NCT01847443|56017|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
11285|NCT01847443|56018|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
11286|NCT01847443|56015|P4|Washout Period Before Study Period 3|Other reason|0
11287|NCT01847443|56016|P3|Washout Period Before Study Period 3|Other reason|0
11288|NCT01847443|56017|P2|Washout Period Before Study Period 3|Other reason|0
11289|NCT01847443|56018|P1|Washout Period Before Study Period 3|Other reason|1
11290|NCT01847443|56015|P4|Washout Period Before Study Period 2|Other reason|0
11291|NCT01847443|56016|P3|Washout Period Before Study Period 2|Other reason|0
11292|NCT01847443|56017|P2|Washout Period Before Study Period 2|Other reason|0
11293|NCT01847443|56018|P1|Washout Period Before Study Period 2|Other reason|1
11294|NCT01847443|56015|P4|Washout Period Before Study Period 2|Adverse Event|0
11295|NCT01847443|56016|P3|Washout Period Before Study Period 2|Adverse Event|0
11296|NCT01847443|56017|P2|Washout Period Before Study Period 2|Adverse Event|1
11297|NCT01847443|56018|P1|Washout Period Before Study Period 2|Adverse Event|1
11298|NCT01847443|56015|P4|Study Period 1|Withdrawal by Subject|0
11299|NCT01847443|56016|P3|Study Period 1|Withdrawal by Subject|0
11300|NCT01847443|56017|P2|Study Period 1|Withdrawal by Subject|1
11301|NCT01847443|56018|P1|Study Period 1|Withdrawal by Subject|0
11302|NCT01846741|56075|P1|Baseline Visit|Subject did not meet entry criteria|2
11303|NCT01846416|56200|P3|Overall Study|Lost to Follow-up|1
11304|NCT01846416|56201|P2|Overall Study|Lost to Follow-up|2
11305|NCT01846416|56202|P1|Overall Study|Lost to Follow-up|0
11306|NCT01846416|56200|P3|Overall Study|Ongoing as of 7 January 2015|3
11307|NCT01846416|56201|P2|Overall Study|Ongoing as of 7 January 2015|41
11308|NCT01846416|56202|P1|Overall Study|Ongoing as of 7 January 2015|21
11309|NCT01846416|56200|P3|Overall Study|Unspecified|0
11310|NCT01846416|56201|P2|Overall Study|Unspecified|0
11311|NCT01846416|56202|P1|Overall Study|Unspecified|1
11312|NCT01846416|56200|P3|Overall Study|Withdrawal by Subject|0
11313|NCT01846416|56201|P2|Overall Study|Withdrawal by Subject|7
11314|NCT01846416|56202|P1|Overall Study|Withdrawal by Subject|1
11315|NCT01846416|56200|P3|Overall Study|Death|9
11316|NCT01846416|56201|P2|Overall Study|Death|43
11317|NCT01846416|56202|P1|Overall Study|Death|8
11318|NCT01846299|56247|P2|Overall Study|Adverse Event|0
11319|NCT01846299|56248|P1|Overall Study|Adverse Event|2
11320|NCT01846299|56247|P2|Overall Study|Withdrawal by Subject|6
11321|NCT01846299|56248|P1|Overall Study|Withdrawal by Subject|1
11322|NCT01846299|56247|P2|Overall Study|Lost to Follow-up|0
11323|NCT01846299|56248|P1|Overall Study|Lost to Follow-up|3
11324|NCT01846299|56247|P2|Overall Study|Death|2
11325|NCT01846299|56248|P1|Overall Study|Death|1
11326|NCT01846299|56247|P2|Overall Study|Protocol deviation|0
11327|NCT01846299|56248|P1|Overall Study|Protocol deviation|1
11328|NCT01846299|56247|P2|Overall Study|Physician Decision|2
11329|NCT01846299|56248|P1|Overall Study|Physician Decision|4
11330|NCT01846104|56284|P1|Overall Study|Withdrawal by Subject|1
11331|NCT01846039|56290|P1|Overall Study|Subject Withdrew Consent|1
11332|NCT01846039|56290|P1|Overall Study|Protocol Violation|1
11333|NCT01845077|56319|P6|Washout Period|Protocol Violation|0
11334|NCT01845077|56320|P5|Washout Period|Protocol Violation|1
11335|NCT01845077|56321|P4|Washout Period|Protocol Violation|1
11336|NCT01845077|56322|P3|Washout Period|Protocol Violation|0
11337|NCT01845077|56323|P2|Washout Period|Protocol Violation|0
11338|NCT01845077|56324|P1|Washout Period|Protocol Violation|0
11339|NCT01845077|56319|P6|Washout Period|elevated lab values (not clinic. sign.)|0
11340|NCT01845077|56320|P5|Washout Period|elevated lab values (not clinic. sign.)|0
11341|NCT01845077|56321|P4|Washout Period|elevated lab values (not clinic. sign.)|0
11342|NCT01845077|56322|P3|Washout Period|elevated lab values (not clinic. sign.)|1
11343|NCT01845077|56323|P2|Washout Period|elevated lab values (not clinic. sign.)|0
11344|NCT01845077|56324|P1|Washout Period|elevated lab values (not clinic. sign.)|0
11345|NCT01845077|56319|P6|Washout Period|Adverse Event|0
11346|NCT01845077|56320|P5|Washout Period|Adverse Event|0
11347|NCT01845077|56321|P4|Washout Period|Adverse Event|0
11348|NCT01845077|56322|P3|Washout Period|Adverse Event|0
11349|NCT01845077|56323|P2|Washout Period|Adverse Event|0
11350|NCT01845077|56324|P1|Washout Period|Adverse Event|1
11351|NCT01845077|56319|P6|Washout Period|Lost to Follow-up|1
11352|NCT01845077|56320|P5|Washout Period|Lost to Follow-up|0
11353|NCT01845077|56321|P4|Washout Period|Lost to Follow-up|1
11354|NCT01845077|56322|P3|Washout Period|Lost to Follow-up|0
11355|NCT01845077|56323|P2|Washout Period|Lost to Follow-up|1
11356|NCT01845077|56324|P1|Washout Period|Lost to Follow-up|0
11357|NCT01844895|56368|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
11358|NCT01844895|56368|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
11359|NCT01844895|56368|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
11360|NCT01844895|56368|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
11361|NCT01844895|56368|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
11362|NCT01844895|56368|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
11363|NCT01844895|56368|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
11364|NCT01844856|56386|P2|Overall Study|Randomized but was a Screen Failure|1
11365|NCT01844856|56387|P1|Overall Study|Randomized but was a Screen Failure|0
11366|NCT01844856|56386|P2|Overall Study|Inadvertently Not Scheduled|0
11367|NCT01844856|56387|P1|Overall Study|Inadvertently Not Scheduled|1
11368|NCT01844856|56386|P2|Overall Study|Enterococcus Resistant|1
11369|NCT01844856|56387|P1|Overall Study|Enterococcus Resistant|0
11370|NCT01844856|56386|P2|Overall Study|Noncompliance|3
11371|NCT01844856|56387|P1|Overall Study|Noncompliance|2
11372|NCT01844856|56386|P2|Overall Study|Withdrawal by Subject|2
11373|NCT01844856|56387|P1|Overall Study|Withdrawal by Subject|3
11374|NCT01844856|56386|P2|Overall Study|Adverse Event|6
11375|NCT01844856|56387|P1|Overall Study|Adverse Event|3
11376|NCT01844856|56386|P2|Overall Study|Lost to Follow-up|3
11377|NCT01844856|56387|P1|Overall Study|Lost to Follow-up|15
11378|NCT01844778|56400|P3|Overall Study|Adverse Event|2
11379|NCT01844778|56401|P2|Overall Study|Adverse Event|2
11380|NCT01844778|56402|P1|Overall Study|Adverse Event|0
11381|NCT01844778|56400|P3|Overall Study|Withdrawal by Subject|0
11382|NCT01844778|56401|P2|Overall Study|Withdrawal by Subject|0
11383|NCT01844778|56402|P1|Overall Study|Withdrawal by Subject|2
11384|NCT01844778|56400|P3|Overall Study|Protocol deviation|2
11385|NCT01844778|56401|P2|Overall Study|Protocol deviation|1
11386|NCT01844778|56402|P1|Overall Study|Protocol deviation|0
11387|NCT01844700|56428|P2|Overall Study|stopped taking meds|1
11388|NCT01844700|56429|P1|Overall Study|stopped taking meds|0
11389|NCT01844700|56428|P2|Overall Study|Withdrawal by Subject|0
11390|NCT01844700|56429|P1|Overall Study|Withdrawal by Subject|1
11391|NCT01844700|56428|P2|Overall Study|refused medication switch|0
11392|NCT01844700|56429|P1|Overall Study|refused medication switch|1
11393|NCT01844700|56428|P2|Overall Study|Lack of Efficacy|0
11394|NCT01844700|56429|P1|Overall Study|Lack of Efficacy|1
11395|NCT01844531|56445|P4|Overall Study|Withdrawal by Subject|0
11396|NCT01844531|56446|P3|Overall Study|Withdrawal by Subject|0
11397|NCT01844531|56447|P2|Overall Study|Withdrawal by Subject|1
11398|NCT01844531|56448|P1|Overall Study|Withdrawal by Subject|0
11399|NCT01844518|56478|P1|Long-Term Extension|Still in On-Going Study|149
11400|NCT01844518|56478|P1|Long-Term Extension|No Longer Met Study Criteria|1
11401|NCT01844518|56478|P1|Long-Term Extension|Adverse Event|1
11402|NCT01844518|56478|P1|Long-Term Extension|Lack of Efficacy|6
11403|NCT01844518|56478|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
11404|NCT01844518|56478|P1|Short-Term (ST) Period|Withdrawal of Consent|2
11405|NCT01844518|56478|P1|Short-Term (ST) Period|Lack of Efficacy|3
11406|NCT01844518|56478|P1|Short-Term (ST) Period|Adverse Event|3
11407|NCT01843972|56553|P10|Overall Study|Withdrawal by Subject|0
11408|NCT01843972|56554|P9|Overall Study|Withdrawal by Subject|0
11409|NCT01843972|56555|P8|Overall Study|Withdrawal by Subject|0
11410|NCT01843972|56556|P7|Overall Study|Withdrawal by Subject|0
11411|NCT01843972|56557|P6|Overall Study|Withdrawal by Subject|0
11412|NCT01843972|56558|P5|Overall Study|Withdrawal by Subject|1
11413|NCT01843972|56559|P4|Overall Study|Withdrawal by Subject|0
11414|NCT01843972|56560|P3|Overall Study|Withdrawal by Subject|0
11415|NCT01843972|56561|P2|Overall Study|Withdrawal by Subject|0
11416|NCT01843972|56562|P1|Overall Study|Withdrawal by Subject|0
11417|NCT01843933|56632|P2|Overall Study|Data lost|4
11418|NCT01843933|56633|P1|Overall Study|Data lost|6
11419|NCT01843777|56650|P2|Overall Study|Withdrawal by Subject|0
11420|NCT01843777|56651|P1|Overall Study|Withdrawal by Subject|1
11421|NCT01843673|56659|P1|Overall Study|Withdrawal by Subject|4
11422|NCT01843673|56659|P1|Overall Study|Lack of Efficacy|2
11423|NCT01843660|56671|P1|Overall Study|Unspecified|30
11424|NCT01843192|56696|P3|Overall Study|Intra-operative exclusions per protocol|2
11425|NCT01843192|56697|P2|Overall Study|Intra-operative exclusions per protocol|6
11426|NCT01843192|56698|P1|Overall Study|Intra-operative exclusions per protocol|2
11427|NCT01842607|56746|P1|Overall Study|Withdrawal by Subject|14
11428|NCT01842607|56746|P1|Overall Study|Physician Decision|9
11429|NCT01842607|56746|P1|Overall Study|Lost to Follow-up|3
11430|NCT01842607|56746|P1|Overall Study|Protocol defined stopping criteria|2
11431|NCT01842607|56746|P1|Overall Study|Protocol Violation|8
11432|NCT01842607|56746|P1|Overall Study|Lack of Efficacy|19
11433|NCT01842607|56746|P1|Overall Study|Adverse Event|11
11434|NCT01842438|56778|P2|T2: 6month Follow-up|Death|1
11435|NCT01842438|56779|P1|T2: 6month Follow-up|Death|0
11436|NCT01842438|56778|P2|T2: 6month Follow-up|Withdrawal by Subject|3
11437|NCT01842438|56779|P1|T2: 6month Follow-up|Withdrawal by Subject|4
11438|NCT01842438|56778|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
11439|NCT01842438|56779|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
11440|NCT01841970|56791|P1|Overall Study|Lost to Follow-up|8
11441|NCT01841970|56791|P1|Overall Study|Physician Decision|2
11442|NCT01841970|56791|P1|Overall Study|Withdrawal by Subject|1
11443|NCT01841697|56809|P2|Overall Study|Withdrawal by Subject|16
11444|NCT01841697|56810|P1|Overall Study|Withdrawal by Subject|16
11445|NCT01841697|56809|P2|Overall Study|Lost to Follow-up|1
11446|NCT01841697|56810|P1|Overall Study|Lost to Follow-up|4
11447|NCT01841697|56809|P2|Overall Study|Death|1
11448|NCT01841697|56810|P1|Overall Study|Death|0
11449|NCT01841593|56836|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
11450|NCT01841593|56837|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
11451|NCT01841593|56836|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
11452|NCT01841593|56837|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
11453|NCT01841567|56853|P1|Overall Study|Adverse Event|3
11454|NCT01840943|56881|P2|Overall Study|Lost to Follow-up|4
11455|NCT01840943|56882|P1|Overall Study|Lost to Follow-up|4
11456|NCT01840943|56881|P2|Overall Study|Physician Decision|2
11457|NCT01840943|56882|P1|Overall Study|Physician Decision|4
11458|NCT01840943|56881|P2|Overall Study|Withdrawal by Subject|6
11459|NCT01840943|56882|P1|Overall Study|Withdrawal by Subject|5
11460|NCT01840605|56918|P2|Overall Study|Physician Decision|1
11461|NCT01840605|56919|P1|Overall Study|Physician Decision|2
11462|NCT01840605|56918|P2|Overall Study|Adverse Event|1
11463|NCT01840605|56919|P1|Overall Study|Adverse Event|0
11464|NCT01840410|56927|P2|Overall Study|Adverse Event|1
11465|NCT01840410|56928|P1|Overall Study|Adverse Event|1
11466|NCT01840410|56927|P2|Overall Study|Withdrawal by Subject|1
11467|NCT01840410|56928|P1|Overall Study|Withdrawal by Subject|2
11468|NCT01840410|56927|P2|Overall Study|Lost to Follow-up|0
11469|NCT01840410|56928|P1|Overall Study|Lost to Follow-up|1
11470|NCT01840410|56927|P2|Overall Study|Protocol deviation|0
11471|NCT01840410|56928|P1|Overall Study|Protocol deviation|1
11472|NCT01840410|56927|P2|Overall Study|Pregnancy|0
11473|NCT01840410|56928|P1|Overall Study|Pregnancy|1
11474|NCT01840410|56927|P2|Overall Study|Physician Decision|2
11475|NCT01840410|56928|P1|Overall Study|Physician Decision|1
11476|NCT01839279|57007|P3|Overall Study|Classified as 'Other'|0
11477|NCT01839279|57008|P2|Overall Study|Classified as 'Other'|0
11478|NCT01839279|57009|P1|Overall Study|Classified as 'Other'|5
11479|NCT01839279|57007|P3|Overall Study|Withdrawal by Subject|1
11480|NCT01839279|57008|P2|Overall Study|Withdrawal by Subject|1
11481|NCT01839279|57009|P1|Overall Study|Withdrawal by Subject|4
11482|NCT01839279|57007|P3|Overall Study|Adverse Event|1
11483|NCT01839279|57008|P2|Overall Study|Adverse Event|1
11484|NCT01839279|57009|P1|Overall Study|Adverse Event|4
11485|NCT01838941|57032|P1|Overall Study|Withdrawal by Subject|1
11486|NCT01838941|57032|P1|Overall Study|Adverse Event|1
11487|NCT01838694|57039|P2|Overall Study|Adverse Event|1
11488|NCT01838694|57040|P1|Overall Study|Adverse Event|0
11489|NCT01838642|57049|P1|Overall Study|Died on study|1
11490|NCT01838616|57062|P2|Pick-up Arm|Technical problems|0
11491|NCT01838616|57063|P1|Pick-up Arm|Technical problems|1
11492|NCT01838616|57062|P2|Pick-up Arm|Withdrawal by Subject|0
11493|NCT01838616|57063|P1|Pick-up Arm|Withdrawal by Subject|1
11494|NCT01838616|57062|P2|Pick-up Arm|Adverse Event|0
11495|NCT01838616|57063|P1|Pick-up Arm|Adverse Event|9
11496|NCT01838616|57062|P2|Pick-up Arm|Lack of Efficacy|0
11497|NCT01838616|57063|P1|Pick-up Arm|Lack of Efficacy|4
11498|NCT01838616|57062|P2|Continuation Period|Technical problems|1
11499|NCT01838616|57063|P1|Continuation Period|Technical problems|0
11500|NCT01838616|57062|P2|Continuation Period|Withdrawal by Subject|4
11501|NCT01838616|57063|P1|Continuation Period|Withdrawal by Subject|0
11502|NCT01838616|57062|P2|Continuation Period|Lost to Follow-up|0
11503|NCT01838616|57063|P1|Continuation Period|Lost to Follow-up|1
11504|NCT01838616|57062|P2|Continuation Period|Protocol Violation|0
11505|NCT01838616|57063|P1|Continuation Period|Protocol Violation|2
11506|NCT01838616|57062|P2|Continuation Period|Adverse Event|4
11507|NCT01838616|57063|P1|Continuation Period|Adverse Event|8
11508|NCT01838616|57062|P2|Continuation Period|Lack of Efficacy|5
11509|NCT01838616|57063|P1|Continuation Period|Lack of Efficacy|3
11510|NCT01838616|57062|P2|Titration Period|Protocol Violation|1
11511|NCT01838616|57063|P1|Titration Period|Protocol Violation|0
11512|NCT01838616|57062|P2|Titration Period|Not specified|0
11513|NCT01838616|57063|P1|Titration Period|Not specified|1
11514|NCT01838616|57062|P2|Titration Period|Technical problems|0
11515|NCT01838616|57063|P1|Titration Period|Technical problems|1
11516|NCT01838616|57062|P2|Titration Period|Withdrawal by Subject|5
11517|NCT01838616|57063|P1|Titration Period|Withdrawal by Subject|5
11518|NCT01838616|57062|P2|Titration Period|Lack of Efficacy|12
11519|NCT01838616|57063|P1|Titration Period|Lack of Efficacy|5
11520|NCT01838616|57062|P2|Titration Period|Adverse Event|48
11521|NCT01838616|57063|P1|Titration Period|Adverse Event|18
11522|NCT01838590|57134|P2|Overall Study|Lost to Follow-up|1
11523|NCT01838590|57135|P1|Overall Study|Lost to Follow-up|0
11524|NCT01838590|57134|P2|Overall Study|Lack of Efficacy|4
11525|NCT01838590|57135|P1|Overall Study|Lack of Efficacy|12
11526|NCT01838499|57159|P2|Overall Study|Withdrawal by Subject|9
11527|NCT01838499|57160|P1|Overall Study|Withdrawal by Subject|19
11528|NCT01838499|57159|P2|Overall Study|Adverse Event|1
11529|NCT01838499|57160|P1|Overall Study|Adverse Event|2
11530|NCT01838499|57159|P2|Overall Study|Lack of Efficacy|2
11531|NCT01838499|57160|P1|Overall Study|Lack of Efficacy|1
11532|NCT01838499|57159|P2|Overall Study|Lost to Follow-up|4
11533|NCT01838499|57160|P1|Overall Study|Lost to Follow-up|2
11534|NCT01838499|57159|P2|Overall Study|Protocol Violation|1
11535|NCT01838499|57160|P1|Overall Study|Protocol Violation|0
11536|NCT01838213|57172|P2|Overall Study|Ineligible|191
11537|NCT01838213|57173|P1|Overall Study|Ineligible|166
11538|NCT01838044|57181|P2|Overall Study|Lost to Follow-up|2
11539|NCT01838044|57182|P1|Overall Study|Lost to Follow-up|0
11540|NCT01838044|57181|P2|Overall Study|Medication error without associated AE|1
11541|NCT01838044|57182|P1|Overall Study|Medication error without associated AE|0
11542|NCT01838044|57181|P2|Overall Study|Insufficient clinical response|2
11543|NCT01838044|57182|P1|Overall Study|Insufficient clinical response|1
11544|NCT01838044|57181|P2|Overall Study|Withdrawal by Subject|2
11545|NCT01838044|57182|P1|Overall Study|Withdrawal by Subject|0
11546|NCT01838044|57181|P2|Overall Study|Protocol Violation|3
11547|NCT01838044|57182|P1|Overall Study|Protocol Violation|3
11548|NCT01838044|57181|P2|Overall Study|Adverse Event|6
11549|NCT01838044|57182|P1|Overall Study|Adverse Event|4
11550|NCT01837966|57215|P2|Overall Study|Withdrawal by Subject|1
11551|NCT01837966|57216|P1|Overall Study|Withdrawal by Subject|2
11552|NCT01837797|57225|P5|Period 3|Other|2
11553|NCT01837797|57226|P4|Period 3|Other|0
11554|NCT01837797|57227|P3|Period 3|Other|0
11555|NCT01837797|57228|P2|Period 3|Other|0
11556|NCT01837797|57229|P1|Period 3|Other|0
11557|NCT01837797|57225|P5|Period 3|Administrative reasons|20
11558|NCT01837797|57226|P4|Period 3|Administrative reasons|0
11559|NCT01837797|57227|P3|Period 3|Administrative reasons|0
11560|NCT01837797|57228|P2|Period 3|Administrative reasons|0
11561|NCT01837797|57229|P1|Period 3|Administrative reasons|0
11562|NCT01837797|57225|P5|Period 3|Adverse Event|1
11563|NCT01837797|57226|P4|Period 3|Adverse Event|0
11564|NCT01837797|57227|P3|Period 3|Adverse Event|0
11565|NCT01837797|57228|P2|Period 3|Adverse Event|0
11566|NCT01837797|57229|P1|Period 3|Adverse Event|0
11567|NCT01837797|57225|P5|Period 2|Adverse Event|0
11568|NCT01837797|57226|P4|Period 2|Adverse Event|1
11569|NCT01837797|57227|P3|Period 2|Adverse Event|0
11570|NCT01837797|57228|P2|Period 2|Adverse Event|0
11571|NCT01837797|57229|P1|Period 2|Adverse Event|0
11572|NCT01837797|57225|P5|Period 2|Administrative or other reasons|0
11573|NCT01837797|57226|P4|Period 2|Administrative or other reasons|4
11574|NCT01837797|57227|P3|Period 2|Administrative or other reasons|2
11575|NCT01837797|57228|P2|Period 2|Administrative or other reasons|5
11576|NCT01837797|57229|P1|Period 2|Administrative or other reasons|0
11577|NCT01837797|57225|P5|Period 1|Other|0
11578|NCT01837797|57226|P4|Period 1|Other|0
11579|NCT01837797|57227|P3|Period 1|Other|0
11580|NCT01837797|57228|P2|Period 1|Other|0
11581|NCT01837797|57229|P1|Period 1|Other|10
11582|NCT01837797|57225|P5|Period 1|Withdrawal of consent before treatment|0
11583|NCT01837797|57226|P4|Period 1|Withdrawal of consent before treatment|0
11584|NCT01837797|57227|P3|Period 1|Withdrawal of consent before treatment|0
11585|NCT01837797|57228|P2|Period 1|Withdrawal of consent before treatment|0
11586|NCT01837797|57229|P1|Period 1|Withdrawal of consent before treatment|1
11587|NCT01837797|57225|P5|Period 1|Administrative reasons|0
11588|NCT01837797|57226|P4|Period 1|Administrative reasons|0
11589|NCT01837797|57227|P3|Period 1|Administrative reasons|0
11590|NCT01837797|57228|P2|Period 1|Administrative reasons|0
11591|NCT01837797|57229|P1|Period 1|Administrative reasons|76
11592|NCT01837797|57225|P5|Period 1|Withdrawal by Subject|0
11593|NCT01837797|57226|P4|Period 1|Withdrawal by Subject|0
11594|NCT01837797|57227|P3|Period 1|Withdrawal by Subject|0
11595|NCT01837797|57228|P2|Period 1|Withdrawal by Subject|0
11596|NCT01837797|57229|P1|Period 1|Withdrawal by Subject|6
11597|NCT01837797|57225|P5|Period 1|Adverse Event|0
11598|NCT01837797|57226|P4|Period 1|Adverse Event|0
11599|NCT01837797|57227|P3|Period 1|Adverse Event|0
11600|NCT01837797|57228|P2|Period 1|Adverse Event|0
11601|NCT01837797|57229|P1|Period 1|Adverse Event|9
11602|NCT01837719|57264|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
11603|NCT01837719|57264|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
11604|NCT01836458|57392|P4|Overall Study|Unsatisfactory therapeutic effect|6
11605|NCT01836458|57393|P3|Overall Study|Unsatisfactory therapeutic effect|5
11606|NCT01836458|57394|P2|Overall Study|Unsatisfactory therapeutic effect|2
11607|NCT01836458|57395|P1|Overall Study|Unsatisfactory therapeutic effect|3
11608|NCT01835899|57451|P3|Overall Study|Other than stated above|0
11609|NCT01835899|57452|P2|Overall Study|Other than stated above|1
11610|NCT01835899|57453|P1|Overall Study|Other than stated above|0
11611|NCT01835899|57451|P3|Overall Study|Adverse Event|1
11612|NCT01835899|57452|P2|Overall Study|Adverse Event|0
11613|NCT01835899|57453|P1|Overall Study|Adverse Event|0
11614|NCT01835470|57504|P1|Long Term Treatment Period|Lack of Efficacy|1
11615|NCT01835470|57504|P1|Long Term Treatment Period|Subject Request to Discontinue|1
11616|NCT01835431|57516|P2|Overall Study|Protocol Violation|0
11617|NCT01835431|57517|P1|Overall Study|Protocol Violation|1
11618|NCT01835431|57516|P2|Overall Study|Withdrawal by Subject|10
11619|NCT01835431|57517|P1|Overall Study|Withdrawal by Subject|6
11620|NCT01835431|57516|P2|Overall Study|other|2
11621|NCT01835431|57517|P1|Overall Study|other|0
11622|NCT01835431|57516|P2|Overall Study|Adverse Event|0
11623|NCT01835431|57517|P1|Overall Study|Adverse Event|1
11624|NCT01835132|57555|P1|Initial Phase|Insufficient Therapeutic Response|2
11625|NCT01835015|57599|P5|Overall Study|Adverse Event|0
11626|NCT01835015|57600|P4|Overall Study|Adverse Event|0
11627|NCT01835015|57601|P3|Overall Study|Adverse Event|1
11628|NCT01835015|57602|P2|Overall Study|Adverse Event|0
11629|NCT01835015|57603|P1|Overall Study|Adverse Event|0
11630|NCT01834274|57711|P2|Overall Study|Other|1
11631|NCT01834274|57712|P1|Overall Study|Other|2
11632|NCT01834274|57711|P2|Overall Study|Lost to Follow-up|1
11633|NCT01834274|57712|P1|Overall Study|Lost to Follow-up|3
11634|NCT01834274|57711|P2|Overall Study|Withdrawal by Subject|1
11635|NCT01834274|57712|P1|Overall Study|Withdrawal by Subject|1
11636|NCT01834274|57711|P2|Overall Study|Study Termination|38
11637|NCT01834274|57712|P1|Overall Study|Study Termination|41
11638|NCT01833897|57735|P1|Overall Study|Lack of Efficacy|1
11639|NCT01833533|57762|P2|Overall Study|Not Specified|7
11640|NCT01833533|57763|P1|Overall Study|Not Specified|2
11641|NCT01833533|57762|P2|Overall Study|To Enter an Extension Study|4
11642|NCT01833533|57763|P1|Overall Study|To Enter an Extension Study|0
11643|NCT01833533|57762|P2|Overall Study|Lost to Follow-up|9
11644|NCT01833533|57763|P1|Overall Study|Lost to Follow-up|4
11645|NCT01833533|57762|P2|Overall Study|Adverse Event|1
11646|NCT01833533|57763|P1|Overall Study|Adverse Event|0
11647|NCT01833065|57858|P5|Overall Study|Others|4
11648|NCT01833065|57859|P4|Overall Study|Others|1
11649|NCT01833065|57860|P3|Overall Study|Others|1
11650|NCT01833065|57861|P2|Overall Study|Others|1
11651|NCT01833065|57862|P1|Overall Study|Others|2
11652|NCT01833065|57858|P5|Overall Study|Trial terminated by sponsor|13
11653|NCT01833065|57859|P4|Overall Study|Trial terminated by sponsor|3
11654|NCT01833065|57860|P3|Overall Study|Trial terminated by sponsor|7
11655|NCT01833065|57861|P2|Overall Study|Trial terminated by sponsor|8
11656|NCT01833065|57862|P1|Overall Study|Trial terminated by sponsor|8
11657|NCT01833065|57858|P5|Overall Study|Subject's substantial non-compliance|0
11658|NCT01833065|57859|P4|Overall Study|Subject's substantial non-compliance|0
11659|NCT01833065|57860|P3|Overall Study|Subject's substantial non-compliance|0
11660|NCT01833065|57861|P2|Overall Study|Subject's substantial non-compliance|1
11661|NCT01833065|57862|P1|Overall Study|Subject's substantial non-compliance|0
11662|NCT01833065|57858|P5|Overall Study|Withdrawal by Subject|11
11663|NCT01833065|57859|P4|Overall Study|Withdrawal by Subject|3
11664|NCT01833065|57860|P3|Overall Study|Withdrawal by Subject|4
11665|NCT01833065|57861|P2|Overall Study|Withdrawal by Subject|2
11666|NCT01833065|57862|P1|Overall Study|Withdrawal by Subject|6
11667|NCT01833065|57858|P5|Overall Study|Lost to Follow-up|3
11668|NCT01833065|57859|P4|Overall Study|Lost to Follow-up|0
11669|NCT01833065|57860|P3|Overall Study|Lost to Follow-up|0
11670|NCT01833065|57861|P2|Overall Study|Lost to Follow-up|0
11671|NCT01833065|57862|P1|Overall Study|Lost to Follow-up|1
11672|NCT01833065|57858|P5|Overall Study|Protocol Violation|2
11673|NCT01833065|57859|P4|Overall Study|Protocol Violation|0
11674|NCT01833065|57860|P3|Overall Study|Protocol Violation|0
11675|NCT01833065|57861|P2|Overall Study|Protocol Violation|0
11676|NCT01833065|57862|P1|Overall Study|Protocol Violation|1
11677|NCT01833065|57858|P5|Overall Study|Adverse Event|3
11678|NCT01833065|57859|P4|Overall Study|Adverse Event|2
11679|NCT01833065|57860|P3|Overall Study|Adverse Event|0
11680|NCT01833065|57861|P2|Overall Study|Adverse Event|1
11681|NCT01833065|57862|P1|Overall Study|Adverse Event|6
11682|NCT01832766|57893|P2|Washout|Lost to Follow-up|1
11683|NCT01832766|57894|P1|Washout|Lost to Follow-up|0
11684|NCT01832493|57960|P1|Overall Study|Unable to place LV lead|2
11685|NCT01832493|57960|P1|Overall Study|Protocol Violation|4
11686|NCT01832493|57960|P1|Overall Study|Physician Decision|2
11687|NCT01832155|57969|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
11688|NCT01832155|57970|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
11689|NCT01832155|57969|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
11690|NCT01832155|57970|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
11691|NCT01831817|57995|P4|Overall Study|Withdrawl of Consent|0
11692|NCT01831817|57996|P3|Overall Study|Withdrawl of Consent|0
11693|NCT01831817|57997|P2|Overall Study|Withdrawl of Consent|0
11694|NCT01831817|57998|P1|Overall Study|Withdrawl of Consent|3
11695|NCT01831817|57995|P4|Overall Study|Lost to Follow-up|0
11696|NCT01831817|57996|P3|Overall Study|Lost to Follow-up|0
11697|NCT01831817|57997|P2|Overall Study|Lost to Follow-up|0
11698|NCT01831817|57998|P1|Overall Study|Lost to Follow-up|1
11699|NCT01831791|58036|P1|Overall Study|Withdrawal by Subject|10
11700|NCT01831466|58074|P12|Overall Study|Adverse Event|2
11701|NCT01831466|58075|P11|Overall Study|Adverse Event|0
11702|NCT01831466|58076|P10|Overall Study|Adverse Event|1
11703|NCT01831466|58077|P9|Overall Study|Adverse Event|1
11704|NCT01831466|58078|P8|Overall Study|Adverse Event|1
11705|NCT01831466|58079|P7|Overall Study|Adverse Event|0
11706|NCT01831466|58080|P6|Overall Study|Adverse Event|7
11707|NCT01831466|58081|P5|Overall Study|Adverse Event|3
11708|NCT01831466|58082|P4|Overall Study|Adverse Event|6
11709|NCT01831466|58083|P3|Overall Study|Adverse Event|4
11710|NCT01831466|58084|P2|Overall Study|Adverse Event|0
11711|NCT01831466|58085|P1|Overall Study|Adverse Event|0
11712|NCT01831466|58074|P12|Overall Study|Lack of Efficacy|0
11713|NCT01831466|58075|P11|Overall Study|Lack of Efficacy|2
11714|NCT01831466|58076|P10|Overall Study|Lack of Efficacy|2
11715|NCT01831466|58077|P9|Overall Study|Lack of Efficacy|2
11716|NCT01831466|58078|P8|Overall Study|Lack of Efficacy|1
11717|NCT01831466|58079|P7|Overall Study|Lack of Efficacy|1
11718|NCT01831466|58080|P6|Overall Study|Lack of Efficacy|8
11719|NCT01831466|58081|P5|Overall Study|Lack of Efficacy|9
11720|NCT01831466|58082|P4|Overall Study|Lack of Efficacy|6
11721|NCT01831466|58083|P3|Overall Study|Lack of Efficacy|7
11722|NCT01831466|58084|P2|Overall Study|Lack of Efficacy|8
11723|NCT01831466|58085|P1|Overall Study|Lack of Efficacy|5
11724|NCT01831466|58074|P12|Overall Study|Lost to Follow-up|1
11725|NCT01831466|58075|P11|Overall Study|Lost to Follow-up|0
11726|NCT01831466|58076|P10|Overall Study|Lost to Follow-up|1
11727|NCT01831466|58077|P9|Overall Study|Lost to Follow-up|0
11728|NCT01831466|58078|P8|Overall Study|Lost to Follow-up|0
11729|NCT01831466|58079|P7|Overall Study|Lost to Follow-up|0
11730|NCT01831466|58080|P6|Overall Study|Lost to Follow-up|3
11731|NCT01831466|58081|P5|Overall Study|Lost to Follow-up|0
11732|NCT01831466|58082|P4|Overall Study|Lost to Follow-up|2
11733|NCT01831466|58083|P3|Overall Study|Lost to Follow-up|4
11734|NCT01831466|58084|P2|Overall Study|Lost to Follow-up|1
11735|NCT01831466|58085|P1|Overall Study|Lost to Follow-up|0
11736|NCT01831466|58074|P12|Overall Study|Withdrawal by Subject|1
11737|NCT01831466|58075|P11|Overall Study|Withdrawal by Subject|0
11738|NCT01831466|58076|P10|Overall Study|Withdrawal by Subject|1
11739|NCT01831466|58077|P9|Overall Study|Withdrawal by Subject|0
11740|NCT01831466|58078|P8|Overall Study|Withdrawal by Subject|0
11741|NCT01831466|58079|P7|Overall Study|Withdrawal by Subject|0
11742|NCT01831466|58080|P6|Overall Study|Withdrawal by Subject|5
11743|NCT01831466|58081|P5|Overall Study|Withdrawal by Subject|3
11744|NCT01831466|58082|P4|Overall Study|Withdrawal by Subject|3
11745|NCT01831466|58083|P3|Overall Study|Withdrawal by Subject|3
11746|NCT01831466|58084|P2|Overall Study|Withdrawal by Subject|3
11747|NCT01831466|58085|P1|Overall Study|Withdrawal by Subject|6
11748|NCT01831466|58074|P12|Overall Study|Death|0
11749|NCT01831466|58075|P11|Overall Study|Death|0
11750|NCT01831466|58076|P10|Overall Study|Death|0
11751|NCT01831466|58077|P9|Overall Study|Death|0
11752|NCT01831466|58078|P8|Overall Study|Death|0
11753|NCT01831466|58079|P7|Overall Study|Death|0
11754|NCT01831466|58080|P6|Overall Study|Death|0
11755|NCT01831466|58081|P5|Overall Study|Death|0
11756|NCT01831466|58082|P4|Overall Study|Death|0
11757|NCT01831466|58083|P3|Overall Study|Death|0
11758|NCT01831466|58084|P2|Overall Study|Death|1
11759|NCT01831466|58085|P1|Overall Study|Death|0
11760|NCT01831466|58074|P12|Overall Study|Non-compliance with study treatment|0
11761|NCT01831466|58075|P11|Overall Study|Non-compliance with study treatment|0
11762|NCT01831466|58076|P10|Overall Study|Non-compliance with study treatment|0
11763|NCT01831466|58077|P9|Overall Study|Non-compliance with study treatment|0
11764|NCT01831466|58078|P8|Overall Study|Non-compliance with study treatment|0
11765|NCT01831466|58079|P7|Overall Study|Non-compliance with study treatment|0
11766|NCT01831466|58080|P6|Overall Study|Non-compliance with study treatment|1
11767|NCT01831466|58081|P5|Overall Study|Non-compliance with study treatment|0
11768|NCT01831466|58082|P4|Overall Study|Non-compliance with study treatment|0
11769|NCT01831466|58083|P3|Overall Study|Non-compliance with study treatment|1
11770|NCT01831466|58084|P2|Overall Study|Non-compliance with study treatment|1
11771|NCT01831466|58085|P1|Overall Study|Non-compliance with study treatment|2
11772|NCT01831466|58074|P12|Overall Study|Not specified|0
11773|NCT01831466|58075|P11|Overall Study|Not specified|0
11774|NCT01831466|58076|P10|Overall Study|Not specified|0
11775|NCT01831466|58077|P9|Overall Study|Not specified|0
11776|NCT01831466|58078|P8|Overall Study|Not specified|0
11777|NCT01831466|58079|P7|Overall Study|Not specified|0
11778|NCT01831466|58080|P6|Overall Study|Not specified|1
11779|NCT01831466|58081|P5|Overall Study|Not specified|2
11780|NCT01831466|58082|P4|Overall Study|Not specified|2
11781|NCT01831466|58083|P3|Overall Study|Not specified|2
11782|NCT01831466|58084|P2|Overall Study|Not specified|3
11783|NCT01831466|58085|P1|Overall Study|Not specified|2
11784|NCT01831466|58074|P12|Overall Study|Protocol Violation|0
11785|NCT01831466|58075|P11|Overall Study|Protocol Violation|0
11786|NCT01831466|58076|P10|Overall Study|Protocol Violation|0
11787|NCT01831466|58077|P9|Overall Study|Protocol Violation|0
11788|NCT01831466|58078|P8|Overall Study|Protocol Violation|0
11789|NCT01831466|58079|P7|Overall Study|Protocol Violation|0
11790|NCT01831466|58080|P6|Overall Study|Protocol Violation|1
11791|NCT01831466|58081|P5|Overall Study|Protocol Violation|0
11792|NCT01831466|58082|P4|Overall Study|Protocol Violation|0
11793|NCT01831466|58083|P3|Overall Study|Protocol Violation|2
11794|NCT01831466|58084|P2|Overall Study|Protocol Violation|1
11795|NCT01831466|58085|P1|Overall Study|Protocol Violation|1
11796|NCT01830855|58247|P4|Overall Study|Lost to Follow-up|33
11797|NCT01830855|58248|P3|Overall Study|Lost to Follow-up|23
11798|NCT01830855|58249|P2|Overall Study|Lost to Follow-up|20
11799|NCT01830855|58250|P1|Overall Study|Lost to Follow-up|47
11800|NCT01830855|58247|P4|Overall Study|No longer willing to participate|17
11801|NCT01830855|58248|P3|Overall Study|No longer willing to participate|12
11802|NCT01830855|58249|P2|Overall Study|No longer willing to participate|13
11803|NCT01830855|58250|P1|Overall Study|No longer willing to participate|32
11804|NCT01830855|58247|P4|Overall Study|Withdrawal by Subject|12
11805|NCT01830855|58248|P3|Overall Study|Withdrawal by Subject|10
11806|NCT01830855|58249|P2|Overall Study|Withdrawal by Subject|14
11807|NCT01830855|58250|P1|Overall Study|Withdrawal by Subject|33
11808|NCT01830855|58247|P4|Overall Study|Protocol deviation|6
11809|NCT01830855|58248|P3|Overall Study|Protocol deviation|6
11810|NCT01830855|58249|P2|Overall Study|Protocol deviation|5
11811|NCT01830855|58250|P1|Overall Study|Protocol deviation|10
11812|NCT01830855|58247|P4|Overall Study|Adverse Event|3
11813|NCT01830855|58248|P3|Overall Study|Adverse Event|6
11814|NCT01830855|58249|P2|Overall Study|Adverse Event|5
11815|NCT01830855|58250|P1|Overall Study|Adverse Event|11
11816|NCT01830855|58247|P4|Overall Study|No longer meets eligibility criteria|5
11817|NCT01830855|58248|P3|Overall Study|No longer meets eligibility criteria|3
11818|NCT01830855|58249|P2|Overall Study|No longer meets eligibility criteria|2
11819|NCT01830855|58250|P1|Overall Study|No longer meets eligibility criteria|11
11820|NCT01830855|58247|P4|Overall Study|Pregnancy|1
11821|NCT01830855|58248|P3|Overall Study|Pregnancy|2
11822|NCT01830855|58249|P2|Overall Study|Pregnancy|1
11823|NCT01830855|58250|P1|Overall Study|Pregnancy|3
11824|NCT01830855|58247|P4|Overall Study|Medication error without associated AE|1
11825|NCT01830855|58248|P3|Overall Study|Medication error without associated AE|0
11826|NCT01830855|58249|P2|Overall Study|Medication error without associated AE|0
11827|NCT01830855|58250|P1|Overall Study|Medication error without associated AE|1
11828|NCT01830855|58247|P4|Overall Study|Unspecified|4
11829|NCT01830855|58248|P3|Overall Study|Unspecified|4
11830|NCT01830855|58249|P2|Overall Study|Unspecified|1
11831|NCT01830855|58250|P1|Overall Study|Unspecified|7
11832|NCT01830127|58478|P2|Overall Study|Other reason not defined above|2
11833|NCT01830127|58479|P1|Overall Study|Other reason not defined above|0
11834|NCT01830127|58478|P2|Overall Study|Withdrawal by Subject|1
11835|NCT01830127|58479|P1|Overall Study|Withdrawal by Subject|1
11836|NCT01830127|58478|P2|Overall Study|Lack of Efficacy|0
11837|NCT01830127|58479|P1|Overall Study|Lack of Efficacy|3
11838|NCT01830127|58478|P2|Overall Study|Adverse Event|6
11839|NCT01830127|58479|P1|Overall Study|Adverse Event|1
11840|NCT01829477|58514|P2|Overall Study|Withdrawal by Subject|0
11841|NCT01829477|58515|P1|Overall Study|Withdrawal by Subject|1
11842|NCT01829477|58514|P2|Overall Study|Study Terminated by Sponsor|15
11843|NCT01829477|58515|P1|Overall Study|Study Terminated by Sponsor|15
11844|NCT01829464|58528|P3|Overall Study|Lack of Efficacy|0
11845|NCT01829464|58529|P2|Overall Study|Lack of Efficacy|1
11846|NCT01829464|58530|P1|Overall Study|Lack of Efficacy|0
11847|NCT01829464|58528|P3|Overall Study|Study terminated by sponsor|25
11848|NCT01829464|58529|P2|Overall Study|Study terminated by sponsor|28
11849|NCT01829464|58530|P1|Overall Study|Study terminated by sponsor|25
11850|NCT01829464|58528|P3|Overall Study|Withdrawal by Subject|0
11851|NCT01829464|58529|P2|Overall Study|Withdrawal by Subject|0
11852|NCT01829464|58530|P1|Overall Study|Withdrawal by Subject|2
11853|NCT01829464|58528|P3|Overall Study|Lost to Follow-up|1
11854|NCT01829464|58529|P2|Overall Study|Lost to Follow-up|0
11855|NCT01829464|58530|P1|Overall Study|Lost to Follow-up|0
11856|NCT01829464|58528|P3|Overall Study|Adverse Event|0
11857|NCT01829464|58529|P2|Overall Study|Adverse Event|0
11858|NCT01829464|58530|P1|Overall Study|Adverse Event|1
11859|NCT01829243|58555|P2|First Intervention|Screen Failure|2
11860|NCT01829243|58556|P1|First Intervention|Screen Failure|4
11861|NCT01829230|58570|P2|Overall Study|Lost to Follow-up|1
11862|NCT01829230|58571|P1|Overall Study|Lost to Follow-up|1
11863|NCT01829230|58570|P2|Overall Study|Withdrawal by Subject|1
11864|NCT01829230|58571|P1|Overall Study|Withdrawal by Subject|0
11865|NCT01829230|58570|P2|Overall Study|Protocol Violation|2
11866|NCT01829230|58571|P1|Overall Study|Protocol Violation|0
11867|NCT01829191|58581|P2|Overall Study|Subject was fit for ortho - k|1
11868|NCT01829191|58582|P1|Overall Study|Subject was fit for ortho - k|0
11869|NCT01829191|58581|P2|Overall Study|Lost to Follow-up|1
11870|NCT01829191|58582|P1|Overall Study|Lost to Follow-up|0
11871|NCT01829191|58581|P2|Overall Study|Withdrawal by Subject|3
11872|NCT01829191|58582|P1|Overall Study|Withdrawal by Subject|2
11873|NCT01829191|58581|P2|Overall Study|Protocol Violation|1
11874|NCT01829191|58582|P1|Overall Study|Protocol Violation|4
11875|NCT01829191|58581|P2|Overall Study|Lens handling difficulty|4
11876|NCT01829191|58582|P1|Overall Study|Lens handling difficulty|1
11877|NCT01829191|58581|P2|Overall Study|Lens discomfort|3
11878|NCT01829191|58582|P1|Overall Study|Lens discomfort|0
11879|NCT01829191|58581|P2|Overall Study|Relocation|1
11880|NCT01829191|58582|P1|Overall Study|Relocation|0
11881|NCT01828281|58606|P2|Overall Study|Withdrawal by Subject|0
11882|NCT01828281|58607|P1|Overall Study|Withdrawal by Subject|1
11883|NCT01827670|58630|P2|Overall Study|Lost to Follow-up|1
11884|NCT01827670|58631|P1|Overall Study|Lost to Follow-up|0
11885|NCT01827670|58630|P2|Overall Study|Withdrawal of Consent|2
11886|NCT01827670|58631|P1|Overall Study|Withdrawal of Consent|3
11887|NCT01827592|58650|P3|Overall Study|Others|3
11888|NCT01827592|58651|P2|Overall Study|Others|1
11889|NCT01827592|58652|P1|Overall Study|Others|0
11890|NCT01827592|58650|P3|Overall Study|Trial terminated by Sponsor|51
11891|NCT01827592|58651|P2|Overall Study|Trial terminated by Sponsor|53
11892|NCT01827592|58652|P1|Overall Study|Trial terminated by Sponsor|47
11893|NCT01827592|58650|P3|Overall Study|Patient's substantial non-compliance|6
11894|NCT01827592|58651|P2|Overall Study|Patient's substantial non-compliance|1
11895|NCT01827592|58652|P1|Overall Study|Patient's substantial non-compliance|1
11896|NCT01827592|58650|P3|Overall Study|Withdrawal by Subject|11
11897|NCT01827592|58651|P2|Overall Study|Withdrawal by Subject|11
11898|NCT01827592|58652|P1|Overall Study|Withdrawal by Subject|12
11899|NCT01827592|58650|P3|Overall Study|Lost to Follow-up|2
11900|NCT01827592|58651|P2|Overall Study|Lost to Follow-up|2
11901|NCT01827592|58652|P1|Overall Study|Lost to Follow-up|1
11902|NCT01827592|58650|P3|Overall Study|Protocol Violation|0
11903|NCT01827592|58651|P2|Overall Study|Protocol Violation|1
11904|NCT01827592|58652|P1|Overall Study|Protocol Violation|2
11905|NCT01827592|58650|P3|Overall Study|Physician Decision|1
11906|NCT01827592|58651|P2|Overall Study|Physician Decision|2
11907|NCT01827592|58652|P1|Overall Study|Physician Decision|0
11908|NCT01827592|58650|P3|Overall Study|Adverse Event|2
11909|NCT01827592|58651|P2|Overall Study|Adverse Event|9
11910|NCT01827592|58652|P1|Overall Study|Adverse Event|11
11911|NCT01827371|58701|P4|Overall Study|Temporary study halt to vaccinations|13
11912|NCT01827371|58702|P3|Overall Study|Temporary study halt to vaccinations|5
11913|NCT01827371|58703|P2|Overall Study|Temporary study halt to vaccinations|2
12001|NCT01826981|58794|P4|Overall Study|Withdrew Consent|0
11914|NCT01827371|58704|P1|Overall Study|Temporary study halt to vaccinations|11
11915|NCT01827371|58701|P4|Overall Study|Physician Decision|1
11916|NCT01827371|58702|P3|Overall Study|Physician Decision|0
11917|NCT01827371|58703|P2|Overall Study|Physician Decision|1
11918|NCT01827371|58704|P1|Overall Study|Physician Decision|0
11919|NCT01827371|58701|P4|Overall Study|Withdrawal by Subject|3
11920|NCT01827371|58702|P3|Overall Study|Withdrawal by Subject|2
11921|NCT01827371|58703|P2|Overall Study|Withdrawal by Subject|2
11922|NCT01827371|58704|P1|Overall Study|Withdrawal by Subject|1
11923|NCT01827371|58701|P4|Overall Study|Protocol Violation|0
11924|NCT01827371|58702|P3|Overall Study|Protocol Violation|0
11925|NCT01827371|58703|P2|Overall Study|Protocol Violation|0
11926|NCT01827371|58704|P1|Overall Study|Protocol Violation|1
11927|NCT01827371|58701|P4|Overall Study|Lost to Follow-up|4
11928|NCT01827371|58702|P3|Overall Study|Lost to Follow-up|0
11929|NCT01827371|58703|P2|Overall Study|Lost to Follow-up|2
11930|NCT01827371|58704|P1|Overall Study|Lost to Follow-up|0
11931|NCT01827371|58701|P4|Overall Study|Adverse Event|2
11932|NCT01827371|58702|P3|Overall Study|Adverse Event|4
11933|NCT01827371|58703|P2|Overall Study|Adverse Event|0
11934|NCT01827371|58704|P1|Overall Study|Adverse Event|0
11935|NCT01827332|58728|P2|Overall Study|Lost to Follow-up|1
11936|NCT01827332|58729|P1|Overall Study|Lost to Follow-up|2
11937|NCT01827319|58737|P1|Overall Study|Lost to Follow-up|3
11938|NCT01827254|58758|P1|Overall Study|Intolerance to treatment|4
11939|NCT01827254|58758|P1|Overall Study|Disease progression|36
11940|NCT01827254|58758|P1|Overall Study|Did not complete re-challenge|1
11941|NCT01827254|58758|P1|Overall Study|Discontinued prior initiation: sunitinib|1
11942|NCT01827254|58758|P1|Overall Study|Invalidated centre|3
11943|NCT01827254|58758|P1|Overall Study|Case report form not completed|4
11944|NCT01827254|58758|P1|Overall Study|Death|10
11945|NCT01826981|58783|P15|Overall Study|Enrolled/Randomized but Not Treated|0
11946|NCT01826981|58784|P14|Overall Study|Enrolled/Randomized but Not Treated|0
11947|NCT01826981|58785|P13|Overall Study|Enrolled/Randomized but Not Treated|0
11948|NCT01826981|58786|P12|Overall Study|Enrolled/Randomized but Not Treated|0
11949|NCT01826981|58787|P11|Overall Study|Enrolled/Randomized but Not Treated|0
11950|NCT01826981|58788|P10|Overall Study|Enrolled/Randomized but Not Treated|0
11951|NCT01826981|58789|P9|Overall Study|Enrolled/Randomized but Not Treated|0
11952|NCT01826981|58790|P8|Overall Study|Enrolled/Randomized but Not Treated|1
11953|NCT01826981|58791|P7|Overall Study|Enrolled/Randomized but Not Treated|0
11954|NCT01826981|58792|P6|Overall Study|Enrolled/Randomized but Not Treated|0
11955|NCT01826981|58793|P5|Overall Study|Enrolled/Randomized but Not Treated|0
11956|NCT01826981|58794|P4|Overall Study|Enrolled/Randomized but Not Treated|0
11957|NCT01826981|58795|P3|Overall Study|Enrolled/Randomized but Not Treated|0
11958|NCT01826981|58796|P2|Overall Study|Enrolled/Randomized but Not Treated|0
11959|NCT01826981|58797|P1|Overall Study|Enrolled/Randomized but Not Treated|0
11960|NCT01826981|58783|P15|Overall Study|Upper G-I Haemorrhage|0
11961|NCT01826981|58784|P14|Overall Study|Upper G-I Haemorrhage|1
11962|NCT01826981|58785|P13|Overall Study|Upper G-I Haemorrhage|0
11963|NCT01826981|58786|P12|Overall Study|Upper G-I Haemorrhage|0
11964|NCT01826981|58787|P11|Overall Study|Upper G-I Haemorrhage|0
11965|NCT01826981|58788|P10|Overall Study|Upper G-I Haemorrhage|0
11966|NCT01826981|58789|P9|Overall Study|Upper G-I Haemorrhage|0
11967|NCT01826981|58790|P8|Overall Study|Upper G-I Haemorrhage|0
11968|NCT01826981|58791|P7|Overall Study|Upper G-I Haemorrhage|0
11969|NCT01826981|58792|P6|Overall Study|Upper G-I Haemorrhage|0
11970|NCT01826981|58793|P5|Overall Study|Upper G-I Haemorrhage|0
11971|NCT01826981|58794|P4|Overall Study|Upper G-I Haemorrhage|0
11972|NCT01826981|58795|P3|Overall Study|Upper G-I Haemorrhage|0
11973|NCT01826981|58796|P2|Overall Study|Upper G-I Haemorrhage|0
11974|NCT01826981|58797|P1|Overall Study|Upper G-I Haemorrhage|0
11975|NCT01826981|58783|P15|Overall Study|Adverse Event|0
11976|NCT01826981|58784|P14|Overall Study|Adverse Event|0
11977|NCT01826981|58785|P13|Overall Study|Adverse Event|0
11978|NCT01826981|58786|P12|Overall Study|Adverse Event|0
11979|NCT01826981|58787|P11|Overall Study|Adverse Event|0
11980|NCT01826981|58788|P10|Overall Study|Adverse Event|0
11981|NCT01826981|58789|P9|Overall Study|Adverse Event|0
11982|NCT01826981|58790|P8|Overall Study|Adverse Event|0
11983|NCT01826981|58791|P7|Overall Study|Adverse Event|0
11984|NCT01826981|58792|P6|Overall Study|Adverse Event|0
11985|NCT01826981|58793|P5|Overall Study|Adverse Event|1
11986|NCT01826981|58794|P4|Overall Study|Adverse Event|0
11987|NCT01826981|58795|P3|Overall Study|Adverse Event|0
11988|NCT01826981|58796|P2|Overall Study|Adverse Event|0
11989|NCT01826981|58797|P1|Overall Study|Adverse Event|0
11990|NCT01826981|58783|P15|Overall Study|Withdrew Consent|0
11991|NCT01826981|58784|P14|Overall Study|Withdrew Consent|1
11992|NCT01826981|58785|P13|Overall Study|Withdrew Consent|0
11993|NCT01826981|58786|P12|Overall Study|Withdrew Consent|1
11994|NCT01826981|58787|P11|Overall Study|Withdrew Consent|0
11995|NCT01826981|58788|P10|Overall Study|Withdrew Consent|0
11996|NCT01826981|58789|P9|Overall Study|Withdrew Consent|0
11997|NCT01826981|58790|P8|Overall Study|Withdrew Consent|1
11998|NCT01826981|58791|P7|Overall Study|Withdrew Consent|1
11999|NCT01826981|58792|P6|Overall Study|Withdrew Consent|0
12000|NCT01826981|58793|P5|Overall Study|Withdrew Consent|0
12002|NCT01826981|58795|P3|Overall Study|Withdrew Consent|0
12003|NCT01826981|58796|P2|Overall Study|Withdrew Consent|0
12004|NCT01826981|58797|P1|Overall Study|Withdrew Consent|0
12005|NCT01826981|58783|P15|Overall Study|Lost to Follow-up|0
12006|NCT01826981|58784|P14|Overall Study|Lost to Follow-up|0
12007|NCT01826981|58785|P13|Overall Study|Lost to Follow-up|1
12008|NCT01826981|58786|P12|Overall Study|Lost to Follow-up|1
12009|NCT01826981|58787|P11|Overall Study|Lost to Follow-up|1
12010|NCT01826981|58788|P10|Overall Study|Lost to Follow-up|1
12011|NCT01826981|58789|P9|Overall Study|Lost to Follow-up|0
12012|NCT01826981|58790|P8|Overall Study|Lost to Follow-up|1
12013|NCT01826981|58791|P7|Overall Study|Lost to Follow-up|0
12014|NCT01826981|58792|P6|Overall Study|Lost to Follow-up|1
12015|NCT01826981|58793|P5|Overall Study|Lost to Follow-up|1
12016|NCT01826981|58794|P4|Overall Study|Lost to Follow-up|0
12017|NCT01826981|58795|P3|Overall Study|Lost to Follow-up|0
12018|NCT01826981|58796|P2|Overall Study|Lost to Follow-up|0
12019|NCT01826981|58797|P1|Overall Study|Lost to Follow-up|0
12020|NCT01826981|58783|P15|Overall Study|Lack of Efficacy|0
12021|NCT01826981|58784|P14|Overall Study|Lack of Efficacy|3
12022|NCT01826981|58785|P13|Overall Study|Lack of Efficacy|0
12023|NCT01826981|58786|P12|Overall Study|Lack of Efficacy|0
12024|NCT01826981|58787|P11|Overall Study|Lack of Efficacy|1
12025|NCT01826981|58788|P10|Overall Study|Lack of Efficacy|0
12026|NCT01826981|58789|P9|Overall Study|Lack of Efficacy|7
12027|NCT01826981|58790|P8|Overall Study|Lack of Efficacy|8
12028|NCT01826981|58791|P7|Overall Study|Lack of Efficacy|0
12029|NCT01826981|58792|P6|Overall Study|Lack of Efficacy|0
12030|NCT01826981|58793|P5|Overall Study|Lack of Efficacy|5
12031|NCT01826981|58794|P4|Overall Study|Lack of Efficacy|0
12032|NCT01826981|58795|P3|Overall Study|Lack of Efficacy|0
12033|NCT01826981|58796|P2|Overall Study|Lack of Efficacy|1
12034|NCT01826981|58797|P1|Overall Study|Lack of Efficacy|0
12035|NCT01826604|58960|P2|Overall Study|Lost to Follow-up|9
12036|NCT01826604|58961|P1|Overall Study|Lost to Follow-up|8
12037|NCT01826370|58969|P1|Overall Study|Other reason not defined above|2
12038|NCT01826370|58969|P1|Overall Study|Lost to Follow-up|12
12039|NCT01826370|58969|P1|Overall Study|Protocol Violation|6
12040|NCT01826214|58977|P2|Overall Study|Subject/guardian decision|3
12041|NCT01826214|58978|P1|Overall Study|Subject/guardian decision|2
12042|NCT01826214|58977|P2|Overall Study|Study terminated by Sponsor|1
12043|NCT01826214|58978|P1|Overall Study|Study terminated by Sponsor|0
12044|NCT01826214|58977|P2|Overall Study|Progressive disease|21
12045|NCT01826214|58978|P1|Overall Study|Progressive disease|22
12046|NCT01826214|58977|P2|Overall Study|Physician Decision|2
12047|NCT01826214|58978|P1|Overall Study|Physician Decision|0
12048|NCT01826214|58977|P2|Overall Study|Lost to Follow-up|0
12049|NCT01826214|58978|P1|Overall Study|Lost to Follow-up|1
12050|NCT01826214|58977|P2|Overall Study|Death|1
12051|NCT01826214|58978|P1|Overall Study|Death|3
12052|NCT01826214|58977|P2|Overall Study|Adverse Event|6
12053|NCT01826214|58978|P1|Overall Study|Adverse Event|7
12054|NCT01826201|58996|P1|Overall Study|Non compliance with protocol|4
12055|NCT01825837|59006|P4|PART II|reason unspecified|0
12056|NCT01825837|59007|P3|PART II|reason unspecified|2
12057|NCT01825837|59008|P2|PART II|reason unspecified|2
12058|NCT01825837|59009|P1|PART II|reason unspecified|2
12059|NCT01825837|59006|P4|PART II|Treatment failure|0
12060|NCT01825837|59007|P3|PART II|Treatment failure|5
12061|NCT01825837|59008|P2|PART II|Treatment failure|4
12062|NCT01825837|59009|P1|PART II|Treatment failure|6
12063|NCT01825837|59006|P4|PART II|Adverse Event|0
12064|NCT01825837|59007|P3|PART II|Adverse Event|1
12065|NCT01825837|59008|P2|PART II|Adverse Event|3
12066|NCT01825837|59009|P1|PART II|Adverse Event|3
12067|NCT01825837|59006|P4|PART II|Patient non-compliance|0
12068|NCT01825837|59007|P3|PART II|Patient non-compliance|4
12069|NCT01825837|59008|P2|PART II|Patient non-compliance|2
12070|NCT01825837|59009|P1|PART II|Patient non-compliance|5
12071|NCT01825837|59006|P4|PART II|Withdrawal by Subject|0
12072|NCT01825837|59007|P3|PART II|Withdrawal by Subject|7
12073|NCT01825837|59008|P2|PART II|Withdrawal by Subject|3
12074|NCT01825837|59009|P1|PART II|Withdrawal by Subject|3
12075|NCT01825837|59006|P4|PART I|reason unspecified|3
12076|NCT01825837|59007|P3|PART I|reason unspecified|0
12077|NCT01825837|59008|P2|PART I|reason unspecified|0
12078|NCT01825837|59009|P1|PART I|reason unspecified|0
12079|NCT01825837|59006|P4|PART I|Treatment failure|7
12080|NCT01825837|59007|P3|PART I|Treatment failure|0
12081|NCT01825837|59008|P2|PART I|Treatment failure|0
12082|NCT01825837|59009|P1|PART I|Treatment failure|0
12083|NCT01825837|59006|P4|PART I|Patient non-compliance|1
12084|NCT01825837|59007|P3|PART I|Patient non-compliance|0
12085|NCT01825837|59008|P2|PART I|Patient non-compliance|0
12086|NCT01825837|59009|P1|PART I|Patient non-compliance|0
12087|NCT01825837|59006|P4|PART I|Withdrawal by Subject|6
12088|NCT01825837|59007|P3|PART I|Withdrawal by Subject|0
12089|NCT01825837|59008|P2|PART I|Withdrawal by Subject|0
12090|NCT01825837|59009|P1|PART I|Withdrawal by Subject|0
12091|NCT01825577|59017|P1|Overall Study|Lack of Efficacy|3
16768|NCT01708954|78367|P3|Step 1|Death|3
12092|NCT01825577|59017|P1|Overall Study|Withdrawn by family members|2
12093|NCT01825577|59017|P1|Overall Study|Withdrawal by Subject|1
12094|NCT01825577|59017|P1|Overall Study|Physician Decision|2
12095|NCT01825200|59024|P2|Overall Study|Withdrawal by Subject|1
12096|NCT01825200|59025|P1|Overall Study|Withdrawal by Subject|0
12097|NCT01825200|59024|P2|Overall Study|Lost to Follow-up|6
12098|NCT01825200|59025|P1|Overall Study|Lost to Follow-up|5
12099|NCT01824823|59055|P2|Overall Study|Off-treatment reason not submitted|0
12100|NCT01824823|59056|P1|Overall Study|Off-treatment reason not submitted|1
12101|NCT01824823|59055|P2|Overall Study|Lack of Efficacy|1
12102|NCT01824823|59056|P1|Overall Study|Lack of Efficacy|1
12103|NCT01824602|59105|P4|Overall Study|Treatment failure|1
12104|NCT01824602|59106|P3|Overall Study|Treatment failure|0
12105|NCT01824602|59107|P2|Overall Study|Treatment failure|0
12106|NCT01824602|59108|P1|Overall Study|Treatment failure|0
12107|NCT01824602|59105|P4|Overall Study|Adverse Event|2
12108|NCT01824602|59106|P3|Overall Study|Adverse Event|2
12109|NCT01824602|59107|P2|Overall Study|Adverse Event|0
12110|NCT01824602|59108|P1|Overall Study|Adverse Event|1
12111|NCT01824602|59105|P4|Overall Study|Patient non-compliance|0
12112|NCT01824602|59106|P3|Overall Study|Patient non-compliance|1
12113|NCT01824602|59107|P2|Overall Study|Patient non-compliance|0
12114|NCT01824602|59108|P1|Overall Study|Patient non-compliance|0
12115|NCT01824602|59105|P4|Overall Study|Withdrawal by Subject|2
12116|NCT01824602|59106|P3|Overall Study|Withdrawal by Subject|1
12117|NCT01824602|59107|P2|Overall Study|Withdrawal by Subject|0
12118|NCT01824602|59108|P1|Overall Study|Withdrawal by Subject|0
12119|NCT01824498|59153|P6|Washout (8 Weeks)|Withdrawal by Subject|0
12120|NCT01824498|59154|P5|Washout (8 Weeks)|Withdrawal by Subject|1
12121|NCT01824498|59155|P4|Washout (8 Weeks)|Withdrawal by Subject|1
12122|NCT01824498|59156|P3|Washout (8 Weeks)|Withdrawal by Subject|2
12123|NCT01824498|59157|P2|Washout (8 Weeks)|Withdrawal by Subject|0
12124|NCT01824498|59158|P1|Washout (8 Weeks)|Withdrawal by Subject|2
12125|NCT01824355|59189|P1|Overall Study|unevaluable reference method results per|1
12126|NCT01824355|59189|P1|Overall Study|Adverse Event|2
12127|NCT01824342|59200|P2|Overall Study|Death|0
12128|NCT01824342|59201|P1|Overall Study|Death|2
12129|NCT01824342|59200|P2|Overall Study|Physician Decision|0
12130|NCT01824342|59201|P1|Overall Study|Physician Decision|5
12131|NCT01824342|59200|P2|Overall Study|Disease Progression|1
12132|NCT01824342|59201|P1|Overall Study|Disease Progression|1
12133|NCT01824342|59200|P2|Overall Study|Adverse Event|1
12134|NCT01824342|59201|P1|Overall Study|Adverse Event|1
12135|NCT01824342|59200|P2|Overall Study|Withdrawal by Subject|3
12136|NCT01824342|59201|P1|Overall Study|Withdrawal by Subject|0
12137|NCT01824303|59215|P2|Randomized Study|Other Miscellaneous Reasons|0
12138|NCT01824303|59216|P1|Randomized Study|Other Miscellaneous Reasons|1
12139|NCT01824303|59215|P2|Randomized Study|Withdrawal by Subject|1
12140|NCT01824303|59216|P1|Randomized Study|Withdrawal by Subject|1
12141|NCT01823536|59250|P6|Overall Study|Subject moved out of the state|0
12142|NCT01823536|59251|P5|Overall Study|Subject moved out of the state|1
12143|NCT01823536|59252|P4|Overall Study|Subject moved out of the state|0
12144|NCT01823536|59253|P3|Overall Study|Subject moved out of the state|0
12145|NCT01823536|59254|P2|Overall Study|Subject moved out of the state|0
12146|NCT01823536|59255|P1|Overall Study|Subject moved out of the state|0
12147|NCT01823536|59250|P6|Overall Study|Met exclusion criterion No 6|0
12148|NCT01823536|59251|P5|Overall Study|Met exclusion criterion No 6|0
12149|NCT01823536|59252|P4|Overall Study|Met exclusion criterion No 6|1
12150|NCT01823536|59253|P3|Overall Study|Met exclusion criterion No 6|0
12151|NCT01823536|59254|P2|Overall Study|Met exclusion criterion No 6|0
12152|NCT01823536|59255|P1|Overall Study|Met exclusion criterion No 6|0
12153|NCT01823536|59250|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
12154|NCT01823536|59251|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
12155|NCT01823536|59252|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
12156|NCT01823536|59253|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
12157|NCT01823536|59254|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
12158|NCT01823536|59255|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
12159|NCT01823536|59250|P6|Overall Study|Withdrawal by Subject|0
12160|NCT01823536|59251|P5|Overall Study|Withdrawal by Subject|0
12161|NCT01823536|59252|P4|Overall Study|Withdrawal by Subject|0
12162|NCT01823536|59253|P3|Overall Study|Withdrawal by Subject|0
12163|NCT01823536|59254|P2|Overall Study|Withdrawal by Subject|1
12164|NCT01823536|59255|P1|Overall Study|Withdrawal by Subject|1
12165|NCT01823536|59250|P6|Overall Study|Protocol Violation|0
12166|NCT01823536|59251|P5|Overall Study|Protocol Violation|0
12167|NCT01823536|59252|P4|Overall Study|Protocol Violation|0
12168|NCT01823536|59253|P3|Overall Study|Protocol Violation|0
12169|NCT01823536|59254|P2|Overall Study|Protocol Violation|1
12170|NCT01823536|59255|P1|Overall Study|Protocol Violation|0
12171|NCT01823536|59250|P6|Overall Study|Lost to Follow-up|0
12172|NCT01823536|59251|P5|Overall Study|Lost to Follow-up|1
12173|NCT01823536|59252|P4|Overall Study|Lost to Follow-up|1
12174|NCT01823536|59253|P3|Overall Study|Lost to Follow-up|0
12175|NCT01823536|59254|P2|Overall Study|Lost to Follow-up|0
12176|NCT01823536|59255|P1|Overall Study|Lost to Follow-up|1
12177|NCT01823341|59293|P1|Overall Study|Adverse Event|1
12178|NCT01823341|59293|P1|Overall Study|Withdrawal by Subject|7
12179|NCT01823341|59293|P1|Overall Study|Failed run-in|7
12180|NCT01823289|59336|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
12181|NCT01823289|59336|P1|Overall Study|Drug affected efficacy and safety|1
12182|NCT01823289|59336|P1|Overall Study|Transaminase increased more than 3 times|1
12183|NCT01823289|59336|P1|Overall Study|Administered contraindicated medicine|1
12184|NCT01823289|59336|P1|Overall Study|Physician Decision|9
12185|NCT01823289|59336|P1|Overall Study|Lack of Efficacy|1
12186|NCT01823289|59336|P1|Overall Study|Adverse Event|5
12187|NCT01823289|59336|P1|Overall Study|Lost to Follow-up|5
12188|NCT01823224|59344|P2|Overall Study|Withdrawal by Subject|1
12189|NCT01823224|59345|P1|Overall Study|Withdrawal by Subject|0
12190|NCT01823224|59344|P2|Overall Study|missed med dose|1
12191|NCT01823224|59345|P1|Overall Study|missed med dose|0
12192|NCT01823224|59344|P2|Overall Study|pharmacy error|1
12193|NCT01823224|59345|P1|Overall Study|pharmacy error|0
12194|NCT01823224|59344|P2|Overall Study|didn't qualify|2
12195|NCT01823224|59345|P1|Overall Study|didn't qualify|1
12196|NCT01823224|59344|P2|Overall Study|Lost to Follow-up|6
12197|NCT01823224|59345|P1|Overall Study|Lost to Follow-up|5
12198|NCT01823146|59355|P2|Overall Study|Lost to Follow-up|1
12199|NCT01823146|59356|P1|Overall Study|Lost to Follow-up|2
12200|NCT01823146|59355|P2|Overall Study|Withdrawal by Subject|1
12201|NCT01823146|59356|P1|Overall Study|Withdrawal by Subject|0
12202|NCT01822899|59368|P2|Overall Study|Withdrawal by Subject|7
12203|NCT01822899|59369|P1|Overall Study|Withdrawal by Subject|5
12204|NCT01822899|59368|P2|Overall Study|Lost to Follow-up|0
12205|NCT01822899|59369|P1|Overall Study|Lost to Follow-up|1
12206|NCT01822899|59368|P2|Overall Study|Protocol Violation|3
12207|NCT01822899|59369|P1|Overall Study|Protocol Violation|6
12208|NCT01822899|59368|P2|Overall Study|Lack of Efficacy|3
12209|NCT01822899|59369|P1|Overall Study|Lack of Efficacy|6
12210|NCT01822899|59368|P2|Overall Study|Adverse Event|5
12211|NCT01822899|59369|P1|Overall Study|Adverse Event|6
12212|NCT01822691|59377|P1|Overall Study|Withdrawal by Subject|2
12213|NCT01822678|59388|P3|Overall Study|Lost to Follow-up|1
12214|NCT01822678|59389|P2|Overall Study|Lost to Follow-up|2
12215|NCT01822678|59390|P1|Overall Study|Lost to Follow-up|0
12216|NCT01822678|59388|P3|Overall Study|Lack of Efficacy|5
12217|NCT01822678|59389|P2|Overall Study|Lack of Efficacy|6
12218|NCT01822678|59390|P1|Overall Study|Lack of Efficacy|3
12219|NCT01822678|59388|P3|Overall Study|Adverse Event|1
12220|NCT01822678|59389|P2|Overall Study|Adverse Event|3
12221|NCT01822678|59390|P1|Overall Study|Adverse Event|4
12222|NCT01822678|59388|P3|Overall Study|Withdrawal by Subject|4
12223|NCT01822678|59389|P2|Overall Study|Withdrawal by Subject|4
12224|NCT01822678|59390|P1|Overall Study|Withdrawal by Subject|5
12225|NCT01822665|59398|P1|Overall Study|Other Reason|5
12226|NCT01822665|59398|P1|Overall Study|Adverse Event|3
12227|NCT01822535|59443|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
12228|NCT01822535|59444|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
12229|NCT01822535|59443|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
12230|NCT01822535|59444|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
12231|NCT01822535|59443|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
12232|NCT01822535|59444|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
12233|NCT01822223|59458|P2|Overall Study|Death|1
12234|NCT01822223|59459|P1|Overall Study|Death|0
12235|NCT01821963|59504|P1|Overall Study|Adverse Event|1
12236|NCT01821937|59510|P2|Overall Study|Adverse Event|3
12237|NCT01821937|59511|P1|Overall Study|Adverse Event|0
12238|NCT01821807|59535|P2|Overall Study|Lost to Follow-up|1
12239|NCT01821807|59536|P1|Overall Study|Lost to Follow-up|3
12240|NCT01820364|59609|P2|Part II: LGX818 + MEK162|Study Termination|1
12241|NCT01820364|59610|P1|Part II: LGX818 + MEK162|Study Termination|0
12242|NCT01820364|59609|P2|Part I: LGX818|Disease Progression|0
12243|NCT01820364|59610|P1|Part I: LGX818|Disease Progression|4
12244|NCT01820364|59609|P2|Part I: LGX818|Adverse Event|0
12245|NCT01820364|59610|P1|Part I: LGX818|Adverse Event|6
12246|NCT01820364|59609|P2|Part I: LGX818|Administrative Problems|0
12247|NCT01820364|59610|P1|Part I: LGX818|Administrative Problems|3
12248|NCT01820364|59609|P2|Part I: LGX818|Death|0
12249|NCT01820364|59610|P1|Part I: LGX818|Death|1
12250|NCT01821118|59624|P2|Overall Study|Death|1
12251|NCT01821118|59625|P1|Overall Study|Death|0
12252|NCT01820585|59668|P4|Overall Study|Pregnancy|0
12253|NCT01820585|59669|P3|Overall Study|Pregnancy|0
12254|NCT01820585|59670|P2|Overall Study|Pregnancy|1
12255|NCT01820585|59671|P1|Overall Study|Pregnancy|0
12256|NCT01820585|59668|P4|Overall Study|at sponsor request|0
12257|NCT01820585|59669|P3|Overall Study|at sponsor request|1
12258|NCT01820585|59670|P2|Overall Study|at sponsor request|0
12259|NCT01820585|59671|P1|Overall Study|at sponsor request|0
12260|NCT01820585|59668|P4|Overall Study|Subject non-compliance|2
12261|NCT01820585|59669|P3|Overall Study|Subject non-compliance|1
12262|NCT01820585|59670|P2|Overall Study|Subject non-compliance|0
12263|NCT01820585|59671|P1|Overall Study|Subject non-compliance|0
12264|NCT01820585|59668|P4|Overall Study|Protocol Violation|1
12265|NCT01820585|59669|P3|Overall Study|Protocol Violation|1
12266|NCT01820585|59670|P2|Overall Study|Protocol Violation|1
12267|NCT01820585|59671|P1|Overall Study|Protocol Violation|3
12268|NCT01820585|59668|P4|Overall Study|Lost to Follow-up|3
12269|NCT01820585|59669|P3|Overall Study|Lost to Follow-up|0
12270|NCT01820585|59670|P2|Overall Study|Lost to Follow-up|3
12271|NCT01820585|59671|P1|Overall Study|Lost to Follow-up|3
12272|NCT01820585|59668|P4|Overall Study|Withdrawal by Subject|8
12273|NCT01820585|59669|P3|Overall Study|Withdrawal by Subject|3
12274|NCT01820585|59670|P2|Overall Study|Withdrawal by Subject|7
12275|NCT01820585|59671|P1|Overall Study|Withdrawal by Subject|3
12276|NCT01820585|59668|P4|Overall Study|Lack of Efficacy|1
12277|NCT01820585|59669|P3|Overall Study|Lack of Efficacy|5
12278|NCT01820585|59670|P2|Overall Study|Lack of Efficacy|7
12279|NCT01820585|59671|P1|Overall Study|Lack of Efficacy|9
12280|NCT01820585|59668|P4|Overall Study|Adverse Event|34
12281|NCT01820585|59669|P3|Overall Study|Adverse Event|23
12282|NCT01820585|59670|P2|Overall Study|Adverse Event|13
12283|NCT01820585|59671|P1|Overall Study|Adverse Event|9
12284|NCT01820559|59684|P3|Overall Study|Lack of Efficacy|3
12285|NCT01820559|59685|P2|Overall Study|Lack of Efficacy|2
12286|NCT01820559|59686|P1|Overall Study|Lack of Efficacy|3
12287|NCT01820559|59684|P3|Overall Study|At sponsor request|1
12288|NCT01820559|59685|P2|Overall Study|At sponsor request|0
12289|NCT01820559|59686|P1|Overall Study|At sponsor request|0
12290|NCT01820559|59684|P3|Overall Study|Lost to Follow-up|2
12291|NCT01820559|59685|P2|Overall Study|Lost to Follow-up|2
12292|NCT01820559|59686|P1|Overall Study|Lost to Follow-up|3
12293|NCT01820559|59684|P3|Overall Study|Subject's non-compliance|2
12294|NCT01820559|59685|P2|Overall Study|Subject's non-compliance|0
12295|NCT01820559|59686|P1|Overall Study|Subject's non-compliance|1
12296|NCT01820559|59684|P3|Overall Study|Protocol Violation|3
12297|NCT01820559|59685|P2|Overall Study|Protocol Violation|1
12298|NCT01820559|59686|P1|Overall Study|Protocol Violation|2
12299|NCT01820559|59684|P3|Overall Study|Withdrawal by Subject|5
12300|NCT01820559|59685|P2|Overall Study|Withdrawal by Subject|2
12301|NCT01820559|59686|P1|Overall Study|Withdrawal by Subject|1
12302|NCT01820559|59684|P3|Overall Study|Adverse Event|13
12303|NCT01820559|59685|P2|Overall Study|Adverse Event|6
12304|NCT01820559|59686|P1|Overall Study|Adverse Event|4
12305|NCT01819272|59825|P6|Overall Study|Loss of Glucose Control|0
12306|NCT01819272|59826|P5|Overall Study|Loss of Glucose Control|2
12307|NCT01819272|59827|P4|Overall Study|Loss of Glucose Control|1
12308|NCT01819272|59828|P3|Overall Study|Loss of Glucose Control|0
12309|NCT01819272|59829|P2|Overall Study|Loss of Glucose Control|1
12310|NCT01819272|59830|P1|Overall Study|Loss of Glucose Control|2
12311|NCT01819272|59825|P6|Overall Study|Withdrawal of Consent|1
12312|NCT01819272|59826|P5|Overall Study|Withdrawal of Consent|0
12313|NCT01819272|59827|P4|Overall Study|Withdrawal of Consent|1
12314|NCT01819272|59828|P3|Overall Study|Withdrawal of Consent|2
12315|NCT01819272|59829|P2|Overall Study|Withdrawal of Consent|1
12316|NCT01819272|59830|P1|Overall Study|Withdrawal of Consent|0
12317|NCT01819272|59825|P6|Overall Study|Physician Decision|0
12318|NCT01819272|59826|P5|Overall Study|Physician Decision|0
12319|NCT01819272|59827|P4|Overall Study|Physician Decision|0
12320|NCT01819272|59828|P3|Overall Study|Physician Decision|0
12321|NCT01819272|59829|P2|Overall Study|Physician Decision|1
12322|NCT01819272|59830|P1|Overall Study|Physician Decision|0
12323|NCT01819272|59825|P6|Overall Study|Protocol Violation|3
12324|NCT01819272|59826|P5|Overall Study|Protocol Violation|2
12325|NCT01819272|59827|P4|Overall Study|Protocol Violation|1
12326|NCT01819272|59828|P3|Overall Study|Protocol Violation|0
12327|NCT01819272|59829|P2|Overall Study|Protocol Violation|0
12328|NCT01819272|59830|P1|Overall Study|Protocol Violation|0
12329|NCT01819272|59825|P6|Overall Study|Lost to Follow-up|3
12330|NCT01819272|59826|P5|Overall Study|Lost to Follow-up|0
12331|NCT01819272|59827|P4|Overall Study|Lost to Follow-up|0
12332|NCT01819272|59828|P3|Overall Study|Lost to Follow-up|1
12333|NCT01819272|59829|P2|Overall Study|Lost to Follow-up|0
12334|NCT01819272|59830|P1|Overall Study|Lost to Follow-up|3
12335|NCT01819272|59825|P6|Overall Study|Adverse Event|0
12336|NCT01819272|59826|P5|Overall Study|Adverse Event|0
12337|NCT01819272|59827|P4|Overall Study|Adverse Event|2
12338|NCT01819272|59828|P3|Overall Study|Adverse Event|0
12339|NCT01819272|59829|P2|Overall Study|Adverse Event|0
12340|NCT01819272|59830|P1|Overall Study|Adverse Event|1
12341|NCT01819194|59856|P1|Overall Study|Loss of study articles|2
12342|NCT01818700|59861|P1|Overall Study|Other|1
12343|NCT01818700|59861|P1|Overall Study|Protocol Violation|2
12344|NCT01818700|59861|P1|Overall Study|Withdrawal by Subject|27
12345|NCT01818700|59861|P1|Overall Study|Lost to Follow-up|5
12346|NCT01818700|59861|P1|Overall Study|Lack of Efficacy|2
12347|NCT01818700|59861|P1|Overall Study|Adverse Event|67
12348|NCT01818596|59872|P2|Overall Study|Still on Study|6
12349|NCT01818596|59873|P1|Overall Study|Still on Study|232
12350|NCT01818596|59872|P2|Overall Study|Lost to Follow-up|0
12351|NCT01818596|59873|P1|Overall Study|Lost to Follow-up|2
12352|NCT01818596|59872|P2|Overall Study|Protocol Violation|0
12353|NCT01818596|59873|P1|Overall Study|Protocol Violation|1
12354|NCT01818596|59872|P2|Overall Study|Withdrew Consent|0
12355|NCT01818596|59873|P1|Overall Study|Withdrew Consent|3
12356|NCT01818596|59872|P2|Overall Study|Adverse Event|0
12357|NCT01818596|59873|P1|Overall Study|Adverse Event|4
12358|NCT01818596|59872|P2|Overall Study|Enrolled but Not Treated|0
12359|NCT01818596|59873|P1|Overall Study|Enrolled but Not Treated|4
12360|NCT01818336|59921|P2|Overall Study|Lost to Follow-up|1
12361|NCT01818336|59922|P1|Overall Study|Lost to Follow-up|0
12362|NCT01818336|59921|P2|Overall Study|Declined retest visit|11
12363|NCT01818336|59922|P1|Overall Study|Declined retest visit|0
12364|NCT01817790|59965|P2|Overall Study|Other: Could not attend appointment|1
12365|NCT01817790|59966|P1|Overall Study|Other: Could not attend appointment|1
12366|NCT01817790|59965|P2|Overall Study|Withdrawal by Subject|3
12367|NCT01817790|59966|P1|Overall Study|Withdrawal by Subject|1
12368|NCT01817790|59965|P2|Overall Study|Protocol Violation|1
12369|NCT01817790|59966|P1|Overall Study|Protocol Violation|2
12370|NCT01817790|59965|P2|Overall Study|Lost to Follow-up|1
12371|NCT01817790|59966|P1|Overall Study|Lost to Follow-up|0
12372|NCT01817790|59965|P2|Overall Study|Adverse Event|2
12373|NCT01817790|59966|P1|Overall Study|Adverse Event|0
12374|NCT01817777|60010|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
12375|NCT01817777|60011|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
12376|NCT01817777|60012|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
12377|NCT01817777|60010|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
12378|NCT01817777|60011|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
12379|NCT01817777|60012|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
12380|NCT01817777|60010|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
12381|NCT01817777|60011|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
12382|NCT01817777|60012|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
12383|NCT01817777|60010|P3|Observational Phase (8 Weeks)|Early Study Termination|0
12384|NCT01817777|60011|P2|Observational Phase (8 Weeks)|Early Study Termination|0
12385|NCT01817777|60012|P1|Observational Phase (8 Weeks)|Early Study Termination|2
12386|NCT01817777|60010|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
12387|NCT01817777|60011|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
12388|NCT01817777|60012|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
12389|NCT01817764|60036|P2|Overall Study|Withdrawal by Subject|12
12390|NCT01817764|60037|P1|Overall Study|Withdrawal by Subject|10
12391|NCT01817764|60036|P2|Overall Study|Lost to Follow-up|4
12392|NCT01817764|60037|P1|Overall Study|Lost to Follow-up|1
12393|NCT01817764|60036|P2|Overall Study|Protocol Violation|5
12394|NCT01817764|60037|P1|Overall Study|Protocol Violation|7
12395|NCT01817764|60036|P2|Overall Study|Lack of Efficacy|7
12396|NCT01817764|60037|P1|Overall Study|Lack of Efficacy|9
12397|NCT01817764|60036|P2|Overall Study|Adverse Event|10
12398|NCT01817764|60037|P1|Overall Study|Adverse Event|7
12399|NCT01816685|60047|P2|Overall Study|Surgery Cancelled|2
12400|NCT01816685|60048|P1|Overall Study|Surgery Cancelled|3
12401|NCT01816685|60047|P2|Overall Study|Lost to Follow-up|9
12402|NCT01816685|60048|P1|Overall Study|Lost to Follow-up|7
12403|NCT01816295|60100|P2|OLE Phase|Lack of Efficacy|7
12404|NCT01816295|60101|P1|OLE Phase|Lack of Efficacy|3
12405|NCT01816295|60100|P2|OLE Phase|Withdrawal by Subject|10
12406|NCT01816295|60101|P1|OLE Phase|Withdrawal by Subject|10
12407|NCT01816295|60100|P2|OLE Phase|Sponsor Decision|9
12408|NCT01816295|60101|P1|OLE Phase|Sponsor Decision|7
12409|NCT01816295|60100|P2|OLE Phase|Protocol Violation|4
12410|NCT01816295|60101|P1|OLE Phase|Protocol Violation|4
12411|NCT01816295|60100|P2|OLE Phase|Physician Decision|1
12412|NCT01816295|60101|P1|OLE Phase|Physician Decision|3
12413|NCT01816295|60100|P2|OLE Phase|Lost to Follow-up|5
12414|NCT01816295|60101|P1|OLE Phase|Lost to Follow-up|5
12415|NCT01816295|60100|P2|OLE Phase|Entry Criteria Not Met|5
12416|NCT01816295|60101|P1|OLE Phase|Entry Criteria Not Met|3
12417|NCT01816295|60100|P2|OLE Phase|Death|0
12418|NCT01816295|60101|P1|OLE Phase|Death|1
12419|NCT01816295|60100|P2|OLE Phase|Adverse Event|15
12420|NCT01816295|60101|P1|OLE Phase|Adverse Event|17
12421|NCT01816295|60100|P2|Double Blind Phase|Withdrawal by Subject|20
12422|NCT01816295|60101|P1|Double Blind Phase|Withdrawal by Subject|22
12423|NCT01816295|60100|P2|Double Blind Phase|Sponsor Decision|8
12424|NCT01816295|60101|P1|Double Blind Phase|Sponsor Decision|8
12425|NCT01816295|60100|P2|Double Blind Phase|Protocol Violation|11
12426|NCT01816295|60101|P1|Double Blind Phase|Protocol Violation|17
12427|NCT01816295|60100|P2|Double Blind Phase|Physician Decision|2
12428|NCT01816295|60101|P1|Double Blind Phase|Physician Decision|2
12429|NCT01816295|60100|P2|Double Blind Phase|Lost to Follow-up|5
12430|NCT01816295|60101|P1|Double Blind Phase|Lost to Follow-up|3
12431|NCT01816295|60100|P2|Double Blind Phase|Entry Criteria Not Met|2
12432|NCT01816295|60101|P1|Double Blind Phase|Entry Criteria Not Met|0
12433|NCT01816295|60100|P2|Double Blind Phase|Adverse Event|8
12434|NCT01816295|60101|P1|Double Blind Phase|Adverse Event|11
12435|NCT01816243|60116|P1|Overall Study|Amputation|3
12436|NCT01816243|60116|P1|Overall Study|Not eligible for the study|1
12437|NCT01816243|60116|P1|Overall Study|Lack of Efficacy|1
12438|NCT01816243|60116|P1|Overall Study|Lost to Follow-up|1
12439|NCT01816243|60116|P1|Overall Study|Adverse Event|6
12440|NCT01815840|60125|P2|Overall Study|Still on Study|64
12441|NCT01815840|60126|P1|Overall Study|Still on Study|73
12442|NCT01815840|60125|P2|Overall Study|Missing|1
12443|NCT01815840|60126|P1|Overall Study|Missing|1
12444|NCT01815840|60125|P2|Overall Study|Withdrew Consent|26
12445|NCT01815840|60126|P1|Overall Study|Withdrew Consent|26
12446|NCT01815840|60125|P2|Overall Study|Refused Treatment|1
12447|NCT01815840|60126|P1|Overall Study|Refused Treatment|3
12448|NCT01815840|60125|P2|Overall Study|Lost to Follow-up|2
12449|NCT01815840|60126|P1|Overall Study|Lost to Follow-up|1
12450|NCT01815840|60125|P2|Overall Study|Investigator Decision|3
12451|NCT01815840|60126|P1|Overall Study|Investigator Decision|1
12452|NCT01815840|60125|P2|Overall Study|Disease Progression|0
12453|NCT01815840|60126|P1|Overall Study|Disease Progression|1
12454|NCT01815840|60125|P2|Overall Study|Death|2
12455|NCT01815840|60126|P1|Overall Study|Death|2
12456|NCT01815840|60125|P2|Overall Study|Adverse Event|14
12457|NCT01815840|60126|P1|Overall Study|Adverse Event|8
12458|NCT01815736|60156|P2|Overall Study|Still on Study|449
12459|NCT01815736|60157|P1|Overall Study|Still on Study|929
12460|NCT01815736|60156|P2|Overall Study|Lost to Follow-up|7
12461|NCT01815736|60157|P1|Overall Study|Lost to Follow-up|6
12462|NCT01815736|60156|P2|Overall Study|Withdrew Consent|15
12463|NCT01815736|60157|P1|Overall Study|Withdrew Consent|7
12464|NCT01815736|60156|P2|Overall Study|Investigator's Discretion|0
12465|NCT01815736|60157|P1|Overall Study|Investigator's Discretion|4
12466|NCT01815736|60156|P2|Overall Study|Death|0
12467|NCT01815736|60157|P1|Overall Study|Death|4
12468|NCT01815736|60156|P2|Overall Study|Adverse Event|4
12469|NCT01815736|60157|P1|Overall Study|Adverse Event|7
12470|NCT01815736|60156|P2|Overall Study|Randomized but Not Treated|3
12471|NCT01815736|60157|P1|Overall Study|Randomized but Not Treated|4
12472|NCT01814878|60193|P2|Overall Study|Unspecified|0
12473|NCT01814878|60194|P1|Overall Study|Unspecified|2
12474|NCT01814878|60193|P2|Overall Study|Screening failure (drop-out)|3
12475|NCT01814878|60194|P1|Overall Study|Screening failure (drop-out)|0
12476|NCT01814878|60193|P2|Overall Study|Physician Decision|1
12477|NCT01814878|60194|P1|Overall Study|Physician Decision|3
12478|NCT01814878|60193|P2|Overall Study|Protocol Violation|5
12479|NCT01814878|60194|P1|Overall Study|Protocol Violation|5
12480|NCT01814878|60193|P2|Overall Study|Withdrawal by Subject|16
12481|NCT01814878|60194|P1|Overall Study|Withdrawal by Subject|20
12482|NCT01814878|60193|P2|Overall Study|Adverse Event|5
12483|NCT01814878|60194|P1|Overall Study|Adverse Event|16
12484|NCT01814800|60214|P1|Overall Study|Subject relocation|1
12485|NCT01814800|60214|P1|Overall Study|Sponsor decision|1
12486|NCT01814800|60214|P1|Overall Study|Pregnancy|1
12487|NCT01814800|60214|P1|Overall Study|Adverse Event|2
12488|NCT01814761|60265|P2|Overall Study|Lost to Follow-up|5
12489|NCT01814761|60266|P1|Overall Study|Lost to Follow-up|1
12490|NCT01814761|60265|P2|Overall Study|Ocular Adverse Event|15
12491|NCT01814761|60266|P1|Overall Study|Ocular Adverse Event|6
12492|NCT01814761|60265|P2|Overall Study|Other Reasons|10
12493|NCT01814761|60266|P1|Overall Study|Other Reasons|1
12494|NCT01814748|60280|P2|Overall Study|Withdrawal by Subject|4
12495|NCT01814748|60281|P1|Overall Study|Withdrawal by Subject|6
12496|NCT01814748|60280|P2|Overall Study|Study site terminated by sponsor|1
12497|NCT01814748|60281|P1|Overall Study|Study site terminated by sponsor|1
12498|NCT01814748|60280|P2|Overall Study|Lost to Follow-up|2
12499|NCT01814748|60281|P1|Overall Study|Lost to Follow-up|1
12500|NCT01814696|60325|P2|Overall Study|Randomized to wrong group|0
12501|NCT01814696|60326|P1|Overall Study|Randomized to wrong group|1
12502|NCT01814696|60325|P2|Overall Study|Withdrawal by Subject|0
12503|NCT01814696|60326|P1|Overall Study|Withdrawal by Subject|1
12504|NCT01814670|60344|P1|Overall Study|Protocol Violation|12
12505|NCT01814553|60354|P2|Overall Study|Other than stated|8
12506|NCT01814553|60355|P1|Overall Study|Other than stated|7
12507|NCT01814553|60354|P2|Overall Study|Withdrawal by Subject|1
12508|NCT01814553|60355|P1|Overall Study|Withdrawal by Subject|1
12509|NCT01814553|60354|P2|Overall Study|Other Adverse Event|5
12510|NCT01814553|60355|P1|Overall Study|Other Adverse Event|4
12511|NCT01814553|60354|P2|Overall Study|PD per clinical progression|8
12512|NCT01814553|60355|P1|Overall Study|PD per clinical progression|6
12513|NCT01814397|60369|P1|Overall Study|Withdrawal by Subject|7
12514|NCT01814397|60369|P1|Overall Study|Adverse Event|7
12515|NCT01814332|60378|P2|Overall Study|Lost to Follow-up|1
12516|NCT01814332|60379|P1|Overall Study|Lost to Follow-up|5
12517|NCT01814332|60378|P2|Overall Study|Protocol Violation|4
12518|NCT01814332|60379|P1|Overall Study|Protocol Violation|0
12519|NCT01814332|60378|P2|Overall Study|Withdrawal by Subject|8
12520|NCT01814332|60379|P1|Overall Study|Withdrawal by Subject|3
12521|NCT01814332|60378|P2|Overall Study|Adverse Event|3
12522|NCT01814332|60379|P1|Overall Study|Adverse Event|8
12523|NCT01814137|60393|P2|Overall Study|Unclassified|1
12524|NCT01814137|60394|P1|Overall Study|Unclassified|2
12525|NCT01814137|60393|P2|Overall Study|Physician Decision|1
12526|NCT01814137|60394|P1|Overall Study|Physician Decision|1
12527|NCT01814137|60393|P2|Overall Study|Withdrawal by Subject|2
12528|NCT01814137|60394|P1|Overall Study|Withdrawal by Subject|2
12529|NCT01814137|60393|P2|Overall Study|Adverse Event|1
12530|NCT01814137|60394|P1|Overall Study|Adverse Event|0
12531|NCT01813890|60411|P3|Overall Study|Lack of Efficacy|2
12532|NCT01813890|60412|P2|Overall Study|Lack of Efficacy|1
12533|NCT01813890|60413|P1|Overall Study|Lack of Efficacy|9
12534|NCT01813890|60411|P3|Overall Study|Adverse Event|4
12535|NCT01813890|60412|P2|Overall Study|Adverse Event|3
12536|NCT01813890|60413|P1|Overall Study|Adverse Event|0
12537|NCT01813721|60442|P1|Overall Study|Withdrawal by Subject|1
12538|NCT01813721|60442|P1|Overall Study|Ineligibility determined|63
12539|NCT01813019|60496|P2|Overall Study|Protocol Deviation|1
12540|NCT01813019|60497|P1|Overall Study|Protocol Deviation|2
12541|NCT01813019|60496|P2|Overall Study|administrative problems|0
12542|NCT01813019|60497|P1|Overall Study|administrative problems|2
12543|NCT01813019|60496|P2|Overall Study|Withdrawal by Subject|2
12544|NCT01813019|60497|P1|Overall Study|Withdrawal by Subject|3
12545|NCT01813019|60496|P2|Overall Study|Adverse Event|3
12546|NCT01813019|60497|P1|Overall Study|Adverse Event|0
12547|NCT01812837|60508|P3|Overall Study|Protocol Violation|0
12548|NCT01812837|60509|P2|Overall Study|Protocol Violation|0
12549|NCT01812837|60510|P1|Overall Study|Protocol Violation|1
12550|NCT01812837|60508|P3|Overall Study|Lost to Follow-up|0
12551|NCT01812837|60509|P2|Overall Study|Lost to Follow-up|1
12552|NCT01812837|60510|P1|Overall Study|Lost to Follow-up|1
12553|NCT01812707|60522|P4|Overall Study|Consent withdrawn by participant|0
12554|NCT01812707|60523|P3|Overall Study|Consent withdrawn by participant|0
12555|NCT01812707|60524|P2|Overall Study|Consent withdrawn by participant|0
12556|NCT01812707|60525|P1|Overall Study|Consent withdrawn by participant|1
12557|NCT01812707|60522|P4|Overall Study|Poor compliance to protocol|0
12558|NCT01812707|60523|P3|Overall Study|Poor compliance to protocol|0
12559|NCT01812707|60524|P2|Overall Study|Poor compliance to protocol|0
12560|NCT01812707|60525|P1|Overall Study|Poor compliance to protocol|1
12561|NCT01812707|60522|P4|Overall Study|Adverse Event|2
12562|NCT01812707|60523|P3|Overall Study|Adverse Event|0
12563|NCT01812707|60524|P2|Overall Study|Adverse Event|0
12564|NCT01812707|60525|P1|Overall Study|Adverse Event|0
12565|NCT01812655|60573|P3|Overall Study|Protocol Violation|0
12566|NCT01812655|60574|P2|Overall Study|Protocol Violation|1
12567|NCT01812655|60575|P1|Overall Study|Protocol Violation|1
12568|NCT01811953|60638|P6|Overall Study|Protocol Violation|0
12569|NCT01811953|60639|P5|Overall Study|Protocol Violation|1
12570|NCT01811953|60640|P4|Overall Study|Protocol Violation|0
12571|NCT01811953|60641|P3|Overall Study|Protocol Violation|0
12572|NCT01811953|60642|P2|Overall Study|Protocol Violation|0
12573|NCT01811953|60643|P1|Overall Study|Protocol Violation|0
12574|NCT01811953|60638|P6|Overall Study|Adverse Event|1
12575|NCT01811953|60639|P5|Overall Study|Adverse Event|0
12576|NCT01811953|60640|P4|Overall Study|Adverse Event|1
12577|NCT01811953|60641|P3|Overall Study|Adverse Event|0
12578|NCT01811953|60642|P2|Overall Study|Adverse Event|0
12579|NCT01811953|60643|P1|Overall Study|Adverse Event|0
12580|NCT01811706|60687|P2|First Intervention ( 4 Weeks)|Adverse Event|0
12581|NCT01811706|60688|P1|First Intervention ( 4 Weeks)|Adverse Event|1
12582|NCT01811485|60706|P3|Overall Study|Protocol Deviation|0
12583|NCT01811485|60707|P2|Overall Study|Protocol Deviation|1
12584|NCT01811485|60708|P1|Overall Study|Protocol Deviation|0
12585|NCT01811485|60706|P3|Overall Study|Administrative problems|0
12586|NCT01811485|60707|P2|Overall Study|Administrative problems|0
12587|NCT01811485|60708|P1|Overall Study|Administrative problems|1
12588|NCT01811485|60706|P3|Overall Study|Unsatisfactory therapeutic effect|3
12589|NCT01811485|60707|P2|Overall Study|Unsatisfactory therapeutic effect|0
12590|NCT01811485|60708|P1|Overall Study|Unsatisfactory therapeutic effect|0
12591|NCT01811485|60706|P3|Overall Study|Adverse Event|2
12592|NCT01811485|60707|P2|Overall Study|Adverse Event|3
12593|NCT01811485|60708|P1|Overall Study|Adverse Event|1
12594|NCT01811472|60728|P3|Overall Study|Subject/guardian decision|0
12595|NCT01811472|60729|P2|Overall Study|Subject/guardian decision|0
12596|NCT01811472|60730|P1|Overall Study|Subject/guardian decision|1
12597|NCT01811472|60728|P3|Overall Study|Lost to Follow-up|1
12598|NCT01811472|60729|P2|Overall Study|Lost to Follow-up|0
12599|NCT01811472|60730|P1|Overall Study|Lost to Follow-up|0
12600|NCT01811472|60728|P3|Overall Study|Adverse Event|4
12601|NCT01811472|60729|P2|Overall Study|Adverse Event|0
12602|NCT01811472|60730|P1|Overall Study|Adverse Event|1
12603|NCT01811238|60786|P1|Overall Study|subject refused study medication|6
12604|NCT01811238|60786|P1|Overall Study|Lack of Efficacy|4
12605|NCT01811238|60786|P1|Overall Study|Protocol Violation|4
12606|NCT01811238|60786|P1|Overall Study|Adverse Event|25
12607|NCT01811238|60786|P1|Overall Study|Withdrawal by Subject|42
12608|NCT01810939|60812|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
12609|NCT01810939|60813|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
12610|NCT01810939|60814|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
12611|NCT01810939|60812|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
12612|NCT01810939|60813|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
12613|NCT01810939|60814|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
12614|NCT01810939|60812|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
12615|NCT01810939|60813|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
12616|NCT01810939|60814|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
12617|NCT01810939|60812|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
12618|NCT01810939|60813|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
12619|NCT01810939|60814|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
12620|NCT01810939|60812|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
12621|NCT01810939|60813|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
12622|NCT01810939|60814|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
12623|NCT01810939|60812|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
12624|NCT01810939|60813|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
12625|NCT01810939|60814|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
12626|NCT01810939|60812|P3|Part B Placebo-Controlled Withdrawal|Death|1
12627|NCT01810939|60813|P2|Part B Placebo-Controlled Withdrawal|Death|0
12628|NCT01810939|60814|P1|Part B Placebo-Controlled Withdrawal|Death|0
12629|NCT01810939|60812|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
12630|NCT01810939|60813|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
12631|NCT01810939|60814|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
12632|NCT01810939|60812|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
12633|NCT01810939|60813|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
12634|NCT01810939|60814|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
12635|NCT01810939|60812|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
12636|NCT01810939|60813|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
12637|NCT01810939|60814|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
12638|NCT01810939|60812|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
12639|NCT01810939|60813|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
12640|NCT01810939|60814|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
12641|NCT01810939|60812|P3|Part A Treatment Period|Protocol-specified (High K+)|0
12642|NCT01810939|60813|P2|Part A Treatment Period|Protocol-specified (High K+)|0
12643|NCT01810939|60814|P1|Part A Treatment Period|Protocol-specified (High K+)|3
12644|NCT01810939|60812|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
12645|NCT01810939|60813|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
12646|NCT01810939|60814|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
12647|NCT01810939|60812|P3|Part A Treatment Period|Withdrawal by Subject|0
12648|NCT01810939|60813|P2|Part A Treatment Period|Withdrawal by Subject|0
12649|NCT01810939|60814|P1|Part A Treatment Period|Withdrawal by Subject|5
12650|NCT01810939|60812|P3|Part A Treatment Period|Adverse Event|0
12651|NCT01810939|60813|P2|Part A Treatment Period|Adverse Event|0
12652|NCT01810939|60814|P1|Part A Treatment Period|Adverse Event|10
12653|NCT01810939|60812|P3|Part A Treatment Period|Protocol Violation|0
12654|NCT01810939|60813|P2|Part A Treatment Period|Protocol Violation|0
12655|NCT01810939|60814|P1|Part A Treatment Period|Protocol Violation|2
12656|NCT01810939|60812|P3|Part A Treatment Period|Non-compliance with Study Drug|0
12657|NCT01810939|60813|P2|Part A Treatment Period|Non-compliance with Study Drug|0
12658|NCT01810939|60814|P1|Part A Treatment Period|Non-compliance with Study Drug|1
12659|NCT01810380|60851|P3|Overall Study|Administrative or other reasons|9
12660|NCT01810380|60852|P2|Overall Study|Administrative or other reasons|13
12661|NCT01810380|60853|P1|Overall Study|Administrative or other reasons|11
12662|NCT01810380|60851|P3|Overall Study|Withdrawal by Subject|6
12663|NCT01810380|60852|P2|Overall Study|Withdrawal by Subject|0
12664|NCT01810380|60853|P1|Overall Study|Withdrawal by Subject|6
12665|NCT01810380|60851|P3|Overall Study|Protocol Violation|1
12666|NCT01810380|60852|P2|Overall Study|Protocol Violation|0
12667|NCT01810380|60853|P1|Overall Study|Protocol Violation|1
12668|NCT01810380|60851|P3|Overall Study|Lack of Efficacy|11
12669|NCT01810380|60852|P2|Overall Study|Lack of Efficacy|10
12670|NCT01810380|60853|P1|Overall Study|Lack of Efficacy|24
12671|NCT01810380|60851|P3|Overall Study|Adverse Event|4
12672|NCT01810380|60852|P2|Overall Study|Adverse Event|14
12673|NCT01810380|60853|P1|Overall Study|Adverse Event|11
12674|NCT01810380|60851|P3|Overall Study|Randomised not treated|1
12675|NCT01810380|60852|P2|Overall Study|Randomised not treated|1
12676|NCT01810380|60853|P1|Overall Study|Randomised not treated|2
12677|NCT01810302|60914|P2|Overall Study|Physician Decision|1
12678|NCT01810302|60915|P1|Overall Study|Physician Decision|0
12679|NCT01810302|60914|P2|Overall Study|Death|0
12680|NCT01810302|60915|P1|Overall Study|Death|1
12681|NCT01810263|60925|P2|Overall Study|Lost to Follow-up|7
12682|NCT01810263|60926|P1|Overall Study|Lost to Follow-up|8
12683|NCT01810042|60932|P1|Overall Study|Lost to Follow-up|10
12684|NCT01808339|60982|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
12685|NCT01808339|60983|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
12686|NCT01808339|60984|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
12687|NCT01808339|60985|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
12688|NCT01808339|60986|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
12689|NCT01808339|60987|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
12690|NCT01808339|60982|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
12691|NCT01808339|60983|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
12692|NCT01808339|60984|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
12693|NCT01808339|60985|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
12694|NCT01808339|60986|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
12695|NCT01808339|60987|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
12696|NCT01808339|60982|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
12697|NCT01808339|60983|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
12698|NCT01808339|60984|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
12699|NCT01808339|60985|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
12700|NCT01808339|60986|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
12701|NCT01808339|60987|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
12702|NCT01809327|61036|P5|Overall Study|Unspecified|9
12703|NCT01809327|61037|P4|Overall Study|Unspecified|4
12704|NCT01809327|61038|P3|Overall Study|Unspecified|7
12705|NCT01809327|61039|P2|Overall Study|Unspecified|15
12706|NCT01809327|61040|P1|Overall Study|Unspecified|14
12707|NCT01809327|61036|P5|Overall Study|Pregnancy|0
12708|NCT01809327|61037|P4|Overall Study|Pregnancy|0
12709|NCT01809327|61038|P3|Overall Study|Pregnancy|0
12710|NCT01809327|61039|P2|Overall Study|Pregnancy|0
12711|NCT01809327|61040|P1|Overall Study|Pregnancy|1
12712|NCT01809327|61036|P5|Overall Study|Physician Decision|0
12713|NCT01809327|61037|P4|Overall Study|Physician Decision|0
12714|NCT01809327|61038|P3|Overall Study|Physician Decision|0
12715|NCT01809327|61039|P2|Overall Study|Physician Decision|1
12716|NCT01809327|61040|P1|Overall Study|Physician Decision|1
12717|NCT01809327|61036|P5|Overall Study|Protocol Violation|0
12718|NCT01809327|61037|P4|Overall Study|Protocol Violation|0
12719|NCT01809327|61038|P3|Overall Study|Protocol Violation|0
12720|NCT01809327|61039|P2|Overall Study|Protocol Violation|1
12721|NCT01809327|61040|P1|Overall Study|Protocol Violation|0
12722|NCT01809327|61036|P5|Overall Study|Death|0
12723|NCT01809327|61037|P4|Overall Study|Death|0
12724|NCT01809327|61038|P3|Overall Study|Death|0
12725|NCT01809327|61039|P2|Overall Study|Death|0
12726|NCT01809327|61040|P1|Overall Study|Death|1
12727|NCT01809327|61036|P5|Overall Study|Adverse Event|8
12728|NCT01809327|61037|P4|Overall Study|Adverse Event|4
12729|NCT01809327|61038|P3|Overall Study|Adverse Event|7
12730|NCT01809327|61039|P2|Overall Study|Adverse Event|3
12731|NCT01809327|61040|P1|Overall Study|Adverse Event|4
12732|NCT01809327|61036|P5|Overall Study|Withdrawal by Subject|5
12733|NCT01809327|61037|P4|Overall Study|Withdrawal by Subject|2
12734|NCT01809327|61038|P3|Overall Study|Withdrawal by Subject|4
12735|NCT01809327|61039|P2|Overall Study|Withdrawal by Subject|4
12736|NCT01809327|61040|P1|Overall Study|Withdrawal by Subject|6
12737|NCT01809327|61036|P5|Overall Study|Lost to Follow-up|3
12738|NCT01809327|61037|P4|Overall Study|Lost to Follow-up|2
12739|NCT01809327|61038|P3|Overall Study|Lost to Follow-up|4
12740|NCT01809327|61039|P2|Overall Study|Lost to Follow-up|2
12741|NCT01809327|61040|P1|Overall Study|Lost to Follow-up|5
12742|NCT01809314|61082|P1|Overall Study|Lost to Follow-up|724
12743|NCT01809314|61082|P1|Overall Study|Insufficient Therapeutic Response|14
12744|NCT01809314|61082|P1|Overall Study|Adverse Event|6
12745|NCT01809314|61082|P1|Overall Study|Withdrawal Prior to Treatment|1
12746|NCT01809262|61088|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
12747|NCT01809262|61089|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
12748|NCT01809262|61090|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
12749|NCT01809262|61091|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
12750|NCT01809262|61092|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
12751|NCT01809262|61093|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
12752|NCT01809262|61094|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
12753|NCT01809262|61095|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
12754|NCT01809262|61096|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
12755|NCT01809262|61097|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
12756|NCT01809262|61088|P10|Period 1 (First Dose + Washout)|Adverse Event|0
12757|NCT01809262|61089|P9|Period 1 (First Dose + Washout)|Adverse Event|0
12758|NCT01809262|61090|P8|Period 1 (First Dose + Washout)|Adverse Event|0
12759|NCT01809262|61091|P7|Period 1 (First Dose + Washout)|Adverse Event|0
12760|NCT01809262|61092|P6|Period 1 (First Dose + Washout)|Adverse Event|0
12761|NCT01809262|61093|P5|Period 1 (First Dose + Washout)|Adverse Event|1
12762|NCT01809262|61094|P4|Period 1 (First Dose + Washout)|Adverse Event|0
12763|NCT01809262|61095|P3|Period 1 (First Dose + Washout)|Adverse Event|0
12764|NCT01809262|61096|P2|Period 1 (First Dose + Washout)|Adverse Event|0
12765|NCT01809262|61097|P1|Period 1 (First Dose + Washout)|Adverse Event|0
12766|NCT01809197|61166|P2|Overall Study|Product not available|1
12767|NCT01809197|61167|P1|Overall Study|Product not available|0
12768|NCT01809197|61166|P2|Overall Study|Withdrawal by Subject|1
12769|NCT01809197|61167|P1|Overall Study|Withdrawal by Subject|1
12770|NCT01809197|61166|P2|Overall Study|Decision Unrelated to an Adverse Event|0
12771|NCT01809197|61167|P1|Overall Study|Decision Unrelated to an Adverse Event|1
12772|NCT01809197|61166|P2|Overall Study|Non-Compliance|1
12773|NCT01809197|61167|P1|Overall Study|Non-Compliance|1
12774|NCT01809197|61166|P2|Overall Study|Failed slit lamp exam|0
12775|NCT01809197|61167|P1|Overall Study|Failed slit lamp exam|1
12776|NCT01809197|61166|P2|Overall Study|Adverse Event|3
12777|NCT01809197|61167|P1|Overall Study|Adverse Event|2
16769|NCT01708954|78368|P2|Step 1|Death|2
12778|NCT01809197|61166|P2|Overall Study|Lost to Follow-up|2
12779|NCT01809197|61167|P1|Overall Study|Lost to Follow-up|4
12780|NCT01808651|61238|P3|Study Period 1|Participant Decision|3
12781|NCT01808651|61239|P2|Study Period 1|Participant Decision|7
12782|NCT01808651|61240|P1|Study Period 1|Participant Decision|9
12783|NCT01808651|61238|P3|Study Period 1|Adverse Event|1
12784|NCT01808651|61239|P2|Study Period 1|Adverse Event|4
12785|NCT01808651|61240|P1|Study Period 1|Adverse Event|10
12786|NCT01808651|61238|P3|Study Period 1|Lack of Efficacy|0
12787|NCT01808651|61239|P2|Study Period 1|Lack of Efficacy|1
12788|NCT01808651|61240|P1|Study Period 1|Lack of Efficacy|2
12789|NCT01808651|61238|P3|Study Period 1|Physician Decision|0
12790|NCT01808651|61239|P2|Study Period 1|Physician Decision|2
12791|NCT01808651|61240|P1|Study Period 1|Physician Decision|3
12792|NCT01808651|61238|P3|Study Period 1|Protocol Violation|1
12793|NCT01808651|61239|P2|Study Period 1|Protocol Violation|0
12794|NCT01808651|61240|P1|Study Period 1|Protocol Violation|1
12795|NCT01808651|61238|P3|Study Period 1|Lost to Follow-up|0
12796|NCT01808651|61239|P2|Study Period 1|Lost to Follow-up|3
12797|NCT01808651|61240|P1|Study Period 1|Lost to Follow-up|1
12798|NCT01808612|61275|P3|Discontinuation Period|Lost to Follow-up|0
12799|NCT01808612|61276|P2|Discontinuation Period|Lost to Follow-up|1
12800|NCT01808612|61277|P1|Discontinuation Period|Lost to Follow-up|0
12801|NCT01808612|61275|P3|Discontinuation Period|Physician Decision|0
12802|NCT01808612|61276|P2|Discontinuation Period|Physician Decision|0
12803|NCT01808612|61277|P1|Discontinuation Period|Physician Decision|1
12804|NCT01808612|61275|P3|Discontinuation Period|Adverse Event|0
12805|NCT01808612|61276|P2|Discontinuation Period|Adverse Event|0
12806|NCT01808612|61277|P1|Discontinuation Period|Adverse Event|1
12807|NCT01808612|61275|P3|Treatment Period|Lack of Efficacy|2
12808|NCT01808612|61276|P2|Treatment Period|Lack of Efficacy|1
12809|NCT01808612|61277|P1|Treatment Period|Lack of Efficacy|1
12810|NCT01808612|61275|P3|Treatment Period|Sponsor Decision|0
12811|NCT01808612|61276|P2|Treatment Period|Sponsor Decision|0
12812|NCT01808612|61277|P1|Treatment Period|Sponsor Decision|1
12813|NCT01808612|61275|P3|Treatment Period|Physician Decision|4
12814|NCT01808612|61276|P2|Treatment Period|Physician Decision|0
12815|NCT01808612|61277|P1|Treatment Period|Physician Decision|1
12816|NCT01808612|61275|P3|Treatment Period|Withdrawal by Subject|4
12817|NCT01808612|61276|P2|Treatment Period|Withdrawal by Subject|0
12818|NCT01808612|61277|P1|Treatment Period|Withdrawal by Subject|1
12819|NCT01808612|61275|P3|Treatment Period|Protocol Violation|0
12820|NCT01808612|61276|P2|Treatment Period|Protocol Violation|0
12821|NCT01808612|61277|P1|Treatment Period|Protocol Violation|1
12822|NCT01808612|61275|P3|Treatment Period|Lost to Follow-up|1
12823|NCT01808612|61276|P2|Treatment Period|Lost to Follow-up|2
12824|NCT01808612|61277|P1|Treatment Period|Lost to Follow-up|2
12825|NCT01808612|61275|P3|Treatment Period|Adverse Event|3
12826|NCT01808612|61276|P2|Treatment Period|Adverse Event|4
12827|NCT01808612|61277|P1|Treatment Period|Adverse Event|8
12828|NCT01808534|61315|P1|Overall Study|Physician Decision|1
12829|NCT01808534|61315|P1|Overall Study|Disease progression|3
12830|NCT01808508|61326|P3|Overall Study|Lost to Follow-up|0
12831|NCT01808508|61327|P2|Overall Study|Lost to Follow-up|0
12832|NCT01808508|61328|P1|Overall Study|Lost to Follow-up|1
12833|NCT01808313|61345|P1|Overall Study|Physician Decision|1
12834|NCT01808313|61345|P1|Overall Study|Lost to Follow-up|1
12835|NCT01808313|61345|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
12836|NCT01808313|61345|P1|Overall Study|Protocol Violation|2
12837|NCT01808313|61345|P1|Overall Study|Adverse Event|5
12838|NCT01808248|61375|P1|Overall Study|Lost to Follow-up|1
12839|NCT01808248|61375|P1|Overall Study|Withdrawal by Subject|1
12840|NCT01808248|61375|P1|Overall Study|Lack of Efficacy|3
12841|NCT01808209|61389|P2|Overall Study|Lost to Follow-up|1
12842|NCT01808209|61390|P1|Overall Study|Lost to Follow-up|0
12843|NCT01808092|61434|P2|Overall Study|Other Eligibility criteria|5
12844|NCT01808092|61435|P1|Overall Study|Other Eligibility criteria|3
12845|NCT01808092|61434|P2|Overall Study|Withdrawal by Subject|4
12846|NCT01808092|61435|P1|Overall Study|Withdrawal by Subject|9
12847|NCT01808092|61434|P2|Overall Study|Lost to Follow-up|7
12848|NCT01808092|61435|P1|Overall Study|Lost to Follow-up|3
12849|NCT01808092|61434|P2|Overall Study|Death|29
12850|NCT01808092|61435|P1|Overall Study|Death|39
12851|NCT01808066|61537|P1|Overall Study|Withdrawal by Subject|15
12852|NCT01807949|61544|P3|Overall Study|Randomized But Not Treated|2
12853|NCT01807949|61545|P2|Overall Study|Randomized But Not Treated|2
12854|NCT01807949|61546|P1|Overall Study|Randomized But Not Treated|0
12855|NCT01807949|61544|P3|Overall Study|Undefined|2
12856|NCT01807949|61545|P2|Overall Study|Undefined|1
12857|NCT01807949|61546|P1|Overall Study|Undefined|0
12858|NCT01807949|61544|P3|Overall Study|Non-Compliance|1
12859|NCT01807949|61545|P2|Overall Study|Non-Compliance|0
12860|NCT01807949|61546|P1|Overall Study|Non-Compliance|0
12861|NCT01807949|61544|P3|Overall Study|Withdrawal by Subject|2
12862|NCT01807949|61545|P2|Overall Study|Withdrawal by Subject|2
12863|NCT01807949|61546|P1|Overall Study|Withdrawal by Subject|1
12864|NCT01807949|61544|P3|Overall Study|Adverse Event|2
12865|NCT01807949|61545|P2|Overall Study|Adverse Event|2
16770|NCT01708954|78369|P1|Step 1|Death|3
12866|NCT01807949|61546|P1|Overall Study|Adverse Event|1
12867|NCT01807923|61598|P3|Overall Study|Randomized But Not Treated|5
12868|NCT01807923|61599|P2|Overall Study|Randomized But Not Treated|2
12869|NCT01807923|61600|P1|Overall Study|Randomized But Not Treated|3
12870|NCT01807923|61598|P3|Overall Study|Not Eligible (Genotype)|1
12871|NCT01807923|61599|P2|Overall Study|Not Eligible (Genotype)|0
12872|NCT01807923|61600|P1|Overall Study|Not Eligible (Genotype)|0
12873|NCT01807923|61598|P3|Overall Study|Physician Decision|1
12874|NCT01807923|61599|P2|Overall Study|Physician Decision|0
12875|NCT01807923|61600|P1|Overall Study|Physician Decision|0
12876|NCT01807923|61598|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
12877|NCT01807923|61599|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
12878|NCT01807923|61600|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
12879|NCT01807923|61598|P3|Overall Study|Adverse Event|2
12880|NCT01807923|61599|P2|Overall Study|Adverse Event|1
12881|NCT01807923|61600|P1|Overall Study|Adverse Event|2
12882|NCT01807156|61673|P1|Overall Study|Physician Decision|1
12883|NCT01806961|61697|P1|Overall Study|sponsor decision|16
12884|NCT01806779|61703|P3|Overall Study|Withdrawal by Subject|22
12885|NCT01806779|61704|P2|Overall Study|Withdrawal by Subject|23
12886|NCT01806779|61705|P1|Overall Study|Withdrawal by Subject|20
12887|NCT01806779|61703|P3|Overall Study|Lost to Follow-up|0
12888|NCT01806779|61704|P2|Overall Study|Lost to Follow-up|20
12889|NCT01806779|61705|P1|Overall Study|Lost to Follow-up|19
12890|NCT01806779|61703|P3|Overall Study|Lack of Efficacy|0
12891|NCT01806779|61704|P2|Overall Study|Lack of Efficacy|1
12892|NCT01806779|61705|P1|Overall Study|Lack of Efficacy|1
12893|NCT01806779|61703|P3|Overall Study|Physician Decision|1
12894|NCT01806779|61704|P2|Overall Study|Physician Decision|0
12895|NCT01806779|61705|P1|Overall Study|Physician Decision|2
12896|NCT01806623|61718|P1|Overall Study|Did not meet the inclusion criteria|56
12897|NCT01806623|61718|P1|Overall Study|Adverse Event|1
12898|NCT01806623|61718|P1|Overall Study|Withdrawal by Subject|1
12899|NCT01806584|61737|P2|Overall Study|Other unspecified|0
12900|NCT01806584|61738|P1|Overall Study|Other unspecified|1
12901|NCT01806584|61737|P2|Overall Study|Withdrawal by Subject|1
12902|NCT01806584|61738|P1|Overall Study|Withdrawal by Subject|1
12903|NCT01806584|61737|P2|Overall Study|Study terminated by sponsor|14
12904|NCT01806584|61738|P1|Overall Study|Study terminated by sponsor|9
12905|NCT01806584|61737|P2|Overall Study|Lost to Follow-up|2
12906|NCT01806584|61738|P1|Overall Study|Lost to Follow-up|0
12907|NCT01806584|61737|P2|Overall Study|Death|0
12908|NCT01806584|61738|P1|Overall Study|Death|1
12909|NCT01806584|61737|P2|Overall Study|Adverse Event|1
12910|NCT01806584|61738|P1|Overall Study|Adverse Event|2
12911|NCT01806545|61752|P2|Overall Study|Withdrawal by Subject|2
12912|NCT01806545|61753|P1|Overall Study|Withdrawal by Subject|3
12913|NCT01806545|61752|P2|Overall Study|Lost to Follow-up|0
12914|NCT01806545|61753|P1|Overall Study|Lost to Follow-up|1
12915|NCT01806545|61752|P2|Overall Study|Adverse Event|3
12916|NCT01806545|61753|P1|Overall Study|Adverse Event|2
12917|NCT01806051|61775|P1|Overall Study|Withdrawal by Subject|6
12918|NCT01805180|61792|P3|Lead-in Donor Phase|screen failure|0
12919|NCT01805180|61793|P2|Lead-in Donor Phase|screen failure|0
12920|NCT01805180|61794|P1|Lead-in Donor Phase|screen failure|1
12921|NCT01804946|61832|P2|Overall Study|Do not meet inclusion criteria|2
12922|NCT01804946|61833|P1|Overall Study|Do not meet inclusion criteria|1
12923|NCT01804946|61832|P2|Overall Study|Insufficient data available|1
12924|NCT01804946|61833|P1|Overall Study|Insufficient data available|0
12925|NCT01804946|61832|P2|Overall Study|Adverse Event|1
12926|NCT01804946|61833|P1|Overall Study|Adverse Event|0
12927|NCT01804946|61832|P2|Overall Study|Protocol Violation|0
12928|NCT01804946|61833|P1|Overall Study|Protocol Violation|1
12929|NCT01804842|61871|P3|Overall Study|Personal Reason|1
12930|NCT01804842|61872|P2|Overall Study|Personal Reason|0
12931|NCT01804842|61873|P1|Overall Study|Personal Reason|0
12932|NCT01804842|61871|P3|Overall Study|Non-Compliance|0
12933|NCT01804842|61872|P2|Overall Study|Non-Compliance|1
12934|NCT01804842|61873|P1|Overall Study|Non-Compliance|1
12935|NCT01804842|61871|P3|Overall Study|Lost to Follow-up|0
12936|NCT01804842|61872|P2|Overall Study|Lost to Follow-up|0
12937|NCT01804842|61873|P1|Overall Study|Lost to Follow-up|1
12938|NCT01804842|61871|P3|Overall Study|Adverse Event|0
12939|NCT01804842|61872|P2|Overall Study|Adverse Event|1
12940|NCT01804842|61873|P1|Overall Study|Adverse Event|1
12941|NCT01804673|61890|P1|Overall Study|Unspecified|4
12942|NCT01804673|61890|P1|Overall Study|Use of Prohibited Medication|1
12943|NCT01804673|61890|P1|Overall Study|No Further Therapy Required|84
12944|NCT01804673|61890|P1|Overall Study|Change to Oral Therapy|37
12945|NCT01804673|61890|P1|Overall Study|Lack of Efficacy|9
12946|NCT01804673|61890|P1|Overall Study|Withdrawal by Subject|1
12947|NCT01804673|61890|P1|Overall Study|Adverse Event|4
12948|NCT01804140|61906|P1|Overall Study|No sampling or biopsy procedures done|114
12949|NCT01803737|61918|P2|Overall Study|Lost to Follow-up|2
12950|NCT01803737|61919|P1|Overall Study|Lost to Follow-up|0
12951|NCT01803737|61918|P2|Overall Study|Medical Reason|1
12952|NCT01803737|61919|P1|Overall Study|Medical Reason|0
12953|NCT01803737|61918|P2|Overall Study|Lack of Time|0
12954|NCT01803737|61919|P1|Overall Study|Lack of Time|1
12955|NCT01802632|61947|P6|Overall Study|Other (not specified)|1
12956|NCT01802632|61948|P5|Overall Study|Other (not specified)|0
12957|NCT01802632|61949|P4|Overall Study|Other (not specified)|1
12958|NCT01802632|61950|P3|Overall Study|Other (not specified)|7
12959|NCT01802632|61951|P2|Overall Study|Other (not specified)|0
12960|NCT01802632|61952|P1|Overall Study|Other (not specified)|0
12961|NCT01802632|61947|P6|Overall Study|Ongoing Study at Data Cut-off|22
12962|NCT01802632|61948|P5|Overall Study|Ongoing Study at Data Cut-off|6
12963|NCT01802632|61949|P4|Overall Study|Ongoing Study at Data Cut-off|50
12964|NCT01802632|61950|P3|Overall Study|Ongoing Study at Data Cut-off|115
12965|NCT01802632|61951|P2|Overall Study|Ongoing Study at Data Cut-off|16
12966|NCT01802632|61952|P1|Overall Study|Ongoing Study at Data Cut-off|168
12967|NCT01802632|61947|P6|Overall Study|Objective Disease Progression|4
12968|NCT01802632|61948|P5|Overall Study|Objective Disease Progression|4
12969|NCT01802632|61949|P4|Overall Study|Objective Disease Progression|6
12970|NCT01802632|61950|P3|Overall Study|Objective Disease Progression|104
12971|NCT01802632|61951|P2|Overall Study|Objective Disease Progression|12
12972|NCT01802632|61952|P1|Overall Study|Objective Disease Progression|1
12973|NCT01802632|61947|P6|Overall Study|Withdrawal by Subject|1
12974|NCT01802632|61948|P5|Overall Study|Withdrawal by Subject|0
12975|NCT01802632|61949|P4|Overall Study|Withdrawal by Subject|3
12976|NCT01802632|61950|P3|Overall Study|Withdrawal by Subject|7
12977|NCT01802632|61951|P2|Overall Study|Withdrawal by Subject|2
12978|NCT01802632|61952|P1|Overall Study|Withdrawal by Subject|4
12979|NCT01802632|61947|P6|Overall Study|Death|0
12980|NCT01802632|61948|P5|Overall Study|Death|2
12981|NCT01802632|61949|P4|Overall Study|Death|0
12982|NCT01802632|61950|P3|Overall Study|Death|38
12983|NCT01802632|61951|P2|Overall Study|Death|1
12984|NCT01802632|61952|P1|Overall Study|Death|28
12985|NCT01802515|61986|P3|Overall Study|Withdrawal by Subject|0
12986|NCT01802515|61987|P2|Overall Study|Withdrawal by Subject|0
12987|NCT01802515|61988|P1|Overall Study|Withdrawal by Subject|3
12988|NCT01801982|62068|P1|Overall Study|Lost to Follow-up|1
12989|NCT01801735|62078|P1|Overall Study|Other, including site closure|19
12990|NCT01801735|62078|P1|Overall Study|Death|1
12991|NCT01801735|62078|P1|Overall Study|Physician Decision|3
12992|NCT01801735|62078|P1|Overall Study|Non-compliance with Trial Drug|13
12993|NCT01801735|62078|P1|Overall Study|Lost to Follow-up|15
12994|NCT01801735|62078|P1|Overall Study|Protocol Violation|25
12995|NCT01801735|62078|P1|Overall Study|Withdrawal by Subject|27
12996|NCT01801735|62078|P1|Overall Study|Lack of Efficacy|28
12997|NCT01801735|62078|P1|Overall Study|Adverse Event|79
12998|NCT01801475|62085|P5|Overall Study|Withdrawal by Subject|1
12999|NCT01801475|62086|P4|Overall Study|Withdrawal by Subject|0
13000|NCT01801475|62087|P3|Overall Study|Withdrawal by Subject|0
13001|NCT01801475|62088|P2|Overall Study|Withdrawal by Subject|0
13002|NCT01801475|62089|P1|Overall Study|Withdrawal by Subject|0
13003|NCT01801436|62100|P1|Overall Study|Progressive disease|4
13004|NCT01801436|62100|P1|Overall Study|Adverse Event|2
13005|NCT01801436|62100|P1|Overall Study|Withdrawal by Subject|3
13006|NCT01801358|62138|P6|Overall Study|Withdrawal by Subject|2
13007|NCT01801358|62139|P5|Overall Study|Withdrawal by Subject|0
13008|NCT01801358|62140|P4|Overall Study|Withdrawal by Subject|1
13009|NCT01801358|62141|P3|Overall Study|Withdrawal by Subject|0
13010|NCT01801358|62142|P2|Overall Study|Withdrawal by Subject|0
13011|NCT01801358|62143|P1|Overall Study|Withdrawal by Subject|0
13012|NCT01801358|62138|P6|Overall Study|Progressive Disease|5
13013|NCT01801358|62139|P5|Overall Study|Progressive Disease|6
13014|NCT01801358|62140|P4|Overall Study|Progressive Disease|5
13015|NCT01801358|62141|P3|Overall Study|Progressive Disease|4
13016|NCT01801358|62142|P2|Overall Study|Progressive Disease|4
13017|NCT01801358|62143|P1|Overall Study|Progressive Disease|6
13018|NCT01801358|62138|P6|Overall Study|Physician Decision|0
13019|NCT01801358|62139|P5|Overall Study|Physician Decision|0
13020|NCT01801358|62140|P4|Overall Study|Physician Decision|0
13021|NCT01801358|62141|P3|Overall Study|Physician Decision|1
13022|NCT01801358|62142|P2|Overall Study|Physician Decision|0
13023|NCT01801358|62143|P1|Overall Study|Physician Decision|0
13024|NCT01801358|62138|P6|Overall Study|Adverse Event|1
13025|NCT01801358|62139|P5|Overall Study|Adverse Event|0
13026|NCT01801358|62140|P4|Overall Study|Adverse Event|0
13027|NCT01801358|62141|P3|Overall Study|Adverse Event|1
13028|NCT01801358|62142|P2|Overall Study|Adverse Event|2
13029|NCT01801358|62143|P1|Overall Study|Adverse Event|0
13030|NCT01801280|62265|P4|Period 4|Protocol Violation|0
13031|NCT01801280|62266|P3|Period 4|Protocol Violation|1
13032|NCT01801280|62267|P2|Period 4|Protocol Violation|0
13033|NCT01801280|62268|P1|Period 4|Protocol Violation|0
13034|NCT01801280|62265|P4|Period 2|Withdrawal by Subject|0
13035|NCT01801280|62266|P3|Period 2|Withdrawal by Subject|0
13036|NCT01801280|62267|P2|Period 2|Withdrawal by Subject|0
13037|NCT01801280|62268|P1|Period 2|Withdrawal by Subject|1
13038|NCT01801280|62265|P4|Period 1|Withdrawal by Subject|0
13039|NCT01801280|62266|P3|Period 1|Withdrawal by Subject|0
13040|NCT01801280|62267|P2|Period 1|Withdrawal by Subject|1
13041|NCT01801280|62268|P1|Period 1|Withdrawal by Subject|0
13042|NCT01801111|62283|P1|Overall Study|On-going Survival Follow up|25
13043|NCT01801111|62283|P1|Overall Study|Death|24
13044|NCT01801111|62283|P1|Overall Study|Treatment On-going|89
13045|NCT01800968|62308|P2|Overall Study|Physician Decision|0
13046|NCT01800968|62309|P1|Overall Study|Physician Decision|1
13047|NCT01800968|62308|P2|Overall Study|Withdrawal by Subject|9
13048|NCT01800968|62309|P1|Overall Study|Withdrawal by Subject|7
13049|NCT01800968|62308|P2|Overall Study|Lost to Follow-up|7
13050|NCT01800968|62309|P1|Overall Study|Lost to Follow-up|5
13051|NCT01800968|62308|P2|Overall Study|Death|16
13052|NCT01800968|62309|P1|Overall Study|Death|23
13053|NCT01800916|62351|P9|Test Period 1 (1 Week)|Adverse Event|0
13054|NCT01800916|62352|P8|Test Period 1 (1 Week)|Adverse Event|0
13055|NCT01800916|62353|P7|Test Period 1 (1 Week)|Adverse Event|0
13056|NCT01800916|62354|P6|Test Period 1 (1 Week)|Adverse Event|0
13057|NCT01800916|62355|P5|Test Period 1 (1 Week)|Adverse Event|1
13058|NCT01800916|62356|P4|Test Period 1 (1 Week)|Adverse Event|0
13059|NCT01800916|62357|P3|Test Period 1 (1 Week)|Adverse Event|0
13060|NCT01800916|62358|P2|Test Period 1 (1 Week)|Adverse Event|0
13061|NCT01800916|62359|P1|Test Period 1 (1 Week)|Adverse Event|0
13062|NCT01800916|62351|P9|Test Period 1 (1 Week)|Convex product user|0
13063|NCT01800916|62352|P8|Test Period 1 (1 Week)|Convex product user|0
13064|NCT01800916|62353|P7|Test Period 1 (1 Week)|Convex product user|0
13065|NCT01800916|62354|P6|Test Period 1 (1 Week)|Convex product user|0
13066|NCT01800916|62355|P5|Test Period 1 (1 Week)|Convex product user|0
13067|NCT01800916|62356|P4|Test Period 1 (1 Week)|Convex product user|1
13068|NCT01800916|62357|P3|Test Period 1 (1 Week)|Convex product user|0
13069|NCT01800916|62358|P2|Test Period 1 (1 Week)|Convex product user|0
13070|NCT01800916|62359|P1|Test Period 1 (1 Week)|Convex product user|0
13071|NCT01800903|62369|P6|Second Test Period|unable to catheterise|0
13072|NCT01800903|62370|P5|Second Test Period|unable to catheterise|0
13073|NCT01800903|62371|P4|Second Test Period|unable to catheterise|0
13074|NCT01800903|62372|P3|Second Test Period|unable to catheterise|0
13075|NCT01800903|62373|P2|Second Test Period|unable to catheterise|0
13076|NCT01800903|62374|P1|Second Test Period|unable to catheterise|1
13077|NCT01799720|62434|P3|Overall Study|Pregnancy|1
13078|NCT01799720|62435|P2|Overall Study|Pregnancy|0
13079|NCT01799720|62436|P1|Overall Study|Pregnancy|0
13080|NCT01799720|62434|P3|Overall Study|Protocol Violation|0
13081|NCT01799720|62435|P2|Overall Study|Protocol Violation|1
13082|NCT01799720|62436|P1|Overall Study|Protocol Violation|0
13083|NCT01799720|62434|P3|Overall Study|Withdrawal by Subject|0
13084|NCT01799720|62435|P2|Overall Study|Withdrawal by Subject|0
13085|NCT01799720|62436|P1|Overall Study|Withdrawal by Subject|3
13086|NCT01799590|62474|P3|Overall Study|Unspecified|1
13087|NCT01799590|62475|P2|Overall Study|Unspecified|0
13088|NCT01799590|62476|P1|Overall Study|Unspecified|3
13089|NCT01799590|62474|P3|Overall Study|Use of prohibited concomitant drugs|0
13090|NCT01799590|62475|P2|Overall Study|Use of prohibited concomitant drugs|0
13091|NCT01799590|62476|P1|Overall Study|Use of prohibited concomitant drugs|1
13092|NCT01799590|62474|P3|Overall Study|Using drugs with restricted days of use|2
13093|NCT01799590|62475|P2|Overall Study|Using drugs with restricted days of use|3
13094|NCT01799590|62476|P1|Overall Study|Using drugs with restricted days of use|0
13095|NCT01799590|62474|P3|Overall Study|Aggravation of complications|1
13096|NCT01799590|62475|P2|Overall Study|Aggravation of complications|1
13097|NCT01799590|62476|P1|Overall Study|Aggravation of complications|0
13098|NCT01799590|62474|P3|Overall Study|Participants convenience|2
13099|NCT01799590|62475|P2|Overall Study|Participants convenience|4
13100|NCT01799590|62476|P1|Overall Study|Participants convenience|4
13101|NCT01799590|62474|P3|Overall Study|Lack of Efficacy|3
13102|NCT01799590|62475|P2|Overall Study|Lack of Efficacy|1
13103|NCT01799590|62476|P1|Overall Study|Lack of Efficacy|3
13104|NCT01799590|62474|P3|Overall Study|Pregnancy|0
13105|NCT01799590|62475|P2|Overall Study|Pregnancy|0
13106|NCT01799590|62476|P1|Overall Study|Pregnancy|2
13107|NCT01799590|62474|P3|Overall Study|Adverse Event|5
13108|NCT01799590|62475|P2|Overall Study|Adverse Event|7
13109|NCT01799590|62476|P1|Overall Study|Adverse Event|13
13110|NCT01799239|62511|P2|Period 2 (7 Days)|Protocol Violation|0
13111|NCT01799239|62512|P1|Period 2 (7 Days)|Protocol Violation|1
13112|NCT01799239|62511|P2|Period 2 (7 Days)|Withdrawal by Subject|1
13113|NCT01799239|62512|P1|Period 2 (7 Days)|Withdrawal by Subject|1
13114|NCT01799239|62511|P2|Period 1 (7 Days)|Protocol Violation|1
13115|NCT01799239|62512|P1|Period 1 (7 Days)|Protocol Violation|0
13116|NCT01799239|62511|P2|Period 1 (7 Days)|Withdrawal by Subject|0
13117|NCT01799239|62512|P1|Period 1 (7 Days)|Withdrawal by Subject|2
13118|NCT01799239|62511|P2|Period 1 (7 Days)|Lack of Efficacy|0
13119|NCT01799239|62512|P1|Period 1 (7 Days)|Lack of Efficacy|1
13120|NCT01799226|62520|P2|Overall Study|Disqualified at Day 14|0
13121|NCT01799226|62521|P1|Overall Study|Disqualified at Day 14|1
13122|NCT01799226|62520|P2|Overall Study|Withdrawal by Subject|0
13123|NCT01799226|62521|P1|Overall Study|Withdrawal by Subject|1
13124|NCT01798927|62535|P1|Overall Study|Withdrawal by Subject|1
13125|NCT01798706|62543|P2|Overall Study|Other than specified above|9
13126|NCT01798706|62544|P1|Overall Study|Other than specified above|5
13127|NCT01798706|62543|P2|Overall Study|Poor compliance to protocol|0
13128|NCT01798706|62544|P1|Overall Study|Poor compliance to protocol|1
13129|NCT01798706|62543|P2|Overall Study|Lack of Efficacy|2
13130|NCT01798706|62544|P1|Overall Study|Lack of Efficacy|0
13131|NCT01798706|62543|P2|Overall Study|Adverse Event|10
13132|NCT01798706|62544|P1|Overall Study|Adverse Event|15
13133|NCT01798485|62572|P2|Overall Study|Clinical Progression|24
13134|NCT01798485|62573|P1|Overall Study|Clinical Progression|35
13135|NCT01798485|62572|P2|Overall Study|Sponsor Decision|54
13136|NCT01798485|62573|P1|Overall Study|Sponsor Decision|61
13137|NCT01798485|62572|P2|Overall Study|Death|22
13138|NCT01798485|62573|P1|Overall Study|Death|25
13139|NCT01798485|62572|P2|Overall Study|Objective Disease Progression|106
13140|NCT01798485|62573|P1|Overall Study|Objective Disease Progression|152
13141|NCT01798485|62572|P2|Overall Study|Physician Decision|10
13142|NCT01798485|62573|P1|Overall Study|Physician Decision|14
13143|NCT01798485|62572|P2|Overall Study|Lost to Follow-up|3
13144|NCT01798485|62573|P1|Overall Study|Lost to Follow-up|0
13145|NCT01798485|62572|P2|Overall Study|Withdrawal by Subject|31
13146|NCT01798485|62573|P1|Overall Study|Withdrawal by Subject|27
13147|NCT01798485|62572|P2|Overall Study|Adverse Event|40
13148|NCT01798485|62573|P1|Overall Study|Adverse Event|32
13149|NCT01798134|62657|P1|Overall Study|Liver transplant/surgery|4
13150|NCT01798134|62657|P1|Overall Study|Physician Decision|3
13151|NCT01798134|62657|P1|Overall Study|Adverse Event|3
13152|NCT01798134|62657|P1|Overall Study|Death|2
13153|NCT01798134|62657|P1|Overall Study|Withdrawal by Subject|3
13154|NCT01798134|62657|P1|Overall Study|Lost to Follow-up|1
13155|NCT01798004|62664|P1|Overall Study|Enrollment another COG therapeutic trial|32
13156|NCT01798004|62664|P1|Overall Study|Initiation of other non-protocol therapy|5
13157|NCT01798004|62664|P1|Overall Study|Patient/parent refusal|7
13158|NCT01798004|62664|P1|Overall Study|Ineligible|4
13159|NCT01798004|62664|P1|Overall Study|Withdrawal by Subject|4
13160|NCT01798004|62664|P1|Overall Study|Physician Decision|25
13161|NCT01798004|62664|P1|Overall Study|Lack of Efficacy|8
13162|NCT01798004|62664|P1|Overall Study|Death|2
13163|NCT01797783|62670|P2|Overall Study|Withdrawal by Subject|0
13164|NCT01797783|62671|P1|Overall Study|Withdrawal by Subject|1
13165|NCT01797783|62670|P2|Overall Study|Adverse Event|1
13166|NCT01797783|62671|P1|Overall Study|Adverse Event|1
13167|NCT01797705|62693|P1|Overall Study|Withdrawal by Subject|1
13168|NCT01797705|62693|P1|Overall Study|Equipment anomalies during sleep studies|4
13169|NCT01797536|62701|P4|Overall Study|Adverse Event|0
13170|NCT01797536|62702|P3|Overall Study|Adverse Event|0
13171|NCT01797536|62703|P2|Overall Study|Adverse Event|1
13172|NCT01797536|62704|P1|Overall Study|Adverse Event|0
13173|NCT01797445|62736|P2|Overall Study|Still on Study|383
13174|NCT01797445|62737|P1|Overall Study|Still on Study|381
13175|NCT01797445|62736|P2|Overall Study|Lost to Follow-up|15
13176|NCT01797445|62737|P1|Overall Study|Lost to Follow-up|22
13177|NCT01797445|62736|P2|Overall Study|Withdrew Consent|19
13178|NCT01797445|62737|P1|Overall Study|Withdrew Consent|12
13179|NCT01797445|62736|P2|Overall Study|Protocol Violation|1
13180|NCT01797445|62737|P1|Overall Study|Protocol Violation|0
13181|NCT01797445|62736|P2|Overall Study|Noncompliance with Study Drug|1
13182|NCT01797445|62737|P1|Overall Study|Noncompliance with Study Drug|3
13183|NCT01797445|62736|P2|Overall Study|Investigator's Discretion|12
13184|NCT01797445|62737|P1|Overall Study|Investigator's Discretion|8
13185|NCT01797445|62736|P2|Overall Study|Lack of Efficacy|2
13186|NCT01797445|62737|P1|Overall Study|Lack of Efficacy|1
13187|NCT01797445|62736|P2|Overall Study|Death|2
13188|NCT01797445|62737|P1|Overall Study|Death|1
13189|NCT01797445|62736|P2|Overall Study|Adverse Event|0
13190|NCT01797445|62737|P1|Overall Study|Adverse Event|3
13191|NCT01797445|62736|P2|Overall Study|Randomized but Not Treated|2
13192|NCT01797445|62737|P1|Overall Study|Randomized but Not Treated|4
13193|NCT01797094|62786|P2|Overall Study|Other Miscellaneous Reasons|0
13194|NCT01797094|62787|P1|Overall Study|Other Miscellaneous Reasons|1
13195|NCT01797094|62786|P2|Overall Study|Protocol Violation|1
13196|NCT01797094|62787|P1|Overall Study|Protocol Violation|0
13197|NCT01797094|62786|P2|Overall Study|Personal Reasons|0
13198|NCT01797094|62787|P1|Overall Study|Personal Reasons|4
13199|NCT01797094|62786|P2|Overall Study|Adverse Event|1
13200|NCT01797094|62787|P1|Overall Study|Adverse Event|1
13201|NCT01797081|62809|P4|Overall Study|Protocol Violation|1
13202|NCT01797081|62810|P3|Overall Study|Protocol Violation|0
13203|NCT01797081|62811|P2|Overall Study|Protocol Violation|0
13204|NCT01797081|62812|P1|Overall Study|Protocol Violation|0
13205|NCT01797081|62809|P4|Overall Study|Personal Reasons|8
13206|NCT01797081|62810|P3|Overall Study|Personal Reasons|4
13207|NCT01797081|62811|P2|Overall Study|Personal Reasons|4
13208|NCT01797081|62812|P1|Overall Study|Personal Reasons|12
13209|NCT01797081|62809|P4|Overall Study|Pregnancy|0
13210|NCT01797081|62810|P3|Overall Study|Pregnancy|0
13211|NCT01797081|62811|P2|Overall Study|Pregnancy|0
13212|NCT01797081|62812|P1|Overall Study|Pregnancy|1
13213|NCT01797081|62809|P4|Overall Study|Adverse Event|0
13214|NCT01797081|62810|P3|Overall Study|Adverse Event|1
13215|NCT01797081|62811|P2|Overall Study|Adverse Event|0
13216|NCT01797081|62812|P1|Overall Study|Adverse Event|1
13217|NCT01796964|62853|P2|Overall Study|Withdrawal by Subject|1
13218|NCT01796964|62854|P1|Overall Study|Withdrawal by Subject|1
13219|NCT01796964|62853|P2|Overall Study|Protocol Violation|1
13220|NCT01796964|62854|P1|Overall Study|Protocol Violation|0
13221|NCT01796964|62853|P2|Overall Study|Death|0
13222|NCT01796964|62854|P1|Overall Study|Death|1
13223|NCT01796964|62853|P2|Overall Study|Adverse Event|1
13224|NCT01796964|62854|P1|Overall Study|Adverse Event|1
13225|NCT01796860|62876|P1|Overall Study|Withdrawal by Subject|3
13226|NCT01796548|62882|P1|Overall Study|unspecified|2
13227|NCT01796548|62882|P1|Overall Study|Lost to Follow-up|1
13228|NCT01795937|62916|P3|Overall Study|Physician Decision|0
13229|NCT01795937|62917|P2|Overall Study|Physician Decision|1
13230|NCT01795937|62918|P1|Overall Study|Physician Decision|0
13231|NCT01795937|62916|P3|Overall Study|Withdrawal by Subject|0
13232|NCT01795937|62917|P2|Overall Study|Withdrawal by Subject|0
13233|NCT01795937|62918|P1|Overall Study|Withdrawal by Subject|1
13234|NCT01795898|62947|P1|Overall Study|Physician Decision|1
13235|NCT01795898|62947|P1|Overall Study|Withdrew consent & had adverse events|3
13236|NCT01795898|62947|P1|Overall Study|Death|1
13237|NCT01795898|62947|P1|Overall Study|No pain|1
13238|NCT01795898|62947|P1|Overall Study|Diagnosed with metastasis|1
13239|NCT01795898|62947|P1|Overall Study|Withdrawal of consent|6
13240|NCT01795898|62947|P1|Overall Study|Lost to Follow-up|20
13241|NCT01795898|62947|P1|Overall Study|Adverse Event|27
13242|NCT01795547|62966|P2|Overall Study|Not stated|1
13243|NCT01795547|62967|P1|Overall Study|Not stated|0
13244|NCT01795547|62966|P2|Overall Study|Others|1
13245|NCT01795547|62967|P1|Overall Study|Others|4
13246|NCT01795547|62966|P2|Overall Study|Non-compliance with IMP|1
13247|NCT01795547|62967|P1|Overall Study|Non-compliance with IMP|1
13248|NCT01795547|62966|P2|Overall Study|Not Treated|10
13249|NCT01795547|62967|P1|Overall Study|Not Treated|4
13250|NCT01795547|62966|P2|Overall Study|Withdrawal of consent|12
13251|NCT01795547|62967|P1|Overall Study|Withdrawal of consent|7
13252|NCT01795547|62966|P2|Overall Study|Lost to Follow-up|5
13253|NCT01795547|62967|P1|Overall Study|Lost to Follow-up|2
13254|NCT01795547|62966|P2|Overall Study|Protocol Violation|4
13255|NCT01795547|62967|P1|Overall Study|Protocol Violation|6
13256|NCT01795547|62966|P2|Overall Study|Lack of Efficacy|3
13257|NCT01795547|62967|P1|Overall Study|Lack of Efficacy|8
13258|NCT01795547|62966|P2|Overall Study|Adverse Event|27
13259|NCT01795547|62967|P1|Overall Study|Adverse Event|16
13260|NCT01794000|63031|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
13261|NCT01794000|63032|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
13262|NCT01794000|63031|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
13263|NCT01794000|63032|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
13264|NCT01794000|63031|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
13265|NCT01794000|63032|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
13266|NCT01794000|63031|P2|Double-Blind Phase (DBP)|Physician Decision|0
13267|NCT01794000|63032|P1|Double-Blind Phase (DBP)|Physician Decision|2
13268|NCT01794000|63031|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
13269|NCT01794000|63032|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
13270|NCT01794000|63031|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
13271|NCT01794000|63032|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
13272|NCT01794000|63031|P2|Double-Blind Phase (DBP)|Death|2
13273|NCT01794000|63032|P1|Double-Blind Phase (DBP)|Death|1
13274|NCT01794000|63031|P2|Double-Blind Phase (DBP)|Adverse Event|2
13275|NCT01794000|63032|P1|Double-Blind Phase (DBP)|Adverse Event|5
13276|NCT01792830|63098|P7|Overall Study|Adverse Event|0
13277|NCT01792830|63099|P6|Overall Study|Adverse Event|0
13278|NCT01792830|63100|P5|Overall Study|Adverse Event|1
13279|NCT01792830|63101|P4|Overall Study|Adverse Event|0
13280|NCT01792830|63102|P3|Overall Study|Adverse Event|0
13281|NCT01792830|63103|P2|Overall Study|Adverse Event|0
13282|NCT01792830|63104|P1|Overall Study|Adverse Event|0
13283|NCT01792830|63098|P7|Overall Study|Death|1
13284|NCT01792830|63099|P6|Overall Study|Death|0
13285|NCT01792830|63100|P5|Overall Study|Death|2
13286|NCT01792830|63101|P4|Overall Study|Death|1
13287|NCT01792830|63102|P3|Overall Study|Death|0
13288|NCT01792830|63103|P2|Overall Study|Death|0
13289|NCT01792830|63104|P1|Overall Study|Death|3
13290|NCT01792830|63098|P7|Overall Study|Withdrawal by Subject|2
13291|NCT01792830|63099|P6|Overall Study|Withdrawal by Subject|0
13292|NCT01792830|63100|P5|Overall Study|Withdrawal by Subject|9
13293|NCT01792830|63101|P4|Overall Study|Withdrawal by Subject|4
13294|NCT01792830|63102|P3|Overall Study|Withdrawal by Subject|0
13295|NCT01792830|63103|P2|Overall Study|Withdrawal by Subject|0
13296|NCT01792830|63104|P1|Overall Study|Withdrawal by Subject|22
13297|NCT01792635|63135|P3|Part B|Study terminated|3
13298|NCT01792635|63136|P2|Part B|Study terminated|4
13299|NCT01792635|63137|P1|Part B|Study terminated|0
13300|NCT01792635|63135|P3|Part B|Adverse Event|1
13301|NCT01792635|63136|P2|Part B|Adverse Event|0
13302|NCT01792635|63137|P1|Part B|Adverse Event|0
13303|NCT01791894|63176|P1|Overall Study|Adverse Event|1
13304|NCT01791725|63186|P3|Overall Study|Withdrawal by Subject|0
13305|NCT01791725|63187|P2|Overall Study|Withdrawal by Subject|1
13306|NCT01791725|63188|P1|Overall Study|Withdrawal by Subject|0
13307|NCT01791413|63210|P2|Overall Study|Lost to Follow-up|1
13308|NCT01791413|63211|P1|Overall Study|Lost to Follow-up|5
13309|NCT01791205|63220|P2|Phase II|Physician’s decision|0
13310|NCT01791205|63221|P1|Phase II|Physician’s decision|1
13311|NCT01791205|63220|P2|Phase II|Remission of disease|0
13312|NCT01791205|63221|P1|Phase II|Remission of disease|1
13313|NCT01791205|63220|P2|Phase II|Lost to Follow-up|0
13314|NCT01791205|63221|P1|Phase II|Lost to Follow-up|1
13315|NCT01791205|63220|P2|Phase II|Safety|0
13316|NCT01791205|63221|P1|Phase II|Safety|1
13317|NCT01791205|63220|P2|Phase II|Adverse Event|0
13318|NCT01791205|63221|P1|Phase II|Adverse Event|2
13319|NCT01791205|63220|P2|Phase II|Lack of Efficacy|0
13320|NCT01791205|63221|P1|Phase II|Lack of Efficacy|6
13321|NCT01790828|63316|P1|Overall Study|Not specified|34
13322|NCT01790633|63355|P2|Overall Study|RT failure and no follow-up ELISA|3
13323|NCT01790633|63356|P1|Overall Study|RT failure and no follow-up ELISA|0
13324|NCT01790633|63355|P2|Overall Study|Did not have serology performed|0
13325|NCT01790633|63356|P1|Overall Study|Did not have serology performed|47
13326|NCT01790633|63355|P2|Overall Study|Protocol Violation|2
13327|NCT01790633|63356|P1|Overall Study|Protocol Violation|1
13328|NCT01790516|63380|P2|Overall Study|Physician Decision|0
13329|NCT01790516|63381|P1|Overall Study|Physician Decision|1
13330|NCT01789476|63422|P2|Overall Study|Unable to get IV access|0
13331|NCT01789476|63423|P1|Overall Study|Unable to get IV access|1
13332|NCT01789476|63422|P2|Overall Study|Adverse Event|0
13333|NCT01789476|63423|P1|Overall Study|Adverse Event|1
13334|NCT01789476|63422|P2|Overall Study|Lack of Efficacy|2
13335|NCT01789476|63423|P1|Overall Study|Lack of Efficacy|6
13336|NCT01788566|63449|P1|Overall Study|Clinical Progressive Disease|3
13337|NCT01788566|63449|P1|Overall Study|Adverse Event|1
13338|NCT01788566|63449|P1|Overall Study|Death|4
13339|NCT01788358|63459|P1|Overall Study|Adverse Event|51
13340|NCT01788358|63459|P1|Overall Study|Lack of Efficacy|1
13341|NCT01788358|63459|P1|Overall Study|Withdrawal by Subject|26
13342|NCT01788358|63459|P1|Overall Study|Protocol Violation|3
13343|NCT01788358|63459|P1|Overall Study|Lost to Follow-up|5
13344|NCT01788358|63459|P1|Overall Study|Logistical difficulties|1
13345|NCT01788358|63459|P1|Overall Study|Unspecified|11
13346|NCT01788228|63473|P2|Overall Study|Migrated/moved from study area|0
13347|NCT01788228|63474|P1|Overall Study|Migrated/moved from study area|1
13348|NCT01788215|63493|P2|Overall Study|Lost to Follow-up|0
13349|NCT01788215|63494|P1|Overall Study|Lost to Follow-up|2
13350|NCT01788215|63493|P2|Overall Study|Withdrawal by Subject|1
13351|NCT01788215|63494|P1|Overall Study|Withdrawal by Subject|0
13352|NCT01788163|63523|P9|Overall Study|Withdrawal by Subject|1
13353|NCT01788163|63524|P8|Overall Study|Withdrawal by Subject|0
13354|NCT01788163|63525|P7|Overall Study|Withdrawal by Subject|0
13355|NCT01788163|63526|P6|Overall Study|Withdrawal by Subject|0
13356|NCT01788163|63527|P5|Overall Study|Withdrawal by Subject|0
13357|NCT01788163|63528|P4|Overall Study|Withdrawal by Subject|0
13358|NCT01788163|63529|P3|Overall Study|Withdrawal by Subject|0
13359|NCT01788163|63530|P2|Overall Study|Withdrawal by Subject|0
13360|NCT01788163|63531|P1|Overall Study|Withdrawal by Subject|2
13361|NCT01788163|63523|P9|Overall Study|Other|15
13362|NCT01788163|63524|P8|Overall Study|Other|48
13363|NCT01788163|63525|P7|Overall Study|Other|1
13364|NCT01788163|63526|P6|Overall Study|Other|7
13365|NCT01788163|63527|P5|Overall Study|Other|0
13366|NCT01788163|63528|P4|Overall Study|Other|0
13367|NCT01788163|63529|P3|Overall Study|Other|0
13368|NCT01788163|63530|P2|Overall Study|Other|0
13369|NCT01788163|63531|P1|Overall Study|Other|53
13370|NCT01787838|63692|P1|Overall Study|refused|1413
13371|NCT01787760|63703|P3|Overall Study|Near vision blur|0
13372|NCT01787760|63704|P2|Overall Study|Near vision blur|0
13373|NCT01787760|63705|P1|Overall Study|Near vision blur|1
13374|NCT01787760|63703|P3|Overall Study|Unsatisfactory visual response|0
13375|NCT01787760|63704|P2|Overall Study|Unsatisfactory visual response|1
13376|NCT01787760|63705|P1|Overall Study|Unsatisfactory visual response|1
13377|NCT01787760|63703|P3|Overall Study|Unsatisfactory physiological response|0
13378|NCT01787760|63704|P2|Overall Study|Unsatisfactory physiological response|4
13379|NCT01787760|63705|P1|Overall Study|Unsatisfactory physiological response|2
13380|NCT01787760|63703|P3|Overall Study|Unsatisfactory lens fitting performance|0
13381|NCT01787760|63704|P2|Overall Study|Unsatisfactory lens fitting performance|6
13382|NCT01787760|63705|P1|Overall Study|Unsatisfactory lens fitting performance|3
13383|NCT01787760|63703|P3|Overall Study|Stroke|0
13384|NCT01787760|63704|P2|Overall Study|Stroke|0
13385|NCT01787760|63705|P1|Overall Study|Stroke|1
13386|NCT01787760|63703|P3|Overall Study|Lost to Follow-up|1
13387|NCT01787760|63704|P2|Overall Study|Lost to Follow-up|0
13388|NCT01787760|63705|P1|Overall Study|Lost to Follow-up|1
13389|NCT01787760|63703|P3|Overall Study|Withdrawal by Subject|2
13390|NCT01787760|63704|P2|Overall Study|Withdrawal by Subject|1
13391|NCT01787760|63705|P1|Overall Study|Withdrawal by Subject|5
13392|NCT01787760|63703|P3|Overall Study|Protocol Violation|1
13393|NCT01787760|63704|P2|Overall Study|Protocol Violation|0
13394|NCT01787760|63705|P1|Overall Study|Protocol Violation|6
13395|NCT01787760|63703|P3|Overall Study|Lens handling difficulty|0
13396|NCT01787760|63704|P2|Overall Study|Lens handling difficulty|2
13397|NCT01787760|63705|P1|Overall Study|Lens handling difficulty|1
13398|NCT01787760|63703|P3|Overall Study|Lens discomfort|0
13399|NCT01787760|63704|P2|Overall Study|Lens discomfort|0
13400|NCT01787760|63705|P1|Overall Study|Lens discomfort|3
13401|NCT01787760|63703|P3|Overall Study|Relocation|0
13402|NCT01787760|63704|P2|Overall Study|Relocation|1
13403|NCT01787760|63705|P1|Overall Study|Relocation|1
13404|NCT01787760|63703|P3|Overall Study|Dryness|0
13405|NCT01787760|63704|P2|Overall Study|Dryness|1
13406|NCT01787760|63705|P1|Overall Study|Dryness|0
13407|NCT01787760|63703|P3|Overall Study|Decompensated on left exotropia|1
13408|NCT01787760|63704|P2|Overall Study|Decompensated on left exotropia|0
13409|NCT01787760|63705|P1|Overall Study|Decompensated on left exotropia|0
13410|NCT01787760|63703|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
13411|NCT01787760|63704|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
13412|NCT01787760|63705|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
13413|NCT01787591|63719|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
13414|NCT01787591|63720|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
13415|NCT01787591|63721|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
13416|NCT01787591|63722|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
13417|NCT01787461|63750|P2|Overall Study|Protocol Violation|0
13418|NCT01787461|63751|P1|Overall Study|Protocol Violation|3
13419|NCT01787461|63750|P2|Overall Study|Withdrawal by Subject|4
13420|NCT01787461|63751|P1|Overall Study|Withdrawal by Subject|3
13421|NCT01787461|63750|P2|Overall Study|No longer met eligibility criteria|0
13422|NCT01787461|63751|P1|Overall Study|No longer met eligibility criteria|1
13423|NCT01787461|63750|P2|Overall Study|Lost to Follow-up|2
13424|NCT01787461|63751|P1|Overall Study|Lost to Follow-up|3
13425|NCT01787461|63750|P2|Overall Study|Adverse Event|3
13426|NCT01787461|63751|P1|Overall Study|Adverse Event|4
13427|NCT01787279|63800|P1|Overall Study|Lack of Efficacy|1
13428|NCT01787279|63800|P1|Overall Study|Lost to Follow-up|2
13429|NCT01787188|63812|P3|Overall Study|Other, including patient moved|0
13430|NCT01787188|63813|P2|Overall Study|Other, including patient moved|3
13431|NCT01787188|63814|P1|Overall Study|Other, including patient moved|0
13432|NCT01787188|63812|P3|Overall Study|Lost to Follow-up|2
13433|NCT01787188|63813|P2|Overall Study|Lost to Follow-up|2
13434|NCT01787188|63814|P1|Overall Study|Lost to Follow-up|1
13435|NCT01787188|63812|P3|Overall Study|Protocol Violation|3
13436|NCT01787188|63813|P2|Overall Study|Protocol Violation|2
13437|NCT01787188|63814|P1|Overall Study|Protocol Violation|3
13438|NCT01787188|63812|P3|Overall Study|Withdrawal by Subject|2
13439|NCT01787188|63813|P2|Overall Study|Withdrawal by Subject|3
13440|NCT01787188|63814|P1|Overall Study|Withdrawal by Subject|4
13441|NCT01787188|63812|P3|Overall Study|Non-compliance with Study Drug|0
13442|NCT01787188|63813|P2|Overall Study|Non-compliance with Study Drug|1
13443|NCT01787188|63814|P1|Overall Study|Non-compliance with Study Drug|0
13444|NCT01787188|63812|P3|Overall Study|Lack of Efficacy|5
13445|NCT01787188|63813|P2|Overall Study|Lack of Efficacy|3
13446|NCT01787188|63814|P1|Overall Study|Lack of Efficacy|7
13447|NCT01787188|63812|P3|Overall Study|Adverse Event|6
13448|NCT01787188|63813|P2|Overall Study|Adverse Event|4
13449|NCT01787188|63814|P1|Overall Study|Adverse Event|2
13450|NCT01786993|63882|P2|Overall Study|Hospice Admission|0
13451|NCT01786993|63883|P1|Overall Study|Hospice Admission|1
13452|NCT01786993|63882|P2|Overall Study|System Explant|0
13453|NCT01786993|63883|P1|Overall Study|System Explant|1
13454|NCT01786993|63882|P2|Overall Study|Subject Non-Compliance|0
13455|NCT01786993|63883|P1|Overall Study|Subject Non-Compliance|1
13456|NCT01786993|63882|P2|Overall Study|Lost to Follow-up|1
13457|NCT01786993|63883|P1|Overall Study|Lost to Follow-up|0
13458|NCT01786993|63882|P2|Overall Study|Withdrawal by Subject|2
13459|NCT01786993|63883|P1|Overall Study|Withdrawal by Subject|3
13460|NCT01786993|63882|P2|Overall Study|Death|7
13461|NCT01786993|63883|P1|Overall Study|Death|6
13462|NCT01786707|63933|P2|Overall Study|Lost to Follow-up|1
13463|NCT01786707|63934|P1|Overall Study|Lost to Follow-up|1
13464|NCT01786668|63944|P4|Overall Study|Lost to Follow-up|0
13465|NCT01786668|63945|P3|Overall Study|Lost to Follow-up|1
13466|NCT01786668|63946|P2|Overall Study|Lost to Follow-up|0
13467|NCT01786668|63947|P1|Overall Study|Lost to Follow-up|1
13468|NCT01786668|63944|P4|Overall Study|Pregnancy|1
13469|NCT01786668|63945|P3|Overall Study|Pregnancy|0
13470|NCT01786668|63946|P2|Overall Study|Pregnancy|0
13471|NCT01786668|63947|P1|Overall Study|Pregnancy|0
13472|NCT01786668|63944|P4|Overall Study|Withdrawal by Subject|1
13473|NCT01786668|63945|P3|Overall Study|Withdrawal by Subject|3
13474|NCT01786668|63946|P2|Overall Study|Withdrawal by Subject|0
13475|NCT01786668|63947|P1|Overall Study|Withdrawal by Subject|0
13476|NCT01786668|63944|P4|Overall Study|Adverse Event|2
13477|NCT01786668|63945|P3|Overall Study|Adverse Event|1
13478|NCT01786668|63946|P2|Overall Study|Adverse Event|1
13479|NCT01786668|63947|P1|Overall Study|Adverse Event|0
13480|NCT01786629|64047|P2|Overall Study|Adverse Event|1
13481|NCT01786629|64048|P1|Overall Study|Adverse Event|0
13482|NCT01786629|64047|P2|Overall Study|Lack of Efficacy|4
13483|NCT01786629|64048|P1|Overall Study|Lack of Efficacy|0
13484|NCT01786330|64056|P2|Overall Study|Protocol Violation|0
13485|NCT01786330|64057|P1|Overall Study|Protocol Violation|1
13486|NCT01786330|64056|P2|Overall Study|Excluded intraoperatively|1
13487|NCT01786330|64057|P1|Overall Study|Excluded intraoperatively|0
13488|NCT01786330|64056|P2|Overall Study|Lost to Follow-up|1
13489|NCT01786330|64057|P1|Overall Study|Lost to Follow-up|0
13490|NCT01786330|64056|P2|Overall Study|Withdrawal by Subject|1
13491|NCT01786330|64057|P1|Overall Study|Withdrawal by Subject|0
13492|NCT01786174|64095|P2|Overall Study|Discontinued Study Drug|0
13493|NCT01786174|64096|P1|Overall Study|Discontinued Study Drug|2
13494|NCT01786109|64113|P3|Overall Study|adverse effects colon preparation|1
13495|NCT01786109|64114|P2|Overall Study|adverse effects colon preparation|0
13496|NCT01786109|64115|P1|Overall Study|adverse effects colon preparation|0
13497|NCT01786109|64113|P3|Overall Study|unrelated illness|1
13498|NCT01786109|64114|P2|Overall Study|unrelated illness|0
13499|NCT01786109|64115|P1|Overall Study|unrelated illness|0
13500|NCT01786109|64113|P3|Overall Study|fail manometry barostat tube placement|0
13501|NCT01786109|64114|P2|Overall Study|fail manometry barostat tube placement|0
13502|NCT01786109|64115|P1|Overall Study|fail manometry barostat tube placement|1
13503|NCT01785628|64146|P2|Overall Study|Lost to Follow-up|3
13504|NCT01785628|64147|P1|Overall Study|Lost to Follow-up|2
13505|NCT01785602|64169|P2|Overall Study|Administrative problems|3
13506|NCT01785602|64170|P1|Overall Study|Administrative problems|7
13507|NCT01785602|64169|P2|Overall Study|Adverse Event|5
13508|NCT01785602|64170|P1|Overall Study|Adverse Event|3
13509|NCT01785602|64169|P2|Overall Study|Lost to Follow-up|1
13510|NCT01785602|64170|P1|Overall Study|Lost to Follow-up|1
13511|NCT01785602|64169|P2|Overall Study|Withdrawal by Subject|0
13512|NCT01785602|64170|P1|Overall Study|Withdrawal by Subject|2
13513|NCT01785524|64180|P2|Overall Study|Withdrawal by Subject|2
13514|NCT01785524|64181|P1|Overall Study|Withdrawal by Subject|2
13515|NCT01785472|64196|P3|Overall Study|Technical problems|1
13516|NCT01785472|64197|P2|Overall Study|Technical problems|0
13517|NCT01785472|64198|P1|Overall Study|Technical problems|0
13518|NCT01785472|64196|P3|Overall Study|Subject/guardian decision|11
13519|NCT01785472|64197|P2|Overall Study|Subject/guardian decision|10
13520|NCT01785472|64198|P1|Overall Study|Subject/guardian decision|15
13521|NCT01785472|64196|P3|Overall Study|Protocol deviation|2
13522|NCT01785472|64197|P2|Overall Study|Protocol deviation|2
13523|NCT01785472|64198|P1|Overall Study|Protocol deviation|0
13524|NCT01785472|64196|P3|Overall Study|Physician Decision|1
13525|NCT01785472|64197|P2|Overall Study|Physician Decision|1
13526|NCT01785472|64198|P1|Overall Study|Physician Decision|1
13527|NCT01785472|64196|P3|Overall Study|Lost to Follow-up|0
13528|NCT01785472|64197|P2|Overall Study|Lost to Follow-up|2
13529|NCT01785472|64198|P1|Overall Study|Lost to Follow-up|1
13530|NCT01785472|64196|P3|Overall Study|Lack of Efficacy|1
13531|NCT01785472|64197|P2|Overall Study|Lack of Efficacy|0
13532|NCT01785472|64198|P1|Overall Study|Lack of Efficacy|2
13533|NCT01785472|64196|P3|Overall Study|Adverse Event|6
13534|NCT01785472|64197|P2|Overall Study|Adverse Event|4
13535|NCT01785472|64198|P1|Overall Study|Adverse Event|5
13536|NCT01785160|64240|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
13537|NCT01785160|64240|P1|Treatment Period 1: Raltegravir|Not treated|1
13538|NCT01783938|64316|P2|Overall Study|Not Specified|0
13539|NCT01783938|64317|P1|Overall Study|Not Specified|1
13540|NCT01783938|64316|P2|Overall Study|Withdrew Consent|0
13541|NCT01783938|64317|P1|Overall Study|Withdrew Consent|3
13542|NCT01783938|64316|P2|Overall Study|Request to Discontinue Study Treatment|2
13543|NCT01783938|64317|P1|Overall Study|Request to Discontinue Study Treatment|1
13544|NCT01783938|64316|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
13545|NCT01783938|64317|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
13546|NCT01783938|64316|P2|Overall Study|Study Drug Toxicity|10
13547|NCT01783938|64317|P1|Overall Study|Study Drug Toxicity|22
13548|NCT01783938|64316|P2|Overall Study|Disease Progression|39
13549|NCT01783938|64317|P1|Overall Study|Disease Progression|18
13550|NCT01783886|64345|P3|Overall Study|Adverse Event|4
13551|NCT01783886|64346|P2|Overall Study|Adverse Event|5
13552|NCT01783886|64347|P1|Overall Study|Adverse Event|4
13553|NCT01783886|64345|P3|Overall Study|Withdrawal of consent by participant|4
13554|NCT01783886|64346|P2|Overall Study|Withdrawal of consent by participant|3
13555|NCT01783886|64347|P1|Overall Study|Withdrawal of consent by participant|1
13556|NCT01783886|64345|P3|Overall Study|Protocol deviation|2
13557|NCT01783886|64346|P2|Overall Study|Protocol deviation|0
13558|NCT01783886|64347|P1|Overall Study|Protocol deviation|0
13559|NCT01783886|64345|P3|Overall Study|Lost to Follow-up|0
13560|NCT01783886|64346|P2|Overall Study|Lost to Follow-up|3
13561|NCT01783886|64347|P1|Overall Study|Lost to Follow-up|0
13562|NCT01783821|64394|P2|Overall Study|Screen Failure|1
13563|NCT01783821|64395|P1|Overall Study|Screen Failure|1
13564|NCT01783730|64411|P1|Overall Study|Failed to meet inclusion criteria|6
13565|NCT01783678|64436|P6|Overall Study|Withdrew Consent|0
13566|NCT01783678|64437|P5|Overall Study|Withdrew Consent|0
13567|NCT01783678|64438|P4|Overall Study|Withdrew Consent|2
13568|NCT01783678|64439|P3|Overall Study|Withdrew Consent|0
13569|NCT01783678|64440|P2|Overall Study|Withdrew Consent|1
13570|NCT01783678|64441|P1|Overall Study|Withdrew Consent|1
13571|NCT01783678|64436|P6|Overall Study|Lost to Follow-up|0
13572|NCT01783678|64437|P5|Overall Study|Lost to Follow-up|1
13573|NCT01783678|64438|P4|Overall Study|Lost to Follow-up|2
13574|NCT01783678|64439|P3|Overall Study|Lost to Follow-up|0
13575|NCT01783678|64440|P2|Overall Study|Lost to Follow-up|4
13576|NCT01783678|64441|P1|Overall Study|Lost to Follow-up|0
13577|NCT01783678|64436|P6|Overall Study|Lack of Efficacy|5
13578|NCT01783678|64437|P5|Overall Study|Lack of Efficacy|6
13579|NCT01783678|64438|P4|Overall Study|Lack of Efficacy|3
13580|NCT01783678|64439|P3|Overall Study|Lack of Efficacy|1
13581|NCT01783678|64440|P2|Overall Study|Lack of Efficacy|13
13582|NCT01783678|64441|P1|Overall Study|Lack of Efficacy|1
13583|NCT01783678|64436|P6|Overall Study|Randomized but Not Treated|0
13584|NCT01783678|64437|P5|Overall Study|Randomized but Not Treated|0
13585|NCT01783678|64438|P4|Overall Study|Randomized but Not Treated|1
13586|NCT01783678|64439|P3|Overall Study|Randomized but Not Treated|0
13587|NCT01783678|64440|P2|Overall Study|Randomized but Not Treated|0
13588|NCT01783678|64441|P1|Overall Study|Randomized but Not Treated|0
13589|NCT01783639|64513|P1|Overall Study|Clinical indication for proximal EPD|1
13590|NCT01783639|64513|P1|Overall Study|Did not meet inclusion/exclusion|21
13591|NCT01783548|64519|P2|Overall Study|Lack of Efficacy|1
13592|NCT01783548|64520|P1|Overall Study|Lack of Efficacy|1
13593|NCT01783548|64519|P2|Overall Study|Lost to Follow-up|3
13594|NCT01783548|64520|P1|Overall Study|Lost to Follow-up|8
13595|NCT01783548|64519|P2|Overall Study|Protocol Violation|2
13596|NCT01783548|64520|P1|Overall Study|Protocol Violation|2
13597|NCT01783548|64519|P2|Overall Study|Non-compliance|0
13598|NCT01783548|64520|P1|Overall Study|Non-compliance|4
13599|NCT01783548|64519|P2|Overall Study|Withdrawal by Subject|8
13600|NCT01783548|64520|P1|Overall Study|Withdrawal by Subject|11
13601|NCT01783548|64519|P2|Overall Study|Adverse Event|4
13602|NCT01783548|64520|P1|Overall Study|Adverse Event|8
13603|NCT01783496|64538|P6|Overall Study|Withdrawal by Subject|0
13604|NCT01783496|64539|P5|Overall Study|Withdrawal by Subject|0
13605|NCT01783496|64540|P4|Overall Study|Withdrawal by Subject|0
13606|NCT01783496|64541|P3|Overall Study|Withdrawal by Subject|0
13607|NCT01783496|64542|P2|Overall Study|Withdrawal by Subject|0
13608|NCT01783496|64543|P1|Overall Study|Withdrawal by Subject|1
13609|NCT01783496|64538|P6|Overall Study|Lost to Follow-up|1
13610|NCT01783496|64539|P5|Overall Study|Lost to Follow-up|0
13611|NCT01783496|64540|P4|Overall Study|Lost to Follow-up|2
13612|NCT01783496|64541|P3|Overall Study|Lost to Follow-up|0
13613|NCT01783496|64542|P2|Overall Study|Lost to Follow-up|0
13614|NCT01783496|64543|P1|Overall Study|Lost to Follow-up|0
13615|NCT01783418|64571|P2|Overall Study|Withdrawal by Subject|0
13616|NCT01783418|64572|P1|Overall Study|Withdrawal by Subject|1
13617|NCT01783015|64601|P3|Open Label Treatment|Study Terminated by Sponsor|6
13618|NCT01783015|64602|P2|Open Label Treatment|Study Terminated by Sponsor|0
13619|NCT01783015|64603|P1|Open Label Treatment|Study Terminated by Sponsor|0
13620|NCT01783015|64601|P3|Blinded Treatment|Study Terminated by Sponsor|0
13621|NCT01783015|64602|P2|Blinded Treatment|Study Terminated by Sponsor|0
13622|NCT01783015|64603|P1|Blinded Treatment|Study Terminated by Sponsor|2
13623|NCT01783015|64601|P3|Blinded Treatment|Withdrawal by Subject|0
13624|NCT01783015|64602|P2|Blinded Treatment|Withdrawal by Subject|1
13625|NCT01783015|64603|P1|Blinded Treatment|Withdrawal by Subject|0
13626|NCT01783015|64601|P3|Blinded Treatment|Protocol Violation|0
13627|NCT01783015|64602|P2|Blinded Treatment|Protocol Violation|1
13628|NCT01783015|64603|P1|Blinded Treatment|Protocol Violation|0
13629|NCT01783015|64601|P3|Blinded Treatment|Adverse Event|0
13630|NCT01783015|64602|P2|Blinded Treatment|Adverse Event|1
13631|NCT01783015|64603|P1|Blinded Treatment|Adverse Event|0
13632|NCT01782885|64703|P2|Overall Study|Lost to Follow-up|6
13633|NCT01782885|64704|P1|Overall Study|Lost to Follow-up|4
13634|NCT01782872|64730|P4|Overall Study|Withdrawal by Subject|0
13635|NCT01782872|64731|P3|Overall Study|Withdrawal by Subject|0
13636|NCT01782872|64732|P2|Overall Study|Withdrawal by Subject|1
13637|NCT01782872|64733|P1|Overall Study|Withdrawal by Subject|0
13638|NCT01782872|64730|P4|Overall Study|Protocol Violation|1
13639|NCT01782872|64731|P3|Overall Study|Protocol Violation|0
13640|NCT01782872|64732|P2|Overall Study|Protocol Violation|0
13641|NCT01782872|64733|P1|Overall Study|Protocol Violation|0
13642|NCT01782859|64757|P2|Overall Study|Withdrawal by Subject|1
13643|NCT01782859|64758|P1|Overall Study|Withdrawal by Subject|0
13644|NCT01782859|64757|P2|Overall Study|Protocol Violation|6
13645|NCT01782859|64758|P1|Overall Study|Protocol Violation|6
13646|NCT01782742|64774|P2|Double-blind Treatment Phase|Adverse Event|0
13647|NCT01782742|64775|P1|Double-blind Treatment Phase|Adverse Event|1
13648|NCT01782482|64810|P2|Overall Study|Habitually wearing toric lens OS|1
13649|NCT01782482|64811|P1|Overall Study|Habitually wearing toric lens OS|0
13650|NCT01782482|64810|P2|Overall Study|Randomized in Error|2
13651|NCT01782482|64811|P1|Overall Study|Randomized in Error|2
13652|NCT01782482|64810|P2|Overall Study|Withdrawal by Subject|3
13653|NCT01782482|64811|P1|Overall Study|Withdrawal by Subject|2
13654|NCT01782482|64810|P2|Overall Study|Protocol Violation|0
13655|NCT01782482|64811|P1|Overall Study|Protocol Violation|1
13656|NCT01782482|64810|P2|Overall Study|Physician Decision|0
13657|NCT01782482|64811|P1|Overall Study|Physician Decision|1
13658|NCT01782482|64810|P2|Overall Study|Lost to Follow-up|3
13659|NCT01782482|64811|P1|Overall Study|Lost to Follow-up|2
13660|NCT01782482|64810|P2|Overall Study|Adverse Event|1
13661|NCT01782482|64811|P1|Overall Study|Adverse Event|2
13662|NCT01782469|64819|P1|Overall Study|Lost to Follow-up|1
13663|NCT01782326|64829|P2|Double-blind Treatment|Technical problems|5
13664|NCT01782326|64830|P1|Double-blind Treatment|Technical problems|0
13665|NCT01782326|64829|P2|Double-blind Treatment|Protocol deviation|7
13666|NCT01782326|64830|P1|Double-blind Treatment|Protocol deviation|8
13667|NCT01782326|64829|P2|Double-blind Treatment|Physician Decision|16
13668|NCT01782326|64830|P1|Double-blind Treatment|Physician Decision|13
13669|NCT01782326|64829|P2|Double-blind Treatment|Lack of Efficacy|22
13670|NCT01782326|64830|P1|Double-blind Treatment|Lack of Efficacy|17
13671|NCT01782326|64829|P2|Double-blind Treatment|Subject/guardian decision|125
13672|NCT01782326|64830|P1|Double-blind Treatment|Subject/guardian decision|111
13673|NCT01782326|64829|P2|Double-blind Treatment|Adverse Event|145
13674|NCT01782326|64830|P1|Double-blind Treatment|Adverse Event|129
13675|NCT01782326|64829|P2|Planned Treatment Epoch|Technical problems|4
13676|NCT01782326|64830|P1|Planned Treatment Epoch|Technical problems|0
13677|NCT01782326|64829|P2|Planned Treatment Epoch|Lost to Follow-up|4
13678|NCT01782326|64830|P1|Planned Treatment Epoch|Lost to Follow-up|4
13679|NCT01782326|64829|P2|Planned Treatment Epoch|Protocol deviation|3
13680|NCT01782326|64830|P1|Planned Treatment Epoch|Protocol deviation|2
13681|NCT01782326|64829|P2|Planned Treatment Epoch|Physician Decision|16
13682|NCT01782326|64830|P1|Planned Treatment Epoch|Physician Decision|18
13683|NCT01782326|64829|P2|Planned Treatment Epoch|Death|30
13684|NCT01782326|64830|P1|Planned Treatment Epoch|Death|29
13685|NCT01782326|64829|P2|Planned Treatment Epoch|Subject/guardian decision|151
13686|NCT01782326|64830|P1|Planned Treatment Epoch|Subject/guardian decision|149
13687|NCT01782222|64893|P3|Overall Study|Moved to other state|0
13688|NCT01782222|64894|P2|Overall Study|Moved to other state|1
13689|NCT01782222|64895|P1|Overall Study|Moved to other state|0
13690|NCT01782222|64893|P3|Overall Study|Withdrawal by Subject|1
13691|NCT01782222|64894|P2|Overall Study|Withdrawal by Subject|4
13692|NCT01782222|64895|P1|Overall Study|Withdrawal by Subject|1
13693|NCT01782222|64893|P3|Overall Study|Protocol Violation|0
13694|NCT01782222|64894|P2|Overall Study|Protocol Violation|0
13695|NCT01782222|64895|P1|Overall Study|Protocol Violation|1
13696|NCT01782222|64893|P3|Overall Study|Lack of Efficacy|0
13697|NCT01782222|64894|P2|Overall Study|Lack of Efficacy|1
13698|NCT01782222|64895|P1|Overall Study|Lack of Efficacy|2
13699|NCT01782222|64893|P3|Overall Study|Adverse Event|3
13700|NCT01782222|64894|P2|Overall Study|Adverse Event|5
13701|NCT01782222|64895|P1|Overall Study|Adverse Event|4
13702|NCT01781962|64927|P1|Overall Study|Other Miscellaneous Reasons|5
13703|NCT01781026|65024|P1|Overall Study|Lack of Efficacy|2
13704|NCT01780987|65030|P2|Overall Study|Not Receiving any Study Medication|1
13705|NCT01780987|65031|P1|Overall Study|Not Receiving any Study Medication|0
13706|NCT01780987|65030|P2|Overall Study|Changing Residence|0
13707|NCT01780987|65031|P1|Overall Study|Changing Residence|1
13708|NCT01780987|65030|P2|Overall Study|Request of Changing Hospital|1
13709|NCT01780987|65031|P1|Overall Study|Request of Changing Hospital|0
13710|NCT01780987|65030|P2|Overall Study|Withdrawal by Subject|0
13711|NCT01780987|65031|P1|Overall Study|Withdrawal by Subject|2
13712|NCT01780987|65030|P2|Overall Study|Adverse Event|4
13713|NCT01780987|65031|P1|Overall Study|Adverse Event|0
13714|NCT01780935|65049|P2|Overall Study|Patient withdrew consent|9
13715|NCT01780935|65050|P1|Overall Study|Patient withdrew consent|8
13716|NCT01780935|65049|P2|Overall Study|Protocol deviation|1
13717|NCT01780935|65050|P1|Overall Study|Protocol deviation|0
13718|NCT01780935|65049|P2|Overall Study|Physician Decision|1
13719|NCT01780935|65050|P1|Overall Study|Physician Decision|1
13720|NCT01780935|65049|P2|Overall Study|Lost to Follow-up|6
13721|NCT01780935|65050|P1|Overall Study|Lost to Follow-up|2
13722|NCT01780935|65049|P2|Overall Study|Death|6
13723|NCT01780935|65050|P1|Overall Study|Death|1
13724|NCT01780935|65049|P2|Overall Study|Adverse Event|4
13725|NCT01780935|65050|P1|Overall Study|Adverse Event|2
13726|NCT01780935|65049|P2|Overall Study|Admin problems due to early termination|309
13727|NCT01780935|65050|P1|Overall Study|Admin problems due to early termination|321
13728|NCT01780584|65141|P3|Overall Study|Protocol Violation|1
13729|NCT01780584|65142|P2|Overall Study|Protocol Violation|0
13730|NCT01780584|65143|P1|Overall Study|Protocol Violation|0
13731|NCT01780584|65141|P3|Overall Study|Adverse Event|0
13732|NCT01780584|65142|P2|Overall Study|Adverse Event|1
13733|NCT01780584|65143|P1|Overall Study|Adverse Event|0
13734|NCT01780584|65141|P3|Overall Study|Death|1
13735|NCT01780584|65142|P2|Overall Study|Death|0
13736|NCT01780584|65143|P1|Overall Study|Death|1
13737|NCT01780506|65165|P2|Overall Study|Still on Study|388
13738|NCT01780506|65166|P1|Overall Study|Still on Study|401
13739|NCT01780506|65165|P2|Overall Study|Lost to Follow-up|14
13740|NCT01780506|65166|P1|Overall Study|Lost to Follow-up|10
13741|NCT01780506|65165|P2|Overall Study|Withdrew Consent|15
13742|NCT01780506|65166|P1|Overall Study|Withdrew Consent|13
13743|NCT01780506|65165|P2|Overall Study|Protocol Violation|3
13744|NCT01780506|65166|P1|Overall Study|Protocol Violation|3
13745|NCT01780506|65165|P2|Overall Study|Non-Compliance with Study Drug|1
13746|NCT01780506|65166|P1|Overall Study|Non-Compliance with Study Drug|1
13747|NCT01780506|65165|P2|Overall Study|Investigator's Discretion|1
13748|NCT01780506|65166|P1|Overall Study|Investigator's Discretion|2
13749|NCT01780506|65165|P2|Overall Study|Lack of Efficacy|1
13750|NCT01780506|65166|P1|Overall Study|Lack of Efficacy|1
13751|NCT01780506|65165|P2|Overall Study|Pregnancy|0
13752|NCT01780506|65166|P1|Overall Study|Pregnancy|1
13753|NCT01780506|65165|P2|Overall Study|Death|1
13754|NCT01780506|65166|P1|Overall Study|Death|0
13755|NCT01780506|65165|P2|Overall Study|Adverse Event|8
13756|NCT01780506|65166|P1|Overall Study|Adverse Event|3
13757|NCT01780506|65165|P2|Overall Study|Randomized but not Treated|2
13758|NCT01780506|65166|P1|Overall Study|Randomized but not Treated|3
13759|NCT01780389|65204|P1|Overall Study|Adverse Event|1
13760|NCT01779648|65244|P2|Overall Study|Protocol Violation|0
13761|NCT01779648|65245|P1|Overall Study|Protocol Violation|1
13762|NCT01778985|65290|P2|Overall Study|Protocol Violation|1
13763|NCT01778985|65291|P1|Overall Study|Protocol Violation|4
13764|NCT01778985|65290|P2|Overall Study|Physician Decision|2
13765|NCT01778985|65291|P1|Overall Study|Physician Decision|2
13766|NCT01778985|65290|P2|Overall Study|Lost to Follow-up|0
13767|NCT01778985|65291|P1|Overall Study|Lost to Follow-up|1
13768|NCT01778751|65337|P2|Overall Study|Transfered care|0
13769|NCT01778751|65338|P1|Overall Study|Transfered care|1
13770|NCT01778751|65337|P2|Overall Study|Withdrawal by Subject|2
13771|NCT01778751|65338|P1|Overall Study|Withdrawal by Subject|0
13772|NCT01778751|65337|P2|Overall Study|Lost to Follow-up|0
13773|NCT01778751|65338|P1|Overall Study|Lost to Follow-up|1
13774|NCT01778530|65350|P1|Overall Study|Adverse event/side effect|1
13775|NCT01778530|65350|P1|Overall Study|Progression on study|1
13776|NCT01778127|65362|P3|Overall Study|Withdrawal by Subject|4
13777|NCT01778127|65363|P2|Overall Study|Withdrawal by Subject|1
13778|NCT01778127|65364|P1|Overall Study|Withdrawal by Subject|3
13779|NCT01778127|65362|P3|Overall Study|Lost to Follow-up|2
13780|NCT01778127|65363|P2|Overall Study|Lost to Follow-up|1
13781|NCT01778127|65364|P1|Overall Study|Lost to Follow-up|5
13782|NCT01778062|65407|P2|Overall Study|major protocol deviation|3
13783|NCT01778062|65408|P1|Overall Study|major protocol deviation|4
13784|NCT01778062|65407|P2|Overall Study|Consent Withdrawal|5
13785|NCT01778062|65408|P1|Overall Study|Consent Withdrawal|1
13786|NCT01778062|65407|P2|Overall Study|Adverse Event|3
13787|NCT01778062|65408|P1|Overall Study|Adverse Event|1
13788|NCT01778049|65422|P6|Double Blind Treatment Period|Other reason not defined above|1
13789|NCT01778049|65423|P5|Double Blind Treatment Period|Other reason not defined above|2
13790|NCT01778049|65424|P4|Double Blind Treatment Period|Other reason not defined above|2
13791|NCT01778049|65425|P3|Double Blind Treatment Period|Other reason not defined above|4
13792|NCT01778049|65426|P2|Double Blind Treatment Period|Other reason not defined above|0
13793|NCT01778049|65427|P1|Double Blind Treatment Period|Other reason not defined above|0
13794|NCT01778049|65422|P6|Double Blind Treatment Period|Not treated|0
13795|NCT01778049|65423|P5|Double Blind Treatment Period|Not treated|2
13796|NCT01778049|65424|P4|Double Blind Treatment Period|Not treated|2
13797|NCT01778049|65425|P3|Double Blind Treatment Period|Not treated|0
13798|NCT01778049|65426|P2|Double Blind Treatment Period|Not treated|0
13799|NCT01778049|65427|P1|Double Blind Treatment Period|Not treated|0
13800|NCT01778049|65422|P6|Double Blind Treatment Period|Withdrawal by Subject|1
13801|NCT01778049|65423|P5|Double Blind Treatment Period|Withdrawal by Subject|0
13802|NCT01778049|65424|P4|Double Blind Treatment Period|Withdrawal by Subject|2
13803|NCT01778049|65425|P3|Double Blind Treatment Period|Withdrawal by Subject|1
13804|NCT01778049|65426|P2|Double Blind Treatment Period|Withdrawal by Subject|0
13805|NCT01778049|65427|P1|Double Blind Treatment Period|Withdrawal by Subject|0
13806|NCT01778049|65422|P6|Double Blind Treatment Period|Lost to Follow-up|2
13807|NCT01778049|65423|P5|Double Blind Treatment Period|Lost to Follow-up|5
13808|NCT01778049|65424|P4|Double Blind Treatment Period|Lost to Follow-up|1
13809|NCT01778049|65425|P3|Double Blind Treatment Period|Lost to Follow-up|4
13810|NCT01778049|65426|P2|Double Blind Treatment Period|Lost to Follow-up|0
13811|NCT01778049|65427|P1|Double Blind Treatment Period|Lost to Follow-up|0
13812|NCT01778049|65422|P6|Double Blind Treatment Period|Protocol Violation|0
13813|NCT01778049|65423|P5|Double Blind Treatment Period|Protocol Violation|0
13814|NCT01778049|65424|P4|Double Blind Treatment Period|Protocol Violation|0
13815|NCT01778049|65425|P3|Double Blind Treatment Period|Protocol Violation|2
13816|NCT01778049|65426|P2|Double Blind Treatment Period|Protocol Violation|0
13817|NCT01778049|65427|P1|Double Blind Treatment Period|Protocol Violation|0
13818|NCT01778049|65422|P6|Double Blind Treatment Period|Lack of Efficacy|1
13819|NCT01778049|65423|P5|Double Blind Treatment Period|Lack of Efficacy|0
13820|NCT01778049|65424|P4|Double Blind Treatment Period|Lack of Efficacy|0
13821|NCT01778049|65425|P3|Double Blind Treatment Period|Lack of Efficacy|0
13822|NCT01778049|65426|P2|Double Blind Treatment Period|Lack of Efficacy|0
13823|NCT01778049|65427|P1|Double Blind Treatment Period|Lack of Efficacy|0
13824|NCT01778049|65422|P6|Double Blind Treatment Period|Adverse Event|2
13825|NCT01778049|65423|P5|Double Blind Treatment Period|Adverse Event|3
13826|NCT01778049|65424|P4|Double Blind Treatment Period|Adverse Event|5
13827|NCT01778049|65425|P3|Double Blind Treatment Period|Adverse Event|4
13828|NCT01778049|65426|P2|Double Blind Treatment Period|Adverse Event|0
13829|NCT01778049|65427|P1|Double Blind Treatment Period|Adverse Event|0
13830|NCT01778049|65422|P6|Open Label Treatment Period|Other reason not defined above|0
13831|NCT01778049|65423|P5|Open Label Treatment Period|Other reason not defined above|0
13832|NCT01778049|65424|P4|Open Label Treatment Period|Other reason not defined above|0
13833|NCT01778049|65425|P3|Open Label Treatment Period|Other reason not defined above|0
13834|NCT01778049|65426|P2|Open Label Treatment Period|Other reason not defined above|94
13835|NCT01778049|65427|P1|Open Label Treatment Period|Other reason not defined above|77
13836|NCT01778049|65422|P6|Open Label Treatment Period|Not treated|0
13837|NCT01778049|65423|P5|Open Label Treatment Period|Not treated|0
13838|NCT01778049|65424|P4|Open Label Treatment Period|Not treated|0
13839|NCT01778049|65425|P3|Open Label Treatment Period|Not treated|0
13840|NCT01778049|65426|P2|Open Label Treatment Period|Not treated|1
13841|NCT01778049|65427|P1|Open Label Treatment Period|Not treated|2
13842|NCT01778049|65422|P6|Open Label Treatment Period|Withdrawal by Subject|0
13843|NCT01778049|65423|P5|Open Label Treatment Period|Withdrawal by Subject|0
13844|NCT01778049|65424|P4|Open Label Treatment Period|Withdrawal by Subject|0
13845|NCT01778049|65425|P3|Open Label Treatment Period|Withdrawal by Subject|0
13846|NCT01778049|65426|P2|Open Label Treatment Period|Withdrawal by Subject|10
13847|NCT01778049|65427|P1|Open Label Treatment Period|Withdrawal by Subject|4
13848|NCT01778049|65422|P6|Open Label Treatment Period|Lost to Follow-up|0
13849|NCT01778049|65423|P5|Open Label Treatment Period|Lost to Follow-up|0
13850|NCT01778049|65424|P4|Open Label Treatment Period|Lost to Follow-up|0
13851|NCT01778049|65425|P3|Open Label Treatment Period|Lost to Follow-up|0
13852|NCT01778049|65426|P2|Open Label Treatment Period|Lost to Follow-up|3
13853|NCT01778049|65427|P1|Open Label Treatment Period|Lost to Follow-up|4
13854|NCT01778049|65422|P6|Open Label Treatment Period|Protocol Violation|0
13855|NCT01778049|65423|P5|Open Label Treatment Period|Protocol Violation|0
13856|NCT01778049|65424|P4|Open Label Treatment Period|Protocol Violation|0
13857|NCT01778049|65425|P3|Open Label Treatment Period|Protocol Violation|0
13858|NCT01778049|65426|P2|Open Label Treatment Period|Protocol Violation|5
13859|NCT01778049|65427|P1|Open Label Treatment Period|Protocol Violation|5
13860|NCT01778049|65422|P6|Open Label Treatment Period|Lack of Efficacy|0
13861|NCT01778049|65423|P5|Open Label Treatment Period|Lack of Efficacy|0
13862|NCT01778049|65424|P4|Open Label Treatment Period|Lack of Efficacy|0
13863|NCT01778049|65425|P3|Open Label Treatment Period|Lack of Efficacy|0
13864|NCT01778049|65426|P2|Open Label Treatment Period|Lack of Efficacy|1
13865|NCT01778049|65427|P1|Open Label Treatment Period|Lack of Efficacy|1
13866|NCT01778049|65422|P6|Open Label Treatment Period|Adverse Event|0
13867|NCT01778049|65423|P5|Open Label Treatment Period|Adverse Event|0
13868|NCT01778049|65424|P4|Open Label Treatment Period|Adverse Event|0
13869|NCT01778049|65425|P3|Open Label Treatment Period|Adverse Event|0
13870|NCT01778049|65426|P2|Open Label Treatment Period|Adverse Event|15
13871|NCT01778049|65427|P1|Open Label Treatment Period|Adverse Event|5
13872|NCT01778023|65445|P2|Overall Study|Withdrawal by Subject|3
13873|NCT01778023|65446|P1|Overall Study|Withdrawal by Subject|0
13874|NCT01777932|65473|P1|Overall Study|Patient refused further treatment|10
13875|NCT01777932|65473|P1|Overall Study|Reimbursement limit|9
13876|NCT01777932|65473|P1|Overall Study|Investigator decision|10
13877|NCT01777932|65473|P1|Overall Study|Lost to Follow-up|3
13878|NCT01777932|65473|P1|Overall Study|Adverse Event|34
13879|NCT01777932|65473|P1|Overall Study|Death|3
13880|NCT01777932|65473|P1|Overall Study|Disease progression|136
13881|NCT01777776|65491|P4|Overall Study|Withdrawal by Subject|1
13882|NCT01777776|65492|P3|Overall Study|Withdrawal by Subject|0
13883|NCT01777776|65493|P2|Overall Study|Withdrawal by Subject|0
13884|NCT01777776|65494|P1|Overall Study|Withdrawal by Subject|0
13885|NCT01777776|65491|P4|Overall Study|Disease Progression|3
13886|NCT01777776|65492|P3|Overall Study|Disease Progression|6
13887|NCT01777776|65493|P2|Overall Study|Disease Progression|8
13888|NCT01777776|65494|P1|Overall Study|Disease Progression|4
13889|NCT01777776|65491|P4|Overall Study|Adverse Event|0
13890|NCT01777776|65492|P3|Overall Study|Adverse Event|0
13891|NCT01777776|65493|P2|Overall Study|Adverse Event|4
13892|NCT01777776|65494|P1|Overall Study|Adverse Event|2
13893|NCT01777763|65553|P2|Overall Study|Treatment Failure|6
13894|NCT01777763|65554|P1|Overall Study|Treatment Failure|1
13895|NCT01777763|65553|P2|Overall Study|Withdrawal by Subject|2
13896|NCT01777763|65554|P1|Overall Study|Withdrawal by Subject|0
13897|NCT01777763|65553|P2|Overall Study|Protocol Violation|7
13898|NCT01777763|65554|P1|Overall Study|Protocol Violation|1
13899|NCT01777763|65553|P2|Overall Study|Adverse Event|32
13900|NCT01777763|65554|P1|Overall Study|Adverse Event|2
13901|NCT01777620|65578|P2|Overall Study|Subject Withdrawal|0
13902|NCT01777620|65579|P1|Overall Study|Subject Withdrawal|1
13903|NCT01777581|65605|P2|Overall Study|Lack of Efficacy|1
13904|NCT01777581|65606|P1|Overall Study|Lack of Efficacy|0
13905|NCT01777581|65605|P2|Overall Study|Adverse Event|0
13906|NCT01777581|65606|P1|Overall Study|Adverse Event|2
13907|NCT01777581|65605|P2|Overall Study|Lost to Follow-up|1
13908|NCT01777581|65606|P1|Overall Study|Lost to Follow-up|1
13909|NCT01777334|65653|P2|Overall Study|Withdrawal by Subject|11
13910|NCT01777334|65654|P1|Overall Study|Withdrawal by Subject|14
13911|NCT01777334|65653|P2|Overall Study|Lost to Follow-up|2
13912|NCT01777334|65654|P1|Overall Study|Lost to Follow-up|3
13913|NCT01777334|65653|P2|Overall Study|Protocol Violation|7
13914|NCT01777334|65654|P1|Overall Study|Protocol Violation|3
13915|NCT01777334|65653|P2|Overall Study|Lack of Efficacy|29
13916|NCT01777334|65654|P1|Overall Study|Lack of Efficacy|15
13917|NCT01777334|65653|P2|Overall Study|Adverse Event|14
13918|NCT01777334|65654|P1|Overall Study|Adverse Event|18
13919|NCT01777321|65664|P2|Overall Study|Withdrawal by Subject|1
13920|NCT01777321|65665|P1|Overall Study|Withdrawal by Subject|0
13921|NCT01777282|65706|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
13922|NCT01777282|65707|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
13923|NCT01777282|65708|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
13924|NCT01777282|65709|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
13925|NCT01777282|65710|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
13926|NCT01777282|65706|P5|Overall Study|Protocol Violation|2
13927|NCT01777282|65707|P4|Overall Study|Protocol Violation|0
13928|NCT01777282|65708|P3|Overall Study|Protocol Violation|1
13929|NCT01777282|65709|P2|Overall Study|Protocol Violation|0
13930|NCT01777282|65710|P1|Overall Study|Protocol Violation|2
13931|NCT01777282|65706|P5|Overall Study|Withdrawal by Subject|2
13932|NCT01777282|65707|P4|Overall Study|Withdrawal by Subject|1
13933|NCT01777282|65708|P3|Overall Study|Withdrawal by Subject|0
13934|NCT01777282|65709|P2|Overall Study|Withdrawal by Subject|0
13935|NCT01777282|65710|P1|Overall Study|Withdrawal by Subject|4
13936|NCT01777282|65706|P5|Overall Study|Adverse Event|3
13937|NCT01777282|65707|P4|Overall Study|Adverse Event|1
13938|NCT01777282|65708|P3|Overall Study|Adverse Event|2
13939|NCT01777282|65709|P2|Overall Study|Adverse Event|4
13940|NCT01777282|65710|P1|Overall Study|Adverse Event|4
13941|NCT01777282|65706|P5|Overall Study|New Antidiabetic Medication|0
13942|NCT01777282|65707|P4|Overall Study|New Antidiabetic Medication|0
13943|NCT01777282|65708|P3|Overall Study|New Antidiabetic Medication|1
13944|NCT01777282|65709|P2|Overall Study|New Antidiabetic Medication|0
13945|NCT01777282|65710|P1|Overall Study|New Antidiabetic Medication|0
13946|NCT01777282|65706|P5|Overall Study|Persistent Hyperglycemia|0
13947|NCT01777282|65707|P4|Overall Study|Persistent Hyperglycemia|0
13948|NCT01777282|65708|P3|Overall Study|Persistent Hyperglycemia|1
13949|NCT01777282|65709|P2|Overall Study|Persistent Hyperglycemia|0
13950|NCT01777282|65710|P1|Overall Study|Persistent Hyperglycemia|0
13951|NCT01777191|65763|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
13952|NCT01777191|65764|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
13953|NCT01777191|65763|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
13954|NCT01777191|65764|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
13955|NCT01777191|65763|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
13956|NCT01777191|65764|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
13957|NCT01777191|65763|P2|Safety Extension Per (Week 12-Week 48)|Death|1
13958|NCT01777191|65764|P1|Safety Extension Per (Week 12-Week 48)|Death|0
13959|NCT01777191|65763|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
13960|NCT01777191|65764|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
13961|NCT01777191|65763|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
13962|NCT01777191|65764|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
13963|NCT01777191|65763|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
13964|NCT01777191|65764|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
13965|NCT01777191|65763|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
13966|NCT01777191|65764|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
13967|NCT01777191|65763|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
13968|NCT01777191|65764|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
13969|NCT01777191|65763|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
13970|NCT01777191|65764|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
13971|NCT01777191|65763|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
13972|NCT01777191|65764|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
13973|NCT01776554|65827|P2|Overall Study|Unclassified|1
13974|NCT01776554|65828|P1|Overall Study|Unclassified|4
13975|NCT01776554|65827|P2|Overall Study|Protocol Violation|0
13976|NCT01776554|65828|P1|Overall Study|Protocol Violation|1
13977|NCT01776554|65827|P2|Overall Study|Administrative Reason|5
13978|NCT01776554|65828|P1|Overall Study|Administrative Reason|2
13979|NCT01776554|65827|P2|Overall Study|Lost to Follow-up|9
13980|NCT01776554|65828|P1|Overall Study|Lost to Follow-up|6
13981|NCT01776554|65827|P2|Overall Study|Withdrawal by Subject|8
13982|NCT01776554|65828|P1|Overall Study|Withdrawal by Subject|3
13983|NCT01776554|65827|P2|Overall Study|Adverse Event|0
13984|NCT01776554|65828|P1|Overall Study|Adverse Event|1
13985|NCT01776541|65871|P2|Overall Study|Withdrawal by Subject|20
13986|NCT01776541|65872|P1|Overall Study|Withdrawal by Subject|12
13987|NCT01776541|65871|P2|Overall Study|Protocol Violation|1
13988|NCT01776541|65872|P1|Overall Study|Protocol Violation|2
13989|NCT01776541|65871|P2|Overall Study|Unclassified|4
13990|NCT01776541|65872|P1|Overall Study|Unclassified|5
13991|NCT01776541|65871|P2|Overall Study|Lost to Follow-up|48
13992|NCT01776541|65872|P1|Overall Study|Lost to Follow-up|27
13993|NCT01776541|65871|P2|Overall Study|Death|0
13994|NCT01776541|65872|P1|Overall Study|Death|4
13995|NCT01776541|65871|P2|Overall Study|Administrative Reason|2
13996|NCT01776541|65872|P1|Overall Study|Administrative Reason|6
13997|NCT01775995|65893|P2|Overall Study|Lost to Follow-up|1
13998|NCT01775995|65894|P1|Overall Study|Lost to Follow-up|1
13999|NCT01775137|65969|P1|Overall Study|Withdrawal by participants|5
14000|NCT01775137|65969|P1|Overall Study|Adverse Event|1
14001|NCT01775137|65969|P1|Overall Study|Unsatisfactory therapeutic effect|2
14002|NCT01775137|65969|P1|Overall Study|Protocol deviation|2
14003|NCT01775137|65969|P1|Overall Study|Death|1
14004|NCT01774968|65996|P2|Overall Study|Withdrawal by Subject|11
14005|NCT01774968|65997|P1|Overall Study|Withdrawal by Subject|6
14006|NCT01774968|65996|P2|Overall Study|Sponsor Decision|2
14007|NCT01774968|65997|P1|Overall Study|Sponsor Decision|0
14008|NCT01774968|65996|P2|Overall Study|Protocol Violation|13
14009|NCT01774968|65997|P1|Overall Study|Protocol Violation|14
14010|NCT01774968|65996|P2|Overall Study|Physician Decision|1
14011|NCT01774968|65997|P1|Overall Study|Physician Decision|5
14012|NCT01774968|65996|P2|Overall Study|Lost to Follow-up|3
14013|NCT01774968|65997|P1|Overall Study|Lost to Follow-up|1
14014|NCT01774968|65996|P2|Overall Study|Death|1
14015|NCT01774968|65997|P1|Overall Study|Death|0
14016|NCT01774968|65996|P2|Overall Study|Adverse Event|4
14017|NCT01774968|65997|P1|Overall Study|Adverse Event|4
14018|NCT01774929|66031|P1|Overall Study|Adverse Event|3
14019|NCT01774903|66037|P1|Overall Study|Ineligible to continue the trial|1
14020|NCT01774903|66037|P1|Overall Study|Lack of Efficacy|1
14021|NCT01774903|66037|P1|Overall Study|Withdrawal by Subject|2
14022|NCT01774903|66037|P1|Overall Study|Adverse Event|7
14023|NCT01774305|66067|P2|Overall Study|Physician Decision|0
14024|NCT01774305|66068|P1|Overall Study|Physician Decision|1
14025|NCT01774253|66076|P1|Overall Study|Death|1
14026|NCT01774253|66076|P1|Overall Study|Withdrawal by Subject|2
14027|NCT01774253|66076|P1|Overall Study|Physician Decision|2
14028|NCT01774253|66076|P1|Overall Study|Lack of Efficacy|4
14029|NCT01774110|66095|P1|Overall Study|Lost to Follow-up|7
14030|NCT01774084|66103|P2|Overall Study|Personal reasons|0
14031|NCT01774084|66104|P1|Overall Study|Personal reasons|1
14032|NCT01773122|66140|P4|Overall Study|Due to amended age eligibility criteria|1
14033|NCT01773122|66141|P3|Overall Study|Due to amended age eligibility criteria|0
14034|NCT01773122|66142|P2|Overall Study|Due to amended age eligibility criteria|1
14035|NCT01773122|66143|P1|Overall Study|Due to amended age eligibility criteria|3
14036|NCT01773889|66157|P1|Overall Study|lack of funding|2
14037|NCT01773473|66163|P2|Overall Study|Lost to Follow-up|0
14038|NCT01773473|66164|P1|Overall Study|Lost to Follow-up|2
14039|NCT01773473|66163|P2|Overall Study|Withdrawal by Subject|3
14040|NCT01773473|66164|P1|Overall Study|Withdrawal by Subject|5
14041|NCT01773473|66163|P2|Overall Study|Non-Compliance with study drug|4
14042|NCT01773473|66164|P1|Overall Study|Non-Compliance with study drug|1
14043|NCT01773473|66163|P2|Overall Study|Lack of Efficacy|1
14044|NCT01773473|66164|P1|Overall Study|Lack of Efficacy|0
14045|NCT01773473|66163|P2|Overall Study|Sponsor Decision|0
14046|NCT01773473|66164|P1|Overall Study|Sponsor Decision|2
14047|NCT01773473|66163|P2|Overall Study|Physician Decision|5
14048|NCT01773473|66164|P1|Overall Study|Physician Decision|3
14049|NCT01773473|66163|P2|Overall Study|Protocol Violation|4
14050|NCT01773473|66164|P1|Overall Study|Protocol Violation|0
14051|NCT01773473|66163|P2|Overall Study|Adverse Event|2
14052|NCT01773473|66164|P1|Overall Study|Adverse Event|3
14053|NCT01773291|66185|P3|Overall Study|Withdrawal by Subject|1
14054|NCT01773291|66186|P2|Overall Study|Withdrawal by Subject|0
14055|NCT01773291|66187|P1|Overall Study|Withdrawal by Subject|0
14056|NCT01773291|66185|P3|Overall Study|Protocol Violation|0
14057|NCT01773291|66186|P2|Overall Study|Protocol Violation|0
14058|NCT01773291|66187|P1|Overall Study|Protocol Violation|1
14059|NCT01773226|66198|P1|Overall Study|Withdrawal by Subject|1
14060|NCT01772550|66218|P3|Overall Study|Adverse Event|1
14061|NCT01772550|66219|P2|Overall Study|Adverse Event|0
14062|NCT01772550|66220|P1|Overall Study|Adverse Event|0
14063|NCT01772550|66218|P3|Overall Study|Unable to insert IV in antecubital vein|5
14064|NCT01772550|66219|P2|Overall Study|Unable to insert IV in antecubital vein|1
14065|NCT01772550|66220|P1|Overall Study|Unable to insert IV in antecubital vein|1
14066|NCT01772316|66258|P1|Overall Study|Withdrawn by sponsor decision|5
14067|NCT01772316|66258|P1|Overall Study|Inform consent withdrawn|1
14068|NCT01772316|66258|P1|Overall Study|Serious adverse event|1
14069|NCT01772147|66279|P3|Overall Study|Lack of Efficacy|6
14070|NCT01772147|66280|P2|Overall Study|Lack of Efficacy|6
14071|NCT01772147|66281|P1|Overall Study|Lack of Efficacy|8
14072|NCT01772147|66279|P3|Overall Study|Protocol Deviation|1
14073|NCT01772147|66280|P2|Overall Study|Protocol Deviation|1
14074|NCT01772147|66281|P1|Overall Study|Protocol Deviation|2
14075|NCT01772147|66279|P3|Overall Study|Lost to Follow-up|1
14076|NCT01772147|66280|P2|Overall Study|Lost to Follow-up|0
14077|NCT01772147|66281|P1|Overall Study|Lost to Follow-up|1
14078|NCT01772147|66279|P3|Overall Study|Withdrew Consent|4
14079|NCT01772147|66280|P2|Overall Study|Withdrew Consent|8
14080|NCT01772147|66281|P1|Overall Study|Withdrew Consent|7
14081|NCT01772147|66279|P3|Overall Study|Adverse Event|6
14082|NCT01772147|66280|P2|Overall Study|Adverse Event|10
14083|NCT01772147|66281|P1|Overall Study|Adverse Event|13
14084|NCT01772134|66301|P3|Overall Study|Randomized Study Medication Not Received|1
14085|NCT01772134|66302|P2|Overall Study|Randomized Study Medication Not Received|0
14086|NCT01772134|66303|P1|Overall Study|Randomized Study Medication Not Received|2
14087|NCT01772134|66301|P3|Overall Study|Protocol-defined Stopping Criteria|0
14088|NCT01772134|66302|P2|Overall Study|Protocol-defined Stopping Criteria|0
14089|NCT01772134|66303|P1|Overall Study|Protocol-defined Stopping Criteria|1
14090|NCT01772134|66301|P3|Overall Study|Lack of Efficacy|3
14091|NCT01772134|66302|P2|Overall Study|Lack of Efficacy|5
14092|NCT01772134|66303|P1|Overall Study|Lack of Efficacy|11
14093|NCT01772134|66301|P3|Overall Study|Protocol Deviation|3
14094|NCT01772134|66302|P2|Overall Study|Protocol Deviation|3
14095|NCT01772134|66303|P1|Overall Study|Protocol Deviation|4
14096|NCT01772134|66301|P3|Overall Study|Lost to Follow-up|0
14097|NCT01772134|66302|P2|Overall Study|Lost to Follow-up|0
14098|NCT01772134|66303|P1|Overall Study|Lost to Follow-up|2
14099|NCT01772134|66301|P3|Overall Study|Withdrew Consent|5
14100|NCT01772134|66302|P2|Overall Study|Withdrew Consent|1
14101|NCT01772134|66303|P1|Overall Study|Withdrew Consent|3
14102|NCT01772134|66301|P3|Overall Study|Adverse Event|10
14103|NCT01772134|66302|P2|Overall Study|Adverse Event|5
14104|NCT01772134|66303|P1|Overall Study|Adverse Event|6
14105|NCT01771913|66331|P2|Overall Study|Withdrawal by Subject|0
14106|NCT01771913|66332|P1|Overall Study|Withdrawal by Subject|1
14107|NCT01770860|66346|P1|Overall Study|Administrative decision made by the PI|1
14108|NCT01770860|66346|P1|Overall Study|Lost to Follow-up|1
14109|NCT01770860|66346|P1|Overall Study|Withdrawal by Subject|4
14110|NCT01770743|66394|P5|Overall Study|Moving Out of State|0
14111|NCT01770743|66395|P4|Overall Study|Moving Out of State|0
14112|NCT01770743|66396|P3|Overall Study|Moving Out of State|0
14113|NCT01770743|66397|P2|Overall Study|Moving Out of State|1
14114|NCT01770743|66398|P1|Overall Study|Moving Out of State|0
14115|NCT01770743|66394|P5|Overall Study|Sponsor Terminated Subject|0
14116|NCT01770743|66395|P4|Overall Study|Sponsor Terminated Subject|1
14117|NCT01770743|66396|P3|Overall Study|Sponsor Terminated Subject|0
14118|NCT01770743|66397|P2|Overall Study|Sponsor Terminated Subject|0
14119|NCT01770743|66398|P1|Overall Study|Sponsor Terminated Subject|1
14120|NCT01770743|66394|P5|Overall Study|Lost to Follow-up|1
14121|NCT01770743|66395|P4|Overall Study|Lost to Follow-up|0
14122|NCT01770743|66396|P3|Overall Study|Lost to Follow-up|0
14123|NCT01770743|66397|P2|Overall Study|Lost to Follow-up|2
14124|NCT01770743|66398|P1|Overall Study|Lost to Follow-up|0
14125|NCT01770743|66394|P5|Overall Study|Withdrawal by Subject|1
14126|NCT01770743|66395|P4|Overall Study|Withdrawal by Subject|1
14127|NCT01770743|66396|P3|Overall Study|Withdrawal by Subject|1
14128|NCT01770743|66397|P2|Overall Study|Withdrawal by Subject|0
14129|NCT01770743|66398|P1|Overall Study|Withdrawal by Subject|0
14130|NCT01770743|66394|P5|Overall Study|Adverse Event|0
14131|NCT01770743|66395|P4|Overall Study|Adverse Event|0
14132|NCT01770743|66396|P3|Overall Study|Adverse Event|0
14133|NCT01770743|66397|P2|Overall Study|Adverse Event|0
14134|NCT01770743|66398|P1|Overall Study|Adverse Event|1
14135|NCT01770509|66500|P2|Overall Study|Lost to Follow-up|2
14136|NCT01770509|66501|P1|Overall Study|Lost to Follow-up|1
14137|NCT01770509|66500|P2|Overall Study|Injury|1
14138|NCT01770509|66501|P1|Overall Study|Injury|0
14139|NCT01770392|66526|P1|Washout Period of at Least 14 Days|Adverse Event|1
14140|NCT01770379|66541|P3|Overall Study|Adverse Event|2
14141|NCT01770379|66542|P2|Overall Study|Adverse Event|3
14142|NCT01770379|66543|P1|Overall Study|Adverse Event|1
14143|NCT01770379|66541|P3|Overall Study|Lack of Efficacy|6
14144|NCT01770379|66542|P2|Overall Study|Lack of Efficacy|6
14145|NCT01770379|66543|P1|Overall Study|Lack of Efficacy|8
14146|NCT01770379|66541|P3|Overall Study|Lost to Follow-up|2
14147|NCT01770379|66542|P2|Overall Study|Lost to Follow-up|0
14148|NCT01770379|66543|P1|Overall Study|Lost to Follow-up|0
14149|NCT01770379|66541|P3|Overall Study|Physician Decision|2
14150|NCT01770379|66542|P2|Overall Study|Physician Decision|1
14151|NCT01770379|66543|P1|Overall Study|Physician Decision|0
14152|NCT01770379|66541|P3|Overall Study|Protocol Violation|1
14153|NCT01770379|66542|P2|Overall Study|Protocol Violation|1
14154|NCT01770379|66543|P1|Overall Study|Protocol Violation|0
14155|NCT01770379|66541|P3|Overall Study|study terminated by sponsor|22
14156|NCT01770379|66542|P2|Overall Study|study terminated by sponsor|23
14157|NCT01770379|66543|P1|Overall Study|study terminated by sponsor|22
14158|NCT01770379|66541|P3|Overall Study|Withdrawal by Subject|7
14159|NCT01770379|66542|P2|Overall Study|Withdrawal by Subject|10
14160|NCT01770379|66543|P1|Overall Study|Withdrawal by Subject|7
14161|NCT01770379|66541|P3|Overall Study|Technical issues|0
14162|NCT01770379|66542|P2|Overall Study|Technical issues|0
14163|NCT01770379|66543|P1|Overall Study|Technical issues|1
14164|NCT01770145|66580|P1|Treatment|Withdrawal by Subject|1
14165|NCT01770145|66580|P1|Treatment|Adverse Event|3
14166|NCT01770145|66580|P1|Baseline|Unable to define optimal dose|4
14167|NCT01770145|66580|P1|Baseline|Lost to Follow-up|1
14168|NCT01770145|66580|P1|Baseline|Withdrawal by Subject|1
14169|NCT01770145|66580|P1|Baseline|Adverse Event|20
14170|NCT01769508|66594|P1|Overall Study|Lost to Follow-up|1
14171|NCT01769508|66594|P1|Overall Study|Adverse Event|1
14172|NCT01769508|66594|P1|Overall Study|Withdrawal by Subject|1
14173|NCT01769508|66594|P1|Overall Study|Death|3
14174|NCT01769443|66605|P2|Overall Study|Study closure|0
14175|NCT01769443|66606|P1|Overall Study|Study closure|1
14176|NCT01769391|66650|P2|Overall Study|On Treatment at Study Conclusion|0
14177|NCT01769391|66651|P1|Overall Study|On Treatment at Study Conclusion|3
14178|NCT01769391|66650|P2|Overall Study|Investigator Decision|0
14179|NCT01769391|66651|P1|Overall Study|Investigator Decision|2
14180|NCT01769391|66650|P2|Overall Study|Withdrawal by Subject|3
14181|NCT01769391|66651|P1|Overall Study|Withdrawal by Subject|4
14182|NCT01769391|66650|P2|Overall Study|Progressive Disease|2
14183|NCT01769391|66651|P1|Overall Study|Progressive Disease|1
14184|NCT01769391|66650|P2|Overall Study|Adverse Event|3
14185|NCT01769391|66651|P1|Overall Study|Adverse Event|0
14186|NCT01769391|66650|P2|Overall Study|Death|1
14187|NCT01769391|66651|P1|Overall Study|Death|10
14188|NCT01769378|66670|P2|Overall Study|Lost to Follow-up|0
14189|NCT01769378|66671|P1|Overall Study|Lost to Follow-up|2
14190|NCT01769378|66670|P2|Overall Study|Sponsor Decision|0
14191|NCT01769378|66671|P1|Overall Study|Sponsor Decision|1
14192|NCT01769378|66670|P2|Overall Study|Withdrawal by Subject|3
14193|NCT01769378|66671|P1|Overall Study|Withdrawal by Subject|10
14194|NCT01769378|66670|P2|Overall Study|Protocol Violation|1
14195|NCT01769378|66671|P1|Overall Study|Protocol Violation|1
14196|NCT01769378|66670|P2|Overall Study|Entry criteria not met|0
14197|NCT01769378|66671|P1|Overall Study|Entry criteria not met|1
14198|NCT01769378|66670|P2|Overall Study|Adverse Event|0
14199|NCT01769378|66671|P1|Overall Study|Adverse Event|10
14200|NCT01769339|66719|P1|Overall Study|Adverse Event|1
14201|NCT01769339|66719|P1|Overall Study|Lost to Follow-up|42
14202|NCT01769105|66737|P2|Cross-over|Lost to Follow-up|0
14203|NCT01769105|66738|P1|Cross-over|Lost to Follow-up|5
14204|NCT01769105|66737|P2|First Intervention|Protocol Violation|2
14205|NCT01769105|66738|P1|First Intervention|Protocol Violation|2
14206|NCT01768676|66759|P2|Overall Study|Withdrawal by Subject|10
14207|NCT01768676|66760|P1|Overall Study|Withdrawal by Subject|3
14208|NCT01768676|66759|P2|Overall Study|Physician Decision|1
14209|NCT01768676|66760|P1|Overall Study|Physician Decision|4
14210|NCT01768676|66759|P2|Overall Study|Protocol Violation|1
14211|NCT01768676|66760|P1|Overall Study|Protocol Violation|1
14212|NCT01768676|66759|P2|Overall Study|Lost to Follow-up|16
14213|NCT01768676|66760|P1|Overall Study|Lost to Follow-up|13
14214|NCT01768676|66759|P2|Overall Study|Adverse Event|3
14215|NCT01768676|66760|P1|Overall Study|Adverse Event|3
14216|NCT01768559|66777|P3|Overall Study|Other than specified|5
14217|NCT01768559|66778|P2|Overall Study|Other than specified|8
14218|NCT01768559|66779|P1|Overall Study|Other than specified|9
14219|NCT01768559|66777|P3|Overall Study|Poor compliance to protocol|2
14220|NCT01768559|66778|P2|Overall Study|Poor compliance to protocol|3
14221|NCT01768559|66779|P1|Overall Study|Poor compliance to protocol|0
14222|NCT01768559|66777|P3|Overall Study|Lack of Efficacy|0
14223|NCT01768559|66778|P2|Overall Study|Lack of Efficacy|4
14224|NCT01768559|66779|P1|Overall Study|Lack of Efficacy|6
14225|NCT01768559|66777|P3|Overall Study|Adverse Event|5
14226|NCT01768559|66778|P2|Overall Study|Adverse Event|2
14227|NCT01768559|66779|P1|Overall Study|Adverse Event|15
14228|NCT01768559|66777|P3|Overall Study|Randomized but not treated|1
14229|NCT01768559|66778|P2|Overall Study|Randomized but not treated|0
14230|NCT01768559|66779|P1|Overall Study|Randomized but not treated|0
14231|NCT01768286|66844|P4|Overall Study|Withdrew Consent|0
14232|NCT01768286|66845|P3|Overall Study|Withdrew Consent|1
14233|NCT01768286|66846|P2|Overall Study|Withdrew Consent|0
14234|NCT01768286|66847|P1|Overall Study|Withdrew Consent|0
14235|NCT01768286|66844|P4|Overall Study|Lack of Efficacy|1
14236|NCT01768286|66845|P3|Overall Study|Lack of Efficacy|0
14237|NCT01768286|66846|P2|Overall Study|Lack of Efficacy|4
14238|NCT01768286|66847|P1|Overall Study|Lack of Efficacy|7
14239|NCT01768286|66844|P4|Overall Study|Randomized But Not Treated|0
14240|NCT01768286|66845|P3|Overall Study|Randomized But Not Treated|1
14241|NCT01768286|66846|P2|Overall Study|Randomized But Not Treated|0
14242|NCT01768286|66847|P1|Overall Study|Randomized But Not Treated|0
14243|NCT01768117|66909|P1|Overall Study|Protocol Violation|3
14244|NCT01768117|66909|P1|Overall Study|Withdrawal by Subject|2
14245|NCT01768117|66909|P1|Overall Study|Lost to Follow-up|1
14246|NCT01767987|66973|P2|Overall Study|Physician Decision|1
14247|NCT01767987|66974|P1|Overall Study|Physician Decision|4
14248|NCT01767597|67021|P2|Overall Study|Withdrawal by Subject|0
14249|NCT01767597|67022|P1|Overall Study|Withdrawal by Subject|1
14250|NCT01767597|67021|P2|Overall Study|Incomplete intervention|1
14251|NCT01767597|67022|P1|Overall Study|Incomplete intervention|3
14252|NCT01767519|67031|P3|Overall Study|Adverse Event|1
14253|NCT01767519|67032|P2|Overall Study|Adverse Event|5
14254|NCT01767519|67033|P1|Overall Study|Adverse Event|5
14255|NCT01767519|67031|P3|Overall Study|Lack of Efficacy|0
14256|NCT01767519|67032|P2|Overall Study|Lack of Efficacy|0
14257|NCT01767519|67033|P1|Overall Study|Lack of Efficacy|1
14258|NCT01767519|67031|P3|Overall Study|Lost to Follow-up|2
14259|NCT01767519|67032|P2|Overall Study|Lost to Follow-up|1
14260|NCT01767519|67033|P1|Overall Study|Lost to Follow-up|3
14261|NCT01767519|67031|P3|Overall Study|Personal Reasons|0
14262|NCT01767519|67032|P2|Overall Study|Personal Reasons|0
14263|NCT01767519|67033|P1|Overall Study|Personal Reasons|1
14264|NCT01767519|67031|P3|Overall Study|Protocol Violation|0
14265|NCT01767519|67032|P2|Overall Study|Protocol Violation|3
14266|NCT01767519|67033|P1|Overall Study|Protocol Violation|0
14267|NCT01767519|67031|P3|Overall Study|Other Reasons|2
14268|NCT01767519|67032|P2|Overall Study|Other Reasons|4
14269|NCT01767519|67033|P1|Overall Study|Other Reasons|4
14270|NCT01767116|67080|P2|Overall Study|Lost to Follow-up|2
14271|NCT01767116|67081|P1|Overall Study|Lost to Follow-up|2
14272|NCT01766921|67130|P2|Overall Study|Withdrawal by Subject|5
14273|NCT01766921|67131|P1|Overall Study|Withdrawal by Subject|14
14274|NCT01766921|67130|P2|Overall Study|Protocol Violation|1
14275|NCT01766921|67131|P1|Overall Study|Protocol Violation|1
14276|NCT01766921|67130|P2|Overall Study|Unclassified|2
14277|NCT01766921|67131|P1|Overall Study|Unclassified|2
14278|NCT01766921|67130|P2|Overall Study|Lost to Follow-up|3
14279|NCT01766921|67131|P1|Overall Study|Lost to Follow-up|1
14280|NCT01766921|67130|P2|Overall Study|Death|1
14281|NCT01766921|67131|P1|Overall Study|Death|1
14282|NCT01766921|67130|P2|Overall Study|Administrative Reason|5
14283|NCT01766921|67131|P1|Overall Study|Administrative Reason|5
14284|NCT01766336|67179|P2|Overall Study|Withdrawal by Subject|15
14285|NCT01766336|67180|P1|Overall Study|Withdrawal by Subject|18
14286|NCT01766336|67179|P2|Overall Study|Sponsor Decision|43
14287|NCT01766336|67180|P1|Overall Study|Sponsor Decision|52
14288|NCT01766336|67179|P2|Overall Study|Protocol Violation|1
14289|NCT01766336|67180|P1|Overall Study|Protocol Violation|0
14290|NCT01766336|67179|P2|Overall Study|Physician Decision|2
14291|NCT01766336|67180|P1|Overall Study|Physician Decision|4
14292|NCT01766336|67179|P2|Overall Study|Lost to Follow-up|3
14293|NCT01766336|67180|P1|Overall Study|Lost to Follow-up|1
14294|NCT01766336|67179|P2|Overall Study|Death|3
14295|NCT01766336|67180|P1|Overall Study|Death|4
14296|NCT01766336|67179|P2|Overall Study|Adverse Event|8
14297|NCT01766336|67180|P1|Overall Study|Adverse Event|11
14298|NCT01766310|67188|P2|Overall Study|Lost to Follow-up|3
14299|NCT01766310|67189|P1|Overall Study|Lost to Follow-up|1
14300|NCT01766050|67206|P1|Overall Study|Withdrawal by Subject|2
14301|NCT01766050|67206|P1|Overall Study|Lost to Follow-up|1
14302|NCT01766050|67206|P1|Overall Study|Adverse Event|1
14303|NCT01766037|67341|P2|Overall Study|nausea / discomfort|0
14304|NCT01766037|67342|P1|Overall Study|nausea / discomfort|3
14305|NCT01766037|67341|P2|Overall Study|medical - unrelated|2
14306|NCT01766037|67342|P1|Overall Study|medical - unrelated|1
14307|NCT01766037|67341|P2|Overall Study|Moved from area|0
14308|NCT01766037|67342|P1|Overall Study|Moved from area|5
14309|NCT01766037|67341|P2|Overall Study|Withdrawal by Subject|16
14310|NCT01766037|67342|P1|Overall Study|Withdrawal by Subject|18
14311|NCT01766037|67341|P2|Overall Study|Physician Decision|1
14312|NCT01766037|67342|P1|Overall Study|Physician Decision|0
14313|NCT01766037|67341|P2|Overall Study|Lost to Follow-up|10
14314|NCT01766037|67342|P1|Overall Study|Lost to Follow-up|0
14315|NCT01766037|67341|P2|Overall Study|Lack of Efficacy|0
14316|NCT01766037|67342|P1|Overall Study|Lack of Efficacy|1
14317|NCT01766037|67341|P2|Overall Study|Adverse Event|0
14318|NCT01766037|67342|P1|Overall Study|Adverse Event|1
14319|NCT01765764|67411|P3|Treatment Period|Other Miscellaneous Reasons|2
14320|NCT01765764|67412|P2|Treatment Period|Other Miscellaneous Reasons|2
14321|NCT01765764|67413|P1|Treatment Period|Other Miscellaneous Reasons|1
14322|NCT01765764|67411|P3|Treatment Period|Personal Reasons|1
14323|NCT01765764|67412|P2|Treatment Period|Personal Reasons|2
14324|NCT01765764|67413|P1|Treatment Period|Personal Reasons|1
14325|NCT01765764|67411|P3|Treatment Period|Lost to Follow-up|2
14326|NCT01765764|67412|P2|Treatment Period|Lost to Follow-up|3
14327|NCT01765764|67413|P1|Treatment Period|Lost to Follow-up|0
14328|NCT01765764|67411|P3|Treatment Period|Adverse Event|1
14329|NCT01765764|67412|P2|Treatment Period|Adverse Event|2
14330|NCT01765764|67413|P1|Treatment Period|Adverse Event|1
14331|NCT01765569|67430|P1|Period C|Death|1
14332|NCT01765569|67430|P1|Period B|Withdrawal by Subject|1
14333|NCT01765543|67451|P1|Overall Study|Withdrawal by Subject|2
14334|NCT01765543|67451|P1|Overall Study|Death|1
14335|NCT01765426|67492|P4|Overall Study|Lost to Follow-up|0
14336|NCT01765426|67493|P3|Overall Study|Lost to Follow-up|0
14337|NCT01765426|67494|P2|Overall Study|Lost to Follow-up|1
14338|NCT01765426|67495|P1|Overall Study|Lost to Follow-up|0
14339|NCT01765270|67551|P2|Overall Study|Withdrawal by Subject|1
14340|NCT01765270|67552|P1|Overall Study|Withdrawal by Subject|0
14341|NCT01765270|67551|P2|Overall Study|Physician Decision|0
14342|NCT01765270|67552|P1|Overall Study|Physician Decision|1
14343|NCT01765192|67574|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
14344|NCT01765192|67575|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
14345|NCT01765192|67574|P2|Treatment Period 2|Reason not specified|2
14346|NCT01765192|67575|P1|Treatment Period 2|Reason not specified|0
14347|NCT01765192|67574|P2|Washout Period|Reason not specified|0
14348|NCT01765192|67575|P1|Washout Period|Reason not specified|1
14349|NCT01765192|67574|P2|Washout Period|Voluntary Withdrawal|1
14350|NCT01765192|67575|P1|Washout Period|Voluntary Withdrawal|1
14351|NCT01765192|67574|P2|Treatment Period 1|Adverse Event|1
14352|NCT01765192|67575|P1|Treatment Period 1|Adverse Event|0
14353|NCT01764945|67601|P8|Overall Study|Adverse Event|0
14354|NCT01764945|67602|P7|Overall Study|Adverse Event|1
14355|NCT01764945|67603|P6|Overall Study|Adverse Event|0
14356|NCT01764945|67604|P5|Overall Study|Adverse Event|0
14357|NCT01764945|67605|P4|Overall Study|Adverse Event|0
14358|NCT01764945|67606|P3|Overall Study|Adverse Event|0
14359|NCT01764945|67607|P2|Overall Study|Adverse Event|1
14360|NCT01764945|67608|P1|Overall Study|Adverse Event|0
14361|NCT01764386|67666|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
14362|NCT01764386|67667|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
14363|NCT01764386|67666|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
14364|NCT01764386|67667|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
14365|NCT01764386|67666|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
14366|NCT01764386|67667|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
14367|NCT01764386|67666|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
14368|NCT01764386|67667|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
14369|NCT01764386|67666|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
14370|NCT01764386|67667|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
14371|NCT01764386|67666|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
14372|NCT01764386|67667|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
14373|NCT01764386|67666|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
14374|NCT01764386|67667|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
14375|NCT01764386|67666|P2|Controlled Treatment Period (CTP)|Adverse Event|0
14376|NCT01764386|67667|P1|Controlled Treatment Period (CTP)|Adverse Event|35
14377|NCT01764022|67710|P2|Overall Study|Protocol Violation|0
14378|NCT01764022|67711|P1|Overall Study|Protocol Violation|1
14379|NCT01764022|67710|P2|Overall Study|Physician Decision|2
14380|NCT01764022|67711|P1|Overall Study|Physician Decision|2
14381|NCT01764022|67710|P2|Overall Study|Lack of Efficacy|5
14382|NCT01764022|67711|P1|Overall Study|Lack of Efficacy|10
14383|NCT01764022|67710|P2|Overall Study|Withdrawal by Subject|4
14384|NCT01764022|67711|P1|Overall Study|Withdrawal by Subject|5
14385|NCT01764022|67710|P2|Overall Study|Death|1
14386|NCT01764022|67711|P1|Overall Study|Death|3
14387|NCT01763996|67739|P2|Treatment Period 2|Adverse Event|1
14388|NCT01763996|67740|P1|Treatment Period 2|Adverse Event|0
14389|NCT01763918|67770|P4|Overall Study|Sponsor Decision|0
14390|NCT01763918|67771|P3|Overall Study|Sponsor Decision|9
14391|NCT01763918|67772|P2|Overall Study|Sponsor Decision|0
14392|NCT01763918|67773|P1|Overall Study|Sponsor Decision|4
14393|NCT01763918|67770|P4|Overall Study|Withdrawal by Subject|2
14394|NCT01763918|67771|P3|Overall Study|Withdrawal by Subject|1
14395|NCT01763918|67772|P2|Overall Study|Withdrawal by Subject|1
14396|NCT01763918|67773|P1|Overall Study|Withdrawal by Subject|2
14397|NCT01763905|67871|P4|Overall Study|Lost to Follow-up|0
14398|NCT01763905|67872|P3|Overall Study|Lost to Follow-up|1
14399|NCT01763905|67873|P2|Overall Study|Lost to Follow-up|0
14400|NCT01763905|67874|P1|Overall Study|Lost to Follow-up|0
14401|NCT01763905|67871|P4|Overall Study|Decision by sponsor|0
14402|NCT01763905|67872|P3|Overall Study|Decision by sponsor|8
14403|NCT01763905|67873|P2|Overall Study|Decision by sponsor|0
14404|NCT01763905|67874|P1|Overall Study|Decision by sponsor|5
14405|NCT01763905|67871|P4|Overall Study|Withdrawal by Subject|1
14406|NCT01763905|67872|P3|Overall Study|Withdrawal by Subject|0
14407|NCT01763905|67873|P2|Overall Study|Withdrawal by Subject|1
14408|NCT01763905|67874|P1|Overall Study|Withdrawal by Subject|1
14409|NCT01763866|67992|P24|Overall Study|Death|0
14410|NCT01763866|67993|P23|Overall Study|Death|0
14411|NCT01763866|67994|P22|Overall Study|Death|0
14412|NCT01763866|67995|P21|Overall Study|Death|0
14413|NCT01763866|67996|P20|Overall Study|Death|0
14414|NCT01763866|67997|P19|Overall Study|Death|0
14415|NCT01763866|67998|P18|Overall Study|Death|0
14416|NCT01763866|67999|P17|Overall Study|Death|1
14417|NCT01763866|68000|P16|Overall Study|Death|0
14418|NCT01763866|68001|P15|Overall Study|Death|0
14419|NCT01763866|68002|P14|Overall Study|Death|0
14420|NCT01763866|68003|P13|Overall Study|Death|0
14421|NCT01763866|68004|P12|Overall Study|Death|0
14422|NCT01763866|68005|P11|Overall Study|Death|0
14423|NCT01763866|68006|P10|Overall Study|Death|0
14424|NCT01763866|68007|P9|Overall Study|Death|0
14425|NCT01763866|68008|P8|Overall Study|Death|0
14426|NCT01763866|68009|P7|Overall Study|Death|0
14427|NCT01763866|68010|P6|Overall Study|Death|0
14428|NCT01763866|68011|P5|Overall Study|Death|0
14429|NCT01763866|68012|P4|Overall Study|Death|0
14430|NCT01763866|68013|P3|Overall Study|Death|0
14431|NCT01763866|68014|P2|Overall Study|Death|0
14432|NCT01763866|68015|P1|Overall Study|Death|0
14433|NCT01763866|67992|P24|Overall Study|Lost to Follow-up|1
14434|NCT01763866|67993|P23|Overall Study|Lost to Follow-up|0
14435|NCT01763866|67994|P22|Overall Study|Lost to Follow-up|0
14436|NCT01763866|67995|P21|Overall Study|Lost to Follow-up|0
14437|NCT01763866|67996|P20|Overall Study|Lost to Follow-up|1
14438|NCT01763866|67997|P19|Overall Study|Lost to Follow-up|1
14439|NCT01763866|67998|P18|Overall Study|Lost to Follow-up|0
14440|NCT01763866|67999|P17|Overall Study|Lost to Follow-up|0
14441|NCT01763866|68000|P16|Overall Study|Lost to Follow-up|0
14442|NCT01763866|68001|P15|Overall Study|Lost to Follow-up|1
14443|NCT01763866|68002|P14|Overall Study|Lost to Follow-up|0
14444|NCT01763866|68003|P13|Overall Study|Lost to Follow-up|1
14445|NCT01763866|68004|P12|Overall Study|Lost to Follow-up|0
14446|NCT01763866|68005|P11|Overall Study|Lost to Follow-up|0
14447|NCT01763866|68006|P10|Overall Study|Lost to Follow-up|0
14448|NCT01763866|68007|P9|Overall Study|Lost to Follow-up|0
14449|NCT01763866|68008|P8|Overall Study|Lost to Follow-up|0
14450|NCT01763866|68009|P7|Overall Study|Lost to Follow-up|1
14451|NCT01763866|68010|P6|Overall Study|Lost to Follow-up|0
14452|NCT01763866|68011|P5|Overall Study|Lost to Follow-up|0
14453|NCT01763866|68012|P4|Overall Study|Lost to Follow-up|0
14454|NCT01763866|68013|P3|Overall Study|Lost to Follow-up|0
14455|NCT01763866|68014|P2|Overall Study|Lost to Follow-up|0
14456|NCT01763866|68015|P1|Overall Study|Lost to Follow-up|0
14457|NCT01763866|67992|P24|Overall Study|Decision by sponsor|0
14458|NCT01763866|67993|P23|Overall Study|Decision by sponsor|1
14459|NCT01763866|67994|P22|Overall Study|Decision by sponsor|0
14460|NCT01763866|67995|P21|Overall Study|Decision by sponsor|2
14461|NCT01763866|67996|P20|Overall Study|Decision by sponsor|0
14462|NCT01763866|67997|P19|Overall Study|Decision by sponsor|4
14463|NCT01763866|67998|P18|Overall Study|Decision by sponsor|0
14464|NCT01763866|67999|P17|Overall Study|Decision by sponsor|0
14465|NCT01763866|68000|P16|Overall Study|Decision by sponsor|0
14466|NCT01763866|68001|P15|Overall Study|Decision by sponsor|5
14467|NCT01763866|68002|P14|Overall Study|Decision by sponsor|0
14468|NCT01763866|68003|P13|Overall Study|Decision by sponsor|1
14469|NCT01763866|68004|P12|Overall Study|Decision by sponsor|0
14470|NCT01763866|68005|P11|Overall Study|Decision by sponsor|6
14471|NCT01763866|68006|P10|Overall Study|Decision by sponsor|0
14472|NCT01763866|68007|P9|Overall Study|Decision by sponsor|2
14473|NCT01763866|68008|P8|Overall Study|Decision by sponsor|0
14474|NCT01763866|68009|P7|Overall Study|Decision by sponsor|2
14475|NCT01763866|68010|P6|Overall Study|Decision by sponsor|0
14476|NCT01763866|68011|P5|Overall Study|Decision by sponsor|2
14477|NCT01763866|68012|P4|Overall Study|Decision by sponsor|0
14478|NCT01763866|68013|P3|Overall Study|Decision by sponsor|1
14479|NCT01763866|68014|P2|Overall Study|Decision by sponsor|0
14480|NCT01763866|68015|P1|Overall Study|Decision by sponsor|0
14481|NCT01763866|67992|P24|Overall Study|Withdrawal by Subject|1
14482|NCT01763866|67993|P23|Overall Study|Withdrawal by Subject|2
14483|NCT01763866|67994|P22|Overall Study|Withdrawal by Subject|1
14484|NCT01763866|67995|P21|Overall Study|Withdrawal by Subject|2
14485|NCT01763866|67996|P20|Overall Study|Withdrawal by Subject|1
14486|NCT01763866|67997|P19|Overall Study|Withdrawal by Subject|1
14487|NCT01763866|67998|P18|Overall Study|Withdrawal by Subject|1
14488|NCT01763866|67999|P17|Overall Study|Withdrawal by Subject|0
14489|NCT01763866|68000|P16|Overall Study|Withdrawal by Subject|3
14490|NCT01763866|68001|P15|Overall Study|Withdrawal by Subject|6
14491|NCT01763866|68002|P14|Overall Study|Withdrawal by Subject|0
14492|NCT01763866|68003|P13|Overall Study|Withdrawal by Subject|2
14493|NCT01763866|68004|P12|Overall Study|Withdrawal by Subject|2
14494|NCT01763866|68005|P11|Overall Study|Withdrawal by Subject|2
14495|NCT01763866|68006|P10|Overall Study|Withdrawal by Subject|1
14496|NCT01763866|68007|P9|Overall Study|Withdrawal by Subject|1
14497|NCT01763866|68008|P8|Overall Study|Withdrawal by Subject|0
14498|NCT01763866|68009|P7|Overall Study|Withdrawal by Subject|4
14499|NCT01763866|68010|P6|Overall Study|Withdrawal by Subject|3
14500|NCT01763866|68011|P5|Overall Study|Withdrawal by Subject|0
14501|NCT01763866|68012|P4|Overall Study|Withdrawal by Subject|0
14502|NCT01763866|68013|P3|Overall Study|Withdrawal by Subject|4
14503|NCT01763866|68014|P2|Overall Study|Withdrawal by Subject|1
14504|NCT01763866|68015|P1|Overall Study|Withdrawal by Subject|2
14505|NCT01763827|68575|P6|Overall Study|Lost to Follow-up|1
14506|NCT01763827|68576|P5|Overall Study|Lost to Follow-up|2
14507|NCT01763827|68577|P4|Overall Study|Lost to Follow-up|1
14508|NCT01763827|68578|P3|Overall Study|Lost to Follow-up|1
14509|NCT01763827|68579|P2|Overall Study|Lost to Follow-up|1
14510|NCT01763827|68580|P1|Overall Study|Lost to Follow-up|0
14511|NCT01763827|68575|P6|Overall Study|Decision by sponsor|1
14512|NCT01763827|68576|P5|Overall Study|Decision by sponsor|2
14513|NCT01763827|68577|P4|Overall Study|Decision by sponsor|0
14514|NCT01763827|68578|P3|Overall Study|Decision by sponsor|3
14515|NCT01763827|68579|P2|Overall Study|Decision by sponsor|0
14516|NCT01763827|68580|P1|Overall Study|Decision by sponsor|2
14517|NCT01763827|68575|P6|Overall Study|Withdrawal by Subject|0
14518|NCT01763827|68576|P5|Overall Study|Withdrawal by Subject|2
14519|NCT01763827|68577|P4|Overall Study|Withdrawal by Subject|0
14520|NCT01763827|68578|P3|Overall Study|Withdrawal by Subject|0
14521|NCT01763827|68579|P2|Overall Study|Withdrawal by Subject|0
14522|NCT01763827|68580|P1|Overall Study|Withdrawal by Subject|1
14523|NCT01763047|68751|P2|Period 2|Unsatisfactory lens Fitting|1
14524|NCT01763047|68752|P1|Period 2|Unsatisfactory lens Fitting|0
14525|NCT01763047|68751|P2|Period 2|Protocol Violation|2
14526|NCT01763047|68752|P1|Period 2|Protocol Violation|0
14527|NCT01763047|68751|P2|Period 2|Unsatisfactory Visual Response|1
14528|NCT01763047|68752|P1|Period 2|Unsatisfactory Visual Response|1
14529|NCT01763047|68751|P2|Period 2|Study Site office Closed|1
14530|NCT01763047|68752|P1|Period 2|Study Site office Closed|1
14531|NCT01763047|68751|P2|Period 2|No longer meets Eligibility Criteria|0
14532|NCT01763047|68752|P1|Period 2|No longer meets Eligibility Criteria|1
14533|NCT01763047|68751|P2|Period 2|Lens Discomfort|0
14534|NCT01763047|68752|P1|Period 2|Lens Discomfort|1
14535|NCT01763047|68751|P2|Period 1|Study Site office Closed|1
14536|NCT01763047|68752|P1|Period 1|Study Site office Closed|0
14537|NCT01763047|68751|P2|Period 1|Lens Power Not Available|1
14538|NCT01763047|68752|P1|Period 1|Lens Power Not Available|0
14539|NCT01763047|68751|P2|Period 1|Unsatisfactory Visual Response|3
14540|NCT01763047|68752|P1|Period 1|Unsatisfactory Visual Response|0
14541|NCT01763047|68751|P2|Period 1|Adverse Event|1
14542|NCT01763047|68752|P1|Period 1|Adverse Event|0
14543|NCT01763047|68751|P2|Period 1|No Longer Meets Eligibility criteria|0
14544|NCT01763047|68752|P1|Period 1|No Longer Meets Eligibility criteria|1
14545|NCT01763047|68751|P2|Period 1|Protocol Violation|4
14546|NCT01763047|68752|P1|Period 1|Protocol Violation|4
14547|NCT01763047|68751|P2|Period 1|Test Article Not Available|1
14548|NCT01763047|68752|P1|Period 1|Test Article Not Available|4
14549|NCT01762800|68798|P2|Overall Study|Withdrawal by Subject|4
14550|NCT01762800|68799|P1|Overall Study|Withdrawal by Subject|7
14551|NCT01762800|68798|P2|Overall Study|Physician Decision|1
14552|NCT01762800|68799|P1|Overall Study|Physician Decision|1
14553|NCT01762800|68798|P2|Overall Study|Study Closed/Terminated|1
14554|NCT01762800|68799|P1|Overall Study|Study Closed/Terminated|0
14555|NCT01762800|68798|P2|Overall Study|Lack of Efficacy|2
14556|NCT01762800|68799|P1|Overall Study|Lack of Efficacy|3
14557|NCT01762800|68798|P2|Overall Study|Adverse Event|13
14558|NCT01762800|68799|P1|Overall Study|Adverse Event|8
14559|NCT01762761|68873|P2|Overall Study|Physician Decision|1
14560|NCT01762761|68874|P1|Overall Study|Physician Decision|0
14561|NCT01762761|68873|P2|Overall Study|Protocol Violation|1
14562|NCT01762761|68874|P1|Overall Study|Protocol Violation|0
14563|NCT01762761|68873|P2|Overall Study|Lack of Efficacy|0
14564|NCT01762761|68874|P1|Overall Study|Lack of Efficacy|1
14565|NCT01762761|68873|P2|Overall Study|Adverse Event|2
14566|NCT01762761|68874|P1|Overall Study|Adverse Event|1
14567|NCT01762345|68952|P1|Overall Study|Protocol Violation|2
14568|NCT01762345|68952|P1|Overall Study|Adverse Event|5
14569|NCT01761565|68973|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
14570|NCT01761162|68995|P1|Overall Study|Withdrawal by Subject|3
14571|NCT01760876|69087|P1|Overall Study|Very poor baseline OCT quality|2
14572|NCT01760876|69087|P1|Overall Study|Major depression|1
14573|NCT01760876|69087|P1|Overall Study|Impaired renal function|1
14574|NCT01760876|69087|P1|Overall Study|Carcinoma of prostate|1
14575|NCT01760876|69087|P1|Overall Study|Non-cardiac death (head injury)|1
14576|NCT01759420|69108|P1|Overall Study|Inaccurate EKG machine readings|1
14577|NCT01759420|69108|P1|Overall Study|Screen failure|5
14578|NCT01759381|69115|P2|Overall Study|Death|0
14579|NCT01759381|69116|P1|Overall Study|Death|1
14580|NCT01759368|69124|P2|Overall Study|Lost to Follow-up|0
14581|NCT01759368|69125|P1|Overall Study|Lost to Follow-up|1
14582|NCT01759290|69143|P1|Overall Study|Unknown reason|4
14583|NCT01759290|69143|P1|Overall Study|Lost to Follow-up|53
14584|NCT01759290|69143|P1|Overall Study|Death|17
14585|NCT01759290|69143|P1|Overall Study|Physician Decision|2
14586|NCT01759290|69143|P1|Overall Study|Subjects withdrawn consent|5
14587|NCT01759264|69203|P1|Overall Study|Discontinued Humira Due to Business Trip|1
14588|NCT01759264|69203|P1|Overall Study|Withdrawal by Subject|3
14589|NCT01759264|69203|P1|Overall Study|Lost to Follow-up|2
14590|NCT01759264|69203|P1|Overall Study|Not Specified|2
14591|NCT01759264|69203|P1|Overall Study|Adverse Event|1
14592|NCT01759264|69203|P1|Overall Study|Serious Adverse Events (SAEs)|1
14593|NCT01758900|69231|P2|Overall Study|difficulty for further intubation|8
14594|NCT01758900|69232|P1|Overall Study|difficulty for further intubation|7
14595|NCT01758289|69250|P1|Overall Study|Adverse Event|9
14596|NCT01758289|69250|P1|Overall Study|Premature Study Termination|44
14597|NCT01757847|69276|P2|Overall Study|Withdrawal by Subject|4
14598|NCT01757847|69277|P1|Overall Study|Withdrawal by Subject|3
14599|NCT01757704|69287|P2|Overall Study|Protocol Violation|3
14600|NCT01757704|69288|P1|Overall Study|Protocol Violation|1
14601|NCT01757691|69306|P2|Overall Study|Administrative problems|0
14602|NCT01757691|69307|P1|Overall Study|Administrative problems|2
14603|NCT01757405|69343|P2|Overall Study|Withdrawal by Subject|1
14604|NCT01757405|69344|P1|Overall Study|Withdrawal by Subject|0
14605|NCT01757405|69343|P2|Overall Study|Lost to Follow-up|1
14606|NCT01757405|69344|P1|Overall Study|Lost to Follow-up|1
14607|NCT01757275|69362|P2|Overall Study|Not treated|4
14608|NCT01757275|69363|P1|Overall Study|Not treated|3
14609|NCT01757275|69362|P2|Overall Study|Withdrawal by Subject|4
14610|NCT01757275|69363|P1|Overall Study|Withdrawal by Subject|2
14611|NCT01757275|69362|P2|Overall Study|Adverse Event|3
14612|NCT01757275|69363|P1|Overall Study|Adverse Event|3
14613|NCT01757275|69362|P2|Overall Study|Lost to Follow-up|2
14614|NCT01757275|69363|P1|Overall Study|Lost to Follow-up|1
14615|NCT01757184|69387|P2|Double-Blind Period|Adverse Event|0
14616|NCT01757184|69388|P1|Double-Blind Period|Adverse Event|1
14617|NCT01756300|69423|P1|Overall Study|Withdrawal by Subject|1
14618|NCT01756300|69423|P1|Overall Study|Death|1
14619|NCT01756274|69445|P1|Overall Study|Laboratory error|1
14620|NCT01756274|69445|P1|Overall Study|Protocol Violation|2
14621|NCT01756157|69452|P2|First Intervention Period|Lost to Follow-up|2
14622|NCT01756157|69453|P1|First Intervention Period|Lost to Follow-up|0
14623|NCT01756157|69452|P2|First Intervention Period|Withdrawal by Subject|0
14624|NCT01756157|69453|P1|First Intervention Period|Withdrawal by Subject|1
14625|NCT01756079|69467|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
14626|NCT01756079|69467|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
14627|NCT01756079|69467|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
14628|NCT01756079|69467|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
14629|NCT01756079|69467|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
14630|NCT01756053|69473|P2|Period 2 (10 Days)|Protocol Violation|2
14631|NCT01756053|69474|P1|Period 2 (10 Days)|Protocol Violation|0
14632|NCT01756053|69473|P2|Period 1 (10 Days)|Protocol Violation|1
14633|NCT01756053|69474|P1|Period 1 (10 Days)|Protocol Violation|1
14634|NCT01755702|69494|P1|Washout Period II|Other Reason|5
14635|NCT01755702|69494|P1|Wash Out Period I|Other Reason|3
14636|NCT01755637|69536|P2|Period 1|Adverse Event|1
14637|NCT01755637|69537|P1|Period 1|Adverse Event|0
14638|NCT01755234|69570|P2|Overall Study|unblinded|0
14639|NCT01755234|69571|P1|Overall Study|unblinded|1
14640|NCT01755234|69570|P2|Overall Study|Withdrawal by Subject|1
14641|NCT01755234|69571|P1|Overall Study|Withdrawal by Subject|0
14642|NCT01755234|69570|P2|Overall Study|case cancelled|0
14643|NCT01755234|69571|P1|Overall Study|case cancelled|1
14644|NCT01755234|69570|P2|Overall Study|Change in surgical case|1
14645|NCT01755234|69571|P1|Overall Study|Change in surgical case|2
14646|NCT01755234|69570|P2|Overall Study|Lost to Follow-up|6
14647|NCT01755234|69571|P1|Overall Study|Lost to Follow-up|11
14648|NCT01755026|69619|P2|Overall Study|Withdrawal by Subject|1
14649|NCT01755026|69620|P1|Overall Study|Withdrawal by Subject|1
14650|NCT01755026|69619|P2|Overall Study|Adverse Event|0
14651|NCT01755026|69620|P1|Overall Study|Adverse Event|1
14652|NCT01754922|69628|P2|Overall Study|Adverse Event|1
14653|NCT01754922|69629|P1|Overall Study|Adverse Event|0
14654|NCT01754766|69642|P3|Overall Study|Personal reasons|0
14655|NCT01754766|69643|P2|Overall Study|Personal reasons|1
14656|NCT01754766|69644|P1|Overall Study|Personal reasons|1
14657|NCT01754493|69762|P1|Overall Study|Scheduling conflict|1
14658|NCT01754493|69762|P1|Overall Study|Moved out of town|1
14659|NCT01754493|69762|P1|Overall Study|Withdrawal by Subject|1
14660|NCT01754493|69762|P1|Overall Study|Lost to Follow-up|3
14661|NCT01754493|69762|P1|Overall Study|Adverse Event|1
14662|NCT01753856|69789|P2|Overall Study|Sponsor Decision|0
14663|NCT01753856|69790|P1|Overall Study|Sponsor Decision|2
14664|NCT01753856|69789|P2|Overall Study|Withdrawal by Subject|2
14665|NCT01753856|69790|P1|Overall Study|Withdrawal by Subject|0
14666|NCT01753856|69789|P2|Overall Study|Adverse Event|0
14667|NCT01753856|69790|P1|Overall Study|Adverse Event|1
14668|NCT01753518|69861|P2|Postpartum Follow-up|Lost to Follow-up|15
14669|NCT01753518|69862|P1|Postpartum Follow-up|Lost to Follow-up|22
14670|NCT01753518|69861|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
14671|NCT01753518|69862|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
14672|NCT01753518|69861|P2|Intention-to-Treat Analysis|Multifetal gestation|3
14673|NCT01753518|69862|P1|Intention-to-Treat Analysis|Multifetal gestation|2
14674|NCT01753518|69861|P2|Intention-to-Treat Analysis|Missing consent form|3
14675|NCT01753518|69862|P1|Intention-to-Treat Analysis|Missing consent form|5
14676|NCT01753323|69887|P3|Overall Study|Adverse Event|1
14677|NCT01753323|69888|P2|Overall Study|Adverse Event|0
14678|NCT01753323|69889|P1|Overall Study|Adverse Event|0
14679|NCT01753323|69887|P3|Overall Study|Protocol deviation|0
14680|NCT01753323|69888|P2|Overall Study|Protocol deviation|0
14681|NCT01753323|69889|P1|Overall Study|Protocol deviation|1
14682|NCT01753323|69887|P3|Overall Study|Lack of Efficacy|8
14683|NCT01753323|69888|P2|Overall Study|Lack of Efficacy|0
14684|NCT01753323|69889|P1|Overall Study|Lack of Efficacy|0
14685|NCT01753115|69928|P3|Overall Study|Used excluded drug|0
14686|NCT01753115|69929|P2|Overall Study|Used excluded drug|1
14687|NCT01753115|69930|P1|Overall Study|Used excluded drug|0
14688|NCT01753115|69928|P3|Overall Study|Subject non-compliant|0
14689|NCT01753115|69929|P2|Overall Study|Subject non-compliant|3
14690|NCT01753115|69930|P1|Overall Study|Subject non-compliant|3
14691|NCT01753115|69928|P3|Overall Study|Withdrawal by Subject|6
14692|NCT01753115|69929|P2|Overall Study|Withdrawal by Subject|5
14693|NCT01753115|69930|P1|Overall Study|Withdrawal by Subject|6
14694|NCT01753115|69928|P3|Overall Study|Lost to Follow-up|8
14695|NCT01753115|69929|P2|Overall Study|Lost to Follow-up|6
14696|NCT01753115|69930|P1|Overall Study|Lost to Follow-up|3
14697|NCT01752907|69940|P2|Overall Study|Decision by Sponsor|9
14698|NCT01752907|69941|P1|Overall Study|Decision by Sponsor|6
14699|NCT01752907|69940|P2|Overall Study|Lost to Follow-up|1
14700|NCT01752907|69941|P1|Overall Study|Lost to Follow-up|2
14701|NCT01752907|69940|P2|Overall Study|Withdrawal by Subject|10
14702|NCT01752907|69941|P1|Overall Study|Withdrawal by Subject|4
14703|NCT01752855|69961|P2|Overall Study|Lack of Efficacy|2
14704|NCT01752855|69962|P1|Overall Study|Lack of Efficacy|0
14705|NCT01752855|69961|P2|Overall Study|Withdrew Consent|2
14706|NCT01752855|69962|P1|Overall Study|Withdrew Consent|0
14707|NCT01752855|69961|P2|Overall Study|Adverse Event|0
14708|NCT01752855|69962|P1|Overall Study|Adverse Event|1
14709|NCT01751867|69978|P2|Overall Study|Randomized but not treated.|1
14710|NCT01751867|69979|P1|Overall Study|Randomized but not treated.|2
14711|NCT01751867|69978|P2|Overall Study|Unspecified|37
14712|NCT01751867|69979|P1|Overall Study|Unspecified|11
14713|NCT01751867|69978|P2|Overall Study|Death|5
14714|NCT01751867|69979|P1|Overall Study|Death|0
14715|NCT01751867|69978|P2|Overall Study|Protocol Violation|2
14716|NCT01751867|69979|P1|Overall Study|Protocol Violation|0
14717|NCT01751867|69978|P2|Overall Study|Physician Decision|7
14718|NCT01751867|69979|P1|Overall Study|Physician Decision|4
14719|NCT01751867|69978|P2|Overall Study|Withdrawal by Subject|1
14720|NCT01751867|69979|P1|Overall Study|Withdrawal by Subject|3
14721|NCT01751867|69978|P2|Overall Study|Poor Compliance|5
14722|NCT01751867|69979|P1|Overall Study|Poor Compliance|0
14723|NCT01751867|69978|P2|Overall Study|Adverse Event|15
14724|NCT01751867|69979|P1|Overall Study|Adverse Event|8
14725|NCT01751867|69978|P2|Overall Study|Diease Progression|18
14726|NCT01751867|69979|P1|Overall Study|Diease Progression|4
14727|NCT01751867|69978|P2|Overall Study|Completed treatment,dropped in follow-up|8
14728|NCT01751867|69979|P1|Overall Study|Completed treatment,dropped in follow-up|4
14729|NCT01751802|69999|P2|Overall Study|Adverse Event|2
14730|NCT01751802|70000|P1|Overall Study|Adverse Event|4
14731|NCT01751178|70061|P3|Overall Study|Other Reason (unknown)|2
14732|NCT01751178|70062|P2|Overall Study|Other Reason (unknown)|0
14733|NCT01751178|70063|P1|Overall Study|Other Reason (unknown)|1
14734|NCT01751178|70061|P3|Overall Study|Adverse Event|0
14735|NCT01751178|70062|P2|Overall Study|Adverse Event|0
14736|NCT01751178|70063|P1|Overall Study|Adverse Event|2
14737|NCT01751113|70080|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
14738|NCT01751113|70081|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
14739|NCT01751113|70082|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
14740|NCT01751113|70083|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
14741|NCT01751113|70084|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
14742|NCT01751113|70085|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
14743|NCT01751113|70080|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
14744|NCT01751113|70081|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
14745|NCT01751113|70082|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
14746|NCT01751113|70083|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
14747|NCT01751113|70084|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
14748|NCT01751113|70085|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
14749|NCT01751087|70126|P3|Overall Study|Physician Decision|1
14750|NCT01751087|70127|P2|Overall Study|Physician Decision|0
14751|NCT01751087|70128|P1|Overall Study|Physician Decision|0
14752|NCT01751087|70126|P3|Overall Study|Withdrawal by Subject|0
14753|NCT01751087|70127|P2|Overall Study|Withdrawal by Subject|0
14754|NCT01751087|70128|P1|Overall Study|Withdrawal by Subject|1
14755|NCT01750840|70197|P1|Overall Study|Lost to Follow-up|4
14756|NCT01750684|70204|P2|Overall Study|Protocol Violation|0
14757|NCT01750684|70205|P1|Overall Study|Protocol Violation|1
14758|NCT01750684|70204|P2|Overall Study|Withdrawn by Sponsor|1
14759|NCT01750684|70205|P1|Overall Study|Withdrawn by Sponsor|0
14760|NCT01750684|70204|P2|Overall Study|Non-compliance with Study Drug|1
14761|NCT01750684|70205|P1|Overall Study|Non-compliance with Study Drug|0
14762|NCT01750684|70204|P2|Overall Study|Death|0
14763|NCT01750684|70205|P1|Overall Study|Death|1
14764|NCT01750346|70240|P3|Overall Study|Adverse Event|0
14765|NCT01750346|70241|P2|Overall Study|Adverse Event|0
14766|NCT01750346|70242|P1|Overall Study|Adverse Event|1
14767|NCT01750294|70268|P1|Overall Study|Safety Endpoint|1
14768|NCT01750294|70268|P1|Overall Study|Withdrawal by Subject|1
14769|NCT01750242|70291|P1|Overall Study|Unreadable Images|3
14770|NCT01749982|70309|P4|Overall Study|Withdrawal by Subject|1
14771|NCT01749982|70310|P3|Overall Study|Withdrawal by Subject|0
14772|NCT01749982|70311|P2|Overall Study|Withdrawal by Subject|0
14773|NCT01749982|70312|P1|Overall Study|Withdrawal by Subject|0
14774|NCT01749982|70309|P4|Overall Study|Lost to Follow-up|1
14775|NCT01749982|70310|P3|Overall Study|Lost to Follow-up|0
14776|NCT01749982|70311|P2|Overall Study|Lost to Follow-up|0
14777|NCT01749982|70312|P1|Overall Study|Lost to Follow-up|0
14778|NCT01749982|70309|P4|Overall Study|Physician Decision|1
14779|NCT01749982|70310|P3|Overall Study|Physician Decision|0
14780|NCT01749982|70311|P2|Overall Study|Physician Decision|0
14781|NCT01749982|70312|P1|Overall Study|Physician Decision|0
14782|NCT01748760|70391|P2|Overall Study|Lost to Follow-up|1
14783|NCT01748760|70392|P1|Overall Study|Lost to Follow-up|5
14784|NCT01748760|70391|P2|Overall Study|Withdrawal by Subject|1
14785|NCT01748760|70392|P1|Overall Study|Withdrawal by Subject|1
14786|NCT01748890|70447|P1|Overall Study|Insufficient recruitment for analysis|4
14787|NCT01748071|70462|P3|Overall Study|Adverse Event|0
14788|NCT01748071|70463|P2|Overall Study|Adverse Event|2
14789|NCT01748071|70464|P1|Overall Study|Adverse Event|2
14790|NCT01747811|70705|P2|Overall Study|Lack of Efficacy|4
14791|NCT01747811|70706|P1|Overall Study|Lack of Efficacy|2
14792|NCT01747655|70722|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
14793|NCT01747655|70723|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
14794|NCT01747655|70722|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
14795|NCT01747655|70723|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
14796|NCT01747655|70722|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
14797|NCT01747655|70723|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
14798|NCT01747629|70753|P2|Overall Study|Not specified|1
14799|NCT01747629|70754|P1|Overall Study|Not specified|2
14800|NCT01747629|70753|P2|Overall Study|Not treated|0
14801|NCT01747629|70754|P1|Overall Study|Not treated|1
14802|NCT01747629|70753|P2|Overall Study|Inclusion criteria not met|0
14803|NCT01747629|70754|P1|Overall Study|Inclusion criteria not met|1
14804|NCT01747629|70753|P2|Overall Study|Noncompliance|1
14805|NCT01747629|70754|P1|Overall Study|Noncompliance|1
14806|NCT01747629|70753|P2|Overall Study|Withdrawal by Subject|2
14807|NCT01747629|70754|P1|Overall Study|Withdrawal by Subject|2
14808|NCT01747629|70753|P2|Overall Study|Adverse Event|2
14809|NCT01747629|70754|P1|Overall Study|Adverse Event|1
14810|NCT01746862|70821|P2|Overall Study|Entered puberty during the study|0
14811|NCT01746862|70822|P1|Overall Study|Entered puberty during the study|1
14812|NCT01746862|70821|P2|Overall Study|Consent withdrawal by parent’s guardian|2
14813|NCT01746862|70822|P1|Overall Study|Consent withdrawal by parent’s guardian|5
14814|NCT01746862|70821|P2|Overall Study|Protocol Violation|0
14815|NCT01746862|70822|P1|Overall Study|Protocol Violation|1
14816|NCT01746862|70821|P2|Overall Study|Withdrawal by Subject|1
14817|NCT01746862|70822|P1|Overall Study|Withdrawal by Subject|1
14818|NCT01746368|70892|P2|Overall Study|Withdrawal by Subject|1
14819|NCT01746368|70893|P1|Overall Study|Withdrawal by Subject|0
14820|NCT01746368|70892|P2|Overall Study|Lost to Follow-up|0
14821|NCT01746368|70893|P1|Overall Study|Lost to Follow-up|2
14822|NCT01746173|70920|P1|Overall Study|Disease Progression|2
14823|NCT01746108|70928|P3|Overall Study|Lost to Follow-up|0
14824|NCT01746108|70929|P2|Overall Study|Lost to Follow-up|1
14825|NCT01746108|70930|P1|Overall Study|Lost to Follow-up|0
14826|NCT01746108|70928|P3|Overall Study|Withdrawal by Subject|0
14827|NCT01746108|70929|P2|Overall Study|Withdrawal by Subject|1
14828|NCT01746108|70930|P1|Overall Study|Withdrawal by Subject|0
14829|NCT01746108|70928|P3|Overall Study|Adverse event, non-fatal|0
14830|NCT01746108|70929|P2|Overall Study|Adverse event, non-fatal|1
14831|NCT01746108|70930|P1|Overall Study|Adverse event, non-fatal|0
14832|NCT01746108|70928|P3|Overall Study|Migrated /moved from study area|0
14833|NCT01746108|70929|P2|Overall Study|Migrated /moved from study area|1
14834|NCT01746108|70930|P1|Overall Study|Migrated /moved from study area|0
14835|NCT01745380|70994|P2|Overall Study|Lack of Efficacy|1
14836|NCT01745380|70995|P1|Overall Study|Lack of Efficacy|0
14837|NCT01745380|70994|P2|Overall Study|Lost to Follow-up|0
14838|NCT01745380|70995|P1|Overall Study|Lost to Follow-up|1
14839|NCT01744977|71079|P2|Overall Study|No longer meets inclusion|0
14840|NCT01744977|71080|P1|Overall Study|No longer meets inclusion|6
14841|NCT01744977|71079|P2|Overall Study|Lost to Follow-up|0
14842|NCT01744977|71080|P1|Overall Study|Lost to Follow-up|2
14843|NCT01744977|71079|P2|Overall Study|Death|3
14844|NCT01744977|71080|P1|Overall Study|Death|2
14845|NCT01744977|71079|P2|Overall Study|Withdrawal by Subject|2
14846|NCT01744977|71080|P1|Overall Study|Withdrawal by Subject|1
14847|NCT01744691|71203|P1|Overall Study|Physician Decision|4
14848|NCT01744691|71203|P1|Overall Study|Withdrawal of consent for treatment|3
14849|NCT01744691|71203|P1|Overall Study|Unacceptable toxicity, AE or death|18
14850|NCT01744691|71203|P1|Overall Study|Progressive Disease|18
14851|NCT01744496|71210|P2|Maintenance Period|Subject left town|0
14852|NCT01744496|71211|P1|Maintenance Period|Subject left town|1
14853|NCT01744496|71210|P2|Maintenance Period|Withdrawal by Subject|1
14854|NCT01744496|71211|P1|Maintenance Period|Withdrawal by Subject|1
14855|NCT01744496|71210|P2|Maintenance Period|Protocol Violation|0
14856|NCT01744496|71211|P1|Maintenance Period|Protocol Violation|1
14857|NCT01744496|71210|P2|Maintenance Period|Adverse Event|3
14858|NCT01744496|71211|P1|Maintenance Period|Adverse Event|1
14859|NCT01744496|71210|P2|Titration Period|Personal reasons|1
14860|NCT01744496|71211|P1|Titration Period|Personal reasons|0
14861|NCT01744496|71210|P2|Titration Period|Adverse Event|1
14862|NCT01744496|71211|P1|Titration Period|Adverse Event|2
14863|NCT01744392|71229|P1|Overall Study|Physician Decision|1
14864|NCT01744197|71269|P2|Overall Study|No patch received|2
14865|NCT01744197|71270|P1|Overall Study|No patch received|2
14866|NCT01744197|71269|P2|Overall Study|Received 1 patch|1
14867|NCT01744197|71270|P1|Overall Study|Received 1 patch|2
14868|NCT01743092|71333|P2|Overall Study|Lost to Follow-up|15
14869|NCT01743092|71334|P1|Overall Study|Lost to Follow-up|14
14870|NCT01743027|71346|P4|Overall Study|Withdrawal by Subject|1
14871|NCT01743027|71347|P3|Overall Study|Withdrawal by Subject|3
14872|NCT01743027|71348|P2|Overall Study|Withdrawal by Subject|0
14873|NCT01743027|71349|P1|Overall Study|Withdrawal by Subject|1
14874|NCT01743027|71346|P4|Overall Study|Protocol Violation|0
14875|NCT01743027|71347|P3|Overall Study|Protocol Violation|1
14876|NCT01743027|71348|P2|Overall Study|Protocol Violation|1
14877|NCT01743027|71349|P1|Overall Study|Protocol Violation|1
14878|NCT01743027|71346|P4|Overall Study|Progressive Disease|0
14879|NCT01743027|71347|P3|Overall Study|Progressive Disease|3
14880|NCT01743027|71348|P2|Overall Study|Progressive Disease|4
14881|NCT01743027|71349|P1|Overall Study|Progressive Disease|1
14882|NCT01743027|71346|P4|Overall Study|Lost to Follow-up|0
14883|NCT01743027|71347|P3|Overall Study|Lost to Follow-up|2
14884|NCT01743027|71348|P2|Overall Study|Lost to Follow-up|0
14885|NCT01743027|71349|P1|Overall Study|Lost to Follow-up|0
14886|NCT01743027|71346|P4|Overall Study|Adverse Event|0
14887|NCT01743027|71347|P3|Overall Study|Adverse Event|0
14888|NCT01743027|71348|P2|Overall Study|Adverse Event|0
14889|NCT01743027|71349|P1|Overall Study|Adverse Event|2
14890|NCT01742897|71398|P1|Overall Study|Unspecified|1
14891|NCT01742897|71398|P1|Overall Study|Withdrawal by Subject|1
14892|NCT01742897|71398|P1|Overall Study|Adverse Event|3
14893|NCT01741792|71438|P3|Overall Study|Death|12
14894|NCT01741792|71439|P2|Overall Study|Death|1
14895|NCT01741792|71440|P1|Overall Study|Death|6
14896|NCT01741701|71507|P2|Overall Study|Withdrawal by Subject|1
14897|NCT01741701|71508|P1|Overall Study|Withdrawal by Subject|0
14898|NCT01741701|71507|P2|Overall Study|Adverse Event|1
14899|NCT01741701|71508|P1|Overall Study|Adverse Event|5
14900|NCT01741688|71524|P1|Overall Study|Withdrawal by Subject|1
14901|NCT01741688|71524|P1|Overall Study|Lack of insurance coverage|2
14902|NCT01740440|71744|P1|Overall Study|Lost to Follow-up|3
14903|NCT01740388|71752|P2|Overall Study|Subjects missing data, completed|36
14904|NCT01740388|71753|P1|Overall Study|Subjects missing data, completed|41
14905|NCT01740388|71752|P2|Overall Study|Physician Decision|6
14906|NCT01740388|71753|P1|Overall Study|Physician Decision|2
14907|NCT01740388|71752|P2|Overall Study|Lost to Follow-up|0
14908|NCT01740388|71753|P1|Overall Study|Lost to Follow-up|2
14909|NCT01740388|71752|P2|Overall Study|Withdrawal by Subject|2
14910|NCT01740388|71753|P1|Overall Study|Withdrawal by Subject|1
14911|NCT01740089|71805|P3|After 12 Weeks|Withdrawal by Subject|1
14912|NCT01740089|71806|P2|After 12 Weeks|Withdrawal by Subject|1
14913|NCT01740089|71807|P1|After 12 Weeks|Withdrawal by Subject|1
14914|NCT01740089|71805|P3|After 12 Weeks|Protocol Violation|1
14915|NCT01740089|71806|P2|After 12 Weeks|Protocol Violation|1
14916|NCT01740089|71807|P1|After 12 Weeks|Protocol Violation|1
14917|NCT01740089|71805|P3|After 12 Weeks|Adverse Event|5
14918|NCT01740089|71806|P2|After 12 Weeks|Adverse Event|0
14919|NCT01740089|71807|P1|After 12 Weeks|Adverse Event|2
14920|NCT01740089|71805|P3|After 12 Weeks|Lack of Efficacy|4
14921|NCT01740089|71806|P2|After 12 Weeks|Lack of Efficacy|1
14922|NCT01740089|71807|P1|After 12 Weeks|Lack of Efficacy|3
14923|NCT01740089|71805|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
14924|NCT01740089|71806|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
14925|NCT01740089|71807|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
14926|NCT01740089|71805|P3|First 12 Weeks of Treatment|Adverse Event|2
14927|NCT01740089|71806|P2|First 12 Weeks of Treatment|Adverse Event|1
14928|NCT01740089|71807|P1|First 12 Weeks of Treatment|Adverse Event|0
14929|NCT01739803|71825|P2|Overall Study|Lost to Follow-up|6
14930|NCT01739803|71826|P1|Overall Study|Lost to Follow-up|9
14931|NCT01739595|71839|P3|Overall Study|Drug discrepancy|0
14932|NCT01739595|71840|P2|Overall Study|Drug discrepancy|0
14933|NCT01739595|71841|P1|Overall Study|Drug discrepancy|1
14934|NCT01739595|71839|P3|Overall Study|Lab assessment|0
14935|NCT01739595|71840|P2|Overall Study|Lab assessment|0
14936|NCT01739595|71841|P1|Overall Study|Lab assessment|1
14937|NCT01739595|71839|P3|Overall Study|Protocol Violation|0
14938|NCT01739595|71840|P2|Overall Study|Protocol Violation|0
14939|NCT01739595|71841|P1|Overall Study|Protocol Violation|1
14940|NCT01739595|71839|P3|Overall Study|Eligibility issue|0
14941|NCT01739595|71840|P2|Overall Study|Eligibility issue|0
14942|NCT01739595|71841|P1|Overall Study|Eligibility issue|3
14943|NCT01739595|71839|P3|Overall Study|Withdrawal by Subject|2
14944|NCT01739595|71840|P2|Overall Study|Withdrawal by Subject|1
14945|NCT01739595|71841|P1|Overall Study|Withdrawal by Subject|2
14946|NCT01739595|71839|P3|Overall Study|Lost to Follow-up|0
14947|NCT01739595|71840|P2|Overall Study|Lost to Follow-up|0
14948|NCT01739595|71841|P1|Overall Study|Lost to Follow-up|2
14949|NCT01739595|71839|P3|Overall Study|Adverse Event|0
14950|NCT01739595|71840|P2|Overall Study|Adverse Event|0
14951|NCT01739595|71841|P1|Overall Study|Adverse Event|3
14952|NCT01738984|71860|P2|Overall Study|Lost to Follow-up|39
14953|NCT01738984|71861|P1|Overall Study|Lost to Follow-up|59
14954|NCT01738984|71860|P2|Overall Study|Withdrawal by Subject|0
14955|NCT01738984|71861|P1|Overall Study|Withdrawal by Subject|1
14956|NCT01738984|71860|P2|Overall Study|Pregnancy|0
14957|NCT01738984|71861|P1|Overall Study|Pregnancy|4
14958|NCT01738971|71874|P3|Overall Study|Lost to Follow-up|17
14959|NCT01738971|71875|P2|Overall Study|Lost to Follow-up|30
14960|NCT01738971|71876|P1|Overall Study|Lost to Follow-up|19
14961|NCT01738919|71892|P2|Overall Study|Not treated in accordance to guidelines|1
14962|NCT01738919|71893|P1|Overall Study|Not treated in accordance to guidelines|0
14963|NCT01738919|71892|P2|Overall Study|Withdrawal by Subject|1
14964|NCT01738919|71893|P1|Overall Study|Withdrawal by Subject|0
14965|NCT01738919|71892|P2|Overall Study|Immigrated|1
14966|NCT01738919|71893|P1|Overall Study|Immigrated|0
14967|NCT01738919|71892|P2|Overall Study|Lost to Follow-up|0
14968|NCT01738919|71893|P1|Overall Study|Lost to Follow-up|1
14969|NCT01738646|72034|P1|Overall Study|Still Receiving Treatment|2
14970|NCT01738581|72044|P2|Overall Study|Lost to Follow-up|0
14971|NCT01738581|72045|P1|Overall Study|Lost to Follow-up|1
14972|NCT01738438|72053|P1|Overall Study|Adverse Event|3
14973|NCT01738438|72053|P1|Overall Study|Disease Progression|32
14974|NCT01737996|72071|P3|Overall Study|Withdrawal by Subject|1
14975|NCT01737996|72072|P2|Overall Study|Withdrawal by Subject|0
14976|NCT01737996|72073|P1|Overall Study|Withdrawal by Subject|0
14977|NCT01737996|72071|P3|Overall Study|Adverse Event|1
14978|NCT01737996|72072|P2|Overall Study|Adverse Event|1
14979|NCT01737996|72073|P1|Overall Study|Adverse Event|0
14980|NCT01737931|72135|P3|Overall Study|Physician Decision|0
14981|NCT01737931|72136|P2|Overall Study|Physician Decision|1
14982|NCT01737931|72137|P1|Overall Study|Physician Decision|0
14983|NCT01737931|72135|P3|Overall Study|Withdrawal by Subject|1
14984|NCT01737931|72136|P2|Overall Study|Withdrawal by Subject|1
14985|NCT01737931|72137|P1|Overall Study|Withdrawal by Subject|0
14986|NCT01737879|72152|P1|Overall Study|Sponsor decision|40
14987|NCT01737879|72152|P1|Overall Study|Death|1
14988|NCT01737840|72161|P2|Overall Study|Diagnosed with an other pathology|2
14989|NCT01737840|72162|P1|Overall Study|Diagnosed with an other pathology|2
14990|NCT01737710|72175|P5|Overall Study|Vaccinated in Error/Ineligible|0
14991|NCT01737710|72176|P4|Overall Study|Vaccinated in Error/Ineligible|0
14992|NCT01737710|72177|P3|Overall Study|Vaccinated in Error/Ineligible|0
14993|NCT01737710|72178|P2|Overall Study|Vaccinated in Error/Ineligible|1
14994|NCT01737710|72179|P1|Overall Study|Vaccinated in Error/Ineligible|1
14995|NCT01737710|72175|P5|Overall Study|Withdrawal by Subject|0
14996|NCT01737710|72176|P4|Overall Study|Withdrawal by Subject|0
14997|NCT01737710|72177|P3|Overall Study|Withdrawal by Subject|1
14998|NCT01737710|72178|P2|Overall Study|Withdrawal by Subject|1
14999|NCT01737710|72179|P1|Overall Study|Withdrawal by Subject|1
15000|NCT01737710|72175|P5|Overall Study|Lost to Follow-up|0
15001|NCT01737710|72176|P4|Overall Study|Lost to Follow-up|0
15002|NCT01737710|72177|P3|Overall Study|Lost to Follow-up|2
15003|NCT01737710|72178|P2|Overall Study|Lost to Follow-up|2
15004|NCT01737710|72179|P1|Overall Study|Lost to Follow-up|0
15005|NCT01737021|72272|P2|Overall Study|Lost to Follow-up|3
15006|NCT01737021|72273|P1|Overall Study|Lost to Follow-up|5
15007|NCT01736917|72319|P1|Overall Study|Protocol Violation|10
15008|NCT01736917|72319|P1|Overall Study|Adverse Event|1
15009|NCT01736696|72333|P7|Overall Study|Withdrawal by Subject|0
15010|NCT01736696|72334|P6|Overall Study|Withdrawal by Subject|0
15011|NCT01736696|72335|P5|Overall Study|Withdrawal by Subject|0
15012|NCT01736696|72336|P4|Overall Study|Withdrawal by Subject|0
15013|NCT01736696|72337|P3|Overall Study|Withdrawal by Subject|1
15014|NCT01736696|72338|P2|Overall Study|Withdrawal by Subject|0
15015|NCT01736696|72339|P1|Overall Study|Withdrawal by Subject|0
15016|NCT01736657|72656|P1|Overall Study|insufficient vascular access|1
15017|NCT01736579|72665|P2|Overall Study|Termination of Study by Sponsor|2
15018|NCT01736579|72666|P1|Overall Study|Termination of Study by Sponsor|2
15019|NCT01736540|72700|P1|Overall Study|Unable to make MRI appointment|3
15020|NCT01736540|72700|P1|Overall Study|No show for MRI appointment|1
15021|NCT01736540|72700|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
15022|NCT01736540|72700|P1|Overall Study|Protocol Violation|1
15023|NCT01736540|72700|P1|Overall Study|Withdrawal by Subject|5
15024|NCT01736540|72700|P1|Overall Study|Abnormal test procedure|1
15025|NCT01736540|72700|P1|Overall Study|Death|1
15026|NCT01736540|72700|P1|Overall Study|Did not complete scan within 45 days|2
15027|NCT01736475|72766|P2|Overall Study|Other - Surgical procedure|0
15028|NCT01736475|72767|P1|Overall Study|Other - Surgical procedure|1
15029|NCT01736475|72766|P2|Overall Study|Other - Screen failure|0
15030|NCT01736475|72767|P1|Overall Study|Other - Screen failure|1
15031|NCT01736475|72766|P2|Overall Study|Protocol Violation|0
15032|NCT01736475|72767|P1|Overall Study|Protocol Violation|4
15033|NCT01736475|72766|P2|Overall Study|Withdrawal by Subject|0
15034|NCT01736475|72767|P1|Overall Study|Withdrawal by Subject|2
15035|NCT01736475|72766|P2|Overall Study|Adverse Event|0
15036|NCT01736475|72767|P1|Overall Study|Adverse Event|4
15037|NCT01736215|72820|P1|Overall Study|Insufficient data to perform analysis|8
15038|NCT01736215|72820|P1|Overall Study|Progressive disease stop chemotherapy|1
15039|NCT01736215|72820|P1|Overall Study|Adverse Event|4
15040|NCT01736215|72820|P1|Overall Study|Early termination of erythropoietin use|1
15041|NCT01736176|72832|P1|Overall Study|Unable to Complete PEG Placement|1
15042|NCT01736176|72832|P1|Overall Study|Lack of Efficacy|3
15043|NCT01736176|72832|P1|Overall Study|Withdrawal by Subject|4
15044|NCT01736176|72832|P1|Overall Study|Adverse Event|3
15045|NCT01735916|72879|P3|Overall Study|Withdrawal by Subject|0
15046|NCT01735916|72880|P2|Overall Study|Withdrawal by Subject|0
15047|NCT01735916|72881|P1|Overall Study|Withdrawal by Subject|3
15048|NCT01735916|72879|P3|Overall Study|Early termination of study by sponsor|7
15049|NCT01735916|72880|P2|Overall Study|Early termination of study by sponsor|19
15050|NCT01735916|72881|P1|Overall Study|Early termination of study by sponsor|4
15051|NCT01735916|72879|P3|Overall Study|Subject not eligible to be randomized|0
15052|NCT01735916|72880|P2|Overall Study|Subject not eligible to be randomized|0
15053|NCT01735916|72881|P1|Overall Study|Subject not eligible to be randomized|11
15054|NCT01735630|72919|P2|Overall Study|Withdrawal by Subject|9
15055|NCT01735630|72920|P1|Overall Study|Withdrawal by Subject|7
15056|NCT01735630|72919|P2|Overall Study|Sponsor Decision|1
15057|NCT01735630|72920|P1|Overall Study|Sponsor Decision|2
15058|NCT01735630|72919|P2|Overall Study|Physician Decision|1
15059|NCT01735630|72920|P1|Overall Study|Physician Decision|0
15060|NCT01735630|72919|P2|Overall Study|Lost to Follow-up|0
15061|NCT01735630|72920|P1|Overall Study|Lost to Follow-up|1
15062|NCT01735630|72919|P2|Overall Study|Adverse Event|7
15063|NCT01735630|72920|P1|Overall Study|Adverse Event|8
15064|NCT01735201|72954|P8|Overall Study|Other Miscellaneous Reasons|1
15065|NCT01735201|72955|P7|Overall Study|Other Miscellaneous Reasons|1
15066|NCT01735201|72956|P6|Overall Study|Other Miscellaneous Reasons|2
15067|NCT01735201|72957|P5|Overall Study|Other Miscellaneous Reasons|0
15068|NCT01735201|72958|P4|Overall Study|Other Miscellaneous Reasons|1
15069|NCT01735201|72959|P3|Overall Study|Other Miscellaneous Reasons|0
15070|NCT01735201|72960|P2|Overall Study|Other Miscellaneous Reasons|0
15071|NCT01735201|72961|P1|Overall Study|Other Miscellaneous Reasons|0
15072|NCT01735201|72954|P8|Overall Study|Protocol Violation|0
15073|NCT01735201|72955|P7|Overall Study|Protocol Violation|0
15074|NCT01735201|72956|P6|Overall Study|Protocol Violation|0
15075|NCT01735201|72957|P5|Overall Study|Protocol Violation|0
15076|NCT01735201|72958|P4|Overall Study|Protocol Violation|0
15077|NCT01735201|72959|P3|Overall Study|Protocol Violation|0
15078|NCT01735201|72960|P2|Overall Study|Protocol Violation|0
15079|NCT01735201|72961|P1|Overall Study|Protocol Violation|1
15080|NCT01735201|72954|P8|Overall Study|Personal Reasons|0
15081|NCT01735201|72955|P7|Overall Study|Personal Reasons|0
15082|NCT01735201|72956|P6|Overall Study|Personal Reasons|0
15083|NCT01735201|72957|P5|Overall Study|Personal Reasons|0
15084|NCT01735201|72958|P4|Overall Study|Personal Reasons|0
15085|NCT01735201|72959|P3|Overall Study|Personal Reasons|0
15086|NCT01735201|72960|P2|Overall Study|Personal Reasons|0
15087|NCT01735201|72961|P1|Overall Study|Personal Reasons|1
15088|NCT01735201|72954|P8|Overall Study|Adverse Event|1
15089|NCT01735201|72955|P7|Overall Study|Adverse Event|2
15090|NCT01735201|72956|P6|Overall Study|Adverse Event|3
15091|NCT01735201|72957|P5|Overall Study|Adverse Event|1
15092|NCT01735201|72958|P4|Overall Study|Adverse Event|1
15093|NCT01735201|72959|P3|Overall Study|Adverse Event|0
15094|NCT01735201|72960|P2|Overall Study|Adverse Event|1
15095|NCT01735201|72961|P1|Overall Study|Adverse Event|1
15096|NCT01734993|72995|P1|Overall Study|Lack of Efficacy|1
15097|NCT01734993|72995|P1|Overall Study|Adverse Event|1
15098|NCT01734785|73032|P4|Double−Blind Period|Not treated|0
15099|NCT01734785|73033|P3|Double−Blind Period|Not treated|0
15100|NCT01734785|73034|P2|Double−Blind Period|Not treated|0
15101|NCT01734785|73035|P1|Double−Blind Period|Not treated|1
15102|NCT01734785|73032|P4|Double−Blind Period|Withdrawal by Subject|0
15103|NCT01734785|73033|P3|Double−Blind Period|Withdrawal by Subject|0
15104|NCT01734785|73034|P2|Double−Blind Period|Withdrawal by Subject|0
15105|NCT01734785|73035|P1|Double−Blind Period|Withdrawal by Subject|2
15106|NCT01734785|73032|P4|Double−Blind Period|Lost to Follow-up|0
15107|NCT01734785|73033|P3|Double−Blind Period|Lost to Follow-up|2
15108|NCT01734785|73034|P2|Double−Blind Period|Lost to Follow-up|4
15109|NCT01734785|73035|P1|Double−Blind Period|Lost to Follow-up|2
15110|NCT01734785|73032|P4|Double−Blind Period|Protocol Violation|0
15111|NCT01734785|73033|P3|Double−Blind Period|Protocol Violation|1
15112|NCT01734785|73034|P2|Double−Blind Period|Protocol Violation|1
15113|NCT01734785|73035|P1|Double−Blind Period|Protocol Violation|0
15114|NCT01734785|73032|P4|Double−Blind Period|Lack of Efficacy|0
15115|NCT01734785|73033|P3|Double−Blind Period|Lack of Efficacy|0
15116|NCT01734785|73034|P2|Double−Blind Period|Lack of Efficacy|1
15117|NCT01734785|73035|P1|Double−Blind Period|Lack of Efficacy|0
15118|NCT01734785|73032|P4|Double−Blind Period|Adverse Event|0
15119|NCT01734785|73033|P3|Double−Blind Period|Adverse Event|2
15120|NCT01734785|73034|P2|Double−Blind Period|Adverse Event|3
15121|NCT01734785|73035|P1|Double−Blind Period|Adverse Event|0
15122|NCT01734785|73032|P4|Open−Label Period|Other Reasons|224
15123|NCT01734785|73033|P3|Open−Label Period|Other Reasons|0
15124|NCT01734785|73034|P2|Open−Label Period|Other Reasons|0
15125|NCT01734785|73035|P1|Open−Label Period|Other Reasons|0
15126|NCT01734785|73032|P4|Open−Label Period|Withdrawal by Subject|12
15127|NCT01734785|73033|P3|Open−Label Period|Withdrawal by Subject|0
15128|NCT01734785|73034|P2|Open−Label Period|Withdrawal by Subject|0
15129|NCT01734785|73035|P1|Open−Label Period|Withdrawal by Subject|0
15130|NCT01734785|73032|P4|Open−Label Period|Lost to Follow-up|14
15131|NCT01734785|73033|P3|Open−Label Period|Lost to Follow-up|0
15132|NCT01734785|73034|P2|Open−Label Period|Lost to Follow-up|0
15133|NCT01734785|73035|P1|Open−Label Period|Lost to Follow-up|0
15134|NCT01734785|73032|P4|Open−Label Period|Protocol Violation|13
15135|NCT01734785|73033|P3|Open−Label Period|Protocol Violation|0
15136|NCT01734785|73034|P2|Open−Label Period|Protocol Violation|0
15137|NCT01734785|73035|P1|Open−Label Period|Protocol Violation|0
15138|NCT01734785|73032|P4|Open−Label Period|Lack of Efficacy|1
15139|NCT01734785|73033|P3|Open−Label Period|Lack of Efficacy|0
15140|NCT01734785|73034|P2|Open−Label Period|Lack of Efficacy|0
15141|NCT01734785|73035|P1|Open−Label Period|Lack of Efficacy|0
15142|NCT01734785|73032|P4|Open−Label Period|Adverse Event|9
15143|NCT01734785|73033|P3|Open−Label Period|Adverse Event|0
15144|NCT01734785|73034|P2|Open−Label Period|Adverse Event|0
15145|NCT01734785|73035|P1|Open−Label Period|Adverse Event|0
15146|NCT01734772|73052|P2|Overall Study|Withdrawal by Subject|1
15147|NCT01734772|73053|P1|Overall Study|Withdrawal by Subject|0
15148|NCT01734772|73052|P2|Overall Study|Adverse Event|2
15149|NCT01734772|73053|P1|Overall Study|Adverse Event|1
15150|NCT01734395|73079|P1|Overall Study|Missing the reasons for not completed|3
15151|NCT01734395|73079|P1|Overall Study|Withdrawal by Subject|10
15152|NCT01734395|73079|P1|Overall Study|Adverse Event|40
15153|NCT01734395|73079|P1|Overall Study|Lack of Efficacy|5
15154|NCT01734395|73079|P1|Overall Study|Lost to Follow-up|287
15155|NCT01734395|73079|P1|Overall Study|Not specified|65
15156|NCT01733758|73128|P4|Overall Study|Inv Decision, HbA1c not controlled|1
15157|NCT01733758|73129|P3|Overall Study|Inv Decision, HbA1c not controlled|0
15158|NCT01733758|73130|P2|Overall Study|Inv Decision, HbA1c not controlled|1
15159|NCT01733758|73131|P1|Overall Study|Inv Decision, HbA1c not controlled|1
15160|NCT01733758|73128|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
15161|NCT01733758|73129|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
15162|NCT01733758|73130|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
15163|NCT01733758|73131|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
15164|NCT01733758|73128|P4|Overall Study|Non-compliance|0
15165|NCT01733758|73129|P3|Overall Study|Non-compliance|0
15166|NCT01733758|73130|P2|Overall Study|Non-compliance|0
15167|NCT01733758|73131|P1|Overall Study|Non-compliance|1
15168|NCT01733758|73128|P4|Overall Study|Protocol Violation|2
15169|NCT01733758|73129|P3|Overall Study|Protocol Violation|2
15170|NCT01733758|73130|P2|Overall Study|Protocol Violation|1
15171|NCT01733758|73131|P1|Overall Study|Protocol Violation|0
15172|NCT01733758|73128|P4|Overall Study|Persistent Hyperglycemia|0
15173|NCT01733758|73129|P3|Overall Study|Persistent Hyperglycemia|0
15174|NCT01733758|73130|P2|Overall Study|Persistent Hyperglycemia|2
15175|NCT01733758|73131|P1|Overall Study|Persistent Hyperglycemia|3
15176|NCT01733758|73128|P4|Overall Study|Withdrawal by Subject|3
15177|NCT01733758|73129|P3|Overall Study|Withdrawal by Subject|5
15178|NCT01733758|73130|P2|Overall Study|Withdrawal by Subject|1
15179|NCT01733758|73131|P1|Overall Study|Withdrawal by Subject|1
15180|NCT01733758|73128|P4|Overall Study|Adverse Event|1
15181|NCT01733758|73129|P3|Overall Study|Adverse Event|8
15182|NCT01733758|73130|P2|Overall Study|Adverse Event|7
15183|NCT01733758|73131|P1|Overall Study|Adverse Event|5
15184|NCT01733732|73197|P2|Overall Study|Did not attend all study visits|0
15185|NCT01733732|73198|P1|Overall Study|Did not attend all study visits|1
15186|NCT01733732|73197|P2|Overall Study|Adverse Event|0
15187|NCT01733732|73198|P1|Overall Study|Adverse Event|1
15188|NCT01733329|73234|P2|Overall Study|Uterine artery injury|0
15189|NCT01733329|73235|P1|Overall Study|Uterine artery injury|1
15190|NCT01733329|73234|P2|Overall Study|Protocol Violation|1
15191|NCT01733329|73235|P1|Overall Study|Protocol Violation|1
15192|NCT01732835|73288|P1|2-year Extended Follow-up|Death|1
15193|NCT01732835|73288|P1|2-year Extended Follow-up|Adverse Event|3
15194|NCT01732835|73288|P1|2-year Extended Follow-up|Withdrawal by Subject|1
15195|NCT01732835|73288|P1|6-month Primary Endpoint|Adverse Event|3
15196|NCT01732835|73288|P1|6-month Primary Endpoint|Withdrawal by Subject|2
15197|NCT01732835|73288|P1|6-month Primary Endpoint|Did not receive device|19
15198|NCT01732796|73322|P3|Overall Study|Other reason not defined above|2
15199|NCT01732796|73323|P2|Overall Study|Other reason not defined above|0
15200|NCT01732796|73324|P1|Overall Study|Other reason not defined above|1
15201|NCT01732796|73322|P3|Overall Study|Withdrawal by Subject|2
15202|NCT01732796|73323|P2|Overall Study|Withdrawal by Subject|8
15203|NCT01732796|73324|P1|Overall Study|Withdrawal by Subject|6
15204|NCT01732796|73322|P3|Overall Study|Lost to Follow-up|0
15205|NCT01732796|73323|P2|Overall Study|Lost to Follow-up|0
15206|NCT01732796|73324|P1|Overall Study|Lost to Follow-up|2
15207|NCT01732796|73322|P3|Overall Study|Lack of Efficacy|5
15208|NCT01732796|73323|P2|Overall Study|Lack of Efficacy|18
15209|NCT01732796|73324|P1|Overall Study|Lack of Efficacy|21
15210|NCT01732796|73322|P3|Overall Study|Adverse Event|4
15211|NCT01732796|73323|P2|Overall Study|Adverse Event|16
15212|NCT01732796|73324|P1|Overall Study|Adverse Event|16
15213|NCT01732770|73342|P2|Overall Study|Death|0
15214|NCT01732770|73343|P1|Overall Study|Death|1
15215|NCT01732770|73342|P2|Overall Study|Decision by Sponsor|2
15216|NCT01732770|73343|P1|Overall Study|Decision by Sponsor|2
15217|NCT01732770|73342|P2|Overall Study|Withdrawal by Subject|3
15218|NCT01732770|73343|P1|Overall Study|Withdrawal by Subject|5
15219|NCT01732770|73342|P2|Overall Study|Lost to Follow-up|3
15220|NCT01732770|73343|P1|Overall Study|Lost to Follow-up|2
15221|NCT01732757|73358|P3|Overall Study|Lost to Follow-up|0
15222|NCT01732757|73359|P2|Overall Study|Lost to Follow-up|0
15223|NCT01732757|73360|P1|Overall Study|Lost to Follow-up|1
15224|NCT01732692|73400|P2|Overall Study|Adverse Event|1
15225|NCT01732692|73401|P1|Overall Study|Adverse Event|0
15226|NCT01732588|73418|P3|First Intervention (7 Days)|Adverse Event|0
15227|NCT01732588|73419|P2|First Intervention (7 Days)|Adverse Event|1
15228|NCT01732588|73420|P1|First Intervention (7 Days)|Adverse Event|0
15229|NCT01732549|73436|P2|Overall Study|Not Specified|14
15230|NCT01732549|73437|P1|Overall Study|Not Specified|8
15231|NCT01732549|73436|P2|Overall Study|Disease progression|50
15232|NCT01732549|73437|P1|Overall Study|Disease progression|37
15233|NCT01732549|73436|P2|Overall Study|Consent withdrawn|6
15234|NCT01732549|73437|P1|Overall Study|Consent withdrawn|13
15235|NCT01732549|73436|P2|Overall Study|Adverse Event|3
15236|NCT01732549|73437|P1|Overall Study|Adverse Event|13
15237|NCT01732510|73464|P7|Overall Study|Study Terminated By Sponsor|6
15238|NCT01732510|73465|P6|Overall Study|Study Terminated By Sponsor|12
15239|NCT01732510|73466|P5|Overall Study|Study Terminated By Sponsor|0
15240|NCT01732510|73467|P4|Overall Study|Study Terminated By Sponsor|1
15241|NCT01732510|73468|P3|Overall Study|Study Terminated By Sponsor|0
15242|NCT01732510|73469|P2|Overall Study|Study Terminated By Sponsor|0
15243|NCT01732510|73470|P1|Overall Study|Study Terminated By Sponsor|0
15244|NCT01732510|73464|P7|Overall Study|Pregnancy|0
15245|NCT01732510|73465|P6|Overall Study|Pregnancy|0
15246|NCT01732510|73466|P5|Overall Study|Pregnancy|0
15247|NCT01732510|73467|P4|Overall Study|Pregnancy|1
15248|NCT01732510|73468|P3|Overall Study|Pregnancy|0
15249|NCT01732510|73469|P2|Overall Study|Pregnancy|0
15250|NCT01732510|73470|P1|Overall Study|Pregnancy|0
15251|NCT01732510|73464|P7|Overall Study|Physician Decision|0
15252|NCT01732510|73465|P6|Overall Study|Physician Decision|0
15253|NCT01732510|73466|P5|Overall Study|Physician Decision|0
15254|NCT01732510|73467|P4|Overall Study|Physician Decision|0
15255|NCT01732510|73468|P3|Overall Study|Physician Decision|0
15256|NCT01732510|73469|P2|Overall Study|Physician Decision|1
15257|NCT01732510|73470|P1|Overall Study|Physician Decision|0
15258|NCT01732510|73464|P7|Overall Study|Lost to Follow-up|0
15259|NCT01732510|73465|P6|Overall Study|Lost to Follow-up|1
15260|NCT01732510|73466|P5|Overall Study|Lost to Follow-up|0
15261|NCT01732510|73467|P4|Overall Study|Lost to Follow-up|1
15262|NCT01732510|73468|P3|Overall Study|Lost to Follow-up|1
15263|NCT01732510|73469|P2|Overall Study|Lost to Follow-up|0
15264|NCT01732510|73470|P1|Overall Study|Lost to Follow-up|0
15265|NCT01732510|73464|P7|Overall Study|Withdrawal by Subject|1
15266|NCT01732510|73465|P6|Overall Study|Withdrawal by Subject|0
15267|NCT01732510|73466|P5|Overall Study|Withdrawal by Subject|5
15268|NCT01732510|73467|P4|Overall Study|Withdrawal by Subject|1
15269|NCT01732510|73468|P3|Overall Study|Withdrawal by Subject|2
15270|NCT01732510|73469|P2|Overall Study|Withdrawal by Subject|3
15271|NCT01732510|73470|P1|Overall Study|Withdrawal by Subject|1
15272|NCT01732510|73464|P7|Overall Study|Protocol Violation|0
15273|NCT01732510|73465|P6|Overall Study|Protocol Violation|0
15274|NCT01732510|73466|P5|Overall Study|Protocol Violation|0
15275|NCT01732510|73467|P4|Overall Study|Protocol Violation|1
15276|NCT01732510|73468|P3|Overall Study|Protocol Violation|0
15277|NCT01732510|73469|P2|Overall Study|Protocol Violation|0
15278|NCT01732510|73470|P1|Overall Study|Protocol Violation|0
15279|NCT01732510|73464|P7|Overall Study|Adverse Event|1
15280|NCT01732510|73465|P6|Overall Study|Adverse Event|0
15281|NCT01732510|73466|P5|Overall Study|Adverse Event|0
15282|NCT01732510|73467|P4|Overall Study|Adverse Event|0
15283|NCT01732510|73468|P3|Overall Study|Adverse Event|1
15284|NCT01732510|73469|P2|Overall Study|Adverse Event|1
15285|NCT01732510|73470|P1|Overall Study|Adverse Event|0
15286|NCT01732484|73549|P1|Overall Study|chronical illness|5
15287|NCT01732484|73549|P1|Overall Study|Lost to Follow-up|14
15288|NCT01732484|73549|P1|Overall Study|Death|7
15289|NCT01732471|73557|P1|Overall Study|Withdrawal by Subject|1
15290|NCT01731470|73607|P1|Overall Study|Did not meet study criteria|1
15291|NCT01731470|73607|P1|Overall Study|Withdrawal by Subject|1
15292|NCT01730378|73625|P2|Overall Study|Lost to Follow-up|0
15293|NCT01730378|73626|P1|Overall Study|Lost to Follow-up|1
15294|NCT01730339|73657|P2|Overall Study|Un-specified|0
15295|NCT01730339|73658|P1|Overall Study|Un-specified|1
15296|NCT01730339|73657|P2|Overall Study|Lost to Follow-up|1
15297|NCT01730339|73658|P1|Overall Study|Lost to Follow-up|1
15298|NCT01730339|73657|P2|Overall Study|Withdrawal by Subject|2
15299|NCT01730339|73658|P1|Overall Study|Withdrawal by Subject|3
15300|NCT01730053|73698|P6|Overall Study|Other than specified|9
15301|NCT01730053|73699|P5|Overall Study|Other than specified|7
15302|NCT01730053|73700|P4|Overall Study|Other than specified|4
15303|NCT01730053|73701|P3|Overall Study|Other than specified|5
15304|NCT01730053|73702|P2|Overall Study|Other than specified|6
15305|NCT01730053|73703|P1|Overall Study|Other than specified|2
15306|NCT01730053|73698|P6|Overall Study|Poor compliance to protocol|2
15307|NCT01730053|73699|P5|Overall Study|Poor compliance to protocol|0
15308|NCT01730053|73700|P4|Overall Study|Poor compliance to protocol|0
15309|NCT01730053|73701|P3|Overall Study|Poor compliance to protocol|2
15310|NCT01730053|73702|P2|Overall Study|Poor compliance to protocol|2
15311|NCT01730053|73703|P1|Overall Study|Poor compliance to protocol|1
15312|NCT01730053|73698|P6|Overall Study|Adverse Event|2
15313|NCT01730053|73699|P5|Overall Study|Adverse Event|2
15314|NCT01730053|73700|P4|Overall Study|Adverse Event|3
15315|NCT01730053|73701|P3|Overall Study|Adverse Event|3
15316|NCT01730053|73702|P2|Overall Study|Adverse Event|6
15317|NCT01730053|73703|P1|Overall Study|Adverse Event|2
15318|NCT01730053|73698|P6|Overall Study|Physician Decision|0
15319|NCT01730053|73699|P5|Overall Study|Physician Decision|0
15320|NCT01730053|73700|P4|Overall Study|Physician Decision|1
15321|NCT01730053|73701|P3|Overall Study|Physician Decision|0
15322|NCT01730053|73702|P2|Overall Study|Physician Decision|0
15323|NCT01730053|73703|P1|Overall Study|Physician Decision|0
15324|NCT01730053|73698|P6|Overall Study|Participant moved|0
15325|NCT01730053|73699|P5|Overall Study|Participant moved|0
15326|NCT01730053|73700|P4|Overall Study|Participant moved|0
15327|NCT01730053|73701|P3|Overall Study|Participant moved|1
15328|NCT01730053|73702|P2|Overall Study|Participant moved|0
15329|NCT01730053|73703|P1|Overall Study|Participant moved|0
15330|NCT01730040|73862|P7|Overall Study|Poor compliance to protocol|1
15331|NCT01730040|73863|P6|Overall Study|Poor compliance to protocol|0
15332|NCT01730040|73864|P5|Overall Study|Poor compliance to protocol|0
15333|NCT01730040|73865|P4|Overall Study|Poor compliance to protocol|0
15334|NCT01730040|73866|P3|Overall Study|Poor compliance to protocol|0
15335|NCT01730040|73867|P2|Overall Study|Poor compliance to protocol|4
15336|NCT01730040|73868|P1|Overall Study|Poor compliance to protocol|2
15337|NCT01730040|73862|P7|Overall Study|Adverse Event|2
15338|NCT01730040|73863|P6|Overall Study|Adverse Event|1
15339|NCT01730040|73864|P5|Overall Study|Adverse Event|1
15340|NCT01730040|73865|P4|Overall Study|Adverse Event|3
15341|NCT01730040|73866|P3|Overall Study|Adverse Event|5
15342|NCT01730040|73867|P2|Overall Study|Adverse Event|3
15343|NCT01730040|73868|P1|Overall Study|Adverse Event|4
15344|NCT01730040|73862|P7|Overall Study|Other than specified|4
15345|NCT01730040|73863|P6|Overall Study|Other than specified|4
15346|NCT01730040|73864|P5|Overall Study|Other than specified|5
15347|NCT01730040|73865|P4|Overall Study|Other than specified|5
15348|NCT01730040|73866|P3|Overall Study|Other than specified|5
15349|NCT01730040|73867|P2|Overall Study|Other than specified|8
15350|NCT01730040|73868|P1|Overall Study|Other than specified|7
15351|NCT01730040|73862|P7|Overall Study|Physician Decision|1
15352|NCT01730040|73863|P6|Overall Study|Physician Decision|1
15353|NCT01730040|73864|P5|Overall Study|Physician Decision|0
15354|NCT01730040|73865|P4|Overall Study|Physician Decision|0
15355|NCT01730040|73866|P3|Overall Study|Physician Decision|0
15356|NCT01730040|73867|P2|Overall Study|Physician Decision|0
15357|NCT01730040|73868|P1|Overall Study|Physician Decision|0
15358|NCT01730040|73862|P7|Overall Study|Subject moved|1
15359|NCT01730040|73863|P6|Overall Study|Subject moved|0
15360|NCT01730040|73864|P5|Overall Study|Subject moved|0
15361|NCT01730040|73865|P4|Overall Study|Subject moved|0
15362|NCT01730040|73866|P3|Overall Study|Subject moved|1
15363|NCT01730040|73867|P2|Overall Study|Subject moved|0
15364|NCT01730040|73868|P1|Overall Study|Subject moved|0
15365|NCT01730040|73862|P7|Overall Study|Randomized but not treated|0
15366|NCT01730040|73863|P6|Overall Study|Randomized but not treated|1
15367|NCT01730040|73864|P5|Overall Study|Randomized but not treated|0
15368|NCT01730040|73865|P4|Overall Study|Randomized but not treated|0
15369|NCT01730040|73866|P3|Overall Study|Randomized but not treated|0
15370|NCT01730040|73867|P2|Overall Study|Randomized but not treated|0
15371|NCT01730040|73868|P1|Overall Study|Randomized but not treated|0
15372|NCT01729871|74047|P2|Overall Study|Unspecified|9
15373|NCT01729871|74048|P1|Overall Study|Unspecified|4
15374|NCT01729871|74047|P2|Overall Study|Withdrawal by Subject|3
15375|NCT01729871|74048|P1|Overall Study|Withdrawal by Subject|0
15376|NCT01729871|74047|P2|Overall Study|Protocol Violation|0
15377|NCT01729871|74048|P1|Overall Study|Protocol Violation|1
15378|NCT01729871|74047|P2|Overall Study|Physician Decision|2
15379|NCT01729871|74048|P1|Overall Study|Physician Decision|0
15380|NCT01729871|74047|P2|Overall Study|Lack of Efficacy|1
15381|NCT01729871|74048|P1|Overall Study|Lack of Efficacy|0
15382|NCT01729871|74047|P2|Overall Study|Death|1
15383|NCT01729871|74048|P1|Overall Study|Death|0
15384|NCT01729871|74047|P2|Overall Study|Adverse Event|7
15385|NCT01729871|74048|P1|Overall Study|Adverse Event|7
15386|NCT01729728|74067|P3|Overall Study|Protocol Violation|1
15387|NCT01729728|74068|P2|Overall Study|Protocol Violation|0
15388|NCT01729728|74069|P1|Overall Study|Protocol Violation|1
15389|NCT01729728|74067|P3|Overall Study|Adverse Event|0
15390|NCT01729728|74068|P2|Overall Study|Adverse Event|6
15391|NCT01729728|74069|P1|Overall Study|Adverse Event|0
15392|NCT01729559|74202|P2|Overall Study|Protocol Violation|28
15393|NCT01729559|74203|P1|Overall Study|Protocol Violation|31
15394|NCT01729026|74231|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
15395|NCT01729026|74232|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
15396|NCT01729026|74231|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
15397|NCT01729026|74232|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
15398|NCT01728792|74243|P5|Overall Study|Lost to Follow-up|0
15399|NCT01728792|74244|P4|Overall Study|Lost to Follow-up|2
15400|NCT01728792|74245|P3|Overall Study|Lost to Follow-up|4
15401|NCT01728792|74246|P2|Overall Study|Lost to Follow-up|1
15402|NCT01728792|74247|P1|Overall Study|Lost to Follow-up|2
15403|NCT01728792|74243|P5|Overall Study|Withdrawal of Consent|0
15404|NCT01728792|74244|P4|Overall Study|Withdrawal of Consent|1
15405|NCT01728792|74245|P3|Overall Study|Withdrawal of Consent|0
15406|NCT01728792|74246|P2|Overall Study|Withdrawal of Consent|1
15407|NCT01728792|74247|P1|Overall Study|Withdrawal of Consent|1
15408|NCT01728584|74298|P4|Overall Study|Other reason (not specified)|1
15409|NCT01728584|74299|P3|Overall Study|Other reason (not specified)|0
15410|NCT01728584|74300|P2|Overall Study|Other reason (not specified)|0
15411|NCT01728584|74301|P1|Overall Study|Other reason (not specified)|1
15412|NCT01728584|74298|P4|Overall Study|Screen failure|0
15413|NCT01728584|74299|P3|Overall Study|Screen failure|0
15414|NCT01728584|74300|P2|Overall Study|Screen failure|0
15415|NCT01728584|74301|P1|Overall Study|Screen failure|1
15416|NCT01728584|74298|P4|Overall Study|Withdrawal by Subject|0
15417|NCT01728584|74299|P3|Overall Study|Withdrawal by Subject|0
15418|NCT01728584|74300|P2|Overall Study|Withdrawal by Subject|0
15419|NCT01728584|74301|P1|Overall Study|Withdrawal by Subject|1
15420|NCT01728584|74298|P4|Overall Study|Physician Decision|0
15421|NCT01728584|74299|P3|Overall Study|Physician Decision|1
15422|NCT01728584|74300|P2|Overall Study|Physician Decision|0
15423|NCT01728584|74301|P1|Overall Study|Physician Decision|4
15424|NCT01728584|74298|P4|Overall Study|Adverse Event|0
15425|NCT01728584|74299|P3|Overall Study|Adverse Event|0
15426|NCT01728584|74300|P2|Overall Study|Adverse Event|0
15427|NCT01728584|74301|P1|Overall Study|Adverse Event|1
15428|NCT01728376|74359|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
15429|NCT01728376|74360|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
15430|NCT01728376|74361|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
15431|NCT01728376|74362|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
15432|NCT01728376|74363|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
15433|NCT01728376|74364|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
15434|NCT01728376|74359|P6|Overall Study|Did not receive treatment|0
15435|NCT01728376|74360|P5|Overall Study|Did not receive treatment|0
15436|NCT01728376|74361|P4|Overall Study|Did not receive treatment|0
15437|NCT01728376|74362|P3|Overall Study|Did not receive treatment|0
15438|NCT01728376|74363|P2|Overall Study|Did not receive treatment|1
15439|NCT01728376|74364|P1|Overall Study|Did not receive treatment|0
15440|NCT01728376|74359|P6|Overall Study|No relevant bacteria|1
15441|NCT01728376|74360|P5|Overall Study|No relevant bacteria|1
15442|NCT01728376|74361|P4|Overall Study|No relevant bacteria|0
15443|NCT01728376|74362|P3|Overall Study|No relevant bacteria|0
15444|NCT01728376|74363|P2|Overall Study|No relevant bacteria|0
15445|NCT01728376|74364|P1|Overall Study|No relevant bacteria|2
15446|NCT01728376|74359|P6|Overall Study|Persistent Positive Blood Cultures|0
15447|NCT01728376|74360|P5|Overall Study|Persistent Positive Blood Cultures|0
15448|NCT01728376|74361|P4|Overall Study|Persistent Positive Blood Cultures|0
15449|NCT01728376|74362|P3|Overall Study|Persistent Positive Blood Cultures|1
15450|NCT01728376|74363|P2|Overall Study|Persistent Positive Blood Cultures|0
15451|NCT01728376|74364|P1|Overall Study|Persistent Positive Blood Cultures|1
15452|NCT01728376|74359|P6|Overall Study|Adverse Event|0
15453|NCT01728376|74360|P5|Overall Study|Adverse Event|1
15454|NCT01728376|74361|P4|Overall Study|Adverse Event|1
15455|NCT01728376|74362|P3|Overall Study|Adverse Event|1
15456|NCT01728376|74363|P2|Overall Study|Adverse Event|1
15457|NCT01728376|74364|P1|Overall Study|Adverse Event|1
15458|NCT01728324|74437|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
15459|NCT01728324|74438|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
15460|NCT01728324|74439|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
15461|NCT01728324|74437|P3|Termination of RBV|Adverse Event (Placebo Period)|0
15462|NCT01728324|74438|P2|Termination of RBV|Adverse Event (Placebo Period)|1
15463|NCT01728324|74439|P1|Termination of RBV|Adverse Event (Placebo Period)|0
15464|NCT01728324|74437|P3|Termination of RBV|Other than stated|1
15465|NCT01728324|74438|P2|Termination of RBV|Other than stated|3
15466|NCT01728324|74439|P1|Termination of RBV|Other than stated|1
15467|NCT01728324|74437|P3|Termination of RBV|Withdrawal by Subject|2
15468|NCT01728324|74438|P2|Termination of RBV|Withdrawal by Subject|5
15469|NCT01728324|74439|P1|Termination of RBV|Withdrawal by Subject|9
15470|NCT01728324|74437|P3|Termination of RBV|Lack of Efficacy|7
15471|NCT01728324|74438|P2|Termination of RBV|Lack of Efficacy|11
15472|NCT01728324|74439|P1|Termination of RBV|Lack of Efficacy|14
15473|NCT01728324|74437|P3|Termination of RBV|Adverse Event|5
15474|NCT01728324|74438|P2|Termination of RBV|Adverse Event|16
15475|NCT01728324|74439|P1|Termination of RBV|Adverse Event|15
15476|NCT01728324|74437|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
15477|NCT01728324|74438|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
15478|NCT01728324|74439|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
15479|NCT01728324|74437|P3|Termination of FDV|Adverse Event (Placebo Period)|0
15480|NCT01728324|74438|P2|Termination of FDV|Adverse Event (Placebo Period)|1
15481|NCT01728324|74439|P1|Termination of FDV|Adverse Event (Placebo Period)|0
15482|NCT01728324|74437|P3|Termination of FDV|Other than stated|0
15483|NCT01728324|74438|P2|Termination of FDV|Other than stated|3
15484|NCT01728324|74439|P1|Termination of FDV|Other than stated|1
15485|NCT01728324|74437|P3|Termination of FDV|Withdrawal by Subject|2
15486|NCT01728324|74438|P2|Termination of FDV|Withdrawal by Subject|6
15487|NCT01728324|74439|P1|Termination of FDV|Withdrawal by Subject|9
15488|NCT01728324|74437|P3|Termination of FDV|Lack of Efficacy|8
15489|NCT01728324|74438|P2|Termination of FDV|Lack of Efficacy|12
15490|NCT01728324|74439|P1|Termination of FDV|Lack of Efficacy|14
15491|NCT01728324|74437|P3|Termination of FDV|Adverse Event|4
15492|NCT01728324|74438|P2|Termination of FDV|Adverse Event|13
15493|NCT01728324|74439|P1|Termination of FDV|Adverse Event|14
15494|NCT01728324|74437|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
15495|NCT01728324|74438|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
15496|NCT01728324|74439|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
15497|NCT01728324|74437|P3|Termination of DBV|Adverse Event (Placebo Period)|0
15498|NCT01728324|74438|P2|Termination of DBV|Adverse Event (Placebo Period)|1
15499|NCT01728324|74439|P1|Termination of DBV|Adverse Event (Placebo Period)|0
15500|NCT01728324|74437|P3|Termination of DBV|Other than stated|0
15501|NCT01728324|74438|P2|Termination of DBV|Other than stated|3
15502|NCT01728324|74439|P1|Termination of DBV|Other than stated|1
15503|NCT01728324|74437|P3|Termination of DBV|Withdrawal by Subject|2
15504|NCT01728324|74438|P2|Termination of DBV|Withdrawal by Subject|6
15505|NCT01728324|74439|P1|Termination of DBV|Withdrawal by Subject|9
15506|NCT01728324|74437|P3|Termination of DBV|Lack of Efficacy|8
15507|NCT01728324|74438|P2|Termination of DBV|Lack of Efficacy|12
15508|NCT01728324|74439|P1|Termination of DBV|Lack of Efficacy|14
15509|NCT01728324|74437|P3|Termination of DBV|Adverse Event|4
15510|NCT01728324|74438|P2|Termination of DBV|Adverse Event|13
15511|NCT01728324|74439|P1|Termination of DBV|Adverse Event|14
15512|NCT01728246|74460|P2|Overall Study|Adverse Event|5
15513|NCT01728246|74461|P1|Overall Study|Adverse Event|8
15514|NCT01728246|74460|P2|Overall Study|Lack of Efficacy|1
15515|NCT01728246|74461|P1|Overall Study|Lack of Efficacy|1
15516|NCT01728246|74460|P2|Overall Study|Lost to Follow-up|22
15517|NCT01728246|74461|P1|Overall Study|Lost to Follow-up|23
15518|NCT01728246|74460|P2|Overall Study|Withdrawal by Subject|3
15519|NCT01728246|74461|P1|Overall Study|Withdrawal by Subject|2
15520|NCT01728246|74460|P2|Overall Study|Protocol Violation|0
15521|NCT01728246|74461|P1|Overall Study|Protocol Violation|1
15522|NCT01728246|74460|P2|Overall Study|Participant needed rescue medication|5
15523|NCT01728246|74461|P1|Overall Study|Participant needed rescue medication|1
15524|NCT01728116|74479|P2|Overall Study|various not noted previously|0
15525|NCT01728116|74480|P1|Overall Study|various not noted previously|5
15526|NCT01728116|74479|P2|Overall Study|Incorrectly enrolled in Study|1
15527|NCT01728116|74480|P1|Overall Study|Incorrectly enrolled in Study|0
15528|NCT01728116|74479|P2|Overall Study|Inter-current finding at procedure|0
15529|NCT01728116|74480|P1|Overall Study|Inter-current finding at procedure|1
15530|NCT01728116|74479|P2|Overall Study|Subject Non-Compliance|0
15531|NCT01728116|74480|P1|Overall Study|Subject Non-Compliance|2
15532|NCT01728116|74479|P2|Overall Study|Physician Decision|0
15533|NCT01728116|74480|P1|Overall Study|Physician Decision|2
15534|NCT01728116|74479|P2|Overall Study|Lost to Follow-up|2
15535|NCT01728116|74480|P1|Overall Study|Lost to Follow-up|9
15536|NCT01728116|74479|P2|Overall Study|Procedure/device failure|0
15537|NCT01728116|74480|P1|Overall Study|Procedure/device failure|7
15538|NCT01728116|74479|P2|Overall Study|Adverse Event|0
15539|NCT01728116|74480|P1|Overall Study|Adverse Event|13
15540|NCT01728116|74479|P2|Overall Study|Withdrawal by Subject|9
15541|NCT01728116|74480|P1|Overall Study|Withdrawal by Subject|16
15542|NCT01728116|74479|P2|Overall Study|Sponsor Terminated Study|35
15543|NCT01728116|74480|P1|Overall Study|Sponsor Terminated Study|106
15544|NCT01727713|74542|P1|Overall Study|Protocol Deviation|2
15545|NCT01727713|74542|P1|Overall Study|Withdrawal by Subject|13
15546|NCT01727713|74542|P1|Overall Study|Participant Met Withdrawal Criteria|5
15547|NCT01727713|74542|P1|Overall Study|Adverse Event|10
15548|NCT01727713|74542|P1|Overall Study|Lost to Follow-up|5
15549|NCT01727700|74569|P3|Overall Study|Protocol Violation|0
15550|NCT01727700|74570|P2|Overall Study|Protocol Violation|0
15551|NCT01727700|74571|P1|Overall Study|Protocol Violation|2
15552|NCT01727700|74569|P3|Overall Study|Particpant withdrew consent|1
15553|NCT01727700|74570|P2|Overall Study|Particpant withdrew consent|3
15554|NCT01727700|74571|P1|Overall Study|Particpant withdrew consent|0
15555|NCT01727700|74569|P3|Overall Study|Adverse Event|1
15556|NCT01727700|74570|P2|Overall Study|Adverse Event|7
15557|NCT01727700|74571|P1|Overall Study|Adverse Event|0
15558|NCT01727258|74597|P3|Overall Study|Lost to Follow-up|0
15559|NCT01727258|74598|P2|Overall Study|Lost to Follow-up|0
15560|NCT01727258|74599|P1|Overall Study|Lost to Follow-up|1
15561|NCT01727258|74597|P3|Overall Study|Withdrawal by Subject|0
15562|NCT01727258|74598|P2|Overall Study|Withdrawal by Subject|1
15563|NCT01727258|74599|P1|Overall Study|Withdrawal by Subject|1
15564|NCT01727258|74597|P3|Overall Study|Noncompliance with Study Drug|1
15565|NCT01727258|74598|P2|Overall Study|Noncompliance with Study Drug|0
15566|NCT01727258|74599|P1|Overall Study|Noncompliance with Study Drug|0
15567|NCT01727258|74597|P3|Overall Study|Adverse Event|0
15568|NCT01727258|74598|P2|Overall Study|Adverse Event|2
15569|NCT01727258|74599|P1|Overall Study|Adverse Event|0
15570|NCT01727141|74641|P4|Overall Study|Withdrawal by Subject|11
15571|NCT01727141|74642|P3|Overall Study|Withdrawal by Subject|2
15572|NCT01727141|74643|P2|Overall Study|Withdrawal by Subject|4
15573|NCT01727141|74644|P1|Overall Study|Withdrawal by Subject|4
15574|NCT01727141|74641|P4|Overall Study|Protocol deviation|1
15575|NCT01727141|74642|P3|Overall Study|Protocol deviation|0
15576|NCT01727141|74643|P2|Overall Study|Protocol deviation|1
15577|NCT01727141|74644|P1|Overall Study|Protocol deviation|1
15578|NCT01727141|74641|P4|Overall Study|Death|1
15579|NCT01727141|74642|P3|Overall Study|Death|1
15580|NCT01727141|74643|P2|Overall Study|Death|1
15581|NCT01727141|74644|P1|Overall Study|Death|0
15582|NCT01727141|74641|P4|Overall Study|Lost to Follow-up|0
15583|NCT01727141|74642|P3|Overall Study|Lost to Follow-up|0
15584|NCT01727141|74643|P2|Overall Study|Lost to Follow-up|2
15585|NCT01727141|74644|P1|Overall Study|Lost to Follow-up|0
15586|NCT01727141|74641|P4|Overall Study|Physician Decision|2
15587|NCT01727141|74642|P3|Overall Study|Physician Decision|0
15588|NCT01727141|74643|P2|Overall Study|Physician Decision|1
15589|NCT01727141|74644|P1|Overall Study|Physician Decision|0
15590|NCT01727024|74694|P2|Period 1|Withdrawal by Subject|3
15591|NCT01727024|74695|P1|Period 1|Withdrawal by Subject|2
15592|NCT01727024|74694|P2|Period 1|Lost to Follow-up|1
15593|NCT01727024|74695|P1|Period 1|Lost to Follow-up|1
15594|NCT01726517|74717|P5|Overall Study|Withdrawal by Subject|0
15595|NCT01726517|74718|P4|Overall Study|Withdrawal by Subject|0
15596|NCT01726517|74719|P3|Overall Study|Withdrawal by Subject|1
15597|NCT01726517|74720|P2|Overall Study|Withdrawal by Subject|0
15598|NCT01726517|74721|P1|Overall Study|Withdrawal by Subject|0
15599|NCT01726335|74777|P1|Overall Study|Exacerbation of psychotic symptoms|1
15600|NCT01726335|74777|P1|Overall Study|Lost to Follow-up|2
15601|NCT01726335|74777|P1|Overall Study|Adverse Event|4
15602|NCT01726335|74777|P1|Overall Study|Withdrawal by Subject|15
15603|NCT01726335|74777|P1|Overall Study|Lost to Follow-up|2
15604|NCT01726049|74795|P2|Overall Study|refused second HC|2
15605|NCT01726049|74796|P1|Overall Study|refused second HC|0
15606|NCT01726049|74795|P2|Overall Study|Adverse Event|1
15607|NCT01726049|74796|P1|Overall Study|Adverse Event|4
15608|NCT01726049|74795|P2|Overall Study|Death|1
15609|NCT01726049|74796|P1|Overall Study|Death|1
15610|NCT01726023|74810|P2|Overall Study|Withdrawal by Subject|8
15611|NCT01726023|74811|P1|Overall Study|Withdrawal by Subject|16
15612|NCT01726023|74810|P2|Overall Study|Other Eligibility criteria|7
15613|NCT01726023|74811|P1|Overall Study|Other Eligibility criteria|7
15614|NCT01726023|74810|P2|Overall Study|Lost to Follow-up|10
15615|NCT01726023|74811|P1|Overall Study|Lost to Follow-up|5
15616|NCT01726023|74810|P2|Overall Study|Death|1
15617|NCT01726023|74811|P1|Overall Study|Death|1
15618|NCT01725529|74931|P3|Overall Study|Withdrawal by Subject|8
15619|NCT01725529|74932|P2|Overall Study|Withdrawal by Subject|14
15620|NCT01725529|74933|P1|Overall Study|Withdrawal by Subject|12
15621|NCT01725529|74931|P3|Overall Study|Protocol Violation|1
15622|NCT01725529|74932|P2|Overall Study|Protocol Violation|1
15623|NCT01725529|74933|P1|Overall Study|Protocol Violation|0
15624|NCT01725529|74931|P3|Overall Study|Lost to Follow-up|1
15625|NCT01725529|74932|P2|Overall Study|Lost to Follow-up|1
15626|NCT01725529|74933|P1|Overall Study|Lost to Follow-up|2
15627|NCT01725529|74931|P3|Overall Study|Adverse Event|0
15628|NCT01725529|74932|P2|Overall Study|Adverse Event|0
15629|NCT01725529|74933|P1|Overall Study|Adverse Event|1
15630|NCT01725451|74959|P4|Period 4|Adverse Event|0
15631|NCT01725451|74960|P3|Period 4|Adverse Event|1
15632|NCT01725451|74961|P2|Period 4|Adverse Event|0
15633|NCT01725451|74962|P1|Period 4|Adverse Event|0
15634|NCT01725451|74959|P4|Washout From Period 3|Adverse Event|0
15635|NCT01725451|74960|P3|Washout From Period 3|Adverse Event|0
15636|NCT01725451|74961|P2|Washout From Period 3|Adverse Event|1
15637|NCT01725451|74962|P1|Washout From Period 3|Adverse Event|0
15638|NCT01725451|74959|P4|Washout From Period 3|Protocol Violation|0
15639|NCT01725451|74960|P3|Washout From Period 3|Protocol Violation|1
15640|NCT01725451|74961|P2|Washout From Period 3|Protocol Violation|0
15641|NCT01725451|74962|P1|Washout From Period 3|Protocol Violation|0
15642|NCT01725451|74959|P4|Period 1|Withdrawal by Subject|0
15643|NCT01725451|74960|P3|Period 1|Withdrawal by Subject|0
15644|NCT01725451|74961|P2|Period 1|Withdrawal by Subject|0
15645|NCT01725451|74962|P1|Period 1|Withdrawal by Subject|1
15646|NCT01725386|74984|P2|Overall Study|Withdrawal by Subject|0
15647|NCT01725386|74985|P1|Overall Study|Withdrawal by Subject|10
15648|NCT01725386|74984|P2|Overall Study|Lost to Follow-up|6
15649|NCT01725386|74985|P1|Overall Study|Lost to Follow-up|81
15650|NCT01725386|74984|P2|Overall Study|Death|40
15651|NCT01725386|74985|P1|Overall Study|Death|84
15652|NCT01725308|75004|P3|Overall Study|Miscellaneous|3
15653|NCT01725308|75005|P2|Overall Study|Miscellaneous|0
15654|NCT01725308|75006|P1|Overall Study|Miscellaneous|2
15655|NCT01725308|75004|P3|Overall Study|Protocol Deviations|1
15656|NCT01725308|75005|P2|Overall Study|Protocol Deviations|1
15657|NCT01725308|75006|P1|Overall Study|Protocol Deviations|3
15658|NCT01725308|75004|P3|Overall Study|Lost to Follow-up|2
15659|NCT01725308|75005|P2|Overall Study|Lost to Follow-up|2
15660|NCT01725308|75006|P1|Overall Study|Lost to Follow-up|3
15661|NCT01725308|75004|P3|Overall Study|Subject Consent Withdrawal|5
15662|NCT01725308|75005|P2|Overall Study|Subject Consent Withdrawal|7
15663|NCT01725308|75006|P1|Overall Study|Subject Consent Withdrawal|12
15664|NCT01725308|75004|P3|Overall Study|Episode Change|2
15665|NCT01725308|75005|P2|Overall Study|Episode Change|0
15666|NCT01725308|75006|P1|Overall Study|Episode Change|3
15667|NCT01725308|75004|P3|Overall Study|Worsening of Underlying Disease|2
15668|NCT01725308|75005|P2|Overall Study|Worsening of Underlying Disease|0
15669|NCT01725308|75006|P1|Overall Study|Worsening of Underlying Disease|8
15670|NCT01725308|75004|P3|Overall Study|Lack of Efficacy|5
15671|NCT01725308|75005|P2|Overall Study|Lack of Efficacy|0
15672|NCT01725308|75006|P1|Overall Study|Lack of Efficacy|7
15673|NCT01725308|75004|P3|Overall Study|Adverse Event|21
15674|NCT01725308|75005|P2|Overall Study|Adverse Event|4
15675|NCT01725308|75006|P1|Overall Study|Adverse Event|5
15676|NCT01725308|75004|P3|Overall Study|Did Not Receive Drug|0
15677|NCT01725308|75005|P2|Overall Study|Did Not Receive Drug|0
15678|NCT01725308|75006|P1|Overall Study|Did Not Receive Drug|1
15679|NCT01725282|75060|P4|Overall Study|Lack of Efficacy|1
15680|NCT01725282|75061|P3|Overall Study|Lack of Efficacy|0
15681|NCT01725282|75062|P2|Overall Study|Lack of Efficacy|1
15682|NCT01725282|75063|P1|Overall Study|Lack of Efficacy|0
15683|NCT01725282|75060|P4|Overall Study|Withdrawal by Subject|1
15684|NCT01725282|75061|P3|Overall Study|Withdrawal by Subject|1
15685|NCT01725282|75062|P2|Overall Study|Withdrawal by Subject|0
15686|NCT01725282|75063|P1|Overall Study|Withdrawal by Subject|0
15687|NCT01725282|75060|P4|Overall Study|Study Site Withdrawal|0
15688|NCT01725282|75061|P3|Overall Study|Study Site Withdrawal|0
15689|NCT01725282|75062|P2|Overall Study|Study Site Withdrawal|1
15690|NCT01725282|75063|P1|Overall Study|Study Site Withdrawal|0
15691|NCT01725282|75060|P4|Overall Study|Met Exclusion Criteria|0
15692|NCT01725282|75061|P3|Overall Study|Met Exclusion Criteria|1
15693|NCT01725282|75062|P2|Overall Study|Met Exclusion Criteria|0
15694|NCT01725282|75063|P1|Overall Study|Met Exclusion Criteria|0
15695|NCT01725282|75060|P4|Overall Study|Exacerbation of Target Disease|1
15696|NCT01725282|75061|P3|Overall Study|Exacerbation of Target Disease|0
15697|NCT01725282|75062|P2|Overall Study|Exacerbation of Target Disease|0
15698|NCT01725282|75063|P1|Overall Study|Exacerbation of Target Disease|1
15699|NCT01725282|75060|P4|Overall Study|Adverse Event|4
15700|NCT01725282|75061|P3|Overall Study|Adverse Event|6
15701|NCT01725282|75062|P2|Overall Study|Adverse Event|3
15702|NCT01725282|75063|P1|Overall Study|Adverse Event|1
15703|NCT01725217|75096|P3|Overall Study|Withdrawal by Subject|0
15704|NCT01725217|75097|P2|Overall Study|Withdrawal by Subject|0
15705|NCT01725217|75098|P1|Overall Study|Withdrawal by Subject|1
15706|NCT01724528|75128|P2|Overall Study|Patient refused to attend last visit|0
15707|NCT01724528|75129|P1|Overall Study|Patient refused to attend last visit|1
15708|NCT01724528|75128|P2|Overall Study|Protocol Violation|1
15709|NCT01724528|75129|P1|Overall Study|Protocol Violation|0
15710|NCT01724528|75128|P2|Overall Study|Withdrawal by Subject|2
15711|NCT01724528|75129|P1|Overall Study|Withdrawal by Subject|0
15712|NCT01724528|75128|P2|Overall Study|Death|0
15713|NCT01724528|75129|P1|Overall Study|Death|3
15714|NCT01724359|75143|P1|Overall Study|Not specified|20
15715|NCT01724359|75143|P1|Overall Study|Death|1
15716|NCT01724359|75143|P1|Overall Study|Adverse Event|10
15717|NCT01724216|75156|P1|Overall Study|Scan was not completed|1
15718|NCT01724177|75160|P1|Overall Study|Unspecified|2
15719|NCT01724177|75160|P1|Overall Study|Progressive disease or Relapsed Disease|13
15720|NCT01724177|75160|P1|Overall Study|Adverse Event|6
15721|NCT01724021|75172|P2|Overall Study|Reason Not Specified|9
15722|NCT01724021|75173|P1|Overall Study|Reason Not Specified|6
15723|NCT01724021|75172|P2|Overall Study|Lack of Compliance|1
15724|NCT01724021|75173|P1|Overall Study|Lack of Compliance|0
15725|NCT01724021|75172|P2|Overall Study|Lost to Follow-up|7
15726|NCT01724021|75173|P1|Overall Study|Lost to Follow-up|0
15727|NCT01724021|75172|P2|Overall Study|Participant request/ Withdrew consent|10
15728|NCT01724021|75173|P1|Overall Study|Participant request/ Withdrew consent|13
15729|NCT01724021|75172|P2|Overall Study|Death|29
15730|NCT01724021|75173|P1|Overall Study|Death|24
15731|NCT01724021|75172|P2|Overall Study|Adverse Event|4
15732|NCT01724021|75173|P1|Overall Study|Adverse Event|5
15733|NCT01723904|75205|P1|Overall Study|Unable to follow protocol/ judged by inv|3
15734|NCT01723904|75205|P1|Overall Study|Adverse Event|5
15735|NCT01723904|75205|P1|Overall Study|Noncompliant|3
15736|NCT01723397|75226|P2|Study Period 2|Protocol Violation|1
15737|NCT01723397|75227|P1|Study Period 2|Protocol Violation|0
15738|NCT01723397|75226|P2|Study Period 1|Protocol Violation|1
15739|NCT01723397|75227|P1|Study Period 1|Protocol Violation|0
15740|NCT01723254|75241|P8|Overall Study|Withdrawal by Subject|2
15741|NCT01723254|75242|P7|Overall Study|Withdrawal by Subject|1
15742|NCT01723254|75243|P6|Overall Study|Withdrawal by Subject|1
15743|NCT01723254|75244|P5|Overall Study|Withdrawal by Subject|1
15744|NCT01723254|75245|P4|Overall Study|Withdrawal by Subject|0
15745|NCT01723254|75246|P3|Overall Study|Withdrawal by Subject|1
15746|NCT01723254|75247|P2|Overall Study|Withdrawal by Subject|2
15747|NCT01723254|75248|P1|Overall Study|Withdrawal by Subject|1
15748|NCT01723254|75241|P8|Overall Study|Protocol Violation|0
15749|NCT01723254|75242|P7|Overall Study|Protocol Violation|0
15750|NCT01723254|75243|P6|Overall Study|Protocol Violation|0
15751|NCT01723254|75244|P5|Overall Study|Protocol Violation|0
15752|NCT01723254|75245|P4|Overall Study|Protocol Violation|0
15753|NCT01723254|75246|P3|Overall Study|Protocol Violation|0
15754|NCT01723254|75247|P2|Overall Study|Protocol Violation|1
15755|NCT01723254|75248|P1|Overall Study|Protocol Violation|0
15756|NCT01723254|75241|P8|Overall Study|Move/Left to another country/city|0
15757|NCT01723254|75242|P7|Overall Study|Move/Left to another country/city|0
15758|NCT01723254|75243|P6|Overall Study|Move/Left to another country/city|0
15759|NCT01723254|75244|P5|Overall Study|Move/Left to another country/city|1
15760|NCT01723254|75245|P4|Overall Study|Move/Left to another country/city|1
15761|NCT01723254|75246|P3|Overall Study|Move/Left to another country/city|2
15762|NCT01723254|75247|P2|Overall Study|Move/Left to another country/city|0
15763|NCT01723254|75248|P1|Overall Study|Move/Left to another country/city|0
15764|NCT01723254|75241|P8|Overall Study|No longer have time to participate|0
15765|NCT01723254|75242|P7|Overall Study|No longer have time to participate|0
15766|NCT01723254|75243|P6|Overall Study|No longer have time to participate|0
15767|NCT01723254|75244|P5|Overall Study|No longer have time to participate|0
15768|NCT01723254|75245|P4|Overall Study|No longer have time to participate|1
15769|NCT01723254|75246|P3|Overall Study|No longer have time to participate|0
15770|NCT01723254|75247|P2|Overall Study|No longer have time to participate|0
15771|NCT01723254|75248|P1|Overall Study|No longer have time to participate|0
15772|NCT01723254|75241|P8|Overall Study|Personal issues|0
15773|NCT01723254|75242|P7|Overall Study|Personal issues|0
15774|NCT01723254|75243|P6|Overall Study|Personal issues|1
15775|NCT01723254|75244|P5|Overall Study|Personal issues|0
15776|NCT01723254|75245|P4|Overall Study|Personal issues|0
15777|NCT01723254|75246|P3|Overall Study|Personal issues|0
15778|NCT01723254|75247|P2|Overall Study|Personal issues|0
15779|NCT01723254|75248|P1|Overall Study|Personal issues|0
15780|NCT01723254|75241|P8|Overall Study|Conflict with work schedule|1
15781|NCT01723254|75242|P7|Overall Study|Conflict with work schedule|0
15782|NCT01723254|75243|P6|Overall Study|Conflict with work schedule|0
15783|NCT01723254|75244|P5|Overall Study|Conflict with work schedule|0
15784|NCT01723254|75245|P4|Overall Study|Conflict with work schedule|0
15785|NCT01723254|75246|P3|Overall Study|Conflict with work schedule|0
15786|NCT01723254|75247|P2|Overall Study|Conflict with work schedule|0
15787|NCT01723254|75248|P1|Overall Study|Conflict with work schedule|0
15788|NCT01723228|75300|P2|Overall Study|Not Specified|1
15789|NCT01723228|75301|P1|Overall Study|Not Specified|2
15790|NCT01723228|75300|P2|Overall Study|Lost to Follow-up|1
15791|NCT01723228|75301|P1|Overall Study|Lost to Follow-up|2
15792|NCT01723228|75300|P2|Overall Study|Protocol Violation|2
15793|NCT01723228|75301|P1|Overall Study|Protocol Violation|0
15794|NCT01723228|75300|P2|Overall Study|Withdrawal by Subject|1
15795|NCT01723228|75301|P1|Overall Study|Withdrawal by Subject|2
15796|NCT01723228|75300|P2|Overall Study|Adverse Event|6
15797|NCT01723228|75301|P1|Overall Study|Adverse Event|2
15798|NCT01722994|75319|P2|Overall Study|Missing data|17
15799|NCT01722994|75320|P1|Overall Study|Missing data|25
15800|NCT01722266|75380|P4|Overall Study|Dropped out due to Nausea|0
15801|NCT01722266|75381|P3|Overall Study|Dropped out due to Nausea|2
15802|NCT01722266|75382|P2|Overall Study|Dropped out due to Nausea|0
15803|NCT01722266|75383|P1|Overall Study|Dropped out due to Nausea|0
15804|NCT01722266|75380|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
15805|NCT01722266|75381|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
15806|NCT01722266|75382|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
15807|NCT01722266|75383|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
15808|NCT01722266|75380|P4|Overall Study|Withdrawal by Subject|0
15809|NCT01722266|75381|P3|Overall Study|Withdrawal by Subject|0
15810|NCT01722266|75382|P2|Overall Study|Withdrawal by Subject|2
15811|NCT01722266|75383|P1|Overall Study|Withdrawal by Subject|1
15812|NCT01722162|75411|P2|Overall Study|Noncompliance|1
15813|NCT01722162|75412|P1|Overall Study|Noncompliance|0
15814|NCT01722162|75411|P2|Overall Study|Insurance denial post enrollment|1
15815|NCT01722162|75412|P1|Overall Study|Insurance denial post enrollment|0
15816|NCT01722162|75411|P2|Overall Study|Adverse Event|1
15817|NCT01722162|75412|P1|Overall Study|Adverse Event|1
15818|NCT01722162|75411|P2|Overall Study|Unrelated to study adverse event|2
15819|NCT01722162|75412|P1|Overall Study|Unrelated to study adverse event|2
15820|NCT01722162|75411|P2|Overall Study|Found ineligible|0
15821|NCT01722162|75412|P1|Overall Study|Found ineligible|1
15822|NCT01722162|75411|P2|Overall Study|Withdrawal by Subject|1
15823|NCT01722162|75412|P1|Overall Study|Withdrawal by Subject|1
15824|NCT01722097|75422|P2|Overall Study|Patient sheets not returned|5
15825|NCT01722097|75423|P1|Overall Study|Patient sheets not returned|6
15826|NCT01722071|75431|P2|Overall Study|Protocol Violation|0
15827|NCT01722071|75432|P1|Overall Study|Protocol Violation|1
15828|NCT01721772|75453|P2|Overall Study|Not specified|1
15829|NCT01721772|75454|P1|Overall Study|Not specified|0
15830|NCT01721772|75453|P2|Overall Study|Maximum clinical benefit|1
15831|NCT01721772|75454|P1|Overall Study|Maximum clinical benefit|1
15832|NCT01721772|75453|P2|Overall Study|Withdrawal by Subject|5
15833|NCT01721772|75454|P1|Overall Study|Withdrawal by Subject|7
15834|NCT01721772|75453|P2|Overall Study|Unrelated adverse event|3
15835|NCT01721772|75454|P1|Overall Study|Unrelated adverse event|2
15836|NCT01721772|75453|P2|Overall Study|Study drug toxicity|7
15837|NCT01721772|75454|P1|Overall Study|Study drug toxicity|5
15838|NCT01721772|75453|P2|Overall Study|Disease progression|175
15839|NCT01721772|75454|P1|Overall Study|Disease progression|96
15840|NCT01721759|75474|P1|Overall Study|Withdrawal by Subject|1
15841|NCT01721759|75474|P1|Overall Study|Adverse event unrelated to study drug|9
15842|NCT01721759|75474|P1|Overall Study|Study drug toxicity|14
15843|NCT01721759|75474|P1|Overall Study|Disease progression|78
15844|NCT01721330|75487|P2|Overall Study|Withdrawal by Subject|1
15845|NCT01721330|75488|P1|Overall Study|Withdrawal by Subject|0
15846|NCT01721317|75496|P2|Overall Study|Withdrawal by Subject|1
15847|NCT01721317|75497|P1|Overall Study|Withdrawal by Subject|0
15848|NCT01721317|75496|P2|Overall Study|Physician Decision|1
15849|NCT01721317|75497|P1|Overall Study|Physician Decision|0
15850|NCT01721317|75496|P2|Overall Study|Study Closed / Terminated|2
15851|NCT01721317|75497|P1|Overall Study|Study Closed / Terminated|2
15852|NCT01721161|75576|P2|Overall Study|Not Specified|1
15853|NCT01721161|75577|P1|Overall Study|Not Specified|0
15854|NCT01721161|75576|P2|Overall Study|Withdrawal by Subject|1
15855|NCT01721161|75577|P1|Overall Study|Withdrawal by Subject|1
15856|NCT01721161|75576|P2|Overall Study|Lost to Follow-up|2
15857|NCT01721161|75577|P1|Overall Study|Lost to Follow-up|1
15858|NCT01721161|75576|P2|Overall Study|Adverse Event|3
15859|NCT01721161|75577|P1|Overall Study|Adverse Event|2
15860|NCT01721070|75693|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
15861|NCT01720797|75703|P2|Overall Study|Withdrawal by Subject|0
15862|NCT01720797|75704|P1|Overall Study|Withdrawal by Subject|3
15863|NCT01720602|75710|P1|Overall Study|Progressive disease on therapy|2
15864|NCT01720602|75710|P1|Overall Study|Adverse Event|3
15865|NCT01719757|75729|P1|Overall Study|well controlled pain|27
15866|NCT01719757|75729|P1|Overall Study|Protocol Violation|1
15867|NCT01719757|75729|P1|Overall Study|Lost to Follow-up|20
15868|NCT01719757|75729|P1|Overall Study|Withdrawal by Subject|15
15869|NCT01719757|75729|P1|Overall Study|Adverse Event|38
15870|NCT01719172|75737|P1|Overall Study|Death|1
15871|NCT01719172|75737|P1|Overall Study|Lost to Follow-up|1
15872|NCT01719003|75751|P9|Overall Study|Lack of Efficacy|0
15873|NCT01719003|75752|P8|Overall Study|Lack of Efficacy|0
15874|NCT01719003|75753|P7|Overall Study|Lack of Efficacy|1
15875|NCT01719003|75754|P6|Overall Study|Lack of Efficacy|0
15876|NCT01719003|75755|P5|Overall Study|Lack of Efficacy|0
15877|NCT01719003|75756|P4|Overall Study|Lack of Efficacy|0
15878|NCT01719003|75757|P3|Overall Study|Lack of Efficacy|0
15879|NCT01719003|75758|P2|Overall Study|Lack of Efficacy|0
15880|NCT01719003|75759|P1|Overall Study|Lack of Efficacy|0
15881|NCT01719003|75751|P9|Overall Study|Reason other than those specified|1
15882|NCT01719003|75752|P8|Overall Study|Reason other than those specified|3
15883|NCT01719003|75753|P7|Overall Study|Reason other than those specified|0
15884|NCT01719003|75754|P6|Overall Study|Reason other than those specified|1
15885|NCT01719003|75755|P5|Overall Study|Reason other than those specified|4
15886|NCT01719003|75756|P4|Overall Study|Reason other than those specified|3
15887|NCT01719003|75757|P3|Overall Study|Reason other than those specified|2
15888|NCT01719003|75758|P2|Overall Study|Reason other than those specified|0
15889|NCT01719003|75759|P1|Overall Study|Reason other than those specified|0
15890|NCT01719003|75751|P9|Overall Study|Refusal to continue, not due to AE|1
15891|NCT01719003|75752|P8|Overall Study|Refusal to continue, not due to AE|7
15892|NCT01719003|75753|P7|Overall Study|Refusal to continue, not due to AE|8
15893|NCT01719003|75754|P6|Overall Study|Refusal to continue, not due to AE|3
15894|NCT01719003|75755|P5|Overall Study|Refusal to continue, not due to AE|4
15895|NCT01719003|75756|P4|Overall Study|Refusal to continue, not due to AE|4
15896|NCT01719003|75757|P3|Overall Study|Refusal to continue, not due to AE|4
15897|NCT01719003|75758|P2|Overall Study|Refusal to continue, not due to AE|5
15898|NCT01719003|75759|P1|Overall Study|Refusal to continue, not due to AE|2
15899|NCT01719003|75751|P9|Overall Study|Lost to Follow-up|2
15900|NCT01719003|75752|P8|Overall Study|Lost to Follow-up|2
15901|NCT01719003|75753|P7|Overall Study|Lost to Follow-up|3
15902|NCT01719003|75754|P6|Overall Study|Lost to Follow-up|4
15903|NCT01719003|75755|P5|Overall Study|Lost to Follow-up|3
15904|NCT01719003|75756|P4|Overall Study|Lost to Follow-up|2
15905|NCT01719003|75757|P3|Overall Study|Lost to Follow-up|7
15906|NCT01719003|75758|P2|Overall Study|Lost to Follow-up|6
15907|NCT01719003|75759|P1|Overall Study|Lost to Follow-up|0
15908|NCT01719003|75751|P9|Overall Study|Adverse Event|0
15909|NCT01719003|75752|P8|Overall Study|Adverse Event|5
15910|NCT01719003|75753|P7|Overall Study|Adverse Event|6
15911|NCT01719003|75754|P6|Overall Study|Adverse Event|3
15912|NCT01719003|75755|P5|Overall Study|Adverse Event|4
15913|NCT01719003|75756|P4|Overall Study|Adverse Event|3
15914|NCT01719003|75757|P3|Overall Study|Adverse Event|4
15915|NCT01719003|75758|P2|Overall Study|Adverse Event|5
15916|NCT01719003|75759|P1|Overall Study|Adverse Event|6
15917|NCT01719003|75751|P9|Overall Study|Non compliant with protocol|0
15918|NCT01719003|75752|P8|Overall Study|Non compliant with protocol|3
15919|NCT01719003|75753|P7|Overall Study|Non compliant with protocol|2
15920|NCT01719003|75754|P6|Overall Study|Non compliant with protocol|1
15921|NCT01719003|75755|P5|Overall Study|Non compliant with protocol|2
15922|NCT01719003|75756|P4|Overall Study|Non compliant with protocol|1
15923|NCT01719003|75757|P3|Overall Study|Non compliant with protocol|0
15924|NCT01719003|75758|P2|Overall Study|Non compliant with protocol|1
15925|NCT01719003|75759|P1|Overall Study|Non compliant with protocol|1
15926|NCT01718535|75840|P10|Overall Study|Bidirectional Sequencing not possible|0
15927|NCT01718535|75841|P9|Overall Study|Bidirectional Sequencing not possible|0
15928|NCT01718535|75842|P8|Overall Study|Bidirectional Sequencing not possible|0
15929|NCT01718535|75843|P7|Overall Study|Bidirectional Sequencing not possible|0
15930|NCT01718535|75844|P6|Overall Study|Bidirectional Sequencing not possible|0
15931|NCT01718535|75845|P5|Overall Study|Bidirectional Sequencing not possible|0
15932|NCT01718535|75846|P4|Overall Study|Bidirectional Sequencing not possible|1
15933|NCT01718535|75847|P3|Overall Study|Bidirectional Sequencing not possible|0
15934|NCT01718535|75848|P2|Overall Study|Bidirectional Sequencing not possible|0
15935|NCT01718535|75849|P1|Overall Study|Bidirectional Sequencing not possible|1
15936|NCT01718509|75873|P2|Overall Study|Lack of Efficacy|0
15937|NCT01718509|75874|P1|Overall Study|Lack of Efficacy|1
15938|NCT01718509|75873|P2|Overall Study|Protocol Violation|2
15939|NCT01718509|75874|P1|Overall Study|Protocol Violation|4
15940|NCT01718509|75873|P2|Overall Study|Not specified|11
15941|NCT01718509|75874|P1|Overall Study|Not specified|13
15942|NCT01718509|75873|P2|Overall Study|Adverse Event|7
15943|NCT01718509|75874|P1|Overall Study|Adverse Event|5
15944|NCT01718509|75873|P2|Overall Study|Withdrawal by Subject|13
15945|NCT01718509|75874|P1|Overall Study|Withdrawal by Subject|7
15946|NCT01718509|75873|P2|Overall Study|Lost to Follow-up|15
15947|NCT01718509|75874|P1|Overall Study|Lost to Follow-up|18
15948|NCT01718483|75920|P2|Overall Study|Lack of Efficacy|0
15949|NCT01718483|75921|P1|Overall Study|Lack of Efficacy|1
15950|NCT01718483|75920|P2|Overall Study|Pregnancy|1
15951|NCT01718483|75921|P1|Overall Study|Pregnancy|1
15952|NCT01718483|75920|P2|Overall Study|Not specified|4
15953|NCT01718483|75921|P1|Overall Study|Not specified|1
15954|NCT01718483|75920|P2|Overall Study|Protocol Violation|2
15955|NCT01718483|75921|P1|Overall Study|Protocol Violation|4
15956|NCT01718483|75920|P2|Overall Study|Lost to Follow-up|3
15957|NCT01718483|75921|P1|Overall Study|Lost to Follow-up|8
15958|NCT01718483|75920|P2|Overall Study|Adverse Event|12
15959|NCT01718483|75921|P1|Overall Study|Adverse Event|5
15960|NCT01718483|75920|P2|Overall Study|Withdrawal by Subject|12
15961|NCT01718483|75921|P1|Overall Study|Withdrawal by Subject|14
15962|NCT01717989|75980|P1|Overall Study|Other|40
15963|NCT01717989|75980|P1|Overall Study|Protocol-specified criteria|551
15964|NCT01717989|75980|P1|Overall Study|Death|439
15965|NCT01717989|75980|P1|Overall Study|Lost to Follow-up|11
15966|NCT01717989|75980|P1|Overall Study|Physician Decision|2
15967|NCT01717989|75980|P1|Overall Study|Withdrawal by Subject|11
15968|NCT01717989|75980|P1|Overall Study|Protocol deviation|6
15969|NCT01717989|75980|P1|Overall Study|Ineligibility determined|6
15970|NCT01717768|76069|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
15971|NCT01717768|76070|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
15972|NCT01717768|76071|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
15973|NCT01717768|76072|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
15974|NCT01717768|76073|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
15975|NCT01717768|76074|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
15976|NCT01717768|76075|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
15977|NCT01717768|76076|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
15978|NCT01717768|76077|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
15979|NCT01717768|76078|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
15980|NCT01717768|76079|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
15981|NCT01717768|76080|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
15982|NCT01717768|76069|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
15983|NCT01717768|76070|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
15984|NCT01717768|76071|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
15985|NCT01717768|76072|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
15986|NCT01717768|76073|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
15987|NCT01717768|76074|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
15988|NCT01717768|76075|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
15989|NCT01717768|76076|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
15990|NCT01717768|76077|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
15991|NCT01717768|76078|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
15992|NCT01717768|76079|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
15993|NCT01717768|76080|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
15994|NCT01717768|76069|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
15995|NCT01717768|76070|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
15996|NCT01717768|76071|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
15997|NCT01717768|76072|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
15998|NCT01717768|76073|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
15999|NCT01717768|76074|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
16000|NCT01717768|76075|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
16001|NCT01717768|76076|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
16002|NCT01717768|76077|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
16003|NCT01717768|76078|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
16004|NCT01717768|76079|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
16005|NCT01717768|76080|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
16006|NCT01717768|76069|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
16007|NCT01717768|76070|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
16008|NCT01717768|76071|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
16009|NCT01717768|76072|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
16010|NCT01717768|76073|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
16011|NCT01717768|76074|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
16012|NCT01717768|76075|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
16013|NCT01717768|76076|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
16014|NCT01717768|76077|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
16015|NCT01717768|76078|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
16016|NCT01717768|76079|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
16017|NCT01717768|76080|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
16018|NCT01717638|76131|P13|Overall Study|Withdrawal by Subject|18
16019|NCT01717638|76132|P12|Overall Study|Withdrawal by Subject|0
16020|NCT01717638|76133|P11|Overall Study|Withdrawal by Subject|0
16021|NCT01717638|76134|P10|Overall Study|Withdrawal by Subject|1
16022|NCT01717638|76135|P9|Overall Study|Withdrawal by Subject|2
16023|NCT01717638|76136|P8|Overall Study|Withdrawal by Subject|1
16024|NCT01717638|76137|P7|Overall Study|Withdrawal by Subject|2
16025|NCT01717638|76138|P6|Overall Study|Withdrawal by Subject|0
16026|NCT01717638|76139|P5|Overall Study|Withdrawal by Subject|1
16027|NCT01717638|76140|P4|Overall Study|Withdrawal by Subject|0
16028|NCT01717638|76141|P3|Overall Study|Withdrawal by Subject|1
16029|NCT01717638|76142|P2|Overall Study|Withdrawal by Subject|1
16030|NCT01717638|76143|P1|Overall Study|Withdrawal by Subject|0
16031|NCT01717638|76131|P13|Overall Study|Father in hospital|1
16032|NCT01717638|76132|P12|Overall Study|Father in hospital|0
16033|NCT01717638|76133|P11|Overall Study|Father in hospital|0
16034|NCT01717638|76134|P10|Overall Study|Father in hospital|0
16035|NCT01717638|76135|P9|Overall Study|Father in hospital|0
16036|NCT01717638|76136|P8|Overall Study|Father in hospital|0
16037|NCT01717638|76137|P7|Overall Study|Father in hospital|0
16038|NCT01717638|76138|P6|Overall Study|Father in hospital|0
16039|NCT01717638|76139|P5|Overall Study|Father in hospital|0
16040|NCT01717638|76140|P4|Overall Study|Father in hospital|0
16041|NCT01717638|76141|P3|Overall Study|Father in hospital|0
16042|NCT01717638|76142|P2|Overall Study|Father in hospital|0
16043|NCT01717638|76143|P1|Overall Study|Father in hospital|0
16044|NCT01717638|76131|P13|Overall Study|Lost to Follow-up|0
16045|NCT01717638|76132|P12|Overall Study|Lost to Follow-up|0
16046|NCT01717638|76133|P11|Overall Study|Lost to Follow-up|0
16047|NCT01717638|76134|P10|Overall Study|Lost to Follow-up|0
16048|NCT01717638|76135|P9|Overall Study|Lost to Follow-up|0
16049|NCT01717638|76136|P8|Overall Study|Lost to Follow-up|0
16050|NCT01717638|76137|P7|Overall Study|Lost to Follow-up|0
16051|NCT01717638|76138|P6|Overall Study|Lost to Follow-up|1
16052|NCT01717638|76139|P5|Overall Study|Lost to Follow-up|0
16053|NCT01717638|76140|P4|Overall Study|Lost to Follow-up|0
16054|NCT01717638|76141|P3|Overall Study|Lost to Follow-up|0
16055|NCT01717638|76142|P2|Overall Study|Lost to Follow-up|0
16056|NCT01717638|76143|P1|Overall Study|Lost to Follow-up|0
16057|NCT01717456|76287|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
16058|NCT01717456|76288|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
16059|NCT01717456|76287|P2|End of Treatment|Lost to Follow-up|1
16060|NCT01717456|76288|P1|End of Treatment|Lost to Follow-up|0
16061|NCT01717456|76287|P2|End of Treatment|Physician Decision|1
16062|NCT01717456|76288|P1|End of Treatment|Physician Decision|0
16063|NCT01717326|76376|P20|Overall Study|Withdrawal by Subject|3
16064|NCT01717326|76377|P19|Overall Study|Withdrawal by Subject|2
16065|NCT01717326|76378|P18|Overall Study|Withdrawal by Subject|0
16066|NCT01717326|76379|P17|Overall Study|Withdrawal by Subject|0
16067|NCT01717326|76380|P16|Overall Study|Withdrawal by Subject|1
16068|NCT01717326|76381|P15|Overall Study|Withdrawal by Subject|0
16069|NCT01717326|76382|P14|Overall Study|Withdrawal by Subject|0
16070|NCT01717326|76383|P13|Overall Study|Withdrawal by Subject|1
16071|NCT01717326|76384|P12|Overall Study|Withdrawal by Subject|0
16072|NCT01717326|76385|P11|Overall Study|Withdrawal by Subject|0
16073|NCT01717326|76386|P10|Overall Study|Withdrawal by Subject|1
16074|NCT01717326|76387|P9|Overall Study|Withdrawal by Subject|0
16075|NCT01717326|76388|P8|Overall Study|Withdrawal by Subject|0
16076|NCT01717326|76389|P7|Overall Study|Withdrawal by Subject|0
16077|NCT01717326|76390|P6|Overall Study|Withdrawal by Subject|0
16078|NCT01717326|76391|P5|Overall Study|Withdrawal by Subject|0
16079|NCT01717326|76392|P4|Overall Study|Withdrawal by Subject|0
16080|NCT01717326|76393|P3|Overall Study|Withdrawal by Subject|0
16081|NCT01717326|76394|P2|Overall Study|Withdrawal by Subject|1
16082|NCT01717326|76395|P1|Overall Study|Withdrawal by Subject|0
16083|NCT01717326|76376|P20|Overall Study|Protocol Violation|0
16084|NCT01717326|76377|P19|Overall Study|Protocol Violation|0
16085|NCT01717326|76378|P18|Overall Study|Protocol Violation|0
16086|NCT01717326|76379|P17|Overall Study|Protocol Violation|0
16087|NCT01717326|76380|P16|Overall Study|Protocol Violation|0
16088|NCT01717326|76381|P15|Overall Study|Protocol Violation|0
16089|NCT01717326|76382|P14|Overall Study|Protocol Violation|0
16090|NCT01717326|76383|P13|Overall Study|Protocol Violation|0
16091|NCT01717326|76384|P12|Overall Study|Protocol Violation|0
16092|NCT01717326|76385|P11|Overall Study|Protocol Violation|0
16093|NCT01717326|76386|P10|Overall Study|Protocol Violation|0
16094|NCT01717326|76387|P9|Overall Study|Protocol Violation|0
16095|NCT01717326|76388|P8|Overall Study|Protocol Violation|0
16096|NCT01717326|76389|P7|Overall Study|Protocol Violation|0
16097|NCT01717326|76390|P6|Overall Study|Protocol Violation|0
16098|NCT01717326|76391|P5|Overall Study|Protocol Violation|1
16099|NCT01717326|76392|P4|Overall Study|Protocol Violation|0
16100|NCT01717326|76393|P3|Overall Study|Protocol Violation|0
16101|NCT01717326|76394|P2|Overall Study|Protocol Violation|0
16102|NCT01717326|76395|P1|Overall Study|Protocol Violation|0
16103|NCT01717326|76376|P20|Overall Study|Physician Decision|0
16104|NCT01717326|76377|P19|Overall Study|Physician Decision|0
16105|NCT01717326|76378|P18|Overall Study|Physician Decision|0
16106|NCT01717326|76379|P17|Overall Study|Physician Decision|0
16107|NCT01717326|76380|P16|Overall Study|Physician Decision|0
16108|NCT01717326|76381|P15|Overall Study|Physician Decision|0
16109|NCT01717326|76382|P14|Overall Study|Physician Decision|0
16110|NCT01717326|76383|P13|Overall Study|Physician Decision|0
16111|NCT01717326|76384|P12|Overall Study|Physician Decision|0
16112|NCT01717326|76385|P11|Overall Study|Physician Decision|0
16113|NCT01717326|76386|P10|Overall Study|Physician Decision|1
16114|NCT01717326|76387|P9|Overall Study|Physician Decision|0
16115|NCT01717326|76388|P8|Overall Study|Physician Decision|0
16116|NCT01717326|76389|P7|Overall Study|Physician Decision|0
16117|NCT01717326|76390|P6|Overall Study|Physician Decision|0
16118|NCT01717326|76391|P5|Overall Study|Physician Decision|0
16119|NCT01717326|76392|P4|Overall Study|Physician Decision|0
16120|NCT01717326|76393|P3|Overall Study|Physician Decision|0
16121|NCT01717326|76394|P2|Overall Study|Physician Decision|0
16122|NCT01717326|76395|P1|Overall Study|Physician Decision|0
16123|NCT01717326|76376|P20|Overall Study|Lost to Follow-up|3
16124|NCT01717326|76377|P19|Overall Study|Lost to Follow-up|2
16125|NCT01717326|76378|P18|Overall Study|Lost to Follow-up|0
16126|NCT01717326|76379|P17|Overall Study|Lost to Follow-up|1
16127|NCT01717326|76380|P16|Overall Study|Lost to Follow-up|2
16128|NCT01717326|76381|P15|Overall Study|Lost to Follow-up|0
16129|NCT01717326|76382|P14|Overall Study|Lost to Follow-up|0
16130|NCT01717326|76383|P13|Overall Study|Lost to Follow-up|0
16131|NCT01717326|76384|P12|Overall Study|Lost to Follow-up|0
16132|NCT01717326|76385|P11|Overall Study|Lost to Follow-up|1
16133|NCT01717326|76386|P10|Overall Study|Lost to Follow-up|0
16134|NCT01717326|76387|P9|Overall Study|Lost to Follow-up|0
16135|NCT01717326|76388|P8|Overall Study|Lost to Follow-up|0
16136|NCT01717326|76389|P7|Overall Study|Lost to Follow-up|1
16137|NCT01717326|76390|P6|Overall Study|Lost to Follow-up|0
16138|NCT01717326|76391|P5|Overall Study|Lost to Follow-up|1
16139|NCT01717326|76392|P4|Overall Study|Lost to Follow-up|2
16140|NCT01717326|76393|P3|Overall Study|Lost to Follow-up|0
16141|NCT01717326|76394|P2|Overall Study|Lost to Follow-up|0
16142|NCT01717326|76395|P1|Overall Study|Lost to Follow-up|3
16143|NCT01717326|76376|P20|Overall Study|Death|0
16144|NCT01717326|76377|P19|Overall Study|Death|0
16145|NCT01717326|76378|P18|Overall Study|Death|0
16146|NCT01717326|76379|P17|Overall Study|Death|0
16147|NCT01717326|76380|P16|Overall Study|Death|0
16148|NCT01717326|76381|P15|Overall Study|Death|0
16149|NCT01717326|76382|P14|Overall Study|Death|0
16150|NCT01717326|76383|P13|Overall Study|Death|0
16151|NCT01717326|76384|P12|Overall Study|Death|0
16152|NCT01717326|76385|P11|Overall Study|Death|1
16153|NCT01717326|76386|P10|Overall Study|Death|0
16154|NCT01717326|76387|P9|Overall Study|Death|0
16155|NCT01717326|76388|P8|Overall Study|Death|0
16156|NCT01717326|76389|P7|Overall Study|Death|0
16157|NCT01717326|76390|P6|Overall Study|Death|0
16158|NCT01717326|76391|P5|Overall Study|Death|0
16159|NCT01717326|76392|P4|Overall Study|Death|0
16160|NCT01717326|76393|P3|Overall Study|Death|0
16161|NCT01717326|76394|P2|Overall Study|Death|0
16162|NCT01717326|76395|P1|Overall Study|Death|0
16163|NCT01717313|76659|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
16164|NCT01717313|76660|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
16165|NCT01717313|76659|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
16166|NCT01717313|76660|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
16167|NCT01717313|76659|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
16168|NCT01717313|76660|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
16169|NCT01717313|76659|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
16170|NCT01717313|76660|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
16171|NCT01717313|76659|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
16172|NCT01717313|76660|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
16173|NCT01717313|76659|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
16174|NCT01717313|76660|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
16175|NCT01717313|76659|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
16176|NCT01717313|76660|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
16177|NCT01717313|76659|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
16178|NCT01717313|76660|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
16179|NCT01717313|76659|P2|Phase A (Weeks 0 to 24)|Death|1
16180|NCT01717313|76660|P1|Phase A (Weeks 0 to 24)|Death|0
16181|NCT01717287|76698|P2|Overall Study|Protocol Violation|1
16182|NCT01717287|76699|P1|Overall Study|Protocol Violation|0
16183|NCT01717287|76698|P2|Overall Study|Lost to Follow-up|2
16184|NCT01717287|76699|P1|Overall Study|Lost to Follow-up|0
16185|NCT01717040|76723|P2|Overall Study|New Substance Use Disorder|0
16186|NCT01717040|76724|P1|Overall Study|New Substance Use Disorder|1
16187|NCT01717040|76723|P2|Overall Study|Required Medication Change|1
16188|NCT01717040|76724|P1|Overall Study|Required Medication Change|0
16189|NCT01717040|76723|P2|Overall Study|Adverse Event|0
16190|NCT01717040|76724|P1|Overall Study|Adverse Event|1
16191|NCT01717040|76723|P2|Overall Study|Lack of Efficacy|1
16192|NCT01717040|76724|P1|Overall Study|Lack of Efficacy|1
16193|NCT01717040|76723|P2|Overall Study|Lost to Follow-up|3
16194|NCT01717040|76724|P1|Overall Study|Lost to Follow-up|2
16195|NCT01716663|76738|P1|Overall Study|Treated with non-study catheter|2
16196|NCT01716663|76738|P1|Overall Study|Withdrawn prior to procedure|4
16197|NCT01716585|76748|P2|Open-label Treatment|Withdrawal by Subject|3
16198|NCT01716585|76749|P1|Open-label Treatment|Withdrawal by Subject|0
16199|NCT01716585|76748|P2|Open-label Treatment|Virologic Failure|2
16200|NCT01716585|76749|P1|Open-label Treatment|Virologic Failure|0
16201|NCT01716585|76748|P2|Open-label Treatment|Adverse Event|2
16202|NCT01716585|76749|P1|Open-label Treatment|Adverse Event|0
16203|NCT01716585|76748|P2|Double-blind Treatment|Not Specified|0
16204|NCT01716585|76749|P1|Double-blind Treatment|Not Specified|1
16205|NCT01716585|76748|P2|Double-blind Treatment|Subject Noncompliant|0
16206|NCT01716585|76749|P1|Double-blind Treatment|Subject Noncompliant|1
16207|NCT01716585|76748|P2|Double-blind Treatment|Lost to Follow-up|0
16208|NCT01716585|76749|P1|Double-blind Treatment|Lost to Follow-up|2
16209|NCT01716585|76748|P2|Double-blind Treatment|Withdrawal by Subject|0
16210|NCT01716585|76749|P1|Double-blind Treatment|Withdrawal by Subject|3
16211|NCT01716585|76748|P2|Double-blind Treatment|Adverse Event|1
16212|NCT01716585|76749|P1|Double-blind Treatment|Adverse Event|2
16213|NCT01716585|76748|P2|Double-blind Treatment|Did Not Receive Study Drug|1
16214|NCT01716585|76749|P1|Double-blind Treatment|Did Not Receive Study Drug|4
16215|NCT01716559|76761|P1|Overall Study|Other withdrawal reason|75
16216|NCT01716559|76761|P1|Overall Study|Withdrawal by Subject|4
16217|NCT01716559|76761|P1|Overall Study|Death|21
16218|NCT01716559|76761|P1|Overall Study|Adverse Event|11
16219|NCT01716520|76769|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
16220|NCT01716520|76770|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
16221|NCT01716520|76771|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
16222|NCT01716520|76772|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
16223|NCT01716520|76773|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
16224|NCT01716520|76774|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
16225|NCT01716520|76769|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
16226|NCT01716520|76770|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
16227|NCT01716520|76771|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
16228|NCT01716520|76772|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
16229|NCT01716520|76773|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
16230|NCT01716520|76774|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
16231|NCT01716520|76769|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
16232|NCT01716520|76770|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
16233|NCT01716520|76771|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
16234|NCT01716520|76772|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
16235|NCT01716520|76773|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
16236|NCT01716520|76774|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
16237|NCT01716520|76769|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
16238|NCT01716520|76770|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
16239|NCT01716520|76771|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
16240|NCT01716520|76772|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
16241|NCT01716520|76773|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
16242|NCT01716520|76774|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
16243|NCT01716520|76769|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
16244|NCT01716520|76770|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
16245|NCT01716520|76771|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
16246|NCT01716520|76772|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
16247|NCT01716520|76773|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
16248|NCT01716520|76774|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
16249|NCT01716520|76769|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
16250|NCT01716520|76770|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
16251|NCT01716520|76771|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
16252|NCT01716520|76772|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
16253|NCT01716520|76773|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
16254|NCT01716520|76774|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
16255|NCT01716520|76769|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
16256|NCT01716520|76770|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
16257|NCT01716520|76771|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
16258|NCT01716520|76772|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
16259|NCT01716520|76773|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
16260|NCT01716520|76774|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
16261|NCT01716520|76769|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
16262|NCT01716520|76770|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
16263|NCT01716520|76771|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
16264|NCT01716520|76772|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
16265|NCT01716520|76773|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
16266|NCT01716520|76774|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
16267|NCT01716520|76769|P6|Treatment Period 2 (14 Days)|Adverse Event|0
16268|NCT01716520|76770|P5|Treatment Period 2 (14 Days)|Adverse Event|1
16269|NCT01716520|76771|P4|Treatment Period 2 (14 Days)|Adverse Event|0
16270|NCT01716520|76772|P3|Treatment Period 2 (14 Days)|Adverse Event|0
16271|NCT01716520|76773|P2|Treatment Period 2 (14 Days)|Adverse Event|0
16272|NCT01716520|76774|P1|Treatment Period 2 (14 Days)|Adverse Event|0
16273|NCT01716520|76769|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
16274|NCT01716520|76770|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
16275|NCT01716520|76771|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
16276|NCT01716520|76772|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
16277|NCT01716520|76773|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
16278|NCT01716520|76774|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
16279|NCT01716520|76769|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
16280|NCT01716520|76770|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
16281|NCT01716520|76771|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
16282|NCT01716520|76772|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
16283|NCT01716520|76773|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
16284|NCT01716520|76774|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
16285|NCT01716520|76769|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
16286|NCT01716520|76770|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
16287|NCT01716520|76771|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
16288|NCT01716520|76772|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
16289|NCT01716520|76773|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
16290|NCT01716520|76774|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
16291|NCT01716520|76769|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
16292|NCT01716520|76770|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
16293|NCT01716520|76771|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
16294|NCT01716520|76772|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
16295|NCT01716520|76773|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
16296|NCT01716520|76774|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
16297|NCT01716520|76769|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
16298|NCT01716520|76770|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
16299|NCT01716520|76771|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
16300|NCT01716520|76772|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
16301|NCT01716520|76773|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
16302|NCT01716520|76774|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
16303|NCT01716520|76769|P6|Treatment Period 1 (14 Days)|Adverse Event|0
16304|NCT01716520|76770|P5|Treatment Period 1 (14 Days)|Adverse Event|0
16305|NCT01716520|76771|P4|Treatment Period 1 (14 Days)|Adverse Event|0
16306|NCT01716520|76772|P3|Treatment Period 1 (14 Days)|Adverse Event|0
16307|NCT01716520|76773|P2|Treatment Period 1 (14 Days)|Adverse Event|0
16308|NCT01716520|76774|P1|Treatment Period 1 (14 Days)|Adverse Event|1
16309|NCT01716234|76829|P7|Overall Study|Withdrawal by Subject|0
16310|NCT01716234|76830|P6|Overall Study|Withdrawal by Subject|3
16311|NCT01716234|76831|P5|Overall Study|Withdrawal by Subject|1
16312|NCT01716234|76832|P4|Overall Study|Withdrawal by Subject|2
16313|NCT01716234|76833|P3|Overall Study|Withdrawal by Subject|2
16314|NCT01716234|76834|P2|Overall Study|Withdrawal by Subject|0
16315|NCT01716234|76835|P1|Overall Study|Withdrawal by Subject|3
16316|NCT01716234|76829|P7|Overall Study|Adverse Event|0
16317|NCT01716234|76830|P6|Overall Study|Adverse Event|6
16318|NCT01716234|76831|P5|Overall Study|Adverse Event|3
16319|NCT01716234|76832|P4|Overall Study|Adverse Event|8
16320|NCT01716234|76833|P3|Overall Study|Adverse Event|2
16321|NCT01716234|76834|P2|Overall Study|Adverse Event|10
16322|NCT01716234|76835|P1|Overall Study|Adverse Event|7
16323|NCT01716234|76829|P7|Overall Study|Did not meet protocol eligibility|0
16324|NCT01716234|76830|P6|Overall Study|Did not meet protocol eligibility|4
16325|NCT01716234|76831|P5|Overall Study|Did not meet protocol eligibility|0
16326|NCT01716234|76832|P4|Overall Study|Did not meet protocol eligibility|0
16327|NCT01716234|76833|P3|Overall Study|Did not meet protocol eligibility|1
16328|NCT01716234|76834|P2|Overall Study|Did not meet protocol eligibility|0
16329|NCT01716234|76835|P1|Overall Study|Did not meet protocol eligibility|0
16330|NCT01716234|76829|P7|Overall Study|Lack of Efficacy|0
16331|NCT01716234|76830|P6|Overall Study|Lack of Efficacy|0
16332|NCT01716234|76831|P5|Overall Study|Lack of Efficacy|0
16333|NCT01716234|76832|P4|Overall Study|Lack of Efficacy|1
16334|NCT01716234|76833|P3|Overall Study|Lack of Efficacy|0
16335|NCT01716234|76834|P2|Overall Study|Lack of Efficacy|0
16336|NCT01716234|76835|P1|Overall Study|Lack of Efficacy|0
16337|NCT01716234|76829|P7|Overall Study|Protocol Violation|0
16338|NCT01716234|76830|P6|Overall Study|Protocol Violation|1
16339|NCT01716234|76831|P5|Overall Study|Protocol Violation|1
16340|NCT01716234|76832|P4|Overall Study|Protocol Violation|1
16341|NCT01716234|76833|P3|Overall Study|Protocol Violation|0
16342|NCT01716234|76834|P2|Overall Study|Protocol Violation|0
16343|NCT01716234|76835|P1|Overall Study|Protocol Violation|0
16344|NCT01716169|76898|P1|Overall Study|inconsistent dressing application|1
16345|NCT01716169|76898|P1|Overall Study|Withdrawal by Subject|1
16346|NCT01716169|76898|P1|Overall Study|Lost to Follow-up|1
16347|NCT01716169|76898|P1|Overall Study|Adverse Event|1
16348|NCT01716156|76907|P3|Overall Study|Lost to Follow-up|0
16349|NCT01716156|76908|P2|Overall Study|Lost to Follow-up|0
16350|NCT01716156|76909|P1|Overall Study|Lost to Follow-up|1
16351|NCT01716156|76907|P3|Overall Study|Withdrawal by Subject|2
16352|NCT01716156|76908|P2|Overall Study|Withdrawal by Subject|1
16353|NCT01716156|76909|P1|Overall Study|Withdrawal by Subject|0
16354|NCT01716156|76907|P3|Overall Study|Protocol Violation|0
16355|NCT01716156|76908|P2|Overall Study|Protocol Violation|0
16356|NCT01716156|76909|P1|Overall Study|Protocol Violation|1
16357|NCT01716052|76935|P2|Overall Study|Withdrawal of funding|1
16358|NCT01716052|76936|P1|Overall Study|Withdrawal of funding|1
16359|NCT01715896|76978|P2|Overall Study|Unspecified|5
16360|NCT01715896|76979|P1|Overall Study|Unspecified|2
16361|NCT01715896|76978|P2|Overall Study|Withdrawal by Subject|4
16362|NCT01715896|76979|P1|Overall Study|Withdrawal by Subject|1
16363|NCT01715896|76978|P2|Overall Study|Lost to Follow-up|2
16364|NCT01715896|76979|P1|Overall Study|Lost to Follow-up|0
16365|NCT01715857|77042|P1|Overall Study|Did Not Meet Eligibility Criteria|96
16366|NCT01715415|77054|P2|Open-label Treatment|Subject Noncompliant|1
16367|NCT01715415|77055|P1|Open-label Treatment|Subject Noncompliant|0
16368|NCT01715415|77054|P2|Open-label Treatment|Adverse Event|1
16369|NCT01715415|77055|P1|Open-label Treatment|Adverse Event|0
16370|NCT01715415|77054|P2|Double-blind Treatment|Not Specified|0
16371|NCT01715415|77055|P1|Double-blind Treatment|Not Specified|1
16372|NCT01715415|77054|P2|Double-blind Treatment|Withdrawal by Subject|1
16373|NCT01715415|77055|P1|Double-blind Treatment|Withdrawal by Subject|1
16374|NCT01715415|77054|P2|Double-blind Treatment|Adverse Event|0
16375|NCT01715415|77055|P1|Double-blind Treatment|Adverse Event|3
16376|NCT01715415|77054|P2|Double-blind Treatment|Did Not Receive Study Drug|1
16377|NCT01715415|77055|P1|Double-blind Treatment|Did Not Receive Study Drug|0
16378|NCT01715298|77069|P2|Overall Study|Patient/guardian decision|9
16379|NCT01715298|77070|P1|Overall Study|Patient/guardian decision|7
16380|NCT01715298|77069|P2|Overall Study|Lost to Follow-up|2
16381|NCT01715298|77070|P1|Overall Study|Lost to Follow-up|0
16382|NCT01715129|77106|P1|Overall Study|Unspecified|1
16383|NCT01715129|77106|P1|Overall Study|Lost to Follow-up|1
16384|NCT01715129|77106|P1|Overall Study|Consent Withdrawn|2
16385|NCT01715129|77106|P1|Overall Study|Protocol Violation|1
16386|NCT01715129|77106|P1|Overall Study|Lack of Efficacy|3
16387|NCT01715129|77106|P1|Overall Study|Adverse Event, fatal|1
16388|NCT01714635|77135|P3|Overall Study|Missed 6-month exam|0
16389|NCT01714635|77136|P2|Overall Study|Missed 6-month exam|0
16390|NCT01714635|77137|P1|Overall Study|Missed 6-month exam|1
16391|NCT01714635|77135|P3|Overall Study|Discontinued|2
16392|NCT01714635|77136|P2|Overall Study|Discontinued|0
16393|NCT01714635|77137|P1|Overall Study|Discontinued|1
16394|NCT01714609|77153|P2|Overall Study|Protocol Violation|0
16395|NCT01714609|77154|P1|Overall Study|Protocol Violation|1
16396|NCT01714544|77160|P1|Overall Study|Withdrawal by Subject|1
16397|NCT01714544|77160|P1|Overall Study|Physician Decision|1
16398|NCT01714544|77160|P1|Overall Study|Lost to Follow-up|1
16399|NCT01713998|77216|P3|Overall Study|Withdrawal by Subject|0
16400|NCT01713998|77217|P2|Overall Study|Withdrawal by Subject|0
16401|NCT01713998|77218|P1|Overall Study|Withdrawal by Subject|1
16402|NCT01713998|77216|P3|Overall Study|Lost to Follow-up|2
16403|NCT01713998|77217|P2|Overall Study|Lost to Follow-up|0
16404|NCT01713998|77218|P1|Overall Study|Lost to Follow-up|2
16405|NCT01713933|77236|P1|Overall Study|Excluded from analysis as a BMI outlier|1
16406|NCT01713933|77236|P1|Overall Study|Withdrawal by Subject|3
16407|NCT01713933|77236|P1|Overall Study|Lost to Follow-up|2
16408|NCT01713686|77248|P1|Overall Study|Withdrawal by Subject|6
16409|NCT01713686|77248|P1|Overall Study|Lost to Follow-up|9
16410|NCT01713530|77299|P2|Overall Study|Unclassified|2
16411|NCT01713530|77300|P1|Overall Study|Unclassified|4
16412|NCT01713530|77299|P2|Overall Study|Withdrawal criteria|12
16413|NCT01713530|77300|P1|Overall Study|Withdrawal criteria|21
16414|NCT01713530|77299|P2|Overall Study|Adverse Event|5
16415|NCT01713530|77300|P1|Overall Study|Adverse Event|0
16416|NCT01713348|77331|P4|Overall Study|Lost to Follow-up|0
16417|NCT01713348|77332|P3|Overall Study|Lost to Follow-up|0
16418|NCT01713348|77333|P2|Overall Study|Lost to Follow-up|0
16419|NCT01713348|77334|P1|Overall Study|Lost to Follow-up|1
16420|NCT01713348|77331|P4|Overall Study|Withdrawal by Subject|0
16421|NCT01713348|77332|P3|Overall Study|Withdrawal by Subject|2
16422|NCT01713348|77333|P2|Overall Study|Withdrawal by Subject|2
16423|NCT01713348|77334|P1|Overall Study|Withdrawal by Subject|3
16424|NCT01713283|77364|P2|Overall Study|Lost to Follow-up|1
16425|NCT01713283|77365|P1|Overall Study|Lost to Follow-up|1
16426|NCT01713283|77364|P2|Overall Study|Lack of Efficacy|2
16427|NCT01713283|77365|P1|Overall Study|Lack of Efficacy|10
16428|NCT01713036|77387|P1|Overall Study|Death|1
16429|NCT01712984|77427|P3|Overall Study|Withdrawal by Subject|7
16430|NCT01712984|77428|P2|Overall Study|Withdrawal by Subject|6
16431|NCT01712984|77429|P1|Overall Study|Withdrawal by Subject|6
16432|NCT01712984|77427|P3|Overall Study|Lost to Follow-up|1
16433|NCT01712984|77428|P2|Overall Study|Lost to Follow-up|10
16434|NCT01712984|77429|P1|Overall Study|Lost to Follow-up|8
16435|NCT01712984|77427|P3|Overall Study|Protocol Violation|1
16436|NCT01712984|77428|P2|Overall Study|Protocol Violation|0
16437|NCT01712984|77429|P1|Overall Study|Protocol Violation|2
16438|NCT01712984|77427|P3|Overall Study|Adverse Event|1
16439|NCT01712984|77428|P2|Overall Study|Adverse Event|0
16440|NCT01712984|77429|P1|Overall Study|Adverse Event|0
16441|NCT01712854|77449|P1|Overall Study|Physician Decision|1
16442|NCT01712685|77472|P1|Overall Study|pt declined to participate before trmt|1
16443|NCT01712516|77488|P4|Overall Study|Withdrawal by Subject|9
16444|NCT01712516|77489|P3|Overall Study|Withdrawal by Subject|3
16445|NCT01712516|77490|P2|Overall Study|Withdrawal by Subject|9
16446|NCT01712516|77491|P1|Overall Study|Withdrawal by Subject|3
16447|NCT01712516|77488|P4|Overall Study|Physician Decision|1
16448|NCT01712516|77489|P3|Overall Study|Physician Decision|0
16449|NCT01712516|77490|P2|Overall Study|Physician Decision|0
16450|NCT01712516|77491|P1|Overall Study|Physician Decision|2
16451|NCT01712516|77488|P4|Overall Study|Protocol deviation|0
16452|NCT01712516|77489|P3|Overall Study|Protocol deviation|1
16453|NCT01712516|77490|P2|Overall Study|Protocol deviation|0
16454|NCT01712516|77491|P1|Overall Study|Protocol deviation|1
16455|NCT01712516|77488|P4|Overall Study|Death|0
16456|NCT01712516|77489|P3|Overall Study|Death|0
16457|NCT01712516|77490|P2|Overall Study|Death|1
16458|NCT01712516|77491|P1|Overall Study|Death|0
16459|NCT01712516|77488|P4|Overall Study|Lost to Follow-up|1
16460|NCT01712516|77489|P3|Overall Study|Lost to Follow-up|2
16461|NCT01712516|77490|P2|Overall Study|Lost to Follow-up|0
16462|NCT01712516|77491|P1|Overall Study|Lost to Follow-up|0
16463|NCT01712516|77488|P4|Overall Study|Technical problems|2
16464|NCT01712516|77489|P3|Overall Study|Technical problems|0
16465|NCT01712516|77490|P2|Overall Study|Technical problems|0
16466|NCT01712516|77491|P1|Overall Study|Technical problems|0
16467|NCT01712334|77574|P2|Treatment Period 1|Randomized in Error|2
16468|NCT01712334|77575|P1|Treatment Period 1|Randomized in Error|0
16469|NCT01712204|77585|P2|Overall Study|Protocol Violation|1
16470|NCT01712204|77586|P1|Overall Study|Protocol Violation|1
16471|NCT01712204|77585|P2|Overall Study|Lost to Follow-up|0
16472|NCT01712204|77586|P1|Overall Study|Lost to Follow-up|1
16473|NCT01712204|77585|P2|Overall Study|Withdrawal by Subject|3
16474|NCT01712204|77586|P1|Overall Study|Withdrawal by Subject|3
16475|NCT01712204|77585|P2|Overall Study|Adverse Event|1
16476|NCT01712204|77586|P1|Overall Study|Adverse Event|3
16477|NCT01712178|77594|P2|Overall Study|Lost to Follow-up|1
16478|NCT01712178|77595|P1|Overall Study|Lost to Follow-up|0
16479|NCT01712178|77594|P2|Overall Study|Serious adverse event/withdrew consent|1
16480|NCT01712178|77595|P1|Overall Study|Serious adverse event/withdrew consent|0
16481|NCT01712178|77594|P2|Overall Study|Withdrew consent due to an adverse event|1
16482|NCT01712178|77595|P1|Overall Study|Withdrew consent due to an adverse event|1
16483|NCT01712061|77619|P3|Overall Study|Unspecified|0
16484|NCT01712061|77620|P2|Overall Study|Unspecified|3
16485|NCT01712061|77621|P1|Overall Study|Unspecified|0
16486|NCT01712061|77619|P3|Overall Study|Withdrawal by Subject|1
16487|NCT01712061|77620|P2|Overall Study|Withdrawal by Subject|7
16488|NCT01712061|77621|P1|Overall Study|Withdrawal by Subject|1
16489|NCT01712061|77619|P3|Overall Study|Medication Error Without Associated AE|0
16490|NCT01712061|77620|P2|Overall Study|Medication Error Without Associated AE|1
16491|NCT01712061|77621|P1|Overall Study|Medication Error Without Associated AE|0
16492|NCT01712061|77619|P3|Overall Study|Did Not Meet Entrance Criteria|3
16493|NCT01712061|77620|P2|Overall Study|Did Not Meet Entrance Criteria|6
16494|NCT01712061|77621|P1|Overall Study|Did Not Meet Entrance Criteria|4
16495|NCT01712061|77619|P3|Overall Study|Lost to Follow-up|1
16496|NCT01712061|77620|P2|Overall Study|Lost to Follow-up|0
16497|NCT01712061|77621|P1|Overall Study|Lost to Follow-up|1
16498|NCT01712061|77619|P3|Overall Study|Death|1
16499|NCT01712061|77620|P2|Overall Study|Death|0
16500|NCT01712061|77621|P1|Overall Study|Death|0
16501|NCT01712061|77619|P3|Overall Study|Adverse Event|5
16502|NCT01712061|77620|P2|Overall Study|Adverse Event|9
16503|NCT01712061|77621|P1|Overall Study|Adverse Event|4
16504|NCT01712009|77661|P3|Overall Study|Decision by Sponsor|12
16505|NCT01712009|77662|P2|Overall Study|Decision by Sponsor|14
16506|NCT01712009|77663|P1|Overall Study|Decision by Sponsor|12
16507|NCT01712009|77661|P3|Overall Study|Lost to Follow-up|1
16508|NCT01712009|77662|P2|Overall Study|Lost to Follow-up|0
16509|NCT01712009|77663|P1|Overall Study|Lost to Follow-up|2
16510|NCT01712009|77661|P3|Overall Study|Withdrawal by Subject|8
16511|NCT01712009|77662|P2|Overall Study|Withdrawal by Subject|15
16512|NCT01712009|77663|P1|Overall Study|Withdrawal by Subject|24
16513|NCT01711866|77697|P1|Overall Study|Adverse Event|2
16514|NCT01711866|77697|P1|Overall Study|Withdrawal by Subject|3
16515|NCT01711866|77697|P1|Overall Study|Noncompliant|3
16516|NCT01711853|77702|P1|Overall Study|Not treated|3
16517|NCT01711736|77709|P2|Overall Study|Migrated/moved from study area|1
16518|NCT01711736|77710|P1|Overall Study|Migrated/moved from study area|2
16519|NCT01711736|77709|P2|Overall Study|Withdrawal by Subject|6
16520|NCT01711736|77710|P1|Overall Study|Withdrawal by Subject|6
16521|NCT01711736|77709|P2|Overall Study|Lost to Follow-up|1
16522|NCT01711736|77710|P1|Overall Study|Lost to Follow-up|4
16523|NCT01711216|77745|P1|Overall Study|no reason specified|22
16524|NCT01711216|77745|P1|Overall Study|variety of other minor reasons|83
16525|NCT01711216|77745|P1|Overall Study|Lost to Follow-up|46
16526|NCT01711216|77745|P1|Overall Study|Withdrawal by Subject|6
16527|NCT01711216|77745|P1|Overall Study|Pregnancy|56
16528|NCT01711216|77745|P1|Overall Study|Adverse Event|4
16529|NCT01710800|77779|P1|Overall Study|Protocol Violation|1
16530|NCT01710800|77779|P1|Overall Study|Withdrawal by Subject|21
16531|NCT01710657|77788|P3|Overall Study|Lack of Efficacy|1
16532|NCT01710657|77789|P2|Overall Study|Lack of Efficacy|1
16533|NCT01710657|77790|P1|Overall Study|Lack of Efficacy|0
16534|NCT01710657|77788|P3|Overall Study|Withdrawal by Subject|2
16535|NCT01710657|77789|P2|Overall Study|Withdrawal by Subject|1
16536|NCT01710657|77790|P1|Overall Study|Withdrawal by Subject|0
16537|NCT01710657|77788|P3|Overall Study|Adverse Event|28
16538|NCT01710657|77789|P2|Overall Study|Adverse Event|8
16539|NCT01710657|77790|P1|Overall Study|Adverse Event|14
16540|NCT01710657|77788|P3|Overall Study|Protocol Violation|0
16541|NCT01710657|77789|P2|Overall Study|Protocol Violation|2
16542|NCT01710657|77790|P1|Overall Study|Protocol Violation|2
16543|NCT01710657|77788|P3|Overall Study|Lost to Follow-up|1
16544|NCT01710657|77789|P2|Overall Study|Lost to Follow-up|0
16545|NCT01710657|77790|P1|Overall Study|Lost to Follow-up|2
16546|NCT01710514|77809|P2|Overall Study|Withdrawal by Subject|0
16547|NCT01710514|77810|P1|Overall Study|Withdrawal by Subject|1
16548|NCT01710514|77809|P2|Overall Study|Adverse Event|7
16549|NCT01710514|77810|P1|Overall Study|Adverse Event|6
16550|NCT01710501|77831|P3|Overall Study|Lost to Follow-up|0
16551|NCT01710501|77832|P2|Overall Study|Lost to Follow-up|0
16552|NCT01710501|77833|P1|Overall Study|Lost to Follow-up|2
16553|NCT01710345|77865|P3|Overall Study|Drug Dosing Error|0
16554|NCT01710345|77866|P2|Overall Study|Drug Dosing Error|0
16555|NCT01710345|77867|P1|Overall Study|Drug Dosing Error|1
16556|NCT01710345|77865|P3|Overall Study|Lack of Efficacy|1
16557|NCT01710345|77866|P2|Overall Study|Lack of Efficacy|3
16558|NCT01710345|77867|P1|Overall Study|Lack of Efficacy|2
16559|NCT01710345|77865|P3|Overall Study|Adverse Event|0
16560|NCT01710345|77866|P2|Overall Study|Adverse Event|2
16561|NCT01710345|77867|P1|Overall Study|Adverse Event|0
16562|NCT01710046|77877|P2|Overall Study|Lost to Follow-up|0
16563|NCT01710046|77878|P1|Overall Study|Lost to Follow-up|1
16564|NCT01710033|77918|P5|Stage 2|Adverse Event|1
16565|NCT01710033|77919|P4|Stage 2|Adverse Event|0
16566|NCT01710033|77920|P3|Stage 2|Adverse Event|0
16567|NCT01710033|77921|P2|Stage 2|Adverse Event|0
16568|NCT01710033|77922|P1|Stage 2|Adverse Event|0
16569|NCT01710020|78003|P1|Period 1|Protocol Violation|1
16570|NCT01709903|78022|P2|Overall Study|Adverse Event|18
16571|NCT01709903|78023|P1|Overall Study|Adverse Event|11
16572|NCT01709903|78022|P2|Overall Study|Withdrawal by Subject|6
16573|NCT01709903|78023|P1|Overall Study|Withdrawal by Subject|6
16574|NCT01709903|78022|P2|Overall Study|Lack of Efficacy|3
16575|NCT01709903|78023|P1|Overall Study|Lack of Efficacy|3
16576|NCT01709903|78022|P2|Overall Study|Protocol Violation|2
16577|NCT01709903|78023|P1|Overall Study|Protocol Violation|3
16578|NCT01709903|78022|P2|Overall Study|Death|0
16579|NCT01709903|78023|P1|Overall Study|Death|2
16580|NCT01709903|78022|P2|Overall Study|Lost to Follow-up|2
16581|NCT01709903|78023|P1|Overall Study|Lost to Follow-up|0
16582|NCT01709903|78022|P2|Overall Study|no longer needed study drug|1
16583|NCT01709903|78023|P1|Overall Study|no longer needed study drug|0
16584|NCT01709903|78022|P2|Overall Study|In ability to use device|1
16585|NCT01709903|78023|P1|Overall Study|In ability to use device|1
16586|NCT01709903|78022|P2|Overall Study|Abnormal test procedure results|0
16587|NCT01709903|78023|P1|Overall Study|Abnormal test procedure results|1
16588|NCT01709903|78022|P2|Overall Study|administrative problems|6
16589|NCT01709903|78023|P1|Overall Study|administrative problems|2
16590|NCT01709864|78047|P2|Overall Study|Death|1
16591|NCT01709864|78048|P1|Overall Study|Death|0
16592|NCT01709864|78047|P2|Overall Study|Adverse Event|2
16593|NCT01709864|78048|P1|Overall Study|Adverse Event|0
16594|NCT01709864|78047|P2|Overall Study|non-compliance with study treatment|1
16595|NCT01709864|78048|P1|Overall Study|non-compliance with study treatment|1
16596|NCT01709864|78047|P2|Overall Study|Lost to Follow-up|0
16597|NCT01709864|78048|P1|Overall Study|Lost to Follow-up|1
16598|NCT01709864|78047|P2|Overall Study|subject/guardian decision|6
16599|NCT01709864|78048|P1|Overall Study|subject/guardian decision|5
16600|NCT01709864|78047|P2|Overall Study|Physician Decision|1
16601|NCT01709864|78048|P1|Overall Study|Physician Decision|0
16602|NCT01709708|78119|P2|Overall Study|Protocol Violation|2
16603|NCT01709708|78120|P1|Overall Study|Protocol Violation|1
16604|NCT01709513|78129|P3|Overall Study|Unspecified|7
16605|NCT01709513|78130|P2|Overall Study|Unspecified|11
16606|NCT01709513|78131|P1|Overall Study|Unspecified|3
16607|NCT01709513|78129|P3|Overall Study|Poor compliance to protocol|0
16608|NCT01709513|78130|P2|Overall Study|Poor compliance to protocol|0
16609|NCT01709513|78131|P1|Overall Study|Poor compliance to protocol|2
16610|NCT01709513|78129|P3|Overall Study|Adverse Event|23
16611|NCT01709513|78130|P2|Overall Study|Adverse Event|31
16612|NCT01709513|78131|P1|Overall Study|Adverse Event|16
16613|NCT01709513|78129|P3|Overall Study|Randomized but not treated|0
16614|NCT01709513|78130|P2|Overall Study|Randomized but not treated|1
16615|NCT01709513|78131|P1|Overall Study|Randomized but not treated|0
16616|NCT01709500|78192|P2|Overall Study|Treatment ongoing|78
16617|NCT01709500|78193|P1|Overall Study|Treatment ongoing|156
16618|NCT01709500|78192|P2|Overall Study|Related to IMP administration|0
16619|NCT01709500|78193|P1|Overall Study|Related to IMP administration|1
16620|NCT01709500|78192|P2|Overall Study|Unspecified|1
16621|NCT01709500|78193|P1|Overall Study|Unspecified|3
16622|NCT01709500|78192|P2|Overall Study|Poor compliance to protocol|1
16623|NCT01709500|78193|P1|Overall Study|Poor compliance to protocol|2
16624|NCT01709500|78192|P2|Overall Study|Adverse Event|1
16625|NCT01709500|78193|P1|Overall Study|Adverse Event|5
16626|NCT01709500|78192|P2|Overall Study|Randomized but not treated|1
16627|NCT01709500|78193|P1|Overall Study|Randomized but not treated|0
16628|NCT01709331|78269|P1|Overall Study|Adverse Event|1
16629|NCT01709305|78275|P5|Phase 2|Withdrawal by Subject|12
16630|NCT01709305|78276|P4|Phase 2|Withdrawal by Subject|15
16631|NCT01709305|78277|P3|Phase 2|Withdrawal by Subject|6
16632|NCT01709305|78278|P2|Phase 2|Withdrawal by Subject|8
16633|NCT01709305|78279|P1|Phase 2|Withdrawal by Subject|0
16634|NCT01709305|78275|P5|Phase 2|Protocol Violation|9
16635|NCT01709305|78276|P4|Phase 2|Protocol Violation|13
16636|NCT01709305|78277|P3|Phase 2|Protocol Violation|19
16637|NCT01709305|78278|P2|Phase 2|Protocol Violation|19
16638|NCT01709305|78279|P1|Phase 2|Protocol Violation|0
16639|NCT01709305|78275|P5|Phase 2|Physician Decision|2
16640|NCT01709305|78276|P4|Phase 2|Physician Decision|1
16641|NCT01709305|78277|P3|Phase 2|Physician Decision|0
16642|NCT01709305|78278|P2|Phase 2|Physician Decision|2
16643|NCT01709305|78279|P1|Phase 2|Physician Decision|0
16644|NCT01709305|78275|P5|Phase 2|Travel, moving, etc.|5
16645|NCT01709305|78276|P4|Phase 2|Travel, moving, etc.|3
16646|NCT01709305|78277|P3|Phase 2|Travel, moving, etc.|3
16647|NCT01709305|78278|P2|Phase 2|Travel, moving, etc.|2
16648|NCT01709305|78279|P1|Phase 2|Travel, moving, etc.|0
16649|NCT01709305|78275|P5|Phase 2|Lost to Follow-up|5
16650|NCT01709305|78276|P4|Phase 2|Lost to Follow-up|9
16651|NCT01709305|78277|P3|Phase 2|Lost to Follow-up|6
16652|NCT01709305|78278|P2|Phase 2|Lost to Follow-up|10
16653|NCT01709305|78279|P1|Phase 2|Lost to Follow-up|0
16654|NCT01709305|78275|P5|Phase 2|Laboratory Adverse Event|1
16655|NCT01709305|78276|P4|Phase 2|Laboratory Adverse Event|1
16656|NCT01709305|78277|P3|Phase 2|Laboratory Adverse Event|0
16657|NCT01709305|78278|P2|Phase 2|Laboratory Adverse Event|1
16658|NCT01709305|78279|P1|Phase 2|Laboratory Adverse Event|0
16659|NCT01709305|78275|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
16660|NCT01709305|78276|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
16661|NCT01709305|78277|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
16662|NCT01709305|78278|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
16663|NCT01709305|78279|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
16664|NCT01709305|78275|P5|Phase 2|Death|0
16665|NCT01709305|78276|P4|Phase 2|Death|0
16666|NCT01709305|78277|P3|Phase 2|Death|1
16667|NCT01709305|78278|P2|Phase 2|Death|0
16668|NCT01709305|78279|P1|Phase 2|Death|0
16669|NCT01709305|78275|P5|Phase 2|Clinical Adverse Event|11
16670|NCT01709305|78276|P4|Phase 2|Clinical Adverse Event|6
16671|NCT01709305|78277|P3|Phase 2|Clinical Adverse Event|10
16672|NCT01709305|78278|P2|Phase 2|Clinical Adverse Event|10
16673|NCT01709305|78279|P1|Phase 2|Clinical Adverse Event|0
16674|NCT01709305|78275|P5|Phase 1|Withdrawal by Subject|0
16675|NCT01709305|78276|P4|Phase 1|Withdrawal by Subject|0
16676|NCT01709305|78277|P3|Phase 1|Withdrawal by Subject|0
16677|NCT01709305|78278|P2|Phase 1|Withdrawal by Subject|0
16678|NCT01709305|78279|P1|Phase 1|Withdrawal by Subject|218
16679|NCT01709305|78275|P5|Phase 1|Protocol Violation|0
16680|NCT01709305|78276|P4|Phase 1|Protocol Violation|0
16681|NCT01709305|78277|P3|Phase 1|Protocol Violation|0
16682|NCT01709305|78278|P2|Phase 1|Protocol Violation|0
16683|NCT01709305|78279|P1|Phase 1|Protocol Violation|118
16684|NCT01709305|78275|P5|Phase 1|Physician Decision|0
16685|NCT01709305|78276|P4|Phase 1|Physician Decision|0
16686|NCT01709305|78277|P3|Phase 1|Physician Decision|0
16687|NCT01709305|78278|P2|Phase 1|Physician Decision|0
16688|NCT01709305|78279|P1|Phase 1|Physician Decision|13
16689|NCT01709305|78275|P5|Phase 1|Travel, moving, etc.|0
16690|NCT01709305|78276|P4|Phase 1|Travel, moving, etc.|0
16691|NCT01709305|78277|P3|Phase 1|Travel, moving, etc.|0
16692|NCT01709305|78278|P2|Phase 1|Travel, moving, etc.|0
16693|NCT01709305|78279|P1|Phase 1|Travel, moving, etc.|30
16694|NCT01709305|78275|P5|Phase 1|Lost to Follow-up|0
16695|NCT01709305|78276|P4|Phase 1|Lost to Follow-up|0
16696|NCT01709305|78277|P3|Phase 1|Lost to Follow-up|0
16697|NCT01709305|78278|P2|Phase 1|Lost to Follow-up|0
16698|NCT01709305|78279|P1|Phase 1|Lost to Follow-up|147
16699|NCT01709305|78275|P5|Phase 1|Laboratory Adverse Event|0
16700|NCT01709305|78276|P4|Phase 1|Laboratory Adverse Event|0
16701|NCT01709305|78277|P3|Phase 1|Laboratory Adverse Event|0
16702|NCT01709305|78278|P2|Phase 1|Laboratory Adverse Event|0
16703|NCT01709305|78279|P1|Phase 1|Laboratory Adverse Event|16
16704|NCT01709305|78275|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
16705|NCT01709305|78276|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
16706|NCT01709305|78277|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
16707|NCT01709305|78278|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
16708|NCT01709305|78279|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
16709|NCT01709305|78275|P5|Phase 1|Death|0
16710|NCT01709305|78276|P4|Phase 1|Death|0
16711|NCT01709305|78277|P3|Phase 1|Death|0
16712|NCT01709305|78278|P2|Phase 1|Death|0
16713|NCT01709305|78279|P1|Phase 1|Death|2
16714|NCT01709305|78275|P5|Phase 1|Clinical Adverse Event|0
16715|NCT01709305|78276|P4|Phase 1|Clinical Adverse Event|0
16716|NCT01709305|78277|P3|Phase 1|Clinical Adverse Event|0
16717|NCT01709305|78278|P2|Phase 1|Clinical Adverse Event|0
16718|NCT01709305|78279|P1|Phase 1|Clinical Adverse Event|80
16719|NCT01709162|78316|P2|Overall Study|Withdrawal by Subject|1
16720|NCT01709162|78317|P1|Overall Study|Withdrawal by Subject|0
16721|NCT01709162|78316|P2|Overall Study|Not specified|0
16722|NCT01709162|78317|P1|Overall Study|Not specified|1
16723|NCT01709162|78316|P2|Overall Study|Administrative reason by sponsor|1
16724|NCT01709162|78317|P1|Overall Study|Administrative reason by sponsor|0
16725|NCT01709162|78316|P2|Overall Study|Study drug toxicity|0
16726|NCT01709162|78317|P1|Overall Study|Study drug toxicity|2
16727|NCT01709162|78316|P2|Overall Study|Disease progression|3
16728|NCT01709162|78317|P1|Overall Study|Disease progression|3
16729|NCT01709084|78338|P2|Overall Study|Not Treated|2
16730|NCT01709084|78339|P1|Overall Study|Not Treated|0
16731|NCT01709084|78338|P2|Overall Study|Participant Reached a Virologic Endpoint|1
16732|NCT01709084|78339|P1|Overall Study|Participant Reached a Virologic Endpoint|0
16733|NCT01709084|78338|P2|Overall Study|unspecified|3
16734|NCT01709084|78339|P1|Overall Study|unspecified|5
16735|NCT01709084|78338|P2|Overall Study|Adverse Event|0
16736|NCT01709084|78339|P1|Overall Study|Adverse Event|5
16737|NCT01709084|78338|P2|Overall Study|Withdrawal by Subject|2
16738|NCT01709084|78339|P1|Overall Study|Withdrawal by Subject|2
16739|NCT01709084|78338|P2|Overall Study|Lost to Follow-up|7
16740|NCT01709084|78339|P1|Overall Study|Lost to Follow-up|4
16741|NCT01708954|78367|P3|Step 2|Withdrawal by Subject|0
16742|NCT01708954|78368|P2|Step 2|Withdrawal by Subject|1
16743|NCT01708954|78369|P1|Step 2|Withdrawal by Subject|1
16744|NCT01708954|78367|P3|Step 2|Adverse Event|0
16745|NCT01708954|78368|P2|Step 2|Adverse Event|2
16746|NCT01708954|78369|P1|Step 2|Adverse Event|3
16747|NCT01708954|78367|P3|Step 2|Disease progression|0
16748|NCT01708954|78368|P2|Step 2|Disease progression|4
16749|NCT01708954|78369|P1|Step 2|Disease progression|9
16750|NCT01708954|78367|P3|Step 1|Ineligible or never received treatment|8
16751|NCT01708954|78368|P2|Step 1|Ineligible or never received treatment|2
16752|NCT01708954|78369|P1|Step 1|Ineligible or never received treatment|4
16753|NCT01708954|78367|P3|Step 1|Off-treatment reason not submitted|1
16754|NCT01708954|78368|P2|Step 1|Off-treatment reason not submitted|1
16755|NCT01708954|78369|P1|Step 1|Off-treatment reason not submitted|1
16756|NCT01708954|78367|P3|Step 1|Symptomatic deterioration|1
16757|NCT01708954|78368|P2|Step 1|Symptomatic deterioration|0
16758|NCT01708954|78369|P1|Step 1|Symptomatic deterioration|1
16759|NCT01708954|78367|P3|Step 1|Crossed over to Step 2|0
16760|NCT01708954|78368|P2|Step 1|Crossed over to Step 2|0
16761|NCT01708954|78369|P1|Step 1|Crossed over to Step 2|2
16762|NCT01708954|78367|P3|Step 1|Other complicating disease|0
16763|NCT01708954|78368|P2|Step 1|Other complicating disease|2
16764|NCT01708954|78369|P1|Step 1|Other complicating disease|0
16765|NCT01708954|78367|P3|Step 1|Withdrawal by Subject|3
16766|NCT01708954|78368|P2|Step 1|Withdrawal by Subject|5
16767|NCT01708954|78369|P1|Step 1|Withdrawal by Subject|2
16771|NCT01708954|78367|P3|Step 1|Adverse Event|13
16772|NCT01708954|78368|P2|Step 1|Adverse Event|11
16773|NCT01708954|78369|P1|Step 1|Adverse Event|3
16774|NCT01708954|78367|P3|Step 1|Disease progression|14
16775|NCT01708954|78368|P2|Step 1|Disease progression|17
16776|NCT01708954|78369|P1|Step 1|Disease progression|26
16777|NCT01708915|78394|P4|Overall Study|Other reasons than stated above|2
16778|NCT01708915|78395|P3|Overall Study|Other reasons than stated above|0
16779|NCT01708915|78396|P2|Overall Study|Other reasons than stated above|1
16780|NCT01708915|78397|P1|Overall Study|Other reasons than stated above|1
16781|NCT01708915|78394|P4|Overall Study|Withdrawal by Subject|2
16782|NCT01708915|78395|P3|Overall Study|Withdrawal by Subject|2
16783|NCT01708915|78396|P2|Overall Study|Withdrawal by Subject|1
16784|NCT01708915|78397|P1|Overall Study|Withdrawal by Subject|0
16785|NCT01708915|78394|P4|Overall Study|Protocol Violation|1
16786|NCT01708915|78395|P3|Overall Study|Protocol Violation|0
16787|NCT01708915|78396|P2|Overall Study|Protocol Violation|0
16788|NCT01708915|78397|P1|Overall Study|Protocol Violation|0
16789|NCT01708915|78394|P4|Overall Study|Lack of Efficacy|15
16790|NCT01708915|78395|P3|Overall Study|Lack of Efficacy|35
16791|NCT01708915|78396|P2|Overall Study|Lack of Efficacy|60
16792|NCT01708915|78397|P1|Overall Study|Lack of Efficacy|84
16793|NCT01708915|78394|P4|Overall Study|Adverse Event|13
16794|NCT01708915|78395|P3|Overall Study|Adverse Event|9
16795|NCT01708915|78396|P2|Overall Study|Adverse Event|0
16796|NCT01708915|78397|P1|Overall Study|Adverse Event|1
16797|NCT01708902|78426|P7|Overall Study|Other Reason|0
16798|NCT01708902|78427|P6|Overall Study|Other Reason|2
16799|NCT01708902|78428|P5|Overall Study|Other Reason|1
16800|NCT01708902|78429|P4|Overall Study|Other Reason|1
16801|NCT01708902|78430|P3|Overall Study|Other Reason|1
16802|NCT01708902|78431|P2|Overall Study|Other Reason|0
16803|NCT01708902|78432|P1|Overall Study|Other Reason|1
16804|NCT01708902|78426|P7|Overall Study|Refused to continue trial medication|1
16805|NCT01708902|78427|P6|Overall Study|Refused to continue trial medication|1
16806|NCT01708902|78428|P5|Overall Study|Refused to continue trial medication|8
16807|NCT01708902|78429|P4|Overall Study|Refused to continue trial medication|2
16808|NCT01708902|78430|P3|Overall Study|Refused to continue trial medication|4
16809|NCT01708902|78431|P2|Overall Study|Refused to continue trial medication|0
16810|NCT01708902|78432|P1|Overall Study|Refused to continue trial medication|8
16811|NCT01708902|78426|P7|Overall Study|Lost to Follow-up|1
16812|NCT01708902|78427|P6|Overall Study|Lost to Follow-up|0
16813|NCT01708902|78428|P5|Overall Study|Lost to Follow-up|0
16814|NCT01708902|78429|P4|Overall Study|Lost to Follow-up|2
16815|NCT01708902|78430|P3|Overall Study|Lost to Follow-up|2
16816|NCT01708902|78431|P2|Overall Study|Lost to Follow-up|1
16817|NCT01708902|78432|P1|Overall Study|Lost to Follow-up|2
16818|NCT01708902|78426|P7|Overall Study|Non compliance with protocol|0
16819|NCT01708902|78427|P6|Overall Study|Non compliance with protocol|0
16820|NCT01708902|78428|P5|Overall Study|Non compliance with protocol|0
16821|NCT01708902|78429|P4|Overall Study|Non compliance with protocol|3
16822|NCT01708902|78430|P3|Overall Study|Non compliance with protocol|1
16823|NCT01708902|78431|P2|Overall Study|Non compliance with protocol|2
16824|NCT01708902|78432|P1|Overall Study|Non compliance with protocol|0
16825|NCT01708902|78426|P7|Overall Study|Lack of Efficacy|0
16826|NCT01708902|78427|P6|Overall Study|Lack of Efficacy|1
16827|NCT01708902|78428|P5|Overall Study|Lack of Efficacy|0
16828|NCT01708902|78429|P4|Overall Study|Lack of Efficacy|0
16829|NCT01708902|78430|P3|Overall Study|Lack of Efficacy|0
16830|NCT01708902|78431|P2|Overall Study|Lack of Efficacy|1
16831|NCT01708902|78432|P1|Overall Study|Lack of Efficacy|3
16832|NCT01708902|78426|P7|Overall Study|Adverse Event|5
16833|NCT01708902|78427|P6|Overall Study|Adverse Event|3
16834|NCT01708902|78428|P5|Overall Study|Adverse Event|7
16835|NCT01708902|78429|P4|Overall Study|Adverse Event|2
16836|NCT01708902|78430|P3|Overall Study|Adverse Event|9
16837|NCT01708902|78431|P2|Overall Study|Adverse Event|4
16838|NCT01708902|78432|P1|Overall Study|Adverse Event|3
16839|NCT01708291|78505|P2|Overall Study|fighting|1
16840|NCT01708291|78506|P1|Overall Study|fighting|2
16841|NCT01708187|78545|P2|Overall Study|Lost to Follow-up|1
16842|NCT01708187|78546|P1|Overall Study|Lost to Follow-up|0
16843|NCT01708057|78563|P3|Overall Study|Withdrawal due to study termination.|1
16844|NCT01708057|78564|P2|Overall Study|Withdrawal due to study termination.|1
16845|NCT01708057|78565|P1|Overall Study|Withdrawal due to study termination.|1
16846|NCT01707667|78623|P2|Period 1|expulsion of colonic sensor catheter|0
16847|NCT01707667|78624|P1|Period 1|expulsion of colonic sensor catheter|1
16848|NCT01706926|78685|P4|Overall Study|Unspecified|3
16849|NCT01706926|78686|P3|Overall Study|Unspecified|4
16850|NCT01706926|78687|P2|Overall Study|Unspecified|4
16851|NCT01706926|78688|P1|Overall Study|Unspecified|4
16852|NCT01706926|78685|P4|Overall Study|Withdrawal by Subject|2
16853|NCT01706926|78686|P3|Overall Study|Withdrawal by Subject|1
16854|NCT01706926|78687|P2|Overall Study|Withdrawal by Subject|0
16855|NCT01706926|78688|P1|Overall Study|Withdrawal by Subject|2
16856|NCT01706926|78685|P4|Overall Study|Lost to Follow-up|0
16857|NCT01706926|78686|P3|Overall Study|Lost to Follow-up|1
16858|NCT01706926|78687|P2|Overall Study|Lost to Follow-up|0
16859|NCT01706926|78688|P1|Overall Study|Lost to Follow-up|0
16860|NCT01706770|78807|P2|Overall Study|Physician Decision|0
16861|NCT01706770|78808|P1|Overall Study|Physician Decision|1
16862|NCT01706770|78807|P2|Overall Study|Lost to Follow-up|0
16863|NCT01706770|78808|P1|Overall Study|Lost to Follow-up|1
16864|NCT01706575|78856|P1|Overall Study|Started but not Treated|6
16865|NCT01706575|78856|P1|Overall Study|Reason not Specified|2
16866|NCT01706575|78856|P1|Overall Study|Lack of Compliance|1
16867|NCT01706575|78856|P1|Overall Study|Participant Withdrew Consent|2
16868|NCT01706575|78856|P1|Overall Study|Adverse Event|8
16869|NCT01706575|78856|P1|Overall Study|No HBsAg Decrease at Week 24|11
16870|NCT01706328|78869|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
16871|NCT01706328|78870|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
16872|NCT01706328|78871|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
16873|NCT01706328|78869|P3|12-week Double-blind Treatment Period|Physician Decision|2
16874|NCT01706328|78870|P2|12-week Double-blind Treatment Period|Physician Decision|2
16875|NCT01706328|78871|P1|12-week Double-blind Treatment Period|Physician Decision|0
16876|NCT01706328|78869|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
16877|NCT01706328|78870|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
16878|NCT01706328|78871|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
16879|NCT01706328|78869|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
16880|NCT01706328|78870|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
16881|NCT01706328|78871|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
16882|NCT01706328|78869|P3|12-week Double-blind Treatment Period|Protocol Violation|2
16883|NCT01706328|78870|P2|12-week Double-blind Treatment Period|Protocol Violation|4
16884|NCT01706328|78871|P1|12-week Double-blind Treatment Period|Protocol Violation|0
16885|NCT01706328|78869|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
16886|NCT01706328|78870|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
16887|NCT01706328|78871|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
16888|NCT01706328|78869|P3|12-week Double-blind Treatment Period|Adverse Event|16
16889|NCT01706328|78870|P2|12-week Double-blind Treatment Period|Adverse Event|14
16890|NCT01706328|78871|P1|12-week Double-blind Treatment Period|Adverse Event|0
16891|NCT01706328|78869|P3|2-week Run-in Period|Lost to Follow-up|0
16892|NCT01706328|78870|P2|2-week Run-in Period|Lost to Follow-up|0
16893|NCT01706328|78871|P1|2-week Run-in Period|Lost to Follow-up|2
16894|NCT01706328|78869|P3|2-week Run-in Period|Adverse Event|0
16895|NCT01706328|78870|P2|2-week Run-in Period|Adverse Event|0
16896|NCT01706328|78871|P1|2-week Run-in Period|Adverse Event|4
16897|NCT01706328|78869|P3|2-week Run-in Period|Physician Decision|0
16898|NCT01706328|78870|P2|2-week Run-in Period|Physician Decision|0
16899|NCT01706328|78871|P1|2-week Run-in Period|Physician Decision|4
16900|NCT01706328|78869|P3|2-week Run-in Period|Withdrawal by Subject|0
16901|NCT01706328|78870|P2|2-week Run-in Period|Withdrawal by Subject|0
16902|NCT01706328|78871|P1|2-week Run-in Period|Withdrawal by Subject|15
16903|NCT01706328|78869|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
16904|NCT01706328|78870|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
16905|NCT01706328|78871|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
16906|NCT01706159|78883|P2|Overall Study|Unclassified|1
16907|NCT01706159|78884|P1|Overall Study|Unclassified|6
16908|NCT01706159|78883|P2|Overall Study|Withdrawal Criteria|1
16909|NCT01706159|78884|P1|Overall Study|Withdrawal Criteria|2
16910|NCT01706146|78898|P1|Overall Study|Developed AF and need for antiplatelets|2
16911|NCT01706146|78898|P1|Overall Study|Adverse Event|3
16912|NCT01706146|78898|P1|Overall Study|Withdrawal by Subject|1
16913|NCT01705717|78905|P2|Overall Study|Not Specified|2
16914|NCT01705717|78906|P1|Overall Study|Not Specified|0
16915|NCT01705717|78905|P2|Overall Study|Lack of Efficacy|1
16916|NCT01705717|78906|P1|Overall Study|Lack of Efficacy|0
16917|NCT01705717|78905|P2|Overall Study|Adverse Event|2
16918|NCT01705717|78906|P1|Overall Study|Adverse Event|2
16919|NCT01705652|78923|P2|Overall Study|non-compliance|1
16920|NCT01705652|78924|P1|Overall Study|non-compliance|1
16921|NCT01705652|78923|P2|Overall Study|Withdrawal by Subject|2
16922|NCT01705652|78924|P1|Overall Study|Withdrawal by Subject|1
16923|NCT01705652|78923|P2|Overall Study|Adverse Event|0
16924|NCT01705652|78924|P1|Overall Study|Adverse Event|1
16925|NCT01705574|78932|P2|Overall Study|Still on Study|125
16926|NCT01705574|78933|P1|Overall Study|Still on Study|135
16927|NCT01705574|78932|P2|Overall Study|Lost to Follow-up|15
16928|NCT01705574|78933|P1|Overall Study|Lost to Follow-up|11
16929|NCT01705574|78932|P2|Overall Study|Withdrew Consent|5
16930|NCT01705574|78933|P1|Overall Study|Withdrew Consent|8
16931|NCT01705574|78932|P2|Overall Study|Protocol Violation|0
16932|NCT01705574|78933|P1|Overall Study|Protocol Violation|1
16933|NCT01705574|78932|P2|Overall Study|Non-Compliance with Study Drug|4
16934|NCT01705574|78933|P1|Overall Study|Non-Compliance with Study Drug|4
16935|NCT01705574|78932|P2|Overall Study|Pregnancy|1
16936|NCT01705574|78933|P1|Overall Study|Pregnancy|1
16937|NCT01705574|78932|P2|Overall Study|Adverse Event|9
16938|NCT01705574|78933|P1|Overall Study|Adverse Event|3
16939|NCT01705574|78932|P2|Overall Study|Randomized but Not Treated|4
16940|NCT01705574|78933|P1|Overall Study|Randomized but Not Treated|4
16941|NCT01705145|78951|P1|Part B|Adverse Event|1
16942|NCT01704846|78998|P2|Treatment Period 2|Withdrawal by Subject|1
16943|NCT01704846|78999|P1|Treatment Period 2|Withdrawal by Subject|0
16944|NCT01704755|79019|P2|Overall Study|Withdrew consent and personal issues|0
16945|NCT01704755|79020|P1|Overall Study|Withdrew consent and personal issues|1
16946|NCT01704755|79019|P2|Overall Study|Other (not specified)|1
16947|NCT01704755|79020|P1|Overall Study|Other (not specified)|3
16948|NCT01704755|79019|P2|Overall Study|Withdrew consent|1
16949|NCT01704755|79020|P1|Overall Study|Withdrew consent|1
16950|NCT01704755|79019|P2|Overall Study|Lost to Follow-up|4
16951|NCT01704755|79020|P1|Overall Study|Lost to Follow-up|3
16952|NCT01704755|79019|P2|Overall Study|Adverse Event|1
16953|NCT01704755|79020|P1|Overall Study|Adverse Event|4
16954|NCT01704651|79034|P2|Overall Study|Post-op did not have laparotomy|1
16955|NCT01704651|79035|P1|Overall Study|Post-op did not have laparotomy|2
16956|NCT01704651|79034|P2|Overall Study|Nasogastric tube placement in surgery|1
16957|NCT01704651|79035|P1|Overall Study|Nasogastric tube placement in surgery|1
16958|NCT01704651|79034|P2|Overall Study|Pre-op change in treatment plan|4
16959|NCT01704651|79035|P1|Overall Study|Pre-op change in treatment plan|1
16960|NCT01704651|79034|P2|Overall Study|Pre-op withdrawal by subject|1
16961|NCT01704651|79035|P1|Overall Study|Pre-op withdrawal by subject|1
16962|NCT01704599|79043|P1|Overall Study|Adverse Event|1
16963|NCT01704495|79083|P4|Optional Safety Extension|Withdrawal by Subject|2
16964|NCT01704495|79084|P3|Optional Safety Extension|Withdrawal by Subject|1
16965|NCT01704495|79085|P2|Optional Safety Extension|Withdrawal by Subject|0
16966|NCT01704495|79086|P1|Optional Safety Extension|Withdrawal by Subject|2
16967|NCT01704495|79083|P4|Optional Safety Extension|Other reason|28
16968|NCT01704495|79084|P3|Optional Safety Extension|Other reason|30
16969|NCT01704495|79085|P2|Optional Safety Extension|Other reason|29
16970|NCT01704495|79086|P1|Optional Safety Extension|Other reason|27
16971|NCT01704495|79083|P4|Optional Safety Extension|Adverse Event|1
16972|NCT01704495|79084|P3|Optional Safety Extension|Adverse Event|0
16973|NCT01704495|79085|P2|Optional Safety Extension|Adverse Event|4
16974|NCT01704495|79086|P1|Optional Safety Extension|Adverse Event|0
16975|NCT01704495|79083|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
16976|NCT01704495|79084|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
16977|NCT01704495|79085|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
16978|NCT01704495|79086|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
16979|NCT01704495|79083|P4|Subjects Randomized|Protocol Violation|0
16980|NCT01704495|79084|P3|Subjects Randomized|Protocol Violation|2
16981|NCT01704495|79085|P2|Subjects Randomized|Protocol Violation|1
16982|NCT01704495|79086|P1|Subjects Randomized|Protocol Violation|1
16983|NCT01704495|79083|P4|Subjects Randomized|Withdrawal by Subject|5
16984|NCT01704495|79084|P3|Subjects Randomized|Withdrawal by Subject|5
16985|NCT01704495|79085|P2|Subjects Randomized|Withdrawal by Subject|5
16986|NCT01704495|79086|P1|Subjects Randomized|Withdrawal by Subject|5
16987|NCT01704495|79083|P4|Subjects Randomized|Adverse Event|7
16988|NCT01704495|79084|P3|Subjects Randomized|Adverse Event|0
16989|NCT01704495|79085|P2|Subjects Randomized|Adverse Event|2
16990|NCT01704495|79086|P1|Subjects Randomized|Adverse Event|8
16991|NCT01704495|79083|P4|Subjects Randomized|Discontinuation criteria met|0
16992|NCT01704495|79084|P3|Subjects Randomized|Discontinuation criteria met|2
16993|NCT01704495|79085|P2|Subjects Randomized|Discontinuation criteria met|2
16994|NCT01704495|79086|P1|Subjects Randomized|Discontinuation criteria met|4
16995|NCT01704495|79083|P4|Subjects Randomized|Other Reason|2
16996|NCT01704495|79084|P3|Subjects Randomized|Other Reason|3
16997|NCT01704495|79085|P2|Subjects Randomized|Other Reason|2
16998|NCT01704495|79086|P1|Subjects Randomized|Other Reason|3
16999|NCT01704261|79262|P2|Overall Study|Lost to Follow-up|0
17000|NCT01704261|79263|P1|Overall Study|Lost to Follow-up|1
17001|NCT01704261|79262|P2|Overall Study|Withdrawal by Subject|15
17002|NCT01704261|79263|P1|Overall Study|Withdrawal by Subject|12
17003|NCT01704079|79279|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
17004|NCT01704079|79280|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
17005|NCT01704079|79279|P2|Overall Study|Subject noncompliance|3
17006|NCT01704079|79280|P1|Overall Study|Subject noncompliance|2
17007|NCT01704079|79279|P2|Overall Study|Protocol Violation|0
17008|NCT01704079|79280|P1|Overall Study|Protocol Violation|1
17009|NCT01704079|79279|P2|Overall Study|Adverse Event|7
17010|NCT01704079|79280|P1|Overall Study|Adverse Event|4
17011|NCT01704079|79279|P2|Overall Study|Lost to Follow-up|5
17012|NCT01704079|79280|P1|Overall Study|Lost to Follow-up|2
17013|NCT01704079|79279|P2|Overall Study|Withdrawal by Subject|7
17014|NCT01704079|79280|P1|Overall Study|Withdrawal by Subject|5
17015|NCT01703858|79295|P3|Overall Study|Withdrawal by Subject|0
17016|NCT01703858|79296|P2|Overall Study|Withdrawal by Subject|1
17017|NCT01703858|79297|P1|Overall Study|Withdrawal by Subject|0
17018|NCT01703845|79322|P2|Overall Study|other than stated above|0
17019|NCT01703845|79323|P1|Overall Study|other than stated above|1
17020|NCT01703845|79322|P2|Overall Study|Protocol Violation|0
17021|NCT01703845|79323|P1|Overall Study|Protocol Violation|1
17022|NCT01703845|79322|P2|Overall Study|Adverse Event|0
17023|NCT01703845|79323|P1|Overall Study|Adverse Event|1
17024|NCT01703832|79360|P2|Overall Study|Withdrawal by Subject|0
17025|NCT01703832|79361|P1|Overall Study|Withdrawal by Subject|1
17026|NCT01703819|79393|P2|Overall Study|Withdrawal by Subject|1
17027|NCT01703819|79394|P1|Overall Study|Withdrawal by Subject|0
17028|NCT01703819|79393|P2|Overall Study|Adverse Event|1
17029|NCT01703819|79394|P1|Overall Study|Adverse Event|0
17030|NCT01703286|79451|P6|Period 2 Including Washout|Adverse Event|0
17031|NCT01703286|79452|P5|Period 2 Including Washout|Adverse Event|0
17032|NCT01703286|79453|P4|Period 2 Including Washout|Adverse Event|1
17033|NCT01703286|79454|P3|Period 2 Including Washout|Adverse Event|0
17034|NCT01703286|79455|P2|Period 2 Including Washout|Adverse Event|0
17035|NCT01703286|79456|P1|Period 2 Including Washout|Adverse Event|0
17036|NCT01703286|79451|P6|Period 1 Including Washout|Withdrawal by Subject|1
17037|NCT01703286|79452|P5|Period 1 Including Washout|Withdrawal by Subject|0
17038|NCT01703286|79453|P4|Period 1 Including Washout|Withdrawal by Subject|1
17039|NCT01703286|79454|P3|Period 1 Including Washout|Withdrawal by Subject|0
17040|NCT01703286|79455|P2|Period 1 Including Washout|Withdrawal by Subject|0
17041|NCT01703286|79456|P1|Period 1 Including Washout|Withdrawal by Subject|0
17042|NCT01703260|79479|P3|Overall Study|Study Termination|0
17043|NCT01703260|79480|P2|Overall Study|Study Termination|2
17044|NCT01703260|79481|P1|Overall Study|Study Termination|1
17045|NCT01703260|79479|P3|Overall Study|Withdrawal by Subject|1
17046|NCT01703260|79480|P2|Overall Study|Withdrawal by Subject|0
17047|NCT01703260|79481|P1|Overall Study|Withdrawal by Subject|0
17048|NCT01703260|79479|P3|Overall Study|Lost to Follow-up|0
17049|NCT01703260|79480|P2|Overall Study|Lost to Follow-up|0
17050|NCT01703260|79481|P1|Overall Study|Lost to Follow-up|1
17051|NCT01703260|79479|P3|Overall Study|Adverse Event|2
17052|NCT01703260|79480|P2|Overall Study|Adverse Event|2
17053|NCT01703260|79481|P1|Overall Study|Adverse Event|1
17054|NCT01703221|79507|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
17055|NCT01703221|79508|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
17056|NCT01703221|79509|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
17057|NCT01703221|79507|P3|Phase B - (Week 25 to 52)|Adverse Event|2
17058|NCT01703221|79508|P2|Phase B - (Week 25 to 52)|Adverse Event|3
17059|NCT01703221|79509|P1|Phase B - (Week 25 to 52)|Adverse Event|2
17060|NCT01703221|79507|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
17061|NCT01703221|79508|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
17062|NCT01703221|79509|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
17063|NCT01703221|79507|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
17064|NCT01703221|79508|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
17065|NCT01703221|79509|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
17066|NCT01703221|79507|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
17067|NCT01703221|79508|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
17068|NCT01703221|79509|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
17069|NCT01703221|79507|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
17070|NCT01703221|79508|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
17071|NCT01703221|79509|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
17072|NCT01703221|79507|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
17073|NCT01703221|79508|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
17074|NCT01703221|79509|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
17075|NCT01703221|79507|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
17076|NCT01703221|79508|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
17077|NCT01703221|79509|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
17078|NCT01703091|79540|P2|Overall Study|Sponsor Decision|0
17079|NCT01703091|79541|P1|Overall Study|Sponsor Decision|1
17080|NCT01703091|79540|P2|Overall Study|Withdrawal by Subject|0
17081|NCT01703091|79541|P1|Overall Study|Withdrawal by Subject|1
17082|NCT01703091|79540|P2|Overall Study|Physician Decision|1
17083|NCT01703091|79541|P1|Overall Study|Physician Decision|2
17084|NCT01703091|79540|P2|Overall Study|Adverse Event|3
17085|NCT01703091|79541|P1|Overall Study|Adverse Event|5
17086|NCT01703000|79557|P1|Overall Study|Death|1
17087|NCT01702961|79588|P1|Overall Study|Ongoing|11
17088|NCT01702961|79588|P1|Overall Study|Lost to Follow-up|2
17089|NCT01702961|79588|P1|Overall Study|Death|6
17090|NCT01702961|79588|P1|Overall Study|Relapse|20
17091|NCT01702961|79588|P1|Overall Study|Progressive disease|5
17092|NCT01702961|79588|P1|Overall Study|Additional treatment|3
17093|NCT01702532|79596|P2|Overall Study|Adverse Event|1
17094|NCT01702532|79597|P1|Overall Study|Adverse Event|0
17095|NCT01702519|79607|P2|Washout Period|Withdrawal by Subject|2
17096|NCT01702519|79608|P1|Washout Period|Withdrawal by Subject|0
17097|NCT01702519|79607|P2|Washout Period|Lost to Follow-up|0
17098|NCT01702519|79608|P1|Washout Period|Lost to Follow-up|1
17099|NCT01702454|79626|P2|Overall Study|Lost to Follow-up|6
17100|NCT01702454|79627|P1|Overall Study|Lost to Follow-up|3
17101|NCT01702454|79626|P2|Overall Study|Migrated/moved from study area|1
17102|NCT01702454|79627|P1|Overall Study|Migrated/moved from study area|0
17103|NCT01702454|79626|P2|Overall Study|Consent withdrawal|1
17104|NCT01702454|79627|P1|Overall Study|Consent withdrawal|0
17105|NCT01702363|79669|P1|Overall Study|Withdrawal by Subject|2
17106|NCT01702363|79669|P1|Overall Study|Lack of Efficacy|4
17107|NCT01702363|79669|P1|Overall Study|Adverse Event|14
17108|NCT01702311|79686|P2|Overall Study|Physician Decision|4
17109|NCT01702311|79687|P1|Overall Study|Physician Decision|3
17110|NCT01702311|79686|P2|Overall Study|Discharge less than 24 hours|7
17111|NCT01702311|79687|P1|Overall Study|Discharge less than 24 hours|10
17112|NCT01702311|79686|P2|Overall Study|Withdrawal by Subject|2
17113|NCT01702311|79687|P1|Overall Study|Withdrawal by Subject|3
17114|NCT01702298|79693|P1|Overall Study|Withdrawal by Subject|1
17115|NCT01702246|79721|P1|Overall Study|Physician Decision|1
17116|NCT01702246|79721|P1|Overall Study|Withdrawal by Subject|2
17117|NCT01702246|79721|P1|Overall Study|Lost to Follow-up|2
17118|NCT01702025|79775|P4|Overall Study|Adverse Event|0
17119|NCT01702025|79776|P3|Overall Study|Adverse Event|1
17120|NCT01702025|79777|P2|Overall Study|Adverse Event|1
17121|NCT01702025|79778|P1|Overall Study|Adverse Event|1
17122|NCT01702025|79775|P4|Overall Study|Equipment failure|0
17123|NCT01702025|79776|P3|Overall Study|Equipment failure|0
17124|NCT01702025|79777|P2|Overall Study|Equipment failure|0
17125|NCT01702025|79778|P1|Overall Study|Equipment failure|1
17126|NCT01701401|79825|P4|Overall Study|Protocol Violation|0
17127|NCT01701401|79826|P3|Overall Study|Protocol Violation|1
17128|NCT01701401|79827|P2|Overall Study|Protocol Violation|0
17129|NCT01701401|79828|P1|Overall Study|Protocol Violation|0
17130|NCT01701401|79825|P4|Overall Study|Adverse Event|0
17131|NCT01701401|79826|P3|Overall Study|Adverse Event|0
17132|NCT01701401|79827|P2|Overall Study|Adverse Event|0
17133|NCT01701401|79828|P1|Overall Study|Adverse Event|1
17134|NCT01701401|79825|P4|Overall Study|Lack of Efficacy|0
17135|NCT01701401|79826|P3|Overall Study|Lack of Efficacy|2
17136|NCT01701401|79827|P2|Overall Study|Lack of Efficacy|0
17137|NCT01701401|79828|P1|Overall Study|Lack of Efficacy|1
17138|NCT01701401|79825|P4|Overall Study|Withdrew Consent|2
17139|NCT01701401|79826|P3|Overall Study|Withdrew Consent|1
17140|NCT01701401|79827|P2|Overall Study|Withdrew Consent|3
17141|NCT01701401|79828|P1|Overall Study|Withdrew Consent|0
17142|NCT01701401|79825|P4|Overall Study|Lost to Follow-up|3
17143|NCT01701401|79826|P3|Overall Study|Lost to Follow-up|1
17144|NCT01701401|79827|P2|Overall Study|Lost to Follow-up|5
17145|NCT01701401|79828|P1|Overall Study|Lost to Follow-up|5
17146|NCT01701401|79825|P4|Overall Study|Randomized But Not Treated|1
17147|NCT01701401|79826|P3|Overall Study|Randomized But Not Treated|0
17148|NCT01701401|79827|P2|Overall Study|Randomized But Not Treated|1
17149|NCT01701401|79828|P1|Overall Study|Randomized But Not Treated|3
17150|NCT01701245|79886|P2|Overall Study|Did not complete the open label period|12
17151|NCT01701245|79887|P1|Overall Study|Did not complete the open label period|11
17152|NCT01701245|79886|P2|Overall Study|Protocol Violation|3
17153|NCT01701245|79887|P1|Overall Study|Protocol Violation|1
17154|NCT01701063|79919|P3|Overall Study|Unspecified|1
17155|NCT01701063|79920|P2|Overall Study|Unspecified|0
17156|NCT01701063|79921|P1|Overall Study|Unspecified|0
17157|NCT01701063|79919|P3|Overall Study|Withdrawal by Subject|1
17158|NCT01701063|79920|P2|Overall Study|Withdrawal by Subject|0
17159|NCT01701063|79921|P1|Overall Study|Withdrawal by Subject|0
17160|NCT01701063|79919|P3|Overall Study|Lost to Follow-up|0
17161|NCT01701063|79920|P2|Overall Study|Lost to Follow-up|1
17162|NCT01701063|79921|P1|Overall Study|Lost to Follow-up|0
17163|NCT01700530|80014|P3|Overall Study|Withdrawal by Subject|1
17164|NCT01700530|80015|P2|Overall Study|Withdrawal by Subject|3
17165|NCT01700530|80016|P1|Overall Study|Withdrawal by Subject|0
17166|NCT01700387|80042|P2|Overall Study|Lost to Follow-up|1
17167|NCT01700387|80043|P1|Overall Study|Lost to Follow-up|2
17168|NCT01700387|80042|P2|Overall Study|Adverse Event|1
17169|NCT01700387|80043|P1|Overall Study|Adverse Event|1
17170|NCT01700387|80042|P2|Overall Study|Withdrawal by Subject|2
17171|NCT01700387|80043|P1|Overall Study|Withdrawal by Subject|1
17172|NCT01700348|80053|P1|Overall Study|Lost to Follow-up|1
17173|NCT01700348|80053|P1|Overall Study|Withdrawal by Subject|22
17174|NCT01700179|80069|P1|Overall Study|Physician Decision|2
17175|NCT01700140|80076|P3|Overall Study|Inclusion/exclusion criteria deviation|0
17176|NCT01700140|80077|P2|Overall Study|Inclusion/exclusion criteria deviation|4
17177|NCT01700140|80078|P1|Overall Study|Inclusion/exclusion criteria deviation|1
17178|NCT01700140|80076|P3|Overall Study|Adverse Event|0
17179|NCT01700140|80077|P2|Overall Study|Adverse Event|1
17180|NCT01700140|80078|P1|Overall Study|Adverse Event|0
17181|NCT01700140|80076|P3|Overall Study|Aggravation of symptoms|0
17182|NCT01700140|80077|P2|Overall Study|Aggravation of symptoms|0
17183|NCT01700140|80078|P1|Overall Study|Aggravation of symptoms|1
17184|NCT01700140|80076|P3|Overall Study|Use of chemotherapy or surgical therapy|0
17185|NCT01700140|80077|P2|Overall Study|Use of chemotherapy or surgical therapy|1
17186|NCT01700140|80078|P1|Overall Study|Use of chemotherapy or surgical therapy|0
17187|NCT01700140|80076|P3|Overall Study|Discontinuation of radiotherapy|0
17188|NCT01700140|80077|P2|Overall Study|Discontinuation of radiotherapy|0
17189|NCT01700140|80078|P1|Overall Study|Discontinuation of radiotherapy|1
17190|NCT01700140|80076|P3|Overall Study|Use of rescue drugs|1
17191|NCT01700140|80077|P2|Overall Study|Use of rescue drugs|3
17192|NCT01700140|80078|P1|Overall Study|Use of rescue drugs|3
17193|NCT01699867|80110|P1|Overall Study|Screening Failure|3
17194|NCT01699815|80117|P2|Overall Study|Adverse Event|1
17195|NCT01699815|80118|P1|Overall Study|Adverse Event|0
17196|NCT01699815|80117|P2|Overall Study|record could not be located|0
17197|NCT01699815|80118|P1|Overall Study|record could not be located|1
17198|NCT01699815|80117|P2|Overall Study|Protocol Violation|7
17199|NCT01699815|80118|P1|Overall Study|Protocol Violation|4
17200|NCT01699789|80130|P2|Overall Study|Lost to Follow-up|101
17201|NCT01699789|80131|P1|Overall Study|Lost to Follow-up|83
17202|NCT01699789|80130|P2|Overall Study|Death|2
17203|NCT01699789|80131|P1|Overall Study|Death|1
17204|NCT01699789|80130|P2|Overall Study|Withdrawal by Subject|23
17205|NCT01699789|80131|P1|Overall Study|Withdrawal by Subject|18
17206|NCT01699750|80201|P2|Overall Study|Other|2
17207|NCT01699750|80202|P1|Overall Study|Other|0
17208|NCT01699750|80201|P2|Overall Study|Withdrew Consent|1
17209|NCT01699750|80202|P1|Overall Study|Withdrew Consent|0
17210|NCT01699685|80237|P2|Period 2|Lost to Follow-up|0
17211|NCT01699685|80238|P1|Period 2|Lost to Follow-up|1
17212|NCT01699685|80237|P2|Period 1|Patient request|1
17213|NCT01699685|80238|P1|Period 1|Patient request|0
17214|NCT01699685|80237|P2|Period 1|Other|1
17215|NCT01699685|80238|P1|Period 1|Other|0
17216|NCT01699685|80237|P2|Period 1|Medical or ethical, noncompliance|0
17217|NCT01699685|80238|P1|Period 1|Medical or ethical, noncompliance|2
17218|NCT01699685|80237|P2|Period 1|Adverse Event|1
17219|NCT01699685|80238|P1|Period 1|Adverse Event|1
17220|NCT01699022|80271|P1|Overall Study|Early discontinuation from the study|3
17221|NCT01698814|80286|P2|Overall Study|Randomized in error|0
17222|NCT01698814|80287|P1|Overall Study|Randomized in error|1
17223|NCT01698814|80286|P2|Overall Study|Pregnancy|0
17224|NCT01698814|80287|P1|Overall Study|Pregnancy|1
17225|NCT01698814|80286|P2|Overall Study|Lost to Follow-up|1
17226|NCT01698814|80287|P1|Overall Study|Lost to Follow-up|0
17227|NCT01698814|80286|P2|Overall Study|Adverse Event|2
17228|NCT01698814|80287|P1|Overall Study|Adverse Event|0
17229|NCT01698801|80293|P1|Follow Up Phase|Death|4
17230|NCT01698801|80293|P1|Follow Up Phase|Withdrawal by Subject|1
17231|NCT01698801|80293|P1|Treatment Phase|Disease progression|1
17232|NCT01698801|80293|P1|Treatment Phase|Withdrawal by Subject|1
17233|NCT01698801|80293|P1|Treatment Phase|Not specified|4
17234|NCT01698801|80293|P1|Treatment Phase|Protocol Violation|1
17235|NCT01698801|80293|P1|Treatment Phase|Adverse Event|4
17236|NCT01698554|80319|P4|Overall Study|Other Miscellaneous Reasons|0
17237|NCT01698554|80320|P3|Overall Study|Other Miscellaneous Reasons|0
17238|NCT01698554|80321|P2|Overall Study|Other Miscellaneous Reasons|0
17239|NCT01698554|80322|P1|Overall Study|Other Miscellaneous Reasons|1
17240|NCT01698554|80319|P4|Overall Study|Protocol Violation|0
17241|NCT01698554|80320|P3|Overall Study|Protocol Violation|1
17242|NCT01698554|80321|P2|Overall Study|Protocol Violation|0
17243|NCT01698554|80322|P1|Overall Study|Protocol Violation|2
17244|NCT01698554|80319|P4|Overall Study|Personal Reasons|1
17245|NCT01698554|80320|P3|Overall Study|Personal Reasons|1
17246|NCT01698554|80321|P2|Overall Study|Personal Reasons|5
17247|NCT01698554|80322|P1|Overall Study|Personal Reasons|0
17248|NCT01698554|80319|P4|Overall Study|Lost to Follow-up|0
17249|NCT01698554|80320|P3|Overall Study|Lost to Follow-up|0
17250|NCT01698554|80321|P2|Overall Study|Lost to Follow-up|0
17251|NCT01698554|80322|P1|Overall Study|Lost to Follow-up|1
17252|NCT01698554|80319|P4|Overall Study|Adverse Event|1
17253|NCT01698554|80320|P3|Overall Study|Adverse Event|0
17254|NCT01698554|80321|P2|Overall Study|Adverse Event|5
17255|NCT01698554|80322|P1|Overall Study|Adverse Event|2
17256|NCT01698320|80361|P3|40-Week Open-Label Period|Lost to Follow-up|0
17257|NCT01698320|80362|P2|40-Week Open-Label Period|Lost to Follow-up|2
17258|NCT01698320|80363|P1|40-Week Open-Label Period|Lost to Follow-up|0
17259|NCT01698320|80361|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
17260|NCT01698320|80362|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
17261|NCT01698320|80363|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
17262|NCT01698320|80361|P3|40-Week Open-Label Period|Pregnancy|1
17263|NCT01698320|80362|P2|40-Week Open-Label Period|Pregnancy|2
17264|NCT01698320|80363|P1|40-Week Open-Label Period|Pregnancy|0
17265|NCT01698320|80361|P3|40-Week Open-Label Period|Withdrawal by Subject|7
17266|NCT01698320|80362|P2|40-Week Open-Label Period|Withdrawal by Subject|11
17267|NCT01698320|80363|P1|40-Week Open-Label Period|Withdrawal by Subject|0
17268|NCT01698320|80361|P3|40-Week Open-Label Period|Adverse Event|2
17269|NCT01698320|80362|P2|40-Week Open-Label Period|Adverse Event|3
17270|NCT01698320|80363|P1|40-Week Open-Label Period|Adverse Event|0
17271|NCT01698320|80361|P3|12-Week Double-Blind Period|Lost to Follow-up|4
17272|NCT01698320|80362|P2|12-Week Double-Blind Period|Lost to Follow-up|0
17273|NCT01698320|80363|P1|12-Week Double-Blind Period|Lost to Follow-up|0
17274|NCT01698320|80361|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
17275|NCT01698320|80362|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
17276|NCT01698320|80363|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
17277|NCT01698320|80361|P3|12-Week Double-Blind Period|Pregnancy|1
17278|NCT01698320|80362|P2|12-Week Double-Blind Period|Pregnancy|1
17279|NCT01698320|80363|P1|12-Week Double-Blind Period|Pregnancy|0
17280|NCT01698320|80361|P3|12-Week Double-Blind Period|Protocol Violation|2
17281|NCT01698320|80362|P2|12-Week Double-Blind Period|Protocol Violation|0
17282|NCT01698320|80363|P1|12-Week Double-Blind Period|Protocol Violation|0
17283|NCT01698320|80361|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
17284|NCT01698320|80362|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
17285|NCT01698320|80363|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
17286|NCT01698320|80361|P3|12-Week Double-Blind Period|Adverse Event|1
17287|NCT01698320|80362|P2|12-Week Double-Blind Period|Adverse Event|1
17288|NCT01698320|80363|P1|12-Week Double-Blind Period|Adverse Event|0
17289|NCT01698320|80361|P3|Run-In Period (Week -1 to Day 0)|Not specified|0
17290|NCT01698320|80362|P2|Run-In Period (Week -1 to Day 0)|Not specified|0
17291|NCT01698320|80363|P1|Run-In Period (Week -1 to Day 0)|Not specified|1
17292|NCT01698320|80361|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
17293|NCT01698320|80362|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
17294|NCT01698320|80363|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
17295|NCT01698320|80361|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
17296|NCT01698320|80362|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
17297|NCT01698320|80363|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
17298|NCT01698320|80361|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
17299|NCT01698320|80362|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
17300|NCT01698320|80363|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
17301|NCT01697969|80381|P1|Overall Study|Did not meet inc/exc criteria|3
17302|NCT01697956|80388|P2|Overall Study|Protocol Violation|1
17303|NCT01697956|80389|P1|Overall Study|Protocol Violation|1
17304|NCT01697696|80419|P2|Overall Study|Subject/guardian decision|35
17305|NCT01697696|80420|P1|Overall Study|Subject/guardian decision|31
17306|NCT01697696|80419|P2|Overall Study|Lost to Follow-up|7
17307|NCT01697696|80420|P1|Overall Study|Lost to Follow-up|10
17308|NCT01697696|80419|P2|Overall Study|Death|2
17309|NCT01697696|80420|P1|Overall Study|Death|4
17310|NCT01697696|80419|P2|Overall Study|Physician Decision|0
17311|NCT01697696|80420|P1|Overall Study|Physician Decision|1
17312|NCT01697696|80419|P2|Overall Study|Protocol deviation|0
17313|NCT01697696|80420|P1|Overall Study|Protocol deviation|1
17314|NCT01697696|80419|P2|Overall Study|Study terminated by sponsor|3
17315|NCT01697696|80420|P1|Overall Study|Study terminated by sponsor|0
17316|NCT01697592|80452|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
17317|NCT01697592|80453|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
17318|NCT01697592|80454|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
17319|NCT01697592|80455|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
17320|NCT01697592|80456|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
17321|NCT01697592|80457|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
17322|NCT01697592|80458|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
17323|NCT01697592|80459|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
17324|NCT01697592|80460|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
17325|NCT01697592|80461|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
17326|NCT01697592|80452|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
17327|NCT01697592|80453|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
17328|NCT01697592|80454|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
17329|NCT01697592|80455|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
17330|NCT01697592|80456|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
17331|NCT01697592|80457|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
17332|NCT01697592|80458|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
17333|NCT01697592|80459|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
17334|NCT01697592|80460|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
17335|NCT01697592|80461|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
17336|NCT01697592|80452|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
17337|NCT01697592|80453|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
17338|NCT01697592|80454|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
17339|NCT01697592|80455|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
17340|NCT01697592|80456|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
17341|NCT01697592|80457|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
17342|NCT01697592|80458|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
17343|NCT01697592|80459|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
17344|NCT01697592|80460|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
17345|NCT01697592|80461|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
17346|NCT01697592|80452|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
17347|NCT01697592|80453|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
17348|NCT01697592|80454|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
17349|NCT01697592|80455|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
17350|NCT01697592|80456|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
17351|NCT01697592|80457|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
17352|NCT01697592|80458|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
17353|NCT01697592|80459|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
17354|NCT01697592|80460|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
17355|NCT01697592|80461|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
17356|NCT01697592|80452|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
17357|NCT01697592|80453|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
17358|NCT01697592|80454|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
17359|NCT01697592|80455|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
17360|NCT01697592|80456|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
17361|NCT01697592|80457|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
17362|NCT01697592|80458|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
17363|NCT01697592|80459|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
17364|NCT01697592|80460|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
17365|NCT01697592|80461|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
17366|NCT01697592|80452|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
17367|NCT01697592|80453|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
17368|NCT01697592|80454|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
17369|NCT01697592|80455|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
17370|NCT01697592|80456|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
17371|NCT01697592|80457|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
17372|NCT01697592|80458|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
17373|NCT01697592|80459|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
17374|NCT01697592|80460|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
17375|NCT01697592|80461|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
17376|NCT01697592|80452|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
17377|NCT01697592|80453|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
17378|NCT01697592|80454|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
17379|NCT01697592|80455|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
17380|NCT01697592|80456|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
17381|NCT01697592|80457|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
17382|NCT01697592|80458|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
17383|NCT01697592|80459|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
17384|NCT01697592|80460|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
17385|NCT01697592|80461|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
17386|NCT01697592|80452|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
17387|NCT01697592|80453|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
17388|NCT01697592|80454|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
17389|NCT01697592|80455|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
17390|NCT01697592|80456|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
17391|NCT01697592|80457|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
17392|NCT01697592|80458|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
17393|NCT01697592|80459|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
17394|NCT01697592|80460|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
17395|NCT01697592|80461|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
17396|NCT01697501|80525|P1|Overall Study|Protocol Violation|2
17397|NCT01697462|80568|P1|Overall Study|Missing|5
17398|NCT01697462|80568|P1|Overall Study|Unspecified|10
17399|NCT01697462|80568|P1|Overall Study|Death|1
17400|NCT01697462|80568|P1|Overall Study|Investigator Decision|21
17401|NCT01697462|80568|P1|Overall Study|Withdrawal by Subject|12
17402|NCT01697462|80568|P1|Overall Study|Lost to Follow-up|21
17403|NCT01697462|80568|P1|Overall Study|Adverse Event|6
17404|NCT01697462|80568|P1|Overall Study|Disease Progression|1
17405|NCT01697449|80575|P1|Overall Study|Missing|25
17406|NCT01697449|80575|P1|Overall Study|Unspecified|1
17407|NCT01697449|80575|P1|Overall Study|Death|2
17408|NCT01697449|80575|P1|Overall Study|Physician Decision|1
17409|NCT01697449|80575|P1|Overall Study|Withdrawal by Subject|2
17410|NCT01697449|80575|P1|Overall Study|Lost to Follow-up|5
17411|NCT01697449|80575|P1|Overall Study|Adverse Event|7
17412|NCT01697449|80575|P1|Overall Study|Disease progression|47
17413|NCT01697345|80584|P1|Overall Study|Withdrawal by Subject|1
17414|NCT01697319|80603|P1|Extension Phase|Terminated by Sponsor|15
17415|NCT01697319|80603|P1|Primary Phase|Withdrawal by Subject|1
17416|NCT01696994|80612|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
17417|NCT01696994|80613|P1|Overall Study|Refused Screen (Ovarian Screening)|0
17418|NCT01696994|80612|P2|Overall Study|Refused ASU (Control)|0
17419|NCT01696994|80613|P1|Overall Study|Refused ASU (Control)|311
17420|NCT01696994|80612|P2|Overall Study|No Ovaries at Baseline|4851
17421|NCT01696994|80613|P1|Overall Study|No Ovaries at Baseline|4807
17422|NCT01696994|80612|P2|Overall Study|Died Before ASU (Control)|0
17423|NCT01696994|80613|P1|Overall Study|Died Before ASU (Control)|73
17424|NCT01696994|80612|P2|Overall Study|Died Before Randomization|2
17425|NCT01696994|80613|P1|Overall Study|Died Before Randomization|1
17426|NCT01696994|80612|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
17427|NCT01696994|80613|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
17428|NCT01696981|80641|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
17429|NCT01696981|80642|P1|Overall Study|Refused Screen (Colorectal Screening)|0
17430|NCT01696981|80641|P2|Overall Study|Refused ASU (Control)|0
17431|NCT01696981|80642|P1|Overall Study|Refused ASU (Control)|920
17432|NCT01696981|80641|P2|Overall Study|Died Before ASU (Control)|0
17433|NCT01696981|80642|P1|Overall Study|Died Before ASU (Control)|278
17434|NCT01696981|80641|P2|Overall Study|Died Before Randomization|8
17435|NCT01696981|80642|P1|Overall Study|Died Before Randomization|3
17436|NCT01696981|80641|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
17437|NCT01696981|80642|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
17438|NCT01696968|80662|P2|Overall Study|Refused Screen (Lung Screening)|6796
17439|NCT01696968|80663|P1|Overall Study|Refused Screen (Lung Screening)|0
17440|NCT01696968|80662|P2|Overall Study|Refused ASU (Control)|0
17441|NCT01696968|80663|P1|Overall Study|Refused ASU (Control)|920
17442|NCT01696968|80662|P2|Overall Study|Died Before ASU (Control)|0
17443|NCT01696968|80663|P1|Overall Study|Died Before ASU (Control)|278
17444|NCT01696968|80662|P2|Overall Study|Died Before Randomization|8
17445|NCT01696968|80663|P1|Overall Study|Died Before Randomization|3
17446|NCT01696968|80662|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
17447|NCT01696968|80663|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
17448|NCT01696929|80683|P1|Overall Study|Physician Decision|1
17449|NCT01696773|80690|P2|Days 15-27, Washout|Adverse Event|0
17450|NCT01696773|80691|P1|Days 15-27, Washout|Adverse Event|1
17451|NCT01696695|80718|P1|Overall Study|Major Protocol Violation|192
17452|NCT01696695|80718|P1|Overall Study|Unspecified|74
17453|NCT01696695|80718|P1|Overall Study|Lost to Follow-up|48
17454|NCT01696695|80718|P1|Overall Study|Withdrawal by Subject|92
17455|NCT01696695|80718|P1|Overall Study|Adverse Event|74
17456|NCT01696695|80718|P1|Overall Study|Death|29
17457|NCT01696695|80718|P1|Overall Study|Disease progression|373
17458|NCT01696643|80730|P2|Overall Study|Participant Did Not Receive Study Drug|2
17459|NCT01696643|80731|P1|Overall Study|Participant Did Not Receive Study Drug|2
17460|NCT01696643|80730|P2|Overall Study|Medical Monitor Decision|2
17461|NCT01696643|80731|P1|Overall Study|Medical Monitor Decision|0
17462|NCT01696643|80730|P2|Overall Study|Participant Incarcerated|1
17463|NCT01696643|80731|P1|Overall Study|Participant Incarcerated|0
17464|NCT01696643|80730|P2|Overall Study|Site Error|1
17465|NCT01696643|80731|P1|Overall Study|Site Error|2
17466|NCT01696643|80730|P2|Overall Study|Participant on Restricted Bed Rest|0
17467|NCT01696643|80731|P1|Overall Study|Participant on Restricted Bed Rest|1
17468|NCT01696643|80730|P2|Overall Study|Withdrawal by Subject|149
17469|NCT01696643|80731|P1|Overall Study|Withdrawal by Subject|142
17470|NCT01696643|80730|P2|Overall Study|Study Terminated by Sponsor|294
17471|NCT01696643|80731|P1|Overall Study|Study Terminated by Sponsor|286
17472|NCT01696643|80730|P2|Overall Study|Protocol Violation|7
17473|NCT01696643|80731|P1|Overall Study|Protocol Violation|7
17474|NCT01696643|80730|P2|Overall Study|Pregnancy|1
17475|NCT01696643|80731|P1|Overall Study|Pregnancy|0
17476|NCT01696643|80730|P2|Overall Study|Physician Decision|2
17477|NCT01696643|80731|P1|Overall Study|Physician Decision|3
17478|NCT01696643|80730|P2|Overall Study|Lost to Follow-up|67
17479|NCT01696643|80731|P1|Overall Study|Lost to Follow-up|67
17480|NCT01696643|80730|P2|Overall Study|Lack of Efficacy|0
17481|NCT01696643|80731|P1|Overall Study|Lack of Efficacy|3
17482|NCT01696643|80730|P2|Overall Study|Death|2
17483|NCT01696643|80731|P1|Overall Study|Death|1
17484|NCT01696643|80730|P2|Overall Study|Adverse Event|7
17485|NCT01696643|80731|P1|Overall Study|Adverse Event|15
17486|NCT01696214|80759|P4|Overall Study|Lost to Follow-up|0
17487|NCT01696214|80760|P3|Overall Study|Lost to Follow-up|0
17488|NCT01696214|80761|P2|Overall Study|Lost to Follow-up|1
17489|NCT01696214|80762|P1|Overall Study|Lost to Follow-up|0
17490|NCT01696188|80774|P2|Overall Study|Protocol Violation|1
17491|NCT01696188|80775|P1|Overall Study|Protocol Violation|1
17492|NCT01696071|80787|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
17493|NCT01696071|80788|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
17494|NCT01696058|80816|P2|Overall Study|Other reason prematurely discontinued|3
17495|NCT01696058|80817|P1|Overall Study|Other reason prematurely discontinued|5
17496|NCT01696058|80816|P2|Overall Study|Withdrawal by Subject|6
17497|NCT01696058|80817|P1|Overall Study|Withdrawal by Subject|4
17498|NCT01696058|80816|P2|Overall Study|Lost to Follow-up|5
17499|NCT01696058|80817|P1|Overall Study|Lost to Follow-up|2
17500|NCT01696058|80816|P2|Overall Study|Protocol Violation|3
17501|NCT01696058|80817|P1|Overall Study|Protocol Violation|9
17502|NCT01696058|80816|P2|Overall Study|Lack of Efficacy|3
17503|NCT01696058|80817|P1|Overall Study|Lack of Efficacy|2
17504|NCT01696058|80816|P2|Overall Study|Adverse Event|11
17505|NCT01696058|80817|P1|Overall Study|Adverse Event|21
17506|NCT01695772|80843|P1|Overall Study|Unspecified Reason|1
17507|NCT01695772|80843|P1|Overall Study|Protocol Violation|2
17508|NCT01695772|80843|P1|Overall Study|Lost to Follow-up|4
17509|NCT01695772|80843|P1|Overall Study|Investigator Decision|5
17510|NCT01695772|80843|P1|Overall Study|Progressive Disease|8
17511|NCT01695772|80843|P1|Overall Study|Withdrawal by Subject|18
17512|NCT01695746|80855|P1|Overall Study|Participant not willing to participate|3
17513|NCT01695746|80855|P1|Overall Study|Protocol Violation|5
17514|NCT01695746|80855|P1|Overall Study|Non-compliance by the participant|3
17515|NCT01695746|80855|P1|Overall Study|Adverse Event|1
17516|NCT01695239|80893|P4|Overall Study|Protocol Violation|0
17517|NCT01695239|80894|P3|Overall Study|Protocol Violation|0
17518|NCT01695239|80895|P2|Overall Study|Protocol Violation|0
17519|NCT01695239|80896|P1|Overall Study|Protocol Violation|1
17520|NCT01695239|80893|P4|Overall Study|Lost to Follow-up|0
17521|NCT01695239|80894|P3|Overall Study|Lost to Follow-up|0
17522|NCT01695239|80895|P2|Overall Study|Lost to Follow-up|0
17523|NCT01695239|80896|P1|Overall Study|Lost to Follow-up|1
17524|NCT01695239|80893|P4|Overall Study|Sponsor Decision|0
17525|NCT01695239|80894|P3|Overall Study|Sponsor Decision|1
17526|NCT01695239|80895|P2|Overall Study|Sponsor Decision|0
17527|NCT01695239|80896|P1|Overall Study|Sponsor Decision|3
17528|NCT01695239|80893|P4|Overall Study|Withdrawal by Subject|0
17529|NCT01695239|80894|P3|Overall Study|Withdrawal by Subject|1
17530|NCT01695239|80895|P2|Overall Study|Withdrawal by Subject|1
17531|NCT01695239|80896|P1|Overall Study|Withdrawal by Subject|3
17532|NCT01695239|80893|P4|Overall Study|Lack of Efficacy|0
17533|NCT01695239|80894|P3|Overall Study|Lack of Efficacy|2
17534|NCT01695239|80895|P2|Overall Study|Lack of Efficacy|0
17535|NCT01695239|80896|P1|Overall Study|Lack of Efficacy|4
17536|NCT01695239|80893|P4|Overall Study|Adverse Event|3
17537|NCT01695239|80894|P3|Overall Study|Adverse Event|2
17538|NCT01695239|80895|P2|Overall Study|Adverse Event|2
17539|NCT01695239|80896|P1|Overall Study|Adverse Event|2
17540|NCT01695239|80893|P4|Overall Study|Entry Criteria Not Met|3
17541|NCT01695239|80894|P3|Overall Study|Entry Criteria Not Met|3
17542|NCT01695239|80895|P2|Overall Study|Entry Criteria Not Met|1
17543|NCT01695239|80896|P1|Overall Study|Entry Criteria Not Met|1
17544|NCT01695239|80893|P4|Overall Study|On Study Treatment|0
17545|NCT01695239|80894|P3|Overall Study|On Study Treatment|1
17546|NCT01695239|80895|P2|Overall Study|On Study Treatment|0
17547|NCT01695239|80896|P1|Overall Study|On Study Treatment|0
17548|NCT01694771|80987|P2|Overall Study|Other reasons|6
17549|NCT01694771|80988|P1|Overall Study|Other reasons|5
17550|NCT01694771|80987|P2|Overall Study|Consent withdrawn|9
17551|NCT01694771|80988|P1|Overall Study|Consent withdrawn|7
17552|NCT01694771|80987|P2|Overall Study|Lost to Follow-up|3
17553|NCT01694771|80988|P1|Overall Study|Lost to Follow-up|2
17554|NCT01694771|80987|P2|Overall Study|Non compliance protocol|6
17555|NCT01694771|80988|P1|Overall Study|Non compliance protocol|7
17556|NCT01694771|80987|P2|Overall Study|Lack of Efficacy|0
17557|NCT01694771|80988|P1|Overall Study|Lack of Efficacy|1
17558|NCT01694771|80987|P2|Overall Study|Adverse Event|16
17559|NCT01694771|80988|P1|Overall Study|Adverse Event|18
17560|NCT01694706|81012|P3|Overall Study|other reason not defined above|0
17561|NCT01694706|81013|P2|Overall Study|other reason not defined above|0
17562|NCT01694706|81014|P1|Overall Study|other reason not defined above|1
17563|NCT01694706|81012|P3|Overall Study|Adverse Event|0
17564|NCT01694706|81013|P2|Overall Study|Adverse Event|1
17565|NCT01694706|81014|P1|Overall Study|Adverse Event|0
17566|NCT01694420|81057|P1|Overall Study|Lost to Follow-up|3
17567|NCT01693367|81134|P2|Overall Study|Physician Decision|1
17568|NCT01693367|81135|P1|Overall Study|Physician Decision|0
17569|NCT01693367|81134|P2|Overall Study|Withdrawal by Subject|1
17570|NCT01693367|81135|P1|Overall Study|Withdrawal by Subject|1
17571|NCT01693185|81153|P2|Overall Study|diagnostic procedure after colonoscopy|6
17572|NCT01693185|81154|P1|Overall Study|diagnostic procedure after colonoscopy|0
17573|NCT01692938|81172|P2|Overall Study|Study completed prior to site completion|3
17574|NCT01692938|81173|P1|Overall Study|Study completed prior to site completion|3
17575|NCT01692938|81172|P2|Overall Study|Protocol Deviation|1
17576|NCT01692938|81173|P1|Overall Study|Protocol Deviation|1
17577|NCT01692782|81184|P3|Overall Study|Withdrawal by Subject|3
17578|NCT01692782|81185|P2|Overall Study|Withdrawal by Subject|10
17579|NCT01692782|81186|P1|Overall Study|Withdrawal by Subject|3
17580|NCT01692782|81184|P3|Overall Study|SAE not related to study drug|0
17581|NCT01692782|81185|P2|Overall Study|SAE not related to study drug|1
17582|NCT01692782|81186|P1|Overall Study|SAE not related to study drug|0
17583|NCT01692782|81184|P3|Overall Study|Non-compliant with study visits|1
17584|NCT01692782|81185|P2|Overall Study|Non-compliant with study visits|0
17585|NCT01692782|81186|P1|Overall Study|Non-compliant with study visits|0
17586|NCT01692782|81184|P3|Overall Study|Non-complance with study drug|1
17587|NCT01692782|81185|P2|Overall Study|Non-complance with study drug|4
17588|NCT01692782|81186|P1|Overall Study|Non-complance with study drug|0
17589|NCT01692782|81184|P3|Overall Study|Protocol Violation|2
17590|NCT01692782|81185|P2|Overall Study|Protocol Violation|0
17591|NCT01692782|81186|P1|Overall Study|Protocol Violation|1
17592|NCT01692782|81184|P3|Overall Study|Pregnancy|0
17593|NCT01692782|81185|P2|Overall Study|Pregnancy|0
17594|NCT01692782|81186|P1|Overall Study|Pregnancy|1
17595|NCT01692782|81184|P3|Overall Study|Lost to Follow-up|1
17596|NCT01692782|81185|P2|Overall Study|Lost to Follow-up|7
17597|NCT01692782|81186|P1|Overall Study|Lost to Follow-up|2
17598|NCT01692782|81184|P3|Overall Study|Lack of Efficacy|0
17599|NCT01692782|81185|P2|Overall Study|Lack of Efficacy|2
17600|NCT01692782|81186|P1|Overall Study|Lack of Efficacy|1
17601|NCT01692782|81184|P3|Overall Study|Adverse Event|2
17602|NCT01692782|81185|P2|Overall Study|Adverse Event|32
17603|NCT01692782|81186|P1|Overall Study|Adverse Event|12
17604|NCT01692301|81238|P2|Overall Study|Lost to Follow-up|1
17605|NCT01692301|81239|P1|Overall Study|Lost to Follow-up|1
17606|NCT01692301|81238|P2|Overall Study|Physician Decision|2
17607|NCT01692301|81239|P1|Overall Study|Physician Decision|2
17608|NCT01692301|81238|P2|Overall Study|Technical problems|1
17609|NCT01692301|81239|P1|Overall Study|Technical problems|0
17610|NCT01692301|81238|P2|Overall Study|Patient/guardian decision|15
17611|NCT01692301|81239|P1|Overall Study|Patient/guardian decision|16
17612|NCT01692301|81238|P2|Overall Study|Protocol deviation|2
17613|NCT01692301|81239|P1|Overall Study|Protocol deviation|9
17614|NCT01692301|81238|P2|Overall Study|Non-compliance with study treatment|2
17615|NCT01692301|81239|P1|Overall Study|Non-compliance with study treatment|1
17616|NCT01692301|81238|P2|Overall Study|Lack of Efficacy|5
17617|NCT01692301|81239|P1|Overall Study|Lack of Efficacy|0
17618|NCT01692301|81238|P2|Overall Study|Death|2
17619|NCT01692301|81239|P1|Overall Study|Death|1
17620|NCT01692301|81238|P2|Overall Study|Adverse Event|12
17621|NCT01692301|81239|P1|Overall Study|Adverse Event|15
17622|NCT01691885|81265|P2|Washout Period (7-9 Days)|Adverse Event|1
17623|NCT01691885|81266|P1|Washout Period (7-9 Days)|Adverse Event|0
17624|NCT01691885|81265|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
17625|NCT01691885|81266|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
17626|NCT01691794|81275|P3|Overall Study|Poor compliance/noncompliance|1
17627|NCT01691794|81276|P2|Overall Study|Poor compliance/noncompliance|0
17628|NCT01691794|81277|P1|Overall Study|Poor compliance/noncompliance|0
17629|NCT01691794|81275|P3|Overall Study|Lack of Efficacy|1
17630|NCT01691794|81276|P2|Overall Study|Lack of Efficacy|1
17631|NCT01691794|81277|P1|Overall Study|Lack of Efficacy|0
17632|NCT01691794|81275|P3|Overall Study|No longer meets study criteria|0
17633|NCT01691794|81276|P2|Overall Study|No longer meets study criteria|2
17634|NCT01691794|81277|P1|Overall Study|No longer meets study criteria|0
17635|NCT01691794|81275|P3|Overall Study|Adverse Event|1
17636|NCT01691794|81276|P2|Overall Study|Adverse Event|0
17637|NCT01691794|81277|P1|Overall Study|Adverse Event|0
17638|NCT01691521|81408|P3|Overall Study|Withdrawal by Subject|4
17639|NCT01691521|81409|P2|Overall Study|Withdrawal by Subject|9
17640|NCT01691521|81410|P1|Overall Study|Withdrawal by Subject|5
17641|NCT01691521|81408|P3|Overall Study|Physician Decision|0
17642|NCT01691521|81409|P2|Overall Study|Physician Decision|1
17643|NCT01691521|81410|P1|Overall Study|Physician Decision|2
17644|NCT01691521|81408|P3|Overall Study|Lost to Follow-up|2
17645|NCT01691521|81409|P2|Overall Study|Lost to Follow-up|2
17646|NCT01691521|81410|P1|Overall Study|Lost to Follow-up|0
17647|NCT01691521|81408|P3|Overall Study|Protocol Violation|0
17648|NCT01691521|81409|P2|Overall Study|Protocol Violation|3
17649|NCT01691521|81410|P1|Overall Study|Protocol Violation|0
17650|NCT01691521|81408|P3|Overall Study|Lack of Efficacy|2
17651|NCT01691521|81409|P2|Overall Study|Lack of Efficacy|1
17652|NCT01691521|81410|P1|Overall Study|Lack of Efficacy|1
17653|NCT01691521|81408|P3|Overall Study|Adverse Event|1
17654|NCT01691521|81409|P2|Overall Study|Adverse Event|0
17655|NCT01691521|81410|P1|Overall Study|Adverse Event|4
17656|NCT01691508|81432|P2|Overall Study|Withdrawal by Subject|0
17657|NCT01691508|81433|P1|Overall Study|Withdrawal by Subject|1
17658|NCT01691508|81432|P2|Overall Study|Adverse Event|3
17659|NCT01691508|81433|P1|Overall Study|Adverse Event|3
17660|NCT01691482|81447|P2|Treatment Period 2|Protocol Violation|1
17661|NCT01691482|81448|P1|Treatment Period 2|Protocol Violation|1
17662|NCT01691482|81447|P2|Treatment Period 2|Adverse Event|1
17663|NCT01691482|81448|P1|Treatment Period 2|Adverse Event|0
17664|NCT01691248|81537|P2|Overall Study|Not Treated|7
17665|NCT01691248|81538|P1|Overall Study|Not Treated|4
17666|NCT01691248|81537|P2|Overall Study|Reason not provided|4
17667|NCT01691248|81538|P1|Overall Study|Reason not provided|4
17668|NCT01691248|81537|P2|Overall Study|Lost to Follow-up|5
17669|NCT01691248|81538|P1|Overall Study|Lost to Follow-up|2
17670|NCT01691248|81537|P2|Overall Study|Confirmed CDAD|31
17671|NCT01691248|81538|P1|Overall Study|Confirmed CDAD|14
17672|NCT01691248|81537|P2|Overall Study|Withdrawal by Subject|18
17673|NCT01691248|81538|P1|Overall Study|Withdrawal by Subject|20
17674|NCT01691248|81537|P2|Overall Study|Adverse Event|22
17675|NCT01691248|81538|P1|Overall Study|Adverse Event|24
17676|NCT01691248|81537|P2|Overall Study|Protocol Violation|27
17677|NCT01691248|81538|P1|Overall Study|Protocol Violation|43
17678|NCT01691014|81552|P4|Overall Study|Lack of Efficacy|0
17679|NCT01691014|81553|P3|Overall Study|Lack of Efficacy|7
17680|NCT01691014|81554|P2|Overall Study|Lack of Efficacy|3
17681|NCT01691014|81555|P1|Overall Study|Lack of Efficacy|2
17682|NCT01691014|81552|P4|Overall Study|Adverse Event|1
17683|NCT01691014|81553|P3|Overall Study|Adverse Event|1
17684|NCT01691014|81554|P2|Overall Study|Adverse Event|5
17685|NCT01691014|81555|P1|Overall Study|Adverse Event|0
17686|NCT01691014|81552|P4|Overall Study|Withdrawal by Subject|1
17687|NCT01691014|81553|P3|Overall Study|Withdrawal by Subject|1
17688|NCT01691014|81554|P2|Overall Study|Withdrawal by Subject|1
17689|NCT01691014|81555|P1|Overall Study|Withdrawal by Subject|0
17690|NCT01691014|81552|P4|Overall Study|Unspecified|0
17691|NCT01691014|81553|P3|Overall Study|Unspecified|2
17692|NCT01691014|81554|P2|Overall Study|Unspecified|0
17693|NCT01691014|81555|P1|Overall Study|Unspecified|0
17694|NCT01691014|81552|P4|Overall Study|Premature Termination|3
17695|NCT01691014|81553|P3|Overall Study|Premature Termination|0
17696|NCT01691014|81554|P2|Overall Study|Premature Termination|6
17697|NCT01691014|81555|P1|Overall Study|Premature Termination|1
17698|NCT01690299|81606|P3|Overall Study|Unspecified|1
17699|NCT01690299|81607|P2|Overall Study|Unspecified|1
17700|NCT01690299|81608|P1|Overall Study|Unspecified|2
17701|NCT01690299|81606|P3|Overall Study|Withdrawal by Subject|0
17702|NCT01690299|81607|P2|Overall Study|Withdrawal by Subject|3
17703|NCT01690299|81608|P1|Overall Study|Withdrawal by Subject|1
17704|NCT01690299|81606|P3|Overall Study|Lack of Efficacy|0
17705|NCT01690299|81607|P2|Overall Study|Lack of Efficacy|0
17706|NCT01690299|81608|P1|Overall Study|Lack of Efficacy|4
17707|NCT01690299|81606|P3|Overall Study|Adverse Event|1
17708|NCT01690299|81607|P2|Overall Study|Adverse Event|2
17709|NCT01690299|81608|P1|Overall Study|Adverse Event|2
17710|NCT01690052|81715|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
17711|NCT01690052|81716|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
17712|NCT01689857|81733|P2|Overall Study|Lost to Follow-up|2
17713|NCT01689857|81734|P1|Overall Study|Lost to Follow-up|5
17714|NCT01689649|81740|P1|Overall Study|Lost to Follow-up|5
17715|NCT01689649|81740|P1|Overall Study|Protocol Violation|3
17716|NCT01689649|81740|P1|Overall Study|Non-compliance|11
17717|NCT01689649|81740|P1|Overall Study|Lack of Efficacy|3
17718|NCT01689532|81752|P2|Overall Study|Physician Decision|0
17719|NCT01689532|81753|P1|Overall Study|Physician Decision|2
17720|NCT01689532|81752|P2|Overall Study|Withdrawal by Subject|2
17721|NCT01689532|81753|P1|Overall Study|Withdrawal by Subject|1
17722|NCT01689532|81752|P2|Overall Study|Lack of Efficacy|2
17723|NCT01689532|81753|P1|Overall Study|Lack of Efficacy|2
17724|NCT01689532|81752|P2|Overall Study|Adverse Event|5
17725|NCT01689532|81753|P1|Overall Study|Adverse Event|9
17726|NCT01689519|81817|P2|Overall Study|Physician Decision|3
17727|NCT01689519|81818|P1|Overall Study|Physician Decision|0
17728|NCT01689519|81817|P2|Overall Study|Withdrawal by Subject|17
17729|NCT01689519|81818|P1|Overall Study|Withdrawal by Subject|17
17730|NCT01689519|81817|P2|Overall Study|Lost to Follow-up|2
17731|NCT01689519|81818|P1|Overall Study|Lost to Follow-up|6
17732|NCT01689519|81817|P2|Overall Study|Death|116
17733|NCT01689519|81818|P1|Overall Study|Death|143
17734|NCT01689363|81845|P8|Overall Study|Protocol Violation|0
17735|NCT01689363|81846|P7|Overall Study|Protocol Violation|0
17736|NCT01689363|81847|P6|Overall Study|Protocol Violation|0
17737|NCT01689363|81848|P5|Overall Study|Protocol Violation|0
17738|NCT01689363|81849|P4|Overall Study|Protocol Violation|0
17739|NCT01689363|81850|P3|Overall Study|Protocol Violation|0
17740|NCT01689363|81851|P2|Overall Study|Protocol Violation|1
17741|NCT01689363|81852|P1|Overall Study|Protocol Violation|0
17742|NCT01689337|81907|P1|Overall Study|Study Discontinuation|1
17743|NCT01689207|81946|P11|Overall Study|Adverse Event|0
17744|NCT01689207|81947|P10|Overall Study|Adverse Event|0
17745|NCT01689207|81948|P9|Overall Study|Adverse Event|1
17746|NCT01689207|81949|P8|Overall Study|Adverse Event|0
17747|NCT01689207|81950|P7|Overall Study|Adverse Event|0
17748|NCT01689207|81951|P6|Overall Study|Adverse Event|1
17749|NCT01689207|81952|P5|Overall Study|Adverse Event|2
17750|NCT01689207|81953|P4|Overall Study|Adverse Event|0
17751|NCT01689207|81954|P3|Overall Study|Adverse Event|0
17752|NCT01689207|81955|P2|Overall Study|Adverse Event|1
17753|NCT01689207|81956|P1|Overall Study|Adverse Event|0
17754|NCT01688921|82063|P2|Overall Study|informed consent|0
17755|NCT01688921|82064|P1|Overall Study|informed consent|3
17756|NCT01688921|82063|P2|Overall Study|Protocol Violation|1
17757|NCT01688921|82064|P1|Overall Study|Protocol Violation|0
17758|NCT01688921|82063|P2|Overall Study|Physician Decision|1
17759|NCT01688921|82064|P1|Overall Study|Physician Decision|6
17760|NCT01688921|82063|P2|Overall Study|Lost to Follow-up|13
17761|NCT01688921|82064|P1|Overall Study|Lost to Follow-up|7
17762|NCT01688882|82089|P2|Overall Study|Administrative problems|0
17763|NCT01688882|82090|P1|Overall Study|Administrative problems|1
17764|NCT01688882|82089|P2|Overall Study|Unsatisfactory therapeutic effect|1
17765|NCT01688882|82090|P1|Overall Study|Unsatisfactory therapeutic effect|1
17766|NCT01688882|82089|P2|Overall Study|Adverse Event|0
17767|NCT01688882|82090|P1|Overall Study|Adverse Event|1
17768|NCT01688830|82125|P21|Overall Study|Lost to Follow-up|0
17769|NCT01688830|82126|P20|Overall Study|Lost to Follow-up|0
17770|NCT01688830|82127|P19|Overall Study|Lost to Follow-up|0
17771|NCT01688830|82128|P18|Overall Study|Lost to Follow-up|0
17772|NCT01688830|82129|P17|Overall Study|Lost to Follow-up|0
17773|NCT01688830|82130|P16|Overall Study|Lost to Follow-up|0
17774|NCT01688830|82131|P15|Overall Study|Lost to Follow-up|0
17775|NCT01688830|82132|P14|Overall Study|Lost to Follow-up|0
17776|NCT01688830|82133|P13|Overall Study|Lost to Follow-up|0
17777|NCT01688830|82134|P12|Overall Study|Lost to Follow-up|0
17778|NCT01688830|82135|P11|Overall Study|Lost to Follow-up|1
17779|NCT01688830|82136|P10|Overall Study|Lost to Follow-up|0
17780|NCT01688830|82137|P9|Overall Study|Lost to Follow-up|0
17781|NCT01688830|82138|P8|Overall Study|Lost to Follow-up|0
17782|NCT01688830|82139|P7|Overall Study|Lost to Follow-up|0
17783|NCT01688830|82140|P6|Overall Study|Lost to Follow-up|0
17784|NCT01688830|82141|P5|Overall Study|Lost to Follow-up|0
17785|NCT01688830|82142|P4|Overall Study|Lost to Follow-up|0
17786|NCT01688830|82143|P3|Overall Study|Lost to Follow-up|0
17787|NCT01688830|82144|P2|Overall Study|Lost to Follow-up|0
17788|NCT01688830|82145|P1|Overall Study|Lost to Follow-up|0
17789|NCT01688726|82291|P2|Overall Study|Relocated abroad|1
17790|NCT01688726|82292|P1|Overall Study|Relocated abroad|0
17791|NCT01688726|82291|P2|Overall Study|Adverse Event|0
17792|NCT01688726|82292|P1|Overall Study|Adverse Event|1
17793|NCT01688635|82304|P2|Washout 3|Withdrawal by Subject|0
17794|NCT01688635|82305|P1|Washout 3|Withdrawal by Subject|1
17795|NCT01688635|82304|P2|Washout 2|Sponsor Decision|2
17796|NCT01688635|82305|P1|Washout 2|Sponsor Decision|1
17797|NCT01688635|82304|P2|Washout 2|Withdrawal by Subject|0
17798|NCT01688635|82305|P1|Washout 2|Withdrawal by Subject|1
17799|NCT01688635|82304|P2|Washout 2|Physician Decision|0
17800|NCT01688635|82305|P1|Washout 2|Physician Decision|1
17801|NCT01688635|82304|P2|Washout 1|Physician Decision|1
17802|NCT01688635|82305|P1|Washout 1|Physician Decision|0
17803|NCT01688635|82304|P2|Washout 1|Adverse Event|1
17804|NCT01688635|82305|P1|Washout 1|Adverse Event|0
17805|NCT01688635|82304|P2|Washout 1|Withdrawal by Subject|0
17806|NCT01688635|82305|P1|Washout 1|Withdrawal by Subject|1
17807|NCT01688050|82347|P1|Overall Study|Still be eligible for follow-up|37
17808|NCT01688050|82347|P1|Overall Study|Withdrawal by Subject|2
17809|NCT01688050|82347|P1|Overall Study|Lost to Follow-up|5
17810|NCT01688050|82347|P1|Overall Study|Conversion to open repair|1
17811|NCT01688050|82347|P1|Overall Study|Death|5
17812|NCT01687270|82358|P1|Overall Study|Lost to Follow-up|1
17813|NCT01687270|82358|P1|Overall Study|Lack of Efficacy|11
17814|NCT01687257|82369|P3|Overall Study|Investigator's Discretion|0
17815|NCT01687257|82370|P2|Overall Study|Investigator's Discretion|3
17816|NCT01687257|82371|P1|Overall Study|Investigator's Discretion|0
17817|NCT01687257|82369|P3|Overall Study|Adverse Event|0
17818|NCT01687257|82370|P2|Overall Study|Adverse Event|0
17819|NCT01687257|82371|P1|Overall Study|Adverse Event|1
17820|NCT01687257|82369|P3|Overall Study|Subject Withdrew Consent|1
17821|NCT01687257|82370|P2|Overall Study|Subject Withdrew Consent|1
17822|NCT01687257|82371|P1|Overall Study|Subject Withdrew Consent|1
17823|NCT01687257|82369|P3|Overall Study|Efficacy Failure|5
17824|NCT01687257|82370|P2|Overall Study|Efficacy Failure|0
17825|NCT01687257|82371|P1|Overall Study|Efficacy Failure|6
17826|NCT01687218|82403|P6|Overall Study|Relocated, no follow-up planned|0
17827|NCT01687218|82404|P5|Overall Study|Relocated, no follow-up planned|0
17828|NCT01687218|82405|P4|Overall Study|Relocated, no follow-up planned|1
17829|NCT01687218|82406|P3|Overall Study|Relocated, no follow-up planned|1
17830|NCT01687218|82407|P2|Overall Study|Relocated, no follow-up planned|0
17831|NCT01687218|82408|P1|Overall Study|Relocated, no follow-up planned|1
17832|NCT01687218|82403|P6|Overall Study|Withdrawal by Subject|0
17833|NCT01687218|82404|P5|Overall Study|Withdrawal by Subject|1
17834|NCT01687218|82405|P4|Overall Study|Withdrawal by Subject|1
17835|NCT01687218|82406|P3|Overall Study|Withdrawal by Subject|0
17836|NCT01687218|82407|P2|Overall Study|Withdrawal by Subject|3
17837|NCT01687218|82408|P1|Overall Study|Withdrawal by Subject|2
17838|NCT01687101|82432|P1|Overall Study|Lost to Follow-up|7
17839|NCT01686932|82459|P2|Period 1|Adverse Event|1
17840|NCT01686932|82460|P1|Period 1|Adverse Event|1
17841|NCT01686633|82542|P3|Overall Study|Lost to Follow-up|1
17842|NCT01686633|82543|P2|Overall Study|Lost to Follow-up|1
17843|NCT01686633|82544|P1|Overall Study|Lost to Follow-up|0
17844|NCT01686633|82542|P3|Overall Study|Protocol-defined Stopping Criteria|1
17845|NCT01686633|82543|P2|Overall Study|Protocol-defined Stopping Criteria|0
17846|NCT01686633|82544|P1|Overall Study|Protocol-defined Stopping Criteria|1
17847|NCT01686633|82542|P3|Overall Study|Protocol Violation|0
17848|NCT01686633|82543|P2|Overall Study|Protocol Violation|3
17849|NCT01686633|82544|P1|Overall Study|Protocol Violation|2
17850|NCT01686633|82542|P3|Overall Study|Adverse Event|3
17851|NCT01686633|82543|P2|Overall Study|Adverse Event|3
17852|NCT01686633|82544|P1|Overall Study|Adverse Event|4
17853|NCT01686633|82542|P3|Overall Study|Physician Decision|4
17854|NCT01686633|82543|P2|Overall Study|Physician Decision|4
17855|NCT01686633|82544|P1|Overall Study|Physician Decision|3
17856|NCT01686633|82542|P3|Overall Study|Withdrawal by Subject|5
17857|NCT01686633|82543|P2|Overall Study|Withdrawal by Subject|8
17858|NCT01686633|82544|P1|Overall Study|Withdrawal by Subject|8
17859|NCT01686633|82542|P3|Overall Study|Lack of Efficacy|11
17860|NCT01686633|82543|P2|Overall Study|Lack of Efficacy|13
17861|NCT01686633|82544|P1|Overall Study|Lack of Efficacy|33
17862|NCT01686568|82569|P2|Overall Study|Liver enzymes above range of exclusion|0
17863|NCT01686568|82570|P1|Overall Study|Liver enzymes above range of exclusion|1
17864|NCT01686568|82569|P2|Overall Study|Noncompliance with protocol|1
17865|NCT01686568|82570|P1|Overall Study|Noncompliance with protocol|0
17866|NCT01686568|82569|P2|Overall Study|Withdrawal by Subject|3
17867|NCT01686568|82570|P1|Overall Study|Withdrawal by Subject|1
17868|NCT01685983|82632|P1|Overall Study|Unspecified|7
17869|NCT01685983|82632|P1|Overall Study|Noncompliance with Study Drug|1
17870|NCT01685983|82632|P1|Overall Study|Physician Decision|13
17871|NCT01685983|82632|P1|Overall Study|Progressive Disease|32
17872|NCT01685983|82632|P1|Overall Study|Protocol Violation|2
17873|NCT01685983|82632|P1|Overall Study|Withdrawal by Subject|19
17874|NCT01685983|82632|P1|Overall Study|Death|1
17875|NCT01685983|82632|P1|Overall Study|Adverse Event|7
17876|NCT01685801|82646|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
17877|NCT01685801|82647|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
17878|NCT01685801|82648|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
17879|NCT01685801|82649|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
17880|NCT01685801|82646|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
17881|NCT01685801|82647|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
17882|NCT01685801|82648|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
17883|NCT01685801|82649|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
17884|NCT01685606|82669|P1|Overall Study|Withdrawal by Subject|1
17885|NCT01685437|82674|P1|Overall Study|Unable to make visits due to work|1
17886|NCT01685437|82674|P1|Overall Study|Protocol Violation|4
17887|NCT01685437|82674|P1|Overall Study|Adverse Event|1
17888|NCT01685437|82674|P1|Overall Study|Lost to Follow-up|3
17889|NCT01685437|82674|P1|Overall Study|Withdrawal by Subject|22
17890|NCT01685216|82697|P1|Overall Study|Did not receive study drug|1
17891|NCT01685203|82714|P7|Overall Study|Patient's decision|0
17892|NCT01685203|82715|P6|Overall Study|Patient's decision|1
17893|NCT01685203|82716|P5|Overall Study|Patient's decision|0
17894|NCT01685203|82717|P4|Overall Study|Patient's decision|0
17895|NCT01685203|82718|P3|Overall Study|Patient's decision|0
17896|NCT01685203|82719|P2|Overall Study|Patient's decision|0
17897|NCT01685203|82720|P1|Overall Study|Patient's decision|0
17898|NCT01685203|82714|P7|Overall Study|Adverse event and withdrew consent|0
17899|NCT01685203|82715|P6|Overall Study|Adverse event and withdrew consent|0
17900|NCT01685203|82716|P5|Overall Study|Adverse event and withdrew consent|0
17901|NCT01685203|82717|P4|Overall Study|Adverse event and withdrew consent|0
17902|NCT01685203|82718|P3|Overall Study|Adverse event and withdrew consent|0
17903|NCT01685203|82719|P2|Overall Study|Adverse event and withdrew consent|0
17904|NCT01685203|82720|P1|Overall Study|Adverse event and withdrew consent|1
17905|NCT01685203|82714|P7|Overall Study|Adverse Event|0
17906|NCT01685203|82715|P6|Overall Study|Adverse Event|2
17907|NCT01685203|82716|P5|Overall Study|Adverse Event|0
17908|NCT01685203|82717|P4|Overall Study|Adverse Event|0
17909|NCT01685203|82718|P3|Overall Study|Adverse Event|0
17910|NCT01685203|82719|P2|Overall Study|Adverse Event|0
17911|NCT01685203|82720|P1|Overall Study|Adverse Event|0
17912|NCT01685203|82714|P7|Overall Study|Lost to Follow-up|0
17913|NCT01685203|82715|P6|Overall Study|Lost to Follow-up|0
17914|NCT01685203|82716|P5|Overall Study|Lost to Follow-up|0
17915|NCT01685203|82717|P4|Overall Study|Lost to Follow-up|1
17916|NCT01685203|82718|P3|Overall Study|Lost to Follow-up|0
17917|NCT01685203|82719|P2|Overall Study|Lost to Follow-up|3
17918|NCT01685203|82720|P1|Overall Study|Lost to Follow-up|3
17919|NCT01684930|82766|P2|Overall Study|Withdrawal by Subject|1
17920|NCT01684930|82767|P1|Overall Study|Withdrawal by Subject|3
17921|NCT01684878|82783|P4|Part 2: Randomized Phase|Death|43
17922|NCT01684878|82784|P3|Part 2: Randomized Phase|Death|39
17923|NCT01684878|82785|P2|Part 2: Randomized Phase|Death|0
17924|NCT01684878|82786|P1|Part 2: Randomized Phase|Death|0
17925|NCT01684878|82783|P4|Part 2: Randomized Phase|Lost to Follow-up|0
17926|NCT01684878|82784|P3|Part 2: Randomized Phase|Lost to Follow-up|2
17927|NCT01684878|82785|P2|Part 2: Randomized Phase|Lost to Follow-up|0
17928|NCT01684878|82786|P1|Part 2: Randomized Phase|Lost to Follow-up|0
17929|NCT01684878|82783|P4|Part 2: Randomized Phase|Participants withdrawn consent|2
17930|NCT01684878|82784|P3|Part 2: Randomized Phase|Participants withdrawn consent|2
17931|NCT01684878|82785|P2|Part 2: Randomized Phase|Participants withdrawn consent|0
17932|NCT01684878|82786|P1|Part 2: Randomized Phase|Participants withdrawn consent|0
17933|NCT01684878|82783|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
17934|NCT01684878|82784|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
17935|NCT01684878|82785|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
17936|NCT01684878|82786|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
17937|NCT01684878|82783|P4|Part 1: Safety Run in Phase|Death|0
17938|NCT01684878|82784|P3|Part 1: Safety Run in Phase|Death|0
17939|NCT01684878|82785|P2|Part 1: Safety Run in Phase|Death|20
17940|NCT01684878|82786|P1|Part 1: Safety Run in Phase|Death|15
17941|NCT01684878|82783|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
17942|NCT01684878|82784|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
17943|NCT01684878|82785|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
17944|NCT01684878|82786|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
17945|NCT01684046|82880|P2|Period 1, First 30 Days|Adverse Event|2
17946|NCT01684046|82881|P1|Period 1, First 30 Days|Adverse Event|0
17947|NCT01684033|82887|P2|Period 2, Second 30 Days|Adverse Event|0
17948|NCT01684033|82888|P1|Period 2, Second 30 Days|Adverse Event|1
17949|NCT01684033|82887|P2|Period 1, First 30 Days|Lost to Follow-up|0
17950|NCT01684033|82888|P1|Period 1, First 30 Days|Lost to Follow-up|1
17951|NCT01684033|82887|P2|Period 1, First 30 Days|Withdrawal by Subject|0
17952|NCT01684033|82888|P1|Period 1, First 30 Days|Withdrawal by Subject|1
17953|NCT01684033|82887|P2|Period 1, First 30 Days|Noncompliance|0
17954|NCT01684033|82888|P1|Period 1, First 30 Days|Noncompliance|1
17955|NCT01684033|82887|P2|Period 1, First 30 Days|Adverse Event|1
17956|NCT01684033|82888|P1|Period 1, First 30 Days|Adverse Event|1
17957|NCT01683838|82909|P2|Overall Study|not specified|3
17958|NCT01683838|82910|P1|Overall Study|not specified|4
17959|NCT01683838|82909|P2|Overall Study|Lost to Follow-up|1
17960|NCT01683838|82910|P1|Overall Study|Lost to Follow-up|1
17961|NCT01683838|82909|P2|Overall Study|Withdrawal by Subject|5
17962|NCT01683838|82910|P1|Overall Study|Withdrawal by Subject|6
17963|NCT01683838|82909|P2|Overall Study|Protocol Violation|1
17964|NCT01683838|82910|P1|Overall Study|Protocol Violation|3
17965|NCT01683838|82909|P2|Overall Study|Adverse Event|2
17966|NCT01683838|82910|P1|Overall Study|Adverse Event|12
17967|NCT01683604|82945|P1|Overall Study|Unspecified|2
17968|NCT01683604|82945|P1|Overall Study|Lack of Efficacy|1
17969|NCT01683604|82945|P1|Overall Study|Adverse Event|2
17970|NCT01683383|83127|P2|Overall Study|Infant was not transported|0
17971|NCT01683383|83128|P1|Overall Study|Infant was not transported|1
17972|NCT01683266|83144|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
17973|NCT01683266|83145|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
17974|NCT01683266|83144|P2|Overall Study|Possibly Hypoglycemia|0
17975|NCT01683266|83145|P1|Overall Study|Possibly Hypoglycemia|1
17976|NCT01683266|83144|P2|Overall Study|Perceived Lack of Efficacy|1
17977|NCT01683266|83145|P1|Overall Study|Perceived Lack of Efficacy|1
17978|NCT01683266|83144|P2|Overall Study|Nonserious Hypoglycemia|3
17979|NCT01683266|83145|P1|Overall Study|Nonserious Hypoglycemia|0
17980|NCT01683266|83144|P2|Overall Study|Site Closure / Site Withdrawal|3
17981|NCT01683266|83145|P1|Overall Study|Site Closure / Site Withdrawal|1
17982|NCT01683266|83144|P2|Overall Study|Lost to Follow-up|0
17983|NCT01683266|83145|P1|Overall Study|Lost to Follow-up|5
17984|NCT01683266|83144|P2|Overall Study|Selection Criterion / Protocol Violation|5
17985|NCT01683266|83145|P1|Overall Study|Selection Criterion / Protocol Violation|7
17986|NCT01683266|83144|P2|Overall Study|Personal Reason|25
17987|NCT01683266|83145|P1|Overall Study|Personal Reason|17
17988|NCT01683266|83144|P2|Overall Study|Protocol Violation|6
17989|NCT01683266|83145|P1|Overall Study|Protocol Violation|13
17990|NCT01683266|83144|P2|Overall Study|Lack of Efficacy|2
17991|NCT01683266|83145|P1|Overall Study|Lack of Efficacy|5
17992|NCT01683266|83144|P2|Overall Study|Adverse Event|4
17993|NCT01683266|83145|P1|Overall Study|Adverse Event|5
17994|NCT01683058|83173|P1|Overall Study|Lack of Efficacy|2
17995|NCT01683058|83173|P1|Overall Study|Withdrawal by Subject|7
17996|NCT01683058|83173|P1|Overall Study|Subject Met Withdrawal Criteria|5
17997|NCT01683058|83173|P1|Overall Study|Adverse Event|6
17998|NCT01683058|83173|P1|Overall Study|Lost to Follow-up|9
17999|NCT01683019|83204|P3|Overall Study|Withdrawal by Subject|4
18000|NCT01683019|83205|P2|Overall Study|Withdrawal by Subject|1
18001|NCT01683019|83206|P1|Overall Study|Withdrawal by Subject|2
18002|NCT01682876|83229|P4|Overall Study|Other|1
18003|NCT01682876|83230|P3|Overall Study|Other|1
18004|NCT01682876|83231|P2|Overall Study|Other|0
18005|NCT01682876|83232|P1|Overall Study|Other|1
18006|NCT01682876|83229|P4|Overall Study|Withdrawal by Subject|2
18007|NCT01682876|83230|P3|Overall Study|Withdrawal by Subject|0
18008|NCT01682876|83231|P2|Overall Study|Withdrawal by Subject|0
18009|NCT01682876|83232|P1|Overall Study|Withdrawal by Subject|4
18010|NCT01682876|83229|P4|Overall Study|Protocol Violation|1
18011|NCT01682876|83230|P3|Overall Study|Protocol Violation|1
18012|NCT01682876|83231|P2|Overall Study|Protocol Violation|1
18013|NCT01682876|83232|P1|Overall Study|Protocol Violation|1
18014|NCT01682876|83229|P4|Overall Study|Lost to Follow-up|11
18015|NCT01682876|83230|P3|Overall Study|Lost to Follow-up|9
18016|NCT01682876|83231|P2|Overall Study|Lost to Follow-up|15
18017|NCT01682876|83232|P1|Overall Study|Lost to Follow-up|11
18018|NCT01682876|83229|P4|Overall Study|Adverse Event|1
18019|NCT01682876|83230|P3|Overall Study|Adverse Event|0
18020|NCT01682876|83231|P2|Overall Study|Adverse Event|0
18021|NCT01682876|83232|P1|Overall Study|Adverse Event|0
18022|NCT01682876|83229|P4|Overall Study|Administrative reason|3
18023|NCT01682876|83230|P3|Overall Study|Administrative reason|0
18024|NCT01682876|83231|P2|Overall Study|Administrative reason|4
18025|NCT01682876|83232|P1|Overall Study|Administrative reason|4
18026|NCT01682863|83278|P3|Overall Study|Physician Decision|1
18027|NCT01682863|83279|P2|Overall Study|Physician Decision|0
18028|NCT01682863|83280|P1|Overall Study|Physician Decision|0
18029|NCT01682863|83278|P3|Overall Study|Adverse Event|2
18030|NCT01682863|83279|P2|Overall Study|Adverse Event|1
18031|NCT01682863|83280|P1|Overall Study|Adverse Event|0
18032|NCT01682863|83278|P3|Overall Study|Technical problems|0
18033|NCT01682863|83279|P2|Overall Study|Technical problems|0
18034|NCT01682863|83280|P1|Overall Study|Technical problems|1
18035|NCT01682863|83278|P3|Overall Study|Protocol deviation|1
18036|NCT01682863|83279|P2|Overall Study|Protocol deviation|0
18037|NCT01682863|83280|P1|Overall Study|Protocol deviation|1
18038|NCT01682863|83278|P3|Overall Study|Death|4
18039|NCT01682863|83279|P2|Overall Study|Death|3
18040|NCT01682863|83280|P1|Overall Study|Death|1
18041|NCT01682863|83278|P3|Overall Study|Lost to Follow-up|6
18042|NCT01682863|83279|P2|Overall Study|Lost to Follow-up|1
18043|NCT01682863|83280|P1|Overall Study|Lost to Follow-up|5
18044|NCT01682863|83278|P3|Overall Study|Subject/guardian decision|10
18045|NCT01682863|83279|P2|Overall Study|Subject/guardian decision|12
18046|NCT01682863|83280|P1|Overall Study|Subject/guardian decision|19
18047|NCT01682759|83311|P2|Overall Study|Withdrawal by Subject|55
18048|NCT01682759|83312|P1|Overall Study|Withdrawal by Subject|56
18049|NCT01682759|83311|P2|Overall Study|Physician Decision|1
18050|NCT01682759|83312|P1|Overall Study|Physician Decision|1
18051|NCT01682759|83311|P2|Overall Study|Lost to Follow-up|13
18052|NCT01682759|83312|P1|Overall Study|Lost to Follow-up|10
18053|NCT01682759|83311|P2|Overall Study|Death|1
18054|NCT01682759|83312|P1|Overall Study|Death|2
18055|NCT01682720|83336|P4|Overall Study|Adverse Event|1
18056|NCT01682720|83337|P3|Overall Study|Adverse Event|1
18057|NCT01682720|83338|P2|Overall Study|Adverse Event|0
18058|NCT01682720|83339|P1|Overall Study|Adverse Event|1
18059|NCT01682720|83336|P4|Overall Study|Subject Withdrew Consent|2
18060|NCT01682720|83337|P3|Overall Study|Subject Withdrew Consent|2
18061|NCT01682720|83338|P2|Overall Study|Subject Withdrew Consent|0
18062|NCT01682720|83339|P1|Overall Study|Subject Withdrew Consent|0
18063|NCT01682720|83336|P4|Overall Study|Lost to Follow-up|6
18064|NCT01682720|83337|P3|Overall Study|Lost to Follow-up|0
18065|NCT01682720|83338|P2|Overall Study|Lost to Follow-up|1
18066|NCT01682720|83339|P1|Overall Study|Lost to Follow-up|1
18067|NCT01682720|83336|P4|Overall Study|Efficacy Failure|30
18068|NCT01682720|83337|P3|Overall Study|Efficacy Failure|3
18069|NCT01682720|83338|P2|Overall Study|Efficacy Failure|3
18070|NCT01682720|83339|P1|Overall Study|Efficacy Failure|0
18071|NCT01682720|83336|P4|Overall Study|Terminated by Sponsor|0
18072|NCT01682720|83337|P3|Overall Study|Terminated by Sponsor|0
18073|NCT01682720|83338|P2|Overall Study|Terminated by Sponsor|0
18074|NCT01682720|83339|P1|Overall Study|Terminated by Sponsor|83
18075|NCT01682720|83336|P4|Overall Study|Randomized but Not Treated|0
18076|NCT01682720|83337|P3|Overall Study|Randomized but Not Treated|1
18077|NCT01682720|83338|P2|Overall Study|Randomized but Not Treated|1
18078|NCT01682720|83339|P1|Overall Study|Randomized but Not Treated|0
18079|NCT01682681|83356|P1|Overall Study|Low compliance|13
18080|NCT01682681|83356|P1|Overall Study|unspecified|21
18081|NCT01682681|83356|P1|Overall Study|tapering of topiramate|5
18082|NCT01682681|83356|P1|Overall Study|Adverse Event|46
18083|NCT01682681|83356|P1|Overall Study|Lost to Follow-up|174
18084|NCT01682681|83356|P1|Overall Study|Moved to other hospital|10
18085|NCT01682681|83356|P1|Overall Study|Withdrawal by Subject|1
18086|NCT01682681|83356|P1|Overall Study|Lack of Efficacy|62
18087|NCT01682603|83385|P1|Overall Study|Lost to Follow-up|3
18088|NCT01682460|83427|P1|Overall Study|Did not meet inclusion criteria|2
18089|NCT01682460|83427|P1|Overall Study|Withdrawal by Subject|2
18090|NCT01682031|83481|P2|Overall Study|Patient stopped selenium on his own|1
18091|NCT01682031|83482|P1|Overall Study|Patient stopped selenium on his own|0
18092|NCT01682031|83481|P2|Overall Study|Patient could not swallow tablets|0
18093|NCT01682031|83482|P1|Overall Study|Patient could not swallow tablets|1
18094|NCT01682031|83481|P2|Overall Study|MRI results indicate increased nodul|1
18095|NCT01682031|83482|P1|Overall Study|MRI results indicate increased nodul|0
18096|NCT01682031|83481|P2|Overall Study|Adverse Event|2
18097|NCT01682031|83482|P1|Overall Study|Adverse Event|0
18098|NCT01682031|83481|P2|Overall Study|Withdrawal by Subject|1
18099|NCT01682031|83482|P1|Overall Study|Withdrawal by Subject|0
18100|NCT01681576|83504|P2|Period 2|Non-compliance with study treatment|0
18101|NCT01681576|83505|P1|Period 2|Non-compliance with study treatment|1
18102|NCT01681576|83504|P2|Period 2|subject/guardian decision|1
18103|NCT01681576|83505|P1|Period 2|subject/guardian decision|3
18104|NCT01681576|83504|P2|Period 1|Protocol Deviation|0
18105|NCT01681576|83505|P1|Period 1|Protocol Deviation|1
18106|NCT01681576|83504|P2|Period 1|Adverse Event|0
18107|NCT01681576|83505|P1|Period 1|Adverse Event|1
18108|NCT01681511|83521|P2|Overall Study|No post-catheter sample collected|4
18109|NCT01681511|83522|P1|Overall Study|No post-catheter sample collected|11
18110|NCT01681511|83521|P2|Overall Study|No Daily Urine Sample Collected|1
18111|NCT01681511|83522|P1|Overall Study|No Daily Urine Sample Collected|0
18112|NCT01681511|83521|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
18113|NCT01681511|83522|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
18114|NCT01681511|83521|P2|Overall Study|Failed Inclusion/Exclusion|0
18115|NCT01681511|83522|P1|Overall Study|Failed Inclusion/Exclusion|3
18116|NCT01681511|83521|P2|Overall Study|No Treatment Received|3
18117|NCT01681511|83522|P1|Overall Study|No Treatment Received|1
18118|NCT01681472|83540|P4|Overall Study|Adverse Event|0
18119|NCT01681472|83541|P3|Overall Study|Adverse Event|0
18120|NCT01681472|83542|P2|Overall Study|Adverse Event|1
18121|NCT01681472|83543|P1|Overall Study|Adverse Event|0
18122|NCT01681368|83553|P1|Overall Study|Refused further follow up|1
18123|NCT01681368|83553|P1|Overall Study|Refused further treatment|1
18124|NCT01681277|83563|P5|Overall Study|Adverse Event|0
18125|NCT01681277|83564|P4|Overall Study|Adverse Event|0
18126|NCT01681277|83565|P3|Overall Study|Adverse Event|0
18127|NCT01681277|83566|P2|Overall Study|Adverse Event|0
18128|NCT01681277|83567|P1|Overall Study|Adverse Event|1
18129|NCT01681212|83608|P1|Overall Study|Administrative reason by sponsor|1
18130|NCT01681212|83608|P1|Overall Study|No longer met study criteria|5
18131|NCT01681069|83625|P2|Overall Study|Adverse Event|1
18132|NCT01681069|83626|P1|Overall Study|Adverse Event|0
18133|NCT01681069|83625|P2|Overall Study|Protocol Violation|1
18134|NCT01681069|83626|P1|Overall Study|Protocol Violation|1
18135|NCT01681069|83625|P2|Overall Study|Withdrawal by Subject|5
18136|NCT01681069|83626|P1|Overall Study|Withdrawal by Subject|4
18137|NCT01680991|83639|P3|Overall Study|PD confirmed in other hospital|0
18138|NCT01680991|83640|P2|Overall Study|PD confirmed in other hospital|0
18139|NCT01680991|83641|P1|Overall Study|PD confirmed in other hospital|1
18140|NCT01680991|83639|P3|Overall Study|Bad physical condition|1
18141|NCT01680991|83640|P2|Overall Study|Bad physical condition|0
18142|NCT01680991|83641|P1|Overall Study|Bad physical condition|0
18143|NCT01680991|83639|P3|Overall Study|Physician Decision|2
18144|NCT01680991|83640|P2|Overall Study|Physician Decision|7
18145|NCT01680991|83641|P1|Overall Study|Physician Decision|0
18146|NCT01680991|83639|P3|Overall Study|Progressive disease (PD)|0
18147|NCT01680991|83640|P2|Overall Study|Progressive disease (PD)|10
18148|NCT01680991|83641|P1|Overall Study|Progressive disease (PD)|0
18149|NCT01680991|83639|P3|Overall Study|Withdrawal by Subject|0
18150|NCT01680991|83640|P2|Overall Study|Withdrawal by Subject|1
18151|NCT01680991|83641|P1|Overall Study|Withdrawal by Subject|5
18152|NCT01680991|83639|P3|Overall Study|Protocol Violation|0
18153|NCT01680991|83640|P2|Overall Study|Protocol Violation|1
18154|NCT01680991|83641|P1|Overall Study|Protocol Violation|0
18155|NCT01680991|83639|P3|Overall Study|Death|1
18156|NCT01680991|83640|P2|Overall Study|Death|0
18157|NCT01680991|83641|P1|Overall Study|Death|1
18158|NCT01680991|83639|P3|Overall Study|Adverse Event|0
18159|NCT01680991|83640|P2|Overall Study|Adverse Event|0
18160|NCT01680991|83641|P1|Overall Study|Adverse Event|1
18161|NCT01680861|83721|P2|Early Post-transplant Period|Protocol Violation|1
18162|NCT01680861|83722|P1|Early Post-transplant Period|Protocol Violation|1
18163|NCT01680497|83753|P1|Overall Study|Lost to Follow-up|2
18164|NCT01680458|83763|P1|Overall Study|Protocol Violation|3
18165|NCT01680341|83774|P2|Overall Study|Unclassified|15
18166|NCT01680341|83775|P1|Overall Study|Unclassified|18
18167|NCT01680341|83774|P2|Overall Study|Adverse Event|2
18168|NCT01680341|83775|P1|Overall Study|Adverse Event|3
18169|NCT01680016|83844|P4|Overall Study|Withdrawal by Subject|1
18170|NCT01680016|83845|P3|Overall Study|Withdrawal by Subject|1
18171|NCT01680016|83846|P2|Overall Study|Withdrawal by Subject|7
18172|NCT01680016|83847|P1|Overall Study|Withdrawal by Subject|5
18173|NCT01680016|83844|P4|Overall Study|Protocol Violation|0
18174|NCT01680016|83845|P3|Overall Study|Protocol Violation|0
18175|NCT01680016|83846|P2|Overall Study|Protocol Violation|1
18176|NCT01680016|83847|P1|Overall Study|Protocol Violation|0
18177|NCT01680016|83844|P4|Overall Study|The Subject went out of The Trial|0
18178|NCT01680016|83845|P3|Overall Study|The Subject went out of The Trial|3
18179|NCT01680016|83846|P2|Overall Study|The Subject went out of The Trial|0
18180|NCT01680016|83847|P1|Overall Study|The Subject went out of The Trial|1
18181|NCT01680016|83844|P4|Overall Study|Adverse Event|4
18182|NCT01680016|83845|P3|Overall Study|Adverse Event|1
18183|NCT01680016|83846|P2|Overall Study|Adverse Event|0
18184|NCT01680016|83847|P1|Overall Study|Adverse Event|0
18185|NCT01679613|83909|P4|Overall Study|other than stated above|2
18186|NCT01679613|83910|P3|Overall Study|other than stated above|2
18187|NCT01679613|83911|P2|Overall Study|other than stated above|1
18188|NCT01679613|83912|P1|Overall Study|other than stated above|0
18189|NCT01679236|83955|P2|Overall Study|Lost to Follow-up|15
18190|NCT01679236|83956|P1|Overall Study|Lost to Follow-up|15
18191|NCT01679002|83990|P3|Overall Study|Adverse Event|0
18192|NCT01679002|83991|P2|Overall Study|Adverse Event|1
18193|NCT01679002|83992|P1|Overall Study|Adverse Event|1
18194|NCT01678911|84019|P2|Second Intervention|Lost to Follow-up|0
18195|NCT01678911|84020|P1|Second Intervention|Lost to Follow-up|2
18196|NCT01678885|84034|P3|Phase II|Withdrawal by Subject|5
18197|NCT01678885|84035|P2|Phase II|Withdrawal by Subject|0
18198|NCT01678885|84036|P1|Phase II|Withdrawal by Subject|0
18199|NCT01678885|84034|P3|Phase 1|Withdrawal by Subject|0
18200|NCT01678885|84035|P2|Phase 1|Withdrawal by Subject|3
18201|NCT01678885|84036|P1|Phase 1|Withdrawal by Subject|0
18202|NCT01678820|84059|P3|Overall Study|Not treated with double-blind study drug|2
18203|NCT01678820|84060|P2|Overall Study|Not treated with double-blind study drug|2
18204|NCT01678820|84061|P1|Overall Study|Not treated with double-blind study drug|0
18205|NCT01678820|84059|P3|Overall Study|Protocol Violation|4
18206|NCT01678820|84060|P2|Overall Study|Protocol Violation|5
18207|NCT01678820|84061|P1|Overall Study|Protocol Violation|4
18208|NCT01678820|84059|P3|Overall Study|Physician Decision|1
18209|NCT01678820|84060|P2|Overall Study|Physician Decision|0
18210|NCT01678820|84061|P1|Overall Study|Physician Decision|0
18211|NCT01678820|84059|P3|Overall Study|Non-compliance with study drug|0
18212|NCT01678820|84060|P2|Overall Study|Non-compliance with study drug|1
18213|NCT01678820|84061|P1|Overall Study|Non-compliance with study drug|0
18214|NCT01678820|84059|P3|Overall Study|Lost to Follow-up|2
18215|NCT01678820|84060|P2|Overall Study|Lost to Follow-up|2
18216|NCT01678820|84061|P1|Overall Study|Lost to Follow-up|7
18217|NCT01678820|84059|P3|Overall Study|Adverse Event|2
18218|NCT01678820|84060|P2|Overall Study|Adverse Event|2
18219|NCT01678820|84061|P1|Overall Study|Adverse Event|2
18220|NCT01678820|84059|P3|Overall Study|Protocol Specified Criteria|1
18221|NCT01678820|84060|P2|Overall Study|Protocol Specified Criteria|3
18222|NCT01678820|84061|P1|Overall Study|Protocol Specified Criteria|2
18223|NCT01678820|84059|P3|Overall Study|Withdrawal by Subject|2
18224|NCT01678820|84060|P2|Overall Study|Withdrawal by Subject|5
18225|NCT01678820|84061|P1|Overall Study|Withdrawal by Subject|2
18226|NCT01678820|84059|P3|Overall Study|Study Terminated by Sponsor|43
18227|NCT01678820|84060|P2|Overall Study|Study Terminated by Sponsor|43
18228|NCT01678820|84061|P1|Overall Study|Study Terminated by Sponsor|45
18229|NCT01678807|84106|P3|Overall Study|Withdrawn by Parent/Guardian|0
18230|NCT01678807|84107|P2|Overall Study|Withdrawn by Parent/Guardian|1
18231|NCT01678807|84108|P1|Overall Study|Withdrawn by Parent/Guardian|0
18232|NCT01678807|84106|P3|Overall Study|Adverse Event|0
18233|NCT01678807|84107|P2|Overall Study|Adverse Event|4
18234|NCT01678807|84108|P1|Overall Study|Adverse Event|4
18235|NCT01678313|84121|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
18236|NCT01678313|84122|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
18237|NCT01678313|84121|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
18238|NCT01678313|84122|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
18239|NCT01678313|84121|P2|Completed the 3-month Therapy|Physician Decision|4
18240|NCT01678313|84122|P1|Completed the 3-month Therapy|Physician Decision|3
18241|NCT01678313|84121|P2|Completed the 3-month Therapy|Lost to Follow-up|8
18242|NCT01678313|84122|P1|Completed the 3-month Therapy|Lost to Follow-up|3
18243|NCT01678131|84156|P3|Overall Study|Withdrawal by Subject|2
18244|NCT01678131|84157|P2|Overall Study|Withdrawal by Subject|0
18245|NCT01678131|84158|P1|Overall Study|Withdrawal by Subject|0
18246|NCT01678131|84156|P3|Overall Study|Adverse Event|0
18247|NCT01678131|84157|P2|Overall Study|Adverse Event|1
18248|NCT01678131|84158|P1|Overall Study|Adverse Event|0
18249|NCT01677988|84166|P1|Overall Study|Lack of Efficacy|2
18250|NCT01677936|84179|P2|Overall Study|Protocol Violation|4
18251|NCT01677936|84180|P1|Overall Study|Protocol Violation|0
18252|NCT01677936|84179|P2|Overall Study|Lost to Follow-up|0
18253|NCT01677936|84180|P1|Overall Study|Lost to Follow-up|1
18254|NCT01677936|84179|P2|Overall Study|Adverse Event|0
18255|NCT01677936|84180|P1|Overall Study|Adverse Event|1
18256|NCT01677936|84179|P2|Overall Study|Protocol Violation|0
18257|NCT01677936|84180|P1|Overall Study|Protocol Violation|3
18258|NCT01677936|84179|P2|Overall Study|Lost to Follow-up|1
18259|NCT01677936|84180|P1|Overall Study|Lost to Follow-up|4
18260|NCT01677767|84188|P1|Overall Study|Non-compliance by the participants|3
18261|NCT01677767|84188|P1|Overall Study|Withdrawal by Subject|10
18262|NCT01677767|84188|P1|Overall Study|Protocol Violation|4
18263|NCT01677767|84188|P1|Overall Study|Death|4
18264|NCT01677767|84188|P1|Overall Study|Adverse Event|1
18265|NCT01677624|84202|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
18266|NCT01677299|84211|P4|Overall Study|Withdrawal by Subject|1
18267|NCT01677299|84212|P3|Overall Study|Withdrawal by Subject|0
18268|NCT01677299|84213|P2|Overall Study|Withdrawal by Subject|1
18269|NCT01677299|84214|P1|Overall Study|Withdrawal by Subject|0
18270|NCT01677299|84211|P4|Overall Study|Adverse Event|0
18271|NCT01677299|84212|P3|Overall Study|Adverse Event|1
18272|NCT01677299|84213|P2|Overall Study|Adverse Event|2
18273|NCT01677299|84214|P1|Overall Study|Adverse Event|0
18274|NCT01677195|84239|P3|Overall Study|Protocol Violation|4
18275|NCT01677195|84240|P2|Overall Study|Protocol Violation|3
18276|NCT01677195|84241|P1|Overall Study|Protocol Violation|7
18277|NCT01677195|84239|P3|Overall Study|Pregnancy|0
18278|NCT01677195|84240|P2|Overall Study|Pregnancy|1
18279|NCT01677195|84241|P1|Overall Study|Pregnancy|0
18280|NCT01677195|84239|P3|Overall Study|Physician Decision|2
18281|NCT01677195|84240|P2|Overall Study|Physician Decision|2
18282|NCT01677195|84241|P1|Overall Study|Physician Decision|1
18283|NCT01677195|84239|P3|Overall Study|Adverse Event|1
18284|NCT01677195|84240|P2|Overall Study|Adverse Event|4
18285|NCT01677195|84241|P1|Overall Study|Adverse Event|6
18286|NCT01677195|84239|P3|Overall Study|Withdrawal by Subject|1
18287|NCT01677195|84240|P2|Overall Study|Withdrawal by Subject|0
18288|NCT01677195|84241|P1|Overall Study|Withdrawal by Subject|1
18289|NCT01677195|84239|P3|Overall Study|Lost to Follow-up|22
18290|NCT01677195|84240|P2|Overall Study|Lost to Follow-up|22
18291|NCT01677195|84241|P1|Overall Study|Lost to Follow-up|14
18292|NCT01677182|84252|P3|Overall Study|Other reasons|2
18293|NCT01677182|84253|P2|Overall Study|Other reasons|5
18294|NCT01677182|84254|P1|Overall Study|Other reasons|1
18295|NCT01677182|84252|P3|Overall Study|Lack of Efficacy|1
18296|NCT01677182|84253|P2|Overall Study|Lack of Efficacy|0
18297|NCT01677182|84254|P1|Overall Study|Lack of Efficacy|3
18298|NCT01677182|84252|P3|Overall Study|Study termination|11
18299|NCT01677182|84253|P2|Overall Study|Study termination|9
18300|NCT01677182|84254|P1|Overall Study|Study termination|12
18301|NCT01677182|84252|P3|Overall Study|Withdrawal by Subject|10
18302|NCT01677182|84253|P2|Overall Study|Withdrawal by Subject|12
18303|NCT01677182|84254|P1|Overall Study|Withdrawal by Subject|7
18304|NCT01677182|84252|P3|Overall Study|Lost to Follow-up|3
18305|NCT01677182|84253|P2|Overall Study|Lost to Follow-up|0
18306|NCT01677182|84254|P1|Overall Study|Lost to Follow-up|4
18307|NCT01677182|84252|P3|Overall Study|Protocol Violation|4
18308|NCT01677182|84253|P2|Overall Study|Protocol Violation|1
18309|NCT01677182|84254|P1|Overall Study|Protocol Violation|5
18310|NCT01677182|84252|P3|Overall Study|Adverse Event|8
18311|NCT01677182|84253|P2|Overall Study|Adverse Event|1
18312|NCT01677182|84254|P1|Overall Study|Adverse Event|2
18313|NCT01676896|84289|P3|Overall Study|Withdrawal by Subject|19
18314|NCT01676896|84290|P2|Overall Study|Withdrawal by Subject|7
18315|NCT01676896|84291|P1|Overall Study|Withdrawal by Subject|12
18316|NCT01676220|84430|P2|Overall Study|No More Need of Insulin|0
18317|NCT01676220|84431|P1|Overall Study|No More Need of Insulin|1
18318|NCT01676220|84430|P2|Overall Study|Non Serious Hypoglycemia|0
18319|NCT01676220|84431|P1|Overall Study|Non Serious Hypoglycemia|2
18320|NCT01676220|84430|P2|Overall Study|Perceived Lack of Efficacy|1
18321|NCT01676220|84431|P1|Overall Study|Perceived Lack of Efficacy|3
18322|NCT01676220|84430|P2|Overall Study|Site Closure/Site Withdrawal|4
18323|NCT01676220|84431|P1|Overall Study|Site Closure/Site Withdrawal|1
18324|NCT01676220|84430|P2|Overall Study|Selection Criterion/Protocol Violation|9
18325|NCT01676220|84431|P1|Overall Study|Selection Criterion/Protocol Violation|9
18326|NCT01676220|84430|P2|Overall Study|Lost to Follow-up|18
18327|NCT01676220|84431|P1|Overall Study|Lost to Follow-up|11
18328|NCT01676220|84430|P2|Overall Study|Personal Reason|45
18329|NCT01676220|84431|P1|Overall Study|Personal Reason|34
18330|NCT01676220|84430|P2|Overall Study|Received Rescue Therapy|22
18331|NCT01676220|84431|P1|Overall Study|Received Rescue Therapy|14
18332|NCT01676220|84430|P2|Overall Study|Protocol Violation|12
18333|NCT01676220|84431|P1|Overall Study|Protocol Violation|11
18334|NCT01676220|84430|P2|Overall Study|Lack of Efficacy|5
18335|NCT01676220|84431|P1|Overall Study|Lack of Efficacy|2
18336|NCT01676220|84430|P2|Overall Study|Adverse Event|8
18337|NCT01676220|84431|P1|Overall Study|Adverse Event|10
18338|NCT01676220|84430|P2|Overall Study|Randomized But Not Treated|1
18339|NCT01676220|84431|P1|Overall Study|Randomized But Not Treated|4
18340|NCT01676012|84461|P1|Overall Study|incomplete set of videos|1
18341|NCT01676012|84461|P1|Overall Study|Adverse Event|2
18342|NCT01675544|84470|P1|Overall Study|Withdrawal by Subject|2
18343|NCT01675531|84475|P1|Overall Study|Protocol Violation|8
18344|NCT01675531|84475|P1|Overall Study|Lack of Efficacy|1
18345|NCT01675531|84475|P1|Overall Study|Withdrawal by Subject|7
18346|NCT01675531|84475|P1|Overall Study|Adverse Event|9
18347|NCT01675427|84491|P1|Overall Study|Not Specified|2
18348|NCT01675427|84491|P1|Overall Study|Lost to Follow-up|5
18349|NCT01675427|84491|P1|Overall Study|Sample not Collected by Mistake|2
18350|NCT01675427|84491|P1|Overall Study|Participant Refused Sample Collection|18
18351|NCT01675427|84491|P1|Overall Study|Withdrawal by Subject|7
18352|NCT01675167|84778|P3|Double-blind Treatment Phase|Not specified|5
18353|NCT01675167|84779|P2|Double-blind Treatment Phase|Not specified|7
18354|NCT01675167|84780|P1|Double-blind Treatment Phase|Not specified|0
18355|NCT01675167|84778|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
18356|NCT01675167|84779|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
18357|NCT01675167|84780|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
18358|NCT01675167|84778|P3|Double-blind Treatment Phase|Lost to Follow-up|5
18359|NCT01675167|84779|P2|Double-blind Treatment Phase|Lost to Follow-up|1
18360|NCT01675167|84780|P1|Double-blind Treatment Phase|Lost to Follow-up|0
18361|NCT01675167|84778|P3|Double-blind Treatment Phase|Protocol Violation|11
18362|NCT01675167|84779|P2|Double-blind Treatment Phase|Protocol Violation|4
18363|NCT01675167|84780|P1|Double-blind Treatment Phase|Protocol Violation|0
18364|NCT01675167|84778|P3|Double-blind Treatment Phase|Adverse Event|13
18365|NCT01675167|84779|P2|Double-blind Treatment Phase|Adverse Event|5
18366|NCT01675167|84780|P1|Double-blind Treatment Phase|Adverse Event|0
18367|NCT01675167|84778|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
18368|NCT01675167|84779|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
18369|NCT01675167|84780|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
18370|NCT01675167|84778|P3|Double-blind Treatment Phase|Lack of Efficacy|61
18371|NCT01675167|84779|P2|Double-blind Treatment Phase|Lack of Efficacy|19
18372|NCT01675167|84780|P1|Double-blind Treatment Phase|Lack of Efficacy|0
18373|NCT01675167|84778|P3|Open-label Titration Phase|Not specified|0
18374|NCT01675167|84779|P2|Open-label Titration Phase|Not specified|0
18375|NCT01675167|84780|P1|Open-label Titration Phase|Not specified|55
18376|NCT01675167|84778|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
18377|NCT01675167|84779|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
18378|NCT01675167|84780|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
18379|NCT01675167|84778|P3|Open-label Titration Phase|Lost to Follow-up|0
18380|NCT01675167|84779|P2|Open-label Titration Phase|Lost to Follow-up|0
18381|NCT01675167|84780|P1|Open-label Titration Phase|Lost to Follow-up|15
18382|NCT01675167|84778|P3|Open-label Titration Phase|Protocol Violation|0
18383|NCT01675167|84779|P2|Open-label Titration Phase|Protocol Violation|0
18384|NCT01675167|84780|P1|Open-label Titration Phase|Protocol Violation|43
18385|NCT01675167|84778|P3|Open-label Titration Phase|Withdrawal by Subject|0
18386|NCT01675167|84779|P2|Open-label Titration Phase|Withdrawal by Subject|0
18387|NCT01675167|84780|P1|Open-label Titration Phase|Withdrawal by Subject|46
18388|NCT01675167|84778|P3|Open-label Titration Phase|Lack of Efficacy|0
18389|NCT01675167|84779|P2|Open-label Titration Phase|Lack of Efficacy|0
18390|NCT01675167|84780|P1|Open-label Titration Phase|Lack of Efficacy|63
18391|NCT01675167|84778|P3|Open-label Titration Phase|Adverse Event|0
18392|NCT01675167|84779|P2|Open-label Titration Phase|Adverse Event|0
18393|NCT01675167|84780|P1|Open-label Titration Phase|Adverse Event|81
18394|NCT01675128|84805|P3|Overall Study|Pulmonary complication; off study|0
18395|NCT01675128|84806|P2|Overall Study|Pulmonary complication; off study|1
18396|NCT01675128|84807|P1|Overall Study|Pulmonary complication; off study|0
18397|NCT01675128|84805|P3|Overall Study|Refused further treatment|0
18398|NCT01675128|84806|P2|Overall Study|Refused further treatment|0
18399|NCT01675128|84807|P1|Overall Study|Refused further treatment|1
18400|NCT01675128|84805|P3|Overall Study|Disease progression on study|1
18401|NCT01675128|84806|P2|Overall Study|Disease progression on study|1
18402|NCT01675128|84807|P1|Overall Study|Disease progression on study|1
18403|NCT01675011|84831|P2|Overall Study|Trial terminated by Sponsor|1
18404|NCT01675011|84832|P1|Overall Study|Trial terminated by Sponsor|3
18405|NCT01674725|84840|P2|Overall Study|Lost to Follow-up|1
18406|NCT01674725|84841|P1|Overall Study|Lost to Follow-up|0
18407|NCT01674725|84840|P2|Overall Study|Withdrawal by Subject|0
18408|NCT01674725|84841|P1|Overall Study|Withdrawal by Subject|1
18409|NCT01674725|84840|P2|Overall Study|Did not receive study drug|0
18410|NCT01674725|84841|P1|Overall Study|Did not receive study drug|1
18411|NCT01674725|84840|P2|Overall Study|Adverse Event|0
18412|NCT01674725|84841|P1|Overall Study|Adverse Event|1
18413|NCT01674712|84860|P5|Overall Study|Lack of Efficacy|1
18414|NCT01674712|84861|P4|Overall Study|Lack of Efficacy|0
18415|NCT01674712|84862|P3|Overall Study|Lack of Efficacy|1
18416|NCT01674712|84863|P2|Overall Study|Lack of Efficacy|0
18417|NCT01674712|84864|P1|Overall Study|Lack of Efficacy|0
18418|NCT01674712|84860|P5|Overall Study|Administrative|1
18419|NCT01674712|84861|P4|Overall Study|Administrative|0
18420|NCT01674712|84862|P3|Overall Study|Administrative|0
18421|NCT01674712|84863|P2|Overall Study|Administrative|1
18422|NCT01674712|84864|P1|Overall Study|Administrative|0
18423|NCT01674712|84860|P5|Overall Study|Withdrawal by Subject|3
18424|NCT01674712|84861|P4|Overall Study|Withdrawal by Subject|4
18425|NCT01674712|84862|P3|Overall Study|Withdrawal by Subject|5
18426|NCT01674712|84863|P2|Overall Study|Withdrawal by Subject|2
18427|NCT01674712|84864|P1|Overall Study|Withdrawal by Subject|2
18428|NCT01674712|84860|P5|Overall Study|Protocol Violation|0
18429|NCT01674712|84861|P4|Overall Study|Protocol Violation|0
18430|NCT01674712|84862|P3|Overall Study|Protocol Violation|0
18431|NCT01674712|84863|P2|Overall Study|Protocol Violation|0
18432|NCT01674712|84864|P1|Overall Study|Protocol Violation|2
18433|NCT01674712|84860|P5|Overall Study|Lost to Follow-up|0
18434|NCT01674712|84861|P4|Overall Study|Lost to Follow-up|0
18435|NCT01674712|84862|P3|Overall Study|Lost to Follow-up|0
18436|NCT01674712|84863|P2|Overall Study|Lost to Follow-up|0
18437|NCT01674712|84864|P1|Overall Study|Lost to Follow-up|1
18438|NCT01674712|84860|P5|Overall Study|Adverse Event|6
18439|NCT01674712|84861|P4|Overall Study|Adverse Event|4
18440|NCT01674712|84862|P3|Overall Study|Adverse Event|3
18441|NCT01674712|84863|P2|Overall Study|Adverse Event|6
18442|NCT01674712|84864|P1|Overall Study|Adverse Event|5
18443|NCT01674647|84888|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
18444|NCT01674647|84889|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
18445|NCT01674647|84888|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
18446|NCT01674647|84889|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
18447|NCT01674647|84888|P2|30-day Safety Follow-up Period|Logistical difficulties|3
18448|NCT01674647|84889|P1|30-day Safety Follow-up Period|Logistical difficulties|1
18449|NCT01674647|84888|P2|30-day Safety Follow-up Period|Protocol Violation|22
18450|NCT01674647|84889|P1|30-day Safety Follow-up Period|Protocol Violation|39
18451|NCT01674647|84888|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
18452|NCT01674647|84889|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
18453|NCT01674647|84888|P2|30-day Safety Follow-up Period|Death|2
18454|NCT01674647|84889|P1|30-day Safety Follow-up Period|Death|3
18455|NCT01674647|84888|P2|Treatment Period|Protocol Violation|36
18456|NCT01674647|84889|P1|Treatment Period|Protocol Violation|56
18457|NCT01674647|84888|P2|Treatment Period|Treatment failure|14
18458|NCT01674647|84889|P1|Treatment Period|Treatment failure|0
18459|NCT01674647|84888|P2|Treatment Period|Logistical difficulties|8
18460|NCT01674647|84889|P1|Treatment Period|Logistical difficulties|5
18461|NCT01674647|84888|P2|Treatment Period|Switching to other therapy|2
18462|NCT01674647|84889|P1|Treatment Period|Switching to other therapy|5
18463|NCT01674647|84888|P2|Treatment Period|Withdrawal by Subject|16
18464|NCT01674647|84889|P1|Treatment Period|Withdrawal by Subject|19
18465|NCT01674647|84888|P2|Treatment Period|Lost to Follow-up|1
18466|NCT01674647|84889|P1|Treatment Period|Lost to Follow-up|1
18467|NCT01674647|84888|P2|Treatment Period|Non-compliance with study drug|0
18468|NCT01674647|84889|P1|Treatment Period|Non-compliance with study drug|3
18469|NCT01674647|84888|P2|Treatment Period|Adverse Event|22
18470|NCT01674647|84889|P1|Treatment Period|Adverse Event|60
18471|NCT01674647|84888|P2|Treatment Period|Physician Decision|1
18472|NCT01674647|84889|P1|Treatment Period|Physician Decision|3
18473|NCT01674647|84888|P2|Treatment Period|Efficacy outcome reached|1
18474|NCT01674647|84889|P1|Treatment Period|Efficacy outcome reached|0
18475|NCT01674647|84888|P2|Treatment Period|Death|1
18476|NCT01674647|84889|P1|Treatment Period|Death|4
18477|NCT01674634|84915|P1|Overall Study|Lost to Follow-up|3
18478|NCT01674634|84915|P1|Overall Study|Withdrawal by Subject|3
18479|NCT01674062|84963|P2|Overall Study|Programming Error|0
18480|NCT01674062|84964|P1|Overall Study|Programming Error|1
18481|NCT01674062|84963|P2|Overall Study|Death|1
18482|NCT01674062|84964|P1|Overall Study|Death|0
18483|NCT01674062|84963|P2|Overall Study|Adverse Event|1
18484|NCT01674062|84964|P1|Overall Study|Adverse Event|1
18485|NCT01674062|84963|P2|Overall Study|Not Specified|1
18486|NCT01674062|84964|P1|Overall Study|Not Specified|8
18487|NCT01674062|84963|P2|Overall Study|Insufficient Therapeutic Response|26
18488|NCT01674062|84964|P1|Overall Study|Insufficient Therapeutic Response|56
18489|NCT01674010|84979|P3|Randomization Phase 2|Withdrawal by Subject|7
18490|NCT01674010|84980|P2|Randomization Phase 2|Withdrawal by Subject|8
18491|NCT01674010|84981|P1|Randomization Phase 2|Withdrawal by Subject|0
18492|NCT01674010|84979|P3|Randomization Phase 2|Sponsor Decision|45
18493|NCT01674010|84980|P2|Randomization Phase 2|Sponsor Decision|42
18494|NCT01674010|84981|P1|Randomization Phase 2|Sponsor Decision|0
18495|NCT01674010|84979|P3|Randomization Phase 2|Protocol Violation|1
18496|NCT01674010|84980|P2|Randomization Phase 2|Protocol Violation|1
18497|NCT01674010|84981|P1|Randomization Phase 2|Protocol Violation|0
18498|NCT01674010|84979|P3|Randomization Phase 2|Pregnancy|1
18499|NCT01674010|84980|P2|Randomization Phase 2|Pregnancy|1
18500|NCT01674010|84981|P1|Randomization Phase 2|Pregnancy|0
18501|NCT01674010|84979|P3|Randomization Phase 2|Physician Decision|2
18502|NCT01674010|84980|P2|Randomization Phase 2|Physician Decision|0
18503|NCT01674010|84981|P1|Randomization Phase 2|Physician Decision|0
18504|NCT01674010|84979|P3|Randomization Phase 2|Mood episode recurrence|2
18505|NCT01674010|84980|P2|Randomization Phase 2|Mood episode recurrence|8
18506|NCT01674010|84981|P1|Randomization Phase 2|Mood episode recurrence|0
18507|NCT01674010|84979|P3|Randomization Phase 2|Lost to Follow-up|2
18508|NCT01674010|84980|P2|Randomization Phase 2|Lost to Follow-up|1
18509|NCT01674010|84981|P1|Randomization Phase 2|Lost to Follow-up|0
18510|NCT01674010|84979|P3|Randomization Phase 2|Adverse Event|1
18511|NCT01674010|84980|P2|Randomization Phase 2|Adverse Event|1
18512|NCT01674010|84981|P1|Randomization Phase 2|Adverse Event|0
18513|NCT01674010|84979|P3|Open Treatment Phase 1|Withdrawal by Subject|0
18514|NCT01674010|84980|P2|Open Treatment Phase 1|Withdrawal by Subject|0
18515|NCT01674010|84981|P1|Open Treatment Phase 1|Withdrawal by Subject|25
18516|NCT01674010|84979|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
18517|NCT01674010|84980|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
18518|NCT01674010|84981|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
18519|NCT01674010|84979|P3|Open Treatment Phase 1|Sponsor Decision|0
18520|NCT01674010|84980|P2|Open Treatment Phase 1|Sponsor Decision|0
18521|NCT01674010|84981|P1|Open Treatment Phase 1|Sponsor Decision|79
18522|NCT01674010|84979|P3|Open Treatment Phase 1|Protocol Violation|0
18523|NCT01674010|84980|P2|Open Treatment Phase 1|Protocol Violation|0
18524|NCT01674010|84981|P1|Open Treatment Phase 1|Protocol Violation|7
18525|NCT01674010|84979|P3|Open Treatment Phase 1|Physician Decision|0
18526|NCT01674010|84980|P2|Open Treatment Phase 1|Physician Decision|0
18527|NCT01674010|84981|P1|Open Treatment Phase 1|Physician Decision|9
18528|NCT01674010|84979|P3|Open Treatment Phase 1|Lost to Follow-up|0
18529|NCT01674010|84980|P2|Open Treatment Phase 1|Lost to Follow-up|0
18530|NCT01674010|84981|P1|Open Treatment Phase 1|Lost to Follow-up|19
18531|NCT01674010|84979|P3|Open Treatment Phase 1|Death|0
18532|NCT01674010|84980|P2|Open Treatment Phase 1|Death|0
18533|NCT01674010|84981|P1|Open Treatment Phase 1|Death|1
18534|NCT01674010|84979|P3|Open Treatment Phase 1|Adverse Event|0
18535|NCT01674010|84980|P2|Open Treatment Phase 1|Adverse Event|0
18536|NCT01674010|84981|P1|Open Treatment Phase 1|Adverse Event|10
18537|NCT01673984|85000|P2|Overall Study|Study termination|6
18538|NCT01673984|85001|P1|Overall Study|Study termination|9
18539|NCT01673984|85000|P2|Overall Study|Adverse Event|0
18540|NCT01673984|85001|P1|Overall Study|Adverse Event|1
18541|NCT01673867|85043|P2|Treatment|Physician Decision|1
18542|NCT01673867|85044|P1|Treatment|Physician Decision|0
18543|NCT01673867|85043|P2|Treatment|Symptomatic deterioration|1
18544|NCT01673867|85044|P1|Treatment|Symptomatic deterioration|0
18545|NCT01673867|85043|P2|Treatment|Required prolonged hospitalization|1
18546|NCT01673867|85044|P1|Treatment|Required prolonged hospitalization|0
18547|NCT01673867|85043|P2|Treatment|Health status not improved|0
18548|NCT01673867|85044|P1|Treatment|Health status not improved|1
18549|NCT01673867|85043|P2|Treatment|Required steroid therapy|0
18550|NCT01673867|85044|P1|Treatment|Required steroid therapy|1
18551|NCT01673867|85043|P2|Treatment|No longer meets criteria|0
18552|NCT01673867|85044|P1|Treatment|No longer meets criteria|2
18553|NCT01673867|85043|P2|Treatment|Maximum clinical benefit|10
18554|NCT01673867|85044|P1|Treatment|Maximum clinical benefit|0
18555|NCT01673867|85043|P2|Treatment|Withdrawal by Subject|6
18556|NCT01673867|85044|P1|Treatment|Withdrawal by Subject|4
18557|NCT01673867|85043|P2|Treatment|Requested treatment discontinuation|16
18558|NCT01673867|85044|P1|Treatment|Requested treatment discontinuation|5
18559|NCT01673867|85043|P2|Treatment|AE unrelated to study drug|11
18560|NCT01673867|85044|P1|Treatment|AE unrelated to study drug|19
18561|NCT01673867|85043|P2|Treatment|Death|1
18562|NCT01673867|85044|P1|Treatment|Death|1
18563|NCT01673867|85043|P2|Treatment|Study Drug Toxicity|42
18564|NCT01673867|85044|P1|Treatment|Study Drug Toxicity|17
18565|NCT01673867|85043|P2|Treatment|Disease Progression|179
18566|NCT01673867|85044|P1|Treatment|Disease Progression|194
18567|NCT01673867|85043|P2|Randomization|No longer meets criteria|5
18568|NCT01673867|85044|P1|Randomization|No longer meets criteria|4
18569|NCT01673867|85043|P2|Randomization|Lost to Follow-up|1
18570|NCT01673867|85044|P1|Randomization|Lost to Follow-up|0
18571|NCT01673867|85043|P2|Randomization|Withdrawal by Subject|12
18572|NCT01673867|85044|P1|Randomization|Withdrawal by Subject|0
18573|NCT01673867|85043|P2|Randomization|Requested treatment discontinuation|4
18574|NCT01673867|85044|P1|Randomization|Requested treatment discontinuation|0
18575|NCT01673867|85043|P2|Randomization|AE unrelated to study drug|0
18576|NCT01673867|85044|P1|Randomization|AE unrelated to study drug|1
18577|NCT01673854|85070|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
18578|NCT01673854|85070|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
18579|NCT01673854|85070|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
18580|NCT01673854|85070|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
18581|NCT01673854|85070|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
18582|NCT01673854|85070|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
18583|NCT01673854|85070|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
18584|NCT01673854|85070|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
18585|NCT01673854|85070|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
18586|NCT01673854|85070|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
18587|NCT01673854|85070|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
18588|NCT01673854|85070|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
18589|NCT01673802|85080|P2|Overall Study|failed screening|1
18590|NCT01673802|85081|P1|Overall Study|failed screening|1
18591|NCT01673698|85089|P2|Overall Study|Lost to Follow-up|13
18592|NCT01673698|85090|P1|Overall Study|Lost to Follow-up|51
18593|NCT01673620|85100|P2|Overall Study|Adverse Event|0
18594|NCT01673620|85101|P1|Overall Study|Adverse Event|1
18595|NCT01673594|85111|P2|Overall Study|Withdrawal by Subject|1
18596|NCT01673594|85112|P1|Overall Study|Withdrawal by Subject|0
18597|NCT01673594|85111|P2|Overall Study|Physician Decision|4
18598|NCT01673594|85112|P1|Overall Study|Physician Decision|2
18599|NCT01673594|85111|P2|Overall Study|Lost to Follow-up|0
18600|NCT01673594|85112|P1|Overall Study|Lost to Follow-up|1
18601|NCT01673594|85111|P2|Overall Study|Adverse Event|1
18602|NCT01673594|85112|P1|Overall Study|Adverse Event|3
18603|NCT01673490|85131|P1|Overall Study|Withdrawal by Subject|3
18604|NCT01673490|85131|P1|Overall Study|Adverse Event|3
18605|NCT01673490|85131|P1|Overall Study|Lost to Follow-up|1
18606|NCT01673282|85150|P2|Overall Study|unspecified|6
18607|NCT01673282|85151|P1|Overall Study|unspecified|1
18608|NCT01673282|85150|P2|Overall Study|Withdrawal by Subject|3
18609|NCT01673282|85151|P1|Overall Study|Withdrawal by Subject|3
18610|NCT01673282|85150|P2|Overall Study|Lost to Follow-up|10
18611|NCT01673282|85151|P1|Overall Study|Lost to Follow-up|11
18612|NCT01673282|85150|P2|Overall Study|Lack of Efficacy|2
18613|NCT01673282|85151|P1|Overall Study|Lack of Efficacy|9
18614|NCT01673282|85150|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
18615|NCT01673282|85151|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
18616|NCT01673178|85166|P5|Overall Study|Unspecified|0
18617|NCT01673178|85167|P4|Overall Study|Unspecified|1
18618|NCT01673178|85168|P3|Overall Study|Unspecified|2
18619|NCT01673178|85169|P2|Overall Study|Unspecified|0
18620|NCT01673178|85170|P1|Overall Study|Unspecified|1
18621|NCT01673178|85166|P5|Overall Study|Adverse Event|0
18622|NCT01673178|85167|P4|Overall Study|Adverse Event|2
18623|NCT01673178|85168|P3|Overall Study|Adverse Event|0
18624|NCT01673178|85169|P2|Overall Study|Adverse Event|0
18625|NCT01673178|85170|P1|Overall Study|Adverse Event|1
18626|NCT01673178|85166|P5|Overall Study|Protocol Violation|0
18627|NCT01673178|85167|P4|Overall Study|Protocol Violation|1
18628|NCT01673178|85168|P3|Overall Study|Protocol Violation|0
18629|NCT01673178|85169|P2|Overall Study|Protocol Violation|1
18630|NCT01673178|85170|P1|Overall Study|Protocol Violation|1
18631|NCT01673178|85166|P5|Overall Study|Withdrawal by Subject|2
18632|NCT01673178|85167|P4|Overall Study|Withdrawal by Subject|4
18633|NCT01673178|85168|P3|Overall Study|Withdrawal by Subject|1
18634|NCT01673178|85169|P2|Overall Study|Withdrawal by Subject|0
18635|NCT01673178|85170|P1|Overall Study|Withdrawal by Subject|0
18636|NCT01673178|85166|P5|Overall Study|Lost to Follow-up|0
18637|NCT01673178|85167|P4|Overall Study|Lost to Follow-up|0
18638|NCT01673178|85168|P3|Overall Study|Lost to Follow-up|0
18639|NCT01673178|85169|P2|Overall Study|Lost to Follow-up|1
18640|NCT01673178|85170|P1|Overall Study|Lost to Follow-up|0
18641|NCT01673126|85409|P2|Overall Study|change of diagnosis|3
18642|NCT01673126|85410|P1|Overall Study|change of diagnosis|4
18643|NCT01673009|85416|P1|Overall Study|Withdrawal by Subject|8
18644|NCT01673009|85416|P1|Overall Study|Physician Decision|5
18645|NCT01672970|85501|P1|Overall Study|Enrolled but not treated|1
18646|NCT01672970|85501|P1|Overall Study|Unspecified|9
18647|NCT01672970|85501|P1|Overall Study|Lost to Follow-up|5
18648|NCT01672970|85501|P1|Overall Study|Withdrawal by Subject|2
18649|NCT01672970|85501|P1|Overall Study|Adverse Event|18
18650|NCT01672970|85501|P1|Overall Study|Lack of Efficacy|12
18651|NCT01672957|85537|P1|Overall Study|ICF Signed After Transplantation|5
18652|NCT01672957|85537|P1|Overall Study|Death|2
18653|NCT01672957|85537|P1|Overall Study|Protocol Violation|48
18654|NCT01672788|85556|P4|Washout Period 2 (7 Days)|Adverse Event|1
18655|NCT01672788|85557|P3|Washout Period 2 (7 Days)|Adverse Event|0
18656|NCT01672788|85558|P2|Washout Period 2 (7 Days)|Adverse Event|0
18657|NCT01672788|85559|P1|Washout Period 2 (7 Days)|Adverse Event|0
18658|NCT01672723|85589|P2|First Intervention|Adverse Event|0
18659|NCT01672723|85590|P1|First Intervention|Adverse Event|3
18660|NCT01671748|85634|P2|4 Week run-in Phase|Not eligible|0
18661|NCT01671748|85635|P1|4 Week run-in Phase|Not eligible|9
18662|NCT01671748|85634|P2|4 Week run-in Phase|Adverse Event|0
18663|NCT01671748|85635|P1|4 Week run-in Phase|Adverse Event|1
18664|NCT01671748|85634|P2|4 Week run-in Phase|Withdrawal by Subject|0
18665|NCT01671748|85635|P1|4 Week run-in Phase|Withdrawal by Subject|1
18666|NCT01671111|85662|P1|Overall Study|Unspecified|24
18667|NCT01671111|85662|P1|Overall Study|Physician Decision|1
18668|NCT01671111|85662|P1|Overall Study|Withdrawal by Subject|2
18669|NCT01671111|85662|P1|Overall Study|Lack of Efficacy|1
18670|NCT01671111|85662|P1|Overall Study|Adverse Event|2
18671|NCT01671059|85672|P1|Overall Study|Lack of Efficacy|1
18672|NCT01671059|85672|P1|Overall Study|Adverse Event|4
18673|NCT01670721|85695|P1|Overall Study|Other than specified above|38
18674|NCT01670721|85695|P1|Overall Study|Participant's decision|15
18675|NCT01670279|85714|P4|Overall Study|Participant met withdrawal criteria|1
18676|NCT01670279|85715|P3|Overall Study|Participant met withdrawal criteria|0
18677|NCT01670279|85716|P2|Overall Study|Participant met withdrawal criteria|0
18678|NCT01670279|85717|P1|Overall Study|Participant met withdrawal criteria|0
18679|NCT01670279|85714|P4|Overall Study|Physician Decision|0
18680|NCT01670279|85715|P3|Overall Study|Physician Decision|0
18681|NCT01670279|85716|P2|Overall Study|Physician Decision|1
18682|NCT01670279|85717|P1|Overall Study|Physician Decision|0
18683|NCT01670279|85714|P4|Overall Study|Adverse Event|0
18684|NCT01670279|85715|P3|Overall Study|Adverse Event|0
18685|NCT01670279|85716|P2|Overall Study|Adverse Event|1
18686|NCT01670279|85717|P1|Overall Study|Adverse Event|0
18687|NCT01670045|85757|P1|Overall Study|Lost to Follow-up|11
18688|NCT01670045|85757|P1|Overall Study|Death|1
18689|NCT01670045|85757|P1|Overall Study|Adverse Event|1
18690|NCT01670045|85757|P1|Overall Study|Withdrawal by Subject|3
18691|NCT01670019|85775|P2|Overall Study|Withdrawal by Subject|0
18692|NCT01670019|85776|P1|Overall Study|Withdrawal by Subject|6
18693|NCT01670019|85775|P2|Overall Study|Adverse Event|0
18694|NCT01670019|85776|P1|Overall Study|Adverse Event|3
18695|NCT01669902|85790|P1|Overall Study|Unspecified|8
18696|NCT01669902|85790|P1|Overall Study|Lack of Efficacy|10
18697|NCT01669902|85790|P1|Overall Study|Adverse Event|11
18698|NCT01669811|85825|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
18699|NCT01669811|85826|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
18700|NCT01669811|85825|P2|Overall Study|Adverse Event|6
18701|NCT01669811|85826|P1|Overall Study|Adverse Event|2
18702|NCT01669811|85825|P2|Overall Study|Withdrawal by Subject|2
18703|NCT01669811|85826|P1|Overall Study|Withdrawal by Subject|1
18704|NCT01669811|85825|P2|Overall Study|Investigator decision|1
18705|NCT01669811|85826|P1|Overall Study|Investigator decision|0
18706|NCT01669629|85893|P2|Period 1|protocol deviation|2
18707|NCT01669629|85894|P1|Period 1|protocol deviation|1
18708|NCT01669577|85908|P1|Overall Study|Physician Decision|34
18709|NCT01669577|85908|P1|Overall Study|Lost to Follow-up|78
18710|NCT01669577|85908|P1|Overall Study|Death|22
18711|NCT01669174|85914|P2|Overall Study|Administrative problems|2
18712|NCT01669174|85915|P1|Overall Study|Administrative problems|1
18713|NCT01669174|85914|P2|Overall Study|Adverse Event|2
18714|NCT01669174|85915|P1|Overall Study|Adverse Event|2
18715|NCT01669174|85914|P2|Overall Study|Lost to Follow-up|0
18716|NCT01669174|85915|P1|Overall Study|Lost to Follow-up|1
18717|NCT01669174|85914|P2|Overall Study|Subject withdrew consent|2
18718|NCT01669174|85915|P1|Overall Study|Subject withdrew consent|2
18719|NCT01669122|85926|P1|Washout Period II|Protocol Violation|2
18720|NCT01669122|85926|P1|Period I|Lost to Follow-up|1
18721|NCT01668797|86019|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
18722|NCT01668797|86020|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
18723|NCT01668797|86021|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
18724|NCT01668797|86022|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
18725|NCT01668797|86019|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
18726|NCT01668797|86020|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
18727|NCT01668797|86021|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
18728|NCT01668797|86022|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
18729|NCT01668797|86019|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
18730|NCT01668797|86020|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
18731|NCT01668797|86021|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
18732|NCT01668797|86022|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
18978|NCT01665807|86565|P2|Overall Study|Withdrawal by Subject|0
18733|NCT01668797|86019|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
18734|NCT01668797|86020|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
18735|NCT01668797|86021|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
18736|NCT01668797|86022|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
18737|NCT01668797|86019|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
18738|NCT01668797|86020|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
18739|NCT01668797|86021|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
18740|NCT01668797|86022|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
18741|NCT01668797|86019|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
18742|NCT01668797|86020|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
18743|NCT01668797|86021|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
18744|NCT01668797|86022|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
18745|NCT01668797|86019|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
18746|NCT01668797|86020|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
18747|NCT01668797|86021|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
18748|NCT01668797|86022|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
18749|NCT01668797|86019|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
18750|NCT01668797|86020|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
18751|NCT01668797|86021|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
18752|NCT01668797|86022|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
18753|NCT01668797|86019|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
18754|NCT01668797|86020|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
18755|NCT01668797|86021|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
18756|NCT01668797|86022|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
18757|NCT01668797|86019|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
18758|NCT01668797|86020|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
18759|NCT01668797|86021|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
18760|NCT01668797|86022|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
18761|NCT01668797|86019|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
18762|NCT01668797|86020|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
18763|NCT01668797|86021|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
18764|NCT01668797|86022|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
18765|NCT01668797|86019|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
18766|NCT01668797|86020|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
18767|NCT01668797|86021|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
18768|NCT01668797|86022|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
18769|NCT01668797|86019|P4|Phase B (Stabilization Phase)|Protocol Violation|0
18770|NCT01668797|86020|P3|Phase B (Stabilization Phase)|Protocol Violation|0
18771|NCT01668797|86021|P2|Phase B (Stabilization Phase)|Protocol Violation|3
18772|NCT01668797|86022|P1|Phase B (Stabilization Phase)|Protocol Violation|0
18773|NCT01668797|86019|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
18774|NCT01668797|86020|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
18775|NCT01668797|86021|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
18776|NCT01668797|86022|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
18777|NCT01668797|86019|P4|Phase B (Stabilization Phase)|Physician Decision|0
18778|NCT01668797|86020|P3|Phase B (Stabilization Phase)|Physician Decision|0
18779|NCT01668797|86021|P2|Phase B (Stabilization Phase)|Physician Decision|11
18780|NCT01668797|86022|P1|Phase B (Stabilization Phase)|Physician Decision|0
18781|NCT01668797|86019|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
18782|NCT01668797|86020|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
18783|NCT01668797|86021|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
18784|NCT01668797|86022|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
18785|NCT01668797|86019|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
18786|NCT01668797|86020|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
18787|NCT01668797|86021|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
18788|NCT01668797|86022|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
18789|NCT01668797|86019|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
18790|NCT01668797|86020|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
18791|NCT01668797|86021|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
18792|NCT01668797|86022|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
18793|NCT01668797|86019|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
18794|NCT01668797|86020|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
18795|NCT01668797|86021|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
18796|NCT01668797|86022|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
18797|NCT01668797|86019|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
18798|NCT01668797|86020|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
18799|NCT01668797|86021|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
18800|NCT01668797|86022|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
18801|NCT01668797|86019|P4|Phase A (Conversion Phase)|Protocol Violation|0
18802|NCT01668797|86020|P3|Phase A (Conversion Phase)|Protocol Violation|0
18803|NCT01668797|86021|P2|Phase A (Conversion Phase)|Protocol Violation|0
18804|NCT01668797|86022|P1|Phase A (Conversion Phase)|Protocol Violation|2
18805|NCT01668797|86019|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
18806|NCT01668797|86020|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
18807|NCT01668797|86021|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
18808|NCT01668797|86022|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
18809|NCT01668797|86019|P4|Phase A (Conversion Phase)|Physician Decision|0
18810|NCT01668797|86020|P3|Phase A (Conversion Phase)|Physician Decision|0
18811|NCT01668797|86021|P2|Phase A (Conversion Phase)|Physician Decision|0
18812|NCT01668797|86022|P1|Phase A (Conversion Phase)|Physician Decision|2
18813|NCT01668797|86019|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
18814|NCT01668797|86020|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
18815|NCT01668797|86021|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
18816|NCT01668797|86022|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
18817|NCT01668797|86019|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
18818|NCT01668797|86020|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
18819|NCT01668797|86021|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
18820|NCT01668797|86022|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
18821|NCT01668784|86087|P2|Treated (Overall)|Not Specified|4
18822|NCT01668784|86088|P1|Treated (Overall)|Not Specified|0
18823|NCT01668784|86087|P2|Treated (Overall)|Maximal Clinical Benefit|3
18824|NCT01668784|86088|P1|Treated (Overall)|Maximal Clinical Benefit|2
18825|NCT01668784|86087|P2|Treated (Overall)|Withdrawal by Subject|3
18826|NCT01668784|86088|P1|Treated (Overall)|Withdrawal by Subject|2
18827|NCT01668784|86087|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
18828|NCT01668784|86088|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
18829|NCT01668784|86087|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
18830|NCT01668784|86088|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
18831|NCT01668784|86087|P2|Treated (Overall)|Death|1
18832|NCT01668784|86088|P1|Treated (Overall)|Death|1
18833|NCT01668784|86087|P2|Treated (Overall)|Study Drug Toxicity|53
18834|NCT01668784|86088|P1|Treated (Overall)|Study Drug Toxicity|35
18835|NCT01668784|86087|P2|Treated (Overall)|Disease Progression|273
18836|NCT01668784|86088|P1|Treated (Overall)|Disease Progression|285
18837|NCT01668784|86087|P2|Randomized (Pre-treatment)|Not Specified|1
18838|NCT01668784|86088|P1|Randomized (Pre-treatment)|Not Specified|0
18839|NCT01668784|86087|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
18840|NCT01668784|86088|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
18841|NCT01668784|86087|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
18842|NCT01668784|86088|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
18843|NCT01668784|86087|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
18844|NCT01668784|86088|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
18845|NCT01668784|86087|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
18846|NCT01668784|86088|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
18847|NCT01668784|86087|P2|Randomized (Pre-treatment)|Disease Progression|1
18848|NCT01668784|86088|P1|Randomized (Pre-treatment)|Disease Progression|0
18849|NCT01668667|86116|P4|Overall Study|Withdrawal by Subject|5
18850|NCT01668667|86117|P3|Overall Study|Withdrawal by Subject|5
18851|NCT01668667|86118|P2|Overall Study|Withdrawal by Subject|4
18852|NCT01668667|86119|P1|Overall Study|Withdrawal by Subject|7
18853|NCT01668667|86116|P4|Overall Study|Physician Decision|0
18854|NCT01668667|86117|P3|Overall Study|Physician Decision|1
18855|NCT01668667|86118|P2|Overall Study|Physician Decision|0
18856|NCT01668667|86119|P1|Overall Study|Physician Decision|3
18857|NCT01668667|86116|P4|Overall Study|Lost to Follow-up|6
18858|NCT01668667|86117|P3|Overall Study|Lost to Follow-up|7
18859|NCT01668667|86118|P2|Overall Study|Lost to Follow-up|4
18860|NCT01668667|86119|P1|Overall Study|Lost to Follow-up|9
18861|NCT01668667|86116|P4|Overall Study|Protocol Violation|5
18862|NCT01668667|86117|P3|Overall Study|Protocol Violation|12
18863|NCT01668667|86118|P2|Overall Study|Protocol Violation|10
18864|NCT01668667|86119|P1|Overall Study|Protocol Violation|6
18865|NCT01668667|86116|P4|Overall Study|Lack of Efficacy|3
18866|NCT01668667|86117|P3|Overall Study|Lack of Efficacy|2
18867|NCT01668667|86118|P2|Overall Study|Lack of Efficacy|2
18868|NCT01668667|86119|P1|Overall Study|Lack of Efficacy|3
18869|NCT01668667|86116|P4|Overall Study|Adverse Event|4
18870|NCT01668667|86117|P3|Overall Study|Adverse Event|4
18871|NCT01668667|86118|P2|Overall Study|Adverse Event|6
18872|NCT01668667|86119|P1|Overall Study|Adverse Event|3
18873|NCT01668654|86141|P1|Overall Study|Withdrawal by Subject|1
18874|NCT01668654|86141|P1|Overall Study|Study Closed/Terminated|3
18875|NCT01668589|86202|P4|Overall Study|Other|15
18876|NCT01668589|86203|P3|Overall Study|Other|7
18877|NCT01668589|86204|P2|Overall Study|Other|10
18878|NCT01668589|86205|P1|Overall Study|Other|44
18879|NCT01668589|86202|P4|Overall Study|Death|11
18880|NCT01668589|86203|P3|Overall Study|Death|2
18881|NCT01668589|86204|P2|Overall Study|Death|3
18882|NCT01668589|86205|P1|Overall Study|Death|12
18883|NCT01668589|86202|P4|Overall Study|Full Consent/Agreement Withdrawn|4
18884|NCT01668589|86203|P3|Overall Study|Full Consent/Agreement Withdrawn|11
18885|NCT01668589|86204|P2|Overall Study|Full Consent/Agreement Withdrawn|8
18886|NCT01668589|86205|P1|Overall Study|Full Consent/Agreement Withdrawn|54
18887|NCT01668589|86202|P4|Overall Study|Lost to Follow-up|5
18888|NCT01668589|86203|P3|Overall Study|Lost to Follow-up|15
18889|NCT01668589|86204|P2|Overall Study|Lost to Follow-up|37
18890|NCT01668589|86205|P1|Overall Study|Lost to Follow-up|29
18891|NCT01668173|86243|P1|Overall Study|Trial suspension|4
18892|NCT01668173|86243|P1|Overall Study|Adverse Event|3
18893|NCT01668004|86247|P1|Overall Study|Non-compliance with treatment|2
18894|NCT01668004|86247|P1|Overall Study|Lack of Efficacy|9
18895|NCT01668004|86247|P1|Overall Study|Lost to Follow-up|5
18896|NCT01668004|86247|P1|Overall Study|Withdrawal by Subject|2
18897|NCT01668004|86247|P1|Overall Study|Adverse Event|7
18898|NCT01667900|86272|P20|Part B|Death|0
18899|NCT01667900|86273|P19|Part B|Death|0
18900|NCT01667900|86274|P18|Part B|Death|0
18901|NCT01667900|86275|P17|Part B|Death|1
18902|NCT01667900|86276|P16|Part B|Death|0
18903|NCT01667900|86277|P15|Part B|Death|0
18904|NCT01667900|86278|P14|Part B|Death|0
18905|NCT01667900|86279|P13|Part B|Death|0
18906|NCT01667900|86280|P12|Part B|Death|0
18907|NCT01667900|86281|P11|Part B|Death|0
18908|NCT01667900|86282|P10|Part B|Death|0
18909|NCT01667900|86283|P9|Part B|Death|0
18910|NCT01667900|86284|P8|Part B|Death|0
18911|NCT01667900|86285|P7|Part B|Death|0
18912|NCT01667900|86286|P6|Part B|Death|0
18913|NCT01667900|86287|P5|Part B|Death|0
18914|NCT01667900|86288|P4|Part B|Death|0
18915|NCT01667900|86289|P3|Part B|Death|0
18916|NCT01667900|86290|P2|Part B|Death|0
18917|NCT01667900|86291|P1|Part B|Death|0
18918|NCT01667731|86354|P5|Overall Study|Death|0
18919|NCT01667731|86355|P4|Overall Study|Death|0
18920|NCT01667731|86356|P3|Overall Study|Death|0
18921|NCT01667731|86357|P2|Overall Study|Death|1
18922|NCT01667731|86358|P1|Overall Study|Death|0
18923|NCT01667731|86354|P5|Overall Study|Subject Withdrew Consent|1
18924|NCT01667731|86355|P4|Overall Study|Subject Withdrew Consent|0
18925|NCT01667731|86356|P3|Overall Study|Subject Withdrew Consent|1
18926|NCT01667731|86357|P2|Overall Study|Subject Withdrew Consent|0
18927|NCT01667731|86358|P1|Overall Study|Subject Withdrew Consent|2
18928|NCT01667731|86354|P5|Overall Study|Lost to Follow-up|2
18929|NCT01667731|86355|P4|Overall Study|Lost to Follow-up|1
18930|NCT01667731|86356|P3|Overall Study|Lost to Follow-up|1
18931|NCT01667731|86357|P2|Overall Study|Lost to Follow-up|3
18932|NCT01667731|86358|P1|Overall Study|Lost to Follow-up|2
18933|NCT01667731|86354|P5|Overall Study|Efficacy Failure|24
18934|NCT01667731|86355|P4|Overall Study|Efficacy Failure|1
18935|NCT01667731|86356|P3|Overall Study|Efficacy Failure|0
18936|NCT01667731|86357|P2|Overall Study|Efficacy Failure|12
18937|NCT01667731|86358|P1|Overall Study|Efficacy Failure|1
18938|NCT01667731|86354|P5|Overall Study|Enrolled but not treated|1
18939|NCT01667731|86355|P4|Overall Study|Enrolled but not treated|0
18940|NCT01667731|86356|P3|Overall Study|Enrolled but not treated|0
18941|NCT01667731|86357|P2|Overall Study|Enrolled but not treated|0
18942|NCT01667731|86358|P1|Overall Study|Enrolled but not treated|0
18943|NCT01667432|86438|P1|Overall Study|Missing Information|4
18944|NCT01667432|86438|P1|Overall Study|Reason Not Specified|2
18945|NCT01667432|86438|P1|Overall Study|Principal Investigator Decision|1
18946|NCT01667432|86438|P1|Overall Study|Protocol Deviation|2
18947|NCT01667432|86438|P1|Overall Study|Adverse Event|1
18948|NCT01667432|86438|P1|Overall Study|Insufficient Therapeutic Response|4
18949|NCT01667432|86438|P1|Overall Study|Refused Treatment/Withdrew Consent|1
18950|NCT01667432|86438|P1|Overall Study|Lost to Follow-up|3
18951|NCT01667432|86438|P1|Overall Study|Moved to Another Center|3
18952|NCT01667432|86438|P1|Overall Study|Failure to Return|10
18953|NCT01667432|86438|P1|Overall Study|Premature Study Termination|26
18954|NCT01667224|86445|P2|Overall Study|Protocol Violation|1
18955|NCT01667224|86446|P1|Overall Study|Protocol Violation|1
18956|NCT01667224|86445|P2|Overall Study|Withdrawal by Subject|1
18957|NCT01667224|86446|P1|Overall Study|Withdrawal by Subject|3
18958|NCT01667107|86460|P2|Overall Study|Lack of Efficacy|1
18959|NCT01667107|86461|P1|Overall Study|Lack of Efficacy|0
18960|NCT01667107|86460|P2|Overall Study|Protocol Violation|1
18961|NCT01667107|86461|P1|Overall Study|Protocol Violation|0
18962|NCT01667107|86460|P2|Overall Study|Tolerability issues|2
18963|NCT01667107|86461|P1|Overall Study|Tolerability issues|0
18964|NCT01667107|86460|P2|Overall Study|Adverse Event|3
18965|NCT01667107|86461|P1|Overall Study|Adverse Event|4
18966|NCT01666951|86479|P2|Overall Study|Not dosed|1
18967|NCT01666951|86480|P1|Overall Study|Not dosed|1
18968|NCT01666782|86518|P2|Overall Study|Enrolled both years; year 1 data used|0
18969|NCT01666782|86519|P1|Overall Study|Enrolled both years; year 1 data used|4
18970|NCT01666782|86518|P2|Overall Study|Received 2 doses of vaccine|1
18971|NCT01666782|86519|P1|Overall Study|Received 2 doses of vaccine|0
18972|NCT01666002|86546|P2|Overall Study|Lost to Follow-up|0
18973|NCT01666002|86547|P1|Overall Study|Lost to Follow-up|5
18974|NCT01665911|86555|P1|Overall Study|Adverse Event|1
18975|NCT01665911|86555|P1|Overall Study|Withdrawal by Subject|1
18976|NCT01665911|86555|P1|Overall Study|Protocol Violation|4
18977|NCT01665807|86564|P3|Overall Study|Withdrawal by Subject|1
18979|NCT01665807|86566|P1|Overall Study|Withdrawal by Subject|2
18980|NCT01664949|86711|P2|Overall Study|Other Miscellaneous Reasons|1
18981|NCT01664949|86712|P1|Overall Study|Other Miscellaneous Reasons|3
18982|NCT01664949|86711|P2|Overall Study|Protocol Violation|5
18983|NCT01664949|86712|P1|Overall Study|Protocol Violation|5
18984|NCT01664949|86711|P2|Overall Study|Personal Reasons|4
18985|NCT01664949|86712|P1|Overall Study|Personal Reasons|3
18986|NCT01664949|86711|P2|Overall Study|Lost to Follow-up|2
18987|NCT01664949|86712|P1|Overall Study|Lost to Follow-up|1
18988|NCT01664949|86711|P2|Overall Study|Lack of Efficacy|1
18989|NCT01664949|86712|P1|Overall Study|Lack of Efficacy|1
18990|NCT01664949|86711|P2|Overall Study|Adverse Event|12
18991|NCT01664949|86712|P1|Overall Study|Adverse Event|11
18992|NCT01664923|86728|P2|Overall Study|Miscellaneous|1
18993|NCT01664923|86729|P1|Overall Study|Miscellaneous|5
18994|NCT01664923|86728|P2|Overall Study|Adverse Event|12
18995|NCT01664923|86729|P1|Overall Study|Adverse Event|16
18996|NCT01664923|86728|P2|Overall Study|Disease Progression|139
18997|NCT01664923|86729|P1|Overall Study|Disease Progression|58
18998|NCT01664923|86728|P2|Overall Study|Withdrawal by Subject|5
18999|NCT01664923|86729|P1|Overall Study|Withdrawal by Subject|11
19000|NCT01664923|86728|P2|Overall Study|Protocol Violation|0
19001|NCT01664923|86729|P1|Overall Study|Protocol Violation|2
19002|NCT01664923|86728|P2|Overall Study|Lost to Follow-up|1
19003|NCT01664923|86729|P1|Overall Study|Lost to Follow-up|0
19004|NCT01664923|86728|P2|Overall Study|Death|0
19005|NCT01664923|86729|P1|Overall Study|Death|1
19006|NCT01664624|86773|P4|Overall Study|Adverse Event|0
19007|NCT01664624|86774|P3|Overall Study|Adverse Event|0
19008|NCT01664624|86775|P2|Overall Study|Adverse Event|1
19009|NCT01664624|86776|P1|Overall Study|Adverse Event|0
19010|NCT01664533|86823|P1|Overall Study|Protocol Violation|3
19011|NCT01664533|86823|P1|Overall Study|Study termination|9
19012|NCT01664533|86823|P1|Overall Study|Lost to Follow-up|3
19013|NCT01664533|86823|P1|Overall Study|Death|42
19014|NCT01664494|86831|P1|Overall Study|Lost to Follow-up|99
19015|NCT01664494|86831|P1|Overall Study|Not specified|49
19016|NCT01664494|86831|P1|Overall Study|Death|18
19017|NCT01664494|86831|P1|Overall Study|Withdrawal by Subject|27
19018|NCT01664247|86838|P2|Overall Study|Unclassified|29
19019|NCT01664247|86839|P1|Overall Study|Unclassified|5
19020|NCT01664247|86838|P2|Overall Study|Withdrawal Criteria|4
19021|NCT01664247|86839|P1|Overall Study|Withdrawal Criteria|1
19022|NCT01664247|86838|P2|Overall Study|Protocol Violation|5
19023|NCT01664247|86839|P1|Overall Study|Protocol Violation|3
19024|NCT01664247|86838|P2|Overall Study|Adverse Event|3
19025|NCT01664247|86839|P1|Overall Study|Adverse Event|5
19026|NCT01664052|86918|P2|Phase 2|No device placement|4
19027|NCT01664052|86919|P1|Phase 2|No device placement|0
19028|NCT01664052|86918|P2|Phase 1|No HSG 1 hr post placement|0
19029|NCT01664052|86919|P1|Phase 1|No HSG 1 hr post placement|1
19030|NCT01664052|86918|P2|Phase 1|No device placement|0
19031|NCT01664052|86919|P1|Phase 1|No device placement|6
19032|NCT01664039|86937|P2|Overall Study|Noncompliance|1
19033|NCT01664039|86938|P1|Overall Study|Noncompliance|1
19034|NCT01664039|86937|P2|Overall Study|Withdrawal by Subject|3
19035|NCT01664039|86938|P1|Overall Study|Withdrawal by Subject|1
19036|NCT01664039|86937|P2|Overall Study|Lost to Follow-up|1
19037|NCT01664039|86938|P1|Overall Study|Lost to Follow-up|1
19038|NCT01664039|86937|P2|Overall Study|Adverse Event|4
19039|NCT01664039|86938|P1|Overall Study|Adverse Event|3
19040|NCT01663987|86960|P2|Overall Study|Other reason not defined above|0
19041|NCT01663987|86961|P1|Overall Study|Other reason not defined above|3
19042|NCT01663987|86960|P2|Overall Study|Withdrawal by Subject|3
19043|NCT01663987|86961|P1|Overall Study|Withdrawal by Subject|2
19044|NCT01663987|86960|P2|Overall Study|Lost to Follow-up|1
19045|NCT01663987|86961|P1|Overall Study|Lost to Follow-up|1
19046|NCT01663987|86960|P2|Overall Study|Adverse Event|2
19047|NCT01663987|86961|P1|Overall Study|Adverse Event|7
19048|NCT01663727|87004|P2|Overall Study|Lost to Follow-up|3
19049|NCT01663727|87005|P1|Overall Study|Lost to Follow-up|8
19050|NCT01663727|87004|P2|Overall Study|Alive in Follow-Up|132
19051|NCT01663727|87005|P1|Overall Study|Alive in Follow-Up|143
19052|NCT01663727|87004|P2|Overall Study|Alive on Treatment|39
19053|NCT01663727|87005|P1|Overall Study|Alive on Treatment|31
19054|NCT01663727|87004|P2|Overall Study|Death|65
19055|NCT01663727|87005|P1|Overall Study|Death|60
19056|NCT01663714|87033|P1|Long-Term Follow-Up|Non-compliance|1
19057|NCT01663714|87033|P1|Long-Term Follow-Up|Death|4
19058|NCT01663714|87033|P1|Long-Term Follow-Up|Lost to Follow-up|1
19059|NCT01663714|87033|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
19060|NCT01663714|87033|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
19061|NCT01663714|87033|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
19062|NCT01663532|87062|P2|Overall Study|Lack of Efficacy|60
19063|NCT01663532|87063|P1|Overall Study|Lack of Efficacy|15
19064|NCT01663532|87062|P2|Overall Study|Withdrawal by Subject|17
19065|NCT01663532|87063|P1|Overall Study|Withdrawal by Subject|35
19066|NCT01663532|87062|P2|Overall Study|Physician Decision|1
19067|NCT01663532|87063|P1|Overall Study|Physician Decision|1
19068|NCT01663532|87062|P2|Overall Study|Met Withdrawal Criteria|6
19069|NCT01663532|87063|P1|Overall Study|Met Withdrawal Criteria|7
19070|NCT01663532|87062|P2|Overall Study|Adverse Event|13
19071|NCT01663532|87063|P1|Overall Study|Adverse Event|7
19072|NCT01663532|87062|P2|Overall Study|Lost to Follow-up|10
19073|NCT01663532|87063|P1|Overall Study|Lost to Follow-up|9
19074|NCT01663506|87081|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
19075|NCT01663506|87081|P1|Overall Study|Adverse Event|1
19076|NCT01663506|87081|P1|Overall Study|Lost to Follow-up|1
19077|NCT01663506|87081|P1|Overall Study|Consent Withdrawal by Subject|1
19078|NCT01663506|87081|P1|Overall Study|Lack of Efficacy|3
19079|NCT01663233|87123|P2|Overall Study|Lost to Follow-up|1
19080|NCT01663233|87124|P1|Overall Study|Lost to Follow-up|0
19081|NCT01663233|87123|P2|Overall Study|Protocol Deviation|4
19082|NCT01663233|87124|P1|Overall Study|Protocol Deviation|1
19083|NCT01663233|87123|P2|Overall Study|Withdrawal by Subject|2
19084|NCT01663233|87124|P1|Overall Study|Withdrawal by Subject|3
19085|NCT01663103|87148|P2|Overall Study|dog bite|0
19086|NCT01663103|87149|P1|Overall Study|dog bite|1
19087|NCT01663103|87148|P2|Overall Study|Adverse Event|0
19088|NCT01663103|87149|P1|Overall Study|Adverse Event|1
19089|NCT01663103|87148|P2|Overall Study|Withdrawal by Subject|2
19090|NCT01663103|87149|P1|Overall Study|Withdrawal by Subject|1
19091|NCT01662999|87177|P6|Period 3|Withdrawal by Subject|0
19092|NCT01662999|87178|P5|Period 3|Withdrawal by Subject|0
19093|NCT01662999|87179|P4|Period 3|Withdrawal by Subject|0
19094|NCT01662999|87180|P3|Period 3|Withdrawal by Subject|0
19095|NCT01662999|87181|P2|Period 3|Withdrawal by Subject|1
19096|NCT01662999|87182|P1|Period 3|Withdrawal by Subject|0
19097|NCT01662986|87253|P2|Overall Study|Other than stated above|0
19098|NCT01662986|87254|P1|Overall Study|Other than stated above|3
19099|NCT01662986|87253|P2|Overall Study|Not Treated|0
19100|NCT01662986|87254|P1|Overall Study|Not Treated|1
19101|NCT01662986|87253|P2|Overall Study|Withdrawal by Subject|2
19102|NCT01662986|87254|P1|Overall Study|Withdrawal by Subject|2
19103|NCT01662986|87253|P2|Overall Study|Lost to Follow-up|4
19104|NCT01662986|87254|P1|Overall Study|Lost to Follow-up|5
19105|NCT01662986|87253|P2|Overall Study|Protocol Violation|3
19106|NCT01662986|87254|P1|Overall Study|Protocol Violation|2
19107|NCT01662986|87253|P2|Overall Study|Adverse Event|4
19108|NCT01662986|87254|P1|Overall Study|Adverse Event|5
19109|NCT01662648|87342|P2|Overall Study|LOE and Participant non-compliant|1
19110|NCT01662648|87343|P1|Overall Study|LOE and Participant non-compliant|0
19111|NCT01662648|87342|P2|Overall Study|LOE and other reason unspecified|0
19112|NCT01662648|87343|P1|Overall Study|LOE and other reason unspecified|1
19113|NCT01662648|87342|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
19114|NCT01662648|87343|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
19115|NCT01662648|87342|P2|Overall Study|Unspecified|11
19116|NCT01662648|87343|P1|Overall Study|Unspecified|8
19117|NCT01662648|87342|P2|Overall Study|Participant non-compliant|20
19118|NCT01662648|87343|P1|Overall Study|Participant non-compliant|16
19119|NCT01662648|87342|P2|Overall Study|Withdrawal by Subject|53
19120|NCT01662648|87343|P1|Overall Study|Withdrawal by Subject|36
19121|NCT01662648|87342|P2|Overall Study|Lost to Follow-up|36
19122|NCT01662648|87343|P1|Overall Study|Lost to Follow-up|24
19123|NCT01662648|87342|P2|Overall Study|Participant ineligible to continue trial|1
19124|NCT01662648|87343|P1|Overall Study|Participant ineligible to continue trial|1
19125|NCT01662648|87342|P2|Overall Study|Lack of Efficacy|16
19126|NCT01662648|87343|P1|Overall Study|Lack of Efficacy|17
19127|NCT01662648|87342|P2|Overall Study|Adverse Event|37
19128|NCT01662648|87343|P1|Overall Study|Adverse Event|40
19129|NCT01662648|87342|P2|Overall Study|Death|3
19130|NCT01662648|87343|P1|Overall Study|Death|1
19131|NCT01662635|87365|P1|Overall Study|scarce samples for evaluation|30
19132|NCT01662440|87417|P4|Overall Study|Withdrawal by Subject|2
19133|NCT01662440|87418|P3|Overall Study|Withdrawal by Subject|2
19134|NCT01662440|87419|P2|Overall Study|Withdrawal by Subject|2
19135|NCT01662440|87420|P1|Overall Study|Withdrawal by Subject|5
19136|NCT01662440|87417|P4|Overall Study|Protocol Violation|0
19137|NCT01662440|87418|P3|Overall Study|Protocol Violation|0
19138|NCT01662440|87419|P2|Overall Study|Protocol Violation|0
19139|NCT01662440|87420|P1|Overall Study|Protocol Violation|1
19140|NCT01662440|87417|P4|Overall Study|Subject moved to another country.|0
19141|NCT01662440|87418|P3|Overall Study|Subject moved to another country.|0
19142|NCT01662440|87419|P2|Overall Study|Subject moved to another country.|1
19143|NCT01662440|87420|P1|Overall Study|Subject moved to another country.|0
19144|NCT01662440|87417|P4|Overall Study|Lost to Follow-up|1
19145|NCT01662440|87418|P3|Overall Study|Lost to Follow-up|4
19146|NCT01662440|87419|P2|Overall Study|Lost to Follow-up|2
19147|NCT01662440|87420|P1|Overall Study|Lost to Follow-up|2
19148|NCT01662440|87417|P4|Overall Study|Death|0
19149|NCT01662440|87418|P3|Overall Study|Death|0
19150|NCT01662440|87419|P2|Overall Study|Death|1
19151|NCT01662440|87420|P1|Overall Study|Death|0
19152|NCT01662440|87417|P4|Overall Study|Adverse Event|1
19153|NCT01662440|87418|P3|Overall Study|Adverse Event|0
19154|NCT01662440|87419|P2|Overall Study|Adverse Event|0
19155|NCT01662440|87420|P1|Overall Study|Adverse Event|1
19156|NCT01662362|87468|P1|Overall Study|Lost to Follow-up|38
19157|NCT01662310|87473|P5|Open-Label Extension Phase|Withdrawal by Subject|7
19158|NCT01662310|87474|P4|Open-Label Extension Phase|Withdrawal by Subject|2
19159|NCT01662310|87475|P3|Open-Label Extension Phase|Withdrawal by Subject|0
19160|NCT01662310|87476|P2|Open-Label Extension Phase|Withdrawal by Subject|0
19161|NCT01662310|87477|P1|Open-Label Extension Phase|Withdrawal by Subject|0
19162|NCT01662310|87473|P5|Open-Label Extension Phase|Pregnancy|0
19163|NCT01662310|87474|P4|Open-Label Extension Phase|Pregnancy|1
19164|NCT01662310|87475|P3|Open-Label Extension Phase|Pregnancy|0
19165|NCT01662310|87476|P2|Open-Label Extension Phase|Pregnancy|0
19166|NCT01662310|87477|P1|Open-Label Extension Phase|Pregnancy|0
19167|NCT01662310|87473|P5|Open-Label Extension Phase|Lost to Follow-up|1
19168|NCT01662310|87474|P4|Open-Label Extension Phase|Lost to Follow-up|2
19169|NCT01662310|87475|P3|Open-Label Extension Phase|Lost to Follow-up|0
19170|NCT01662310|87476|P2|Open-Label Extension Phase|Lost to Follow-up|0
19171|NCT01662310|87477|P1|Open-Label Extension Phase|Lost to Follow-up|0
19172|NCT01662310|87473|P5|Open-Label Extension Phase|Lack of Efficacy|2
19173|NCT01662310|87474|P4|Open-Label Extension Phase|Lack of Efficacy|2
19174|NCT01662310|87475|P3|Open-Label Extension Phase|Lack of Efficacy|0
19175|NCT01662310|87476|P2|Open-Label Extension Phase|Lack of Efficacy|0
19176|NCT01662310|87477|P1|Open-Label Extension Phase|Lack of Efficacy|0
19177|NCT01662310|87473|P5|Open-Label Extension Phase|Death|0
19178|NCT01662310|87474|P4|Open-Label Extension Phase|Death|1
19179|NCT01662310|87475|P3|Open-Label Extension Phase|Death|0
19180|NCT01662310|87476|P2|Open-Label Extension Phase|Death|0
19181|NCT01662310|87477|P1|Open-Label Extension Phase|Death|0
19182|NCT01662310|87473|P5|Open-Label Extension Phase|Adverse Event|0
19183|NCT01662310|87474|P4|Open-Label Extension Phase|Adverse Event|3
19184|NCT01662310|87475|P3|Open-Label Extension Phase|Adverse Event|0
19185|NCT01662310|87476|P2|Open-Label Extension Phase|Adverse Event|0
19186|NCT01662310|87477|P1|Open-Label Extension Phase|Adverse Event|0
19187|NCT01662310|87473|P5|Double-Blind Phase|Randomized but not treated|0
19188|NCT01662310|87474|P4|Double-Blind Phase|Randomized but not treated|0
19189|NCT01662310|87475|P3|Double-Blind Phase|Randomized but not treated|0
19190|NCT01662310|87476|P2|Double-Blind Phase|Randomized but not treated|1
19191|NCT01662310|87477|P1|Double-Blind Phase|Randomized but not treated|0
19192|NCT01662310|87473|P5|Double-Blind Phase|unspecified|0
19193|NCT01662310|87474|P4|Double-Blind Phase|unspecified|0
19194|NCT01662310|87475|P3|Double-Blind Phase|unspecified|1
19195|NCT01662310|87476|P2|Double-Blind Phase|unspecified|0
19196|NCT01662310|87477|P1|Double-Blind Phase|unspecified|0
19197|NCT01662310|87473|P5|Double-Blind Phase|Withdrawal by Subject|0
19198|NCT01662310|87474|P4|Double-Blind Phase|Withdrawal by Subject|0
19199|NCT01662310|87475|P3|Double-Blind Phase|Withdrawal by Subject|3
19200|NCT01662310|87476|P2|Double-Blind Phase|Withdrawal by Subject|9
19201|NCT01662310|87477|P1|Double-Blind Phase|Withdrawal by Subject|0
19202|NCT01662310|87473|P5|Double-Blind Phase|Pregnancy|0
19203|NCT01662310|87474|P4|Double-Blind Phase|Pregnancy|0
19204|NCT01662310|87475|P3|Double-Blind Phase|Pregnancy|0
19205|NCT01662310|87476|P2|Double-Blind Phase|Pregnancy|2
19206|NCT01662310|87477|P1|Double-Blind Phase|Pregnancy|0
19207|NCT01662310|87473|P5|Double-Blind Phase|Lost to Follow-up|0
19208|NCT01662310|87474|P4|Double-Blind Phase|Lost to Follow-up|0
19209|NCT01662310|87475|P3|Double-Blind Phase|Lost to Follow-up|0
19210|NCT01662310|87476|P2|Double-Blind Phase|Lost to Follow-up|3
19211|NCT01662310|87477|P1|Double-Blind Phase|Lost to Follow-up|0
19212|NCT01662310|87473|P5|Double-Blind Phase|Adverse Event|0
19213|NCT01662310|87474|P4|Double-Blind Phase|Adverse Event|0
19214|NCT01662310|87475|P3|Double-Blind Phase|Adverse Event|1
19215|NCT01662310|87476|P2|Double-Blind Phase|Adverse Event|0
19216|NCT01662310|87477|P1|Double-Blind Phase|Adverse Event|0
19217|NCT01662310|87473|P5|Run-In or Stabilization Phase|unspecified|0
19218|NCT01662310|87474|P4|Run-In or Stabilization Phase|unspecified|0
19219|NCT01662310|87475|P3|Run-In or Stabilization Phase|unspecified|0
19220|NCT01662310|87476|P2|Run-In or Stabilization Phase|unspecified|0
19221|NCT01662310|87477|P1|Run-In or Stabilization Phase|unspecified|1
19222|NCT01662310|87473|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
19223|NCT01662310|87474|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
19224|NCT01662310|87475|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
19225|NCT01662310|87476|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
19226|NCT01662310|87477|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
19227|NCT01662310|87473|P5|Run-In or Stabilization Phase|Protocol Violation|0
19228|NCT01662310|87474|P4|Run-In or Stabilization Phase|Protocol Violation|0
19229|NCT01662310|87475|P3|Run-In or Stabilization Phase|Protocol Violation|0
19230|NCT01662310|87476|P2|Run-In or Stabilization Phase|Protocol Violation|0
19231|NCT01662310|87477|P1|Run-In or Stabilization Phase|Protocol Violation|15
19232|NCT01662310|87473|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
19233|NCT01662310|87474|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
19234|NCT01662310|87475|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
19235|NCT01662310|87476|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
19236|NCT01662310|87477|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
19237|NCT01662310|87473|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
19238|NCT01662310|87474|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
19239|NCT01662310|87475|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
19240|NCT01662310|87476|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
19241|NCT01662310|87477|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
19242|NCT01662310|87473|P5|Run-In or Stabilization Phase|Adverse Event|0
19243|NCT01662310|87474|P4|Run-In or Stabilization Phase|Adverse Event|0
19244|NCT01662310|87475|P3|Run-In or Stabilization Phase|Adverse Event|0
19245|NCT01662310|87476|P2|Run-In or Stabilization Phase|Adverse Event|0
19246|NCT01662310|87477|P1|Run-In or Stabilization Phase|Adverse Event|11
19247|NCT01662102|87511|P2|Overall Study|Sponsor's decision|0
19248|NCT01662102|87512|P1|Overall Study|Sponsor's decision|1
19249|NCT01662063|87520|P3|Overall Study|Not Specified|0
19250|NCT01662063|87521|P2|Overall Study|Not Specified|1
19251|NCT01662063|87522|P1|Overall Study|Not Specified|0
19252|NCT01662063|87520|P3|Overall Study|Physician Decision|0
19253|NCT01662063|87521|P2|Overall Study|Physician Decision|2
19254|NCT01662063|87522|P1|Overall Study|Physician Decision|0
19255|NCT01662063|87520|P3|Overall Study|Withdrawal by Subject|1
19256|NCT01662063|87521|P2|Overall Study|Withdrawal by Subject|4
19257|NCT01662063|87522|P1|Overall Study|Withdrawal by Subject|2
19258|NCT01662063|87520|P3|Overall Study|Protocol Violation|0
19259|NCT01662063|87521|P2|Overall Study|Protocol Violation|0
19260|NCT01662063|87522|P1|Overall Study|Protocol Violation|1
19261|NCT01662063|87520|P3|Overall Study|Lost to Follow-up|0
19262|NCT01662063|87521|P2|Overall Study|Lost to Follow-up|4
19263|NCT01662063|87522|P1|Overall Study|Lost to Follow-up|0
19264|NCT01662063|87520|P3|Overall Study|Lack of Efficacy|0
19265|NCT01662063|87521|P2|Overall Study|Lack of Efficacy|6
19266|NCT01662063|87522|P1|Overall Study|Lack of Efficacy|1
19267|NCT01662063|87520|P3|Overall Study|Adverse Event or Intercurrent Illness|0
19268|NCT01662063|87521|P2|Overall Study|Adverse Event or Intercurrent Illness|12
19269|NCT01662063|87522|P1|Overall Study|Adverse Event or Intercurrent Illness|1
19270|NCT01661933|87601|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
19271|NCT01661933|87601|P1|Low-dose Gluten Challenge|Physician Decision|2
19272|NCT01661790|87616|P2|Overall Study|Lost to Follow-up|2
19273|NCT01661790|87617|P1|Overall Study|Lost to Follow-up|0
19274|NCT01661179|87660|P1|Overall Study|Other Eligibility criteria|4
19275|NCT01661179|87660|P1|Overall Study|Withdrawal by Subject|1
19276|NCT01661179|87660|P1|Overall Study|Death|1
19277|NCT01661140|87664|P3|Double-Blind Period|Administrative/Other|6
19278|NCT01661140|87665|P2|Double-Blind Period|Administrative/Other|7
19279|NCT01661140|87666|P1|Double-Blind Period|Administrative/Other|0
19280|NCT01661140|87664|P3|Double-Blind Period|Sponsor Termination|17
19281|NCT01661140|87665|P2|Double-Blind Period|Sponsor Termination|14
19282|NCT01661140|87666|P1|Double-Blind Period|Sponsor Termination|0
19283|NCT01661140|87664|P3|Double-Blind Period|Investigator's Decision|2
19284|NCT01661140|87665|P2|Double-Blind Period|Investigator's Decision|1
19285|NCT01661140|87666|P1|Double-Blind Period|Investigator's Decision|0
19286|NCT01661140|87664|P3|Double-Blind Period|Withdrawal by Subject|3
19287|NCT01661140|87665|P2|Double-Blind Period|Withdrawal by Subject|1
19288|NCT01661140|87666|P1|Double-Blind Period|Withdrawal by Subject|0
19289|NCT01661140|87664|P3|Double-Blind Period|Protocol Violation|3
19290|NCT01661140|87665|P2|Double-Blind Period|Protocol Violation|2
19291|NCT01661140|87666|P1|Double-Blind Period|Protocol Violation|0
19292|NCT01661140|87664|P3|Double-Blind Period|Adverse Event|18
19293|NCT01661140|87665|P2|Double-Blind Period|Adverse Event|16
19294|NCT01661140|87666|P1|Double-Blind Period|Adverse Event|0
19295|NCT01661140|87664|P3|Double-Blind Period|Refused Treatment|1
19296|NCT01661140|87665|P2|Double-Blind Period|Refused Treatment|0
19297|NCT01661140|87666|P1|Double-Blind Period|Refused Treatment|0
19298|NCT01661140|87664|P3|Open-Label Period|Lost to Follow-up|0
19299|NCT01661140|87665|P2|Open-Label Period|Lost to Follow-up|0
19300|NCT01661140|87666|P1|Open-Label Period|Lost to Follow-up|2
19301|NCT01661140|87664|P3|Open-Label Period|Did not meet EULAR criteria|0
19302|NCT01661140|87665|P2|Open-Label Period|Did not meet EULAR criteria|0
19303|NCT01661140|87666|P1|Open-Label Period|Did not meet EULAR criteria|1
19304|NCT01661140|87664|P3|Open-Label Period|Sponsor termination|0
19305|NCT01661140|87665|P2|Open-Label Period|Sponsor termination|0
19306|NCT01661140|87666|P1|Open-Label Period|Sponsor termination|16
19307|NCT01661140|87664|P3|Open-Label Period|Administrative/Other|0
19308|NCT01661140|87665|P2|Open-Label Period|Administrative/Other|0
19309|NCT01661140|87666|P1|Open-Label Period|Administrative/Other|1
19310|NCT01661140|87664|P3|Open-Label Period|Death|0
19311|NCT01661140|87665|P2|Open-Label Period|Death|0
19312|NCT01661140|87666|P1|Open-Label Period|Death|1
19313|NCT01661140|87664|P3|Open-Label Period|Investigator Decision|0
19314|NCT01661140|87665|P2|Open-Label Period|Investigator Decision|0
19315|NCT01661140|87666|P1|Open-Label Period|Investigator Decision|3
19316|NCT01661140|87664|P3|Open-Label Period|Withdrawal by Subject|0
19317|NCT01661140|87665|P2|Open-Label Period|Withdrawal by Subject|0
19318|NCT01661140|87666|P1|Open-Label Period|Withdrawal by Subject|5
19319|NCT01661140|87664|P3|Open-Label Period|Protocol Violation|0
19320|NCT01661140|87665|P2|Open-Label Period|Protocol Violation|0
19321|NCT01661140|87666|P1|Open-Label Period|Protocol Violation|3
19322|NCT01661140|87664|P3|Open-Label Period|Adverse Event|0
19323|NCT01661140|87665|P2|Open-Label Period|Adverse Event|0
19324|NCT01661140|87666|P1|Open-Label Period|Adverse Event|44
19325|NCT01661062|87712|P1|Overall Study|Withdrawal by Subject|2
19326|NCT01661062|87712|P1|Overall Study|Completed Treatment Off Study|3
19327|NCT01660906|87717|P1|Overall Study|Discontinued due to study drug toxicity|3
19328|NCT01660763|87748|P2|Overall Study|Patient ready for early discharge|4
19329|NCT01660763|87749|P1|Overall Study|Patient ready for early discharge|28
19330|NCT01660763|87748|P2|Overall Study|Withdrawal by Subject|0
19331|NCT01660763|87749|P1|Overall Study|Withdrawal by Subject|4
19332|NCT01660763|87748|P2|Overall Study|Protocol Violation|0
19333|NCT01660763|87749|P1|Overall Study|Protocol Violation|1
19334|NCT01660763|87748|P2|Overall Study|Adverse Event|7
19335|NCT01660763|87749|P1|Overall Study|Adverse Event|22
19336|NCT01660763|87748|P2|Overall Study|Lack of Efficacy|50
19337|NCT01660763|87749|P1|Overall Study|Lack of Efficacy|45
19338|NCT01659736|87781|P2|3-month Follow-up|Lost to Follow-up|1
19339|NCT01659736|87782|P1|3-month Follow-up|Lost to Follow-up|0
19340|NCT01659736|87781|P2|Treatment Period|Withdrawal by Subject|0
19341|NCT01659736|87782|P1|Treatment Period|Withdrawal by Subject|1
19342|NCT01659736|87781|P2|Treatment Period|Protocol Violation|1
19343|NCT01659736|87782|P1|Treatment Period|Protocol Violation|3
19344|NCT01659736|87781|P2|Treatment Period|Adverse Event|1
19345|NCT01659736|87782|P1|Treatment Period|Adverse Event|1
19346|NCT01659554|87796|P1|Overall Study|Study Termination|4
19347|NCT01660334|87803|P1|Overall Study|Lost to Follow-up|1
19348|NCT01660022|88046|P6|First Sequence (7 Days)|Protocol Violation|1
19349|NCT01660022|88047|P5|First Sequence (7 Days)|Protocol Violation|0
19350|NCT01660022|88048|P4|First Sequence (7 Days)|Protocol Violation|0
19351|NCT01660022|88049|P3|First Sequence (7 Days)|Protocol Violation|0
19352|NCT01660022|88050|P2|First Sequence (7 Days)|Protocol Violation|0
19353|NCT01660022|88051|P1|First Sequence (7 Days)|Protocol Violation|0
19354|NCT01660022|88046|P6|First Sequence (7 Days)|Adverse Event|3
19355|NCT01660022|88047|P5|First Sequence (7 Days)|Adverse Event|1
19356|NCT01660022|88048|P4|First Sequence (7 Days)|Adverse Event|0
19357|NCT01660022|88049|P3|First Sequence (7 Days)|Adverse Event|0
19358|NCT01660022|88050|P2|First Sequence (7 Days)|Adverse Event|0
19359|NCT01660022|88051|P1|First Sequence (7 Days)|Adverse Event|0
19360|NCT01660022|88046|P6|First Sequence (7 Days)|Withdrawal by Subject|0
19361|NCT01660022|88047|P5|First Sequence (7 Days)|Withdrawal by Subject|0
19362|NCT01660022|88048|P4|First Sequence (7 Days)|Withdrawal by Subject|1
19363|NCT01660022|88049|P3|First Sequence (7 Days)|Withdrawal by Subject|0
19364|NCT01660022|88050|P2|First Sequence (7 Days)|Withdrawal by Subject|1
19365|NCT01660022|88051|P1|First Sequence (7 Days)|Withdrawal by Subject|0
19366|NCT01659996|88110|P3|Overall Study|Withdrawal by Subject|5
19367|NCT01659996|88111|P2|Overall Study|Withdrawal by Subject|1
19368|NCT01659996|88112|P1|Overall Study|Withdrawal by Subject|4
19369|NCT01659996|88110|P3|Overall Study|Adverse Event|1
19370|NCT01659996|88111|P2|Overall Study|Adverse Event|0
19371|NCT01659996|88112|P1|Overall Study|Adverse Event|0
19372|NCT01659996|88110|P3|Overall Study|Lost to Follow-up|2
19373|NCT01659996|88111|P2|Overall Study|Lost to Follow-up|3
19374|NCT01659996|88112|P1|Overall Study|Lost to Follow-up|1
19375|NCT01659996|88110|P3|Overall Study|Protocol Violation|3
19376|NCT01659996|88111|P2|Overall Study|Protocol Violation|3
19377|NCT01659996|88112|P1|Overall Study|Protocol Violation|3
19378|NCT01659853|88144|P2|Washout , 3 to 7 Days|Protocol Violation|0
19379|NCT01659853|88145|P1|Washout , 3 to 7 Days|Protocol Violation|1
19380|NCT01659853|88144|P2|Washout , 3 to 7 Days|Adverse Event|0
19381|NCT01659853|88145|P1|Washout , 3 to 7 Days|Adverse Event|1
19382|NCT01659125|88168|P1|Overall Study|Failed to Start Treatment|2
19383|NCT01659125|88168|P1|Overall Study|Time Constraints|2
19384|NCT01659125|88168|P1|Overall Study|Technical Problem|1
19385|NCT01659125|88168|P1|Overall Study|Lost to Follow-up|7
19386|NCT01659125|88168|P1|Overall Study|Withdrawal by Subject|2
19387|NCT01658943|88175|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
19388|NCT01658943|88176|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
19389|NCT01658943|88175|P2|Overall Study|Not eligible|9
19390|NCT01658943|88176|P1|Overall Study|Not eligible|7
19391|NCT01658943|88175|P2|Overall Study|not protocol specified|1
19392|NCT01658943|88176|P1|Overall Study|not protocol specified|4
19393|NCT01658943|88175|P2|Overall Study|Death|2
19394|NCT01658943|88176|P1|Overall Study|Death|4
19395|NCT01658943|88175|P2|Overall Study|Progression/Relapse|40
19396|NCT01658943|88176|P1|Overall Study|Progression/Relapse|39
19397|NCT01658943|88175|P2|Overall Study|Withdrawal by Subject|2
19398|NCT01658943|88176|P1|Overall Study|Withdrawal by Subject|9
19399|NCT01658943|88175|P2|Overall Study|Adverse Event|13
19400|NCT01658943|88176|P1|Overall Study|Adverse Event|6
19401|NCT01658904|88191|P3|Overall Study|Principal Investigator discretion|0
19402|NCT01658904|88192|P2|Overall Study|Principal Investigator discretion|0
19403|NCT01658904|88193|P1|Overall Study|Principal Investigator discretion|2
19404|NCT01658813|88219|P1|Overall Study|Disease progression|3
19405|NCT01658735|88230|P3|Overall Study|Withdrawal by Subject|3
19406|NCT01658735|88231|P2|Overall Study|Withdrawal by Subject|5
19407|NCT01658735|88232|P1|Overall Study|Withdrawal by Subject|3
19408|NCT01658735|88230|P3|Overall Study|Protocol Violation|0
19409|NCT01658735|88231|P2|Overall Study|Protocol Violation|1
19410|NCT01658735|88232|P1|Overall Study|Protocol Violation|0
19411|NCT01658735|88230|P3|Overall Study|Lost to Follow-up|0
19412|NCT01658735|88231|P2|Overall Study|Lost to Follow-up|1
19413|NCT01658735|88232|P1|Overall Study|Lost to Follow-up|1
19414|NCT01658735|88230|P3|Overall Study|Lack of Efficacy|1
19415|NCT01658735|88231|P2|Overall Study|Lack of Efficacy|0
19416|NCT01658735|88232|P1|Overall Study|Lack of Efficacy|1
19417|NCT01658579|88274|P4|Treatment Period B|Unspecified|1
19418|NCT01658579|88275|P3|Treatment Period B|Unspecified|0
19419|NCT01658579|88276|P2|Treatment Period B|Unspecified|0
19420|NCT01658579|88277|P1|Treatment Period B|Unspecified|0
19421|NCT01658579|88274|P4|Treatment Period A|Adverse Event|0
19422|NCT01658579|88275|P3|Treatment Period A|Adverse Event|0
19423|NCT01658579|88276|P2|Treatment Period A|Adverse Event|0
19424|NCT01658579|88277|P1|Treatment Period A|Adverse Event|1
19425|NCT01658579|88274|P4|Treatment Period A|Unspecified|1
19426|NCT01658579|88275|P3|Treatment Period A|Unspecified|1
19427|NCT01658579|88276|P2|Treatment Period A|Unspecified|0
19428|NCT01658579|88277|P1|Treatment Period A|Unspecified|0
19429|NCT01658514|88305|P3|Overall Study|Protocol Violation|2
19430|NCT01658514|88306|P2|Overall Study|Protocol Violation|0
19431|NCT01658514|88307|P1|Overall Study|Protocol Violation|1
19432|NCT01658436|88318|P2|Overall Study|Death|0
19433|NCT01658436|88319|P1|Overall Study|Death|1
19434|NCT01658436|88318|P2|Overall Study|Subject/guardian decision|1
19435|NCT01658436|88319|P1|Overall Study|Subject/guardian decision|0
19436|NCT01658436|88318|P2|Overall Study|Study terminated by sponsor|1
19437|NCT01658436|88319|P1|Overall Study|Study terminated by sponsor|0
19438|NCT01658436|88318|P2|Overall Study|Progressive disease|4
19439|NCT01658436|88319|P1|Overall Study|Progressive disease|12
19440|NCT01658436|88318|P2|Overall Study|Physician Decision|0
19441|NCT01658436|88319|P1|Overall Study|Physician Decision|1
19442|NCT01658436|88318|P2|Overall Study|Adverse Event|5
19443|NCT01658436|88319|P1|Overall Study|Adverse Event|6
19444|NCT01658072|88328|P2|Overall Study|Protocol Violation|2
19445|NCT01658072|88329|P1|Overall Study|Protocol Violation|4
19446|NCT01658020|88337|P2|Overall Study|Protocol Violation|1
19447|NCT01658020|88338|P1|Overall Study|Protocol Violation|0
19448|NCT01658020|88337|P2|Overall Study|Withdrawal by Subject|5
19449|NCT01658020|88338|P1|Overall Study|Withdrawal by Subject|4
19450|NCT01658020|88337|P2|Overall Study|Lost to Follow-up|0
19451|NCT01658020|88338|P1|Overall Study|Lost to Follow-up|1
19452|NCT01658020|88337|P2|Overall Study|Adverse Event|3
19453|NCT01658020|88338|P1|Overall Study|Adverse Event|3
19454|NCT01657903|88354|P1|Overall Study|Withdrawal by Subject|1
19455|NCT01657903|88354|P1|Overall Study|Lost to Follow-up|1
19456|NCT01657877|88376|P1|Overall Study|Other Reason|2
19457|NCT01657877|88376|P1|Overall Study|Adverse Event|2
19458|NCT01657877|88376|P1|Overall Study|Protocol Violation|6
19459|NCT01657877|88376|P1|Overall Study|Withdrawal by Subject|4
19460|NCT01657370|88399|P6|Overall Study|Lost to Follow-up|1
19461|NCT01657370|88400|P5|Overall Study|Lost to Follow-up|0
19462|NCT01657370|88401|P4|Overall Study|Lost to Follow-up|0
19463|NCT01657370|88402|P3|Overall Study|Lost to Follow-up|1
19464|NCT01657370|88403|P2|Overall Study|Lost to Follow-up|0
19465|NCT01657370|88404|P1|Overall Study|Lost to Follow-up|2
19466|NCT01657370|88399|P6|Overall Study|Protocol Violation|0
19467|NCT01657370|88400|P5|Overall Study|Protocol Violation|0
19468|NCT01657370|88401|P4|Overall Study|Protocol Violation|1
19469|NCT01657370|88402|P3|Overall Study|Protocol Violation|1
19470|NCT01657370|88403|P2|Overall Study|Protocol Violation|1
19471|NCT01657370|88404|P1|Overall Study|Protocol Violation|1
19472|NCT01657370|88399|P6|Overall Study|Adverse Event|0
19473|NCT01657370|88400|P5|Overall Study|Adverse Event|1
19474|NCT01657370|88401|P4|Overall Study|Adverse Event|0
19475|NCT01657370|88402|P3|Overall Study|Adverse Event|0
19476|NCT01657370|88403|P2|Overall Study|Adverse Event|0
19477|NCT01657370|88404|P1|Overall Study|Adverse Event|0
19478|NCT01657370|88399|P6|Overall Study|Lack of Qualifying Event|2
19479|NCT01657370|88400|P5|Overall Study|Lack of Qualifying Event|1
19480|NCT01657370|88401|P4|Overall Study|Lack of Qualifying Event|2
19481|NCT01657370|88402|P3|Overall Study|Lack of Qualifying Event|3
19482|NCT01657370|88403|P2|Overall Study|Lack of Qualifying Event|0
19483|NCT01657370|88404|P1|Overall Study|Lack of Qualifying Event|1
19484|NCT01657370|88399|P6|Overall Study|Physician Decision|0
19485|NCT01657370|88400|P5|Overall Study|Physician Decision|5
19486|NCT01657370|88401|P4|Overall Study|Physician Decision|2
19487|NCT01657370|88402|P3|Overall Study|Physician Decision|1
19488|NCT01657370|88403|P2|Overall Study|Physician Decision|3
19489|NCT01657370|88404|P1|Overall Study|Physician Decision|2
19490|NCT01657370|88399|P6|Overall Study|Withdrawal by Subject|1
19491|NCT01657370|88400|P5|Overall Study|Withdrawal by Subject|0
19492|NCT01657370|88401|P4|Overall Study|Withdrawal by Subject|0
19493|NCT01657370|88402|P3|Overall Study|Withdrawal by Subject|1
19494|NCT01657370|88403|P2|Overall Study|Withdrawal by Subject|0
19495|NCT01657370|88404|P1|Overall Study|Withdrawal by Subject|0
19496|NCT01657292|88486|P1|Overall Study|Change of therapy|1
19497|NCT01657292|88486|P1|Overall Study|Violation of eligibility criteria|1
19498|NCT01657292|88486|P1|Overall Study|Withdrawal by Subject|2
19499|NCT01657292|88486|P1|Overall Study|Adverse Event|6
19500|NCT01657032|88495|P2|Overall Study|Lost to Follow-up|7
19501|NCT01657032|88496|P1|Overall Study|Lost to Follow-up|0
19502|NCT01657019|88522|P1|Overall Study|Not Specified|58
19503|NCT01657019|88522|P1|Overall Study|Lack of Efficacy|3
19504|NCT01657019|88522|P1|Overall Study|Protocol Violation|6
19505|NCT01657019|88522|P1|Overall Study|Lost to Follow-up|48
19506|NCT01657019|88522|P1|Overall Study|Adverse Event|55
19507|NCT01657019|88522|P1|Overall Study|Withdrawal by Subject|65
19508|NCT01656967|88536|P2|Overall Study|unsuccessful ETT insertion|2
19509|NCT01656967|88537|P1|Overall Study|unsuccessful ETT insertion|3
19510|NCT01656967|88536|P2|Overall Study|faulty monitor|0
19511|NCT01656967|88537|P1|Overall Study|faulty monitor|1
19512|NCT01656889|88559|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
19513|NCT01656889|88560|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
19514|NCT01656889|88559|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
19515|NCT01656889|88560|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
19516|NCT01656889|88559|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
19517|NCT01656889|88560|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
19518|NCT01656889|88559|P2|Post Treatment Follow-Up, 3 Months|Death|5
19519|NCT01656889|88560|P1|Post Treatment Follow-Up, 3 Months|Death|1
19520|NCT01656889|88559|P2|Treatment Period, 12 Weeks|Moved out of the area|2
19521|NCT01656889|88560|P1|Treatment Period, 12 Weeks|Moved out of the area|0
19522|NCT01656889|88559|P2|Treatment Period, 12 Weeks|Protocol Violation|1
19523|NCT01656889|88560|P1|Treatment Period, 12 Weeks|Protocol Violation|0
19524|NCT01656889|88559|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
19525|NCT01656889|88560|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
19526|NCT01656889|88559|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
19527|NCT01656889|88560|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
19528|NCT01656889|88559|P2|Treatment Period, 12 Weeks|Death|1
19529|NCT01656889|88560|P1|Treatment Period, 12 Weeks|Death|0
19530|NCT01656889|88559|P2|Treatment Period, 12 Weeks|Adverse Event|4
19531|NCT01656889|88560|P1|Treatment Period, 12 Weeks|Adverse Event|10
19532|NCT01656850|88580|P2|First Intervention (3 Months)|Withdrawal by Subject|4
19533|NCT01656850|88581|P1|First Intervention (3 Months)|Withdrawal by Subject|3
19534|NCT01656759|88672|P2|Overall Study|Protocol Violation|3
19535|NCT01656759|88673|P1|Overall Study|Protocol Violation|2
19536|NCT01656434|88704|P2|Overall Study|Withdrawal by Subject|7
19537|NCT01656434|88705|P1|Overall Study|Withdrawal by Subject|64
19538|NCT01656434|88704|P2|Overall Study|Participant withdrew consent|9
19539|NCT01656434|88705|P1|Overall Study|Participant withdrew consent|28
19540|NCT01656434|88704|P2|Overall Study|Participant moved|12
19541|NCT01656434|88705|P1|Overall Study|Participant moved|40
19542|NCT01656434|88704|P2|Overall Study|Non-compliance with protocol|15
19543|NCT01656434|88705|P1|Overall Study|Non-compliance with protocol|39
19544|NCT01656434|88704|P2|Overall Study|Part. discontinued; unrelated to drug|10
19545|NCT01656434|88705|P1|Overall Study|Part. discontinued; unrelated to drug|55
19546|NCT01656434|88704|P2|Overall Study|Participant discontinued; drug related|4
19547|NCT01656434|88705|P1|Overall Study|Participant discontinued; drug related|13
19548|NCT01656434|88704|P2|Overall Study|Study terminated by sponsor|348
19549|NCT01656434|88705|P1|Overall Study|Study terminated by sponsor|1501
19550|NCT01656434|88704|P2|Overall Study|Non-compliance with study drug|9
19551|NCT01656434|88705|P1|Overall Study|Non-compliance with study drug|48
19552|NCT01656434|88704|P2|Overall Study|Physician Decision|2
19553|NCT01656434|88705|P1|Overall Study|Physician Decision|7
19554|NCT01656434|88704|P2|Overall Study|Pregnancy|10
19555|NCT01656434|88705|P1|Overall Study|Pregnancy|45
19556|NCT01656434|88704|P2|Overall Study|Pregnancy wish|6
19557|NCT01656434|88705|P1|Overall Study|Pregnancy wish|18
19558|NCT01656434|88704|P2|Overall Study|Protocol Violation|0
19559|NCT01656434|88705|P1|Overall Study|Protocol Violation|7
19560|NCT01656434|88704|P2|Overall Study|Screen failure|0
19561|NCT01656434|88705|P1|Overall Study|Screen failure|2
19562|NCT01656434|88704|P2|Overall Study|Site discontinued study participation|9
19563|NCT01656434|88705|P1|Overall Study|Site discontinued study participation|24
19564|NCT01656434|88704|P2|Overall Study|Lost to Follow-up|76
19565|NCT01656434|88705|P1|Overall Study|Lost to Follow-up|309
19566|NCT01656434|88704|P2|Overall Study|Enrollment terminated at trial site|0
19567|NCT01656434|88705|P1|Overall Study|Enrollment terminated at trial site|2
19568|NCT01656434|88704|P2|Overall Study|Adverse Event|63
19569|NCT01656434|88705|P1|Overall Study|Adverse Event|199
19570|NCT01656408|88731|P10|Overall Study|Physician Decision|3
19571|NCT01656408|88732|P9|Overall Study|Physician Decision|1
19572|NCT01656408|88733|P8|Overall Study|Physician Decision|1
19573|NCT01656408|88734|P7|Overall Study|Physician Decision|0
19574|NCT01656408|88735|P6|Overall Study|Physician Decision|1
19575|NCT01656408|88736|P5|Overall Study|Physician Decision|1
19576|NCT01656408|88737|P4|Overall Study|Physician Decision|0
19577|NCT01656408|88738|P3|Overall Study|Physician Decision|1
19578|NCT01656408|88739|P2|Overall Study|Physician Decision|0
19579|NCT01656408|88740|P1|Overall Study|Physician Decision|1
19580|NCT01656408|88731|P10|Overall Study|Adverse Event|0
19581|NCT01656408|88732|P9|Overall Study|Adverse Event|1
19582|NCT01656408|88733|P8|Overall Study|Adverse Event|0
19583|NCT01656408|88734|P7|Overall Study|Adverse Event|1
19584|NCT01656408|88735|P6|Overall Study|Adverse Event|1
19585|NCT01656408|88736|P5|Overall Study|Adverse Event|0
19586|NCT01656408|88737|P4|Overall Study|Adverse Event|0
19587|NCT01656408|88738|P3|Overall Study|Adverse Event|1
19588|NCT01656408|88739|P2|Overall Study|Adverse Event|0
19589|NCT01656408|88740|P1|Overall Study|Adverse Event|0
19590|NCT01656304|88929|P1|Overall Study|Ineligible, uncontrolled hypertension|1
19591|NCT01656161|88935|P1|Overall Study|Withdrawal by Subject|1
19592|NCT01656161|88935|P1|Overall Study|Protocol Violation|1
19593|NCT01656161|88935|P1|Overall Study|Adverse Event|2
19594|NCT01656161|88935|P1|Overall Study|Death|3
19595|NCT01655498|88953|P1|Overall Study|Withdrawal by Subject|1
19596|NCT01655498|88953|P1|Overall Study|Protocol Violation|2
19597|NCT01655498|88953|P1|Overall Study|Unrelated health issue|2
19598|NCT01655381|88960|P1|Overall Study|Insufficient Treatment Response|1
19599|NCT01655381|88960|P1|Overall Study|Moved to Another City|1
19600|NCT01655381|88960|P1|Overall Study|Investigator Decision|1
19601|NCT01654666|89008|P3|Overall Study|Withdrawal by Subject|1
19602|NCT01654666|89009|P2|Overall Study|Withdrawal by Subject|4
19603|NCT01654666|89010|P1|Overall Study|Withdrawal by Subject|4
19604|NCT01654666|89008|P3|Overall Study|Lost to Follow-up|5
19605|NCT01654666|89009|P2|Overall Study|Lost to Follow-up|5
19606|NCT01654666|89010|P1|Overall Study|Lost to Follow-up|4
19607|NCT01654666|89008|P3|Overall Study|Protocol Violation|8
19608|NCT01654666|89009|P2|Overall Study|Protocol Violation|4
19609|NCT01654666|89010|P1|Overall Study|Protocol Violation|7
19610|NCT01654601|89035|P2|2nd Administration|Protocol Violation|1
19611|NCT01654601|89036|P1|2nd Administration|Protocol Violation|0
19612|NCT01654601|89035|P2|2nd Administration|Adverse Event|0
19613|NCT01654601|89036|P1|2nd Administration|Adverse Event|1
19614|NCT01654601|89035|P2|1st Administration|Protocol Violation|2
19615|NCT01654601|89036|P1|1st Administration|Protocol Violation|0
19616|NCT01654601|89035|P2|1st Administration|Withdrawal by Subject|0
19617|NCT01654601|89036|P1|1st Administration|Withdrawal by Subject|2
19618|NCT01654549|89050|P2|Overall Study|H.pylori eradication not successful|1
19619|NCT01654549|89051|P1|Overall Study|H.pylori eradication not successful|0
19620|NCT01654536|89063|P2|Overall Study|Withdrawal by Subject|25
19621|NCT01654536|89064|P1|Overall Study|Withdrawal by Subject|27
19622|NCT01654536|89063|P2|Overall Study|Physician Decision|8
19623|NCT01654536|89064|P1|Overall Study|Physician Decision|12
19624|NCT01654536|89063|P2|Overall Study|Lost to Follow-up|5
19625|NCT01654536|89064|P1|Overall Study|Lost to Follow-up|5
19626|NCT01654523|89100|P1|Overall Study|Withdrawal by Subject|1
19627|NCT01654302|89106|P2|Second Intervention (Day 7)|Lost to Follow-up|1
19628|NCT01654302|89107|P1|Second Intervention (Day 7)|Lost to Follow-up|1
19629|NCT01654276|89113|P1|Overall Study|Withdrawal by Subject|1
19630|NCT01654276|89113|P1|Overall Study|Lost to Follow-up|4
19631|NCT01654276|89113|P1|Overall Study|Lack of Efficacy|1
19632|NCT01654250|89167|P2|Overall Study|Lost to Follow-up|0
19633|NCT01654250|89168|P1|Overall Study|Lost to Follow-up|1
19634|NCT01654224|89185|P2|Overall Study|Insufficient blood sample|2
19635|NCT01654224|89186|P1|Overall Study|Insufficient blood sample|3
19636|NCT01654224|89185|P2|Overall Study|Did not receive allocation|8
19637|NCT01654224|89186|P1|Overall Study|Did not receive allocation|1
19638|NCT01654224|89185|P2|Overall Study|Lost to Follow-up|2
19639|NCT01654224|89186|P1|Overall Study|Lost to Follow-up|2
19640|NCT01653782|89208|P3|Overall Study|Lost to Follow-up|2
19641|NCT01653782|89209|P2|Overall Study|Lost to Follow-up|3
19642|NCT01653782|89210|P1|Overall Study|Lost to Follow-up|7
19643|NCT01653782|89208|P3|Overall Study|Withdrawal by Subject|4
19644|NCT01653782|89209|P2|Overall Study|Withdrawal by Subject|15
19645|NCT01653782|89210|P1|Overall Study|Withdrawal by Subject|9
19646|NCT01653743|89220|P2|Overall Study|Investigator discretion|0
19647|NCT01653743|89221|P1|Overall Study|Investigator discretion|3
19648|NCT01653743|89220|P2|Overall Study|Withdrawal by Subject|0
19649|NCT01653743|89221|P1|Overall Study|Withdrawal by Subject|1
19650|NCT01653262|89268|P1|Overall Study|AE, non-serious non-fatal|1
19651|NCT01653262|89268|P1|Overall Study|SAE, non-fatal|1
19652|NCT01653262|89268|P1|Overall Study|Lack of Efficacy|1
19653|NCT01653158|89281|P8|Overall Study|Withdrawal by Subject|0
19654|NCT01653158|89282|P7|Overall Study|Withdrawal by Subject|0
19655|NCT01653158|89283|P6|Overall Study|Withdrawal by Subject|0
19656|NCT01653158|89284|P5|Overall Study|Withdrawal by Subject|0
19657|NCT01653158|89285|P4|Overall Study|Withdrawal by Subject|0
19658|NCT01653158|89286|P3|Overall Study|Withdrawal by Subject|0
19659|NCT01653158|89287|P2|Overall Study|Withdrawal by Subject|0
19660|NCT01653158|89288|P1|Overall Study|Withdrawal by Subject|1
19661|NCT01653158|89281|P8|Overall Study|Progressive disease|9
19662|NCT01653158|89282|P7|Overall Study|Progressive disease|2
19663|NCT01653158|89283|P6|Overall Study|Progressive disease|1
19664|NCT01653158|89284|P5|Overall Study|Progressive disease|1
19665|NCT01653158|89285|P4|Overall Study|Progressive disease|0
19666|NCT01653158|89286|P3|Overall Study|Progressive disease|0
19667|NCT01653158|89287|P2|Overall Study|Progressive disease|0
19668|NCT01653158|89288|P1|Overall Study|Progressive disease|0
19669|NCT01653158|89281|P8|Overall Study|Unspecified|1
19670|NCT01653158|89282|P7|Overall Study|Unspecified|0
19671|NCT01653158|89283|P6|Overall Study|Unspecified|0
19672|NCT01653158|89284|P5|Overall Study|Unspecified|0
19673|NCT01653158|89285|P4|Overall Study|Unspecified|0
19674|NCT01653158|89286|P3|Overall Study|Unspecified|0
19675|NCT01653158|89287|P2|Overall Study|Unspecified|0
19676|NCT01653158|89288|P1|Overall Study|Unspecified|0
19677|NCT01653158|89281|P8|Overall Study|Adverse Event|3
19678|NCT01653158|89282|P7|Overall Study|Adverse Event|0
19679|NCT01653158|89283|P6|Overall Study|Adverse Event|0
19680|NCT01653158|89284|P5|Overall Study|Adverse Event|0
19681|NCT01653158|89285|P4|Overall Study|Adverse Event|1
19682|NCT01653158|89286|P3|Overall Study|Adverse Event|0
19683|NCT01653158|89287|P2|Overall Study|Adverse Event|0
19684|NCT01653158|89288|P1|Overall Study|Adverse Event|0
19685|NCT01653158|89281|P8|Overall Study|Death|2
19686|NCT01653158|89282|P7|Overall Study|Death|0
19687|NCT01653158|89283|P6|Overall Study|Death|0
19688|NCT01653158|89284|P5|Overall Study|Death|0
19689|NCT01653158|89285|P4|Overall Study|Death|1
19690|NCT01653158|89286|P3|Overall Study|Death|0
19691|NCT01653158|89287|P2|Overall Study|Death|0
19692|NCT01653158|89288|P1|Overall Study|Death|0
19693|NCT01653132|89560|P2|First Intervention|Protocol Violation|0
19694|NCT01653132|89561|P1|First Intervention|Protocol Violation|1
19695|NCT01652729|89614|P3|Overall Study|Administrative|0
19696|NCT01652729|89615|P2|Overall Study|Administrative|0
19697|NCT01652729|89616|P1|Overall Study|Administrative|1
19698|NCT01652729|89614|P3|Overall Study|Lost to Follow-up|3
19699|NCT01652729|89615|P2|Overall Study|Lost to Follow-up|6
19700|NCT01652729|89616|P1|Overall Study|Lost to Follow-up|6
19701|NCT01652729|89614|P3|Overall Study|Protocol Violation|0
19702|NCT01652729|89615|P2|Overall Study|Protocol Violation|0
19703|NCT01652729|89616|P1|Overall Study|Protocol Violation|1
19704|NCT01652729|89614|P3|Overall Study|Physician Decision|1
19705|NCT01652729|89615|P2|Overall Study|Physician Decision|0
19706|NCT01652729|89616|P1|Overall Study|Physician Decision|1
19707|NCT01652729|89614|P3|Overall Study|Adverse Event|3
19708|NCT01652729|89615|P2|Overall Study|Adverse Event|0
19709|NCT01652729|89616|P1|Overall Study|Adverse Event|4
19710|NCT01652729|89614|P3|Overall Study|Withdrawal by Subject|7
19711|NCT01652729|89615|P2|Overall Study|Withdrawal by Subject|7
19712|NCT01652729|89616|P1|Overall Study|Withdrawal by Subject|14
19713|NCT01652716|89638|P2|Overall Study|Withdrawal by Subject|18
19714|NCT01652716|89639|P1|Overall Study|Withdrawal by Subject|33
19715|NCT01652716|89638|P2|Overall Study|Adverse Event|10
19716|NCT01652716|89639|P1|Overall Study|Adverse Event|7
19717|NCT01652716|89638|P2|Overall Study|Protocol Violation|1
19718|NCT01652716|89639|P1|Overall Study|Protocol Violation|2
19719|NCT01652716|89638|P2|Overall Study|Lost to Follow-up|11
19720|NCT01652716|89639|P1|Overall Study|Lost to Follow-up|12
19721|NCT01652716|89638|P2|Overall Study|Investigator decision|4
19722|NCT01652716|89639|P1|Overall Study|Investigator decision|1
19723|NCT01652716|89638|P2|Overall Study|Administrative|2
19724|NCT01652716|89639|P1|Overall Study|Administrative|0
19725|NCT01652716|89638|P2|Overall Study|Loss of glucose control|0
19726|NCT01652716|89639|P1|Overall Study|Loss of glucose control|1
19727|NCT01652703|89659|P6|Overall Study|Other|1
19728|NCT01652703|89660|P5|Overall Study|Other|1
19729|NCT01652703|89661|P4|Overall Study|Other|1
19730|NCT01652703|89662|P3|Overall Study|Other|0
19731|NCT01652703|89663|P2|Overall Study|Other|0
19732|NCT01652703|89664|P1|Overall Study|Other|0
19733|NCT01652703|89659|P6|Overall Study|Withdrawal by Subject|1
19734|NCT01652703|89660|P5|Overall Study|Withdrawal by Subject|0
19735|NCT01652703|89661|P4|Overall Study|Withdrawal by Subject|1
19736|NCT01652703|89662|P3|Overall Study|Withdrawal by Subject|3
19737|NCT01652703|89663|P2|Overall Study|Withdrawal by Subject|1
19738|NCT01652703|89664|P1|Overall Study|Withdrawal by Subject|0
19739|NCT01652690|89722|P2|Overall Study|Death|2
19740|NCT01652690|89723|P1|Overall Study|Death|5
19741|NCT01652690|89722|P2|Overall Study|Lost to Follow-up|6
19742|NCT01652690|89723|P1|Overall Study|Lost to Follow-up|6
19743|NCT01652690|89722|P2|Overall Study|Other|9
19744|NCT01652690|89723|P1|Overall Study|Other|8
19745|NCT01652690|89722|P2|Overall Study|Withdrawal by Subject|4
19746|NCT01652690|89723|P1|Overall Study|Withdrawal by Subject|16
19747|NCT01652664|89757|P2|Overall Study|Inadequate IOP control|0
19748|NCT01652664|89758|P1|Overall Study|Inadequate IOP control|1
19749|NCT01652664|89757|P2|Overall Study|Treatment Failure|1
19750|NCT01652664|89758|P1|Overall Study|Treatment Failure|5
19751|NCT01651949|89792|P3|Overall Study|Withdrawal by Subject|9
19752|NCT01651949|89793|P2|Overall Study|Withdrawal by Subject|18
19753|NCT01651949|89794|P1|Overall Study|Withdrawal by Subject|17
19754|NCT01651949|89792|P3|Overall Study|Screen failure|0
19755|NCT01651949|89793|P2|Overall Study|Screen failure|2
19756|NCT01651949|89794|P1|Overall Study|Screen failure|2
19757|NCT01651949|89792|P3|Overall Study|Adverse Event|1
19758|NCT01651949|89793|P2|Overall Study|Adverse Event|2
19759|NCT01651949|89794|P1|Overall Study|Adverse Event|0
19760|NCT01651949|89792|P3|Overall Study|Physician Decision|0
19761|NCT01651949|89793|P2|Overall Study|Physician Decision|2
19762|NCT01651949|89794|P1|Overall Study|Physician Decision|0
19763|NCT01651949|89792|P3|Overall Study|Protocol Violation|1
19764|NCT01651949|89793|P2|Overall Study|Protocol Violation|2
19765|NCT01651949|89794|P1|Overall Study|Protocol Violation|0
19766|NCT01651949|89792|P3|Overall Study|Lost to Follow-up|20
19767|NCT01651949|89793|P2|Overall Study|Lost to Follow-up|56
19768|NCT01651949|89794|P1|Overall Study|Lost to Follow-up|30
19769|NCT01651949|89792|P3|Overall Study|Unknown status|0
19770|NCT01651949|89793|P2|Overall Study|Unknown status|4
19771|NCT01651949|89794|P1|Overall Study|Unknown status|4
19772|NCT01651260|89832|P1|Overall Study|unable to apply product|3
19773|NCT01651208|89839|P2|Overall Study|Lost to Follow-up|16
19774|NCT01651208|89840|P1|Overall Study|Lost to Follow-up|14
19775|NCT01651000|89857|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
19776|NCT01651000|89858|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
19777|NCT01651000|89857|P2|Overall Study|Administrative reason|0
19778|NCT01651000|89858|P1|Overall Study|Administrative reason|1
19779|NCT01651000|89857|P2|Overall Study|Physician Decision|0
19780|NCT01651000|89858|P1|Overall Study|Physician Decision|1
19781|NCT01651000|89857|P2|Overall Study|Lack of Efficacy|1
19782|NCT01651000|89858|P1|Overall Study|Lack of Efficacy|1
19783|NCT01651000|89857|P2|Overall Study|Subject noncompliance|3
19784|NCT01651000|89858|P1|Overall Study|Subject noncompliance|0
19785|NCT01651000|89857|P2|Overall Study|Withdrawal by Subject|10
19786|NCT01651000|89858|P1|Overall Study|Withdrawal by Subject|2
19787|NCT01651000|89857|P2|Overall Study|Protocol Violation|3
19788|NCT01651000|89858|P1|Overall Study|Protocol Violation|0
19789|NCT01651000|89857|P2|Overall Study|Lost to Follow-up|2
19790|NCT01651000|89858|P1|Overall Study|Lost to Follow-up|3
19791|NCT01651000|89857|P2|Overall Study|Adverse Event|8
19792|NCT01651000|89858|P1|Overall Study|Adverse Event|2
19793|NCT01650831|89870|P1|Overall Study|Screen failure|1
19794|NCT01650805|89880|P2|Overall Study|Withdrawal by Subject|0
19795|NCT01650805|89881|P1|Overall Study|Withdrawal by Subject|1
19796|NCT01650779|89891|P1|Overall Study|Withdrawal by Subject|1
19797|NCT01650519|89900|P2|Overall Study|Withdrawal by Subject|0
19798|NCT01650519|89901|P1|Overall Study|Withdrawal by Subject|1
19799|NCT01650285|89961|P1|Overall Study|Adverse Event|1
19800|NCT01650246|89965|P1|Overall Study|Lack of Efficacy|30
19801|NCT01650246|89965|P1|Overall Study|Death|1
19802|NCT01650246|89965|P1|Overall Study|Withdrawal by Subject|26
19803|NCT01650246|89965|P1|Overall Study|Lost to Follow-up|5
19804|NCT01650246|89965|P1|Overall Study|Sponsor terminated study|53
19805|NCT01650246|89965|P1|Overall Study|Protocol Violation|5
19806|NCT01650246|89965|P1|Overall Study|Adverse Event|23
19807|NCT01649856|89972|P2|Overall Study|Ongoing in Follow-Up|152
19808|NCT01649856|89973|P1|Overall Study|Ongoing in Follow-Up|303
19809|NCT01649856|89972|P2|Overall Study|Not Specified|0
19810|NCT01649856|89973|P1|Overall Study|Not Specified|1
19811|NCT01649856|89972|P2|Overall Study|Lack of Compliance|1
19812|NCT01649856|89973|P1|Overall Study|Lack of Compliance|0
19813|NCT01649856|89972|P2|Overall Study|Lost to Follow-up|7
19814|NCT01649856|89973|P1|Overall Study|Lost to Follow-up|9
19815|NCT01649856|89972|P2|Overall Study|Stable or Progressed Disease|3
19816|NCT01649856|89973|P1|Overall Study|Stable or Progressed Disease|5
19817|NCT01649856|89972|P2|Overall Study|Death|26
19818|NCT01649856|89973|P1|Overall Study|Death|37
19819|NCT01649856|89972|P2|Overall Study|Treatment Failure|1
19820|NCT01649856|89973|P1|Overall Study|Treatment Failure|4
19821|NCT01649856|89972|P2|Overall Study|Protocol Violation|4
19822|NCT01649856|89973|P1|Overall Study|Protocol Violation|4
19823|NCT01649856|89972|P2|Overall Study|Withdrawal by Subject|9
19824|NCT01649856|89973|P1|Overall Study|Withdrawal by Subject|6
19825|NCT01649804|90005|P1|Overall Study|Administrative/Other|8
19826|NCT01649791|90017|P1|Overall Study|Adverse Event|1
19827|NCT01649791|90017|P1|Overall Study|Disease Progression|2
19828|NCT01649557|90027|P3|Overall Study|Lack of Efficacy|0
19829|NCT01649557|90028|P2|Overall Study|Lack of Efficacy|0
19830|NCT01649557|90029|P1|Overall Study|Lack of Efficacy|5
19831|NCT01649557|90027|P3|Overall Study|Protocol deviation|0
19832|NCT01649557|90028|P2|Overall Study|Protocol deviation|2
19833|NCT01649557|90029|P1|Overall Study|Protocol deviation|0
19834|NCT01649557|90027|P3|Overall Study|Withdrawal by Subject|4
19835|NCT01649557|90028|P2|Overall Study|Withdrawal by Subject|5
19836|NCT01649557|90029|P1|Overall Study|Withdrawal by Subject|15
19837|NCT01649557|90027|P3|Overall Study|Physician Decision|1
19838|NCT01649557|90028|P2|Overall Study|Physician Decision|2
19839|NCT01649557|90029|P1|Overall Study|Physician Decision|8
19840|NCT01649557|90027|P3|Overall Study|Met withdrawal criteria|0
19841|NCT01649557|90028|P2|Overall Study|Met withdrawal criteria|0
19842|NCT01649557|90029|P1|Overall Study|Met withdrawal criteria|4
19843|NCT01649557|90027|P3|Overall Study|Adverse Event|1
19844|NCT01649557|90028|P2|Overall Study|Adverse Event|5
19845|NCT01649557|90029|P1|Overall Study|Adverse Event|7
19846|NCT01649557|90027|P3|Overall Study|Lost to Follow-up|3
19847|NCT01649557|90028|P2|Overall Study|Lost to Follow-up|0
19848|NCT01649557|90029|P1|Overall Study|Lost to Follow-up|5
19849|NCT01649297|90091|P5|Overall Study|For other reason|0
19850|NCT01649297|90092|P4|Overall Study|For other reason|0
19851|NCT01649297|90093|P3|Overall Study|For other reason|2
19852|NCT01649297|90094|P2|Overall Study|For other reason|1
19853|NCT01649297|90095|P1|Overall Study|For other reason|4
19854|NCT01649297|90091|P5|Overall Study|Patient withdrawal (not due to AE)|1
19855|NCT01649297|90092|P4|Overall Study|Patient withdrawal (not due to AE)|1
19856|NCT01649297|90093|P3|Overall Study|Patient withdrawal (not due to AE)|4
19857|NCT01649297|90094|P2|Overall Study|Patient withdrawal (not due to AE)|6
19858|NCT01649297|90095|P1|Overall Study|Patient withdrawal (not due to AE)|3
19859|NCT01649297|90091|P5|Overall Study|Lost to Follow-up|0
19860|NCT01649297|90092|P4|Overall Study|Lost to Follow-up|3
19861|NCT01649297|90093|P3|Overall Study|Lost to Follow-up|4
19862|NCT01649297|90094|P2|Overall Study|Lost to Follow-up|1
19863|NCT01649297|90095|P1|Overall Study|Lost to Follow-up|1
19864|NCT01649297|90091|P5|Overall Study|Non compliant with Protocol|1
19865|NCT01649297|90092|P4|Overall Study|Non compliant with Protocol|2
19866|NCT01649297|90093|P3|Overall Study|Non compliant with Protocol|3
19867|NCT01649297|90094|P2|Overall Study|Non compliant with Protocol|0
19868|NCT01649297|90095|P1|Overall Study|Non compliant with Protocol|1
19869|NCT01649297|90091|P5|Overall Study|Lack of Efficacy|1
19870|NCT01649297|90092|P4|Overall Study|Lack of Efficacy|0
19871|NCT01649297|90093|P3|Overall Study|Lack of Efficacy|0
19872|NCT01649297|90094|P2|Overall Study|Lack of Efficacy|0
19873|NCT01649297|90095|P1|Overall Study|Lack of Efficacy|0
19874|NCT01649297|90091|P5|Overall Study|Adverse Event|1
19875|NCT01649297|90092|P4|Overall Study|Adverse Event|13
19876|NCT01649297|90093|P3|Overall Study|Adverse Event|4
19877|NCT01649297|90094|P2|Overall Study|Adverse Event|5
19878|NCT01649297|90095|P1|Overall Study|Adverse Event|5
19879|NCT01649232|90114|P2|Overall Study|Physician Decision|0
19880|NCT01649232|90115|P1|Overall Study|Physician Decision|2
19881|NCT01648790|90159|P5|Treatment 3|Withdrawal by Subject|0
19882|NCT01648790|90160|P4|Treatment 3|Withdrawal by Subject|1
19883|NCT01648790|90161|P3|Treatment 3|Withdrawal by Subject|0
19884|NCT01648790|90162|P2|Treatment 3|Withdrawal by Subject|0
19885|NCT01648790|90163|P1|Treatment 3|Withdrawal by Subject|0
19886|NCT01648699|90184|P1|Overall Study|Unspecified/unable to complete 4 visits|2
19887|NCT01648699|90184|P1|Overall Study|Lost to Follow-up|2
19888|NCT01648699|90184|P1|Overall Study|Death|1
19889|NCT01648582|90213|P3|Overall Study|Sponsor Decision|1
19890|NCT01648582|90214|P2|Overall Study|Sponsor Decision|1
19891|NCT01648582|90215|P1|Overall Study|Sponsor Decision|0
19892|NCT01648582|90213|P3|Overall Study|Physician Decision|3
19893|NCT01648582|90214|P2|Overall Study|Physician Decision|1
19894|NCT01648582|90215|P1|Overall Study|Physician Decision|0
19895|NCT01648582|90213|P3|Overall Study|Withdrawal by Subject|17
19896|NCT01648582|90214|P2|Overall Study|Withdrawal by Subject|17
19897|NCT01648582|90215|P1|Overall Study|Withdrawal by Subject|15
19898|NCT01648582|90213|P3|Overall Study|Protocol Violation|1
19899|NCT01648582|90214|P2|Overall Study|Protocol Violation|2
19900|NCT01648582|90215|P1|Overall Study|Protocol Violation|1
19901|NCT01648582|90213|P3|Overall Study|Lost to Follow-up|8
19902|NCT01648582|90214|P2|Overall Study|Lost to Follow-up|6
19903|NCT01648582|90215|P1|Overall Study|Lost to Follow-up|9
19904|NCT01648582|90213|P3|Overall Study|Death|0
19905|NCT01648582|90214|P2|Overall Study|Death|0
19906|NCT01648582|90215|P1|Overall Study|Death|1
19907|NCT01648582|90213|P3|Overall Study|Adverse Event|2
19908|NCT01648582|90214|P2|Overall Study|Adverse Event|11
19909|NCT01648582|90215|P1|Overall Study|Adverse Event|6
19910|NCT01648101|90318|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
19911|NCT01648101|90319|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
19912|NCT01648101|90320|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
19913|NCT01648101|90318|P3|Transition Phase (4 Weeks)|Study Terminated|0
19914|NCT01648101|90319|P2|Transition Phase (4 Weeks)|Study Terminated|0
19915|NCT01648101|90320|P1|Transition Phase (4 Weeks)|Study Terminated|1
19916|NCT01648101|90318|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
19917|NCT01648101|90319|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
19918|NCT01648101|90320|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
19919|NCT01648101|90318|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
19920|NCT01648101|90319|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
19921|NCT01648101|90320|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
19922|NCT01648101|90318|P3|Transition Phase (4 Weeks)|Adverse Event|2
19923|NCT01648101|90319|P2|Transition Phase (4 Weeks)|Adverse Event|3
19924|NCT01648101|90320|P1|Transition Phase (4 Weeks)|Adverse Event|4
19925|NCT01648101|90318|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
19926|NCT01648101|90319|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
19927|NCT01648101|90320|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
19928|NCT01648101|90318|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
19929|NCT01648101|90319|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
19930|NCT01648101|90320|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
19931|NCT01648101|90318|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
19932|NCT01648101|90319|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
19933|NCT01648101|90320|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
19934|NCT01648101|90318|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
20354|NCT01642004|91784|P2|Treatment|Withdrawal by Subject|9
19935|NCT01648101|90319|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
19936|NCT01648101|90320|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
19937|NCT01648101|90318|P3|Titration Phase (4 Weeks)|Adverse Event|3
19938|NCT01648101|90319|P2|Titration Phase (4 Weeks)|Adverse Event|2
19939|NCT01648101|90320|P1|Titration Phase (4 Weeks)|Adverse Event|0
19940|NCT01648101|90318|P3|Titration Phase (4 Weeks)|Protocol Violation|2
19941|NCT01648101|90319|P2|Titration Phase (4 Weeks)|Protocol Violation|1
19942|NCT01648101|90320|P1|Titration Phase (4 Weeks)|Protocol Violation|2
19943|NCT01647711|90407|P5|Overall Study|Other reason not defined|0
19944|NCT01647711|90408|P4|Overall Study|Other reason not defined|1
19945|NCT01647711|90409|P3|Overall Study|Other reason not defined|1
19946|NCT01647711|90410|P2|Overall Study|Other reason not defined|1
19947|NCT01647711|90411|P1|Overall Study|Other reason not defined|0
19948|NCT01647711|90407|P5|Overall Study|Refused to continue taking medication|1
19949|NCT01647711|90408|P4|Overall Study|Refused to continue taking medication|2
19950|NCT01647711|90409|P3|Overall Study|Refused to continue taking medication|0
19951|NCT01647711|90410|P2|Overall Study|Refused to continue taking medication|0
19952|NCT01647711|90411|P1|Overall Study|Refused to continue taking medication|0
19953|NCT01647711|90407|P5|Overall Study|Protocol Violation|1
19954|NCT01647711|90408|P4|Overall Study|Protocol Violation|0
19955|NCT01647711|90409|P3|Overall Study|Protocol Violation|0
19956|NCT01647711|90410|P2|Overall Study|Protocol Violation|0
19957|NCT01647711|90411|P1|Overall Study|Protocol Violation|0
19958|NCT01647711|90407|P5|Overall Study|Other adverse event|2
19959|NCT01647711|90408|P4|Overall Study|Other adverse event|0
19960|NCT01647711|90409|P3|Overall Study|Other adverse event|2
19961|NCT01647711|90410|P2|Overall Study|Other adverse event|0
19962|NCT01647711|90411|P1|Overall Study|Other adverse event|0
19963|NCT01647711|90407|P5|Overall Study|Progressive disease|2
19964|NCT01647711|90408|P4|Overall Study|Progressive disease|8
19965|NCT01647711|90409|P3|Overall Study|Progressive disease|6
19966|NCT01647711|90410|P2|Overall Study|Progressive disease|2
19967|NCT01647711|90411|P1|Overall Study|Progressive disease|6
19968|NCT01647542|90439|P3|Overall Study|Death|1
19969|NCT01647542|90440|P2|Overall Study|Death|0
19970|NCT01647542|90441|P1|Overall Study|Death|0
19971|NCT01647542|90439|P3|Overall Study|Lack of Efficacy|0
19972|NCT01647542|90440|P2|Overall Study|Lack of Efficacy|1
19973|NCT01647542|90441|P1|Overall Study|Lack of Efficacy|1
19974|NCT01647542|90439|P3|Overall Study|Study Termination|65
19975|NCT01647542|90440|P2|Overall Study|Study Termination|61
19976|NCT01647542|90441|P1|Overall Study|Study Termination|64
19977|NCT01647542|90439|P3|Overall Study|Withdrawal by Subject|0
19978|NCT01647542|90440|P2|Overall Study|Withdrawal by Subject|4
19979|NCT01647542|90441|P1|Overall Study|Withdrawal by Subject|6
19980|NCT01647542|90439|P3|Overall Study|Lost to Follow-up|2
19981|NCT01647542|90440|P2|Overall Study|Lost to Follow-up|2
19982|NCT01647542|90441|P1|Overall Study|Lost to Follow-up|0
19983|NCT01647542|90439|P3|Overall Study|Adverse Event|4
19984|NCT01647542|90440|P2|Overall Study|Adverse Event|5
19985|NCT01647542|90441|P1|Overall Study|Adverse Event|4
19986|NCT01647542|90439|P3|Overall Study|Major Protocol Deviation|0
19987|NCT01647542|90440|P2|Overall Study|Major Protocol Deviation|0
19988|NCT01647542|90441|P1|Overall Study|Major Protocol Deviation|1
19989|NCT01646827|90475|P2|Overall Study|Withdrawal by Subject|0
19990|NCT01646827|90476|P1|Overall Study|Withdrawal by Subject|1
19991|NCT01646827|90475|P2|Overall Study|Physician Decision|2
19992|NCT01646827|90476|P1|Overall Study|Physician Decision|1
19993|NCT01646827|90475|P2|Overall Study|Lost to Follow-up|3
19994|NCT01646827|90476|P1|Overall Study|Lost to Follow-up|0
19995|NCT01646398|90554|P2|Overall Study|Withdrawal by Subject|0
19996|NCT01646398|90555|P1|Overall Study|Withdrawal by Subject|1
19997|NCT01646385|90571|P2|Overall Study|Switched to alternate biologic|649
19998|NCT01646385|90572|P1|Overall Study|Switched to alternate biologic|636
19999|NCT01646385|90571|P2|Overall Study|Death|222
20000|NCT01646385|90572|P1|Overall Study|Death|202
20001|NCT01646320|90605|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
20002|NCT01646320|90606|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
20003|NCT01646320|90605|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
20004|NCT01646320|90606|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
20005|NCT01646320|90605|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
20006|NCT01646320|90606|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
20007|NCT01646320|90605|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
20008|NCT01646320|90606|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
20009|NCT01646320|90605|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
20010|NCT01646320|90606|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
20011|NCT01646320|90605|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
20012|NCT01646320|90606|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
20013|NCT01646320|90605|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
20014|NCT01646320|90606|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
20015|NCT01646320|90605|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
20016|NCT01646320|90606|P1|Short-term Period (Day 1 to Week 24)|Not specified|1
20017|NCT01646320|90605|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
20018|NCT01646320|90606|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
20019|NCT01646320|90605|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
20020|NCT01646320|90606|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
20021|NCT01646320|90605|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
20022|NCT01646320|90606|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
20023|NCT01646268|90622|P2|Overall Study|Other|0
20024|NCT01646268|90623|P1|Overall Study|Other|2
20025|NCT01646268|90622|P2|Overall Study|Withdrawal by Subject|5
20026|NCT01646268|90623|P1|Overall Study|Withdrawal by Subject|2
20027|NCT01646268|90622|P2|Overall Study|Protocol Violation|1
20028|NCT01646268|90623|P1|Overall Study|Protocol Violation|0
20029|NCT01646268|90622|P2|Overall Study|Lack of Efficacy|3
20030|NCT01646268|90623|P1|Overall Study|Lack of Efficacy|1
20031|NCT01646268|90622|P2|Overall Study|Adverse Event|7
20032|NCT01646268|90623|P1|Overall Study|Adverse Event|6
20033|NCT01646255|90637|P2|Overall Study|Inclusion Criteria Deviation|0
20034|NCT01646255|90638|P1|Overall Study|Inclusion Criteria Deviation|1
20035|NCT01646255|90637|P2|Overall Study|Compliance is not well|0
20036|NCT01646255|90638|P1|Overall Study|Compliance is not well|1
20037|NCT01646255|90637|P2|Overall Study|Withdrawal by Subject|6
20038|NCT01646255|90638|P1|Overall Study|Withdrawal by Subject|10
20039|NCT01646255|90637|P2|Overall Study|Lack of Efficacy|0
20040|NCT01646255|90638|P1|Overall Study|Lack of Efficacy|2
20041|NCT01646255|90637|P2|Overall Study|Adverse Event|8
20042|NCT01646255|90638|P1|Overall Study|Adverse Event|7
20043|NCT01646177|90672|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
20044|NCT01646177|90673|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
20045|NCT01646177|90674|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
20046|NCT01646177|90675|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
20047|NCT01646177|90672|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
20048|NCT01646177|90673|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
20049|NCT01646177|90674|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
20050|NCT01646177|90675|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
20051|NCT01646177|90672|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
20052|NCT01646177|90673|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
20053|NCT01646177|90674|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
20054|NCT01646177|90675|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
20055|NCT01646177|90672|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
20056|NCT01646177|90673|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
20057|NCT01646177|90674|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
20058|NCT01646177|90675|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
20059|NCT01646177|90672|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
20060|NCT01646177|90673|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
20061|NCT01646177|90674|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
20062|NCT01646177|90675|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
20063|NCT01646177|90672|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
20064|NCT01646177|90673|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
20065|NCT01646177|90674|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
20066|NCT01646177|90675|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
20067|NCT01646138|90769|P5|Overall Study|Lost to Follow-up|2
20068|NCT01646138|90770|P4|Overall Study|Lost to Follow-up|0
20069|NCT01646138|90771|P3|Overall Study|Lost to Follow-up|0
20070|NCT01646138|90772|P2|Overall Study|Lost to Follow-up|0
20071|NCT01646138|90773|P1|Overall Study|Lost to Follow-up|0
20072|NCT01646073|90787|P2|Period B (12 Weeks)|Lost to Follow-up|1
20073|NCT01646073|90788|P1|Period B (12 Weeks)|Lost to Follow-up|0
20074|NCT01646073|90787|P2|Period B (12 Weeks)|Withdrawal by Subject|5
20075|NCT01646073|90788|P1|Period B (12 Weeks)|Withdrawal by Subject|1
20076|NCT01646073|90787|P2|Period B (12 Weeks)|Adverse Event|7
20077|NCT01646073|90788|P1|Period B (12 Weeks)|Adverse Event|0
20078|NCT01646073|90787|P2|Period A (12 Weeks)|Not Specified|1
20079|NCT01646073|90788|P1|Period A (12 Weeks)|Not Specified|0
20080|NCT01646073|90787|P2|Period A (12 Weeks)|Protocol Violation|1
20081|NCT01646073|90788|P1|Period A (12 Weeks)|Protocol Violation|0
20082|NCT01646073|90787|P2|Period A (12 Weeks)|Lack of Efficacy|0
20083|NCT01646073|90788|P1|Period A (12 Weeks)|Lack of Efficacy|1
20084|NCT01646073|90787|P2|Period A (12 Weeks)|Withdrawal by Subject|1
20085|NCT01646073|90788|P1|Period A (12 Weeks)|Withdrawal by Subject|1
20086|NCT01646073|90787|P2|Period A (12 Weeks)|Adverse Event|2
20087|NCT01646073|90788|P1|Period A (12 Weeks)|Adverse Event|0
20088|NCT01645735|90829|P2|Overall Study|Adverse Event|1
20089|NCT01645735|90830|P1|Overall Study|Adverse Event|0
20090|NCT01645735|90829|P2|Overall Study|Protocol Violation|0
20091|NCT01645735|90830|P1|Overall Study|Protocol Violation|1
20092|NCT01645735|90829|P2|Overall Study|Withdrawal by Subject|0
20093|NCT01645735|90830|P1|Overall Study|Withdrawal by Subject|1
20094|NCT01645735|90829|P2|Overall Study|Physician Decision|0
20095|NCT01645735|90830|P1|Overall Study|Physician Decision|2
20096|NCT01645280|90872|P5|Overall Study|Treatment not completed/Completed f/u|2
20097|NCT01645280|90873|P4|Overall Study|Treatment not completed/Completed f/u|0
20098|NCT01645280|90874|P3|Overall Study|Treatment not completed/Completed f/u|2
20099|NCT01645280|90875|P2|Overall Study|Treatment not completed/Completed f/u|1
20100|NCT01645280|90876|P1|Overall Study|Treatment not completed/Completed f/u|1
20101|NCT01645280|90872|P5|Overall Study|Unspecified|0
20102|NCT01645280|90873|P4|Overall Study|Unspecified|0
20103|NCT01645280|90874|P3|Overall Study|Unspecified|2
20104|NCT01645280|90875|P2|Overall Study|Unspecified|1
20105|NCT01645280|90876|P1|Overall Study|Unspecified|1
20106|NCT01645280|90872|P5|Overall Study|Lost to Follow-up|1
20107|NCT01645280|90873|P4|Overall Study|Lost to Follow-up|2
20108|NCT01645280|90874|P3|Overall Study|Lost to Follow-up|0
20109|NCT01645280|90875|P2|Overall Study|Lost to Follow-up|0
20110|NCT01645280|90876|P1|Overall Study|Lost to Follow-up|0
20111|NCT01645280|90872|P5|Overall Study|Withdrawal by Subject|5
20112|NCT01645280|90873|P4|Overall Study|Withdrawal by Subject|4
20113|NCT01645280|90874|P3|Overall Study|Withdrawal by Subject|2
20114|NCT01645280|90875|P2|Overall Study|Withdrawal by Subject|0
20115|NCT01645280|90876|P1|Overall Study|Withdrawal by Subject|4
20116|NCT01645280|90872|P5|Overall Study|Death|0
20117|NCT01645280|90873|P4|Overall Study|Death|0
20118|NCT01645280|90874|P3|Overall Study|Death|0
20119|NCT01645280|90875|P2|Overall Study|Death|1
20120|NCT01645280|90876|P1|Overall Study|Death|0
20121|NCT01645111|90904|P1|Overall Study|Did not require Clevidipine|15
20122|NCT01644734|90943|P1|Overall Study|Missing documentation|238
20123|NCT01644734|90943|P1|Overall Study|Reasons other than stated above|7
20124|NCT01644734|90943|P1|Overall Study|Lost to Follow-up|17
20125|NCT01644734|90943|P1|Overall Study|Adverse Event|4
20126|NCT01644643|90957|P4|Overall Study|Other Eligibility criteria|2
20127|NCT01644643|90958|P3|Overall Study|Other Eligibility criteria|0
20128|NCT01644643|90959|P2|Overall Study|Other Eligibility criteria|0
20129|NCT01644643|90960|P1|Overall Study|Other Eligibility criteria|0
20130|NCT01644643|90957|P4|Overall Study|Withdrawal by Subject|1
20131|NCT01644643|90958|P3|Overall Study|Withdrawal by Subject|2
20132|NCT01644643|90959|P2|Overall Study|Withdrawal by Subject|0
20133|NCT01644643|90960|P1|Overall Study|Withdrawal by Subject|1
20134|NCT01644643|90957|P4|Overall Study|Lost to Follow-up|4
20135|NCT01644643|90958|P3|Overall Study|Lost to Follow-up|0
20136|NCT01644643|90959|P2|Overall Study|Lost to Follow-up|0
20137|NCT01644643|90960|P1|Overall Study|Lost to Follow-up|0
20138|NCT01644643|90957|P4|Overall Study|Death|3
20139|NCT01644643|90958|P3|Overall Study|Death|3
20140|NCT01644643|90959|P2|Overall Study|Death|0
20141|NCT01644643|90960|P1|Overall Study|Death|1
20142|NCT01644617|91125|P3|Overall Study|Adverse Event|6
20143|NCT01644617|91126|P2|Overall Study|Adverse Event|0
20144|NCT01644617|91127|P1|Overall Study|Adverse Event|3
20145|NCT01644617|91125|P3|Overall Study|Lost to Follow-up|0
20146|NCT01644617|91126|P2|Overall Study|Lost to Follow-up|1
20147|NCT01644617|91127|P1|Overall Study|Lost to Follow-up|0
20148|NCT01644617|91125|P3|Overall Study|Withdrawal by Subject|1
20149|NCT01644617|91126|P2|Overall Study|Withdrawal by Subject|4
20150|NCT01644617|91127|P1|Overall Study|Withdrawal by Subject|3
20151|NCT01644500|91180|P3|Overall Study|Lost to Follow-up|2
20152|NCT01644500|91181|P2|Overall Study|Lost to Follow-up|11
20153|NCT01644500|91182|P1|Overall Study|Lost to Follow-up|4
20154|NCT01644500|91180|P3|Overall Study|Sponsor Decision|1
20155|NCT01644500|91181|P2|Overall Study|Sponsor Decision|0
20156|NCT01644500|91182|P1|Overall Study|Sponsor Decision|0
20157|NCT01644500|91180|P3|Overall Study|Physician Decision|1
20158|NCT01644500|91181|P2|Overall Study|Physician Decision|1
20159|NCT01644500|91182|P1|Overall Study|Physician Decision|1
20160|NCT01644500|91180|P3|Overall Study|Withdrawal by Subject|12
20161|NCT01644500|91181|P2|Overall Study|Withdrawal by Subject|13
20162|NCT01644500|91182|P1|Overall Study|Withdrawal by Subject|11
20163|NCT01644500|91180|P3|Overall Study|Protocol Violation|0
20164|NCT01644500|91181|P2|Overall Study|Protocol Violation|1
20165|NCT01644500|91182|P1|Overall Study|Protocol Violation|1
20166|NCT01644500|91180|P3|Overall Study|Death|0
20167|NCT01644500|91181|P2|Overall Study|Death|1
20168|NCT01644500|91182|P1|Overall Study|Death|0
20169|NCT01644500|91180|P3|Overall Study|Adverse Event|2
20170|NCT01644500|91181|P2|Overall Study|Adverse Event|1
20171|NCT01644500|91182|P1|Overall Study|Adverse Event|7
20172|NCT01644474|91252|P2|Overall Study|Protocol Violation|0
20173|NCT01644474|91253|P1|Overall Study|Protocol Violation|1
20174|NCT01644474|91252|P2|Overall Study|Site scheduling error|1
20175|NCT01644474|91253|P1|Overall Study|Site scheduling error|1
20176|NCT01644474|91252|P2|Overall Study|Adverse Event|5
20177|NCT01644474|91253|P1|Overall Study|Adverse Event|4
20178|NCT01644474|91252|P2|Overall Study|Participant moved|1
20179|NCT01644474|91253|P1|Overall Study|Participant moved|0
20180|NCT01644474|91252|P2|Overall Study|Consent withdrawn by participant|1
20181|NCT01644474|91253|P1|Overall Study|Consent withdrawn by participant|0
20182|NCT01644474|91252|P2|Overall Study|Poor compliance to protocol|0
20183|NCT01644474|91253|P1|Overall Study|Poor compliance to protocol|1
20184|NCT01644188|91341|P2|Overall Study|Other than specified above|7
20185|NCT01644188|91342|P1|Overall Study|Other than specified above|6
20186|NCT01644188|91341|P2|Overall Study|Site closure|1
20187|NCT01644188|91342|P1|Overall Study|Site closure|1
20188|NCT01644188|91341|P2|Overall Study|Last visit outside protocol visit window|16
20189|NCT01644188|91342|P1|Overall Study|Last visit outside protocol visit window|14
20190|NCT01644188|91341|P2|Overall Study|Death|3
20191|NCT01644188|91342|P1|Overall Study|Death|4
20192|NCT01644188|91341|P2|Overall Study|Lost to Follow-up|0
20193|NCT01644188|91342|P1|Overall Study|Lost to Follow-up|1
20194|NCT01644188|91341|P2|Overall Study|Selection criteria finally not met|0
20195|NCT01644188|91342|P1|Overall Study|Selection criteria finally not met|2
20196|NCT01644188|91341|P2|Overall Study|Consent withdrawn by participant|7
20197|NCT01644188|91342|P1|Overall Study|Consent withdrawn by participant|14
20198|NCT01644188|91341|P2|Overall Study|Related to auto-injector administration|2
20199|NCT01644188|91342|P1|Overall Study|Related to auto-injector administration|2
20200|NCT01644188|91341|P2|Overall Study|Participant moved|2
20201|NCT01644188|91342|P1|Overall Study|Participant moved|7
20202|NCT01644188|91341|P2|Overall Study|Physician Decision|3
20203|NCT01644188|91342|P1|Overall Study|Physician Decision|1
20204|NCT01644188|91341|P2|Overall Study|Poor compliance to protocol|14
20205|NCT01644188|91342|P1|Overall Study|Poor compliance to protocol|26
20206|NCT01644188|91341|P2|Overall Study|Adverse Event|20
20207|NCT01644188|91342|P1|Overall Study|Adverse Event|44
20208|NCT01644175|91400|P2|Overall Study|Other than specified above|3
20209|NCT01644175|91401|P1|Overall Study|Other than specified above|0
20210|NCT01644175|91400|P2|Overall Study|Lost to Follow-up|0
20211|NCT01644175|91401|P1|Overall Study|Lost to Follow-up|1
20212|NCT01644175|91400|P2|Overall Study|Site closure|2
20213|NCT01644175|91401|P1|Overall Study|Site closure|2
20214|NCT01644175|91400|P2|Overall Study|Selection criteria finally not met|1
20215|NCT01644175|91401|P1|Overall Study|Selection criteria finally not met|0
20216|NCT01644175|91400|P2|Overall Study|Last visit outside protocol visit window|11
20217|NCT01644175|91401|P1|Overall Study|Last visit outside protocol visit window|4
20218|NCT01644175|91400|P2|Overall Study|Related to Autoinjector Administration|1
20219|NCT01644175|91401|P1|Overall Study|Related to Autoinjector Administration|2
20220|NCT01644175|91400|P2|Overall Study|Consent withdrawn by participant|4
20221|NCT01644175|91401|P1|Overall Study|Consent withdrawn by participant|3
20222|NCT01644175|91400|P2|Overall Study|Participant Moved|2
20223|NCT01644175|91401|P1|Overall Study|Participant Moved|1
20224|NCT01644175|91400|P2|Overall Study|Physician Decision|2
20225|NCT01644175|91401|P1|Overall Study|Physician Decision|1
20226|NCT01644175|91400|P2|Overall Study|Poor compliance to protocol|10
20227|NCT01644175|91401|P1|Overall Study|Poor compliance to protocol|9
20228|NCT01644175|91400|P2|Overall Study|Death|2
20229|NCT01644175|91401|P1|Overall Study|Death|1
20230|NCT01644175|91400|P2|Overall Study|Adverse Event|13
20231|NCT01644175|91401|P1|Overall Study|Adverse Event|8
20232|NCT01644175|91400|P2|Overall Study|Randomized But Not Treated|2
20233|NCT01644175|91401|P1|Overall Study|Randomized But Not Treated|0
20234|NCT01643798|91461|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
20235|NCT01643798|91462|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
20236|NCT01643044|91501|P2|Overall Study|Delivered outside of hospital|2
20237|NCT01643044|91502|P1|Overall Study|Delivered outside of hospital|1
20238|NCT01643044|91501|P2|Overall Study|Miscarried baby|2
20239|NCT01643044|91502|P1|Overall Study|Miscarried baby|2
20240|NCT01643044|91501|P2|Overall Study|Lost to Follow-up|1
20241|NCT01643044|91502|P1|Overall Study|Lost to Follow-up|1
20242|NCT01642914|91511|P3|Overall Study|Other Reason|0
20243|NCT01642914|91512|P2|Overall Study|Other Reason|0
20244|NCT01642914|91513|P1|Overall Study|Other Reason|1
20245|NCT01642914|91511|P3|Overall Study|Lost to Follow-up|7
20246|NCT01642914|91512|P2|Overall Study|Lost to Follow-up|3
20247|NCT01642914|91513|P1|Overall Study|Lost to Follow-up|5
20248|NCT01642914|91511|P3|Overall Study|Withdrawal by Subject|10
20249|NCT01642914|91512|P2|Overall Study|Withdrawal by Subject|5
20250|NCT01642914|91513|P1|Overall Study|Withdrawal by Subject|5
20251|NCT01642914|91511|P3|Overall Study|Protocol Violation|6
20252|NCT01642914|91512|P2|Overall Study|Protocol Violation|13
20253|NCT01642914|91513|P1|Overall Study|Protocol Violation|15
20254|NCT01642914|91511|P3|Overall Study|Lack of Efficacy|2
20255|NCT01642914|91512|P2|Overall Study|Lack of Efficacy|4
20256|NCT01642914|91513|P1|Overall Study|Lack of Efficacy|9
20257|NCT01642914|91511|P3|Overall Study|Adverse Event|15
20258|NCT01642914|91512|P2|Overall Study|Adverse Event|7
20259|NCT01642914|91513|P1|Overall Study|Adverse Event|11
20260|NCT01642732|91588|P1|Overall Study|Withdrawal by Subject|1
20261|NCT01642615|91593|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
20262|NCT01642615|91594|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
20263|NCT01642615|91595|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
20264|NCT01642615|91593|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
20265|NCT01642615|91594|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
20266|NCT01642615|91595|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
20267|NCT01642615|91593|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
20268|NCT01642615|91594|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
20269|NCT01642615|91595|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
20270|NCT01642615|91593|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
20271|NCT01642615|91594|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
20272|NCT01642615|91595|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
20273|NCT01642615|91593|P3|Open Label Maintenance Phase|Did not receive treatment|0
20274|NCT01642615|91594|P2|Open Label Maintenance Phase|Did not receive treatment|0
20275|NCT01642615|91595|P1|Open Label Maintenance Phase|Did not receive treatment|1
20276|NCT01642615|91593|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
20277|NCT01642615|91594|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
20278|NCT01642615|91595|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
20279|NCT01642615|91593|P3|Open Label Maintenance Phase|Lost to Follow-up|0
20280|NCT01642615|91594|P2|Open Label Maintenance Phase|Lost to Follow-up|0
20281|NCT01642615|91595|P1|Open Label Maintenance Phase|Lost to Follow-up|1
20282|NCT01642615|91593|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
20283|NCT01642615|91594|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
20284|NCT01642615|91595|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
20285|NCT01642615|91593|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
20286|NCT01642615|91594|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
20287|NCT01642615|91595|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
20288|NCT01642602|91609|P1|Overall Study|Adverse Event|2
20289|NCT01642589|91616|P2|Overall Study|Withdrawal by Subject|1
20290|NCT01642589|91617|P1|Overall Study|Withdrawal by Subject|1
20291|NCT01642277|91658|P2|Overall Study|Withdrawal by Subject|0
20292|NCT01642277|91659|P1|Overall Study|Withdrawal by Subject|11
20293|NCT01642277|91658|P2|Overall Study|Protocol Violation|0
20294|NCT01642277|91659|P1|Overall Study|Protocol Violation|1
20295|NCT01642277|91658|P2|Overall Study|Physician Decision|0
20296|NCT01642277|91659|P1|Overall Study|Physician Decision|2
20297|NCT01642277|91658|P2|Overall Study|Adverse Event|0
20298|NCT01642277|91659|P1|Overall Study|Adverse Event|10
20299|NCT01642212|91691|P5|Open-label Extension|Not Specified|1
20300|NCT01642212|91692|P4|Open-label Extension|Not Specified|0
20301|NCT01642212|91693|P3|Open-label Extension|Not Specified|0
20302|NCT01642212|91694|P2|Open-label Extension|Not Specified|0
20303|NCT01642212|91695|P1|Open-label Extension|Not Specified|0
20304|NCT01642212|91691|P5|Open-label Extension|Lost to Follow-up|1
20305|NCT01642212|91692|P4|Open-label Extension|Lost to Follow-up|0
20306|NCT01642212|91693|P3|Open-label Extension|Lost to Follow-up|0
20307|NCT01642212|91694|P2|Open-label Extension|Lost to Follow-up|0
20308|NCT01642212|91695|P1|Open-label Extension|Lost to Follow-up|0
20309|NCT01642212|91691|P5|Open-label Extension|Consent Withdrawn|2
20310|NCT01642212|91692|P4|Open-label Extension|Consent Withdrawn|0
20311|NCT01642212|91693|P3|Open-label Extension|Consent Withdrawn|0
20312|NCT01642212|91694|P2|Open-label Extension|Consent Withdrawn|0
20313|NCT01642212|91695|P1|Open-label Extension|Consent Withdrawn|0
20314|NCT01642212|91691|P5|Open-label Extension|Sponsor Decision|4
20315|NCT01642212|91692|P4|Open-label Extension|Sponsor Decision|7
20316|NCT01642212|91693|P3|Open-label Extension|Sponsor Decision|0
20317|NCT01642212|91694|P2|Open-label Extension|Sponsor Decision|0
20318|NCT01642212|91695|P1|Open-label Extension|Sponsor Decision|0
20319|NCT01642212|91691|P5|Open-label Extension|Adverse Event|0
20320|NCT01642212|91692|P4|Open-label Extension|Adverse Event|3
20321|NCT01642212|91693|P3|Open-label Extension|Adverse Event|0
20322|NCT01642212|91694|P2|Open-label Extension|Adverse Event|0
20323|NCT01642212|91695|P1|Open-label Extension|Adverse Event|0
20324|NCT01642212|91691|P5|Double-blind Treatment|Adverse Event|0
20325|NCT01642212|91692|P4|Double-blind Treatment|Adverse Event|0
20326|NCT01642212|91693|P3|Double-blind Treatment|Adverse Event|1
20327|NCT01642212|91694|P2|Double-blind Treatment|Adverse Event|0
20328|NCT01642212|91695|P1|Double-blind Treatment|Adverse Event|0
20329|NCT01642212|91691|P5|Double-blind Treatment|Non-compliance|0
20330|NCT01642212|91692|P4|Double-blind Treatment|Non-compliance|0
20331|NCT01642212|91693|P3|Double-blind Treatment|Non-compliance|0
20332|NCT01642212|91694|P2|Double-blind Treatment|Non-compliance|1
20333|NCT01642212|91695|P1|Double-blind Treatment|Non-compliance|0
20334|NCT01642212|91691|P5|Double-blind Treatment|Not Specified|0
20335|NCT01642212|91692|P4|Double-blind Treatment|Not Specified|0
20336|NCT01642212|91693|P3|Double-blind Treatment|Not Specified|1
20337|NCT01642212|91694|P2|Double-blind Treatment|Not Specified|2
20338|NCT01642212|91695|P1|Double-blind Treatment|Not Specified|0
20339|NCT01642212|91691|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
20340|NCT01642212|91692|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
20341|NCT01642212|91693|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
20342|NCT01642212|91694|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
20343|NCT01642212|91695|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
20344|NCT01642004|91784|P2|Treatment|Missing from data|1
20345|NCT01642004|91785|P1|Treatment|Missing from data|0
20346|NCT01642004|91784|P2|Treatment|Unspecified|2
20347|NCT01642004|91785|P1|Treatment|Unspecified|1
20348|NCT01642004|91784|P2|Treatment|No longer meets study criteria|2
20349|NCT01642004|91785|P1|Treatment|No longer meets study criteria|1
20350|NCT01642004|91784|P2|Treatment|Poor/non-compliance|0
20351|NCT01642004|91785|P1|Treatment|Poor/non-compliance|1
20352|NCT01642004|91784|P2|Treatment|Maximum clinical benefit|7
20353|NCT01642004|91785|P1|Treatment|Maximum clinical benefit|2
20355|NCT01642004|91785|P1|Treatment|Withdrawal by Subject|5
20356|NCT01642004|91784|P2|Treatment|Adverse event unrelated to study drug|13
20357|NCT01642004|91785|P1|Treatment|Adverse event unrelated to study drug|6
20358|NCT01642004|91784|P2|Treatment|Death|0
20359|NCT01642004|91785|P1|Treatment|Death|1
20360|NCT01642004|91784|P2|Treatment|Study drug toxicity|13
20361|NCT01642004|91785|P1|Treatment|Study drug toxicity|5
20362|NCT01642004|91784|P2|Treatment|Disease progression|80
20363|NCT01642004|91785|P1|Treatment|Disease progression|88
20364|NCT01642004|91784|P2|Randomization|No longer meets study criteria|2
20365|NCT01642004|91785|P1|Randomization|No longer meets study criteria|2
20366|NCT01642004|91784|P2|Randomization|Withdrawal by Subject|6
20367|NCT01642004|91785|P1|Randomization|Withdrawal by Subject|1
20368|NCT01642004|91784|P2|Randomization|Adverse Event unrelated to study drug|0
20369|NCT01642004|91785|P1|Randomization|Adverse Event unrelated to study drug|1
20370|NCT01641991|91819|P4|Overall Study|no longer eligible|4
20371|NCT01641991|91820|P3|Overall Study|no longer eligible|0
20372|NCT01641991|91821|P2|Overall Study|no longer eligible|1
20373|NCT01641991|91822|P1|Overall Study|no longer eligible|2
20374|NCT01641991|91819|P4|Overall Study|Pregnancy|0
20375|NCT01641991|91820|P3|Overall Study|Pregnancy|1
20376|NCT01641991|91821|P2|Overall Study|Pregnancy|0
20377|NCT01641991|91822|P1|Overall Study|Pregnancy|0
20378|NCT01641991|91819|P4|Overall Study|Protocol Violation|0
20379|NCT01641991|91820|P3|Overall Study|Protocol Violation|3
20380|NCT01641991|91821|P2|Overall Study|Protocol Violation|1
20381|NCT01641991|91822|P1|Overall Study|Protocol Violation|1
20382|NCT01641991|91819|P4|Overall Study|Lost to Follow-up|1
20383|NCT01641991|91820|P3|Overall Study|Lost to Follow-up|3
20384|NCT01641991|91821|P2|Overall Study|Lost to Follow-up|2
20385|NCT01641991|91822|P1|Overall Study|Lost to Follow-up|0
20386|NCT01641991|91819|P4|Overall Study|Adverse Event|1
20387|NCT01641991|91820|P3|Overall Study|Adverse Event|2
20388|NCT01641991|91821|P2|Overall Study|Adverse Event|1
20389|NCT01641991|91822|P1|Overall Study|Adverse Event|2
20390|NCT01641991|91819|P4|Overall Study|Withdrawal by Subject|5
20391|NCT01641991|91820|P3|Overall Study|Withdrawal by Subject|1
20392|NCT01641991|91821|P2|Overall Study|Withdrawal by Subject|2
20393|NCT01641991|91822|P1|Overall Study|Withdrawal by Subject|4
20394|NCT01641991|91819|P4|Overall Study|Physician Decision|5
20395|NCT01641991|91820|P3|Overall Study|Physician Decision|7
20396|NCT01641991|91821|P2|Overall Study|Physician Decision|1
20397|NCT01641991|91822|P1|Overall Study|Physician Decision|0
20398|NCT01641952|91906|P1|Overall Study|Adverse Event|6
20399|NCT01641952|91906|P1|Overall Study|Lost to Follow-up|28
20400|NCT01641939|91922|P3|Overall Study|In follow-up|9
20401|NCT01641939|91923|P2|Overall Study|In follow-up|44
20402|NCT01641939|91924|P1|Overall Study|In follow-up|28
20403|NCT01641939|91922|P3|Overall Study|On treatment|2
20404|NCT01641939|91923|P2|Overall Study|On treatment|7
20405|NCT01641939|91924|P1|Overall Study|On treatment|1
20406|NCT01641939|91922|P3|Overall Study|Withdrawal by Subject|4
20407|NCT01641939|91923|P2|Overall Study|Withdrawal by Subject|11
20408|NCT01641939|91924|P1|Overall Study|Withdrawal by Subject|14
20409|NCT01641939|91922|P3|Overall Study|Lost to Follow-up|1
20410|NCT01641939|91923|P2|Overall Study|Lost to Follow-up|2
20411|NCT01641939|91924|P1|Overall Study|Lost to Follow-up|2
20412|NCT01641939|91922|P3|Overall Study|Death|54
20413|NCT01641939|91923|P2|Overall Study|Death|164
20414|NCT01641939|91924|P1|Overall Study|Death|72
20415|NCT01641926|91967|P4|Overall Study|Not Treated|0
20416|NCT01641926|91968|P3|Overall Study|Not Treated|1
20417|NCT01641926|91969|P2|Overall Study|Not Treated|1
20418|NCT01641926|91970|P1|Overall Study|Not Treated|1
20419|NCT01641926|91967|P4|Overall Study|Withdrawal by Subject|1
20420|NCT01641926|91968|P3|Overall Study|Withdrawal by Subject|6
20421|NCT01641926|91969|P2|Overall Study|Withdrawal by Subject|5
20422|NCT01641926|91970|P1|Overall Study|Withdrawal by Subject|13
20423|NCT01641926|91967|P4|Overall Study|Protocol Violation|1
20424|NCT01641926|91968|P3|Overall Study|Protocol Violation|0
20425|NCT01641926|91969|P2|Overall Study|Protocol Violation|0
20426|NCT01641926|91970|P1|Overall Study|Protocol Violation|1
20427|NCT01641926|91967|P4|Overall Study|Physician Decision|1
20428|NCT01641926|91968|P3|Overall Study|Physician Decision|0
20429|NCT01641926|91969|P2|Overall Study|Physician Decision|5
20430|NCT01641926|91970|P1|Overall Study|Physician Decision|6
20431|NCT01641926|91967|P4|Overall Study|Lost to Follow-up|0
20432|NCT01641926|91968|P3|Overall Study|Lost to Follow-up|1
20433|NCT01641926|91969|P2|Overall Study|Lost to Follow-up|2
20434|NCT01641926|91970|P1|Overall Study|Lost to Follow-up|2
20435|NCT01641926|91967|P4|Overall Study|Adverse Event|1
20436|NCT01641926|91968|P3|Overall Study|Adverse Event|3
20437|NCT01641926|91969|P2|Overall Study|Adverse Event|2
20438|NCT01641926|91970|P1|Overall Study|Adverse Event|5
20439|NCT01641861|91998|P2|Overall Study|Died due to drowning|1
20440|NCT01641861|91999|P1|Overall Study|Died due to drowning|0
20441|NCT01641861|91998|P2|Overall Study|Lost the tooth due to normal exfoliation|8
20442|NCT01641861|91999|P1|Overall Study|Lost the tooth due to normal exfoliation|14
20443|NCT01641861|91998|P2|Overall Study|Lost to Follow-up|16
20444|NCT01641861|91999|P1|Overall Study|Lost to Follow-up|21
20445|NCT01641822|92020|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
20446|NCT01641822|92021|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
20447|NCT01641822|92022|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
20448|NCT01641822|92020|P3|Comparative Phase|Withdrew consent|7
20449|NCT01641822|92021|P2|Comparative Phase|Withdrew consent|3
20450|NCT01641822|92022|P1|Comparative Phase|Withdrew consent|0
20451|NCT01641822|92020|P3|Comparative Phase|Adverse event, serious fatal|0
20452|NCT01641822|92021|P2|Comparative Phase|Adverse event, serious fatal|1
20453|NCT01641822|92022|P1|Comparative Phase|Adverse event, serious fatal|0
20454|NCT01641822|92020|P3|Comparative Phase|Pregnancy|1
20455|NCT01641822|92021|P2|Comparative Phase|Pregnancy|0
20456|NCT01641822|92022|P1|Comparative Phase|Pregnancy|0
20457|NCT01641822|92020|P3|Comparative Phase|Investigator's discretion|1
20458|NCT01641822|92021|P2|Comparative Phase|Investigator's discretion|0
20459|NCT01641822|92022|P1|Comparative Phase|Investigator's discretion|0
20460|NCT01641822|92020|P3|Comparative Phase|Noncompliance with study drug|0
20461|NCT01641822|92021|P2|Comparative Phase|Noncompliance with study drug|1
20462|NCT01641822|92022|P1|Comparative Phase|Noncompliance with study drug|0
20463|NCT01641822|92020|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
20464|NCT01641822|92021|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
20465|NCT01641822|92022|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
20466|NCT01641822|92020|P3|Run-in Phase|Withdrew consent|0
20467|NCT01641822|92021|P2|Run-in Phase|Withdrew consent|0
20468|NCT01641822|92022|P1|Run-in Phase|Withdrew consent|1
20469|NCT01641822|92020|P3|Run-in Phase|Adverse Event|0
20470|NCT01641822|92021|P2|Run-in Phase|Adverse Event|0
20471|NCT01641822|92022|P1|Run-in Phase|Adverse Event|3
20472|NCT01641822|92020|P3|Run-in Phase|Noncompliance with study drug|0
20473|NCT01641822|92021|P2|Run-in Phase|Noncompliance with study drug|0
20474|NCT01641822|92022|P1|Run-in Phase|Noncompliance with study drug|1
20475|NCT01641692|92039|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
20476|NCT01641692|92040|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
20477|NCT01641692|92041|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
20478|NCT01641692|92042|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
20479|NCT01641692|92043|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
20480|NCT01641692|92044|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
20481|NCT01641692|92045|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
20482|NCT01641692|92046|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
20483|NCT01641692|92039|P8|Washout Period 3 or Follow-up|Protocol Violation|0
20484|NCT01641692|92040|P7|Washout Period 3 or Follow-up|Protocol Violation|0
20485|NCT01641692|92041|P6|Washout Period 3 or Follow-up|Protocol Violation|1
20486|NCT01641692|92042|P5|Washout Period 3 or Follow-up|Protocol Violation|0
20487|NCT01641692|92043|P4|Washout Period 3 or Follow-up|Protocol Violation|0
20488|NCT01641692|92044|P3|Washout Period 3 or Follow-up|Protocol Violation|0
20489|NCT01641692|92045|P2|Washout Period 3 or Follow-up|Protocol Violation|0
20490|NCT01641692|92046|P1|Washout Period 3 or Follow-up|Protocol Violation|0
20491|NCT01641692|92039|P8|Treatment Period 3|Lost to Follow-up|0
20492|NCT01641692|92040|P7|Treatment Period 3|Lost to Follow-up|0
20493|NCT01641692|92041|P6|Treatment Period 3|Lost to Follow-up|0
20494|NCT01641692|92042|P5|Treatment Period 3|Lost to Follow-up|0
20495|NCT01641692|92043|P4|Treatment Period 3|Lost to Follow-up|0
20496|NCT01641692|92044|P3|Treatment Period 3|Lost to Follow-up|0
20497|NCT01641692|92045|P2|Treatment Period 3|Lost to Follow-up|1
20498|NCT01641692|92046|P1|Treatment Period 3|Lost to Follow-up|0
20499|NCT01641692|92039|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
20500|NCT01641692|92040|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
20501|NCT01641692|92041|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
20502|NCT01641692|92042|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
20503|NCT01641692|92043|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
20504|NCT01641692|92044|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
20505|NCT01641692|92045|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
20506|NCT01641692|92046|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
20507|NCT01641692|92039|P8|Treatment Period 3|Protocol Violation|0
20508|NCT01641692|92040|P7|Treatment Period 3|Protocol Violation|0
20509|NCT01641692|92041|P6|Treatment Period 3|Protocol Violation|0
20510|NCT01641692|92042|P5|Treatment Period 3|Protocol Violation|0
20511|NCT01641692|92043|P4|Treatment Period 3|Protocol Violation|0
20512|NCT01641692|92044|P3|Treatment Period 3|Protocol Violation|1
20513|NCT01641692|92045|P2|Treatment Period 3|Protocol Violation|0
20514|NCT01641692|92046|P1|Treatment Period 3|Protocol Violation|0
20515|NCT01641692|92039|P8|Treatment Period 3|Adverse Event|0
20516|NCT01641692|92040|P7|Treatment Period 3|Adverse Event|1
20517|NCT01641692|92041|P6|Treatment Period 3|Adverse Event|0
20518|NCT01641692|92042|P5|Treatment Period 3|Adverse Event|0
20519|NCT01641692|92043|P4|Treatment Period 3|Adverse Event|0
20520|NCT01641692|92044|P3|Treatment Period 3|Adverse Event|0
20521|NCT01641692|92045|P2|Treatment Period 3|Adverse Event|0
20522|NCT01641692|92046|P1|Treatment Period 3|Adverse Event|0
20523|NCT01641692|92039|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
20524|NCT01641692|92040|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
20525|NCT01641692|92041|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
20526|NCT01641692|92042|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
20527|NCT01641692|92043|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
20528|NCT01641692|92044|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
20529|NCT01641692|92045|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
20530|NCT01641692|92046|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
20531|NCT01641692|92039|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
20532|NCT01641692|92040|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
20533|NCT01641692|92041|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
20534|NCT01641692|92042|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
20535|NCT01641692|92043|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
20536|NCT01641692|92044|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
20537|NCT01641692|92045|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
20538|NCT01641692|92046|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
20539|NCT01641692|92039|P8|Treatment Period 2|Withdrawal by Subject|1
20540|NCT01641692|92040|P7|Treatment Period 2|Withdrawal by Subject|0
20541|NCT01641692|92041|P6|Treatment Period 2|Withdrawal by Subject|1
20542|NCT01641692|92042|P5|Treatment Period 2|Withdrawal by Subject|0
20543|NCT01641692|92043|P4|Treatment Period 2|Withdrawal by Subject|0
20544|NCT01641692|92044|P3|Treatment Period 2|Withdrawal by Subject|0
20545|NCT01641692|92045|P2|Treatment Period 2|Withdrawal by Subject|0
20546|NCT01641692|92046|P1|Treatment Period 2|Withdrawal by Subject|1
20547|NCT01641692|92039|P8|Treatment Period 2|Lost to Follow-up|0
20548|NCT01641692|92040|P7|Treatment Period 2|Lost to Follow-up|0
20549|NCT01641692|92041|P6|Treatment Period 2|Lost to Follow-up|1
20550|NCT01641692|92042|P5|Treatment Period 2|Lost to Follow-up|0
20551|NCT01641692|92043|P4|Treatment Period 2|Lost to Follow-up|0
20552|NCT01641692|92044|P3|Treatment Period 2|Lost to Follow-up|0
20553|NCT01641692|92045|P2|Treatment Period 2|Lost to Follow-up|0
20554|NCT01641692|92046|P1|Treatment Period 2|Lost to Follow-up|0
20555|NCT01641692|92039|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
20556|NCT01641692|92040|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
20557|NCT01641692|92041|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
20558|NCT01641692|92042|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
20559|NCT01641692|92043|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
20560|NCT01641692|92044|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
20561|NCT01641692|92045|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
20562|NCT01641692|92046|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
20563|NCT01641692|92039|P8|Treatment Period 2|Lack of Efficacy|0
20564|NCT01641692|92040|P7|Treatment Period 2|Lack of Efficacy|0
20565|NCT01641692|92041|P6|Treatment Period 2|Lack of Efficacy|0
20566|NCT01641692|92042|P5|Treatment Period 2|Lack of Efficacy|0
20567|NCT01641692|92043|P4|Treatment Period 2|Lack of Efficacy|0
20568|NCT01641692|92044|P3|Treatment Period 2|Lack of Efficacy|0
20569|NCT01641692|92045|P2|Treatment Period 2|Lack of Efficacy|0
20570|NCT01641692|92046|P1|Treatment Period 2|Lack of Efficacy|1
20571|NCT01641692|92039|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
20572|NCT01641692|92040|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
20573|NCT01641692|92041|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
20574|NCT01641692|92042|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
20575|NCT01641692|92043|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
20576|NCT01641692|92044|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
20577|NCT01641692|92045|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
20578|NCT01641692|92046|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
20579|NCT01641692|92039|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
20580|NCT01641692|92040|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
20581|NCT01641692|92041|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
20582|NCT01641692|92042|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
20583|NCT01641692|92043|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
20584|NCT01641692|92044|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
20585|NCT01641692|92045|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
20586|NCT01641692|92046|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
20587|NCT01641692|92039|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
20588|NCT01641692|92040|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
20589|NCT01641692|92041|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
20590|NCT01641692|92042|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
20591|NCT01641692|92043|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
20592|NCT01641692|92044|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
20593|NCT01641692|92045|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
20594|NCT01641692|92046|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
20595|NCT01641692|92039|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
20596|NCT01641692|92040|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
20597|NCT01641692|92041|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
20598|NCT01641692|92042|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
20599|NCT01641692|92043|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
20600|NCT01641692|92044|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
20601|NCT01641692|92045|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
20602|NCT01641692|92046|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
20603|NCT01641692|92039|P8|Treatment Period 1|Withdrawal by Subject|1
20604|NCT01641692|92040|P7|Treatment Period 1|Withdrawal by Subject|0
20605|NCT01641692|92041|P6|Treatment Period 1|Withdrawal by Subject|2
20606|NCT01641692|92042|P5|Treatment Period 1|Withdrawal by Subject|0
20607|NCT01641692|92043|P4|Treatment Period 1|Withdrawal by Subject|0
20608|NCT01641692|92044|P3|Treatment Period 1|Withdrawal by Subject|0
20609|NCT01641692|92045|P2|Treatment Period 1|Withdrawal by Subject|0
20610|NCT01641692|92046|P1|Treatment Period 1|Withdrawal by Subject|0
20611|NCT01641692|92039|P8|Treatment Period 1|Physician Decision|0
20612|NCT01641692|92040|P7|Treatment Period 1|Physician Decision|0
20613|NCT01641692|92041|P6|Treatment Period 1|Physician Decision|0
20614|NCT01641692|92042|P5|Treatment Period 1|Physician Decision|1
20615|NCT01641692|92043|P4|Treatment Period 1|Physician Decision|0
20616|NCT01641692|92044|P3|Treatment Period 1|Physician Decision|0
20617|NCT01641692|92045|P2|Treatment Period 1|Physician Decision|0
20618|NCT01641692|92046|P1|Treatment Period 1|Physician Decision|0
20619|NCT01641692|92039|P8|Treatment Period 1|Lost to Follow-up|0
20620|NCT01641692|92040|P7|Treatment Period 1|Lost to Follow-up|0
20621|NCT01641692|92041|P6|Treatment Period 1|Lost to Follow-up|0
20622|NCT01641692|92042|P5|Treatment Period 1|Lost to Follow-up|0
20623|NCT01641692|92043|P4|Treatment Period 1|Lost to Follow-up|0
20624|NCT01641692|92044|P3|Treatment Period 1|Lost to Follow-up|1
20625|NCT01641692|92045|P2|Treatment Period 1|Lost to Follow-up|0
20626|NCT01641692|92046|P1|Treatment Period 1|Lost to Follow-up|0
20627|NCT01641692|92039|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
20628|NCT01641692|92040|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
20629|NCT01641692|92041|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
20630|NCT01641692|92042|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
20631|NCT01641692|92043|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
20632|NCT01641692|92044|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
20633|NCT01641692|92045|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
20634|NCT01641692|92046|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
20635|NCT01641692|92039|P8|Treatment Period 1|Protocol Violation|0
20636|NCT01641692|92040|P7|Treatment Period 1|Protocol Violation|0
20637|NCT01641692|92041|P6|Treatment Period 1|Protocol Violation|0
20638|NCT01641692|92042|P5|Treatment Period 1|Protocol Violation|2
20639|NCT01641692|92043|P4|Treatment Period 1|Protocol Violation|0
20640|NCT01641692|92044|P3|Treatment Period 1|Protocol Violation|0
20641|NCT01641692|92045|P2|Treatment Period 1|Protocol Violation|0
20642|NCT01641692|92046|P1|Treatment Period 1|Protocol Violation|1
20643|NCT01641692|92039|P8|Treatment Period 1|Lack of Efficacy|1
20644|NCT01641692|92040|P7|Treatment Period 1|Lack of Efficacy|0
20645|NCT01641692|92041|P6|Treatment Period 1|Lack of Efficacy|0
20646|NCT01641692|92042|P5|Treatment Period 1|Lack of Efficacy|0
20647|NCT01641692|92043|P4|Treatment Period 1|Lack of Efficacy|0
20648|NCT01641692|92044|P3|Treatment Period 1|Lack of Efficacy|0
20649|NCT01641692|92045|P2|Treatment Period 1|Lack of Efficacy|0
20650|NCT01641692|92046|P1|Treatment Period 1|Lack of Efficacy|0
20651|NCT01641692|92039|P8|Treatment Period 1|Adverse Event|0
20652|NCT01641692|92040|P7|Treatment Period 1|Adverse Event|0
20653|NCT01641692|92041|P6|Treatment Period 1|Adverse Event|0
20654|NCT01641692|92042|P5|Treatment Period 1|Adverse Event|0
20655|NCT01641692|92043|P4|Treatment Period 1|Adverse Event|0
20656|NCT01641692|92044|P3|Treatment Period 1|Adverse Event|0
20657|NCT01641692|92045|P2|Treatment Period 1|Adverse Event|0
20658|NCT01641692|92046|P1|Treatment Period 1|Adverse Event|1
20659|NCT01641640|92246|P1|Overall Study|Adverse Event|1
20660|NCT01641640|92246|P1|Overall Study|Withdrawal by Subject|2
20661|NCT01641640|92246|P1|Overall Study|Lost to Follow-up|3
20662|NCT01641640|92246|P1|Overall Study|Efficacy failure|29
20663|NCT01641640|92246|P1|Overall Study|Enrolled but not treated|1
20664|NCT01641471|92257|P2|Overall Study|Protocol Violation|4
20665|NCT01641471|92258|P1|Overall Study|Protocol Violation|2
20666|NCT01641471|92257|P2|Overall Study|Lost to Follow-up|4
20667|NCT01641471|92258|P1|Overall Study|Lost to Follow-up|2
20668|NCT01641471|92257|P2|Overall Study|Withdrawal by Subject|19
20669|NCT01641471|92258|P1|Overall Study|Withdrawal by Subject|19
20670|NCT01641237|92264|P4|Period III|Lost to Follow-up|0
20671|NCT01641237|92265|P3|Period III|Lost to Follow-up|0
20672|NCT01641237|92266|P2|Period III|Lost to Follow-up|0
20673|NCT01641237|92267|P1|Period III|Lost to Follow-up|1
20674|NCT01641237|92264|P4|Period II|Withdrawal by Subject|0
20675|NCT01641237|92265|P3|Period II|Withdrawal by Subject|0
20676|NCT01641237|92266|P2|Period II|Withdrawal by Subject|0
20677|NCT01641237|92267|P1|Period II|Withdrawal by Subject|1
20678|NCT01641159|92291|P2|Overall Study|Withdrawal by Subject|1
20679|NCT01641159|92292|P1|Overall Study|Withdrawal by Subject|0
20680|NCT01641159|92291|P2|Overall Study|Lost to Follow-up|1
20681|NCT01641159|92292|P1|Overall Study|Lost to Follow-up|2
20682|NCT01641081|92312|P10|Period 5|Adverse Event|0
20683|NCT01641081|92313|P9|Period 5|Adverse Event|0
20684|NCT01641081|92314|P8|Period 5|Adverse Event|0
20685|NCT01641081|92315|P7|Period 5|Adverse Event|0
20686|NCT01641081|92316|P6|Period 5|Adverse Event|0
20687|NCT01641081|92317|P5|Period 5|Adverse Event|0
20688|NCT01641081|92318|P4|Period 5|Adverse Event|0
20689|NCT01641081|92319|P3|Period 5|Adverse Event|2
20690|NCT01641081|92320|P2|Period 5|Adverse Event|0
20691|NCT01641081|92321|P1|Period 5|Adverse Event|0
20692|NCT01641081|92312|P10|Period 4|Adverse Event|0
20693|NCT01641081|92313|P9|Period 4|Adverse Event|0
20694|NCT01641081|92314|P8|Period 4|Adverse Event|0
20695|NCT01641081|92315|P7|Period 4|Adverse Event|0
20696|NCT01641081|92316|P6|Period 4|Adverse Event|0
20697|NCT01641081|92317|P5|Period 4|Adverse Event|0
20698|NCT01641081|92318|P4|Period 4|Adverse Event|1
20699|NCT01641081|92319|P3|Period 4|Adverse Event|0
20700|NCT01641081|92320|P2|Period 4|Adverse Event|1
20701|NCT01641081|92321|P1|Period 4|Adverse Event|0
20702|NCT01641081|92312|P10|Period 3|Withdrawal by Subject|0
20703|NCT01641081|92313|P9|Period 3|Withdrawal by Subject|1
20704|NCT01641081|92314|P8|Period 3|Withdrawal by Subject|0
20705|NCT01641081|92315|P7|Period 3|Withdrawal by Subject|0
20706|NCT01641081|92316|P6|Period 3|Withdrawal by Subject|0
20707|NCT01641081|92317|P5|Period 3|Withdrawal by Subject|0
20708|NCT01641081|92318|P4|Period 3|Withdrawal by Subject|0
20709|NCT01641081|92319|P3|Period 3|Withdrawal by Subject|0
20710|NCT01641081|92320|P2|Period 3|Withdrawal by Subject|0
20711|NCT01641081|92321|P1|Period 3|Withdrawal by Subject|0
20712|NCT01641081|92312|P10|Period 3|Adverse Event|0
20713|NCT01641081|92313|P9|Period 3|Adverse Event|0
20714|NCT01641081|92314|P8|Period 3|Adverse Event|0
20715|NCT01641081|92315|P7|Period 3|Adverse Event|0
20716|NCT01641081|92316|P6|Period 3|Adverse Event|0
20717|NCT01641081|92317|P5|Period 3|Adverse Event|0
20718|NCT01641081|92318|P4|Period 3|Adverse Event|0
20719|NCT01641081|92319|P3|Period 3|Adverse Event|1
20720|NCT01641081|92320|P2|Period 3|Adverse Event|0
20721|NCT01641081|92321|P1|Period 3|Adverse Event|0
20722|NCT01641081|92312|P10|Period 2|Protocol Violation|0
20723|NCT01641081|92313|P9|Period 2|Protocol Violation|0
20724|NCT01641081|92314|P8|Period 2|Protocol Violation|0
20725|NCT01641081|92315|P7|Period 2|Protocol Violation|0
20726|NCT01641081|92316|P6|Period 2|Protocol Violation|0
20727|NCT01641081|92317|P5|Period 2|Protocol Violation|0
20728|NCT01641081|92318|P4|Period 2|Protocol Violation|0
20729|NCT01641081|92319|P3|Period 2|Protocol Violation|0
20730|NCT01641081|92320|P2|Period 2|Protocol Violation|0
20731|NCT01641081|92321|P1|Period 2|Protocol Violation|1
20732|NCT01641081|92312|P10|Period 2|Withdrawal by Subject|0
20733|NCT01641081|92313|P9|Period 2|Withdrawal by Subject|0
20734|NCT01641081|92314|P8|Period 2|Withdrawal by Subject|0
20735|NCT01641081|92315|P7|Period 2|Withdrawal by Subject|2
20736|NCT01641081|92316|P6|Period 2|Withdrawal by Subject|0
20737|NCT01641081|92317|P5|Period 2|Withdrawal by Subject|0
20738|NCT01641081|92318|P4|Period 2|Withdrawal by Subject|1
20739|NCT01641081|92319|P3|Period 2|Withdrawal by Subject|0
20740|NCT01641081|92320|P2|Period 2|Withdrawal by Subject|0
20741|NCT01641081|92321|P1|Period 2|Withdrawal by Subject|0
20742|NCT01641081|92312|P10|Period 2|Adverse Event|0
20743|NCT01641081|92313|P9|Period 2|Adverse Event|0
20744|NCT01641081|92314|P8|Period 2|Adverse Event|0
20745|NCT01641081|92315|P7|Period 2|Adverse Event|0
20746|NCT01641081|92316|P6|Period 2|Adverse Event|1
20747|NCT01641081|92317|P5|Period 2|Adverse Event|0
20748|NCT01641081|92318|P4|Period 2|Adverse Event|0
20749|NCT01641081|92319|P3|Period 2|Adverse Event|0
20750|NCT01641081|92320|P2|Period 2|Adverse Event|0
20751|NCT01641081|92321|P1|Period 2|Adverse Event|0
20752|NCT01641081|92312|P10|Period 1|Adverse Event|0
20753|NCT01641081|92313|P9|Period 1|Adverse Event|0
20754|NCT01641081|92314|P8|Period 1|Adverse Event|2
20755|NCT01641081|92315|P7|Period 1|Adverse Event|0
20756|NCT01641081|92316|P6|Period 1|Adverse Event|0
20757|NCT01641081|92317|P5|Period 1|Adverse Event|0
20758|NCT01641081|92318|P4|Period 1|Adverse Event|0
20759|NCT01641081|92319|P3|Period 1|Adverse Event|0
20760|NCT01641081|92320|P2|Period 1|Adverse Event|0
20761|NCT01641081|92321|P1|Period 1|Adverse Event|1
20762|NCT01641081|92312|P10|Period 1|Protocol Violation|0
20763|NCT01641081|92313|P9|Period 1|Protocol Violation|0
20764|NCT01641081|92314|P8|Period 1|Protocol Violation|1
20765|NCT01641081|92315|P7|Period 1|Protocol Violation|0
20766|NCT01641081|92316|P6|Period 1|Protocol Violation|0
20767|NCT01641081|92317|P5|Period 1|Protocol Violation|1
20768|NCT01641081|92318|P4|Period 1|Protocol Violation|0
20769|NCT01641081|92319|P3|Period 1|Protocol Violation|0
20770|NCT01641081|92320|P2|Period 1|Protocol Violation|0
20771|NCT01641081|92321|P1|Period 1|Protocol Violation|0
20772|NCT01641081|92312|P10|Period 1|Sponsor request (potential unblinding)|0
20773|NCT01641081|92313|P9|Period 1|Sponsor request (potential unblinding)|0
20774|NCT01641081|92314|P8|Period 1|Sponsor request (potential unblinding)|0
20775|NCT01641081|92315|P7|Period 1|Sponsor request (potential unblinding)|1
20776|NCT01641081|92316|P6|Period 1|Sponsor request (potential unblinding)|0
20777|NCT01641081|92317|P5|Period 1|Sponsor request (potential unblinding)|0
20778|NCT01641081|92318|P4|Period 1|Sponsor request (potential unblinding)|0
20779|NCT01641081|92319|P3|Period 1|Sponsor request (potential unblinding)|0
20780|NCT01641081|92320|P2|Period 1|Sponsor request (potential unblinding)|0
20781|NCT01641081|92321|P1|Period 1|Sponsor request (potential unblinding)|0
20782|NCT01640964|92341|P3|Overall Study|Protocol Deviation|2
20783|NCT01640964|92342|P2|Overall Study|Protocol Deviation|1
20784|NCT01640964|92343|P1|Overall Study|Protocol Deviation|1
20785|NCT01640964|92341|P3|Overall Study|Lost to Follow-up|1
20786|NCT01640964|92342|P2|Overall Study|Lost to Follow-up|0
20787|NCT01640964|92343|P1|Overall Study|Lost to Follow-up|0
20788|NCT01640925|92360|P2|Overall Study|Previously enrolled in this trial|11
20789|NCT01640925|92361|P1|Overall Study|Previously enrolled in this trial|13
20790|NCT01640925|92360|P2|Overall Study|Withdrawal by Subject|0
20791|NCT01640925|92361|P1|Overall Study|Withdrawal by Subject|1
20792|NCT01640314|92419|P2|Overall Study|Protocol Violation|1
20793|NCT01640314|92420|P1|Overall Study|Protocol Violation|0
20794|NCT01640184|92458|P3|Overall Study|Protocol Violation|1
20795|NCT01640184|92459|P2|Overall Study|Protocol Violation|0
20796|NCT01640184|92460|P1|Overall Study|Protocol Violation|0
20797|NCT01640184|92458|P3|Overall Study|Withdrawal by Subject|1
20798|NCT01640184|92459|P2|Overall Study|Withdrawal by Subject|1
20799|NCT01640184|92460|P1|Overall Study|Withdrawal by Subject|0
20800|NCT01640184|92458|P3|Overall Study|Physician Decision|0
20801|NCT01640184|92459|P2|Overall Study|Physician Decision|0
20802|NCT01640184|92460|P1|Overall Study|Physician Decision|3
20803|NCT01640184|92458|P3|Overall Study|Lost to Follow-up|0
20804|NCT01640184|92459|P2|Overall Study|Lost to Follow-up|1
20805|NCT01640184|92460|P1|Overall Study|Lost to Follow-up|4
20806|NCT01640184|92458|P3|Overall Study|Death|0
20807|NCT01640184|92459|P2|Overall Study|Death|0
20808|NCT01640184|92460|P1|Overall Study|Death|1
20809|NCT01640054|92489|P1|Overall Study|Adverse Event|2
20810|NCT01640054|92489|P1|Overall Study|Lack of Efficacy|3
20811|NCT01640054|92489|P1|Overall Study|Study-specific disc criteria|1
20812|NCT01639833|92499|P2|Overall Study|Withdrawal by Subject|2
20813|NCT01639833|92500|P1|Overall Study|Withdrawal by Subject|2
20814|NCT01639833|92499|P2|Overall Study|Death|2
20815|NCT01639833|92500|P1|Overall Study|Death|4
20816|NCT01639755|92508|P1|Overall Study|Patient had device explantation|4
20817|NCT01639755|92508|P1|Overall Study|Study Ongoing|15
20818|NCT01639742|92516|P1|Overall Study|Lost to Follow-up|1
20819|NCT01639742|92516|P1|Overall Study|Study Ongoing|17
20820|NCT01639729|92524|P6|Overall Study|Withdrawal by Subject|0
20821|NCT01639729|92525|P5|Overall Study|Withdrawal by Subject|0
20822|NCT01639729|92526|P4|Overall Study|Withdrawal by Subject|1
20823|NCT01639729|92527|P3|Overall Study|Withdrawal by Subject|1
20824|NCT01639729|92528|P2|Overall Study|Withdrawal by Subject|0
20825|NCT01639729|92529|P1|Overall Study|Withdrawal by Subject|1
20826|NCT01639560|92553|P2|Overall Study|Adverse Event|2
20827|NCT01639560|92554|P1|Overall Study|Adverse Event|0
20828|NCT01639560|92553|P2|Overall Study|Lost to Follow-up|11
20829|NCT01639560|92554|P1|Overall Study|Lost to Follow-up|9
20830|NCT01639560|92553|P2|Overall Study|Lack of Efficacy|2
20831|NCT01639560|92554|P1|Overall Study|Lack of Efficacy|1
20832|NCT01639560|92553|P2|Overall Study|Withdrawal by Subject|14
20833|NCT01639560|92554|P1|Overall Study|Withdrawal by Subject|9
20834|NCT01639144|92656|P2|Overall Study|Met postoperative exclusion criteria|3
20835|NCT01639144|92657|P1|Overall Study|Met postoperative exclusion criteria|4
20836|NCT01639144|92656|P2|Overall Study|Physician Decision|0
20837|NCT01639144|92657|P1|Overall Study|Physician Decision|2
20838|NCT01639144|92656|P2|Overall Study|Withdrawal by Subject|2
20839|NCT01639144|92657|P1|Overall Study|Withdrawal by Subject|4
20840|NCT01638000|92701|P2|Overall Study|Miscellaneous|2
20841|NCT01638000|92702|P1|Overall Study|Miscellaneous|2
20842|NCT01638000|92701|P2|Overall Study|Withdrawal by Subject|24
20843|NCT01638000|92702|P1|Overall Study|Withdrawal by Subject|21
20844|NCT01638000|92701|P2|Overall Study|Protocol Violation|13
20845|NCT01638000|92702|P1|Overall Study|Protocol Violation|11
20846|NCT01638000|92701|P2|Overall Study|Lack of Efficacy|6
20847|NCT01638000|92702|P1|Overall Study|Lack of Efficacy|5
20848|NCT01638000|92701|P2|Overall Study|Adverse Event|16
20849|NCT01638000|92702|P1|Overall Study|Adverse Event|14
20850|NCT01638000|92701|P2|Overall Study|Randomized but Never Received Drug|10
20851|NCT01638000|92702|P1|Overall Study|Randomized but Never Received Drug|7
20852|NCT01637961|92800|P1|Overall Study|Ineligible: inadequate pathology|1
20853|NCT01637961|92800|P1|Overall Study|Ineligible: wrong primary|1
20854|NCT01637922|92825|P2|Overall Study|Lost to Follow-up|0
20855|NCT01637922|92826|P1|Overall Study|Lost to Follow-up|2
20856|NCT01637922|92825|P2|Overall Study|Withdrawal by Subject|3
20857|NCT01637922|92826|P1|Overall Study|Withdrawal by Subject|0
20858|NCT01637922|92825|P2|Overall Study|Protocol Violation|1
20859|NCT01637922|92826|P1|Overall Study|Protocol Violation|0
20860|NCT01637922|92825|P2|Overall Study|Adverse Event|1
20861|NCT01637922|92826|P1|Overall Study|Adverse Event|0
20862|NCT01636986|92867|P2|Overall Study|Corneal Staining|1
20863|NCT01636986|92868|P1|Overall Study|Corneal Staining|0
20864|NCT01636986|92867|P2|Overall Study|Withdrawal by Subject|1
20865|NCT01636986|92868|P1|Overall Study|Withdrawal by Subject|0
20866|NCT01636960|92874|P1|Maintenance Phase|Adverse Event|2
20867|NCT01636960|92874|P1|Maintenance Phase|Participants still receiving drug|5
20868|NCT01636960|92874|P1|Induction Phase|Adverse Event|2
20869|NCT01636947|92882|P2|Overall Study|Did Not Meet Eligibility Criteria|4
20870|NCT01636947|92883|P1|Overall Study|Did Not Meet Eligibility Criteria|1
20871|NCT01636947|92882|P2|Overall Study|Adverse Event|1
20872|NCT01636947|92883|P1|Overall Study|Adverse Event|1
20873|NCT01636947|92882|P2|Overall Study|Withdrawal by Subject|3
20874|NCT01636947|92883|P1|Overall Study|Withdrawal by Subject|3
20875|NCT01636947|92882|P2|Overall Study|Protocol Violation|1
20876|NCT01636947|92883|P1|Overall Study|Protocol Violation|1
20877|NCT01636947|92882|P2|Overall Study|Lost to Follow-up|0
20878|NCT01636947|92883|P1|Overall Study|Lost to Follow-up|4
20879|NCT01636947|92882|P2|Overall Study|Not Treated|2
20880|NCT01636947|92883|P1|Overall Study|Not Treated|2
20881|NCT01636778|92903|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
20882|NCT01636778|92904|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
20883|NCT01636778|92905|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
20884|NCT01636778|92903|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
20885|NCT01636778|92904|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
20886|NCT01636778|92905|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
20887|NCT01636778|92903|P3|Follow-up Period After Part 2|Other|1
20888|NCT01636778|92904|P2|Follow-up Period After Part 2|Other|0
20889|NCT01636778|92905|P1|Follow-up Period After Part 2|Other|0
20890|NCT01636778|92903|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
20891|NCT01636778|92904|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
20892|NCT01636778|92905|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
20893|NCT01636778|92903|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
20894|NCT01636778|92904|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
20895|NCT01636778|92905|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
20896|NCT01636778|92903|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
20897|NCT01636778|92904|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
20898|NCT01636778|92905|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
20899|NCT01636778|92903|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
20900|NCT01636778|92904|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
20901|NCT01636778|92905|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
20902|NCT01636778|92903|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
20903|NCT01636778|92904|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
20904|NCT01636778|92905|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
20905|NCT01636713|92976|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
20906|NCT01636713|92977|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
20907|NCT01636713|92978|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
20908|NCT01636713|92976|P3|Overall Study|Withdrawal by Subject|8
20909|NCT01636713|92977|P2|Overall Study|Withdrawal by Subject|4
20910|NCT01636713|92978|P1|Overall Study|Withdrawal by Subject|5
20911|NCT01636713|92976|P3|Overall Study|Lost to Follow-up|1
20912|NCT01636713|92977|P2|Overall Study|Lost to Follow-up|0
20913|NCT01636713|92978|P1|Overall Study|Lost to Follow-up|0
20914|NCT01636713|92976|P3|Overall Study|Protocol Violation|1
20915|NCT01636713|92977|P2|Overall Study|Protocol Violation|0
20916|NCT01636713|92978|P1|Overall Study|Protocol Violation|3
20917|NCT01636713|92976|P3|Overall Study|Lack of Efficacy|2
20918|NCT01636713|92977|P2|Overall Study|Lack of Efficacy|6
20919|NCT01636713|92978|P1|Overall Study|Lack of Efficacy|6
20920|NCT01636713|92976|P3|Overall Study|Adverse Event|7
20921|NCT01636713|92977|P2|Overall Study|Adverse Event|16
20922|NCT01636713|92978|P1|Overall Study|Adverse Event|16
20923|NCT01636362|93028|P1|Overall Study|Withdrawal by Subject|1
20924|NCT01636362|93028|P1|Overall Study|Subject healed, not returning|1
20925|NCT01636362|93028|P1|Overall Study|Physician Decision|6
20926|NCT01636258|93036|P2|Overall Study|Lost to Follow-up|0
20927|NCT01636258|93037|P1|Overall Study|Lost to Follow-up|1
20928|NCT01636076|93077|P2|Overall Study|Withdrawal by Subject|10
20929|NCT01636076|93078|P1|Overall Study|Withdrawal by Subject|7
20930|NCT01636076|93077|P2|Overall Study|Adverse Event|11
20931|NCT01636076|93078|P1|Overall Study|Adverse Event|6
20932|NCT01636076|93077|P2|Overall Study|Non-compliance with study treatment|1
20933|NCT01636076|93078|P1|Overall Study|Non-compliance with study treatment|1
20934|NCT01636076|93077|P2|Overall Study|Physician Decision|1
20935|NCT01636076|93078|P1|Overall Study|Physician Decision|1
20936|NCT01636076|93077|P2|Overall Study|Lost to Follow-up|0
20937|NCT01636076|93078|P1|Overall Study|Lost to Follow-up|1
20938|NCT01636076|93077|P2|Overall Study|Lack of Efficacy|1
20939|NCT01636076|93078|P1|Overall Study|Lack of Efficacy|0
20940|NCT01636076|93077|P2|Overall Study|Terminated by sponsor|1
20941|NCT01636076|93078|P1|Overall Study|Terminated by sponsor|1
20942|NCT01635933|93140|P2|Overall Study|No longer had transportation|1
20943|NCT01635933|93141|P1|Overall Study|No longer had transportation|0
20944|NCT01635933|93140|P2|Overall Study|Noncompliance|1
20945|NCT01635933|93141|P1|Overall Study|Noncompliance|0
20946|NCT01635933|93140|P2|Overall Study|Subject decision|1
20947|NCT01635933|93141|P1|Overall Study|Subject decision|1
20948|NCT01635933|93140|P2|Overall Study|Lost to Follow-up|5
20949|NCT01635933|93141|P1|Overall Study|Lost to Follow-up|0
20950|NCT01635933|93140|P2|Overall Study|Adverse Event|0
20951|NCT01635933|93141|P1|Overall Study|Adverse Event|1
20952|NCT01635920|93153|P2|Overall Study|Subject decision|0
20953|NCT01635920|93154|P1|Overall Study|Subject decision|2
20954|NCT01635920|93153|P2|Overall Study|Lost to Follow-up|1
20955|NCT01635920|93154|P1|Overall Study|Lost to Follow-up|0
20956|NCT01635920|93153|P2|Overall Study|Adverse Event|0
20957|NCT01635920|93154|P1|Overall Study|Adverse Event|1
20958|NCT01635855|93167|P1|Overall Study|Withdrawal by Subject|4
20959|NCT01635218|93209|P3|Overall Study|Lost to Follow-up|6
20960|NCT01635218|93210|P2|Overall Study|Lost to Follow-up|7
20961|NCT01635218|93211|P1|Overall Study|Lost to Follow-up|3
20962|NCT01634659|93233|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
20963|NCT01634659|93234|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
20964|NCT01634659|93233|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
20965|NCT01634659|93234|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
20966|NCT01634555|93264|P1|Overall Study|Ongoing receiving treatment|13
20967|NCT01634555|93264|P1|Overall Study|Physician Decision|1
20968|NCT01634555|93264|P1|Overall Study|Adverse Event|3
20969|NCT01634360|93274|P2|Overall Study|Study termination by sponsor|44
20970|NCT01634360|93275|P1|Overall Study|Study termination by sponsor|18
20971|NCT01634360|93274|P2|Overall Study|Not specified|20
20972|NCT01634360|93275|P1|Overall Study|Not specified|3
20973|NCT01634360|93274|P2|Overall Study|Lack of Efficacy|14
20974|NCT01634360|93275|P1|Overall Study|Lack of Efficacy|4
20975|NCT01634360|93274|P2|Overall Study|Protocol Violation|1
20976|NCT01634360|93275|P1|Overall Study|Protocol Violation|1
20977|NCT01634360|93274|P2|Overall Study|subject withdrew consent|23
20978|NCT01634360|93275|P1|Overall Study|subject withdrew consent|13
20979|NCT01634360|93274|P2|Overall Study|Adverse Event|34
20980|NCT01634360|93275|P1|Overall Study|Adverse Event|10
20981|NCT01634243|93304|P2|Overall Study|Lack of Efficacy|0
20982|NCT01634243|93305|P1|Overall Study|Lack of Efficacy|1
20983|NCT01634243|93304|P2|Overall Study|Adverse Event|5
20984|NCT01634243|93305|P1|Overall Study|Adverse Event|5
20985|NCT01634165|93331|P4|Period 2|Adverse Event|0
20986|NCT01634165|93332|P3|Period 2|Adverse Event|0
20987|NCT01634165|93333|P2|Period 2|Adverse Event|1
20988|NCT01634165|93334|P1|Period 2|Adverse Event|0
20989|NCT01634152|93367|P3|Overall Study|Other reason not defined above|1
20990|NCT01634152|93368|P2|Overall Study|Other reason not defined above|0
20991|NCT01634152|93369|P1|Overall Study|Other reason not defined above|1
20992|NCT01634152|93367|P3|Overall Study|Not treated|0
20993|NCT01634152|93368|P2|Overall Study|Not treated|1
20994|NCT01634152|93369|P1|Overall Study|Not treated|0
20995|NCT01634152|93367|P3|Overall Study|Consent withdrawn not due to AE|1
20996|NCT01634152|93368|P2|Overall Study|Consent withdrawn not due to AE|0
20997|NCT01634152|93369|P1|Overall Study|Consent withdrawn not due to AE|1
20998|NCT01634152|93367|P3|Overall Study|Adverse Event|2
20999|NCT01634152|93368|P2|Overall Study|Adverse Event|0
21000|NCT01634152|93369|P1|Overall Study|Adverse Event|2
21001|NCT01634139|93452|P3|Overall Study|Not treated|0
21002|NCT01634139|93453|P2|Overall Study|Not treated|1
21003|NCT01634139|93454|P1|Overall Study|Not treated|1
21004|NCT01634139|93452|P3|Overall Study|Lost to Follow-up|0
21005|NCT01634139|93453|P2|Overall Study|Lost to Follow-up|2
21006|NCT01634139|93454|P1|Overall Study|Lost to Follow-up|0
21007|NCT01634139|93452|P3|Overall Study|Other|3
21008|NCT01634139|93453|P2|Overall Study|Other|0
21009|NCT01634139|93454|P1|Overall Study|Other|4
21010|NCT01634139|93452|P3|Overall Study|Consent withdrawn not due to AE|2
21011|NCT01634139|93453|P2|Overall Study|Consent withdrawn not due to AE|3
21012|NCT01634139|93454|P1|Overall Study|Consent withdrawn not due to AE|4
21013|NCT01634139|93452|P3|Overall Study|Non compliant with protocol|0
21014|NCT01634139|93453|P2|Overall Study|Non compliant with protocol|0
21015|NCT01634139|93454|P1|Overall Study|Non compliant with protocol|1
21016|NCT01634113|93555|P3|Overall Study|Not treated|1
21017|NCT01634113|93556|P2|Overall Study|Not treated|0
21018|NCT01634113|93557|P1|Overall Study|Not treated|0
21019|NCT01634100|93601|P6|Overall Study|Withdrawal by Subject|0
21020|NCT01634100|93602|P5|Overall Study|Withdrawal by Subject|0
21021|NCT01634100|93603|P4|Overall Study|Withdrawal by Subject|0
21022|NCT01634100|93604|P3|Overall Study|Withdrawal by Subject|1
21023|NCT01634100|93605|P2|Overall Study|Withdrawal by Subject|0
21024|NCT01634100|93606|P1|Overall Study|Withdrawal by Subject|1
21025|NCT01633944|93622|P3|Double-blind Treatment Phase|Not specified|0
21026|NCT01633944|93623|P2|Double-blind Treatment Phase|Not specified|7
21027|NCT01633944|93624|P1|Double-blind Treatment Phase|Not specified|0
21028|NCT01633944|93622|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
21029|NCT01633944|93623|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
21030|NCT01633944|93624|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
21031|NCT01633944|93622|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
21032|NCT01633944|93623|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
21033|NCT01633944|93624|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
21034|NCT01633944|93622|P3|Double-blind Treatment Phase|Lost to Follow-up|9
21035|NCT01633944|93623|P2|Double-blind Treatment Phase|Lost to Follow-up|4
21036|NCT01633944|93624|P1|Double-blind Treatment Phase|Lost to Follow-up|0
21037|NCT01633944|93622|P3|Double-blind Treatment Phase|Protocol Violation|10
21038|NCT01633944|93623|P2|Double-blind Treatment Phase|Protocol Violation|7
21039|NCT01633944|93624|P1|Double-blind Treatment Phase|Protocol Violation|0
21040|NCT01633944|93622|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
21041|NCT01633944|93623|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
21042|NCT01633944|93624|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
21043|NCT01633944|93622|P3|Double-blind Treatment Phase|Lack of Efficacy|23
21044|NCT01633944|93623|P2|Double-blind Treatment Phase|Lack of Efficacy|8
21045|NCT01633944|93624|P1|Double-blind Treatment Phase|Lack of Efficacy|0
21046|NCT01633944|93622|P3|Double-blind Treatment Phase|Adverse Event|7
21047|NCT01633944|93623|P2|Double-blind Treatment Phase|Adverse Event|13
21048|NCT01633944|93624|P1|Double-blind Treatment Phase|Adverse Event|0
21049|NCT01633944|93622|P3|Open-label Titration Phase|Not specified|0
21050|NCT01633944|93623|P2|Open-label Titration Phase|Not specified|0
21051|NCT01633944|93624|P1|Open-label Titration Phase|Not specified|68
21052|NCT01633944|93622|P3|Open-label Titration Phase|Lost to Follow-up|0
21053|NCT01633944|93623|P2|Open-label Titration Phase|Lost to Follow-up|0
21054|NCT01633944|93624|P1|Open-label Titration Phase|Lost to Follow-up|22
21055|NCT01633944|93622|P3|Open-label Titration Phase|Protocol Violation|0
21056|NCT01633944|93623|P2|Open-label Titration Phase|Protocol Violation|0
21057|NCT01633944|93624|P1|Open-label Titration Phase|Protocol Violation|24
21058|NCT01633944|93622|P3|Open-label Titration Phase|Withdrawal by Subject|0
21059|NCT01633944|93623|P2|Open-label Titration Phase|Withdrawal by Subject|0
21060|NCT01633944|93624|P1|Open-label Titration Phase|Withdrawal by Subject|34
21061|NCT01633944|93622|P3|Open-label Titration Phase|Lack of Efficacy|0
21062|NCT01633944|93623|P2|Open-label Titration Phase|Lack of Efficacy|0
21063|NCT01633944|93624|P1|Open-label Titration Phase|Lack of Efficacy|33
21064|NCT01633944|93622|P3|Open-label Titration Phase|Adverse Event|0
21065|NCT01633944|93623|P2|Open-label Titration Phase|Adverse Event|0
21066|NCT01633944|93624|P1|Open-label Titration Phase|Adverse Event|109
21067|NCT01632904|93674|P2|Overall Study|Reason for discontinuation not available|1
21068|NCT01632904|93675|P1|Overall Study|Reason for discontinuation not available|0
21069|NCT01632904|93674|P2|Overall Study|Disease Progression|1
21070|NCT01632904|93675|P1|Overall Study|Disease Progression|0
21071|NCT01632904|93674|P2|Overall Study|Subject decision|2
21072|NCT01632904|93675|P1|Overall Study|Subject decision|3
21073|NCT01632904|93674|P2|Overall Study|Physician Decision|1
21074|NCT01632904|93675|P1|Overall Study|Physician Decision|0
21075|NCT01632904|93674|P2|Overall Study|Adverse Event|1
21076|NCT01632904|93675|P1|Overall Study|Adverse Event|4
21077|NCT01632878|93685|P1|Treatment|no information on study completion|43
21078|NCT01632878|93685|P1|Treatment|missing information|4
21079|NCT01632878|93685|P1|Treatment|Physician Decision|34
21080|NCT01632878|93685|P1|Treatment|Withdrawal by Subject|36
21081|NCT01632878|93685|P1|Treatment|Lost to Follow-up|41
21082|NCT01632878|93685|P1|Screening|Physician Decision|268
21083|NCT01632800|93689|P1|Overall Study|Subject did not fit in apparatus|1
21084|NCT01632150|93769|P1|Overall Study|Patient underwent autologous transplant|1
21085|NCT01632150|93769|P1|Overall Study|Withdrawal by Subject|2
21086|NCT01632150|93769|P1|Overall Study|Unrelated adverse event|6
21087|NCT01632150|93769|P1|Overall Study|Study drug toxicity|1
21088|NCT01632150|93769|P1|Overall Study|Disease progression|17
21089|NCT01632020|93778|P2|Overall Study|Adverse Event|0
21090|NCT01632020|93779|P1|Overall Study|Adverse Event|1
21091|NCT01632020|93778|P2|Overall Study|Withdrawal by Subject|0
21092|NCT01632020|93779|P1|Overall Study|Withdrawal by Subject|1
21093|NCT01631864|93798|P2|Overall Study|Adverse Event|3
21094|NCT01631864|93799|P1|Overall Study|Adverse Event|2
21095|NCT01631864|93798|P2|Overall Study|Withdrawal by Subject|1
21096|NCT01631864|93799|P1|Overall Study|Withdrawal by Subject|0
21097|NCT01631825|93811|P1|Overall Study|Physician Decision|2
21098|NCT01631825|93811|P1|Overall Study|Discontinuation criteria|1
21099|NCT01631825|93811|P1|Overall Study|Protocol Violation|4
21100|NCT01631825|93811|P1|Overall Study|Withdrawal by Subject|9
21101|NCT01631825|93811|P1|Overall Study|Lack of Efficacy|7
21102|NCT01631825|93811|P1|Overall Study|Adverse Event|42
21103|NCT01631812|93831|P1|Overall Study|Physician Decision|3
21104|NCT01631812|93831|P1|Overall Study|Withdrawal by Subject|4
21105|NCT01631812|93831|P1|Overall Study|Lack of Efficacy|5
21106|NCT01631812|93831|P1|Overall Study|Adverse Event|25
21107|NCT01631435|93952|P1|Overall Study|incomplete study procedure|5
21108|NCT01631435|93952|P1|Overall Study|Withdrawal by Subject|2
21109|NCT01631435|93952|P1|Overall Study|Adverse Event|2
21110|NCT01631227|93959|P2|Overall Study|administrative|1
21111|NCT01631227|93960|P1|Overall Study|administrative|2
21112|NCT01631227|93959|P2|Overall Study|Adverse Event|0
21113|NCT01631227|93960|P1|Overall Study|Adverse Event|1
21114|NCT01631227|93959|P2|Overall Study|withdrawn consent|21
21115|NCT01631227|93960|P1|Overall Study|withdrawn consent|27
21382|NCT01625338|94902|P1|Overall Study|Investigator Decision|0
21116|NCT01630135|94026|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
21117|NCT01630135|94027|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
21118|NCT01629706|94115|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
21119|NCT01629706|94115|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
21120|NCT01629706|94115|P1|Phase 2 Habitual|Relocation prior to Dispense|1
21121|NCT01629706|94115|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
21122|NCT01629706|94115|P1|Phase 2 Habitual|Screen Failure|6
21123|NCT01629706|94115|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
21124|NCT01629706|94115|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
21125|NCT01629706|94115|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
21126|NCT01629706|94115|P1|Phase 1 PureVision|Screen Failure|4
21127|NCT01629693|94143|P2|Overall Study|Subject decision unrelated to AE|1
21128|NCT01629693|94144|P1|Overall Study|Subject decision unrelated to AE|0
21129|NCT01629693|94143|P2|Overall Study|Poor comfort of study lenses|2
21130|NCT01629693|94144|P1|Overall Study|Poor comfort of study lenses|0
21131|NCT01629693|94143|P2|Overall Study|Investigator decision|1
21132|NCT01629693|94144|P1|Overall Study|Investigator decision|0
21133|NCT01629693|94143|P2|Overall Study|Adverse Event|0
21134|NCT01629693|94144|P1|Overall Study|Adverse Event|1
21135|NCT01629693|94143|P2|Overall Study|Withdrawal by Subject|2
21136|NCT01629693|94144|P1|Overall Study|Withdrawal by Subject|2
21137|NCT01629693|94143|P2|Overall Study|Lost to Follow-up|4
21138|NCT01629693|94144|P1|Overall Study|Lost to Follow-up|2
21139|NCT01629589|94152|P2|Overall Study|Did not receive study vaccine|1
21140|NCT01629589|94153|P1|Overall Study|Did not receive study vaccine|0
21141|NCT01629589|94152|P2|Overall Study|Withdrawal by Subject|3
21142|NCT01629589|94153|P1|Overall Study|Withdrawal by Subject|2
21143|NCT01629589|94152|P2|Overall Study|Lost to Follow-up|1
21144|NCT01629589|94153|P1|Overall Study|Lost to Follow-up|2
21145|NCT01629589|94152|P2|Overall Study|Protocol Violation|2
21146|NCT01629589|94153|P1|Overall Study|Protocol Violation|4
21147|NCT01628965|94182|P1|Overall Study|Discontinuation criteria|8
21148|NCT01628965|94182|P1|Overall Study|Lost to Follow-up|1
21149|NCT01628965|94182|P1|Overall Study|Withdrawal by Subject|3
21150|NCT01628965|94182|P1|Overall Study|Lack of Efficacy|7
21151|NCT01628965|94182|P1|Overall Study|Adverse Event|30
21152|NCT01628926|94191|P3|Overall Study|Physician Decision|1
21153|NCT01628926|94192|P2|Overall Study|Physician Decision|2
21154|NCT01628926|94193|P1|Overall Study|Physician Decision|2
21155|NCT01628926|94191|P3|Overall Study|Discontinuation criteria|0
21156|NCT01628926|94192|P2|Overall Study|Discontinuation criteria|4
21157|NCT01628926|94193|P1|Overall Study|Discontinuation criteria|3
21158|NCT01628926|94191|P3|Overall Study|Protocol Violation|0
21159|NCT01628926|94192|P2|Overall Study|Protocol Violation|1
21160|NCT01628926|94193|P1|Overall Study|Protocol Violation|0
21161|NCT01628926|94191|P3|Overall Study|Withdrawal by Subject|2
21162|NCT01628926|94192|P2|Overall Study|Withdrawal by Subject|4
21163|NCT01628926|94193|P1|Overall Study|Withdrawal by Subject|6
21164|NCT01628926|94191|P3|Overall Study|Lack of Efficacy|5
21165|NCT01628926|94192|P2|Overall Study|Lack of Efficacy|1
21166|NCT01628926|94193|P1|Overall Study|Lack of Efficacy|2
21167|NCT01628926|94191|P3|Overall Study|Adverse Event|9
21168|NCT01628926|94192|P2|Overall Study|Adverse Event|11
21169|NCT01628926|94193|P1|Overall Study|Adverse Event|13
21170|NCT01628913|94242|P2|Overall Study|Physician Decision|3
21171|NCT01628913|94243|P1|Overall Study|Physician Decision|1
21172|NCT01628913|94242|P2|Overall Study|Withdrawal by Subject|0
21173|NCT01628913|94243|P1|Overall Study|Withdrawal by Subject|1
21174|NCT01628913|94242|P2|Overall Study|study terminated by Sponsor|9
21175|NCT01628913|94243|P1|Overall Study|study terminated by Sponsor|4
21176|NCT01628913|94242|P2|Overall Study|Death|0
21177|NCT01628913|94243|P1|Overall Study|Death|1
21178|NCT01628913|94242|P2|Overall Study|Protocol Violation|0
21179|NCT01628913|94243|P1|Overall Study|Protocol Violation|1
21180|NCT01628913|94242|P2|Overall Study|Disease Progression|14
21181|NCT01628913|94243|P1|Overall Study|Disease Progression|11
21182|NCT01628913|94242|P2|Overall Study|Adverse Event|5
21183|NCT01628913|94243|P1|Overall Study|Adverse Event|12
21184|NCT01628848|94257|P2|Overall Study|Physician Decision|1
21185|NCT01628848|94258|P1|Overall Study|Physician Decision|3
21186|NCT01628848|94257|P2|Overall Study|Withdrawal by Subject|2
21187|NCT01628848|94258|P1|Overall Study|Withdrawal by Subject|0
21188|NCT01628848|94257|P2|Overall Study|Lack of Efficacy|4
21189|NCT01628848|94258|P1|Overall Study|Lack of Efficacy|0
21190|NCT01628848|94257|P2|Overall Study|Adverse Event|7
21191|NCT01628848|94258|P1|Overall Study|Adverse Event|9
21192|NCT01628692|94292|P6|Overall Study|Completed 12 Week only|1
21193|NCT01628692|94293|P5|Overall Study|Completed 12 Week only|0
21194|NCT01628692|94294|P4|Overall Study|Completed 12 Week only|0
21195|NCT01628692|94295|P3|Overall Study|Completed 12 Week only|0
21196|NCT01628692|94296|P2|Overall Study|Completed 12 Week only|0
21197|NCT01628692|94297|P1|Overall Study|Completed 12 Week only|0
21198|NCT01628692|94292|P6|Overall Study|Administrative reason by sponsor|1
21199|NCT01628692|94293|P5|Overall Study|Administrative reason by sponsor|0
21200|NCT01628692|94294|P4|Overall Study|Administrative reason by sponsor|0
21201|NCT01628692|94295|P3|Overall Study|Administrative reason by sponsor|0
21202|NCT01628692|94296|P2|Overall Study|Administrative reason by sponsor|0
21203|NCT01628692|94297|P1|Overall Study|Administrative reason by sponsor|0
21204|NCT01628692|94292|P6|Overall Study|Poor compliance/noncompliance|0
21205|NCT01628692|94293|P5|Overall Study|Poor compliance/noncompliance|0
21206|NCT01628692|94294|P4|Overall Study|Poor compliance/noncompliance|0
21207|NCT01628692|94295|P3|Overall Study|Poor compliance/noncompliance|0
21208|NCT01628692|94296|P2|Overall Study|Poor compliance/noncompliance|0
21209|NCT01628692|94297|P1|Overall Study|Poor compliance/noncompliance|1
21210|NCT01628692|94292|P6|Overall Study|Death|0
21211|NCT01628692|94293|P5|Overall Study|Death|0
21212|NCT01628692|94294|P4|Overall Study|Death|0
21213|NCT01628692|94295|P3|Overall Study|Death|0
21214|NCT01628692|94296|P2|Overall Study|Death|1
21215|NCT01628692|94297|P1|Overall Study|Death|0
21216|NCT01628692|94292|P6|Overall Study|Withdrawal by Subject|0
21217|NCT01628692|94293|P5|Overall Study|Withdrawal by Subject|0
21218|NCT01628692|94294|P4|Overall Study|Withdrawal by Subject|0
21219|NCT01628692|94295|P3|Overall Study|Withdrawal by Subject|1
21220|NCT01628692|94296|P2|Overall Study|Withdrawal by Subject|1
21221|NCT01628692|94297|P1|Overall Study|Withdrawal by Subject|0
21222|NCT01628692|94292|P6|Overall Study|Adverse Event|0
21223|NCT01628692|94293|P5|Overall Study|Adverse Event|0
21224|NCT01628692|94294|P4|Overall Study|Adverse Event|0
21225|NCT01628692|94295|P3|Overall Study|Adverse Event|2
21226|NCT01628692|94296|P2|Overall Study|Adverse Event|0
21227|NCT01628692|94297|P1|Overall Study|Adverse Event|2
21228|NCT01628692|94292|P6|Overall Study|Lack of Efficacy|7
21229|NCT01628692|94293|P5|Overall Study|Lack of Efficacy|4
21230|NCT01628692|94294|P4|Overall Study|Lack of Efficacy|1
21231|NCT01628692|94295|P3|Overall Study|Lack of Efficacy|5
21232|NCT01628692|94296|P2|Overall Study|Lack of Efficacy|4
21233|NCT01628692|94297|P1|Overall Study|Lack of Efficacy|4
21234|NCT01628510|94365|P2|Overall Study|Death|1
21235|NCT01628510|94366|P1|Overall Study|Death|3
21236|NCT01628510|94365|P2|Overall Study|Withdrawal by Subject|4
21237|NCT01628510|94366|P1|Overall Study|Withdrawal by Subject|0
21238|NCT01628367|94374|P2|Overall Study|Adverse Event|0
21239|NCT01628367|94375|P1|Overall Study|Adverse Event|1
21240|NCT01627860|94421|P2|Overall Study|Protocol Violation|0
21241|NCT01627860|94422|P1|Overall Study|Protocol Violation|1
21242|NCT01627860|94421|P2|Overall Study|Seizure frequency doubled|1
21243|NCT01627860|94422|P1|Overall Study|Seizure frequency doubled|0
21244|NCT01627860|94421|P2|Overall Study|Withdrawal by Subject|1
21245|NCT01627860|94422|P1|Overall Study|Withdrawal by Subject|2
21246|NCT01627860|94421|P2|Overall Study|Adverse Event|4
21247|NCT01627860|94422|P1|Overall Study|Adverse Event|9
21248|NCT01627782|94436|P4|Overall Study|Randomized But Not Treated|0
21249|NCT01627782|94437|P3|Overall Study|Randomized But Not Treated|0
21250|NCT01627782|94438|P2|Overall Study|Randomized But Not Treated|0
21251|NCT01627782|94439|P1|Overall Study|Randomized But Not Treated|1
21252|NCT01627782|94436|P4|Overall Study|Unspecified|3
21253|NCT01627782|94437|P3|Overall Study|Unspecified|0
21254|NCT01627782|94438|P2|Overall Study|Unspecified|2
21255|NCT01627782|94439|P1|Overall Study|Unspecified|0
21256|NCT01627782|94436|P4|Overall Study|Withdrawal by Subject|0
21257|NCT01627782|94437|P3|Overall Study|Withdrawal by Subject|0
21258|NCT01627782|94438|P2|Overall Study|Withdrawal by Subject|1
21259|NCT01627782|94439|P1|Overall Study|Withdrawal by Subject|2
21260|NCT01627782|94436|P4|Overall Study|Protocol Violation|0
21261|NCT01627782|94437|P3|Overall Study|Protocol Violation|0
21262|NCT01627782|94438|P2|Overall Study|Protocol Violation|0
21263|NCT01627782|94439|P1|Overall Study|Protocol Violation|1
21264|NCT01627782|94436|P4|Overall Study|Lack of Efficacy|2
21265|NCT01627782|94437|P3|Overall Study|Lack of Efficacy|15
21266|NCT01627782|94438|P2|Overall Study|Lack of Efficacy|1
21267|NCT01627782|94439|P1|Overall Study|Lack of Efficacy|11
21268|NCT01627782|94436|P4|Overall Study|Adverse Event|1
21269|NCT01627782|94437|P3|Overall Study|Adverse Event|0
21270|NCT01627782|94438|P2|Overall Study|Adverse Event|2
21271|NCT01627782|94439|P1|Overall Study|Adverse Event|1
21272|NCT01627561|94497|P2|Overall Study|Withdrawal by Subject|1
21273|NCT01627561|94498|P1|Overall Study|Withdrawal by Subject|0
21274|NCT01627561|94497|P2|Overall Study|Migrated/moved from study area|1
21275|NCT01627561|94498|P1|Overall Study|Migrated/moved from study area|0
21276|NCT01627340|94538|P2|Overall Study|Withdrawal by Subject|0
21277|NCT01627340|94539|P1|Overall Study|Withdrawal by Subject|2
21278|NCT01627340|94538|P2|Overall Study|Pregnancy|0
21279|NCT01627340|94539|P1|Overall Study|Pregnancy|1
21280|NCT01627340|94538|P2|Overall Study|Lost to Follow-up|4
21281|NCT01627340|94539|P1|Overall Study|Lost to Follow-up|8
21282|NCT01627340|94538|P2|Overall Study|Adverse Event|0
21283|NCT01627340|94539|P1|Overall Study|Adverse Event|1
21284|NCT01627327|94557|P2|Overall Study|Withdrawal by Subject|3
21285|NCT01627327|94558|P1|Overall Study|Withdrawal by Subject|3
21286|NCT01627327|94557|P2|Overall Study|Physician Decision|0
21287|NCT01627327|94558|P1|Overall Study|Physician Decision|1
21288|NCT01627327|94557|P2|Overall Study|Lost to Follow-up|3
21289|NCT01627327|94558|P1|Overall Study|Lost to Follow-up|1
21290|NCT01627327|94557|P2|Overall Study|Protocol Violation|10
21291|NCT01627327|94558|P1|Overall Study|Protocol Violation|4
21292|NCT01627327|94557|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
21293|NCT01627327|94558|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
21294|NCT01627327|94557|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
21295|NCT01627327|94558|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
21296|NCT01627327|94557|P2|Overall Study|Adverse Event|12
21297|NCT01627327|94558|P1|Overall Study|Adverse Event|6
21298|NCT01627249|94571|P3|Overall Study|Missed Visit|0
21299|NCT01627249|94572|P2|Overall Study|Missed Visit|1
21300|NCT01627249|94573|P1|Overall Study|Missed Visit|1
21301|NCT01627249|94571|P3|Overall Study|Withdrawal by Subject|9
21302|NCT01627249|94572|P2|Overall Study|Withdrawal by Subject|6
21303|NCT01627249|94573|P1|Overall Study|Withdrawal by Subject|12
21304|NCT01627249|94571|P3|Overall Study|Death|3
21305|NCT01627249|94572|P2|Overall Study|Death|5
21306|NCT01627249|94573|P1|Overall Study|Death|3
21307|NCT01626690|94694|P2|Overall Study|Adverse Event|0
21308|NCT01626690|94695|P1|Overall Study|Adverse Event|1
21309|NCT01626690|94694|P2|Overall Study|Protocol Violation|0
21310|NCT01626690|94695|P1|Overall Study|Protocol Violation|1
21311|NCT01626456|94717|P2|Overall Study|Incarceration|2
21312|NCT01626456|94718|P1|Overall Study|Incarceration|0
21313|NCT01626456|94717|P2|Overall Study|Site Closure|3
21314|NCT01626456|94718|P1|Overall Study|Site Closure|2
21315|NCT01626456|94717|P2|Overall Study|Protocol Violation|1
21316|NCT01626456|94718|P1|Overall Study|Protocol Violation|1
21317|NCT01626456|94717|P2|Overall Study|Physician Decision|4
21318|NCT01626456|94718|P1|Overall Study|Physician Decision|1
21319|NCT01626456|94717|P2|Overall Study|Lack of Efficacy|7
21320|NCT01626456|94718|P1|Overall Study|Lack of Efficacy|6
21321|NCT01626456|94717|P2|Overall Study|Lost to Follow-up|27
21322|NCT01626456|94718|P1|Overall Study|Lost to Follow-up|2
21323|NCT01626456|94717|P2|Overall Study|Adverse Event|27
21324|NCT01626456|94718|P1|Overall Study|Adverse Event|2
21325|NCT01626456|94717|P2|Overall Study|Withdrawal by Subject|46
21326|NCT01626456|94718|P1|Overall Study|Withdrawal by Subject|21
21327|NCT01626391|94748|P2|Overall Study|Withdrawal by Subject|0
21328|NCT01626391|94749|P1|Overall Study|Withdrawal by Subject|1
21329|NCT01626391|94748|P2|Overall Study|Physician Decision|0
21330|NCT01626391|94749|P1|Overall Study|Physician Decision|1
21331|NCT01626118|94759|P4|Overall Study|Investigator Decision|0
21332|NCT01626118|94760|P3|Overall Study|Investigator Decision|0
21333|NCT01626118|94761|P2|Overall Study|Investigator Decision|1
21334|NCT01626118|94762|P1|Overall Study|Investigator Decision|0
21335|NCT01626118|94759|P4|Overall Study|Adverse Event|0
21336|NCT01626118|94760|P3|Overall Study|Adverse Event|1
21337|NCT01626118|94761|P2|Overall Study|Adverse Event|1
21338|NCT01626118|94762|P1|Overall Study|Adverse Event|0
21339|NCT01626118|94759|P4|Overall Study|Lost to Follow-up|0
21340|NCT01626118|94760|P3|Overall Study|Lost to Follow-up|0
21341|NCT01626118|94761|P2|Overall Study|Lost to Follow-up|0
21342|NCT01626118|94762|P1|Overall Study|Lost to Follow-up|1
21343|NCT01626118|94759|P4|Overall Study|Lack of Efficacy|3
21344|NCT01626118|94760|P3|Overall Study|Lack of Efficacy|1
21345|NCT01626118|94761|P2|Overall Study|Lack of Efficacy|0
21346|NCT01626118|94762|P1|Overall Study|Lack of Efficacy|1
21347|NCT01625910|94808|P2|Overall Study|Lost to Follow-up|4
21348|NCT01625910|94809|P1|Overall Study|Lost to Follow-up|3
21349|NCT01625845|94819|P2|Overall Study|Withdrawal by Subject|0
21350|NCT01625845|94820|P1|Overall Study|Withdrawal by Subject|2
21351|NCT01625845|94819|P2|Overall Study|Lost to Follow-up|1
21352|NCT01625845|94820|P1|Overall Study|Lost to Follow-up|2
21353|NCT01625845|94819|P2|Overall Study|Adverse Event|2
21354|NCT01625845|94820|P1|Overall Study|Adverse Event|1
21355|NCT01625689|94840|P2|Overall Study|Migration|1
21356|NCT01625689|94841|P1|Overall Study|Migration|2
21357|NCT01625377|94866|P2|Overall Study|Abnormal laboratory values|0
21358|NCT01625377|94867|P1|Overall Study|Abnormal laboratory values|1
21359|NCT01625377|94866|P2|Overall Study|Unsatisfactory therapeutic effect|1
21360|NCT01625377|94867|P1|Overall Study|Unsatisfactory therapeutic effect|0
21361|NCT01625377|94866|P2|Overall Study|Graft loss|0
21362|NCT01625377|94867|P1|Overall Study|Graft loss|1
21363|NCT01625377|94866|P2|Overall Study|Adverse Event|16
21364|NCT01625377|94867|P1|Overall Study|Adverse Event|3
21365|NCT01625377|94866|P2|Overall Study|Protocol Violation|3
21366|NCT01625377|94867|P1|Overall Study|Protocol Violation|0
21367|NCT01625377|94866|P2|Overall Study|Administrative Problem|1
21368|NCT01625377|94867|P1|Overall Study|Administrative Problem|1
21369|NCT01625377|94866|P2|Overall Study|Death|1
21370|NCT01625377|94867|P1|Overall Study|Death|1
21371|NCT01625338|94900|P3|Overall Study|Study Discontinued by Sponsor|1
21372|NCT01625338|94901|P2|Overall Study|Study Discontinued by Sponsor|0
21373|NCT01625338|94902|P1|Overall Study|Study Discontinued by Sponsor|0
21374|NCT01625338|94900|P3|Overall Study|Adverse Event|1
21375|NCT01625338|94901|P2|Overall Study|Adverse Event|0
21376|NCT01625338|94902|P1|Overall Study|Adverse Event|1
21377|NCT01625338|94900|P3|Overall Study|Subject Withdrew Consent|2
21378|NCT01625338|94901|P2|Overall Study|Subject Withdrew Consent|0
21379|NCT01625338|94902|P1|Overall Study|Subject Withdrew Consent|1
21380|NCT01625338|94900|P3|Overall Study|Investigator Decision|1
21381|NCT01625338|94901|P2|Overall Study|Investigator Decision|2
21383|NCT01625338|94900|P3|Overall Study|Lost to Follow-up|2
21384|NCT01625338|94901|P2|Overall Study|Lost to Follow-up|3
21385|NCT01625338|94902|P1|Overall Study|Lost to Follow-up|3
21386|NCT01625338|94900|P3|Overall Study|Efficacy Failure|31
21387|NCT01625338|94901|P2|Overall Study|Efficacy Failure|39
21388|NCT01625338|94902|P1|Overall Study|Efficacy Failure|27
21389|NCT01625338|94900|P3|Overall Study|Enrolled but not Treated|1
21390|NCT01625338|94901|P2|Overall Study|Enrolled but not Treated|0
21391|NCT01625338|94902|P1|Overall Study|Enrolled but not Treated|0
21392|NCT01624467|94968|P1|Overall Study|Subject Withdrew from Treatment|1
21393|NCT01624467|94968|P1|Overall Study|Per Sponsor Requirement|1
21394|NCT01624467|94968|P1|Overall Study|Progressive Disease|19
21395|NCT01624467|94968|P1|Overall Study|Adverse Event|7
21396|NCT01624467|94968|P1|Overall Study|Lost to Follow-up|1
21397|NCT01624467|94968|P1|Overall Study|Withdrawal by Subject|2
21398|NCT01624259|95003|P2|Overall Study|Abnormal laboratory measure|0
21399|NCT01624259|95004|P1|Overall Study|Abnormal laboratory measure|3
21400|NCT01624259|95003|P2|Overall Study|Lost to Follow-up|3
21401|NCT01624259|95004|P1|Overall Study|Lost to Follow-up|2
21402|NCT01624259|95003|P2|Overall Study|Physician Decision|1
21403|NCT01624259|95004|P1|Overall Study|Physician Decision|1
21404|NCT01624259|95003|P2|Overall Study|Withdrawal by Subject|7
21405|NCT01624259|95004|P1|Overall Study|Withdrawal by Subject|5
21406|NCT01624259|95003|P2|Overall Study|Protocol Violation|2
21407|NCT01624259|95004|P1|Overall Study|Protocol Violation|1
21408|NCT01624259|95003|P2|Overall Study|Adverse Event|18
21409|NCT01624259|95004|P1|Overall Study|Adverse Event|18
21410|NCT01624233|95053|P1|Period 3 - Maintenance|Withdrawal by Subject|2
21411|NCT01624233|95053|P1|Period 3 - Maintenance|Physician Decision|2
21412|NCT01624233|95053|P1|Period 3 - Maintenance|Lack of Efficacy|1
21413|NCT01624233|95053|P1|Period 3 - Maintenance|Adverse Event|2
21414|NCT01624233|95053|P1|Period 2 - Induction|Adverse Event|1
21415|NCT01623830|95106|P2|Overall Study|Exclusion from Study|2
21416|NCT01623830|95107|P1|Overall Study|Exclusion from Study|1
21417|NCT01623830|95106|P2|Overall Study|Withdrawal by Subject|7
21418|NCT01623830|95107|P1|Overall Study|Withdrawal by Subject|6
21419|NCT01623154|95131|P1|Overall Study|Did not drink Pranactin Citric|4
21420|NCT01623115|95139|P2|Overall Study|Other than specified above|3
21421|NCT01623115|95140|P1|Overall Study|Other than specified above|0
21422|NCT01623115|95139|P2|Overall Study|Death|4
21423|NCT01623115|95140|P1|Overall Study|Death|0
21424|NCT01623115|95139|P2|Overall Study|Site closure|7
21425|NCT01623115|95140|P1|Overall Study|Site closure|1
21426|NCT01623115|95139|P2|Overall Study|Last visit outside protocol visit window|26
21427|NCT01623115|95140|P1|Overall Study|Last visit outside protocol visit window|14
21428|NCT01623115|95139|P2|Overall Study|Related to study drug administration|2
21429|NCT01623115|95140|P1|Overall Study|Related to study drug administration|0
21430|NCT01623115|95139|P2|Overall Study|Consent withdrawn by participant|6
21431|NCT01623115|95140|P1|Overall Study|Consent withdrawn by participant|2
21432|NCT01623115|95139|P2|Overall Study|Poor compliance to protocol|10
21433|NCT01623115|95140|P1|Overall Study|Poor compliance to protocol|4
21434|NCT01623115|95139|P2|Overall Study|Adverse Event|13
21435|NCT01623115|95140|P1|Overall Study|Adverse Event|10
21436|NCT01623115|95139|P2|Overall Study|Participants moved|5
21437|NCT01623115|95140|P1|Overall Study|Participants moved|1
21438|NCT01623115|95139|P2|Overall Study|Physician Decision|0
21439|NCT01623115|95140|P1|Overall Study|Physician Decision|1
21440|NCT01623115|95139|P2|Overall Study|Randomized but not treated|1
21441|NCT01623115|95140|P1|Overall Study|Randomized but not treated|0
21442|NCT01623050|95200|P1|Overall Study|Lost to Follow-up|9
21443|NCT01622673|95214|P6|Treatment Period 3|Protocol Violation|0
21444|NCT01622673|95215|P5|Treatment Period 3|Protocol Violation|0
21445|NCT01622673|95216|P4|Treatment Period 3|Protocol Violation|0
21446|NCT01622673|95217|P3|Treatment Period 3|Protocol Violation|0
21447|NCT01622673|95218|P2|Treatment Period 3|Protocol Violation|1
21448|NCT01622673|95219|P1|Treatment Period 3|Protocol Violation|0
21449|NCT01622673|95214|P6|Treatment Period 2|Withdrawal by Subject|0
21450|NCT01622673|95215|P5|Treatment Period 2|Withdrawal by Subject|0
21451|NCT01622673|95216|P4|Treatment Period 2|Withdrawal by Subject|1
21452|NCT01622673|95217|P3|Treatment Period 2|Withdrawal by Subject|0
21453|NCT01622673|95218|P2|Treatment Period 2|Withdrawal by Subject|0
21454|NCT01622673|95219|P1|Treatment Period 2|Withdrawal by Subject|0
21455|NCT01622673|95214|P6|Treatment Period 1|Protocol Violation|0
21456|NCT01622673|95215|P5|Treatment Period 1|Protocol Violation|0
21457|NCT01622673|95216|P4|Treatment Period 1|Protocol Violation|0
21458|NCT01622673|95217|P3|Treatment Period 1|Protocol Violation|0
21459|NCT01622673|95218|P2|Treatment Period 1|Protocol Violation|1
21460|NCT01622673|95219|P1|Treatment Period 1|Protocol Violation|0
21461|NCT01622673|95214|P6|Treatment Period 1|Withdrawal by Subject|0
21462|NCT01622673|95215|P5|Treatment Period 1|Withdrawal by Subject|0
21463|NCT01622673|95216|P4|Treatment Period 1|Withdrawal by Subject|1
21464|NCT01622673|95217|P3|Treatment Period 1|Withdrawal by Subject|0
21465|NCT01622673|95218|P2|Treatment Period 1|Withdrawal by Subject|0
21466|NCT01622673|95219|P1|Treatment Period 1|Withdrawal by Subject|0
21467|NCT01622231|95285|P1|Overall Study|Withdrawal by Subject|1
21468|NCT01622231|95285|P1|Overall Study|Physician Decision|1
21469|NCT01621191|95370|P1|Overall Study|Site Removed From Study|1
21470|NCT01621191|95370|P1|Overall Study|Lost to Follow-up|1
21471|NCT01621191|95370|P1|Overall Study|Lack of Efficacy|6
21472|NCT01621191|95370|P1|Overall Study|Withdrawal by Subject|8
21473|NCT01621191|95370|P1|Overall Study|Adverse Event|9
21474|NCT01621126|95381|P1|Overall Study|Physician Decision|6
21475|NCT01620489|95402|P2|Overall Study|Unclassified|2
21476|NCT01620489|95403|P1|Overall Study|Unclassified|1
21477|NCT01620489|95402|P2|Overall Study|Withdrawal Criteria|25
21478|NCT01620489|95403|P1|Overall Study|Withdrawal Criteria|17
21479|NCT01620489|95402|P2|Overall Study|Protocol Violation|3
21480|NCT01620489|95403|P1|Overall Study|Protocol Violation|0
21481|NCT01620489|95402|P2|Overall Study|Adverse Event|4
21482|NCT01620489|95403|P1|Overall Study|Adverse Event|17
21483|NCT01620138|95421|P2|Overall Study|Adverse Event|0
21484|NCT01620138|95422|P1|Overall Study|Adverse Event|2
21485|NCT01620138|95421|P2|Overall Study|Lack of Efficacy|0
21486|NCT01620138|95422|P1|Overall Study|Lack of Efficacy|1
21487|NCT01620138|95421|P2|Overall Study|Withdrawal by Subject|0
21488|NCT01620138|95422|P1|Overall Study|Withdrawal by Subject|3
21489|NCT01620086|95430|P3|Overall Study|Physician Decision|0
21490|NCT01620086|95431|P2|Overall Study|Physician Decision|0
21491|NCT01620086|95432|P1|Overall Study|Physician Decision|1
21492|NCT01620086|95430|P3|Overall Study|failed study criteria|0
21493|NCT01620086|95431|P2|Overall Study|failed study criteria|4
21494|NCT01620086|95432|P1|Overall Study|failed study criteria|1
21495|NCT01620086|95430|P3|Overall Study|Withdrawal by Subject|0
21496|NCT01620086|95431|P2|Overall Study|Withdrawal by Subject|3
21497|NCT01620086|95432|P1|Overall Study|Withdrawal by Subject|3
21498|NCT01620060|95451|P1|Overall Study|Per Sponsor Decision|2
21499|NCT01620060|95451|P1|Overall Study|Family emergency|1
21500|NCT01620060|95451|P1|Overall Study|Did not comply with Study Produre|1
21501|NCT01620060|95451|P1|Overall Study|Withdrawal by Subject|1
21502|NCT01620060|95451|P1|Overall Study|Protocol Violation|1
21503|NCT01620060|95451|P1|Overall Study|Adverse Event|9
21504|NCT01619878|95470|P1|Follow-up at 12 Months of Age|Death|2
21505|NCT01619878|95470|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
21506|NCT01619878|95470|P1|6 Week Follow-up Phase|Adverse Event|1
21507|NCT01619800|95484|P2|Overall Study|study terminated|0
21508|NCT01619800|95485|P1|Overall Study|study terminated|2
21509|NCT01619787|95493|P1|Overall Study|Lost to Follow-up|5
21510|NCT01619579|95510|P2|Overall Study|Withdrawal by Subject|3
21511|NCT01619579|95511|P1|Overall Study|Withdrawal by Subject|0
21512|NCT01619059|95523|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
21513|NCT01619059|95524|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
21514|NCT01619059|95523|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
21515|NCT01619059|95524|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
21516|NCT01619059|95523|P2|Long-Term (LT) Treatment Period|Death|0
21517|NCT01619059|95524|P1|Long-Term (LT) Treatment Period|Death|1
21518|NCT01619059|95523|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
21519|NCT01619059|95524|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
21520|NCT01619059|95523|P2|Long-Term (LT) Treatment Period|Adverse Event|3
21521|NCT01619059|95524|P1|Long-Term (LT) Treatment Period|Adverse Event|2
21522|NCT01619059|95523|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
21523|NCT01619059|95524|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
21524|NCT01619059|95523|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
21525|NCT01619059|95524|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
21526|NCT01619059|95523|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
21527|NCT01619059|95524|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
21528|NCT01619059|95523|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
21529|NCT01619059|95524|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
21530|NCT01619059|95523|P2|Short-Term (ST) Treatment Period|Adverse Event|0
21531|NCT01619059|95524|P1|Short-Term (ST) Treatment Period|Adverse Event|1
21532|NCT01618968|95540|P4|Overall Study|Death|1
21533|NCT01618968|95541|P3|Overall Study|Death|0
21534|NCT01618968|95542|P2|Overall Study|Death|0
21535|NCT01618968|95543|P1|Overall Study|Death|0
21536|NCT01618968|95540|P4|Overall Study|Adverse Event|0
21537|NCT01618968|95541|P3|Overall Study|Adverse Event|0
21538|NCT01618968|95542|P2|Overall Study|Adverse Event|0
21539|NCT01618968|95543|P1|Overall Study|Adverse Event|1
21540|NCT01618864|95610|P1|Overall Study|Lost to Follow-up|2
21541|NCT01618864|95610|P1|Overall Study|Withdrawal by Subject|2
21542|NCT01618838|95619|P1|Overall Study|slow accrual, trial closed prematurely.|4
21543|NCT01618708|95625|P2|Overall Study|Randomized but not treated|2
21544|NCT01618708|95626|P1|Overall Study|Randomized but not treated|3
21545|NCT01618708|95625|P2|Overall Study|Other than specified above|1
21546|NCT01618708|95626|P1|Overall Study|Other than specified above|1
21547|NCT01618708|95625|P2|Overall Study|Technical problems|0
21548|NCT01618708|95626|P1|Overall Study|Technical problems|2
21549|NCT01618708|95625|P2|Overall Study|Lack of Efficacy|8
21550|NCT01618708|95626|P1|Overall Study|Lack of Efficacy|8
21551|NCT01618708|95625|P2|Overall Study|Withdrawal by Subject|22
21552|NCT01618708|95626|P1|Overall Study|Withdrawal by Subject|17
21553|NCT01618708|95625|P2|Overall Study|Lost to Follow-up|3
21554|NCT01618708|95626|P1|Overall Study|Lost to Follow-up|3
21555|NCT01618708|95625|P2|Overall Study|Adverse Event|10
21556|NCT01618708|95626|P1|Overall Study|Adverse Event|10
21557|NCT01618669|95640|P2|Overall Study|Miscellaneous Reason|1
21558|NCT01618669|95641|P1|Overall Study|Miscellaneous Reason|0
21559|NCT01618669|95640|P2|Overall Study|Withdrawal by Subject|9
21560|NCT01618669|95641|P1|Overall Study|Withdrawal by Subject|9
21561|NCT01618669|95640|P2|Overall Study|Protocol Violation|3
21562|NCT01618669|95641|P1|Overall Study|Protocol Violation|5
21563|NCT01618669|95640|P2|Overall Study|Adverse Event|7
21564|NCT01618669|95641|P1|Overall Study|Adverse Event|16
21565|NCT01618669|95640|P2|Overall Study|Randomized but Never Received Study Drug|2
21566|NCT01618669|95641|P1|Overall Study|Randomized but Never Received Study Drug|3
21567|NCT01618669|95640|P2|Overall Study|Lost to Follow-up|1
21568|NCT01618669|95641|P1|Overall Study|Lost to Follow-up|1
21569|NCT01618266|95694|P1|Overall Study|Protocol Violation|43
21570|NCT01618266|95694|P1|Overall Study|Lack of Efficacy|23
21571|NCT01618266|95694|P1|Overall Study|Other reasons|11
21572|NCT01618266|95694|P1|Overall Study|Treatment satisfaction|10
21573|NCT01618266|95694|P1|Overall Study|Lost to Follow-up|9
21574|NCT01618214|95716|P2|Overall Study|Unclassified|5
21575|NCT01618214|95717|P1|Overall Study|Unclassified|4
21576|NCT01618214|95716|P2|Overall Study|Withdrawal Criteria|2
21577|NCT01618214|95717|P1|Overall Study|Withdrawal Criteria|1
21578|NCT01618214|95716|P2|Overall Study|Protocol Violation|4
21579|NCT01618214|95717|P1|Overall Study|Protocol Violation|1
21580|NCT01618214|95716|P2|Overall Study|Lack of Efficacy|1
21581|NCT01618214|95717|P1|Overall Study|Lack of Efficacy|1
21582|NCT01618214|95716|P2|Overall Study|Adverse Event|1
21583|NCT01618214|95717|P1|Overall Study|Adverse Event|3
21584|NCT01618162|95733|P2|Overall Study|Unclassified|13
21585|NCT01618162|95734|P1|Overall Study|Unclassified|14
21586|NCT01618162|95733|P2|Overall Study|Withdrawal Criteria|10
21587|NCT01618162|95734|P1|Overall Study|Withdrawal Criteria|2
21588|NCT01618162|95733|P2|Overall Study|Adverse Event|2
21589|NCT01618162|95734|P1|Overall Study|Adverse Event|9
21590|NCT01618162|95733|P2|Overall Study|Protocol Violation|10
21591|NCT01618162|95734|P1|Overall Study|Protocol Violation|13
21592|NCT01618019|95754|P2|Overall Study|Withdrawal by Subject|14
21593|NCT01618019|95755|P1|Overall Study|Withdrawal by Subject|14
21594|NCT01617668|95777|P4|Overall Study|Subject/guardian decision|1
21595|NCT01617668|95778|P3|Overall Study|Subject/guardian decision|2
21596|NCT01617668|95779|P2|Overall Study|Subject/guardian decision|3
21597|NCT01617668|95780|P1|Overall Study|Subject/guardian decision|1
21598|NCT01617668|95777|P4|Overall Study|Progressive Disease|9
21599|NCT01617668|95778|P3|Overall Study|Progressive Disease|6
21600|NCT01617668|95779|P2|Overall Study|Progressive Disease|4
21601|NCT01617668|95780|P1|Overall Study|Progressive Disease|4
21602|NCT01617668|95777|P4|Overall Study|Physician Decision|0
21603|NCT01617668|95778|P3|Overall Study|Physician Decision|3
21604|NCT01617668|95779|P2|Overall Study|Physician Decision|2
21605|NCT01617668|95780|P1|Overall Study|Physician Decision|1
21606|NCT01617668|95777|P4|Overall Study|Adverse Event|5
21607|NCT01617668|95778|P3|Overall Study|Adverse Event|12
21608|NCT01617668|95779|P2|Overall Study|Adverse Event|0
21609|NCT01617668|95780|P1|Overall Study|Adverse Event|7
21610|NCT01617655|95821|P2|Overall Study|Other than specified above|2
21611|NCT01617655|95822|P1|Overall Study|Other than specified above|1
21612|NCT01617655|95821|P2|Overall Study|Site closure|5
21613|NCT01617655|95822|P1|Overall Study|Site closure|3
21614|NCT01617655|95821|P2|Overall Study|Last visit outside protocol visit window|10
21615|NCT01617655|95822|P1|Overall Study|Last visit outside protocol visit window|1
21616|NCT01617655|95821|P2|Overall Study|Consent withdrawn by participant|1
21617|NCT01617655|95822|P1|Overall Study|Consent withdrawn by participant|1
21618|NCT01617655|95821|P2|Overall Study|Participants moved|4
21619|NCT01617655|95822|P1|Overall Study|Participants moved|0
21620|NCT01617655|95821|P2|Overall Study|Poor compliance to protocol|4
21621|NCT01617655|95822|P1|Overall Study|Poor compliance to protocol|1
21622|NCT01617655|95821|P2|Overall Study|Adverse Event|3
21623|NCT01617655|95822|P1|Overall Study|Adverse Event|2
21624|NCT01617434|95907|P2|Overall Study|Unclassified|4
21625|NCT01617434|95908|P1|Overall Study|Unclassified|3
21626|NCT01617434|95907|P2|Overall Study|Withdrawal Criteria|37
21627|NCT01617434|95908|P1|Overall Study|Withdrawal Criteria|12
21628|NCT01617434|95907|P2|Overall Study|Protocol Violation|7
21629|NCT01617434|95908|P1|Overall Study|Protocol Violation|8
21630|NCT01617434|95907|P2|Overall Study|Adverse Event|3
21631|NCT01617434|95908|P1|Overall Study|Adverse Event|12
21632|NCT01617187|95934|P4|Treatment Through Study Completion|Protocol Violation|1
21633|NCT01617187|95935|P3|Treatment Through Study Completion|Protocol Violation|0
21634|NCT01617187|95936|P2|Treatment Through Study Completion|Protocol Violation|0
21635|NCT01617187|95937|P1|Treatment Through Study Completion|Protocol Violation|1
21636|NCT01617187|95934|P4|Treatment Through Study Completion|Withdrawal by Subject|6
21637|NCT01617187|95935|P3|Treatment Through Study Completion|Withdrawal by Subject|3
21638|NCT01617187|95936|P2|Treatment Through Study Completion|Withdrawal by Subject|8
21639|NCT01617187|95937|P1|Treatment Through Study Completion|Withdrawal by Subject|5
21640|NCT01617187|95934|P4|Treatment Through Study Completion|Lost to Follow-up|2
21641|NCT01617187|95935|P3|Treatment Through Study Completion|Lost to Follow-up|2
21642|NCT01617187|95936|P2|Treatment Through Study Completion|Lost to Follow-up|2
21643|NCT01617187|95937|P1|Treatment Through Study Completion|Lost to Follow-up|4
21644|NCT01617187|95934|P4|Treatment Through Study Completion|Adverse Event|1
21645|NCT01617187|95935|P3|Treatment Through Study Completion|Adverse Event|0
21646|NCT01617187|95936|P2|Treatment Through Study Completion|Adverse Event|1
21647|NCT01617187|95937|P1|Treatment Through Study Completion|Adverse Event|1
21648|NCT01617187|95934|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
21649|NCT01617187|95935|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
21650|NCT01617187|95936|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
21651|NCT01617187|95937|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
21652|NCT01617187|95934|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
21653|NCT01617187|95935|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
21654|NCT01617187|95936|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
21655|NCT01617187|95937|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
21656|NCT01617187|95934|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
21657|NCT01617187|95935|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
21658|NCT01617187|95936|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
21659|NCT01617187|95937|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
21660|NCT01617070|96007|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
21661|NCT01617005|96025|P1|Overall Study|Lack of motivation for treatment|1
21662|NCT01617005|96025|P1|Overall Study|Pregnancy|1
21663|NCT01616771|96032|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
21664|NCT01616459|96057|P4|Overall Study|Other|0
21665|NCT01616459|96058|P3|Overall Study|Other|1
21666|NCT01616459|96059|P2|Overall Study|Other|1
21667|NCT01616459|96060|P1|Overall Study|Other|0
21668|NCT01616459|96057|P4|Overall Study|Withdrawal by Subject|4
21669|NCT01616459|96058|P3|Overall Study|Withdrawal by Subject|4
21670|NCT01616459|96059|P2|Overall Study|Withdrawal by Subject|4
21671|NCT01616459|96060|P1|Overall Study|Withdrawal by Subject|2
21672|NCT01616459|96057|P4|Overall Study|Protocol Violation|2
21673|NCT01616459|96058|P3|Overall Study|Protocol Violation|0
21674|NCT01616459|96059|P2|Overall Study|Protocol Violation|0
21675|NCT01616459|96060|P1|Overall Study|Protocol Violation|0
21676|NCT01616459|96057|P4|Overall Study|Lost to Follow-up|2
21677|NCT01616459|96058|P3|Overall Study|Lost to Follow-up|3
21678|NCT01616459|96059|P2|Overall Study|Lost to Follow-up|11
21679|NCT01616459|96060|P1|Overall Study|Lost to Follow-up|1
21680|NCT01616459|96057|P4|Overall Study|Adverse Event|0
21681|NCT01616459|96058|P3|Overall Study|Adverse Event|2
21682|NCT01616459|96059|P2|Overall Study|Adverse Event|1
21683|NCT01616459|96060|P1|Overall Study|Adverse Event|1
21684|NCT01616173|96109|P3|Overall Study|Lost to Follow-up|0
21685|NCT01616173|96110|P2|Overall Study|Lost to Follow-up|2
21686|NCT01616173|96111|P1|Overall Study|Lost to Follow-up|0
21687|NCT01615939|96127|P2|Overall Study|Lost to Follow-up|0
21688|NCT01615939|96128|P1|Overall Study|Lost to Follow-up|5
21689|NCT01615822|96141|P3|Period 2|Lost to Follow-up|2
21690|NCT01615822|96142|P2|Period 2|Lost to Follow-up|1
21691|NCT01615822|96143|P1|Period 2|Lost to Follow-up|0
21692|NCT01615822|96141|P3|Period 1|Adverse Event|0
21693|NCT01615822|96142|P2|Period 1|Adverse Event|1
21694|NCT01615822|96143|P1|Period 1|Adverse Event|1
21695|NCT01615822|96141|P3|Period 1|Withdrawal by Subject|0
21696|NCT01615822|96142|P2|Period 1|Withdrawal by Subject|1
21697|NCT01615822|96143|P1|Period 1|Withdrawal by Subject|0
21698|NCT01615328|96189|P2|Overall Study|Lost to Follow-up|5
21699|NCT01615328|96190|P1|Overall Study|Lost to Follow-up|3
21700|NCT01615263|96202|P2|Overall Study|Post-randomization exclusion|2
21701|NCT01615263|96203|P1|Overall Study|Post-randomization exclusion|0
21702|NCT01615198|96217|P2|Overall Study|Adverse Event|5
21703|NCT01615198|96218|P1|Overall Study|Adverse Event|11
21704|NCT01615198|96217|P2|Overall Study|Lack of Efficacy|6
21705|NCT01615198|96218|P1|Overall Study|Lack of Efficacy|1
21706|NCT01615198|96217|P2|Overall Study|Lost to Follow-up|1
21707|NCT01615198|96218|P1|Overall Study|Lost to Follow-up|1
21708|NCT01615198|96217|P2|Overall Study|Physician Decision|1
21709|NCT01615198|96218|P1|Overall Study|Physician Decision|5
21710|NCT01615198|96217|P2|Overall Study|Protocol deviation|1
21711|NCT01615198|96218|P1|Overall Study|Protocol deviation|1
21712|NCT01615198|96217|P2|Overall Study|Withdrawal by Subject|5
21713|NCT01615198|96218|P1|Overall Study|Withdrawal by Subject|5
21714|NCT01614886|96248|P2|Overall Study|Protocol deviation|2
21715|NCT01614886|96249|P1|Overall Study|Protocol deviation|0
21716|NCT01614886|96248|P2|Overall Study|Death|0
21717|NCT01614886|96249|P1|Overall Study|Death|1
21718|NCT01614886|96248|P2|Overall Study|Withdrawal by Subject|4
21719|NCT01614886|96249|P1|Overall Study|Withdrawal by Subject|4
21720|NCT01614886|96248|P2|Overall Study|Adverse Event|20
21721|NCT01614886|96249|P1|Overall Study|Adverse Event|15
21722|NCT01614795|96267|P4|Overall Study|Ineligible|0
21723|NCT01614795|96268|P3|Overall Study|Ineligible|0
21724|NCT01614795|96269|P2|Overall Study|Ineligible|1
21725|NCT01614795|96270|P1|Overall Study|Ineligible|0
21726|NCT01614795|96267|P4|Overall Study|Withdrawal by Subject|2
21727|NCT01614795|96268|P3|Overall Study|Withdrawal by Subject|0
21728|NCT01614795|96269|P2|Overall Study|Withdrawal by Subject|1
21729|NCT01614795|96270|P1|Overall Study|Withdrawal by Subject|0
21730|NCT01614795|96267|P4|Overall Study|Physician Decision|1
21731|NCT01614795|96268|P3|Overall Study|Physician Decision|1
21732|NCT01614795|96269|P2|Overall Study|Physician Decision|0
21733|NCT01614795|96270|P1|Overall Study|Physician Decision|1
21734|NCT01614795|96267|P4|Overall Study|Lack of Efficacy|8
21735|NCT01614795|96268|P3|Overall Study|Lack of Efficacy|9
21736|NCT01614795|96269|P2|Overall Study|Lack of Efficacy|10
21737|NCT01614795|96270|P1|Overall Study|Lack of Efficacy|10
21738|NCT01614795|96267|P4|Overall Study|Adverse Event|1
21739|NCT01614795|96268|P3|Overall Study|Adverse Event|1
21740|NCT01614795|96269|P2|Overall Study|Adverse Event|0
21741|NCT01614795|96270|P1|Overall Study|Adverse Event|0
21742|NCT01614769|96280|P6|Period 3|Withdrawal by Subject|0
21743|NCT01614769|96281|P5|Period 3|Withdrawal by Subject|0
21744|NCT01614769|96282|P4|Period 3|Withdrawal by Subject|0
21745|NCT01614769|96283|P3|Period 3|Withdrawal by Subject|1
21746|NCT01614769|96284|P2|Period 3|Withdrawal by Subject|0
21747|NCT01614769|96285|P1|Period 3|Withdrawal by Subject|0
21748|NCT01614769|96280|P6|Period 1|Withdrawal by Subject|0
21749|NCT01614769|96281|P5|Period 1|Withdrawal by Subject|0
21750|NCT01614769|96282|P4|Period 1|Withdrawal by Subject|0
21751|NCT01614769|96283|P3|Period 1|Withdrawal by Subject|0
21752|NCT01614769|96284|P2|Period 1|Withdrawal by Subject|0
21753|NCT01614769|96285|P1|Period 1|Withdrawal by Subject|1
21754|NCT01614769|96280|P6|Period 1|Protocol Violation|0
21755|NCT01614769|96281|P5|Period 1|Protocol Violation|0
21756|NCT01614769|96282|P4|Period 1|Protocol Violation|1
21757|NCT01614769|96283|P3|Period 1|Protocol Violation|0
21758|NCT01614769|96284|P2|Period 1|Protocol Violation|0
21759|NCT01614769|96285|P1|Period 1|Protocol Violation|0
21760|NCT01614769|96280|P6|Period 1|Discontinued due to Hypoglycemia|1
21761|NCT01614769|96281|P5|Period 1|Discontinued due to Hypoglycemia|0
21762|NCT01614769|96282|P4|Period 1|Discontinued due to Hypoglycemia|1
21763|NCT01614769|96283|P3|Period 1|Discontinued due to Hypoglycemia|0
21764|NCT01614769|96284|P2|Period 1|Discontinued due to Hypoglycemia|0
21765|NCT01614769|96285|P1|Period 1|Discontinued due to Hypoglycemia|0
21766|NCT01614600|96307|P1|Overall Study|Protocol deviation|1
21767|NCT01614600|96307|P1|Overall Study|Unable to remove lens at the end of day|1
21768|NCT01614600|96307|P1|Overall Study|Discomfort|1
21769|NCT01614600|96307|P1|Overall Study|Unacceptable fit|1
21770|NCT01614470|96338|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
21771|NCT01614470|96339|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
21772|NCT01614470|96340|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
21773|NCT01614470|96338|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
21774|NCT01614470|96339|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
21775|NCT01614470|96340|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
21776|NCT01614457|96362|P2|Overall Study|Pregnancy (Self or Partner)|0
21777|NCT01614457|96363|P1|Overall Study|Pregnancy (Self or Partner)|1
21778|NCT01614457|96362|P2|Overall Study|Non-Compliance|0
21779|NCT01614457|96363|P1|Overall Study|Non-Compliance|1
21780|NCT01614249|96381|P2|Overall Study|Lost to Follow-up|23
21781|NCT01614249|96382|P1|Overall Study|Lost to Follow-up|11
21782|NCT01613599|96388|P1|Overall Study|Ongoing|81
21783|NCT01613599|96388|P1|Overall Study|Reason not specified|2
21784|NCT01613599|96388|P1|Overall Study|Withdrawal by Subject|6
21785|NCT01613599|96388|P1|Overall Study|Lost to Follow-up|2
21786|NCT01613599|96388|P1|Overall Study|Death|6
21787|NCT01613417|96403|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
21788|NCT01613417|96404|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
21789|NCT01613378|96441|P1|Overall Study|Other Reason|4
21790|NCT01613378|96441|P1|Overall Study|Lost to Follow-up|1
21791|NCT01613378|96441|P1|Overall Study|Death|2
21792|NCT01613378|96441|P1|Overall Study|Withdrawal by Subject|8
21793|NCT01613378|96441|P1|Overall Study|Adverse Event|11
21794|NCT01613378|96441|P1|Overall Study|Lack of Efficacy|13
21795|NCT01613326|96471|P2|Overall Study|Protocol Violation|1
21796|NCT01613326|96472|P1|Overall Study|Protocol Violation|0
21797|NCT01613326|96471|P2|Overall Study|Administrative|2
21798|NCT01613326|96472|P1|Overall Study|Administrative|0
21799|NCT01613326|96471|P2|Overall Study|Lost to Follow-up|1
21800|NCT01613326|96472|P1|Overall Study|Lost to Follow-up|0
21801|NCT01613326|96471|P2|Overall Study|Lack of Efficacy|1
21802|NCT01613326|96472|P1|Overall Study|Lack of Efficacy|0
21803|NCT01613326|96471|P2|Overall Study|inability to use device|0
21804|NCT01613326|96472|P1|Overall Study|inability to use device|1
21805|NCT01613326|96471|P2|Overall Study|Abnormal test procedure result(s)|0
21806|NCT01613326|96472|P1|Overall Study|Abnormal test procedure result(s)|2
21807|NCT01613326|96471|P2|Overall Study|Withdrawal by Subject|4
21808|NCT01613326|96472|P1|Overall Study|Withdrawal by Subject|3
21809|NCT01613326|96471|P2|Overall Study|Adverse Event|5
21810|NCT01613326|96472|P1|Overall Study|Adverse Event|7
21811|NCT01613248|96529|P6|Overall Study|Pregnancy|0
21812|NCT01613248|96530|P5|Overall Study|Pregnancy|0
21813|NCT01613248|96531|P4|Overall Study|Pregnancy|1
21814|NCT01613248|96532|P3|Overall Study|Pregnancy|0
21815|NCT01613248|96533|P2|Overall Study|Pregnancy|0
21816|NCT01613248|96534|P1|Overall Study|Pregnancy|0
21817|NCT01613248|96529|P6|Overall Study|Lack of Qualifying Event|18
21818|NCT01613248|96530|P5|Overall Study|Lack of Qualifying Event|15
21819|NCT01613248|96531|P4|Overall Study|Lack of Qualifying Event|11
21820|NCT01613248|96532|P3|Overall Study|Lack of Qualifying Event|10
21821|NCT01613248|96533|P2|Overall Study|Lack of Qualifying Event|11
21822|NCT01613248|96534|P1|Overall Study|Lack of Qualifying Event|9
21823|NCT01613248|96529|P6|Overall Study|Physician Decision|6
21824|NCT01613248|96530|P5|Overall Study|Physician Decision|7
21825|NCT01613248|96531|P4|Overall Study|Physician Decision|4
21826|NCT01613248|96532|P3|Overall Study|Physician Decision|9
21827|NCT01613248|96533|P2|Overall Study|Physician Decision|8
21828|NCT01613248|96534|P1|Overall Study|Physician Decision|8
21829|NCT01613248|96529|P6|Overall Study|Study Terminated by Sponsor|11
21830|NCT01613248|96530|P5|Overall Study|Study Terminated by Sponsor|9
21831|NCT01613248|96531|P4|Overall Study|Study Terminated by Sponsor|8
21832|NCT01613248|96532|P3|Overall Study|Study Terminated by Sponsor|8
21833|NCT01613248|96533|P2|Overall Study|Study Terminated by Sponsor|6
21834|NCT01613248|96534|P1|Overall Study|Study Terminated by Sponsor|4
21835|NCT01613248|96529|P6|Overall Study|Lost to Follow-up|2
21836|NCT01613248|96530|P5|Overall Study|Lost to Follow-up|4
21837|NCT01613248|96531|P4|Overall Study|Lost to Follow-up|8
21838|NCT01613248|96532|P3|Overall Study|Lost to Follow-up|4
21839|NCT01613248|96533|P2|Overall Study|Lost to Follow-up|7
21840|NCT01613248|96534|P1|Overall Study|Lost to Follow-up|5
21841|NCT01613248|96529|P6|Overall Study|Withdrawal by Subject|1
21842|NCT01613248|96530|P5|Overall Study|Withdrawal by Subject|0
21843|NCT01613248|96531|P4|Overall Study|Withdrawal by Subject|5
21844|NCT01613248|96532|P3|Overall Study|Withdrawal by Subject|2
21845|NCT01613248|96533|P2|Overall Study|Withdrawal by Subject|2
21846|NCT01613248|96534|P1|Overall Study|Withdrawal by Subject|3
21847|NCT01613248|96529|P6|Overall Study|Adverse Event|0
21848|NCT01613248|96530|P5|Overall Study|Adverse Event|0
21849|NCT01613248|96531|P4|Overall Study|Adverse Event|1
21850|NCT01613248|96532|P3|Overall Study|Adverse Event|0
21851|NCT01613248|96533|P2|Overall Study|Adverse Event|0
21852|NCT01613248|96534|P1|Overall Study|Adverse Event|0
21853|NCT01613131|96634|P2|Overall Study|Withdrawal by Subject|5
21854|NCT01613131|96635|P1|Overall Study|Withdrawal by Subject|3
21855|NCT01613027|96663|P1|Overall Study|Patient’s Decision Due to Adverse Event|1
21856|NCT01613027|96663|P1|Overall Study|Lack of Efficacy|1
21857|NCT01613027|96663|P1|Overall Study|Switched Physician|1
21858|NCT01613027|96663|P1|Overall Study|Lost to Follow-up|5
21859|NCT01612858|96684|P2|Overall Study|Withdrawal by Subject|1
21860|NCT01612858|96685|P1|Overall Study|Withdrawal by Subject|5
21861|NCT01612702|96695|P2|Overall Study|Protocol Violation|11
21862|NCT01612702|96696|P1|Overall Study|Protocol Violation|11
21863|NCT01612676|96710|P4|Overall Study|Protocol Violation|0
21864|NCT01612676|96711|P3|Overall Study|Protocol Violation|0
21865|NCT01612676|96712|P2|Overall Study|Protocol Violation|1
21866|NCT01612676|96713|P1|Overall Study|Protocol Violation|0
21867|NCT01612676|96710|P4|Overall Study|Adverse Event|3
21868|NCT01612676|96711|P3|Overall Study|Adverse Event|1
21869|NCT01612676|96712|P2|Overall Study|Adverse Event|3
21870|NCT01612676|96713|P1|Overall Study|Adverse Event|2
21871|NCT01612156|96780|P2|Overall Study|Protocol Violation|0
21872|NCT01612156|96781|P1|Overall Study|Protocol Violation|2
21873|NCT01612000|96793|P4|Overall Study|Withdrawal by Subject|2
21874|NCT01612000|96794|P3|Overall Study|Withdrawal by Subject|2
21875|NCT01612000|96795|P2|Overall Study|Withdrawal by Subject|1
21876|NCT01612000|96796|P1|Overall Study|Withdrawal by Subject|3
21877|NCT01612000|96793|P4|Overall Study|Physician Decision|0
21878|NCT01612000|96794|P3|Overall Study|Physician Decision|1
21879|NCT01612000|96795|P2|Overall Study|Physician Decision|0
21880|NCT01612000|96796|P1|Overall Study|Physician Decision|0
21881|NCT01612000|96793|P4|Overall Study|Lost to Follow-up|8
21882|NCT01612000|96794|P3|Overall Study|Lost to Follow-up|4
21883|NCT01612000|96795|P2|Overall Study|Lost to Follow-up|4
21884|NCT01612000|96796|P1|Overall Study|Lost to Follow-up|6
21885|NCT01611974|96821|P3|Overall Study|Withdrawal by Subject|4
21886|NCT01611974|96822|P2|Overall Study|Withdrawal by Subject|1
21887|NCT01611974|96823|P1|Overall Study|Withdrawal by Subject|0
21888|NCT01611974|96821|P3|Overall Study|Physician Decision|2
21889|NCT01611974|96822|P2|Overall Study|Physician Decision|1
21890|NCT01611974|96823|P1|Overall Study|Physician Decision|5
21891|NCT01611974|96821|P3|Overall Study|Lost to Follow-up|0
21892|NCT01611974|96822|P2|Overall Study|Lost to Follow-up|1
21893|NCT01611974|96823|P1|Overall Study|Lost to Follow-up|0
21894|NCT01611974|96821|P3|Overall Study|Death|10
21895|NCT01611974|96822|P2|Overall Study|Death|12
21896|NCT01611974|96823|P1|Overall Study|Death|10
21897|NCT01611883|96860|P2|Overall Study|Adverse Event|1
21898|NCT01611883|96861|P1|Overall Study|Adverse Event|1
21899|NCT01611857|96887|P2|Overall Study|Withdrawal by Subject|2
21900|NCT01611857|96888|P1|Overall Study|Withdrawal by Subject|0
21901|NCT01611558|96932|P1|Maintenance Phase|Study drug toxicity|1
21902|NCT01611558|96932|P1|Maintenance Phase|Withdrawal by Subject|1
21903|NCT01611558|96932|P1|Induction Phase|Death|1
21904|NCT01611558|96932|P1|Induction Phase|Adverse event unrelated to study drug|1
21905|NCT01611558|96932|P1|Induction Phase|Not reported|5
21906|NCT01611558|96932|P1|Induction Phase|Disease progression|14
21907|NCT01611558|96932|P1|Induction Phase|Study drug toxicity|17
21908|NCT01610791|96938|P1|Overall Study|Not determined|5
21909|NCT01610791|96938|P1|Overall Study|Death|1
21910|NCT01610791|96938|P1|Overall Study|Adverse event and Investigator decision|1
21911|NCT01610791|96938|P1|Overall Study|Physician Decision|1
21912|NCT01610791|96938|P1|Overall Study|Adverse Event|6
21913|NCT01610791|96938|P1|Overall Study|Lost to Follow-up|7
21914|NCT01610713|96961|P2|Overall Study|Lost to Follow-up|1
21915|NCT01610713|96962|P1|Overall Study|Lost to Follow-up|0
21916|NCT01610713|96961|P2|Overall Study|adv. to use original dose/amitriptyline|0
21917|NCT01610713|96962|P1|Overall Study|adv. to use original dose/amitriptyline|1
21918|NCT01610713|96961|P2|Overall Study|low mood and poor motivation|0
21919|NCT01610713|96962|P1|Overall Study|low mood and poor motivation|1
21920|NCT01610713|96961|P2|Overall Study|Lack of Efficacy|0
21921|NCT01610713|96962|P1|Overall Study|Lack of Efficacy|1
21922|NCT01610713|96961|P2|Overall Study|Adverse Event|0
21923|NCT01610713|96962|P1|Overall Study|Adverse Event|3
21924|NCT01610700|97020|P2|Overall Study|subject took one dose of street cannabis|1
21925|NCT01610700|97021|P1|Overall Study|subject took one dose of street cannabis|0
21926|NCT01610700|97020|P2|Overall Study|Withdrawal by Subject|1
21927|NCT01610700|97021|P1|Overall Study|Withdrawal by Subject|0
21928|NCT01610700|97020|P2|Overall Study|Adverse Event|1
21929|NCT01610700|97021|P1|Overall Study|Adverse Event|3
21930|NCT01610687|97075|P1|Overall Study|Felt more alter without study medication|1
21931|NCT01610687|97075|P1|Overall Study|Cannabis affecting job|1
21932|NCT01610687|97075|P1|Overall Study|Death|1
21933|NCT01610687|97075|P1|Overall Study|Unable to make journey|1
21934|NCT01610687|97075|P1|Overall Study|Symptom control without study medication|2
21935|NCT01610687|97075|P1|Overall Study|Lost to Follow-up|4
21936|NCT01610687|97075|P1|Overall Study|Withdrawal by Subject|7
21937|NCT01610687|97075|P1|Overall Study|Moved out of area|6
21938|NCT01610687|97075|P1|Overall Study|Adverse Event|18
21939|NCT01610687|97075|P1|Overall Study|Lack of Efficacy|26
21940|NCT01610596|97088|P2|Overall Study|Lost to Follow-up|1
21941|NCT01610596|97089|P1|Overall Study|Lost to Follow-up|0
21942|NCT01610557|97126|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
21943|NCT01610557|97127|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
21944|NCT01610557|97128|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
21945|NCT01610557|97129|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
21946|NCT01610557|97130|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
21947|NCT01610557|97126|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
21948|NCT01610557|97127|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
21949|NCT01610557|97128|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
21950|NCT01610557|97129|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
21951|NCT01610557|97130|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
21952|NCT01610492|97143|P1|Overall Study|Physician Decision|1
21953|NCT01610492|97143|P1|Overall Study|Lack of Efficacy|2
21954|NCT01610297|97155|P1|Overall Study|Lost to Follow-up|1
21955|NCT01610167|97166|P3|Overall Study|Scheduling conflict.|2
21956|NCT01610167|97167|P2|Overall Study|Scheduling conflict.|0
21957|NCT01610167|97168|P1|Overall Study|Scheduling conflict.|0
21958|NCT01610076|97190|P2|Overall Study|Lost to Follow-up|4
21959|NCT01610076|97191|P1|Overall Study|Lost to Follow-up|3
21960|NCT01610076|97190|P2|Overall Study|Technical issue with video|1
21961|NCT01610076|97191|P1|Overall Study|Technical issue with video|0
21962|NCT01610037|97203|P3|Treatment and Follow up Period|Lost to Follow-up|4
21963|NCT01610037|97204|P2|Treatment and Follow up Period|Lost to Follow-up|6
21964|NCT01610037|97205|P1|Treatment and Follow up Period|Lost to Follow-up|1
21965|NCT01610037|97203|P3|Treatment and Follow up Period|Administrative problems|2
21966|NCT01610037|97204|P2|Treatment and Follow up Period|Administrative problems|3
21967|NCT01610037|97205|P1|Treatment and Follow up Period|Administrative problems|1
21968|NCT01610037|97203|P3|Treatment and Follow up Period|Death|4
21969|NCT01610037|97204|P2|Treatment and Follow up Period|Death|5
21970|NCT01610037|97205|P1|Treatment and Follow up Period|Death|10
21971|NCT01610037|97203|P3|Treatment and Follow up Period|Subject withdrew consent|16
21972|NCT01610037|97204|P2|Treatment and Follow up Period|Subject withdrew consent|14
21973|NCT01610037|97205|P1|Treatment and Follow up Period|Subject withdrew consent|13
21974|NCT01610037|97203|P3|All Patients|Abnormal test procedure result(s)|3
21975|NCT01610037|97204|P2|All Patients|Abnormal test procedure result(s)|1
21976|NCT01610037|97205|P1|All Patients|Abnormal test procedure result(s)|0
21977|NCT01610037|97203|P3|All Patients|Lost to Follow-up|0
21978|NCT01610037|97204|P2|All Patients|Lost to Follow-up|0
21979|NCT01610037|97205|P1|All Patients|Lost to Follow-up|1
21980|NCT01610037|97203|P3|All Patients|Administrative problems|4
21981|NCT01610037|97204|P2|All Patients|Administrative problems|4
21982|NCT01610037|97205|P1|All Patients|Administrative problems|1
21983|NCT01610037|97203|P3|All Patients|Abnormal laboratory value|0
21984|NCT01610037|97204|P2|All Patients|Abnormal laboratory value|1
21985|NCT01610037|97205|P1|All Patients|Abnormal laboratory value|1
21986|NCT01610037|97203|P3|All Patients|Protocol deviation|3
21987|NCT01610037|97204|P2|All Patients|Protocol deviation|3
21988|NCT01610037|97205|P1|All Patients|Protocol deviation|4
21989|NCT01610037|97203|P3|All Patients|Death|1
21990|NCT01610037|97204|P2|All Patients|Death|2
21991|NCT01610037|97205|P1|All Patients|Death|4
21992|NCT01610037|97203|P3|All Patients|Unsatisfactory therapeutic effect|27
21993|NCT01610037|97204|P2|All Patients|Unsatisfactory therapeutic effect|8
21994|NCT01610037|97205|P1|All Patients|Unsatisfactory therapeutic effect|9
21995|NCT01610037|97203|P3|All Patients|Withdrawal by Subject|20
21996|NCT01610037|97204|P2|All Patients|Withdrawal by Subject|10
21997|NCT01610037|97205|P1|All Patients|Withdrawal by Subject|12
21998|NCT01610037|97203|P3|All Patients|Adverse Event|26
21999|NCT01610037|97204|P2|All Patients|Adverse Event|22
22000|NCT01610037|97205|P1|All Patients|Adverse Event|27
22001|NCT01609582|97257|P2|Overall Study|Randomized, but not treated|3
22002|NCT01609582|97258|P1|Overall Study|Randomized, but not treated|0
22003|NCT01609582|97257|P2|Overall Study|Other|10
22004|NCT01609582|97258|P1|Overall Study|Other|9
22005|NCT01609582|97257|P2|Overall Study|Study Terminated by Sponsor|1548
22006|NCT01609582|97258|P1|Overall Study|Study Terminated by Sponsor|1543
22007|NCT01609582|97257|P2|Overall Study|Withdrawal by Subject|15
22008|NCT01609582|97258|P1|Overall Study|Withdrawal by Subject|21
22009|NCT01609582|97257|P2|Overall Study|Lost to Follow-up|10
22010|NCT01609582|97258|P1|Overall Study|Lost to Follow-up|10
22011|NCT01609582|97257|P2|Overall Study|Adverse Event|18
22012|NCT01609582|97258|P1|Overall Study|Adverse Event|20
22013|NCT01609543|97266|P1|Overall Study|Death|7
22014|NCT01609543|97266|P1|Overall Study|Protocol Violation|1
22015|NCT01609543|97266|P1|Overall Study|Withdrawal by Subject|1
22016|NCT01609543|97266|P1|Overall Study|Adverse Event|5
22017|NCT01609543|97266|P1|Overall Study|Disease Progression|28
22018|NCT01609478|97275|P3|Overall Study|Withdrawal by Subject|2
22019|NCT01609478|97276|P2|Overall Study|Withdrawal by Subject|0
22020|NCT01609478|97277|P1|Overall Study|Withdrawal by Subject|2
22021|NCT01609478|97275|P3|Overall Study|Physician Decision|1
22022|NCT01609478|97276|P2|Overall Study|Physician Decision|0
22023|NCT01609478|97277|P1|Overall Study|Physician Decision|1
22024|NCT01609478|97275|P3|Overall Study|Non-Compliance with study treatment|0
22025|NCT01609478|97276|P2|Overall Study|Non-Compliance with study treatment|0
22026|NCT01609478|97277|P1|Overall Study|Non-Compliance with study treatment|1
22027|NCT01609478|97275|P3|Overall Study|Protocol Deviation|1
22028|NCT01609478|97276|P2|Overall Study|Protocol Deviation|1
22029|NCT01609478|97277|P1|Overall Study|Protocol Deviation|0
22030|NCT01609478|97275|P3|Overall Study|Adverse Event|5
22031|NCT01609478|97276|P2|Overall Study|Adverse Event|1
22032|NCT01609478|97277|P1|Overall Study|Adverse Event|3
22033|NCT01609257|97343|P2|Overall Study|Non-compliance/Protocol deviation|6
22034|NCT01609257|97344|P1|Overall Study|Non-compliance/Protocol deviation|4
22035|NCT01609257|97343|P2|Overall Study|Voluntary Withdrawal by Subject|1
22036|NCT01609257|97344|P1|Overall Study|Voluntary Withdrawal by Subject|0
22037|NCT01609257|97343|P2|Overall Study|Lost to Follow-up|1
22038|NCT01609257|97344|P1|Overall Study|Lost to Follow-up|2
22039|NCT01609062|97416|P2|Extension Phase|Anticipated surgery & transition to EAP|1
22040|NCT01609062|97417|P1|Extension Phase|Anticipated surgery & transition to EAP|0
22041|NCT01609062|97416|P2|Extension Phase|Discontinued drug and then was pregnant|0
22042|NCT01609062|97417|P1|Extension Phase|Discontinued drug and then was pregnant|1
22043|NCT01609062|97416|P2|Extension Phase|Terminated by Sponsor|9
22044|NCT01609062|97417|P1|Extension Phase|Terminated by Sponsor|14
22045|NCT01609010|97462|P2|Overall Study|Lost to Follow-up|1
22046|NCT01609010|97463|P1|Overall Study|Lost to Follow-up|1
22047|NCT01609010|97462|P2|Overall Study|New cancer|0
22048|NCT01609010|97463|P1|Overall Study|New cancer|1
22049|NCT01609010|97462|P2|Overall Study|Protocol Violation|1
22050|NCT01609010|97463|P1|Overall Study|Protocol Violation|1
22051|NCT01609010|97462|P2|Overall Study|Pathology review|1
22052|NCT01609010|97463|P1|Overall Study|Pathology review|2
22053|NCT01609010|97462|P2|Overall Study|Other malignancy|0
22054|NCT01609010|97463|P1|Overall Study|Other malignancy|1
22055|NCT01609010|97462|P2|Overall Study|Not specified|0
22056|NCT01609010|97463|P1|Overall Study|Not specified|2
22057|NCT01609010|97462|P2|Overall Study|Withdrawal by Subject|2
22058|NCT01609010|97463|P1|Overall Study|Withdrawal by Subject|2
22059|NCT01609010|97462|P2|Overall Study|Adverse Event|6
22060|NCT01609010|97463|P1|Overall Study|Adverse Event|3
22061|NCT01609010|97462|P2|Overall Study|Progressive disease (PD)|10
22062|NCT01609010|97463|P1|Overall Study|Progressive disease (PD)|8
22063|NCT01609010|97462|P2|Overall Study|Stable disease (SD)|16
22064|NCT01609010|97463|P1|Overall Study|Stable disease (SD)|22
22065|NCT01608724|97524|P1|Overall Study|Safety reasons|1
22066|NCT01608724|97524|P1|Overall Study|bood sugar too high, etc.|3
22067|NCT01608724|97524|P1|Overall Study|Protocol Violation|6
22068|NCT01608724|97524|P1|Overall Study|Adverse Event|29
22069|NCT01608724|97524|P1|Overall Study|Study-specific discontinuation criteria|32
22070|NCT01608724|97524|P1|Overall Study|Lost to Follow-up|41
22071|NCT01608724|97524|P1|Overall Study|Withdrawal by Subject|131
22072|NCT01608308|97545|P2|Overall Study|pretreatment medical and billing reasons|2
22073|NCT01608308|97546|P1|Overall Study|pretreatment medical and billing reasons|0
22074|NCT01607593|97699|P1|Overall Study|Unspecified|4
22075|NCT01607593|97699|P1|Overall Study|Continuation|33
22076|NCT01607593|97699|P1|Overall Study|Lost to Follow-up|25
22077|NCT01607593|97699|P1|Overall Study|Lack of Efficacy|16
22078|NCT01607593|97699|P1|Overall Study|Adverse Event|15
22079|NCT01607476|97708|P3|Overall Study|Lost to Follow-up|2
22080|NCT01607476|97709|P2|Overall Study|Lost to Follow-up|0
22081|NCT01607476|97710|P1|Overall Study|Lost to Follow-up|0
22082|NCT01607476|97708|P3|Overall Study|Withdrawal by Subject|1
22083|NCT01607476|97709|P2|Overall Study|Withdrawal by Subject|0
22084|NCT01607476|97710|P1|Overall Study|Withdrawal by Subject|1
22085|NCT01607398|97804|P2|Overall Study|Severe COPD|0
22086|NCT01607398|97805|P1|Overall Study|Severe COPD|2
22087|NCT01607398|97804|P2|Overall Study|Adverse Event|2
22088|NCT01607398|97805|P1|Overall Study|Adverse Event|0
22089|NCT01606800|97906|P2|Overall Study|Missing completion status|0
22090|NCT01606800|97907|P1|Overall Study|Missing completion status|2
22091|NCT01606800|97906|P2|Overall Study|Participant withdrew consent|1
22092|NCT01606800|97907|P1|Overall Study|Participant withdrew consent|0
22093|NCT01606800|97906|P2|Overall Study|Adverse Event|1
22094|NCT01606800|97907|P1|Overall Study|Adverse Event|3
22095|NCT01606748|97915|P2|Overall Study|On study treatment|11
22096|NCT01606748|97916|P1|Overall Study|On study treatment|2
22097|NCT01606748|97915|P2|Overall Study|Withdrawal by Subject|0
22098|NCT01606748|97916|P1|Overall Study|Withdrawal by Subject|1
22099|NCT01606748|97915|P2|Overall Study|Progressive Disease|0
22100|NCT01606748|97916|P1|Overall Study|Progressive Disease|1
22101|NCT01606748|97915|P2|Overall Study|Adverse Event|0
22102|NCT01606748|97916|P1|Overall Study|Adverse Event|1
22103|NCT01606670|97957|P1|Overall Study|Other Reason|2
22104|NCT01606670|97957|P1|Overall Study|Withdrawal by Subject|3
22105|NCT01606670|97957|P1|Overall Study|Lost to Follow-up|3
22106|NCT01606670|97957|P1|Overall Study|Lack of Efficacy|2
22107|NCT01606670|97957|P1|Overall Study|Adverse Event|6
22108|NCT01606319|97967|P2|Overall Study|Adverse Event|4
22109|NCT01606319|97968|P1|Overall Study|Adverse Event|1
22110|NCT01606319|97967|P2|Overall Study|Lack of Efficacy|8
22111|NCT01606319|97968|P1|Overall Study|Lack of Efficacy|6
22112|NCT01606319|97967|P2|Overall Study|Physician Decision|2
22113|NCT01606319|97968|P1|Overall Study|Physician Decision|1
22114|NCT01606319|97967|P2|Overall Study|Withdrawal by Subject|12
22115|NCT01606319|97968|P1|Overall Study|Withdrawal by Subject|9
22116|NCT01606319|97967|P2|Overall Study|Lost to Follow-up|14
22117|NCT01606319|97968|P1|Overall Study|Lost to Follow-up|17
22118|NCT01606254|97984|P4|Overall Study|Adverse Event|1
22119|NCT01606254|97985|P3|Overall Study|Adverse Event|0
22120|NCT01606254|97986|P2|Overall Study|Adverse Event|1
22121|NCT01606254|97987|P1|Overall Study|Adverse Event|1
22122|NCT01606254|97984|P4|Overall Study|Withdrawal by Subject|2
22123|NCT01606254|97985|P3|Overall Study|Withdrawal by Subject|0
22124|NCT01606254|97986|P2|Overall Study|Withdrawal by Subject|3
22125|NCT01606254|97987|P1|Overall Study|Withdrawal by Subject|1
22126|NCT01606228|98069|P1|Overall Study|Adverse Event|1
22127|NCT01606228|98069|P1|Overall Study|Lack of Efficacy|2
22128|NCT01606228|98069|P1|Overall Study|Non-compliant|3
22129|NCT01606228|98069|P1|Overall Study|Withdrawal by Subject|3
22130|NCT01606228|98069|P1|Overall Study|Lost to Follow-up|20
22131|NCT01606202|98086|P2|Overall Study|Problems with administration|1
22132|NCT01606202|98087|P1|Overall Study|Problems with administration|0
22133|NCT01606202|98086|P2|Overall Study|Personal problems|1
22134|NCT01606202|98087|P1|Overall Study|Personal problems|0
22135|NCT01606202|98086|P2|Overall Study|Withdrawal by Subject|1
22136|NCT01606202|98087|P1|Overall Study|Withdrawal by Subject|2
22137|NCT01606202|98086|P2|Overall Study|Adverse Event|0
22138|NCT01606202|98087|P1|Overall Study|Adverse Event|5
22139|NCT01606189|98119|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
22140|NCT01606189|98120|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
22141|NCT01606189|98121|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
22142|NCT01606189|98122|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
22143|NCT01606189|98123|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
22144|NCT01606189|98124|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
22145|NCT01606189|98119|P6|Second Intenvention (14-20 Days)|Adverse Event|1
22146|NCT01606189|98120|P5|Second Intenvention (14-20 Days)|Adverse Event|0
22147|NCT01606189|98121|P4|Second Intenvention (14-20 Days)|Adverse Event|0
22148|NCT01606189|98122|P3|Second Intenvention (14-20 Days)|Adverse Event|0
22149|NCT01606189|98123|P2|Second Intenvention (14-20 Days)|Adverse Event|0
22150|NCT01606189|98124|P1|Second Intenvention (14-20 Days)|Adverse Event|0
22151|NCT01606176|98158|P2|Overall Study|Withdrawal by Subject|0
22152|NCT01606176|98159|P1|Overall Study|Withdrawal by Subject|1
22153|NCT01606176|98158|P2|Overall Study|Disease progression|0
22154|NCT01606176|98159|P1|Overall Study|Disease progression|1
22155|NCT01606176|98158|P2|Overall Study|Adverse Event|3
22156|NCT01606176|98159|P1|Overall Study|Adverse Event|2
22157|NCT01606137|98204|P1|Overall Study|Unable to collect consistent data|1
22158|NCT01606137|98204|P1|Overall Study|Patient moving|1
22159|NCT01606137|98204|P1|Overall Study|Unable to tolerate study med. taste|1
22160|NCT01606137|98204|P1|Overall Study|Personal reasons|1
22161|NCT01606137|98204|P1|Overall Study|Patient leaving country|1
22162|NCT01606137|98204|P1|Overall Study|Wanted to try another treatment|1
22163|NCT01606137|98204|P1|Overall Study|Not enough improvement|4
22164|NCT01606137|98204|P1|Overall Study|Spray causes nausea|1
22165|NCT01606137|98204|P1|Overall Study|Increased bilirubin|1
22166|NCT01606137|98204|P1|Overall Study|multiple sclerosis less stable|1
22167|NCT01606137|98204|P1|Overall Study|Issues with driving|4
22168|NCT01606137|98204|P1|Overall Study|Decreased/no pain|4
22169|NCT01606137|98204|P1|Overall Study|Death|1
22170|NCT01606137|98204|P1|Overall Study|Patient non-compliance|9
22171|NCT01606137|98204|P1|Overall Study|Protocol Violation|1
22172|NCT01606137|98204|P1|Overall Study|Lost to Follow-up|15
22173|NCT01606137|98204|P1|Overall Study|Lack of Efficacy|56
22174|NCT01606137|98204|P1|Overall Study|Withdrawal by Subject|74
22175|NCT01606137|98204|P1|Overall Study|Adverse Event|85
22176|NCT01606007|98227|P3|Overall Study|Poor/Non-compliance|0
22177|NCT01606007|98228|P2|Overall Study|Poor/Non-compliance|0
22178|NCT01606007|98229|P1|Overall Study|Poor/Non-compliance|1
22179|NCT01606007|98227|P3|Overall Study|Lost to Follow-up|5
22180|NCT01606007|98228|P2|Overall Study|Lost to Follow-up|8
22181|NCT01606007|98229|P1|Overall Study|Lost to Follow-up|6
22182|NCT01606007|98227|P3|Overall Study|discontinue study treatment|1
22183|NCT01606007|98228|P2|Overall Study|discontinue study treatment|2
22184|NCT01606007|98229|P1|Overall Study|discontinue study treatment|0
22185|NCT01606007|98227|P3|Overall Study|Adverse Event|1
22186|NCT01606007|98228|P2|Overall Study|Adverse Event|1
22187|NCT01606007|98229|P1|Overall Study|Adverse Event|0
22188|NCT01606007|98227|P3|Overall Study|Withdrawal by Subject|1
22189|NCT01606007|98228|P2|Overall Study|Withdrawal by Subject|6
22190|NCT01606007|98229|P1|Overall Study|Withdrawal by Subject|8
22191|NCT01606007|98227|P3|Overall Study|Pregnancy|1
22192|NCT01606007|98228|P2|Overall Study|Pregnancy|1
22193|NCT01606007|98229|P1|Overall Study|Pregnancy|0
22194|NCT01606007|98227|P3|Overall Study|Reason 'Other' in the protocol|1
22195|NCT01606007|98228|P2|Overall Study|Reason 'Other' in the protocol|1
22196|NCT01606007|98229|P1|Overall Study|Reason 'Other' in the protocol|0
22197|NCT01605916|98264|P5|Overall Study|Withdrawal by Subject|2
22198|NCT01605916|98265|P4|Overall Study|Withdrawal by Subject|0
22199|NCT01605916|98266|P3|Overall Study|Withdrawal by Subject|0
22200|NCT01605916|98267|P2|Overall Study|Withdrawal by Subject|1
22201|NCT01605916|98268|P1|Overall Study|Withdrawal by Subject|1
22202|NCT01605916|98264|P5|Overall Study|Lack of Efficacy|4
22203|NCT01605916|98265|P4|Overall Study|Lack of Efficacy|5
22204|NCT01605916|98266|P3|Overall Study|Lack of Efficacy|3
22205|NCT01605916|98267|P2|Overall Study|Lack of Efficacy|3
22206|NCT01605916|98268|P1|Overall Study|Lack of Efficacy|2
22207|NCT01605916|98264|P5|Overall Study|Adverse Event|0
22208|NCT01605916|98265|P4|Overall Study|Adverse Event|1
22209|NCT01605916|98266|P3|Overall Study|Adverse Event|0
22210|NCT01605916|98267|P2|Overall Study|Adverse Event|0
22211|NCT01605916|98268|P1|Overall Study|Adverse Event|1
22212|NCT01605877|98341|P1|Overall Study|Withdrawal by Subject|1
22213|NCT01605825|98405|P2|Overall Study|Non-Compliance with Protocol|0
22214|NCT01605825|98406|P1|Overall Study|Non-Compliance with Protocol|3
22215|NCT01605825|98405|P2|Overall Study|Non-Compliance -Investigational Drug|0
22216|NCT01605825|98406|P1|Overall Study|Non-Compliance -Investigational Drug|3
22217|NCT01605825|98405|P2|Overall Study|Withdrawal by Subject|1
22218|NCT01605825|98406|P1|Overall Study|Withdrawal by Subject|0
22219|NCT01605825|98405|P2|Overall Study|Adverse Event|2
22220|NCT01605825|98406|P1|Overall Study|Adverse Event|4
22221|NCT01605799|98414|P2|Overall Study|Withdrawal by Subject|1
22222|NCT01605799|98415|P1|Overall Study|Withdrawal by Subject|2
22223|NCT01605617|98430|P2|Washout Period of 4 Weeks|Study Terminated|1
22224|NCT01605617|98431|P1|Washout Period of 4 Weeks|Study Terminated|2
22225|NCT01605617|98430|P2|First Intervention|Adverse Event|1
22226|NCT01605617|98431|P1|First Intervention|Adverse Event|0
22227|NCT01605461|98490|P1|Overall Study|Withdrawal by Subject|1
22228|NCT01605461|98490|P1|Overall Study|Lost to Follow-up|3
22229|NCT01605370|98501|P2|Overall Study|Adverse Event|0
22230|NCT01605370|98502|P1|Overall Study|Adverse Event|1
22231|NCT01603875|98538|P3|Overall Study|Protocol Violation|0
22232|NCT01603875|98539|P2|Overall Study|Protocol Violation|1
22233|NCT01603875|98540|P1|Overall Study|Protocol Violation|0
22234|NCT01603875|98538|P3|Overall Study|Lost to Follow-up|6
22235|NCT01603875|98539|P2|Overall Study|Lost to Follow-up|3
22236|NCT01603875|98540|P1|Overall Study|Lost to Follow-up|4
22237|NCT01603875|98538|P3|Overall Study|Preexisting rabies antibody|3
22238|NCT01603875|98539|P2|Overall Study|Preexisting rabies antibody|4
22239|NCT01603875|98540|P1|Overall Study|Preexisting rabies antibody|3
22240|NCT01604941|98562|P6|Overall Study|Early Study Termination|0
22241|NCT01604941|98563|P5|Overall Study|Early Study Termination|0
22242|NCT01604941|98564|P4|Overall Study|Early Study Termination|3
22243|NCT01604941|98565|P3|Overall Study|Early Study Termination|3
22244|NCT01604941|98566|P2|Overall Study|Early Study Termination|2
22245|NCT01604941|98567|P1|Overall Study|Early Study Termination|9
22246|NCT01604941|98562|P6|Overall Study|Participant Decision|2
22247|NCT01604941|98563|P5|Overall Study|Participant Decision|0
22248|NCT01604941|98564|P4|Overall Study|Participant Decision|0
22249|NCT01604941|98565|P3|Overall Study|Participant Decision|0
22250|NCT01604941|98566|P2|Overall Study|Participant Decision|0
22251|NCT01604941|98567|P1|Overall Study|Participant Decision|0
22252|NCT01604941|98562|P6|Overall Study|Non-compliance|0
22253|NCT01604941|98563|P5|Overall Study|Non-compliance|0
22254|NCT01604941|98564|P4|Overall Study|Non-compliance|0
22255|NCT01604941|98565|P3|Overall Study|Non-compliance|0
22256|NCT01604941|98566|P2|Overall Study|Non-compliance|0
22257|NCT01604941|98567|P1|Overall Study|Non-compliance|1
22258|NCT01604941|98562|P6|Overall Study|Adverse Event|5
22259|NCT01604941|98563|P5|Overall Study|Adverse Event|1
22260|NCT01604941|98564|P4|Overall Study|Adverse Event|0
22261|NCT01604941|98565|P3|Overall Study|Adverse Event|0
22262|NCT01604941|98566|P2|Overall Study|Adverse Event|2
22263|NCT01604941|98567|P1|Overall Study|Adverse Event|1
22264|NCT01604850|98595|P2|Overall Study|Subject withdrew consent|0
22265|NCT01604850|98596|P1|Overall Study|Subject withdrew consent|1
22266|NCT01604850|98595|P2|Overall Study|Lost to Follow-up|0
22267|NCT01604850|98596|P1|Overall Study|Lost to Follow-up|1
22268|NCT01604850|98595|P2|Overall Study|Efficacy Failure|29
22269|NCT01604850|98596|P1|Overall Study|Efficacy Failure|50
22270|NCT01604850|98595|P2|Overall Study|Enrolled but never treated|1
22271|NCT01604850|98596|P1|Overall Study|Enrolled but never treated|0
22272|NCT01604278|98620|P2|Overall Study|Protocol Deviation|3
22273|NCT01604278|98621|P1|Overall Study|Protocol Deviation|5
22274|NCT01604278|98620|P2|Overall Study|Adverse Event|5
22275|NCT01604278|98621|P1|Overall Study|Adverse Event|3
22276|NCT01604278|98620|P2|Overall Study|Withdrawal by Subject|3
22277|NCT01604278|98621|P1|Overall Study|Withdrawal by Subject|3
22278|NCT01604278|98620|P2|Overall Study|Administrative problems|1
22279|NCT01604278|98621|P1|Overall Study|Administrative problems|2
22280|NCT01604278|98620|P2|Overall Study|Lost to Follow-up|0
22281|NCT01604278|98621|P1|Overall Study|Lost to Follow-up|1
22282|NCT01604278|98620|P2|Overall Study|Lack of Efficacy|1
22283|NCT01604278|98621|P1|Overall Study|Lack of Efficacy|0
22284|NCT01604265|98647|P2|Overall Study|Withdrawal by Subject|0
22285|NCT01604265|98648|P1|Overall Study|Withdrawal by Subject|1
22286|NCT01604265|98647|P2|Overall Study|Adverse Event|0
22287|NCT01604265|98648|P1|Overall Study|Adverse Event|1
22288|NCT01603459|98708|P1|Overall Study|Administrative reason|1
22289|NCT01603459|98708|P1|Overall Study|Non-compliance|1
22290|NCT01603459|98708|P1|Overall Study|Predefined discontinuation criteria|3
22291|NCT01603459|98708|P1|Overall Study|Lost to Follow-up|3
22292|NCT01603459|98708|P1|Overall Study|Withdrawal by Subject|5
22293|NCT01603459|98708|P1|Overall Study|Adverse Event|5
22294|NCT01603394|98859|P1|Overall Study|Adverse Event|1
22295|NCT01603277|98876|P2|Overall Study|Non-Compliance|1
22296|NCT01603277|98877|P1|Overall Study|Non-Compliance|2
22297|NCT01603277|98876|P2|Overall Study|Withdrawal by Subject|4
22298|NCT01603277|98877|P1|Overall Study|Withdrawal by Subject|5
22299|NCT01603277|98876|P2|Overall Study|Protocol Violation|10
22300|NCT01603277|98877|P1|Overall Study|Protocol Violation|6
22301|NCT01603277|98876|P2|Overall Study|Physician Decision|1
22302|NCT01603277|98877|P1|Overall Study|Physician Decision|0
22303|NCT01603277|98876|P2|Overall Study|Adverse Event|2
22304|NCT01603277|98877|P1|Overall Study|Adverse Event|1
22305|NCT01603121|98883|P2|Second Intervention, 10 Hours|Adverse Event|0
22306|NCT01603121|98884|P1|Second Intervention, 10 Hours|Adverse Event|1
22307|NCT01603082|98896|P2|Overall Study|Failed inclusion criterion after dosed|0
22308|NCT01603082|98897|P1|Overall Study|Failed inclusion criterion after dosed|1
22309|NCT01603082|98896|P2|Overall Study|Withdrawal by Subject|0
22310|NCT01603082|98897|P1|Overall Study|Withdrawal by Subject|1
22311|NCT01603082|98896|P2|Overall Study|Adverse Event|1
22312|NCT01603082|98897|P1|Overall Study|Adverse Event|0
22313|NCT01603043|98938|P2|Overall Study|Study Futility|3
22314|NCT01603043|98939|P1|Overall Study|Study Futility|7
22315|NCT01602744|98951|P2|Overall Study|Lost to Follow-up|8
22316|NCT01602744|98952|P1|Overall Study|Lost to Follow-up|13
22317|NCT01602744|98951|P2|Overall Study|Death|15
22318|NCT01602744|98952|P1|Overall Study|Death|17
22319|NCT01602562|98976|P2|Overall Study|Withdrawal by Subject|1
22320|NCT01602562|98977|P1|Overall Study|Withdrawal by Subject|1
22321|NCT01602562|98976|P2|Overall Study|Physician Decision|1
22322|NCT01602562|98977|P1|Overall Study|Physician Decision|1
22323|NCT01602562|98976|P2|Overall Study|Adverse Event|1
22324|NCT01602562|98977|P1|Overall Study|Adverse Event|3
22325|NCT01602549|99013|P2|Overall Study|Withdrawal by Subject|0
22326|NCT01602549|99014|P1|Overall Study|Withdrawal by Subject|1
22327|NCT01602549|99013|P2|Overall Study|Protocol Violation|1
22328|NCT01602549|99014|P1|Overall Study|Protocol Violation|0
22329|NCT01602510|99093|P3|Randomized Phase|Withdrawal by Subject|7
22330|NCT01602510|99094|P2|Randomized Phase|Withdrawal by Subject|6
22331|NCT01602510|99095|P1|Randomized Phase|Withdrawal by Subject|0
22332|NCT01602510|99093|P3|Randomized Phase|Physician Decision|2
22333|NCT01602510|99094|P2|Randomized Phase|Physician Decision|0
22334|NCT01602510|99095|P1|Randomized Phase|Physician Decision|0
22335|NCT01602510|99093|P3|Randomized Phase|Lost to Follow-up|3
22336|NCT01602510|99094|P2|Randomized Phase|Lost to Follow-up|1
22337|NCT01602510|99095|P1|Randomized Phase|Lost to Follow-up|0
22338|NCT01602510|99093|P3|Randomized Phase|Met protocol-defined stopping criteria|48
22339|NCT01602510|99094|P2|Randomized Phase|Met protocol-defined stopping criteria|58
22340|NCT01602510|99095|P1|Randomized Phase|Met protocol-defined stopping criteria|0
22341|NCT01602510|99093|P3|Randomized Phase|Protocol Violation|3
22342|NCT01602510|99094|P2|Randomized Phase|Protocol Violation|3
22343|NCT01602510|99095|P1|Randomized Phase|Protocol Violation|0
22344|NCT01602510|99093|P3|Randomized Phase|Lack of Efficacy|4
22345|NCT01602510|99094|P2|Randomized Phase|Lack of Efficacy|4
22346|NCT01602510|99095|P1|Randomized Phase|Lack of Efficacy|0
22347|NCT01602510|99093|P3|Randomized Phase|Adverse Event|6
22348|NCT01602510|99094|P2|Randomized Phase|Adverse Event|2
22349|NCT01602510|99095|P1|Randomized Phase|Adverse Event|0
22350|NCT01602510|99093|P3|Open Label Phase|Withdrawal by Subject|0
22351|NCT01602510|99094|P2|Open Label Phase|Withdrawal by Subject|0
22352|NCT01602510|99095|P1|Open Label Phase|Withdrawal by Subject|57
22353|NCT01602510|99093|P3|Open Label Phase|Physician Decision|0
22354|NCT01602510|99094|P2|Open Label Phase|Physician Decision|0
22355|NCT01602510|99095|P1|Open Label Phase|Physician Decision|19
22356|NCT01602510|99093|P3|Open Label Phase|Lost to Follow-up|0
22357|NCT01602510|99094|P2|Open Label Phase|Lost to Follow-up|0
22358|NCT01602510|99095|P1|Open Label Phase|Lost to Follow-up|22
22359|NCT01602510|99093|P3|Open Label Phase|Met protocol-defined stopping criteria|0
22360|NCT01602510|99094|P2|Open Label Phase|Met protocol-defined stopping criteria|0
22361|NCT01602510|99095|P1|Open Label Phase|Met protocol-defined stopping criteria|122
22362|NCT01602510|99093|P3|Open Label Phase|Protocol Violation|0
22363|NCT01602510|99094|P2|Open Label Phase|Protocol Violation|0
22364|NCT01602510|99095|P1|Open Label Phase|Protocol Violation|15
22365|NCT01602510|99093|P3|Open Label Phase|Lack of Efficacy|0
22366|NCT01602510|99094|P2|Open Label Phase|Lack of Efficacy|0
22367|NCT01602510|99095|P1|Open Label Phase|Lack of Efficacy|22
22368|NCT01602510|99093|P3|Open Label Phase|Adverse Event|0
22369|NCT01602510|99094|P2|Open Label Phase|Adverse Event|0
22370|NCT01602510|99095|P1|Open Label Phase|Adverse Event|46
22371|NCT01601821|99147|P2|Overall Study|Unspecified|1
22372|NCT01601821|99148|P1|Overall Study|Unspecified|5
22373|NCT01601821|99147|P2|Overall Study|Study Events|1
22374|NCT01601821|99148|P1|Overall Study|Study Events|7
22375|NCT01601821|99147|P2|Overall Study|Graft Loss|6
22376|NCT01601821|99148|P1|Overall Study|Graft Loss|6
22377|NCT01601821|99147|P2|Overall Study|Withdrawal by Subject|0
22378|NCT01601821|99148|P1|Overall Study|Withdrawal by Subject|1
22379|NCT01601821|99147|P2|Overall Study|Lost to Follow-up|14
22380|NCT01601821|99148|P1|Overall Study|Lost to Follow-up|6
22381|NCT01601821|99147|P2|Overall Study|Protocol Violation|2
22382|NCT01601821|99148|P1|Overall Study|Protocol Violation|2
22383|NCT01601821|99147|P2|Overall Study|Death|5
22384|NCT01601821|99148|P1|Overall Study|Death|2
22385|NCT01601470|99186|P1|Period 2 - LCZ696|Physician Decision|1
22386|NCT01601132|99201|P1|Overall Study|Protocol deviation|1
22387|NCT01601132|99201|P1|Overall Study|Patient withdrew consent|1
22388|NCT01600885|99235|P2|First Period|moved out of area|0
22389|NCT01600885|99236|P1|First Period|moved out of area|1
22390|NCT01600885|99235|P2|First Period|Adverse Event|1
22391|NCT01600885|99236|P1|First Period|Adverse Event|1
22392|NCT01600716|99253|P2|Overall Study|Adverse Event|1
22393|NCT01600716|99254|P1|Overall Study|Adverse Event|1
22394|NCT01600716|99253|P2|Overall Study|Lack of Efficacy|1
22395|NCT01600716|99254|P1|Overall Study|Lack of Efficacy|2
22396|NCT01600716|99253|P2|Overall Study|Pregnancy|0
22397|NCT01600716|99254|P1|Overall Study|Pregnancy|1
22398|NCT01600716|99253|P2|Overall Study|Lost to Follow-up|2
22399|NCT01600716|99254|P1|Overall Study|Lost to Follow-up|0
22400|NCT01600716|99253|P2|Overall Study|Personal Reasons|2
22401|NCT01600716|99254|P1|Overall Study|Personal Reasons|0
22402|NCT01600716|99253|P2|Overall Study|Other Reasons|1
22403|NCT01600716|99254|P1|Overall Study|Other Reasons|3
22404|NCT01599104|99376|P3|Overall Study|Adverse Event|12
22405|NCT01599104|99377|P2|Overall Study|Adverse Event|6
22406|NCT01599104|99378|P1|Overall Study|Adverse Event|7
22407|NCT01599104|99376|P3|Overall Study|Lack of Efficacy|10
22408|NCT01599104|99377|P2|Overall Study|Lack of Efficacy|4
22409|NCT01599104|99378|P1|Overall Study|Lack of Efficacy|4
22410|NCT01599104|99376|P3|Overall Study|Non-compliance with study treatment|0
22411|NCT01599104|99377|P2|Overall Study|Non-compliance with study treatment|1
22412|NCT01599104|99378|P1|Overall Study|Non-compliance with study treatment|0
22413|NCT01599104|99376|P3|Overall Study|Physician Decision|2
22414|NCT01599104|99377|P2|Overall Study|Physician Decision|2
22415|NCT01599104|99378|P1|Overall Study|Physician Decision|3
22416|NCT01599104|99376|P3|Overall Study|Technical Problems|0
22417|NCT01599104|99377|P2|Overall Study|Technical Problems|0
22418|NCT01599104|99378|P1|Overall Study|Technical Problems|1
22419|NCT01599104|99376|P3|Overall Study|Withdrawal by Subject|2
22420|NCT01599104|99377|P2|Overall Study|Withdrawal by Subject|1
22421|NCT01599104|99378|P1|Overall Study|Withdrawal by Subject|1
22422|NCT01598987|99416|P1|Period up to 24 Month|Lost to Follow-up|1
22423|NCT01598987|99416|P1|Period up to 24 Month|Administrative problems|2
22424|NCT01598987|99416|P1|Period up to 24 Month|Withdrawal by Subject|5
22425|NCT01598987|99416|P1|Period up to Month 12|Withdrawal by Subject|4
22426|NCT01598987|99416|P1|Period up to Month 12|Administrative problems|2
22427|NCT01600092|99452|P2|Overall Study|Randomized but not vaccinated|3
22428|NCT01600092|99453|P1|Overall Study|Randomized but not vaccinated|3
22429|NCT01600092|99452|P2|Overall Study|Physician Decision|1
22430|NCT01600092|99453|P1|Overall Study|Physician Decision|1
22431|NCT01600092|99452|P2|Overall Study|Withdrawal by parent/guardian|6
22432|NCT01600092|99453|P1|Overall Study|Withdrawal by parent/guardian|8
22433|NCT01600092|99452|P2|Overall Study|Lost to Follow-up|6
22434|NCT01600092|99453|P1|Overall Study|Lost to Follow-up|4
22435|NCT01600092|99452|P2|Overall Study|Adverse Event|0
22436|NCT01600092|99453|P1|Overall Study|Adverse Event|2
22437|NCT01600053|99467|P1|Overall Study|trial will not meet the interim endpoint|9
22438|NCT01600053|99467|P1|Overall Study|Adverse Event|2
22439|NCT01600014|99472|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
22440|NCT01600014|99473|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
22441|NCT01600014|99472|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
22442|NCT01600014|99473|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
22443|NCT01600014|99472|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
22444|NCT01600014|99473|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
22445|NCT01600014|99472|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
22446|NCT01600014|99473|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
22447|NCT01600014|99472|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
22448|NCT01600014|99473|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
22449|NCT01600014|99472|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
22450|NCT01600014|99473|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
22451|NCT01600014|99472|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
22452|NCT01600014|99473|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
22453|NCT01600014|99472|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
22454|NCT01600014|99473|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
22455|NCT01600014|99472|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
22456|NCT01600014|99473|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
22457|NCT01600014|99472|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
22458|NCT01600014|99473|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
22459|NCT01600014|99472|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
22460|NCT01600014|99473|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
22461|NCT01600014|99472|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
22462|NCT01600014|99473|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
22463|NCT01600014|99472|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
22464|NCT01600014|99473|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
22465|NCT01600014|99472|P2|1. Cycle & Observation Period D1 to W52|Other|0
22466|NCT01600014|99473|P1|1. Cycle & Observation Period D1 to W52|Other|27
22467|NCT01600014|99472|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
22468|NCT01600014|99473|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
22469|NCT01600014|99472|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
22470|NCT01600014|99473|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
22471|NCT01600014|99472|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
22472|NCT01600014|99473|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
22473|NCT01599806|99493|P2|Overall Study|Other Eligibility criteria|9
22474|NCT01599806|99494|P1|Overall Study|Other Eligibility criteria|11
22475|NCT01599806|99493|P2|Overall Study|Withdrawal by Subject|12
22476|NCT01599806|99494|P1|Overall Study|Withdrawal by Subject|12
22477|NCT01599806|99493|P2|Overall Study|Lost to Follow-up|20
22478|NCT01599806|99494|P1|Overall Study|Lost to Follow-up|20
22479|NCT01599650|99627|P3|Overall Study|Adverse Event|4
22480|NCT01599650|99628|P2|Overall Study|Adverse Event|8
22481|NCT01599650|99629|P1|Overall Study|Adverse Event|3
22482|NCT01599650|99627|P3|Overall Study|Withdrawal by Subject|10
22483|NCT01599650|99628|P2|Overall Study|Withdrawal by Subject|11
22484|NCT01599650|99629|P1|Overall Study|Withdrawal by Subject|11
22485|NCT01599650|99627|P3|Overall Study|Lost to Follow-up|3
22486|NCT01599650|99628|P2|Overall Study|Lost to Follow-up|3
22487|NCT01599650|99629|P1|Overall Study|Lost to Follow-up|3
22488|NCT01599650|99627|P3|Overall Study|Death|2
22489|NCT01599650|99628|P2|Overall Study|Death|1
22490|NCT01599650|99629|P1|Overall Study|Death|2
22491|NCT01599650|99627|P3|Overall Study|Protocol Violation|0
22492|NCT01599650|99628|P2|Overall Study|Protocol Violation|3
22493|NCT01599650|99629|P1|Overall Study|Protocol Violation|0
22494|NCT01599650|99627|P3|Overall Study|Physician Decision|7
22495|NCT01599650|99628|P2|Overall Study|Physician Decision|0
22496|NCT01599650|99629|P1|Overall Study|Physician Decision|2
22497|NCT01599650|99627|P3|Overall Study|Administrative issue|1
22498|NCT01599650|99628|P2|Overall Study|Administrative issue|0
22499|NCT01599650|99629|P1|Overall Study|Administrative issue|1
22500|NCT01599637|99668|P3|Overall Study|Adverse Event|0
22501|NCT01599637|99669|P2|Overall Study|Adverse Event|0
22502|NCT01599637|99670|P1|Overall Study|Adverse Event|1
22503|NCT01599637|99668|P3|Overall Study|administrative problems|0
22504|NCT01599637|99669|P2|Overall Study|administrative problems|2
22505|NCT01599637|99670|P1|Overall Study|administrative problems|0
22506|NCT01599325|99715|P1|Overall Study|Unspecified|2
22507|NCT01599325|99715|P1|Overall Study|Lack of Therapeutic Effect|9
22508|NCT01599325|99715|P1|Overall Study|Protocol Violation|1
22509|NCT01599325|99715|P1|Overall Study|Death|13
22510|NCT01599325|99715|P1|Overall Study|Withdrawal by Subject|20
22511|NCT01599325|99715|P1|Overall Study|Disease Progression|7
22512|NCT01599325|99715|P1|Overall Study|Adverse Event|5
22513|NCT01599234|99737|P2|Overall Study|Pregnancy|1
22514|NCT01599234|99738|P1|Overall Study|Pregnancy|0
22515|NCT01599234|99737|P2|Overall Study|Contra-indication discovered|1
22516|NCT01599234|99738|P1|Overall Study|Contra-indication discovered|0
22517|NCT01599234|99737|P2|Overall Study|Patient would not stop driving|0
22518|NCT01599234|99738|P1|Overall Study|Patient would not stop driving|1
22519|NCT01599234|99737|P2|Overall Study|Death|0
22520|NCT01599234|99738|P1|Overall Study|Death|1
22521|NCT01599234|99737|P2|Overall Study|Sponsor request as creatinine levels <50|1
22522|NCT01599234|99738|P1|Overall Study|Sponsor request as creatinine levels <50|0
22523|NCT01599234|99737|P2|Overall Study|Unable to operate spray|0
22524|NCT01599234|99738|P1|Overall Study|Unable to operate spray|1
22525|NCT01599234|99737|P2|Overall Study|Lack of Efficacy|4
22526|NCT01599234|99738|P1|Overall Study|Lack of Efficacy|2
22527|NCT01599234|99737|P2|Overall Study|Lost to Follow-up|2
22528|NCT01599234|99738|P1|Overall Study|Lost to Follow-up|1
22529|NCT01599234|99737|P2|Overall Study|Withdrawal by Subject|1
22530|NCT01599234|99738|P1|Overall Study|Withdrawal by Subject|2
22531|NCT01599234|99737|P2|Overall Study|Adverse Event|5
22532|NCT01599234|99738|P1|Overall Study|Adverse Event|9
22533|NCT01598610|99775|P1|Overall Study|Adverse Event|1
22534|NCT01598532|99792|P1|Overall Study|Did not meet inclusion criteria|8
22535|NCT01598532|99792|P1|Overall Study|Lost to Follow-up|3
22536|NCT01598506|99801|P1|Overall Study|Withdrawal by Subject|2
22537|NCT01598129|99820|P1|Overall Study|Withdrawal by Subject|1
22538|NCT01598129|99820|P1|Overall Study|Deterioration of WHO status to WHO 4|2
22539|NCT01598129|99820|P1|Overall Study|Disease progression|6
22540|NCT01597908|99842|P2|Overall Study|Ongoing|202
22541|NCT01597908|99843|P1|Overall Study|Ongoing|236
22542|NCT01597908|99842|P2|Overall Study|Withdrawal by Subject|18
22543|NCT01597908|99843|P1|Overall Study|Withdrawal by Subject|10
22544|NCT01597908|99842|P2|Overall Study|Physician Decision|1
22545|NCT01597908|99843|P1|Overall Study|Physician Decision|2
22546|NCT01597908|99842|P2|Overall Study|Lost to Follow-up|9
22547|NCT01597908|99843|P1|Overall Study|Lost to Follow-up|4
22548|NCT01597908|99842|P2|Overall Study|Death|122
22549|NCT01597908|99843|P1|Overall Study|Death|100
22550|NCT01597596|99870|P2|Overall Study|Physician Decision|1
22551|NCT01597596|99871|P1|Overall Study|Physician Decision|0
22552|NCT01597596|99870|P2|Overall Study|Study terminated by sponsor|0
22553|NCT01597596|99871|P1|Overall Study|Study terminated by sponsor|1
22554|NCT01597492|99885|P2|Overall Study|Other Reason|0
22555|NCT01597492|99886|P1|Overall Study|Other Reason|2
22556|NCT01597492|99885|P2|Overall Study|Lost to Follow-up|2
22557|NCT01597492|99886|P1|Overall Study|Lost to Follow-up|0
22558|NCT01597492|99885|P2|Overall Study|Adverse Event|0
22559|NCT01597492|99886|P1|Overall Study|Adverse Event|3
22560|NCT01597492|99885|P2|Overall Study|Withdrawal by Subject|2
22561|NCT01597492|99886|P1|Overall Study|Withdrawal by Subject|1
22562|NCT01597479|99894|P2|Overall Study|Lost to Follow-up|0
22563|NCT01597479|99895|P1|Overall Study|Lost to Follow-up|1
22564|NCT01597479|99894|P2|Overall Study|Protocol Violation|0
22565|NCT01597479|99895|P1|Overall Study|Protocol Violation|1
22566|NCT01597245|99906|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
22567|NCT01597245|99907|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
22568|NCT01597245|99908|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
22569|NCT01597245|99909|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
22570|NCT01597245|99910|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
22571|NCT01597245|99911|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
22572|NCT01597245|99912|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
22573|NCT01597245|99913|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
22574|NCT01597245|99914|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
22575|NCT01597245|99915|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
22576|NCT01597245|99916|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
22577|NCT01597245|99917|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
22578|NCT01597245|99918|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
22579|NCT01597245|99906|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
22580|NCT01597245|99907|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
22581|NCT01597245|99908|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
22582|NCT01597245|99909|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
22583|NCT01597245|99910|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
22584|NCT01597245|99911|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
22585|NCT01597245|99912|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
22586|NCT01597245|99913|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
22587|NCT01597245|99914|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
22588|NCT01597245|99915|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
22589|NCT01597245|99916|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
22590|NCT01597245|99917|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
22591|NCT01597245|99918|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
22592|NCT01597245|99906|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
22593|NCT01597245|99907|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
22594|NCT01597245|99908|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
22595|NCT01597245|99909|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
22596|NCT01597245|99910|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
22597|NCT01597245|99911|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
22598|NCT01597245|99912|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
22599|NCT01597245|99913|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
22600|NCT01597245|99914|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
22601|NCT01597245|99915|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
22602|NCT01597245|99916|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
22603|NCT01597245|99917|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
22604|NCT01597245|99918|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
22605|NCT01597245|99906|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
22606|NCT01597245|99907|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
22607|NCT01597245|99908|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
22608|NCT01597245|99909|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
22609|NCT01597245|99910|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
22610|NCT01597245|99911|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
22611|NCT01597245|99912|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
22612|NCT01597245|99913|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
22613|NCT01597245|99914|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
22614|NCT01597245|99915|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
22615|NCT01597245|99916|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
22616|NCT01597245|99917|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
22617|NCT01597245|99918|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
22618|NCT01597245|99906|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
22619|NCT01597245|99907|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
22620|NCT01597245|99908|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
22621|NCT01597245|99909|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
22622|NCT01597245|99910|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
22623|NCT01597245|99911|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
22624|NCT01597245|99912|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
22625|NCT01597245|99913|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
22626|NCT01597245|99914|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
22627|NCT01597245|99915|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
22628|NCT01597245|99916|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
22629|NCT01597245|99917|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
22630|NCT01597245|99918|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
22631|NCT01597245|99906|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
22632|NCT01597245|99907|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
22633|NCT01597245|99908|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
22634|NCT01597245|99909|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
22635|NCT01597245|99910|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
22636|NCT01597245|99911|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
22637|NCT01597245|99912|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
22638|NCT01597245|99913|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
22639|NCT01597245|99914|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
22640|NCT01597245|99915|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
22641|NCT01597245|99916|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
22642|NCT01597245|99917|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
22643|NCT01597245|99918|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
22644|NCT01597245|99906|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
22645|NCT01597245|99907|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
22646|NCT01597245|99908|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
22647|NCT01597245|99909|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
22648|NCT01597245|99910|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
22649|NCT01597245|99911|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
22650|NCT01597245|99912|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
22651|NCT01597245|99913|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
22652|NCT01597245|99914|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
22653|NCT01597245|99915|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
22654|NCT01597245|99916|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
22655|NCT01597245|99917|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
22656|NCT01597245|99918|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
22657|NCT01597245|99906|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
22658|NCT01597245|99907|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
22659|NCT01597245|99908|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
22660|NCT01597245|99909|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|111
22661|NCT01597245|99910|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
22662|NCT01597245|99911|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
22663|NCT01597245|99912|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|21
22664|NCT01597245|99913|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|80
22665|NCT01597245|99914|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|148
22666|NCT01597245|99915|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
22667|NCT01597245|99916|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
22668|NCT01597245|99917|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
22669|NCT01597245|99918|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
22670|NCT01597245|99906|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
22671|NCT01597245|99907|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
22672|NCT01597245|99908|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
22673|NCT01597245|99909|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
22674|NCT01597245|99910|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
22675|NCT01597245|99911|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
22676|NCT01597245|99912|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
22677|NCT01597245|99913|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
22678|NCT01597245|99914|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
22679|NCT01597245|99915|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
22680|NCT01597245|99916|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
22681|NCT01597245|99917|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
22682|NCT01597245|99918|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
22683|NCT01597245|99906|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
22684|NCT01597245|99907|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
22685|NCT01597245|99908|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
22686|NCT01597245|99909|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
22687|NCT01597245|99910|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
22688|NCT01597245|99911|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
22689|NCT01597245|99912|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
22690|NCT01597245|99913|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
22691|NCT01597245|99914|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
22692|NCT01597245|99915|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
22693|NCT01597245|99916|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
22694|NCT01597245|99917|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
22695|NCT01597245|99918|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
22696|NCT01597245|99906|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
22697|NCT01597245|99907|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
22698|NCT01597245|99908|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
22699|NCT01597245|99909|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
22700|NCT01597245|99910|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
22701|NCT01597245|99911|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
22702|NCT01597245|99912|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
22703|NCT01597245|99913|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
22704|NCT01597245|99914|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
22705|NCT01597245|99915|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
22706|NCT01597245|99916|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
22707|NCT01597245|99917|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
22708|NCT01597245|99918|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
22709|NCT01597245|99906|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
22710|NCT01597245|99907|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
22711|NCT01597245|99908|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
22712|NCT01597245|99909|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
22713|NCT01597245|99910|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
22714|NCT01597245|99911|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
22715|NCT01597245|99912|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
22716|NCT01597245|99913|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
22717|NCT01597245|99914|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
22718|NCT01597245|99915|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
22719|NCT01597245|99916|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
22720|NCT01597245|99917|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
22800|NCT01594749|100379|P1|Overall Study|Lost Source Documentation|1
22721|NCT01597245|99918|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
22722|NCT01597245|99906|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
22723|NCT01597245|99907|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
22724|NCT01597245|99908|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
22725|NCT01597245|99909|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
22726|NCT01597245|99910|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
22727|NCT01597245|99911|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
22728|NCT01597245|99912|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
22729|NCT01597245|99913|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
22730|NCT01597245|99914|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
22731|NCT01597245|99915|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
22732|NCT01597245|99916|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
22733|NCT01597245|99917|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
22734|NCT01597245|99918|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
22735|NCT01597245|99906|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
22736|NCT01597245|99907|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
22737|NCT01597245|99908|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
22738|NCT01597245|99909|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
22739|NCT01597245|99910|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
22740|NCT01597245|99911|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
22741|NCT01597245|99912|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
22742|NCT01597245|99913|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
22743|NCT01597245|99914|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
22744|NCT01597245|99915|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
22745|NCT01597245|99916|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
22746|NCT01597245|99917|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
22747|NCT01597245|99918|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
22748|NCT01597245|99906|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
22749|NCT01597245|99907|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
22750|NCT01597245|99908|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
22751|NCT01597245|99909|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
22752|NCT01597245|99910|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
22753|NCT01597245|99911|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
22754|NCT01597245|99912|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
22755|NCT01597245|99913|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
22756|NCT01597245|99914|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
22757|NCT01597245|99915|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
22758|NCT01597245|99916|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
22759|NCT01597245|99917|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
22760|NCT01597245|99918|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
22761|NCT01597050|100014|P2|Overall Study|Withdrawal by Subject|0
22762|NCT01597050|100015|P1|Overall Study|Withdrawal by Subject|1
22763|NCT01596972|100023|P2|Overall Study|Withdrawal by Subject|1
22764|NCT01596972|100024|P1|Overall Study|Withdrawal by Subject|0
22765|NCT01596972|100023|P2|Overall Study|Lost to Follow-up|4
22766|NCT01596972|100024|P1|Overall Study|Lost to Follow-up|0
22767|NCT01596972|100023|P2|Overall Study|Physician Decision|9
22768|NCT01596972|100024|P1|Overall Study|Physician Decision|1
22769|NCT01596504|100048|P3|Overall Study|Withdrawal by Subject|0
22770|NCT01596504|100049|P2|Overall Study|Withdrawal by Subject|0
22771|NCT01596504|100050|P1|Overall Study|Withdrawal by Subject|1
22772|NCT01596504|100048|P3|Overall Study|Adverse Event|1
22773|NCT01596504|100049|P2|Overall Study|Adverse Event|2
22774|NCT01596504|100050|P1|Overall Study|Adverse Event|1
22775|NCT01596504|100048|P3|Overall Study|Participant's Private Reason|0
22776|NCT01596504|100049|P2|Overall Study|Participant's Private Reason|1
22777|NCT01596504|100050|P1|Overall Study|Participant's Private Reason|0
22778|NCT01596062|100122|P3|Overall Study|Lack of Efficacy|1
22779|NCT01596062|100123|P2|Overall Study|Lack of Efficacy|0
22780|NCT01596062|100124|P1|Overall Study|Lack of Efficacy|0
22781|NCT01596062|100122|P3|Overall Study|Adverse Event|2
22782|NCT01596062|100123|P2|Overall Study|Adverse Event|0
22783|NCT01596062|100124|P1|Overall Study|Adverse Event|1
22784|NCT01595438|100187|P2|Overall Study|Other Eligibility criteria|9
22785|NCT01595438|100188|P1|Overall Study|Other Eligibility criteria|11
22786|NCT01595438|100187|P2|Overall Study|Withdrawal by Subject|12
22787|NCT01595438|100188|P1|Overall Study|Withdrawal by Subject|12
22788|NCT01595438|100187|P2|Overall Study|Lost to Follow-up|20
22789|NCT01595438|100188|P1|Overall Study|Lost to Follow-up|20
22790|NCT01594970|100357|P3|Overall Study|Lost to Follow-up|37
22791|NCT01594970|100358|P2|Overall Study|Lost to Follow-up|54
22792|NCT01594970|100359|P1|Overall Study|Lost to Follow-up|54
22793|NCT01594970|100357|P3|Overall Study|Adverse Event|23
22794|NCT01594970|100358|P2|Overall Study|Adverse Event|23
22795|NCT01594970|100359|P1|Overall Study|Adverse Event|17
22796|NCT01594970|100357|P3|Overall Study|Non-Adverse Event Related|6
22797|NCT01594970|100358|P2|Overall Study|Non-Adverse Event Related|5
22798|NCT01594970|100359|P1|Overall Study|Non-Adverse Event Related|4
22799|NCT01594749|100378|P2|Overall Study|Lost Source Documentation|0
22801|NCT01594749|100378|P2|Overall Study|Not Treated|10
22802|NCT01594749|100379|P1|Overall Study|Not Treated|4
22803|NCT01594749|100378|P2|Overall Study|Death|3
22804|NCT01594749|100379|P1|Overall Study|Death|9
22805|NCT01594749|100378|P2|Overall Study|Lost to Follow-up|0
22806|NCT01594749|100379|P1|Overall Study|Lost to Follow-up|1
22807|NCT01594749|100378|P2|Overall Study|Non-compliance with Protocol|1
22808|NCT01594749|100379|P1|Overall Study|Non-compliance with Protocol|0
22809|NCT01594749|100378|P2|Overall Study|Physician Decision|1
22810|NCT01594749|100379|P1|Overall Study|Physician Decision|1
22811|NCT01594749|100378|P2|Overall Study|Protocol Violation|0
22812|NCT01594749|100379|P1|Overall Study|Protocol Violation|2
22813|NCT01594749|100378|P2|Overall Study|Withdrawal by Subject|2
22814|NCT01594749|100379|P1|Overall Study|Withdrawal by Subject|2
22815|NCT01594749|100378|P2|Overall Study|Adverse Event|1
22816|NCT01594749|100379|P1|Overall Study|Adverse Event|2
22817|NCT01594411|100508|P1|Overall Study|Lost to Follow-up|2
22818|NCT01594125|100537|P5|Overall Study|Progressive Disease|7
22819|NCT01594125|100538|P4|Overall Study|Progressive Disease|3
22820|NCT01594125|100539|P3|Overall Study|Progressive Disease|3
22821|NCT01594125|100540|P2|Overall Study|Progressive Disease|12
22822|NCT01594125|100541|P1|Overall Study|Progressive Disease|3
22823|NCT01594125|100537|P5|Overall Study|Withdrawal by Subject|0
22824|NCT01594125|100538|P4|Overall Study|Withdrawal by Subject|1
22825|NCT01594125|100539|P3|Overall Study|Withdrawal by Subject|0
22826|NCT01594125|100540|P2|Overall Study|Withdrawal by Subject|0
22827|NCT01594125|100541|P1|Overall Study|Withdrawal by Subject|1
22828|NCT01593787|100601|P3|Overall Study|Adverse Event|0
22829|NCT01593787|100602|P2|Overall Study|Adverse Event|0
22830|NCT01593787|100603|P1|Overall Study|Adverse Event|1
22831|NCT01592864|100682|P2|Overall Study|Withdrawal by Subject|1
22832|NCT01592864|100683|P1|Overall Study|Withdrawal by Subject|0
22833|NCT01592786|100714|P1|Overall Study|Other|3
22834|NCT01592786|100714|P1|Overall Study|Lost to Follow-up|19
22835|NCT01592786|100714|P1|Overall Study|Withdrawal by Subject|23
22836|NCT01592786|100714|P1|Overall Study|Protocol Violation|14
22837|NCT01592786|100714|P1|Overall Study|Lack of Efficacy|19
22838|NCT01592786|100714|P1|Overall Study|Adverse Event|60
22839|NCT01592773|100718|P1|Overall Study|Other Reason|1
22840|NCT01592773|100718|P1|Overall Study|Inclusion/exclusion not meet|1
22841|NCT01592773|100718|P1|Overall Study|Protocol Violation|2
22842|NCT01592773|100718|P1|Overall Study|Lack of Efficacy|9
22843|NCT01592773|100718|P1|Overall Study|Adverse Event|17
22844|NCT01592773|100718|P1|Overall Study|Lost to Follow-up|19
22845|NCT01592773|100718|P1|Overall Study|Withdrawal by Subject|35
22846|NCT01592773|100718|P1|Overall Study|Study Terminated by Sponsor|582
22847|NCT01592760|100725|P3|24-hour Follow-Up|Lost to Follow-up|2
22848|NCT01592760|100726|P2|24-hour Follow-Up|Lost to Follow-up|3
22849|NCT01592760|100727|P1|24-hour Follow-Up|Lost to Follow-up|4
22850|NCT01592708|100770|P2|Overall Study|Protocol Violation|0
22851|NCT01592708|100771|P1|Overall Study|Protocol Violation|3
22852|NCT01592344|100805|P2|Overall Study|not available at primary outcome visit|4
22853|NCT01592344|100806|P1|Overall Study|not available at primary outcome visit|2
22854|NCT01592344|100805|P2|Overall Study|Lack of Efficacy|0
22855|NCT01592344|100806|P1|Overall Study|Lack of Efficacy|1
22856|NCT01592344|100805|P2|Overall Study|Adverse Event|1
22857|NCT01592344|100806|P1|Overall Study|Adverse Event|1
22858|NCT01592292|100820|P4|Overall Study|Not specified|1
22859|NCT01592292|100821|P3|Overall Study|Not specified|2
22860|NCT01592292|100822|P2|Overall Study|Not specified|1
22861|NCT01592292|100823|P1|Overall Study|Not specified|1
22862|NCT01592292|100820|P4|Overall Study|Withdrew consent|0
22863|NCT01592292|100821|P3|Overall Study|Withdrew consent|0
22864|NCT01592292|100822|P2|Overall Study|Withdrew consent|1
22865|NCT01592292|100823|P1|Overall Study|Withdrew consent|2
22866|NCT01592292|100820|P4|Overall Study|Follow-up loss|0
22867|NCT01592292|100821|P3|Overall Study|Follow-up loss|1
22868|NCT01592292|100822|P2|Overall Study|Follow-up loss|3
22869|NCT01592292|100823|P1|Overall Study|Follow-up loss|3
22870|NCT01592045|100868|P2|Overall Study|Moved out of country|0
22871|NCT01592045|100869|P1|Overall Study|Moved out of country|2
22872|NCT01592045|100868|P2|Overall Study|Withdrawal by Subject|0
22873|NCT01592045|100869|P1|Overall Study|Withdrawal by Subject|1
22874|NCT01592045|100868|P2|Overall Study|Adverse Event|1
22875|NCT01592045|100869|P1|Overall Study|Adverse Event|1
22876|NCT01592045|100868|P2|Overall Study|Disease Progression|1
22877|NCT01592045|100869|P1|Overall Study|Disease Progression|1
22878|NCT01591863|100887|P1|Overall Study|Lack of Efficacy|1
22879|NCT01591863|100887|P1|Overall Study|recurrence|9
22880|NCT01591863|100887|P1|Overall Study|Withdrawal by Subject|1
22881|NCT01591863|100887|P1|Overall Study|Adverse Event|3
22882|NCT01591681|100914|P1|Overall Study|Failed to use system during run-in|1
22883|NCT01591681|100914|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
22884|NCT01591616|100940|P1|Overall Study|Withdrawal by Subject|1
22885|NCT01591499|101081|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
22886|NCT01591499|101082|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
22887|NCT01591499|101083|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
22888|NCT01591499|101084|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
23056|NCT01587079|102012|P1|Overall Study|Physician Decision|2
22889|NCT01591499|101081|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
22890|NCT01591499|101082|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
22891|NCT01591499|101083|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
22892|NCT01591499|101084|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
22893|NCT01591499|101081|P4|Baseline Visit|Withdrawal by Subject|2
22894|NCT01591499|101082|P3|Baseline Visit|Withdrawal by Subject|0
22895|NCT01591499|101083|P2|Baseline Visit|Withdrawal by Subject|2
22896|NCT01591499|101084|P1|Baseline Visit|Withdrawal by Subject|0
22897|NCT01591460|101150|P1|Overall Study|Protocol Violation|1
22898|NCT01591460|101150|P1|Overall Study|Withdrawal by Subject|1
22899|NCT01591460|101150|P1|Overall Study|Participant Refusal|3
22900|NCT01591460|101150|P1|Overall Study|Noncompliance|1
22901|NCT01591460|101150|P1|Overall Study|Lost to Follow-up|1
22902|NCT01591460|101150|P1|Overall Study|Treatment Discontinued by Error|1
22903|NCT01591460|101150|P1|Overall Study|Rebound or Breakthrough|3
22904|NCT01591460|101150|P1|Overall Study|Futility Rule (Week 24)|3
22905|NCT01591460|101150|P1|Overall Study|Futility Rule (Week 12)|7
22906|NCT01591460|101150|P1|Overall Study|Adverse Event or Intercurrent Illness|5
22907|NCT01590888|101340|P3|Overall Study|Lost to Follow-up|0
22908|NCT01590888|101341|P2|Overall Study|Lost to Follow-up|0
22909|NCT01590888|101342|P1|Overall Study|Lost to Follow-up|1
22910|NCT01590888|101340|P3|Overall Study|Adverse Event|1
22911|NCT01590888|101341|P2|Overall Study|Adverse Event|0
22912|NCT01590888|101342|P1|Overall Study|Adverse Event|3
22913|NCT01590810|101391|P5|Overall Study|Physician Decision|0
22914|NCT01590810|101392|P4|Overall Study|Physician Decision|0
22915|NCT01590810|101393|P3|Overall Study|Physician Decision|1
22916|NCT01590810|101394|P2|Overall Study|Physician Decision|1
22917|NCT01590810|101395|P1|Overall Study|Physician Decision|0
22918|NCT01590797|101540|P2|Overall Study|Other Protocol Specified Criteria|4
22919|NCT01590797|101541|P1|Overall Study|Other Protocol Specified Criteria|2
22920|NCT01590797|101540|P2|Overall Study|Withdrawal by Subject|5
22921|NCT01590797|101541|P1|Overall Study|Withdrawal by Subject|7
22922|NCT01590797|101540|P2|Overall Study|Protocol Violation|1
22923|NCT01590797|101541|P1|Overall Study|Protocol Violation|4
22924|NCT01590797|101540|P2|Overall Study|Lost to Follow-up|1
22925|NCT01590797|101541|P1|Overall Study|Lost to Follow-up|0
22926|NCT01590797|101540|P2|Overall Study|Lack of Efficacy|2
22927|NCT01590797|101541|P1|Overall Study|Lack of Efficacy|0
22928|NCT01590797|101540|P2|Overall Study|Adverse Event|3
22929|NCT01590797|101541|P1|Overall Study|Adverse Event|4
22930|NCT01590771|101557|P2|Overall Study|Adverse Event|7
22931|NCT01590771|101558|P1|Overall Study|Adverse Event|3
22932|NCT01590771|101557|P2|Overall Study|Lack of Efficacy|0
22933|NCT01590771|101558|P1|Overall Study|Lack of Efficacy|1
22934|NCT01590771|101557|P2|Overall Study|Lost to Follow-up|1
22935|NCT01590771|101558|P1|Overall Study|Lost to Follow-up|1
22936|NCT01590771|101557|P2|Overall Study|Protocol Violation|2
22937|NCT01590771|101558|P1|Overall Study|Protocol Violation|1
22938|NCT01590771|101557|P2|Overall Study|Withdrawal by Subject|15
22939|NCT01590771|101558|P1|Overall Study|Withdrawal by Subject|8
22940|NCT01590771|101557|P2|Overall Study|Other Protocol Specified Criteria|14
22941|NCT01590771|101558|P1|Overall Study|Other Protocol Specified Criteria|5
22942|NCT01590563|101584|P1|Overall Study|simple uterine hyperplasia - not related|1
22943|NCT01590212|101608|P3|Overall Study|Lost to Follow-up|3
22944|NCT01590212|101609|P2|Overall Study|Lost to Follow-up|2
22945|NCT01590212|101610|P1|Overall Study|Lost to Follow-up|1
22946|NCT01590212|101608|P3|Overall Study|Withdrawal by Subject|2
22947|NCT01590212|101609|P2|Overall Study|Withdrawal by Subject|2
22948|NCT01590212|101610|P1|Overall Study|Withdrawal by Subject|2
22949|NCT01589822|101654|P3|Overall Study|Missed 90 day visit|1
22950|NCT01589822|101655|P2|Overall Study|Missed 90 day visit|1
22951|NCT01589822|101656|P1|Overall Study|Missed 90 day visit|2
22952|NCT01589822|101654|P3|Overall Study|Death|0
22953|NCT01589822|101655|P2|Overall Study|Death|0
22954|NCT01589822|101656|P1|Overall Study|Death|1
22955|NCT01589822|101654|P3|Overall Study|Withdrawal by Subject|0
22956|NCT01589822|101655|P2|Overall Study|Withdrawal by Subject|2
22957|NCT01589822|101656|P1|Overall Study|Withdrawal by Subject|1
22958|NCT01589653|101675|P2|Overall Study|Unclassified|3
22959|NCT01589653|101676|P1|Overall Study|Unclassified|0
22960|NCT01589653|101675|P2|Overall Study|Withdrawal criteria|7
22961|NCT01589653|101676|P1|Overall Study|Withdrawal criteria|4
22962|NCT01589653|101675|P2|Overall Study|Protocol Violation|1
22963|NCT01589653|101676|P1|Overall Study|Protocol Violation|3
22964|NCT01589445|101706|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
22965|NCT01589445|101706|P1|002 (Metformin)-3 Months|Adverse Event|2
22966|NCT01589445|101706|P1|002 (Metformin)-3 Months|Protocol Violation|2
22967|NCT01589445|101706|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
22968|NCT01589445|101706|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
22969|NCT01589445|101706|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
22970|NCT01589445|101706|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
22971|NCT01589445|101706|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
22972|NCT01589445|101706|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
22973|NCT01589445|101706|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
22974|NCT01589237|101726|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
22975|NCT01589237|101727|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
22976|NCT01589237|101728|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
22977|NCT01589237|101729|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
22978|NCT01589237|101726|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
22979|NCT01589237|101727|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
22980|NCT01589237|101728|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
22981|NCT01589237|101729|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
22982|NCT01589237|101726|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
22983|NCT01589237|101727|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
22984|NCT01589237|101728|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
22985|NCT01589237|101729|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
22986|NCT01589237|101726|P4|Part A (52 Weeks)|Subject/guardian decision|0
22987|NCT01589237|101727|P3|Part A (52 Weeks)|Subject/guardian decision|2
22988|NCT01589237|101728|P2|Part A (52 Weeks)|Subject/guardian decision|3
22989|NCT01589237|101729|P1|Part A (52 Weeks)|Subject/guardian decision|2
22990|NCT01588548|101781|P6|Overall Study|Condition Under Investigation Worsened|3
22991|NCT01588548|101782|P5|Overall Study|Condition Under Investigation Worsened|3
22992|NCT01588548|101783|P4|Overall Study|Condition Under Investigation Worsened|4
22993|NCT01588548|101784|P3|Overall Study|Condition Under Investigation Worsened|4
22994|NCT01588548|101785|P2|Overall Study|Condition Under Investigation Worsened|6
22995|NCT01588548|101786|P1|Overall Study|Condition Under Investigation Worsened|3
22996|NCT01588548|101781|P6|Overall Study|Adverse Event|0
22997|NCT01588548|101782|P5|Overall Study|Adverse Event|1
22998|NCT01588548|101783|P4|Overall Study|Adverse Event|2
22999|NCT01588548|101784|P3|Overall Study|Adverse Event|1
23000|NCT01588548|101785|P2|Overall Study|Adverse Event|0
23001|NCT01588548|101786|P1|Overall Study|Adverse Event|0
23002|NCT01588548|101781|P6|Overall Study|Withdrawal by Subject|3
23003|NCT01588548|101782|P5|Overall Study|Withdrawal by Subject|2
23004|NCT01588548|101783|P4|Overall Study|Withdrawal by Subject|1
23005|NCT01588548|101784|P3|Overall Study|Withdrawal by Subject|1
23006|NCT01588548|101785|P2|Overall Study|Withdrawal by Subject|1
23007|NCT01588548|101786|P1|Overall Study|Withdrawal by Subject|0
23008|NCT01588496|101803|P3|Overall Study|Withdrawal by Subject|0
23009|NCT01588496|101804|P2|Overall Study|Withdrawal by Subject|1
23010|NCT01588496|101805|P1|Overall Study|Withdrawal by Subject|0
23011|NCT01588405|101839|P1|Overall Study|Clinical Worsening|1
23012|NCT01588405|101839|P1|Overall Study|Adverse Event|1
23013|NCT01588353|101866|P3|Step3|Adverse Event|2
23014|NCT01588353|101867|P2|Step3|Adverse Event|0
23015|NCT01588353|101868|P1|Step3|Adverse Event|0
23016|NCT01588353|101866|P3|Step2|Withdrawal by Subject|0
23017|NCT01588353|101867|P2|Step2|Withdrawal by Subject|1
23018|NCT01588353|101868|P1|Step2|Withdrawal by Subject|0
23019|NCT01587989|101907|P3|Randomized Study Treatment|Physician Decision|1
23020|NCT01587989|101908|P2|Randomized Study Treatment|Physician Decision|0
23021|NCT01587989|101909|P1|Randomized Study Treatment|Physician Decision|0
23022|NCT01587989|101907|P3|Randomized Study Treatment|Screening failure|0
23023|NCT01587989|101908|P2|Randomized Study Treatment|Screening failure|1
23024|NCT01587989|101909|P1|Randomized Study Treatment|Screening failure|0
23025|NCT01587989|101907|P3|Randomized Study Treatment|Withdrawal by Subject|0
23026|NCT01587989|101908|P2|Randomized Study Treatment|Withdrawal by Subject|1
23027|NCT01587989|101909|P1|Randomized Study Treatment|Withdrawal by Subject|0
23028|NCT01587989|101907|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
23029|NCT01587989|101908|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
23030|NCT01587989|101909|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
23031|NCT01587989|101907|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
23032|NCT01587989|101908|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
23033|NCT01587989|101909|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
23034|NCT01587989|101907|P3|12-Week Open-Label Run-In Period|Physician Decision|0
23035|NCT01587989|101908|P2|12-Week Open-Label Run-In Period|Physician Decision|0
23036|NCT01587989|101909|P1|12-Week Open-Label Run-In Period|Physician Decision|7
23037|NCT01587885|101961|P2|Treatment Period 1|Protocol Violation|2
23038|NCT01587885|101962|P1|Treatment Period 1|Protocol Violation|0
23039|NCT01587885|101961|P2|Treatment Period 1|Failure to Return|1
23040|NCT01587885|101962|P1|Treatment Period 1|Failure to Return|0
23041|NCT01587651|101978|P3|Overall Study|Withdrawal by Subject|0
23042|NCT01587651|101979|P2|Overall Study|Withdrawal by Subject|1
23043|NCT01587651|101980|P1|Overall Study|Withdrawal by Subject|0
23044|NCT01587651|101978|P3|Overall Study|Protocol Violation|1
23045|NCT01587651|101979|P2|Overall Study|Protocol Violation|1
23046|NCT01587651|101980|P1|Overall Study|Protocol Violation|0
23047|NCT01587651|101978|P3|Overall Study|Adverse Event|0
23048|NCT01587651|101979|P2|Overall Study|Adverse Event|1
23049|NCT01587651|101980|P1|Overall Study|Adverse Event|0
23050|NCT01587118|102007|P1|Overall Study|nonresponse|1
23051|NCT01587118|102007|P1|Overall Study|Relocation|1
23052|NCT01587118|102007|P1|Overall Study|Lost to Follow-up|2
23053|NCT01587118|102007|P1|Overall Study|Adverse Event|3
23054|NCT01587079|102012|P1|Overall Study|Adverse Event|14
23055|NCT01587079|102012|P1|Overall Study|Withdrawal by Subject|7
23057|NCT01587079|102012|P1|Overall Study|Lost to Follow-up|2
23058|NCT01587079|102012|P1|Overall Study|Protocol Violation|5
23059|NCT01587079|102012|P1|Overall Study|Protocol-specified criteria|9
23060|NCT01587014|102143|P1|Overall Study|Death|2
23061|NCT01587001|102150|P2|Overall Study|Insufficient samples to complete testing|1
23062|NCT01587001|102151|P1|Overall Study|Insufficient samples to complete testing|4
23063|NCT01587001|102150|P2|Overall Study|Lost to Follow-up|0
23064|NCT01587001|102151|P1|Overall Study|Lost to Follow-up|2
23065|NCT01586806|102200|P3|Overall Study|Lost to Follow-up|2
23066|NCT01586806|102201|P2|Overall Study|Lost to Follow-up|3
23067|NCT01586806|102202|P1|Overall Study|Lost to Follow-up|2
23068|NCT01586806|102200|P3|Overall Study|Withdrawal by Subject|0
23069|NCT01586806|102201|P2|Overall Study|Withdrawal by Subject|0
23070|NCT01586806|102202|P1|Overall Study|Withdrawal by Subject|1
23071|NCT01586806|102200|P3|Overall Study|Protocol Violation|0
23072|NCT01586806|102201|P2|Overall Study|Protocol Violation|1
23073|NCT01586806|102202|P1|Overall Study|Protocol Violation|0
23074|NCT01586364|102222|P1|Overall Study|Other-Not specified|1
23075|NCT01586364|102222|P1|Overall Study|Other-PI discretion, site closing|2
23076|NCT01586364|102222|P1|Overall Study|Other-Site closure due to PI illness|1
23077|NCT01586364|102222|P1|Overall Study|Other-Subject wasn't getting much relief|1
23078|NCT01586364|102222|P1|Overall Study|Other-Did not feel better post-treatment|1
23079|NCT01586364|102222|P1|Overall Study|Lack of Efficacy|1
23080|NCT01586364|102222|P1|Overall Study|Protocol Violation|16
23081|NCT01586364|102222|P1|Overall Study|Lost to Follow-up|17
23082|NCT01586364|102222|P1|Overall Study|Adverse Event|37
23083|NCT01586364|102222|P1|Overall Study|Withdrawal by Subject|40
23084|NCT01586338|102275|P1|Overall Study|Unspecified|1
23085|NCT01586338|102275|P1|Overall Study|Withdrawal by participant|3
23086|NCT01586338|102275|P1|Overall Study|Lost to Follow-up|1
23087|NCT01586338|102275|P1|Overall Study|Adverse Event|3
23088|NCT01585987|102310|P2|Treated|Poor/Non-Compliance|1
23089|NCT01585987|102311|P1|Treated|Poor/Non-Compliance|0
23090|NCT01585987|102310|P2|Treated|Subject Request|1
23091|NCT01585987|102311|P1|Treated|Subject Request|0
23092|NCT01585987|102310|P2|Treated|Non-Specified|2
23093|NCT01585987|102311|P1|Treated|Non-Specified|1
23094|NCT01585987|102310|P2|Treated|Maximum Clinical Benefit|1
23095|NCT01585987|102311|P1|Treated|Maximum Clinical Benefit|0
23096|NCT01585987|102310|P2|Treated|Lost to Follow-up|1
23097|NCT01585987|102311|P1|Treated|Lost to Follow-up|0
23098|NCT01585987|102310|P2|Treated|Death|0
23099|NCT01585987|102311|P1|Treated|Death|1
23100|NCT01585987|102310|P2|Treated|Withdrawal by Subject|2
23101|NCT01585987|102311|P1|Treated|Withdrawal by Subject|1
23102|NCT01585987|102310|P2|Treated|Adverse Event|0
23103|NCT01585987|102311|P1|Treated|Adverse Event|3
23104|NCT01585987|102310|P2|Treated|Study Drug Toxicity|5
23105|NCT01585987|102311|P1|Treated|Study Drug Toxicity|9
23106|NCT01585987|102310|P2|Treated|Disease Progression|36
23107|NCT01585987|102311|P1|Treated|Disease Progression|39
23108|NCT01585987|102310|P2|Randomized|No longer met criteria|2
23109|NCT01585987|102311|P1|Randomized|No longer met criteria|0
23110|NCT01585987|102310|P2|Randomized|Withdrawal by Subject|4
23111|NCT01585987|102311|P1|Randomized|Withdrawal by Subject|0
23112|NCT01585961|102326|P1|Overall Study|Ablation cancelled for slow-heal wound|1
23113|NCT01585961|102326|P1|Overall Study|Lost to Follow-up|23
23114|NCT01585961|102326|P1|Overall Study|Withdrawal by Subject|1
23115|NCT01585961|102326|P1|Overall Study|Decision to use non-study catheter|1
23116|NCT01585961|102326|P1|Overall Study|Physician Decision|1
23117|NCT01585961|102326|P1|Overall Study|Death|6
23118|NCT01585584|102346|P1|Overall Study|Physician Decision|2
23119|NCT01585584|102346|P1|Overall Study|Withdrawal by Subject|1
23120|NCT01585584|102346|P1|Overall Study|Lack of Efficacy|1
23121|NCT01585558|102353|P3|Overall Study|Lack of Efficacy|1
23122|NCT01585558|102354|P2|Overall Study|Lack of Efficacy|0
23123|NCT01585558|102355|P1|Overall Study|Lack of Efficacy|0
23124|NCT01585558|102353|P3|Overall Study|Protocol Violation|2
23125|NCT01585558|102354|P2|Overall Study|Protocol Violation|3
23126|NCT01585558|102355|P1|Overall Study|Protocol Violation|4
23127|NCT01585558|102353|P3|Overall Study|Adverse Event|1
23128|NCT01585558|102354|P2|Overall Study|Adverse Event|4
23129|NCT01585558|102355|P1|Overall Study|Adverse Event|3
23130|NCT01585558|102353|P3|Overall Study|Lost to Follow-up|3
23131|NCT01585558|102354|P2|Overall Study|Lost to Follow-up|0
23132|NCT01585558|102355|P1|Overall Study|Lost to Follow-up|2
23133|NCT01585558|102353|P3|Overall Study|Withdrawal by Subject|8
23134|NCT01585558|102354|P2|Overall Study|Withdrawal by Subject|5
23135|NCT01585558|102355|P1|Overall Study|Withdrawal by Subject|4
23136|NCT01585272|102603|P1|Overall Study|Withdrawal by Subject|10
23137|NCT01585272|102603|P1|Overall Study|Protocol Violation|7
23138|NCT01585272|102603|P1|Overall Study|Adverse Event|22
23139|NCT01585038|102613|P2|Overall Study|Adverse Event|2
23140|NCT01585038|102614|P1|Overall Study|Adverse Event|2
23141|NCT01584843|102630|P6|Second Treatment Period|Withdrawal by Subject|1
23142|NCT01584843|102631|P5|Second Treatment Period|Withdrawal by Subject|0
23143|NCT01584843|102632|P4|Second Treatment Period|Withdrawal by Subject|0
23144|NCT01584843|102633|P3|Second Treatment Period|Withdrawal by Subject|0
23145|NCT01584843|102634|P2|Second Treatment Period|Withdrawal by Subject|0
23146|NCT01584843|102635|P1|Second Treatment Period|Withdrawal by Subject|0
23147|NCT01584843|102630|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
23148|NCT01584843|102631|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
23149|NCT01584843|102632|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
23150|NCT01584843|102633|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
23151|NCT01584843|102634|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
23152|NCT01584843|102635|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
23153|NCT01584843|102630|P6|First Treatment Period|Protocol Violation|1
23154|NCT01584843|102631|P5|First Treatment Period|Protocol Violation|0
23155|NCT01584843|102632|P4|First Treatment Period|Protocol Violation|0
23156|NCT01584843|102633|P3|First Treatment Period|Protocol Violation|0
23157|NCT01584843|102634|P2|First Treatment Period|Protocol Violation|0
23158|NCT01584843|102635|P1|First Treatment Period|Protocol Violation|0
23159|NCT01584843|102630|P6|First Treatment Period|Adverse Event|0
23160|NCT01584843|102631|P5|First Treatment Period|Adverse Event|0
23161|NCT01584843|102632|P4|First Treatment Period|Adverse Event|0
23162|NCT01584843|102633|P3|First Treatment Period|Adverse Event|1
23163|NCT01584843|102634|P2|First Treatment Period|Adverse Event|0
23164|NCT01584843|102635|P1|First Treatment Period|Adverse Event|0
23165|NCT01584648|102746|P2|Overall Study|Ongoing|147
23166|NCT01584648|102747|P1|Overall Study|Ongoing|154
23167|NCT01584648|102746|P2|Overall Study|Death|55
23168|NCT01584648|102747|P1|Overall Study|Death|40
23169|NCT01584648|102746|P2|Overall Study|Withdrawal by Subject|5
23170|NCT01584648|102747|P1|Overall Study|Withdrawal by Subject|11
23171|NCT01584648|102746|P2|Overall Study|Physician Decision|2
23172|NCT01584648|102747|P1|Overall Study|Physician Decision|2
23173|NCT01584648|102746|P2|Overall Study|Lost to Follow-up|3
23174|NCT01584648|102747|P1|Overall Study|Lost to Follow-up|4
23175|NCT01584232|102834|P2|Overall Study|Lost to Follow-up|0
23176|NCT01584232|102835|P1|Overall Study|Lost to Follow-up|1
23177|NCT01584232|102834|P2|Overall Study|Physician Decision|1
23178|NCT01584232|102835|P1|Overall Study|Physician Decision|2
23179|NCT01584232|102834|P2|Overall Study|Withdrawal by Subject|1
23180|NCT01584232|102835|P1|Overall Study|Withdrawal by Subject|2
23181|NCT01584232|102834|P2|Overall Study|Adverse Event|1
23182|NCT01584232|102835|P1|Overall Study|Adverse Event|3
23183|NCT01583530|102874|P6|Overall Study|Lack of compliance|0
23184|NCT01583530|102875|P5|Overall Study|Lack of compliance|1
23185|NCT01583530|102876|P4|Overall Study|Lack of compliance|0
23186|NCT01583530|102877|P3|Overall Study|Lack of compliance|0
23187|NCT01583530|102878|P2|Overall Study|Lack of compliance|0
23188|NCT01583530|102879|P1|Overall Study|Lack of compliance|0
23189|NCT01583530|102874|P6|Overall Study|Lost to Follow-up|0
23190|NCT01583530|102875|P5|Overall Study|Lost to Follow-up|3
23191|NCT01583530|102876|P4|Overall Study|Lost to Follow-up|0
23192|NCT01583530|102877|P3|Overall Study|Lost to Follow-up|0
23193|NCT01583530|102878|P2|Overall Study|Lost to Follow-up|0
23194|NCT01583530|102879|P1|Overall Study|Lost to Follow-up|0
23195|NCT01583530|102874|P6|Overall Study|Withdrawal by Subject|2
23196|NCT01583530|102875|P5|Overall Study|Withdrawal by Subject|1
23197|NCT01583530|102876|P4|Overall Study|Withdrawal by Subject|1
23198|NCT01583530|102877|P3|Overall Study|Withdrawal by Subject|0
23199|NCT01583530|102878|P2|Overall Study|Withdrawal by Subject|3
23200|NCT01583530|102879|P1|Overall Study|Withdrawal by Subject|0
23201|NCT01583530|102874|P6|Overall Study|Adverse Event|1
23202|NCT01583530|102875|P5|Overall Study|Adverse Event|0
23203|NCT01583530|102876|P4|Overall Study|Adverse Event|0
23204|NCT01583530|102877|P3|Overall Study|Adverse Event|0
23205|NCT01583530|102878|P2|Overall Study|Adverse Event|0
23206|NCT01583530|102879|P1|Overall Study|Adverse Event|0
23207|NCT01583374|102941|P3|Overall Study|Unspecified|0
23208|NCT01583374|102942|P2|Overall Study|Unspecified|1
23209|NCT01583374|102943|P1|Overall Study|Unspecified|0
23210|NCT01583374|102941|P3|Overall Study|Protocol Violation|3
23211|NCT01583374|102942|P2|Overall Study|Protocol Violation|0
23212|NCT01583374|102943|P1|Overall Study|Protocol Violation|0
23213|NCT01583374|102941|P3|Overall Study|Lost to Follow-up|0
23214|NCT01583374|102942|P2|Overall Study|Lost to Follow-up|2
23215|NCT01583374|102943|P1|Overall Study|Lost to Follow-up|1
23216|NCT01583374|102941|P3|Overall Study|Withdrawal by Subject|5
23217|NCT01583374|102942|P2|Overall Study|Withdrawal by Subject|3
23218|NCT01583374|102943|P1|Overall Study|Withdrawal by Subject|8
23219|NCT01583374|102941|P3|Overall Study|Non-compliance with study drug|0
23220|NCT01583374|102942|P2|Overall Study|Non-compliance with study drug|1
23221|NCT01583374|102943|P1|Overall Study|Non-compliance with study drug|1
23222|NCT01583374|102941|P3|Overall Study|Lack of Efficacy|5
23223|NCT01583374|102942|P2|Overall Study|Lack of Efficacy|2
23224|NCT01583374|102943|P1|Overall Study|Lack of Efficacy|3
23225|NCT01583374|102941|P3|Overall Study|Adverse Event|12
23226|NCT01583374|102942|P2|Overall Study|Adverse Event|7
23227|NCT01583374|102943|P1|Overall Study|Adverse Event|6
23228|NCT01582854|102955|P2|Overall Study|Other Miscellaneous Reason|0
23229|NCT01582854|102956|P1|Overall Study|Other Miscellaneous Reason|1
23230|NCT01582854|102955|P2|Overall Study|General Anaesthesia|1
23231|NCT01582854|102956|P1|Overall Study|General Anaesthesia|0
23232|NCT01582854|102955|P2|Overall Study|Carotid or Neurosurgery|1
23233|NCT01582854|102956|P1|Overall Study|Carotid or Neurosurgery|0
23234|NCT01582854|102955|P2|Overall Study|Disallowed Concomitant Medication|2
23235|NCT01582854|102956|P1|Overall Study|Disallowed Concomitant Medication|3
23236|NCT01582854|102955|P2|Overall Study|Recurrent Stroke|8
23237|NCT01582854|102956|P1|Overall Study|Recurrent Stroke|13
23238|NCT01582854|102955|P2|Overall Study|Physician Decision|1
23239|NCT01582854|102956|P1|Overall Study|Physician Decision|0
23240|NCT01582854|102955|P2|Overall Study|Lost to Follow-up|2
23241|NCT01582854|102956|P1|Overall Study|Lost to Follow-up|1
23242|NCT01582854|102955|P2|Overall Study|Withdrawal by Participant|11
23243|NCT01582854|102956|P1|Overall Study|Withdrawal by Participant|8
23244|NCT01582854|102955|P2|Overall Study|Adverse Event|3
23245|NCT01582854|102956|P1|Overall Study|Adverse Event|2
23246|NCT01582854|102955|P2|Overall Study|Death|5
23247|NCT01582854|102956|P1|Overall Study|Death|8
23248|NCT01582789|102984|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
23249|NCT01582789|102985|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
23250|NCT01582308|103043|P10|Period 4|Physician Decision|1
23251|NCT01582308|103044|P9|Period 4|Physician Decision|0
23252|NCT01582308|103045|P8|Period 4|Physician Decision|0
23253|NCT01582308|103046|P7|Period 4|Physician Decision|0
23254|NCT01582308|103047|P6|Period 4|Physician Decision|1
23255|NCT01582308|103048|P5|Period 4|Physician Decision|0
23256|NCT01582308|103049|P4|Period 4|Physician Decision|0
23257|NCT01582308|103050|P3|Period 4|Physician Decision|0
23258|NCT01582308|103051|P2|Period 4|Physician Decision|0
23259|NCT01582308|103052|P1|Period 4|Physician Decision|1
23260|NCT01582308|103043|P10|10-day Washout Following Period 1|Physician Decision|0
23261|NCT01582308|103044|P9|10-day Washout Following Period 1|Physician Decision|0
23262|NCT01582308|103045|P8|10-day Washout Following Period 1|Physician Decision|0
23263|NCT01582308|103046|P7|10-day Washout Following Period 1|Physician Decision|0
23264|NCT01582308|103047|P6|10-day Washout Following Period 1|Physician Decision|0
23265|NCT01582308|103048|P5|10-day Washout Following Period 1|Physician Decision|1
23266|NCT01582308|103049|P4|10-day Washout Following Period 1|Physician Decision|0
23267|NCT01582308|103050|P3|10-day Washout Following Period 1|Physician Decision|0
23268|NCT01582308|103051|P2|10-day Washout Following Period 1|Physician Decision|0
23269|NCT01582308|103052|P1|10-day Washout Following Period 1|Physician Decision|0
23270|NCT01582308|103043|P10|Period 1|Withdrawal by Subject|0
23271|NCT01582308|103044|P9|Period 1|Withdrawal by Subject|0
23272|NCT01582308|103045|P8|Period 1|Withdrawal by Subject|0
23273|NCT01582308|103046|P7|Period 1|Withdrawal by Subject|1
23274|NCT01582308|103047|P6|Period 1|Withdrawal by Subject|0
23275|NCT01582308|103048|P5|Period 1|Withdrawal by Subject|0
23276|NCT01582308|103049|P4|Period 1|Withdrawal by Subject|0
23277|NCT01582308|103050|P3|Period 1|Withdrawal by Subject|0
23278|NCT01582308|103051|P2|Period 1|Withdrawal by Subject|0
23279|NCT01582308|103052|P1|Period 1|Withdrawal by Subject|0
23280|NCT01582282|103080|P3|Overall Study|fasting blood glucose outside Protocol|0
23281|NCT01582282|103081|P2|Overall Study|fasting blood glucose outside Protocol|1
23282|NCT01582282|103082|P1|Overall Study|fasting blood glucose outside Protocol|0
23283|NCT01582282|103080|P3|Overall Study|Lost to Follow-up|0
23284|NCT01582282|103081|P2|Overall Study|Lost to Follow-up|0
23285|NCT01582282|103082|P1|Overall Study|Lost to Follow-up|1
23286|NCT01582282|103080|P3|Overall Study|Adverse Event|0
23287|NCT01582282|103081|P2|Overall Study|Adverse Event|1
23288|NCT01582282|103082|P1|Overall Study|Adverse Event|1
23289|NCT01582243|103105|P1|Overall Study|Lost to Follow-up|1
23290|NCT01582243|103105|P1|Overall Study|Adverse Event|1
23291|NCT01582243|103105|P1|Overall Study|Withdrawal by Subject|1
23292|NCT01582178|103116|P2|Overall Study|Physician Decision|5
23293|NCT01582178|103117|P1|Overall Study|Physician Decision|6
23294|NCT01582100|103138|P1|Overall Study|Withdrawal by Subject|1
23295|NCT01582100|103138|P1|Overall Study|Adverse Event|1
23296|NCT01581931|103142|P2|Washout|Adverse Event|1
23297|NCT01581931|103143|P1|Washout|Adverse Event|0
23298|NCT01581684|103167|P10|Overall Study|Other reason not defined|0
23299|NCT01581684|103168|P9|Overall Study|Other reason not defined|1
23300|NCT01581684|103169|P8|Overall Study|Other reason not defined|0
23301|NCT01581684|103170|P7|Overall Study|Other reason not defined|0
23302|NCT01581684|103171|P6|Overall Study|Other reason not defined|0
23303|NCT01581684|103172|P5|Overall Study|Other reason not defined|0
23304|NCT01581684|103173|P4|Overall Study|Other reason not defined|0
23305|NCT01581684|103174|P3|Overall Study|Other reason not defined|0
23306|NCT01581684|103175|P2|Overall Study|Other reason not defined|0
23307|NCT01581684|103176|P1|Overall Study|Other reason not defined|0
23308|NCT01581307|103283|P1|Overall Study|Withdrawal by Subject|1
23309|NCT01581021|103291|P2|Overall Study|Lack of Efficacy|1
23310|NCT01581021|103292|P1|Overall Study|Lack of Efficacy|0
23311|NCT01581021|103291|P2|Overall Study|Lenke 6 Classification|1
23312|NCT01581021|103292|P1|Overall Study|Lenke 6 Classification|0
23313|NCT01581021|103291|P2|Overall Study|Not Randomized|2
23314|NCT01581021|103292|P1|Overall Study|Not Randomized|1
23315|NCT01581021|103291|P2|Overall Study|Neuromuscular|1
23316|NCT01581021|103292|P1|Overall Study|Neuromuscular|2
23317|NCT01581021|103291|P2|Overall Study|More than 2 hooks in thoracic|0
23318|NCT01581021|103292|P1|Overall Study|More than 2 hooks in thoracic|3
23319|NCT01581021|103291|P2|Overall Study|Lost to Follow-up|6
23320|NCT01581021|103292|P1|Overall Study|Lost to Follow-up|4
23321|NCT01580995|103318|P2|Overall Study|Lost to Follow-up|2
23322|NCT01580995|103319|P1|Overall Study|Lost to Follow-up|2
23323|NCT01580488|103369|P1|Overall Study|Withdrawal by Subject|1
23324|NCT01580020|103510|P4|Overall Study|Lost to Follow-up|0
23325|NCT01580020|103511|P3|Overall Study|Lost to Follow-up|1
23326|NCT01580020|103512|P2|Overall Study|Lost to Follow-up|0
23327|NCT01580020|103513|P1|Overall Study|Lost to Follow-up|0
23328|NCT01580020|103510|P4|Overall Study|Administrative Problems|0
23329|NCT01580020|103511|P3|Overall Study|Administrative Problems|1
23330|NCT01580020|103512|P2|Overall Study|Administrative Problems|0
23331|NCT01580020|103513|P1|Overall Study|Administrative Problems|0
23332|NCT01580020|103510|P4|Overall Study|Adverse Event|1
23333|NCT01580020|103511|P3|Overall Study|Adverse Event|1
23334|NCT01580020|103512|P2|Overall Study|Adverse Event|1
23335|NCT01580020|103513|P1|Overall Study|Adverse Event|1
23336|NCT01580020|103510|P4|Overall Study|Withdrawal by Subject|0
23337|NCT01580020|103511|P3|Overall Study|Withdrawal by Subject|1
23338|NCT01580020|103512|P2|Overall Study|Withdrawal by Subject|1
23339|NCT01580020|103513|P1|Overall Study|Withdrawal by Subject|0
23340|NCT01580020|103510|P4|Overall Study|Lack of Efficacy|1
23341|NCT01580020|103511|P3|Overall Study|Lack of Efficacy|0
23342|NCT01580020|103512|P2|Overall Study|Lack of Efficacy|5
23343|NCT01580020|103513|P1|Overall Study|Lack of Efficacy|0
23344|NCT01579916|103557|P2|Overall Study|Death|0
23345|NCT01579916|103558|P1|Overall Study|Death|1
23346|NCT01579916|103557|P2|Overall Study|Withdrawal by Subject|1
23347|NCT01579916|103558|P1|Overall Study|Withdrawal by Subject|1
23348|NCT01579916|103557|P2|Overall Study|Lost to Follow-up|1
23349|NCT01579916|103558|P1|Overall Study|Lost to Follow-up|6
23350|NCT01579578|103610|P2|Overall Study|Ongoing|0
23351|NCT01579578|103611|P1|Overall Study|Ongoing|3
23352|NCT01579578|103610|P2|Overall Study|Eligibility criteria|9
23353|NCT01579578|103611|P1|Overall Study|Eligibility criteria|3
23354|NCT01579578|103610|P2|Overall Study|Withdrawal by Subject|1
23355|NCT01579578|103611|P1|Overall Study|Withdrawal by Subject|2
23356|NCT01579578|103610|P2|Overall Study|Lost to Follow-up|1
23357|NCT01579578|103611|P1|Overall Study|Lost to Follow-up|1
23358|NCT01579578|103610|P2|Overall Study|Death|1
23359|NCT01579578|103611|P1|Overall Study|Death|4
23360|NCT01579565|103623|P2|Treated|declined to return for final visit|1
23361|NCT01579565|103624|P1|Treated|declined to return for final visit|0
23362|NCT01579565|103623|P2|Treated|Lost to Follow-up|1
23363|NCT01579565|103624|P1|Treated|Lost to Follow-up|2
23364|NCT01579565|103623|P2|Treated|Physician Decision|1
23365|NCT01579565|103624|P1|Treated|Physician Decision|0
23366|NCT01579565|103623|P2|Randomized|prohibited preoperative medication|1
23367|NCT01579565|103624|P1|Randomized|prohibited preoperative medication|0
23368|NCT01579565|103623|P2|Randomized|prohibited preoperative eating|0
23369|NCT01579565|103624|P1|Randomized|prohibited preoperative eating|1
23370|NCT01579565|103623|P2|Randomized|inadequate preoperative pupil dilation|1
23371|NCT01579565|103624|P1|Randomized|inadequate preoperative pupil dilation|0
23372|NCT01579565|103623|P2|Randomized|Withdrawal by Subject|0
23373|NCT01579565|103624|P1|Randomized|Withdrawal by Subject|3
23374|NCT01579565|103623|P2|Randomized|Adverse Event|3
23375|NCT01579565|103624|P1|Randomized|Adverse Event|1
23376|NCT01579474|103658|P6|Overall Study|Withdrawal by Subject|0
23377|NCT01579474|103659|P5|Overall Study|Withdrawal by Subject|0
23378|NCT01579474|103660|P4|Overall Study|Withdrawal by Subject|0
23379|NCT01579474|103661|P3|Overall Study|Withdrawal by Subject|0
23380|NCT01579474|103662|P2|Overall Study|Withdrawal by Subject|0
23381|NCT01579474|103663|P1|Overall Study|Withdrawal by Subject|1
23382|NCT01579474|103658|P6|Overall Study|Lack of Efficacy|0
23383|NCT01579474|103659|P5|Overall Study|Lack of Efficacy|1
23384|NCT01579474|103660|P4|Overall Study|Lack of Efficacy|0
23385|NCT01579474|103661|P3|Overall Study|Lack of Efficacy|0
23386|NCT01579474|103662|P2|Overall Study|Lack of Efficacy|0
23387|NCT01579474|103663|P1|Overall Study|Lack of Efficacy|1
23388|NCT01579474|103658|P6|Overall Study|Adverse Event|1
23389|NCT01579474|103659|P5|Overall Study|Adverse Event|0
23390|NCT01579474|103660|P4|Overall Study|Adverse Event|0
23391|NCT01579474|103661|P3|Overall Study|Adverse Event|2
23392|NCT01579474|103662|P2|Overall Study|Adverse Event|13
23393|NCT01579474|103663|P1|Overall Study|Adverse Event|1
23394|NCT01579006|103810|P1|Overall Study|Scheduled surgery|1
23395|NCT01579006|103810|P1|Overall Study|Due to participant's health fund|1
23396|NCT01579006|103810|P1|Overall Study|Non-compliance|3
23397|NCT01579006|103810|P1|Overall Study|Withdrawal by Subject|5
23398|NCT01579006|103810|P1|Overall Study|Adverse Event|13
23399|NCT01579006|103810|P1|Overall Study|Lack of Efficacy|10
23400|NCT01578850|103860|P3|Period 2|Unspecified Reasons|0
23401|NCT01578850|103861|P2|Period 2|Unspecified Reasons|1
23402|NCT01578850|103862|P1|Period 2|Unspecified Reasons|0
23403|NCT01578850|103860|P3|Period 2|Study Terminated by Sponsor|4
23404|NCT01578850|103861|P2|Period 2|Study Terminated by Sponsor|5
23405|NCT01578850|103862|P1|Period 2|Study Terminated by Sponsor|0
23406|NCT01578850|103860|P3|Period 2|Withdrawal by Subject|2
23407|NCT01578850|103861|P2|Period 2|Withdrawal by Subject|2
23408|NCT01578850|103862|P1|Period 2|Withdrawal by Subject|0
23409|NCT01578850|103860|P3|Period 2|Lost to Follow-up|2
23410|NCT01578850|103861|P2|Period 2|Lost to Follow-up|1
23411|NCT01578850|103862|P1|Period 2|Lost to Follow-up|0
23412|NCT01578850|103860|P3|Period 2|Adverse Event|6
23413|NCT01578850|103861|P2|Period 2|Adverse Event|3
23414|NCT01578850|103862|P1|Period 2|Adverse Event|0
23415|NCT01578850|103860|P3|Period 2|Insufficient Clinical Response|0
23416|NCT01578850|103861|P2|Period 2|Insufficient Clinical Response|1
23417|NCT01578850|103862|P1|Period 2|Insufficient Clinical Response|0
23418|NCT01578850|103860|P3|Period 1|Study Terminated by Sponsor|0
23419|NCT01578850|103861|P2|Period 1|Study Terminated by Sponsor|0
23420|NCT01578850|103862|P1|Period 1|Study Terminated by Sponsor|3
23421|NCT01578850|103860|P3|Period 1|Withdrawal by Subject|0
23422|NCT01578850|103861|P2|Period 1|Withdrawal by Subject|0
23423|NCT01578850|103862|P1|Period 1|Withdrawal by Subject|9
23424|NCT01578850|103860|P3|Period 1|Does Not Meet Entrance Criteria|0
23425|NCT01578850|103861|P2|Period 1|Does Not Meet Entrance Criteria|0
23426|NCT01578850|103862|P1|Period 1|Does Not Meet Entrance Criteria|12
23427|NCT01578850|103860|P3|Period 1|Death|0
23428|NCT01578850|103861|P2|Period 1|Death|0
23429|NCT01578850|103862|P1|Period 1|Death|1
23430|NCT01578850|103860|P3|Period 1|Adverse Event|0
23431|NCT01578850|103861|P2|Period 1|Adverse Event|0
23432|NCT01578850|103862|P1|Period 1|Adverse Event|11
23433|NCT01578850|103860|P3|Period 1|Insufficient Clinical Response|0
23434|NCT01578850|103861|P2|Period 1|Insufficient Clinical Response|0
23435|NCT01578850|103862|P1|Period 1|Insufficient Clinical Response|1
23436|NCT01578785|103914|P2|Overall Study|Study terminated by sponsor|118
23437|NCT01578785|103915|P1|Overall Study|Study terminated by sponsor|59
23438|NCT01578785|103914|P2|Overall Study|Withdrawal by Subject|1
23439|NCT01578785|103915|P1|Overall Study|Withdrawal by Subject|0
23440|NCT01578330|103945|P1|Overall Study|Protocol Violation|5
23441|NCT01578330|103945|P1|Overall Study|Adverse Event|2
23442|NCT01578187|103952|P1|Usability Phase|Withdrawal by Subject|1
23443|NCT01577758|103971|P8|mCRC Expansion Phase|Progression Disease|19
23444|NCT01577758|103972|P7|mCRC Expansion Phase|Progression Disease|0
23445|NCT01577758|103973|P6|mCRC Expansion Phase|Progression Disease|0
23446|NCT01577758|103974|P5|mCRC Expansion Phase|Progression Disease|0
23447|NCT01577758|103975|P4|mCRC Expansion Phase|Progression Disease|0
23448|NCT01577758|103976|P3|mCRC Expansion Phase|Progression Disease|0
23449|NCT01577758|103977|P2|mCRC Expansion Phase|Progression Disease|0
23450|NCT01577758|103978|P1|mCRC Expansion Phase|Progression Disease|0
23451|NCT01577758|103971|P8|mCRC Expansion Phase|Withdrawal by Subject|2
23452|NCT01577758|103972|P7|mCRC Expansion Phase|Withdrawal by Subject|0
23453|NCT01577758|103973|P6|mCRC Expansion Phase|Withdrawal by Subject|0
23454|NCT01577758|103974|P5|mCRC Expansion Phase|Withdrawal by Subject|0
23455|NCT01577758|103975|P4|mCRC Expansion Phase|Withdrawal by Subject|0
23456|NCT01577758|103976|P3|mCRC Expansion Phase|Withdrawal by Subject|0
23457|NCT01577758|103977|P2|mCRC Expansion Phase|Withdrawal by Subject|0
23458|NCT01577758|103978|P1|mCRC Expansion Phase|Withdrawal by Subject|0
23459|NCT01577758|103971|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
23460|NCT01577758|103972|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
23461|NCT01577758|103973|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
23462|NCT01577758|103974|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
23463|NCT01577758|103975|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
23464|NCT01577758|103976|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
23465|NCT01577758|103977|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
23466|NCT01577758|103978|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
23467|NCT01577758|103971|P8|Dose Escalation Phase|Progression Disease|0
23468|NCT01577758|103972|P7|Dose Escalation Phase|Progression Disease|0
23469|NCT01577758|103973|P6|Dose Escalation Phase|Progression Disease|0
23470|NCT01577758|103974|P5|Dose Escalation Phase|Progression Disease|5
23471|NCT01577758|103975|P4|Dose Escalation Phase|Progression Disease|2
23472|NCT01577758|103976|P3|Dose Escalation Phase|Progression Disease|1
23473|NCT01577758|103977|P2|Dose Escalation Phase|Progression Disease|2
23474|NCT01577758|103978|P1|Dose Escalation Phase|Progression Disease|2
23475|NCT01577758|103971|P8|Dose Escalation Phase|Withdrawal by Subject|0
23476|NCT01577758|103972|P7|Dose Escalation Phase|Withdrawal by Subject|0
23477|NCT01577758|103973|P6|Dose Escalation Phase|Withdrawal by Subject|1
23478|NCT01577758|103974|P5|Dose Escalation Phase|Withdrawal by Subject|0
23479|NCT01577758|103975|P4|Dose Escalation Phase|Withdrawal by Subject|0
23480|NCT01577758|103976|P3|Dose Escalation Phase|Withdrawal by Subject|0
23481|NCT01577758|103977|P2|Dose Escalation Phase|Withdrawal by Subject|0
23482|NCT01577758|103978|P1|Dose Escalation Phase|Withdrawal by Subject|0
23483|NCT01577758|103971|P8|Dose Escalation Phase|Symptomatic Deterioration|0
23484|NCT01577758|103972|P7|Dose Escalation Phase|Symptomatic Deterioration|0
23485|NCT01577758|103973|P6|Dose Escalation Phase|Symptomatic Deterioration|1
23486|NCT01577758|103974|P5|Dose Escalation Phase|Symptomatic Deterioration|1
23487|NCT01577758|103975|P4|Dose Escalation Phase|Symptomatic Deterioration|0
23488|NCT01577758|103976|P3|Dose Escalation Phase|Symptomatic Deterioration|1
23489|NCT01577758|103977|P2|Dose Escalation Phase|Symptomatic Deterioration|0
23490|NCT01577758|103978|P1|Dose Escalation Phase|Symptomatic Deterioration|0
23491|NCT01577758|103971|P8|Dose Escalation Phase|Adverse Event|0
23492|NCT01577758|103972|P7|Dose Escalation Phase|Adverse Event|1
23493|NCT01577758|103973|P6|Dose Escalation Phase|Adverse Event|2
23494|NCT01577758|103974|P5|Dose Escalation Phase|Adverse Event|0
23495|NCT01577758|103975|P4|Dose Escalation Phase|Adverse Event|0
23496|NCT01577758|103976|P3|Dose Escalation Phase|Adverse Event|0
23497|NCT01577758|103977|P2|Dose Escalation Phase|Adverse Event|0
23498|NCT01577758|103978|P1|Dose Escalation Phase|Adverse Event|0
23499|NCT01577381|104050|P4|Overall Study|Ongoing at Date of Cut-Off|0
23500|NCT01577381|104051|P3|Overall Study|Ongoing at Date of Cut-Off|1
23501|NCT01577381|104052|P2|Overall Study|Ongoing at Date of Cut-Off|2
23502|NCT01577381|104053|P1|Overall Study|Ongoing at Date of Cut-Off|0
23503|NCT01577381|104050|P4|Overall Study|Discontinued|2
23504|NCT01577381|104051|P3|Overall Study|Discontinued|2
23505|NCT01577381|104052|P2|Overall Study|Discontinued|1
23506|NCT01577381|104053|P1|Overall Study|Discontinued|2
23507|NCT01577186|104182|P1|Overall Study|Unspecified|2
23508|NCT01577186|104182|P1|Overall Study|Non-Compliant|8
23509|NCT01577186|104182|P1|Overall Study|Ineligible to Continue|15
23510|NCT01577186|104182|P1|Overall Study|Insufficient Response|18
23511|NCT01577186|104182|P1|Overall Study|Withdrawal by Subject|35
23512|NCT01577186|104182|P1|Overall Study|Lost to Follow-up|28
23513|NCT01577186|104182|P1|Overall Study|Death|1
23514|NCT01577186|104182|P1|Overall Study|Adverse Event|23
23515|NCT01577160|104190|P1|Overall Study|Unspecified|9
23516|NCT01577160|104190|P1|Overall Study|Subject Uncooperative|7
23517|NCT01577160|104190|P1|Overall Study|Withdrawal by Subject|18
23518|NCT01577160|104190|P1|Overall Study|Lost to Follow-up|40
23519|NCT01577160|104190|P1|Overall Study|Lack of Efficacy|15
23520|NCT01577160|104190|P1|Overall Study|Adverse Event|9
23521|NCT01576367|104213|P1|Overall Study|Moved to commercial use after 6 months|1
23522|NCT01576367|104213|P1|Overall Study|Unsatisfactory therapeutic effect|2
23523|NCT01576159|104225|P4|Overall Study|Protocol Violation|0
23524|NCT01576159|104226|P3|Overall Study|Protocol Violation|0
23525|NCT01576159|104227|P2|Overall Study|Protocol Violation|0
23526|NCT01576159|104228|P1|Overall Study|Protocol Violation|1
23527|NCT01576159|104225|P4|Overall Study|Lost to Follow-up|1
23528|NCT01576159|104226|P3|Overall Study|Lost to Follow-up|0
23529|NCT01576159|104227|P2|Overall Study|Lost to Follow-up|0
23530|NCT01576159|104228|P1|Overall Study|Lost to Follow-up|0
23531|NCT01576159|104225|P4|Overall Study|Physician Decision|0
23532|NCT01576159|104226|P3|Overall Study|Physician Decision|1
23533|NCT01576159|104227|P2|Overall Study|Physician Decision|0
23534|NCT01576159|104228|P1|Overall Study|Physician Decision|0
23535|NCT01576159|104225|P4|Overall Study|Withdrawal by Subject|0
23536|NCT01576159|104226|P3|Overall Study|Withdrawal by Subject|0
23537|NCT01576159|104227|P2|Overall Study|Withdrawal by Subject|1
23538|NCT01576159|104228|P1|Overall Study|Withdrawal by Subject|0
23539|NCT01576042|104272|P2|Overall Study|Physician Decision|0
23540|NCT01576042|104273|P1|Overall Study|Physician Decision|2
23541|NCT01575899|104296|P3|Overall Study|Protocol Violation|0
23542|NCT01575899|104297|P2|Overall Study|Protocol Violation|1
23543|NCT01575899|104298|P1|Overall Study|Protocol Violation|2
23544|NCT01575899|104296|P3|Overall Study|Lost to Follow-up|2
23545|NCT01575899|104297|P2|Overall Study|Lost to Follow-up|4
23546|NCT01575899|104298|P1|Overall Study|Lost to Follow-up|3
23547|NCT01575769|104308|P1|Overall Study|Study terminated by sponsor|40
23548|NCT01575769|104308|P1|Overall Study|Adverse Event|1
23549|NCT01575561|104351|P1|Overall Study|administration|1
23550|NCT01575561|104351|P1|Overall Study|Withdrawal by Subject|11
23551|NCT01575561|104351|P1|Overall Study|Protocol Violation|4
23552|NCT01575561|104351|P1|Overall Study|Lost to Follow-up|6
23553|NCT01575561|104351|P1|Overall Study|Lack of Efficacy|8
23554|NCT01575561|104351|P1|Overall Study|Adverse Event|9
23555|NCT01575197|104374|P3|Overall Study|Protocol Violation|1
23556|NCT01575197|104375|P2|Overall Study|Protocol Violation|1
23557|NCT01575197|104376|P1|Overall Study|Protocol Violation|2
23558|NCT01575197|104374|P3|Overall Study|Withdrawal by Subject|1
23559|NCT01575197|104375|P2|Overall Study|Withdrawal by Subject|1
23560|NCT01575197|104376|P1|Overall Study|Withdrawal by Subject|0
23561|NCT01575197|104374|P3|Overall Study|Lost to Follow-up|0
23562|NCT01575197|104375|P2|Overall Study|Lost to Follow-up|1
23563|NCT01575197|104376|P1|Overall Study|Lost to Follow-up|0
23564|NCT01575197|104374|P3|Overall Study|SAE|0
23565|NCT01575197|104375|P2|Overall Study|SAE|1
23566|NCT01575197|104376|P1|Overall Study|SAE|0
23567|NCT01575197|104374|P3|Overall Study|Migration out of study area|4
23568|NCT01575197|104375|P2|Overall Study|Migration out of study area|5
23569|NCT01575197|104376|P1|Overall Study|Migration out of study area|1
23570|NCT01575054|104398|P2|Overall Study|Adverse Event|8
23571|NCT01575054|104399|P1|Overall Study|Adverse Event|9
23572|NCT01575054|104398|P2|Overall Study|Lost to Follow-up|3
23573|NCT01575054|104399|P1|Overall Study|Lost to Follow-up|3
23574|NCT01575054|104398|P2|Overall Study|Personal Reasons|11
23575|NCT01575054|104399|P1|Overall Study|Personal Reasons|10
23576|NCT01575054|104398|P2|Overall Study|Protocol Violation|1
23577|NCT01575054|104399|P1|Overall Study|Protocol Violation|2
23578|NCT01575054|104398|P2|Overall Study|Other Reasons|3
23579|NCT01575054|104399|P1|Overall Study|Other Reasons|5
23580|NCT01575028|104415|P2|Overall Study|Physician Decision|1
23581|NCT01575028|104416|P1|Overall Study|Physician Decision|0
23582|NCT01574703|104426|P4|Overall Study|Death|0
23583|NCT01574703|104427|P3|Overall Study|Death|1
23584|NCT01574703|104428|P2|Overall Study|Death|1
23585|NCT01574703|104429|P1|Overall Study|Death|2
23586|NCT01574703|104426|P4|Overall Study|Lost to Follow-up|35
23587|NCT01574703|104427|P3|Overall Study|Lost to Follow-up|46
23588|NCT01574703|104428|P2|Overall Study|Lost to Follow-up|41
23589|NCT01574703|104429|P1|Overall Study|Lost to Follow-up|43
23590|NCT01574703|104426|P4|Overall Study|Met Withdrawal Criteria|0
23591|NCT01574703|104427|P3|Overall Study|Met Withdrawal Criteria|1
23592|NCT01574703|104428|P2|Overall Study|Met Withdrawal Criteria|1
23593|NCT01574703|104429|P1|Overall Study|Met Withdrawal Criteria|0
23594|NCT01574703|104426|P4|Overall Study|Withdrawal by Subject|61
23595|NCT01574703|104427|P3|Overall Study|Withdrawal by Subject|36
23596|NCT01574703|104428|P2|Overall Study|Withdrawal by Subject|52
23597|NCT01574703|104429|P1|Overall Study|Withdrawal by Subject|53
23598|NCT01574703|104426|P4|Overall Study|Unspecified Reason|16
23599|NCT01574703|104427|P3|Overall Study|Unspecified Reason|20
23600|NCT01574703|104428|P2|Overall Study|Unspecified Reason|15
23601|NCT01574703|104429|P1|Overall Study|Unspecified Reason|27
23602|NCT01574703|104426|P4|Overall Study|Protocol Violation|1
23603|NCT01574703|104427|P3|Overall Study|Protocol Violation|0
23604|NCT01574703|104428|P2|Overall Study|Protocol Violation|0
23605|NCT01574703|104429|P1|Overall Study|Protocol Violation|0
23606|NCT01574703|104426|P4|Overall Study|Adverse Event|1
23607|NCT01574703|104427|P3|Overall Study|Adverse Event|1
23608|NCT01574703|104428|P2|Overall Study|Adverse Event|2
23609|NCT01574703|104429|P1|Overall Study|Adverse Event|0
23610|NCT01574651|104473|P2|Overall Study|Withdrawal by Subject|10
23611|NCT01574651|104474|P1|Overall Study|Withdrawal by Subject|9
23612|NCT01574651|104473|P2|Overall Study|Protocol Violation|5
23613|NCT01574651|104474|P1|Overall Study|Protocol Violation|3
23614|NCT01574651|104473|P2|Overall Study|Unsatisfactory therapeutic effect|0
23615|NCT01574651|104474|P1|Overall Study|Unsatisfactory therapeutic effect|6
23616|NCT01574651|104473|P2|Overall Study|Abnormal test procedure result(s)|1
23617|NCT01574651|104474|P1|Overall Study|Abnormal test procedure result(s)|1
23618|NCT01574651|104473|P2|Overall Study|Abnormal laboratory value(s)|0
23619|NCT01574651|104474|P1|Overall Study|Abnormal laboratory value(s)|1
23620|NCT01574651|104473|P2|Overall Study|Adverse Event|27
23621|NCT01574651|104474|P1|Overall Study|Adverse Event|36
23622|NCT01574651|104473|P2|Overall Study|Patient's inability to use the device|1
23623|NCT01574651|104474|P1|Overall Study|Patient's inability to use the device|0
23624|NCT01574651|104473|P2|Overall Study|Death|3
23625|NCT01574651|104474|P1|Overall Study|Death|3
23626|NCT01574651|104473|P2|Overall Study|Administrative problems|1
23627|NCT01574651|104474|P1|Overall Study|Administrative problems|0
23628|NCT01574651|104473|P2|Overall Study|Lost to Follow-up|4
23629|NCT01574651|104474|P1|Overall Study|Lost to Follow-up|2
23630|NCT01574612|104496|P1|Overall Study|Lost to Follow-up|2
23631|NCT01574612|104496|P1|Overall Study|Withdrawal by Subject|1
23632|NCT01574612|104496|P1|Overall Study|non compliant with drug|2
23633|NCT01574612|104496|P1|Overall Study|Adverse Event|3
23634|NCT01574326|104502|P2|Overall Study|Other: Mainly kidney transplant|8
23635|NCT01574326|104503|P1|Overall Study|Other: Mainly kidney transplant|8
23636|NCT01574326|104502|P2|Overall Study|Adverse Event|3
23637|NCT01574326|104503|P1|Overall Study|Adverse Event|1
23638|NCT01574326|104502|P2|Overall Study|Physician Decision|3
23639|NCT01574326|104503|P1|Overall Study|Physician Decision|5
23640|NCT01574326|104502|P2|Overall Study|Withdrawal by Participant|4
23641|NCT01574326|104503|P1|Overall Study|Withdrawal by Participant|2
23642|NCT01574326|104502|P2|Overall Study|Randomized but not treated|1
23643|NCT01574326|104503|P1|Overall Study|Randomized but not treated|0
23644|NCT01574248|104516|P2|Overall Study|Missing primary endpoint data|0
23645|NCT01574248|104517|P1|Overall Study|Missing primary endpoint data|1
23646|NCT01574248|104516|P2|Overall Study|Withdrawal by Subject|0
23647|NCT01574248|104517|P1|Overall Study|Withdrawal by Subject|2
23648|NCT01574079|104561|P2|Overall Study|Lost to Follow-up|0
23649|NCT01574079|104562|P1|Overall Study|Lost to Follow-up|1
23650|NCT01574079|104561|P2|Overall Study|Physician Decision|2
23651|NCT01574079|104562|P1|Overall Study|Physician Decision|0
23652|NCT01573910|104574|P2|Overall Study|Patient decision unrelated to Advs Event|11
23653|NCT01573910|104575|P1|Overall Study|Patient decision unrelated to Advs Event|11
23654|NCT01573910|104574|P2|Overall Study|Protocol Violation|0
23655|NCT01573910|104575|P1|Overall Study|Protocol Violation|3
23656|NCT01573910|104574|P2|Overall Study|Withdrawal by Subject|1
23657|NCT01573910|104575|P1|Overall Study|Withdrawal by Subject|0
23658|NCT01573910|104574|P2|Overall Study|Lost to Follow-up|1
23659|NCT01573910|104575|P1|Overall Study|Lost to Follow-up|2
23660|NCT01573910|104574|P2|Overall Study|Adverse Event|4
23661|NCT01573910|104575|P1|Overall Study|Adverse Event|4
23662|NCT01573767|104587|P4|Overall Study|Withdrawal by Subject|0
23663|NCT01573767|104588|P3|Overall Study|Withdrawal by Subject|0
23664|NCT01573767|104589|P2|Overall Study|Withdrawal by Subject|1
23665|NCT01573767|104590|P1|Overall Study|Withdrawal by Subject|0
23666|NCT01573767|104587|P4|Overall Study|Physician Decision|2
23667|NCT01573767|104588|P3|Overall Study|Physician Decision|0
23668|NCT01573767|104589|P2|Overall Study|Physician Decision|2
23669|NCT01573767|104590|P1|Overall Study|Physician Decision|1
23670|NCT01573767|104587|P4|Overall Study|Lost to Follow-up|1
23671|NCT01573767|104588|P3|Overall Study|Lost to Follow-up|1
23672|NCT01573767|104589|P2|Overall Study|Lost to Follow-up|1
23673|NCT01573767|104590|P1|Overall Study|Lost to Follow-up|0
23674|NCT01573767|104587|P4|Overall Study|Protocol Violation|3
23675|NCT01573767|104588|P3|Overall Study|Protocol Violation|1
23676|NCT01573767|104589|P2|Overall Study|Protocol Violation|1
23677|NCT01573767|104590|P1|Overall Study|Protocol Violation|3
23678|NCT01573767|104587|P4|Overall Study|Lack of Efficacy|17
23679|NCT01573767|104588|P3|Overall Study|Lack of Efficacy|12
23680|NCT01573767|104589|P2|Overall Study|Lack of Efficacy|15
23681|NCT01573767|104590|P1|Overall Study|Lack of Efficacy|18
23682|NCT01573767|104587|P4|Overall Study|Adverse Event|1
23683|NCT01573767|104588|P3|Overall Study|Adverse Event|0
23684|NCT01573767|104589|P2|Overall Study|Adverse Event|1
23685|NCT01573767|104590|P1|Overall Study|Adverse Event|0
23686|NCT01573000|104666|P2|Long-Term Follow-Up|Lost to Follow-up|1
23687|NCT01573000|104667|P1|Long-Term Follow-Up|Lost to Follow-up|0
23688|NCT01573000|104666|P2|Long-Term Follow-Up|Death|0
23689|NCT01573000|104667|P1|Long-Term Follow-Up|Death|3
23690|NCT01573000|104666|P2|Crossover Phase|Death|3
23691|NCT01573000|104667|P1|Crossover Phase|Death|0
23692|NCT01573000|104666|P2|Crossover Phase|Lost to Follow-up|2
23693|NCT01573000|104667|P1|Crossover Phase|Lost to Follow-up|0
23694|NCT01573000|104666|P2|Crossover Phase|Lack of Efficacy|13
23695|NCT01573000|104667|P1|Crossover Phase|Lack of Efficacy|0
23696|NCT01573000|104666|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
23697|NCT01573000|104667|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
23698|NCT01573000|104666|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
23699|NCT01573000|104667|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
23700|NCT01573000|104666|P2|Dosimetric and Therapeutic Treatment|Death|1
23701|NCT01573000|104667|P1|Dosimetric and Therapeutic Treatment|Death|0
23702|NCT01573000|104666|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
23703|NCT01573000|104667|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
23704|NCT01573000|104666|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
23705|NCT01573000|104667|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
23706|NCT01572948|104763|P2|Overall Study|unable to contact|1
23707|NCT01572948|104764|P1|Overall Study|unable to contact|0
23708|NCT01572948|104763|P2|Overall Study|Lost to Follow-up|0
23709|NCT01572948|104764|P1|Overall Study|Lost to Follow-up|1
23710|NCT01572740|104782|P2|Overall Study|unclassified|3
23711|NCT01572740|104783|P1|Overall Study|unclassified|4
23712|NCT01572740|104782|P2|Overall Study|Withdrawal by Subject|1
23713|NCT01572740|104783|P1|Overall Study|Withdrawal by Subject|1
23714|NCT01572740|104782|P2|Overall Study|Adverse Event|1
23715|NCT01572740|104783|P1|Overall Study|Adverse Event|1
23716|NCT01572727|104813|P2|Overall Study|Untreated|7
23717|NCT01572727|104814|P1|Overall Study|Untreated|4
23718|NCT01572727|104813|P2|Overall Study|Death|2
23719|NCT01572727|104814|P1|Overall Study|Death|2
23720|NCT01572727|104813|P2|Overall Study|Parent/guardian decision|9
23721|NCT01572727|104814|P1|Overall Study|Parent/guardian decision|14
23722|NCT01572727|104813|P2|Overall Study|Study terminated by sponsor|83
23723|NCT01572727|104814|P1|Overall Study|Study terminated by sponsor|61
23724|NCT01572727|104813|P2|Overall Study|Protocol Violation|1
23725|NCT01572727|104814|P1|Overall Study|Protocol Violation|0
23726|NCT01572727|104813|P2|Overall Study|Progressive disease|82
23727|NCT01572727|104814|P1|Overall Study|Progressive disease|59
23728|NCT01572727|104813|P2|Overall Study|Physician Decision|9
23729|NCT01572727|104814|P1|Overall Study|Physician Decision|23
23730|NCT01572727|104813|P2|Overall Study|Lost to Follow-up|1
23731|NCT01572727|104814|P1|Overall Study|Lost to Follow-up|1
23732|NCT01572727|104813|P2|Overall Study|Adverse Event|15
23733|NCT01572727|104814|P1|Overall Study|Adverse Event|43
23734|NCT01572675|104836|P2|Overall Study|Lost to Follow-up|27
23735|NCT01572675|104837|P1|Overall Study|Lost to Follow-up|22
23736|NCT01572675|104836|P2|Overall Study|Missing data|4
23737|NCT01572675|104837|P1|Overall Study|Missing data|1
23738|NCT01572675|104836|P2|Overall Study|Rheumatologist new evaluation|1
23739|NCT01572675|104837|P1|Overall Study|Rheumatologist new evaluation|0
23740|NCT01572675|104836|P2|Overall Study|Unknown reason|1
23741|NCT01572675|104837|P1|Overall Study|Unknown reason|1
23742|NCT01572675|104836|P2|Overall Study|Other disease detected|1
23743|NCT01572675|104837|P1|Overall Study|Other disease detected|1
23744|NCT01572675|104836|P2|Overall Study|Death unrelated to coxibs|1
23745|NCT01572675|104837|P1|Overall Study|Death unrelated to coxibs|1
23746|NCT01572675|104836|P2|Overall Study|Physician Decision|2
23747|NCT01572675|104837|P1|Overall Study|Physician Decision|2
23748|NCT01572675|104836|P2|Overall Study|Withdrawal by Subject|1
23749|NCT01572675|104837|P1|Overall Study|Withdrawal by Subject|5
23750|NCT01572675|104836|P2|Overall Study|Surgical intervention|6
23751|NCT01572675|104837|P1|Overall Study|Surgical intervention|3
23752|NCT01572675|104836|P2|Overall Study|Improved symptoms|2
23753|NCT01572675|104837|P1|Overall Study|Improved symptoms|8
23754|NCT01572675|104836|P2|Overall Study|Intolerance|5
23755|NCT01572675|104837|P1|Overall Study|Intolerance|6
23756|NCT01572675|104836|P2|Overall Study|Lack of Efficacy|31
23757|NCT01572675|104837|P1|Overall Study|Lack of Efficacy|31
23758|NCT01572675|104836|P2|Overall Study|Recovery|23
23759|NCT01572675|104837|P1|Overall Study|Recovery|16
23760|NCT01572675|104836|P2|Overall Study|End of prescribed treatment|118
23761|NCT01572675|104837|P1|Overall Study|End of prescribed treatment|140
23762|NCT01571453|104965|P2|Overall Study|Administrative or other reason(s)|3
23763|NCT01571453|104966|P1|Overall Study|Administrative or other reason(s)|4
23764|NCT01571453|104965|P2|Overall Study|Lost to Follow-up|2
23765|NCT01571453|104966|P1|Overall Study|Lost to Follow-up|4
23766|NCT01571453|104965|P2|Overall Study|Withdrawal of consent|13
23767|NCT01571453|104966|P1|Overall Study|Withdrawal of consent|5
23768|NCT01571453|104965|P2|Overall Study|Protocol Violation|5
23769|NCT01571453|104966|P1|Overall Study|Protocol Violation|1
23770|NCT01571453|104965|P2|Overall Study|Non-compliance|4
23771|NCT01571453|104966|P1|Overall Study|Non-compliance|2
23772|NCT01571453|104965|P2|Overall Study|Lack of Efficacy|3
23773|NCT01571453|104966|P1|Overall Study|Lack of Efficacy|8
23774|NCT01571453|104965|P2|Overall Study|Adverse Event|32
23775|NCT01571453|104966|P1|Overall Study|Adverse Event|14
23776|NCT01570751|104984|P2|Period B (16 Weeks)|Protocol Violation|1
23777|NCT01570751|104985|P1|Period B (16 Weeks)|Protocol Violation|0
23778|NCT01570751|104984|P2|Period B (16 Weeks)|Adverse Event|0
23779|NCT01570751|104985|P1|Period B (16 Weeks)|Adverse Event|1
23780|NCT01570751|104984|P2|Period A (16 Weeks)|Unclassified|3
23781|NCT01570751|104985|P1|Period A (16 Weeks)|Unclassified|2
23782|NCT01570751|104984|P2|Period A (16 Weeks)|Withdrawal criteria|1
23783|NCT01570751|104985|P1|Period A (16 Weeks)|Withdrawal criteria|0
23784|NCT01570751|104984|P2|Period A (16 Weeks)|Protocol Violation|1
23785|NCT01570751|104985|P1|Period A (16 Weeks)|Protocol Violation|1
23786|NCT01570686|105003|P2|Overall Study|Unsatisfactory therapeutic effect|1
23787|NCT01570686|105004|P1|Overall Study|Unsatisfactory therapeutic effect|2
23788|NCT01570686|105003|P2|Overall Study|Withdrawal by Subject|4
23789|NCT01570686|105004|P1|Overall Study|Withdrawal by Subject|4
23790|NCT01570686|105003|P2|Overall Study|Protocol Deviation|0
23791|NCT01570686|105004|P1|Overall Study|Protocol Deviation|3
23792|NCT01570686|105003|P2|Overall Study|Lost to Follow-up|3
23793|NCT01570686|105004|P1|Overall Study|Lost to Follow-up|4
23794|NCT01570686|105003|P2|Overall Study|Adverse Event|6
23795|NCT01570686|105004|P1|Overall Study|Adverse Event|8
23796|NCT01570686|105003|P2|Overall Study|Administrative problems|1
23797|NCT01570686|105004|P1|Overall Study|Administrative problems|0
23798|NCT01570686|105003|P2|Overall Study|Abnormal test procedure result(s)|1
23799|NCT01570686|105004|P1|Overall Study|Abnormal test procedure result(s)|1
23800|NCT01570309|105040|P2|Overall Study|Withdrawal by Subject|3
23801|NCT01570309|105041|P1|Overall Study|Withdrawal by Subject|3
23802|NCT01570244|105055|P1|Microgynon+Faldaprevir|Adverse Event|1
23803|NCT01569841|105075|P2|Period A (6 Weeks)|Withdrawal by Subject|1
23804|NCT01569841|105076|P1|Period A (6 Weeks)|Withdrawal by Subject|0
23805|NCT01569763|105165|P2|Overall Study|Adverse Event|0
23806|NCT01569763|105166|P1|Overall Study|Adverse Event|1
23807|NCT01569763|105165|P2|Overall Study|Lack of Efficacy|7
23808|NCT01569763|105166|P1|Overall Study|Lack of Efficacy|2
23809|NCT01569464|105187|P2|Overall Study|Other|1
23810|NCT01569464|105188|P1|Overall Study|Other|1
23811|NCT01569464|105187|P2|Overall Study|Withdrawal by Subject|1
23812|NCT01569464|105188|P1|Overall Study|Withdrawal by Subject|1
23813|NCT01569464|105187|P2|Overall Study|Lost to Follow-up|3
23814|NCT01569464|105188|P1|Overall Study|Lost to Follow-up|2
23815|NCT01569464|105187|P2|Overall Study|Protocol Violation|0
23816|NCT01569464|105188|P1|Overall Study|Protocol Violation|1
23817|NCT01569464|105187|P2|Overall Study|Lack of Efficacy|0
23818|NCT01569464|105188|P1|Overall Study|Lack of Efficacy|1
23819|NCT01569464|105187|P2|Overall Study|Adverse Event|0
23820|NCT01569464|105188|P1|Overall Study|Adverse Event|4
23821|NCT01569438|105226|P2|Overall Study|Protocol Violation|0
23822|NCT01569438|105227|P1|Overall Study|Protocol Violation|1
23823|NCT01569438|105226|P2|Overall Study|Withdrawal by Subject|1
23824|NCT01569438|105227|P1|Overall Study|Withdrawal by Subject|0
23825|NCT01569438|105226|P2|Overall Study|Lack of Efficacy|1
23826|NCT01569438|105227|P1|Overall Study|Lack of Efficacy|1
23827|NCT01569438|105226|P2|Overall Study|Adverse Event|7
23828|NCT01569438|105227|P1|Overall Study|Adverse Event|0
23829|NCT01569074|105318|P5|Overall Study|Adverse Event|0
23830|NCT01569074|105319|P4|Overall Study|Adverse Event|0
23831|NCT01569074|105320|P3|Overall Study|Adverse Event|3
23832|NCT01569074|105321|P2|Overall Study|Adverse Event|0
23833|NCT01569074|105322|P1|Overall Study|Adverse Event|1
23834|NCT01569074|105318|P5|Overall Study|eg change in circumstances|1
23835|NCT01569074|105319|P4|Overall Study|eg change in circumstances|1
23836|NCT01569074|105320|P3|Overall Study|eg change in circumstances|0
23837|NCT01569074|105321|P2|Overall Study|eg change in circumstances|2
23838|NCT01569074|105322|P1|Overall Study|eg change in circumstances|0
23839|NCT01569074|105318|P5|Overall Study|Severe non-compliance to protocol|0
23840|NCT01569074|105319|P4|Overall Study|Severe non-compliance to protocol|0
23841|NCT01569074|105320|P3|Overall Study|Severe non-compliance to protocol|1
23842|NCT01569074|105321|P2|Overall Study|Severe non-compliance to protocol|0
23843|NCT01569074|105322|P1|Overall Study|Severe non-compliance to protocol|0
23844|NCT01569074|105318|P5|Overall Study|Study-specific discontinuation criteria|0
23845|NCT01569074|105319|P4|Overall Study|Study-specific discontinuation criteria|0
23846|NCT01569074|105320|P3|Overall Study|Study-specific discontinuation criteria|0
23847|NCT01569074|105321|P2|Overall Study|Study-specific discontinuation criteria|1
23848|NCT01569074|105322|P1|Overall Study|Study-specific discontinuation criteria|0
23849|NCT01569074|105318|P5|Overall Study|Study stopped|7
23850|NCT01569074|105319|P4|Overall Study|Study stopped|7
23851|NCT01569074|105320|P3|Overall Study|Study stopped|8
23852|NCT01569074|105321|P2|Overall Study|Study stopped|6
23853|NCT01569074|105322|P1|Overall Study|Study stopped|6
23854|NCT01568892|105402|P2|Open-label Phase|Ongoing|15
23855|NCT01568892|105403|P1|Open-label Phase|Ongoing|12
23856|NCT01568892|105402|P2|Open-label Phase|Lack of Efficacy|1
23857|NCT01568892|105403|P1|Open-label Phase|Lack of Efficacy|0
23858|NCT01568892|105402|P2|Open-label Phase|Adverse Event|0
23859|NCT01568892|105403|P1|Open-label Phase|Adverse Event|1
23860|NCT01568866|105441|P2|Overall Study|Randomized but Not Dosed|1
23861|NCT01568866|105442|P1|Overall Study|Randomized but Not Dosed|9
23862|NCT01568866|105441|P2|Overall Study|Lost to Follow-up|0
23863|NCT01568866|105442|P1|Overall Study|Lost to Follow-up|1
23864|NCT01568866|105441|P2|Overall Study|Protocol Non-compliance|4
23865|NCT01568866|105442|P1|Overall Study|Protocol Non-compliance|1
23866|NCT01568866|105441|P2|Overall Study|Death|13
23867|NCT01568866|105442|P1|Overall Study|Death|9
23868|NCT01568866|105441|P2|Overall Study|Withdrawal by Subject|6
23869|NCT01568866|105442|P1|Overall Study|Withdrawal by Subject|19
23870|NCT01568866|105441|P2|Overall Study|Physician Decision|18
23871|NCT01568866|105442|P1|Overall Study|Physician Decision|35
23872|NCT01568866|105441|P2|Overall Study|Patient Request|40
23873|NCT01568866|105442|P1|Overall Study|Patient Request|45
23874|NCT01568866|105441|P2|Overall Study|Adverse Event|65
23875|NCT01568866|105442|P1|Overall Study|Adverse Event|73
23876|NCT01568866|105441|P2|Overall Study|Disease Progression|117
23877|NCT01568866|105442|P1|Overall Study|Disease Progression|168
23878|NCT01568593|105473|P2|Overall Study|Adverse Event|2
23879|NCT01568593|105474|P1|Overall Study|Adverse Event|3
23880|NCT01568593|105473|P2|Overall Study|Lack of Efficacy|1
23881|NCT01568593|105474|P1|Overall Study|Lack of Efficacy|4
23882|NCT01568112|105484|P4|Overall Study|Withdrawal by Physician|1
23883|NCT01568112|105485|P3|Overall Study|Withdrawal by Physician|1
23884|NCT01568112|105486|P2|Overall Study|Withdrawal by Physician|0
23885|NCT01568112|105487|P1|Overall Study|Withdrawal by Physician|1
23886|NCT01568112|105484|P4|Overall Study|Withdrawal by Subject|7
23887|NCT01568112|105485|P3|Overall Study|Withdrawal by Subject|0
23888|NCT01568112|105486|P2|Overall Study|Withdrawal by Subject|3
23889|NCT01568112|105487|P1|Overall Study|Withdrawal by Subject|2
23890|NCT01568112|105484|P4|Overall Study|Lost to Follow-up|1
23891|NCT01568112|105485|P3|Overall Study|Lost to Follow-up|0
23892|NCT01568112|105486|P2|Overall Study|Lost to Follow-up|0
23893|NCT01568112|105487|P1|Overall Study|Lost to Follow-up|0
23894|NCT01568112|105484|P4|Overall Study|Withdrew due to Adverse Event|3
23895|NCT01568112|105485|P3|Overall Study|Withdrew due to Adverse Event|6
23896|NCT01568112|105486|P2|Overall Study|Withdrew due to Adverse Event|4
23897|NCT01568112|105487|P1|Overall Study|Withdrew due to Adverse Event|2
23898|NCT01568112|105484|P4|Overall Study|Randomized But Not Treated|0
23899|NCT01568112|105485|P3|Overall Study|Randomized But Not Treated|0
23900|NCT01568112|105486|P2|Overall Study|Randomized But Not Treated|1
23901|NCT01568112|105487|P1|Overall Study|Randomized But Not Treated|0
23902|NCT01568047|105645|P4|Overall Study|Adverse Event|1
23903|NCT01568047|105646|P3|Overall Study|Adverse Event|1
23904|NCT01568047|105647|P2|Overall Study|Adverse Event|0
23905|NCT01568047|105648|P1|Overall Study|Adverse Event|0
23906|NCT01568047|105645|P4|Overall Study|Withdrawal by Subject|0
23907|NCT01568047|105646|P3|Overall Study|Withdrawal by Subject|0
23908|NCT01568047|105647|P2|Overall Study|Withdrawal by Subject|1
23909|NCT01568047|105648|P1|Overall Study|Withdrawal by Subject|0
23910|NCT01568047|105645|P4|Overall Study|Ineligibility|0
23911|NCT01568047|105646|P3|Overall Study|Ineligibility|0
23912|NCT01568047|105647|P2|Overall Study|Ineligibility|0
23913|NCT01568047|105648|P1|Overall Study|Ineligibility|1
23914|NCT01568034|105666|P4|Overall Study|Withdrawal by Subject|0
23915|NCT01568034|105667|P3|Overall Study|Withdrawal by Subject|0
23916|NCT01568034|105668|P2|Overall Study|Withdrawal by Subject|0
23917|NCT01568034|105669|P1|Overall Study|Withdrawal by Subject|1
23918|NCT01567852|105713|P2|Overall Study|ECT discontinued|1
23919|NCT01567852|105714|P1|Overall Study|ECT discontinued|1
23920|NCT01567852|105713|P2|Overall Study|Withdrawal by Subject|6
23921|NCT01567852|105714|P1|Overall Study|Withdrawal by Subject|3
23922|NCT01567163|105735|P1|Overall Study|Lost to Follow-up|2
23923|NCT01567163|105735|P1|Overall Study|Progressive Disease|2
23924|NCT01566981|105775|P2|Overall Study|Lost to Follow-up|8
23925|NCT01566981|105776|P1|Overall Study|Lost to Follow-up|5
23926|NCT01566604|105864|P2|Overall Study|Withdrawal by Subject|6
23927|NCT01566604|105865|P1|Overall Study|Withdrawal by Subject|9
23928|NCT01566604|105864|P2|Overall Study|Adverse Event|2
23929|NCT01566604|105865|P1|Overall Study|Adverse Event|4
23930|NCT01566604|105864|P2|Overall Study|Death|1
23931|NCT01566604|105865|P1|Overall Study|Death|4
23932|NCT01566604|105864|P2|Overall Study|Abnormal laboratory value|0
23933|NCT01566604|105865|P1|Overall Study|Abnormal laboratory value|2
23934|NCT01566604|105864|P2|Overall Study|Protocol deviation|0
23935|NCT01566604|105865|P1|Overall Study|Protocol deviation|2
23936|NCT01566604|105864|P2|Overall Study|Lack of Efficacy|2
23937|NCT01566604|105865|P1|Overall Study|Lack of Efficacy|1
23938|NCT01566604|105864|P2|Overall Study|Administrative problems|0
23939|NCT01566604|105865|P1|Overall Study|Administrative problems|1
23940|NCT01566604|105864|P2|Overall Study|Patient's inability to use the device|0
23941|NCT01566604|105865|P1|Overall Study|Patient's inability to use the device|1
23942|NCT01566435|105952|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
23943|NCT01566149|106021|P2|Overall Study|Withdrawal by Subject|0
23944|NCT01566149|106022|P1|Overall Study|Withdrawal by Subject|1
23945|NCT01566149|106021|P2|Overall Study|Protocol Violation|1
23946|NCT01566149|106022|P1|Overall Study|Protocol Violation|0
23947|NCT01566149|106021|P2|Overall Study|Non-compliance with study medication|0
23948|NCT01566149|106022|P1|Overall Study|Non-compliance with study medication|2
23949|NCT01566149|106021|P2|Overall Study|Adverse Event|1
23950|NCT01566149|106022|P1|Overall Study|Adverse Event|0
23951|NCT01565993|106055|P2|Overall Study|Physician Decision|3
23952|NCT01565993|106056|P1|Overall Study|Physician Decision|0
23953|NCT01565980|106064|P2|Overall Study|Withdrawal by Subject|3
23954|NCT01565980|106065|P1|Overall Study|Withdrawal by Subject|0
23955|NCT01565980|106064|P2|Overall Study|stopped medical treatment|0
23956|NCT01565980|106065|P1|Overall Study|stopped medical treatment|1
23957|NCT01565980|106064|P2|Overall Study|health complications|1
23958|NCT01565980|106065|P1|Overall Study|health complications|1
23959|NCT01565980|106064|P2|Overall Study|Lost to Follow-up|0
23960|NCT01565980|106065|P1|Overall Study|Lost to Follow-up|1
23961|NCT01565980|106064|P2|Overall Study|Death|0
23962|NCT01565980|106065|P1|Overall Study|Death|1
23963|NCT01565889|106124|P6|Part B|Lost to Follow-up|1
23964|NCT01565889|106125|P5|Part B|Lost to Follow-up|0
23965|NCT01565889|106126|P4|Part B|Lost to Follow-up|0
23966|NCT01565889|106127|P3|Part B|Lost to Follow-up|0
23967|NCT01565889|106128|P2|Part B|Lost to Follow-up|0
23968|NCT01565889|106129|P1|Part B|Lost to Follow-up|0
23969|NCT01565889|106124|P6|Part B|Lack of Efficacy|2
23970|NCT01565889|106125|P5|Part B|Lack of Efficacy|0
23971|NCT01565889|106126|P4|Part B|Lack of Efficacy|0
23972|NCT01565889|106127|P3|Part B|Lack of Efficacy|0
23973|NCT01565889|106128|P2|Part B|Lack of Efficacy|0
23974|NCT01565889|106129|P1|Part B|Lack of Efficacy|0
23975|NCT01565889|106124|P6|Part B|Withdrawal by Subject|1
23976|NCT01565889|106125|P5|Part B|Withdrawal by Subject|0
23977|NCT01565889|106126|P4|Part B|Withdrawal by Subject|0
23978|NCT01565889|106127|P3|Part B|Withdrawal by Subject|0
23979|NCT01565889|106128|P2|Part B|Withdrawal by Subject|0
23980|NCT01565889|106129|P1|Part B|Withdrawal by Subject|0
23981|NCT01565889|106124|P6|Part A|Withdrawal by Subject|0
23982|NCT01565889|106125|P5|Part A|Withdrawal by Subject|0
23983|NCT01565889|106126|P4|Part A|Withdrawal by Subject|0
23984|NCT01565889|106127|P3|Part A|Withdrawal by Subject|0
23985|NCT01565889|106128|P2|Part A|Withdrawal by Subject|0
23986|NCT01565889|106129|P1|Part A|Withdrawal by Subject|1
23987|NCT01565850|106160|P2|Overall Study|Withdrew Consent|2
23988|NCT01565850|106161|P1|Overall Study|Withdrew Consent|4
23989|NCT01565850|106160|P2|Overall Study|Participant noncompliance|0
23990|NCT01565850|106161|P1|Overall Study|Participant noncompliance|2
23991|NCT01565850|106160|P2|Overall Study|Investigator’s Discretion|1
23992|NCT01565850|106161|P1|Overall Study|Investigator’s Discretion|2
23993|NCT01565850|106160|P2|Overall Study|Lost to Follow-up|4
23994|NCT01565850|106161|P1|Overall Study|Lost to Follow-up|12
23995|NCT01565850|106160|P2|Overall Study|Adverse Event|1
23996|NCT01565850|106161|P1|Overall Study|Adverse Event|0
23997|NCT01565707|106181|P4|Overall Study|Miscellaneous|2
23998|NCT01565707|106182|P3|Overall Study|Miscellaneous|0
23999|NCT01565707|106183|P2|Overall Study|Miscellaneous|1
24000|NCT01565707|106184|P1|Overall Study|Miscellaneous|1
24001|NCT01565707|106181|P4|Overall Study|Randomized but not evaluable|0
24002|NCT01565707|106182|P3|Overall Study|Randomized but not evaluable|0
24003|NCT01565707|106183|P2|Overall Study|Randomized but not evaluable|0
24004|NCT01565707|106184|P1|Overall Study|Randomized but not evaluable|2
24005|NCT01565707|106181|P4|Overall Study|Withdrawal by Subject|1
24006|NCT01565707|106182|P3|Overall Study|Withdrawal by Subject|1
24007|NCT01565707|106183|P2|Overall Study|Withdrawal by Subject|1
24008|NCT01565707|106184|P1|Overall Study|Withdrawal by Subject|3
24009|NCT01565707|106181|P4|Overall Study|Protocol Violation|1
24010|NCT01565707|106182|P3|Overall Study|Protocol Violation|0
24011|NCT01565707|106183|P2|Overall Study|Protocol Violation|0
24012|NCT01565707|106184|P1|Overall Study|Protocol Violation|1
24013|NCT01565707|106181|P4|Overall Study|Lost to Follow-up|0
24014|NCT01565707|106182|P3|Overall Study|Lost to Follow-up|0
24015|NCT01565707|106183|P2|Overall Study|Lost to Follow-up|0
24016|NCT01565707|106184|P1|Overall Study|Lost to Follow-up|1
24017|NCT01565707|106181|P4|Overall Study|Adverse Event|1
24018|NCT01565707|106182|P3|Overall Study|Adverse Event|2
24019|NCT01565707|106183|P2|Overall Study|Adverse Event|6
24020|NCT01565707|106184|P1|Overall Study|Adverse Event|1
24021|NCT01565564|106277|P2|Overall Study|Lost to Follow-up|1
24022|NCT01565564|106278|P1|Overall Study|Lost to Follow-up|5
24023|NCT01565343|106328|P3|Overall Study|Administrative decision/technical issues|0
24024|NCT01565343|106329|P2|Overall Study|Administrative decision/technical issues|0
24025|NCT01565343|106330|P1|Overall Study|Administrative decision/technical issues|1
24026|NCT01565291|106360|P2|Overall Study|Withdrawal by Subject|0
24027|NCT01565291|106361|P1|Overall Study|Withdrawal by Subject|1
24028|NCT01565083|106371|P2|Overall Study|Unspecified|5
24029|NCT01565083|106372|P1|Overall Study|Unspecified|3
24030|NCT01565083|106371|P2|Overall Study|Death|23
24031|NCT01565083|106372|P1|Overall Study|Death|22
24032|NCT01565083|106371|P2|Overall Study|Lost to Follow-up|7
24033|NCT01565083|106372|P1|Overall Study|Lost to Follow-up|2
24034|NCT01565083|106371|P2|Overall Study|Withdrawal by Subject|4
24035|NCT01565083|106372|P1|Overall Study|Withdrawal by Subject|6
24036|NCT01564862|106401|P3|Overall Study|Other reason(s)|0
24037|NCT01564862|106402|P2|Overall Study|Other reason(s)|0
24038|NCT01564862|106403|P1|Overall Study|Other reason(s)|1
24039|NCT01564862|106401|P3|Overall Study|Lack of Efficacy|6
24040|NCT01564862|106402|P2|Overall Study|Lack of Efficacy|5
24041|NCT01564862|106403|P1|Overall Study|Lack of Efficacy|1
24042|NCT01564862|106401|P3|Overall Study|Voluntary Withdrawal|8
24043|NCT01564862|106402|P2|Overall Study|Voluntary Withdrawal|6
24044|NCT01564862|106403|P1|Overall Study|Voluntary Withdrawal|9
24045|NCT01564862|106401|P3|Overall Study|Lost to Follow-up|6
24046|NCT01564862|106402|P2|Overall Study|Lost to Follow-up|8
24047|NCT01564862|106403|P1|Overall Study|Lost to Follow-up|10
24048|NCT01564862|106401|P3|Overall Study|Major Protocol Deviation|4
24049|NCT01564862|106402|P2|Overall Study|Major Protocol Deviation|3
24050|NCT01564862|106403|P1|Overall Study|Major Protocol Deviation|3
24051|NCT01564862|106401|P3|Overall Study|Pretreatment Event or Adverse Event|6
24052|NCT01564862|106402|P2|Overall Study|Pretreatment Event or Adverse Event|12
24053|NCT01564862|106403|P1|Overall Study|Pretreatment Event or Adverse Event|6
24054|NCT01564758|106452|P1|Overall Study|Unspecified|3
24055|NCT01564758|106452|P1|Overall Study|Adverse Event|3
24056|NCT01564758|106452|P1|Overall Study|Death|8
24057|NCT01564732|106459|P2|Overall Study|Early termination by the study sponsor|5
24058|NCT01564732|106460|P1|Overall Study|Early termination by the study sponsor|6
24059|NCT01564537|106520|P2|Overall Study|Other Miscellaneous Reasons|2
24060|NCT01564537|106521|P1|Overall Study|Other Miscellaneous Reasons|1
24061|NCT01564537|106520|P2|Overall Study|Lost to Follow-up|0
24062|NCT01564537|106521|P1|Overall Study|Lost to Follow-up|1
24063|NCT01564537|106520|P2|Overall Study|Withdrawal by Participant|4
24064|NCT01564537|106521|P1|Overall Study|Withdrawal by Participant|4
24065|NCT01564459|106544|P3|Double-blind Treatment|Adverse Event|1
24066|NCT01564459|106545|P2|Double-blind Treatment|Adverse Event|0
24067|NCT01564459|106546|P1|Double-blind Treatment|Adverse Event|0
24068|NCT01564459|106544|P3|Run-In|Withdrawal by Subject|0
24069|NCT01564459|106545|P2|Run-In|Withdrawal by Subject|0
24070|NCT01564459|106546|P1|Run-In|Withdrawal by Subject|1
24071|NCT01564459|106544|P3|Run-In|Protocol Violation|0
24072|NCT01564459|106545|P2|Run-In|Protocol Violation|0
24073|NCT01564459|106546|P1|Run-In|Protocol Violation|1
24074|NCT01564459|106544|P3|Run-In|Non-compliance with study drug|0
24075|NCT01564459|106545|P2|Run-In|Non-compliance with study drug|0
24076|NCT01564459|106546|P1|Run-In|Non-compliance with study drug|2
24077|NCT01564459|106544|P3|Run-In|Lost to Follow-up|0
24078|NCT01564459|106545|P2|Run-In|Lost to Follow-up|0
24079|NCT01564459|106546|P1|Run-In|Lost to Follow-up|1
24080|NCT01564459|106544|P3|Run-In|Adverse Event|0
24081|NCT01564459|106545|P2|Run-In|Adverse Event|0
24082|NCT01564459|106546|P1|Run-In|Adverse Event|7
24083|NCT01564394|106567|P2|Overall Study|Withdrawal by Subject|10
24084|NCT01564394|106568|P1|Overall Study|Withdrawal by Subject|6
24085|NCT01563978|106582|P2|Overall Study|Adverse Event|2
24086|NCT01563978|106583|P1|Overall Study|Adverse Event|1
24087|NCT01563978|106582|P2|Overall Study|Dev. of study specific discont. criteria|0
24088|NCT01563978|106583|P1|Overall Study|Dev. of study specific discont. criteria|1
24089|NCT01563978|106582|P2|Overall Study|Lost to Follow-up|0
24090|NCT01563978|106583|P1|Overall Study|Lost to Follow-up|1
24091|NCT01563978|106582|P2|Overall Study|Physician Decision|0
24092|NCT01563978|106583|P1|Overall Study|Physician Decision|1
24093|NCT01563536|106609|P2|Overall Study|Lost to Follow-up|0
24094|NCT01563536|106610|P1|Overall Study|Lost to Follow-up|1
24095|NCT01563536|106609|P2|Overall Study|Withdrawal by Subject|2
24096|NCT01563536|106610|P1|Overall Study|Withdrawal by Subject|0
24097|NCT01563185|106638|P1|Overall Study|Non-Compliance with study drug|1
24098|NCT01563185|106638|P1|Overall Study|Withdrawal by Subject|1
24099|NCT01563029|106731|P5|Overall Study|Withdrawal by Subject|3
24100|NCT01563029|106732|P4|Overall Study|Withdrawal by Subject|4
24101|NCT01563029|106733|P3|Overall Study|Withdrawal by Subject|3
24102|NCT01563029|106734|P2|Overall Study|Withdrawal by Subject|1
24103|NCT01563029|106735|P1|Overall Study|Withdrawal by Subject|4
24104|NCT01563029|106731|P5|Overall Study|Physician Decision|2
24105|NCT01563029|106732|P4|Overall Study|Physician Decision|4
24106|NCT01563029|106733|P3|Overall Study|Physician Decision|2
24107|NCT01563029|106734|P2|Overall Study|Physician Decision|5
24108|NCT01563029|106735|P1|Overall Study|Physician Decision|3
24109|NCT01563029|106731|P5|Overall Study|Lost to Follow-up|1
24110|NCT01563029|106732|P4|Overall Study|Lost to Follow-up|1
24111|NCT01563029|106733|P3|Overall Study|Lost to Follow-up|1
24112|NCT01563029|106734|P2|Overall Study|Lost to Follow-up|0
24113|NCT01563029|106735|P1|Overall Study|Lost to Follow-up|1
24114|NCT01563029|106731|P5|Overall Study|Protocol defined stopping criteria|0
24115|NCT01563029|106732|P4|Overall Study|Protocol defined stopping criteria|0
24116|NCT01563029|106733|P3|Overall Study|Protocol defined stopping criteria|0
24117|NCT01563029|106734|P2|Overall Study|Protocol defined stopping criteria|0
24118|NCT01563029|106735|P1|Overall Study|Protocol defined stopping criteria|1
24119|NCT01563029|106731|P5|Overall Study|Protocol Violation|3
24120|NCT01563029|106732|P4|Overall Study|Protocol Violation|1
24121|NCT01563029|106733|P3|Overall Study|Protocol Violation|3
24122|NCT01563029|106734|P2|Overall Study|Protocol Violation|2
24123|NCT01563029|106735|P1|Overall Study|Protocol Violation|1
24124|NCT01563029|106731|P5|Overall Study|Lack of Efficacy|19
24125|NCT01563029|106732|P4|Overall Study|Lack of Efficacy|21
24126|NCT01563029|106733|P3|Overall Study|Lack of Efficacy|23
24127|NCT01563029|106734|P2|Overall Study|Lack of Efficacy|16
24128|NCT01563029|106735|P1|Overall Study|Lack of Efficacy|42
24129|NCT01563029|106731|P5|Overall Study|Adverse Event|1
24130|NCT01563029|106732|P4|Overall Study|Adverse Event|2
24131|NCT01563029|106733|P3|Overall Study|Adverse Event|1
24132|NCT01563029|106734|P2|Overall Study|Adverse Event|0
24133|NCT01563029|106735|P1|Overall Study|Adverse Event|1
24134|NCT01562743|106801|P1|Overall Study|Physician Decision|2
24135|NCT01562743|106801|P1|Overall Study|Lost to Follow-up|2
24136|NCT01562743|106801|P1|Overall Study|Discontinuation criteria|2
24137|NCT01562743|106801|P1|Overall Study|Protocol Violation|1
24138|NCT01562743|106801|P1|Overall Study|Withdrawal by Subject|13
24139|NCT01562743|106801|P1|Overall Study|Lack of Efficacy|3
24140|NCT01562743|106801|P1|Overall Study|Adverse Event|29
24141|NCT01562613|106811|P1|Overall Study|Withdrawal by Subject|2
24142|NCT01562613|106811|P1|Overall Study|Lost to Follow-up|2
24143|NCT01562548|106821|P4|Overall Study|Lost to Follow-up|0
24144|NCT01562548|106822|P3|Overall Study|Lost to Follow-up|1
24145|NCT01562548|106823|P2|Overall Study|Lost to Follow-up|0
24146|NCT01562548|106824|P1|Overall Study|Lost to Follow-up|0
24147|NCT01562327|106874|P1|Overall Study|Infusion not received at 6 month window|4
24148|NCT01562327|106874|P1|Overall Study|Participant drop-out|1
24149|NCT01562327|106874|P1|Overall Study|Lack of Efficacy|1
24150|NCT01562327|106874|P1|Overall Study|Adverse Event|2
24151|NCT01562314|106904|P2|Overall Study|Withdrawal by Subject|1
24152|NCT01562314|106905|P1|Overall Study|Withdrawal by Subject|0
24153|NCT01562314|106904|P2|Overall Study|Met Withdrawal Criteria|2
24154|NCT01562314|106905|P1|Overall Study|Met Withdrawal Criteria|3
24155|NCT01562314|106904|P2|Overall Study|Adverse Event|5
24156|NCT01562314|106905|P1|Overall Study|Adverse Event|10
24157|NCT01562275|106992|P13|Stage 2|Progression of Disease|4
24158|NCT01562275|106993|P12|Stage 2|Progression of Disease|12
24159|NCT01562275|106994|P11|Stage 2|Progression of Disease|0
24160|NCT01562275|106995|P10|Stage 2|Progression of Disease|0
24161|NCT01562275|106996|P9|Stage 2|Progression of Disease|0
24162|NCT01562275|106997|P8|Stage 2|Progression of Disease|0
24163|NCT01562275|106998|P7|Stage 2|Progression of Disease|0
24164|NCT01562275|106999|P6|Stage 2|Progression of Disease|0
24165|NCT01562275|107000|P5|Stage 2|Progression of Disease|0
24166|NCT01562275|107001|P4|Stage 2|Progression of Disease|0
24167|NCT01562275|107002|P3|Stage 2|Progression of Disease|0
24168|NCT01562275|107003|P2|Stage 2|Progression of Disease|0
24169|NCT01562275|107004|P1|Stage 2|Progression of Disease|0
24170|NCT01562275|106992|P13|Stage 2|Death|1
24171|NCT01562275|106993|P12|Stage 2|Death|2
24172|NCT01562275|106994|P11|Stage 2|Death|0
24173|NCT01562275|106995|P10|Stage 2|Death|0
24174|NCT01562275|106996|P9|Stage 2|Death|0
24175|NCT01562275|106997|P8|Stage 2|Death|0
24176|NCT01562275|106998|P7|Stage 2|Death|0
24177|NCT01562275|106999|P6|Stage 2|Death|0
24178|NCT01562275|107000|P5|Stage 2|Death|0
24179|NCT01562275|107001|P4|Stage 2|Death|0
24180|NCT01562275|107002|P3|Stage 2|Death|0
24181|NCT01562275|107003|P2|Stage 2|Death|0
24182|NCT01562275|107004|P1|Stage 2|Death|0
24183|NCT01562275|106992|P13|Stage 1|Withdrawal by Subject|0
24184|NCT01562275|106993|P12|Stage 1|Withdrawal by Subject|0
24185|NCT01562275|106994|P11|Stage 1|Withdrawal by Subject|0
24186|NCT01562275|106995|P10|Stage 1|Withdrawal by Subject|1
24187|NCT01562275|106996|P9|Stage 1|Withdrawal by Subject|0
24188|NCT01562275|106997|P8|Stage 1|Withdrawal by Subject|0
24189|NCT01562275|106998|P7|Stage 1|Withdrawal by Subject|1
24190|NCT01562275|106999|P6|Stage 1|Withdrawal by Subject|0
24191|NCT01562275|107000|P5|Stage 1|Withdrawal by Subject|0
24192|NCT01562275|107001|P4|Stage 1|Withdrawal by Subject|2
24193|NCT01562275|107002|P3|Stage 1|Withdrawal by Subject|0
24194|NCT01562275|107003|P2|Stage 1|Withdrawal by Subject|1
24195|NCT01562275|107004|P1|Stage 1|Withdrawal by Subject|0
24196|NCT01562275|106992|P13|Stage 1|Progression of Disease|0
24197|NCT01562275|106993|P12|Stage 1|Progression of Disease|0
24198|NCT01562275|106994|P11|Stage 1|Progression of Disease|3
24199|NCT01562275|106995|P10|Stage 1|Progression of Disease|5
24200|NCT01562275|106996|P9|Stage 1|Progression of Disease|2
24201|NCT01562275|106997|P8|Stage 1|Progression of Disease|7
24202|NCT01562275|106998|P7|Stage 1|Progression of Disease|1
24203|NCT01562275|106999|P6|Stage 1|Progression of Disease|4
24204|NCT01562275|107000|P5|Stage 1|Progression of Disease|2
24205|NCT01562275|107001|P4|Stage 1|Progression of Disease|1
24206|NCT01562275|107002|P3|Stage 1|Progression of Disease|2
24207|NCT01562275|107003|P2|Stage 1|Progression of Disease|6
24208|NCT01562275|107004|P1|Stage 1|Progression of Disease|2
24209|NCT01562275|106992|P13|Stage 1|Physician Decision|0
24210|NCT01562275|106993|P12|Stage 1|Physician Decision|0
24211|NCT01562275|106994|P11|Stage 1|Physician Decision|0
24212|NCT01562275|106995|P10|Stage 1|Physician Decision|0
24213|NCT01562275|106996|P9|Stage 1|Physician Decision|1
24214|NCT01562275|106997|P8|Stage 1|Physician Decision|0
24215|NCT01562275|106998|P7|Stage 1|Physician Decision|1
24216|NCT01562275|106999|P6|Stage 1|Physician Decision|0
24217|NCT01562275|107000|P5|Stage 1|Physician Decision|1
24218|NCT01562275|107001|P4|Stage 1|Physician Decision|0
24219|NCT01562275|107002|P3|Stage 1|Physician Decision|0
24220|NCT01562275|107003|P2|Stage 1|Physician Decision|0
24221|NCT01562275|107004|P1|Stage 1|Physician Decision|0
24222|NCT01562275|106992|P13|Stage 1|Non Compliance|0
24223|NCT01562275|106993|P12|Stage 1|Non Compliance|0
24224|NCT01562275|106994|P11|Stage 1|Non Compliance|0
24225|NCT01562275|106995|P10|Stage 1|Non Compliance|0
24226|NCT01562275|106996|P9|Stage 1|Non Compliance|0
24227|NCT01562275|106997|P8|Stage 1|Non Compliance|0
24228|NCT01562275|106998|P7|Stage 1|Non Compliance|0
24229|NCT01562275|106999|P6|Stage 1|Non Compliance|0
24230|NCT01562275|107000|P5|Stage 1|Non Compliance|0
24231|NCT01562275|107001|P4|Stage 1|Non Compliance|0
24232|NCT01562275|107002|P3|Stage 1|Non Compliance|1
24233|NCT01562275|107003|P2|Stage 1|Non Compliance|0
24234|NCT01562275|107004|P1|Stage 1|Non Compliance|0
24235|NCT01562275|106992|P13|Stage 1|Death|0
24236|NCT01562275|106993|P12|Stage 1|Death|0
24237|NCT01562275|106994|P11|Stage 1|Death|0
24238|NCT01562275|106995|P10|Stage 1|Death|0
24239|NCT01562275|106996|P9|Stage 1|Death|0
24240|NCT01562275|106997|P8|Stage 1|Death|0
24241|NCT01562275|106998|P7|Stage 1|Death|0
24242|NCT01562275|106999|P6|Stage 1|Death|0
24243|NCT01562275|107000|P5|Stage 1|Death|0
24244|NCT01562275|107001|P4|Stage 1|Death|0
24245|NCT01562275|107002|P3|Stage 1|Death|0
24246|NCT01562275|107003|P2|Stage 1|Death|0
24247|NCT01562275|107004|P1|Stage 1|Death|1
24248|NCT01562275|106992|P13|Stage 1|Adverse Event|0
24249|NCT01562275|106993|P12|Stage 1|Adverse Event|0
24250|NCT01562275|106994|P11|Stage 1|Adverse Event|0
24251|NCT01562275|106995|P10|Stage 1|Adverse Event|1
24252|NCT01562275|106996|P9|Stage 1|Adverse Event|0
24253|NCT01562275|106997|P8|Stage 1|Adverse Event|0
24254|NCT01562275|106998|P7|Stage 1|Adverse Event|0
24255|NCT01562275|106999|P6|Stage 1|Adverse Event|0
24256|NCT01562275|107000|P5|Stage 1|Adverse Event|1
24257|NCT01562275|107001|P4|Stage 1|Adverse Event|1
24258|NCT01562275|107002|P3|Stage 1|Adverse Event|0
24259|NCT01562275|107003|P2|Stage 1|Adverse Event|0
24260|NCT01562275|107004|P1|Stage 1|Adverse Event|0
24261|NCT01561898|107147|P4|Overall Study|Physician Decision|1
24262|NCT01561898|107148|P3|Overall Study|Physician Decision|7
24263|NCT01561898|107149|P2|Overall Study|Physician Decision|5
24264|NCT01561898|107150|P1|Overall Study|Physician Decision|1
24265|NCT01561898|107147|P4|Overall Study|Adverse Event|9
24266|NCT01561898|107148|P3|Overall Study|Adverse Event|14
24267|NCT01561898|107149|P2|Overall Study|Adverse Event|19
24268|NCT01561898|107150|P1|Overall Study|Adverse Event|1
24269|NCT01561898|107147|P4|Overall Study|Lost to Follow-up|0
24270|NCT01561898|107148|P3|Overall Study|Lost to Follow-up|1
24271|NCT01561898|107149|P2|Overall Study|Lost to Follow-up|0
24272|NCT01561898|107150|P1|Overall Study|Lost to Follow-up|0
24273|NCT01561898|107147|P4|Overall Study|Worsening of complications|0
24274|NCT01561898|107148|P3|Overall Study|Worsening of complications|0
24275|NCT01561898|107149|P2|Overall Study|Worsening of complications|1
24276|NCT01561898|107150|P1|Overall Study|Worsening of complications|0
24277|NCT01561898|107147|P4|Overall Study|Lack of Efficacy|5
24278|NCT01561898|107148|P3|Overall Study|Lack of Efficacy|10
24279|NCT01561898|107149|P2|Overall Study|Lack of Efficacy|8
24280|NCT01561898|107150|P1|Overall Study|Lack of Efficacy|0
24281|NCT01561898|107147|P4|Overall Study|Withdrawal by Subject|5
24282|NCT01561898|107148|P3|Overall Study|Withdrawal by Subject|12
24283|NCT01561898|107149|P2|Overall Study|Withdrawal by Subject|8
24284|NCT01561898|107150|P1|Overall Study|Withdrawal by Subject|0
24285|NCT01561560|107196|P2|Second Two Weeks of Wear|Adverse Event|1
24286|NCT01561560|107197|P1|Second Two Weeks of Wear|Adverse Event|0
24287|NCT01561560|107196|P2|First Two Weeks of Wear|Adverse Event|1
24288|NCT01561560|107197|P1|First Two Weeks of Wear|Adverse Event|0
24289|NCT01561560|107196|P2|First Two Weeks of Wear|Time/job conflict|1
24290|NCT01561560|107197|P1|First Two Weeks of Wear|Time/job conflict|0
24291|NCT01561313|107226|P2|Overall Study|Adverse event and withdrawal by subject|0
24292|NCT01561313|107227|P1|Overall Study|Adverse event and withdrawal by subject|1
24293|NCT01561313|107226|P2|Overall Study|Withdrawal by Subject|0
24294|NCT01561313|107227|P1|Overall Study|Withdrawal by Subject|1
24295|NCT01560819|107260|P2|Overall Study|Physician Decision|0
24296|NCT01560819|107261|P1|Overall Study|Physician Decision|1
24297|NCT01560507|107268|P3|Overall Study|Withdrawal by Subject|0
24298|NCT01560507|107269|P2|Overall Study|Withdrawal by Subject|1
24299|NCT01560507|107270|P1|Overall Study|Withdrawal by Subject|1
24300|NCT01560507|107268|P3|Overall Study|Lost to Follow-up|2
24301|NCT01560507|107269|P2|Overall Study|Lost to Follow-up|1
24302|NCT01560507|107270|P1|Overall Study|Lost to Follow-up|3
24303|NCT01560429|107283|P2|Overall Study|Protocol Violation|6
24304|NCT01560429|107284|P1|Overall Study|Protocol Violation|3
24305|NCT01560403|107294|P2|Overall Study|Lost to Follow-up|1
24306|NCT01560403|107295|P1|Overall Study|Lost to Follow-up|0
24307|NCT01560234|107313|P8|Overall Study|Lost to Follow-up|2
24308|NCT01560234|107314|P7|Overall Study|Lost to Follow-up|0
24309|NCT01560234|107315|P6|Overall Study|Lost to Follow-up|2
24310|NCT01560234|107316|P5|Overall Study|Lost to Follow-up|0
24311|NCT01560234|107317|P4|Overall Study|Lost to Follow-up|0
24312|NCT01560234|107318|P3|Overall Study|Lost to Follow-up|1
24313|NCT01560234|107319|P2|Overall Study|Lost to Follow-up|0
24314|NCT01560234|107320|P1|Overall Study|Lost to Follow-up|3
24315|NCT01559844|107407|P1|Overall Study|No Longer A Transplant Candidate|3
24316|NCT01559844|107407|P1|Overall Study|Efficacy Failure|10
24317|NCT01559844|107407|P1|Overall Study|Death|5
24318|NCT01559844|107407|P1|Overall Study|Consent Withdrawn|7
24319|NCT01559675|107420|P2|Overall Study|2nd operation on same patient excluded|12
24320|NCT01559675|107421|P1|Overall Study|2nd operation on same patient excluded|14
24321|NCT01559675|107420|P2|Overall Study|Protocol Violation|2
24322|NCT01559675|107421|P1|Overall Study|Protocol Violation|1
24323|NCT01559311|107453|P3|Overall Study|Adverse Event|1
24324|NCT01559311|107454|P2|Overall Study|Adverse Event|0
24325|NCT01559311|107455|P1|Overall Study|Adverse Event|0
24326|NCT01559311|107453|P3|Overall Study|Lost to Follow-up|2
24327|NCT01559311|107454|P2|Overall Study|Lost to Follow-up|3
24328|NCT01559311|107455|P1|Overall Study|Lost to Follow-up|0
24329|NCT01559311|107453|P3|Overall Study|Death|3
24330|NCT01559311|107454|P2|Overall Study|Death|2
24331|NCT01559311|107455|P1|Overall Study|Death|0
24332|NCT01559311|107453|P3|Overall Study|Withdrawal by Subject|0
24333|NCT01559311|107454|P2|Overall Study|Withdrawal by Subject|1
24334|NCT01559311|107455|P1|Overall Study|Withdrawal by Subject|2
24335|NCT01559311|107453|P3|Overall Study|Difficulty in cannulating the lateral ve|0
24336|NCT01559311|107454|P2|Overall Study|Difficulty in cannulating the lateral ve|0
24337|NCT01559311|107455|P1|Overall Study|Difficulty in cannulating the lateral ve|1
24338|NCT01559311|107453|P3|Overall Study|Protocol Violation|2
24339|NCT01559311|107454|P2|Overall Study|Protocol Violation|0
24340|NCT01559311|107455|P1|Overall Study|Protocol Violation|0
24341|NCT01559116|107466|P1|Overall Study|other than stated above|9
24342|NCT01559116|107466|P1|Overall Study|Withdrawal by Subject|4
24343|NCT01559116|107466|P1|Overall Study|Protocol Violation|1
24344|NCT01559116|107466|P1|Overall Study|Lost to Follow-up|1
24345|NCT01559116|107466|P1|Overall Study|Lack of Efficacy|1
24346|NCT01559116|107466|P1|Overall Study|Adverse Event|10
24347|NCT01559012|107549|P2|Overall Study|Withdrawal by Subject|1
24348|NCT01559012|107550|P1|Overall Study|Withdrawal by Subject|0
24349|NCT01558739|107586|P1|Overall Study|Protocol Violation|1
24350|NCT01558739|107586|P1|Overall Study|Disease Progression|4
24351|NCT01558739|107586|P1|Overall Study|Death|3
24352|NCT01558739|107586|P1|Overall Study|Withdrawal by Subject|2
24353|NCT01558739|107586|P1|Overall Study|Adverse Event|7
24354|NCT01558297|107621|P3|Overall Study|Withdrawal by Subject|1
24355|NCT01558297|107622|P2|Overall Study|Withdrawal by Subject|2
24356|NCT01558297|107623|P1|Overall Study|Withdrawal by Subject|2
24357|NCT01558271|107640|P3|Overall Study|Physician Decision|1
24358|NCT01558271|107641|P2|Overall Study|Physician Decision|2
24359|NCT01558271|107642|P1|Overall Study|Physician Decision|0
24360|NCT01558271|107640|P3|Overall Study|Withdrawal by Subject|12
24361|NCT01558271|107641|P2|Overall Study|Withdrawal by Subject|6
24362|NCT01558271|107642|P1|Overall Study|Withdrawal by Subject|10
24363|NCT01558271|107640|P3|Overall Study|Protocol Violation|0
24364|NCT01558271|107641|P2|Overall Study|Protocol Violation|0
24365|NCT01558271|107642|P1|Overall Study|Protocol Violation|1
24366|NCT01558271|107640|P3|Overall Study|Lost to Follow-up|0
24367|NCT01558271|107641|P2|Overall Study|Lost to Follow-up|0
24368|NCT01558271|107642|P1|Overall Study|Lost to Follow-up|1
24369|NCT01558271|107640|P3|Overall Study|Adverse Event|4
24370|NCT01558271|107641|P2|Overall Study|Adverse Event|3
24371|NCT01558271|107642|P1|Overall Study|Adverse Event|6
24372|NCT01558089|107704|P1|Overall Study|Withdrawal by Subject|6
24373|NCT01558089|107704|P1|Overall Study|Lost to Follow-up|5
24374|NCT01558089|107704|P1|Overall Study|Lack of Efficacy|1
24375|NCT01558089|107704|P1|Overall Study|Adverse Event|1
24376|NCT01557920|107719|P2|Overall Study|Lack of Efficacy|0
24377|NCT01557920|107720|P1|Overall Study|Lack of Efficacy|1
24378|NCT01557920|107719|P2|Overall Study|Withdrawal by Subject|3
24379|NCT01557920|107720|P1|Overall Study|Withdrawal by Subject|2
24380|NCT01557842|107783|P2|Overall Study|Not Ablated|0
24381|NCT01557842|107784|P1|Overall Study|Not Ablated|2
24382|NCT01557842|107783|P2|Overall Study|Study Terminated by Sponsor|4
24383|NCT01557842|107784|P1|Overall Study|Study Terminated by Sponsor|3
24384|NCT01557842|107783|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
24385|NCT01557842|107784|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
24386|NCT01557842|107783|P2|Overall Study|Lack of Efficacy|1
24387|NCT01557842|107784|P1|Overall Study|Lack of Efficacy|0
24388|NCT01557842|107783|P2|Overall Study|Death|0
24389|NCT01557842|107784|P1|Overall Study|Death|1
24390|NCT01557842|107783|P2|Overall Study|Lost to Follow-up|1
24391|NCT01557842|107784|P1|Overall Study|Lost to Follow-up|0
24392|NCT01557582|107854|P1|Overall Study|Operator error|2
24393|NCT01557582|107854|P1|Overall Study|Protocol Violation|4
24394|NCT01557569|107862|P2|Overall Study|noncompliance with rules of residential|1
24395|NCT01557569|107863|P1|Overall Study|noncompliance with rules of residential|0
24396|NCT01557569|107862|P2|Overall Study|Withdrawal by Subject|5
24397|NCT01557569|107863|P1|Overall Study|Withdrawal by Subject|3
24398|NCT01557569|107862|P2|Overall Study|high blood pressure|1
24399|NCT01557569|107863|P1|Overall Study|high blood pressure|0
24400|NCT01557569|107862|P2|Overall Study|Adverse Event|0
24401|NCT01557569|107863|P1|Overall Study|Adverse Event|2
24402|NCT01557504|107871|P2|Overall Study|Physician Decision|0
24403|NCT01557504|107872|P1|Overall Study|Physician Decision|1
24404|NCT01557348|107897|P2|Overall Study|Administrative|11
24405|NCT01557348|107898|P1|Overall Study|Administrative|18
24406|NCT01557348|107897|P2|Overall Study|Lost to Follow-up|22
24407|NCT01557348|107898|P1|Overall Study|Lost to Follow-up|26
24408|NCT01557348|107897|P2|Overall Study|Withdrawal by Subject|4
24409|NCT01557348|107898|P1|Overall Study|Withdrawal by Subject|5
24410|NCT01557348|107897|P2|Overall Study|Insufficient Therapeutic Response|28
24411|NCT01557348|107898|P1|Overall Study|Insufficient Therapeutic Response|13
24412|NCT01557348|107897|P2|Overall Study|Death|4
24413|NCT01557348|107898|P1|Overall Study|Death|7
24414|NCT01557348|107897|P2|Overall Study|Infusion reaction event|5
24415|NCT01557348|107898|P1|Overall Study|Infusion reaction event|5
24416|NCT01557348|107897|P2|Overall Study|Adverse Event|16
24417|NCT01557348|107898|P1|Overall Study|Adverse Event|6
24418|NCT01557283|108015|P1|Overall Study|Unspecified|6
24419|NCT01557283|108015|P1|Overall Study|Worsening of psoriasis|1
24420|NCT01557283|108015|P1|Overall Study|Participant’s weight too high for dose|1
24421|NCT01557283|108015|P1|Overall Study|Withdrawal by Subject|1
24422|NCT01557283|108015|P1|Overall Study|Non-compliance|1
24423|NCT01557283|108015|P1|Overall Study|Lack of Efficacy|1
24424|NCT01557283|108015|P1|Overall Study|Adverse Event|7
24425|NCT01557283|108015|P1|Overall Study|Non-responder|19
24426|NCT01557283|108015|P1|Overall Study|Lost to Follow-up|7
24427|NCT01557166|108027|P2|Overall Study|Unclassified|5
24428|NCT01557166|108028|P1|Overall Study|Unclassified|2
24429|NCT01557166|108027|P2|Overall Study|Psychiatric disorder|0
24430|NCT01557166|108028|P1|Overall Study|Psychiatric disorder|1
24431|NCT01557166|108027|P2|Overall Study|Target dose not tolerated|0
24432|NCT01557166|108028|P1|Overall Study|Target dose not tolerated|1
24433|NCT01557166|108027|P2|Overall Study|Withdrawn consent|20
24434|NCT01557166|108028|P1|Overall Study|Withdrawn consent|12
24435|NCT01557166|108027|P2|Overall Study|Protocol Violation|5
24436|NCT01557166|108028|P1|Overall Study|Protocol Violation|8
24437|NCT01557166|108027|P2|Overall Study|Lack of Efficacy|1
24438|NCT01557166|108028|P1|Overall Study|Lack of Efficacy|2
24439|NCT01557166|108027|P2|Overall Study|Adverse Event|6
24440|NCT01557166|108028|P1|Overall Study|Adverse Event|20
24441|NCT01556997|108043|P3|Overall Study|Not specified|7
24442|NCT01556997|108044|P2|Overall Study|Not specified|3
24443|NCT01556997|108045|P1|Overall Study|Not specified|2
24444|NCT01556997|108043|P3|Overall Study|Withdrawal by Subject|8
24445|NCT01556997|108044|P2|Overall Study|Withdrawal by Subject|6
24446|NCT01556997|108045|P1|Overall Study|Withdrawal by Subject|7
24447|NCT01556997|108043|P3|Overall Study|Physician Decision|1
24448|NCT01556997|108044|P2|Overall Study|Physician Decision|1
24449|NCT01556997|108045|P1|Overall Study|Physician Decision|1
24450|NCT01556997|108043|P3|Overall Study|Lost to Follow-up|4
24451|NCT01556997|108044|P2|Overall Study|Lost to Follow-up|6
24452|NCT01556997|108045|P1|Overall Study|Lost to Follow-up|6
24453|NCT01556997|108043|P3|Overall Study|Adverse Event|12
24454|NCT01556997|108044|P2|Overall Study|Adverse Event|12
24455|NCT01556997|108045|P1|Overall Study|Adverse Event|10
24456|NCT01556932|108056|P2|Time Point 60 Minutes|Withdrawal by Subject|1
24457|NCT01556932|108057|P1|Time Point 60 Minutes|Withdrawal by Subject|1
24458|NCT01556763|108083|P3|Overall Study|Withdrawal by Subject|0
24459|NCT01556763|108084|P2|Overall Study|Withdrawal by Subject|1
24460|NCT01556763|108085|P1|Overall Study|Withdrawal by Subject|0
24461|NCT01555463|108123|P2|Follow up|Other reason|3
24462|NCT01555463|108124|P1|Follow up|Other reason|3
24463|NCT01555463|108123|P2|Follow up|Protocol Violation|4
24464|NCT01555463|108124|P1|Follow up|Protocol Violation|2
24465|NCT01555463|108123|P2|Follow up|Lost to Follow-up|10
24466|NCT01555463|108124|P1|Follow up|Lost to Follow-up|9
24467|NCT01555463|108123|P2|Follow up|Withdrawal by Subject|22
24468|NCT01555463|108124|P1|Follow up|Withdrawal by Subject|22
24469|NCT01555463|108123|P2|Follow up|Death|1
24470|NCT01555463|108124|P1|Follow up|Death|0
24471|NCT01555463|108123|P2|Follow up|Adverse Event|5
24472|NCT01555463|108124|P1|Follow up|Adverse Event|2
24473|NCT01555463|108123|P2|Treatment|Other reason|3
24474|NCT01555463|108124|P1|Treatment|Other reason|2
24475|NCT01555463|108123|P2|Treatment|Protocol Violation|5
24476|NCT01555463|108124|P1|Treatment|Protocol Violation|4
24477|NCT01555463|108123|P2|Treatment|Lost to Follow-up|23
24478|NCT01555463|108124|P1|Treatment|Lost to Follow-up|28
24479|NCT01555463|108123|P2|Treatment|Withdrawal by Subject|36
24480|NCT01555463|108124|P1|Treatment|Withdrawal by Subject|24
24481|NCT01555463|108123|P2|Treatment|Adverse Event|12
24482|NCT01555463|108124|P1|Treatment|Adverse Event|6
24483|NCT01556165|108241|P2|Overall Study|Withdrawal of Consent|1
24484|NCT01556165|108242|P1|Overall Study|Withdrawal of Consent|7
24485|NCT01556165|108241|P2|Overall Study|Protocol Violation|3
24486|NCT01556165|108242|P1|Overall Study|Protocol Violation|0
24487|NCT01556165|108241|P2|Overall Study|Adverse Event|3
24488|NCT01556165|108242|P1|Overall Study|Adverse Event|5
24489|NCT01555983|108267|P6|Overall Study|Withdrawal by Subject|1
24490|NCT01555983|108268|P5|Overall Study|Withdrawal by Subject|1
24491|NCT01555983|108269|P4|Overall Study|Withdrawal by Subject|0
24492|NCT01555983|108270|P3|Overall Study|Withdrawal by Subject|0
24493|NCT01555983|108271|P2|Overall Study|Withdrawal by Subject|0
24494|NCT01555983|108272|P1|Overall Study|Withdrawal by Subject|1
24495|NCT01555931|108282|P2|Overall Study|Lost to Follow-up|5
24496|NCT01555931|108283|P1|Overall Study|Lost to Follow-up|2
24497|NCT01555164|108293|P2|Overall Study|Subject Withdrew Consent|11
24498|NCT01555164|108294|P1|Overall Study|Subject Withdrew Consent|6
24499|NCT01555164|108293|P2|Overall Study|Subject Non-compliance|6
24500|NCT01555164|108294|P1|Overall Study|Subject Non-compliance|14
24501|NCT01555164|108293|P2|Overall Study|Protocol Violation|5
24502|NCT01555164|108294|P1|Overall Study|Protocol Violation|9
24503|NCT01555164|108293|P2|Overall Study|Lost to Follow-up|3
24504|NCT01555164|108294|P1|Overall Study|Lost to Follow-up|4
24505|NCT01555164|108293|P2|Overall Study|Investigator's Discretion|2
24506|NCT01555164|108294|P1|Overall Study|Investigator's Discretion|2
24507|NCT01555164|108293|P2|Overall Study|Hyperglycemia|1
24508|NCT01555164|108294|P1|Overall Study|Hyperglycemia|0
24509|NCT01555164|108293|P2|Overall Study|Adverse Event|7
24510|NCT01555164|108294|P1|Overall Study|Adverse Event|5
24511|NCT01555151|108308|P4|Overall Study|Lost to Follow-up|1
24512|NCT01555151|108309|P3|Overall Study|Lost to Follow-up|0
24513|NCT01555151|108310|P2|Overall Study|Lost to Follow-up|0
24514|NCT01555151|108311|P1|Overall Study|Lost to Follow-up|0
24515|NCT01555151|108308|P4|Overall Study|Adverse Event|2
24516|NCT01555151|108309|P3|Overall Study|Adverse Event|1
24517|NCT01555151|108310|P2|Overall Study|Adverse Event|2
24518|NCT01555151|108311|P1|Overall Study|Adverse Event|1
24519|NCT01555151|108308|P4|Overall Study|Protocol Violation|5
24520|NCT01555151|108309|P3|Overall Study|Protocol Violation|3
24521|NCT01555151|108310|P2|Overall Study|Protocol Violation|3
24522|NCT01555151|108311|P1|Overall Study|Protocol Violation|3
24523|NCT01555151|108308|P4|Overall Study|Administrative|0
24524|NCT01555151|108309|P3|Overall Study|Administrative|2
24525|NCT01555151|108310|P2|Overall Study|Administrative|1
24526|NCT01555151|108311|P1|Overall Study|Administrative|3
24527|NCT01555151|108308|P4|Overall Study|Withdrawal by Subject|2
24528|NCT01555151|108309|P3|Overall Study|Withdrawal by Subject|0
24529|NCT01555151|108310|P2|Overall Study|Withdrawal by Subject|2
24530|NCT01555151|108311|P1|Overall Study|Withdrawal by Subject|6
24531|NCT01555138|108364|P2|Overall Study|Adverse Event|14
24532|NCT01555138|108365|P1|Overall Study|Adverse Event|14
24533|NCT01555138|108364|P2|Overall Study|Withdrawal by Subject|15
24534|NCT01555138|108365|P1|Overall Study|Withdrawal by Subject|16
24535|NCT01555138|108364|P2|Overall Study|Administrative problems|0
24536|NCT01555138|108365|P1|Overall Study|Administrative problems|8
24537|NCT01555138|108364|P2|Overall Study|Protocol Violation|3
24538|NCT01555138|108365|P1|Overall Study|Protocol Violation|5
24539|NCT01555138|108364|P2|Overall Study|Lack of Efficacy|2
24540|NCT01555138|108365|P1|Overall Study|Lack of Efficacy|2
24541|NCT01555138|108364|P2|Overall Study|Abnormal Lab reults|3
24542|NCT01555138|108365|P1|Overall Study|Abnormal Lab reults|1
24543|NCT01555138|108364|P2|Overall Study|Lost to Follow-up|0
24544|NCT01555138|108365|P1|Overall Study|Lost to Follow-up|1
24545|NCT01555138|108364|P2|Overall Study|Death|1
24546|NCT01555138|108365|P1|Overall Study|Death|0
24547|NCT01555073|108395|P4|Overall Study|Lost to Follow-up|5
24548|NCT01555073|108396|P3|Overall Study|Lost to Follow-up|0
24549|NCT01555073|108397|P2|Overall Study|Lost to Follow-up|2
24550|NCT01555073|108398|P1|Overall Study|Lost to Follow-up|1
24551|NCT01554904|108425|P1|Overall Study|Had sleep apnea on Home Study 1|1
24552|NCT01554904|108425|P1|Overall Study|Withdrawal by Subject|3
24553|NCT01554241|108447|P4|Overall Study|Withdrawal by Subject|0
24554|NCT01554241|108448|P3|Overall Study|Withdrawal by Subject|2
24555|NCT01554241|108449|P2|Overall Study|Withdrawal by Subject|0
24556|NCT01554241|108450|P1|Overall Study|Withdrawal by Subject|0
24557|NCT01554241|108447|P4|Overall Study|protocol specified change in eGFR|0
24558|NCT01554241|108448|P3|Overall Study|protocol specified change in eGFR|1
24559|NCT01554241|108449|P2|Overall Study|protocol specified change in eGFR|0
24560|NCT01554241|108450|P1|Overall Study|protocol specified change in eGFR|0
24561|NCT01554241|108447|P4|Overall Study|protocol specified renal stone|1
24562|NCT01554241|108448|P3|Overall Study|protocol specified renal stone|0
24563|NCT01554241|108449|P2|Overall Study|protocol specified renal stone|0
24564|NCT01554241|108450|P1|Overall Study|protocol specified renal stone|0
24565|NCT01554241|108447|P4|Overall Study|Death|0
24566|NCT01554241|108448|P3|Overall Study|Death|1
24567|NCT01554241|108449|P2|Overall Study|Death|1
24568|NCT01554241|108450|P1|Overall Study|Death|3
24569|NCT01554176|108466|P5|Run-out Phase|Protocol Violation|0
24570|NCT01554176|108467|P4|Run-out Phase|Protocol Violation|1
24571|NCT01554176|108468|P3|Run-out Phase|Protocol Violation|0
24572|NCT01554176|108469|P2|Run-out Phase|Protocol Violation|0
24573|NCT01554176|108470|P1|Run-out Phase|Protocol Violation|0
24574|NCT01554176|108466|P5|Treatment Phase|Lost to Follow-up|0
24575|NCT01554176|108467|P4|Treatment Phase|Lost to Follow-up|0
24576|NCT01554176|108468|P3|Treatment Phase|Lost to Follow-up|0
24577|NCT01554176|108469|P2|Treatment Phase|Lost to Follow-up|0
24578|NCT01554176|108470|P1|Treatment Phase|Lost to Follow-up|3
24579|NCT01554176|108466|P5|Treatment Phase|Withdrawal by Subject|0
24580|NCT01554176|108467|P4|Treatment Phase|Withdrawal by Subject|0
24581|NCT01554176|108468|P3|Treatment Phase|Withdrawal by Subject|0
24582|NCT01554176|108469|P2|Treatment Phase|Withdrawal by Subject|0
24583|NCT01554176|108470|P1|Treatment Phase|Withdrawal by Subject|1
24584|NCT01554176|108466|P5|Treatment Phase|Non-compliance with study drug|0
24585|NCT01554176|108467|P4|Treatment Phase|Non-compliance with study drug|0
24586|NCT01554176|108468|P3|Treatment Phase|Non-compliance with study drug|0
24587|NCT01554176|108469|P2|Treatment Phase|Non-compliance with study drug|0
24588|NCT01554176|108470|P1|Treatment Phase|Non-compliance with study drug|1
24589|NCT01554176|108466|P5|Treatment Phase|Adverse event, non-fatal|0
24590|NCT01554176|108467|P4|Treatment Phase|Adverse event, non-fatal|0
24591|NCT01554176|108468|P3|Treatment Phase|Adverse event, non-fatal|0
24592|NCT01554176|108469|P2|Treatment Phase|Adverse event, non-fatal|1
24593|NCT01554176|108470|P1|Treatment Phase|Adverse event, non-fatal|1
24594|NCT01554176|108466|P5|Treatment Phase|Lack of Efficacy|0
24595|NCT01554176|108467|P4|Treatment Phase|Lack of Efficacy|0
24596|NCT01554176|108468|P3|Treatment Phase|Lack of Efficacy|0
24597|NCT01554176|108469|P2|Treatment Phase|Lack of Efficacy|1
24598|NCT01554176|108470|P1|Treatment Phase|Lack of Efficacy|0
24599|NCT01554176|108466|P5|Treatment Phase|Physician Decision|0
24600|NCT01554176|108467|P4|Treatment Phase|Physician Decision|0
24601|NCT01554176|108468|P3|Treatment Phase|Physician Decision|0
24602|NCT01554176|108469|P2|Treatment Phase|Physician Decision|1
24603|NCT01554176|108470|P1|Treatment Phase|Physician Decision|1
24604|NCT01554176|108466|P5|Treatment Phase|Protocol Violation|0
24605|NCT01554176|108467|P4|Treatment Phase|Protocol Violation|0
24606|NCT01554176|108468|P3|Treatment Phase|Protocol Violation|0
24607|NCT01554176|108469|P2|Treatment Phase|Protocol Violation|2
24608|NCT01554176|108470|P1|Treatment Phase|Protocol Violation|1
24609|NCT01554163|108497|P2|Overall Study|Not Treated|0
24610|NCT01554163|108498|P1|Overall Study|Not Treated|1
24611|NCT01554163|108497|P2|Overall Study|Withdrawal by Subject|5
24612|NCT01554163|108498|P1|Overall Study|Withdrawal by Subject|1
24613|NCT01554163|108497|P2|Overall Study|Protocol Violation|4
24614|NCT01554163|108498|P1|Overall Study|Protocol Violation|0
24615|NCT01554163|108497|P2|Overall Study|Non-Compliance With Study Drug|1
24616|NCT01554163|108498|P1|Overall Study|Non-Compliance With Study Drug|1
24617|NCT01554163|108497|P2|Overall Study|Lost to Follow-up|0
24618|NCT01554163|108498|P1|Overall Study|Lost to Follow-up|1
24619|NCT01554163|108497|P2|Overall Study|Lack of Efficacy|0
24620|NCT01554163|108498|P1|Overall Study|Lack of Efficacy|1
24621|NCT01554163|108497|P2|Overall Study|Adverse Event|0
24622|NCT01554163|108498|P1|Overall Study|Adverse Event|3
24623|NCT01553851|108516|P1|Overall Study|constipation|1
24624|NCT01553851|108516|P1|Overall Study|Adverse Event|2
24625|NCT01553318|108544|P2|Overall Study|Protocol Violation|2
24626|NCT01553318|108545|P1|Overall Study|Protocol Violation|3
24627|NCT01552954|108580|P2|Overall Study|diagnosed DM|0
24628|NCT01552954|108581|P1|Overall Study|diagnosed DM|1
24629|NCT01552954|108580|P2|Overall Study|Protocol Violation|2
24630|NCT01552954|108581|P1|Overall Study|Protocol Violation|1
24631|NCT01552954|108580|P2|Overall Study|Withdrawal by Subject|1
24632|NCT01552954|108581|P1|Overall Study|Withdrawal by Subject|1
24633|NCT01552954|108580|P2|Overall Study|Lost to Follow-up|1
24634|NCT01552954|108581|P1|Overall Study|Lost to Follow-up|1
24635|NCT01552954|108580|P2|Overall Study|Adverse Event|2
24636|NCT01552954|108581|P1|Overall Study|Adverse Event|1
24637|NCT01552928|108597|P4|Period 3|Adverse Event|0
24638|NCT01552928|108598|P3|Period 3|Adverse Event|1
24639|NCT01552928|108599|P2|Period 3|Adverse Event|0
24640|NCT01552928|108600|P1|Period 3|Adverse Event|0
24641|NCT01552915|108647|P3|Overall Study|Not specified|6
24642|NCT01552915|108648|P2|Overall Study|Not specified|0
24643|NCT01552915|108649|P1|Overall Study|Not specified|2
24644|NCT01552915|108647|P3|Overall Study|Lack of Efficacy|4
24645|NCT01552915|108648|P2|Overall Study|Lack of Efficacy|1
24646|NCT01552915|108649|P1|Overall Study|Lack of Efficacy|8
24647|NCT01552915|108647|P3|Overall Study|Protocol Violation|4
24648|NCT01552915|108648|P2|Overall Study|Protocol Violation|4
24649|NCT01552915|108649|P1|Overall Study|Protocol Violation|0
24650|NCT01552915|108647|P3|Overall Study|Withdrawal by Subject|5
24651|NCT01552915|108648|P2|Overall Study|Withdrawal by Subject|4
24652|NCT01552915|108649|P1|Overall Study|Withdrawal by Subject|6
24653|NCT01552915|108647|P3|Overall Study|Lost to Follow-up|5
24654|NCT01552915|108648|P2|Overall Study|Lost to Follow-up|6
24655|NCT01552915|108649|P1|Overall Study|Lost to Follow-up|4
24656|NCT01552915|108647|P3|Overall Study|Adverse Event|3
24657|NCT01552915|108648|P2|Overall Study|Adverse Event|14
24658|NCT01552915|108649|P1|Overall Study|Adverse Event|3
24659|NCT01552902|108672|P3|Overall Study|Unspecified|3
24660|NCT01552902|108673|P2|Overall Study|Unspecified|4
24661|NCT01552902|108674|P1|Overall Study|Unspecified|3
24662|NCT01552902|108672|P3|Overall Study|Lost to Follow-up|6
24663|NCT01552902|108673|P2|Overall Study|Lost to Follow-up|3
24664|NCT01552902|108674|P1|Overall Study|Lost to Follow-up|1
24665|NCT01552902|108672|P3|Overall Study|Withdrawal by Subject|6
24666|NCT01552902|108673|P2|Overall Study|Withdrawal by Subject|9
24667|NCT01552902|108674|P1|Overall Study|Withdrawal by Subject|1
24668|NCT01552902|108672|P3|Overall Study|Lack of Efficacy|1
24669|NCT01552902|108673|P2|Overall Study|Lack of Efficacy|3
24670|NCT01552902|108674|P1|Overall Study|Lack of Efficacy|4
24671|NCT01552902|108672|P3|Overall Study|Protocol Violation|3
24672|NCT01552902|108673|P2|Overall Study|Protocol Violation|3
24673|NCT01552902|108674|P1|Overall Study|Protocol Violation|3
24674|NCT01552902|108672|P3|Overall Study|Adverse Event|14
24675|NCT01552902|108673|P2|Overall Study|Adverse Event|15
24676|NCT01552902|108674|P1|Overall Study|Adverse Event|1
24677|NCT01552772|108711|P1|Overall Study|Protocol Deviation|1
24678|NCT01552772|108711|P1|Overall Study|Adverse Event|1
24679|NCT01552772|108711|P1|Overall Study|Lost to Follow-up|2
24680|NCT01552694|108727|P2|Overall Study|Protocol Violation|1
24681|NCT01552694|108728|P1|Overall Study|Protocol Violation|0
24682|NCT01552694|108727|P2|Overall Study|Lost to Follow-up|1
24683|NCT01552694|108728|P1|Overall Study|Lost to Follow-up|0
24684|NCT01552681|108740|P2|Overall Study|Subject moved away|1
24685|NCT01552681|108741|P1|Overall Study|Subject moved away|0
24686|NCT01552681|108740|P2|Overall Study|Physician Decision|0
24687|NCT01552681|108741|P1|Overall Study|Physician Decision|1
24688|NCT01552681|108740|P2|Overall Study|Withdrawal by Subject|0
24689|NCT01552681|108741|P1|Overall Study|Withdrawal by Subject|4
24690|NCT01552603|108789|P1|Overall Study|Physician Decision|1
24691|NCT01552057|108796|P2|Overall Study|Physician Decision|0
24692|NCT01552057|108797|P1|Overall Study|Physician Decision|1
24693|NCT01552057|108796|P2|Overall Study|Entry Criteria Not Met|2
24694|NCT01552057|108797|P1|Overall Study|Entry Criteria Not Met|2
24695|NCT01552057|108796|P2|Overall Study|Withdrawal by Subject|8
24696|NCT01552057|108797|P1|Overall Study|Withdrawal by Subject|5
24697|NCT01552057|108796|P2|Overall Study|Lack of Efficacy|23
24698|NCT01552057|108797|P1|Overall Study|Lack of Efficacy|8
24699|NCT01552057|108796|P2|Overall Study|Adverse Event|15
24700|NCT01552057|108797|P1|Overall Study|Adverse Event|14
24701|NCT01551355|108848|P6|Overall Study|Lost to Follow-up|6
24702|NCT01551355|108849|P5|Overall Study|Lost to Follow-up|9
24703|NCT01551355|108850|P4|Overall Study|Lost to Follow-up|24
24704|NCT01551355|108851|P3|Overall Study|Lost to Follow-up|34
24705|NCT01551355|108852|P2|Overall Study|Lost to Follow-up|49
24706|NCT01551355|108853|P1|Overall Study|Lost to Follow-up|51
24707|NCT01551303|108867|P2|Overall Study|failed awareness check on vision test|7
24708|NCT01551303|108868|P1|Overall Study|failed awareness check on vision test|4
24709|NCT01551173|108882|P2|Overall Study|Not specified|3
24710|NCT01551173|108883|P1|Overall Study|Not specified|5
24711|NCT01551173|108882|P2|Overall Study|Lost to Follow-up|7
24712|NCT01551173|108883|P1|Overall Study|Lost to Follow-up|5
24713|NCT01551173|108882|P2|Overall Study|Adverse Event|6
24714|NCT01551173|108883|P1|Overall Study|Adverse Event|7
24715|NCT01551173|108882|P2|Overall Study|Withdrawal by Subject|16
24716|NCT01551173|108883|P1|Overall Study|Withdrawal by Subject|11
24717|NCT01550965|108903|P1|Overall Study|Not Specified|13
24718|NCT01550965|108903|P1|Overall Study|Lack of Efficacy|59
24719|NCT01550965|108903|P1|Overall Study|Lost to Follow-up|2
24720|NCT01550965|108903|P1|Overall Study|Withdrawal by Subject|10
24721|NCT01550965|108903|P1|Overall Study|Adverse Event|26
24722|NCT01550744|108943|P3|Double-Blind|unspecified|10
24723|NCT01550744|108944|P2|Double-Blind|unspecified|2
24724|NCT01550744|108945|P1|Double-Blind|unspecified|0
24725|NCT01550744|108943|P3|Double-Blind|Pregnancy|3
24726|NCT01550744|108944|P2|Double-Blind|Pregnancy|0
24727|NCT01550744|108945|P1|Double-Blind|Pregnancy|0
24728|NCT01550744|108943|P3|Double-Blind|Protocol Violation|4
24729|NCT01550744|108944|P2|Double-Blind|Protocol Violation|0
24730|NCT01550744|108945|P1|Double-Blind|Protocol Violation|0
24731|NCT01550744|108943|P3|Double-Blind|Lack of Efficacy|8
24732|NCT01550744|108944|P2|Double-Blind|Lack of Efficacy|2
24733|NCT01550744|108945|P1|Double-Blind|Lack of Efficacy|0
24734|NCT01550744|108943|P3|Double-Blind|Death|0
24735|NCT01550744|108944|P2|Double-Blind|Death|1
24736|NCT01550744|108945|P1|Double-Blind|Death|0
24737|NCT01550744|108943|P3|Double-Blind|Adverse Event|15
24738|NCT01550744|108944|P2|Double-Blind|Adverse Event|4
24739|NCT01550744|108945|P1|Double-Blind|Adverse Event|0
24740|NCT01550744|108943|P3|Double-Blind|Withdrawal by Subject|15
24741|NCT01550744|108944|P2|Double-Blind|Withdrawal by Subject|2
24742|NCT01550744|108945|P1|Double-Blind|Withdrawal by Subject|0
24743|NCT01550744|108943|P3|Double-Blind|Lost to Follow-up|12
24744|NCT01550744|108944|P2|Double-Blind|Lost to Follow-up|6
24745|NCT01550744|108945|P1|Double-Blind|Lost to Follow-up|0
24746|NCT01550744|108943|P3|Open-Label|unspecified|0
24747|NCT01550744|108944|P2|Open-Label|unspecified|0
24748|NCT01550744|108945|P1|Open-Label|unspecified|1
24749|NCT01550744|108943|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
24750|NCT01550744|108944|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
24751|NCT01550744|108945|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
24752|NCT01550744|108943|P3|Open-Label|Not all 3 study drug injections received|0
24753|NCT01550744|108944|P2|Open-Label|Not all 3 study drug injections received|0
24754|NCT01550744|108945|P1|Open-Label|Not all 3 study drug injections received|2
24755|NCT01550744|108943|P3|Open-Label|Protocol Violation|0
24756|NCT01550744|108944|P2|Open-Label|Protocol Violation|0
24757|NCT01550744|108945|P1|Open-Label|Protocol Violation|4
24758|NCT01550744|108943|P3|Open-Label|Lack of Efficacy|0
24759|NCT01550744|108944|P2|Open-Label|Lack of Efficacy|0
24760|NCT01550744|108945|P1|Open-Label|Lack of Efficacy|4
24761|NCT01550744|108943|P3|Open-Label|Adverse Event|0
24762|NCT01550744|108944|P2|Open-Label|Adverse Event|0
24763|NCT01550744|108945|P1|Open-Label|Adverse Event|11
24764|NCT01550744|108943|P3|Open-Label|Withdrawal by Subject|0
24765|NCT01550744|108944|P2|Open-Label|Withdrawal by Subject|0
24766|NCT01550744|108945|P1|Open-Label|Withdrawal by Subject|13
24767|NCT01550744|108943|P3|Open-Label|Lost to Follow-up|0
24768|NCT01550744|108944|P2|Open-Label|Lost to Follow-up|0
24769|NCT01550744|108945|P1|Open-Label|Lost to Follow-up|7
24770|NCT01550289|108977|P2|Overall Study|Withdrawal by Subject|3
24771|NCT01550289|108978|P1|Overall Study|Withdrawal by Subject|11
24772|NCT01550289|108977|P2|Overall Study|Lost to Follow-up|1
24773|NCT01550289|108978|P1|Overall Study|Lost to Follow-up|1
24774|NCT01550289|108977|P2|Overall Study|Protocol Violation|0
24775|NCT01550289|108978|P1|Overall Study|Protocol Violation|1
24776|NCT01549964|109029|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
24777|NCT01549964|109030|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
24778|NCT01549964|109031|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
24779|NCT01549964|109032|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
24780|NCT01549964|109029|P4|80-Week Extension Period|Lost to Follow-up|1
24781|NCT01549964|109030|P3|80-Week Extension Period|Lost to Follow-up|2
24782|NCT01549964|109031|P2|80-Week Extension Period|Lost to Follow-up|0
24783|NCT01549964|109032|P1|80-Week Extension Period|Lost to Follow-up|1
24784|NCT01549964|109029|P4|80-Week Extension Period|Voluntary Withdrawal|2
24785|NCT01549964|109030|P3|80-Week Extension Period|Voluntary Withdrawal|4
24786|NCT01549964|109031|P2|80-Week Extension Period|Voluntary Withdrawal|1
24787|NCT01549964|109032|P1|80-Week Extension Period|Voluntary Withdrawal|0
24788|NCT01549964|109029|P4|80-Week Extension Period|Study Terminated by Sponsor|132
24789|NCT01549964|109030|P3|80-Week Extension Period|Study Terminated by Sponsor|132
24790|NCT01549964|109031|P2|80-Week Extension Period|Study Terminated by Sponsor|137
24791|NCT01549964|109032|P1|80-Week Extension Period|Study Terminated by Sponsor|65
24792|NCT01549964|109029|P4|80-Week Extension Period|Pregnancy|0
24793|NCT01549964|109030|P3|80-Week Extension Period|Pregnancy|1
24794|NCT01549964|109031|P2|80-Week Extension Period|Pregnancy|0
24795|NCT01549964|109032|P1|80-Week Extension Period|Pregnancy|0
24796|NCT01549964|109029|P4|24-Week Treatment Period|Completion Status Unknown|0
24797|NCT01549964|109030|P3|24-Week Treatment Period|Completion Status Unknown|1
24798|NCT01549964|109031|P2|24-Week Treatment Period|Completion Status Unknown|0
24799|NCT01549964|109032|P1|24-Week Treatment Period|Completion Status Unknown|1
24800|NCT01549964|109029|P4|24-Week Treatment Period|Randomized but Not Treated|1
24801|NCT01549964|109030|P3|24-Week Treatment Period|Randomized but Not Treated|0
24802|NCT01549964|109031|P2|24-Week Treatment Period|Randomized but Not Treated|0
24803|NCT01549964|109032|P1|24-Week Treatment Period|Randomized but Not Treated|0
24804|NCT01549964|109029|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
24805|NCT01549964|109030|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
24806|NCT01549964|109031|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
24807|NCT01549964|109032|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
24808|NCT01549964|109029|P4|24-Week Treatment Period|Other|0
24809|NCT01549964|109030|P3|24-Week Treatment Period|Other|1
24810|NCT01549964|109031|P2|24-Week Treatment Period|Other|0
24811|NCT01549964|109032|P1|24-Week Treatment Period|Other|1
24812|NCT01549964|109029|P4|24-Week Treatment Period|Lack of Efficacy|1
24813|NCT01549964|109030|P3|24-Week Treatment Period|Lack of Efficacy|1
24814|NCT01549964|109031|P2|24-Week Treatment Period|Lack of Efficacy|0
24815|NCT01549964|109032|P1|24-Week Treatment Period|Lack of Efficacy|1
24816|NCT01549964|109029|P4|24-Week Treatment Period|Lost to Follow-up|2
24817|NCT01549964|109030|P3|24-Week Treatment Period|Lost to Follow-up|1
24818|NCT01549964|109031|P2|24-Week Treatment Period|Lost to Follow-up|0
24819|NCT01549964|109032|P1|24-Week Treatment Period|Lost to Follow-up|1
24820|NCT01549964|109029|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
24821|NCT01549964|109030|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
24822|NCT01549964|109031|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
24823|NCT01549964|109032|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
24824|NCT01549964|109029|P4|24-Week Treatment Period|Voluntary Withdrawal|8
24825|NCT01549964|109030|P3|24-Week Treatment Period|Voluntary Withdrawal|3
24826|NCT01549964|109031|P2|24-Week Treatment Period|Voluntary Withdrawal|3
24827|NCT01549964|109032|P1|24-Week Treatment Period|Voluntary Withdrawal|6
24828|NCT01549964|109029|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
24829|NCT01549964|109030|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
24830|NCT01549964|109031|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
24831|NCT01549964|109032|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
24832|NCT01549951|109050|P1|Overall Study|Other|2
24833|NCT01549951|109050|P1|Overall Study|Symptomatic deterioration|1
24834|NCT01549951|109050|P1|Overall Study|Progressive disease|29
24835|NCT01549951|109050|P1|Overall Study|Unsatisfactory therapeutic response|1
24836|NCT01549951|109050|P1|Overall Study|Withdrawal by Subject|2
24837|NCT01549951|109050|P1|Overall Study|Adverse Event|15
24838|NCT01549873|109077|P2|Overall Study|Physician Decision|1
24839|NCT01549873|109078|P1|Overall Study|Physician Decision|0
24840|NCT01549860|109090|P2|Overall Study|Physician Decision|1
24841|NCT01549860|109091|P1|Overall Study|Physician Decision|1
24842|NCT01549860|109090|P2|Overall Study|Withdrawal by Subject|0
24843|NCT01549860|109091|P1|Overall Study|Withdrawal by Subject|1
24844|NCT01549613|109103|P2|Overall Study|Lost to Follow-up|11
24845|NCT01549613|109104|P1|Overall Study|Lost to Follow-up|11
24846|NCT01549392|109123|P2|Overall Study|Withdrawal by Subject|0
24847|NCT01549392|109124|P1|Overall Study|Withdrawal by Subject|1
24848|NCT01549275|109143|P2|Overall Study|Lost to Follow-up|0
24849|NCT01549275|109144|P1|Overall Study|Lost to Follow-up|1
24850|NCT01549041|109156|P2|Overall Study|Adverse Event|4
24851|NCT01549041|109157|P1|Overall Study|Adverse Event|0
24852|NCT01549041|109156|P2|Overall Study|Lack of Efficacy|4
24853|NCT01549041|109157|P1|Overall Study|Lack of Efficacy|2
24854|NCT01548638|109204|P1|Overall Study|Withdrawal by Subject|1
24855|NCT01548638|109204|P1|Overall Study|Protocol Violation|3
24856|NCT01548417|109213|P2|Overall Study|Withdrawal by Subject|2
24857|NCT01548417|109214|P1|Overall Study|Withdrawal by Subject|0
24858|NCT01548287|109226|P5|Randomized Period|Adverse Event|0
24859|NCT01548287|109227|P4|Randomized Period|Adverse Event|0
24860|NCT01548287|109228|P3|Randomized Period|Adverse Event|5
24861|NCT01548287|109229|P2|Randomized Period|Adverse Event|2
24862|NCT01548287|109230|P1|Randomized Period|Adverse Event|0
24863|NCT01548287|109226|P5|Randomized Period|Did not meet inclusion criteria|0
24864|NCT01548287|109227|P4|Randomized Period|Did not meet inclusion criteria|0
24865|NCT01548287|109228|P3|Randomized Period|Did not meet inclusion criteria|2
24866|NCT01548287|109229|P2|Randomized Period|Did not meet inclusion criteria|0
24867|NCT01548287|109230|P1|Randomized Period|Did not meet inclusion criteria|0
24868|NCT01548287|109226|P5|Screening|Did not meet eligibility criteria|74
24869|NCT01548287|109227|P4|Screening|Did not meet eligibility criteria|0
24870|NCT01548287|109228|P3|Screening|Did not meet eligibility criteria|0
24871|NCT01548287|109229|P2|Screening|Did not meet eligibility criteria|0
24872|NCT01548287|109230|P1|Screening|Did not meet eligibility criteria|0
24873|NCT01548287|109226|P5|Screening|No reason provided|9
24874|NCT01548287|109227|P4|Screening|No reason provided|0
24875|NCT01548287|109228|P3|Screening|No reason provided|0
24876|NCT01548287|109229|P2|Screening|No reason provided|0
24877|NCT01548287|109230|P1|Screening|No reason provided|0
24878|NCT01547728|109260|P1|Overall Study|Screen failure|39
24879|NCT01547728|109260|P1|Overall Study|Drug not ready for subject|1
24880|NCT01547728|109260|P1|Overall Study|Change in procedure and equipment|1
24881|NCT01547598|109369|P2|Overall Study|Other Miscellaneous Reasons|1
24882|NCT01547598|109370|P1|Overall Study|Other Miscellaneous Reasons|2
24883|NCT01547598|109369|P2|Overall Study|Protocol Violation|1
24884|NCT01547598|109370|P1|Overall Study|Protocol Violation|1
24885|NCT01547598|109369|P2|Overall Study|Adverse Event|1
24886|NCT01547598|109370|P1|Overall Study|Adverse Event|1
24887|NCT01547598|109369|P2|Overall Study|Lost to Follow-up|1
24888|NCT01547598|109370|P1|Overall Study|Lost to Follow-up|1
24889|NCT01547598|109369|P2|Overall Study|Withdrew consent|1
24890|NCT01547598|109370|P1|Overall Study|Withdrew consent|1
24891|NCT01547130|109461|P2|Overall Study|Lost to Follow-up|5
24892|NCT01547130|109462|P1|Overall Study|Lost to Follow-up|9
24893|NCT01546922|109476|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
24894|NCT01546922|109477|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
24895|NCT01546922|109476|P2|Second Period of 10 Weeks|Protocol Violation|1
24896|NCT01546922|109477|P1|Second Period of 10 Weeks|Protocol Violation|3
24897|NCT01546922|109476|P2|First Period of 10 Weeks|Investigator's judgment|0
24898|NCT01546922|109477|P1|First Period of 10 Weeks|Investigator's judgment|1
24899|NCT01546922|109476|P2|First Period of 10 Weeks|Withdrawal by Subject|1
24900|NCT01546922|109477|P1|First Period of 10 Weeks|Withdrawal by Subject|1
24901|NCT01546922|109476|P2|First Period of 10 Weeks|Protocol Violation|1
24902|NCT01546922|109477|P1|First Period of 10 Weeks|Protocol Violation|3
24903|NCT01546883|109483|P1|Overall Study|other unrelated illness|1
24904|NCT01546883|109483|P1|Overall Study|early closure of study|2
24905|NCT01546883|109483|P1|Overall Study|Lost to Follow-up|2
24906|NCT01546883|109483|P1|Overall Study|Adverse Event|4
24907|NCT01546883|109483|P1|Overall Study|Withdrawal by Subject|3
24908|NCT01546688|109489|P2|Overall Study|Lack of Efficacy|0
24909|NCT01546688|109490|P1|Overall Study|Lack of Efficacy|1
24910|NCT01546688|109489|P2|Overall Study|Withdrawal by Subject|1
24911|NCT01546688|109490|P1|Overall Study|Withdrawal by Subject|2
24912|NCT01546688|109489|P2|Overall Study|Adverse Event|4
24913|NCT01546688|109490|P1|Overall Study|Adverse Event|0
24914|NCT01546649|109522|P2|Overall Study|Withdrawal by Subject|2
24915|NCT01546649|109523|P1|Overall Study|Withdrawal by Subject|1
24916|NCT01546649|109522|P2|Overall Study|Discovery of secondary cancer|1
24917|NCT01546649|109523|P1|Overall Study|Discovery of secondary cancer|0
24918|NCT01546649|109522|P2|Overall Study|Recurrence|1
24919|NCT01546649|109523|P1|Overall Study|Recurrence|1
24920|NCT01546649|109522|P2|Overall Study|Lack of Efficacy|0
24921|NCT01546649|109523|P1|Overall Study|Lack of Efficacy|1
24922|NCT01546649|109522|P2|Overall Study|Protocol Violation|0
24923|NCT01546649|109523|P1|Overall Study|Protocol Violation|1
24924|NCT01546649|109522|P2|Overall Study|Adverse Event|5
24925|NCT01546649|109523|P1|Overall Study|Adverse Event|4
24926|NCT01546623|109558|P2|Overall Study|Did Not Receive Study Drug|1
24927|NCT01546623|109559|P1|Overall Study|Did Not Receive Study Drug|1
24928|NCT01546623|109558|P2|Overall Study|High Prostate specific antigen|1
24929|NCT01546623|109559|P1|Overall Study|High Prostate specific antigen|2
24930|NCT01546623|109558|P2|Overall Study|Major Protocol Deviation|1
24931|NCT01546623|109559|P1|Overall Study|Major Protocol Deviation|1
24932|NCT01546623|109558|P2|Overall Study|Adverse Event|3
24933|NCT01546623|109559|P1|Overall Study|Adverse Event|2
24934|NCT01546519|109589|P4|Overall Study|Withdrawal by Subject|0
24935|NCT01546519|109590|P3|Overall Study|Withdrawal by Subject|0
24936|NCT01546519|109591|P2|Overall Study|Withdrawal by Subject|0
24937|NCT01546519|109592|P1|Overall Study|Withdrawal by Subject|1
24938|NCT01546519|109589|P4|Overall Study|Physician Decision|3
24939|NCT01546519|109590|P3|Overall Study|Physician Decision|2
24940|NCT01546519|109591|P2|Overall Study|Physician Decision|5
24941|NCT01546519|109592|P1|Overall Study|Physician Decision|6
24942|NCT01546519|109589|P4|Overall Study|related to disease progression|1
24943|NCT01546519|109590|P3|Overall Study|related to disease progression|2
24944|NCT01546519|109591|P2|Overall Study|related to disease progression|2
24945|NCT01546519|109592|P1|Overall Study|related to disease progression|2
24946|NCT01546519|109589|P4|Overall Study|Death|1
24947|NCT01546519|109590|P3|Overall Study|Death|3
24948|NCT01546519|109591|P2|Overall Study|Death|1
24949|NCT01546519|109592|P1|Overall Study|Death|0
24950|NCT01546519|109589|P4|Overall Study|Adverse Event|1
24951|NCT01546519|109590|P3|Overall Study|Adverse Event|1
24952|NCT01546519|109591|P2|Overall Study|Adverse Event|0
24953|NCT01546519|109592|P1|Overall Study|Adverse Event|0
24954|NCT01546207|109657|P1|Overall Study|Death|1
24955|NCT01546142|109672|P2|Overall Study|Subject Randomized but Not Treated|0
24956|NCT01546142|109673|P1|Overall Study|Subject Randomized but Not Treated|1
24957|NCT01546142|109672|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
24958|NCT01546142|109673|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
24959|NCT01546142|109672|P2|Overall Study|Lost to Follow-up|15
24960|NCT01546142|109673|P1|Overall Study|Lost to Follow-up|20
24961|NCT01546142|109672|P2|Overall Study|Adverse Event|3
24962|NCT01546142|109673|P1|Overall Study|Adverse Event|6
24963|NCT01546142|109672|P2|Overall Study|Subject Noncompliance|1
24964|NCT01546142|109673|P1|Overall Study|Subject Noncompliance|1
24965|NCT01546142|109672|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
24966|NCT01546142|109673|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
24967|NCT01545388|109764|P3|Overall Study|Not specified|0
24968|NCT01545388|109765|P2|Overall Study|Not specified|1
24969|NCT01545388|109766|P1|Overall Study|Not specified|1
24970|NCT01545388|109764|P3|Overall Study|Withdrawal by Subject|2
24971|NCT01545388|109765|P2|Overall Study|Withdrawal by Subject|4
24972|NCT01545388|109766|P1|Overall Study|Withdrawal by Subject|1
24973|NCT01545388|109764|P3|Overall Study|Participant moved or relocated|0
24974|NCT01545388|109765|P2|Overall Study|Participant moved or relocated|0
24975|NCT01545388|109766|P1|Overall Study|Participant moved or relocated|1
24976|NCT01545388|109764|P3|Overall Study|Lack of Efficacy|5
24977|NCT01545388|109765|P2|Overall Study|Lack of Efficacy|2
24978|NCT01545388|109766|P1|Overall Study|Lack of Efficacy|3
24979|NCT01545388|109764|P3|Overall Study|Adverse Event|1
24980|NCT01545388|109765|P2|Overall Study|Adverse Event|4
24981|NCT01545388|109766|P1|Overall Study|Adverse Event|2
24982|NCT01544153|109846|P4|Overall Study|Non-smoker|0
24983|NCT01544153|109847|P3|Overall Study|Non-smoker|1
24984|NCT01544153|109848|P2|Overall Study|Non-smoker|0
24985|NCT01544153|109849|P1|Overall Study|Non-smoker|0
24986|NCT01544153|109846|P4|Overall Study|Under 18|0
24987|NCT01544153|109847|P3|Overall Study|Under 18|0
24988|NCT01544153|109848|P2|Overall Study|Under 18|1
24989|NCT01544153|109849|P1|Overall Study|Under 18|0
24990|NCT01544920|109930|P2|Overall Study|Withdrawal by Subject|4
24991|NCT01544920|109931|P1|Overall Study|Withdrawal by Subject|4
24992|NCT01544920|109930|P2|Overall Study|Physician Decision|1
24993|NCT01544920|109931|P1|Overall Study|Physician Decision|4
24994|NCT01544920|109930|P2|Overall Study|Protocol Violation|2
24995|NCT01544920|109931|P1|Overall Study|Protocol Violation|0
24996|NCT01544920|109930|P2|Overall Study|Lost to Follow-up|12
24997|NCT01544920|109931|P1|Overall Study|Lost to Follow-up|11
24998|NCT01544920|109930|P2|Overall Study|Death|1
24999|NCT01544920|109931|P1|Overall Study|Death|0
25000|NCT01544920|109930|P2|Overall Study|Adverse Event|3
25001|NCT01544920|109931|P1|Overall Study|Adverse Event|0
25002|NCT01544582|109942|P4|Analysis Population|Participant in Jail|0
25003|NCT01544582|109943|P3|Analysis Population|Participant in Jail|1
25004|NCT01544582|109944|P2|Analysis Population|Participant in Jail|0
25005|NCT01544582|109945|P1|Analysis Population|Participant in Jail|0
25006|NCT01544582|109942|P4|Analysis Population|Programmed Surgery|0
25007|NCT01544582|109943|P3|Analysis Population|Programmed Surgery|0
25008|NCT01544582|109944|P2|Analysis Population|Programmed Surgery|1
25009|NCT01544582|109945|P1|Analysis Population|Programmed Surgery|0
25010|NCT01544582|109942|P4|Analysis Population|Poor Participant Compliance|0
25011|NCT01544582|109943|P3|Analysis Population|Poor Participant Compliance|0
25012|NCT01544582|109944|P2|Analysis Population|Poor Participant Compliance|1
25013|NCT01544582|109945|P1|Analysis Population|Poor Participant Compliance|0
25014|NCT01544582|109942|P4|Analysis Population|Poor Adherence|0
25015|NCT01544582|109943|P3|Analysis Population|Poor Adherence|1
25016|NCT01544582|109944|P2|Analysis Population|Poor Adherence|0
25017|NCT01544582|109945|P1|Analysis Population|Poor Adherence|0
25018|NCT01544582|109942|P4|Analysis Population|No Social Insurance|0
25019|NCT01544582|109943|P3|Analysis Population|No Social Insurance|1
25020|NCT01544582|109944|P2|Analysis Population|No Social Insurance|0
25021|NCT01544582|109945|P1|Analysis Population|No Social Insurance|0
25022|NCT01544582|109942|P4|Analysis Population|Liver Transplantation|0
25023|NCT01544582|109943|P3|Analysis Population|Liver Transplantation|1
25024|NCT01544582|109944|P2|Analysis Population|Liver Transplantation|0
25025|NCT01544582|109945|P1|Analysis Population|Liver Transplantation|0
25026|NCT01544582|109942|P4|Analysis Population|Intolerance|0
25027|NCT01544582|109943|P3|Analysis Population|Intolerance|0
25028|NCT01544582|109944|P2|Analysis Population|Intolerance|1
25029|NCT01544582|109945|P1|Analysis Population|Intolerance|0
25030|NCT01544582|109942|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
25031|NCT01544582|109943|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
25032|NCT01544582|109944|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
25033|NCT01544582|109945|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
25034|NCT01544582|109942|P4|Analysis Population|Bad Tolerance to Treatment|0
25035|NCT01544582|109943|P3|Analysis Population|Bad Tolerance to Treatment|2
25036|NCT01544582|109944|P2|Analysis Population|Bad Tolerance to Treatment|0
25037|NCT01544582|109945|P1|Analysis Population|Bad Tolerance to Treatment|0
25038|NCT01544582|109942|P4|Analysis Population|Lost to Follow-up|5
25039|NCT01544582|109943|P3|Analysis Population|Lost to Follow-up|6
25040|NCT01544582|109944|P2|Analysis Population|Lost to Follow-up|6
25041|NCT01544582|109945|P1|Analysis Population|Lost to Follow-up|0
25042|NCT01544582|109942|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
25043|NCT01544582|109943|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
25044|NCT01544582|109944|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
25045|NCT01544582|109945|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
25046|NCT01544582|109942|P4|Analysis Population|Effectiveness Reason|12
25047|NCT01544582|109943|P3|Analysis Population|Effectiveness Reason|29
25048|NCT01544582|109944|P2|Analysis Population|Effectiveness Reason|48
25049|NCT01544582|109945|P1|Analysis Population|Effectiveness Reason|0
25050|NCT01544582|109942|P4|Analysis Population|Safety Reason|8
25051|NCT01544582|109943|P3|Analysis Population|Safety Reason|31
25052|NCT01544582|109944|P2|Analysis Population|Safety Reason|33
25053|NCT01544582|109945|P1|Analysis Population|Safety Reason|0
25054|NCT01544582|109942|P4|Analysis Population|Physician Decision|9
25055|NCT01544582|109943|P3|Analysis Population|Physician Decision|10
25056|NCT01544582|109944|P2|Analysis Population|Physician Decision|13
25057|NCT01544582|109945|P1|Analysis Population|Physician Decision|0
25058|NCT01544582|109942|P4|Analysis Population|Participant Refuses to Continue Study|4
25059|NCT01544582|109943|P3|Analysis Population|Participant Refuses to Continue Study|17
25060|NCT01544582|109944|P2|Analysis Population|Participant Refuses to Continue Study|15
25061|NCT01544582|109945|P1|Analysis Population|Participant Refuses to Continue Study|0
25062|NCT01544582|109942|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
25063|NCT01544582|109943|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
25064|NCT01544582|109944|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
25065|NCT01544582|109945|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
25066|NCT01544582|109942|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
25067|NCT01544582|109943|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
25068|NCT01544582|109944|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
25069|NCT01544582|109945|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
25070|NCT01544348|110042|P8|Overall Study|Physician Decision|0
25071|NCT01544348|110043|P7|Overall Study|Physician Decision|0
25072|NCT01544348|110044|P6|Overall Study|Physician Decision|1
25073|NCT01544348|110045|P5|Overall Study|Physician Decision|0
25074|NCT01544348|110046|P4|Overall Study|Physician Decision|0
25075|NCT01544348|110047|P3|Overall Study|Physician Decision|0
25076|NCT01544348|110048|P2|Overall Study|Physician Decision|0
25077|NCT01544348|110049|P1|Overall Study|Physician Decision|0
25078|NCT01544348|110042|P8|Overall Study|Withdrawal by Subject|0
25079|NCT01544348|110043|P7|Overall Study|Withdrawal by Subject|1
25080|NCT01544348|110044|P6|Overall Study|Withdrawal by Subject|2
25081|NCT01544348|110045|P5|Overall Study|Withdrawal by Subject|1
25082|NCT01544348|110046|P4|Overall Study|Withdrawal by Subject|0
25083|NCT01544348|110047|P3|Overall Study|Withdrawal by Subject|0
25084|NCT01544348|110048|P2|Overall Study|Withdrawal by Subject|0
25085|NCT01544348|110049|P1|Overall Study|Withdrawal by Subject|1
25086|NCT01544348|110042|P8|Overall Study|Lost to Follow-up|0
25087|NCT01544348|110043|P7|Overall Study|Lost to Follow-up|1
25088|NCT01544348|110044|P6|Overall Study|Lost to Follow-up|0
25089|NCT01544348|110045|P5|Overall Study|Lost to Follow-up|0
25090|NCT01544348|110046|P4|Overall Study|Lost to Follow-up|0
25091|NCT01544348|110047|P3|Overall Study|Lost to Follow-up|0
25092|NCT01544348|110048|P2|Overall Study|Lost to Follow-up|0
25093|NCT01544348|110049|P1|Overall Study|Lost to Follow-up|1
25094|NCT01544309|110091|P2|Overall Study|Administered prohibit prior medication|0
25095|NCT01544309|110092|P1|Overall Study|Administered prohibit prior medication|1
25096|NCT01544309|110091|P2|Overall Study|Not performed pre-dose examination|2
25097|NCT01544309|110092|P1|Overall Study|Not performed pre-dose examination|1
25098|NCT01544309|110091|P2|Overall Study|Physician Decision|1
25099|NCT01544309|110092|P1|Overall Study|Physician Decision|4
25100|NCT01544309|110091|P2|Overall Study|Protocol Violation|1
25101|NCT01544309|110092|P1|Overall Study|Protocol Violation|2
25102|NCT01544309|110091|P2|Overall Study|Withdrawal by Subject|7
25103|NCT01544309|110092|P1|Overall Study|Withdrawal by Subject|12
25104|NCT01544179|110130|P2|Overall Study|Eligibility criteria not fulfilled|0
25105|NCT01544179|110131|P1|Overall Study|Eligibility criteria not fulfilled|1
25106|NCT01544179|110130|P2|Overall Study|Withdrawal by Subject|7
25107|NCT01544179|110131|P1|Overall Study|Withdrawal by Subject|12
25108|NCT01544179|110130|P2|Overall Study|Adverse Event|1
25109|NCT01544179|110131|P1|Overall Study|Adverse Event|0
25110|NCT01544179|110130|P2|Overall Study|Lost to Follow-up|1
25111|NCT01544179|110131|P1|Overall Study|Lost to Follow-up|0
25112|NCT01544179|110130|P2|Overall Study|Death|37
25113|NCT01544179|110131|P1|Overall Study|Death|50
25114|NCT01543958|110220|P1|Overall Study|ART initiation|1
25115|NCT01543958|110220|P1|Overall Study|Loss to follow-up|3
25116|NCT01543828|110275|P2|Treatment 2|Lost to Follow-up|0
25117|NCT01543828|110276|P1|Treatment 2|Lost to Follow-up|1
25118|NCT01543685|110289|P5|Overall Study|Adverse Event|2
25119|NCT01543685|110290|P4|Overall Study|Adverse Event|0
25120|NCT01543685|110291|P3|Overall Study|Adverse Event|0
25121|NCT01543685|110292|P2|Overall Study|Adverse Event|1
25122|NCT01543685|110293|P1|Overall Study|Adverse Event|2
25123|NCT01543685|110289|P5|Overall Study|Lack of Efficacy|2
25124|NCT01543685|110290|P4|Overall Study|Lack of Efficacy|0
25125|NCT01543685|110291|P3|Overall Study|Lack of Efficacy|2
25126|NCT01543685|110292|P2|Overall Study|Lack of Efficacy|2
25127|NCT01543685|110293|P1|Overall Study|Lack of Efficacy|1
25128|NCT01543503|110359|P2|Overall Study|Screen failure|0
25129|NCT01543503|110360|P1|Overall Study|Screen failure|1
25130|NCT01543503|110359|P2|Overall Study|Participant went to United States|0
25131|NCT01543503|110360|P1|Overall Study|Participant went to United States|1
25132|NCT01543503|110359|P2|Overall Study|Participant consented to another study|2
25133|NCT01543503|110360|P1|Overall Study|Participant consented to another study|0
25134|NCT01543503|110359|P2|Overall Study|Moved to other rheumatologic site|1
25135|NCT01543503|110360|P1|Overall Study|Moved to other rheumatologic site|0
25136|NCT01543503|110359|P2|Overall Study|Participant did not attend a visit|0
25137|NCT01543503|110360|P1|Overall Study|Participant did not attend a visit|1
25138|NCT01543503|110359|P2|Overall Study|Site stopped participation|1
25139|NCT01543503|110360|P1|Overall Study|Site stopped participation|5
25140|NCT01543503|110359|P2|Overall Study|Participant recruited after closing date|1
25141|NCT01543503|110360|P1|Overall Study|Participant recruited after closing date|0
25142|NCT01543503|110359|P2|Overall Study|Investigator did not wish to participate|1
25143|NCT01543503|110360|P1|Overall Study|Investigator did not wish to participate|1
25144|NCT01543503|110359|P2|Overall Study|Participant decision to stop treatment|0
25145|NCT01543503|110360|P1|Overall Study|Participant decision to stop treatment|1
25146|NCT01543503|110359|P2|Overall Study|Participant moved to Scotland|0
25147|NCT01543503|110360|P1|Overall Study|Participant moved to Scotland|1
25148|NCT01543503|110359|P2|Overall Study|Participant transferred to another city|0
25149|NCT01543503|110360|P1|Overall Study|Participant transferred to another city|1
25150|NCT01543503|110359|P2|Overall Study|Participant will not return for visits|2
25151|NCT01543503|110360|P1|Overall Study|Participant will not return for visits|0
25152|NCT01543503|110359|P2|Overall Study|Participant moved to another city|0
25153|NCT01543503|110360|P1|Overall Study|Participant moved to another city|2
25154|NCT01543503|110359|P2|Overall Study|Incorrect medication received|0
25155|NCT01543503|110360|P1|Overall Study|Incorrect medication received|1
25156|NCT01543503|110359|P2|Overall Study|Refused to continue treatment|0
25157|NCT01543503|110360|P1|Overall Study|Refused to continue treatment|7
25158|NCT01543503|110359|P2|Overall Study|Participant did not complete last visit|2
25159|NCT01543503|110360|P1|Overall Study|Participant did not complete last visit|0
25160|NCT01543503|110359|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
25161|NCT01543503|110360|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
25162|NCT01543503|110359|P2|Overall Study|Intolerance to the biologic treatment|1
25163|NCT01543503|110360|P1|Overall Study|Intolerance to the biologic treatment|0
25164|NCT01543503|110359|P2|Overall Study|Change of jobs|1
25165|NCT01543503|110360|P1|Overall Study|Change of jobs|0
25166|NCT01543503|110359|P2|Overall Study|Participant withdrew informed consent|10
25167|NCT01543503|110360|P1|Overall Study|Participant withdrew informed consent|8
25168|NCT01543503|110359|P2|Overall Study|Lack of Efficacy|16
25169|NCT01543503|110360|P1|Overall Study|Lack of Efficacy|4
25170|NCT01543503|110359|P2|Overall Study|Adverse Event|13
25171|NCT01543503|110360|P1|Overall Study|Adverse Event|9
25172|NCT01543503|110359|P2|Overall Study|Lost to Follow-up|36
25173|NCT01543503|110360|P1|Overall Study|Lost to Follow-up|32
25174|NCT01543204|110404|P1|Overall Study|Lost to Follow-up|1
25175|NCT01543204|110404|P1|Overall Study|Requirement for Alternative Therapy|1
25176|NCT01543204|110404|P1|Overall Study|Withdrawal by Subject|4
25177|NCT01543204|110404|P1|Overall Study|Adverse Event|1
25178|NCT01543204|110404|P1|Overall Study|Non-compliance|1
25179|NCT01542788|110494|P2|Overall Study|Withdrawal by Subject|0
25180|NCT01542788|110495|P1|Overall Study|Withdrawal by Subject|1
25181|NCT01542788|110494|P2|Overall Study|Physician Decision|0
25182|NCT01542788|110495|P1|Overall Study|Physician Decision|1
25183|NCT01542788|110494|P2|Overall Study|Protocol Violation|0
25184|NCT01542788|110495|P1|Overall Study|Protocol Violation|2
25185|NCT01542788|110494|P2|Overall Study|Death|0
25186|NCT01542788|110495|P1|Overall Study|Death|3
25187|NCT01542788|110494|P2|Overall Study|Lost to Follow-up|0
25188|NCT01542788|110495|P1|Overall Study|Lost to Follow-up|5
25189|NCT01542788|110494|P2|Overall Study|Lack of Efficacy|71
25190|NCT01542788|110495|P1|Overall Study|Lack of Efficacy|41
25191|NCT01542788|110494|P2|Overall Study|Randomized but Not Treated|0
25192|NCT01542788|110495|P1|Overall Study|Randomized but Not Treated|2
25193|NCT01542632|110534|P6|Overall Study|Sponsor/Investigator Decision|0
25194|NCT01542632|110535|P5|Overall Study|Sponsor/Investigator Decision|1
25195|NCT01542632|110536|P4|Overall Study|Sponsor/Investigator Decision|0
25196|NCT01542632|110537|P3|Overall Study|Sponsor/Investigator Decision|0
25197|NCT01542632|110538|P2|Overall Study|Sponsor/Investigator Decision|0
25198|NCT01542632|110539|P1|Overall Study|Sponsor/Investigator Decision|0
25199|NCT01542632|110534|P6|Overall Study|Lost to Follow-up|0
25200|NCT01542632|110535|P5|Overall Study|Lost to Follow-up|0
25201|NCT01542632|110536|P4|Overall Study|Lost to Follow-up|0
25202|NCT01542632|110537|P3|Overall Study|Lost to Follow-up|0
25203|NCT01542632|110538|P2|Overall Study|Lost to Follow-up|1
25204|NCT01542632|110539|P1|Overall Study|Lost to Follow-up|0
25205|NCT01542632|110534|P6|Overall Study|Adverse Event|0
25206|NCT01542632|110535|P5|Overall Study|Adverse Event|0
25207|NCT01542632|110536|P4|Overall Study|Adverse Event|0
25208|NCT01542632|110537|P3|Overall Study|Adverse Event|1
25209|NCT01542632|110538|P2|Overall Study|Adverse Event|0
25210|NCT01542632|110539|P1|Overall Study|Adverse Event|0
25211|NCT01542632|110534|P6|Overall Study|Withdrawal of Consent|0
25212|NCT01542632|110535|P5|Overall Study|Withdrawal of Consent|3
25213|NCT01542632|110536|P4|Overall Study|Withdrawal of Consent|2
25214|NCT01542632|110537|P3|Overall Study|Withdrawal of Consent|0
25215|NCT01542632|110538|P2|Overall Study|Withdrawal of Consent|0
25216|NCT01542632|110539|P1|Overall Study|Withdrawal of Consent|0
25217|NCT01542034|110616|P2|Overall Study|Lost to Follow-up|6
25218|NCT01542034|110617|P1|Overall Study|Lost to Follow-up|7
25219|NCT01542034|110616|P2|Overall Study|Adverse Event|2
25220|NCT01542034|110617|P1|Overall Study|Adverse Event|2
25221|NCT01542034|110616|P2|Overall Study|Subject Noncompliance|0
25222|NCT01542034|110617|P1|Overall Study|Subject Noncompliance|1
25223|NCT01542034|110616|P2|Overall Study|Administrative decision|3
25224|NCT01542034|110617|P1|Overall Study|Administrative decision|0
25225|NCT01542034|110616|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
25226|NCT01542034|110617|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
25227|NCT01541969|110631|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
25228|NCT01541969|110632|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
25229|NCT01541969|110631|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
25230|NCT01541969|110632|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
25231|NCT01541969|110631|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
25232|NCT01541969|110632|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
25233|NCT01541969|110631|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
25234|NCT01541969|110632|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
25235|NCT01541969|110631|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
25236|NCT01541969|110632|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
25237|NCT01541969|110631|P2|Double-blind (0-12 Weeks)|Adverse Event|0
25238|NCT01541969|110632|P1|Double-blind (0-12 Weeks)|Adverse Event|2
25239|NCT01541969|110631|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
25240|NCT01541969|110632|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
25241|NCT01541969|110631|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
25242|NCT01541969|110632|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
25243|NCT01541969|110631|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
25244|NCT01541969|110632|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
25245|NCT01541969|110631|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
25246|NCT01541969|110632|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
25247|NCT01541930|110648|P1|Overall Study|Withdrawal by Subject|1
25248|NCT01541865|110667|P1|Overall Study|Protocol Violation|1
25249|NCT01541865|110667|P1|Overall Study|Adverse Event|1
25250|NCT01541865|110667|P1|Overall Study|Withdrawal by Subject|9
25251|NCT01541865|110667|P1|Overall Study|Lost to Follow-up|11
25252|NCT01541644|110697|P1|Overall Study|Withdrawal by Subject|3
25253|NCT01541397|110716|P2|Overall Study|Study ended prior to data collection|2
25254|NCT01541397|110717|P1|Overall Study|Study ended prior to data collection|4
25255|NCT01541371|110729|P1|Overall Study|Unspecified|6
25256|NCT01541371|110729|P1|Overall Study|Study medication non-compliance|3
25257|NCT01541371|110729|P1|Overall Study|Protocol Violation|6
25258|NCT01541371|110729|P1|Overall Study|Lack of Efficacy|12
25259|NCT01541371|110729|P1|Overall Study|Adverse Event|15
25260|NCT01541371|110729|P1|Overall Study|Lost to Follow-up|21
25261|NCT01541371|110729|P1|Overall Study|Withdrawal by Subject|14
25262|NCT01541254|110752|P1|Overall Study|alternate stent used|1
25263|NCT01541254|110752|P1|Overall Study|stent not required|1
25264|NCT01541254|110752|P1|Overall Study|GI bleed prior to procedure|1
25265|NCT01541254|110752|P1|Overall Study|enrolled after study closed|1
25266|NCT01541254|110752|P1|Overall Study|excluded - metal allergy|1
25267|NCT01541254|110752|P1|Overall Study|Withdrawal by Subject|1
25268|NCT01540981|110759|P2|Overall Study|Withdrawal by Subject|0
25269|NCT01540981|110760|P1|Overall Study|Withdrawal by Subject|1
25270|NCT01540851|110770|P2|Overall Study|Withdrawal by Subject|3
25271|NCT01540851|110771|P1|Overall Study|Withdrawal by Subject|7
25272|NCT01540851|110770|P2|Overall Study|Lost to Follow-up|15
25273|NCT01540851|110771|P1|Overall Study|Lost to Follow-up|14
25274|NCT01540487|110900|P2|Overall Study|Protocol Violation|0
25275|NCT01540487|110901|P1|Overall Study|Protocol Violation|1
25276|NCT01539759|111036|P2|Overall Study|Lost to Follow-up|8
25277|NCT01539759|111037|P1|Overall Study|Lost to Follow-up|6
25278|NCT01539642|111047|P2|Overall Study|Withdrawal by Subject|2
25279|NCT01539642|111048|P1|Overall Study|Withdrawal by Subject|2
25280|NCT01539642|111047|P2|Overall Study|Adverse Event|4
25281|NCT01539642|111048|P1|Overall Study|Adverse Event|6
25282|NCT01539642|111047|P2|Overall Study|Patient ready for early discharge|7
25283|NCT01539642|111048|P1|Overall Study|Patient ready for early discharge|8
25284|NCT01539642|111047|P2|Overall Study|Lack of Efficacy|18
25285|NCT01539642|111048|P1|Overall Study|Lack of Efficacy|20
25286|NCT01539538|111065|P2|Overall Study|PCA no longer required or PCA problem|7
25287|NCT01539538|111066|P1|Overall Study|PCA no longer required or PCA problem|3
25288|NCT01539538|111065|P2|Overall Study|Withdrawal by Subject|3
25289|NCT01539538|111066|P1|Overall Study|Withdrawal by Subject|2
25290|NCT01539538|111065|P2|Overall Study|Lack of Efficacy|16
25291|NCT01539538|111066|P1|Overall Study|Lack of Efficacy|13
25292|NCT01539538|111065|P2|Overall Study|Adverse Event|18
25293|NCT01539538|111066|P1|Overall Study|Adverse Event|13
25294|NCT01539512|111074|P2|Overall Study|Richter's Transformation|0
25295|NCT01539512|111075|P1|Overall Study|Richter's Transformation|1
25296|NCT01539512|111074|P2|Overall Study|Withdrawal by Subject|5
25297|NCT01539512|111075|P1|Overall Study|Withdrawal by Subject|12
25298|NCT01539512|111074|P2|Overall Study|Physician Decision|1
25299|NCT01539512|111075|P1|Overall Study|Physician Decision|1
25300|NCT01539512|111074|P2|Overall Study|Adverse Event|7
25301|NCT01539512|111075|P1|Overall Study|Adverse Event|9
25302|NCT01539317|111091|P2|Overall Study|Screening Error. Deleted from analysis.|0
25303|NCT01539317|111092|P1|Overall Study|Screening Error. Deleted from analysis.|1
25304|NCT01539083|111122|P3|After Randomization (TP and VTP)|Progressive Disease|2
25305|NCT01539083|111123|P2|After Randomization (TP and VTP)|Progressive Disease|3
25306|NCT01539083|111124|P1|After Randomization (TP and VTP)|Progressive Disease|0
25307|NCT01539083|111122|P3|After Randomization (TP and VTP)|Death|6
25308|NCT01539083|111123|P2|After Randomization (TP and VTP)|Death|4
25309|NCT01539083|111124|P1|After Randomization (TP and VTP)|Death|0
25310|NCT01539083|111122|P3|After Randomization (TP and VTP)|Adverse Event|0
25311|NCT01539083|111123|P2|After Randomization (TP and VTP)|Adverse Event|1
25312|NCT01539083|111124|P1|After Randomization (TP and VTP)|Adverse Event|0
25313|NCT01539083|111122|P3|After Randomization (TP and VTP)|Withdrawal by Subject|1
25314|NCT01539083|111123|P2|After Randomization (TP and VTP)|Withdrawal by Subject|3
25315|NCT01539083|111124|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
25316|NCT01539083|111122|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
25317|NCT01539083|111123|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
25318|NCT01539083|111124|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
25319|NCT01539083|111122|P3|Before Randomization (VCD Induction)|Unspecified|0
25320|NCT01539083|111123|P2|Before Randomization (VCD Induction)|Unspecified|0
25321|NCT01539083|111124|P1|Before Randomization (VCD Induction)|Unspecified|5
25322|NCT01539083|111122|P3|Before Randomization (VCD Induction)|Progressive Disease|0
25323|NCT01539083|111123|P2|Before Randomization (VCD Induction)|Progressive Disease|0
25324|NCT01539083|111124|P1|Before Randomization (VCD Induction)|Progressive Disease|8
25325|NCT01539083|111122|P3|Before Randomization (VCD Induction)|Physician Decision|0
25326|NCT01539083|111123|P2|Before Randomization (VCD Induction)|Physician Decision|0
25327|NCT01539083|111124|P1|Before Randomization (VCD Induction)|Physician Decision|14
25328|NCT01539083|111122|P3|Before Randomization (VCD Induction)|Protocol Violation|0
25329|NCT01539083|111123|P2|Before Randomization (VCD Induction)|Protocol Violation|0
25330|NCT01539083|111124|P1|Before Randomization (VCD Induction)|Protocol Violation|2
25331|NCT01539083|111122|P3|Before Randomization (VCD Induction)|Death|0
25332|NCT01539083|111123|P2|Before Randomization (VCD Induction)|Death|0
25333|NCT01539083|111124|P1|Before Randomization (VCD Induction)|Death|6
25334|NCT01539083|111122|P3|Before Randomization (VCD Induction)|Adverse Event|0
25335|NCT01539083|111123|P2|Before Randomization (VCD Induction)|Adverse Event|0
25336|NCT01539083|111124|P1|Before Randomization (VCD Induction)|Adverse Event|14
25337|NCT01539083|111122|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
25338|NCT01539083|111123|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
25339|NCT01539083|111124|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
25340|NCT01538472|111160|P1|Overall Study|Death|1
25341|NCT01538472|111160|P1|Overall Study|Disease Progression|3
25342|NCT01537432|111239|P2|Overall Study|Unsatisfactory therapeutic effect|0
25343|NCT01537432|111240|P1|Overall Study|Unsatisfactory therapeutic effect|1
25344|NCT01537432|111239|P2|Overall Study|Adverse Event|0
25345|NCT01537432|111240|P1|Overall Study|Adverse Event|1
25346|NCT01537432|111239|P2|Overall Study|Administrative problems|0
25347|NCT01537432|111240|P1|Overall Study|Administrative problems|1
25348|NCT01537432|111239|P2|Overall Study|Withdrawal by Subject|1
25349|NCT01537432|111240|P1|Overall Study|Withdrawal by Subject|0
25350|NCT01537432|111239|P2|Overall Study|Lost to Follow-up|1
25351|NCT01537432|111240|P1|Overall Study|Lost to Follow-up|3
25352|NCT01537302|111276|P1|Overall Study|Withdrawal by Subject|1
25353|NCT01537302|111276|P1|Overall Study|Lost to Follow-up|1
25354|NCT01537198|111283|P1|Overall Study|Not Specified|111
25355|NCT01537198|111283|P1|Overall Study|No Further Visits to the Clinic|37
25356|NCT01537198|111283|P1|Overall Study|Adverse Event|4
25357|NCT01537198|111283|P1|Overall Study|RSV infection|2
25358|NCT01537133|111312|P4|Overall Study|Lost to Follow-up|0
25359|NCT01537133|111313|P3|Overall Study|Lost to Follow-up|0
25360|NCT01537133|111314|P2|Overall Study|Lost to Follow-up|0
25361|NCT01537133|111315|P1|Overall Study|Lost to Follow-up|1
25362|NCT01537133|111312|P4|Overall Study|Withdrawal by Subject|0
25363|NCT01537133|111313|P3|Overall Study|Withdrawal by Subject|0
25364|NCT01537133|111314|P2|Overall Study|Withdrawal by Subject|0
25365|NCT01537133|111315|P1|Overall Study|Withdrawal by Subject|2
25366|NCT01537120|111331|P1|3 Weeks Placebo|Withdrawal by Subject|1
25367|NCT01537120|111331|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
25368|NCT01537081|111344|P3|Overall Study|Assigned but never dosed|0
25369|NCT01537081|111345|P2|Overall Study|Assigned but never dosed|0
25370|NCT01537081|111346|P1|Overall Study|Assigned but never dosed|1
25371|NCT01537081|111344|P3|Overall Study|Sponsor decision|0
25372|NCT01537081|111345|P2|Overall Study|Sponsor decision|1
25373|NCT01537081|111346|P1|Overall Study|Sponsor decision|0
25374|NCT01537081|111344|P3|Overall Study|Physician Decision|0
25375|NCT01537081|111345|P2|Overall Study|Physician Decision|6
25376|NCT01537081|111346|P1|Overall Study|Physician Decision|5
25377|NCT01537081|111344|P3|Overall Study|Withdrawal by Subject|3
25378|NCT01537081|111345|P2|Overall Study|Withdrawal by Subject|11
25379|NCT01537081|111346|P1|Overall Study|Withdrawal by Subject|6
25380|NCT01537081|111344|P3|Overall Study|Protocol Violation|2
25381|NCT01537081|111345|P2|Overall Study|Protocol Violation|2
25382|NCT01537081|111346|P1|Overall Study|Protocol Violation|3
25383|NCT01537081|111344|P3|Overall Study|Lost to Follow-up|9
25384|NCT01537081|111345|P2|Overall Study|Lost to Follow-up|15
25385|NCT01537081|111346|P1|Overall Study|Lost to Follow-up|17
25386|NCT01537081|111344|P3|Overall Study|Lack of Efficacy|0
25387|NCT01537081|111345|P2|Overall Study|Lack of Efficacy|1
25388|NCT01537081|111346|P1|Overall Study|Lack of Efficacy|2
25389|NCT01537081|111344|P3|Overall Study|Adverse Event|2
25390|NCT01537081|111345|P2|Overall Study|Adverse Event|2
25391|NCT01537081|111346|P1|Overall Study|Adverse Event|5
25392|NCT01537042|111359|P2|Overall Study|Other|1
25393|NCT01537042|111360|P1|Overall Study|Other|0
25394|NCT01537042|111359|P2|Overall Study|Protocol Violation|1
25395|NCT01537042|111360|P1|Overall Study|Protocol Violation|0
25396|NCT01537042|111359|P2|Overall Study|Lack of Efficacy|1
25397|NCT01537042|111360|P1|Overall Study|Lack of Efficacy|0
25398|NCT01537042|111359|P2|Overall Study|Adverse Event|2
25399|NCT01537042|111360|P1|Overall Study|Adverse Event|0
25400|NCT01536860|111426|P3|Washout Period (3 Days)|Lost to Follow-up|0
25401|NCT01536860|111427|P2|Washout Period (3 Days)|Lost to Follow-up|0
25402|NCT01536860|111428|P1|Washout Period (3 Days)|Lost to Follow-up|1
25403|NCT01536704|111436|P4|Washout Period 3|Adverse Event|0
25404|NCT01536704|111437|P3|Washout Period 3|Adverse Event|1
25405|NCT01536704|111438|P2|Washout Period 3|Adverse Event|0
25406|NCT01536704|111439|P1|Washout Period 3|Adverse Event|0
25407|NCT01536704|111436|P4|Period 3|Adverse Event|1
25408|NCT01536704|111437|P3|Period 3|Adverse Event|0
25409|NCT01536704|111438|P2|Period 3|Adverse Event|0
25410|NCT01536704|111439|P1|Period 3|Adverse Event|0
25411|NCT01536704|111436|P4|Washout Period 2|Withdrawal by Subject|1
25412|NCT01536704|111437|P3|Washout Period 2|Withdrawal by Subject|0
25413|NCT01536704|111438|P2|Washout Period 2|Withdrawal by Subject|0
25414|NCT01536704|111439|P1|Washout Period 2|Withdrawal by Subject|0
25415|NCT01536704|111436|P4|Washout Period 2|Adverse Event|0
25416|NCT01536704|111437|P3|Washout Period 2|Adverse Event|0
25417|NCT01536704|111438|P2|Washout Period 2|Adverse Event|0
25418|NCT01536704|111439|P1|Washout Period 2|Adverse Event|1
25419|NCT01536704|111436|P4|Washout Period 1|Withdrawal by Subject|0
25420|NCT01536704|111437|P3|Washout Period 1|Withdrawal by Subject|0
25421|NCT01536704|111438|P2|Washout Period 1|Withdrawal by Subject|2
25422|NCT01536704|111439|P1|Washout Period 1|Withdrawal by Subject|1
25423|NCT01536587|111469|P1|Overall Study|Adverse Event|2
25424|NCT01536574|111508|P2|Overall Study|Lack of Efficacy|0
25425|NCT01536574|111509|P1|Overall Study|Lack of Efficacy|1
25426|NCT01536574|111508|P2|Overall Study|Withdrawal by Subject|2
25427|NCT01536574|111509|P1|Overall Study|Withdrawal by Subject|1
25428|NCT01536574|111508|P2|Overall Study|Adverse Event|5
25429|NCT01536574|111509|P1|Overall Study|Adverse Event|4
25430|NCT01536561|111527|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
25431|NCT01536561|111527|P1|Dosimetric and Therapeutic Treatment|Death|2
25432|NCT01536561|111527|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
25433|NCT01536561|111527|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
25434|NCT01536561|111527|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
25435|NCT01536561|111527|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
25436|NCT01536405|111604|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
25437|NCT01536405|111605|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
25438|NCT01536405|111604|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
25439|NCT01536405|111605|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
25440|NCT01536405|111604|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
25441|NCT01536405|111605|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
25442|NCT01536405|111604|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
25443|NCT01536405|111605|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
25444|NCT01536405|111604|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
25445|NCT01536405|111605|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
25446|NCT01536405|111604|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
25447|NCT01536405|111605|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
25448|NCT01536405|111604|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
25449|NCT01536405|111605|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
25450|NCT01536405|111604|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
25451|NCT01536405|111605|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
25452|NCT01536405|111604|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
25453|NCT01536405|111605|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
25454|NCT01536405|111604|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
25455|NCT01536405|111605|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
25456|NCT01536405|111604|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
25457|NCT01536405|111605|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
25458|NCT01536405|111604|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
25459|NCT01536405|111605|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
25460|NCT01536405|111604|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
25461|NCT01536405|111605|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
25462|NCT01536262|111659|P3|Overall Study|Other than stated above|0
25463|NCT01536262|111660|P2|Overall Study|Other than stated above|0
25464|NCT01536262|111661|P1|Overall Study|Other than stated above|1
25465|NCT01536262|111659|P3|Overall Study|Withdrawal by Subject|0
25466|NCT01536262|111660|P2|Overall Study|Withdrawal by Subject|1
25467|NCT01536262|111661|P1|Overall Study|Withdrawal by Subject|1
25468|NCT01536262|111659|P3|Overall Study|Adverse Event|2
25469|NCT01536262|111660|P2|Overall Study|Adverse Event|1
25470|NCT01536262|111661|P1|Overall Study|Adverse Event|6
25471|NCT01536171|111703|P1|Overall Study|Withdrawal by Subject|1
25472|NCT01536145|111708|P11|Overall Study|Adverse Event|3
25473|NCT01536145|111709|P10|Overall Study|Adverse Event|0
25474|NCT01536145|111710|P9|Overall Study|Adverse Event|0
25475|NCT01536145|111711|P8|Overall Study|Adverse Event|2
25476|NCT01536145|111712|P7|Overall Study|Adverse Event|0
25477|NCT01536145|111713|P6|Overall Study|Adverse Event|0
25478|NCT01536145|111714|P5|Overall Study|Adverse Event|0
25479|NCT01536145|111715|P4|Overall Study|Adverse Event|0
25480|NCT01536145|111716|P3|Overall Study|Adverse Event|0
25481|NCT01536145|111717|P2|Overall Study|Adverse Event|0
25482|NCT01536145|111718|P1|Overall Study|Adverse Event|0
25483|NCT01536145|111708|P11|Overall Study|Death|0
25484|NCT01536145|111709|P10|Overall Study|Death|0
25485|NCT01536145|111710|P9|Overall Study|Death|0
25486|NCT01536145|111711|P8|Overall Study|Death|0
25487|NCT01536145|111712|P7|Overall Study|Death|1
25488|NCT01536145|111713|P6|Overall Study|Death|0
25489|NCT01536145|111714|P5|Overall Study|Death|0
25490|NCT01536145|111715|P4|Overall Study|Death|0
25491|NCT01536145|111716|P3|Overall Study|Death|0
25492|NCT01536145|111717|P2|Overall Study|Death|0
25493|NCT01536145|111718|P1|Overall Study|Death|0
25494|NCT01536145|111708|P11|Overall Study|Unspecified|2
25495|NCT01536145|111709|P10|Overall Study|Unspecified|3
25496|NCT01536145|111710|P9|Overall Study|Unspecified|0
25497|NCT01536145|111711|P8|Overall Study|Unspecified|0
25498|NCT01536145|111712|P7|Overall Study|Unspecified|0
25499|NCT01536145|111713|P6|Overall Study|Unspecified|0
25500|NCT01536145|111714|P5|Overall Study|Unspecified|1
25501|NCT01536145|111715|P4|Overall Study|Unspecified|0
25502|NCT01536145|111716|P3|Overall Study|Unspecified|0
25503|NCT01536145|111717|P2|Overall Study|Unspecified|0
25504|NCT01536145|111718|P1|Overall Study|Unspecified|0
25505|NCT01536145|111708|P11|Overall Study|Withdrawal by Subject|2
25506|NCT01536145|111709|P10|Overall Study|Withdrawal by Subject|0
25507|NCT01536145|111710|P9|Overall Study|Withdrawal by Subject|2
25508|NCT01536145|111711|P8|Overall Study|Withdrawal by Subject|0
25509|NCT01536145|111712|P7|Overall Study|Withdrawal by Subject|0
25510|NCT01536145|111713|P6|Overall Study|Withdrawal by Subject|1
25511|NCT01536145|111714|P5|Overall Study|Withdrawal by Subject|0
25512|NCT01536145|111715|P4|Overall Study|Withdrawal by Subject|0
25513|NCT01536145|111716|P3|Overall Study|Withdrawal by Subject|1
25514|NCT01536145|111717|P2|Overall Study|Withdrawal by Subject|0
25515|NCT01536145|111718|P1|Overall Study|Withdrawal by Subject|0
25516|NCT01536145|111708|P11|Overall Study|Progressive disease|3
25517|NCT01536145|111709|P10|Overall Study|Progressive disease|3
25518|NCT01536145|111710|P9|Overall Study|Progressive disease|1
25519|NCT01536145|111711|P8|Overall Study|Progressive disease|2
25520|NCT01536145|111712|P7|Overall Study|Progressive disease|1
25521|NCT01536145|111713|P6|Overall Study|Progressive disease|2
25522|NCT01536145|111714|P5|Overall Study|Progressive disease|1
25523|NCT01536145|111715|P4|Overall Study|Progressive disease|2
25524|NCT01536145|111716|P3|Overall Study|Progressive disease|1
25525|NCT01536145|111717|P2|Overall Study|Progressive disease|4
25526|NCT01536145|111718|P1|Overall Study|Progressive disease|3
25527|NCT01536119|111825|P2|Overall Study|Lost to Follow-up|14
25528|NCT01536119|111826|P1|Overall Study|Lost to Follow-up|17
25529|NCT01536093|111852|P2|Overall Study|Withdrawal by Subject|1
25530|NCT01536093|111853|P1|Overall Study|Withdrawal by Subject|0
25531|NCT01536093|111852|P2|Overall Study|absence of maternal colostrum|0
25532|NCT01536093|111853|P1|Overall Study|absence of maternal colostrum|2
25533|NCT01536093|111852|P2|Overall Study|Death|2
25534|NCT01536093|111853|P1|Overall Study|Death|1
25535|NCT01536067|111869|P1|Overall Study|Disease Progression|1
25536|NCT01536015|111882|P2|Overall Study|Study closure|5
25537|NCT01536015|111883|P1|Overall Study|Study closure|5
25538|NCT01536015|111882|P2|Overall Study|Inclusion Criterion not met|0
25539|NCT01536015|111883|P1|Overall Study|Inclusion Criterion not met|2
25540|NCT01536015|111882|P2|Overall Study|Lost to Follow-up|1
25541|NCT01536015|111883|P1|Overall Study|Lost to Follow-up|0
25542|NCT01536015|111882|P2|Overall Study|Adverse Event|4
25543|NCT01536015|111883|P1|Overall Study|Adverse Event|1
25544|NCT01535807|111910|P2|Overall Study|Data collection error|1
25545|NCT01535807|111911|P1|Overall Study|Data collection error|1
25546|NCT01535807|111910|P2|Overall Study|Withdrawal by Subject|1
25547|NCT01535807|111911|P1|Overall Study|Withdrawal by Subject|1
25548|NCT01535729|111917|P1|Overall Study|No participant record available|5
25549|NCT01535729|111917|P1|Overall Study|Not treated|9
25550|NCT01535729|111917|P1|Overall Study|Screening failure|1
25551|NCT01535729|111917|P1|Overall Study|Protocol Violation|11
25552|NCT01535729|111917|P1|Overall Study|NSCLC grade IV histology not confirmed|20
25553|NCT01535729|111917|P1|Overall Study|No previous chemotherapy|33
25554|NCT01535729|111917|P1|Overall Study|Did not sign informed consent|1
25555|NCT01535729|111917|P1|Overall Study|Unspecified|19
25556|NCT01535729|111917|P1|Overall Study|Death|52
25557|NCT01535729|111917|P1|Overall Study|Lost to Follow-up|8
25558|NCT01535729|111917|P1|Overall Study|Discontinued treatment|25
25559|NCT01535729|111917|P1|Overall Study|Disease progression|230
25560|NCT01535729|111917|P1|Overall Study|Withdrawal by Subject|2
25561|NCT01535638|111958|P6|Treatment 3 (Single Dose)|Protocol Violation|0
25562|NCT01535638|111959|P5|Treatment 3 (Single Dose)|Protocol Violation|0
25563|NCT01535638|111960|P4|Treatment 3 (Single Dose)|Protocol Violation|1
25564|NCT01535638|111961|P3|Treatment 3 (Single Dose)|Protocol Violation|0
25565|NCT01535638|111962|P2|Treatment 3 (Single Dose)|Protocol Violation|0
25566|NCT01535638|111963|P1|Treatment 3 (Single Dose)|Protocol Violation|0
25567|NCT01535638|111958|P6|Treatment 1 (Single Dose)|Protocol Violation|1
25568|NCT01535638|111959|P5|Treatment 1 (Single Dose)|Protocol Violation|0
25569|NCT01535638|111960|P4|Treatment 1 (Single Dose)|Protocol Violation|0
25570|NCT01535638|111961|P3|Treatment 1 (Single Dose)|Protocol Violation|0
25571|NCT01535638|111962|P2|Treatment 1 (Single Dose)|Protocol Violation|0
25572|NCT01535638|111963|P1|Treatment 1 (Single Dose)|Protocol Violation|0
25573|NCT01535599|111977|P2|Overall Study|Noncompliance|1
25574|NCT01535599|111978|P1|Overall Study|Noncompliance|0
25575|NCT01535599|111977|P2|Overall Study|Stopped medication|1
25576|NCT01535599|111978|P1|Overall Study|Stopped medication|0
25577|NCT01535599|111977|P2|Overall Study|Unspecified|0
25578|NCT01535599|111978|P1|Overall Study|Unspecified|1
25579|NCT01535599|111977|P2|Overall Study|Did not use product|0
25580|NCT01535599|111978|P1|Overall Study|Did not use product|1
25581|NCT01535599|111977|P2|Overall Study|Randomized in Error|4
25582|NCT01535599|111978|P1|Overall Study|Randomized in Error|2
25583|NCT01535599|111977|P2|Overall Study|BL Culture + for Yeast//Fungi|1
25584|NCT01535599|111978|P1|Overall Study|BL Culture + for Yeast//Fungi|0
25585|NCT01535599|111977|P2|Overall Study|BL Culture + for Group A Strep|1
25586|NCT01535599|111978|P1|Overall Study|BL Culture + for Group A Strep|0
25587|NCT01535599|111977|P2|Overall Study|Treatment Failure|66
25588|NCT01535599|111978|P1|Overall Study|Treatment Failure|33
25589|NCT01535599|111977|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
25590|NCT01535599|111978|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
25591|NCT01535599|111977|P2|Overall Study|Lost to Follow-up|4
25592|NCT01535599|111978|P1|Overall Study|Lost to Follow-up|3
25593|NCT01535599|111977|P2|Overall Study|Adverse Event|15
25594|NCT01535599|111978|P1|Overall Study|Adverse Event|6
25595|NCT01535560|111990|P2|Overall Study|Randomized in Error|1
25596|NCT01535560|111991|P1|Overall Study|Randomized in Error|0
25597|NCT01535560|111990|P2|Overall Study|Other|1
25598|NCT01535560|111991|P1|Overall Study|Other|0
25599|NCT01535560|111990|P2|Overall Study|Treatment Failure|83
25600|NCT01535560|111991|P1|Overall Study|Treatment Failure|21
25601|NCT01535560|111990|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
25602|NCT01535560|111991|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
25603|NCT01535560|111990|P2|Overall Study|Lost to Follow-up|3
25604|NCT01535560|111991|P1|Overall Study|Lost to Follow-up|1
25605|NCT01535560|111990|P2|Overall Study|Adverse Event|7
25606|NCT01535560|111991|P1|Overall Study|Adverse Event|12
25607|NCT01535261|112034|P1|Overall Study|Adverse Event|12
25608|NCT01535261|112034|P1|Overall Study|Withdrawal by Subject|14
25609|NCT01535261|112034|P1|Overall Study|Lost to Follow-up|8
25610|NCT01535261|112034|P1|Overall Study|Death|5
25611|NCT01535261|112034|P1|Overall Study|Protocol Violation|3
25612|NCT01535261|112034|P1|Overall Study|Physician Decision|8
25613|NCT01535235|112047|P2|Overall Study|Adverse Event|0
25614|NCT01535235|112048|P1|Overall Study|Adverse Event|1
25615|NCT01535222|112062|P6|Overall Study|Inclusion/exclusion|0
25616|NCT01535222|112063|P5|Overall Study|Inclusion/exclusion|0
25617|NCT01535222|112064|P4|Overall Study|Inclusion/exclusion|0
25618|NCT01535222|112065|P3|Overall Study|Inclusion/exclusion|1
25619|NCT01535222|112066|P2|Overall Study|Inclusion/exclusion|0
25620|NCT01535222|112067|P1|Overall Study|Inclusion/exclusion|0
25621|NCT01535040|112098|P2|Overall Study|Multiple Reasons|1
25622|NCT01535040|112099|P1|Overall Study|Multiple Reasons|1
25623|NCT01535040|112098|P2|Overall Study|Toxicity|5
25624|NCT01535040|112099|P1|Overall Study|Toxicity|7
25625|NCT01535040|112098|P2|Overall Study|Never Started|4
25626|NCT01535040|112099|P1|Overall Study|Never Started|9
25627|NCT01535040|112098|P2|Overall Study|Withdrawal by Subject|10
25628|NCT01535040|112099|P1|Overall Study|Withdrawal by Subject|13
25629|NCT01535040|112098|P2|Overall Study|Physician Decision|1
25630|NCT01535040|112099|P1|Overall Study|Physician Decision|0
25631|NCT01534962|112140|P4|Overall Study|Discontinued at AF recurrence|31
25632|NCT01534962|112141|P3|Overall Study|Discontinued at AF recurrence|24
25633|NCT01534962|112142|P2|Overall Study|Discontinued at AF recurrence|26
25634|NCT01534962|112143|P1|Overall Study|Discontinued at AF recurrence|35
25635|NCT01534962|112140|P4|Overall Study|Randomized but did not start treatment|1
25636|NCT01534962|112141|P3|Overall Study|Randomized but did not start treatment|0
25637|NCT01534962|112142|P2|Overall Study|Randomized but did not start treatment|0
25638|NCT01534962|112143|P1|Overall Study|Randomized but did not start treatment|2
25639|NCT01534676|112190|P2|Overall Study|Study closed due to poor enrollment|1
25640|NCT01534676|112191|P1|Overall Study|Study closed due to poor enrollment|2
25641|NCT01534637|112197|P1|Overall Study|Liver Mets before treatment|1
25642|NCT01534637|112197|P1|Overall Study|Adverse Event|1
25643|NCT01534637|112197|P1|Overall Study|Withdrawal by Subject|1
25644|NCT01534637|112197|P1|Overall Study|Lack of Efficacy|3
25645|NCT01534637|112197|P1|Overall Study|Physician Decision|3
25646|NCT01534533|112207|P4|Overall Study|Withdrawal by Subject|1
25647|NCT01534533|112208|P3|Overall Study|Withdrawal by Subject|4
25648|NCT01534533|112209|P2|Overall Study|Withdrawal by Subject|3
25649|NCT01534533|112210|P1|Overall Study|Withdrawal by Subject|5
25650|NCT01534533|112207|P4|Overall Study|Lost to Follow-up|3
25651|NCT01534533|112208|P3|Overall Study|Lost to Follow-up|4
25652|NCT01534533|112209|P2|Overall Study|Lost to Follow-up|0
25653|NCT01534533|112210|P1|Overall Study|Lost to Follow-up|3
25654|NCT01534520|112238|P2|Overall Study|Adverse Event|1
25655|NCT01534520|112239|P1|Overall Study|Adverse Event|0
25656|NCT01534351|112254|P3|Overall Study|Study Terminated Early|0
25657|NCT01534351|112255|P2|Overall Study|Study Terminated Early|0
25658|NCT01534351|112256|P1|Overall Study|Study Terminated Early|1
25659|NCT01534208|112275|P2|Overall Study|Needed prohibited meds|0
25660|NCT01534208|112276|P1|Overall Study|Needed prohibited meds|1
25661|NCT01534208|112275|P2|Overall Study|PCP decision|0
25662|NCT01534208|112276|P1|Overall Study|PCP decision|1
25663|NCT01534208|112275|P2|Overall Study|Eligibility error|0
25664|NCT01534208|112276|P1|Overall Study|Eligibility error|3
25665|NCT01534208|112275|P2|Overall Study|Lab assessment|1
25666|NCT01534208|112276|P1|Overall Study|Lab assessment|2
25667|NCT01534208|112275|P2|Overall Study|Subject relocation|0
25668|NCT01534208|112276|P1|Overall Study|Subject relocation|2
25669|NCT01534208|112275|P2|Overall Study|Sponsor decision|1
25670|NCT01534208|112276|P1|Overall Study|Sponsor decision|4
25671|NCT01534208|112275|P2|Overall Study|Protocol Violation|2
25672|NCT01534208|112276|P1|Overall Study|Protocol Violation|2
25673|NCT01534208|112275|P2|Overall Study|Lack of Efficacy|3
25674|NCT01534208|112276|P1|Overall Study|Lack of Efficacy|0
25675|NCT01534208|112275|P2|Overall Study|Physician Decision|0
25676|NCT01534208|112276|P1|Overall Study|Physician Decision|2
25677|NCT01534208|112275|P2|Overall Study|Adverse Event|8
25678|NCT01534208|112276|P1|Overall Study|Adverse Event|15
25679|NCT01534208|112275|P2|Overall Study|Withdrawal by Subject|20
25680|NCT01534208|112276|P1|Overall Study|Withdrawal by Subject|6
25681|NCT01534208|112275|P2|Overall Study|Lost to Follow-up|14
25682|NCT01534208|112276|P1|Overall Study|Lost to Follow-up|19
25683|NCT01534182|112294|P2|Overall Study|Adverse Event|3
25684|NCT01534182|112295|P1|Overall Study|Adverse Event|7
25685|NCT01534182|112294|P2|Overall Study|Withdrawal by Subject|7
25686|NCT01534182|112295|P1|Overall Study|Withdrawal by Subject|4
25687|NCT01534182|112294|P2|Overall Study|Administrative problems|0
25688|NCT01534182|112295|P1|Overall Study|Administrative problems|1
25689|NCT01533935|112335|P5|Overall Study|Other reason not defined above|1
25690|NCT01533935|112336|P4|Overall Study|Other reason not defined above|0
25691|NCT01533935|112337|P3|Overall Study|Other reason not defined above|1
25692|NCT01533935|112338|P2|Overall Study|Other reason not defined above|0
25693|NCT01533935|112339|P1|Overall Study|Other reason not defined above|1
25694|NCT01533935|112335|P5|Overall Study|Withdrawal by Subject|4
25695|NCT01533935|112336|P4|Overall Study|Withdrawal by Subject|2
25696|NCT01533935|112337|P3|Overall Study|Withdrawal by Subject|5
25697|NCT01533935|112338|P2|Overall Study|Withdrawal by Subject|4
25698|NCT01533935|112339|P1|Overall Study|Withdrawal by Subject|0
25699|NCT01533935|112335|P5|Overall Study|Lost to Follow-up|0
25700|NCT01533935|112336|P4|Overall Study|Lost to Follow-up|0
25701|NCT01533935|112337|P3|Overall Study|Lost to Follow-up|1
25702|NCT01533935|112338|P2|Overall Study|Lost to Follow-up|0
25703|NCT01533935|112339|P1|Overall Study|Lost to Follow-up|0
25704|NCT01533935|112335|P5|Overall Study|Protocol Violation|0
25705|NCT01533935|112336|P4|Overall Study|Protocol Violation|0
25706|NCT01533935|112337|P3|Overall Study|Protocol Violation|0
25707|NCT01533935|112338|P2|Overall Study|Protocol Violation|2
25708|NCT01533935|112339|P1|Overall Study|Protocol Violation|0
25709|NCT01533935|112335|P5|Overall Study|Adverse Event|3
25710|NCT01533935|112336|P4|Overall Study|Adverse Event|5
25711|NCT01533935|112337|P3|Overall Study|Adverse Event|1
25712|NCT01533935|112338|P2|Overall Study|Adverse Event|7
25713|NCT01533935|112339|P1|Overall Study|Adverse Event|5
25714|NCT01533922|112366|P5|Overall Study|Other reason not defined above|0
25715|NCT01533922|112367|P4|Overall Study|Other reason not defined above|0
25716|NCT01533922|112368|P3|Overall Study|Other reason not defined above|1
25717|NCT01533922|112369|P2|Overall Study|Other reason not defined above|0
25718|NCT01533922|112370|P1|Overall Study|Other reason not defined above|2
25719|NCT01533922|112366|P5|Overall Study|Withdrawal by Subject|1
25720|NCT01533922|112367|P4|Overall Study|Withdrawal by Subject|2
25721|NCT01533922|112368|P3|Overall Study|Withdrawal by Subject|2
25722|NCT01533922|112369|P2|Overall Study|Withdrawal by Subject|1
25723|NCT01533922|112370|P1|Overall Study|Withdrawal by Subject|3
25724|NCT01533922|112366|P5|Overall Study|Protocol Violation|1
25725|NCT01533922|112367|P4|Overall Study|Protocol Violation|0
25726|NCT01533922|112368|P3|Overall Study|Protocol Violation|0
25727|NCT01533922|112369|P2|Overall Study|Protocol Violation|3
25728|NCT01533922|112370|P1|Overall Study|Protocol Violation|0
25729|NCT01533922|112366|P5|Overall Study|Lack of Efficacy|0
25730|NCT01533922|112367|P4|Overall Study|Lack of Efficacy|0
25731|NCT01533922|112368|P3|Overall Study|Lack of Efficacy|1
25732|NCT01533922|112369|P2|Overall Study|Lack of Efficacy|0
25733|NCT01533922|112370|P1|Overall Study|Lack of Efficacy|0
25734|NCT01533922|112366|P5|Overall Study|Adverse Event|4
25735|NCT01533922|112367|P4|Overall Study|Adverse Event|3
25736|NCT01533922|112368|P3|Overall Study|Adverse Event|6
25737|NCT01533922|112369|P2|Overall Study|Adverse Event|8
25738|NCT01533922|112370|P1|Overall Study|Adverse Event|5
25739|NCT01533493|112433|P2|Overall Study|Lost to Follow-up|0
25740|NCT01533493|112434|P1|Overall Study|Lost to Follow-up|2
25741|NCT01533493|112433|P2|Overall Study|Withdrawal by Subject|2
25742|NCT01533493|112434|P1|Overall Study|Withdrawal by Subject|1
25743|NCT01533493|112433|P2|Overall Study|Adverse Event|1
25744|NCT01533493|112434|P1|Overall Study|Adverse Event|2
25745|NCT01533428|112442|P2|Overall Study|Withdrawal by Subject|6
25746|NCT01533428|112443|P1|Overall Study|Withdrawal by Subject|7
25747|NCT01533428|112442|P2|Overall Study|Lost to Follow-up|1
25748|NCT01533428|112443|P1|Overall Study|Lost to Follow-up|2
25749|NCT01533428|112442|P2|Overall Study|Adverse Event|1
25750|NCT01533428|112443|P1|Overall Study|Adverse Event|0
25751|NCT01533246|112489|P1|Overall Study|Withdrawal by Subject|1
25752|NCT01533246|112489|P1|Overall Study|Adverse Event|1
25753|NCT01533181|112500|P2|Overall Study|Patient withdrawal pre-active treatment|0
25754|NCT01533181|112501|P1|Overall Study|Patient withdrawal pre-active treatment|1
25755|NCT01533181|112500|P2|Overall Study|Disease progression pre-active treatment|1
25756|NCT01533181|112501|P1|Overall Study|Disease progression pre-active treatment|0
25757|NCT01532999|112618|P2|Overall Study|New job|2
25758|NCT01532999|112619|P1|Overall Study|New job|0
25759|NCT01532999|112618|P2|Overall Study|incarcerated|1
25760|NCT01532999|112619|P1|Overall Study|incarcerated|0
25761|NCT01532999|112618|P2|Overall Study|Adverse Event|1
25762|NCT01532999|112619|P1|Overall Study|Adverse Event|0
25763|NCT01532999|112618|P2|Overall Study|no show for week 9 assessments|4
25764|NCT01532999|112619|P1|Overall Study|no show for week 9 assessments|6
25765|NCT01532999|112618|P2|Overall Study|substantial noncompliance|0
25766|NCT01532999|112619|P1|Overall Study|substantial noncompliance|2
25767|NCT01532999|112618|P2|Overall Study|should not have been randomized|0
25768|NCT01532999|112619|P1|Overall Study|should not have been randomized|1
25769|NCT01532999|112618|P2|Overall Study|Relocated|0
25770|NCT01532999|112619|P1|Overall Study|Relocated|2
25771|NCT01532999|112618|P2|Overall Study|Withdrawal by Subject|0
25772|NCT01532999|112619|P1|Overall Study|Withdrawal by Subject|5
25773|NCT01532999|112618|P2|Overall Study|Physician Decision|2
25774|NCT01532999|112619|P1|Overall Study|Physician Decision|1
25775|NCT01532999|112618|P2|Overall Study|Lost to Follow-up|8
25776|NCT01532999|112619|P1|Overall Study|Lost to Follow-up|14
25777|NCT01532934|112701|P2|Overall Study|In controlled environment|2
25778|NCT01532934|112702|P1|Overall Study|In controlled environment|3
25779|NCT01532934|112701|P2|Overall Study|Lost to Follow-up|11
25780|NCT01532934|112702|P1|Overall Study|Lost to Follow-up|11
25781|NCT01532869|112714|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
25782|NCT01532869|112715|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
25783|NCT01532869|112714|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
25784|NCT01532869|112715|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
25785|NCT01532869|112714|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
25786|NCT01532869|112715|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
25787|NCT01532869|112714|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
25788|NCT01532869|112715|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
25789|NCT01532869|112714|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
25790|NCT01532869|112715|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
25791|NCT01532869|112714|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
25792|NCT01532869|112715|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
25793|NCT01532869|112714|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
25794|NCT01532869|112715|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
25795|NCT01532869|112714|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
25796|NCT01532869|112715|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
25797|NCT01532869|112714|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
25798|NCT01532869|112715|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
25799|NCT01532869|112714|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
25800|NCT01532869|112715|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
25801|NCT01532869|112714|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
25802|NCT01532869|112715|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
25803|NCT01532869|112714|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
25804|NCT01532869|112715|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
25805|NCT01532869|112714|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
25806|NCT01532869|112715|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
25807|NCT01532869|112714|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
25808|NCT01532869|112715|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
25809|NCT01532869|112714|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
25810|NCT01532869|112715|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
25811|NCT01532869|112714|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
25812|NCT01532869|112715|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
25813|NCT01532869|112714|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
25814|NCT01532869|112715|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
25815|NCT01532570|112768|P4|Overall Study|Withdrawal by Subject|0
25816|NCT01532570|112769|P3|Overall Study|Withdrawal by Subject|0
25817|NCT01532570|112770|P2|Overall Study|Withdrawal by Subject|1
25818|NCT01532570|112771|P1|Overall Study|Withdrawal by Subject|0
25819|NCT01532570|112768|P4|Overall Study|Lack of Efficacy|0
25820|NCT01532570|112769|P3|Overall Study|Lack of Efficacy|0
25821|NCT01532570|112770|P2|Overall Study|Lack of Efficacy|0
25822|NCT01532570|112771|P1|Overall Study|Lack of Efficacy|1
25823|NCT01532414|112816|P3|Overall Study|Withdrawn by sponsor|0
25824|NCT01532414|112817|P2|Overall Study|Withdrawn by sponsor|0
25825|NCT01532414|112818|P1|Overall Study|Withdrawn by sponsor|1
25826|NCT01532414|112816|P3|Overall Study|Unable to complete 24 hour PK|1
25827|NCT01532414|112817|P2|Overall Study|Unable to complete 24 hour PK|0
25828|NCT01532414|112818|P1|Overall Study|Unable to complete 24 hour PK|0
25829|NCT01532414|112816|P3|Overall Study|Adverse Event|1
25830|NCT01532414|112817|P2|Overall Study|Adverse Event|1
25831|NCT01532414|112818|P1|Overall Study|Adverse Event|0
25832|NCT01532414|112816|P3|Overall Study|No V6 semen sample|0
25833|NCT01532414|112817|P2|Overall Study|No V6 semen sample|1
25834|NCT01532414|112818|P1|Overall Study|No V6 semen sample|0
25835|NCT01532414|112816|P3|Overall Study|Withdrawal by Subject|0
25836|NCT01532414|112817|P2|Overall Study|Withdrawal by Subject|0
25837|NCT01532414|112818|P1|Overall Study|Withdrawal by Subject|3
25838|NCT01532414|112816|P3|Overall Study|Lost to Follow-up|1
25839|NCT01532414|112817|P2|Overall Study|Lost to Follow-up|0
25840|NCT01532414|112818|P1|Overall Study|Lost to Follow-up|3
25841|NCT01531998|112875|P1|Overall Study|Withdrawal by Subject|3
25842|NCT01531725|112880|P1|Overall Study|Protocol Violation|5
25843|NCT01531387|112887|P2|Overall Study|Early termination of study|11
25844|NCT01531387|112888|P1|Overall Study|Early termination of study|11
25845|NCT01531205|112913|P1|Overall Study|Did not proceed to surgery|1
25846|NCT01530464|112935|P2|Washout (24h)|Withdrawal by Subject|1
25847|NCT01530464|112936|P1|Washout (24h)|Withdrawal by Subject|0
25848|NCT01530464|112935|P2|Washout (24h)|Withdrawal by Subject|0
25849|NCT01530464|112936|P1|Washout (24h)|Withdrawal by Subject|1
25850|NCT01530334|112988|P1|Overall Study|Progressive disease|47
25851|NCT01530334|112988|P1|Overall Study|unknown reason|1
25852|NCT01530334|112988|P1|Overall Study|Adverse Event|3
25853|NCT01530087|113022|P1|Overall Study|Physician Decision|2
25854|NCT01529645|113037|P10|Overall Study|Withdrawal by Subject|0
25855|NCT01529645|113038|P9|Overall Study|Withdrawal by Subject|0
25856|NCT01529645|113039|P8|Overall Study|Withdrawal by Subject|0
25857|NCT01529645|113040|P7|Overall Study|Withdrawal by Subject|0
25858|NCT01529645|113041|P6|Overall Study|Withdrawal by Subject|1
25859|NCT01529645|113042|P5|Overall Study|Withdrawal by Subject|1
25860|NCT01529645|113043|P4|Overall Study|Withdrawal by Subject|1
25861|NCT01529645|113044|P3|Overall Study|Withdrawal by Subject|0
25862|NCT01529645|113045|P2|Overall Study|Withdrawal by Subject|0
25863|NCT01529645|113046|P1|Overall Study|Withdrawal by Subject|2
25864|NCT01529645|113037|P10|Overall Study|SAE - Premature contractions|0
25865|NCT01529645|113038|P9|Overall Study|SAE - Premature contractions|0
25866|NCT01529645|113039|P8|Overall Study|SAE - Premature contractions|0
25867|NCT01529645|113040|P7|Overall Study|SAE - Premature contractions|0
25868|NCT01529645|113041|P6|Overall Study|SAE - Premature contractions|0
25869|NCT01529645|113042|P5|Overall Study|SAE - Premature contractions|0
25870|NCT01529645|113043|P4|Overall Study|SAE - Premature contractions|0
25871|NCT01529645|113044|P3|Overall Study|SAE - Premature contractions|1
25872|NCT01529645|113045|P2|Overall Study|SAE - Premature contractions|0
25873|NCT01529645|113046|P1|Overall Study|SAE - Premature contractions|0
25874|NCT01529645|113037|P10|Overall Study|Lost to Follow-up|0
25875|NCT01529645|113038|P9|Overall Study|Lost to Follow-up|1
25876|NCT01529645|113039|P8|Overall Study|Lost to Follow-up|0
25877|NCT01529645|113040|P7|Overall Study|Lost to Follow-up|2
25878|NCT01529645|113041|P6|Overall Study|Lost to Follow-up|0
25879|NCT01529645|113042|P5|Overall Study|Lost to Follow-up|1
25880|NCT01529645|113043|P4|Overall Study|Lost to Follow-up|1
25881|NCT01529645|113044|P3|Overall Study|Lost to Follow-up|1
25882|NCT01529645|113045|P2|Overall Study|Lost to Follow-up|1
25883|NCT01529645|113046|P1|Overall Study|Lost to Follow-up|0
25884|NCT01529632|113144|P2|Overall Study|Adverse Event|1
25885|NCT01529632|113145|P1|Overall Study|Adverse Event|1
25886|NCT01529632|113144|P2|Overall Study|Protocol Violation|1
25887|NCT01529632|113145|P1|Overall Study|Protocol Violation|0
25888|NCT01529632|113144|P2|Overall Study|Administrative problem|1
25889|NCT01529632|113145|P1|Overall Study|Administrative problem|2
25890|NCT01529515|113165|P4|DOUBLE BLIND PHASE|Unspecified|2
25891|NCT01529515|113166|P3|DOUBLE BLIND PHASE|Unspecified|9
25892|NCT01529515|113167|P2|DOUBLE BLIND PHASE|Unspecified|0
25893|NCT01529515|113168|P1|DOUBLE BLIND PHASE|Unspecified|0
25894|NCT01529515|113165|P4|DOUBLE BLIND PHASE|Protocol Violation|0
25895|NCT01529515|113166|P3|DOUBLE BLIND PHASE|Protocol Violation|1
25896|NCT01529515|113167|P2|DOUBLE BLIND PHASE|Protocol Violation|0
25897|NCT01529515|113168|P1|DOUBLE BLIND PHASE|Protocol Violation|0
25898|NCT01529515|113165|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
25899|NCT01529515|113166|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
25900|NCT01529515|113167|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
25901|NCT01529515|113168|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
25902|NCT01529515|113165|P4|DOUBLE BLIND PHASE|Pregnancy|0
25903|NCT01529515|113166|P3|DOUBLE BLIND PHASE|Pregnancy|1
25904|NCT01529515|113167|P2|DOUBLE BLIND PHASE|Pregnancy|0
25905|NCT01529515|113168|P1|DOUBLE BLIND PHASE|Pregnancy|0
25906|NCT01529515|113165|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
25907|NCT01529515|113166|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
25908|NCT01529515|113167|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
25909|NCT01529515|113168|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
25910|NCT01529515|113165|P4|DOUBLE BLIND PHASE|Adverse Event|0
25911|NCT01529515|113166|P3|DOUBLE BLIND PHASE|Adverse Event|1
25912|NCT01529515|113167|P2|DOUBLE BLIND PHASE|Adverse Event|0
25913|NCT01529515|113168|P1|DOUBLE BLIND PHASE|Adverse Event|0
25914|NCT01529515|113165|P4|MAINTENANCE PHASE|Unspecified|0
25915|NCT01529515|113166|P3|MAINTENANCE PHASE|Unspecified|0
25916|NCT01529515|113167|P2|MAINTENANCE PHASE|Unspecified|10
25917|NCT01529515|113168|P1|MAINTENANCE PHASE|Unspecified|0
25918|NCT01529515|113165|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
25919|NCT01529515|113166|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
25920|NCT01529515|113167|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
25921|NCT01529515|113168|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
25922|NCT01529515|113165|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
25923|NCT01529515|113166|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
25924|NCT01529515|113167|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
25925|NCT01529515|113168|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
25926|NCT01529515|113165|P4|MAINTENANCE PHASE|Protocol Violation|0
25927|NCT01529515|113166|P3|MAINTENANCE PHASE|Protocol Violation|0
25928|NCT01529515|113167|P2|MAINTENANCE PHASE|Protocol Violation|12
25929|NCT01529515|113168|P1|MAINTENANCE PHASE|Protocol Violation|0
25930|NCT01529515|113165|P4|MAINTENANCE PHASE|Lost to Follow-up|0
25931|NCT01529515|113166|P3|MAINTENANCE PHASE|Lost to Follow-up|0
25932|NCT01529515|113167|P2|MAINTENANCE PHASE|Lost to Follow-up|5
25933|NCT01529515|113168|P1|MAINTENANCE PHASE|Lost to Follow-up|0
25934|NCT01529515|113165|P4|MAINTENANCE PHASE|Lack of Efficacy|0
25935|NCT01529515|113166|P3|MAINTENANCE PHASE|Lack of Efficacy|0
25936|NCT01529515|113167|P2|MAINTENANCE PHASE|Lack of Efficacy|9
25937|NCT01529515|113168|P1|MAINTENANCE PHASE|Lack of Efficacy|0
25938|NCT01529515|113165|P4|MAINTENANCE PHASE|Adverse Event|0
25939|NCT01529515|113166|P3|MAINTENANCE PHASE|Adverse Event|0
25940|NCT01529515|113167|P2|MAINTENANCE PHASE|Adverse Event|10
25941|NCT01529515|113168|P1|MAINTENANCE PHASE|Adverse Event|0
25942|NCT01529515|113165|P4|TRANSITION PHASE|Unspecified|0
25943|NCT01529515|113166|P3|TRANSITION PHASE|Unspecified|0
25944|NCT01529515|113167|P2|TRANSITION PHASE|Unspecified|0
25945|NCT01529515|113168|P1|TRANSITION PHASE|Unspecified|9
25946|NCT01529515|113165|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
25947|NCT01529515|113166|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
25948|NCT01529515|113167|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
25949|NCT01529515|113168|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
25950|NCT01529515|113165|P4|TRANSITION PHASE|Withdrawal by Subject|0
25951|NCT01529515|113166|P3|TRANSITION PHASE|Withdrawal by Subject|0
25952|NCT01529515|113167|P2|TRANSITION PHASE|Withdrawal by Subject|0
25953|NCT01529515|113168|P1|TRANSITION PHASE|Withdrawal by Subject|51
25954|NCT01529515|113165|P4|TRANSITION PHASE|Protocol Violation|0
25955|NCT01529515|113166|P3|TRANSITION PHASE|Protocol Violation|0
25956|NCT01529515|113167|P2|TRANSITION PHASE|Protocol Violation|0
25957|NCT01529515|113168|P1|TRANSITION PHASE|Protocol Violation|4
25958|NCT01529515|113165|P4|TRANSITION PHASE|Lost to Follow-up|0
25959|NCT01529515|113166|P3|TRANSITION PHASE|Lost to Follow-up|0
25960|NCT01529515|113167|P2|TRANSITION PHASE|Lost to Follow-up|0
25961|NCT01529515|113168|P1|TRANSITION PHASE|Lost to Follow-up|19
25962|NCT01529515|113165|P4|TRANSITION PHASE|Lack of Efficacy|0
25963|NCT01529515|113166|P3|TRANSITION PHASE|Lack of Efficacy|0
25964|NCT01529515|113167|P2|TRANSITION PHASE|Lack of Efficacy|0
25965|NCT01529515|113168|P1|TRANSITION PHASE|Lack of Efficacy|19
25966|NCT01529515|113165|P4|TRANSITION PHASE|Death|0
25967|NCT01529515|113166|P3|TRANSITION PHASE|Death|0
25968|NCT01529515|113167|P2|TRANSITION PHASE|Death|0
25969|NCT01529515|113168|P1|TRANSITION PHASE|Death|1
25970|NCT01529515|113165|P4|TRANSITION PHASE|Adverse Event|0
25971|NCT01529515|113166|P3|TRANSITION PHASE|Adverse Event|0
25972|NCT01529515|113167|P2|TRANSITION PHASE|Adverse Event|0
25973|NCT01529515|113168|P1|TRANSITION PHASE|Adverse Event|16
25974|NCT01529385|113193|P2|Overall Study|Lost to Follow-up|1
25975|NCT01529385|113194|P1|Overall Study|Lost to Follow-up|2
25976|NCT01529112|113226|P2|Overall Study|Withdrawal by Subject|3
25977|NCT01529112|113227|P1|Overall Study|Withdrawal by Subject|7
25978|NCT01529112|113226|P2|Overall Study|Protocol Violation|0
25979|NCT01529112|113227|P1|Overall Study|Protocol Violation|1
25980|NCT01529112|113226|P2|Overall Study|Death|38
25981|NCT01529112|113227|P1|Overall Study|Death|59
25982|NCT01529112|113226|P2|Overall Study|Adverse Event|0
25983|NCT01529112|113227|P1|Overall Study|Adverse Event|2
25984|NCT01528969|113254|P2|Overall Study|absent from the school at baseline|0
25985|NCT01528969|113255|P1|Overall Study|absent from the school at baseline|2
25986|NCT01528735|113278|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
25987|NCT01528735|113279|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
25988|NCT01528735|113278|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
25989|NCT01528735|113279|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
25990|NCT01528605|113385|P6|Overall Study|Death|0
25991|NCT01528605|113386|P5|Overall Study|Death|0
25992|NCT01528605|113387|P4|Overall Study|Death|0
25993|NCT01528605|113388|P3|Overall Study|Death|0
25994|NCT01528605|113389|P2|Overall Study|Death|0
25995|NCT01528605|113390|P1|Overall Study|Death|1
25996|NCT01528605|113385|P6|Overall Study|Lost to Follow-up|0
25997|NCT01528605|113386|P5|Overall Study|Lost to Follow-up|0
25998|NCT01528605|113387|P4|Overall Study|Lost to Follow-up|1
25999|NCT01528605|113388|P3|Overall Study|Lost to Follow-up|1
26000|NCT01528605|113389|P2|Overall Study|Lost to Follow-up|0
26001|NCT01528605|113390|P1|Overall Study|Lost to Follow-up|1
26002|NCT01528345|113420|P2|Overall Study|Subject/Guardian Decision|0
26003|NCT01528345|113421|P1|Overall Study|Subject/Guardian Decision|5
26004|NCT01528345|113420|P2|Overall Study|Study Terminated by Sponsor|8
26005|NCT01528345|113421|P1|Overall Study|Study Terminated by Sponsor|4
26006|NCT01528345|113420|P2|Overall Study|Progressive Disease|40
26007|NCT01528345|113421|P1|Overall Study|Progressive Disease|26
26008|NCT01528345|113420|P2|Overall Study|Non-compliance with study treatment|0
26009|NCT01528345|113421|P1|Overall Study|Non-compliance with study treatment|1
26010|NCT01528345|113420|P2|Overall Study|Death|1
26011|NCT01528345|113421|P1|Overall Study|Death|1
26012|NCT01528345|113420|P2|Overall Study|Adverse Event|1
26013|NCT01528345|113421|P1|Overall Study|Adverse Event|10
26014|NCT01527487|113511|P2|Overall Study|Death|1
26015|NCT01527487|113512|P1|Overall Study|Death|0
26016|NCT01527487|113511|P2|Overall Study|Adverse Event|1
26017|NCT01527487|113512|P1|Overall Study|Adverse Event|1
26018|NCT01527487|113511|P2|Overall Study|Disease Progression|1
26019|NCT01527487|113512|P1|Overall Study|Disease Progression|4
26020|NCT01527487|113511|P2|Overall Study|MD Discretion/Lack of Efficacy|4
26021|NCT01527487|113512|P1|Overall Study|MD Discretion/Lack of Efficacy|3
26022|NCT01527370|113524|P1|Overall Study|Death|1
26023|NCT01527370|113524|P1|Overall Study|Physician Decision|1
26024|NCT01527370|113524|P1|Overall Study|Withdrawal by Subject|4
26025|NCT01527006|113543|P2|Extension Phase|Not Specified|3
26026|NCT01527006|113544|P1|Extension Phase|Not Specified|0
26027|NCT01527006|113543|P2|Extension Phase|Inadequate therapeutic effect|1
26028|NCT01527006|113544|P1|Extension Phase|Inadequate therapeutic effect|1
26029|NCT01527006|113543|P2|Extension Phase|Subject Choice|1
26030|NCT01527006|113544|P1|Extension Phase|Subject Choice|1
26031|NCT01527006|113543|P2|Extension Phase|Lost to Follow-up|1
26032|NCT01527006|113544|P1|Extension Phase|Lost to Follow-up|0
26033|NCT01527006|113543|P2|Extension Phase|Adverse Event|2
26034|NCT01527006|113544|P1|Extension Phase|Adverse Event|4
26035|NCT01527006|113543|P2|Core Study|Not Specified|2
26036|NCT01527006|113544|P1|Core Study|Not Specified|0
26037|NCT01527006|113543|P2|Core Study|Withdrawal by Subject|1
26038|NCT01527006|113544|P1|Core Study|Withdrawal by Subject|0
26039|NCT01527006|113543|P2|Core Study|Inadequate Therapeutic Effect|0
26040|NCT01527006|113544|P1|Core Study|Inadequate Therapeutic Effect|1
26041|NCT01527006|113543|P2|Core Study|Subject Choice|0
26042|NCT01527006|113544|P1|Core Study|Subject Choice|1
26043|NCT01527006|113543|P2|Core Study|Lost to Follow-up|1
26044|NCT01527006|113544|P1|Core Study|Lost to Follow-up|0
26045|NCT01527006|113543|P2|Core Study|Adverse Event|2
26046|NCT01527006|113544|P1|Core Study|Adverse Event|0
26047|NCT01526785|113611|P1|Overall Study|Withdrawal by Subject|2
26048|NCT01526785|113611|P1|Overall Study|Physician Decision|1
26049|NCT01526785|113611|P1|Overall Study|Death|2
26050|NCT01526785|113611|P1|Overall Study|Study Terminated by Sponsor|8
26051|NCT01526733|113621|P2|Phase 1|Withdrawal by Subject|1
26052|NCT01526733|113622|P1|Phase 1|Withdrawal by Subject|1
26053|NCT01526733|113621|P2|Phase 1|Protocol Violation|0
26054|NCT01526733|113622|P1|Phase 1|Protocol Violation|1
26055|NCT01526551|113640|P1|Overall Study|Lack of returned parental consent form|424
26056|NCT01526148|113682|P2|Overall Study|Incarcerated|2
26057|NCT01526148|113683|P1|Overall Study|Incarcerated|0
26058|NCT01526148|113682|P2|Overall Study|Moved out of state|0
26059|NCT01526148|113683|P1|Overall Study|Moved out of state|1
26060|NCT01526148|113682|P2|Overall Study|Unable to discontinue concomitant med|0
26061|NCT01526148|113683|P1|Overall Study|Unable to discontinue concomitant med|1
26062|NCT01526148|113682|P2|Overall Study|Unstable Medical Condition|0
26063|NCT01526148|113683|P1|Overall Study|Unstable Medical Condition|1
26064|NCT01526148|113682|P2|Overall Study|Withdrawal by Subject|0
26065|NCT01526148|113683|P1|Overall Study|Withdrawal by Subject|2
26066|NCT01526148|113682|P2|Overall Study|Lost to Follow-up|6
26067|NCT01526148|113683|P1|Overall Study|Lost to Follow-up|4
26068|NCT01526148|113682|P2|Overall Study|Adverse Event|5
26069|NCT01526148|113683|P1|Overall Study|Adverse Event|6
26070|NCT01525641|113740|P1|Overall Study|Other than stated above|7
26071|NCT01525641|113740|P1|Overall Study|Lost to follow-up (Changing hospital)|19
26072|NCT01525641|113740|P1|Overall Study|Lost to follow-up (Unknown reason)|10
26073|NCT01525641|113740|P1|Overall Study|Lost to follow-up (relocation)|1
26074|NCT01525641|113740|P1|Overall Study|Improvement|5
26075|NCT01525641|113740|P1|Overall Study|Lack of Efficacy|24
26076|NCT01525641|113740|P1|Overall Study|Adverse Event|73
26077|NCT01525641|113740|P1|Overall Study|No visit since the first visit|16
26078|NCT01525641|113740|P1|Overall Study|Case report form not collected|25
26079|NCT01525628|113754|P5|Overall Study|Other reason not defined above|0
26080|NCT01525628|113755|P4|Overall Study|Other reason not defined above|3
26081|NCT01525628|113756|P3|Overall Study|Other reason not defined above|0
26082|NCT01525628|113757|P2|Overall Study|Other reason not defined above|0
26083|NCT01525628|113758|P1|Overall Study|Other reason not defined above|0
26084|NCT01525628|113754|P5|Overall Study|Withdrawal by Subject|0
26085|NCT01525628|113755|P4|Overall Study|Withdrawal by Subject|0
26086|NCT01525628|113756|P3|Overall Study|Withdrawal by Subject|0
26087|NCT01525628|113757|P2|Overall Study|Withdrawal by Subject|1
26088|NCT01525628|113758|P1|Overall Study|Withdrawal by Subject|0
26089|NCT01525628|113754|P5|Overall Study|Lost to Follow-up|0
26090|NCT01525628|113755|P4|Overall Study|Lost to Follow-up|0
26091|NCT01525628|113756|P3|Overall Study|Lost to Follow-up|0
26092|NCT01525628|113757|P2|Overall Study|Lost to Follow-up|1
26093|NCT01525628|113758|P1|Overall Study|Lost to Follow-up|1
26094|NCT01525628|113754|P5|Overall Study|Protocol Violation|0
26095|NCT01525628|113755|P4|Overall Study|Protocol Violation|0
26096|NCT01525628|113756|P3|Overall Study|Protocol Violation|1
26097|NCT01525628|113757|P2|Overall Study|Protocol Violation|0
26098|NCT01525628|113758|P1|Overall Study|Protocol Violation|0
26099|NCT01525628|113754|P5|Overall Study|Lack of Efficacy|2
26100|NCT01525628|113755|P4|Overall Study|Lack of Efficacy|1
26101|NCT01525628|113756|P3|Overall Study|Lack of Efficacy|2
26102|NCT01525628|113757|P2|Overall Study|Lack of Efficacy|2
26103|NCT01525628|113758|P1|Overall Study|Lack of Efficacy|0
26104|NCT01525628|113754|P5|Overall Study|Adverse Event|1
26105|NCT01525628|113755|P4|Overall Study|Adverse Event|0
26106|NCT01525628|113756|P3|Overall Study|Adverse Event|2
26107|NCT01525628|113757|P2|Overall Study|Adverse Event|1
26108|NCT01525628|113758|P1|Overall Study|Adverse Event|1
26109|NCT01525615|113825|P3|Overall Study|Other reason not described above|1
26110|NCT01525615|113826|P2|Overall Study|Other reason not described above|0
26111|NCT01525615|113827|P1|Overall Study|Other reason not described above|1
26112|NCT01525615|113825|P3|Overall Study|Withdrawal by Subject|0
26113|NCT01525615|113826|P2|Overall Study|Withdrawal by Subject|0
26114|NCT01525615|113827|P1|Overall Study|Withdrawal by Subject|1
26115|NCT01525615|113825|P3|Overall Study|Lost to Follow-up|0
26116|NCT01525615|113826|P2|Overall Study|Lost to Follow-up|0
26117|NCT01525615|113827|P1|Overall Study|Lost to Follow-up|1
26118|NCT01525615|113825|P3|Overall Study|Adverse Event|5
26119|NCT01525615|113826|P2|Overall Study|Adverse Event|7
26120|NCT01525615|113827|P1|Overall Study|Adverse Event|11
26121|NCT01525238|113893|P3|Overall Study|Withdrawal by Subject|0
26122|NCT01525238|113894|P2|Overall Study|Withdrawal by Subject|0
26123|NCT01525238|113895|P1|Overall Study|Withdrawal by Subject|1
26124|NCT01525225|113960|P1|Enrollment|Not Specified|1
26125|NCT01525225|113960|P1|Enrollment|No longer met study criteria|1
26126|NCT01524900|113979|P5|Overall Study|No reason documented|0
26127|NCT01524900|113980|P4|Overall Study|No reason documented|1
26128|NCT01524900|113981|P3|Overall Study|No reason documented|0
26129|NCT01524900|113982|P2|Overall Study|No reason documented|1
26130|NCT01524900|113983|P1|Overall Study|No reason documented|2
26131|NCT01524900|113979|P5|Overall Study|Other reason than stated above|0
26132|NCT01524900|113980|P4|Overall Study|Other reason than stated above|0
26133|NCT01524900|113981|P3|Overall Study|Other reason than stated above|0
26134|NCT01524900|113982|P2|Overall Study|Other reason than stated above|1
26135|NCT01524900|113983|P1|Overall Study|Other reason than stated above|1
26136|NCT01524900|113979|P5|Overall Study|Lost to Follow-up|0
26137|NCT01524900|113980|P4|Overall Study|Lost to Follow-up|0
26138|NCT01524900|113981|P3|Overall Study|Lost to Follow-up|1
26139|NCT01524900|113982|P2|Overall Study|Lost to Follow-up|12
26140|NCT01524900|113983|P1|Overall Study|Lost to Follow-up|3
26141|NCT01524887|114028|P3|Overall Study|Use of prohibited medication|0
26142|NCT01524887|114029|P2|Overall Study|Use of prohibited medication|0
26143|NCT01524887|114030|P1|Overall Study|Use of prohibited medication|1
26144|NCT01524887|114028|P3|Overall Study|Withdrawal by Caregiver|2
26145|NCT01524887|114029|P2|Overall Study|Withdrawal by Caregiver|0
26146|NCT01524887|114030|P1|Overall Study|Withdrawal by Caregiver|0
26147|NCT01524887|114028|P3|Overall Study|Study termination|79
26148|NCT01524887|114029|P2|Overall Study|Study termination|87
26149|NCT01524887|114030|P1|Overall Study|Study termination|73
26150|NCT01524887|114028|P3|Overall Study|Protocol Violation|1
26151|NCT01524887|114029|P2|Overall Study|Protocol Violation|0
26152|NCT01524887|114030|P1|Overall Study|Protocol Violation|0
26153|NCT01524887|114028|P3|Overall Study|Adverse Event|1
26154|NCT01524887|114029|P2|Overall Study|Adverse Event|1
26155|NCT01524887|114030|P1|Overall Study|Adverse Event|5
26156|NCT01524887|114028|P3|Overall Study|Withdrawal by Subject|3
26157|NCT01524887|114029|P2|Overall Study|Withdrawal by Subject|2
26158|NCT01524887|114030|P1|Overall Study|Withdrawal by Subject|6
26159|NCT01524796|114074|P1|Overall Study|Adverse Event and Lack of Efficacy|1
26160|NCT01524796|114074|P1|Overall Study|Switch to carbamazapine|1
26161|NCT01524796|114074|P1|Overall Study|Nervous about confidentiality|1
26162|NCT01524796|114074|P1|Overall Study|Gall stone surgery|1
26163|NCT01524796|114074|P1|Overall Study|Deterioration of pains|1
26164|NCT01524796|114074|P1|Overall Study|Move|1
26165|NCT01524796|114074|P1|Overall Study|Withdrawal by Subject|4
26166|NCT01524796|114074|P1|Overall Study|The price|1
26167|NCT01524796|114074|P1|Overall Study|Lost to Follow-up|1
26168|NCT01524796|114074|P1|Overall Study|Lack of Efficacy|3
26169|NCT01524796|114074|P1|Overall Study|Adverse Event|13
26170|NCT01524783|114089|P2|Randomized and Treated|Death|1
26171|NCT01524783|114090|P1|Randomized and Treated|Death|4
26172|NCT01524783|114089|P2|Randomized and Treated|Protocol Violation|1
26173|NCT01524783|114090|P1|Randomized and Treated|Protocol Violation|1
26174|NCT01524783|114089|P2|Randomized and Treated|Withdrawal by Subject|5
26175|NCT01524783|114090|P1|Randomized and Treated|Withdrawal by Subject|15
26176|NCT01524783|114089|P2|Randomized and Treated|Disease Progression|70
26177|NCT01524783|114090|P1|Randomized and Treated|Disease Progression|76
26178|NCT01524783|114089|P2|Randomized and Treated|Adverse Event|7
26179|NCT01524783|114090|P1|Randomized and Treated|Adverse Event|59
26180|NCT01524783|114089|P2|Randomized But Not Treated|Randomized, did not receive drug|0
26181|NCT01524783|114090|P1|Randomized But Not Treated|Randomized, did not receive drug|2
26182|NCT01524770|114098|P2|First Intervention|Protocol Violation|0
26183|NCT01524770|114099|P1|First Intervention|Protocol Violation|1
26184|NCT01524770|114098|P2|First Intervention|Adverse Event|1
26185|NCT01524770|114099|P1|First Intervention|Adverse Event|1
26186|NCT01524770|114098|P2|First Intervention|Withdrawal by Subject|0
26187|NCT01524770|114099|P1|First Intervention|Withdrawal by Subject|1
26188|NCT01524198|114130|P2|Overall Study|Withdrawal by Subject|10
26189|NCT01524198|114131|P1|Overall Study|Withdrawal by Subject|15
26190|NCT01524198|114130|P2|Overall Study|Protocol Violation|6
26191|NCT01524198|114131|P1|Overall Study|Protocol Violation|8
26192|NCT01523886|114158|P2|Overall Study|surgery cancelled|1
26193|NCT01523886|114159|P1|Overall Study|surgery cancelled|0
26194|NCT01523873|114165|P1|Overall Study|Protocol Violation|422
26195|NCT01523756|114172|P2|Test Period 2|Withdrawal by Subject|1
26196|NCT01523756|114173|P1|Test Period 2|Withdrawal by Subject|0
26197|NCT01523756|114172|P2|Test Period 1|Adverse Event|0
26198|NCT01523756|114173|P1|Test Period 1|Adverse Event|1
26199|NCT01523756|114172|P2|Baseline Period|Adverse Event|1
26200|NCT01523756|114173|P1|Baseline Period|Adverse Event|0
26201|NCT01523743|114181|P2|Period 2|Adverse Event|0
26202|NCT01523743|114182|P1|Period 2|Adverse Event|1
26203|NCT01523743|114181|P2|Period 2|Withdrawal by Subject|2
26204|NCT01523743|114182|P1|Period 2|Withdrawal by Subject|0
26205|NCT01523743|114181|P2|Period 1|Felt unable to empty bladder|0
26206|NCT01523743|114182|P1|Period 1|Felt unable to empty bladder|1
26207|NCT01523743|114181|P2|Period 1|Lack of Efficacy|0
26208|NCT01523743|114182|P1|Period 1|Lack of Efficacy|1
26209|NCT01523743|114181|P2|Period 1|Lost to Follow-up|0
26210|NCT01523743|114182|P1|Period 1|Lost to Follow-up|1
26211|NCT01523743|114181|P2|Period 1|Withdrawal by Subject|2
26212|NCT01523743|114182|P1|Period 1|Withdrawal by Subject|6
26213|NCT01523743|114181|P2|Period 1|Adverse Event|0
26214|NCT01523743|114182|P1|Period 1|Adverse Event|1
26215|NCT01523587|114190|P2|Overall Study|Randomised but not treated|2
26216|NCT01523587|114191|P1|Overall Study|Randomised but not treated|6
26217|NCT01523587|114190|P2|Overall Study|no reason given|3
26218|NCT01523587|114191|P1|Overall Study|no reason given|2
26219|NCT01523587|114190|P2|Overall Study|Withdrawal by Subject|12
26220|NCT01523587|114191|P1|Overall Study|Withdrawal by Subject|23
26221|NCT01523587|114190|P2|Overall Study|Lost to Follow-up|2
26222|NCT01523587|114191|P1|Overall Study|Lost to Follow-up|2
26223|NCT01523587|114190|P2|Overall Study|Non Compliance with protocol|1
26224|NCT01523587|114191|P1|Overall Study|Non Compliance with protocol|2
26225|NCT01523587|114190|P2|Overall Study|Adverse Event|34
26226|NCT01523587|114191|P1|Overall Study|Adverse Event|52
26227|NCT01523392|114211|P2|Washout Period - 10 to 14 Days|Adverse Event|0
26228|NCT01523392|114212|P1|Washout Period - 10 to 14 Days|Adverse Event|1
26229|NCT01523392|114211|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
26230|NCT01523392|114212|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
26231|NCT01523392|114211|P2|Treatment Period 1|Withdrawal by Subject|0
26232|NCT01523392|114212|P1|Treatment Period 1|Withdrawal by Subject|2
26233|NCT01523366|114228|P2|Treatment Period 2|Not completed at least 7 days treatment|0
26234|NCT01523366|114229|P1|Treatment Period 2|Not completed at least 7 days treatment|1
26235|NCT01523366|114228|P2|Treatment Period 1|Withdrawal by Subject|0
26236|NCT01523366|114229|P1|Treatment Period 1|Withdrawal by Subject|1
26237|NCT01523301|114245|P2|Overall Study|Other Reason|2
26238|NCT01523301|114246|P1|Overall Study|Other Reason|0
26239|NCT01523301|114245|P2|Overall Study|Withdrawal by Subject|8
26240|NCT01523301|114246|P1|Overall Study|Withdrawal by Subject|6
26241|NCT01523301|114245|P2|Overall Study|Lost to Follow-up|0
26242|NCT01523301|114246|P1|Overall Study|Lost to Follow-up|1
26243|NCT01523301|114245|P2|Overall Study|Protocol Violation|4
26244|NCT01523301|114246|P1|Overall Study|Protocol Violation|3
26245|NCT01523301|114245|P2|Overall Study|Lack of Efficacy|2
26246|NCT01523301|114246|P1|Overall Study|Lack of Efficacy|0
26247|NCT01523301|114245|P2|Overall Study|Adverse Event|16
26248|NCT01523301|114246|P1|Overall Study|Adverse Event|25
26249|NCT01522976|114267|P3|Overall Study|Not protocol specified|27
26250|NCT01522976|114268|P2|Overall Study|Not protocol specified|27
26251|NCT01522976|114269|P1|Overall Study|Not protocol specified|22
26252|NCT01522976|114267|P3|Overall Study|Refusal unrelated to adverse event|14
26253|NCT01522976|114268|P2|Overall Study|Refusal unrelated to adverse event|13
26254|NCT01522976|114269|P1|Overall Study|Refusal unrelated to adverse event|10
26255|NCT01522976|114267|P3|Overall Study|Adverse Event|18
26256|NCT01522976|114268|P2|Overall Study|Adverse Event|7
26257|NCT01522976|114269|P1|Overall Study|Adverse Event|17
26258|NCT01522976|114267|P3|Overall Study|Disease progression|25
26259|NCT01522976|114268|P2|Overall Study|Disease progression|30
26260|NCT01522976|114269|P1|Overall Study|Disease progression|28
26261|NCT01522976|114267|P3|Overall Study|Still on treatment|6
26262|NCT01522976|114268|P2|Overall Study|Still on treatment|9
26263|NCT01522976|114269|P1|Overall Study|Still on treatment|9
26264|NCT01522976|114267|P3|Overall Study|Death|2
26265|NCT01522976|114268|P2|Overall Study|Death|6
26266|NCT01522976|114269|P1|Overall Study|Death|7
26267|NCT01522976|114267|P3|Overall Study|Ineligible|1
26268|NCT01522976|114268|P2|Overall Study|Ineligible|0
26269|NCT01522976|114269|P1|Overall Study|Ineligible|4
26270|NCT01522456|114319|P1|Overall Study|Tolerability Assessment|1
26271|NCT01522456|114319|P1|Overall Study|Pregnancy|1
26272|NCT01522456|114319|P1|Overall Study|Withdrawal by Subject|2
26273|NCT01522456|114319|P1|Overall Study|Lost to Follow-up|2
26274|NCT01522456|114319|P1|Overall Study|Adverse Event|2
26275|NCT01521923|114400|P4|Overall Study|AE, captured in Period 1|1
26276|NCT01521923|114401|P3|Overall Study|AE, captured in Period 1|0
26277|NCT01521923|114402|P2|Overall Study|AE, captured in Period 1|1
26278|NCT01521923|114403|P1|Overall Study|AE, captured in Period 1|0
26279|NCT01521923|114400|P4|Overall Study|Other|6
26280|NCT01521923|114401|P3|Overall Study|Other|3
26281|NCT01521923|114402|P2|Overall Study|Other|1
26282|NCT01521923|114403|P1|Overall Study|Other|2
26283|NCT01521923|114400|P4|Overall Study|Withdrawal by Subject|2
26284|NCT01521923|114401|P3|Overall Study|Withdrawal by Subject|1
26285|NCT01521923|114402|P2|Overall Study|Withdrawal by Subject|1
26286|NCT01521923|114403|P1|Overall Study|Withdrawal by Subject|1
26287|NCT01521923|114400|P4|Overall Study|Lost to Follow-up|1
26288|NCT01521923|114401|P3|Overall Study|Lost to Follow-up|2
26289|NCT01521923|114402|P2|Overall Study|Lost to Follow-up|0
26290|NCT01521923|114403|P1|Overall Study|Lost to Follow-up|1
26291|NCT01521923|114400|P4|Overall Study|Protocol Violation|0
26292|NCT01521923|114401|P3|Overall Study|Protocol Violation|1
26293|NCT01521923|114402|P2|Overall Study|Protocol Violation|0
26294|NCT01521923|114403|P1|Overall Study|Protocol Violation|0
26295|NCT01521923|114400|P4|Overall Study|Lack of Efficacy|0
26296|NCT01521923|114401|P3|Overall Study|Lack of Efficacy|0
26297|NCT01521923|114402|P2|Overall Study|Lack of Efficacy|1
26298|NCT01521923|114403|P1|Overall Study|Lack of Efficacy|1
26299|NCT01521923|114400|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
26300|NCT01521923|114401|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
26301|NCT01521923|114402|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
26302|NCT01521923|114403|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
26303|NCT01521923|114400|P4|Overall Study|AE, non-serious, non-fatal|2
26304|NCT01521923|114401|P3|Overall Study|AE, non-serious, non-fatal|6
26305|NCT01521923|114402|P2|Overall Study|AE, non-serious, non-fatal|3
26306|NCT01521923|114403|P1|Overall Study|AE, non-serious, non-fatal|1
26307|NCT01521923|114400|P4|Overall Study|SAE, non-fatal|0
26308|NCT01521923|114401|P3|Overall Study|SAE, non-fatal|2
26309|NCT01521923|114402|P2|Overall Study|SAE, non-fatal|2
26310|NCT01521923|114403|P1|Overall Study|SAE, non-fatal|0
26311|NCT01521923|114400|P4|Overall Study|AE, serious fatal|0
26312|NCT01521923|114401|P3|Overall Study|AE, serious fatal|0
26313|NCT01521923|114402|P2|Overall Study|AE, serious fatal|0
26314|NCT01521923|114403|P1|Overall Study|AE, serious fatal|1
26315|NCT01521897|114523|P1|Overall Study|Lost to Follow-up|5
26316|NCT01521897|114523|P1|Overall Study|Protocol Violation|18
26317|NCT01521884|114535|P1|Overall Study|Lost to Follow-up|4
26318|NCT01521884|114535|P1|Overall Study|Participant non-eligible|1
26319|NCT01521884|114535|P1|Overall Study|Protocol Violation|3
26320|NCT01521884|114535|P1|Overall Study|Physician Decision|2
26321|NCT01521884|114535|P1|Overall Study|Withdrawal by Subject|1
26322|NCT01521884|114535|P1|Overall Study|Pregnancy|1
26323|NCT01521884|114535|P1|Overall Study|Adverse Event|5
26324|NCT01521884|114535|P1|Overall Study|Non Responders|10
26325|NCT01521559|114632|P2|Overall Study|Other|2
26326|NCT01521559|114633|P1|Overall Study|Other|1
26327|NCT01521559|114632|P2|Overall Study|Protocol Violation|0
26328|NCT01521559|114633|P1|Overall Study|Protocol Violation|1
26329|NCT01521559|114632|P2|Overall Study|Lost to Follow-up|1
26330|NCT01521559|114633|P1|Overall Study|Lost to Follow-up|3
26331|NCT01521559|114632|P2|Overall Study|Withdrawal by Subject|11
26332|NCT01521559|114633|P1|Overall Study|Withdrawal by Subject|9
26333|NCT01521559|114632|P2|Overall Study|Death|0
26334|NCT01521559|114633|P1|Overall Study|Death|1
26335|NCT01521559|114632|P2|Overall Study|Adverse Event|4
26336|NCT01521559|114633|P1|Overall Study|Adverse Event|0
26337|NCT01521507|114656|P2|Stage 2: Observational Design|Physician Decision|0
26338|NCT01521507|114657|P1|Stage 2: Observational Design|Physician Decision|1
26339|NCT01521507|114656|P2|Stage 2: Observational Design|Withdrawal by Subject|1
26340|NCT01521507|114657|P1|Stage 2: Observational Design|Withdrawal by Subject|3
26341|NCT01521507|114656|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
26342|NCT01521507|114657|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
26343|NCT01521507|114656|P2|Stage 1: Randomized Design|Lost to Follow-up|2
26344|NCT01521507|114657|P1|Stage 1: Randomized Design|Lost to Follow-up|0
26345|NCT01521507|114656|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
26346|NCT01521507|114657|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
26347|NCT01521507|114656|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
26348|NCT01521507|114657|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
26349|NCT01521364|114674|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
26350|NCT01521364|114674|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
26351|NCT01520987|114750|P8|Overall Study|Withdrawal by Subject|0
26352|NCT01520987|114751|P7|Overall Study|Withdrawal by Subject|0
26353|NCT01520987|114752|P6|Overall Study|Withdrawal by Subject|1
26354|NCT01520987|114753|P5|Overall Study|Withdrawal by Subject|0
26355|NCT01520987|114754|P4|Overall Study|Withdrawal by Subject|0
26356|NCT01520987|114755|P3|Overall Study|Withdrawal by Subject|0
26357|NCT01520987|114756|P2|Overall Study|Withdrawal by Subject|0
26358|NCT01520987|114757|P1|Overall Study|Withdrawal by Subject|1
26359|NCT01520922|114817|P2|Survival Follow-up|Withdrawal by Subject|0
26360|NCT01520922|114818|P1|Survival Follow-up|Withdrawal by Subject|1
26361|NCT01520922|114817|P2|Follow up|Lost to Follow-up|1
26362|NCT01520922|114818|P1|Follow up|Lost to Follow-up|0
26363|NCT01520922|114817|P2|Treatment Phase|Adverse Event|5
26364|NCT01520922|114818|P1|Treatment Phase|Adverse Event|3
26365|NCT01520922|114817|P2|Treatment Phase|Progression|2
26366|NCT01520922|114818|P1|Treatment Phase|Progression|0
26367|NCT01520922|114817|P2|Treatment Phase|Physician Decision|1
26368|NCT01520922|114818|P1|Treatment Phase|Physician Decision|2
26369|NCT01520909|114880|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
26370|NCT01520909|114881|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
26371|NCT01520909|114882|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
26372|NCT01520909|114880|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
26373|NCT01520909|114881|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
26374|NCT01520909|114882|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
26375|NCT01520909|114880|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
26376|NCT01520909|114881|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
26377|NCT01520909|114882|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
26378|NCT01520909|114880|P3|Part 1 (Randomized Period)|Adverse Event|0
26379|NCT01520909|114881|P2|Part 1 (Randomized Period)|Adverse Event|2
26380|NCT01520909|114882|P1|Part 1 (Randomized Period)|Adverse Event|1
26381|NCT01520714|114999|P2|Overall Study|Lack of Efficacy|1
26382|NCT01520714|115000|P1|Overall Study|Lack of Efficacy|0
26383|NCT01520714|114999|P2|Overall Study|Adverse Event|2
26384|NCT01520714|115000|P1|Overall Study|Adverse Event|0
26385|NCT01520714|114999|P2|Overall Study|Protocol Violation|3
26386|NCT01520714|115000|P1|Overall Study|Protocol Violation|0
26387|NCT01520506|115012|P1|Overall Study|Withdrawal by Subject|1
26388|NCT01520506|115012|P1|Overall Study|Lost to Follow-up|1
26389|NCT01520506|115012|P1|Overall Study|Missed Visit|4
26390|NCT01520402|115018|P1|Overall Study|Physician Decision|3
26391|NCT01520402|115018|P1|Overall Study|Withdrawal by Subject|2
26392|NCT01519960|115032|P3|Overall Study|Lost to Follow-up|0
26393|NCT01519960|115033|P2|Overall Study|Lost to Follow-up|1
26394|NCT01519960|115034|P1|Overall Study|Lost to Follow-up|0
26395|NCT01519960|115032|P3|Overall Study|Withdrawal by Subject|0
26396|NCT01519960|115033|P2|Overall Study|Withdrawal by Subject|4
26397|NCT01519960|115034|P1|Overall Study|Withdrawal by Subject|0
26398|NCT01519960|115032|P3|Overall Study|Adverse Event|0
26399|NCT01519960|115033|P2|Overall Study|Adverse Event|1
26400|NCT01519960|115034|P1|Overall Study|Adverse Event|0
26401|NCT01519960|115032|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
26402|NCT01519960|115033|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
26403|NCT01519960|115034|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
26404|NCT01519960|115032|P3|Overall Study|Ongoing in Follow-Up|10
26405|NCT01519960|115033|P2|Overall Study|Ongoing in Follow-Up|11
26406|NCT01519960|115034|P1|Overall Study|Ongoing in Follow-Up|101
26407|NCT01519934|115140|P1|Overall Study|Lost to Follow-up|3
26408|NCT01519921|115149|P2|Overall Study|High alanine aminotransferase (ALT)|1
26409|NCT01519921|115150|P1|Overall Study|High alanine aminotransferase (ALT)|0
26410|NCT01519921|115149|P2|Overall Study|Treatment refusal|1
26411|NCT01519921|115150|P1|Overall Study|Treatment refusal|2
26412|NCT01519921|115149|P2|Overall Study|Lost to Follow-up|1
26413|NCT01519921|115150|P1|Overall Study|Lost to Follow-up|2
26414|NCT01519921|115149|P2|Overall Study|Withdrawal by Subject|0
26415|NCT01519921|115150|P1|Overall Study|Withdrawal by Subject|3
26416|NCT01519921|115149|P2|Overall Study|Lack of Efficacy|3
26417|NCT01519921|115150|P1|Overall Study|Lack of Efficacy|4
26418|NCT01519921|115149|P2|Overall Study|Adverse Event|9
26419|NCT01519921|115150|P1|Overall Study|Adverse Event|10
26420|NCT01519791|115201|P2|Overall Study|Lost to Follow-up|14
26421|NCT01519791|115202|P1|Overall Study|Lost to Follow-up|6
26422|NCT01519791|115201|P2|Overall Study|Withdrawal by Subject|37
26423|NCT01519791|115202|P1|Overall Study|Withdrawal by Subject|15
26424|NCT01519791|115201|P2|Overall Study|AE, non-serious non-fatal|31
26425|NCT01519791|115202|P1|Overall Study|AE, non-serious non-fatal|12
26426|NCT01519791|115201|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
26427|NCT01519791|115202|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
26428|NCT01519791|115201|P2|Overall Study|AE, serious fatal|1
26429|NCT01519791|115202|P1|Overall Study|AE, serious fatal|0
26430|NCT01519791|115201|P2|Overall Study|SAE, non-fatal|22
26431|NCT01519791|115202|P1|Overall Study|SAE, non-fatal|6
26432|NCT01519791|115201|P2|Overall Study|Lack of Efficacy|20
26433|NCT01519791|115202|P1|Overall Study|Lack of Efficacy|16
26434|NCT01519791|115201|P2|Overall Study|subjects randomized in error|0
26435|NCT01519791|115202|P1|Overall Study|subjects randomized in error|2
26436|NCT01519791|115201|P2|Overall Study|Other Reason|222
26437|NCT01519791|115202|P1|Overall Study|Other Reason|87
26438|NCT01519791|115201|P2|Overall Study|Protocol Violation|19
26439|NCT01519791|115202|P1|Overall Study|Protocol Violation|6
26440|NCT01519791|115201|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
26441|NCT01519791|115202|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
26442|NCT01519778|115266|P1|Overall Study|Physician Decision|1
26443|NCT01519778|115266|P1|Overall Study|Lost to Follow-up|10
26444|NCT01519778|115266|P1|Overall Study|Withdrawal by Subject|3
26445|NCT01519765|115272|P2|Overall Study|Withdrawal by Subject|1
26446|NCT01519765|115273|P1|Overall Study|Withdrawal by Subject|0
26447|NCT01519765|115272|P2|Overall Study|Protocol Violation|0
26448|NCT01519765|115273|P1|Overall Study|Protocol Violation|1
26449|NCT01519765|115272|P2|Overall Study|Lack of Efficacy|0
26450|NCT01519765|115273|P1|Overall Study|Lack of Efficacy|2
26451|NCT01519765|115272|P2|Overall Study|Adverse Event|1
26452|NCT01519765|115273|P1|Overall Study|Adverse Event|0
26453|NCT01519700|115351|P4|Overall Study|Other Reason|4
26454|NCT01519700|115352|P3|Overall Study|Other Reason|0
26455|NCT01519700|115353|P2|Overall Study|Other Reason|2
26456|NCT01519700|115354|P1|Overall Study|Other Reason|2
26457|NCT01519700|115351|P4|Overall Study|Withdrawal by Subject|2
26458|NCT01519700|115352|P3|Overall Study|Withdrawal by Subject|3
26459|NCT01519700|115353|P2|Overall Study|Withdrawal by Subject|3
26460|NCT01519700|115354|P1|Overall Study|Withdrawal by Subject|5
26461|NCT01519700|115351|P4|Overall Study|Physician Decision|0
26462|NCT01519700|115352|P3|Overall Study|Physician Decision|3
26463|NCT01519700|115353|P2|Overall Study|Physician Decision|1
26464|NCT01519700|115354|P1|Overall Study|Physician Decision|1
26465|NCT01519700|115351|P4|Overall Study|Lost to Follow-up|1
26466|NCT01519700|115352|P3|Overall Study|Lost to Follow-up|1
26467|NCT01519700|115353|P2|Overall Study|Lost to Follow-up|0
26468|NCT01519700|115354|P1|Overall Study|Lost to Follow-up|0
26469|NCT01519700|115351|P4|Overall Study|Death|0
26470|NCT01519700|115352|P3|Overall Study|Death|0
26471|NCT01519700|115353|P2|Overall Study|Death|0
26472|NCT01519700|115354|P1|Overall Study|Death|1
26473|NCT01519674|115389|P3|Overall Study|Unsclassified|3
26474|NCT01519674|115390|P2|Overall Study|Unsclassified|4
26475|NCT01519674|115391|P1|Overall Study|Unsclassified|10
26476|NCT01519674|115389|P3|Overall Study|Withdrawal Criteria|7
26477|NCT01519674|115390|P2|Overall Study|Withdrawal Criteria|2
26478|NCT01519674|115391|P1|Overall Study|Withdrawal Criteria|7
26479|NCT01519674|115389|P3|Overall Study|Protocol Violation|1
26480|NCT01519674|115390|P2|Overall Study|Protocol Violation|3
26481|NCT01519674|115391|P1|Overall Study|Protocol Violation|0
26482|NCT01519674|115389|P3|Overall Study|Lack of Efficacy|1
26483|NCT01519674|115390|P2|Overall Study|Lack of Efficacy|1
26484|NCT01519674|115391|P1|Overall Study|Lack of Efficacy|1
26485|NCT01519674|115389|P3|Overall Study|Adverse Event|0
26486|NCT01519674|115390|P2|Overall Study|Adverse Event|3
26487|NCT01519674|115391|P1|Overall Study|Adverse Event|3
26488|NCT01519661|115429|P1|Overall Study|Adverse Event|29
26489|NCT01519661|115429|P1|Overall Study|Lack of Efficacy|6
26490|NCT01519661|115429|P1|Overall Study|Withdrawal by Subject|17
26491|NCT01519661|115429|P1|Overall Study|Lost to Follow-up|3
26492|NCT01519661|115429|P1|Overall Study|Protocol deviation|6
26493|NCT01519518|115455|P2|Overall Study|Consent not available|10
26494|NCT01519518|115456|P1|Overall Study|Consent not available|7
26495|NCT01519427|115481|P1|Overall Study|disease progression|2
26496|NCT01519323|115488|P2|Overall Study|Study terminated by sponsor|1
26497|NCT01519323|115489|P1|Overall Study|Study terminated by sponsor|0
26498|NCT01519323|115488|P2|Overall Study|Death|2
26499|NCT01519323|115489|P1|Overall Study|Death|3
26500|NCT01519245|115538|P2|Overall Study|Met exclusion criteria, not analysed|2
26501|NCT01519245|115539|P1|Overall Study|Met exclusion criteria, not analysed|1
26502|NCT01519206|115551|P1|Overall Study|Missed Visit|2
26503|NCT01519206|115551|P1|Overall Study|Lost to Follow-up|3
26504|NCT01519167|115565|P2|Overall Study|Physician Decision|1
26505|NCT01519167|115566|P1|Overall Study|Physician Decision|0
26506|NCT01519167|115565|P2|Overall Study|Medical condition changes&deep sedation|2
26507|NCT01519167|115566|P1|Overall Study|Medical condition changes&deep sedation|0
26508|NCT01519167|115565|P2|Overall Study|Lack of Efficacy|1
26509|NCT01519167|115566|P1|Overall Study|Lack of Efficacy|0
26510|NCT01519167|115565|P2|Overall Study|Adverse Event|1
26511|NCT01519167|115566|P1|Overall Study|Adverse Event|0
26512|NCT01519167|115565|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
26513|NCT01519167|115566|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
26514|NCT01519089|115592|P2|Overall Study|Not received study drug|1
26515|NCT01519089|115593|P1|Overall Study|Not received study drug|0
26516|NCT01519089|115592|P2|Overall Study|Unspecified|6
26517|NCT01519089|115593|P1|Overall Study|Unspecified|2
26518|NCT01519089|115592|P2|Overall Study|Withdrawal by Subject|2
26519|NCT01519089|115593|P1|Overall Study|Withdrawal by Subject|0
26520|NCT01519089|115592|P2|Overall Study|Lost to Follow-up|0
26521|NCT01519089|115593|P1|Overall Study|Lost to Follow-up|1
26522|NCT01519089|115592|P2|Overall Study|Lack of Efficacy|2
26523|NCT01519089|115593|P1|Overall Study|Lack of Efficacy|0
26524|NCT01519089|115592|P2|Overall Study|Adverse Event|4
26525|NCT01519089|115593|P1|Overall Study|Adverse Event|4
26526|NCT01518946|115714|P3|Randomized Phase (First Intervention)|Not specified|0
26527|NCT01518946|115715|P2|Randomized Phase (First Intervention)|Not specified|1
26528|NCT01518946|115716|P1|Randomized Phase (First Intervention)|Not specified|0
26529|NCT01518946|115714|P3|Open-label Phase|Not specified|0
26530|NCT01518946|115715|P2|Open-label Phase|Not specified|0
26531|NCT01518946|115716|P1|Open-label Phase|Not specified|4
26532|NCT01518322|115727|P1|Overall Study|FeNO measurement was missing|13
26533|NCT01518257|115748|P2|Overall Study|Other Miscellaneous Reason|0
26534|NCT01518257|115749|P1|Overall Study|Other Miscellaneous Reason|1
26535|NCT01518257|115748|P2|Overall Study|Lost to Follow-up|0
26536|NCT01518257|115749|P1|Overall Study|Lost to Follow-up|1
26537|NCT01518244|115771|P1|Overall Study|Adverse Event|3
26538|NCT01518192|115779|P3|Overall Study|Lost to Follow-up|35
26539|NCT01518192|115780|P2|Overall Study|Lost to Follow-up|26
26540|NCT01518192|115781|P1|Overall Study|Lost to Follow-up|29
26541|NCT01518153|115802|P3|Donor Lymphocyte Infusion|Death|1
26542|NCT01518153|115803|P2|Donor Lymphocyte Infusion|Death|2
26543|NCT01518153|115804|P1|Donor Lymphocyte Infusion|Death|0
26544|NCT01518153|115802|P3|Stem Cell Transplant|Adverse Event|0
26545|NCT01518153|115803|P2|Stem Cell Transplant|Adverse Event|0
26546|NCT01518153|115804|P1|Stem Cell Transplant|Adverse Event|1
26547|NCT01518153|115802|P3|Stem Cell Transplant|Secondary graft failure|0
26548|NCT01518153|115803|P2|Stem Cell Transplant|Secondary graft failure|0
26549|NCT01518153|115804|P1|Stem Cell Transplant|Secondary graft failure|1
26550|NCT01518153|115802|P3|Stem Cell Transplant|Death|0
26551|NCT01518153|115803|P2|Stem Cell Transplant|Death|0
26552|NCT01518153|115804|P1|Stem Cell Transplant|Death|2
26553|NCT01518153|115802|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
26554|NCT01518153|115803|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
26555|NCT01518153|115804|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
26556|NCT01517984|115815|P4|Overall Study|Ineligible for randomization|0
26557|NCT01517984|115816|P3|Overall Study|Ineligible for randomization|0
26558|NCT01517984|115817|P2|Overall Study|Ineligible for randomization|14
26559|NCT01517984|115818|P1|Overall Study|Ineligible for randomization|0
26560|NCT01517984|115815|P4|Overall Study|Screen Failure|0
26561|NCT01517984|115816|P3|Overall Study|Screen Failure|0
26562|NCT01517984|115817|P2|Overall Study|Screen Failure|0
26563|NCT01517984|115818|P1|Overall Study|Screen Failure|4
26564|NCT01517984|115815|P4|Overall Study|Withdrawal by Subject|1
26565|NCT01517984|115816|P3|Overall Study|Withdrawal by Subject|4
26566|NCT01517984|115817|P2|Overall Study|Withdrawal by Subject|8
26567|NCT01517984|115818|P1|Overall Study|Withdrawal by Subject|1
26568|NCT01517984|115815|P4|Overall Study|Lost to Follow-up|0
26569|NCT01517984|115816|P3|Overall Study|Lost to Follow-up|0
26570|NCT01517984|115817|P2|Overall Study|Lost to Follow-up|1
26571|NCT01517984|115818|P1|Overall Study|Lost to Follow-up|0
26572|NCT01517750|115855|P4|Overall Study|Lost to Follow-up|1
26573|NCT01517750|115856|P3|Overall Study|Lost to Follow-up|4
26574|NCT01517750|115857|P2|Overall Study|Lost to Follow-up|2
26575|NCT01517750|115858|P1|Overall Study|Lost to Follow-up|1
26576|NCT01517412|115895|P2|Overall Study|Other than specified above|5
26577|NCT01517412|115896|P1|Overall Study|Other than specified above|8
26578|NCT01517412|115895|P2|Overall Study|Poor compliance to protocol|3
26579|NCT01517412|115896|P1|Overall Study|Poor compliance to protocol|8
26580|NCT01517412|115895|P2|Overall Study|Lack of Efficacy|5
26581|NCT01517412|115896|P1|Overall Study|Lack of Efficacy|10
26582|NCT01517412|115895|P2|Overall Study|Adverse Event|11
26583|NCT01517412|115896|P1|Overall Study|Adverse Event|10
26584|NCT01517373|115925|P6|Treatment Period|Medication error without AEs|2
26585|NCT01517373|115926|P5|Treatment Period|Medication error without AEs|0
26586|NCT01517373|115927|P4|Treatment Period|Medication error without AEs|1
26587|NCT01517373|115928|P3|Treatment Period|Medication error without AEs|2
26588|NCT01517373|115929|P2|Treatment Period|Medication error without AEs|0
26589|NCT01517373|115930|P1|Treatment Period|Medication error without AEs|0
26590|NCT01517373|115925|P6|Treatment Period|Lack of Efficacy|0
26591|NCT01517373|115926|P5|Treatment Period|Lack of Efficacy|2
26592|NCT01517373|115927|P4|Treatment Period|Lack of Efficacy|3
26593|NCT01517373|115928|P3|Treatment Period|Lack of Efficacy|1
26594|NCT01517373|115929|P2|Treatment Period|Lack of Efficacy|1
26595|NCT01517373|115930|P1|Treatment Period|Lack of Efficacy|0
26596|NCT01517373|115925|P6|Treatment Period|Protocol Violation|0
26597|NCT01517373|115926|P5|Treatment Period|Protocol Violation|1
26598|NCT01517373|115927|P4|Treatment Period|Protocol Violation|0
26599|NCT01517373|115928|P3|Treatment Period|Protocol Violation|0
26600|NCT01517373|115929|P2|Treatment Period|Protocol Violation|0
26601|NCT01517373|115930|P1|Treatment Period|Protocol Violation|0
26602|NCT01517373|115925|P6|Treatment Period|Unspecified|0
26603|NCT01517373|115926|P5|Treatment Period|Unspecified|1
26604|NCT01517373|115927|P4|Treatment Period|Unspecified|0
26605|NCT01517373|115928|P3|Treatment Period|Unspecified|0
26606|NCT01517373|115929|P2|Treatment Period|Unspecified|0
26607|NCT01517373|115930|P1|Treatment Period|Unspecified|0
26608|NCT01517373|115925|P6|Treatment Period|Withdrawal by Subject|3
26609|NCT01517373|115926|P5|Treatment Period|Withdrawal by Subject|2
26610|NCT01517373|115927|P4|Treatment Period|Withdrawal by Subject|2
26611|NCT01517373|115928|P3|Treatment Period|Withdrawal by Subject|2
26612|NCT01517373|115929|P2|Treatment Period|Withdrawal by Subject|3
26613|NCT01517373|115930|P1|Treatment Period|Withdrawal by Subject|0
26614|NCT01517373|115925|P6|Treatment Period|Lost to Follow-up|0
26615|NCT01517373|115926|P5|Treatment Period|Lost to Follow-up|0
26616|NCT01517373|115927|P4|Treatment Period|Lost to Follow-up|1
26617|NCT01517373|115928|P3|Treatment Period|Lost to Follow-up|1
26618|NCT01517373|115929|P2|Treatment Period|Lost to Follow-up|0
26619|NCT01517373|115930|P1|Treatment Period|Lost to Follow-up|0
26620|NCT01517373|115925|P6|Treatment Period|Adverse Event|2
26621|NCT01517373|115926|P5|Treatment Period|Adverse Event|0
26622|NCT01517373|115927|P4|Treatment Period|Adverse Event|0
26623|NCT01517373|115928|P3|Treatment Period|Adverse Event|0
26624|NCT01517373|115929|P2|Treatment Period|Adverse Event|0
26625|NCT01517373|115930|P1|Treatment Period|Adverse Event|0
26626|NCT01517373|115925|P6|Run-in Period|Unspecified|0
26627|NCT01517373|115926|P5|Run-in Period|Unspecified|0
26628|NCT01517373|115927|P4|Run-in Period|Unspecified|0
26629|NCT01517373|115928|P3|Run-in Period|Unspecified|0
26630|NCT01517373|115929|P2|Run-in Period|Unspecified|0
26631|NCT01517373|115930|P1|Run-in Period|Unspecified|1
26632|NCT01517373|115925|P6|Run-in Period|Sponsor Decision|0
26633|NCT01517373|115926|P5|Run-in Period|Sponsor Decision|0
26634|NCT01517373|115927|P4|Run-in Period|Sponsor Decision|0
26635|NCT01517373|115928|P3|Run-in Period|Sponsor Decision|0
26636|NCT01517373|115929|P2|Run-in Period|Sponsor Decision|0
26637|NCT01517373|115930|P1|Run-in Period|Sponsor Decision|3
26638|NCT01517373|115925|P6|Run-in Period|Withdrawal by Subject|0
26639|NCT01517373|115926|P5|Run-in Period|Withdrawal by Subject|0
26640|NCT01517373|115927|P4|Run-in Period|Withdrawal by Subject|0
26641|NCT01517373|115928|P3|Run-in Period|Withdrawal by Subject|0
26642|NCT01517373|115929|P2|Run-in Period|Withdrawal by Subject|0
26643|NCT01517373|115930|P1|Run-in Period|Withdrawal by Subject|12
26644|NCT01517373|115925|P6|Run-in Period|Lost to Follow-up|0
26645|NCT01517373|115926|P5|Run-in Period|Lost to Follow-up|0
26646|NCT01517373|115927|P4|Run-in Period|Lost to Follow-up|0
26647|NCT01517373|115928|P3|Run-in Period|Lost to Follow-up|0
26648|NCT01517373|115929|P2|Run-in Period|Lost to Follow-up|0
26649|NCT01517373|115930|P1|Run-in Period|Lost to Follow-up|1
26650|NCT01517373|115925|P6|Run-in Period|Did not meet eligibility criteria|0
26651|NCT01517373|115926|P5|Run-in Period|Did not meet eligibility criteria|0
26652|NCT01517373|115927|P4|Run-in Period|Did not meet eligibility criteria|0
26653|NCT01517373|115928|P3|Run-in Period|Did not meet eligibility criteria|0
26654|NCT01517373|115929|P2|Run-in Period|Did not meet eligibility criteria|0
26655|NCT01517373|115930|P1|Run-in Period|Did not meet eligibility criteria|34
26656|NCT01517373|115925|P6|Run-in Period|Adverse Event|0
26657|NCT01517373|115926|P5|Run-in Period|Adverse Event|0
26658|NCT01517373|115927|P4|Run-in Period|Adverse Event|0
26659|NCT01517373|115928|P3|Run-in Period|Adverse Event|0
26660|NCT01517373|115929|P2|Run-in Period|Adverse Event|0
26661|NCT01517373|115930|P1|Run-in Period|Adverse Event|5
26662|NCT01517373|115925|P6|Run-in Period|Death|0
26663|NCT01517373|115926|P5|Run-in Period|Death|0
26664|NCT01517373|115927|P4|Run-in Period|Death|0
26665|NCT01517373|115928|P3|Run-in Period|Death|0
26666|NCT01517373|115929|P2|Run-in Period|Death|0
26667|NCT01517373|115930|P1|Run-in Period|Death|1
26668|NCT01517295|116000|P2|Overall Study|Physician Decision|0
26669|NCT01517295|116001|P1|Overall Study|Physician Decision|1
26670|NCT01517282|116015|P4|Overall Study|Physician Decision|0
26671|NCT01517282|116016|P3|Overall Study|Physician Decision|0
26672|NCT01517282|116017|P2|Overall Study|Physician Decision|0
26673|NCT01517282|116018|P1|Overall Study|Physician Decision|1
26674|NCT01517282|116015|P4|Overall Study|Consent withdrawn|1
26675|NCT01517282|116016|P3|Overall Study|Consent withdrawn|1
26676|NCT01517282|116017|P2|Overall Study|Consent withdrawn|1
26677|NCT01517282|116018|P1|Overall Study|Consent withdrawn|0
26678|NCT01517178|116052|P2|Period 2|E.g. study termination|2
26679|NCT01517178|116053|P1|Period 2|E.g. study termination|2
26680|NCT01517178|116052|P2|Period 2|Withdrawal by Subject|0
26681|NCT01517178|116053|P1|Period 2|Withdrawal by Subject|3
26682|NCT01517178|116052|P2|Period 2|Adverse Event|0
26683|NCT01517178|116053|P1|Period 2|Adverse Event|1
26684|NCT01517178|116052|P2|Period 1|Withdrawal by Subject|1
26685|NCT01517178|116053|P1|Period 1|Withdrawal by Subject|0
26686|NCT01517178|116052|P2|Period 1|E.g. study termination|1
26687|NCT01517178|116053|P1|Period 1|E.g. study termination|3
26688|NCT01517178|116052|P2|Period 1|Lack of Efficacy|1
26689|NCT01517178|116053|P1|Period 1|Lack of Efficacy|0
26690|NCT01517178|116052|P2|Period 1|Adverse Event|2
26691|NCT01517178|116053|P1|Period 1|Adverse Event|1
26692|NCT01516970|116072|P2|Overall Study|Unspecified|7
26693|NCT01516970|116073|P1|Overall Study|Unspecified|9
26694|NCT01516970|116072|P2|Overall Study|Withdrawal by Subject|1
26695|NCT01516970|116073|P1|Overall Study|Withdrawal by Subject|1
26696|NCT01516970|116072|P2|Overall Study|Adverse Event|5
26697|NCT01516970|116073|P1|Overall Study|Adverse Event|1
26698|NCT01516970|116072|P2|Overall Study|Lost to Follow-up|8
26699|NCT01516970|116073|P1|Overall Study|Lost to Follow-up|7
26700|NCT01516892|116085|P1|Overall Study|Missing|1
26701|NCT01516892|116085|P1|Overall Study|Other Miscellaneous Reasons|43
26702|NCT01516892|116085|P1|Overall Study|Protocol Violation|60
26703|NCT01516892|116085|P1|Overall Study|Subject Withdrew Consent|92
26704|NCT01516892|116085|P1|Overall Study|Lost to Follow-up|82
26705|NCT01516892|116085|P1|Overall Study|Pregnancy|5
26706|NCT01516892|116085|P1|Overall Study|Lack of Efficacy|35
26707|NCT01516892|116085|P1|Overall Study|Adverse Event|25
26708|NCT01516879|116093|P2|Overall Study|Other|10
26709|NCT01516879|116094|P1|Overall Study|Other|5
26710|NCT01516879|116093|P2|Overall Study|Lost to Follow-up|11
26711|NCT01516879|116094|P1|Overall Study|Lost to Follow-up|2
26712|NCT01516879|116093|P2|Overall Study|Death|2
26713|NCT01516879|116094|P1|Overall Study|Death|0
26714|NCT01516879|116093|P2|Overall Study|Withdrawal by Subject|11
26715|NCT01516879|116094|P1|Overall Study|Withdrawal by Subject|9
26716|NCT01516749|116128|P1|Follow-up Off Therapy|Lost to Follow-up|1
26717|NCT01516749|116128|P1|Active Therapy|Lost to Follow-up|1
26718|NCT01516034|116157|P1|Overall Study|Lack of Efficacy|7
26719|NCT01516034|116157|P1|Overall Study|Physician Decision|1
26720|NCT01516008|116164|P3|Overall Study|Reason not specified|1
26721|NCT01516008|116165|P2|Overall Study|Reason not specified|0
26722|NCT01516008|116166|P1|Overall Study|Reason not specified|0
26723|NCT01516008|116164|P3|Overall Study|Protocol Violation|0
26724|NCT01516008|116165|P2|Overall Study|Protocol Violation|0
26725|NCT01516008|116166|P1|Overall Study|Protocol Violation|1
26726|NCT01516008|116164|P3|Overall Study|Lack of Efficacy|10
26727|NCT01516008|116165|P2|Overall Study|Lack of Efficacy|14
26728|NCT01516008|116166|P1|Overall Study|Lack of Efficacy|44
26729|NCT01516008|116164|P3|Overall Study|Adverse Event|7
26730|NCT01516008|116165|P2|Overall Study|Adverse Event|2
26731|NCT01516008|116166|P1|Overall Study|Adverse Event|0
26732|NCT01515865|116233|P3|Part B (Open-label)|Not Specified|0
26733|NCT01515865|116234|P2|Part B (Open-label)|Not Specified|0
26734|NCT01515865|116235|P1|Part B (Open-label)|Not Specified|1
26735|NCT01515865|116233|P3|Part B (Open-label)|Withdrawal by Subject|0
26736|NCT01515865|116234|P2|Part B (Open-label)|Withdrawal by Subject|0
26737|NCT01515865|116235|P1|Part B (Open-label)|Withdrawal by Subject|1
26738|NCT01515865|116233|P3|Part A (Open-label)|Not Specified|0
26739|NCT01515865|116234|P2|Part A (Open-label)|Not Specified|0
26740|NCT01515865|116235|P1|Part A (Open-label)|Not Specified|3
26741|NCT01515423|116303|P3|DOUBLE BLIND|Blind broken by investigator|0
26742|NCT01515423|116304|P2|DOUBLE BLIND|Blind broken by investigator|1
26743|NCT01515423|116305|P1|DOUBLE BLIND|Blind broken by investigator|0
26744|NCT01515423|116303|P3|DOUBLE BLIND|Unspecified|12
26745|NCT01515423|116304|P2|DOUBLE BLIND|Unspecified|6
26746|NCT01515423|116305|P1|DOUBLE BLIND|Unspecified|0
26747|NCT01515423|116303|P3|DOUBLE BLIND|Withdrawal by Subject|53
26748|NCT01515423|116304|P2|DOUBLE BLIND|Withdrawal by Subject|50
26749|NCT01515423|116305|P1|DOUBLE BLIND|Withdrawal by Subject|0
26750|NCT01515423|116303|P3|DOUBLE BLIND|Pregnancy|0
26751|NCT01515423|116304|P2|DOUBLE BLIND|Pregnancy|2
26752|NCT01515423|116305|P1|DOUBLE BLIND|Pregnancy|0
26753|NCT01515423|116303|P3|DOUBLE BLIND|Lost to Follow-up|12
26754|NCT01515423|116304|P2|DOUBLE BLIND|Lost to Follow-up|7
26755|NCT01515423|116305|P1|DOUBLE BLIND|Lost to Follow-up|0
26756|NCT01515423|116303|P3|DOUBLE BLIND|Death|2
26757|NCT01515423|116304|P2|DOUBLE BLIND|Death|1
26758|NCT01515423|116305|P1|DOUBLE BLIND|Death|0
26759|NCT01515423|116303|P3|DOUBLE BLIND|Adverse Event|13
26760|NCT01515423|116304|P2|DOUBLE BLIND|Adverse Event|15
26761|NCT01515423|116305|P1|DOUBLE BLIND|Adverse Event|0
26762|NCT01515423|116303|P3|Open Label Phase|Unspecified|0
26763|NCT01515423|116304|P2|Open Label Phase|Unspecified|0
26764|NCT01515423|116305|P1|Open Label Phase|Unspecified|28
26765|NCT01515423|116303|P3|Open Label Phase|excluded from DB Phase|0
26766|NCT01515423|116304|P2|Open Label Phase|excluded from DB Phase|0
26767|NCT01515423|116305|P1|Open Label Phase|excluded from DB Phase|70
26768|NCT01515423|116303|P3|Open Label Phase|Withdrawal by Subject|0
26769|NCT01515423|116304|P2|Open Label Phase|Withdrawal by Subject|0
26770|NCT01515423|116305|P1|Open Label Phase|Withdrawal by Subject|118
26771|NCT01515423|116303|P3|Open Label Phase|Lost to Follow-up|0
26772|NCT01515423|116304|P2|Open Label Phase|Lost to Follow-up|0
26773|NCT01515423|116305|P1|Open Label Phase|Lost to Follow-up|21
26774|NCT01515423|116303|P3|Open Label Phase|Lack of Efficacy|0
26775|NCT01515423|116304|P2|Open Label Phase|Lack of Efficacy|0
26776|NCT01515423|116305|P1|Open Label Phase|Lack of Efficacy|117
26777|NCT01515423|116303|P3|Open Label Phase|Death|0
26778|NCT01515423|116304|P2|Open Label Phase|Death|0
26779|NCT01515423|116305|P1|Open Label Phase|Death|2
26780|NCT01515423|116303|P3|Open Label Phase|Adverse Event|0
26781|NCT01515423|116304|P2|Open Label Phase|Adverse Event|0
26782|NCT01515423|116305|P1|Open Label Phase|Adverse Event|57
26783|NCT01515306|116346|P2|Overall Study|Ongoing receiving treatment|14
26784|NCT01515306|116347|P1|Overall Study|Ongoing receiving treatment|9
26785|NCT01515306|116346|P2|Overall Study|Progressive Disease|0
26786|NCT01515306|116347|P1|Overall Study|Progressive Disease|1
26787|NCT01515306|116346|P2|Overall Study|Adverse Event|0
26788|NCT01515306|116347|P1|Overall Study|Adverse Event|2
26789|NCT01514864|116360|P2|Overall Study|Study drug toxicity|0
26790|NCT01514864|116361|P1|Overall Study|Study drug toxicity|2
26791|NCT01514864|116360|P2|Overall Study|Disease progression|5
26792|NCT01514864|116361|P1|Overall Study|Disease progression|7
26793|NCT01514760|116377|P1|Overall Study|Lost to Follow-up|2
26794|NCT01514461|116406|P3|Overall Study|Death|0
26795|NCT01514461|116407|P2|Overall Study|Death|0
26796|NCT01514461|116408|P1|Overall Study|Death|1
26797|NCT01514461|116406|P3|Overall Study|Patient/guardian decision|1
26798|NCT01514461|116407|P2|Overall Study|Patient/guardian decision|1
26799|NCT01514461|116408|P1|Overall Study|Patient/guardian decision|1
26800|NCT01514461|116406|P3|Overall Study|Physician Decision|0
26801|NCT01514461|116407|P2|Overall Study|Physician Decision|1
26802|NCT01514461|116408|P1|Overall Study|Physician Decision|1
26803|NCT01514461|116406|P3|Overall Study|Adverse Event|3
26804|NCT01514461|116407|P2|Overall Study|Adverse Event|1
26805|NCT01514461|116408|P1|Overall Study|Adverse Event|2
26806|NCT01514422|116445|P1|Overall Study|Lost to Follow-up|1
26807|NCT01514240|116463|P2|Overall Study|Subject Decision|7
26808|NCT01514240|116464|P1|Overall Study|Subject Decision|2
26809|NCT01514240|116463|P2|Overall Study|Adverse Event|4
26810|NCT01514240|116464|P1|Overall Study|Adverse Event|4
26811|NCT01514136|116540|P8|Test Period 2; Test C*|Protocol Violation|0
26812|NCT01514136|116541|P7|Test Period 2; Test C*|Protocol Violation|1
26813|NCT01514136|116542|P6|Test Period 2; Test C*|Protocol Violation|0
26814|NCT01514136|116543|P5|Test Period 2; Test C*|Protocol Violation|0
26815|NCT01514136|116544|P4|Test Period 2; Test C*|Protocol Violation|0
26816|NCT01514136|116545|P3|Test Period 2; Test C*|Protocol Violation|0
26817|NCT01514136|116546|P2|Test Period 2; Test C*|Protocol Violation|0
26818|NCT01514136|116547|P1|Test Period 2; Test C*|Protocol Violation|0
26819|NCT01514136|116540|P8|Test Period 2; Test C*|holiday|0
26820|NCT01514136|116541|P7|Test Period 2; Test C*|holiday|1
26821|NCT01514136|116542|P6|Test Period 2; Test C*|holiday|0
26822|NCT01514136|116543|P5|Test Period 2; Test C*|holiday|0
26823|NCT01514136|116544|P4|Test Period 2; Test C*|holiday|0
26824|NCT01514136|116545|P3|Test Period 2; Test C*|holiday|0
26825|NCT01514136|116546|P2|Test Period 2; Test C*|holiday|0
26826|NCT01514136|116547|P1|Test Period 2; Test C*|holiday|0
26827|NCT01514136|116540|P8|Test Period 2; Test C*|Withdrawal by Subject|0
26828|NCT01514136|116541|P7|Test Period 2; Test C*|Withdrawal by Subject|1
26829|NCT01514136|116542|P6|Test Period 2; Test C*|Withdrawal by Subject|0
26830|NCT01514136|116543|P5|Test Period 2; Test C*|Withdrawal by Subject|0
26831|NCT01514136|116544|P4|Test Period 2; Test C*|Withdrawal by Subject|0
26832|NCT01514136|116545|P3|Test Period 2; Test C*|Withdrawal by Subject|0
26833|NCT01514136|116546|P2|Test Period 2; Test C*|Withdrawal by Subject|0
26834|NCT01514136|116547|P1|Test Period 2; Test C*|Withdrawal by Subject|0
26835|NCT01514136|116540|P8|Test Period 2; Test B*|Withdrawal by Subject|0
26836|NCT01514136|116541|P7|Test Period 2; Test B*|Withdrawal by Subject|0
26837|NCT01514136|116542|P6|Test Period 2; Test B*|Withdrawal by Subject|2
26838|NCT01514136|116543|P5|Test Period 2; Test B*|Withdrawal by Subject|0
26839|NCT01514136|116544|P4|Test Period 2; Test B*|Withdrawal by Subject|0
26840|NCT01514136|116545|P3|Test Period 2; Test B*|Withdrawal by Subject|0
26841|NCT01514136|116546|P2|Test Period 2; Test B*|Withdrawal by Subject|0
26842|NCT01514136|116547|P1|Test Period 2; Test B*|Withdrawal by Subject|0
26843|NCT01514136|116540|P8|Test Period 2; Test A*|Holiday|0
26844|NCT01514136|116541|P7|Test Period 2; Test A*|Holiday|0
26845|NCT01514136|116542|P6|Test Period 2; Test A*|Holiday|0
26846|NCT01514136|116543|P5|Test Period 2; Test A*|Holiday|1
26847|NCT01514136|116544|P4|Test Period 2; Test A*|Holiday|0
26848|NCT01514136|116545|P3|Test Period 2; Test A*|Holiday|0
26849|NCT01514136|116546|P2|Test Period 2; Test A*|Holiday|0
26850|NCT01514136|116547|P1|Test Period 2; Test A*|Holiday|0
26851|NCT01514136|116540|P8|Test Period 2; Test A*|Adverse Event|0
26852|NCT01514136|116541|P7|Test Period 2; Test A*|Adverse Event|0
26853|NCT01514136|116542|P6|Test Period 2; Test A*|Adverse Event|0
26854|NCT01514136|116543|P5|Test Period 2; Test A*|Adverse Event|1
26855|NCT01514136|116544|P4|Test Period 2; Test A*|Adverse Event|0
26856|NCT01514136|116545|P3|Test Period 2; Test A*|Adverse Event|0
26857|NCT01514136|116546|P2|Test Period 2; Test A*|Adverse Event|0
26858|NCT01514136|116547|P1|Test Period 2; Test A*|Adverse Event|0
26859|NCT01514136|116540|P8|Test Period 1; Test D|Subject took a break due to holiday|0
26860|NCT01514136|116541|P7|Test Period 1; Test D|Subject took a break due to holiday|0
26861|NCT01514136|116542|P6|Test Period 1; Test D|Subject took a break due to holiday|0
26862|NCT01514136|116543|P5|Test Period 1; Test D|Subject took a break due to holiday|0
26863|NCT01514136|116544|P4|Test Period 1; Test D|Subject took a break due to holiday|2
26864|NCT01514136|116545|P3|Test Period 1; Test D|Subject took a break due to holiday|0
26865|NCT01514136|116546|P2|Test Period 1; Test D|Subject took a break due to holiday|0
26866|NCT01514136|116547|P1|Test Period 1; Test D|Subject took a break due to holiday|0
26867|NCT01514136|116540|P8|Test Period 1; Test B|Withdrawal by Subject|0
26868|NCT01514136|116541|P7|Test Period 1; Test B|Withdrawal by Subject|0
26869|NCT01514136|116542|P6|Test Period 1; Test B|Withdrawal by Subject|0
26870|NCT01514136|116543|P5|Test Period 1; Test B|Withdrawal by Subject|0
26871|NCT01514136|116544|P4|Test Period 1; Test B|Withdrawal by Subject|0
26872|NCT01514136|116545|P3|Test Period 1; Test B|Withdrawal by Subject|0
26873|NCT01514136|116546|P2|Test Period 1; Test B|Withdrawal by Subject|1
26874|NCT01514136|116547|P1|Test Period 1; Test B|Withdrawal by Subject|0
26875|NCT01514136|116540|P8|Test Period 1; Test A|Break from study holiday|0
26876|NCT01514136|116541|P7|Test Period 1; Test A|Break from study holiday|0
26877|NCT01514136|116542|P6|Test Period 1; Test A|Break from study holiday|0
26878|NCT01514136|116543|P5|Test Period 1; Test A|Break from study holiday|0
26879|NCT01514136|116544|P4|Test Period 1; Test A|Break from study holiday|0
26880|NCT01514136|116545|P3|Test Period 1; Test A|Break from study holiday|0
26881|NCT01514136|116546|P2|Test Period 1; Test A|Break from study holiday|0
26882|NCT01514136|116547|P1|Test Period 1; Test A|Break from study holiday|2
26883|NCT01514136|116540|P8|Test Period 1; Test A|Protocol Violation|0
26884|NCT01514136|116541|P7|Test Period 1; Test A|Protocol Violation|0
26885|NCT01514136|116542|P6|Test Period 1; Test A|Protocol Violation|0
26886|NCT01514136|116543|P5|Test Period 1; Test A|Protocol Violation|0
26887|NCT01514136|116544|P4|Test Period 1; Test A|Protocol Violation|0
26888|NCT01514136|116545|P3|Test Period 1; Test A|Protocol Violation|0
26889|NCT01514136|116546|P2|Test Period 1; Test A|Protocol Violation|0
26890|NCT01514136|116547|P1|Test Period 1; Test A|Protocol Violation|1
26891|NCT01513590|116615|P2|Overall Study|Unclassified|10
26892|NCT01513590|116616|P1|Overall Study|Unclassified|5
26893|NCT01513590|116615|P2|Overall Study|Withdrawal Criteria|0
26894|NCT01513590|116616|P1|Overall Study|Withdrawal Criteria|3
26895|NCT01513590|116615|P2|Overall Study|Adverse Event|3
26896|NCT01513590|116616|P1|Overall Study|Adverse Event|2
26897|NCT01513473|116636|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
26898|NCT01513473|116637|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
26899|NCT01513473|116636|P2|Extension Trial (26 Weeks)|Adverse Event|1
26900|NCT01513473|116637|P1|Extension Trial (26 Weeks)|Adverse Event|0
26901|NCT01513473|116636|P2|Main Trial (26 Weeks)|Unclassified|2
26902|NCT01513473|116637|P1|Main Trial (26 Weeks)|Unclassified|0
26903|NCT01513473|116636|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
26904|NCT01513473|116637|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
26905|NCT01513473|116636|P2|Main Trial (26 Weeks)|Adverse Event|2
26906|NCT01513473|116637|P1|Main Trial (26 Weeks)|Adverse Event|0
26907|NCT01513460|116664|P3|Overall Study|Abnormal test procedure|0
26908|NCT01513460|116665|P2|Overall Study|Abnormal test procedure|0
26909|NCT01513460|116666|P1|Overall Study|Abnormal test procedure|1
26910|NCT01513460|116664|P3|Overall Study|Adverse Event|23
26911|NCT01513460|116665|P2|Overall Study|Adverse Event|18
26912|NCT01513460|116666|P1|Overall Study|Adverse Event|16
26913|NCT01513460|116664|P3|Overall Study|Withdrawal by Subject|21
26914|NCT01513460|116665|P2|Overall Study|Withdrawal by Subject|8
26915|NCT01513460|116666|P1|Overall Study|Withdrawal by Subject|7
26916|NCT01513460|116664|P3|Overall Study|Protocol deviations|3
26917|NCT01513460|116665|P2|Overall Study|Protocol deviations|4
26918|NCT01513460|116666|P1|Overall Study|Protocol deviations|3
26919|NCT01513460|116664|P3|Overall Study|Lack of Efficacy|5
26920|NCT01513460|116665|P2|Overall Study|Lack of Efficacy|2
26921|NCT01513460|116666|P1|Overall Study|Lack of Efficacy|1
26922|NCT01513460|116664|P3|Overall Study|Abnormal laboratory value|1
26923|NCT01513460|116665|P2|Overall Study|Abnormal laboratory value|0
26924|NCT01513460|116666|P1|Overall Study|Abnormal laboratory value|1
26925|NCT01513460|116664|P3|Overall Study|Lost to Follow-up|2
26926|NCT01513460|116665|P2|Overall Study|Lost to Follow-up|0
26927|NCT01513460|116666|P1|Overall Study|Lost to Follow-up|0
26928|NCT01513460|116664|P3|Overall Study|Death|1
26929|NCT01513460|116665|P2|Overall Study|Death|0
26930|NCT01513460|116666|P1|Overall Study|Death|0
26931|NCT01513330|116701|P2|Standard Care First,|not known|0
26932|NCT01513330|116702|P1|Standard Care First,|not known|1
26933|NCT01513330|116701|P2|Standard Care First,|Withdrawal by Subject|2
26934|NCT01513330|116702|P1|Standard Care First,|Withdrawal by Subject|1
26935|NCT01513330|116701|P2|Standard Care First,|Lack of Efficacy|2
26936|NCT01513330|116702|P1|Standard Care First,|Lack of Efficacy|2
26937|NCT01513330|116701|P2|SenSura Mio First,|not known|0
26938|NCT01513330|116702|P1|SenSura Mio First,|not known|1
26939|NCT01513330|116701|P2|SenSura Mio First,|Withdrawal by Subject|1
26940|NCT01513330|116702|P1|SenSura Mio First,|Withdrawal by Subject|1
26941|NCT01513330|116701|P2|SenSura Mio First,|Lack of Efficacy|1
26942|NCT01513330|116702|P1|SenSura Mio First,|Lack of Efficacy|0
26943|NCT01513330|116701|P2|SenSura Mio First,|Adverse Event|0
26944|NCT01513330|116702|P1|SenSura Mio First,|Adverse Event|2
26945|NCT01513317|116710|P2|Overall Study|Not specified|1
26946|NCT01513317|116711|P1|Overall Study|Not specified|0
26947|NCT01513317|116710|P2|Overall Study|Study terminated by sponsor|18
26948|NCT01513317|116711|P1|Overall Study|Study terminated by sponsor|18
26949|NCT01513317|116710|P2|Overall Study|Death|1
26950|NCT01513317|116711|P1|Overall Study|Death|1
26951|NCT01513317|116710|P2|Overall Study|Withdrawal by Subject|4
26952|NCT01513317|116711|P1|Overall Study|Withdrawal by Subject|15
26953|NCT01513291|116729|P5|Run-out Period|Withdrawal by Subject|0
26954|NCT01513291|116730|P4|Run-out Period|Withdrawal by Subject|1
26955|NCT01513291|116731|P3|Run-out Period|Withdrawal by Subject|0
26956|NCT01513291|116732|P2|Run-out Period|Withdrawal by Subject|0
26957|NCT01513291|116733|P1|Run-out Period|Withdrawal by Subject|0
26958|NCT01513291|116729|P5|Run-out Period|Lost to Follow-up|0
26959|NCT01513291|116730|P4|Run-out Period|Lost to Follow-up|1
26960|NCT01513291|116731|P3|Run-out Period|Lost to Follow-up|0
26961|NCT01513291|116732|P2|Run-out Period|Lost to Follow-up|0
26962|NCT01513291|116733|P1|Run-out Period|Lost to Follow-up|0
26963|NCT01513291|116729|P5|Treatment Period|Randomized not treated|0
26964|NCT01513291|116730|P4|Treatment Period|Randomized not treated|0
26965|NCT01513291|116731|P3|Treatment Period|Randomized not treated|0
26966|NCT01513291|116732|P2|Treatment Period|Randomized not treated|2
26967|NCT01513291|116733|P1|Treatment Period|Randomized not treated|0
26968|NCT01513291|116729|P5|Treatment Period|Withdrawal by Subject|0
26969|NCT01513291|116730|P4|Treatment Period|Withdrawal by Subject|0
26970|NCT01513291|116731|P3|Treatment Period|Withdrawal by Subject|0
26971|NCT01513291|116732|P2|Treatment Period|Withdrawal by Subject|5
26972|NCT01513291|116733|P1|Treatment Period|Withdrawal by Subject|8
26973|NCT01513291|116729|P5|Treatment Period|Protocol Violation|0
26974|NCT01513291|116730|P4|Treatment Period|Protocol Violation|0
26975|NCT01513291|116731|P3|Treatment Period|Protocol Violation|0
26976|NCT01513291|116732|P2|Treatment Period|Protocol Violation|2
26977|NCT01513291|116733|P1|Treatment Period|Protocol Violation|1
26978|NCT01513291|116729|P5|Treatment Period|Physician Decision|0
26979|NCT01513291|116730|P4|Treatment Period|Physician Decision|0
26980|NCT01513291|116731|P3|Treatment Period|Physician Decision|0
26981|NCT01513291|116732|P2|Treatment Period|Physician Decision|0
26982|NCT01513291|116733|P1|Treatment Period|Physician Decision|1
26983|NCT01513291|116729|P5|Treatment Period|Lost to Follow-up|0
26984|NCT01513291|116730|P4|Treatment Period|Lost to Follow-up|0
26985|NCT01513291|116731|P3|Treatment Period|Lost to Follow-up|0
26986|NCT01513291|116732|P2|Treatment Period|Lost to Follow-up|3
26987|NCT01513291|116733|P1|Treatment Period|Lost to Follow-up|2
26988|NCT01513291|116729|P5|Treatment Period|Lack of Efficacy|0
26989|NCT01513291|116730|P4|Treatment Period|Lack of Efficacy|0
26990|NCT01513291|116731|P3|Treatment Period|Lack of Efficacy|0
26991|NCT01513291|116732|P2|Treatment Period|Lack of Efficacy|0
26992|NCT01513291|116733|P1|Treatment Period|Lack of Efficacy|3
26993|NCT01513291|116729|P5|Treatment Period|Adverse Event|0
26994|NCT01513291|116730|P4|Treatment Period|Adverse Event|0
26995|NCT01513291|116731|P3|Treatment Period|Adverse Event|0
26996|NCT01513291|116732|P2|Treatment Period|Adverse Event|4
26997|NCT01513291|116733|P1|Treatment Period|Adverse Event|8
26998|NCT01513239|116761|P3|Overall Study|Withdrawal by Subject|42
26999|NCT01513239|116762|P2|Overall Study|Withdrawal by Subject|29
27000|NCT01513239|116763|P1|Overall Study|Withdrawal by Subject|27
27001|NCT01513239|116761|P3|Overall Study|Technical Problems|0
27002|NCT01513239|116762|P2|Overall Study|Technical Problems|2
27003|NCT01513239|116763|P1|Overall Study|Technical Problems|1
27004|NCT01513239|116761|P3|Overall Study|Protocol Violation|2
27005|NCT01513239|116762|P2|Overall Study|Protocol Violation|2
27006|NCT01513239|116763|P1|Overall Study|Protocol Violation|2
27007|NCT01513239|116761|P3|Overall Study|Physician Decision|4
27008|NCT01513239|116762|P2|Overall Study|Physician Decision|4
27009|NCT01513239|116763|P1|Overall Study|Physician Decision|4
27010|NCT01513239|116761|P3|Overall Study|Lost to Follow-up|6
27011|NCT01513239|116762|P2|Overall Study|Lost to Follow-up|10
27012|NCT01513239|116763|P1|Overall Study|Lost to Follow-up|11
27013|NCT01513239|116761|P3|Overall Study|Death|32
27014|NCT01513239|116762|P2|Overall Study|Death|22
27015|NCT01513239|116763|P1|Overall Study|Death|29
27016|NCT01513239|116761|P3|Overall Study|Adverse Event|2
27017|NCT01513239|116762|P2|Overall Study|Adverse Event|1
27018|NCT01513239|116763|P1|Overall Study|Adverse Event|1
27019|NCT01513148|116813|P2|Overall Study|Protocol Violation|2
27020|NCT01513148|116814|P1|Overall Study|Protocol Violation|2
27021|NCT01512979|116881|P2|Overall Study|Reason other than stated above|9
27022|NCT01512979|116882|P1|Overall Study|Reason other than stated above|13
27023|NCT01512979|116881|P2|Overall Study|Withdrawal by Subject|2
27024|NCT01512979|116882|P1|Overall Study|Withdrawal by Subject|1
27025|NCT01512979|116881|P2|Overall Study|Lost to Follow-up|5
27026|NCT01512979|116882|P1|Overall Study|Lost to Follow-up|2
27027|NCT01512979|116881|P2|Overall Study|Protocol Violation|4
27028|NCT01512979|116882|P1|Overall Study|Protocol Violation|1
27029|NCT01512979|116881|P2|Overall Study|Adverse Event|2
27030|NCT01512979|116882|P1|Overall Study|Adverse Event|2
27031|NCT01512745|116929|P2|Overall Study|Protocol Violation|0
27032|NCT01512745|116930|P1|Overall Study|Protocol Violation|1
27033|NCT01512745|116929|P2|Overall Study|Lack of Efficacy|2
27034|NCT01512745|116930|P1|Overall Study|Lack of Efficacy|2
27035|NCT01512745|116929|P2|Overall Study|Lost to Follow-up|0
27036|NCT01512745|116930|P1|Overall Study|Lost to Follow-up|4
27037|NCT01512745|116929|P2|Overall Study|Withdrawal by Subject|2
27038|NCT01512745|116930|P1|Overall Study|Withdrawal by Subject|2
27039|NCT01512745|116929|P2|Overall Study|Death|13
27040|NCT01512745|116930|P1|Overall Study|Death|9
27041|NCT01512745|116929|P2|Overall Study|Adverse Event|3
27042|NCT01512745|116930|P1|Overall Study|Adverse Event|22
27043|NCT01512368|116944|P1|Overall Study|Protocol Violation|3
27044|NCT01512160|116957|P4|Overall Study|Withdrawal by Subject|1
27045|NCT01512160|116958|P3|Overall Study|Withdrawal by Subject|0
27046|NCT01512160|116959|P2|Overall Study|Withdrawal by Subject|0
27047|NCT01512160|116960|P1|Overall Study|Withdrawal by Subject|1
27048|NCT01512160|116957|P4|Overall Study|Lost to Follow-up|0
27049|NCT01512160|116958|P3|Overall Study|Lost to Follow-up|0
27050|NCT01512160|116959|P2|Overall Study|Lost to Follow-up|0
27051|NCT01512160|116960|P1|Overall Study|Lost to Follow-up|1
27052|NCT01512108|117052|P2|Overall Study|Unclassified|3
27053|NCT01512108|117053|P1|Overall Study|Unclassified|11
27054|NCT01512108|117052|P2|Overall Study|Withdrawal Criteria|0
27055|NCT01512108|117053|P1|Overall Study|Withdrawal Criteria|1
27056|NCT01512108|117052|P2|Overall Study|Protocol Violation|2
27057|NCT01512108|117053|P1|Overall Study|Protocol Violation|1
27058|NCT01512108|117052|P2|Overall Study|Adverse Event|4
27059|NCT01512108|117053|P1|Overall Study|Adverse Event|9
27060|NCT01511939|117068|P3|Overall Study|Withdrawal by Subject|0
27061|NCT01511939|117069|P2|Overall Study|Withdrawal by Subject|1
27062|NCT01511939|117070|P1|Overall Study|Withdrawal by Subject|2
27063|NCT01511536|117099|P3|Phase 2|Unspecified|9
27064|NCT01511536|117100|P2|Phase 2|Unspecified|0
27065|NCT01511536|117101|P1|Phase 2|Unspecified|0
27066|NCT01511536|117099|P3|Phase 1|Unspecified|0
27067|NCT01511536|117100|P2|Phase 1|Unspecified|1
27068|NCT01511536|117101|P1|Phase 1|Unspecified|0
27069|NCT01511107|117133|P2|Overall Study|Withdrawal by Subject|20
27070|NCT01511107|117134|P1|Overall Study|Withdrawal by Subject|9
27071|NCT01511107|117133|P2|Overall Study|Lost to Follow-up|19
27072|NCT01511107|117134|P1|Overall Study|Lost to Follow-up|10
27073|NCT01511107|117133|P2|Overall Study|Ineligible|2
27074|NCT01511107|117134|P1|Overall Study|Ineligible|3
27075|NCT01510912|117201|P1|Overall Study|Other, including joint replacement|5
27076|NCT01510912|117201|P1|Overall Study|Lost to Follow-up|26
27077|NCT01510912|117201|P1|Overall Study|Protocol Violation|27
27078|NCT01510912|117201|P1|Overall Study|Physician Decision|1
27079|NCT01510912|117201|P1|Overall Study|Withdrawal by Subject|49
27080|NCT01510912|117201|P1|Overall Study|Non-compliance with trial drug|23
27081|NCT01510912|117201|P1|Overall Study|Lack of Efficacy|12
27082|NCT01510912|117201|P1|Overall Study|Adverse Event|99
27083|NCT01510769|117217|P3|Overall Study|Death|0
27084|NCT01510769|117218|P2|Overall Study|Death|1
27085|NCT01510769|117219|P1|Overall Study|Death|1
27086|NCT01510769|117217|P3|Overall Study|Withdrawal by Subject|3
27087|NCT01510769|117218|P2|Overall Study|Withdrawal by Subject|4
27088|NCT01510769|117219|P1|Overall Study|Withdrawal by Subject|3
27089|NCT01510769|117217|P3|Overall Study|Lost to Follow-up|5
27090|NCT01510769|117218|P2|Overall Study|Lost to Follow-up|1
27091|NCT01510769|117219|P1|Overall Study|Lost to Follow-up|5
27092|NCT01510769|117217|P3|Overall Study|Protocol Violation|9
27093|NCT01510769|117218|P2|Overall Study|Protocol Violation|10
27094|NCT01510769|117219|P1|Overall Study|Protocol Violation|11
27095|NCT01510769|117217|P3|Overall Study|Gout Flare|1
27096|NCT01510769|117218|P2|Overall Study|Gout Flare|3
27097|NCT01510769|117219|P1|Overall Study|Gout Flare|0
27098|NCT01510769|117217|P3|Overall Study|Adverse Event|4
27099|NCT01510769|117218|P2|Overall Study|Adverse Event|6
27100|NCT01510769|117219|P1|Overall Study|Adverse Event|7
27101|NCT01510756|117236|P1|Overall Study|Physician Decision|1
27102|NCT01510756|117236|P1|Overall Study|Lack of Efficacy|2
27103|NCT01510756|117236|P1|Overall Study|Death|1
27104|NCT01510717|117244|P2|Overall Study|Withdrawal by Subject|2
27105|NCT01510717|117245|P1|Overall Study|Withdrawal by Subject|0
27106|NCT01510717|117244|P2|Overall Study|Lost to Follow-up|1
27107|NCT01510717|117245|P1|Overall Study|Lost to Follow-up|0
27108|NCT01510717|117244|P2|Overall Study|Death|0
27109|NCT01510717|117245|P1|Overall Study|Death|1
27110|NCT01510717|117244|P2|Overall Study|Adverse Event|2
27111|NCT01510717|117245|P1|Overall Study|Adverse Event|1
27112|NCT01510158|117365|P3|Overall Study|Death|0
27113|NCT01510158|117366|P2|Overall Study|Death|0
27114|NCT01510158|117367|P1|Overall Study|Death|1
27115|NCT01510158|117365|P3|Overall Study|Withdrawal by Subject|10
27116|NCT01510158|117366|P2|Overall Study|Withdrawal by Subject|13
27117|NCT01510158|117367|P1|Overall Study|Withdrawal by Subject|10
27118|NCT01510158|117365|P3|Overall Study|Lost to Follow-up|9
27119|NCT01510158|117366|P2|Overall Study|Lost to Follow-up|16
27120|NCT01510158|117367|P1|Overall Study|Lost to Follow-up|13
27121|NCT01510158|117365|P3|Overall Study|Sponsor terminated study.|2
27122|NCT01510158|117366|P2|Overall Study|Sponsor terminated study.|0
27123|NCT01510158|117367|P1|Overall Study|Sponsor terminated study.|2
27124|NCT01510158|117365|P3|Overall Study|Protocol Violation|24
27125|NCT01510158|117366|P2|Overall Study|Protocol Violation|16
27126|NCT01510158|117367|P1|Overall Study|Protocol Violation|17
27127|NCT01510158|117365|P3|Overall Study|Gout flare|0
27128|NCT01510158|117366|P2|Overall Study|Gout flare|0
27129|NCT01510158|117367|P1|Overall Study|Gout flare|1
27130|NCT01510158|117365|P3|Overall Study|Adverse Event|5
27131|NCT01510158|117366|P2|Overall Study|Adverse Event|8
27132|NCT01510158|117367|P1|Overall Study|Adverse Event|7
27133|NCT01510145|117381|P1|Overall Study|Relative reported subject withdrew|1
27134|NCT01510145|117381|P1|Overall Study|Withdrawal by Subject|6
27135|NCT01510145|117381|P1|Overall Study|Lost to Follow-up|5
27136|NCT01510145|117381|P1|Overall Study|Adverse Event|6
27137|NCT01509664|117415|P2|Overall Study|Lost to Follow-up|21
27138|NCT01509664|117416|P1|Overall Study|Lost to Follow-up|15
27139|NCT01509079|117491|P2|Overall Study|started an excluded medication|1
27140|NCT01509079|117492|P1|Overall Study|started an excluded medication|0
27141|NCT01509079|117491|P2|Overall Study|Lack of Efficacy|2
27142|NCT01509079|117492|P1|Overall Study|Lack of Efficacy|0
27143|NCT01509053|117508|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
27144|NCT01509053|117508|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
27145|NCT01509053|117508|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
27146|NCT01509053|117508|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
27147|NCT01509053|117508|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
27148|NCT01509053|117508|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
27149|NCT01508936|117570|P2|Overall Study|Data from 2 sites deemed invalid|11
27150|NCT01508936|117571|P1|Overall Study|Data from 2 sites deemed invalid|4
27151|NCT01508936|117570|P2|Overall Study|Not specified|5
27152|NCT01508936|117571|P1|Overall Study|Not specified|0
27153|NCT01508936|117570|P2|Overall Study|Lost to Follow-up|9
27154|NCT01508936|117571|P1|Overall Study|Lost to Follow-up|2
27155|NCT01508936|117570|P2|Overall Study|Protocol Violation|3
27156|NCT01508936|117571|P1|Overall Study|Protocol Violation|2
27157|NCT01508936|117570|P2|Overall Study|Withdrawal by Subject|18
27158|NCT01508936|117571|P1|Overall Study|Withdrawal by Subject|4
27159|NCT01508936|117570|P2|Overall Study|Lack of Efficacy|1
27160|NCT01508936|117571|P1|Overall Study|Lack of Efficacy|0
27161|NCT01508936|117570|P2|Overall Study|Adverse Event|32
27162|NCT01508936|117571|P1|Overall Study|Adverse Event|11
27163|NCT01508910|117610|P4|Treatment|Sponsor Decision|1
27164|NCT01508910|117611|P3|Treatment|Sponsor Decision|0
27165|NCT01508910|117612|P2|Treatment|Sponsor Decision|0
27166|NCT01508910|117613|P1|Treatment|Sponsor Decision|0
27167|NCT01508910|117610|P4|Treatment|Withdrawal by Subject|1
27168|NCT01508910|117611|P3|Treatment|Withdrawal by Subject|6
27169|NCT01508910|117612|P2|Treatment|Withdrawal by Subject|1
27170|NCT01508910|117613|P1|Treatment|Withdrawal by Subject|0
27171|NCT01508910|117610|P4|Treatment|Lost to Follow-up|1
27172|NCT01508910|117611|P3|Treatment|Lost to Follow-up|2
27173|NCT01508910|117612|P2|Treatment|Lost to Follow-up|0
27174|NCT01508910|117613|P1|Treatment|Lost to Follow-up|0
27175|NCT01508910|117610|P4|Treatment|Death|0
27176|NCT01508910|117611|P3|Treatment|Death|2
27177|NCT01508910|117612|P2|Treatment|Death|3
27178|NCT01508910|117613|P1|Treatment|Death|2
27179|NCT01508702|117646|P2|Overall Study|Withdrawal by Subject|7
27180|NCT01508702|117647|P1|Overall Study|Withdrawal by Subject|11
27181|NCT01508702|117646|P2|Overall Study|Lost to Follow-up|2
27182|NCT01508702|117647|P1|Overall Study|Lost to Follow-up|1
27183|NCT01508702|117646|P2|Overall Study|Protocol Violation|1
27184|NCT01508702|117647|P1|Overall Study|Protocol Violation|2
27185|NCT01508702|117646|P2|Overall Study|Gout flare|0
27186|NCT01508702|117647|P1|Overall Study|Gout flare|2
27187|NCT01508702|117646|P2|Overall Study|Adverse Event|3
27188|NCT01508702|117647|P1|Overall Study|Adverse Event|7
27189|NCT01508676|117655|P2|Phase II (2 Weeks)|Medication Exclusion|0
27190|NCT01508676|117656|P1|Phase II (2 Weeks)|Medication Exclusion|1
27191|NCT01508676|117655|P2|Phase II (2 Weeks)|Skin Sensitivity|1
27192|NCT01508676|117656|P1|Phase II (2 Weeks)|Skin Sensitivity|0
27193|NCT01508676|117655|P2|Phase I (2 Weeks)|Positive Drug Screen|2
27194|NCT01508676|117656|P1|Phase I (2 Weeks)|Positive Drug Screen|0
27195|NCT01508676|117655|P2|Phase I (2 Weeks)|Wrong Pain Type|0
27196|NCT01508676|117656|P1|Phase I (2 Weeks)|Wrong Pain Type|1
27197|NCT01508676|117655|P2|Phase I (2 Weeks)|Medication Exclusion|1
27198|NCT01508676|117656|P1|Phase I (2 Weeks)|Medication Exclusion|1
27199|NCT01508325|117677|P2|Overall Study|Unspecified|2
27200|NCT01508325|117678|P1|Overall Study|Unspecified|2
27201|NCT01508325|117677|P2|Overall Study|Lost to Follow-up|6
27202|NCT01508325|117678|P1|Overall Study|Lost to Follow-up|5
27203|NCT01508325|117677|P2|Overall Study|Adverse Event|0
27204|NCT01508325|117678|P1|Overall Study|Adverse Event|1
27205|NCT01508325|117677|P2|Overall Study|Physician Decision|1
27206|NCT01508325|117678|P1|Overall Study|Physician Decision|2
27207|NCT01508325|117677|P2|Overall Study|Protocol Violation|3
27208|NCT01508325|117678|P1|Overall Study|Protocol Violation|0
27209|NCT01508325|117677|P2|Overall Study|Withdrawal by Subject|9
27210|NCT01508325|117678|P1|Overall Study|Withdrawal by Subject|8
27211|NCT01508169|117708|P2|Overall Study|Lost to Follow-up|2
27212|NCT01508169|117709|P1|Overall Study|Lost to Follow-up|1
27213|NCT01508169|117708|P2|Overall Study|Withdrawal by Subject|0
27214|NCT01508169|117709|P1|Overall Study|Withdrawal by Subject|1
27215|NCT01508169|117708|P2|Overall Study|Adverse Event|0
27216|NCT01508169|117709|P1|Overall Study|Adverse Event|1
27217|NCT01508130|117723|P2|Overall Study|Administrative|3
27218|NCT01508130|117724|P1|Overall Study|Administrative|14
27219|NCT01508130|117723|P2|Overall Study|Insufficient therapeutic response|23
27220|NCT01508130|117724|P1|Overall Study|Insufficient therapeutic response|74
27221|NCT01508130|117723|P2|Overall Study|Subject’s substantial non-compliance|9
27222|NCT01508130|117724|P1|Overall Study|Subject’s substantial non-compliance|25
27223|NCT01508130|117723|P2|Overall Study|Withdrawal by Subject|3
27224|NCT01508130|117724|P1|Overall Study|Withdrawal by Subject|3
27225|NCT01508130|117723|P2|Overall Study|Lost to Follow-up|2
27226|NCT01508130|117724|P1|Overall Study|Lost to Follow-up|25
27227|NCT01508130|117723|P2|Overall Study|Protocol Violation|0
27228|NCT01508130|117724|P1|Overall Study|Protocol Violation|2
27229|NCT01508130|117723|P2|Overall Study|Death|1
27230|NCT01508130|117724|P1|Overall Study|Death|3
27231|NCT01508130|117723|P2|Overall Study|Adverse Event|28
27232|NCT01508130|117724|P1|Overall Study|Adverse Event|81
27233|NCT01507896|117788|P1|Overall Study|The surgery was denied by the sponsor.|1
27234|NCT01507896|117788|P1|Overall Study|Withdrawal by Subject|1
27235|NCT01507831|117831|P2|Overall Study|Unspecified|6
27236|NCT01507831|117832|P1|Overall Study|Unspecified|3
27237|NCT01507831|117831|P2|Overall Study|Potential lost to follow-up|0
27238|NCT01507831|117832|P1|Overall Study|Potential lost to follow-up|3
27239|NCT01507831|117831|P2|Overall Study|Site closure|3
27240|NCT01507831|117832|P1|Overall Study|Site closure|0
27241|NCT01507831|117831|P2|Overall Study|Selection criteria finally not met|1
27242|NCT01507831|117832|P1|Overall Study|Selection criteria finally not met|0
27243|NCT01507831|117831|P2|Overall Study|Last visit outside protocol visit window|143
27244|NCT01507831|117832|P1|Overall Study|Last visit outside protocol visit window|51
27245|NCT01507831|117831|P2|Overall Study|Related to study drug administration|14
27246|NCT01507831|117832|P1|Overall Study|Related to study drug administration|5
27247|NCT01507831|117831|P2|Overall Study|Consent withdrawn by participant|72
27248|NCT01507831|117832|P1|Overall Study|Consent withdrawn by participant|34
27249|NCT01507831|117831|P2|Overall Study|Participant moved|19
27250|NCT01507831|117832|P1|Overall Study|Participant moved|5
27251|NCT01507831|117831|P2|Overall Study|Physician Decision|4
27252|NCT01507831|117832|P1|Overall Study|Physician Decision|0
27253|NCT01507831|117831|P2|Overall Study|Poor compliance to protocol|60
27254|NCT01507831|117832|P1|Overall Study|Poor compliance to protocol|38
27255|NCT01507831|117831|P2|Overall Study|Death|2
27256|NCT01507831|117832|P1|Overall Study|Death|6
27257|NCT01507831|117831|P2|Overall Study|Adverse Event|113
27258|NCT01507831|117832|P1|Overall Study|Adverse Event|48
27259|NCT01507831|117831|P2|Overall Study|Randomized but not treated|3
27260|NCT01507831|117832|P1|Overall Study|Randomized but not treated|0
27261|NCT01507246|117919|P2|Overall Study|Required different surgical procedures|1
27262|NCT01507246|117920|P1|Overall Study|Required different surgical procedures|2
27263|NCT01507090|118018|P1|Overall Study|incomplete dataset|18
27264|NCT01507051|118057|P4|Overall Study|Adverse Event|0
27265|NCT01507051|118058|P3|Overall Study|Adverse Event|0
27266|NCT01507051|118059|P2|Overall Study|Adverse Event|0
27267|NCT01507051|118060|P1|Overall Study|Adverse Event|1
27268|NCT01507051|118057|P4|Overall Study|Physician Decision|1
27269|NCT01507051|118058|P3|Overall Study|Physician Decision|0
27270|NCT01507051|118059|P2|Overall Study|Physician Decision|0
27271|NCT01507051|118060|P1|Overall Study|Physician Decision|0
27272|NCT01507051|118057|P4|Overall Study|Withdrawal by Subject|6
27273|NCT01507051|118058|P3|Overall Study|Withdrawal by Subject|1
27274|NCT01507051|118059|P2|Overall Study|Withdrawal by Subject|3
27275|NCT01507051|118060|P1|Overall Study|Withdrawal by Subject|1
27276|NCT01506960|118178|P1|Overall Study|Did not meet angiographic criteria|47
27277|NCT01506908|118186|P2|Overall Study|Adverse Event|0
27278|NCT01506908|118187|P1|Overall Study|Adverse Event|1
27279|NCT01506882|118205|P2|Overall Study|Other Reason|0
27280|NCT01506882|118206|P1|Overall Study|Other Reason|2
27281|NCT01506882|118205|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
27282|NCT01506882|118206|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
27283|NCT01506882|118205|P2|Overall Study|AE, non-serious non-fatal|1
27284|NCT01506882|118206|P1|Overall Study|AE, non-serious non-fatal|3
27285|NCT01506882|118205|P2|Overall Study|SAE, non-fatal|0
27286|NCT01506882|118206|P1|Overall Study|SAE, non-fatal|2
27287|NCT01506882|118205|P2|Overall Study|Withdrawal by Subject|3
27288|NCT01506882|118206|P1|Overall Study|Withdrawal by Subject|9
27289|NCT01506882|118205|P2|Overall Study|Lost to Follow-up|0
27290|NCT01506882|118206|P1|Overall Study|Lost to Follow-up|1
27291|NCT01506882|118205|P2|Overall Study|Lack of Efficacy|3
27292|NCT01506882|118206|P1|Overall Study|Lack of Efficacy|4
27293|NCT01506726|118220|P2|Overall Study|Adverse Event|2
27294|NCT01506726|118221|P1|Overall Study|Adverse Event|1
27295|NCT01506596|118261|P1|Overall Study|ineligible pathology|1
27296|NCT01506323|118275|P2|Overall Study|Started another treatment|0
27297|NCT01506323|118276|P1|Overall Study|Started another treatment|1
27298|NCT01506323|118275|P2|Overall Study|Schedule or Transportation conflict|0
27299|NCT01506323|118276|P1|Overall Study|Schedule or Transportation conflict|8
27300|NCT01506323|118275|P2|Overall Study|Moved out of area|2
27301|NCT01506323|118276|P1|Overall Study|Moved out of area|5
27302|NCT01506323|118275|P2|Overall Study|Lack of Efficacy|3
27303|NCT01506323|118276|P1|Overall Study|Lack of Efficacy|1
27304|NCT01506323|118275|P2|Overall Study|Withdrawal by Subject|4
27305|NCT01506323|118276|P1|Overall Study|Withdrawal by Subject|4
27306|NCT01506323|118275|P2|Overall Study|Lost to Follow-up|4
27307|NCT01506323|118276|P1|Overall Study|Lost to Follow-up|5
27308|NCT01506193|118305|P3|Overall Study|Lost to Follow-up|3
27309|NCT01506193|118306|P2|Overall Study|Lost to Follow-up|3
27310|NCT01506193|118307|P1|Overall Study|Lost to Follow-up|8
27311|NCT01506193|118305|P3|Overall Study|Withdrawal by Subject|8
27312|NCT01506193|118306|P2|Overall Study|Withdrawal by Subject|1
27313|NCT01506193|118307|P1|Overall Study|Withdrawal by Subject|5
27314|NCT01506193|118305|P3|Overall Study|Adverse event, non-fatal|1
27315|NCT01506193|118306|P2|Overall Study|Adverse event, non-fatal|0
27316|NCT01506193|118307|P1|Overall Study|Adverse event, non-fatal|0
27317|NCT01506193|118305|P3|Overall Study|Migrated/moved from study area|1
27318|NCT01506193|118306|P2|Overall Study|Migrated/moved from study area|0
27319|NCT01506193|118307|P1|Overall Study|Migrated/moved from study area|0
27320|NCT01506193|118305|P3|Overall Study|Protocol Violation|1
27321|NCT01506193|118306|P2|Overall Study|Protocol Violation|0
27322|NCT01506193|118307|P1|Overall Study|Protocol Violation|1
27323|NCT01505881|118340|P2|Overall Study|Withdrawal by Subject|0
27324|NCT01505881|118341|P1|Overall Study|Withdrawal by Subject|2
27325|NCT01505881|118340|P2|Overall Study|Lost to Follow-up|0
27326|NCT01505881|118341|P1|Overall Study|Lost to Follow-up|2
27327|NCT01505881|118340|P2|Overall Study|Adverse Event|1
27328|NCT01505881|118341|P1|Overall Study|Adverse Event|0
27329|NCT01505647|118355|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
27330|NCT01505647|118356|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
27331|NCT01505647|118355|P2|Day 43 Through Day 182 Follow-up|Death|1
27332|NCT01505647|118356|P1|Day 43 Through Day 182 Follow-up|Death|0
27333|NCT01505647|118355|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
27334|NCT01505647|118356|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
27335|NCT01505647|118355|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
27336|NCT01505647|118356|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
27337|NCT01505647|118355|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
27338|NCT01505647|118356|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
27339|NCT01505608|118372|P2|Phase II|Protocol Violation|1
27340|NCT01505608|118373|P1|Phase II|Protocol Violation|0
27341|NCT01505608|118372|P2|Phase II|Lack of Efficacy|1
27342|NCT01505608|118373|P1|Phase II|Lack of Efficacy|2
27343|NCT01505608|118372|P2|Phase I|Withdrawal by Subject|1
27344|NCT01505608|118373|P1|Phase I|Withdrawal by Subject|0
27345|NCT01505608|118372|P2|Phase I|Adverse Event|1
27346|NCT01505608|118373|P1|Phase I|Adverse Event|0
27347|NCT01505608|118372|P2|Phase I|Lack of Efficacy|4
27348|NCT01505608|118373|P1|Phase I|Lack of Efficacy|0
27349|NCT01505387|118391|P2|Overall Study|Withdrawal by Subject|1
27350|NCT01505387|118392|P1|Overall Study|Withdrawal by Subject|1
27351|NCT01505387|118391|P2|Overall Study|Protocol Violation|0
27352|NCT01505387|118392|P1|Overall Study|Protocol Violation|1
27353|NCT01504971|118402|P1|Overall Study|Physician Decision|13
27354|NCT01504867|118412|P2|Overall Study|Consent revoked|1
27355|NCT01504867|118413|P1|Overall Study|Consent revoked|5
27356|NCT01504867|118412|P2|Overall Study|Inclusion criteria not met|2
27357|NCT01504867|118413|P1|Overall Study|Inclusion criteria not met|2
27358|NCT01503021|118466|P2|Overall Study|Moved, received transplant, etc.|7
27359|NCT01503021|118467|P1|Overall Study|Moved, received transplant, etc.|5
27360|NCT01503021|118466|P2|Overall Study|Withdrawal by Subject|8
27361|NCT01503021|118467|P1|Overall Study|Withdrawal by Subject|9
27362|NCT01503021|118466|P2|Overall Study|Protocol Violation|3
27363|NCT01503021|118467|P1|Overall Study|Protocol Violation|1
27364|NCT01503021|118466|P2|Overall Study|Physician Decision|0
27365|NCT01503021|118467|P1|Overall Study|Physician Decision|3
27366|NCT01503021|118466|P2|Overall Study|Lost to Follow-up|0
27367|NCT01503021|118467|P1|Overall Study|Lost to Follow-up|2
27368|NCT01503021|118466|P2|Overall Study|Death|2
27369|NCT01503021|118467|P1|Overall Study|Death|0
27370|NCT01503021|118466|P2|Overall Study|Adverse Event|6
27371|NCT01503021|118467|P1|Overall Study|Adverse Event|7
27372|NCT01502709|118523|P2|Overall Study|Lost to Follow-up|0
27373|NCT01502709|118524|P1|Overall Study|Lost to Follow-up|4
27374|NCT01502423|118536|P2|Overall Study|Withdrawal by Subject|1
27375|NCT01502423|118537|P1|Overall Study|Withdrawal by Subject|0
27376|NCT01502410|118559|P4|Overall Study|Withdrawal by Subject|0
27377|NCT01502410|118560|P3|Overall Study|Withdrawal by Subject|0
27378|NCT01502410|118561|P2|Overall Study|Withdrawal by Subject|0
27379|NCT01502410|118562|P1|Overall Study|Withdrawal by Subject|2
27380|NCT01502410|118559|P4|Overall Study|Physician Decision|0
27381|NCT01502410|118560|P3|Overall Study|Physician Decision|0
27382|NCT01502410|118561|P2|Overall Study|Physician Decision|1
27383|NCT01502410|118562|P1|Overall Study|Physician Decision|0
27384|NCT01502410|118559|P4|Overall Study|Lack of Efficacy|0
27385|NCT01502410|118560|P3|Overall Study|Lack of Efficacy|0
27386|NCT01502410|118561|P2|Overall Study|Lack of Efficacy|7
27387|NCT01502410|118562|P1|Overall Study|Lack of Efficacy|7
27388|NCT01502410|118559|P4|Overall Study|Adverse Event|0
27389|NCT01502410|118560|P3|Overall Study|Adverse Event|0
27390|NCT01502410|118561|P2|Overall Study|Adverse Event|2
27391|NCT01502410|118562|P1|Overall Study|Adverse Event|1
27392|NCT01502371|118575|P5|Overall Study|Excluded Medication|1
27393|NCT01502371|118576|P4|Overall Study|Excluded Medication|0
27394|NCT01502371|118577|P3|Overall Study|Excluded Medication|1
27395|NCT01502371|118578|P2|Overall Study|Excluded Medication|1
27396|NCT01502371|118579|P1|Overall Study|Excluded Medication|0
27397|NCT01502371|118575|P5|Overall Study|Protocol Violation|10
27398|NCT01502371|118576|P4|Overall Study|Protocol Violation|5
27399|NCT01502371|118577|P3|Overall Study|Protocol Violation|6
27400|NCT01502371|118578|P2|Overall Study|Protocol Violation|5
27401|NCT01502371|118579|P1|Overall Study|Protocol Violation|9
27402|NCT01502371|118575|P5|Overall Study|Technical Problems|1
27403|NCT01502371|118576|P4|Overall Study|Technical Problems|4
27404|NCT01502371|118577|P3|Overall Study|Technical Problems|2
27405|NCT01502371|118578|P2|Overall Study|Technical Problems|0
27406|NCT01502371|118579|P1|Overall Study|Technical Problems|1
27407|NCT01502371|118575|P5|Overall Study|Noncompliance with Study Drug|1
27408|NCT01502371|118576|P4|Overall Study|Noncompliance with Study Drug|2
27409|NCT01502371|118577|P3|Overall Study|Noncompliance with Study Drug|1
27410|NCT01502371|118578|P2|Overall Study|Noncompliance with Study Drug|0
27411|NCT01502371|118579|P1|Overall Study|Noncompliance with Study Drug|0
27412|NCT01502371|118575|P5|Overall Study|Physician Decision|1
27413|NCT01502371|118576|P4|Overall Study|Physician Decision|0
27414|NCT01502371|118577|P3|Overall Study|Physician Decision|0
27415|NCT01502371|118578|P2|Overall Study|Physician Decision|0
27416|NCT01502371|118579|P1|Overall Study|Physician Decision|3
27417|NCT01502371|118575|P5|Overall Study|Lack of Efficacy|4
27418|NCT01502371|118576|P4|Overall Study|Lack of Efficacy|2
27419|NCT01502371|118577|P3|Overall Study|Lack of Efficacy|2
27420|NCT01502371|118578|P2|Overall Study|Lack of Efficacy|3
27421|NCT01502371|118579|P1|Overall Study|Lack of Efficacy|3
27422|NCT01502371|118575|P5|Overall Study|Treatment Failure|30
27423|NCT01502371|118576|P4|Overall Study|Treatment Failure|19
27424|NCT01502371|118577|P3|Overall Study|Treatment Failure|12
27425|NCT01502371|118578|P2|Overall Study|Treatment Failure|20
27426|NCT01502371|118579|P1|Overall Study|Treatment Failure|22
27427|NCT01502371|118575|P5|Overall Study|Adverse Event|3
27428|NCT01502371|118576|P4|Overall Study|Adverse Event|4
27429|NCT01502371|118577|P3|Overall Study|Adverse Event|0
27430|NCT01502371|118578|P2|Overall Study|Adverse Event|1
27431|NCT01502371|118579|P1|Overall Study|Adverse Event|2
27432|NCT01502371|118575|P5|Overall Study|Withdrawal by Subject|1
27433|NCT01502371|118576|P4|Overall Study|Withdrawal by Subject|1
27434|NCT01502371|118577|P3|Overall Study|Withdrawal by Subject|1
27435|NCT01502371|118578|P2|Overall Study|Withdrawal by Subject|2
27436|NCT01502371|118579|P1|Overall Study|Withdrawal by Subject|1
27437|NCT01502033|118619|P1|Overall Study|1 participant went back to school|1
27438|NCT01502033|118619|P1|Overall Study|1 participant had worsening depression|1
27439|NCT01502033|118619|P1|Overall Study|1 participant had scalp discomfort|1
27440|NCT01500434|118625|P1|Overall Study|Missed 12-month follow-up|5
27441|NCT01500434|118625|P1|Overall Study|Withdrawal by Subject|1
27442|NCT01500434|118625|P1|Overall Study|Death|1
27443|NCT01500382|118658|P4|Washout Period|Study site went out of business|0
27444|NCT01500382|118659|P3|Washout Period|Study site went out of business|1
27445|NCT01500382|118660|P2|Washout Period|Study site went out of business|0
27446|NCT01500382|118661|P1|Washout Period|Study site went out of business|0
27447|NCT01501110|118696|P2|Overall Study|Death|1
27448|NCT01501110|118697|P1|Overall Study|Death|0
27449|NCT01500720|118721|P2|Overall Study|Unspecified|8
27450|NCT01500720|118722|P1|Overall Study|Unspecified|4
27451|NCT01500720|118721|P2|Overall Study|Randomized But Not Treated|1
27452|NCT01500720|118722|P1|Overall Study|Randomized But Not Treated|1
27453|NCT01500629|118736|P2|Washout Period of 14 to 30 Days|Pregnancy|0
27454|NCT01500629|118737|P1|Washout Period of 14 to 30 Days|Pregnancy|1
27455|NCT01500317|118824|P3|Overall Study|Withdrawal by Subject|0
27456|NCT01500317|118825|P2|Overall Study|Withdrawal by Subject|2
27457|NCT01500317|118826|P1|Overall Study|Withdrawal by Subject|3
27458|NCT01500252|118848|P2|Overall Study|Lost to Follow-up|4
27459|NCT01500252|118849|P1|Overall Study|Lost to Follow-up|5
27460|NCT01500252|118848|P2|Overall Study|Death|2
27461|NCT01500252|118849|P1|Overall Study|Death|4
27462|NCT01500226|118875|P2|Overall Study|Other Reasons|16
27463|NCT01500226|118876|P1|Overall Study|Other Reasons|19
27464|NCT01500226|118875|P2|Overall Study|Lost to Follow-up|5
27465|NCT01500226|118876|P1|Overall Study|Lost to Follow-up|9
27466|NCT01500226|118875|P2|Overall Study|Lack of Efficacy|30
27467|NCT01500226|118876|P1|Overall Study|Lack of Efficacy|14
27468|NCT01500226|118875|P2|Overall Study|Physician Decision|15
27469|NCT01500226|118876|P1|Overall Study|Physician Decision|17
27470|NCT01500226|118875|P2|Overall Study|Protocol Violation|39
27471|NCT01500226|118876|P1|Overall Study|Protocol Violation|53
27472|NCT01500226|118875|P2|Overall Study|Disease Progression|14
27473|NCT01500226|118876|P1|Overall Study|Disease Progression|16
27474|NCT01500226|118875|P2|Overall Study|Death|4
27475|NCT01500226|118876|P1|Overall Study|Death|12
27476|NCT01500226|118875|P2|Overall Study|Withdrawal by Subject|96
27477|NCT01500226|118876|P1|Overall Study|Withdrawal by Subject|93
27478|NCT01500226|118875|P2|Overall Study|Chemo Completed or Change in Therapy|237
27479|NCT01500226|118876|P1|Overall Study|Chemo Completed or Change in Therapy|235
27480|NCT01500226|118875|P2|Overall Study|Adverse Event|38
27481|NCT01500226|118876|P1|Overall Study|Adverse Event|31
27482|NCT01500213|118888|P2|Overall Study|Other Reasons|5
27483|NCT01500213|118889|P1|Overall Study|Other Reasons|7
27484|NCT01500213|118888|P2|Overall Study|Lost to Follow-up|6
27485|NCT01500213|118889|P1|Overall Study|Lost to Follow-up|3
27486|NCT01500213|118888|P2|Overall Study|Lack of Efficacy|7
27487|NCT01500213|118889|P1|Overall Study|Lack of Efficacy|9
27488|NCT01500213|118888|P2|Overall Study|Physician Decision|10
27489|NCT01500213|118889|P1|Overall Study|Physician Decision|12
27490|NCT01500213|118888|P2|Overall Study|Protocol Violation|19
27491|NCT01500213|118889|P1|Overall Study|Protocol Violation|19
27492|NCT01500213|118888|P2|Overall Study|Disease Progression|21
27493|NCT01500213|118889|P1|Overall Study|Disease Progression|13
27494|NCT01500213|118888|P2|Overall Study|Death|3
27495|NCT01500213|118889|P1|Overall Study|Death|7
27496|NCT01500213|118888|P2|Overall Study|Withdrawal by Subject|37
27497|NCT01500213|118889|P1|Overall Study|Withdrawal by Subject|28
27498|NCT01500213|118888|P2|Overall Study|Chemo Completed or Change in Therapy|81
27499|NCT01500213|118889|P1|Overall Study|Chemo Completed or Change in Therapy|84
27500|NCT01500213|118888|P2|Overall Study|Adverse Event|35
27501|NCT01500213|118889|P1|Overall Study|Adverse Event|35
27502|NCT01500135|118901|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
27503|NCT01500135|118902|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
27504|NCT01500135|118901|P2|Overall Study|Participant was a Safety Concern|0
27505|NCT01500135|118902|P1|Overall Study|Participant was a Safety Concern|1
27506|NCT01500135|118901|P2|Overall Study|Patient Missed Scheduled Appointments|1
27507|NCT01500135|118902|P1|Overall Study|Patient Missed Scheduled Appointments|0
27508|NCT01500135|118901|P2|Overall Study|Principal Investigator (PI) Discretion|0
27509|NCT01500135|118902|P1|Overall Study|Principal Investigator (PI) Discretion|1
27510|NCT01500135|118901|P2|Overall Study|Fatal Adverse Event (AE)|5
27511|NCT01500135|118902|P1|Overall Study|Fatal Adverse Event (AE)|5
27512|NCT01500135|118901|P2|Overall Study|Lost to Follow-up|4
27513|NCT01500135|118902|P1|Overall Study|Lost to Follow-up|6
27514|NCT01500135|118901|P2|Overall Study|Withdrawal of Consent|0
27515|NCT01500135|118902|P1|Overall Study|Withdrawal of Consent|4
27516|NCT01500083|118927|P2|Overall Study|Other Reasons|5
27517|NCT01500083|118928|P1|Overall Study|Other Reasons|2
27518|NCT01500083|118927|P2|Overall Study|Investigator Discretion|8
27519|NCT01500083|118928|P1|Overall Study|Investigator Discretion|3
27520|NCT01500083|118927|P2|Overall Study|Disease Progression|10
27521|NCT01500083|118928|P1|Overall Study|Disease Progression|2
27522|NCT01500083|118927|P2|Overall Study|Withdrawal of Consent|1
27523|NCT01500083|118928|P1|Overall Study|Withdrawal of Consent|0
27524|NCT01500083|118927|P2|Overall Study|Lost to Follow-up|0
27525|NCT01500083|118928|P1|Overall Study|Lost to Follow-up|1
27526|NCT01500083|118927|P2|Overall Study|Death|2
27527|NCT01500083|118928|P1|Overall Study|Death|0
27528|NCT01500083|118927|P2|Overall Study|Adverse Event|17
27529|NCT01500083|118928|P1|Overall Study|Adverse Event|4
27530|NCT01500031|118934|P1|Overall Study|Withdrawal by Subject|4
27531|NCT01500031|118934|P1|Overall Study|Death|1
27532|NCT01499849|118969|P2|Overall Study|Other Reasons|30
27533|NCT01499849|118970|P1|Overall Study|Other Reasons|27
27534|NCT01499849|118969|P2|Overall Study|Lost to Follow-up|3
27535|NCT01499849|118970|P1|Overall Study|Lost to Follow-up|6
27536|NCT01499849|118969|P2|Overall Study|Lack of Efficacy|4
27537|NCT01499849|118970|P1|Overall Study|Lack of Efficacy|3
27538|NCT01499849|118969|P2|Overall Study|Physician Decision|19
27539|NCT01499849|118970|P1|Overall Study|Physician Decision|20
27540|NCT01499849|118969|P2|Overall Study|Protocol Violation|11
27541|NCT01499849|118970|P1|Overall Study|Protocol Violation|11
27542|NCT01499849|118969|P2|Overall Study|Disease Progression|10
27543|NCT01499849|118970|P1|Overall Study|Disease Progression|11
27544|NCT01499849|118969|P2|Overall Study|Death|7
27545|NCT01499849|118970|P1|Overall Study|Death|5
27546|NCT01499849|118969|P2|Overall Study|Withdrawal by Subject|43
27547|NCT01499849|118970|P1|Overall Study|Withdrawal by Subject|43
27548|NCT01499849|118969|P2|Overall Study|Chemo completed or Change in Therapy|67
27549|NCT01499849|118970|P1|Overall Study|Chemo completed or Change in Therapy|70
27550|NCT01499849|118969|P2|Overall Study|Adverse Event|32
27551|NCT01499849|118970|P1|Overall Study|Adverse Event|28
27552|NCT01499810|118980|P1|Overall Study|Withdrawal by Subject|1
27553|NCT01499810|118980|P1|Overall Study|Protocol Violation|1
27554|NCT01499810|118980|P1|Overall Study|Lost to Follow-up|10
27555|NCT01499667|119030|P3|Overall Study|Lack of Efficacy|0
27556|NCT01499667|119031|P2|Overall Study|Lack of Efficacy|0
27557|NCT01499667|119032|P1|Overall Study|Lack of Efficacy|2
27558|NCT01499667|119030|P3|Overall Study|Withdrawal by Subject|1
27559|NCT01499667|119031|P2|Overall Study|Withdrawal by Subject|1
27560|NCT01499667|119032|P1|Overall Study|Withdrawal by Subject|2
27561|NCT01499667|119030|P3|Overall Study|Adverse Event|2
27562|NCT01499667|119031|P2|Overall Study|Adverse Event|2
27563|NCT01499667|119032|P1|Overall Study|Adverse Event|0
27564|NCT01499667|119030|P3|Overall Study|Protocol Violation|2
27565|NCT01499667|119031|P2|Overall Study|Protocol Violation|3
27566|NCT01499667|119032|P1|Overall Study|Protocol Violation|1
27567|NCT01499667|119030|P3|Overall Study|administrative problems|5
27568|NCT01499667|119031|P2|Overall Study|administrative problems|5
27569|NCT01499667|119032|P1|Overall Study|administrative problems|4
27570|NCT01499576|119080|P1|Overall Study|Withdrawal by Subject|9
27571|NCT01499576|119080|P1|Overall Study|Physician Decision|12
27572|NCT01499355|119094|P4|Double-Blind Period|Lost to Follow-up|0
27573|NCT01499355|119095|P3|Double-Blind Period|Lost to Follow-up|0
27574|NCT01499355|119096|P2|Double-Blind Period|Lost to Follow-up|1
27575|NCT01499355|119097|P1|Double-Blind Period|Lost to Follow-up|0
27576|NCT01499355|119094|P4|Double-Blind Period|Consent Withdrawn|2
27577|NCT01499355|119095|P3|Double-Blind Period|Consent Withdrawn|1
27578|NCT01499355|119096|P2|Double-Blind Period|Consent Withdrawn|0
27579|NCT01499355|119097|P1|Double-Blind Period|Consent Withdrawn|0
27580|NCT01499355|119094|P4|Double-Blind Period|Investigator Decision|3
27581|NCT01499355|119095|P3|Double-Blind Period|Investigator Decision|3
27582|NCT01499355|119096|P2|Double-Blind Period|Investigator Decision|0
27583|NCT01499355|119097|P1|Double-Blind Period|Investigator Decision|0
27584|NCT01499355|119094|P4|Double-Blind Period|Death|0
27585|NCT01499355|119095|P3|Double-Blind Period|Death|0
27586|NCT01499355|119096|P2|Double-Blind Period|Death|1
27587|NCT01499355|119097|P1|Double-Blind Period|Death|0
27588|NCT01499355|119094|P4|Double-Blind Period|Not Specified|2
27589|NCT01499355|119095|P3|Double-Blind Period|Not Specified|2
27590|NCT01499355|119096|P2|Double-Blind Period|Not Specified|1
27591|NCT01499355|119097|P1|Double-Blind Period|Not Specified|0
27592|NCT01499355|119094|P4|Double-Blind Period|Study Termination|14
27593|NCT01499355|119095|P3|Double-Blind Period|Study Termination|16
27594|NCT01499355|119096|P2|Double-Blind Period|Study Termination|18
27595|NCT01499355|119097|P1|Double-Blind Period|Study Termination|0
27596|NCT01499355|119094|P4|Double-Blind Period|Adverse Event|2
27597|NCT01499355|119095|P3|Double-Blind Period|Adverse Event|3
27598|NCT01499355|119096|P2|Double-Blind Period|Adverse Event|2
27599|NCT01499355|119097|P1|Double-Blind Period|Adverse Event|0
27600|NCT01499355|119094|P4|Run-In Period|Adverse Event|0
27601|NCT01499355|119095|P3|Run-In Period|Adverse Event|0
27602|NCT01499355|119096|P2|Run-In Period|Adverse Event|0
27603|NCT01499355|119097|P1|Run-In Period|Adverse Event|8
27604|NCT01499355|119094|P4|Run-In Period|Consent Withdrawn|0
27605|NCT01499355|119095|P3|Run-In Period|Consent Withdrawn|0
27606|NCT01499355|119096|P2|Run-In Period|Consent Withdrawn|0
27607|NCT01499355|119097|P1|Run-In Period|Consent Withdrawn|1
27608|NCT01499355|119094|P4|Run-In Period|Investigator Decision|0
27609|NCT01499355|119095|P3|Run-In Period|Investigator Decision|0
27610|NCT01499355|119096|P2|Run-In Period|Investigator Decision|0
27611|NCT01499355|119097|P1|Run-In Period|Investigator Decision|2
27612|NCT01499355|119094|P4|Run-In Period|Death|0
27613|NCT01499355|119095|P3|Run-In Period|Death|0
27614|NCT01499355|119096|P2|Run-In Period|Death|0
27615|NCT01499355|119097|P1|Run-In Period|Death|2
27616|NCT01499355|119094|P4|Run-In Period|Not Specified|0
27617|NCT01499355|119095|P3|Run-In Period|Not Specified|0
27618|NCT01499355|119096|P2|Run-In Period|Not Specified|0
27619|NCT01499355|119097|P1|Run-In Period|Not Specified|3
27620|NCT01499355|119094|P4|Run-In Period|Study Termination|0
27621|NCT01499355|119095|P3|Run-In Period|Study Termination|0
27622|NCT01499355|119096|P2|Run-In Period|Study Termination|0
27623|NCT01499355|119097|P1|Run-In Period|Study Termination|15
27624|NCT01499303|119130|P2|Overall Study|Other|1
27625|NCT01499303|119131|P1|Overall Study|Other|0
27626|NCT01499303|119130|P2|Overall Study|Adverse Event|4
27627|NCT01499303|119131|P1|Overall Study|Adverse Event|1
27628|NCT01499303|119130|P2|Overall Study|Withdrawal by Subject|1
27629|NCT01499303|119131|P1|Overall Study|Withdrawal by Subject|0
27630|NCT01499303|119130|P2|Overall Study|Ongoing|1
27631|NCT01499303|119131|P1|Overall Study|Ongoing|2
27632|NCT01499290|119139|P2|Overall Study|Adverse Event|7
27633|NCT01499290|119140|P1|Overall Study|Adverse Event|14
27634|NCT01499290|119139|P2|Overall Study|Lack of Efficacy|8
27635|NCT01499290|119140|P1|Overall Study|Lack of Efficacy|7
27636|NCT01499290|119139|P2|Overall Study|Condition improved/subject recovered|0
27637|NCT01499290|119140|P1|Overall Study|Condition improved/subject recovered|1
27638|NCT01499290|119139|P2|Overall Study|Not specified in study report|5
27639|NCT01499290|119140|P1|Overall Study|Not specified in study report|11
27640|NCT01499290|119139|P2|Overall Study|Withdrawal by Subject|15
27641|NCT01499290|119140|P1|Overall Study|Withdrawal by Subject|22
27642|NCT01499277|119190|P2|Overall Study|Lack of therapeutic response and other|7
27643|NCT01499277|119191|P1|Overall Study|Lack of therapeutic response and other|8
27644|NCT01499277|119190|P2|Overall Study|Withdrawal by Subject|6
27645|NCT01499277|119191|P1|Overall Study|Withdrawal by Subject|16
27646|NCT01499277|119190|P2|Overall Study|Protocol Violation|3
27647|NCT01499277|119191|P1|Overall Study|Protocol Violation|2
27648|NCT01499277|119190|P2|Overall Study|Lost to Follow-up|8
27649|NCT01499277|119191|P1|Overall Study|Lost to Follow-up|15
27650|NCT01499277|119190|P2|Overall Study|Death|2
27651|NCT01499277|119191|P1|Overall Study|Death|3
27652|NCT01499277|119190|P2|Overall Study|Adverse Event|6
27653|NCT01499277|119191|P1|Overall Study|Adverse Event|3
27654|NCT01499199|119213|P1|Overall Study|Lack of Efficacy|1
27655|NCT01499199|119213|P1|Overall Study|Adverse Event|1
27656|NCT01499134|119234|P2|Overall Study|Withdrawal by Subject|1
27657|NCT01499134|119235|P1|Overall Study|Withdrawal by Subject|0
27658|NCT01499095|119257|P2|Overall Study|Perceived Lack of Efficacy|1
27659|NCT01499095|119258|P1|Overall Study|Perceived Lack of Efficacy|1
27660|NCT01499095|119257|P2|Overall Study|Change in Injection Schedule|0
27661|NCT01499095|119258|P1|Overall Study|Change in Injection Schedule|2
27662|NCT01499095|119257|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
27663|NCT01499095|119258|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
27664|NCT01499095|119257|P2|Overall Study|Hypoglycemia|1
27665|NCT01499095|119258|P1|Overall Study|Hypoglycemia|3
27666|NCT01499095|119257|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
27667|NCT01499095|119258|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
27668|NCT01499095|119257|P2|Overall Study|Lost to Follow-up|4
27669|NCT01499095|119258|P1|Overall Study|Lost to Follow-up|6
27670|NCT01499095|119257|P2|Overall Study|Diverse Reasons|25
27671|NCT01499095|119258|P1|Overall Study|Diverse Reasons|22
27672|NCT01499095|119257|P2|Overall Study|Received Rescue Therapy|40
27673|NCT01499095|119258|P1|Overall Study|Received Rescue Therapy|32
27674|NCT01499095|119257|P2|Overall Study|Protocol Violation|7
27675|NCT01499095|119258|P1|Overall Study|Protocol Violation|6
27676|NCT01499095|119257|P2|Overall Study|Lack of Efficacy|1
27677|NCT01499095|119258|P1|Overall Study|Lack of Efficacy|2
27678|NCT01499095|119257|P2|Overall Study|Adverse Event|7
27679|NCT01499095|119258|P1|Overall Study|Adverse Event|12
27680|NCT01499095|119257|P2|Overall Study|Randomized But Not Treated|1
27681|NCT01499095|119258|P1|Overall Study|Randomized But Not Treated|1
27682|NCT01499082|119288|P2|Overall Study|Lost to Follow-up|3
27683|NCT01499082|119289|P1|Overall Study|Lost to Follow-up|1
27684|NCT01499082|119288|P2|Overall Study|Hypoglycemia|3
27685|NCT01499082|119289|P1|Overall Study|Hypoglycemia|2
27686|NCT01499082|119288|P2|Overall Study|Site Closure for Noncompliance|2
27687|NCT01499082|119289|P1|Overall Study|Site Closure for Noncompliance|5
27688|NCT01499082|119288|P2|Overall Study|Diverse Reasons|14
27689|NCT01499082|119289|P1|Overall Study|Diverse Reasons|18
27690|NCT01499082|119288|P2|Overall Study|Protocol Violation|8
27691|NCT01499082|119289|P1|Overall Study|Protocol Violation|6
27692|NCT01499082|119288|P2|Overall Study|Lack of Efficacy|1
27693|NCT01499082|119289|P1|Overall Study|Lack of Efficacy|1
27694|NCT01499082|119288|P2|Overall Study|Adverse Event|16
27695|NCT01499082|119289|P1|Overall Study|Adverse Event|12
27696|NCT01499082|119288|P2|Overall Study|Randomized but not Treated|1
27697|NCT01499082|119289|P1|Overall Study|Randomized but not Treated|0
27698|NCT01498822|119319|P2|Overall Study|Lost to Follow-up|3
27699|NCT01498822|119320|P1|Overall Study|Lost to Follow-up|8
27700|NCT01498822|119319|P2|Overall Study|Withdrawal by Subject|25
27701|NCT01498822|119320|P1|Overall Study|Withdrawal by Subject|15
27702|NCT01498822|119319|P2|Overall Study|Adverse Event, serious fatal|1
27703|NCT01498822|119320|P1|Overall Study|Adverse Event, serious fatal|1
27704|NCT01498822|119319|P2|Overall Study|SAE, non-fatal|2
27705|NCT01498822|119320|P1|Overall Study|SAE, non-fatal|2
27706|NCT01498822|119319|P2|Overall Study|AE, non-serious non-fatal|17
27707|NCT01498822|119320|P1|Overall Study|AE, non-serious non-fatal|8
27708|NCT01498822|119319|P2|Overall Study|Lack of Efficacy|2
27709|NCT01498822|119320|P1|Overall Study|Lack of Efficacy|7
27710|NCT01498822|119319|P2|Overall Study|Other Reason|2
27711|NCT01498822|119320|P1|Overall Study|Other Reason|5
27712|NCT01498822|119319|P2|Overall Study|Protocol Violation|4
27713|NCT01498822|119320|P1|Overall Study|Protocol Violation|8
27714|NCT01498692|119347|P1|Overall Study|Missed 12-month visit|3
27715|NCT01498692|119347|P1|Overall Study|Withdrawal by Subject|1
27716|NCT01498692|119347|P1|Overall Study|Death|4
27717|NCT01498679|119378|P2|Overall Study|Withdrawal by Subject|4
27718|NCT01498679|119379|P1|Overall Study|Withdrawal by Subject|12
27719|NCT01498679|119378|P2|Overall Study|Physician Decision|2
27720|NCT01498679|119379|P1|Overall Study|Physician Decision|0
27721|NCT01498679|119378|P2|Overall Study|Protocol Violation|0
27722|NCT01498679|119379|P1|Overall Study|Protocol Violation|4
27723|NCT01498679|119378|P2|Overall Study|Lack of Efficacy|12
27724|NCT01498679|119379|P1|Overall Study|Lack of Efficacy|72
27725|NCT01498679|119378|P2|Overall Study|Adverse Event|4
27726|NCT01498679|119379|P1|Overall Study|Adverse Event|1
27727|NCT01498653|119395|P2|Overall Study|Withdrawal by Subject|3
27728|NCT01498653|119396|P1|Overall Study|Withdrawal by Subject|2
27729|NCT01498653|119395|P2|Overall Study|Physician Decision|0
27730|NCT01498653|119396|P1|Overall Study|Physician Decision|2
27731|NCT01498653|119395|P2|Overall Study|Lost to Follow-up|0
27732|NCT01498653|119396|P1|Overall Study|Lost to Follow-up|1
27733|NCT01498653|119395|P2|Overall Study|Protocol Violation|4
27734|NCT01498653|119396|P1|Overall Study|Protocol Violation|0
27735|NCT01498653|119395|P2|Overall Study|Lack of Efficacy|26
27736|NCT01498653|119396|P1|Overall Study|Lack of Efficacy|12
27737|NCT01498653|119395|P2|Overall Study|Adverse Event|2
27738|NCT01498653|119396|P1|Overall Study|Adverse Event|2
27739|NCT01498640|119410|P1|Overall Study|not specified|3
27740|NCT01498640|119410|P1|Overall Study|Death|1
27741|NCT01498640|119410|P1|Overall Study|Lost to Follow-up|1
27742|NCT01498575|119440|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
27743|NCT01498575|119441|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
27744|NCT01498575|119440|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
27745|NCT01498575|119441|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
27746|NCT01498575|119440|P2|Overall Sample|Withdrawal by Subject|14
27747|NCT01498575|119441|P1|Overall Sample|Withdrawal by Subject|60
27748|NCT01498458|119447|P1|Overall Study|Physician Decision|3
27749|NCT01498458|119447|P1|Overall Study|Adverse Event|4
27750|NCT01498185|119502|P5|Overall Study|No longer met criteria, etc|2
27751|NCT01498185|119503|P4|Overall Study|No longer met criteria, etc|0
27752|NCT01498185|119504|P3|Overall Study|No longer met criteria, etc|0
27753|NCT01498185|119505|P2|Overall Study|No longer met criteria, etc|0
27754|NCT01498185|119506|P1|Overall Study|No longer met criteria, etc|0
27755|NCT01498185|119502|P5|Overall Study|Withdrawal by Subject|1
27756|NCT01498185|119503|P4|Overall Study|Withdrawal by Subject|2
27757|NCT01498185|119504|P3|Overall Study|Withdrawal by Subject|0
27758|NCT01498185|119505|P2|Overall Study|Withdrawal by Subject|1
27759|NCT01498185|119506|P1|Overall Study|Withdrawal by Subject|1
27760|NCT01498185|119502|P5|Overall Study|Adverse Event|0
27761|NCT01498185|119503|P4|Overall Study|Adverse Event|1
27762|NCT01498185|119504|P3|Overall Study|Adverse Event|0
27763|NCT01498185|119505|P2|Overall Study|Adverse Event|0
27764|NCT01498185|119506|P1|Overall Study|Adverse Event|0
27765|NCT01498120|119546|P1|Overall Study|Unspecified|4
27766|NCT01498120|119546|P1|Overall Study|AE, non-serious non-fatal|3
27767|NCT01498120|119546|P1|Overall Study|Withdrawal by Subject|5
27768|NCT01498120|119546|P1|Overall Study|Lost to Follow-up|1
27769|NCT01498068|119553|P2|Overall Study|Withdrawal by Subject|1
27770|NCT01498068|119554|P1|Overall Study|Withdrawal by Subject|1
27771|NCT01497938|119572|P2|Overall Study|Device Violation|0
27772|NCT01497938|119573|P1|Overall Study|Device Violation|1
27773|NCT01497938|119572|P2|Overall Study|Withdrawal by Subject|0
27774|NCT01497938|119573|P1|Overall Study|Withdrawal by Subject|4
27775|NCT01497938|119572|P2|Overall Study|Physician Decision|1
27776|NCT01497938|119573|P1|Overall Study|Physician Decision|0
27777|NCT01497938|119572|P2|Overall Study|Adverse Event|1
27778|NCT01497938|119573|P1|Overall Study|Adverse Event|0
27779|NCT01497899|119585|P4|Open-Label Extension Phase|Still in the Open-Label Extension Phase|38
27780|NCT01497899|119586|P3|Open-Label Extension Phase|Still in the Open-Label Extension Phase|69
27781|NCT01497899|119587|P2|Open-Label Extension Phase|Still in the Open-Label Extension Phase|53
27782|NCT01497899|119588|P1|Open-Label Extension Phase|Still in the Open-Label Extension Phase|104
27783|NCT01497899|119585|P4|Open-Label Extension Phase|Lost to Follow-up|0
27784|NCT01497899|119586|P3|Open-Label Extension Phase|Lost to Follow-up|1
27785|NCT01497899|119587|P2|Open-Label Extension Phase|Lost to Follow-up|0
27786|NCT01497899|119588|P1|Open-Label Extension Phase|Lost to Follow-up|1
27787|NCT01497899|119585|P4|Double-Blind Phase|Subject Non-Compliance|0
27788|NCT01497899|119586|P3|Double-Blind Phase|Subject Non-Compliance|0
27789|NCT01497899|119587|P2|Double-Blind Phase|Subject Non-Compliance|1
27790|NCT01497899|119588|P1|Double-Blind Phase|Subject Non-Compliance|0
27791|NCT01497899|119585|P4|Double-Blind Phase|Lost to Follow-up|0
27792|NCT01497899|119586|P3|Double-Blind Phase|Lost to Follow-up|0
27793|NCT01497899|119587|P2|Double-Blind Phase|Lost to Follow-up|2
27794|NCT01497899|119588|P1|Double-Blind Phase|Lost to Follow-up|3
27795|NCT01497899|119585|P4|Double-Blind Phase|Withdrew Consent|0
27796|NCT01497899|119586|P3|Double-Blind Phase|Withdrew Consent|0
27797|NCT01497899|119587|P2|Double-Blind Phase|Withdrew Consent|1
27798|NCT01497899|119588|P1|Double-Blind Phase|Withdrew Consent|0
27799|NCT01497899|119585|P4|Double-Blind Phase|Investigator's Discretion|0
27800|NCT01497899|119586|P3|Double-Blind Phase|Investigator's Discretion|0
27801|NCT01497899|119587|P2|Double-Blind Phase|Investigator's Discretion|0
27802|NCT01497899|119588|P1|Double-Blind Phase|Investigator's Discretion|1
27803|NCT01497899|119585|P4|Double-Blind Phase|Lack of Efficacy|0
27804|NCT01497899|119586|P3|Double-Blind Phase|Lack of Efficacy|0
27805|NCT01497899|119587|P2|Double-Blind Phase|Lack of Efficacy|1
27806|NCT01497899|119588|P1|Double-Blind Phase|Lack of Efficacy|0
27807|NCT01497899|119585|P4|Double-Blind Phase|Adverse Event|0
27808|NCT01497899|119586|P3|Double-Blind Phase|Adverse Event|0
27809|NCT01497899|119587|P2|Double-Blind Phase|Adverse Event|0
27810|NCT01497899|119588|P1|Double-Blind Phase|Adverse Event|1
27811|NCT01497899|119585|P4|Double-Blind Phase|Randomized but not Treated|0
27812|NCT01497899|119586|P3|Double-Blind Phase|Randomized but not Treated|0
27813|NCT01497899|119587|P2|Double-Blind Phase|Randomized but not Treated|0
27814|NCT01497899|119588|P1|Double-Blind Phase|Randomized but not Treated|1
27815|NCT01497366|119616|P2|Overall Study|Randomized but not treated|21
27816|NCT01497366|119617|P1|Overall Study|Randomized but not treated|7
27817|NCT01497366|119616|P2|Overall Study|Death|1
27818|NCT01497366|119617|P1|Overall Study|Death|1
27819|NCT01497366|119616|P2|Overall Study|Other|0
27820|NCT01497366|119617|P1|Overall Study|Other|5
27821|NCT01497366|119616|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
27822|NCT01497366|119617|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
27823|NCT01497366|119616|P2|Overall Study|Withdrawal by Subject|6
27824|NCT01497366|119617|P1|Overall Study|Withdrawal by Subject|6
27825|NCT01497366|119616|P2|Overall Study|Lost to Follow-up|10
27826|NCT01497366|119617|P1|Overall Study|Lost to Follow-up|11
27827|NCT01497366|119616|P2|Overall Study|Virologic failure|50
27828|NCT01497366|119617|P1|Overall Study|Virologic failure|2
27829|NCT01497275|119635|P1|Overall Study|Adverse Event|1
27830|NCT01497275|119635|P1|Overall Study|Death|1
27831|NCT01497262|119642|P1|Overall Study|Protocol Violation|1
27832|NCT01497262|119642|P1|Overall Study|Adverse Event|2
27833|NCT01497262|119642|P1|Overall Study|Withdrawal by Subject|2
27834|NCT01497262|119642|P1|Overall Study|Physician Decision|1
27835|NCT01497262|119642|P1|Overall Study|Abnormal Test Procedure Result|1
27836|NCT01497262|119642|P1|Overall Study|Abnormal Lab Values|4
27837|NCT01497197|119649|P2|Overall Study|Unspecified|1
27838|NCT01497197|119650|P1|Overall Study|Unspecified|3
27839|NCT01497197|119649|P2|Overall Study|All embryos discarded|3
27840|NCT01497197|119650|P1|Overall Study|All embryos discarded|0
27841|NCT01497197|119649|P2|Overall Study|Intention to freeze all embryos|1
27842|NCT01497197|119650|P1|Overall Study|Intention to freeze all embryos|0
27843|NCT01497197|119649|P2|Overall Study|No fertilisation|5
27844|NCT01497197|119650|P1|Overall Study|No fertilisation|6
27845|NCT01497197|119649|P2|Overall Study|No oocytes retrieved|2
27846|NCT01497197|119650|P1|Overall Study|No oocytes retrieved|3
27847|NCT01497197|119649|P2|Overall Study|Risk of OHSS|0
27848|NCT01497197|119650|P1|Overall Study|Risk of OHSS|1
27849|NCT01497197|119649|P2|Overall Study|Excessive/lack of response to treatment|0
27850|NCT01497197|119650|P1|Overall Study|Excessive/lack of response to treatment|1
27851|NCT01497197|119649|P2|Overall Study|Withdrawal by Subject|1
27852|NCT01497197|119650|P1|Overall Study|Withdrawal by Subject|2
27853|NCT01497197|119649|P2|Overall Study|Protocol Violation|2
27854|NCT01497197|119650|P1|Overall Study|Protocol Violation|0
27855|NCT01497197|119649|P2|Overall Study|Lost to Follow-up|0
27856|NCT01497197|119650|P1|Overall Study|Lost to Follow-up|1
27857|NCT01496469|119687|P2|Overall Study|Other|1
27858|NCT01496469|119688|P1|Overall Study|Other|1
27859|NCT01496469|119687|P2|Overall Study|BP exceeds protocol limits|2
27860|NCT01496469|119688|P1|Overall Study|BP exceeds protocol limits|1
27861|NCT01496469|119687|P2|Overall Study|Withdrawal by Subject|4
27862|NCT01496469|119688|P1|Overall Study|Withdrawal by Subject|4
27863|NCT01496469|119687|P2|Overall Study|Lost to Follow-up|1
27864|NCT01496469|119688|P1|Overall Study|Lost to Follow-up|1
27865|NCT01496469|119687|P2|Overall Study|Protocol Violation|0
27866|NCT01496469|119688|P1|Overall Study|Protocol Violation|2
27867|NCT01496469|119687|P2|Overall Study|Adverse Event|0
27868|NCT01496469|119688|P1|Overall Study|Adverse Event|1
27869|NCT01496456|119698|P1|Overall Study|Lost to Follow-up|7
27870|NCT01496456|119698|P1|Overall Study|Protocol Violation|1
27871|NCT01496430|119711|P3|Overall Study|Other|0
27872|NCT01496430|119712|P2|Overall Study|Other|0
27873|NCT01496430|119713|P1|Overall Study|Other|2
27874|NCT01496430|119711|P3|Overall Study|Principal Investigator Discretion|1
27875|NCT01496430|119712|P2|Overall Study|Principal Investigator Discretion|1
27876|NCT01496430|119713|P1|Overall Study|Principal Investigator Discretion|0
27877|NCT01496430|119711|P3|Overall Study|Voluntary Withdrawal|6
27878|NCT01496430|119712|P2|Overall Study|Voluntary Withdrawal|1
27879|NCT01496430|119713|P1|Overall Study|Voluntary Withdrawal|2
27880|NCT01496430|119711|P3|Overall Study|Lost to Follow-up|1
27881|NCT01496430|119712|P2|Overall Study|Lost to Follow-up|3
27882|NCT01496430|119713|P1|Overall Study|Lost to Follow-up|2
27883|NCT01496430|119711|P3|Overall Study|Major Protocol Deviation|1
27884|NCT01496430|119712|P2|Overall Study|Major Protocol Deviation|0
27885|NCT01496430|119713|P1|Overall Study|Major Protocol Deviation|0
27886|NCT01496430|119711|P3|Overall Study|Adverse Event|1
27887|NCT01496430|119712|P2|Overall Study|Adverse Event|0
27888|NCT01496430|119713|P1|Overall Study|Adverse Event|0
27889|NCT01496287|119825|P1|Overall Study|Incomplete anesthesia|5
27890|NCT01496287|119825|P1|Overall Study|Lost to Follow-up|1
27891|NCT01496274|119835|P2|Overall Study|Lost to Follow-up|3
27892|NCT01496274|119836|P1|Overall Study|Lost to Follow-up|0
27893|NCT01496274|119835|P2|Overall Study|Withdrawal by Subject|0
27894|NCT01496274|119836|P1|Overall Study|Withdrawal by Subject|2
27895|NCT01496274|119835|P2|Overall Study|Adverse Event|1
27896|NCT01496274|119836|P1|Overall Study|Adverse Event|1
27897|NCT01496274|119835|P2|Overall Study|Protocol Violation|1
27898|NCT01496274|119836|P1|Overall Study|Protocol Violation|0
27899|NCT01496183|119881|P2|Overall Study|Withdrawal by Subject|1
27900|NCT01496183|119882|P1|Overall Study|Withdrawal by Subject|0
27901|NCT01496183|119881|P2|Overall Study|Physician Decision|1
27902|NCT01496183|119882|P1|Overall Study|Physician Decision|3
27903|NCT01495975|119890|P2|Overall Study|Lost to Follow-up|0
27904|NCT01495975|119891|P1|Overall Study|Lost to Follow-up|1
27905|NCT01495793|119982|P1|Overall Study|Violation of inclusion criteria|1
27906|NCT01495793|119982|P1|Overall Study|Lost to Follow-up|1
27907|NCT01495702|119995|P2|Randomized Phase|Protocol Violation|1
27908|NCT01495702|119996|P1|Randomized Phase|Protocol Violation|3
27909|NCT01495702|119995|P2|Randomized Phase|Participant Noncompliance|0
27910|NCT01495702|119996|P1|Randomized Phase|Participant Noncompliance|1
27911|NCT01495702|119995|P2|Randomized Phase|Lost to Follow-up|3
27912|NCT01495702|119996|P1|Randomized Phase|Lost to Follow-up|4
27913|NCT01495702|119995|P2|Randomized Phase|Withdrew Consent|18
27914|NCT01495702|119996|P1|Randomized Phase|Withdrew Consent|10
27915|NCT01495702|119995|P2|Randomized Phase|Investigators Discretion|0
27916|NCT01495702|119996|P1|Randomized Phase|Investigators Discretion|2
27917|NCT01495702|119995|P2|Randomized Phase|Lack of Efficacy|0
27918|NCT01495702|119996|P1|Randomized Phase|Lack of Efficacy|2
27919|NCT01495702|119995|P2|Randomized Phase|Death|0
27920|NCT01495702|119996|P1|Randomized Phase|Death|1
27921|NCT01495702|119995|P2|Randomized Phase|Adverse Event|2
27922|NCT01495702|119996|P1|Randomized Phase|Adverse Event|2
27923|NCT01495702|119995|P2|Randomized Phase|Randomized But Not Treated|4
27924|NCT01495702|119996|P1|Randomized Phase|Randomized But Not Treated|1
27925|NCT01495000|120046|P2|Overall Study|Withdrawal by Subject|10
27926|NCT01495000|120047|P1|Overall Study|Withdrawal by Subject|10
27927|NCT01495000|120046|P2|Overall Study|Protocol Violation|0
27928|NCT01495000|120047|P1|Overall Study|Protocol Violation|1
27929|NCT01495000|120046|P2|Overall Study|Lost to Follow-up|2
27930|NCT01495000|120047|P1|Overall Study|Lost to Follow-up|2
27931|NCT01494987|120089|P2|Overall Study|Subject Withdrew Consent|3
27932|NCT01494987|120090|P1|Overall Study|Subject Withdrew Consent|2
27933|NCT01494987|120089|P2|Overall Study|Subject Non-Compliance|10
27934|NCT01494987|120090|P1|Overall Study|Subject Non-Compliance|9
27935|NCT01494987|120089|P2|Overall Study|Protocol Violation|3
27936|NCT01494987|120090|P1|Overall Study|Protocol Violation|3
27937|NCT01494987|120089|P2|Overall Study|Lost to Follow-up|1
27938|NCT01494987|120090|P1|Overall Study|Lost to Follow-up|1
27939|NCT01494987|120089|P2|Overall Study|Investigator's Discretion|2
27940|NCT01494987|120090|P1|Overall Study|Investigator's Discretion|1
27941|NCT01494987|120089|P2|Overall Study|Hyperglycemia|4
27942|NCT01494987|120090|P1|Overall Study|Hyperglycemia|6
27943|NCT01494987|120089|P2|Overall Study|Adverse Event|5
27944|NCT01494987|120090|P1|Overall Study|Adverse Event|6
27945|NCT01494818|120104|P2|Overall Study|Lost to Follow-up|0
27946|NCT01494818|120105|P1|Overall Study|Lost to Follow-up|1
27947|NCT01494818|120104|P2|Overall Study|Relocation|2
27948|NCT01494818|120105|P1|Overall Study|Relocation|1
27949|NCT01494649|120136|P2|Overall Study|Lost to Follow-up|1
27950|NCT01494649|120137|P1|Overall Study|Lost to Follow-up|0
27951|NCT01494610|120153|P2|Period 4|Protocol Violation|0
27952|NCT01494610|120154|P1|Period 4|Protocol Violation|1
27953|NCT01494610|120153|P2|Period 3|Withdrawal by Subject|0
27954|NCT01494610|120154|P1|Period 3|Withdrawal by Subject|1
27955|NCT01494610|120153|P2|Period 3|Adverse Event|0
27956|NCT01494610|120154|P1|Period 3|Adverse Event|1
27957|NCT01494610|120153|P2|Period 1|Withdrawal by Subject|1
27958|NCT01494610|120154|P1|Period 1|Withdrawal by Subject|1
27959|NCT01494584|120222|P1|Overall Study|Study Closed/Terminated|1
27960|NCT01494532|120354|P6|Overall Study|Withdrawal by Subject|0
27961|NCT01494532|120355|P5|Overall Study|Withdrawal by Subject|2
27962|NCT01494532|120356|P4|Overall Study|Withdrawal by Subject|3
27963|NCT01494532|120357|P3|Overall Study|Withdrawal by Subject|4
27964|NCT01494532|120358|P2|Overall Study|Withdrawal by Subject|1
27965|NCT01494532|120359|P1|Overall Study|Withdrawal by Subject|3
27966|NCT01494532|120354|P6|Overall Study|Physician Decision|0
27967|NCT01494532|120355|P5|Overall Study|Physician Decision|0
27968|NCT01494532|120356|P4|Overall Study|Physician Decision|2
27969|NCT01494532|120357|P3|Overall Study|Physician Decision|1
27970|NCT01494532|120358|P2|Overall Study|Physician Decision|1
27971|NCT01494532|120359|P1|Overall Study|Physician Decision|0
27972|NCT01494532|120354|P6|Overall Study|Lost to Follow-up|0
27973|NCT01494532|120355|P5|Overall Study|Lost to Follow-up|0
27974|NCT01494532|120356|P4|Overall Study|Lost to Follow-up|2
27975|NCT01494532|120357|P3|Overall Study|Lost to Follow-up|0
27976|NCT01494532|120358|P2|Overall Study|Lost to Follow-up|0
27977|NCT01494532|120359|P1|Overall Study|Lost to Follow-up|1
27978|NCT01494532|120354|P6|Overall Study|Protocol-defined stopping criteria|0
27979|NCT01494532|120355|P5|Overall Study|Protocol-defined stopping criteria|0
27980|NCT01494532|120356|P4|Overall Study|Protocol-defined stopping criteria|0
27981|NCT01494532|120357|P3|Overall Study|Protocol-defined stopping criteria|1
27982|NCT01494532|120358|P2|Overall Study|Protocol-defined stopping criteria|0
27983|NCT01494532|120359|P1|Overall Study|Protocol-defined stopping criteria|0
27984|NCT01494532|120354|P6|Overall Study|Protocol deviation|0
27985|NCT01494532|120355|P5|Overall Study|Protocol deviation|3
27986|NCT01494532|120356|P4|Overall Study|Protocol deviation|2
27987|NCT01494532|120357|P3|Overall Study|Protocol deviation|3
27988|NCT01494532|120358|P2|Overall Study|Protocol deviation|1
27989|NCT01494532|120359|P1|Overall Study|Protocol deviation|2
27990|NCT01494532|120354|P6|Overall Study|Lack of Efficacy|0
27991|NCT01494532|120355|P5|Overall Study|Lack of Efficacy|2
27992|NCT01494532|120356|P4|Overall Study|Lack of Efficacy|0
27993|NCT01494532|120357|P3|Overall Study|Lack of Efficacy|0
27994|NCT01494532|120358|P2|Overall Study|Lack of Efficacy|0
27995|NCT01494532|120359|P1|Overall Study|Lack of Efficacy|0
27996|NCT01494532|120354|P6|Overall Study|Adverse Event|0
27997|NCT01494532|120355|P5|Overall Study|Adverse Event|5
27998|NCT01494532|120356|P4|Overall Study|Adverse Event|6
27999|NCT01494532|120357|P3|Overall Study|Adverse Event|8
28000|NCT01494532|120358|P2|Overall Study|Adverse Event|1
28001|NCT01494532|120359|P1|Overall Study|Adverse Event|4
28002|NCT01494506|120514|P3|Overall Study|Other|1
28003|NCT01494506|120515|P2|Overall Study|Other|3
28004|NCT01494506|120516|P1|Overall Study|Other|0
28005|NCT01494506|120514|P3|Overall Study|Sponsor Decision|1
28006|NCT01494506|120515|P2|Overall Study|Sponsor Decision|0
28007|NCT01494506|120516|P1|Overall Study|Sponsor Decision|0
28008|NCT01494506|120514|P3|Overall Study|Clinical Deterioration|13
28009|NCT01494506|120515|P2|Overall Study|Clinical Deterioration|17
28010|NCT01494506|120516|P1|Overall Study|Clinical Deterioration|21
28011|NCT01494506|120514|P3|Overall Study|Withdrawal by Subject|14
28012|NCT01494506|120515|P2|Overall Study|Withdrawal by Subject|20
28013|NCT01494506|120516|P1|Overall Study|Withdrawal by Subject|17
28014|NCT01494506|120514|P3|Overall Study|Physician Decision|4
28015|NCT01494506|120515|P2|Overall Study|Physician Decision|5
28016|NCT01494506|120516|P1|Overall Study|Physician Decision|7
28017|NCT01494506|120514|P3|Overall Study|Death|2
28018|NCT01494506|120515|P2|Overall Study|Death|5
28019|NCT01494506|120516|P1|Overall Study|Death|9
28020|NCT01494506|120514|P3|Overall Study|Adverse Event|11
28021|NCT01494506|120515|P2|Overall Study|Adverse Event|10
28022|NCT01494506|120516|P1|Overall Study|Adverse Event|17
28023|NCT01494506|120514|P3|Overall Study|Lack of Efficacy|57
28024|NCT01494506|120515|P2|Overall Study|Lack of Efficacy|83
28025|NCT01494506|120516|P1|Overall Study|Lack of Efficacy|77
28026|NCT01494467|120553|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
28027|NCT01494467|120554|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
28028|NCT01494467|120553|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
28029|NCT01494467|120554|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
28030|NCT01494467|120553|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
28031|NCT01494467|120554|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
28032|NCT01494467|120553|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
28033|NCT01494467|120554|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
28034|NCT01494467|120553|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
28035|NCT01494467|120554|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
28036|NCT01494467|120553|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
28037|NCT01494467|120554|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
28038|NCT01494467|120553|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
28039|NCT01494467|120554|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
28040|NCT01494467|120553|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
28041|NCT01494467|120554|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
28042|NCT01494467|120553|P2|Part A Vehicle Control (12 Weeks)|Other|1
28043|NCT01494467|120554|P1|Part A Vehicle Control (12 Weeks)|Other|1
28044|NCT01494467|120553|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
28045|NCT01494467|120554|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
28046|NCT01494467|120553|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
28047|NCT01494467|120554|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
28048|NCT01494467|120553|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
28049|NCT01494467|120554|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
28050|NCT01494467|120553|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
28051|NCT01494467|120554|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
28052|NCT01494467|120553|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
28053|NCT01494467|120554|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
28054|NCT01494350|120570|P1|Overall Study|Worsening of lesion|1
28055|NCT01494298|120580|P2|Overall Study|Protocol Violation|8
28056|NCT01494298|120581|P1|Overall Study|Protocol Violation|2
28057|NCT01493687|120606|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
28058|NCT01493687|120607|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
28059|NCT01493687|120606|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
28060|NCT01493687|120607|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
28061|NCT01493687|120606|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
28062|NCT01493687|120607|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
28063|NCT01493687|120606|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
28064|NCT01493687|120607|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
28065|NCT01493687|120606|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
28066|NCT01493687|120607|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
28067|NCT01493687|120606|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
28068|NCT01493687|120607|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
28069|NCT01493687|120606|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
28070|NCT01493687|120607|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
28071|NCT01493687|120606|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
28072|NCT01493687|120607|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
28073|NCT01493687|120606|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
28074|NCT01493687|120607|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
28075|NCT01493687|120606|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
28076|NCT01493687|120607|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
28077|NCT01493687|120606|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
28078|NCT01493687|120607|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
28079|NCT01493687|120606|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
28080|NCT01493687|120607|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
28081|NCT01493687|120606|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
28082|NCT01493687|120607|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
28083|NCT01493687|120606|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
28084|NCT01493687|120607|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
28085|NCT01493687|120606|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
28086|NCT01493687|120607|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
28087|NCT01493557|120626|P3|Adding the Second Strategy|Withdrawal by Subject|0
28088|NCT01493557|120627|P2|Adding the Second Strategy|Withdrawal by Subject|1
28089|NCT01493557|120628|P1|Adding the Second Strategy|Withdrawal by Subject|0
28090|NCT01493557|120626|P3|Adding the Second Strategy|Other adverse event|0
28091|NCT01493557|120627|P2|Adding the Second Strategy|Other adverse event|2
28092|NCT01493557|120628|P1|Adding the Second Strategy|Other adverse event|1
28093|NCT01493557|120626|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
28094|NCT01493557|120627|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
28095|NCT01493557|120628|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
28096|NCT01493557|120626|P3|Randomized to Management Strategies|Other than stated above|0
28097|NCT01493557|120627|P2|Randomized to Management Strategies|Other than stated above|3
28098|NCT01493557|120628|P1|Randomized to Management Strategies|Other than stated above|1
28099|NCT01493557|120626|P3|Randomized to Management Strategies|Withdrawal by Subject|0
28100|NCT01493557|120627|P2|Randomized to Management Strategies|Withdrawal by Subject|1
28101|NCT01493557|120628|P1|Randomized to Management Strategies|Withdrawal by Subject|0
28102|NCT01493557|120626|P3|Randomized to Management Strategies|Protocol Violation|0
28103|NCT01493557|120627|P2|Randomized to Management Strategies|Protocol Violation|0
28104|NCT01493557|120628|P1|Randomized to Management Strategies|Protocol Violation|3
28105|NCT01493557|120626|P3|Randomized to Management Strategies|Other adverse event|0
28106|NCT01493557|120627|P2|Randomized to Management Strategies|Other adverse event|5
28107|NCT01493557|120628|P1|Randomized to Management Strategies|Other adverse event|8
28108|NCT01493557|120626|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
28109|NCT01493557|120627|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
28110|NCT01493557|120628|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
28111|NCT01493557|120626|P3|Not Randomized to Management Strategies|Other than stated above|21
28112|NCT01493557|120627|P2|Not Randomized to Management Strategies|Other than stated above|0
28113|NCT01493557|120628|P1|Not Randomized to Management Strategies|Other than stated above|0
28114|NCT01493557|120626|P3|Not Randomized to Management Strategies|Early termination|34
28115|NCT01493557|120627|P2|Not Randomized to Management Strategies|Early termination|0
28116|NCT01493557|120628|P1|Not Randomized to Management Strategies|Early termination|0
28117|NCT01493557|120626|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
28118|NCT01493557|120627|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
28119|NCT01493557|120628|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
28120|NCT01493557|120626|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
28121|NCT01493557|120627|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
28122|NCT01493557|120628|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
28123|NCT01493557|120626|P3|Not Randomized to Management Strategies|Protocol Violation|1
28124|NCT01493557|120627|P2|Not Randomized to Management Strategies|Protocol Violation|0
28125|NCT01493557|120628|P1|Not Randomized to Management Strategies|Protocol Violation|0
28126|NCT01493557|120626|P3|Not Randomized to Management Strategies|Other adverse event|54
28127|NCT01493557|120627|P2|Not Randomized to Management Strategies|Other adverse event|0
28128|NCT01493557|120628|P1|Not Randomized to Management Strategies|Other adverse event|0
28129|NCT01493557|120626|P3|Not Randomized to Management Strategies|Worsening of other pre−existing disease|9
28130|NCT01493557|120627|P2|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
28131|NCT01493557|120628|P1|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
28132|NCT01493557|120626|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
28133|NCT01493557|120627|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
28134|NCT01493557|120628|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
28135|NCT01493531|120656|P3|Overall Study|Death|0
28136|NCT01493531|120657|P2|Overall Study|Death|1
28137|NCT01493531|120658|P1|Overall Study|Death|0
28138|NCT01493531|120656|P3|Overall Study|Withdrawal by Subject|11
28139|NCT01493531|120657|P2|Overall Study|Withdrawal by Subject|13
28140|NCT01493531|120658|P1|Overall Study|Withdrawal by Subject|16
28141|NCT01493531|120656|P3|Overall Study|Lost to Follow-up|11
28142|NCT01493531|120657|P2|Overall Study|Lost to Follow-up|7
28143|NCT01493531|120658|P1|Overall Study|Lost to Follow-up|5
28144|NCT01493531|120656|P3|Overall Study|Sponsor terminated study|3
28145|NCT01493531|120657|P2|Overall Study|Sponsor terminated study|2
28146|NCT01493531|120658|P1|Overall Study|Sponsor terminated study|5
28147|NCT01493531|120656|P3|Overall Study|Protocol Violation|12
28148|NCT01493531|120657|P2|Overall Study|Protocol Violation|15
28149|NCT01493531|120658|P1|Overall Study|Protocol Violation|8
28150|NCT01493531|120656|P3|Overall Study|Gout flare|2
28151|NCT01493531|120657|P2|Overall Study|Gout flare|0
28152|NCT01493531|120658|P1|Overall Study|Gout flare|3
28153|NCT01493531|120656|P3|Overall Study|Adverse Event|9
28154|NCT01493531|120657|P2|Overall Study|Adverse Event|12
28155|NCT01493531|120658|P1|Overall Study|Adverse Event|4
28156|NCT01493427|120672|P1|Overall Study|Other|2
28157|NCT01493427|120672|P1|Overall Study|Inability to Follow Instructions|2
28158|NCT01493427|120672|P1|Overall Study|Lost to Follow-up|2
28159|NCT01493427|120672|P1|Overall Study|Personal Reasons|4
28160|NCT01493427|120672|P1|Overall Study|Adverse Event|10
28161|NCT01493089|120692|P2|Overall Study|Physician Decision|1
28162|NCT01493089|120693|P1|Overall Study|Physician Decision|0
28163|NCT01493089|120692|P2|Overall Study|Withdrawal by Subject|0
28164|NCT01493089|120693|P1|Overall Study|Withdrawal by Subject|1
28165|NCT01493089|120692|P2|Overall Study|Protocol Violation|2
28166|NCT01493089|120693|P1|Overall Study|Protocol Violation|2
28167|NCT01492439|120711|P2|Overall Study|Withdrew from RTE|9
28168|NCT01492439|120712|P1|Overall Study|Withdrew from RTE|4
28169|NCT01492426|120760|P2|Follow-Up|Lost to Follow-up|6
28170|NCT01492426|120761|P1|Follow-Up|Lost to Follow-up|12
28171|NCT01492426|120760|P2|Follow-Up|Participant Withdrew Consent|1
28172|NCT01492426|120761|P1|Follow-Up|Participant Withdrew Consent|6
28173|NCT01492426|120760|P2|Follow-Up|Unspecified|2
28174|NCT01492426|120761|P1|Follow-Up|Unspecified|4
28175|NCT01492426|120760|P2|Follow-Up|Death|0
28176|NCT01492426|120761|P1|Follow-Up|Death|1
28177|NCT01492426|120760|P2|Follow-Up|Protocol Requires no Follow-Up|1
28178|NCT01492426|120761|P1|Follow-Up|Protocol Requires no Follow-Up|2
28179|NCT01492426|120760|P2|Treatment|Participant does not meet study criteria|0
28180|NCT01492426|120761|P1|Treatment|Participant does not meet study criteria|1
28181|NCT01492426|120760|P2|Treatment|Lost to Follow-up|4
28182|NCT01492426|120761|P1|Treatment|Lost to Follow-up|9
28183|NCT01492426|120760|P2|Treatment|Subject requested discontinue study drug|3
28184|NCT01492426|120761|P1|Treatment|Subject requested discontinue study drug|7
28185|NCT01492426|120760|P2|Treatment|Poor compliance/noncompliance|0
28186|NCT01492426|120761|P1|Treatment|Poor compliance/noncompliance|1
28187|NCT01492426|120760|P2|Treatment|Participant withdrew consent|2
28188|NCT01492426|120761|P1|Treatment|Participant withdrew consent|1
28189|NCT01492426|120760|P2|Treatment|Lack of Efficacy|5
28190|NCT01492426|120761|P1|Treatment|Lack of Efficacy|38
28191|NCT01492426|120760|P2|Treatment|Adverse Event|25
28192|NCT01492426|120761|P1|Treatment|Adverse Event|25
28193|NCT01492426|120760|P2|Treatment|Unspecified|0
28194|NCT01492426|120761|P1|Treatment|Unspecified|1
28195|NCT01492426|120760|P2|Treatment|Death|1
28196|NCT01492426|120761|P1|Treatment|Death|0
28197|NCT01492400|120779|P2|Overall Study|Adverse Event|5
28198|NCT01492400|120780|P1|Overall Study|Adverse Event|10
28199|NCT01492400|120779|P2|Overall Study|Lack of Efficacy|1
28200|NCT01492400|120780|P1|Overall Study|Lack of Efficacy|1
28201|NCT01492400|120779|P2|Overall Study|Pregnancy|1
28202|NCT01492400|120780|P1|Overall Study|Pregnancy|0
28203|NCT01492400|120779|P2|Overall Study|Lost to Follow-up|1
28204|NCT01492400|120780|P1|Overall Study|Lost to Follow-up|3
28205|NCT01492400|120779|P2|Overall Study|Personal Reasons|5
28206|NCT01492400|120780|P1|Overall Study|Personal Reasons|0
28207|NCT01492400|120779|P2|Overall Study|Miscellaneous Reasons|3
28208|NCT01492400|120780|P1|Overall Study|Miscellaneous Reasons|2
28209|NCT01491919|120802|P3|Overall Study|Insufficient PK sampling|1
28210|NCT01491919|120803|P2|Overall Study|Insufficient PK sampling|2
28211|NCT01491919|120804|P1|Overall Study|Insufficient PK sampling|1
28212|NCT01491672|120853|P3|Overall Study|Death|0
28213|NCT01491672|120854|P2|Overall Study|Death|4
28214|NCT01491672|120855|P1|Overall Study|Death|0
28215|NCT01491672|120853|P3|Overall Study|Protocol deviation|0
28216|NCT01491672|120854|P2|Overall Study|Protocol deviation|1
28217|NCT01491672|120855|P1|Overall Study|Protocol deviation|0
28218|NCT01491672|120853|P3|Overall Study|Disease progression|6
28219|NCT01491672|120854|P2|Overall Study|Disease progression|34
28220|NCT01491672|120855|P1|Overall Study|Disease progression|42
28221|NCT01491672|120853|P3|Overall Study|Adverse Event|4
28222|NCT01491672|120854|P2|Overall Study|Adverse Event|10
28223|NCT01491672|120855|P1|Overall Study|Adverse Event|8
28224|NCT01491672|120853|P3|Overall Study|Withdrawal by Subject|0
28225|NCT01491672|120854|P2|Overall Study|Withdrawal by Subject|7
28226|NCT01491672|120855|P1|Overall Study|Withdrawal by Subject|6
28227|NCT01491672|120853|P3|Overall Study|Lost to Follow-up|1
28228|NCT01491672|120854|P2|Overall Study|Lost to Follow-up|4
28229|NCT01491672|120855|P1|Overall Study|Lost to Follow-up|0
28230|NCT01491607|120892|P1|Overall Study|Withdrawal by Subject|3
28231|NCT01491607|120892|P1|Overall Study|Lost to Follow-up|7
28232|NCT01491035|121101|P8|Overall Study|Lost to Follow-up|0
28233|NCT01491035|121102|P7|Overall Study|Lost to Follow-up|0
28234|NCT01491035|121103|P6|Overall Study|Lost to Follow-up|0
28235|NCT01491035|121104|P5|Overall Study|Lost to Follow-up|1
28236|NCT01491035|121105|P4|Overall Study|Lost to Follow-up|0
28237|NCT01491035|121106|P3|Overall Study|Lost to Follow-up|0
28238|NCT01491035|121107|P2|Overall Study|Lost to Follow-up|0
28239|NCT01491035|121108|P1|Overall Study|Lost to Follow-up|0
28240|NCT01490866|121190|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
28241|NCT01490866|121190|P1|Axitinib Maintenance Therapy|Protocol Violation|2
28242|NCT01490866|121190|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
28243|NCT01490866|121190|P1|Axitinib Maintenance Therapy|Adverse Event|12
28244|NCT01490866|121190|P1|Axitinib Maintenance Therapy|Disease Progression|30
28245|NCT01490866|121190|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
28246|NCT01490866|121190|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
28247|NCT01490866|121190|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
28248|NCT01490866|121190|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
28249|NCT01490866|121190|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
28250|NCT01490866|121190|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
28251|NCT01490840|121201|P2|Phase 2|Adverse Event|1
28252|NCT01490840|121202|P1|Phase 2|Adverse Event|1
28253|NCT01490840|121201|P2|Phase 2|Lost to Follow-up|1
28254|NCT01490840|121202|P1|Phase 2|Lost to Follow-up|1
28255|NCT01490840|121201|P2|Phase 2|Permanent interruption of fingolimod|1
28256|NCT01490840|121202|P1|Phase 2|Permanent interruption of fingolimod|0
28257|NCT01490840|121201|P2|Phase 2|Withdrawal by Subject|3
28258|NCT01490840|121202|P1|Phase 2|Withdrawal by Subject|4
28259|NCT01490840|121201|P2|Phase 1|Visit 6a omitted|0
28260|NCT01490840|121202|P1|Phase 1|Visit 6a omitted|1
28261|NCT01490840|121201|P2|Phase 1|Withdrawal by Subject|5
28262|NCT01490840|121202|P1|Phase 1|Withdrawal by Subject|6
28263|NCT01490840|121201|P2|Phase 1|Adverse Event|1
28264|NCT01490840|121202|P1|Phase 1|Adverse Event|2
28265|NCT01490840|121201|P2|Phase 1|Lost to Follow-up|0
28266|NCT01490840|121202|P1|Phase 1|Lost to Follow-up|1
28267|NCT01490294|121228|P4|Overall Study|Adverse Event|0
28268|NCT01490294|121229|P3|Overall Study|Adverse Event|0
28269|NCT01490294|121230|P2|Overall Study|Adverse Event|0
28270|NCT01490294|121231|P1|Overall Study|Adverse Event|1
28271|NCT01490294|121228|P4|Overall Study|Prematurely discontinuation|1
28272|NCT01490294|121229|P3|Overall Study|Prematurely discontinuation|1
28273|NCT01490294|121230|P2|Overall Study|Prematurely discontinuation|0
28274|NCT01490294|121231|P1|Overall Study|Prematurely discontinuation|4
28275|NCT01490190|121465|P1|Overall Study|Ring expulsion|2
28276|NCT01490190|121465|P1|Overall Study|Inconvenience|1
28277|NCT01490190|121465|P1|Overall Study|Relocation|1
28278|NCT01490190|121465|P1|Overall Study|Lost to Follow-up|13
28279|NCT01490190|121465|P1|Overall Study|Protocol Violation|5
28280|NCT01490190|121465|P1|Overall Study|Adverse Event|17
28281|NCT01490190|121465|P1|Overall Study|Withdrawal by Subject|9
28282|NCT01490125|121486|P6|Period III|Lack of Efficacy|0
28283|NCT01490125|121487|P5|Period III|Lack of Efficacy|1
28284|NCT01490125|121488|P4|Period III|Lack of Efficacy|0
28285|NCT01490125|121489|P3|Period III|Lack of Efficacy|0
28286|NCT01490125|121490|P2|Period III|Lack of Efficacy|0
28287|NCT01490125|121491|P1|Period III|Lack of Efficacy|0
28288|NCT01490125|121486|P6|Period III|Death|0
28289|NCT01490125|121487|P5|Period III|Death|0
28290|NCT01490125|121488|P4|Period III|Death|1
28291|NCT01490125|121489|P3|Period III|Death|0
28292|NCT01490125|121490|P2|Period III|Death|0
28293|NCT01490125|121491|P1|Period III|Death|0
28294|NCT01490125|121486|P6|Period III|Adverse Event|0
28295|NCT01490125|121487|P5|Period III|Adverse Event|0
28296|NCT01490125|121488|P4|Period III|Adverse Event|1
28297|NCT01490125|121489|P3|Period III|Adverse Event|0
28298|NCT01490125|121490|P2|Period III|Adverse Event|1
28299|NCT01490125|121491|P1|Period III|Adverse Event|3
28300|NCT01490125|121486|P6|Period II|Withdrawal by Subject|0
28301|NCT01490125|121487|P5|Period II|Withdrawal by Subject|0
28302|NCT01490125|121488|P4|Period II|Withdrawal by Subject|0
28303|NCT01490125|121489|P3|Period II|Withdrawal by Subject|0
28304|NCT01490125|121490|P2|Period II|Withdrawal by Subject|0
28305|NCT01490125|121491|P1|Period II|Withdrawal by Subject|1
28306|NCT01490125|121486|P6|Period II|Lost to Follow-up|0
28307|NCT01490125|121487|P5|Period II|Lost to Follow-up|0
28308|NCT01490125|121488|P4|Period II|Lost to Follow-up|0
28309|NCT01490125|121489|P3|Period II|Lost to Follow-up|0
28310|NCT01490125|121490|P2|Period II|Lost to Follow-up|1
28311|NCT01490125|121491|P1|Period II|Lost to Follow-up|0
28312|NCT01490125|121486|P6|Period II|Protocol Violation|0
28313|NCT01490125|121487|P5|Period II|Protocol Violation|0
28314|NCT01490125|121488|P4|Period II|Protocol Violation|1
28315|NCT01490125|121489|P3|Period II|Protocol Violation|1
28316|NCT01490125|121490|P2|Period II|Protocol Violation|0
28317|NCT01490125|121491|P1|Period II|Protocol Violation|0
28318|NCT01490125|121486|P6|Period II|Adverse Event|2
28319|NCT01490125|121487|P5|Period II|Adverse Event|4
28320|NCT01490125|121488|P4|Period II|Adverse Event|2
28321|NCT01490125|121489|P3|Period II|Adverse Event|2
28322|NCT01490125|121490|P2|Period II|Adverse Event|3
28323|NCT01490125|121491|P1|Period II|Adverse Event|2
28324|NCT01490125|121486|P6|Period I|Withdrawal by Subject|1
28325|NCT01490125|121487|P5|Period I|Withdrawal by Subject|2
28326|NCT01490125|121488|P4|Period I|Withdrawal by Subject|1
28327|NCT01490125|121489|P3|Period I|Withdrawal by Subject|2
28328|NCT01490125|121490|P2|Period I|Withdrawal by Subject|3
28329|NCT01490125|121491|P1|Period I|Withdrawal by Subject|1
28330|NCT01490125|121486|P6|Period I|Protocol Violation|0
28331|NCT01490125|121487|P5|Period I|Protocol Violation|0
28332|NCT01490125|121488|P4|Period I|Protocol Violation|1
28333|NCT01490125|121489|P3|Period I|Protocol Violation|1
28334|NCT01490125|121490|P2|Period I|Protocol Violation|1
28335|NCT01490125|121491|P1|Period I|Protocol Violation|1
28336|NCT01490125|121486|P6|Period I|Adverse Event|4
28337|NCT01490125|121487|P5|Period I|Adverse Event|2
28338|NCT01490125|121488|P4|Period I|Adverse Event|3
28339|NCT01490125|121489|P3|Period I|Adverse Event|1
28340|NCT01490125|121490|P2|Period I|Adverse Event|1
28341|NCT01490125|121491|P1|Period I|Adverse Event|4
28342|NCT01490086|121519|P5|Overall Study|Subject left hospital|0
28343|NCT01490086|121520|P4|Overall Study|Subject left hospital|1
28344|NCT01490086|121521|P3|Overall Study|Subject left hospital|0
28345|NCT01490086|121522|P2|Overall Study|Subject left hospital|1
28346|NCT01490086|121523|P1|Overall Study|Subject left hospital|0
28347|NCT01490086|121519|P5|Overall Study|Subject uncontrollable and abusive|0
28348|NCT01490086|121520|P4|Overall Study|Subject uncontrollable and abusive|0
28349|NCT01490086|121521|P3|Overall Study|Subject uncontrollable and abusive|0
28350|NCT01490086|121522|P2|Overall Study|Subject uncontrollable and abusive|1
28351|NCT01490086|121523|P1|Overall Study|Subject uncontrollable and abusive|0
28352|NCT01490086|121519|P5|Overall Study|Worsening of symptoms|0
28353|NCT01490086|121520|P4|Overall Study|Worsening of symptoms|1
28354|NCT01490086|121521|P3|Overall Study|Worsening of symptoms|0
28355|NCT01490086|121522|P2|Overall Study|Worsening of symptoms|1
28356|NCT01490086|121523|P1|Overall Study|Worsening of symptoms|0
28357|NCT01490086|121519|P5|Overall Study|Lack of Efficacy|8
28358|NCT01490086|121520|P4|Overall Study|Lack of Efficacy|0
28359|NCT01490086|121521|P3|Overall Study|Lack of Efficacy|1
28360|NCT01490086|121522|P2|Overall Study|Lack of Efficacy|3
28361|NCT01490086|121523|P1|Overall Study|Lack of Efficacy|0
28362|NCT01490086|121519|P5|Overall Study|Adverse Event|0
28363|NCT01490086|121520|P4|Overall Study|Adverse Event|2
28364|NCT01490086|121521|P3|Overall Study|Adverse Event|1
28365|NCT01490086|121522|P2|Overall Study|Adverse Event|0
28366|NCT01490086|121523|P1|Overall Study|Adverse Event|0
28367|NCT01490086|121519|P5|Overall Study|Physician Decision|1
28368|NCT01490086|121520|P4|Overall Study|Physician Decision|3
28369|NCT01490086|121521|P3|Overall Study|Physician Decision|2
28370|NCT01490086|121522|P2|Overall Study|Physician Decision|4
28371|NCT01490086|121523|P1|Overall Study|Physician Decision|3
28372|NCT01490086|121519|P5|Overall Study|Lost to Follow-up|1
28373|NCT01490086|121520|P4|Overall Study|Lost to Follow-up|0
28374|NCT01490086|121521|P3|Overall Study|Lost to Follow-up|0
28375|NCT01490086|121522|P2|Overall Study|Lost to Follow-up|0
28376|NCT01490086|121523|P1|Overall Study|Lost to Follow-up|0
28377|NCT01490086|121519|P5|Overall Study|Abnormal laboratory findings|0
28378|NCT01490086|121520|P4|Overall Study|Abnormal laboratory findings|0
28379|NCT01490086|121521|P3|Overall Study|Abnormal laboratory findings|0
28380|NCT01490086|121522|P2|Overall Study|Abnormal laboratory findings|0
28381|NCT01490086|121523|P1|Overall Study|Abnormal laboratory findings|1
28382|NCT01490086|121519|P5|Overall Study|Non-compliance|0
28383|NCT01490086|121520|P4|Overall Study|Non-compliance|0
28384|NCT01490086|121521|P3|Overall Study|Non-compliance|0
28385|NCT01490086|121522|P2|Overall Study|Non-compliance|1
28386|NCT01490086|121523|P1|Overall Study|Non-compliance|0
28387|NCT01490086|121519|P5|Overall Study|Consent withdrawn|1
28388|NCT01490086|121520|P4|Overall Study|Consent withdrawn|0
28389|NCT01490086|121521|P3|Overall Study|Consent withdrawn|3
28390|NCT01490086|121522|P2|Overall Study|Consent withdrawn|4
28391|NCT01490086|121523|P1|Overall Study|Consent withdrawn|4
28392|NCT01490060|121557|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
28393|NCT01490060|121558|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
28394|NCT01490060|121559|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
28395|NCT01490060|121560|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
28396|NCT01490060|121557|P4|Cycle 2|Non-Compliance|0
28397|NCT01490060|121558|P3|Cycle 2|Non-Compliance|1
28398|NCT01490060|121559|P2|Cycle 2|Non-Compliance|0
28399|NCT01490060|121560|P1|Cycle 2|Non-Compliance|0
28400|NCT01490060|121557|P4|Cycle 2|Change of Treatment|0
28401|NCT01490060|121558|P3|Cycle 2|Change of Treatment|0
28402|NCT01490060|121559|P2|Cycle 2|Change of Treatment|1
28403|NCT01490060|121560|P1|Cycle 2|Change of Treatment|1
28404|NCT01490060|121557|P4|Cycle 1|Treatment at Another Facility|1
28405|NCT01490060|121558|P3|Cycle 1|Treatment at Another Facility|0
28406|NCT01490060|121559|P2|Cycle 1|Treatment at Another Facility|0
28407|NCT01490060|121560|P1|Cycle 1|Treatment at Another Facility|0
28408|NCT01490060|121557|P4|Cycle 1|Withdrawal by Subject|1
28409|NCT01490060|121558|P3|Cycle 1|Withdrawal by Subject|0
28410|NCT01490060|121559|P2|Cycle 1|Withdrawal by Subject|0
28411|NCT01490060|121560|P1|Cycle 1|Withdrawal by Subject|0
28412|NCT01490060|121557|P4|Cycle 1|Insurance Denied|0
28413|NCT01490060|121558|P3|Cycle 1|Insurance Denied|2
28414|NCT01490060|121559|P2|Cycle 1|Insurance Denied|0
28415|NCT01490060|121560|P1|Cycle 1|Insurance Denied|0
28416|NCT01490060|121557|P4|Cycle 1|Change of Treatment|1
28417|NCT01490060|121558|P3|Cycle 1|Change of Treatment|1
28418|NCT01490060|121559|P2|Cycle 1|Change of Treatment|1
28419|NCT01490060|121560|P1|Cycle 1|Change of Treatment|0
28420|NCT01489956|121570|P3|Overall Study|Withdrawal by Subject|1
28421|NCT01489956|121571|P2|Overall Study|Withdrawal by Subject|0
28422|NCT01489956|121572|P1|Overall Study|Withdrawal by Subject|0
28423|NCT01489956|121570|P3|Overall Study|Lost to Follow-up|0
28424|NCT01489956|121571|P2|Overall Study|Lost to Follow-up|0
28425|NCT01489956|121572|P1|Overall Study|Lost to Follow-up|1
28426|NCT01489891|121609|P2|Overall Study|Endoscopy failure|0
28427|NCT01489891|121610|P1|Overall Study|Endoscopy failure|1
28428|NCT01489527|121748|P2|Overall Study|Not compliant|0
28429|NCT01489527|121749|P1|Overall Study|Not compliant|1
28430|NCT01489527|121748|P2|Overall Study|Procedures|0
28431|NCT01489527|121749|P1|Overall Study|Procedures|1
28432|NCT01489527|121748|P2|Overall Study|Lost to Follow-up|1
28433|NCT01489527|121749|P1|Overall Study|Lost to Follow-up|5
28434|NCT01489527|121748|P2|Overall Study|Withdrawal by Subject|4
28435|NCT01489527|121749|P1|Overall Study|Withdrawal by Subject|0
28436|NCT01489527|121748|P2|Overall Study|Participant moved|7
28437|NCT01489527|121749|P1|Overall Study|Participant moved|6
28438|NCT01489527|121748|P2|Overall Study|Pregnancy|14
28439|NCT01489527|121749|P1|Overall Study|Pregnancy|9
28440|NCT01489358|121766|P3|Overall Study|Lost to Follow-up|2
28441|NCT01489358|121767|P2|Overall Study|Lost to Follow-up|0
28442|NCT01489358|121768|P1|Overall Study|Lost to Follow-up|0
28443|NCT01489254|121818|P4|Open-label Extension Part|Other reasons for not completing study|5
28444|NCT01489254|121819|P3|Open-label Extension Part|Other reasons for not completing study|0
28445|NCT01489254|121820|P2|Open-label Extension Part|Other reasons for not completing study|0
28446|NCT01489254|121821|P1|Open-label Extension Part|Other reasons for not completing study|0
28447|NCT01489254|121818|P4|Open-label Extension Part|Lost to Follow-up|9
28448|NCT01489254|121819|P3|Open-label Extension Part|Lost to Follow-up|0
28449|NCT01489254|121820|P2|Open-label Extension Part|Lost to Follow-up|0
28450|NCT01489254|121821|P1|Open-label Extension Part|Lost to Follow-up|0
28451|NCT01489254|121818|P4|Open-label Extension Part|Protocol Violation|1
28452|NCT01489254|121819|P3|Open-label Extension Part|Protocol Violation|0
28453|NCT01489254|121820|P2|Open-label Extension Part|Protocol Violation|0
28454|NCT01489254|121821|P1|Open-label Extension Part|Protocol Violation|0
28455|NCT01489254|121818|P4|Open-label Extension Part|Withdrawal by Subject|30
28456|NCT01489254|121819|P3|Open-label Extension Part|Withdrawal by Subject|0
28457|NCT01489254|121820|P2|Open-label Extension Part|Withdrawal by Subject|0
28458|NCT01489254|121821|P1|Open-label Extension Part|Withdrawal by Subject|0
28459|NCT01489254|121818|P4|Open-label Extension Part|Pregnancy|3
28460|NCT01489254|121819|P3|Open-label Extension Part|Pregnancy|0
28461|NCT01489254|121820|P2|Open-label Extension Part|Pregnancy|0
28462|NCT01489254|121821|P1|Open-label Extension Part|Pregnancy|0
28463|NCT01489254|121818|P4|Open-label Extension Part|Adverse Event|10
28464|NCT01489254|121819|P3|Open-label Extension Part|Adverse Event|0
28465|NCT01489254|121820|P2|Open-label Extension Part|Adverse Event|0
28466|NCT01489254|121821|P1|Open-label Extension Part|Adverse Event|0
28467|NCT01489254|121818|P4|Double-blind Part|Other reasons for not completing study|0
28468|NCT01489254|121819|P3|Double-blind Part|Other reasons for not completing study|0
28469|NCT01489254|121820|P2|Double-blind Part|Other reasons for not completing study|6
28470|NCT01489254|121821|P1|Double-blind Part|Other reasons for not completing study|4
28471|NCT01489254|121818|P4|Double-blind Part|Lost to Follow-up|0
28472|NCT01489254|121819|P3|Double-blind Part|Lost to Follow-up|0
28473|NCT01489254|121820|P2|Double-blind Part|Lost to Follow-up|2
28474|NCT01489254|121821|P1|Double-blind Part|Lost to Follow-up|1
28475|NCT01489254|121818|P4|Double-blind Part|Withdrawal by Subject|0
28476|NCT01489254|121819|P3|Double-blind Part|Withdrawal by Subject|1
28477|NCT01489254|121820|P2|Double-blind Part|Withdrawal by Subject|20
28478|NCT01489254|121821|P1|Double-blind Part|Withdrawal by Subject|12
28479|NCT01489254|121818|P4|Double-blind Part|Pregnancy|0
28480|NCT01489254|121819|P3|Double-blind Part|Pregnancy|0
28481|NCT01489254|121820|P2|Double-blind Part|Pregnancy|3
28482|NCT01489254|121821|P1|Double-blind Part|Pregnancy|1
28483|NCT01489254|121818|P4|Double-blind Part|Adverse Event|0
28484|NCT01489254|121819|P3|Double-blind Part|Adverse Event|2
28485|NCT01489254|121820|P2|Double-blind Part|Adverse Event|2
28486|NCT01489254|121821|P1|Double-blind Part|Adverse Event|7
28487|NCT01489189|121832|P2|Overall Study|Missed Visit|4
28488|NCT01489189|121833|P1|Overall Study|Missed Visit|1
28489|NCT01489189|121832|P2|Overall Study|Death|8
28490|NCT01489189|121833|P1|Overall Study|Death|10
28491|NCT01489189|121832|P2|Overall Study|Withdrawal by Subject|23
28492|NCT01489189|121833|P1|Overall Study|Withdrawal by Subject|20
28493|NCT01488994|121860|P2|Overall Study|Withdrawal by Subject|1
28494|NCT01488994|121861|P1|Overall Study|Withdrawal by Subject|0
28495|NCT01488578|121965|P1|Overall Study|Protocol Violation|1836
28496|NCT01488487|121999|P1|Overall Study|Withdrawal by Subject|2
28497|NCT01488487|121999|P1|Overall Study|Death|1
28498|NCT01488487|121999|P1|Overall Study|Adverse Event|6
28499|NCT01488448|122008|P2|Overall Study|Protocol Violation|3
28500|NCT01488448|122009|P1|Overall Study|Protocol Violation|4
28501|NCT01488448|122008|P2|Overall Study|Physician Decision|9
28502|NCT01488448|122009|P1|Overall Study|Physician Decision|4
28503|NCT01488448|122008|P2|Overall Study|Adverse Event|4
28504|NCT01488448|122009|P1|Overall Study|Adverse Event|9
28505|NCT01488448|122008|P2|Overall Study|Withdrawal by Subject|1
28506|NCT01488448|122009|P1|Overall Study|Withdrawal by Subject|3
28507|NCT01488071|122075|P2|Overall Study|Administrative or Other Reason(s)|4
28508|NCT01488071|122076|P1|Overall Study|Administrative or Other Reason(s)|5
28509|NCT01488071|122075|P2|Overall Study|Lost to Follow-up|0
28510|NCT01488071|122076|P1|Overall Study|Lost to Follow-up|1
28511|NCT01488071|122075|P2|Overall Study|Withdrawal of Consent|12
28512|NCT01488071|122076|P1|Overall Study|Withdrawal of Consent|14
28513|NCT01488071|122075|P2|Overall Study|Protocol Violation|7
28514|NCT01488071|122076|P1|Overall Study|Protocol Violation|5
28515|NCT01488071|122075|P2|Overall Study|Non-compliance with study drug|0
28516|NCT01488071|122076|P1|Overall Study|Non-compliance with study drug|2
28517|NCT01488071|122075|P2|Overall Study|Lack of Efficacy|17
28518|NCT01488071|122076|P1|Overall Study|Lack of Efficacy|11
28519|NCT01488071|122075|P2|Overall Study|Adverse Event|23
28520|NCT01488071|122076|P1|Overall Study|Adverse Event|15
28521|NCT01487577|122130|P1|Overall Study|Became ineligible after signing consent|1
28522|NCT01487525|122144|P2|Overall Study|Withdrawal by Subject|1
28523|NCT01487525|122145|P1|Overall Study|Withdrawal by Subject|0
28524|NCT01486966|122163|P2|Overall Study|Withdrawal by Subject|1
28525|NCT01486966|122164|P1|Overall Study|Withdrawal by Subject|0
28526|NCT01486966|122163|P2|Overall Study|Adverse Event|1
28527|NCT01486966|122164|P1|Overall Study|Adverse Event|0
28528|NCT01486927|122188|P1|Overall Study|Subject did not reach 6 mo of treatment|1
28529|NCT01486927|122188|P1|Overall Study|Withdrawal by Subject|8
28530|NCT01486927|122188|P1|Overall Study|50 Exposure days not reached|2
28531|NCT01486927|122188|P1|Overall Study|Physician Decision|1
28532|NCT01486927|122188|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
28533|NCT01486446|122266|P2|Overall Study|Adverse Event|0
28534|NCT01486446|122267|P1|Overall Study|Adverse Event|1
28535|NCT01486238|122289|P2|Overall Study|Lost to Follow-up|3
28536|NCT01486238|122290|P1|Overall Study|Lost to Follow-up|0
28537|NCT01486238|122289|P2|Overall Study|Withdrawal by Subject|1
28538|NCT01486238|122290|P1|Overall Study|Withdrawal by Subject|2
28539|NCT01486238|122289|P2|Overall Study|Death|2
28540|NCT01486238|122290|P1|Overall Study|Death|0
28541|NCT01485991|122304|P2|Overall Study|randomized but not treated|2
28542|NCT01485991|122305|P1|Overall Study|randomized but not treated|6
28543|NCT01485991|122304|P2|Overall Study|Withdrawal by Subject|20
28544|NCT01485991|122305|P1|Overall Study|Withdrawal by Subject|13
28545|NCT01485991|122304|P2|Overall Study|Lost to Follow-up|10
28546|NCT01485991|122305|P1|Overall Study|Lost to Follow-up|13
28547|NCT01485991|122304|P2|Overall Study|Adverse Event|4
28548|NCT01485991|122305|P1|Overall Study|Adverse Event|0
28549|NCT01485887|122315|P1|Overall Study|Primary disease markedly improved|1
28550|NCT01485887|122315|P1|Overall Study|Deterioration of primary disease|1
28551|NCT01485887|122315|P1|Overall Study|Adverse Event|8
28552|NCT01485887|122315|P1|Overall Study|Withdrawal by Subject|2
28553|NCT01485640|122327|P1|Overall Study|Terminated by Sponsor|95
28554|NCT01485640|122327|P1|Overall Study|Withdrawal by Subject|14
28555|NCT01485640|122327|P1|Overall Study|Protocol Violation|1
28556|NCT01485640|122327|P1|Overall Study|Lack of Efficacy|2
28557|NCT01485640|122327|P1|Overall Study|Adverse Event|10
28558|NCT01485536|122332|P1|Overall Study|Adverse Event|1
28559|NCT01485536|122332|P1|Overall Study|Withdrawal by Subject|3
28560|NCT01485172|122347|P6|Overall Study|Withdrawal by Subject|1
28561|NCT01485172|122348|P5|Overall Study|Withdrawal by Subject|1
28562|NCT01485172|122349|P4|Overall Study|Withdrawal by Subject|1
28563|NCT01485172|122350|P3|Overall Study|Withdrawal by Subject|0
28564|NCT01485172|122351|P2|Overall Study|Withdrawal by Subject|0
28565|NCT01485172|122352|P1|Overall Study|Withdrawal by Subject|2
28566|NCT01485172|122347|P6|Overall Study|Physician Decision|0
28567|NCT01485172|122348|P5|Overall Study|Physician Decision|1
28568|NCT01485172|122349|P4|Overall Study|Physician Decision|0
28569|NCT01485172|122350|P3|Overall Study|Physician Decision|0
28570|NCT01485172|122351|P2|Overall Study|Physician Decision|0
28571|NCT01485172|122352|P1|Overall Study|Physician Decision|0
28572|NCT01485172|122347|P6|Overall Study|Lost to Follow-up|1
28573|NCT01485172|122348|P5|Overall Study|Lost to Follow-up|0
28574|NCT01485172|122349|P4|Overall Study|Lost to Follow-up|0
28575|NCT01485172|122350|P3|Overall Study|Lost to Follow-up|1
28576|NCT01485172|122351|P2|Overall Study|Lost to Follow-up|0
28577|NCT01485172|122352|P1|Overall Study|Lost to Follow-up|0
28578|NCT01485172|122347|P6|Overall Study|Protocol defined stopping criteria|0
28579|NCT01485172|122348|P5|Overall Study|Protocol defined stopping criteria|1
28580|NCT01485172|122349|P4|Overall Study|Protocol defined stopping criteria|0
28581|NCT01485172|122350|P3|Overall Study|Protocol defined stopping criteria|0
28582|NCT01485172|122351|P2|Overall Study|Protocol defined stopping criteria|0
28583|NCT01485172|122352|P1|Overall Study|Protocol defined stopping criteria|1
28584|NCT01485172|122347|P6|Overall Study|Protocol Violation|0
28585|NCT01485172|122348|P5|Overall Study|Protocol Violation|1
28586|NCT01485172|122349|P4|Overall Study|Protocol Violation|5
28587|NCT01485172|122350|P3|Overall Study|Protocol Violation|4
28588|NCT01485172|122351|P2|Overall Study|Protocol Violation|0
28589|NCT01485172|122352|P1|Overall Study|Protocol Violation|0
28590|NCT01485172|122347|P6|Overall Study|Lack of Efficacy|0
28591|NCT01485172|122348|P5|Overall Study|Lack of Efficacy|0
28592|NCT01485172|122349|P4|Overall Study|Lack of Efficacy|0
28593|NCT01485172|122350|P3|Overall Study|Lack of Efficacy|0
28594|NCT01485172|122351|P2|Overall Study|Lack of Efficacy|0
28595|NCT01485172|122352|P1|Overall Study|Lack of Efficacy|2
28596|NCT01485172|122347|P6|Overall Study|Adverse Event|2
28597|NCT01485172|122348|P5|Overall Study|Adverse Event|1
28598|NCT01485172|122349|P4|Overall Study|Adverse Event|2
28599|NCT01485172|122350|P3|Overall Study|Adverse Event|2
28600|NCT01485172|122351|P2|Overall Study|Adverse Event|1
28601|NCT01485172|122352|P1|Overall Study|Adverse Event|2
28602|NCT01485094|122429|P3|Overall Study|Withdrawal by Subject|0
28603|NCT01485094|122430|P2|Overall Study|Withdrawal by Subject|1
28604|NCT01485094|122431|P1|Overall Study|Withdrawal by Subject|1
28605|NCT01485094|122429|P3|Overall Study|Lost to Follow-up|0
28606|NCT01485094|122430|P2|Overall Study|Lost to Follow-up|0
28607|NCT01485094|122431|P1|Overall Study|Lost to Follow-up|1
28608|NCT01485094|122429|P3|Overall Study|Adverse Event|1
28609|NCT01485094|122430|P2|Overall Study|Adverse Event|1
28610|NCT01485094|122431|P1|Overall Study|Adverse Event|1
28611|NCT01484977|122472|P1|Overall Study|Lack of Compliance|1
28612|NCT01484977|122472|P1|Overall Study|Low White Blood Cell Count|1
28613|NCT01484977|122472|P1|Overall Study|Moving Overseas|1
28614|NCT01484977|122472|P1|Overall Study|Subject Protocol Non-compliant|1
28615|NCT01484977|122472|P1|Overall Study|Withdrawal by Subject|4
28616|NCT01484977|122472|P1|Overall Study|Lost to Follow-up|1
28617|NCT01484977|122472|P1|Overall Study|Protocol Violation|6
28618|NCT01484977|122472|P1|Overall Study|Lack of Efficacy|4
28619|NCT01484977|122472|P1|Overall Study|Adverse Event|8
28620|NCT01484951|122476|P1|Overall Study|Non-Compliance|1
28621|NCT01484951|122476|P1|Overall Study|Personal Reasons|1
28622|NCT01484951|122476|P1|Overall Study|Adverse Event|3
28623|NCT01484938|122481|P1|Overall Study|Noncompliance|1
28624|NCT01484938|122481|P1|Overall Study|Lost to Follow-up|1
28625|NCT01484938|122481|P1|Overall Study|Adverse Event|2
28626|NCT01484912|122488|P2|Overall Study|Physician Decision|1
28627|NCT01484912|122489|P1|Overall Study|Physician Decision|0
28628|NCT01484912|122488|P2|Overall Study|Withdrawal by Subject|0
28629|NCT01484912|122489|P1|Overall Study|Withdrawal by Subject|1
28630|NCT01484873|122499|P1|Overall Study|Withdrawal by Subject|2
28631|NCT01484561|122518|P2|Overall Study|Adverse Event|4
28632|NCT01484561|122519|P1|Overall Study|Adverse Event|1
28633|NCT01484561|122518|P2|Overall Study|Not specified|1
28634|NCT01484561|122519|P1|Overall Study|Not specified|1
28635|NCT01484561|122518|P2|Overall Study|Withdrawal by Subject|0
28636|NCT01484561|122519|P1|Overall Study|Withdrawal by Subject|3
28637|NCT01484561|122518|P2|Overall Study|Lost to Follow-up|0
28638|NCT01484561|122519|P1|Overall Study|Lost to Follow-up|1
28639|NCT01484561|122518|P2|Overall Study|Lack of Efficacy|1
28640|NCT01484561|122519|P1|Overall Study|Lack of Efficacy|3
28641|NCT01484197|122611|P4|Treatment Period 2|Subject withdrew consent|1
28642|NCT01484197|122612|P3|Treatment Period 2|Subject withdrew consent|0
28643|NCT01484197|122613|P2|Treatment Period 2|Subject withdrew consent|0
28644|NCT01484197|122614|P1|Treatment Period 2|Subject withdrew consent|0
28645|NCT01484197|122611|P4|Treatment Period 1|Adverse Event|0
28646|NCT01484197|122612|P3|Treatment Period 1|Adverse Event|0
28647|NCT01484197|122613|P2|Treatment Period 1|Adverse Event|0
28648|NCT01484197|122614|P1|Treatment Period 1|Adverse Event|1
28649|NCT01484132|122697|P1|Overall Study|No post-treatment urine sample collected|10
28650|NCT01484132|122697|P1|Overall Study|No pre-treatment urine sample collected|1
28651|NCT01484132|122697|P1|Overall Study|Ineligible|1
28652|NCT01484132|122697|P1|Overall Study|Difficulty with time commitment|2
28653|NCT01484132|122697|P1|Overall Study|Lost to Follow-up|8
28654|NCT01484054|122705|P2|Period 1|Withdrawal by Subject|1
28655|NCT01484054|122706|P1|Period 1|Withdrawal by Subject|0
28656|NCT01484028|122724|P4|Period 1|Lens Discomfort|0
28657|NCT01484028|122725|P3|Period 1|Lens Discomfort|0
28658|NCT01484028|122726|P2|Period 1|Lens Discomfort|1
28659|NCT01484028|122727|P1|Period 1|Lens Discomfort|0
28660|NCT01484028|122724|P4|Period 1|Non-Compliance to Protocol|1
28661|NCT01484028|122725|P3|Period 1|Non-Compliance to Protocol|0
28662|NCT01484028|122726|P2|Period 1|Non-Compliance to Protocol|1
28663|NCT01484028|122727|P1|Period 1|Non-Compliance to Protocol|0
28664|NCT01484028|122724|P4|Period 1|Lost to Follow-up|0
28665|NCT01484028|122725|P3|Period 1|Lost to Follow-up|0
28666|NCT01484028|122726|P2|Period 1|Lost to Follow-up|1
28667|NCT01484028|122727|P1|Period 1|Lost to Follow-up|0
28668|NCT01483937|122739|P2|Overall Study|Withdrawal by Subject|3
28669|NCT01483937|122740|P1|Overall Study|Withdrawal by Subject|4
28670|NCT01483924|122767|P5|Overall Study|Sponsor concern over ECG result|0
28671|NCT01483924|122768|P4|Overall Study|Sponsor concern over ECG result|1
28672|NCT01483924|122769|P3|Overall Study|Sponsor concern over ECG result|0
28673|NCT01483924|122770|P2|Overall Study|Sponsor concern over ECG result|0
28674|NCT01483924|122771|P1|Overall Study|Sponsor concern over ECG result|0
28675|NCT01483924|122767|P5|Overall Study|Non-compliance|1
28676|NCT01483924|122768|P4|Overall Study|Non-compliance|1
28677|NCT01483924|122769|P3|Overall Study|Non-compliance|0
28678|NCT01483924|122770|P2|Overall Study|Non-compliance|0
28679|NCT01483924|122771|P1|Overall Study|Non-compliance|0
28680|NCT01483924|122767|P5|Overall Study|Adverse Event|0
28681|NCT01483924|122768|P4|Overall Study|Adverse Event|1
28682|NCT01483924|122769|P3|Overall Study|Adverse Event|1
28683|NCT01483924|122770|P2|Overall Study|Adverse Event|0
28684|NCT01483924|122771|P1|Overall Study|Adverse Event|0
28685|NCT01483924|122767|P5|Overall Study|Withdrawal by Subject|1
28686|NCT01483924|122768|P4|Overall Study|Withdrawal by Subject|1
28687|NCT01483924|122769|P3|Overall Study|Withdrawal by Subject|0
28688|NCT01483924|122770|P2|Overall Study|Withdrawal by Subject|0
28689|NCT01483924|122771|P1|Overall Study|Withdrawal by Subject|2
28690|NCT01483820|122819|P1|Overall Study|Death|1
28691|NCT01483820|122819|P1|Overall Study|Adverse Event|1
28692|NCT01483820|122819|P1|Overall Study|Lack of Efficacy|6
28693|NCT01483651|122828|P6|Overall Study|Withdrawal by Subject|1
28694|NCT01483651|122829|P5|Overall Study|Withdrawal by Subject|0
28695|NCT01483651|122830|P4|Overall Study|Withdrawal by Subject|0
28696|NCT01483651|122831|P3|Overall Study|Withdrawal by Subject|1
28697|NCT01483651|122832|P2|Overall Study|Withdrawal by Subject|1
28698|NCT01483651|122833|P1|Overall Study|Withdrawal by Subject|0
28699|NCT01483625|122843|P2|Overall Study|Due to other reason|0
28700|NCT01483625|122844|P1|Overall Study|Due to other reason|1
28701|NCT01483625|122843|P2|Overall Study|Refused to continue medication|1
28702|NCT01483625|122844|P1|Overall Study|Refused to continue medication|2
28703|NCT01483625|122843|P2|Overall Study|Adverse Event|1
28704|NCT01483625|122844|P1|Overall Study|Adverse Event|1
28705|NCT01482910|122893|P2|Overall Study|Death|0
28706|NCT01482910|122894|P1|Overall Study|Death|1
28707|NCT01482910|122893|P2|Overall Study|Withdrawal by Subject|2
28708|NCT01482910|122894|P1|Overall Study|Withdrawal by Subject|7
28709|NCT01482910|122893|P2|Overall Study|Protocol Violation|1
28710|NCT01482910|122894|P1|Overall Study|Protocol Violation|1
28711|NCT01482910|122893|P2|Overall Study|Lost to Follow-up|1
28712|NCT01482910|122894|P1|Overall Study|Lost to Follow-up|0
28713|NCT01482910|122893|P2|Overall Study|Adverse Event|5
28714|NCT01482910|122894|P1|Overall Study|Adverse Event|6
28715|NCT01482884|122906|P2|Overall Study|Withdrawal by Subject|13
28716|NCT01482884|122907|P1|Overall Study|Withdrawal by Subject|8
28717|NCT01482884|122906|P2|Overall Study|Adverse Event|1
28718|NCT01482884|122907|P1|Overall Study|Adverse Event|2
28719|NCT01482884|122906|P2|Overall Study|Lack of Efficacy|1
28720|NCT01482884|122907|P1|Overall Study|Lack of Efficacy|0
28721|NCT01482884|122906|P2|Overall Study|Lost to Follow-up|2
28722|NCT01482884|122907|P1|Overall Study|Lost to Follow-up|2
28723|NCT01482884|122906|P2|Overall Study|Protocol Violation|0
28724|NCT01482884|122907|P1|Overall Study|Protocol Violation|1
28725|NCT01482884|122906|P2|Overall Study|Medical decision due to lack of efficacy|1
28726|NCT01482884|122907|P1|Overall Study|Medical decision due to lack of efficacy|0
28727|NCT01482819|122933|P1|Overall Study|Lost to Follow-up|2
28728|NCT01482767|122953|P2|Overall Study|Nurse error|0
28729|NCT01482767|122954|P1|Overall Study|Nurse error|1
28730|NCT01482767|122953|P2|Overall Study|Ineligible|5
28731|NCT01482767|122954|P1|Overall Study|Ineligible|0
28732|NCT01482767|122953|P2|Overall Study|Alternate HCV treatment|8
28733|NCT01482767|122954|P1|Overall Study|Alternate HCV treatment|7
28734|NCT01482767|122953|P2|Overall Study|Non-adherence to study requirements|7
28735|NCT01482767|122954|P1|Overall Study|Non-adherence to study requirements|4
28736|NCT01482767|122953|P2|Overall Study|Site closure|14
28737|NCT01482767|122954|P1|Overall Study|Site closure|22
28738|NCT01482767|122953|P2|Overall Study|Adverse Event|3
28739|NCT01482767|122954|P1|Overall Study|Adverse Event|0
28740|NCT01482767|122953|P2|Overall Study|Lost to Follow-up|6
28741|NCT01482767|122954|P1|Overall Study|Lost to Follow-up|12
28742|NCT01482767|122953|P2|Overall Study|Withdrawal by Subject|5
28743|NCT01482767|122954|P1|Overall Study|Withdrawal by Subject|7
28744|NCT01482767|122953|P2|Overall Study|Death|1
28745|NCT01482767|122954|P1|Overall Study|Death|1
28746|NCT01482429|122976|P2|Protocol|Protocol Violation|0
28747|NCT01482429|122977|P1|Protocol|Protocol Violation|275
28748|NCT01482429|122976|P2|Care Usual|Lost to Follow-up|1
28749|NCT01482429|122977|P1|Care Usual|Lost to Follow-up|0
28750|NCT01482429|122976|P2|Care Usual|Protocol Violation|172
28751|NCT01482429|122977|P1|Care Usual|Protocol Violation|0
28752|NCT01482312|122989|P3|Period 2, 90 Minutes of Wear|Unspecified|0
28753|NCT01482312|122990|P2|Period 2, 90 Minutes of Wear|Unspecified|0
28754|NCT01482312|122991|P1|Period 2, 90 Minutes of Wear|Unspecified|1
28755|NCT01482312|122989|P3|Period 1, 90 Minutes of Wear|Unspecified|0
28756|NCT01482312|122990|P2|Period 1, 90 Minutes of Wear|Unspecified|0
28757|NCT01482312|122991|P1|Period 1, 90 Minutes of Wear|Unspecified|1
28758|NCT01482065|123037|P2|Overall Study|Withdrawal by Subject|1
28759|NCT01482065|123038|P1|Overall Study|Withdrawal by Subject|0
28760|NCT01481896|123059|P1|Overall Study|Lost to Follow-up|12
28761|NCT01481324|123112|P3|Overall Study|Missing Data|2
28762|NCT01481324|123113|P2|Overall Study|Missing Data|2
28763|NCT01481324|123114|P1|Overall Study|Missing Data|0
28764|NCT01481116|123125|P3|Overall Study|Hypoglycemic Event|0
28765|NCT01481116|123126|P2|Overall Study|Hypoglycemic Event|0
28766|NCT01481116|123127|P1|Overall Study|Hypoglycemic Event|4
28767|NCT01481116|123125|P3|Overall Study|Death|0
28768|NCT01481116|123126|P2|Overall Study|Death|1
28769|NCT01481116|123127|P1|Overall Study|Death|2
28770|NCT01481116|123125|P3|Overall Study|Investigator's Discretion|0
28771|NCT01481116|123126|P2|Overall Study|Investigator's Discretion|0
28772|NCT01481116|123127|P1|Overall Study|Investigator's Discretion|2
28773|NCT01481116|123125|P3|Overall Study|Non-Compliant With Study Drug|1
28774|NCT01481116|123126|P2|Overall Study|Non-Compliant With Study Drug|1
28775|NCT01481116|123127|P1|Overall Study|Non-Compliant With Study Drug|0
28776|NCT01481116|123125|P3|Overall Study|Sponsor Decision|3
28777|NCT01481116|123126|P2|Overall Study|Sponsor Decision|1
28778|NCT01481116|123127|P1|Overall Study|Sponsor Decision|0
28779|NCT01481116|123125|P3|Overall Study|Investigator Decision|1
28780|NCT01481116|123126|P2|Overall Study|Investigator Decision|2
28781|NCT01481116|123127|P1|Overall Study|Investigator Decision|3
28782|NCT01481116|123125|P3|Overall Study|Participant Moved Out of Country|1
28783|NCT01481116|123126|P2|Overall Study|Participant Moved Out of Country|0
28784|NCT01481116|123127|P1|Overall Study|Participant Moved Out of Country|1
28785|NCT01481116|123125|P3|Overall Study|Participant Moved Out of Area|1
28786|NCT01481116|123126|P2|Overall Study|Participant Moved Out of Area|0
28787|NCT01481116|123127|P1|Overall Study|Participant Moved Out of Area|2
28788|NCT01481116|123125|P3|Overall Study|Participant Started Taking Glipizide|0
28789|NCT01481116|123126|P2|Overall Study|Participant Started Taking Glipizide|0
28790|NCT01481116|123127|P1|Overall Study|Participant Started Taking Glipizide|1
28791|NCT01481116|123125|P3|Overall Study|Unspecified|0
28792|NCT01481116|123126|P2|Overall Study|Unspecified|1
28793|NCT01481116|123127|P1|Overall Study|Unspecified|1
28794|NCT01481116|123125|P3|Overall Study|Contraindications|0
28795|NCT01481116|123126|P2|Overall Study|Contraindications|1
28796|NCT01481116|123127|P1|Overall Study|Contraindications|1
28797|NCT01481116|123125|P3|Overall Study|Lack of Efficacy|1
28798|NCT01481116|123126|P2|Overall Study|Lack of Efficacy|3
28799|NCT01481116|123127|P1|Overall Study|Lack of Efficacy|3
28800|NCT01481116|123125|P3|Overall Study|Pregnancy|1
28801|NCT01481116|123126|P2|Overall Study|Pregnancy|0
28802|NCT01481116|123127|P1|Overall Study|Pregnancy|0
28803|NCT01481116|123125|P3|Overall Study|Study Termination|713
28804|NCT01481116|123126|P2|Overall Study|Study Termination|729
28805|NCT01481116|123127|P1|Overall Study|Study Termination|730
28806|NCT01481116|123125|P3|Overall Study|Withdrawal by Subject|37
28807|NCT01481116|123126|P2|Overall Study|Withdrawal by Subject|33
28808|NCT01481116|123127|P1|Overall Study|Withdrawal by Subject|37
28809|NCT01481116|123125|P3|Overall Study|Lost to Follow-up|11
28810|NCT01481116|123126|P2|Overall Study|Lost to Follow-up|12
28811|NCT01481116|123127|P1|Overall Study|Lost to Follow-up|8
28812|NCT01481116|123125|P3|Overall Study|Major Protocol Deviation|1
28813|NCT01481116|123126|P2|Overall Study|Major Protocol Deviation|7
28814|NCT01481116|123127|P1|Overall Study|Major Protocol Deviation|3
28815|NCT01481116|123125|P3|Overall Study|Adverse Event|42
28816|NCT01481116|123126|P2|Overall Study|Adverse Event|26
28817|NCT01481116|123127|P1|Overall Study|Adverse Event|26
28818|NCT01480674|123153|P1|Overall Study|visit not done|10
28819|NCT01480674|123153|P1|Overall Study|Lost to Follow-up|2
28820|NCT01480674|123153|P1|Overall Study|Death|23
28821|NCT01480596|123167|P2|Overall Study|MG exacerbation or change in medication|2
28822|NCT01480596|123168|P1|Overall Study|MG exacerbation or change in medication|2
28823|NCT01480596|123167|P2|Overall Study|Adverse Event|0
28824|NCT01480596|123168|P1|Overall Study|Adverse Event|3
28825|NCT01480284|123216|P2|Overall Study|Physician Decision|0
28826|NCT01480284|123217|P1|Overall Study|Physician Decision|1
28827|NCT01480284|123216|P2|Overall Study|Lost to Follow-up|0
28828|NCT01480284|123217|P1|Overall Study|Lost to Follow-up|1
28829|NCT01480284|123216|P2|Overall Study|Study closed/terminated|0
28830|NCT01480284|123217|P1|Overall Study|Study closed/terminated|3
28831|NCT01480284|123216|P2|Overall Study|Adverse Event|0
28832|NCT01480284|123217|P1|Overall Study|Adverse Event|1
28833|NCT01480284|123216|P2|Overall Study|Withdrawal by Subject|0
28834|NCT01480284|123217|P1|Overall Study|Withdrawal by Subject|2
28835|NCT01480076|123267|P1|Overall Study|Not Specified|52
28836|NCT01480076|123267|P1|Overall Study|Investigator Decision|13
28837|NCT01480076|123267|P1|Overall Study|Lost to Follow-up|7
28838|NCT01480076|123267|P1|Overall Study|Withdrawal by Subject|105
28839|NCT01480076|123267|P1|Overall Study|Non-compliance With Study Protocol|15
28840|NCT01480076|123267|P1|Overall Study|Disease Progression|5
28841|NCT01480076|123267|P1|Overall Study|Death|2
28842|NCT01480076|123267|P1|Overall Study|Adverse Event|39
28843|NCT01480076|123267|P1|Overall Study|Run-in Failure|52
28844|NCT01479868|123386|P1|Overall Study|Initiation of new HCV Therapy|1
28845|NCT01479868|123386|P1|Overall Study|Sponsor's Decision|1
28846|NCT01479868|123386|P1|Overall Study|Withdrawal by Subject|1
28847|NCT01479868|123386|P1|Overall Study|Protocol Violation|1
28848|NCT01479868|123386|P1|Overall Study|Lost to Follow-up|4
28849|NCT01479868|123386|P1|Overall Study|Adverse Event|1
28850|NCT01479777|123401|P1|Overall Study|Physician Decision|2
28851|NCT01479764|123413|P2|Treated|Lost to Follow-up|2
28852|NCT01479764|123414|P1|Treated|Lost to Follow-up|0
28853|NCT01479764|123413|P2|Randomized|Withdrawal by Subject|0
28854|NCT01479764|123414|P1|Randomized|Withdrawal by Subject|1
28855|NCT01479764|123413|P2|Randomized|Adverse Event|1
28856|NCT01479764|123414|P1|Randomized|Adverse Event|1
28857|NCT01479595|123424|P2|Overall Study|Adverse Event|1
28858|NCT01479595|123425|P1|Overall Study|Adverse Event|2
28859|NCT01479595|123424|P2|Overall Study|Protocol deviation|1
28860|NCT01479595|123425|P1|Overall Study|Protocol deviation|0
28861|NCT01479530|123470|P2|Overall Study|Withdrawal of Consent|2
28862|NCT01479530|123471|P1|Overall Study|Withdrawal of Consent|3
28863|NCT01479530|123470|P2|Overall Study|Protocol Violation|3
28864|NCT01479530|123471|P1|Overall Study|Protocol Violation|2
28865|NCT01479530|123470|P2|Overall Study|Lack of Efficacy|1
28866|NCT01479530|123471|P1|Overall Study|Lack of Efficacy|0
28867|NCT01479530|123470|P2|Overall Study|Adverse Event|6
28868|NCT01479530|123471|P1|Overall Study|Adverse Event|5
28869|NCT01479374|123508|P3|Overall Study|Other|5
28870|NCT01479374|123509|P2|Overall Study|Other|4
28871|NCT01479374|123510|P1|Overall Study|Other|0
28872|NCT01479374|123508|P3|Overall Study|Decision Unrelated to Adverse Event|0
28873|NCT01479374|123509|P2|Overall Study|Decision Unrelated to Adverse Event|1
28874|NCT01479374|123510|P1|Overall Study|Decision Unrelated to Adverse Event|0
28875|NCT01479374|123508|P3|Overall Study|Lost to Follow-up|0
28876|NCT01479374|123509|P2|Overall Study|Lost to Follow-up|2
28877|NCT01479374|123510|P1|Overall Study|Lost to Follow-up|1
28878|NCT01479374|123508|P3|Overall Study|Adverse Event|0
28879|NCT01479374|123509|P2|Overall Study|Adverse Event|1
28880|NCT01479374|123510|P1|Overall Study|Adverse Event|2
28881|NCT01478971|123575|P1|Peginesatide Treatment Period|Other|4
28882|NCT01478971|123575|P1|Peginesatide Treatment Period|Lost to Follow-up|4
28883|NCT01478971|123575|P1|Peginesatide Treatment Period|Death|4
28884|NCT01478971|123575|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
28885|NCT01478971|123575|P1|Peginesatide Treatment Period|Adverse Event|1
28886|NCT01478971|123575|P1|Standard of Care Period|Other|4
28887|NCT01478971|123575|P1|Standard of Care Period|Lost to Follow-up|9
28888|NCT01478971|123575|P1|Standard of Care Period|Death|8
28889|NCT01478971|123575|P1|Standard of Care Period|Withdrawal by Subject|3
28890|NCT01478971|123575|P1|Standard of Care Period|Adverse Event|1
28891|NCT01478958|123592|P3|Overall Study|Unable to comply|2
28892|NCT01478958|123593|P2|Overall Study|Unable to comply|0
28893|NCT01478958|123594|P1|Overall Study|Unable to comply|0
28894|NCT01478958|123592|P3|Overall Study|Re-located|0
28895|NCT01478958|123593|P2|Overall Study|Re-located|1
28896|NCT01478958|123594|P1|Overall Study|Re-located|0
28897|NCT01478958|123592|P3|Overall Study|Weight loss|0
28898|NCT01478958|123593|P2|Overall Study|Weight loss|0
28899|NCT01478958|123594|P1|Overall Study|Weight loss|1
28900|NCT01478958|123592|P3|Overall Study|Withdrawal by Subject|1
28901|NCT01478958|123593|P2|Overall Study|Withdrawal by Subject|1
28902|NCT01478958|123594|P1|Overall Study|Withdrawal by Subject|1
28903|NCT01478828|123602|P1|Overall Study|Adverse Event|1
28904|NCT01478620|123607|P1|Overall Study|Lost to Follow-up|6
28905|NCT01478594|123613|P2|Overall Study|Study Closed by Sponsor|5
28906|NCT01478594|123614|P1|Overall Study|Study Closed by Sponsor|8
28907|NCT01478594|123613|P2|Overall Study|Withdrawal by Subject|3
28908|NCT01478594|123614|P1|Overall Study|Withdrawal by Subject|9
28909|NCT01478594|123613|P2|Overall Study|Lost to Follow-up|1
28910|NCT01478594|123614|P1|Overall Study|Lost to Follow-up|3
28911|NCT01478594|123613|P2|Overall Study|Death|18
28912|NCT01478594|123614|P1|Overall Study|Death|45
28913|NCT01478594|123613|P2|Overall Study|Randomized but Never Received Study Drug|1
28914|NCT01478594|123614|P1|Overall Study|Randomized but Never Received Study Drug|0
28915|NCT01478373|123686|P1|Survival Phase|Progressive Disease|27
28916|NCT01478373|123686|P1|Survival Phase|crossover to another study|2
28917|NCT01478373|123686|P1|Survival Phase|Protocol Violation|1
28918|NCT01478373|123686|P1|Survival Phase|Adverse Event|8
28919|NCT01478373|123686|P1|Treatment Phase|Protocol Violation|1
28920|NCT01478360|123699|P2|Overall Study|Administrative problems|2
28921|NCT01478360|123700|P1|Overall Study|Administrative problems|1
28922|NCT01478360|123699|P2|Overall Study|Adverse Event|1
28923|NCT01478360|123700|P1|Overall Study|Adverse Event|0
28924|NCT01478360|123699|P2|Overall Study|Lost to Follow-up|0
28925|NCT01478360|123700|P1|Overall Study|Lost to Follow-up|1
28926|NCT01478347|123706|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
28927|NCT01478347|123706|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
28928|NCT01478347|123706|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
28929|NCT01478087|123722|P1|Overall Study|due to sponsor closing study|1
28930|NCT01478048|123729|P2|Overall Study|Physician Decision|0
28931|NCT01478048|123730|P1|Overall Study|Physician Decision|1
28932|NCT01478048|123729|P2|Overall Study|Not reported|0
28933|NCT01478048|123730|P1|Overall Study|Not reported|1
28934|NCT01478048|123729|P2|Overall Study|no longer meets study criteria|0
28935|NCT01478048|123730|P1|Overall Study|no longer meets study criteria|1
28936|NCT01478048|123729|P2|Overall Study|poor/non-compliance|1
28937|NCT01478048|123730|P1|Overall Study|poor/non-compliance|1
28938|NCT01478048|123729|P2|Overall Study|non-specified|3
28939|NCT01478048|123730|P1|Overall Study|non-specified|1
28940|NCT01478048|123729|P2|Overall Study|Withdrawal by Subject|5
28941|NCT01478048|123730|P1|Overall Study|Withdrawal by Subject|2
28942|NCT01478048|123729|P2|Overall Study|subject request to discontinue treatment|5
28943|NCT01478048|123730|P1|Overall Study|subject request to discontinue treatment|1
28944|NCT01478048|123729|P2|Overall Study|Adverse Event|9
28945|NCT01478048|123730|P1|Overall Study|Adverse Event|1
28946|NCT01478048|123729|P2|Overall Study|study drug toxicity|13
28947|NCT01478048|123730|P1|Overall Study|study drug toxicity|8
28948|NCT01478048|123729|P2|Overall Study|Disease Progression|32
28949|NCT01478048|123730|P1|Overall Study|Disease Progression|46
28950|NCT01477892|123759|P2|Overall Study|Withdrawal by Subject|2
28951|NCT01477892|123760|P1|Overall Study|Withdrawal by Subject|0
28952|NCT01477853|123771|P3|Phase B|Study terminated by sponsor|11
28953|NCT01477853|123772|P2|Phase B|Study terminated by sponsor|10
28954|NCT01477853|123773|P1|Phase B|Study terminated by sponsor|12
28955|NCT01477853|123771|P3|Phase B|Lost to Follow-up|0
28956|NCT01477853|123772|P2|Phase B|Lost to Follow-up|1
28957|NCT01477853|123773|P1|Phase B|Lost to Follow-up|0
28958|NCT01477853|123771|P3|Phase A|Study terminated by sponsor|39
28959|NCT01477853|123772|P2|Phase A|Study terminated by sponsor|40
28960|NCT01477853|123773|P1|Phase A|Study terminated by sponsor|37
28961|NCT01477853|123771|P3|Phase A|Physician Decision|1
28962|NCT01477853|123772|P2|Phase A|Physician Decision|0
28963|NCT01477853|123773|P1|Phase A|Physician Decision|1
28964|NCT01477853|123771|P3|Phase A|Lost to Follow-up|2
28965|NCT01477853|123772|P2|Phase A|Lost to Follow-up|3
28966|NCT01477853|123773|P1|Phase A|Lost to Follow-up|4
28967|NCT01477853|123771|P3|Phase A|Adverse Event|2
28968|NCT01477853|123772|P2|Phase A|Adverse Event|2
28969|NCT01477853|123773|P1|Phase A|Adverse Event|1
28970|NCT01477749|123811|P1|Overall Study|Physician Decision|4
28971|NCT01475734|123921|P2|Overall Study|Physician Decision|1
28972|NCT01475734|123922|P1|Overall Study|Physician Decision|0
28973|NCT01475734|123921|P2|Overall Study|Protocol Violation|0
28974|NCT01475734|123922|P1|Overall Study|Protocol Violation|1
28975|NCT01475734|123921|P2|Overall Study|Withdrawal by Subject|0
28976|NCT01475734|123922|P1|Overall Study|Withdrawal by Subject|1
28977|NCT01475721|123950|P2|Overall Study|Withdrawal by Subject|8
28978|NCT01475721|123951|P1|Overall Study|Withdrawal by Subject|8
28979|NCT01475721|123950|P2|Overall Study|Death|6
28980|NCT01475721|123951|P1|Overall Study|Death|3
28981|NCT01476722|123981|P1|Overall Study|Adverse Event|1
28982|NCT01476696|123988|P3|Overall Study|Withdrawal by Subject|0
28983|NCT01476696|123989|P2|Overall Study|Withdrawal by Subject|0
28984|NCT01476696|123990|P1|Overall Study|Withdrawal by Subject|1
28985|NCT01476696|123988|P3|Overall Study|Sponsor decision|0
28986|NCT01476696|123989|P2|Overall Study|Sponsor decision|1
28987|NCT01476696|123990|P1|Overall Study|Sponsor decision|2
28988|NCT01476475|124006|P2|Overall Study|Other reasons|2
28989|NCT01476475|124007|P1|Overall Study|Other reasons|4
28990|NCT01476475|124006|P2|Overall Study|Poor compliance to protocol|1
28991|NCT01476475|124007|P1|Overall Study|Poor compliance to protocol|1
28992|NCT01476475|124006|P2|Overall Study|Adverse Event|0
28993|NCT01476475|124007|P1|Overall Study|Adverse Event|6
28994|NCT01475851|124436|P2|Overall Study|Protocol defined stopping criteria|0
28995|NCT01475851|124437|P1|Overall Study|Protocol defined stopping criteria|1
28996|NCT01475838|124465|P2|Extension Phase|Participant Noncompliance|0
28997|NCT01475838|124466|P1|Extension Phase|Participant Noncompliance|1
28998|NCT01475838|124465|P2|Randomized Phase|Protocol Violation|4
28999|NCT01475838|124466|P1|Randomized Phase|Protocol Violation|9
29000|NCT01475838|124465|P2|Randomized Phase|Participant Noncompliance|5
29001|NCT01475838|124466|P1|Randomized Phase|Participant Noncompliance|1
29002|NCT01475838|124465|P2|Randomized Phase|Lost to Follow-up|4
29003|NCT01475838|124466|P1|Randomized Phase|Lost to Follow-up|3
29004|NCT01475838|124465|P2|Randomized Phase|Withdrew Consent|14
29005|NCT01475838|124466|P1|Randomized Phase|Withdrew Consent|10
29006|NCT01475838|124465|P2|Randomized Phase|Investigators Discretion|2
29007|NCT01475838|124466|P1|Randomized Phase|Investigators Discretion|1
29008|NCT01475838|124465|P2|Randomized Phase|Pregnancy|1
29009|NCT01475838|124466|P1|Randomized Phase|Pregnancy|0
29010|NCT01475838|124465|P2|Randomized Phase|Adverse Event|1
29011|NCT01475838|124466|P1|Randomized Phase|Adverse Event|6
29012|NCT01475838|124465|P2|Randomized Phase|Randomized but Not Treated|5
29013|NCT01475838|124466|P1|Randomized Phase|Randomized but Not Treated|0
29014|NCT01475487|124481|P2|Overall Study|had to leave early for personal reasons|1
29015|NCT01475487|124482|P1|Overall Study|had to leave early for personal reasons|2
29016|NCT01475474|124494|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
29017|NCT01475474|124494|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
29018|NCT01475461|124505|P7|Treatment Period|Adverse Event|0
29019|NCT01475461|124506|P6|Treatment Period|Adverse Event|0
29020|NCT01475461|124507|P5|Treatment Period|Adverse Event|0
29021|NCT01475461|124508|P4|Treatment Period|Adverse Event|1
29022|NCT01475461|124509|P3|Treatment Period|Adverse Event|0
29023|NCT01475461|124510|P2|Treatment Period|Adverse Event|0
29024|NCT01475461|124511|P1|Treatment Period|Adverse Event|0
29025|NCT01475461|124505|P7|Treatment Period|Medication Error|0
29026|NCT01475461|124506|P6|Treatment Period|Medication Error|0
29027|NCT01475461|124507|P5|Treatment Period|Medication Error|0
29028|NCT01475461|124508|P4|Treatment Period|Medication Error|1
29029|NCT01475461|124509|P3|Treatment Period|Medication Error|0
29030|NCT01475461|124510|P2|Treatment Period|Medication Error|0
29031|NCT01475461|124511|P1|Treatment Period|Medication Error|0
29032|NCT01475461|124505|P7|Treatment Period|Lack of Efficacy|0
29033|NCT01475461|124506|P6|Treatment Period|Lack of Efficacy|1
29034|NCT01475461|124507|P5|Treatment Period|Lack of Efficacy|1
29035|NCT01475461|124508|P4|Treatment Period|Lack of Efficacy|2
29036|NCT01475461|124509|P3|Treatment Period|Lack of Efficacy|0
29037|NCT01475461|124510|P2|Treatment Period|Lack of Efficacy|2
29038|NCT01475461|124511|P1|Treatment Period|Lack of Efficacy|0
29039|NCT01475461|124505|P7|Treatment Period|Protocol Violation|1
29040|NCT01475461|124506|P6|Treatment Period|Protocol Violation|0
29041|NCT01475461|124507|P5|Treatment Period|Protocol Violation|0
29042|NCT01475461|124508|P4|Treatment Period|Protocol Violation|0
29043|NCT01475461|124509|P3|Treatment Period|Protocol Violation|0
29044|NCT01475461|124510|P2|Treatment Period|Protocol Violation|1
29045|NCT01475461|124511|P1|Treatment Period|Protocol Violation|0
29046|NCT01475461|124505|P7|Treatment Period|Unspecified|0
29047|NCT01475461|124506|P6|Treatment Period|Unspecified|0
29048|NCT01475461|124507|P5|Treatment Period|Unspecified|0
29049|NCT01475461|124508|P4|Treatment Period|Unspecified|0
29050|NCT01475461|124509|P3|Treatment Period|Unspecified|0
29051|NCT01475461|124510|P2|Treatment Period|Unspecified|1
29052|NCT01475461|124511|P1|Treatment Period|Unspecified|0
29053|NCT01475461|124505|P7|Treatment Period|Withdrawal by Subject|0
29054|NCT01475461|124506|P6|Treatment Period|Withdrawal by Subject|2
29055|NCT01475461|124507|P5|Treatment Period|Withdrawal by Subject|2
29056|NCT01475461|124508|P4|Treatment Period|Withdrawal by Subject|0
29057|NCT01475461|124509|P3|Treatment Period|Withdrawal by Subject|2
29058|NCT01475461|124510|P2|Treatment Period|Withdrawal by Subject|2
29059|NCT01475461|124511|P1|Treatment Period|Withdrawal by Subject|0
29060|NCT01475461|124505|P7|Treatment Period|Lost to Follow-up|1
29061|NCT01475461|124506|P6|Treatment Period|Lost to Follow-up|2
29062|NCT01475461|124507|P5|Treatment Period|Lost to Follow-up|1
29063|NCT01475461|124508|P4|Treatment Period|Lost to Follow-up|3
29064|NCT01475461|124509|P3|Treatment Period|Lost to Follow-up|2
29065|NCT01475461|124510|P2|Treatment Period|Lost to Follow-up|3
29066|NCT01475461|124511|P1|Treatment Period|Lost to Follow-up|0
29067|NCT01475461|124505|P7|Treatment Period|Death|0
29068|NCT01475461|124506|P6|Treatment Period|Death|0
29069|NCT01475461|124507|P5|Treatment Period|Death|0
29070|NCT01475461|124508|P4|Treatment Period|Death|1
29071|NCT01475461|124509|P3|Treatment Period|Death|0
29072|NCT01475461|124510|P2|Treatment Period|Death|0
29073|NCT01475461|124511|P1|Treatment Period|Death|0
29074|NCT01475461|124505|P7|Run-in Period|Protocol Violation|0
29075|NCT01475461|124506|P6|Run-in Period|Protocol Violation|0
29076|NCT01475461|124507|P5|Run-in Period|Protocol Violation|0
29077|NCT01475461|124508|P4|Run-in Period|Protocol Violation|0
29078|NCT01475461|124509|P3|Run-in Period|Protocol Violation|0
29079|NCT01475461|124510|P2|Run-in Period|Protocol Violation|0
29080|NCT01475461|124511|P1|Run-in Period|Protocol Violation|4
29081|NCT01475461|124505|P7|Run-in Period|Unspecified|0
29082|NCT01475461|124506|P6|Run-in Period|Unspecified|0
29083|NCT01475461|124507|P5|Run-in Period|Unspecified|0
29084|NCT01475461|124508|P4|Run-in Period|Unspecified|0
29085|NCT01475461|124509|P3|Run-in Period|Unspecified|0
29086|NCT01475461|124510|P2|Run-in Period|Unspecified|0
29087|NCT01475461|124511|P1|Run-in Period|Unspecified|3
29088|NCT01475461|124505|P7|Run-in Period|Withdrawal by Subject|0
29089|NCT01475461|124506|P6|Run-in Period|Withdrawal by Subject|0
29090|NCT01475461|124507|P5|Run-in Period|Withdrawal by Subject|0
29091|NCT01475461|124508|P4|Run-in Period|Withdrawal by Subject|0
29092|NCT01475461|124509|P3|Run-in Period|Withdrawal by Subject|0
29093|NCT01475461|124510|P2|Run-in Period|Withdrawal by Subject|0
29094|NCT01475461|124511|P1|Run-in Period|Withdrawal by Subject|11
29095|NCT01475461|124505|P7|Run-in Period|Lost to Follow-up|0
29096|NCT01475461|124506|P6|Run-in Period|Lost to Follow-up|0
29097|NCT01475461|124507|P5|Run-in Period|Lost to Follow-up|0
29098|NCT01475461|124508|P4|Run-in Period|Lost to Follow-up|0
29099|NCT01475461|124509|P3|Run-in Period|Lost to Follow-up|0
29100|NCT01475461|124510|P2|Run-in Period|Lost to Follow-up|0
29101|NCT01475461|124511|P1|Run-in Period|Lost to Follow-up|7
29102|NCT01475461|124505|P7|Run-in Period|Not meet eligibility criteria|0
29103|NCT01475461|124506|P6|Run-in Period|Not meet eligibility criteria|0
29104|NCT01475461|124507|P5|Run-in Period|Not meet eligibility criteria|0
29105|NCT01475461|124508|P4|Run-in Period|Not meet eligibility criteria|0
29106|NCT01475461|124509|P3|Run-in Period|Not meet eligibility criteria|0
29107|NCT01475461|124510|P2|Run-in Period|Not meet eligibility criteria|0
29108|NCT01475461|124511|P1|Run-in Period|Not meet eligibility criteria|16
29109|NCT01475253|124592|P4|Randomized, Blinded Study|Lost to Follow-up|0
29110|NCT01475253|124593|P3|Randomized, Blinded Study|Lost to Follow-up|0
29111|NCT01475253|124594|P2|Randomized, Blinded Study|Lost to Follow-up|0
29112|NCT01475253|124595|P1|Randomized, Blinded Study|Lost to Follow-up|1
29113|NCT01475253|124592|P4|Randomized, Blinded Study|Withdrawal by Subject|0
29114|NCT01475253|124593|P3|Randomized, Blinded Study|Withdrawal by Subject|0
29115|NCT01475253|124594|P2|Randomized, Blinded Study|Withdrawal by Subject|1
29116|NCT01475253|124595|P1|Randomized, Blinded Study|Withdrawal by Subject|1
29117|NCT01475214|124624|P3|Overall Study|Withdrawal by Subject|1
29118|NCT01475214|124625|P2|Overall Study|Withdrawal by Subject|4
29119|NCT01475214|124626|P1|Overall Study|Withdrawal by Subject|2
29120|NCT01475214|124624|P3|Overall Study|Physician Decision|0
29121|NCT01475214|124625|P2|Overall Study|Physician Decision|0
29122|NCT01475214|124626|P1|Overall Study|Physician Decision|2
29123|NCT01475214|124624|P3|Overall Study|Lost to Follow-up|1
29124|NCT01475214|124625|P2|Overall Study|Lost to Follow-up|0
29125|NCT01475214|124626|P1|Overall Study|Lost to Follow-up|1
29126|NCT01475097|124651|P2|Overall Study|Protocol Violation|1
29127|NCT01475097|124652|P1|Overall Study|Protocol Violation|1
29128|NCT01475071|124660|P1|Overall Study|Lost to Follow-up|1
29129|NCT01475071|124660|P1|Overall Study|Withdrawal by Subject|6
29130|NCT01475071|124660|P1|Overall Study|Physician Decision|1
29131|NCT01474993|124670|P2|Overall Study|Adverse Event|1
29132|NCT01474993|124671|P1|Overall Study|Adverse Event|0
29133|NCT01474993|124670|P2|Overall Study|Lost to Follow-up|2
29134|NCT01474993|124671|P1|Overall Study|Lost to Follow-up|1
29135|NCT01474876|124709|P3|Overall Study|Investigator's decision and pt request|0
29136|NCT01474876|124710|P2|Overall Study|Investigator's decision and pt request|0
29137|NCT01474876|124711|P1|Overall Study|Investigator's decision and pt request|1
29138|NCT01474876|124709|P3|Overall Study|Patient's request|0
29139|NCT01474876|124710|P2|Overall Study|Patient's request|5
29140|NCT01474876|124711|P1|Overall Study|Patient's request|19
29141|NCT01474876|124709|P3|Overall Study|Investigator's decision|0
29142|NCT01474876|124710|P2|Overall Study|Investigator's decision|6
29143|NCT01474876|124711|P1|Overall Study|Investigator's decision|28
29144|NCT01474876|124709|P3|Overall Study|Lost to Follow-up|0
29145|NCT01474876|124710|P2|Overall Study|Lost to Follow-up|4
29146|NCT01474876|124711|P1|Overall Study|Lost to Follow-up|5
29147|NCT01474876|124709|P3|Overall Study|Serious Adverse Event|0
29148|NCT01474876|124710|P2|Overall Study|Serious Adverse Event|3
29149|NCT01474876|124711|P1|Overall Study|Serious Adverse Event|2
29150|NCT01474876|124709|P3|Overall Study|Adverse Event|0
29151|NCT01474876|124710|P2|Overall Study|Adverse Event|5
29152|NCT01474876|124711|P1|Overall Study|Adverse Event|11
29153|NCT01474772|124744|P2|Follow-up|AE not Related to Study Drug|1
29154|NCT01474772|124745|P1|Follow-up|AE not Related to Study Drug|0
29155|NCT01474772|124744|P2|Period 2|Reason not Specified|2
29156|NCT01474772|124745|P1|Period 2|Reason not Specified|0
29157|NCT01474772|124744|P2|Period 2|Lost to Follow-up|1
29158|NCT01474772|124745|P1|Period 2|Lost to Follow-up|1
29159|NCT01474772|124744|P2|Period 2|Withdrawal by Subject|4
29160|NCT01474772|124745|P1|Period 2|Withdrawal by Subject|3
29161|NCT01474772|124744|P2|Period 2|Lack of Efficacy|0
29162|NCT01474772|124745|P1|Period 2|Lack of Efficacy|1
29163|NCT01474772|124744|P2|Period 2|AE not Related to Study Drug|1
29164|NCT01474772|124745|P1|Period 2|AE not Related to Study Drug|4
29165|NCT01474772|124744|P2|Period 2|AE Related to Study Drug|1
29166|NCT01474772|124745|P1|Period 2|AE Related to Study Drug|0
29167|NCT01474772|124744|P2|Period 2|Death|1
29168|NCT01474772|124745|P1|Period 2|Death|0
29169|NCT01474772|124744|P2|Washout|Reason not Specified|1
29170|NCT01474772|124745|P1|Washout|Reason not Specified|0
29171|NCT01474772|124744|P2|Washout|Lost to Follow-up|1
29172|NCT01474772|124745|P1|Washout|Lost to Follow-up|0
29173|NCT01474772|124744|P2|Washout|Withdrawal by Subject|0
29174|NCT01474772|124745|P1|Washout|Withdrawal by Subject|1
29175|NCT01474772|124744|P2|Washout|AE not Related to Study Drug|0
29176|NCT01474772|124745|P1|Washout|AE not Related to Study Drug|2
29177|NCT01474772|124744|P2|Period 1|Reason not Specified|1
29178|NCT01474772|124745|P1|Period 1|Reason not Specified|1
29179|NCT01474772|124744|P2|Period 1|Lost to Follow-up|0
29180|NCT01474772|124745|P1|Period 1|Lost to Follow-up|1
29181|NCT01474772|124744|P2|Period 1|Withdrawal by Subject|1
29182|NCT01474772|124745|P1|Period 1|Withdrawal by Subject|3
29183|NCT01474772|124744|P2|Period 1|AE not Related to Study Drug|0
29184|NCT01474772|124745|P1|Period 1|AE not Related to Study Drug|1
29185|NCT01474772|124744|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
29186|NCT01474772|124745|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
29187|NCT01474551|124793|P1|Overall Study|Death|1
29188|NCT01474538|124799|P2|Treatment Period 2|Protocol Violation|0
29189|NCT01474538|124800|P1|Treatment Period 2|Protocol Violation|1
29190|NCT01474538|124799|P2|Treatment Period 2|Physician Decision|1
29191|NCT01474538|124800|P1|Treatment Period 2|Physician Decision|0
29192|NCT01474538|124799|P2|Treatment Period 2|Sponsor decision|0
29193|NCT01474538|124800|P1|Treatment Period 2|Sponsor decision|1
29194|NCT01474538|124799|P2|Treatment Period 2|Withdrawal by Subject|0
29195|NCT01474538|124800|P1|Treatment Period 2|Withdrawal by Subject|2
29196|NCT01474538|124799|P2|Treatment Period 2|Adverse Event|1
29197|NCT01474538|124800|P1|Treatment Period 2|Adverse Event|1
29198|NCT01474538|124799|P2|Treatment Period 2|Death|0
29199|NCT01474538|124800|P1|Treatment Period 2|Death|1
29200|NCT01474538|124799|P2|Treatment Period 1|Protocol Violation|1
29201|NCT01474538|124800|P1|Treatment Period 1|Protocol Violation|0
29202|NCT01474538|124799|P2|Treatment Period 1|Withdrawal by Subject|3
29203|NCT01474538|124800|P1|Treatment Period 1|Withdrawal by Subject|1
29204|NCT01474538|124799|P2|Treatment Period 1|Physician Decision|0
29205|NCT01474538|124800|P1|Treatment Period 1|Physician Decision|1
29206|NCT01474538|124799|P2|Treatment Period 1|Death|0
29207|NCT01474538|124800|P1|Treatment Period 1|Death|1
29208|NCT01474512|124817|P10|Maintenance Period|Treated but Discontinued in Induction|0
29209|NCT01474512|124818|P9|Maintenance Period|Treated but Discontinued in Induction|0
29210|NCT01474512|124819|P8|Maintenance Period|Treated but Discontinued in Induction|0
29211|NCT01474512|124820|P7|Maintenance Period|Treated but Discontinued in Induction|0
29212|NCT01474512|124821|P6|Maintenance Period|Treated but Discontinued in Induction|0
29213|NCT01474512|124822|P5|Maintenance Period|Treated but Discontinued in Induction|1
29214|NCT01474512|124823|P4|Maintenance Period|Treated but Discontinued in Induction|0
29215|NCT01474512|124824|P3|Maintenance Period|Treated but Discontinued in Induction|0
29216|NCT01474512|124825|P2|Maintenance Period|Treated but Discontinued in Induction|0
29217|NCT01474512|124826|P1|Maintenance Period|Treated but Discontinued in Induction|0
29218|NCT01474512|124817|P10|Maintenance Period|Protocol Violation|1
29219|NCT01474512|124818|P9|Maintenance Period|Protocol Violation|0
29220|NCT01474512|124819|P8|Maintenance Period|Protocol Violation|1
29221|NCT01474512|124820|P7|Maintenance Period|Protocol Violation|0
29222|NCT01474512|124821|P6|Maintenance Period|Protocol Violation|0
29223|NCT01474512|124822|P5|Maintenance Period|Protocol Violation|0
29224|NCT01474512|124823|P4|Maintenance Period|Protocol Violation|1
29225|NCT01474512|124824|P3|Maintenance Period|Protocol Violation|0
29226|NCT01474512|124825|P2|Maintenance Period|Protocol Violation|0
29227|NCT01474512|124826|P1|Maintenance Period|Protocol Violation|0
29228|NCT01474512|124817|P10|Maintenance Period|Lack of Efficacy|12
29229|NCT01474512|124818|P9|Maintenance Period|Lack of Efficacy|11
29230|NCT01474512|124819|P8|Maintenance Period|Lack of Efficacy|11
29231|NCT01474512|124820|P7|Maintenance Period|Lack of Efficacy|0
29232|NCT01474512|124821|P6|Maintenance Period|Lack of Efficacy|0
29233|NCT01474512|124822|P5|Maintenance Period|Lack of Efficacy|0
29234|NCT01474512|124823|P4|Maintenance Period|Lack of Efficacy|1
29235|NCT01474512|124824|P3|Maintenance Period|Lack of Efficacy|0
29236|NCT01474512|124825|P2|Maintenance Period|Lack of Efficacy|0
29237|NCT01474512|124826|P1|Maintenance Period|Lack of Efficacy|0
29238|NCT01474512|124817|P10|Maintenance Period|Clinical Relapse|0
29239|NCT01474512|124818|P9|Maintenance Period|Clinical Relapse|0
29240|NCT01474512|124819|P8|Maintenance Period|Clinical Relapse|0
29241|NCT01474512|124820|P7|Maintenance Period|Clinical Relapse|0
29242|NCT01474512|124821|P6|Maintenance Period|Clinical Relapse|0
29243|NCT01474512|124822|P5|Maintenance Period|Clinical Relapse|0
29244|NCT01474512|124823|P4|Maintenance Period|Clinical Relapse|1
29245|NCT01474512|124824|P3|Maintenance Period|Clinical Relapse|0
29246|NCT01474512|124825|P2|Maintenance Period|Clinical Relapse|0
29247|NCT01474512|124826|P1|Maintenance Period|Clinical Relapse|0
29248|NCT01474512|124817|P10|Maintenance Period|Investigator Decision|0
29249|NCT01474512|124818|P9|Maintenance Period|Investigator Decision|0
29250|NCT01474512|124819|P8|Maintenance Period|Investigator Decision|2
29251|NCT01474512|124820|P7|Maintenance Period|Investigator Decision|0
29252|NCT01474512|124821|P6|Maintenance Period|Investigator Decision|1
29253|NCT01474512|124822|P5|Maintenance Period|Investigator Decision|0
29254|NCT01474512|124823|P4|Maintenance Period|Investigator Decision|0
29255|NCT01474512|124824|P3|Maintenance Period|Investigator Decision|0
29256|NCT01474512|124825|P2|Maintenance Period|Investigator Decision|0
29257|NCT01474512|124826|P1|Maintenance Period|Investigator Decision|0
29258|NCT01474512|124817|P10|Maintenance Period|Death|0
29259|NCT01474512|124818|P9|Maintenance Period|Death|0
29260|NCT01474512|124819|P8|Maintenance Period|Death|0
29261|NCT01474512|124820|P7|Maintenance Period|Death|0
29262|NCT01474512|124821|P6|Maintenance Period|Death|2
29263|NCT01474512|124822|P5|Maintenance Period|Death|0
29264|NCT01474512|124823|P4|Maintenance Period|Death|0
29265|NCT01474512|124824|P3|Maintenance Period|Death|0
29266|NCT01474512|124825|P2|Maintenance Period|Death|0
29267|NCT01474512|124826|P1|Maintenance Period|Death|0
29268|NCT01474512|124817|P10|Maintenance Period|Lost to Follow-up|1
29269|NCT01474512|124818|P9|Maintenance Period|Lost to Follow-up|1
29270|NCT01474512|124819|P8|Maintenance Period|Lost to Follow-up|2
29271|NCT01474512|124820|P7|Maintenance Period|Lost to Follow-up|0
29272|NCT01474512|124821|P6|Maintenance Period|Lost to Follow-up|0
29273|NCT01474512|124822|P5|Maintenance Period|Lost to Follow-up|3
29274|NCT01474512|124823|P4|Maintenance Period|Lost to Follow-up|3
29275|NCT01474512|124824|P3|Maintenance Period|Lost to Follow-up|0
29276|NCT01474512|124825|P2|Maintenance Period|Lost to Follow-up|0
29277|NCT01474512|124826|P1|Maintenance Period|Lost to Follow-up|0
29278|NCT01474512|124817|P10|Maintenance Period|Withdrawal by Subject|1
29279|NCT01474512|124818|P9|Maintenance Period|Withdrawal by Subject|3
29280|NCT01474512|124819|P8|Maintenance Period|Withdrawal by Subject|6
29281|NCT01474512|124820|P7|Maintenance Period|Withdrawal by Subject|1
29282|NCT01474512|124821|P6|Maintenance Period|Withdrawal by Subject|3
29283|NCT01474512|124822|P5|Maintenance Period|Withdrawal by Subject|2
29284|NCT01474512|124823|P4|Maintenance Period|Withdrawal by Subject|6
29285|NCT01474512|124824|P3|Maintenance Period|Withdrawal by Subject|0
29286|NCT01474512|124825|P2|Maintenance Period|Withdrawal by Subject|0
29287|NCT01474512|124826|P1|Maintenance Period|Withdrawal by Subject|0
29288|NCT01474512|124817|P10|Maintenance Period|Adverse Event|3
29289|NCT01474512|124818|P9|Maintenance Period|Adverse Event|1
29290|NCT01474512|124819|P8|Maintenance Period|Adverse Event|19
29291|NCT01474512|124820|P7|Maintenance Period|Adverse Event|0
29292|NCT01474512|124821|P6|Maintenance Period|Adverse Event|7
29293|NCT01474512|124822|P5|Maintenance Period|Adverse Event|2
29294|NCT01474512|124823|P4|Maintenance Period|Adverse Event|4
29295|NCT01474512|124824|P3|Maintenance Period|Adverse Event|0
29296|NCT01474512|124825|P2|Maintenance Period|Adverse Event|0
29297|NCT01474512|124826|P1|Maintenance Period|Adverse Event|0
29298|NCT01474512|124817|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
29299|NCT01474512|124818|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
29300|NCT01474512|124819|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
29301|NCT01474512|124820|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
29302|NCT01474512|124821|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
29303|NCT01474512|124822|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
29304|NCT01474512|124823|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
29305|NCT01474512|124824|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
29306|NCT01474512|124825|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
29307|NCT01474512|124826|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
29308|NCT01474512|124817|P10|Induction Period|Lost to Follow-up|0
29309|NCT01474512|124818|P9|Induction Period|Lost to Follow-up|0
29310|NCT01474512|124819|P8|Induction Period|Lost to Follow-up|0
29311|NCT01474512|124820|P7|Induction Period|Lost to Follow-up|0
29312|NCT01474512|124821|P6|Induction Period|Lost to Follow-up|0
29313|NCT01474512|124822|P5|Induction Period|Lost to Follow-up|0
29314|NCT01474512|124823|P4|Induction Period|Lost to Follow-up|0
29315|NCT01474512|124824|P3|Induction Period|Lost to Follow-up|2
29316|NCT01474512|124825|P2|Induction Period|Lost to Follow-up|0
29317|NCT01474512|124826|P1|Induction Period|Lost to Follow-up|1
29318|NCT01474512|124817|P10|Induction Period|Sponsor Decision|0
29319|NCT01474512|124818|P9|Induction Period|Sponsor Decision|0
29320|NCT01474512|124819|P8|Induction Period|Sponsor Decision|0
29321|NCT01474512|124820|P7|Induction Period|Sponsor Decision|0
29322|NCT01474512|124821|P6|Induction Period|Sponsor Decision|0
29323|NCT01474512|124822|P5|Induction Period|Sponsor Decision|0
29324|NCT01474512|124823|P4|Induction Period|Sponsor Decision|0
29325|NCT01474512|124824|P3|Induction Period|Sponsor Decision|1
29326|NCT01474512|124825|P2|Induction Period|Sponsor Decision|1
29327|NCT01474512|124826|P1|Induction Period|Sponsor Decision|1
29328|NCT01474512|124817|P10|Induction Period|Protocol Violation|0
29329|NCT01474512|124818|P9|Induction Period|Protocol Violation|0
29330|NCT01474512|124819|P8|Induction Period|Protocol Violation|0
29331|NCT01474512|124820|P7|Induction Period|Protocol Violation|0
29332|NCT01474512|124821|P6|Induction Period|Protocol Violation|0
29333|NCT01474512|124822|P5|Induction Period|Protocol Violation|0
29334|NCT01474512|124823|P4|Induction Period|Protocol Violation|0
29335|NCT01474512|124824|P3|Induction Period|Protocol Violation|0
29336|NCT01474512|124825|P2|Induction Period|Protocol Violation|6
29337|NCT01474512|124826|P1|Induction Period|Protocol Violation|3
29338|NCT01474512|124817|P10|Induction Period|Withdrawal by Subject|0
29339|NCT01474512|124818|P9|Induction Period|Withdrawal by Subject|0
29340|NCT01474512|124819|P8|Induction Period|Withdrawal by Subject|0
29341|NCT01474512|124820|P7|Induction Period|Withdrawal by Subject|0
29342|NCT01474512|124821|P6|Induction Period|Withdrawal by Subject|0
29343|NCT01474512|124822|P5|Induction Period|Withdrawal by Subject|0
29344|NCT01474512|124823|P4|Induction Period|Withdrawal by Subject|0
29345|NCT01474512|124824|P3|Induction Period|Withdrawal by Subject|5
29346|NCT01474512|124825|P2|Induction Period|Withdrawal by Subject|6
29347|NCT01474512|124826|P1|Induction Period|Withdrawal by Subject|6
29348|NCT01474512|124817|P10|Induction Period|Lack of Efficacy|0
29349|NCT01474512|124818|P9|Induction Period|Lack of Efficacy|0
29350|NCT01474512|124819|P8|Induction Period|Lack of Efficacy|0
29351|NCT01474512|124820|P7|Induction Period|Lack of Efficacy|0
29352|NCT01474512|124821|P6|Induction Period|Lack of Efficacy|0
29353|NCT01474512|124822|P5|Induction Period|Lack of Efficacy|0
29354|NCT01474512|124823|P4|Induction Period|Lack of Efficacy|0
29355|NCT01474512|124824|P3|Induction Period|Lack of Efficacy|0
29356|NCT01474512|124825|P2|Induction Period|Lack of Efficacy|1
29357|NCT01474512|124826|P1|Induction Period|Lack of Efficacy|7
29358|NCT01474512|124817|P10|Induction Period|Adverse Event|0
29359|NCT01474512|124818|P9|Induction Period|Adverse Event|0
29360|NCT01474512|124819|P8|Induction Period|Adverse Event|0
29361|NCT01474512|124820|P7|Induction Period|Adverse Event|0
29362|NCT01474512|124821|P6|Induction Period|Adverse Event|0
29363|NCT01474512|124822|P5|Induction Period|Adverse Event|0
29364|NCT01474512|124823|P4|Induction Period|Adverse Event|0
29365|NCT01474512|124824|P3|Induction Period|Adverse Event|10
29366|NCT01474512|124825|P2|Induction Period|Adverse Event|10
29367|NCT01474512|124826|P1|Induction Period|Adverse Event|6
29368|NCT01474434|124895|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
29369|NCT01474434|124896|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
29370|NCT01474434|124897|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
29371|NCT01474434|124898|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
29372|NCT01474434|124895|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
29373|NCT01474434|124896|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
29374|NCT01474434|124897|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
29375|NCT01474434|124898|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
29376|NCT01474434|124895|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
29377|NCT01474434|124896|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
29378|NCT01474434|124897|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
29379|NCT01474434|124898|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
29380|NCT01474317|124940|P1|Overall Study|Subject ineligible for study|1
29381|NCT01474317|124940|P1|Overall Study|Adverse Event|1
29382|NCT01474291|124949|P1|Overall Study|Death|2
29383|NCT01474291|124949|P1|Overall Study|No Reason Reported|10
29384|NCT01474291|124949|P1|Overall Study|Patient No Longer Wanted to Participate|12
29385|NCT01474291|124949|P1|Overall Study|Lost to Follow-up|29
29386|NCT01474291|124949|P1|Overall Study|Adverse Event|53
29387|NCT01474291|124949|P1|Overall Study|Lack of Treatment Efficacy|88
29388|NCT01474291|124949|P1|Overall Study|Not Evaluable for Efficacy|26
29389|NCT01474239|124993|P2|Overall Study|Withdrawal for Economic Reason|0
29390|NCT01474239|124994|P1|Overall Study|Withdrawal for Economic Reason|1
29391|NCT01474239|124993|P2|Overall Study|Clinical Disease Progression|1
29392|NCT01474239|124994|P1|Overall Study|Clinical Disease Progression|7
29393|NCT01474239|124993|P2|Overall Study|Death|1
29394|NCT01474239|124994|P1|Overall Study|Death|1
29395|NCT01474239|124993|P2|Overall Study|Withdrawal by Subject|2
29396|NCT01474239|124994|P1|Overall Study|Withdrawal by Subject|1
29397|NCT01474239|124993|P2|Overall Study|Adverse Event|3
29398|NCT01474239|124994|P1|Overall Study|Adverse Event|12
29399|NCT01474239|124993|P2|Overall Study|Disease Progression|25
29400|NCT01474239|124994|P1|Overall Study|Disease Progression|37
29401|NCT01473953|125188|P5|Overall Study|Unspecified|0
29402|NCT01473953|125189|P4|Overall Study|Unspecified|0
29403|NCT01473953|125190|P3|Overall Study|Unspecified|0
29404|NCT01473953|125191|P2|Overall Study|Unspecified|0
29405|NCT01473953|125192|P1|Overall Study|Unspecified|1
29406|NCT01473836|125234|P1|Overall Study|Does not meet entrance criteria|1
29407|NCT01473836|125234|P1|Overall Study|Lack of Efficacy|1
29408|NCT01473836|125234|P1|Overall Study|Adverse Event|4
29409|NCT01473758|125245|P4|Cycle 2|Adverse Event|0
29410|NCT01473758|125246|P3|Cycle 2|Adverse Event|5
29411|NCT01473758|125247|P2|Cycle 2|Adverse Event|0
29412|NCT01473758|125248|P1|Cycle 2|Adverse Event|0
29413|NCT01473758|125245|P4|Cycle 1|Withdrawal by Subject|0
29414|NCT01473758|125246|P3|Cycle 1|Withdrawal by Subject|0
29415|NCT01473758|125247|P2|Cycle 1|Withdrawal by Subject|1
29416|NCT01473758|125248|P1|Cycle 1|Withdrawal by Subject|1
29417|NCT01473758|125245|P4|Cycle 1|Adverse Event|0
29418|NCT01473758|125246|P3|Cycle 1|Adverse Event|0
29419|NCT01473758|125247|P2|Cycle 1|Adverse Event|2
29420|NCT01473758|125248|P1|Cycle 1|Adverse Event|10
29421|NCT01473602|125385|P2|Overall Study|Physician Decision|0
29422|NCT01473602|125386|P1|Overall Study|Physician Decision|1
29423|NCT01473602|125385|P2|Overall Study|Withdrawal by Subject|4
29424|NCT01473602|125386|P1|Overall Study|Withdrawal by Subject|5
29425|NCT01473602|125385|P2|Overall Study|Lost to Follow-up|1
29426|NCT01473602|125386|P1|Overall Study|Lost to Follow-up|1
29427|NCT01473602|125385|P2|Overall Study|Death|1
29428|NCT01473602|125386|P1|Overall Study|Death|0
29429|NCT01473602|125385|P2|Overall Study|Adverse Event|2
29430|NCT01473602|125386|P1|Overall Study|Adverse Event|1
29431|NCT01473589|125422|P2|Overall Study|Entry criteria not met|1
29432|NCT01473589|125423|P1|Overall Study|Entry criteria not met|0
29433|NCT01473589|125422|P2|Overall Study|Physician Decision|1
29434|NCT01473589|125423|P1|Overall Study|Physician Decision|0
29435|NCT01473589|125422|P2|Overall Study|Withdrawal by Subject|11
29436|NCT01473589|125423|P1|Overall Study|Withdrawal by Subject|5
29437|NCT01473589|125422|P2|Overall Study|Protocol Violation|0
29438|NCT01473589|125423|P1|Overall Study|Protocol Violation|1
29439|NCT01473589|125422|P2|Overall Study|Lost to Follow-up|2
29440|NCT01473589|125423|P1|Overall Study|Lost to Follow-up|2
29441|NCT01473589|125422|P2|Overall Study|Death|0
29442|NCT01473589|125423|P1|Overall Study|Death|2
29443|NCT01473589|125422|P2|Overall Study|Adverse Event|1
29444|NCT01473589|125423|P1|Overall Study|Adverse Event|1
29445|NCT01473563|125457|P1|Overall Study|Lost to FU post tx discontinuation|1
29446|NCT01473524|125479|P3|Overall Study|Withdrawal by Subject|1
29447|NCT01473524|125480|P2|Overall Study|Withdrawal by Subject|1
29448|NCT01473524|125481|P1|Overall Study|Withdrawal by Subject|2
29449|NCT01473524|125479|P3|Overall Study|Death|0
29450|NCT01473524|125480|P2|Overall Study|Death|0
29451|NCT01473524|125481|P1|Overall Study|Death|1
29452|NCT01473524|125479|P3|Overall Study|Adverse Event|2
29453|NCT01473524|125480|P2|Overall Study|Adverse Event|8
29454|NCT01473524|125481|P1|Overall Study|Adverse Event|4
29455|NCT01473394|125514|P2|Overall Study|Lost to Follow-up|11
29456|NCT01473394|125515|P1|Overall Study|Lost to Follow-up|9
29457|NCT01473394|125514|P2|Overall Study|Withdrew Consent|10
29458|NCT01473394|125515|P1|Overall Study|Withdrew Consent|12
29459|NCT01473394|125514|P2|Overall Study|Protocol Violation|5
29460|NCT01473394|125515|P1|Overall Study|Protocol Violation|7
29461|NCT01473394|125514|P2|Overall Study|Insufficient Therapeutic Response|1
29462|NCT01473394|125515|P1|Overall Study|Insufficient Therapeutic Response|4
29463|NCT01473394|125514|P2|Overall Study|Adverse Event|16
29464|NCT01473394|125515|P1|Overall Study|Adverse Event|13
29465|NCT01473381|125529|P4|Overall Study|Other Reasons|3
29466|NCT01473381|125530|P3|Overall Study|Other Reasons|1
29467|NCT01473381|125531|P2|Overall Study|Other Reasons|0
29468|NCT01473381|125532|P1|Overall Study|Other Reasons|0
29469|NCT01473381|125529|P4|Overall Study|Lost to Follow-up|23
29470|NCT01473381|125530|P3|Overall Study|Lost to Follow-up|35
29471|NCT01473381|125531|P2|Overall Study|Lost to Follow-up|28
29472|NCT01473381|125532|P1|Overall Study|Lost to Follow-up|25
29473|NCT01473381|125529|P4|Overall Study|Withdrawal of Consent|26
29474|NCT01473381|125530|P3|Overall Study|Withdrawal of Consent|20
29475|NCT01473381|125531|P2|Overall Study|Withdrawal of Consent|21
29476|NCT01473381|125532|P1|Overall Study|Withdrawal of Consent|20
29477|NCT01473381|125529|P4|Overall Study|Protocol Violation|17
29478|NCT01473381|125530|P3|Overall Study|Protocol Violation|19
29479|NCT01473381|125531|P2|Overall Study|Protocol Violation|23
29480|NCT01473381|125532|P1|Overall Study|Protocol Violation|17
29481|NCT01473381|125529|P4|Overall Study|Insufficient Therapeutic Response|3
29482|NCT01473381|125530|P3|Overall Study|Insufficient Therapeutic Response|2
29483|NCT01473381|125531|P2|Overall Study|Insufficient Therapeutic Response|1
29484|NCT01473381|125532|P1|Overall Study|Insufficient Therapeutic Response|10
29485|NCT01473381|125529|P4|Overall Study|Adverse Event|17
29486|NCT01473381|125530|P3|Overall Study|Adverse Event|25
29487|NCT01473381|125531|P2|Overall Study|Adverse Event|20
29488|NCT01473381|125532|P1|Overall Study|Adverse Event|8
29489|NCT01472939|125616|P4|Overall Study|Withdrawal by Subject|4
29490|NCT01472939|125617|P3|Overall Study|Withdrawal by Subject|1
29491|NCT01472939|125618|P2|Overall Study|Withdrawal by Subject|3
29492|NCT01472939|125619|P1|Overall Study|Withdrawal by Subject|9
29493|NCT01472939|125616|P4|Overall Study|Protocol Violation|1
29494|NCT01472939|125617|P3|Overall Study|Protocol Violation|0
29495|NCT01472939|125618|P2|Overall Study|Protocol Violation|3
29496|NCT01472939|125619|P1|Overall Study|Protocol Violation|3
29497|NCT01472939|125616|P4|Overall Study|Withdrawal By PI|0
29498|NCT01472939|125617|P3|Overall Study|Withdrawal By PI|0
29499|NCT01472939|125618|P2|Overall Study|Withdrawal By PI|0
29500|NCT01472939|125619|P1|Overall Study|Withdrawal By PI|1
29501|NCT01472939|125616|P4|Overall Study|Prohibited Medication|0
29502|NCT01472939|125617|P3|Overall Study|Prohibited Medication|0
29503|NCT01472939|125618|P2|Overall Study|Prohibited Medication|1
29504|NCT01472939|125619|P1|Overall Study|Prohibited Medication|0
29505|NCT01472939|125616|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
29506|NCT01472939|125617|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
29507|NCT01472939|125618|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
29508|NCT01472939|125619|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
29509|NCT01472939|125616|P4|Overall Study|Lost to Follow-up|0
29510|NCT01472939|125617|P3|Overall Study|Lost to Follow-up|2
29511|NCT01472939|125618|P2|Overall Study|Lost to Follow-up|0
29512|NCT01472939|125619|P1|Overall Study|Lost to Follow-up|3
29513|NCT01472939|125616|P4|Overall Study|Lack of Efficacy|1
29514|NCT01472939|125617|P3|Overall Study|Lack of Efficacy|0
29515|NCT01472939|125618|P2|Overall Study|Lack of Efficacy|0
29516|NCT01472939|125619|P1|Overall Study|Lack of Efficacy|1
29517|NCT01472939|125616|P4|Overall Study|Adverse Event|14
29518|NCT01472939|125617|P3|Overall Study|Adverse Event|7
29519|NCT01472939|125618|P2|Overall Study|Adverse Event|7
29520|NCT01472939|125619|P1|Overall Study|Adverse Event|3
29521|NCT01472835|125663|P2|Overall Study|Lost to Follow-up|0
29522|NCT01472835|125664|P1|Overall Study|Lost to Follow-up|2
29523|NCT01472380|125714|P1|1 Day Period Between Dosing|Protocol Violation|1
29524|NCT01472380|125714|P1|Efavirenz Alone|Withdrawal by Subject|1
29525|NCT01472341|125725|P1|Overall Study|Death|9
29526|NCT01472341|125725|P1|Overall Study|Laboratory parameters unavailable|25
29527|NCT01472341|125725|P1|Overall Study|Lost to Follow-up|52
29528|NCT01472341|125725|P1|Overall Study|Withdrawal by Subject|39
29529|NCT01472341|125725|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
29530|NCT01472341|125725|P1|Overall Study|Started insulin therapy|55
29531|NCT01472289|125731|P1|Overall Study|Death|2
29532|NCT01472185|125743|P2|Overall Study|Subject Withdrew Consent|3
29533|NCT01472185|125744|P1|Overall Study|Subject Withdrew Consent|6
29534|NCT01472185|125743|P2|Overall Study|Subject Noncompliance|15
29535|NCT01472185|125744|P1|Overall Study|Subject Noncompliance|8
29536|NCT01472185|125743|P2|Overall Study|Protocol Violation|1
29537|NCT01472185|125744|P1|Overall Study|Protocol Violation|5
29538|NCT01472185|125743|P2|Overall Study|Lost to Follow-up|1
29539|NCT01472185|125744|P1|Overall Study|Lost to Follow-up|4
29540|NCT01472185|125743|P2|Overall Study|Investigator’s Discretion|1
29541|NCT01472185|125744|P1|Overall Study|Investigator’s Discretion|3
29542|NCT01472185|125743|P2|Overall Study|Hyperglycemia|2
29543|NCT01472185|125744|P1|Overall Study|Hyperglycemia|5
29544|NCT01472185|125743|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
29545|NCT01472185|125744|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
29546|NCT01472185|125743|P2|Overall Study|Randomized but Not Treated|1
29547|NCT01472185|125744|P1|Overall Study|Randomized but Not Treated|0
29548|NCT01471782|125764|P6|Overall Study|Death|1
29549|NCT01471782|125765|P5|Overall Study|Death|0
29550|NCT01471782|125766|P4|Overall Study|Death|0
29551|NCT01471782|125767|P3|Overall Study|Death|0
29552|NCT01471782|125768|P2|Overall Study|Death|0
29553|NCT01471782|125769|P1|Overall Study|Death|0
29554|NCT01471782|125764|P6|Overall Study|Withdrawal by Parent/Guardian|0
29555|NCT01471782|125765|P5|Overall Study|Withdrawal by Parent/Guardian|1
29556|NCT01471782|125766|P4|Overall Study|Withdrawal by Parent/Guardian|0
29557|NCT01471782|125767|P3|Overall Study|Withdrawal by Parent/Guardian|0
29558|NCT01471782|125768|P2|Overall Study|Withdrawal by Parent/Guardian|0
29559|NCT01471782|125769|P1|Overall Study|Withdrawal by Parent/Guardian|0
29560|NCT01471782|125764|P6|Overall Study|Physician Decision|8
29561|NCT01471782|125765|P5|Overall Study|Physician Decision|3
29562|NCT01471782|125766|P4|Overall Study|Physician Decision|0
29563|NCT01471782|125767|P3|Overall Study|Physician Decision|0
29564|NCT01471782|125768|P2|Overall Study|Physician Decision|0
29565|NCT01471782|125769|P1|Overall Study|Physician Decision|0
29566|NCT01471782|125764|P6|Overall Study|Disease Relapse|1
29567|NCT01471782|125765|P5|Overall Study|Disease Relapse|2
29568|NCT01471782|125766|P4|Overall Study|Disease Relapse|1
29569|NCT01471782|125767|P3|Overall Study|Disease Relapse|0
29570|NCT01471782|125768|P2|Overall Study|Disease Relapse|0
29571|NCT01471782|125769|P1|Overall Study|Disease Relapse|0
29572|NCT01471782|125764|P6|Overall Study|Change of Chemotherapy|4
29573|NCT01471782|125765|P5|Overall Study|Change of Chemotherapy|1
29574|NCT01471782|125766|P4|Overall Study|Change of Chemotherapy|0
29575|NCT01471782|125767|P3|Overall Study|Change of Chemotherapy|0
29576|NCT01471782|125768|P2|Overall Study|Change of Chemotherapy|1
29577|NCT01471782|125769|P1|Overall Study|Change of Chemotherapy|1
29578|NCT01471782|125764|P6|Overall Study|Other|5
29579|NCT01471782|125765|P5|Overall Study|Other|6
29580|NCT01471782|125766|P4|Overall Study|Other|1
29581|NCT01471782|125767|P3|Overall Study|Other|1
29582|NCT01471782|125768|P2|Overall Study|Other|0
29583|NCT01471782|125769|P1|Overall Study|Other|0
29584|NCT01471782|125764|P6|Overall Study|Adverse Event|1
29585|NCT01471782|125765|P5|Overall Study|Adverse Event|3
29586|NCT01471782|125766|P4|Overall Study|Adverse Event|2
29587|NCT01471782|125767|P3|Overall Study|Adverse Event|2
29588|NCT01471782|125768|P2|Overall Study|Adverse Event|1
29589|NCT01471782|125769|P1|Overall Study|Adverse Event|1
29590|NCT01471782|125764|P6|Overall Study|Lack of Efficacy|18
29591|NCT01471782|125765|P5|Overall Study|Lack of Efficacy|5
29592|NCT01471782|125766|P4|Overall Study|Lack of Efficacy|1
29593|NCT01471782|125767|P3|Overall Study|Lack of Efficacy|1
29594|NCT01471782|125768|P2|Overall Study|Lack of Efficacy|2
29595|NCT01471782|125769|P1|Overall Study|Lack of Efficacy|1
29596|NCT01471782|125764|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
29597|NCT01471782|125765|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
29598|NCT01471782|125766|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
29599|NCT01471782|125767|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
29600|NCT01471782|125768|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
29601|NCT01471782|125769|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
29602|NCT01471691|125823|P2|Overall Study|Lack of Efficacy|1
29603|NCT01471691|125824|P1|Overall Study|Lack of Efficacy|0
29604|NCT01471574|125838|P4|Follow-up Period|Follow-up no longer required|0
29605|NCT01471574|125839|P3|Follow-up Period|Follow-up no longer required|0
29606|NCT01471574|125840|P2|Follow-up Period|Follow-up no longer required|1
29607|NCT01471574|125841|P1|Follow-up Period|Follow-up no longer required|0
29608|NCT01471574|125838|P4|Follow-up Period|Death|0
29609|NCT01471574|125839|P3|Follow-up Period|Death|1
29610|NCT01471574|125840|P2|Follow-up Period|Death|0
29611|NCT01471574|125841|P1|Follow-up Period|Death|0
29612|NCT01471574|125838|P4|Follow-up Period|Lost to Follow-up|2
29613|NCT01471574|125839|P3|Follow-up Period|Lost to Follow-up|3
29614|NCT01471574|125840|P2|Follow-up Period|Lost to Follow-up|1
29615|NCT01471574|125841|P1|Follow-up Period|Lost to Follow-up|4
29616|NCT01471574|125838|P4|Follow-up Period|Withdrawal by Subject|1
29617|NCT01471574|125839|P3|Follow-up Period|Withdrawal by Subject|3
29618|NCT01471574|125840|P2|Follow-up Period|Withdrawal by Subject|0
29619|NCT01471574|125841|P1|Follow-up Period|Withdrawal by Subject|3
29620|NCT01471574|125838|P4|Treatment Period|Not specified|0
29621|NCT01471574|125839|P3|Treatment Period|Not specified|0
29622|NCT01471574|125840|P2|Treatment Period|Not specified|0
29623|NCT01471574|125841|P1|Treatment Period|Not specified|1
29624|NCT01471574|125838|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
29625|NCT01471574|125839|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
29626|NCT01471574|125840|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
29627|NCT01471574|125841|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
29628|NCT01471574|125838|P4|Treatment Period|Lost to Follow-up|0
29629|NCT01471574|125839|P3|Treatment Period|Lost to Follow-up|2
29630|NCT01471574|125840|P2|Treatment Period|Lost to Follow-up|2
29631|NCT01471574|125841|P1|Treatment Period|Lost to Follow-up|1
29632|NCT01471574|125838|P4|Treatment Period|Patient Requested Discontinue Study drug|1
29633|NCT01471574|125839|P3|Treatment Period|Patient Requested Discontinue Study drug|1
29634|NCT01471574|125840|P2|Treatment Period|Patient Requested Discontinue Study drug|0
29635|NCT01471574|125841|P1|Treatment Period|Patient Requested Discontinue Study drug|4
29636|NCT01471574|125838|P4|Treatment Period|Withdrawal by Subject|0
29637|NCT01471574|125839|P3|Treatment Period|Withdrawal by Subject|1
29638|NCT01471574|125840|P2|Treatment Period|Withdrawal by Subject|1
29639|NCT01471574|125841|P1|Treatment Period|Withdrawal by Subject|5
29640|NCT01471574|125838|P4|Treatment Period|Adverse Event|1
29641|NCT01471574|125839|P3|Treatment Period|Adverse Event|6
29642|NCT01471574|125840|P2|Treatment Period|Adverse Event|3
29643|NCT01471574|125841|P1|Treatment Period|Adverse Event|7
29644|NCT01471574|125838|P4|Treatment Period|Lack of Efficacy|1
29645|NCT01471574|125839|P3|Treatment Period|Lack of Efficacy|14
29646|NCT01471574|125840|P2|Treatment Period|Lack of Efficacy|4
29647|NCT01471574|125841|P1|Treatment Period|Lack of Efficacy|12
29648|NCT01471379|125873|P3|Overall Study|Study terminated|0
29649|NCT01471379|125874|P2|Overall Study|Study terminated|1
29650|NCT01471379|125875|P1|Overall Study|Study terminated|0
29651|NCT01471379|125873|P3|Overall Study|Adverse Event|0
29652|NCT01471379|125874|P2|Overall Study|Adverse Event|0
29653|NCT01471379|125875|P1|Overall Study|Adverse Event|1
29654|NCT01471197|125897|P2|Overall Study|Study Drug Toxicity|0
29655|NCT01471197|125898|P1|Overall Study|Study Drug Toxicity|1
29656|NCT01471197|125897|P2|Overall Study|Death|0
29657|NCT01471197|125898|P1|Overall Study|Death|1
29658|NCT01471197|125897|P2|Overall Study|Disease Progression|2
29659|NCT01471197|125898|P1|Overall Study|Disease Progression|4
29660|NCT01471171|125908|P2|Treatment Period 2|Adverse Event|0
29661|NCT01471171|125909|P1|Treatment Period 2|Adverse Event|1
29662|NCT01471171|125908|P2|Treatment Period 1|Adverse Event|1
29663|NCT01471171|125909|P1|Treatment Period 1|Adverse Event|4
29664|NCT01471015|125927|P3|Overall Study|Death|1
29665|NCT01471015|125928|P2|Overall Study|Death|1
29666|NCT01471015|125929|P1|Overall Study|Death|0
29667|NCT01470469|125971|P2|Overall Study|Not specified|1
29668|NCT01470469|125972|P1|Overall Study|Not specified|2
29669|NCT01470469|125971|P2|Overall Study|Protocol Violation|1
29670|NCT01470469|125972|P1|Overall Study|Protocol Violation|1
29671|NCT01470469|125971|P2|Overall Study|Lost to Follow-up|2
29672|NCT01470469|125972|P1|Overall Study|Lost to Follow-up|2
29673|NCT01470469|125971|P2|Overall Study|Adverse Event|7
29674|NCT01470469|125972|P1|Overall Study|Adverse Event|0
29675|NCT01470469|125971|P2|Overall Study|Lack of Efficacy|7
29676|NCT01470469|125972|P1|Overall Study|Lack of Efficacy|1
29677|NCT01470469|125971|P2|Overall Study|Withdrawal by Subject|6
29678|NCT01470469|125972|P1|Overall Study|Withdrawal by Subject|4
29679|NCT01470417|125992|P2|Overall Study|Disease progression|2
29680|NCT01470417|125993|P1|Overall Study|Disease progression|0
29681|NCT01470144|126046|P1|Overall Study|Patient’s and investigator’s decision|1
29682|NCT01470144|126046|P1|Overall Study|Lung transplant|6
29683|NCT01470144|126046|P1|Overall Study|Death|1
29684|NCT01470144|126046|P1|Overall Study|Adverse Event|2
29685|NCT01469819|126085|P1|Overall Study|Technical malfunction of SmartPill data|3
29686|NCT01469819|126085|P1|Overall Study|Could not swallow SmartPill|2
29687|NCT01469819|126085|P1|Overall Study|Did not meet inclusionary criteria|2
29688|NCT01469819|126085|P1|Overall Study|Withdrawal by Subject|1
29689|NCT01469637|126101|P2|Second Intervention|Incarcerated|0
29690|NCT01469637|126102|P1|Second Intervention|Incarcerated|1
29691|NCT01469637|126101|P2|First Intervention|Unacceptable behavior|1
29692|NCT01469637|126102|P1|First Intervention|Unacceptable behavior|0
29693|NCT01469546|126110|P1|Received 5 mg Dose|Physician Decision|3
29694|NCT01469546|126110|P1|Received 5 mg Dose|Progressive Disease|3
29695|NCT01469546|126110|P1|Received 5 mg Dose|Protocol Violation|2
29696|NCT01469546|126110|P1|Received 5 mg Dose|Death|2
29697|NCT01469546|126110|P1|Received 5 mg Dose|Adverse Event|13
29698|NCT01469364|126117|P1|Overall Study|Withdrawal by Subject|1
29699|NCT01469364|126117|P1|Overall Study|Adverse Event|1
29700|NCT01469182|126168|P2|Overall Study|Did not meet Protocol Eligibility|0
29701|NCT01469182|126169|P1|Overall Study|Did not meet Protocol Eligibility|3
29702|NCT01469182|126168|P2|Overall Study|Protocol Violation|2
29703|NCT01469182|126169|P1|Overall Study|Protocol Violation|4
29704|NCT01469182|126168|P2|Overall Study|Withdrawal by Subject|1
29705|NCT01469182|126169|P1|Overall Study|Withdrawal by Subject|4
29706|NCT01469182|126168|P2|Overall Study|Lost to Follow-up|0
29707|NCT01469182|126169|P1|Overall Study|Lost to Follow-up|3
29708|NCT01469182|126168|P2|Overall Study|Adverse Event|3
29709|NCT01469182|126169|P1|Overall Study|Adverse Event|21
29710|NCT01469065|126196|P5|Overall Study|Not specified|0
29711|NCT01469065|126197|P4|Overall Study|Not specified|0
29712|NCT01469065|126198|P3|Overall Study|Not specified|0
29713|NCT01469065|126199|P2|Overall Study|Not specified|1
29714|NCT01469065|126200|P1|Overall Study|Not specified|0
29715|NCT01469065|126196|P5|Overall Study|Lack of Efficacy|1
29716|NCT01469065|126197|P4|Overall Study|Lack of Efficacy|0
29717|NCT01469065|126198|P3|Overall Study|Lack of Efficacy|0
29718|NCT01469065|126199|P2|Overall Study|Lack of Efficacy|0
29719|NCT01469065|126200|P1|Overall Study|Lack of Efficacy|0
29720|NCT01469052|126296|P6|Overall Study|Unspecified|0
29721|NCT01469052|126297|P5|Overall Study|Unspecified|1
29722|NCT01469052|126298|P4|Overall Study|Unspecified|0
29723|NCT01469052|126299|P3|Overall Study|Unspecified|0
29724|NCT01469052|126300|P2|Overall Study|Unspecified|1
29725|NCT01469052|126301|P1|Overall Study|Unspecified|0
29726|NCT01469052|126296|P6|Overall Study|Moved to rollover protocol|1
29727|NCT01469052|126297|P5|Overall Study|Moved to rollover protocol|0
29728|NCT01469052|126298|P4|Overall Study|Moved to rollover protocol|0
29729|NCT01469052|126299|P3|Overall Study|Moved to rollover protocol|1
29730|NCT01469052|126300|P2|Overall Study|Moved to rollover protocol|0
29731|NCT01469052|126301|P1|Overall Study|Moved to rollover protocol|1
29732|NCT01469052|126296|P6|Overall Study|Lack of Efficacy|2
29733|NCT01469052|126297|P5|Overall Study|Lack of Efficacy|0
29734|NCT01469052|126298|P4|Overall Study|Lack of Efficacy|0
29735|NCT01469052|126299|P3|Overall Study|Lack of Efficacy|0
29736|NCT01469052|126300|P2|Overall Study|Lack of Efficacy|0
29737|NCT01469052|126301|P1|Overall Study|Lack of Efficacy|0
29738|NCT01469052|126296|P6|Overall Study|Progressive disease|2
29739|NCT01469052|126297|P5|Overall Study|Progressive disease|7
29740|NCT01469052|126298|P4|Overall Study|Progressive disease|3
29741|NCT01469052|126299|P3|Overall Study|Progressive disease|5
29742|NCT01469052|126300|P2|Overall Study|Progressive disease|0
29743|NCT01469052|126301|P1|Overall Study|Progressive disease|3
29744|NCT01469052|126296|P6|Overall Study|Adverse Event|1
29745|NCT01469052|126297|P5|Overall Study|Adverse Event|0
29746|NCT01469052|126298|P4|Overall Study|Adverse Event|2
29747|NCT01469052|126299|P3|Overall Study|Adverse Event|0
29748|NCT01469052|126300|P2|Overall Study|Adverse Event|3
29749|NCT01469052|126301|P1|Overall Study|Adverse Event|2
29750|NCT01469000|126363|P2|Overall Study|On treatment, not yet died or PD|7
29751|NCT01469000|126364|P1|Overall Study|On treatment, not yet died or PD|23
29752|NCT01469000|126363|P2|Overall Study|Entry Criteria Not Met|0
29753|NCT01469000|126364|P1|Overall Study|Entry Criteria Not Met|1
29754|NCT01469000|126363|P2|Overall Study|Physician Decision|1
29755|NCT01469000|126364|P1|Overall Study|Physician Decision|0
29756|NCT01469000|126363|P2|Overall Study|Withdrawal by Subject|1
29757|NCT01469000|126364|P1|Overall Study|Withdrawal by Subject|9
29758|NCT01468818|126378|P1|Overall Study|Death during treatment|2
29759|NCT01468233|126429|P6|Treatment Period 2|Not specified|0
29760|NCT01468233|126430|P5|Treatment Period 2|Not specified|1
29761|NCT01468233|126431|P4|Treatment Period 2|Not specified|0
29762|NCT01468233|126432|P3|Treatment Period 2|Not specified|3
29763|NCT01468233|126433|P2|Treatment Period 2|Not specified|0
29764|NCT01468233|126434|P1|Treatment Period 2|Not specified|0
29765|NCT01468233|126429|P6|Treatment Period 2|Lost to Follow-up|0
29766|NCT01468233|126430|P5|Treatment Period 2|Lost to Follow-up|2
29767|NCT01468233|126431|P4|Treatment Period 2|Lost to Follow-up|0
29768|NCT01468233|126432|P3|Treatment Period 2|Lost to Follow-up|3
29769|NCT01468233|126433|P2|Treatment Period 2|Lost to Follow-up|0
29770|NCT01468233|126434|P1|Treatment Period 2|Lost to Follow-up|0
29771|NCT01468233|126429|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
29772|NCT01468233|126430|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
29773|NCT01468233|126431|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
29774|NCT01468233|126432|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
29775|NCT01468233|126433|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
29776|NCT01468233|126434|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
29777|NCT01468233|126429|P6|Treatment Period 2|Withdrawal by Subject|1
29778|NCT01468233|126430|P5|Treatment Period 2|Withdrawal by Subject|1
29779|NCT01468233|126431|P4|Treatment Period 2|Withdrawal by Subject|1
29780|NCT01468233|126432|P3|Treatment Period 2|Withdrawal by Subject|9
29781|NCT01468233|126433|P2|Treatment Period 2|Withdrawal by Subject|0
29782|NCT01468233|126434|P1|Treatment Period 2|Withdrawal by Subject|0
29783|NCT01468233|126429|P6|Treatment Period 2|Lack of Efficacy|1
29784|NCT01468233|126430|P5|Treatment Period 2|Lack of Efficacy|0
29785|NCT01468233|126431|P4|Treatment Period 2|Lack of Efficacy|2
29786|NCT01468233|126432|P3|Treatment Period 2|Lack of Efficacy|9
29787|NCT01468233|126433|P2|Treatment Period 2|Lack of Efficacy|0
29788|NCT01468233|126434|P1|Treatment Period 2|Lack of Efficacy|0
29789|NCT01468233|126429|P6|Treatment Period 2|Adverse Event|1
29790|NCT01468233|126430|P5|Treatment Period 2|Adverse Event|2
29791|NCT01468233|126431|P4|Treatment Period 2|Adverse Event|0
29792|NCT01468233|126432|P3|Treatment Period 2|Adverse Event|3
29793|NCT01468233|126433|P2|Treatment Period 2|Adverse Event|0
29794|NCT01468233|126434|P1|Treatment Period 2|Adverse Event|0
29795|NCT01468233|126429|P6|Treatment Period 1|Not specified|0
29796|NCT01468233|126430|P5|Treatment Period 1|Not specified|0
29797|NCT01468233|126431|P4|Treatment Period 1|Not specified|0
29798|NCT01468233|126432|P3|Treatment Period 1|Not specified|0
29799|NCT01468233|126433|P2|Treatment Period 1|Not specified|1
29800|NCT01468233|126434|P1|Treatment Period 1|Not specified|1
29801|NCT01468233|126429|P6|Treatment Period 1|Lost to Follow-up|0
29802|NCT01468233|126430|P5|Treatment Period 1|Lost to Follow-up|0
29803|NCT01468233|126431|P4|Treatment Period 1|Lost to Follow-up|0
29804|NCT01468233|126432|P3|Treatment Period 1|Lost to Follow-up|0
29805|NCT01468233|126433|P2|Treatment Period 1|Lost to Follow-up|0
29806|NCT01468233|126434|P1|Treatment Period 1|Lost to Follow-up|3
29807|NCT01468233|126429|P6|Treatment Period 1|Withdrawal by Subject|0
29808|NCT01468233|126430|P5|Treatment Period 1|Withdrawal by Subject|0
29809|NCT01468233|126431|P4|Treatment Period 1|Withdrawal by Subject|0
29810|NCT01468233|126432|P3|Treatment Period 1|Withdrawal by Subject|0
29811|NCT01468233|126433|P2|Treatment Period 1|Withdrawal by Subject|4
29812|NCT01468233|126434|P1|Treatment Period 1|Withdrawal by Subject|3
29813|NCT01468233|126429|P6|Treatment Period 1|Adverse Event|0
29814|NCT01468233|126430|P5|Treatment Period 1|Adverse Event|0
29815|NCT01468233|126431|P4|Treatment Period 1|Adverse Event|0
29816|NCT01468233|126432|P3|Treatment Period 1|Adverse Event|0
29817|NCT01468233|126433|P2|Treatment Period 1|Adverse Event|3
29818|NCT01468233|126434|P1|Treatment Period 1|Adverse Event|5
29819|NCT01468207|126456|P6|Treatment Period 2|Not specified|2
29820|NCT01468207|126457|P5|Treatment Period 2|Not specified|1
29821|NCT01468207|126458|P4|Treatment Period 2|Not specified|1
29822|NCT01468207|126459|P3|Treatment Period 2|Not specified|5
29823|NCT01468207|126460|P2|Treatment Period 2|Not specified|0
29824|NCT01468207|126461|P1|Treatment Period 2|Not specified|0
29825|NCT01468207|126456|P6|Treatment Period 2|Lost to Follow-up|0
29826|NCT01468207|126457|P5|Treatment Period 2|Lost to Follow-up|0
29827|NCT01468207|126458|P4|Treatment Period 2|Lost to Follow-up|1
29828|NCT01468207|126459|P3|Treatment Period 2|Lost to Follow-up|5
29829|NCT01468207|126460|P2|Treatment Period 2|Lost to Follow-up|0
29830|NCT01468207|126461|P1|Treatment Period 2|Lost to Follow-up|0
29831|NCT01468207|126456|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
29832|NCT01468207|126457|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
29833|NCT01468207|126458|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
29834|NCT01468207|126459|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
29835|NCT01468207|126460|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
29836|NCT01468207|126461|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
29837|NCT01468207|126456|P6|Treatment Period 2|Withdrawal by Subject|2
29838|NCT01468207|126457|P5|Treatment Period 2|Withdrawal by Subject|0
29839|NCT01468207|126458|P4|Treatment Period 2|Withdrawal by Subject|0
29840|NCT01468207|126459|P3|Treatment Period 2|Withdrawal by Subject|5
29841|NCT01468207|126460|P2|Treatment Period 2|Withdrawal by Subject|0
29842|NCT01468207|126461|P1|Treatment Period 2|Withdrawal by Subject|0
29843|NCT01468207|126456|P6|Treatment Period 2|Lack of Efficacy|2
29844|NCT01468207|126457|P5|Treatment Period 2|Lack of Efficacy|0
29845|NCT01468207|126458|P4|Treatment Period 2|Lack of Efficacy|1
29846|NCT01468207|126459|P3|Treatment Period 2|Lack of Efficacy|1
29847|NCT01468207|126460|P2|Treatment Period 2|Lack of Efficacy|0
29848|NCT01468207|126461|P1|Treatment Period 2|Lack of Efficacy|0
29849|NCT01468207|126456|P6|Treatment Period 2|Adverse Event|1
29850|NCT01468207|126457|P5|Treatment Period 2|Adverse Event|2
29851|NCT01468207|126458|P4|Treatment Period 2|Adverse Event|1
29852|NCT01468207|126459|P3|Treatment Period 2|Adverse Event|6
29853|NCT01468207|126460|P2|Treatment Period 2|Adverse Event|0
29854|NCT01468207|126461|P1|Treatment Period 2|Adverse Event|0
29855|NCT01468207|126456|P6|Treatment Period 1|Not specified|0
29856|NCT01468207|126457|P5|Treatment Period 1|Not specified|0
29857|NCT01468207|126458|P4|Treatment Period 1|Not specified|0
29858|NCT01468207|126459|P3|Treatment Period 1|Not specified|0
29859|NCT01468207|126460|P2|Treatment Period 1|Not specified|2
29860|NCT01468207|126461|P1|Treatment Period 1|Not specified|0
29861|NCT01468207|126456|P6|Treatment Period 1|Lost to Follow-up|0
29862|NCT01468207|126457|P5|Treatment Period 1|Lost to Follow-up|0
29863|NCT01468207|126458|P4|Treatment Period 1|Lost to Follow-up|0
29864|NCT01468207|126459|P3|Treatment Period 1|Lost to Follow-up|0
29865|NCT01468207|126460|P2|Treatment Period 1|Lost to Follow-up|1
29866|NCT01468207|126461|P1|Treatment Period 1|Lost to Follow-up|2
29867|NCT01468207|126456|P6|Treatment Period 1|Withdrawal by Subject|0
29868|NCT01468207|126457|P5|Treatment Period 1|Withdrawal by Subject|0
29869|NCT01468207|126458|P4|Treatment Period 1|Withdrawal by Subject|0
29870|NCT01468207|126459|P3|Treatment Period 1|Withdrawal by Subject|0
29871|NCT01468207|126460|P2|Treatment Period 1|Withdrawal by Subject|4
29872|NCT01468207|126461|P1|Treatment Period 1|Withdrawal by Subject|5
29873|NCT01468207|126456|P6|Treatment Period 1|Protocol Violation|0
29874|NCT01468207|126457|P5|Treatment Period 1|Protocol Violation|0
29875|NCT01468207|126458|P4|Treatment Period 1|Protocol Violation|0
29876|NCT01468207|126459|P3|Treatment Period 1|Protocol Violation|0
29877|NCT01468207|126460|P2|Treatment Period 1|Protocol Violation|1
29878|NCT01468207|126461|P1|Treatment Period 1|Protocol Violation|1
29879|NCT01468207|126456|P6|Treatment Period 1|Adverse Event|0
29880|NCT01468207|126457|P5|Treatment Period 1|Adverse Event|0
29881|NCT01468207|126458|P4|Treatment Period 1|Adverse Event|0
29882|NCT01468207|126459|P3|Treatment Period 1|Adverse Event|0
29883|NCT01468207|126460|P2|Treatment Period 1|Adverse Event|0
29884|NCT01468207|126461|P1|Treatment Period 1|Adverse Event|1
29885|NCT01468181|126486|P5|Overall Study|Withdrawal by Subject|0
29886|NCT01468181|126487|P4|Overall Study|Withdrawal by Subject|0
29887|NCT01468181|126488|P3|Overall Study|Withdrawal by Subject|0
29888|NCT01468181|126489|P2|Overall Study|Withdrawal by Subject|1
29889|NCT01468181|126490|P1|Overall Study|Withdrawal by Subject|0
29890|NCT01468181|126486|P5|Overall Study|Lost to Follow-up|1
29891|NCT01468181|126487|P4|Overall Study|Lost to Follow-up|0
29892|NCT01468181|126488|P3|Overall Study|Lost to Follow-up|1
29893|NCT01468181|126489|P2|Overall Study|Lost to Follow-up|0
29894|NCT01468181|126490|P1|Overall Study|Lost to Follow-up|0
29895|NCT01468181|126486|P5|Overall Study|Physician Decision|1
29896|NCT01468181|126487|P4|Overall Study|Physician Decision|1
29897|NCT01468181|126488|P3|Overall Study|Physician Decision|0
29898|NCT01468181|126489|P2|Overall Study|Physician Decision|0
29899|NCT01468181|126490|P1|Overall Study|Physician Decision|0
29900|NCT01468181|126486|P5|Overall Study|Protocol Violation|1
29901|NCT01468181|126487|P4|Overall Study|Protocol Violation|0
29902|NCT01468181|126488|P3|Overall Study|Protocol Violation|1
29903|NCT01468181|126489|P2|Overall Study|Protocol Violation|0
29904|NCT01468181|126490|P1|Overall Study|Protocol Violation|2
29905|NCT01468181|126486|P5|Overall Study|Adverse Event|2
29906|NCT01468181|126487|P4|Overall Study|Adverse Event|2
29907|NCT01468181|126488|P3|Overall Study|Adverse Event|6
29908|NCT01468181|126489|P2|Overall Study|Adverse Event|1
29909|NCT01468181|126490|P1|Overall Study|Adverse Event|8
29910|NCT01468077|126539|P2|Overall Study|Physician Decision|0
29911|NCT01468077|126540|P1|Overall Study|Physician Decision|1
29912|NCT01468077|126539|P2|Overall Study|Lack of Efficacy|1
29913|NCT01468077|126540|P1|Overall Study|Lack of Efficacy|1
29914|NCT01468077|126539|P2|Overall Study|Adverse Event|2
29915|NCT01468077|126540|P1|Overall Study|Adverse Event|2
29916|NCT01467960|126593|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
29917|NCT01467960|126594|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
29918|NCT01467960|126595|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
29919|NCT01467960|126596|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
29920|NCT01467960|126597|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
29921|NCT01467960|126598|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
29922|NCT01467713|126657|P4|Overall Study|Reason not Specified|7
29923|NCT01467713|126658|P3|Overall Study|Reason not Specified|8
29924|NCT01467713|126659|P2|Overall Study|Reason not Specified|11
29925|NCT01467713|126660|P1|Overall Study|Reason not Specified|6
29926|NCT01467713|126657|P4|Overall Study|Relapse|35
29927|NCT01467713|126658|P3|Overall Study|Relapse|28
29928|NCT01467713|126659|P2|Overall Study|Relapse|25
29929|NCT01467713|126660|P1|Overall Study|Relapse|35
29930|NCT01467713|126657|P4|Overall Study|Pregnancy|3
29931|NCT01467713|126658|P3|Overall Study|Pregnancy|1
29932|NCT01467713|126659|P2|Overall Study|Pregnancy|1
29933|NCT01467713|126660|P1|Overall Study|Pregnancy|0
29934|NCT01467713|126657|P4|Overall Study|Study Termination|29
29935|NCT01467713|126658|P3|Overall Study|Study Termination|28
29936|NCT01467713|126659|P2|Overall Study|Study Termination|33
29937|NCT01467713|126660|P1|Overall Study|Study Termination|23
29938|NCT01467713|126657|P4|Overall Study|Voluntary Withdrawal|20
29939|NCT01467713|126658|P3|Overall Study|Voluntary Withdrawal|21
29940|NCT01467713|126659|P2|Overall Study|Voluntary Withdrawal|14
29941|NCT01467713|126660|P1|Overall Study|Voluntary Withdrawal|18
29942|NCT01467713|126657|P4|Overall Study|Lost to Follow-up|9
29943|NCT01467713|126658|P3|Overall Study|Lost to Follow-up|6
29944|NCT01467713|126659|P2|Overall Study|Lost to Follow-up|12
29945|NCT01467713|126660|P1|Overall Study|Lost to Follow-up|9
29946|NCT01467713|126657|P4|Overall Study|Major Protocol Deviation|1
29947|NCT01467713|126658|P3|Overall Study|Major Protocol Deviation|4
29948|NCT01467713|126659|P2|Overall Study|Major Protocol Deviation|4
29949|NCT01467713|126660|P1|Overall Study|Major Protocol Deviation|2
29950|NCT01467713|126657|P4|Overall Study|Pretreatment Event or Adverse Event|5
29951|NCT01467713|126658|P3|Overall Study|Pretreatment Event or Adverse Event|6
29952|NCT01467713|126659|P2|Overall Study|Pretreatment Event or Adverse Event|4
29953|NCT01467713|126660|P1|Overall Study|Pretreatment Event or Adverse Event|9
29954|NCT01467700|126714|P4|Overall Study|Reason not Specified|8
29955|NCT01467700|126715|P3|Overall Study|Reason not Specified|2
29956|NCT01467700|126716|P2|Overall Study|Reason not Specified|3
29957|NCT01467700|126717|P1|Overall Study|Reason not Specified|1
29958|NCT01467700|126714|P4|Overall Study|Lack of Efficacy|1
29959|NCT01467700|126715|P3|Overall Study|Lack of Efficacy|2
29960|NCT01467700|126716|P2|Overall Study|Lack of Efficacy|0
29961|NCT01467700|126717|P1|Overall Study|Lack of Efficacy|2
29962|NCT01467700|126714|P4|Overall Study|Pregnancy|0
29963|NCT01467700|126715|P3|Overall Study|Pregnancy|1
29964|NCT01467700|126716|P2|Overall Study|Pregnancy|1
29965|NCT01467700|126717|P1|Overall Study|Pregnancy|0
29966|NCT01467700|126714|P4|Overall Study|Study Termination|7
29967|NCT01467700|126715|P3|Overall Study|Study Termination|10
29968|NCT01467700|126716|P2|Overall Study|Study Termination|5
29969|NCT01467700|126717|P1|Overall Study|Study Termination|6
29970|NCT01467700|126714|P4|Overall Study|Voluntary Withdrawal|2
29971|NCT01467700|126715|P3|Overall Study|Voluntary Withdrawal|6
29972|NCT01467700|126716|P2|Overall Study|Voluntary Withdrawal|7
29973|NCT01467700|126717|P1|Overall Study|Voluntary Withdrawal|5
29974|NCT01467700|126714|P4|Overall Study|Lost to Follow-up|3
29975|NCT01467700|126715|P3|Overall Study|Lost to Follow-up|2
29976|NCT01467700|126716|P2|Overall Study|Lost to Follow-up|5
29977|NCT01467700|126717|P1|Overall Study|Lost to Follow-up|6
29978|NCT01467700|126714|P4|Overall Study|Major Protocol Deviation|3
29979|NCT01467700|126715|P3|Overall Study|Major Protocol Deviation|2
29980|NCT01467700|126716|P2|Overall Study|Major Protocol Deviation|3
29981|NCT01467700|126717|P1|Overall Study|Major Protocol Deviation|3
29982|NCT01467700|126714|P4|Overall Study|Pretreatment Event or Adverse Event|3
29983|NCT01467700|126715|P3|Overall Study|Pretreatment Event or Adverse Event|2
29984|NCT01467700|126716|P2|Overall Study|Pretreatment Event or Adverse Event|4
29985|NCT01467700|126717|P1|Overall Study|Pretreatment Event or Adverse Event|6
29986|NCT01467661|126759|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
29987|NCT01467661|126759|P1|Overall Study|Lack of Efficacy|3
29988|NCT01467661|126759|P1|Overall Study|Withdrawal by Subject|1
29989|NCT01467661|126759|P1|Overall Study|Adverse Event|16
29990|NCT01467583|126779|P3|Overall Study|Protocol Violation|2
29991|NCT01467583|126780|P2|Overall Study|Protocol Violation|0
29992|NCT01467583|126781|P1|Overall Study|Protocol Violation|0
29993|NCT01467583|126779|P3|Overall Study|Withdrawal by Subject|0
29994|NCT01467583|126780|P2|Overall Study|Withdrawal by Subject|0
29995|NCT01467583|126781|P1|Overall Study|Withdrawal by Subject|1
29996|NCT01467583|126779|P3|Overall Study|Death|0
29997|NCT01467583|126780|P2|Overall Study|Death|1
29998|NCT01467583|126781|P1|Overall Study|Death|1
29999|NCT01467570|126794|P2|Overall Study|Lost to Follow-up|9
30000|NCT01467570|126795|P1|Overall Study|Lost to Follow-up|8
30001|NCT01467505|126832|P2|Overall Study|Study Terminated by Sponsor|3
30002|NCT01467505|126833|P1|Overall Study|Study Terminated by Sponsor|28
30003|NCT01467505|126832|P2|Overall Study|Withdrawal by Subject|0
30004|NCT01467505|126833|P1|Overall Study|Withdrawal by Subject|4
30005|NCT01467505|126832|P2|Overall Study|Adverse Event|0
30006|NCT01467505|126833|P1|Overall Study|Adverse Event|1
30007|NCT01467492|126865|P2|Overall Study|Enrolled But Not Treated|0
30008|NCT01467492|126866|P1|Overall Study|Enrolled But Not Treated|1
30009|NCT01467492|126865|P2|Overall Study|Undefined|0
30010|NCT01467492|126866|P1|Overall Study|Undefined|2
30011|NCT01467492|126865|P2|Overall Study|Lost to Follow-up|2
30012|NCT01467492|126866|P1|Overall Study|Lost to Follow-up|3
30013|NCT01467492|126865|P2|Overall Study|Adverse Event|3
30014|NCT01467492|126866|P1|Overall Study|Adverse Event|4
30015|NCT01467492|126865|P2|Overall Study|Study Terminated by Sponsor|4
30016|NCT01467492|126866|P1|Overall Study|Study Terminated by Sponsor|6
30017|NCT01467492|126865|P2|Overall Study|Withdrawal by Subject|4
30018|NCT01467492|126866|P1|Overall Study|Withdrawal by Subject|6
30019|NCT01467479|126890|P3|Overall Study|Unspecified|0
30020|NCT01467479|126891|P2|Overall Study|Unspecified|0
30021|NCT01467479|126892|P1|Overall Study|Unspecified|1
30022|NCT01467479|126890|P3|Overall Study|Study Terminated by Sponsor|3
30023|NCT01467479|126891|P2|Overall Study|Study Terminated by Sponsor|3
30024|NCT01467479|126892|P1|Overall Study|Study Terminated by Sponsor|1
30025|NCT01467479|126890|P3|Overall Study|Withdrawal of Consent|7
30026|NCT01467479|126891|P2|Overall Study|Withdrawal of Consent|7
30027|NCT01467479|126892|P1|Overall Study|Withdrawal of Consent|3
30028|NCT01467479|126890|P3|Overall Study|Lost to Follow-up|3
30029|NCT01467479|126891|P2|Overall Study|Lost to Follow-up|5
30030|NCT01467479|126892|P1|Overall Study|Lost to Follow-up|2
30031|NCT01467479|126890|P3|Overall Study|Death|1
30032|NCT01467479|126891|P2|Overall Study|Death|0
30033|NCT01467479|126892|P1|Overall Study|Death|0
30034|NCT01467479|126890|P3|Overall Study|Adverse Event|0
30035|NCT01467479|126891|P2|Overall Study|Adverse Event|2
30036|NCT01467479|126892|P1|Overall Study|Adverse Event|1
30037|NCT01467479|126890|P3|Overall Study|No Study Medication|2
30038|NCT01467479|126891|P2|Overall Study|No Study Medication|0
30039|NCT01467479|126892|P1|Overall Study|No Study Medication|1
30040|NCT01467076|126922|P3|Overall Study|Lost to Follow-up|0
30041|NCT01467076|126923|P2|Overall Study|Lost to Follow-up|0
30042|NCT01467076|126924|P1|Overall Study|Lost to Follow-up|1
30043|NCT01466881|126941|P1|Overall Study|Other reason not protocol specified|5
30044|NCT01466881|126941|P1|Overall Study|Death|4
30045|NCT01466881|126941|P1|Overall Study|Progression/relapse|20
30046|NCT01466881|126941|P1|Overall Study|Adverse Event|6
30047|NCT01466881|126941|P1|Overall Study|Ineligible|5
30048|NCT01466790|126958|P8|Overall Study|Withdrawal by Subject|1
30049|NCT01466790|126959|P7|Overall Study|Withdrawal by Subject|1
30050|NCT01466790|126960|P6|Overall Study|Withdrawal by Subject|0
30051|NCT01466790|126961|P5|Overall Study|Withdrawal by Subject|1
30052|NCT01466790|126962|P4|Overall Study|Withdrawal by Subject|0
30053|NCT01466790|126963|P3|Overall Study|Withdrawal by Subject|0
30054|NCT01466790|126964|P2|Overall Study|Withdrawal by Subject|1
30055|NCT01466790|126965|P1|Overall Study|Withdrawal by Subject|1
30056|NCT01466790|126958|P8|Overall Study|Lost to Follow-up|0
30057|NCT01466790|126959|P7|Overall Study|Lost to Follow-up|0
30058|NCT01466790|126960|P6|Overall Study|Lost to Follow-up|0
30059|NCT01466790|126961|P5|Overall Study|Lost to Follow-up|0
30060|NCT01466790|126962|P4|Overall Study|Lost to Follow-up|0
30061|NCT01466790|126963|P3|Overall Study|Lost to Follow-up|0
30062|NCT01466790|126964|P2|Overall Study|Lost to Follow-up|0
30063|NCT01466790|126965|P1|Overall Study|Lost to Follow-up|2
30064|NCT01466790|126958|P8|Overall Study|Adverse Event|0
30065|NCT01466790|126959|P7|Overall Study|Adverse Event|0
30066|NCT01466790|126960|P6|Overall Study|Adverse Event|0
30067|NCT01466790|126961|P5|Overall Study|Adverse Event|2
30068|NCT01466790|126962|P4|Overall Study|Adverse Event|0
30069|NCT01466790|126963|P3|Overall Study|Adverse Event|0
30070|NCT01466790|126964|P2|Overall Study|Adverse Event|0
30071|NCT01466790|126965|P1|Overall Study|Adverse Event|1
30072|NCT01466673|127029|P2|Overall Study|Adverse Event|1
30073|NCT01466673|127030|P1|Overall Study|Adverse Event|2
30074|NCT01466673|127029|P2|Overall Study|Lost to Follow-up|5
30075|NCT01466673|127030|P1|Overall Study|Lost to Follow-up|3
30076|NCT01466673|127029|P2|Overall Study|Non-compliance with study treatment|0
30077|NCT01466673|127030|P1|Overall Study|Non-compliance with study treatment|2
30078|NCT01466595|127056|P2|Overall Study|Withdrawal by Subject|1
30079|NCT01466595|127057|P1|Overall Study|Withdrawal by Subject|0
30080|NCT01466387|127153|P6|Overall Study|Protocol Violation|0
30081|NCT01466387|127154|P5|Overall Study|Protocol Violation|0
30082|NCT01466387|127155|P4|Overall Study|Protocol Violation|1
30083|NCT01466387|127156|P3|Overall Study|Protocol Violation|0
30084|NCT01466387|127157|P2|Overall Study|Protocol Violation|0
30085|NCT01466387|127158|P1|Overall Study|Protocol Violation|1
30086|NCT01466387|127153|P6|Overall Study|Lost to Follow-up|1
30087|NCT01466387|127154|P5|Overall Study|Lost to Follow-up|0
30088|NCT01466387|127155|P4|Overall Study|Lost to Follow-up|0
30089|NCT01466387|127156|P3|Overall Study|Lost to Follow-up|0
30090|NCT01466387|127157|P2|Overall Study|Lost to Follow-up|0
30091|NCT01466387|127158|P1|Overall Study|Lost to Follow-up|0
30092|NCT01466387|127153|P6|Overall Study|Adverse Event|0
30093|NCT01466387|127154|P5|Overall Study|Adverse Event|0
30094|NCT01466387|127155|P4|Overall Study|Adverse Event|1
30095|NCT01466387|127156|P3|Overall Study|Adverse Event|1
30096|NCT01466387|127157|P2|Overall Study|Adverse Event|0
30097|NCT01466387|127158|P1|Overall Study|Adverse Event|0
30098|NCT01466348|127219|P2|Period I - First Intervention|Withdrawal by Subject|1
30099|NCT01466348|127220|P1|Period I - First Intervention|Withdrawal by Subject|0
30100|NCT01466270|127248|P2|Overall Study|Multiple|1
30101|NCT01466270|127249|P1|Overall Study|Multiple|1
30102|NCT01466270|127248|P2|Overall Study|Toxicity|1
30103|NCT01466270|127249|P1|Overall Study|Toxicity|4
30104|NCT01466270|127248|P2|Overall Study|Progression|0
30105|NCT01466270|127249|P1|Overall Study|Progression|1
30106|NCT01466270|127248|P2|Overall Study|Lost to Follow-up|3
30107|NCT01466270|127249|P1|Overall Study|Lost to Follow-up|1
30108|NCT01466270|127248|P2|Overall Study|Physician Decision|0
30109|NCT01466270|127249|P1|Overall Study|Physician Decision|1
30110|NCT01466270|127248|P2|Overall Study|Withdrawal by Subject|1
30111|NCT01466270|127249|P1|Overall Study|Withdrawal by Subject|4
30112|NCT01466192|127261|P1|Overall Study|Withdrawal by Subject|3
30113|NCT01466192|127261|P1|Overall Study|Physician Decision|1
30114|NCT01466179|127265|P1|Overall Study|Other|3
30115|NCT01466179|127265|P1|Overall Study|Protocol Violation|2
30116|NCT01466179|127265|P1|Overall Study|Withdrawal by Subject|7
30117|NCT01466179|127265|P1|Overall Study|Death|7
30118|NCT01466179|127265|P1|Overall Study|Lack of Efficacy|14
30119|NCT01466179|127265|P1|Overall Study|Disease relapse|23
30120|NCT01466179|127265|P1|Overall Study|Adverse Event|32
30121|NCT01466179|127265|P1|Overall Study|Progressive disease|43
30122|NCT01466179|127265|P1|Overall Study|Physician Decision|46
30123|NCT01466179|127265|P1|Overall Study|Ongoing in core study|2
30124|NCT01466062|127292|P1|Overall Study|Withdrawal by Subject|1
30125|NCT01466062|127292|P1|Overall Study|Adverse Event|1
30126|NCT01465958|127313|P2|Subcutaneous (SC) Phase|Adverse Event|1
30127|NCT01465958|127314|P1|Subcutaneous (SC) Phase|Adverse Event|0
30128|NCT01465958|127313|P2|Run-in Phase|Protocol Violation|0
30129|NCT01465958|127314|P1|Run-in Phase|Protocol Violation|1
30130|NCT01465802|127327|P5|Overall Study|Death|2
30131|NCT01465802|127328|P4|Overall Study|Death|10
30132|NCT01465802|127329|P3|Overall Study|Death|0
30133|NCT01465802|127330|P2|Overall Study|Death|12
30134|NCT01465802|127331|P1|Overall Study|Death|15
30135|NCT01465802|127327|P5|Overall Study|Reason not specified|2
30136|NCT01465802|127328|P4|Overall Study|Reason not specified|10
30137|NCT01465802|127329|P3|Overall Study|Reason not specified|0
30138|NCT01465802|127330|P2|Overall Study|Reason not specified|4
30139|NCT01465802|127331|P1|Overall Study|Reason not specified|9
30140|NCT01465802|127327|P5|Overall Study|Lost to Follow-up|0
30141|NCT01465802|127328|P4|Overall Study|Lost to Follow-up|0
30142|NCT01465802|127329|P3|Overall Study|Lost to Follow-up|0
30143|NCT01465802|127330|P2|Overall Study|Lost to Follow-up|1
30144|NCT01465802|127331|P1|Overall Study|Lost to Follow-up|1
30145|NCT01465802|127327|P5|Overall Study|Withdrawal by Subject|1
30146|NCT01465802|127328|P4|Overall Study|Withdrawal by Subject|8
30147|NCT01465802|127329|P3|Overall Study|Withdrawal by Subject|0
30148|NCT01465802|127330|P2|Overall Study|Withdrawal by Subject|7
30149|NCT01465802|127331|P1|Overall Study|Withdrawal by Subject|7
30150|NCT01465802|127327|P5|Overall Study|Study terminated by sponsor|7
30151|NCT01465802|127328|P4|Overall Study|Study terminated by sponsor|1
30152|NCT01465802|127329|P3|Overall Study|Study terminated by sponsor|0
30153|NCT01465802|127330|P2|Overall Study|Study terminated by sponsor|0
30154|NCT01465802|127331|P1|Overall Study|Study terminated by sponsor|1
30155|NCT01465763|127383|P3|Overall Study|Death|0
30156|NCT01465763|127384|P2|Overall Study|Death|0
30157|NCT01465763|127385|P1|Overall Study|Death|1
30158|NCT01465763|127383|P3|Overall Study|Protocol Violation|1
30159|NCT01465763|127384|P2|Overall Study|Protocol Violation|1
30160|NCT01465763|127385|P1|Overall Study|Protocol Violation|4
30161|NCT01465763|127383|P3|Overall Study|Unspecified|0
30162|NCT01465763|127384|P2|Overall Study|Unspecified|0
30163|NCT01465763|127385|P1|Overall Study|Unspecified|2
30164|NCT01465763|127383|P3|Overall Study|Adverse Event|1
30165|NCT01465763|127384|P2|Overall Study|Adverse Event|0
30166|NCT01465763|127385|P1|Overall Study|Adverse Event|9
30167|NCT01465763|127383|P3|Overall Study|Insufficient Clinical Response|1
30168|NCT01465763|127384|P2|Overall Study|Insufficient Clinical Response|0
30169|NCT01465763|127385|P1|Overall Study|Insufficient Clinical Response|11
30170|NCT01465763|127383|P3|Overall Study|Withdrawal by Subject|1
30171|NCT01465763|127384|P2|Overall Study|Withdrawal by Subject|0
30172|NCT01465763|127385|P1|Overall Study|Withdrawal by Subject|4
30173|NCT01465230|127455|P1|Overall Study|Withdrawal by Subject|2
30174|NCT01465178|127461|P2|Overall Study|Withdrawal by Subject|0
30175|NCT01465178|127462|P1|Overall Study|Withdrawal by Subject|1
30176|NCT01465022|127486|P3|Overall Study|Not Randomized|70
30177|NCT01465022|127487|P2|Overall Study|Not Randomized|0
30178|NCT01465022|127488|P1|Overall Study|Not Randomized|0
30179|NCT01465022|127486|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
30180|NCT01465022|127487|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
30181|NCT01465022|127488|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
30182|NCT01465022|127486|P3|Overall Study|Lost to Follow-up|0
30183|NCT01465022|127487|P2|Overall Study|Lost to Follow-up|14
30184|NCT01465022|127488|P1|Overall Study|Lost to Follow-up|15
30185|NCT01464931|127522|P2|Overall Study|Withdrawal by Subject|0
30186|NCT01464931|127523|P1|Overall Study|Withdrawal by Subject|1
30187|NCT01464827|127587|P14|Overall Study|Not Treated|2
30188|NCT01464827|127588|P13|Overall Study|Not Treated|0
30189|NCT01464827|127589|P12|Overall Study|Not Treated|1
30190|NCT01464827|127590|P11|Overall Study|Not Treated|0
30191|NCT01464827|127591|P10|Overall Study|Not Treated|2
30192|NCT01464827|127592|P9|Overall Study|Not Treated|0
30193|NCT01464827|127593|P8|Overall Study|Not Treated|0
30194|NCT01464827|127594|P7|Overall Study|Not Treated|1
30195|NCT01464827|127595|P6|Overall Study|Not Treated|0
30196|NCT01464827|127596|P5|Overall Study|Not Treated|1
30197|NCT01464827|127597|P4|Overall Study|Not Treated|0
30198|NCT01464827|127598|P3|Overall Study|Not Treated|0
30199|NCT01464827|127599|P2|Overall Study|Not Treated|2
30200|NCT01464827|127600|P1|Overall Study|Not Treated|0
30201|NCT01464827|127587|P14|Overall Study|Other|0
30202|NCT01464827|127588|P13|Overall Study|Other|1
30203|NCT01464827|127589|P12|Overall Study|Other|0
30204|NCT01464827|127590|P11|Overall Study|Other|2
30205|NCT01464827|127591|P10|Overall Study|Other|1
30206|NCT01464827|127592|P9|Overall Study|Other|3
30207|NCT01464827|127593|P8|Overall Study|Other|0
30208|NCT01464827|127594|P7|Overall Study|Other|1
30209|NCT01464827|127595|P6|Overall Study|Other|0
30210|NCT01464827|127596|P5|Overall Study|Other|3
30211|NCT01464827|127597|P4|Overall Study|Other|2
30212|NCT01464827|127598|P3|Overall Study|Other|0
30213|NCT01464827|127599|P2|Overall Study|Other|3
30214|NCT01464827|127600|P1|Overall Study|Other|2
30215|NCT01464827|127587|P14|Overall Study|Lost to Follow-up|1
30216|NCT01464827|127588|P13|Overall Study|Lost to Follow-up|0
30217|NCT01464827|127589|P12|Overall Study|Lost to Follow-up|1
30218|NCT01464827|127590|P11|Overall Study|Lost to Follow-up|0
30219|NCT01464827|127591|P10|Overall Study|Lost to Follow-up|0
30220|NCT01464827|127592|P9|Overall Study|Lost to Follow-up|0
30221|NCT01464827|127593|P8|Overall Study|Lost to Follow-up|2
30222|NCT01464827|127594|P7|Overall Study|Lost to Follow-up|2
30223|NCT01464827|127595|P6|Overall Study|Lost to Follow-up|1
30224|NCT01464827|127596|P5|Overall Study|Lost to Follow-up|3
30225|NCT01464827|127597|P4|Overall Study|Lost to Follow-up|2
30226|NCT01464827|127598|P3|Overall Study|Lost to Follow-up|0
30227|NCT01464827|127599|P2|Overall Study|Lost to Follow-up|2
30228|NCT01464827|127600|P1|Overall Study|Lost to Follow-up|0
30229|NCT01464827|127587|P14|Overall Study|Withdrawal by Subject|0
30230|NCT01464827|127588|P13|Overall Study|Withdrawal by Subject|0
30231|NCT01464827|127589|P12|Overall Study|Withdrawal by Subject|0
30232|NCT01464827|127590|P11|Overall Study|Withdrawal by Subject|0
30233|NCT01464827|127591|P10|Overall Study|Withdrawal by Subject|0
30234|NCT01464827|127592|P9|Overall Study|Withdrawal by Subject|0
30235|NCT01464827|127593|P8|Overall Study|Withdrawal by Subject|1
30236|NCT01464827|127594|P7|Overall Study|Withdrawal by Subject|0
30237|NCT01464827|127595|P6|Overall Study|Withdrawal by Subject|0
30238|NCT01464827|127596|P5|Overall Study|Withdrawal by Subject|1
30239|NCT01464827|127597|P4|Overall Study|Withdrawal by Subject|0
30240|NCT01464827|127598|P3|Overall Study|Withdrawal by Subject|0
30241|NCT01464827|127599|P2|Overall Study|Withdrawal by Subject|0
30242|NCT01464827|127600|P1|Overall Study|Withdrawal by Subject|1
30243|NCT01464827|127587|P14|Overall Study|Adverse Event|0
30244|NCT01464827|127588|P13|Overall Study|Adverse Event|1
30245|NCT01464827|127589|P12|Overall Study|Adverse Event|0
30246|NCT01464827|127590|P11|Overall Study|Adverse Event|0
30247|NCT01464827|127591|P10|Overall Study|Adverse Event|0
30248|NCT01464827|127592|P9|Overall Study|Adverse Event|0
30249|NCT01464827|127593|P8|Overall Study|Adverse Event|0
30250|NCT01464827|127594|P7|Overall Study|Adverse Event|0
30251|NCT01464827|127595|P6|Overall Study|Adverse Event|0
30252|NCT01464827|127596|P5|Overall Study|Adverse Event|0
30253|NCT01464827|127597|P4|Overall Study|Adverse Event|0
30254|NCT01464827|127598|P3|Overall Study|Adverse Event|0
30255|NCT01464827|127599|P2|Overall Study|Adverse Event|0
30256|NCT01464827|127600|P1|Overall Study|Adverse Event|0
30257|NCT01464619|127646|P2|Overall Study|Lost to Follow-up|4
30258|NCT01464619|127647|P1|Overall Study|Lost to Follow-up|3
30259|NCT01464424|127667|P2|Period 1, First 6 Weeks|Adverse Event|1
30260|NCT01464424|127668|P1|Period 1, First 6 Weeks|Adverse Event|0
30261|NCT01464307|127682|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
30262|NCT01464307|127683|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
30263|NCT01464307|127682|P2|Open-Label Extension Period|Non-compliance|0
30264|NCT01464307|127683|P1|Open-Label Extension Period|Non-compliance|9
30265|NCT01464307|127682|P2|Open-Label Extension Period|Lost to Follow-up|0
30266|NCT01464307|127683|P1|Open-Label Extension Period|Lost to Follow-up|1
30267|NCT01464307|127682|P2|Open-Label Extension Period|Death|0
30268|NCT01464307|127683|P1|Open-Label Extension Period|Death|1
30269|NCT01464307|127682|P2|Open-Label Extension Period|Lack of Efficacy|0
30270|NCT01464307|127683|P1|Open-Label Extension Period|Lack of Efficacy|5
30271|NCT01464307|127682|P2|Open-Label Extension Period|Withdrawal by Subject|0
30272|NCT01464307|127683|P1|Open-Label Extension Period|Withdrawal by Subject|14
30273|NCT01464307|127682|P2|Open-Label Extension Period|Adverse Event|0
30274|NCT01464307|127683|P1|Open-Label Extension Period|Adverse Event|15
30275|NCT01464307|127682|P2|Main Period|Predefined discontinuation criteria|1
30276|NCT01464307|127683|P1|Main Period|Predefined discontinuation criteria|2
30277|NCT01464307|127682|P2|Main Period|Withdrawal by Subject|2
30278|NCT01464307|127683|P1|Main Period|Withdrawal by Subject|5
30279|NCT01464307|127682|P2|Main Period|Lack of Efficacy|0
30280|NCT01464307|127683|P1|Main Period|Lack of Efficacy|2
30281|NCT01464307|127682|P2|Main Period|Adverse Event|1
30282|NCT01464307|127683|P1|Main Period|Adverse Event|6
30283|NCT01464307|127682|P2|Main Period|Death|1
30284|NCT01464307|127683|P1|Main Period|Death|0
30285|NCT01464255|127698|P2|Overall Study|unresolve corneal staining|1
30286|NCT01464255|127699|P1|Overall Study|unresolve corneal staining|0
30287|NCT01464021|127735|P1|Overall Study|various|11
30288|NCT01464021|127735|P1|Overall Study|Lack of Efficacy|1
30289|NCT01464021|127735|P1|Overall Study|Lost to Follow-up|1
30290|NCT01464021|127735|P1|Overall Study|Withdrawal by Subject|13
30291|NCT01463982|127751|P4|Overall Study|Treatment delay over 5 week|0
30292|NCT01463982|127752|P3|Overall Study|Treatment delay over 5 week|1
30293|NCT01463982|127753|P2|Overall Study|Treatment delay over 5 week|0
30294|NCT01463982|127754|P1|Overall Study|Treatment delay over 5 week|0
30295|NCT01463982|127751|P4|Overall Study|Withdrawal by Subject|0
30296|NCT01463982|127752|P3|Overall Study|Withdrawal by Subject|1
30297|NCT01463982|127753|P2|Overall Study|Withdrawal by Subject|1
30298|NCT01463982|127754|P1|Overall Study|Withdrawal by Subject|0
30299|NCT01463878|127770|P2|Overall Study|no longer met criteria for tube feed|2
30300|NCT01463878|127771|P1|Overall Study|no longer met criteria for tube feed|2
30301|NCT01463696|127785|P8|Overall Study|Not Treated|0
30302|NCT01463696|127786|P7|Overall Study|Not Treated|1
30303|NCT01463696|127787|P6|Overall Study|Not Treated|0
30304|NCT01463696|127788|P5|Overall Study|Not Treated|0
30305|NCT01463696|127789|P4|Overall Study|Not Treated|0
30306|NCT01463696|127790|P3|Overall Study|Not Treated|0
30307|NCT01463696|127791|P2|Overall Study|Not Treated|0
30308|NCT01463696|127792|P1|Overall Study|Not Treated|0
30309|NCT01463696|127785|P8|Overall Study|Withdrawal by Subject|0
30310|NCT01463696|127786|P7|Overall Study|Withdrawal by Subject|2
30311|NCT01463696|127787|P6|Overall Study|Withdrawal by Subject|1
30312|NCT01463696|127788|P5|Overall Study|Withdrawal by Subject|1
30313|NCT01463696|127789|P4|Overall Study|Withdrawal by Subject|1
30314|NCT01463696|127790|P3|Overall Study|Withdrawal by Subject|0
30315|NCT01463696|127791|P2|Overall Study|Withdrawal by Subject|0
30316|NCT01463696|127792|P1|Overall Study|Withdrawal by Subject|0
30317|NCT01463696|127785|P8|Overall Study|Progressive Disease|2
30318|NCT01463696|127786|P7|Overall Study|Progressive Disease|4
30319|NCT01463696|127787|P6|Overall Study|Progressive Disease|1
30320|NCT01463696|127788|P5|Overall Study|Progressive Disease|0
30321|NCT01463696|127789|P4|Overall Study|Progressive Disease|1
30322|NCT01463696|127790|P3|Overall Study|Progressive Disease|0
30323|NCT01463696|127791|P2|Overall Study|Progressive Disease|1
30324|NCT01463696|127792|P1|Overall Study|Progressive Disease|0
30325|NCT01463696|127785|P8|Overall Study|Lost to Follow-up|0
30326|NCT01463696|127786|P7|Overall Study|Lost to Follow-up|0
30327|NCT01463696|127787|P6|Overall Study|Lost to Follow-up|0
30328|NCT01463696|127788|P5|Overall Study|Lost to Follow-up|0
30329|NCT01463696|127789|P4|Overall Study|Lost to Follow-up|0
30330|NCT01463696|127790|P3|Overall Study|Lost to Follow-up|1
30331|NCT01463696|127791|P2|Overall Study|Lost to Follow-up|0
30332|NCT01463696|127792|P1|Overall Study|Lost to Follow-up|0
30333|NCT01463696|127785|P8|Overall Study|Adverse Event|2
30334|NCT01463696|127786|P7|Overall Study|Adverse Event|3
30335|NCT01463696|127787|P6|Overall Study|Adverse Event|1
30336|NCT01463696|127788|P5|Overall Study|Adverse Event|0
30337|NCT01463696|127789|P4|Overall Study|Adverse Event|2
30338|NCT01463696|127790|P3|Overall Study|Adverse Event|0
30339|NCT01463696|127791|P2|Overall Study|Adverse Event|1
30340|NCT01463696|127792|P1|Overall Study|Adverse Event|0
30341|NCT01463683|127845|P3|Overall Study|Withdrawal by Subject|2
30342|NCT01463683|127846|P2|Overall Study|Withdrawal by Subject|17
30343|NCT01463683|127847|P1|Overall Study|Withdrawal by Subject|5
30344|NCT01463683|127845|P3|Overall Study|Pregnancy|1
30345|NCT01463683|127846|P2|Overall Study|Pregnancy|2
30346|NCT01463683|127847|P1|Overall Study|Pregnancy|2
30347|NCT01463683|127845|P3|Overall Study|Physician Decision|1
30348|NCT01463683|127846|P2|Overall Study|Physician Decision|3
30349|NCT01463683|127847|P1|Overall Study|Physician Decision|0
30350|NCT01463683|127845|P3|Overall Study|Lost to Follow-up|7
30351|NCT01463683|127846|P2|Overall Study|Lost to Follow-up|9
30352|NCT01463683|127847|P1|Overall Study|Lost to Follow-up|10
30353|NCT01463683|127845|P3|Overall Study|Adverse Event|0
30354|NCT01463683|127846|P2|Overall Study|Adverse Event|0
30355|NCT01463683|127847|P1|Overall Study|Adverse Event|2
30356|NCT01463527|127862|P2|Overall Study|Crying >20% of sedation|6
30357|NCT01463527|127863|P1|Overall Study|Crying >20% of sedation|5
30358|NCT01463527|127862|P2|Overall Study|Protocol Violation|1
30359|NCT01463527|127863|P1|Overall Study|Protocol Violation|1
30360|NCT01463293|127884|P3|Overall Study|Other|2
30361|NCT01463293|127885|P2|Overall Study|Other|0
30362|NCT01463293|127886|P1|Overall Study|Other|0
30363|NCT01463293|127884|P3|Overall Study|Withdrawal by Subject|5
30364|NCT01463293|127885|P2|Overall Study|Withdrawal by Subject|10
30365|NCT01463293|127886|P1|Overall Study|Withdrawal by Subject|4
30366|NCT01463293|127884|P3|Overall Study|Adverse Event|0
30367|NCT01463293|127885|P2|Overall Study|Adverse Event|2
30368|NCT01463293|127886|P1|Overall Study|Adverse Event|1
30369|NCT01463293|127884|P3|Overall Study|Lost to Follow-up|5
30370|NCT01463293|127885|P2|Overall Study|Lost to Follow-up|4
30371|NCT01463293|127886|P1|Overall Study|Lost to Follow-up|1
30372|NCT01463033|127896|P2|Overall Study|Death|2
30373|NCT01463033|127897|P1|Overall Study|Death|3
30374|NCT01463033|127896|P2|Overall Study|Lost to Follow-up|4
30375|NCT01463033|127897|P1|Overall Study|Lost to Follow-up|4
30376|NCT01463007|127904|P1|Overall Study|Physician Decision|1
30377|NCT01462942|127915|P5|Overall Study|Protocol Violation|6
30378|NCT01462942|127916|P4|Overall Study|Protocol Violation|9
30379|NCT01462942|127917|P3|Overall Study|Protocol Violation|9
30380|NCT01462942|127918|P2|Overall Study|Protocol Violation|6
30381|NCT01462942|127919|P1|Overall Study|Protocol Violation|4
30382|NCT01462942|127915|P5|Overall Study|Lost to Follow-up|1
30383|NCT01462942|127916|P4|Overall Study|Lost to Follow-up|1
30384|NCT01462942|127917|P3|Overall Study|Lost to Follow-up|1
30385|NCT01462942|127918|P2|Overall Study|Lost to Follow-up|1
30386|NCT01462942|127919|P1|Overall Study|Lost to Follow-up|0
30387|NCT01462942|127915|P5|Overall Study|Lack of Efficacy|3
30388|NCT01462942|127916|P4|Overall Study|Lack of Efficacy|5
30389|NCT01462942|127917|P3|Overall Study|Lack of Efficacy|4
30390|NCT01462942|127918|P2|Overall Study|Lack of Efficacy|0
30391|NCT01462942|127919|P1|Overall Study|Lack of Efficacy|6
30392|NCT01462942|127915|P5|Overall Study|Withdrawal by Subject|19
30393|NCT01462942|127916|P4|Overall Study|Withdrawal by Subject|16
30394|NCT01462942|127917|P3|Overall Study|Withdrawal by Subject|14
30395|NCT01462942|127918|P2|Overall Study|Withdrawal by Subject|10
30396|NCT01462942|127919|P1|Overall Study|Withdrawal by Subject|14
30397|NCT01462942|127915|P5|Overall Study|Other, including COPD exacerbation|5
30398|NCT01462942|127916|P4|Overall Study|Other, including COPD exacerbation|8
30399|NCT01462942|127917|P3|Overall Study|Other, including COPD exacerbation|2
30400|NCT01462942|127918|P2|Overall Study|Other, including COPD exacerbation|5
30401|NCT01462942|127919|P1|Overall Study|Other, including COPD exacerbation|3
30402|NCT01462942|127915|P5|Overall Study|Adverse Event|11
30403|NCT01462942|127916|P4|Overall Study|Adverse Event|11
30404|NCT01462942|127917|P3|Overall Study|Adverse Event|10
30405|NCT01462942|127918|P2|Overall Study|Adverse Event|12
30406|NCT01462942|127919|P1|Overall Study|Adverse Event|7
30407|NCT01462929|127949|P3|Overall Study|Lack of Efficacy|1
30408|NCT01462929|127950|P2|Overall Study|Lack of Efficacy|0
30409|NCT01462929|127951|P1|Overall Study|Lack of Efficacy|0
30410|NCT01462929|127949|P3|Overall Study|Withdrawal by Subject|0
30411|NCT01462929|127950|P2|Overall Study|Withdrawal by Subject|1
30412|NCT01462929|127951|P1|Overall Study|Withdrawal by Subject|2
30413|NCT01462929|127949|P3|Overall Study|Adverse Event|4
30414|NCT01462929|127950|P2|Overall Study|Adverse Event|3
30415|NCT01462929|127951|P1|Overall Study|Adverse Event|3
30416|NCT01462695|127992|P2|Overall Study|Inevaluable (did not receive study drug)|0
30417|NCT01462695|127993|P1|Overall Study|Inevaluable (did not receive study drug)|1
30418|NCT01462695|127992|P2|Overall Study|Withdrawal by Subject|0
30419|NCT01462695|127993|P1|Overall Study|Withdrawal by Subject|2
30420|NCT01462695|127992|P2|Overall Study|Physician Decision|0
30421|NCT01462695|127993|P1|Overall Study|Physician Decision|5
30422|NCT01462695|127992|P2|Overall Study|Lack of Efficacy|12
30423|NCT01462695|127993|P1|Overall Study|Lack of Efficacy|6
30424|NCT01462695|127992|P2|Overall Study|Death|0
30425|NCT01462695|127993|P1|Overall Study|Death|2
30426|NCT01462695|127992|P2|Overall Study|Adverse Event|1
30427|NCT01462695|127993|P1|Overall Study|Adverse Event|1
30428|NCT01462435|128003|P4|Overall Study|Lost to Follow-up|1
30429|NCT01462435|128004|P3|Overall Study|Lost to Follow-up|0
30430|NCT01462435|128005|P2|Overall Study|Lost to Follow-up|0
30431|NCT01462435|128006|P1|Overall Study|Lost to Follow-up|0
30432|NCT01462435|128003|P4|Overall Study|Withdrawal by Subject|1
30433|NCT01462435|128004|P3|Overall Study|Withdrawal by Subject|0
30434|NCT01462435|128005|P2|Overall Study|Withdrawal by Subject|0
30435|NCT01462435|128006|P1|Overall Study|Withdrawal by Subject|0
30436|NCT01462435|128003|P4|Overall Study|Physician Decision|0
30437|NCT01462435|128004|P3|Overall Study|Physician Decision|1
30438|NCT01462435|128005|P2|Overall Study|Physician Decision|0
30439|NCT01462435|128006|P1|Overall Study|Physician Decision|0
30440|NCT01462435|128003|P4|Overall Study|Lack of Efficacy|3
30441|NCT01462435|128004|P3|Overall Study|Lack of Efficacy|0
30442|NCT01462435|128005|P2|Overall Study|Lack of Efficacy|0
30443|NCT01462435|128006|P1|Overall Study|Lack of Efficacy|1
30444|NCT01462370|128044|P2|Overall Study|Withdrawal by Subject|3
30445|NCT01462370|128045|P1|Overall Study|Withdrawal by Subject|0
30446|NCT01462370|128044|P2|Overall Study|Physician Decision|1
30447|NCT01462370|128045|P1|Overall Study|Physician Decision|0
30448|NCT01462370|128044|P2|Overall Study|Lack of Qualifying Event|1
30449|NCT01462370|128045|P1|Overall Study|Lack of Qualifying Event|1
30450|NCT01462357|128080|P3|Month 24|Migrated/moved from study area|0
30451|NCT01462357|128081|P2|Month 24|Migrated/moved from study area|2
30452|NCT01462357|128082|P1|Month 24|Migrated/moved from study area|0
30453|NCT01462357|128080|P3|Month 24|Lost to Follow-up|6
30454|NCT01462357|128081|P2|Month 24|Lost to Follow-up|4
30455|NCT01462357|128082|P1|Month 24|Lost to Follow-up|2
30456|NCT01462357|128080|P3|Month 24|Withdrawal by Subject|3
30457|NCT01462357|128081|P2|Month 24|Withdrawal by Subject|8
30458|NCT01462357|128082|P1|Month 24|Withdrawal by Subject|2
30459|NCT01462357|128080|P3|Month 18|Unspecified|1
30460|NCT01462357|128081|P2|Month 18|Unspecified|1
30461|NCT01462357|128082|P1|Month 18|Unspecified|0
30462|NCT01462357|128080|P3|Month 18|Lost to Follow-up|5
30463|NCT01462357|128081|P2|Month 18|Lost to Follow-up|4
30464|NCT01462357|128082|P1|Month 18|Lost to Follow-up|1
30465|NCT01462357|128080|P3|Month 18|Withdrawal by Subject|3
30466|NCT01462357|128081|P2|Month 18|Withdrawal by Subject|6
30467|NCT01462357|128082|P1|Month 18|Withdrawal by Subject|2
30468|NCT01462357|128080|P3|Month 12|Lost to Follow-up|5
30469|NCT01462357|128081|P2|Month 12|Lost to Follow-up|4
30470|NCT01462357|128082|P1|Month 12|Lost to Follow-up|1
30471|NCT01462357|128080|P3|Month 12|Withdrawal by Subject|3
30472|NCT01462357|128081|P2|Month 12|Withdrawal by Subject|6
30473|NCT01462357|128082|P1|Month 12|Withdrawal by Subject|2
30474|NCT01462357|128080|P3|Month 7|Withdrawal by Subject|6
30475|NCT01462357|128081|P2|Month 7|Withdrawal by Subject|5
30476|NCT01462357|128082|P1|Month 7|Withdrawal by Subject|1
30477|NCT01462344|128155|P2|Overall Study|Lost to Follow-up|7
30478|NCT01462344|128156|P1|Overall Study|Lost to Follow-up|7
30479|NCT01462344|128155|P2|Overall Study|Protocol Violation|53
30480|NCT01462344|128156|P1|Overall Study|Protocol Violation|68
30481|NCT01462344|128155|P2|Overall Study|Lack of Efficacy|6
30482|NCT01462344|128156|P1|Overall Study|Lack of Efficacy|5
30483|NCT01462344|128155|P2|Overall Study|Asthma Exacerbation|35
30484|NCT01462344|128156|P1|Overall Study|Asthma Exacerbation|34
30485|NCT01462344|128155|P2|Overall Study|Adverse Event|23
30486|NCT01462344|128156|P1|Overall Study|Adverse Event|24
30487|NCT01462344|128155|P2|Overall Study|Withdrawal by Subject|226
30488|NCT01462344|128156|P1|Overall Study|Withdrawal by Subject|245
30489|NCT01462266|128182|P2|Overall Study|Screen failure|1
30490|NCT01462266|128183|P1|Overall Study|Screen failure|1
30491|NCT01462266|128182|P2|Overall Study|Withdrawal by Subject|2
30492|NCT01462266|128183|P1|Overall Study|Withdrawal by Subject|7
30493|NCT01462266|128182|P2|Overall Study|Protocol Violation|3
30494|NCT01462266|128183|P1|Overall Study|Protocol Violation|1
30495|NCT01462266|128182|P2|Overall Study|Physician Decision|5
30496|NCT01462266|128183|P1|Overall Study|Physician Decision|2
30497|NCT01462266|128182|P2|Overall Study|Creatinine and eGFR, excluded medication|4
30498|NCT01462266|128183|P1|Overall Study|Creatinine and eGFR, excluded medication|8
30499|NCT01462266|128182|P2|Overall Study|Non-compliance with study drug|0
30500|NCT01462266|128183|P1|Overall Study|Non-compliance with study drug|3
30501|NCT01462266|128182|P2|Overall Study|Lost to Follow-up|3
30502|NCT01462266|128183|P1|Overall Study|Lost to Follow-up|4
30503|NCT01462266|128182|P2|Overall Study|Lack of Efficacy|2
30504|NCT01462266|128183|P1|Overall Study|Lack of Efficacy|0
30505|NCT01462266|128182|P2|Overall Study|Death|1
30506|NCT01462266|128183|P1|Overall Study|Death|2
30507|NCT01462266|128182|P2|Overall Study|Adverse Event|6
30508|NCT01462266|128183|P1|Overall Study|Adverse Event|7
30509|NCT01462227|128199|P4|Second Assignment|Protocol Violation|0
30510|NCT01462227|128200|P3|Second Assignment|Protocol Violation|1
30511|NCT01462227|128201|P2|Second Assignment|Protocol Violation|1
30512|NCT01462227|128202|P1|Second Assignment|Protocol Violation|0
30513|NCT01462227|128199|P4|Second Assignment|Lost to Follow-up|0
30514|NCT01462227|128200|P3|Second Assignment|Lost to Follow-up|0
30515|NCT01462227|128201|P2|Second Assignment|Lost to Follow-up|0
30516|NCT01462227|128202|P1|Second Assignment|Lost to Follow-up|1
30517|NCT01462162|128220|P1|Overall Study|Unspecified|2
30518|NCT01462162|128220|P1|Overall Study|Abnormal laboratory parameters|1
30519|NCT01462162|128220|P1|Overall Study|Lack of Efficacy|4
30520|NCT01462162|128220|P1|Overall Study|Adverse Event|5
30521|NCT01462045|128248|P3|Overall Study|Family matter|0
30522|NCT01462045|128249|P2|Overall Study|Family matter|1
30523|NCT01462045|128250|P1|Overall Study|Family matter|0
30524|NCT01461993|128264|P3|Overall Study|Unspecified|6
30525|NCT01461993|128265|P2|Overall Study|Unspecified|15
30526|NCT01461993|128266|P1|Overall Study|Unspecified|13
30527|NCT01461993|128264|P3|Overall Study|Did not meet entrance criteria|0
30528|NCT01461993|128265|P2|Overall Study|Did not meet entrance criteria|3
30529|NCT01461993|128266|P1|Overall Study|Did not meet entrance criteria|2
30530|NCT01461993|128264|P3|Overall Study|No longer met eligibility criteria|10
30531|NCT01461993|128265|P2|Overall Study|No longer met eligibility criteria|18
30532|NCT01461993|128266|P1|Overall Study|No longer met eligibility criteria|13
30533|NCT01461993|128264|P3|Overall Study|Adverse Event|3
30534|NCT01461993|128265|P2|Overall Study|Adverse Event|11
30535|NCT01461993|128266|P1|Overall Study|Adverse Event|9
30536|NCT01461993|128264|P3|Overall Study|Protocol Violation|7
30537|NCT01461993|128265|P2|Overall Study|Protocol Violation|9
30538|NCT01461993|128266|P1|Overall Study|Protocol Violation|10
30539|NCT01461993|128264|P3|Overall Study|Lost to Follow-up|22
30540|NCT01461993|128265|P2|Overall Study|Lost to Follow-up|48
30541|NCT01461993|128266|P1|Overall Study|Lost to Follow-up|44
30542|NCT01461993|128264|P3|Overall Study|Withdrawal by Subject|16
30543|NCT01461993|128265|P2|Overall Study|Withdrawal by Subject|53
30544|NCT01461993|128266|P1|Overall Study|Withdrawal by Subject|60
30545|NCT01461980|128291|P3|Overall Study|Randomized but not vaccinated|7
30546|NCT01461980|128292|P2|Overall Study|Randomized but not vaccinated|8
30547|NCT01461980|128293|P1|Overall Study|Randomized but not vaccinated|4
30548|NCT01461980|128291|P3|Overall Study|No longer willing to participate|54
30549|NCT01461980|128292|P2|Overall Study|No longer willing to participate|38
30550|NCT01461980|128293|P1|Overall Study|No longer willing to participate|52
30551|NCT01461980|128291|P3|Overall Study|Lost to Follow-up|51
30552|NCT01461980|128292|P2|Overall Study|Lost to Follow-up|53
30553|NCT01461980|128293|P1|Overall Study|Lost to Follow-up|52
30554|NCT01461980|128291|P3|Overall Study|No longer meets eligibility criteria|19
30555|NCT01461980|128292|P2|Overall Study|No longer meets eligibility criteria|9
30556|NCT01461980|128293|P1|Overall Study|No longer meets eligibility criteria|18
30557|NCT01461980|128291|P3|Overall Study|Protocol Violation|16
30558|NCT01461980|128292|P2|Overall Study|Protocol Violation|19
30559|NCT01461980|128293|P1|Overall Study|Protocol Violation|12
30560|NCT01461980|128291|P3|Overall Study|Adverse Event|6
30561|NCT01461980|128292|P2|Overall Study|Adverse Event|5
30562|NCT01461980|128293|P1|Overall Study|Adverse Event|12
30563|NCT01461980|128291|P3|Overall Study|Medication error|6
30564|NCT01461980|128292|P2|Overall Study|Medication error|5
30565|NCT01461980|128293|P1|Overall Study|Medication error|7
30566|NCT01461980|128291|P3|Overall Study|Unspecified|6
30567|NCT01461980|128292|P2|Overall Study|Unspecified|8
30568|NCT01461980|128293|P1|Overall Study|Unspecified|9
30569|NCT01461811|128325|P2|Overall Study|Noncompliance|1
30570|NCT01461811|128326|P1|Overall Study|Noncompliance|1
30571|NCT01461811|128325|P2|Overall Study|Subject decision unrelated to an AE|1
30572|NCT01461811|128326|P1|Overall Study|Subject decision unrelated to an AE|1
30573|NCT01461811|128325|P2|Overall Study|Adverse Event|1
30574|NCT01461811|128326|P1|Overall Study|Adverse Event|2
30575|NCT01461551|128383|P3|Overall Study|Physician Decision|2
30576|NCT01461551|128384|P2|Overall Study|Physician Decision|1
30577|NCT01461551|128385|P1|Overall Study|Physician Decision|2
30578|NCT01461538|128396|P3|Overall Study|Withdrawal by Subject|0
30579|NCT01461538|128397|P2|Overall Study|Withdrawal by Subject|1
30580|NCT01461538|128398|P1|Overall Study|Withdrawal by Subject|1
30581|NCT01461538|128396|P3|Overall Study|Study Stopped by Sponsor|0
30582|NCT01461538|128397|P2|Overall Study|Study Stopped by Sponsor|1
30583|NCT01461538|128398|P1|Overall Study|Study Stopped by Sponsor|2
30584|NCT01461538|128396|P3|Overall Study|Death|2
30585|NCT01461538|128397|P2|Overall Study|Death|6
30586|NCT01461538|128398|P1|Overall Study|Death|15
30587|NCT01461369|128437|P3|Overall Study|Withdrawal by Subject|2
30588|NCT01461369|128438|P2|Overall Study|Withdrawal by Subject|3
30589|NCT01461369|128439|P1|Overall Study|Withdrawal by Subject|1
30590|NCT01461369|128437|P3|Overall Study|Protocol Violation|2
30591|NCT01461369|128438|P2|Overall Study|Protocol Violation|2
30592|NCT01461369|128439|P1|Overall Study|Protocol Violation|1
30593|NCT01461369|128437|P3|Overall Study|Adverse Event|4
30594|NCT01461369|128438|P2|Overall Study|Adverse Event|12
30595|NCT01461369|128439|P1|Overall Study|Adverse Event|9
30596|NCT01461369|128437|P3|Overall Study|Lost to Follow-up|3
30597|NCT01461369|128438|P2|Overall Study|Lost to Follow-up|0
30598|NCT01461369|128439|P1|Overall Study|Lost to Follow-up|0
30599|NCT01461369|128437|P3|Overall Study|Lack of Efficacy|6
30600|NCT01461369|128438|P2|Overall Study|Lack of Efficacy|0
30601|NCT01461369|128439|P1|Overall Study|Lack of Efficacy|2
30602|NCT01461096|128464|P2|Overall Study|Lost to Follow-up|4
30603|NCT01461096|128465|P1|Overall Study|Lost to Follow-up|8
30604|NCT01461096|128464|P2|Overall Study|Subj not willing to adhere to reqs|4
30605|NCT01461096|128465|P1|Overall Study|Subj not willing to adhere to reqs|3
30606|NCT01461096|128464|P2|Overall Study|Withdrawal by Subject|3
30607|NCT01461096|128465|P1|Overall Study|Withdrawal by Subject|5
30608|NCT01461096|128464|P2|Overall Study|Site is closing|30
30609|NCT01461096|128465|P1|Overall Study|Site is closing|27
30610|NCT01461096|128464|P2|Overall Study|Subj not able to get to clinic|13
30611|NCT01461096|128465|P1|Overall Study|Subj not able to get to clinic|15
30612|NCT01461096|128464|P2|Overall Study|Severe debilitation, unable to continue|1
30613|NCT01461096|128465|P1|Overall Study|Severe debilitation, unable to continue|1
30614|NCT01461096|128464|P2|Overall Study|Death|6
30615|NCT01461096|128465|P1|Overall Study|Death|3
30616|NCT01461057|128481|P2|Overall Study|Physician Decision|1
30617|NCT01461057|128482|P1|Overall Study|Physician Decision|0
30618|NCT01461057|128481|P2|Overall Study|Withdrawal by Subject|3
30619|NCT01461057|128482|P1|Overall Study|Withdrawal by Subject|2
30620|NCT01461057|128481|P2|Overall Study|Death|8
30621|NCT01461057|128482|P1|Overall Study|Death|7
30622|NCT01461057|128481|P2|Overall Study|Currently in safety follow up|3
30623|NCT01461057|128482|P1|Overall Study|Currently in safety follow up|4
30624|NCT01461057|128481|P2|Overall Study|Currently in treatment|0
30625|NCT01461057|128482|P1|Overall Study|Currently in treatment|2
30626|NCT01461044|128492|P2|Overall Study|Lost to Follow-up|5
30627|NCT01461044|128493|P1|Overall Study|Lost to Follow-up|12
30628|NCT01461044|128492|P2|Overall Study|Death|35
30629|NCT01461044|128493|P1|Overall Study|Death|58
30630|NCT01460446|128589|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
30631|NCT01460446|128590|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
30632|NCT01460446|128589|P2|Overall Study|Pregnancy|0
30633|NCT01460446|128590|P1|Overall Study|Pregnancy|1
30634|NCT01460446|128589|P2|Overall Study|Surgery/Illness|1
30635|NCT01460446|128590|P1|Overall Study|Surgery/Illness|1
30636|NCT01460446|128589|P2|Overall Study|Non-compliance & Consent Withdrawn|3
30637|NCT01460446|128590|P1|Overall Study|Non-compliance & Consent Withdrawn|1
30638|NCT01460446|128589|P2|Overall Study|Consent Withdrawn|4
30639|NCT01460446|128590|P1|Overall Study|Consent Withdrawn|0
30640|NCT01460446|128589|P2|Overall Study|Non-compliance|9
30641|NCT01460446|128590|P1|Overall Study|Non-compliance|2
30642|NCT01460342|128619|P2|Overall Study|Lack of Efficacy|0
30643|NCT01460342|128620|P1|Overall Study|Lack of Efficacy|1
30644|NCT01460342|128619|P2|Overall Study|Physician Decision|3
30645|NCT01460342|128620|P1|Overall Study|Physician Decision|1
30646|NCT01460342|128619|P2|Overall Study|Withdrawal by Subject|4
30647|NCT01460342|128620|P1|Overall Study|Withdrawal by Subject|3
30648|NCT01460342|128619|P2|Overall Study|Protocol Violation|1
30649|NCT01460342|128620|P1|Overall Study|Protocol Violation|0
30650|NCT01460342|128619|P2|Overall Study|Lost to Follow-up|2
30651|NCT01460342|128620|P1|Overall Study|Lost to Follow-up|1
30652|NCT01460342|128619|P2|Overall Study|Adverse Event|4
30653|NCT01460342|128620|P1|Overall Study|Adverse Event|5
30654|NCT01460290|128640|P1|Overall Study|Elevated liver function|1
30655|NCT01460290|128640|P1|Overall Study|Adverse Event|3
30656|NCT01459913|128664|P4|Overall Study|Did Not Meet Inclusion Criteria|1
30657|NCT01459913|128665|P3|Overall Study|Did Not Meet Inclusion Criteria|0
30658|NCT01459913|128666|P2|Overall Study|Did Not Meet Inclusion Criteria|0
30659|NCT01459913|128667|P1|Overall Study|Did Not Meet Inclusion Criteria|0
30660|NCT01459913|128664|P4|Overall Study|Unspecified|1
30661|NCT01459913|128665|P3|Overall Study|Unspecified|3
30662|NCT01459913|128666|P2|Overall Study|Unspecified|0
30663|NCT01459913|128667|P1|Overall Study|Unspecified|0
30664|NCT01459913|128664|P4|Overall Study|Study Terminated by Sponsor|11
30665|NCT01459913|128665|P3|Overall Study|Study Terminated by Sponsor|9
30666|NCT01459913|128666|P2|Overall Study|Study Terminated by Sponsor|15
30667|NCT01459913|128667|P1|Overall Study|Study Terminated by Sponsor|30
30668|NCT01459913|128664|P4|Overall Study|Physician Decision|0
30669|NCT01459913|128665|P3|Overall Study|Physician Decision|0
30670|NCT01459913|128666|P2|Overall Study|Physician Decision|1
30671|NCT01459913|128667|P1|Overall Study|Physician Decision|0
30672|NCT01459913|128664|P4|Overall Study|Non- Compliance|3
30673|NCT01459913|128665|P3|Overall Study|Non- Compliance|0
30674|NCT01459913|128666|P2|Overall Study|Non- Compliance|0
30675|NCT01459913|128667|P1|Overall Study|Non- Compliance|0
30676|NCT01459913|128664|P4|Overall Study|Death|1
30677|NCT01459913|128665|P3|Overall Study|Death|0
30678|NCT01459913|128666|P2|Overall Study|Death|0
30679|NCT01459913|128667|P1|Overall Study|Death|0
30680|NCT01459913|128664|P4|Overall Study|Lost to Follow-up|8
30681|NCT01459913|128665|P3|Overall Study|Lost to Follow-up|1
30682|NCT01459913|128666|P2|Overall Study|Lost to Follow-up|4
30683|NCT01459913|128667|P1|Overall Study|Lost to Follow-up|7
30684|NCT01459913|128664|P4|Overall Study|Withdrawal by Subject|5
30685|NCT01459913|128665|P3|Overall Study|Withdrawal by Subject|0
30686|NCT01459913|128666|P2|Overall Study|Withdrawal by Subject|0
30687|NCT01459913|128667|P1|Overall Study|Withdrawal by Subject|4
30688|NCT01459913|128664|P4|Overall Study|Adverse Event|3
30689|NCT01459913|128665|P3|Overall Study|Adverse Event|0
30690|NCT01459913|128666|P2|Overall Study|Adverse Event|0
30691|NCT01459913|128667|P1|Overall Study|Adverse Event|0
30692|NCT01459783|128698|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
30693|NCT01459783|128699|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
30694|NCT01459783|128698|P2|6 Months to 12 Months|Lost to Follow-up|7
30695|NCT01459783|128699|P1|6 Months to 12 Months|Lost to Follow-up|2
30696|NCT01459783|128698|P2|6 Months to 12 Months|Withdrawal by Subject|5
30697|NCT01459783|128699|P1|6 Months to 12 Months|Withdrawal by Subject|6
30698|NCT01459783|128698|P2|6 Months to 12 Months|Death|1
30699|NCT01459783|128699|P1|6 Months to 12 Months|Death|0
30700|NCT01459783|128698|P2|Baseline to 6 Months|Lost to Follow-up|14
30701|NCT01459783|128699|P1|Baseline to 6 Months|Lost to Follow-up|19
30702|NCT01459783|128698|P2|Baseline to 6 Months|Withdrawal by Subject|6
30703|NCT01459783|128699|P1|Baseline to 6 Months|Withdrawal by Subject|12
30704|NCT01459783|128698|P2|Baseline to 6 Months|Death|0
30705|NCT01459783|128699|P1|Baseline to 6 Months|Death|1
30706|NCT01459068|128911|P2|Overall Study|Death|1
30707|NCT01459068|128912|P1|Overall Study|Death|0
30708|NCT01459068|128911|P2|Overall Study|Lost to Follow-up|15
30709|NCT01459068|128912|P1|Overall Study|Lost to Follow-up|31
30710|NCT01459068|128911|P2|Overall Study|Withdrawal by Subject|18
30711|NCT01459068|128912|P1|Overall Study|Withdrawal by Subject|8
30712|NCT01459016|128928|P1|Overall Study|Amendment Discontinuation Criteria|4
30713|NCT01459016|128928|P1|Overall Study|Withdrawal by Subject|11
30714|NCT01458951|128945|P3|Overall Study|Insufficient Clinical Response|11
30715|NCT01458951|128946|P2|Overall Study|Insufficient Clinical Response|0
30716|NCT01458951|128947|P1|Overall Study|Insufficient Clinical Response|17
30717|NCT01458951|128945|P3|Overall Study|Adverse Event|2
30718|NCT01458951|128946|P2|Overall Study|Adverse Event|0
30719|NCT01458951|128947|P1|Overall Study|Adverse Event|7
30720|NCT01458951|128945|P3|Overall Study|Withdrawal by Subject|2
30721|NCT01458951|128946|P2|Overall Study|Withdrawal by Subject|0
30722|NCT01458951|128947|P1|Overall Study|Withdrawal by Subject|2
30723|NCT01458951|128945|P3|Overall Study|Protocol Violation|0
30724|NCT01458951|128946|P2|Overall Study|Protocol Violation|1
30725|NCT01458951|128947|P1|Overall Study|Protocol Violation|5
30726|NCT01458951|128945|P3|Overall Study|Unspecified|0
30727|NCT01458951|128946|P2|Overall Study|Unspecified|0
30728|NCT01458951|128947|P1|Overall Study|Unspecified|1
30729|NCT01458639|128972|P1|Overall Study|Inability to obtain subject blood sample|1
30730|NCT01458639|128972|P1|Overall Study|Equipment issue|1
30731|NCT01458639|128972|P1|Overall Study|Physician Decision|4
30732|NCT01458587|128984|P2|Overall Study|Withdrawal by Subject|0
30733|NCT01458587|128985|P1|Overall Study|Withdrawal by Subject|1
30734|NCT01458535|129192|P6|Overall Study|Adverse Event|0
30735|NCT01458535|129193|P5|Overall Study|Adverse Event|0
30736|NCT01458535|129194|P4|Overall Study|Adverse Event|1
30737|NCT01458535|129195|P3|Overall Study|Adverse Event|0
30738|NCT01458535|129196|P2|Overall Study|Adverse Event|0
30739|NCT01458535|129197|P1|Overall Study|Adverse Event|0
30740|NCT01458535|129192|P6|Overall Study|Lost to Follow-up|2
30741|NCT01458535|129193|P5|Overall Study|Lost to Follow-up|2
30742|NCT01458535|129194|P4|Overall Study|Lost to Follow-up|3
30743|NCT01458535|129195|P3|Overall Study|Lost to Follow-up|0
30744|NCT01458535|129196|P2|Overall Study|Lost to Follow-up|2
30745|NCT01458535|129197|P1|Overall Study|Lost to Follow-up|0
30746|NCT01458535|129192|P6|Overall Study|Withdrawal by Subject|1
30747|NCT01458535|129193|P5|Overall Study|Withdrawal by Subject|1
30748|NCT01458535|129194|P4|Overall Study|Withdrawal by Subject|0
30749|NCT01458535|129195|P3|Overall Study|Withdrawal by Subject|2
30750|NCT01458535|129196|P2|Overall Study|Withdrawal by Subject|0
30751|NCT01458535|129197|P1|Overall Study|Withdrawal by Subject|0
30752|NCT01458535|129192|P6|Overall Study|Other|1
30753|NCT01458535|129193|P5|Overall Study|Other|1
30754|NCT01458535|129194|P4|Overall Study|Other|0
30755|NCT01458535|129195|P3|Overall Study|Other|0
30756|NCT01458535|129196|P2|Overall Study|Other|0
30757|NCT01458535|129197|P1|Overall Study|Other|0
30758|NCT01458275|129255|P3|Overall Study|Withdrawal by Subject|1
30759|NCT01458275|129256|P2|Overall Study|Withdrawal by Subject|2
30760|NCT01458275|129257|P1|Overall Study|Withdrawal by Subject|3
30761|NCT01458275|129255|P3|Overall Study|Protocol Violation|2
30762|NCT01458275|129256|P2|Overall Study|Protocol Violation|5
30763|NCT01458275|129257|P1|Overall Study|Protocol Violation|5
30764|NCT01458275|129255|P3|Overall Study|Lost to Follow-up|5
30765|NCT01458275|129256|P2|Overall Study|Lost to Follow-up|2
30766|NCT01458275|129257|P1|Overall Study|Lost to Follow-up|3
30767|NCT01458275|129255|P3|Overall Study|Adverse Event|1
30768|NCT01458275|129256|P2|Overall Study|Adverse Event|4
30769|NCT01458275|129257|P1|Overall Study|Adverse Event|3
30770|NCT01458249|129299|P1|Overall Study|Ongoing|1
30771|NCT01458249|129299|P1|Overall Study|Not specified|2
30772|NCT01458249|129299|P1|Overall Study|Adverse Event|4
30773|NCT01458249|129299|P1|Overall Study|Not treated|1
30774|NCT01458210|129318|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
30775|NCT01458210|129318|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
30776|NCT01458210|129318|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
30777|NCT01458210|129318|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
30778|NCT01458171|129335|P1|Overall Study|Adverse Event|1
30779|NCT01458106|129358|P2|Overall Study|Withdrawn Per Protocol|1
30780|NCT01458106|129359|P1|Overall Study|Withdrawn Per Protocol|0
30781|NCT01458106|129358|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
30782|NCT01458106|129359|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
30783|NCT01458106|129358|P2|Overall Study|Withdrawal by Subject|0
30784|NCT01458106|129359|P1|Overall Study|Withdrawal by Subject|2
30785|NCT01457950|129436|P4|Open-Label Phase|Withdrawal by Subject|0
30786|NCT01457950|129437|P3|Open-Label Phase|Withdrawal by Subject|2
30787|NCT01457950|129438|P2|Open-Label Phase|Withdrawal by Subject|0
30788|NCT01457950|129439|P1|Open-Label Phase|Withdrawal by Subject|0
30789|NCT01457950|129436|P4|Open-Label Phase|Protocol Violation|1
30790|NCT01457950|129437|P3|Open-Label Phase|Protocol Violation|0
30791|NCT01457950|129438|P2|Open-Label Phase|Protocol Violation|0
30792|NCT01457950|129439|P1|Open-Label Phase|Protocol Violation|0
30793|NCT01457950|129436|P4|Open-Label Phase|Adverse Event|1
30794|NCT01457950|129437|P3|Open-Label Phase|Adverse Event|0
30795|NCT01457950|129438|P2|Open-Label Phase|Adverse Event|0
30796|NCT01457950|129439|P1|Open-Label Phase|Adverse Event|0
30797|NCT01457950|129436|P4|Double-Blind Phase|Withdrawal by Subject|0
30798|NCT01457950|129437|P3|Double-Blind Phase|Withdrawal by Subject|0
30799|NCT01457950|129438|P2|Double-Blind Phase|Withdrawal by Subject|2
30800|NCT01457950|129439|P1|Double-Blind Phase|Withdrawal by Subject|6
30801|NCT01457950|129436|P4|Double-Blind Phase|Protocol Violation|0
30802|NCT01457950|129437|P3|Double-Blind Phase|Protocol Violation|0
30803|NCT01457950|129438|P2|Double-Blind Phase|Protocol Violation|1
30804|NCT01457950|129439|P1|Double-Blind Phase|Protocol Violation|2
30805|NCT01457950|129436|P4|Double-Blind Phase|Continuation Criteria Not Met|0
30806|NCT01457950|129437|P3|Double-Blind Phase|Continuation Criteria Not Met|0
30807|NCT01457950|129438|P2|Double-Blind Phase|Continuation Criteria Not Met|0
30808|NCT01457950|129439|P1|Double-Blind Phase|Continuation Criteria Not Met|1
30809|NCT01457703|129521|P2|Overall Study|Withdrawal by Subject|4
30810|NCT01457703|129522|P1|Overall Study|Withdrawal by Subject|1
30811|NCT01457703|129521|P2|Overall Study|Screen Failure|7
30812|NCT01457703|129522|P1|Overall Study|Screen Failure|5
30813|NCT01457339|129619|P2|Period 6 (250 mg)|Personal appointment|1
30814|NCT01457339|129620|P1|Period 6 (250 mg)|Personal appointment|0
30815|NCT01457339|129619|P2|Period 6 (250 mg)|Family Emergency|0
30816|NCT01457339|129620|P1|Period 6 (250 mg)|Family Emergency|1
30817|NCT01457339|129619|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
30818|NCT01457339|129620|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
30819|NCT01457339|129619|P2|Period 3 (100 mg)|Adverse Event|1
30820|NCT01457339|129620|P1|Period 3 (100 mg)|Adverse Event|0
30821|NCT01457053|129786|P2|Overall Study|Unable to undergo selected treatment|1
30822|NCT01457053|129787|P1|Overall Study|Unable to undergo selected treatment|1
30823|NCT01457014|129793|P4|First Night|Withdrawal by Subject|0
30824|NCT01457014|129794|P3|First Night|Withdrawal by Subject|0
30825|NCT01457014|129795|P2|First Night|Withdrawal by Subject|0
30826|NCT01457014|129796|P1|First Night|Withdrawal by Subject|3
30827|NCT01457014|129793|P4|First Night|Didn't meet inclusion/exclusion criteria|0
30828|NCT01457014|129794|P3|First Night|Didn't meet inclusion/exclusion criteria|0
30829|NCT01457014|129795|P2|First Night|Didn't meet inclusion/exclusion criteria|0
30830|NCT01457014|129796|P1|First Night|Didn't meet inclusion/exclusion criteria|37
30831|NCT01456962|129813|P2|Overall Study|Lost to Follow-up|1
30832|NCT01456962|129814|P1|Overall Study|Lost to Follow-up|2
30833|NCT01456936|129824|P4|Overall Study|Randomized but not treated|21
30834|NCT01456936|129825|P3|Overall Study|Randomized but not treated|16
30835|NCT01456936|129826|P2|Overall Study|Randomized but not treated|28
30836|NCT01456936|129827|P1|Overall Study|Randomized but not treated|21
30837|NCT01456936|129824|P4|Overall Study|Death|3
30838|NCT01456936|129825|P3|Overall Study|Death|1
30839|NCT01456936|129826|P2|Overall Study|Death|3
30840|NCT01456936|129827|P1|Overall Study|Death|0
30841|NCT01456936|129824|P4|Overall Study|Adverse event (study drug unrelated)|9
30842|NCT01456936|129825|P3|Overall Study|Adverse event (study drug unrelated)|9
30843|NCT01456936|129826|P2|Overall Study|Adverse event (study drug unrelated)|7
30844|NCT01456936|129827|P1|Overall Study|Adverse event (study drug unrelated)|9
30845|NCT01456936|129824|P4|Overall Study|Adverse event (study drug)|17
30846|NCT01456936|129825|P3|Overall Study|Adverse event (study drug)|26
30847|NCT01456936|129826|P2|Overall Study|Adverse event (study drug)|21
30848|NCT01456936|129827|P1|Overall Study|Adverse event (study drug)|25
30849|NCT01456936|129824|P4|Overall Study|Medication error|1
30850|NCT01456936|129825|P3|Overall Study|Medication error|0
30851|NCT01456936|129826|P2|Overall Study|Medication error|1
30852|NCT01456936|129827|P1|Overall Study|Medication error|0
30853|NCT01456936|129824|P4|Overall Study|Lost to Follow-up|127
30854|NCT01456936|129825|P3|Overall Study|Lost to Follow-up|144
30855|NCT01456936|129826|P2|Overall Study|Lost to Follow-up|126
30856|NCT01456936|129827|P1|Overall Study|Lost to Follow-up|135
30857|NCT01456936|129824|P4|Overall Study|No longer willing to participate|248
30858|NCT01456936|129825|P3|Overall Study|No longer willing to participate|224
30859|NCT01456936|129826|P2|Overall Study|No longer willing to participate|218
30860|NCT01456936|129827|P1|Overall Study|No longer willing to participate|195
30861|NCT01456936|129824|P4|Overall Study|Insufficient clinical response|13
30862|NCT01456936|129825|P3|Overall Study|Insufficient clinical response|14
30863|NCT01456936|129826|P2|Overall Study|Insufficient clinical response|4
30864|NCT01456936|129827|P1|Overall Study|Insufficient clinical response|4
30865|NCT01456936|129824|P4|Overall Study|Pregnancy|1
30866|NCT01456936|129825|P3|Overall Study|Pregnancy|0
30867|NCT01456936|129826|P2|Overall Study|Pregnancy|0
30868|NCT01456936|129827|P1|Overall Study|Pregnancy|1
30869|NCT01456936|129824|P4|Overall Study|Protocol Violation|5
30870|NCT01456936|129825|P3|Overall Study|Protocol Violation|5
30871|NCT01456936|129826|P2|Overall Study|Protocol Violation|2
30872|NCT01456936|129827|P1|Overall Study|Protocol Violation|4
30873|NCT01456936|129824|P4|Overall Study|No longer meets eligibility criteria|5
30874|NCT01456936|129825|P3|Overall Study|No longer meets eligibility criteria|6
30875|NCT01456936|129826|P2|Overall Study|No longer meets eligibility criteria|8
30876|NCT01456936|129827|P1|Overall Study|No longer meets eligibility criteria|4
30877|NCT01456936|129824|P4|Overall Study|Other reason|33
30878|NCT01456936|129825|P3|Overall Study|Other reason|36
30879|NCT01456936|129826|P2|Overall Study|Other reason|30
30880|NCT01456936|129827|P1|Overall Study|Other reason|41
30881|NCT01456195|129949|P3|Overall Study|Other Reasons|3
30882|NCT01456195|129950|P2|Overall Study|Other Reasons|1
30883|NCT01456195|129951|P1|Overall Study|Other Reasons|2
30884|NCT01456195|129949|P3|Overall Study|Lack of Efficacy|0
30885|NCT01456195|129950|P2|Overall Study|Lack of Efficacy|1
30886|NCT01456195|129951|P1|Overall Study|Lack of Efficacy|0
30887|NCT01456195|129949|P3|Overall Study|Voluntary Withdrawal|7
30888|NCT01456195|129950|P2|Overall Study|Voluntary Withdrawal|3
30889|NCT01456195|129951|P1|Overall Study|Voluntary Withdrawal|5
30890|NCT01456195|129949|P3|Overall Study|Lost to Follow-up|3
30891|NCT01456195|129950|P2|Overall Study|Lost to Follow-up|1
30892|NCT01456195|129951|P1|Overall Study|Lost to Follow-up|3
30893|NCT01456195|129949|P3|Overall Study|Pretreatment Event/Adverse Event|1
30894|NCT01456195|129950|P2|Overall Study|Pretreatment Event/Adverse Event|4
30895|NCT01456195|129951|P1|Overall Study|Pretreatment Event/Adverse Event|1
30896|NCT01456169|129971|P3|Overall Study|Other|0
30897|NCT01456169|129972|P2|Overall Study|Other|1
30898|NCT01456169|129973|P1|Overall Study|Other|1
30899|NCT01456169|129971|P3|Overall Study|Lack of Efficacy|0
30900|NCT01456169|129972|P2|Overall Study|Lack of Efficacy|0
30901|NCT01456169|129973|P1|Overall Study|Lack of Efficacy|2
30902|NCT01456169|129971|P3|Overall Study|Voluntary Withdrawal|2
30903|NCT01456169|129972|P2|Overall Study|Voluntary Withdrawal|0
30904|NCT01456169|129973|P1|Overall Study|Voluntary Withdrawal|3
30905|NCT01456169|129971|P3|Overall Study|Major Protocol Deviation|3
30906|NCT01456169|129972|P2|Overall Study|Major Protocol Deviation|2
30907|NCT01456169|129973|P1|Overall Study|Major Protocol Deviation|3
30908|NCT01456169|129971|P3|Overall Study|Adverse Event|7
30909|NCT01456169|129972|P2|Overall Study|Adverse Event|2
30910|NCT01456169|129973|P1|Overall Study|Adverse Event|1
30911|NCT01456130|130033|P1|Overall Study|Other|1
30912|NCT01456130|130033|P1|Overall Study|Lack of Efficacy|4
30913|NCT01456130|130033|P1|Overall Study|Voluntary Withdrawal|1
30914|NCT01456130|130033|P1|Overall Study|Adverse Event|4
30915|NCT01456052|130043|P3|Overall Study|Treatment Failure|1
30916|NCT01456052|130044|P2|Overall Study|Treatment Failure|1
30917|NCT01456052|130045|P1|Overall Study|Treatment Failure|0
30918|NCT01456052|130043|P3|Overall Study|Physician Decision|1
30919|NCT01456052|130044|P2|Overall Study|Physician Decision|0
30920|NCT01456052|130045|P1|Overall Study|Physician Decision|1
30921|NCT01456052|130043|P3|Overall Study|Protocol Violation|0
30922|NCT01456052|130044|P2|Overall Study|Protocol Violation|1
30923|NCT01456052|130045|P1|Overall Study|Protocol Violation|0
30924|NCT01456052|130043|P3|Overall Study|Consent withdrawn|1
30925|NCT01456052|130044|P2|Overall Study|Consent withdrawn|2
30926|NCT01456052|130045|P1|Overall Study|Consent withdrawn|0
30927|NCT01456052|130043|P3|Overall Study|Adverse Event|2
30928|NCT01456052|130044|P2|Overall Study|Adverse Event|1
30929|NCT01456052|130045|P1|Overall Study|Adverse Event|1
30930|NCT01456039|130065|P3|Phase 2 (Second Step)|Unspecified|1
30931|NCT01456039|130066|P2|Phase 2 (Second Step)|Unspecified|0
30932|NCT01456039|130067|P1|Phase 2 (Second Step)|Unspecified|0
30933|NCT01456039|130065|P3|Phase 2 (Second Step)|Protocol Violation|1
30934|NCT01456039|130066|P2|Phase 2 (Second Step)|Protocol Violation|0
30935|NCT01456039|130067|P1|Phase 2 (Second Step)|Protocol Violation|0
30936|NCT01456039|130065|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
30937|NCT01456039|130066|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
30938|NCT01456039|130067|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
30939|NCT01456039|130065|P3|Phase 2 (Second Step)|Adverse Event|10
30940|NCT01456039|130066|P2|Phase 2 (Second Step)|Adverse Event|0
30941|NCT01456039|130067|P1|Phase 2 (Second Step)|Adverse Event|0
30942|NCT01456039|130065|P3|Phase 2 (Second Step)|Disease Progression|17
30943|NCT01456039|130066|P2|Phase 2 (Second Step)|Disease Progression|0
30944|NCT01456039|130067|P1|Phase 2 (Second Step)|Disease Progression|0
30945|NCT01456039|130065|P3|Phase 1 (First Step)|Not specified|0
30946|NCT01456039|130066|P2|Phase 1 (First Step)|Not specified|1
30947|NCT01456039|130067|P1|Phase 1 (First Step)|Not specified|0
30948|NCT01456039|130065|P3|Phase 1 (First Step)|Adverse Event|0
30949|NCT01456039|130066|P2|Phase 1 (First Step)|Adverse Event|3
30950|NCT01456039|130067|P1|Phase 1 (First Step)|Adverse Event|0
30951|NCT01456039|130065|P3|Phase 1 (First Step)|Withdrawal by Subject|0
30952|NCT01456039|130066|P2|Phase 1 (First Step)|Withdrawal by Subject|2
30953|NCT01456039|130067|P1|Phase 1 (First Step)|Withdrawal by Subject|1
30954|NCT01456039|130065|P3|Phase 1 (First Step)|Disease Progression|0
30955|NCT01456039|130066|P2|Phase 1 (First Step)|Disease Progression|1
30956|NCT01456039|130067|P1|Phase 1 (First Step)|Disease Progression|1
30957|NCT01455428|130210|P2|Overall Study|Unspecified|4
30958|NCT01455428|130211|P1|Overall Study|Unspecified|2
30959|NCT01455428|130210|P2|Overall Study|Did not receive treatment|1
30960|NCT01455428|130211|P1|Overall Study|Did not receive treatment|1
30961|NCT01455428|130210|P2|Overall Study|Insufficient clinical response|2
30962|NCT01455428|130211|P1|Overall Study|Insufficient clinical response|0
30963|NCT01455428|130210|P2|Overall Study|Did not meet entrance criteria|2
30964|NCT01455428|130211|P1|Overall Study|Did not meet entrance criteria|0
30965|NCT01455428|130210|P2|Overall Study|Withdrawal by Subject|5
30966|NCT01455428|130211|P1|Overall Study|Withdrawal by Subject|2
30967|NCT01455428|130210|P2|Overall Study|Lost to Follow-up|1
30968|NCT01455428|130211|P1|Overall Study|Lost to Follow-up|1
30969|NCT01455428|130210|P2|Overall Study|Adverse Event|2
30970|NCT01455428|130211|P1|Overall Study|Adverse Event|6
30971|NCT01455428|130210|P2|Overall Study|Protocol Violation|1
30972|NCT01455428|130211|P1|Overall Study|Protocol Violation|2
30973|NCT01455415|130267|P2|Follow-up|Unspecified Reason|0
30974|NCT01455415|130268|P1|Follow-up|Unspecified Reason|1
30975|NCT01455415|130267|P2|Follow-up|Withdrawal by Subject|0
30976|NCT01455415|130268|P1|Follow-up|Withdrawal by Subject|2
30977|NCT01455415|130267|P2|Follow-up|Lack of Efficacy|1
30978|NCT01455415|130268|P1|Follow-up|Lack of Efficacy|0
30979|NCT01455415|130267|P2|Follow-up|AE Related to Study Drug|1
30980|NCT01455415|130268|P1|Follow-up|AE Related to Study Drug|0
30981|NCT01455415|130267|P2|Period 2|Protocol Violation|0
30982|NCT01455415|130268|P1|Period 2|Protocol Violation|2
30983|NCT01455415|130267|P2|Period 2|Unspecified Reason|3
30984|NCT01455415|130268|P1|Period 2|Unspecified Reason|2
30985|NCT01455415|130267|P2|Period 2|Withdrawal by Subject|3
30986|NCT01455415|130268|P1|Period 2|Withdrawal by Subject|2
30987|NCT01455415|130267|P2|Period 2|Lack of Efficacy|0
30988|NCT01455415|130268|P1|Period 2|Lack of Efficacy|2
30989|NCT01455415|130267|P2|Period 2|AE Not Related to Study Drug|1
30990|NCT01455415|130268|P1|Period 2|AE Not Related to Study Drug|2
30991|NCT01455415|130267|P2|Period 2|Lost to Follow-up|1
30992|NCT01455415|130268|P1|Period 2|Lost to Follow-up|2
30993|NCT01455415|130267|P2|Period 2|AE Related to Study Drug|2
30994|NCT01455415|130268|P1|Period 2|AE Related to Study Drug|1
30995|NCT01455415|130267|P2|Washout|Protocol Violation|1
30996|NCT01455415|130268|P1|Washout|Protocol Violation|0
30997|NCT01455415|130267|P2|Washout|Unspecified Reason|2
30998|NCT01455415|130268|P1|Washout|Unspecified Reason|1
30999|NCT01455415|130267|P2|Washout|AE Not Related to Study Drug|3
31000|NCT01455415|130268|P1|Washout|AE Not Related to Study Drug|2
31001|NCT01455415|130267|P2|Washout|Drug Error not Associated to AE|1
31002|NCT01455415|130268|P1|Washout|Drug Error not Associated to AE|2
31003|NCT01455415|130267|P2|Washout|Lost to Follow-up|0
31004|NCT01455415|130268|P1|Washout|Lost to Follow-up|1
31005|NCT01455415|130267|P2|Washout|AE Related to Study Drug|0
31006|NCT01455415|130268|P1|Washout|AE Related to Study Drug|2
31007|NCT01455415|130267|P2|Period 1|Protocol Violation|2
31008|NCT01455415|130268|P1|Period 1|Protocol Violation|0
31009|NCT01455415|130267|P2|Period 1|Unspecified Reason|1
31010|NCT01455415|130268|P1|Period 1|Unspecified Reason|1
31011|NCT01455415|130267|P2|Period 1|Withdrawal by Subject|5
31012|NCT01455415|130268|P1|Period 1|Withdrawal by Subject|4
31013|NCT01455415|130267|P2|Period 1|AE Not Related to Study Drug|6
31014|NCT01455415|130268|P1|Period 1|AE Not Related to Study Drug|2
31015|NCT01455415|130267|P2|Period 1|Drug Error not Associated to AE|1
31016|NCT01455415|130268|P1|Period 1|Drug Error not Associated to AE|0
31017|NCT01455415|130267|P2|Period 1|Lost To Follow-up Related to Study Drug|3
31018|NCT01455415|130268|P1|Period 1|Lost To Follow-up Related to Study Drug|3
31019|NCT01455415|130267|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
31020|NCT01455415|130268|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
31021|NCT01455194|130321|P4|Overall Study|Miscellaneous|4
31022|NCT01455194|130322|P3|Overall Study|Miscellaneous|1
31023|NCT01455194|130323|P2|Overall Study|Miscellaneous|5
31024|NCT01455194|130324|P1|Overall Study|Miscellaneous|4
31025|NCT01455194|130321|P4|Overall Study|Discontinuation criterion fulfilled|2
31026|NCT01455194|130322|P3|Overall Study|Discontinuation criterion fulfilled|0
31027|NCT01455194|130323|P2|Overall Study|Discontinuation criterion fulfilled|2
31028|NCT01455194|130324|P1|Overall Study|Discontinuation criterion fulfilled|3
31029|NCT01455194|130321|P4|Overall Study|Pregnancy|0
31030|NCT01455194|130322|P3|Overall Study|Pregnancy|1
31031|NCT01455194|130323|P2|Overall Study|Pregnancy|1
31032|NCT01455194|130324|P1|Overall Study|Pregnancy|0
31033|NCT01455194|130321|P4|Overall Study|Lost to Follow-up|1
31034|NCT01455194|130322|P3|Overall Study|Lost to Follow-up|1
31035|NCT01455194|130323|P2|Overall Study|Lost to Follow-up|0
31036|NCT01455194|130324|P1|Overall Study|Lost to Follow-up|2
31037|NCT01455194|130321|P4|Overall Study|Withdrawal by Subject|9
31038|NCT01455194|130322|P3|Overall Study|Withdrawal by Subject|12
31039|NCT01455194|130323|P2|Overall Study|Withdrawal by Subject|16
31040|NCT01455194|130324|P1|Overall Study|Withdrawal by Subject|21
31041|NCT01455194|130321|P4|Overall Study|Adverse Event|3
31042|NCT01455194|130322|P3|Overall Study|Adverse Event|1
31043|NCT01455194|130323|P2|Overall Study|Adverse Event|1
31044|NCT01455194|130324|P1|Overall Study|Adverse Event|1
31045|NCT01455194|130321|P4|Overall Study|Deterioration in asthma|9
31046|NCT01455194|130322|P3|Overall Study|Deterioration in asthma|14
31047|NCT01455194|130323|P2|Overall Study|Deterioration in asthma|6
31048|NCT01455194|130324|P1|Overall Study|Deterioration in asthma|12
31049|NCT01455194|130321|P4|Overall Study|Randomisation Failure|0
31050|NCT01455194|130322|P3|Overall Study|Randomisation Failure|0
31051|NCT01455194|130323|P2|Overall Study|Randomisation Failure|0
31052|NCT01455194|130324|P1|Overall Study|Randomisation Failure|90
31053|NCT01455194|130321|P4|Overall Study|Screen Failure|0
31054|NCT01455194|130322|P3|Overall Study|Screen Failure|0
31055|NCT01455194|130323|P2|Overall Study|Screen Failure|0
31056|NCT01455194|130324|P1|Overall Study|Screen Failure|20
31057|NCT01455012|130387|P2|Overall Study|Unknown reason|0
31058|NCT01455012|130388|P1|Overall Study|Unknown reason|2
31059|NCT01455012|130387|P2|Overall Study|Withdrawal by Subject|1
31060|NCT01455012|130388|P1|Overall Study|Withdrawal by Subject|3
31061|NCT01455012|130387|P2|Overall Study|Lack of Efficacy|1
31062|NCT01455012|130388|P1|Overall Study|Lack of Efficacy|6
31063|NCT01455012|130387|P2|Overall Study|Adverse Event|2
31064|NCT01455012|130388|P1|Overall Study|Adverse Event|0
31065|NCT01454830|130422|P2|Overall Study|Withdrawal - no polysomnography|2
31066|NCT01454830|130423|P1|Overall Study|Withdrawal - no polysomnography|3
31067|NCT01454830|130422|P2|Overall Study|Post-allocation Exclude-other treatment|7
31068|NCT01454830|130423|P1|Overall Study|Post-allocation Exclude-other treatment|6
31069|NCT01454830|130422|P2|Overall Study|Post-allocation Exclude-refused PAP|2
31070|NCT01454830|130423|P1|Overall Study|Post-allocation Exclude-refused PAP|0
31071|NCT01454830|130422|P2|Overall Study|Post-allocation Exclude- AHI<10|12
31072|NCT01454830|130423|P1|Overall Study|Post-allocation Exclude- AHI<10|18
31073|NCT01454830|130422|P2|Overall Study|Withdrawal by Subject|4
31074|NCT01454830|130423|P1|Overall Study|Withdrawal by Subject|4
31075|NCT01454778|130454|P1|Overall Study|Death|1
31076|NCT01454778|130454|P1|Overall Study|Lost to Follow-up|2
31077|NCT01454726|130465|P2|Overall Study|Withdrawal by Subject|1
31078|NCT01454726|130466|P1|Overall Study|Withdrawal by Subject|0
31079|NCT01454583|130475|P3|3rd Year|Lost to Follow-up|297
31080|NCT01454583|130476|P2|3rd Year|Lost to Follow-up|512
31081|NCT01454583|130477|P1|3rd Year|Lost to Follow-up|1959
31082|NCT01454583|130475|P3|2nd Year|Lost to Follow-up|737
31083|NCT01454583|130476|P2|2nd Year|Lost to Follow-up|1049
31084|NCT01454583|130477|P1|2nd Year|Lost to Follow-up|3965
31085|NCT01454583|130475|P3|1st Year|Lost to Follow-up|180
31086|NCT01454583|130476|P2|1st Year|Lost to Follow-up|318
31087|NCT01454583|130477|P1|1st Year|Lost to Follow-up|1057
31088|NCT01454531|130545|P1|Overall Study|Other|1
31089|NCT01454531|130545|P1|Overall Study|Delay in IMP administration|1
31090|NCT01454531|130545|P1|Overall Study|Physician Decision|1
31091|NCT01454531|130545|P1|Overall Study|Lost to Follow-up|1
31092|NCT01454531|130545|P1|Overall Study|Withdrawal by Subject|5
31093|NCT01454531|130545|P1|Overall Study|Adverse Event|14
31094|NCT01454401|130581|P1|Overall Study|non-adherence|1
31095|NCT01454401|130581|P1|Overall Study|osteomyelitis|2
31096|NCT01454401|130581|P1|Overall Study|hospitalised|1
31097|NCT01454401|130581|P1|Overall Study|Death|1
31098|NCT01454063|130594|P2|Randomized|Protocol Violation|1
31099|NCT01454063|130595|P1|Randomized|Protocol Violation|0
31100|NCT01454063|130594|P2|Randomized|Adverse Event|1
31101|NCT01454063|130595|P1|Randomized|Adverse Event|1
31102|NCT01453998|130616|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
31103|NCT01453998|130617|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
31104|NCT01453998|130618|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
31105|NCT01453946|130683|P1|Overall Study|Adverse Event|3
31106|NCT01453946|130683|P1|Overall Study|Lack of Efficacy|3
31107|NCT01453946|130683|P1|Overall Study|Protocol Violation|2
31108|NCT01453946|130683|P1|Overall Study|Did not receive drug for the taper phase|1
31109|NCT01453855|130700|P2|Overall Study|Other|1
31110|NCT01453855|130701|P1|Overall Study|Other|0
31111|NCT01453855|130700|P2|Overall Study|Inadequate Control of IOP|5
31112|NCT01453855|130701|P1|Overall Study|Inadequate Control of IOP|1
31113|NCT01453855|130700|P2|Overall Study|Noncompliance|0
31114|NCT01453855|130701|P1|Overall Study|Noncompliance|1
31115|NCT01453855|130700|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
31116|NCT01453855|130701|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
31117|NCT01453855|130700|P2|Overall Study|Lost to Follow-up|1
31118|NCT01453855|130701|P1|Overall Study|Lost to Follow-up|2
31119|NCT01453855|130700|P2|Overall Study|Adverse Event|4
31120|NCT01453855|130701|P1|Overall Study|Adverse Event|3
31121|NCT01453725|130709|P2|Overall Study|Physician Decision|1
31122|NCT01453725|130710|P1|Overall Study|Physician Decision|1
31123|NCT01453725|130709|P2|Overall Study|Pregnancy|0
31124|NCT01453725|130710|P1|Overall Study|Pregnancy|1
31125|NCT01453725|130709|P2|Overall Study|Pregnancy Wish|2
31126|NCT01453725|130710|P1|Overall Study|Pregnancy Wish|0
31127|NCT01453725|130709|P2|Overall Study|Withdrawal by Subject|3
31128|NCT01453725|130710|P1|Overall Study|Withdrawal by Subject|2
31129|NCT01453725|130709|P2|Overall Study|Protocol Violation|0
31130|NCT01453725|130710|P1|Overall Study|Protocol Violation|1
31131|NCT01453725|130709|P2|Overall Study|Non-compliance With Protocol|2
31132|NCT01453725|130710|P1|Overall Study|Non-compliance With Protocol|1
31133|NCT01453725|130709|P2|Overall Study|Lost to Follow-up|0
31134|NCT01453725|130710|P1|Overall Study|Lost to Follow-up|4
31135|NCT01453725|130709|P2|Overall Study|Adverse Event|3
31136|NCT01453725|130710|P1|Overall Study|Adverse Event|3
31137|NCT01453595|130733|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
31138|NCT01453595|130734|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
31139|NCT01453595|130735|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
31140|NCT01453374|130768|P1|Overall Study|Incarcerated|2
31141|NCT01453374|130768|P1|Overall Study|Withdrawal by Subject|5
31142|NCT01453374|130768|P1|Overall Study|Lost to Follow-up|3
31143|NCT01453374|130768|P1|Overall Study|Lack of Efficacy|1
31144|NCT01453374|130768|P1|Overall Study|Adverse Event|7
31145|NCT01453348|130787|P3|Overall Study|Protocol Violation|0
31146|NCT01453348|130788|P2|Overall Study|Protocol Violation|0
31147|NCT01453348|130789|P1|Overall Study|Protocol Violation|1
31148|NCT01453348|130787|P3|Overall Study|Withdrawal by Subject|0
31149|NCT01453348|130788|P2|Overall Study|Withdrawal by Subject|1
31150|NCT01453348|130789|P1|Overall Study|Withdrawal by Subject|0
31151|NCT01453348|130787|P3|Overall Study|Death|1
31152|NCT01453348|130788|P2|Overall Study|Death|0
31153|NCT01453348|130789|P1|Overall Study|Death|0
31154|NCT01453296|130805|P2|Treatment Period 2|Withdrawal by Subject|0
31155|NCT01453296|130806|P1|Treatment Period 2|Withdrawal by Subject|1
31156|NCT01453296|130805|P2|Treatment Period 2|Adverse Event|0
31157|NCT01453296|130806|P1|Treatment Period 2|Adverse Event|1
31158|NCT01453296|130805|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
31159|NCT01453296|130806|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
31160|NCT01453296|130805|P2|Treatment Period 1|Adverse Event|1
31161|NCT01453296|130806|P1|Treatment Period 1|Adverse Event|0
31162|NCT01453049|130906|P2|Overall Study|Randomized in Error|0
31163|NCT01453049|130907|P1|Overall Study|Randomized in Error|1
31164|NCT01453049|130906|P2|Overall Study|Withdrawal by Subject|0
31165|NCT01453049|130907|P1|Overall Study|Withdrawal by Subject|1
31166|NCT01453049|130906|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
31167|NCT01453049|130907|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
31168|NCT01453049|130906|P2|Overall Study|Lost to Follow-up|1
31169|NCT01453049|130907|P1|Overall Study|Lost to Follow-up|2
31170|NCT01453049|130906|P2|Overall Study|Protocol Violation|5
31171|NCT01453049|130907|P1|Overall Study|Protocol Violation|2
31172|NCT01453036|130980|P3|Overall Study|Lost to Follow-up|31
31173|NCT01453036|130981|P2|Overall Study|Lost to Follow-up|115
31174|NCT01453036|130982|P1|Overall Study|Lost to Follow-up|26
31175|NCT01453023|130990|P2|Treatment Period 2|Protocol Violation|1
31176|NCT01453023|130991|P1|Treatment Period 2|Protocol Violation|0
31177|NCT01453023|130990|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
31178|NCT01453023|130991|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
31179|NCT01453023|130990|P2|Treatment Period (TP) 1|Protocol Violation|0
31180|NCT01453023|130991|P1|Treatment Period (TP) 1|Protocol Violation|1
31181|NCT01452529|131065|P3|Double-blind (DB) Period|Administrative|7
31182|NCT01452529|131066|P2|Double-blind (DB) Period|Administrative|11
31183|NCT01452529|131067|P1|Double-blind (DB) Period|Administrative|0
31184|NCT01452529|131065|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
31185|NCT01452529|131066|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
31186|NCT01452529|131067|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
31187|NCT01452529|131065|P3|Double-blind (DB) Period|Lack of Efficacy|44
31188|NCT01452529|131066|P2|Double-blind (DB) Period|Lack of Efficacy|16
31189|NCT01452529|131067|P1|Double-blind (DB) Period|Lack of Efficacy|0
31190|NCT01452529|131065|P3|Double-blind (DB) Period|Lost to Follow-up|3
31191|NCT01452529|131066|P2|Double-blind (DB) Period|Lost to Follow-up|5
31192|NCT01452529|131067|P1|Double-blind (DB) Period|Lost to Follow-up|0
31193|NCT01452529|131065|P3|Double-blind (DB) Period|Withdrawal by Subject|14
31194|NCT01452529|131066|P2|Double-blind (DB) Period|Withdrawal by Subject|15
31195|NCT01452529|131067|P1|Double-blind (DB) Period|Withdrawal by Subject|0
31196|NCT01452529|131065|P3|Double-blind (DB) Period|Adverse Event|11
31197|NCT01452529|131066|P2|Double-blind (DB) Period|Adverse Event|18
31198|NCT01452529|131067|P1|Double-blind (DB) Period|Adverse Event|0
31199|NCT01452529|131065|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
31200|NCT01452529|131066|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
31201|NCT01452529|131067|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
31202|NCT01452529|131065|P3|Run-in Period|Administrative|0
31203|NCT01452529|131066|P2|Run-in Period|Administrative|0
31204|NCT01452529|131067|P1|Run-in Period|Administrative|21
31205|NCT01452529|131065|P3|Run-in Period|Confirmed or suspected diversion|0
31206|NCT01452529|131066|P2|Run-in Period|Confirmed or suspected diversion|0
31207|NCT01452529|131067|P1|Run-in Period|Confirmed or suspected diversion|23
31208|NCT01452529|131065|P3|Run-in Period|Lack of Efficacy|0
31209|NCT01452529|131066|P2|Run-in Period|Lack of Efficacy|0
31210|NCT01452529|131067|P1|Run-in Period|Lack of Efficacy|46
31211|NCT01452529|131065|P3|Run-in Period|Lost to Follow-up|0
31212|NCT01452529|131066|P2|Run-in Period|Lost to Follow-up|0
31213|NCT01452529|131067|P1|Run-in Period|Lost to Follow-up|19
31214|NCT01452529|131065|P3|Run-in Period|Withdrawal by Subject|0
31215|NCT01452529|131066|P2|Run-in Period|Withdrawal by Subject|0
31216|NCT01452529|131067|P1|Run-in Period|Withdrawal by Subject|49
31217|NCT01452529|131065|P3|Run-in Period|Adverse Event|0
31218|NCT01452529|131066|P2|Run-in Period|Adverse Event|0
31219|NCT01452529|131067|P1|Run-in Period|Adverse Event|96
31220|NCT01452347|131081|P2|Overall Study|Other reason not defined above|0
31221|NCT01452347|131082|P1|Overall Study|Other reason not defined above|2
31222|NCT01452347|131081|P2|Overall Study|Not treated|3
31223|NCT01452347|131082|P1|Overall Study|Not treated|6
31224|NCT01452347|131081|P2|Overall Study|Withdrawal by Subject|3
31225|NCT01452347|131082|P1|Overall Study|Withdrawal by Subject|3
31226|NCT01452347|131081|P2|Overall Study|Lost to Follow-up|0
31227|NCT01452347|131082|P1|Overall Study|Lost to Follow-up|2
31228|NCT01452347|131081|P2|Overall Study|Non compliance protocol|0
31229|NCT01452347|131082|P1|Overall Study|Non compliance protocol|2
31230|NCT01452347|131081|P2|Overall Study|Adverse Event|1
31231|NCT01452347|131082|P1|Overall Study|Adverse Event|2
31232|NCT01452152|131114|P3|Overall Study|Study termination by sponsor|4
31233|NCT01452152|131115|P2|Overall Study|Study termination by sponsor|0
31234|NCT01452152|131116|P1|Overall Study|Study termination by sponsor|5
31235|NCT01451931|131152|P3|Overall Study|Withdrawal by Subject|22
31236|NCT01451931|131153|P2|Overall Study|Withdrawal by Subject|22
31237|NCT01451931|131154|P1|Overall Study|Withdrawal by Subject|16
31238|NCT01451931|131152|P3|Overall Study|Lost to Follow-up|21
31239|NCT01451931|131153|P2|Overall Study|Lost to Follow-up|36
31240|NCT01451931|131154|P1|Overall Study|Lost to Follow-up|17
31241|NCT01451814|131176|P2|Overall Study|Lost to Follow-up|4
31242|NCT01451814|131177|P1|Overall Study|Lost to Follow-up|5
31243|NCT01451814|131176|P2|Overall Study|Withdrawal by Subject|1
31244|NCT01451814|131177|P1|Overall Study|Withdrawal by Subject|1
31245|NCT01451762|131209|P3|Overall Study|Lost to Follow-up|6
31246|NCT01451762|131210|P2|Overall Study|Lost to Follow-up|6
31247|NCT01451762|131211|P1|Overall Study|Lost to Follow-up|3
31248|NCT01451749|131221|P2|Overall Study|Withdrawal by Subject|1
31249|NCT01451749|131222|P1|Overall Study|Withdrawal by Subject|0
31250|NCT01451749|131221|P2|Overall Study|Adverse Event|0
31251|NCT01451749|131222|P1|Overall Study|Adverse Event|2
31252|NCT01451749|131221|P2|Overall Study|Meet the exclusion criteria,and|1
31253|NCT01451749|131222|P1|Overall Study|Meet the exclusion criteria,and|1
31254|NCT01451749|131221|P2|Overall Study|Lost to Follow-up|5
31255|NCT01451749|131222|P1|Overall Study|Lost to Follow-up|15
31256|NCT01451749|131221|P2|Overall Study|Protocol Violation|7
31257|NCT01451749|131222|P1|Overall Study|Protocol Violation|14
31258|NCT01451723|131234|P2|Overall Study|study halted|5
31259|NCT01451723|131235|P1|Overall Study|study halted|6
31260|NCT01451645|131245|P2|Overall Study|Lost to Follow-up|3
31261|NCT01451645|131246|P1|Overall Study|Lost to Follow-up|4
31262|NCT01451645|131245|P2|Overall Study|Withdrawal by Subject|2
31263|NCT01451645|131246|P1|Overall Study|Withdrawal by Subject|4
31264|NCT01451645|131245|P2|Overall Study|Adverse Event|3
31265|NCT01451645|131246|P1|Overall Study|Adverse Event|0
31266|NCT01451645|131245|P2|Overall Study|Protocol Violation|0
31267|NCT01451645|131246|P1|Overall Study|Protocol Violation|1
31268|NCT01451554|131317|P2|Overall Study|Withdrawal by Subject|9
31269|NCT01451554|131318|P1|Overall Study|Withdrawal by Subject|14
31270|NCT01451541|131329|P3|Overall Study|randomization error, noncompliance|8
31271|NCT01451541|131330|P2|Overall Study|randomization error, noncompliance|10
31272|NCT01451541|131331|P1|Overall Study|randomization error, noncompliance|11
31273|NCT01451541|131329|P3|Overall Study|Withdrawal by Subject|6
31274|NCT01451541|131330|P2|Overall Study|Withdrawal by Subject|8
31275|NCT01451541|131331|P1|Overall Study|Withdrawal by Subject|15
31276|NCT01451541|131329|P3|Overall Study|Lost to Follow-up|7
31277|NCT01451541|131330|P2|Overall Study|Lost to Follow-up|4
31278|NCT01451541|131331|P1|Overall Study|Lost to Follow-up|4
31279|NCT01451541|131329|P3|Overall Study|Lack of Efficacy|0
31280|NCT01451541|131330|P2|Overall Study|Lack of Efficacy|0
31281|NCT01451541|131331|P1|Overall Study|Lack of Efficacy|2
31282|NCT01451541|131329|P3|Overall Study|Adverse Event|6
31283|NCT01451541|131330|P2|Overall Study|Adverse Event|3
31284|NCT01451541|131331|P1|Overall Study|Adverse Event|4
31285|NCT01451437|131380|P9|Overall Study|Withdrawal by Subject|0
31286|NCT01451437|131381|P8|Overall Study|Withdrawal by Subject|0
31287|NCT01451437|131382|P7|Overall Study|Withdrawal by Subject|1
31288|NCT01451437|131383|P6|Overall Study|Withdrawal by Subject|0
31289|NCT01451437|131384|P5|Overall Study|Withdrawal by Subject|1
31290|NCT01451437|131385|P4|Overall Study|Withdrawal by Subject|0
31291|NCT01451437|131386|P3|Overall Study|Withdrawal by Subject|0
31292|NCT01451437|131387|P2|Overall Study|Withdrawal by Subject|0
31293|NCT01451437|131388|P1|Overall Study|Withdrawal by Subject|0
31294|NCT01451437|131380|P9|Overall Study|Protocol Violation|0
31295|NCT01451437|131381|P8|Overall Study|Protocol Violation|0
31296|NCT01451437|131382|P7|Overall Study|Protocol Violation|1
31297|NCT01451437|131383|P6|Overall Study|Protocol Violation|0
31298|NCT01451437|131384|P5|Overall Study|Protocol Violation|0
31299|NCT01451437|131385|P4|Overall Study|Protocol Violation|0
31300|NCT01451437|131386|P3|Overall Study|Protocol Violation|0
31301|NCT01451437|131387|P2|Overall Study|Protocol Violation|0
31302|NCT01451437|131388|P1|Overall Study|Protocol Violation|0
31303|NCT01451437|131380|P9|Overall Study|Disease Progression|3
31304|NCT01451437|131381|P8|Overall Study|Disease Progression|1
31305|NCT01451437|131382|P7|Overall Study|Disease Progression|3
31306|NCT01451437|131383|P6|Overall Study|Disease Progression|2
31307|NCT01451437|131384|P5|Overall Study|Disease Progression|3
31308|NCT01451437|131385|P4|Overall Study|Disease Progression|1
31309|NCT01451437|131386|P3|Overall Study|Disease Progression|1
31310|NCT01451437|131387|P2|Overall Study|Disease Progression|0
31311|NCT01451437|131388|P1|Overall Study|Disease Progression|0
31312|NCT01451437|131380|P9|Overall Study|Physician Decision|0
31313|NCT01451437|131381|P8|Overall Study|Physician Decision|0
31314|NCT01451437|131382|P7|Overall Study|Physician Decision|0
31315|NCT01451437|131383|P6|Overall Study|Physician Decision|0
31316|NCT01451437|131384|P5|Overall Study|Physician Decision|0
31317|NCT01451437|131385|P4|Overall Study|Physician Decision|0
31318|NCT01451437|131386|P3|Overall Study|Physician Decision|2
31319|NCT01451437|131387|P2|Overall Study|Physician Decision|1
31320|NCT01451437|131388|P1|Overall Study|Physician Decision|1
31321|NCT01451437|131380|P9|Overall Study|Adverse Event|1
31322|NCT01451437|131381|P8|Overall Study|Adverse Event|2
31323|NCT01451437|131382|P7|Overall Study|Adverse Event|1
31324|NCT01451437|131383|P6|Overall Study|Adverse Event|1
31325|NCT01451437|131384|P5|Overall Study|Adverse Event|0
31326|NCT01451437|131385|P4|Overall Study|Adverse Event|0
31327|NCT01451437|131386|P3|Overall Study|Adverse Event|0
31328|NCT01451437|131387|P2|Overall Study|Adverse Event|0
31329|NCT01451437|131388|P1|Overall Study|Adverse Event|0
31330|NCT01451424|131520|P4|Overall Study|Adverse Event|1
31331|NCT01451424|131521|P3|Overall Study|Adverse Event|0
31332|NCT01451424|131522|P2|Overall Study|Adverse Event|0
31333|NCT01451424|131523|P1|Overall Study|Adverse Event|0
31334|NCT01451424|131520|P4|Overall Study|Physician Decision|1
31335|NCT01451424|131521|P3|Overall Study|Physician Decision|1
31336|NCT01451424|131522|P2|Overall Study|Physician Decision|0
31337|NCT01451424|131523|P1|Overall Study|Physician Decision|0
31338|NCT01451424|131520|P4|Overall Study|Lost to Follow-up|1
31339|NCT01451424|131521|P3|Overall Study|Lost to Follow-up|0
31340|NCT01451424|131522|P2|Overall Study|Lost to Follow-up|1
31341|NCT01451424|131523|P1|Overall Study|Lost to Follow-up|0
31342|NCT01451424|131520|P4|Overall Study|Withdrawal by Subject|2
31343|NCT01451424|131521|P3|Overall Study|Withdrawal by Subject|0
31344|NCT01451424|131522|P2|Overall Study|Withdrawal by Subject|1
31345|NCT01451424|131523|P1|Overall Study|Withdrawal by Subject|1
31346|NCT01451398|131581|P2|Overall Study|Lack of Efficacy|1
31347|NCT01451398|131582|P1|Overall Study|Lack of Efficacy|0
31348|NCT01451398|131581|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
31349|NCT01451398|131582|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
31350|NCT01451398|131581|P2|Overall Study|Moved out of country|1
31351|NCT01451398|131582|P1|Overall Study|Moved out of country|0
31352|NCT01451398|131581|P2|Overall Study|Non-compliance with protocol|1
31353|NCT01451398|131582|P1|Overall Study|Non-compliance with protocol|1
31354|NCT01451398|131581|P2|Overall Study|Non-compliance with study drug|3
31355|NCT01451398|131582|P1|Overall Study|Non-compliance with study drug|1
31356|NCT01451398|131581|P2|Overall Study|Lost to Follow-up|4
31357|NCT01451398|131582|P1|Overall Study|Lost to Follow-up|6
31358|NCT01451398|131581|P2|Overall Study|Withdrawal by Subject|14
31359|NCT01451398|131582|P1|Overall Study|Withdrawal by Subject|10
31360|NCT01451398|131581|P2|Overall Study|Physician Decision|1
31361|NCT01451398|131582|P1|Overall Study|Physician Decision|1
31362|NCT01451398|131581|P2|Overall Study|Protocol Violation|2
31363|NCT01451398|131582|P1|Overall Study|Protocol Violation|1
31364|NCT01451398|131581|P2|Overall Study|Adverse Event|9
31365|NCT01451398|131582|P1|Overall Study|Adverse Event|7
31366|NCT01451203|131616|P2|Post-treatment Period|Investigator decision|1
31367|NCT01451203|131617|P1|Post-treatment Period|Investigator decision|0
31368|NCT01451203|131616|P2|Post-treatment Period|Adverse Event|1
31369|NCT01451203|131617|P1|Post-treatment Period|Adverse Event|0
31370|NCT01451203|131616|P2|Post-treatment Period|Lack of Efficacy|28
31371|NCT01451203|131617|P1|Post-treatment Period|Lack of Efficacy|12
31372|NCT01451203|131616|P2|Post-treatment Period|Consent withdrawn|4
31373|NCT01451203|131617|P1|Post-treatment Period|Consent withdrawn|2
31374|NCT01451203|131616|P2|Double-blind Treatment Period|Investigator decision|0
31375|NCT01451203|131617|P1|Double-blind Treatment Period|Investigator decision|2
31376|NCT01451203|131616|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
31377|NCT01451203|131617|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
31378|NCT01451203|131616|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
31379|NCT01451203|131617|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
31380|NCT01451203|131616|P2|Double-blind Treatment Period|Adverse Event|9
31381|NCT01451203|131617|P1|Double-blind Treatment Period|Adverse Event|6
31382|NCT01451203|131616|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
31383|NCT01451203|131617|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
31384|NCT01451203|131616|P2|Double-blind Treatment Period|Lack of Efficacy|36
31385|NCT01451203|131617|P1|Double-blind Treatment Period|Lack of Efficacy|71
31386|NCT01451203|131616|P2|Double-blind Treatment Period|Consent Withdrawn|2
31387|NCT01451203|131617|P1|Double-blind Treatment Period|Consent Withdrawn|3
31388|NCT01451203|131616|P2|Double-blind Treatment Period|Did not receive treatment|2
31389|NCT01451203|131617|P1|Double-blind Treatment Period|Did not receive treatment|1
31390|NCT01450800|131633|P2|Overall Study|Protocol Violation|3
31391|NCT01450800|131634|P1|Overall Study|Protocol Violation|1
31392|NCT01450761|131669|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
31393|NCT01450761|131670|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
31394|NCT01450761|131669|P2|Treatment With Blinded Study Therapy|Not reported|1
31395|NCT01450761|131670|P1|Treatment With Blinded Study Therapy|Not reported|0
31396|NCT01450761|131669|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
31397|NCT01450761|131670|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
31398|NCT01450761|131669|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
31399|NCT01450761|131670|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
31400|NCT01450761|131669|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
31401|NCT01450761|131670|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
31402|NCT01450761|131669|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
31403|NCT01450761|131670|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
31404|NCT01450761|131669|P2|Treatment With Blinded Study Therapy|Death|6
31405|NCT01450761|131670|P1|Treatment With Blinded Study Therapy|Death|5
31406|NCT01450761|131669|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
31407|NCT01450761|131670|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|11
31408|NCT01450761|131669|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
31409|NCT01450761|131670|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|14
31410|NCT01450761|131669|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
31411|NCT01450761|131670|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|25
31412|NCT01450761|131669|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
31413|NCT01450761|131670|P1|Treatment With Blinded Study Therapy|Study drug toxicity|85
31414|NCT01450761|131669|P2|Treatment With Blinded Study Therapy|Disease progression|409
31415|NCT01450761|131670|P1|Treatment With Blinded Study Therapy|Disease progression|314
31416|NCT01450761|131669|P2|Lead-in Chemotherapy|Lost to Follow-up|0
31417|NCT01450761|131670|P1|Lead-in Chemotherapy|Lost to Follow-up|2
31418|NCT01450761|131669|P2|Lead-in Chemotherapy|Unspecified|2
31419|NCT01450761|131670|P1|Lead-in Chemotherapy|Unspecified|2
31420|NCT01450761|131669|P2|Lead-in Chemotherapy|Death|3
31421|NCT01450761|131670|P1|Lead-in Chemotherapy|Death|3
31422|NCT01450761|131669|P2|Lead-in Chemotherapy|No longer meets study criteria|7
31423|NCT01450761|131670|P1|Lead-in Chemotherapy|No longer meets study criteria|3
31424|NCT01450761|131669|P2|Lead-in Chemotherapy|Study drug toxicity|10
31425|NCT01450761|131670|P1|Lead-in Chemotherapy|Study drug toxicity|6
31426|NCT01450761|131669|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
31427|NCT01450761|131670|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
31428|NCT01450761|131669|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
31429|NCT01450761|131670|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
31430|NCT01450761|131669|P2|Lead-in Chemotherapy|Disease progression|32
31431|NCT01450761|131670|P1|Lead-in Chemotherapy|Disease progression|33
31432|NCT01450761|131669|P2|Randomization|Unspecified|1
31433|NCT01450761|131670|P1|Randomization|Unspecified|0
31434|NCT01450761|131669|P2|Randomization|Adverse Event unrelated to study drug|0
31435|NCT01450761|131670|P1|Randomization|Adverse Event unrelated to study drug|1
31436|NCT01450761|131669|P2|Randomization|Disease progression|2
31437|NCT01450761|131670|P1|Randomization|Disease progression|0
31438|NCT01450761|131669|P2|Randomization|Withdrawal by Subject|0
31439|NCT01450761|131670|P1|Randomization|Withdrawal by Subject|2
31440|NCT01450761|131669|P2|Randomization|Subject no longer meets study criteria|2
31441|NCT01450761|131670|P1|Randomization|Subject no longer meets study criteria|1
31442|NCT01450696|131682|P2|Overall Study|Study Terminated by Sponsor|58
31443|NCT01450696|131683|P1|Overall Study|Study Terminated by Sponsor|53
31444|NCT01450696|131682|P2|Overall Study|Withdrawal by Subject|2
31445|NCT01450696|131683|P1|Overall Study|Withdrawal by Subject|13
31446|NCT01450696|131682|P2|Overall Study|Non-Compliance|0
31447|NCT01450696|131683|P1|Overall Study|Non-Compliance|1
31448|NCT01450696|131682|P2|Overall Study|Lost to Follow-up|3
31449|NCT01450696|131683|P1|Overall Study|Lost to Follow-up|3
31450|NCT01450696|131682|P2|Overall Study|Death|84
31451|NCT01450696|131683|P1|Overall Study|Death|77
31452|NCT01450696|131682|P2|Overall Study|Never Treated|1
31453|NCT01450696|131683|P1|Overall Study|Never Treated|1
31454|NCT01450683|131705|P1|Overall Study|Adverse Event|2
31455|NCT01450631|131711|P2|Overall Study|Withdrawal by Subject|0
31456|NCT01450631|131712|P1|Overall Study|Withdrawal by Subject|1
31457|NCT01450631|131711|P2|Overall Study|Lost to Follow-up|4
31458|NCT01450631|131712|P1|Overall Study|Lost to Follow-up|2
31459|NCT01450007|131843|P3|Overall Study|Adverse Event|0
31460|NCT01450007|131844|P2|Overall Study|Adverse Event|1
31461|NCT01450007|131845|P1|Overall Study|Adverse Event|0
31462|NCT01450007|131843|P3|Overall Study|Protocol Violation|1
31463|NCT01450007|131844|P2|Overall Study|Protocol Violation|1
31464|NCT01450007|131845|P1|Overall Study|Protocol Violation|0
31465|NCT01450007|131843|P3|Overall Study|Late exclusion before treatment|2
31466|NCT01450007|131844|P2|Overall Study|Late exclusion before treatment|3
31467|NCT01450007|131845|P1|Overall Study|Late exclusion before treatment|2
31468|NCT01449955|131864|P2|Overall Study|Withdrawal by Subject|2
31469|NCT01449955|131865|P1|Overall Study|Withdrawal by Subject|1
31470|NCT01449929|131873|P2|Overall Study|Ongoing|213
31471|NCT01449929|131874|P1|Overall Study|Ongoing|224
31472|NCT01449929|131873|P2|Overall Study|Physician Decision|3
31473|NCT01449929|131874|P1|Overall Study|Physician Decision|2
31474|NCT01449929|131873|P2|Overall Study|Withdrawal by Subject|1
31475|NCT01449929|131874|P1|Overall Study|Withdrawal by Subject|1
31476|NCT01449929|131873|P2|Overall Study|Lost to Follow-up|10
31477|NCT01449929|131874|P1|Overall Study|Lost to Follow-up|6
31478|NCT01449929|131873|P2|Overall Study|Protocol-defined Stopping Criteria|1
31479|NCT01449929|131874|P1|Overall Study|Protocol-defined Stopping Criteria|1
31480|NCT01449929|131873|P2|Overall Study|Protocol Violation|3
31481|NCT01449929|131874|P1|Overall Study|Protocol Violation|3
31482|NCT01449929|131873|P2|Overall Study|Lack of Efficacy|2
31483|NCT01449929|131874|P1|Overall Study|Lack of Efficacy|2
31484|NCT01449929|131873|P2|Overall Study|Adverse Event|9
31485|NCT01449929|131874|P1|Overall Study|Adverse Event|3
31486|NCT01449708|131933|P2|Overall Study|respiratory failure|0
31487|NCT01449708|131934|P1|Overall Study|respiratory failure|1
31488|NCT01449708|131933|P2|Overall Study|surgical complication|2
31489|NCT01449708|131934|P1|Overall Study|surgical complication|1
31490|NCT01449708|131933|P2|Overall Study|Protocol Violation|1
31491|NCT01449708|131934|P1|Overall Study|Protocol Violation|0
31492|NCT01449539|131943|P1|Overall Study|Toxicity not study related|1
31493|NCT01449539|131943|P1|Overall Study|Withdrawal by Subject|3
31494|NCT01449526|131949|P2|Overall Study|Cannot maintain visits|1
31495|NCT01449526|131950|P1|Overall Study|Cannot maintain visits|0
31496|NCT01449526|131949|P2|Overall Study|Lack of Motivation|1
31497|NCT01449526|131950|P1|Overall Study|Lack of Motivation|0
31498|NCT01449526|131949|P2|Overall Study|Symptoms/complaints|1
31499|NCT01449526|131950|P1|Overall Study|Symptoms/complaints|0
31500|NCT01449526|131949|P2|Overall Study|Withdrawal by Subject|1
31501|NCT01449526|131950|P1|Overall Study|Withdrawal by Subject|1
31502|NCT01449526|131949|P2|Overall Study|Lost to Follow-up|2
31503|NCT01449526|131950|P1|Overall Study|Lost to Follow-up|1
31504|NCT01449006|132032|P2|Overall Study|Protocol Violation|0
31505|NCT01449006|132033|P1|Overall Study|Protocol Violation|1
31506|NCT01449006|132032|P2|Overall Study|Withdrawal by Subject|0
31507|NCT01449006|132033|P1|Overall Study|Withdrawal by Subject|1
31508|NCT01449006|132032|P2|Overall Study|Lost to Follow-up|0
31509|NCT01449006|132033|P1|Overall Study|Lost to Follow-up|1
31510|NCT01448850|132047|P2|Overall Study|Unspecified|12
31511|NCT01448850|132048|P1|Overall Study|Unspecified|15
31512|NCT01448850|132047|P2|Overall Study|Lost to Follow-up|1
31513|NCT01448850|132048|P1|Overall Study|Lost to Follow-up|3
31514|NCT01448850|132047|P2|Overall Study|Withdrawal by Subject|21
31515|NCT01448850|132048|P1|Overall Study|Withdrawal by Subject|13
31516|NCT01448850|132047|P2|Overall Study|Death|6
31517|NCT01448850|132048|P1|Overall Study|Death|3
31518|NCT01448707|132073|P2|Overall Study|Unspecified|4
31519|NCT01448707|132074|P1|Overall Study|Unspecified|7
31520|NCT01448707|132073|P2|Overall Study|Withdrawal by Subject|7
31521|NCT01448707|132074|P1|Overall Study|Withdrawal by Subject|6
31522|NCT01448707|132073|P2|Overall Study|Lost to Follow-up|6
31523|NCT01448707|132074|P1|Overall Study|Lost to Follow-up|2
31524|NCT01448707|132073|P2|Overall Study|Adverse Event|1
31525|NCT01448707|132074|P1|Overall Study|Adverse Event|3
31526|NCT01448616|132095|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
31527|NCT01448616|132096|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
31528|NCT01448616|132097|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
31529|NCT01448616|132098|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
31530|NCT01448616|132095|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
31531|NCT01448616|132096|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
31532|NCT01448616|132097|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
31533|NCT01448616|132098|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
31534|NCT01448616|132095|P4|Study Drug (Treatment Phase)|Adverse Event|0
31535|NCT01448616|132096|P3|Study Drug (Treatment Phase)|Adverse Event|1
31536|NCT01448616|132097|P2|Study Drug (Treatment Phase)|Adverse Event|1
31537|NCT01448616|132098|P1|Study Drug (Treatment Phase)|Adverse Event|0
31538|NCT01448616|132095|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
31539|NCT01448616|132096|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
31540|NCT01448616|132097|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
31541|NCT01448616|132098|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
31542|NCT01448616|132095|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
31543|NCT01448616|132096|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
31544|NCT01448616|132097|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
31545|NCT01448616|132098|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
31546|NCT01448213|132145|P2|Overall Study|Protocol Violation|2
31547|NCT01448213|132146|P1|Overall Study|Protocol Violation|1
31548|NCT01448213|132145|P2|Overall Study|Adverse Event|10
31549|NCT01448213|132146|P1|Overall Study|Adverse Event|4
31550|NCT01448213|132145|P2|Overall Study|Lost to Follow-up|10
31551|NCT01448213|132146|P1|Overall Study|Lost to Follow-up|12
31552|NCT01448057|132156|P2|Overall Study|Withdrawal by Subject|0
31553|NCT01448057|132157|P1|Overall Study|Withdrawal by Subject|2
31554|NCT01448057|132156|P2|Overall Study|Adverse Event|2
31555|NCT01448057|132157|P1|Overall Study|Adverse Event|0
31556|NCT01448057|132156|P2|Overall Study|Lost to Follow-up|0
31557|NCT01448057|132157|P1|Overall Study|Lost to Follow-up|3
31558|NCT01448057|132156|P2|Overall Study|Protocol Violation|2
31559|NCT01448057|132157|P1|Overall Study|Protocol Violation|3
31560|NCT01448044|132167|P2|Follow Up Period|not specified|11
31561|NCT01448044|132168|P1|Follow Up Period|not specified|5
31562|NCT01448044|132167|P2|Follow Up Period|Lost to Follow-up|2
31563|NCT01448044|132168|P1|Follow Up Period|Lost to Follow-up|6
31564|NCT01448044|132167|P2|Follow Up Period|Withdrawal by Subject|1
31565|NCT01448044|132168|P1|Follow Up Period|Withdrawal by Subject|1
31566|NCT01448044|132167|P2|Treatment Period|Other reason|0
31567|NCT01448044|132168|P1|Treatment Period|Other reason|2
31568|NCT01448044|132167|P2|Treatment Period|Lost to Follow-up|1
31569|NCT01448044|132168|P1|Treatment Period|Lost to Follow-up|2
31570|NCT01448044|132167|P2|Treatment Period|Participant does not meet study criteria|0
31571|NCT01448044|132168|P1|Treatment Period|Participant does not meet study criteria|1
31572|NCT01448044|132167|P2|Treatment Period|Completed 24 weeks treatment period only|0
31573|NCT01448044|132168|P1|Treatment Period|Completed 24 weeks treatment period only|8
31574|NCT01448044|132167|P2|Treatment Period|Subject requested discontinue study drug|0
31575|NCT01448044|132168|P1|Treatment Period|Subject requested discontinue study drug|1
31576|NCT01448044|132167|P2|Treatment Period|Lack of Efficacy|12
31577|NCT01448044|132168|P1|Treatment Period|Lack of Efficacy|5
31578|NCT01448044|132167|P2|Treatment Period|Adverse Event|3
31579|NCT01448044|132168|P1|Treatment Period|Adverse Event|4
31580|NCT01447927|132184|P2|Overall Study|Withdrawal by Subject|0
31581|NCT01447927|132185|P1|Overall Study|Withdrawal by Subject|1
31582|NCT01447927|132184|P2|Overall Study|Adverse Event|3
31583|NCT01447927|132185|P1|Overall Study|Adverse Event|4
31584|NCT01447719|132215|P1|Overall Study|Family withdrew autopsy consent|7
31585|NCT01447719|132215|P1|Overall Study|Withdrawal by Subject|2
31586|NCT01447719|132215|P1|Overall Study|Subject still living at end of study|79
31587|NCT01447719|132215|P1|Overall Study|Invalid image or not imaged|3
31588|NCT01447719|132215|P1|Overall Study|Image acquisition failure|2
31589|NCT01447576|132241|P1|Overall Study|Physician Decision|6
31590|NCT01447576|132241|P1|Overall Study|Lack of Efficacy|68
31591|NCT01447576|132241|P1|Overall Study|Protocol deviation|83
31592|NCT01447576|132241|P1|Overall Study|Withdrawal by Subject|100
31593|NCT01447576|132241|P1|Overall Study|Participant met withdrawal criteria|40
31594|NCT01447576|132241|P1|Overall Study|Adverse Event|127
31595|NCT01447576|132241|P1|Overall Study|Lost to Follow-up|52
31596|NCT01447433|132270|P2|Overall Study|Protocol Violation|1
31597|NCT01447433|132271|P1|Overall Study|Protocol Violation|1
31598|NCT01447433|132270|P2|Overall Study|Withdrawal by Subject|3
31599|NCT01447433|132271|P1|Overall Study|Withdrawal by Subject|3
31600|NCT01447433|132270|P2|Overall Study|Lost to Follow-up|2
31601|NCT01447433|132271|P1|Overall Study|Lost to Follow-up|0
31602|NCT01447420|132298|P3|Overall Study|Lack of Efficacy|8
31603|NCT01447420|132299|P2|Overall Study|Lack of Efficacy|19
31604|NCT01447420|132300|P1|Overall Study|Lack of Efficacy|1
31605|NCT01447420|132298|P3|Overall Study|Withdrawal by Subject|0
31606|NCT01447420|132299|P2|Overall Study|Withdrawal by Subject|1
31607|NCT01447420|132300|P1|Overall Study|Withdrawal by Subject|4
31608|NCT01447420|132298|P3|Overall Study|Protocol Violation|0
31609|NCT01447420|132299|P2|Overall Study|Protocol Violation|3
31610|NCT01447420|132300|P1|Overall Study|Protocol Violation|3
31611|NCT01447420|132298|P3|Overall Study|Adverse Event|2
31612|NCT01447420|132299|P2|Overall Study|Adverse Event|4
31613|NCT01447420|132300|P1|Overall Study|Adverse Event|2
31614|NCT01446796|132413|P2|Overall Study|Withdrawal by Subject|0
31615|NCT01446796|132414|P1|Overall Study|Withdrawal by Subject|1
31616|NCT01446419|132439|P2|Overall Study|Terminated per protocol|0
31617|NCT01446419|132440|P1|Overall Study|Terminated per protocol|3
31618|NCT01446419|132439|P2|Overall Study|Withdrawal by Subject|1
31619|NCT01446419|132440|P1|Overall Study|Withdrawal by Subject|1
31620|NCT01446419|132439|P2|Overall Study|Death|0
31621|NCT01446419|132440|P1|Overall Study|Death|1
31622|NCT01446289|132454|P4|Overall Study|Withdrawal by Subject|0
31623|NCT01446289|132455|P3|Overall Study|Withdrawal by Subject|1
31624|NCT01446289|132456|P2|Overall Study|Withdrawal by Subject|0
31625|NCT01446289|132457|P1|Overall Study|Withdrawal by Subject|1
31626|NCT01445951|132503|P3|Overall Study|Cough|0
31627|NCT01445951|132504|P2|Overall Study|Cough|1
31628|NCT01445951|132505|P1|Overall Study|Cough|0
31629|NCT01445951|132503|P3|Overall Study|Sponsor decision - subject travel|0
31630|NCT01445951|132504|P2|Overall Study|Sponsor decision - subject travel|1
31631|NCT01445951|132505|P1|Overall Study|Sponsor decision - subject travel|0
31632|NCT01445951|132503|P3|Overall Study|Non-compliance with protocol|0
31633|NCT01445951|132504|P2|Overall Study|Non-compliance with protocol|1
31634|NCT01445951|132505|P1|Overall Study|Non-compliance with protocol|0
31635|NCT01445951|132503|P3|Overall Study|Non-compliance with study drug|0
31636|NCT01445951|132504|P2|Overall Study|Non-compliance with study drug|2
31637|NCT01445951|132505|P1|Overall Study|Non-compliance with study drug|1
31638|NCT01445951|132503|P3|Overall Study|Death|1
31639|NCT01445951|132504|P2|Overall Study|Death|0
31640|NCT01445951|132505|P1|Overall Study|Death|0
31641|NCT01445951|132503|P3|Overall Study|Pregnancy|4
31642|NCT01445951|132504|P2|Overall Study|Pregnancy|1
31643|NCT01445951|132505|P1|Overall Study|Pregnancy|0
31644|NCT01445951|132503|P3|Overall Study|Lost to Follow-up|4
31645|NCT01445951|132504|P2|Overall Study|Lost to Follow-up|2
31646|NCT01445951|132505|P1|Overall Study|Lost to Follow-up|1
31647|NCT01445951|132503|P3|Overall Study|Physician Decision|0
31648|NCT01445951|132504|P2|Overall Study|Physician Decision|1
31649|NCT01445951|132505|P1|Overall Study|Physician Decision|3
31650|NCT01445951|132503|P3|Overall Study|Withdrawal by Subject|8
31651|NCT01445951|132504|P2|Overall Study|Withdrawal by Subject|16
31652|NCT01445951|132505|P1|Overall Study|Withdrawal by Subject|21
31653|NCT01445951|132503|P3|Overall Study|Protocol Violation|2
31654|NCT01445951|132504|P2|Overall Study|Protocol Violation|2
31655|NCT01445951|132505|P1|Overall Study|Protocol Violation|2
31656|NCT01445951|132503|P3|Overall Study|Adverse Event|0
31657|NCT01445951|132504|P2|Overall Study|Adverse Event|9
31658|NCT01445951|132505|P1|Overall Study|Adverse Event|16
31659|NCT01445847|132573|P2|Overall Study|Terminated by data monitoring committee|133
31660|NCT01445847|132574|P1|Overall Study|Terminated by data monitoring committee|133
31661|NCT01445847|132573|P2|Overall Study|Protocol Violation|14
31662|NCT01445847|132574|P1|Overall Study|Protocol Violation|13
31663|NCT01445769|132580|P1|Overall Study|Lost to Follow-up|5
31664|NCT01445769|132580|P1|Overall Study|Disease Progression|1
31665|NCT01445769|132580|P1|Overall Study|Consent Withdrawn|2
31666|NCT01445678|132600|P2|Overall Study|Withdrawal by Subject|5
31667|NCT01445678|132601|P1|Overall Study|Withdrawal by Subject|9
31668|NCT01445678|132600|P2|Overall Study|Protocol Violation|1
31669|NCT01445678|132601|P1|Overall Study|Protocol Violation|1
31670|NCT01445678|132600|P2|Overall Study|Lost to Follow-up|5
31671|NCT01445678|132601|P1|Overall Study|Lost to Follow-up|8
31672|NCT01445678|132600|P2|Overall Study|Lack of Efficacy|2
31673|NCT01445678|132601|P1|Overall Study|Lack of Efficacy|0
31674|NCT01445678|132600|P2|Overall Study|Adverse Event|8
31675|NCT01445678|132601|P1|Overall Study|Adverse Event|12
31676|NCT01445652|132619|P2|Overall Study|Adverse Event|0
31677|NCT01445652|132620|P1|Overall Study|Adverse Event|1
31678|NCT01445652|132619|P2|Overall Study|Failed teach session|0
31679|NCT01445652|132620|P1|Overall Study|Failed teach session|2
31680|NCT01445652|132619|P2|Overall Study|Failed to attend scheduled visit|3
31681|NCT01445652|132620|P1|Overall Study|Failed to attend scheduled visit|2
31682|NCT01445652|132619|P2|Overall Study|Not comfortable in lenses|0
31683|NCT01445652|132620|P1|Overall Study|Not comfortable in lenses|5
31684|NCT01445613|132638|P1|1-year Follow-up|Received a non-study stent|2
31685|NCT01445613|132638|P1|1-year Follow-up|Physician Decision|2
31686|NCT01445613|132638|P1|1-year Follow-up|Death|30
31687|NCT01445613|132638|P1|1-year Follow-up|Lost to Follow-up|2
31688|NCT01445613|132638|P1|1-year Follow-up|Missed visit|29
31689|NCT01445613|132638|P1|1-year Follow-up|Withdrawal by Subject|12
31690|NCT01445613|132638|P1|30-day Follow-up|Death|3
31691|NCT01445613|132638|P1|30-day Follow-up|Missed visit|23
31692|NCT01445613|132638|P1|30-day Follow-up|Physician Decision|3
31693|NCT01445613|132638|P1|30-day Follow-up|Withdrawal by Subject|6
31694|NCT01445548|132656|P1|Overall Study|Adverse Event|1
31695|NCT01444898|132686|P1|Overall Study|Withdrawal by Subject|1
31696|NCT01444781|132701|P3|Overall Study|Withdrawal by Subject|2
31697|NCT01444781|132702|P2|Overall Study|Withdrawal by Subject|1
31698|NCT01444781|132703|P1|Overall Study|Withdrawal by Subject|3
31699|NCT01444781|132701|P3|Overall Study|Lost to Follow-up|1
31700|NCT01444781|132702|P2|Overall Study|Lost to Follow-up|3
31701|NCT01444781|132703|P1|Overall Study|Lost to Follow-up|0
31702|NCT01444651|132743|P2|Overall Study|Missing data|1
31703|NCT01444651|132744|P1|Overall Study|Missing data|1
31704|NCT01444651|132743|P2|Overall Study|Non-fasting|1
31705|NCT01444651|132744|P1|Overall Study|Non-fasting|2
31706|NCT01444651|132743|P2|Overall Study|Lost to Follow-up|5
31707|NCT01444651|132744|P1|Overall Study|Lost to Follow-up|5
31708|NCT01444651|132743|P2|Overall Study|Adverse Event|2
31709|NCT01444651|132744|P1|Overall Study|Adverse Event|3
31710|NCT01444456|132760|P1|Overall Study|Not treated|104
31711|NCT01444456|132760|P1|Overall Study|Other|18
31712|NCT01444456|132760|P1|Overall Study|Ineligibility determined|23
31713|NCT01444456|132760|P1|Overall Study|Death|73
31714|NCT01444456|132760|P1|Overall Study|Lost to Follow-up|37
31715|NCT01444456|132760|P1|Overall Study|Physician Decision|9
31716|NCT01444456|132760|P1|Overall Study|Withdrawal by Subject|21
31717|NCT01444430|132771|P2|Overall Study|CRF termination module not completed.|1
31718|NCT01444430|132772|P1|Overall Study|CRF termination module not completed.|0
31719|NCT01444430|132771|P2|Overall Study|Lost to Follow-up|0
31720|NCT01444430|132772|P1|Overall Study|Lost to Follow-up|2
31721|NCT01444430|132771|P2|Overall Study|Death|8
31722|NCT01444430|132772|P1|Overall Study|Death|6
31723|NCT01444430|132771|P2|Overall Study|Withdrawal by Subject|72
31724|NCT01444430|132772|P1|Overall Study|Withdrawal by Subject|53
31725|NCT01444417|132794|P2|Overall Study|Withdrawal by Subject|0
31726|NCT01444417|132795|P1|Overall Study|Withdrawal by Subject|2
31727|NCT01444417|132794|P2|Overall Study|Ineligibility Determined|1
31728|NCT01444417|132795|P1|Overall Study|Ineligibility Determined|0
31729|NCT01444391|132811|P1|Overall Study|Death|1
31730|NCT01444300|132821|P2|Overall Study|Adverse Event|0
31731|NCT01444300|132822|P1|Overall Study|Adverse Event|4
31732|NCT01444092|132854|P1|Overall Study|Other Eligibility criteria|7
31733|NCT01444092|132854|P1|Overall Study|Withdrawal by Subject|1
31734|NCT01444092|132854|P1|Overall Study|Protocol Violation|1
31735|NCT01444092|132854|P1|Overall Study|Adverse Event|8
31736|NCT01443923|132862|P2|Overall Study|Adverse Event|0
31737|NCT01443923|132863|P1|Overall Study|Adverse Event|1
31738|NCT01443858|132880|P3|Overall Study|Lost to Follow-up|2
31739|NCT01443858|132881|P2|Overall Study|Lost to Follow-up|5
31740|NCT01443858|132882|P1|Overall Study|Lost to Follow-up|5
31741|NCT01443858|132880|P3|Overall Study|Lack of Efficacy|0
31742|NCT01443858|132881|P2|Overall Study|Lack of Efficacy|0
31743|NCT01443858|132882|P1|Overall Study|Lack of Efficacy|1
31744|NCT01443858|132880|P3|Overall Study|Withdrawal by Subject|5
31745|NCT01443858|132881|P2|Overall Study|Withdrawal by Subject|8
31746|NCT01443858|132882|P1|Overall Study|Withdrawal by Subject|9
31747|NCT01443845|132904|P2|Overall Study|Lost to Follow-up|13
31748|NCT01443845|132905|P1|Overall Study|Lost to Follow-up|9
31749|NCT01443845|132904|P2|Overall Study|Military Conflict - Site Terminated|21
31750|NCT01443845|132905|P1|Overall Study|Military Conflict - Site Terminated|20
31751|NCT01443845|132904|P2|Overall Study|Withdrawal by Subject|67
31752|NCT01443845|132905|P1|Overall Study|Withdrawal by Subject|63
31753|NCT01443845|132904|P2|Overall Study|Adverse Event|138
31754|NCT01443845|132905|P1|Overall Study|Adverse Event|64
31755|NCT01443845|132904|P2|Overall Study|Lack of Efficacy|5
31756|NCT01443845|132905|P1|Overall Study|Lack of Efficacy|10
31757|NCT01443845|132904|P2|Overall Study|Deterioration in pulmonary function|4
31758|NCT01443845|132905|P1|Overall Study|Deterioration in pulmonary function|1
31759|NCT01443845|132904|P2|Overall Study|Other reasons, such as COPD exacerbation|44
31760|NCT01443845|132905|P1|Overall Study|Other reasons, such as COPD exacerbation|44
31761|NCT01443845|132904|P2|Overall Study|Protocol Violation|45
31762|NCT01443845|132905|P1|Overall Study|Protocol Violation|43
31763|NCT01443364|132922|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
31764|NCT01443364|132922|P1|Overall Study|AE, non-serious non-fatal|8
31765|NCT01443364|132922|P1|Overall Study|SAE, non-fatal|6
31766|NCT01443364|132922|P1|Overall Study|Other Reason|4
31767|NCT01443364|132922|P1|Overall Study|Withdrawal by Subject|5
31768|NCT01443364|132922|P1|Overall Study|Lost to Follow-up|3
31769|NCT01443364|132922|P1|Overall Study|Lack of Efficacy|14
31770|NCT01443130|133051|P6|Overall Study|Death of Subject's Infant|0
31771|NCT01443130|133052|P5|Overall Study|Death of Subject's Infant|0
31772|NCT01443130|133053|P4|Overall Study|Death of Subject's Infant|0
31773|NCT01443130|133054|P3|Overall Study|Death of Subject's Infant|11
31774|NCT01443130|133055|P2|Overall Study|Death of Subject's Infant|10
31775|NCT01443130|133056|P1|Overall Study|Death of Subject's Infant|5
31776|NCT01443130|133051|P6|Overall Study|Withdrawal by Subject|2
31777|NCT01443130|133052|P5|Overall Study|Withdrawal by Subject|7
31778|NCT01443130|133053|P4|Overall Study|Withdrawal by Subject|7
31779|NCT01443130|133054|P3|Overall Study|Withdrawal by Subject|12
31780|NCT01443130|133055|P2|Overall Study|Withdrawal by Subject|14
31781|NCT01443130|133056|P1|Overall Study|Withdrawal by Subject|15
31782|NCT01443130|133051|P6|Overall Study|Protocol Violation|3
31783|NCT01443130|133052|P5|Overall Study|Protocol Violation|2
31784|NCT01443130|133053|P4|Overall Study|Protocol Violation|2
31785|NCT01443130|133054|P3|Overall Study|Protocol Violation|3
31786|NCT01443130|133055|P2|Overall Study|Protocol Violation|1
31787|NCT01443130|133056|P1|Overall Study|Protocol Violation|2
31788|NCT01443130|133051|P6|Overall Study|Adverse Event|0
31789|NCT01443130|133052|P5|Overall Study|Adverse Event|0
31790|NCT01443130|133053|P4|Overall Study|Adverse Event|0
31791|NCT01443130|133054|P3|Overall Study|Adverse Event|1
31792|NCT01443130|133055|P2|Overall Study|Adverse Event|1
31793|NCT01443130|133056|P1|Overall Study|Adverse Event|2
31794|NCT01443130|133051|P6|Overall Study|Death|8
31795|NCT01443130|133052|P5|Overall Study|Death|10
31796|NCT01443130|133053|P4|Overall Study|Death|7
31797|NCT01443130|133054|P3|Overall Study|Death|0
31798|NCT01443130|133055|P2|Overall Study|Death|1
31799|NCT01443130|133056|P1|Overall Study|Death|0
31800|NCT01443130|133051|P6|Overall Study|Lost to Follow-up|21
31801|NCT01443130|133052|P5|Overall Study|Lost to Follow-up|25
31802|NCT01443130|133053|P4|Overall Study|Lost to Follow-up|23
31803|NCT01443130|133054|P3|Overall Study|Lost to Follow-up|50
31804|NCT01443130|133055|P2|Overall Study|Lost to Follow-up|42
31805|NCT01443130|133056|P1|Overall Study|Lost to Follow-up|44
31806|NCT01443078|133106|P1|Overall Study|Patient had brain mets|1
31807|NCT01443078|133106|P1|Overall Study|Withdrawal by Subject|1
31808|NCT01443078|133106|P1|Overall Study|Responded to neoadjuvant platinum txt|27
31809|NCT01443026|133112|P2|Overall Study|Lost to Follow-up|1
31810|NCT01443026|133113|P1|Overall Study|Lost to Follow-up|2
31811|NCT01443026|133112|P2|Overall Study|Withdrawal by Subject|3
31812|NCT01443026|133113|P1|Overall Study|Withdrawal by Subject|0
31813|NCT01443026|133112|P2|Overall Study|Death|1
31814|NCT01443026|133113|P1|Overall Study|Death|0
31815|NCT01443026|133112|P2|Overall Study|Physician Decision|0
31816|NCT01443026|133113|P1|Overall Study|Physician Decision|1
31817|NCT01442779|133128|P1|Overall Study|Non-compliance|1
31818|NCT01442779|133128|P1|Overall Study|Death|3
31819|NCT01442779|133128|P1|Overall Study|Withdrawal by Subject|3
31820|NCT01442688|133136|P2|Second Intervention|Adverse Event|0
31821|NCT01442688|133137|P1|Second Intervention|Adverse Event|1
31822|NCT01442688|133136|P2|First Intervention|subject incarcerated|0
31823|NCT01442688|133137|P1|First Intervention|subject incarcerated|1
31824|NCT01442688|133136|P2|First Intervention|Withdrawal by Subject|0
31825|NCT01442688|133137|P1|First Intervention|Withdrawal by Subject|1
31826|NCT01442675|133145|P1|Overall Study|Withdrawal by Subject|4
31827|NCT01442675|133145|P1|Overall Study|Lost to Follow-up|2
31828|NCT01442675|133145|P1|Overall Study|Protocol Violation|6
31829|NCT01442376|133158|P3|Overall Study|Not eligible for subsequent cycles|0
31830|NCT01442376|133159|P2|Overall Study|Not eligible for subsequent cycles|2
31831|NCT01442376|133160|P1|Overall Study|Not eligible for subsequent cycles|1
31832|NCT01442376|133158|P3|Overall Study|Patients not treated|1
31833|NCT01442376|133159|P2|Overall Study|Patients not treated|3
31834|NCT01442376|133160|P1|Overall Study|Patients not treated|2
31835|NCT01442376|133158|P3|Overall Study|Withdrawal of consent|1
31836|NCT01442376|133159|P2|Overall Study|Withdrawal of consent|0
31837|NCT01442376|133160|P1|Overall Study|Withdrawal of consent|0
31838|NCT01442376|133158|P3|Overall Study|Death|1
31839|NCT01442376|133159|P2|Overall Study|Death|1
31840|NCT01442376|133160|P1|Overall Study|Death|0
31841|NCT01442376|133158|P3|Overall Study|Adverse Event|2
31842|NCT01442376|133159|P2|Overall Study|Adverse Event|3
31843|NCT01442376|133160|P1|Overall Study|Adverse Event|0
31844|NCT01442181|133173|P2|Overall Study|atrial fibrillation not noted|1
31845|NCT01442181|133174|P1|Overall Study|atrial fibrillation not noted|0
31846|NCT01442181|133173|P2|Overall Study|patient in an additional study|0
31847|NCT01442181|133174|P1|Overall Study|patient in an additional study|1
31848|NCT01442181|133173|P2|Overall Study|Lost to Follow-up|1
31849|NCT01442181|133174|P1|Overall Study|Lost to Follow-up|1
31850|NCT01442181|133173|P2|Overall Study|low ejection factor|1
31851|NCT01442181|133174|P1|Overall Study|low ejection factor|0
31852|NCT01442181|133173|P2|Overall Study|no insurance for surgery|0
31853|NCT01442181|133174|P1|Overall Study|no insurance for surgery|1
31854|NCT01442181|133173|P2|Overall Study|patient refused surgery|0
31855|NCT01442181|133174|P1|Overall Study|patient refused surgery|1
31856|NCT01442155|133198|P1|Overall Study|Lost to Follow-up|2
31857|NCT01442155|133198|P1|Overall Study|Adverse Event|2
31858|NCT01442155|133198|P1|Overall Study|Recurrence|26
31859|NCT01442155|133198|P1|Overall Study|Complete remission|35
31860|NCT01442103|133214|P1|Overall Study|Lost to Follow-up|2
31861|NCT01442064|133224|P6|Overall Study|Condition mandated other intervention|2
31862|NCT01442064|133225|P5|Overall Study|Condition mandated other intervention|0
31863|NCT01442064|133226|P4|Overall Study|Condition mandated other intervention|0
31864|NCT01442064|133227|P3|Overall Study|Condition mandated other intervention|2
31865|NCT01442064|133228|P2|Overall Study|Condition mandated other intervention|1
31866|NCT01442064|133229|P1|Overall Study|Condition mandated other intervention|1
31867|NCT01442064|133224|P6|Overall Study|Subject non-compliance|2
31868|NCT01442064|133225|P5|Overall Study|Subject non-compliance|0
31869|NCT01442064|133226|P4|Overall Study|Subject non-compliance|0
31870|NCT01442064|133227|P3|Overall Study|Subject non-compliance|0
31871|NCT01442064|133228|P2|Overall Study|Subject non-compliance|0
31872|NCT01442064|133229|P1|Overall Study|Subject non-compliance|0
31873|NCT01442064|133224|P6|Overall Study|Sponsor decision|87
31874|NCT01442064|133225|P5|Overall Study|Sponsor decision|95
31875|NCT01442064|133226|P4|Overall Study|Sponsor decision|88
31876|NCT01442064|133227|P3|Overall Study|Sponsor decision|92
31877|NCT01442064|133228|P2|Overall Study|Sponsor decision|88
31878|NCT01442064|133229|P1|Overall Study|Sponsor decision|82
31879|NCT01442064|133224|P6|Overall Study|Withdrawal by Subject|1
31880|NCT01442064|133225|P5|Overall Study|Withdrawal by Subject|2
31881|NCT01442064|133226|P4|Overall Study|Withdrawal by Subject|2
31882|NCT01442064|133227|P3|Overall Study|Withdrawal by Subject|2
31883|NCT01442064|133228|P2|Overall Study|Withdrawal by Subject|3
31884|NCT01442064|133229|P1|Overall Study|Withdrawal by Subject|6
31885|NCT01442064|133224|P6|Overall Study|Physician Decision|1
31886|NCT01442064|133225|P5|Overall Study|Physician Decision|3
31887|NCT01442064|133226|P4|Overall Study|Physician Decision|3
31888|NCT01442064|133227|P3|Overall Study|Physician Decision|2
31889|NCT01442064|133228|P2|Overall Study|Physician Decision|1
31890|NCT01442064|133229|P1|Overall Study|Physician Decision|1
31891|NCT01442064|133224|P6|Overall Study|Lost to Follow-up|3
31892|NCT01442064|133225|P5|Overall Study|Lost to Follow-up|3
31893|NCT01442064|133226|P4|Overall Study|Lost to Follow-up|1
31894|NCT01442064|133227|P3|Overall Study|Lost to Follow-up|1
31895|NCT01442064|133228|P2|Overall Study|Lost to Follow-up|5
31896|NCT01442064|133229|P1|Overall Study|Lost to Follow-up|5
31897|NCT01442064|133224|P6|Overall Study|Death|3
31898|NCT01442064|133225|P5|Overall Study|Death|1
31899|NCT01442064|133226|P4|Overall Study|Death|3
31900|NCT01442064|133227|P3|Overall Study|Death|3
31901|NCT01442064|133228|P2|Overall Study|Death|1
31902|NCT01442064|133229|P1|Overall Study|Death|0
31903|NCT01442064|133224|P6|Overall Study|Adverse Event|0
31904|NCT01442064|133225|P5|Overall Study|Adverse Event|2
31905|NCT01442064|133226|P4|Overall Study|Adverse Event|1
31906|NCT01442064|133227|P3|Overall Study|Adverse Event|2
31907|NCT01442064|133228|P2|Overall Study|Adverse Event|2
31908|NCT01442064|133229|P1|Overall Study|Adverse Event|2
31909|NCT01442038|133266|P2|Overall Study|Study Terminated By Sponsor|3
31910|NCT01442038|133267|P1|Overall Study|Study Terminated By Sponsor|2
31911|NCT01442038|133266|P2|Overall Study|Investigator's Discretion|16
31912|NCT01442038|133267|P1|Overall Study|Investigator's Discretion|13
31913|NCT01442038|133266|P2|Overall Study|Protocol Deviation|20
31914|NCT01442038|133267|P1|Overall Study|Protocol Deviation|9
31915|NCT01442038|133266|P2|Overall Study|Adverse Event|15
31916|NCT01442038|133267|P1|Overall Study|Adverse Event|26
31917|NCT01442038|133266|P2|Overall Study|Lost to Follow-up|51
31918|NCT01442038|133267|P1|Overall Study|Lost to Follow-up|37
31919|NCT01442038|133266|P2|Overall Study|Participant Withdrew Consent|102
31920|NCT01442038|133267|P1|Overall Study|Participant Withdrew Consent|137
31921|NCT01442038|133266|P2|Overall Study|Investigator-Initiated Early Closure|43
31922|NCT01442038|133267|P1|Overall Study|Investigator-Initiated Early Closure|44
31923|NCT01442038|133266|P2|Overall Study|Death|29
31924|NCT01442038|133267|P1|Overall Study|Death|35
31925|NCT01441973|133281|P2|Overall Study|Nonrelated cardiac amyloidosis|1
31926|NCT01441973|133282|P1|Overall Study|Nonrelated cardiac amyloidosis|0
31927|NCT01441973|133281|P2|Overall Study|Poor compliance/noncompliance|1
31928|NCT01441973|133282|P1|Overall Study|Poor compliance/noncompliance|0
31929|NCT01441973|133281|P2|Overall Study|Patient request to discontinue treatment|1
31930|NCT01441973|133282|P1|Overall Study|Patient request to discontinue treatment|1
31931|NCT01441973|133281|P2|Overall Study|Adverse event unrelated to study drug|0
31932|NCT01441973|133282|P1|Overall Study|Adverse event unrelated to study drug|3
31933|NCT01441973|133281|P2|Overall Study|Disease progression|2
31934|NCT01441973|133282|P1|Overall Study|Disease progression|4
31935|NCT01441960|133296|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
31936|NCT01441960|133297|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
31937|NCT01441960|133296|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
31938|NCT01441960|133297|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
31939|NCT01441960|133296|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
31940|NCT01441960|133297|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
31941|NCT01441765|133318|P2|Overall Study|Death|0
31942|NCT01441765|133319|P1|Overall Study|Death|1
31943|NCT01441596|133336|P3|Overall Study|Not treated|1
31944|NCT01441596|133337|P2|Overall Study|Not treated|1
31945|NCT01441596|133338|P1|Overall Study|Not treated|0
31946|NCT01441596|133336|P3|Overall Study|Withdrawal by Subject|2
31947|NCT01441596|133337|P2|Overall Study|Withdrawal by Subject|0
31948|NCT01441596|133338|P1|Overall Study|Withdrawal by Subject|4
31949|NCT01441596|133336|P3|Overall Study|Other reason not defined below|1
31950|NCT01441596|133337|P2|Overall Study|Other reason not defined below|2
31951|NCT01441596|133338|P1|Overall Study|Other reason not defined below|0
31952|NCT01441440|133374|P3|Overall Study|Difficllty in keeping the schedule|0
31953|NCT01441440|133375|P2|Overall Study|Difficllty in keeping the schedule|1
31954|NCT01441440|133376|P1|Overall Study|Difficllty in keeping the schedule|1
31955|NCT01441440|133374|P3|Overall Study|Work-related matter|0
31956|NCT01441440|133375|P2|Overall Study|Work-related matter|1
31957|NCT01441440|133376|P1|Overall Study|Work-related matter|0
31958|NCT01441440|133374|P3|Overall Study|Moving|1
31959|NCT01441440|133375|P2|Overall Study|Moving|1
31960|NCT01441440|133376|P1|Overall Study|Moving|0
31961|NCT01441440|133374|P3|Overall Study|Lack of Efficacy|1
31962|NCT01441440|133375|P2|Overall Study|Lack of Efficacy|0
31963|NCT01441440|133376|P1|Overall Study|Lack of Efficacy|1
31964|NCT01441440|133374|P3|Overall Study|Pregnancy|0
31965|NCT01441440|133375|P2|Overall Study|Pregnancy|0
31966|NCT01441440|133376|P1|Overall Study|Pregnancy|1
31967|NCT01441440|133374|P3|Overall Study|Withdrawal by Subject|9
31968|NCT01441440|133375|P2|Overall Study|Withdrawal by Subject|9
31969|NCT01441440|133376|P1|Overall Study|Withdrawal by Subject|11
31970|NCT01441440|133374|P3|Overall Study|Lost to Follow-up|1
31971|NCT01441440|133375|P2|Overall Study|Lost to Follow-up|2
31972|NCT01441440|133376|P1|Overall Study|Lost to Follow-up|0
31973|NCT01441440|133374|P3|Overall Study|Adverse Event|9
31974|NCT01441440|133375|P2|Overall Study|Adverse Event|9
31975|NCT01441440|133376|P1|Overall Study|Adverse Event|2
31976|NCT01441440|133374|P3|Overall Study|Death|1
31977|NCT01441440|133375|P2|Overall Study|Death|0
31978|NCT01441440|133376|P1|Overall Study|Death|1
31979|NCT01441414|133399|P1|Overall Study|Subject refused further follow-up|1
31980|NCT01441414|133399|P1|Overall Study|Study terminated by sponsor|2
31981|NCT01441414|133399|P1|Overall Study|Other reasons|3
31982|NCT01441414|133399|P1|Overall Study|Participant died|9
31983|NCT01441180|133478|P3|Overall Study|Discontinued|2
31984|NCT01441180|133479|P2|Overall Study|Discontinued|0
31985|NCT01441180|133480|P1|Overall Study|Discontinued|0
31986|NCT01441180|133478|P3|Overall Study|Lost to Follow-up|1
31987|NCT01441180|133479|P2|Overall Study|Lost to Follow-up|1
31988|NCT01441180|133480|P1|Overall Study|Lost to Follow-up|1
31989|NCT01440972|133498|P2|Overall Study|Withdrawal by Subject|2
31990|NCT01440972|133499|P1|Overall Study|Withdrawal by Subject|3
31991|NCT01440946|133523|P2|Overall Study|Physician Decision|0
31992|NCT01440946|133524|P1|Overall Study|Physician Decision|1
31993|NCT01440946|133523|P2|Overall Study|Lost to Follow-up|1
31994|NCT01440946|133524|P1|Overall Study|Lost to Follow-up|1
31995|NCT01440881|133563|P2|Overall Study|Death|1
31996|NCT01440881|133564|P1|Overall Study|Death|0
31997|NCT01440647|133578|P2|Overall Study|Death|3
31998|NCT01440647|133579|P1|Overall Study|Death|2
31999|NCT01440595|133598|P3|Overall Study|Study terminated by sponsor.|1
32000|NCT01440595|133599|P2|Overall Study|Study terminated by sponsor.|2
32001|NCT01440595|133600|P1|Overall Study|Study terminated by sponsor.|1
32002|NCT01440595|133598|P3|Overall Study|Lost to Follow-up|0
32003|NCT01440595|133599|P2|Overall Study|Lost to Follow-up|1
32004|NCT01440595|133600|P1|Overall Study|Lost to Follow-up|0
32005|NCT01440569|133620|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
32006|NCT01440569|133621|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
32007|NCT01440569|133620|P2|Open-Label Rollover Phase|Lost to Follow-up|3
32008|NCT01440569|133621|P1|Open-Label Rollover Phase|Lost to Follow-up|26
32009|NCT01440569|133620|P2|Open-Label Rollover Phase|Withdrew Consent|1
32010|NCT01440569|133621|P1|Open-Label Rollover Phase|Withdrew Consent|11
32011|NCT01440569|133620|P2|Open-Label Rollover Phase|Investigator’s Discretion|1
32012|NCT01440569|133621|P1|Open-Label Rollover Phase|Investigator’s Discretion|3
32013|NCT01440569|133620|P2|Open-Label Rollover Phase|Lack of Efficacy|0
32014|NCT01440569|133621|P1|Open-Label Rollover Phase|Lack of Efficacy|2
32015|NCT01440569|133620|P2|Open-Label Rollover Phase|Pregnancy|0
32016|NCT01440569|133621|P1|Open-Label Rollover Phase|Pregnancy|1
32017|NCT01440569|133620|P2|Open-Label Rollover Phase|Adverse Event|0
32018|NCT01440569|133621|P1|Open-Label Rollover Phase|Adverse Event|3
32019|NCT01440569|133620|P2|Main Study|Protocol Violation|0
32020|NCT01440569|133621|P1|Main Study|Protocol Violation|1
32021|NCT01440569|133620|P2|Main Study|Subject Non-Compliance|0
32022|NCT01440569|133621|P1|Main Study|Subject Non-Compliance|3
32023|NCT01440569|133620|P2|Main Study|Lost to Follow-up|2
32024|NCT01440569|133621|P1|Main Study|Lost to Follow-up|13
32025|NCT01440569|133620|P2|Main Study|Withdrew Consent|1
32026|NCT01440569|133621|P1|Main Study|Withdrew Consent|7
32027|NCT01440569|133620|P2|Main Study|Investigator's Discretion|1
32028|NCT01440569|133621|P1|Main Study|Investigator's Discretion|1
32029|NCT01440569|133620|P2|Main Study|Pregnancy|0
32030|NCT01440569|133621|P1|Main Study|Pregnancy|1
32031|NCT01440569|133620|P2|Main Study|Adverse Event|0
32032|NCT01440569|133621|P1|Main Study|Adverse Event|9
32033|NCT01440569|133620|P2|Main Study|Enrolled but not treated|0
32034|NCT01440569|133621|P1|Main Study|Enrolled but not treated|1
32035|NCT01440517|133656|P1|Overall Study|Subject withdrawn prior to dosing|1
32036|NCT01440374|133687|P3|Part 2; Double-blind Phase|Ongoing|11
32037|NCT01440374|133688|P2|Part 2; Double-blind Phase|Ongoing|4
32038|NCT01440374|133689|P1|Part 2; Double-blind Phase|Ongoing|0
32039|NCT01440374|133687|P3|Part 2; Double-blind Phase|Withdrawal by Subject|13
32040|NCT01440374|133688|P2|Part 2; Double-blind Phase|Withdrawal by Subject|7
32041|NCT01440374|133689|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
32042|NCT01440374|133687|P3|Part 2; Double-blind Phase|Physician Decision|1
32043|NCT01440374|133688|P2|Part 2; Double-blind Phase|Physician Decision|1
32044|NCT01440374|133689|P1|Part 2; Double-blind Phase|Physician Decision|0
32045|NCT01440374|133687|P3|Part 2; Double-blind Phase|Lost to Follow-up|1
32046|NCT01440374|133688|P2|Part 2; Double-blind Phase|Lost to Follow-up|0
32047|NCT01440374|133689|P1|Part 2; Double-blind Phase|Lost to Follow-up|0
32048|NCT01440374|133687|P3|Part 1: Open-label Phase|Withdrawal by Subject|0
32049|NCT01440374|133688|P2|Part 1: Open-label Phase|Withdrawal by Subject|0
32050|NCT01440374|133689|P1|Part 1: Open-label Phase|Withdrawal by Subject|3
32051|NCT01440322|133699|P2|Overall Study|Other Non-Product Related|0
32052|NCT01440322|133700|P1|Overall Study|Other Non-Product Related|1
32053|NCT01440322|133699|P2|Overall Study|Unrelated Medical Problem|1
32054|NCT01440322|133700|P1|Overall Study|Unrelated Medical Problem|0
32055|NCT01440322|133699|P2|Overall Study|Other Product Related|0
32056|NCT01440322|133700|P1|Overall Study|Other Product Related|1
32057|NCT01440322|133699|P2|Overall Study|Unacceptable Subjective Vision|0
32058|NCT01440322|133700|P1|Overall Study|Unacceptable Subjective Vision|1
32059|NCT01440322|133699|P2|Overall Study|Symptoms and Problems|0
32060|NCT01440322|133700|P1|Overall Study|Symptoms and Problems|1
32061|NCT01440322|133699|P2|Overall Study|Biomicroscopy|0
32062|NCT01440322|133700|P1|Overall Study|Biomicroscopy|1
32063|NCT01440322|133699|P2|Overall Study|Discomfort|0
32064|NCT01440322|133700|P1|Overall Study|Discomfort|2
32065|NCT01440283|133722|P1|Overall Study|Physician Decision|3
32066|NCT01440283|133722|P1|Overall Study|Withdrawal by Subject|4
32067|NCT01440283|133722|P1|Overall Study|Death|3
32068|NCT01440101|133737|P3|Overall Study|Not Specified|0
32069|NCT01440101|133738|P2|Overall Study|Not Specified|1
32070|NCT01440101|133739|P1|Overall Study|Not Specified|0
32071|NCT01440101|133737|P3|Overall Study|Withdrawal by Subject|1
32072|NCT01440101|133738|P2|Overall Study|Withdrawal by Subject|3
32073|NCT01440101|133739|P1|Overall Study|Withdrawal by Subject|0
32074|NCT01440101|133737|P3|Overall Study|Adverse Event|0
32075|NCT01440101|133738|P2|Overall Study|Adverse Event|0
32076|NCT01440101|133739|P1|Overall Study|Adverse Event|2
32077|NCT01440049|133772|P1|Overall Study|Adverse Event|5
32078|NCT01439724|133801|P2|Overall Study|missing consultation|8
32079|NCT01439724|133802|P1|Overall Study|missing consultation|9
32080|NCT01439282|133814|P2|Overall Study|Not specified|1
32081|NCT01439282|133815|P1|Overall Study|Not specified|1
32082|NCT01439282|133814|P2|Overall Study|Withdrawal by Subject|0
32083|NCT01439282|133815|P1|Overall Study|Withdrawal by Subject|2
32084|NCT01439282|133814|P2|Overall Study|Adverse Event|0
32085|NCT01439282|133815|P1|Overall Study|Adverse Event|5
32086|NCT01439204|133825|P2|Overall Study|poor/non-compliance|0
32087|NCT01439204|133826|P1|Overall Study|poor/non-compliance|3
32088|NCT01439204|133825|P2|Overall Study|No longer meets study criteria|0
32089|NCT01439204|133826|P1|Overall Study|No longer meets study criteria|1
32090|NCT01439204|133825|P2|Overall Study|Lost to Follow-up|2
32091|NCT01439204|133826|P1|Overall Study|Lost to Follow-up|0
32092|NCT01439204|133825|P2|Overall Study|Withdrawal by Subject|1
32093|NCT01439204|133826|P1|Overall Study|Withdrawal by Subject|0
32094|NCT01439126|133860|P2|Overall Study|Other-Miscellaneous|12
32095|NCT01439126|133861|P1|Overall Study|Other-Miscellaneous|12
32096|NCT01439126|133860|P2|Overall Study|Other-Use of prohibited treatment|2
32097|NCT01439126|133861|P1|Overall Study|Other-Use of prohibited treatment|0
32098|NCT01439126|133860|P2|Overall Study|Lost to Follow-up|3
32099|NCT01439126|133861|P1|Overall Study|Lost to Follow-up|6
32100|NCT01439126|133860|P2|Overall Study|Protocol Violation|4
32101|NCT01439126|133861|P1|Overall Study|Protocol Violation|6
32102|NCT01439126|133860|P2|Overall Study|Withdrawal by Subject|21
32103|NCT01439126|133861|P1|Overall Study|Withdrawal by Subject|5
32104|NCT01439126|133860|P2|Overall Study|Adverse Event|0
32105|NCT01439126|133861|P1|Overall Study|Adverse Event|2
32106|NCT01438996|133899|P3|Overall Study|Not meeting Inclusion Criteria|0
32107|NCT01438996|133900|P2|Overall Study|Not meeting Inclusion Criteria|1
32108|NCT01438996|133901|P1|Overall Study|Not meeting Inclusion Criteria|4
32109|NCT01438814|133935|P2|Overall Study|Not specified|4
32110|NCT01438814|133936|P1|Overall Study|Not specified|2
32111|NCT01438814|133935|P2|Overall Study|Withdrawal by Subject|2
32112|NCT01438814|133936|P1|Overall Study|Withdrawal by Subject|4
32113|NCT01438814|133935|P2|Overall Study|Lost to Follow-up|3
32114|NCT01438814|133936|P1|Overall Study|Lost to Follow-up|4
32115|NCT01438814|133935|P2|Overall Study|Protocol Violation|2
32116|NCT01438814|133936|P1|Overall Study|Protocol Violation|1
32117|NCT01438814|133935|P2|Overall Study|Adverse Event|3
32118|NCT01438814|133936|P1|Overall Study|Adverse Event|3
32119|NCT01438541|133972|P1|Overall Study|discharge from the hospital|5
32120|NCT01438541|133972|P1|Overall Study|Withdrawal by Subject|1
32121|NCT01438541|133972|P1|Overall Study|Physician Decision|1
32122|NCT01438489|133981|P3|Overall Study|Inadequate venous access|0
32123|NCT01438489|133982|P2|Overall Study|Inadequate venous access|2
32124|NCT01438489|133983|P1|Overall Study|Inadequate venous access|0
32125|NCT01438489|133981|P3|Overall Study|Did not complete all 3 follow-up visits|2
32126|NCT01438489|133982|P2|Overall Study|Did not complete all 3 follow-up visits|5
32127|NCT01438489|133983|P1|Overall Study|Did not complete all 3 follow-up visits|2
32128|NCT01438489|133981|P3|Overall Study|Received prohibited medication|0
32129|NCT01438489|133982|P2|Overall Study|Received prohibited medication|0
32130|NCT01438489|133983|P1|Overall Study|Received prohibited medication|1
32131|NCT01438489|133981|P3|Overall Study|AE/SAEs|1
32132|NCT01438489|133982|P2|Overall Study|AE/SAEs|1
32133|NCT01438489|133983|P1|Overall Study|AE/SAEs|2
32134|NCT01438489|133981|P3|Overall Study|Investigator decision|0
32135|NCT01438489|133982|P2|Overall Study|Investigator decision|1
32136|NCT01438489|133983|P1|Overall Study|Investigator decision|0
32137|NCT01438489|133981|P3|Overall Study|Subject choice/Subject moved|1
32138|NCT01438489|133982|P2|Overall Study|Subject choice/Subject moved|1
32139|NCT01438489|133983|P1|Overall Study|Subject choice/Subject moved|2
32140|NCT01438489|133981|P3|Overall Study|Sponsor decision|4
32141|NCT01438489|133982|P2|Overall Study|Sponsor decision|1
32142|NCT01438489|133983|P1|Overall Study|Sponsor decision|4
32143|NCT01438489|133981|P3|Overall Study|Death|1
32144|NCT01438489|133982|P2|Overall Study|Death|0
32145|NCT01438489|133983|P1|Overall Study|Death|0
32146|NCT01438489|133981|P3|Overall Study|Withdrawal by Subject|8
32147|NCT01438489|133982|P2|Overall Study|Withdrawal by Subject|3
32148|NCT01438489|133983|P1|Overall Study|Withdrawal by Subject|11
32149|NCT01438489|133981|P3|Overall Study|Lost to Follow-up|2
32150|NCT01438489|133982|P2|Overall Study|Lost to Follow-up|2
32151|NCT01438489|133983|P1|Overall Study|Lost to Follow-up|4
32152|NCT01438424|134026|P1|Overall Study|Participant noncompliance|20
32153|NCT01438424|134026|P1|Overall Study|No longer met inclusion criteria|1
32154|NCT01438424|134026|P1|Overall Study|Pregnancy|7
32155|NCT01438424|134026|P1|Overall Study|Need for drug prohibited by protocol|14
32156|NCT01438424|134026|P1|Overall Study|Abnormal laboratory test result|14
32157|NCT01438424|134026|P1|Overall Study|Lost to Follow-up|17
32158|NCT01438424|134026|P1|Overall Study|Adverse Event|17
32159|NCT01438424|134026|P1|Overall Study|Death|22
32160|NCT01438424|134026|P1|Overall Study|Progression of chronic hepatitis B|22
32161|NCT01438424|134026|P1|Overall Study|Withdrawal by Subject|104
32162|NCT01438424|134026|P1|Overall Study|Not identified|55
32163|NCT01438424|134026|P1|Overall Study|Minimal virologic response|95
32164|NCT01438424|134026|P1|Overall Study|Continuing treatment|29
32165|NCT01438294|134064|P2|Overall Study|Lost to Follow-up|7
32166|NCT01438294|134065|P1|Overall Study|Lost to Follow-up|3
32167|NCT01438177|134108|P1|Overall Study|Initiation of new therapy|1
32168|NCT01438177|134108|P1|Overall Study|Withdrawal by Subject|1
32169|NCT01438151|134114|P1|Overall Study|study terminated|8
32170|NCT01438060|134120|P2|On Study Beyond Week 140|Other Reason|3
32171|NCT01438060|134121|P1|On Study Beyond Week 140|Other Reason|0
32172|NCT01438060|134120|P2|On Study Beyond Week 140|Death|1
32173|NCT01438060|134121|P1|On Study Beyond Week 140|Death|0
32174|NCT01438060|134120|P2|On Study Beyond Week 140|Withdrawal by Subject|1
32175|NCT01438060|134121|P1|On Study Beyond Week 140|Withdrawal by Subject|0
32176|NCT01438060|134120|P2|On Study Beyond Week 140|Lack of Efficacy|1
32177|NCT01438060|134121|P1|On Study Beyond Week 140|Lack of Efficacy|0
32178|NCT01438060|134120|P2|On Study Beyond Week 140|Adverse Event|2
32179|NCT01438060|134121|P1|On Study Beyond Week 140|Adverse Event|0
32180|NCT01438060|134120|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
32181|NCT01438060|134121|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
32182|NCT01438060|134120|P2|Extension Phase: Week 10 to Week 130|Death|12
32183|NCT01438060|134121|P1|Extension Phase: Week 10 to Week 130|Death|22
32184|NCT01438060|134120|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
32185|NCT01438060|134121|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
32186|NCT01438060|134120|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
32187|NCT01438060|134121|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
32188|NCT01438060|134120|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
32189|NCT01438060|134121|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
32190|NCT01438060|134120|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
32191|NCT01438060|134121|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
32192|NCT01438060|134120|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
32193|NCT01438060|134121|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
32194|NCT01438060|134120|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
32195|NCT01438060|134121|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
32196|NCT01438060|134120|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
32197|NCT01438060|134121|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
32198|NCT01438060|134120|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
32199|NCT01438060|134121|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
32200|NCT01438060|134120|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
32201|NCT01438060|134121|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
32202|NCT01438060|134120|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
32203|NCT01438060|134121|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
32204|NCT01438060|134120|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
32205|NCT01438060|134121|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
32206|NCT01437878|134201|P2|Overall Study|Withdrawal by Subject|0
32207|NCT01437878|134202|P1|Overall Study|Withdrawal by Subject|1
32208|NCT01437423|134251|P1|Overall Study|Off label usage|3
32209|NCT01437423|134251|P1|Overall Study|Lost to Follow-up|12
32210|NCT01437319|134258|P3|Phase II|Protocol Violation|0
32211|NCT01437319|134259|P2|Phase II|Protocol Violation|1
32212|NCT01437319|134260|P1|Phase II|Protocol Violation|0
32213|NCT01437319|134258|P3|Phase II|Study related symptoms/complaints|19
32214|NCT01437319|134259|P2|Phase II|Study related symptoms/complaints|28
32215|NCT01437319|134260|P1|Phase II|Study related symptoms/complaints|0
32216|NCT01437319|134258|P3|Phase II|Lost to Follow-up|2
32217|NCT01437319|134259|P2|Phase II|Lost to Follow-up|7
32218|NCT01437319|134260|P1|Phase II|Lost to Follow-up|0
32219|NCT01437319|134258|P3|Phase II|Withdrawal by Subject|16
32220|NCT01437319|134259|P2|Phase II|Withdrawal by Subject|8
32221|NCT01437319|134260|P1|Phase II|Withdrawal by Subject|0
32222|NCT01437319|134258|P3|Phase I|Withdrawal by Subject|0
32223|NCT01437319|134259|P2|Phase I|Withdrawal by Subject|0
32224|NCT01437319|134260|P1|Phase I|Withdrawal by Subject|25
32225|NCT01437319|134258|P3|Phase I|Study related symptoms/complaints|0
32226|NCT01437319|134259|P2|Phase I|Study related symptoms/complaints|0
32227|NCT01437319|134260|P1|Phase I|Study related symptoms/complaints|27
32228|NCT01437319|134258|P3|Phase I|Protocol Violation|0
32229|NCT01437319|134259|P2|Phase I|Protocol Violation|0
32230|NCT01437319|134260|P1|Phase I|Protocol Violation|1
32231|NCT01437319|134258|P3|Phase I|Lost to Follow-up|0
32232|NCT01437319|134259|P2|Phase I|Lost to Follow-up|0
32233|NCT01437319|134260|P1|Phase I|Lost to Follow-up|2
32234|NCT01437267|134275|P6|Overall Study|Protocol Violation|0
32235|NCT01437267|134276|P5|Overall Study|Protocol Violation|0
32236|NCT01437267|134277|P4|Overall Study|Protocol Violation|0
32237|NCT01437267|134278|P3|Overall Study|Protocol Violation|0
32238|NCT01437267|134279|P2|Overall Study|Protocol Violation|1
32239|NCT01437267|134280|P1|Overall Study|Protocol Violation|0
32240|NCT01437267|134275|P6|Overall Study|Withdrawal by Subject|0
32241|NCT01437267|134276|P5|Overall Study|Withdrawal by Subject|0
32242|NCT01437267|134277|P4|Overall Study|Withdrawal by Subject|1
32243|NCT01437267|134278|P3|Overall Study|Withdrawal by Subject|0
32244|NCT01437267|134279|P2|Overall Study|Withdrawal by Subject|0
32245|NCT01437267|134280|P1|Overall Study|Withdrawal by Subject|0
32246|NCT01437111|134323|P1|Overall Study|Protocol Violation|1
32247|NCT01437111|134323|P1|Overall Study|Lost to Follow-up|5
32248|NCT01437111|134323|P1|Overall Study|Physician Decision|1
32249|NCT01437111|134323|P1|Overall Study|Not reported|5
32250|NCT01437111|134323|P1|Overall Study|Withdrawal by Subject|4
32251|NCT01437111|134323|P1|Overall Study|Adverse Event|2
32252|NCT01436643|134401|P4|Core Phase (16 Weeks)|Protocol Violation|0
32253|NCT01436643|134402|P3|Core Phase (16 Weeks)|Protocol Violation|1
32254|NCT01436643|134403|P2|Core Phase (16 Weeks)|Protocol Violation|1
32255|NCT01436643|134404|P1|Core Phase (16 Weeks)|Protocol Violation|1
32256|NCT01436643|134401|P4|Core Phase (16 Weeks)|Abnormal Test result|0
32257|NCT01436643|134402|P3|Core Phase (16 Weeks)|Abnormal Test result|1
32258|NCT01436643|134403|P2|Core Phase (16 Weeks)|Abnormal Test result|0
32259|NCT01436643|134404|P1|Core Phase (16 Weeks)|Abnormal Test result|0
32260|NCT01436643|134401|P4|Core Phase (16 Weeks)|Adverse Event|0
32261|NCT01436643|134402|P3|Core Phase (16 Weeks)|Adverse Event|1
32262|NCT01436643|134403|P2|Core Phase (16 Weeks)|Adverse Event|3
32263|NCT01436643|134404|P1|Core Phase (16 Weeks)|Adverse Event|0
32264|NCT01436643|134401|P4|2-week Pre-treatment|Protocol Violation|4
32265|NCT01436643|134402|P3|2-week Pre-treatment|Protocol Violation|0
32266|NCT01436643|134403|P2|2-week Pre-treatment|Protocol Violation|0
32267|NCT01436643|134404|P1|2-week Pre-treatment|Protocol Violation|0
32268|NCT01436643|134401|P4|2-week Pre-treatment|Adverse Event|5
32269|NCT01436643|134402|P3|2-week Pre-treatment|Adverse Event|0
32270|NCT01436643|134403|P2|2-week Pre-treatment|Adverse Event|0
32271|NCT01436643|134404|P1|2-week Pre-treatment|Adverse Event|0
32272|NCT01436643|134401|P4|2-week Pre-treatment|Abnormal test result|1
32273|NCT01436643|134402|P3|2-week Pre-treatment|Abnormal test result|0
32274|NCT01436643|134403|P2|2-week Pre-treatment|Abnormal test result|0
32275|NCT01436643|134404|P1|2-week Pre-treatment|Abnormal test result|0
32276|NCT01436500|134439|P2|Overall Study|not specified|0
32277|NCT01436500|134440|P1|Overall Study|not specified|2
32278|NCT01436500|134439|P2|Overall Study|discontinued study drug|0
32279|NCT01436500|134440|P1|Overall Study|discontinued study drug|1
32280|NCT01436500|134439|P2|Overall Study|initiation of dialysis|1
32281|NCT01436500|134440|P1|Overall Study|initiation of dialysis|0
32282|NCT01436500|134439|P2|Overall Study|liver transplant|0
32283|NCT01436500|134440|P1|Overall Study|liver transplant|1
32284|NCT01436500|134439|P2|Overall Study|Physician Decision|0
32285|NCT01436500|134440|P1|Overall Study|Physician Decision|1
32286|NCT01436500|134439|P2|Overall Study|Withdrawal by Subject|2
32287|NCT01436500|134440|P1|Overall Study|Withdrawal by Subject|2
32288|NCT01436500|134439|P2|Overall Study|Adverse Event|1
32289|NCT01436500|134440|P1|Overall Study|Adverse Event|4
32290|NCT01436500|134439|P2|Overall Study|Death|0
32291|NCT01436500|134440|P1|Overall Study|Death|1
32292|NCT01436370|134511|P8|Overall Study|Lost to Follow-up|0
32293|NCT01436370|134512|P7|Overall Study|Lost to Follow-up|0
32294|NCT01436370|134513|P6|Overall Study|Lost to Follow-up|0
32295|NCT01436370|134514|P5|Overall Study|Lost to Follow-up|1
32296|NCT01436370|134515|P4|Overall Study|Lost to Follow-up|0
32297|NCT01436370|134516|P3|Overall Study|Lost to Follow-up|0
32298|NCT01436370|134517|P2|Overall Study|Lost to Follow-up|0
32299|NCT01436370|134518|P1|Overall Study|Lost to Follow-up|0
32300|NCT01436253|134596|P1|Overall Study|Not meeting all eligibility criteria|117
32301|NCT01436253|134596|P1|Overall Study|Lost to Follow-up|182
32302|NCT01436201|134601|P1|Overall Study|Protocol Violation|1
32303|NCT01436201|134601|P1|Overall Study|Withdrawal by Subject|1
32304|NCT01436201|134601|P1|Overall Study|Adverse Event|2
32305|NCT01436175|134611|P1|Overall Study|Unspecified|826
32306|NCT01436175|134611|P1|Overall Study|Met blood pressure or pulse withdrawal|63
32307|NCT01436175|134611|P1|Overall Study|Lack of Efficacy|24
32308|NCT01436175|134611|P1|Overall Study|Lost to Follow-up|89
32309|NCT01436175|134611|P1|Overall Study|Withdrawal by Subject|108
32310|NCT01436175|134611|P1|Overall Study|Protocol Violation|49
32311|NCT01436175|134611|P1|Overall Study|Adverse Event|111
32312|NCT01436162|134638|P3|Randomized Phase|Not Specified|4
32313|NCT01436162|134639|P2|Randomized Phase|Not Specified|5
32314|NCT01436162|134640|P1|Randomized Phase|Not Specified|2
32315|NCT01436162|134638|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
32316|NCT01436162|134639|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
32317|NCT01436162|134640|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
32318|NCT01436162|134638|P3|Randomized Phase|Lack of Efficacy|1
32319|NCT01436162|134639|P2|Randomized Phase|Lack of Efficacy|1
32320|NCT01436162|134640|P1|Randomized Phase|Lack of Efficacy|0
32321|NCT01436162|134638|P3|Randomized Phase|Lost to Follow-up|4
32322|NCT01436162|134639|P2|Randomized Phase|Lost to Follow-up|5
32323|NCT01436162|134640|P1|Randomized Phase|Lost to Follow-up|17
32324|NCT01436162|134638|P3|Randomized Phase|Withdrawal by Subject|8
32325|NCT01436162|134639|P2|Randomized Phase|Withdrawal by Subject|9
32326|NCT01436162|134640|P1|Randomized Phase|Withdrawal by Subject|16
32327|NCT01436162|134638|P3|Randomized Phase|Protocol Violation|2
32328|NCT01436162|134639|P2|Randomized Phase|Protocol Violation|4
32329|NCT01436162|134640|P1|Randomized Phase|Protocol Violation|4
32330|NCT01436162|134638|P3|Randomized Phase|Adverse Event|6
32331|NCT01436162|134639|P2|Randomized Phase|Adverse Event|5
32332|NCT01436162|134640|P1|Randomized Phase|Adverse Event|1
32333|NCT01436162|134638|P3|Single-blind Lead-in Phase|Not Specified|0
32334|NCT01436162|134639|P2|Single-blind Lead-in Phase|Not Specified|0
32335|NCT01436162|134640|P1|Single-blind Lead-in Phase|Not Specified|107
32336|NCT01436162|134638|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
32337|NCT01436162|134639|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
32338|NCT01436162|134640|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
32339|NCT01436162|134638|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
32340|NCT01436162|134639|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
32341|NCT01436162|134640|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
32342|NCT01436162|134638|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
32343|NCT01436162|134639|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
32344|NCT01436162|134640|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
32345|NCT01436162|134638|P3|Single-blind Lead-in Phase|Protocol Violation|0
32346|NCT01436162|134639|P2|Single-blind Lead-in Phase|Protocol Violation|0
32347|NCT01436162|134640|P1|Single-blind Lead-in Phase|Protocol Violation|24
32348|NCT01436162|134638|P3|Single-blind Lead-in Phase|Adverse Event|0
32349|NCT01436162|134639|P2|Single-blind Lead-in Phase|Adverse Event|0
32350|NCT01436162|134640|P1|Single-blind Lead-in Phase|Adverse Event|26
32351|NCT01436149|134674|P3|Randomized Phase|Not Specified|11
32352|NCT01436149|134675|P2|Randomized Phase|Not Specified|5
32353|NCT01436149|134676|P1|Randomized Phase|Not Specified|12
32354|NCT01436149|134674|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
32355|NCT01436149|134675|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
32356|NCT01436149|134676|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
32357|NCT01436149|134674|P3|Randomized Phase|Lack of Efficacy|1
32358|NCT01436149|134675|P2|Randomized Phase|Lack of Efficacy|0
32359|NCT01436149|134676|P1|Randomized Phase|Lack of Efficacy|0
32360|NCT01436149|134674|P3|Randomized Phase|Lost to Follow-up|6
32361|NCT01436149|134675|P2|Randomized Phase|Lost to Follow-up|5
32362|NCT01436149|134676|P1|Randomized Phase|Lost to Follow-up|34
32363|NCT01436149|134674|P3|Randomized Phase|Withdrawal by Subject|10
32364|NCT01436149|134675|P2|Randomized Phase|Withdrawal by Subject|10
32365|NCT01436149|134676|P1|Randomized Phase|Withdrawal by Subject|16
32366|NCT01436149|134674|P3|Randomized Phase|Protocol Violation|0
32367|NCT01436149|134675|P2|Randomized Phase|Protocol Violation|5
32368|NCT01436149|134676|P1|Randomized Phase|Protocol Violation|4
32369|NCT01436149|134674|P3|Randomized Phase|Adverse Event|11
32370|NCT01436149|134675|P2|Randomized Phase|Adverse Event|10
32371|NCT01436149|134676|P1|Randomized Phase|Adverse Event|9
32372|NCT01436149|134674|P3|Antidepressant Lead-in Phase|Not Specified|0
32373|NCT01436149|134675|P2|Antidepressant Lead-in Phase|Not Specified|0
32374|NCT01436149|134676|P1|Antidepressant Lead-in Phase|Not Specified|119
32375|NCT01436149|134674|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
32376|NCT01436149|134675|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
32377|NCT01436149|134676|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
32378|NCT01436149|134674|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
32379|NCT01436149|134675|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
32380|NCT01436149|134676|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
32381|NCT01436149|134674|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
32382|NCT01436149|134675|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
32383|NCT01436149|134676|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
32384|NCT01436149|134674|P3|Antidepressant Lead-in Phase|Protocol Violation|0
32385|NCT01436149|134675|P2|Antidepressant Lead-in Phase|Protocol Violation|0
32386|NCT01436149|134676|P1|Antidepressant Lead-in Phase|Protocol Violation|29
32387|NCT01436149|134674|P3|Antidepressant Lead-in Phase|Adverse Event|0
32388|NCT01436149|134675|P2|Antidepressant Lead-in Phase|Adverse Event|0
32389|NCT01436149|134676|P1|Antidepressant Lead-in Phase|Adverse Event|39
32390|NCT01436110|134707|P3|Overall Study|Did Not Receive Trial Medication|3
32391|NCT01436110|134708|P2|Overall Study|Did Not Receive Trial Medication|0
32392|NCT01436110|134709|P1|Overall Study|Did Not Receive Trial Medication|1
32393|NCT01436110|134707|P3|Overall Study|Protocol Violation|1
32394|NCT01436110|134708|P2|Overall Study|Protocol Violation|1
32395|NCT01436110|134709|P1|Overall Study|Protocol Violation|3
32396|NCT01436110|134707|P3|Overall Study|Lost to Follow-up|3
32397|NCT01436110|134708|P2|Overall Study|Lost to Follow-up|1
32398|NCT01436110|134709|P1|Overall Study|Lost to Follow-up|1
32399|NCT01436110|134707|P3|Overall Study|Physician Decision|1
32400|NCT01436110|134708|P2|Overall Study|Physician Decision|1
32401|NCT01436110|134709|P1|Overall Study|Physician Decision|3
32402|NCT01436110|134707|P3|Overall Study|Adverse Event|2
32403|NCT01436110|134708|P2|Overall Study|Adverse Event|1
32404|NCT01436110|134709|P1|Overall Study|Adverse Event|2
32405|NCT01436110|134707|P3|Overall Study|Withdrawal by Subject|4
32406|NCT01436110|134708|P2|Overall Study|Withdrawal by Subject|8
32407|NCT01436110|134709|P1|Overall Study|Withdrawal by Subject|6
32408|NCT01436110|134707|P3|Overall Study|Lack of Efficacy|9
32409|NCT01436110|134708|P2|Overall Study|Lack of Efficacy|14
32410|NCT01436110|134709|P1|Overall Study|Lack of Efficacy|23
32411|NCT01436084|134732|P1|Overall Study|Early Closure of Study|1
32412|NCT01436084|134732|P1|Overall Study|Withdrawal by Subject|1
32413|NCT01436084|134732|P1|Overall Study|Disease Progression|2
32414|NCT01436071|134738|P2|Overall Study|Did Not Receive Trial Medication|3
32415|NCT01436071|134739|P1|Overall Study|Did Not Receive Trial Medication|3
32416|NCT01436071|134738|P2|Overall Study|Withdrawal by Subject|2
32417|NCT01436071|134739|P1|Overall Study|Withdrawal by Subject|2
32418|NCT01436071|134738|P2|Overall Study|Physician Decision|0
32419|NCT01436071|134739|P1|Overall Study|Physician Decision|1
32420|NCT01436071|134738|P2|Overall Study|Lost to Follow-up|1
32421|NCT01436071|134739|P1|Overall Study|Lost to Follow-up|3
32422|NCT01436071|134738|P2|Overall Study|Protocol Violation|1
32423|NCT01436071|134739|P1|Overall Study|Protocol Violation|0
32424|NCT01436071|134738|P2|Overall Study|Lack of Efficacy|7
32425|NCT01436071|134739|P1|Overall Study|Lack of Efficacy|16
32426|NCT01436071|134738|P2|Overall Study|Adverse Event|0
32427|NCT01436071|134739|P1|Overall Study|Adverse Event|1
32428|NCT01435928|134781|P3|Double Blind Phase - 28 Weeks|Administrative|2
32429|NCT01435928|134782|P2|Double Blind Phase - 28 Weeks|Administrative|5
32430|NCT01435928|134783|P1|Double Blind Phase - 28 Weeks|Administrative|0
32431|NCT01435928|134781|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
32432|NCT01435928|134782|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
32433|NCT01435928|134783|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
32434|NCT01435928|134781|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
32435|NCT01435928|134782|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
32436|NCT01435928|134783|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
32437|NCT01435928|134781|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
32438|NCT01435928|134782|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
32439|NCT01435928|134783|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
32440|NCT01435928|134781|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
32441|NCT01435928|134782|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
32442|NCT01435928|134783|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
32443|NCT01435928|134781|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
32444|NCT01435928|134782|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
32445|NCT01435928|134783|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
32446|NCT01435928|134781|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
32447|NCT01435928|134782|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
32448|NCT01435928|134783|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
32449|NCT01435928|134781|P3|Open Label Phase - up to 24 Weeks|Administrative|0
32450|NCT01435928|134782|P2|Open Label Phase - up to 24 Weeks|Administrative|0
32451|NCT01435928|134783|P1|Open Label Phase - up to 24 Weeks|Administrative|14
32452|NCT01435928|134781|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
32453|NCT01435928|134782|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
32454|NCT01435928|134783|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
32455|NCT01435928|134781|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
32456|NCT01435928|134782|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
32457|NCT01435928|134783|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
32458|NCT01435928|134781|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
32459|NCT01435928|134782|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
32460|NCT01435928|134783|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
32461|NCT01435928|134781|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
32462|NCT01435928|134782|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
32463|NCT01435928|134783|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
32464|NCT01435928|134781|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
32465|NCT01435928|134782|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
32466|NCT01435928|134783|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
32467|NCT01435928|134781|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
32468|NCT01435928|134782|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
32469|NCT01435928|134783|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
32470|NCT01435928|134781|P3|Open Label Phase - up to 24 Weeks|Death|0
32471|NCT01435928|134782|P2|Open Label Phase - up to 24 Weeks|Death|0
32472|NCT01435928|134783|P1|Open Label Phase - up to 24 Weeks|Death|1
32473|NCT01435928|134781|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
32474|NCT01435928|134782|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
32475|NCT01435928|134783|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
32476|NCT01435759|134815|P6|Double-blind Phase|Not Specified|0
32477|NCT01435759|134816|P5|Double-blind Phase|Not Specified|0
32478|NCT01435759|134817|P4|Double-blind Phase|Not Specified|2
32479|NCT01435759|134818|P3|Double-blind Phase|Not Specified|0
32480|NCT01435759|134819|P2|Double-blind Phase|Not Specified|2
32481|NCT01435759|134820|P1|Double-blind Phase|Not Specified|8
32482|NCT01435759|134815|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
32483|NCT01435759|134816|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
32484|NCT01435759|134817|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
32485|NCT01435759|134818|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
32486|NCT01435759|134819|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
32487|NCT01435759|134820|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
32488|NCT01435759|134815|P6|Double-blind Phase|Lost to Follow-up|3
32489|NCT01435759|134816|P5|Double-blind Phase|Lost to Follow-up|3
32490|NCT01435759|134817|P4|Double-blind Phase|Lost to Follow-up|0
32491|NCT01435759|134818|P3|Double-blind Phase|Lost to Follow-up|2
32492|NCT01435759|134819|P2|Double-blind Phase|Lost to Follow-up|1
32493|NCT01435759|134820|P1|Double-blind Phase|Lost to Follow-up|31
32494|NCT01435759|134815|P6|Double-blind Phase|Withdrawal by Subject|2
32495|NCT01435759|134816|P5|Double-blind Phase|Withdrawal by Subject|2
32496|NCT01435759|134817|P4|Double-blind Phase|Withdrawal by Subject|4
32497|NCT01435759|134818|P3|Double-blind Phase|Withdrawal by Subject|3
32498|NCT01435759|134819|P2|Double-blind Phase|Withdrawal by Subject|4
32499|NCT01435759|134820|P1|Double-blind Phase|Withdrawal by Subject|17
32500|NCT01435759|134815|P6|Double-blind Phase|Protocol Violation|1
32501|NCT01435759|134816|P5|Double-blind Phase|Protocol Violation|0
32502|NCT01435759|134817|P4|Double-blind Phase|Protocol Violation|2
32503|NCT01435759|134818|P3|Double-blind Phase|Protocol Violation|1
32504|NCT01435759|134819|P2|Double-blind Phase|Protocol Violation|0
32505|NCT01435759|134820|P1|Double-blind Phase|Protocol Violation|2
32506|NCT01435759|134815|P6|Double-blind Phase|Adverse Event|3
32507|NCT01435759|134816|P5|Double-blind Phase|Adverse Event|1
32508|NCT01435759|134817|P4|Double-blind Phase|Adverse Event|1
32509|NCT01435759|134818|P3|Double-blind Phase|Adverse Event|1
32510|NCT01435759|134819|P2|Double-blind Phase|Adverse Event|0
32511|NCT01435759|134820|P1|Double-blind Phase|Adverse Event|7
32512|NCT01435759|134815|P6|Antidepressant Lead-in Phase|Not Specified|0
32513|NCT01435759|134816|P5|Antidepressant Lead-in Phase|Not Specified|0
32514|NCT01435759|134817|P4|Antidepressant Lead-in Phase|Not Specified|0
32515|NCT01435759|134818|P3|Antidepressant Lead-in Phase|Not Specified|0
32516|NCT01435759|134819|P2|Antidepressant Lead-in Phase|Not Specified|0
32517|NCT01435759|134820|P1|Antidepressant Lead-in Phase|Not Specified|119
32518|NCT01435759|134815|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
32519|NCT01435759|134816|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
32520|NCT01435759|134817|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
32521|NCT01435759|134818|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
32522|NCT01435759|134819|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
32523|NCT01435759|134820|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
32524|NCT01435759|134815|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
32525|NCT01435759|134816|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
32526|NCT01435759|134817|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
32527|NCT01435759|134818|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
32528|NCT01435759|134819|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
32529|NCT01435759|134820|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
32530|NCT01435759|134815|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
32531|NCT01435759|134816|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
32532|NCT01435759|134817|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
32533|NCT01435759|134818|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
32534|NCT01435759|134819|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
32535|NCT01435759|134820|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
32536|NCT01435759|134815|P6|Antidepressant Lead-in Phase|Protocol Violation|0
32537|NCT01435759|134816|P5|Antidepressant Lead-in Phase|Protocol Violation|0
32538|NCT01435759|134817|P4|Antidepressant Lead-in Phase|Protocol Violation|0
32539|NCT01435759|134818|P3|Antidepressant Lead-in Phase|Protocol Violation|0
32540|NCT01435759|134819|P2|Antidepressant Lead-in Phase|Protocol Violation|0
32541|NCT01435759|134820|P1|Antidepressant Lead-in Phase|Protocol Violation|16
32542|NCT01435759|134815|P6|Antidepressant Lead-in Phase|Adverse Event|0
32543|NCT01435759|134816|P5|Antidepressant Lead-in Phase|Adverse Event|0
32544|NCT01435759|134817|P4|Antidepressant Lead-in Phase|Adverse Event|0
32545|NCT01435759|134818|P3|Antidepressant Lead-in Phase|Adverse Event|0
32546|NCT01435759|134819|P2|Antidepressant Lead-in Phase|Adverse Event|0
32547|NCT01435759|134820|P1|Antidepressant Lead-in Phase|Adverse Event|40
32548|NCT01435655|134847|P1|Overall Study|Unspecified|1
32549|NCT01435655|134847|P1|Overall Study|Death|2
32550|NCT01435577|134861|P2|Overall Study|Alternative treatment started|1
32551|NCT01435577|134862|P1|Overall Study|Alternative treatment started|0
32552|NCT01435577|134861|P2|Overall Study|Lack of Efficacy|51
32553|NCT01435577|134862|P1|Overall Study|Lack of Efficacy|7
32554|NCT01435577|134861|P2|Overall Study|Adverse Event|0
32555|NCT01435577|134862|P1|Overall Study|Adverse Event|10
32556|NCT01435460|134912|P2|Overall Study|Did not meet eligibility criteria|0
32557|NCT01435460|134913|P1|Overall Study|Did not meet eligibility criteria|2
32558|NCT01435460|134912|P2|Overall Study|Protocol Violation|1
32559|NCT01435460|134913|P1|Overall Study|Protocol Violation|0
32560|NCT01435460|134912|P2|Overall Study|Withdrawal by Subject|3
32561|NCT01435460|134913|P1|Overall Study|Withdrawal by Subject|1
32562|NCT01435460|134912|P2|Overall Study|Lost to Follow-up|1
32563|NCT01435460|134913|P1|Overall Study|Lost to Follow-up|6
32564|NCT01435460|134912|P2|Overall Study|Adverse Event|1
32565|NCT01435460|134913|P1|Overall Study|Adverse Event|2
32566|NCT01435265|134927|P2|Overall Study|Lost to Follow-up|1
32567|NCT01435265|134928|P1|Overall Study|Lost to Follow-up|0
32568|NCT01435031|134942|P1|ITT at 1 Year|Withdrawal by Subject|2
32569|NCT01435031|134942|P1|ITT at 1 Year|Death|1
32570|NCT01435031|134942|P1|ITT at 6 Months|Lost to Follow-up|2
32571|NCT01435031|134942|P1|ITT at 6 Months|Death|2
32572|NCT01435031|134942|P1|ITT at 1 Month|Lost to Follow-up|4
32573|NCT01435031|134942|P1|ITT at 1 Month|Death|1
32574|NCT01435031|134942|P1|ITT at 1 Month|Withdrawal by Subject|1
32575|NCT01434823|135009|P2|Overall Study|Incomplete data in medical record|7
32576|NCT01434823|135010|P1|Overall Study|Incomplete data in medical record|4
32577|NCT01434693|135028|P4|Overall Study|Lost to Follow-up|0
32578|NCT01434693|135029|P3|Overall Study|Lost to Follow-up|0
32579|NCT01434693|135030|P2|Overall Study|Lost to Follow-up|0
32580|NCT01434693|135031|P1|Overall Study|Lost to Follow-up|1
32581|NCT01434693|135028|P4|Overall Study|Withdrawal by Subject|1
32582|NCT01434693|135029|P3|Overall Study|Withdrawal by Subject|1
32583|NCT01434693|135030|P2|Overall Study|Withdrawal by Subject|0
32584|NCT01434693|135031|P1|Overall Study|Withdrawal by Subject|1
32585|NCT01434693|135028|P4|Overall Study|Adverse Event|0
32586|NCT01434693|135029|P3|Overall Study|Adverse Event|0
32587|NCT01434693|135030|P2|Overall Study|Adverse Event|0
32588|NCT01434693|135031|P1|Overall Study|Adverse Event|1
32589|NCT01434680|135045|P4|Overall Study|Protocol Violation|0
32590|NCT01434680|135046|P3|Overall Study|Protocol Violation|0
32591|NCT01434680|135047|P2|Overall Study|Protocol Violation|1
32592|NCT01434680|135048|P1|Overall Study|Protocol Violation|1
32593|NCT01434680|135045|P4|Overall Study|Lost to Follow-up|0
32594|NCT01434680|135046|P3|Overall Study|Lost to Follow-up|0
32595|NCT01434680|135047|P2|Overall Study|Lost to Follow-up|1
32596|NCT01434680|135048|P1|Overall Study|Lost to Follow-up|1
32597|NCT01434680|135045|P4|Overall Study|Withdrawal by Subject|0
32598|NCT01434680|135046|P3|Overall Study|Withdrawal by Subject|2
32599|NCT01434680|135047|P2|Overall Study|Withdrawal by Subject|0
32600|NCT01434680|135048|P1|Overall Study|Withdrawal by Subject|1
32601|NCT01434654|135065|P2|Overall Study|Lost to Follow-up|0
32602|NCT01434654|135066|P1|Overall Study|Lost to Follow-up|1
32603|NCT01434654|135065|P2|Overall Study|Withdrawal by Subject|0
32604|NCT01434654|135066|P1|Overall Study|Withdrawal by Subject|1
32605|NCT01433549|135142|P2|Phase 2: Second Study Product|Adverse Event|1
32606|NCT01433549|135143|P1|Phase 2: Second Study Product|Adverse Event|0
32607|NCT01433471|135153|P2|Overall Study|Withdrawal by Subject|1
32608|NCT01433471|135154|P1|Overall Study|Withdrawal by Subject|0
32609|NCT01433354|135170|P1|Overall Study|Subject Withdrew Consent|3
32610|NCT01433354|135170|P1|Overall Study|Lack of Efficacy|17
32611|NCT01433354|135170|P1|Overall Study|Protocol Violation|2
32612|NCT01433354|135170|P1|Overall Study|Administrative problems|90
32613|NCT01433354|135170|P1|Overall Study|Lost to Follow-up|1
32614|NCT01433354|135170|P1|Overall Study|Adverse Event|6
32615|NCT01433263|135186|P2|Overall Study|Withdrawal by Subject|7
32616|NCT01433263|135187|P1|Overall Study|Withdrawal by Subject|10
32617|NCT01433263|135186|P2|Overall Study|Protocol Deviation|0
32618|NCT01433263|135187|P1|Overall Study|Protocol Deviation|1
32619|NCT01433263|135186|P2|Overall Study|Lost to Follow-up|1
32620|NCT01433263|135187|P1|Overall Study|Lost to Follow-up|0
32621|NCT01433263|135186|P2|Overall Study|Death|3
32622|NCT01433263|135187|P1|Overall Study|Death|5
32623|NCT01433263|135186|P2|Overall Study|Adverse Event|1
32624|NCT01433263|135187|P1|Overall Study|Adverse Event|3
32625|NCT01433250|135216|P2|Overall Study|Withdrawal by Subject|2
32626|NCT01433250|135217|P1|Overall Study|Withdrawal by Subject|3
32627|NCT01433250|135216|P2|Overall Study|Protocol Violation|1
32628|NCT01433250|135217|P1|Overall Study|Protocol Violation|0
32629|NCT01433159|135235|P2|Overall Study|Protocol Violation|1
32630|NCT01433159|135236|P1|Overall Study|Protocol Violation|0
32631|NCT01433159|135235|P2|Overall Study|Physician Decision|0
32632|NCT01433159|135236|P1|Overall Study|Physician Decision|1
32633|NCT01433159|135235|P2|Overall Study|Adverse Event|0
32634|NCT01433159|135236|P1|Overall Study|Adverse Event|1
32635|NCT01432938|135274|P2|Second Intervention|Adverse Event|0
32636|NCT01432938|135275|P1|Second Intervention|Adverse Event|1
32637|NCT01432938|135274|P2|First Intervention|Physician Decision|0
32638|NCT01432938|135275|P1|First Intervention|Physician Decision|1
32639|NCT01432938|135274|P2|First Intervention|Protocol Violation|0
32640|NCT01432938|135275|P1|First Intervention|Protocol Violation|1
32641|NCT01432756|135305|P4|Overall Study|Lost to Follow-up|1
32642|NCT01432756|135306|P3|Overall Study|Lost to Follow-up|2
32643|NCT01432756|135307|P2|Overall Study|Lost to Follow-up|0
32644|NCT01432756|135308|P1|Overall Study|Lost to Follow-up|1
32645|NCT01432626|135316|P1|Overall Study|Imaging agent not available|1
32646|NCT01432626|135316|P1|Overall Study|Only 1 image competed|2
32647|NCT01432626|135316|P1|Overall Study|Withdrawal by Subject|2
32648|NCT01432626|135316|P1|Overall Study|LV function recovered|2
32649|NCT01432574|135320|P1|Overall Study|Not interested|1
32650|NCT01432574|135320|P1|Overall Study|Moved|2
32651|NCT01432457|135366|P3|Overall Study|Did not take study drug|3
32652|NCT01432457|135367|P2|Overall Study|Did not take study drug|6
32653|NCT01432457|135368|P1|Overall Study|Did not take study drug|6
32654|NCT01432457|135366|P3|Overall Study|Reasons not defined|4
32655|NCT01432457|135367|P2|Overall Study|Reasons not defined|3
32656|NCT01432457|135368|P1|Overall Study|Reasons not defined|2
32657|NCT01432457|135366|P3|Overall Study|Withdrawal by Subject|9
32658|NCT01432457|135367|P2|Overall Study|Withdrawal by Subject|11
32659|NCT01432457|135368|P1|Overall Study|Withdrawal by Subject|6
32660|NCT01432457|135366|P3|Overall Study|Protocol Violation|6
32661|NCT01432457|135367|P2|Overall Study|Protocol Violation|2
32662|NCT01432457|135368|P1|Overall Study|Protocol Violation|3
32663|NCT01432457|135366|P3|Overall Study|Lost to Follow-up|20
32664|NCT01432457|135367|P2|Overall Study|Lost to Follow-up|15
32665|NCT01432457|135368|P1|Overall Study|Lost to Follow-up|11
32666|NCT01432457|135366|P3|Overall Study|Lack of Efficacy|1
32667|NCT01432457|135367|P2|Overall Study|Lack of Efficacy|1
32668|NCT01432457|135368|P1|Overall Study|Lack of Efficacy|2
32669|NCT01432457|135366|P3|Overall Study|Adverse Event|16
32670|NCT01432457|135367|P2|Overall Study|Adverse Event|10
32671|NCT01432457|135368|P1|Overall Study|Adverse Event|7
32672|NCT01432444|135397|P3|Extension Phase|Withdrawal by Subject|13
32673|NCT01432444|135398|P2|Extension Phase|Withdrawal by Subject|0
32674|NCT01432444|135399|P1|Extension Phase|Withdrawal by Subject|0
32675|NCT01432444|135397|P3|Extension Phase|Physician Decision|1
32676|NCT01432444|135398|P2|Extension Phase|Physician Decision|0
32677|NCT01432444|135399|P1|Extension Phase|Physician Decision|0
32678|NCT01432444|135397|P3|Extension Phase|Met Withdrawal Criteria|144
32679|NCT01432444|135398|P2|Extension Phase|Met Withdrawal Criteria|0
32680|NCT01432444|135399|P1|Extension Phase|Met Withdrawal Criteria|0
32681|NCT01432444|135397|P3|Extension Phase|Sponsor Discontinued Trial|7
32682|NCT01432444|135398|P2|Extension Phase|Sponsor Discontinued Trial|0
32683|NCT01432444|135399|P1|Extension Phase|Sponsor Discontinued Trial|0
32684|NCT01432444|135397|P3|Extension Phase|Adverse Event|10
32685|NCT01432444|135398|P2|Extension Phase|Adverse Event|0
32686|NCT01432444|135399|P1|Extension Phase|Adverse Event|0
32687|NCT01432444|135397|P3|Extension Phase|Lost to Follow-up|17
32688|NCT01432444|135398|P2|Extension Phase|Lost to Follow-up|0
32689|NCT01432444|135399|P1|Extension Phase|Lost to Follow-up|0
32690|NCT01432444|135397|P3|Treatment Phase|Lack of Efficacy|0
32691|NCT01432444|135398|P2|Treatment Phase|Lack of Efficacy|10
32692|NCT01432444|135399|P1|Treatment Phase|Lack of Efficacy|0
32693|NCT01432444|135397|P3|Treatment Phase|Protocol Deviation|0
32694|NCT01432444|135398|P2|Treatment Phase|Protocol Deviation|3
32695|NCT01432444|135399|P1|Treatment Phase|Protocol Deviation|0
32696|NCT01432444|135397|P3|Treatment Phase|Withdrawal by Subject|0
32697|NCT01432444|135398|P2|Treatment Phase|Withdrawal by Subject|41
32698|NCT01432444|135399|P1|Treatment Phase|Withdrawal by Subject|0
32699|NCT01432444|135397|P3|Treatment Phase|Physician Decision|0
32700|NCT01432444|135398|P2|Treatment Phase|Physician Decision|5
32701|NCT01432444|135399|P1|Treatment Phase|Physician Decision|0
32702|NCT01432444|135397|P3|Treatment Phase|Met Withdrawal Criteria|0
32703|NCT01432444|135398|P2|Treatment Phase|Met Withdrawal Criteria|11
32704|NCT01432444|135399|P1|Treatment Phase|Met Withdrawal Criteria|0
32705|NCT01432444|135397|P3|Treatment Phase|Adverse Event|0
32706|NCT01432444|135398|P2|Treatment Phase|Adverse Event|37
32707|NCT01432444|135399|P1|Treatment Phase|Adverse Event|0
32708|NCT01432444|135397|P3|Treatment Phase|Lost to Follow-up|0
32709|NCT01432444|135398|P2|Treatment Phase|Lost to Follow-up|33
32710|NCT01432444|135399|P1|Treatment Phase|Lost to Follow-up|0
32711|NCT01432444|135397|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
32712|NCT01432444|135398|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
32713|NCT01432444|135399|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
32714|NCT01432444|135397|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
32715|NCT01432444|135398|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
32716|NCT01432444|135399|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
32717|NCT01432444|135397|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
32718|NCT01432444|135398|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
32719|NCT01432444|135399|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
32720|NCT01432444|135397|P3|Tolerability/Cross-titration Phase|Physician Decision|0
32721|NCT01432444|135398|P2|Tolerability/Cross-titration Phase|Physician Decision|0
32722|NCT01432444|135399|P1|Tolerability/Cross-titration Phase|Physician Decision|8
32723|NCT01432444|135397|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
32724|NCT01432444|135398|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
32725|NCT01432444|135399|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
32726|NCT01432444|135397|P3|Tolerability/Cross-titration Phase|Adverse Event|0
32727|NCT01432444|135398|P2|Tolerability/Cross-titration Phase|Adverse Event|0
32728|NCT01432444|135399|P1|Tolerability/Cross-titration Phase|Adverse Event|16
32729|NCT01432444|135397|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
32730|NCT01432444|135398|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
32731|NCT01432444|135399|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
32732|NCT01432366|135425|P1|Overall Study|Unspecified|14
32733|NCT01432366|135425|P1|Overall Study|Investigator Forget to Complete Visits|1
32734|NCT01432366|135425|P1|Overall Study|Site Closed|20
32735|NCT01432366|135425|P1|Overall Study|Lack of Efficacy|1
32736|NCT01432366|135425|P1|Overall Study|Lost to Follow-up|13
32737|NCT01432366|135425|P1|Overall Study|Pregnancy|1
32738|NCT01432366|135425|P1|Overall Study|Withdrawal Due to Non-Compliance|3
32739|NCT01432366|135425|P1|Overall Study|Adverse Event|8
32740|NCT01432366|135425|P1|Overall Study|Non-Responder|7
32741|NCT01432327|135447|P4|Posttest 1 Year|Allergic reaction|1
32742|NCT01432327|135448|P3|Posttest 1 Year|Allergic reaction|1
32743|NCT01432327|135449|P2|Posttest 1 Year|Allergic reaction|0
32744|NCT01432327|135450|P1|Posttest 1 Year|Allergic reaction|0
32745|NCT01432327|135447|P4|Posttest 1 Year|Lost to Follow-up|2
32746|NCT01432327|135448|P3|Posttest 1 Year|Lost to Follow-up|4
32747|NCT01432327|135449|P2|Posttest 1 Year|Lost to Follow-up|0
32748|NCT01432327|135450|P1|Posttest 1 Year|Lost to Follow-up|0
32749|NCT01432327|135447|P4|Posttest 1 Year|Measurement have to take place in future|20
32750|NCT01432327|135448|P3|Posttest 1 Year|Measurement have to take place in future|15
32751|NCT01432327|135449|P2|Posttest 1 Year|Measurement have to take place in future|28
32752|NCT01432327|135450|P1|Posttest 1 Year|Measurement have to take place in future|24
32753|NCT01432327|135447|P4|Posttest 6 Months|Withdrawal by Subject|0
32754|NCT01432327|135448|P3|Posttest 6 Months|Withdrawal by Subject|1
32755|NCT01432327|135449|P2|Posttest 6 Months|Withdrawal by Subject|0
32756|NCT01432327|135450|P1|Posttest 6 Months|Withdrawal by Subject|0
32757|NCT01432327|135447|P4|Posttest 6 Months|Allergic reaction|0
32758|NCT01432327|135448|P3|Posttest 6 Months|Allergic reaction|1
32759|NCT01432327|135449|P2|Posttest 6 Months|Allergic reaction|0
32760|NCT01432327|135450|P1|Posttest 6 Months|Allergic reaction|0
32761|NCT01432327|135447|P4|Posttest 6 Months|Lost to Follow-up|2
32762|NCT01432327|135448|P3|Posttest 6 Months|Lost to Follow-up|3
32763|NCT01432327|135449|P2|Posttest 6 Months|Lost to Follow-up|0
32764|NCT01432327|135450|P1|Posttest 6 Months|Lost to Follow-up|0
32765|NCT01432327|135447|P4|Posttest 3 Months|Allergic reaction|0
32766|NCT01432327|135448|P3|Posttest 3 Months|Allergic reaction|0
32767|NCT01432327|135449|P2|Posttest 3 Months|Allergic reaction|2
32768|NCT01432327|135450|P1|Posttest 3 Months|Allergic reaction|0
32769|NCT01432327|135447|P4|Posttest 3 Months|Lost to Follow-up|1
32770|NCT01432327|135448|P3|Posttest 3 Months|Lost to Follow-up|2
32771|NCT01432327|135449|P2|Posttest 3 Months|Lost to Follow-up|0
32772|NCT01432327|135450|P1|Posttest 3 Months|Lost to Follow-up|1
32773|NCT01432327|135447|P4|Posttest 3 Months|depression|0
32774|NCT01432327|135448|P3|Posttest 3 Months|depression|0
32775|NCT01432327|135449|P2|Posttest 3 Months|depression|0
32776|NCT01432327|135450|P1|Posttest 3 Months|depression|3
32777|NCT01432262|135462|P2|Overall Study|Withdrawal by Subject|1
32778|NCT01432262|135463|P1|Overall Study|Withdrawal by Subject|2
32779|NCT01431976|135557|P1|Overall Study|Withdrawal by Subject|1
32780|NCT01431976|135557|P1|Overall Study|Physician Decision|1
32781|NCT01431976|135557|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
32782|NCT01431976|135557|P1|Overall Study|Lack of Efficacy|2
32783|NCT01431976|135557|P1|Overall Study|Adverse Event|6
32784|NCT01431963|135568|P1|Overall Study|Withdrawal by Subject|3
32785|NCT01431963|135568|P1|Overall Study|Physician Decision|4
32786|NCT01431963|135568|P1|Overall Study|Protocol-defined Stopping Criteria|2
32787|NCT01431963|135568|P1|Overall Study|Protocol Violation|1
32788|NCT01431963|135568|P1|Overall Study|Lack of Efficacy|7
32789|NCT01431963|135568|P1|Overall Study|Adverse Event|18
32790|NCT01431950|135576|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
32791|NCT01431950|135577|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
32792|NCT01431950|135576|P2|Overall Study|Lost to Follow-up|1
32793|NCT01431950|135577|P1|Overall Study|Lost to Follow-up|0
32794|NCT01431950|135576|P2|Overall Study|Lack of Efficacy|1
32795|NCT01431950|135577|P1|Overall Study|Lack of Efficacy|2
32796|NCT01431950|135576|P2|Overall Study|Physician Decision|1
32797|NCT01431950|135577|P1|Overall Study|Physician Decision|2
32798|NCT01431950|135576|P2|Overall Study|Adverse Event|2
32799|NCT01431950|135577|P1|Overall Study|Adverse Event|2
32800|NCT01431950|135576|P2|Overall Study|Protocol Violation|3
32801|NCT01431950|135577|P1|Overall Study|Protocol Violation|2
32802|NCT01431950|135576|P2|Overall Study|Withdrawal by Subject|3
32803|NCT01431950|135577|P1|Overall Study|Withdrawal by Subject|4
32804|NCT01431950|135576|P2|Overall Study|Study Site Closed/Terminated|3
32805|NCT01431950|135577|P1|Overall Study|Study Site Closed/Terminated|7
32806|NCT01431716|135615|P1|Overall Study|Withdrawal of consent|1
32807|NCT01431521|135636|P4|Overall Study|Withdrawal by Subject|0
32808|NCT01431521|135637|P3|Overall Study|Withdrawal by Subject|1
32809|NCT01431521|135638|P2|Overall Study|Withdrawal by Subject|0
32810|NCT01431521|135639|P1|Overall Study|Withdrawal by Subject|0
32811|NCT01431508|135660|P1|Overall Study|Unable to Follow Protocol Procedures|1
32812|NCT01431508|135660|P1|Overall Study|Lack of Efficacy|1
32813|NCT01431287|135700|P5|Overall Study|not stated above|1
32814|NCT01431287|135701|P4|Overall Study|not stated above|2
32815|NCT01431287|135702|P3|Overall Study|not stated above|2
32816|NCT01431287|135703|P2|Overall Study|not stated above|2
32817|NCT01431287|135704|P1|Overall Study|not stated above|4
32818|NCT01431287|135700|P5|Overall Study|Consent withdrawn not due to AE|29
32819|NCT01431287|135701|P4|Overall Study|Consent withdrawn not due to AE|19
32820|NCT01431287|135702|P3|Overall Study|Consent withdrawn not due to AE|34
32821|NCT01431287|135703|P2|Overall Study|Consent withdrawn not due to AE|30
32822|NCT01431287|135704|P1|Overall Study|Consent withdrawn not due to AE|29
32823|NCT01431287|135700|P5|Overall Study|Lost to Follow-up|1
32824|NCT01431287|135701|P4|Overall Study|Lost to Follow-up|3
32825|NCT01431287|135702|P3|Overall Study|Lost to Follow-up|2
32826|NCT01431287|135703|P2|Overall Study|Lost to Follow-up|3
32827|NCT01431287|135704|P1|Overall Study|Lost to Follow-up|0
32828|NCT01431287|135700|P5|Overall Study|Non compliant with protocol|5
32829|NCT01431287|135701|P4|Overall Study|Non compliant with protocol|6
32830|NCT01431287|135702|P3|Overall Study|Non compliant with protocol|5
32831|NCT01431287|135703|P2|Overall Study|Non compliant with protocol|6
32832|NCT01431287|135704|P1|Overall Study|Non compliant with protocol|6
32833|NCT01431287|135700|P5|Overall Study|Adverse Event|41
32834|NCT01431287|135701|P4|Overall Study|Adverse Event|33
32835|NCT01431287|135702|P3|Overall Study|Adverse Event|53
32836|NCT01431287|135703|P2|Overall Study|Adverse Event|57
32837|NCT01431287|135704|P1|Overall Study|Adverse Event|59
32838|NCT01431287|135700|P5|Overall Study|not treated|0
32839|NCT01431287|135701|P4|Overall Study|not treated|0
32840|NCT01431287|135702|P3|Overall Study|not treated|1
32841|NCT01431287|135703|P2|Overall Study|not treated|0
32842|NCT01431287|135704|P1|Overall Study|not treated|0
32843|NCT01431274|135866|P5|Overall Study|Other reason not stated above|4
32844|NCT01431274|135867|P4|Overall Study|Other reason not stated above|2
32845|NCT01431274|135868|P3|Overall Study|Other reason not stated above|7
32846|NCT01431274|135869|P2|Overall Study|Other reason not stated above|5
32847|NCT01431274|135870|P1|Overall Study|Other reason not stated above|6
32848|NCT01431274|135866|P5|Overall Study|Lost to Follow-up|0
32849|NCT01431274|135867|P4|Overall Study|Lost to Follow-up|4
32850|NCT01431274|135868|P3|Overall Study|Lost to Follow-up|1
32851|NCT01431274|135869|P2|Overall Study|Lost to Follow-up|7
32852|NCT01431274|135870|P1|Overall Study|Lost to Follow-up|6
32853|NCT01431274|135866|P5|Overall Study|Non compliant with protocol|4
32854|NCT01431274|135867|P4|Overall Study|Non compliant with protocol|4
32855|NCT01431274|135868|P3|Overall Study|Non compliant with protocol|4
32856|NCT01431274|135869|P2|Overall Study|Non compliant with protocol|8
32857|NCT01431274|135870|P1|Overall Study|Non compliant with protocol|5
32858|NCT01431274|135866|P5|Overall Study|Consent withdrawn not due to AE|11
32859|NCT01431274|135867|P4|Overall Study|Consent withdrawn not due to AE|20
32860|NCT01431274|135868|P3|Overall Study|Consent withdrawn not due to AE|17
32861|NCT01431274|135869|P2|Overall Study|Consent withdrawn not due to AE|20
32862|NCT01431274|135870|P1|Overall Study|Consent withdrawn not due to AE|29
32863|NCT01431274|135866|P5|Overall Study|Adverse Event|37
32864|NCT01431274|135867|P4|Overall Study|Adverse Event|30
32865|NCT01431274|135868|P3|Overall Study|Adverse Event|43
32866|NCT01431274|135869|P2|Overall Study|Adverse Event|37
32867|NCT01431274|135870|P1|Overall Study|Adverse Event|51
32868|NCT01431144|136048|P2|Overall Study|Implant mobility and removal|0
32869|NCT01431144|136049|P1|Overall Study|Implant mobility and removal|2
32870|NCT01431079|136068|P2|Overall Study|Lost to Follow-up|39
32871|NCT01431079|136069|P1|Overall Study|Lost to Follow-up|35
32872|NCT01430754|136148|P2|Run-In Phase|Lost to Follow-up|0
32873|NCT01430754|136149|P1|Run-In Phase|Lost to Follow-up|1
32874|NCT01430754|136148|P2|Run-In Phase|Withdrawal by Subject|0
32875|NCT01430754|136149|P1|Run-In Phase|Withdrawal by Subject|2
32876|NCT01430754|136148|P2|Run-In Phase|Other|0
32877|NCT01430754|136149|P1|Run-In Phase|Other|2
32878|NCT01430754|136148|P2|Run-In Phase|Adverse Event|0
32879|NCT01430754|136149|P1|Run-In Phase|Adverse Event|2
32880|NCT01430754|136148|P2|Run-In Phase|Protocol Violation|0
32881|NCT01430754|136149|P1|Run-In Phase|Protocol Violation|6
32882|NCT01430754|136148|P2|Run-In Phase|Circadian Period Ineligible|0
32883|NCT01430754|136149|P1|Run-In Phase|Circadian Period Ineligible|24
32884|NCT01430624|136170|P3|Overall Study|technical or eligibility|2
32885|NCT01430624|136171|P2|Overall Study|technical or eligibility|5
32886|NCT01430624|136172|P1|Overall Study|technical or eligibility|5
32887|NCT01430624|136170|P3|Overall Study|Lost to Follow-up|27
32888|NCT01430624|136171|P2|Overall Study|Lost to Follow-up|29
32889|NCT01430624|136172|P1|Overall Study|Lost to Follow-up|23
32890|NCT01430611|136203|P2|Overall Study|Withdrawal by Subject|14
32891|NCT01430611|136204|P1|Overall Study|Withdrawal by Subject|15
32892|NCT01430611|136203|P2|Overall Study|Lost to Follow-up|0
32893|NCT01430611|136204|P1|Overall Study|Lost to Follow-up|1
32894|NCT01430611|136203|P2|Overall Study|Protocol Violation|0
32895|NCT01430611|136204|P1|Overall Study|Protocol Violation|1
32896|NCT01430611|136203|P2|Overall Study|Adverse Event|1
32897|NCT01430611|136204|P1|Overall Study|Adverse Event|0
32898|NCT01430585|136222|P1|Overall Study|Unspecified|7
32899|NCT01430585|136222|P1|Overall Study|Study Terminated by Sponsor|3
32900|NCT01430585|136222|P1|Overall Study|Objective Progression or Relapse|3
32901|NCT01430585|136222|P1|Overall Study|Death|1
32902|NCT01430403|136258|P3|Overall Study|Withdrawal by Subject|3
32903|NCT01430403|136259|P2|Overall Study|Withdrawal by Subject|1
32904|NCT01430403|136260|P1|Overall Study|Withdrawal by Subject|9
32905|NCT01430403|136258|P3|Overall Study|Protocol Violation|2
32906|NCT01430403|136259|P2|Overall Study|Protocol Violation|3
32907|NCT01430403|136260|P1|Overall Study|Protocol Violation|2
32908|NCT01430403|136258|P3|Overall Study|Physician Decision|0
32909|NCT01430403|136259|P2|Overall Study|Physician Decision|0
32910|NCT01430403|136260|P1|Overall Study|Physician Decision|1
32911|NCT01430403|136258|P3|Overall Study|Lost to Follow-up|3
32912|NCT01430403|136259|P2|Overall Study|Lost to Follow-up|5
32913|NCT01430403|136260|P1|Overall Study|Lost to Follow-up|5
32914|NCT01430130|136350|P1|Overall Study|Infection on Control Side of Incision|1
32915|NCT01430130|136350|P1|Overall Study|Lost to Follow-up|1
32916|NCT01430104|136356|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
32917|NCT01429584|136392|P2|Overall Study|Protocol Violation|1
32918|NCT01429584|136393|P1|Overall Study|Protocol Violation|0
32919|NCT01429584|136392|P2|Overall Study|Withdrawal by Subject|0
32920|NCT01429584|136393|P1|Overall Study|Withdrawal by Subject|1
32921|NCT01429441|136424|P2|Overall Study|Withdrawal by Subject|18
32922|NCT01429441|136425|P1|Overall Study|Withdrawal by Subject|27
32923|NCT01429441|136424|P2|Overall Study|Physician Decision|0
32924|NCT01429441|136425|P1|Overall Study|Physician Decision|1
32925|NCT01429441|136424|P2|Overall Study|Lost to Follow-up|2
32926|NCT01429441|136425|P1|Overall Study|Lost to Follow-up|5
32927|NCT01429441|136424|P2|Overall Study|Death|2
32928|NCT01429441|136425|P1|Overall Study|Death|0
32929|NCT01429441|136424|P2|Overall Study|Adverse Event|1
32930|NCT01429441|136425|P1|Overall Study|Adverse Event|5
32931|NCT01429077|136440|P2|Overall Study|Lost to Follow-up|3
32932|NCT01429077|136441|P1|Overall Study|Lost to Follow-up|0
32933|NCT01429051|136464|P1|Tolerability Phase|Other|2
32934|NCT01429051|136464|P1|Tolerability Phase|Physician Decision|1
32935|NCT01429051|136464|P1|Tolerability Phase|Withdrawal by Subject|5
32936|NCT01429051|136464|P1|Tolerability Phase|Adverse Event|2
32937|NCT01429051|136464|P1|Tolerability Phase|Death|5
32938|NCT01429051|136464|P1|Efficacy Phase|Death|1
32939|NCT01429051|136464|P1|Efficacy Phase|Adverse Event|1
32940|NCT01429051|136464|P1|Titration Phase|Less than 3 BTP episodes per week|2
32941|NCT01429051|136464|P1|Titration Phase|Unsuccessful titration at any dose|1
32942|NCT01429051|136464|P1|Titration Phase|Physician Decision|1
32943|NCT01429051|136464|P1|Titration Phase|Withdrawal by Subject|7
32944|NCT01429051|136464|P1|Titration Phase|Death|1
32945|NCT01428882|136487|P2|Overall Study|Protocol Violation|3
32946|NCT01428882|136488|P1|Overall Study|Protocol Violation|4
32947|NCT01428882|136487|P2|Overall Study|Lack of Efficacy|7
32948|NCT01428882|136488|P1|Overall Study|Lack of Efficacy|2
32949|NCT01428713|136511|P2|Overall Study|Adverse Event|2
32950|NCT01428713|136512|P1|Overall Study|Adverse Event|0
32951|NCT01428713|136511|P2|Overall Study|Withdrawal by Subject|1
32952|NCT01428713|136512|P1|Overall Study|Withdrawal by Subject|1
32953|NCT01428713|136511|P2|Overall Study|Non-compliance|2
32954|NCT01428713|136512|P1|Overall Study|Non-compliance|2
32955|NCT01428661|136521|P3|Open Label Extension|**Various|185
32956|NCT01428661|136522|P2|Open Label Extension|**Various|0
32957|NCT01428661|136523|P1|Open Label Extension|**Various|0
32958|NCT01428661|136521|P3|Open Label Extension|Lack of Efficacy|24
32959|NCT01428661|136522|P2|Open Label Extension|Lack of Efficacy|0
32960|NCT01428661|136523|P1|Open Label Extension|Lack of Efficacy|0
32961|NCT01428661|136521|P3|Open Label Extension|Withdrawal by Subject|49
32962|NCT01428661|136522|P2|Open Label Extension|Withdrawal by Subject|0
32963|NCT01428661|136523|P1|Open Label Extension|Withdrawal by Subject|0
32964|NCT01428661|136521|P3|Open Label Extension|Lost to Follow-up|38
32965|NCT01428661|136522|P2|Open Label Extension|Lost to Follow-up|0
32966|NCT01428661|136523|P1|Open Label Extension|Lost to Follow-up|0
32967|NCT01428661|136521|P3|Open Label Extension|Adverse Event|15
32968|NCT01428661|136522|P2|Open Label Extension|Adverse Event|0
32969|NCT01428661|136523|P1|Open Label Extension|Adverse Event|0
32970|NCT01428661|136521|P3|Open Label Extension|Protocol Violation|9
32971|NCT01428661|136522|P2|Open Label Extension|Protocol Violation|0
32972|NCT01428661|136523|P1|Open Label Extension|Protocol Violation|0
32973|NCT01428661|136521|P3|Double-Masked Phase|*Various|0
32974|NCT01428661|136522|P2|Double-Masked Phase|*Various|6
32975|NCT01428661|136523|P1|Double-Masked Phase|*Various|1
32976|NCT01428661|136521|P3|Double-Masked Phase|Lack of Efficacy|0
32977|NCT01428661|136522|P2|Double-Masked Phase|Lack of Efficacy|1
32978|NCT01428661|136523|P1|Double-Masked Phase|Lack of Efficacy|2
32979|NCT01428661|136521|P3|Double-Masked Phase|Withdrawal by Subject|0
32980|NCT01428661|136522|P2|Double-Masked Phase|Withdrawal by Subject|20
32981|NCT01428661|136523|P1|Double-Masked Phase|Withdrawal by Subject|18
32982|NCT01428661|136521|P3|Double-Masked Phase|Lost to Follow-up|0
32983|NCT01428661|136522|P2|Double-Masked Phase|Lost to Follow-up|14
32984|NCT01428661|136523|P1|Double-Masked Phase|Lost to Follow-up|14
32985|NCT01428661|136521|P3|Double-Masked Phase|Adverse Event|0
32986|NCT01428661|136522|P2|Double-Masked Phase|Adverse Event|4
32987|NCT01428661|136523|P1|Double-Masked Phase|Adverse Event|13
32988|NCT01428661|136521|P3|Double-Masked Phase|Protocol Violation|0
32989|NCT01428661|136522|P2|Double-Masked Phase|Protocol Violation|4
32990|NCT01428661|136523|P1|Double-Masked Phase|Protocol Violation|9
32991|NCT01428583|136531|P1|Overall Study|Unspecified|6
32992|NCT01428583|136531|P1|Overall Study|Sponsor’s request|3
32993|NCT01428583|136531|P1|Overall Study|Confirmed positive urine drug test|8
32994|NCT01428583|136531|P1|Overall Study|Non-compliant|25
32995|NCT01428583|136531|P1|Overall Study|Physician Decision|12
32996|NCT01428583|136531|P1|Overall Study|Protocol Violation|1
32997|NCT01428583|136531|P1|Overall Study|Pregnancy|1
32998|NCT01428583|136531|P1|Overall Study|Death|1
32999|NCT01428583|136531|P1|Overall Study|Lost to Follow-up|17
33000|NCT01428583|136531|P1|Overall Study|Lack of Efficacy|37
33001|NCT01428583|136531|P1|Overall Study|Withdrawal by Subject|51
33002|NCT01428583|136531|P1|Overall Study|Adverse Event|75
33003|NCT01428128|136557|P1|Overall Study|Adverse Event|1
33004|NCT01428128|136557|P1|Overall Study|Received Neulasta in one cycle|2
33005|NCT01428128|136557|P1|Overall Study|Screen failure by p53|10
33006|NCT01428128|136557|P1|Overall Study|Withdrawal by Subject|4
33007|NCT01428115|136561|P1|Overall Study|Withdrawal by Subject|4
33008|NCT01428115|136561|P1|Overall Study|Protocol Violation|3
33009|NCT01428115|136561|P1|Overall Study|Pregnancy|1
33010|NCT01428115|136561|P1|Overall Study|Lost to Follow-up|10
33011|NCT01428115|136561|P1|Overall Study|Lack of Efficacy|3
33012|NCT01428076|136576|P2|Overall Study|Adverse Event|1
33013|NCT01428076|136577|P1|Overall Study|Adverse Event|0
33014|NCT01428063|136588|P3|Overall Study|No longer meets study criteria|0
33015|NCT01428063|136589|P2|Overall Study|No longer meets study criteria|1
33016|NCT01428063|136590|P1|Overall Study|No longer meets study criteria|0
33017|NCT01428063|136588|P3|Overall Study|Lost to Follow-up|0
33018|NCT01428063|136589|P2|Overall Study|Lost to Follow-up|2
33019|NCT01428063|136590|P1|Overall Study|Lost to Follow-up|0
33020|NCT01428063|136588|P3|Overall Study|Adverse Event|0
33021|NCT01428063|136589|P2|Overall Study|Adverse Event|3
33022|NCT01428063|136590|P1|Overall Study|Adverse Event|2
33023|NCT01428063|136588|P3|Overall Study|Lack of Efficacy|1
33024|NCT01428063|136589|P2|Overall Study|Lack of Efficacy|4
33025|NCT01428063|136590|P1|Overall Study|Lack of Efficacy|8
33026|NCT01427933|136661|P2|Overall Study|Investigator's Decision|0
33027|NCT01427933|136662|P1|Overall Study|Investigator's Decision|1
33028|NCT01427933|136661|P2|Overall Study|Not Specified|0
33029|NCT01427933|136662|P1|Overall Study|Not Specified|1
33030|NCT01427933|136661|P2|Overall Study|Lost to Follow-up|5
33031|NCT01427933|136662|P1|Overall Study|Lost to Follow-up|1
33032|NCT01427933|136661|P2|Overall Study|Withdrawal by Subject|8
33033|NCT01427933|136662|P1|Overall Study|Withdrawal by Subject|5
33034|NCT01427920|136682|P2|Overall Study|Unclassified|8
33035|NCT01427920|136683|P1|Overall Study|Unclassified|2
33036|NCT01427920|136682|P2|Overall Study|Withdrawal Criteria|4
33037|NCT01427920|136683|P1|Overall Study|Withdrawal Criteria|4
33038|NCT01427920|136682|P2|Overall Study|Protocol Violation|3
33039|NCT01427920|136683|P1|Overall Study|Protocol Violation|1
33040|NCT01427920|136682|P2|Overall Study|Lack of Efficacy|0
33041|NCT01427920|136683|P1|Overall Study|Lack of Efficacy|1
33042|NCT01427920|136682|P2|Overall Study|Adverse Event|2
33043|NCT01427920|136683|P1|Overall Study|Adverse Event|1
33044|NCT01427907|136703|P2|Overall Study|Withdrawal by Subject|4
33045|NCT01427907|136704|P1|Overall Study|Withdrawal by Subject|3
33046|NCT01427803|136712|P2|Overall Study|did not take product|0
33047|NCT01427803|136713|P1|Overall Study|did not take product|1
33048|NCT01427803|136712|P2|Overall Study|Physician Decision|0
33049|NCT01427803|136713|P1|Overall Study|Physician Decision|3
33050|NCT01427803|136712|P2|Overall Study|Protocol Violation|0
33051|NCT01427803|136713|P1|Overall Study|Protocol Violation|1
33052|NCT01427803|136712|P2|Overall Study|Unable to complete full treatment period|0
33053|NCT01427803|136713|P1|Overall Study|Unable to complete full treatment period|6
33054|NCT01427803|136712|P2|Overall Study|Withdrawal by Subject|0
33055|NCT01427803|136713|P1|Overall Study|Withdrawal by Subject|20
33056|NCT01427803|136712|P2|Overall Study|Lost to Follow-up|26
33057|NCT01427803|136713|P1|Overall Study|Lost to Follow-up|32
33058|NCT01427751|136727|P2|Overall Study|Other miscellaneous reasons|4
33059|NCT01427751|136728|P1|Overall Study|Other miscellaneous reasons|6
33060|NCT01427751|136727|P2|Overall Study|Death|0
33061|NCT01427751|136728|P1|Overall Study|Death|2
33062|NCT01427751|136727|P2|Overall Study|Protocol Violation|4
33063|NCT01427751|136728|P1|Overall Study|Protocol Violation|6
33064|NCT01427751|136727|P2|Overall Study|Withdrawal of consent|2
33065|NCT01427751|136728|P1|Overall Study|Withdrawal of consent|2
33066|NCT01427751|136727|P2|Overall Study|Lost to Follow-up|1
33067|NCT01427751|136728|P1|Overall Study|Lost to Follow-up|3
33068|NCT01427751|136727|P2|Overall Study|No further treatment benefit expected|1
33069|NCT01427751|136728|P1|Overall Study|No further treatment benefit expected|5
33070|NCT01427751|136727|P2|Overall Study|Adverse Event|2
33071|NCT01427751|136728|P1|Overall Study|Adverse Event|18
33072|NCT01427738|136748|P2|Overall Study|Lost to Follow-up|5
33073|NCT01427738|136749|P1|Overall Study|Lost to Follow-up|1
33074|NCT01427738|136748|P2|Overall Study|Subject not willing to adhere to reqs|2
33075|NCT01427738|136749|P1|Overall Study|Subject not willing to adhere to reqs|1
33076|NCT01427738|136748|P2|Overall Study|Withdrawal by Subject|2
33077|NCT01427738|136749|P1|Overall Study|Withdrawal by Subject|0
33078|NCT01427738|136748|P2|Overall Study|Subject unable to get to clinic|2
33079|NCT01427738|136749|P1|Overall Study|Subject unable to get to clinic|5
33080|NCT01427738|136748|P2|Overall Study|Severe debilitation, unable to continue|1
33081|NCT01427738|136749|P1|Overall Study|Severe debilitation, unable to continue|0
33082|NCT01427738|136748|P2|Overall Study|Death|9
33083|NCT01427738|136749|P1|Overall Study|Death|12
33084|NCT01427309|136812|P4|Overall Study|Withdrawal by Subject|55
33085|NCT01427309|136813|P3|Overall Study|Withdrawal by Subject|61
33086|NCT01427309|136814|P2|Overall Study|Withdrawal by Subject|148
33087|NCT01427309|136815|P1|Overall Study|Withdrawal by Subject|148
33088|NCT01427309|136812|P4|Overall Study|Serious adverse event|61
33089|NCT01427309|136813|P3|Overall Study|Serious adverse event|50
33090|NCT01427309|136814|P2|Overall Study|Serious adverse event|45
33091|NCT01427309|136815|P1|Overall Study|Serious adverse event|52
33092|NCT01427309|136812|P4|Overall Study|Adverse Event|1
33093|NCT01427309|136813|P3|Overall Study|Adverse Event|3
33094|NCT01427309|136814|P2|Overall Study|Adverse Event|0
33095|NCT01427309|136815|P1|Overall Study|Adverse Event|0
33096|NCT01427309|136812|P4|Overall Study|Protocol Violation|124
33097|NCT01427309|136813|P3|Overall Study|Protocol Violation|125
33098|NCT01427309|136814|P2|Overall Study|Protocol Violation|69
33099|NCT01427309|136815|P1|Overall Study|Protocol Violation|42
33100|NCT01427309|136812|P4|Overall Study|Lost to Follow-up|135
33101|NCT01427309|136813|P3|Overall Study|Lost to Follow-up|122
33102|NCT01427309|136814|P2|Overall Study|Lost to Follow-up|145
33103|NCT01427309|136815|P1|Overall Study|Lost to Follow-up|130
33104|NCT01426958|136853|P1|Overall Study|Adverse Event|2
33105|NCT01426854|136882|P2|Overall Study|Other|2
33106|NCT01426854|136883|P1|Overall Study|Other|3
33107|NCT01426854|136882|P2|Overall Study|Protocol Deviation|1
33108|NCT01426854|136883|P1|Overall Study|Protocol Deviation|0
33109|NCT01426854|136882|P2|Overall Study|Treatment Failure|16
33110|NCT01426854|136883|P1|Overall Study|Treatment Failure|0
33111|NCT01426854|136882|P2|Overall Study|Noncompliance|1
33112|NCT01426854|136883|P1|Overall Study|Noncompliance|0
33113|NCT01426854|136882|P2|Overall Study|Lost to Follow-up|0
33114|NCT01426854|136883|P1|Overall Study|Lost to Follow-up|3
33115|NCT01426854|136882|P2|Overall Study|Subject Decision Unrelated to AE|6
33116|NCT01426854|136883|P1|Overall Study|Subject Decision Unrelated to AE|5
33117|NCT01426854|136882|P2|Overall Study|Adverse Event|5
33118|NCT01426854|136883|P1|Overall Study|Adverse Event|1
33119|NCT01426789|136893|P6|Part 2|Adverse Event|0
33120|NCT01426789|136894|P5|Part 2|Adverse Event|1
33121|NCT01426789|136895|P4|Part 2|Adverse Event|0
33122|NCT01426789|136896|P3|Part 2|Adverse Event|2
33123|NCT01426789|136897|P2|Part 2|Adverse Event|0
33124|NCT01426789|136898|P1|Part 2|Adverse Event|0
33125|NCT01426789|136893|P6|Part 2|Lack of Efficacy|0
33126|NCT01426789|136894|P5|Part 2|Lack of Efficacy|2
33127|NCT01426789|136895|P4|Part 2|Lack of Efficacy|0
33128|NCT01426789|136896|P3|Part 2|Lack of Efficacy|5
33129|NCT01426789|136897|P2|Part 2|Lack of Efficacy|0
33130|NCT01426789|136898|P1|Part 2|Lack of Efficacy|0
33131|NCT01426789|136893|P6|Part 2|Withdrawal by Subject|0
33132|NCT01426789|136894|P5|Part 2|Withdrawal by Subject|2
33133|NCT01426789|136895|P4|Part 2|Withdrawal by Subject|1
33134|NCT01426789|136896|P3|Part 2|Withdrawal by Subject|0
33135|NCT01426789|136897|P2|Part 2|Withdrawal by Subject|0
33136|NCT01426789|136898|P1|Part 2|Withdrawal by Subject|0
33137|NCT01426789|136893|P6|Part 2|Lost to Follow-up|0
33138|NCT01426789|136894|P5|Part 2|Lost to Follow-up|1
33139|NCT01426789|136895|P4|Part 2|Lost to Follow-up|0
33140|NCT01426789|136896|P3|Part 2|Lost to Follow-up|4
33141|NCT01426789|136897|P2|Part 2|Lost to Follow-up|0
33142|NCT01426789|136898|P1|Part 2|Lost to Follow-up|0
33143|NCT01426789|136893|P6|Part 2|Administrative problems|0
33144|NCT01426789|136894|P5|Part 2|Administrative problems|1
33145|NCT01426789|136895|P4|Part 2|Administrative problems|0
33146|NCT01426789|136896|P3|Part 2|Administrative problems|2
33147|NCT01426789|136897|P2|Part 2|Administrative problems|0
33148|NCT01426789|136898|P1|Part 2|Administrative problems|0
33149|NCT01426789|136893|P6|Part 2|Death|0
33150|NCT01426789|136894|P5|Part 2|Death|1
33151|NCT01426789|136895|P4|Part 2|Death|0
33152|NCT01426789|136896|P3|Part 2|Death|1
33153|NCT01426789|136897|P2|Part 2|Death|0
33154|NCT01426789|136898|P1|Part 2|Death|0
33155|NCT01426789|136893|P6|Part 2|Protocol deviation|0
33156|NCT01426789|136894|P5|Part 2|Protocol deviation|0
33157|NCT01426789|136895|P4|Part 2|Protocol deviation|0
33158|NCT01426789|136896|P3|Part 2|Protocol deviation|1
33159|NCT01426789|136897|P2|Part 2|Protocol deviation|0
33160|NCT01426789|136898|P1|Part 2|Protocol deviation|0
33161|NCT01426789|136893|P6|Part 1|Adverse Event|0
33162|NCT01426789|136894|P5|Part 1|Adverse Event|0
33163|NCT01426789|136895|P4|Part 1|Adverse Event|0
33164|NCT01426789|136896|P3|Part 1|Adverse Event|0
33165|NCT01426789|136897|P2|Part 1|Adverse Event|0
33166|NCT01426789|136898|P1|Part 1|Adverse Event|3
33167|NCT01426789|136893|P6|Part 1|Lack of Efficacy|0
33168|NCT01426789|136894|P5|Part 1|Lack of Efficacy|0
33169|NCT01426789|136895|P4|Part 1|Lack of Efficacy|0
33170|NCT01426789|136896|P3|Part 1|Lack of Efficacy|0
33171|NCT01426789|136897|P2|Part 1|Lack of Efficacy|1
33172|NCT01426789|136898|P1|Part 1|Lack of Efficacy|2
33173|NCT01426789|136893|P6|Part 1|Lost to Follow-up|0
33174|NCT01426789|136894|P5|Part 1|Lost to Follow-up|0
33175|NCT01426789|136895|P4|Part 1|Lost to Follow-up|0
33176|NCT01426789|136896|P3|Part 1|Lost to Follow-up|0
33177|NCT01426789|136897|P2|Part 1|Lost to Follow-up|2
33178|NCT01426789|136898|P1|Part 1|Lost to Follow-up|1
33179|NCT01426789|136893|P6|Part 1|Protocol deviation|0
33180|NCT01426789|136894|P5|Part 1|Protocol deviation|0
33181|NCT01426789|136895|P4|Part 1|Protocol deviation|0
33182|NCT01426789|136896|P3|Part 1|Protocol deviation|0
33183|NCT01426789|136897|P2|Part 1|Protocol deviation|1
33184|NCT01426789|136898|P1|Part 1|Protocol deviation|0
33185|NCT01426438|136943|P2|Overall Study|Missed Scan|2
33186|NCT01426438|136944|P1|Overall Study|Missed Scan|2
33187|NCT01426438|136943|P2|Overall Study|Poor scan quality|2
33188|NCT01426438|136944|P1|Overall Study|Poor scan quality|3
33189|NCT01426438|136943|P2|Overall Study|Off study Treatment|3
33190|NCT01426438|136944|P1|Overall Study|Off study Treatment|9
33191|NCT01426438|136943|P2|Overall Study|Lost to Follow-up|3
33192|NCT01426438|136944|P1|Overall Study|Lost to Follow-up|1
33193|NCT01426373|136976|P1|Overall Study|Miscellaneous Reasons|4
33194|NCT01426373|136976|P1|Overall Study|Participant Convenience|10
33195|NCT01426373|136976|P1|Overall Study|Lost to Follow-up|14
33196|NCT01426373|136976|P1|Overall Study|Adverse Event|6
33197|NCT01426269|137007|P3|Period 2: 40 Weeks|Relapsed|18
33198|NCT01426269|137008|P2|Period 2: 40 Weeks|Relapsed|9
33199|NCT01426269|137009|P1|Period 2: 40 Weeks|Relapsed|0
33200|NCT01426269|137007|P3|Period 2: 40 Weeks|Site closed|5
33201|NCT01426269|137008|P2|Period 2: 40 Weeks|Site closed|6
33202|NCT01426269|137009|P1|Period 2: 40 Weeks|Site closed|0
33203|NCT01426269|137007|P3|Period 2: 40 Weeks|Lost to Follow-up|6
33204|NCT01426269|137008|P2|Period 2: 40 Weeks|Lost to Follow-up|8
33205|NCT01426269|137009|P1|Period 2: 40 Weeks|Lost to Follow-up|0
33206|NCT01426269|137007|P3|Period 2: 40 Weeks|Protocol Violation|5
33207|NCT01426269|137008|P2|Period 2: 40 Weeks|Protocol Violation|5
33208|NCT01426269|137009|P1|Period 2: 40 Weeks|Protocol Violation|0
33209|NCT01426269|137007|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
33210|NCT01426269|137008|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
33211|NCT01426269|137009|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
33212|NCT01426269|137007|P3|Period 2: 40 Weeks|Adverse Event|2
33213|NCT01426269|137008|P2|Period 2: 40 Weeks|Adverse Event|1
33214|NCT01426269|137009|P1|Period 2: 40 Weeks|Adverse Event|0
33215|NCT01426269|137007|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
33216|NCT01426269|137008|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
33217|NCT01426269|137009|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
33218|NCT01426269|137007|P3|Eligibility for Period 2, Randomization|Did not qualify|0
33219|NCT01426269|137008|P2|Eligibility for Period 2, Randomization|Did not qualify|0
33220|NCT01426269|137009|P1|Eligibility for Period 2, Randomization|Did not qualify|42
33221|NCT01426269|137007|P3|Period 1: 12 Weeks|Pregnancy|0
33222|NCT01426269|137008|P2|Period 1: 12 Weeks|Pregnancy|0
33223|NCT01426269|137009|P1|Period 1: 12 Weeks|Pregnancy|1
33224|NCT01426269|137007|P3|Period 1: 12 Weeks|Lost to Follow-up|0
33225|NCT01426269|137008|P2|Period 1: 12 Weeks|Lost to Follow-up|0
33226|NCT01426269|137009|P1|Period 1: 12 Weeks|Lost to Follow-up|22
33227|NCT01426269|137007|P3|Period 1: 12 Weeks|Protocol Violation|0
33228|NCT01426269|137008|P2|Period 1: 12 Weeks|Protocol Violation|0
33229|NCT01426269|137009|P1|Period 1: 12 Weeks|Protocol Violation|5
33230|NCT01426269|137007|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
33231|NCT01426269|137008|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
33232|NCT01426269|137009|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
33233|NCT01426269|137007|P3|Period 1: 12 Weeks|Adverse Event|0
33234|NCT01426269|137008|P2|Period 1: 12 Weeks|Adverse Event|0
33235|NCT01426269|137009|P1|Period 1: 12 Weeks|Adverse Event|5
33236|NCT01426113|137044|P2|Overall Study|Adverse Event|1
33237|NCT01426113|137045|P1|Overall Study|Adverse Event|0
33238|NCT01426113|137044|P2|Overall Study|Study Discontinued|1
33239|NCT01426113|137045|P1|Overall Study|Study Discontinued|1
33240|NCT01425749|137093|P2|Overall Study|progression of melanoma|1
33241|NCT01425749|137094|P1|Overall Study|progression of melanoma|0
33242|NCT01425632|137112|P3|Overall Study|Withdrawal by Subject|1
33243|NCT01425632|137113|P2|Overall Study|Withdrawal by Subject|0
33244|NCT01425632|137114|P1|Overall Study|Withdrawal by Subject|0
33245|NCT01425632|137112|P3|Overall Study|Protocol Violation|2
33246|NCT01425632|137113|P2|Overall Study|Protocol Violation|0
33247|NCT01425632|137114|P1|Overall Study|Protocol Violation|0
33248|NCT01425632|137112|P3|Overall Study|Physician Decision|0
33249|NCT01425632|137113|P2|Overall Study|Physician Decision|0
33250|NCT01425632|137114|P1|Overall Study|Physician Decision|1
33251|NCT01425632|137112|P3|Overall Study|Adverse Event|1
33252|NCT01425632|137113|P2|Overall Study|Adverse Event|1
33253|NCT01425632|137114|P1|Overall Study|Adverse Event|0
33254|NCT01425528|137124|P2|Overall Study|Withdrawal by Subject|1
33255|NCT01425528|137125|P1|Overall Study|Withdrawal by Subject|1
33256|NCT01425463|137133|P2|Overall Study|Unknown Reason|7
33257|NCT01425463|137134|P1|Overall Study|Unknown Reason|4
33258|NCT01425463|137133|P2|Overall Study|Withdrawal by Subject|5
33259|NCT01425463|137134|P1|Overall Study|Withdrawal by Subject|7
33260|NCT01425463|137133|P2|Overall Study|Lost to Follow-up|2
33261|NCT01425463|137134|P1|Overall Study|Lost to Follow-up|5
33262|NCT01425463|137133|P2|Overall Study|Protocol Violation|2
33263|NCT01425463|137134|P1|Overall Study|Protocol Violation|2
33264|NCT01425463|137133|P2|Overall Study|Lack of Efficacy|1
33265|NCT01425463|137134|P1|Overall Study|Lack of Efficacy|1
33266|NCT01425463|137133|P2|Overall Study|Adverse Event|7
33267|NCT01425463|137134|P1|Overall Study|Adverse Event|5
33268|NCT01425359|137150|P2|Overall Study|Did Not Meet Qualifying Criteria|5
33269|NCT01425359|137151|P1|Overall Study|Did Not Meet Qualifying Criteria|3
33270|NCT01425359|137150|P2|Overall Study|Investigator’s Discretion|0
33271|NCT01425359|137151|P1|Overall Study|Investigator’s Discretion|2
33272|NCT01425359|137150|P2|Overall Study|Subject Withdrew Consent|2
33273|NCT01425359|137151|P1|Overall Study|Subject Withdrew Consent|1
33274|NCT01425359|137150|P2|Overall Study|Protocol Violation|2
33275|NCT01425359|137151|P1|Overall Study|Protocol Violation|1
33276|NCT01425359|137150|P2|Overall Study|Unsatisfactory Response|0
33277|NCT01425359|137151|P1|Overall Study|Unsatisfactory Response|1
33278|NCT01425359|137150|P2|Overall Study|Death|1
33279|NCT01425359|137151|P1|Overall Study|Death|0
33280|NCT01425359|137150|P2|Overall Study|Revascularization|1
33281|NCT01425359|137151|P1|Overall Study|Revascularization|0
33282|NCT01425359|137150|P2|Overall Study|Adverse Event|8
33283|NCT01425359|137151|P1|Overall Study|Adverse Event|9
33284|NCT01425359|137150|P2|Overall Study|Randomized but Not Treated|3
33285|NCT01425359|137151|P1|Overall Study|Randomized but Not Treated|2
33286|NCT01425203|137180|P3|Crossover Phase|Other virologic failure criteria|3
33287|NCT01425203|137181|P2|Crossover Phase|Other virologic failure criteria|0
33288|NCT01425203|137182|P1|Crossover Phase|Other virologic failure criteria|0
33289|NCT01425203|137180|P3|Crossover Phase|Failure at futility timepoint|3
33290|NCT01425203|137181|P2|Crossover Phase|Failure at futility timepoint|0
33291|NCT01425203|137182|P1|Crossover Phase|Failure at futility timepoint|0
33292|NCT01425203|137180|P3|Treatment Phase|Did not receive treatment|0
33293|NCT01425203|137181|P2|Treatment Phase|Did not receive treatment|1
33294|NCT01425203|137182|P1|Treatment Phase|Did not receive treatment|0
33295|NCT01425203|137180|P3|Treatment Phase|Unidentified reasons|0
33296|NCT01425203|137181|P2|Treatment Phase|Unidentified reasons|5
33297|NCT01425203|137182|P1|Treatment Phase|Unidentified reasons|11
33298|NCT01425203|137180|P3|Treatment Phase|Other virologic failure criteria|0
33299|NCT01425203|137181|P2|Treatment Phase|Other virologic failure criteria|3
33300|NCT01425203|137182|P1|Treatment Phase|Other virologic failure criteria|5
33301|NCT01425203|137180|P3|Treatment Phase|Failure at futility timepoint|0
33302|NCT01425203|137181|P2|Treatment Phase|Failure at futility timepoint|27
33303|NCT01425203|137182|P1|Treatment Phase|Failure at futility timepoint|8
33304|NCT01425203|137180|P3|Treatment Phase|DC during PR Lead-in Phase|0
33305|NCT01425203|137181|P2|Treatment Phase|DC during PR Lead-in Phase|1
33306|NCT01425203|137182|P1|Treatment Phase|DC during PR Lead-in Phase|3
33307|NCT01425190|137199|P3|Overall Study|Full dose not consumed.|0
33308|NCT01425190|137200|P2|Overall Study|Full dose not consumed.|0
33309|NCT01425190|137201|P1|Overall Study|Full dose not consumed.|1
33310|NCT01424930|137237|P2|Overall Study|Reason not specified|6
33311|NCT01424930|137238|P1|Overall Study|Reason not specified|0
33312|NCT01424930|137237|P2|Overall Study|Screen Failure|1
33313|NCT01424930|137238|P1|Overall Study|Screen Failure|0
33314|NCT01424930|137237|P2|Overall Study|Progressive Disease|6
33315|NCT01424930|137238|P1|Overall Study|Progressive Disease|3
33316|NCT01424930|137237|P2|Overall Study|Death|0
33317|NCT01424930|137238|P1|Overall Study|Death|1
33318|NCT01424930|137237|P2|Overall Study|Adverse Event|1
33319|NCT01424930|137238|P1|Overall Study|Adverse Event|0
33320|NCT01424813|137252|P2|Overall Study|not specified|2
33321|NCT01424813|137253|P1|Overall Study|not specified|1
33322|NCT01424813|137252|P2|Overall Study|Protocol Violation|0
33323|NCT01424813|137253|P1|Overall Study|Protocol Violation|1
33324|NCT01424813|137252|P2|Overall Study|Withdrawal by Subject|0
33325|NCT01424813|137253|P1|Overall Study|Withdrawal by Subject|3
33326|NCT01424644|137273|P2|Overall Study|Unable to Classify|0
33327|NCT01424644|137274|P1|Overall Study|Unable to Classify|1
33328|NCT01424644|137273|P2|Overall Study|Administrative Reason|0
33329|NCT01424644|137274|P1|Overall Study|Administrative Reason|1
33330|NCT01424644|137273|P2|Overall Study|Protocol Violation|3
33331|NCT01424644|137274|P1|Overall Study|Protocol Violation|4
33332|NCT01424644|137273|P2|Overall Study|Lost to Follow-up|12
33333|NCT01424644|137274|P1|Overall Study|Lost to Follow-up|16
33334|NCT01424644|137273|P2|Overall Study|Withdrawal by Subject|12
33335|NCT01424644|137274|P1|Overall Study|Withdrawal by Subject|9
33336|NCT01424644|137273|P2|Overall Study|Adverse Event|0
33337|NCT01424644|137274|P1|Overall Study|Adverse Event|2
33338|NCT01424501|137294|P6|Overall Study|Lost to Follow-up|0
33339|NCT01424501|137295|P5|Overall Study|Lost to Follow-up|0
33340|NCT01424501|137296|P4|Overall Study|Lost to Follow-up|0
33341|NCT01424501|137297|P3|Overall Study|Lost to Follow-up|1
33342|NCT01424501|137298|P2|Overall Study|Lost to Follow-up|0
33343|NCT01424501|137299|P1|Overall Study|Lost to Follow-up|0
33344|NCT01424501|137294|P6|Overall Study|Withdrawal by Subject|0
33345|NCT01424501|137295|P5|Overall Study|Withdrawal by Subject|0
33346|NCT01424501|137296|P4|Overall Study|Withdrawal by Subject|0
33347|NCT01424501|137297|P3|Overall Study|Withdrawal by Subject|1
33348|NCT01424501|137298|P2|Overall Study|Withdrawal by Subject|1
33349|NCT01424501|137299|P1|Overall Study|Withdrawal by Subject|1
33350|NCT01424228|137465|P2|Overall Study|Unplanned journey|1
33351|NCT01424228|137466|P1|Overall Study|Unplanned journey|0
33352|NCT01424228|137465|P2|Overall Study|Worsening of symptoms|0
33353|NCT01424228|137466|P1|Overall Study|Worsening of symptoms|1
33354|NCT01424228|137465|P2|Overall Study|Non-compliance|0
33355|NCT01424228|137466|P1|Overall Study|Non-compliance|2
33356|NCT01424228|137465|P2|Overall Study|inclusion/exclusion criteria not met|2
33357|NCT01424228|137466|P1|Overall Study|inclusion/exclusion criteria not met|2
33358|NCT01424228|137465|P2|Overall Study|Lack of Efficacy|7
33359|NCT01424228|137466|P1|Overall Study|Lack of Efficacy|5
33360|NCT01424228|137465|P2|Overall Study|Sponsor's decision|12
33361|NCT01424228|137466|P1|Overall Study|Sponsor's decision|9
33362|NCT01424228|137465|P2|Overall Study|Adverse Event|14
33363|NCT01424228|137466|P1|Overall Study|Adverse Event|10
33364|NCT01424228|137465|P2|Overall Study|Withdrawal by Subject|11
33365|NCT01424228|137466|P1|Overall Study|Withdrawal by Subject|27
33366|NCT01423916|137533|P3|Overall Study|Protocol Deviation|0
33367|NCT01423916|137534|P2|Overall Study|Protocol Deviation|0
33368|NCT01423916|137535|P1|Overall Study|Protocol Deviation|1
33369|NCT01423916|137533|P3|Overall Study|Withdrawal by Subject|3
33370|NCT01423916|137534|P2|Overall Study|Withdrawal by Subject|10
33371|NCT01423916|137535|P1|Overall Study|Withdrawal by Subject|3
33372|NCT01423916|137533|P3|Overall Study|Physician Decision|1
33373|NCT01423916|137534|P2|Overall Study|Physician Decision|0
33374|NCT01423916|137535|P1|Overall Study|Physician Decision|1
33375|NCT01423916|137533|P3|Overall Study|Met Withdrawal Criteria|1
33376|NCT01423916|137534|P2|Overall Study|Met Withdrawal Criteria|1
33377|NCT01423916|137535|P1|Overall Study|Met Withdrawal Criteria|1
33378|NCT01423916|137533|P3|Overall Study|Adverse Event|2
33379|NCT01423916|137534|P2|Overall Study|Adverse Event|9
33380|NCT01423916|137535|P1|Overall Study|Adverse Event|5
33381|NCT01423617|137609|P2|Overall Study|Lost to Follow-up|1
33382|NCT01423617|137610|P1|Overall Study|Lost to Follow-up|0
33383|NCT01423604|137627|P2|Randomized|Patient decision|9
33384|NCT01423604|137628|P1|Randomized|Patient decision|5
33385|NCT01423604|137627|P2|Randomized|Other - unspecified|31
33386|NCT01423604|137628|P1|Randomized|Other - unspecified|37
33387|NCT01423604|137627|P2|Randomized|Physician Decision|13
33388|NCT01423604|137628|P1|Randomized|Physician Decision|16
33389|NCT01423604|137627|P2|Randomized|Death|0
33390|NCT01423604|137628|P1|Randomized|Death|1
33391|NCT01423604|137627|P2|Randomized|Adverse Event|10
33392|NCT01423604|137628|P1|Randomized|Adverse Event|4
33393|NCT01423604|137627|P2|Safety Run-In|Patient decision|0
33394|NCT01423604|137628|P1|Safety Run-In|Patient decision|1
33395|NCT01423604|137627|P2|Safety Run-In|Disease progression|0
33396|NCT01423604|137628|P1|Safety Run-In|Disease progression|3
33397|NCT01423604|137627|P2|Safety Run-In|Physician Decision|0
33398|NCT01423604|137628|P1|Safety Run-In|Physician Decision|1
33399|NCT01423604|137627|P2|Safety Run-In|Death|0
33400|NCT01423604|137628|P1|Safety Run-In|Death|1
33401|NCT01423604|137627|P2|Safety Run-In|Adverse Event|0
33402|NCT01423604|137628|P1|Safety Run-In|Adverse Event|3
33403|NCT01423253|137643|P1|Overall Study|Withdrawal by Subject|2
33404|NCT01423253|137643|P1|Overall Study|Protocol Violation|2
33405|NCT01423253|137643|P1|Overall Study|Lost to Follow-up|1
33406|NCT01423253|137643|P1|Overall Study|Lack of Efficacy|2
33407|NCT01423253|137643|P1|Overall Study|Adverse Event|2
33408|NCT01423084|137665|P2|Overall Study|Withdrawal by Subject|3
33409|NCT01423084|137666|P1|Overall Study|Withdrawal by Subject|2
33410|NCT01423084|137665|P2|Overall Study|Adverse Event|1
33411|NCT01423084|137666|P1|Overall Study|Adverse Event|0
33412|NCT01422889|137696|P1|Overall Study|No Data Entered for Study Stent|9
33413|NCT01422876|137711|P10|Week 52|Death|0
33414|NCT01422876|137712|P9|Week 52|Death|1
33415|NCT01422876|137713|P8|Week 52|Death|3
33416|NCT01422876|137714|P7|Week 52|Death|1
33417|NCT01422876|137715|P6|Week 52|Death|0
33418|NCT01422876|137716|P5|Week 52|Death|0
33419|NCT01422876|137717|P4|Week 52|Death|1
33420|NCT01422876|137718|P3|Week 52|Death|0
33421|NCT01422876|137719|P2|Week 52|Death|1
33422|NCT01422876|137720|P1|Week 52|Death|0
33423|NCT01422876|137711|P10|Week 52|Consent withdrawn|9
33424|NCT01422876|137712|P9|Week 52|Consent withdrawn|13
33425|NCT01422876|137713|P8|Week 52|Consent withdrawn|12
33426|NCT01422876|137714|P7|Week 52|Consent withdrawn|10
33427|NCT01422876|137715|P6|Week 52|Consent withdrawn|12
33428|NCT01422876|137716|P5|Week 52|Consent withdrawn|7
33429|NCT01422876|137717|P4|Week 52|Consent withdrawn|12
33430|NCT01422876|137718|P3|Week 52|Consent withdrawn|6
33431|NCT01422876|137719|P2|Week 52|Consent withdrawn|4
33432|NCT01422876|137720|P1|Week 52|Consent withdrawn|9
33433|NCT01422876|137711|P10|Week 52|Lost to Follow-up|8
33434|NCT01422876|137712|P9|Week 52|Lost to Follow-up|7
33435|NCT01422876|137713|P8|Week 52|Lost to Follow-up|8
33436|NCT01422876|137714|P7|Week 52|Lost to Follow-up|5
33437|NCT01422876|137715|P6|Week 52|Lost to Follow-up|5
33438|NCT01422876|137716|P5|Week 52|Lost to Follow-up|8
33439|NCT01422876|137717|P4|Week 52|Lost to Follow-up|5
33440|NCT01422876|137718|P3|Week 52|Lost to Follow-up|7
33441|NCT01422876|137719|P2|Week 52|Lost to Follow-up|5
33442|NCT01422876|137720|P1|Week 52|Lost to Follow-up|3
33443|NCT01422876|137711|P10|Week 24|Death|0
33444|NCT01422876|137712|P9|Week 24|Death|0
33445|NCT01422876|137713|P8|Week 24|Death|0
33446|NCT01422876|137714|P7|Week 24|Death|0
33447|NCT01422876|137715|P6|Week 24|Death|0
33448|NCT01422876|137716|P5|Week 24|Death|0
33449|NCT01422876|137717|P4|Week 24|Death|0
33450|NCT01422876|137718|P3|Week 24|Death|0
33451|NCT01422876|137719|P2|Week 24|Death|1
33452|NCT01422876|137720|P1|Week 24|Death|0
33453|NCT01422876|137711|P10|Week 24|Consent withdrawn|6
33454|NCT01422876|137712|P9|Week 24|Consent withdrawn|3
33455|NCT01422876|137713|P8|Week 24|Consent withdrawn|4
33456|NCT01422876|137714|P7|Week 24|Consent withdrawn|5
33457|NCT01422876|137715|P6|Week 24|Consent withdrawn|6
33458|NCT01422876|137716|P5|Week 24|Consent withdrawn|5
33459|NCT01422876|137717|P4|Week 24|Consent withdrawn|4
33460|NCT01422876|137718|P3|Week 24|Consent withdrawn|3
33461|NCT01422876|137719|P2|Week 24|Consent withdrawn|1
33462|NCT01422876|137720|P1|Week 24|Consent withdrawn|5
33463|NCT01422876|137711|P10|Week 24|Lost to Follow-up|4
33464|NCT01422876|137712|P9|Week 24|Lost to Follow-up|3
33465|NCT01422876|137713|P8|Week 24|Lost to Follow-up|3
33466|NCT01422876|137714|P7|Week 24|Lost to Follow-up|1
33467|NCT01422876|137715|P6|Week 24|Lost to Follow-up|0
33468|NCT01422876|137716|P5|Week 24|Lost to Follow-up|2
33469|NCT01422876|137717|P4|Week 24|Lost to Follow-up|4
33470|NCT01422876|137718|P3|Week 24|Lost to Follow-up|2
33471|NCT01422876|137719|P2|Week 24|Lost to Follow-up|1
33472|NCT01422876|137720|P1|Week 24|Lost to Follow-up|1
33473|NCT01422850|137767|P1|Overall Study|Physician Decision|3
33474|NCT01422824|137773|P1|Overall Study|Lost to Follow-up|37
33475|NCT01422824|137773|P1|Overall Study|Case record form not evaluated|1
33476|NCT01422720|137778|P1|Overall Study|Ineligibility|1
33477|NCT01422720|137778|P1|Overall Study|Withdrawal by Subject|4
33478|NCT01422720|137778|P1|Overall Study|Lack of Efficacy|1
33479|NCT01422720|137778|P1|Overall Study|Adverse Event|16
33480|NCT01422538|137789|P3|Overall Study|Missed visit|1
33481|NCT01422538|137790|P2|Overall Study|Missed visit|1
33482|NCT01422538|137791|P1|Overall Study|Missed visit|0
33483|NCT01422538|137789|P3|Overall Study|Lost to Follow-up|1
33484|NCT01422538|137790|P2|Overall Study|Lost to Follow-up|1
33485|NCT01422538|137791|P1|Overall Study|Lost to Follow-up|0
33486|NCT01422382|137835|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
33487|NCT01422304|137851|P2|Overall Study|Not Treated|11
33488|NCT01422304|137852|P1|Overall Study|Not Treated|3
33489|NCT01422304|137851|P2|Overall Study|Did Not Meet Protocol Eligibility|2
33490|NCT01422304|137852|P1|Overall Study|Did Not Meet Protocol Eligibility|0
33491|NCT01422304|137851|P2|Overall Study|Withdrawal by Subject|2
33492|NCT01422304|137852|P1|Overall Study|Withdrawal by Subject|4
33493|NCT01422304|137851|P2|Overall Study|Protocol Violation|0
33494|NCT01422304|137852|P1|Overall Study|Protocol Violation|1
33495|NCT01422304|137851|P2|Overall Study|Never Entered Follow-up|1
33496|NCT01422304|137852|P1|Overall Study|Never Entered Follow-up|2
33497|NCT01422304|137851|P2|Overall Study|Lost to Follow-up|20
33498|NCT01422304|137852|P1|Overall Study|Lost to Follow-up|14
33499|NCT01422304|137851|P2|Overall Study|Adverse Event|1
33500|NCT01422304|137852|P1|Overall Study|Adverse Event|0
33501|NCT01422239|137884|P2|Overall Study|Lost to Follow-up|3
33502|NCT01422239|137885|P1|Overall Study|Lost to Follow-up|4
33503|NCT01422213|137907|P3|Overall Study|Administrative or Other Reason(s)|2
33504|NCT01422213|137908|P2|Overall Study|Administrative or Other Reason(s)|4
33505|NCT01422213|137909|P1|Overall Study|Administrative or Other Reason(s)|5
33506|NCT01422213|137907|P3|Overall Study|Lost to Follow-up|5
33507|NCT01422213|137908|P2|Overall Study|Lost to Follow-up|3
33508|NCT01422213|137909|P1|Overall Study|Lost to Follow-up|3
33509|NCT01422213|137907|P3|Overall Study|Withdrawal of Consent|5
33510|NCT01422213|137908|P2|Overall Study|Withdrawal of Consent|3
33511|NCT01422213|137909|P1|Overall Study|Withdrawal of Consent|7
33512|NCT01422213|137907|P3|Overall Study|Protocol Violation|4
33513|NCT01422213|137908|P2|Overall Study|Protocol Violation|2
33514|NCT01422213|137909|P1|Overall Study|Protocol Violation|0
33515|NCT01422213|137907|P3|Overall Study|Non-compliance with study drug|0
33516|NCT01422213|137908|P2|Overall Study|Non-compliance with study drug|1
33517|NCT01422213|137909|P1|Overall Study|Non-compliance with study drug|0
33518|NCT01422213|137907|P3|Overall Study|Lack of Efficacy|2
33519|NCT01422213|137908|P2|Overall Study|Lack of Efficacy|2
33520|NCT01422213|137909|P1|Overall Study|Lack of Efficacy|10
33521|NCT01422213|137907|P3|Overall Study|Adverse Event|11
33522|NCT01422213|137908|P2|Overall Study|Adverse Event|7
33523|NCT01422213|137909|P1|Overall Study|Adverse Event|8
33524|NCT01422187|137970|P3|Overall Study|Lost to Follow-up|0
33525|NCT01422187|137971|P2|Overall Study|Lost to Follow-up|1
33526|NCT01422187|137972|P1|Overall Study|Lost to Follow-up|0
33527|NCT01422187|137970|P3|Overall Study|Personal reason|0
33528|NCT01422187|137971|P2|Overall Study|Personal reason|0
33529|NCT01422187|137972|P1|Overall Study|Personal reason|1
33530|NCT01421667|138007|P4|Overall Study|Lost to Follow-up|0
33531|NCT01421667|138008|P3|Overall Study|Lost to Follow-up|0
33532|NCT01421667|138009|P2|Overall Study|Lost to Follow-up|1
33533|NCT01421667|138010|P1|Overall Study|Lost to Follow-up|0
33534|NCT01421667|138007|P4|Overall Study|Withdrawal by Subject|1
33535|NCT01421667|138008|P3|Overall Study|Withdrawal by Subject|2
33536|NCT01421667|138009|P2|Overall Study|Withdrawal by Subject|1
33537|NCT01421667|138010|P1|Overall Study|Withdrawal by Subject|0
33538|NCT01421641|138071|P2|Overall Study|Protocol Violation|2
33539|NCT01421641|138072|P1|Overall Study|Protocol Violation|2
33540|NCT01421511|138094|P2|Overall Study|Death|1
33541|NCT01421511|138095|P1|Overall Study|Death|1
33542|NCT01421511|138094|P2|Overall Study|Withdrawal by Subject|5
33543|NCT01421511|138095|P1|Overall Study|Withdrawal by Subject|6
33544|NCT01421511|138094|P2|Overall Study|Physician Decision|1
33545|NCT01421511|138095|P1|Overall Study|Physician Decision|0
33546|NCT01421511|138094|P2|Overall Study|Randomized but didn't receive study drug|7
33547|NCT01421511|138095|P1|Overall Study|Randomized but didn't receive study drug|1
33548|NCT01421511|138094|P2|Overall Study|Lost to Follow-up|14
33549|NCT01421511|138095|P1|Overall Study|Lost to Follow-up|11
33550|NCT01421459|138134|P2|Overall Study|Withdrawal by Subject|16
33551|NCT01421459|138135|P1|Overall Study|Withdrawal by Subject|12
33552|NCT01421459|138134|P2|Overall Study|Protocol Violation|5
33553|NCT01421459|138135|P1|Overall Study|Protocol Violation|8
33554|NCT01421459|138134|P2|Overall Study|Physician Decision|9
33555|NCT01421459|138135|P1|Overall Study|Physician Decision|9
33556|NCT01421459|138134|P2|Overall Study|Lost to Follow-up|9
33557|NCT01421459|138135|P1|Overall Study|Lost to Follow-up|8
33558|NCT01421459|138134|P2|Overall Study|Lack of Efficacy|2
33559|NCT01421459|138135|P1|Overall Study|Lack of Efficacy|1
33560|NCT01421459|138134|P2|Overall Study|Death|1
33561|NCT01421459|138135|P1|Overall Study|Death|1
33562|NCT01421459|138134|P2|Overall Study|Adverse Event|10
33563|NCT01421459|138135|P1|Overall Study|Adverse Event|6
33564|NCT01421303|138173|P1|Overall Study|Withdrawal by Subject|1
33565|NCT01421303|138173|P1|Overall Study|Unspecified|7
33566|NCT01421303|138173|P1|Overall Study|Non compliance with study procedure|1
33567|NCT01421303|138173|P1|Overall Study|Lost to Follow-up|13
33568|NCT01421277|138200|P2|Overall Study|Incomplete baseline data|31
33569|NCT01421277|138201|P1|Overall Study|Incomplete baseline data|0
33570|NCT01421277|138200|P2|Overall Study|Lack of qualifying event|61
33571|NCT01421277|138201|P1|Overall Study|Lack of qualifying event|0
33572|NCT01421147|138213|P2|Extension Period|Withdrawal by Subject|3
33573|NCT01421147|138214|P1|Extension Period|Withdrawal by Subject|5
33574|NCT01421147|138213|P2|Extension Period|Physician Decision|0
33575|NCT01421147|138214|P1|Extension Period|Physician Decision|1
33576|NCT01421147|138213|P2|Extension Period|Lost to Follow-up|5
33577|NCT01421147|138214|P1|Extension Period|Lost to Follow-up|2
33578|NCT01421147|138213|P2|Extension Period|Death|1
33579|NCT01421147|138214|P1|Extension Period|Death|0
33580|NCT01421147|138213|P2|Extension Period|Adverse Event|2
33581|NCT01421147|138214|P1|Extension Period|Adverse Event|0
33582|NCT01421147|138213|P2|Treatment Period|Withdrawal by Subject|5
33583|NCT01421147|138214|P1|Treatment Period|Withdrawal by Subject|10
33584|NCT01421147|138213|P2|Treatment Period|Physician Decision|2
33585|NCT01421147|138214|P1|Treatment Period|Physician Decision|2
33586|NCT01421147|138213|P2|Treatment Period|Lost to Follow-up|1
33587|NCT01421147|138214|P1|Treatment Period|Lost to Follow-up|2
33588|NCT01421147|138213|P2|Treatment Period|Adverse Event|3
33589|NCT01421147|138214|P1|Treatment Period|Adverse Event|2
33590|NCT01421134|138246|P2|Overall Study|Lost to Follow-up|1
33591|NCT01421134|138247|P1|Overall Study|Lost to Follow-up|1
33592|NCT01421134|138246|P2|Overall Study|Administrative|1
33593|NCT01421134|138247|P1|Overall Study|Administrative|0
33594|NCT01421134|138246|P2|Overall Study|Withdrawal by Subject|1
33595|NCT01421134|138247|P1|Overall Study|Withdrawal by Subject|1
33596|NCT01421134|138246|P2|Overall Study|Protocol Violation|3
33597|NCT01421134|138247|P1|Overall Study|Protocol Violation|0
33598|NCT01421134|138246|P2|Overall Study|Lack of Efficacy|4
33599|NCT01421134|138247|P1|Overall Study|Lack of Efficacy|2
33600|NCT01421134|138246|P2|Overall Study|Adverse Event|5
33601|NCT01421134|138247|P1|Overall Study|Adverse Event|3
33602|NCT01420926|138267|P2|Overall Study|Continues on active treatment|3
33603|NCT01420926|138268|P1|Overall Study|Continues on active treatment|1
33604|NCT01420926|138267|P2|Overall Study|Physician Decision|5
33605|NCT01420926|138268|P1|Overall Study|Physician Decision|7
33606|NCT01420926|138267|P2|Overall Study|Non-protocol treatment|20
33607|NCT01420926|138268|P1|Overall Study|Non-protocol treatment|17
33608|NCT01420926|138267|P2|Overall Study|Withdrawal by Subject|16
33609|NCT01420926|138268|P1|Overall Study|Withdrawal by Subject|11
33610|NCT01420926|138267|P2|Overall Study|Death|17
33611|NCT01420926|138268|P1|Overall Study|Death|18
33612|NCT01420926|138267|P2|Overall Study|Adverse Event|4
33613|NCT01420926|138268|P1|Overall Study|Adverse Event|6
33614|NCT01420081|138314|P9|Overall Study|Ongoing at data cut off|0
33615|NCT01420081|138315|P8|Overall Study|Ongoing at data cut off|0
33616|NCT01420081|138316|P7|Overall Study|Ongoing at data cut off|0
33617|NCT01420081|138317|P6|Overall Study|Ongoing at data cut off|1
33618|NCT01420081|138318|P5|Overall Study|Ongoing at data cut off|2
33619|NCT01420081|138319|P4|Overall Study|Ongoing at data cut off|0
33620|NCT01420081|138320|P3|Overall Study|Ongoing at data cut off|0
33621|NCT01420081|138321|P2|Overall Study|Ongoing at data cut off|0
33622|NCT01420081|138322|P1|Overall Study|Ongoing at data cut off|0
33623|NCT01420081|138314|P9|Overall Study|Other Reasons|0
33624|NCT01420081|138315|P8|Overall Study|Other Reasons|0
33625|NCT01420081|138316|P7|Overall Study|Other Reasons|0
33626|NCT01420081|138317|P6|Overall Study|Other Reasons|0
33627|NCT01420081|138318|P5|Overall Study|Other Reasons|0
33628|NCT01420081|138319|P4|Overall Study|Other Reasons|0
33629|NCT01420081|138320|P3|Overall Study|Other Reasons|1
33630|NCT01420081|138321|P2|Overall Study|Other Reasons|0
33631|NCT01420081|138322|P1|Overall Study|Other Reasons|0
33632|NCT01420081|138314|P9|Overall Study|Subject Refused Futher Follow-up|0
33633|NCT01420081|138315|P8|Overall Study|Subject Refused Futher Follow-up|0
33634|NCT01420081|138316|P7|Overall Study|Subject Refused Futher Follow-up|0
33635|NCT01420081|138317|P6|Overall Study|Subject Refused Futher Follow-up|0
33636|NCT01420081|138318|P5|Overall Study|Subject Refused Futher Follow-up|1
33637|NCT01420081|138319|P4|Overall Study|Subject Refused Futher Follow-up|0
33638|NCT01420081|138320|P3|Overall Study|Subject Refused Futher Follow-up|1
33639|NCT01420081|138321|P2|Overall Study|Subject Refused Futher Follow-up|0
33640|NCT01420081|138322|P1|Overall Study|Subject Refused Futher Follow-up|0
33641|NCT01420081|138314|P9|Overall Study|Study Terminated by Sponsor|2
33642|NCT01420081|138315|P8|Overall Study|Study Terminated by Sponsor|2
33643|NCT01420081|138316|P7|Overall Study|Study Terminated by Sponsor|3
33644|NCT01420081|138317|P6|Overall Study|Study Terminated by Sponsor|6
33645|NCT01420081|138318|P5|Overall Study|Study Terminated by Sponsor|9
33646|NCT01420081|138319|P4|Overall Study|Study Terminated by Sponsor|3
33647|NCT01420081|138320|P3|Overall Study|Study Terminated by Sponsor|1
33648|NCT01420081|138321|P2|Overall Study|Study Terminated by Sponsor|1
33649|NCT01420081|138322|P1|Overall Study|Study Terminated by Sponsor|2
33650|NCT01420081|138314|P9|Overall Study|Lost to Follow-up|0
33651|NCT01420081|138315|P8|Overall Study|Lost to Follow-up|0
33652|NCT01420081|138316|P7|Overall Study|Lost to Follow-up|0
33653|NCT01420081|138317|P6|Overall Study|Lost to Follow-up|1
33654|NCT01420081|138318|P5|Overall Study|Lost to Follow-up|1
33655|NCT01420081|138319|P4|Overall Study|Lost to Follow-up|0
33656|NCT01420081|138320|P3|Overall Study|Lost to Follow-up|0
33657|NCT01420081|138321|P2|Overall Study|Lost to Follow-up|0
33658|NCT01420081|138322|P1|Overall Study|Lost to Follow-up|0
33659|NCT01420081|138314|P9|Overall Study|Death|1
33660|NCT01420081|138315|P8|Overall Study|Death|1
33661|NCT01420081|138316|P7|Overall Study|Death|0
33662|NCT01420081|138317|P6|Overall Study|Death|12
33663|NCT01420081|138318|P5|Overall Study|Death|7
33664|NCT01420081|138319|P4|Overall Study|Death|0
33665|NCT01420081|138320|P3|Overall Study|Death|8
33666|NCT01420081|138321|P2|Overall Study|Death|0
33667|NCT01420081|138322|P1|Overall Study|Death|1
33668|NCT01419769|138369|P1|Overall Study|Not evaluable due to pigtail stents|1
33669|NCT01419769|138369|P1|Overall Study|Did not receive the AXIOS stent|3
33670|NCT01419314|138390|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
33671|NCT01419314|138391|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
33672|NCT01419314|138390|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
33673|NCT01419314|138391|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
33674|NCT01419314|138390|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
33675|NCT01419314|138391|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
33676|NCT01419236|138428|P2|Overall Study|Entry Criteria Not Met|0
33677|NCT01419236|138429|P1|Overall Study|Entry Criteria Not Met|1
33678|NCT01419236|138428|P2|Overall Study|Withdrawal by Subject|4
33679|NCT01419236|138429|P1|Overall Study|Withdrawal by Subject|1
33680|NCT01419236|138428|P2|Overall Study|Physician Decision|0
33681|NCT01419236|138429|P1|Overall Study|Physician Decision|1
33682|NCT01419236|138428|P2|Overall Study|Lost to Follow-up|0
33683|NCT01419236|138429|P1|Overall Study|Lost to Follow-up|1
33684|NCT01419236|138428|P2|Overall Study|Lack of Efficacy|1
33685|NCT01419236|138429|P1|Overall Study|Lack of Efficacy|0
33686|NCT01419236|138428|P2|Overall Study|Adverse Event|0
33687|NCT01419236|138429|P1|Overall Study|Adverse Event|1
33688|NCT01419197|138453|P2|Overall Study|Lost to Follow-up|4
33689|NCT01419197|138454|P1|Overall Study|Lost to Follow-up|14
33690|NCT01419197|138453|P2|Overall Study|Reason Not Specified|1
33691|NCT01419197|138454|P1|Overall Study|Reason Not Specified|0
33692|NCT01419197|138453|P2|Overall Study|Study Completed by Sponsor|34
33693|NCT01419197|138454|P1|Overall Study|Study Completed by Sponsor|103
33694|NCT01419197|138453|P2|Overall Study|Withdrawal by Subject|32
33695|NCT01419197|138454|P1|Overall Study|Withdrawal by Subject|33
33696|NCT01419197|138453|P2|Overall Study|Non-compliance|1
33697|NCT01419197|138454|P1|Overall Study|Non-compliance|3
33698|NCT01419197|138453|P2|Overall Study|Physician Decision|4
33699|NCT01419197|138454|P1|Overall Study|Physician Decision|4
33700|NCT01419197|138453|P2|Overall Study|Death|122
33701|NCT01419197|138454|P1|Overall Study|Death|247
33702|NCT01419184|138479|P2|Overall Study|Participant randomized, not treated|0
33703|NCT01419184|138480|P1|Overall Study|Participant randomized, not treated|1
33704|NCT01419184|138479|P2|Overall Study|No IRLOS-No adverse event treatment date|1
33705|NCT01419184|138480|P1|Overall Study|No IRLOS-No adverse event treatment date|0
33706|NCT01419184|138479|P2|Overall Study|No IRLOS-non trial antibiotic used|2
33707|NCT01419184|138480|P1|Overall Study|No IRLOS-non trial antibiotic used|1
33708|NCT01419184|138479|P2|Overall Study|No IRLOS-randomized, not treated|4
33709|NCT01419184|138480|P1|Overall Study|No IRLOS-randomized, not treated|2
33710|NCT01419184|138479|P2|Overall Study|No IRLOS-No in-patient end date reported|6
33711|NCT01419184|138480|P1|Overall Study|No IRLOS-No in-patient end date reported|3
33712|NCT01419184|138479|P2|Overall Study|Site data not available|2
33713|NCT01419184|138480|P1|Overall Study|Site data not available|3
33714|NCT01418937|138518|P1|Overall Study|Withdrawal by Subject|1
33715|NCT01418937|138518|P1|Overall Study|Pregnancy|1
33716|NCT01418937|138518|P1|Overall Study|Protocol Violation|1
33717|NCT01418937|138518|P1|Overall Study|Lost to Follow-up|5
33718|NCT01418365|138543|P2|Second Intervention|Withdrawal by Subject|1
33719|NCT01418365|138544|P1|Second Intervention|Withdrawal by Subject|0
33720|NCT01418365|138543|P2|First Intervention|Non-compliance|0
33721|NCT01418365|138544|P1|First Intervention|Non-compliance|1
33722|NCT01418365|138543|P2|First Intervention|Withdrawal by Subject|1
33723|NCT01418365|138544|P1|First Intervention|Withdrawal by Subject|0
33724|NCT01418209|138555|P3|Overall Study|Did not provide hot flash diary data|3
33725|NCT01418209|138556|P2|Overall Study|Did not provide hot flash diary data|3
33726|NCT01418209|138557|P1|Overall Study|Did not provide hot flash diary data|1
33727|NCT01418209|138555|P3|Overall Study|Withdrawal by Subject|1
33728|NCT01418209|138556|P2|Overall Study|Withdrawal by Subject|0
33729|NCT01418209|138557|P1|Overall Study|Withdrawal by Subject|1
33730|NCT01417481|138611|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
33731|NCT01417481|138612|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
33732|NCT01417377|138677|P1|Overall Study|Enrolled, but not treated|1
33733|NCT01417377|138677|P1|Overall Study|Lost to Follow-up|12
33734|NCT01417195|138686|P2|Overall Study|No transfer due to elevated progesterone|0
33735|NCT01417195|138687|P1|Overall Study|No transfer due to elevated progesterone|1
33736|NCT01417195|138686|P2|Overall Study|No transfer due to risk of OHSS|0
33737|NCT01417195|138687|P1|Overall Study|No transfer due to risk of OHSS|1
33738|NCT01417195|138686|P2|Overall Study|No embryos for transfer|1
33739|NCT01417195|138687|P1|Overall Study|No embryos for transfer|0
33740|NCT01417195|138686|P2|Overall Study|Stimulation failure|0
33741|NCT01417195|138687|P1|Overall Study|Stimulation failure|1
33742|NCT01417104|138705|P2|Overall Study|Adverse Event|0
33743|NCT01417104|138706|P1|Overall Study|Adverse Event|1
33744|NCT01417104|138705|P2|Overall Study|Failure to make contact|1
33745|NCT01417104|138706|P1|Overall Study|Failure to make contact|0
33746|NCT01417104|138705|P2|Overall Study|Withdrawal by Subject|1
33747|NCT01417104|138706|P1|Overall Study|Withdrawal by Subject|5
33748|NCT01416610|138716|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
33749|NCT01416610|138716|P1|Overall Study|Lost to Follow-up|7
33750|NCT01416610|138716|P1|Overall Study|Withdrawal by Subject|13
33751|NCT01416610|138716|P1|Overall Study|No reason given|5
33752|NCT01416610|138716|P1|Overall Study|Lack of Efficacy|4
33753|NCT01416610|138716|P1|Overall Study|Adverse Event -Patient decision|3
33754|NCT01416610|138716|P1|Overall Study|Adverse Event|4
33755|NCT01416571|138730|P1|Overall Study|Lost to Follow-up|2
33756|NCT01416272|138757|P1|Overall Study|Study related complaints|1
33757|NCT01416272|138757|P1|Overall Study|Lost to Follow-up|1
33758|NCT01416272|138757|P1|Overall Study|Unacceptable distance visual acuity|2
33759|NCT01416155|138763|P1|Overall Study|Not specified|7
33760|NCT01416155|138763|P1|Overall Study|Investigator decision|8
33761|NCT01416155|138763|P1|Overall Study|Withdrawal by Subject|33
33762|NCT01416155|138763|P1|Overall Study|Positive for anti-BG00002 antibodies|2
33763|NCT01416155|138763|P1|Overall Study|Adverse Event|8
33764|NCT01416142|138770|P3|PureVision2 HD|Inability to maintain lens wear|1
33765|NCT01416142|138771|P2|PureVision2 HD|Inability to maintain lens wear|0
33766|NCT01416142|138772|P1|PureVision2 HD|Inability to maintain lens wear|0
33767|NCT01415986|138799|P1|Overall Study|Lost to Follow-up|1
33768|NCT01415921|138816|P2|Overall Study|Other|0
33769|NCT01415921|138817|P1|Overall Study|Other|2
33770|NCT01415921|138816|P2|Overall Study|Withdrawal by Subject|1
33771|NCT01415921|138817|P1|Overall Study|Withdrawal by Subject|0
33772|NCT01415921|138816|P2|Overall Study|Physician Decision|1
33773|NCT01415921|138817|P1|Overall Study|Physician Decision|1
33774|NCT01415921|138816|P2|Overall Study|Adverse Event|1
33775|NCT01415921|138817|P1|Overall Study|Adverse Event|0
33776|NCT01415908|138827|P2|Overall Study|Withdrawal by Subject|0
33777|NCT01415908|138828|P1|Overall Study|Withdrawal by Subject|1
33778|NCT01415531|138856|P2|Overall Study|Other Reasons|2
33779|NCT01415531|138857|P1|Overall Study|Other Reasons|3
33780|NCT01415531|138856|P2|Overall Study|Lack of Compliance|4
33781|NCT01415531|138857|P1|Overall Study|Lack of Compliance|1
33782|NCT01415531|138856|P2|Overall Study|Lost to Follow-up|14
33783|NCT01415531|138857|P1|Overall Study|Lost to Follow-up|6
33784|NCT01415531|138856|P2|Overall Study|Withdrawal by Subject|4
33785|NCT01415531|138857|P1|Overall Study|Withdrawal by Subject|5
33786|NCT01415531|138856|P2|Overall Study|Protocol Violation|1
33787|NCT01415531|138857|P1|Overall Study|Protocol Violation|0
33788|NCT01415531|138856|P2|Overall Study|Lack of Efficacy|2
33789|NCT01415531|138857|P1|Overall Study|Lack of Efficacy|3
33790|NCT01415531|138856|P2|Overall Study|Adverse Event|10
33791|NCT01415531|138857|P1|Overall Study|Adverse Event|7
33792|NCT01415518|138867|P2|Overall Study|Condition under Investigation Worsened|1
33793|NCT01415518|138868|P1|Overall Study|Condition under Investigation Worsened|1
33794|NCT01415518|138867|P2|Overall Study|Death|1
33795|NCT01415518|138868|P1|Overall Study|Death|1
33796|NCT01415518|138867|P2|Overall Study|Adverse Event|4
33797|NCT01415518|138868|P1|Overall Study|Adverse Event|3
33798|NCT01415518|138867|P2|Overall Study|Lost to Follow-up|5
33799|NCT01415518|138868|P1|Overall Study|Lost to Follow-up|3
33800|NCT01415518|138867|P2|Overall Study|Protocol Violation|8
33801|NCT01415518|138868|P1|Overall Study|Protocol Violation|6
33802|NCT01415518|138867|P2|Overall Study|Withdrawal by Subject|12
33803|NCT01415518|138868|P1|Overall Study|Withdrawal by Subject|2
33804|NCT01415401|138924|P1|Overall Study|Terminated by Sponsor|1
33805|NCT01415401|138924|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
33806|NCT01415401|138924|P1|Overall Study|Adverse Event|5
33807|NCT01415349|138929|P2|Treatment Period 1|Withdrawal by Subject|1
33808|NCT01415349|138930|P1|Treatment Period 1|Withdrawal by Subject|0
33809|NCT01415349|138929|P2|Treatment Period 1|Adverse Event|1
33810|NCT01415349|138930|P1|Treatment Period 1|Adverse Event|0
33811|NCT01414855|138942|P1|Overall Study|Withdrawal by Subject|1
33812|NCT01414855|138942|P1|Overall Study|Physician Decision|1
33813|NCT01414855|138942|P1|Overall Study|Other Reasons- Unspecified|1
33814|NCT01414855|138942|P1|Overall Study|Disease progression,|2
33815|NCT01414855|138942|P1|Overall Study|Adverse Event|8
33816|NCT01412983|138991|P2|1st Period|Inability to maintain wear|1
33817|NCT01412983|138992|P1|1st Period|Inability to maintain wear|0
33818|NCT01412983|138991|P2|1st Period|Unacceptable lens movement|1
33819|NCT01412983|138992|P1|1st Period|Unacceptable lens movement|0
33820|NCT01412983|138991|P2|1st Period|Positive slit lamp finding|1
33821|NCT01412983|138992|P1|1st Period|Positive slit lamp finding|0
33822|NCT01412983|138991|P2|1st Period|Ineligible|1
33823|NCT01412983|138992|P1|1st Period|Ineligible|0
33824|NCT01414205|139002|P2|Overall Study|Adverse Event|5
33825|NCT01414205|139003|P1|Overall Study|Adverse Event|2
33826|NCT01414205|139002|P2|Overall Study|Withdrew consent|0
33827|NCT01414205|139003|P1|Overall Study|Withdrew consent|1
33828|NCT01414205|139002|P2|Overall Study|Death|1
33829|NCT01414205|139003|P1|Overall Study|Death|1
33830|NCT01414166|139066|P2|Overall Study|Withdrawal by Subject|5
33831|NCT01414166|139067|P1|Overall Study|Withdrawal by Subject|3
33832|NCT01414166|139066|P2|Overall Study|Study terminated by Sponsor|75
33833|NCT01414166|139067|P1|Overall Study|Study terminated by Sponsor|68
33834|NCT01414166|139066|P2|Overall Study|Protocol Violation|0
33835|NCT01414166|139067|P1|Overall Study|Protocol Violation|2
33836|NCT01414166|139066|P2|Overall Study|Physician Decision|0
33837|NCT01414166|139067|P1|Overall Study|Physician Decision|2
33838|NCT01414166|139066|P2|Overall Study|Non-compliance with study drug|0
33839|NCT01414166|139067|P1|Overall Study|Non-compliance with study drug|2
33840|NCT01414166|139066|P2|Overall Study|Lost to Follow-up|1
33841|NCT01414166|139067|P1|Overall Study|Lost to Follow-up|4
33842|NCT01414166|139066|P2|Overall Study|Adverse Event|2
33843|NCT01414166|139067|P1|Overall Study|Adverse Event|10
33844|NCT01413958|139145|P2|Overall Study|Lost to Follow-up|1
33845|NCT01413958|139146|P1|Overall Study|Lost to Follow-up|0
33846|NCT01413542|139197|P4|Overall Study|Adverse Event|1
33847|NCT01413542|139198|P3|Overall Study|Adverse Event|0
33848|NCT01413542|139199|P2|Overall Study|Adverse Event|0
33849|NCT01413542|139200|P1|Overall Study|Adverse Event|0
33850|NCT01413542|139197|P4|Overall Study|Physician Decision|0
33851|NCT01413542|139198|P3|Overall Study|Physician Decision|3
33852|NCT01413542|139199|P2|Overall Study|Physician Decision|0
33853|NCT01413542|139200|P1|Overall Study|Physician Decision|1
33854|NCT01413360|139222|P1|Overall Study|Adverse Event|1
33855|NCT01413360|139222|P1|Overall Study|Lost to Follow-up|2
33856|NCT01413204|139230|P3|Overall Study|Fasting plasma glucose level increased|10
33857|NCT01413204|139231|P2|Overall Study|Fasting plasma glucose level increased|0
33858|NCT01413204|139232|P1|Overall Study|Fasting plasma glucose level increased|1
33859|NCT01413204|139230|P3|Overall Study|Clearly not eligible for the study|1
33860|NCT01413204|139231|P2|Overall Study|Clearly not eligible for the study|0
33861|NCT01413204|139232|P1|Overall Study|Clearly not eligible for the study|0
33862|NCT01413204|139230|P3|Overall Study|Withdrawal by Subject|4
33863|NCT01413204|139231|P2|Overall Study|Withdrawal by Subject|4
33864|NCT01413204|139232|P1|Overall Study|Withdrawal by Subject|1
33865|NCT01413204|139230|P3|Overall Study|Physician Decision|2
33866|NCT01413204|139231|P2|Overall Study|Physician Decision|0
33867|NCT01413204|139232|P1|Overall Study|Physician Decision|3
33868|NCT01413204|139230|P3|Overall Study|Adverse Event|2
33869|NCT01413204|139231|P2|Overall Study|Adverse Event|2
33870|NCT01413204|139232|P1|Overall Study|Adverse Event|1
33871|NCT01413191|139240|P1|Overall Study|Death|1
33872|NCT01413191|139240|P1|Overall Study|Disease Progression|5
33873|NCT01413191|139240|P1|Overall Study|Lost to Follow-up|5
33874|NCT01412957|139246|P2|Overall Study|Death|133
33875|NCT01412957|139247|P1|Overall Study|Death|136
33876|NCT01412957|139246|P2|Overall Study|Lost to Follow-up|2
33877|NCT01412957|139247|P1|Overall Study|Lost to Follow-up|7
33878|NCT01412957|139246|P2|Overall Study|Withdrawal by Subject|22
33879|NCT01412957|139247|P1|Overall Study|Withdrawal by Subject|6
33880|NCT01412944|139269|P6|Entire: IV + Maintenance|Adverse Event|0
33881|NCT01412944|139270|P5|Entire: IV + Maintenance|Adverse Event|0
33882|NCT01412944|139271|P4|Entire: IV + Maintenance|Adverse Event|0
33883|NCT01412944|139272|P3|Entire: IV + Maintenance|Adverse Event|0
33884|NCT01412944|139273|P2|Entire: IV + Maintenance|Adverse Event|1
33885|NCT01412944|139274|P1|Entire: IV + Maintenance|Adverse Event|0
33886|NCT01412944|139269|P6|Entire: IV + Maintenance|Lack of Efficacy|0
33887|NCT01412944|139270|P5|Entire: IV + Maintenance|Lack of Efficacy|0
33888|NCT01412944|139271|P4|Entire: IV + Maintenance|Lack of Efficacy|0
33889|NCT01412944|139272|P3|Entire: IV + Maintenance|Lack of Efficacy|0
33890|NCT01412944|139273|P2|Entire: IV + Maintenance|Lack of Efficacy|1
33891|NCT01412944|139274|P1|Entire: IV + Maintenance|Lack of Efficacy|0
33892|NCT01412944|139269|P6|Entire: IV + Maintenance|Lost to Follow-up|0
33893|NCT01412944|139270|P5|Entire: IV + Maintenance|Lost to Follow-up|0
33894|NCT01412944|139271|P4|Entire: IV + Maintenance|Lost to Follow-up|0
33895|NCT01412944|139272|P3|Entire: IV + Maintenance|Lost to Follow-up|0
33896|NCT01412944|139273|P2|Entire: IV + Maintenance|Lost to Follow-up|1
33897|NCT01412944|139274|P1|Entire: IV + Maintenance|Lost to Follow-up|0
33898|NCT01412944|139269|P6|Entire: IV + Maintenance|Protocol deviation|0
33899|NCT01412944|139270|P5|Entire: IV + Maintenance|Protocol deviation|0
33900|NCT01412944|139271|P4|Entire: IV + Maintenance|Protocol deviation|0
33901|NCT01412944|139272|P3|Entire: IV + Maintenance|Protocol deviation|0
33902|NCT01412944|139273|P2|Entire: IV + Maintenance|Protocol deviation|1
33903|NCT01412944|139274|P1|Entire: IV + Maintenance|Protocol deviation|0
33904|NCT01412944|139269|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
33905|NCT01412944|139270|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
33906|NCT01412944|139271|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
33907|NCT01412944|139272|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
33908|NCT01412944|139273|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
33909|NCT01412944|139274|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
33910|NCT01412944|139269|P6|Entire: IV + Maintenance|Lack of Efficacy|0
33911|NCT01412944|139270|P5|Entire: IV + Maintenance|Lack of Efficacy|1
33912|NCT01412944|139271|P4|Entire: IV + Maintenance|Lack of Efficacy|0
33913|NCT01412944|139272|P3|Entire: IV + Maintenance|Lack of Efficacy|0
33914|NCT01412944|139273|P2|Entire: IV + Maintenance|Lack of Efficacy|0
33915|NCT01412944|139274|P1|Entire: IV + Maintenance|Lack of Efficacy|0
33916|NCT01412944|139269|P6|Entire: IV + Maintenance|Lost to Follow-up|1
33917|NCT01412944|139270|P5|Entire: IV + Maintenance|Lost to Follow-up|0
33918|NCT01412944|139271|P4|Entire: IV + Maintenance|Lost to Follow-up|0
33919|NCT01412944|139272|P3|Entire: IV + Maintenance|Lost to Follow-up|0
33920|NCT01412944|139273|P2|Entire: IV + Maintenance|Lost to Follow-up|0
33921|NCT01412944|139274|P1|Entire: IV + Maintenance|Lost to Follow-up|0
33922|NCT01412944|139269|P6|Entire: IV + Maintenance|Protocol deviation|1
33923|NCT01412944|139270|P5|Entire: IV + Maintenance|Protocol deviation|0
33924|NCT01412944|139271|P4|Entire: IV + Maintenance|Protocol deviation|0
33925|NCT01412944|139272|P3|Entire: IV + Maintenance|Protocol deviation|0
33926|NCT01412944|139273|P2|Entire: IV + Maintenance|Protocol deviation|0
33927|NCT01412944|139274|P1|Entire: IV + Maintenance|Protocol deviation|0
33928|NCT01412944|139269|P6|Entire: IV + Maintenance|Adverse Event|0
33929|NCT01412944|139270|P5|Entire: IV + Maintenance|Adverse Event|1
33930|NCT01412944|139271|P4|Entire: IV + Maintenance|Adverse Event|0
33931|NCT01412944|139272|P3|Entire: IV + Maintenance|Adverse Event|0
33932|NCT01412944|139273|P2|Entire: IV + Maintenance|Adverse Event|0
33933|NCT01412944|139274|P1|Entire: IV + Maintenance|Adverse Event|0
33934|NCT01412944|139269|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
33935|NCT01412944|139270|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
33936|NCT01412944|139271|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
33937|NCT01412944|139272|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
33938|NCT01412944|139273|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
33939|NCT01412944|139274|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
33940|NCT01412944|139269|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
33941|NCT01412944|139270|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
33942|NCT01412944|139271|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
33943|NCT01412944|139272|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
33944|NCT01412944|139273|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
33945|NCT01412944|139274|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
33946|NCT01412944|139269|P6|IV: Per CAIN457A2307|Protocol deviation|0
33947|NCT01412944|139270|P5|IV: Per CAIN457A2307|Protocol deviation|0
33948|NCT01412944|139271|P4|IV: Per CAIN457A2307|Protocol deviation|0
33949|NCT01412944|139272|P3|IV: Per CAIN457A2307|Protocol deviation|0
33950|NCT01412944|139273|P2|IV: Per CAIN457A2307|Protocol deviation|1
33951|NCT01412944|139274|P1|IV: Per CAIN457A2307|Protocol deviation|0
33952|NCT01412944|139269|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
33953|NCT01412944|139270|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
33954|NCT01412944|139271|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
33955|NCT01412944|139272|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
33956|NCT01412944|139273|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
33957|NCT01412944|139274|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
33958|NCT01412944|139269|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
33959|NCT01412944|139270|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
33960|NCT01412944|139271|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
33961|NCT01412944|139272|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
33962|NCT01412944|139273|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
33963|NCT01412944|139274|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
33964|NCT01412944|139269|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
33965|NCT01412944|139270|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
33966|NCT01412944|139271|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
33967|NCT01412944|139272|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
33968|NCT01412944|139273|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
33969|NCT01412944|139274|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
33970|NCT01412944|139269|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
33971|NCT01412944|139270|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
33972|NCT01412944|139271|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
33973|NCT01412944|139272|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
33974|NCT01412944|139273|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
33975|NCT01412944|139274|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
33976|NCT01412801|139324|P6|Overall Study|Relocated to another area|0
33977|NCT01412801|139325|P5|Overall Study|Relocated to another area|0
33978|NCT01412801|139326|P4|Overall Study|Relocated to another area|0
33979|NCT01412801|139327|P3|Overall Study|Relocated to another area|2
33980|NCT01412801|139328|P2|Overall Study|Relocated to another area|0
33981|NCT01412801|139329|P1|Overall Study|Relocated to another area|0
33982|NCT01412801|139324|P6|Overall Study|Withdrawal by Subject|0
33983|NCT01412801|139325|P5|Overall Study|Withdrawal by Subject|0
33984|NCT01412801|139326|P4|Overall Study|Withdrawal by Subject|0
33985|NCT01412801|139327|P3|Overall Study|Withdrawal by Subject|1
33986|NCT01412801|139328|P2|Overall Study|Withdrawal by Subject|2
33987|NCT01412801|139329|P1|Overall Study|Withdrawal by Subject|3
33988|NCT01412801|139324|P6|Overall Study|Lost to Follow-up|1
33989|NCT01412801|139325|P5|Overall Study|Lost to Follow-up|1
33990|NCT01412801|139326|P4|Overall Study|Lost to Follow-up|0
33991|NCT01412801|139327|P3|Overall Study|Lost to Follow-up|4
33992|NCT01412801|139328|P2|Overall Study|Lost to Follow-up|2
33993|NCT01412801|139329|P1|Overall Study|Lost to Follow-up|1
33994|NCT01412801|139324|P6|Overall Study|Death|2
33995|NCT01412801|139325|P5|Overall Study|Death|2
33996|NCT01412801|139326|P4|Overall Study|Death|4
33997|NCT01412801|139327|P3|Overall Study|Death|0
33998|NCT01412801|139328|P2|Overall Study|Death|1
33999|NCT01412801|139329|P1|Overall Study|Death|0
34000|NCT01412424|139477|P1|Extension Treatment Period|Patient Request|2
34001|NCT01412424|139477|P1|Extension Treatment Period|Treatment Failure|2
34002|NCT01412424|139477|P1|Extension Treatment Period|Adverse Event|2
34003|NCT01412424|139477|P1|Core Treatment Period|Sponsor Request|1
34004|NCT01412424|139477|P1|Core Treatment Period|Lost to Follow-up|2
34005|NCT01412424|139477|P1|Core Treatment Period|Patient Request|5
34006|NCT01412424|139477|P1|Core Treatment Period|Adverse Event|21
34007|NCT01412424|139477|P1|Core Treatment Period|Treatment Failure|24
34008|NCT01412151|139526|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
34009|NCT01412151|139526|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
34010|NCT01412151|139526|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
34011|NCT01412151|139526|P1|Week 0 - 306 - Treatment Period|Death|1
34012|NCT01411891|139537|P2|Overall Study|Catheter dislodgement or loss to follow-|2
34013|NCT01411891|139538|P1|Overall Study|Catheter dislodgement or loss to follow-|3
34014|NCT01411852|139546|P2|Hospital Intervention Phase|Vascular access failed|0
34015|NCT01411852|139547|P1|Hospital Intervention Phase|Vascular access failed|1
34016|NCT01411852|139546|P2|Hospital Intervention Phase|Withdrawal by Subject|0
34017|NCT01411852|139547|P1|Hospital Intervention Phase|Withdrawal by Subject|1
34018|NCT01411852|139546|P2|Hospital Intervention Phase|Spinal cord injury|0
34019|NCT01411852|139547|P1|Hospital Intervention Phase|Spinal cord injury|2
34020|NCT01411852|139546|P2|Hospital Intervention Phase|Other ineligible|2
34021|NCT01411852|139547|P1|Hospital Intervention Phase|Other ineligible|2
34022|NCT01411852|139546|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
34023|NCT01411852|139547|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
34024|NCT01411852|139546|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
34025|NCT01411852|139547|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
34026|NCT01411852|139546|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
34027|NCT01411852|139547|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
34028|NCT01411852|139546|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
34029|NCT01411852|139547|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
34030|NCT01411852|139546|P2|Hospital Intervention Phase|CPR administered|1
34031|NCT01411852|139547|P1|Hospital Intervention Phase|CPR administered|3
34032|NCT01411852|139546|P2|Hospital Intervention Phase|Miscommunication error|2
34033|NCT01411852|139547|P1|Hospital Intervention Phase|Miscommunication error|1
34034|NCT01411852|139546|P2|Hospital Intervention Phase|No qualifying SBP|1
34035|NCT01411852|139547|P1|Hospital Intervention Phase|No qualifying SBP|5
34036|NCT01411852|139546|P2|Hospital Intervention Phase|Severe head injury|4
34037|NCT01411852|139547|P1|Hospital Intervention Phase|Severe head injury|5
34038|NCT01411852|139546|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
34039|NCT01411852|139547|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
34040|NCT01411852|139546|P2|Prehospital Intervention Phase|Found to be under age|1
34041|NCT01411852|139547|P1|Prehospital Intervention Phase|Found to be under age|0
34042|NCT01411852|139546|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
34043|NCT01411852|139547|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
34044|NCT01411852|139546|P2|Prehospital Intervention Phase|No qualifying SBP|4
34045|NCT01411852|139547|P1|Prehospital Intervention Phase|No qualifying SBP|5
34046|NCT01411228|139648|P3|Overall Study|Withdrawal by Subject|0
34047|NCT01411228|139649|P2|Overall Study|Withdrawal by Subject|0
34048|NCT01411228|139650|P1|Overall Study|Withdrawal by Subject|1
34049|NCT01411228|139648|P3|Overall Study|Lost to Follow-up|1
34050|NCT01411228|139649|P2|Overall Study|Lost to Follow-up|0
34051|NCT01411228|139650|P1|Overall Study|Lost to Follow-up|0
34052|NCT01411215|139672|P2|Overall Study|Screen failure|1
34053|NCT01411215|139673|P1|Overall Study|Screen failure|0
34054|NCT01411215|139672|P2|Overall Study|Unspecified|17
34055|NCT01411215|139673|P1|Overall Study|Unspecified|12
34056|NCT01411215|139672|P2|Overall Study|Withdrawal by Subject|21
34057|NCT01411215|139673|P1|Overall Study|Withdrawal by Subject|34
34058|NCT01411215|139672|P2|Overall Study|Protocol Violation|5
34059|NCT01411215|139673|P1|Overall Study|Protocol Violation|3
34060|NCT01411215|139672|P2|Overall Study|Study terminated by sponsor|15
34061|NCT01411215|139673|P1|Overall Study|Study terminated by sponsor|2
34062|NCT01411215|139672|P2|Overall Study|Did not meet entrance criteria|1
34063|NCT01411215|139673|P1|Overall Study|Did not meet entrance criteria|0
34064|NCT01411215|139672|P2|Overall Study|Lost to Follow-up|18
34065|NCT01411215|139673|P1|Overall Study|Lost to Follow-up|12
34066|NCT01411215|139672|P2|Overall Study|Lack of Efficacy|4
34067|NCT01411215|139673|P1|Overall Study|Lack of Efficacy|2
34068|NCT01411215|139672|P2|Overall Study|Adverse Event|2
34069|NCT01411215|139673|P1|Overall Study|Adverse Event|1
34070|NCT01410604|139713|P2|Overall Study|Physician Decision|1
34071|NCT01410604|139714|P1|Overall Study|Physician Decision|0
34072|NCT01410604|139713|P2|Overall Study|Lost to Follow-up|0
34073|NCT01410604|139714|P1|Overall Study|Lost to Follow-up|1
34074|NCT01410604|139713|P2|Overall Study|Adverse Event|1
34075|NCT01410604|139714|P1|Overall Study|Adverse Event|2
34076|NCT01410474|139750|P2|Overall Study|Withdrawal by Subject|1
34077|NCT01410474|139751|P1|Overall Study|Withdrawal by Subject|0
34078|NCT01410240|139800|P3|Overall Study|Missed week 6 assessments|1
34079|NCT01410240|139801|P2|Overall Study|Missed week 6 assessments|1
34080|NCT01410240|139802|P1|Overall Study|Missed week 6 assessments|1
34081|NCT01410240|139800|P3|Overall Study|Physician Decision|1
34082|NCT01410240|139801|P2|Overall Study|Physician Decision|0
34083|NCT01410240|139802|P1|Overall Study|Physician Decision|0
34084|NCT01410227|139873|P4|Overall Study|Met Excl. Criteria After Starting Study|0
34085|NCT01410227|139874|P3|Overall Study|Met Excl. Criteria After Starting Study|1
34086|NCT01410227|139875|P2|Overall Study|Met Excl. Criteria After Starting Study|0
34087|NCT01410227|139876|P1|Overall Study|Met Excl. Criteria After Starting Study|0
34088|NCT01410227|139873|P4|Overall Study|Pregnancy|1
34089|NCT01410227|139874|P3|Overall Study|Pregnancy|0
34090|NCT01410227|139875|P2|Overall Study|Pregnancy|0
34091|NCT01410227|139876|P1|Overall Study|Pregnancy|0
34092|NCT01410227|139873|P4|Overall Study|Withdrawal by Subject|0
34093|NCT01410227|139874|P3|Overall Study|Withdrawal by Subject|1
34094|NCT01410227|139875|P2|Overall Study|Withdrawal by Subject|0
34095|NCT01410227|139876|P1|Overall Study|Withdrawal by Subject|3
34096|NCT01410227|139873|P4|Overall Study|Adverse Event|0
34097|NCT01410227|139874|P3|Overall Study|Adverse Event|0
34098|NCT01410227|139875|P2|Overall Study|Adverse Event|0
34099|NCT01410227|139876|P1|Overall Study|Adverse Event|1
34100|NCT01410110|139948|P2|Overall Study|Withdrawal by Subject|2
34101|NCT01410110|139949|P1|Overall Study|Withdrawal by Subject|4
34102|NCT01409837|139973|P2|Overall Study|Physician Decision|1
34103|NCT01409837|139974|P1|Overall Study|Physician Decision|0
34104|NCT01409837|139973|P2|Overall Study|Lost to Follow-up|0
34105|NCT01409837|139974|P1|Overall Study|Lost to Follow-up|1
34106|NCT01409837|139973|P2|Overall Study|Withdrawal by Subject|1
34107|NCT01409837|139974|P1|Overall Study|Withdrawal by Subject|2
34108|NCT01409707|139999|P3|Overall Study|Withdrawal by Subject|16
34109|NCT01409707|140000|P2|Overall Study|Withdrawal by Subject|17
34110|NCT01409707|140001|P1|Overall Study|Withdrawal by Subject|5
34111|NCT01408628|140011|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
34112|NCT01408628|140011|P1|Completed 6 Month Follow-Up|Protocol Violation|6
34113|NCT01408628|140011|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
34114|NCT01408628|140011|P1|Consented|Withdrawal by Subject|12
34115|NCT01408537|140017|P1|Overall Study|Lost to Follow-up|3
34116|NCT01408537|140017|P1|Overall Study|Protocol Violation|3
34117|NCT01408537|140017|P1|Overall Study|Withdrawal by Subject|2
34118|NCT01408485|140033|P1|Overall Study|Withdrawal by Subject|21
34119|NCT01409564|140041|P2|Overall Study|brain abnormalities found in T1 MR|2
34120|NCT01409564|140042|P1|Overall Study|brain abnormalities found in T1 MR|1
34121|NCT01409564|140041|P2|Overall Study|low medication compliance|3
34122|NCT01409564|140042|P1|Overall Study|low medication compliance|4
34123|NCT01409434|140060|P1|Overall Study|Protocol Violation|4
34124|NCT01409382|140070|P2|Overall Study|Had a 2nd trimester loss after accident|0
34125|NCT01409382|140071|P1|Overall Study|Had a 2nd trimester loss after accident|1
34126|NCT01409382|140070|P2|Overall Study|Did not manage to get pregnant|70
34127|NCT01409382|140071|P1|Overall Study|Did not manage to get pregnant|64
34128|NCT01409382|140070|P2|Overall Study|Still pregnant when study ended|2
34129|NCT01409382|140071|P1|Overall Study|Still pregnant when study ended|13
34130|NCT01409382|140070|P2|Overall Study|Multiple pregnancy|4
34131|NCT01409382|140071|P1|Overall Study|Multiple pregnancy|2
34132|NCT01409382|140070|P2|Overall Study|Protocol Violation|3
34133|NCT01409382|140071|P1|Overall Study|Protocol Violation|0
34134|NCT01409382|140070|P2|Overall Study|Lost to Follow-up|1
34135|NCT01409382|140071|P1|Overall Study|Lost to Follow-up|1
34136|NCT01408888|140135|P2|Second Intervention|Adverse Event|0
34137|NCT01408888|140136|P1|Second Intervention|Adverse Event|1
34138|NCT01408888|140135|P2|Second Intervention|Withdrawal by Subject|0
34139|NCT01408888|140136|P1|Second Intervention|Withdrawal by Subject|1
34140|NCT01408888|140135|P2|First Intervention|Withdrawal by Subject|2
34141|NCT01408888|140136|P1|First Intervention|Withdrawal by Subject|0
34142|NCT01408888|140135|P2|First Intervention|Adverse Event|1
34143|NCT01408888|140136|P1|First Intervention|Adverse Event|0
34144|NCT01408303|140225|P3|Overall Study|Noncompliance|1
34145|NCT01408303|140226|P2|Overall Study|Noncompliance|0
34146|NCT01408303|140227|P1|Overall Study|Noncompliance|1
34147|NCT01408303|140225|P3|Overall Study|Protocol Violation|0
34148|NCT01408303|140226|P2|Overall Study|Protocol Violation|1
34149|NCT01408303|140227|P1|Overall Study|Protocol Violation|0
34150|NCT01408303|140225|P3|Overall Study|Withdrawal by Subject|1
34151|NCT01408303|140226|P2|Overall Study|Withdrawal by Subject|3
34152|NCT01408303|140227|P1|Overall Study|Withdrawal by Subject|2
34153|NCT01408303|140225|P3|Overall Study|Lost to Follow-up|2
34154|NCT01408303|140226|P2|Overall Study|Lost to Follow-up|1
34155|NCT01408303|140227|P1|Overall Study|Lost to Follow-up|0
34156|NCT01408303|140225|P3|Overall Study|Adverse Event|2
34157|NCT01408303|140226|P2|Overall Study|Adverse Event|7
34158|NCT01408303|140227|P1|Overall Study|Adverse Event|3
34159|NCT01408277|140237|P2|Overall Study|Protocol Violation|0
34160|NCT01408277|140238|P1|Overall Study|Protocol Violation|2
34161|NCT01408277|140237|P2|Overall Study|Withdrawal by Subject|0
34162|NCT01408277|140238|P1|Overall Study|Withdrawal by Subject|2
34163|NCT01408277|140237|P2|Overall Study|Lost to Follow-up|0
34164|NCT01408277|140238|P1|Overall Study|Lost to Follow-up|1
34165|NCT01408277|140237|P2|Overall Study|Adverse Event|4
34166|NCT01408277|140238|P1|Overall Study|Adverse Event|3
34167|NCT01407354|140275|P2|First Intervention|Physician Decision|0
34168|NCT01407354|140276|P1|First Intervention|Physician Decision|1
34169|NCT01407354|140275|P2|First Intervention|Adverse Event|0
34170|NCT01407354|140276|P1|First Intervention|Adverse Event|1
34171|NCT01407354|140275|P2|First Intervention|Withdrawal by Subject|2
34172|NCT01407354|140276|P1|First Intervention|Withdrawal by Subject|0
34173|NCT01407276|140292|P8|Overall Study|Withdrawal by Subject|1
34174|NCT01407276|140293|P7|Overall Study|Withdrawal by Subject|0
34175|NCT01407276|140294|P6|Overall Study|Withdrawal by Subject|0
34176|NCT01407276|140295|P5|Overall Study|Withdrawal by Subject|0
34177|NCT01407276|140296|P4|Overall Study|Withdrawal by Subject|0
34178|NCT01407276|140297|P3|Overall Study|Withdrawal by Subject|0
34179|NCT01407276|140298|P2|Overall Study|Withdrawal by Subject|0
34180|NCT01407276|140299|P1|Overall Study|Withdrawal by Subject|0
34181|NCT01406938|140438|P6|Follow up|Lost to Follow-up|1
34182|NCT01406938|140439|P5|Follow up|Lost to Follow-up|2
34183|NCT01406938|140440|P4|Follow up|Lost to Follow-up|1
34184|NCT01406938|140441|P3|Follow up|Lost to Follow-up|0
34185|NCT01406938|140442|P2|Follow up|Lost to Follow-up|1
34186|NCT01406938|140443|P1|Follow up|Lost to Follow-up|1
34187|NCT01406938|140438|P6|Follow up|Physician Decision|1
34188|NCT01406938|140439|P5|Follow up|Physician Decision|3
34189|NCT01406938|140440|P4|Follow up|Physician Decision|0
34190|NCT01406938|140441|P3|Follow up|Physician Decision|2
34191|NCT01406938|140442|P2|Follow up|Physician Decision|0
34192|NCT01406938|140443|P1|Follow up|Physician Decision|0
34193|NCT01406938|140438|P6|Follow up|Protocol Violation|0
34194|NCT01406938|140439|P5|Follow up|Protocol Violation|0
34195|NCT01406938|140440|P4|Follow up|Protocol Violation|0
34196|NCT01406938|140441|P3|Follow up|Protocol Violation|1
34197|NCT01406938|140442|P2|Follow up|Protocol Violation|0
34198|NCT01406938|140443|P1|Follow up|Protocol Violation|0
34199|NCT01406938|140438|P6|Follow up|Patient/guardian decision|1
34200|NCT01406938|140439|P5|Follow up|Patient/guardian decision|4
34201|NCT01406938|140440|P4|Follow up|Patient/guardian decision|2
34202|NCT01406938|140441|P3|Follow up|Patient/guardian decision|4
34203|NCT01406938|140442|P2|Follow up|Patient/guardian decision|2
34204|NCT01406938|140443|P1|Follow up|Patient/guardian decision|4
34205|NCT01406938|140438|P6|Follow up|Lack of Efficacy|0
34206|NCT01406938|140439|P5|Follow up|Lack of Efficacy|0
34207|NCT01406938|140440|P4|Follow up|Lack of Efficacy|0
34208|NCT01406938|140441|P3|Follow up|Lack of Efficacy|1
34209|NCT01406938|140442|P2|Follow up|Lack of Efficacy|2
34210|NCT01406938|140443|P1|Follow up|Lack of Efficacy|3
34211|NCT01406938|140438|P6|Maintenance Period|Lack of Efficacy|5
34212|NCT01406938|140439|P5|Maintenance Period|Lack of Efficacy|3
34213|NCT01406938|140440|P4|Maintenance Period|Lack of Efficacy|1
34214|NCT01406938|140441|P3|Maintenance Period|Lack of Efficacy|2
34215|NCT01406938|140442|P2|Maintenance Period|Lack of Efficacy|0
34216|NCT01406938|140443|P1|Maintenance Period|Lack of Efficacy|0
34217|NCT01406938|140438|P6|Maintenance Period|Lost to Follow-up|0
34218|NCT01406938|140439|P5|Maintenance Period|Lost to Follow-up|4
34219|NCT01406938|140440|P4|Maintenance Period|Lost to Follow-up|0
34220|NCT01406938|140441|P3|Maintenance Period|Lost to Follow-up|0
34221|NCT01406938|140442|P2|Maintenance Period|Lost to Follow-up|0
34222|NCT01406938|140443|P1|Maintenance Period|Lost to Follow-up|0
34223|NCT01406938|140438|P6|Maintenance Period|Pregnancy|0
34224|NCT01406938|140439|P5|Maintenance Period|Pregnancy|1
34225|NCT01406938|140440|P4|Maintenance Period|Pregnancy|0
34226|NCT01406938|140441|P3|Maintenance Period|Pregnancy|0
34227|NCT01406938|140442|P2|Maintenance Period|Pregnancy|0
34228|NCT01406938|140443|P1|Maintenance Period|Pregnancy|0
34229|NCT01406938|140438|P6|Maintenance Period|Protocol Violation|2
34230|NCT01406938|140439|P5|Maintenance Period|Protocol Violation|2
34231|NCT01406938|140440|P4|Maintenance Period|Protocol Violation|2
34232|NCT01406938|140441|P3|Maintenance Period|Protocol Violation|2
34233|NCT01406938|140442|P2|Maintenance Period|Protocol Violation|0
34234|NCT01406938|140443|P1|Maintenance Period|Protocol Violation|0
34235|NCT01406938|140438|P6|Maintenance Period|Subject/guardian decision|7
34236|NCT01406938|140439|P5|Maintenance Period|Subject/guardian decision|10
34237|NCT01406938|140440|P4|Maintenance Period|Subject/guardian decision|7
34238|NCT01406938|140441|P3|Maintenance Period|Subject/guardian decision|11
34239|NCT01406938|140442|P2|Maintenance Period|Subject/guardian decision|0
34240|NCT01406938|140443|P1|Maintenance Period|Subject/guardian decision|0
34241|NCT01406938|140438|P6|Maintenance Period|Death|0
34242|NCT01406938|140439|P5|Maintenance Period|Death|1
34243|NCT01406938|140440|P4|Maintenance Period|Death|0
34244|NCT01406938|140441|P3|Maintenance Period|Death|0
34245|NCT01406938|140442|P2|Maintenance Period|Death|0
34246|NCT01406938|140443|P1|Maintenance Period|Death|0
34247|NCT01406938|140438|P6|Maintenance Period|Adverse Event|2
34248|NCT01406938|140439|P5|Maintenance Period|Adverse Event|4
34249|NCT01406938|140440|P4|Maintenance Period|Adverse Event|8
34250|NCT01406938|140441|P3|Maintenance Period|Adverse Event|2
34251|NCT01406938|140442|P2|Maintenance Period|Adverse Event|0
34252|NCT01406938|140443|P1|Maintenance Period|Adverse Event|0
34253|NCT01406938|140438|P6|Induction Period|Lost to Follow-up|0
34254|NCT01406938|140439|P5|Induction Period|Lost to Follow-up|0
34255|NCT01406938|140440|P4|Induction Period|Lost to Follow-up|0
34256|NCT01406938|140441|P3|Induction Period|Lost to Follow-up|0
34257|NCT01406938|140442|P2|Induction Period|Lost to Follow-up|3
34258|NCT01406938|140443|P1|Induction Period|Lost to Follow-up|2
34259|NCT01406938|140438|P6|Induction Period|Lack of Efficacy|0
34260|NCT01406938|140439|P5|Induction Period|Lack of Efficacy|0
34261|NCT01406938|140440|P4|Induction Period|Lack of Efficacy|0
34262|NCT01406938|140441|P3|Induction Period|Lack of Efficacy|0
34263|NCT01406938|140442|P2|Induction Period|Lack of Efficacy|0
34264|NCT01406938|140443|P1|Induction Period|Lack of Efficacy|1
34265|NCT01406938|140438|P6|Induction Period|Adverse Event|0
34266|NCT01406938|140439|P5|Induction Period|Adverse Event|0
34267|NCT01406938|140440|P4|Induction Period|Adverse Event|0
34268|NCT01406938|140441|P3|Induction Period|Adverse Event|0
34269|NCT01406938|140442|P2|Induction Period|Adverse Event|9
34270|NCT01406938|140443|P1|Induction Period|Adverse Event|8
34271|NCT01406938|140438|P6|Induction Period|Protocol deviation|0
34272|NCT01406938|140439|P5|Induction Period|Protocol deviation|0
34273|NCT01406938|140440|P4|Induction Period|Protocol deviation|0
34274|NCT01406938|140441|P3|Induction Period|Protocol deviation|0
34275|NCT01406938|140442|P2|Induction Period|Protocol deviation|0
34276|NCT01406938|140443|P1|Induction Period|Protocol deviation|1
34277|NCT01406938|140438|P6|Induction Period|Subject/guardian decision|0
34278|NCT01406938|140439|P5|Induction Period|Subject/guardian decision|0
34279|NCT01406938|140440|P4|Induction Period|Subject/guardian decision|0
34280|NCT01406938|140441|P3|Induction Period|Subject/guardian decision|0
34281|NCT01406938|140442|P2|Induction Period|Subject/guardian decision|8
34282|NCT01406938|140443|P1|Induction Period|Subject/guardian decision|6
34283|NCT01406574|140559|P4|Overall Study|Definite progression of primary disease|0
34284|NCT01406574|140560|P3|Overall Study|Definite progression of primary disease|0
34285|NCT01406574|140561|P2|Overall Study|Definite progression of primary disease|0
34286|NCT01406574|140562|P1|Overall Study|Definite progression of primary disease|1
34287|NCT01406574|140559|P4|Overall Study|Withdrawal by Subject|0
34288|NCT01406574|140560|P3|Overall Study|Withdrawal by Subject|0
34289|NCT01406574|140561|P2|Overall Study|Withdrawal by Subject|1
34290|NCT01406574|140562|P1|Overall Study|Withdrawal by Subject|0
34291|NCT01406574|140559|P4|Overall Study|Physician Decision|1
34292|NCT01406574|140560|P3|Overall Study|Physician Decision|0
34293|NCT01406574|140561|P2|Overall Study|Physician Decision|0
34294|NCT01406574|140562|P1|Overall Study|Physician Decision|0
34295|NCT01406574|140559|P4|Overall Study|Adverse Event|3
34296|NCT01406574|140560|P3|Overall Study|Adverse Event|1
34297|NCT01406574|140561|P2|Overall Study|Adverse Event|0
34298|NCT01406574|140562|P1|Overall Study|Adverse Event|0
34299|NCT01405950|140576|P4|Overall Study|Withdrawal by Subject|0
34300|NCT01405950|140577|P3|Overall Study|Withdrawal by Subject|0
34301|NCT01405950|140578|P2|Overall Study|Withdrawal by Subject|0
34302|NCT01405950|140579|P1|Overall Study|Withdrawal by Subject|1
34303|NCT01405924|140614|P1|Overall Study|Missing/Incomplete Data|2
34304|NCT01405924|140614|P1|Overall Study|Protocol Violation|8
34305|NCT01405898|140626|P2|Overall Study|Withdrawal by Subject|2
34306|NCT01405898|140627|P1|Overall Study|Withdrawal by Subject|2
34307|NCT01405820|140651|P6|Open-Label Treatment Period|Adverse Event|0
34308|NCT01405820|140652|P5|Open-Label Treatment Period|Adverse Event|0
34309|NCT01405820|140653|P4|Open-Label Treatment Period|Adverse Event|1
34310|NCT01405820|140654|P3|Open-Label Treatment Period|Adverse Event|0
34311|NCT01405820|140655|P2|Open-Label Treatment Period|Adverse Event|0
34312|NCT01405820|140656|P1|Open-Label Treatment Period|Adverse Event|0
34313|NCT01405820|140651|P6|Open-Label Treatment Period|Physician Decision|0
34314|NCT01405820|140652|P5|Open-Label Treatment Period|Physician Decision|1
34315|NCT01405820|140653|P4|Open-Label Treatment Period|Physician Decision|2
34316|NCT01405820|140654|P3|Open-Label Treatment Period|Physician Decision|1
34317|NCT01405820|140655|P2|Open-Label Treatment Period|Physician Decision|0
34318|NCT01405820|140656|P1|Open-Label Treatment Period|Physician Decision|0
34319|NCT01405820|140651|P6|Open-Label Treatment Period|Not Specified|1
34320|NCT01405820|140652|P5|Open-Label Treatment Period|Not Specified|1
34321|NCT01405820|140653|P4|Open-Label Treatment Period|Not Specified|1
34322|NCT01405820|140654|P3|Open-Label Treatment Period|Not Specified|1
34323|NCT01405820|140655|P2|Open-Label Treatment Period|Not Specified|1
34324|NCT01405820|140656|P1|Open-Label Treatment Period|Not Specified|1
34325|NCT01405820|140651|P6|Open-Label Treatment Period|Withdrawal by Subject|1
34326|NCT01405820|140652|P5|Open-Label Treatment Period|Withdrawal by Subject|0
34327|NCT01405820|140653|P4|Open-Label Treatment Period|Withdrawal by Subject|1
34328|NCT01405820|140654|P3|Open-Label Treatment Period|Withdrawal by Subject|1
34329|NCT01405820|140655|P2|Open-Label Treatment Period|Withdrawal by Subject|1
34330|NCT01405820|140656|P1|Open-Label Treatment Period|Withdrawal by Subject|3
34331|NCT01405820|140651|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
34332|NCT01405820|140652|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
34333|NCT01405820|140653|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
34334|NCT01405820|140654|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
34335|NCT01405820|140655|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
34336|NCT01405820|140656|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
34337|NCT01405820|140651|P6|Randomized Treatment Period|Death|0
34338|NCT01405820|140652|P5|Randomized Treatment Period|Death|0
34339|NCT01405820|140653|P4|Randomized Treatment Period|Death|1
34340|NCT01405820|140654|P3|Randomized Treatment Period|Death|0
34341|NCT01405820|140655|P2|Randomized Treatment Period|Death|0
34342|NCT01405820|140656|P1|Randomized Treatment Period|Death|0
34343|NCT01405820|140651|P6|Randomized Treatment Period|Treatment Arm Closed|28
34344|NCT01405820|140652|P5|Randomized Treatment Period|Treatment Arm Closed|33
34345|NCT01405820|140653|P4|Randomized Treatment Period|Treatment Arm Closed|36
34346|NCT01405820|140654|P3|Randomized Treatment Period|Treatment Arm Closed|20
34347|NCT01405820|140655|P2|Randomized Treatment Period|Treatment Arm Closed|0
34348|NCT01405820|140656|P1|Randomized Treatment Period|Treatment Arm Closed|0
34349|NCT01405820|140651|P6|Randomized Treatment Period|Incorrect Study Treatment|0
34350|NCT01405820|140652|P5|Randomized Treatment Period|Incorrect Study Treatment|2
34351|NCT01405820|140653|P4|Randomized Treatment Period|Incorrect Study Treatment|0
34352|NCT01405820|140654|P3|Randomized Treatment Period|Incorrect Study Treatment|3
34353|NCT01405820|140655|P2|Randomized Treatment Period|Incorrect Study Treatment|0
34354|NCT01405820|140656|P1|Randomized Treatment Period|Incorrect Study Treatment|0
34355|NCT01405820|140651|P6|Randomized Treatment Period|Rescue|8
34356|NCT01405820|140652|P5|Randomized Treatment Period|Rescue|8
34357|NCT01405820|140653|P4|Randomized Treatment Period|Rescue|10
34358|NCT01405820|140654|P3|Randomized Treatment Period|Rescue|13
34359|NCT01405820|140655|P2|Randomized Treatment Period|Rescue|1
34360|NCT01405820|140656|P1|Randomized Treatment Period|Rescue|0
34361|NCT01405820|140651|P6|Randomized Treatment Period|Physician Decision|0
34362|NCT01405820|140652|P5|Randomized Treatment Period|Physician Decision|0
34363|NCT01405820|140653|P4|Randomized Treatment Period|Physician Decision|0
34364|NCT01405820|140654|P3|Randomized Treatment Period|Physician Decision|1
34365|NCT01405820|140655|P2|Randomized Treatment Period|Physician Decision|2
34366|NCT01405820|140656|P1|Randomized Treatment Period|Physician Decision|0
34367|NCT01405820|140651|P6|Randomized Treatment Period|Not Specified|0
34368|NCT01405820|140652|P5|Randomized Treatment Period|Not Specified|0
34369|NCT01405820|140653|P4|Randomized Treatment Period|Not Specified|1
34370|NCT01405820|140654|P3|Randomized Treatment Period|Not Specified|1
34371|NCT01405820|140655|P2|Randomized Treatment Period|Not Specified|2
34372|NCT01405820|140656|P1|Randomized Treatment Period|Not Specified|2
34373|NCT01405820|140651|P6|Randomized Treatment Period|Withdrawal by Subject|0
34374|NCT01405820|140652|P5|Randomized Treatment Period|Withdrawal by Subject|0
34375|NCT01405820|140653|P4|Randomized Treatment Period|Withdrawal by Subject|2
34376|NCT01405820|140654|P3|Randomized Treatment Period|Withdrawal by Subject|2
34377|NCT01405820|140655|P2|Randomized Treatment Period|Withdrawal by Subject|2
34378|NCT01405820|140656|P1|Randomized Treatment Period|Withdrawal by Subject|6
34379|NCT01405820|140651|P6|Randomized Treatment Period|Adverse Event|1
34380|NCT01405820|140652|P5|Randomized Treatment Period|Adverse Event|2
34381|NCT01405820|140653|P4|Randomized Treatment Period|Adverse Event|0
34382|NCT01405820|140654|P3|Randomized Treatment Period|Adverse Event|3
34383|NCT01405820|140655|P2|Randomized Treatment Period|Adverse Event|3
34384|NCT01405820|140656|P1|Randomized Treatment Period|Adverse Event|3
34385|NCT01405768|140752|P2|Overall Study|Didn't complete questionnaire correctly|0
34386|NCT01405768|140753|P1|Overall Study|Didn't complete questionnaire correctly|4
34387|NCT01405742|140765|P2|Overall Study|Lost to Follow-up|0
34388|NCT01405742|140766|P1|Overall Study|Lost to Follow-up|1
34389|NCT01405560|140776|P1|Overall Study|Physician Decision|1
34390|NCT01405508|140791|P4|Overall Study|AE, non-serious non-fatal|0
34391|NCT01405508|140792|P3|Overall Study|AE, non-serious non-fatal|0
34392|NCT01405508|140793|P2|Overall Study|AE, non-serious non-fatal|1
34393|NCT01405508|140794|P1|Overall Study|AE, non-serious non-fatal|1
34394|NCT01405027|140826|P2|Overall Study|Other or Unknown|25
34395|NCT01405027|140827|P1|Overall Study|Other or Unknown|12
34396|NCT01405027|140826|P2|Overall Study|Death|0
34397|NCT01405027|140827|P1|Overall Study|Death|1
34398|NCT01405027|140826|P2|Overall Study|Investigator judgement|2
34399|NCT01405027|140827|P1|Overall Study|Investigator judgement|0
34400|NCT01405027|140826|P2|Overall Study|Lost to Follow-up|24
34401|NCT01405027|140827|P1|Overall Study|Lost to Follow-up|16
34402|NCT01405027|140826|P2|Overall Study|Withdrawn consent|0
34403|NCT01405027|140827|P1|Overall Study|Withdrawn consent|3
34404|NCT01404988|140844|P3|Overall Study|Lost to Follow-up|1
34405|NCT01404988|140845|P2|Overall Study|Lost to Follow-up|2
34406|NCT01404988|140846|P1|Overall Study|Lost to Follow-up|1
34407|NCT01404988|140844|P3|Overall Study|Withdrawal by Subject|0
34408|NCT01404988|140845|P2|Overall Study|Withdrawal by Subject|2
34409|NCT01404988|140846|P1|Overall Study|Withdrawal by Subject|2
34410|NCT01404988|140844|P3|Overall Study|Adverse Event|0
34411|NCT01404988|140845|P2|Overall Study|Adverse Event|0
34412|NCT01404988|140846|P1|Overall Study|Adverse Event|1
34413|NCT01404988|140844|P3|Overall Study|Death|2
34414|NCT01404988|140845|P2|Overall Study|Death|0
34415|NCT01404988|140846|P1|Overall Study|Death|2
34416|NCT01404234|140974|P1|Overall Study|Withdrawal by Subject|2
34417|NCT01403987|141000|P3|Overall Study|Residents forgot their secret PIN|18
34418|NCT01403987|141001|P2|Overall Study|Residents forgot their secret PIN|17
34419|NCT01403987|141002|P1|Overall Study|Residents forgot their secret PIN|18
34420|NCT01403805|141018|P2|Overall Study|Death|1
34421|NCT01403805|141019|P1|Overall Study|Death|0
34422|NCT01403805|141018|P2|Overall Study|Lost to Follow-up|2
34423|NCT01403805|141019|P1|Overall Study|Lost to Follow-up|0
34424|NCT01403805|141018|P2|Overall Study|Withdrawal by Subject|4
34425|NCT01403805|141019|P1|Overall Study|Withdrawal by Subject|0
34426|NCT01403194|141056|P1|Overall Study|Lost to Follow-up|8
34427|NCT01403194|141056|P1|Overall Study|Screen Failure|2
34428|NCT01403051|141068|P2|Overall Study|Lost to Follow-up|5
34429|NCT01403051|141069|P1|Overall Study|Lost to Follow-up|5
34430|NCT01403051|141068|P2|Overall Study|Withdrawal by Subject|1
34431|NCT01403051|141069|P1|Overall Study|Withdrawal by Subject|2
34432|NCT01403051|141068|P2|Overall Study|Death|0
34433|NCT01403051|141069|P1|Overall Study|Death|1
34434|NCT01403051|141068|P2|Overall Study|Protocol Violation|0
34435|NCT01403051|141069|P1|Overall Study|Protocol Violation|2
34436|NCT01402947|141103|P2|First Intervention|Adverse Event|1
34437|NCT01402947|141104|P1|First Intervention|Adverse Event|0
34438|NCT01402869|141115|P3|Overall Study|Required Tooth Extraction|1
34439|NCT01402869|141116|P2|Overall Study|Required Tooth Extraction|0
34440|NCT01402869|141117|P1|Overall Study|Required Tooth Extraction|0
34441|NCT01402817|141131|P1|Overall Study|Study Suspended by FDA|8
34442|NCT01402817|141131|P1|Overall Study|Withdrawal by Subject|3
34443|NCT01402700|141136|P1|Overall Study|Missed Visit|1
34444|NCT01402700|141136|P1|Overall Study|Withdrawal by Subject|3
34445|NCT01402700|141136|P1|Overall Study|Death|3
34446|NCT01402570|141140|P1|Overall Study|Adverse Event|1
34447|NCT01402102|141239|P2|Overall Study|Withdrawal by Subject|2
34448|NCT01402102|141240|P1|Overall Study|Withdrawal by Subject|0
34449|NCT01402102|141239|P2|Overall Study|Insufficiency of compliance|1
34450|NCT01402102|141240|P1|Overall Study|Insufficiency of compliance|1
34451|NCT01402102|141239|P2|Overall Study|Protocol Violation|0
34452|NCT01402102|141240|P1|Overall Study|Protocol Violation|1
34453|NCT01402063|141260|P2|Overall Study|Withdrawal by Subject|3
34454|NCT01402063|141261|P1|Overall Study|Withdrawal by Subject|3
34455|NCT01401842|141269|P2|Overall Study|other/unknown|17
34456|NCT01401842|141270|P1|Overall Study|other/unknown|28
34457|NCT01401842|141269|P2|Overall Study|on profile|5
34458|NCT01401842|141270|P1|Overall Study|on profile|9
34459|NCT01401842|141269|P2|Overall Study|invalid follow-up strength data|4
34460|NCT01401842|141270|P1|Overall Study|invalid follow-up strength data|1
34461|NCT01401842|141269|P2|Overall Study|discharged from US Army|4
34462|NCT01401842|141270|P1|Overall Study|discharged from US Army|3
34463|NCT01401842|141269|P2|Overall Study|changed companies|34
34464|NCT01401842|141270|P1|Overall Study|changed companies|20
34465|NCT01401842|141269|P2|Overall Study|academic reason|1
34466|NCT01401842|141270|P1|Overall Study|academic reason|4
34467|NCT01401842|141269|P2|Overall Study|Withdrawal by Subject|2
34468|NCT01401842|141270|P1|Overall Study|Withdrawal by Subject|3
34469|NCT01400698|141284|P6|Overall Study|Unspecified|0
34470|NCT01400698|141285|P5|Overall Study|Unspecified|1
34471|NCT01400698|141286|P4|Overall Study|Unspecified|2
34472|NCT01400698|141287|P3|Overall Study|Unspecified|0
34473|NCT01400698|141288|P2|Overall Study|Unspecified|2
34474|NCT01400698|141289|P1|Overall Study|Unspecified|4
34475|NCT01400698|141284|P6|Overall Study|Adverse Event|0
34476|NCT01400698|141285|P5|Overall Study|Adverse Event|0
34477|NCT01400698|141286|P4|Overall Study|Adverse Event|0
34478|NCT01400698|141287|P3|Overall Study|Adverse Event|0
34479|NCT01400698|141288|P2|Overall Study|Adverse Event|0
34480|NCT01400698|141289|P1|Overall Study|Adverse Event|1
34481|NCT01400698|141284|P6|Overall Study|Non-compliance|0
34482|NCT01400698|141285|P5|Overall Study|Non-compliance|0
34483|NCT01400698|141286|P4|Overall Study|Non-compliance|1
34484|NCT01400698|141287|P3|Overall Study|Non-compliance|0
34485|NCT01400698|141288|P2|Overall Study|Non-compliance|1
34486|NCT01400698|141289|P1|Overall Study|Non-compliance|0
34487|NCT01400698|141284|P6|Overall Study|Protocol Violation|0
34488|NCT01400698|141285|P5|Overall Study|Protocol Violation|1
34489|NCT01400698|141286|P4|Overall Study|Protocol Violation|0
34490|NCT01400698|141287|P3|Overall Study|Protocol Violation|0
34491|NCT01400698|141288|P2|Overall Study|Protocol Violation|1
34492|NCT01400698|141289|P1|Overall Study|Protocol Violation|0
34493|NCT01400698|141284|P6|Overall Study|Withdrawal by Subject|3
34494|NCT01400698|141285|P5|Overall Study|Withdrawal by Subject|1
34495|NCT01400698|141286|P4|Overall Study|Withdrawal by Subject|4
34496|NCT01400698|141287|P3|Overall Study|Withdrawal by Subject|0
34497|NCT01400698|141288|P2|Overall Study|Withdrawal by Subject|2
34498|NCT01400698|141289|P1|Overall Study|Withdrawal by Subject|8
34499|NCT01400698|141284|P6|Overall Study|Lost to Follow-up|3
34500|NCT01400698|141285|P5|Overall Study|Lost to Follow-up|4
34501|NCT01400698|141286|P4|Overall Study|Lost to Follow-up|1
34502|NCT01400698|141287|P3|Overall Study|Lost to Follow-up|2
34503|NCT01400698|141288|P2|Overall Study|Lost to Follow-up|5
34504|NCT01400698|141289|P1|Overall Study|Lost to Follow-up|2
34505|NCT01401647|141314|P3|Overall Study|Lost to Follow-up|1
34506|NCT01401647|141315|P2|Overall Study|Lost to Follow-up|3
34507|NCT01401647|141316|P1|Overall Study|Lost to Follow-up|3
34508|NCT01401647|141314|P3|Overall Study|Withdrawal by Subject|2
34509|NCT01401647|141315|P2|Overall Study|Withdrawal by Subject|5
34510|NCT01401647|141316|P1|Overall Study|Withdrawal by Subject|1
34511|NCT01401478|141340|P1|Overall Study|Serious adverse event|1
34512|NCT01401478|141340|P1|Overall Study|Low intact parathyroid hormone|1
34513|NCT01401478|141340|P1|Overall Study|Hyperphosphatemia and adverse event|1
34514|NCT01401478|141340|P1|Overall Study|Blood samples not available|1
34515|NCT01401478|141340|P1|Overall Study|Withdrawal by Subject|3
34516|NCT01401478|141340|P1|Overall Study|Kidney transplantation|3
34517|NCT01401478|141340|P1|Overall Study|Lost to Follow-up|5
34518|NCT01401478|141340|P1|Overall Study|Hyperphosphatemia|5
34519|NCT01401478|141340|P1|Overall Study|Adverse Event|5
34520|NCT01401478|141340|P1|Overall Study|Study drug not available|6
34521|NCT01401465|141353|P2|Treatment Period 2|Withdrawal by Subject|1
34522|NCT01401465|141354|P1|Treatment Period 2|Withdrawal by Subject|0
34523|NCT01401465|141353|P2|Treatment Period 2|Lost to Follow-up|1
34524|NCT01401465|141354|P1|Treatment Period 2|Lost to Follow-up|0
34525|NCT01401465|141353|P2|Treatment Period 1|Scheduling Difficulties|1
34526|NCT01401465|141354|P1|Treatment Period 1|Scheduling Difficulties|1
34527|NCT01401465|141353|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
34528|NCT01401465|141354|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
34529|NCT01401465|141353|P2|Treatment Period 1|Non-Compliance to Study Drug|0
34530|NCT01401465|141354|P1|Treatment Period 1|Non-Compliance to Study Drug|1
34531|NCT01401465|141353|P2|Treatment Period 1|Withdrawal by Subject|4
34532|NCT01401465|141354|P1|Treatment Period 1|Withdrawal by Subject|1
34533|NCT01401465|141353|P2|Treatment Period 1|Protocol Violation|0
34534|NCT01401465|141354|P1|Treatment Period 1|Protocol Violation|5
34535|NCT01401465|141353|P2|Treatment Period 1|Pregnancy|1
34536|NCT01401465|141354|P1|Treatment Period 1|Pregnancy|0
34537|NCT01401465|141353|P2|Treatment Period 1|Adverse Event|1
34538|NCT01401465|141354|P1|Treatment Period 1|Adverse Event|4
34539|NCT01401361|141417|P1|Overall Study|Subject/family decision post procedure|2
34540|NCT01401361|141417|P1|Overall Study|Lost to Follow-up|3
34541|NCT01401361|141417|P1|Overall Study|Physician Decision|1
34542|NCT01401361|141417|P1|Overall Study|Lack of Efficacy|6
34543|NCT01401361|141417|P1|Overall Study|Withdrawal by Subject|16
34544|NCT01401322|141423|P1|Overall Study|Physician Decision|1
34545|NCT01401322|141423|P1|Overall Study|Withdrawal by Subject|1
34546|NCT01401283|141429|P2|Overall Study|suspicion of malignant hyperthermia|1
34547|NCT01401283|141430|P1|Overall Study|suspicion of malignant hyperthermia|0
34548|NCT01401283|141429|P2|Overall Study|no central venous access|1
34549|NCT01401283|141430|P1|Overall Study|no central venous access|0
34550|NCT01401283|141429|P2|Overall Study|preoperative arrhythmia|0
34551|NCT01401283|141430|P1|Overall Study|preoperative arrhythmia|5
34552|NCT01401283|141429|P2|Overall Study|surgery cancelled|8
34553|NCT01401283|141430|P1|Overall Study|surgery cancelled|5
34554|NCT01401153|141475|P2|Second Test Day|illness|5
34555|NCT01401153|141476|P1|Second Test Day|illness|0
34556|NCT01401153|141475|P2|First Test Day|Learning disabilities; illness|10
34557|NCT01401153|141476|P1|First Test Day|Learning disabilities; illness|1
34558|NCT01401010|141538|P2|Overall Study|Could not interpret assay results|0
34559|NCT01401010|141539|P1|Overall Study|Could not interpret assay results|1
34560|NCT01400958|141564|P2|Overall Study|Adverse Event|0
34561|NCT01400958|141565|P1|Overall Study|Adverse Event|1
34562|NCT01400958|141564|P2|Overall Study|Withdrawal by Subject|1
34563|NCT01400958|141565|P1|Overall Study|Withdrawal by Subject|0
34564|NCT01400958|141564|P2|Overall Study|Physician Decision|1
34565|NCT01400958|141565|P1|Overall Study|Physician Decision|0
34566|NCT01400932|141575|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
34567|NCT01400932|141576|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
34568|NCT01400932|141575|P2|Overall Study|Protocol Deviation|1
34569|NCT01400932|141576|P1|Overall Study|Protocol Deviation|0
34570|NCT01400932|141575|P2|Overall Study|Lost to Follow-up|0
34571|NCT01400932|141576|P1|Overall Study|Lost to Follow-up|1
34572|NCT01400932|141575|P2|Overall Study|Withdrawal by Subject|6
34573|NCT01400932|141576|P1|Overall Study|Withdrawal by Subject|2
34574|NCT01400932|141575|P2|Overall Study|Lack of Efficacy|3
34575|NCT01400932|141576|P1|Overall Study|Lack of Efficacy|0
34576|NCT01400932|141575|P2|Overall Study|Adverse Event|5
34577|NCT01400932|141576|P1|Overall Study|Adverse Event|10
34578|NCT01400919|141598|P1|Overall Study|Missed visit|2
34579|NCT01400919|141598|P1|Overall Study|Lost to Follow-up|2
34580|NCT01400919|141598|P1|Overall Study|Withdrawal by Subject|4
34581|NCT01400841|141643|P1|Extended Study Phase (2 Years)|Adverse Event|2
34582|NCT01400841|141643|P1|Initial Study Phase (6 Months)|Death|1
34583|NCT01400451|141680|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
34584|NCT01400451|141681|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
34585|NCT01400451|141682|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
34586|NCT01400451|141680|P3|Combination Treatment (or Intended)|Disease Progression|1
34587|NCT01400451|141681|P2|Combination Treatment (or Intended)|Disease Progression|1
34588|NCT01400451|141682|P1|Combination Treatment (or Intended)|Disease Progression|3
34589|NCT01400451|141680|P3|Combination Treatment (or Intended)|Adverse Event|0
34590|NCT01400451|141681|P2|Combination Treatment (or Intended)|Adverse Event|0
34591|NCT01400451|141682|P1|Combination Treatment (or Intended)|Adverse Event|1
34592|NCT01400451|141680|P3|Combination Treatment (or Intended)|Drug Toxicity|0
34593|NCT01400451|141681|P2|Combination Treatment (or Intended)|Drug Toxicity|1
34594|NCT01400451|141682|P1|Combination Treatment (or Intended)|Drug Toxicity|0
34595|NCT01400451|141680|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
34596|NCT01400451|141681|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
34597|NCT01400451|141682|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
34598|NCT01400425|141696|P1|Overall Study|Withdrawal by Subject|10
34599|NCT01400412|141709|P2|Overall Study|Never started study treatment|3
34600|NCT01400412|141710|P1|Overall Study|Never started study treatment|0
34601|NCT01400412|141709|P2|Overall Study|Unable to complete|3
34602|NCT01400412|141710|P1|Overall Study|Unable to complete|3
34603|NCT01400412|141709|P2|Overall Study|Withdrawal by Subject|4
34604|NCT01400412|141710|P1|Overall Study|Withdrawal by Subject|3
34605|NCT01400412|141709|P2|Overall Study|Lost to Follow-up|7
34606|NCT01400412|141710|P1|Overall Study|Lost to Follow-up|4
34607|NCT01400243|141756|P2|Overall Study|Protocol Violation|11
34608|NCT01400243|141757|P1|Overall Study|Protocol Violation|8
34609|NCT01400139|141779|P1|HYD Extension Period|Administrative|10
34610|NCT01400139|141779|P1|HYD Extension Period|Withdrawal by Subject|5
34611|NCT01400139|141779|P1|HYD Extension Period|Adverse Event|8
34612|NCT01400139|141779|P1|HYD Core Study|Did not qualify for Maintenance Period|14
34613|NCT01400139|141779|P1|HYD Core Study|Administrative|56
34614|NCT01400139|141779|P1|HYD Core Study|Confirmed or suspected diversion|20
34615|NCT01400139|141779|P1|HYD Core Study|Lost to Follow-up|39
34616|NCT01400139|141779|P1|HYD Core Study|Withdrawal by Subject|114
34617|NCT01400139|141779|P1|HYD Core Study|Lack of Efficacy|59
34618|NCT01400139|141779|P1|HYD Core Study|Adverse Event|210
34619|NCT01400113|141789|P2|Overall Study|Withdrawal by Subject|1
34620|NCT01400113|141790|P1|Overall Study|Withdrawal by Subject|1
34621|NCT01399788|141805|P2|First Intervention Period|Adverse Event|0
34622|NCT01399788|141806|P1|First Intervention Period|Adverse Event|1
34623|NCT01399723|141828|P2|Overall Study|Lost to Follow-up|1
34624|NCT01399723|141829|P1|Overall Study|Lost to Follow-up|0
34625|NCT01399697|141842|P3|Overall Study|Sponsor Decision|0
34626|NCT01399697|141843|P2|Overall Study|Sponsor Decision|0
34627|NCT01399697|141844|P1|Overall Study|Sponsor Decision|1
34628|NCT01399697|141842|P3|Overall Study|Clinical RA remission|0
34629|NCT01399697|141843|P2|Overall Study|Clinical RA remission|0
34630|NCT01399697|141844|P1|Overall Study|Clinical RA remission|1
34631|NCT01399697|141842|P3|Overall Study|Positive result for hepatitis B|0
34632|NCT01399697|141843|P2|Overall Study|Positive result for hepatitis B|0
34633|NCT01399697|141844|P1|Overall Study|Positive result for hepatitis B|1
34634|NCT01399697|141842|P3|Overall Study|Inclusion Error|0
34635|NCT01399697|141843|P2|Overall Study|Inclusion Error|0
34636|NCT01399697|141844|P1|Overall Study|Inclusion Error|2
34637|NCT01399697|141842|P3|Overall Study|Non-Compliant|0
34638|NCT01399697|141843|P2|Overall Study|Non-Compliant|0
34639|NCT01399697|141844|P1|Overall Study|Non-Compliant|1
34640|NCT01399697|141842|P3|Overall Study|Protocol Violation|0
34641|NCT01399697|141843|P2|Overall Study|Protocol Violation|0
34642|NCT01399697|141844|P1|Overall Study|Protocol Violation|2
34643|NCT01399697|141842|P3|Overall Study|Lack of Efficacy|1
34644|NCT01399697|141843|P2|Overall Study|Lack of Efficacy|0
34645|NCT01399697|141844|P1|Overall Study|Lack of Efficacy|9
34646|NCT01399697|141842|P3|Overall Study|Investigator Decisión|2
34647|NCT01399697|141843|P2|Overall Study|Investigator Decisión|0
34648|NCT01399697|141844|P1|Overall Study|Investigator Decisión|1
34649|NCT01399697|141842|P3|Overall Study|Withdrawal by Subject|0
34650|NCT01399697|141843|P2|Overall Study|Withdrawal by Subject|0
34651|NCT01399697|141844|P1|Overall Study|Withdrawal by Subject|8
34652|NCT01399697|141842|P3|Overall Study|Lost to Follow-up|0
34653|NCT01399697|141843|P2|Overall Study|Lost to Follow-up|0
34654|NCT01399697|141844|P1|Overall Study|Lost to Follow-up|2
34655|NCT01399697|141842|P3|Overall Study|Adverse Event|1
34656|NCT01399697|141843|P2|Overall Study|Adverse Event|3
34657|NCT01399697|141844|P1|Overall Study|Adverse Event|13
34658|NCT01399619|141871|P4|Overall Study|Not treated|2
34659|NCT01399619|141872|P3|Overall Study|Not treated|0
34660|NCT01399619|141873|P2|Overall Study|Not treated|0
34661|NCT01399619|141874|P1|Overall Study|Not treated|0
34662|NCT01399619|141871|P4|Overall Study|Protocol Violation|1
34663|NCT01399619|141872|P3|Overall Study|Protocol Violation|0
34664|NCT01399619|141873|P2|Overall Study|Protocol Violation|0
34665|NCT01399619|141874|P1|Overall Study|Protocol Violation|0
34666|NCT01399619|141871|P4|Overall Study|Withdrawal by Subject|4
34667|NCT01399619|141872|P3|Overall Study|Withdrawal by Subject|3
34668|NCT01399619|141873|P2|Overall Study|Withdrawal by Subject|0
34669|NCT01399619|141874|P1|Overall Study|Withdrawal by Subject|6
34670|NCT01399619|141871|P4|Overall Study|Lack of Efficacy|0
34671|NCT01399619|141872|P3|Overall Study|Lack of Efficacy|5
34672|NCT01399619|141873|P2|Overall Study|Lack of Efficacy|0
34673|NCT01399619|141874|P1|Overall Study|Lack of Efficacy|9
34674|NCT01399619|141871|P4|Overall Study|Adverse Event|10
34675|NCT01399619|141872|P3|Overall Study|Adverse Event|4
34676|NCT01399619|141873|P2|Overall Study|Adverse Event|0
34677|NCT01399619|141874|P1|Overall Study|Adverse Event|10
34678|NCT01399190|141941|P1|Overall Study|Physician Decision|2
34679|NCT01399190|141941|P1|Overall Study|Participant's Request|5
34680|NCT01399190|141941|P1|Overall Study|Adverse Event|8
34681|NCT01399190|141941|P1|Overall Study|Not Eligible for Final Analysis|5
34682|NCT01399125|141949|P2|Overall Study|Protocol Deviation|2
34683|NCT01399125|141950|P1|Overall Study|Protocol Deviation|5
34684|NCT01399125|141949|P2|Overall Study|Death|1
34685|NCT01399125|141950|P1|Overall Study|Death|0
34686|NCT01399125|141949|P2|Overall Study|Administrative Problems|11
34687|NCT01399125|141950|P1|Overall Study|Administrative Problems|7
34688|NCT01399125|141949|P2|Overall Study|Lost to Follow-up|3
34689|NCT01399125|141950|P1|Overall Study|Lost to Follow-up|2
34690|NCT01399125|141949|P2|Overall Study|Withdrawal by Subject|8
34691|NCT01399125|141950|P1|Overall Study|Withdrawal by Subject|5
34692|NCT01399125|141949|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
34693|NCT01399125|141950|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
34694|NCT01399125|141949|P2|Overall Study|Abnormal Lab values|1
34695|NCT01399125|141950|P1|Overall Study|Abnormal Lab values|0
34696|NCT01399125|141949|P2|Overall Study|Adverse Event|30
34697|NCT01399125|141950|P1|Overall Study|Adverse Event|32
34698|NCT01399099|141964|P1|Overall Study|Miscellaneous|4
34699|NCT01399099|141964|P1|Overall Study|Infection|1
34700|NCT01399099|141964|P1|Overall Study|Skin Irritation|13
34701|NCT01399099|141964|P1|Overall Study|Protocol Violation|1
34702|NCT01399099|141964|P1|Overall Study|Physician Decision|1
34703|NCT01399099|141964|P1|Overall Study|Lost to Follow-up|11
34704|NCT01399047|141971|P2|Overall Study|Withdrawal by Subject|1
34705|NCT01399047|141972|P1|Overall Study|Withdrawal by Subject|0
34706|NCT01398787|142013|P1|Overall Study|Adverse Event|1
34707|NCT01398514|142031|P2|Overall Study|Failure to show a conditioned response|3
34708|NCT01398514|142032|P1|Overall Study|Failure to show a conditioned response|4
34709|NCT01398514|142031|P2|Overall Study|Physiologic non-responsiveness|3
34710|NCT01398514|142032|P1|Overall Study|Physiologic non-responsiveness|1
34711|NCT01398514|142031|P2|Overall Study|Non-compliance with study procedures|0
34712|NCT01398514|142032|P1|Overall Study|Non-compliance with study procedures|2
34713|NCT01398514|142031|P2|Overall Study|Adverse Event|0
34714|NCT01398514|142032|P1|Overall Study|Adverse Event|1
34715|NCT01398410|142046|P2|Overall Study|Not Specified|29
34716|NCT01398410|142047|P1|Overall Study|Not Specified|36
34717|NCT01398410|142046|P2|Overall Study|Inadequate Therapeutic Effect|0
34718|NCT01398410|142047|P1|Overall Study|Inadequate Therapeutic Effect|2
34719|NCT01398410|142046|P2|Overall Study|Participants Choice|11
34720|NCT01398410|142047|P1|Overall Study|Participants Choice|8
34721|NCT01398410|142046|P2|Overall Study|Adverse Event|16
34722|NCT01398410|142047|P1|Overall Study|Adverse Event|12
34723|NCT01398176|142057|P2|Overall Study|Physician Decision|3
34724|NCT01398176|142058|P1|Overall Study|Physician Decision|2
34725|NCT01398176|142057|P2|Overall Study|Lost to Follow-up|3
34726|NCT01398176|142058|P1|Overall Study|Lost to Follow-up|1
34727|NCT01397890|142066|P2|Overall Study|Others|1
34728|NCT01397890|142067|P1|Overall Study|Others|2
34729|NCT01397890|142066|P2|Overall Study|Severe Non-Compliance to Protocol|1
34730|NCT01397890|142067|P1|Overall Study|Severe Non-Compliance to Protocol|2
34731|NCT01397890|142066|P2|Overall Study|Adverse Event|2
34732|NCT01397890|142067|P1|Overall Study|Adverse Event|1
34733|NCT01397890|142066|P2|Overall Study|Condition under Investigation Worsened|3
34734|NCT01397890|142067|P1|Overall Study|Condition under Investigation Worsened|1
34735|NCT01397890|142066|P2|Overall Study|Lost to Follow-up|4
34736|NCT01397890|142067|P1|Overall Study|Lost to Follow-up|1
34737|NCT01397890|142066|P2|Overall Study|Death|3
34738|NCT01397890|142067|P1|Overall Study|Death|2
34739|NCT01397890|142066|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
34740|NCT01397890|142067|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
34741|NCT01397890|142066|P2|Overall Study|Withdrawal by Subject|11
34742|NCT01397890|142067|P1|Overall Study|Withdrawal by Subject|7
34743|NCT01397747|142134|P1|Overall Study|FIT excluded|34
34744|NCT01397747|142134|P1|Overall Study|Colonoscopy excluded|304
34745|NCT01397747|142134|P1|Overall Study|Multitarget DNA test excluded|689
34746|NCT01397461|142166|P3|Overall Study|Not treated|1
34747|NCT01397461|142167|P2|Overall Study|Not treated|0
34748|NCT01397461|142168|P1|Overall Study|Not treated|0
34749|NCT01397461|142166|P3|Overall Study|Lack of Efficacy|0
34750|NCT01397461|142167|P2|Overall Study|Lack of Efficacy|3
34751|NCT01397461|142168|P1|Overall Study|Lack of Efficacy|0
34752|NCT01397461|142166|P3|Overall Study|Lost to Follow-up|1
34753|NCT01397461|142167|P2|Overall Study|Lost to Follow-up|2
34754|NCT01397461|142168|P1|Overall Study|Lost to Follow-up|0
34755|NCT01397461|142166|P3|Overall Study|Withdrawal by Subject|0
34756|NCT01397461|142167|P2|Overall Study|Withdrawal by Subject|1
34757|NCT01397461|142168|P1|Overall Study|Withdrawal by Subject|2
34758|NCT01397448|142179|P3|Overall Study|Not specified|4
34759|NCT01397448|142180|P2|Overall Study|Not specified|7
34760|NCT01397448|142181|P1|Overall Study|Not specified|8
34761|NCT01397448|142179|P3|Overall Study|Lack of Efficacy|5
34762|NCT01397448|142180|P2|Overall Study|Lack of Efficacy|0
34763|NCT01397448|142181|P1|Overall Study|Lack of Efficacy|2
34764|NCT01397448|142179|P3|Overall Study|Withdrawal by Subject|3
34765|NCT01397448|142180|P2|Overall Study|Withdrawal by Subject|4
34766|NCT01397448|142181|P1|Overall Study|Withdrawal by Subject|4
34767|NCT01397448|142179|P3|Overall Study|Adverse Event|6
34768|NCT01397448|142180|P2|Overall Study|Adverse Event|4
34769|NCT01397448|142181|P1|Overall Study|Adverse Event|4
34770|NCT01397409|142202|P10|Stage 3|Other Miscellaneous Reasons|0
34771|NCT01397409|142203|P9|Stage 3|Other Miscellaneous Reasons|0
34772|NCT01397409|142204|P8|Stage 3|Other Miscellaneous Reasons|1
34773|NCT01397409|142205|P7|Stage 3|Other Miscellaneous Reasons|0
34774|NCT01397409|142206|P6|Stage 3|Other Miscellaneous Reasons|0
34775|NCT01397409|142207|P5|Stage 3|Other Miscellaneous Reasons|0
34776|NCT01397409|142208|P4|Stage 3|Other Miscellaneous Reasons|0
34777|NCT01397409|142209|P3|Stage 3|Other Miscellaneous Reasons|0
34778|NCT01397409|142210|P2|Stage 3|Other Miscellaneous Reasons|0
34779|NCT01397409|142211|P1|Stage 3|Other Miscellaneous Reasons|0
34780|NCT01397409|142202|P10|Stage 3|Adverse Event|0
34781|NCT01397409|142203|P9|Stage 3|Adverse Event|0
34782|NCT01397409|142204|P8|Stage 3|Adverse Event|1
34783|NCT01397409|142205|P7|Stage 3|Adverse Event|0
34784|NCT01397409|142206|P6|Stage 3|Adverse Event|0
34785|NCT01397409|142207|P5|Stage 3|Adverse Event|0
34786|NCT01397409|142208|P4|Stage 3|Adverse Event|0
34787|NCT01397409|142209|P3|Stage 3|Adverse Event|0
34788|NCT01397409|142210|P2|Stage 3|Adverse Event|0
34789|NCT01397409|142211|P1|Stage 3|Adverse Event|0
34790|NCT01397409|142202|P10|Stage 2|Other Miscellaneous Reasons|0
34791|NCT01397409|142203|P9|Stage 2|Other Miscellaneous Reasons|0
34792|NCT01397409|142204|P8|Stage 2|Other Miscellaneous Reasons|0
34793|NCT01397409|142205|P7|Stage 2|Other Miscellaneous Reasons|0
34794|NCT01397409|142206|P6|Stage 2|Other Miscellaneous Reasons|1
34795|NCT01397409|142207|P5|Stage 2|Other Miscellaneous Reasons|1
34796|NCT01397409|142208|P4|Stage 2|Other Miscellaneous Reasons|0
34797|NCT01397409|142209|P3|Stage 2|Other Miscellaneous Reasons|0
34798|NCT01397409|142210|P2|Stage 2|Other Miscellaneous Reasons|0
34799|NCT01397409|142211|P1|Stage 2|Other Miscellaneous Reasons|0
34800|NCT01397409|142202|P10|Stage 2|Personal Reasons|0
34801|NCT01397409|142203|P9|Stage 2|Personal Reasons|0
34802|NCT01397409|142204|P8|Stage 2|Personal Reasons|0
34803|NCT01397409|142205|P7|Stage 2|Personal Reasons|0
34804|NCT01397409|142206|P6|Stage 2|Personal Reasons|0
34805|NCT01397409|142207|P5|Stage 2|Personal Reasons|1
34806|NCT01397409|142208|P4|Stage 2|Personal Reasons|0
34807|NCT01397409|142209|P3|Stage 2|Personal Reasons|0
34808|NCT01397409|142210|P2|Stage 2|Personal Reasons|0
34809|NCT01397409|142211|P1|Stage 2|Personal Reasons|0
34810|NCT01397409|142202|P10|Stage 2|Adverse Event|0
34811|NCT01397409|142203|P9|Stage 2|Adverse Event|0
34812|NCT01397409|142204|P8|Stage 2|Adverse Event|0
34813|NCT01397409|142205|P7|Stage 2|Adverse Event|0
34814|NCT01397409|142206|P6|Stage 2|Adverse Event|3
34815|NCT01397409|142207|P5|Stage 2|Adverse Event|6
34816|NCT01397409|142208|P4|Stage 2|Adverse Event|0
34817|NCT01397409|142209|P3|Stage 2|Adverse Event|0
34818|NCT01397409|142210|P2|Stage 2|Adverse Event|0
34819|NCT01397409|142211|P1|Stage 2|Adverse Event|0
34820|NCT01397253|142251|P2|Overall Study|Reviewed by only 1 pharmacist|149
34821|NCT01397253|142252|P1|Overall Study|Reviewed by only 1 pharmacist|126
34822|NCT01397084|142258|P1|Overall Study|Used other proton pump inhibitor|1
34823|NCT01397084|142258|P1|Overall Study|Lost to Follow-up|1
34824|NCT01397084|142258|P1|Overall Study|Withdrawal by Subject|1
34825|NCT01397084|142258|P1|Overall Study|Adverse Event|2
34826|NCT01397084|142258|P1|Overall Study|Protocol Violation|2
34827|NCT01397084|142258|P1|Overall Study|Severe Non-Compliance to Protocol|1
34828|NCT01396525|142265|P1|Overall Study|Lost to Follow-up|4
34829|NCT01396525|142265|P1|Overall Study|Death|14
34830|NCT01396525|142265|P1|Overall Study|Withdrawal by Subject|8
34831|NCT01396512|142365|P2|Overall Study|Withdrawal by Subject|1
34832|NCT01396512|142366|P1|Overall Study|Withdrawal by Subject|0
34833|NCT01396434|142381|P3|Overall Study|Unspecified|0
34834|NCT01396434|142382|P2|Overall Study|Unspecified|0
34835|NCT01396434|142383|P1|Overall Study|Unspecified|10
34836|NCT01396434|142381|P3|Overall Study|Lost to Follow-up|0
34837|NCT01396434|142382|P2|Overall Study|Lost to Follow-up|0
34838|NCT01396434|142383|P1|Overall Study|Lost to Follow-up|1
34839|NCT01396421|142395|P4|Overall Study|Lack of Efficacy|18
34840|NCT01396421|142396|P3|Overall Study|Lack of Efficacy|7
34841|NCT01396421|142397|P2|Overall Study|Lack of Efficacy|17
34842|NCT01396421|142398|P1|Overall Study|Lack of Efficacy|7
34843|NCT01396421|142395|P4|Overall Study|Protocol Deviation|0
34844|NCT01396421|142396|P3|Overall Study|Protocol Deviation|1
34845|NCT01396421|142397|P2|Overall Study|Protocol Deviation|1
34846|NCT01396421|142398|P1|Overall Study|Protocol Deviation|2
34847|NCT01396421|142395|P4|Overall Study|Withdrawal by Subject|21
34848|NCT01396421|142396|P3|Overall Study|Withdrawal by Subject|13
34849|NCT01396421|142397|P2|Overall Study|Withdrawal by Subject|24
34850|NCT01396421|142398|P1|Overall Study|Withdrawal by Subject|31
34851|NCT01396421|142395|P4|Overall Study|Physician Decision|3
34852|NCT01396421|142396|P3|Overall Study|Physician Decision|0
34853|NCT01396421|142397|P2|Overall Study|Physician Decision|1
34854|NCT01396421|142398|P1|Overall Study|Physician Decision|1
34855|NCT01396421|142395|P4|Overall Study|Participant Met Withdrawal Criteria|0
34856|NCT01396421|142396|P3|Overall Study|Participant Met Withdrawal Criteria|1
34857|NCT01396421|142397|P2|Overall Study|Participant Met Withdrawal Criteria|0
34858|NCT01396421|142398|P1|Overall Study|Participant Met Withdrawal Criteria|1
34859|NCT01396421|142395|P4|Overall Study|Adverse Event|32
34860|NCT01396421|142396|P3|Overall Study|Adverse Event|12
34861|NCT01396421|142397|P2|Overall Study|Adverse Event|15
34862|NCT01396421|142398|P1|Overall Study|Adverse Event|17
34863|NCT01396421|142395|P4|Overall Study|Lost to Follow-up|1
34864|NCT01396421|142396|P3|Overall Study|Lost to Follow-up|0
34865|NCT01396421|142397|P2|Overall Study|Lost to Follow-up|0
34866|NCT01396421|142398|P1|Overall Study|Lost to Follow-up|0
34867|NCT01396395|142470|P2|Overall Study|Unspecified|1
34868|NCT01396395|142471|P1|Overall Study|Unspecified|0
34869|NCT01396395|142470|P2|Overall Study|Lost to Follow-up|11
34870|NCT01396395|142471|P1|Overall Study|Lost to Follow-up|17
34871|NCT01396395|142470|P2|Overall Study|Adverse Event|2
34872|NCT01396395|142471|P1|Overall Study|Adverse Event|10
34873|NCT01396395|142470|P2|Overall Study|Protocol Violation|1
34874|NCT01396395|142471|P1|Overall Study|Protocol Violation|3
34875|NCT01396395|142470|P2|Overall Study|Withdrawal by Subject|12
34876|NCT01396395|142471|P1|Overall Study|Withdrawal by Subject|10
34877|NCT01396265|142511|P1|Rifa+Afatinib|Withdrawal by Subject|1
34878|NCT01396187|142600|P5|Overall Study|Unspecified|1
34879|NCT01396187|142601|P4|Overall Study|Unspecified|0
34880|NCT01396187|142602|P3|Overall Study|Unspecified|0
34881|NCT01396187|142603|P2|Overall Study|Unspecified|1
34882|NCT01396187|142604|P1|Overall Study|Unspecified|1
34883|NCT01396187|142600|P5|Overall Study|Withdrawal by Subject|0
34884|NCT01396187|142601|P4|Overall Study|Withdrawal by Subject|0
34885|NCT01396187|142602|P3|Overall Study|Withdrawal by Subject|1
34886|NCT01396187|142603|P2|Overall Study|Withdrawal by Subject|1
34887|NCT01396187|142604|P1|Overall Study|Withdrawal by Subject|0
34888|NCT01396187|142600|P5|Overall Study|Adverse Event|0
34889|NCT01396187|142601|P4|Overall Study|Adverse Event|0
34890|NCT01396187|142602|P3|Overall Study|Adverse Event|0
34891|NCT01396187|142603|P2|Overall Study|Adverse Event|1
34892|NCT01396187|142604|P1|Overall Study|Adverse Event|0
34893|NCT01396161|142704|P7|Overall Study|unspecified|1
34894|NCT01396161|142705|P6|Overall Study|unspecified|0
34895|NCT01396161|142706|P5|Overall Study|unspecified|0
34896|NCT01396161|142707|P4|Overall Study|unspecified|0
34897|NCT01396161|142708|P3|Overall Study|unspecified|0
34898|NCT01396161|142709|P2|Overall Study|unspecified|0
34899|NCT01396161|142710|P1|Overall Study|unspecified|0
34900|NCT01396161|142704|P7|Overall Study|Withdrawal by Subject|0
34901|NCT01396161|142705|P6|Overall Study|Withdrawal by Subject|0
34902|NCT01396161|142706|P5|Overall Study|Withdrawal by Subject|1
34903|NCT01396161|142707|P4|Overall Study|Withdrawal by Subject|0
34904|NCT01396161|142708|P3|Overall Study|Withdrawal by Subject|0
34905|NCT01396161|142709|P2|Overall Study|Withdrawal by Subject|0
34906|NCT01396161|142710|P1|Overall Study|Withdrawal by Subject|0
34907|NCT01396083|142765|P2|Overall Study|Lost to Follow-up|0
34908|NCT01396083|142766|P1|Overall Study|Lost to Follow-up|1
34909|NCT01396083|142765|P2|Overall Study|Administrative problems|0
34910|NCT01396083|142766|P1|Overall Study|Administrative problems|1
34911|NCT01396083|142765|P2|Overall Study|Abnormal laboratory value(s)|0
34912|NCT01396083|142766|P1|Overall Study|Abnormal laboratory value(s)|1
34913|NCT01396083|142765|P2|Overall Study|Protocol deviation(s)|1
34914|NCT01396083|142766|P1|Overall Study|Protocol deviation(s)|0
34915|NCT01396083|142765|P2|Overall Study|Consent withdrawn|5
34916|NCT01396083|142766|P1|Overall Study|Consent withdrawn|4
34917|NCT01396083|142765|P2|Overall Study|Unsatisfactory therapeutic effect|13
34918|NCT01396083|142766|P1|Overall Study|Unsatisfactory therapeutic effect|2
34919|NCT01396083|142765|P2|Overall Study|Adverse Event|28
34920|NCT01396083|142766|P1|Overall Study|Adverse Event|2
34921|NCT01396057|142792|P2|Overall Study|Consent withdrawn|2
34922|NCT01396057|142793|P1|Overall Study|Consent withdrawn|3
34923|NCT01396057|142792|P2|Overall Study|Protocol deviation|4
34924|NCT01396057|142793|P1|Overall Study|Protocol deviation|4
34925|NCT01396057|142792|P2|Overall Study|Unsatisfactory therapeutic effect|6
34926|NCT01396057|142793|P1|Overall Study|Unsatisfactory therapeutic effect|2
34927|NCT01396057|142792|P2|Overall Study|Adverse Event|6
34928|NCT01396057|142793|P1|Overall Study|Adverse Event|2
34929|NCT01396005|142842|P2|Overall Study|Non-compliance with protocol|1
34930|NCT01396005|142843|P1|Overall Study|Non-compliance with protocol|0
34931|NCT01396005|142842|P2|Overall Study|Withdrawal by Subject|1
34932|NCT01396005|142843|P1|Overall Study|Withdrawal by Subject|0
34933|NCT01395901|142874|P2|Overall Study|Withdrawal of consent|0
34934|NCT01395901|142875|P1|Overall Study|Withdrawal of consent|1
34935|NCT01395901|142874|P2|Overall Study|Adverse Event|1
34936|NCT01395901|142875|P1|Overall Study|Adverse Event|0
34937|NCT01395901|142874|P2|Overall Study|Randomized but not received study drug|4
34938|NCT01395901|142875|P1|Overall Study|Randomized but not received study drug|5
34939|NCT01395901|142874|P2|Overall Study|Lost to Follow-up|0
34940|NCT01395901|142875|P1|Overall Study|Lost to Follow-up|4
34941|NCT01395888|142891|P3|Treatment Period (TP)|Withdrawal by Subject|3
34942|NCT01395888|142892|P2|Treatment Period (TP)|Withdrawal by Subject|2
34943|NCT01395888|142893|P1|Treatment Period (TP)|Withdrawal by Subject|0
34944|NCT01395888|142891|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
34945|NCT01395888|142892|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
34946|NCT01395888|142893|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
34947|NCT01395888|142891|P3|Treatment Period (TP)|Protocol Violation|5
34948|NCT01395888|142892|P2|Treatment Period (TP)|Protocol Violation|1
34949|NCT01395888|142893|P1|Treatment Period (TP)|Protocol Violation|0
34950|NCT01395888|142891|P3|Treatment Period (TP)|Lack of Efficacy|3
34951|NCT01395888|142892|P2|Treatment Period (TP)|Lack of Efficacy|4
34952|NCT01395888|142893|P1|Treatment Period (TP)|Lack of Efficacy|0
34953|NCT01395888|142891|P3|Treatment Period (TP)|Adverse Event|6
34954|NCT01395888|142892|P2|Treatment Period (TP)|Adverse Event|7
34955|NCT01395888|142893|P1|Treatment Period (TP)|Adverse Event|0
34956|NCT01395888|142891|P3|2-week Run-in Period|Withdrawal by Subject|0
34957|NCT01395888|142892|P2|2-week Run-in Period|Withdrawal by Subject|0
34958|NCT01395888|142893|P1|2-week Run-in Period|Withdrawal by Subject|4
34959|NCT01395888|142891|P3|2-week Run-in Period|Protocol Violation|0
34960|NCT01395888|142892|P2|2-week Run-in Period|Protocol Violation|0
34961|NCT01395888|142893|P1|2-week Run-in Period|Protocol Violation|2
34962|NCT01395888|142891|P3|2-week Run-in Period|Lost to Follow-up|0
34963|NCT01395888|142892|P2|2-week Run-in Period|Lost to Follow-up|0
34964|NCT01395888|142893|P1|2-week Run-in Period|Lost to Follow-up|1
34965|NCT01395888|142891|P3|2-week Run-in Period|Continuation Criteria Not Met|0
34966|NCT01395888|142892|P2|2-week Run-in Period|Continuation Criteria Not Met|0
34967|NCT01395888|142893|P1|2-week Run-in Period|Continuation Criteria Not Met|13
34968|NCT01395888|142891|P3|2-week Run-in Period|Adverse Event|0
34969|NCT01395888|142892|P2|2-week Run-in Period|Adverse Event|0
34970|NCT01395888|142893|P1|2-week Run-in Period|Adverse Event|2
34971|NCT01395823|142901|P2|Overall Study|Withdrawal by Subject|4
34972|NCT01395823|142902|P1|Overall Study|Withdrawal by Subject|5
34973|NCT01395823|142901|P2|Overall Study|GI symptoms|0
34974|NCT01395823|142902|P1|Overall Study|GI symptoms|1
34975|NCT01395823|142901|P2|Overall Study|Transplant|0
34976|NCT01395823|142902|P1|Overall Study|Transplant|1
34977|NCT01395823|142901|P2|Overall Study|Lost to Follow-up|0
34978|NCT01395823|142902|P1|Overall Study|Lost to Follow-up|1
34979|NCT01395823|142901|P2|Overall Study|Physician Decision|1
34980|NCT01395823|142902|P1|Overall Study|Physician Decision|3
34981|NCT01395823|142901|P2|Overall Study|Death|4
34982|NCT01395823|142902|P1|Overall Study|Death|4
34983|NCT01395784|142908|P1|Overall Study|Physician Decision|5
34984|NCT01395784|142908|P1|Overall Study|Withdrawal by Subject|3
34985|NCT01395784|142908|P1|Overall Study|Lost to Follow-up|7
34986|NCT01395524|142916|P3|Overall Study|Subject had spinal surgery|1
34987|NCT01395524|142917|P2|Overall Study|Subject had spinal surgery|0
34988|NCT01395524|142918|P1|Overall Study|Subject had spinal surgery|0
34989|NCT01395524|142916|P3|Overall Study|Did not receive treatment|3
34990|NCT01395524|142917|P2|Overall Study|Did not receive treatment|1
34991|NCT01395524|142918|P1|Overall Study|Did not receive treatment|1
34992|NCT01395524|142916|P3|Overall Study|Withdrawal by Subject|8
34993|NCT01395524|142917|P2|Overall Study|Withdrawal by Subject|8
34994|NCT01395524|142918|P1|Overall Study|Withdrawal by Subject|4
34995|NCT01395524|142916|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
34996|NCT01395524|142917|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
34997|NCT01395524|142918|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
34998|NCT01395524|142916|P3|Overall Study|Death|0
34999|NCT01395524|142917|P2|Overall Study|Death|0
35000|NCT01395524|142918|P1|Overall Study|Death|1
35001|NCT01395524|142916|P3|Overall Study|Adverse Event|3
35002|NCT01395524|142917|P2|Overall Study|Adverse Event|4
35003|NCT01395524|142918|P1|Overall Study|Adverse Event|4
35004|NCT01395524|142916|P3|Overall Study|Severe noncompliance with protocol|0
35005|NCT01395524|142917|P2|Overall Study|Severe noncompliance with protocol|0
35006|NCT01395524|142918|P1|Overall Study|Severe noncompliance with protocol|1
35007|NCT01395524|142916|P3|Overall Study|Study-Specific Withdrawal Criteria|0
35008|NCT01395524|142917|P2|Overall Study|Study-Specific Withdrawal Criteria|2
35009|NCT01395524|142918|P1|Overall Study|Study-Specific Withdrawal Criteria|1
35010|NCT01395524|142916|P3|Overall Study|Lost to Follow-up|1
35011|NCT01395524|142917|P2|Overall Study|Lost to Follow-up|1
35012|NCT01395524|142918|P1|Overall Study|Lost to Follow-up|3
35013|NCT01395524|142916|P3|Overall Study|Non-compliance with study schedule|1
35014|NCT01395524|142917|P2|Overall Study|Non-compliance with study schedule|0
35015|NCT01395524|142918|P1|Overall Study|Non-compliance with study schedule|1
35016|NCT01395394|142941|P3|Baseline Study Visit|Protocol Violation|0
35017|NCT01395394|142942|P2|Baseline Study Visit|Protocol Violation|0
35018|NCT01395394|142943|P1|Baseline Study Visit|Protocol Violation|1
35019|NCT01395368|142954|P1|Overall Study|Withdrawal by Subject|2
35020|NCT01395368|142954|P1|Overall Study|Physician Decision|14
35021|NCT01395017|142976|P2|Overall Study|Sponsor discontinued study|4
35022|NCT01395017|142977|P1|Overall Study|Sponsor discontinued study|1
35023|NCT01395017|142976|P2|Overall Study|Disease progression|58
35024|NCT01395017|142977|P1|Overall Study|Disease progression|42
35025|NCT01395017|142976|P2|Overall Study|Death|3
35026|NCT01395017|142977|P1|Overall Study|Death|4
35027|NCT01395017|142976|P2|Overall Study|Protocol deviation|2
35028|NCT01395017|142977|P1|Overall Study|Protocol deviation|1
35029|NCT01395017|142976|P2|Overall Study|Withdrawal by Subject|8
35030|NCT01395017|142977|P1|Overall Study|Withdrawal by Subject|14
35031|NCT01395017|142976|P2|Overall Study|Physician Decision|15
35032|NCT01395017|142977|P1|Overall Study|Physician Decision|11
35033|NCT01395017|142976|P2|Overall Study|Adverse Event|12
35034|NCT01395017|142977|P1|Overall Study|Adverse Event|26
35035|NCT01395017|142976|P2|Overall Study|Lost to Follow-up|0
35036|NCT01395017|142977|P1|Overall Study|Lost to Follow-up|1
35037|NCT01394991|142987|P2|Overall Study|Prematurely Termination of Trial|10
35038|NCT01394991|142988|P1|Overall Study|Prematurely Termination of Trial|9
35039|NCT01394991|142987|P2|Overall Study|Disease Progression|7
35040|NCT01394991|142988|P1|Overall Study|Disease Progression|7
35041|NCT01394991|142987|P2|Overall Study|Chemotherapy Termination|15
35042|NCT01394991|142988|P1|Overall Study|Chemotherapy Termination|10
35043|NCT01394991|142987|P2|Overall Study|Withdrawal by Subject|17
35044|NCT01394991|142988|P1|Overall Study|Withdrawal by Subject|20
35045|NCT01394991|142987|P2|Overall Study|Protocol Violation|1
35046|NCT01394991|142988|P1|Overall Study|Protocol Violation|1
35047|NCT01394991|142987|P2|Overall Study|Physician Decision|3
35048|NCT01394991|142988|P1|Overall Study|Physician Decision|1
35049|NCT01394991|142987|P2|Overall Study|Lost to Follow-up|8
35050|NCT01394991|142988|P1|Overall Study|Lost to Follow-up|6
35051|NCT01394991|142987|P2|Overall Study|Lack of Efficacy|7
35052|NCT01394991|142988|P1|Overall Study|Lack of Efficacy|5
35053|NCT01394991|142987|P2|Overall Study|Adverse Event|4
35054|NCT01394991|142988|P1|Overall Study|Adverse Event|0
35055|NCT01394718|143019|P2|Overall Study|Met protocol-specific stopping criteria|1
35056|NCT01394718|143020|P1|Overall Study|Met protocol-specific stopping criteria|2
35057|NCT01394276|143056|P1|Overall Study|Symptoms of concurrent diseases|1
35058|NCT01394276|143056|P1|Overall Study|unavailability of drug at the Hospital|2
35059|NCT01394276|143056|P1|Overall Study|Pregnancy|1
35060|NCT01394276|143056|P1|Overall Study|Participant moved to another site|1
35061|NCT01394276|143056|P1|Overall Study|Lost to Follow-up|5
35062|NCT01394276|143056|P1|Overall Study|Insufficient compliance|9
35063|NCT01394276|143056|P1|Overall Study|Insufficient therapeutic effect|17
35064|NCT01394276|143056|P1|Overall Study|Remission of disease|2
35065|NCT01394276|143056|P1|Overall Study|Not related AEs|9
35066|NCT01394276|143056|P1|Overall Study|Related Adverse event (AEs)|15
35067|NCT01394250|143080|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
35068|NCT01394250|143081|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
35069|NCT01394250|143080|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
35070|NCT01394250|143081|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
35071|NCT01393964|143105|P3|Overall Study|non-specified|1
35072|NCT01393964|143106|P2|Overall Study|non-specified|0
35073|NCT01393964|143107|P1|Overall Study|non-specified|2
35074|NCT01393964|143105|P3|Overall Study|study drug toxicity|0
35075|NCT01393964|143106|P2|Overall Study|study drug toxicity|0
35076|NCT01393964|143107|P1|Overall Study|study drug toxicity|1
35077|NCT01393964|143105|P3|Overall Study|Disease Progression|3
35078|NCT01393964|143106|P2|Overall Study|Disease Progression|3
35079|NCT01393964|143107|P1|Overall Study|Disease Progression|3
35080|NCT01393964|143105|P3|Overall Study|Withdrawal by Subject|1
35081|NCT01393964|143106|P2|Overall Study|Withdrawal by Subject|0
35082|NCT01393964|143107|P1|Overall Study|Withdrawal by Subject|0
35083|NCT01393964|143105|P3|Overall Study|Adverse Event|0
35084|NCT01393964|143106|P2|Overall Study|Adverse Event|1
35085|NCT01393964|143107|P1|Overall Study|Adverse Event|0
35086|NCT01393899|143148|P3|Overall Study|Adverse Event|3
35087|NCT01393899|143149|P2|Overall Study|Adverse Event|5
35088|NCT01393899|143150|P1|Overall Study|Adverse Event|1
35089|NCT01393899|143148|P3|Overall Study|Lack of Efficacy|16
35090|NCT01393899|143149|P2|Overall Study|Lack of Efficacy|21
35091|NCT01393899|143150|P1|Overall Study|Lack of Efficacy|26
35092|NCT01393899|143148|P3|Overall Study|Does not meet entrance criteria|1
35093|NCT01393899|143149|P2|Overall Study|Does not meet entrance criteria|0
35094|NCT01393899|143150|P1|Overall Study|Does not meet entrance criteria|1
35095|NCT01393899|143148|P3|Overall Study|Lost to Follow-up|1
35096|NCT01393899|143149|P2|Overall Study|Lost to Follow-up|0
35097|NCT01393899|143150|P1|Overall Study|Lost to Follow-up|0
35098|NCT01393899|143148|P3|Overall Study|Withdrawal by Subject|1
35099|NCT01393899|143149|P2|Overall Study|Withdrawal by Subject|2
35100|NCT01393899|143150|P1|Overall Study|Withdrawal by Subject|2
35101|NCT01393899|143148|P3|Overall Study|Unspecified|0
35102|NCT01393899|143149|P2|Overall Study|Unspecified|0
35103|NCT01393899|143150|P1|Overall Study|Unspecified|1
35104|NCT01393899|143148|P3|Overall Study|Study terminated by sponsor|1
35105|NCT01393899|143149|P2|Overall Study|Study terminated by sponsor|0
35106|NCT01393899|143150|P1|Overall Study|Study terminated by sponsor|1
35107|NCT01393743|143204|P2|Overall Study|Inadequate therapeutic effect|0
35108|NCT01393743|143205|P1|Overall Study|Inadequate therapeutic effect|2
35109|NCT01393743|143204|P2|Overall Study|Participant's Choice|3
35110|NCT01393743|143205|P1|Overall Study|Participant's Choice|2
35111|NCT01393743|143204|P2|Overall Study|Lost to Follow-up|1
35112|NCT01393743|143205|P1|Overall Study|Lost to Follow-up|1
35113|NCT01393743|143204|P2|Overall Study|Adverse Event|9
35114|NCT01393743|143205|P1|Overall Study|Adverse Event|5
35115|NCT01393613|143227|P4|Overall Study|Lack of Efficacy|21
35116|NCT01393613|143228|P3|Overall Study|Lack of Efficacy|16
35117|NCT01393613|143229|P2|Overall Study|Lack of Efficacy|20
35118|NCT01393613|143230|P1|Overall Study|Lack of Efficacy|9
35119|NCT01393613|143227|P4|Overall Study|Protocol Deviation|0
35120|NCT01393613|143228|P3|Overall Study|Protocol Deviation|0
35121|NCT01393613|143229|P2|Overall Study|Protocol Deviation|1
35122|NCT01393613|143230|P1|Overall Study|Protocol Deviation|2
35123|NCT01393613|143227|P4|Overall Study|Withdrawal by Subject|21
35124|NCT01393613|143228|P3|Overall Study|Withdrawal by Subject|23
35125|NCT01393613|143229|P2|Overall Study|Withdrawal by Subject|25
35126|NCT01393613|143230|P1|Overall Study|Withdrawal by Subject|15
35127|NCT01393613|143227|P4|Overall Study|Physician Decision|1
35128|NCT01393613|143228|P3|Overall Study|Physician Decision|0
35129|NCT01393613|143229|P2|Overall Study|Physician Decision|0
35130|NCT01393613|143230|P1|Overall Study|Physician Decision|2
35131|NCT01393613|143227|P4|Overall Study|Participant Met Withdrawal Criteria|1
35132|NCT01393613|143228|P3|Overall Study|Participant Met Withdrawal Criteria|2
35133|NCT01393613|143229|P2|Overall Study|Participant Met Withdrawal Criteria|0
35134|NCT01393613|143230|P1|Overall Study|Participant Met Withdrawal Criteria|0
35135|NCT01393613|143227|P4|Overall Study|Adverse Event|22
35136|NCT01393613|143228|P3|Overall Study|Adverse Event|13
35137|NCT01393613|143229|P2|Overall Study|Adverse Event|11
35138|NCT01393613|143230|P1|Overall Study|Adverse Event|11
35139|NCT01393444|143292|P1|Overall Study|Determined ineligible during screening.|2
35140|NCT01393444|143292|P1|Overall Study|Withdrawal by Subject|1
35141|NCT01393106|143312|P1|Overall Study|Lack of Efficacy|1
35142|NCT01393106|143312|P1|Overall Study|Withdrawal by Subject|1
35143|NCT01393106|143312|P1|Overall Study|Adverse Event|3
35144|NCT01392742|143329|P1|Overall Study|Missing information|13
35145|NCT01392742|143329|P1|Overall Study|Unspecified|3
35146|NCT01392742|143329|P1|Overall Study|Protocol Violation|14
35147|NCT01392742|143329|P1|Overall Study|Adverse event/intercurrent illness|17
35148|NCT01392742|143329|P1|Overall Study|ITR and Protocol deviation|1
35149|NCT01392742|143329|P1|Overall Study|Insufficient therapeutic response (ITR)|30
35150|NCT01392742|143329|P1|Overall Study|Lost to Follow-up|34
35151|NCT01392742|143329|P1|Overall Study|No treatment/no cooperation/withdrew|12
35152|NCT01392742|143329|P1|Overall Study|Failure to return|35
35153|NCT01392742|143329|P1|Overall Study|Premature study termination|42
35154|NCT01392677|143375|P2|Overall Study|Other reason|2
35155|NCT01392677|143376|P1|Overall Study|Other reason|3
35156|NCT01392677|143375|P2|Overall Study|Incorrect enrollment|3
35157|NCT01392677|143376|P1|Overall Study|Incorrect enrollment|2
35158|NCT01392677|143375|P2|Overall Study|Withdrawal by Subject|2
35159|NCT01392677|143376|P1|Overall Study|Withdrawal by Subject|0
35160|NCT01392677|143375|P2|Overall Study|Adverse Event|1
35161|NCT01392677|143376|P1|Overall Study|Adverse Event|3
35162|NCT01392573|143392|P2|Overall Study|Unclassified|6
35163|NCT01392573|143393|P1|Overall Study|Unclassified|9
35164|NCT01392573|143392|P2|Overall Study|Site closure|7
35165|NCT01392573|143393|P1|Overall Study|Site closure|8
35166|NCT01392573|143392|P2|Overall Study|Withdrawal Criteria|15
35167|NCT01392573|143393|P1|Overall Study|Withdrawal Criteria|13
35168|NCT01392573|143392|P2|Overall Study|Protocol Violation|2
35169|NCT01392573|143393|P1|Overall Study|Protocol Violation|0
35170|NCT01392573|143392|P2|Overall Study|Lack of Efficacy|2
35171|NCT01392573|143393|P1|Overall Study|Lack of Efficacy|1
35172|NCT01392573|143392|P2|Overall Study|Adverse Event|3
35173|NCT01392573|143393|P1|Overall Study|Adverse Event|1
35174|NCT01392560|143401|P1|Overall Study|discontinued during placebo run-in|2
35175|NCT01392560|143401|P1|Overall Study|not entered|8
35176|NCT01392560|143401|P1|Overall Study|Adverse Event|2
35177|NCT01392547|143407|P1|Overall Study|Unclassified|1
35178|NCT01392547|143407|P1|Overall Study|Withdrawal criteria|3
35179|NCT01392547|143407|P1|Overall Study|Non-compliance|2
35180|NCT01392547|143407|P1|Overall Study|Adverse Event|2
35181|NCT01392495|143421|P1|Overall Study|Adverse Event|3
35182|NCT01392495|143421|P1|Overall Study|Withdrawal by Subject|2
35183|NCT01392495|143421|P1|Overall Study|Administrative problems|8
35184|NCT01392495|143421|P1|Overall Study|Death|3
35185|NCT01392378|143438|P5|Toddler Dose|Withdrawal by Parent|1
35186|NCT01392378|143439|P4|Toddler Dose|Withdrawal by Parent|1
35187|NCT01392378|143440|P3|Toddler Dose|Withdrawal by Parent|0
35188|NCT01392378|143441|P2|Toddler Dose|Withdrawal by Parent|1
35189|NCT01392378|143442|P1|Toddler Dose|Withdrawal by Parent|0
35190|NCT01392378|143438|P5|Toddler Dose|Lost to Follow-up|0
35191|NCT01392378|143439|P4|Toddler Dose|Lost to Follow-up|1
35192|NCT01392378|143440|P3|Toddler Dose|Lost to Follow-up|0
35193|NCT01392378|143441|P2|Toddler Dose|Lost to Follow-up|0
35194|NCT01392378|143442|P1|Toddler Dose|Lost to Follow-up|0
35195|NCT01392378|143438|P5|After Infant Series|Withdrawal by Parent|1
35196|NCT01392378|143439|P4|After Infant Series|Withdrawal by Parent|0
35197|NCT01392378|143440|P3|After Infant Series|Withdrawal by Parent|1
35198|NCT01392378|143441|P2|After Infant Series|Withdrawal by Parent|1
35199|NCT01392378|143442|P1|After Infant Series|Withdrawal by Parent|0
35200|NCT01392378|143438|P5|After Infant Series|Lost to Follow-up|0
35201|NCT01392378|143439|P4|After Infant Series|Lost to Follow-up|0
35202|NCT01392378|143440|P3|After Infant Series|Lost to Follow-up|1
35203|NCT01392378|143441|P2|After Infant Series|Lost to Follow-up|0
35204|NCT01392378|143442|P1|After Infant Series|Lost to Follow-up|0
35205|NCT01392378|143438|P5|Infant Series|Withdrawal by Parent|0
35206|NCT01392378|143439|P4|Infant Series|Withdrawal by Parent|0
35207|NCT01392378|143440|P3|Infant Series|Withdrawal by Parent|0
35208|NCT01392378|143441|P2|Infant Series|Withdrawal by Parent|1
35209|NCT01392378|143442|P1|Infant Series|Withdrawal by Parent|4
35210|NCT01392378|143438|P5|Infant Series|Protocol Violation|0
35211|NCT01392378|143439|P4|Infant Series|Protocol Violation|0
35212|NCT01392378|143440|P3|Infant Series|Protocol Violation|0
35213|NCT01392378|143441|P2|Infant Series|Protocol Violation|1
35214|NCT01392378|143442|P1|Infant Series|Protocol Violation|0
35215|NCT01392378|143438|P5|Infant Series|Lost to Follow-up|0
35216|NCT01392378|143439|P4|Infant Series|Lost to Follow-up|1
35217|NCT01392378|143440|P3|Infant Series|Lost to Follow-up|0
35218|NCT01392378|143441|P2|Infant Series|Lost to Follow-up|0
35219|NCT01392378|143442|P1|Infant Series|Lost to Follow-up|0
35220|NCT01392378|143438|P5|Infant Series|Adverse Event|0
35221|NCT01392378|143439|P4|Infant Series|Adverse Event|1
35222|NCT01392378|143440|P3|Infant Series|Adverse Event|0
35223|NCT01392378|143441|P2|Infant Series|Adverse Event|0
35224|NCT01392378|143442|P1|Infant Series|Adverse Event|0
35225|NCT01392326|143582|P3|Overall Study|Adverse Event|11
35226|NCT01392326|143583|P2|Overall Study|Adverse Event|6
35227|NCT01392326|143584|P1|Overall Study|Adverse Event|9
35228|NCT01392326|143582|P3|Overall Study|Lack of Efficacy|15
35229|NCT01392326|143583|P2|Overall Study|Lack of Efficacy|10
35230|NCT01392326|143584|P1|Overall Study|Lack of Efficacy|14
35231|NCT01392326|143582|P3|Overall Study|Lost to Follow-up|4
35232|NCT01392326|143583|P2|Overall Study|Lost to Follow-up|3
35233|NCT01392326|143584|P1|Overall Study|Lost to Follow-up|1
35234|NCT01392326|143582|P3|Overall Study|Physician Decision|2
35235|NCT01392326|143583|P2|Overall Study|Physician Decision|5
35236|NCT01392326|143584|P1|Overall Study|Physician Decision|7
35237|NCT01392326|143582|P3|Overall Study|Pregnancy|1
35238|NCT01392326|143583|P2|Overall Study|Pregnancy|0
35239|NCT01392326|143584|P1|Overall Study|Pregnancy|0
35240|NCT01392326|143582|P3|Overall Study|Protocol Violation|0
35241|NCT01392326|143583|P2|Overall Study|Protocol Violation|0
35242|NCT01392326|143584|P1|Overall Study|Protocol Violation|2
35243|NCT01392326|143582|P3|Overall Study|Withdrawal by Subject|15
35244|NCT01392326|143583|P2|Overall Study|Withdrawal by Subject|11
35245|NCT01392326|143584|P1|Overall Study|Withdrawal by Subject|12
35246|NCT01392326|143582|P3|Overall Study|Death|0
35247|NCT01392326|143583|P2|Overall Study|Death|0
35248|NCT01392326|143584|P1|Overall Study|Death|2
35249|NCT01391507|143630|P4|Overall Study|Protocol Violation|2
35250|NCT01391507|143631|P3|Overall Study|Protocol Violation|1
35251|NCT01391507|143632|P2|Overall Study|Protocol Violation|1
35252|NCT01391507|143633|P1|Overall Study|Protocol Violation|2
35253|NCT01391507|143630|P4|Overall Study|Lack of Efficacy|1
35254|NCT01391507|143631|P3|Overall Study|Lack of Efficacy|0
35255|NCT01391507|143632|P2|Overall Study|Lack of Efficacy|0
35256|NCT01391507|143633|P1|Overall Study|Lack of Efficacy|0
35257|NCT01391507|143630|P4|Overall Study|Withdrawal by Subject|1
35258|NCT01391507|143631|P3|Overall Study|Withdrawal by Subject|1
35259|NCT01391507|143632|P2|Overall Study|Withdrawal by Subject|2
35260|NCT01391507|143633|P1|Overall Study|Withdrawal by Subject|1
35261|NCT01391507|143630|P4|Overall Study|Adverse Event|2
35262|NCT01391507|143631|P3|Overall Study|Adverse Event|2
35263|NCT01391507|143632|P2|Overall Study|Adverse Event|1
35264|NCT01391507|143633|P1|Overall Study|Adverse Event|1
35265|NCT01391507|143630|P4|Overall Study|Death|1
35266|NCT01391507|143631|P3|Overall Study|Death|0
35267|NCT01391507|143632|P2|Overall Study|Death|0
35268|NCT01391507|143633|P1|Overall Study|Death|0
35269|NCT01392300|143681|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
35270|NCT01392300|143682|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
35271|NCT01392300|143683|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
35272|NCT01392300|143681|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
35273|NCT01392300|143682|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
35274|NCT01392300|143683|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
35275|NCT01392300|143681|P3|Open Label Extension (OLEX) Period|Adverse Event|7
35276|NCT01392300|143682|P2|Open Label Extension (OLEX) Period|Adverse Event|0
35277|NCT01392300|143683|P1|Open Label Extension (OLEX) Period|Adverse Event|0
35278|NCT01392300|143681|P3|Open Label Extension (OLEX) Period|Death|4
35279|NCT01392300|143682|P2|Open Label Extension (OLEX) Period|Death|0
35280|NCT01392300|143683|P1|Open Label Extension (OLEX) Period|Death|0
35281|NCT01392300|143681|P3|Open Label Extension (OLEX) Period|Non-compliance|1
35282|NCT01392300|143682|P2|Open Label Extension (OLEX) Period|Non-compliance|0
35283|NCT01392300|143683|P1|Open Label Extension (OLEX) Period|Non-compliance|0
35284|NCT01392300|143681|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
35285|NCT01392300|143682|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
35286|NCT01392300|143683|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
35287|NCT01392300|143681|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
35288|NCT01392300|143682|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
35289|NCT01392300|143683|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
35290|NCT01392300|143681|P3|Main Period (MP)|Non-compliance|0
35291|NCT01392300|143682|P2|Main Period (MP)|Non-compliance|0
35292|NCT01392300|143683|P1|Main Period (MP)|Non-compliance|1
35293|NCT01392300|143681|P3|Main Period (MP)|Lost to Follow-up|0
35294|NCT01392300|143682|P2|Main Period (MP)|Lost to Follow-up|3
35295|NCT01392300|143683|P1|Main Period (MP)|Lost to Follow-up|3
35296|NCT01392300|143681|P3|Main Period (MP)|Withdrawal by Subject|0
35297|NCT01392300|143682|P2|Main Period (MP)|Withdrawal by Subject|1
35298|NCT01392300|143683|P1|Main Period (MP)|Withdrawal by Subject|5
35385|NCT01390402|144229|P1|Overall Study|Disease Progression|4
35299|NCT01392300|143681|P3|Main Period (MP)|Predefined discontinuation criteria|0
35300|NCT01392300|143682|P2|Main Period (MP)|Predefined discontinuation criteria|3
35301|NCT01392300|143683|P1|Main Period (MP)|Predefined discontinuation criteria|2
35302|NCT01392170|143788|P1|Overall Study|Ineligible|1
35303|NCT01392170|143788|P1|Overall Study|Withdrawal by Subject|1
35304|NCT01391663|143840|P4|Overall Study|Withdrawal by Subject|0
35305|NCT01391663|143841|P3|Overall Study|Withdrawal by Subject|1
35306|NCT01391663|143842|P2|Overall Study|Withdrawal by Subject|0
35307|NCT01391663|143843|P1|Overall Study|Withdrawal by Subject|0
35308|NCT01390857|144037|P1|Overall Study|No Visit after the First Visit|7
35309|NCT01390857|144037|P1|Overall Study|Lost to Follow-up|1
35310|NCT01390857|144037|P1|Overall Study|Protocol Violation|2
35311|NCT01390844|144048|P4|Follow-Up Phase|Non-Medical Reasons|0
35312|NCT01390844|144049|P3|Follow-Up Phase|Non-Medical Reasons|1
35313|NCT01390844|144050|P2|Follow-Up Phase|Non-Medical Reasons|1
35314|NCT01390844|144051|P1|Follow-Up Phase|Non-Medical Reasons|1
35315|NCT01390844|144048|P4|Treatment Phase|Non-GCP Compliant|3
35316|NCT01390844|144049|P3|Treatment Phase|Non-GCP Compliant|10
35317|NCT01390844|144050|P2|Treatment Phase|Non-GCP Compliant|0
35318|NCT01390844|144051|P1|Treatment Phase|Non-GCP Compliant|0
35319|NCT01390844|144048|P4|Treatment Phase|Non-Medical Reasons|1
35320|NCT01390844|144049|P3|Treatment Phase|Non-Medical Reasons|8
35321|NCT01390844|144050|P2|Treatment Phase|Non-Medical Reasons|1
35322|NCT01390844|144051|P1|Treatment Phase|Non-Medical Reasons|5
35323|NCT01390844|144048|P4|Treatment Phase|Treatment Failure|13
35324|NCT01390844|144049|P3|Treatment Phase|Treatment Failure|10
35325|NCT01390844|144050|P2|Treatment Phase|Treatment Failure|25
35326|NCT01390844|144051|P1|Treatment Phase|Treatment Failure|23
35327|NCT01390844|144048|P4|Treatment Phase|Adverse Event|2
35328|NCT01390844|144049|P3|Treatment Phase|Adverse Event|3
35329|NCT01390844|144050|P2|Treatment Phase|Adverse Event|2
35330|NCT01390844|144051|P1|Treatment Phase|Adverse Event|12
35331|NCT01390779|144077|P1|Overall Study|Physician Decision|1
35332|NCT01390649|144082|P1|Overall Study|Physician Decision|1
35333|NCT01390441|144092|P5|Extension Period|Protocol Violation|0
35334|NCT01390441|144093|P4|Extension Period|Protocol Violation|1
35335|NCT01390441|144094|P3|Extension Period|Protocol Violation|0
35336|NCT01390441|144095|P2|Extension Period|Protocol Violation|1
35337|NCT01390441|144096|P1|Extension Period|Protocol Violation|3
35338|NCT01390441|144092|P5|Treatment Period|Lost to Follow-up|0
35339|NCT01390441|144093|P4|Treatment Period|Lost to Follow-up|0
35340|NCT01390441|144094|P3|Treatment Period|Lost to Follow-up|0
35341|NCT01390441|144095|P2|Treatment Period|Lost to Follow-up|0
35342|NCT01390441|144096|P1|Treatment Period|Lost to Follow-up|1
35343|NCT01390441|144092|P5|Treatment Period|Withdrawal by Subject|1
35344|NCT01390441|144093|P4|Treatment Period|Withdrawal by Subject|0
35345|NCT01390441|144094|P3|Treatment Period|Withdrawal by Subject|1
35346|NCT01390441|144095|P2|Treatment Period|Withdrawal by Subject|0
35347|NCT01390441|144096|P1|Treatment Period|Withdrawal by Subject|0
35348|NCT01390441|144092|P5|Treatment Period|Adverse Event|2
35349|NCT01390441|144093|P4|Treatment Period|Adverse Event|1
35350|NCT01390441|144094|P3|Treatment Period|Adverse Event|1
35351|NCT01390441|144095|P2|Treatment Period|Adverse Event|0
35352|NCT01390441|144096|P1|Treatment Period|Adverse Event|0
35353|NCT01390441|144092|P5|Treatment Period|Unknown due to early stopping of study|7
35354|NCT01390441|144093|P4|Treatment Period|Unknown due to early stopping of study|11
35355|NCT01390441|144094|P3|Treatment Period|Unknown due to early stopping of study|8
35356|NCT01390441|144095|P2|Treatment Period|Unknown due to early stopping of study|0
35357|NCT01390441|144096|P1|Treatment Period|Unknown due to early stopping of study|0
35358|NCT01390441|144092|P5|Treatment Period|Lack of Efficacy|1
35359|NCT01390441|144093|P4|Treatment Period|Lack of Efficacy|0
35360|NCT01390441|144094|P3|Treatment Period|Lack of Efficacy|0
35361|NCT01390441|144095|P2|Treatment Period|Lack of Efficacy|0
35362|NCT01390441|144096|P1|Treatment Period|Lack of Efficacy|0
35363|NCT01390441|144092|P5|Treatment Period|Physician Decision|0
35364|NCT01390441|144093|P4|Treatment Period|Physician Decision|1
35365|NCT01390441|144094|P3|Treatment Period|Physician Decision|0
35366|NCT01390441|144095|P2|Treatment Period|Physician Decision|0
35367|NCT01390441|144096|P1|Treatment Period|Physician Decision|0
35368|NCT01390441|144092|P5|Treatment Period|Protocol Violation|0
35369|NCT01390441|144093|P4|Treatment Period|Protocol Violation|0
35370|NCT01390441|144094|P3|Treatment Period|Protocol Violation|0
35371|NCT01390441|144095|P2|Treatment Period|Protocol Violation|1
35372|NCT01390441|144096|P1|Treatment Period|Protocol Violation|0
35373|NCT01390428|144161|P6|Overall Study|Withdrawal by Subject|0
35374|NCT01390428|144162|P5|Overall Study|Withdrawal by Subject|0
35375|NCT01390428|144163|P4|Overall Study|Withdrawal by Subject|0
35376|NCT01390428|144164|P3|Overall Study|Withdrawal by Subject|1
35377|NCT01390428|144165|P2|Overall Study|Withdrawal by Subject|0
35378|NCT01390428|144166|P1|Overall Study|Withdrawal by Subject|0
35379|NCT01390428|144161|P6|Overall Study|Elective Surgery|0
35380|NCT01390428|144162|P5|Overall Study|Elective Surgery|1
35381|NCT01390428|144163|P4|Overall Study|Elective Surgery|0
35382|NCT01390428|144164|P3|Overall Study|Elective Surgery|0
35383|NCT01390428|144165|P2|Overall Study|Elective Surgery|0
35384|NCT01390428|144166|P1|Overall Study|Elective Surgery|0
35386|NCT01390402|144229|P1|Overall Study|Death|1
35387|NCT01390389|144235|P2|Overall Study|Screen Fail|1
35388|NCT01390389|144236|P1|Overall Study|Screen Fail|2
35389|NCT01390389|144235|P2|Overall Study|Withdrawal by Subject|0
35390|NCT01390389|144236|P1|Overall Study|Withdrawal by Subject|2
35391|NCT01390038|144265|P1|Overall Study|Simpliciti System Removal|2
35392|NCT01390038|144265|P1|Overall Study|Withdrawal by Subject|4
35393|NCT01390038|144265|P1|Overall Study|Lost to Follow-up|1
35394|NCT01390038|144265|P1|Overall Study|Death|1
35395|NCT01389973|144275|P1|Overall Study|Unspecified|10
35396|NCT01389973|144275|P1|Overall Study|Trial Stopped by Sponsor|9
35397|NCT01389973|144275|P1|Overall Study|Lost to Follow-up|1
35398|NCT01389882|144285|P2|Overall Study|Withdrawal by Subject|1
35399|NCT01389882|144286|P1|Overall Study|Withdrawal by Subject|0
35400|NCT01389882|144285|P2|Overall Study|Respiratory rate > 80/min during study|3
35401|NCT01389882|144286|P1|Overall Study|Respiratory rate > 80/min during study|1
35402|NCT01389817|144374|P2|Overall Study|Withdrawal by Subject|0
35403|NCT01389817|144375|P1|Overall Study|Withdrawal by Subject|2
35404|NCT01389817|144374|P2|Overall Study|Lost to Follow-up|0
35405|NCT01389817|144375|P1|Overall Study|Lost to Follow-up|1
35406|NCT01389817|144374|P2|Overall Study|Physician Decision|0
35407|NCT01389817|144375|P1|Overall Study|Physician Decision|1
35408|NCT01389323|144381|P1|Follow-up Period (up to 48 Weeks)|Unspecified|3
35409|NCT01389323|144381|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
35410|NCT01389323|144381|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
35411|NCT01389323|144381|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
35412|NCT01389323|144381|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
35413|NCT01389323|144381|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
35414|NCT01389323|144381|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
35415|NCT01389323|144381|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
35416|NCT01389323|144381|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
35417|NCT01389323|144381|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
35418|NCT01389323|144381|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
35419|NCT01389102|144444|P6|Overall Study|Investigator Judgement|0
35420|NCT01389102|144445|P5|Overall Study|Investigator Judgement|0
35421|NCT01389102|144446|P4|Overall Study|Investigator Judgement|0
35422|NCT01389102|144447|P3|Overall Study|Investigator Judgement|0
35423|NCT01389102|144448|P2|Overall Study|Investigator Judgement|1
35424|NCT01389102|144449|P1|Overall Study|Investigator Judgement|0
35425|NCT01389102|144444|P6|Overall Study|Unavailable due to husband's illness|0
35426|NCT01389102|144445|P5|Overall Study|Unavailable due to husband's illness|0
35427|NCT01389102|144446|P4|Overall Study|Unavailable due to husband's illness|0
35428|NCT01389102|144447|P3|Overall Study|Unavailable due to husband's illness|0
35429|NCT01389102|144448|P2|Overall Study|Unavailable due to husband's illness|1
35430|NCT01389102|144449|P1|Overall Study|Unavailable due to husband's illness|0
35431|NCT01389102|144444|P6|Overall Study|Subject Moved|0
35432|NCT01389102|144445|P5|Overall Study|Subject Moved|0
35433|NCT01389102|144446|P4|Overall Study|Subject Moved|0
35434|NCT01389102|144447|P3|Overall Study|Subject Moved|1
35435|NCT01389102|144448|P2|Overall Study|Subject Moved|0
35436|NCT01389102|144449|P1|Overall Study|Subject Moved|2
35437|NCT01389102|144444|P6|Overall Study|Subject Traveling Out of Country|0
35438|NCT01389102|144445|P5|Overall Study|Subject Traveling Out of Country|0
35439|NCT01389102|144446|P4|Overall Study|Subject Traveling Out of Country|1
35440|NCT01389102|144447|P3|Overall Study|Subject Traveling Out of Country|0
35441|NCT01389102|144448|P2|Overall Study|Subject Traveling Out of Country|0
35442|NCT01389102|144449|P1|Overall Study|Subject Traveling Out of Country|0
35443|NCT01389102|144444|P6|Overall Study|Withdrawal by Subject|3
35444|NCT01389102|144445|P5|Overall Study|Withdrawal by Subject|3
35445|NCT01389102|144446|P4|Overall Study|Withdrawal by Subject|2
35446|NCT01389102|144447|P3|Overall Study|Withdrawal by Subject|9
35447|NCT01389102|144448|P2|Overall Study|Withdrawal by Subject|4
35448|NCT01389102|144449|P1|Overall Study|Withdrawal by Subject|7
35449|NCT01389102|144444|P6|Overall Study|Protocol Violation|1
35450|NCT01389102|144445|P5|Overall Study|Protocol Violation|1
35451|NCT01389102|144446|P4|Overall Study|Protocol Violation|0
35452|NCT01389102|144447|P3|Overall Study|Protocol Violation|3
35453|NCT01389102|144448|P2|Overall Study|Protocol Violation|0
35454|NCT01389102|144449|P1|Overall Study|Protocol Violation|0
35455|NCT01389102|144444|P6|Overall Study|Lost to Follow-up|1
35456|NCT01389102|144445|P5|Overall Study|Lost to Follow-up|4
35457|NCT01389102|144446|P4|Overall Study|Lost to Follow-up|2
35458|NCT01389102|144447|P3|Overall Study|Lost to Follow-up|1
35459|NCT01389102|144448|P2|Overall Study|Lost to Follow-up|1
35460|NCT01389102|144449|P1|Overall Study|Lost to Follow-up|4
35461|NCT01389102|144444|P6|Overall Study|Hurricane Katrina|1
35462|NCT01389102|144445|P5|Overall Study|Hurricane Katrina|3
35463|NCT01389102|144446|P4|Overall Study|Hurricane Katrina|0
35464|NCT01389102|144447|P3|Overall Study|Hurricane Katrina|3
35465|NCT01389102|144448|P2|Overall Study|Hurricane Katrina|2
35466|NCT01389102|144449|P1|Overall Study|Hurricane Katrina|4
35467|NCT01389102|144444|P6|Overall Study|Adverse Event|2
35468|NCT01389102|144445|P5|Overall Study|Adverse Event|2
35469|NCT01389102|144446|P4|Overall Study|Adverse Event|2
35470|NCT01389102|144447|P3|Overall Study|Adverse Event|2
35471|NCT01389102|144448|P2|Overall Study|Adverse Event|3
35472|NCT01389102|144449|P1|Overall Study|Adverse Event|1
35473|NCT01388907|144527|P2|Overall Study|Adverse Event|0
35474|NCT01388907|144528|P1|Overall Study|Adverse Event|2
35475|NCT01388816|144544|P4|Overall Study|Protocol Violation|0
35476|NCT01388816|144545|P3|Overall Study|Protocol Violation|2
35477|NCT01388816|144546|P2|Overall Study|Protocol Violation|0
35478|NCT01388816|144547|P1|Overall Study|Protocol Violation|0
35479|NCT01388816|144544|P4|Overall Study|Withdrawal by Subject|0
35480|NCT01388816|144545|P3|Overall Study|Withdrawal by Subject|1
35481|NCT01388816|144546|P2|Overall Study|Withdrawal by Subject|1
35482|NCT01388816|144547|P1|Overall Study|Withdrawal by Subject|2
35483|NCT01388816|144544|P4|Overall Study|Lost to Follow-up|0
35484|NCT01388816|144545|P3|Overall Study|Lost to Follow-up|0
35485|NCT01388816|144546|P2|Overall Study|Lost to Follow-up|1
35486|NCT01388816|144547|P1|Overall Study|Lost to Follow-up|0
35487|NCT01388816|144544|P4|Overall Study|Adverse Event|0
35488|NCT01388816|144545|P3|Overall Study|Adverse Event|0
35489|NCT01388816|144546|P2|Overall Study|Adverse Event|2
35490|NCT01388816|144547|P1|Overall Study|Adverse Event|0
35491|NCT01388790|144576|P1|Overall Study|Ongoing at data cut−off date|8
35492|NCT01388647|144583|P2|Overall Study|Adverse Event|2
35493|NCT01388647|144584|P1|Overall Study|Adverse Event|1
35494|NCT01388530|144595|P1|Overall Study|Lost to Follow-up|5
35495|NCT01388491|144604|P2|Overall Study|Pregnancy|0
35496|NCT01388491|144605|P1|Overall Study|Pregnancy|1
35497|NCT01388491|144604|P2|Overall Study|Noncompliance|0
35498|NCT01388491|144605|P1|Overall Study|Noncompliance|2
35499|NCT01388491|144604|P2|Overall Study|Protocol Violation|0
35500|NCT01388491|144605|P1|Overall Study|Protocol Violation|2
35501|NCT01388491|144604|P2|Overall Study|Lost to Follow-up|3
35502|NCT01388491|144605|P1|Overall Study|Lost to Follow-up|4
35503|NCT01388491|144604|P2|Overall Study|Withdrawal by Subject|10
35504|NCT01388491|144605|P1|Overall Study|Withdrawal by Subject|6
35505|NCT01388491|144604|P2|Overall Study|Sponsor Request|7
35506|NCT01388491|144605|P1|Overall Study|Sponsor Request|9
35507|NCT01388491|144604|P2|Overall Study|Adverse Event|9
35508|NCT01388491|144605|P1|Overall Study|Adverse Event|10
35509|NCT01388361|144640|P3|Overall Study|Unclassified|1
35510|NCT01388361|144641|P2|Overall Study|Unclassified|0
35511|NCT01388361|144642|P1|Overall Study|Unclassified|0
35512|NCT01388361|144640|P3|Overall Study|Withdrawal criteria|10
35513|NCT01388361|144641|P2|Overall Study|Withdrawal criteria|7
35514|NCT01388361|144642|P1|Overall Study|Withdrawal criteria|12
35515|NCT01388361|144640|P3|Overall Study|Protocol Violation|2
35516|NCT01388361|144641|P2|Overall Study|Protocol Violation|0
35517|NCT01388361|144642|P1|Overall Study|Protocol Violation|0
35518|NCT01388361|144640|P3|Overall Study|Adverse Event|1
35519|NCT01388361|144641|P2|Overall Study|Adverse Event|5
35520|NCT01388361|144642|P1|Overall Study|Adverse Event|0
35521|NCT01388166|144659|P1|Overall Study|Others than specified above|13
35522|NCT01388166|144659|P1|Overall Study|Lost to Follow-up|30
35523|NCT01388166|144659|P1|Overall Study|Adverse Event|16
35524|NCT01387789|144665|P1|Overall Study|Lost to Follow-up|1
35525|NCT01387789|144665|P1|Overall Study|Lack of Efficacy|2
35526|NCT01387789|144665|P1|Overall Study|Adverse Event|5
35527|NCT01387737|144679|P2|Overall Study|Clearly not eligible for the study|3
35528|NCT01387737|144680|P1|Overall Study|Clearly not eligible for the study|1
35529|NCT01387737|144679|P2|Overall Study|Withdrawal by Subject|31
35530|NCT01387737|144680|P1|Overall Study|Withdrawal by Subject|27
35531|NCT01387737|144679|P2|Overall Study|Physician Decision|10
35532|NCT01387737|144680|P1|Overall Study|Physician Decision|3
35533|NCT01387737|144679|P2|Overall Study|Lack of Efficacy|0
35534|NCT01387737|144680|P1|Overall Study|Lack of Efficacy|1
35535|NCT01387737|144679|P2|Overall Study|Adverse Event|30
35536|NCT01387737|144680|P1|Overall Study|Adverse Event|20
35537|NCT01387542|144728|P1|Overall Study|Lost to Follow-up|1
35538|NCT01387542|144728|P1|Overall Study|Non-compliant|1
35539|NCT01387542|144728|P1|Overall Study|Insufficient response|1
35540|NCT01387542|144728|P1|Overall Study|Changed diagnosis|1
35541|NCT01387542|144728|P1|Overall Study|Withdrawal by Subject|1
35542|NCT01387542|144728|P1|Overall Study|Adverse Event|3
35543|NCT01387347|144746|P2|Overall Study|Lost to Follow-up|1
35544|NCT01387347|144747|P1|Overall Study|Lost to Follow-up|2
35545|NCT01387230|144760|P3|Overall Study|Withdrawal by Subject|0
35546|NCT01387230|144761|P2|Overall Study|Withdrawal by Subject|1
35547|NCT01387230|144762|P1|Overall Study|Withdrawal by Subject|4
35548|NCT01387230|144760|P3|Overall Study|Lost to Follow-up|1
35549|NCT01387230|144761|P2|Overall Study|Lost to Follow-up|0
35550|NCT01387230|144762|P1|Overall Study|Lost to Follow-up|0
35551|NCT01387230|144760|P3|Overall Study|Protocol-defined Stopping Criteria|5
35552|NCT01387230|144761|P2|Overall Study|Protocol-defined Stopping Criteria|0
35553|NCT01387230|144762|P1|Overall Study|Protocol-defined Stopping Criteria|6
35554|NCT01387230|144760|P3|Overall Study|Lack of Efficacy|4
35555|NCT01387230|144761|P2|Overall Study|Lack of Efficacy|5
35556|NCT01387230|144762|P1|Overall Study|Lack of Efficacy|8
35557|NCT01387230|144760|P3|Overall Study|Adverse Event|3
35558|NCT01387230|144761|P2|Overall Study|Adverse Event|1
35559|NCT01387230|144762|P1|Overall Study|Adverse Event|0
35560|NCT01387074|144808|P1|Overall Study|Lack of Efficacy|1
35561|NCT01387074|144808|P1|Overall Study|Lost to Follow-up|7
35562|NCT01386008|144819|P1|Overall Study|Adverse Event|3
35563|NCT01386008|144819|P1|Overall Study|exited w/o incident /study discontinued|17
35564|NCT01385995|144828|P2|Period 1, 2 Months|Physician Decision|0
35565|NCT01385995|144829|P1|Period 1, 2 Months|Physician Decision|1
35566|NCT01386944|144854|P1|Overall Study|Unspecified reason|8
35567|NCT01386944|144854|P1|Overall Study|Lost to Follow-up|8
35568|NCT01386944|144854|P1|Overall Study|Lack of Efficacy|14
35569|NCT01386944|144854|P1|Overall Study|Adverse Event|26
35570|NCT01386788|144864|P1|Overall Study|Lost to Follow-up|2
35571|NCT01386606|144873|P4|Overall Study|T levels too high|0
35572|NCT01386606|144874|P3|Overall Study|T levels too high|1
35573|NCT01386606|144875|P2|Overall Study|T levels too high|1
35574|NCT01386606|144876|P1|Overall Study|T levels too high|0
35575|NCT01386606|144873|P4|Overall Study|Unable to draw PK|0
35576|NCT01386606|144874|P3|Overall Study|Unable to draw PK|0
35577|NCT01386606|144875|P2|Overall Study|Unable to draw PK|0
35578|NCT01386606|144876|P1|Overall Study|Unable to draw PK|1
35579|NCT01386606|144873|P4|Overall Study|Subject incarcerated|0
35580|NCT01386606|144874|P3|Overall Study|Subject incarcerated|0
35581|NCT01386606|144875|P2|Overall Study|Subject incarcerated|1
35582|NCT01386606|144876|P1|Overall Study|Subject incarcerated|0
35583|NCT01386606|144873|P4|Overall Study|Lost to Follow-up|0
35584|NCT01386606|144874|P3|Overall Study|Lost to Follow-up|0
35585|NCT01386606|144875|P2|Overall Study|Lost to Follow-up|0
35586|NCT01386606|144876|P1|Overall Study|Lost to Follow-up|2
35587|NCT01386606|144873|P4|Overall Study|Protocol Violation|1
35588|NCT01386606|144874|P3|Overall Study|Protocol Violation|1
35589|NCT01386606|144875|P2|Overall Study|Protocol Violation|0
35590|NCT01386606|144876|P1|Overall Study|Protocol Violation|1
35591|NCT01386606|144873|P4|Overall Study|Withdrawal by Subject|0
35592|NCT01386606|144874|P3|Overall Study|Withdrawal by Subject|1
35593|NCT01386606|144875|P2|Overall Study|Withdrawal by Subject|1
35594|NCT01386606|144876|P1|Overall Study|Withdrawal by Subject|0
35595|NCT01386606|144873|P4|Overall Study|Adverse Event|0
35596|NCT01386606|144874|P3|Overall Study|Adverse Event|0
35597|NCT01386606|144875|P2|Overall Study|Adverse Event|1
35598|NCT01386606|144876|P1|Overall Study|Adverse Event|0
35599|NCT01386125|144906|P2|Overall Study|Participant Leaving Country|0
35600|NCT01386125|144907|P1|Overall Study|Participant Leaving Country|1
35601|NCT01386125|144906|P2|Overall Study|Lack of Efficacy|1
35602|NCT01386125|144907|P1|Overall Study|Lack of Efficacy|0
35603|NCT01386125|144906|P2|Overall Study|Adverse Event|5
35604|NCT01386125|144907|P1|Overall Study|Adverse Event|2
35605|NCT01386125|144906|P2|Overall Study|Withdrawal by Subject|12
35606|NCT01386125|144907|P1|Overall Study|Withdrawal by Subject|13
35607|NCT01386125|144906|P2|Overall Study|Disease Progress|2
35608|NCT01386125|144907|P1|Overall Study|Disease Progress|1
35609|NCT01386125|144906|P2|Overall Study|Protocol Violation|7
35610|NCT01386125|144907|P1|Overall Study|Protocol Violation|5
35611|NCT01386125|144906|P2|Overall Study|Physician Decision|1
35612|NCT01386125|144907|P1|Overall Study|Physician Decision|0
35613|NCT01386125|144906|P2|Overall Study|Lost to Follow-up|9
35614|NCT01386125|144907|P1|Overall Study|Lost to Follow-up|3
35615|NCT01385566|144955|P6|Overall Study|Withdrawal by Subject|0
35616|NCT01385566|144956|P5|Overall Study|Withdrawal by Subject|0
35617|NCT01385566|144957|P4|Overall Study|Withdrawal by Subject|1
35618|NCT01385566|144958|P3|Overall Study|Withdrawal by Subject|0
35619|NCT01385566|144959|P2|Overall Study|Withdrawal by Subject|0
35620|NCT01385566|144960|P1|Overall Study|Withdrawal by Subject|0
35621|NCT01385566|144955|P6|Overall Study|Lost to Follow-up|0
35622|NCT01385566|144956|P5|Overall Study|Lost to Follow-up|0
35623|NCT01385566|144957|P4|Overall Study|Lost to Follow-up|0
35624|NCT01385566|144958|P3|Overall Study|Lost to Follow-up|0
35625|NCT01385566|144959|P2|Overall Study|Lost to Follow-up|0
35626|NCT01385566|144960|P1|Overall Study|Lost to Follow-up|1
35627|NCT01385371|145014|P2|Overall Study|Administrative|2
35628|NCT01385371|145015|P1|Overall Study|Administrative|2
35629|NCT01385371|145014|P2|Overall Study|Protocol Violation|21
35630|NCT01385371|145015|P1|Overall Study|Protocol Violation|25
35631|NCT01385371|145014|P2|Overall Study|Withdrawal by Subject|39
35632|NCT01385371|145015|P1|Overall Study|Withdrawal by Subject|52
35633|NCT01385371|145014|P2|Overall Study|Lost to Follow-up|16
35634|NCT01385371|145015|P1|Overall Study|Lost to Follow-up|16
35635|NCT01385371|145014|P2|Overall Study|Adverse Event|19
35636|NCT01385371|145015|P1|Overall Study|Adverse Event|54
35637|NCT01385202|145035|P1|Overall Study|Withdrawn|1
35638|NCT01385202|145035|P1|Overall Study|Not Eligible|11
35639|NCT01385202|145035|P1|Overall Study|Lost to Follow-up|6
35640|NCT01384760|145058|P2|Overall Study|Protocol Violation|0
35641|NCT01384760|145059|P1|Overall Study|Protocol Violation|16
35642|NCT01384760|145058|P2|Overall Study|Lost to Follow-up|6
35643|NCT01384760|145059|P1|Overall Study|Lost to Follow-up|0
35644|NCT01384292|145070|P3|Part B|Severe non-compliance to protocol|0
35645|NCT01384292|145071|P2|Part B|Severe non-compliance to protocol|0
35646|NCT01384292|145072|P1|Part B|Severe non-compliance to protocol|1
35647|NCT01384019|145084|P2|Overall Study|MRI refusal|6
35648|NCT01384019|145085|P1|Overall Study|MRI refusal|6
35649|NCT01384019|145084|P2|Overall Study|Death|0
35650|NCT01384019|145085|P1|Overall Study|Death|1
35651|NCT01384019|145084|P2|Overall Study|Withdrawal by Subject|0
35652|NCT01384019|145085|P1|Overall Study|Withdrawal by Subject|3
35653|NCT01383993|145094|P3|Overall Study|Marketed voriconazole in post-therapy|0
35654|NCT01383993|145095|P2|Overall Study|Marketed voriconazole in post-therapy|0
35655|NCT01383993|145096|P1|Overall Study|Marketed voriconazole in post-therapy|2
35656|NCT01383993|145094|P3|Overall Study|Withdrawal by Subject|1
35657|NCT01383993|145095|P2|Overall Study|Withdrawal by Subject|0
35658|NCT01383993|145096|P1|Overall Study|Withdrawal by Subject|0
35659|NCT01383993|145094|P3|Overall Study|Adverse Event|0
35660|NCT01383993|145095|P2|Overall Study|Adverse Event|1
35661|NCT01383993|145096|P1|Overall Study|Adverse Event|1
35662|NCT01383928|145146|P3|Phase 2|Unsatisfactory therapeutic response|1
35663|NCT01383928|145147|P2|Phase 2|Unsatisfactory therapeutic response|0
35664|NCT01383928|145148|P1|Phase 2|Unsatisfactory therapeutic response|0
35665|NCT01383928|145146|P3|Phase 2|Withdrawal by Subject|4
35666|NCT01383928|145147|P2|Phase 2|Withdrawal by Subject|0
35667|NCT01383928|145148|P1|Phase 2|Withdrawal by Subject|0
35668|NCT01383928|145146|P3|Phase 2|Progressive Disease|5
35669|NCT01383928|145147|P2|Phase 2|Progressive Disease|0
35670|NCT01383928|145148|P1|Phase 2|Progressive Disease|0
35671|NCT01383928|145146|P3|Phase 2|Other|4
35672|NCT01383928|145147|P2|Phase 2|Other|0
35673|NCT01383928|145148|P1|Phase 2|Other|0
35674|NCT01383928|145146|P3|Phase 2|Adverse Event|8
35675|NCT01383928|145147|P2|Phase 2|Adverse Event|0
35676|NCT01383928|145148|P1|Phase 2|Adverse Event|0
35677|NCT01383928|145146|P3|Phase 2|Autologous Stem Cell Transplantation|18
35678|NCT01383928|145147|P2|Phase 2|Autologous Stem Cell Transplantation|0
35679|NCT01383928|145148|P1|Phase 2|Autologous Stem Cell Transplantation|0
35680|NCT01383928|145146|P3|Phase 1|Progressive Disease|0
35681|NCT01383928|145147|P2|Phase 1|Progressive Disease|1
35682|NCT01383928|145148|P1|Phase 1|Progressive Disease|1
35683|NCT01383928|145146|P3|Phase 1|Other|0
35684|NCT01383928|145147|P2|Phase 1|Other|3
35685|NCT01383928|145148|P1|Phase 1|Other|1
35686|NCT01383928|145146|P3|Phase 1|Adverse Event|0
35687|NCT01383928|145147|P2|Phase 1|Adverse Event|2
35688|NCT01383928|145148|P1|Phase 1|Adverse Event|1
35689|NCT01383928|145146|P3|Phase 1|Autologous Stem Cell Transplantation|0
35690|NCT01383928|145147|P2|Phase 1|Autologous Stem Cell Transplantation|1
35691|NCT01383928|145148|P1|Phase 1|Autologous Stem Cell Transplantation|2
35692|NCT01383707|145212|P1|Overall Study|Not specified|1
35693|NCT01383707|145212|P1|Overall Study|Death|15
35694|NCT01383707|145212|P1|Overall Study|Consent withdrawal|1
35695|NCT01383499|145226|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
35696|NCT01383499|145227|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
35697|NCT01383499|145228|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
35698|NCT01383499|145229|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
35699|NCT01383486|145279|P1|Overall Study|Did not take any product|6
35700|NCT01383486|145279|P1|Overall Study|Incomplete information for analysis|2
35701|NCT01383486|145279|P1|Overall Study|Lost to Follow-up|10
35702|NCT01383356|145285|P2|Period 1|Personal|2
35703|NCT01383356|145286|P1|Period 1|Personal|0
35704|NCT01383356|145285|P2|Period 1|Out of Range Mid-study-Test|1
35705|NCT01383356|145286|P1|Period 1|Out of Range Mid-study-Test|0
35706|NCT01383356|145285|P2|Period 1|Non-compliance|0
35707|NCT01383356|145286|P1|Period 1|Non-compliance|3
35708|NCT01383356|145285|P2|Period 1|Adverse Event|3
35709|NCT01383356|145286|P1|Period 1|Adverse Event|5
35710|NCT01383174|145316|P2|6 Month Assessment|Refused to complete|0
35711|NCT01383174|145317|P1|6 Month Assessment|Refused to complete|4
35712|NCT01383174|145316|P2|6 Month Assessment|Lost to Follow-up|1
35713|NCT01383174|145317|P1|6 Month Assessment|Lost to Follow-up|1
35714|NCT01383174|145316|P2|3 Month Assessment|Refused to complete|0
35715|NCT01383174|145317|P1|3 Month Assessment|Refused to complete|4
35716|NCT01383174|145316|P2|3 Month Assessment|Lost to Follow-up|0
35717|NCT01383174|145317|P1|3 Month Assessment|Lost to Follow-up|2
35718|NCT01383174|145316|P2|3 Month Assessment|Death|1
35719|NCT01383174|145317|P1|3 Month Assessment|Death|0
35720|NCT01383096|145344|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
35721|NCT01383096|145345|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
35722|NCT01383096|145346|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
35723|NCT01383096|145344|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
35724|NCT01383096|145345|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
35725|NCT01383096|145346|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
35726|NCT01383096|145344|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
35727|NCT01383096|145345|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
35728|NCT01383096|145346|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
35729|NCT01383096|145344|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
35730|NCT01383096|145345|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
35731|NCT01383096|145346|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
35732|NCT01383096|145344|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
35733|NCT01383096|145345|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
35734|NCT01383096|145346|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
35735|NCT01383096|145344|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
35736|NCT01383096|145345|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
35737|NCT01383096|145346|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
35738|NCT01383096|145344|P3|Third Intervention (8 Days)|Adverse Event|0
35739|NCT01383096|145345|P2|Third Intervention (8 Days)|Adverse Event|0
35740|NCT01383096|145346|P1|Third Intervention (8 Days)|Adverse Event|1
35741|NCT01383096|145344|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
35742|NCT01383096|145345|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
35743|NCT01383096|145346|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
35744|NCT01383096|145344|P3|Third Intervention (8 Days)|Elevated AST|0
35745|NCT01383096|145345|P2|Third Intervention (8 Days)|Elevated AST|1
35746|NCT01383096|145346|P1|Third Intervention (8 Days)|Elevated AST|0
35747|NCT01383096|145344|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
35748|NCT01383096|145345|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
35749|NCT01383096|145346|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
35750|NCT01383096|145344|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
35751|NCT01383096|145345|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
35752|NCT01383096|145346|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
35753|NCT01382940|145414|P1|Overall Study|Protocol Violation|20
35754|NCT01382940|145414|P1|Overall Study|Withdrawal by Subject|23
35755|NCT01382940|145414|P1|Overall Study|Physician Decision|7
35756|NCT01382940|145414|P1|Overall Study|Lost to Follow-up|4
35757|NCT01382940|145414|P1|Overall Study|Adverse Event|19
35758|NCT01382446|145476|P2|Overall Study|Removal from Mechanical Ventilation|3
35759|NCT01382446|145477|P1|Overall Study|Removal from Mechanical Ventilation|3
35760|NCT01382446|145476|P2|Overall Study|Withdrawal by Subject|1
35761|NCT01382446|145477|P1|Overall Study|Withdrawal by Subject|0
35762|NCT01382251|145485|P2|Overall Study|Contacted after study closed|1
35763|NCT01382251|145486|P1|Overall Study|Contacted after study closed|1
35764|NCT01382251|145485|P2|Overall Study|Lost to Follow-up|4
35765|NCT01382251|145486|P1|Overall Study|Lost to Follow-up|4
35766|NCT01382251|145485|P2|Overall Study|Surgeries cancelled or delayed|16
35767|NCT01382251|145486|P1|Overall Study|Surgeries cancelled or delayed|16
35768|NCT01382225|145499|P2|Overall Study|Other|2
35769|NCT01382225|145500|P1|Overall Study|Other|4
35770|NCT01382225|145499|P2|Overall Study|Subject Withdrew Consent|2
35771|NCT01382225|145500|P1|Overall Study|Subject Withdrew Consent|5
35772|NCT01382225|145499|P2|Overall Study|Protocol Violation|1
35773|NCT01382225|145500|P1|Overall Study|Protocol Violation|2
35774|NCT01382225|145499|P2|Overall Study|Adverse Event|2
35775|NCT01382225|145500|P1|Overall Study|Adverse Event|3
35776|NCT01382212|145522|P1|Overall Study|Withdrew consent|1
35777|NCT01382212|145522|P1|Overall Study|Kidney transplant|1
35778|NCT01381900|145586|P3|Overall Study|Early withdraw|1
35779|NCT01381900|145587|P2|Overall Study|Early withdraw|1
35780|NCT01381900|145588|P1|Overall Study|Early withdraw|3
35781|NCT01381900|145586|P3|Overall Study|Withdrawal by Subject|1
35782|NCT01381900|145587|P2|Overall Study|Withdrawal by Subject|0
35783|NCT01381900|145588|P1|Overall Study|Withdrawal by Subject|0
35784|NCT01381900|145586|P3|Overall Study|Protocol Violation|1
35785|NCT01381900|145587|P2|Overall Study|Protocol Violation|1
35786|NCT01381900|145588|P1|Overall Study|Protocol Violation|0
35787|NCT01381900|145586|P3|Overall Study|Physician Decision|1
35788|NCT01381900|145587|P2|Overall Study|Physician Decision|1
35789|NCT01381900|145588|P1|Overall Study|Physician Decision|0
35790|NCT01381900|145586|P3|Overall Study|Noncompliance with study drug|1
35791|NCT01381900|145587|P2|Overall Study|Noncompliance with study drug|0
35792|NCT01381900|145588|P1|Overall Study|Noncompliance with study drug|0
35793|NCT01381900|145586|P3|Overall Study|Adverse Event|7
35794|NCT01381900|145587|P2|Overall Study|Adverse Event|6
35795|NCT01381900|145588|P1|Overall Study|Adverse Event|4
35796|NCT01381900|145586|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
35797|NCT01381900|145587|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
35798|NCT01381900|145588|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
35799|NCT01381679|145608|P1|Overall Study|Lost to Follow-up|885
35800|NCT01381679|145608|P1|Overall Study|Adverse Event|3
35801|NCT01381575|145623|P3|Overall Study|Withdrawal by Subject|4
35802|NCT01381575|145624|P2|Overall Study|Withdrawal by Subject|0
35803|NCT01381575|145625|P1|Overall Study|Withdrawal by Subject|0
35804|NCT01381575|145623|P3|Overall Study|Protocol Violation|1
35805|NCT01381575|145624|P2|Overall Study|Protocol Violation|0
35806|NCT01381575|145625|P1|Overall Study|Protocol Violation|0
35807|NCT01381575|145623|P3|Overall Study|Lost to Follow-up|1
35808|NCT01381575|145624|P2|Overall Study|Lost to Follow-up|0
35809|NCT01381575|145625|P1|Overall Study|Lost to Follow-up|0
35810|NCT01381575|145623|P3|Overall Study|Adverse Event|1
35811|NCT01381575|145624|P2|Overall Study|Adverse Event|0
35812|NCT01381575|145625|P1|Overall Study|Adverse Event|0
35813|NCT01381575|145623|P3|Overall Study|Unspecified|0
35814|NCT01381575|145624|P2|Overall Study|Unspecified|10
35815|NCT01381575|145625|P1|Overall Study|Unspecified|2
35816|NCT01381016|145710|P2|Overall Study|Physician Decision|2
35817|NCT01381016|145711|P1|Overall Study|Physician Decision|0
35818|NCT01381016|145710|P2|Overall Study|Withdrawal by Subject|1
35819|NCT01381016|145711|P1|Overall Study|Withdrawal by Subject|0
35820|NCT01381016|145710|P2|Overall Study|Screen Failure|2
35821|NCT01381016|145711|P1|Overall Study|Screen Failure|2
35822|NCT01381016|145710|P2|Overall Study|Lost to Follow-up|1
35823|NCT01381016|145711|P1|Overall Study|Lost to Follow-up|1
35824|NCT01380834|145721|P2|Overall Study|Physician Decision|0
35825|NCT01380834|145722|P1|Overall Study|Physician Decision|1
35826|NCT01380782|145734|P4|Overall Study|Withdrawal by Subject|1
35827|NCT01380782|145735|P3|Overall Study|Withdrawal by Subject|1
35828|NCT01380782|145736|P2|Overall Study|Withdrawal by Subject|0
35829|NCT01380782|145737|P1|Overall Study|Withdrawal by Subject|0
35830|NCT01380782|145734|P4|Overall Study|Physician Decision|0
35831|NCT01380782|145735|P3|Overall Study|Physician Decision|0
35832|NCT01380782|145736|P2|Overall Study|Physician Decision|0
35833|NCT01380782|145737|P1|Overall Study|Physician Decision|1
35834|NCT01380782|145734|P4|Overall Study|Lack of Efficacy|3
35835|NCT01380782|145735|P3|Overall Study|Lack of Efficacy|10
35836|NCT01380782|145736|P2|Overall Study|Lack of Efficacy|9
35837|NCT01380782|145737|P1|Overall Study|Lack of Efficacy|10
35838|NCT01380782|145734|P4|Overall Study|Death|0
35839|NCT01380782|145735|P3|Overall Study|Death|0
35840|NCT01380782|145736|P2|Overall Study|Death|0
35841|NCT01380782|145737|P1|Overall Study|Death|1
35842|NCT01380782|145734|P4|Overall Study|Adverse Event|0
35843|NCT01380782|145735|P3|Overall Study|Adverse Event|0
35844|NCT01380782|145736|P2|Overall Study|Adverse Event|1
35845|NCT01380782|145737|P1|Overall Study|Adverse Event|0
35846|NCT01380730|145766|P8|Overall Study|Death|0
35847|NCT01380730|145767|P7|Overall Study|Death|0
35848|NCT01380730|145768|P6|Overall Study|Death|0
35849|NCT01380730|145769|P5|Overall Study|Death|1
35850|NCT01380730|145770|P4|Overall Study|Death|0
35851|NCT01380730|145771|P3|Overall Study|Death|0
35852|NCT01380730|145772|P2|Overall Study|Death|0
35853|NCT01380730|145773|P1|Overall Study|Death|0
35854|NCT01380379|145840|P1|Overall Study|Pregnancy|1
35855|NCT01380327|145853|P3|Overall Study|Questionable onset of epilepsy|1
35856|NCT01380327|145854|P2|Overall Study|Questionable onset of epilepsy|0
35857|NCT01380327|145855|P1|Overall Study|Questionable onset of epilepsy|0
35858|NCT01380327|145853|P3|Overall Study|Housing situation precluded ability to k|1
35859|NCT01380327|145854|P2|Overall Study|Housing situation precluded ability to k|0
35860|NCT01380327|145855|P1|Overall Study|Housing situation precluded ability to k|0
35861|NCT01380327|145853|P3|Overall Study|Withdrawal by Subject|1
35862|NCT01380327|145854|P2|Overall Study|Withdrawal by Subject|0
35863|NCT01380327|145855|P1|Overall Study|Withdrawal by Subject|0
35864|NCT01380327|145853|P3|Overall Study|Protocol Violation|3
35865|NCT01380327|145854|P2|Overall Study|Protocol Violation|2
35866|NCT01380327|145855|P1|Overall Study|Protocol Violation|3
35867|NCT01380327|145853|P3|Overall Study|Lost to Follow-up|1
35868|NCT01380327|145854|P2|Overall Study|Lost to Follow-up|1
35869|NCT01380327|145855|P1|Overall Study|Lost to Follow-up|0
35870|NCT01380145|145905|P1|Overall Study|Progressive disease|4
35871|NCT01380093|145913|P9|Treatment Phase: Third Intervention|Unspecified|1
35872|NCT01380093|145914|P8|Treatment Phase: Third Intervention|Unspecified|0
35873|NCT01380093|145915|P7|Treatment Phase: Third Intervention|Unspecified|0
35874|NCT01380093|145916|P6|Treatment Phase: Third Intervention|Unspecified|0
35875|NCT01380093|145917|P5|Treatment Phase: Third Intervention|Unspecified|0
35876|NCT01380093|145918|P4|Treatment Phase: Third Intervention|Unspecified|0
35877|NCT01380093|145919|P3|Treatment Phase: Third Intervention|Unspecified|0
35878|NCT01380093|145920|P2|Treatment Phase: Third Intervention|Unspecified|0
35879|NCT01380093|145921|P1|Treatment Phase: Third Intervention|Unspecified|0
35880|NCT01380093|145913|P9|Treatment Phase: Third Intervention|Non-compliance|1
35881|NCT01380093|145914|P8|Treatment Phase: Third Intervention|Non-compliance|0
35882|NCT01380093|145915|P7|Treatment Phase: Third Intervention|Non-compliance|0
35883|NCT01380093|145916|P6|Treatment Phase: Third Intervention|Non-compliance|0
35884|NCT01380093|145917|P5|Treatment Phase: Third Intervention|Non-compliance|0
35885|NCT01380093|145918|P4|Treatment Phase: Third Intervention|Non-compliance|0
35886|NCT01380093|145919|P3|Treatment Phase: Third Intervention|Non-compliance|0
35887|NCT01380093|145920|P2|Treatment Phase: Third Intervention|Non-compliance|0
35888|NCT01380093|145921|P1|Treatment Phase: Third Intervention|Non-compliance|0
35889|NCT01380093|145913|P9|Treatment Phase: Second Intervention|Unspecified|0
35890|NCT01380093|145914|P8|Treatment Phase: Second Intervention|Unspecified|0
35891|NCT01380093|145915|P7|Treatment Phase: Second Intervention|Unspecified|0
35892|NCT01380093|145916|P6|Treatment Phase: Second Intervention|Unspecified|0
35893|NCT01380093|145917|P5|Treatment Phase: Second Intervention|Unspecified|0
35894|NCT01380093|145918|P4|Treatment Phase: Second Intervention|Unspecified|1
35895|NCT01380093|145919|P3|Treatment Phase: Second Intervention|Unspecified|0
35896|NCT01380093|145920|P2|Treatment Phase: Second Intervention|Unspecified|0
35897|NCT01380093|145921|P1|Treatment Phase: Second Intervention|Unspecified|0
35898|NCT01380093|145913|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
35899|NCT01380093|145914|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
35900|NCT01380093|145915|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
35901|NCT01380093|145916|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
35902|NCT01380093|145917|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
35903|NCT01380093|145918|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
35904|NCT01380093|145919|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
35905|NCT01380093|145920|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
35906|NCT01380093|145921|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
35907|NCT01380093|145913|P9|Drug Discrimination Phase: Day 2|Backup participant|0
35908|NCT01380093|145914|P8|Drug Discrimination Phase: Day 2|Backup participant|0
35909|NCT01380093|145915|P7|Drug Discrimination Phase: Day 2|Backup participant|0
35910|NCT01380093|145916|P6|Drug Discrimination Phase: Day 2|Backup participant|0
35911|NCT01380093|145917|P5|Drug Discrimination Phase: Day 2|Backup participant|0
35912|NCT01380093|145918|P4|Drug Discrimination Phase: Day 2|Backup participant|0
35913|NCT01380093|145919|P3|Drug Discrimination Phase: Day 2|Backup participant|1
35914|NCT01380093|145920|P2|Drug Discrimination Phase: Day 2|Backup participant|0
35915|NCT01380093|145921|P1|Drug Discrimination Phase: Day 2|Backup participant|0
35916|NCT01380093|145913|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
35917|NCT01380093|145914|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
35918|NCT01380093|145915|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
35919|NCT01380093|145916|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
35920|NCT01380093|145917|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
35921|NCT01380093|145918|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
35922|NCT01380093|145919|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
35923|NCT01380093|145920|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
35924|NCT01380093|145921|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
35925|NCT01380093|145913|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
35926|NCT01380093|145914|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
35927|NCT01380093|145915|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
35928|NCT01380093|145916|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
35929|NCT01380093|145917|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
35930|NCT01380093|145918|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
35931|NCT01380093|145919|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
35932|NCT01380093|145920|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
35933|NCT01380093|145921|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
35934|NCT01380093|145913|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
35935|NCT01380093|145914|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
35936|NCT01380093|145915|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
35937|NCT01380093|145916|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
35938|NCT01380093|145917|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
35939|NCT01380093|145918|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
35940|NCT01380093|145919|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
35941|NCT01380093|145920|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
35942|NCT01380093|145921|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
35943|NCT01380093|145913|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
35944|NCT01380093|145914|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
35945|NCT01380093|145915|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
35946|NCT01380093|145916|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
35947|NCT01380093|145917|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
35948|NCT01380093|145918|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
35949|NCT01380093|145919|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
35950|NCT01380093|145920|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
35951|NCT01380093|145921|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
35952|NCT01380093|145913|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
35953|NCT01380093|145914|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
35954|NCT01380093|145915|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
35955|NCT01380093|145916|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
35956|NCT01380093|145917|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
35957|NCT01380093|145918|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
35958|NCT01380093|145919|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
35959|NCT01380093|145920|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
35960|NCT01380093|145921|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
35961|NCT01380093|145913|P9|Naloxone Challenge Phase|Screen failures|0
35962|NCT01380093|145914|P8|Naloxone Challenge Phase|Screen failures|0
35963|NCT01380093|145915|P7|Naloxone Challenge Phase|Screen failures|0
35964|NCT01380093|145916|P6|Naloxone Challenge Phase|Screen failures|0
35965|NCT01380093|145917|P5|Naloxone Challenge Phase|Screen failures|0
35966|NCT01380093|145918|P4|Naloxone Challenge Phase|Screen failures|0
35967|NCT01380093|145919|P3|Naloxone Challenge Phase|Screen failures|0
35968|NCT01380093|145920|P2|Naloxone Challenge Phase|Screen failures|0
35969|NCT01380093|145921|P1|Naloxone Challenge Phase|Screen failures|21
35970|NCT01380080|146213|P2|Overall Study|Lost to Follow-up|0
35971|NCT01380080|146214|P1|Overall Study|Lost to Follow-up|2
35972|NCT01380080|146213|P2|Overall Study|Not willing to adhere to requirements|1
35973|NCT01380080|146214|P1|Overall Study|Not willing to adhere to requirements|3
35974|NCT01380080|146213|P2|Overall Study|Not able to get to clinic|0
35975|NCT01380080|146214|P1|Overall Study|Not able to get to clinic|4
35976|NCT01380080|146213|P2|Overall Study|Withdrawal by Subject|0
35977|NCT01380080|146214|P1|Overall Study|Withdrawal by Subject|4
35978|NCT01380080|146213|P2|Overall Study|Death|22
35979|NCT01380080|146214|P1|Overall Study|Death|20
35980|NCT01379937|146239|P4|Overall Study|Lost to Follow-up|0
35981|NCT01379937|146240|P3|Overall Study|Lost to Follow-up|2
35982|NCT01379937|146241|P2|Overall Study|Lost to Follow-up|2
35983|NCT01379937|146242|P1|Overall Study|Lost to Follow-up|1
35984|NCT01379937|146239|P4|Overall Study|Consent withdrawal|0
35985|NCT01379937|146240|P3|Overall Study|Consent withdrawal|0
35986|NCT01379937|146241|P2|Overall Study|Consent withdrawal|1
35987|NCT01379937|146242|P1|Overall Study|Consent withdrawal|0
35988|NCT01379937|146239|P4|Overall Study|Protocol Violation|1
35989|NCT01379937|146240|P3|Overall Study|Protocol Violation|0
35990|NCT01379937|146241|P2|Overall Study|Protocol Violation|0
35991|NCT01379937|146242|P1|Overall Study|Protocol Violation|0
35992|NCT01379781|146324|P2|Overall Study|Lost to Follow-up|8
35993|NCT01379781|146325|P1|Overall Study|Lost to Follow-up|11
35994|NCT01379768|146334|P3|Overall Study|Lost to Follow-up|0
35995|NCT01379768|146335|P2|Overall Study|Lost to Follow-up|0
35996|NCT01379768|146336|P1|Overall Study|Lost to Follow-up|2
35997|NCT01379768|146334|P3|Overall Study|Adverse Event|0
35998|NCT01379768|146335|P2|Overall Study|Adverse Event|1
35999|NCT01379768|146336|P1|Overall Study|Adverse Event|1
36000|NCT01379703|146359|P3|9 Months Through 18 Months|Reason Unknown|0
36001|NCT01379703|146360|P2|9 Months Through 18 Months|Reason Unknown|23
36002|NCT01379703|146361|P1|9 Months Through 18 Months|Reason Unknown|0
36003|NCT01379703|146359|P3|9 Months Through 18 Months|Fatigue|0
36004|NCT01379703|146360|P2|9 Months Through 18 Months|Fatigue|1
36005|NCT01379703|146361|P1|9 Months Through 18 Months|Fatigue|0
36006|NCT01379703|146359|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
36007|NCT01379703|146360|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
36008|NCT01379703|146361|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
36009|NCT01379703|146359|P3|9 Months Through 18 Months|Patient Noncompliance|0
36010|NCT01379703|146360|P2|9 Months Through 18 Months|Patient Noncompliance|4
36011|NCT01379703|146361|P1|9 Months Through 18 Months|Patient Noncompliance|0
36012|NCT01379703|146359|P3|9 Months Through 18 Months|Treatment failure|0
36013|NCT01379703|146360|P2|9 Months Through 18 Months|Treatment failure|5
36014|NCT01379703|146361|P1|9 Months Through 18 Months|Treatment failure|0
36015|NCT01379703|146359|P3|9 Months Through 18 Months|Adverse Event|0
36016|NCT01379703|146360|P2|9 Months Through 18 Months|Adverse Event|6
36017|NCT01379703|146361|P1|9 Months Through 18 Months|Adverse Event|0
36018|NCT01379703|146359|P3|9 Months Through 18 Months|Withdrawal by Subject|0
36019|NCT01379703|146360|P2|9 Months Through 18 Months|Withdrawal by Subject|11
36020|NCT01379703|146361|P1|9 Months Through 18 Months|Withdrawal by Subject|0
36021|NCT01379703|146359|P3|9 Months Through 18 Months|Lost to Follow-up|0
36022|NCT01379703|146360|P2|9 Months Through 18 Months|Lost to Follow-up|178
36023|NCT01379703|146361|P1|9 Months Through 18 Months|Lost to Follow-up|0
36024|NCT01379703|146359|P3|Study Start Through 9 Months|Reason unknown|24
36025|NCT01379703|146360|P2|Study Start Through 9 Months|Reason unknown|31
36026|NCT01379703|146361|P1|Study Start Through 9 Months|Reason unknown|2
36027|NCT01379703|146359|P3|Study Start Through 9 Months|Increased triglycerides|0
36028|NCT01379703|146360|P2|Study Start Through 9 Months|Increased triglycerides|1
36029|NCT01379703|146361|P1|Study Start Through 9 Months|Increased triglycerides|0
36030|NCT01379703|146359|P3|Study Start Through 9 Months|Poor general condition|0
36031|NCT01379703|146360|P2|Study Start Through 9 Months|Poor general condition|1
36032|NCT01379703|146361|P1|Study Start Through 9 Months|Poor general condition|0
36033|NCT01379703|146359|P3|Study Start Through 9 Months|Medication not available|1
36034|NCT01379703|146360|P2|Study Start Through 9 Months|Medication not available|2
36035|NCT01379703|146361|P1|Study Start Through 9 Months|Medication not available|0
36036|NCT01379703|146359|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
36037|NCT01379703|146360|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
36038|NCT01379703|146361|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
36039|NCT01379703|146359|P3|Study Start Through 9 Months|Patient Noncompliance|1
36040|NCT01379703|146360|P2|Study Start Through 9 Months|Patient Noncompliance|0
36041|NCT01379703|146361|P1|Study Start Through 9 Months|Patient Noncompliance|0
36042|NCT01379703|146359|P3|Study Start Through 9 Months|Treatment Failure|2
36043|NCT01379703|146360|P2|Study Start Through 9 Months|Treatment Failure|2
36044|NCT01379703|146361|P1|Study Start Through 9 Months|Treatment Failure|0
36045|NCT01379703|146359|P3|Study Start Through 9 Months|Withdrawal by Subject|1
36046|NCT01379703|146360|P2|Study Start Through 9 Months|Withdrawal by Subject|6
36047|NCT01379703|146361|P1|Study Start Through 9 Months|Withdrawal by Subject|0
36048|NCT01379703|146359|P3|Study Start Through 9 Months|Adverse Event|10
36049|NCT01379703|146360|P2|Study Start Through 9 Months|Adverse Event|14
36050|NCT01379703|146361|P1|Study Start Through 9 Months|Adverse Event|0
36051|NCT01379703|146359|P3|Study Start Through 9 Months|Lost to Follow-up|104
36052|NCT01379703|146360|P2|Study Start Through 9 Months|Lost to Follow-up|61
36053|NCT01379703|146361|P1|Study Start Through 9 Months|Lost to Follow-up|2
36054|NCT01379534|146435|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
36055|NCT01379534|146436|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
36056|NCT01379534|146435|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
36057|NCT01379534|146436|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
36058|NCT01379534|146435|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
36059|NCT01379534|146436|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
36060|NCT01379534|146435|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
36061|NCT01379534|146436|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
36062|NCT01379534|146435|P2|Treatment Phase|Adverse Event|7
36063|NCT01379534|146436|P1|Treatment Phase|Adverse Event|7
36064|NCT01379534|146435|P2|Treatment Phase|Progressive disease|22
36065|NCT01379534|146436|P1|Treatment Phase|Progressive disease|13
36066|NCT01379534|146435|P2|Treatment Phase|Withdrawal by Subject|2
36067|NCT01379534|146436|P1|Treatment Phase|Withdrawal by Subject|2
36068|NCT01378975|146487|P2|Overall Study|Withdrew Consent|3
36069|NCT01378975|146488|P1|Overall Study|Withdrew Consent|4
36070|NCT01378975|146487|P2|Overall Study|Lost to Follow-up|1
36071|NCT01378975|146488|P1|Overall Study|Lost to Follow-up|4
36072|NCT01378975|146487|P2|Overall Study|Investigator Request|0
36073|NCT01378975|146488|P1|Overall Study|Investigator Request|1
36074|NCT01378975|146487|P2|Overall Study|Death|46
36075|NCT01378975|146488|P1|Overall Study|Death|77
36076|NCT01378962|146514|P1|Overall Study|Unspecified|2
36077|NCT01378962|146514|P1|Overall Study|Lost to Follow-up|1
36078|NCT01378962|146514|P1|Overall Study|Death|14
36079|NCT01378429|146540|P2|Overall Study|Noncompliance with study drug|0
36080|NCT01378429|146541|P1|Overall Study|Noncompliance with study drug|1
36081|NCT01378325|146583|P2|Overall Study|Protocol Violation|1
36082|NCT01378325|146584|P1|Overall Study|Protocol Violation|0
36083|NCT01378195|146601|P2|Overall Study|Lost to Follow-up|18
36084|NCT01378195|146602|P1|Overall Study|Lost to Follow-up|29
36085|NCT01378117|146615|P3|Overall Study|discharged before med given|1
36086|NCT01378117|146616|P2|Overall Study|discharged before med given|0
36087|NCT01378117|146617|P1|Overall Study|discharged before med given|2
36088|NCT01378117|146615|P3|Overall Study|withdrawal|2
36089|NCT01378117|146616|P2|Overall Study|withdrawal|1
36090|NCT01378117|146617|P1|Overall Study|withdrawal|2
36091|NCT01378104|146627|P2|Overall Study|Withdrawal by Subject|13
36092|NCT01378104|146628|P1|Overall Study|Withdrawal by Subject|12
36093|NCT01378104|146627|P2|Overall Study|Lack of Efficacy|5
36094|NCT01378104|146628|P1|Overall Study|Lack of Efficacy|7
36095|NCT01378104|146627|P2|Overall Study|Adverse Event|8
36096|NCT01378104|146628|P1|Overall Study|Adverse Event|8
36097|NCT01377480|146706|P4|Overall Study|Not specified|6
36098|NCT01377480|146707|P3|Overall Study|Not specified|7
36099|NCT01377480|146708|P2|Overall Study|Not specified|0
36100|NCT01377480|146709|P1|Overall Study|Not specified|0
36101|NCT01377480|146706|P4|Overall Study|Serious adverse event|1
36102|NCT01377480|146707|P3|Overall Study|Serious adverse event|1
36103|NCT01377480|146708|P2|Overall Study|Serious adverse event|0
36104|NCT01377480|146709|P1|Overall Study|Serious adverse event|0
36105|NCT01377480|146706|P4|Overall Study|Withdrawal by Subject|0
36106|NCT01377480|146707|P3|Overall Study|Withdrawal by Subject|1
36107|NCT01377480|146708|P2|Overall Study|Withdrawal by Subject|0
36108|NCT01377480|146709|P1|Overall Study|Withdrawal by Subject|0
36109|NCT01377480|146706|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
36110|NCT01377480|146707|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
36111|NCT01377480|146708|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
36112|NCT01377480|146709|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
36113|NCT01377480|146706|P4|Overall Study|Protocol Violation|4
36114|NCT01377480|146707|P3|Overall Study|Protocol Violation|0
36115|NCT01377480|146708|P2|Overall Study|Protocol Violation|0
36116|NCT01377480|146709|P1|Overall Study|Protocol Violation|0
36117|NCT01377233|146786|P5|Double-blind|Administrative or other|1
36118|NCT01377233|146787|P4|Double-blind|Administrative or other|1
36119|NCT01377233|146788|P3|Double-blind|Administrative or other|0
36120|NCT01377233|146789|P2|Double-blind|Administrative or other|0
36121|NCT01377233|146790|P1|Double-blind|Administrative or other|0
36122|NCT01377233|146786|P5|Double-blind|Withdrawal by Subject|0
36123|NCT01377233|146787|P4|Double-blind|Withdrawal by Subject|1
36124|NCT01377233|146788|P3|Double-blind|Withdrawal by Subject|0
36125|NCT01377233|146789|P2|Double-blind|Withdrawal by Subject|0
36126|NCT01377233|146790|P1|Double-blind|Withdrawal by Subject|0
36127|NCT01377233|146786|P5|Double-blind|Protocol Violation|1
36128|NCT01377233|146787|P4|Double-blind|Protocol Violation|0
36129|NCT01377233|146788|P3|Double-blind|Protocol Violation|0
36130|NCT01377233|146789|P2|Double-blind|Protocol Violation|0
36131|NCT01377233|146790|P1|Double-blind|Protocol Violation|0
36132|NCT01377233|146786|P5|Double-blind|Adverse Event|0
36133|NCT01377233|146787|P4|Double-blind|Adverse Event|2
36134|NCT01377233|146788|P3|Double-blind|Adverse Event|2
36135|NCT01377233|146789|P2|Double-blind|Adverse Event|1
36136|NCT01377233|146790|P1|Double-blind|Adverse Event|0
36137|NCT01377233|146786|P5|Open-label|Withdrawal by Subject|0
36138|NCT01377233|146787|P4|Open-label|Withdrawal by Subject|0
36139|NCT01377233|146788|P3|Open-label|Withdrawal by Subject|0
36140|NCT01377233|146789|P2|Open-label|Withdrawal by Subject|0
36141|NCT01377233|146790|P1|Open-label|Withdrawal by Subject|3
36142|NCT01377233|146786|P5|Open-label|Adverse Event|0
36143|NCT01377233|146787|P4|Open-label|Adverse Event|0
36144|NCT01377233|146788|P3|Open-label|Adverse Event|0
36145|NCT01377233|146789|P2|Open-label|Adverse Event|0
36146|NCT01377233|146790|P1|Open-label|Adverse Event|1
36147|NCT01377194|146817|P3|Overall Study|Lost to Follow-up|11
36148|NCT01377194|146818|P2|Overall Study|Lost to Follow-up|8
36149|NCT01377194|146819|P1|Overall Study|Lost to Follow-up|14
36150|NCT01377194|146817|P3|Overall Study|Withdrawal by Subject|7
36151|NCT01377194|146818|P2|Overall Study|Withdrawal by Subject|10
36152|NCT01377194|146819|P1|Overall Study|Withdrawal by Subject|8
36153|NCT01377194|146817|P3|Overall Study|Protocol Violation|6
36154|NCT01377194|146818|P2|Overall Study|Protocol Violation|10
36155|NCT01377194|146819|P1|Overall Study|Protocol Violation|4
36156|NCT01377194|146817|P3|Overall Study|Lack of Efficacy|3
36157|NCT01377194|146818|P2|Overall Study|Lack of Efficacy|3
36158|NCT01377194|146819|P1|Overall Study|Lack of Efficacy|3
36159|NCT01377194|146817|P3|Overall Study|Adverse Event|19
36160|NCT01377194|146818|P2|Overall Study|Adverse Event|12
36161|NCT01377194|146819|P1|Overall Study|Adverse Event|3
36162|NCT01376908|146832|P2|Overall Study|Withdrawal by Subject|2
36163|NCT01376908|146833|P1|Overall Study|Withdrawal by Subject|1
36164|NCT01376908|146832|P2|Overall Study|Protocol Violation|1
36165|NCT01376908|146833|P1|Overall Study|Protocol Violation|1
36166|NCT01376804|146866|P1|Treatment Period|Patient did not receive study drug|1
36167|NCT01376804|146866|P1|Treatment Period|Adverse Event|6
36168|NCT01376804|146866|P1|Treatment Period|Withdrawal by Subject|1
36169|NCT01376700|146877|P1|Overall Study|Low or high titer inhibitor|8
36170|NCT01376700|146877|P1|Overall Study|Sponsor terminated study early|8
36171|NCT01376388|146939|P1|Overall Study|Withdrawal by Subject|3
36172|NCT01376388|146939|P1|Overall Study|Lack of Efficacy|2
36173|NCT01376388|146939|P1|Overall Study|Adverse Event|13
36174|NCT01376245|146987|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
36175|NCT01376245|146988|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
36176|NCT01376245|146989|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
36177|NCT01376245|146990|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
36178|NCT01376245|146991|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
36179|NCT01376245|146987|P5|24-week, Double-blind Treatment Period|Physician Decision|0
36180|NCT01376245|146988|P4|24-week, Double-blind Treatment Period|Physician Decision|1
36181|NCT01376245|146989|P3|24-week, Double-blind Treatment Period|Physician Decision|1
36182|NCT01376245|146990|P2|24-week, Double-blind Treatment Period|Physician Decision|0
36183|NCT01376245|146991|P1|24-week, Double-blind Treatment Period|Physician Decision|0
36184|NCT01376245|146987|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
36185|NCT01376245|146988|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
36186|NCT01376245|146989|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
36187|NCT01376245|146990|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
36188|NCT01376245|146991|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
36189|NCT01376245|146987|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
36190|NCT01376245|146988|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
36191|NCT01376245|146989|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
36192|NCT01376245|146990|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
36193|NCT01376245|146991|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
36194|NCT01376245|146987|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
36195|NCT01376245|146988|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
36196|NCT01376245|146989|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
36197|NCT01376245|146990|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
36198|NCT01376245|146991|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
36199|NCT01376245|146987|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
36200|NCT01376245|146988|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
36201|NCT01376245|146989|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
36202|NCT01376245|146990|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
36203|NCT01376245|146991|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
36204|NCT01376245|146987|P5|24-week, Double-blind Treatment Period|Adverse Event|18
36205|NCT01376245|146988|P4|24-week, Double-blind Treatment Period|Adverse Event|8
36206|NCT01376245|146989|P3|24-week, Double-blind Treatment Period|Adverse Event|7
36207|NCT01376245|146990|P2|24-week, Double-blind Treatment Period|Adverse Event|16
36208|NCT01376245|146991|P1|24-week, Double-blind Treatment Period|Adverse Event|0
36209|NCT01376245|146987|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
36210|NCT01376245|146988|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
36211|NCT01376245|146989|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
36212|NCT01376245|146990|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
36213|NCT01376245|146991|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
36214|NCT01376245|146987|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
36215|NCT01376245|146988|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
36216|NCT01376245|146989|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
36217|NCT01376245|146990|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
36218|NCT01376245|146991|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
36219|NCT01376245|146987|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
36220|NCT01376245|146988|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
36221|NCT01376245|146989|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
36222|NCT01376245|146990|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
36223|NCT01376245|146991|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
36224|NCT01376245|146987|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
36225|NCT01376245|146988|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
36226|NCT01376245|146989|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
36227|NCT01376245|146990|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
36228|NCT01376245|146991|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
36229|NCT01376245|146987|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
36230|NCT01376245|146988|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
36231|NCT01376245|146989|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
36232|NCT01376245|146990|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
36233|NCT01376245|146991|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
36234|NCT01376089|147007|P2|Overall Study|Patient received no contrast media|4
36235|NCT01376089|147008|P1|Overall Study|Patient received no contrast media|3
36236|NCT01376037|147031|P2|Overall Study|Lost to Follow-up|2
36237|NCT01376037|147032|P1|Overall Study|Lost to Follow-up|0
36238|NCT01375777|147047|P9|Overall Study|Other|1
36239|NCT01375777|147048|P8|Overall Study|Other|0
36240|NCT01375777|147049|P7|Overall Study|Other|0
36241|NCT01375777|147050|P6|Overall Study|Other|0
36242|NCT01375777|147051|P5|Overall Study|Other|0
36243|NCT01375777|147052|P4|Overall Study|Other|0
36244|NCT01375777|147053|P3|Overall Study|Other|0
36245|NCT01375777|147054|P2|Overall Study|Other|1
36246|NCT01375777|147055|P1|Overall Study|Other|1
36247|NCT01375777|147047|P9|Overall Study|Lost to Follow-up|0
36248|NCT01375777|147048|P8|Overall Study|Lost to Follow-up|0
36249|NCT01375777|147049|P7|Overall Study|Lost to Follow-up|1
36250|NCT01375777|147050|P6|Overall Study|Lost to Follow-up|0
36251|NCT01375777|147051|P5|Overall Study|Lost to Follow-up|0
36252|NCT01375777|147052|P4|Overall Study|Lost to Follow-up|0
36253|NCT01375777|147053|P3|Overall Study|Lost to Follow-up|0
36254|NCT01375777|147054|P2|Overall Study|Lost to Follow-up|0
36255|NCT01375777|147055|P1|Overall Study|Lost to Follow-up|1
36256|NCT01375777|147047|P9|Overall Study|Withdrawal by Subject|1
36257|NCT01375777|147048|P8|Overall Study|Withdrawal by Subject|2
36258|NCT01375777|147049|P7|Overall Study|Withdrawal by Subject|1
36259|NCT01375777|147050|P6|Overall Study|Withdrawal by Subject|1
36260|NCT01375777|147051|P5|Overall Study|Withdrawal by Subject|1
36261|NCT01375777|147052|P4|Overall Study|Withdrawal by Subject|0
36262|NCT01375777|147053|P3|Overall Study|Withdrawal by Subject|1
36263|NCT01375777|147054|P2|Overall Study|Withdrawal by Subject|2
36264|NCT01375777|147055|P1|Overall Study|Withdrawal by Subject|0
36265|NCT01375764|147125|P5|Overall Study|Other|0
36266|NCT01375764|147126|P4|Overall Study|Other|1
36267|NCT01375764|147127|P3|Overall Study|Other|0
36268|NCT01375764|147128|P2|Overall Study|Other|0
36269|NCT01375764|147129|P1|Overall Study|Other|0
36270|NCT01375764|147125|P5|Overall Study|Withdrawal by Subject|1
36271|NCT01375764|147126|P4|Overall Study|Withdrawal by Subject|0
36272|NCT01375764|147127|P3|Overall Study|Withdrawal by Subject|0
36273|NCT01375764|147128|P2|Overall Study|Withdrawal by Subject|0
36274|NCT01375764|147129|P1|Overall Study|Withdrawal by Subject|2
36275|NCT01375764|147125|P5|Overall Study|Lost to Follow-up|0
36276|NCT01375764|147126|P4|Overall Study|Lost to Follow-up|0
36277|NCT01375764|147127|P3|Overall Study|Lost to Follow-up|0
36278|NCT01375764|147128|P2|Overall Study|Lost to Follow-up|1
36279|NCT01375764|147129|P1|Overall Study|Lost to Follow-up|0
36280|NCT01375751|147175|P3|Overall Study|Other|0
36281|NCT01375751|147176|P2|Overall Study|Other|1
36282|NCT01375751|147177|P1|Overall Study|Other|0
36283|NCT01375374|147226|P1|Overall Study|Adverse Event|1
36284|NCT01375049|147276|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
36285|NCT01375049|147276|P1|Overall Study|Withdrawal by Subject|2
36286|NCT01375049|147276|P1|Overall Study|Lost to Follow-up|1
36287|NCT01375049|147276|P1|Overall Study|Adverse Event|2
36288|NCT01374971|147291|P1|Overall Study|Withdrawal by Subject|1
36289|NCT01374919|147296|P1|Overall Study|Withdrawal by Subject|2
36290|NCT01374451|147315|P2|Overall Study|Administrative problems|0
36291|NCT01374451|147316|P1|Overall Study|Administrative problems|1
36292|NCT01374425|147362|P2|Overall Study|Not Specified|43
36293|NCT01374425|147363|P1|Overall Study|Not Specified|41
36294|NCT01374425|147362|P2|Overall Study|Lost to Follow-up|1
36295|NCT01374425|147363|P1|Overall Study|Lost to Follow-up|2
36296|NCT01374425|147362|P2|Overall Study|Sponsor Decision|1
36297|NCT01374425|147363|P1|Overall Study|Sponsor Decision|0
36298|NCT01374425|147362|P2|Overall Study|Protocol Violation|3
36299|NCT01374425|147363|P1|Overall Study|Protocol Violation|2
36300|NCT01374425|147362|P2|Overall Study|Refused Treatment|24
36301|NCT01374425|147363|P1|Overall Study|Refused Treatment|10
36302|NCT01374425|147362|P2|Overall Study|Withdrawal by Subject|7
36303|NCT01374425|147363|P1|Overall Study|Withdrawal by Subject|6
36304|NCT01374425|147362|P2|Overall Study|Death (Adverse Event)|4
36305|NCT01374425|147363|P1|Overall Study|Death (Adverse Event)|2
36306|NCT01374425|147362|P2|Overall Study|Death (Progression of Disease)|0
36307|NCT01374425|147363|P1|Overall Study|Death (Progression of Disease)|1
36308|NCT01374425|147362|P2|Overall Study|Adverse Event|18
36309|NCT01374425|147363|P1|Overall Study|Adverse Event|29
36310|NCT01374425|147362|P2|Overall Study|Clinical Disease Progression|6
36311|NCT01374425|147363|P1|Overall Study|Clinical Disease Progression|9
36312|NCT01374425|147362|P2|Overall Study|Radiographic Disease Progression|81
36313|NCT01374425|147363|P1|Overall Study|Radiographic Disease Progression|86
36314|NCT01374269|147443|P2|Overall Study|closed research|2
36315|NCT01374269|147444|P1|Overall Study|closed research|1
36316|NCT01374269|147443|P2|Overall Study|Lost to Follow-up|3
36317|NCT01374269|147444|P1|Overall Study|Lost to Follow-up|1
36318|NCT01374269|147443|P2|Overall Study|Withdrawal by Subject|0
36319|NCT01374269|147444|P1|Overall Study|Withdrawal by Subject|4
36320|NCT01374178|147572|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
36321|NCT01374178|147573|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
36322|NCT01374178|147572|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
36323|NCT01374178|147573|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
36324|NCT01373918|147591|P2|Overall Study|Physician Decision|1
36325|NCT01373918|147592|P1|Overall Study|Physician Decision|0
36326|NCT01373346|147636|P1|Overall Study|Death|1
36327|NCT01373294|147659|P2|Overall Study|Adverse Event|0
36328|NCT01373294|147660|P1|Overall Study|Adverse Event|1
36329|NCT01373281|147669|P2|Overall Study|Serious adverse event|5
36330|NCT01373281|147670|P1|Overall Study|Serious adverse event|6
36331|NCT01373281|147669|P2|Overall Study|Adverse Event|4
36332|NCT01373281|147670|P1|Overall Study|Adverse Event|4
36333|NCT01373281|147669|P2|Overall Study|Lost to Follow-up|1
36334|NCT01373281|147670|P1|Overall Study|Lost to Follow-up|4
36335|NCT01373281|147669|P2|Overall Study|Protocol Violation|4
36336|NCT01373281|147670|P1|Overall Study|Protocol Violation|13
36337|NCT01373281|147669|P2|Overall Study|Withdrawal by Subject|31
36338|NCT01373281|147670|P1|Overall Study|Withdrawal by Subject|52
36339|NCT01372995|147689|P3|Overall Study|Physician Decision|1
36340|NCT01372995|147690|P2|Overall Study|Physician Decision|0
36341|NCT01372995|147691|P1|Overall Study|Physician Decision|0
36342|NCT01372995|147689|P3|Overall Study|Spouse withdrew participant from study|0
36343|NCT01372995|147690|P2|Overall Study|Spouse withdrew participant from study|1
36344|NCT01372995|147691|P1|Overall Study|Spouse withdrew participant from study|0
36345|NCT01372878|147738|P1|Overall Study|incomplete study procedure|104
36346|NCT01372878|147738|P1|Overall Study|Protocol Violation|17
36347|NCT01372878|147738|P1|Overall Study|Withdrawal by Subject|63
36348|NCT01372748|147758|P2|Overall Study|Withdrawal by Subject|5
36349|NCT01372748|147759|P1|Overall Study|Withdrawal by Subject|7
36350|NCT01372748|147758|P2|Overall Study|Lost to Follow-up|34
36351|NCT01372748|147759|P1|Overall Study|Lost to Follow-up|16
36352|NCT01372605|147769|P2|Overall Study|Changed medical home|0
36353|NCT01372605|147770|P1|Overall Study|Changed medical home|2
36354|NCT01372605|147769|P2|Overall Study|Moved|0
36355|NCT01372605|147770|P1|Overall Study|Moved|3
36356|NCT01372605|147769|P2|Overall Study|Withdrawal by Subject|7
36357|NCT01372605|147770|P1|Overall Study|Withdrawal by Subject|4
36358|NCT01372605|147769|P2|Overall Study|Lost to Follow-up|1
36359|NCT01372605|147770|P1|Overall Study|Lost to Follow-up|2
36360|NCT01372605|147769|P2|Overall Study|Death|2
36361|NCT01372605|147770|P1|Overall Study|Death|1
36362|NCT01372501|147796|P1|Overall Study|Device migration|1
36363|NCT01372501|147796|P1|Overall Study|Adverse Event|4
36364|NCT01372410|147819|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
36365|NCT01372410|147820|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
36366|NCT01372410|147821|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
36367|NCT01372410|147822|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
36368|NCT01372410|147823|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
36369|NCT01372410|147824|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
36370|NCT01372410|147825|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
36371|NCT01372410|147826|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
36372|NCT01372410|147819|P8|Treatment Period 3 (7 Days)|Adverse Event|0
36373|NCT01372410|147820|P7|Treatment Period 3 (7 Days)|Adverse Event|0
36374|NCT01372410|147821|P6|Treatment Period 3 (7 Days)|Adverse Event|0
36375|NCT01372410|147822|P5|Treatment Period 3 (7 Days)|Adverse Event|0
36376|NCT01372410|147823|P4|Treatment Period 3 (7 Days)|Adverse Event|0
36377|NCT01372410|147824|P3|Treatment Period 3 (7 Days)|Adverse Event|1
36378|NCT01372410|147825|P2|Treatment Period 3 (7 Days)|Adverse Event|0
36379|NCT01372410|147826|P1|Treatment Period 3 (7 Days)|Adverse Event|0
36380|NCT01372410|147819|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
36381|NCT01372410|147820|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
36382|NCT01372410|147821|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
36383|NCT01372410|147822|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
36384|NCT01372410|147823|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
36385|NCT01372410|147824|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
36386|NCT01372410|147825|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
36387|NCT01372410|147826|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
36388|NCT01372410|147819|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
36389|NCT01372410|147820|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
36390|NCT01372410|147821|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
36391|NCT01372410|147822|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
36392|NCT01372410|147823|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
36393|NCT01372410|147824|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
36394|NCT01372410|147825|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
36395|NCT01372410|147826|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
36396|NCT01372410|147819|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
36397|NCT01372410|147820|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
36398|NCT01372410|147821|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
36399|NCT01372410|147822|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
36400|NCT01372410|147823|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
36401|NCT01372410|147824|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
36402|NCT01372410|147825|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
36403|NCT01372410|147826|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
36404|NCT01372410|147819|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
36405|NCT01372410|147820|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
36406|NCT01372410|147821|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
36407|NCT01372410|147822|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
36408|NCT01372410|147823|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
36409|NCT01372410|147824|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
36410|NCT01372410|147825|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
36411|NCT01372410|147826|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
36412|NCT01372410|147819|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
36413|NCT01372410|147820|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
36414|NCT01372410|147821|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
36415|NCT01372410|147822|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
36416|NCT01372410|147823|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
36417|NCT01372410|147824|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
36418|NCT01372410|147825|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
36419|NCT01372410|147826|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
36420|NCT01372410|147819|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
36421|NCT01372410|147820|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
36422|NCT01372410|147821|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
36423|NCT01372410|147822|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
36424|NCT01372410|147823|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
36425|NCT01372410|147824|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
36426|NCT01372410|147825|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
36427|NCT01372410|147826|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
36428|NCT01372410|147819|P8|Treatment Period 1 (7 Days)|Adverse Event|0
36429|NCT01372410|147820|P7|Treatment Period 1 (7 Days)|Adverse Event|1
36430|NCT01372410|147821|P6|Treatment Period 1 (7 Days)|Adverse Event|0
36431|NCT01372410|147822|P5|Treatment Period 1 (7 Days)|Adverse Event|0
36432|NCT01372410|147823|P4|Treatment Period 1 (7 Days)|Adverse Event|0
36433|NCT01372410|147824|P3|Treatment Period 1 (7 Days)|Adverse Event|0
36434|NCT01372410|147825|P2|Treatment Period 1 (7 Days)|Adverse Event|1
36435|NCT01372410|147826|P1|Treatment Period 1 (7 Days)|Adverse Event|0
36436|NCT01372410|147819|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
36437|NCT01372410|147820|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
36438|NCT01372410|147821|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
36439|NCT01372410|147822|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
36440|NCT01372410|147823|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
36441|NCT01372410|147824|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
36442|NCT01372410|147825|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
36443|NCT01372410|147826|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
36444|NCT01372384|147863|P1|Overall Study|Progression of disease|3
36445|NCT01372150|147873|P3|Overall Study|Randomized but not treated|0
36446|NCT01372150|147874|P2|Overall Study|Randomized but not treated|1
36447|NCT01372150|147875|P1|Overall Study|Randomized but not treated|0
36448|NCT01372150|147873|P3|Overall Study|Adverse Event|2
36449|NCT01372150|147874|P2|Overall Study|Adverse Event|1
36450|NCT01372150|147875|P1|Overall Study|Adverse Event|2
36451|NCT01372150|147873|P3|Overall Study|Other|2
36452|NCT01372150|147874|P2|Overall Study|Other|0
36453|NCT01372150|147875|P1|Overall Study|Other|1
36454|NCT01372150|147873|P3|Overall Study|Withdrawal by Subject|2
36455|NCT01372150|147874|P2|Overall Study|Withdrawal by Subject|7
36456|NCT01372150|147875|P1|Overall Study|Withdrawal by Subject|2
36457|NCT01372150|147873|P3|Overall Study|Protocol Violation|3
36458|NCT01372150|147874|P2|Overall Study|Protocol Violation|0
36459|NCT01372150|147875|P1|Overall Study|Protocol Violation|1
36460|NCT01372150|147873|P3|Overall Study|Lost to Follow-up|6
36461|NCT01372150|147874|P2|Overall Study|Lost to Follow-up|5
36462|NCT01372150|147875|P1|Overall Study|Lost to Follow-up|4
36463|NCT01372150|147873|P3|Overall Study|Lack of Efficacy|1
36464|NCT01372150|147874|P2|Overall Study|Lack of Efficacy|0
36465|NCT01372150|147875|P1|Overall Study|Lack of Efficacy|3
36466|NCT01371994|147894|P2|Overall Study|Miscellaneous Reasons|4
36467|NCT01371994|147895|P1|Overall Study|Miscellaneous Reasons|6
36468|NCT01371994|147894|P2|Overall Study|Physician Decision|1
36469|NCT01371994|147895|P1|Overall Study|Physician Decision|1
36470|NCT01371994|147894|P2|Overall Study|Randomized but Never Received Study Drug|6
36471|NCT01371994|147895|P1|Overall Study|Randomized but Never Received Study Drug|6
36472|NCT01371994|147894|P2|Overall Study|Protocol Violation|17
36473|NCT01371994|147895|P1|Overall Study|Protocol Violation|24
36474|NCT01371994|147894|P2|Overall Study|Lost to Follow-up|1
36475|NCT01371994|147895|P1|Overall Study|Lost to Follow-up|1
36476|NCT01371994|147894|P2|Overall Study|Withdrawal by Subject|7
36477|NCT01371994|147895|P1|Overall Study|Withdrawal by Subject|13
36478|NCT01371994|147894|P2|Overall Study|Lack of Efficacy|0
36479|NCT01371994|147895|P1|Overall Study|Lack of Efficacy|3
36480|NCT01371994|147894|P2|Overall Study|Adverse Event|6
36481|NCT01371994|147895|P1|Overall Study|Adverse Event|3
36482|NCT01371877|147939|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
36483|NCT01371877|147940|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
36484|NCT01371851|147952|P2|Overall Study|Blood Pressure outside study parameters|0
36485|NCT01371851|147953|P1|Overall Study|Blood Pressure outside study parameters|2
36486|NCT01371851|147952|P2|Overall Study|non study related adverse event|0
36487|NCT01371851|147953|P1|Overall Study|non study related adverse event|1
36488|NCT01371851|147952|P2|Overall Study|was arrested and put in jail|1
36489|NCT01371851|147953|P1|Overall Study|was arrested and put in jail|0
36490|NCT01371851|147952|P2|Overall Study|Lost to Follow-up|8
36491|NCT01371851|147953|P1|Overall Study|Lost to Follow-up|5
36492|NCT01371838|147961|P2|Overall Study|Surgery|0
36493|NCT01371838|147962|P1|Overall Study|Surgery|1
36494|NCT01371838|147961|P2|Overall Study|Lack of therapeutic response|1
36495|NCT01371838|147962|P1|Overall Study|Lack of therapeutic response|0
36496|NCT01371838|147961|P2|Overall Study|Last follow-up visit not conducted|0
36497|NCT01371838|147962|P1|Overall Study|Last follow-up visit not conducted|2
36498|NCT01371838|147961|P2|Overall Study|Investigator Decision|8
36499|NCT01371838|147962|P1|Overall Study|Investigator Decision|3
36500|NCT01371838|147961|P2|Overall Study|Protocol Violation|0
36501|NCT01371838|147962|P1|Overall Study|Protocol Violation|3
36502|NCT01371838|147961|P2|Overall Study|Death|4
36503|NCT01371838|147962|P1|Overall Study|Death|3
36504|NCT01371838|147961|P2|Overall Study|Lost to Follow-up|20
36505|NCT01371838|147962|P1|Overall Study|Lost to Follow-up|10
36506|NCT01371838|147961|P2|Overall Study|Withdrawal by Subject|33
36507|NCT01371838|147962|P1|Overall Study|Withdrawal by Subject|27
36508|NCT01371825|147998|P1|Primary Efficacy Analysis Period|Death|3
36509|NCT01371747|148033|P6|Overall Study|Other Reasons|1
36510|NCT01371747|148034|P5|Overall Study|Other Reasons|0
36511|NCT01371747|148035|P4|Overall Study|Other Reasons|0
36512|NCT01371747|148036|P3|Overall Study|Other Reasons|2
36513|NCT01371747|148037|P2|Overall Study|Other Reasons|1
36514|NCT01371747|148038|P1|Overall Study|Other Reasons|2
36515|NCT01371747|148033|P6|Overall Study|Withdrawal by Subject|4
36516|NCT01371747|148034|P5|Overall Study|Withdrawal by Subject|2
36517|NCT01371747|148035|P4|Overall Study|Withdrawal by Subject|2
36518|NCT01371747|148036|P3|Overall Study|Withdrawal by Subject|5
36519|NCT01371747|148037|P2|Overall Study|Withdrawal by Subject|12
36520|NCT01371747|148038|P1|Overall Study|Withdrawal by Subject|6
36521|NCT01371747|148033|P6|Overall Study|Physician Decision|0
36522|NCT01371747|148034|P5|Overall Study|Physician Decision|1
36523|NCT01371747|148035|P4|Overall Study|Physician Decision|0
36524|NCT01371747|148036|P3|Overall Study|Physician Decision|0
36525|NCT01371747|148037|P2|Overall Study|Physician Decision|0
36526|NCT01371747|148038|P1|Overall Study|Physician Decision|0
36527|NCT01371747|148033|P6|Overall Study|Non-Compliance|1
36528|NCT01371747|148034|P5|Overall Study|Non-Compliance|0
36529|NCT01371747|148035|P4|Overall Study|Non-Compliance|0
36530|NCT01371747|148036|P3|Overall Study|Non-Compliance|3
36531|NCT01371747|148037|P2|Overall Study|Non-Compliance|4
36532|NCT01371747|148038|P1|Overall Study|Non-Compliance|3
36533|NCT01371747|148033|P6|Overall Study|Protocol Violation|0
36534|NCT01371747|148034|P5|Overall Study|Protocol Violation|0
36535|NCT01371747|148035|P4|Overall Study|Protocol Violation|0
36536|NCT01371747|148036|P3|Overall Study|Protocol Violation|1
36537|NCT01371747|148037|P2|Overall Study|Protocol Violation|0
36538|NCT01371747|148038|P1|Overall Study|Protocol Violation|0
36539|NCT01371747|148033|P6|Overall Study|Low Serum Potassium Results|3
36540|NCT01371747|148034|P5|Overall Study|Low Serum Potassium Results|0
36541|NCT01371747|148035|P4|Overall Study|Low Serum Potassium Results|1
36542|NCT01371747|148036|P3|Overall Study|Low Serum Potassium Results|1
36543|NCT01371747|148037|P2|Overall Study|Low Serum Potassium Results|1
36544|NCT01371747|148038|P1|Overall Study|Low Serum Potassium Results|1
36545|NCT01371747|148033|P6|Overall Study|High Serum Potassium Results|2
36546|NCT01371747|148034|P5|Overall Study|High Serum Potassium Results|0
36547|NCT01371747|148035|P4|Overall Study|High Serum Potassium Results|2
36548|NCT01371747|148036|P3|Overall Study|High Serum Potassium Results|1
36549|NCT01371747|148037|P2|Overall Study|High Serum Potassium Results|1
36550|NCT01371747|148038|P1|Overall Study|High Serum Potassium Results|1
36551|NCT01371747|148033|P6|Overall Study|Abnormal Renal Function|1
36552|NCT01371747|148034|P5|Overall Study|Abnormal Renal Function|0
36553|NCT01371747|148035|P4|Overall Study|Abnormal Renal Function|1
36554|NCT01371747|148036|P3|Overall Study|Abnormal Renal Function|0
36555|NCT01371747|148037|P2|Overall Study|Abnormal Renal Function|2
36556|NCT01371747|148038|P1|Overall Study|Abnormal Renal Function|0
36557|NCT01371747|148033|P6|Overall Study|Death|0
36558|NCT01371747|148034|P5|Overall Study|Death|2
36559|NCT01371747|148035|P4|Overall Study|Death|1
36560|NCT01371747|148036|P3|Overall Study|Death|4
36561|NCT01371747|148037|P2|Overall Study|Death|0
36562|NCT01371747|148038|P1|Overall Study|Death|1
36563|NCT01371747|148033|P6|Overall Study|Adverse Event|2
36564|NCT01371747|148034|P5|Overall Study|Adverse Event|2
36565|NCT01371747|148035|P4|Overall Study|Adverse Event|2
36566|NCT01371747|148036|P3|Overall Study|Adverse Event|7
36567|NCT01371747|148037|P2|Overall Study|Adverse Event|2
36568|NCT01371747|148038|P1|Overall Study|Adverse Event|4
36569|NCT01371721|148103|P3|Overall Study|Randomized but not treated|0
36570|NCT01371721|148104|P2|Overall Study|Randomized but not treated|0
36571|NCT01371721|148105|P1|Overall Study|Randomized but not treated|1
36572|NCT01371721|148103|P3|Overall Study|Lack of Efficacy|3
36573|NCT01371721|148104|P2|Overall Study|Lack of Efficacy|4
36574|NCT01371721|148105|P1|Overall Study|Lack of Efficacy|2
36575|NCT01371721|148103|P3|Overall Study|Not specified|0
36576|NCT01371721|148104|P2|Overall Study|Not specified|3
36577|NCT01371721|148105|P1|Overall Study|Not specified|2
36578|NCT01371721|148103|P3|Overall Study|Withdrawal by Subject|11
36579|NCT01371721|148104|P2|Overall Study|Withdrawal by Subject|7
36580|NCT01371721|148105|P1|Overall Study|Withdrawal by Subject|5
36581|NCT01371721|148103|P3|Overall Study|Lost to Follow-up|6
36582|NCT01371721|148104|P2|Overall Study|Lost to Follow-up|2
36583|NCT01371721|148105|P1|Overall Study|Lost to Follow-up|8
36584|NCT01371721|148103|P3|Overall Study|Protocol Violation|5
36585|NCT01371721|148104|P2|Overall Study|Protocol Violation|4
36586|NCT01371721|148105|P1|Overall Study|Protocol Violation|6
36587|NCT01371721|148103|P3|Overall Study|Adverse Event|5
36588|NCT01371721|148104|P2|Overall Study|Adverse Event|4
36589|NCT01371721|148105|P1|Overall Study|Adverse Event|5
36590|NCT01371708|148138|P3|Overall Study|Started but did not receive treatment|1
36591|NCT01371708|148139|P2|Overall Study|Started but did not receive treatment|0
36592|NCT01371708|148140|P1|Overall Study|Started but did not receive treatment|1
36593|NCT01371708|148138|P3|Overall Study|Adverse Event|12
36594|NCT01371708|148139|P2|Overall Study|Adverse Event|8
36595|NCT01371708|148140|P1|Overall Study|Adverse Event|5
36596|NCT01371708|148138|P3|Overall Study|Not specified|4
36597|NCT01371708|148139|P2|Overall Study|Not specified|2
36598|NCT01371708|148140|P1|Overall Study|Not specified|3
36599|NCT01371708|148138|P3|Overall Study|Medication error/not related to AE|0
36600|NCT01371708|148139|P2|Overall Study|Medication error/not related to AE|1
36601|NCT01371708|148140|P1|Overall Study|Medication error/not related to AE|0
36602|NCT01371708|148138|P3|Overall Study|No longer willing to participate|13
36603|NCT01371708|148139|P2|Overall Study|No longer willing to participate|7
36604|NCT01371708|148140|P1|Overall Study|No longer willing to participate|7
36605|NCT01371708|148138|P3|Overall Study|Protocol Violation|2
36606|NCT01371708|148139|P2|Overall Study|Protocol Violation|1
36607|NCT01371708|148140|P1|Overall Study|Protocol Violation|2
36608|NCT01371708|148138|P3|Overall Study|Lost to Follow-up|7
36609|NCT01371708|148139|P2|Overall Study|Lost to Follow-up|9
36610|NCT01371708|148140|P1|Overall Study|Lost to Follow-up|5
36611|NCT01371708|148138|P3|Overall Study|Insufficient clinical response|0
36612|NCT01371708|148139|P2|Overall Study|Insufficient clinical response|2
36613|NCT01371708|148140|P1|Overall Study|Insufficient clinical response|3
36614|NCT01371643|148172|P2|Overall Study|Withdrawal by Subject|0
36615|NCT01371643|148173|P1|Overall Study|Withdrawal by Subject|3
36616|NCT01371565|148183|P1|Overall Study|Resection of neuroendocrine tumor|1
36617|NCT01371565|148183|P1|Overall Study|Death|1
36618|NCT01371565|148183|P1|Overall Study|Withdrawal by Subject|1
36619|NCT01371552|148187|P6|Part 1, First 3 Days|Inconvenience|0
36620|NCT01371552|148188|P5|Part 1, First 3 Days|Inconvenience|0
36621|NCT01371552|148189|P4|Part 1, First 3 Days|Inconvenience|0
36622|NCT01371552|148190|P3|Part 1, First 3 Days|Inconvenience|1
36623|NCT01371552|148191|P2|Part 1, First 3 Days|Inconvenience|0
36624|NCT01371552|148192|P1|Part 1, First 3 Days|Inconvenience|0
36625|NCT01371539|148219|P2|Period Two: One Week|Time/job conflict|1
36626|NCT01371539|148220|P1|Period Two: One Week|Time/job conflict|0
36627|NCT01371539|148219|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
36628|NCT01371539|148220|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
36629|NCT01371539|148219|P2|Period Two: One Week|Lost to Follow-up|1
36630|NCT01371539|148220|P1|Period Two: One Week|Lost to Follow-up|0
36631|NCT01371539|148219|P2|Period One: One Week|Lost to Follow-up|1
36632|NCT01371539|148220|P1|Period One: One Week|Lost to Follow-up|0
36633|NCT01371006|148230|P2|Overall Study|Adverse Event|0
36634|NCT01371006|148231|P1|Overall Study|Adverse Event|1
36635|NCT01370863|148272|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
36636|NCT01370863|148273|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
36637|NCT01370863|148272|P2|Overall Study|Did not want second pH/MII monitoring|1
36638|NCT01370863|148273|P1|Overall Study|Did not want second pH/MII monitoring|1
36639|NCT01370863|148272|P2|Overall Study|Adverse Event|1
36640|NCT01370863|148273|P1|Overall Study|Adverse Event|1
36641|NCT01370733|148298|P2|Overall Study|Protocol Violation|3
36642|NCT01370733|148299|P1|Overall Study|Protocol Violation|1
36643|NCT01370733|148298|P2|Overall Study|Physician Decision|2
36644|NCT01370733|148299|P1|Overall Study|Physician Decision|0
36645|NCT01370733|148298|P2|Overall Study|Lack of Efficacy|5
36646|NCT01370733|148299|P1|Overall Study|Lack of Efficacy|3
36647|NCT01370733|148298|P2|Overall Study|Adverse Event|4
36648|NCT01370733|148299|P1|Overall Study|Adverse Event|2
36649|NCT01370733|148298|P2|Overall Study|Lost to Follow-up|0
36650|NCT01370733|148299|P1|Overall Study|Lost to Follow-up|3
36651|NCT01370733|148298|P2|Overall Study|Withdrawal by Subject|8
36652|NCT01370733|148299|P1|Overall Study|Withdrawal by Subject|8
36653|NCT01370694|148321|P1|Overall Study|Progressive disease|2
36654|NCT01370694|148321|P1|Overall Study|Switched to rituximab|4
36655|NCT01370642|148334|P3|Overall Study|Withdrawal by Subject|3
36656|NCT01370642|148335|P2|Overall Study|Withdrawal by Subject|4
36657|NCT01370642|148336|P1|Overall Study|Withdrawal by Subject|2
36658|NCT01370642|148334|P3|Overall Study|Physician Decision|2
36659|NCT01370642|148335|P2|Overall Study|Physician Decision|1
36660|NCT01370642|148336|P1|Overall Study|Physician Decision|4
36661|NCT01370642|148334|P3|Overall Study|Lost to Follow-up|1
36662|NCT01370642|148335|P2|Overall Study|Lost to Follow-up|0
36663|NCT01370642|148336|P1|Overall Study|Lost to Follow-up|0
36664|NCT01370642|148334|P3|Overall Study|Detectable HCV RNA|22
36665|NCT01370642|148335|P2|Overall Study|Detectable HCV RNA|0
36666|NCT01370642|148336|P1|Overall Study|Detectable HCV RNA|0
36667|NCT01370642|148334|P3|Overall Study|Adverse Event|1
36668|NCT01370642|148335|P2|Overall Study|Adverse Event|1
36669|NCT01370642|148336|P1|Overall Study|Adverse Event|2
36670|NCT01370616|148367|P2|Overall Study|Withdrawal by Subject|34
36671|NCT01370616|148368|P1|Overall Study|Withdrawal by Subject|34
36672|NCT01370616|148367|P2|Overall Study|Technical Problems|5
36673|NCT01370616|148368|P1|Overall Study|Technical Problems|3
36674|NCT01370616|148367|P2|Overall Study|Recovery|0
36675|NCT01370616|148368|P1|Overall Study|Recovery|1
36676|NCT01370616|148367|P2|Overall Study|Progressive Disease|1
36677|NCT01370616|148368|P1|Overall Study|Progressive Disease|0
36678|NCT01370616|148367|P2|Overall Study|Physician Decision|6
36679|NCT01370616|148368|P1|Overall Study|Physician Decision|6
36680|NCT01370616|148367|P2|Overall Study|Lost to Follow-up|3
36681|NCT01370616|148368|P1|Overall Study|Lost to Follow-up|0
36682|NCT01370616|148367|P2|Overall Study|Lack of Efficacy|2
36683|NCT01370616|148368|P1|Overall Study|Lack of Efficacy|6
36684|NCT01370616|148367|P2|Overall Study|Death|0
36685|NCT01370616|148368|P1|Overall Study|Death|1
36686|NCT01370616|148367|P2|Overall Study|Adverse Event|16
36687|NCT01370616|148368|P1|Overall Study|Adverse Event|11
36688|NCT01370603|148392|P2|Period 2|Withdrawal by Subject|0
36689|NCT01370603|148393|P1|Period 2|Withdrawal by Subject|1
36690|NCT01370603|148392|P2|Period 2|Lost to Follow-up|0
36691|NCT01370603|148393|P1|Period 2|Lost to Follow-up|1
36692|NCT01370603|148392|P2|Period 2|Adverse Event|4
36693|NCT01370603|148393|P1|Period 2|Adverse Event|1
36694|NCT01370603|148392|P2|Crossover Washout|Non-compliance with Study Drug|2
36695|NCT01370603|148393|P1|Crossover Washout|Non-compliance with Study Drug|0
36696|NCT01370603|148392|P2|Crossover Washout|Withdrawal by Subject|1
36697|NCT01370603|148393|P1|Crossover Washout|Withdrawal by Subject|4
36698|NCT01370603|148392|P2|Crossover Washout|Protocol Violation|0
36699|NCT01370603|148393|P1|Crossover Washout|Protocol Violation|1
36700|NCT01370603|148392|P2|Crossover Washout|Lost to Follow-up|0
36701|NCT01370603|148393|P1|Crossover Washout|Lost to Follow-up|2
36702|NCT01370603|148392|P2|Crossover Washout|Adverse Event|1
36703|NCT01370603|148393|P1|Crossover Washout|Adverse Event|2
36704|NCT01370603|148392|P2|Period 1|Withdrawal by Subject|5
36705|NCT01370603|148393|P1|Period 1|Withdrawal by Subject|5
36706|NCT01370603|148392|P2|Period 1|Protocol Violation|2
36707|NCT01370603|148393|P1|Period 1|Protocol Violation|2
36708|NCT01370603|148392|P2|Period 1|Lost to Follow-up|0
36709|NCT01370603|148393|P1|Period 1|Lost to Follow-up|2
36710|NCT01370603|148392|P2|Period 1|Adverse Event|3
36711|NCT01370603|148393|P1|Period 1|Adverse Event|5
36712|NCT01370590|148411|P2|Period 2|Withdrawal by Subject|1
36713|NCT01370590|148412|P1|Period 2|Withdrawal by Subject|1
36714|NCT01370590|148411|P2|Period 2|Adverse Event|1
36715|NCT01370590|148412|P1|Period 2|Adverse Event|0
36716|NCT01370590|148411|P2|Crossover Washout Period|Withdrawal by Subject|2
36717|NCT01370590|148412|P1|Crossover Washout Period|Withdrawal by Subject|2
36718|NCT01370590|148411|P2|Crossover Washout Period|Non-compliance with Study Drug|0
36719|NCT01370590|148412|P1|Crossover Washout Period|Non-compliance with Study Drug|1
36720|NCT01370590|148411|P2|Crossover Washout Period|Lost to Follow-up|0
36721|NCT01370590|148412|P1|Crossover Washout Period|Lost to Follow-up|2
36722|NCT01370590|148411|P2|Crossover Washout Period|Adverse Event|4
36723|NCT01370590|148412|P1|Crossover Washout Period|Adverse Event|1
36724|NCT01370590|148411|P2|Period 1|Could not access randomization system|1
36725|NCT01370590|148412|P1|Period 1|Could not access randomization system|0
36726|NCT01370590|148411|P2|Period 1|Withdrawal by Subject|2
36727|NCT01370590|148412|P1|Period 1|Withdrawal by Subject|4
36728|NCT01370590|148411|P2|Period 1|Protocol Violation|2
36729|NCT01370590|148412|P1|Period 1|Protocol Violation|2
36730|NCT01370590|148411|P2|Period 1|Lost to Follow-up|2
36731|NCT01370590|148412|P1|Period 1|Lost to Follow-up|2
36732|NCT01370590|148411|P2|Period 1|Adverse Event|4
36733|NCT01370590|148412|P1|Period 1|Adverse Event|8
36734|NCT01370538|148430|P2|Overall Study|Lost to follow up|10
36735|NCT01370538|148431|P1|Overall Study|Lost to follow up|6
36736|NCT01370538|148430|P2|Overall Study|Development of study specific withdrawal|1
36737|NCT01370538|148431|P1|Overall Study|Development of study specific withdrawal|1
36738|NCT01370538|148430|P2|Overall Study|Protocol Violation|5
36739|NCT01370538|148431|P1|Overall Study|Protocol Violation|8
36740|NCT01370538|148430|P2|Overall Study|Adverse Event|0
36741|NCT01370538|148431|P1|Overall Study|Adverse Event|1
36742|NCT01370538|148430|P2|Overall Study|Eligibility criteria not fulfilled|1
36743|NCT01370538|148431|P1|Overall Study|Eligibility criteria not fulfilled|0
36744|NCT01370538|148430|P2|Overall Study|Voluntary Discontinuation by Subject|2
36745|NCT01370538|148431|P1|Overall Study|Voluntary Discontinuation by Subject|3
36746|NCT01370525|148447|P2|Overall Study|Lost to follow up|6
36747|NCT01370525|148448|P1|Overall Study|Lost to follow up|2
36748|NCT01370525|148447|P2|Overall Study|Protocol Violation|1
36749|NCT01370525|148448|P1|Overall Study|Protocol Violation|2
36750|NCT01370525|148447|P2|Overall Study|Adverse Event|1
36751|NCT01370525|148448|P1|Overall Study|Adverse Event|0
36752|NCT01370525|148447|P2|Overall Study|Eligibility criteria not fulfilled|0
36753|NCT01370525|148448|P1|Overall Study|Eligibility criteria not fulfilled|2
36754|NCT01370525|148447|P2|Overall Study|Voluntary Discontinuation by Subject|3
36755|NCT01370525|148448|P1|Overall Study|Voluntary Discontinuation by Subject|2
36756|NCT01370408|148472|P1|Overall Study|treatment failure|9
36757|NCT01370356|148485|P2|Overall Study|AE Not Related to Study Drug|4
36758|NCT01370356|148486|P1|Overall Study|AE Not Related to Study Drug|1
36759|NCT01370356|148485|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
36760|NCT01370356|148486|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
36761|NCT01370356|148485|P2|Overall Study|Protocol Violation|3
36762|NCT01370356|148486|P1|Overall Study|Protocol Violation|3
36763|NCT01370356|148485|P2|Overall Study|Reason not specified|43
36764|NCT01370356|148486|P1|Overall Study|Reason not specified|39
36765|NCT01370356|148485|P2|Overall Study|Withdrawal by Subject|59
36766|NCT01370356|148486|P1|Overall Study|Withdrawal by Subject|54
36767|NCT01370356|148485|P2|Overall Study|Lost to Follow-up|81
36768|NCT01370356|148486|P1|Overall Study|Lost to Follow-up|76
36769|NCT01370356|148485|P2|Overall Study|Lack of Efficacy|28
36770|NCT01370356|148486|P1|Overall Study|Lack of Efficacy|6
36771|NCT01370356|148485|P2|Overall Study|Death|0
36772|NCT01370356|148486|P1|Overall Study|Death|1
36773|NCT01370265|148500|P2|First Intervention|Adverse Event|1
36774|NCT01370265|148501|P1|First Intervention|Adverse Event|1
36775|NCT01370083|148520|P2|Overall Study|Adverse Event|1
36776|NCT01370083|148521|P1|Overall Study|Adverse Event|0
36777|NCT01370083|148520|P2|Overall Study|Lost to Follow-up|0
36778|NCT01370083|148521|P1|Overall Study|Lost to Follow-up|2
36779|NCT01370005|148534|P3|Overall Study|Other reason not defined above|2
36780|NCT01370005|148535|P2|Overall Study|Other reason not defined above|0
36781|NCT01370005|148536|P1|Overall Study|Other reason not defined above|3
36782|NCT01370005|148534|P3|Overall Study|Patient refusal to continue,not due toAE|0
36783|NCT01370005|148535|P2|Overall Study|Patient refusal to continue,not due toAE|4
36784|NCT01370005|148536|P1|Overall Study|Patient refusal to continue,not due toAE|5
36785|NCT01370005|148534|P3|Overall Study|Lost to Follow-up|1
36786|NCT01370005|148535|P2|Overall Study|Lost to Follow-up|1
36787|NCT01370005|148536|P1|Overall Study|Lost to Follow-up|1
36788|NCT01370005|148534|P3|Overall Study|Non compliant with protocol|2
36789|NCT01370005|148535|P2|Overall Study|Non compliant with protocol|1
36790|NCT01370005|148536|P1|Overall Study|Non compliant with protocol|0
36791|NCT01370005|148534|P3|Overall Study|Lack of Efficacy|0
36792|NCT01370005|148535|P2|Overall Study|Lack of Efficacy|0
36793|NCT01370005|148536|P1|Overall Study|Lack of Efficacy|1
36794|NCT01370005|148534|P3|Overall Study|Adverse Event|6
36795|NCT01370005|148535|P2|Overall Study|Adverse Event|5
36796|NCT01370005|148536|P1|Overall Study|Adverse Event|5
36797|NCT01370005|148534|P3|Overall Study|Not treated|0
36798|NCT01370005|148535|P2|Overall Study|Not treated|0
36799|NCT01370005|148536|P1|Overall Study|Not treated|1
36800|NCT01369849|148618|P3|Overall Study|Ineligible prior to treatment|1
36801|NCT01369849|148619|P2|Overall Study|Ineligible prior to treatment|0
36802|NCT01369849|148620|P1|Overall Study|Ineligible prior to treatment|0
36803|NCT01369784|148629|P1|Overall Study|Protocol Violation|12
36804|NCT01369680|148712|P4|Overall Study|Lost to Follow-up|2
36805|NCT01369680|148713|P3|Overall Study|Lost to Follow-up|1
36806|NCT01369680|148714|P2|Overall Study|Lost to Follow-up|0
36807|NCT01369680|148715|P1|Overall Study|Lost to Follow-up|0
36808|NCT01369641|148736|P1|Overall Study|Withdrawal by Subject|1
36809|NCT01369615|148742|P2|Overall Study|Lost to Follow-up|1
36810|NCT01369615|148743|P1|Overall Study|Lost to Follow-up|0
36811|NCT01369615|148742|P2|Overall Study|Withdrawal by Subject|1
36812|NCT01369615|148743|P1|Overall Study|Withdrawal by Subject|0
36813|NCT01369485|148751|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
36814|NCT01369485|148752|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
36815|NCT01369485|148751|P2|Open Label Phase (Week 12 to Month 12)|Death|1
36816|NCT01369485|148752|P1|Open Label Phase (Week 12 to Month 12)|Death|0
36817|NCT01369485|148751|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
36818|NCT01369485|148752|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
36819|NCT01369485|148751|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
36820|NCT01369485|148752|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
36821|NCT01369485|148751|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
36822|NCT01369485|148752|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
36823|NCT01369485|148751|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
36824|NCT01369485|148752|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
36825|NCT01369485|148751|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
36826|NCT01369485|148752|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
36827|NCT01369485|148751|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
36828|NCT01369485|148752|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
36829|NCT01369485|148751|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
36830|NCT01369485|148752|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
36831|NCT01369485|148751|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
36832|NCT01369485|148752|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
36833|NCT01369342|148795|P3|Overall Study|Not Treated|0
36834|NCT01369342|148796|P2|Overall Study|Not Treated|0
36835|NCT01369342|148797|P1|Overall Study|Not Treated|1
36836|NCT01369342|148795|P3|Overall Study|Lost to Follow-up|1
36837|NCT01369342|148796|P2|Overall Study|Lost to Follow-up|2
36838|NCT01369342|148797|P1|Overall Study|Lost to Follow-up|5
36839|NCT01369342|148795|P3|Overall Study|Withdrawal by Subject|2
36840|NCT01369342|148796|P2|Overall Study|Withdrawal by Subject|7
36841|NCT01369342|148797|P1|Overall Study|Withdrawal by Subject|7
36842|NCT01369329|148820|P3|Overall Study|Unspecified|2
36843|NCT01369329|148821|P2|Overall Study|Unspecified|3
36844|NCT01369329|148822|P1|Overall Study|Unspecified|2
36845|NCT01369329|148820|P3|Overall Study|Lost to Follow-up|2
36846|NCT01369329|148821|P2|Overall Study|Lost to Follow-up|2
36847|NCT01369329|148822|P1|Overall Study|Lost to Follow-up|2
36848|NCT01369329|148820|P3|Overall Study|Withdrawal by Subject|10
36849|NCT01369329|148821|P2|Overall Study|Withdrawal by Subject|6
36850|NCT01369329|148822|P1|Overall Study|Withdrawal by Subject|8
36851|NCT01368965|148848|P1|Overall Study|Lost to Follow-up|12
36852|NCT01368900|148857|P1|Overall Study|Lost to Follow-up|7
36853|NCT01368835|148932|P1|Overall Study|Lost to Follow-up|11
36854|NCT01368835|148932|P1|Overall Study|Inclusion criteria/photography quality|22
36855|NCT01368536|148974|P3|Overall Study|Protocol deviation|1
36856|NCT01368536|148975|P2|Overall Study|Protocol deviation|3
36857|NCT01368536|148976|P1|Overall Study|Protocol deviation|0
36858|NCT01368536|148974|P3|Overall Study|Administrative problems|35
36859|NCT01368536|148975|P2|Overall Study|Administrative problems|39
36860|NCT01368536|148976|P1|Overall Study|Administrative problems|34
36861|NCT01368536|148974|P3|Overall Study|Lost to Follow-up|5
36862|NCT01368536|148975|P2|Overall Study|Lost to Follow-up|3
36863|NCT01368536|148976|P1|Overall Study|Lost to Follow-up|3
36864|NCT01368536|148974|P3|Overall Study|Withdrawal by Subject|4
36865|NCT01368536|148975|P2|Overall Study|Withdrawal by Subject|5
36866|NCT01368536|148976|P1|Overall Study|Withdrawal by Subject|2
36867|NCT01368536|148974|P3|Overall Study|No longer required study medication|1
36868|NCT01368536|148975|P2|Overall Study|No longer required study medication|0
36869|NCT01368536|148976|P1|Overall Study|No longer required study medication|0
36870|NCT01368536|148974|P3|Overall Study|Unsatisfactory therapeutic effect|2
36871|NCT01368536|148975|P2|Overall Study|Unsatisfactory therapeutic effect|2
36872|NCT01368536|148976|P1|Overall Study|Unsatisfactory therapeutic effect|7
36873|NCT01368536|148974|P3|Overall Study|Abnormal test procedure result(s)|1
36874|NCT01368536|148975|P2|Overall Study|Abnormal test procedure result(s)|0
36875|NCT01368536|148976|P1|Overall Study|Abnormal test procedure result(s)|0
36876|NCT01368536|148974|P3|Overall Study|Abnormal laboratory value(s)|2
36877|NCT01368536|148975|P2|Overall Study|Abnormal laboratory value(s)|1
36878|NCT01368536|148976|P1|Overall Study|Abnormal laboratory value(s)|0
36879|NCT01368536|148974|P3|Overall Study|Adverse Event|8
36880|NCT01368536|148975|P2|Overall Study|Adverse Event|6
36881|NCT01368536|148976|P1|Overall Study|Adverse Event|5
36882|NCT01368432|148999|P2|Overall Study|Lost to Follow-up|1
36883|NCT01368432|149000|P1|Overall Study|Lost to Follow-up|0
36884|NCT01368406|149034|P2|Overall Study|started working|3
36885|NCT01368406|149035|P1|Overall Study|started working|2
36886|NCT01368406|149034|P2|Overall Study|relapse of the disease|2
36887|NCT01368406|149035|P1|Overall Study|relapse of the disease|3
36888|NCT01368406|149034|P2|Overall Study|Withdrawal by Subject|4
36889|NCT01368406|149035|P1|Overall Study|Withdrawal by Subject|8
36890|NCT01368406|149034|P2|Overall Study|Lost to Follow-up|4
36891|NCT01368406|149035|P1|Overall Study|Lost to Follow-up|8
36892|NCT01368276|149043|P2|Overall Study|Death|10
36893|NCT01368276|149044|P1|Overall Study|Death|1
36894|NCT01368211|149081|P2|Second Platelets Transfusion|No need for additional transfusion|2
36895|NCT01368211|149082|P1|Second Platelets Transfusion|No need for additional transfusion|1
36896|NCT01368081|149110|P13|Overall Study|Other reason not defined above|3
36897|NCT01368081|149111|P12|Overall Study|Other reason not defined above|0
36898|NCT01368081|149112|P11|Overall Study|Other reason not defined above|0
36899|NCT01368081|149113|P10|Overall Study|Other reason not defined above|1
36900|NCT01368081|149114|P9|Overall Study|Other reason not defined above|0
36901|NCT01368081|149115|P8|Overall Study|Other reason not defined above|0
36902|NCT01368081|149116|P7|Overall Study|Other reason not defined above|2
36903|NCT01368081|149117|P6|Overall Study|Other reason not defined above|1
36904|NCT01368081|149118|P5|Overall Study|Other reason not defined above|0
36905|NCT01368081|149119|P4|Overall Study|Other reason not defined above|1
36906|NCT01368081|149120|P3|Overall Study|Other reason not defined above|0
36907|NCT01368081|149121|P2|Overall Study|Other reason not defined above|0
36908|NCT01368081|149122|P1|Overall Study|Other reason not defined above|2
36909|NCT01368081|149110|P13|Overall Study|Withdrawal by Subject|0
36910|NCT01368081|149111|P12|Overall Study|Withdrawal by Subject|2
36911|NCT01368081|149112|P11|Overall Study|Withdrawal by Subject|3
36912|NCT01368081|149113|P10|Overall Study|Withdrawal by Subject|4
36913|NCT01368081|149114|P9|Overall Study|Withdrawal by Subject|5
36914|NCT01368081|149115|P8|Overall Study|Withdrawal by Subject|2
36915|NCT01368081|149116|P7|Overall Study|Withdrawal by Subject|4
36916|NCT01368081|149117|P6|Overall Study|Withdrawal by Subject|3
36917|NCT01368081|149118|P5|Overall Study|Withdrawal by Subject|0
36918|NCT01368081|149119|P4|Overall Study|Withdrawal by Subject|1
36919|NCT01368081|149120|P3|Overall Study|Withdrawal by Subject|1
36920|NCT01368081|149121|P2|Overall Study|Withdrawal by Subject|4
36921|NCT01368081|149122|P1|Overall Study|Withdrawal by Subject|4
36922|NCT01368081|149110|P13|Overall Study|Lost to Follow-up|1
36923|NCT01368081|149111|P12|Overall Study|Lost to Follow-up|0
36924|NCT01368081|149112|P11|Overall Study|Lost to Follow-up|0
36925|NCT01368081|149113|P10|Overall Study|Lost to Follow-up|0
36926|NCT01368081|149114|P9|Overall Study|Lost to Follow-up|0
36927|NCT01368081|149115|P8|Overall Study|Lost to Follow-up|0
36928|NCT01368081|149116|P7|Overall Study|Lost to Follow-up|0
36929|NCT01368081|149117|P6|Overall Study|Lost to Follow-up|0
36930|NCT01368081|149118|P5|Overall Study|Lost to Follow-up|0
36931|NCT01368081|149119|P4|Overall Study|Lost to Follow-up|0
36932|NCT01368081|149120|P3|Overall Study|Lost to Follow-up|0
36933|NCT01368081|149121|P2|Overall Study|Lost to Follow-up|0
36934|NCT01368081|149122|P1|Overall Study|Lost to Follow-up|0
36935|NCT01368081|149110|P13|Overall Study|Protocol Violation|0
36936|NCT01368081|149111|P12|Overall Study|Protocol Violation|0
36937|NCT01368081|149112|P11|Overall Study|Protocol Violation|0
36938|NCT01368081|149113|P10|Overall Study|Protocol Violation|0
36939|NCT01368081|149114|P9|Overall Study|Protocol Violation|0
36940|NCT01368081|149115|P8|Overall Study|Protocol Violation|1
36941|NCT01368081|149116|P7|Overall Study|Protocol Violation|0
36942|NCT01368081|149117|P6|Overall Study|Protocol Violation|1
36943|NCT01368081|149118|P5|Overall Study|Protocol Violation|0
36944|NCT01368081|149119|P4|Overall Study|Protocol Violation|0
36945|NCT01368081|149120|P3|Overall Study|Protocol Violation|0
36946|NCT01368081|149121|P2|Overall Study|Protocol Violation|0
36947|NCT01368081|149122|P1|Overall Study|Protocol Violation|0
36948|NCT01368081|149110|P13|Overall Study|Lack of Efficacy|0
36949|NCT01368081|149111|P12|Overall Study|Lack of Efficacy|0
36950|NCT01368081|149112|P11|Overall Study|Lack of Efficacy|0
36951|NCT01368081|149113|P10|Overall Study|Lack of Efficacy|0
36952|NCT01368081|149114|P9|Overall Study|Lack of Efficacy|0
36953|NCT01368081|149115|P8|Overall Study|Lack of Efficacy|2
36954|NCT01368081|149116|P7|Overall Study|Lack of Efficacy|0
36955|NCT01368081|149117|P6|Overall Study|Lack of Efficacy|0
36956|NCT01368081|149118|P5|Overall Study|Lack of Efficacy|0
36957|NCT01368081|149119|P4|Overall Study|Lack of Efficacy|1
36958|NCT01368081|149120|P3|Overall Study|Lack of Efficacy|0
36959|NCT01368081|149121|P2|Overall Study|Lack of Efficacy|1
36960|NCT01368081|149122|P1|Overall Study|Lack of Efficacy|0
36961|NCT01368081|149110|P13|Overall Study|Adverse Event|3
36962|NCT01368081|149111|P12|Overall Study|Adverse Event|1
36963|NCT01368081|149112|P11|Overall Study|Adverse Event|6
36964|NCT01368081|149113|P10|Overall Study|Adverse Event|5
36965|NCT01368081|149114|P9|Overall Study|Adverse Event|3
36966|NCT01368081|149115|P8|Overall Study|Adverse Event|2
36967|NCT01368081|149116|P7|Overall Study|Adverse Event|6
36968|NCT01368081|149117|P6|Overall Study|Adverse Event|5
36969|NCT01368081|149118|P5|Overall Study|Adverse Event|2
36970|NCT01368081|149119|P4|Overall Study|Adverse Event|2
36971|NCT01368081|149120|P3|Overall Study|Adverse Event|3
36972|NCT01368081|149121|P2|Overall Study|Adverse Event|4
36973|NCT01368081|149122|P1|Overall Study|Adverse Event|4
36974|NCT01368042|149176|P1|Overall Study|Transplanted|1
36975|NCT01368042|149176|P1|Overall Study|Lost to Follow-up|4
36976|NCT01368042|149176|P1|Overall Study|Protocol Violation|11
36977|NCT01368042|149176|P1|Overall Study|Death|14
36978|NCT01367886|149196|P1|Overall Study|Death|1
36979|NCT01367886|149196|P1|Overall Study|Lack of Efficacy|2
36980|NCT01367886|149196|P1|Overall Study|Lost to Follow-up|4
36981|NCT01367704|149246|P2|Overall Study|Lost to Follow-up|161
36982|NCT01367704|149247|P1|Overall Study|Lost to Follow-up|47
36983|NCT01367665|149259|P2|Overall Study|Other|0
36984|NCT01367665|149260|P1|Overall Study|Other|8
36985|NCT01367665|149259|P2|Overall Study|Suitable for surgery|0
36986|NCT01367665|149260|P1|Overall Study|Suitable for surgery|2
36987|NCT01367665|149259|P2|Overall Study|Lack of Efficacy|0
36988|NCT01367665|149260|P1|Overall Study|Lack of Efficacy|2
36989|NCT01367665|149259|P2|Overall Study|Non-compliance|0
36990|NCT01367665|149260|P1|Overall Study|Non-compliance|4
36991|NCT01367665|149259|P2|Overall Study|Protocol Violation|0
36992|NCT01367665|149260|P1|Overall Study|Protocol Violation|4
36993|NCT01367665|149259|P2|Overall Study|Not treated|0
36994|NCT01367665|149260|P1|Overall Study|Not treated|1
36995|NCT01367665|149259|P2|Overall Study|Progression of Disease|15
36996|NCT01367665|149260|P1|Overall Study|Progression of Disease|55
36997|NCT01367665|149259|P2|Overall Study|Withdrawal by Subject|2
36998|NCT01367665|149260|P1|Overall Study|Withdrawal by Subject|60
36999|NCT01367665|149259|P2|Overall Study|Complete Response|0
37000|NCT01367665|149260|P1|Overall Study|Complete Response|42
37001|NCT01367665|149259|P2|Overall Study|Lost to Follow-up|0
37002|NCT01367665|149260|P1|Overall Study|Lost to Follow-up|4
37003|NCT01367665|149259|P2|Overall Study|Investigator Request|1
37004|NCT01367665|149260|P1|Overall Study|Investigator Request|13
37005|NCT01367665|149259|P2|Overall Study|Death|1
37006|NCT01367665|149260|P1|Overall Study|Death|9
37007|NCT01367665|149259|P2|Overall Study|Adverse Event|5
37008|NCT01367665|149260|P1|Overall Study|Adverse Event|173
37009|NCT01367457|149269|P3|Overall Study|Suspected DP/suspected active infection|0
37010|NCT01367457|149270|P2|Overall Study|Suspected DP/suspected active infection|0
37011|NCT01367457|149271|P1|Overall Study|Suspected DP/suspected active infection|1
37012|NCT01367457|149269|P3|Overall Study|Palliative. Overall decline|0
37013|NCT01367457|149270|P2|Overall Study|Palliative. Overall decline|0
37014|NCT01367457|149271|P1|Overall Study|Palliative. Overall decline|1
37015|NCT01367457|149269|P3|Overall Study|Patient's Wish|0
37016|NCT01367457|149270|P2|Overall Study|Patient's Wish|0
37017|NCT01367457|149271|P1|Overall Study|Patient's Wish|1
37018|NCT01367457|149269|P3|Overall Study|CD, Suspected disease progression (DP)|0
37019|NCT01367457|149270|P2|Overall Study|CD, Suspected disease progression (DP)|0
37020|NCT01367457|149271|P1|Overall Study|CD, Suspected disease progression (DP)|1
37021|NCT01367457|149269|P3|Overall Study|Death from septic shock|0
37022|NCT01367457|149270|P2|Overall Study|Death from septic shock|0
37023|NCT01367457|149271|P1|Overall Study|Death from septic shock|1
37024|NCT01367457|149269|P3|Overall Study|Lost to Follow-up|0
37025|NCT01367457|149270|P2|Overall Study|Lost to Follow-up|0
37026|NCT01367457|149271|P1|Overall Study|Lost to Follow-up|1
37027|NCT01367457|149269|P3|Overall Study|Rejection of treatment|0
37028|NCT01367457|149270|P2|Overall Study|Rejection of treatment|0
37029|NCT01367457|149271|P1|Overall Study|Rejection of treatment|1
37030|NCT01367457|149269|P3|Overall Study|Overall decline|0
37031|NCT01367457|149270|P2|Overall Study|Overall decline|0
37032|NCT01367457|149271|P1|Overall Study|Overall decline|1
37033|NCT01367457|149269|P3|Overall Study|Intestinal obstruction with necrosis|0
37034|NCT01367457|149270|P2|Overall Study|Intestinal obstruction with necrosis|0
37035|NCT01367457|149271|P1|Overall Study|Intestinal obstruction with necrosis|1
37036|NCT01367457|149269|P3|Overall Study|No clinical benefit|0
37037|NCT01367457|149270|P2|Overall Study|No clinical benefit|0
37038|NCT01367457|149271|P1|Overall Study|No clinical benefit|1
37039|NCT01367457|149269|P3|Overall Study|Stabilisation + frequent infections|0
37040|NCT01367457|149270|P2|Overall Study|Stabilisation + frequent infections|0
37041|NCT01367457|149271|P1|Overall Study|Stabilisation + frequent infections|1
37042|NCT01367457|149269|P3|Overall Study|Overall status worsens to grade 4|0
37043|NCT01367457|149270|P2|Overall Study|Overall status worsens to grade 4|0
37044|NCT01367457|149271|P1|Overall Study|Overall status worsens to grade 4|1
37045|NCT01367457|149269|P3|Overall Study|Uncontrolled pain|0
37046|NCT01367457|149270|P2|Overall Study|Uncontrolled pain|0
37047|NCT01367457|149271|P1|Overall Study|Uncontrolled pain|1
37048|NCT01367457|149269|P3|Overall Study|CD, associated leukaemia|0
37049|NCT01367457|149270|P2|Overall Study|CD, associated leukaemia|0
37050|NCT01367457|149271|P1|Overall Study|CD, associated leukaemia|1
37051|NCT01367457|149269|P3|Overall Study|Withdrawal by Subject|0
37052|NCT01367457|149270|P2|Overall Study|Withdrawal by Subject|0
37053|NCT01367457|149271|P1|Overall Study|Withdrawal by Subject|1
37054|NCT01367457|149269|P3|Overall Study|Choledocolithiasis and pancreatitis|0
37055|NCT01367457|149270|P2|Overall Study|Choledocolithiasis and pancreatitis|0
37056|NCT01367457|149271|P1|Overall Study|Choledocolithiasis and pancreatitis|1
37057|NCT01367457|149269|P3|Overall Study|low grade toxicities + stable disease|0
37058|NCT01367457|149270|P2|Overall Study|low grade toxicities + stable disease|0
37059|NCT01367457|149271|P1|Overall Study|low grade toxicities + stable disease|1
37060|NCT01367457|149269|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
37061|NCT01367457|149270|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
37062|NCT01367457|149271|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
37063|NCT01367457|149269|P3|Overall Study|Bleeding from cavernous haemangioma|0
37064|NCT01367457|149270|P2|Overall Study|Bleeding from cavernous haemangioma|0
37065|NCT01367457|149271|P1|Overall Study|Bleeding from cavernous haemangioma|1
37066|NCT01367457|149269|P3|Overall Study|Investigator's opinion, stable disease|0
37067|NCT01367457|149270|P2|Overall Study|Investigator's opinion, stable disease|0
37068|NCT01367457|149271|P1|Overall Study|Investigator's opinion, stable disease|1
37069|NCT01367457|149269|P3|Overall Study|Patient asks for rest + slow progression|0
37070|NCT01367457|149270|P2|Overall Study|Patient asks for rest + slow progression|0
37071|NCT01367457|149271|P1|Overall Study|Patient asks for rest + slow progression|1
37072|NCT01367457|149269|P3|Overall Study|Progression|0
37073|NCT01367457|149270|P2|Overall Study|Progression|0
37074|NCT01367457|149271|P1|Overall Study|Progression|137
37075|NCT01367457|149269|P3|Overall Study|Toxicity|0
37076|NCT01367457|149270|P2|Overall Study|Toxicity|0
37077|NCT01367457|149271|P1|Overall Study|Toxicity|16
37078|NCT01367457|149269|P3|Overall Study|Progression and death|0
37079|NCT01367457|149270|P2|Overall Study|Progression and death|0
37080|NCT01367457|149271|P1|Overall Study|Progression and death|8
37081|NCT01367457|149269|P3|Overall Study|Clinical decline (CD)|0
37082|NCT01367457|149270|P2|Overall Study|Clinical decline (CD)|0
37083|NCT01367457|149271|P1|Overall Study|Clinical decline (CD)|2
37084|NCT01367457|149269|P3|Overall Study|Investigator's decision|0
37085|NCT01367457|149270|P2|Overall Study|Investigator's decision|0
37086|NCT01367457|149271|P1|Overall Study|Investigator's decision|2
37087|NCT01367457|149269|P3|Overall Study|Death|0
37088|NCT01367457|149270|P2|Overall Study|Death|0
37089|NCT01367457|149271|P1|Overall Study|Death|2
37090|NCT01367249|149293|P2|Overall Study|Not Specified|10
37091|NCT01367249|149294|P1|Overall Study|Not Specified|3
37092|NCT01367249|149293|P2|Overall Study|Withdrawal by Subject|6
37093|NCT01367249|149294|P1|Overall Study|Withdrawal by Subject|6
37094|NCT01367158|149313|P11|Overall Study|Protocol Violation|0
37095|NCT01367158|149314|P10|Overall Study|Protocol Violation|0
37096|NCT01367158|149315|P9|Overall Study|Protocol Violation|0
37097|NCT01367158|149316|P8|Overall Study|Protocol Violation|0
37098|NCT01367158|149317|P7|Overall Study|Protocol Violation|0
37099|NCT01367158|149318|P6|Overall Study|Protocol Violation|0
37100|NCT01367158|149319|P5|Overall Study|Protocol Violation|0
37101|NCT01367158|149320|P4|Overall Study|Protocol Violation|0
37102|NCT01367158|149321|P3|Overall Study|Protocol Violation|0
37103|NCT01367158|149322|P2|Overall Study|Protocol Violation|1
37104|NCT01367158|149323|P1|Overall Study|Protocol Violation|0
37105|NCT01367158|149313|P11|Overall Study|Lost to Follow-up|1
37106|NCT01367158|149314|P10|Overall Study|Lost to Follow-up|0
37107|NCT01367158|149315|P9|Overall Study|Lost to Follow-up|0
37108|NCT01367158|149316|P8|Overall Study|Lost to Follow-up|1
37109|NCT01367158|149317|P7|Overall Study|Lost to Follow-up|0
37110|NCT01367158|149318|P6|Overall Study|Lost to Follow-up|2
37111|NCT01367158|149319|P5|Overall Study|Lost to Follow-up|0
37112|NCT01367158|149320|P4|Overall Study|Lost to Follow-up|1
37113|NCT01367158|149321|P3|Overall Study|Lost to Follow-up|0
37114|NCT01367158|149322|P2|Overall Study|Lost to Follow-up|0
37115|NCT01367158|149323|P1|Overall Study|Lost to Follow-up|0
37116|NCT01367158|149313|P11|Overall Study|Withdrew consent|0
37117|NCT01367158|149314|P10|Overall Study|Withdrew consent|0
37118|NCT01367158|149315|P9|Overall Study|Withdrew consent|0
37119|NCT01367158|149316|P8|Overall Study|Withdrew consent|1
37120|NCT01367158|149317|P7|Overall Study|Withdrew consent|0
37121|NCT01367158|149318|P6|Overall Study|Withdrew consent|0
37122|NCT01367158|149319|P5|Overall Study|Withdrew consent|2
37123|NCT01367158|149320|P4|Overall Study|Withdrew consent|0
37124|NCT01367158|149321|P3|Overall Study|Withdrew consent|1
37125|NCT01367158|149322|P2|Overall Study|Withdrew consent|2
37126|NCT01367158|149323|P1|Overall Study|Withdrew consent|0
37127|NCT01367119|149467|P2|Overall Study|Withdrawal by Subject|1
37128|NCT01367119|149468|P1|Overall Study|Withdrawal by Subject|1
37129|NCT01367119|149467|P2|Overall Study|Adverse Event|0
37130|NCT01367119|149468|P1|Overall Study|Adverse Event|1
37131|NCT01366846|149523|P2|Overall Study|Scheduling Conflicts|0
37132|NCT01366846|149524|P1|Overall Study|Scheduling Conflicts|1
37133|NCT01366846|149523|P2|Overall Study|Communication Difficulties|5
37134|NCT01366846|149524|P1|Overall Study|Communication Difficulties|1
37135|NCT01366846|149523|P2|Overall Study|Withdrawal by Subject|0
37136|NCT01366846|149524|P1|Overall Study|Withdrawal by Subject|2
37137|NCT01366638|149547|P3|Overall Study|Not specified|0
37138|NCT01366638|149548|P2|Overall Study|Not specified|0
37139|NCT01366638|149549|P1|Overall Study|Not specified|1
37140|NCT01366638|149547|P3|Overall Study|Withdrawal by Subject|6
37141|NCT01366638|149548|P2|Overall Study|Withdrawal by Subject|0
37142|NCT01366638|149549|P1|Overall Study|Withdrawal by Subject|0
37143|NCT01366521|149587|P4|Overall Study|Withdrawal by Subject|0
37144|NCT01366521|149588|P3|Overall Study|Withdrawal by Subject|0
37145|NCT01366521|149589|P2|Overall Study|Withdrawal by Subject|1
37146|NCT01366521|149590|P1|Overall Study|Withdrawal by Subject|0
37147|NCT01366521|149587|P4|Overall Study|Physician Decision|0
37148|NCT01366521|149588|P3|Overall Study|Physician Decision|1
37149|NCT01366521|149589|P2|Overall Study|Physician Decision|0
37150|NCT01366521|149590|P1|Overall Study|Physician Decision|0
37151|NCT01366521|149587|P4|Overall Study|Protocol Violation|0
37152|NCT01366521|149588|P3|Overall Study|Protocol Violation|1
37153|NCT01366521|149589|P2|Overall Study|Protocol Violation|0
37154|NCT01366521|149590|P1|Overall Study|Protocol Violation|0
37155|NCT01366521|149587|P4|Overall Study|Adverse Event|0
37156|NCT01366521|149588|P3|Overall Study|Adverse Event|0
37157|NCT01366521|149589|P2|Overall Study|Adverse Event|0
37158|NCT01366521|149590|P1|Overall Study|Adverse Event|1
37159|NCT01366443|149665|P1|Overall Study|Under 18 yo|1
37160|NCT01366443|149665|P1|Overall Study|Lost to Follow-up|2
37161|NCT01366209|149679|P2|Overall Study|Withdrew consent|3
37162|NCT01366209|149680|P1|Overall Study|Withdrew consent|4
37163|NCT01366209|149679|P2|Overall Study|Sponsors decision|1
37164|NCT01366209|149680|P1|Overall Study|Sponsors decision|0
37165|NCT01366209|149679|P2|Overall Study|Physician Decision|0
37166|NCT01366209|149680|P1|Overall Study|Physician Decision|1
37167|NCT01366209|149679|P2|Overall Study|Lost to Follow-up|1
37168|NCT01366209|149680|P1|Overall Study|Lost to Follow-up|2
37169|NCT01366209|149679|P2|Overall Study|Lung transplantation|1
37170|NCT01366209|149680|P1|Overall Study|Lung transplantation|6
37171|NCT01366209|149679|P2|Overall Study|Death|19
37172|NCT01366209|149680|P1|Overall Study|Death|12
37173|NCT01366209|149679|P2|Overall Study|Withdrawal by Subject|4
37174|NCT01366209|149680|P1|Overall Study|Withdrawal by Subject|4
37175|NCT01366209|149679|P2|Overall Study|Adverse Event|7
37176|NCT01366209|149680|P1|Overall Study|Adverse Event|6
37177|NCT01366092|149686|P1|Overall Study|Withdrawal by Subject|1
37178|NCT01366092|149686|P1|Overall Study|Physician Decision|1
37179|NCT01366092|149686|P1|Overall Study|Progressive cGVHD|2
37180|NCT01365910|149695|P1|Overall Study|pt did not get tx, nausea/vomiting|1
37181|NCT01365910|149695|P1|Overall Study|other complicating disease|1
37182|NCT01365910|149695|P1|Overall Study|Adverse Event|3
37183|NCT01365910|149695|P1|Overall Study|disease progression|18
37184|NCT01365910|149695|P1|Overall Study|Withdrawal by Subject|7
37185|NCT01365546|149791|P1|Overall Study|Study termination|1
37186|NCT01365546|149791|P1|Overall Study|Screen failure|9
37187|NCT01365546|149791|P1|Overall Study|Withdrawal by Subject|1
37188|NCT01365507|149801|P2|Overall Study|Unclassified|4
37189|NCT01365507|149802|P1|Overall Study|Unclassified|1
37190|NCT01365507|149801|P2|Overall Study|Withdrawal Criteria|5
37191|NCT01365507|149802|P1|Overall Study|Withdrawal Criteria|8
37192|NCT01365494|149818|P2|Overall Study|Lost to Follow-up|2
37193|NCT01365494|149819|P1|Overall Study|Lost to Follow-up|1
37194|NCT01365494|149818|P2|Overall Study|Withdrawal by Subject|1
37195|NCT01365494|149819|P1|Overall Study|Withdrawal by Subject|0
37196|NCT01365494|149818|P2|Overall Study|Adverse Event|0
37197|NCT01365494|149819|P1|Overall Study|Adverse Event|1
37198|NCT01365481|149835|P4|Overall Study|Unsatisfactory therapeutic effect|0
37199|NCT01365481|149836|P3|Overall Study|Unsatisfactory therapeutic effect|1
37200|NCT01365481|149837|P2|Overall Study|Unsatisfactory therapeutic effect|0
37201|NCT01365481|149838|P1|Overall Study|Unsatisfactory therapeutic effect|0
37202|NCT01365481|149835|P4|Overall Study|Protocol deviation|1
37203|NCT01365481|149836|P3|Overall Study|Protocol deviation|0
37204|NCT01365481|149837|P2|Overall Study|Protocol deviation|1
37205|NCT01365481|149838|P1|Overall Study|Protocol deviation|0
37206|NCT01365481|149835|P4|Overall Study|Administrative problems|0
37207|NCT01365481|149836|P3|Overall Study|Administrative problems|0
37208|NCT01365481|149837|P2|Overall Study|Administrative problems|1
37209|NCT01365481|149838|P1|Overall Study|Administrative problems|0
37210|NCT01365481|149835|P4|Overall Study|Abnormal laboratory value(s)|0
37211|NCT01365481|149836|P3|Overall Study|Abnormal laboratory value(s)|0
37212|NCT01365481|149837|P2|Overall Study|Abnormal laboratory value(s)|1
37213|NCT01365481|149838|P1|Overall Study|Abnormal laboratory value(s)|0
37214|NCT01365481|149835|P4|Overall Study|Lost to Follow-up|3
37215|NCT01365481|149836|P3|Overall Study|Lost to Follow-up|2
37216|NCT01365481|149837|P2|Overall Study|Lost to Follow-up|1
37217|NCT01365481|149838|P1|Overall Study|Lost to Follow-up|1
37218|NCT01365481|149835|P4|Overall Study|Withdrawal by Subject|1
37219|NCT01365481|149836|P3|Overall Study|Withdrawal by Subject|1
37220|NCT01365481|149837|P2|Overall Study|Withdrawal by Subject|2
37221|NCT01365481|149838|P1|Overall Study|Withdrawal by Subject|0
37222|NCT01365481|149835|P4|Overall Study|Adverse Event|2
37223|NCT01365481|149836|P3|Overall Study|Adverse Event|0
37224|NCT01365481|149837|P2|Overall Study|Adverse Event|9
37225|NCT01365481|149838|P1|Overall Study|Adverse Event|6
37226|NCT01365468|149858|P2|Overall Study|Lost to Follow-up|0
37227|NCT01365468|149859|P1|Overall Study|Lost to Follow-up|2
37228|NCT01365468|149858|P2|Overall Study|Disease progression|0
37229|NCT01365468|149859|P1|Overall Study|Disease progression|1
37230|NCT01365468|149858|P2|Overall Study|Physician Decision|0
37231|NCT01365468|149859|P1|Overall Study|Physician Decision|1
37232|NCT01365455|149874|P5|Maintenance Period|Subject/guardian decision|1
37233|NCT01365455|149875|P4|Maintenance Period|Subject/guardian decision|4
37234|NCT01365455|149876|P3|Maintenance Period|Subject/guardian decision|2
37235|NCT01365455|149877|P2|Maintenance Period|Subject/guardian decision|6
37236|NCT01365455|149878|P1|Maintenance Period|Subject/guardian decision|4
37237|NCT01365455|149874|P5|Maintenance Period|Protocol deviation|0
37238|NCT01365455|149875|P4|Maintenance Period|Protocol deviation|0
37239|NCT01365455|149876|P3|Maintenance Period|Protocol deviation|0
37240|NCT01365455|149877|P2|Maintenance Period|Protocol deviation|1
37241|NCT01365455|149878|P1|Maintenance Period|Protocol deviation|1
37242|NCT01365455|149874|P5|Maintenance Period|Pregnancy|2
37243|NCT01365455|149875|P4|Maintenance Period|Pregnancy|0
37244|NCT01365455|149876|P3|Maintenance Period|Pregnancy|0
37245|NCT01365455|149877|P2|Maintenance Period|Pregnancy|4
37246|NCT01365455|149878|P1|Maintenance Period|Pregnancy|0
37247|NCT01365455|149874|P5|Maintenance Period|Physician Decision|1
37248|NCT01365455|149875|P4|Maintenance Period|Physician Decision|0
37249|NCT01365455|149876|P3|Maintenance Period|Physician Decision|0
37250|NCT01365455|149877|P2|Maintenance Period|Physician Decision|1
37251|NCT01365455|149878|P1|Maintenance Period|Physician Decision|0
37252|NCT01365455|149874|P5|Maintenance Period|Non-compliance with study treatment|0
37253|NCT01365455|149875|P4|Maintenance Period|Non-compliance with study treatment|1
37254|NCT01365455|149876|P3|Maintenance Period|Non-compliance with study treatment|0
37255|NCT01365455|149877|P2|Maintenance Period|Non-compliance with study treatment|0
37256|NCT01365455|149878|P1|Maintenance Period|Non-compliance with study treatment|0
37257|NCT01365455|149874|P5|Maintenance Period|Lost to Follow-up|3
37258|NCT01365455|149875|P4|Maintenance Period|Lost to Follow-up|0
37259|NCT01365455|149876|P3|Maintenance Period|Lost to Follow-up|0
37260|NCT01365455|149877|P2|Maintenance Period|Lost to Follow-up|4
37261|NCT01365455|149878|P1|Maintenance Period|Lost to Follow-up|2
37262|NCT01365455|149874|P5|Maintenance Period|Lack of Efficacy|2
37263|NCT01365455|149875|P4|Maintenance Period|Lack of Efficacy|2
37264|NCT01365455|149876|P3|Maintenance Period|Lack of Efficacy|0
37265|NCT01365455|149877|P2|Maintenance Period|Lack of Efficacy|2
37266|NCT01365455|149878|P1|Maintenance Period|Lack of Efficacy|10
37267|NCT01365455|149874|P5|Maintenance Period|Adverse Event|4
37268|NCT01365455|149875|P4|Maintenance Period|Adverse Event|2
37269|NCT01365455|149876|P3|Maintenance Period|Adverse Event|1
37270|NCT01365455|149877|P2|Maintenance Period|Adverse Event|5
37271|NCT01365455|149878|P1|Maintenance Period|Adverse Event|12
37272|NCT01365455|149874|P5|Induction Period|Lost to Follow-up|0
37273|NCT01365455|149875|P4|Induction Period|Lost to Follow-up|0
37274|NCT01365455|149876|P3|Induction Period|Lost to Follow-up|3
37275|NCT01365455|149877|P2|Induction Period|Lost to Follow-up|0
37276|NCT01365455|149878|P1|Induction Period|Lost to Follow-up|0
37277|NCT01365455|149874|P5|Induction Period|Subject/guardian decision|0
37278|NCT01365455|149875|P4|Induction Period|Subject/guardian decision|0
37279|NCT01365455|149876|P3|Induction Period|Subject/guardian decision|8
37280|NCT01365455|149877|P2|Induction Period|Subject/guardian decision|1
37281|NCT01365455|149878|P1|Induction Period|Subject/guardian decision|9
37282|NCT01365455|149874|P5|Induction Period|Protocol deviation|0
37283|NCT01365455|149875|P4|Induction Period|Protocol deviation|0
37284|NCT01365455|149876|P3|Induction Period|Protocol deviation|1
37285|NCT01365455|149877|P2|Induction Period|Protocol deviation|1
37286|NCT01365455|149878|P1|Induction Period|Protocol deviation|0
37287|NCT01365455|149874|P5|Induction Period|Pregnancy|0
37288|NCT01365455|149875|P4|Induction Period|Pregnancy|0
37289|NCT01365455|149876|P3|Induction Period|Pregnancy|0
37290|NCT01365455|149877|P2|Induction Period|Pregnancy|1
37291|NCT01365455|149878|P1|Induction Period|Pregnancy|0
37292|NCT01365455|149874|P5|Induction Period|Lack of Efficacy|0
37293|NCT01365455|149875|P4|Induction Period|Lack of Efficacy|0
37294|NCT01365455|149876|P3|Induction Period|Lack of Efficacy|0
37295|NCT01365455|149877|P2|Induction Period|Lack of Efficacy|1
37296|NCT01365455|149878|P1|Induction Period|Lack of Efficacy|1
37297|NCT01365455|149874|P5|Induction Period|Adverse Event|0
37298|NCT01365455|149875|P4|Induction Period|Adverse Event|0
37299|NCT01365455|149876|P3|Induction Period|Adverse Event|4
37300|NCT01365455|149877|P2|Induction Period|Adverse Event|3
37301|NCT01365455|149878|P1|Induction Period|Adverse Event|5
37302|NCT01365273|149968|P2|Overall Study|Physician Decision|0
37303|NCT01365273|149969|P1|Overall Study|Physician Decision|1
37304|NCT01365273|149968|P2|Overall Study|Protocol Violation|1
37305|NCT01365273|149969|P1|Overall Study|Protocol Violation|0
37306|NCT01365273|149968|P2|Overall Study|Lost to Follow-up|0
37307|NCT01365273|149969|P1|Overall Study|Lost to Follow-up|1
37308|NCT01365130|149979|P1|Overall Study|Progression/worsening of Dx prior to txt|2
37309|NCT01365091|149987|P4|Period 2|Adverse Event|0
37310|NCT01365091|149988|P3|Period 2|Adverse Event|1
37311|NCT01365091|149989|P2|Period 2|Adverse Event|0
37312|NCT01365091|149990|P1|Period 2|Adverse Event|0
37313|NCT01365091|149987|P4|Period 2|Withdrawal by Subject|0
37314|NCT01365091|149988|P3|Period 2|Withdrawal by Subject|0
37315|NCT01365091|149989|P2|Period 2|Withdrawal by Subject|0
37316|NCT01365091|149990|P1|Period 2|Withdrawal by Subject|1
37317|NCT01365091|149987|P4|Period 1|Personal reasons|0
37318|NCT01365091|149988|P3|Period 1|Personal reasons|1
37319|NCT01365091|149989|P2|Period 1|Personal reasons|0
37320|NCT01365091|149990|P1|Period 1|Personal reasons|0
37321|NCT01365091|149987|P4|Period 1|Withdrawal by Subject|0
37322|NCT01365091|149988|P3|Period 1|Withdrawal by Subject|0
37323|NCT01365091|149989|P2|Period 1|Withdrawal by Subject|1
37324|NCT01365091|149990|P1|Period 1|Withdrawal by Subject|0
37325|NCT01365091|149987|P4|Period 1|No longer met study criteria|0
37326|NCT01365091|149988|P3|Period 1|No longer met study criteria|0
37327|NCT01365091|149989|P2|Period 1|No longer met study criteria|1
37328|NCT01365091|149990|P1|Period 1|No longer met study criteria|0
37329|NCT01365091|149987|P4|Period 1|Positive test result for drugs of abuse|0
37330|NCT01365091|149988|P3|Period 1|Positive test result for drugs of abuse|0
37331|NCT01365091|149989|P2|Period 1|Positive test result for drugs of abuse|0
37332|NCT01365091|149990|P1|Period 1|Positive test result for drugs of abuse|1
37333|NCT01365091|149987|P4|Period 1|Adverse Event|3
37334|NCT01365091|149988|P3|Period 1|Adverse Event|2
37335|NCT01365091|149989|P2|Period 1|Adverse Event|0
37336|NCT01365091|149990|P1|Period 1|Adverse Event|1
37337|NCT01365052|150018|P2|Overall Study|Adverse Event|4
37338|NCT01365052|150019|P1|Overall Study|Adverse Event|4
37339|NCT01365039|150035|P2|Overall Study|Study related symptoms and complaints|0
37340|NCT01365039|150036|P1|Overall Study|Study related symptoms and complaints|1
37341|NCT01364922|150047|P3|Double-Blind (DB) Period|Other, Unspecified|0
37342|NCT01364922|150048|P2|Double-Blind (DB) Period|Other, Unspecified|1
37343|NCT01364922|150049|P1|Double-Blind (DB) Period|Other, Unspecified|0
37344|NCT01364922|150047|P3|Double-Blind (DB) Period|Adverse Event|1
37345|NCT01364922|150048|P2|Double-Blind (DB) Period|Adverse Event|0
37346|NCT01364922|150049|P1|Double-Blind (DB) Period|Adverse Event|0
37347|NCT01364922|150047|P3|Double-Blind (DB) Period|Subject Noncompliant|0
37348|NCT01364922|150048|P2|Double-Blind (DB) Period|Subject Noncompliant|1
37349|NCT01364922|150049|P1|Double-Blind (DB) Period|Subject Noncompliant|0
37350|NCT01364922|150047|P3|Double-Blind (DB) Period|Lack of Efficacy|4
37351|NCT01364922|150048|P2|Double-Blind (DB) Period|Lack of Efficacy|3
37352|NCT01364922|150049|P1|Double-Blind (DB) Period|Lack of Efficacy|0
37353|NCT01364922|150047|P3|Open-label (OL) Period|Other, Unspecified|0
37354|NCT01364922|150048|P2|Open-label (OL) Period|Other, Unspecified|0
37355|NCT01364922|150049|P1|Open-label (OL) Period|Other, Unspecified|1
37356|NCT01364922|150047|P3|Open-label (OL) Period|Lost to Follow-up|0
37357|NCT01364922|150048|P2|Open-label (OL) Period|Lost to Follow-up|0
37358|NCT01364922|150049|P1|Open-label (OL) Period|Lost to Follow-up|1
37359|NCT01364922|150047|P3|Open-label (OL) Period|Lack of Efficacy|0
37360|NCT01364922|150048|P2|Open-label (OL) Period|Lack of Efficacy|0
37361|NCT01364922|150049|P1|Open-label (OL) Period|Lack of Efficacy|3
37362|NCT01364922|150047|P3|Open-label (OL) Period|Withdrawal by Subject|0
37363|NCT01364922|150048|P2|Open-label (OL) Period|Withdrawal by Subject|0
37364|NCT01364922|150049|P1|Open-label (OL) Period|Withdrawal by Subject|4
37365|NCT01364922|150047|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
37366|NCT01364922|150048|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
37367|NCT01364922|150049|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
37368|NCT01364922|150047|P3|Open-label (OL) Period|Adverse Event|0
37369|NCT01364922|150048|P2|Open-label (OL) Period|Adverse Event|0
37370|NCT01364922|150049|P1|Open-label (OL) Period|Adverse Event|7
37371|NCT01364649|150078|P2|Overall Study|Other|1
37372|NCT01364649|150079|P1|Overall Study|Other|4
37373|NCT01364649|150078|P2|Overall Study|Lost to Follow-up|13
37374|NCT01364649|150079|P1|Overall Study|Lost to Follow-up|12
37375|NCT01364649|150078|P2|Overall Study|Withdrawal of Consent|7
37376|NCT01364649|150079|P1|Overall Study|Withdrawal of Consent|9
37377|NCT01364649|150078|P2|Overall Study|Protocol Deviations|8
37378|NCT01364649|150079|P1|Overall Study|Protocol Deviations|4
37379|NCT01364649|150078|P2|Overall Study|Non-compliance with Investigational Drug|0
37380|NCT01364649|150079|P1|Overall Study|Non-compliance with Investigational Drug|1
37381|NCT01364649|150078|P2|Overall Study|Lack of Efficacy|0
37382|NCT01364649|150079|P1|Overall Study|Lack of Efficacy|6
37383|NCT01364649|150078|P2|Overall Study|Pretreatment Event or Adverse Event|14
37384|NCT01364649|150079|P1|Overall Study|Pretreatment Event or Adverse Event|20
37385|NCT01364428|150091|P2|Overall Study|Other|3
37386|NCT01364428|150092|P1|Overall Study|Other|3
37387|NCT01364428|150091|P2|Overall Study|Withdrawal Criteria|10
37388|NCT01364428|150092|P1|Overall Study|Withdrawal Criteria|14
37389|NCT01364428|150091|P2|Overall Study|Protocol Violation|0
37390|NCT01364428|150092|P1|Overall Study|Protocol Violation|2
37391|NCT01364428|150091|P2|Overall Study|Adverse Event|2
37392|NCT01364428|150092|P1|Overall Study|Adverse Event|1
37393|NCT01364389|150109|P3|Overall Study|Adverse Event|0
37394|NCT01364389|150110|P2|Overall Study|Adverse Event|0
37395|NCT01364389|150111|P1|Overall Study|Adverse Event|1
37396|NCT01364389|150109|P3|Overall Study|Administrative problems|0
37397|NCT01364389|150110|P2|Overall Study|Administrative problems|0
37398|NCT01364389|150111|P1|Overall Study|Administrative problems|1
37399|NCT01364389|150109|P3|Overall Study|Protocol deviation|1
37400|NCT01364389|150110|P2|Overall Study|Protocol deviation|0
37401|NCT01364389|150111|P1|Overall Study|Protocol deviation|0
37402|NCT01364389|150109|P3|Overall Study|Withdrawal by Subject|0
37403|NCT01364389|150110|P2|Overall Study|Withdrawal by Subject|1
37404|NCT01364389|150111|P1|Overall Study|Withdrawal by Subject|0
37405|NCT01364298|150130|P2|Overall Study|Unspecified|3
37406|NCT01364298|150131|P1|Overall Study|Unspecified|1
37407|NCT01364298|150130|P2|Overall Study|Withdrawal by Subject|3
37408|NCT01364298|150131|P1|Overall Study|Withdrawal by Subject|3
37409|NCT01364298|150130|P2|Overall Study|Lost to Follow-up|10
37410|NCT01364298|150131|P1|Overall Study|Lost to Follow-up|5
37411|NCT01364298|150130|P2|Overall Study|Lack of Efficacy|0
37412|NCT01364298|150131|P1|Overall Study|Lack of Efficacy|1
37413|NCT01364298|150130|P2|Overall Study|Lack of adherence to treatment|3
37414|NCT01364298|150131|P1|Overall Study|Lack of adherence to treatment|1
37415|NCT01364298|150130|P2|Overall Study|Adverse Event|4
37416|NCT01364298|150131|P1|Overall Study|Adverse Event|3
37417|NCT01363986|150162|P1|Overall Study|Disease progression|1
37418|NCT01363908|150172|P2|Chronic Dosing (CD) Phase|Early study termination|3
37419|NCT01363908|150173|P1|Chronic Dosing (CD) Phase|Early study termination|9
37420|NCT01363908|150172|P2|Chronic Dosing (CD) Phase|Physician Decision|1
37421|NCT01363908|150173|P1|Chronic Dosing (CD) Phase|Physician Decision|0
37422|NCT01363908|150172|P2|Chronic Dosing (CD) Phase|Patient decision|1
37423|NCT01363908|150173|P1|Chronic Dosing (CD) Phase|Patient decision|0
37424|NCT01363908|150172|P2|Chronic Dosing (CD) Phase|Adverse Event|1
37425|NCT01363908|150173|P1|Chronic Dosing (CD) Phase|Adverse Event|1
37426|NCT01363765|150209|P2|Overall Study|smear during intervention|0
37427|NCT01363765|150210|P1|Overall Study|smear during intervention|2170
37428|NCT01363765|150209|P2|Overall Study|age not recorded (used for cross-linkage|354
37429|NCT01363765|150210|P1|Overall Study|age not recorded (used for cross-linkage|117
37430|NCT01363765|150209|P2|Overall Study|non-resident|76
37431|NCT01363765|150210|P1|Overall Study|non-resident|156
37432|NCT01363765|150209|P2|Overall Study|duplicate records|3177
37433|NCT01363765|150210|P1|Overall Study|duplicate records|736
37434|NCT01363765|150209|P2|Overall Study|non-diagnostic|1124
37435|NCT01363765|150210|P1|Overall Study|non-diagnostic|2621
37436|NCT01363713|150222|P1|Overall Study|Withdrawal by Subject|2
37437|NCT01363713|150222|P1|Overall Study|Protocol Violation|3
37438|NCT01363713|150222|P1|Overall Study|Adverse Event|1
37439|NCT01363700|150231|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
37440|NCT01363700|150232|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
37441|NCT01363700|150233|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
37442|NCT01363700|150234|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
37443|NCT01363700|150235|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
37444|NCT01363661|150254|P2|Overall Study|Lost to Follow-up|1
37445|NCT01363661|150255|P1|Overall Study|Lost to Follow-up|3
37446|NCT01363661|150254|P2|Overall Study|Protocol Violation|0
37447|NCT01363661|150255|P1|Overall Study|Protocol Violation|1
37448|NCT01363661|150254|P2|Overall Study|Withdrawal by Subject|1
37449|NCT01363661|150255|P1|Overall Study|Withdrawal by Subject|1
37450|NCT01363661|150254|P2|Overall Study|Adverse Event|2
37451|NCT01363661|150255|P1|Overall Study|Adverse Event|9
37452|NCT01363440|150296|P3|Overall Study|Other|2
37453|NCT01363440|150297|P2|Overall Study|Other|5
37454|NCT01363440|150298|P1|Overall Study|Other|4
37455|NCT01363440|150296|P3|Overall Study|Lost to Follow-up|5
37456|NCT01363440|150297|P2|Overall Study|Lost to Follow-up|4
37457|NCT01363440|150298|P1|Overall Study|Lost to Follow-up|2
37458|NCT01363440|150296|P3|Overall Study|Withdrawal by Subject|11
37459|NCT01363440|150297|P2|Overall Study|Withdrawal by Subject|11
37460|NCT01363440|150298|P1|Overall Study|Withdrawal by Subject|9
37461|NCT01363440|150296|P3|Overall Study|Death|5
37462|NCT01363440|150297|P2|Overall Study|Death|7
37463|NCT01363440|150298|P1|Overall Study|Death|3
37464|NCT01363440|150296|P3|Overall Study|Adverse Event|4
37465|NCT01363440|150297|P2|Overall Study|Adverse Event|4
37466|NCT01363440|150298|P1|Overall Study|Adverse Event|5
37467|NCT01363349|150344|P2|Overall Study|missing|2
37468|NCT01363349|150345|P1|Overall Study|missing|1
37469|NCT01363349|150344|P2|Overall Study|Not reported|37
37470|NCT01363349|150345|P1|Overall Study|Not reported|36
37471|NCT01363349|150344|P2|Overall Study|Lost to Follow-up|6
37472|NCT01363349|150345|P1|Overall Study|Lost to Follow-up|5
37473|NCT01363349|150344|P2|Overall Study|Withdrawal by Subject|6
37474|NCT01363349|150345|P1|Overall Study|Withdrawal by Subject|14
37475|NCT01363349|150344|P2|Overall Study|Non compliance/Protocol deviations|2
37476|NCT01363349|150345|P1|Overall Study|Non compliance/Protocol deviations|2
37477|NCT01363349|150344|P2|Overall Study|Lack of Efficacy|10
37478|NCT01363349|150345|P1|Overall Study|Lack of Efficacy|3
37479|NCT01363349|150344|P2|Overall Study|Adverse Event|7
37480|NCT01363349|150345|P1|Overall Study|Adverse Event|6
37481|NCT01363076|150353|P2|Overall Study|Withdrawal by Subject|1
37482|NCT01363076|150354|P1|Overall Study|Withdrawal by Subject|0
37483|NCT01363011|150386|P2|Extension Phase|Rolled Over to Another Gilead Study|1
37484|NCT01363011|150387|P1|Extension Phase|Rolled Over to Another Gilead Study|2
37485|NCT01363011|150386|P2|Extension Phase|Lost to Follow-up|2
37486|NCT01363011|150387|P1|Extension Phase|Lost to Follow-up|0
37487|NCT01363011|150386|P2|Extension Phase|Withdrew Consent|1
37488|NCT01363011|150387|P1|Extension Phase|Withdrew Consent|0
37489|NCT01363011|150386|P2|Extension Phase|Investigator's Discretion|2
37490|NCT01363011|150387|P1|Extension Phase|Investigator's Discretion|2
37491|NCT01363011|150386|P2|Extension Phase|Lack of Efficacy|1
37492|NCT01363011|150387|P1|Extension Phase|Lack of Efficacy|0
37493|NCT01363011|150386|P2|Extension Phase|Adverse Event|1
37494|NCT01363011|150387|P1|Extension Phase|Adverse Event|1
37495|NCT01363011|150386|P2|Main Study|Protocol Violation|1
37496|NCT01363011|150387|P1|Main Study|Protocol Violation|0
37497|NCT01363011|150386|P2|Main Study|Withdrew Consent|4
37498|NCT01363011|150387|P1|Main Study|Withdrew Consent|1
37499|NCT01363011|150386|P2|Main Study|Investigator's Discretion|1
37500|NCT01363011|150387|P1|Main Study|Investigator's Discretion|1
37501|NCT01363011|150386|P2|Main Study|Adverse Event|3
37502|NCT01363011|150387|P1|Main Study|Adverse Event|2
37503|NCT01362530|150493|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
37504|NCT01362530|150494|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
37505|NCT01362530|150493|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
37506|NCT01362530|150494|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
37507|NCT01362530|150493|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
37508|NCT01362530|150494|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
37509|NCT01362530|150493|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
37510|NCT01362530|150494|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
37511|NCT01362530|150493|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
37512|NCT01362530|150494|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
37513|NCT01362530|150493|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
37514|NCT01362530|150494|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
37515|NCT01362530|150493|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
37516|NCT01362530|150494|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
37517|NCT01362530|150493|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
37518|NCT01362530|150494|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
37519|NCT01362530|150493|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
37520|NCT01362530|150494|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
37521|NCT01362530|150493|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
37522|NCT01362530|150494|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
37523|NCT01362530|150493|P2|Base Study (Cycle 1)|Protocol Violation|0
37524|NCT01362530|150494|P1|Base Study (Cycle 1)|Protocol Violation|2
37525|NCT01362530|150493|P2|Base Study (Cycle 1)|Physician Decision|1
37526|NCT01362530|150494|P1|Base Study (Cycle 1)|Physician Decision|0
37527|NCT01362530|150493|P2|Base Study (Cycle 1)|Adverse Event|0
37528|NCT01362530|150494|P1|Base Study (Cycle 1)|Adverse Event|2
37529|NCT01362517|150507|P1|Overall Study|Lost to Follow-up|1
37530|NCT01362517|150507|P1|Overall Study|Protocol Violation|1
37531|NCT01362491|150518|P3|Overall Study|Ineligible|0
37532|NCT01362491|150519|P2|Overall Study|Ineligible|0
37533|NCT01362491|150520|P1|Overall Study|Ineligible|1
37534|NCT01362439|150568|P1|Overall Study|Participant who withdrew consent|8
37535|NCT01362439|150568|P1|Overall Study|Study medication non-compliant|1
37536|NCT01362439|150568|P1|Overall Study|Lost to Follow-up|2
37537|NCT01362439|150568|P1|Overall Study|Lack of Efficacy|3
37538|NCT01362439|150568|P1|Overall Study|Adverse Event|1
37539|NCT01362296|150585|P4|Crossover Phase|Study Closed/Terminated|0
37540|NCT01362296|150586|P3|Crossover Phase|Study Closed/Terminated|1
37541|NCT01362296|150587|P2|Crossover Phase|Study Closed/Terminated|0
37542|NCT01362296|150588|P1|Crossover Phase|Study Closed/Terminated|0
37543|NCT01362296|150585|P4|Crossover Phase|Adverse Event|0
37544|NCT01362296|150586|P3|Crossover Phase|Adverse Event|4
37545|NCT01362296|150587|P2|Crossover Phase|Adverse Event|0
37546|NCT01362296|150588|P1|Crossover Phase|Adverse Event|0
37547|NCT01362296|150585|P4|Crossover Phase|Withdrawal by Subject|1
37548|NCT01362296|150586|P3|Crossover Phase|Withdrawal by Subject|2
37549|NCT01362296|150587|P2|Crossover Phase|Withdrawal by Subject|0
37550|NCT01362296|150588|P1|Crossover Phase|Withdrawal by Subject|0
37551|NCT01362296|150585|P4|Crossover Phase|PD including Death due to PD|1
37552|NCT01362296|150586|P3|Crossover Phase|PD including Death due to PD|16
37553|NCT01362296|150587|P2|Crossover Phase|PD including Death due to PD|0
37554|NCT01362296|150588|P1|Crossover Phase|PD including Death due to PD|0
37555|NCT01362296|150585|P4|Randomized Phase (RP)|Study Closed/Terminated|0
37556|NCT01362296|150586|P3|Randomized Phase (RP)|Study Closed/Terminated|0
37557|NCT01362296|150587|P2|Randomized Phase (RP)|Study Closed/Terminated|1
37558|NCT01362296|150588|P1|Randomized Phase (RP)|Study Closed/Terminated|8
37559|NCT01362296|150585|P4|Randomized Phase (RP)|Adverse Event|0
37560|NCT01362296|150586|P3|Randomized Phase (RP)|Adverse Event|0
37561|NCT01362296|150587|P2|Randomized Phase (RP)|Adverse Event|4
37562|NCT01362296|150588|P1|Randomized Phase (RP)|Adverse Event|20
37563|NCT01362296|150585|P4|Randomized Phase (RP)|Withdrawal by Subject|0
37564|NCT01362296|150586|P3|Randomized Phase (RP)|Withdrawal by Subject|0
37565|NCT01362296|150587|P2|Randomized Phase (RP)|Withdrawal by Subject|1
37566|NCT01362296|150588|P1|Randomized Phase (RP)|Withdrawal by Subject|2
37567|NCT01362296|150585|P4|Randomized Phase (RP)|Physician Decision|0
37568|NCT01362296|150586|P3|Randomized Phase (RP)|Physician Decision|0
37569|NCT01362296|150587|P2|Randomized Phase (RP)|Physician Decision|9
37570|NCT01362296|150588|P1|Randomized Phase (RP)|Physician Decision|1
37571|NCT01362296|150585|P4|Randomized Phase (RP)|PD including Death due to PD|0
37572|NCT01362296|150586|P3|Randomized Phase (RP)|PD including Death due to PD|0
37573|NCT01362296|150587|P2|Randomized Phase (RP)|PD including Death due to PD|28
37574|NCT01362296|150588|P1|Randomized Phase (RP)|PD including Death due to PD|56
37575|NCT01362244|150636|P2|Overall Study|Protocol Defined Stopping Criteria|1
37576|NCT01362244|150637|P1|Overall Study|Protocol Defined Stopping Criteria|0
37577|NCT01362244|150636|P2|Overall Study|Did not Meet Continuation Criteria|11
37578|NCT01362244|150637|P1|Overall Study|Did not Meet Continuation Criteria|17
37579|NCT01362244|150636|P2|Overall Study|Withdrawal by Subject|1
37580|NCT01362244|150637|P1|Overall Study|Withdrawal by Subject|2
37581|NCT01362244|150636|P2|Overall Study|Protocol Violation|1
37582|NCT01362244|150637|P1|Overall Study|Protocol Violation|5
37583|NCT01362244|150636|P2|Overall Study|Lost to Follow-up|2
37584|NCT01362244|150637|P1|Overall Study|Lost to Follow-up|0
37585|NCT01362244|150636|P2|Overall Study|Lack of Efficacy|11
37586|NCT01362244|150637|P1|Overall Study|Lack of Efficacy|5
37587|NCT01362244|150636|P2|Overall Study|Adverse Event|5
37588|NCT01362244|150637|P1|Overall Study|Adverse Event|3
37589|NCT01362140|150720|P2|Overall Study|Discontinued Without Receiving Treatment|1
37590|NCT01362140|150721|P1|Overall Study|Discontinued Without Receiving Treatment|0
37591|NCT01362140|150720|P2|Overall Study|Protocol-specified Criteria|2
37592|NCT01362140|150721|P1|Overall Study|Protocol-specified Criteria|1
37593|NCT01362140|150720|P2|Overall Study|Other|1
37594|NCT01362140|150721|P1|Overall Study|Other|1
37595|NCT01362140|150720|P2|Overall Study|Death|1
37596|NCT01362140|150721|P1|Overall Study|Death|2
37597|NCT01362140|150720|P2|Overall Study|Administrative Decision|1
37598|NCT01362140|150721|P1|Overall Study|Administrative Decision|0
37599|NCT01362140|150720|P2|Overall Study|Withdrawal by Subject|3
37600|NCT01362140|150721|P1|Overall Study|Withdrawal by Subject|3
37601|NCT01362140|150720|P2|Overall Study|Adverse Event|2
37602|NCT01362140|150721|P1|Overall Study|Adverse Event|2
37603|NCT01362140|150720|P2|Overall Study|Noncompliance|0
37604|NCT01362140|150721|P1|Overall Study|Noncompliance|1
37605|NCT01362062|150745|P2|Overall Study|Had significant improvement|0
37606|NCT01362062|150746|P1|Overall Study|Had significant improvement|9
37607|NCT01362062|150745|P2|Overall Study|Detected with Spondylo-arthritis|0
37608|NCT01362062|150746|P1|Overall Study|Detected with Spondylo-arthritis|1
37609|NCT01362062|150745|P2|Overall Study|Non-compliant participant|0
37610|NCT01362062|150746|P1|Overall Study|Non-compliant participant|2
37611|NCT01362062|150745|P2|Overall Study|Withdrawal by Subject|0
37612|NCT01362062|150746|P1|Overall Study|Withdrawal by Subject|2
37613|NCT01362062|150745|P2|Overall Study|Lost to Follow-up|0
37614|NCT01362062|150746|P1|Overall Study|Lost to Follow-up|11
37615|NCT01362062|150745|P2|Overall Study|Adverse Event|0
37616|NCT01362062|150746|P1|Overall Study|Adverse Event|1
37617|NCT01361594|150785|P2|Overall Study|Withdrawal by Subject|2
37618|NCT01361594|150786|P1|Overall Study|Withdrawal by Subject|1
37619|NCT01361568|150800|P6|Overall Study|Withdrawal by Subject|1
37620|NCT01361568|150801|P5|Overall Study|Withdrawal by Subject|0
37621|NCT01361568|150802|P4|Overall Study|Withdrawal by Subject|0
37622|NCT01361568|150803|P3|Overall Study|Withdrawal by Subject|0
37623|NCT01361568|150804|P2|Overall Study|Withdrawal by Subject|1
37624|NCT01361568|150805|P1|Overall Study|Withdrawal by Subject|2
37625|NCT01361568|150800|P6|Overall Study|Physician Decision|1
37626|NCT01361568|150801|P5|Overall Study|Physician Decision|0
37627|NCT01361568|150802|P4|Overall Study|Physician Decision|0
37628|NCT01361568|150803|P3|Overall Study|Physician Decision|0
37629|NCT01361568|150804|P2|Overall Study|Physician Decision|0
37630|NCT01361568|150805|P1|Overall Study|Physician Decision|0
37631|NCT01361568|150800|P6|Overall Study|Adverse Event|0
37632|NCT01361568|150801|P5|Overall Study|Adverse Event|1
37633|NCT01361568|150802|P4|Overall Study|Adverse Event|0
37634|NCT01361568|150803|P3|Overall Study|Adverse Event|0
37635|NCT01361568|150804|P2|Overall Study|Adverse Event|0
37636|NCT01361568|150805|P1|Overall Study|Adverse Event|0
37637|NCT01361464|150835|P1|Overall Study|Withdrawal by Subject|2
37638|NCT01361464|150835|P1|Overall Study|Death|1
37639|NCT01361308|150844|P2|Overall Study|Not Specified|1
37640|NCT01361308|150845|P1|Overall Study|Not Specified|0
37641|NCT01361308|150844|P2|Overall Study|Failed C-SSRS|2
37642|NCT01361308|150845|P1|Overall Study|Failed C-SSRS|5
37643|NCT01361308|150844|P2|Overall Study|Eligibility Criteria Not Met|3
37644|NCT01361308|150845|P1|Overall Study|Eligibility Criteria Not Met|2
37645|NCT01361308|150844|P2|Overall Study|Adverse Event|4
37646|NCT01361308|150845|P1|Overall Study|Adverse Event|8
37647|NCT01361308|150844|P2|Overall Study|Lost to Follow-up|4
37648|NCT01361308|150845|P1|Overall Study|Lost to Follow-up|5
37649|NCT01361308|150844|P2|Overall Study|Protocol Violation|0
37650|NCT01361308|150845|P1|Overall Study|Protocol Violation|1
37651|NCT01361308|150844|P2|Overall Study|Lack of Efficacy|0
37652|NCT01361308|150845|P1|Overall Study|Lack of Efficacy|2
37653|NCT01361308|150844|P2|Overall Study|Physician Decision|3
37654|NCT01361308|150845|P1|Overall Study|Physician Decision|3
37655|NCT01361308|150844|P2|Overall Study|Withdrawal by Subject|13
37656|NCT01361308|150845|P1|Overall Study|Withdrawal by Subject|9
37657|NCT01361126|150887|P2|Overall Study|Sponsor decision|2
37658|NCT01361126|150888|P1|Overall Study|Sponsor decision|0
37659|NCT01361009|150916|P1|Overall Study|Protocol Violation|116
37660|NCT01360840|150926|P3|Overall Study|Ongoing at data cut-off|9
37661|NCT01360840|150927|P2|Overall Study|Ongoing at data cut-off|10
37662|NCT01360840|150928|P1|Overall Study|Ongoing at data cut-off|10
37663|NCT01360645|150980|P4|Phase A+|Protocol Deviation|4
37664|NCT01360645|150981|P3|Phase A+|Protocol Deviation|0
37665|NCT01360645|150982|P2|Phase A+|Protocol Deviation|0
37666|NCT01360645|150983|P1|Phase A+|Protocol Deviation|0
37667|NCT01360645|150980|P4|Phase A+|Withdrawal by Subject|5
37668|NCT01360645|150981|P3|Phase A+|Withdrawal by Subject|0
37669|NCT01360645|150982|P2|Phase A+|Withdrawal by Subject|0
37670|NCT01360645|150983|P1|Phase A+|Withdrawal by Subject|0
37671|NCT01360645|150980|P4|Phase A+|Physician Decision|2
37672|NCT01360645|150981|P3|Phase A+|Physician Decision|0
37673|NCT01360645|150982|P2|Phase A+|Physician Decision|0
37674|NCT01360645|150983|P1|Phase A+|Physician Decision|0
37675|NCT01360645|150980|P4|Phase A+|Met Withdrawal Criteria|4
37676|NCT01360645|150981|P3|Phase A+|Met Withdrawal Criteria|0
37677|NCT01360645|150982|P2|Phase A+|Met Withdrawal Criteria|0
37678|NCT01360645|150983|P1|Phase A+|Met Withdrawal Criteria|0
37679|NCT01360645|150980|P4|Phase A+|Adverse Event|2
37680|NCT01360645|150981|P3|Phase A+|Adverse Event|0
37681|NCT01360645|150982|P2|Phase A+|Adverse Event|0
37682|NCT01360645|150983|P1|Phase A+|Adverse Event|0
37683|NCT01360645|150980|P4|Phase A+|Lost to Follow-up|7
37684|NCT01360645|150981|P3|Phase A+|Lost to Follow-up|0
37685|NCT01360645|150982|P2|Phase A+|Lost to Follow-up|0
37686|NCT01360645|150983|P1|Phase A+|Lost to Follow-up|0
37687|NCT01360645|150980|P4|Phase B (6 Weeks)|Protocol Deviation|0
37688|NCT01360645|150981|P3|Phase B (6 Weeks)|Protocol Deviation|3
37689|NCT01360645|150982|P2|Phase B (6 Weeks)|Protocol Deviation|1
37690|NCT01360645|150983|P1|Phase B (6 Weeks)|Protocol Deviation|0
37691|NCT01360645|150980|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
37692|NCT01360645|150981|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
37693|NCT01360645|150982|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
37694|NCT01360645|150983|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
37695|NCT01360645|150980|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
37696|NCT01360645|150981|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
37697|NCT01360645|150982|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
37698|NCT01360645|150983|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
37699|NCT01360645|150980|P4|Phase B (6 Weeks)|Adverse Event|0
37700|NCT01360645|150981|P3|Phase B (6 Weeks)|Adverse Event|0
37701|NCT01360645|150982|P2|Phase B (6 Weeks)|Adverse Event|6
37702|NCT01360645|150983|P1|Phase B (6 Weeks)|Adverse Event|0
37703|NCT01360645|150980|P4|Phase B (6 Weeks)|Lost to Follow-up|0
37704|NCT01360645|150981|P3|Phase B (6 Weeks)|Lost to Follow-up|0
37705|NCT01360645|150982|P2|Phase B (6 Weeks)|Lost to Follow-up|1
37706|NCT01360645|150983|P1|Phase B (6 Weeks)|Lost to Follow-up|0
37707|NCT01360645|150980|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
37708|NCT01360645|150981|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
37709|NCT01360645|150982|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
37710|NCT01360645|150983|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
37711|NCT01360645|150980|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
37712|NCT01360645|150981|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
37713|NCT01360645|150982|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
37714|NCT01360645|150983|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
37715|NCT01360645|150980|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
37716|NCT01360645|150981|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
37717|NCT01360645|150982|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
37718|NCT01360645|150983|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
37719|NCT01360645|150980|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
37720|NCT01360645|150981|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
37721|NCT01360645|150982|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
37722|NCT01360645|150983|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
37723|NCT01360645|150980|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
37724|NCT01360645|150981|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
37725|NCT01360645|150982|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
37726|NCT01360645|150983|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
37727|NCT01360645|150980|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
37728|NCT01360645|150981|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
37729|NCT01360645|150982|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
37730|NCT01360645|150983|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
37731|NCT01360632|151038|P5|Phase A+|Protocol Deviation|3
37732|NCT01360632|151039|P4|Phase A+|Protocol Deviation|0
37733|NCT01360632|151040|P3|Phase A+|Protocol Deviation|0
37734|NCT01360632|151041|P2|Phase A+|Protocol Deviation|0
37735|NCT01360632|151042|P1|Phase A+|Protocol Deviation|0
37736|NCT01360632|151038|P5|Phase A+|Withdrawal by Subject|8
37737|NCT01360632|151039|P4|Phase A+|Withdrawal by Subject|0
37738|NCT01360632|151040|P3|Phase A+|Withdrawal by Subject|0
37739|NCT01360632|151041|P2|Phase A+|Withdrawal by Subject|0
37740|NCT01360632|151042|P1|Phase A+|Withdrawal by Subject|0
37741|NCT01360632|151038|P5|Phase A+|Physician Decision|3
37742|NCT01360632|151039|P4|Phase A+|Physician Decision|0
37743|NCT01360632|151040|P3|Phase A+|Physician Decision|0
37744|NCT01360632|151041|P2|Phase A+|Physician Decision|0
37745|NCT01360632|151042|P1|Phase A+|Physician Decision|0
37746|NCT01360632|151038|P5|Phase A+|Met Withdrawal Criteria|7
37747|NCT01360632|151039|P4|Phase A+|Met Withdrawal Criteria|0
37748|NCT01360632|151040|P3|Phase A+|Met Withdrawal Criteria|0
37749|NCT01360632|151041|P2|Phase A+|Met Withdrawal Criteria|0
37750|NCT01360632|151042|P1|Phase A+|Met Withdrawal Criteria|0
37751|NCT01360632|151038|P5|Phase A+|Adverse Event|2
37752|NCT01360632|151039|P4|Phase A+|Adverse Event|0
37753|NCT01360632|151040|P3|Phase A+|Adverse Event|0
37754|NCT01360632|151041|P2|Phase A+|Adverse Event|0
37755|NCT01360632|151042|P1|Phase A+|Adverse Event|0
37756|NCT01360632|151038|P5|Phase A+|Lost to Follow-up|2
37757|NCT01360632|151039|P4|Phase A+|Lost to Follow-up|0
37758|NCT01360632|151040|P3|Phase A+|Lost to Follow-up|0
37759|NCT01360632|151041|P2|Phase A+|Lost to Follow-up|0
37760|NCT01360632|151042|P1|Phase A+|Lost to Follow-up|0
37761|NCT01360632|151038|P5|Phase B (6 Weeks)|Lack of Efficacy|0
37762|NCT01360632|151039|P4|Phase B (6 Weeks)|Lack of Efficacy|0
37763|NCT01360632|151040|P3|Phase B (6 Weeks)|Lack of Efficacy|0
37764|NCT01360632|151041|P2|Phase B (6 Weeks)|Lack of Efficacy|1
37765|NCT01360632|151042|P1|Phase B (6 Weeks)|Lack of Efficacy|0
37766|NCT01360632|151038|P5|Phase B (6 Weeks)|Protocol Deviation|0
37767|NCT01360632|151039|P4|Phase B (6 Weeks)|Protocol Deviation|1
37768|NCT01360632|151040|P3|Phase B (6 Weeks)|Protocol Deviation|4
37769|NCT01360632|151041|P2|Phase B (6 Weeks)|Protocol Deviation|1
37770|NCT01360632|151042|P1|Phase B (6 Weeks)|Protocol Deviation|0
37771|NCT01360632|151038|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
37772|NCT01360632|151039|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
37773|NCT01360632|151040|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
37774|NCT01360632|151041|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
37775|NCT01360632|151042|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
37776|NCT01360632|151038|P5|Phase B (6 Weeks)|Physician Decision|0
37777|NCT01360632|151039|P4|Phase B (6 Weeks)|Physician Decision|1
37778|NCT01360632|151040|P3|Phase B (6 Weeks)|Physician Decision|0
37779|NCT01360632|151041|P2|Phase B (6 Weeks)|Physician Decision|0
37780|NCT01360632|151042|P1|Phase B (6 Weeks)|Physician Decision|0
37781|NCT01360632|151038|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
37782|NCT01360632|151039|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
37783|NCT01360632|151040|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
37784|NCT01360632|151041|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
37785|NCT01360632|151042|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
37786|NCT01360632|151038|P5|Phase B (6 Weeks)|Adverse Event|0
37787|NCT01360632|151039|P4|Phase B (6 Weeks)|Adverse Event|3
37788|NCT01360632|151040|P3|Phase B (6 Weeks)|Adverse Event|9
37789|NCT01360632|151041|P2|Phase B (6 Weeks)|Adverse Event|3
37790|NCT01360632|151042|P1|Phase B (6 Weeks)|Adverse Event|0
37791|NCT01360632|151038|P5|Phase B (6 Weeks)|Lost to Follow-up|0
37792|NCT01360632|151039|P4|Phase B (6 Weeks)|Lost to Follow-up|0
37793|NCT01360632|151040|P3|Phase B (6 Weeks)|Lost to Follow-up|1
37794|NCT01360632|151041|P2|Phase B (6 Weeks)|Lost to Follow-up|1
37795|NCT01360632|151042|P1|Phase B (6 Weeks)|Lost to Follow-up|0
37796|NCT01360632|151038|P5|Phase A (8 Weeks)|Protocol Deviation|0
37797|NCT01360632|151039|P4|Phase A (8 Weeks)|Protocol Deviation|0
37798|NCT01360632|151040|P3|Phase A (8 Weeks)|Protocol Deviation|0
37799|NCT01360632|151041|P2|Phase A (8 Weeks)|Protocol Deviation|0
37800|NCT01360632|151042|P1|Phase A (8 Weeks)|Protocol Deviation|39
37801|NCT01360632|151038|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
37802|NCT01360632|151039|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
37803|NCT01360632|151040|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
37804|NCT01360632|151041|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
37805|NCT01360632|151042|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
37806|NCT01360632|151038|P5|Phase A (8 Weeks)|Physician Decision|0
37807|NCT01360632|151039|P4|Phase A (8 Weeks)|Physician Decision|0
37808|NCT01360632|151040|P3|Phase A (8 Weeks)|Physician Decision|0
37809|NCT01360632|151041|P2|Phase A (8 Weeks)|Physician Decision|0
37810|NCT01360632|151042|P1|Phase A (8 Weeks)|Physician Decision|10
37811|NCT01360632|151038|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
37812|NCT01360632|151039|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
37813|NCT01360632|151040|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
37814|NCT01360632|151041|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
37815|NCT01360632|151042|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
37816|NCT01360632|151038|P5|Phase A (8 Weeks)|Adverse Event|0
37817|NCT01360632|151039|P4|Phase A (8 Weeks)|Adverse Event|0
37818|NCT01360632|151040|P3|Phase A (8 Weeks)|Adverse Event|0
37819|NCT01360632|151041|P2|Phase A (8 Weeks)|Adverse Event|0
37820|NCT01360632|151042|P1|Phase A (8 Weeks)|Adverse Event|60
37821|NCT01360632|151038|P5|Phase A (8 Weeks)|Lost to Follow-up|0
37822|NCT01360632|151039|P4|Phase A (8 Weeks)|Lost to Follow-up|0
37823|NCT01360632|151040|P3|Phase A (8 Weeks)|Lost to Follow-up|0
37824|NCT01360632|151041|P2|Phase A (8 Weeks)|Lost to Follow-up|0
37825|NCT01360632|151042|P1|Phase A (8 Weeks)|Lost to Follow-up|27
37826|NCT01360021|151122|P3|Overall Study|Adverse Event|3
37827|NCT01360021|151123|P2|Overall Study|Adverse Event|3
37828|NCT01360021|151124|P1|Overall Study|Adverse Event|2
37829|NCT01360021|151122|P3|Overall Study|Withdrawal by Subject|2
37830|NCT01360021|151123|P2|Overall Study|Withdrawal by Subject|0
37831|NCT01360021|151124|P1|Overall Study|Withdrawal by Subject|4
37832|NCT01360021|151122|P3|Overall Study|Protocol Violation|1
37833|NCT01360021|151123|P2|Overall Study|Protocol Violation|0
37834|NCT01360021|151124|P1|Overall Study|Protocol Violation|0
37835|NCT01360021|151122|P3|Overall Study|Eligibility criteria + other|1
37836|NCT01360021|151123|P2|Overall Study|Eligibility criteria + other|1
37837|NCT01360021|151124|P1|Overall Study|Eligibility criteria + other|2
37838|NCT01359943|151150|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
37839|NCT01359943|151151|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
37840|NCT01359943|151152|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
37841|NCT01359943|151150|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
37842|NCT01359943|151151|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
37843|NCT01359943|151152|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
37844|NCT01359943|151150|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
37845|NCT01359943|151151|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
37846|NCT01359943|151152|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
37847|NCT01359943|151150|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
37848|NCT01359943|151151|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
37849|NCT01359943|151152|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
37850|NCT01359943|151150|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
37851|NCT01359943|151151|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
37852|NCT01359943|151152|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
37853|NCT01359943|151150|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
37854|NCT01359943|151151|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
37855|NCT01359943|151152|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
37856|NCT01359943|151150|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
37857|NCT01359943|151151|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
37858|NCT01359943|151152|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
37859|NCT01359943|151150|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
37860|NCT01359943|151151|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
37861|NCT01359943|151152|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
37862|NCT01359943|151150|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
37863|NCT01359943|151151|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
37864|NCT01359943|151152|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
37865|NCT01359943|151150|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
37866|NCT01359943|151151|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
37867|NCT01359943|151152|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
37868|NCT01359943|151150|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
37869|NCT01359943|151151|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
37870|NCT01359943|151152|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
37871|NCT01359943|151150|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
37872|NCT01359943|151151|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
37873|NCT01359943|151152|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
37874|NCT01359943|151150|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
37875|NCT01359943|151151|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
37876|NCT01359943|151152|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
37877|NCT01359943|151150|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
37878|NCT01359943|151151|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
37879|NCT01359943|151152|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
37880|NCT01359943|151150|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
37881|NCT01359943|151151|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
37882|NCT01359943|151152|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
37883|NCT01359904|151200|P2|Overall Study|Withdrawal by Subject|0
37884|NCT01359904|151201|P1|Overall Study|Withdrawal by Subject|1
37885|NCT01359644|151238|P10|Follow-up Period|Lost to Follow-up|0
37886|NCT01359644|151239|P9|Follow-up Period|Lost to Follow-up|0
37887|NCT01359644|151240|P8|Follow-up Period|Lost to Follow-up|2
37888|NCT01359644|151241|P7|Follow-up Period|Lost to Follow-up|1
37889|NCT01359644|151242|P6|Follow-up Period|Lost to Follow-up|0
37890|NCT01359644|151243|P5|Follow-up Period|Lost to Follow-up|0
37891|NCT01359644|151244|P4|Follow-up Period|Lost to Follow-up|0
37892|NCT01359644|151245|P3|Follow-up Period|Lost to Follow-up|0
37893|NCT01359644|151246|P2|Follow-up Period|Lost to Follow-up|0
37894|NCT01359644|151247|P1|Follow-up Period|Lost to Follow-up|0
37895|NCT01359644|151238|P10|Follow-up Period|Withdrawal by Subject|0
37896|NCT01359644|151239|P9|Follow-up Period|Withdrawal by Subject|0
37897|NCT01359644|151240|P8|Follow-up Period|Withdrawal by Subject|0
37898|NCT01359644|151241|P7|Follow-up Period|Withdrawal by Subject|0
37899|NCT01359644|151242|P6|Follow-up Period|Withdrawal by Subject|1
37900|NCT01359644|151243|P5|Follow-up Period|Withdrawal by Subject|0
37901|NCT01359644|151244|P4|Follow-up Period|Withdrawal by Subject|0
37902|NCT01359644|151245|P3|Follow-up Period|Withdrawal by Subject|0
37903|NCT01359644|151246|P2|Follow-up Period|Withdrawal by Subject|0
37904|NCT01359644|151247|P1|Follow-up Period|Withdrawal by Subject|0
37905|NCT01359644|151238|P10|Treatment Period|Lost to Follow-up|0
37906|NCT01359644|151239|P9|Treatment Period|Lost to Follow-up|0
37907|NCT01359644|151240|P8|Treatment Period|Lost to Follow-up|0
37908|NCT01359644|151241|P7|Treatment Period|Lost to Follow-up|0
37909|NCT01359644|151242|P6|Treatment Period|Lost to Follow-up|1
37910|NCT01359644|151243|P5|Treatment Period|Lost to Follow-up|0
37911|NCT01359644|151244|P4|Treatment Period|Lost to Follow-up|0
37912|NCT01359644|151245|P3|Treatment Period|Lost to Follow-up|0
37913|NCT01359644|151246|P2|Treatment Period|Lost to Follow-up|0
37914|NCT01359644|151247|P1|Treatment Period|Lost to Follow-up|0
37915|NCT01359644|151238|P10|Treatment Period|Adverse Event|0
37916|NCT01359644|151239|P9|Treatment Period|Adverse Event|0
37917|NCT01359644|151240|P8|Treatment Period|Adverse Event|0
37918|NCT01359644|151241|P7|Treatment Period|Adverse Event|0
37919|NCT01359644|151242|P6|Treatment Period|Adverse Event|1
37920|NCT01359644|151243|P5|Treatment Period|Adverse Event|0
37921|NCT01359644|151244|P4|Treatment Period|Adverse Event|0
37922|NCT01359644|151245|P3|Treatment Period|Adverse Event|1
37923|NCT01359644|151246|P2|Treatment Period|Adverse Event|0
37924|NCT01359644|151247|P1|Treatment Period|Adverse Event|0
37925|NCT01359644|151238|P10|Treatment Period|Lack of Efficacy|0
37926|NCT01359644|151239|P9|Treatment Period|Lack of Efficacy|0
37927|NCT01359644|151240|P8|Treatment Period|Lack of Efficacy|0
37928|NCT01359644|151241|P7|Treatment Period|Lack of Efficacy|0
37929|NCT01359644|151242|P6|Treatment Period|Lack of Efficacy|0
37930|NCT01359644|151243|P5|Treatment Period|Lack of Efficacy|0
37931|NCT01359644|151244|P4|Treatment Period|Lack of Efficacy|0
37932|NCT01359644|151245|P3|Treatment Period|Lack of Efficacy|0
37933|NCT01359644|151246|P2|Treatment Period|Lack of Efficacy|1
37934|NCT01359644|151247|P1|Treatment Period|Lack of Efficacy|0
37935|NCT01359449|151291|P2|Overall Study|Withdrawal by Subject|2
37936|NCT01359449|151292|P1|Overall Study|Withdrawal by Subject|3
37937|NCT01359449|151291|P2|Overall Study|Protocol Violation|2
37938|NCT01359449|151292|P1|Overall Study|Protocol Violation|0
37939|NCT01359449|151291|P2|Overall Study|Lost to Follow-up|0
37940|NCT01359449|151292|P1|Overall Study|Lost to Follow-up|1
37941|NCT01359254|151321|P2|Overall Study|Death|0
37942|NCT01359254|151322|P1|Overall Study|Death|1
37943|NCT01359150|151332|P2|Overall Study|Unspecified|0
37944|NCT01359150|151333|P1|Overall Study|Unspecified|1
37945|NCT01359150|151332|P2|Overall Study|Adverse Event|3
37946|NCT01359150|151333|P1|Overall Study|Adverse Event|4
37947|NCT01359150|151332|P2|Overall Study|Withdrawal by Subject|1
37948|NCT01359150|151333|P1|Overall Study|Withdrawal by Subject|1
37949|NCT01359150|151332|P2|Overall Study|Lack of Efficacy|1
37950|NCT01359150|151333|P1|Overall Study|Lack of Efficacy|1
37951|NCT01358864|151370|P8|Overall Study|Not treated|0
37952|NCT01358864|151371|P7|Overall Study|Not treated|1
37953|NCT01358864|151372|P6|Overall Study|Not treated|0
37954|NCT01358864|151373|P5|Overall Study|Not treated|0
37955|NCT01358864|151374|P4|Overall Study|Not treated|0
37956|NCT01358864|151375|P3|Overall Study|Not treated|0
37957|NCT01358864|151376|P2|Overall Study|Not treated|0
37958|NCT01358864|151377|P1|Overall Study|Not treated|0
37959|NCT01358864|151370|P8|Overall Study|Other reason not defined above|0
37960|NCT01358864|151371|P7|Overall Study|Other reason not defined above|2
37961|NCT01358864|151372|P6|Overall Study|Other reason not defined above|0
37962|NCT01358864|151373|P5|Overall Study|Other reason not defined above|0
37963|NCT01358864|151374|P4|Overall Study|Other reason not defined above|0
37964|NCT01358864|151375|P3|Overall Study|Other reason not defined above|0
37965|NCT01358864|151376|P2|Overall Study|Other reason not defined above|0
37966|NCT01358864|151377|P1|Overall Study|Other reason not defined above|2
37967|NCT01358864|151370|P8|Overall Study|Withdrawal by Subject|3
37968|NCT01358864|151371|P7|Overall Study|Withdrawal by Subject|1
37969|NCT01358864|151372|P6|Overall Study|Withdrawal by Subject|1
37970|NCT01358864|151373|P5|Overall Study|Withdrawal by Subject|0
37971|NCT01358864|151374|P4|Overall Study|Withdrawal by Subject|0
37972|NCT01358864|151375|P3|Overall Study|Withdrawal by Subject|2
37973|NCT01358864|151376|P2|Overall Study|Withdrawal by Subject|4
37974|NCT01358864|151377|P1|Overall Study|Withdrawal by Subject|3
37975|NCT01358864|151370|P8|Overall Study|Lost to Follow-up|1
37976|NCT01358864|151371|P7|Overall Study|Lost to Follow-up|0
37977|NCT01358864|151372|P6|Overall Study|Lost to Follow-up|0
37978|NCT01358864|151373|P5|Overall Study|Lost to Follow-up|0
37979|NCT01358864|151374|P4|Overall Study|Lost to Follow-up|0
37980|NCT01358864|151375|P3|Overall Study|Lost to Follow-up|1
37981|NCT01358864|151376|P2|Overall Study|Lost to Follow-up|0
37982|NCT01358864|151377|P1|Overall Study|Lost to Follow-up|0
37983|NCT01358864|151370|P8|Overall Study|Lack of Efficacy|44
37984|NCT01358864|151371|P7|Overall Study|Lack of Efficacy|49
37985|NCT01358864|151372|P6|Overall Study|Lack of Efficacy|4
37986|NCT01358864|151373|P5|Overall Study|Lack of Efficacy|7
37987|NCT01358864|151374|P4|Overall Study|Lack of Efficacy|19
37988|NCT01358864|151375|P3|Overall Study|Lack of Efficacy|4
37989|NCT01358864|151376|P2|Overall Study|Lack of Efficacy|3
37990|NCT01358864|151377|P1|Overall Study|Lack of Efficacy|26
37991|NCT01358864|151370|P8|Overall Study|Adverse Event|7
37992|NCT01358864|151371|P7|Overall Study|Adverse Event|12
37993|NCT01358864|151372|P6|Overall Study|Adverse Event|8
37994|NCT01358864|151373|P5|Overall Study|Adverse Event|4
37995|NCT01358864|151374|P4|Overall Study|Adverse Event|0
37996|NCT01358864|151375|P3|Overall Study|Adverse Event|9
37997|NCT01358864|151376|P2|Overall Study|Adverse Event|6
37998|NCT01358864|151377|P1|Overall Study|Adverse Event|0
37999|NCT01358825|151468|P2|Overall Study|Blood sample not drawn|1
38000|NCT01358825|151469|P1|Overall Study|Blood sample not drawn|0
38001|NCT01358734|151493|P3|Overall Study|Not Specified|4
38002|NCT01358734|151494|P2|Overall Study|Not Specified|5
38003|NCT01358734|151495|P1|Overall Study|Not Specified|2
38004|NCT01358734|151493|P3|Overall Study|Non-compliance with study drug|1
38005|NCT01358734|151494|P2|Overall Study|Non-compliance with study drug|0
38006|NCT01358734|151495|P1|Overall Study|Non-compliance with study drug|0
38007|NCT01358734|151493|P3|Overall Study|Progressive Disease|13
38008|NCT01358734|151494|P2|Overall Study|Progressive Disease|11
38009|NCT01358734|151495|P1|Overall Study|Progressive Disease|5
38010|NCT01358734|151493|P3|Overall Study|Death|2
38011|NCT01358734|151494|P2|Overall Study|Death|7
38012|NCT01358734|151495|P1|Overall Study|Death|3
38013|NCT01358734|151493|P3|Overall Study|Withdrawal by Subject|3
38014|NCT01358734|151494|P2|Overall Study|Withdrawal by Subject|6
38015|NCT01358734|151495|P1|Overall Study|Withdrawal by Subject|1
38016|NCT01358734|151493|P3|Overall Study|Lack of Efficacy|3
38017|NCT01358734|151494|P2|Overall Study|Lack of Efficacy|1
38018|NCT01358734|151495|P1|Overall Study|Lack of Efficacy|0
38019|NCT01358734|151493|P3|Overall Study|Adverse Event|3
38020|NCT01358734|151494|P2|Overall Study|Adverse Event|7
38021|NCT01358734|151495|P1|Overall Study|Adverse Event|4
38022|NCT01358708|151514|P2|Double-Blind Treatment Phase|Protocol Violation|0
38023|NCT01358708|151515|P1|Double-Blind Treatment Phase|Protocol Violation|1
38024|NCT01358708|151514|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
38025|NCT01358708|151515|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
38026|NCT01358578|151538|P6|Follow-up Period|Physician Decision|0
38027|NCT01358578|151539|P5|Follow-up Period|Physician Decision|0
38028|NCT01358578|151540|P4|Follow-up Period|Physician Decision|2
38029|NCT01358578|151541|P3|Follow-up Period|Physician Decision|0
38030|NCT01358578|151542|P2|Follow-up Period|Physician Decision|1
38031|NCT01358578|151543|P1|Follow-up Period|Physician Decision|1
38032|NCT01358578|151538|P6|Follow-up Period|Withdrawal by Subject|0
38033|NCT01358578|151539|P5|Follow-up Period|Withdrawal by Subject|0
38034|NCT01358578|151540|P4|Follow-up Period|Withdrawal by Subject|12
38035|NCT01358578|151541|P3|Follow-up Period|Withdrawal by Subject|1
38036|NCT01358578|151542|P2|Follow-up Period|Withdrawal by Subject|3
38037|NCT01358578|151543|P1|Follow-up Period|Withdrawal by Subject|3
38038|NCT01358578|151538|P6|Follow-up Period|Pregnancy|0
38039|NCT01358578|151539|P5|Follow-up Period|Pregnancy|0
38040|NCT01358578|151540|P4|Follow-up Period|Pregnancy|0
38041|NCT01358578|151541|P3|Follow-up Period|Pregnancy|0
38042|NCT01358578|151542|P2|Follow-up Period|Pregnancy|0
38043|NCT01358578|151543|P1|Follow-up Period|Pregnancy|1
38044|NCT01358578|151538|P6|Follow-up Period|non- compliance with study treatment|0
38045|NCT01358578|151539|P5|Follow-up Period|non- compliance with study treatment|0
38046|NCT01358578|151540|P4|Follow-up Period|non- compliance with study treatment|0
38047|NCT01358578|151541|P3|Follow-up Period|non- compliance with study treatment|0
38048|NCT01358578|151542|P2|Follow-up Period|non- compliance with study treatment|0
38049|NCT01358578|151543|P1|Follow-up Period|non- compliance with study treatment|1
38050|NCT01358578|151538|P6|Follow-up Period|Lost to Follow-up|0
38051|NCT01358578|151539|P5|Follow-up Period|Lost to Follow-up|0
38052|NCT01358578|151540|P4|Follow-up Period|Lost to Follow-up|4
38053|NCT01358578|151541|P3|Follow-up Period|Lost to Follow-up|0
38054|NCT01358578|151542|P2|Follow-up Period|Lost to Follow-up|1
38055|NCT01358578|151543|P1|Follow-up Period|Lost to Follow-up|0
38056|NCT01358578|151538|P6|Follow-up Period|Lack of Efficacy|0
38057|NCT01358578|151539|P5|Follow-up Period|Lack of Efficacy|0
38058|NCT01358578|151540|P4|Follow-up Period|Lack of Efficacy|1
38059|NCT01358578|151541|P3|Follow-up Period|Lack of Efficacy|4
38060|NCT01358578|151542|P2|Follow-up Period|Lack of Efficacy|0
38061|NCT01358578|151543|P1|Follow-up Period|Lack of Efficacy|3
38062|NCT01358578|151538|P6|Follow-up Period|Adverse Event|0
38063|NCT01358578|151539|P5|Follow-up Period|Adverse Event|0
38064|NCT01358578|151540|P4|Follow-up Period|Adverse Event|0
38065|NCT01358578|151541|P3|Follow-up Period|Adverse Event|0
38066|NCT01358578|151542|P2|Follow-up Period|Adverse Event|1
38067|NCT01358578|151543|P1|Follow-up Period|Adverse Event|1
38068|NCT01358578|151538|P6|Maintenance Period|Withdrawal by Subject|3
38069|NCT01358578|151539|P5|Maintenance Period|Withdrawal by Subject|6
38070|NCT01358578|151540|P4|Maintenance Period|Withdrawal by Subject|15
38071|NCT01358578|151541|P3|Maintenance Period|Withdrawal by Subject|2
38072|NCT01358578|151542|P2|Maintenance Period|Withdrawal by Subject|7
38073|NCT01358578|151543|P1|Maintenance Period|Withdrawal by Subject|12
38074|NCT01358578|151538|P6|Maintenance Period|Protocol deviation|2
38075|NCT01358578|151539|P5|Maintenance Period|Protocol deviation|2
38076|NCT01358578|151540|P4|Maintenance Period|Protocol deviation|2
38077|NCT01358578|151541|P3|Maintenance Period|Protocol deviation|0
38078|NCT01358578|151542|P2|Maintenance Period|Protocol deviation|4
38079|NCT01358578|151543|P1|Maintenance Period|Protocol deviation|7
38080|NCT01358578|151538|P6|Maintenance Period|Pregnancy|0
38081|NCT01358578|151539|P5|Maintenance Period|Pregnancy|0
38082|NCT01358578|151540|P4|Maintenance Period|Pregnancy|0
38083|NCT01358578|151541|P3|Maintenance Period|Pregnancy|0
38084|NCT01358578|151542|P2|Maintenance Period|Pregnancy|0
38085|NCT01358578|151543|P1|Maintenance Period|Pregnancy|1
38086|NCT01358578|151538|P6|Maintenance Period|Physician Decision|0
38087|NCT01358578|151539|P5|Maintenance Period|Physician Decision|0
38088|NCT01358578|151540|P4|Maintenance Period|Physician Decision|1
38089|NCT01358578|151541|P3|Maintenance Period|Physician Decision|0
38090|NCT01358578|151542|P2|Maintenance Period|Physician Decision|1
38091|NCT01358578|151543|P1|Maintenance Period|Physician Decision|0
38092|NCT01358578|151538|P6|Maintenance Period|Non-compliance with study treatment|2
38093|NCT01358578|151539|P5|Maintenance Period|Non-compliance with study treatment|1
38094|NCT01358578|151540|P4|Maintenance Period|Non-compliance with study treatment|2
38095|NCT01358578|151541|P3|Maintenance Period|Non-compliance with study treatment|0
38096|NCT01358578|151542|P2|Maintenance Period|Non-compliance with study treatment|1
38097|NCT01358578|151543|P1|Maintenance Period|Non-compliance with study treatment|3
38098|NCT01358578|151538|P6|Maintenance Period|Lost to Follow-up|1
38099|NCT01358578|151539|P5|Maintenance Period|Lost to Follow-up|1
38100|NCT01358578|151540|P4|Maintenance Period|Lost to Follow-up|5
38101|NCT01358578|151541|P3|Maintenance Period|Lost to Follow-up|0
38102|NCT01358578|151542|P2|Maintenance Period|Lost to Follow-up|0
38103|NCT01358578|151543|P1|Maintenance Period|Lost to Follow-up|4
38104|NCT01358578|151538|P6|Maintenance Period|Lack of Efficacy|0
38105|NCT01358578|151539|P5|Maintenance Period|Lack of Efficacy|3
38106|NCT01358578|151540|P4|Maintenance Period|Lack of Efficacy|11
38107|NCT01358578|151541|P3|Maintenance Period|Lack of Efficacy|0
38108|NCT01358578|151542|P2|Maintenance Period|Lack of Efficacy|2
38109|NCT01358578|151543|P1|Maintenance Period|Lack of Efficacy|10
38110|NCT01358578|151538|P6|Maintenance Period|Adverse Event|3
38111|NCT01358578|151539|P5|Maintenance Period|Adverse Event|4
38112|NCT01358578|151540|P4|Maintenance Period|Adverse Event|6
38113|NCT01358578|151541|P3|Maintenance Period|Adverse Event|0
38114|NCT01358578|151542|P2|Maintenance Period|Adverse Event|7
38115|NCT01358578|151543|P1|Maintenance Period|Adverse Event|2
38116|NCT01358578|151538|P6|Induction Period|Withdrawal by Subject|0
38117|NCT01358578|151539|P5|Induction Period|Withdrawal by Subject|0
38118|NCT01358578|151540|P4|Induction Period|Withdrawal by Subject|6
38119|NCT01358578|151541|P3|Induction Period|Withdrawal by Subject|10
38120|NCT01358578|151542|P2|Induction Period|Withdrawal by Subject|5
38121|NCT01358578|151543|P1|Induction Period|Withdrawal by Subject|5
38122|NCT01358578|151538|P6|Induction Period|technical problems|0
38123|NCT01358578|151539|P5|Induction Period|technical problems|0
38124|NCT01358578|151540|P4|Induction Period|technical problems|1
38125|NCT01358578|151541|P3|Induction Period|technical problems|1
38126|NCT01358578|151542|P2|Induction Period|technical problems|0
38127|NCT01358578|151543|P1|Induction Period|technical problems|0
38128|NCT01358578|151538|P6|Induction Period|Protocol Deviation|0
38129|NCT01358578|151539|P5|Induction Period|Protocol Deviation|0
38130|NCT01358578|151540|P4|Induction Period|Protocol Deviation|3
38131|NCT01358578|151541|P3|Induction Period|Protocol Deviation|0
38132|NCT01358578|151542|P2|Induction Period|Protocol Deviation|5
38133|NCT01358578|151543|P1|Induction Period|Protocol Deviation|3
38134|NCT01358578|151538|P6|Induction Period|Physician Decision|0
38135|NCT01358578|151539|P5|Induction Period|Physician Decision|0
38136|NCT01358578|151540|P4|Induction Period|Physician Decision|0
38137|NCT01358578|151541|P3|Induction Period|Physician Decision|2
38138|NCT01358578|151542|P2|Induction Period|Physician Decision|1
38139|NCT01358578|151543|P1|Induction Period|Physician Decision|2
38140|NCT01358578|151538|P6|Induction Period|Lost to Follow-up|0
38141|NCT01358578|151539|P5|Induction Period|Lost to Follow-up|0
38142|NCT01358578|151540|P4|Induction Period|Lost to Follow-up|4
38143|NCT01358578|151541|P3|Induction Period|Lost to Follow-up|1
38144|NCT01358578|151542|P2|Induction Period|Lost to Follow-up|0
38145|NCT01358578|151543|P1|Induction Period|Lost to Follow-up|0
38146|NCT01358578|151538|P6|Induction Period|Lack of Efficacy|0
38147|NCT01358578|151539|P5|Induction Period|Lack of Efficacy|0
38148|NCT01358578|151540|P4|Induction Period|Lack of Efficacy|1
38149|NCT01358578|151541|P3|Induction Period|Lack of Efficacy|9
38150|NCT01358578|151542|P2|Induction Period|Lack of Efficacy|0
38151|NCT01358578|151543|P1|Induction Period|Lack of Efficacy|0
38152|NCT01358578|151538|P6|Induction Period|Adverse Event|0
38153|NCT01358578|151539|P5|Induction Period|Adverse Event|0
38154|NCT01358578|151540|P4|Induction Period|Adverse Event|6
38155|NCT01358578|151541|P3|Induction Period|Adverse Event|2
38156|NCT01358578|151542|P2|Induction Period|Adverse Event|4
38157|NCT01358578|151543|P1|Induction Period|Adverse Event|2
38158|NCT01358526|151595|P3|Double-blind Phase|Administrative|10
38159|NCT01358526|151596|P2|Double-blind Phase|Administrative|6
38160|NCT01358526|151597|P1|Double-blind Phase|Administrative|0
38161|NCT01358526|151595|P3|Double-blind Phase|Confirmed or suspected diversion|6
38162|NCT01358526|151596|P2|Double-blind Phase|Confirmed or suspected diversion|5
38163|NCT01358526|151597|P1|Double-blind Phase|Confirmed or suspected diversion|0
38164|NCT01358526|151595|P3|Double-blind Phase|Lack of Efficacy|73
38165|NCT01358526|151596|P2|Double-blind Phase|Lack of Efficacy|31
38166|NCT01358526|151597|P1|Double-blind Phase|Lack of Efficacy|0
38167|NCT01358526|151595|P3|Double-blind Phase|Lost to Follow-up|1
38168|NCT01358526|151596|P2|Double-blind Phase|Lost to Follow-up|4
38169|NCT01358526|151597|P1|Double-blind Phase|Lost to Follow-up|0
38170|NCT01358526|151595|P3|Double-blind Phase|Withdrawal by Subject|8
38171|NCT01358526|151596|P2|Double-blind Phase|Withdrawal by Subject|10
38172|NCT01358526|151597|P1|Double-blind Phase|Withdrawal by Subject|0
38173|NCT01358526|151595|P3|Double-blind Phase|Adverse Event|23
38174|NCT01358526|151596|P2|Double-blind Phase|Adverse Event|24
38175|NCT01358526|151597|P1|Double-blind Phase|Adverse Event|0
38176|NCT01358526|151595|P3|Open-label Titration Period|Did not qualify|0
38177|NCT01358526|151596|P2|Open-label Titration Period|Did not qualify|0
38178|NCT01358526|151597|P1|Open-label Titration Period|Did not qualify|178
38179|NCT01358526|151595|P3|Open-label Titration Period|Administrative|0
38180|NCT01358526|151596|P2|Open-label Titration Period|Administrative|0
38181|NCT01358526|151597|P1|Open-label Titration Period|Administrative|8
38182|NCT01358526|151595|P3|Open-label Titration Period|Confirmed or suspected diversion|0
38183|NCT01358526|151596|P2|Open-label Titration Period|Confirmed or suspected diversion|0
38184|NCT01358526|151597|P1|Open-label Titration Period|Confirmed or suspected diversion|16
38185|NCT01358526|151595|P3|Open-label Titration Period|Lack of Efficacy|0
38186|NCT01358526|151596|P2|Open-label Titration Period|Lack of Efficacy|0
38187|NCT01358526|151597|P1|Open-label Titration Period|Lack of Efficacy|107
38188|NCT01358526|151595|P3|Open-label Titration Period|Lost to Follow-up|0
38189|NCT01358526|151596|P2|Open-label Titration Period|Lost to Follow-up|0
38190|NCT01358526|151597|P1|Open-label Titration Period|Lost to Follow-up|25
38191|NCT01358526|151595|P3|Open-label Titration Period|Withdrawal by Subject|0
38192|NCT01358526|151596|P2|Open-label Titration Period|Withdrawal by Subject|0
38193|NCT01358526|151597|P1|Open-label Titration Period|Withdrawal by Subject|65
38194|NCT01358526|151595|P3|Open-label Titration Period|Adverse Event|0
38195|NCT01358526|151596|P2|Open-label Titration Period|Adverse Event|0
38196|NCT01358526|151597|P1|Open-label Titration Period|Adverse Event|95
38197|NCT01358357|151614|P3|Double-Blind Phase|Administrative|0
38198|NCT01358357|151615|P2|Double-Blind Phase|Administrative|1
38199|NCT01358357|151616|P1|Double-Blind Phase|Administrative|0
38200|NCT01358357|151614|P3|Double-Blind Phase|Recurrence of mood event|0
38201|NCT01358357|151615|P2|Double-Blind Phase|Recurrence of mood event|64
38202|NCT01358357|151616|P1|Double-Blind Phase|Recurrence of mood event|48
38203|NCT01358357|151614|P3|Double-Blind Phase|Terminated at study completion|0
38204|NCT01358357|151615|P2|Double-Blind Phase|Terminated at study completion|0
38205|NCT01358357|151616|P1|Double-Blind Phase|Terminated at study completion|2
38206|NCT01358357|151614|P3|Double-Blind Phase|Protocol Violation|0
38207|NCT01358357|151615|P2|Double-Blind Phase|Protocol Violation|12
38208|NCT01358357|151616|P1|Double-Blind Phase|Protocol Violation|16
38209|NCT01358357|151614|P3|Double-Blind Phase|Protocol Violation|0
38210|NCT01358357|151615|P2|Double-Blind Phase|Protocol Violation|11
38211|NCT01358357|151616|P1|Double-Blind Phase|Protocol Violation|1
38212|NCT01358357|151614|P3|Double-Blind Phase|Lost to Follow-up|0
38213|NCT01358357|151615|P2|Double-Blind Phase|Lost to Follow-up|7
38214|NCT01358357|151616|P1|Double-Blind Phase|Lost to Follow-up|5
38215|NCT01358357|151614|P3|Double-Blind Phase|Adverse Event|0
38216|NCT01358357|151615|P2|Double-Blind Phase|Adverse Event|5
38217|NCT01358357|151616|P1|Double-Blind Phase|Adverse Event|8
38218|NCT01358357|151614|P3|Open Label Phase|Mood episode|42
38219|NCT01358357|151615|P2|Open Label Phase|Mood episode|0
38220|NCT01358357|151616|P1|Open Label Phase|Mood episode|0
38221|NCT01358357|151614|P3|Open Label Phase|Terminated at study completion|5
38222|NCT01358357|151615|P2|Open Label Phase|Terminated at study completion|0
38223|NCT01358357|151616|P1|Open Label Phase|Terminated at study completion|0
38224|NCT01358357|151614|P3|Open Label Phase|Did not meet criteria for DB phase|16
38225|NCT01358357|151615|P2|Open Label Phase|Did not meet criteria for DB phase|0
38226|NCT01358357|151616|P1|Open Label Phase|Did not meet criteria for DB phase|0
38227|NCT01358357|151614|P3|Open Label Phase|Withdrawal by Subject|112
38228|NCT01358357|151615|P2|Open Label Phase|Withdrawal by Subject|0
38229|NCT01358357|151616|P1|Open Label Phase|Withdrawal by Subject|0
38230|NCT01358357|151614|P3|Open Label Phase|Protocol Violation|45
38231|NCT01358357|151615|P2|Open Label Phase|Protocol Violation|0
38232|NCT01358357|151616|P1|Open Label Phase|Protocol Violation|0
38233|NCT01358357|151614|P3|Open Label Phase|Lost to Follow-up|76
38234|NCT01358357|151615|P2|Open Label Phase|Lost to Follow-up|0
38235|NCT01358357|151616|P1|Open Label Phase|Lost to Follow-up|0
38236|NCT01358357|151614|P3|Open Label Phase|Lack of Efficacy|107
38237|NCT01358357|151615|P2|Open Label Phase|Lack of Efficacy|0
38238|NCT01358357|151616|P1|Open Label Phase|Lack of Efficacy|0
38239|NCT01358357|151614|P3|Open Label Phase|Adverse Event|59
38240|NCT01358357|151615|P2|Open Label Phase|Adverse Event|0
38241|NCT01358357|151616|P1|Open Label Phase|Adverse Event|0
38242|NCT01358175|151652|P3|Overall Study|Adverse Event|11
38243|NCT01358175|151653|P2|Overall Study|Adverse Event|11
38244|NCT01358175|151654|P1|Overall Study|Adverse Event|6
38245|NCT01358175|151652|P3|Overall Study|Lack of Efficacy|6
38246|NCT01358175|151653|P2|Overall Study|Lack of Efficacy|8
38247|NCT01358175|151654|P1|Overall Study|Lack of Efficacy|3
38248|NCT01358175|151652|P3|Overall Study|Lost to Follow-up|3
38249|NCT01358175|151653|P2|Overall Study|Lost to Follow-up|1
38250|NCT01358175|151654|P1|Overall Study|Lost to Follow-up|1
38251|NCT01358175|151652|P3|Overall Study|Non Compliance with Study Treatment|1
38252|NCT01358175|151653|P2|Overall Study|Non Compliance with Study Treatment|1
38253|NCT01358175|151654|P1|Overall Study|Non Compliance with Study Treatment|0
38254|NCT01358175|151652|P3|Overall Study|Physician Decision|0
38255|NCT01358175|151653|P2|Overall Study|Physician Decision|0
38256|NCT01358175|151654|P1|Overall Study|Physician Decision|1
38257|NCT01358175|151652|P3|Overall Study|Pregnancy|0
38258|NCT01358175|151653|P2|Overall Study|Pregnancy|1
38259|NCT01358175|151654|P1|Overall Study|Pregnancy|0
38260|NCT01358175|151652|P3|Overall Study|Technical issues|0
38261|NCT01358175|151653|P2|Overall Study|Technical issues|1
38262|NCT01358175|151654|P1|Overall Study|Technical issues|0
38263|NCT01358175|151652|P3|Overall Study|Withdrawal by Subject|10
38264|NCT01358175|151653|P2|Overall Study|Withdrawal by Subject|5
38265|NCT01358175|151654|P1|Overall Study|Withdrawal by Subject|9
38266|NCT01358175|151652|P3|Overall Study|Death|1
38267|NCT01358175|151653|P2|Overall Study|Death|0
38268|NCT01358175|151654|P1|Overall Study|Death|1
38269|NCT01357980|151691|P4|Overall Study|Consent withdrawn|0
38270|NCT01357980|151692|P3|Overall Study|Consent withdrawn|1
38271|NCT01357980|151693|P2|Overall Study|Consent withdrawn|0
38272|NCT01357980|151694|P1|Overall Study|Consent withdrawn|0
38273|NCT01357980|151691|P4|Overall Study|Lack of Efficacy|0
38274|NCT01357980|151692|P3|Overall Study|Lack of Efficacy|0
38275|NCT01357980|151693|P2|Overall Study|Lack of Efficacy|1
38276|NCT01357980|151694|P1|Overall Study|Lack of Efficacy|0
38277|NCT01357889|151738|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
38278|NCT01357889|151739|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
38279|NCT01357889|151738|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
38280|NCT01357889|151739|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
38281|NCT01357889|151738|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
38282|NCT01357889|151739|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
38283|NCT01357889|151738|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
38284|NCT01357889|151739|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
38285|NCT01357889|151738|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
38286|NCT01357889|151739|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
38287|NCT01357889|151738|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
38288|NCT01357889|151739|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
38289|NCT01357889|151738|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
38290|NCT01357889|151739|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
38291|NCT01357889|151738|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
38292|NCT01357889|151739|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
38293|NCT01357889|151738|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
38294|NCT01357889|151739|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
38295|NCT01357889|151738|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
38296|NCT01357889|151739|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
38297|NCT01357889|151738|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
38298|NCT01357889|151739|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
38299|NCT01357889|151738|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
38300|NCT01357889|151739|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
38301|NCT01357889|151738|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
38302|NCT01357889|151739|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
38303|NCT01357850|151783|P4|Overall Study|Lost to Follow-up|0
38304|NCT01357850|151784|P3|Overall Study|Lost to Follow-up|0
38305|NCT01357850|151785|P2|Overall Study|Lost to Follow-up|0
38306|NCT01357850|151786|P1|Overall Study|Lost to Follow-up|1
38307|NCT01357616|151877|P2|Overall Study|Withdrawal by Subject|0
38308|NCT01357616|151878|P1|Overall Study|Withdrawal by Subject|1
38309|NCT01357616|151877|P2|Overall Study|Decision Unrelated to Adverse Event|1
38310|NCT01357616|151878|P1|Overall Study|Decision Unrelated to Adverse Event|3
38311|NCT01357616|151877|P2|Overall Study|Inadequate Control of IOP|2
38312|NCT01357616|151878|P1|Overall Study|Inadequate Control of IOP|1
38313|NCT01357616|151877|P2|Overall Study|Protocol Violation|2
38314|NCT01357616|151878|P1|Overall Study|Protocol Violation|0
38315|NCT01357616|151877|P2|Overall Study|Lost to Follow-up|3
38316|NCT01357616|151878|P1|Overall Study|Lost to Follow-up|4
38317|NCT01357616|151877|P2|Overall Study|Adverse Event|1
38318|NCT01357616|151878|P1|Overall Study|Adverse Event|1
38319|NCT01357551|151892|P2|Overall Study|Lost to Follow-up|6
38320|NCT01357551|151893|P1|Overall Study|Lost to Follow-up|16
38321|NCT01357551|151892|P2|Overall Study|Death|1
38322|NCT01357551|151893|P1|Overall Study|Death|0
38323|NCT01357551|151892|P2|Overall Study|Withdrawal by Subject|4
38324|NCT01357551|151893|P1|Overall Study|Withdrawal by Subject|6
38325|NCT01357239|151920|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
38326|NCT01357239|151921|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
38327|NCT01357239|151922|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
38328|NCT01357239|151923|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
38329|NCT01357239|151920|P4|Stratum II: Partially-Methylated|Adverse Event|1
38330|NCT01357239|151921|P3|Stratum II: Partially-Methylated|Adverse Event|0
38331|NCT01357239|151922|P2|Stratum II: Partially-Methylated|Adverse Event|0
38332|NCT01357239|151923|P1|Stratum II: Partially-Methylated|Adverse Event|0
38333|NCT01357239|151920|P4|Stratum I: Fully-Methylated|Adverse Event|0
38334|NCT01357239|151921|P3|Stratum I: Fully-Methylated|Adverse Event|1
38335|NCT01357239|151922|P2|Stratum I: Fully-Methylated|Adverse Event|0
38336|NCT01357239|151923|P1|Stratum I: Fully-Methylated|Adverse Event|0
38337|NCT01357239|151920|P4|Stratum: All Patients|Subject withdrew consent|1
38338|NCT01357239|151921|P3|Stratum: All Patients|Subject withdrew consent|1
38339|NCT01357239|151922|P2|Stratum: All Patients|Subject withdrew consent|0
38340|NCT01357239|151923|P1|Stratum: All Patients|Subject withdrew consent|0
38341|NCT01357239|151920|P4|Stratum: All Patients|Adverse Event|1
38342|NCT01357239|151921|P3|Stratum: All Patients|Adverse Event|1
38343|NCT01357239|151922|P2|Stratum: All Patients|Adverse Event|0
38344|NCT01357239|151923|P1|Stratum: All Patients|Adverse Event|0
38345|NCT01356966|152001|P2|Overall Study|Physician Decision|0
38346|NCT01356966|152002|P1|Overall Study|Physician Decision|1
38347|NCT01356966|152001|P2|Overall Study|Withdrawal by Subject|2
38348|NCT01356966|152002|P1|Overall Study|Withdrawal by Subject|1
38349|NCT01356940|152014|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
38350|NCT01356940|152015|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
38351|NCT01356940|152014|P2|First Intervention (28 Days)|Adverse Event|0
38352|NCT01356940|152015|P1|First Intervention (28 Days)|Adverse Event|1
38353|NCT01356602|152037|P3|Overall Study|Adverse Event|1
38354|NCT01356602|152038|P2|Overall Study|Adverse Event|1
38355|NCT01356602|152039|P1|Overall Study|Adverse Event|0
38356|NCT01356602|152037|P3|Overall Study|Lack of Efficacy|4
38357|NCT01356602|152038|P2|Overall Study|Lack of Efficacy|1
38358|NCT01356602|152039|P1|Overall Study|Lack of Efficacy|0
38359|NCT01356602|152037|P3|Overall Study|Withdrawal by Subject|7
38360|NCT01356602|152038|P2|Overall Study|Withdrawal by Subject|3
38361|NCT01356602|152039|P1|Overall Study|Withdrawal by Subject|4
38362|NCT01356602|152037|P3|Overall Study|Lost to Follow-up|6
38363|NCT01356602|152038|P2|Overall Study|Lost to Follow-up|5
38364|NCT01356602|152039|P1|Overall Study|Lost to Follow-up|4
38365|NCT01356602|152037|P3|Overall Study|Administrative Problems|5
38366|NCT01356602|152038|P2|Overall Study|Administrative Problems|4
38367|NCT01356602|152039|P1|Overall Study|Administrative Problems|1
38368|NCT01356602|152037|P3|Overall Study|Protocol Deviation|1
38369|NCT01356602|152038|P2|Overall Study|Protocol Deviation|1
38370|NCT01356602|152039|P1|Overall Study|Protocol Deviation|0
38371|NCT01356589|152098|P1|Overall Study|Dose data not recorded|2
38372|NCT01356589|152098|P1|Overall Study|Enrolled, but not treated|3
38373|NCT01356407|152155|P2|Overall Study|Not complete Endoscopy|2
38374|NCT01356407|152156|P1|Overall Study|Not complete Endoscopy|2
38375|NCT01356407|152155|P2|Overall Study|Could not afford IMP administration|1
38376|NCT01356407|152156|P1|Overall Study|Could not afford IMP administration|0
38377|NCT01356407|152155|P2|Overall Study|Patient Withdrew Consent|1
38378|NCT01356407|152156|P1|Overall Study|Patient Withdrew Consent|2
38379|NCT01356407|152155|P2|Overall Study|Lost to Follow-up|0
38380|NCT01356407|152156|P1|Overall Study|Lost to Follow-up|2
38381|NCT01355679|152187|P1|Overall Study|benign tumor types found at biopsy|2
38382|NCT01355627|152196|P2|Overall Study|Other|1
38383|NCT01355627|152197|P1|Overall Study|Other|1
38384|NCT01355627|152196|P2|Overall Study|Fatal Adverse Event|23
38385|NCT01355627|152197|P1|Overall Study|Fatal Adverse Event|19
38386|NCT01355627|152196|P2|Overall Study|Lost to Follow-up|7
38387|NCT01355627|152197|P1|Overall Study|Lost to Follow-up|8
38388|NCT01355627|152196|P2|Overall Study|Request By the Patient to Discontinue|7
38389|NCT01355627|152197|P1|Overall Study|Request By the Patient to Discontinue|5
38390|NCT01355523|152236|P2|Overall Study|Adverse Event|2
38391|NCT01355523|152237|P1|Overall Study|Adverse Event|0
38392|NCT01355523|152236|P2|Overall Study|Protocol Violation|2
38393|NCT01355523|152237|P1|Overall Study|Protocol Violation|0
38394|NCT01355523|152236|P2|Overall Study|Lost to Follow-up|2
38395|NCT01355523|152237|P1|Overall Study|Lost to Follow-up|0
38396|NCT01355523|152236|P2|Overall Study|Withdrawal by Subject|4
38397|NCT01355523|152237|P1|Overall Study|Withdrawal by Subject|1
38398|NCT01355081|152316|P3|Overall Study|Non Compliance with Study Medication|0
38399|NCT01355081|152317|P2|Overall Study|Non Compliance with Study Medication|1
38400|NCT01355081|152318|P1|Overall Study|Non Compliance with Study Medication|0
38401|NCT01355081|152316|P3|Overall Study|Lack of Efficacy|1
38402|NCT01355081|152317|P2|Overall Study|Lack of Efficacy|1
38403|NCT01355081|152318|P1|Overall Study|Lack of Efficacy|2
38404|NCT01355081|152316|P3|Overall Study|Withdrawal of Consent|3
38405|NCT01355081|152317|P2|Overall Study|Withdrawal of Consent|3
38406|NCT01355081|152318|P1|Overall Study|Withdrawal of Consent|2
38407|NCT01355081|152316|P3|Overall Study|Lost to Follow-up|1
38408|NCT01355081|152317|P2|Overall Study|Lost to Follow-up|0
38409|NCT01355081|152318|P1|Overall Study|Lost to Follow-up|0
38410|NCT01355081|152316|P3|Overall Study|Major Protocol Deviation|0
38411|NCT01355081|152317|P2|Overall Study|Major Protocol Deviation|1
38412|NCT01355081|152318|P1|Overall Study|Major Protocol Deviation|0
38413|NCT01355081|152316|P3|Overall Study|Pretreatment Event or Adverse Event|6
38414|NCT01355081|152317|P2|Overall Study|Pretreatment Event or Adverse Event|4
38415|NCT01355081|152318|P1|Overall Study|Pretreatment Event or Adverse Event|3
38416|NCT01355068|152341|P2|First Intervention Period|Withdrawal by Subject|1
38417|NCT01355068|152342|P1|First Intervention Period|Withdrawal by Subject|0
38418|NCT01355068|152341|P2|First Intervention Period|Adverse Event|1
38419|NCT01355068|152342|P1|First Intervention Period|Adverse Event|0
38420|NCT01354938|152365|P1|Overall Study|Lost to Follow-up|1
38421|NCT01354899|152371|P1|Overall Study|Protocol Violation|1
38422|NCT01354899|152371|P1|Overall Study|discharge from the hospital|2
38423|NCT01354431|152392|P3|Participants Treated|Withdrawal by Subject|1
38424|NCT01354431|152393|P2|Participants Treated|Withdrawal by Subject|2
38425|NCT01354431|152394|P1|Participants Treated|Withdrawal by Subject|1
38426|NCT01354431|152392|P3|Participants Treated|Adverse Event|4
38427|NCT01354431|152393|P2|Participants Treated|Adverse Event|2
38428|NCT01354431|152394|P1|Participants Treated|Adverse Event|1
38429|NCT01354431|152392|P3|Participants Treated|Death|0
38430|NCT01354431|152393|P2|Participants Treated|Death|1
38431|NCT01354431|152394|P1|Participants Treated|Death|0
38432|NCT01354431|152392|P3|Participants Treated|Study Drug Toxicity|4
38433|NCT01354431|152393|P2|Participants Treated|Study Drug Toxicity|7
38434|NCT01354431|152394|P1|Participants Treated|Study Drug Toxicity|2
38435|NCT01354431|152392|P3|Participants Treated|Disease Progression|41
38436|NCT01354431|152393|P2|Participants Treated|Disease Progression|40
38437|NCT01354431|152394|P1|Participants Treated|Disease Progression|49
38438|NCT01354431|152392|P3|Participants Treated|Continuing Treatment|4
38439|NCT01354431|152393|P2|Participants Treated|Continuing Treatment|2
38440|NCT01354431|152394|P1|Participants Treated|Continuing Treatment|6
38441|NCT01354431|152392|P3|Randomized to Enter Treatment Period|No longer met criteria|0
38442|NCT01354431|152393|P2|Randomized to Enter Treatment Period|No longer met criteria|0
38443|NCT01354431|152394|P1|Randomized to Enter Treatment Period|No longer met criteria|1
38444|NCT01354223|152416|P2|Overall Study|Withdrawal by Subject|1
38445|NCT01354223|152417|P1|Overall Study|Withdrawal by Subject|3
38446|NCT01354106|152466|P1|Overall Study|Withdrawal by Subject|2
38447|NCT01354028|152472|P2|Overall Study|No quiet alert state|1
38448|NCT01354028|152473|P1|Overall Study|No quiet alert state|0
38449|NCT01354028|152472|P2|Overall Study|Discharged before study start|2
38450|NCT01354028|152473|P1|Overall Study|Discharged before study start|2
38451|NCT01354028|152472|P2|Overall Study|Physician Decision|2
38452|NCT01354028|152473|P1|Overall Study|Physician Decision|0
38453|NCT01353963|152509|P1|Overall Study|Adverse Event|2
38454|NCT01353911|152527|P8|Overall Study|Status Not Recorded|0
38455|NCT01353911|152528|P7|Overall Study|Status Not Recorded|0
38456|NCT01353911|152529|P6|Overall Study|Status Not Recorded|0
38457|NCT01353911|152530|P5|Overall Study|Status Not Recorded|0
38458|NCT01353911|152531|P4|Overall Study|Status Not Recorded|0
38459|NCT01353911|152532|P3|Overall Study|Status Not Recorded|1
38460|NCT01353911|152533|P2|Overall Study|Status Not Recorded|0
38461|NCT01353911|152534|P1|Overall Study|Status Not Recorded|4
38462|NCT01353911|152527|P8|Overall Study|Withdrawal by Subject|9
38463|NCT01353911|152528|P7|Overall Study|Withdrawal by Subject|3
38464|NCT01353911|152529|P6|Overall Study|Withdrawal by Subject|3
38465|NCT01353911|152530|P5|Overall Study|Withdrawal by Subject|2
38466|NCT01353911|152531|P4|Overall Study|Withdrawal by Subject|2
38467|NCT01353911|152532|P3|Overall Study|Withdrawal by Subject|4
38468|NCT01353911|152533|P2|Overall Study|Withdrawal by Subject|3
38469|NCT01353911|152534|P1|Overall Study|Withdrawal by Subject|2
38470|NCT01353911|152527|P8|Overall Study|Lost to Follow-up|6
38471|NCT01353911|152528|P7|Overall Study|Lost to Follow-up|3
38472|NCT01353911|152529|P6|Overall Study|Lost to Follow-up|4
38473|NCT01353911|152530|P5|Overall Study|Lost to Follow-up|4
38474|NCT01353911|152531|P4|Overall Study|Lost to Follow-up|0
38475|NCT01353911|152532|P3|Overall Study|Lost to Follow-up|4
38476|NCT01353911|152533|P2|Overall Study|Lost to Follow-up|6
38477|NCT01353911|152534|P1|Overall Study|Lost to Follow-up|2
38478|NCT01353898|152614|P6|Overall Study|Study site terminated|1
38479|NCT01353898|152615|P5|Overall Study|Study site terminated|0
38480|NCT01353898|152616|P4|Overall Study|Study site terminated|0
38481|NCT01353898|152617|P3|Overall Study|Study site terminated|0
38482|NCT01353898|152618|P2|Overall Study|Study site terminated|0
38483|NCT01353898|152619|P1|Overall Study|Study site terminated|0
38484|NCT01353859|152645|P1|Overall Study|Lack of Efficacy|1
38485|NCT01353859|152645|P1|Overall Study|Adverse Event|3
38486|NCT01353664|152658|P1|Overall Study|Disease Progression|16
38487|NCT01353664|152658|P1|Overall Study|Unspecified|3
38488|NCT01353586|152664|P2|Overall Study|Neurological exam not done|1
38489|NCT01353586|152665|P1|Overall Study|Neurological exam not done|0
38490|NCT01353586|152664|P2|Overall Study|Never had insertion of study catheter|1
38491|NCT01353586|152665|P1|Overall Study|Never had insertion of study catheter|4
38492|NCT01353586|152664|P2|Overall Study|Procedure terminated prior to ablation|0
38493|NCT01353586|152665|P1|Overall Study|Procedure terminated prior to ablation|3
38494|NCT01353508|152683|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
38495|NCT01353508|152684|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
38496|NCT01353508|152685|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
38497|NCT01353508|152686|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
38498|NCT01353508|152683|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
38499|NCT01353508|152684|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
38500|NCT01353508|152685|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
38501|NCT01353508|152686|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
38502|NCT01353274|152764|P1|Overall Study|No case report form (CRF) collected|28
38503|NCT01352845|152800|P2|Overall Study|Death|0
38504|NCT01352845|152801|P1|Overall Study|Death|3
38505|NCT01352845|152800|P2|Overall Study|Protocol Violation|6
38506|NCT01352845|152801|P1|Overall Study|Protocol Violation|12
38507|NCT01352845|152800|P2|Overall Study|Unspecified|7
38508|NCT01352845|152801|P1|Overall Study|Unspecified|17
38509|NCT01352845|152800|P2|Overall Study|Adverse Event|6
38510|NCT01352845|152801|P1|Overall Study|Adverse Event|22
38511|NCT01352845|152800|P2|Overall Study|Pregnancy|7
38512|NCT01352845|152801|P1|Overall Study|Pregnancy|27
38513|NCT01352845|152800|P2|Overall Study|No Longer Meets Eligibility Criteria|11
38514|NCT01352845|152801|P1|Overall Study|No Longer Meets Eligibility Criteria|24
38515|NCT01352845|152800|P2|Overall Study|Withdrawal by Subject|16
38516|NCT01352845|152801|P1|Overall Study|Withdrawal by Subject|48
38517|NCT01352845|152800|P2|Overall Study|No Longer Willing to Participate|58
38518|NCT01352845|152801|P1|Overall Study|No Longer Willing to Participate|205
38519|NCT01352845|152800|P2|Overall Study|Lost to Follow-up|92
38520|NCT01352845|152801|P1|Overall Study|Lost to Follow-up|313
38521|NCT01352793|152890|P2|Overall Study|No longer meets eligibility criteria|15
38522|NCT01352793|152891|P1|Overall Study|No longer meets eligibility criteria|25
38523|NCT01352793|152890|P2|Overall Study|Randomized but not vaccinated|0
38524|NCT01352793|152891|P1|Overall Study|Randomized but not vaccinated|8
38525|NCT01352793|152890|P2|Overall Study|Death|0
38526|NCT01352793|152891|P1|Overall Study|Death|1
38527|NCT01352793|152890|P2|Overall Study|Medication error|2
38528|NCT01352793|152891|P1|Overall Study|Medication error|2
38529|NCT01352793|152890|P2|Overall Study|Unspecified|7
38530|NCT01352793|152891|P1|Overall Study|Unspecified|25
38531|NCT01352793|152890|P2|Overall Study|Pregnancy|8
38532|NCT01352793|152891|P1|Overall Study|Pregnancy|26
38533|NCT01352793|152890|P2|Overall Study|Physician Decision|0
38534|NCT01352793|152891|P1|Overall Study|Physician Decision|1
38535|NCT01352793|152890|P2|Overall Study|Adverse Event|10
38536|NCT01352793|152891|P1|Overall Study|Adverse Event|44
38537|NCT01352793|152890|P2|Overall Study|Protocol Violation|23
38538|NCT01352793|152891|P1|Overall Study|Protocol Violation|44
38539|NCT01352793|152890|P2|Overall Study|Withdrawal by Subject|55
38540|NCT01352793|152891|P1|Overall Study|Withdrawal by Subject|120
38541|NCT01352793|152890|P2|Overall Study|Lost to Follow-up|125
38542|NCT01352793|152891|P1|Overall Study|Lost to Follow-up|289
38543|NCT01352741|152915|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
38544|NCT01352741|152916|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
38545|NCT01352741|152915|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
38546|NCT01352741|152916|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
38547|NCT01352741|152915|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
38548|NCT01352741|152916|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
38549|NCT01352741|152915|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
38550|NCT01352741|152916|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
38551|NCT01352741|152915|P2|Double-blind Comparative Period|Not Specified|2
38552|NCT01352741|152916|P1|Double-blind Comparative Period|Not Specified|1
38553|NCT01352741|152915|P2|Double-blind Comparative Period|Withdrawal of consent|3
38554|NCT01352741|152916|P1|Double-blind Comparative Period|Withdrawal of consent|8
38555|NCT01352741|152915|P2|Double-blind Comparative Period|Death|1
38556|NCT01352741|152916|P1|Double-blind Comparative Period|Death|0
38557|NCT01352741|152915|P2|Double-blind Comparative Period|Lost to Follow-up|0
38558|NCT01352741|152916|P1|Double-blind Comparative Period|Lost to Follow-up|1
38559|NCT01352741|152915|P2|Double-blind Comparative Period|Adverse Event|17
38560|NCT01352741|152916|P1|Double-blind Comparative Period|Adverse Event|16
38561|NCT01352741|152915|P2|Double-blind Comparative Period|Lack of Efficacy|3
38562|NCT01352741|152916|P1|Double-blind Comparative Period|Lack of Efficacy|0
38563|NCT01352741|152915|P2|Double-blind Comparative Period|Protocol Violation|0
38564|NCT01352741|152916|P1|Double-blind Comparative Period|Protocol Violation|2
38565|NCT01352741|152915|P2|Open-label Tapentadol Titration Period|Not Specified|0
38566|NCT01352741|152916|P1|Open-label Tapentadol Titration Period|Not Specified|4
38567|NCT01352741|152915|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
38568|NCT01352741|152916|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
38569|NCT01352741|152915|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
38570|NCT01352741|152916|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
38571|NCT01352741|152915|P2|Open-label Tapentadol Titration Period|Adverse Event|0
38572|NCT01352741|152916|P1|Open-label Tapentadol Titration Period|Adverse Event|34
38573|NCT01352741|152915|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
38574|NCT01352741|152916|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
38575|NCT01352741|152915|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
38576|NCT01352741|152916|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
38577|NCT01352715|153010|P2|Overall Study|major ineligibility|1
38578|NCT01352715|153011|P1|Overall Study|major ineligibility|2
38579|NCT01352715|153010|P2|Overall Study|no final visit in closeout period|12
38580|NCT01352715|153011|P1|Overall Study|no final visit in closeout period|15
38581|NCT01352715|153010|P2|Overall Study|site closure|15
38582|NCT01352715|153011|P1|Overall Study|site closure|16
38583|NCT01352715|153010|P2|Overall Study|Withdrawal by Subject|8
38584|NCT01352715|153011|P1|Overall Study|Withdrawal by Subject|4
38585|NCT01352715|153010|P2|Overall Study|Lost to Follow-up|7
38586|NCT01352715|153011|P1|Overall Study|Lost to Follow-up|5
38587|NCT01352715|153010|P2|Overall Study|Death|3
38588|NCT01352715|153011|P1|Overall Study|Death|3
38589|NCT01352585|153033|P1|Overall Study|Not specified|7
38590|NCT01352585|153033|P1|Overall Study|Lost to Follow-up|1
38591|NCT01352585|153033|P1|Overall Study|Adverse Event|3
38592|NCT01352507|153046|P2|Treatment Period 2|Lack of Efficacy|0
38593|NCT01352507|153047|P1|Treatment Period 2|Lack of Efficacy|1
38594|NCT01352507|153046|P2|Treatment Period 2|Withdrawal by Subject|3
38595|NCT01352507|153047|P1|Treatment Period 2|Withdrawal by Subject|4
38596|NCT01352507|153046|P2|Treatment Period 2|Entry Criteria Not Met|0
38597|NCT01352507|153047|P1|Treatment Period 2|Entry Criteria Not Met|1
38598|NCT01352507|153046|P2|Washout Period|Withdrawal by Subject|1
38599|NCT01352507|153047|P1|Washout Period|Withdrawal by Subject|0
38600|NCT01352507|153046|P2|Treatment Period 1|Physician Decision|0
38601|NCT01352507|153047|P1|Treatment Period 1|Physician Decision|1
38602|NCT01352507|153046|P2|Treatment Period 1|Withdrawal by Subject|5
38603|NCT01352507|153047|P1|Treatment Period 1|Withdrawal by Subject|7
38604|NCT01352507|153046|P2|Treatment Period 1|Lost to Follow-up|4
38605|NCT01352507|153047|P1|Treatment Period 1|Lost to Follow-up|3
38606|NCT01352507|153046|P2|Treatment Period 1|Adverse Event|0
38607|NCT01352507|153047|P1|Treatment Period 1|Adverse Event|3
38608|NCT01352416|153087|P4|Overall Study|Physician Decision|1
38609|NCT01352416|153088|P3|Overall Study|Physician Decision|2
38610|NCT01352416|153089|P2|Overall Study|Physician Decision|2
38611|NCT01352416|153090|P1|Overall Study|Physician Decision|1
38612|NCT01351025|153153|P2|Week 24 - 44|unable to get to clinic|1
38613|NCT01351025|153154|P1|Week 24 - 44|unable to get to clinic|1
38614|NCT01351025|153153|P2|Week 24 - 44|Site closed|1
38615|NCT01351025|153154|P1|Week 24 - 44|Site closed|0
38616|NCT01351025|153153|P2|Week 24 - 44|Lost to Follow-up|2
38617|NCT01351025|153154|P1|Week 24 - 44|Lost to Follow-up|0
38618|NCT01351025|153153|P2|Week 0 - 20|Withdrawal by Subject|0
38619|NCT01351025|153154|P1|Week 0 - 20|Withdrawal by Subject|1
38620|NCT01351025|153153|P2|Week 0 - 20|Lost to Follow-up|1
38621|NCT01351025|153154|P1|Week 0 - 20|Lost to Follow-up|2
38622|NCT01350999|153187|P3|Overall Study|Difficulty Making it to Study Visit|5
38623|NCT01350999|153188|P2|Overall Study|Difficulty Making it to Study Visit|1
38624|NCT01350999|153189|P1|Overall Study|Difficulty Making it to Study Visit|1
38625|NCT01350999|153187|P3|Overall Study|Voluntary withdrawal|6
38626|NCT01350999|153188|P2|Overall Study|Voluntary withdrawal|4
38627|NCT01350999|153189|P1|Overall Study|Voluntary withdrawal|3
38628|NCT01350999|153187|P3|Overall Study|Adverse Event|10
38629|NCT01350999|153188|P2|Overall Study|Adverse Event|9
38630|NCT01350999|153189|P1|Overall Study|Adverse Event|4
38631|NCT01350973|153227|P3|Overall Study|Voluntary Withdrawal|1
38632|NCT01350973|153228|P2|Overall Study|Voluntary Withdrawal|1
38633|NCT01350973|153229|P1|Overall Study|Voluntary Withdrawal|2
38634|NCT01350973|153227|P3|Overall Study|Adverse Event|7
38635|NCT01350973|153228|P2|Overall Study|Adverse Event|7
38636|NCT01350973|153229|P1|Overall Study|Adverse Event|4
38637|NCT01350934|153270|P2|Extension Study|Withdrawal by Subject|1
38638|NCT01350934|153271|P1|Extension Study|Withdrawal by Subject|0
38639|NCT01350934|153270|P2|Extension Study|Lack of Efficacy|1
38640|NCT01350934|153271|P1|Extension Study|Lack of Efficacy|0
38641|NCT01350934|153270|P2|Extension Study|Protocol Violation|1
38642|NCT01350934|153271|P1|Extension Study|Protocol Violation|1
38643|NCT01350934|153270|P2|Extension Study|Lost to Follow-up|0
38644|NCT01350934|153271|P1|Extension Study|Lost to Follow-up|2
38645|NCT01350934|153270|P2|Extension Study|Adverse Event|1
38646|NCT01350934|153271|P1|Extension Study|Adverse Event|2
38647|NCT01350934|153270|P2|Base Study|Non-Compliance With Study Drug|0
38648|NCT01350934|153271|P1|Base Study|Non-Compliance With Study Drug|2
38649|NCT01350934|153270|P2|Base Study|Withdrawal by Subject|2
38650|NCT01350934|153271|P1|Base Study|Withdrawal by Subject|1
38651|NCT01350934|153270|P2|Base Study|Protocol Violation|1
38652|NCT01350934|153271|P1|Base Study|Protocol Violation|1
38653|NCT01350934|153270|P2|Base Study|Lost to Follow-up|0
38654|NCT01350934|153271|P1|Base Study|Lost to Follow-up|1
38655|NCT01350934|153270|P2|Base Study|Adverse Event|0
38656|NCT01350934|153271|P1|Base Study|Adverse Event|6
38657|NCT01350804|153293|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
38658|NCT01350804|153294|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
38659|NCT01350804|153295|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
38660|NCT01350804|153296|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
38661|NCT01350804|153293|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
38662|NCT01350804|153294|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
38663|NCT01350804|153295|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
38664|NCT01350804|153296|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
38665|NCT01350804|153293|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
38666|NCT01350804|153294|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
38667|NCT01350804|153295|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
38668|NCT01350804|153296|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
38669|NCT01350804|153293|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
38670|NCT01350804|153294|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
38671|NCT01350804|153295|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
38672|NCT01350804|153296|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
38673|NCT01350804|153293|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
38674|NCT01350804|153294|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
38675|NCT01350804|153295|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
38676|NCT01350804|153296|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
38677|NCT01350804|153293|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
38678|NCT01350804|153294|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
38679|NCT01350804|153295|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
38680|NCT01350804|153296|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
38681|NCT01350804|153293|P4|Core Study|Adverse Event|8
38682|NCT01350804|153294|P3|Core Study|Adverse Event|8
38683|NCT01350804|153295|P2|Core Study|Adverse Event|10
38684|NCT01350804|153296|P1|Core Study|Adverse Event|8
38685|NCT01350804|153293|P4|Core Study|Death|0
38686|NCT01350804|153294|P3|Core Study|Death|1
38687|NCT01350804|153295|P2|Core Study|Death|1
38688|NCT01350804|153296|P1|Core Study|Death|1
38689|NCT01350804|153293|P4|Core Study|Lack of Efficacy|5
38690|NCT01350804|153294|P3|Core Study|Lack of Efficacy|18
38691|NCT01350804|153295|P2|Core Study|Lack of Efficacy|19
38692|NCT01350804|153296|P1|Core Study|Lack of Efficacy|16
38693|NCT01350804|153293|P4|Core Study|Lost to Follow-up|1
38694|NCT01350804|153294|P3|Core Study|Lost to Follow-up|2
38695|NCT01350804|153295|P2|Core Study|Lost to Follow-up|0
38696|NCT01350804|153296|P1|Core Study|Lost to Follow-up|3
38697|NCT01350804|153293|P4|Core Study|Physician Decision|3
38698|NCT01350804|153294|P3|Core Study|Physician Decision|1
38699|NCT01350804|153295|P2|Core Study|Physician Decision|0
38700|NCT01350804|153296|P1|Core Study|Physician Decision|1
38701|NCT01350804|153293|P4|Core Study|Protocol deviation|0
38702|NCT01350804|153294|P3|Core Study|Protocol deviation|1
38703|NCT01350804|153295|P2|Core Study|Protocol deviation|0
38704|NCT01350804|153296|P1|Core Study|Protocol deviation|1
38705|NCT01350804|153293|P4|Core Study|Study terminated by Sponsor|2
38706|NCT01350804|153294|P3|Core Study|Study terminated by Sponsor|0
38707|NCT01350804|153295|P2|Core Study|Study terminated by Sponsor|0
38708|NCT01350804|153296|P1|Core Study|Study terminated by Sponsor|0
38709|NCT01350804|153293|P4|Core Study|Withdrawal by Subject|7
38710|NCT01350804|153294|P3|Core Study|Withdrawal by Subject|16
38711|NCT01350804|153295|P2|Core Study|Withdrawal by Subject|17
38712|NCT01350804|153296|P1|Core Study|Withdrawal by Subject|11
38713|NCT01350414|153391|P1|Overall Study|Physician Decision|2
38714|NCT01350414|153391|P1|Overall Study|Withdrawal by Subject|4
38715|NCT01350414|153391|P1|Overall Study|Lost to Follow-up|13
38716|NCT01350271|153430|P3|Overall Study|Lost to Follow-up|26
38717|NCT01350271|153431|P2|Overall Study|Lost to Follow-up|17
38718|NCT01350271|153432|P1|Overall Study|Lost to Follow-up|21
38719|NCT01350115|153473|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
38720|NCT01350115|153474|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
38721|NCT01350115|153473|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
38722|NCT01350115|153474|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
38723|NCT01350115|153473|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
38724|NCT01350115|153474|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
38725|NCT01349959|153486|P1|Overall Study|Patients are followed for survival|7
38726|NCT01349907|153517|P2|Overall Study|Administrative|1
38727|NCT01349907|153518|P1|Overall Study|Administrative|1
38728|NCT01349907|153517|P2|Overall Study|Protocol Violation|13
38729|NCT01349907|153518|P1|Overall Study|Protocol Violation|33
38730|NCT01349907|153517|P2|Overall Study|Withdrawal by Subject|8
38731|NCT01349907|153518|P1|Overall Study|Withdrawal by Subject|30
38732|NCT01349907|153517|P2|Overall Study|Lost to Follow-up|6
38733|NCT01349907|153518|P1|Overall Study|Lost to Follow-up|25
38734|NCT01349907|153517|P2|Overall Study|Treatment failure|4
38735|NCT01349907|153518|P1|Overall Study|Treatment failure|13
38736|NCT01349907|153517|P2|Overall Study|Adverse Event|11
38737|NCT01349907|153518|P1|Overall Study|Adverse Event|37
38738|NCT01349829|153556|P2|Overall Study|Migrated/moved|7
38739|NCT01349829|153557|P1|Overall Study|Migrated/moved|2
38740|NCT01349829|153556|P2|Overall Study|Consent withdrawal|8
38741|NCT01349829|153557|P1|Overall Study|Consent withdrawal|3
38742|NCT01349829|153556|P2|Overall Study|Lost to Follow-up|8
38743|NCT01349829|153557|P1|Overall Study|Lost to Follow-up|4
38744|NCT01349803|153579|P4|Overall Study|Protocol-specified criteria|0
38745|NCT01349803|153580|P3|Overall Study|Protocol-specified criteria|3
38746|NCT01349803|153581|P2|Overall Study|Protocol-specified criteria|1
38747|NCT01349803|153582|P1|Overall Study|Protocol-specified criteria|0
38748|NCT01349803|153579|P4|Overall Study|Withdrawal by Subject|0
38749|NCT01349803|153580|P3|Overall Study|Withdrawal by Subject|0
38750|NCT01349803|153581|P2|Overall Study|Withdrawal by Subject|0
38751|NCT01349803|153582|P1|Overall Study|Withdrawal by Subject|1
38752|NCT01349803|153579|P4|Overall Study|Adverse Event|2
38753|NCT01349803|153580|P3|Overall Study|Adverse Event|0
38754|NCT01349803|153581|P2|Overall Study|Adverse Event|0
38755|NCT01349803|153582|P1|Overall Study|Adverse Event|0
38756|NCT01349595|153654|P2|Overall Study|Lack of funding|2
38757|NCT01349595|153655|P1|Overall Study|Lack of funding|2
38758|NCT01349465|153663|P2|Overall Study|Subject Ineligible To Continue The Trial|19
38759|NCT01349465|153664|P1|Overall Study|Subject Ineligible To Continue The Trial|0
38760|NCT01349465|153663|P2|Overall Study|Withdrawal by Subject|2
38761|NCT01349465|153664|P1|Overall Study|Withdrawal by Subject|4
38762|NCT01349465|153663|P2|Overall Study|Lost to Follow-up|1
38763|NCT01349465|153664|P1|Overall Study|Lost to Follow-up|10
38764|NCT01349465|153663|P2|Overall Study|Death|0
38765|NCT01349465|153664|P1|Overall Study|Death|3
38766|NCT01349465|153663|P2|Overall Study|Adverse Event|0
38767|NCT01349465|153664|P1|Overall Study|Adverse Event|1
38768|NCT01348854|153696|P2|Overall Study|Withdrawal by Subject|0
38769|NCT01348854|153697|P1|Overall Study|Withdrawal by Subject|1
38770|NCT01348854|153696|P2|Overall Study|Lost to Follow-up|1
38771|NCT01348854|153697|P1|Overall Study|Lost to Follow-up|2
38772|NCT01348789|153705|P1|Overall Study|Withdrawal by Subject|2
38773|NCT01348789|153705|P1|Overall Study|Protocol Violation|2
38774|NCT01348776|153716|P1|Overall Study|Lost to Follow-up|3
38775|NCT01348425|153747|P2|Overall Study|Imaging was not taken.|1
38776|NCT01348425|153748|P1|Overall Study|Imaging was not taken.|1
38777|NCT01348165|153760|P7|Overall Study|Adverse Event|1
38778|NCT01348165|153761|P6|Overall Study|Adverse Event|0
38779|NCT01348165|153762|P5|Overall Study|Adverse Event|0
38780|NCT01348165|153763|P4|Overall Study|Adverse Event|0
38781|NCT01348165|153764|P3|Overall Study|Adverse Event|0
38782|NCT01348165|153765|P2|Overall Study|Adverse Event|0
38783|NCT01348165|153766|P1|Overall Study|Adverse Event|0
38784|NCT01348139|153895|P6|Period 1|Adverse Event|0
38785|NCT01348139|153896|P5|Period 1|Adverse Event|0
38786|NCT01348139|153897|P4|Period 1|Adverse Event|0
38787|NCT01348139|153898|P3|Period 1|Adverse Event|0
38788|NCT01348139|153899|P2|Period 1|Adverse Event|0
38789|NCT01348139|153900|P1|Period 1|Adverse Event|1
38790|NCT01348100|153981|P7|Overall Study|Administrative Problems|1
38791|NCT01348100|153982|P6|Overall Study|Administrative Problems|1
38792|NCT01348100|153983|P5|Overall Study|Administrative Problems|0
38793|NCT01348100|153984|P4|Overall Study|Administrative Problems|0
38794|NCT01348100|153985|P3|Overall Study|Administrative Problems|0
38795|NCT01348100|153986|P2|Overall Study|Administrative Problems|0
38796|NCT01348100|153987|P1|Overall Study|Administrative Problems|0
38797|NCT01348100|153981|P7|Overall Study|Lost to Follow-up|1
38798|NCT01348100|153982|P6|Overall Study|Lost to Follow-up|0
38799|NCT01348100|153983|P5|Overall Study|Lost to Follow-up|0
38800|NCT01348100|153984|P4|Overall Study|Lost to Follow-up|0
38801|NCT01348100|153985|P3|Overall Study|Lost to Follow-up|0
38802|NCT01348100|153986|P2|Overall Study|Lost to Follow-up|0
38803|NCT01348100|153987|P1|Overall Study|Lost to Follow-up|0
38804|NCT01348100|153981|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
38805|NCT01348100|153982|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
38806|NCT01348100|153983|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
38807|NCT01348100|153984|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
38808|NCT01348100|153985|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
38809|NCT01348100|153986|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
38810|NCT01348100|153987|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
38811|NCT01348100|153981|P7|Overall Study|Protocol Deviation|0
38812|NCT01348100|153982|P6|Overall Study|Protocol Deviation|0
38813|NCT01348100|153983|P5|Overall Study|Protocol Deviation|0
38814|NCT01348100|153984|P4|Overall Study|Protocol Deviation|1
38815|NCT01348100|153985|P3|Overall Study|Protocol Deviation|0
38816|NCT01348100|153986|P2|Overall Study|Protocol Deviation|0
38817|NCT01348100|153987|P1|Overall Study|Protocol Deviation|0
38818|NCT01348100|153981|P7|Overall Study|Subject Withdrew Consent|1
38819|NCT01348100|153982|P6|Overall Study|Subject Withdrew Consent|0
38820|NCT01348100|153983|P5|Overall Study|Subject Withdrew Consent|1
38821|NCT01348100|153984|P4|Overall Study|Subject Withdrew Consent|0
38822|NCT01348100|153985|P3|Overall Study|Subject Withdrew Consent|2
38823|NCT01348100|153986|P2|Overall Study|Subject Withdrew Consent|0
38824|NCT01348100|153987|P1|Overall Study|Subject Withdrew Consent|0
38825|NCT01348087|154032|P1|Overall Study|Adverse Event|25
38826|NCT01348087|154032|P1|Overall Study|Subject withdrew consent|7
38827|NCT01348087|154032|P1|Overall Study|Lost to Follow-up|1
38828|NCT01348087|154032|P1|Overall Study|protocol deviation|1
38829|NCT01348087|154032|P1|Overall Study|Administrative problems|79
38830|NCT01348087|154032|P1|Overall Study|Unsatisfactory therapeutic effect|35
38831|NCT01347931|154046|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
38832|NCT01347879|154058|P2|Overall Study|Not known|3
38833|NCT01347879|154059|P1|Overall Study|Not known|2
38834|NCT01347879|154058|P2|Overall Study|Withdrawal by Subject|2
38835|NCT01347879|154059|P1|Overall Study|Withdrawal by Subject|3
38836|NCT01347879|154058|P2|Overall Study|Lost to Follow-up|0
38837|NCT01347879|154059|P1|Overall Study|Lost to Follow-up|2
38838|NCT01347879|154058|P2|Overall Study|Adverse Event|12
38839|NCT01347879|154059|P1|Overall Study|Adverse Event|0
38840|NCT01347840|154091|P1|Overall Study|Withdrawal by Subject|1
38841|NCT01347710|154114|P1|Overall Study|Other|3
38842|NCT01347710|154114|P1|Overall Study|Physician Decision|2
38843|NCT01347710|154114|P1|Overall Study|Lost to Follow-up|1
38844|NCT01347710|154114|P1|Overall Study|issue with vitals prior to dosing|1
38845|NCT01347710|154114|P1|Overall Study|Angio or SPECT not completed|18
38846|NCT01347710|154114|P1|Overall Study|Adverse Event|4
38847|NCT01347710|154114|P1|Overall Study|Withdrawal by Subject|2
38848|NCT01347580|154135|P2|Overall Study|Had other reason|6
38849|NCT01347580|154136|P1|Overall Study|Had other reason|9
38850|NCT01347580|154135|P2|Overall Study|Lost to Follow-up|1
38851|NCT01347580|154136|P1|Overall Study|Lost to Follow-up|3
38852|NCT01347580|154135|P2|Overall Study|Protocol Violation|7
38853|NCT01347580|154136|P1|Overall Study|Protocol Violation|10
38854|NCT01347580|154135|P2|Overall Study|Death|19
38855|NCT01347580|154136|P1|Overall Study|Death|30
38856|NCT01347580|154135|P2|Overall Study|Withdrawal by Subject|23
38857|NCT01347580|154136|P1|Overall Study|Withdrawal by Subject|13
38858|NCT01347554|154166|P2|Overall Study|Lack of Efficacy|11
38859|NCT01347554|154167|P1|Overall Study|Lack of Efficacy|7
38860|NCT01347112|154204|P2|Overall Study|Lost to Follow-up|5
38861|NCT01347112|154205|P1|Overall Study|Lost to Follow-up|3
38862|NCT01347112|154204|P2|Overall Study|Withdrawal by Subject|7
38863|NCT01347112|154205|P1|Overall Study|Withdrawal by Subject|1
38864|NCT01347086|154225|P10|Overall Study|failed screening visit|1
38865|NCT01347086|154226|P9|Overall Study|failed screening visit|0
38866|NCT01347086|154227|P8|Overall Study|failed screening visit|1
38867|NCT01347086|154228|P7|Overall Study|failed screening visit|1
38868|NCT01347086|154229|P6|Overall Study|failed screening visit|0
38869|NCT01347086|154230|P5|Overall Study|failed screening visit|0
38870|NCT01347086|154231|P4|Overall Study|failed screening visit|0
38871|NCT01347086|154232|P3|Overall Study|failed screening visit|1
38872|NCT01347086|154233|P2|Overall Study|failed screening visit|0
38873|NCT01347086|154234|P1|Overall Study|failed screening visit|0
38874|NCT01347073|154333|P1|Overall Study|Liver Transplant|1
38875|NCT01347073|154333|P1|Overall Study|Adverse Event|1
38876|NCT01346774|154412|P2|Overall Study|Adverse Event|2
38877|NCT01346774|154413|P1|Overall Study|Adverse Event|1
38878|NCT01346774|154412|P2|Overall Study|Protocol Violation|3
38879|NCT01346774|154413|P1|Overall Study|Protocol Violation|2
38880|NCT01346774|154412|P2|Overall Study|Withdrawal by Subject|4
38881|NCT01346774|154413|P1|Overall Study|Withdrawal by Subject|1
38882|NCT01346774|154412|P2|Overall Study|Lost to Follow-up|4
38883|NCT01346774|154413|P1|Overall Study|Lost to Follow-up|3
38884|NCT01346774|154412|P2|Overall Study|Did not take a single dose|4
38885|NCT01346774|154413|P1|Overall Study|Did not take a single dose|6
38886|NCT01346592|154422|P3|Overall Study|Unable to Classify|6
38887|NCT01346592|154423|P2|Overall Study|Unable to Classify|3
38888|NCT01346592|154424|P1|Overall Study|Unable to Classify|7
38889|NCT01346592|154422|P3|Overall Study|Administrative reason|0
38890|NCT01346592|154423|P2|Overall Study|Administrative reason|0
38891|NCT01346592|154424|P1|Overall Study|Administrative reason|1
38892|NCT01346592|154422|P3|Overall Study|Inappropriate enrollment|1
38893|NCT01346592|154423|P2|Overall Study|Inappropriate enrollment|1
38894|NCT01346592|154424|P1|Overall Study|Inappropriate enrollment|3
38895|NCT01346592|154422|P3|Overall Study|Withdrawal by Subject|38
38896|NCT01346592|154423|P2|Overall Study|Withdrawal by Subject|51
38897|NCT01346592|154424|P1|Overall Study|Withdrawal by Subject|77
38898|NCT01346592|154422|P3|Overall Study|Adverse Event|0
38899|NCT01346592|154423|P2|Overall Study|Adverse Event|1
38900|NCT01346592|154424|P1|Overall Study|Adverse Event|0
38901|NCT01346592|154422|P3|Overall Study|Death|4
38902|NCT01346592|154423|P2|Overall Study|Death|3
38903|NCT01346592|154424|P1|Overall Study|Death|1
38904|NCT01346592|154422|P3|Overall Study|Protocol Violation|0
38905|NCT01346592|154423|P2|Overall Study|Protocol Violation|1
38906|NCT01346592|154424|P1|Overall Study|Protocol Violation|2
38907|NCT01346592|154422|P3|Overall Study|Lost to Follow-up|29
38908|NCT01346592|154423|P2|Overall Study|Lost to Follow-up|29
38909|NCT01346592|154424|P1|Overall Study|Lost to Follow-up|62
38910|NCT01346501|154516|P2|Overall Study|Not Specified|12
38911|NCT01346501|154517|P1|Overall Study|Not Specified|8
38912|NCT01346501|154516|P2|Overall Study|Initiated Other Biological Agents|1
38913|NCT01346501|154517|P1|Overall Study|Initiated Other Biological Agents|3
38914|NCT01346293|154543|P2|Overall Study|Other|0
38915|NCT01346293|154544|P1|Overall Study|Other|1
38916|NCT01346293|154543|P2|Overall Study|Withdrawal by Subject|4
38917|NCT01346293|154544|P1|Overall Study|Withdrawal by Subject|15
38918|NCT01346293|154543|P2|Overall Study|Lost to Follow-up|8
38919|NCT01346293|154544|P1|Overall Study|Lost to Follow-up|21
38920|NCT01346293|154543|P2|Overall Study|Protocol Violation|9
38921|NCT01346293|154544|P1|Overall Study|Protocol Violation|30
38922|NCT01346176|154573|P3|Completed Satisfaction Survey|Lost to Follow-up|4
38923|NCT01346176|154574|P2|Completed Satisfaction Survey|Lost to Follow-up|4
38924|NCT01346176|154575|P1|Completed Satisfaction Survey|Lost to Follow-up|3
38925|NCT01346176|154573|P3|Completed Satisfaction Survey|Death|2
38926|NCT01346176|154574|P2|Completed Satisfaction Survey|Death|0
38927|NCT01346176|154575|P1|Completed Satisfaction Survey|Death|3
38928|NCT01346176|154573|P3|Completed Advance Directive|Other reason did not complete AD|7
38929|NCT01346176|154574|P2|Completed Advance Directive|Other reason did not complete AD|12
38930|NCT01346176|154575|P1|Completed Advance Directive|Other reason did not complete AD|7
38931|NCT01346176|154573|P3|Completed Advance Directive|Became Ineligible|1
38932|NCT01346176|154574|P2|Completed Advance Directive|Became Ineligible|0
38933|NCT01346176|154575|P1|Completed Advance Directive|Became Ineligible|3
38934|NCT01346176|154573|P3|Completed Advance Directive|Death|2
38935|NCT01346176|154574|P2|Completed Advance Directive|Death|2
38936|NCT01346176|154575|P1|Completed Advance Directive|Death|3
38937|NCT01346176|154573|P3|Recruited|Protocol Violation|0
38938|NCT01346176|154574|P2|Recruited|Protocol Violation|0
38939|NCT01346176|154575|P1|Recruited|Protocol Violation|1
38940|NCT01345929|154593|P2|Overall Study|Patient withdrawal|1
38941|NCT01345929|154594|P1|Overall Study|Patient withdrawal|0
38942|NCT01345929|154593|P2|Overall Study|40,000 CFU/ML|0
38943|NCT01345929|154594|P1|Overall Study|40,000 CFU/ML|1
38944|NCT01345929|154593|P2|Overall Study|Didn't meet eligibility criteria|0
38945|NCT01345929|154594|P1|Overall Study|Didn't meet eligibility criteria|2
38946|NCT01345929|154593|P2|Overall Study|Adverse Event|1
38947|NCT01345929|154594|P1|Overall Study|Adverse Event|0
38948|NCT01345929|154593|P2|Overall Study|Lost to Follow-up|9
38949|NCT01345929|154594|P1|Overall Study|Lost to Follow-up|9
38950|NCT01345929|154593|P2|Overall Study|Withdrawal by Subject|8
38951|NCT01345929|154594|P1|Overall Study|Withdrawal by Subject|9
38952|NCT01345786|154606|P4|Overall Study|Lost to Follow-up|2
38953|NCT01345786|154607|P3|Overall Study|Lost to Follow-up|0
38954|NCT01345786|154608|P2|Overall Study|Lost to Follow-up|0
38955|NCT01345786|154609|P1|Overall Study|Lost to Follow-up|0
38956|NCT01345786|154606|P4|Overall Study|Administrative|0
38957|NCT01345786|154607|P3|Overall Study|Administrative|0
38958|NCT01345786|154608|P2|Overall Study|Administrative|5
38959|NCT01345786|154609|P1|Overall Study|Administrative|3
38960|NCT01345786|154606|P4|Overall Study|Noncompliance with protocol|0
38961|NCT01345786|154607|P3|Overall Study|Noncompliance with protocol|1
38962|NCT01345786|154608|P2|Overall Study|Noncompliance with protocol|0
38963|NCT01345786|154609|P1|Overall Study|Noncompliance with protocol|1
38964|NCT01345786|154606|P4|Overall Study|Subject withdrew consent|0
38965|NCT01345786|154607|P3|Overall Study|Subject withdrew consent|1
38966|NCT01345786|154608|P2|Overall Study|Subject withdrew consent|2
38967|NCT01345786|154609|P1|Overall Study|Subject withdrew consent|2
38968|NCT01345786|154606|P4|Overall Study|Adverse Event|1
38969|NCT01345786|154607|P3|Overall Study|Adverse Event|3
38970|NCT01345786|154608|P2|Overall Study|Adverse Event|1
38971|NCT01345786|154609|P1|Overall Study|Adverse Event|0
38972|NCT01345682|154689|P2|Overall Study|Reason other than those specified above|2
38973|NCT01345682|154690|P1|Overall Study|Reason other than those specified above|3
38974|NCT01345682|154689|P2|Overall Study|Not treated|1
38975|NCT01345682|154690|P1|Overall Study|Not treated|2
38976|NCT01345682|154689|P2|Overall Study|Refused to continue trial medication|9
38977|NCT01345682|154690|P1|Overall Study|Refused to continue trial medication|16
38978|NCT01345682|154689|P2|Overall Study|Lost to Follow-up|1
38979|NCT01345682|154690|P1|Overall Study|Lost to Follow-up|0
38980|NCT01345682|154689|P2|Overall Study|Non-compliance with protocol|1
38981|NCT01345682|154690|P1|Overall Study|Non-compliance with protocol|0
38982|NCT01345682|154689|P2|Overall Study|Adverse Event|41
38983|NCT01345682|154690|P1|Overall Study|Adverse Event|49
38984|NCT01345682|154689|P2|Overall Study|Worsening of underlying cancer disease|13
38985|NCT01345682|154690|P1|Overall Study|Worsening of underlying cancer disease|21
38986|NCT01345682|154689|P2|Overall Study|Progressive disease per RECIST|89
38987|NCT01345682|154690|P1|Overall Study|Progressive disease per RECIST|215
38988|NCT01345630|154724|P2|Overall Study|Insufficient clinical response|11
38989|NCT01345630|154725|P1|Overall Study|Insufficient clinical response|48
38990|NCT01345630|154724|P2|Overall Study|No longer willing to participate|12
38991|NCT01345630|154725|P1|Overall Study|No longer willing to participate|9
38992|NCT01345630|154724|P2|Overall Study|Withdrawn due to pregnancy|2
38993|NCT01345630|154725|P1|Overall Study|Withdrawn due to pregnancy|1
38994|NCT01345630|154724|P2|Overall Study|Other reasons|8
38995|NCT01345630|154725|P1|Overall Study|Other reasons|6
38996|NCT01345630|154724|P2|Overall Study|Study terminated by sponsor|285
38997|NCT01345630|154725|P1|Overall Study|Study terminated by sponsor|254
38998|NCT01345630|154724|P2|Overall Study|Medication error without associated AE|1
38999|NCT01345630|154725|P1|Overall Study|Medication error without associated AE|0
39000|NCT01345630|154724|P2|Overall Study|Protocol Violation|1
39001|NCT01345630|154725|P1|Overall Study|Protocol Violation|4
39002|NCT01345630|154724|P2|Overall Study|Lost to Follow-up|16
39003|NCT01345630|154725|P1|Overall Study|Lost to Follow-up|17
39004|NCT01345630|154724|P2|Overall Study|Adverse Event|23
39005|NCT01345630|154725|P1|Overall Study|Adverse Event|22
39006|NCT01345292|154784|P3|Overall Study|Withdrawal by Subject|1
39007|NCT01345292|154785|P2|Overall Study|Withdrawal by Subject|0
39008|NCT01345292|154786|P1|Overall Study|Withdrawal by Subject|2
39009|NCT01345253|154817|P2|Overall Study|Withdrawal by Subject|19
39010|NCT01345253|154818|P1|Overall Study|Withdrawal by Subject|9
39011|NCT01345253|154817|P2|Overall Study|Physician Decision|12
39012|NCT01345253|154818|P1|Overall Study|Physician Decision|4
39013|NCT01345253|154817|P2|Overall Study|Lost to Follow-up|8
39014|NCT01345253|154818|P1|Overall Study|Lost to Follow-up|3
39015|NCT01345253|154817|P2|Overall Study|Met Protocol Defined Stopping Criteria|1
39016|NCT01345253|154818|P1|Overall Study|Met Protocol Defined Stopping Criteria|6
39017|NCT01345253|154817|P2|Overall Study|Protocol Violation|5
39018|NCT01345253|154818|P1|Overall Study|Protocol Violation|1
39019|NCT01345253|154817|P2|Overall Study|Lack of Efficacy|7
39020|NCT01345253|154818|P1|Overall Study|Lack of Efficacy|11
39021|NCT01345253|154817|P2|Overall Study|Adverse Event|27
39022|NCT01345253|154818|P1|Overall Study|Adverse Event|22
39023|NCT01345240|154837|P5|Overall Study|Serious Adverse Event|1
39024|NCT01345240|154838|P4|Overall Study|Serious Adverse Event|2
39025|NCT01345240|154839|P3|Overall Study|Serious Adverse Event|2
39026|NCT01345240|154840|P2|Overall Study|Serious Adverse Event|2
39027|NCT01345240|154841|P1|Overall Study|Serious Adverse Event|1
39028|NCT01345240|154837|P5|Overall Study|Lost to Follow-up|6
39029|NCT01345240|154838|P4|Overall Study|Lost to Follow-up|8
39030|NCT01345240|154839|P3|Overall Study|Lost to Follow-up|8
39031|NCT01345240|154840|P2|Overall Study|Lost to Follow-up|12
39032|NCT01345240|154841|P1|Overall Study|Lost to Follow-up|1
39033|NCT01345162|154936|P2|Overall Study|Protocol Violation|4
39034|NCT01345162|154937|P1|Overall Study|Protocol Violation|2
39035|NCT01345123|154946|P3|Overall Study|participants no longer with health plan|88
39036|NCT01345123|154947|P2|Overall Study|participants no longer with health plan|85
39037|NCT01345123|154948|P1|Overall Study|participants no longer with health plan|79
39038|NCT01344876|154968|P5|Overall Study|Definite progression of primary disease|0
39039|NCT01344876|154969|P4|Overall Study|Definite progression of primary disease|3
39040|NCT01344876|154970|P3|Overall Study|Definite progression of primary disease|0
39041|NCT01344876|154971|P2|Overall Study|Definite progression of primary disease|0
39042|NCT01344876|154972|P1|Overall Study|Definite progression of primary disease|1
39043|NCT01344876|154968|P5|Overall Study|Withdrawal by Subject|0
39044|NCT01344876|154969|P4|Overall Study|Withdrawal by Subject|0
39045|NCT01344876|154970|P3|Overall Study|Withdrawal by Subject|1
39046|NCT01344876|154971|P2|Overall Study|Withdrawal by Subject|0
39047|NCT01344876|154972|P1|Overall Study|Withdrawal by Subject|0
39048|NCT01344876|154968|P5|Overall Study|Adverse Event|1
39049|NCT01344876|154969|P4|Overall Study|Adverse Event|0
39050|NCT01344876|154970|P3|Overall Study|Adverse Event|0
39051|NCT01344876|154971|P2|Overall Study|Adverse Event|0
39052|NCT01344876|154972|P1|Overall Study|Adverse Event|0
39053|NCT01344759|154988|P2|Overall Study|Patients failed to reach sedation level|2
39054|NCT01344759|154989|P1|Overall Study|Patients failed to reach sedation level|0
39055|NCT01344629|155021|P2|Crossover Period 2|Withdrawal by Subject|1
39056|NCT01344629|155022|P1|Crossover Period 2|Withdrawal by Subject|0
39057|NCT01344538|155060|P2|Overall Study|Lost to Follow-up|0
39058|NCT01344538|155061|P1|Overall Study|Lost to Follow-up|1
39059|NCT01344538|155060|P2|Overall Study|Adverse Event|1
39060|NCT01344538|155061|P1|Overall Study|Adverse Event|1
39061|NCT01344460|155067|P1|Overall Study|Lost to Follow-up|2
39062|NCT01344460|155067|P1|Overall Study|Withdrawal by Subject|1
39063|NCT01344447|155112|P1|Overall Study|Error of power injector|1
39064|NCT01344447|155112|P1|Overall Study|Bolus tracking failed|1
39065|NCT01344447|155112|P1|Overall Study|MRA unsuccessful|1
39066|NCT01344447|155112|P1|Overall Study|Physician Decision|1
39067|NCT01344447|155112|P1|Overall Study|The contrast was not seen|1
39068|NCT01344447|155112|P1|Overall Study|Withdrawal by Subject|1
39069|NCT01344447|155112|P1|Overall Study|Protocol Violation|1
39070|NCT01344447|155112|P1|Overall Study|Adverse Event|1
39071|NCT01344369|155156|P2|Second Intervention|Emesis within 2 x Tmax|1
39072|NCT01344369|155157|P1|Second Intervention|Emesis within 2 x Tmax|0
39073|NCT01344369|155156|P2|Washout of 28 Days|Physician Decision|1
39074|NCT01344369|155157|P1|Washout of 28 Days|Physician Decision|0
39075|NCT01344369|155156|P2|Washout of 28 Days|Withdrawal by Subject|0
39076|NCT01344369|155157|P1|Washout of 28 Days|Withdrawal by Subject|1
39077|NCT01344161|155175|P2|Overall Study|Protocol Violation|1
39078|NCT01344161|155176|P1|Overall Study|Protocol Violation|1
39079|NCT01344161|155175|P2|Overall Study|Pregnancy|1
39080|NCT01344161|155176|P1|Overall Study|Pregnancy|0
39081|NCT01344161|155175|P2|Overall Study|Lost to Follow-up|1
39082|NCT01344161|155176|P1|Overall Study|Lost to Follow-up|4
39083|NCT01344057|155188|P1|Overall Study|Premature Withdrawal|1
39084|NCT01343888|155198|P3|Overall Study|other than stated above|1
39085|NCT01343888|155199|P2|Overall Study|other than stated above|0
39086|NCT01343888|155200|P1|Overall Study|other than stated above|0
39087|NCT01343888|155198|P3|Overall Study|Withdrawal by Subject|2
39088|NCT01343888|155199|P2|Overall Study|Withdrawal by Subject|4
39089|NCT01343888|155200|P1|Overall Study|Withdrawal by Subject|4
39090|NCT01343888|155198|P3|Overall Study|Protocol Violation|0
39091|NCT01343888|155199|P2|Overall Study|Protocol Violation|2
39092|NCT01343888|155200|P1|Overall Study|Protocol Violation|0
39093|NCT01343888|155198|P3|Overall Study|Lost to Follow-up|1
39094|NCT01343888|155199|P2|Overall Study|Lost to Follow-up|2
39095|NCT01343888|155200|P1|Overall Study|Lost to Follow-up|0
39096|NCT01343888|155198|P3|Overall Study|Lack of Efficacy|13
39097|NCT01343888|155199|P2|Overall Study|Lack of Efficacy|9
39098|NCT01343888|155200|P1|Overall Study|Lack of Efficacy|9
39099|NCT01343888|155198|P3|Overall Study|Adverse Event|5
39100|NCT01343888|155199|P2|Overall Study|Adverse Event|22
39101|NCT01343888|155200|P1|Overall Study|Adverse Event|12
39102|NCT01343823|155242|P4|Overall Study|Withdrawal by Subject|0
39103|NCT01343823|155243|P3|Overall Study|Withdrawal by Subject|0
39104|NCT01343823|155244|P2|Overall Study|Withdrawal by Subject|0
39105|NCT01343823|155245|P1|Overall Study|Withdrawal by Subject|1
39106|NCT01343823|155242|P4|Overall Study|Study Terminated|1
39107|NCT01343823|155243|P3|Overall Study|Study Terminated|0
39108|NCT01343823|155244|P2|Overall Study|Study Terminated|0
39109|NCT01343823|155245|P1|Overall Study|Study Terminated|1
39110|NCT01343277|155270|P2|Overall Study|Subsequent anticancer therapy|0
39111|NCT01343277|155271|P1|Overall Study|Subsequent anticancer therapy|1
39112|NCT01343277|155270|P2|Overall Study|Treatment ongoing|2
39113|NCT01343277|155271|P1|Overall Study|Treatment ongoing|8
39114|NCT01343277|155270|P2|Overall Study|Randomized not treated|21
39115|NCT01343277|155271|P1|Overall Study|Randomized not treated|6
39116|NCT01343277|155270|P2|Overall Study|Disease progression|138
39117|NCT01343277|155271|P1|Overall Study|Disease progression|270
39118|NCT01343277|155270|P2|Overall Study|Adverse Event|13
39119|NCT01343277|155271|P1|Overall Study|Adverse Event|67
39120|NCT01343277|155270|P2|Overall Study|Death|1
39121|NCT01343277|155271|P1|Overall Study|Death|10
39122|NCT01343277|155270|P2|Overall Study|Physician Decision|2
39123|NCT01343277|155271|P1|Overall Study|Physician Decision|1
39124|NCT01343277|155270|P2|Overall Study|Withdrawal by Subject|13
39125|NCT01343277|155271|P1|Overall Study|Withdrawal by Subject|18
39126|NCT01343277|155270|P2|Overall Study|Unspecified|3
39127|NCT01343277|155271|P1|Overall Study|Unspecified|3
39128|NCT01343082|155304|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
39129|NCT01343082|155305|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
39130|NCT01343082|155306|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
39131|NCT01343082|155304|P3|Treatment Period , Switched to DE-111|Physician Decision|2
39132|NCT01343082|155305|P2|Treatment Period , Switched to DE-111|Physician Decision|2
39133|NCT01343082|155306|P1|Treatment Period , Switched to DE-111|Physician Decision|0
39134|NCT01343082|155304|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
39135|NCT01343082|155305|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
39136|NCT01343082|155306|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
39137|NCT01343082|155304|P3|Treatment Period , Switched to DE-111|Adverse Event|3
39138|NCT01343082|155305|P2|Treatment Period , Switched to DE-111|Adverse Event|4
39139|NCT01343082|155306|P1|Treatment Period , Switched to DE-111|Adverse Event|1
39140|NCT01343082|155304|P3|The run-in Period|Not meeting criteria|5
39141|NCT01343082|155305|P2|The run-in Period|Not meeting criteria|4
39142|NCT01343082|155306|P1|The run-in Period|Not meeting criteria|3
39143|NCT01342965|155312|P2|Overall Study|Withdrawal by Subject|9
39144|NCT01342965|155313|P1|Overall Study|Withdrawal by Subject|2
39145|NCT01342965|155312|P2|Overall Study|Other Reasons- Unspecified|38
39146|NCT01342965|155313|P1|Overall Study|Other Reasons- Unspecified|44
39147|NCT01342965|155312|P2|Overall Study|Lost to Follow-up|3
39148|NCT01342965|155313|P1|Overall Study|Lost to Follow-up|5
39149|NCT01342965|155312|P2|Overall Study|Death|57
39150|NCT01342965|155313|P1|Overall Study|Death|58
39151|NCT01342913|155329|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
39152|NCT01342913|155330|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
39153|NCT01342913|155331|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
39154|NCT01342913|155329|P3|Double-Blind Treatment Period|Physician Decision|0
39155|NCT01342913|155330|P2|Double-Blind Treatment Period|Physician Decision|2
39156|NCT01342913|155331|P1|Double-Blind Treatment Period|Physician Decision|0
39157|NCT01342913|155329|P3|Double-Blind Treatment Period|Lost to Follow-up|3
39158|NCT01342913|155330|P2|Double-Blind Treatment Period|Lost to Follow-up|1
39159|NCT01342913|155331|P1|Double-Blind Treatment Period|Lost to Follow-up|0
39160|NCT01342913|155329|P3|Double-Blind Treatment Period|Protocol Violation|9
39161|NCT01342913|155330|P2|Double-Blind Treatment Period|Protocol Violation|6
39162|NCT01342913|155331|P1|Double-Blind Treatment Period|Protocol Violation|0
39163|NCT01342913|155329|P3|Double-Blind Treatment Period|Lack of Efficacy|3
39164|NCT01342913|155330|P2|Double-Blind Treatment Period|Lack of Efficacy|2
39165|NCT01342913|155331|P1|Double-Blind Treatment Period|Lack of Efficacy|0
39166|NCT01342913|155329|P3|Double-Blind Treatment Period|Adverse Event|6
39167|NCT01342913|155330|P2|Double-Blind Treatment Period|Adverse Event|3
39168|NCT01342913|155331|P1|Double-Blind Treatment Period|Adverse Event|0
39169|NCT01342913|155329|P3|2-week Run-in Period|Continuation Criteria Not Met|0
39170|NCT01342913|155330|P2|2-week Run-in Period|Continuation Criteria Not Met|0
39171|NCT01342913|155331|P1|2-week Run-in Period|Continuation Criteria Not Met|88
39172|NCT01342913|155329|P3|2-week Run-in Period|Protocol Violation|0
39173|NCT01342913|155330|P2|2-week Run-in Period|Protocol Violation|0
39174|NCT01342913|155331|P1|2-week Run-in Period|Protocol Violation|5
39175|NCT01342913|155329|P3|2-week Run-in Period|Adverse Event|0
39176|NCT01342913|155330|P2|2-week Run-in Period|Adverse Event|0
39177|NCT01342913|155331|P1|2-week Run-in Period|Adverse Event|2
39178|NCT01342913|155329|P3|2-week Run-in Period|Withdrawal by Subject|0
39179|NCT01342913|155330|P2|2-week Run-in Period|Withdrawal by Subject|0
39180|NCT01342913|155331|P1|2-week Run-in Period|Withdrawal by Subject|7
39181|NCT01342913|155329|P3|2-week Run-in Period|Physician Decision|0
39182|NCT01342913|155330|P2|2-week Run-in Period|Physician Decision|0
39183|NCT01342913|155331|P1|2-week Run-in Period|Physician Decision|6
39184|NCT01342913|155329|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
39185|NCT01342913|155330|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
39186|NCT01342913|155331|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
39187|NCT01342640|155368|P1|Overall Study|Unspecified|1
39188|NCT01342640|155368|P1|Overall Study|Lost to Follow-up|21
39189|NCT01342640|155368|P1|Overall Study|Protocol Violation|16
39190|NCT01342640|155368|P1|Overall Study|Adverse Event|3
39191|NCT01342510|155463|P4|Overall Study|Protocol Violation|11
39192|NCT01342510|155464|P3|Overall Study|Protocol Violation|13
39193|NCT01342510|155465|P2|Overall Study|Protocol Violation|6
39194|NCT01342510|155466|P1|Overall Study|Protocol Violation|12
39195|NCT01342484|155479|P3|Overall Study|Withdrawal by Subject|0
39196|NCT01342484|155480|P2|Overall Study|Withdrawal by Subject|0
39197|NCT01342484|155481|P1|Overall Study|Withdrawal by Subject|1
39198|NCT01342484|155479|P3|Overall Study|Protocol Violation|1
39199|NCT01342484|155480|P2|Overall Study|Protocol Violation|0
39200|NCT01342484|155481|P1|Overall Study|Protocol Violation|0
39201|NCT01342484|155479|P3|Overall Study|Other Reasons|0
39202|NCT01342484|155480|P2|Overall Study|Other Reasons|0
39203|NCT01342484|155481|P1|Overall Study|Other Reasons|1
39204|NCT01342445|155537|P2|Overall Study|Experienced side effects|2
39205|NCT01342445|155538|P1|Overall Study|Experienced side effects|0
39206|NCT01342341|155554|P2|Overall Study|Lost to Follow-up|4
39207|NCT01342341|155555|P1|Overall Study|Lost to Follow-up|4
39208|NCT01342094|155576|P2|Overall Study|Withdrawal by Subject|2
39209|NCT01342094|155577|P1|Overall Study|Withdrawal by Subject|0
39210|NCT01342094|155576|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
39211|NCT01342094|155577|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
39212|NCT01342094|155576|P2|Overall Study|Adverse Event|0
39213|NCT01342094|155577|P1|Overall Study|Adverse Event|5
39214|NCT01342081|155586|P3|Overall Study|Withdrawal by Subject|0
39215|NCT01342081|155587|P2|Overall Study|Withdrawal by Subject|1
39216|NCT01342081|155588|P1|Overall Study|Withdrawal by Subject|1
39217|NCT01342081|155586|P3|Overall Study|Physician Decision|0
39218|NCT01342081|155587|P2|Overall Study|Physician Decision|1
39219|NCT01342081|155588|P1|Overall Study|Physician Decision|0
39220|NCT01342081|155586|P3|Overall Study|Adverse Event|0
39221|NCT01342081|155587|P2|Overall Study|Adverse Event|0
39222|NCT01342081|155588|P1|Overall Study|Adverse Event|1
39223|NCT01342081|155586|P3|Overall Study|Did not receive allocated intervention|1
39224|NCT01342081|155587|P2|Overall Study|Did not receive allocated intervention|0
39225|NCT01342081|155588|P1|Overall Study|Did not receive allocated intervention|0
39226|NCT01341990|155598|P2|Overall Study|Withdrawal by Subject|0
39227|NCT01341990|155599|P1|Overall Study|Withdrawal by Subject|2
39228|NCT01341990|155598|P2|Overall Study|Torn Study Lens|0
39229|NCT01341990|155599|P1|Overall Study|Torn Study Lens|1
39230|NCT01341990|155598|P2|Overall Study|Adverse Event|1
39231|NCT01341990|155599|P1|Overall Study|Adverse Event|0
39232|NCT01341782|155623|P2|Overall Study|Other|0
39233|NCT01341782|155624|P1|Overall Study|Other|5
39234|NCT01341782|155623|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
39235|NCT01341782|155624|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
39236|NCT01341782|155623|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
39237|NCT01341782|155624|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
39238|NCT01341782|155623|P2|Overall Study|Missed 3 consecutive doses|4
39239|NCT01341782|155624|P1|Overall Study|Missed 3 consecutive doses|0
39240|NCT01341782|155623|P2|Overall Study|Withdrawal by Subject|5
39241|NCT01341782|155624|P1|Overall Study|Withdrawal by Subject|6
39242|NCT01341782|155623|P2|Overall Study|Adverse Event|1
39243|NCT01341782|155624|P1|Overall Study|Adverse Event|1
39244|NCT01340937|155651|P4|Period 3: Toddler Vaccinations|Technical problem|0
39245|NCT01340937|155652|P3|Period 3: Toddler Vaccinations|Technical problem|1
39246|NCT01340937|155653|P2|Period 3: Toddler Vaccinations|Technical problem|1
39247|NCT01340937|155654|P1|Period 3: Toddler Vaccinations|Technical problem|1
39248|NCT01340937|155651|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
39249|NCT01340937|155652|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
39250|NCT01340937|155653|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
39251|NCT01340937|155654|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
39252|NCT01340937|155651|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
39253|NCT01340937|155652|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
39254|NCT01340937|155653|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
39255|NCT01340937|155654|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
39256|NCT01340937|155651|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
39257|NCT01340937|155652|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
39258|NCT01340937|155653|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
39259|NCT01340937|155654|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
39260|NCT01340937|155651|P4|Period 2: Interim Period|Technical problems|3
39261|NCT01340937|155652|P3|Period 2: Interim Period|Technical problems|6
39262|NCT01340937|155653|P2|Period 2: Interim Period|Technical problems|4
39263|NCT01340937|155654|P1|Period 2: Interim Period|Technical problems|4
39264|NCT01340937|155651|P4|Period 2: Interim Period|Protocol Violation|3
39265|NCT01340937|155652|P3|Period 2: Interim Period|Protocol Violation|6
39266|NCT01340937|155653|P2|Period 2: Interim Period|Protocol Violation|3
39267|NCT01340937|155654|P1|Period 2: Interim Period|Protocol Violation|5
39268|NCT01340937|155651|P4|Period 2: Interim Period|Physician Decision|0
39269|NCT01340937|155652|P3|Period 2: Interim Period|Physician Decision|1
39270|NCT01340937|155653|P2|Period 2: Interim Period|Physician Decision|1
39271|NCT01340937|155654|P1|Period 2: Interim Period|Physician Decision|0
39272|NCT01340937|155651|P4|Period 2: Interim Period|Lost to Follow-up|23
39273|NCT01340937|155652|P3|Period 2: Interim Period|Lost to Follow-up|53
39274|NCT01340937|155653|P2|Period 2: Interim Period|Lost to Follow-up|48
39275|NCT01340937|155654|P1|Period 2: Interim Period|Lost to Follow-up|29
39276|NCT01340937|155651|P4|Period 2: Interim Period|Adverse Event|0
39277|NCT01340937|155652|P3|Period 2: Interim Period|Adverse Event|1
39278|NCT01340937|155653|P2|Period 2: Interim Period|Adverse Event|0
39279|NCT01340937|155654|P1|Period 2: Interim Period|Adverse Event|1
39280|NCT01340937|155651|P4|Period 2: Interim Period|Withdrawal by Subject|12
39281|NCT01340937|155652|P3|Period 2: Interim Period|Withdrawal by Subject|17
39282|NCT01340937|155653|P2|Period 2: Interim Period|Withdrawal by Subject|23
39283|NCT01340937|155654|P1|Period 2: Interim Period|Withdrawal by Subject|28
39284|NCT01340937|155651|P4|Period 1: Infant Series|Randomized but not vaccinated|1
39285|NCT01340937|155652|P3|Period 1: Infant Series|Randomized but not vaccinated|2
39286|NCT01340937|155653|P2|Period 1: Infant Series|Randomized but not vaccinated|5
39287|NCT01340937|155654|P1|Period 1: Infant Series|Randomized but not vaccinated|0
39288|NCT01340937|155651|P4|Period 1: Infant Series|Withdrawal by Subject|15
39289|NCT01340937|155652|P3|Period 1: Infant Series|Withdrawal by Subject|30
39290|NCT01340937|155653|P2|Period 1: Infant Series|Withdrawal by Subject|32
39291|NCT01340937|155654|P1|Period 1: Infant Series|Withdrawal by Subject|33
39292|NCT01340937|155651|P4|Period 1: Infant Series|Protocol Violation|3
39293|NCT01340937|155652|P3|Period 1: Infant Series|Protocol Violation|4
39294|NCT01340937|155653|P2|Period 1: Infant Series|Protocol Violation|4
39295|NCT01340937|155654|P1|Period 1: Infant Series|Protocol Violation|1
39296|NCT01340937|155651|P4|Period 1: Infant Series|Physician Decision|0
39297|NCT01340937|155652|P3|Period 1: Infant Series|Physician Decision|1
39298|NCT01340937|155653|P2|Period 1: Infant Series|Physician Decision|3
39299|NCT01340937|155654|P1|Period 1: Infant Series|Physician Decision|2
39300|NCT01340937|155651|P4|Period 1: Infant Series|Lost to Follow-up|13
39301|NCT01340937|155652|P3|Period 1: Infant Series|Lost to Follow-up|12
39302|NCT01340937|155653|P2|Period 1: Infant Series|Lost to Follow-up|14
39303|NCT01340937|155654|P1|Period 1: Infant Series|Lost to Follow-up|20
39304|NCT01340937|155651|P4|Period 1: Infant Series|Death|0
39305|NCT01340937|155652|P3|Period 1: Infant Series|Death|2
39306|NCT01340937|155653|P2|Period 1: Infant Series|Death|0
39307|NCT01340937|155654|P1|Period 1: Infant Series|Death|2
39308|NCT01340937|155651|P4|Period 1: Infant Series|Adverse Event|0
39309|NCT01340937|155652|P3|Period 1: Infant Series|Adverse Event|4
39310|NCT01340937|155653|P2|Period 1: Infant Series|Adverse Event|1
39311|NCT01340937|155654|P1|Period 1: Infant Series|Adverse Event|0
39312|NCT01340937|155651|P4|Period 1: Infant Series|Other protocol criterion not met|0
39313|NCT01340937|155652|P3|Period 1: Infant Series|Other protocol criterion not met|1
39314|NCT01340937|155653|P2|Period 1: Infant Series|Other protocol criterion not met|1
39315|NCT01340937|155654|P1|Period 1: Infant Series|Other protocol criterion not met|0
39316|NCT01340794|155813|P2|Overall Study|Withdrawal by Subject|1
39317|NCT01340794|155814|P1|Overall Study|Withdrawal by Subject|0
39318|NCT01340768|155830|P2|Overall Study|Other|0
39319|NCT01340768|155831|P1|Overall Study|Other|2
39320|NCT01340768|155830|P2|Overall Study|Withdrawal by Subject|1
39321|NCT01340768|155831|P1|Overall Study|Withdrawal by Subject|5
39322|NCT01340768|155830|P2|Overall Study|Lost to Follow-up|4
39323|NCT01340768|155831|P1|Overall Study|Lost to Follow-up|10
39324|NCT01340664|155842|P3|Overall Study|Not specified|2
39325|NCT01340664|155843|P2|Overall Study|Not specified|2
39326|NCT01340664|155844|P1|Overall Study|Not specified|1
39327|NCT01340664|155842|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
39328|NCT01340664|155843|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
39329|NCT01340664|155844|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
39330|NCT01340664|155842|P3|Overall Study|Glycemic withdrawal criteria|0
39331|NCT01340664|155843|P2|Overall Study|Glycemic withdrawal criteria|0
39332|NCT01340664|155844|P1|Overall Study|Glycemic withdrawal criteria|2
39333|NCT01340664|155842|P3|Overall Study|Withdrawal by Subject|0
39334|NCT01340664|155843|P2|Overall Study|Withdrawal by Subject|4
39335|NCT01340664|155844|P1|Overall Study|Withdrawal by Subject|2
39336|NCT01340664|155842|P3|Overall Study|Lost to Follow-up|2
39337|NCT01340664|155843|P2|Overall Study|Lost to Follow-up|0
39338|NCT01340664|155844|P1|Overall Study|Lost to Follow-up|2
39339|NCT01340664|155842|P3|Overall Study|Adverse Event|7
39340|NCT01340664|155843|P2|Overall Study|Adverse Event|1
39341|NCT01340664|155844|P1|Overall Study|Adverse Event|0
39342|NCT01340651|155861|P1|Overall Study|Commercial Supply per Sponsor|12
39343|NCT01340651|155861|P1|Overall Study|Consent Withdrawn|2
39344|NCT01340651|155861|P1|Overall Study|Adverse Event|3
39345|NCT01340625|155877|P2|Washout Period of 28 Days|Withdrawal by Subject|0
39346|NCT01340625|155878|P1|Washout Period of 28 Days|Withdrawal by Subject|1
39347|NCT01340625|155877|P2|First Intervention|Adverse Event|0
39348|NCT01340625|155878|P1|First Intervention|Adverse Event|1
39349|NCT01340209|155986|P3|Overall Study|Other reason not defined above|4
39350|NCT01340209|155987|P2|Overall Study|Other reason not defined above|5
39351|NCT01340209|155988|P1|Overall Study|Other reason not defined above|3
39352|NCT01340209|155986|P3|Overall Study|Withdrawal by Subject|1
39353|NCT01340209|155987|P2|Overall Study|Withdrawal by Subject|0
39354|NCT01340209|155988|P1|Overall Study|Withdrawal by Subject|0
39355|NCT01340209|155986|P3|Overall Study|Protocol Violation|1
39356|NCT01340209|155987|P2|Overall Study|Protocol Violation|2
39357|NCT01340209|155988|P1|Overall Study|Protocol Violation|1
39358|NCT01340209|155986|P3|Overall Study|Adverse Event|2
39359|NCT01340209|155987|P2|Overall Study|Adverse Event|1
39360|NCT01340209|155988|P1|Overall Study|Adverse Event|1
39361|NCT01340196|156023|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
39362|NCT01340066|156063|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
39363|NCT01340066|156064|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
39364|NCT01340066|156065|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
39365|NCT01340066|156063|P3|5 Week Double Blind Randomization Period|Physician Decision|0
39366|NCT01340066|156064|P2|5 Week Double Blind Randomization Period|Physician Decision|1
39367|NCT01340066|156065|P1|5 Week Double Blind Randomization Period|Physician Decision|0
39368|NCT01340066|156063|P3|5 Week Double Blind Randomization Period|Adverse Event|2
39369|NCT01340066|156064|P2|5 Week Double Blind Randomization Period|Adverse Event|2
39370|NCT01340066|156065|P1|5 Week Double Blind Randomization Period|Adverse Event|0
39371|NCT01340066|156063|P3|Placebo Run in Period|Screen Failures|0
39372|NCT01340066|156064|P2|Placebo Run in Period|Screen Failures|0
39373|NCT01340066|156065|P1|Placebo Run in Period|Screen Failures|27
39374|NCT01340027|156084|P12|Overall Study|Miscellaneous|0
39375|NCT01340027|156085|P11|Overall Study|Miscellaneous|1
39376|NCT01340027|156086|P10|Overall Study|Miscellaneous|0
39377|NCT01340027|156087|P9|Overall Study|Miscellaneous|0
39378|NCT01340027|156088|P8|Overall Study|Miscellaneous|0
39379|NCT01340027|156089|P7|Overall Study|Miscellaneous|0
39380|NCT01340027|156090|P6|Overall Study|Miscellaneous|0
39381|NCT01340027|156091|P5|Overall Study|Miscellaneous|0
39382|NCT01340027|156092|P4|Overall Study|Miscellaneous|1
39383|NCT01340027|156093|P3|Overall Study|Miscellaneous|0
39384|NCT01340027|156094|P2|Overall Study|Miscellaneous|0
39385|NCT01340027|156095|P1|Overall Study|Miscellaneous|0
39386|NCT01340027|156084|P12|Overall Study|Withdrawal by Subject|1
39387|NCT01340027|156085|P11|Overall Study|Withdrawal by Subject|0
39388|NCT01340027|156086|P10|Overall Study|Withdrawal by Subject|2
39389|NCT01340027|156087|P9|Overall Study|Withdrawal by Subject|1
39390|NCT01340027|156088|P8|Overall Study|Withdrawal by Subject|4
39391|NCT01340027|156089|P7|Overall Study|Withdrawal by Subject|3
39392|NCT01340027|156090|P6|Overall Study|Withdrawal by Subject|2
39393|NCT01340027|156091|P5|Overall Study|Withdrawal by Subject|3
39394|NCT01340027|156092|P4|Overall Study|Withdrawal by Subject|3
39395|NCT01340027|156093|P3|Overall Study|Withdrawal by Subject|1
39396|NCT01340027|156094|P2|Overall Study|Withdrawal by Subject|3
39397|NCT01340027|156095|P1|Overall Study|Withdrawal by Subject|4
39398|NCT01340027|156084|P12|Overall Study|Protocol Violation|0
39399|NCT01340027|156085|P11|Overall Study|Protocol Violation|0
39400|NCT01340027|156086|P10|Overall Study|Protocol Violation|2
39401|NCT01340027|156087|P9|Overall Study|Protocol Violation|2
39402|NCT01340027|156088|P8|Overall Study|Protocol Violation|1
39403|NCT01340027|156089|P7|Overall Study|Protocol Violation|0
39404|NCT01340027|156090|P6|Overall Study|Protocol Violation|0
39405|NCT01340027|156091|P5|Overall Study|Protocol Violation|6
39406|NCT01340027|156092|P4|Overall Study|Protocol Violation|0
39407|NCT01340027|156093|P3|Overall Study|Protocol Violation|0
39408|NCT01340027|156094|P2|Overall Study|Protocol Violation|2
39409|NCT01340027|156095|P1|Overall Study|Protocol Violation|1
39410|NCT01340027|156084|P12|Overall Study|Lost to Follow-up|0
39411|NCT01340027|156085|P11|Overall Study|Lost to Follow-up|0
39412|NCT01340027|156086|P10|Overall Study|Lost to Follow-up|1
39413|NCT01340027|156087|P9|Overall Study|Lost to Follow-up|0
39414|NCT01340027|156088|P8|Overall Study|Lost to Follow-up|0
39415|NCT01340027|156089|P7|Overall Study|Lost to Follow-up|1
39416|NCT01340027|156090|P6|Overall Study|Lost to Follow-up|0
39417|NCT01340027|156091|P5|Overall Study|Lost to Follow-up|0
39418|NCT01340027|156092|P4|Overall Study|Lost to Follow-up|0
39419|NCT01340027|156093|P3|Overall Study|Lost to Follow-up|0
39420|NCT01340027|156094|P2|Overall Study|Lost to Follow-up|1
39421|NCT01340027|156095|P1|Overall Study|Lost to Follow-up|0
39422|NCT01340027|156084|P12|Overall Study|Lack of Efficacy|0
39423|NCT01340027|156085|P11|Overall Study|Lack of Efficacy|0
39424|NCT01340027|156086|P10|Overall Study|Lack of Efficacy|0
39425|NCT01340027|156087|P9|Overall Study|Lack of Efficacy|1
39426|NCT01340027|156088|P8|Overall Study|Lack of Efficacy|1
39427|NCT01340027|156089|P7|Overall Study|Lack of Efficacy|1
39428|NCT01340027|156090|P6|Overall Study|Lack of Efficacy|0
39429|NCT01340027|156091|P5|Overall Study|Lack of Efficacy|0
39430|NCT01340027|156092|P4|Overall Study|Lack of Efficacy|0
39431|NCT01340027|156093|P3|Overall Study|Lack of Efficacy|0
39432|NCT01340027|156094|P2|Overall Study|Lack of Efficacy|0
39433|NCT01340027|156095|P1|Overall Study|Lack of Efficacy|0
39434|NCT01340027|156084|P12|Overall Study|Adverse Event|3
39435|NCT01340027|156085|P11|Overall Study|Adverse Event|1
39436|NCT01340027|156086|P10|Overall Study|Adverse Event|1
39437|NCT01340027|156087|P9|Overall Study|Adverse Event|4
39438|NCT01340027|156088|P8|Overall Study|Adverse Event|1
39439|NCT01340027|156089|P7|Overall Study|Adverse Event|2
39440|NCT01340027|156090|P6|Overall Study|Adverse Event|2
39441|NCT01340027|156091|P5|Overall Study|Adverse Event|1
39442|NCT01340027|156092|P4|Overall Study|Adverse Event|0
39443|NCT01340027|156093|P3|Overall Study|Adverse Event|2
39444|NCT01340027|156094|P2|Overall Study|Adverse Event|1
39445|NCT01340027|156095|P1|Overall Study|Adverse Event|0
39446|NCT01340027|156084|P12|Overall Study|Randomized but Never Received Study Drug|0
39447|NCT01340027|156085|P11|Overall Study|Randomized but Never Received Study Drug|0
39448|NCT01340027|156086|P10|Overall Study|Randomized but Never Received Study Drug|0
39449|NCT01340027|156087|P9|Overall Study|Randomized but Never Received Study Drug|0
39450|NCT01340027|156088|P8|Overall Study|Randomized but Never Received Study Drug|0
39451|NCT01340027|156089|P7|Overall Study|Randomized but Never Received Study Drug|0
39452|NCT01340027|156090|P6|Overall Study|Randomized but Never Received Study Drug|0
39453|NCT01340027|156091|P5|Overall Study|Randomized but Never Received Study Drug|0
39454|NCT01340027|156092|P4|Overall Study|Randomized but Never Received Study Drug|0
39455|NCT01340027|156093|P3|Overall Study|Randomized but Never Received Study Drug|1
39456|NCT01340027|156094|P2|Overall Study|Randomized but Never Received Study Drug|0
39457|NCT01340027|156095|P1|Overall Study|Randomized but Never Received Study Drug|0
39458|NCT01340014|156471|P2|Period 2, Second 7 Days|Adverse Event|1
39459|NCT01340014|156472|P1|Period 2, Second 7 Days|Adverse Event|0
39460|NCT01340014|156471|P2|Period 1, First 7 Days|Personal Reasons|0
39461|NCT01340014|156472|P1|Period 1, First 7 Days|Personal Reasons|1
39462|NCT01340014|156471|P2|Period 1, First 7 Days|Adverse Event|0
39463|NCT01340014|156472|P1|Period 1, First 7 Days|Adverse Event|1
39464|NCT01339923|156493|P7|Overall Study|Withdrawal by Subject|2
39465|NCT01339923|156494|P6|Overall Study|Withdrawal by Subject|3
39466|NCT01339923|156495|P5|Overall Study|Withdrawal by Subject|4
39467|NCT01339923|156496|P4|Overall Study|Withdrawal by Subject|1
39468|NCT01339923|156497|P3|Overall Study|Withdrawal by Subject|6
39469|NCT01339923|156498|P2|Overall Study|Withdrawal by Subject|11
39470|NCT01339923|156499|P1|Overall Study|Withdrawal by Subject|7
39471|NCT01339923|156493|P7|Overall Study|Unable to Classify|5
39472|NCT01339923|156494|P6|Overall Study|Unable to Classify|1
39473|NCT01339923|156495|P5|Overall Study|Unable to Classify|0
39474|NCT01339923|156496|P4|Overall Study|Unable to Classify|0
39475|NCT01339923|156497|P3|Overall Study|Unable to Classify|1
39476|NCT01339923|156498|P2|Overall Study|Unable to Classify|0
39477|NCT01339923|156499|P1|Overall Study|Unable to Classify|1
39478|NCT01339923|156493|P7|Overall Study|Protocol Violation|1
39479|NCT01339923|156494|P6|Overall Study|Protocol Violation|3
39480|NCT01339923|156495|P5|Overall Study|Protocol Violation|0
39481|NCT01339923|156496|P4|Overall Study|Protocol Violation|0
39482|NCT01339923|156497|P3|Overall Study|Protocol Violation|0
39483|NCT01339923|156498|P2|Overall Study|Protocol Violation|0
39484|NCT01339923|156499|P1|Overall Study|Protocol Violation|0
39485|NCT01339923|156493|P7|Overall Study|Lost to Follow-up|5
39486|NCT01339923|156494|P6|Overall Study|Lost to Follow-up|1
39487|NCT01339923|156495|P5|Overall Study|Lost to Follow-up|1
39488|NCT01339923|156496|P4|Overall Study|Lost to Follow-up|3
39489|NCT01339923|156497|P3|Overall Study|Lost to Follow-up|0
39490|NCT01339923|156498|P2|Overall Study|Lost to Follow-up|4
39491|NCT01339923|156499|P1|Overall Study|Lost to Follow-up|4
39492|NCT01339923|156493|P7|Overall Study|Inappropriate Enrollment|0
39493|NCT01339923|156494|P6|Overall Study|Inappropriate Enrollment|1
39494|NCT01339923|156495|P5|Overall Study|Inappropriate Enrollment|0
39495|NCT01339923|156496|P4|Overall Study|Inappropriate Enrollment|0
39496|NCT01339923|156497|P3|Overall Study|Inappropriate Enrollment|0
39497|NCT01339923|156498|P2|Overall Study|Inappropriate Enrollment|0
39498|NCT01339923|156499|P1|Overall Study|Inappropriate Enrollment|1
39499|NCT01339923|156493|P7|Overall Study|Adverse Event|1
39500|NCT01339923|156494|P6|Overall Study|Adverse Event|0
39501|NCT01339923|156495|P5|Overall Study|Adverse Event|0
39502|NCT01339923|156496|P4|Overall Study|Adverse Event|0
39503|NCT01339923|156497|P3|Overall Study|Adverse Event|1
39504|NCT01339923|156498|P2|Overall Study|Adverse Event|1
39505|NCT01339923|156499|P1|Overall Study|Adverse Event|1
39506|NCT01339897|156572|P4|Overall Study|Adverse Event|1
39507|NCT01339897|156573|P3|Overall Study|Adverse Event|0
39508|NCT01339897|156574|P2|Overall Study|Adverse Event|0
39509|NCT01339897|156575|P1|Overall Study|Adverse Event|1
39510|NCT01339832|156601|P1|Overall Study|Death|11
39511|NCT01339832|156601|P1|Overall Study|Lost to Follow-up|3
39512|NCT01339429|156612|P1|Overall Study|Physician Decision|3
39513|NCT01339429|156612|P1|Overall Study|Withdrawal by Subject|1
39514|NCT01339390|156652|P2|Overall Study|Lost to Follow-up|127
39515|NCT01339390|156653|P1|Overall Study|Lost to Follow-up|125
39516|NCT01339390|156652|P2|Overall Study|Death|29
39517|NCT01339390|156653|P1|Overall Study|Death|32
39518|NCT01339000|156715|P2|Overall Study|study closed due to lack of drug supply|0
39519|NCT01339000|156716|P1|Overall Study|study closed due to lack of drug supply|1
39520|NCT01338870|156736|P6|Overall Study|Adverse Event|1
39521|NCT01338870|156737|P5|Overall Study|Adverse Event|4
39522|NCT01338870|156738|P4|Overall Study|Adverse Event|5
39523|NCT01338870|156739|P3|Overall Study|Adverse Event|1
39524|NCT01338870|156740|P2|Overall Study|Adverse Event|4
39525|NCT01338870|156741|P1|Overall Study|Adverse Event|4
39526|NCT01338870|156736|P6|Overall Study|Protocol Violation|1
39527|NCT01338870|156737|P5|Overall Study|Protocol Violation|1
39528|NCT01338870|156738|P4|Overall Study|Protocol Violation|2
39529|NCT01338870|156739|P3|Overall Study|Protocol Violation|2
39530|NCT01338870|156740|P2|Overall Study|Protocol Violation|2
39531|NCT01338870|156741|P1|Overall Study|Protocol Violation|0
39532|NCT01338870|156736|P6|Overall Study|Unspecified|2
39533|NCT01338870|156737|P5|Overall Study|Unspecified|0
39534|NCT01338870|156738|P4|Overall Study|Unspecified|2
39535|NCT01338870|156739|P3|Overall Study|Unspecified|3
39536|NCT01338870|156740|P2|Overall Study|Unspecified|3
39537|NCT01338870|156741|P1|Overall Study|Unspecified|3
39538|NCT01338870|156736|P6|Overall Study|Withdrawal by Subject|2
39539|NCT01338870|156737|P5|Overall Study|Withdrawal by Subject|0
39540|NCT01338870|156738|P4|Overall Study|Withdrawal by Subject|0
39541|NCT01338870|156739|P3|Overall Study|Withdrawal by Subject|4
39542|NCT01338870|156740|P2|Overall Study|Withdrawal by Subject|3
39543|NCT01338870|156741|P1|Overall Study|Withdrawal by Subject|2
39544|NCT01338870|156736|P6|Overall Study|Lost to Follow-up|0
39545|NCT01338870|156737|P5|Overall Study|Lost to Follow-up|1
39546|NCT01338870|156738|P4|Overall Study|Lost to Follow-up|0
39547|NCT01338870|156739|P3|Overall Study|Lost to Follow-up|1
39548|NCT01338870|156740|P2|Overall Study|Lost to Follow-up|0
39549|NCT01338870|156741|P1|Overall Study|Lost to Follow-up|0
39550|NCT01338818|156796|P1|Overall Study|Protocol Deviation|4
39551|NCT01338818|156796|P1|Overall Study|Administrative problems|3
39552|NCT01338818|156796|P1|Overall Study|Lost to Follow-up|4
39553|NCT01338818|156796|P1|Overall Study|Withdrawal by Subject|11
39554|NCT01338818|156796|P1|Overall Study|no longer require study drug|1
39555|NCT01338818|156796|P1|Overall Study|Lack of Efficacy|5
39556|NCT01338818|156796|P1|Overall Study|Adverse Event|8
39557|NCT01338792|156802|P1|Overall Study|Withdrawal by Subject|1
39558|NCT01338792|156802|P1|Overall Study|Death|1
39559|NCT01338792|156802|P1|Overall Study|Adverse Event|2
39560|NCT01338610|156820|P3|Overall Study|Adverse Event|0
39561|NCT01338610|156821|P2|Overall Study|Adverse Event|0
39562|NCT01338610|156822|P1|Overall Study|Adverse Event|3
39563|NCT01338610|156820|P3|Overall Study|Protocol Violation|1
39564|NCT01338610|156821|P2|Overall Study|Protocol Violation|0
39565|NCT01338610|156822|P1|Overall Study|Protocol Violation|1
39566|NCT01338610|156820|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
39567|NCT01338610|156821|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
39568|NCT01338610|156822|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
39569|NCT01338493|156829|P1|12 Months Follow up|Lost to Follow-up|9
39570|NCT01338493|156829|P1|6 Months Follow up|Missed visit|8
39571|NCT01338493|156829|P1|6 Months Follow up|Lost to Follow-up|11
39572|NCT01338493|156829|P1|Discharge|Missed visit|1
39573|NCT01338493|156829|P1|Discharge|Death|1
39574|NCT01338493|156829|P1|Enrolled|Patient not implanted|4
39575|NCT01338493|156829|P1|Enrolled|Withdrawal by Subject|1
39576|NCT01338025|156836|P2|Overall Study|Found ineligible after starting|0
39577|NCT01338025|156837|P1|Overall Study|Found ineligible after starting|1
39578|NCT01338025|156836|P2|Overall Study|Withdrawal by Subject|2
39579|NCT01338025|156837|P1|Overall Study|Withdrawal by Subject|0
39580|NCT01338025|156836|P2|Overall Study|Unexpected closure of study|9
39581|NCT01338025|156837|P1|Overall Study|Unexpected closure of study|10
39582|NCT01337960|156852|P3|Overall Study|Withdrawal by Subject|0
39583|NCT01337960|156853|P2|Overall Study|Withdrawal by Subject|0
39584|NCT01337960|156854|P1|Overall Study|Withdrawal by Subject|1
39585|NCT01337960|156852|P3|Overall Study|Lost to Follow-up|0
39586|NCT01337960|156853|P2|Overall Study|Lost to Follow-up|0
39587|NCT01337960|156854|P1|Overall Study|Lost to Follow-up|1
39588|NCT01337674|156887|P4|Treatment Period 2|Withdrawal by Subject|0
39589|NCT01337674|156888|P3|Treatment Period 2|Withdrawal by Subject|1
39590|NCT01337674|156889|P2|Treatment Period 2|Withdrawal by Subject|0
39591|NCT01337674|156890|P1|Treatment Period 2|Withdrawal by Subject|0
39592|NCT01337674|156887|P4|Treatment Period 1|Discontinued due to blood draws|1
39593|NCT01337674|156888|P3|Treatment Period 1|Discontinued due to blood draws|0
39594|NCT01337674|156889|P2|Treatment Period 1|Discontinued due to blood draws|0
39595|NCT01337674|156890|P1|Treatment Period 1|Discontinued due to blood draws|0
39596|NCT01337674|156887|P4|Treatment Period 1|Adverse Event|0
39597|NCT01337674|156888|P3|Treatment Period 1|Adverse Event|0
39598|NCT01337674|156889|P2|Treatment Period 1|Adverse Event|1
39599|NCT01337674|156890|P1|Treatment Period 1|Adverse Event|0
39600|NCT01337635|156908|P2|Overall Study|Lost to Follow-up|1
39601|NCT01337635|156909|P1|Overall Study|Lost to Follow-up|0
39602|NCT01337297|156957|P2|Overall Study|Lost to Follow-up|3
39603|NCT01337297|156958|P1|Overall Study|Lost to Follow-up|1
39604|NCT01337297|156957|P2|Overall Study|They entered to single anodal tDCS|3
39605|NCT01337297|156958|P1|Overall Study|They entered to single anodal tDCS|4
39606|NCT01337167|156966|P2|Toddler Vaccinations|Withdrawal by Subject|0
39607|NCT01337167|156967|P1|Toddler Vaccinations|Withdrawal by Subject|3
39608|NCT01337167|156966|P2|Toddler Vaccinations|Protocol Violation|1
39609|NCT01337167|156967|P1|Toddler Vaccinations|Protocol Violation|0
39610|NCT01337167|156966|P2|Toddler Vaccinations|Lost to Follow-up|12
39611|NCT01337167|156967|P1|Toddler Vaccinations|Lost to Follow-up|11
39612|NCT01337167|156966|P2|Interim Period|Other protocol criterion not met|1
39613|NCT01337167|156967|P1|Interim Period|Other protocol criterion not met|0
39614|NCT01337167|156966|P2|Interim Period|Withdrawal by Subject|10
39615|NCT01337167|156967|P1|Interim Period|Withdrawal by Subject|18
39616|NCT01337167|156966|P2|Interim Period|Protocol Violation|3
39617|NCT01337167|156967|P1|Interim Period|Protocol Violation|5
39618|NCT01337167|156966|P2|Interim Period|Physician Decision|3
39619|NCT01337167|156967|P1|Interim Period|Physician Decision|6
39620|NCT01337167|156966|P2|Interim Period|Non-compliance with study drug|0
39621|NCT01337167|156967|P1|Interim Period|Non-compliance with study drug|1
39622|NCT01337167|156966|P2|Interim Period|Lost to Follow-up|23
39623|NCT01337167|156967|P1|Interim Period|Lost to Follow-up|51
39624|NCT01337167|156966|P2|Infant Series|Randomized but not vaccinated|3
39625|NCT01337167|156967|P1|Infant Series|Randomized but not vaccinated|5
39626|NCT01337167|156966|P2|Infant Series|Withdrawal by Subject|4
39627|NCT01337167|156967|P1|Infant Series|Withdrawal by Subject|15
39628|NCT01337167|156966|P2|Infant Series|Protocol Violation|9
39629|NCT01337167|156967|P1|Infant Series|Protocol Violation|22
39630|NCT01337167|156966|P2|Infant Series|Physician Decision|1
39631|NCT01337167|156967|P1|Infant Series|Physician Decision|3
39632|NCT01337167|156966|P2|Infant Series|Non-compliance with study drug|1
39633|NCT01337167|156967|P1|Infant Series|Non-compliance with study drug|2
39634|NCT01337167|156966|P2|Infant Series|Lost to Follow-up|7
39635|NCT01337167|156967|P1|Infant Series|Lost to Follow-up|13
39636|NCT01337167|156966|P2|Infant Series|Death|1
39637|NCT01337167|156967|P1|Infant Series|Death|1
39638|NCT01337167|156966|P2|Infant Series|Adverse Event|1
39639|NCT01337167|156967|P1|Infant Series|Adverse Event|1
39640|NCT01337115|157035|P2|Overall Study|Protocol Violation|0
39641|NCT01337115|157036|P1|Overall Study|Protocol Violation|2
39642|NCT01337050|157055|P3|Overall Study|Participants refused further follow-up|7
39643|NCT01337050|157056|P2|Overall Study|Participants refused further follow-up|7
39644|NCT01337050|157057|P1|Overall Study|Participants refused further follow-up|0
39645|NCT01337050|157055|P3|Overall Study|Unspecified|8
39646|NCT01337050|157056|P2|Overall Study|Unspecified|6
39647|NCT01337050|157057|P1|Overall Study|Unspecified|4
39648|NCT01337050|157055|P3|Overall Study|Death|4
39649|NCT01337050|157056|P2|Overall Study|Death|0
39650|NCT01337050|157057|P1|Overall Study|Death|0
39651|NCT01336738|157120|P5|Overall Study|Unspecified|4
39652|NCT01336738|157121|P4|Overall Study|Unspecified|3
39653|NCT01336738|157122|P3|Overall Study|Unspecified|2
39654|NCT01336738|157123|P2|Overall Study|Unspecified|3
39655|NCT01336738|157124|P1|Overall Study|Unspecified|3
39656|NCT01336738|157120|P5|Overall Study|Withdrawal by Subject|1
39657|NCT01336738|157121|P4|Overall Study|Withdrawal by Subject|1
39658|NCT01336738|157122|P3|Overall Study|Withdrawal by Subject|2
39659|NCT01336738|157123|P2|Overall Study|Withdrawal by Subject|0
39660|NCT01336738|157124|P1|Overall Study|Withdrawal by Subject|2
39661|NCT01336738|157120|P5|Overall Study|Protocol Violation|0
39662|NCT01336738|157121|P4|Overall Study|Protocol Violation|0
39663|NCT01336738|157122|P3|Overall Study|Protocol Violation|0
39664|NCT01336738|157123|P2|Overall Study|Protocol Violation|1
39665|NCT01336738|157124|P1|Overall Study|Protocol Violation|0
39666|NCT01336738|157120|P5|Overall Study|Did not meet entrance criteria|0
39667|NCT01336738|157121|P4|Overall Study|Did not meet entrance criteria|0
39668|NCT01336738|157122|P3|Overall Study|Did not meet entrance criteria|0
39669|NCT01336738|157123|P2|Overall Study|Did not meet entrance criteria|1
39670|NCT01336738|157124|P1|Overall Study|Did not meet entrance criteria|0
39671|NCT01336738|157120|P5|Overall Study|Lost to Follow-up|2
39672|NCT01336738|157121|P4|Overall Study|Lost to Follow-up|2
39673|NCT01336738|157122|P3|Overall Study|Lost to Follow-up|2
39674|NCT01336738|157123|P2|Overall Study|Lost to Follow-up|1
39675|NCT01336738|157124|P1|Overall Study|Lost to Follow-up|2
39676|NCT01336738|157120|P5|Overall Study|Adverse Event|3
39677|NCT01336738|157121|P4|Overall Study|Adverse Event|1
39678|NCT01336738|157122|P3|Overall Study|Adverse Event|2
39679|NCT01336738|157123|P2|Overall Study|Adverse Event|3
39680|NCT01336738|157124|P1|Overall Study|Adverse Event|0
39681|NCT01336712|157166|P1|Overall Study|Lack of Efficacy|1
39682|NCT01336712|157166|P1|Overall Study|Death|2
39683|NCT01336647|157179|P3|Overall Study|Lost to Follow-up|3
39684|NCT01336647|157180|P2|Overall Study|Lost to Follow-up|1
39685|NCT01336647|157181|P1|Overall Study|Lost to Follow-up|4
39686|NCT01336608|157195|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
39687|NCT01336608|157196|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
39688|NCT01336608|157197|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
39689|NCT01336608|157198|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
39690|NCT01336608|157195|P4|24-week, Double-blind Treatment Period|Physician Decision|1
39691|NCT01336608|157196|P3|24-week, Double-blind Treatment Period|Physician Decision|1
39692|NCT01336608|157197|P2|24-week, Double-blind Treatment Period|Physician Decision|3
39693|NCT01336608|157198|P1|24-week, Double-blind Treatment Period|Physician Decision|0
39694|NCT01336608|157195|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
39695|NCT01336608|157196|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
39696|NCT01336608|157197|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
39697|NCT01336608|157198|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
39698|NCT01336608|157195|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
39699|NCT01336608|157196|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
39700|NCT01336608|157197|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
39701|NCT01336608|157198|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
39702|NCT01336608|157195|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
39703|NCT01336608|157196|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
39704|NCT01336608|157197|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
39782|NCT01335698|157336|P4|Treatment Stage 2|Continuing treatment|19
39705|NCT01336608|157198|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
39706|NCT01336608|157195|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
39707|NCT01336608|157196|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
39708|NCT01336608|157197|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
39709|NCT01336608|157198|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
39710|NCT01336608|157195|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
39711|NCT01336608|157196|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
39712|NCT01336608|157197|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
39713|NCT01336608|157198|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
39714|NCT01336608|157195|P4|24-week, Double-blind Treatment Period|Adverse Event|7
39715|NCT01336608|157196|P3|24-week, Double-blind Treatment Period|Adverse Event|6
39716|NCT01336608|157197|P2|24-week, Double-blind Treatment Period|Adverse Event|8
39717|NCT01336608|157198|P1|24-week, Double-blind Treatment Period|Adverse Event|0
39718|NCT01336608|157195|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
39719|NCT01336608|157196|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
39720|NCT01336608|157197|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
39721|NCT01336608|157198|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
39722|NCT01336608|157195|P4|2-week, Single-blind Run-In Period|Physician Decision|0
39723|NCT01336608|157196|P3|2-week, Single-blind Run-In Period|Physician Decision|0
39724|NCT01336608|157197|P2|2-week, Single-blind Run-In Period|Physician Decision|0
39725|NCT01336608|157198|P1|2-week, Single-blind Run-In Period|Physician Decision|1
39726|NCT01336608|157195|P4|2-week, Single-blind Run-In Period|Adverse Event|0
39727|NCT01336608|157196|P3|2-week, Single-blind Run-In Period|Adverse Event|0
39728|NCT01336608|157197|P2|2-week, Single-blind Run-In Period|Adverse Event|0
39729|NCT01336608|157198|P1|2-week, Single-blind Run-In Period|Adverse Event|1
39730|NCT01336608|157195|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
39731|NCT01336608|157196|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
39732|NCT01336608|157197|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
39733|NCT01336608|157198|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
39734|NCT01336608|157195|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
39735|NCT01336608|157196|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
39736|NCT01336608|157197|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
39737|NCT01336608|157198|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
39738|NCT01336569|157212|P1|Overall Study|Lost to Follow-up|4
39739|NCT01336205|157235|P2|Overall Study|Did not receive treatment|0
39740|NCT01336205|157236|P1|Overall Study|Did not receive treatment|4
39741|NCT01336205|157235|P2|Overall Study|Withdrawal by Subject|38
39742|NCT01336205|157236|P1|Overall Study|Withdrawal by Subject|72
39743|NCT01336205|157235|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
39744|NCT01336205|157236|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
39745|NCT01336205|157235|P2|Overall Study|Death|1
39746|NCT01336205|157236|P1|Overall Study|Death|1
39747|NCT01336205|157235|P2|Overall Study|Adverse Event|6
39748|NCT01336205|157236|P1|Overall Study|Adverse Event|56
39749|NCT01336205|157235|P2|Overall Study|Severe noncompliance with protocol|2
39750|NCT01336205|157236|P1|Overall Study|Severe noncompliance with protocol|9
39751|NCT01336205|157235|P2|Overall Study|Lack of Efficacy|0
39752|NCT01336205|157236|P1|Overall Study|Lack of Efficacy|4
39753|NCT01336205|157235|P2|Overall Study|Study-Specific Withdrawal Criteria|7
39754|NCT01336205|157236|P1|Overall Study|Study-Specific Withdrawal Criteria|16
39755|NCT01336205|157235|P2|Overall Study|Lost to Follow-up|20
39756|NCT01336205|157236|P1|Overall Study|Lost to Follow-up|40
39757|NCT01336205|157235|P2|Overall Study|Other|9
39758|NCT01336205|157236|P1|Overall Study|Other|22
39759|NCT01335997|157263|P2|Period III|Lost to Follow-up|0
39760|NCT01335997|157264|P1|Period III|Lost to Follow-up|1
39761|NCT01335997|157263|P2|Period III|Protocol Violation|1
39762|NCT01335997|157264|P1|Period III|Protocol Violation|0
39763|NCT01335997|157263|P2|Period III|Study Terminated by Sponsor|76
39764|NCT01335997|157264|P1|Period III|Study Terminated by Sponsor|77
39765|NCT01335997|157263|P2|Period III|Adverse Event|2
39766|NCT01335997|157264|P1|Period III|Adverse Event|0
39767|NCT01335997|157263|P2|Period I and II|Physician Decision|1
39768|NCT01335997|157264|P1|Period I and II|Physician Decision|2
39769|NCT01335997|157263|P2|Period I and II|Protocol Violation|10
39770|NCT01335997|157264|P1|Period I and II|Protocol Violation|9
39771|NCT01335997|157263|P2|Period I and II|Study Terminated by Sponsor|415
39772|NCT01335997|157264|P1|Period I and II|Study Terminated by Sponsor|406
39773|NCT01335997|157263|P2|Period I and II|Withdrawal by Subject|4
39774|NCT01335997|157264|P1|Period I and II|Withdrawal by Subject|9
39775|NCT01335997|157263|P2|Period I and II|Lost to Follow-up|5
39776|NCT01335997|157264|P1|Period I and II|Lost to Follow-up|3
39777|NCT01335997|157263|P2|Period I and II|Noncompliance with Study Drug|1
39778|NCT01335997|157264|P1|Period I and II|Noncompliance with Study Drug|1
39779|NCT01335997|157263|P2|Period I and II|Adverse Event|43
39780|NCT01335997|157264|P1|Period I and II|Adverse Event|63
39781|NCT01335698|157335|P5|Treatment Stage 2|Continuing treatment|6
39783|NCT01335698|157337|P3|Treatment Stage 2|Continuing treatment|13
39784|NCT01335698|157338|P2|Treatment Stage 2|Continuing treatment|3
39785|NCT01335698|157339|P1|Treatment Stage 2|Continuing treatment|11
39786|NCT01335698|157335|P5|Treatment Stage 2|Poor compliance/noncompliance|0
39787|NCT01335698|157336|P4|Treatment Stage 2|Poor compliance/noncompliance|3
39788|NCT01335698|157337|P3|Treatment Stage 2|Poor compliance/noncompliance|0
39789|NCT01335698|157338|P2|Treatment Stage 2|Poor compliance/noncompliance|0
39790|NCT01335698|157339|P1|Treatment Stage 2|Poor compliance/noncompliance|1
39791|NCT01335698|157335|P5|Treatment Stage 2|Withdrawal by Subject|0
39792|NCT01335698|157336|P4|Treatment Stage 2|Withdrawal by Subject|0
39793|NCT01335698|157337|P3|Treatment Stage 2|Withdrawal by Subject|0
39794|NCT01335698|157338|P2|Treatment Stage 2|Withdrawal by Subject|0
39795|NCT01335698|157339|P1|Treatment Stage 2|Withdrawal by Subject|1
39796|NCT01335698|157335|P5|Treatment Stage 2|Adverse Event|0
39797|NCT01335698|157336|P4|Treatment Stage 2|Adverse Event|1
39798|NCT01335698|157337|P3|Treatment Stage 2|Adverse Event|0
39799|NCT01335698|157338|P2|Treatment Stage 2|Adverse Event|0
39800|NCT01335698|157339|P1|Treatment Stage 2|Adverse Event|0
39801|NCT01335698|157335|P5|Treatment Stage 2|Lack of Efficacy|0
39802|NCT01335698|157336|P4|Treatment Stage 2|Lack of Efficacy|1
39803|NCT01335698|157337|P3|Treatment Stage 2|Lack of Efficacy|3
39804|NCT01335698|157338|P2|Treatment Stage 2|Lack of Efficacy|1
39805|NCT01335698|157339|P1|Treatment Stage 2|Lack of Efficacy|2
39806|NCT01335698|157335|P5|Treatment Stage 1|Not specified|0
39807|NCT01335698|157336|P4|Treatment Stage 1|Not specified|1
39808|NCT01335698|157337|P3|Treatment Stage 1|Not specified|0
39809|NCT01335698|157338|P2|Treatment Stage 1|Not specified|0
39810|NCT01335698|157339|P1|Treatment Stage 1|Not specified|1
39811|NCT01335698|157335|P5|Treatment Stage 1|No longer meets study criteria|0
39812|NCT01335698|157336|P4|Treatment Stage 1|No longer meets study criteria|1
39813|NCT01335698|157337|P3|Treatment Stage 1|No longer meets study criteria|0
39814|NCT01335698|157338|P2|Treatment Stage 1|No longer meets study criteria|1
39815|NCT01335698|157339|P1|Treatment Stage 1|No longer meets study criteria|1
39816|NCT01335698|157335|P5|Treatment Stage 1|Poor compliance/noncompliance|0
39817|NCT01335698|157336|P4|Treatment Stage 1|Poor compliance/noncompliance|2
39818|NCT01335698|157337|P3|Treatment Stage 1|Poor compliance/noncompliance|0
39819|NCT01335698|157338|P2|Treatment Stage 1|Poor compliance/noncompliance|1
39820|NCT01335698|157339|P1|Treatment Stage 1|Poor compliance/noncompliance|0
39821|NCT01335698|157335|P5|Treatment Stage 1|Lost to Follow-up|0
39822|NCT01335698|157336|P4|Treatment Stage 1|Lost to Follow-up|0
39823|NCT01335698|157337|P3|Treatment Stage 1|Lost to Follow-up|0
39824|NCT01335698|157338|P2|Treatment Stage 1|Lost to Follow-up|1
39825|NCT01335698|157339|P1|Treatment Stage 1|Lost to Follow-up|1
39826|NCT01335698|157335|P5|Treatment Stage 1|Withdrawal by Subject|0
39827|NCT01335698|157336|P4|Treatment Stage 1|Withdrawal by Subject|1
39828|NCT01335698|157337|P3|Treatment Stage 1|Withdrawal by Subject|0
39829|NCT01335698|157338|P2|Treatment Stage 1|Withdrawal by Subject|2
39830|NCT01335698|157339|P1|Treatment Stage 1|Withdrawal by Subject|1
39831|NCT01335698|157335|P5|Treatment Stage 1|Adverse Event|1
39832|NCT01335698|157336|P4|Treatment Stage 1|Adverse Event|1
39833|NCT01335698|157337|P3|Treatment Stage 1|Adverse Event|2
39834|NCT01335698|157338|P2|Treatment Stage 1|Adverse Event|2
39835|NCT01335698|157339|P1|Treatment Stage 1|Adverse Event|1
39836|NCT01335698|157335|P5|Treatment Stage 1|Lack of Efficacy|1
39837|NCT01335698|157336|P4|Treatment Stage 1|Lack of Efficacy|3
39838|NCT01335698|157337|P3|Treatment Stage 1|Lack of Efficacy|3
39839|NCT01335698|157338|P2|Treatment Stage 1|Lack of Efficacy|1
39840|NCT01335698|157339|P1|Treatment Stage 1|Lack of Efficacy|3
39841|NCT01335477|157397|P2|Overall Study|Reason other than those stated above|2
39842|NCT01335477|157398|P1|Overall Study|Reason other than those stated above|2
39843|NCT01335477|157397|P2|Overall Study|Not treated|2
39844|NCT01335477|157398|P1|Overall Study|Not treated|1
39845|NCT01335477|157397|P2|Overall Study|Consent withdrawn, not due to AE|9
39846|NCT01335477|157398|P1|Overall Study|Consent withdrawn, not due to AE|7
39847|NCT01335477|157397|P2|Overall Study|Lost to Follow-up|2
39848|NCT01335477|157398|P1|Overall Study|Lost to Follow-up|1
39849|NCT01335477|157397|P2|Overall Study|Non compliant with protocol|2
39850|NCT01335477|157398|P1|Overall Study|Non compliant with protocol|0
39851|NCT01335477|157397|P2|Overall Study|Adverse Event|42
39852|NCT01335477|157398|P1|Overall Study|Adverse Event|30
39853|NCT01335464|157462|P2|Overall Study|Reason other than those stated above|1
39854|NCT01335464|157463|P1|Overall Study|Reason other than those stated above|1
39855|NCT01335464|157462|P2|Overall Study|Not treated|0
39856|NCT01335464|157463|P1|Overall Study|Not treated|2
39857|NCT01335464|157462|P2|Overall Study|Consent withdrawn, not due to AE|23
39858|NCT01335464|157463|P1|Overall Study|Consent withdrawn, not due to AE|12
39859|NCT01335464|157462|P2|Overall Study|Non compliant with protocol|0
39860|NCT01335464|157463|P1|Overall Study|Non compliant with protocol|2
39861|NCT01335464|157462|P2|Overall Study|Adverse Event|25
39862|NCT01335464|157463|P1|Overall Study|Adverse Event|15
39863|NCT01334918|157601|P2|Overall Study|Withdrawal by Subject|1
39864|NCT01334918|157602|P1|Overall Study|Withdrawal by Subject|0
39865|NCT01334918|157601|P2|Overall Study|Adverse Event|0
39866|NCT01334918|157602|P1|Overall Study|Adverse Event|2
39867|NCT01334918|157601|P2|Overall Study|Did not receive study drug|0
39868|NCT01334918|157602|P1|Overall Study|Did not receive study drug|6
39869|NCT01334866|157628|P1|Overall Study|medically necessary post-procedure|1
39870|NCT01334866|157628|P1|Overall Study|medically necessary prior to procedure|2
39871|NCT01334866|157628|P1|Overall Study|Physician Decision|3
39872|NCT01334866|157628|P1|Overall Study|Lost to Follow-up|3
39873|NCT01334866|157628|P1|Overall Study|Withdrawal by Subject|10
39874|NCT01334710|157665|P1|Overall Study|Trial was terminated|3
39875|NCT01334606|157669|P1|Overall Study|Study Terminated due to slow enrolment|18
39876|NCT01334554|157677|P2|Overall Study|Adverse Event|2
39877|NCT01334554|157678|P1|Overall Study|Adverse Event|4
39878|NCT01334515|157688|P2|Overall Study|Withdrawal by Subject|1
39879|NCT01334515|157689|P1|Overall Study|Withdrawal by Subject|1
39880|NCT01334515|157688|P2|Overall Study|Physician Decision|1
39881|NCT01334515|157689|P1|Overall Study|Physician Decision|1
39882|NCT01334515|157688|P2|Overall Study|Lack of Efficacy|21
39883|NCT01334515|157689|P1|Overall Study|Lack of Efficacy|8
39884|NCT01334515|157688|P2|Overall Study|Death|0
39885|NCT01334515|157689|P1|Overall Study|Death|1
39886|NCT01334515|157688|P2|Overall Study|Adverse Event|6
39887|NCT01334515|157689|P1|Overall Study|Adverse Event|1
39888|NCT01334125|157718|P2|Overall Study|Lost to Follow-up|3
39889|NCT01334125|157719|P1|Overall Study|Lost to Follow-up|3
39890|NCT01333956|157735|P4|Overall Study|Withdrawal by Subject|0
39891|NCT01333956|157736|P3|Overall Study|Withdrawal by Subject|1
39892|NCT01333956|157737|P2|Overall Study|Withdrawal by Subject|2
39893|NCT01333956|157738|P1|Overall Study|Withdrawal by Subject|0
39894|NCT01333956|157735|P4|Overall Study|Unable to complete study procedure|1
39895|NCT01333956|157736|P3|Overall Study|Unable to complete study procedure|0
39896|NCT01333956|157737|P2|Overall Study|Unable to complete study procedure|0
39897|NCT01333956|157738|P1|Overall Study|Unable to complete study procedure|1
39898|NCT01333956|157735|P4|Overall Study|Lost to Follow-up|1
39899|NCT01333956|157736|P3|Overall Study|Lost to Follow-up|0
39900|NCT01333956|157737|P2|Overall Study|Lost to Follow-up|2
39901|NCT01333956|157738|P1|Overall Study|Lost to Follow-up|1
39902|NCT01333865|157772|P1|Overall Study|Adverse Event|2
39903|NCT01333722|157792|P2|Overall Study|Withdrawal by Subject|1
39904|NCT01333722|157793|P1|Overall Study|Withdrawal by Subject|0
39905|NCT01333722|157792|P2|Overall Study|Lack of Efficacy|2
39906|NCT01333722|157793|P1|Overall Study|Lack of Efficacy|0
39907|NCT01333475|157837|P2|Overall Study|Toxicity|3
39908|NCT01333475|157838|P1|Overall Study|Toxicity|1
39909|NCT01333475|157837|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
39910|NCT01333475|157838|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
39911|NCT01333397|157864|P5|Overall Study|Lost to Follow-up|0
39912|NCT01333397|157865|P4|Overall Study|Lost to Follow-up|1
39913|NCT01333397|157866|P3|Overall Study|Lost to Follow-up|0
39914|NCT01333397|157867|P2|Overall Study|Lost to Follow-up|0
39915|NCT01333397|157868|P1|Overall Study|Lost to Follow-up|1
39916|NCT01333189|157942|P2|Overall Study|Moved from region|1
39917|NCT01333189|157943|P1|Overall Study|Moved from region|0
39918|NCT01333189|157942|P2|Overall Study|Transportation difficulties|1
39919|NCT01333189|157943|P1|Overall Study|Transportation difficulties|0
39920|NCT01333189|157942|P2|Overall Study|Adverse Event|0
39921|NCT01333189|157943|P1|Overall Study|Adverse Event|1
39922|NCT01333189|157942|P2|Overall Study|Time constraints|0
39923|NCT01333189|157943|P1|Overall Study|Time constraints|1
39924|NCT01332994|157971|P1|Overall Study|Not Specified|8
39925|NCT01332994|157971|P1|Overall Study|Administrative Problem|2
39926|NCT01332994|157971|P1|Overall Study|Withdrawal by Subject|15
39927|NCT01332994|157971|P1|Overall Study|Protocol Violation|6
39928|NCT01332994|157971|P1|Overall Study|Lost to Follow-up|4
39929|NCT01332994|157971|P1|Overall Study|Lack of Efficacy|1
39930|NCT01332994|157971|P1|Overall Study|Death|1
39931|NCT01332994|157971|P1|Overall Study|Adverse Event|34
39932|NCT01332318|158158|P4|Overall Study|Protocol Violation|1
39933|NCT01332318|158159|P3|Overall Study|Protocol Violation|1
39934|NCT01332318|158160|P2|Overall Study|Protocol Violation|0
39935|NCT01332318|158161|P1|Overall Study|Protocol Violation|1
39936|NCT01332318|158158|P4|Overall Study|Withdrawal by Subject|1
39937|NCT01332318|158159|P3|Overall Study|Withdrawal by Subject|0
39938|NCT01332318|158160|P2|Overall Study|Withdrawal by Subject|1
39939|NCT01332318|158161|P1|Overall Study|Withdrawal by Subject|1
39940|NCT01332318|158158|P4|Overall Study|Adverse Event|0
39941|NCT01332318|158159|P3|Overall Study|Adverse Event|0
39942|NCT01332318|158160|P2|Overall Study|Adverse Event|3
39943|NCT01332318|158161|P1|Overall Study|Adverse Event|0
39944|NCT01332305|158272|P5|Overall Study|Physician Decision|0
39945|NCT01332305|158273|P4|Overall Study|Physician Decision|1
39946|NCT01332305|158274|P3|Overall Study|Physician Decision|0
39947|NCT01332305|158275|P2|Overall Study|Physician Decision|0
39948|NCT01332305|158276|P1|Overall Study|Physician Decision|0
39949|NCT01332305|158272|P5|Overall Study|Treatment Failure|0
39950|NCT01332305|158273|P4|Overall Study|Treatment Failure|0
39951|NCT01332305|158274|P3|Overall Study|Treatment Failure|0
39952|NCT01332305|158275|P2|Overall Study|Treatment Failure|1
39953|NCT01332305|158276|P1|Overall Study|Treatment Failure|1
39954|NCT01332305|158272|P5|Overall Study|Withdrawal by Sponsor|1
39955|NCT01332305|158273|P4|Overall Study|Withdrawal by Sponsor|1
39956|NCT01332305|158274|P3|Overall Study|Withdrawal by Sponsor|0
39957|NCT01332305|158275|P2|Overall Study|Withdrawal by Sponsor|0
39958|NCT01332305|158276|P1|Overall Study|Withdrawal by Sponsor|1
39959|NCT01332305|158272|P5|Overall Study|Protocol Violation|3
39960|NCT01332305|158273|P4|Overall Study|Protocol Violation|0
39961|NCT01332305|158274|P3|Overall Study|Protocol Violation|1
39962|NCT01332305|158275|P2|Overall Study|Protocol Violation|2
39963|NCT01332305|158276|P1|Overall Study|Protocol Violation|1
39964|NCT01332305|158272|P5|Overall Study|Lost to Follow-up|3
39965|NCT01332305|158273|P4|Overall Study|Lost to Follow-up|2
39966|NCT01332305|158274|P3|Overall Study|Lost to Follow-up|3
39967|NCT01332305|158275|P2|Overall Study|Lost to Follow-up|2
39968|NCT01332305|158276|P1|Overall Study|Lost to Follow-up|0
39969|NCT01332305|158272|P5|Overall Study|Withdrawal by Subject|0
39970|NCT01332305|158273|P4|Overall Study|Withdrawal by Subject|1
39971|NCT01332305|158274|P3|Overall Study|Withdrawal by Subject|4
39972|NCT01332305|158275|P2|Overall Study|Withdrawal by Subject|5
39973|NCT01332305|158276|P1|Overall Study|Withdrawal by Subject|6
39974|NCT01332305|158272|P5|Overall Study|Adverse Event|5
39975|NCT01332305|158273|P4|Overall Study|Adverse Event|3
39976|NCT01332305|158274|P3|Overall Study|Adverse Event|6
39977|NCT01332305|158275|P2|Overall Study|Adverse Event|4
39978|NCT01332305|158276|P1|Overall Study|Adverse Event|1
39979|NCT01332292|158298|P2|Treatment Period 2 (14 Days)|Physician Decision|1
39980|NCT01332292|158299|P1|Treatment Period 2 (14 Days)|Physician Decision|1
39981|NCT01332292|158298|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
39982|NCT01332292|158299|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
39983|NCT01332292|158298|P2|Treatment Period 1 (14 Days)|Adverse Event|0
39984|NCT01332292|158299|P1|Treatment Period 1 (14 Days)|Adverse Event|1
39985|NCT01332227|158390|P2|Overall Study|Patient began prohibited medication|1
39986|NCT01332227|158391|P1|Overall Study|Patient began prohibited medication|0
39987|NCT01332227|158390|P2|Overall Study|Patient moved from area|0
39988|NCT01332227|158391|P1|Overall Study|Patient moved from area|1
39989|NCT01332227|158390|P2|Overall Study|Poor compliance/noncompliance|1
39990|NCT01332227|158391|P1|Overall Study|Poor compliance/noncompliance|1
39991|NCT01332227|158390|P2|Overall Study|Lack of Efficacy|1
39992|NCT01332227|158391|P1|Overall Study|Lack of Efficacy|3
39993|NCT01332227|158390|P2|Overall Study|Lost to Follow-up|0
39994|NCT01332227|158391|P1|Overall Study|Lost to Follow-up|2
39995|NCT01332227|158390|P2|Overall Study|Withdrawal by Subject|1
39996|NCT01332227|158391|P1|Overall Study|Withdrawal by Subject|5
39997|NCT01332227|158390|P2|Overall Study|Adverse Event|1
39998|NCT01332227|158391|P1|Overall Study|Adverse Event|4
39999|NCT01332149|158411|P2|Overall Study|Randomized but not treated|2
40000|NCT01332149|158412|P1|Overall Study|Randomized but not treated|1
40001|NCT01332149|158411|P2|Overall Study|Did not meet entrance criteria|4
40002|NCT01332149|158412|P1|Overall Study|Did not meet entrance criteria|3
40003|NCT01332149|158411|P2|Overall Study|Insufficient clinical response|7
40004|NCT01332149|158412|P1|Overall Study|Insufficient clinical response|4
40005|NCT01332149|158411|P2|Overall Study|Lost to Follow-up|1
40006|NCT01332149|158412|P1|Overall Study|Lost to Follow-up|1
40007|NCT01332149|158411|P2|Overall Study|Withdrawal by Subject|5
40008|NCT01332149|158412|P1|Overall Study|Withdrawal by Subject|4
40009|NCT01332149|158411|P2|Overall Study|Protocol Violation|3
40010|NCT01332149|158412|P1|Overall Study|Protocol Violation|1
40011|NCT01332149|158411|P2|Overall Study|Other unspecified|7
40012|NCT01332149|158412|P1|Overall Study|Other unspecified|5
40013|NCT01332149|158411|P2|Overall Study|Adverse Event|9
40014|NCT01332149|158412|P1|Overall Study|Adverse Event|11
40015|NCT01332019|158490|P2|Overall Study|Adverse Event|22
40016|NCT01332019|158491|P1|Overall Study|Adverse Event|13
40017|NCT01332019|158490|P2|Overall Study|Lost to Follow-up|7
40018|NCT01332019|158491|P1|Overall Study|Lost to Follow-up|4
40019|NCT01332019|158490|P2|Overall Study|Withdrawal by Subject|71
40020|NCT01332019|158491|P1|Overall Study|Withdrawal by Subject|73
40021|NCT01332019|158490|P2|Overall Study|Physician Decision|3
40022|NCT01332019|158491|P1|Overall Study|Physician Decision|4
40023|NCT01332019|158490|P2|Overall Study|Death|1
40024|NCT01332019|158491|P1|Overall Study|Death|2
40025|NCT01332019|158490|P2|Overall Study|Not Specified|18
40026|NCT01332019|158491|P1|Overall Study|Not Specified|16
40027|NCT01332019|158490|P2|Overall Study|Was Not Dosed|0
40028|NCT01332019|158491|P1|Overall Study|Was Not Dosed|1
40029|NCT01331824|158573|P1|Overall Study|Withdrawal by Subject|1
40030|NCT01331824|158573|P1|Overall Study|Disease Progression|9
40031|NCT01331824|158573|P1|Overall Study|Death|1
40032|NCT01331824|158573|P1|Overall Study|Adverse Event|2
40033|NCT01331681|158607|P3|Overall Study|Not Received Study Treatment|2
40034|NCT01331681|158608|P2|Overall Study|Not Received Study Treatment|0
40035|NCT01331681|158609|P1|Overall Study|Not Received Study Treatment|0
40036|NCT01331681|158607|P3|Overall Study|Switching to other therapy|1
40037|NCT01331681|158608|P2|Overall Study|Switching to other therapy|0
40038|NCT01331681|158609|P1|Overall Study|Switching to other therapy|0
40039|NCT01331681|158607|P3|Overall Study|Sponsor decision|0
40040|NCT01331681|158608|P2|Overall Study|Sponsor decision|1
40041|NCT01331681|158609|P1|Overall Study|Sponsor decision|1
40042|NCT01331681|158607|P3|Overall Study|Therapeutic procedure required|0
40043|NCT01331681|158608|P2|Overall Study|Therapeutic procedure required|0
40044|NCT01331681|158609|P1|Overall Study|Therapeutic procedure required|1
40045|NCT01331681|158607|P3|Overall Study|Physician Decision|4
40046|NCT01331681|158608|P2|Overall Study|Physician Decision|0
40047|NCT01331681|158609|P1|Overall Study|Physician Decision|2
40048|NCT01331681|158607|P3|Overall Study|Lost to Follow-up|1
40049|NCT01331681|158608|P2|Overall Study|Lost to Follow-up|4
40050|NCT01331681|158609|P1|Overall Study|Lost to Follow-up|2
40051|NCT01331681|158607|P3|Overall Study|Protocol Violation|0
40052|NCT01331681|158608|P2|Overall Study|Protocol Violation|1
40053|NCT01331681|158609|P1|Overall Study|Protocol Violation|1
40054|NCT01331681|158607|P3|Overall Study|Withdrawal by Subject|15
40055|NCT01331681|158608|P2|Overall Study|Withdrawal by Subject|8
40056|NCT01331681|158609|P1|Overall Study|Withdrawal by Subject|12
40057|NCT01331681|158607|P3|Overall Study|Lack of Efficacy|0
40058|NCT01331681|158608|P2|Overall Study|Lack of Efficacy|1
40059|NCT01331681|158609|P1|Overall Study|Lack of Efficacy|0
40060|NCT01331681|158607|P3|Overall Study|Death|2
40061|NCT01331681|158608|P2|Overall Study|Death|6
40062|NCT01331681|158609|P1|Overall Study|Death|6
40063|NCT01331681|158607|P3|Overall Study|Adverse Event|10
40064|NCT01331681|158608|P2|Overall Study|Adverse Event|13
40065|NCT01331681|158609|P1|Overall Study|Adverse Event|10
40066|NCT01331291|158648|P2|Overall Study|Death|1
40067|NCT01331291|158649|P1|Overall Study|Death|0
40068|NCT01331291|158648|P2|Overall Study|Lack of Efficacy|8
40069|NCT01331291|158649|P1|Overall Study|Lack of Efficacy|2
40070|NCT01331161|158683|P2|Overall Study|Pregnancy|1
40071|NCT01331161|158684|P1|Overall Study|Pregnancy|0
40072|NCT01331161|158683|P2|Overall Study|Lost to Follow-up|1
40073|NCT01331161|158684|P1|Overall Study|Lost to Follow-up|0
40074|NCT01331161|158683|P2|Overall Study|Physician Decision|0
40075|NCT01331161|158684|P1|Overall Study|Physician Decision|1
40076|NCT01331109|158692|P1|Overall Study|Study Terminated by Sponsor|38
40077|NCT01331109|158692|P1|Overall Study|Lost to Follow-up|1
40078|NCT01331109|158692|P1|Overall Study|Withdrawal by Subject|7
40079|NCT01331109|158692|P1|Overall Study|Protocol Violation|3
40080|NCT01331109|158692|P1|Overall Study|Lack of Efficacy|2
40081|NCT01331109|158692|P1|Overall Study|Adverse Event|6
40082|NCT01331005|158704|P2|Overall Study|Withdrawal by Subject|3
40083|NCT01331005|158705|P1|Overall Study|Withdrawal by Subject|2
40084|NCT01331005|158704|P2|Overall Study|Lost to Follow-up|1
40085|NCT01331005|158705|P1|Overall Study|Lost to Follow-up|2
40086|NCT01330914|158711|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
40087|NCT01330914|158711|P1|Overall Study|Withdrawal by Subject|4
40088|NCT01330628|158717|P2|Overall Study|Didn't receive study treatment|0
40089|NCT01330628|158718|P1|Overall Study|Didn't receive study treatment|1
40090|NCT01330628|158717|P2|Overall Study|Withdrawn|6
40091|NCT01330628|158718|P1|Overall Study|Withdrawn|18
40092|NCT01330628|158717|P2|Overall Study|Adverse Event|25
40093|NCT01330628|158718|P1|Overall Study|Adverse Event|44
40094|NCT01330628|158717|P2|Overall Study|Lost to Follow-up|6
40095|NCT01330628|158718|P1|Overall Study|Lost to Follow-up|5
40096|NCT01330628|158717|P2|Overall Study|Death|3
40097|NCT01330628|158718|P1|Overall Study|Death|2
40098|NCT01330433|158728|P2|Overall Study|Lost to Follow-up|0
40099|NCT01330433|158729|P1|Overall Study|Lost to Follow-up|1
40100|NCT01330433|158728|P2|Overall Study|Death|3
40101|NCT01330433|158729|P1|Overall Study|Death|1
40102|NCT01330381|158768|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
40103|NCT01330381|158769|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
40104|NCT01330381|158770|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
40105|NCT01330381|158768|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
40106|NCT01330381|158769|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
40107|NCT01330381|158770|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
40108|NCT01330381|158768|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
40109|NCT01330381|158769|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
40110|NCT01330381|158770|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
40111|NCT01330381|158768|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
40112|NCT01330381|158769|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
40113|NCT01330381|158770|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
40114|NCT01330381|158768|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
40115|NCT01330381|158769|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
40116|NCT01330381|158770|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
40117|NCT01330381|158768|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
40118|NCT01330381|158769|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
40119|NCT01330381|158770|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
40120|NCT01330381|158768|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
40121|NCT01330381|158769|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
40122|NCT01330381|158770|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
40123|NCT01330381|158768|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
40124|NCT01330381|158769|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
40125|NCT01330381|158770|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
40126|NCT01330381|158768|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
40127|NCT01330381|158769|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
40128|NCT01330381|158770|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
40129|NCT01330381|158768|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
40130|NCT01330381|158769|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
40131|NCT01330381|158770|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
40132|NCT01330316|158831|P2|Overall Study|other than above|1
40133|NCT01330316|158832|P1|Overall Study|other than above|0
40134|NCT01330316|158831|P2|Overall Study|Withdrawal by Subject|1
40135|NCT01330316|158832|P1|Overall Study|Withdrawal by Subject|0
40136|NCT01330316|158831|P2|Overall Study|Lost to Follow-up|1
40137|NCT01330316|158832|P1|Overall Study|Lost to Follow-up|0
40138|NCT01330316|158831|P2|Overall Study|Lack of Efficacy|10
40139|NCT01330316|158832|P1|Overall Study|Lack of Efficacy|0
40140|NCT01330316|158831|P2|Overall Study|Adverse Event|2
40141|NCT01330316|158832|P1|Overall Study|Adverse Event|2
40142|NCT01330303|158868|P2|Period 1|Withdrawal by Subject|1
40143|NCT01330303|158869|P1|Period 1|Withdrawal by Subject|0
40144|NCT01330303|158868|P2|Period 1|Protocol Violation|1
40145|NCT01330303|158869|P1|Period 1|Protocol Violation|0
40146|NCT01330303|158868|P2|Period 1|Adverse Event|0
40147|NCT01330303|158869|P1|Period 1|Adverse Event|1
40148|NCT01330108|158903|P1|Overall Study|Withdrawal by Subject|4
40149|NCT01330030|158910|P2|Overall Study|Lost to Follow-up|17
40150|NCT01330030|158911|P1|Overall Study|Lost to Follow-up|16
40151|NCT01330017|158922|P5|Overall Study|Unknown Reason|2
40152|NCT01330017|158923|P4|Overall Study|Unknown Reason|7
40153|NCT01330017|158924|P3|Overall Study|Unknown Reason|5
40154|NCT01330017|158925|P2|Overall Study|Unknown Reason|3
40155|NCT01330017|158926|P1|Overall Study|Unknown Reason|5
40156|NCT01330017|158922|P5|Overall Study|Protocol Violation|0
40157|NCT01330017|158923|P4|Overall Study|Protocol Violation|1
40158|NCT01330017|158924|P3|Overall Study|Protocol Violation|0
40159|NCT01330017|158925|P2|Overall Study|Protocol Violation|0
40160|NCT01330017|158926|P1|Overall Study|Protocol Violation|0
40161|NCT01330017|158922|P5|Overall Study|Lost to Follow-up|0
40162|NCT01330017|158923|P4|Overall Study|Lost to Follow-up|0
40163|NCT01330017|158924|P3|Overall Study|Lost to Follow-up|1
40164|NCT01330017|158925|P2|Overall Study|Lost to Follow-up|0
40165|NCT01330017|158926|P1|Overall Study|Lost to Follow-up|0
40166|NCT01330017|158922|P5|Overall Study|Withdrawal by Subject|1
40167|NCT01330017|158923|P4|Overall Study|Withdrawal by Subject|0
40168|NCT01330017|158924|P3|Overall Study|Withdrawal by Subject|1
40169|NCT01330017|158925|P2|Overall Study|Withdrawal by Subject|0
40170|NCT01330017|158926|P1|Overall Study|Withdrawal by Subject|0
40171|NCT01330017|158922|P5|Overall Study|Adverse Event|0
40172|NCT01330017|158923|P4|Overall Study|Adverse Event|4
40173|NCT01330017|158924|P3|Overall Study|Adverse Event|1
40174|NCT01330017|158925|P2|Overall Study|Adverse Event|1
40175|NCT01330017|158926|P1|Overall Study|Adverse Event|0
40176|NCT01329978|158975|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
40177|NCT01329978|158976|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
40178|NCT01329978|158977|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
40179|NCT01329978|158978|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
40180|NCT01329978|158979|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
40181|NCT01329978|158975|P5|Rerandomization Treatment Period|Lost to Follow-up|3
40182|NCT01329978|158976|P4|Rerandomization Treatment Period|Lost to Follow-up|5
40183|NCT01329978|158977|P3|Rerandomization Treatment Period|Lost to Follow-up|0
40184|NCT01329978|158978|P2|Rerandomization Treatment Period|Lost to Follow-up|0
40185|NCT01329978|158979|P1|Rerandomization Treatment Period|Lost to Follow-up|0
40186|NCT01329978|158975|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
40187|NCT01329978|158976|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
40188|NCT01329978|158977|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
40189|NCT01329978|158978|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
40190|NCT01329978|158979|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
40191|NCT01329978|158975|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
40192|NCT01329978|158976|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
40193|NCT01329978|158977|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
40194|NCT01329978|158978|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
40195|NCT01329978|158979|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
40196|NCT01329978|158975|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
40197|NCT01329978|158976|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
40198|NCT01329978|158977|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
40199|NCT01329978|158978|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
40200|NCT01329978|158979|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
40201|NCT01329978|158975|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
40202|NCT01329978|158976|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
40203|NCT01329978|158977|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
40204|NCT01329978|158978|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
40205|NCT01329978|158979|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
40206|NCT01329978|158975|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
40207|NCT01329978|158976|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
40208|NCT01329978|158977|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
40209|NCT01329978|158978|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
40210|NCT01329978|158979|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
40211|NCT01329939|159053|P4|Overall Study|Adverse Event|3
40212|NCT01329939|159054|P3|Overall Study|Adverse Event|0
40213|NCT01329939|159055|P2|Overall Study|Adverse Event|0
40214|NCT01329939|159056|P1|Overall Study|Adverse Event|0
40215|NCT01329939|159053|P4|Overall Study|Withdrawal by Subject|0
40216|NCT01329939|159054|P3|Overall Study|Withdrawal by Subject|0
40217|NCT01329939|159055|P2|Overall Study|Withdrawal by Subject|1
40218|NCT01329939|159056|P1|Overall Study|Withdrawal by Subject|0
40219|NCT01329939|159053|P4|Overall Study|Lost to Follow-up|2
40220|NCT01329939|159054|P3|Overall Study|Lost to Follow-up|1
40221|NCT01329939|159055|P2|Overall Study|Lost to Follow-up|0
40222|NCT01329939|159056|P1|Overall Study|Lost to Follow-up|3
40223|NCT01329562|159120|P2|Overall Study|Physician Decision|1
40224|NCT01329562|159121|P1|Overall Study|Physician Decision|0
40225|NCT01329562|159120|P2|Overall Study|Subject withdrew due to personal issues.|2
40226|NCT01329562|159121|P1|Overall Study|Subject withdrew due to personal issues.|3
40227|NCT01329562|159120|P2|Overall Study|Lost to Follow-up|1
40228|NCT01329562|159121|P1|Overall Study|Lost to Follow-up|1
40229|NCT01329562|159120|P2|Overall Study|Protocol Violation|3
40230|NCT01329562|159121|P1|Overall Study|Protocol Violation|5
40231|NCT01329549|159170|P1|Overall Study|Adverse Event|1
40232|NCT01329549|159170|P1|Overall Study|Withdrawal by Subject|1
40233|NCT01329419|159181|P1|Overall Study|Protocol Violation|235
40234|NCT01329263|159189|P2|Overall Study|Withdrawal by Subject|2
40235|NCT01329263|159190|P1|Overall Study|Withdrawal by Subject|1
40236|NCT01329263|159189|P2|Overall Study|Lost to Follow-up|21
40237|NCT01329263|159190|P1|Overall Study|Lost to Follow-up|4
40238|NCT01329029|159227|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
40239|NCT01329029|159228|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
40240|NCT01329029|159227|P2|Overall Study|Lost to Follow-up|5
40241|NCT01329029|159228|P1|Overall Study|Lost to Follow-up|8
40242|NCT01329029|159227|P2|Overall Study|Physician Decision|13
40243|NCT01329029|159228|P1|Overall Study|Physician Decision|16
40244|NCT01329029|159227|P2|Overall Study|COPD Exacerbation|18
40245|NCT01329029|159228|P1|Overall Study|COPD Exacerbation|11
40246|NCT01329029|159227|P2|Overall Study|Other|20
40247|NCT01329029|159228|P1|Overall Study|Other|14
40248|NCT01329029|159227|P2|Overall Study|Death|19
40249|NCT01329029|159228|P1|Overall Study|Death|16
40250|NCT01329029|159227|P2|Overall Study|Adverse Event|29
40251|NCT01329029|159228|P1|Overall Study|Adverse Event|82
40252|NCT01329029|159227|P2|Overall Study|Withdrawal by Subject|87
40253|NCT01329029|159228|P1|Overall Study|Withdrawal by Subject|117
40254|NCT01328951|159318|P2|Overall Study|Not Specified|6
40255|NCT01328951|159319|P1|Overall Study|Not Specified|11
40256|NCT01328951|159318|P2|Overall Study|Study Closed by the Sponsor|31
40257|NCT01328951|159319|P1|Overall Study|Study Closed by the Sponsor|36
40258|NCT01328951|159318|P2|Overall Study|Withdrawal by Subject|6
40259|NCT01328951|159319|P1|Overall Study|Withdrawal by Subject|6
40260|NCT01328951|159318|P2|Overall Study|Lost to Follow-up|7
40261|NCT01328951|159319|P1|Overall Study|Lost to Follow-up|6
40262|NCT01328951|159318|P2|Overall Study|Death|258
40263|NCT01328951|159319|P1|Overall Study|Death|243
40264|NCT01328951|159318|P2|Overall Study|Adverse Event|0
40265|NCT01328951|159319|P1|Overall Study|Adverse Event|2
40266|NCT01328951|159318|P2|Overall Study|Disease Progression|14
40267|NCT01328951|159319|P1|Overall Study|Disease Progression|17
40268|NCT01328756|159379|P1|Overall Study|Unspecified|29
40269|NCT01328756|159379|P1|Overall Study|Lost to Follow-up|5
40270|NCT01328756|159379|P1|Overall Study|Withdrawal by Subject|41
40271|NCT01328756|159379|P1|Overall Study|Lack of Efficacy|5
40272|NCT01328756|159379|P1|Overall Study|Adverse Event|39
40273|NCT01328756|159379|P1|Overall Study|Protocol Violation|4
40274|NCT01328717|159396|P1|Overall Study|Adverse Event|1
40275|NCT01328574|159401|P1|Overall Study|Refused further treatment|1
40276|NCT01328444|159413|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
40277|NCT01328444|159414|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
40278|NCT01328444|159415|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
40279|NCT01328444|159416|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
40280|NCT01328444|159417|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
40281|NCT01328444|159418|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
40282|NCT01328444|159413|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
40283|NCT01328444|159414|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
40284|NCT01328444|159415|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
40285|NCT01328444|159416|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
40286|NCT01328444|159417|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
40287|NCT01328444|159418|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
40288|NCT01328444|159413|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
40289|NCT01328444|159414|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
40290|NCT01328444|159415|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
40291|NCT01328444|159416|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
40292|NCT01328444|159417|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
40293|NCT01328444|159418|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
40294|NCT01328444|159413|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
40295|NCT01328444|159414|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
40296|NCT01328444|159415|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
40297|NCT01328444|159416|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
40298|NCT01328444|159417|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
40299|NCT01328444|159418|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
40300|NCT01328444|159413|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
40301|NCT01328444|159414|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
40302|NCT01328444|159415|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
40303|NCT01328444|159416|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
40304|NCT01328444|159417|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
40305|NCT01328444|159418|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
40306|NCT01328444|159413|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
40307|NCT01328444|159414|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
40308|NCT01328444|159415|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
40309|NCT01328444|159416|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
40310|NCT01328444|159417|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
40311|NCT01328444|159418|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
40312|NCT01328444|159413|P6|Washout Period (14 Days)|Withdrawal by Subject|1
40313|NCT01328444|159414|P5|Washout Period (14 Days)|Withdrawal by Subject|0
40314|NCT01328444|159415|P4|Washout Period (14 Days)|Withdrawal by Subject|0
40315|NCT01328444|159416|P3|Washout Period (14 Days)|Withdrawal by Subject|0
40316|NCT01328444|159417|P2|Washout Period (14 Days)|Withdrawal by Subject|0
40317|NCT01328444|159418|P1|Washout Period (14 Days)|Withdrawal by Subject|0
40318|NCT01328444|159413|P6|Washout Period (14 Days)|Lack of Efficacy|1
40319|NCT01328444|159414|P5|Washout Period (14 Days)|Lack of Efficacy|0
40320|NCT01328444|159415|P4|Washout Period (14 Days)|Lack of Efficacy|0
40321|NCT01328444|159416|P3|Washout Period (14 Days)|Lack of Efficacy|0
40322|NCT01328444|159417|P2|Washout Period (14 Days)|Lack of Efficacy|0
40323|NCT01328444|159418|P1|Washout Period (14 Days)|Lack of Efficacy|0
40324|NCT01328444|159413|P6|Washout Period (14 Days)|Adverse Event|2
40325|NCT01328444|159414|P5|Washout Period (14 Days)|Adverse Event|1
40326|NCT01328444|159415|P4|Washout Period (14 Days)|Adverse Event|1
40327|NCT01328444|159416|P3|Washout Period (14 Days)|Adverse Event|0
40328|NCT01328444|159417|P2|Washout Period (14 Days)|Adverse Event|1
40329|NCT01328444|159418|P1|Washout Period (14 Days)|Adverse Event|1
40330|NCT01328444|159413|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
40331|NCT01328444|159414|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
40332|NCT01328444|159415|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
40333|NCT01328444|159416|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
40334|NCT01328444|159417|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
40335|NCT01328444|159418|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
40336|NCT01328444|159413|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
40337|NCT01328444|159414|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
40338|NCT01328444|159415|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
40339|NCT01328444|159416|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
40340|NCT01328444|159417|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
40341|NCT01328444|159418|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
40342|NCT01328444|159413|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
40343|NCT01328444|159414|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
40344|NCT01328444|159415|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
40345|NCT01328444|159416|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
40346|NCT01328444|159417|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
40347|NCT01328444|159418|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
40348|NCT01328444|159413|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
40349|NCT01328444|159414|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
40350|NCT01328444|159415|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
40351|NCT01328444|159416|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
40352|NCT01328444|159417|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
40353|NCT01328444|159418|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
40354|NCT01328444|159413|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
40355|NCT01328444|159414|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
40356|NCT01328444|159415|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
40357|NCT01328444|159416|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
40358|NCT01328444|159417|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
40359|NCT01328444|159418|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
40360|NCT01328444|159413|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
40361|NCT01328444|159414|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
40362|NCT01328444|159415|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
40363|NCT01328444|159416|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
40364|NCT01328444|159417|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
40365|NCT01328444|159418|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
40366|NCT01328431|159464|P2|12 Month (12M)|Lost to Follow-up|91
40367|NCT01328431|159465|P1|12 Month (12M)|Lost to Follow-up|82
40368|NCT01328431|159464|P2|12 Month (12M)|Death|6
40369|NCT01328431|159465|P1|12 Month (12M)|Death|2
40370|NCT01328431|159464|P2|3 Month (3M)|Lost to Follow-up|70
40371|NCT01328431|159465|P1|3 Month (3M)|Lost to Follow-up|75
40372|NCT01328431|159464|P2|3 Month (3M)|Death|2
40373|NCT01328431|159465|P1|3 Month (3M)|Death|2
40374|NCT01328431|159464|P2|1 Month (1M)|Lost to Follow-up|58
40375|NCT01328431|159465|P1|1 Month (1M)|Lost to Follow-up|55
40376|NCT01328431|159464|P2|Baseline|Protocol Violation|2
40377|NCT01328431|159465|P1|Baseline|Protocol Violation|0
40378|NCT01328366|159521|P1|Overall Study|Lost to Follow-up|7
40379|NCT01328366|159521|P1|Overall Study|Withdrawal by Subject|2
40380|NCT01328366|159521|P1|Overall Study|Death|1
40381|NCT01328080|159617|P1|Overall Study|Lost to Follow-up|5
40382|NCT01328054|159621|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
40383|NCT01328054|159622|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
40384|NCT01328054|159621|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
40385|NCT01328054|159622|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
40386|NCT01328054|159621|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
40387|NCT01328054|159622|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
40388|NCT01328041|159647|P1|Overall Study|Withdrawal by Subject|7
40389|NCT01328041|159647|P1|Overall Study|Physician Decision|2
40390|NCT01328041|159647|P1|Overall Study|Lost to Follow-up|7
40391|NCT01328041|159647|P1|Overall Study|Protocol Violation|7
40392|NCT01328041|159647|P1|Overall Study|Lack of Efficacy|27
40393|NCT01328041|159647|P1|Overall Study|Adverse Event|7
40394|NCT01327703|159694|P2|Second Treatment Period|Protocol Violation|1
40395|NCT01327703|159695|P1|Second Treatment Period|Protocol Violation|0
40396|NCT01327703|159694|P2|Second Treatment Period|Adverse Event|1
40397|NCT01327703|159695|P1|Second Treatment Period|Adverse Event|1
40398|NCT01327599|159727|P1|Overall Study|Withdrawal of Consent|1
40399|NCT01327599|159727|P1|Overall Study|Could Not Attend Visit|1
40400|NCT01327599|159727|P1|Overall Study|Adverse Event|1
40401|NCT01327547|159737|P2|Overall Study|Continuing in the study|56
40402|NCT01327547|159738|P1|Overall Study|Continuing in the study|56
40403|NCT01327547|159737|P2|Overall Study|Non-compliance with study procedures|0
40404|NCT01327547|159738|P1|Overall Study|Non-compliance with study procedures|1
40405|NCT01327547|159737|P2|Overall Study|Requirement for prohibited medication|0
40406|NCT01327547|159738|P1|Overall Study|Requirement for prohibited medication|2
40407|NCT01327547|159737|P2|Overall Study|Non-compliance - alcohol consumption|1
40408|NCT01327547|159738|P1|Overall Study|Non-compliance - alcohol consumption|0
40409|NCT01327547|159737|P2|Overall Study|Does Not Meet Entrance Criteria|2
40410|NCT01327547|159738|P1|Overall Study|Does Not Meet Entrance Criteria|2
40411|NCT01327547|159737|P2|Overall Study|Withdrawal by Subject|4
40412|NCT01327547|159738|P1|Overall Study|Withdrawal by Subject|2
40413|NCT01327547|159737|P2|Overall Study|Non-Compliance With Study Treatment|1
40414|NCT01327547|159738|P1|Overall Study|Non-Compliance With Study Treatment|0
40415|NCT01327547|159737|P2|Overall Study|Lost to Follow-up|1
40416|NCT01327547|159738|P1|Overall Study|Lost to Follow-up|3
40417|NCT01327547|159737|P2|Overall Study|Death|1
40418|NCT01327547|159738|P1|Overall Study|Death|0
40419|NCT01327547|159737|P2|Overall Study|Adverse Event|1
40420|NCT01327547|159738|P1|Overall Study|Adverse Event|4
40421|NCT01327482|159783|P1|Overall Study|Adverse Event|1
40422|NCT01327339|159788|P1|Overall Study|Protocol Violation|8
40423|NCT01327300|159923|P2|Washout (3 Weeks)|Withdrawal by Subject|0
40424|NCT01327300|159924|P1|Washout (3 Weeks)|Withdrawal by Subject|1
40425|NCT01327053|159942|P2|Overall Study|Untreated|1
40426|NCT01327053|159943|P1|Overall Study|Untreated|0
40427|NCT01327053|159942|P2|Overall Study|Withdrawal by Subject|28
40428|NCT01327053|159943|P1|Overall Study|Withdrawal by Subject|5
40429|NCT01327053|159942|P2|Overall Study|Protocol Violation|1
40430|NCT01327053|159943|P1|Overall Study|Protocol Violation|0
40431|NCT01327053|159942|P2|Overall Study|Progressive Disease|6
40432|NCT01327053|159943|P1|Overall Study|Progressive Disease|15
40433|NCT01327053|159942|P2|Overall Study|Physician Decision|10
40434|NCT01327053|159943|P1|Overall Study|Physician Decision|3
40435|NCT01327053|159942|P2|Overall Study|Non-compliance with study treatment|3
40436|NCT01327053|159943|P1|Overall Study|Non-compliance with study treatment|0
40437|NCT01327053|159942|P2|Overall Study|Lost to Follow-up|4
40438|NCT01327053|159943|P1|Overall Study|Lost to Follow-up|1
40439|NCT01327053|159942|P2|Overall Study|Death|4
40440|NCT01327053|159943|P1|Overall Study|Death|0
40441|NCT01327053|159942|P2|Overall Study|Adverse Event|48
40442|NCT01327053|159943|P1|Overall Study|Adverse Event|16
40443|NCT01326962|159971|P1|Overall Study|Not Specified|2
40444|NCT01326962|159971|P1|Overall Study|Lost to Follow-up|3
40445|NCT01326962|159971|P1|Overall Study|Withdrawal by Subject|1
40446|NCT01326962|159971|P1|Overall Study|Adverse Event|1
40447|NCT01326910|159989|P2|Overall Study|Protocol Violation|1
40448|NCT01326910|159990|P1|Overall Study|Protocol Violation|1
40449|NCT01326910|159989|P2|Overall Study|Withdrawal by Subject|2
40450|NCT01326910|159990|P1|Overall Study|Withdrawal by Subject|3
40451|NCT01326845|160004|P2|Overall Study|Misisng|3
40452|NCT01326845|160005|P1|Overall Study|Misisng|1
40453|NCT01326845|160004|P2|Overall Study|Adverse Event|0
40454|NCT01326845|160005|P1|Overall Study|Adverse Event|1
40455|NCT01326845|160004|P2|Overall Study|Administrative Problems|2
40456|NCT01326845|160005|P1|Overall Study|Administrative Problems|5
40457|NCT01326533|160029|P2|Overall Study|Adverse Event|0
40458|NCT01326533|160030|P1|Overall Study|Adverse Event|1
40459|NCT01326533|160029|P2|Overall Study|Withdrawal by Subject|0
40460|NCT01326533|160030|P1|Overall Study|Withdrawal by Subject|1
40461|NCT01326533|160029|P2|Overall Study|Lost to Follow-up|0
40462|NCT01326533|160030|P1|Overall Study|Lost to Follow-up|2
40463|NCT01326026|160040|P2|Overall Study|Other|3
40464|NCT01326026|160041|P1|Overall Study|Other|3
40465|NCT01326026|160040|P2|Overall Study|Withdrawal Criteria|7
40466|NCT01326026|160041|P1|Overall Study|Withdrawal Criteria|5
40467|NCT01326026|160040|P2|Overall Study|Adverse Event|3
40468|NCT01326026|160041|P1|Overall Study|Adverse Event|4
40469|NCT01325701|160106|P2|Overall Study|Rollerover Extension Study|0
40470|NCT01325701|160107|P1|Overall Study|Rollerover Extension Study|4
40471|NCT01325701|160106|P2|Overall Study|Withdrawal by Subject|1
40472|NCT01325701|160107|P1|Overall Study|Withdrawal by Subject|2
40473|NCT01325701|160106|P2|Overall Study|Physician Decision|2
40474|NCT01325701|160107|P1|Overall Study|Physician Decision|2
40475|NCT01325701|160106|P2|Overall Study|Protocol Violation|0
40476|NCT01325701|160107|P1|Overall Study|Protocol Violation|1
40477|NCT01325701|160106|P2|Overall Study|Adverse Event|0
40478|NCT01325701|160107|P1|Overall Study|Adverse Event|12
40479|NCT01325623|160117|P1|Overall Study|Withdrawal by Subject|3
40480|NCT01325532|160161|P2|Overall Study|Withdrawal by Subject|0
40481|NCT01325532|160162|P1|Overall Study|Withdrawal by Subject|2
40482|NCT01325493|160174|P2|Overall Study|Allergy|0
40483|NCT01325493|160175|P1|Overall Study|Allergy|1
40484|NCT01325493|160174|P2|Overall Study|loss of neuromonitoring signals|2
40485|NCT01325493|160175|P1|Overall Study|loss of neuromonitoring signals|0
40486|NCT01325493|160174|P2|Overall Study|Protocol Violation|1
40487|NCT01325493|160175|P1|Overall Study|Protocol Violation|0
40488|NCT01325428|160187|P1|Part B|Other reason not defined above|1
40489|NCT01325428|160187|P1|Part B|Refused continue taking trial medication|2
40490|NCT01325428|160187|P1|Part A|Other reason not defined above|2
40491|NCT01325428|160187|P1|Part A|Refused continue taking trial medication|2
40492|NCT01325428|160187|P1|Part A|Other adverse event|1
40493|NCT01325428|160187|P1|Part A|Clinical signs, symptoms of progression|2
40494|NCT01325428|160187|P1|Part A|Progressive disease according to RECIST|9
40495|NCT01325350|160207|P5|Overall Study|Did Not Receive Treatment|1
40496|NCT01325350|160208|P4|Overall Study|Did Not Receive Treatment|0
40497|NCT01325350|160209|P3|Overall Study|Did Not Receive Treatment|1
40498|NCT01325350|160210|P2|Overall Study|Did Not Receive Treatment|1
40499|NCT01325350|160211|P1|Overall Study|Did Not Receive Treatment|0
40500|NCT01325350|160207|P5|Overall Study|Withdrawal by Subject|0
40501|NCT01325350|160208|P4|Overall Study|Withdrawal by Subject|1
40502|NCT01325350|160209|P3|Overall Study|Withdrawal by Subject|1
40503|NCT01325350|160210|P2|Overall Study|Withdrawal by Subject|0
40504|NCT01325350|160211|P1|Overall Study|Withdrawal by Subject|0
40505|NCT01325350|160207|P5|Overall Study|Protocol Violation|0
40506|NCT01325350|160208|P4|Overall Study|Protocol Violation|1
40507|NCT01325350|160209|P3|Overall Study|Protocol Violation|0
40508|NCT01325350|160210|P2|Overall Study|Protocol Violation|0
40509|NCT01325350|160211|P1|Overall Study|Protocol Violation|0
40510|NCT01325350|160207|P5|Overall Study|Personal Reasons|3
40511|NCT01325350|160208|P4|Overall Study|Personal Reasons|5
40512|NCT01325350|160209|P3|Overall Study|Personal Reasons|6
40513|NCT01325350|160210|P2|Overall Study|Personal Reasons|1
40514|NCT01325350|160211|P1|Overall Study|Personal Reasons|2
40515|NCT01325350|160207|P5|Overall Study|Lost to Follow-up|5
40516|NCT01325350|160208|P4|Overall Study|Lost to Follow-up|1
40517|NCT01325350|160209|P3|Overall Study|Lost to Follow-up|5
40518|NCT01325350|160210|P2|Overall Study|Lost to Follow-up|0
40519|NCT01325350|160211|P1|Overall Study|Lost to Follow-up|1
40520|NCT01325350|160207|P5|Overall Study|Pregnancy|1
40521|NCT01325350|160208|P4|Overall Study|Pregnancy|0
40522|NCT01325350|160209|P3|Overall Study|Pregnancy|1
40523|NCT01325350|160210|P2|Overall Study|Pregnancy|0
40524|NCT01325350|160211|P1|Overall Study|Pregnancy|0
40525|NCT01325350|160207|P5|Overall Study|Adverse Event|2
40526|NCT01325350|160208|P4|Overall Study|Adverse Event|1
40527|NCT01325350|160209|P3|Overall Study|Adverse Event|3
40528|NCT01325350|160210|P2|Overall Study|Adverse Event|3
40529|NCT01325350|160211|P1|Overall Study|Adverse Event|3
40530|NCT01325337|160253|P5|Overall Study|Withdrawal by Subject|1
40531|NCT01325337|160254|P4|Overall Study|Withdrawal by Subject|0
40532|NCT01325337|160255|P3|Overall Study|Withdrawal by Subject|1
40533|NCT01325337|160256|P2|Overall Study|Withdrawal by Subject|0
40534|NCT01325337|160257|P1|Overall Study|Withdrawal by Subject|1
40535|NCT01325337|160253|P5|Overall Study|Personal Reasons|3
40536|NCT01325337|160254|P4|Overall Study|Personal Reasons|8
40537|NCT01325337|160255|P3|Overall Study|Personal Reasons|4
40538|NCT01325337|160256|P2|Overall Study|Personal Reasons|5
40539|NCT01325337|160257|P1|Overall Study|Personal Reasons|2
40540|NCT01325337|160253|P5|Overall Study|Lost to Follow-up|2
40541|NCT01325337|160254|P4|Overall Study|Lost to Follow-up|1
40542|NCT01325337|160255|P3|Overall Study|Lost to Follow-up|2
40543|NCT01325337|160256|P2|Overall Study|Lost to Follow-up|2
40544|NCT01325337|160257|P1|Overall Study|Lost to Follow-up|2
40545|NCT01325337|160253|P5|Overall Study|Adverse Event|2
40546|NCT01325337|160254|P4|Overall Study|Adverse Event|1
40547|NCT01325337|160255|P3|Overall Study|Adverse Event|2
40548|NCT01325337|160256|P2|Overall Study|Adverse Event|2
40549|NCT01325337|160257|P1|Overall Study|Adverse Event|0
40550|NCT01324947|160340|P1|Overall Study|1 discontinued before starting drug|1
40551|NCT01324947|160340|P1|Overall Study|Withdrawal by Subject|3
40552|NCT01324947|160340|P1|Overall Study|Progressive Disease|50
40553|NCT01324947|160340|P1|Overall Study|Unspecified|3
40554|NCT01324947|160340|P1|Overall Study|Death|10
40555|NCT01324947|160340|P1|Overall Study|Adverse Event|7
40556|NCT01324440|160371|P2|Overall Study|Subject moved|1
40557|NCT01324440|160372|P1|Overall Study|Subject moved|0
40558|NCT01324401|160386|P2|Overall Study|Screen Fail|2
40559|NCT01324401|160387|P1|Overall Study|Screen Fail|0
40560|NCT01324401|160386|P2|Overall Study|Withdrawal by Subject|3
40561|NCT01324401|160387|P1|Overall Study|Withdrawal by Subject|1
40562|NCT01324401|160386|P2|Overall Study|Physician Decision|2
40563|NCT01324401|160387|P1|Overall Study|Physician Decision|0
40564|NCT01324388|160398|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
40565|NCT01324388|160399|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
40566|NCT01324388|160400|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
40567|NCT01324388|160401|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
40568|NCT01324388|160398|P4|Part 2 of Study: First Intervention|Protocol Violation|1
40569|NCT01324388|160399|P3|Part 2 of Study: First Intervention|Protocol Violation|0
40570|NCT01324388|160400|P2|Part 2 of Study: First Intervention|Protocol Violation|0
40571|NCT01324388|160401|P1|Part 2 of Study: First Intervention|Protocol Violation|0
40572|NCT01324388|160398|P4|Part 1 of Study|Physician Decision|0
40573|NCT01324388|160399|P3|Part 1 of Study|Physician Decision|0
40574|NCT01324388|160400|P2|Part 1 of Study|Physician Decision|0
40575|NCT01324388|160401|P1|Part 1 of Study|Physician Decision|1
40576|NCT01324388|160398|P4|Part 1 of Study|Protocol Violation|0
40577|NCT01324388|160399|P3|Part 1 of Study|Protocol Violation|0
40578|NCT01324388|160400|P2|Part 1 of Study|Protocol Violation|2
40579|NCT01324388|160401|P1|Part 1 of Study|Protocol Violation|1
40580|NCT01324388|160398|P4|Part 1 of Study|Adverse Event|0
40581|NCT01324388|160399|P3|Part 1 of Study|Adverse Event|0
40582|NCT01324388|160400|P2|Part 1 of Study|Adverse Event|0
40583|NCT01324388|160401|P1|Part 1 of Study|Adverse Event|2
40584|NCT01324349|160422|P2|Overall Study|Withdrawal by Subject|1
40585|NCT01324349|160423|P1|Overall Study|Withdrawal by Subject|0
40586|NCT01324349|160422|P2|Overall Study|Death|1
40587|NCT01324349|160423|P1|Overall Study|Death|1
40588|NCT01324323|160433|P1|Overall Study|Withdrawal by Subject|1
40589|NCT01324310|160453|P1|Overall Study|Disease Progression|1
40590|NCT01324310|160453|P1|Overall Study|Adverse Event|1
40591|NCT01324271|160473|P2|Overall Study|Physician Decision|0
40592|NCT01324271|160474|P1|Overall Study|Physician Decision|1
40593|NCT01324271|160473|P2|Overall Study|Lost to Follow-up|0
40594|NCT01324271|160474|P1|Overall Study|Lost to Follow-up|3
40595|NCT01324102|160497|P2|Overall Study|illness|6
40596|NCT01324102|160498|P1|Overall Study|illness|1
40597|NCT01323920|160526|P1|Overall Study|Withdrawal by Subject|1
40598|NCT01323920|160526|P1|Overall Study|Death|5
40599|NCT01323790|160567|P3|Overall Study|Severe non-compliance with protocol|2
40600|NCT01323790|160568|P2|Overall Study|Severe non-compliance with protocol|2
40601|NCT01323790|160569|P1|Overall Study|Severe non-compliance with protocol|2
40602|NCT01323790|160567|P3|Overall Study|Did Not Receive Treatment|1
40603|NCT01323790|160568|P2|Overall Study|Did Not Receive Treatment|0
40604|NCT01323790|160569|P1|Overall Study|Did Not Receive Treatment|2
40605|NCT01323790|160567|P3|Overall Study|Withdrawal by Subject|13
40606|NCT01323790|160568|P2|Overall Study|Withdrawal by Subject|20
40607|NCT01323790|160569|P1|Overall Study|Withdrawal by Subject|23
40608|NCT01323790|160567|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
40609|NCT01323790|160568|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
40610|NCT01323790|160569|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
40611|NCT01323790|160567|P3|Overall Study|Adverse Event|12
40612|NCT01323790|160568|P2|Overall Study|Adverse Event|24
40613|NCT01323790|160569|P1|Overall Study|Adverse Event|11
40614|NCT01323790|160567|P3|Overall Study|Lack of Efficacy|3
40615|NCT01323790|160568|P2|Overall Study|Lack of Efficacy|0
40616|NCT01323790|160569|P1|Overall Study|Lack of Efficacy|3
40617|NCT01323790|160567|P3|Overall Study|Study-Specific Withdrawal Criteria|3
40618|NCT01323790|160568|P2|Overall Study|Study-Specific Withdrawal Criteria|3
40619|NCT01323790|160569|P1|Overall Study|Study-Specific Withdrawal Criteria|0
40620|NCT01323790|160567|P3|Overall Study|Lost to Follow-up|9
40621|NCT01323790|160568|P2|Overall Study|Lost to Follow-up|9
40622|NCT01323790|160569|P1|Overall Study|Lost to Follow-up|11
40623|NCT01323790|160567|P3|Overall Study|Other|1
40624|NCT01323790|160568|P2|Overall Study|Other|2
40625|NCT01323790|160569|P1|Overall Study|Other|3
40626|NCT01323673|160609|P2|Overall Study|Withdrawal by Subject|3
40627|NCT01323673|160610|P1|Overall Study|Withdrawal by Subject|2
40628|NCT01323673|160609|P2|Overall Study|Protocol Violation|0
40629|NCT01323673|160610|P1|Overall Study|Protocol Violation|1
40630|NCT01323673|160609|P2|Overall Study|Lost to Follow-up|1
40631|NCT01323673|160610|P1|Overall Study|Lost to Follow-up|0
40632|NCT01323673|160609|P2|Overall Study|Adverse Event|1
40633|NCT01323673|160610|P1|Overall Study|Adverse Event|0
40634|NCT01323660|160630|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
40635|NCT01323660|160631|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
40636|NCT01323660|160632|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
40637|NCT01323660|160633|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
40638|NCT01323660|160634|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
40639|NCT01323660|160635|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
40640|NCT01323660|160630|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
40641|NCT01323660|160631|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
40642|NCT01323660|160632|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
40643|NCT01323660|160633|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
40644|NCT01323660|160634|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
40645|NCT01323660|160635|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
40646|NCT01323660|160630|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
40647|NCT01323660|160631|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
40648|NCT01323660|160632|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
40649|NCT01323660|160633|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
40650|NCT01323660|160634|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
40651|NCT01323660|160635|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
40652|NCT01323660|160630|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
40653|NCT01323660|160631|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
40654|NCT01323660|160632|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
40655|NCT01323660|160633|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
40656|NCT01323660|160634|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
40657|NCT01323660|160635|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
40658|NCT01323660|160630|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
40659|NCT01323660|160631|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
40660|NCT01323660|160632|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
40661|NCT01323660|160633|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
40662|NCT01323660|160634|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
40663|NCT01323660|160635|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
40664|NCT01323660|160630|P6|Washout Period (14 Days)|Lack of Efficacy|2
40665|NCT01323660|160631|P5|Washout Period (14 Days)|Lack of Efficacy|2
40666|NCT01323660|160632|P4|Washout Period (14 Days)|Lack of Efficacy|3
40667|NCT01323660|160633|P3|Washout Period (14 Days)|Lack of Efficacy|1
40668|NCT01323660|160634|P2|Washout Period (14 Days)|Lack of Efficacy|0
40669|NCT01323660|160635|P1|Washout Period (14 Days)|Lack of Efficacy|0
40670|NCT01323660|160630|P6|Washout Period (14 Days)|Adverse Event|0
40671|NCT01323660|160631|P5|Washout Period (14 Days)|Adverse Event|1
40672|NCT01323660|160632|P4|Washout Period (14 Days)|Adverse Event|0
40673|NCT01323660|160633|P3|Washout Period (14 Days)|Adverse Event|0
40674|NCT01323660|160634|P2|Washout Period (14 Days)|Adverse Event|0
40675|NCT01323660|160635|P1|Washout Period (14 Days)|Adverse Event|0
40676|NCT01323660|160630|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
40677|NCT01323660|160631|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
40678|NCT01323660|160632|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
40679|NCT01323660|160633|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
40680|NCT01323660|160634|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
40681|NCT01323660|160635|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
40682|NCT01323660|160630|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
40683|NCT01323660|160631|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
40684|NCT01323660|160632|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
40685|NCT01323660|160633|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
40686|NCT01323660|160634|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
40687|NCT01323660|160635|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
40688|NCT01323660|160630|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
40689|NCT01323660|160631|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
40690|NCT01323660|160632|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
40691|NCT01323660|160633|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
40692|NCT01323660|160634|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
40693|NCT01323660|160635|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
40694|NCT01323660|160630|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
40695|NCT01323660|160631|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
40696|NCT01323660|160632|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
40697|NCT01323660|160633|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
40698|NCT01323660|160634|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
40699|NCT01323660|160635|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
40700|NCT01323660|160630|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
40701|NCT01323660|160631|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
40702|NCT01323660|160632|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
40703|NCT01323660|160633|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
40704|NCT01323660|160634|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
40705|NCT01323660|160635|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
40706|NCT01323660|160630|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
40707|NCT01323660|160631|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
40708|NCT01323660|160632|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
40709|NCT01323660|160633|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
40710|NCT01323660|160634|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
40711|NCT01323660|160635|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
40712|NCT01323647|160681|P2|Overall Study|Lost to Follow-up|0
40713|NCT01323647|160682|P1|Overall Study|Lost to Follow-up|2
40714|NCT01323647|160681|P2|Overall Study|Withdrawal by Subject|0
40715|NCT01323647|160682|P1|Overall Study|Withdrawal by Subject|5
40716|NCT01323647|160681|P2|Overall Study|Migrated/moved from study area|0
40717|NCT01323647|160682|P1|Overall Study|Migrated/moved from study area|2
40718|NCT01323634|160699|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
40719|NCT01323634|160700|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
40720|NCT01323634|160701|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
40721|NCT01323634|160699|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
40722|NCT01323634|160700|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
40723|NCT01323634|160701|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
40724|NCT01323634|160699|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
40725|NCT01323634|160700|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
40726|NCT01323634|160701|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
40727|NCT01323634|160699|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
40728|NCT01323634|160700|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
40729|NCT01323634|160701|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
40730|NCT01323634|160699|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
40731|NCT01323634|160700|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
40732|NCT01323634|160701|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
40733|NCT01323634|160699|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
40734|NCT01323634|160700|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
40735|NCT01323634|160701|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
40736|NCT01323634|160699|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
40737|NCT01323634|160700|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
40738|NCT01323634|160701|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
40739|NCT01323634|160699|P3|2-week Run-in Period|Adverse Event|0
40740|NCT01323634|160700|P2|2-week Run-in Period|Adverse Event|0
40741|NCT01323634|160701|P1|2-week Run-in Period|Adverse Event|1
40742|NCT01323634|160699|P3|2-week Run-in Period|Protocol Violation|0
40743|NCT01323634|160700|P2|2-week Run-in Period|Protocol Violation|0
40744|NCT01323634|160701|P1|2-week Run-in Period|Protocol Violation|1
40745|NCT01323634|160699|P3|2-week Run-in Period|Physician Decision|0
40746|NCT01323634|160700|P2|2-week Run-in Period|Physician Decision|0
40747|NCT01323634|160701|P1|2-week Run-in Period|Physician Decision|5
40748|NCT01323634|160699|P3|2-week Run-in Period|Withdrawal by Subject|0
40749|NCT01323634|160700|P2|2-week Run-in Period|Withdrawal by Subject|0
40750|NCT01323634|160701|P1|2-week Run-in Period|Withdrawal by Subject|7
40751|NCT01323634|160699|P3|2-week Run-in Period|Continuation Criteria not Met|0
40752|NCT01323634|160700|P2|2-week Run-in Period|Continuation Criteria not Met|0
40753|NCT01323634|160701|P1|2-week Run-in Period|Continuation Criteria not Met|73
40754|NCT01323634|160699|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
40755|NCT01323634|160700|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
40756|NCT01323634|160701|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
40757|NCT01323621|160711|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
40758|NCT01323621|160712|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
40759|NCT01323621|160713|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
40760|NCT01323621|160711|P3|12-week, Double-blind Treatment Period|Physician Decision|1
40761|NCT01323621|160712|P2|12-week, Double-blind Treatment Period|Physician Decision|2
40762|NCT01323621|160713|P1|12-week, Double-blind Treatment Period|Physician Decision|0
40763|NCT01323621|160711|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
40764|NCT01323621|160712|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
40765|NCT01323621|160713|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
40766|NCT01323621|160711|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
40767|NCT01323621|160712|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
40768|NCT01323621|160713|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
40769|NCT01323621|160711|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
40770|NCT01323621|160712|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
40771|NCT01323621|160713|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
40772|NCT01323621|160711|P3|12-week, Double-blind Treatment Period|Adverse Event|5
40773|NCT01323621|160712|P2|12-week, Double-blind Treatment Period|Adverse Event|1
40774|NCT01323621|160713|P1|12-week, Double-blind Treatment Period|Adverse Event|0
40775|NCT01323621|160711|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
40776|NCT01323621|160712|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
40777|NCT01323621|160713|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
40778|NCT01323621|160711|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
40779|NCT01323621|160712|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
40780|NCT01323621|160713|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
40781|NCT01323621|160711|P3|2-week, Single-blind Run In Period|Protocol Violation|0
40782|NCT01323621|160712|P2|2-week, Single-blind Run In Period|Protocol Violation|0
40783|NCT01323621|160713|P1|2-week, Single-blind Run In Period|Protocol Violation|1
40784|NCT01323621|160711|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
40785|NCT01323621|160712|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
40786|NCT01323621|160713|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
40787|NCT01323621|160711|P3|2-week, Single-blind Run In Period|Physician Decision|0
40788|NCT01323621|160712|P2|2-week, Single-blind Run In Period|Physician Decision|0
40789|NCT01323621|160713|P1|2-week, Single-blind Run In Period|Physician Decision|7
40790|NCT01323621|160711|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
40791|NCT01323621|160712|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
40792|NCT01323621|160713|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
40793|NCT01323582|160732|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
40794|NCT01323582|160733|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
40795|NCT01323582|160732|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
40796|NCT01323582|160733|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
40797|NCT01323582|160732|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
40798|NCT01323582|160733|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
40799|NCT01323478|160749|P1|Overall Study|Administrative or Other Reasons|8
40800|NCT01323478|160749|P1|Overall Study|Withdrawal of Consent|1
40801|NCT01323478|160749|P1|Overall Study|Protocol Violation|1
40802|NCT01323478|160749|P1|Overall Study|Non-compliance With Study Product|3
40803|NCT01323478|160749|P1|Overall Study|Lack of Efficacy|4
40804|NCT01323478|160749|P1|Overall Study|Adverse Event|7
40805|NCT01323270|160764|P2|Overall Study|Randomized, but not vaccinated|0
40806|NCT01323270|160765|P1|Overall Study|Randomized, but not vaccinated|1
40807|NCT01323270|160764|P2|Overall Study|Death|0
40808|NCT01323270|160765|P1|Overall Study|Death|1
40809|NCT01323270|160764|P2|Overall Study|Not eligible|1
40810|NCT01323270|160765|P1|Overall Study|Not eligible|1
40811|NCT01323270|160764|P2|Overall Study|Physician Decision|2
40812|NCT01323270|160765|P1|Overall Study|Physician Decision|0
40813|NCT01323270|160764|P2|Overall Study|Unspecified|3
40814|NCT01323270|160765|P1|Overall Study|Unspecified|0
40815|NCT01323270|160764|P2|Overall Study|Adverse Event|0
40816|NCT01323270|160765|P1|Overall Study|Adverse Event|8
40817|NCT01323270|160764|P2|Overall Study|Lost to Follow-up|6
40818|NCT01323270|160765|P1|Overall Study|Lost to Follow-up|4
40819|NCT01323270|160764|P2|Overall Study|Protocol Violation|7
40820|NCT01323270|160765|P1|Overall Study|Protocol Violation|9
40821|NCT01323270|160764|P2|Overall Study|Withdrawal by Subject|10
40822|NCT01323270|160765|P1|Overall Study|Withdrawal by Subject|19
40823|NCT01323192|160787|P2|Overall Study|Nonmedical reasons|1
40824|NCT01323192|160788|P1|Overall Study|Nonmedical reasons|0
40825|NCT01323192|160787|P2|Overall Study|Noncompliance with study medication|3
40826|NCT01323192|160788|P1|Overall Study|Noncompliance with study medication|0
40827|NCT01323192|160787|P2|Overall Study|Withdrawal by Subject|1
40828|NCT01323192|160788|P1|Overall Study|Withdrawal by Subject|3
40829|NCT01323192|160787|P2|Overall Study|Adverse Event|1
40830|NCT01323192|160788|P1|Overall Study|Adverse Event|6
40831|NCT01322386|161027|P2|Overall Study|Physician Decision|1
40832|NCT01322386|161028|P1|Overall Study|Physician Decision|0
40833|NCT01322386|161027|P2|Overall Study|Protocol Violation|1
40834|NCT01322386|161028|P1|Overall Study|Protocol Violation|0
40835|NCT01322347|161043|P2|Overall Study|moved/changed dialysis|4
40836|NCT01322347|161044|P1|Overall Study|moved/changed dialysis|2
40837|NCT01322347|161043|P2|Overall Study|study drug withheld > 12 wks|1
40838|NCT01322347|161044|P1|Overall Study|study drug withheld > 12 wks|0
40839|NCT01322347|161043|P2|Overall Study|kidney transplant|1
40840|NCT01322347|161044|P1|Overall Study|kidney transplant|3
40841|NCT01322347|161043|P2|Overall Study|ineligible|3
40842|NCT01322347|161044|P1|Overall Study|ineligible|6
40843|NCT01322347|161043|P2|Overall Study|sponsor decision|3
40844|NCT01322347|161044|P1|Overall Study|sponsor decision|1
40845|NCT01322347|161043|P2|Overall Study|blood transfusion|5
40846|NCT01322347|161044|P1|Overall Study|blood transfusion|5
40847|NCT01322347|161043|P2|Overall Study|non-protocol change to ESA or IV iron|6
40848|NCT01322347|161044|P1|Overall Study|non-protocol change to ESA or IV iron|14
40849|NCT01322347|161043|P2|Overall Study|Withdrawal by Subject|4
40850|NCT01322347|161044|P1|Overall Study|Withdrawal by Subject|1
40851|NCT01322347|161043|P2|Overall Study|Protocol Violation|2
40852|NCT01322347|161044|P1|Overall Study|Protocol Violation|5
40853|NCT01322347|161043|P2|Overall Study|Physician Decision|1
40854|NCT01322347|161044|P1|Overall Study|Physician Decision|2
40855|NCT01322347|161043|P2|Overall Study|Death|3
40856|NCT01322347|161044|P1|Overall Study|Death|5
40857|NCT01322347|161043|P2|Overall Study|Adverse Event|2
40858|NCT01322347|161044|P1|Overall Study|Adverse Event|7
40859|NCT01322009|161096|P2|Overall Study|ng tube discontinued|1
40860|NCT01322009|161097|P1|Overall Study|ng tube discontinued|0
40861|NCT01322009|161096|P2|Overall Study|Adverse Event|1
40862|NCT01322009|161097|P1|Overall Study|Adverse Event|0
40863|NCT01322009|161096|P2|Overall Study|Death|1
40864|NCT01322009|161097|P1|Overall Study|Death|0
40865|NCT01321749|161107|P2|Overall Study|Withdrawal by Subject|4
40866|NCT01321749|161108|P1|Overall Study|Withdrawal by Subject|5
40867|NCT01321749|161107|P2|Overall Study|Protocol Violation|7
40868|NCT01321749|161108|P1|Overall Study|Protocol Violation|4
40869|NCT01321749|161107|P2|Overall Study|Lost to Follow-up|11
40870|NCT01321749|161108|P1|Overall Study|Lost to Follow-up|4
40871|NCT01321723|161117|P3|Overall Study|Withdrawal by Subject|2
40872|NCT01321723|161118|P2|Overall Study|Withdrawal by Subject|0
40873|NCT01321723|161119|P1|Overall Study|Withdrawal by Subject|2
40874|NCT01321723|161117|P3|Overall Study|Adverse Event|2
40875|NCT01321723|161118|P2|Overall Study|Adverse Event|5
40876|NCT01321723|161119|P1|Overall Study|Adverse Event|3
40877|NCT01321710|161141|P3|Overall Study|Lost to Follow-up|0
40878|NCT01321710|161142|P2|Overall Study|Lost to Follow-up|5
40879|NCT01321710|161143|P1|Overall Study|Lost to Follow-up|4
40880|NCT01321697|161158|P1|Overall Study|Study Terminated|7
40881|NCT01321554|161164|P4|OOL Lenvatinib Treatment Period|Death|1
40882|NCT01321554|161165|P3|OOL Lenvatinib Treatment Period|Death|1
40883|NCT01321554|161166|P2|OOL Lenvatinib Treatment Period|Death|0
40884|NCT01321554|161167|P1|OOL Lenvatinib Treatment Period|Death|0
40885|NCT01321554|161164|P4|OOL Lenvatinib Treatment Period|Worsening disease|0
40886|NCT01321554|161165|P3|OOL Lenvatinib Treatment Period|Worsening disease|1
40887|NCT01321554|161166|P2|OOL Lenvatinib Treatment Period|Worsening disease|0
40888|NCT01321554|161167|P1|OOL Lenvatinib Treatment Period|Worsening disease|0
40889|NCT01321554|161164|P4|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
40890|NCT01321554|161165|P3|OOL Lenvatinib Treatment Period|Lost to Follow-up|1
40891|NCT01321554|161166|P2|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
40892|NCT01321554|161167|P1|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
40893|NCT01321554|161164|P4|OOL Lenvatinib Treatment Period|Not specified|0
40894|NCT01321554|161165|P3|OOL Lenvatinib Treatment Period|Not specified|5
40895|NCT01321554|161166|P2|OOL Lenvatinib Treatment Period|Not specified|0
40896|NCT01321554|161167|P1|OOL Lenvatinib Treatment Period|Not specified|0
40897|NCT01321554|161164|P4|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
40898|NCT01321554|161165|P3|OOL Lenvatinib Treatment Period|Withdrawal by Subject|1
40899|NCT01321554|161166|P2|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
40900|NCT01321554|161167|P1|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
40901|NCT01321554|161164|P4|OOL Lenvatinib Treatment Period|Participant choice|0
40902|NCT01321554|161165|P3|OOL Lenvatinib Treatment Period|Participant choice|3
40903|NCT01321554|161166|P2|OOL Lenvatinib Treatment Period|Participant choice|0
40904|NCT01321554|161167|P1|OOL Lenvatinib Treatment Period|Participant choice|0
40905|NCT01321554|161164|P4|OOL Lenvatinib Treatment Period|Adverse Event|1
40906|NCT01321554|161165|P3|OOL Lenvatinib Treatment Period|Adverse Event|16
40907|NCT01321554|161166|P2|OOL Lenvatinib Treatment Period|Adverse Event|0
40908|NCT01321554|161167|P1|OOL Lenvatinib Treatment Period|Adverse Event|0
40909|NCT01321554|161164|P4|Randomization Phase|Death|0
40910|NCT01321554|161165|P3|Randomization Phase|Death|0
40911|NCT01321554|161166|P2|Randomization Phase|Death|1
40912|NCT01321554|161167|P1|Randomization Phase|Death|0
40913|NCT01321554|161164|P4|Randomization Phase|Withdrawal by Subject|0
40914|NCT01321554|161165|P3|Randomization Phase|Withdrawal by Subject|0
40915|NCT01321554|161166|P2|Randomization Phase|Withdrawal by Subject|0
40916|NCT01321554|161167|P1|Randomization Phase|Withdrawal by Subject|4
40917|NCT01321554|161164|P4|Randomization Phase|Participant choice|0
40918|NCT01321554|161165|P3|Randomization Phase|Participant choice|0
40919|NCT01321554|161166|P2|Randomization Phase|Participant choice|0
40920|NCT01321554|161167|P1|Randomization Phase|Participant choice|4
40921|NCT01321554|161164|P4|Randomization Phase|Adverse Event|0
40922|NCT01321554|161165|P3|Randomization Phase|Adverse Event|0
40923|NCT01321554|161166|P2|Randomization Phase|Adverse Event|3
40924|NCT01321554|161167|P1|Randomization Phase|Adverse Event|37
40925|NCT01321008|161180|P1|Overall Study|Early Study Termination|1
40926|NCT01320735|161199|P1|Overall Study|Investigator Unable to be Contacted|17
40927|NCT01320735|161199|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
40928|NCT01320735|161199|P1|Overall Study|Not Specified|1
40929|NCT01320735|161199|P1|Overall Study|Protocol Violation|1
40930|NCT01320735|161199|P1|Overall Study|Progression/Hormone-Refractory Pca|55
40931|NCT01320735|161199|P1|Overall Study|Administrative Reason|6
40932|NCT01320735|161199|P1|Overall Study|Lost to Follow-up|13
40933|NCT01320735|161199|P1|Overall Study|Withdrawal by Subject|3
40934|NCT01320735|161199|P1|Overall Study|Adverse Event|3
40935|NCT01320683|161216|P1|Overall Study|Positive antibody response|1
40936|NCT01320293|161242|P1|Overall Study|Adverse Event|1
40937|NCT01320293|161242|P1|Overall Study|Lack of Efficacy|1
40938|NCT01320202|161250|P2|Overall Study|regained renal function|0
40939|NCT01320202|161251|P1|Overall Study|regained renal function|1
40940|NCT01320202|161250|P2|Overall Study|ineligible|0
40941|NCT01320202|161251|P1|Overall Study|ineligible|3
40942|NCT01320202|161250|P2|Overall Study|sponsor request|0
40943|NCT01320202|161251|P1|Overall Study|sponsor request|2
40944|NCT01320202|161250|P2|Overall Study|moved/changed dialysis|2
40945|NCT01320202|161251|P1|Overall Study|moved/changed dialysis|5
40946|NCT01320202|161250|P2|Overall Study|blood transfusion|7
40947|NCT01320202|161251|P1|Overall Study|blood transfusion|1
40948|NCT01320202|161250|P2|Overall Study|kidney transplant|2
40949|NCT01320202|161251|P1|Overall Study|kidney transplant|1
40950|NCT01320202|161250|P2|Overall Study|non-protocol change to ESA or IV iron|20
40951|NCT01320202|161251|P1|Overall Study|non-protocol change to ESA or IV iron|17
40952|NCT01320202|161250|P2|Overall Study|Withdrawal by Subject|3
40953|NCT01320202|161251|P1|Overall Study|Withdrawal by Subject|10
40954|NCT01320202|161250|P2|Overall Study|Protocol Violation|1
40955|NCT01320202|161251|P1|Overall Study|Protocol Violation|2
40956|NCT01320202|161250|P2|Overall Study|Physician Decision|1
40957|NCT01320202|161251|P1|Overall Study|Physician Decision|3
40958|NCT01320202|161250|P2|Overall Study|Lost to Follow-up|0
40959|NCT01320202|161251|P1|Overall Study|Lost to Follow-up|1
40960|NCT01320202|161250|P2|Overall Study|Death|3
40961|NCT01320202|161251|P1|Overall Study|Death|5
40962|NCT01320202|161250|P2|Overall Study|Adverse Event|5
40963|NCT01320202|161251|P1|Overall Study|Adverse Event|5
40964|NCT01319877|161315|P2|Overall Study|Reason Not Specified|5
40965|NCT01319877|161316|P1|Overall Study|Reason Not Specified|4
40966|NCT01319877|161315|P2|Overall Study|Withdrawal by Subject|1
40967|NCT01319877|161316|P1|Overall Study|Withdrawal by Subject|0
40968|NCT01319877|161315|P2|Overall Study|Disease Progression|2
40969|NCT01319877|161316|P1|Overall Study|Disease Progression|2
40970|NCT01319877|161315|P2|Overall Study|Physician Decision|0
40971|NCT01319877|161316|P1|Overall Study|Physician Decision|2
40972|NCT01319877|161315|P2|Overall Study|Lost to Follow-up|37
40973|NCT01319877|161316|P1|Overall Study|Lost to Follow-up|100
40974|NCT01319721|161386|P2|Overall Study|Lost to Follow-up|6
40975|NCT01319721|161387|P1|Overall Study|Lost to Follow-up|1
40976|NCT01319422|161432|P2|Overall Study|Withdrawal by Subject|0
40977|NCT01319422|161433|P1|Overall Study|Withdrawal by Subject|1
40978|NCT01318876|161467|P1|Day 29 Survey|survey not completed-don't know why|1825
40979|NCT01318876|161467|P1|Day 8 Survey|survey not completed-don't know why|1724
40980|NCT01318876|161467|P1|Day 8 Survey|email address invalid|96
40981|NCT01318512|161537|P1|Maintenance Period (6 Months)|Protocol Violation|9
40982|NCT01318512|161537|P1|Maintenance Period (6 Months)|Death|2
40983|NCT01318499|161556|P3|Overall Study|Not Specified|22
40984|NCT01318499|161557|P2|Overall Study|Not Specified|10
40985|NCT01318499|161558|P1|Overall Study|Not Specified|7
40986|NCT01318499|161556|P3|Overall Study|Patient Did Not Use Study Medication|14
40987|NCT01318499|161557|P2|Overall Study|Patient Did Not Use Study Medication|28
40988|NCT01318499|161558|P1|Overall Study|Patient Did Not Use Study Medication|18
40989|NCT01318499|161556|P3|Overall Study|Protocol Violation|2
40990|NCT01318499|161557|P2|Overall Study|Protocol Violation|4
40991|NCT01318499|161558|P1|Overall Study|Protocol Violation|2
40992|NCT01318499|161556|P3|Overall Study|Treatment Failure|101
40993|NCT01318499|161557|P2|Overall Study|Treatment Failure|19
40994|NCT01318499|161558|P1|Overall Study|Treatment Failure|19
40995|NCT01318499|161556|P3|Overall Study|Noncompliance|0
40996|NCT01318499|161557|P2|Overall Study|Noncompliance|3
40997|NCT01318499|161558|P1|Overall Study|Noncompliance|2
40998|NCT01318499|161556|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
40999|NCT01318499|161557|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
41000|NCT01318499|161558|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
41001|NCT01318499|161556|P3|Overall Study|Adverse Event|6
41002|NCT01318499|161557|P2|Overall Study|Adverse Event|11
41003|NCT01318499|161558|P1|Overall Study|Adverse Event|16
41004|NCT01318382|161581|P1|Overall Study|Protocol Violation|1
41005|NCT01318382|161581|P1|Overall Study|Device Malfunction|10
41006|NCT01318382|161581|P1|Overall Study|Physician Decision|2
41007|NCT01318135|161639|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
41008|NCT01318135|161640|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
41009|NCT01318135|161641|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
41010|NCT01318135|161642|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
41011|NCT01318135|161643|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
41012|NCT01318135|161644|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
41013|NCT01318135|161645|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
41014|NCT01318135|161646|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
41015|NCT01318135|161639|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
41016|NCT01318135|161640|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
41017|NCT01318135|161641|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
41018|NCT01318135|161642|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
41019|NCT01318135|161643|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
41020|NCT01318135|161644|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
41021|NCT01318135|161645|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
41022|NCT01318135|161646|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
41023|NCT01318135|161639|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
41024|NCT01318135|161640|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
41025|NCT01318135|161641|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
41026|NCT01318135|161642|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
41027|NCT01318135|161643|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
41028|NCT01318135|161644|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
41029|NCT01318135|161645|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
41030|NCT01318135|161646|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
41031|NCT01318135|161639|P8|Entered - Long-Term Extension Study|Protocol Violation|0
41032|NCT01318135|161640|P7|Entered - Long-Term Extension Study|Protocol Violation|0
41033|NCT01318135|161641|P6|Entered - Long-Term Extension Study|Protocol Violation|0
41034|NCT01318135|161642|P5|Entered - Long-Term Extension Study|Protocol Violation|1
41035|NCT01318135|161643|P4|Entered - Long-Term Extension Study|Protocol Violation|0
41036|NCT01318135|161644|P3|Entered - Long-Term Extension Study|Protocol Violation|0
41037|NCT01318135|161645|P2|Entered - Long-Term Extension Study|Protocol Violation|1
41038|NCT01318135|161646|P1|Entered - Long-Term Extension Study|Protocol Violation|1
41039|NCT01318135|161639|P8|Entered - Long-Term Extension Study|Adverse Event|0
41040|NCT01318135|161640|P7|Entered - Long-Term Extension Study|Adverse Event|0
41041|NCT01318135|161641|P6|Entered - Long-Term Extension Study|Adverse Event|2
41042|NCT01318135|161642|P5|Entered - Long-Term Extension Study|Adverse Event|4
41043|NCT01318135|161643|P4|Entered - Long-Term Extension Study|Adverse Event|3
41044|NCT01318135|161644|P3|Entered - Long-Term Extension Study|Adverse Event|4
41045|NCT01318135|161645|P2|Entered - Long-Term Extension Study|Adverse Event|3
41046|NCT01318135|161646|P1|Entered - Long-Term Extension Study|Adverse Event|9
41047|NCT01318135|161639|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
41048|NCT01318135|161640|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
41049|NCT01318135|161641|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
41050|NCT01318135|161642|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
41051|NCT01318135|161643|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
41052|NCT01318135|161644|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
41053|NCT01318135|161645|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
41054|NCT01318135|161646|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
41055|NCT01318135|161639|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
41056|NCT01318135|161640|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
41057|NCT01318135|161641|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
41058|NCT01318135|161642|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
41059|NCT01318135|161643|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
41060|NCT01318135|161644|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
41061|NCT01318135|161645|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
41062|NCT01318135|161646|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
41063|NCT01318122|161778|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
41064|NCT01318122|161779|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
41065|NCT01318122|161780|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
41066|NCT01318122|161781|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
41067|NCT01318122|161778|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
41068|NCT01318122|161779|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
41069|NCT01318122|161780|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
41070|NCT01318122|161781|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
41071|NCT01318122|161778|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
41072|NCT01318122|161779|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
41073|NCT01318122|161780|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
41074|NCT01318122|161781|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
41075|NCT01318122|161778|P4|Entered - Long-Term Extension Study|Adverse Event|4
41076|NCT01318122|161779|P3|Entered - Long-Term Extension Study|Adverse Event|2
41077|NCT01318122|161780|P2|Entered - Long-Term Extension Study|Adverse Event|6
41078|NCT01318122|161781|P1|Entered - Long-Term Extension Study|Adverse Event|6
41079|NCT01318122|161778|P4|Enrolled - Long-Term Extension Study|Other|0
41080|NCT01318122|161779|P3|Enrolled - Long-Term Extension Study|Other|0
41081|NCT01318122|161780|P2|Enrolled - Long-Term Extension Study|Other|0
41082|NCT01318122|161781|P1|Enrolled - Long-Term Extension Study|Other|1
41083|NCT01318122|161778|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
41084|NCT01318122|161779|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
41085|NCT01318122|161780|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
41086|NCT01318122|161781|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
41087|NCT01318109|161850|P3|Overall Study|Schedule Conflict|0
41088|NCT01318109|161851|P2|Overall Study|Schedule Conflict|1
41089|NCT01318109|161852|P1|Overall Study|Schedule Conflict|0
41090|NCT01318109|161850|P3|Overall Study|Withdrawal by Subject|0
41091|NCT01318109|161851|P2|Overall Study|Withdrawal by Subject|0
41092|NCT01318109|161852|P1|Overall Study|Withdrawal by Subject|1
41093|NCT01318109|161850|P3|Overall Study|Adverse Event|0
41094|NCT01318109|161851|P2|Overall Study|Adverse Event|2
41095|NCT01318109|161852|P1|Overall Study|Adverse Event|0
41096|NCT01318083|161887|P3|Overall Study|Lack of Study Medication Compliance|0
41097|NCT01318083|161888|P2|Overall Study|Lack of Study Medication Compliance|1
41098|NCT01318083|161889|P1|Overall Study|Lack of Study Medication Compliance|0
41099|NCT01318083|161887|P3|Overall Study|Treatment Complications|0
41100|NCT01318083|161888|P2|Overall Study|Treatment Complications|0
41101|NCT01318083|161889|P1|Overall Study|Treatment Complications|1
41102|NCT01318083|161887|P3|Overall Study|Lack of Efficacy|1
41103|NCT01318083|161888|P2|Overall Study|Lack of Efficacy|0
41104|NCT01318083|161889|P1|Overall Study|Lack of Efficacy|0
41105|NCT01318083|161887|P3|Overall Study|Withdrawal by Subject|2
41106|NCT01318083|161888|P2|Overall Study|Withdrawal by Subject|0
41107|NCT01318083|161889|P1|Overall Study|Withdrawal by Subject|1
41108|NCT01318083|161887|P3|Overall Study|Adverse Event|2
41109|NCT01318083|161888|P2|Overall Study|Adverse Event|1
41110|NCT01318083|161889|P1|Overall Study|Adverse Event|4
41111|NCT01318070|161924|P3|Overall Study|Principal Investigator Discretion|0
41112|NCT01318070|161925|P2|Overall Study|Principal Investigator Discretion|0
41113|NCT01318070|161926|P1|Overall Study|Principal Investigator Discretion|1
41114|NCT01318070|161924|P3|Overall Study|Lack of Efficacy|1
41115|NCT01318070|161925|P2|Overall Study|Lack of Efficacy|0
41116|NCT01318070|161926|P1|Overall Study|Lack of Efficacy|0
41117|NCT01318070|161924|P3|Overall Study|Withdrawal by Subject|1
41118|NCT01318070|161925|P2|Overall Study|Withdrawal by Subject|1
41119|NCT01318070|161926|P1|Overall Study|Withdrawal by Subject|0
41120|NCT01318070|161924|P3|Overall Study|Adverse Event|5
41121|NCT01318070|161925|P2|Overall Study|Adverse Event|1
41122|NCT01318070|161926|P1|Overall Study|Adverse Event|1
41123|NCT01317797|161969|P3|Overall Study|Withdrawal of Patient|1
41124|NCT01317797|161970|P2|Overall Study|Withdrawal of Patient|0
41125|NCT01317797|161971|P1|Overall Study|Withdrawal of Patient|0
41126|NCT01317797|161969|P3|Overall Study|Other|0
41127|NCT01317797|161970|P2|Overall Study|Other|1
41128|NCT01317797|161971|P1|Overall Study|Other|0
41129|NCT01317615|162039|P1|Overall Study|Adverse Event|7
41130|NCT01317615|162039|P1|Overall Study|Abnormal laboratory value(s)|1
41131|NCT01317615|162039|P1|Overall Study|Withdrawal by Subject|5
41132|NCT01317615|162039|P1|Overall Study|Death|6
41133|NCT01317615|162039|P1|Overall Study|New cancer therapy|5
41134|NCT01317615|162039|P1|Overall Study|Disease progression|25
41135|NCT01317160|162050|P2|Overall Study|Withdrawal by Subject|2
41136|NCT01317160|162051|P1|Overall Study|Withdrawal by Subject|0
41137|NCT01317160|162050|P2|Overall Study|Lost to Follow-up|3
41138|NCT01317160|162051|P1|Overall Study|Lost to Follow-up|3
41139|NCT01317160|162050|P2|Overall Study|Incorrect inclusion|1
41140|NCT01317160|162051|P1|Overall Study|Incorrect inclusion|1
41141|NCT01317004|162061|P2|Overall Study|Adverse Event|3
41142|NCT01317004|162062|P1|Overall Study|Adverse Event|3
41143|NCT01317004|162061|P2|Overall Study|Protocol Violation|2
41144|NCT01317004|162062|P1|Overall Study|Protocol Violation|0
41145|NCT01317004|162061|P2|Overall Study|Withdrawal by Subject|4
41146|NCT01317004|162062|P1|Overall Study|Withdrawal by Subject|1
41147|NCT01316913|162095|P4|Overall Study|Withdrawal by Subject|6
41148|NCT01316913|162096|P3|Overall Study|Withdrawal by Subject|10
41149|NCT01316913|162097|P2|Overall Study|Withdrawal by Subject|9
41150|NCT01316913|162098|P1|Overall Study|Withdrawal by Subject|10
41151|NCT01316913|162095|P4|Overall Study|Lost to Follow-up|2
41152|NCT01316913|162096|P3|Overall Study|Lost to Follow-up|0
41153|NCT01316913|162097|P2|Overall Study|Lost to Follow-up|1
41154|NCT01316913|162098|P1|Overall Study|Lost to Follow-up|0
41155|NCT01316913|162095|P4|Overall Study|Protocol-defined Stopping Criteria|6
41156|NCT01316913|162096|P3|Overall Study|Protocol-defined Stopping Criteria|11
41157|NCT01316913|162097|P2|Overall Study|Protocol-defined Stopping Criteria|8
41158|NCT01316913|162098|P1|Overall Study|Protocol-defined Stopping Criteria|7
41159|NCT01316913|162095|P4|Overall Study|Protocol Violation|1
41160|NCT01316913|162096|P3|Overall Study|Protocol Violation|4
41161|NCT01316913|162097|P2|Overall Study|Protocol Violation|4
41162|NCT01316913|162098|P1|Overall Study|Protocol Violation|1
41163|NCT01316913|162095|P4|Overall Study|Lack of Efficacy|13
41164|NCT01316913|162096|P3|Overall Study|Lack of Efficacy|9
41165|NCT01316913|162097|P2|Overall Study|Lack of Efficacy|12
41166|NCT01316913|162098|P1|Overall Study|Lack of Efficacy|22
41167|NCT01316913|162095|P4|Overall Study|Adverse Event|11
41168|NCT01316913|162096|P3|Overall Study|Adverse Event|15
41169|NCT01316913|162097|P2|Overall Study|Adverse Event|20
41170|NCT01316913|162098|P1|Overall Study|Adverse Event|17
41171|NCT01316900|162120|P4|Overall Study|Withdrawal by Subject|9
41172|NCT01316900|162121|P3|Overall Study|Withdrawal by Subject|6
41173|NCT01316900|162122|P2|Overall Study|Withdrawal by Subject|8
41174|NCT01316900|162123|P1|Overall Study|Withdrawal by Subject|7
41175|NCT01316900|162120|P4|Overall Study|Lost to Follow-up|1
41176|NCT01316900|162121|P3|Overall Study|Lost to Follow-up|1
41177|NCT01316900|162122|P2|Overall Study|Lost to Follow-up|0
41178|NCT01316900|162123|P1|Overall Study|Lost to Follow-up|1
41179|NCT01316900|162120|P4|Overall Study|Protocol-defined Stopping Criteria|5
41180|NCT01316900|162121|P3|Overall Study|Protocol-defined Stopping Criteria|10
41181|NCT01316900|162122|P2|Overall Study|Protocol-defined Stopping Criteria|3
41182|NCT01316900|162123|P1|Overall Study|Protocol-defined Stopping Criteria|2
41183|NCT01316900|162120|P4|Overall Study|Protocol Violation|0
41184|NCT01316900|162121|P3|Overall Study|Protocol Violation|4
41185|NCT01316900|162122|P2|Overall Study|Protocol Violation|1
41186|NCT01316900|162123|P1|Overall Study|Protocol Violation|7
41187|NCT01316900|162120|P4|Overall Study|Lack of Efficacy|7
41188|NCT01316900|162121|P3|Overall Study|Lack of Efficacy|5
41189|NCT01316900|162122|P2|Overall Study|Lack of Efficacy|9
41190|NCT01316900|162123|P1|Overall Study|Lack of Efficacy|17
41191|NCT01316900|162120|P4|Overall Study|Adverse Event|9
41192|NCT01316900|162121|P3|Overall Study|Adverse Event|15
41193|NCT01316900|162122|P2|Overall Study|Adverse Event|10
41194|NCT01316900|162123|P1|Overall Study|Adverse Event|10
41195|NCT01316887|162144|P3|Overall Study|Withdrawal by Subject|15
41196|NCT01316887|162145|P2|Overall Study|Withdrawal by Subject|16
41197|NCT01316887|162146|P1|Overall Study|Withdrawal by Subject|8
41198|NCT01316887|162144|P3|Overall Study|Lost to Follow-up|5
41199|NCT01316887|162145|P2|Overall Study|Lost to Follow-up|7
41200|NCT01316887|162146|P1|Overall Study|Lost to Follow-up|1
41201|NCT01316887|162144|P3|Overall Study|Study Closed/Terminated|3
41202|NCT01316887|162145|P2|Overall Study|Study Closed/Terminated|4
41203|NCT01316887|162146|P1|Overall Study|Study Closed/Terminated|2
41204|NCT01316887|162144|P3|Overall Study|Protocol-defined Stopping Criteria|36
41205|NCT01316887|162145|P2|Overall Study|Protocol-defined Stopping Criteria|37
41206|NCT01316887|162146|P1|Overall Study|Protocol-defined Stopping Criteria|8
41207|NCT01316887|162144|P3|Overall Study|Protocol Violation|6
41208|NCT01316887|162145|P2|Overall Study|Protocol Violation|6
41209|NCT01316887|162146|P1|Overall Study|Protocol Violation|2
41210|NCT01316887|162144|P3|Overall Study|Lack of Efficacy|1
41211|NCT01316887|162145|P2|Overall Study|Lack of Efficacy|3
41212|NCT01316887|162146|P1|Overall Study|Lack of Efficacy|9
41213|NCT01316887|162144|P3|Overall Study|Adverse Event|17
41214|NCT01316887|162145|P2|Overall Study|Adverse Event|21
41215|NCT01316887|162146|P1|Overall Study|Adverse Event|13
41216|NCT01316692|162208|P1|Overall Study|Disease Progression|7
41217|NCT01316692|162208|P1|Overall Study|Adverse Event|5
41218|NCT01316614|162217|P1|Overall Study|Medically unstable|1
41219|NCT01316614|162217|P1|Overall Study|Inadequate number of passes|2
41220|NCT01316614|162217|P1|Overall Study|Cystic lesion|5
41221|NCT01316614|162217|P1|Overall Study|Cytology slides not available for review|4
41222|NCT01316614|162217|P1|Overall Study|No solid lesion and FNA not indicated|25
41223|NCT01316575|162234|P2|Overall Study|Required alternate treatment|1
41224|NCT01316575|162235|P1|Overall Study|Required alternate treatment|0
41225|NCT01316575|162234|P2|Overall Study|Withdrawal by Subject|0
41226|NCT01316575|162235|P1|Overall Study|Withdrawal by Subject|2
41227|NCT01316419|162247|P1|Overall Study|Lost to Follow-up|19
41228|NCT01316419|162247|P1|Overall Study|Violated inclusion/exclusion criterion|143
41229|NCT01316419|162247|P1|Overall Study|Not treated|103
41230|NCT01316380|162273|P3|Overall Study|Not treated|0
41231|NCT01316380|162274|P2|Overall Study|Not treated|0
41232|NCT01316380|162275|P1|Overall Study|Not treated|1
41233|NCT01316380|162273|P3|Overall Study|Other|1
41234|NCT01316380|162274|P2|Overall Study|Other|1
41235|NCT01316380|162275|P1|Overall Study|Other|0
41236|NCT01316380|162273|P3|Overall Study|Withdrawal by Subject|0
41237|NCT01316380|162274|P2|Overall Study|Withdrawal by Subject|2
41238|NCT01316380|162275|P1|Overall Study|Withdrawal by Subject|1
41239|NCT01316380|162273|P3|Overall Study|Protocol Violation|1
41240|NCT01316380|162274|P2|Overall Study|Protocol Violation|0
41241|NCT01316380|162275|P1|Overall Study|Protocol Violation|0
41242|NCT01316380|162273|P3|Overall Study|Adverse Event|1
41243|NCT01316380|162274|P2|Overall Study|Adverse Event|2
41244|NCT01316380|162275|P1|Overall Study|Adverse Event|0
41245|NCT01316224|162441|P1|Overall Study|Not Specified|1
41246|NCT01316224|162441|P1|Overall Study|Adverse Event With Treatment Failure|1
41247|NCT01316224|162441|P1|Overall Study|Withdrawal by Subject|1
41248|NCT01316224|162441|P1|Overall Study|Lack of Efficacy|1
41249|NCT01316224|162441|P1|Overall Study|Adverse Event|3
41250|NCT01316224|162441|P1|Overall Study|Protocol Violation|3
41251|NCT01316055|162458|P3|Overall Study|Lost to Follow-up|0
41252|NCT01316055|162459|P2|Overall Study|Lost to Follow-up|0
41253|NCT01316055|162460|P1|Overall Study|Lost to Follow-up|1
41254|NCT01315847|162485|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
41255|NCT01315847|162486|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
41256|NCT01315847|162485|P2|Part I, Period 1|Reached maximum number of arterial lines|0
41257|NCT01315847|162486|P1|Part I, Period 1|Reached maximum number of arterial lines|3
41258|NCT01315249|162530|P2|Overall Study|Death|1
41259|NCT01315249|162531|P1|Overall Study|Death|0
41260|NCT01315249|162530|P2|Overall Study|Lost to Follow-up|2
41261|NCT01315249|162531|P1|Overall Study|Lost to Follow-up|0
41262|NCT01315249|162530|P2|Overall Study|Lack of Efficacy|1
41263|NCT01315249|162531|P1|Overall Study|Lack of Efficacy|0
41264|NCT01315249|162530|P2|Overall Study|inability to use device|0
41265|NCT01315249|162531|P1|Overall Study|inability to use device|1
41266|NCT01315249|162530|P2|Overall Study|Administrative problems|0
41267|NCT01315249|162531|P1|Overall Study|Administrative problems|1
41268|NCT01315249|162530|P2|Overall Study|Abnormal test results|2
41269|NCT01315249|162531|P1|Overall Study|Abnormal test results|1
41270|NCT01315249|162530|P2|Overall Study|Protocol Violation|5
41271|NCT01315249|162531|P1|Overall Study|Protocol Violation|8
41272|NCT01315249|162530|P2|Overall Study|Withdrawal by Subject|10
41273|NCT01315249|162531|P1|Overall Study|Withdrawal by Subject|11
41274|NCT01315249|162530|P2|Overall Study|Adverse Event|26
41275|NCT01315249|162531|P1|Overall Study|Adverse Event|22
41276|NCT01315028|162593|P2|Overall Study|Death|1
41277|NCT01315028|162594|P1|Overall Study|Death|0
41278|NCT01315028|162593|P2|Overall Study|Lost to Follow-up|0
41279|NCT01315028|162594|P1|Overall Study|Lost to Follow-up|1
41280|NCT01314872|162624|P15|Period 2|Lost to Follow-up|6
41281|NCT01314872|162625|P14|Period 2|Lost to Follow-up|2
41282|NCT01314872|162626|P13|Period 2|Lost to Follow-up|7
41283|NCT01314872|162627|P12|Period 2|Lost to Follow-up|6
41284|NCT01314872|162628|P11|Period 2|Lost to Follow-up|0
41285|NCT01314872|162629|P10|Period 2|Lost to Follow-up|0
41286|NCT01314872|162630|P9|Period 2|Lost to Follow-up|0
41287|NCT01314872|162631|P8|Period 2|Lost to Follow-up|0
41288|NCT01314872|162632|P7|Period 2|Lost to Follow-up|0
41289|NCT01314872|162633|P6|Period 2|Lost to Follow-up|0
41290|NCT01314872|162634|P5|Period 2|Lost to Follow-up|0
41291|NCT01314872|162635|P4|Period 2|Lost to Follow-up|0
41292|NCT01314872|162636|P3|Period 2|Lost to Follow-up|0
41293|NCT01314872|162637|P2|Period 2|Lost to Follow-up|0
41294|NCT01314872|162638|P1|Period 2|Lost to Follow-up|0
41295|NCT01314872|162624|P15|Period 2|Withdrawal by Subject|4
41296|NCT01314872|162625|P14|Period 2|Withdrawal by Subject|12
41297|NCT01314872|162626|P13|Period 2|Withdrawal by Subject|17
41298|NCT01314872|162627|P12|Period 2|Withdrawal by Subject|14
41299|NCT01314872|162628|P11|Period 2|Withdrawal by Subject|0
41300|NCT01314872|162629|P10|Period 2|Withdrawal by Subject|0
41301|NCT01314872|162630|P9|Period 2|Withdrawal by Subject|0
41302|NCT01314872|162631|P8|Period 2|Withdrawal by Subject|0
41303|NCT01314872|162632|P7|Period 2|Withdrawal by Subject|0
41304|NCT01314872|162633|P6|Period 2|Withdrawal by Subject|0
41305|NCT01314872|162634|P5|Period 2|Withdrawal by Subject|0
41306|NCT01314872|162635|P4|Period 2|Withdrawal by Subject|0
41307|NCT01314872|162636|P3|Period 2|Withdrawal by Subject|0
41308|NCT01314872|162637|P2|Period 2|Withdrawal by Subject|0
41309|NCT01314872|162638|P1|Period 2|Withdrawal by Subject|0
41310|NCT01314872|162624|P15|Period 2|Adverse event, non-fatal|9
41311|NCT01314872|162625|P14|Period 2|Adverse event, non-fatal|24
41312|NCT01314872|162626|P13|Period 2|Adverse event, non-fatal|16
41313|NCT01314872|162627|P12|Period 2|Adverse event, non-fatal|13
41314|NCT01314872|162628|P11|Period 2|Adverse event, non-fatal|0
41315|NCT01314872|162629|P10|Period 2|Adverse event, non-fatal|0
41316|NCT01314872|162630|P9|Period 2|Adverse event, non-fatal|0
41317|NCT01314872|162631|P8|Period 2|Adverse event, non-fatal|0
41318|NCT01314872|162632|P7|Period 2|Adverse event, non-fatal|0
41319|NCT01314872|162633|P6|Period 2|Adverse event, non-fatal|0
41320|NCT01314872|162634|P5|Period 2|Adverse event, non-fatal|0
41321|NCT01314872|162635|P4|Period 2|Adverse event, non-fatal|0
41322|NCT01314872|162636|P3|Period 2|Adverse event, non-fatal|0
41323|NCT01314872|162637|P2|Period 2|Adverse event, non-fatal|0
41324|NCT01314872|162638|P1|Period 2|Adverse event, non-fatal|0
41325|NCT01314872|162624|P15|Period 2|Study terminated by Sponsor|0
41326|NCT01314872|162625|P14|Period 2|Study terminated by Sponsor|3
41327|NCT01314872|162626|P13|Period 2|Study terminated by Sponsor|2
41328|NCT01314872|162627|P12|Period 2|Study terminated by Sponsor|2
41329|NCT01314872|162628|P11|Period 2|Study terminated by Sponsor|0
41330|NCT01314872|162629|P10|Period 2|Study terminated by Sponsor|0
41331|NCT01314872|162630|P9|Period 2|Study terminated by Sponsor|0
41332|NCT01314872|162631|P8|Period 2|Study terminated by Sponsor|0
41333|NCT01314872|162632|P7|Period 2|Study terminated by Sponsor|0
41334|NCT01314872|162633|P6|Period 2|Study terminated by Sponsor|0
41335|NCT01314872|162634|P5|Period 2|Study terminated by Sponsor|0
41336|NCT01314872|162635|P4|Period 2|Study terminated by Sponsor|0
41337|NCT01314872|162636|P3|Period 2|Study terminated by Sponsor|0
41338|NCT01314872|162637|P2|Period 2|Study terminated by Sponsor|0
41339|NCT01314872|162638|P1|Period 2|Study terminated by Sponsor|0
41340|NCT01314872|162624|P15|Period 2|Pregnancy|1
41341|NCT01314872|162625|P14|Period 2|Pregnancy|0
41342|NCT01314872|162626|P13|Period 2|Pregnancy|0
41343|NCT01314872|162627|P12|Period 2|Pregnancy|0
41344|NCT01314872|162628|P11|Period 2|Pregnancy|0
41345|NCT01314872|162629|P10|Period 2|Pregnancy|0
41346|NCT01314872|162630|P9|Period 2|Pregnancy|0
41347|NCT01314872|162631|P8|Period 2|Pregnancy|0
41348|NCT01314872|162632|P7|Period 2|Pregnancy|0
41349|NCT01314872|162633|P6|Period 2|Pregnancy|0
41350|NCT01314872|162634|P5|Period 2|Pregnancy|0
41351|NCT01314872|162635|P4|Period 2|Pregnancy|0
41352|NCT01314872|162636|P3|Period 2|Pregnancy|0
41353|NCT01314872|162637|P2|Period 2|Pregnancy|0
41354|NCT01314872|162638|P1|Period 2|Pregnancy|0
41355|NCT01314872|162624|P15|Period 2|Lack of Efficacy|2
41356|NCT01314872|162625|P14|Period 2|Lack of Efficacy|9
41357|NCT01314872|162626|P13|Period 2|Lack of Efficacy|12
41358|NCT01314872|162627|P12|Period 2|Lack of Efficacy|7
41359|NCT01314872|162628|P11|Period 2|Lack of Efficacy|0
41360|NCT01314872|162629|P10|Period 2|Lack of Efficacy|0
41361|NCT01314872|162630|P9|Period 2|Lack of Efficacy|0
41362|NCT01314872|162631|P8|Period 2|Lack of Efficacy|0
41363|NCT01314872|162632|P7|Period 2|Lack of Efficacy|0
41364|NCT01314872|162633|P6|Period 2|Lack of Efficacy|0
41365|NCT01314872|162634|P5|Period 2|Lack of Efficacy|0
41366|NCT01314872|162635|P4|Period 2|Lack of Efficacy|0
41367|NCT01314872|162636|P3|Period 2|Lack of Efficacy|0
41368|NCT01314872|162637|P2|Period 2|Lack of Efficacy|0
41369|NCT01314872|162638|P1|Period 2|Lack of Efficacy|0
41370|NCT01314872|162624|P15|Period 2|Non-compliance with study drug|2
41371|NCT01314872|162625|P14|Period 2|Non-compliance with study drug|1
41372|NCT01314872|162626|P13|Period 2|Non-compliance with study drug|3
41373|NCT01314872|162627|P12|Period 2|Non-compliance with study drug|3
41374|NCT01314872|162628|P11|Period 2|Non-compliance with study drug|0
41375|NCT01314872|162629|P10|Period 2|Non-compliance with study drug|0
41376|NCT01314872|162630|P9|Period 2|Non-compliance with study drug|0
41377|NCT01314872|162631|P8|Period 2|Non-compliance with study drug|0
41378|NCT01314872|162632|P7|Period 2|Non-compliance with study drug|0
41379|NCT01314872|162633|P6|Period 2|Non-compliance with study drug|0
41380|NCT01314872|162634|P5|Period 2|Non-compliance with study drug|0
41381|NCT01314872|162635|P4|Period 2|Non-compliance with study drug|0
41382|NCT01314872|162636|P3|Period 2|Non-compliance with study drug|0
41383|NCT01314872|162637|P2|Period 2|Non-compliance with study drug|0
41384|NCT01314872|162638|P1|Period 2|Non-compliance with study drug|0
41385|NCT01314872|162624|P15|Period 2|Protocol Violation|0
41386|NCT01314872|162625|P14|Period 2|Protocol Violation|2
41387|NCT01314872|162626|P13|Period 2|Protocol Violation|3
41388|NCT01314872|162627|P12|Period 2|Protocol Violation|3
41389|NCT01314872|162628|P11|Period 2|Protocol Violation|0
41390|NCT01314872|162629|P10|Period 2|Protocol Violation|0
41391|NCT01314872|162630|P9|Period 2|Protocol Violation|0
41392|NCT01314872|162631|P8|Period 2|Protocol Violation|0
41393|NCT01314872|162632|P7|Period 2|Protocol Violation|0
41394|NCT01314872|162633|P6|Period 2|Protocol Violation|0
41395|NCT01314872|162634|P5|Period 2|Protocol Violation|0
41396|NCT01314872|162635|P4|Period 2|Protocol Violation|0
41397|NCT01314872|162636|P3|Period 2|Protocol Violation|0
41398|NCT01314872|162637|P2|Period 2|Protocol Violation|0
41399|NCT01314872|162638|P1|Period 2|Protocol Violation|0
41400|NCT01314872|162624|P15|Treatment Period 1|Lost to Follow-up|0
41401|NCT01314872|162625|P14|Treatment Period 1|Lost to Follow-up|0
41402|NCT01314872|162626|P13|Treatment Period 1|Lost to Follow-up|0
41403|NCT01314872|162627|P12|Treatment Period 1|Lost to Follow-up|0
41404|NCT01314872|162628|P11|Treatment Period 1|Lost to Follow-up|0
41405|NCT01314872|162629|P10|Treatment Period 1|Lost to Follow-up|0
41406|NCT01314872|162630|P9|Treatment Period 1|Lost to Follow-up|1
41407|NCT01314872|162631|P8|Treatment Period 1|Lost to Follow-up|1
41408|NCT01314872|162632|P7|Treatment Period 1|Lost to Follow-up|1
41409|NCT01314872|162633|P6|Treatment Period 1|Lost to Follow-up|1
41410|NCT01314872|162634|P5|Treatment Period 1|Lost to Follow-up|1
41411|NCT01314872|162635|P4|Treatment Period 1|Lost to Follow-up|2
41412|NCT01314872|162636|P3|Treatment Period 1|Lost to Follow-up|2
41413|NCT01314872|162637|P2|Treatment Period 1|Lost to Follow-up|1
41414|NCT01314872|162638|P1|Treatment Period 1|Lost to Follow-up|0
41415|NCT01314872|162624|P15|Treatment Period 1|Withdrawal by Subject|0
41416|NCT01314872|162625|P14|Treatment Period 1|Withdrawal by Subject|0
41417|NCT01314872|162626|P13|Treatment Period 1|Withdrawal by Subject|0
41418|NCT01314872|162627|P12|Treatment Period 1|Withdrawal by Subject|0
41419|NCT01314872|162628|P11|Treatment Period 1|Withdrawal by Subject|1
41420|NCT01314872|162629|P10|Treatment Period 1|Withdrawal by Subject|2
41421|NCT01314872|162630|P9|Treatment Period 1|Withdrawal by Subject|2
41422|NCT01314872|162631|P8|Treatment Period 1|Withdrawal by Subject|2
41423|NCT01314872|162632|P7|Treatment Period 1|Withdrawal by Subject|3
41424|NCT01314872|162633|P6|Treatment Period 1|Withdrawal by Subject|1
41425|NCT01314872|162634|P5|Treatment Period 1|Withdrawal by Subject|3
41426|NCT01314872|162635|P4|Treatment Period 1|Withdrawal by Subject|2
41427|NCT01314872|162636|P3|Treatment Period 1|Withdrawal by Subject|0
41428|NCT01314872|162637|P2|Treatment Period 1|Withdrawal by Subject|1
41429|NCT01314872|162638|P1|Treatment Period 1|Withdrawal by Subject|3
41430|NCT01314872|162624|P15|Treatment Period 1|Adverse event, non-fatal|0
41431|NCT01314872|162625|P14|Treatment Period 1|Adverse event, non-fatal|0
41432|NCT01314872|162626|P13|Treatment Period 1|Adverse event, non-fatal|0
41433|NCT01314872|162627|P12|Treatment Period 1|Adverse event, non-fatal|0
41434|NCT01314872|162628|P11|Treatment Period 1|Adverse event, non-fatal|1
41435|NCT01314872|162629|P10|Treatment Period 1|Adverse event, non-fatal|0
41436|NCT01314872|162630|P9|Treatment Period 1|Adverse event, non-fatal|3
41437|NCT01314872|162631|P8|Treatment Period 1|Adverse event, non-fatal|2
41438|NCT01314872|162632|P7|Treatment Period 1|Adverse event, non-fatal|4
41439|NCT01314872|162633|P6|Treatment Period 1|Adverse event, non-fatal|4
41440|NCT01314872|162634|P5|Treatment Period 1|Adverse event, non-fatal|2
41441|NCT01314872|162635|P4|Treatment Period 1|Adverse event, non-fatal|2
41442|NCT01314872|162636|P3|Treatment Period 1|Adverse event, non-fatal|3
41443|NCT01314872|162637|P2|Treatment Period 1|Adverse event, non-fatal|2
41444|NCT01314872|162638|P1|Treatment Period 1|Adverse event, non-fatal|4
41445|NCT01314872|162624|P15|Treatment Period 1|Lack of Efficacy|0
41446|NCT01314872|162625|P14|Treatment Period 1|Lack of Efficacy|0
41447|NCT01314872|162626|P13|Treatment Period 1|Lack of Efficacy|0
41448|NCT01314872|162627|P12|Treatment Period 1|Lack of Efficacy|0
41449|NCT01314872|162628|P11|Treatment Period 1|Lack of Efficacy|0
41450|NCT01314872|162629|P10|Treatment Period 1|Lack of Efficacy|0
41451|NCT01314872|162630|P9|Treatment Period 1|Lack of Efficacy|0
41452|NCT01314872|162631|P8|Treatment Period 1|Lack of Efficacy|2
41453|NCT01314872|162632|P7|Treatment Period 1|Lack of Efficacy|0
41454|NCT01314872|162633|P6|Treatment Period 1|Lack of Efficacy|1
41455|NCT01314872|162634|P5|Treatment Period 1|Lack of Efficacy|0
41456|NCT01314872|162635|P4|Treatment Period 1|Lack of Efficacy|0
41457|NCT01314872|162636|P3|Treatment Period 1|Lack of Efficacy|0
41458|NCT01314872|162637|P2|Treatment Period 1|Lack of Efficacy|0
41459|NCT01314872|162638|P1|Treatment Period 1|Lack of Efficacy|1
41460|NCT01314872|162624|P15|Treatment Period 1|Physician Decision|0
41461|NCT01314872|162625|P14|Treatment Period 1|Physician Decision|0
41462|NCT01314872|162626|P13|Treatment Period 1|Physician Decision|0
41463|NCT01314872|162627|P12|Treatment Period 1|Physician Decision|0
41464|NCT01314872|162628|P11|Treatment Period 1|Physician Decision|0
41465|NCT01314872|162629|P10|Treatment Period 1|Physician Decision|1
41466|NCT01314872|162630|P9|Treatment Period 1|Physician Decision|0
41467|NCT01314872|162631|P8|Treatment Period 1|Physician Decision|0
41468|NCT01314872|162632|P7|Treatment Period 1|Physician Decision|0
41469|NCT01314872|162633|P6|Treatment Period 1|Physician Decision|0
41470|NCT01314872|162634|P5|Treatment Period 1|Physician Decision|0
41471|NCT01314872|162635|P4|Treatment Period 1|Physician Decision|1
41472|NCT01314872|162636|P3|Treatment Period 1|Physician Decision|0
41473|NCT01314872|162637|P2|Treatment Period 1|Physician Decision|1
41474|NCT01314872|162638|P1|Treatment Period 1|Physician Decision|0
41475|NCT01314872|162624|P15|Treatment Period 1|Protocol Violation|0
41476|NCT01314872|162625|P14|Treatment Period 1|Protocol Violation|0
41477|NCT01314872|162626|P13|Treatment Period 1|Protocol Violation|0
41478|NCT01314872|162627|P12|Treatment Period 1|Protocol Violation|0
41479|NCT01314872|162628|P11|Treatment Period 1|Protocol Violation|1
41480|NCT01314872|162629|P10|Treatment Period 1|Protocol Violation|1
41481|NCT01314872|162630|P9|Treatment Period 1|Protocol Violation|0
41482|NCT01314872|162631|P8|Treatment Period 1|Protocol Violation|0
41483|NCT01314872|162632|P7|Treatment Period 1|Protocol Violation|0
41484|NCT01314872|162633|P6|Treatment Period 1|Protocol Violation|0
41485|NCT01314872|162634|P5|Treatment Period 1|Protocol Violation|1
41486|NCT01314872|162635|P4|Treatment Period 1|Protocol Violation|0
41487|NCT01314872|162636|P3|Treatment Period 1|Protocol Violation|1
41488|NCT01314872|162637|P2|Treatment Period 1|Protocol Violation|1
41489|NCT01314872|162638|P1|Treatment Period 1|Protocol Violation|2
41490|NCT01314716|162742|P2|Open-Label Phase|Physician Decision|4
41491|NCT01314716|162743|P1|Open-Label Phase|Physician Decision|5
41492|NCT01314716|162742|P2|Open-Label Phase|Withdrawal by Subject|2
41493|NCT01314716|162743|P1|Open-Label Phase|Withdrawal by Subject|1
41494|NCT01314716|162742|P2|Open-Label Phase|Adverse Event|6
41495|NCT01314716|162743|P1|Open-Label Phase|Adverse Event|4
41496|NCT01314716|162742|P2|Double-Blind Phase|Physician Decision|1
41497|NCT01314716|162743|P1|Double-Blind Phase|Physician Decision|0
41498|NCT01314716|162742|P2|Double-Blind Phase|Sponsor request|2
41499|NCT01314716|162743|P1|Double-Blind Phase|Sponsor request|1
41500|NCT01314716|162742|P2|Double-Blind Phase|Lost to Follow-up|1
41501|NCT01314716|162743|P1|Double-Blind Phase|Lost to Follow-up|0
41502|NCT01314716|162742|P2|Double-Blind Phase|Withdrawal by Subject|6
41503|NCT01314716|162743|P1|Double-Blind Phase|Withdrawal by Subject|5
41504|NCT01314716|162742|P2|Double-Blind Phase|Adverse Event|4
41505|NCT01314716|162743|P1|Double-Blind Phase|Adverse Event|10
41506|NCT01314716|162742|P2|Double-Blind Phase|Randomized but not treated|1
41507|NCT01314716|162743|P1|Double-Blind Phase|Randomized but not treated|1
41508|NCT01314703|162755|P1|Overall Study|screen failure and closed enrollment|8
41509|NCT01314443|162764|P4|Overall Study|Protocol Violation|1
41510|NCT01314443|162765|P3|Overall Study|Protocol Violation|1
41511|NCT01314443|162766|P2|Overall Study|Protocol Violation|2
41512|NCT01314443|162767|P1|Overall Study|Protocol Violation|2
41513|NCT01314443|162764|P4|Overall Study|Withdrawal by Subject|1
41514|NCT01314443|162765|P3|Overall Study|Withdrawal by Subject|1
41515|NCT01314443|162766|P2|Overall Study|Withdrawal by Subject|1
41516|NCT01314443|162767|P1|Overall Study|Withdrawal by Subject|2
41517|NCT01314261|162816|P4|Overall Study|Virologic Failure|1
41518|NCT01314261|162817|P3|Overall Study|Virologic Failure|0
41519|NCT01314261|162818|P2|Overall Study|Virologic Failure|1
41520|NCT01314261|162819|P1|Overall Study|Virologic Failure|0
41521|NCT01314261|162816|P4|Overall Study|Lost to Follow-up|2
41522|NCT01314261|162817|P3|Overall Study|Lost to Follow-up|2
41523|NCT01314261|162818|P2|Overall Study|Lost to Follow-up|0
41524|NCT01314261|162819|P1|Overall Study|Lost to Follow-up|1
41525|NCT01314261|162816|P4|Overall Study|Withdrawal by Subject|0
41526|NCT01314261|162817|P3|Overall Study|Withdrawal by Subject|1
41527|NCT01314261|162818|P2|Overall Study|Withdrawal by Subject|3
41528|NCT01314261|162819|P1|Overall Study|Withdrawal by Subject|0
41529|NCT01314261|162816|P4|Overall Study|Adverse Event|0
41530|NCT01314261|162817|P3|Overall Study|Adverse Event|0
41531|NCT01314261|162818|P2|Overall Study|Adverse Event|0
41532|NCT01314261|162819|P1|Overall Study|Adverse Event|1
41533|NCT01314118|162870|P1|Overall Study|Ongoing|62
41534|NCT01314118|162870|P1|Overall Study|Unspecified|2
41535|NCT01314118|162870|P1|Overall Study|Withdrawal by Subject|11
41536|NCT01314118|162870|P1|Overall Study|Protocol Violation|5
41537|NCT01314118|162870|P1|Overall Study|Death|4
41538|NCT01314118|162870|P1|Overall Study|Physician Decision|11
41539|NCT01314118|162870|P1|Overall Study|Progressive disease|27
41540|NCT01314118|162870|P1|Overall Study|Adverse Event|9
41541|NCT01314105|162879|P2|Overall Study|Progressive Disease|4
41542|NCT01314105|162880|P1|Overall Study|Progressive Disease|6
41543|NCT01313923|162973|P1|Overall Study|Physician Decision|3
41544|NCT01313884|162977|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
41545|NCT01313858|162984|P3|Overall Study|Lost to Follow-up|47
41546|NCT01313858|162985|P2|Overall Study|Lost to Follow-up|51
41547|NCT01313858|162986|P1|Overall Study|Lost to Follow-up|35
41548|NCT01313858|162984|P3|Overall Study|Premature Treatment Termination|191
41549|NCT01313858|162985|P2|Overall Study|Premature Treatment Termination|219
41550|NCT01313858|162986|P1|Overall Study|Premature Treatment Termination|251
41551|NCT01313780|163009|P2|Overall Study|missing data|3
41552|NCT01313780|163010|P1|Overall Study|missing data|3
41553|NCT01313780|163009|P2|Overall Study|Protocol Violation|4
41554|NCT01313780|163010|P1|Overall Study|Protocol Violation|10
41555|NCT01313780|163009|P2|Overall Study|Withdrawal by Subject|8
41556|NCT01313780|163010|P1|Overall Study|Withdrawal by Subject|2
41557|NCT01313780|163009|P2|Overall Study|Adverse Event|11
41558|NCT01313780|163010|P1|Overall Study|Adverse Event|6
41559|NCT01313780|163009|P2|Overall Study|Lack of Efficacy|2
41560|NCT01313780|163010|P1|Overall Study|Lack of Efficacy|4
41561|NCT01313728|163018|P1|Informed Consent to Baseline|Withdrawal by Subject|1
41562|NCT01313689|163035|P4|24-Week Randomization 2|Withdrawal by Subject|1
41563|NCT01313689|163036|P3|24-Week Randomization 2|Withdrawal by Subject|1
41564|NCT01313689|163037|P2|24-Week Randomization 2|Withdrawal by Subject|0
41565|NCT01313689|163038|P1|24-Week Randomization 2|Withdrawal by Subject|0
41566|NCT01313689|163035|P4|24-Week Randomization 2|Adverse Event|0
41567|NCT01313689|163036|P3|24-Week Randomization 2|Adverse Event|2
41568|NCT01313689|163037|P2|24-Week Randomization 2|Adverse Event|0
41569|NCT01313689|163038|P1|24-Week Randomization 2|Adverse Event|0
41570|NCT01313689|163035|P4|24-Week Randomization 1|Withdrawal by Subject|0
41571|NCT01313689|163036|P3|24-Week Randomization 1|Withdrawal by Subject|0
41572|NCT01313689|163037|P2|24-Week Randomization 1|Withdrawal by Subject|0
41573|NCT01313689|163038|P1|24-Week Randomization 1|Withdrawal by Subject|5
41574|NCT01313689|163035|P4|24-Week Randomization 1|Physician Decision|0
41575|NCT01313689|163036|P3|24-Week Randomization 1|Physician Decision|0
41576|NCT01313689|163037|P2|24-Week Randomization 1|Physician Decision|5
41577|NCT01313689|163038|P1|24-Week Randomization 1|Physician Decision|4
41578|NCT01313689|163035|P4|24-Week Randomization 1|Adverse Event|0
41579|NCT01313689|163036|P3|24-Week Randomization 1|Adverse Event|0
41580|NCT01313689|163037|P2|24-Week Randomization 1|Adverse Event|5
41581|NCT01313689|163038|P1|24-Week Randomization 1|Adverse Event|10
41582|NCT01313676|163105|P4|Overall Study|Missing|0
41583|NCT01313676|163106|P3|Overall Study|Missing|1
41584|NCT01313676|163107|P2|Overall Study|Missing|1
41585|NCT01313676|163108|P1|Overall Study|Missing|1
41586|NCT01313676|163105|P4|Overall Study|Investigator Site Closed|10
41587|NCT01313676|163106|P3|Overall Study|Investigator Site Closed|15
41588|NCT01313676|163107|P2|Overall Study|Investigator Site Closed|11
41589|NCT01313676|163108|P1|Overall Study|Investigator Site Closed|12
41590|NCT01313676|163105|P4|Overall Study|Sponsor Terminated Study Treatment|1
41591|NCT01313676|163106|P3|Overall Study|Sponsor Terminated Study Treatment|0
41592|NCT01313676|163107|P2|Overall Study|Sponsor Terminated Study Treatment|1
41593|NCT01313676|163108|P1|Overall Study|Sponsor Terminated Study Treatment|1
41594|NCT01313676|163105|P4|Overall Study|Decision by Participant or Proxy|492
41595|NCT01313676|163106|P3|Overall Study|Decision by Participant or Proxy|515
41596|NCT01313676|163107|P2|Overall Study|Decision by Participant or Proxy|527
41597|NCT01313676|163108|P1|Overall Study|Decision by Participant or Proxy|643
41598|NCT01313676|163105|P4|Overall Study|Physician Decision|48
41599|NCT01313676|163106|P3|Overall Study|Physician Decision|62
41600|NCT01313676|163107|P2|Overall Study|Physician Decision|64
41601|NCT01313676|163108|P1|Overall Study|Physician Decision|53
41602|NCT01313676|163105|P4|Overall Study|Lost to Follow-up|0
41603|NCT01313676|163106|P3|Overall Study|Lost to Follow-up|1
41604|NCT01313676|163107|P2|Overall Study|Lost to Follow-up|0
41605|NCT01313676|163108|P1|Overall Study|Lost to Follow-up|0
41606|NCT01313676|163105|P4|Overall Study|Study Closed/terminated|9
41607|NCT01313676|163106|P3|Overall Study|Study Closed/terminated|9
41608|NCT01313676|163107|P2|Overall Study|Study Closed/terminated|6
41609|NCT01313676|163108|P1|Overall Study|Study Closed/terminated|7
41610|NCT01313676|163105|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
41611|NCT01313676|163106|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
41612|NCT01313676|163107|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
41613|NCT01313676|163108|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
41614|NCT01313676|163105|P4|Overall Study|Protocol Violation|44
41615|NCT01313676|163106|P3|Overall Study|Protocol Violation|46
41616|NCT01313676|163107|P2|Overall Study|Protocol Violation|44
41617|NCT01313676|163108|P1|Overall Study|Protocol Violation|37
41618|NCT01313676|163105|P4|Overall Study|Lack of Efficacy|46
41619|NCT01313676|163106|P3|Overall Study|Lack of Efficacy|65
41620|NCT01313676|163107|P2|Overall Study|Lack of Efficacy|90
41621|NCT01313676|163108|P1|Overall Study|Lack of Efficacy|98
41622|NCT01313676|163105|P4|Overall Study|Adverse Event|333
41623|NCT01313676|163106|P3|Overall Study|Adverse Event|372
41624|NCT01313676|163107|P2|Overall Study|Adverse Event|365
41625|NCT01313676|163108|P1|Overall Study|Adverse Event|395
41626|NCT01313663|163128|P2|Overall Study|Withdrawal by Subject|1
41627|NCT01313663|163129|P1|Overall Study|Withdrawal by Subject|2
41628|NCT01313663|163128|P2|Overall Study|Physician Decision|2
41629|NCT01313663|163129|P1|Overall Study|Physician Decision|0
41630|NCT01313663|163128|P2|Overall Study|Lost to Follow-up|1
41631|NCT01313663|163129|P1|Overall Study|Lost to Follow-up|0
41632|NCT01313663|163128|P2|Overall Study|Study Closed/Terminated|4
41633|NCT01313663|163129|P1|Overall Study|Study Closed/Terminated|2
41634|NCT01313650|163167|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
41635|NCT01313650|163168|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
41636|NCT01313650|163169|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
41637|NCT01313650|163170|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
41638|NCT01313650|163167|P4|Overall Study|Protocol Violation|6
41639|NCT01313650|163168|P3|Overall Study|Protocol Violation|5
41640|NCT01313650|163169|P2|Overall Study|Protocol Violation|7
41641|NCT01313650|163170|P1|Overall Study|Protocol Violation|4
41642|NCT01313650|163167|P4|Overall Study|Withdrawal by Subject|15
41643|NCT01313650|163168|P3|Overall Study|Withdrawal by Subject|15
41644|NCT01313650|163169|P2|Overall Study|Withdrawal by Subject|20
41645|NCT01313650|163170|P1|Overall Study|Withdrawal by Subject|16
41646|NCT01313650|163167|P4|Overall Study|Lost to Follow-up|2
41647|NCT01313650|163168|P3|Overall Study|Lost to Follow-up|3
41648|NCT01313650|163169|P2|Overall Study|Lost to Follow-up|0
41649|NCT01313650|163170|P1|Overall Study|Lost to Follow-up|1
41650|NCT01313650|163167|P4|Overall Study|Lack of Efficacy|20
41651|NCT01313650|163168|P3|Overall Study|Lack of Efficacy|32
41652|NCT01313650|163169|P2|Overall Study|Lack of Efficacy|20
41653|NCT01313650|163170|P1|Overall Study|Lack of Efficacy|37
41654|NCT01313650|163167|P4|Overall Study|Adverse Event|23
41655|NCT01313650|163168|P3|Overall Study|Adverse Event|24
41656|NCT01313650|163169|P2|Overall Study|Adverse Event|34
41657|NCT01313650|163170|P1|Overall Study|Adverse Event|9
41658|NCT01313637|163196|P4|Overall Study|Withdrawal by Subject|15
41659|NCT01313637|163197|P3|Overall Study|Withdrawal by Subject|18
41660|NCT01313637|163198|P2|Overall Study|Withdrawal by Subject|13
41661|NCT01313637|163199|P1|Overall Study|Withdrawal by Subject|11
41662|NCT01313637|163196|P4|Overall Study|Lost to Follow-up|3
41663|NCT01313637|163197|P3|Overall Study|Lost to Follow-up|1
41664|NCT01313637|163198|P2|Overall Study|Lost to Follow-up|2
41665|NCT01313637|163199|P1|Overall Study|Lost to Follow-up|0
41666|NCT01313637|163196|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
41667|NCT01313637|163197|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
41668|NCT01313637|163198|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
41669|NCT01313637|163199|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
41670|NCT01313637|163196|P4|Overall Study|Protocol Violation|5
41671|NCT01313637|163197|P3|Overall Study|Protocol Violation|11
41672|NCT01313637|163198|P2|Overall Study|Protocol Violation|3
41673|NCT01313637|163199|P1|Overall Study|Protocol Violation|4
41674|NCT01313637|163196|P4|Overall Study|Lack of Efficacy|24
41675|NCT01313637|163197|P3|Overall Study|Lack of Efficacy|37
41676|NCT01313637|163198|P2|Overall Study|Lack of Efficacy|38
41677|NCT01313637|163199|P1|Overall Study|Lack of Efficacy|44
41678|NCT01313637|163196|P4|Overall Study|Adverse Event|18
41679|NCT01313637|163197|P3|Overall Study|Adverse Event|25
41680|NCT01313637|163198|P2|Overall Study|Adverse Event|24
41681|NCT01313637|163199|P1|Overall Study|Adverse Event|17
41682|NCT01313624|163223|P2|Open-Label Phase|Lost to Follow-up|1
41683|NCT01313624|163224|P1|Open-Label Phase|Lost to Follow-up|1
41684|NCT01313624|163223|P2|Open-Label Phase|Withdrawal by Subject|2
41685|NCT01313624|163224|P1|Open-Label Phase|Withdrawal by Subject|2
41686|NCT01313624|163223|P2|Open-Label Phase|Adverse Event|10
41687|NCT01313624|163224|P1|Open-Label Phase|Adverse Event|1
41688|NCT01313624|163223|P2|Double-Blind Phase|Lack of Efficacy|0
41689|NCT01313624|163224|P1|Double-Blind Phase|Lack of Efficacy|1
41690|NCT01313624|163223|P2|Double-Blind Phase|Physician Decision|0
41691|NCT01313624|163224|P1|Double-Blind Phase|Physician Decision|1
41692|NCT01313624|163223|P2|Double-Blind Phase|Lost to Follow-up|2
41693|NCT01313624|163224|P1|Double-Blind Phase|Lost to Follow-up|0
41694|NCT01313624|163223|P2|Double-Blind Phase|Withdrawal by Subject|4
41695|NCT01313624|163224|P1|Double-Blind Phase|Withdrawal by Subject|9
41696|NCT01313624|163223|P2|Double-Blind Phase|Adverse Event|4
41697|NCT01313624|163224|P1|Double-Blind Phase|Adverse Event|27
41698|NCT01313299|163317|P3|Overall Study|Lack of subject compliance|1
41699|NCT01313299|163318|P2|Overall Study|Lack of subject compliance|0
41700|NCT01313299|163319|P1|Overall Study|Lack of subject compliance|0
41701|NCT01313299|163317|P3|Overall Study|Family reason and moved out of state|0
41702|NCT01313299|163318|P2|Overall Study|Family reason and moved out of state|2
41703|NCT01313299|163319|P1|Overall Study|Family reason and moved out of state|0
41704|NCT01313299|163317|P3|Overall Study|Withdrawal by Subject|2
41705|NCT01313299|163318|P2|Overall Study|Withdrawal by Subject|0
41706|NCT01313299|163319|P1|Overall Study|Withdrawal by Subject|1
41707|NCT01313299|163317|P3|Overall Study|Protocol Violation|0
41708|NCT01313299|163318|P2|Overall Study|Protocol Violation|0
41709|NCT01313299|163319|P1|Overall Study|Protocol Violation|2
41710|NCT01313299|163317|P3|Overall Study|Lost to Follow-up|0
41711|NCT01313299|163318|P2|Overall Study|Lost to Follow-up|0
41712|NCT01313299|163319|P1|Overall Study|Lost to Follow-up|1
41713|NCT01313299|163317|P3|Overall Study|Adverse Event|1
41714|NCT01313299|163318|P2|Overall Study|Adverse Event|1
41715|NCT01313299|163319|P1|Overall Study|Adverse Event|3
41716|NCT01313273|163335|P2|Overall Study|Screening Chromogranin A-in normal range|1
41717|NCT01313273|163336|P1|Overall Study|Screening Chromogranin A-in normal range|0
41718|NCT01313273|163335|P2|Overall Study|Withdrawal by Subject|0
41719|NCT01313273|163336|P1|Overall Study|Withdrawal by Subject|1
41720|NCT01313273|163335|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
41721|NCT01313273|163336|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
41722|NCT01313221|163351|P3|Overall Study|Pregnancy|2
41723|NCT01313221|163352|P2|Overall Study|Pregnancy|0
41724|NCT01313221|163353|P1|Overall Study|Pregnancy|0
41725|NCT01313221|163351|P3|Overall Study|Physician Decision|2
41726|NCT01313221|163352|P2|Overall Study|Physician Decision|0
41727|NCT01313221|163353|P1|Overall Study|Physician Decision|0
41728|NCT01313221|163351|P3|Overall Study|Disease progression|2
41729|NCT01313221|163352|P2|Overall Study|Disease progression|0
41730|NCT01313221|163353|P1|Overall Study|Disease progression|0
41731|NCT01313221|163351|P3|Overall Study|Adverse Event|7
41732|NCT01313221|163352|P2|Overall Study|Adverse Event|0
41733|NCT01313221|163353|P1|Overall Study|Adverse Event|0
41734|NCT01313221|163351|P3|Overall Study|Other|0
41735|NCT01313221|163352|P2|Overall Study|Other|0
41736|NCT01313221|163353|P1|Overall Study|Other|1
41737|NCT01313221|163351|P3|Overall Study|Lost to Follow-up|1
41738|NCT01313221|163352|P2|Overall Study|Lost to Follow-up|3
41739|NCT01313221|163353|P1|Overall Study|Lost to Follow-up|6
41740|NCT01313221|163351|P3|Overall Study|Requirement for alternative therapy|1
41741|NCT01313221|163352|P2|Overall Study|Requirement for alternative therapy|1
41742|NCT01313221|163353|P1|Overall Study|Requirement for alternative therapy|0
41743|NCT01313221|163351|P3|Overall Study|Withdrawal by Subject|5
41744|NCT01313221|163352|P2|Overall Study|Withdrawal by Subject|3
41745|NCT01313221|163353|P1|Overall Study|Withdrawal by Subject|2
41746|NCT01313221|163351|P3|Overall Study|Non-compliance|2
41747|NCT01313221|163352|P2|Overall Study|Non-compliance|0
41748|NCT01313221|163353|P1|Overall Study|Non-compliance|3
41749|NCT01313221|163351|P3|Overall Study|Protocol Violation|1
41750|NCT01313221|163352|P2|Overall Study|Protocol Violation|1
41751|NCT01313221|163353|P1|Overall Study|Protocol Violation|0
41752|NCT01313208|163405|P2|Open-label Phase (Weeks 13 - 24)|Other|0
41753|NCT01313208|163406|P1|Open-label Phase (Weeks 13 - 24)|Other|2
41754|NCT01313208|163405|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
41755|NCT01313208|163406|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
41756|NCT01313208|163405|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
41757|NCT01313208|163406|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
41758|NCT01313208|163405|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
41759|NCT01313208|163406|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
41760|NCT01313208|163405|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
41761|NCT01313208|163406|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
41762|NCT01313208|163405|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
41763|NCT01313208|163406|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
41764|NCT01313208|163405|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
41765|NCT01313208|163406|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
41766|NCT01313208|163405|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
41767|NCT01313208|163406|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
41768|NCT01313208|163405|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
41769|NCT01313208|163406|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
41770|NCT01313182|163496|P2|Overall Study|Protocol Violation|92
41771|NCT01313182|163497|P1|Overall Study|Protocol Violation|66
41772|NCT01313117|163503|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
41773|NCT01313117|163503|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
41774|NCT01313078|163510|P1|Overall Study|Withdrawal by Subject|1
41775|NCT01313078|163510|P1|Overall Study|Discontinued study drug|1
41776|NCT01313078|163510|P1|Overall Study|Death|1
41777|NCT01313039|163515|P1|Overall Study|Adverse Event|1
41778|NCT01313039|163515|P1|Overall Study|Physician Decision|1
41779|NCT01312467|163585|P1|Overall Study|Ineligible|4
41780|NCT01312467|163585|P1|Overall Study|Another medical condition|1
41781|NCT01312467|163585|P1|Overall Study|Deported to country of origin|1
41782|NCT01312467|163585|P1|Overall Study|Withdrawal by Subject|2
41783|NCT01312467|163585|P1|Overall Study|Lost to Follow-up|1
41784|NCT01312467|163585|P1|Overall Study|Adverse Event|4
41785|NCT01312428|163591|P2|Overall Study|Study Termination|4
41786|NCT01312428|163592|P1|Overall Study|Study Termination|3
41787|NCT01312129|163619|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
41788|NCT01312129|163620|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
41789|NCT01311687|163637|P2|PFS Follow-up Phase|On PFS follow-up at data cut-off|1
41790|NCT01311687|163638|P1|PFS Follow-up Phase|On PFS follow-up at data cut-off|3
41791|NCT01311687|163637|P2|Treatment Phase|On treatment at data cut-off|11
41792|NCT01311687|163638|P1|Treatment Phase|On treatment at data cut-off|60
41793|NCT01311661|163688|P1|Overall Study|Withdrawal by Subject|2
41794|NCT01311661|163688|P1|Overall Study|Protocol Violation|3
41795|NCT01311661|163688|P1|Overall Study|Adverse Event|2
41796|NCT01311557|163832|P2|Overall Study|Withdrawal by Subject|2
41797|NCT01311557|163833|P1|Overall Study|Withdrawal by Subject|1
41798|NCT01311557|163832|P2|Overall Study|Lost to Follow-up|1
41799|NCT01311557|163833|P1|Overall Study|Lost to Follow-up|0
41800|NCT01311557|163832|P2|Overall Study|Protocol Violation|2
41801|NCT01311557|163833|P1|Overall Study|Protocol Violation|4
41802|NCT01311557|163832|P2|Overall Study|Serious adverse event|1
41803|NCT01311557|163833|P1|Overall Study|Serious adverse event|0
41804|NCT01311505|163849|P2|First Intervention Period|Protocol Violation|1
41805|NCT01311505|163850|P1|First Intervention Period|Protocol Violation|0
41806|NCT01311024|163906|P2|Overall Study|Protocol Violation|22
41807|NCT01311024|163907|P1|Overall Study|Protocol Violation|35
41808|NCT01310855|163915|P2|Overall Study|cediranib manufacture discontinued by AZ|37
41809|NCT01310855|163916|P1|Overall Study|cediranib manufacture discontinued by AZ|37
41810|NCT01310803|163924|P2|Overall Study|Subject terminated by Sponsor|0
41811|NCT01310803|163925|P1|Overall Study|Subject terminated by Sponsor|1
41812|NCT01310777|163936|P3|Overall Study|Other|2
41813|NCT01310777|163937|P2|Overall Study|Other|1
41814|NCT01310777|163938|P1|Overall Study|Other|4
41815|NCT01310777|163936|P3|Overall Study|Inadequate Control of IOP|10
41816|NCT01310777|163937|P2|Overall Study|Inadequate Control of IOP|7
41817|NCT01310777|163938|P1|Overall Study|Inadequate Control of IOP|5
41818|NCT01310777|163936|P3|Overall Study|Patient's Decision Unrelated to AE|2
41819|NCT01310777|163937|P2|Overall Study|Patient's Decision Unrelated to AE|1
41820|NCT01310777|163938|P1|Overall Study|Patient's Decision Unrelated to AE|1
41821|NCT01310777|163936|P3|Overall Study|Lost to Follow-up|1
41822|NCT01310777|163937|P2|Overall Study|Lost to Follow-up|4
41823|NCT01310777|163938|P1|Overall Study|Lost to Follow-up|0
41824|NCT01310777|163936|P3|Overall Study|Adverse Event|15
41825|NCT01310777|163937|P2|Overall Study|Adverse Event|1
41826|NCT01310777|163938|P1|Overall Study|Adverse Event|23
41827|NCT01310413|163963|P7|From Day U0 to Day U385|Lost to Follow-up|2
41828|NCT01310413|163964|P6|From Day U0 to Day U385|Lost to Follow-up|0
41829|NCT01310413|163965|P5|From Day U0 to Day U385|Lost to Follow-up|0
41830|NCT01310413|163966|P4|From Day U0 to Day U385|Lost to Follow-up|0
41831|NCT01310413|163967|P3|From Day U0 to Day U385|Lost to Follow-up|0
41832|NCT01310413|163968|P2|From Day U0 to Day U385|Lost to Follow-up|0
41833|NCT01310413|163969|P1|From Day U0 to Day U385|Lost to Follow-up|0
41834|NCT01310413|163963|P7|From Day U0 to Day U385|Withdrawal by Subject|1
41835|NCT01310413|163964|P6|From Day U0 to Day U385|Withdrawal by Subject|0
41836|NCT01310413|163965|P5|From Day U0 to Day U385|Withdrawal by Subject|0
41837|NCT01310413|163966|P4|From Day U0 to Day U385|Withdrawal by Subject|0
41838|NCT01310413|163967|P3|From Day U0 to Day U385|Withdrawal by Subject|0
41839|NCT01310413|163968|P2|From Day U0 to Day U385|Withdrawal by Subject|0
41840|NCT01310413|163969|P1|From Day U0 to Day U385|Withdrawal by Subject|0
41841|NCT01310413|163963|P7|Day 0 to Day 385|Unspecified|0
41842|NCT01310413|163964|P6|Day 0 to Day 385|Unspecified|0
41843|NCT01310413|163965|P5|Day 0 to Day 385|Unspecified|0
41844|NCT01310413|163966|P4|Day 0 to Day 385|Unspecified|0
41845|NCT01310413|163967|P3|Day 0 to Day 385|Unspecified|3
41846|NCT01310413|163968|P2|Day 0 to Day 385|Unspecified|0
41847|NCT01310413|163969|P1|Day 0 to Day 385|Unspecified|1
41848|NCT01310413|163963|P7|Day 0 to Day 385|Migrated/moved from study area|0
41849|NCT01310413|163964|P6|Day 0 to Day 385|Migrated/moved from study area|0
41850|NCT01310413|163965|P5|Day 0 to Day 385|Migrated/moved from study area|1
41851|NCT01310413|163966|P4|Day 0 to Day 385|Migrated/moved from study area|1
41852|NCT01310413|163967|P3|Day 0 to Day 385|Migrated/moved from study area|1
41853|NCT01310413|163968|P2|Day 0 to Day 385|Migrated/moved from study area|3
41854|NCT01310413|163969|P1|Day 0 to Day 385|Migrated/moved from study area|3
41855|NCT01310413|163963|P7|Day 0 to Day 385|Lost to Follow-up|0
41856|NCT01310413|163964|P6|Day 0 to Day 385|Lost to Follow-up|2
41857|NCT01310413|163965|P5|Day 0 to Day 385|Lost to Follow-up|1
41858|NCT01310413|163966|P4|Day 0 to Day 385|Lost to Follow-up|5
41859|NCT01310413|163967|P3|Day 0 to Day 385|Lost to Follow-up|3
41860|NCT01310413|163968|P2|Day 0 to Day 385|Lost to Follow-up|3
41861|NCT01310413|163969|P1|Day 0 to Day 385|Lost to Follow-up|18
41862|NCT01310413|163963|P7|Day 0 to Day 385|Withdrawal by Subject|0
41863|NCT01310413|163964|P6|Day 0 to Day 385|Withdrawal by Subject|1
41864|NCT01310413|163965|P5|Day 0 to Day 385|Withdrawal by Subject|1
41865|NCT01310413|163966|P4|Day 0 to Day 385|Withdrawal by Subject|2
41866|NCT01310413|163967|P3|Day 0 to Day 385|Withdrawal by Subject|0
41867|NCT01310413|163968|P2|Day 0 to Day 385|Withdrawal by Subject|2
41868|NCT01310413|163969|P1|Day 0 to Day 385|Withdrawal by Subject|5
41869|NCT01310127|164151|P2|Overall Study|advanced psc cataract outlier|0
41870|NCT01310127|164152|P1|Overall Study|advanced psc cataract outlier|1
41871|NCT01310127|164151|P2|Overall Study|Protocol Violation|1
41872|NCT01310127|164152|P1|Overall Study|Protocol Violation|1
41873|NCT01309997|164166|P2|Overall Study|Withdrawal by Subject|1
41874|NCT01309997|164167|P1|Overall Study|Withdrawal by Subject|1
41875|NCT01309997|164166|P2|Overall Study|Lack of Efficacy|2
41876|NCT01309997|164167|P1|Overall Study|Lack of Efficacy|2
41877|NCT01309997|164166|P2|Overall Study|Death|3
41878|NCT01309997|164167|P1|Overall Study|Death|1
41879|NCT01309997|164166|P2|Overall Study|Adverse Event|0
41880|NCT01309997|164167|P1|Overall Study|Adverse Event|1
41881|NCT01309919|164191|P2|Overall Study|Did not receive a postpartum IUD|48
41882|NCT01309919|164192|P1|Overall Study|Did not receive a postpartum IUD|17
41883|NCT01309893|164204|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
41884|NCT01309893|164205|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
41885|NCT01309893|164204|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
41886|NCT01309893|164205|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
41887|NCT01309841|164229|P3|Overall Study|Severe non-compliance with protocol|2
41888|NCT01309841|164230|P2|Overall Study|Severe non-compliance with protocol|5
41889|NCT01309841|164231|P1|Overall Study|Severe non-compliance with protocol|0
41890|NCT01309841|164229|P3|Overall Study|Did Not Receive Treatment|1
41891|NCT01309841|164230|P2|Overall Study|Did Not Receive Treatment|0
41892|NCT01309841|164231|P1|Overall Study|Did Not Receive Treatment|2
41893|NCT01309841|164229|P3|Overall Study|Withdrawal by Subject|13
41894|NCT01309841|164230|P2|Overall Study|Withdrawal by Subject|6
41895|NCT01309841|164231|P1|Overall Study|Withdrawal by Subject|17
41896|NCT01309841|164229|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
41897|NCT01309841|164230|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
41898|NCT01309841|164231|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
41899|NCT01309841|164229|P3|Overall Study|Death|0
41900|NCT01309841|164230|P2|Overall Study|Death|0
41901|NCT01309841|164231|P1|Overall Study|Death|1
41902|NCT01309841|164229|P3|Overall Study|Adverse Event|11
41903|NCT01309841|164230|P2|Overall Study|Adverse Event|22
41904|NCT01309841|164231|P1|Overall Study|Adverse Event|9
41905|NCT01309841|164229|P3|Overall Study|Lack of Efficacy|2
41906|NCT01309841|164230|P2|Overall Study|Lack of Efficacy|0
41907|NCT01309841|164231|P1|Overall Study|Lack of Efficacy|0
41908|NCT01309841|164229|P3|Overall Study|Study-Specific Withdrawal Criteria|2
41909|NCT01309841|164230|P2|Overall Study|Study-Specific Withdrawal Criteria|1
41910|NCT01309841|164231|P1|Overall Study|Study-Specific Withdrawal Criteria|3
41911|NCT01309841|164229|P3|Overall Study|Lost to Follow-up|4
41912|NCT01309841|164230|P2|Overall Study|Lost to Follow-up|6
41913|NCT01309841|164231|P1|Overall Study|Lost to Follow-up|7
41914|NCT01309841|164229|P3|Overall Study|Other|1
41915|NCT01309841|164230|P2|Overall Study|Other|1
41916|NCT01309841|164231|P1|Overall Study|Other|0
41917|NCT01309828|164271|P2|Overall Study|Other|0
41918|NCT01309828|164272|P1|Overall Study|Other|1
41919|NCT01309828|164271|P2|Overall Study|Major Protocol Deviation|1
41920|NCT01309828|164272|P1|Overall Study|Major Protocol Deviation|0
41921|NCT01309828|164271|P2|Overall Study|Voluntary Withdrawal|4
41922|NCT01309828|164272|P1|Overall Study|Voluntary Withdrawal|5
41923|NCT01309828|164271|P2|Overall Study|Adverse Event|11
41924|NCT01309828|164272|P1|Overall Study|Adverse Event|10
41925|NCT01309737|164287|P5|Week 16 to 52|Unspecified|0
41926|NCT01309737|164288|P4|Week 16 to 52|Unspecified|2
41927|NCT01309737|164289|P3|Week 16 to 52|Unspecified|0
41928|NCT01309737|164290|P2|Week 16 to 52|Unspecified|12
41929|NCT01309737|164291|P1|Week 16 to 52|Unspecified|10
41930|NCT01309737|164287|P5|Week 16 to 52|Withdrawal by Subject|2
41931|NCT01309737|164288|P4|Week 16 to 52|Withdrawal by Subject|0
41932|NCT01309737|164289|P3|Week 16 to 52|Withdrawal by Subject|0
41933|NCT01309737|164290|P2|Week 16 to 52|Withdrawal by Subject|6
41934|NCT01309737|164291|P1|Week 16 to 52|Withdrawal by Subject|5
41935|NCT01309737|164287|P5|Week 16 to 52|Lost to Follow-up|4
41936|NCT01309737|164288|P4|Week 16 to 52|Lost to Follow-up|1
41937|NCT01309737|164289|P3|Week 16 to 52|Lost to Follow-up|0
41938|NCT01309737|164290|P2|Week 16 to 52|Lost to Follow-up|2
41939|NCT01309737|164291|P1|Week 16 to 52|Lost to Follow-up|4
41940|NCT01309737|164287|P5|Week 16 to 52|Lack of Efficacy|21
41941|NCT01309737|164288|P4|Week 16 to 52|Lack of Efficacy|25
41942|NCT01309737|164289|P3|Week 16 to 52|Lack of Efficacy|0
41943|NCT01309737|164290|P2|Week 16 to 52|Lack of Efficacy|76
41944|NCT01309737|164291|P1|Week 16 to 52|Lack of Efficacy|107
41945|NCT01309737|164287|P5|Week 16 to 52|Adverse Event|5
41946|NCT01309737|164288|P4|Week 16 to 52|Adverse Event|6
41947|NCT01309737|164289|P3|Week 16 to 52|Adverse Event|0
41948|NCT01309737|164290|P2|Week 16 to 52|Adverse Event|7
41949|NCT01309737|164291|P1|Week 16 to 52|Adverse Event|7
41950|NCT01309737|164287|P5|Week 16 to 52|Death|1
41951|NCT01309737|164288|P4|Week 16 to 52|Death|0
41952|NCT01309737|164289|P3|Week 16 to 52|Death|0
41953|NCT01309737|164290|P2|Week 16 to 52|Death|0
41954|NCT01309737|164291|P1|Week 16 to 52|Death|0
41955|NCT01309737|164287|P5|Week 0 to 16|Randomized, but not treated|0
41956|NCT01309737|164288|P4|Week 0 to 16|Randomized, but not treated|0
41957|NCT01309737|164289|P3|Week 0 to 16|Randomized, but not treated|0
41958|NCT01309737|164290|P2|Week 0 to 16|Randomized, but not treated|0
41959|NCT01309737|164291|P1|Week 0 to 16|Randomized, but not treated|1
41960|NCT01309737|164287|P5|Week 0 to 16|Unspecified|0
41961|NCT01309737|164288|P4|Week 0 to 16|Unspecified|0
41962|NCT01309737|164289|P3|Week 0 to 16|Unspecified|4
41963|NCT01309737|164290|P2|Week 0 to 16|Unspecified|14
41964|NCT01309737|164291|P1|Week 0 to 16|Unspecified|10
41965|NCT01309737|164287|P5|Week 0 to 16|Withdrawal by Subject|0
41966|NCT01309737|164288|P4|Week 0 to 16|Withdrawal by Subject|0
41967|NCT01309737|164289|P3|Week 0 to 16|Withdrawal by Subject|7
41968|NCT01309737|164290|P2|Week 0 to 16|Withdrawal by Subject|6
41969|NCT01309737|164291|P1|Week 0 to 16|Withdrawal by Subject|7
41970|NCT01309737|164287|P5|Week 0 to 16|Lost to Follow-up|0
41971|NCT01309737|164288|P4|Week 0 to 16|Lost to Follow-up|0
41972|NCT01309737|164289|P3|Week 0 to 16|Lost to Follow-up|3
41973|NCT01309737|164290|P2|Week 0 to 16|Lost to Follow-up|8
41974|NCT01309737|164291|P1|Week 0 to 16|Lost to Follow-up|7
41975|NCT01309737|164287|P5|Week 0 to 16|Lack of Efficacy|0
41976|NCT01309737|164288|P4|Week 0 to 16|Lack of Efficacy|0
41977|NCT01309737|164289|P3|Week 0 to 16|Lack of Efficacy|24
41978|NCT01309737|164290|P2|Week 0 to 16|Lack of Efficacy|2
41979|NCT01309737|164291|P1|Week 0 to 16|Lack of Efficacy|15
41980|NCT01309737|164287|P5|Week 0 to 16|Adverse Event|0
41981|NCT01309737|164288|P4|Week 0 to 16|Adverse Event|0
41982|NCT01309737|164289|P3|Week 0 to 16|Adverse Event|5
41983|NCT01309737|164290|P2|Week 0 to 16|Adverse Event|10
41984|NCT01309737|164291|P1|Week 0 to 16|Adverse Event|11
41985|NCT01309737|164287|P5|Week 0 to 16|Death|0
41986|NCT01309737|164288|P4|Week 0 to 16|Death|0
41987|NCT01309737|164289|P3|Week 0 to 16|Death|1
41988|NCT01309737|164290|P2|Week 0 to 16|Death|0
41989|NCT01309737|164291|P1|Week 0 to 16|Death|1
41990|NCT01309659|164488|P2|Overall Study|Protocol Violation|1
41991|NCT01309659|164489|P1|Overall Study|Protocol Violation|0
41992|NCT01309386|164594|P2|Overall Study|Adverse Event|8
41993|NCT01309386|164595|P1|Overall Study|Adverse Event|5
41994|NCT01309386|164594|P2|Overall Study|Lack of Efficacy|1
41995|NCT01309386|164595|P1|Overall Study|Lack of Efficacy|3
41996|NCT01309386|164594|P2|Overall Study|Physician Decision|1
41997|NCT01309386|164595|P1|Overall Study|Physician Decision|1
41998|NCT01309386|164594|P2|Overall Study|Progressive disease|11
41999|NCT01309386|164595|P1|Overall Study|Progressive disease|9
42000|NCT01309386|164594|P2|Overall Study|Withdrawal by Subject|0
42001|NCT01309386|164595|P1|Overall Study|Withdrawal by Subject|2
42002|NCT01309386|164594|P2|Overall Study|Unspecified|0
42003|NCT01309386|164595|P1|Overall Study|Unspecified|2
42004|NCT01309308|164643|P2|Overall Study|Lost to Follow-up|4
42005|NCT01309308|164644|P1|Overall Study|Lost to Follow-up|6
42006|NCT01309282|164652|P1|Overall Study|Lost to Follow-up|1
42007|NCT01309269|164669|P1|Overall Study|Enrolled but not Treated|107
42008|NCT01309269|164669|P1|Overall Study|Study Completion Data Not Recorded|95
42009|NCT01309269|164669|P1|Overall Study|Other|1
42010|NCT01309269|164669|P1|Overall Study|Unspecified|256
42011|NCT01309269|164669|P1|Overall Study|Administrative Problems|141
42012|NCT01309269|164669|P1|Overall Study|Kidney Transplant|25
42013|NCT01309269|164669|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
42014|NCT01309269|164669|P1|Overall Study|Lack of Acceptance|15
42015|NCT01309269|164669|P1|Overall Study|Withdrawal by Subject|25
42016|NCT01309269|164669|P1|Overall Study|Adverse Event|56
42017|NCT01309243|164677|P2|Extension Phase|Lost to Follow-up|0
42018|NCT01309243|164678|P1|Extension Phase|Lost to Follow-up|6
42019|NCT01309243|164677|P2|Randomized Phase Through Week 96|Protocol Violation|1
42020|NCT01309243|164678|P1|Randomized Phase Through Week 96|Protocol Violation|1
42021|NCT01309243|164677|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
42022|NCT01309243|164678|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
42023|NCT01309243|164677|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
42024|NCT01309243|164678|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
42025|NCT01309243|164677|P2|Randomized Phase Through Week 96|Withdrew Consent|18
42026|NCT01309243|164678|P1|Randomized Phase Through Week 96|Withdrew Consent|12
42027|NCT01309243|164677|P2|Randomized Phase Through Week 96|Investigators Discretion|6
42028|NCT01309243|164678|P1|Randomized Phase Through Week 96|Investigators Discretion|3
42029|NCT01309243|164677|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
42030|NCT01309243|164678|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
42031|NCT01309243|164677|P2|Randomized Phase Through Week 96|Pregnancy|0
42032|NCT01309243|164678|P1|Randomized Phase Through Week 96|Pregnancy|2
42033|NCT01309243|164677|P2|Randomized Phase Through Week 96|Death|1
42034|NCT01309243|164678|P1|Randomized Phase Through Week 96|Death|0
42035|NCT01309243|164677|P2|Randomized Phase Through Week 96|Adverse Event|43
42036|NCT01309243|164678|P1|Randomized Phase Through Week 96|Adverse Event|12
42037|NCT01309243|164677|P2|Randomized Phase Through Week 96|Randomized but not treated|7
42038|NCT01309243|164678|P1|Randomized Phase Through Week 96|Randomized but not treated|6
42039|NCT01309204|164704|P2|Overall Study|Other|1
42040|NCT01309204|164705|P1|Overall Study|Other|4
42041|NCT01309204|164704|P2|Overall Study|Inadequate control of IOP|4
42042|NCT01309204|164705|P1|Overall Study|Inadequate control of IOP|4
42043|NCT01309204|164704|P2|Overall Study|Subject's decision unrelated to an AE|10
42044|NCT01309204|164705|P1|Overall Study|Subject's decision unrelated to an AE|9
42045|NCT01309204|164704|P2|Overall Study|Lost to Follow-up|2
42046|NCT01309204|164705|P1|Overall Study|Lost to Follow-up|2
42047|NCT01309204|164704|P2|Overall Study|Adverse Event|58
42048|NCT01309204|164705|P1|Overall Study|Adverse Event|48
42049|NCT01309100|164711|P1|Overall Study|Positive Slit lamp finding|1
42050|NCT01309100|164711|P1|Overall Study|Protocol Violation|1
42051|NCT01308788|164738|P2|2-year Treatment|medication change by treating physician|11
42052|NCT01308788|164739|P1|2-year Treatment|medication change by treating physician|4
42053|NCT01308762|164774|P3|Overall Study|Protocol Violation|0
42054|NCT01308762|164775|P2|Overall Study|Protocol Violation|1
42055|NCT01308762|164776|P1|Overall Study|Protocol Violation|0
42056|NCT01308736|164789|P2|Overall Study|Did not attend a single session|5
42057|NCT01308736|164790|P1|Overall Study|Did not attend a single session|6
42058|NCT01308580|164813|P2|Overall Study|Lost to Follow-up|7
42059|NCT01308580|164814|P1|Overall Study|Lost to Follow-up|12
42060|NCT01308476|164856|P2|Overall Study|Other|0
42061|NCT01308476|164857|P1|Overall Study|Other|1
42062|NCT01308476|164856|P2|Overall Study|Lost to Follow-up|2
42063|NCT01308476|164857|P1|Overall Study|Lost to Follow-up|2
42064|NCT01308424|164883|P3|Randomization|Physician Decision|1
42065|NCT01308424|164884|P2|Randomization|Physician Decision|1
42066|NCT01308424|164885|P1|Randomization|Physician Decision|0
42067|NCT01308424|164883|P3|Randomization|Lost to Follow-up|0
42068|NCT01308424|164884|P2|Randomization|Lost to Follow-up|1
42069|NCT01308424|164885|P1|Randomization|Lost to Follow-up|0
42070|NCT01308424|164883|P3|Randomization|Adverse Event|1
42071|NCT01308424|164884|P2|Randomization|Adverse Event|1
42072|NCT01308424|164885|P1|Randomization|Adverse Event|0
42073|NCT01308424|164883|P3|Baseline Eligibility|Screen Failures|0
42074|NCT01308424|164884|P2|Baseline Eligibility|Screen Failures|0
42075|NCT01308424|164885|P1|Baseline Eligibility|Screen Failures|71
42076|NCT01307787|164894|P2|Overall Study|Withdrawal by Subject|0
42077|NCT01307787|164895|P1|Overall Study|Withdrawal by Subject|2
42078|NCT01307423|164937|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
42079|NCT01307423|164938|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
42080|NCT01307423|164939|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
42081|NCT01307423|164940|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
42082|NCT01307423|164941|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
42083|NCT01307423|164942|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
42084|NCT01307423|164943|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
42085|NCT01307423|164937|P7|Active Treatment Phase (Week 25-52)|Unspecified|0
42086|NCT01307423|164938|P6|Active Treatment Phase (Week 25-52)|Unspecified|0
42087|NCT01307423|164939|P5|Active Treatment Phase (Week 25-52)|Unspecified|0
42088|NCT01307423|164940|P4|Active Treatment Phase (Week 25-52)|Unspecified|1
42089|NCT01307423|164941|P3|Active Treatment Phase (Week 25-52)|Unspecified|0
42090|NCT01307423|164942|P2|Active Treatment Phase (Week 25-52)|Unspecified|0
42091|NCT01307423|164943|P1|Active Treatment Phase (Week 25-52)|Unspecified|0
42092|NCT01307423|164937|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
42093|NCT01307423|164938|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
42094|NCT01307423|164939|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
42095|NCT01307423|164940|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
42096|NCT01307423|164941|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
42097|NCT01307423|164942|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
42098|NCT01307423|164943|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
42099|NCT01307423|164937|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
42100|NCT01307423|164938|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
42101|NCT01307423|164939|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
42102|NCT01307423|164940|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
42103|NCT01307423|164941|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
42104|NCT01307423|164942|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
42105|NCT01307423|164943|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
42106|NCT01307423|164937|P7|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
42107|NCT01307423|164938|P6|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|1
42108|NCT01307423|164939|P5|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
42109|NCT01307423|164940|P4|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
42110|NCT01307423|164941|P3|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
42111|NCT01307423|164942|P2|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
42112|NCT01307423|164943|P1|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
42113|NCT01307423|164937|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
42114|NCT01307423|164938|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
42115|NCT01307423|164939|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
42116|NCT01307423|164940|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
42117|NCT01307423|164941|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
42118|NCT01307423|164942|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
42119|NCT01307423|164943|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
42120|NCT01307423|164937|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
42121|NCT01307423|164938|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
42122|NCT01307423|164939|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
42123|NCT01307423|164940|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
42124|NCT01307423|164941|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
42125|NCT01307423|164942|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
42126|NCT01307423|164943|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
42127|NCT01307423|164937|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
42128|NCT01307423|164938|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
42129|NCT01307423|164939|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
42130|NCT01307423|164940|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
42131|NCT01307423|164941|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
42132|NCT01307423|164942|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
42133|NCT01307423|164943|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
42134|NCT01307423|164937|P7|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
42135|NCT01307423|164938|P6|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
42136|NCT01307423|164939|P5|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
42137|NCT01307423|164940|P4|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
42138|NCT01307423|164941|P3|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
42139|NCT01307423|164942|P2|Placebo-controlled Phase (Week 0 - 24)|Unspecified|2
42140|NCT01307423|164943|P1|Placebo-controlled Phase (Week 0 - 24)|Unspecified|1
42141|NCT01307423|164937|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
42142|NCT01307423|164938|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
42143|NCT01307423|164939|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
42144|NCT01307423|164940|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
42145|NCT01307423|164941|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
42146|NCT01307423|164942|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
42147|NCT01307423|164943|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
42148|NCT01307423|164937|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
42149|NCT01307423|164938|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
42150|NCT01307423|164939|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
42151|NCT01307423|164940|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
42152|NCT01307423|164941|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
42153|NCT01307423|164942|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
42154|NCT01307423|164943|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
42155|NCT01307423|164937|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
42156|NCT01307423|164938|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
42157|NCT01307423|164939|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
42158|NCT01307423|164940|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
42159|NCT01307423|164941|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
42160|NCT01307423|164942|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
42161|NCT01307423|164943|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
42162|NCT01307423|164937|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
42163|NCT01307423|164938|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
42164|NCT01307423|164939|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
42165|NCT01307423|164940|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
42166|NCT01307423|164941|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
42167|NCT01307423|164942|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
42168|NCT01307423|164943|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
42169|NCT01307423|164937|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
42170|NCT01307423|164938|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
42171|NCT01307423|164939|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
42172|NCT01307423|164940|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
42173|NCT01307423|164941|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
42174|NCT01307423|164942|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
42175|NCT01307423|164943|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
42176|NCT01307423|164937|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
42177|NCT01307423|164938|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
42178|NCT01307423|164939|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
42179|NCT01307423|164940|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
42180|NCT01307423|164941|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
42181|NCT01307423|164942|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
42182|NCT01307423|164943|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
42183|NCT01307319|165055|P3|Overall Study|Not specified|3
42184|NCT01307319|165056|P2|Overall Study|Not specified|4
42185|NCT01307319|165057|P1|Overall Study|Not specified|0
42186|NCT01307319|165055|P3|Overall Study|Withdrawal by Subject|2
42187|NCT01307319|165056|P2|Overall Study|Withdrawal by Subject|1
42188|NCT01307319|165057|P1|Overall Study|Withdrawal by Subject|0
42189|NCT01307319|165055|P3|Overall Study|Protocol Violation|0
42190|NCT01307319|165056|P2|Overall Study|Protocol Violation|1
42191|NCT01307319|165057|P1|Overall Study|Protocol Violation|1
42192|NCT01307319|165055|P3|Overall Study|Lost to Follow-up|1
42193|NCT01307319|165056|P2|Overall Study|Lost to Follow-up|0
42194|NCT01307319|165057|P1|Overall Study|Lost to Follow-up|1
42195|NCT01307319|165055|P3|Overall Study|Adverse Event|1
42196|NCT01307319|165056|P2|Overall Study|Adverse Event|2
42197|NCT01307319|165057|P1|Overall Study|Adverse Event|2
42198|NCT01307111|165071|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
42199|NCT01307111|165072|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
42200|NCT01307111|165071|P2|IUD Insertion|Lost to Follow-up|0
42201|NCT01307111|165072|P1|IUD Insertion|Lost to Follow-up|2
42202|NCT01307046|165082|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
42203|NCT01307046|165083|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
42204|NCT01307046|165082|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
42205|NCT01307046|165083|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
42206|NCT01307046|165082|P2|Overall Study|Withdrawal by Subject|1
42207|NCT01307046|165083|P1|Overall Study|Withdrawal by Subject|1
42208|NCT01307046|165082|P2|Overall Study|Physician Decision|0
42209|NCT01307046|165083|P1|Overall Study|Physician Decision|2
42210|NCT01307046|165082|P2|Overall Study|Lack of Efficacy|2
42211|NCT01307046|165083|P1|Overall Study|Lack of Efficacy|0
42212|NCT01307046|165082|P2|Overall Study|Adverse Event|3
42213|NCT01307046|165083|P1|Overall Study|Adverse Event|3
42214|NCT01307033|165095|P4|44-week Open-label Extension|Death|1
42215|NCT01307033|165096|P3|44-week Open-label Extension|Death|0
42216|NCT01307033|165097|P2|44-week Open-label Extension|Death|0
42217|NCT01307033|165098|P1|44-week Open-label Extension|Death|0
42218|NCT01307033|165095|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
42219|NCT01307033|165096|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
42220|NCT01307033|165097|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
42221|NCT01307033|165098|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
42222|NCT01307033|165095|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
42223|NCT01307033|165096|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
42224|NCT01307033|165097|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
42225|NCT01307033|165098|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
42226|NCT01307033|165095|P4|44-week Open-label Extension|Physician Decision|0
42227|NCT01307033|165096|P3|44-week Open-label Extension|Physician Decision|1
42228|NCT01307033|165097|P2|44-week Open-label Extension|Physician Decision|0
42229|NCT01307033|165098|P1|44-week Open-label Extension|Physician Decision|0
42230|NCT01307033|165095|P4|44-week Open-label Extension|Withdrawal by Subject|1
42231|NCT01307033|165096|P3|44-week Open-label Extension|Withdrawal by Subject|2
42232|NCT01307033|165097|P2|44-week Open-label Extension|Withdrawal by Subject|0
42233|NCT01307033|165098|P1|44-week Open-label Extension|Withdrawal by Subject|0
42234|NCT01307033|165095|P4|44-week Open-label Extension|Adverse Event|1
42235|NCT01307033|165096|P3|44-week Open-label Extension|Adverse Event|2
42236|NCT01307033|165097|P2|44-week Open-label Extension|Adverse Event|0
42237|NCT01307033|165098|P1|44-week Open-label Extension|Adverse Event|0
42238|NCT01307033|165095|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
42239|NCT01307033|165096|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
42240|NCT01307033|165097|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
42241|NCT01307033|165098|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
42242|NCT01307033|165095|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
42243|NCT01307033|165096|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
42244|NCT01307033|165097|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
42245|NCT01307033|165098|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
42246|NCT01307033|165095|P4|8-week Double-blind Period|Lack of Efficacy|0
42247|NCT01307033|165096|P3|8-week Double-blind Period|Lack of Efficacy|0
42248|NCT01307033|165097|P2|8-week Double-blind Period|Lack of Efficacy|0
42249|NCT01307033|165098|P1|8-week Double-blind Period|Lack of Efficacy|1
42250|NCT01307033|165095|P4|8-week Double-blind Period|Withdrawal by Subject|0
42251|NCT01307033|165096|P3|8-week Double-blind Period|Withdrawal by Subject|0
42252|NCT01307033|165097|P2|8-week Double-blind Period|Withdrawal by Subject|1
42253|NCT01307033|165098|P1|8-week Double-blind Period|Withdrawal by Subject|4
42254|NCT01307033|165095|P4|8-week Double-blind Period|Adverse Event|0
42255|NCT01307033|165096|P3|8-week Double-blind Period|Adverse Event|0
42256|NCT01307033|165097|P2|8-week Double-blind Period|Adverse Event|0
42257|NCT01307033|165098|P1|8-week Double-blind Period|Adverse Event|2
42258|NCT01307020|165120|P10|Overall Study|Electronic data capture failure|0
42259|NCT01307020|165121|P9|Overall Study|Electronic data capture failure|0
42260|NCT01307020|165122|P8|Overall Study|Electronic data capture failure|0
42261|NCT01307020|165123|P7|Overall Study|Electronic data capture failure|0
42262|NCT01307020|165124|P6|Overall Study|Electronic data capture failure|0
42263|NCT01307020|165125|P5|Overall Study|Electronic data capture failure|0
42264|NCT01307020|165126|P4|Overall Study|Electronic data capture failure|0
42265|NCT01307020|165127|P3|Overall Study|Electronic data capture failure|0
42266|NCT01307020|165128|P2|Overall Study|Electronic data capture failure|1
42267|NCT01307020|165129|P1|Overall Study|Electronic data capture failure|0
42268|NCT01307020|165120|P10|Overall Study|Lost to Follow-up|0
42269|NCT01307020|165121|P9|Overall Study|Lost to Follow-up|0
42270|NCT01307020|165122|P8|Overall Study|Lost to Follow-up|0
42271|NCT01307020|165123|P7|Overall Study|Lost to Follow-up|1
42272|NCT01307020|165124|P6|Overall Study|Lost to Follow-up|0
42273|NCT01307020|165125|P5|Overall Study|Lost to Follow-up|0
42274|NCT01307020|165126|P4|Overall Study|Lost to Follow-up|1
42275|NCT01307020|165127|P3|Overall Study|Lost to Follow-up|1
42276|NCT01307020|165128|P2|Overall Study|Lost to Follow-up|0
42277|NCT01307020|165129|P1|Overall Study|Lost to Follow-up|0
42278|NCT01306968|165175|P4|Overall Study|Withdrew over privacy concerns|1
42279|NCT01306968|165176|P3|Overall Study|Withdrew over privacy concerns|0
42280|NCT01306968|165177|P2|Overall Study|Withdrew over privacy concerns|0
42281|NCT01306968|165178|P1|Overall Study|Withdrew over privacy concerns|0
42282|NCT01306968|165175|P4|Overall Study|Withdrew - time commitment|2
42283|NCT01306968|165176|P3|Overall Study|Withdrew - time commitment|0
42284|NCT01306968|165177|P2|Overall Study|Withdrew - time commitment|0
42285|NCT01306968|165178|P1|Overall Study|Withdrew - time commitment|0
42286|NCT01306968|165175|P4|Overall Study|Relocated and left active duty|1
42287|NCT01306968|165176|P3|Overall Study|Relocated and left active duty|1
42288|NCT01306968|165177|P2|Overall Study|Relocated and left active duty|1
42289|NCT01306968|165178|P1|Overall Study|Relocated and left active duty|0
42290|NCT01306968|165175|P4|Overall Study|Physician Decision|0
42291|NCT01306968|165176|P3|Overall Study|Physician Decision|0
42292|NCT01306968|165177|P2|Overall Study|Physician Decision|1
42293|NCT01306968|165178|P1|Overall Study|Physician Decision|0
42294|NCT01306968|165175|P4|Overall Study|Lost to Follow-up|0
42295|NCT01306968|165176|P3|Overall Study|Lost to Follow-up|0
42296|NCT01306968|165177|P2|Overall Study|Lost to Follow-up|1
42297|NCT01306968|165178|P1|Overall Study|Lost to Follow-up|1
42298|NCT01306877|165202|P2|Overall Study|Physician Decision|1
42299|NCT01306877|165203|P1|Overall Study|Physician Decision|0
42300|NCT01306877|165202|P2|Overall Study|Lost to Follow-up|3
42301|NCT01306877|165203|P1|Overall Study|Lost to Follow-up|3
42302|NCT01306643|165221|P1|Overall Study|Other: Change in Eligibility Status|1
42303|NCT01306643|165221|P1|Overall Study|Disease Progression|7
42304|NCT01306643|165221|P1|Overall Study|Adverse Event|5
42305|NCT01306617|165233|P3|Overall Study|Non-compliance|0
42306|NCT01306617|165234|P2|Overall Study|Non-compliance|1
42307|NCT01306617|165235|P1|Overall Study|Non-compliance|0
42308|NCT01306617|165233|P3|Overall Study|Virologic Failure|5
42309|NCT01306617|165234|P2|Overall Study|Virologic Failure|0
42310|NCT01306617|165235|P1|Overall Study|Virologic Failure|0
42311|NCT01306617|165233|P3|Overall Study|Adverse Event|0
42312|NCT01306617|165234|P2|Overall Study|Adverse Event|0
42313|NCT01306617|165235|P1|Overall Study|Adverse Event|1
42314|NCT01306305|165278|P2|Overall Study|Withdrew consent|0
42315|NCT01306305|165279|P1|Overall Study|Withdrew consent|1
42316|NCT01306305|165278|P2|Overall Study|Lost to Follow-up|0
42317|NCT01306305|165279|P1|Overall Study|Lost to Follow-up|1
42318|NCT01306253|165316|P2|Overall Study|Lost to Follow-up|1
42319|NCT01306253|165317|P1|Overall Study|Lost to Follow-up|1
42320|NCT01306214|165334|P3|Overall Study|Not treated|1
42321|NCT01306214|165335|P2|Overall Study|Not treated|1
42322|NCT01306214|165336|P1|Overall Study|Not treated|1
42323|NCT01306214|165334|P3|Overall Study|Withdrawal by Subject|16
42324|NCT01306214|165335|P2|Overall Study|Withdrawal by Subject|22
42325|NCT01306214|165336|P1|Overall Study|Withdrawal by Subject|24
42326|NCT01306214|165334|P3|Overall Study|Lost to Follow-up|4
42327|NCT01306214|165335|P2|Overall Study|Lost to Follow-up|5
42328|NCT01306214|165336|P1|Overall Study|Lost to Follow-up|3
42329|NCT01306214|165334|P3|Overall Study|Death|1
42330|NCT01306214|165335|P2|Overall Study|Death|0
42331|NCT01306214|165336|P1|Overall Study|Death|0
42332|NCT01306201|165353|P1|Overall Study|Files unreadable|3
42333|NCT01306201|165353|P1|Overall Study|Files could not be processed|3
42334|NCT01306201|165353|P1|Overall Study|Arrhythmia|4
42335|NCT01306162|165375|P4|Washout 1|Non-compliance to protocol|0
42336|NCT01306162|165376|P3|Washout 1|Non-compliance to protocol|0
42337|NCT01306162|165377|P2|Washout 1|Non-compliance to protocol|1
42338|NCT01306162|165378|P1|Washout 1|Non-compliance to protocol|0
42339|NCT01306162|165375|P4|Period 1|Adverse Event|1
42340|NCT01306162|165376|P3|Period 1|Adverse Event|0
42341|NCT01306162|165377|P2|Period 1|Adverse Event|0
42342|NCT01306162|165378|P1|Period 1|Adverse Event|0
42343|NCT01306032|165412|P6|Disease Progression/Crossover|other/symptomatic progression|0
42344|NCT01306032|165413|P5|Disease Progression/Crossover|other/symptomatic progression|0
42345|NCT01306032|165414|P4|Disease Progression/Crossover|other/symptomatic progression|2
42346|NCT01306032|165415|P3|Disease Progression/Crossover|other/symptomatic progression|0
42347|NCT01306032|165416|P2|Disease Progression/Crossover|other/symptomatic progression|2
42348|NCT01306032|165417|P1|Disease Progression/Crossover|other/symptomatic progression|0
42349|NCT01306032|165412|P6|Disease Progression/Crossover|Withdrawal by Subject|0
42350|NCT01306032|165413|P5|Disease Progression/Crossover|Withdrawal by Subject|0
42351|NCT01306032|165414|P4|Disease Progression/Crossover|Withdrawal by Subject|1
42352|NCT01306032|165415|P3|Disease Progression/Crossover|Withdrawal by Subject|0
42353|NCT01306032|165416|P2|Disease Progression/Crossover|Withdrawal by Subject|0
42354|NCT01306032|165417|P1|Disease Progression/Crossover|Withdrawal by Subject|0
42355|NCT01306032|165412|P6|First Intervention|Progressive disease|0
42356|NCT01306032|165413|P5|First Intervention|Progressive disease|2
42357|NCT01306032|165414|P4|First Intervention|Progressive disease|0
42358|NCT01306032|165415|P3|First Intervention|Progressive disease|0
42359|NCT01306032|165416|P2|First Intervention|Progressive disease|0
42360|NCT01306032|165417|P1|First Intervention|Progressive disease|0
42361|NCT01306032|165412|P6|First Intervention|Ineligible|1
42362|NCT01306032|165413|P5|First Intervention|Ineligible|0
42363|NCT01306032|165414|P4|First Intervention|Ineligible|0
42364|NCT01306032|165415|P3|First Intervention|Ineligible|0
42365|NCT01306032|165416|P2|First Intervention|Ineligible|0
42366|NCT01306032|165417|P1|First Intervention|Ineligible|0
42367|NCT01306032|165412|P6|First Intervention|Death|0
42368|NCT01306032|165413|P5|First Intervention|Death|0
42369|NCT01306032|165414|P4|First Intervention|Death|0
42370|NCT01306032|165415|P3|First Intervention|Death|1
42371|NCT01306032|165416|P2|First Intervention|Death|0
42372|NCT01306032|165417|P1|First Intervention|Death|0
42373|NCT01306032|165412|P6|First Intervention|Withdrawal by Subject|0
42374|NCT01306032|165413|P5|First Intervention|Withdrawal by Subject|0
42375|NCT01306032|165414|P4|First Intervention|Withdrawal by Subject|1
42376|NCT01306032|165415|P3|First Intervention|Withdrawal by Subject|0
42377|NCT01306032|165416|P2|First Intervention|Withdrawal by Subject|2
42378|NCT01306032|165417|P1|First Intervention|Withdrawal by Subject|0
42379|NCT01306032|165412|P6|First Intervention|Adverse Event|1
42380|NCT01306032|165413|P5|First Intervention|Adverse Event|0
42381|NCT01306032|165414|P4|First Intervention|Adverse Event|0
42382|NCT01306032|165415|P3|First Intervention|Adverse Event|1
42383|NCT01306032|165416|P2|First Intervention|Adverse Event|0
42384|NCT01306032|165417|P1|First Intervention|Adverse Event|1
42385|NCT01305577|165473|P3|Overall Study|Protocol Deviation|1
42386|NCT01305577|165474|P2|Overall Study|Protocol Deviation|1
42387|NCT01305577|165475|P1|Overall Study|Protocol Deviation|0
42388|NCT01305577|165473|P3|Overall Study|Lost to Follow-up|2
42389|NCT01305577|165474|P2|Overall Study|Lost to Follow-up|3
42390|NCT01305577|165475|P1|Overall Study|Lost to Follow-up|4
42391|NCT01305577|165473|P3|Overall Study|Withdrawal by Subject|6
42392|NCT01305577|165474|P2|Overall Study|Withdrawal by Subject|5
42393|NCT01305577|165475|P1|Overall Study|Withdrawal by Subject|7
42394|NCT01305577|165473|P3|Overall Study|Adverse Event|1
42395|NCT01305577|165474|P2|Overall Study|Adverse Event|2
42396|NCT01305577|165475|P1|Overall Study|Adverse Event|2
42397|NCT01305564|165504|P1|Overall Study|Physician Decision|3
42398|NCT01305564|165504|P1|Overall Study|Withdrawal by Subject|1
42399|NCT01305564|165504|P1|Overall Study|Lost to Follow-up|12
42400|NCT01305564|165504|P1|Overall Study|Death|21
42401|NCT01305408|165531|P2|Overall Study|Not specified|0
42402|NCT01305408|165532|P1|Overall Study|Not specified|1
42403|NCT01305408|165531|P2|Overall Study|Noncompliance with study procedures|1
42404|NCT01305408|165532|P1|Overall Study|Noncompliance with study procedures|0
42405|NCT01305408|165531|P2|Overall Study|Noncompliance with study medication|1
42406|NCT01305408|165532|P1|Overall Study|Noncompliance with study medication|0
42407|NCT01305408|165531|P2|Overall Study|Lost to Follow-up|3
42408|NCT01305408|165532|P1|Overall Study|Lost to Follow-up|5
42409|NCT01305408|165531|P2|Overall Study|Protocol Violation|6
42410|NCT01305408|165532|P1|Overall Study|Protocol Violation|4
42411|NCT01305408|165531|P2|Overall Study|Withdrawal by Subject|9
42412|NCT01305408|165532|P1|Overall Study|Withdrawal by Subject|9
42413|NCT01305408|165531|P2|Overall Study|Lack of Efficacy|4
42414|NCT01305408|165532|P1|Overall Study|Lack of Efficacy|3
42415|NCT01305408|165531|P2|Overall Study|Adverse Event|7
42416|NCT01305408|165532|P1|Overall Study|Adverse Event|10
42417|NCT01305239|165591|P1|Overall Study|Exemestane taken prior to inclusion only|1
42418|NCT01305239|165591|P1|Overall Study|Adverse Event|22
42419|NCT01305044|165601|P2|Overall Study|Withdrawal by Subject|6
42420|NCT01305044|165602|P1|Overall Study|Withdrawal by Subject|3
42421|NCT01304706|165632|P1|Overall Study|Discontinued due to failed drug admin.|1
42422|NCT01304706|165632|P1|Overall Study|Lost to Follow-up|7
42423|NCT01304706|165632|P1|Overall Study|Withdrawal by Subject|3
42424|NCT01304706|165632|P1|Overall Study|Death|3
42425|NCT01304706|165632|P1|Overall Study|Lack of Efficacy|1
42426|NCT01304706|165632|P1|Overall Study|Adverse Event|2
42427|NCT01304693|165641|P5|Overall Study|Decision Unrelated to an Adverse Event|0
42428|NCT01304693|165642|P4|Overall Study|Decision Unrelated to an Adverse Event|1
42429|NCT01304693|165643|P3|Overall Study|Decision Unrelated to an Adverse Event|1
42430|NCT01304693|165644|P2|Overall Study|Decision Unrelated to an Adverse Event|0
42431|NCT01304693|165645|P1|Overall Study|Decision Unrelated to an Adverse Event|0
42432|NCT01304693|165641|P5|Overall Study|Adverse Event|1
42433|NCT01304693|165642|P4|Overall Study|Adverse Event|0
42434|NCT01304693|165643|P3|Overall Study|Adverse Event|0
42435|NCT01304693|165644|P2|Overall Study|Adverse Event|0
42436|NCT01304693|165645|P1|Overall Study|Adverse Event|0
42437|NCT01304329|165690|P6|Third Intervention (3 Days)|Adverse Event|0
42438|NCT01304329|165691|P5|Third Intervention (3 Days)|Adverse Event|0
42439|NCT01304329|165692|P4|Third Intervention (3 Days)|Adverse Event|0
42440|NCT01304329|165693|P3|Third Intervention (3 Days)|Adverse Event|0
42441|NCT01304329|165694|P2|Third Intervention (3 Days)|Adverse Event|1
42442|NCT01304329|165695|P1|Third Intervention (3 Days)|Adverse Event|0
42443|NCT01304147|165815|P2|Second Intervention (7days)|Withdrawal by Subject|1
42444|NCT01304147|165816|P1|Second Intervention (7days)|Withdrawal by Subject|1
42445|NCT01303861|165829|P4|Overall Study|Pregnancy|0
42446|NCT01303861|165830|P3|Overall Study|Pregnancy|0
42447|NCT01303861|165831|P2|Overall Study|Pregnancy|0
42448|NCT01303861|165832|P1|Overall Study|Pregnancy|1
42449|NCT01303861|165829|P4|Overall Study|Adverse Event|5
42450|NCT01303861|165830|P3|Overall Study|Adverse Event|0
42451|NCT01303861|165831|P2|Overall Study|Adverse Event|1
42452|NCT01303861|165832|P1|Overall Study|Adverse Event|4
42453|NCT01303861|165829|P4|Overall Study|Withdrawal by Subject|23
42454|NCT01303861|165830|P3|Overall Study|Withdrawal by Subject|8
42455|NCT01303861|165831|P2|Overall Study|Withdrawal by Subject|8
42456|NCT01303861|165832|P1|Overall Study|Withdrawal by Subject|16
42457|NCT01303861|165829|P4|Overall Study|Lack of Efficacy|0
42458|NCT01303861|165830|P3|Overall Study|Lack of Efficacy|1
42459|NCT01303861|165831|P2|Overall Study|Lack of Efficacy|2
42460|NCT01303861|165832|P1|Overall Study|Lack of Efficacy|3
42461|NCT01303861|165829|P4|Overall Study|Lost to Follow-up|31
42462|NCT01303861|165830|P3|Overall Study|Lost to Follow-up|27
42463|NCT01303861|165831|P2|Overall Study|Lost to Follow-up|14
42464|NCT01303861|165832|P1|Overall Study|Lost to Follow-up|34
42465|NCT01303627|165891|P2|Overall Study|the failure while performing URS|1
42466|NCT01303627|165892|P1|Overall Study|the failure while performing URS|0
42467|NCT01303510|165900|P2|Overall Study|Lost to Follow-up|0
42468|NCT01303510|165901|P1|Overall Study|Lost to Follow-up|1
42469|NCT01303445|165915|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
42470|NCT01303445|165916|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
42471|NCT01303445|165915|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
42472|NCT01303445|165916|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
42473|NCT01303445|165915|P2|Washout (14 Days)|Lost to Follow-up|2
42474|NCT01303445|165916|P1|Washout (14 Days)|Lost to Follow-up|0
42475|NCT01303445|165915|P2|Washout (14 Days)|Protocol Violation|0
42476|NCT01303445|165916|P1|Washout (14 Days)|Protocol Violation|1
42477|NCT01303445|165915|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
42478|NCT01303445|165916|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
42479|NCT01303445|165915|P2|Second Intervention (7 Days)|Adverse Event|2
42480|NCT01303445|165916|P1|Second Intervention (7 Days)|Adverse Event|0
42481|NCT01303445|165915|P2|First Intervention (7 Days)|Withdrawal by Subject|0
42482|NCT01303445|165916|P1|First Intervention (7 Days)|Withdrawal by Subject|1
42483|NCT01303380|165957|P1|Overall Study|Lack of compliance to study procedures|1
42484|NCT01302938|166018|P2|Overall Study|Adverse Event|0
42485|NCT01302938|166019|P1|Overall Study|Adverse Event|1
42486|NCT01302938|166018|P2|Overall Study|Withdrawal by Subject|0
42487|NCT01302938|166019|P1|Overall Study|Withdrawal by Subject|1
42488|NCT01302899|166064|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
42489|NCT01302899|166065|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
42490|NCT01302899|166064|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
42491|NCT01302899|166065|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
42492|NCT01302691|166129|P2|Overall Study|Protocol Violation|0
42493|NCT01302691|166130|P1|Overall Study|Protocol Violation|1
42494|NCT01302691|166129|P2|Overall Study|Physician Decision|1
42495|NCT01302691|166130|P1|Overall Study|Physician Decision|0
42496|NCT01302691|166129|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
42497|NCT01302691|166130|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
42498|NCT01302691|166129|P2|Overall Study|Lost to Follow-up|0
42499|NCT01302691|166130|P1|Overall Study|Lost to Follow-up|1
42500|NCT01302691|166129|P2|Overall Study|Death|1
42501|NCT01302691|166130|P1|Overall Study|Death|0
42502|NCT01302691|166129|P2|Overall Study|Adverse Event|0
42503|NCT01302691|166130|P1|Overall Study|Adverse Event|2
42504|NCT01302548|166150|P2|Overall Study|Lost to Follow-up|1
42505|NCT01302548|166151|P1|Overall Study|Lost to Follow-up|2
42506|NCT01302418|166201|P1|Overall Study|Non-evaluable|9
42507|NCT01302418|166201|P1|Overall Study|Protocol Violation|9
42508|NCT01302392|166207|P2|Overall Study|Withdrawal by Subject|1
42509|NCT01302392|166208|P1|Overall Study|Withdrawal by Subject|6
42510|NCT01302392|166207|P2|Overall Study|Lost to Follow-up|0
42511|NCT01302392|166208|P1|Overall Study|Lost to Follow-up|1
42512|NCT01302366|166228|P1|Overall Study|patient choice or noncompliance|5
42513|NCT01302119|166236|P2|Overall Study|Non-specific|1
42514|NCT01302119|166237|P1|Overall Study|Non-specific|4
42515|NCT01302119|166236|P2|Overall Study|Non-compliance|2
42516|NCT01302119|166237|P1|Overall Study|Non-compliance|4
42517|NCT01302119|166236|P2|Overall Study|Adverse Event|1
42518|NCT01302119|166237|P1|Overall Study|Adverse Event|2
42519|NCT01302119|166236|P2|Overall Study|Lost to Follow-up|4
42520|NCT01302119|166237|P1|Overall Study|Lost to Follow-up|10
42521|NCT01302119|166236|P2|Overall Study|Withdrawal by Subject|20
42522|NCT01302119|166237|P1|Overall Study|Withdrawal by Subject|30
42523|NCT01302067|166252|P3|Overall Study|Adverse Event|45
42524|NCT01302067|166253|P2|Overall Study|Adverse Event|14
42525|NCT01302067|166254|P1|Overall Study|Adverse Event|27
42526|NCT01302067|166252|P3|Overall Study|Protocol Violation|8
42527|NCT01302067|166253|P2|Overall Study|Protocol Violation|0
42528|NCT01302067|166254|P1|Overall Study|Protocol Violation|11
42529|NCT01302067|166252|P3|Overall Study|Not specified|3
42530|NCT01302067|166253|P2|Overall Study|Not specified|1
42531|NCT01302067|166254|P1|Overall Study|Not specified|1
42532|NCT01302067|166252|P3|Overall Study|Withdrawal by Subject|10
42533|NCT01302067|166253|P2|Overall Study|Withdrawal by Subject|6
42534|NCT01302067|166254|P1|Overall Study|Withdrawal by Subject|13
42535|NCT01302067|166252|P3|Overall Study|Lost to Follow-up|15
42536|NCT01302067|166253|P2|Overall Study|Lost to Follow-up|4
42537|NCT01302067|166254|P1|Overall Study|Lost to Follow-up|9
42538|NCT01302067|166252|P3|Overall Study|Lack of Efficacy|2
42539|NCT01302067|166253|P2|Overall Study|Lack of Efficacy|4
42540|NCT01302067|166254|P1|Overall Study|Lack of Efficacy|8
42541|NCT01302067|166252|P3|Overall Study|Physician Decision|14
42542|NCT01302067|166253|P2|Overall Study|Physician Decision|5
42543|NCT01302067|166254|P1|Overall Study|Physician Decision|9
42544|NCT01302067|166252|P3|Overall Study|Death|1
42545|NCT01302067|166253|P2|Overall Study|Death|0
42546|NCT01302067|166254|P1|Overall Study|Death|0
42547|NCT01302054|166325|P3|Double-Blind Treatment Phase|Unspecified|9
42548|NCT01302054|166326|P2|Double-Blind Treatment Phase|Unspecified|4
42549|NCT01302054|166327|P1|Double-Blind Treatment Phase|Unspecified|0
42550|NCT01302054|166325|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
42551|NCT01302054|166326|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
42552|NCT01302054|166327|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
42553|NCT01302054|166325|P3|Double-Blind Treatment Phase|Adverse Event|10
42554|NCT01302054|166326|P2|Double-Blind Treatment Phase|Adverse Event|10
42555|NCT01302054|166327|P1|Double-Blind Treatment Phase|Adverse Event|0
42556|NCT01302054|166325|P3|Double-Blind Treatment Phase|Protocol Violation|6
42557|NCT01302054|166326|P2|Double-Blind Treatment Phase|Protocol Violation|3
42558|NCT01302054|166327|P1|Double-Blind Treatment Phase|Protocol Violation|0
42559|NCT01302054|166325|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
42560|NCT01302054|166326|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
42561|NCT01302054|166327|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
42562|NCT01302054|166325|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
42563|NCT01302054|166326|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
42564|NCT01302054|166327|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
42565|NCT01302054|166325|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
42566|NCT01302054|166326|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
42567|NCT01302054|166327|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
42568|NCT01302054|166325|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
42569|NCT01302054|166326|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
42570|NCT01302054|166327|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
42571|NCT01302054|166325|P3|Tolterodine Open-Label Run-In Phase|Unspecified|0
42572|NCT01302054|166326|P2|Tolterodine Open-Label Run-In Phase|Unspecified|0
42573|NCT01302054|166327|P1|Tolterodine Open-Label Run-In Phase|Unspecified|7
42574|NCT01302054|166325|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
42575|NCT01302054|166326|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
42576|NCT01302054|166327|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
42577|NCT01302054|166325|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
42578|NCT01302054|166326|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
42579|NCT01302054|166327|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
42580|NCT01302054|166325|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
42581|NCT01302054|166326|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
42582|NCT01302054|166327|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
42583|NCT01302054|166325|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
42584|NCT01302054|166326|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
42585|NCT01302054|166327|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
42586|NCT01302054|166325|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
42587|NCT01302054|166326|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
42588|NCT01302054|166327|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
42589|NCT01302054|166325|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
42590|NCT01302054|166326|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
42591|NCT01302054|166327|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
42592|NCT01302041|166354|P1|Overall Study|Other - Miscellaneous Reason|1
42593|NCT01302041|166354|P1|Overall Study|Withdrawal by Subject|1
42594|NCT01302041|166354|P1|Overall Study|Death|3
42595|NCT01302041|166354|P1|Overall Study|Continuing on Study|45
42596|NCT01301950|166396|P2|Overall Study|Surgery was cancelled by patient|1
42597|NCT01301950|166397|P1|Overall Study|Surgery was cancelled by patient|0
42598|NCT01301833|166415|P4|Overall Study|Personal matter|0
42599|NCT01301833|166416|P3|Overall Study|Personal matter|0
42600|NCT01301833|166417|P2|Overall Study|Personal matter|0
42601|NCT01301833|166418|P1|Overall Study|Personal matter|1
42602|NCT01301833|166415|P4|Overall Study|Withdrawal by Subject|2
42603|NCT01301833|166416|P3|Overall Study|Withdrawal by Subject|1
42604|NCT01301833|166417|P2|Overall Study|Withdrawal by Subject|1
42605|NCT01301833|166418|P1|Overall Study|Withdrawal by Subject|3
42606|NCT01301833|166415|P4|Overall Study|Physician Decision|0
42607|NCT01301833|166416|P3|Overall Study|Physician Decision|1
42608|NCT01301833|166417|P2|Overall Study|Physician Decision|1
42609|NCT01301833|166418|P1|Overall Study|Physician Decision|3
42610|NCT01301833|166415|P4|Overall Study|Lack of Efficacy|0
42611|NCT01301833|166416|P3|Overall Study|Lack of Efficacy|0
42612|NCT01301833|166417|P2|Overall Study|Lack of Efficacy|1
42613|NCT01301833|166418|P1|Overall Study|Lack of Efficacy|1
42614|NCT01301833|166415|P4|Overall Study|Adverse Event|5
42615|NCT01301833|166416|P3|Overall Study|Adverse Event|5
42616|NCT01301833|166417|P2|Overall Study|Adverse Event|5
42617|NCT01301833|166418|P1|Overall Study|Adverse Event|7
42618|NCT01301729|166456|P1|Overall Study|Violated Selection Criteria|1
42619|NCT01301729|166456|P1|Overall Study|Participant did not Return for Treatment|1
42620|NCT01301729|166456|P1|Overall Study|Withdrawal by Subject|2
42621|NCT01301274|166469|P2|Overall Study|Physician Decision|1
42622|NCT01301274|166470|P1|Overall Study|Physician Decision|2
42623|NCT01301092|166485|P3|Overall Study|Lost to Follow-up|1
42624|NCT01301092|166486|P2|Overall Study|Lost to Follow-up|0
42625|NCT01301092|166487|P1|Overall Study|Lost to Follow-up|0
42626|NCT01301079|166504|P2|Overall Study|Lost to Follow-up|2
42627|NCT01301079|166505|P1|Overall Study|Lost to Follow-up|2
42628|NCT01301066|166583|P2|Overall Study|Other|0
42629|NCT01301066|166584|P1|Overall Study|Other|2
42630|NCT01301066|166583|P2|Overall Study|Physician Decision|1
42631|NCT01301066|166584|P1|Overall Study|Physician Decision|0
42632|NCT01301066|166583|P2|Overall Study|Sponsor Decision|1
42633|NCT01301066|166584|P1|Overall Study|Sponsor Decision|2
42634|NCT01301066|166583|P2|Overall Study|Adverse Event|6
42635|NCT01301066|166584|P1|Overall Study|Adverse Event|6
42636|NCT01301066|166583|P2|Overall Study|Withdrawal by Subject|9
42637|NCT01301066|166584|P1|Overall Study|Withdrawal by Subject|4
42638|NCT01301066|166583|P2|Overall Study|Protocol Violation|7
42639|NCT01301066|166584|P1|Overall Study|Protocol Violation|8
42640|NCT01301066|166583|P2|Overall Study|Lost to Follow-up|11
42641|NCT01301066|166584|P1|Overall Study|Lost to Follow-up|5
42642|NCT01301027|166592|P2|Overall Study|Volume Overload|0
42643|NCT01301027|166593|P1|Overall Study|Volume Overload|3
42644|NCT01301027|166592|P2|Overall Study|Transplant|2
42645|NCT01301027|166593|P1|Overall Study|Transplant|0
42646|NCT01301027|166592|P2|Overall Study|Fracture|3
42647|NCT01301027|166593|P1|Overall Study|Fracture|1
42648|NCT01301027|166592|P2|Overall Study|Adverse Event|2
42649|NCT01301027|166593|P1|Overall Study|Adverse Event|0
42650|NCT01301027|166592|P2|Overall Study|Withdrawal by Subject|3
42651|NCT01301027|166593|P1|Overall Study|Withdrawal by Subject|2
42652|NCT01301027|166592|P2|Overall Study|Physician Decision|0
42653|NCT01301027|166593|P1|Overall Study|Physician Decision|2
42654|NCT01300819|166607|P2|Overall Study|Follow up call was not done|0
42655|NCT01300819|166608|P1|Overall Study|Follow up call was not done|1
42656|NCT01300819|166607|P2|Overall Study|Safety follow up not done by mistake|1
42657|NCT01300819|166608|P1|Overall Study|Safety follow up not done by mistake|0
42658|NCT01300819|166607|P2|Overall Study|Administrative reason|1
42659|NCT01300819|166608|P1|Overall Study|Administrative reason|0
42660|NCT01300819|166607|P2|Overall Study|Refusal to down titrate study drug|1
42661|NCT01300819|166608|P1|Overall Study|Refusal to down titrate study drug|0
42662|NCT01300819|166607|P2|Overall Study|Patient was 1 month late for Visit 10|1
42663|NCT01300819|166608|P1|Overall Study|Patient was 1 month late for Visit 10|0
42664|NCT01300819|166607|P2|Overall Study|Withdrawal by Subject|12
42665|NCT01300819|166608|P1|Overall Study|Withdrawal by Subject|10
42666|NCT01300819|166607|P2|Overall Study|Lack of Efficacy|1
42667|NCT01300819|166608|P1|Overall Study|Lack of Efficacy|2
42668|NCT01300819|166607|P2|Overall Study|Adverse Event|27
42669|NCT01300819|166608|P1|Overall Study|Adverse Event|9
42670|NCT01300767|166636|P1|Overall Study|Unacceptable fit|1
42671|NCT01300767|166636|P1|Overall Study|Biomicroscopy|1
42672|NCT01300767|166636|P1|Overall Study|Discomfort|2
42673|NCT01300741|166664|P1|Overall Study|Discomfort|1
42674|NCT01300741|166664|P1|Overall Study|Lost to Follow-up|1
42675|NCT01300741|166664|P1|Overall Study|Lens deposits|1
42676|NCT01300728|166694|P2|Overall Study|Physician Decision|0
42677|NCT01300728|166695|P1|Overall Study|Physician Decision|1
42678|NCT01300728|166694|P2|Overall Study|Withdrawal by Subject|1
42679|NCT01300728|166695|P1|Overall Study|Withdrawal by Subject|1
42680|NCT01300650|166709|P1|Overall Study|Adverse Event|1
42681|NCT01300546|166736|P2|Overall Study|Adverse Event|1
42682|NCT01300546|166737|P1|Overall Study|Adverse Event|0
42683|NCT01300546|166736|P2|Overall Study|Lack of Efficacy|3
42684|NCT01300546|166737|P1|Overall Study|Lack of Efficacy|0
42685|NCT01300546|166736|P2|Overall Study|Lost to Follow-up|2
42686|NCT01300546|166737|P1|Overall Study|Lost to Follow-up|0
42687|NCT01300546|166736|P2|Overall Study|Withdrawal by Subject|0
42688|NCT01300546|166737|P1|Overall Study|Withdrawal by Subject|1
42689|NCT01300455|166767|P2|Washout|Withdrawal by Subject|0
42690|NCT01300455|166768|P1|Washout|Withdrawal by Subject|1
42691|NCT01300351|166788|P2|Overall Study|Withdrawal by Subject|10
42692|NCT01300351|166789|P1|Overall Study|Withdrawal by Subject|7
42693|NCT01300351|166788|P2|Overall Study|Adverse Event|4
42694|NCT01300351|166789|P1|Overall Study|Adverse Event|0
42695|NCT01300351|166788|P2|Overall Study|Lost to Follow-up|1
42696|NCT01300351|166789|P1|Overall Study|Lost to Follow-up|0
42697|NCT01300351|166788|P2|Overall Study|Ongoing treatment at data cut-off|23
42698|NCT01300351|166789|P1|Overall Study|Ongoing treatment at data cut-off|27
42699|NCT01300351|166788|P2|Overall Study|Did not receive treatment|0
42700|NCT01300351|166789|P1|Overall Study|Did not receive treatment|2
42701|NCT01300338|166805|P2|Overall Study|Lost to Follow-up|0
42702|NCT01300338|166806|P1|Overall Study|Lost to Follow-up|5
42703|NCT01300286|166814|P1|Overall Study|did not get dosed|1
42704|NCT01300260|166824|P2|Period 2 of Study: Second Intervention|Adverse Event|1
42705|NCT01300260|166825|P1|Period 2 of Study: Second Intervention|Adverse Event|0
42706|NCT01300260|166824|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
42707|NCT01300260|166825|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
42708|NCT01300260|166824|P2|Period 1 of Study: First Intervention|Adverse Event|1
42709|NCT01300260|166825|P1|Period 1 of Study: First Intervention|Adverse Event|0
42710|NCT01300247|166857|P2|Overall Study|Non-Compliance|1
42711|NCT01300247|166858|P1|Overall Study|Non-Compliance|0
42712|NCT01300247|166857|P2|Overall Study|Withdrawal by Subject|0
42713|NCT01300247|166858|P1|Overall Study|Withdrawal by Subject|1
42714|NCT01300247|166857|P2|Overall Study|Lost to Follow-up|0
42715|NCT01300247|166858|P1|Overall Study|Lost to Follow-up|2
42716|NCT01300247|166857|P2|Overall Study|Death|1
42717|NCT01300247|166858|P1|Overall Study|Death|1
42718|NCT01300234|166890|P2|Overall Study|Lost to Follow-up|2
42719|NCT01300234|166891|P1|Overall Study|Lost to Follow-up|0
42720|NCT01300234|166890|P2|Overall Study|Withdrawal by Subject|5
42721|NCT01300234|166891|P1|Overall Study|Withdrawal by Subject|1
42722|NCT01300234|166890|P2|Overall Study|Protocol Violation|3
42723|NCT01300234|166891|P1|Overall Study|Protocol Violation|2
42724|NCT01300234|166890|P2|Overall Study|Adverse Event|0
42725|NCT01300234|166891|P1|Overall Study|Adverse Event|1
42726|NCT01299961|166921|P1|Overall Study|Lost to Follow-up|1
42727|NCT01299961|166921|P1|Overall Study|Lack of Efficacy|2
42728|NCT01299961|166921|P1|Overall Study|Adverse Event|3
42729|NCT01299909|166930|P3|Overall Study|Lost to Follow-up|17
42730|NCT01299909|166931|P2|Overall Study|Lost to Follow-up|18
42731|NCT01299909|166932|P1|Overall Study|Lost to Follow-up|22
42732|NCT01299896|166941|P2|Overall Study|Lost to Follow-up|11
42733|NCT01299896|166942|P1|Overall Study|Lost to Follow-up|0
42734|NCT01299896|166941|P2|Overall Study|Withdrawal by Subject|7
42735|NCT01299896|166942|P1|Overall Study|Withdrawal by Subject|1
42736|NCT01299805|166950|P2|Overall Study|Adverse Event|0
42737|NCT01299805|166951|P1|Overall Study|Adverse Event|2
42738|NCT01299584|166979|P1|Overall Study|Protocol Violation|9
42739|NCT01299571|166986|P1|Overall Study|Protocol Violation|107
42740|NCT01299480|166997|P5|Overall Study|Started, but not vaccinated|0
42741|NCT01299480|166998|P4|Overall Study|Started, but not vaccinated|1
42742|NCT01299480|166999|P3|Overall Study|Started, but not vaccinated|1
42743|NCT01299480|167000|P2|Overall Study|Started, but not vaccinated|0
42744|NCT01299480|167001|P1|Overall Study|Started, but not vaccinated|0
42745|NCT01299480|166997|P5|Overall Study|Unspecified|3
42746|NCT01299480|166998|P4|Overall Study|Unspecified|0
42747|NCT01299480|166999|P3|Overall Study|Unspecified|3
42748|NCT01299480|167000|P2|Overall Study|Unspecified|2
42749|NCT01299480|167001|P1|Overall Study|Unspecified|3
42750|NCT01299480|166997|P5|Overall Study|Lost to Follow-up|2
42751|NCT01299480|166998|P4|Overall Study|Lost to Follow-up|1
42752|NCT01299480|166999|P3|Overall Study|Lost to Follow-up|2
42753|NCT01299480|167000|P2|Overall Study|Lost to Follow-up|1
42754|NCT01299480|167001|P1|Overall Study|Lost to Follow-up|3
42755|NCT01299480|166997|P5|Overall Study|Physician Decision|0
42756|NCT01299480|166998|P4|Overall Study|Physician Decision|2
42757|NCT01299480|166999|P3|Overall Study|Physician Decision|0
42758|NCT01299480|167000|P2|Overall Study|Physician Decision|1
42759|NCT01299480|167001|P1|Overall Study|Physician Decision|1
42760|NCT01299480|166997|P5|Overall Study|Withdrawal due to pregnancy|0
42761|NCT01299480|166998|P4|Overall Study|Withdrawal due to pregnancy|0
42762|NCT01299480|166999|P3|Overall Study|Withdrawal due to pregnancy|1
42763|NCT01299480|167000|P2|Overall Study|Withdrawal due to pregnancy|1
42764|NCT01299480|167001|P1|Overall Study|Withdrawal due to pregnancy|0
42765|NCT01299480|166997|P5|Overall Study|Adverse Event|0
42766|NCT01299480|166998|P4|Overall Study|Adverse Event|4
42767|NCT01299480|166999|P3|Overall Study|Adverse Event|5
42768|NCT01299480|167000|P2|Overall Study|Adverse Event|4
42769|NCT01299480|167001|P1|Overall Study|Adverse Event|6
42770|NCT01299480|166997|P5|Overall Study|Withdrawal by Subject|4
42771|NCT01299480|166998|P4|Overall Study|Withdrawal by Subject|3
42772|NCT01299480|166999|P3|Overall Study|Withdrawal by Subject|7
42773|NCT01299480|167000|P2|Overall Study|Withdrawal by Subject|4
42774|NCT01299480|167001|P1|Overall Study|Withdrawal by Subject|3
42775|NCT01299480|166997|P5|Overall Study|Protocol Violation|1
42776|NCT01299480|166998|P4|Overall Study|Protocol Violation|1
42777|NCT01299480|166999|P3|Overall Study|Protocol Violation|8
42778|NCT01299480|167000|P2|Overall Study|Protocol Violation|5
42779|NCT01299480|167001|P1|Overall Study|Protocol Violation|7
42780|NCT01299480|166997|P5|Overall Study|No longer willing to participate|10
42781|NCT01299480|166998|P4|Overall Study|No longer willing to participate|13
42782|NCT01299480|166999|P3|Overall Study|No longer willing to participate|14
42783|NCT01299480|167000|P2|Overall Study|No longer willing to participate|17
42784|NCT01299480|167001|P1|Overall Study|No longer willing to participate|19
42785|NCT01299389|167203|P4|Post-observational|unspecified|6
42786|NCT01299389|167204|P3|Post-observational|unspecified|12
42787|NCT01299389|167205|P2|Post-observational|unspecified|0
42788|NCT01299389|167206|P1|Post-observational|unspecified|0
42789|NCT01299389|167203|P4|Double-blind|fail to meet “study population” criteria|0
42790|NCT01299389|167204|P3|Double-blind|fail to meet “study population” criteria|0
42791|NCT01299389|167205|P2|Double-blind|fail to meet “study population” criteria|1
42792|NCT01299389|167206|P1|Double-blind|fail to meet “study population” criteria|0
42793|NCT01299389|167203|P4|Double-blind|unspecified|0
42794|NCT01299389|167204|P3|Double-blind|unspecified|0
42795|NCT01299389|167205|P2|Double-blind|unspecified|1
42796|NCT01299389|167206|P1|Double-blind|unspecified|1
42797|NCT01299389|167203|P4|Double-blind|Withdrawal by Subject|0
42798|NCT01299389|167204|P3|Double-blind|Withdrawal by Subject|0
42799|NCT01299389|167205|P2|Double-blind|Withdrawal by Subject|13
42800|NCT01299389|167206|P1|Double-blind|Withdrawal by Subject|16
42801|NCT01299389|167203|P4|Double-blind|Lost to Follow-up|0
42802|NCT01299389|167204|P3|Double-blind|Lost to Follow-up|0
42803|NCT01299389|167205|P2|Double-blind|Lost to Follow-up|1
42804|NCT01299389|167206|P1|Double-blind|Lost to Follow-up|2
42805|NCT01299389|167203|P4|Double-blind|Lack of Efficacy|0
42806|NCT01299389|167204|P3|Double-blind|Lack of Efficacy|0
42807|NCT01299389|167205|P2|Double-blind|Lack of Efficacy|21
42808|NCT01299389|167206|P1|Double-blind|Lack of Efficacy|45
42809|NCT01299389|167203|P4|Double-blind|Adverse Event|0
42810|NCT01299389|167204|P3|Double-blind|Adverse Event|0
42811|NCT01299389|167205|P2|Double-blind|Adverse Event|27
42812|NCT01299389|167206|P1|Double-blind|Adverse Event|45
42813|NCT01299376|167228|P2|Extension (Weeks 9 to 52)|Physician Decision|0
42814|NCT01299376|167229|P1|Extension (Weeks 9 to 52)|Physician Decision|1
42815|NCT01299376|167228|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
42816|NCT01299376|167229|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
42817|NCT01299376|167228|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
42818|NCT01299376|167229|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
42819|NCT01299376|167228|P2|Extension (Weeks 9 to 52)|Adverse Event|3
42820|NCT01299376|167229|P1|Extension (Weeks 9 to 52)|Adverse Event|2
42821|NCT01299376|167228|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
42822|NCT01299376|167229|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
42823|NCT01299376|167228|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
42824|NCT01299376|167229|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
42825|NCT01299376|167228|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
42826|NCT01299376|167229|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
42827|NCT01299376|167228|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
42828|NCT01299376|167229|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
42829|NCT01299376|167228|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
42830|NCT01299376|167229|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
42831|NCT01299376|167228|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
42832|NCT01299376|167229|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
42833|NCT01299376|167228|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
42834|NCT01299376|167229|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
42835|NCT01299025|167290|P2|Overall Study|Lost to Follow-up|0
42836|NCT01299025|167291|P1|Overall Study|Lost to Follow-up|1
42837|NCT01299025|167290|P2|Overall Study|Withdrawal by Subject|1
42838|NCT01299025|167291|P1|Overall Study|Withdrawal by Subject|2
42839|NCT01298661|167306|P3|Overall Study|Withdrawal by Subject|2
42840|NCT01298661|167307|P2|Overall Study|Withdrawal by Subject|0
42841|NCT01298661|167308|P1|Overall Study|Withdrawal by Subject|2
42842|NCT01298648|167386|P1|Overall Study|Lost to Follow-up|21
42843|NCT01298648|167386|P1|Overall Study|Withdrawal by Subject|2
42844|NCT01298531|167406|P2|Overall Study|Not specified|1
42845|NCT01298531|167407|P1|Overall Study|Not specified|2
42846|NCT01298531|167406|P2|Overall Study|Does not meet entrance criteria|1
42847|NCT01298531|167407|P1|Overall Study|Does not meet entrance criteria|0
42848|NCT01298531|167406|P2|Overall Study|Adverse Event|3
42849|NCT01298531|167407|P1|Overall Study|Adverse Event|4
42850|NCT01298531|167406|P2|Overall Study|Protocol Violation|1
42851|NCT01298531|167407|P1|Overall Study|Protocol Violation|1
42852|NCT01298531|167406|P2|Overall Study|Lost to Follow-up|0
42853|NCT01298531|167407|P1|Overall Study|Lost to Follow-up|2
42854|NCT01298531|167406|P2|Overall Study|Lack of Efficacy|1
42855|NCT01298531|167407|P1|Overall Study|Lack of Efficacy|0
42856|NCT01298518|167536|P3|Overall Study|Withdrawal by Subject|1
42857|NCT01298518|167537|P2|Overall Study|Withdrawal by Subject|0
42858|NCT01298518|167538|P1|Overall Study|Withdrawal by Subject|0
42859|NCT01298362|167592|P2|Overall Study|Did not provide 12month BMD measurements|43
42860|NCT01298362|167593|P1|Overall Study|Did not provide 12month BMD measurements|38
42861|NCT01298323|167613|P2|Overall Study|Eligibility criteria not fulfilled|1
42862|NCT01298323|167614|P1|Overall Study|Eligibility criteria not fulfilled|0
42863|NCT01298323|167613|P2|Overall Study|Ongoing|55
42864|NCT01298323|167614|P1|Overall Study|Ongoing|55
42865|NCT01298323|167613|P2|Overall Study|Other|9
42866|NCT01298323|167614|P1|Overall Study|Other|10
42867|NCT01298323|167613|P2|Overall Study|Protocol Violation|0
42868|NCT01298323|167614|P1|Overall Study|Protocol Violation|1
42869|NCT01298323|167613|P2|Overall Study|Withdrawal by Subject|3
42870|NCT01298323|167614|P1|Overall Study|Withdrawal by Subject|6
42871|NCT01298323|167613|P2|Overall Study|Lost to Follow-up|0
42872|NCT01298323|167614|P1|Overall Study|Lost to Follow-up|1
42873|NCT01298323|167613|P2|Overall Study|Death|16
42874|NCT01298323|167614|P1|Overall Study|Death|11
42875|NCT01298323|167613|P2|Overall Study|Adverse Event|4
42876|NCT01298323|167614|P1|Overall Study|Adverse Event|2
42877|NCT01297920|167677|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
42878|NCT01297920|167678|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
42879|NCT01297920|167679|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
42880|NCT01297920|167677|P3|Overall Study|Inadequate Control of IOP|17
42881|NCT01297920|167678|P2|Overall Study|Inadequate Control of IOP|9
42882|NCT01297920|167679|P1|Overall Study|Inadequate Control of IOP|7
42883|NCT01297920|167677|P3|Overall Study|Protocol Violation|0
42884|NCT01297920|167678|P2|Overall Study|Protocol Violation|3
42885|NCT01297920|167679|P1|Overall Study|Protocol Violation|1
42886|NCT01297920|167677|P3|Overall Study|Noncompliance|0
42887|NCT01297920|167678|P2|Overall Study|Noncompliance|0
42888|NCT01297920|167679|P1|Overall Study|Noncompliance|1
42889|NCT01297920|167677|P3|Overall Study|Patient Decision Unrelated to AE|2
42890|NCT01297920|167678|P2|Overall Study|Patient Decision Unrelated to AE|5
42891|NCT01297920|167679|P1|Overall Study|Patient Decision Unrelated to AE|6
42892|NCT01297920|167677|P3|Overall Study|Adverse Event|38
42893|NCT01297920|167678|P2|Overall Study|Adverse Event|10
42894|NCT01297920|167679|P1|Overall Study|Adverse Event|42
42895|NCT01297517|167723|P3|Overall Study|Inadequate Control of IOP|2
42896|NCT01297517|167724|P2|Overall Study|Inadequate Control of IOP|1
42897|NCT01297517|167725|P1|Overall Study|Inadequate Control of IOP|1
42898|NCT01297517|167723|P3|Overall Study|Protocol Violation|1
42899|NCT01297517|167724|P2|Overall Study|Protocol Violation|1
42900|NCT01297517|167725|P1|Overall Study|Protocol Violation|1
42901|NCT01297517|167723|P3|Overall Study|Noncompliance|0
42902|NCT01297517|167724|P2|Overall Study|Noncompliance|0
42903|NCT01297517|167725|P1|Overall Study|Noncompliance|1
42904|NCT01297517|167723|P3|Overall Study|Patient Decision Unrelated to AE|7
42905|NCT01297517|167724|P2|Overall Study|Patient Decision Unrelated to AE|3
42906|NCT01297517|167725|P1|Overall Study|Patient Decision Unrelated to AE|2
42907|NCT01297517|167723|P3|Overall Study|Lost to Follow-up|1
42908|NCT01297517|167724|P2|Overall Study|Lost to Follow-up|0
42909|NCT01297517|167725|P1|Overall Study|Lost to Follow-up|1
42910|NCT01297517|167723|P3|Overall Study|Adverse Event|16
42911|NCT01297517|167724|P2|Overall Study|Adverse Event|7
42912|NCT01297517|167725|P1|Overall Study|Adverse Event|21
42913|NCT01297504|167733|P1|Overall Study|Protocol Violation|3
42914|NCT01297504|167733|P1|Overall Study|Site Closure|3
42915|NCT01297504|167733|P1|Overall Study|Withdrawal by Subject|9
42916|NCT01297504|167733|P1|Overall Study|Lost to Follow-up|43
42917|NCT01297504|167733|P1|Overall Study|Death|3
42918|NCT01297504|167733|P1|Overall Study|No Study Visits|4
42919|NCT01297504|167733|P1|Overall Study|Received Palivizumab in Previous Season|1
42920|NCT01297504|167733|P1|Overall Study|Invalid Consent|1
42921|NCT01297491|167747|P2|Overall Study|Death|1
42922|NCT01297491|167748|P1|Overall Study|Death|2
42923|NCT01297491|167747|P2|Overall Study|Patient/Guardian decision|4
42924|NCT01297491|167748|P1|Overall Study|Patient/Guardian decision|3
42925|NCT01297491|167747|P2|Overall Study|Progressive disease|20
42926|NCT01297491|167748|P1|Overall Study|Progressive disease|11
42927|NCT01297491|167747|P2|Overall Study|Physician Decision|2
42928|NCT01297491|167748|P1|Overall Study|Physician Decision|3
42929|NCT01297491|167747|P2|Overall Study|Adverse Event|6
42930|NCT01297491|167748|P1|Overall Study|Adverse Event|11
42931|NCT01297465|167766|P2|Overall Study|Intention to Freeze all Embryos|1
42932|NCT01297465|167767|P1|Overall Study|Intention to Freeze all Embryos|0
42933|NCT01297465|167766|P2|Overall Study|All Embryos Discarded|1
42934|NCT01297465|167767|P1|Overall Study|All Embryos Discarded|0
42935|NCT01297465|167766|P2|Overall Study|No Fertilization|4
42936|NCT01297465|167767|P1|Overall Study|No Fertilization|6
42937|NCT01297465|167766|P2|Overall Study|Poor oocyte quality|1
42938|NCT01297465|167767|P1|Overall Study|Poor oocyte quality|0
42939|NCT01297465|167766|P2|Overall Study|No Oocytes Retrieved|1
42940|NCT01297465|167767|P1|Overall Study|No Oocytes Retrieved|1
42941|NCT01297465|167766|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
42942|NCT01297465|167767|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
42943|NCT01297465|167766|P2|Overall Study|Lack of Ovarian Response|1
42944|NCT01297465|167767|P1|Overall Study|Lack of Ovarian Response|1
42945|NCT01297322|167820|P2|Overall Study|Withdrawal by Subject|1
42946|NCT01297322|167821|P1|Overall Study|Withdrawal by Subject|0
42947|NCT01297322|167820|P2|Overall Study|Lost to Follow-up|0
42948|NCT01297322|167821|P1|Overall Study|Lost to Follow-up|1
42949|NCT01297270|167849|P3|Overall Study|Not treated|0
42950|NCT01297270|167850|P2|Overall Study|Not treated|1
42951|NCT01297270|167851|P1|Overall Study|Not treated|0
42952|NCT01297270|167849|P3|Overall Study|Other reason not defined above|1
42953|NCT01297270|167850|P2|Overall Study|Other reason not defined above|3
42954|NCT01297270|167851|P1|Overall Study|Other reason not defined above|3
42955|NCT01297270|167849|P3|Overall Study|Withdrawal by Subject|7
42956|NCT01297270|167850|P2|Overall Study|Withdrawal by Subject|15
42957|NCT01297270|167851|P1|Overall Study|Withdrawal by Subject|7
42958|NCT01297270|167849|P3|Overall Study|Protocol Violation|0
42959|NCT01297270|167850|P2|Overall Study|Protocol Violation|2
42960|NCT01297270|167851|P1|Overall Study|Protocol Violation|0
42961|NCT01297270|167849|P3|Overall Study|Lost to Follow-up|1
42962|NCT01297270|167850|P2|Overall Study|Lost to Follow-up|2
42963|NCT01297270|167851|P1|Overall Study|Lost to Follow-up|1
42964|NCT01297270|167849|P3|Overall Study|Lack of Efficacy|15
42965|NCT01297270|167850|P2|Overall Study|Lack of Efficacy|17
42966|NCT01297270|167851|P1|Overall Study|Lack of Efficacy|15
42967|NCT01297270|167849|P3|Overall Study|Adverse Event|5
42968|NCT01297270|167850|P2|Overall Study|Adverse Event|32
42969|NCT01297270|167851|P1|Overall Study|Adverse Event|19
42970|NCT01297062|167900|P7|Overall Study|Subject Decision|2
42971|NCT01297062|167901|P6|Overall Study|Subject Decision|1
42972|NCT01297062|167902|P5|Overall Study|Subject Decision|1
42973|NCT01297062|167903|P4|Overall Study|Subject Decision|1
42974|NCT01297062|167904|P3|Overall Study|Subject Decision|0
42975|NCT01297062|167905|P2|Overall Study|Subject Decision|1
42976|NCT01297062|167906|P1|Overall Study|Subject Decision|1
42977|NCT01297062|167900|P7|Overall Study|Protocol Violation|0
42978|NCT01297062|167901|P6|Overall Study|Protocol Violation|0
42979|NCT01297062|167902|P5|Overall Study|Protocol Violation|1
42980|NCT01297062|167903|P4|Overall Study|Protocol Violation|0
42981|NCT01297062|167904|P3|Overall Study|Protocol Violation|0
42982|NCT01297062|167905|P2|Overall Study|Protocol Violation|0
42983|NCT01297062|167906|P1|Overall Study|Protocol Violation|0
42984|NCT01297062|167900|P7|Overall Study|Physician Decision|6
42985|NCT01297062|167901|P6|Overall Study|Physician Decision|0
42986|NCT01297062|167902|P5|Overall Study|Physician Decision|0
42987|NCT01297062|167903|P4|Overall Study|Physician Decision|0
42988|NCT01297062|167904|P3|Overall Study|Physician Decision|1
42989|NCT01297062|167905|P2|Overall Study|Physician Decision|0
42990|NCT01297062|167906|P1|Overall Study|Physician Decision|1
42991|NCT01297062|167900|P7|Overall Study|Adverse Event|0
42992|NCT01297062|167901|P6|Overall Study|Adverse Event|0
42993|NCT01297062|167902|P5|Overall Study|Adverse Event|0
42994|NCT01297062|167903|P4|Overall Study|Adverse Event|0
42995|NCT01297062|167904|P3|Overall Study|Adverse Event|1
42996|NCT01297062|167905|P2|Overall Study|Adverse Event|0
42997|NCT01297062|167906|P1|Overall Study|Adverse Event|2
42998|NCT01296698|167968|P2|Overall Study|Study Terminated by Sponsor|12
42999|NCT01296698|167969|P1|Overall Study|Study Terminated by Sponsor|209
43000|NCT01296698|167968|P2|Overall Study|Difficulty Contacting Subject|0
43001|NCT01296698|167969|P1|Overall Study|Difficulty Contacting Subject|2
43002|NCT01296698|167968|P2|Overall Study|Withdrawal by Subject|0
43003|NCT01296698|167969|P1|Overall Study|Withdrawal by Subject|12
43004|NCT01296698|167968|P2|Overall Study|Lost to Follow-up|1
43005|NCT01296698|167969|P1|Overall Study|Lost to Follow-up|19
43006|NCT01296698|167968|P2|Overall Study|Death|0
43007|NCT01296698|167969|P1|Overall Study|Death|1
43008|NCT01296698|167968|P2|Overall Study|Adverse Event|0
43009|NCT01296698|167969|P1|Overall Study|Adverse Event|1
43010|NCT01296412|168034|P2|Overall Study|Withdrawal by Subject|13
43011|NCT01296412|168035|P1|Overall Study|Withdrawal by Subject|10
43012|NCT01296412|168034|P2|Overall Study|Pregnancy|1
43013|NCT01296412|168035|P1|Overall Study|Pregnancy|0
43014|NCT01296412|168034|P2|Overall Study|Physician Decision|3
43015|NCT01296412|168035|P1|Overall Study|Physician Decision|1
43016|NCT01296412|168034|P2|Overall Study|Other reason not specified|15
43017|NCT01296412|168035|P1|Overall Study|Other reason not specified|20
43018|NCT01296412|168034|P2|Overall Study|Non-compliance with study drug|2
43019|NCT01296412|168035|P1|Overall Study|Non-compliance with study drug|1
43020|NCT01296412|168034|P2|Overall Study|Lost to Follow-up|7
43021|NCT01296412|168035|P1|Overall Study|Lost to Follow-up|10
43022|NCT01296412|168034|P2|Overall Study|Lack of Efficacy|0
43023|NCT01296412|168035|P1|Overall Study|Lack of Efficacy|1
43024|NCT01296412|168034|P2|Overall Study|Adverse Event|29
43025|NCT01296412|168035|P1|Overall Study|Adverse Event|8
43026|NCT01296152|168056|P1|Overall Study|Unwilling to adhere to study requirement|1
43027|NCT01296035|168083|P1|Overall Study|Withdrawal by Subject|1
43028|NCT01295905|168090|P2|Overall Study|Met exclusion criteria|0
43029|NCT01295905|168091|P1|Overall Study|Met exclusion criteria|1
43030|NCT01295905|168090|P2|Overall Study|Did not meet inclusion criteria|0
43031|NCT01295905|168091|P1|Overall Study|Did not meet inclusion criteria|1
43032|NCT01295814|168125|P2|Overall Study|Withdrawal by Subject|0
43033|NCT01295814|168126|P1|Overall Study|Withdrawal by Subject|2
43034|NCT01295814|168125|P2|Overall Study|Lack of Efficacy|2
43035|NCT01295814|168126|P1|Overall Study|Lack of Efficacy|0
43036|NCT01295281|168142|P2|First Intervention (7 Days)|Death|1
43037|NCT01295281|168143|P1|First Intervention (7 Days)|Death|0
43038|NCT01294917|168149|P1|Overall Study|Inconvenience|1
43039|NCT01294917|168149|P1|Overall Study|Relocation|5
43040|NCT01294800|168159|P4|Overall Study|Did Not Meet Protocol Eligibility|0
43041|NCT01294800|168160|P3|Overall Study|Did Not Meet Protocol Eligibility|1
43042|NCT01294800|168161|P2|Overall Study|Did Not Meet Protocol Eligibility|1
43043|NCT01294800|168162|P1|Overall Study|Did Not Meet Protocol Eligibility|2
43044|NCT01294800|168159|P4|Overall Study|Non-compliance With Protocol|0
43045|NCT01294800|168160|P3|Overall Study|Non-compliance With Protocol|1
43046|NCT01294800|168161|P2|Overall Study|Non-compliance With Protocol|1
43047|NCT01294800|168162|P1|Overall Study|Non-compliance With Protocol|0
43048|NCT01294800|168159|P4|Overall Study|Lost to Follow-up|0
43049|NCT01294800|168160|P3|Overall Study|Lost to Follow-up|1
43050|NCT01294800|168161|P2|Overall Study|Lost to Follow-up|0
43051|NCT01294800|168162|P1|Overall Study|Lost to Follow-up|0
43052|NCT01294800|168159|P4|Overall Study|Subject Withdrew Consent|11
43053|NCT01294800|168160|P3|Overall Study|Subject Withdrew Consent|2
43054|NCT01294800|168161|P2|Overall Study|Subject Withdrew Consent|2
43055|NCT01294800|168162|P1|Overall Study|Subject Withdrew Consent|2
43056|NCT01294800|168159|P4|Overall Study|Adverse Event|5
43057|NCT01294800|168160|P3|Overall Study|Adverse Event|12
43058|NCT01294800|168161|P2|Overall Study|Adverse Event|6
43059|NCT01294800|168162|P1|Overall Study|Adverse Event|7
43060|NCT01294787|168188|P6|Period 3|Adverse Event|0
43061|NCT01294787|168189|P5|Period 3|Adverse Event|1
43062|NCT01294787|168190|P4|Period 3|Adverse Event|0
43063|NCT01294787|168191|P3|Period 3|Adverse Event|0
43064|NCT01294787|168192|P2|Period 3|Adverse Event|0
43065|NCT01294787|168193|P1|Period 3|Adverse Event|0
43066|NCT01294787|168188|P6|Period 2|No longer needs study drug|0
43067|NCT01294787|168189|P5|Period 2|No longer needs study drug|0
43068|NCT01294787|168190|P4|Period 2|No longer needs study drug|1
43069|NCT01294787|168191|P3|Period 2|No longer needs study drug|0
43070|NCT01294787|168192|P2|Period 2|No longer needs study drug|0
43071|NCT01294787|168193|P1|Period 2|No longer needs study drug|0
43072|NCT01294787|168188|P6|Period 2|Adverse Event|0
43073|NCT01294787|168189|P5|Period 2|Adverse Event|0
43074|NCT01294787|168190|P4|Period 2|Adverse Event|1
43075|NCT01294787|168191|P3|Period 2|Adverse Event|0
43076|NCT01294787|168192|P2|Period 2|Adverse Event|3
43077|NCT01294787|168193|P1|Period 2|Adverse Event|0
43078|NCT01294787|168188|P6|Period 1|Administrative problem|1
43079|NCT01294787|168189|P5|Period 1|Administrative problem|0
43080|NCT01294787|168190|P4|Period 1|Administrative problem|0
43081|NCT01294787|168191|P3|Period 1|Administrative problem|1
43082|NCT01294787|168192|P2|Period 1|Administrative problem|0
43083|NCT01294787|168193|P1|Period 1|Administrative problem|0
43084|NCT01294787|168188|P6|Period 1|Withdrawal by Subject|1
43085|NCT01294787|168189|P5|Period 1|Withdrawal by Subject|1
43086|NCT01294787|168190|P4|Period 1|Withdrawal by Subject|1
43087|NCT01294787|168191|P3|Period 1|Withdrawal by Subject|0
43088|NCT01294787|168192|P2|Period 1|Withdrawal by Subject|0
43089|NCT01294787|168193|P1|Period 1|Withdrawal by Subject|0
43090|NCT01294787|168188|P6|Period 1|Adverse Event|0
43091|NCT01294787|168189|P5|Period 1|Adverse Event|1
43092|NCT01294787|168190|P4|Period 1|Adverse Event|0
43093|NCT01294787|168191|P3|Period 1|Adverse Event|0
43094|NCT01294787|168192|P2|Period 1|Adverse Event|0
43095|NCT01294787|168193|P1|Period 1|Adverse Event|0
43096|NCT01294696|168284|P1|Overall Study|Site closure|52
43097|NCT01294696|168284|P1|Overall Study|Missing BPI Response|7
43098|NCT01294696|168284|P1|Overall Study|Protocol Violation|8
43099|NCT01294696|168284|P1|Overall Study|Screening failures|7
43100|NCT01294683|168298|P2|Post Crossover (Period III)|Withdrawal by Subject|2
43101|NCT01294683|168299|P1|Post Crossover (Period III)|Withdrawal by Subject|3
43102|NCT01294683|168298|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
43103|NCT01294683|168299|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
43104|NCT01294683|168298|P2|Post Crossover (Period III)|Lost to Follow-up|3
43105|NCT01294683|168299|P1|Post Crossover (Period III)|Lost to Follow-up|1
43106|NCT01294683|168298|P2|Post Crossover (Period III)|Adverse Event|6
43107|NCT01294683|168299|P1|Post Crossover (Period III)|Adverse Event|6
43108|NCT01294683|168298|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
43109|NCT01294683|168299|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
43110|NCT01294683|168298|P2|Precrossover (Periods I/II)|Technical Problems|1
43111|NCT01294683|168299|P1|Precrossover (Periods I/II)|Technical Problems|0
43112|NCT01294683|168298|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
43113|NCT01294683|168299|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
43114|NCT01294683|168298|P2|Precrossover (Periods I/II)|Protocol Violation|5
43115|NCT01294683|168299|P1|Precrossover (Periods I/II)|Protocol Violation|5
43116|NCT01294683|168298|P2|Precrossover (Periods I/II)|Physician Decision|0
43117|NCT01294683|168299|P1|Precrossover (Periods I/II)|Physician Decision|1
43118|NCT01294683|168298|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
43119|NCT01294683|168299|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
43120|NCT01294683|168298|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
43121|NCT01294683|168299|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
43122|NCT01294683|168298|P2|Precrossover (Periods I/II)|Adverse Event|52
43123|NCT01294683|168299|P1|Precrossover (Periods I/II)|Adverse Event|49
43124|NCT01294644|168352|P3|Overall Study|Miscellaneous Reason|4
43125|NCT01294644|168353|P2|Overall Study|Miscellaneous Reason|1
43126|NCT01294644|168354|P1|Overall Study|Miscellaneous Reason|2
43127|NCT01294644|168352|P3|Overall Study|Lost to Follow-up|5
43128|NCT01294644|168353|P2|Overall Study|Lost to Follow-up|2
43129|NCT01294644|168354|P1|Overall Study|Lost to Follow-up|3
43130|NCT01294644|168352|P3|Overall Study|Withdrawal by Subject|4
43131|NCT01294644|168353|P2|Overall Study|Withdrawal by Subject|7
43132|NCT01294644|168354|P1|Overall Study|Withdrawal by Subject|3
43133|NCT01294644|168352|P3|Overall Study|Adverse Event|1
43134|NCT01294644|168353|P2|Overall Study|Adverse Event|0
43135|NCT01294644|168354|P1|Overall Study|Adverse Event|2
43136|NCT01294592|168385|P2|Overall Study|Withdrawal by Subject|28
43137|NCT01294592|168386|P1|Overall Study|Withdrawal by Subject|28
43138|NCT01294592|168385|P2|Overall Study|Physician Decision|11
43139|NCT01294592|168386|P1|Overall Study|Physician Decision|6
43140|NCT01294592|168385|P2|Overall Study|Lost to Follow-up|9
43141|NCT01294592|168386|P1|Overall Study|Lost to Follow-up|7
43142|NCT01294592|168385|P2|Overall Study|Protocol Violation|7
43143|NCT01294592|168386|P1|Overall Study|Protocol Violation|1
43144|NCT01294592|168385|P2|Overall Study|Lack of Efficacy|5
43145|NCT01294592|168386|P1|Overall Study|Lack of Efficacy|7
43146|NCT01294592|168385|P2|Overall Study|Adverse Event|13
43147|NCT01294592|168386|P1|Overall Study|Adverse Event|28
43148|NCT01294553|168414|P1|Overall Study|Protocol Violation|268
43149|NCT01294553|168414|P1|Overall Study|Duplicated Participants|1
43150|NCT01294514|168420|P1|Overall Study|Excluded due to Arrhythmia|1
43151|NCT01294462|168430|P2|Overall Study|Withdrawal by Subject|63
43152|NCT01294462|168431|P1|Overall Study|Withdrawal by Subject|65
43153|NCT01294462|168430|P2|Overall Study|Lost to Follow-up|0
43154|NCT01294462|168431|P1|Overall Study|Lost to Follow-up|1
43155|NCT01294449|168445|P2|Overall Study|Withdrawal by Subject|3
43156|NCT01294449|168446|P1|Overall Study|Withdrawal by Subject|1
43157|NCT01294449|168445|P2|Overall Study|Death|12
43158|NCT01294449|168446|P1|Overall Study|Death|11
43159|NCT01294436|168454|P2|Overall Study|poor/non-compliance|5
43160|NCT01294436|168455|P1|Overall Study|poor/non-compliance|2
43161|NCT01294436|168454|P2|Overall Study|subject no longer meets study criteria|20
43162|NCT01294436|168455|P1|Overall Study|subject no longer meets study criteria|5
43163|NCT01294436|168454|P2|Overall Study|Withdrawal by Subject|28
43164|NCT01294436|168455|P1|Overall Study|Withdrawal by Subject|11
43165|NCT01294436|168454|P2|Overall Study|Adverse Event|17
43166|NCT01294436|168455|P1|Overall Study|Adverse Event|10
43167|NCT01294423|168490|P3|Overall Study|poor/non-compliance|1
43168|NCT01294423|168491|P2|Overall Study|poor/non-compliance|0
43169|NCT01294423|168492|P1|Overall Study|poor/non-compliance|1
43170|NCT01294423|168490|P3|Overall Study|subject no longer meets study criteria|2
43171|NCT01294423|168491|P2|Overall Study|subject no longer meets study criteria|5
43172|NCT01294423|168492|P1|Overall Study|subject no longer meets study criteria|2
43173|NCT01294423|168490|P3|Overall Study|Withdrawal by Subject|2
43174|NCT01294423|168491|P2|Overall Study|Withdrawal by Subject|2
43175|NCT01294423|168492|P1|Overall Study|Withdrawal by Subject|1
43176|NCT01294423|168490|P3|Overall Study|Adverse Event|3
43177|NCT01294423|168491|P2|Overall Study|Adverse Event|2
43178|NCT01294423|168492|P1|Overall Study|Adverse Event|1
43179|NCT01294371|168540|P1|Overall Study|Other|14
43180|NCT01294371|168540|P1|Overall Study|Administrative Reason|1
43181|NCT01294371|168540|P1|Overall Study|Lost to Follow-up|6
43182|NCT01294371|168540|P1|Overall Study|Withdrawal by Subject|12
43183|NCT01294371|168540|P1|Overall Study|Adverse Event|1
43184|NCT01294150|168585|P2|Overall Study|Physician Decision|2
43185|NCT01294150|168586|P1|Overall Study|Physician Decision|2
43186|NCT01293968|168597|P2|Overall Study|non-cooperation|3
43187|NCT01293968|168598|P1|Overall Study|non-cooperation|3
43188|NCT01293695|168618|P2|Overall Study|Lost to Follow-up|6
43189|NCT01293695|168619|P1|Overall Study|Lost to Follow-up|8
43190|NCT01293695|168618|P2|Overall Study|Withdrawal by Subject|1
43191|NCT01293695|168619|P1|Overall Study|Withdrawal by Subject|7
43192|NCT01293240|168633|P1|Overall Study|Noncompliance|2
43193|NCT01293084|168648|P1|Overall Study|Withdrawal by Subject|2
43194|NCT01293084|168648|P1|Overall Study|Physician Decision|3
43195|NCT01293032|168660|P4|Treatment|Disease Progression, relapse|0
43196|NCT01293032|168661|P3|Treatment|Disease Progression, relapse|0
43197|NCT01293032|168662|P2|Treatment|Disease Progression, relapse|1
43198|NCT01293032|168663|P1|Treatment|Disease Progression, relapse|0
43199|NCT01293032|168660|P4|Treatment|Withdrawal by Subject|0
43200|NCT01293032|168661|P3|Treatment|Withdrawal by Subject|0
43201|NCT01293032|168662|P2|Treatment|Withdrawal by Subject|4
43202|NCT01293032|168663|P1|Treatment|Withdrawal by Subject|2
43203|NCT01293032|168660|P4|Treatment|Adverse Event|1
43204|NCT01293032|168661|P3|Treatment|Adverse Event|1
43205|NCT01293032|168662|P2|Treatment|Adverse Event|0
43206|NCT01293032|168663|P1|Treatment|Adverse Event|0
43207|NCT01293032|168660|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
43208|NCT01293032|168661|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
43209|NCT01293032|168662|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
43210|NCT01293032|168663|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
43211|NCT01293006|168674|P4|Period 2|Lost to Follow-up|0
43212|NCT01293006|168675|P3|Period 2|Lost to Follow-up|0
43213|NCT01293006|168676|P2|Period 2|Lost to Follow-up|0
43214|NCT01293006|168677|P1|Period 2|Lost to Follow-up|1
43215|NCT01292928|168698|P1|Overall Study|Physician Decision|2
43216|NCT01292928|168698|P1|Overall Study|Lost to Follow-up|6
43217|NCT01292928|168698|P1|Overall Study|Withdrawal by Subject|8
43218|NCT01292928|168698|P1|Overall Study|Death|8
43219|NCT01292837|168715|P1|Overall Study|Further treatment determined|1
43220|NCT01292837|168715|P1|Overall Study|Adverse Event|1
43221|NCT01292603|168752|P6|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
43222|NCT01292603|168753|P5|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
43223|NCT01292603|168754|P4|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
43224|NCT01292603|168755|P3|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
43225|NCT01292603|168756|P2|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
43226|NCT01292603|168757|P1|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
43227|NCT01292603|168752|P6|Part 2: Survival Follow-UP|Death|3
43228|NCT01292603|168753|P5|Part 2: Survival Follow-UP|Death|1
43229|NCT01292603|168754|P4|Part 2: Survival Follow-UP|Death|0
43230|NCT01292603|168755|P3|Part 2: Survival Follow-UP|Death|0
43231|NCT01292603|168756|P2|Part 2: Survival Follow-UP|Death|0
43232|NCT01292603|168757|P1|Part 2: Survival Follow-UP|Death|0
43233|NCT01292603|168752|P6|Part 2: Regular Follow-Up|Noncompliance|0
43234|NCT01292603|168753|P5|Part 2: Regular Follow-Up|Noncompliance|1
43235|NCT01292603|168754|P4|Part 2: Regular Follow-Up|Noncompliance|0
43236|NCT01292603|168755|P3|Part 2: Regular Follow-Up|Noncompliance|0
43237|NCT01292603|168756|P2|Part 2: Regular Follow-Up|Noncompliance|0
43238|NCT01292603|168757|P1|Part 2: Regular Follow-Up|Noncompliance|0
43239|NCT01292603|168752|P6|Part 2: Regular Follow-Up|Disease Progression|4
43240|NCT01292603|168753|P5|Part 2: Regular Follow-Up|Disease Progression|2
43241|NCT01292603|168754|P4|Part 2: Regular Follow-Up|Disease Progression|0
43242|NCT01292603|168755|P3|Part 2: Regular Follow-Up|Disease Progression|0
43243|NCT01292603|168756|P2|Part 2: Regular Follow-Up|Disease Progression|0
43244|NCT01292603|168757|P1|Part 2: Regular Follow-Up|Disease Progression|0
43245|NCT01292603|168752|P6|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|72
43246|NCT01292603|168753|P5|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|73
43247|NCT01292603|168754|P4|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
43248|NCT01292603|168755|P3|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
43249|NCT01292603|168756|P2|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
43250|NCT01292603|168757|P1|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
43251|NCT01292603|168752|P6|Part 2: Regular Follow-Up|Death|2
43252|NCT01292603|168753|P5|Part 2: Regular Follow-Up|Death|2
43253|NCT01292603|168754|P4|Part 2: Regular Follow-Up|Death|0
43254|NCT01292603|168755|P3|Part 2: Regular Follow-Up|Death|0
43255|NCT01292603|168756|P2|Part 2: Regular Follow-Up|Death|0
43256|NCT01292603|168757|P1|Part 2: Regular Follow-Up|Death|0
43257|NCT01292603|168752|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
43258|NCT01292603|168753|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
43259|NCT01292603|168754|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
43260|NCT01292603|168755|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
43261|NCT01292603|168756|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
43262|NCT01292603|168757|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
43263|NCT01292603|168752|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
43264|NCT01292603|168753|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
43265|NCT01292603|168754|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
43266|NCT01292603|168755|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
43267|NCT01292603|168756|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
43268|NCT01292603|168757|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
43269|NCT01292603|168752|P6|Part 2: Dose Confirmation Period|Adverse Event|9
43270|NCT01292603|168753|P5|Part 2: Dose Confirmation Period|Adverse Event|7
43271|NCT01292603|168754|P4|Part 2: Dose Confirmation Period|Adverse Event|0
43272|NCT01292603|168755|P3|Part 2: Dose Confirmation Period|Adverse Event|0
43273|NCT01292603|168756|P2|Part 2: Dose Confirmation Period|Adverse Event|0
43274|NCT01292603|168757|P1|Part 2: Dose Confirmation Period|Adverse Event|0
43275|NCT01292603|168752|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
43276|NCT01292603|168753|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
43277|NCT01292603|168754|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
43278|NCT01292603|168755|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
43279|NCT01292603|168756|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
43280|NCT01292603|168757|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
43281|NCT01292603|168752|P6|Part 2: Dose Confirmation Period|Physician Decision|0
43282|NCT01292603|168753|P5|Part 2: Dose Confirmation Period|Physician Decision|2
43283|NCT01292603|168754|P4|Part 2: Dose Confirmation Period|Physician Decision|0
43284|NCT01292603|168755|P3|Part 2: Dose Confirmation Period|Physician Decision|0
43285|NCT01292603|168756|P2|Part 2: Dose Confirmation Period|Physician Decision|0
43286|NCT01292603|168757|P1|Part 2: Dose Confirmation Period|Physician Decision|0
43287|NCT01292603|168752|P6|Part 2: Dose Confirmation Period|Death|0
43288|NCT01292603|168753|P5|Part 2: Dose Confirmation Period|Death|1
43289|NCT01292603|168754|P4|Part 2: Dose Confirmation Period|Death|0
43290|NCT01292603|168755|P3|Part 2: Dose Confirmation Period|Death|0
43291|NCT01292603|168756|P2|Part 2: Dose Confirmation Period|Death|0
43292|NCT01292603|168757|P1|Part 2: Dose Confirmation Period|Death|0
43293|NCT01292603|168752|P6|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
43294|NCT01292603|168753|P5|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
43295|NCT01292603|168754|P4|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
43296|NCT01292603|168755|P3|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|1
43297|NCT01292603|168756|P2|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|2
43298|NCT01292603|168757|P1|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|3
43299|NCT01292603|168752|P6|Part 1: Survival Follow-Up|Death|0
43300|NCT01292603|168753|P5|Part 1: Survival Follow-Up|Death|0
43301|NCT01292603|168754|P4|Part 1: Survival Follow-Up|Death|0
43302|NCT01292603|168755|P3|Part 1: Survival Follow-Up|Death|1
43303|NCT01292603|168756|P2|Part 1: Survival Follow-Up|Death|0
43304|NCT01292603|168757|P1|Part 1: Survival Follow-Up|Death|1
43305|NCT01292603|168752|P6|Part 1: Regular Follow-Up Period|Adverse Event|0
43306|NCT01292603|168753|P5|Part 1: Regular Follow-Up Period|Adverse Event|0
43307|NCT01292603|168754|P4|Part 1: Regular Follow-Up Period|Adverse Event|0
43308|NCT01292603|168755|P3|Part 1: Regular Follow-Up Period|Adverse Event|0
43309|NCT01292603|168756|P2|Part 1: Regular Follow-Up Period|Adverse Event|0
43310|NCT01292603|168757|P1|Part 1: Regular Follow-Up Period|Adverse Event|1
43311|NCT01292603|168752|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
43312|NCT01292603|168753|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
43313|NCT01292603|168754|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
43314|NCT01292603|168755|P3|Part 1: Regular Follow-Up Period|Disease Progression|2
43315|NCT01292603|168756|P2|Part 1: Regular Follow-Up Period|Disease Progression|2
43316|NCT01292603|168757|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
43317|NCT01292603|168752|P6|Part 1: Regular Follow-Up Period|Death|0
43318|NCT01292603|168753|P5|Part 1: Regular Follow-Up Period|Death|0
43319|NCT01292603|168754|P4|Part 1: Regular Follow-Up Period|Death|0
43320|NCT01292603|168755|P3|Part 1: Regular Follow-Up Period|Death|2
43321|NCT01292603|168756|P2|Part 1: Regular Follow-Up Period|Death|0
43322|NCT01292603|168757|P1|Part 1: Regular Follow-Up Period|Death|1
43323|NCT01292603|168752|P6|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
43324|NCT01292603|168753|P5|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
43325|NCT01292603|168754|P4|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
43326|NCT01292603|168755|P3|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|19
43327|NCT01292603|168756|P2|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|15
43328|NCT01292603|168757|P1|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|11
43329|NCT01292603|168752|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
43330|NCT01292603|168753|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
43331|NCT01292603|168754|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
43332|NCT01292603|168755|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
43333|NCT01292603|168756|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
43334|NCT01292603|168757|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
43335|NCT01292603|168752|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
43336|NCT01292603|168753|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
43337|NCT01292603|168754|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
43338|NCT01292603|168755|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
43339|NCT01292603|168756|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
43340|NCT01292603|168757|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
43341|NCT01292603|168752|P6|Part 1: Pilot Dose Selection Period|Death|0
43342|NCT01292603|168753|P5|Part 1: Pilot Dose Selection Period|Death|0
43343|NCT01292603|168754|P4|Part 1: Pilot Dose Selection Period|Death|1
43344|NCT01292603|168755|P3|Part 1: Pilot Dose Selection Period|Death|0
43345|NCT01292603|168756|P2|Part 1: Pilot Dose Selection Period|Death|0
43346|NCT01292603|168757|P1|Part 1: Pilot Dose Selection Period|Death|0
43347|NCT01292603|168752|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
43348|NCT01292603|168753|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
43349|NCT01292603|168754|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
43350|NCT01292603|168755|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
43351|NCT01292603|168756|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
43352|NCT01292603|168757|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
43353|NCT01292486|168810|P1|Overall Study|Physician Decision|1
43354|NCT01292486|168810|P1|Overall Study|Adverse Event|1
43355|NCT01292486|168810|P1|Overall Study|Did not meet screening criteria|2
43356|NCT01292486|168810|P1|Overall Study|Protocol Violation|2
43357|NCT01292473|168824|P4|Overall Study|Disease Progression|6
43358|NCT01292473|168825|P3|Overall Study|Disease Progression|3
43359|NCT01292473|168826|P2|Overall Study|Disease Progression|1
43360|NCT01292473|168827|P1|Overall Study|Disease Progression|0
43361|NCT01292473|168824|P4|Overall Study|Physician Decision|0
43362|NCT01292473|168825|P3|Overall Study|Physician Decision|0
43363|NCT01292473|168826|P2|Overall Study|Physician Decision|1
43364|NCT01292473|168827|P1|Overall Study|Physician Decision|0
43365|NCT01292473|168824|P4|Overall Study|Withdrawal by Subject|3
43366|NCT01292473|168825|P3|Overall Study|Withdrawal by Subject|3
43367|NCT01292473|168826|P2|Overall Study|Withdrawal by Subject|4
43368|NCT01292473|168827|P1|Overall Study|Withdrawal by Subject|3
43369|NCT01292473|168824|P4|Overall Study|Lost to Follow-up|2
43370|NCT01292473|168825|P3|Overall Study|Lost to Follow-up|2
43371|NCT01292473|168826|P2|Overall Study|Lost to Follow-up|1
43372|NCT01292473|168827|P1|Overall Study|Lost to Follow-up|1
43373|NCT01292473|168824|P4|Overall Study|Adverse Event|1
43374|NCT01292473|168825|P3|Overall Study|Adverse Event|1
43375|NCT01292473|168826|P2|Overall Study|Adverse Event|0
43376|NCT01292473|168827|P1|Overall Study|Adverse Event|1
43377|NCT01292239|168886|P2|Overall Study|Withdrawal by Subject|6
43378|NCT01292239|168887|P1|Overall Study|Withdrawal by Subject|3
43379|NCT01292239|168886|P2|Overall Study|Not specified|1
43380|NCT01292239|168887|P1|Overall Study|Not specified|1
43381|NCT01292226|168908|P1|Overall Study|Not specified|2
43382|NCT01292226|168908|P1|Overall Study|Withdrawal by Subject|1
43383|NCT01292226|168908|P1|Overall Study|Protocol Violation|3
43384|NCT01292226|168908|P1|Overall Study|Graft loss|1
43385|NCT01292226|168908|P1|Overall Study|Death|1
43386|NCT01292226|168908|P1|Overall Study|Adverse Event|5
43387|NCT01292187|168941|P2|Overall Study|All other reasons|3
43388|NCT01292187|168942|P1|Overall Study|All other reasons|1
43389|NCT01292187|168941|P2|Overall Study|Withdrawal by Subject|5
43390|NCT01292187|168942|P1|Overall Study|Withdrawal by Subject|6
43391|NCT01292187|168941|P2|Overall Study|Adverse Event|5
43392|NCT01292187|168942|P1|Overall Study|Adverse Event|10
43393|NCT01291277|169032|P2|Overall Study|Lost to Follow-up|1
43394|NCT01291277|169033|P1|Overall Study|Lost to Follow-up|3
43395|NCT01291277|169032|P2|Overall Study|Death|2
43396|NCT01291277|169033|P1|Overall Study|Death|2
43397|NCT01291225|169045|P2|Overall Study|Lost to Follow-up|39
43398|NCT01291225|169046|P1|Overall Study|Lost to Follow-up|85
43399|NCT01291173|169060|P4|Overall Study|Excluded therapy|0
43400|NCT01291173|169061|P3|Overall Study|Excluded therapy|1
43401|NCT01291173|169062|P2|Overall Study|Excluded therapy|0
43402|NCT01291173|169063|P1|Overall Study|Excluded therapy|0
43403|NCT01291173|169060|P4|Overall Study|Subject was unblinded|0
43404|NCT01291173|169061|P3|Overall Study|Subject was unblinded|1
43405|NCT01291173|169062|P2|Overall Study|Subject was unblinded|0
43406|NCT01291173|169063|P1|Overall Study|Subject was unblinded|0
43407|NCT01291173|169060|P4|Overall Study|Lack of compliance|1
43408|NCT01291173|169061|P3|Overall Study|Lack of compliance|0
43409|NCT01291173|169062|P2|Overall Study|Lack of compliance|0
43410|NCT01291173|169063|P1|Overall Study|Lack of compliance|0
43411|NCT01291173|169060|P4|Overall Study|Unable to meet visit schedule|0
43412|NCT01291173|169061|P3|Overall Study|Unable to meet visit schedule|1
43413|NCT01291173|169062|P2|Overall Study|Unable to meet visit schedule|0
43414|NCT01291173|169063|P1|Overall Study|Unable to meet visit schedule|0
43415|NCT01291173|169060|P4|Overall Study|Lost to Follow-up|2
43416|NCT01291173|169061|P3|Overall Study|Lost to Follow-up|3
43417|NCT01291173|169062|P2|Overall Study|Lost to Follow-up|6
43418|NCT01291173|169063|P1|Overall Study|Lost to Follow-up|4
43419|NCT01291173|169060|P4|Overall Study|Withdrawal by Subject|2
43420|NCT01291173|169061|P3|Overall Study|Withdrawal by Subject|4
43421|NCT01291173|169062|P2|Overall Study|Withdrawal by Subject|4
43422|NCT01291173|169063|P1|Overall Study|Withdrawal by Subject|6
43423|NCT01291173|169060|P4|Overall Study|Protocol Violation|5
43424|NCT01291173|169061|P3|Overall Study|Protocol Violation|2
43425|NCT01291173|169062|P2|Overall Study|Protocol Violation|2
43426|NCT01291173|169063|P1|Overall Study|Protocol Violation|7
43427|NCT01291173|169060|P4|Overall Study|Adverse Event|3
43428|NCT01291173|169061|P3|Overall Study|Adverse Event|1
43429|NCT01291173|169062|P2|Overall Study|Adverse Event|3
43430|NCT01291173|169063|P1|Overall Study|Adverse Event|0
43431|NCT01291017|169172|P1|Overall Study|Withdrawal by Subject|3
43432|NCT01291017|169172|P1|Overall Study|Lost to Follow-up|2
43433|NCT01290887|169205|P2|Overall Study|Not specified|6
43434|NCT01290887|169206|P1|Overall Study|Not specified|3
43435|NCT01290887|169205|P2|Overall Study|Sponsor closure of study|476
43436|NCT01290887|169206|P1|Overall Study|Sponsor closure of study|420
43437|NCT01290887|169205|P2|Overall Study|Non-compliance to study medications|0
43438|NCT01290887|169206|P1|Overall Study|Non-compliance to study medications|1
43439|NCT01290887|169205|P2|Overall Study|Non-compliance to study procedures|1
43440|NCT01290887|169206|P1|Overall Study|Non-compliance to study procedures|0
43441|NCT01290887|169205|P2|Overall Study|Lost to Follow-up|4
43442|NCT01290887|169206|P1|Overall Study|Lost to Follow-up|4
43443|NCT01290887|169205|P2|Overall Study|Protocol Violation|1
43444|NCT01290887|169206|P1|Overall Study|Protocol Violation|2
43445|NCT01290887|169205|P2|Overall Study|Withdrawal by Subject|32
43446|NCT01290887|169206|P1|Overall Study|Withdrawal by Subject|26
43447|NCT01290887|169205|P2|Overall Study|Lack of Efficacy|5
43448|NCT01290887|169206|P1|Overall Study|Lack of Efficacy|4
43449|NCT01290887|169205|P2|Overall Study|Adverse Event|11
43450|NCT01290887|169206|P1|Overall Study|Adverse Event|6
43451|NCT01290822|169244|P1|Overall Study|Physician Decision|10
43452|NCT01290822|169244|P1|Overall Study|Withdrawal by Subject|1
43453|NCT01290796|169253|P1|Overall Study|Secondary Surgical Intervention|1
43454|NCT01290796|169253|P1|Overall Study|Physician Decision|2
43455|NCT01290796|169253|P1|Overall Study|Withdrawal by Subject|4
43456|NCT01290796|169253|P1|Overall Study|Lost to Follow-up|10
43457|NCT01290757|169260|P2|Overall Study|Other|1
43458|NCT01290757|169261|P1|Overall Study|Other|0
43459|NCT01290757|169260|P2|Overall Study|Protocol Violation|1
43460|NCT01290757|169261|P1|Overall Study|Protocol Violation|1
43461|NCT01290757|169260|P2|Overall Study|Adverse Event|0
43462|NCT01290757|169261|P1|Overall Study|Adverse Event|1
43463|NCT01290731|169277|P1|Overall Study|Withdrawal by Subject|1
43464|NCT01290718|169289|P1|Overall Study|Early termination of the study|4
43465|NCT01290679|169298|P2|Overall Study|Subject Entered Another Trial|5
43466|NCT01290679|169299|P1|Overall Study|Subject Entered Another Trial|0
43467|NCT01290679|169298|P2|Overall Study|Withdrawal by Subject|5
43468|NCT01290679|169299|P1|Overall Study|Withdrawal by Subject|6
43469|NCT01290679|169298|P2|Overall Study|Protocol Violation|1
43470|NCT01290679|169299|P1|Overall Study|Protocol Violation|0
43471|NCT01290679|169298|P2|Overall Study|Lost to Follow-up|10
43472|NCT01290679|169299|P1|Overall Study|Lost to Follow-up|8
43473|NCT01290679|169298|P2|Overall Study|Adverse Event|0
43474|NCT01290679|169299|P1|Overall Study|Adverse Event|2
43475|NCT01290666|169368|P1|Overall Study|Early Termination of Study|4
43476|NCT01290666|169368|P1|Overall Study|Withdrawal by Subject|23
43477|NCT01290666|169368|P1|Overall Study|Lost to Follow-up|11
43478|NCT01290341|169437|P2|Overall Study|Negative baseline culture and others|11
43479|NCT01290341|169438|P1|Overall Study|Negative baseline culture and others|44
43480|NCT01290341|169437|P2|Overall Study|Withdrawal by Subject|5
43481|NCT01290341|169438|P1|Overall Study|Withdrawal by Subject|19
43482|NCT01290341|169437|P2|Overall Study|Lost to Follow-up|10
43483|NCT01290341|169438|P1|Overall Study|Lost to Follow-up|21
43484|NCT01290341|169437|P2|Overall Study|Adverse Event|0
43485|NCT01290341|169438|P1|Overall Study|Adverse Event|1
43486|NCT01290341|169437|P2|Overall Study|Protocol Violation|3
43487|NCT01290341|169438|P1|Overall Study|Protocol Violation|7
43488|NCT01290224|169446|P1|Overall Study|Refused Further Treatment|4
43489|NCT01290224|169446|P1|Overall Study|Adverse Event|1
43490|NCT01290094|169457|P1|Overall Study|Lost to Follow-up|5
43491|NCT01290094|169457|P1|Overall Study|Withdrawal by Subject|1
43492|NCT01290029|169468|P1|Overall Study|Other|2
43493|NCT01289990|169494|P13|Overall Study|Not treated|0
43494|NCT01289990|169495|P12|Overall Study|Not treated|2
43495|NCT01289990|169496|P11|Overall Study|Not treated|1
43496|NCT01289990|169497|P10|Overall Study|Not treated|0
43497|NCT01289990|169498|P9|Overall Study|Not treated|1
43498|NCT01289990|169499|P8|Overall Study|Not treated|0
43499|NCT01289990|169500|P7|Overall Study|Not treated|1
43500|NCT01289990|169501|P6|Overall Study|Not treated|0
43501|NCT01289990|169502|P5|Overall Study|Not treated|0
43502|NCT01289990|169503|P4|Overall Study|Not treated|0
43503|NCT01289990|169504|P3|Overall Study|Not treated|0
43504|NCT01289990|169505|P2|Overall Study|Not treated|0
43505|NCT01289990|169506|P1|Overall Study|Not treated|0
43506|NCT01289990|169494|P13|Overall Study|did not continue in extension|56
43507|NCT01289990|169495|P12|Overall Study|did not continue in extension|34
43508|NCT01289990|169496|P11|Overall Study|did not continue in extension|45
43509|NCT01289990|169497|P10|Overall Study|did not continue in extension|48
43510|NCT01289990|169498|P9|Overall Study|did not continue in extension|44
43511|NCT01289990|169499|P8|Overall Study|did not continue in extension|36
43512|NCT01289990|169500|P7|Overall Study|did not continue in extension|54
43513|NCT01289990|169501|P6|Overall Study|did not continue in extension|50
43514|NCT01289990|169502|P5|Overall Study|did not continue in extension|48
43515|NCT01289990|169503|P4|Overall Study|did not continue in extension|51
43516|NCT01289990|169504|P3|Overall Study|did not continue in extension|51
43517|NCT01289990|169505|P2|Overall Study|did not continue in extension|45
43518|NCT01289990|169506|P1|Overall Study|did not continue in extension|41
43519|NCT01289990|169494|P13|Overall Study|discontinued in preceding trial|24
43520|NCT01289990|169495|P12|Overall Study|discontinued in preceding trial|17
43521|NCT01289990|169496|P11|Overall Study|discontinued in preceding trial|17
43522|NCT01289990|169497|P10|Overall Study|discontinued in preceding trial|21
43523|NCT01289990|169498|P9|Overall Study|discontinued in preceding trial|17
43524|NCT01289990|169499|P8|Overall Study|discontinued in preceding trial|8
43525|NCT01289990|169500|P7|Overall Study|discontinued in preceding trial|18
43526|NCT01289990|169501|P6|Overall Study|discontinued in preceding trial|12
43527|NCT01289990|169502|P5|Overall Study|discontinued in preceding trial|11
43528|NCT01289990|169503|P4|Overall Study|discontinued in preceding trial|17
43529|NCT01289990|169504|P3|Overall Study|discontinued in preceding trial|41
43530|NCT01289990|169505|P2|Overall Study|discontinued in preceding trial|20
43531|NCT01289990|169506|P1|Overall Study|discontinued in preceding trial|18
43532|NCT01289990|169494|P13|Overall Study|Withdrawal by Subject|16
43533|NCT01289990|169495|P12|Overall Study|Withdrawal by Subject|13
43534|NCT01289990|169496|P11|Overall Study|Withdrawal by Subject|11
43535|NCT01289990|169497|P10|Overall Study|Withdrawal by Subject|13
43536|NCT01289990|169498|P9|Overall Study|Withdrawal by Subject|12
43537|NCT01289990|169499|P8|Overall Study|Withdrawal by Subject|9
43538|NCT01289990|169500|P7|Overall Study|Withdrawal by Subject|13
43539|NCT01289990|169501|P6|Overall Study|Withdrawal by Subject|7
43540|NCT01289990|169502|P5|Overall Study|Withdrawal by Subject|8
43541|NCT01289990|169503|P4|Overall Study|Withdrawal by Subject|13
43542|NCT01289990|169504|P3|Overall Study|Withdrawal by Subject|12
43543|NCT01289990|169505|P2|Overall Study|Withdrawal by Subject|14
43544|NCT01289990|169506|P1|Overall Study|Withdrawal by Subject|15
43545|NCT01289990|169494|P13|Overall Study|Lost to Follow-up|2
43546|NCT01289990|169495|P12|Overall Study|Lost to Follow-up|1
43547|NCT01289990|169496|P11|Overall Study|Lost to Follow-up|2
43548|NCT01289990|169497|P10|Overall Study|Lost to Follow-up|4
43549|NCT01289990|169498|P9|Overall Study|Lost to Follow-up|1
43550|NCT01289990|169499|P8|Overall Study|Lost to Follow-up|2
43551|NCT01289990|169500|P7|Overall Study|Lost to Follow-up|2
43552|NCT01289990|169501|P6|Overall Study|Lost to Follow-up|4
43553|NCT01289990|169502|P5|Overall Study|Lost to Follow-up|3
43554|NCT01289990|169503|P4|Overall Study|Lost to Follow-up|5
43555|NCT01289990|169504|P3|Overall Study|Lost to Follow-up|5
43556|NCT01289990|169505|P2|Overall Study|Lost to Follow-up|2
43557|NCT01289990|169506|P1|Overall Study|Lost to Follow-up|3
43558|NCT01289990|169494|P13|Overall Study|Death|0
43559|NCT01289990|169495|P12|Overall Study|Death|1
43560|NCT01289990|169496|P11|Overall Study|Death|0
43561|NCT01289990|169497|P10|Overall Study|Death|0
43562|NCT01289990|169498|P9|Overall Study|Death|0
43563|NCT01289990|169499|P8|Overall Study|Death|0
43564|NCT01289990|169500|P7|Overall Study|Death|0
43565|NCT01289990|169501|P6|Overall Study|Death|1
43566|NCT01289990|169502|P5|Overall Study|Death|2
43567|NCT01289990|169503|P4|Overall Study|Death|1
43568|NCT01289990|169504|P3|Overall Study|Death|0
43569|NCT01289990|169505|P2|Overall Study|Death|0
43570|NCT01289990|169506|P1|Overall Study|Death|0
43571|NCT01289847|169690|P1|Overall Study|Patient could not comply with visits|1
43572|NCT01289821|169699|P1|Survival Follow-up Period|Protocol Violation|1
43573|NCT01289821|169699|P1|Survival Follow-up Period|Death|5
43574|NCT01289821|169699|P1|Safety Follow-up Period|Protocol Violation|2
43575|NCT01289821|169699|P1|Safety Follow-up Period|Withdrawal by Subject|1
43576|NCT01289821|169699|P1|Safety Follow-up Period|Death|1
43577|NCT01289821|169699|P1|Treatment Period|Clinical Progression|2
43578|NCT01289821|169699|P1|Treatment Period|Radiological Progression|19
43579|NCT01289821|169699|P1|Treatment Period|Adverse Event|3
43580|NCT01289821|169699|P1|Treatment Period|Physician Decision|3
43581|NCT01289821|169699|P1|Treatment Period|Withdrawal by Subject|1
43582|NCT01289782|169710|P2|Overall Study|Reason not specified|2
43583|NCT01289782|169711|P1|Overall Study|Reason not specified|1
43584|NCT01289782|169710|P2|Overall Study|Sponsor's Decision|0
43585|NCT01289782|169711|P1|Overall Study|Sponsor's Decision|1
43586|NCT01289782|169710|P2|Overall Study|Withdrawal by Subject|2
43587|NCT01289782|169711|P1|Overall Study|Withdrawal by Subject|8
43588|NCT01289782|169710|P2|Overall Study|Protocol Violation|1
43589|NCT01289782|169711|P1|Overall Study|Protocol Violation|1
43590|NCT01289782|169710|P2|Overall Study|Lost to Follow-up|7
43591|NCT01289782|169711|P1|Overall Study|Lost to Follow-up|14
43592|NCT01289639|169783|P3|Overall Study|Lost to Follow-up|0
43593|NCT01289639|169784|P2|Overall Study|Lost to Follow-up|0
43594|NCT01289639|169785|P1|Overall Study|Lost to Follow-up|1
43595|NCT01289574|169811|P3|Overall Study|Subject wanted alternate treatment|0
43596|NCT01289574|169812|P2|Overall Study|Subject wanted alternate treatment|1
43597|NCT01289574|169813|P1|Overall Study|Subject wanted alternate treatment|0
43598|NCT01289574|169811|P3|Overall Study|Adverse Event|0
43599|NCT01289574|169812|P2|Overall Study|Adverse Event|1
43600|NCT01289574|169813|P1|Overall Study|Adverse Event|0
43601|NCT01289574|169811|P3|Overall Study|Withdrawal by Subject|1
43602|NCT01289574|169812|P2|Overall Study|Withdrawal by Subject|1
43603|NCT01289574|169813|P1|Overall Study|Withdrawal by Subject|1
43604|NCT01289574|169811|P3|Overall Study|Lost to Follow-up|1
43605|NCT01289574|169812|P2|Overall Study|Lost to Follow-up|0
43606|NCT01289574|169813|P1|Overall Study|Lost to Follow-up|2
43607|NCT01289574|169811|P3|Overall Study|Lack of Efficacy|1
43608|NCT01289574|169812|P2|Overall Study|Lack of Efficacy|0
43609|NCT01289574|169813|P1|Overall Study|Lack of Efficacy|4
43610|NCT01289418|169879|P1|Day 29 Survey|participants did not complete the survey|2185
43611|NCT01289418|169879|P1|Day 29 Survey|email address invalid|283
43612|NCT01289418|169879|P1|Day 8 Survey|participants did not complete the survey|1935
43613|NCT01289418|169879|P1|Day 8 Survey|email address invalid|283
43614|NCT01289210|169898|P1|Overall Study|Adverse Event|1
43615|NCT01289119|169908|P6|Overall Study|Other|0
43616|NCT01289119|169909|P5|Overall Study|Other|0
43617|NCT01289119|169910|P4|Overall Study|Other|0
43618|NCT01289119|169911|P3|Overall Study|Other|1
43619|NCT01289119|169912|P2|Overall Study|Other|0
43620|NCT01289119|169913|P1|Overall Study|Other|1
43621|NCT01289119|169908|P6|Overall Study|Lack of Efficacy|1
43622|NCT01289119|169909|P5|Overall Study|Lack of Efficacy|1
43623|NCT01289119|169910|P4|Overall Study|Lack of Efficacy|1
43624|NCT01289119|169911|P3|Overall Study|Lack of Efficacy|1
43625|NCT01289119|169912|P2|Overall Study|Lack of Efficacy|1
43626|NCT01289119|169913|P1|Overall Study|Lack of Efficacy|0
43627|NCT01289119|169908|P6|Overall Study|Pregnancy|0
43628|NCT01289119|169909|P5|Overall Study|Pregnancy|0
43629|NCT01289119|169910|P4|Overall Study|Pregnancy|0
43630|NCT01289119|169911|P3|Overall Study|Pregnancy|0
43631|NCT01289119|169912|P2|Overall Study|Pregnancy|1
43632|NCT01289119|169913|P1|Overall Study|Pregnancy|0
43633|NCT01289119|169908|P6|Overall Study|Withdrawal by Subject|1
43634|NCT01289119|169909|P5|Overall Study|Withdrawal by Subject|1
43635|NCT01289119|169910|P4|Overall Study|Withdrawal by Subject|3
43636|NCT01289119|169911|P3|Overall Study|Withdrawal by Subject|4
43637|NCT01289119|169912|P2|Overall Study|Withdrawal by Subject|2
43638|NCT01289119|169913|P1|Overall Study|Withdrawal by Subject|4
43639|NCT01289119|169908|P6|Overall Study|Lost to Follow-up|1
43640|NCT01289119|169909|P5|Overall Study|Lost to Follow-up|0
43641|NCT01289119|169910|P4|Overall Study|Lost to Follow-up|0
43642|NCT01289119|169911|P3|Overall Study|Lost to Follow-up|0
43643|NCT01289119|169912|P2|Overall Study|Lost to Follow-up|3
43644|NCT01289119|169913|P1|Overall Study|Lost to Follow-up|0
43645|NCT01289119|169908|P6|Overall Study|Major Protocol Deviation|1
43646|NCT01289119|169909|P5|Overall Study|Major Protocol Deviation|2
43647|NCT01289119|169910|P4|Overall Study|Major Protocol Deviation|0
43648|NCT01289119|169911|P3|Overall Study|Major Protocol Deviation|3
43649|NCT01289119|169912|P2|Overall Study|Major Protocol Deviation|1
43650|NCT01289119|169913|P1|Overall Study|Major Protocol Deviation|2
43651|NCT01289119|169908|P6|Overall Study|Adverse Event|0
43652|NCT01289119|169909|P5|Overall Study|Adverse Event|1
43653|NCT01289119|169910|P4|Overall Study|Adverse Event|2
43654|NCT01289119|169911|P3|Overall Study|Adverse Event|0
43655|NCT01289119|169912|P2|Overall Study|Adverse Event|1
43656|NCT01289119|169913|P1|Overall Study|Adverse Event|2
43657|NCT01289041|170027|P1|Overall Study|Death|1
43658|NCT01289041|170027|P1|Overall Study|Withdrawal by Subject|3
43659|NCT01289041|170027|P1|Overall Study|Progressive Disease|41
43660|NCT01289041|170027|P1|Overall Study|Physician Decision|1
43661|NCT01289041|170027|P1|Overall Study|Adverse Event|24
43662|NCT01289028|170039|P1|Overall Study|Missing reason for discon|1
43663|NCT01289028|170039|P1|Overall Study|Abnormal Lab Value|1
43664|NCT01289028|170039|P1|Overall Study|New Cancer Therapy|2
43665|NCT01289028|170039|P1|Overall Study|Lost to Follow-up|2
43666|NCT01289028|170039|P1|Overall Study|No longer required|2
43667|NCT01289028|170039|P1|Overall Study|Lack of Efficacy|2
43668|NCT01289028|170039|P1|Overall Study|Death|4
43669|NCT01289028|170039|P1|Overall Study|Withdrawal by Subject|6
43670|NCT01289028|170039|P1|Overall Study|Adverse Event|14
43671|NCT01289028|170039|P1|Overall Study|Progressive Disease|49
43672|NCT01289015|170053|P2|Overall Study|Negative baseline culture and others|20
43673|NCT01289015|170054|P1|Overall Study|Negative baseline culture and others|33
43674|NCT01289015|170053|P2|Overall Study|Disease progression|0
43675|NCT01289015|170054|P1|Overall Study|Disease progression|1
43676|NCT01289015|170053|P2|Overall Study|Withdrawal by Subject|8
43677|NCT01289015|170054|P1|Overall Study|Withdrawal by Subject|17
43678|NCT01289015|170053|P2|Overall Study|Lost to Follow-up|17
43679|NCT01289015|170054|P1|Overall Study|Lost to Follow-up|33
43680|NCT01289015|170053|P2|Overall Study|Adverse Event|0
43681|NCT01289015|170054|P1|Overall Study|Adverse Event|3
43682|NCT01289015|170053|P2|Overall Study|Protocol Violation|9
43683|NCT01289015|170054|P1|Overall Study|Protocol Violation|12
43684|NCT01288911|170064|P2|Overall Study|Randomized but never received study drug|2
43685|NCT01288911|170065|P1|Overall Study|Randomized but never received study drug|1
43686|NCT01288911|170064|P2|Overall Study|Miscellaneous Reason|39
43687|NCT01288911|170065|P1|Overall Study|Miscellaneous Reason|23
43688|NCT01288911|170064|P2|Overall Study|Withdrawal by Subject|21
43689|NCT01288911|170065|P1|Overall Study|Withdrawal by Subject|21
43690|NCT01288911|170064|P2|Overall Study|Protocol Violation|0
43691|NCT01288911|170065|P1|Overall Study|Protocol Violation|1
43692|NCT01288911|170064|P2|Overall Study|Progressive Disease|99
43693|NCT01288911|170065|P1|Overall Study|Progressive Disease|69
43694|NCT01288911|170064|P2|Overall Study|Lost to Follow-up|2
43695|NCT01288911|170065|P1|Overall Study|Lost to Follow-up|0
43696|NCT01288911|170064|P2|Overall Study|Death|7
43697|NCT01288911|170065|P1|Overall Study|Death|10
43698|NCT01288612|170148|P3|Overall Study|Unable to intubate|0
43699|NCT01288612|170149|P2|Overall Study|Unable to intubate|3
43700|NCT01288612|170150|P1|Overall Study|Unable to intubate|0
43701|NCT01288612|170148|P3|Overall Study|Declined|62
43702|NCT01288612|170149|P2|Overall Study|Declined|63
43703|NCT01288612|170150|P1|Overall Study|Declined|78
43704|NCT01288612|170148|P3|Overall Study|Unable to contact|20
43705|NCT01288612|170149|P2|Overall Study|Unable to contact|16
43706|NCT01288612|170150|P1|Overall Study|Unable to contact|11
43707|NCT01288469|170186|P3|Overall Study|Exclusion criteria finally met|0
43708|NCT01288469|170187|P2|Overall Study|Exclusion criteria finally met|0
43709|NCT01288469|170188|P1|Overall Study|Exclusion criteria finally met|1
43710|NCT01288469|170186|P3|Overall Study|Consent withdrawn by subject|1
43711|NCT01288469|170187|P2|Overall Study|Consent withdrawn by subject|1
43712|NCT01288469|170188|P1|Overall Study|Consent withdrawn by subject|1
43713|NCT01288469|170186|P3|Overall Study|Participant Moved|0
43714|NCT01288469|170187|P2|Overall Study|Participant Moved|0
43715|NCT01288469|170188|P1|Overall Study|Participant Moved|1
43716|NCT01288469|170186|P3|Overall Study|Poor compliance to protocol|0
43717|NCT01288469|170187|P2|Overall Study|Poor compliance to protocol|1
43718|NCT01288469|170188|P1|Overall Study|Poor compliance to protocol|0
43719|NCT01288469|170186|P3|Overall Study|Adverse Event|1
43720|NCT01288469|170187|P2|Overall Study|Adverse Event|1
43721|NCT01288469|170188|P1|Overall Study|Adverse Event|4
43722|NCT01288443|170220|P6|Overall Study|Other than above|0
43723|NCT01288443|170221|P5|Overall Study|Other than above|1
43724|NCT01288443|170222|P4|Overall Study|Other than above|2
43725|NCT01288443|170223|P3|Overall Study|Other than above|0
43726|NCT01288443|170224|P2|Overall Study|Other than above|0
43727|NCT01288443|170225|P1|Overall Study|Other than above|0
43728|NCT01288443|170220|P6|Overall Study|Study drug auto-injector administration|1
43729|NCT01288443|170221|P5|Overall Study|Study drug auto-injector administration|1
43730|NCT01288443|170222|P4|Overall Study|Study drug auto-injector administration|0
43731|NCT01288443|170223|P3|Overall Study|Study drug auto-injector administration|0
43732|NCT01288443|170224|P2|Overall Study|Study drug auto-injector administration|0
43733|NCT01288443|170225|P1|Overall Study|Study drug auto-injector administration|0
43734|NCT01288443|170220|P6|Overall Study|Lost to Follow-up|0
43735|NCT01288443|170221|P5|Overall Study|Lost to Follow-up|0
43736|NCT01288443|170222|P4|Overall Study|Lost to Follow-up|0
43737|NCT01288443|170223|P3|Overall Study|Lost to Follow-up|0
43738|NCT01288443|170224|P2|Overall Study|Lost to Follow-up|1
43739|NCT01288443|170225|P1|Overall Study|Lost to Follow-up|0
43740|NCT01288443|170220|P6|Overall Study|Consent withdrawn by Participant|1
43741|NCT01288443|170221|P5|Overall Study|Consent withdrawn by Participant|0
43742|NCT01288443|170222|P4|Overall Study|Consent withdrawn by Participant|0
43743|NCT01288443|170223|P3|Overall Study|Consent withdrawn by Participant|0
43744|NCT01288443|170224|P2|Overall Study|Consent withdrawn by Participant|0
43745|NCT01288443|170225|P1|Overall Study|Consent withdrawn by Participant|0
43746|NCT01288443|170220|P6|Overall Study|Participant Moved|1
43747|NCT01288443|170221|P5|Overall Study|Participant Moved|2
43748|NCT01288443|170222|P4|Overall Study|Participant Moved|1
43749|NCT01288443|170223|P3|Overall Study|Participant Moved|0
43750|NCT01288443|170224|P2|Overall Study|Participant Moved|0
43751|NCT01288443|170225|P1|Overall Study|Participant Moved|0
43752|NCT01288443|170220|P6|Overall Study|Poor compliance to protocol|1
43753|NCT01288443|170221|P5|Overall Study|Poor compliance to protocol|0
43754|NCT01288443|170222|P4|Overall Study|Poor compliance to protocol|0
43755|NCT01288443|170223|P3|Overall Study|Poor compliance to protocol|0
43756|NCT01288443|170224|P2|Overall Study|Poor compliance to protocol|0
43757|NCT01288443|170225|P1|Overall Study|Poor compliance to protocol|0
43758|NCT01288443|170220|P6|Overall Study|Adverse Event|1
43759|NCT01288443|170221|P5|Overall Study|Adverse Event|3
43760|NCT01288443|170222|P4|Overall Study|Adverse Event|1
43761|NCT01288443|170223|P3|Overall Study|Adverse Event|1
43762|NCT01288443|170224|P2|Overall Study|Adverse Event|0
43763|NCT01288443|170225|P1|Overall Study|Adverse Event|0
43764|NCT01288287|170275|P1|Overall Study|Unknown Status|7
43765|NCT01288287|170275|P1|Overall Study|Unknown Reason|1
43766|NCT01288287|170275|P1|Overall Study|Other Reason|13
43767|NCT01288287|170275|P1|Overall Study|Lack of Efficacy|13
43768|NCT01288287|170275|P1|Overall Study|Withdrawal by Subject|4
43769|NCT01288287|170275|P1|Overall Study|Lost to Follow-up|8
43770|NCT01288209|170290|P2|Overall Study|Not specified|0
43771|NCT01288209|170291|P1|Overall Study|Not specified|1
43772|NCT01288209|170290|P2|Overall Study|Withdrawal by Subject|3
43773|NCT01288209|170291|P1|Overall Study|Withdrawal by Subject|1
43774|NCT01288079|170321|P4|Overall Study|Other or Study Termination|8
43775|NCT01288079|170322|P3|Overall Study|Other or Study Termination|14
43776|NCT01288079|170323|P2|Overall Study|Other or Study Termination|15
43777|NCT01288079|170324|P1|Overall Study|Other or Study Termination|11
43778|NCT01288079|170321|P4|Overall Study|Lost to Follow-up|0
43779|NCT01288079|170322|P3|Overall Study|Lost to Follow-up|1
43780|NCT01288079|170323|P2|Overall Study|Lost to Follow-up|1
43781|NCT01288079|170324|P1|Overall Study|Lost to Follow-up|1
43782|NCT01288079|170321|P4|Overall Study|Study-Specific Withdrawal Criteria|0
43783|NCT01288079|170322|P3|Overall Study|Study-Specific Withdrawal Criteria|0
43784|NCT01288079|170323|P2|Overall Study|Study-Specific Withdrawal Criteria|1
43785|NCT01288079|170324|P1|Overall Study|Study-Specific Withdrawal Criteria|1
43786|NCT01288079|170321|P4|Overall Study|Lack of Efficacy|2
43787|NCT01288079|170322|P3|Overall Study|Lack of Efficacy|0
43788|NCT01288079|170323|P2|Overall Study|Lack of Efficacy|2
43789|NCT01288079|170324|P1|Overall Study|Lack of Efficacy|2
43790|NCT01288079|170321|P4|Overall Study|Condition under Investigation Worsened|1
43791|NCT01288079|170322|P3|Overall Study|Condition under Investigation Worsened|0
43792|NCT01288079|170323|P2|Overall Study|Condition under Investigation Worsened|0
43793|NCT01288079|170324|P1|Overall Study|Condition under Investigation Worsened|0
43794|NCT01288079|170321|P4|Overall Study|Severe Non-Compliance to Protocol|3
43795|NCT01288079|170322|P3|Overall Study|Severe Non-Compliance to Protocol|1
43796|NCT01288079|170323|P2|Overall Study|Severe Non-Compliance to Protocol|3
43797|NCT01288079|170324|P1|Overall Study|Severe Non-Compliance to Protocol|1
43798|NCT01288079|170321|P4|Overall Study|Adverse Event|3
43799|NCT01288079|170322|P3|Overall Study|Adverse Event|2
43800|NCT01288079|170323|P2|Overall Study|Adverse Event|1
43801|NCT01288079|170324|P1|Overall Study|Adverse Event|2
43802|NCT01288079|170321|P4|Overall Study|Withdrawal by Subject|0
43803|NCT01288079|170322|P3|Overall Study|Withdrawal by Subject|1
43804|NCT01288079|170323|P2|Overall Study|Withdrawal by Subject|4
43805|NCT01288079|170324|P1|Overall Study|Withdrawal by Subject|2
43806|NCT01287897|170348|P4|Overall Study|Unspecified|0
43807|NCT01287897|170349|P3|Overall Study|Unspecified|1
43808|NCT01287897|170350|P2|Overall Study|Unspecified|0
43809|NCT01287897|170351|P1|Overall Study|Unspecified|1
43810|NCT01287897|170348|P4|Overall Study|Not meeting entrance criteria|0
43811|NCT01287897|170349|P3|Overall Study|Not meeting entrance criteria|0
43812|NCT01287897|170350|P2|Overall Study|Not meeting entrance criteria|1
43813|NCT01287897|170351|P1|Overall Study|Not meeting entrance criteria|1
43814|NCT01287897|170348|P4|Overall Study|Not consented properly|0
43815|NCT01287897|170349|P3|Overall Study|Not consented properly|0
43816|NCT01287897|170350|P2|Overall Study|Not consented properly|1
43817|NCT01287897|170351|P1|Overall Study|Not consented properly|0
43818|NCT01287897|170348|P4|Overall Study|Withdrawal by Subject|2
43819|NCT01287897|170349|P3|Overall Study|Withdrawal by Subject|3
43820|NCT01287897|170350|P2|Overall Study|Withdrawal by Subject|5
43821|NCT01287897|170351|P1|Overall Study|Withdrawal by Subject|1
43822|NCT01287897|170348|P4|Overall Study|Lost to Follow-up|0
43823|NCT01287897|170349|P3|Overall Study|Lost to Follow-up|2
43824|NCT01287897|170350|P2|Overall Study|Lost to Follow-up|0
43825|NCT01287897|170351|P1|Overall Study|Lost to Follow-up|0
43826|NCT01287897|170348|P4|Overall Study|Protocol Violation|1
43827|NCT01287897|170349|P3|Overall Study|Protocol Violation|0
43828|NCT01287897|170350|P2|Overall Study|Protocol Violation|1
43829|NCT01287897|170351|P1|Overall Study|Protocol Violation|1
43830|NCT01287897|170348|P4|Overall Study|Lack of Efficacy|0
43831|NCT01287897|170349|P3|Overall Study|Lack of Efficacy|0
43832|NCT01287897|170350|P2|Overall Study|Lack of Efficacy|0
43833|NCT01287897|170351|P1|Overall Study|Lack of Efficacy|2
43834|NCT01287897|170348|P4|Overall Study|Adverse Event|4
43835|NCT01287897|170349|P3|Overall Study|Adverse Event|6
43836|NCT01287897|170350|P2|Overall Study|Adverse Event|3
43837|NCT01287897|170351|P1|Overall Study|Adverse Event|5
43838|NCT01287832|170402|P2|Overall Study|Death|1
43839|NCT01287832|170403|P1|Overall Study|Death|0
43840|NCT01287832|170402|P2|Overall Study|Adverse Event|0
43841|NCT01287832|170403|P1|Overall Study|Adverse Event|1
43842|NCT01287754|170411|P2|Overall Study|Protocol Violation|3
43843|NCT01287754|170412|P1|Overall Study|Protocol Violation|0
43844|NCT01287754|170411|P2|Overall Study|Lost to Follow-up|6
43845|NCT01287754|170412|P1|Overall Study|Lost to Follow-up|1
43846|NCT01287754|170411|P2|Overall Study|Death|12
43847|NCT01287754|170412|P1|Overall Study|Death|2
43848|NCT01287611|170424|P2|Overall Study|Exclusion due to expanded Kerr incision|3
43849|NCT01287611|170425|P1|Overall Study|Exclusion due to expanded Kerr incision|4
43850|NCT01287611|170424|P2|Overall Study|Lost to Follow-up|16
43851|NCT01287611|170425|P1|Overall Study|Lost to Follow-up|29
43852|NCT01287416|170435|P2|6 Month Follow-up|Lost to Follow-up|2
43853|NCT01287416|170436|P1|6 Month Follow-up|Lost to Follow-up|3
43854|NCT01287416|170435|P2|Pre-post Training|Lost to Follow-up|1
43855|NCT01287416|170436|P1|Pre-post Training|Lost to Follow-up|5
43856|NCT01287416|170435|P2|Pre-post Training|Withdrawal by Subject|24
43857|NCT01287416|170436|P1|Pre-post Training|Withdrawal by Subject|17
43858|NCT01287403|170472|P1|1st Intervention (1 Day)|Adverse Event|1
43859|NCT01287364|170488|P2|Overall Study|Other Reason|2
43860|NCT01287364|170489|P1|Overall Study|Other Reason|4
43861|NCT01287364|170488|P2|Overall Study|Protocol Violation|5
43862|NCT01287364|170489|P1|Overall Study|Protocol Violation|5
43863|NCT01287364|170488|P2|Overall Study|Adverse Event|3
43864|NCT01287364|170489|P1|Overall Study|Adverse Event|0
43865|NCT01287221|170511|P2|Overall Study|Withdrawal by Subject|1
43866|NCT01287221|170512|P1|Overall Study|Withdrawal by Subject|0
43867|NCT01287221|170511|P2|Overall Study|Adverse Event|3
43868|NCT01287221|170512|P1|Overall Study|Adverse Event|3
43869|NCT01287221|170511|P2|Overall Study|Lack of Perceived Benefit|1
43870|NCT01287221|170512|P1|Overall Study|Lack of Perceived Benefit|1
43871|NCT01287117|170543|P4|Overall Study|Disease Progression|5
43872|NCT01287117|170544|P3|Overall Study|Disease Progression|6
43873|NCT01287117|170545|P2|Overall Study|Disease Progression|5
43874|NCT01287117|170546|P1|Overall Study|Disease Progression|10
43875|NCT01287117|170543|P4|Overall Study|Patient/Legal Guardian's Decision|5
43876|NCT01287117|170544|P3|Overall Study|Patient/Legal Guardian's Decision|8
43877|NCT01287117|170545|P2|Overall Study|Patient/Legal Guardian's Decision|6
43878|NCT01287117|170546|P1|Overall Study|Patient/Legal Guardian's Decision|2
43879|NCT01287117|170543|P4|Overall Study|Physician Decision|1
43880|NCT01287117|170544|P3|Overall Study|Physician Decision|1
43881|NCT01287117|170545|P2|Overall Study|Physician Decision|1
43882|NCT01287117|170546|P1|Overall Study|Physician Decision|0
43883|NCT01287117|170543|P4|Overall Study|Lost to Follow-up|0
43884|NCT01287117|170544|P3|Overall Study|Lost to Follow-up|0
43885|NCT01287117|170545|P2|Overall Study|Lost to Follow-up|1
43886|NCT01287117|170546|P1|Overall Study|Lost to Follow-up|1
43887|NCT01287117|170543|P4|Overall Study|Adverse Event|1
43888|NCT01287117|170544|P3|Overall Study|Adverse Event|1
43889|NCT01287117|170545|P2|Overall Study|Adverse Event|1
43890|NCT01287117|170546|P1|Overall Study|Adverse Event|2
43891|NCT01287065|170592|P6|Treatment Period 1|Withdrawal by Subject|1
43892|NCT01287065|170593|P5|Treatment Period 1|Withdrawal by Subject|0
43893|NCT01287065|170594|P4|Treatment Period 1|Withdrawal by Subject|0
43894|NCT01287065|170595|P3|Treatment Period 1|Withdrawal by Subject|0
43895|NCT01287065|170596|P2|Treatment Period 1|Withdrawal by Subject|0
43896|NCT01287065|170597|P1|Treatment Period 1|Withdrawal by Subject|0
43897|NCT01287065|170592|P6|Treatment Period 1|Adverse Event|0
43898|NCT01287065|170593|P5|Treatment Period 1|Adverse Event|1
43899|NCT01287065|170594|P4|Treatment Period 1|Adverse Event|0
43900|NCT01287065|170595|P3|Treatment Period 1|Adverse Event|0
43901|NCT01287065|170596|P2|Treatment Period 1|Adverse Event|0
43902|NCT01287065|170597|P1|Treatment Period 1|Adverse Event|0
43903|NCT01287039|170616|P2|Overall Study|Lost to Follow-up|2
43904|NCT01287039|170617|P1|Overall Study|Lost to Follow-up|3
43905|NCT01287039|170616|P2|Overall Study|Withdrawal by Subject|11
43906|NCT01287039|170617|P1|Overall Study|Withdrawal by Subject|14
43907|NCT01287039|170616|P2|Overall Study|Adverse Event|4
43908|NCT01287039|170617|P1|Overall Study|Adverse Event|7
43909|NCT01287039|170616|P2|Overall Study|Change of residence|0
43910|NCT01287039|170617|P1|Overall Study|Change of residence|1
43911|NCT01287039|170616|P2|Overall Study|Death|0
43912|NCT01287039|170617|P1|Overall Study|Death|1
43913|NCT01287039|170616|P2|Overall Study|Problem with travel|1
43914|NCT01287039|170617|P1|Overall Study|Problem with travel|0
43915|NCT01287039|170616|P2|Overall Study|Noncompliance with study medication|1
43916|NCT01287039|170617|P1|Overall Study|Noncompliance with study medication|0
43917|NCT01287039|170616|P2|Overall Study|Excluded medication taken|0
43918|NCT01287039|170617|P1|Overall Study|Excluded medication taken|1
43919|NCT01287039|170616|P2|Overall Study|Protocol Violation|3
43920|NCT01287039|170617|P1|Overall Study|Protocol Violation|2
43921|NCT01287039|170616|P2|Overall Study|Elective surgery|1
43922|NCT01287039|170617|P1|Overall Study|Elective surgery|0
43923|NCT01287039|170616|P2|Overall Study|Change of location/residence|3
43924|NCT01287039|170617|P1|Overall Study|Change of location/residence|0
43925|NCT01287039|170616|P2|Overall Study|Noncompliance with study procedures|1
43926|NCT01287039|170617|P1|Overall Study|Noncompliance with study procedures|0
43927|NCT01286753|170684|P2|Overall Study|Participant to Receive Radiotherapy|0
43928|NCT01286753|170685|P1|Overall Study|Participant to Receive Radiotherapy|1
43929|NCT01286753|170684|P2|Overall Study|Discontinued to Join Extension Study|4
43930|NCT01286753|170685|P1|Overall Study|Discontinued to Join Extension Study|6
43931|NCT01286753|170684|P2|Overall Study|Withdrawal of Consent|2
43932|NCT01286753|170685|P1|Overall Study|Withdrawal of Consent|0
43933|NCT01286753|170684|P2|Overall Study|Refused Treatment|0
43934|NCT01286753|170685|P1|Overall Study|Refused Treatment|1
43935|NCT01286753|170684|P2|Overall Study|Progression|13
43936|NCT01286753|170685|P1|Overall Study|Progression|11
43937|NCT01286753|170684|P2|Overall Study|Adverse Event|6
43938|NCT01286753|170685|P1|Overall Study|Adverse Event|7
43939|NCT01286740|170703|P1|Overall Study|Protocol Violation|1
43940|NCT01286740|170703|P1|Overall Study|Enrolled but not treated|1
43941|NCT01286558|170721|P2|Overall Study|Withdrawal by Subject|1
43942|NCT01286558|170722|P1|Overall Study|Withdrawal by Subject|0
43943|NCT01286558|170721|P2|Overall Study|Adverse Event|1
43944|NCT01286558|170722|P1|Overall Study|Adverse Event|1
43945|NCT01286311|170824|P2|Overall Study|Physician did not want outreach sent|0
43946|NCT01286311|170825|P1|Overall Study|Physician did not want outreach sent|14
43947|NCT01286207|170842|P3|Overall Study|Unspecified|13
43948|NCT01286207|170843|P2|Overall Study|Unspecified|47
43949|NCT01286207|170844|P1|Overall Study|Unspecified|37
43950|NCT01286207|170842|P3|Overall Study|Lack of Response|8
43951|NCT01286207|170843|P2|Overall Study|Lack of Response|38
43952|NCT01286207|170844|P1|Overall Study|Lack of Response|92
43953|NCT01286207|170842|P3|Overall Study|Withdrawal by Subject|41
43954|NCT01286207|170843|P2|Overall Study|Withdrawal by Subject|79
43955|NCT01286207|170844|P1|Overall Study|Withdrawal by Subject|93
43956|NCT01286207|170842|P3|Overall Study|Lost to Follow-up|20
43957|NCT01286207|170843|P2|Overall Study|Lost to Follow-up|43
43958|NCT01286207|170844|P1|Overall Study|Lost to Follow-up|49
43959|NCT01286207|170842|P3|Overall Study|Adverse Event|8
43960|NCT01286207|170843|P2|Overall Study|Adverse Event|41
43961|NCT01286207|170844|P1|Overall Study|Adverse Event|27
43962|NCT01286168|170864|P1|Overall Study|Surgical Drains Fell Out at Home|2
43963|NCT01286168|170864|P1|Overall Study|Withdrawal by Subject|1
43964|NCT01286129|170878|P2|Overall Study|Could not comply with study requirements|4
43965|NCT01286129|170879|P1|Overall Study|Could not comply with study requirements|4
43966|NCT01286129|170878|P2|Overall Study|Withdrawal by Subject|1
43967|NCT01286129|170879|P1|Overall Study|Withdrawal by Subject|4
43968|NCT01286077|170889|P2|Overall Study|refill medication not received in time|0
43969|NCT01286077|170890|P1|Overall Study|refill medication not received in time|1
43970|NCT01286077|170889|P2|Overall Study|Progression of disease|1
43971|NCT01286077|170890|P1|Overall Study|Progression of disease|0
43972|NCT01286077|170889|P2|Overall Study|Patient's decision to stop treatment|0
43973|NCT01286077|170890|P1|Overall Study|Patient's decision to stop treatment|3
43974|NCT01286077|170889|P2|Overall Study|The subject starts with alternative MMY|3
43975|NCT01286077|170890|P1|Overall Study|The subject starts with alternative MMY|0
43976|NCT01286077|170889|P2|Overall Study|Non-compliance|0
43977|NCT01286077|170890|P1|Overall Study|Non-compliance|1
43978|NCT01286077|170889|P2|Overall Study|Intercurrent illness|0
43979|NCT01286077|170890|P1|Overall Study|Intercurrent illness|1
43980|NCT01286077|170889|P2|Overall Study|Withdrawal by Subject|2
43981|NCT01286077|170890|P1|Overall Study|Withdrawal by Subject|0
43982|NCT01286077|170889|P2|Overall Study|Protocol Violation|1
43983|NCT01286077|170890|P1|Overall Study|Protocol Violation|1
43984|NCT01286077|170889|P2|Overall Study|Death|0
43985|NCT01286077|170890|P1|Overall Study|Death|1
43986|NCT01286077|170889|P2|Overall Study|Adverse Event|0
43987|NCT01286077|170890|P1|Overall Study|Adverse Event|2
43988|NCT01286012|170926|P2|Overall Study|peritoneal dialysis, randomized in error|3
43989|NCT01286012|170927|P1|Overall Study|peritoneal dialysis, randomized in error|1
43990|NCT01286012|170926|P2|Overall Study|Physician Decision|0
43991|NCT01286012|170927|P1|Overall Study|Physician Decision|2
43992|NCT01286012|170926|P2|Overall Study|Withdrawal by Subject|4
43993|NCT01286012|170927|P1|Overall Study|Withdrawal by Subject|4
43994|NCT01286012|170926|P2|Overall Study|Protocol Violation|1
43995|NCT01286012|170927|P1|Overall Study|Protocol Violation|1
43996|NCT01286012|170926|P2|Overall Study|Death|3
43997|NCT01286012|170927|P1|Overall Study|Death|2
43998|NCT01286012|170926|P2|Overall Study|Adverse Event|3
43999|NCT01286012|170927|P1|Overall Study|Adverse Event|3
44000|NCT01285908|170944|P3|Baseline Measurement|unable to tolerate procedure|0
44001|NCT01285908|170945|P2|Baseline Measurement|unable to tolerate procedure|0
44002|NCT01285908|170946|P1|Baseline Measurement|unable to tolerate procedure|1
44003|NCT01285908|170944|P3|Baseline Measurement|History of stroke, exclusion criteria|0
44004|NCT01285908|170945|P2|Baseline Measurement|History of stroke, exclusion criteria|0
44005|NCT01285908|170946|P1|Baseline Measurement|History of stroke, exclusion criteria|1
44006|NCT01285908|170944|P3|Baseline Measurement|unable to insert catheter|0
44007|NCT01285908|170945|P2|Baseline Measurement|unable to insert catheter|0
44008|NCT01285908|170946|P1|Baseline Measurement|unable to insert catheter|1
44009|NCT01285609|171040|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
44010|NCT01285609|171041|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
44011|NCT01285609|171040|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
44012|NCT01285609|171041|P1|Treated With Blinded Therapy|Poor/Non-Compliance|0
44013|NCT01285609|171040|P2|Treated With Blinded Therapy|Not Reported|4
44014|NCT01285609|171041|P1|Treated With Blinded Therapy|Not Reported|4
44015|NCT01285609|171040|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
44016|NCT01285609|171041|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
44017|NCT01285609|171040|P2|Treated With Blinded Therapy|Death|3
44018|NCT01285609|171041|P1|Treated With Blinded Therapy|Death|11
44019|NCT01285609|171040|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
44020|NCT01285609|171041|P1|Treated With Blinded Therapy|Withdrawal by Subject|18
44021|NCT01285609|171040|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
44022|NCT01285609|171041|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
44023|NCT01285609|171040|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
44024|NCT01285609|171041|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
44025|NCT01285609|171040|P2|Treated With Blinded Therapy|Progressive Disease|305
44026|NCT01285609|171041|P1|Treated With Blinded Therapy|Progressive Disease|220
44027|NCT01285609|171040|P2|Randomized|Randomized but not Treated|4
44028|NCT01285609|171041|P1|Randomized|Randomized but not Treated|4
44029|NCT01285609|171040|P2|Randomized|Undisclosed Reasons|0
44030|NCT01285609|171041|P1|Randomized|Undisclosed Reasons|1
44031|NCT01285609|171040|P2|Randomized|Subject No Longer Met Study Criteria|1
44032|NCT01285609|171041|P1|Randomized|Subject No Longer Met Study Criteria|1
44033|NCT01285609|171040|P2|Randomized|Withdrawal by Subject|11
44034|NCT01285609|171041|P1|Randomized|Withdrawal by Subject|8
44035|NCT01285609|171040|P2|Randomized|Death|7
44036|NCT01285609|171041|P1|Randomized|Death|5
44037|NCT01285609|171040|P2|Randomized|Study Drug Toxicity|14
44038|NCT01285609|171041|P1|Randomized|Study Drug Toxicity|13
44039|NCT01285609|171040|P2|Randomized|Adverse Event Unrelated to Study Drug|18
44040|NCT01285609|171041|P1|Randomized|Adverse Event Unrelated to Study Drug|18
44041|NCT01285609|171040|P2|Randomized|Progressive Disease|61
44042|NCT01285609|171041|P1|Randomized|Progressive Disease|41
44043|NCT01285518|171059|P8|Overall Study|Lost to Follow-up|0
44044|NCT01285518|171060|P7|Overall Study|Lost to Follow-up|0
44045|NCT01285518|171061|P6|Overall Study|Lost to Follow-up|1
44046|NCT01285518|171062|P5|Overall Study|Lost to Follow-up|0
44047|NCT01285518|171063|P4|Overall Study|Lost to Follow-up|0
44048|NCT01285518|171064|P3|Overall Study|Lost to Follow-up|0
44049|NCT01285518|171065|P2|Overall Study|Lost to Follow-up|0
44050|NCT01285518|171066|P1|Overall Study|Lost to Follow-up|0
44051|NCT01285492|171326|P2|Overall Study|Death|0
44052|NCT01285492|171327|P1|Overall Study|Death|1
44053|NCT01285492|171326|P2|Overall Study|Withdrawal by Subject|1
44054|NCT01285492|171327|P1|Overall Study|Withdrawal by Subject|2
44055|NCT01285492|171326|P2|Overall Study|Protocol Violation|0
44056|NCT01285492|171327|P1|Overall Study|Protocol Violation|3
44057|NCT01285492|171326|P2|Overall Study|Adverse Event|0
44058|NCT01285492|171327|P1|Overall Study|Adverse Event|11
44059|NCT01285401|171359|P2|Overall Study|Prematurely withdrawn from the study|29
44060|NCT01285401|171360|P1|Overall Study|Prematurely withdrawn from the study|17
44061|NCT01285323|171400|P2|Overall Study|Not specified|3
44062|NCT01285323|171401|P1|Overall Study|Not specified|1
44063|NCT01285323|171400|P2|Overall Study|Lost to Follow-up|1
44064|NCT01285323|171401|P1|Overall Study|Lost to Follow-up|1
44065|NCT01285323|171400|P2|Overall Study|Non-compliance with study procedures|3
44066|NCT01285323|171401|P1|Overall Study|Non-compliance with study procedures|2
44067|NCT01285323|171400|P2|Overall Study|Protocol Violation|2
44068|NCT01285323|171401|P1|Overall Study|Protocol Violation|1
44069|NCT01285323|171400|P2|Overall Study|Withdrawal by Subject|11
44070|NCT01285323|171401|P1|Overall Study|Withdrawal by Subject|15
44071|NCT01285323|171400|P2|Overall Study|Lack of Efficacy|2
44072|NCT01285323|171401|P1|Overall Study|Lack of Efficacy|4
44073|NCT01285323|171400|P2|Overall Study|Adverse Event|8
44074|NCT01285323|171401|P1|Overall Study|Adverse Event|9
44075|NCT01285310|171436|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
44076|NCT01285310|171437|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
44077|NCT01285310|171438|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
44152|NCT01284504|171945|P1|Overall Study|Withdrawal by Subject|1
44078|NCT01285310|171439|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
44079|NCT01285310|171440|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
44080|NCT01285310|171436|P5|Active Treatment Phase: Weeks 25-52|Not Specified|0
44081|NCT01285310|171437|P4|Active Treatment Phase: Weeks 25-52|Not Specified|0
44082|NCT01285310|171438|P3|Active Treatment Phase: Weeks 25-52|Not Specified|0
44083|NCT01285310|171439|P2|Active Treatment Phase: Weeks 25-52|Not Specified|1
44084|NCT01285310|171440|P1|Active Treatment Phase: Weeks 25-52|Not Specified|0
44085|NCT01285310|171436|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
44086|NCT01285310|171437|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
44087|NCT01285310|171438|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
44088|NCT01285310|171439|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
44089|NCT01285310|171440|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
44090|NCT01285310|171436|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
44091|NCT01285310|171437|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
44092|NCT01285310|171438|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
44093|NCT01285310|171439|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
44094|NCT01285310|171440|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
44095|NCT01285310|171436|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
44096|NCT01285310|171437|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
44097|NCT01285310|171438|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
44098|NCT01285310|171439|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
44099|NCT01285310|171440|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
44100|NCT01285310|171436|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
44101|NCT01285310|171437|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
44102|NCT01285310|171438|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
44103|NCT01285310|171439|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
44104|NCT01285310|171440|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
44105|NCT01285310|171436|P5|Placebo Controlled Phase: Weeks 0-24|Not specified|0
44106|NCT01285310|171437|P4|Placebo Controlled Phase: Weeks 0-24|Not specified|0
44107|NCT01285310|171438|P3|Placebo Controlled Phase: Weeks 0-24|Not specified|1
44108|NCT01285310|171439|P2|Placebo Controlled Phase: Weeks 0-24|Not specified|0
44109|NCT01285310|171440|P1|Placebo Controlled Phase: Weeks 0-24|Not specified|1
44110|NCT01285310|171436|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
44111|NCT01285310|171437|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
44112|NCT01285310|171438|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
44113|NCT01285310|171439|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
44114|NCT01285310|171440|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
44115|NCT01285310|171436|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
44116|NCT01285310|171437|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
44117|NCT01285310|171438|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
44118|NCT01285310|171439|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
44119|NCT01285310|171440|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
44120|NCT01285310|171436|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
44121|NCT01285310|171437|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
44122|NCT01285310|171438|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
44123|NCT01285310|171439|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
44124|NCT01285310|171440|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
44125|NCT01285310|171436|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
44126|NCT01285310|171437|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
44127|NCT01285310|171438|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
44128|NCT01285310|171439|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
44129|NCT01285310|171440|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
44130|NCT01285310|171436|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
44131|NCT01285310|171437|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
44132|NCT01285310|171438|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
44133|NCT01285310|171439|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
44134|NCT01285310|171440|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
44135|NCT01284959|171705|P3|Overall Study|Adverse Event|1
44136|NCT01284959|171706|P2|Overall Study|Adverse Event|0
44137|NCT01284959|171707|P1|Overall Study|Adverse Event|0
44138|NCT01284959|171705|P3|Overall Study|Withdrawal by Subject|0
44139|NCT01284959|171706|P2|Overall Study|Withdrawal by Subject|0
44140|NCT01284959|171707|P1|Overall Study|Withdrawal by Subject|1
44141|NCT01284634|171737|P4|Overall Study|Adverse Event|1
44142|NCT01284634|171738|P3|Overall Study|Adverse Event|2
44143|NCT01284634|171739|P2|Overall Study|Adverse Event|0
44144|NCT01284634|171740|P1|Overall Study|Adverse Event|1
44145|NCT01284621|171882|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
44146|NCT01284621|171883|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
44147|NCT01284621|171884|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
44148|NCT01284621|171885|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
44149|NCT01284621|171886|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
44150|NCT01284621|171887|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
44151|NCT01284504|171944|P2|Overall Study|Withdrawal by Subject|0
44153|NCT01284491|171951|P1|Overall Study|Study termination|13
44154|NCT01284361|171961|P1|Overall Study|Lost to Follow-up|2
44155|NCT01284361|171961|P1|Overall Study|Adverse Event|1
44156|NCT01284361|171961|P1|Overall Study|Protocol Violation|5
44157|NCT01284361|171961|P1|Overall Study|Withdrawal by Subject|1
44158|NCT01284114|171973|P1|Overall Study|dizziness|1
44159|NCT01284114|171973|P1|Overall Study|Symptomatic hypotension|1
44160|NCT01284114|171973|P1|Overall Study|From the results of ALLTITUDE study|1
44161|NCT01284114|171973|P1|Overall Study|viral infection|1
44162|NCT01284062|171985|P4|Overall Study|Site Closed|0
44163|NCT01284062|171986|P3|Overall Study|Site Closed|1
44164|NCT01284062|171987|P2|Overall Study|Site Closed|0
44165|NCT01284062|171988|P1|Overall Study|Site Closed|0
44166|NCT01284062|171985|P4|Overall Study|Unspecified|1
44167|NCT01284062|171986|P3|Overall Study|Unspecified|0
44168|NCT01284062|171987|P2|Overall Study|Unspecified|0
44169|NCT01284062|171988|P1|Overall Study|Unspecified|0
44170|NCT01284062|171985|P4|Overall Study|Withdrawal by Subject|5
44171|NCT01284062|171986|P3|Overall Study|Withdrawal by Subject|2
44172|NCT01284062|171987|P2|Overall Study|Withdrawal by Subject|1
44173|NCT01284062|171988|P1|Overall Study|Withdrawal by Subject|3
44174|NCT01284062|171985|P4|Overall Study|Protocol Violation|2
44175|NCT01284062|171986|P3|Overall Study|Protocol Violation|0
44176|NCT01284062|171987|P2|Overall Study|Protocol Violation|0
44177|NCT01284062|171988|P1|Overall Study|Protocol Violation|1
44178|NCT01284062|171985|P4|Overall Study|Medication error without adverse event|0
44179|NCT01284062|171986|P3|Overall Study|Medication error without adverse event|1
44180|NCT01284062|171987|P2|Overall Study|Medication error without adverse event|0
44181|NCT01284062|171988|P1|Overall Study|Medication error without adverse event|0
44182|NCT01284062|171985|P4|Overall Study|Lack of Efficacy|1
44183|NCT01284062|171986|P3|Overall Study|Lack of Efficacy|2
44184|NCT01284062|171987|P2|Overall Study|Lack of Efficacy|2
44185|NCT01284062|171988|P1|Overall Study|Lack of Efficacy|3
44186|NCT01284062|171985|P4|Overall Study|Adverse Event|5
44187|NCT01284062|171986|P3|Overall Study|Adverse Event|0
44188|NCT01284062|171987|P2|Overall Study|Adverse Event|5
44189|NCT01284062|171988|P1|Overall Study|Adverse Event|4
44190|NCT01283971|172062|P2|Overall Study|Administrative reasons|1
44191|NCT01283971|172063|P1|Overall Study|Administrative reasons|1
44192|NCT01283971|172062|P2|Overall Study|Failure to return|1
44193|NCT01283971|172063|P1|Overall Study|Failure to return|0
44194|NCT01283971|172062|P2|Overall Study|Refused treatment|1
44195|NCT01283971|172063|P1|Overall Study|Refused treatment|3
44196|NCT01283971|172062|P2|Overall Study|Protocol Violation|1
44197|NCT01283971|172063|P1|Overall Study|Protocol Violation|5
44198|NCT01283971|172062|P2|Overall Study|Insufficient therapeutic responses|3
44199|NCT01283971|172063|P1|Overall Study|Insufficient therapeutic responses|3
44200|NCT01283971|172062|P2|Overall Study|Adverse Event|5
44201|NCT01283971|172063|P1|Overall Study|Adverse Event|3
44202|NCT01283581|172110|P3|Overall Study|"Early termination"|1
44203|NCT01283581|172111|P2|Overall Study|"Early termination"|0
44204|NCT01283581|172112|P1|Overall Study|"Early termination"|0
44205|NCT01283581|172110|P3|Overall Study|Investigator unblinded|1
44206|NCT01283581|172111|P2|Overall Study|Investigator unblinded|0
44207|NCT01283581|172112|P1|Overall Study|Investigator unblinded|0
44208|NCT01283581|172110|P3|Overall Study|Noncompliance|0
44209|NCT01283581|172111|P2|Overall Study|Noncompliance|0
44210|NCT01283581|172112|P1|Overall Study|Noncompliance|1
44211|NCT01283581|172110|P3|Overall Study|Protocol Violation|2
44212|NCT01283581|172111|P2|Overall Study|Protocol Violation|1
44213|NCT01283581|172112|P1|Overall Study|Protocol Violation|0
44214|NCT01283581|172110|P3|Overall Study|Physician Decision|2
44215|NCT01283581|172111|P2|Overall Study|Physician Decision|1
44216|NCT01283581|172112|P1|Overall Study|Physician Decision|0
44217|NCT01283581|172110|P3|Overall Study|Adverse Event|4
44218|NCT01283581|172111|P2|Overall Study|Adverse Event|1
44219|NCT01283581|172112|P1|Overall Study|Adverse Event|1
44220|NCT01283581|172110|P3|Overall Study|Withdrawal by Subject|2
44221|NCT01283581|172111|P2|Overall Study|Withdrawal by Subject|5
44222|NCT01283581|172112|P1|Overall Study|Withdrawal by Subject|2
44223|NCT01283581|172110|P3|Overall Study|Lost to Follow-up|8
44224|NCT01283581|172111|P2|Overall Study|Lost to Follow-up|6
44225|NCT01283581|172112|P1|Overall Study|Lost to Follow-up|8
44226|NCT01283516|172176|P9|Overall Study|Withdrawal by Subject|11
44227|NCT01283516|172177|P8|Overall Study|Withdrawal by Subject|0
44228|NCT01283516|172178|P7|Overall Study|Withdrawal by Subject|0
44229|NCT01283516|172179|P6|Overall Study|Withdrawal by Subject|0
44230|NCT01283516|172180|P5|Overall Study|Withdrawal by Subject|1
44231|NCT01283516|172181|P4|Overall Study|Withdrawal by Subject|0
44232|NCT01283516|172182|P3|Overall Study|Withdrawal by Subject|0
44233|NCT01283516|172183|P2|Overall Study|Withdrawal by Subject|0
44234|NCT01283516|172184|P1|Overall Study|Withdrawal by Subject|0
44235|NCT01283516|172176|P9|Overall Study|Disease Progression|81
44236|NCT01283516|172177|P8|Overall Study|Disease Progression|2
44237|NCT01283516|172178|P7|Overall Study|Disease Progression|6
44238|NCT01283516|172179|P6|Overall Study|Disease Progression|7
44239|NCT01283516|172180|P5|Overall Study|Disease Progression|12
44240|NCT01283516|172181|P4|Overall Study|Disease Progression|3
44241|NCT01283516|172182|P3|Overall Study|Disease Progression|2
44242|NCT01283516|172183|P2|Overall Study|Disease Progression|2
44243|NCT01283516|172184|P1|Overall Study|Disease Progression|2
44244|NCT01283516|172176|P9|Overall Study|Death|6
44245|NCT01283516|172177|P8|Overall Study|Death|1
44246|NCT01283516|172178|P7|Overall Study|Death|0
44247|NCT01283516|172179|P6|Overall Study|Death|1
44248|NCT01283516|172180|P5|Overall Study|Death|0
44249|NCT01283516|172181|P4|Overall Study|Death|0
44250|NCT01283516|172182|P3|Overall Study|Death|0
44251|NCT01283516|172183|P2|Overall Study|Death|0
44252|NCT01283516|172184|P1|Overall Study|Death|0
44253|NCT01283516|172176|P9|Overall Study|Adverse Event|24
44254|NCT01283516|172177|P8|Overall Study|Adverse Event|0
44255|NCT01283516|172178|P7|Overall Study|Adverse Event|2
44256|NCT01283516|172179|P6|Overall Study|Adverse Event|0
44257|NCT01283516|172180|P5|Overall Study|Adverse Event|0
44258|NCT01283516|172181|P4|Overall Study|Adverse Event|0
44259|NCT01283516|172182|P3|Overall Study|Adverse Event|0
44260|NCT01283516|172183|P2|Overall Study|Adverse Event|0
44261|NCT01283516|172184|P1|Overall Study|Adverse Event|0
44262|NCT01283464|172208|P2|Overall Study|Physician Decision|0
44263|NCT01283464|172209|P1|Overall Study|Physician Decision|1
44264|NCT01283464|172208|P2|Overall Study|Withdrawal by Subject|0
44265|NCT01283464|172209|P1|Overall Study|Withdrawal by Subject|1
44266|NCT01283464|172208|P2|Overall Study|Lost to Follow-up|1
44267|NCT01283464|172209|P1|Overall Study|Lost to Follow-up|0
44268|NCT01283334|172215|P1|Overall Study|Physician Decision|1
44269|NCT01283334|172215|P1|Overall Study|Adverse Event|4
44270|NCT01283334|172215|P1|Overall Study|Inability to Swallow Everolimus Pills|1
44271|NCT01283334|172215|P1|Overall Study|Withdrawal by Subject|1
44272|NCT01283282|172230|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
44273|NCT01283282|172231|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
44274|NCT01283282|172230|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
44275|NCT01283282|172231|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
44276|NCT01283282|172230|P2|First Intervention (6 Weeks)|Physician Decision|1
44277|NCT01283282|172231|P1|First Intervention (6 Weeks)|Physician Decision|0
44278|NCT01283152|172251|P2|Overall Study|Refused HESA|0
44279|NCT01283152|172252|P1|Overall Study|Refused HESA|1
44280|NCT01283152|172251|P2|Overall Study|Discharged prior to 24 hr assessment|0
44281|NCT01283152|172252|P1|Overall Study|Discharged prior to 24 hr assessment|1
44282|NCT01283139|172266|P4|Overall Study|Participant randomized in error|0
44283|NCT01283139|172267|P3|Overall Study|Participant randomized in error|1
44284|NCT01283139|172268|P2|Overall Study|Participant randomized in error|0
44285|NCT01283139|172269|P1|Overall Study|Participant randomized in error|0
44286|NCT01283139|172266|P4|Overall Study|Missed follow-up visit|2
44287|NCT01283139|172267|P3|Overall Study|Missed follow-up visit|2
44288|NCT01283139|172268|P2|Overall Study|Missed follow-up visit|1
44289|NCT01283139|172269|P1|Overall Study|Missed follow-up visit|0
44290|NCT01283139|172266|P4|Overall Study|Pregnancy|0
44291|NCT01283139|172267|P3|Overall Study|Pregnancy|1
44292|NCT01283139|172268|P2|Overall Study|Pregnancy|1
44293|NCT01283139|172269|P1|Overall Study|Pregnancy|0
44294|NCT01283139|172266|P4|Overall Study|Participant's refusal to continue|1
44295|NCT01283139|172267|P3|Overall Study|Participant's refusal to continue|1
44296|NCT01283139|172268|P2|Overall Study|Participant's refusal to continue|3
44297|NCT01283139|172269|P1|Overall Study|Participant's refusal to continue|0
44298|NCT01283139|172266|P4|Overall Study|Early termination due to AE/SAE|0
44299|NCT01283139|172267|P3|Overall Study|Early termination due to AE/SAE|0
44300|NCT01283139|172268|P2|Overall Study|Early termination due to AE/SAE|1
44301|NCT01283139|172269|P1|Overall Study|Early termination due to AE/SAE|1
44302|NCT01283139|172266|P4|Overall Study|Lack of Efficacy|1
44303|NCT01283139|172267|P3|Overall Study|Lack of Efficacy|2
44304|NCT01283139|172268|P2|Overall Study|Lack of Efficacy|2
44305|NCT01283139|172269|P1|Overall Study|Lack of Efficacy|1
44306|NCT01283139|172266|P4|Overall Study|Death|2
44307|NCT01283139|172267|P3|Overall Study|Death|2
44308|NCT01283139|172268|P2|Overall Study|Death|0
44309|NCT01283139|172269|P1|Overall Study|Death|2
44310|NCT01283139|172266|P4|Overall Study|Withdrawal by Subject|8
44311|NCT01283139|172267|P3|Overall Study|Withdrawal by Subject|6
44312|NCT01283139|172268|P2|Overall Study|Withdrawal by Subject|8
44313|NCT01283139|172269|P1|Overall Study|Withdrawal by Subject|8
44314|NCT01283139|172266|P4|Overall Study|Lost to Follow-up|1
44315|NCT01283139|172267|P3|Overall Study|Lost to Follow-up|3
44316|NCT01283139|172268|P2|Overall Study|Lost to Follow-up|2
44317|NCT01283139|172269|P1|Overall Study|Lost to Follow-up|5
44318|NCT01283035|172311|P1|Overall Study|Subject later found ineligible|1
44319|NCT01282866|172326|P1|Overall Study|Adverse Event|1
44320|NCT01282814|172334|P2|Washout of 7 Days|Withdrawal by Subject|0
44321|NCT01282814|172335|P1|Washout of 7 Days|Withdrawal by Subject|2
44322|NCT01282814|172334|P2|First Intervention|Emesis During Dosing Interval|3
44323|NCT01282814|172335|P1|First Intervention|Emesis During Dosing Interval|0
44324|NCT01282801|172347|P2|Second Intervention|Emesis During Critical Breakfast|1
44325|NCT01282801|172348|P1|Second Intervention|Emesis During Critical Breakfast|0
44326|NCT01282424|172372|P1|Overall Study|Investigator Request|7
44327|NCT01282424|172372|P1|Overall Study|Withdrew Consent|4
44328|NCT01282424|172372|P1|Overall Study|Adverse Event|25
44329|NCT01282424|172372|P1|Overall Study|Treatment Ongoing|40
44330|NCT01282372|172389|P1|Overall Study|Adverse Event|12
44331|NCT01282372|172389|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
44332|NCT01282372|172389|P1|Overall Study|Presence of AE, Regression of Symptoms|1
44333|NCT01282372|172389|P1|Overall Study|Presence of AE, Lack of Efficacy|1
44334|NCT01282372|172389|P1|Overall Study|Death|1
44335|NCT01282372|172389|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
44336|NCT01282372|172389|P1|Overall Study|Withdrawal by Subject|11
44337|NCT01282372|172389|P1|Overall Study|Lost to Follow-up|23
44338|NCT01282372|172389|P1|Overall Study|Lack of Efficacy / Exacerbation|25
44339|NCT01282294|172417|P1|Overall Study|Physician Decision|1
44340|NCT01282294|172417|P1|Overall Study|Patient non-compliance|2
44341|NCT01282294|172417|P1|Overall Study|Adverse Event|1
44342|NCT01282294|172417|P1|Overall Study|Screening failure|1
44343|NCT01282294|172417|P1|Overall Study|Lost to Follow-up|14
44344|NCT01282229|172435|P1|Overall Study|Protocol Violation|2
44345|NCT01282203|172465|P1|Overall Study|Adverse Event|1
44346|NCT01281865|172515|P2|Overall Study|Lack of Efficacy|0
44347|NCT01281865|172516|P1|Overall Study|Lack of Efficacy|1
44348|NCT01281865|172515|P2|Overall Study|Withdrawal by Subject|0
44349|NCT01281865|172516|P1|Overall Study|Withdrawal by Subject|1
44350|NCT01281865|172515|P2|Overall Study|Adverse Event|1
44351|NCT01281865|172516|P1|Overall Study|Adverse Event|1
44352|NCT01281839|172524|P2|Overall Study|Reason not specified|1
44353|NCT01281839|172525|P1|Overall Study|Reason not specified|0
44354|NCT01281839|172524|P2|Overall Study|Withdrawal by Subject|10
44355|NCT01281839|172525|P1|Overall Study|Withdrawal by Subject|4
44356|NCT01281839|172524|P2|Overall Study|Lost to Follow-up|3
44357|NCT01281839|172525|P1|Overall Study|Lost to Follow-up|6
44358|NCT01281644|172586|P1|Overall Study|Withdrawal by Subject|2
44359|NCT01281644|172586|P1|Overall Study|Lost to Follow-up|3
44360|NCT01281306|172627|P7|Overall Study|Randomized in error|0
44361|NCT01281306|172628|P6|Overall Study|Randomized in error|0
44362|NCT01281306|172629|P5|Overall Study|Randomized in error|0
44363|NCT01281306|172630|P4|Overall Study|Randomized in error|1
44364|NCT01281306|172631|P3|Overall Study|Randomized in error|0
44365|NCT01281306|172632|P2|Overall Study|Randomized in error|0
44366|NCT01281306|172633|P1|Overall Study|Randomized in error|1
44367|NCT01281306|172627|P7|Overall Study|Adverse Event|3
44368|NCT01281306|172628|P6|Overall Study|Adverse Event|3
44369|NCT01281306|172629|P5|Overall Study|Adverse Event|5
44370|NCT01281306|172630|P4|Overall Study|Adverse Event|3
44371|NCT01281306|172631|P3|Overall Study|Adverse Event|2
44372|NCT01281306|172632|P2|Overall Study|Adverse Event|2
44373|NCT01281306|172633|P1|Overall Study|Adverse Event|3
44374|NCT01281306|172627|P7|Overall Study|Death|0
44375|NCT01281306|172628|P6|Overall Study|Death|0
44376|NCT01281306|172629|P5|Overall Study|Death|0
44377|NCT01281306|172630|P4|Overall Study|Death|0
44378|NCT01281306|172631|P3|Overall Study|Death|0
44379|NCT01281306|172632|P2|Overall Study|Death|0
44380|NCT01281306|172633|P1|Overall Study|Death|1
44381|NCT01281306|172627|P7|Overall Study|Lost to Follow-up|1
44382|NCT01281306|172628|P6|Overall Study|Lost to Follow-up|0
44383|NCT01281306|172629|P5|Overall Study|Lost to Follow-up|0
44384|NCT01281306|172630|P4|Overall Study|Lost to Follow-up|2
44385|NCT01281306|172631|P3|Overall Study|Lost to Follow-up|0
44386|NCT01281306|172632|P2|Overall Study|Lost to Follow-up|0
44387|NCT01281306|172633|P1|Overall Study|Lost to Follow-up|1
44388|NCT01281306|172627|P7|Overall Study|Condition no longer requires study drug|1
44389|NCT01281306|172628|P6|Overall Study|Condition no longer requires study drug|1
44390|NCT01281306|172629|P5|Overall Study|Condition no longer requires study drug|0
44391|NCT01281306|172630|P4|Overall Study|Condition no longer requires study drug|0
44392|NCT01281306|172631|P3|Overall Study|Condition no longer requires study drug|0
44393|NCT01281306|172632|P2|Overall Study|Condition no longer requires study drug|0
44394|NCT01281306|172633|P1|Overall Study|Condition no longer requires study drug|1
44395|NCT01281306|172627|P7|Overall Study|Protocol deviation|0
44396|NCT01281306|172628|P6|Overall Study|Protocol deviation|0
44397|NCT01281306|172629|P5|Overall Study|Protocol deviation|1
44398|NCT01281306|172630|P4|Overall Study|Protocol deviation|1
44399|NCT01281306|172631|P3|Overall Study|Protocol deviation|1
44400|NCT01281306|172632|P2|Overall Study|Protocol deviation|1
44401|NCT01281306|172633|P1|Overall Study|Protocol deviation|0
44402|NCT01281306|172627|P7|Overall Study|Withdrawal by Subject|1
44403|NCT01281306|172628|P6|Overall Study|Withdrawal by Subject|3
44404|NCT01281306|172629|P5|Overall Study|Withdrawal by Subject|1
44405|NCT01281306|172630|P4|Overall Study|Withdrawal by Subject|4
44406|NCT01281306|172631|P3|Overall Study|Withdrawal by Subject|2
44407|NCT01281306|172632|P2|Overall Study|Withdrawal by Subject|0
44408|NCT01281306|172633|P1|Overall Study|Withdrawal by Subject|1
44409|NCT01281306|172627|P7|Overall Study|Lack of Efficacy|1
44410|NCT01281306|172628|P6|Overall Study|Lack of Efficacy|0
44411|NCT01281306|172629|P5|Overall Study|Lack of Efficacy|2
44412|NCT01281306|172630|P4|Overall Study|Lack of Efficacy|0
44413|NCT01281306|172631|P3|Overall Study|Lack of Efficacy|3
44414|NCT01281306|172632|P2|Overall Study|Lack of Efficacy|1
44415|NCT01281306|172633|P1|Overall Study|Lack of Efficacy|0
44416|NCT01281202|172749|P2|Overall Study|Incarceration|3
44417|NCT01281202|172750|P1|Overall Study|Incarceration|0
44418|NCT01281202|172749|P2|Overall Study|Lost to Follow-up|13
44419|NCT01281202|172750|P1|Overall Study|Lost to Follow-up|11
44420|NCT01281202|172749|P2|Overall Study|Administrative|8
44421|NCT01281202|172750|P1|Overall Study|Administrative|2
44422|NCT01281202|172749|P2|Overall Study|Protocol Violation|10
44423|NCT01281202|172750|P1|Overall Study|Protocol Violation|11
44424|NCT01281202|172749|P2|Overall Study|Withdrawal by Subject|2
44425|NCT01281202|172750|P1|Overall Study|Withdrawal by Subject|2
44426|NCT01281202|172749|P2|Overall Study|Adverse Event|0
44427|NCT01281202|172750|P1|Overall Study|Adverse Event|2
44428|NCT01281124|172758|P1|Overall Study|Death|1
44429|NCT01280981|172773|P1|Overall Study|Study site closure|1
44430|NCT01280981|172773|P1|Overall Study|Elective surgery|2
44431|NCT01280981|172773|P1|Overall Study|Withdrawal of consent|3
44432|NCT01280981|172773|P1|Overall Study|Non-compliance with protocol|3
44433|NCT01280981|172773|P1|Overall Study|Failed to return|45
44434|NCT01280981|172773|P1|Overall Study|Irregular or discontinued menses|3
44435|NCT01280981|172773|P1|Overall Study|Adverse Event|6
44436|NCT01280981|172773|P1|Overall Study|Lost to Follow-up|3
44437|NCT01280981|172773|P1|Overall Study|Lack of Efficacy|13
44438|NCT01280981|172773|P1|Overall Study|Protocol Violation|2
44439|NCT01280981|172773|P1|Overall Study|Withdrawal by Subject|11
44440|NCT01280968|172784|P2|Overall Study|Unable to Smoke in Supine Position|0
44441|NCT01280968|172785|P1|Overall Study|Unable to Smoke in Supine Position|1
44442|NCT01280968|172784|P2|Overall Study|Pre-existing Neurological Condition|0
44443|NCT01280968|172785|P1|Overall Study|Pre-existing Neurological Condition|1
44444|NCT01280968|172784|P2|Overall Study|Scheduling Conflicts|1
44445|NCT01280968|172785|P1|Overall Study|Scheduling Conflicts|1
44446|NCT01280968|172784|P2|Overall Study|Adverse Event|0
44447|NCT01280968|172785|P1|Overall Study|Adverse Event|1
44448|NCT01280968|172784|P2|Overall Study|Anxiety|0
44449|NCT01280968|172785|P1|Overall Study|Anxiety|2
44450|NCT01280968|172784|P2|Overall Study|Commuting Problems|0
44451|NCT01280968|172785|P1|Overall Study|Commuting Problems|2
44452|NCT01280968|172784|P2|Overall Study|Unable to Follow Experimental Protocol|0
44453|NCT01280968|172785|P1|Overall Study|Unable to Follow Experimental Protocol|2
44454|NCT01280968|172784|P2|Overall Study|Lost to Follow-up|2
44455|NCT01280968|172785|P1|Overall Study|Lost to Follow-up|8
44456|NCT01280656|172857|P3|Overall Study|Other|7
44457|NCT01280656|172858|P2|Overall Study|Other|7
44458|NCT01280656|172859|P1|Overall Study|Other|1
44459|NCT01280656|172857|P3|Overall Study|Treatment shortening (RGT)|5
44460|NCT01280656|172858|P2|Overall Study|Treatment shortening (RGT)|4
44461|NCT01280656|172859|P1|Overall Study|Treatment shortening (RGT)|0
44462|NCT01280656|172857|P3|Overall Study|Lack of Efficacy|38
44463|NCT01280656|172858|P2|Overall Study|Lack of Efficacy|22
44464|NCT01280656|172859|P1|Overall Study|Lack of Efficacy|1
44465|NCT01280656|172857|P3|Overall Study|Adverse Event|13
44466|NCT01280656|172858|P2|Overall Study|Adverse Event|14
44467|NCT01280656|172859|P1|Overall Study|Adverse Event|1
44468|NCT01280591|172926|P4|Overall Study|Does not meet exclusion #27 criteria|1
44469|NCT01280591|172927|P3|Overall Study|Does not meet exclusion #27 criteria|0
44470|NCT01280591|172928|P2|Overall Study|Does not meet exclusion #27 criteria|0
44471|NCT01280591|172929|P1|Overall Study|Does not meet exclusion #27 criteria|0
44472|NCT01280591|172926|P4|Overall Study|Withdrawal by Subject|2
44473|NCT01280591|172927|P3|Overall Study|Withdrawal by Subject|0
44474|NCT01280591|172928|P2|Overall Study|Withdrawal by Subject|0
44475|NCT01280591|172929|P1|Overall Study|Withdrawal by Subject|0
44476|NCT01280357|173034|P1|Overall Study|IInsufficient data/No data supplied|12
44477|NCT01280357|173034|P1|Overall Study|Excluded no internal monitoring|14
44478|NCT01280266|173043|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
44479|NCT01280266|173044|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
44480|NCT01280266|173043|P2|First Intervention (Week 1-4)|Adverse Event|0
44481|NCT01280266|173044|P1|First Intervention (Week 1-4)|Adverse Event|1
44482|NCT01279447|173116|P2|Overall Study|Lost to Follow-up|1
44483|NCT01279447|173117|P1|Overall Study|Lost to Follow-up|3
44484|NCT01279200|173144|P2|Overall Study|Adverse Event|0
44485|NCT01279200|173145|P1|Overall Study|Adverse Event|1
44486|NCT01279200|173144|P2|Overall Study|Lost to Follow-up|1
44487|NCT01279200|173145|P1|Overall Study|Lost to Follow-up|0
44488|NCT01279200|173144|P2|Overall Study|ultrasound screening failure|1
44489|NCT01279200|173145|P1|Overall Study|ultrasound screening failure|0
44490|NCT01279200|173144|P2|Overall Study|Inconvenience of ultrasound visit|1
44491|NCT01279200|173145|P1|Overall Study|Inconvenience of ultrasound visit|0
44492|NCT01279200|173144|P2|Overall Study|Patient withdrawal due to high cost|1
44493|NCT01279200|173145|P1|Overall Study|Patient withdrawal due to high cost|0
44494|NCT01279200|173144|P2|Overall Study|Withdrawal by Subject|3
44495|NCT01279200|173145|P1|Overall Study|Withdrawal by Subject|1
44496|NCT01279070|173155|P2|Overall Study|Acute exacerbation|1
44497|NCT01279070|173156|P1|Overall Study|Acute exacerbation|3
44498|NCT01279070|173155|P2|Overall Study|Withdrawal by Subject|3
44499|NCT01279070|173156|P1|Overall Study|Withdrawal by Subject|2
44500|NCT01279044|173175|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
44501|NCT01279044|173176|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
44502|NCT01279044|173177|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
44503|NCT01279044|173175|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
44504|NCT01279044|173176|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
44505|NCT01279044|173177|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
44506|NCT01279044|173175|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
44507|NCT01279044|173176|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
44508|NCT01279044|173177|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
44509|NCT01278797|173251|P2|Period 1|Protocol Violation|0
44510|NCT01278797|173252|P1|Period 1|Protocol Violation|1
44511|NCT01278797|173251|P2|Period 1|Adverse Event|1
44512|NCT01278797|173252|P1|Period 1|Adverse Event|0
44513|NCT01278615|173262|P1|Overall Study|Withdrawal by Subject|2
44514|NCT01278407|173288|P5|Extension Phase|Not Specified|3
44515|NCT01278407|173289|P4|Extension Phase|Not Specified|1
44516|NCT01278407|173290|P3|Extension Phase|Not Specified|0
44517|NCT01278407|173291|P2|Extension Phase|Not Specified|0
44518|NCT01278407|173292|P1|Extension Phase|Not Specified|0
44519|NCT01278407|173288|P5|Extension Phase|Participant's Choice|11
44520|NCT01278407|173289|P4|Extension Phase|Participant's Choice|4
44521|NCT01278407|173290|P3|Extension Phase|Participant's Choice|0
44522|NCT01278407|173291|P2|Extension Phase|Participant's Choice|0
44523|NCT01278407|173292|P1|Extension Phase|Participant's Choice|0
44524|NCT01278407|173288|P5|Extension Phase|Adverse Event|16
44525|NCT01278407|173289|P4|Extension Phase|Adverse Event|7
44526|NCT01278407|173290|P3|Extension Phase|Adverse Event|0
44527|NCT01278407|173291|P2|Extension Phase|Adverse Event|0
44528|NCT01278407|173292|P1|Extension Phase|Adverse Event|0
44529|NCT01278407|173288|P5|Confirmatory Phase|Not Specified|0
44530|NCT01278407|173289|P4|Confirmatory Phase|Not Specified|0
44531|NCT01278407|173290|P3|Confirmatory Phase|Not Specified|2
44532|NCT01278407|173291|P2|Confirmatory Phase|Not Specified|1
44533|NCT01278407|173292|P1|Confirmatory Phase|Not Specified|1
44534|NCT01278407|173288|P5|Confirmatory Phase|Participant's Choice|0
44535|NCT01278407|173289|P4|Confirmatory Phase|Participant's Choice|0
44536|NCT01278407|173290|P3|Confirmatory Phase|Participant's Choice|3
44537|NCT01278407|173291|P2|Confirmatory Phase|Participant's Choice|5
44538|NCT01278407|173292|P1|Confirmatory Phase|Participant's Choice|3
44539|NCT01278407|173288|P5|Confirmatory Phase|Adverse Event|0
44540|NCT01278407|173289|P4|Confirmatory Phase|Adverse Event|0
44541|NCT01278407|173290|P3|Confirmatory Phase|Adverse Event|1
44542|NCT01278407|173291|P2|Confirmatory Phase|Adverse Event|10
44543|NCT01278407|173292|P1|Confirmatory Phase|Adverse Event|5
44544|NCT01278394|173305|P1|Overall Study|Lost to Follow-up|1
44545|NCT01278342|173318|P3|Overall Study|Other|0
44546|NCT01278342|173319|P2|Overall Study|Other|0
44547|NCT01278342|173320|P1|Overall Study|Other|1
44548|NCT01278342|173318|P3|Overall Study|Administrative problems|0
44549|NCT01278342|173319|P2|Overall Study|Administrative problems|0
44550|NCT01278342|173320|P1|Overall Study|Administrative problems|2
44551|NCT01278342|173318|P3|Overall Study|Lost to Follow-up|0
44552|NCT01278342|173319|P2|Overall Study|Lost to Follow-up|0
44553|NCT01278342|173320|P1|Overall Study|Lost to Follow-up|1
44554|NCT01278342|173318|P3|Overall Study|Physician Decision|0
44555|NCT01278342|173319|P2|Overall Study|Physician Decision|1
44556|NCT01278342|173320|P1|Overall Study|Physician Decision|0
44557|NCT01277211|173342|P2|Overall Study|Discontinued prior to treatment|13
44558|NCT01277211|173343|P1|Overall Study|Discontinued prior to treatment|24
44559|NCT01277211|173342|P2|Overall Study|Pregnancy wish|2
44560|NCT01277211|173343|P1|Overall Study|Pregnancy wish|0
44561|NCT01277211|173342|P2|Overall Study|Administrative|0
44562|NCT01277211|173343|P1|Overall Study|Administrative|3
44563|NCT01277211|173342|P2|Overall Study|Did not meet protocol eligibility|0
44564|NCT01277211|173343|P1|Overall Study|Did not meet protocol eligibility|1
44565|NCT01277211|173342|P2|Overall Study|Non-compliance with protocol|4
44566|NCT01277211|173343|P1|Overall Study|Non-compliance with protocol|13
44567|NCT01277211|173342|P2|Overall Study|Withdrew Consent|9
44568|NCT01277211|173343|P1|Overall Study|Withdrew Consent|9
44569|NCT01277211|173342|P2|Overall Study|Did not wish to continue|0
44570|NCT01277211|173343|P1|Overall Study|Did not wish to continue|17
44571|NCT01277211|173342|P2|Overall Study|Lost to Follow-up|9
44572|NCT01277211|173343|P1|Overall Study|Lost to Follow-up|14
44573|NCT01277211|173342|P2|Overall Study|Pregnancy|4
44574|NCT01277211|173343|P1|Overall Study|Pregnancy|9
44575|NCT01277211|173342|P2|Overall Study|Adverse Event|22
44576|NCT01277211|173343|P1|Overall Study|Adverse Event|60
44577|NCT01278173|173372|P1|Overall Study|Withdrawal by Subject|1
44578|NCT01278173|173372|P1|Overall Study|Protocol Violation|1
44579|NCT01278173|173372|P1|Overall Study|Administrative or other reason|4
44580|NCT01278173|173372|P1|Overall Study|Adverse Event|8
44581|NCT01278173|173372|P1|Overall Study|Lack of Efficacy|13
44582|NCT01278160|173379|P2|Overall Study|Unclassified|2
44583|NCT01278160|173380|P1|Overall Study|Unclassified|1
44584|NCT01278160|173379|P2|Overall Study|Withdrawal by Subject|2
44585|NCT01278160|173380|P1|Overall Study|Withdrawal by Subject|3
44586|NCT01278160|173379|P2|Overall Study|Lost to Follow-up|1
44587|NCT01278160|173380|P1|Overall Study|Lost to Follow-up|0
44588|NCT01278160|173379|P2|Overall Study|Adverse Event|1
44589|NCT01278160|173380|P1|Overall Study|Adverse Event|1
44590|NCT01278030|173396|P2|Overall Study|Withdrawal by Subject|4
44591|NCT01278030|173397|P1|Overall Study|Withdrawal by Subject|8
44592|NCT01277861|173405|P2|Overall Study|Physician Decision|2
44593|NCT01277861|173406|P1|Overall Study|Physician Decision|2
44594|NCT01277822|173418|P2|Overall Study|Participant moved|0
44595|NCT01277822|173419|P1|Overall Study|Participant moved|1
44596|NCT01277822|173418|P2|Overall Study|Contraindicated medication used|1
44597|NCT01277822|173419|P1|Overall Study|Contraindicated medication used|2
44598|NCT01277822|173418|P2|Overall Study|Lost to Follow-up|1
44599|NCT01277822|173419|P1|Overall Study|Lost to Follow-up|2
44600|NCT01277822|173418|P2|Overall Study|Protocol Violation|0
44601|NCT01277822|173419|P1|Overall Study|Protocol Violation|1
44602|NCT01277822|173418|P2|Overall Study|Physician Decision|1
44603|NCT01277822|173419|P1|Overall Study|Physician Decision|1
44604|NCT01277822|173418|P2|Overall Study|Withdrawal by Subject|7
44605|NCT01277822|173419|P1|Overall Study|Withdrawal by Subject|6
44606|NCT01277822|173418|P2|Overall Study|Adverse Event|1
44607|NCT01277822|173419|P1|Overall Study|Adverse Event|2
44608|NCT01277757|173439|P1|Overall Study|Withdrawal by Subject|1
44609|NCT01277757|173439|P1|Overall Study|Disease Progression|1
44610|NCT01277718|173446|P2|Period 2 - Second Intervention|Physician Decision|2
44611|NCT01277718|173447|P1|Period 2 - Second Intervention|Physician Decision|0
44612|NCT01277718|173446|P2|Period 2 - Second Intervention|Protocol Violation|1
44613|NCT01277718|173447|P1|Period 2 - Second Intervention|Protocol Violation|0
44614|NCT01277601|173462|P4|Overall Study|Subject Terminated from Study by Sponsor|2
44615|NCT01277601|173463|P3|Overall Study|Subject Terminated from Study by Sponsor|0
44616|NCT01277601|173464|P2|Overall Study|Subject Terminated from Study by Sponsor|1
44617|NCT01277601|173465|P1|Overall Study|Subject Terminated from Study by Sponsor|0
44618|NCT01277601|173462|P4|Overall Study|Protocol Violation|0
44619|NCT01277601|173463|P3|Overall Study|Protocol Violation|5
44620|NCT01277601|173464|P2|Overall Study|Protocol Violation|2
44621|NCT01277601|173465|P1|Overall Study|Protocol Violation|0
44622|NCT01277601|173462|P4|Overall Study|Subject Never Dosed with Study Drug|1
44623|NCT01277601|173463|P3|Overall Study|Subject Never Dosed with Study Drug|3
44624|NCT01277601|173464|P2|Overall Study|Subject Never Dosed with Study Drug|2
44625|NCT01277601|173465|P1|Overall Study|Subject Never Dosed with Study Drug|1
44626|NCT01277601|173462|P4|Overall Study|Noncompliance with Study Drug|0
44627|NCT01277601|173463|P3|Overall Study|Noncompliance with Study Drug|2
44628|NCT01277601|173464|P2|Overall Study|Noncompliance with Study Drug|3
44629|NCT01277601|173465|P1|Overall Study|Noncompliance with Study Drug|1
44630|NCT01277601|173462|P4|Overall Study|Pregnancy|1
44631|NCT01277601|173463|P3|Overall Study|Pregnancy|4
44632|NCT01277601|173464|P2|Overall Study|Pregnancy|2
44633|NCT01277601|173465|P1|Overall Study|Pregnancy|2
44634|NCT01277601|173462|P4|Overall Study|Physician Decision|6
44635|NCT01277601|173463|P3|Overall Study|Physician Decision|1
44636|NCT01277601|173464|P2|Overall Study|Physician Decision|5
44637|NCT01277601|173465|P1|Overall Study|Physician Decision|3
44638|NCT01277601|173462|P4|Overall Study|Lost to Follow-up|2
44639|NCT01277601|173463|P3|Overall Study|Lost to Follow-up|4
44640|NCT01277601|173464|P2|Overall Study|Lost to Follow-up|9
44641|NCT01277601|173465|P1|Overall Study|Lost to Follow-up|7
44642|NCT01277601|173462|P4|Overall Study|Withdrawal by Subject|17
44643|NCT01277601|173463|P3|Overall Study|Withdrawal by Subject|8
44644|NCT01277601|173464|P2|Overall Study|Withdrawal by Subject|21
44645|NCT01277601|173465|P1|Overall Study|Withdrawal by Subject|18
44646|NCT01277601|173462|P4|Overall Study|Adverse Event|7
44647|NCT01277601|173463|P3|Overall Study|Adverse Event|0
44648|NCT01277601|173464|P2|Overall Study|Adverse Event|3
44649|NCT01277601|173465|P1|Overall Study|Adverse Event|5
44650|NCT01277549|173556|P2|Overall Study|Physician Decision|1
44651|NCT01277549|173557|P1|Overall Study|Physician Decision|2
44652|NCT01277549|173556|P2|Overall Study|Protocol Violation|1
44653|NCT01277549|173557|P1|Overall Study|Protocol Violation|10
44654|NCT01277549|173556|P2|Overall Study|Withdrawal by Subject|3
44655|NCT01277549|173557|P1|Overall Study|Withdrawal by Subject|1
44656|NCT01277549|173556|P2|Overall Study|Failed to meet eligibility criteria|9
44657|NCT01277549|173557|P1|Overall Study|Failed to meet eligibility criteria|13
44658|NCT01277523|173574|P3|Overall Study|Other Reason not Defined|0
44659|NCT01277523|173575|P2|Overall Study|Other Reason not Defined|1
44660|NCT01277523|173576|P1|Overall Study|Other Reason not Defined|0
44661|NCT01277523|173574|P3|Overall Study|Protocol Violation|0
44662|NCT01277523|173575|P2|Overall Study|Protocol Violation|0
44663|NCT01277523|173576|P1|Overall Study|Protocol Violation|2
44664|NCT01277523|173574|P3|Overall Study|Adverse Event|0
44665|NCT01277523|173575|P2|Overall Study|Adverse Event|0
44666|NCT01277523|173576|P1|Overall Study|Adverse Event|1
44667|NCT01277510|173628|P2|Open-label Phase|Never received investigational product|0
44668|NCT01277510|173629|P1|Open-label Phase|Never received investigational product|2
44669|NCT01277510|173628|P2|Open-label Phase|Protocol-specified criteria|0
44670|NCT01277510|173629|P1|Open-label Phase|Protocol-specified criteria|1
44671|NCT01277510|173628|P2|Open-label Phase|Administrative decision|3
44672|NCT01277510|173629|P1|Open-label Phase|Administrative decision|4
44673|NCT01277510|173628|P2|Double-blind Phase|Other|1
44674|NCT01277510|173629|P1|Double-blind Phase|Other|1
44675|NCT01277510|173628|P2|Double-blind Phase|Protocol-specified criteria|6
44676|NCT01277510|173629|P1|Double-blind Phase|Protocol-specified criteria|2
44677|NCT01277510|173628|P2|Double-blind Phase|Death|1
44678|NCT01277510|173629|P1|Double-blind Phase|Death|0
44679|NCT01277510|173628|P2|Double-blind Phase|Administrative decision|9
44680|NCT01277510|173629|P1|Double-blind Phase|Administrative decision|7
44681|NCT01277510|173628|P2|Double-blind Phase|Withdrawal by Subject|0
44682|NCT01277510|173629|P1|Double-blind Phase|Withdrawal by Subject|2
44683|NCT01277510|173628|P2|Double-blind Phase|Adverse Event|0
44684|NCT01277510|173629|P1|Double-blind Phase|Adverse Event|1
44685|NCT01277510|173628|P2|Double-blind Phase|Non-compliance|1
44686|NCT01277510|173629|P1|Double-blind Phase|Non-compliance|0
44687|NCT01277302|173663|P3|8-Month Alternate Dose Regimen Period|Relocation|1
44688|NCT01277302|173664|P2|8-Month Alternate Dose Regimen Period|Relocation|0
44689|NCT01277302|173665|P1|8-Month Alternate Dose Regimen Period|Relocation|1
44690|NCT01277302|173663|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
44691|NCT01277302|173664|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
44692|NCT01277302|173665|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
44693|NCT01277302|173663|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
44694|NCT01277302|173664|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
44695|NCT01277302|173665|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
44696|NCT01277302|173663|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
44697|NCT01277302|173664|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
44698|NCT01277302|173665|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
44699|NCT01277302|173663|P3|8-Month Alternate Dose Regimen Period|Death|0
44700|NCT01277302|173664|P2|8-Month Alternate Dose Regimen Period|Death|1
44701|NCT01277302|173665|P1|8-Month Alternate Dose Regimen Period|Death|0
44702|NCT01277302|173663|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
44703|NCT01277302|173664|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
44704|NCT01277302|173665|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
44705|NCT01277302|173663|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
44706|NCT01277302|173664|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
44707|NCT01277302|173665|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
44708|NCT01277302|173663|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
44709|NCT01277302|173664|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
44710|NCT01277302|173665|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
44711|NCT01277302|173663|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
44712|NCT01277302|173664|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
44713|NCT01277302|173665|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
44714|NCT01277042|173697|P2|Overall Study|Withdrawal by Subject|0
44715|NCT01277042|173698|P1|Overall Study|Withdrawal by Subject|2
44716|NCT01277042|173697|P2|Overall Study|Lost to Follow-up|2
44717|NCT01277042|173698|P1|Overall Study|Lost to Follow-up|2
44718|NCT01277042|173697|P2|Overall Study|Adverse Event|3
44719|NCT01277042|173698|P1|Overall Study|Adverse Event|4
44720|NCT01276847|173723|P3|Overall Study|Withdrawal by Subject|0
44721|NCT01276847|173724|P2|Overall Study|Withdrawal by Subject|0
44722|NCT01276847|173725|P1|Overall Study|Withdrawal by Subject|1
44723|NCT01276821|173735|P2|Overall Study|Protocol Violation|1
44724|NCT01276821|173736|P1|Overall Study|Protocol Violation|0
44725|NCT01276756|173756|P2|Overall Study|Adverse Event|2
44726|NCT01276756|173757|P1|Overall Study|Adverse Event|3
44727|NCT01276756|173756|P2|Overall Study|Lost to Follow-up|0
44728|NCT01276756|173757|P1|Overall Study|Lost to Follow-up|2
44729|NCT01276639|173774|P5|Week 16 to 52|Unspecified|3
44730|NCT01276639|173775|P4|Week 16 to 52|Unspecified|1
44731|NCT01276639|173776|P3|Week 16 to 52|Unspecified|0
44732|NCT01276639|173777|P2|Week 16 to 52|Unspecified|12
44733|NCT01276639|173778|P1|Week 16 to 52|Unspecified|10
44734|NCT01276639|173774|P5|Week 16 to 52|Withdrawal by Subject|1
44735|NCT01276639|173775|P4|Week 16 to 52|Withdrawal by Subject|0
44736|NCT01276639|173776|P3|Week 16 to 52|Withdrawal by Subject|0
44737|NCT01276639|173777|P2|Week 16 to 52|Withdrawal by Subject|4
44738|NCT01276639|173778|P1|Week 16 to 52|Withdrawal by Subject|4
44739|NCT01276639|173774|P5|Week 16 to 52|Lost to Follow-up|1
44740|NCT01276639|173775|P4|Week 16 to 52|Lost to Follow-up|0
44741|NCT01276639|173776|P3|Week 16 to 52|Lost to Follow-up|0
44742|NCT01276639|173777|P2|Week 16 to 52|Lost to Follow-up|1
44743|NCT01276639|173778|P1|Week 16 to 52|Lost to Follow-up|3
44744|NCT01276639|173774|P5|Week 16 to 52|Lack of Efficacy|13
44745|NCT01276639|173775|P4|Week 16 to 52|Lack of Efficacy|14
44746|NCT01276639|173776|P3|Week 16 to 52|Lack of Efficacy|0
44747|NCT01276639|173777|P2|Week 16 to 52|Lack of Efficacy|71
44748|NCT01276639|173778|P1|Week 16 to 52|Lack of Efficacy|99
44749|NCT01276639|173774|P5|Week 16 to 52|Adverse Event|3
44750|NCT01276639|173775|P4|Week 16 to 52|Adverse Event|1
44751|NCT01276639|173776|P3|Week 16 to 52|Adverse Event|0
44752|NCT01276639|173777|P2|Week 16 to 52|Adverse Event|13
44753|NCT01276639|173778|P1|Week 16 to 52|Adverse Event|10
44754|NCT01276639|173774|P5|Week 16 to 52|Death|0
44755|NCT01276639|173775|P4|Week 16 to 52|Death|0
44756|NCT01276639|173776|P3|Week 16 to 52|Death|0
44757|NCT01276639|173777|P2|Week 16 to 52|Death|0
44758|NCT01276639|173778|P1|Week 16 to 52|Death|1
44759|NCT01276639|173774|P5|Week 0 to 16|Randomized, But Not Treated|0
44760|NCT01276639|173775|P4|Week 0 to 16|Randomized, But Not Treated|0
44761|NCT01276639|173776|P3|Week 0 to 16|Randomized, But Not Treated|0
44762|NCT01276639|173777|P2|Week 0 to 16|Randomized, But Not Treated|1
44763|NCT01276639|173778|P1|Week 0 to 16|Randomized, But Not Treated|0
44764|NCT01276639|173774|P5|Week 0 to 16|Unspecified|0
44765|NCT01276639|173775|P4|Week 0 to 16|Unspecified|0
44766|NCT01276639|173776|P3|Week 0 to 16|Unspecified|2
44767|NCT01276639|173777|P2|Week 0 to 16|Unspecified|7
44768|NCT01276639|173778|P1|Week 0 to 16|Unspecified|7
44769|NCT01276639|173774|P5|Week 0 to 16|Withdrawal by Subject|0
44770|NCT01276639|173775|P4|Week 0 to 16|Withdrawal by Subject|0
44771|NCT01276639|173776|P3|Week 0 to 16|Withdrawal by Subject|4
44772|NCT01276639|173777|P2|Week 0 to 16|Withdrawal by Subject|5
44773|NCT01276639|173778|P1|Week 0 to 16|Withdrawal by Subject|8
44774|NCT01276639|173774|P5|Week 0 to 16|Lost to Follow-up|0
44775|NCT01276639|173775|P4|Week 0 to 16|Lost to Follow-up|0
44776|NCT01276639|173776|P3|Week 0 to 16|Lost to Follow-up|3
44777|NCT01276639|173777|P2|Week 0 to 16|Lost to Follow-up|5
44778|NCT01276639|173778|P1|Week 0 to 16|Lost to Follow-up|3
44779|NCT01276639|173774|P5|Week 0 to 16|Lack of Efficacy|0
44780|NCT01276639|173775|P4|Week 0 to 16|Lack of Efficacy|0
44781|NCT01276639|173776|P3|Week 0 to 16|Lack of Efficacy|25
44782|NCT01276639|173777|P2|Week 0 to 16|Lack of Efficacy|15
44783|NCT01276639|173778|P1|Week 0 to 16|Lack of Efficacy|20
44784|NCT01276639|173774|P5|Week 0 to 16|Adverse Event|0
44785|NCT01276639|173775|P4|Week 0 to 16|Adverse Event|0
44786|NCT01276639|173776|P3|Week 0 to 16|Adverse Event|11
44787|NCT01276639|173777|P2|Week 0 to 16|Adverse Event|8
44788|NCT01276639|173778|P1|Week 0 to 16|Adverse Event|11
44789|NCT01276639|173774|P5|Week 0 to 16|Death|0
44790|NCT01276639|173775|P4|Week 0 to 16|Death|0
44791|NCT01276639|173776|P3|Week 0 to 16|Death|0
44792|NCT01276639|173777|P2|Week 0 to 16|Death|0
44793|NCT01276639|173778|P1|Week 0 to 16|Death|1
44794|NCT01276457|173981|P2|Extension Study|Lack of Efficacy|1
44795|NCT01276457|173982|P1|Extension Study|Lack of Efficacy|3
44796|NCT01276457|173981|P2|Extension Study|Death|1
44797|NCT01276457|173982|P1|Extension Study|Death|0
44798|NCT01276457|173981|P2|Extension Study|Lost to Follow-up|0
44799|NCT01276457|173982|P1|Extension Study|Lost to Follow-up|3
44800|NCT01276457|173981|P2|Core Study|Lack of Efficacy|12
44801|NCT01276457|173982|P1|Core Study|Lack of Efficacy|3
44802|NCT01276457|173981|P2|Core Study|Death|2
44803|NCT01276457|173982|P1|Core Study|Death|2
44804|NCT01276457|173981|P2|Core Study|Administrative problems|1
44805|NCT01276457|173982|P1|Core Study|Administrative problems|1
44806|NCT01276457|173981|P2|Core Study|Lost to Follow-up|2
44807|NCT01276457|173982|P1|Core Study|Lost to Follow-up|1
44808|NCT01276457|173981|P2|Core Study|Adverse Event|3
44809|NCT01276457|173982|P1|Core Study|Adverse Event|6
44810|NCT01276353|173996|P2|Extension|Prohibited concomitant medications|1
44811|NCT01276353|173997|P1|Extension|Prohibited concomitant medications|0
44812|NCT01276353|173996|P2|Extension|Physician Decision|0
44813|NCT01276353|173997|P1|Extension|Physician Decision|1
44814|NCT01276353|173996|P2|Extension|Withdrawal of study drug 4 days in a row|1
44815|NCT01276353|173997|P1|Extension|Withdrawal of study drug 4 days in a row|3
44816|NCT01276353|173996|P2|Extension|Withdrawal by Subject|2
44817|NCT01276353|173997|P1|Extension|Withdrawal by Subject|1
44818|NCT01276353|173996|P2|Extension|Adverse Event|5
44819|NCT01276353|173997|P1|Extension|Adverse Event|2
44820|NCT01276353|173996|P2|Double-blind|Withdrawal by Subject|0
44821|NCT01276353|173997|P1|Double-blind|Withdrawal by Subject|1
44822|NCT01276353|173996|P2|Double-blind|Adverse Event|0
44823|NCT01276353|173997|P1|Double-blind|Adverse Event|2
44824|NCT01276327|174009|P2|Overall Study|Withdrawal by Subject|0
44825|NCT01276327|174010|P1|Overall Study|Withdrawal by Subject|1
44826|NCT01276327|174009|P2|Overall Study|Adverse Event|3
44827|NCT01276327|174010|P1|Overall Study|Adverse Event|1
44828|NCT01276288|174060|P4|Overall Study|not treated|0
44829|NCT01276288|174061|P3|Overall Study|not treated|0
44830|NCT01276288|174062|P2|Overall Study|not treated|0
44831|NCT01276288|174063|P1|Overall Study|not treated|1
44832|NCT01276288|174060|P4|Overall Study|Adverse Event|0
44833|NCT01276288|174061|P3|Overall Study|Adverse Event|0
44834|NCT01276288|174062|P2|Overall Study|Adverse Event|1
44835|NCT01276288|174063|P1|Overall Study|Adverse Event|1
44836|NCT01276223|174190|P3|Overall Study|Protocol Violation|0
44837|NCT01276223|174191|P2|Overall Study|Protocol Violation|0
44838|NCT01276223|174192|P1|Overall Study|Protocol Violation|1
44839|NCT01276223|174190|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
44840|NCT01276223|174191|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
44841|NCT01276223|174192|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
44842|NCT01276223|174190|P3|Overall Study|Not specified|1
44843|NCT01276223|174191|P2|Overall Study|Not specified|0
44844|NCT01276223|174192|P1|Overall Study|Not specified|0
44845|NCT01276223|174190|P3|Overall Study|Lost to Follow-up|1
44846|NCT01276223|174191|P2|Overall Study|Lost to Follow-up|0
44847|NCT01276223|174192|P1|Overall Study|Lost to Follow-up|0
44848|NCT01276223|174190|P3|Overall Study|Adverse Event|1
44849|NCT01276223|174191|P2|Overall Study|Adverse Event|4
44850|NCT01276223|174192|P1|Overall Study|Adverse Event|7
44851|NCT01276106|174214|P4|Overall Study|Insufficient therapeutic effects|0
44852|NCT01276106|174215|P3|Overall Study|Insufficient therapeutic effects|2
44853|NCT01276106|174216|P2|Overall Study|Insufficient therapeutic effects|0
44854|NCT01276106|174217|P1|Overall Study|Insufficient therapeutic effects|0
44855|NCT01276106|174214|P4|Overall Study|Protocol Violation|2
44856|NCT01276106|174215|P3|Overall Study|Protocol Violation|0
44857|NCT01276106|174216|P2|Overall Study|Protocol Violation|1
44858|NCT01276106|174217|P1|Overall Study|Protocol Violation|1
44859|NCT01276106|174214|P4|Overall Study|Physician Decision|1
44860|NCT01276106|174215|P3|Overall Study|Physician Decision|1
44861|NCT01276106|174216|P2|Overall Study|Physician Decision|0
44862|NCT01276106|174217|P1|Overall Study|Physician Decision|0
44863|NCT01276106|174214|P4|Overall Study|Lost to Follow-up|0
44864|NCT01276106|174215|P3|Overall Study|Lost to Follow-up|1
44865|NCT01276106|174216|P2|Overall Study|Lost to Follow-up|1
44866|NCT01276106|174217|P1|Overall Study|Lost to Follow-up|2
44867|NCT01276106|174214|P4|Overall Study|Lack of Efficacy|1
44868|NCT01276106|174215|P3|Overall Study|Lack of Efficacy|0
44869|NCT01276106|174216|P2|Overall Study|Lack of Efficacy|1
44870|NCT01276106|174217|P1|Overall Study|Lack of Efficacy|0
44871|NCT01276106|174214|P4|Overall Study|Withdrawal by Subject|6
44872|NCT01276106|174215|P3|Overall Study|Withdrawal by Subject|1
44873|NCT01276106|174216|P2|Overall Study|Withdrawal by Subject|3
44874|NCT01276106|174217|P1|Overall Study|Withdrawal by Subject|6
44875|NCT01276106|174214|P4|Overall Study|Adverse Event|3
44876|NCT01276106|174215|P3|Overall Study|Adverse Event|11
44877|NCT01276106|174216|P2|Overall Study|Adverse Event|3
44878|NCT01276106|174217|P1|Overall Study|Adverse Event|3
44879|NCT01276054|174229|P2|Overall Study|No one to oversee trial after P.I. left|2
44880|NCT01276054|174230|P1|Overall Study|No one to oversee trial after P.I. left|2
44881|NCT01275755|174238|P2|Run-out Placebo Period|Lost to Follow-up|0
44882|NCT01275755|174239|P1|Run-out Placebo Period|Lost to Follow-up|1
44883|NCT01275755|174238|P2|Double-blind Treatment Period|Withdrawal by Subject|0
44884|NCT01275755|174239|P1|Double-blind Treatment Period|Withdrawal by Subject|1
44885|NCT01275755|174238|P2|Double-blind Treatment Period|Lost to Follow-up|1
44886|NCT01275755|174239|P1|Double-blind Treatment Period|Lost to Follow-up|1
44887|NCT01275755|174238|P2|Double-blind Treatment Period|Adverse Event|2
44888|NCT01275755|174239|P1|Double-blind Treatment Period|Adverse Event|0
44889|NCT01275625|174245|P1|Overall Study|Not specified|1
44890|NCT01275625|174245|P1|Overall Study|Adverse Event|4
44891|NCT01275625|174245|P1|Overall Study|Protocol Violation|1
44892|NCT01275625|174245|P1|Overall Study|Withdrawal by Subject|3
44893|NCT01275625|174245|P1|Overall Study|Lost to Follow-up|1
44894|NCT01275625|174245|P1|Overall Study|Lack of Efficacy|2
44895|NCT01275625|174245|P1|Overall Study|Death|1
44896|NCT01275430|174259|P1|Overall Study|Inability to achieve maximum p-wave|1
44897|NCT01275430|174259|P1|Overall Study|Device Malfunction|1
44898|NCT01275430|174259|P1|Overall Study|No Contrast Injection|6
44899|NCT01275430|174259|P1|Overall Study|Adverse Event|1
44900|NCT01275196|174269|P2|Overall Study|Suboptimal response/treatment failure|6
44901|NCT01275196|174270|P1|Overall Study|Suboptimal response/treatment failure|5
44902|NCT01275196|174269|P2|Overall Study|Protocol Violation|0
44903|NCT01275196|174270|P1|Overall Study|Protocol Violation|1
44904|NCT01275196|174269|P2|Overall Study|Disease Progression|5
44905|NCT01275196|174270|P1|Overall Study|Disease Progression|6
44906|NCT01275196|174269|P2|Overall Study|Lost to Follow-up|0
44907|NCT01275196|174270|P1|Overall Study|Lost to Follow-up|1
44908|NCT01275196|174269|P2|Overall Study|Withdrawal by Subject|5
44909|NCT01275196|174270|P1|Overall Study|Withdrawal by Subject|4
44910|NCT01275196|174269|P2|Overall Study|Adverse Event|5
44911|NCT01275196|174270|P1|Overall Study|Adverse Event|3
44912|NCT01275131|174313|P4|Period 2 (Crossover)|Withdrawal by Subject|2
44913|NCT01275131|174314|P3|Period 2 (Crossover)|Withdrawal by Subject|1
44914|NCT01275131|174315|P2|Period 2 (Crossover)|Withdrawal by Subject|0
44915|NCT01275131|174316|P1|Period 2 (Crossover)|Withdrawal by Subject|1
44916|NCT01275131|174313|P4|Period 2 (Crossover)|Adverse Event|0
44917|NCT01275131|174314|P3|Period 2 (Crossover)|Adverse Event|0
44918|NCT01275131|174315|P2|Period 2 (Crossover)|Adverse Event|1
44919|NCT01275131|174316|P1|Period 2 (Crossover)|Adverse Event|0
44920|NCT01275131|174313|P4|Period 1|Physician Decision|0
44921|NCT01275131|174314|P3|Period 1|Physician Decision|0
44922|NCT01275131|174315|P2|Period 1|Physician Decision|0
44923|NCT01275131|174316|P1|Period 1|Physician Decision|1
44924|NCT01275131|174313|P4|Period 1|Withdrawal by Subject|2
44925|NCT01275131|174314|P3|Period 1|Withdrawal by Subject|3
44926|NCT01275131|174315|P2|Period 1|Withdrawal by Subject|0
44927|NCT01275131|174316|P1|Period 1|Withdrawal by Subject|1
44928|NCT01275066|174359|P3|Overall Study|Not Diagnosed w/ Disease|0
44929|NCT01275066|174360|P2|Overall Study|Not Diagnosed w/ Disease|0
44930|NCT01275066|174361|P1|Overall Study|Not Diagnosed w/ Disease|1
44931|NCT01275066|174359|P3|Overall Study|Withdrawal by Subject|1
44932|NCT01275066|174360|P2|Overall Study|Withdrawal by Subject|0
44933|NCT01275066|174361|P1|Overall Study|Withdrawal by Subject|0
44934|NCT01274715|174390|P1|Overall Study|After consent, met exclusion criteria.|1
44935|NCT01274715|174390|P1|Overall Study|After consent, met exclusion criteria.|1
44936|NCT01274715|174390|P1|Overall Study|After consent, met exclusion criteria.|1
44937|NCT01274715|174390|P1|Overall Study|Lost to Follow-up|1
44938|NCT01274559|174414|P2|Overall Study|Withdrawal by Subject|13
44939|NCT01274559|174415|P1|Overall Study|Withdrawal by Subject|25
44940|NCT01274559|174414|P2|Overall Study|Study Terminated by Sponsor|87
44941|NCT01274559|174415|P1|Overall Study|Study Terminated by Sponsor|79
44942|NCT01274559|174414|P2|Overall Study|Protocol Violation|23
44943|NCT01274559|174415|P1|Overall Study|Protocol Violation|28
44944|NCT01274559|174414|P2|Overall Study|Physician Decision|1
44945|NCT01274559|174415|P1|Overall Study|Physician Decision|2
44946|NCT01274559|174414|P2|Overall Study|Non-compliance with Study Drug|4
44947|NCT01274559|174415|P1|Overall Study|Non-compliance with Study Drug|2
44948|NCT01274559|174414|P2|Overall Study|Lost to Follow-up|3
44949|NCT01274559|174415|P1|Overall Study|Lost to Follow-up|3
44950|NCT01274559|174414|P2|Overall Study|Death|1
44951|NCT01274559|174415|P1|Overall Study|Death|1
44952|NCT01274559|174414|P2|Overall Study|Adverse Event|13
44953|NCT01274559|174415|P1|Overall Study|Adverse Event|57
44954|NCT01274533|174465|P1|Overall Study|Disease progression|2
44955|NCT01274533|174465|P1|Overall Study|Non-compliance|1
44956|NCT01274533|174465|P1|Overall Study|Withdrawal by Subject|1
44957|NCT01273883|174474|P2|Second Intervention|Lack of Efficacy|0
44958|NCT01273883|174475|P1|Second Intervention|Lack of Efficacy|1
44959|NCT01273883|174474|P2|Second Intervention|Lost to Follow-up|1
44960|NCT01273883|174475|P1|Second Intervention|Lost to Follow-up|1
44961|NCT01273883|174474|P2|First Intervention|Adverse Event|1
44962|NCT01273883|174475|P1|First Intervention|Adverse Event|2
44963|NCT01273818|174501|P3|Overall Study|Physician Decision|9
44964|NCT01273818|174502|P2|Overall Study|Physician Decision|2
44965|NCT01273818|174503|P1|Overall Study|Physician Decision|13
44966|NCT01273623|174522|P1|Overall Study|did not meet IVUS criteria|29
44967|NCT01273597|174529|P1|Overall Study|Reason Not Reported|1
44968|NCT01273597|174529|P1|Overall Study|Underwent Kidney Transplantation|2
44969|NCT01273597|174529|P1|Overall Study|Adverse Event|5
44970|NCT01273519|174544|P3|Overall Study|Not Specified|1
44971|NCT01273519|174545|P2|Overall Study|Not Specified|1
44972|NCT01273519|174546|P1|Overall Study|Not Specified|6
44973|NCT01273519|174544|P3|Overall Study|Lack of Efficacy|4
44974|NCT01273519|174545|P2|Overall Study|Lack of Efficacy|3
44975|NCT01273519|174546|P1|Overall Study|Lack of Efficacy|8
44976|NCT01273519|174544|P3|Overall Study|Lost to Follow-up|3
44977|NCT01273519|174545|P2|Overall Study|Lost to Follow-up|1
44978|NCT01273519|174546|P1|Overall Study|Lost to Follow-up|2
44979|NCT01273519|174544|P3|Overall Study|Adverse Event|0
44980|NCT01273519|174545|P2|Overall Study|Adverse Event|0
44981|NCT01273519|174546|P1|Overall Study|Adverse Event|3
44982|NCT01273181|174583|P4|Phase 2, Dose 2|Death during treatment|1
44983|NCT01273181|174584|P3|Phase 2, Dose 2|Death during treatment|0
44984|NCT01273181|174585|P2|Phase 2, Dose 2|Death during treatment|0
44985|NCT01273181|174586|P1|Phase 2, Dose 2|Death during treatment|0
44986|NCT01273181|174583|P4|Phase 2, Dose 1|Study termination|0
44987|NCT01273181|174584|P3|Phase 2, Dose 1|Study termination|1
44988|NCT01273181|174585|P2|Phase 2, Dose 1|Study termination|0
44989|NCT01273181|174586|P1|Phase 2, Dose 1|Study termination|0
44990|NCT01273181|174583|P4|Phase I, Dose 2|Death during treatment|0
44991|NCT01273181|174584|P3|Phase I, Dose 2|Death during treatment|0
44992|NCT01273181|174585|P2|Phase I, Dose 2|Death during treatment|1
44993|NCT01273181|174586|P1|Phase I, Dose 2|Death during treatment|0
44994|NCT01273181|174583|P4|Phase I, Dose 1|Study termination|0
44995|NCT01273181|174584|P3|Phase I, Dose 1|Study termination|0
44996|NCT01273181|174585|P2|Phase I, Dose 1|Study termination|0
44997|NCT01273181|174586|P1|Phase I, Dose 1|Study termination|1
44998|NCT01273064|174605|P5|Overall Study|Physician Decision|1
44999|NCT01273064|174606|P4|Overall Study|Physician Decision|0
45000|NCT01273064|174607|P3|Overall Study|Physician Decision|0
45001|NCT01273064|174608|P2|Overall Study|Physician Decision|0
45002|NCT01273064|174609|P1|Overall Study|Physician Decision|0
45003|NCT01273064|174605|P5|Overall Study|Lost to Follow-up|0
45004|NCT01273064|174606|P4|Overall Study|Lost to Follow-up|0
45005|NCT01273064|174607|P3|Overall Study|Lost to Follow-up|0
45006|NCT01273064|174608|P2|Overall Study|Lost to Follow-up|0
45007|NCT01273064|174609|P1|Overall Study|Lost to Follow-up|1
45008|NCT01273064|174605|P5|Overall Study|Study Termination|8
45009|NCT01273064|174606|P4|Overall Study|Study Termination|16
45010|NCT01273064|174607|P3|Overall Study|Study Termination|26
45011|NCT01273064|174608|P2|Overall Study|Study Termination|27
45012|NCT01273064|174609|P1|Overall Study|Study Termination|13
45013|NCT01273064|174605|P5|Overall Study|Withdrawal by Subject|0
45014|NCT01273064|174606|P4|Overall Study|Withdrawal by Subject|2
45015|NCT01273064|174607|P3|Overall Study|Withdrawal by Subject|2
45016|NCT01273064|174608|P2|Overall Study|Withdrawal by Subject|2
45017|NCT01273064|174609|P1|Overall Study|Withdrawal by Subject|4
45018|NCT01273064|174605|P5|Overall Study|Adverse Event|1
45019|NCT01273064|174606|P4|Overall Study|Adverse Event|2
45020|NCT01273064|174607|P3|Overall Study|Adverse Event|3
45021|NCT01273064|174608|P2|Overall Study|Adverse Event|1
45022|NCT01273064|174609|P1|Overall Study|Adverse Event|5
45023|NCT01273038|174628|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
45024|NCT01273038|174629|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
45025|NCT01273038|174628|P2|Second Intervention (14 Days)|Adverse Event|1
45026|NCT01273038|174629|P1|Second Intervention (14 Days)|Adverse Event|0
45027|NCT01272947|174637|P2|Overall Study|Abnormal Laboratory Value|2
45028|NCT01272947|174638|P1|Overall Study|Abnormal Laboratory Value|2
45029|NCT01272934|174648|P2|Overall Study|Abnormal Laboratory Value|1
45030|NCT01272934|174649|P1|Overall Study|Abnormal Laboratory Value|0
45031|NCT01272934|174648|P2|Overall Study|Adverse Event|1
45032|NCT01272934|174649|P1|Overall Study|Adverse Event|0
45033|NCT01272921|174659|P2|Overall Study|Protocol Violation|1
45034|NCT01272921|174660|P1|Overall Study|Protocol Violation|2
45035|NCT01272908|174668|P1|Re-Treatment Period|Withdrawal by Subject|1
45036|NCT01272908|174668|P1|Re-Treatment Period|Lack of Efficacy|3
45037|NCT01272908|174668|P1|Re-Treatment Period|Adverse Event|2
45038|NCT01272908|174668|P1|Initial Treatment Period|Withdrawal by Subject|1
45039|NCT01272908|174668|P1|Initial Treatment Period|Protocol Violation|1
45040|NCT01272908|174668|P1|Initial Treatment Period|Lack of Efficacy|5
45041|NCT01272908|174668|P1|Initial Treatment Period|Adverse Event|1
45042|NCT01272869|174708|P2|Period 2 (14 Days)|Adverse Event|0
45043|NCT01272869|174709|P1|Period 2 (14 Days)|Adverse Event|1
45044|NCT01272804|174721|P6|Overall Study|Adverse Event|1
45045|NCT01272804|174722|P5|Overall Study|Adverse Event|2
45046|NCT01272804|174723|P4|Overall Study|Adverse Event|0
45047|NCT01272804|174724|P3|Overall Study|Adverse Event|0
45048|NCT01272804|174725|P2|Overall Study|Adverse Event|0
45049|NCT01272804|174726|P1|Overall Study|Adverse Event|1
45050|NCT01272661|174884|P3|Overall Study|lost to followup/case closed/ no birth|72
45051|NCT01272661|174885|P2|Overall Study|lost to followup/case closed/ no birth|209
45052|NCT01272661|174886|P1|Overall Study|lost to followup/case closed/ no birth|126
45053|NCT01272635|174911|P4|Overall Study|Lost to Follow-up|23
45054|NCT01272635|174912|P3|Overall Study|Lost to Follow-up|31
45055|NCT01272635|174913|P2|Overall Study|Lost to Follow-up|20
45056|NCT01272635|174914|P1|Overall Study|Lost to Follow-up|31
45057|NCT01272232|174979|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
45058|NCT01272232|174980|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
45059|NCT01272232|174981|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
45060|NCT01272232|174979|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
45061|NCT01272232|174980|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
45062|NCT01272232|174981|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
45063|NCT01272232|174979|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
45064|NCT01272232|174980|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
45065|NCT01272232|174981|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
45066|NCT01272232|174979|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
45067|NCT01272232|174980|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
45068|NCT01272232|174981|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
45069|NCT01272232|174979|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
45070|NCT01272232|174980|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
45071|NCT01272232|174981|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
45072|NCT01272232|174979|P3|Weeks 0-56|Unclassified|12
45073|NCT01272232|174980|P2|Weeks 0-56|Unclassified|7
45074|NCT01272232|174981|P1|Weeks 0-56|Unclassified|16
45075|NCT01272232|174979|P3|Weeks 0-56|Withdrawal criteria|37
45076|NCT01272232|174980|P2|Weeks 0-56|Withdrawal criteria|14
45077|NCT01272232|174981|P1|Weeks 0-56|Withdrawal criteria|32
45078|NCT01272232|174979|P3|Weeks 0-56|Protocol Violation|13
45079|NCT01272232|174980|P2|Weeks 0-56|Protocol Violation|8
45080|NCT01272232|174981|P1|Weeks 0-56|Protocol Violation|12
45081|NCT01272232|174979|P3|Weeks 0-56|Lack of Efficacy|3
45082|NCT01272232|174980|P2|Weeks 0-56|Lack of Efficacy|0
45083|NCT01272232|174981|P1|Weeks 0-56|Lack of Efficacy|0
45084|NCT01272232|174979|P3|Weeks 0-56|Adverse Event|7
45085|NCT01272232|174980|P2|Weeks 0-56|Adverse Event|18
45086|NCT01272232|174981|P1|Weeks 0-56|Adverse Event|39
45087|NCT01272219|175026|P6|Main + Extension Period: Week 0-172|Unclassified|51
45088|NCT01272219|175027|P5|Main + Extension Period: Week 0-172|Unclassified|61
45089|NCT01272219|175028|P4|Main + Extension Period: Week 0-172|Unclassified|0
45090|NCT01272219|175029|P3|Main + Extension Period: Week 0-172|Unclassified|0
45091|NCT01272219|175030|P2|Main + Extension Period: Week 0-172|Unclassified|0
45092|NCT01272219|175031|P1|Main + Extension Period: Week 0-172|Unclassified|0
45093|NCT01272219|175026|P6|Main + Extension Period: Week 0-172|Missing reason|0
45094|NCT01272219|175027|P5|Main + Extension Period: Week 0-172|Missing reason|1
45095|NCT01272219|175028|P4|Main + Extension Period: Week 0-172|Missing reason|0
45096|NCT01272219|175029|P3|Main + Extension Period: Week 0-172|Missing reason|0
45097|NCT01272219|175030|P2|Main + Extension Period: Week 0-172|Missing reason|0
45098|NCT01272219|175031|P1|Main + Extension Period: Week 0-172|Missing reason|0
45099|NCT01272219|175026|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
45100|NCT01272219|175027|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
45101|NCT01272219|175028|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
45102|NCT01272219|175029|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
45103|NCT01272219|175030|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
45104|NCT01272219|175031|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
45105|NCT01272219|175026|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
45106|NCT01272219|175027|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
45107|NCT01272219|175028|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
45108|NCT01272219|175029|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
45109|NCT01272219|175030|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
45110|NCT01272219|175031|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
45111|NCT01272219|175026|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
45112|NCT01272219|175027|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
45113|NCT01272219|175028|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
45114|NCT01272219|175029|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
45115|NCT01272219|175030|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
45116|NCT01272219|175031|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
45117|NCT01272219|175026|P6|Main + Extension Period: Week 0-172|Adverse Event|43
45118|NCT01272219|175027|P5|Main + Extension Period: Week 0-172|Adverse Event|191
45119|NCT01272219|175028|P4|Main + Extension Period: Week 0-172|Adverse Event|0
45120|NCT01272219|175029|P3|Main + Extension Period: Week 0-172|Adverse Event|0
45121|NCT01272219|175030|P2|Main + Extension Period: Week 0-172|Adverse Event|0
45122|NCT01272219|175031|P1|Main + Extension Period: Week 0-172|Adverse Event|0
45123|NCT01272219|175026|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
45124|NCT01272219|175027|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
45125|NCT01272219|175028|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
45126|NCT01272219|175029|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
45127|NCT01272219|175030|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
45128|NCT01272219|175031|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
45129|NCT01272219|175026|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
45130|NCT01272219|175027|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
45131|NCT01272219|175028|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
45132|NCT01272219|175029|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
45133|NCT01272219|175030|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
45134|NCT01272219|175031|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
45135|NCT01272219|175026|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
45136|NCT01272219|175027|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
45137|NCT01272219|175028|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
45138|NCT01272219|175029|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
45139|NCT01272219|175030|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
45140|NCT01272219|175031|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
45141|NCT01272219|175026|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
45142|NCT01272219|175027|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
45143|NCT01272219|175028|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
45144|NCT01272219|175029|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
45145|NCT01272219|175030|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
45146|NCT01272219|175031|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
45147|NCT01272219|175026|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
45148|NCT01272219|175027|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
45149|NCT01272219|175028|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
45150|NCT01272219|175029|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
45151|NCT01272219|175030|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
45152|NCT01272219|175031|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
45153|NCT01272219|175026|P6|Main Period: Week 0 to Week 56|Unclassified|34
45154|NCT01272219|175027|P5|Main Period: Week 0 to Week 56|Unclassified|42
45155|NCT01272219|175028|P4|Main Period: Week 0 to Week 56|Unclassified|29
45156|NCT01272219|175029|P3|Main Period: Week 0 to Week 56|Unclassified|0
45157|NCT01272219|175030|P2|Main Period: Week 0 to Week 56|Unclassified|0
45158|NCT01272219|175031|P1|Main Period: Week 0 to Week 56|Unclassified|36
45159|NCT01272219|175026|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
45160|NCT01272219|175027|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
45161|NCT01272219|175028|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
45162|NCT01272219|175029|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
45163|NCT01272219|175030|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
45164|NCT01272219|175031|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
45165|NCT01272219|175026|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
45166|NCT01272219|175027|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
45167|NCT01272219|175028|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
45168|NCT01272219|175029|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
45169|NCT01272219|175030|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
45170|NCT01272219|175031|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
45171|NCT01272219|175026|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
45172|NCT01272219|175027|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
45173|NCT01272219|175028|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
45174|NCT01272219|175029|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
45175|NCT01272219|175030|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
45176|NCT01272219|175031|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
45177|NCT01272219|175026|P6|Main Period: Week 0 to Week 56|Adverse Event|29
45178|NCT01272219|175027|P5|Main Period: Week 0 to Week 56|Adverse Event|152
45179|NCT01272219|175028|P4|Main Period: Week 0 to Week 56|Adverse Event|16
45180|NCT01272219|175029|P3|Main Period: Week 0 to Week 56|Adverse Event|0
45181|NCT01272219|175030|P2|Main Period: Week 0 to Week 56|Adverse Event|0
45182|NCT01272219|175031|P1|Main Period: Week 0 to Week 56|Adverse Event|86
45183|NCT01272193|175065|P2|Overall Study|Unclassified|7
45184|NCT01272193|175066|P1|Overall Study|Unclassified|8
45185|NCT01272193|175065|P2|Overall Study|Withdrawal Criteria|1
45186|NCT01272193|175066|P1|Overall Study|Withdrawal Criteria|1
45187|NCT01272193|175065|P2|Overall Study|Lack of Efficacy|3
45188|NCT01272193|175066|P1|Overall Study|Lack of Efficacy|0
45189|NCT01272193|175065|P2|Overall Study|Adverse Event|1
45190|NCT01272193|175066|P1|Overall Study|Adverse Event|1
45191|NCT01272180|175086|P4|Overall Study|Protocol Violation|1
45192|NCT01272180|175087|P3|Overall Study|Protocol Violation|0
45193|NCT01272180|175088|P2|Overall Study|Protocol Violation|1
45194|NCT01272180|175089|P1|Overall Study|Protocol Violation|0
45195|NCT01272180|175086|P4|Overall Study|Inappropriate enrollment|1
45196|NCT01272180|175087|P3|Overall Study|Inappropriate enrollment|1
45197|NCT01272180|175088|P2|Overall Study|Inappropriate enrollment|0
45198|NCT01272180|175089|P1|Overall Study|Inappropriate enrollment|0
45199|NCT01272180|175086|P4|Overall Study|Lost to Follow-up|10
45200|NCT01272180|175087|P3|Overall Study|Lost to Follow-up|8
45201|NCT01272180|175088|P2|Overall Study|Lost to Follow-up|14
45202|NCT01272180|175089|P1|Overall Study|Lost to Follow-up|15
45203|NCT01272180|175086|P4|Overall Study|Withdrawal by Subject|2
45204|NCT01272180|175087|P3|Overall Study|Withdrawal by Subject|3
45205|NCT01272180|175088|P2|Overall Study|Withdrawal by Subject|6
45206|NCT01272180|175089|P1|Overall Study|Withdrawal by Subject|2
45207|NCT01272180|175086|P4|Overall Study|Adverse Event|0
45208|NCT01272180|175087|P3|Overall Study|Adverse Event|1
45209|NCT01272180|175088|P2|Overall Study|Adverse Event|0
45210|NCT01272180|175089|P1|Overall Study|Adverse Event|0
45211|NCT01272011|175138|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
45212|NCT01272011|175139|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
45213|NCT01272011|175140|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
45214|NCT01271803|175204|P12|Stage 2|Ongoing in the Study|14
45215|NCT01271803|175205|P11|Stage 2|Ongoing in the Study|6
45216|NCT01271803|175206|P10|Stage 2|Ongoing in the Study|0
45217|NCT01271803|175207|P9|Stage 2|Ongoing in the Study|0
45218|NCT01271803|175208|P8|Stage 2|Ongoing in the Study|0
45219|NCT01271803|175209|P7|Stage 2|Ongoing in the Study|0
45220|NCT01271803|175210|P6|Stage 2|Ongoing in the Study|0
45221|NCT01271803|175211|P5|Stage 2|Ongoing in the Study|0
45222|NCT01271803|175212|P4|Stage 2|Ongoing in the Study|0
45223|NCT01271803|175213|P3|Stage 2|Ongoing in the Study|0
45224|NCT01271803|175214|P2|Stage 2|Ongoing in the Study|0
45225|NCT01271803|175215|P1|Stage 2|Ongoing in the Study|0
45226|NCT01271803|175204|P12|Stage 2|Unspecified|0
45227|NCT01271803|175205|P11|Stage 2|Unspecified|1
45228|NCT01271803|175206|P10|Stage 2|Unspecified|0
45229|NCT01271803|175207|P9|Stage 2|Unspecified|0
45230|NCT01271803|175208|P8|Stage 2|Unspecified|0
45231|NCT01271803|175209|P7|Stage 2|Unspecified|0
45232|NCT01271803|175210|P6|Stage 2|Unspecified|0
45233|NCT01271803|175211|P5|Stage 2|Unspecified|0
45234|NCT01271803|175212|P4|Stage 2|Unspecified|0
45235|NCT01271803|175213|P3|Stage 2|Unspecified|0
45236|NCT01271803|175214|P2|Stage 2|Unspecified|0
45237|NCT01271803|175215|P1|Stage 2|Unspecified|0
45238|NCT01271803|175204|P12|Stage 2|Physician Decision|1
45239|NCT01271803|175205|P11|Stage 2|Physician Decision|0
45240|NCT01271803|175206|P10|Stage 2|Physician Decision|0
45241|NCT01271803|175207|P9|Stage 2|Physician Decision|0
45242|NCT01271803|175208|P8|Stage 2|Physician Decision|0
45243|NCT01271803|175209|P7|Stage 2|Physician Decision|0
45244|NCT01271803|175210|P6|Stage 2|Physician Decision|0
45245|NCT01271803|175211|P5|Stage 2|Physician Decision|0
45246|NCT01271803|175212|P4|Stage 2|Physician Decision|0
45247|NCT01271803|175213|P3|Stage 2|Physician Decision|0
45248|NCT01271803|175214|P2|Stage 2|Physician Decision|0
45249|NCT01271803|175215|P1|Stage 2|Physician Decision|0
45250|NCT01271803|175204|P12|Stage 2|Withdrawal by Subject|2
45251|NCT01271803|175205|P11|Stage 2|Withdrawal by Subject|0
45252|NCT01271803|175206|P10|Stage 2|Withdrawal by Subject|0
45253|NCT01271803|175207|P9|Stage 2|Withdrawal by Subject|0
45254|NCT01271803|175208|P8|Stage 2|Withdrawal by Subject|0
45255|NCT01271803|175209|P7|Stage 2|Withdrawal by Subject|0
45256|NCT01271803|175210|P6|Stage 2|Withdrawal by Subject|0
45257|NCT01271803|175211|P5|Stage 2|Withdrawal by Subject|0
45258|NCT01271803|175212|P4|Stage 2|Withdrawal by Subject|0
45259|NCT01271803|175213|P3|Stage 2|Withdrawal by Subject|0
45260|NCT01271803|175214|P2|Stage 2|Withdrawal by Subject|0
45261|NCT01271803|175215|P1|Stage 2|Withdrawal by Subject|0
45262|NCT01271803|175204|P12|Stage 2|Death|2
45263|NCT01271803|175205|P11|Stage 2|Death|2
45264|NCT01271803|175206|P10|Stage 2|Death|0
45265|NCT01271803|175207|P9|Stage 2|Death|0
45266|NCT01271803|175208|P8|Stage 2|Death|0
45267|NCT01271803|175209|P7|Stage 2|Death|0
45268|NCT01271803|175210|P6|Stage 2|Death|0
45269|NCT01271803|175211|P5|Stage 2|Death|0
45270|NCT01271803|175212|P4|Stage 2|Death|0
45271|NCT01271803|175213|P3|Stage 2|Death|0
45272|NCT01271803|175214|P2|Stage 2|Death|0
45273|NCT01271803|175215|P1|Stage 2|Death|0
45274|NCT01271803|175204|P12|Stage 2|Adverse Event|3
45275|NCT01271803|175205|P11|Stage 2|Adverse Event|1
45276|NCT01271803|175206|P10|Stage 2|Adverse Event|0
45277|NCT01271803|175207|P9|Stage 2|Adverse Event|0
45278|NCT01271803|175208|P8|Stage 2|Adverse Event|0
45279|NCT01271803|175209|P7|Stage 2|Adverse Event|0
45280|NCT01271803|175210|P6|Stage 2|Adverse Event|0
45281|NCT01271803|175211|P5|Stage 2|Adverse Event|0
45282|NCT01271803|175212|P4|Stage 2|Adverse Event|0
45283|NCT01271803|175213|P3|Stage 2|Adverse Event|0
45284|NCT01271803|175214|P2|Stage 2|Adverse Event|0
45285|NCT01271803|175215|P1|Stage 2|Adverse Event|0
45286|NCT01271803|175204|P12|Stage 2|Progressive disease|17
45287|NCT01271803|175205|P11|Stage 2|Progressive disease|17
45288|NCT01271803|175206|P10|Stage 2|Progressive disease|0
45289|NCT01271803|175207|P9|Stage 2|Progressive disease|0
45290|NCT01271803|175208|P8|Stage 2|Progressive disease|0
45291|NCT01271803|175209|P7|Stage 2|Progressive disease|0
45292|NCT01271803|175210|P6|Stage 2|Progressive disease|0
45293|NCT01271803|175211|P5|Stage 2|Progressive disease|0
45294|NCT01271803|175212|P4|Stage 2|Progressive disease|0
45295|NCT01271803|175213|P3|Stage 2|Progressive disease|0
45296|NCT01271803|175214|P2|Stage 2|Progressive disease|0
45297|NCT01271803|175215|P1|Stage 2|Progressive disease|0
45298|NCT01271803|175204|P12|Stage 1|Ongoing in the Study|0
45299|NCT01271803|175205|P11|Stage 1|Ongoing in the Study|0
45300|NCT01271803|175206|P10|Stage 1|Ongoing in the Study|0
45301|NCT01271803|175207|P9|Stage 1|Ongoing in the Study|1
45302|NCT01271803|175208|P8|Stage 1|Ongoing in the Study|1
45303|NCT01271803|175209|P7|Stage 1|Ongoing in the Study|1
45304|NCT01271803|175210|P6|Stage 1|Ongoing in the Study|0
45305|NCT01271803|175211|P5|Stage 1|Ongoing in the Study|3
45306|NCT01271803|175212|P4|Stage 1|Ongoing in the Study|1
45307|NCT01271803|175213|P3|Stage 1|Ongoing in the Study|11
45308|NCT01271803|175214|P2|Stage 1|Ongoing in the Study|1
45309|NCT01271803|175215|P1|Stage 1|Ongoing in the Study|0
45310|NCT01271803|175204|P12|Stage 1|Unspecified|0
45311|NCT01271803|175205|P11|Stage 1|Unspecified|0
45312|NCT01271803|175206|P10|Stage 1|Unspecified|0
45313|NCT01271803|175207|P9|Stage 1|Unspecified|0
45314|NCT01271803|175208|P8|Stage 1|Unspecified|0
45315|NCT01271803|175209|P7|Stage 1|Unspecified|0
45316|NCT01271803|175210|P6|Stage 1|Unspecified|0
45317|NCT01271803|175211|P5|Stage 1|Unspecified|0
45318|NCT01271803|175212|P4|Stage 1|Unspecified|0
45319|NCT01271803|175213|P3|Stage 1|Unspecified|2
45320|NCT01271803|175214|P2|Stage 1|Unspecified|0
45321|NCT01271803|175215|P1|Stage 1|Unspecified|0
45322|NCT01271803|175204|P12|Stage 1|Withdrawal by Subject|0
45323|NCT01271803|175205|P11|Stage 1|Withdrawal by Subject|0
45324|NCT01271803|175206|P10|Stage 1|Withdrawal by Subject|0
45325|NCT01271803|175207|P9|Stage 1|Withdrawal by Subject|0
45326|NCT01271803|175208|P8|Stage 1|Withdrawal by Subject|0
45327|NCT01271803|175209|P7|Stage 1|Withdrawal by Subject|0
45328|NCT01271803|175210|P6|Stage 1|Withdrawal by Subject|0
45329|NCT01271803|175211|P5|Stage 1|Withdrawal by Subject|0
45330|NCT01271803|175212|P4|Stage 1|Withdrawal by Subject|0
45331|NCT01271803|175213|P3|Stage 1|Withdrawal by Subject|1
45332|NCT01271803|175214|P2|Stage 1|Withdrawal by Subject|0
45333|NCT01271803|175215|P1|Stage 1|Withdrawal by Subject|0
45334|NCT01271803|175204|P12|Stage 1|Physician Decision|0
45335|NCT01271803|175205|P11|Stage 1|Physician Decision|0
45336|NCT01271803|175206|P10|Stage 1|Physician Decision|0
45337|NCT01271803|175207|P9|Stage 1|Physician Decision|0
45338|NCT01271803|175208|P8|Stage 1|Physician Decision|0
45339|NCT01271803|175209|P7|Stage 1|Physician Decision|1
45340|NCT01271803|175210|P6|Stage 1|Physician Decision|0
45341|NCT01271803|175211|P5|Stage 1|Physician Decision|0
45342|NCT01271803|175212|P4|Stage 1|Physician Decision|0
45343|NCT01271803|175213|P3|Stage 1|Physician Decision|0
45344|NCT01271803|175214|P2|Stage 1|Physician Decision|0
45345|NCT01271803|175215|P1|Stage 1|Physician Decision|1
45346|NCT01271803|175204|P12|Stage 1|Death|0
45347|NCT01271803|175205|P11|Stage 1|Death|0
45348|NCT01271803|175206|P10|Stage 1|Death|0
45349|NCT01271803|175207|P9|Stage 1|Death|0
45350|NCT01271803|175208|P8|Stage 1|Death|0
45351|NCT01271803|175209|P7|Stage 1|Death|0
45352|NCT01271803|175210|P6|Stage 1|Death|1
45353|NCT01271803|175211|P5|Stage 1|Death|0
45354|NCT01271803|175212|P4|Stage 1|Death|0
45355|NCT01271803|175213|P3|Stage 1|Death|0
45356|NCT01271803|175214|P2|Stage 1|Death|0
45357|NCT01271803|175215|P1|Stage 1|Death|1
45358|NCT01271803|175204|P12|Stage 1|Adverse Event|0
45359|NCT01271803|175205|P11|Stage 1|Adverse Event|0
45360|NCT01271803|175206|P10|Stage 1|Adverse Event|0
45361|NCT01271803|175207|P9|Stage 1|Adverse Event|0
45362|NCT01271803|175208|P8|Stage 1|Adverse Event|0
45363|NCT01271803|175209|P7|Stage 1|Adverse Event|0
45364|NCT01271803|175210|P6|Stage 1|Adverse Event|0
45365|NCT01271803|175211|P5|Stage 1|Adverse Event|0
45366|NCT01271803|175212|P4|Stage 1|Adverse Event|0
45367|NCT01271803|175213|P3|Stage 1|Adverse Event|1
45368|NCT01271803|175214|P2|Stage 1|Adverse Event|0
45369|NCT01271803|175215|P1|Stage 1|Adverse Event|0
45370|NCT01271803|175204|P12|Stage 1|Progressive disease|0
45371|NCT01271803|175205|P11|Stage 1|Progressive disease|0
45372|NCT01271803|175206|P10|Stage 1|Progressive disease|2
45373|NCT01271803|175207|P9|Stage 1|Progressive disease|4
45374|NCT01271803|175208|P8|Stage 1|Progressive disease|2
45375|NCT01271803|175209|P7|Stage 1|Progressive disease|2
45376|NCT01271803|175210|P6|Stage 1|Progressive disease|3
45377|NCT01271803|175211|P5|Stage 1|Progressive disease|1
45378|NCT01271803|175212|P4|Stage 1|Progressive disease|2
45379|NCT01271803|175213|P3|Stage 1|Progressive disease|12
45380|NCT01271803|175214|P2|Stage 1|Progressive disease|7
45381|NCT01271803|175215|P1|Stage 1|Progressive disease|3
45382|NCT01271712|175388|P2|Survival Follow-up|Ongoing with open-label treatment|1
45383|NCT01271712|175389|P1|Survival Follow-up|Ongoing with open-label treatment|14
45384|NCT01271712|175388|P2|Survival Follow-up|Death|3
45385|NCT01271712|175389|P1|Survival Follow-up|Death|13
45386|NCT01271712|175388|P2|Safety Follow-up|Ongoing with open-label treatment|0
45387|NCT01271712|175389|P1|Safety Follow-up|Ongoing with open-label treatment|3
45388|NCT01271712|175388|P2|Safety Follow-up|Protocol Violation|0
45389|NCT01271712|175389|P1|Safety Follow-up|Protocol Violation|1
45390|NCT01271712|175388|P2|Safety Follow-up|Withdrawal by Subject|1
45391|NCT01271712|175389|P1|Safety Follow-up|Withdrawal by Subject|1
45392|NCT01271712|175388|P2|Safety Follow-up|Death|2
45393|NCT01271712|175389|P1|Safety Follow-up|Death|4
45394|NCT01271712|175388|P2|Open Label Treatment|Ongoing with open-label treatment|33
45395|NCT01271712|175389|P1|Open Label Treatment|Ongoing with open-label treatment|24
45396|NCT01271712|175388|P2|Open Label Treatment|Progressive disease|13
45397|NCT01271712|175389|P1|Open Label Treatment|Progressive disease|12
45398|NCT01271712|175388|P2|Open Label Treatment|Adverse Event|4
45399|NCT01271712|175389|P1|Open Label Treatment|Adverse Event|2
45400|NCT01271712|175388|P2|Open Label Treatment|Physician Decision|0
45401|NCT01271712|175389|P1|Open Label Treatment|Physician Decision|2
45402|NCT01271712|175388|P2|Open Label Treatment|Withdrawal by Subject|5
45403|NCT01271712|175389|P1|Open Label Treatment|Withdrawal by Subject|0
45404|NCT01271712|175388|P2|Open Label Treatment|Death|1
45405|NCT01271712|175389|P1|Open Label Treatment|Death|1
45406|NCT01271712|175388|P2|Double Blind Treatment|receive no study drug|0
45407|NCT01271712|175389|P1|Double Blind Treatment|receive no study drug|1
45408|NCT01271712|175388|P2|Double Blind Treatment|Ongoing in double-blind treatment|3
45409|NCT01271712|175389|P1|Double Blind Treatment|Ongoing in double-blind treatment|53
45410|NCT01271712|175388|P2|Double Blind Treatment|Non compliance with study drug|0
45411|NCT01271712|175389|P1|Double Blind Treatment|Non compliance with study drug|2
45412|NCT01271712|175388|P2|Double Blind Treatment|Withdrawal by Subject|0
45413|NCT01271712|175389|P1|Double Blind Treatment|Withdrawal by Subject|4
45414|NCT01271712|175388|P2|Double Blind Treatment|Progressive disease|3
45415|NCT01271712|175389|P1|Double Blind Treatment|Progressive disease|21
45416|NCT01271712|175388|P2|Double Blind Treatment|Adverse Event|4
45417|NCT01271712|175389|P1|Double Blind Treatment|Adverse Event|8
45418|NCT01271712|175388|P2|Double Blind Treatment|Lack of Efficacy|0
45419|NCT01271712|175389|P1|Double Blind Treatment|Lack of Efficacy|1
45420|NCT01271712|175388|P2|Double Blind Treatment|Death|0
45421|NCT01271712|175389|P1|Double Blind Treatment|Death|2
45422|NCT01270971|175484|P2|Overall Study|Non-specific|3
45423|NCT01270971|175485|P1|Overall Study|Non-specific|7
45424|NCT01270971|175484|P2|Overall Study|Non compliance|2
45425|NCT01270971|175485|P1|Overall Study|Non compliance|2
45426|NCT01270971|175484|P2|Overall Study|Adverse Event|2
45427|NCT01270971|175485|P1|Overall Study|Adverse Event|1
45428|NCT01270971|175484|P2|Overall Study|Lost to Follow-up|5
45429|NCT01270971|175485|P1|Overall Study|Lost to Follow-up|18
45430|NCT01270971|175484|P2|Overall Study|Withdrawal by Subject|11
45431|NCT01270971|175485|P1|Overall Study|Withdrawal by Subject|24
45432|NCT01270958|175497|P1|Overall Study|Did not meet inclusion criteria for age|2
45433|NCT01270958|175497|P1|Overall Study|Lost to Follow-up|2
45434|NCT01270880|175526|P1|Overall Study|Never rec'd treatment, but registered.|1
45435|NCT01270841|175551|P4|Overall Study|Enrolled in error|0
45436|NCT01270841|175552|P3|Overall Study|Enrolled in error|0
45437|NCT01270841|175553|P2|Overall Study|Enrolled in error|1
45438|NCT01270841|175554|P1|Overall Study|Enrolled in error|0
45439|NCT01270841|175551|P4|Overall Study|Protocol Violation|0
45440|NCT01270841|175552|P3|Overall Study|Protocol Violation|0
45441|NCT01270841|175553|P2|Overall Study|Protocol Violation|5
45442|NCT01270841|175554|P1|Overall Study|Protocol Violation|1
45443|NCT01270841|175551|P4|Overall Study|Did not qualify|5
45444|NCT01270841|175552|P3|Overall Study|Did not qualify|4
45445|NCT01270841|175553|P2|Overall Study|Did not qualify|3
45446|NCT01270841|175554|P1|Overall Study|Did not qualify|6
45447|NCT01270841|175551|P4|Overall Study|Physician Decision|0
45448|NCT01270841|175552|P3|Overall Study|Physician Decision|0
45449|NCT01270841|175553|P2|Overall Study|Physician Decision|1
45450|NCT01270841|175554|P1|Overall Study|Physician Decision|0
45451|NCT01270841|175551|P4|Overall Study|Lost to Follow-up|2
45452|NCT01270841|175552|P3|Overall Study|Lost to Follow-up|4
45453|NCT01270841|175553|P2|Overall Study|Lost to Follow-up|1
45454|NCT01270841|175554|P1|Overall Study|Lost to Follow-up|3
45455|NCT01270841|175551|P4|Overall Study|Withdrawal by Subject|3
45456|NCT01270841|175552|P3|Overall Study|Withdrawal by Subject|3
45457|NCT01270841|175553|P2|Overall Study|Withdrawal by Subject|2
45458|NCT01270841|175554|P1|Overall Study|Withdrawal by Subject|3
45459|NCT01270841|175551|P4|Overall Study|Adverse Event|3
45460|NCT01270841|175552|P3|Overall Study|Adverse Event|0
45461|NCT01270841|175553|P2|Overall Study|Adverse Event|1
45462|NCT01270841|175554|P1|Overall Study|Adverse Event|0
45463|NCT01270828|175578|P3|Double Blind Phase|Adverse event related to study drug|0
45464|NCT01270828|175579|P2|Double Blind Phase|Adverse event related to study drug|7
45465|NCT01270828|175580|P1|Double Blind Phase|Adverse event related to study drug|5
45466|NCT01270828|175578|P3|Double Blind Phase|Adverse event not related to study drug|0
45467|NCT01270828|175579|P2|Double Blind Phase|Adverse event not related to study drug|1
45468|NCT01270828|175580|P1|Double Blind Phase|Adverse event not related to study drug|1
45469|NCT01270828|175578|P3|Double Blind Phase|Lack of Efficacy|0
45470|NCT01270828|175579|P2|Double Blind Phase|Lack of Efficacy|11
45471|NCT01270828|175580|P1|Double Blind Phase|Lack of Efficacy|2
45472|NCT01270828|175578|P3|Double Blind Phase|Lost to Follow-up|0
45473|NCT01270828|175579|P2|Double Blind Phase|Lost to Follow-up|2
45474|NCT01270828|175580|P1|Double Blind Phase|Lost to Follow-up|1
45475|NCT01270828|175578|P3|Double Blind Phase|Withdrawal by Subject|0
45476|NCT01270828|175579|P2|Double Blind Phase|Withdrawal by Subject|15
45477|NCT01270828|175580|P1|Double Blind Phase|Withdrawal by Subject|6
45478|NCT01270828|175578|P3|Double Blind Phase|Reason Unspecified|0
45479|NCT01270828|175579|P2|Double Blind Phase|Reason Unspecified|4
45480|NCT01270828|175580|P1|Double Blind Phase|Reason Unspecified|7
45481|NCT01270828|175578|P3|Double Blind Phase|Protocol and GCP non-compliance|0
45482|NCT01270828|175579|P2|Double Blind Phase|Protocol and GCP non-compliance|3
45483|NCT01270828|175580|P1|Double Blind Phase|Protocol and GCP non-compliance|4
45484|NCT01270828|175578|P3|Double Blind Phase|Protocol Violation|0
45485|NCT01270828|175579|P2|Double Blind Phase|Protocol Violation|1
45486|NCT01270828|175580|P1|Double Blind Phase|Protocol Violation|0
45487|NCT01270828|175578|P3|Double Blind Phase|Death|0
45488|NCT01270828|175579|P2|Double Blind Phase|Death|1
45489|NCT01270828|175580|P1|Double Blind Phase|Death|0
45490|NCT01270828|175578|P3|Pregabalin CR SB|Protocol Violation|8
45491|NCT01270828|175579|P2|Pregabalin CR SB|Protocol Violation|0
45492|NCT01270828|175580|P1|Pregabalin CR SB|Protocol Violation|0
45493|NCT01270828|175578|P3|Pregabalin CR SB|Unrelated AE|8
45494|NCT01270828|175579|P2|Pregabalin CR SB|Unrelated AE|0
45495|NCT01270828|175580|P1|Pregabalin CR SB|Unrelated AE|0
45496|NCT01270828|175578|P3|Pregabalin CR SB|Lost to Follow-up|10
45497|NCT01270828|175579|P2|Pregabalin CR SB|Lost to Follow-up|0
45498|NCT01270828|175580|P1|Pregabalin CR SB|Lost to Follow-up|0
45499|NCT01270828|175578|P3|Pregabalin CR SB|Withdrawal by Subject|29
45500|NCT01270828|175579|P2|Pregabalin CR SB|Withdrawal by Subject|0
45501|NCT01270828|175580|P1|Pregabalin CR SB|Withdrawal by Subject|0
45502|NCT01270828|175578|P3|Pregabalin CR SB|Lack of Efficacy|32
45503|NCT01270828|175579|P2|Pregabalin CR SB|Lack of Efficacy|0
45504|NCT01270828|175580|P1|Pregabalin CR SB|Lack of Efficacy|0
45505|NCT01270828|175578|P3|Pregabalin CR SB|Related adverse event|46
45506|NCT01270828|175579|P2|Pregabalin CR SB|Related adverse event|0
45507|NCT01270828|175580|P1|Pregabalin CR SB|Related adverse event|0
45508|NCT01270828|175578|P3|Pregabalin CR SB|Enrolled but not treated|5
45509|NCT01270828|175579|P2|Pregabalin CR SB|Enrolled but not treated|0
45510|NCT01270828|175580|P1|Pregabalin CR SB|Enrolled but not treated|0
45511|NCT01270828|175578|P3|Pregabalin CR SB|Reason Unspecified|8
45512|NCT01270828|175579|P2|Pregabalin CR SB|Reason Unspecified|0
45513|NCT01270828|175580|P1|Pregabalin CR SB|Reason Unspecified|0
45514|NCT01270802|175622|P2|Overall Study|Lost to Follow-up|1
45515|NCT01270802|175623|P1|Overall Study|Lost to Follow-up|0
45516|NCT01270802|175622|P2|Overall Study|Adverse Event|0
45517|NCT01270802|175623|P1|Overall Study|Adverse Event|1
45518|NCT01270802|175622|P2|Overall Study|Withdrawal by Subject|0
45519|NCT01270802|175623|P1|Overall Study|Withdrawal by Subject|1
45520|NCT01270620|175745|P2|Overall Study|Withdrawal by Subject|3
45521|NCT01270620|175746|P1|Overall Study|Withdrawal by Subject|1
45522|NCT01270503|175828|P1|Overall Study|Lost to Follow-up|1
45523|NCT01270464|175836|P3|Overall Study|Not Specified|3
45524|NCT01270464|175837|P2|Overall Study|Not Specified|1
45525|NCT01270464|175838|P1|Overall Study|Not Specified|1
45526|NCT01270464|175836|P3|Overall Study|Lost to Follow-up|1
45527|NCT01270464|175837|P2|Overall Study|Lost to Follow-up|3
45528|NCT01270464|175838|P1|Overall Study|Lost to Follow-up|2
45529|NCT01270464|175836|P3|Overall Study|Withdrawal by Subject|4
45530|NCT01270464|175837|P2|Overall Study|Withdrawal by Subject|1
45531|NCT01270464|175838|P1|Overall Study|Withdrawal by Subject|2
45532|NCT01270464|175836|P3|Overall Study|Adverse Event|7
45533|NCT01270464|175837|P2|Overall Study|Adverse Event|1
45534|NCT01270464|175838|P1|Overall Study|Adverse Event|9
45535|NCT01270464|175836|P3|Overall Study|Lack of Efficacy|1
45536|NCT01270464|175837|P2|Overall Study|Lack of Efficacy|3
45537|NCT01270464|175838|P1|Overall Study|Lack of Efficacy|2
45538|NCT01270464|175836|P3|Overall Study|Protocol Violation|2
45539|NCT01270464|175837|P2|Overall Study|Protocol Violation|3
45540|NCT01270464|175838|P1|Overall Study|Protocol Violation|4
45541|NCT01270256|175887|P2|Overall Study|Withdrawal by Subject|0
45542|NCT01270256|175888|P1|Overall Study|Withdrawal by Subject|1
45543|NCT01270139|175897|P3|Overall Study|Lost to Follow-up|2
45544|NCT01270139|175898|P2|Overall Study|Lost to Follow-up|9
45545|NCT01270139|175899|P1|Overall Study|Lost to Follow-up|10
45546|NCT01270139|175897|P3|Overall Study|Adverse Event|18
45547|NCT01270139|175898|P2|Overall Study|Adverse Event|17
45548|NCT01270139|175899|P1|Overall Study|Adverse Event|8
45549|NCT01269918|175951|P2|Overall Study|Did not receive study drug|3
45550|NCT01269918|175952|P1|Overall Study|Did not receive study drug|0
45551|NCT01269125|176004|P3|Overall Study|Lost to Follow-up|0
45552|NCT01269125|176005|P2|Overall Study|Lost to Follow-up|0
45553|NCT01269125|176006|P1|Overall Study|Lost to Follow-up|4
45554|NCT01269125|176004|P3|Overall Study|Adverse Event|0
45555|NCT01269125|176005|P2|Overall Study|Adverse Event|5
45556|NCT01269125|176006|P1|Overall Study|Adverse Event|3
45557|NCT01268891|176045|P2|Overall Study|Administrative or other reason(s)|0
45558|NCT01268891|176046|P1|Overall Study|Administrative or other reason(s)|1
45559|NCT01268891|176045|P2|Overall Study|Withdrawal of Consent|1
45560|NCT01268891|176046|P1|Overall Study|Withdrawal of Consent|3
45561|NCT01268891|176045|P2|Overall Study|Lack of Efficacy|0
45562|NCT01268891|176046|P1|Overall Study|Lack of Efficacy|1
45563|NCT01268891|176045|P2|Overall Study|Adverse Event|7
45564|NCT01268891|176046|P1|Overall Study|Adverse Event|3
45565|NCT01268501|176065|P1|Overall Study|Handling Difficulties|2
45566|NCT01268501|176065|P1|Overall Study|Unacceptable Subjective Vision|3
45567|NCT01268501|176065|P1|Overall Study|Withdrawal by Subject|3
45568|NCT01268501|176065|P1|Overall Study|Lost to Follow-up|1
45569|NCT01268488|176069|P1|Overall Study|Physician Decision|2
45570|NCT01268488|176069|P1|Overall Study|Adverse Event|3
45571|NCT01268306|176076|P1|Overall Study|Lost to Follow-up|1
45572|NCT01268293|176080|P1|Overall Study|Subject choice|1
45573|NCT01268293|176080|P1|Overall Study|Adverse Event|1
45574|NCT01268293|176080|P1|Overall Study|Disease progression|7
45575|NCT01268267|176085|P1|Overall Study|Protocol Violation|1
45576|NCT01268150|176106|P1|Extension Phase|Not specified|6
45577|NCT01268150|176106|P1|Extension Phase|Disease progression|18
45578|NCT01268150|176106|P1|Extension Phase|Adverse Event|3
45579|NCT01268150|176106|P1|Treatment Phase|Not specified|4
45580|NCT01268150|176106|P1|Treatment Phase|Withdrawal by Subject|3
45581|NCT01268150|176106|P1|Treatment Phase|Adverse Event|3
45582|NCT01268150|176106|P1|Treatment Phase|Progression of disease|18
45583|NCT01268098|176125|P2|Overall Study|Adverse Event|0
45584|NCT01268098|176126|P1|Overall Study|Adverse Event|1
45585|NCT01267994|176134|P1|Overall Study|Adverse Event|2
45586|NCT01267266|176166|P2|Lead-in Phase|Withdrawal by Subject|0
45587|NCT01267266|176167|P1|Lead-in Phase|Withdrawal by Subject|1
45588|NCT01267266|176166|P2|Lead-in Phase|Adverse Event|0
45589|NCT01267266|176167|P1|Lead-in Phase|Adverse Event|2
45590|NCT01267266|176166|P2|Lead-in Phase|Lack of Efficacy|0
45591|NCT01267266|176167|P1|Lead-in Phase|Lack of Efficacy|20
45592|NCT01267266|176166|P2|Enrollment Phase|Withdrawal by Subject|0
45593|NCT01267266|176167|P1|Enrollment Phase|Withdrawal by Subject|2
45594|NCT01267253|176180|P1|Overall Study|Inevaluable-never received study treatme|2
45595|NCT01267253|176180|P1|Overall Study|Ineligible - required test not done|1
45596|NCT01267201|176209|P6|Second Intervention Period|Withdrawal by Subject|0
45597|NCT01267201|176210|P5|Second Intervention Period|Withdrawal by Subject|0
45598|NCT01267201|176211|P4|Second Intervention Period|Withdrawal by Subject|0
45599|NCT01267201|176212|P3|Second Intervention Period|Withdrawal by Subject|0
45600|NCT01267201|176213|P2|Second Intervention Period|Withdrawal by Subject|1
45601|NCT01267201|176214|P1|Second Intervention Period|Withdrawal by Subject|0
45602|NCT01267201|176209|P6|First Intervention Period|Withdrawal by Subject|0
45603|NCT01267201|176210|P5|First Intervention Period|Withdrawal by Subject|0
45604|NCT01267201|176211|P4|First Intervention Period|Withdrawal by Subject|0
45605|NCT01267201|176212|P3|First Intervention Period|Withdrawal by Subject|0
45606|NCT01267201|176213|P2|First Intervention Period|Withdrawal by Subject|0
45607|NCT01267201|176214|P1|First Intervention Period|Withdrawal by Subject|1
45608|NCT01267175|176231|P1|Overall Study|Lost to Follow-up|1
45609|NCT01267175|176231|P1|Overall Study|Withdrawal by Subject|1
45610|NCT01266967|176284|P2|Overall Study|Withdrawal by Subject|3
45611|NCT01266967|176285|P1|Overall Study|Withdrawal by Subject|3
45612|NCT01266967|176284|P2|Overall Study|Physician Decision|1
45613|NCT01266967|176285|P1|Overall Study|Physician Decision|0
45614|NCT01266967|176284|P2|Overall Study|Lost to Follow-up|1
45615|NCT01266967|176285|P1|Overall Study|Lost to Follow-up|2
45616|NCT01266967|176284|P2|Overall Study|Study Closed/Terminated|17
45617|NCT01266967|176285|P1|Overall Study|Study Closed/Terminated|15
45618|NCT01266967|176284|P2|Overall Study|Death|61
45619|NCT01266967|176285|P1|Overall Study|Death|69
45620|NCT01266876|176337|P5|Overall Study|Adverse Event|0
45621|NCT01266876|176338|P4|Overall Study|Adverse Event|1
45622|NCT01266876|176339|P3|Overall Study|Adverse Event|0
45623|NCT01266876|176340|P2|Overall Study|Adverse Event|0
45624|NCT01266876|176341|P1|Overall Study|Adverse Event|0
45625|NCT01266850|176448|P5|Overall Study|Site Closure|0
45626|NCT01266850|176449|P4|Overall Study|Site Closure|1
45627|NCT01266850|176450|P3|Overall Study|Site Closure|1
45628|NCT01266850|176451|P2|Overall Study|Site Closure|1
45629|NCT01266850|176452|P1|Overall Study|Site Closure|0
45630|NCT01266850|176448|P5|Overall Study|Adverse Event|1
45631|NCT01266850|176449|P4|Overall Study|Adverse Event|0
45632|NCT01266850|176450|P3|Overall Study|Adverse Event|0
45633|NCT01266850|176451|P2|Overall Study|Adverse Event|0
45634|NCT01266850|176452|P1|Overall Study|Adverse Event|0
45635|NCT01266850|176448|P5|Overall Study|Protocol Violation|2
45636|NCT01266850|176449|P4|Overall Study|Protocol Violation|1
45637|NCT01266850|176450|P3|Overall Study|Protocol Violation|0
45638|NCT01266850|176451|P2|Overall Study|Protocol Violation|1
45639|NCT01266850|176452|P1|Overall Study|Protocol Violation|0
45640|NCT01266850|176448|P5|Overall Study|Physician Decision|3
45641|NCT01266850|176449|P4|Overall Study|Physician Decision|4
45642|NCT01266850|176450|P3|Overall Study|Physician Decision|4
45643|NCT01266850|176451|P2|Overall Study|Physician Decision|6
45644|NCT01266850|176452|P1|Overall Study|Physician Decision|3
45645|NCT01266850|176448|P5|Overall Study|Withdrawal by Subject|12
45646|NCT01266850|176449|P4|Overall Study|Withdrawal by Subject|9
45647|NCT01266850|176450|P3|Overall Study|Withdrawal by Subject|6
45648|NCT01266850|176451|P2|Overall Study|Withdrawal by Subject|9
45649|NCT01266850|176452|P1|Overall Study|Withdrawal by Subject|8
45650|NCT01266850|176448|P5|Overall Study|Lost to Follow-up|12
45651|NCT01266850|176449|P4|Overall Study|Lost to Follow-up|13
45652|NCT01266850|176450|P3|Overall Study|Lost to Follow-up|13
45653|NCT01266850|176451|P2|Overall Study|Lost to Follow-up|19
45654|NCT01266850|176452|P1|Overall Study|Lost to Follow-up|19
45655|NCT01266824|176506|P2|Overall Study|Study terminated prior to completion|3
45656|NCT01266824|176507|P1|Overall Study|Study terminated prior to completion|2
45657|NCT01266265|176530|P2|Overall Study|Clinical worsening|1
45658|NCT01266265|176531|P1|Overall Study|Clinical worsening|1
45659|NCT01266265|176530|P2|Overall Study|Site closed early|3
45660|NCT01266265|176531|P1|Overall Study|Site closed early|4
45661|NCT01266265|176530|P2|Overall Study|Lung transplant|5
45662|NCT01266265|176531|P1|Overall Study|Lung transplant|6
45663|NCT01266265|176530|P2|Overall Study|Non-compliance|5
45664|NCT01266265|176531|P1|Overall Study|Non-compliance|8
45665|NCT01266265|176530|P2|Overall Study|Enrolled in another clinical study|26
45666|NCT01266265|176531|P1|Overall Study|Enrolled in another clinical study|15
45667|NCT01266265|176530|P2|Overall Study|Stopped/changed PAH medication(s)|9
45668|NCT01266265|176531|P1|Overall Study|Stopped/changed PAH medication(s)|16
45669|NCT01266265|176530|P2|Overall Study|Transferred care to another provider|28
45670|NCT01266265|176531|P1|Overall Study|Transferred care to another provider|22
45671|NCT01266265|176530|P2|Overall Study|Respiratory-related adverse event|1
45672|NCT01266265|176531|P1|Overall Study|Respiratory-related adverse event|2
45673|NCT01266265|176530|P2|Overall Study|Withdrawal by Subject|11
45674|NCT01266265|176531|P1|Overall Study|Withdrawal by Subject|13
45675|NCT01266265|176530|P2|Overall Study|Lost to Follow-up|28
45676|NCT01266265|176531|P1|Overall Study|Lost to Follow-up|23
45677|NCT01266265|176530|P2|Overall Study|Death|73
45678|NCT01266265|176531|P1|Overall Study|Death|95
45679|NCT01266148|176539|P2|Overall Study|missing mGFR value + AE|0
45680|NCT01266148|176540|P1|Overall Study|missing mGFR value + AE|1
45681|NCT01266148|176539|P2|Overall Study|Death|3
45682|NCT01266148|176540|P1|Overall Study|Death|2
45683|NCT01266148|176539|P2|Overall Study|2 2R rejections|0
45684|NCT01266148|176540|P1|Overall Study|2 2R rejections|1
45685|NCT01266148|176539|P2|Overall Study|Ongoing rejection|0
45686|NCT01266148|176540|P1|Overall Study|Ongoing rejection|1
45687|NCT01266148|176539|P2|Overall Study|Adverse Event|0
45688|NCT01266148|176540|P1|Overall Study|Adverse Event|2
45689|NCT01266122|176568|P2|Overall Study|Lost to Follow-up|6
45690|NCT01266122|176569|P1|Overall Study|Lost to Follow-up|6
45691|NCT01266070|176577|P1|Overall Study|Protocol Violation|1
45692|NCT01266070|176577|P1|Overall Study|Adverse Event|3
45693|NCT01266031|176585|P3|Overall Study|Adverse Event|3
45694|NCT01266031|176586|P2|Overall Study|Adverse Event|0
45695|NCT01266031|176587|P1|Overall Study|Adverse Event|0
45696|NCT01266031|176585|P3|Overall Study|Not treated|0
45697|NCT01266031|176586|P2|Overall Study|Not treated|3
45698|NCT01266031|176587|P1|Overall Study|Not treated|0
45699|NCT01265992|176595|P1|Overall Study|Did not receive treatment|1
45700|NCT01265992|176595|P1|Overall Study|Stopped treatment|3
45701|NCT01265992|176595|P1|Overall Study|Administrative reasons|2
45702|NCT01265992|176595|P1|Overall Study|Adverse Event|1
45703|NCT01265992|176595|P1|Overall Study|Withdrawal by Subject|1
45704|NCT01265992|176595|P1|Overall Study|Lost to Follow-up|1
45705|NCT01265875|176621|P1|Overall Study|Uncooperative/unreliable|1
45706|NCT01265823|176629|P1|Overall Study|Participant Request|1
45707|NCT01265823|176629|P1|Overall Study|Protocol Violation|1
45708|NCT01265823|176629|P1|Overall Study|Failure to Return|4
45709|NCT01265823|176629|P1|Overall Study|Unsatisfactory Response Efficacy|1
45710|NCT01265797|176658|P2|Open Label Month|Lost to Follow-up|1
45711|NCT01265797|176659|P1|Open Label Month|Lost to Follow-up|0
45712|NCT01265797|176658|P2|Blinded Month|Diary data incomplete|1
45713|NCT01265797|176659|P1|Blinded Month|Diary data incomplete|0
45714|NCT01265797|176658|P2|Blinded Month|Adverse Event|0
45715|NCT01265797|176659|P1|Blinded Month|Adverse Event|2
45716|NCT01265797|176658|P2|Blinded Month|Protocol Violation|1
45717|NCT01265797|176659|P1|Blinded Month|Protocol Violation|2
45718|NCT01265797|176658|P2|Blinded Month|Lost to Follow-up|0
45719|NCT01265797|176659|P1|Blinded Month|Lost to Follow-up|1
45720|NCT01265797|176658|P2|Blinded Month|Lack of Efficacy|0
45721|NCT01265797|176659|P1|Blinded Month|Lack of Efficacy|5
45722|NCT01265797|176658|P2|Run-in Month|1st seizure during run-in month|1
45723|NCT01265797|176659|P1|Run-in Month|1st seizure during run-in month|0
45724|NCT01265797|176658|P2|Run-in Month|Withdrawal by Subject|4
45725|NCT01265797|176659|P1|Run-in Month|Withdrawal by Subject|0
45726|NCT01265784|176690|P3|Overall Study|Incorrectly Randomized|1
45727|NCT01265784|176691|P2|Overall Study|Incorrectly Randomized|0
45728|NCT01265784|176692|P1|Overall Study|Incorrectly Randomized|0
45729|NCT01265784|176690|P3|Overall Study|Protocol Violation|0
45730|NCT01265784|176691|P2|Overall Study|Protocol Violation|0
45731|NCT01265784|176692|P1|Overall Study|Protocol Violation|2
45732|NCT01265784|176690|P3|Overall Study|Death|0
45733|NCT01265784|176691|P2|Overall Study|Death|0
45734|NCT01265784|176692|P1|Overall Study|Death|3
45735|NCT01265784|176690|P3|Overall Study|Adverse Event|0
45736|NCT01265784|176691|P2|Overall Study|Adverse Event|0
45737|NCT01265784|176692|P1|Overall Study|Adverse Event|1
45738|NCT01265784|176690|P3|Overall Study|Physician Decision|1
45739|NCT01265784|176691|P2|Overall Study|Physician Decision|0
45740|NCT01265784|176692|P1|Overall Study|Physician Decision|1
45741|NCT01265784|176690|P3|Overall Study|Withdrawal by Subject|0
45742|NCT01265784|176691|P2|Overall Study|Withdrawal by Subject|5
45743|NCT01265784|176692|P1|Overall Study|Withdrawal by Subject|0
45744|NCT01265784|176690|P3|Overall Study|Lost to Follow-up|2
45745|NCT01265784|176691|P2|Overall Study|Lost to Follow-up|3
45746|NCT01265784|176692|P1|Overall Study|Lost to Follow-up|5
45747|NCT01265615|176762|P4|Overall Study|Protocol Violation|3
45748|NCT01265615|176763|P3|Overall Study|Protocol Violation|4
45749|NCT01265615|176764|P2|Overall Study|Protocol Violation|2
45750|NCT01265615|176765|P1|Overall Study|Protocol Violation|2
45751|NCT01265498|176834|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
45752|NCT01265498|176835|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
45753|NCT01265420|176971|P1|Overall Study|Lost to Follow-up|1
45754|NCT01265394|176975|P1|Overall Study|Subjects withdrawn|37
45755|NCT01265056|176982|P2|Overall Study|Withdrawal by Subject|1
45756|NCT01265056|176983|P1|Overall Study|Withdrawal by Subject|1
45757|NCT01265056|176982|P2|Overall Study|Withdrawal by Subject|1
45758|NCT01265056|176983|P1|Overall Study|Withdrawal by Subject|1
45759|NCT01264939|177010|P2|Overall Study|Disease Progression|11
45760|NCT01264939|177011|P1|Overall Study|Disease Progression|8
45761|NCT01264939|177010|P2|Overall Study|Patient/Guardian Decision|10
45762|NCT01264939|177011|P1|Overall Study|Patient/Guardian Decision|8
45763|NCT01264939|177010|P2|Overall Study|Physician Decision|1
45764|NCT01264939|177011|P1|Overall Study|Physician Decision|1
45765|NCT01264939|177010|P2|Overall Study|Lost to Follow-up|3
45766|NCT01264939|177011|P1|Overall Study|Lost to Follow-up|0
45767|NCT01264939|177010|P2|Overall Study|Adverse Event|3
45768|NCT01264939|177011|P1|Overall Study|Adverse Event|1
45769|NCT01264887|177037|P1|Overall Study|Not Specified|2
45770|NCT01264887|177037|P1|Overall Study|Sponsor Decision Administrative Reasons|2
45771|NCT01264887|177037|P1|Overall Study|Withdrawal by Subject|6
45772|NCT01264887|177037|P1|Overall Study|Physician Decision|4
45773|NCT01264887|177037|P1|Overall Study|Lack of Efficacy|5
45774|NCT01264887|177037|P1|Overall Study|Death|7
45775|NCT01264887|177037|P1|Overall Study|Adverse Event|5
45776|NCT01264835|177048|P1|Overall Study|Lost to Follow-up|1
45777|NCT01264770|177058|P6|Overall Study|Adverse Event|1
45778|NCT01264770|177059|P5|Overall Study|Adverse Event|2
45779|NCT01264770|177060|P4|Overall Study|Adverse Event|0
45780|NCT01264770|177061|P3|Overall Study|Adverse Event|8
45781|NCT01264770|177062|P2|Overall Study|Adverse Event|7
45782|NCT01264770|177063|P1|Overall Study|Adverse Event|7
45783|NCT01264770|177058|P6|Overall Study|Lost to Follow-up|0
45784|NCT01264770|177059|P5|Overall Study|Lost to Follow-up|0
45785|NCT01264770|177060|P4|Overall Study|Lost to Follow-up|1
45786|NCT01264770|177061|P3|Overall Study|Lost to Follow-up|1
45787|NCT01264770|177062|P2|Overall Study|Lost to Follow-up|0
45788|NCT01264770|177063|P1|Overall Study|Lost to Follow-up|0
45789|NCT01264770|177058|P6|Overall Study|Dev. of study specific discont. criteria|1
45790|NCT01264770|177059|P5|Overall Study|Dev. of study specific discont. criteria|1
45791|NCT01264770|177060|P4|Overall Study|Dev. of study specific discont. criteria|0
45792|NCT01264770|177061|P3|Overall Study|Dev. of study specific discont. criteria|0
45793|NCT01264770|177062|P2|Overall Study|Dev. of study specific discont. criteria|0
45794|NCT01264770|177063|P1|Overall Study|Dev. of study specific discont. criteria|2
45795|NCT01264770|177058|P6|Overall Study|Lack of therapeutic response|0
45796|NCT01264770|177059|P5|Overall Study|Lack of therapeutic response|1
45797|NCT01264770|177060|P4|Overall Study|Lack of therapeutic response|1
45798|NCT01264770|177061|P3|Overall Study|Lack of therapeutic response|2
45799|NCT01264770|177062|P2|Overall Study|Lack of therapeutic response|0
45800|NCT01264770|177063|P1|Overall Study|Lack of therapeutic response|1
45801|NCT01264770|177058|P6|Overall Study|Severe non-compliance to protocol|0
45802|NCT01264770|177059|P5|Overall Study|Severe non-compliance to protocol|0
45803|NCT01264770|177060|P4|Overall Study|Severe non-compliance to protocol|1
45804|NCT01264770|177061|P3|Overall Study|Severe non-compliance to protocol|1
45805|NCT01264770|177062|P2|Overall Study|Severe non-compliance to protocol|0
45806|NCT01264770|177063|P1|Overall Study|Severe non-compliance to protocol|0
45807|NCT01264770|177058|P6|Overall Study|e.g., change in circumstances|4
45808|NCT01264770|177059|P5|Overall Study|e.g., change in circumstances|4
45809|NCT01264770|177060|P4|Overall Study|e.g., change in circumstances|3
45810|NCT01264770|177061|P3|Overall Study|e.g., change in circumstances|3
45811|NCT01264770|177062|P2|Overall Study|e.g., change in circumstances|3
45812|NCT01264770|177063|P1|Overall Study|e.g., change in circumstances|8
45813|NCT01264770|177058|P6|Overall Study|Not reported|0
45814|NCT01264770|177059|P5|Overall Study|Not reported|0
45815|NCT01264770|177060|P4|Overall Study|Not reported|0
45816|NCT01264770|177061|P3|Overall Study|Not reported|1
45817|NCT01264770|177062|P2|Overall Study|Not reported|0
45818|NCT01264770|177063|P1|Overall Study|Not reported|0
45819|NCT01264380|177164|P3|Period C|Adverse Event|1
45820|NCT01264380|177165|P2|Period C|Adverse Event|0
45821|NCT01264380|177166|P1|Period C|Adverse Event|0
45822|NCT01264380|177164|P3|Period C|Withdrawal by Subject|1
45823|NCT01264380|177165|P2|Period C|Withdrawal by Subject|0
45824|NCT01264380|177166|P1|Period C|Withdrawal by Subject|0
45825|NCT01264380|177164|P3|Period C|Follow-up for survival status|6
45826|NCT01264380|177165|P2|Period C|Follow-up for survival status|0
45827|NCT01264380|177166|P1|Period C|Follow-up for survival status|0
45828|NCT01264380|177164|P3|Period C|Death|2
45829|NCT01264380|177165|P2|Period C|Death|0
45830|NCT01264380|177166|P1|Period C|Death|0
45831|NCT01264380|177164|P3|Period C|Disease Progression|4
45832|NCT01264380|177165|P2|Period C|Disease Progression|0
45833|NCT01264380|177166|P1|Period C|Disease Progression|0
45834|NCT01264081|177187|P1|Started Treatment|Not complete cycle 1 due to death|1
45835|NCT01264081|177187|P1|Started Treatment|Withdrawal by Subject|1
45836|NCT01264081|177187|P1|Participants Screened|Screening failures|30
45837|NCT01264016|177192|P1|Overall Study|Felt faint at sight of blood|1
45838|NCT01264016|177192|P1|Overall Study|Withdrawal by Subject|1
45839|NCT01263925|177200|P2|Overall Study|Withdrawal/ Not specified|1
45840|NCT01263925|177201|P1|Overall Study|Withdrawal/ Not specified|0
45841|NCT01263925|177200|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
45842|NCT01263925|177201|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
45843|NCT01263925|177200|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
45844|NCT01263925|177201|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
45845|NCT01263925|177200|P2|Overall Study|AE/ Withdrawal|4
45846|NCT01263925|177201|P1|Overall Study|AE/ Withdrawal|1
45847|NCT01263925|177200|P2|Overall Study|AE/ Unsatisfactory Compliance|2
45848|NCT01263925|177201|P1|Overall Study|AE/ Unsatisfactory Compliance|2
45849|NCT01263925|177200|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
45850|NCT01263925|177201|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
45851|NCT01263925|177200|P2|Overall Study|Lost to Follow-up|1
45852|NCT01263925|177201|P1|Overall Study|Lost to Follow-up|3
45853|NCT01263925|177200|P2|Overall Study|Not specified|4
45854|NCT01263925|177201|P1|Overall Study|Not specified|4
45855|NCT01263925|177200|P2|Overall Study|Withdrawal by Subject|8
45856|NCT01263925|177201|P1|Overall Study|Withdrawal by Subject|6
45857|NCT01263925|177200|P2|Overall Study|Unsatisfactory Compliance of Subject|5
45858|NCT01263925|177201|P1|Overall Study|Unsatisfactory Compliance of Subject|8
45859|NCT01263925|177200|P2|Overall Study|Adverse Event|22
45860|NCT01263925|177201|P1|Overall Study|Adverse Event|23
45861|NCT01263925|177200|P2|Overall Study|Lack of Efficacy|1
45862|NCT01263925|177201|P1|Overall Study|Lack of Efficacy|0
45863|NCT01263925|177200|P2|Overall Study|Protocol Violation|0
45864|NCT01263925|177201|P1|Overall Study|Protocol Violation|1
45865|NCT01263873|177235|P2|Overall Study|One provider unable to complete numbers|1
45866|NCT01263873|177236|P1|Overall Study|One provider unable to complete numbers|1
45867|NCT01263691|177281|P6|Overall Study|Adverse Event|0
45868|NCT01263691|177282|P5|Overall Study|Adverse Event|0
45869|NCT01263691|177283|P4|Overall Study|Adverse Event|0
45870|NCT01263691|177284|P3|Overall Study|Adverse Event|0
45871|NCT01263691|177285|P2|Overall Study|Adverse Event|0
45872|NCT01263691|177286|P1|Overall Study|Adverse Event|1
45873|NCT01263691|177281|P6|Overall Study|Withdrawal by Subject|0
45874|NCT01263691|177282|P5|Overall Study|Withdrawal by Subject|0
45875|NCT01263691|177283|P4|Overall Study|Withdrawal by Subject|0
45876|NCT01263691|177284|P3|Overall Study|Withdrawal by Subject|0
45877|NCT01263691|177285|P2|Overall Study|Withdrawal by Subject|0
45878|NCT01263691|177286|P1|Overall Study|Withdrawal by Subject|1
45879|NCT01263691|177281|P6|Overall Study|Lost to Follow-up|0
45880|NCT01263691|177282|P5|Overall Study|Lost to Follow-up|0
45881|NCT01263691|177283|P4|Overall Study|Lost to Follow-up|1
45882|NCT01263691|177284|P3|Overall Study|Lost to Follow-up|1
45883|NCT01263691|177285|P2|Overall Study|Lost to Follow-up|0
45884|NCT01263691|177286|P1|Overall Study|Lost to Follow-up|1
45885|NCT01263665|177396|P1|Overall Study|Surgical Bypass|2
45886|NCT01263665|177396|P1|Overall Study|Amputation above the ankle|1
45887|NCT01263665|177396|P1|Overall Study|Death|2
45888|NCT01263665|177396|P1|Overall Study|Lost to Follow-up|3
45889|NCT01263665|177396|P1|Overall Study|Withdrew Consent|1
45890|NCT01263639|177403|P2|Overall Study|Exclusion =Admission greater than 7 days|9
45891|NCT01263639|177404|P1|Overall Study|Exclusion =Admission greater than 7 days|7
45892|NCT01263639|177403|P2|Overall Study|Lost to Follow-up|70
45893|NCT01263639|177404|P1|Overall Study|Lost to Follow-up|66
45894|NCT01263561|177412|P2|Overall Study|Death|2
45895|NCT01263561|177413|P1|Overall Study|Death|1
45896|NCT01263509|177425|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
45897|NCT01263509|177426|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
45898|NCT01263509|177427|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
45899|NCT01263509|177428|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
45900|NCT01263509|177425|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
45901|NCT01263509|177426|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
45902|NCT01263509|177427|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
45903|NCT01263509|177428|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
45904|NCT01263509|177425|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
45905|NCT01263509|177426|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
45906|NCT01263509|177427|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
45907|NCT01263509|177428|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
45908|NCT01263509|177425|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
45909|NCT01263509|177426|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
45910|NCT01263509|177427|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
45911|NCT01263509|177428|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
45912|NCT01263509|177425|P4|Entered - Long-Term Extension Study|Adverse Event|1
45913|NCT01263509|177426|P3|Entered - Long-Term Extension Study|Adverse Event|4
45914|NCT01263509|177427|P2|Entered - Long-Term Extension Study|Adverse Event|5
45915|NCT01263509|177428|P1|Entered - Long-Term Extension Study|Adverse Event|5
45916|NCT01263496|177557|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
45917|NCT01263496|177558|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
45918|NCT01263496|177559|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
45919|NCT01263496|177560|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
45920|NCT01263496|177561|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
45921|NCT01263496|177562|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
45922|NCT01263496|177563|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
45923|NCT01263496|177564|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
45924|NCT01263496|177565|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
45925|NCT01263496|177557|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
45926|NCT01263496|177558|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
45927|NCT01263496|177559|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
45928|NCT01263496|177560|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
45929|NCT01263496|177561|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
45930|NCT01263496|177562|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
45931|NCT01263496|177563|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
45932|NCT01263496|177564|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
45933|NCT01263496|177565|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
45934|NCT01263496|177557|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
45935|NCT01263496|177558|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
45936|NCT01263496|177559|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
45937|NCT01263496|177560|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
45938|NCT01263496|177561|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
45939|NCT01263496|177562|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
45940|NCT01263496|177563|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
45941|NCT01263496|177564|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
45942|NCT01263496|177565|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
45943|NCT01263496|177557|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
45944|NCT01263496|177558|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
45945|NCT01263496|177559|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
45946|NCT01263496|177560|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
45947|NCT01263496|177561|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
45948|NCT01263496|177562|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
45949|NCT01263496|177563|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
45950|NCT01263496|177564|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
45951|NCT01263496|177565|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
45952|NCT01263496|177557|P9|Entered - Long-Term Extension Study|Adverse Event|1
45953|NCT01263496|177558|P8|Entered - Long-Term Extension Study|Adverse Event|0
45954|NCT01263496|177559|P7|Entered - Long-Term Extension Study|Adverse Event|0
45955|NCT01263496|177560|P6|Entered - Long-Term Extension Study|Adverse Event|0
45956|NCT01263496|177561|P5|Entered - Long-Term Extension Study|Adverse Event|1
45957|NCT01263496|177562|P4|Entered - Long-Term Extension Study|Adverse Event|3
45958|NCT01263496|177563|P3|Entered - Long-Term Extension Study|Adverse Event|6
45959|NCT01263496|177564|P2|Entered - Long-Term Extension Study|Adverse Event|5
45960|NCT01263496|177565|P1|Entered - Long-Term Extension Study|Adverse Event|0
45961|NCT01263496|177557|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
45962|NCT01263496|177558|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
45963|NCT01263496|177559|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
45964|NCT01263496|177560|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
45965|NCT01263496|177561|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
45966|NCT01263496|177562|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
45967|NCT01263496|177563|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
45968|NCT01263496|177564|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
45969|NCT01263496|177565|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
45970|NCT01263496|177557|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
45971|NCT01263496|177558|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
45972|NCT01263496|177559|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
45973|NCT01263496|177560|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
45974|NCT01263496|177561|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
45975|NCT01263496|177562|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
45976|NCT01263496|177563|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
45977|NCT01263496|177564|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
45978|NCT01263496|177565|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
45979|NCT01263483|177860|P3|Overall Study|Participant Unavailability|1
45980|NCT01263483|177861|P2|Overall Study|Participant Unavailability|1
45981|NCT01263483|177862|P1|Overall Study|Participant Unavailability|0
45982|NCT01263483|177860|P3|Overall Study|Protocol Violation|1
45983|NCT01263483|177861|P2|Overall Study|Protocol Violation|1
45984|NCT01263483|177862|P1|Overall Study|Protocol Violation|0
45985|NCT01263483|177860|P3|Overall Study|Lack of Efficacy|0
45986|NCT01263483|177861|P2|Overall Study|Lack of Efficacy|0
45987|NCT01263483|177862|P1|Overall Study|Lack of Efficacy|2
45988|NCT01263483|177860|P3|Overall Study|Withdrawal by Subject|0
45989|NCT01263483|177861|P2|Overall Study|Withdrawal by Subject|0
45990|NCT01263483|177862|P1|Overall Study|Withdrawal by Subject|1
45991|NCT01263483|177860|P3|Overall Study|Adverse Event|3
45992|NCT01263483|177861|P2|Overall Study|Adverse Event|0
45993|NCT01263483|177862|P1|Overall Study|Adverse Event|4
45994|NCT01263470|177924|P6|Overall Study|Study Drug Non-compliance|0
45995|NCT01263470|177925|P5|Overall Study|Study Drug Non-compliance|1
45996|NCT01263470|177926|P4|Overall Study|Study Drug Non-compliance|0
45997|NCT01263470|177927|P3|Overall Study|Study Drug Non-compliance|0
45998|NCT01263470|177928|P2|Overall Study|Study Drug Non-compliance|0
45999|NCT01263470|177929|P1|Overall Study|Study Drug Non-compliance|0
46000|NCT01263470|177924|P6|Overall Study|Participant Unavailability|0
46001|NCT01263470|177925|P5|Overall Study|Participant Unavailability|0
46002|NCT01263470|177926|P4|Overall Study|Participant Unavailability|0
46003|NCT01263470|177927|P3|Overall Study|Participant Unavailability|0
46004|NCT01263470|177928|P2|Overall Study|Participant Unavailability|1
46005|NCT01263470|177929|P1|Overall Study|Participant Unavailability|0
46006|NCT01263470|177924|P6|Overall Study|Lack of Efficacy|0
46007|NCT01263470|177925|P5|Overall Study|Lack of Efficacy|0
46008|NCT01263470|177926|P4|Overall Study|Lack of Efficacy|0
46009|NCT01263470|177927|P3|Overall Study|Lack of Efficacy|2
46010|NCT01263470|177928|P2|Overall Study|Lack of Efficacy|0
46011|NCT01263470|177929|P1|Overall Study|Lack of Efficacy|0
46012|NCT01263470|177924|P6|Overall Study|Withdrawal by Subject|2
46013|NCT01263470|177925|P5|Overall Study|Withdrawal by Subject|0
46014|NCT01263470|177926|P4|Overall Study|Withdrawal by Subject|2
46015|NCT01263470|177927|P3|Overall Study|Withdrawal by Subject|1
46016|NCT01263470|177928|P2|Overall Study|Withdrawal by Subject|1
46017|NCT01263470|177929|P1|Overall Study|Withdrawal by Subject|0
46018|NCT01263470|177924|P6|Overall Study|Protocol Violation|1
46019|NCT01263470|177925|P5|Overall Study|Protocol Violation|0
46020|NCT01263470|177926|P4|Overall Study|Protocol Violation|0
46021|NCT01263470|177927|P3|Overall Study|Protocol Violation|0
46022|NCT01263470|177928|P2|Overall Study|Protocol Violation|1
46023|NCT01263470|177929|P1|Overall Study|Protocol Violation|0
46024|NCT01263470|177924|P6|Overall Study|Adverse Event|2
46025|NCT01263470|177925|P5|Overall Study|Adverse Event|2
46026|NCT01263470|177926|P4|Overall Study|Adverse Event|1
46027|NCT01263470|177927|P3|Overall Study|Adverse Event|1
46028|NCT01263470|177928|P2|Overall Study|Adverse Event|2
46029|NCT01263470|177929|P1|Overall Study|Adverse Event|2
46030|NCT01263444|178039|P1|Overall Study|Protocol Violation|1
46031|NCT01263444|178039|P1|Overall Study|Withdrawal by Subject|1
46032|NCT01263444|178039|P1|Overall Study|Adverse Event|8
46033|NCT01263054|178080|P2|Overall Study|Other|1
46034|NCT01263054|178081|P1|Overall Study|Other|0
46035|NCT01263054|178080|P2|Overall Study|Qualification Violation|0
46036|NCT01263054|178081|P1|Overall Study|Qualification Violation|1
46037|NCT01263054|178080|P2|Overall Study|Withdrawal by Subject|3
46038|NCT01263054|178081|P1|Overall Study|Withdrawal by Subject|1
46039|NCT01263054|178080|P2|Overall Study|Lost to Follow-up|2
46040|NCT01263054|178081|P1|Overall Study|Lost to Follow-up|2
46041|NCT01263054|178080|P2|Overall Study|Death|0
46042|NCT01263054|178081|P1|Overall Study|Death|1
46043|NCT01263028|178099|P1|Overall Study|Study terminated due to low enrollment.|4
46044|NCT01263028|178099|P1|Overall Study|Adverse Event|1
46045|NCT01263028|178099|P1|Overall Study|Withdrawal by Subject|1
46046|NCT01263015|178109|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
46047|NCT01263015|178110|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
46048|NCT01263015|178109|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
46049|NCT01263015|178110|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
46050|NCT01263015|178109|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
46051|NCT01263015|178110|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
46052|NCT01263015|178109|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
46053|NCT01263015|178110|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
46054|NCT01263015|178109|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
46055|NCT01263015|178110|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
46056|NCT01263015|178109|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
46057|NCT01263015|178110|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
46058|NCT01263015|178109|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
46059|NCT01263015|178110|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
46060|NCT01263015|178109|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
46061|NCT01263015|178110|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
46062|NCT01263015|178109|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
46063|NCT01263015|178110|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
46064|NCT01263015|178109|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
46065|NCT01263015|178110|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
46066|NCT01263015|178109|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
46067|NCT01263015|178110|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
46068|NCT01263015|178109|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
46069|NCT01263015|178110|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
46070|NCT01262989|178136|P2|Period 2|Intercurrent disease|1
46071|NCT01262989|178137|P1|Period 2|Intercurrent disease|0
46072|NCT01262989|178136|P2|Period 1|Positive answer for exclusion criteria|1
46073|NCT01262989|178137|P1|Period 1|Positive answer for exclusion criteria|0
46074|NCT01262989|178136|P2|Period 1|Intercurrent disease|1
46075|NCT01262989|178137|P1|Period 1|Intercurrent disease|0
46076|NCT01262989|178136|P2|Period 1|Lost to Follow-up|1
46077|NCT01262989|178137|P1|Period 1|Lost to Follow-up|1
46078|NCT01262872|178155|P8|Step 2|Migrated/moved from study area|3
46079|NCT01262872|178156|P7|Step 2|Migrated/moved from study area|2
46080|NCT01262872|178157|P6|Step 2|Migrated/moved from study area|6
46081|NCT01262872|178158|P5|Step 2|Migrated/moved from study area|2
46082|NCT01262872|178159|P4|Step 2|Migrated/moved from study area|3
46083|NCT01262872|178160|P3|Step 2|Migrated/moved from study area|4
46084|NCT01262872|178161|P2|Step 2|Migrated/moved from study area|0
46085|NCT01262872|178162|P1|Step 2|Migrated/moved from study area|0
46086|NCT01262872|178155|P8|Step 2|Withdrawal by Subject|1
46087|NCT01262872|178156|P7|Step 2|Withdrawal by Subject|2
46088|NCT01262872|178157|P6|Step 2|Withdrawal by Subject|1
46089|NCT01262872|178158|P5|Step 2|Withdrawal by Subject|3
46090|NCT01262872|178159|P4|Step 2|Withdrawal by Subject|6
46091|NCT01262872|178160|P3|Step 2|Withdrawal by Subject|4
46092|NCT01262872|178161|P2|Step 2|Withdrawal by Subject|0
46093|NCT01262872|178162|P1|Step 2|Withdrawal by Subject|0
46094|NCT01262872|178155|P8|Step 2|Protocol Violation|1
46095|NCT01262872|178156|P7|Step 2|Protocol Violation|3
46096|NCT01262872|178157|P6|Step 2|Protocol Violation|0
46097|NCT01262872|178158|P5|Step 2|Protocol Violation|0
46098|NCT01262872|178159|P4|Step 2|Protocol Violation|0
46099|NCT01262872|178160|P3|Step 2|Protocol Violation|1
46100|NCT01262872|178161|P2|Step 2|Protocol Violation|0
46101|NCT01262872|178162|P1|Step 2|Protocol Violation|0
46102|NCT01262872|178155|P8|Step 2|Death|1
46103|NCT01262872|178156|P7|Step 2|Death|2
46104|NCT01262872|178157|P6|Step 2|Death|2
46105|NCT01262872|178158|P5|Step 2|Death|0
46106|NCT01262872|178159|P4|Step 2|Death|1
46107|NCT01262872|178160|P3|Step 2|Death|0
46108|NCT01262872|178161|P2|Step 2|Death|0
46109|NCT01262872|178162|P1|Step 2|Death|0
46110|NCT01262820|178363|P1|Overall Study|Drug held for 21+ days|1
46111|NCT01262820|178363|P1|Overall Study|Lack of Efficacy|9
46112|NCT01262820|178363|P1|Overall Study|Adverse Event|5
46113|NCT01262573|178385|P2|Overall Study|Withdrawal by Subject|1
46114|NCT01262573|178386|P1|Overall Study|Withdrawal by Subject|0
46115|NCT01262456|178417|P3|1-Month Open-Label Extension Period|Other Reason|0
46116|NCT01262456|178418|P2|1-Month Open-Label Extension Period|Other Reason|1
46117|NCT01262456|178419|P1|1-Month Open-Label Extension Period|Other Reason|0
46118|NCT01262456|178417|P3|1-Month Open-Label Extension Period|Protocol Violation|2
46119|NCT01262456|178418|P2|1-Month Open-Label Extension Period|Protocol Violation|0
46120|NCT01262456|178419|P1|1-Month Open-Label Extension Period|Protocol Violation|1
46121|NCT01262456|178417|P3|1-Month Open-Label Extension Period|Adverse Event|2
46122|NCT01262456|178418|P2|1-Month Open-Label Extension Period|Adverse Event|0
46123|NCT01262456|178419|P1|1-Month Open-Label Extension Period|Adverse Event|2
46124|NCT01262456|178417|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
46125|NCT01262456|178418|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
46126|NCT01262456|178419|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
46127|NCT01262456|178417|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
46128|NCT01262456|178418|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
46129|NCT01262456|178419|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
46130|NCT01262456|178417|P3|3-Month Double-Blind Period|Protocol Violation|6
46131|NCT01262456|178418|P2|3-Month Double-Blind Period|Protocol Violation|6
46132|NCT01262456|178419|P1|3-Month Double-Blind Period|Protocol Violation|3
46133|NCT01262456|178417|P3|3-Month Double-Blind Period|Adverse Event|8
46134|NCT01262456|178418|P2|3-Month Double-Blind Period|Adverse Event|4
46135|NCT01262456|178419|P1|3-Month Double-Blind Period|Adverse Event|6
46136|NCT01262456|178417|P3|3-Month Double-Blind Period|Lost to Follow-up|3
46137|NCT01262456|178418|P2|3-Month Double-Blind Period|Lost to Follow-up|5
46138|NCT01262456|178419|P1|3-Month Double-Blind Period|Lost to Follow-up|4
46139|NCT01262456|178417|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
46140|NCT01262456|178418|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
46141|NCT01262456|178419|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
46142|NCT01262352|178462|P2|Washout|Extended Washout|1
46143|NCT01262352|178463|P1|Washout|Extended Washout|0
46144|NCT01262352|178462|P2|Washout|Adverse Event|1
46145|NCT01262352|178463|P1|Washout|Adverse Event|1
46146|NCT01262352|178462|P2|Period 1|Illness after randomization|0
46147|NCT01262352|178463|P1|Period 1|Illness after randomization|1
46148|NCT01262287|178481|P2|Overall Study|Withdrawal by Subject|1
46149|NCT01262287|178482|P1|Overall Study|Withdrawal by Subject|0
46150|NCT01262287|178481|P2|Overall Study|Lost to Follow-up|1
46151|NCT01262287|178482|P1|Overall Study|Lost to Follow-up|2
46152|NCT01262092|178543|P2|Gabapentin Taper|noncompliance - missed medications|0
46153|NCT01262092|178544|P1|Gabapentin Taper|noncompliance - missed medications|1
46154|NCT01262092|178543|P2|Buprenorphine Taper|noncompliance - missed medication|1
46155|NCT01262092|178544|P1|Buprenorphine Taper|noncompliance - missed medication|1
46156|NCT01262092|178543|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
46157|NCT01262092|178544|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
46158|NCT01262092|178543|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
46159|NCT01262092|178544|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
46160|NCT01262027|178550|P1|Overall Study|Protocol Violation|1
46161|NCT01262027|178550|P1|Overall Study|Withdrawal by Subject|3
46162|NCT01262027|178550|P1|Overall Study|Adverse Event|1
46163|NCT01261975|178555|P1|Overall Study|Surgical complication|1
46164|NCT01261624|178576|P2|Week 13 to Week 24|Insufficient Response|1
46165|NCT01261624|178577|P1|Week 13 to Week 24|Insufficient Response|0
46166|NCT01261624|178576|P2|Week 0 to Week 12|Insufficient Response|2
46167|NCT01261624|178577|P1|Week 0 to Week 12|Insufficient Response|0
46168|NCT01261624|178576|P2|Week 0 to Week 12|Disease Progression|1
46169|NCT01261624|178577|P1|Week 0 to Week 12|Disease Progression|1
46170|NCT01261325|178608|P3|Overall Study|AE, serious fatal|2
46171|NCT01261325|178609|P2|Overall Study|AE, serious fatal|0
46172|NCT01261325|178610|P1|Overall Study|AE, serious fatal|0
46173|NCT01261325|178608|P3|Overall Study|Lost to Follow-up|3
46174|NCT01261325|178609|P2|Overall Study|Lost to Follow-up|1
46175|NCT01261325|178610|P1|Overall Study|Lost to Follow-up|0
46176|NCT01261325|178608|P3|Overall Study|Protocol Violation|1
46177|NCT01261325|178609|P2|Overall Study|Protocol Violation|3
46178|NCT01261325|178610|P1|Overall Study|Protocol Violation|0
46179|NCT01261325|178608|P3|Overall Study|Randomized in Error|1
46180|NCT01261325|178609|P2|Overall Study|Randomized in Error|0
46181|NCT01261325|178610|P1|Overall Study|Randomized in Error|0
46182|NCT01261325|178608|P3|Overall Study|Screen Failure|0
46183|NCT01261325|178609|P2|Overall Study|Screen Failure|0
46184|NCT01261325|178610|P1|Overall Study|Screen Failure|1
46185|NCT01261325|178608|P3|Overall Study|Erroneously Randomized|0
46186|NCT01261325|178609|P2|Overall Study|Erroneously Randomized|0
46187|NCT01261325|178610|P1|Overall Study|Erroneously Randomized|1
46188|NCT01261325|178608|P3|Overall Study|Patient Randomized by Mistake|0
46189|NCT01261325|178609|P2|Overall Study|Patient Randomized by Mistake|1
46190|NCT01261325|178610|P1|Overall Study|Patient Randomized by Mistake|0
46191|NCT01261325|178608|P3|Overall Study|Non Compliance|0
46192|NCT01261325|178609|P2|Overall Study|Non Compliance|0
46193|NCT01261325|178610|P1|Overall Study|Non Compliance|2
46194|NCT01261325|178608|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
46195|NCT01261325|178609|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
46196|NCT01261325|178610|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
46197|NCT01261325|178608|P3|Overall Study|AE, non-serious non-fatal|13
46198|NCT01261325|178609|P2|Overall Study|AE, non-serious non-fatal|15
46199|NCT01261325|178610|P1|Overall Study|AE, non-serious non-fatal|9
46200|NCT01261325|178608|P3|Overall Study|SAE, non-fatal|1
46201|NCT01261325|178609|P2|Overall Study|SAE, non-fatal|5
46202|NCT01261325|178610|P1|Overall Study|SAE, non-fatal|1
46203|NCT01261325|178608|P3|Overall Study|Withdrawal by Subject|4
46204|NCT01261325|178609|P2|Overall Study|Withdrawal by Subject|2
46205|NCT01261325|178610|P1|Overall Study|Withdrawal by Subject|2
46206|NCT01261325|178608|P3|Overall Study|Lack of Efficacy|0
46207|NCT01261325|178609|P2|Overall Study|Lack of Efficacy|1
46208|NCT01261325|178610|P1|Overall Study|Lack of Efficacy|1
46209|NCT01260948|178650|P2|Second Intervention|Emesis|1
46210|NCT01260948|178651|P1|Second Intervention|Emesis|0
46211|NCT01260948|178650|P2|Washout of 28 Days|Withdrawal by Subject|3
46212|NCT01260948|178651|P1|Washout of 28 Days|Withdrawal by Subject|1
46213|NCT01260922|178661|P2|Second Intervention|Emesis|2
46214|NCT01260922|178662|P1|Second Intervention|Emesis|0
46215|NCT01260922|178661|P2|Washout of 28 Days|Withdrawal by Subject|2
46216|NCT01260922|178662|P1|Washout of 28 Days|Withdrawal by Subject|4
46217|NCT01260922|178661|P2|First Intervention|Withdrawal by Subject|1
46218|NCT01260922|178662|P1|First Intervention|Withdrawal by Subject|0
46219|NCT01260896|178672|P2|First Intervention|Withdrawn Due to Emesis|0
46220|NCT01260896|178673|P1|First Intervention|Withdrawn Due to Emesis|2
46221|NCT01260701|178731|P1|Overall Study|Did not begin protocol therapy|1
46222|NCT01260701|178731|P1|Overall Study|Ineligible|4
46223|NCT01260701|178731|P1|Overall Study|Under review|1
46224|NCT01260701|178731|P1|Overall Study|Not protocol specified|3
46225|NCT01260701|178731|P1|Overall Study|Death|2
46226|NCT01260701|178731|P1|Overall Study|Progression|53
46227|NCT01260701|178731|P1|Overall Study|Withdrawal by Subject|2
46228|NCT01260701|178731|P1|Overall Study|Adverse Event|9
46229|NCT01260584|178773|P4|Period 2|Withdrawal by Subject|0
46230|NCT01260584|178774|P3|Period 2|Withdrawal by Subject|0
46231|NCT01260584|178775|P2|Period 2|Withdrawal by Subject|1
46232|NCT01260584|178776|P1|Period 2|Withdrawal by Subject|0
46233|NCT01260584|178773|P4|Period 2|Adverse Event|0
46234|NCT01260584|178774|P3|Period 2|Adverse Event|2
46235|NCT01260584|178775|P2|Period 2|Adverse Event|0
46236|NCT01260584|178776|P1|Period 2|Adverse Event|1
46237|NCT01260584|178773|P4|Period 2|Protocol Violation|1
46238|NCT01260584|178774|P3|Period 2|Protocol Violation|3
46239|NCT01260584|178775|P2|Period 2|Protocol Violation|2
46240|NCT01260584|178776|P1|Period 2|Protocol Violation|0
46241|NCT01260584|178773|P4|Period 1|Adverse Event|0
46242|NCT01260584|178774|P3|Period 1|Adverse Event|1
46243|NCT01260584|178775|P2|Period 1|Adverse Event|0
46244|NCT01260584|178776|P1|Period 1|Adverse Event|0
46245|NCT01260584|178773|P4|Period 1|Protocol Violation|1
46246|NCT01260584|178774|P3|Period 1|Protocol Violation|1
46247|NCT01260584|178775|P2|Period 1|Protocol Violation|0
46248|NCT01260584|178776|P1|Period 1|Protocol Violation|0
46249|NCT01260467|178819|P1|Overall Study|Withdrawal by Subject|2
46250|NCT01260350|178851|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
46251|NCT01260350|178852|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
46252|NCT01260350|178853|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
46253|NCT01260350|178854|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
46254|NCT01260350|178855|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
46255|NCT01260350|178856|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
46256|NCT01260350|178857|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
46257|NCT01260350|178858|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
46258|NCT01260350|178859|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
46259|NCT01260350|178860|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
46260|NCT01260350|178861|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
46261|NCT01260350|178862|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
46262|NCT01260350|178863|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
46263|NCT01260350|178864|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
46264|NCT01260350|178865|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
46265|NCT01260350|178866|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
46266|NCT01260350|178867|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
46267|NCT01260350|178868|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
46268|NCT01260350|178869|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
46269|NCT01260350|178870|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
46270|NCT01260350|178871|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
46271|NCT01260350|178872|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
46272|NCT01260350|178851|P22|Overall Study|Lack of Efficacy|0
46273|NCT01260350|178852|P21|Overall Study|Lack of Efficacy|3
46274|NCT01260350|178853|P20|Overall Study|Lack of Efficacy|0
46275|NCT01260350|178854|P19|Overall Study|Lack of Efficacy|0
46276|NCT01260350|178855|P18|Overall Study|Lack of Efficacy|1
46277|NCT01260350|178856|P17|Overall Study|Lack of Efficacy|0
46278|NCT01260350|178857|P16|Overall Study|Lack of Efficacy|0
46279|NCT01260350|178858|P15|Overall Study|Lack of Efficacy|0
46280|NCT01260350|178859|P14|Overall Study|Lack of Efficacy|0
46281|NCT01260350|178860|P13|Overall Study|Lack of Efficacy|0
46282|NCT01260350|178861|P12|Overall Study|Lack of Efficacy|0
46283|NCT01260350|178862|P11|Overall Study|Lack of Efficacy|0
46284|NCT01260350|178863|P10|Overall Study|Lack of Efficacy|0
46285|NCT01260350|178864|P9|Overall Study|Lack of Efficacy|0
46286|NCT01260350|178865|P8|Overall Study|Lack of Efficacy|0
46287|NCT01260350|178866|P7|Overall Study|Lack of Efficacy|0
46288|NCT01260350|178867|P6|Overall Study|Lack of Efficacy|0
46289|NCT01260350|178868|P5|Overall Study|Lack of Efficacy|0
46290|NCT01260350|178869|P4|Overall Study|Lack of Efficacy|0
46291|NCT01260350|178870|P3|Overall Study|Lack of Efficacy|0
46292|NCT01260350|178871|P2|Overall Study|Lack of Efficacy|0
46293|NCT01260350|178872|P1|Overall Study|Lack of Efficacy|0
46294|NCT01260311|179079|P1|Overall Study|Fesoterodine Started Before Enrollment|1
46295|NCT01260311|179079|P1|Overall Study|Medication Stopped|1
46296|NCT01260311|179079|P1|Overall Study|Gone to Province|2
46297|NCT01260311|179079|P1|Overall Study|Financial Constraints|77
46298|NCT01260311|179079|P1|Overall Study|Withdrawal by Subject|6
46299|NCT01260311|179079|P1|Overall Study|Lost to Follow-up|25
46300|NCT01260311|179079|P1|Overall Study|Lack of Efficacy|4
46301|NCT01260311|179079|P1|Overall Study|Adverse Event|11
46302|NCT01260194|179110|P1|Overall Study|Withdrawal of Consent|1
46303|NCT01260142|179128|P6|Treatment Period 1|Withdrawal by Subject|1
46304|NCT01260142|179129|P5|Treatment Period 1|Withdrawal by Subject|0
46305|NCT01260142|179130|P4|Treatment Period 1|Withdrawal by Subject|0
46306|NCT01260142|179131|P3|Treatment Period 1|Withdrawal by Subject|0
46307|NCT01260142|179132|P2|Treatment Period 1|Withdrawal by Subject|0
46308|NCT01260142|179133|P1|Treatment Period 1|Withdrawal by Subject|0
46309|NCT01260142|179128|P6|Treatment Period 1|Unexplained elevated sys. BP|0
46310|NCT01260142|179129|P5|Treatment Period 1|Unexplained elevated sys. BP|1
46311|NCT01260142|179130|P4|Treatment Period 1|Unexplained elevated sys. BP|0
46312|NCT01260142|179131|P3|Treatment Period 1|Unexplained elevated sys. BP|0
46313|NCT01260142|179132|P2|Treatment Period 1|Unexplained elevated sys. BP|0
46314|NCT01260142|179133|P1|Treatment Period 1|Unexplained elevated sys. BP|0
46315|NCT01260142|179128|P6|Treatment Period 1|Study on hold|2
46316|NCT01260142|179129|P5|Treatment Period 1|Study on hold|1
46317|NCT01260142|179130|P4|Treatment Period 1|Study on hold|0
46318|NCT01260142|179131|P3|Treatment Period 1|Study on hold|0
46319|NCT01260142|179132|P2|Treatment Period 1|Study on hold|1
46320|NCT01260142|179133|P1|Treatment Period 1|Study on hold|1
46321|NCT01259726|179187|P4|Overall Study|Lost to Follow-up|3
46322|NCT01259726|179188|P3|Overall Study|Lost to Follow-up|1
46323|NCT01259726|179189|P2|Overall Study|Lost to Follow-up|1
46324|NCT01259726|179190|P1|Overall Study|Lost to Follow-up|1
46325|NCT01259726|179187|P4|Overall Study|Withdrawal by Subject|1
46326|NCT01259726|179188|P3|Overall Study|Withdrawal by Subject|2
46327|NCT01259726|179189|P2|Overall Study|Withdrawal by Subject|3
46328|NCT01259726|179190|P1|Overall Study|Withdrawal by Subject|1
46329|NCT01259726|179187|P4|Overall Study|Physician Decision|1
46330|NCT01259726|179188|P3|Overall Study|Physician Decision|1
46331|NCT01259726|179189|P2|Overall Study|Physician Decision|0
46332|NCT01259726|179190|P1|Overall Study|Physician Decision|2
46333|NCT01259726|179187|P4|Overall Study|Death|0
46334|NCT01259726|179188|P3|Overall Study|Death|0
46335|NCT01259726|179189|P2|Overall Study|Death|0
46336|NCT01259726|179190|P1|Overall Study|Death|1
46337|NCT01259713|179222|P2|Overall Study|Subject Withdrew Consent|7
46338|NCT01259713|179223|P1|Overall Study|Subject Withdrew Consent|12
46339|NCT01259713|179222|P2|Overall Study|Protocol Violation|4
46340|NCT01259713|179223|P1|Overall Study|Protocol Violation|5
46341|NCT01259713|179222|P2|Overall Study|Lack of Efficacy|0
46342|NCT01259713|179223|P1|Overall Study|Lack of Efficacy|2
46343|NCT01259713|179222|P2|Overall Study|Investigators Discretion|6
46344|NCT01259713|179223|P1|Overall Study|Investigators Discretion|14
46345|NCT01259713|179222|P2|Overall Study|Death Not Related to IFI|1
46346|NCT01259713|179223|P1|Overall Study|Death Not Related to IFI|8
46347|NCT01259713|179222|P2|Overall Study|Adverse Event|23
46348|NCT01259713|179223|P1|Overall Study|Adverse Event|54
46349|NCT01259492|179249|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
46350|NCT01259492|179250|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
46351|NCT01259492|179251|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
46352|NCT01259492|179252|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
46353|NCT01259492|179249|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
46354|NCT01259492|179250|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
46355|NCT01259492|179251|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
46356|NCT01259492|179252|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
46357|NCT01259492|179249|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
46358|NCT01259492|179250|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
46359|NCT01259492|179251|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
46360|NCT01259492|179252|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
46361|NCT01259492|179249|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
46362|NCT01259492|179250|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
46363|NCT01259492|179251|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
46364|NCT01259492|179252|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
46365|NCT01259492|179249|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
46366|NCT01259492|179250|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
46367|NCT01259492|179251|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
46368|NCT01259492|179252|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
46369|NCT01259492|179249|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
46370|NCT01259492|179250|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
46371|NCT01259492|179251|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
46372|NCT01259492|179252|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
46373|NCT01259492|179249|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
46374|NCT01259492|179250|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
46375|NCT01259492|179251|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
46376|NCT01259492|179252|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
46377|NCT01259492|179249|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
46378|NCT01259492|179250|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
46379|NCT01259492|179251|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
46380|NCT01259492|179252|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
46381|NCT01259492|179249|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
46382|NCT01259492|179250|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
46383|NCT01259492|179251|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
46384|NCT01259492|179252|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
46385|NCT01259492|179249|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
46386|NCT01259492|179250|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
46387|NCT01259492|179251|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
46388|NCT01259492|179252|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
46389|NCT01259492|179249|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
46390|NCT01259492|179250|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
46391|NCT01259492|179251|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
46392|NCT01259492|179252|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
46393|NCT01259492|179249|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
46394|NCT01259492|179250|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
46395|NCT01259492|179251|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
46396|NCT01259492|179252|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
46397|NCT01259492|179249|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
46398|NCT01259492|179250|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
46399|NCT01259492|179251|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
46400|NCT01259492|179252|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
46401|NCT01259492|179249|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
46402|NCT01259492|179250|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
46403|NCT01259492|179251|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
46404|NCT01259492|179252|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
46405|NCT01259492|179249|P4|Period 1 (9 Weeks)|Protocol Violation|1
46406|NCT01259492|179250|P3|Period 1 (9 Weeks)|Protocol Violation|3
46407|NCT01259492|179251|P2|Period 1 (9 Weeks)|Protocol Violation|6
46408|NCT01259492|179252|P1|Period 1 (9 Weeks)|Protocol Violation|5
46409|NCT01259492|179249|P4|Period 1 (9 Weeks)|Administrative Problems|2
46410|NCT01259492|179250|P3|Period 1 (9 Weeks)|Administrative Problems|1
46411|NCT01259492|179251|P2|Period 1 (9 Weeks)|Administrative Problems|1
46412|NCT01259492|179252|P1|Period 1 (9 Weeks)|Administrative Problems|0
46413|NCT01259492|179249|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
46414|NCT01259492|179250|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
46415|NCT01259492|179251|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
46416|NCT01259492|179252|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
46417|NCT01259492|179249|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
46418|NCT01259492|179250|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
46419|NCT01259492|179251|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
46420|NCT01259492|179252|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
46421|NCT01259492|179249|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
46422|NCT01259492|179250|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
46423|NCT01259492|179251|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
46424|NCT01259492|179252|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
46425|NCT01259492|179249|P4|Period 1 (9 Weeks)|Adverse Event|3
46426|NCT01259492|179250|P3|Period 1 (9 Weeks)|Adverse Event|26
46427|NCT01259492|179251|P2|Period 1 (9 Weeks)|Adverse Event|18
46428|NCT01259492|179252|P1|Period 1 (9 Weeks)|Adverse Event|13
46429|NCT01259466|179301|P2|Overall Study|Withdrawal by Subject|9
46430|NCT01259466|179302|P1|Overall Study|Withdrawal by Subject|1
46431|NCT01259401|179340|P2|4-month Follow-up|Lost to Follow-up|1
46432|NCT01259401|179341|P1|4-month Follow-up|Lost to Follow-up|0
46433|NCT01259401|179340|P2|4-month Follow-up|Death|1
46434|NCT01259401|179341|P1|4-month Follow-up|Death|0
46435|NCT01259297|179357|P8|Double Blind Randomized Period|Other reasons|1
46436|NCT01259297|179358|P7|Double Blind Randomized Period|Other reasons|3
46437|NCT01259297|179359|P6|Double Blind Randomized Period|Other reasons|2
46438|NCT01259297|179360|P5|Double Blind Randomized Period|Other reasons|1
46439|NCT01259297|179361|P4|Double Blind Randomized Period|Other reasons|0
46440|NCT01259297|179362|P3|Double Blind Randomized Period|Other reasons|0
46441|NCT01259297|179363|P2|Double Blind Randomized Period|Other reasons|1
46442|NCT01259297|179364|P1|Double Blind Randomized Period|Other reasons|0
46443|NCT01259297|179357|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
46444|NCT01259297|179358|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
46445|NCT01259297|179359|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
46446|NCT01259297|179360|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
46447|NCT01259297|179361|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
46448|NCT01259297|179362|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
46449|NCT01259297|179363|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
46450|NCT01259297|179364|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
46451|NCT01259297|179357|P8|Double Blind Randomized Period|Death|1
46452|NCT01259297|179358|P7|Double Blind Randomized Period|Death|2
46453|NCT01259297|179359|P6|Double Blind Randomized Period|Death|5
46454|NCT01259297|179360|P5|Double Blind Randomized Period|Death|1
46455|NCT01259297|179361|P4|Double Blind Randomized Period|Death|2
46456|NCT01259297|179362|P3|Double Blind Randomized Period|Death|1
46457|NCT01259297|179363|P2|Double Blind Randomized Period|Death|1
46458|NCT01259297|179364|P1|Double Blind Randomized Period|Death|1
46459|NCT01259284|179395|P3|Overall Study|Study Termination|0
46460|NCT01259284|179396|P2|Overall Study|Study Termination|0
46461|NCT01259284|179397|P1|Overall Study|Study Termination|2
46462|NCT01259245|179407|P2|Overall Study|Death|2
46463|NCT01259245|179408|P1|Overall Study|Death|1
46464|NCT01259245|179407|P2|Overall Study|Withdrawal by Subject|24
46465|NCT01259245|179408|P1|Overall Study|Withdrawal by Subject|27
46466|NCT01259115|179432|P2|Period 2|Adverse Event|0
46467|NCT01259115|179433|P1|Period 2|Adverse Event|1
46468|NCT01259115|179432|P2|Period 1|Lost to Follow-up|1
46469|NCT01259115|179433|P1|Period 1|Lost to Follow-up|0
46470|NCT01259115|179432|P2|Period 1|Protocol Violation|0
46471|NCT01259115|179433|P1|Period 1|Protocol Violation|2
46472|NCT01259115|179432|P2|Period 1|Adverse Event|0
46473|NCT01259115|179433|P1|Period 1|Adverse Event|1
46474|NCT01259102|179469|P5|Overall Study|Other|1
46475|NCT01259102|179470|P4|Overall Study|Other|1
46476|NCT01259102|179471|P3|Overall Study|Other|1
46477|NCT01259102|179472|P2|Overall Study|Other|0
46478|NCT01259102|179473|P1|Overall Study|Other|0
46479|NCT01259102|179469|P5|Overall Study|Adverse Event|0
46480|NCT01259102|179470|P4|Overall Study|Adverse Event|1
46481|NCT01259102|179471|P3|Overall Study|Adverse Event|1
46482|NCT01259102|179472|P2|Overall Study|Adverse Event|0
46483|NCT01259102|179473|P1|Overall Study|Adverse Event|1
46484|NCT01258998|179530|P1|Overall Study|Ineligible|1
46485|NCT01258803|179563|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
46486|NCT01258803|179564|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
46487|NCT01258803|179565|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
46488|NCT01258803|179566|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
46489|NCT01258803|179567|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
46490|NCT01258803|179568|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
46491|NCT01258803|179563|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
46492|NCT01258803|179564|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
46493|NCT01258803|179565|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
46494|NCT01258803|179566|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
46495|NCT01258803|179567|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
46496|NCT01258803|179568|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
46497|NCT01258803|179563|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
46498|NCT01258803|179564|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
46499|NCT01258803|179565|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
46500|NCT01258803|179566|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
46501|NCT01258803|179567|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
46502|NCT01258803|179568|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
46503|NCT01258738|179605|P2|Open-label Period|Withdrawn due to pregnancy|1
46504|NCT01258738|179606|P1|Open-label Period|Withdrawn due to pregnancy|1
46505|NCT01258738|179605|P2|Open-label Period|Other Reasons|1
46506|NCT01258738|179606|P1|Open-label Period|Other Reasons|0
46507|NCT01258738|179605|P2|Open-label Period|Adverse Event|5
46508|NCT01258738|179606|P1|Open-label Period|Adverse Event|4
46509|NCT01258738|179605|P2|Open-label Period|Protocol Violation|2
46510|NCT01258738|179606|P1|Open-label Period|Protocol Violation|2
46511|NCT01258738|179605|P2|Open-label Period|Withdrawal by Subject|6
46512|NCT01258738|179606|P1|Open-label Period|Withdrawal by Subject|5
46513|NCT01258738|179605|P2|Open-label Period|Lost to Follow-up|2
46514|NCT01258738|179606|P1|Open-label Period|Lost to Follow-up|0
46515|NCT01258738|179605|P2|Open-label Period|Insufficient clinical response|3
46516|NCT01258738|179606|P1|Open-label Period|Insufficient clinical response|5
46517|NCT01258738|179605|P2|Open-label Period|Did not meet inclusion criteria|1
46518|NCT01258738|179606|P1|Open-label Period|Did not meet inclusion criteria|0
46519|NCT01258738|179605|P2|Double-blind Period|Adverse Event|1
46520|NCT01258738|179606|P1|Double-blind Period|Adverse Event|3
46521|NCT01258738|179605|P2|Double-blind Period|Protocol Violation|1
46522|NCT01258738|179606|P1|Double-blind Period|Protocol Violation|1
46523|NCT01258738|179605|P2|Double-blind Period|Withdrawal by Subject|2
46524|NCT01258738|179606|P1|Double-blind Period|Withdrawal by Subject|2
46525|NCT01258738|179605|P2|Double-blind Period|Did not meet inclusion criteria|3
46526|NCT01258738|179606|P1|Double-blind Period|Did not meet inclusion criteria|3
46527|NCT01258660|179744|P2|Overall Study|Invalid for primary analysis data set|6
46528|NCT01258660|179745|P1|Overall Study|Invalid for primary analysis data set|4
46529|NCT01258660|179744|P2|Overall Study|Protocol Violation|1
46530|NCT01258660|179745|P1|Overall Study|Protocol Violation|0
46531|NCT01258660|179744|P2|Overall Study|due to relocation|0
46532|NCT01258660|179745|P1|Overall Study|due to relocation|2
46533|NCT01258660|179744|P2|Overall Study|Withdrawal by Subject|0
46534|NCT01258660|179745|P1|Overall Study|Withdrawal by Subject|3
46535|NCT01258660|179744|P2|Overall Study|Adverse Event|4
46536|NCT01258660|179745|P1|Overall Study|Adverse Event|2
46537|NCT01258595|179764|P2|Overall Study|Withdrawal by Subject|1
46538|NCT01258595|179765|P1|Overall Study|Withdrawal by Subject|0
46539|NCT01258595|179764|P2|Overall Study|Lost to Follow-up|0
46540|NCT01258595|179765|P1|Overall Study|Lost to Follow-up|1
46541|NCT01257204|179802|P3|Follow-up Period (up to Week 48)|Unspecified|5
46542|NCT01257204|179803|P2|Follow-up Period (up to Week 48)|Unspecified|0
46543|NCT01257204|179804|P1|Follow-up Period (up to Week 48)|Unspecified|0
46544|NCT01257204|179802|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
46545|NCT01257204|179803|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
46546|NCT01257204|179804|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
46547|NCT01257204|179802|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
46548|NCT01257204|179803|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
46549|NCT01257204|179804|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
46550|NCT01257204|179802|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
46551|NCT01257204|179803|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
46552|NCT01257204|179804|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
46553|NCT01257204|179802|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
46554|NCT01257204|179803|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
46555|NCT01257204|179804|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
46556|NCT01257204|179802|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
46557|NCT01257204|179803|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
46558|NCT01257204|179804|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
46559|NCT01257204|179802|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
46560|NCT01257204|179803|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
46561|NCT01257204|179804|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
46562|NCT01257204|179802|P3|Treatment Period (up to Week 24)|Adverse Event|2
46563|NCT01257204|179803|P2|Treatment Period (up to Week 24)|Adverse Event|1
46564|NCT01257204|179804|P1|Treatment Period (up to Week 24)|Adverse Event|3
46565|NCT01257204|179802|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
46566|NCT01257204|179803|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
46567|NCT01257204|179804|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
46568|NCT01258101|179936|P4|Overall Study|Other reason|8
46569|NCT01258101|179937|P3|Overall Study|Other reason|1
46570|NCT01258101|179938|P2|Overall Study|Other reason|8
46571|NCT01258101|179939|P1|Overall Study|Other reason|7
46572|NCT01258101|179936|P4|Overall Study|PCR positive at week 24|1
46573|NCT01258101|179937|P3|Overall Study|PCR positive at week 24|0
46574|NCT01258101|179938|P2|Overall Study|PCR positive at week 24|0
46575|NCT01258101|179939|P1|Overall Study|PCR positive at week 24|0
46576|NCT01258101|179936|P4|Overall Study|Lost to Follow-up|6
46577|NCT01258101|179937|P3|Overall Study|Lost to Follow-up|0
46578|NCT01258101|179938|P2|Overall Study|Lost to Follow-up|5
46579|NCT01258101|179939|P1|Overall Study|Lost to Follow-up|5
46580|NCT01258101|179936|P4|Overall Study|Patient´s compliance|2
46581|NCT01258101|179937|P3|Overall Study|Patient´s compliance|1
46582|NCT01258101|179938|P2|Overall Study|Patient´s compliance|3
46583|NCT01258101|179939|P1|Overall Study|Patient´s compliance|4
46584|NCT01258101|179936|P4|Overall Study|Patient is not able to attend visits|6
46585|NCT01258101|179937|P3|Overall Study|Patient is not able to attend visits|7
46586|NCT01258101|179938|P2|Overall Study|Patient is not able to attend visits|9
46587|NCT01258101|179939|P1|Overall Study|Patient is not able to attend visits|8
46588|NCT01258101|179936|P4|Overall Study|Informed consent has been withdrawn|1
46589|NCT01258101|179937|P3|Overall Study|Informed consent has been withdrawn|1
46590|NCT01258101|179938|P2|Overall Study|Informed consent has been withdrawn|2
46591|NCT01258101|179939|P1|Overall Study|Informed consent has been withdrawn|2
46592|NCT01258101|179936|P4|Overall Study|Extra exclusion criterion amended|1
46593|NCT01258101|179937|P3|Overall Study|Extra exclusion criterion amended|1
46594|NCT01258101|179938|P2|Overall Study|Extra exclusion criterion amended|1
46595|NCT01258101|179939|P1|Overall Study|Extra exclusion criterion amended|2
46596|NCT01258101|179936|P4|Overall Study|Adverse Event|0
46597|NCT01258101|179937|P3|Overall Study|Adverse Event|0
46598|NCT01258101|179938|P2|Overall Study|Adverse Event|6
46599|NCT01258101|179939|P1|Overall Study|Adverse Event|5
46600|NCT01257581|180103|P3|Overall Study|Death|4
46601|NCT01257581|180104|P2|Overall Study|Death|2
46602|NCT01257581|180105|P1|Overall Study|Death|2
46603|NCT01257581|180103|P3|Overall Study|Early Termination|2
46604|NCT01257581|180104|P2|Overall Study|Early Termination|1
46605|NCT01257581|180105|P1|Overall Study|Early Termination|3
46606|NCT01257542|180145|P2|Overall Study|Withdrawal by Subject|2
46607|NCT01257542|180146|P1|Overall Study|Withdrawal by Subject|0
46608|NCT01257542|180145|P2|Overall Study|Protocol Violation|5
46609|NCT01257542|180146|P1|Overall Study|Protocol Violation|3
46610|NCT01257503|180166|P2|Overall Study|strep culture positive at enrollment|0
46611|NCT01257503|180167|P1|Overall Study|strep culture positive at enrollment|1
46612|NCT01257503|180166|P2|Overall Study|Over 5 years old at enrollment|1
46613|NCT01257503|180167|P1|Overall Study|Over 5 years old at enrollment|0
46614|NCT01257503|180166|P2|Overall Study|Lost to Follow-up|10
46615|NCT01257503|180167|P1|Overall Study|Lost to Follow-up|7
46616|NCT01257425|180196|P2|Overall Study|Death|0
46617|NCT01257425|180197|P1|Overall Study|Death|1
46618|NCT01257425|180196|P2|Overall Study|Withdrawal by Subject|1
46619|NCT01257425|180197|P1|Overall Study|Withdrawal by Subject|0
46620|NCT01257425|180196|P2|Overall Study|Protocol Violation|1
46621|NCT01257425|180197|P1|Overall Study|Protocol Violation|1
46622|NCT01257425|180196|P2|Overall Study|Adverse Event|1
46623|NCT01257425|180197|P1|Overall Study|Adverse Event|1
46624|NCT01257425|180196|P2|Overall Study|Lack of Efficacy|3
46625|NCT01257425|180197|P1|Overall Study|Lack of Efficacy|3
46626|NCT01257230|180218|P3|Overall Study|Other reason not defined above|3
46627|NCT01257230|180219|P2|Overall Study|Other reason not defined above|5
46628|NCT01257230|180220|P1|Overall Study|Other reason not defined above|1
46629|NCT01257230|180218|P3|Overall Study|Withdrawal by Subject|1
46630|NCT01257230|180219|P2|Overall Study|Withdrawal by Subject|4
46631|NCT01257230|180220|P1|Overall Study|Withdrawal by Subject|0
46632|NCT01257230|180218|P3|Overall Study|Protocol Violation|1
46633|NCT01257230|180219|P2|Overall Study|Protocol Violation|0
46634|NCT01257230|180220|P1|Overall Study|Protocol Violation|3
46635|NCT01257230|180218|P3|Overall Study|Lack of Efficacy|0
46636|NCT01257230|180219|P2|Overall Study|Lack of Efficacy|1
46637|NCT01257230|180220|P1|Overall Study|Lack of Efficacy|0
46638|NCT01257230|180218|P3|Overall Study|Adverse Event|0
46639|NCT01257230|180219|P2|Overall Study|Adverse Event|0
46640|NCT01257230|180220|P1|Overall Study|Adverse Event|2
46641|NCT01257230|180218|P3|Overall Study|Not Treated|1
46642|NCT01257230|180219|P2|Overall Study|Not Treated|0
46643|NCT01257230|180220|P1|Overall Study|Not Treated|0
46644|NCT01256658|180275|P2|Period 1|Death|44
46645|NCT01256658|180276|P1|Period 1|Death|48
46646|NCT01256658|180275|P2|Period 1|Withdrawal by Subject|43
46647|NCT01256658|180276|P1|Period 1|Withdrawal by Subject|35
46648|NCT01256658|180275|P2|Period 1|Lost to Follow-up|661
46649|NCT01256658|180276|P1|Period 1|Lost to Follow-up|837
46650|NCT01256567|180326|P1|Overall Study|Withdrawal by Subject|1
46651|NCT01256502|180336|P1|Overall Study|Protocol deviation|1
46652|NCT01256502|180336|P1|Overall Study|Personal reasons|5
46653|NCT01256502|180336|P1|Overall Study|Had scaffold removed|4
46654|NCT01256476|180348|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
46655|NCT01256476|180349|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
46656|NCT01256476|180348|P2|Overall Study|Subject non-compliance|1
46657|NCT01256476|180349|P1|Overall Study|Subject non-compliance|0
46658|NCT01256476|180348|P2|Overall Study|Physician Decision|1
46659|NCT01256476|180349|P1|Overall Study|Physician Decision|0
46660|NCT01256476|180348|P2|Overall Study|Persistent ALT or AST elevation|0
46661|NCT01256476|180349|P1|Overall Study|Persistent ALT or AST elevation|1
46662|NCT01256476|180348|P2|Overall Study|Lost to Follow-up|2
46663|NCT01256476|180349|P1|Overall Study|Lost to Follow-up|1
46664|NCT01256476|180348|P2|Overall Study|Withdrawal by Subject|1
46665|NCT01256476|180349|P1|Overall Study|Withdrawal by Subject|2
46666|NCT01256476|180348|P2|Overall Study|Adverse Event|1
46667|NCT01256476|180349|P1|Overall Study|Adverse Event|2
46668|NCT01256450|180357|P3|Double-blind Treatment|Not specified|12
46669|NCT01256450|180358|P2|Double-blind Treatment|Not specified|9
46670|NCT01256450|180359|P1|Double-blind Treatment|Not specified|0
46671|NCT01256450|180357|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
46672|NCT01256450|180358|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
46673|NCT01256450|180359|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
46674|NCT01256450|180357|P3|Double-blind Treatment|Non-compliance|4
46675|NCT01256450|180358|P2|Double-blind Treatment|Non-compliance|5
46676|NCT01256450|180359|P1|Double-blind Treatment|Non-compliance|0
46677|NCT01256450|180357|P3|Double-blind Treatment|Lack of analgesic effect|6
46678|NCT01256450|180358|P2|Double-blind Treatment|Lack of analgesic effect|5
46679|NCT01256450|180359|P1|Double-blind Treatment|Lack of analgesic effect|0
46680|NCT01256450|180357|P3|Double-blind Treatment|Withdrawal by Subject|1
46681|NCT01256450|180358|P2|Double-blind Treatment|Withdrawal by Subject|0
46682|NCT01256450|180359|P1|Double-blind Treatment|Withdrawal by Subject|0
46683|NCT01256450|180357|P3|Double-blind Treatment|Lost to Follow-up|7
46684|NCT01256450|180358|P2|Double-blind Treatment|Lost to Follow-up|1
46685|NCT01256450|180359|P1|Double-blind Treatment|Lost to Follow-up|0
46686|NCT01256450|180357|P3|Double-blind Treatment|Adverse Event|6
46687|NCT01256450|180358|P2|Double-blind Treatment|Adverse Event|8
46688|NCT01256450|180359|P1|Double-blind Treatment|Adverse Event|0
46689|NCT01256450|180357|P3|Open-label Titration|Not specified|0
46690|NCT01256450|180358|P2|Open-label Titration|Not specified|0
46691|NCT01256450|180359|P1|Open-label Titration|Not specified|13
46692|NCT01256450|180357|P3|Open-label Titration|Screen failure|0
46693|NCT01256450|180358|P2|Open-label Titration|Screen failure|0
46694|NCT01256450|180359|P1|Open-label Titration|Screen failure|1
46695|NCT01256450|180357|P3|Open-label Titration|Non-compliance|0
46696|NCT01256450|180358|P2|Open-label Titration|Non-compliance|0
46697|NCT01256450|180359|P1|Open-label Titration|Non-compliance|9
46698|NCT01256450|180357|P3|Open-label Titration|Lack of analgesic effect|0
46699|NCT01256450|180358|P2|Open-label Titration|Lack of analgesic effect|0
46700|NCT01256450|180359|P1|Open-label Titration|Lack of analgesic effect|30
46701|NCT01256450|180357|P3|Open-label Titration|Lost to Follow-up|0
46702|NCT01256450|180358|P2|Open-label Titration|Lost to Follow-up|0
46703|NCT01256450|180359|P1|Open-label Titration|Lost to Follow-up|7
46704|NCT01256450|180357|P3|Open-label Titration|Adverse Event|0
46705|NCT01256450|180358|P2|Open-label Titration|Adverse Event|0
46706|NCT01256450|180359|P1|Open-label Titration|Adverse Event|39
46707|NCT01256411|180417|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
46708|NCT01256411|180418|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
46709|NCT01256411|180419|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
46710|NCT01256411|180420|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
46711|NCT01256411|180421|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
46712|NCT01256411|180422|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
46713|NCT01256411|180417|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
46714|NCT01256411|180418|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
46715|NCT01256411|180419|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
46716|NCT01256411|180420|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
46717|NCT01256411|180421|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
46718|NCT01256411|180422|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
46719|NCT01256411|180417|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
46720|NCT01256411|180418|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
46721|NCT01256411|180419|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
46722|NCT01256411|180420|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
46723|NCT01256411|180421|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
46724|NCT01256411|180422|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
46725|NCT01256411|180417|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
46726|NCT01256411|180418|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
46727|NCT01256411|180419|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
46728|NCT01256411|180420|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
46729|NCT01256411|180421|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
46730|NCT01256411|180422|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
46731|NCT01256411|180417|P6|Extension by Mono or Combination Therapy|Adverse Event|1
46732|NCT01256411|180418|P5|Extension by Mono or Combination Therapy|Adverse Event|6
46733|NCT01256411|180419|P4|Extension by Mono or Combination Therapy|Adverse Event|0
46734|NCT01256411|180420|P3|Extension by Mono or Combination Therapy|Adverse Event|0
46735|NCT01256411|180421|P2|Extension by Mono or Combination Therapy|Adverse Event|0
46736|NCT01256411|180422|P1|Extension by Mono or Combination Therapy|Adverse Event|0
46737|NCT01256411|180417|P6|Extension by Maximum Treatment|Adverse Event|0
46738|NCT01256411|180418|P5|Extension by Maximum Treatment|Adverse Event|0
46739|NCT01256411|180419|P4|Extension by Maximum Treatment|Adverse Event|0
46740|NCT01256411|180420|P3|Extension by Maximum Treatment|Adverse Event|1
46741|NCT01256411|180421|P2|Extension by Maximum Treatment|Adverse Event|2
46742|NCT01256411|180422|P1|Extension by Maximum Treatment|Adverse Event|4
46743|NCT01256411|180417|P6|Extension by Maximum Treatment|Lack of Efficacy|0
46744|NCT01256411|180418|P5|Extension by Maximum Treatment|Lack of Efficacy|0
46745|NCT01256411|180419|P4|Extension by Maximum Treatment|Lack of Efficacy|0
46746|NCT01256411|180420|P3|Extension by Maximum Treatment|Lack of Efficacy|1
46747|NCT01256411|180421|P2|Extension by Maximum Treatment|Lack of Efficacy|0
46748|NCT01256411|180422|P1|Extension by Maximum Treatment|Lack of Efficacy|1
46749|NCT01256411|180417|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
46750|NCT01256411|180418|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
46751|NCT01256411|180419|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
46752|NCT01256411|180420|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
46753|NCT01256411|180421|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
46754|NCT01256411|180422|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
46755|NCT01256411|180417|P6|Extension by Maximum Treatment|Lost to Follow-up|0
46756|NCT01256411|180418|P5|Extension by Maximum Treatment|Lost to Follow-up|0
46757|NCT01256411|180419|P4|Extension by Maximum Treatment|Lost to Follow-up|0
46758|NCT01256411|180420|P3|Extension by Maximum Treatment|Lost to Follow-up|0
46759|NCT01256411|180421|P2|Extension by Maximum Treatment|Lost to Follow-up|2
46760|NCT01256411|180422|P1|Extension by Maximum Treatment|Lost to Follow-up|1
46761|NCT01256411|180417|P6|Extension by Maximum Treatment|Protocol deviation|0
46762|NCT01256411|180418|P5|Extension by Maximum Treatment|Protocol deviation|0
46763|NCT01256411|180419|P4|Extension by Maximum Treatment|Protocol deviation|0
46764|NCT01256411|180420|P3|Extension by Maximum Treatment|Protocol deviation|1
46765|NCT01256411|180421|P2|Extension by Maximum Treatment|Protocol deviation|0
46766|NCT01256411|180422|P1|Extension by Maximum Treatment|Protocol deviation|0
46767|NCT01256385|180448|P2|Overall Study|Withdrawal by Subject|2
46768|NCT01256385|180449|P1|Overall Study|Withdrawal by Subject|2
46769|NCT01256385|180448|P2|Overall Study|Physician Decision|1
46770|NCT01256385|180449|P1|Overall Study|Physician Decision|1
46771|NCT01256294|180469|P2|Overall Study|Protocol deviation|1
46772|NCT01256294|180470|P1|Overall Study|Protocol deviation|2
46773|NCT01256294|180469|P2|Overall Study|Withdrawal by Subject|1
46774|NCT01256294|180470|P1|Overall Study|Withdrawal by Subject|1
46775|NCT01256294|180469|P2|Overall Study|Adverse Event|0
46776|NCT01256294|180470|P1|Overall Study|Adverse Event|1
46777|NCT01256190|180492|P2|Overall Study|Lost to Follow-up|0
46778|NCT01256190|180493|P1|Overall Study|Lost to Follow-up|2
46779|NCT01256177|180509|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
46780|NCT01256177|180510|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
46781|NCT01256177|180509|P2|Overall Study|Lack of Efficacy|2
46782|NCT01256177|180510|P1|Overall Study|Lack of Efficacy|11
46783|NCT01256177|180509|P2|Overall Study|Condition under Investigation Worsened|0
46784|NCT01256177|180510|P1|Overall Study|Condition under Investigation Worsened|1
46785|NCT01256177|180509|P2|Overall Study|Severe Non-Compliance to Protocol|2
46786|NCT01256177|180510|P1|Overall Study|Severe Non-Compliance to Protocol|4
46787|NCT01256177|180509|P2|Overall Study|Adverse Event|9
46788|NCT01256177|180510|P1|Overall Study|Adverse Event|8
46789|NCT01256177|180509|P2|Overall Study|Lost to Follow-up|2
46790|NCT01256177|180510|P1|Overall Study|Lost to Follow-up|2
46791|NCT01256177|180509|P2|Overall Study|Withdrawal by Subject|22
46792|NCT01256177|180510|P1|Overall Study|Withdrawal by Subject|23
46793|NCT01256060|180566|P4|Overall Study|Lost to Follow-up|0
46794|NCT01256060|180567|P3|Overall Study|Lost to Follow-up|0
46795|NCT01256060|180568|P2|Overall Study|Lost to Follow-up|1
46796|NCT01256060|180569|P1|Overall Study|Lost to Follow-up|0
46797|NCT01256008|180588|P3|Overall Study|Withdrawal by Subject|10
46798|NCT01256008|180589|P2|Overall Study|Withdrawal by Subject|3
46799|NCT01256008|180590|P1|Overall Study|Withdrawal by Subject|2
46800|NCT01256008|180588|P3|Overall Study|Lost to Follow-up|11
46801|NCT01256008|180589|P2|Overall Study|Lost to Follow-up|4
46802|NCT01256008|180590|P1|Overall Study|Lost to Follow-up|6
46803|NCT01255904|180612|P2|Overall Study|Physician Decision|4
46804|NCT01255904|180613|P1|Overall Study|Physician Decision|1
46805|NCT01255787|180623|P4|Overall Study|Noncompliance with Study Drug|0
46806|NCT01255787|180624|P3|Overall Study|Noncompliance with Study Drug|0
46807|NCT01255787|180625|P2|Overall Study|Noncompliance with Study Drug|1
46808|NCT01255787|180626|P1|Overall Study|Noncompliance with Study Drug|3
46809|NCT01255787|180623|P4|Overall Study|Lack of Efficacy|2
46810|NCT01255787|180624|P3|Overall Study|Lack of Efficacy|2
46811|NCT01255787|180625|P2|Overall Study|Lack of Efficacy|2
46812|NCT01255787|180626|P1|Overall Study|Lack of Efficacy|2
46813|NCT01255787|180623|P4|Overall Study|Pregnancy|1
46814|NCT01255787|180624|P3|Overall Study|Pregnancy|0
46815|NCT01255787|180625|P2|Overall Study|Pregnancy|0
46816|NCT01255787|180626|P1|Overall Study|Pregnancy|0
46817|NCT01255787|180623|P4|Overall Study|Withdrawal of Consent|4
46818|NCT01255787|180624|P3|Overall Study|Withdrawal of Consent|3
46819|NCT01255787|180625|P2|Overall Study|Withdrawal of Consent|9
46820|NCT01255787|180626|P1|Overall Study|Withdrawal of Consent|3
46821|NCT01255787|180623|P4|Overall Study|Lost to Follow-up|2
46822|NCT01255787|180624|P3|Overall Study|Lost to Follow-up|4
46823|NCT01255787|180625|P2|Overall Study|Lost to Follow-up|2
46824|NCT01255787|180626|P1|Overall Study|Lost to Follow-up|1
46825|NCT01255787|180623|P4|Overall Study|Major Protocol Deviation|4
46826|NCT01255787|180624|P3|Overall Study|Major Protocol Deviation|0
46827|NCT01255787|180625|P2|Overall Study|Major Protocol Deviation|1
46828|NCT01255787|180626|P1|Overall Study|Major Protocol Deviation|1
46829|NCT01255787|180623|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
46830|NCT01255787|180624|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
46831|NCT01255787|180625|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
46832|NCT01255787|180626|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
46833|NCT01255761|180654|P2|Overall Study|Other Reasons|18
46834|NCT01255761|180655|P1|Overall Study|Other Reasons|37
46835|NCT01255761|180654|P2|Overall Study|Withdrawal by Subject|27
46836|NCT01255761|180655|P1|Overall Study|Withdrawal by Subject|11
46837|NCT01255761|180654|P2|Overall Study|Lost to Follow-up|8
46838|NCT01255761|180655|P1|Overall Study|Lost to Follow-up|10
46839|NCT01255761|180654|P2|Overall Study|Protocol Violation|5
46840|NCT01255761|180655|P1|Overall Study|Protocol Violation|9
46841|NCT01255761|180654|P2|Overall Study|Lack of Efficacy|74
46842|NCT01255761|180655|P1|Overall Study|Lack of Efficacy|86
46843|NCT01255761|180654|P2|Overall Study|Adverse Event|43
46844|NCT01255761|180655|P1|Overall Study|Adverse Event|29
46845|NCT01255722|180740|P3|Overall Study|beta-blocker contraindicated|0
46846|NCT01255722|180741|P2|Overall Study|beta-blocker contraindicated|0
46847|NCT01255722|180742|P1|Overall Study|beta-blocker contraindicated|2
46848|NCT01255722|180740|P3|Overall Study|asymptomatic patient|0
46849|NCT01255722|180741|P2|Overall Study|asymptomatic patient|0
46850|NCT01255722|180742|P1|Overall Study|asymptomatic patient|1
46851|NCT01255722|180740|P3|Overall Study|Adverse Event|1
46852|NCT01255722|180741|P2|Overall Study|Adverse Event|1
46853|NCT01255722|180742|P1|Overall Study|Adverse Event|0
46854|NCT01255631|180767|P2|Overall Study|poor enrollment, no data analyzed|6
46855|NCT01255631|180768|P1|Overall Study|poor enrollment, no data analyzed|9
46856|NCT01255592|180786|P2|Overall Study|Other|1
46857|NCT01255592|180787|P1|Overall Study|Other|0
46858|NCT01255592|180786|P2|Overall Study|Withdrawal by Subject|0
46859|NCT01255592|180787|P1|Overall Study|Withdrawal by Subject|1
46860|NCT01255592|180786|P2|Overall Study|Adverse Event|0
46861|NCT01255592|180787|P1|Overall Study|Adverse Event|5
46862|NCT01255436|180850|P2|Overall Study|Death, stroke, or MI|3
46863|NCT01255436|180851|P1|Overall Study|Death, stroke, or MI|4
46864|NCT01255436|180850|P2|Overall Study|Lost to Follow-up|191
46865|NCT01255436|180851|P1|Overall Study|Lost to Follow-up|178
46866|NCT01255423|180865|P2|Overall Study|Use of prohibited medications|1
46867|NCT01255423|180866|P1|Overall Study|Use of prohibited medications|0
46868|NCT01255423|180865|P2|Overall Study|Abnormal Laboratory value|2
46869|NCT01255423|180866|P1|Overall Study|Abnormal Laboratory value|3
46870|NCT01255306|180882|P2|Overall Study|Physician Decision|1
46871|NCT01255306|180883|P1|Overall Study|Physician Decision|1
46872|NCT01254890|180894|P2|Overall Study|Disease Progression|5
46873|NCT01254890|180895|P1|Overall Study|Disease Progression|0
46874|NCT01254890|180894|P2|Overall Study|Withdrawal by Subject|2
46875|NCT01254890|180895|P1|Overall Study|Withdrawal by Subject|1
46876|NCT01254890|180894|P2|Overall Study|Ineligible|3
46877|NCT01254890|180895|P1|Overall Study|Ineligible|0
46878|NCT01254747|180929|P4|Overall Study|Discomfort|0
46879|NCT01254747|180930|P3|Overall Study|Discomfort|0
46880|NCT01254747|180931|P2|Overall Study|Discomfort|4
46881|NCT01254747|180932|P1|Overall Study|Discomfort|0
46882|NCT01254747|180929|P4|Overall Study|Biomicroscopy|0
46883|NCT01254747|180930|P3|Overall Study|Biomicroscopy|1
46884|NCT01254747|180931|P2|Overall Study|Biomicroscopy|0
46885|NCT01254747|180932|P1|Overall Study|Biomicroscopy|0
46886|NCT01254747|180929|P4|Overall Study|Lost to Follow-up|0
46887|NCT01254747|180930|P3|Overall Study|Lost to Follow-up|1
46888|NCT01254747|180931|P2|Overall Study|Lost to Follow-up|0
46889|NCT01254747|180932|P1|Overall Study|Lost to Follow-up|0
46890|NCT01254747|180929|P4|Overall Study|Symptoms and problems|0
46891|NCT01254747|180930|P3|Overall Study|Symptoms and problems|1
46892|NCT01254747|180931|P2|Overall Study|Symptoms and problems|2
46893|NCT01254747|180932|P1|Overall Study|Symptoms and problems|0
46894|NCT01254747|180929|P4|Overall Study|Difficult removal handling|0
46895|NCT01254747|180930|P3|Overall Study|Difficult removal handling|1
46896|NCT01254747|180931|P2|Overall Study|Difficult removal handling|0
46897|NCT01254747|180932|P1|Overall Study|Difficult removal handling|0
46898|NCT01254747|180929|P4|Overall Study|Unacceptable subjective vision|2
46899|NCT01254747|180930|P3|Overall Study|Unacceptable subjective vision|0
46900|NCT01254747|180931|P2|Overall Study|Unacceptable subjective vision|0
46901|NCT01254747|180932|P1|Overall Study|Unacceptable subjective vision|0
46902|NCT01254721|180972|P2|Overall Study|Wrongly randomization|1
46903|NCT01254721|180973|P1|Overall Study|Wrongly randomization|0
46904|NCT01254721|180972|P2|Overall Study|Withdrawal by Subject|11
46905|NCT01254721|180973|P1|Overall Study|Withdrawal by Subject|8
46906|NCT01254721|180972|P2|Overall Study|Adverse Event|3
46907|NCT01254721|180973|P1|Overall Study|Adverse Event|2
46908|NCT01254721|180972|P2|Overall Study|technical problum|0
46909|NCT01254721|180973|P1|Overall Study|technical problum|1
46910|NCT01254721|180972|P2|Overall Study|Death|1
46911|NCT01254721|180973|P1|Overall Study|Death|0
46912|NCT01254721|180972|P2|Overall Study|Lack of Efficacy|2
46913|NCT01254721|180973|P1|Overall Study|Lack of Efficacy|4
46914|NCT01254721|180972|P2|Overall Study|Lost to Follow-up|4
46915|NCT01254721|180973|P1|Overall Study|Lost to Follow-up|0
46916|NCT01254669|180983|P2|Overall Study|called to clinic visit during interventi|1
46917|NCT01254669|180984|P1|Overall Study|called to clinic visit during interventi|1
46918|NCT01254669|180983|P2|Overall Study|time constraint|2
46919|NCT01254669|180984|P1|Overall Study|time constraint|2
46920|NCT01254669|180983|P2|Overall Study|Withdrawal by Subject|1
46921|NCT01254669|180984|P1|Overall Study|Withdrawal by Subject|0
46922|NCT01254656|180995|P3|Overall Study|Death|0
46923|NCT01254656|180996|P2|Overall Study|Death|1
46924|NCT01254656|180997|P1|Overall Study|Death|0
46925|NCT01254656|180995|P3|Overall Study|Adverse Event|0
46926|NCT01254656|180996|P2|Overall Study|Adverse Event|1
46927|NCT01254656|180997|P1|Overall Study|Adverse Event|1
46928|NCT01254656|180995|P3|Overall Study|Pregnancy|2
46929|NCT01254656|180996|P2|Overall Study|Pregnancy|0
46930|NCT01254656|180997|P1|Overall Study|Pregnancy|0
46931|NCT01254656|180995|P3|Overall Study|Withdrawal by Subject|1
46932|NCT01254656|180996|P2|Overall Study|Withdrawal by Subject|2
46933|NCT01254656|180997|P1|Overall Study|Withdrawal by Subject|2
46934|NCT01254656|180995|P3|Overall Study|Lost to Follow-up|2
46935|NCT01254656|180996|P2|Overall Study|Lost to Follow-up|0
46936|NCT01254656|180997|P1|Overall Study|Lost to Follow-up|1
46937|NCT01254656|180995|P3|Overall Study|Lack of Efficacy|0
46938|NCT01254656|180996|P2|Overall Study|Lack of Efficacy|0
46939|NCT01254656|180997|P1|Overall Study|Lack of Efficacy|3
46940|NCT01254656|180995|P3|Overall Study|Discontinued due to termination of study|13
46941|NCT01254656|180996|P2|Overall Study|Discontinued due to termination of study|39
46942|NCT01254656|180997|P1|Overall Study|Discontinued due to termination of study|40
46943|NCT01254643|181023|P1|Overall Study|Withdrawal by Subject|1
46944|NCT01254604|181033|P2|Overall Study|Adverse Event|2
46945|NCT01254604|181034|P1|Overall Study|Adverse Event|3
46946|NCT01254604|181033|P2|Overall Study|Withdrawal by Subject|4
46947|NCT01254604|181034|P1|Overall Study|Withdrawal by Subject|2
46948|NCT01254604|181033|P2|Overall Study|Protocol Violation|2
46949|NCT01254604|181034|P1|Overall Study|Protocol Violation|2
46950|NCT01254604|181033|P2|Overall Study|Lost to Follow-up|1
46951|NCT01254604|181034|P1|Overall Study|Lost to Follow-up|1
46952|NCT01254409|181050|P4|Overall Study|Adverse Event|0
46953|NCT01254409|181051|P3|Overall Study|Adverse Event|0
46954|NCT01254409|181052|P2|Overall Study|Adverse Event|1
46955|NCT01254409|181053|P1|Overall Study|Adverse Event|0
46956|NCT01254344|181122|P2|Overall Study|Withdrawal by Subject|6
46957|NCT01254344|181123|P1|Overall Study|Withdrawal by Subject|3
46958|NCT01254344|181122|P2|Overall Study|Protocol Violation|4
46959|NCT01254344|181123|P1|Overall Study|Protocol Violation|1
46960|NCT01254344|181122|P2|Overall Study|Physician Decision|4
46961|NCT01254344|181123|P1|Overall Study|Physician Decision|7
46962|NCT01254344|181122|P2|Overall Study|Adverse Event|5
46963|NCT01254344|181123|P1|Overall Study|Adverse Event|2
46964|NCT01254331|181131|P1|Extension Phase|Lost to Follow-up|3
46965|NCT01254331|181131|P1|Extension Phase|Lack of Efficacy|1
46966|NCT01254331|181131|P1|Initial Phase|Pregnancy|1
46967|NCT01254331|181131|P1|Initial Phase|Withdrawal by Subject|1
46968|NCT01254331|181131|P1|Initial Phase|Adverse Event|3
46969|NCT01254318|181149|P1|Overall Study|Death|47
46970|NCT01254318|181149|P1|Overall Study|Lost to Follow-up|5
46971|NCT01254305|181158|P3|Overall Study|Other Reasons|2
46972|NCT01254305|181159|P2|Overall Study|Other Reasons|0
46973|NCT01254305|181160|P1|Overall Study|Other Reasons|0
46974|NCT01254305|181158|P3|Overall Study|Lost to Follow-up|5
46975|NCT01254305|181159|P2|Overall Study|Lost to Follow-up|6
46976|NCT01254305|181160|P1|Overall Study|Lost to Follow-up|10
46977|NCT01254305|181158|P3|Overall Study|Withdrawal by Subject|4
46978|NCT01254305|181159|P2|Overall Study|Withdrawal by Subject|2
46979|NCT01254305|181160|P1|Overall Study|Withdrawal by Subject|4
46980|NCT01254305|181158|P3|Overall Study|Protocol Violation|3
46981|NCT01254305|181159|P2|Overall Study|Protocol Violation|7
46982|NCT01254305|181160|P1|Overall Study|Protocol Violation|1
46983|NCT01254305|181158|P3|Overall Study|Lack of Efficacy|1
46984|NCT01254305|181159|P2|Overall Study|Lack of Efficacy|0
46985|NCT01254305|181160|P1|Overall Study|Lack of Efficacy|1
46986|NCT01254305|181158|P3|Overall Study|Adverse Event|2
46987|NCT01254305|181159|P2|Overall Study|Adverse Event|3
46988|NCT01254305|181160|P1|Overall Study|Adverse Event|6
46989|NCT01254292|181176|P2|LCS12 Extension Phase|Lost to Follow-up|0
46990|NCT01254292|181177|P1|LCS12 Extension Phase|Lost to Follow-up|1
46991|NCT01254292|181176|P2|LCS12 Extension Phase|Pregnancy|0
46992|NCT01254292|181177|P1|LCS12 Extension Phase|Pregnancy|2
46993|NCT01254292|181176|P2|LCS12 Extension Phase|Other unknown|0
46994|NCT01254292|181177|P1|LCS12 Extension Phase|Other unknown|4
46995|NCT01254292|181176|P2|LCS12 Extension Phase|Withdrawal by Subject|0
46996|NCT01254292|181177|P1|LCS12 Extension Phase|Withdrawal by Subject|7
46997|NCT01254292|181176|P2|LCS12 Extension Phase|Adverse Event|0
46998|NCT01254292|181177|P1|LCS12 Extension Phase|Adverse Event|9
46999|NCT01254292|181176|P2|LCS12 Extension Phase|Wish for pregnancy|0
47000|NCT01254292|181177|P1|LCS12 Extension Phase|Wish for pregnancy|14
47001|NCT01254292|181176|P2|Comparative Phase|Wish for pregnancy|6
47002|NCT01254292|181177|P1|Comparative Phase|Wish for pregnancy|4
47003|NCT01254292|181176|P2|Comparative Phase|Protocol Violation|2
47004|NCT01254292|181177|P1|Comparative Phase|Protocol Violation|1
47005|NCT01254292|181176|P2|Comparative Phase|Withdrawal by Subject|21
47006|NCT01254292|181177|P1|Comparative Phase|Withdrawal by Subject|20
47007|NCT01254292|181176|P2|Comparative Phase|Pregnancy|6
47008|NCT01254292|181177|P1|Comparative Phase|Pregnancy|2
47009|NCT01254292|181176|P2|Comparative Phase|Lost to Follow-up|21
47010|NCT01254292|181177|P1|Comparative Phase|Lost to Follow-up|3
47011|NCT01254292|181176|P2|Comparative Phase|Adverse Event|25
47012|NCT01254292|181177|P1|Comparative Phase|Adverse Event|25
47013|NCT01254188|181250|P1|Overall Study|per investigator discretion|20
47014|NCT01254188|181250|P1|Overall Study|Adverse Event|43
47015|NCT01254188|181250|P1|Overall Study|Withdrawal by Subject|7
47016|NCT01254188|181250|P1|Overall Study|Lost to Follow-up|5
47017|NCT01254188|181250|P1|Overall Study|Death|4
47018|NCT01254188|181250|P1|Overall Study|Pregnancy|2
47019|NCT01254188|181250|P1|Overall Study|Protocol Violation|6
47020|NCT01254188|181250|P1|Overall Study|Disease Progression|6
47021|NCT01254045|181261|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
47022|NCT01254045|181262|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
47023|NCT01254045|181263|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
47024|NCT01254045|181264|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
47025|NCT01254045|181265|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
47026|NCT01254045|181266|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
47027|NCT01253811|181320|P1|Overall Study|Withdrawal criteria|1
47028|NCT01253577|181339|P1|Overall Study|Lost to Follow-up|3
47029|NCT01253564|181347|P1|Overall Study|Serious Adverse Event|1
47030|NCT01253564|181347|P1|Overall Study|Withdrawal by Subject|1
47031|NCT01253564|181347|P1|Overall Study|Disease Progression|22
47032|NCT01253447|181391|P1|Overall Study|Adverse Event|2
47033|NCT01253408|181398|P3|Overall Study|Adverse Event|0
47034|NCT01253408|181399|P2|Overall Study|Adverse Event|1
47035|NCT01253408|181400|P1|Overall Study|Adverse Event|0
47036|NCT01253369|181423|P1|Overall Study|Not Evaluable|3
47037|NCT01253369|181423|P1|Overall Study|Progressive disease|23
47038|NCT01253369|181423|P1|Overall Study|Death|1
47039|NCT01253369|181423|P1|Overall Study|Withdrawal by Subject|2
47040|NCT01253369|181423|P1|Overall Study|Adverse Event|4
47041|NCT01253304|181457|P4|Overall Study|Adverse Event|1
47042|NCT01253304|181458|P3|Overall Study|Adverse Event|0
47043|NCT01253304|181459|P2|Overall Study|Adverse Event|0
47044|NCT01253304|181460|P1|Overall Study|Adverse Event|0
47045|NCT01253265|181499|P5|Overall Study|Withdrawal by Subject|1
47046|NCT01253265|181500|P4|Overall Study|Withdrawal by Subject|0
47047|NCT01253265|181501|P3|Overall Study|Withdrawal by Subject|0
47048|NCT01253265|181502|P2|Overall Study|Withdrawal by Subject|0
47049|NCT01253265|181503|P1|Overall Study|Withdrawal by Subject|0
47050|NCT01253265|181499|P5|Overall Study|Met Predefined Discontinuation Criteria|0
47051|NCT01253265|181500|P4|Overall Study|Met Predefined Discontinuation Criteria|0
47052|NCT01253265|181501|P3|Overall Study|Met Predefined Discontinuation Criteria|0
47053|NCT01253265|181502|P2|Overall Study|Met Predefined Discontinuation Criteria|0
47054|NCT01253265|181503|P1|Overall Study|Met Predefined Discontinuation Criteria|1
47055|NCT01253187|181547|P6|Period 3|non-compliance|0
47056|NCT01253187|181548|P5|Period 3|non-compliance|1
47057|NCT01253187|181549|P4|Period 3|non-compliance|0
47058|NCT01253187|181550|P3|Period 3|non-compliance|0
47059|NCT01253187|181551|P2|Period 3|non-compliance|0
47060|NCT01253187|181552|P1|Period 3|non-compliance|0
47061|NCT01253187|181547|P6|Period 3|difficulty with blood sampling|0
47062|NCT01253187|181548|P5|Period 3|difficulty with blood sampling|0
47063|NCT01253187|181549|P4|Period 3|difficulty with blood sampling|0
47064|NCT01253187|181550|P3|Period 3|difficulty with blood sampling|0
47065|NCT01253187|181551|P2|Period 3|difficulty with blood sampling|1
47066|NCT01253187|181552|P1|Period 3|difficulty with blood sampling|0
47067|NCT01253187|181547|P6|Period 3|Pregnancy|0
47068|NCT01253187|181548|P5|Period 3|Pregnancy|0
47069|NCT01253187|181549|P4|Period 3|Pregnancy|0
47070|NCT01253187|181550|P3|Period 3|Pregnancy|0
47071|NCT01253187|181551|P2|Period 3|Pregnancy|0
47072|NCT01253187|181552|P1|Period 3|Pregnancy|1
47073|NCT01253187|181547|P6|Period 2|Withdrawal by Subject|0
47074|NCT01253187|181548|P5|Period 2|Withdrawal by Subject|1
47075|NCT01253187|181549|P4|Period 2|Withdrawal by Subject|0
47076|NCT01253187|181550|P3|Period 2|Withdrawal by Subject|0
47077|NCT01253187|181551|P2|Period 2|Withdrawal by Subject|0
47078|NCT01253187|181552|P1|Period 2|Withdrawal by Subject|0
47079|NCT01253174|181581|P6|Period 3|Pregnancy|0
47080|NCT01253174|181582|P5|Period 3|Pregnancy|0
47081|NCT01253174|181583|P4|Period 3|Pregnancy|0
47082|NCT01253174|181584|P3|Period 3|Pregnancy|1
47083|NCT01253174|181585|P2|Period 3|Pregnancy|0
47084|NCT01253174|181586|P1|Period 3|Pregnancy|0
47085|NCT01253174|181581|P6|Period 3|Withdrawal by Subject|0
47086|NCT01253174|181582|P5|Period 3|Withdrawal by Subject|1
47087|NCT01253174|181583|P4|Period 3|Withdrawal by Subject|0
47088|NCT01253174|181584|P3|Period 3|Withdrawal by Subject|0
47089|NCT01253174|181585|P2|Period 3|Withdrawal by Subject|1
47090|NCT01253174|181586|P1|Period 3|Withdrawal by Subject|0
47091|NCT01253174|181581|P6|Period 2|Adverse Event|0
47092|NCT01253174|181582|P5|Period 2|Adverse Event|0
47093|NCT01253174|181583|P4|Period 2|Adverse Event|0
47094|NCT01253174|181584|P3|Period 2|Adverse Event|1
47095|NCT01253174|181585|P2|Period 2|Adverse Event|0
47096|NCT01253174|181586|P1|Period 2|Adverse Event|0
47097|NCT01253174|181581|P6|Period 1|Randomized but not treated|0
47098|NCT01253174|181582|P5|Period 1|Randomized but not treated|1
47099|NCT01253174|181583|P4|Period 1|Randomized but not treated|0
47100|NCT01253174|181584|P3|Period 1|Randomized but not treated|1
47101|NCT01253174|181585|P2|Period 1|Randomized but not treated|1
47102|NCT01253174|181586|P1|Period 1|Randomized but not treated|0
47103|NCT01253135|181621|P1|Amended Protocol|Non-compliance|1
47104|NCT01253135|181621|P1|Original Protocol|Protocol Amendment|15
47105|NCT01253044|181640|P2|Overall Study|Lost to Follow-up|29
47106|NCT01253044|181641|P1|Overall Study|Lost to Follow-up|38
47107|NCT01253018|181651|P2|Overall Study|Withdrawal by Subject|1
47108|NCT01253018|181652|P1|Overall Study|Withdrawal by Subject|1
47109|NCT01253018|181651|P2|Overall Study|Robot Repair Issues|0
47110|NCT01253018|181652|P1|Overall Study|Robot Repair Issues|2
47111|NCT01253018|181651|P2|Overall Study|Lost to Follow-up|1
47112|NCT01253018|181652|P1|Overall Study|Lost to Follow-up|1
47113|NCT01252966|181666|P2|Overall Study|Withdrawal by Subject|3
47114|NCT01252966|181667|P1|Overall Study|Withdrawal by Subject|7
47115|NCT01252966|181666|P2|Overall Study|Lost to Follow-up|10
47116|NCT01252966|181667|P1|Overall Study|Lost to Follow-up|16
47117|NCT01252940|181683|P2|Extension Phase|Withdrawal by Subject|1
47118|NCT01252940|181684|P1|Extension Phase|Withdrawal by Subject|1
47119|NCT01252940|181683|P2|Extension Phase|Subject Non-compliance|0
47120|NCT01252940|181684|P1|Extension Phase|Subject Non-compliance|1
47121|NCT01252940|181683|P2|Extension Phase|Physician Decision|1
47122|NCT01252940|181684|P1|Extension Phase|Physician Decision|0
47123|NCT01252940|181683|P2|Extension Phase|Lost to Follow-up|0
47124|NCT01252940|181684|P1|Extension Phase|Lost to Follow-up|5
47125|NCT01252940|181683|P2|Extension Phase|Lack of Efficacy|0
47126|NCT01252940|181684|P1|Extension Phase|Lack of Efficacy|1
47127|NCT01252940|181683|P2|Extension Phase|Adverse Event|1
47128|NCT01252940|181684|P1|Extension Phase|Adverse Event|2
47129|NCT01252940|181683|P2|Main Study Phase|Subject Non-compliance|1
47130|NCT01252940|181684|P1|Main Study Phase|Subject Non-compliance|1
47131|NCT01252940|181683|P2|Main Study Phase|Withdrawal by Subject|5
47132|NCT01252940|181684|P1|Main Study Phase|Withdrawal by Subject|6
47133|NCT01252940|181683|P2|Main Study Phase|Protocol Violation|2
47134|NCT01252940|181684|P1|Main Study Phase|Protocol Violation|4
47135|NCT01252940|181683|P2|Main Study Phase|Physician Decision|0
47136|NCT01252940|181684|P1|Main Study Phase|Physician Decision|1
47137|NCT01252940|181683|P2|Main Study Phase|Lost to Follow-up|1
47138|NCT01252940|181684|P1|Main Study Phase|Lost to Follow-up|6
47139|NCT01252940|181683|P2|Main Study Phase|Lack of Efficacy|0
47140|NCT01252940|181684|P1|Main Study Phase|Lack of Efficacy|1
47141|NCT01252940|181683|P2|Main Study Phase|Adverse Event|1
47142|NCT01252940|181684|P1|Main Study Phase|Adverse Event|3
47143|NCT01252940|181683|P2|Main Study Phase|Randomized but not treated|2
47144|NCT01252940|181684|P1|Main Study Phase|Randomized but not treated|4
47145|NCT01252810|181715|P2|Overall Study|Various reasons|0
47146|NCT01252810|181716|P1|Overall Study|Various reasons|8
47147|NCT01252810|181715|P2|Overall Study|Physician Decision|1
47148|NCT01252810|181716|P1|Overall Study|Physician Decision|2
47149|NCT01252810|181715|P2|Overall Study|Lost to Follow-up|1
47150|NCT01252810|181716|P1|Overall Study|Lost to Follow-up|0
47151|NCT01252810|181715|P2|Overall Study|Withdrawal by Subject|1
47152|NCT01252810|181716|P1|Overall Study|Withdrawal by Subject|4
47153|NCT01252355|181729|P3|Overall Study|Other Than Above|7
47154|NCT01252355|181730|P2|Overall Study|Other Than Above|7
47155|NCT01252355|181731|P1|Overall Study|Other Than Above|8
47156|NCT01252355|181729|P3|Overall Study|Randomized but not Treated|0
47157|NCT01252355|181730|P2|Overall Study|Randomized but not Treated|0
47158|NCT01252355|181731|P1|Overall Study|Randomized but not Treated|2
47159|NCT01252355|181729|P3|Overall Study|Sponsor Early Termination of Study|146
47160|NCT01252355|181730|P2|Overall Study|Sponsor Early Termination of Study|149
47161|NCT01252355|181731|P1|Overall Study|Sponsor Early Termination of Study|149
47162|NCT01252355|181729|P3|Overall Study|Progressive Disease|0
47163|NCT01252355|181730|P2|Overall Study|Progressive Disease|0
47164|NCT01252355|181731|P1|Overall Study|Progressive Disease|2
47165|NCT01252355|181729|P3|Overall Study|Poor Compliance to Protocol|1
47166|NCT01252355|181730|P2|Overall Study|Poor Compliance to Protocol|1
47167|NCT01252355|181731|P1|Overall Study|Poor Compliance to Protocol|1
47168|NCT01252355|181729|P3|Overall Study|Lost to Follow-up|1
47169|NCT01252355|181730|P2|Overall Study|Lost to Follow-up|0
47170|NCT01252355|181731|P1|Overall Study|Lost to Follow-up|0
47171|NCT01252355|181729|P3|Overall Study|Lack of Efficacy|2
47172|NCT01252355|181730|P2|Overall Study|Lack of Efficacy|4
47173|NCT01252355|181731|P1|Overall Study|Lack of Efficacy|6
47174|NCT01252355|181729|P3|Overall Study|Adverse Event|22
47175|NCT01252355|181730|P2|Overall Study|Adverse Event|17
47176|NCT01252355|181731|P1|Overall Study|Adverse Event|9
47177|NCT01252290|181769|P1|Overall Study|Withdrawal by Subject|1
47178|NCT01252238|181788|P3|Overall Study|Sponsor terminated study|4
47179|NCT01252238|181789|P2|Overall Study|Sponsor terminated study|4
47180|NCT01252238|181790|P1|Overall Study|Sponsor terminated study|4
47181|NCT01252186|181801|P3|Overall Study|Other - Miscellaneous Reasons|7
47182|NCT01252186|181802|P2|Overall Study|Other - Miscellaneous Reasons|5
47183|NCT01252186|181803|P1|Overall Study|Other - Miscellaneous Reasons|5
47184|NCT01252186|181801|P3|Overall Study|Lost to Follow-up|11
47185|NCT01252186|181802|P2|Overall Study|Lost to Follow-up|10
47186|NCT01252186|181803|P1|Overall Study|Lost to Follow-up|10
47187|NCT01252186|181801|P3|Overall Study|Sponsor Request|0
47188|NCT01252186|181802|P2|Overall Study|Sponsor Request|1
47189|NCT01252186|181803|P1|Overall Study|Sponsor Request|2
47190|NCT01252186|181801|P3|Overall Study|Pregnancy|0
47191|NCT01252186|181802|P2|Overall Study|Pregnancy|2
47192|NCT01252186|181803|P1|Overall Study|Pregnancy|2
47193|NCT01252186|181801|P3|Overall Study|Protocol Violation|1
47194|NCT01252186|181802|P2|Overall Study|Protocol Violation|0
47195|NCT01252186|181803|P1|Overall Study|Protocol Violation|0
47196|NCT01252186|181801|P3|Overall Study|Non-compliance|4
47197|NCT01252186|181802|P2|Overall Study|Non-compliance|3
47198|NCT01252186|181803|P1|Overall Study|Non-compliance|0
47199|NCT01252186|181801|P3|Overall Study|Physician Decision|1
47200|NCT01252186|181802|P2|Overall Study|Physician Decision|0
47201|NCT01252186|181803|P1|Overall Study|Physician Decision|0
47202|NCT01252186|181801|P3|Overall Study|Withdrawal by Subject|2
47203|NCT01252186|181802|P2|Overall Study|Withdrawal by Subject|5
47204|NCT01252186|181803|P1|Overall Study|Withdrawal by Subject|2
47205|NCT01252186|181801|P3|Overall Study|Adverse Event|8
47206|NCT01252186|181802|P2|Overall Study|Adverse Event|6
47207|NCT01252186|181803|P1|Overall Study|Adverse Event|9
47208|NCT01252134|181876|P6|Period 1, 8 Hours|Personal Reasons|0
47209|NCT01252134|181877|P5|Period 1, 8 Hours|Personal Reasons|0
47210|NCT01252134|181878|P4|Period 1, 8 Hours|Personal Reasons|0
47211|NCT01252134|181879|P3|Period 1, 8 Hours|Personal Reasons|1
47212|NCT01252134|181880|P2|Period 1, 8 Hours|Personal Reasons|1
47213|NCT01252134|181881|P1|Period 1, 8 Hours|Personal Reasons|0
47214|NCT01252095|181900|P2|Overall Study|Disease progression|0
47215|NCT01252095|181901|P1|Overall Study|Disease progression|1
47216|NCT01251952|181919|P1|Overall Study|Adverse Event|1
47217|NCT01251770|181925|P2|Overall Study|Protocol Violation|7
47218|NCT01251770|181926|P1|Overall Study|Protocol Violation|13
47219|NCT01251653|181977|P9|Overall Study|Other reason not mentioned above|0
47220|NCT01251653|181978|P8|Overall Study|Other reason not mentioned above|2
47221|NCT01251653|181979|P7|Overall Study|Other reason not mentioned above|0
47222|NCT01251653|181980|P6|Overall Study|Other reason not mentioned above|0
47223|NCT01251653|181981|P5|Overall Study|Other reason not mentioned above|0
47224|NCT01251653|181982|P4|Overall Study|Other reason not mentioned above|0
47225|NCT01251653|181983|P3|Overall Study|Other reason not mentioned above|0
47226|NCT01251653|181984|P2|Overall Study|Other reason not mentioned above|0
47227|NCT01251653|181985|P1|Overall Study|Other reason not mentioned above|0
47228|NCT01251653|181977|P9|Overall Study|Withdrawal by Subject|0
47229|NCT01251653|181978|P8|Overall Study|Withdrawal by Subject|1
47230|NCT01251653|181979|P7|Overall Study|Withdrawal by Subject|0
47231|NCT01251653|181980|P6|Overall Study|Withdrawal by Subject|1
47232|NCT01251653|181981|P5|Overall Study|Withdrawal by Subject|1
47233|NCT01251653|181982|P4|Overall Study|Withdrawal by Subject|0
47234|NCT01251653|181983|P3|Overall Study|Withdrawal by Subject|1
47235|NCT01251653|181984|P2|Overall Study|Withdrawal by Subject|0
47236|NCT01251653|181985|P1|Overall Study|Withdrawal by Subject|1
47237|NCT01251653|181977|P9|Overall Study|Adverse Event|1
47238|NCT01251653|181978|P8|Overall Study|Adverse Event|2
47239|NCT01251653|181979|P7|Overall Study|Adverse Event|2
47240|NCT01251653|181980|P6|Overall Study|Adverse Event|0
47241|NCT01251653|181981|P5|Overall Study|Adverse Event|1
47242|NCT01251653|181982|P4|Overall Study|Adverse Event|1
47243|NCT01251653|181983|P3|Overall Study|Adverse Event|2
47244|NCT01251653|181984|P2|Overall Study|Adverse Event|0
47245|NCT01251653|181985|P1|Overall Study|Adverse Event|1
47246|NCT01251653|181977|P9|Overall Study|Dose-limiting toxicity|0
47247|NCT01251653|181978|P8|Overall Study|Dose-limiting toxicity|0
47248|NCT01251653|181979|P7|Overall Study|Dose-limiting toxicity|2
47249|NCT01251653|181980|P6|Overall Study|Dose-limiting toxicity|0
47250|NCT01251653|181981|P5|Overall Study|Dose-limiting toxicity|0
47251|NCT01251653|181982|P4|Overall Study|Dose-limiting toxicity|1
47252|NCT01251653|181983|P3|Overall Study|Dose-limiting toxicity|1
47253|NCT01251653|181984|P2|Overall Study|Dose-limiting toxicity|1
47254|NCT01251653|181985|P1|Overall Study|Dose-limiting toxicity|0
47255|NCT01251653|181977|P9|Overall Study|Progressive Disease|5
47256|NCT01251653|181978|P8|Overall Study|Progressive Disease|7
47257|NCT01251653|181979|P7|Overall Study|Progressive Disease|14
47258|NCT01251653|181980|P6|Overall Study|Progressive Disease|17
47259|NCT01251653|181981|P5|Overall Study|Progressive Disease|0
47260|NCT01251653|181982|P4|Overall Study|Progressive Disease|4
47261|NCT01251653|181983|P3|Overall Study|Progressive Disease|16
47262|NCT01251653|181984|P2|Overall Study|Progressive Disease|7
47263|NCT01251653|181985|P1|Overall Study|Progressive Disease|1
47264|NCT01251354|182110|P1|Overall Study|Disease Progression|4
47265|NCT01251354|182110|P1|Overall Study|Investigator's Decision|1
47266|NCT01251354|182110|P1|Overall Study|Adverse Event|1
47267|NCT01251146|182153|P2|Overall Study|Lost to Follow-up|10
47268|NCT01251146|182154|P1|Overall Study|Lost to Follow-up|3
47269|NCT01251120|182176|P2|Overall Study|Lack of Efficacy|1
47270|NCT01251120|182177|P1|Overall Study|Lack of Efficacy|0
47271|NCT01250925|182242|P3|Overall Study|Adverse Event|1
47272|NCT01250925|182243|P2|Overall Study|Adverse Event|0
47273|NCT01250925|182244|P1|Overall Study|Adverse Event|0
47274|NCT01250925|182242|P3|Overall Study|Physician Decision|1
47275|NCT01250925|182243|P2|Overall Study|Physician Decision|2
47276|NCT01250925|182244|P1|Overall Study|Physician Decision|0
47277|NCT01250925|182242|P3|Overall Study|Protocol Violation|0
47278|NCT01250925|182243|P2|Overall Study|Protocol Violation|0
47279|NCT01250925|182244|P1|Overall Study|Protocol Violation|2
47280|NCT01250925|182242|P3|Overall Study|Withdrawal by Subject|0
47281|NCT01250925|182243|P2|Overall Study|Withdrawal by Subject|0
47282|NCT01250925|182244|P1|Overall Study|Withdrawal by Subject|2
47283|NCT01250925|182242|P3|Overall Study|Lost to Follow-up|0
47284|NCT01250925|182243|P2|Overall Study|Lost to Follow-up|1
47285|NCT01250925|182244|P1|Overall Study|Lost to Follow-up|1
47286|NCT01250769|182310|P4|Overall Study|Adverse Event|0
47287|NCT01250769|182311|P3|Overall Study|Adverse Event|1
47288|NCT01250769|182312|P2|Overall Study|Adverse Event|0
47289|NCT01250769|182313|P1|Overall Study|Adverse Event|0
47290|NCT01250769|182310|P4|Overall Study|Withdrawal by Subject|0
47291|NCT01250769|182311|P3|Overall Study|Withdrawal by Subject|1
47292|NCT01250769|182312|P2|Overall Study|Withdrawal by Subject|1
47293|NCT01250769|182313|P1|Overall Study|Withdrawal by Subject|0
47294|NCT01250756|182345|P2|After Toddler Dose|Adverse Event|1
47295|NCT01250756|182346|P1|After Toddler Dose|Adverse Event|0
47296|NCT01250756|182345|P2|Toddler Dose|Adverse Event|1
47297|NCT01250756|182346|P1|Toddler Dose|Adverse Event|0
47298|NCT01250756|182345|P2|After Infant Series|Unspecified|1
47299|NCT01250756|182346|P1|After Infant Series|Unspecified|2
47300|NCT01250756|182345|P2|After Infant Series|Withdrawal by Subject|1
47301|NCT01250756|182346|P1|After Infant Series|Withdrawal by Subject|4
47302|NCT01250756|182345|P2|After Infant Series|Adverse Event|2
47303|NCT01250756|182346|P1|After Infant Series|Adverse Event|5
47304|NCT01250756|182345|P2|Infant Series|Unspecified|0
47305|NCT01250756|182346|P1|Infant Series|Unspecified|22
47306|NCT01250756|182345|P2|Infant Series|Randomized, Not Vaccinated|2
47307|NCT01250756|182346|P1|Infant Series|Randomized, Not Vaccinated|2
47308|NCT01250756|182345|P2|Infant Series|Withdrawal by Subject|5
47309|NCT01250756|182346|P1|Infant Series|Withdrawal by Subject|4
47310|NCT01250509|182463|P2|Overall Study|Lost to Follow-up|2
47311|NCT01250509|182464|P1|Overall Study|Lost to Follow-up|5
47312|NCT01250418|182478|P2|Overall Study|monitor data failure|1
47313|NCT01250418|182479|P1|Overall Study|monitor data failure|1
47314|NCT01250379|182487|P2|Overall Study|Participant noncompliance|0
47315|NCT01250379|182488|P1|Overall Study|Participant noncompliance|2
47316|NCT01250379|182487|P2|Overall Study|Not specified|4
47317|NCT01250379|182488|P1|Overall Study|Not specified|0
47318|NCT01250379|182487|P2|Overall Study|Adverse Event|4
47319|NCT01250379|182488|P1|Overall Study|Adverse Event|5
47320|NCT01250379|182487|P2|Overall Study|Lost to Follow-up|6
47321|NCT01250379|182488|P1|Overall Study|Lost to Follow-up|9
47322|NCT01250379|182487|P2|Overall Study|Protocol Violation|8
47323|NCT01250379|182488|P1|Overall Study|Protocol Violation|2
47324|NCT01250379|182487|P2|Overall Study|Physician Decision|3
47325|NCT01250379|182488|P1|Overall Study|Physician Decision|11
47326|NCT01250379|182487|P2|Overall Study|Withdrawal by Subject|20
47327|NCT01250379|182488|P1|Overall Study|Withdrawal by Subject|32
47328|NCT01250379|182487|P2|Overall Study|Death|148
47329|NCT01250379|182488|P1|Overall Study|Death|141
47330|NCT01250171|182577|P3|Overall Study|Administrative reasons|0
47331|NCT01250171|182578|P2|Overall Study|Administrative reasons|0
47332|NCT01250171|182579|P1|Overall Study|Administrative reasons|1
47333|NCT01250145|182610|P2|Overall Study|Withdrawal by Subject|4
47334|NCT01250145|182611|P1|Overall Study|Withdrawal by Subject|0
47335|NCT01250145|182610|P2|Overall Study|Adverse Event|1
47336|NCT01250145|182611|P1|Overall Study|Adverse Event|2
47337|NCT01250119|182631|P2|Treatment Phase|Unknown reason|4
47338|NCT01250119|182632|P1|Treatment Phase|Unknown reason|0
47339|NCT01250119|182631|P2|Treatment Phase|Adverse Event|2
47340|NCT01250119|182632|P1|Treatment Phase|Adverse Event|0
47341|NCT01250119|182631|P2|Treatment Phase|Withdrawal by Subject|1
47342|NCT01250119|182632|P1|Treatment Phase|Withdrawal by Subject|0
47343|NCT01250119|182631|P2|Treatment Phase|Death|2
47344|NCT01250119|182632|P1|Treatment Phase|Death|0
47345|NCT01250119|182631|P2|Treatment Phase|Progressive Disease|32
47346|NCT01250119|182632|P1|Treatment Phase|Progressive Disease|0
47347|NCT01250119|182631|P2|Diagnostic Phase|Participants Not Tested|0
47348|NCT01250119|182632|P1|Diagnostic Phase|Participants Not Tested|44
47349|NCT01250119|182631|P2|Diagnostic Phase|Failed to Produce a Test Results|0
47350|NCT01250119|182632|P1|Diagnostic Phase|Failed to Produce a Test Results|69
47351|NCT01250054|182647|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
47352|NCT01250054|182648|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
47353|NCT01250002|182656|P2|Overall Study|Change to open surgical procedure|3
47354|NCT01250002|182657|P1|Overall Study|Change to open surgical procedure|4
47355|NCT01249664|182722|P2|Overall Study|Adverse Event|0
47356|NCT01249664|182723|P1|Overall Study|Adverse Event|1
47357|NCT01249664|182722|P2|Overall Study|Withdrawal by Subject|0
47358|NCT01249664|182723|P1|Overall Study|Withdrawal by Subject|5
47359|NCT01249651|182773|P1|Overall Study|Sponsor Decision|1
47360|NCT01249651|182773|P1|Overall Study|Protocol Violation|1
47361|NCT01249651|182773|P1|Overall Study|Adverse Event|1
47362|NCT01249651|182773|P1|Overall Study|Withdrawal by Subject|4
47363|NCT01249417|182783|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
47364|NCT01249417|182784|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
47365|NCT01249417|182785|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
47366|NCT01249417|182783|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
47367|NCT01249417|182784|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
47368|NCT01249417|182785|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
47369|NCT01249417|182783|P3|Treatment Phase - ITT Population|Adverse Event|1
47370|NCT01249417|182784|P2|Treatment Phase - ITT Population|Adverse Event|0
47371|NCT01249417|182785|P1|Treatment Phase - ITT Population|Adverse Event|0
47372|NCT01249417|182783|P3|Treatment Phase - ITT Population|Not specified|1
47373|NCT01249417|182784|P2|Treatment Phase - ITT Population|Not specified|0
47374|NCT01249417|182785|P1|Treatment Phase - ITT Population|Not specified|0
47375|NCT01249417|182783|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
47376|NCT01249417|182784|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
47377|NCT01249417|182785|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
47378|NCT01249417|182783|P3|Randomised Population|Study treatment not received|2
47379|NCT01249417|182784|P2|Randomised Population|Study treatment not received|0
47380|NCT01249417|182785|P1|Randomised Population|Study treatment not received|0
47381|NCT01249274|182801|P2|Overall Study|Received inpatient substance treatment|2
47382|NCT01249274|182802|P1|Overall Study|Received inpatient substance treatment|1
47383|NCT01249274|182801|P2|Overall Study|Lost to Follow-up|4
47384|NCT01249274|182802|P1|Overall Study|Lost to Follow-up|3
47385|NCT01249261|182828|P2|Overall Study|Withdrawal by Subject|0
47386|NCT01249261|182829|P1|Overall Study|Withdrawal by Subject|1
47387|NCT01249157|182857|P1|Overall Study|Withdrawal by Subject|1
47388|NCT01249131|182861|P6|Washout Period of 10 Days|Adverse Event|0
47389|NCT01249131|182862|P5|Washout Period of 10 Days|Adverse Event|1
47390|NCT01249131|182863|P4|Washout Period of 10 Days|Adverse Event|0
47391|NCT01249131|182864|P3|Washout Period of 10 Days|Adverse Event|0
47392|NCT01249131|182865|P2|Washout Period of 10 Days|Adverse Event|0
47393|NCT01249131|182866|P1|Washout Period of 10 Days|Adverse Event|0
47394|NCT01249118|182886|P3|First Washout Period|Physician Decision|0
47395|NCT01249118|182887|P2|First Washout Period|Physician Decision|1
47396|NCT01249118|182888|P1|First Washout Period|Physician Decision|0
47397|NCT01249092|182922|P1|Overall Study|Unable to tolerate expected SE -nausea|1
47398|NCT01249092|182922|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
47399|NCT01248936|182928|P1|Overall Study|Other reason|3
47400|NCT01248936|182928|P1|Overall Study|Refused Treatment|1
47401|NCT01248936|182928|P1|Overall Study|Lost to Follow-up|7
47402|NCT01248936|182928|P1|Overall Study|Adverse Event|8
47403|NCT01248936|182928|P1|Overall Study|Withdrawal of Consent|20
47404|NCT01248936|182928|P1|Overall Study|Death|26
47405|NCT01248936|182928|P1|Overall Study|Progression of Disease|50
47406|NCT01248936|182928|P1|Overall Study|Sponsor Decision|259
47407|NCT01248884|182941|P3|Overall Study|Adverse Event|0
47408|NCT01248884|182942|P2|Overall Study|Adverse Event|0
47409|NCT01248884|182943|P1|Overall Study|Adverse Event|1
47410|NCT01248884|182941|P3|Overall Study|Withdrawal by Subject|1
47411|NCT01248884|182942|P2|Overall Study|Withdrawal by Subject|3
47412|NCT01248884|182943|P1|Overall Study|Withdrawal by Subject|1
47413|NCT01248793|182995|P2|Overall Study|Withdrawal by Subject|3
47414|NCT01248793|182996|P1|Overall Study|Withdrawal by Subject|3
47415|NCT01248793|182995|P2|Overall Study|Protocol Violation|1
47416|NCT01248793|182996|P1|Overall Study|Protocol Violation|0
47417|NCT01248793|182995|P2|Overall Study|Adverse Event|1
47418|NCT01248793|182996|P1|Overall Study|Adverse Event|1
47419|NCT01248793|182995|P2|Overall Study|Lost to Follow-up|1
47420|NCT01248793|182996|P1|Overall Study|Lost to Follow-up|0
47421|NCT01248780|183010|P2|Overall Study|Not treated|1
47422|NCT01248780|183011|P1|Overall Study|Not treated|0
47423|NCT01248780|183010|P2|Overall Study|Withdrawal by Subject|4
47424|NCT01248780|183011|P1|Overall Study|Withdrawal by Subject|4
47425|NCT01248780|183010|P2|Overall Study|Protocol Violation|1
47426|NCT01248780|183011|P1|Overall Study|Protocol Violation|1
47427|NCT01248780|183010|P2|Overall Study|Adverse Event|7
47428|NCT01248780|183011|P1|Overall Study|Adverse Event|2
47429|NCT01248780|183010|P2|Overall Study|Death|1
47430|NCT01248780|183011|P1|Overall Study|Death|0
47431|NCT01248780|183010|P2|Overall Study|Lost to Follow-up|1
47432|NCT01248780|183011|P1|Overall Study|Lost to Follow-up|0
47433|NCT01248780|183010|P2|Overall Study|Lack of Efficacy|0
47434|NCT01248780|183011|P1|Overall Study|Lack of Efficacy|2
47435|NCT01248728|183025|P2|Overall Study|Lack of Efficacy|0
47436|NCT01248728|183026|P1|Overall Study|Lack of Efficacy|1
47437|NCT01248728|183025|P2|Overall Study|Withdrawal by Subject|1
47438|NCT01248728|183026|P1|Overall Study|Withdrawal by Subject|2
47439|NCT01248728|183025|P2|Overall Study|Adverse Event|1
47440|NCT01248728|183026|P1|Overall Study|Adverse Event|1
47441|NCT01248468|183043|P3|Overall Study|Withdrawal by Subject|0
47442|NCT01248468|183044|P2|Overall Study|Withdrawal by Subject|2
47443|NCT01248468|183045|P1|Overall Study|Withdrawal by Subject|4
47444|NCT01248468|183043|P3|Overall Study|Pregnancy|0
47445|NCT01248468|183044|P2|Overall Study|Pregnancy|0
47446|NCT01248468|183045|P1|Overall Study|Pregnancy|1
47447|NCT01248468|183043|P3|Overall Study|Lost to Follow-up|4
47448|NCT01248468|183044|P2|Overall Study|Lost to Follow-up|12
47449|NCT01248468|183045|P1|Overall Study|Lost to Follow-up|9
47450|NCT01248468|183043|P3|Overall Study|Administrative problem|0
47451|NCT01248468|183044|P2|Overall Study|Administrative problem|0
47452|NCT01248468|183045|P1|Overall Study|Administrative problem|1
47453|NCT01248455|183062|P1|Overall Study|switched to alternate treatment|1
47454|NCT01248364|183071|P4|Overall Study|Adverse Event|0
47455|NCT01248364|183072|P3|Overall Study|Adverse Event|0
47456|NCT01248364|183073|P2|Overall Study|Adverse Event|1
47457|NCT01248364|183074|P1|Overall Study|Adverse Event|0
47458|NCT01248130|183137|P2|Overall Study|Ineligible|0
47459|NCT01248130|183138|P1|Overall Study|Ineligible|1
47460|NCT01248130|183137|P2|Overall Study|Protocol Violation|0
47461|NCT01248130|183138|P1|Overall Study|Protocol Violation|1
47462|NCT01248065|183146|P2|Overall Study|Other|5
47463|NCT01248065|183147|P1|Overall Study|Other|3
47464|NCT01248065|183146|P2|Overall Study|Third treatment failure event|1
47465|NCT01248065|183147|P1|Overall Study|Third treatment failure event|3
47466|NCT01248065|183146|P2|Overall Study|Adverse Event|0
47467|NCT01248065|183147|P1|Overall Study|Adverse Event|3
47468|NCT01248065|183146|P2|Overall Study|Withdrawal by Subject|11
47469|NCT01248065|183147|P1|Overall Study|Withdrawal by Subject|14
47470|NCT01248065|183146|P2|Overall Study|Lost to Follow-up|5
47471|NCT01248065|183147|P1|Overall Study|Lost to Follow-up|3
47472|NCT01248013|183157|P1|Overall Study|Withdrawal by Subject|14
47473|NCT01247922|183172|P1|Overall Study|Disease progression|4
47474|NCT01245751|183254|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
47475|NCT01245751|183255|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
47476|NCT01245751|183256|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
47477|NCT01245751|183257|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
47478|NCT01245751|183254|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
47479|NCT01245751|183255|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
47480|NCT01245751|183256|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
47481|NCT01245751|183257|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
47482|NCT01245751|183254|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
47483|NCT01245751|183255|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
47484|NCT01245751|183256|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
47485|NCT01245751|183257|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
47486|NCT01247090|183316|P3|Overall Study|Withdrawal by Subject|0
47487|NCT01247090|183317|P2|Overall Study|Withdrawal by Subject|1
47488|NCT01247090|183318|P1|Overall Study|Withdrawal by Subject|0
47489|NCT01247090|183316|P3|Overall Study|Physician Decision|0
47490|NCT01247090|183317|P2|Overall Study|Physician Decision|0
47491|NCT01247090|183318|P1|Overall Study|Physician Decision|1
47492|NCT01246999|183347|P4|Overall Study|Withdrawal by Subject|2
47493|NCT01246999|183348|P3|Overall Study|Withdrawal by Subject|0
47494|NCT01246999|183349|P2|Overall Study|Withdrawal by Subject|0
47495|NCT01246999|183350|P1|Overall Study|Withdrawal by Subject|0
47496|NCT01246999|183347|P4|Overall Study|Lost to Follow-up|0
47497|NCT01246999|183348|P3|Overall Study|Lost to Follow-up|0
47498|NCT01246999|183349|P2|Overall Study|Lost to Follow-up|1
47499|NCT01246999|183350|P1|Overall Study|Lost to Follow-up|0
47500|NCT01246973|183385|P2|Overall Study|Withdrawal by Subject|13
47501|NCT01246973|183386|P1|Overall Study|Withdrawal by Subject|7
47502|NCT01246973|183385|P2|Overall Study|Adverse Event|9
47503|NCT01246973|183386|P1|Overall Study|Adverse Event|16
47504|NCT01246973|183385|P2|Overall Study|unspecified|25
47505|NCT01246973|183386|P1|Overall Study|unspecified|38
47506|NCT01246960|183396|P2|Overall Study|Withdrawal (by participant or physician)|3
47507|NCT01246960|183397|P1|Overall Study|Withdrawal (by participant or physician)|3
47508|NCT01246960|183396|P2|Overall Study|Lost to Follow-up|1
47509|NCT01246960|183397|P1|Overall Study|Lost to Follow-up|3
47510|NCT01246011|183471|P3|Overall Study|Withdrawal by Subject|1
47511|NCT01246011|183472|P2|Overall Study|Withdrawal by Subject|0
47512|NCT01246011|183473|P1|Overall Study|Withdrawal by Subject|0
47513|NCT01246011|183471|P3|Overall Study|If needed warfarin clinically, withdrawn|3
47514|NCT01246011|183472|P2|Overall Study|If needed warfarin clinically, withdrawn|0
47515|NCT01246011|183473|P1|Overall Study|If needed warfarin clinically, withdrawn|0
47516|NCT01245764|183485|P4|Study Phase A|Lost to Follow-up|0
47517|NCT01245764|183486|P3|Study Phase A|Lost to Follow-up|5
47518|NCT01245764|183487|P2|Study Phase A|Lost to Follow-up|0
47519|NCT01245764|183488|P1|Study Phase A|Lost to Follow-up|0
47520|NCT01245764|183485|P4|Study Phase A|Protocol Violation|2
47521|NCT01245764|183486|P3|Study Phase A|Protocol Violation|2
47522|NCT01245764|183487|P2|Study Phase A|Protocol Violation|3
47523|NCT01245764|183488|P1|Study Phase A|Protocol Violation|6
47524|NCT01245764|183485|P4|Study Phase A|Other|1
47525|NCT01245764|183486|P3|Study Phase A|Other|3
47526|NCT01245764|183487|P2|Study Phase A|Other|2
47527|NCT01245764|183488|P1|Study Phase A|Other|3
47528|NCT01245387|183560|P1|Overall Study|Missing discontinuation status|369
47529|NCT01245387|183560|P1|Overall Study|Unspecified|131
47530|NCT01245387|183560|P1|Overall Study|Death|3
47531|NCT01245387|183560|P1|Overall Study|Adverse Event|9
47532|NCT01245387|183560|P1|Overall Study|Lack of Efficacy|195
47533|NCT01245387|183560|P1|Overall Study|Lost to Follow-up|106
47534|NCT01245374|183609|P1|Overall Study|Withdrawal by Subject|3
47535|NCT01245374|183609|P1|Overall Study|Protocol Violation|1
47536|NCT01245283|183632|P3|Overall Study|Lost to Follow-up|11
47537|NCT01245283|183633|P2|Overall Study|Lost to Follow-up|11
47538|NCT01245283|183634|P1|Overall Study|Lost to Follow-up|14
47539|NCT01245101|183679|P2|Period 3 (Treatment)|Withdrawal by Subject|0
47540|NCT01245101|183680|P1|Period 3 (Treatment)|Withdrawal by Subject|1
47541|NCT01245101|183679|P2|Period 2 (Washout)|Withdrawal by Subject|0
47542|NCT01245101|183680|P1|Period 2 (Washout)|Withdrawal by Subject|1
47543|NCT01245101|183679|P2|Period 1 (Treatment)|Withdrawal by Subject|0
47544|NCT01245101|183680|P1|Period 1 (Treatment)|Withdrawal by Subject|2
47545|NCT01245062|183690|P3|Cross-over Phase|Ongoing|34
47546|NCT01245062|183691|P2|Cross-over Phase|Ongoing|0
47547|NCT01245062|183692|P1|Cross-over Phase|Ongoing|0
47548|NCT01245062|183690|P3|Cross-over Phase|Withdrew Consent|3
47549|NCT01245062|183691|P2|Cross-over Phase|Withdrew Consent|0
47550|NCT01245062|183692|P1|Cross-over Phase|Withdrew Consent|0
47551|NCT01245062|183690|P3|Cross-over Phase|Death|14
47552|NCT01245062|183691|P2|Cross-over Phase|Death|0
47553|NCT01245062|183692|P1|Cross-over Phase|Death|0
47554|NCT01245062|183690|P3|Randomization Phase|Ongoing|0
47555|NCT01245062|183691|P2|Randomization Phase|Ongoing|65
47556|NCT01245062|183692|P1|Randomization Phase|Ongoing|169
47557|NCT01245062|183690|P3|Randomization Phase|Withdrew Consent|0
47558|NCT01245062|183691|P2|Randomization Phase|Withdrew Consent|10
47559|NCT01245062|183692|P1|Randomization Phase|Withdrew Consent|6
47560|NCT01245062|183690|P3|Randomization Phase|Physician Decision|0
47561|NCT01245062|183691|P2|Randomization Phase|Physician Decision|3
47562|NCT01245062|183692|P1|Randomization Phase|Physician Decision|2
47563|NCT01245062|183690|P3|Randomization Phase|Lost to Follow-up|0
47564|NCT01245062|183691|P2|Randomization Phase|Lost to Follow-up|1
47565|NCT01245062|183692|P1|Randomization Phase|Lost to Follow-up|2
47566|NCT01245062|183690|P3|Randomization Phase|Death|0
47567|NCT01245062|183691|P2|Randomization Phase|Death|29
47568|NCT01245062|183692|P1|Randomization Phase|Death|35
47569|NCT01244984|183727|P3|Overall Study|Withdrawal by Subject|2
47570|NCT01244984|183728|P2|Overall Study|Withdrawal by Subject|2
47571|NCT01244984|183729|P1|Overall Study|Withdrawal by Subject|1
47572|NCT01244984|183727|P3|Overall Study|Protocol Defined Stopping Criteria|0
47573|NCT01244984|183728|P2|Overall Study|Protocol Defined Stopping Criteria|1
47574|NCT01244984|183729|P1|Overall Study|Protocol Defined Stopping Criteria|1
47575|NCT01244984|183727|P3|Overall Study|Protocol Violation|0
47576|NCT01244984|183728|P2|Overall Study|Protocol Violation|0
47577|NCT01244984|183729|P1|Overall Study|Protocol Violation|1
47578|NCT01244984|183727|P3|Overall Study|Adverse Event|2
47579|NCT01244984|183728|P2|Overall Study|Adverse Event|11
47580|NCT01244984|183729|P1|Overall Study|Adverse Event|2
47581|NCT01244906|183803|P1|Overall Study|Progression of disease post treatment|6
47582|NCT01244906|183803|P1|Overall Study|Death|2
47583|NCT01244893|183812|P2|1-Week Follow Up|Lost to Follow-up|0
47584|NCT01244893|183813|P1|1-Week Follow Up|Lost to Follow-up|1
47585|NCT01244893|183812|P2|Baseline|Protocol Violation|1
47586|NCT01244893|183813|P1|Baseline|Protocol Violation|0
47587|NCT01244828|183825|P1|Overall Study|Other reason (not specified)|1
47588|NCT01244828|183825|P1|Overall Study|Lost to Follow-up|2
47589|NCT01244828|183825|P1|Overall Study|Lack of Efficacy|7
47590|NCT01244828|183825|P1|Overall Study|Withdrawal by Subject|31
47591|NCT01244828|183825|P1|Overall Study|Adverse Event|37
47592|NCT01244815|183841|P4|Overall Study|Did Not Meet Protocol Eligibility|0
47593|NCT01244815|183842|P3|Overall Study|Did Not Meet Protocol Eligibility|0
47594|NCT01244815|183843|P2|Overall Study|Did Not Meet Protocol Eligibility|1
47595|NCT01244815|183844|P1|Overall Study|Did Not Meet Protocol Eligibility|0
47596|NCT01244815|183841|P4|Overall Study|Protocol Violation|1
47597|NCT01244815|183842|P3|Overall Study|Protocol Violation|3
47598|NCT01244815|183843|P2|Overall Study|Protocol Violation|4
47599|NCT01244815|183844|P1|Overall Study|Protocol Violation|7
47600|NCT01244815|183841|P4|Overall Study|Withdrawal by Subject|3
47601|NCT01244815|183842|P3|Overall Study|Withdrawal by Subject|0
47602|NCT01244815|183843|P2|Overall Study|Withdrawal by Subject|2
47603|NCT01244815|183844|P1|Overall Study|Withdrawal by Subject|0
47604|NCT01244815|183841|P4|Overall Study|Lost to Follow-up|2
47605|NCT01244815|183842|P3|Overall Study|Lost to Follow-up|3
47606|NCT01244815|183843|P2|Overall Study|Lost to Follow-up|2
47607|NCT01244815|183844|P1|Overall Study|Lost to Follow-up|3
47608|NCT01244815|183841|P4|Overall Study|Treatment Failure|1
47609|NCT01244815|183842|P3|Overall Study|Treatment Failure|0
47610|NCT01244815|183843|P2|Overall Study|Treatment Failure|0
47611|NCT01244815|183844|P1|Overall Study|Treatment Failure|0
47612|NCT01244815|183841|P4|Overall Study|Adverse Event|5
47613|NCT01244815|183842|P3|Overall Study|Adverse Event|5
47614|NCT01244815|183843|P2|Overall Study|Adverse Event|7
47615|NCT01244815|183844|P1|Overall Study|Adverse Event|4
47616|NCT01244815|183841|P4|Overall Study|Not Treated|0
47617|NCT01244815|183842|P3|Overall Study|Not Treated|0
47618|NCT01244815|183843|P2|Overall Study|Not Treated|1
47619|NCT01244815|183844|P1|Overall Study|Not Treated|0
47620|NCT01244620|183930|P4|Overall Study|Study terminated|4
47621|NCT01244620|183931|P3|Overall Study|Study terminated|4
47622|NCT01244620|183932|P2|Overall Study|Study terminated|4
47623|NCT01244620|183933|P1|Overall Study|Study terminated|4
47624|NCT01244516|183992|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
47625|NCT01244516|183993|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
47626|NCT01244516|183994|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
47627|NCT01244516|183992|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
47628|NCT01244516|183993|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
47629|NCT01244516|183994|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
47630|NCT01244516|183992|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
47631|NCT01244516|183993|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
47632|NCT01244516|183994|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
47633|NCT01244516|183992|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
47634|NCT01244516|183993|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
47635|NCT01244516|183994|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
47636|NCT01244516|183992|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
47637|NCT01244516|183993|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
47638|NCT01244516|183994|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
47639|NCT01244516|183992|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
47640|NCT01244516|183993|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
47641|NCT01244516|183994|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
47642|NCT01244516|183992|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
47643|NCT01244516|183993|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
47644|NCT01244516|183994|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
47645|NCT01244490|184015|P3|Overall Study|Not specified|1
47646|NCT01244490|184016|P2|Overall Study|Not specified|0
47647|NCT01244490|184017|P1|Overall Study|Not specified|0
47648|NCT01244490|184015|P3|Overall Study|Lost to Follow-up|3
47649|NCT01244490|184016|P2|Overall Study|Lost to Follow-up|6
47650|NCT01244490|184017|P1|Overall Study|Lost to Follow-up|0
47651|NCT01244490|184015|P3|Overall Study|Adverse Event|5
47652|NCT01244490|184016|P2|Overall Study|Adverse Event|9
47653|NCT01244490|184017|P1|Overall Study|Adverse Event|1
47654|NCT01244490|184015|P3|Overall Study|Withdrawal by Subject|9
47655|NCT01244490|184016|P2|Overall Study|Withdrawal by Subject|4
47656|NCT01244490|184017|P1|Overall Study|Withdrawal by Subject|4
47657|NCT01244490|184015|P3|Overall Study|Lack of Efficacy|5
47658|NCT01244490|184016|P2|Overall Study|Lack of Efficacy|5
47659|NCT01244490|184017|P1|Overall Study|Lack of Efficacy|14
47660|NCT01244425|184085|P2|Overall Study|Adverse Event|1
47661|NCT01244425|184086|P1|Overall Study|Adverse Event|1
47662|NCT01244425|184085|P2|Overall Study|Withdrawal by Subject|2
47663|NCT01244425|184086|P1|Overall Study|Withdrawal by Subject|2
47664|NCT01244126|184118|P3|Overall Study|Protocol Violation|9
47665|NCT01244126|184119|P2|Overall Study|Protocol Violation|3
47666|NCT01244126|184120|P1|Overall Study|Protocol Violation|3
47667|NCT01244061|184133|P2|Overall Study|Randomized but not treated|2
47668|NCT01244061|184134|P1|Overall Study|Randomized but not treated|2
47669|NCT01244061|184133|P2|Overall Study|Adverse Event|2
47670|NCT01244061|184134|P1|Overall Study|Adverse Event|5
47671|NCT01244061|184133|P2|Overall Study|Protocol Violation|1
47672|NCT01244061|184134|P1|Overall Study|Protocol Violation|1
47673|NCT01244061|184133|P2|Overall Study|Not specified|19
47674|NCT01244061|184134|P1|Overall Study|Not specified|8
47675|NCT01244061|184133|P2|Overall Study|Withdrawal by Subject|46
47676|NCT01244061|184134|P1|Overall Study|Withdrawal by Subject|29
47677|NCT01244061|184133|P2|Overall Study|Lost to Follow-up|30
47678|NCT01244061|184134|P1|Overall Study|Lost to Follow-up|34
47679|NCT01244061|184133|P2|Overall Study|Lack of Efficacy|3
47680|NCT01244061|184134|P1|Overall Study|Lack of Efficacy|1
47681|NCT01244061|184133|P2|Overall Study|Did not meet entrance criteria|0
47682|NCT01244061|184134|P1|Overall Study|Did not meet entrance criteria|1
47683|NCT01244061|184133|P2|Overall Study|Death|0
47684|NCT01244061|184134|P1|Overall Study|Death|1
47685|NCT01243944|184148|P2|Overall Study|Physician Decision|2
47686|NCT01243944|184149|P1|Overall Study|Physician Decision|2
47687|NCT01243944|184148|P2|Overall Study|Patient decision|5
47688|NCT01243944|184149|P1|Overall Study|Patient decision|6
47689|NCT01243944|184148|P2|Overall Study|Disease progression|1
47690|NCT01243944|184149|P1|Overall Study|Disease progression|5
47691|NCT01243944|184148|P2|Overall Study|Lack of Efficacy|98
47692|NCT01243944|184149|P1|Overall Study|Lack of Efficacy|0
47693|NCT01243944|184148|P2|Overall Study|Adverse Event|2
47694|NCT01243944|184149|P1|Overall Study|Adverse Event|4
47695|NCT01243892|184173|P2|Overall Study|Did not meet eligibility criteria|0
47696|NCT01243892|184174|P1|Overall Study|Did not meet eligibility criteria|2
47697|NCT01243775|184184|P1|Overall Study|Withdrawal by Subject|2
47698|NCT01243671|184191|P1|Overall Study|Not Specified|1
47699|NCT01243671|184191|P1|Overall Study|Anti-adalimumab antibody positive|1
47700|NCT01243671|184191|P1|Overall Study|Adverse Event|3
47701|NCT01243411|184238|P1|Overall Study|Other|8
47702|NCT01243411|184238|P1|Overall Study|Adverse Event|5
47703|NCT01243411|184238|P1|Overall Study|Lost to Follow-up|10
47704|NCT01243411|184238|P1|Overall Study|Withdrawal by Subject|18
47705|NCT01243242|184345|P2|Overall Study|non compliance|0
47706|NCT01243242|184346|P1|Overall Study|non compliance|1
47707|NCT01243242|184345|P2|Overall Study|sponsor decision|1
47708|NCT01243242|184346|P1|Overall Study|sponsor decision|0
47709|NCT01243242|184345|P2|Overall Study|Physician Decision|1
47710|NCT01243242|184346|P1|Overall Study|Physician Decision|0
47711|NCT01243242|184345|P2|Overall Study|Withdrawal by Subject|1
47712|NCT01243242|184346|P1|Overall Study|Withdrawal by Subject|1
47713|NCT01243242|184345|P2|Overall Study|Adverse Event|1
47714|NCT01243242|184346|P1|Overall Study|Adverse Event|1
47715|NCT01243177|184360|P2|Overall Study|Other Reason|12
47716|NCT01243177|184361|P1|Overall Study|Other Reason|11
47717|NCT01243177|184360|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
47718|NCT01243177|184361|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
47719|NCT01243177|184360|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
47720|NCT01243177|184361|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
47721|NCT01243177|184360|P2|Overall Study|AE, non-serious non-fatal|58
47722|NCT01243177|184361|P1|Overall Study|AE, non-serious non-fatal|40
47723|NCT01243177|184360|P2|Overall Study|SAE, non-fatal|9
47724|NCT01243177|184361|P1|Overall Study|SAE, non-fatal|7
47725|NCT01243177|184360|P2|Overall Study|AE, serious fatal|1
47726|NCT01243177|184361|P1|Overall Study|AE, serious fatal|0
47727|NCT01243177|184360|P2|Overall Study|Withdrawal by Subject|38
47728|NCT01243177|184361|P1|Overall Study|Withdrawal by Subject|46
47729|NCT01243177|184360|P2|Overall Study|Lost to Follow-up|18
47730|NCT01243177|184361|P1|Overall Study|Lost to Follow-up|15
47731|NCT01243177|184360|P2|Overall Study|Protocol Violation|10
47732|NCT01243177|184361|P1|Overall Study|Protocol Violation|11
47733|NCT01243177|184360|P2|Overall Study|Lack of Efficacy|31
47734|NCT01243177|184361|P1|Overall Study|Lack of Efficacy|47
47735|NCT01242813|184382|P1|Overall Study|Lost to Follow-up|2
47736|NCT01242748|184404|P2|Overall Study|Miscellaneous reasons|3
47737|NCT01242748|184405|P1|Overall Study|Miscellaneous reasons|8
47738|NCT01242748|184404|P2|Overall Study|Withdrawal by Subject|2
47739|NCT01242748|184405|P1|Overall Study|Withdrawal by Subject|10
47740|NCT01242748|184404|P2|Overall Study|Protocol Violation|0
47741|NCT01242748|184405|P1|Overall Study|Protocol Violation|1
47742|NCT01242748|184404|P2|Overall Study|Physician Decision|2
47743|NCT01242748|184405|P1|Overall Study|Physician Decision|3
47744|NCT01242748|184404|P2|Overall Study|Lost to Follow-up|2
47745|NCT01242748|184405|P1|Overall Study|Lost to Follow-up|6
47746|NCT01242748|184404|P2|Overall Study|Adverse Event|5
47747|NCT01242748|184405|P1|Overall Study|Adverse Event|10
47748|NCT01242514|184445|P3|Overall Study|Adverse Event|19
47749|NCT01242514|184446|P2|Overall Study|Adverse Event|18
47750|NCT01242514|184447|P1|Overall Study|Adverse Event|129
47751|NCT01242514|184445|P3|Overall Study|Lost to Follow-up|4
47752|NCT01242514|184446|P2|Overall Study|Lost to Follow-up|5
47753|NCT01242514|184447|P1|Overall Study|Lost to Follow-up|14
47754|NCT01242514|184445|P3|Overall Study|Dev. of study specific discont. criteria|5
47755|NCT01242514|184446|P2|Overall Study|Dev. of study specific discont. criteria|3
47756|NCT01242514|184447|P1|Overall Study|Dev. of study specific discont. criteria|21
47757|NCT01242514|184445|P3|Overall Study|Lack of therapeutic response|10
47758|NCT01242514|184446|P2|Overall Study|Lack of therapeutic response|16
47759|NCT01242514|184447|P1|Overall Study|Lack of therapeutic response|99
47760|NCT01242514|184445|P3|Overall Study|Severe non-compliance to protocol|1
47761|NCT01242514|184446|P2|Overall Study|Severe non-compliance to protocol|2
47762|NCT01242514|184447|P1|Overall Study|Severe non-compliance to protocol|5
47763|NCT01242514|184445|P3|Overall Study|Subject decision|2
47764|NCT01242514|184446|P2|Overall Study|Subject decision|8
47765|NCT01242514|184447|P1|Overall Study|Subject decision|33
47766|NCT01242514|184445|P3|Overall Study|e.g., project closure|171
47767|NCT01242514|184446|P2|Overall Study|e.g., project closure|305
47768|NCT01242514|184447|P1|Overall Study|e.g., project closure|1042
47769|NCT01242371|184466|P2|Overall Study|Protocol Violation|3
47770|NCT01242371|184467|P1|Overall Study|Protocol Violation|0
47771|NCT01242371|184466|P2|Overall Study|Withdrawal by Subject|2
47772|NCT01242371|184467|P1|Overall Study|Withdrawal by Subject|2
47773|NCT01242176|184473|P2|Washout Period of 7 Days|Non-compliant with protocol|0
47774|NCT01242176|184474|P1|Washout Period of 7 Days|Non-compliant with protocol|1
47775|NCT01242176|184473|P2|Washout Period of 7 Days|Adverse Event|2
47776|NCT01242176|184474|P1|Washout Period of 7 Days|Adverse Event|0
47777|NCT01242111|184484|P1|Overall Study|Did not consent to MOR-100 follow-up|1
47778|NCT01242111|184484|P1|Overall Study|Withdrawal by Subject|1
47779|NCT01242111|184484|P1|Overall Study|Adverse Event|1
47780|NCT01242085|184496|P3|Overall Study|medically unable to have surgery|0
47781|NCT01242085|184497|P2|Overall Study|medically unable to have surgery|5
47782|NCT01242085|184498|P1|Overall Study|medically unable to have surgery|4
47783|NCT01242085|184496|P3|Overall Study|Withdrawal by Subject|0
47784|NCT01242085|184497|P2|Overall Study|Withdrawal by Subject|2
47785|NCT01242085|184498|P1|Overall Study|Withdrawal by Subject|4
47786|NCT01241760|184528|P2|Overall Study|Not specified|1
47787|NCT01241760|184529|P1|Overall Study|Not specified|1
47788|NCT01241760|184528|P2|Overall Study|Switch To Commercially Available Medicat|4
47789|NCT01241760|184529|P1|Overall Study|Switch To Commercially Available Medicat|1
47790|NCT01241760|184528|P2|Overall Study|Withdrawal by Subject|13
47791|NCT01241760|184529|P1|Overall Study|Withdrawal by Subject|13
47792|NCT01241760|184528|P2|Overall Study|Lost to Follow-up|22
47793|NCT01241760|184529|P1|Overall Study|Lost to Follow-up|18
47794|NCT01241760|184528|P2|Overall Study|Adverse Event|0
47795|NCT01241760|184529|P1|Overall Study|Adverse Event|1
47796|NCT01241591|184552|P4|Overall Study|Adverse Event|4
47797|NCT01241591|184553|P3|Overall Study|Adverse Event|12
47798|NCT01241591|184554|P2|Overall Study|Adverse Event|11
47799|NCT01241591|184555|P1|Overall Study|Adverse Event|3
47800|NCT01241591|184552|P4|Overall Study|Not specified|1
47801|NCT01241591|184553|P3|Overall Study|Not specified|0
47802|NCT01241591|184554|P2|Overall Study|Not specified|1
47803|NCT01241591|184555|P1|Overall Study|Not specified|0
47804|NCT01241591|184552|P4|Overall Study|Withdrawal by Subject|2
47805|NCT01241591|184553|P3|Overall Study|Withdrawal by Subject|2
47806|NCT01241591|184554|P2|Overall Study|Withdrawal by Subject|4
47807|NCT01241591|184555|P1|Overall Study|Withdrawal by Subject|6
47808|NCT01241591|184552|P4|Overall Study|Screen Failure|0
47809|NCT01241591|184553|P3|Overall Study|Screen Failure|1
47810|NCT01241591|184554|P2|Overall Study|Screen Failure|2
47811|NCT01241591|184555|P1|Overall Study|Screen Failure|3
47812|NCT01241591|184552|P4|Overall Study|Lost to Follow-up|2
47813|NCT01241591|184553|P3|Overall Study|Lost to Follow-up|2
47814|NCT01241591|184554|P2|Overall Study|Lost to Follow-up|2
47815|NCT01241591|184555|P1|Overall Study|Lost to Follow-up|1
47816|NCT01241591|184552|P4|Overall Study|Protocol Violation|0
47817|NCT01241591|184553|P3|Overall Study|Protocol Violation|3
47818|NCT01241591|184554|P2|Overall Study|Protocol Violation|2
47819|NCT01241591|184555|P1|Overall Study|Protocol Violation|5
47820|NCT01241591|184552|P4|Overall Study|Lack of Efficacy|3
47821|NCT01241591|184553|P3|Overall Study|Lack of Efficacy|2
47822|NCT01241591|184554|P2|Overall Study|Lack of Efficacy|2
47823|NCT01241591|184555|P1|Overall Study|Lack of Efficacy|5
47824|NCT01241552|184758|P4|Overall Study|Lost to Follow-up|16
47825|NCT01241552|184759|P3|Overall Study|Lost to Follow-up|15
47826|NCT01241552|184760|P2|Overall Study|Lost to Follow-up|11
47827|NCT01241552|184761|P1|Overall Study|Lost to Follow-up|2
47828|NCT01241552|184758|P4|Overall Study|Physician Decision|3
47829|NCT01241552|184759|P3|Overall Study|Physician Decision|2
47830|NCT01241552|184760|P2|Overall Study|Physician Decision|4
47831|NCT01241552|184761|P1|Overall Study|Physician Decision|2
47832|NCT01241552|184758|P4|Overall Study|Withdrawal by Subject|15
47833|NCT01241552|184759|P3|Overall Study|Withdrawal by Subject|14
47834|NCT01241552|184760|P2|Overall Study|Withdrawal by Subject|15
47835|NCT01241552|184761|P1|Overall Study|Withdrawal by Subject|7
47836|NCT01241552|184758|P4|Overall Study|Protocol Violation|1
47837|NCT01241552|184759|P3|Overall Study|Protocol Violation|6
47838|NCT01241552|184760|P2|Overall Study|Protocol Violation|2
47839|NCT01241552|184761|P1|Overall Study|Protocol Violation|0
47840|NCT01241552|184758|P4|Overall Study|Progressive Disease|2
47841|NCT01241552|184759|P3|Overall Study|Progressive Disease|1
47842|NCT01241552|184760|P2|Overall Study|Progressive Disease|0
47843|NCT01241552|184761|P1|Overall Study|Progressive Disease|0
47844|NCT01241552|184758|P4|Overall Study|Technical Problems|2
47845|NCT01241552|184759|P3|Overall Study|Technical Problems|2
47846|NCT01241552|184760|P2|Overall Study|Technical Problems|0
47847|NCT01241552|184761|P1|Overall Study|Technical Problems|2
47848|NCT01241552|184758|P4|Overall Study|Adverse Event|0
47849|NCT01241552|184759|P3|Overall Study|Adverse Event|0
47850|NCT01241552|184760|P2|Overall Study|Adverse Event|1
47851|NCT01241552|184761|P1|Overall Study|Adverse Event|1
47852|NCT01241552|184758|P4|Overall Study|Death|25
47853|NCT01241552|184759|P3|Overall Study|Death|20
47854|NCT01241552|184760|P2|Overall Study|Death|30
47855|NCT01241552|184761|P1|Overall Study|Death|26
47856|NCT01241552|184758|P4|Overall Study|Lack of Efficacy|0
47857|NCT01241552|184759|P3|Overall Study|Lack of Efficacy|0
47858|NCT01241552|184760|P2|Overall Study|Lack of Efficacy|0
47859|NCT01241552|184761|P1|Overall Study|Lack of Efficacy|1
47860|NCT01241292|184856|P2|Overall Study|Withdrawal by Subject|2
47861|NCT01241292|184857|P1|Overall Study|Withdrawal by Subject|0
47862|NCT01241292|184856|P2|Overall Study|Disease Progression|0
47863|NCT01241292|184857|P1|Overall Study|Disease Progression|1
47864|NCT01241279|184881|P2|Overall Study|Lost to Follow-up|1
47865|NCT01241279|184882|P1|Overall Study|Lost to Follow-up|0
47866|NCT01241240|184892|P2|Overall Study|Personal Reasons|1
47867|NCT01241240|184893|P1|Overall Study|Personal Reasons|1
47868|NCT01241240|184892|P2|Overall Study|Lost to Follow-up|4
47869|NCT01241240|184893|P1|Overall Study|Lost to Follow-up|2
47870|NCT01241240|184892|P2|Overall Study|Adverse Event|4
47871|NCT01241240|184893|P1|Overall Study|Adverse Event|5
47872|NCT01240915|184911|P9|Overall Study|Insufficient Clinical Response|3
47873|NCT01240915|184912|P8|Overall Study|Insufficient Clinical Response|0
47874|NCT01240915|184913|P7|Overall Study|Insufficient Clinical Response|6
47875|NCT01240915|184914|P6|Overall Study|Insufficient Clinical Response|3
47876|NCT01240915|184915|P5|Overall Study|Insufficient Clinical Response|1
47877|NCT01240915|184916|P4|Overall Study|Insufficient Clinical Response|0
47878|NCT01240915|184917|P3|Overall Study|Insufficient Clinical Response|0
47879|NCT01240915|184918|P2|Overall Study|Insufficient Clinical Response|0
47880|NCT01240915|184919|P1|Overall Study|Insufficient Clinical Response|0
47881|NCT01240915|184911|P9|Overall Study|Unspecified|0
47882|NCT01240915|184912|P8|Overall Study|Unspecified|0
47883|NCT01240915|184913|P7|Overall Study|Unspecified|0
47884|NCT01240915|184914|P6|Overall Study|Unspecified|0
47885|NCT01240915|184915|P5|Overall Study|Unspecified|2
47886|NCT01240915|184916|P4|Overall Study|Unspecified|0
47887|NCT01240915|184917|P3|Overall Study|Unspecified|0
47888|NCT01240915|184918|P2|Overall Study|Unspecified|0
47889|NCT01240915|184919|P1|Overall Study|Unspecified|0
47890|NCT01240915|184911|P9|Overall Study|Withdrawal by Subject|3
47891|NCT01240915|184912|P8|Overall Study|Withdrawal by Subject|3
47892|NCT01240915|184913|P7|Overall Study|Withdrawal by Subject|2
47893|NCT01240915|184914|P6|Overall Study|Withdrawal by Subject|4
47894|NCT01240915|184915|P5|Overall Study|Withdrawal by Subject|0
47895|NCT01240915|184916|P4|Overall Study|Withdrawal by Subject|2
47896|NCT01240915|184917|P3|Overall Study|Withdrawal by Subject|0
47897|NCT01240915|184918|P2|Overall Study|Withdrawal by Subject|1
47898|NCT01240915|184919|P1|Overall Study|Withdrawal by Subject|2
47899|NCT01240915|184911|P9|Overall Study|Lost to Follow-up|1
47900|NCT01240915|184912|P8|Overall Study|Lost to Follow-up|1
47901|NCT01240915|184913|P7|Overall Study|Lost to Follow-up|0
47902|NCT01240915|184914|P6|Overall Study|Lost to Follow-up|1
47903|NCT01240915|184915|P5|Overall Study|Lost to Follow-up|1
47904|NCT01240915|184916|P4|Overall Study|Lost to Follow-up|0
47905|NCT01240915|184917|P3|Overall Study|Lost to Follow-up|0
47906|NCT01240915|184918|P2|Overall Study|Lost to Follow-up|0
47907|NCT01240915|184919|P1|Overall Study|Lost to Follow-up|0
47908|NCT01240915|184911|P9|Overall Study|Adverse Event|1
47909|NCT01240915|184912|P8|Overall Study|Adverse Event|0
47910|NCT01240915|184913|P7|Overall Study|Adverse Event|0
47911|NCT01240915|184914|P6|Overall Study|Adverse Event|2
47912|NCT01240915|184915|P5|Overall Study|Adverse Event|0
47913|NCT01240915|184916|P4|Overall Study|Adverse Event|1
47914|NCT01240915|184917|P3|Overall Study|Adverse Event|0
47915|NCT01240915|184918|P2|Overall Study|Adverse Event|0
47916|NCT01240915|184919|P1|Overall Study|Adverse Event|0
47917|NCT01240811|185194|P3|Overall Study|Withdrawal by Subject|1
47918|NCT01240811|185195|P2|Overall Study|Withdrawal by Subject|0
47919|NCT01240811|185196|P1|Overall Study|Withdrawal by Subject|0
47920|NCT01240811|185194|P3|Overall Study|Physician Decision|0
47921|NCT01240811|185195|P2|Overall Study|Physician Decision|1
47922|NCT01240811|185196|P1|Overall Study|Physician Decision|0
47923|NCT01240785|185206|P2|Overall Study|Protocol Violation|3
47924|NCT01240785|185207|P1|Overall Study|Protocol Violation|0
47925|NCT01240785|185206|P2|Overall Study|Lost to Follow-up|0
47926|NCT01240785|185207|P1|Overall Study|Lost to Follow-up|1
47927|NCT01240746|185238|P3|Overall Study|Withdrawal by Subject|59
47928|NCT01240746|185239|P2|Overall Study|Withdrawal by Subject|13
47929|NCT01240746|185240|P1|Overall Study|Withdrawal by Subject|10
47930|NCT01240746|185238|P3|Overall Study|Protocol Violation|72
47931|NCT01240746|185239|P2|Overall Study|Protocol Violation|15
47932|NCT01240746|185240|P1|Overall Study|Protocol Violation|24
47933|NCT01240746|185238|P3|Overall Study|Lost to Follow-up|102
47934|NCT01240746|185239|P2|Overall Study|Lost to Follow-up|20
47935|NCT01240746|185240|P1|Overall Study|Lost to Follow-up|23
47936|NCT01240746|185238|P3|Overall Study|Adverse Event|10
47937|NCT01240746|185239|P2|Overall Study|Adverse Event|0
47938|NCT01240746|185240|P1|Overall Study|Adverse Event|2
47939|NCT01240590|185295|P5|Phase II|Refused further treatment|1
47940|NCT01240590|185296|P4|Phase II|Refused further treatment|2
47941|NCT01240590|185297|P3|Phase II|Refused further treatment|0
47942|NCT01240590|185298|P2|Phase II|Refused further treatment|0
47943|NCT01240590|185299|P1|Phase II|Refused further treatment|0
47944|NCT01240590|185295|P5|Phase I|Refused further treatment|0
47945|NCT01240590|185296|P4|Phase I|Refused further treatment|0
47946|NCT01240590|185297|P3|Phase I|Refused further treatment|3
47947|NCT01240590|185298|P2|Phase I|Refused further treatment|0
47948|NCT01240590|185299|P1|Phase I|Refused further treatment|0
47949|NCT01240551|185317|P2|Overall Study|Lost to Follow-up|1
47950|NCT01240551|185318|P1|Overall Study|Lost to Follow-up|1
47951|NCT01240551|185317|P2|Overall Study|Refused further treatment|2
47952|NCT01240551|185318|P1|Overall Study|Refused further treatment|3
47953|NCT01240382|185328|P2|Overall Study|Fear of adverse events|1
47954|NCT01240382|185329|P1|Overall Study|Fear of adverse events|0
47955|NCT01240382|185328|P2|Overall Study|Lack of Efficacy|2
47956|NCT01240382|185329|P1|Overall Study|Lack of Efficacy|0
47957|NCT01240382|185328|P2|Overall Study|Adverse Event|1
47958|NCT01240382|185329|P1|Overall Study|Adverse Event|2
47959|NCT01240356|185339|P2|Overall Study|MRI contraindication|0
47960|NCT01240356|185340|P1|Overall Study|MRI contraindication|1
47961|NCT01240356|185339|P2|Overall Study|Withdrawal by Subject|0
47962|NCT01240356|185340|P1|Overall Study|Withdrawal by Subject|2
47963|NCT01240200|185359|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
47964|NCT01240200|185360|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
47965|NCT01240135|185368|P2|Period Two, 14 Days of Wear|Adverse Event|1
47966|NCT01240135|185369|P1|Period Two, 14 Days of Wear|Adverse Event|0
47967|NCT01240135|185368|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
47968|NCT01240135|185369|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
47969|NCT01239992|185384|P1|Overall Study|Withdrawal by Subject|2
47970|NCT01239797|185393|P2|Treated Participants|Poor/Non-compliance|1
47971|NCT01239797|185394|P1|Treated Participants|Poor/Non-compliance|0
47972|NCT01239797|185393|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
47973|NCT01239797|185394|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
47974|NCT01239797|185393|P2|Treated Participants|Death|1
47975|NCT01239797|185394|P1|Treated Participants|Death|1
47976|NCT01239797|185393|P2|Treated Participants|Non-specified|11
47977|NCT01239797|185394|P1|Treated Participants|Non-specified|1
47978|NCT01239797|185393|P2|Treated Participants|Withdrawal by Subject|23
47979|NCT01239797|185394|P1|Treated Participants|Withdrawal by Subject|27
47980|NCT01239797|185393|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
47981|NCT01239797|185394|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
47982|NCT01239797|185393|P2|Treated Participants|Study Drug Toxicity|44
47983|NCT01239797|185394|P1|Treated Participants|Study Drug Toxicity|30
47984|NCT01239797|185393|P2|Treated Participants|Disease Progression|161
47985|NCT01239797|185394|P1|Treated Participants|Disease Progression|153
47986|NCT01239745|185402|P1|Overall Study|Adverse Event|1
47987|NCT01239745|185402|P1|Overall Study|Study terminated by sponsor|45
47988|NCT01239732|185413|P1|Overall Study|Unspecified|19
47989|NCT01239732|185413|P1|Overall Study|Treatment failure|2
47990|NCT01239732|185413|P1|Overall Study|Investigator's decision|4
47991|NCT01239732|185413|P1|Overall Study|Study termination by sponsor|2
47992|NCT01239732|185413|P1|Overall Study|Participant non compliance|5
47993|NCT01239732|185413|P1|Overall Study|Protocol Violation|3
47994|NCT01239732|185413|P1|Overall Study|Adverse Event|6
47995|NCT01239732|185413|P1|Overall Study|Withdrawal by Subject|87
47996|NCT01239732|185413|P1|Overall Study|Death|226
47997|NCT01239732|185413|P1|Overall Study|Termination of study per protocol|667
47998|NCT01239680|185426|P2|Overall Study|Withdrawal by Subject|0
47999|NCT01239680|185427|P1|Overall Study|Withdrawal by Subject|2
48000|NCT01239316|185456|P1|Overall Study|Adverse Event|1
48001|NCT01239316|185456|P1|Overall Study|Progression/Relapse|11
48002|NCT01239121|185471|P3|Overall Study|Withdrawal by Subject|0
48003|NCT01239121|185472|P2|Overall Study|Withdrawal by Subject|4
48004|NCT01239121|185473|P1|Overall Study|Withdrawal by Subject|2
48005|NCT01239043|185495|P2|Overall Study|Protocol Violation|1
48006|NCT01239043|185496|P1|Overall Study|Protocol Violation|2
48007|NCT01238991|185524|P10|Overall Study|Admission to a nursing home|0
48008|NCT01238991|185525|P9|Overall Study|Admission to a nursing home|0
48009|NCT01238991|185526|P8|Overall Study|Admission to a nursing home|0
48010|NCT01238991|185527|P7|Overall Study|Admission to a nursing home|0
48011|NCT01238991|185528|P6|Overall Study|Admission to a nursing home|0
48012|NCT01238991|185529|P5|Overall Study|Admission to a nursing home|0
48013|NCT01238991|185530|P4|Overall Study|Admission to a nursing home|0
48014|NCT01238991|185531|P3|Overall Study|Admission to a nursing home|1
48015|NCT01238991|185532|P2|Overall Study|Admission to a nursing home|0
48016|NCT01238991|185533|P1|Overall Study|Admission to a nursing home|1
48017|NCT01238991|185524|P10|Overall Study|Caregiver's request|0
48018|NCT01238991|185525|P9|Overall Study|Caregiver's request|1
48019|NCT01238991|185526|P8|Overall Study|Caregiver's request|0
48020|NCT01238991|185527|P7|Overall Study|Caregiver's request|0
48021|NCT01238991|185528|P6|Overall Study|Caregiver's request|0
48022|NCT01238991|185529|P5|Overall Study|Caregiver's request|0
48023|NCT01238991|185530|P4|Overall Study|Caregiver's request|0
48024|NCT01238991|185531|P3|Overall Study|Caregiver's request|0
48025|NCT01238991|185532|P2|Overall Study|Caregiver's request|0
48026|NCT01238991|185533|P1|Overall Study|Caregiver's request|0
48027|NCT01238991|185524|P10|Overall Study|Study Terminated by Sponsor|2
48028|NCT01238991|185525|P9|Overall Study|Study Terminated by Sponsor|2
48029|NCT01238991|185526|P8|Overall Study|Study Terminated by Sponsor|4
48030|NCT01238991|185527|P7|Overall Study|Study Terminated by Sponsor|7
48031|NCT01238991|185528|P6|Overall Study|Study Terminated by Sponsor|0
48032|NCT01238991|185529|P5|Overall Study|Study Terminated by Sponsor|1
48033|NCT01238991|185530|P4|Overall Study|Study Terminated by Sponsor|0
48034|NCT01238991|185531|P3|Overall Study|Study Terminated by Sponsor|0
48035|NCT01238991|185532|P2|Overall Study|Study Terminated by Sponsor|0
48036|NCT01238991|185533|P1|Overall Study|Study Terminated by Sponsor|0
48037|NCT01238991|185524|P10|Overall Study|Withdrawal by Subject|0
48038|NCT01238991|185525|P9|Overall Study|Withdrawal by Subject|0
48039|NCT01238991|185526|P8|Overall Study|Withdrawal by Subject|0
48040|NCT01238991|185527|P7|Overall Study|Withdrawal by Subject|0
48041|NCT01238991|185528|P6|Overall Study|Withdrawal by Subject|0
48042|NCT01238991|185529|P5|Overall Study|Withdrawal by Subject|0
48043|NCT01238991|185530|P4|Overall Study|Withdrawal by Subject|0
48044|NCT01238991|185531|P3|Overall Study|Withdrawal by Subject|1
48045|NCT01238991|185532|P2|Overall Study|Withdrawal by Subject|0
48046|NCT01238991|185533|P1|Overall Study|Withdrawal by Subject|0
48047|NCT01238991|185524|P10|Overall Study|Lack of Efficacy|0
48048|NCT01238991|185525|P9|Overall Study|Lack of Efficacy|1
48049|NCT01238991|185526|P8|Overall Study|Lack of Efficacy|0
48050|NCT01238991|185527|P7|Overall Study|Lack of Efficacy|0
48051|NCT01238991|185528|P6|Overall Study|Lack of Efficacy|0
48052|NCT01238991|185529|P5|Overall Study|Lack of Efficacy|0
48053|NCT01238991|185530|P4|Overall Study|Lack of Efficacy|0
48054|NCT01238991|185531|P3|Overall Study|Lack of Efficacy|1
48055|NCT01238991|185532|P2|Overall Study|Lack of Efficacy|0
48056|NCT01238991|185533|P1|Overall Study|Lack of Efficacy|0
48057|NCT01238991|185524|P10|Overall Study|Death|0
48058|NCT01238991|185525|P9|Overall Study|Death|0
48059|NCT01238991|185526|P8|Overall Study|Death|0
48060|NCT01238991|185527|P7|Overall Study|Death|0
48061|NCT01238991|185528|P6|Overall Study|Death|0
48062|NCT01238991|185529|P5|Overall Study|Death|0
48063|NCT01238991|185530|P4|Overall Study|Death|1
48064|NCT01238991|185531|P3|Overall Study|Death|0
48065|NCT01238991|185532|P2|Overall Study|Death|0
48066|NCT01238991|185533|P1|Overall Study|Death|0
48067|NCT01238991|185524|P10|Overall Study|Adverse Event|0
48068|NCT01238991|185525|P9|Overall Study|Adverse Event|0
48069|NCT01238991|185526|P8|Overall Study|Adverse Event|1
48070|NCT01238991|185527|P7|Overall Study|Adverse Event|1
48071|NCT01238991|185528|P6|Overall Study|Adverse Event|0
48072|NCT01238991|185529|P5|Overall Study|Adverse Event|1
48073|NCT01238991|185530|P4|Overall Study|Adverse Event|1
48074|NCT01238991|185531|P3|Overall Study|Adverse Event|3
48075|NCT01238991|185532|P2|Overall Study|Adverse Event|0
48076|NCT01238991|185533|P1|Overall Study|Adverse Event|1
48077|NCT01238900|185620|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
48078|NCT01238900|185620|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
48079|NCT01238861|185634|P6|Overall Study|Withdrawal by Subject|9
48080|NCT01238861|185635|P5|Overall Study|Withdrawal by Subject|10
48081|NCT01238861|185636|P4|Overall Study|Withdrawal by Subject|8
48082|NCT01238861|185637|P3|Overall Study|Withdrawal by Subject|4
48083|NCT01238861|185638|P2|Overall Study|Withdrawal by Subject|5
48084|NCT01238861|185639|P1|Overall Study|Withdrawal by Subject|6
48085|NCT01238861|185634|P6|Overall Study|Adverse Event|0
48086|NCT01238861|185635|P5|Overall Study|Adverse Event|0
48087|NCT01238861|185636|P4|Overall Study|Adverse Event|0
48088|NCT01238861|185637|P3|Overall Study|Adverse Event|0
48089|NCT01238861|185638|P2|Overall Study|Adverse Event|1
48090|NCT01238861|185639|P1|Overall Study|Adverse Event|0
48091|NCT01238861|185634|P6|Overall Study|Lack of compliance|1
48092|NCT01238861|185635|P5|Overall Study|Lack of compliance|0
48093|NCT01238861|185636|P4|Overall Study|Lack of compliance|0
48094|NCT01238861|185637|P3|Overall Study|Lack of compliance|0
48095|NCT01238861|185638|P2|Overall Study|Lack of compliance|0
48096|NCT01238861|185639|P1|Overall Study|Lack of compliance|0
48097|NCT01238861|185634|P6|Overall Study|Serious adverse event|1
48098|NCT01238861|185635|P5|Overall Study|Serious adverse event|0
48099|NCT01238861|185636|P4|Overall Study|Serious adverse event|0
48100|NCT01238861|185637|P3|Overall Study|Serious adverse event|0
48101|NCT01238861|185638|P2|Overall Study|Serious adverse event|0
48102|NCT01238861|185639|P1|Overall Study|Serious adverse event|0
48103|NCT01238861|185634|P6|Overall Study|Unable to continue visits|1
48104|NCT01238861|185635|P5|Overall Study|Unable to continue visits|0
48105|NCT01238861|185636|P4|Overall Study|Unable to continue visits|1
48106|NCT01238861|185637|P3|Overall Study|Unable to continue visits|0
48107|NCT01238861|185638|P2|Overall Study|Unable to continue visits|0
48108|NCT01238861|185639|P1|Overall Study|Unable to continue visits|0
48109|NCT01238861|185634|P6|Overall Study|Personal problems|0
48110|NCT01238861|185635|P5|Overall Study|Personal problems|0
48111|NCT01238861|185636|P4|Overall Study|Personal problems|1
48112|NCT01238861|185637|P3|Overall Study|Personal problems|0
48113|NCT01238861|185638|P2|Overall Study|Personal problems|0
48114|NCT01238861|185639|P1|Overall Study|Personal problems|0
48115|NCT01238861|185634|P6|Overall Study|Strongyloides stercoralis antibodies +|0
48116|NCT01238861|185635|P5|Overall Study|Strongyloides stercoralis antibodies +|0
48117|NCT01238861|185636|P4|Overall Study|Strongyloides stercoralis antibodies +|1
48118|NCT01238861|185637|P3|Overall Study|Strongyloides stercoralis antibodies +|0
48119|NCT01238861|185638|P2|Overall Study|Strongyloides stercoralis antibodies +|0
48120|NCT01238861|185639|P1|Overall Study|Strongyloides stercoralis antibodies +|0
48121|NCT01238861|185634|P6|Overall Study|Subject moved out of state/area|0
48122|NCT01238861|185635|P5|Overall Study|Subject moved out of state/area|0
48123|NCT01238861|185636|P4|Overall Study|Subject moved out of state/area|1
48124|NCT01238861|185637|P3|Overall Study|Subject moved out of state/area|1
48125|NCT01238861|185638|P2|Overall Study|Subject moved out of state/area|0
48126|NCT01238861|185639|P1|Overall Study|Subject moved out of state/area|0
48127|NCT01238861|185634|P6|Overall Study|Subject traveled to Argentina by 1 year|0
48128|NCT01238861|185635|P5|Overall Study|Subject traveled to Argentina by 1 year|0
48129|NCT01238861|185636|P4|Overall Study|Subject traveled to Argentina by 1 year|0
48130|NCT01238861|185637|P3|Overall Study|Subject traveled to Argentina by 1 year|1
48131|NCT01238861|185638|P2|Overall Study|Subject traveled to Argentina by 1 year|0
48132|NCT01238861|185639|P1|Overall Study|Subject traveled to Argentina by 1 year|0
48133|NCT01238861|185634|P6|Overall Study|Incorrect enrollment/randomization|0
48134|NCT01238861|185635|P5|Overall Study|Incorrect enrollment/randomization|1
48135|NCT01238861|185636|P4|Overall Study|Incorrect enrollment/randomization|0
48136|NCT01238861|185637|P3|Overall Study|Incorrect enrollment/randomization|1
48137|NCT01238861|185638|P2|Overall Study|Incorrect enrollment/randomization|0
48138|NCT01238861|185639|P1|Overall Study|Incorrect enrollment/randomization|0
48139|NCT01238861|185634|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
48140|NCT01238861|185635|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
48141|NCT01238861|185636|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
48142|NCT01238861|185637|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
48143|NCT01238861|185638|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
48144|NCT01238861|185639|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
48145|NCT01238861|185634|P6|Overall Study|Unplanned surgery|0
48146|NCT01238861|185635|P5|Overall Study|Unplanned surgery|0
48147|NCT01238861|185636|P4|Overall Study|Unplanned surgery|0
48148|NCT01238861|185637|P3|Overall Study|Unplanned surgery|0
48149|NCT01238861|185638|P2|Overall Study|Unplanned surgery|0
48150|NCT01238861|185639|P1|Overall Study|Unplanned surgery|1
48151|NCT01238861|185634|P6|Overall Study|Lost to Follow-up|2
48152|NCT01238861|185635|P5|Overall Study|Lost to Follow-up|1
48153|NCT01238861|185636|P4|Overall Study|Lost to Follow-up|1
48154|NCT01238861|185637|P3|Overall Study|Lost to Follow-up|3
48155|NCT01238861|185638|P2|Overall Study|Lost to Follow-up|2
48156|NCT01238861|185639|P1|Overall Study|Lost to Follow-up|4
48157|NCT01238848|185719|P2|Overall Study|Physician Decision|5
48158|NCT01238848|185720|P1|Overall Study|Physician Decision|13
48159|NCT01238822|185728|P1|Overall Study|COULD NOT SWALLOW PILLS|3
48160|NCT01238575|185757|P2|Overall Study|Adverse Event|0
48161|NCT01238575|185758|P1|Overall Study|Adverse Event|2
48162|NCT01238575|185757|P2|Overall Study|Lack of Efficacy|4
48163|NCT01238575|185758|P1|Overall Study|Lack of Efficacy|2
48164|NCT01238211|185810|P1|Overall Study|Investigator/Patient Decision|3
48165|NCT01238211|185810|P1|Overall Study|Non-protocol treatment|4
48166|NCT01238211|185810|P1|Overall Study|Withdrawal by Subject|7
48167|NCT01238211|185810|P1|Overall Study|Relapse/Progression|2
48168|NCT01238211|185810|P1|Overall Study|Death|4
48169|NCT01238211|185810|P1|Overall Study|Adverse Event|7
48170|NCT01238211|185810|P1|Overall Study|Continues active treatment|31
48171|NCT01237340|185843|P1|Overall Study|Early termination of the trial|36
48172|NCT01237340|185843|P1|Overall Study|Withdrawal by Subject|1
48173|NCT01237340|185843|P1|Overall Study|Adverse Event|3
48174|NCT01237327|185857|P2|Overall Study|Lost to Follow-up|0
48175|NCT01237327|185858|P1|Overall Study|Lost to Follow-up|3
48176|NCT01237327|185857|P2|Overall Study|Withdrawal by Subject|3
48177|NCT01237327|185858|P1|Overall Study|Withdrawal by Subject|1
48178|NCT01237327|185857|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
48179|NCT01237327|185858|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
48180|NCT01237327|185857|P2|Overall Study|Progression of Disease: Extension Study|13
48181|NCT01237327|185858|P1|Overall Study|Progression of Disease: Extension Study|15
48182|NCT01237327|185857|P2|Overall Study|Progression of Disease: Core Study|22
48183|NCT01237327|185858|P1|Overall Study|Progression of Disease: Core Study|18
48184|NCT01237327|185857|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
48185|NCT01237327|185858|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
48186|NCT01237327|185857|P2|Overall Study|Protocol Violation: Core Study|0
48187|NCT01237327|185858|P1|Overall Study|Protocol Violation: Core Study|1
48188|NCT01237223|185887|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
48189|NCT01237223|185888|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
48190|NCT01237223|185889|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
48191|NCT01237223|185890|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
48192|NCT01237223|185891|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
48193|NCT01237223|185892|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
48194|NCT01237223|185887|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
48195|NCT01237223|185888|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
48196|NCT01237223|185889|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
48197|NCT01237223|185890|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
48198|NCT01237223|185891|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
48199|NCT01237223|185892|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
48200|NCT01237223|185887|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
48201|NCT01237223|185888|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
48202|NCT01237223|185889|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
48203|NCT01237223|185890|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
48204|NCT01237223|185891|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
48205|NCT01237223|185892|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
48206|NCT01237223|185887|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
48207|NCT01237223|185888|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
48208|NCT01237223|185889|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
48209|NCT01237223|185890|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
48210|NCT01237223|185891|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
48211|NCT01237223|185892|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
48212|NCT01237223|185887|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
48213|NCT01237223|185888|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
48214|NCT01237223|185889|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
48215|NCT01237223|185890|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
48216|NCT01237223|185891|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
48217|NCT01237223|185892|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
48218|NCT01237223|185887|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
48219|NCT01237223|185888|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
48220|NCT01237223|185889|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
48221|NCT01237223|185890|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
48222|NCT01237223|185891|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
48223|NCT01237223|185892|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
48224|NCT01237223|185887|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
48225|NCT01237223|185888|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
48226|NCT01237223|185889|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
48227|NCT01237223|185890|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
48228|NCT01237223|185891|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
48229|NCT01237223|185892|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
48230|NCT01237223|185887|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
48231|NCT01237223|185888|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
48232|NCT01237223|185889|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
48233|NCT01237223|185890|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
48234|NCT01237223|185891|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
48235|NCT01237223|185892|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
48236|NCT01237223|185887|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
48237|NCT01237223|185888|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
48238|NCT01237223|185889|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
48239|NCT01237223|185890|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
48240|NCT01237223|185891|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
48241|NCT01237223|185892|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
48242|NCT01237223|185887|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
48243|NCT01237223|185888|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
48244|NCT01237223|185889|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
48245|NCT01237223|185890|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
48246|NCT01237223|185891|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
48247|NCT01237223|185892|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
48248|NCT01237054|185951|P1|Overall Study|imaging 10C0096|1
48249|NCT01236573|185971|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
48250|NCT01236573|185972|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
48251|NCT01236573|185973|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
48252|NCT01236573|185974|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
48253|NCT01236573|185975|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
48254|NCT01236573|185976|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
48255|NCT01236573|185977|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
48256|NCT01236573|185978|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
48257|NCT01236573|185979|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
48258|NCT01236573|185980|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
48259|NCT01236573|185981|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
48260|NCT01236573|185971|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
48261|NCT01236573|185972|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
48262|NCT01236573|185973|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
48263|NCT01236573|185974|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
48264|NCT01236573|185975|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
48265|NCT01236573|185976|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
48266|NCT01236573|185977|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
48267|NCT01236573|185978|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
48268|NCT01236573|185979|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
48269|NCT01236573|185980|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
48270|NCT01236573|185981|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
48271|NCT01236573|185971|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
48272|NCT01236573|185972|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
48273|NCT01236573|185973|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
48274|NCT01236573|185974|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
48275|NCT01236573|185975|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
48276|NCT01236573|185976|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
48277|NCT01236573|185977|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
48278|NCT01236573|185978|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
48279|NCT01236573|185979|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
48280|NCT01236573|185980|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
48281|NCT01236573|185981|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
48282|NCT01236534|186019|P2|Overall Study|Adverse Event|0
48283|NCT01236534|186020|P1|Overall Study|Adverse Event|3
48284|NCT01236365|186050|P2|Overall Study|Dropped at Randomization due to high LFT|0
48285|NCT01236365|186051|P1|Overall Study|Dropped at Randomization due to high LFT|1
48286|NCT01236365|186050|P2|Overall Study|Moved Out of State|0
48287|NCT01236365|186051|P1|Overall Study|Moved Out of State|1
48288|NCT01236365|186050|P2|Overall Study|Lost to Follow-up|2
48289|NCT01236365|186051|P1|Overall Study|Lost to Follow-up|0
48290|NCT01236339|186065|P2|Overall Study|Termination of study by sponsor|13
48291|NCT01236339|186066|P1|Overall Study|Termination of study by sponsor|11
48292|NCT01236118|186134|P3|Overall Study|Withdrawal by Subject|1
48293|NCT01236118|186135|P2|Overall Study|Withdrawal by Subject|0
48294|NCT01236118|186136|P1|Overall Study|Withdrawal by Subject|0
48295|NCT01236118|186134|P3|Overall Study|Physician Decision|0
48296|NCT01236118|186135|P2|Overall Study|Physician Decision|1
48297|NCT01236118|186136|P1|Overall Study|Physician Decision|0
48298|NCT01236118|186134|P3|Overall Study|Adverse Event|2
48299|NCT01236118|186135|P2|Overall Study|Adverse Event|0
48300|NCT01236118|186136|P1|Overall Study|Adverse Event|2
48301|NCT01236001|186337|P2|Overall Study|Planned Visit After End of Study|1
48302|NCT01236001|186338|P1|Overall Study|Planned Visit After End of Study|0
48303|NCT01236001|186337|P2|Overall Study|Incompliance|0
48304|NCT01236001|186338|P1|Overall Study|Incompliance|1
48305|NCT01236001|186337|P2|Overall Study|Lost to Follow-up|1
48306|NCT01236001|186338|P1|Overall Study|Lost to Follow-up|6
48307|NCT01236001|186337|P2|Overall Study|Lack of Efficacy|6
48308|NCT01236001|186338|P1|Overall Study|Lack of Efficacy|6
48309|NCT01236001|186337|P2|Overall Study|Adverse Event|14
48310|NCT01236001|186338|P1|Overall Study|Adverse Event|5
48311|NCT01235741|186391|P3|Follow-Up Post Treatment up to Month 6|not specified|0
48312|NCT01235741|186392|P2|Follow-Up Post Treatment up to Month 6|not specified|1
48313|NCT01235741|186393|P1|Follow-Up Post Treatment up to Month 6|not specified|0
48314|NCT01235741|186391|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
48315|NCT01235741|186392|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
48316|NCT01235741|186393|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
48317|NCT01235741|186391|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
48318|NCT01235741|186392|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
48319|NCT01235741|186393|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
48320|NCT01235741|186391|P3|Randomized to Treatment|Sponsor terminated study|34
48321|NCT01235741|186392|P2|Randomized to Treatment|Sponsor terminated study|35
48322|NCT01235741|186393|P1|Randomized to Treatment|Sponsor terminated study|0
48323|NCT01235741|186391|P3|Randomized to Treatment|Adverse Event|1
48324|NCT01235741|186392|P2|Randomized to Treatment|Adverse Event|1
48325|NCT01235741|186393|P1|Randomized to Treatment|Adverse Event|0
48326|NCT01235741|186391|P3|Randomized to Treatment|Withdrawal by Subject|1
48327|NCT01235741|186392|P2|Randomized to Treatment|Withdrawal by Subject|0
48328|NCT01235741|186393|P1|Randomized to Treatment|Withdrawal by Subject|0
48329|NCT01235741|186391|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
48330|NCT01235741|186392|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
48331|NCT01235741|186393|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
48332|NCT01235741|186391|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
48333|NCT01235741|186392|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
48334|NCT01235741|186393|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
48335|NCT01235741|186391|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
48336|NCT01235741|186392|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
48337|NCT01235741|186393|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
48338|NCT01235741|186391|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
48339|NCT01235741|186392|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
48340|NCT01235741|186393|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
48341|NCT01235741|186391|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
48342|NCT01235741|186392|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
48343|NCT01235741|186393|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
48344|NCT01235741|186391|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
48345|NCT01235741|186392|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
48346|NCT01235741|186393|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
48347|NCT01235728|186420|P8|Overall Study|Protocol Violation|0
48348|NCT01235728|186421|P7|Overall Study|Protocol Violation|0
48349|NCT01235728|186422|P6|Overall Study|Protocol Violation|0
48350|NCT01235728|186423|P5|Overall Study|Protocol Violation|0
48351|NCT01235728|186424|P4|Overall Study|Protocol Violation|1
48352|NCT01235728|186425|P3|Overall Study|Protocol Violation|0
48353|NCT01235728|186426|P2|Overall Study|Protocol Violation|0
48354|NCT01235728|186427|P1|Overall Study|Protocol Violation|0
48355|NCT01235715|186437|P2|Overall Study|Physician Decision|2
48356|NCT01235715|186438|P1|Overall Study|Physician Decision|0
48357|NCT01235598|186478|P2|Overall Study|Withdrawal by Subject|0
48358|NCT01235598|186479|P1|Overall Study|Withdrawal by Subject|1
48359|NCT01235598|186478|P2|Overall Study|Lack of Efficacy|1
48360|NCT01235598|186479|P1|Overall Study|Lack of Efficacy|0
48361|NCT01235598|186478|P2|Overall Study|Adverse Event|3
48362|NCT01235598|186479|P1|Overall Study|Adverse Event|0
48363|NCT01235507|186522|P1|Overall Study|Withdrawal by Subject|1
48364|NCT01235507|186522|P1|Overall Study|Adverse Event|1
48365|NCT01235442|186536|P2|Overall Study|Other unspecified|2
48366|NCT01235442|186537|P1|Overall Study|Other unspecified|1
48367|NCT01235442|186536|P2|Overall Study|Administrative decision|2
48368|NCT01235442|186537|P1|Overall Study|Administrative decision|1
48369|NCT01235442|186536|P2|Overall Study|Noncompliance|2
48370|NCT01235442|186537|P1|Overall Study|Noncompliance|1
48371|NCT01235442|186536|P2|Overall Study|Lack of Efficacy|3
48372|NCT01235442|186537|P1|Overall Study|Lack of Efficacy|1
48373|NCT01235442|186536|P2|Overall Study|Withdrawal by Subject|9
48374|NCT01235442|186537|P1|Overall Study|Withdrawal by Subject|15
48375|NCT01235442|186536|P2|Overall Study|Adverse Event|6
48376|NCT01235442|186537|P1|Overall Study|Adverse Event|4
48377|NCT01235442|186536|P2|Overall Study|Protocol Violation|3
48378|NCT01235442|186537|P1|Overall Study|Protocol Violation|3
48379|NCT01235442|186536|P2|Overall Study|Ineligibility determined|4
48380|NCT01235442|186537|P1|Overall Study|Ineligibility determined|5
48381|NCT01235442|186536|P2|Overall Study|Pregnancy|1
48382|NCT01235442|186537|P1|Overall Study|Pregnancy|1
48383|NCT01235442|186536|P2|Overall Study|Death|2
48384|NCT01235442|186537|P1|Overall Study|Death|0
48385|NCT01235442|186536|P2|Overall Study|Lost to Follow-up|10
48386|NCT01235442|186537|P1|Overall Study|Lost to Follow-up|12
48387|NCT01235403|186555|P1|Overall Study|Other reasons for premature termination|4
48388|NCT01235403|186555|P1|Overall Study|Lack of Efficacy|2
48389|NCT01235403|186555|P1|Overall Study|Withdrawal by Subject|4
48390|NCT01235403|186555|P1|Overall Study|Lost to Follow-up|2
48391|NCT01235403|186555|P1|Overall Study|Adverse Event|14
48392|NCT01235338|186572|P2|Overall Study|Prohibited meds|0
48393|NCT01235338|186573|P1|Overall Study|Prohibited meds|1
48394|NCT01235338|186572|P2|Overall Study|Positive drug screen|1
48395|NCT01235338|186573|P1|Overall Study|Positive drug screen|0
48396|NCT01235338|186572|P2|Overall Study|Exclusion criteria violations|1
48397|NCT01235338|186573|P1|Overall Study|Exclusion criteria violations|1
48398|NCT01235338|186572|P2|Overall Study|Withdrawal by Subject|0
48399|NCT01235338|186573|P1|Overall Study|Withdrawal by Subject|5
48400|NCT01235338|186572|P2|Overall Study|Protocol Violation|1
48401|NCT01235338|186573|P1|Overall Study|Protocol Violation|1
48402|NCT01235338|186572|P2|Overall Study|Adverse Event|2
48403|NCT01235338|186573|P1|Overall Study|Adverse Event|3
48404|NCT01235234|186618|P3|Overall Study|Adverse Event|1
48405|NCT01235234|186619|P2|Overall Study|Adverse Event|2
48406|NCT01235234|186620|P1|Overall Study|Adverse Event|2
48407|NCT01234883|186664|P2|Overall Study|Inclusion/exclusion failure|0
48408|NCT01234883|186665|P1|Overall Study|Inclusion/exclusion failure|1
48409|NCT01234883|186664|P2|Overall Study|Technical difficulties with IV infusion|1
48410|NCT01234883|186665|P1|Overall Study|Technical difficulties with IV infusion|0
48411|NCT01234883|186664|P2|Overall Study|Parent/guardian withdrew consent|2
48412|NCT01234883|186665|P1|Overall Study|Parent/guardian withdrew consent|1
48413|NCT01234883|186664|P2|Overall Study|Early treatment release|10
48414|NCT01234883|186665|P1|Overall Study|Early treatment release|8
48415|NCT01234675|186707|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
48416|NCT01234675|186708|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
48417|NCT01234675|186707|P2|First Intervention (6 Weeks)|Adverse Event|1
48418|NCT01234675|186708|P1|First Intervention (6 Weeks)|Adverse Event|0
48419|NCT01234337|186724|P2|Overall Study|Withdrawal by Subject|7
48420|NCT01234337|186725|P1|Overall Study|Withdrawal by Subject|11
48421|NCT01234337|186724|P2|Overall Study|Protocol Violation|3
48422|NCT01234337|186725|P1|Overall Study|Protocol Violation|2
48423|NCT01234337|186724|P2|Overall Study|Lost to Follow-up|1
48424|NCT01234337|186725|P1|Overall Study|Lost to Follow-up|0
48425|NCT01234337|186724|P2|Overall Study|Randomized but not Treated|4
48426|NCT01234337|186725|P1|Overall Study|Randomized but not Treated|6
48427|NCT01234337|186724|P2|Overall Study|Non-compliant with study medication|2
48428|NCT01234337|186725|P1|Overall Study|Non-compliant with study medication|3
48429|NCT01234337|186724|P2|Overall Study|InvestigatorDecision notProtocolDriven|3
48430|NCT01234337|186725|P1|Overall Study|InvestigatorDecision notProtocolDriven|4
48431|NCT01234337|186724|P2|Overall Study|Ongoing|24
48432|NCT01234337|186725|P1|Overall Study|Ongoing|16
48433|NCT01234337|186724|P2|Overall Study|Adverse Event|20
48434|NCT01234337|186725|P1|Overall Study|Adverse Event|55
48435|NCT01233999|186753|P1|Overall Study|Lost to Follow-up|1
48436|NCT01233999|186753|P1|Overall Study|Withdrawal by Subject|1
48437|NCT01233869|186772|P4|Extended Treatment Period (46 Months)|Adverse Event|1
48438|NCT01233869|186773|P3|Extended Treatment Period (46 Months)|Adverse Event|0
48439|NCT01233869|186774|P2|Extended Treatment Period (46 Months)|Adverse Event|0
48440|NCT01233869|186775|P1|Extended Treatment Period (46 Months)|Adverse Event|1
48441|NCT01233869|186772|P4|Extended Treatment Period (46 Months)|Unspecified|3
48442|NCT01233869|186773|P3|Extended Treatment Period (46 Months)|Unspecified|0
48443|NCT01233869|186774|P2|Extended Treatment Period (46 Months)|Unspecified|0
48444|NCT01233869|186775|P1|Extended Treatment Period (46 Months)|Unspecified|3
48445|NCT01233869|186772|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
48446|NCT01233869|186773|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
48447|NCT01233869|186774|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
48448|NCT01233869|186775|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
48449|NCT01233869|186772|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
48450|NCT01233869|186773|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
48451|NCT01233869|186774|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
48452|NCT01233869|186775|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
48453|NCT01233869|186772|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
48454|NCT01233869|186773|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
48455|NCT01233869|186774|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
48456|NCT01233869|186775|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
48457|NCT01233869|186772|P4|Initial Treatment Period (24 Months)|Adverse Event|3
48458|NCT01233869|186773|P3|Initial Treatment Period (24 Months)|Adverse Event|0
48459|NCT01233869|186774|P2|Initial Treatment Period (24 Months)|Adverse Event|17
48460|NCT01233869|186775|P1|Initial Treatment Period (24 Months)|Adverse Event|9
48461|NCT01233869|186772|P4|Initial Treatment Period (24 Months)|Death|0
48462|NCT01233869|186773|P3|Initial Treatment Period (24 Months)|Death|0
48463|NCT01233869|186774|P2|Initial Treatment Period (24 Months)|Death|0
48464|NCT01233869|186775|P1|Initial Treatment Period (24 Months)|Death|1
48465|NCT01233817|186861|P1|Overall Study|Withdrawal by Subject|2
48466|NCT01233817|186861|P1|Overall Study|Lost to Follow-up|1
48467|NCT01233687|186908|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
48468|NCT01233687|186908|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
48469|NCT01233687|186908|P1|Phase II AMG 102 + Erlotinib|Death|1
48470|NCT01233284|186916|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
48471|NCT01233284|186917|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
48472|NCT01233284|186918|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
48473|NCT01233284|186919|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
48474|NCT01233284|186920|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
48475|NCT01233284|186916|P5|Period 4 (4 Weeks)|Adverse Event|0
48476|NCT01233284|186917|P4|Period 4 (4 Weeks)|Adverse Event|0
48477|NCT01233284|186918|P3|Period 4 (4 Weeks)|Adverse Event|0
48478|NCT01233284|186919|P2|Period 4 (4 Weeks)|Adverse Event|1
48479|NCT01233284|186920|P1|Period 4 (4 Weeks)|Adverse Event|0
48480|NCT01233284|186916|P5|Period 3 (4 Weeks)|Other|0
48481|NCT01233284|186917|P4|Period 3 (4 Weeks)|Other|1
48482|NCT01233284|186918|P3|Period 3 (4 Weeks)|Other|0
48483|NCT01233284|186919|P2|Period 3 (4 Weeks)|Other|0
48484|NCT01233284|186920|P1|Period 3 (4 Weeks)|Other|0
48485|NCT01233284|186916|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
48486|NCT01233284|186917|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
48487|NCT01233284|186918|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
48488|NCT01233284|186919|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
48489|NCT01233284|186920|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
48490|NCT01233284|186916|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
48491|NCT01233284|186917|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
48492|NCT01233284|186918|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
48493|NCT01233284|186919|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
48494|NCT01233284|186920|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
48495|NCT01233284|186916|P5|Period 1 (4 Weeks)|Other|0
48496|NCT01233284|186917|P4|Period 1 (4 Weeks)|Other|0
48497|NCT01233284|186918|P3|Period 1 (4 Weeks)|Other|1
48498|NCT01233284|186919|P2|Period 1 (4 Weeks)|Other|0
48499|NCT01233284|186920|P1|Period 1 (4 Weeks)|Other|0
48500|NCT01233284|186916|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
48501|NCT01233284|186917|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
48502|NCT01233284|186918|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
48503|NCT01233284|186919|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
48504|NCT01233284|186920|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
48505|NCT01233284|186916|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
48506|NCT01233284|186917|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
48507|NCT01233284|186918|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
48508|NCT01233284|186919|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
48509|NCT01233284|186920|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
48510|NCT01233258|187001|P6|First Intervention (6 Months)|Non-compliance with study medication|0
48511|NCT01233258|187002|P5|First Intervention (6 Months)|Non-compliance with study medication|0
48512|NCT01233258|187003|P4|First Intervention (6 Months)|Non-compliance with study medication|0
48513|NCT01233258|187004|P3|First Intervention (6 Months)|Non-compliance with study medication|0
48514|NCT01233258|187005|P2|First Intervention (6 Months)|Non-compliance with study medication|0
48515|NCT01233258|187006|P1|First Intervention (6 Months)|Non-compliance with study medication|1
48516|NCT01233258|187001|P6|First Intervention (6 Months)|Protocol Violation|0
48517|NCT01233258|187002|P5|First Intervention (6 Months)|Protocol Violation|0
48518|NCT01233258|187003|P4|First Intervention (6 Months)|Protocol Violation|0
48519|NCT01233258|187004|P3|First Intervention (6 Months)|Protocol Violation|1
48520|NCT01233258|187005|P2|First Intervention (6 Months)|Protocol Violation|0
48521|NCT01233258|187006|P1|First Intervention (6 Months)|Protocol Violation|0
48522|NCT01233258|187001|P6|First Intervention (6 Months)|Withdrawal by Subject|1
48523|NCT01233258|187002|P5|First Intervention (6 Months)|Withdrawal by Subject|0
48524|NCT01233258|187003|P4|First Intervention (6 Months)|Withdrawal by Subject|1
48525|NCT01233258|187004|P3|First Intervention (6 Months)|Withdrawal by Subject|0
48526|NCT01233258|187005|P2|First Intervention (6 Months)|Withdrawal by Subject|0
48527|NCT01233258|187006|P1|First Intervention (6 Months)|Withdrawal by Subject|0
48528|NCT01233232|187026|P3|Overall Study|Voluntary Discontinuation by Subject|0
48529|NCT01233232|187027|P2|Overall Study|Voluntary Discontinuation by Subject|0
48530|NCT01233232|187028|P1|Overall Study|Voluntary Discontinuation by Subject|1
48531|NCT01233076|187081|P2|Period 2, One Week|Lost to Follow-up|0
48532|NCT01233076|187082|P1|Period 2, One Week|Lost to Follow-up|1
48533|NCT01232894|187105|P2|Overall Study|Physician Decision|1
48534|NCT01232894|187106|P1|Overall Study|Physician Decision|2
48535|NCT01232894|187105|P2|Overall Study|Withdrawal by Subject|5
48536|NCT01232894|187106|P1|Overall Study|Withdrawal by Subject|8
48537|NCT01232894|187105|P2|Overall Study|Protocol Violation|1
48538|NCT01232894|187106|P1|Overall Study|Protocol Violation|1
48539|NCT01232894|187105|P2|Overall Study|Death|0
48540|NCT01232894|187106|P1|Overall Study|Death|1
48541|NCT01232894|187105|P2|Overall Study|Lost to Follow-up|1
48542|NCT01232894|187106|P1|Overall Study|Lost to Follow-up|0
48543|NCT01232868|187114|P2|Overall Study|Lost to Follow-up|4
48544|NCT01232868|187115|P1|Overall Study|Lost to Follow-up|2
48545|NCT01232790|187129|P2|Second Crossover|Withdrawal by Subject|2
48546|NCT01232790|187130|P1|Second Crossover|Withdrawal by Subject|1
48547|NCT01232790|187129|P2|First Crossover|Withdrawal by Subject|0
48548|NCT01232790|187130|P1|First Crossover|Withdrawal by Subject|1
48549|NCT01232790|187129|P2|Initial Assessment|Withdrawal by Subject|1
48550|NCT01232790|187130|P1|Initial Assessment|Withdrawal by Subject|0
48551|NCT01232790|187129|P2|Randomization|Physician Decision|1
48552|NCT01232790|187130|P1|Randomization|Physician Decision|0
48553|NCT01232790|187129|P2|Randomization|Protocol Violation|1
48554|NCT01232790|187130|P1|Randomization|Protocol Violation|0
48555|NCT01232790|187129|P2|Randomization|Withdrawal by Subject|0
48556|NCT01232790|187130|P1|Randomization|Withdrawal by Subject|2
48557|NCT01232569|187186|P4|Double-blind Treatment Period|Death|0
48558|NCT01232569|187187|P3|Double-blind Treatment Period|Death|0
48559|NCT01232569|187188|P2|Double-blind Treatment Period|Death|0
48560|NCT01232569|187189|P1|Double-blind Treatment Period|Death|2
48561|NCT01232569|187186|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
48562|NCT01232569|187187|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
48563|NCT01232569|187188|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
48564|NCT01232569|187189|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
48565|NCT01232569|187186|P4|Double-blind Treatment Period|Physician Decision|0
48566|NCT01232569|187187|P3|Double-blind Treatment Period|Physician Decision|0
48567|NCT01232569|187188|P2|Double-blind Treatment Period|Physician Decision|0
48568|NCT01232569|187189|P1|Double-blind Treatment Period|Physician Decision|1
48569|NCT01232569|187186|P4|Double-blind Treatment Period|Lack of Efficacy|0
48570|NCT01232569|187187|P3|Double-blind Treatment Period|Lack of Efficacy|0
48571|NCT01232569|187188|P2|Double-blind Treatment Period|Lack of Efficacy|2
48572|NCT01232569|187189|P1|Double-blind Treatment Period|Lack of Efficacy|1
48573|NCT01232569|187186|P4|Double-blind Treatment Period|Lost to Follow-up|0
48574|NCT01232569|187187|P3|Double-blind Treatment Period|Lost to Follow-up|0
48575|NCT01232569|187188|P2|Double-blind Treatment Period|Lost to Follow-up|0
48576|NCT01232569|187189|P1|Double-blind Treatment Period|Lost to Follow-up|4
48577|NCT01232569|187186|P4|Double-blind Treatment Period|Escape|0
48578|NCT01232569|187187|P3|Double-blind Treatment Period|Escape|0
48579|NCT01232569|187188|P2|Double-blind Treatment Period|Escape|2
48580|NCT01232569|187189|P1|Double-blind Treatment Period|Escape|2
48581|NCT01232569|187186|P4|Double-blind Treatment Period|Withdrawal by Subject|0
48582|NCT01232569|187187|P3|Double-blind Treatment Period|Withdrawal by Subject|0
48583|NCT01232569|187188|P2|Double-blind Treatment Period|Withdrawal by Subject|2
48584|NCT01232569|187189|P1|Double-blind Treatment Period|Withdrawal by Subject|9
48585|NCT01232491|187269|P2|Overall Study|Other|18
48586|NCT01232491|187270|P1|Overall Study|Other|21
48587|NCT01232491|187269|P2|Overall Study|Withdrawal Criteria|21
48588|NCT01232491|187270|P1|Overall Study|Withdrawal Criteria|12
48589|NCT01232491|187269|P2|Overall Study|Protocol Violation|11
48590|NCT01232491|187270|P1|Overall Study|Protocol Violation|13
48591|NCT01232491|187269|P2|Overall Study|Lack of Efficacy|5
48592|NCT01232491|187270|P1|Overall Study|Lack of Efficacy|1
48593|NCT01232491|187269|P2|Overall Study|Adverse Event|8
48594|NCT01232491|187270|P1|Overall Study|Adverse Event|13
48595|NCT01232296|187299|P2|Overall Study|Death|6
48596|NCT01232296|187300|P1|Overall Study|Death|1
48597|NCT01232296|187299|P2|Overall Study|Subject/guardian decision|2
48598|NCT01232296|187300|P1|Overall Study|Subject/guardian decision|10
48599|NCT01232296|187299|P2|Overall Study|Technical problems|0
48600|NCT01232296|187300|P1|Overall Study|Technical problems|3
48601|NCT01232296|187299|P2|Overall Study|Study terminated by sponsor|1
48602|NCT01232296|187300|P1|Overall Study|Study terminated by sponsor|0
48603|NCT01232296|187299|P2|Overall Study|Progressive disease|61
48604|NCT01232296|187300|P1|Overall Study|Progressive disease|43
48605|NCT01232296|187299|P2|Overall Study|Physician Decision|1
48606|NCT01232296|187300|P1|Overall Study|Physician Decision|1
48607|NCT01232296|187299|P2|Overall Study|Adverse Event|12
48608|NCT01232296|187300|P1|Overall Study|Adverse Event|24
48609|NCT01232283|187317|P8|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
48610|NCT01232283|187318|P7|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
48611|NCT01232283|187319|P6|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|1
48612|NCT01232283|187320|P5|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
48613|NCT01232283|187321|P4|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
48614|NCT01232283|187322|P3|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
48615|NCT01232283|187323|P2|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
48616|NCT01232283|187324|P1|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
48617|NCT01232283|187317|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
48618|NCT01232283|187318|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
48619|NCT01232283|187319|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
48620|NCT01232283|187320|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
48621|NCT01232283|187321|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
48622|NCT01232283|187322|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
48623|NCT01232283|187323|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
48624|NCT01232283|187324|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
48625|NCT01232283|187317|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
48626|NCT01232283|187318|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
48627|NCT01232283|187319|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
48628|NCT01232283|187320|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
48629|NCT01232283|187321|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
48630|NCT01232283|187322|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
48631|NCT01232283|187323|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
48632|NCT01232283|187324|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
48633|NCT01232283|187317|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
48634|NCT01232283|187318|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
48635|NCT01232283|187319|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
48636|NCT01232283|187320|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
48637|NCT01232283|187321|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
48638|NCT01232283|187322|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
48639|NCT01232283|187323|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
48640|NCT01232283|187324|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
48641|NCT01232283|187317|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
48642|NCT01232283|187318|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
48643|NCT01232283|187319|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
48644|NCT01232283|187320|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
48645|NCT01232283|187321|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
48646|NCT01232283|187322|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
48647|NCT01232283|187323|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
48648|NCT01232283|187324|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
48649|NCT01232283|187317|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
48650|NCT01232283|187318|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
48651|NCT01232283|187319|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
48652|NCT01232283|187320|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
48653|NCT01232283|187321|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
48654|NCT01232283|187322|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
48655|NCT01232283|187323|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
48656|NCT01232283|187324|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
48657|NCT01232283|187317|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
48658|NCT01232283|187318|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
48659|NCT01232283|187319|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
48660|NCT01232283|187320|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
48661|NCT01232283|187321|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
48662|NCT01232283|187322|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
48663|NCT01232283|187323|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
48664|NCT01232283|187324|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
48665|NCT01232283|187317|P8|Maintenance Phase (Weeks16-32)|Unspecified|0
48666|NCT01232283|187318|P7|Maintenance Phase (Weeks16-32)|Unspecified|0
48667|NCT01232283|187319|P6|Maintenance Phase (Weeks16-32)|Unspecified|0
48668|NCT01232283|187320|P5|Maintenance Phase (Weeks16-32)|Unspecified|0
48669|NCT01232283|187321|P4|Maintenance Phase (Weeks16-32)|Unspecified|0
48670|NCT01232283|187322|P3|Maintenance Phase (Weeks16-32)|Unspecified|2
48671|NCT01232283|187323|P2|Maintenance Phase (Weeks16-32)|Unspecified|0
48672|NCT01232283|187324|P1|Maintenance Phase (Weeks16-32)|Unspecified|0
48673|NCT01232283|187317|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
48674|NCT01232283|187318|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
48675|NCT01232283|187319|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
48676|NCT01232283|187320|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
48677|NCT01232283|187321|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
48678|NCT01232283|187322|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
48679|NCT01232283|187323|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
48680|NCT01232283|187324|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
48681|NCT01232283|187317|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
48682|NCT01232283|187318|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
48683|NCT01232283|187319|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
48684|NCT01232283|187320|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
48685|NCT01232283|187321|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
48686|NCT01232283|187322|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
48687|NCT01232283|187323|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
48688|NCT01232283|187324|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
48689|NCT01232283|187317|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
48690|NCT01232283|187318|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
48691|NCT01232283|187319|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
48692|NCT01232283|187320|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
48693|NCT01232283|187321|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
48694|NCT01232283|187322|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
48695|NCT01232283|187323|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
48696|NCT01232283|187324|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
48697|NCT01232283|187317|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
48698|NCT01232283|187318|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
48699|NCT01232283|187319|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
48700|NCT01232283|187320|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
48701|NCT01232283|187321|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
48702|NCT01232283|187322|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
48703|NCT01232283|187323|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
48704|NCT01232283|187324|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
48705|NCT01232283|187317|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
48706|NCT01232283|187318|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
48707|NCT01232283|187319|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
48708|NCT01232283|187320|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
48709|NCT01232283|187321|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
48710|NCT01232283|187322|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
48711|NCT01232283|187323|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
48712|NCT01232283|187324|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
48713|NCT01232283|187317|P8|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
48714|NCT01232283|187318|P7|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
48715|NCT01232283|187319|P6|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
48716|NCT01232283|187320|P5|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
48717|NCT01232283|187321|P4|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
48718|NCT01232283|187322|P3|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
48719|NCT01232283|187323|P2|Placebo Controlled Phase (Weeks 0-16)|Not specified|1
48720|NCT01232283|187324|P1|Placebo Controlled Phase (Weeks 0-16)|Not specified|2
48721|NCT01232283|187317|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
48722|NCT01232283|187318|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
48723|NCT01232283|187319|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
48724|NCT01232283|187320|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
48725|NCT01232283|187321|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
48726|NCT01232283|187322|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
48727|NCT01232283|187323|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
48728|NCT01232283|187324|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
48729|NCT01232283|187317|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
48730|NCT01232283|187318|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
48731|NCT01232283|187319|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
48732|NCT01232283|187320|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
48733|NCT01232283|187321|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
48734|NCT01232283|187322|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
48735|NCT01232283|187323|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
48736|NCT01232283|187324|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
48737|NCT01232283|187317|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
48738|NCT01232283|187318|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
48739|NCT01232283|187319|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
48740|NCT01232283|187320|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
48741|NCT01232283|187321|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
48742|NCT01232283|187322|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
48743|NCT01232283|187323|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
48744|NCT01232283|187324|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
48745|NCT01232283|187317|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
48746|NCT01232283|187318|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
48747|NCT01232283|187319|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
48748|NCT01232283|187320|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
48749|NCT01232283|187321|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
48750|NCT01232283|187322|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
48751|NCT01232283|187323|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
48752|NCT01232283|187324|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
48753|NCT01232283|187317|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
48754|NCT01232283|187318|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
48755|NCT01232283|187319|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
48756|NCT01232283|187320|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
48757|NCT01232283|187321|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
48758|NCT01232283|187322|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
48759|NCT01232283|187323|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
48760|NCT01232283|187324|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
48761|NCT01232283|187317|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
48762|NCT01232283|187318|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
48763|NCT01232283|187319|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
48764|NCT01232283|187320|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
48765|NCT01232283|187321|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
48766|NCT01232283|187322|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
48767|NCT01232283|187323|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
48768|NCT01232283|187324|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
48769|NCT01232127|187363|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
48770|NCT01232127|187364|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
48771|NCT01232127|187365|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
48772|NCT01231984|187389|P4|Study Period 2|Did not continue to meet I/E Criteria|1
48773|NCT01231984|187390|P3|Study Period 2|Did not continue to meet I/E Criteria|0
48774|NCT01231984|187391|P2|Study Period 2|Did not continue to meet I/E Criteria|1
48775|NCT01231984|187392|P1|Study Period 2|Did not continue to meet I/E Criteria|1
48776|NCT01231984|187389|P4|Study Period 2|Lost to Follow-up|3
48777|NCT01231984|187390|P3|Study Period 2|Lost to Follow-up|0
48778|NCT01231984|187391|P2|Study Period 2|Lost to Follow-up|0
48779|NCT01231984|187392|P1|Study Period 2|Lost to Follow-up|1
48780|NCT01231984|187389|P4|Study Period 2|Withdrawal by Subject|0
48781|NCT01231984|187390|P3|Study Period 2|Withdrawal by Subject|0
48782|NCT01231984|187391|P2|Study Period 2|Withdrawal by Subject|1
48783|NCT01231984|187392|P1|Study Period 2|Withdrawal by Subject|1
48784|NCT01231984|187389|P4|Study Period 1|Not Specified|1
48785|NCT01231984|187390|P3|Study Period 1|Not Specified|0
48786|NCT01231984|187391|P2|Study Period 1|Not Specified|0
48787|NCT01231984|187392|P1|Study Period 1|Not Specified|0
48788|NCT01231984|187389|P4|Study Period 1|Adverse Event|0
48789|NCT01231984|187390|P3|Study Period 1|Adverse Event|0
48790|NCT01231984|187391|P2|Study Period 1|Adverse Event|0
48791|NCT01231984|187392|P1|Study Period 1|Adverse Event|1
48792|NCT01231984|187389|P4|Study Period 1|Protocol Violation|3
48793|NCT01231984|187390|P3|Study Period 1|Protocol Violation|2
48794|NCT01231984|187391|P2|Study Period 1|Protocol Violation|4
48795|NCT01231984|187392|P1|Study Period 1|Protocol Violation|3
48796|NCT01231984|187389|P4|Study Period 1|Non-compliance with study requirements|1
48797|NCT01231984|187390|P3|Study Period 1|Non-compliance with study requirements|2
48798|NCT01231984|187391|P2|Study Period 1|Non-compliance with study requirements|0
48799|NCT01231984|187392|P1|Study Period 1|Non-compliance with study requirements|5
48800|NCT01231984|187389|P4|Study Period 1|Screen Failure|1
48801|NCT01231984|187390|P3|Study Period 1|Screen Failure|0
48802|NCT01231984|187391|P2|Study Period 1|Screen Failure|0
48803|NCT01231984|187392|P1|Study Period 1|Screen Failure|0
48804|NCT01231984|187389|P4|Study Period 1|Did not continue to meet I/E Criteria|2
48805|NCT01231984|187390|P3|Study Period 1|Did not continue to meet I/E Criteria|2
48806|NCT01231984|187391|P2|Study Period 1|Did not continue to meet I/E Criteria|2
48807|NCT01231984|187392|P1|Study Period 1|Did not continue to meet I/E Criteria|2
48808|NCT01231984|187389|P4|Study Period 1|Lost to Follow-up|0
48809|NCT01231984|187390|P3|Study Period 1|Lost to Follow-up|1
48810|NCT01231984|187391|P2|Study Period 1|Lost to Follow-up|1
48811|NCT01231984|187392|P1|Study Period 1|Lost to Follow-up|1
48812|NCT01231984|187389|P4|Study Period 1|Withdrawal by Subject|1
48813|NCT01231984|187390|P3|Study Period 1|Withdrawal by Subject|0
48814|NCT01231984|187391|P2|Study Period 1|Withdrawal by Subject|0
48815|NCT01231984|187392|P1|Study Period 1|Withdrawal by Subject|0
48816|NCT01231607|187450|P5|Overall Study|Withdrawal by Subject|9
48817|NCT01231607|187451|P4|Overall Study|Withdrawal by Subject|17
48818|NCT01231607|187452|P3|Overall Study|Withdrawal by Subject|14
48819|NCT01231607|187453|P2|Overall Study|Withdrawal by Subject|9
48820|NCT01231607|187454|P1|Overall Study|Withdrawal by Subject|9
48821|NCT01231607|187450|P5|Overall Study|Protocol Violation|2
48822|NCT01231607|187451|P4|Overall Study|Protocol Violation|2
48823|NCT01231607|187452|P3|Overall Study|Protocol Violation|0
48824|NCT01231607|187453|P2|Overall Study|Protocol Violation|2
48825|NCT01231607|187454|P1|Overall Study|Protocol Violation|3
48826|NCT01231607|187450|P5|Overall Study|Physician Decision|4
48827|NCT01231607|187451|P4|Overall Study|Physician Decision|5
48828|NCT01231607|187452|P3|Overall Study|Physician Decision|3
48829|NCT01231607|187453|P2|Overall Study|Physician Decision|4
48830|NCT01231607|187454|P1|Overall Study|Physician Decision|4
48831|NCT01231607|187450|P5|Overall Study|Lost to Follow-up|4
48832|NCT01231607|187451|P4|Overall Study|Lost to Follow-up|10
48833|NCT01231607|187452|P3|Overall Study|Lost to Follow-up|10
48834|NCT01231607|187453|P2|Overall Study|Lost to Follow-up|11
48835|NCT01231607|187454|P1|Overall Study|Lost to Follow-up|13
48836|NCT01231607|187450|P5|Overall Study|Adverse Event|5
48837|NCT01231607|187451|P4|Overall Study|Adverse Event|4
48838|NCT01231607|187452|P3|Overall Study|Adverse Event|4
48839|NCT01231607|187453|P2|Overall Study|Adverse Event|8
48840|NCT01231607|187454|P1|Overall Study|Adverse Event|0
48841|NCT01231581|187546|P2|Overall Study|Ongoing|0
48842|NCT01231581|187547|P1|Overall Study|Ongoing|1
48843|NCT01231581|187546|P2|Overall Study|Death|64
48844|NCT01231581|187547|P1|Overall Study|Death|65
48845|NCT01231581|187546|P2|Overall Study|Study Closed/Terminated|5
48846|NCT01231581|187547|P1|Overall Study|Study Closed/Terminated|6
48847|NCT01231581|187546|P2|Overall Study|Withdrawal by Subject|9
48848|NCT01231581|187547|P1|Overall Study|Withdrawal by Subject|6
48849|NCT01231581|187546|P2|Overall Study|Lost to Follow-up|2
48850|NCT01231581|187547|P1|Overall Study|Lost to Follow-up|2
48851|NCT01231516|187567|P2|Open-label Phase|Ongoing at the time of analysis|23
48852|NCT01231516|187568|P1|Open-label Phase|Ongoing at the time of analysis|282
48853|NCT01231516|187567|P2|Open-label Phase|Withdrawal by Subject|0
48854|NCT01231516|187568|P1|Open-label Phase|Withdrawal by Subject|1
48855|NCT01231516|187567|P2|Open-label Phase|Lost to Follow-up|0
48856|NCT01231516|187568|P1|Open-label Phase|Lost to Follow-up|3
48857|NCT01231516|187567|P2|Open-label Phase|Protocol Violation|0
48858|NCT01231516|187568|P1|Open-label Phase|Protocol Violation|2
48859|NCT01231516|187567|P2|Open-label Phase|Lack of Efficacy|3
48860|NCT01231516|187568|P1|Open-label Phase|Lack of Efficacy|7
48861|NCT01231516|187567|P2|48 Week Double-blind Phase|Site Closed|1
48862|NCT01231516|187568|P1|48 Week Double-blind Phase|Site Closed|3
48863|NCT01231516|187567|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
48864|NCT01231516|187568|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
48865|NCT01231516|187567|P2|48 Week Double-blind Phase|Physician Decision|1
48866|NCT01231516|187568|P1|48 Week Double-blind Phase|Physician Decision|1
48867|NCT01231516|187567|P2|48 Week Double-blind Phase|Lost to Follow-up|10
48868|NCT01231516|187568|P1|48 Week Double-blind Phase|Lost to Follow-up|5
48869|NCT01231516|187567|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
48870|NCT01231516|187568|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
48871|NCT01231516|187567|P2|48 Week Double-blind Phase|Protocol Violation|6
48872|NCT01231516|187568|P1|48 Week Double-blind Phase|Protocol Violation|9
48873|NCT01231516|187567|P2|48 Week Double-blind Phase|Lack of Efficacy|42
48874|NCT01231516|187568|P1|48 Week Double-blind Phase|Lack of Efficacy|20
48875|NCT01231516|187567|P2|48 Week Double-blind Phase|Adverse Event|11
48876|NCT01231516|187568|P1|48 Week Double-blind Phase|Adverse Event|4
48877|NCT01231503|187598|P8|Overall Study|Protocol Violation|0
48878|NCT01231503|187599|P7|Overall Study|Protocol Violation|0
48879|NCT01231503|187600|P6|Overall Study|Protocol Violation|0
48880|NCT01231503|187601|P5|Overall Study|Protocol Violation|0
48881|NCT01231503|187602|P4|Overall Study|Protocol Violation|1
48882|NCT01231503|187603|P3|Overall Study|Protocol Violation|0
48883|NCT01231503|187604|P2|Overall Study|Protocol Violation|0
48884|NCT01231503|187605|P1|Overall Study|Protocol Violation|0
48885|NCT01231503|187598|P8|Overall Study|Lost to Follow-up|6
48886|NCT01231503|187599|P7|Overall Study|Lost to Follow-up|6
48887|NCT01231503|187600|P6|Overall Study|Lost to Follow-up|9
48888|NCT01231503|187601|P5|Overall Study|Lost to Follow-up|7
48889|NCT01231503|187602|P4|Overall Study|Lost to Follow-up|5
48890|NCT01231503|187603|P3|Overall Study|Lost to Follow-up|8
48891|NCT01231503|187604|P2|Overall Study|Lost to Follow-up|10
48892|NCT01231503|187605|P1|Overall Study|Lost to Follow-up|8
48893|NCT01231503|187598|P8|Overall Study|Withdrawal by Subject|2
48894|NCT01231503|187599|P7|Overall Study|Withdrawal by Subject|1
48895|NCT01231503|187600|P6|Overall Study|Withdrawal by Subject|5
48896|NCT01231503|187601|P5|Overall Study|Withdrawal by Subject|3
48897|NCT01231503|187602|P4|Overall Study|Withdrawal by Subject|1
48898|NCT01231503|187603|P3|Overall Study|Withdrawal by Subject|3
48899|NCT01231503|187604|P2|Overall Study|Withdrawal by Subject|3
48900|NCT01231503|187605|P1|Overall Study|Withdrawal by Subject|6
48901|NCT01231503|187598|P8|Overall Study|Adverse event, serious fatal|0
48902|NCT01231503|187599|P7|Overall Study|Adverse event, serious fatal|0
48903|NCT01231503|187600|P6|Overall Study|Adverse event, serious fatal|1
48904|NCT01231503|187601|P5|Overall Study|Adverse event, serious fatal|0
48905|NCT01231503|187602|P4|Overall Study|Adverse event, serious fatal|1
48906|NCT01231503|187603|P3|Overall Study|Adverse event, serious fatal|1
48907|NCT01231503|187604|P2|Overall Study|Adverse event, serious fatal|0
48908|NCT01231503|187605|P1|Overall Study|Adverse event, serious fatal|0
48909|NCT01231503|187598|P8|Overall Study|Adverse Event|0
48910|NCT01231503|187599|P7|Overall Study|Adverse Event|0
48911|NCT01231503|187600|P6|Overall Study|Adverse Event|1
48912|NCT01231503|187601|P5|Overall Study|Adverse Event|0
48913|NCT01231503|187602|P4|Overall Study|Adverse Event|0
48914|NCT01231503|187603|P3|Overall Study|Adverse Event|0
48915|NCT01231503|187604|P2|Overall Study|Adverse Event|0
48916|NCT01231503|187605|P1|Overall Study|Adverse Event|0
48917|NCT01231464|187821|P2|Overall Study|Withdrawal by Subject|2
48918|NCT01231464|187822|P1|Overall Study|Withdrawal by Subject|3
48919|NCT01231464|187821|P2|Overall Study|Lost to Follow-up|2
48920|NCT01231464|187822|P1|Overall Study|Lost to Follow-up|1
48921|NCT01231464|187821|P2|Overall Study|Protocol Violation|2
48922|NCT01231464|187822|P1|Overall Study|Protocol Violation|1
48923|NCT01231464|187821|P2|Overall Study|Adverse Event|1
48924|NCT01231464|187822|P1|Overall Study|Adverse Event|0
48925|NCT01231373|187836|P4|Overall Study|Withdrew Consent|0
48926|NCT01231373|187837|P3|Overall Study|Withdrew Consent|0
48927|NCT01231373|187838|P2|Overall Study|Withdrew Consent|0
48928|NCT01231373|187839|P1|Overall Study|Withdrew Consent|1
48929|NCT01231373|187836|P4|Overall Study|Lost to Follow-up|1
48930|NCT01231373|187837|P3|Overall Study|Lost to Follow-up|0
48931|NCT01231373|187838|P2|Overall Study|Lost to Follow-up|0
48932|NCT01231373|187839|P1|Overall Study|Lost to Follow-up|0
48933|NCT01231373|187836|P4|Overall Study|Withdrew consent prior to randomization|0
48934|NCT01231373|187837|P3|Overall Study|Withdrew consent prior to randomization|0
48935|NCT01231373|187838|P2|Overall Study|Withdrew consent prior to randomization|1
48936|NCT01231373|187839|P1|Overall Study|Withdrew consent prior to randomization|2
48937|NCT01231321|187878|P1|Overall Study|Lack of Efficacy|2
48938|NCT01231321|187878|P1|Overall Study|Adverse Event|3
48939|NCT01230892|187901|P2|Overall Study|Lost to Follow-up|0
48940|NCT01230892|187902|P1|Overall Study|Lost to Follow-up|2
48941|NCT01230892|187901|P2|Overall Study|Withdrawal by Subject|1
48942|NCT01230892|187902|P1|Overall Study|Withdrawal by Subject|1
48943|NCT01230827|187912|P4|Overall Study|Study terminated by Sponsor|63
48944|NCT01230827|187913|P3|Overall Study|Study terminated by Sponsor|56
48945|NCT01230827|187914|P2|Overall Study|Study terminated by Sponsor|2
48946|NCT01230827|187915|P1|Overall Study|Study terminated by Sponsor|0
48947|NCT01230827|187912|P4|Overall Study|Recovery|0
48948|NCT01230827|187913|P3|Overall Study|Recovery|0
48949|NCT01230827|187914|P2|Overall Study|Recovery|6
48950|NCT01230827|187915|P1|Overall Study|Recovery|0
48951|NCT01230827|187912|P4|Overall Study|Adverse Event|7
48952|NCT01230827|187913|P3|Overall Study|Adverse Event|3
48953|NCT01230827|187914|P2|Overall Study|Adverse Event|2
48954|NCT01230827|187915|P1|Overall Study|Adverse Event|4
48955|NCT01230827|187912|P4|Overall Study|Lack of Efficacy|3
48956|NCT01230827|187913|P3|Overall Study|Lack of Efficacy|2
48957|NCT01230827|187914|P2|Overall Study|Lack of Efficacy|1
48958|NCT01230827|187915|P1|Overall Study|Lack of Efficacy|14
48959|NCT01230827|187912|P4|Overall Study|Withdrawal by Subject|2
48960|NCT01230827|187913|P3|Overall Study|Withdrawal by Subject|3
48961|NCT01230827|187914|P2|Overall Study|Withdrawal by Subject|0
48962|NCT01230827|187915|P1|Overall Study|Withdrawal by Subject|1
48963|NCT01230827|187912|P4|Overall Study|Lost to Follow-up|3
48964|NCT01230827|187913|P3|Overall Study|Lost to Follow-up|1
48965|NCT01230827|187914|P2|Overall Study|Lost to Follow-up|0
48966|NCT01230827|187915|P1|Overall Study|Lost to Follow-up|0
48967|NCT01230814|187931|P2|Overall Study|Discontinued (not due to adverse event)|1
48968|NCT01230814|187932|P1|Overall Study|Discontinued (not due to adverse event)|2
48969|NCT01230814|187931|P2|Overall Study|Lost to Follow-up|3
48970|NCT01230814|187932|P1|Overall Study|Lost to Follow-up|11
48971|NCT01230788|187944|P1|Overall Study|Prescribed exclusion drug|1
48972|NCT01230749|187956|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
48973|NCT01230749|187957|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
48974|NCT01230749|187958|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
48975|NCT01230749|187959|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
48976|NCT01230749|187956|P4|Overall Study|Withdrawal by Subject|0
48977|NCT01230749|187957|P3|Overall Study|Withdrawal by Subject|0
48978|NCT01230749|187958|P2|Overall Study|Withdrawal by Subject|1
48979|NCT01230749|187959|P1|Overall Study|Withdrawal by Subject|0
48980|NCT01230749|187956|P4|Overall Study|Physician Decision|0
48981|NCT01230749|187957|P3|Overall Study|Physician Decision|1
48982|NCT01230749|187958|P2|Overall Study|Physician Decision|0
48983|NCT01230749|187959|P1|Overall Study|Physician Decision|0
48984|NCT01230749|187956|P4|Overall Study|Adverse Event|1
48985|NCT01230749|187957|P3|Overall Study|Adverse Event|0
48986|NCT01230749|187958|P2|Overall Study|Adverse Event|0
48987|NCT01230749|187959|P1|Overall Study|Adverse Event|0
48988|NCT01230710|187994|P1|Overall Study|Withdrawal of Consent|1
48989|NCT01230710|187994|P1|Overall Study|Death|4
48990|NCT01230710|187994|P1|Overall Study|Lost to Follow-up|3
48991|NCT01230710|187994|P1|Overall Study|Disease Progression|41
48992|NCT01230307|188020|P2|Overall Study|LVAD Placement|2
48993|NCT01230307|188021|P1|Overall Study|LVAD Placement|0
48994|NCT01230060|188033|P1|Overall Study|Withdrawal by Subject|1
48995|NCT01229735|188106|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
48996|NCT01229735|188107|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
48997|NCT01229735|188106|P2|Overall Study|AE, non-serious non-fatal|17
48998|NCT01229735|188107|P1|Overall Study|AE, non-serious non-fatal|13
48999|NCT01229735|188106|P2|Overall Study|SAE, non-fatal|4
49000|NCT01229735|188107|P1|Overall Study|SAE, non-fatal|0
49001|NCT01229735|188106|P2|Overall Study|Other Reason|10
49002|NCT01229735|188107|P1|Overall Study|Other Reason|13
49003|NCT01229735|188106|P2|Overall Study|Withdrawal by Subject|17
49004|NCT01229735|188107|P1|Overall Study|Withdrawal by Subject|18
49005|NCT01229735|188106|P2|Overall Study|Lost to Follow-up|2
49006|NCT01229735|188107|P1|Overall Study|Lost to Follow-up|0
49007|NCT01229735|188106|P2|Overall Study|Protocol Violation|8
49008|NCT01229735|188107|P1|Overall Study|Protocol Violation|13
49009|NCT01229735|188106|P2|Overall Study|Lack of Efficacy|8
49010|NCT01229735|188107|P1|Overall Study|Lack of Efficacy|8
49011|NCT01229436|188155|P1|Overall Study|Lost to Follow-up|3
49012|NCT01229436|188155|P1|Overall Study|Withdrawal by Subject|2
49013|NCT01229397|188217|P2|Overall Study|Migrated/moved from study area|0
49014|NCT01229397|188218|P1|Overall Study|Migrated/moved from study area|1
49015|NCT01229397|188217|P2|Overall Study|Lost to Follow-up|6
49016|NCT01229397|188218|P1|Overall Study|Lost to Follow-up|7
49017|NCT01229397|188217|P2|Overall Study|Withdrawal by Subject|3
49018|NCT01229397|188218|P1|Overall Study|Withdrawal by Subject|3
49019|NCT01229371|188236|P4|Overall Study|Withdrawal by Subject|0
49020|NCT01229371|188237|P3|Overall Study|Withdrawal by Subject|0
49021|NCT01229371|188238|P2|Overall Study|Withdrawal by Subject|1
49022|NCT01229371|188239|P1|Overall Study|Withdrawal by Subject|0
49023|NCT01229176|188290|P8|Overall Study|Lost to Follow-up|2
49024|NCT01229176|188291|P7|Overall Study|Lost to Follow-up|0
49025|NCT01229176|188292|P6|Overall Study|Lost to Follow-up|1
49026|NCT01229176|188293|P5|Overall Study|Lost to Follow-up|1
49027|NCT01229176|188294|P4|Overall Study|Lost to Follow-up|0
49028|NCT01229176|188295|P3|Overall Study|Lost to Follow-up|0
49029|NCT01229176|188296|P2|Overall Study|Lost to Follow-up|3
49030|NCT01229176|188297|P1|Overall Study|Lost to Follow-up|0
49031|NCT01229176|188290|P8|Overall Study|Withdrawal by Subject|1
49032|NCT01229176|188291|P7|Overall Study|Withdrawal by Subject|0
49033|NCT01229176|188292|P6|Overall Study|Withdrawal by Subject|1
49034|NCT01229176|188293|P5|Overall Study|Withdrawal by Subject|1
49035|NCT01229176|188294|P4|Overall Study|Withdrawal by Subject|1
49036|NCT01229176|188295|P3|Overall Study|Withdrawal by Subject|0
49037|NCT01229176|188296|P2|Overall Study|Withdrawal by Subject|0
49038|NCT01229176|188297|P1|Overall Study|Withdrawal by Subject|0
49039|NCT01229150|188351|P4|Overall Study|Toxicity|0
49040|NCT01229150|188352|P3|Overall Study|Toxicity|0
49041|NCT01229150|188353|P2|Overall Study|Toxicity|2
49042|NCT01229150|188354|P1|Overall Study|Toxicity|2
49043|NCT01228747|188388|P2|Overall Study|Other Reason|5
49044|NCT01228747|188389|P1|Overall Study|Other Reason|2
49045|NCT01228747|188388|P2|Overall Study|Withdrawal by Subject|1
49046|NCT01228747|188389|P1|Overall Study|Withdrawal by Subject|5
49047|NCT01228747|188388|P2|Overall Study|Lost to Follow-up|3
49048|NCT01228747|188389|P1|Overall Study|Lost to Follow-up|4
49049|NCT01228747|188388|P2|Overall Study|Protocol Violation|5
49050|NCT01228747|188389|P1|Overall Study|Protocol Violation|6
49051|NCT01228747|188388|P2|Overall Study|Lack of Efficacy|27
49052|NCT01228747|188389|P1|Overall Study|Lack of Efficacy|40
49053|NCT01228747|188388|P2|Overall Study|Adverse Event|4
49054|NCT01228747|188389|P1|Overall Study|Adverse Event|8
49055|NCT01228591|188403|P2|Baseline|Lack of Efficacy|2
49056|NCT01228591|188404|P1|Baseline|Lack of Efficacy|1
49057|NCT01228175|188431|P2|Overall Study|Physician Decision|1
49058|NCT01228175|188432|P1|Overall Study|Physician Decision|1
49059|NCT01228175|188431|P2|Overall Study|Withdrawal by Subject|2
49060|NCT01228175|188432|P1|Overall Study|Withdrawal by Subject|1
49061|NCT01228175|188431|P2|Overall Study|Lost to Follow-up|50
49062|NCT01228175|188432|P1|Overall Study|Lost to Follow-up|61
49063|NCT01228071|188449|P1|Overall Study|Withdrawal by Subject|1
49064|NCT01228071|188449|P1|Overall Study|Protocol Violation|1
49065|NCT01228019|188455|P1|Overall Study|Violation of Entry Criterion|9
49066|NCT01228019|188455|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
49067|NCT01228019|188455|P1|Overall Study|Missing pre-treatment data|72
49068|NCT01228019|188455|P1|Overall Study|Duplicate enrollment|1
49069|NCT01228019|188455|P1|Overall Study|Dose Violation|70
49070|NCT01227928|188521|P2|Overall Study|Death|12
49071|NCT01227928|188522|P1|Overall Study|Death|14
49072|NCT01227928|188521|P2|Overall Study|Withdrawal by Subject|3
49073|NCT01227928|188522|P1|Overall Study|Withdrawal by Subject|4
49074|NCT01227928|188521|P2|Overall Study|Lost to Follow-up|2
49075|NCT01227928|188522|P1|Overall Study|Lost to Follow-up|4
49076|NCT01227902|188560|P4|Overall Study|Withdrawal by Subject|3
49077|NCT01227902|188561|P3|Overall Study|Withdrawal by Subject|4
49078|NCT01227902|188562|P2|Overall Study|Withdrawal by Subject|2
49079|NCT01227902|188563|P1|Overall Study|Withdrawal by Subject|4
49080|NCT01227902|188560|P4|Overall Study|Physician Decision|0
49081|NCT01227902|188561|P3|Overall Study|Physician Decision|1
49082|NCT01227902|188562|P2|Overall Study|Physician Decision|1
49083|NCT01227902|188563|P1|Overall Study|Physician Decision|0
49084|NCT01227902|188560|P4|Overall Study|Lost to Follow-up|2
49085|NCT01227902|188561|P3|Overall Study|Lost to Follow-up|1
49086|NCT01227902|188562|P2|Overall Study|Lost to Follow-up|0
49087|NCT01227902|188563|P1|Overall Study|Lost to Follow-up|0
49088|NCT01227902|188560|P4|Overall Study|Protocol Violation|0
49089|NCT01227902|188561|P3|Overall Study|Protocol Violation|0
49090|NCT01227902|188562|P2|Overall Study|Protocol Violation|0
49091|NCT01227902|188563|P1|Overall Study|Protocol Violation|1
49092|NCT01227902|188560|P4|Overall Study|Lack of Efficacy|1
49093|NCT01227902|188561|P3|Overall Study|Lack of Efficacy|2
49094|NCT01227902|188562|P2|Overall Study|Lack of Efficacy|2
49095|NCT01227902|188563|P1|Overall Study|Lack of Efficacy|1
49096|NCT01227902|188560|P4|Overall Study|Adverse Event|4
49097|NCT01227902|188561|P3|Overall Study|Adverse Event|11
49098|NCT01227902|188562|P2|Overall Study|Adverse Event|8
49099|NCT01227902|188563|P1|Overall Study|Adverse Event|12
49100|NCT01227889|188656|P2|Crossover Phase|In Follow-up|11
49101|NCT01227889|188657|P1|Crossover Phase|In Follow-up|0
49102|NCT01227889|188656|P2|Crossover Phase|Ongoing|4
49103|NCT01227889|188657|P1|Crossover Phase|Ongoing|0
49104|NCT01227889|188656|P2|Crossover Phase|Death|20
49105|NCT01227889|188657|P1|Crossover Phase|Death|0
49106|NCT01227889|188656|P2|Crossover Phase|Withdrawal by Subject|1
49107|NCT01227889|188657|P1|Crossover Phase|Withdrawal by Subject|0
49108|NCT01227889|188656|P2|Randomized Phase (RP)|In Follow-up|10
49109|NCT01227889|188657|P1|Randomized Phase (RP)|In Follow-up|49
49110|NCT01227889|188656|P2|Randomized Phase (RP)|Ongoing|2
49111|NCT01227889|188657|P1|Randomized Phase (RP)|Ongoing|53
49112|NCT01227889|188656|P2|Randomized Phase (RP)|Crossed Over|36
49113|NCT01227889|188657|P1|Randomized Phase (RP)|Crossed Over|0
49114|NCT01227889|188656|P2|Randomized Phase (RP)|Death|8
49115|NCT01227889|188657|P1|Randomized Phase (RP)|Death|78
49116|NCT01227889|188656|P2|Randomized Phase (RP)|Withdrawal by Subject|5
49117|NCT01227889|188657|P1|Randomized Phase (RP)|Withdrawal by Subject|2
49118|NCT01227889|188656|P2|Randomized Phase (RP)|Physician Decision|1
49119|NCT01227889|188657|P1|Randomized Phase (RP)|Physician Decision|2
49120|NCT01227889|188656|P2|Randomized Phase (RP)|Lost to Follow-up|1
49121|NCT01227889|188657|P1|Randomized Phase (RP)|Lost to Follow-up|3
49122|NCT01227824|188685|P2|Open-label Phase|Ongoing|0
49123|NCT01227824|188686|P1|Open-label Phase|Ongoing|337
49124|NCT01227824|188685|P2|Open-label Phase|Protocol Violation|0
49125|NCT01227824|188686|P1|Open-label Phase|Protocol Violation|1
49126|NCT01227824|188685|P2|Double-blind Phase|Withdrawal by Subject|14
49127|NCT01227824|188686|P1|Double-blind Phase|Withdrawal by Subject|10
49128|NCT01227824|188685|P2|Double-blind Phase|Lost to Follow-up|10
49129|NCT01227824|188686|P1|Double-blind Phase|Lost to Follow-up|6
49130|NCT01227824|188685|P2|Double-blind Phase|Study Closed/Terminated|4
49131|NCT01227824|188686|P1|Double-blind Phase|Study Closed/Terminated|6
49132|NCT01227824|188685|P2|Double-blind Phase|Met Protocol-defined Stopping Criteria|3
49133|NCT01227824|188686|P1|Double-blind Phase|Met Protocol-defined Stopping Criteria|2
49134|NCT01227824|188685|P2|Double-blind Phase|Protocol Violation|16
49135|NCT01227824|188686|P1|Double-blind Phase|Protocol Violation|13
49136|NCT01227824|188685|P2|Double-blind Phase|Lack of Efficacy|25
49137|NCT01227824|188686|P1|Double-blind Phase|Lack of Efficacy|17
49138|NCT01227824|188685|P2|Double-blind Phase|Adverse Event|7
49139|NCT01227824|188686|P1|Double-blind Phase|Adverse Event|8
49140|NCT01227707|188780|P1|Overall Study|Death|1
49141|NCT01227707|188780|P1|Overall Study|Medical decision|6
49142|NCT01227707|188780|P1|Overall Study|Patient non-compliance|3
49143|NCT01227707|188780|P1|Overall Study|Withdrawal by Subject|1
49144|NCT01227707|188780|P1|Overall Study|Progression of disease|3
49145|NCT01227707|188780|P1|Overall Study|Adverse Event|10
49146|NCT01227668|188807|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
49147|NCT01227668|188808|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
49148|NCT01227668|188807|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
49149|NCT01227668|188808|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
49150|NCT01227668|188807|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
49151|NCT01227668|188808|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
49152|NCT01227668|188807|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
49153|NCT01227668|188808|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
49154|NCT01227668|188807|P2|Phase 2 (Randomization Phase)|Adverse Event|1
49155|NCT01227668|188808|P1|Phase 2 (Randomization Phase)|Adverse Event|0
49156|NCT01227668|188807|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
49157|NCT01227668|188808|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
49158|NCT01227668|188807|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
49159|NCT01227668|188808|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
49160|NCT01227668|188807|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
49161|NCT01227668|188808|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
49162|NCT01227668|188807|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
49163|NCT01227668|188808|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
49164|NCT01227668|188807|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
49165|NCT01227668|188808|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
49166|NCT01227668|188807|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
49167|NCT01227668|188808|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
49168|NCT01227668|188807|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
49169|NCT01227668|188808|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
49170|NCT01227629|188854|P10|Overall Study|Not Specified|1
49171|NCT01227629|188855|P9|Overall Study|Not Specified|2
49172|NCT01227629|188856|P8|Overall Study|Not Specified|0
49173|NCT01227629|188857|P7|Overall Study|Not Specified|0
49174|NCT01227629|188858|P6|Overall Study|Not Specified|0
49175|NCT01227629|188859|P5|Overall Study|Not Specified|0
49176|NCT01227629|188860|P4|Overall Study|Not Specified|1
49177|NCT01227629|188861|P3|Overall Study|Not Specified|0
49178|NCT01227629|188862|P2|Overall Study|Not Specified|0
49179|NCT01227629|188863|P1|Overall Study|Not Specified|0
49180|NCT01227629|188854|P10|Overall Study|Withdrawal by Subject|1
49181|NCT01227629|188855|P9|Overall Study|Withdrawal by Subject|0
49182|NCT01227629|188856|P8|Overall Study|Withdrawal by Subject|0
49183|NCT01227629|188857|P7|Overall Study|Withdrawal by Subject|2
49184|NCT01227629|188858|P6|Overall Study|Withdrawal by Subject|0
49185|NCT01227629|188859|P5|Overall Study|Withdrawal by Subject|0
49186|NCT01227629|188860|P4|Overall Study|Withdrawal by Subject|0
49187|NCT01227629|188861|P3|Overall Study|Withdrawal by Subject|0
49188|NCT01227629|188862|P2|Overall Study|Withdrawal by Subject|0
49189|NCT01227629|188863|P1|Overall Study|Withdrawal by Subject|0
49190|NCT01227629|188854|P10|Overall Study|Lost to Follow-up|0
49191|NCT01227629|188855|P9|Overall Study|Lost to Follow-up|0
49192|NCT01227629|188856|P8|Overall Study|Lost to Follow-up|0
49193|NCT01227629|188857|P7|Overall Study|Lost to Follow-up|0
49194|NCT01227629|188858|P6|Overall Study|Lost to Follow-up|0
49195|NCT01227629|188859|P5|Overall Study|Lost to Follow-up|1
49196|NCT01227629|188860|P4|Overall Study|Lost to Follow-up|0
49197|NCT01227629|188861|P3|Overall Study|Lost to Follow-up|0
49198|NCT01227629|188862|P2|Overall Study|Lost to Follow-up|0
49199|NCT01227629|188863|P1|Overall Study|Lost to Follow-up|0
49200|NCT01227629|188854|P10|Overall Study|Protocol Violation|0
49201|NCT01227629|188855|P9|Overall Study|Protocol Violation|0
49202|NCT01227629|188856|P8|Overall Study|Protocol Violation|0
49203|NCT01227629|188857|P7|Overall Study|Protocol Violation|0
49204|NCT01227629|188858|P6|Overall Study|Protocol Violation|0
49205|NCT01227629|188859|P5|Overall Study|Protocol Violation|0
49206|NCT01227629|188860|P4|Overall Study|Protocol Violation|1
49207|NCT01227629|188861|P3|Overall Study|Protocol Violation|0
49208|NCT01227629|188862|P2|Overall Study|Protocol Violation|0
49209|NCT01227629|188863|P1|Overall Study|Protocol Violation|0
49210|NCT01227629|188854|P10|Overall Study|Adverse Event|0
49211|NCT01227629|188855|P9|Overall Study|Adverse Event|4
49212|NCT01227629|188856|P8|Overall Study|Adverse Event|6
49213|NCT01227629|188857|P7|Overall Study|Adverse Event|6
49214|NCT01227629|188858|P6|Overall Study|Adverse Event|1
49215|NCT01227629|188859|P5|Overall Study|Adverse Event|1
49216|NCT01227629|188860|P4|Overall Study|Adverse Event|6
49217|NCT01227629|188861|P3|Overall Study|Adverse Event|1
49218|NCT01227629|188862|P2|Overall Study|Adverse Event|2
49219|NCT01227629|188863|P1|Overall Study|Adverse Event|2
49220|NCT01227577|189099|P1|Overall Study|Adverse Event|17
49221|NCT01227577|189099|P1|Overall Study|Lack of Efficacy|5
49222|NCT01227577|189099|P1|Overall Study|Withdrawal by Subject|4
49223|NCT01227577|189099|P1|Overall Study|Lost to Follow-up|1
49224|NCT01227577|189099|P1|Overall Study|Administrative problems|2
49225|NCT01227577|189099|P1|Overall Study|Death|3
49226|NCT01227577|189099|P1|Overall Study|Protocol deviation|3
49227|NCT01227564|189114|P3|Overall Study|Participant moved to another town|1
49228|NCT01227564|189115|P2|Overall Study|Participant moved to another town|0
49229|NCT01227564|189116|P1|Overall Study|Participant moved to another town|0
49230|NCT01227564|189114|P3|Overall Study|No Longer Willing to Participate|5
49231|NCT01227564|189115|P2|Overall Study|No Longer Willing to Participate|2
49232|NCT01227564|189116|P1|Overall Study|No Longer Willing to Participate|4
49233|NCT01227512|189249|P2|Overall Study|Participant met withdrawal criteria|1
49234|NCT01227512|189250|P1|Overall Study|Participant met withdrawal criteria|0
49235|NCT01227512|189249|P2|Overall Study|Withdrawal by Subject|0
49236|NCT01227512|189250|P1|Overall Study|Withdrawal by Subject|3
49237|NCT01227512|189249|P2|Overall Study|Adverse Event|3
49238|NCT01227512|189250|P1|Overall Study|Adverse Event|4
49239|NCT01227512|189249|P2|Overall Study|Physician Decision|6
49240|NCT01227512|189250|P1|Overall Study|Physician Decision|6
49241|NCT01227421|189284|P3|Overall Study|Randomized in error|0
49242|NCT01227421|189285|P2|Overall Study|Randomized in error|1
49243|NCT01227421|189286|P1|Overall Study|Randomized in error|1
49244|NCT01227421|189284|P3|Overall Study|Protocol Violation|2
49245|NCT01227421|189285|P2|Overall Study|Protocol Violation|1
49246|NCT01227421|189286|P1|Overall Study|Protocol Violation|1
49247|NCT01227421|189284|P3|Overall Study|Withdrawal by Subject|1
49248|NCT01227421|189285|P2|Overall Study|Withdrawal by Subject|2
49249|NCT01227421|189286|P1|Overall Study|Withdrawal by Subject|1
49250|NCT01227421|189284|P3|Overall Study|Adverse Event|2
49251|NCT01227421|189285|P2|Overall Study|Adverse Event|7
49252|NCT01227421|189286|P1|Overall Study|Adverse Event|2
49253|NCT01227421|189284|P3|Overall Study|Lost to Follow-up|5
49254|NCT01227421|189285|P2|Overall Study|Lost to Follow-up|7
49255|NCT01227421|189286|P1|Overall Study|Lost to Follow-up|6
49256|NCT01227395|189338|P2|Overall Study|Protocol Violation|1
49257|NCT01227395|189339|P1|Overall Study|Protocol Violation|0
49258|NCT01227278|189379|P2|Overall Study|Unspecified|2
49259|NCT01227278|189380|P1|Overall Study|Unspecified|1
49260|NCT01227278|189379|P2|Overall Study|Death|2
49261|NCT01227278|189380|P1|Overall Study|Death|0
49262|NCT01227278|189379|P2|Overall Study|Withdrawal by Subject|4
49263|NCT01227278|189380|P1|Overall Study|Withdrawal by Subject|4
49264|NCT01227265|189407|P3|Overall Study|Adverse Event|5
49265|NCT01227265|189408|P2|Overall Study|Adverse Event|10
49266|NCT01227265|189409|P1|Overall Study|Adverse Event|6
49267|NCT01227265|189407|P3|Overall Study|Lost to Follow-up|3
49268|NCT01227265|189408|P2|Overall Study|Lost to Follow-up|0
49269|NCT01227265|189409|P1|Overall Study|Lost to Follow-up|2
49270|NCT01227265|189407|P3|Overall Study|Withdrawal by Subject|3
49271|NCT01227265|189408|P2|Overall Study|Withdrawal by Subject|7
49272|NCT01227265|189409|P1|Overall Study|Withdrawal by Subject|7
49273|NCT01227265|189407|P3|Overall Study|Protocol Violation|0
49274|NCT01227265|189408|P2|Overall Study|Protocol Violation|1
49275|NCT01227265|189409|P1|Overall Study|Protocol Violation|2
49276|NCT01227265|189407|P3|Overall Study|Did Not Meet Protocol Eligibility|1
49277|NCT01227265|189408|P2|Overall Study|Did Not Meet Protocol Eligibility|0
49278|NCT01227265|189409|P1|Overall Study|Did Not Meet Protocol Eligibility|0
49279|NCT01227265|189407|P3|Overall Study|Administrative|2
49280|NCT01227265|189408|P2|Overall Study|Administrative|0
49281|NCT01227265|189409|P1|Overall Study|Administrative|1
49282|NCT01227265|189407|P3|Overall Study|Did Not Receive Treatment|0
49283|NCT01227265|189408|P2|Overall Study|Did Not Receive Treatment|2
49284|NCT01227265|189409|P1|Overall Study|Did Not Receive Treatment|1
49285|NCT01227018|189446|P1|Overall Study|Withdrew after beginning treatment|4
49286|NCT01227018|189446|P1|Overall Study|Toxicity|2
49287|NCT01227018|189446|P1|Overall Study|Disease progression|9
49288|NCT01226745|189473|P6|Overall Study|Unspecified|1
49289|NCT01226745|189474|P5|Overall Study|Unspecified|3
49290|NCT01226745|189475|P4|Overall Study|Unspecified|4
49291|NCT01226745|189476|P3|Overall Study|Unspecified|8
49292|NCT01226745|189477|P2|Overall Study|Unspecified|7
49293|NCT01226745|189478|P1|Overall Study|Unspecified|6
49294|NCT01226745|189473|P6|Overall Study|Death|1
49295|NCT01226745|189474|P5|Overall Study|Death|0
49296|NCT01226745|189475|P4|Overall Study|Death|0
49297|NCT01226745|189476|P3|Overall Study|Death|0
49298|NCT01226745|189477|P2|Overall Study|Death|0
49299|NCT01226745|189478|P1|Overall Study|Death|1
49300|NCT01226745|189473|P6|Overall Study|Lost to Follow-up|2
49301|NCT01226745|189474|P5|Overall Study|Lost to Follow-up|1
49302|NCT01226745|189475|P4|Overall Study|Lost to Follow-up|1
49303|NCT01226745|189476|P3|Overall Study|Lost to Follow-up|6
49304|NCT01226745|189477|P2|Overall Study|Lost to Follow-up|6
49305|NCT01226745|189478|P1|Overall Study|Lost to Follow-up|2
49306|NCT01226745|189473|P6|Overall Study|Did not complete schedule of assessments|1
49307|NCT01226745|189474|P5|Overall Study|Did not complete schedule of assessments|0
49308|NCT01226745|189475|P4|Overall Study|Did not complete schedule of assessments|0
49309|NCT01226745|189476|P3|Overall Study|Did not complete schedule of assessments|6
49310|NCT01226745|189477|P2|Overall Study|Did not complete schedule of assessments|3
49311|NCT01226745|189478|P1|Overall Study|Did not complete schedule of assessments|8
49312|NCT01226511|189589|P2|Taper Period|Parent/Caregiver Decision|1
49313|NCT01226511|189590|P1|Taper Period|Parent/Caregiver Decision|1
49314|NCT01226511|189589|P2|Taper Period|Protocol Violation|0
49315|NCT01226511|189590|P1|Taper Period|Protocol Violation|1
49316|NCT01226511|189589|P2|Taper Period|Lost to Follow-up|2
49317|NCT01226511|189590|P1|Taper Period|Lost to Follow-up|2
49318|NCT01226511|189589|P2|Taper Period|Adverse Event|0
49319|NCT01226511|189590|P1|Taper Period|Adverse Event|1
49320|NCT01226511|189589|P2|Extension Treatment Period|Sponsor Decision|1
49321|NCT01226511|189590|P1|Extension Treatment Period|Sponsor Decision|1
49322|NCT01226511|189589|P2|Extension Treatment Period|Parent/Caregiver Decision|8
49323|NCT01226511|189590|P1|Extension Treatment Period|Parent/Caregiver Decision|8
49324|NCT01226511|189589|P2|Extension Treatment Period|Withdrawal by Subject|3
49325|NCT01226511|189590|P1|Extension Treatment Period|Withdrawal by Subject|1
49326|NCT01226511|189589|P2|Extension Treatment Period|Protocol Violation|2
49327|NCT01226511|189590|P1|Extension Treatment Period|Protocol Violation|2
49328|NCT01226511|189589|P2|Extension Treatment Period|Lost to Follow-up|3
49329|NCT01226511|189590|P1|Extension Treatment Period|Lost to Follow-up|4
49330|NCT01226511|189589|P2|Extension Treatment Period|Lack of Efficacy|2
49331|NCT01226511|189590|P1|Extension Treatment Period|Lack of Efficacy|3
49332|NCT01226511|189589|P2|Extension Treatment Period|Adverse Event|8
49333|NCT01226511|189590|P1|Extension Treatment Period|Adverse Event|8
49334|NCT01226511|189589|P2|Acute Treatment Period|Withdrawal by Subject|6
49335|NCT01226511|189590|P1|Acute Treatment Period|Withdrawal by Subject|10
49336|NCT01226511|189589|P2|Acute Treatment Period|Protocol Violation|5
49337|NCT01226511|189590|P1|Acute Treatment Period|Protocol Violation|5
49338|NCT01226511|189589|P2|Acute Treatment Period|Parent/caregiver decision|7
49339|NCT01226511|189590|P1|Acute Treatment Period|Parent/caregiver decision|5
49340|NCT01226511|189589|P2|Acute Treatment Period|Lost to Follow-up|6
49341|NCT01226511|189590|P1|Acute Treatment Period|Lost to Follow-up|3
49342|NCT01226511|189589|P2|Acute Treatment Period|Lack of Efficacy|1
49343|NCT01226511|189590|P1|Acute Treatment Period|Lack of Efficacy|2
49344|NCT01226511|189589|P2|Acute Treatment Period|Adverse Event|6
49345|NCT01226511|189590|P1|Acute Treatment Period|Adverse Event|7
49346|NCT01226459|189628|P2|Overall Study|Pregnancy|0
49347|NCT01226459|189629|P1|Overall Study|Pregnancy|1
49348|NCT01226459|189628|P2|Overall Study|Lost to Follow-up|8
49349|NCT01226459|189629|P1|Overall Study|Lost to Follow-up|4
49350|NCT01226459|189628|P2|Overall Study|Withdrawal by Subject|13
49351|NCT01226459|189629|P1|Overall Study|Withdrawal by Subject|10
49352|NCT01226459|189628|P2|Overall Study|Protocol Violation|3
49353|NCT01226459|189629|P1|Overall Study|Protocol Violation|4
49354|NCT01226459|189628|P2|Overall Study|Adverse Event|8
49355|NCT01226459|189629|P1|Overall Study|Adverse Event|2
49356|NCT01226121|189647|P3|Overall Study|Lost to Follow-up|1
49357|NCT01226121|189648|P2|Overall Study|Lost to Follow-up|0
49358|NCT01226121|189649|P1|Overall Study|Lost to Follow-up|2
49359|NCT01226095|189660|P1|Overall Study|Poor compliance|1
49360|NCT01226043|189685|P4|30-week Observational Phase|Physician Decision|2
49361|NCT01226043|189686|P3|30-week Observational Phase|Physician Decision|2
49362|NCT01226043|189687|P2|30-week Observational Phase|Physician Decision|0
49363|NCT01226043|189688|P1|30-week Observational Phase|Physician Decision|0
49364|NCT01226043|189685|P4|30-week Observational Phase|Withdrawal by Subject|7
49365|NCT01226043|189686|P3|30-week Observational Phase|Withdrawal by Subject|1
49366|NCT01226043|189687|P2|30-week Observational Phase|Withdrawal by Subject|0
49367|NCT01226043|189688|P1|30-week Observational Phase|Withdrawal by Subject|0
49368|NCT01226043|189685|P4|30-week Observational Phase|Lost to Follow-up|2
49369|NCT01226043|189686|P3|30-week Observational Phase|Lost to Follow-up|2
49370|NCT01226043|189687|P2|30-week Observational Phase|Lost to Follow-up|0
49371|NCT01226043|189688|P1|30-week Observational Phase|Lost to Follow-up|0
49372|NCT01226043|189685|P4|30-week Observational Phase|Protocol Violation|1
49373|NCT01226043|189686|P3|30-week Observational Phase|Protocol Violation|0
49374|NCT01226043|189687|P2|30-week Observational Phase|Protocol Violation|0
49375|NCT01226043|189688|P1|30-week Observational Phase|Protocol Violation|0
49376|NCT01226043|189685|P4|30-week Observational Phase|Adverse Event|1
49377|NCT01226043|189686|P3|30-week Observational Phase|Adverse Event|1
49378|NCT01226043|189687|P2|30-week Observational Phase|Adverse Event|0
49379|NCT01226043|189688|P1|30-week Observational Phase|Adverse Event|0
49380|NCT01226043|189685|P4|6-week Re-randomization Phase|completed in error|1
49381|NCT01226043|189686|P3|6-week Re-randomization Phase|completed in error|0
49382|NCT01226043|189687|P2|6-week Re-randomization Phase|completed in error|0
49383|NCT01226043|189688|P1|6-week Re-randomization Phase|completed in error|0
49384|NCT01226043|189685|P4|6-week Re-randomization Phase|Physician Decision|2
49385|NCT01226043|189686|P3|6-week Re-randomization Phase|Physician Decision|3
49386|NCT01226043|189687|P2|6-week Re-randomization Phase|Physician Decision|0
49387|NCT01226043|189688|P1|6-week Re-randomization Phase|Physician Decision|0
49388|NCT01226043|189685|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
49389|NCT01226043|189686|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
49390|NCT01226043|189687|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
49391|NCT01226043|189688|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
49392|NCT01226043|189685|P4|6-week Re-randomization Phase|Lost to Follow-up|3
49393|NCT01226043|189686|P3|6-week Re-randomization Phase|Lost to Follow-up|1
49394|NCT01226043|189687|P2|6-week Re-randomization Phase|Lost to Follow-up|0
49395|NCT01226043|189688|P1|6-week Re-randomization Phase|Lost to Follow-up|0
49396|NCT01226043|189685|P4|6-week Re-randomization Phase|Protocol Violation|1
49397|NCT01226043|189686|P3|6-week Re-randomization Phase|Protocol Violation|1
49398|NCT01226043|189687|P2|6-week Re-randomization Phase|Protocol Violation|0
49399|NCT01226043|189688|P1|6-week Re-randomization Phase|Protocol Violation|0
49400|NCT01226043|189685|P4|6-week Re-randomization Phase|Adverse Event|1
49401|NCT01226043|189686|P3|6-week Re-randomization Phase|Adverse Event|1
49402|NCT01226043|189687|P2|6-week Re-randomization Phase|Adverse Event|0
49403|NCT01226043|189688|P1|6-week Re-randomization Phase|Adverse Event|0
49404|NCT01226043|189685|P4|4-week Crossover Phase - Period 2|Physician Decision|0
49405|NCT01226043|189686|P3|4-week Crossover Phase - Period 2|Physician Decision|0
49406|NCT01226043|189687|P2|4-week Crossover Phase - Period 2|Physician Decision|5
49407|NCT01226043|189688|P1|4-week Crossover Phase - Period 2|Physician Decision|4
49408|NCT01226043|189685|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
49409|NCT01226043|189686|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
49410|NCT01226043|189687|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
49411|NCT01226043|189688|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
49412|NCT01226043|189685|P4|4-week Crossover Phase - Period 1|Physician Decision|0
49413|NCT01226043|189686|P3|4-week Crossover Phase - Period 1|Physician Decision|0
49414|NCT01226043|189687|P2|4-week Crossover Phase - Period 1|Physician Decision|6
49415|NCT01226043|189688|P1|4-week Crossover Phase - Period 1|Physician Decision|0
49416|NCT01226043|189685|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
49417|NCT01226043|189686|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
49418|NCT01226043|189687|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
49419|NCT01226043|189688|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
49420|NCT01226043|189685|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
49421|NCT01226043|189686|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
49422|NCT01226043|189687|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
49423|NCT01226043|189688|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
49424|NCT01226043|189685|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
49425|NCT01226043|189686|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
49426|NCT01226043|189687|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
49427|NCT01226043|189688|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
49428|NCT01225991|189726|P1|Overall Study|Withdrawal by Subject|6
49429|NCT01225952|189733|P3|Overall Study|Surgical complications|0
49430|NCT01225952|189734|P2|Overall Study|Surgical complications|0
49431|NCT01225952|189735|P1|Overall Study|Surgical complications|1
49432|NCT01225952|189733|P3|Overall Study|Withdrawal by Subject|5
49433|NCT01225952|189734|P2|Overall Study|Withdrawal by Subject|4
49434|NCT01225952|189735|P1|Overall Study|Withdrawal by Subject|4
49435|NCT01225952|189733|P3|Overall Study|Study Eye Explanted|1
49436|NCT01225952|189734|P2|Overall Study|Study Eye Explanted|0
49437|NCT01225952|189735|P1|Overall Study|Study Eye Explanted|0
49438|NCT01225952|189733|P3|Overall Study|Lost to Follow-up|0
49439|NCT01225952|189734|P2|Overall Study|Lost to Follow-up|0
49440|NCT01225952|189735|P1|Overall Study|Lost to Follow-up|1
49441|NCT01225835|189829|P2|Overall Study|not specified|1
49442|NCT01225835|189830|P1|Overall Study|not specified|1
49443|NCT01225835|189829|P2|Overall Study|Adverse Event|1
49444|NCT01225835|189830|P1|Overall Study|Adverse Event|2
49445|NCT01225835|189829|P2|Overall Study|Did not meet hCG criterion|0
49446|NCT01225835|189830|P1|Overall Study|Did not meet hCG criterion|2
49447|NCT01225835|189829|P2|Overall Study|Completed protocol|1
49448|NCT01225835|189830|P1|Overall Study|Completed protocol|2
49449|NCT01225822|189878|P5|Overall Study|Not Specified|7
49450|NCT01225822|189879|P4|Overall Study|Not Specified|10
49451|NCT01225822|189880|P3|Overall Study|Not Specified|7
49452|NCT01225822|189881|P2|Overall Study|Not Specified|10
49453|NCT01225822|189882|P1|Overall Study|Not Specified|13
49454|NCT01225822|189878|P5|Overall Study|Withdrawal by Subject|6
49455|NCT01225822|189879|P4|Overall Study|Withdrawal by Subject|11
49456|NCT01225822|189880|P3|Overall Study|Withdrawal by Subject|7
49457|NCT01225822|189881|P2|Overall Study|Withdrawal by Subject|7
49458|NCT01225822|189882|P1|Overall Study|Withdrawal by Subject|6
49459|NCT01225822|189878|P5|Overall Study|Lost to Follow-up|0
49460|NCT01225822|189879|P4|Overall Study|Lost to Follow-up|1
49461|NCT01225822|189880|P3|Overall Study|Lost to Follow-up|0
49462|NCT01225822|189881|P2|Overall Study|Lost to Follow-up|0
49463|NCT01225822|189882|P1|Overall Study|Lost to Follow-up|0
49464|NCT01225822|189878|P5|Overall Study|Protocol Violation|4
49465|NCT01225822|189879|P4|Overall Study|Protocol Violation|7
49466|NCT01225822|189880|P3|Overall Study|Protocol Violation|6
49467|NCT01225822|189881|P2|Overall Study|Protocol Violation|8
49468|NCT01225822|189882|P1|Overall Study|Protocol Violation|6
49469|NCT01225822|189878|P5|Overall Study|Adverse Event|14
49470|NCT01225822|189879|P4|Overall Study|Adverse Event|23
49471|NCT01225822|189880|P3|Overall Study|Adverse Event|18
49472|NCT01225822|189881|P2|Overall Study|Adverse Event|31
49473|NCT01225822|189882|P1|Overall Study|Adverse Event|13
49474|NCT01225731|189949|P13|Part 3|Withdrawal by Subject|4
49475|NCT01225731|189950|P12|Part 3|Withdrawal by Subject|6
49476|NCT01225731|189951|P11|Part 3|Withdrawal by Subject|4
49477|NCT01225731|189952|P10|Part 3|Withdrawal by Subject|0
49478|NCT01225731|189953|P9|Part 3|Withdrawal by Subject|0
49479|NCT01225731|189954|P8|Part 3|Withdrawal by Subject|0
49480|NCT01225731|189955|P7|Part 3|Withdrawal by Subject|0
49481|NCT01225731|189956|P6|Part 3|Withdrawal by Subject|0
49482|NCT01225731|189957|P5|Part 3|Withdrawal by Subject|0
49483|NCT01225731|189958|P4|Part 3|Withdrawal by Subject|0
49484|NCT01225731|189959|P3|Part 3|Withdrawal by Subject|0
49485|NCT01225731|189960|P2|Part 3|Withdrawal by Subject|0
49486|NCT01225731|189961|P1|Part 3|Withdrawal by Subject|0
49487|NCT01225731|189949|P13|Part 3|Physician Decision|2
49488|NCT01225731|189950|P12|Part 3|Physician Decision|1
49489|NCT01225731|189951|P11|Part 3|Physician Decision|0
49490|NCT01225731|189952|P10|Part 3|Physician Decision|0
49491|NCT01225731|189953|P9|Part 3|Physician Decision|0
49492|NCT01225731|189954|P8|Part 3|Physician Decision|0
49493|NCT01225731|189955|P7|Part 3|Physician Decision|0
49494|NCT01225731|189956|P6|Part 3|Physician Decision|0
49495|NCT01225731|189957|P5|Part 3|Physician Decision|0
49496|NCT01225731|189958|P4|Part 3|Physician Decision|0
49497|NCT01225731|189959|P3|Part 3|Physician Decision|0
49498|NCT01225731|189960|P2|Part 3|Physician Decision|0
49499|NCT01225731|189961|P1|Part 3|Physician Decision|0
49500|NCT01225731|189949|P13|Part 3|Lost to Follow-up|1
49501|NCT01225731|189950|P12|Part 3|Lost to Follow-up|2
49502|NCT01225731|189951|P11|Part 3|Lost to Follow-up|1
49503|NCT01225731|189952|P10|Part 3|Lost to Follow-up|0
49504|NCT01225731|189953|P9|Part 3|Lost to Follow-up|0
49505|NCT01225731|189954|P8|Part 3|Lost to Follow-up|0
49506|NCT01225731|189955|P7|Part 3|Lost to Follow-up|0
49507|NCT01225731|189956|P6|Part 3|Lost to Follow-up|0
49508|NCT01225731|189957|P5|Part 3|Lost to Follow-up|0
49509|NCT01225731|189958|P4|Part 3|Lost to Follow-up|0
49510|NCT01225731|189959|P3|Part 3|Lost to Follow-up|0
49511|NCT01225731|189960|P2|Part 3|Lost to Follow-up|0
49512|NCT01225731|189961|P1|Part 3|Lost to Follow-up|0
49513|NCT01225731|189949|P13|Part 3|Adverse Event|0
49514|NCT01225731|189950|P12|Part 3|Adverse Event|1
49515|NCT01225731|189951|P11|Part 3|Adverse Event|1
49516|NCT01225731|189952|P10|Part 3|Adverse Event|0
49517|NCT01225731|189953|P9|Part 3|Adverse Event|0
49518|NCT01225731|189954|P8|Part 3|Adverse Event|0
49519|NCT01225731|189955|P7|Part 3|Adverse Event|0
49520|NCT01225731|189956|P6|Part 3|Adverse Event|0
49521|NCT01225731|189957|P5|Part 3|Adverse Event|0
49522|NCT01225731|189958|P4|Part 3|Adverse Event|0
49523|NCT01225731|189959|P3|Part 3|Adverse Event|0
49524|NCT01225731|189960|P2|Part 3|Adverse Event|0
49525|NCT01225731|189961|P1|Part 3|Adverse Event|0
49526|NCT01225731|189949|P13|Part 2|Withdrawal by Subject|0
49527|NCT01225731|189950|P12|Part 2|Withdrawal by Subject|0
49528|NCT01225731|189951|P11|Part 2|Withdrawal by Subject|0
49529|NCT01225731|189952|P10|Part 2|Withdrawal by Subject|0
49530|NCT01225731|189953|P9|Part 2|Withdrawal by Subject|1
49531|NCT01225731|189954|P8|Part 2|Withdrawal by Subject|4
49532|NCT01225731|189955|P7|Part 2|Withdrawal by Subject|3
49533|NCT01225731|189956|P6|Part 2|Withdrawal by Subject|1
49534|NCT01225731|189957|P5|Part 2|Withdrawal by Subject|0
49535|NCT01225731|189958|P4|Part 2|Withdrawal by Subject|0
49536|NCT01225731|189959|P3|Part 2|Withdrawal by Subject|0
49537|NCT01225731|189960|P2|Part 2|Withdrawal by Subject|0
49538|NCT01225731|189961|P1|Part 2|Withdrawal by Subject|0
49539|NCT01225731|189949|P13|Part 2|Physician Decision|0
49540|NCT01225731|189950|P12|Part 2|Physician Decision|0
49541|NCT01225731|189951|P11|Part 2|Physician Decision|0
49542|NCT01225731|189952|P10|Part 2|Physician Decision|0
49543|NCT01225731|189953|P9|Part 2|Physician Decision|2
49544|NCT01225731|189954|P8|Part 2|Physician Decision|2
49545|NCT01225731|189955|P7|Part 2|Physician Decision|0
49546|NCT01225731|189956|P6|Part 2|Physician Decision|0
49547|NCT01225731|189957|P5|Part 2|Physician Decision|0
49548|NCT01225731|189958|P4|Part 2|Physician Decision|0
49549|NCT01225731|189959|P3|Part 2|Physician Decision|0
49550|NCT01225731|189960|P2|Part 2|Physician Decision|0
49551|NCT01225731|189961|P1|Part 2|Physician Decision|0
49552|NCT01225731|189949|P13|Part 2|Lost to Follow-up|0
49553|NCT01225731|189950|P12|Part 2|Lost to Follow-up|0
49554|NCT01225731|189951|P11|Part 2|Lost to Follow-up|0
49555|NCT01225731|189952|P10|Part 2|Lost to Follow-up|0
49556|NCT01225731|189953|P9|Part 2|Lost to Follow-up|1
49557|NCT01225731|189954|P8|Part 2|Lost to Follow-up|3
49558|NCT01225731|189955|P7|Part 2|Lost to Follow-up|0
49559|NCT01225731|189956|P6|Part 2|Lost to Follow-up|0
49560|NCT01225731|189957|P5|Part 2|Lost to Follow-up|0
49561|NCT01225731|189958|P4|Part 2|Lost to Follow-up|0
49562|NCT01225731|189959|P3|Part 2|Lost to Follow-up|0
49563|NCT01225731|189960|P2|Part 2|Lost to Follow-up|0
49564|NCT01225731|189961|P1|Part 2|Lost to Follow-up|0
49565|NCT01225731|189949|P13|Part 2|Pregnancy|0
49566|NCT01225731|189950|P12|Part 2|Pregnancy|0
49567|NCT01225731|189951|P11|Part 2|Pregnancy|0
49568|NCT01225731|189952|P10|Part 2|Pregnancy|0
49569|NCT01225731|189953|P9|Part 2|Pregnancy|1
49570|NCT01225731|189954|P8|Part 2|Pregnancy|0
49571|NCT01225731|189955|P7|Part 2|Pregnancy|1
49572|NCT01225731|189956|P6|Part 2|Pregnancy|0
49573|NCT01225731|189957|P5|Part 2|Pregnancy|0
49574|NCT01225731|189958|P4|Part 2|Pregnancy|0
49575|NCT01225731|189959|P3|Part 2|Pregnancy|0
49576|NCT01225731|189960|P2|Part 2|Pregnancy|0
49577|NCT01225731|189961|P1|Part 2|Pregnancy|0
49578|NCT01225731|189949|P13|Part 2|Lack of Efficacy|0
49579|NCT01225731|189950|P12|Part 2|Lack of Efficacy|0
49580|NCT01225731|189951|P11|Part 2|Lack of Efficacy|0
49581|NCT01225731|189952|P10|Part 2|Lack of Efficacy|0
49582|NCT01225731|189953|P9|Part 2|Lack of Efficacy|3
49583|NCT01225731|189954|P8|Part 2|Lack of Efficacy|12
49584|NCT01225731|189955|P7|Part 2|Lack of Efficacy|0
49585|NCT01225731|189956|P6|Part 2|Lack of Efficacy|1
49586|NCT01225731|189957|P5|Part 2|Lack of Efficacy|0
49587|NCT01225731|189958|P4|Part 2|Lack of Efficacy|0
49588|NCT01225731|189959|P3|Part 2|Lack of Efficacy|0
49589|NCT01225731|189960|P2|Part 2|Lack of Efficacy|0
49590|NCT01225731|189961|P1|Part 2|Lack of Efficacy|0
49591|NCT01225731|189949|P13|Part 2|Adverse Event|0
49592|NCT01225731|189950|P12|Part 2|Adverse Event|0
49593|NCT01225731|189951|P11|Part 2|Adverse Event|0
49594|NCT01225731|189952|P10|Part 2|Adverse Event|0
49595|NCT01225731|189953|P9|Part 2|Adverse Event|2
49596|NCT01225731|189954|P8|Part 2|Adverse Event|4
49597|NCT01225731|189955|P7|Part 2|Adverse Event|4
49598|NCT01225731|189956|P6|Part 2|Adverse Event|0
49599|NCT01225731|189957|P5|Part 2|Adverse Event|0
49600|NCT01225731|189958|P4|Part 2|Adverse Event|0
49601|NCT01225731|189959|P3|Part 2|Adverse Event|0
49602|NCT01225731|189960|P2|Part 2|Adverse Event|0
49603|NCT01225731|189961|P1|Part 2|Adverse Event|0
49604|NCT01225731|189949|P13|Part 2|Protocol Violation|0
49605|NCT01225731|189950|P12|Part 2|Protocol Violation|0
49606|NCT01225731|189951|P11|Part 2|Protocol Violation|0
49607|NCT01225731|189952|P10|Part 2|Protocol Violation|0
49608|NCT01225731|189953|P9|Part 2|Protocol Violation|1
49609|NCT01225731|189954|P8|Part 2|Protocol Violation|0
49610|NCT01225731|189955|P7|Part 2|Protocol Violation|0
49611|NCT01225731|189956|P6|Part 2|Protocol Violation|1
49612|NCT01225731|189957|P5|Part 2|Protocol Violation|0
49613|NCT01225731|189958|P4|Part 2|Protocol Violation|0
49614|NCT01225731|189959|P3|Part 2|Protocol Violation|0
49615|NCT01225731|189960|P2|Part 2|Protocol Violation|0
49616|NCT01225731|189961|P1|Part 2|Protocol Violation|0
49617|NCT01225731|189949|P13|Part 1|Protocol Violation|0
49618|NCT01225731|189950|P12|Part 1|Protocol Violation|0
49619|NCT01225731|189951|P11|Part 1|Protocol Violation|0
49620|NCT01225731|189952|P10|Part 1|Protocol Violation|0
49621|NCT01225731|189953|P9|Part 1|Protocol Violation|0
49622|NCT01225731|189954|P8|Part 1|Protocol Violation|0
49623|NCT01225731|189955|P7|Part 1|Protocol Violation|0
49624|NCT01225731|189956|P6|Part 1|Protocol Violation|0
49625|NCT01225731|189957|P5|Part 1|Protocol Violation|0
49626|NCT01225731|189958|P4|Part 1|Protocol Violation|1
49627|NCT01225731|189959|P3|Part 1|Protocol Violation|0
49628|NCT01225731|189960|P2|Part 1|Protocol Violation|0
49629|NCT01225731|189961|P1|Part 1|Protocol Violation|0
49630|NCT01225731|189949|P13|Part 1|Withdrawal by Subject|0
49631|NCT01225731|189950|P12|Part 1|Withdrawal by Subject|0
49632|NCT01225731|189951|P11|Part 1|Withdrawal by Subject|0
49633|NCT01225731|189952|P10|Part 1|Withdrawal by Subject|0
49634|NCT01225731|189953|P9|Part 1|Withdrawal by Subject|0
49635|NCT01225731|189954|P8|Part 1|Withdrawal by Subject|0
49636|NCT01225731|189955|P7|Part 1|Withdrawal by Subject|0
49637|NCT01225731|189956|P6|Part 1|Withdrawal by Subject|0
49638|NCT01225731|189957|P5|Part 1|Withdrawal by Subject|4
49639|NCT01225731|189958|P4|Part 1|Withdrawal by Subject|0
49640|NCT01225731|189959|P3|Part 1|Withdrawal by Subject|0
49641|NCT01225731|189960|P2|Part 1|Withdrawal by Subject|3
49642|NCT01225731|189961|P1|Part 1|Withdrawal by Subject|0
49643|NCT01225731|189949|P13|Part 1|Adverse Event|0
49644|NCT01225731|189950|P12|Part 1|Adverse Event|0
49645|NCT01225731|189951|P11|Part 1|Adverse Event|0
49646|NCT01225731|189952|P10|Part 1|Adverse Event|0
49647|NCT01225731|189953|P9|Part 1|Adverse Event|0
49648|NCT01225731|189954|P8|Part 1|Adverse Event|0
49649|NCT01225731|189955|P7|Part 1|Adverse Event|0
49650|NCT01225731|189956|P6|Part 1|Adverse Event|0
49651|NCT01225731|189957|P5|Part 1|Adverse Event|1
49652|NCT01225731|189958|P4|Part 1|Adverse Event|1
49653|NCT01225731|189959|P3|Part 1|Adverse Event|1
49654|NCT01225731|189960|P2|Part 1|Adverse Event|2
49655|NCT01225731|189961|P1|Part 1|Adverse Event|1
49656|NCT01225731|189949|P13|Part 1|Did not meet eligibility criteria|0
49657|NCT01225731|189950|P12|Part 1|Did not meet eligibility criteria|0
49658|NCT01225731|189951|P11|Part 1|Did not meet eligibility criteria|0
49659|NCT01225731|189952|P10|Part 1|Did not meet eligibility criteria|0
49660|NCT01225731|189953|P9|Part 1|Did not meet eligibility criteria|0
49661|NCT01225731|189954|P8|Part 1|Did not meet eligibility criteria|0
49662|NCT01225731|189955|P7|Part 1|Did not meet eligibility criteria|0
49663|NCT01225731|189956|P6|Part 1|Did not meet eligibility criteria|0
49664|NCT01225731|189957|P5|Part 1|Did not meet eligibility criteria|1
49665|NCT01225731|189958|P4|Part 1|Did not meet eligibility criteria|0
49666|NCT01225731|189959|P3|Part 1|Did not meet eligibility criteria|0
49667|NCT01225731|189960|P2|Part 1|Did not meet eligibility criteria|0
49668|NCT01225731|189961|P1|Part 1|Did not meet eligibility criteria|1
49669|NCT01225562|190056|P3|Overall Study|Lost to Follow-up|1
49670|NCT01225562|190057|P2|Overall Study|Lost to Follow-up|6
49671|NCT01225562|190058|P1|Overall Study|Lost to Follow-up|3
49672|NCT01225562|190056|P3|Overall Study|Withdrawal by Subject|52
49673|NCT01225562|190057|P2|Overall Study|Withdrawal by Subject|50
49674|NCT01225562|190058|P1|Overall Study|Withdrawal by Subject|52
49675|NCT01225549|190075|P10|Period 6 - Washout|Disallowed medication|0
49676|NCT01225549|190076|P9|Period 6 - Washout|Disallowed medication|0
49677|NCT01225549|190077|P8|Period 6 - Washout|Disallowed medication|0
49678|NCT01225549|190078|P7|Period 6 - Washout|Disallowed medication|0
49679|NCT01225549|190079|P6|Period 6 - Washout|Disallowed medication|0
49680|NCT01225549|190080|P5|Period 6 - Washout|Disallowed medication|0
49681|NCT01225549|190081|P4|Period 6 - Washout|Disallowed medication|1
49682|NCT01225549|190082|P3|Period 6 - Washout|Disallowed medication|0
49683|NCT01225549|190083|P2|Period 6 - Washout|Disallowed medication|0
49684|NCT01225549|190084|P1|Period 6 - Washout|Disallowed medication|0
49685|NCT01225549|190075|P10|Period 4 - Washout|Disallowed medication|0
49686|NCT01225549|190076|P9|Period 4 - Washout|Disallowed medication|0
49687|NCT01225549|190077|P8|Period 4 - Washout|Disallowed medication|0
49688|NCT01225549|190078|P7|Period 4 - Washout|Disallowed medication|0
49689|NCT01225549|190079|P6|Period 4 - Washout|Disallowed medication|0
49690|NCT01225549|190080|P5|Period 4 - Washout|Disallowed medication|0
49691|NCT01225549|190081|P4|Period 4 - Washout|Disallowed medication|0
49692|NCT01225549|190082|P3|Period 4 - Washout|Disallowed medication|0
49693|NCT01225549|190083|P2|Period 4 - Washout|Disallowed medication|1
49694|NCT01225549|190084|P1|Period 4 - Washout|Disallowed medication|0
49695|NCT01225211|190167|P10|Overall Study|Unspecified|1
49696|NCT01225211|190168|P9|Overall Study|Unspecified|0
49697|NCT01225211|190169|P8|Overall Study|Unspecified|0
49698|NCT01225211|190170|P7|Overall Study|Unspecified|0
49699|NCT01225211|190171|P6|Overall Study|Unspecified|0
49700|NCT01225211|190172|P5|Overall Study|Unspecified|0
49701|NCT01225211|190173|P4|Overall Study|Unspecified|0
49702|NCT01225211|190174|P3|Overall Study|Unspecified|0
49703|NCT01225211|190175|P2|Overall Study|Unspecified|0
49704|NCT01225211|190176|P1|Overall Study|Unspecified|0
49705|NCT01225211|190167|P10|Overall Study|Withdrawal by Subject|3
49706|NCT01225211|190168|P9|Overall Study|Withdrawal by Subject|1
49707|NCT01225211|190169|P8|Overall Study|Withdrawal by Subject|0
49708|NCT01225211|190170|P7|Overall Study|Withdrawal by Subject|1
49709|NCT01225211|190171|P6|Overall Study|Withdrawal by Subject|0
49710|NCT01225211|190172|P5|Overall Study|Withdrawal by Subject|0
49711|NCT01225211|190173|P4|Overall Study|Withdrawal by Subject|0
49712|NCT01225211|190174|P3|Overall Study|Withdrawal by Subject|0
49713|NCT01225211|190175|P2|Overall Study|Withdrawal by Subject|0
49714|NCT01225211|190176|P1|Overall Study|Withdrawal by Subject|0
49715|NCT01225211|190167|P10|Overall Study|Adverse Event|1
49716|NCT01225211|190168|P9|Overall Study|Adverse Event|0
49717|NCT01225211|190169|P8|Overall Study|Adverse Event|0
49718|NCT01225211|190170|P7|Overall Study|Adverse Event|0
49719|NCT01225211|190171|P6|Overall Study|Adverse Event|0
49720|NCT01225211|190172|P5|Overall Study|Adverse Event|0
49721|NCT01225211|190173|P4|Overall Study|Adverse Event|0
49722|NCT01225211|190174|P3|Overall Study|Adverse Event|1
49723|NCT01225211|190175|P2|Overall Study|Adverse Event|0
49724|NCT01225211|190176|P1|Overall Study|Adverse Event|0
49725|NCT01225159|190279|P2|Overall Study|Change operation|0
49726|NCT01225159|190280|P1|Overall Study|Change operation|1
49727|NCT01224821|190310|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
49728|NCT01224821|190310|P1|Long-Term Follow-Up|Death|2
49729|NCT01224821|190310|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
49730|NCT01224821|190310|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
49731|NCT01224821|190310|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
49732|NCT01224821|190310|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
49733|NCT01224821|190310|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
49734|NCT01224821|190310|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
49735|NCT01224782|190329|P1|Overall Study|Transplantation|1
49736|NCT01224782|190329|P1|Overall Study|Deterioration|1
49737|NCT01224782|190329|P1|Overall Study|Financial Reasons|1
49738|NCT01224782|190329|P1|Overall Study|Change of Treatment|1
49739|NCT01224782|190329|P1|Overall Study|Start of Dialysis|3
49740|NCT01224782|190329|P1|Overall Study|Not Specified|4
49741|NCT01224782|190329|P1|Overall Study|Noncompliance|10
49742|NCT01224782|190329|P1|Overall Study|Adverse Reaction|11
49743|NCT01224782|190329|P1|Overall Study|Adverse Event|12
49744|NCT01224782|190329|P1|Overall Study|Improvement|13
49745|NCT01224782|190329|P1|Overall Study|Death|14
49746|NCT01224782|190329|P1|Overall Study|Withdrawal by Subject|16
49747|NCT01224782|190329|P1|Overall Study|Lost to Follow-up|177
49748|NCT01224431|190350|P2|Overall Study|no video record|1
49749|NCT01224431|190351|P1|Overall Study|no video record|0
49750|NCT01224431|190350|P2|Overall Study|not randomized|4
49751|NCT01224431|190351|P1|Overall Study|not randomized|0
49752|NCT01224171|190370|P2|Overall Study|Lost to Follow-up|3
49753|NCT01224171|190371|P1|Overall Study|Lost to Follow-up|0
49754|NCT01224171|190370|P2|Overall Study|Withdrawal of Consent|4
49755|NCT01224171|190371|P1|Overall Study|Withdrawal of Consent|2
49756|NCT01224171|190370|P2|Overall Study|Lack of Efficacy|1
49757|NCT01224171|190371|P1|Overall Study|Lack of Efficacy|5
49758|NCT01224171|190370|P2|Overall Study|Protocol Violation|1
49759|NCT01224171|190371|P1|Overall Study|Protocol Violation|0
49760|NCT01224171|190370|P2|Overall Study|Adverse Event|4
49761|NCT01224171|190371|P1|Overall Study|Adverse Event|8
49762|NCT01223937|190406|P2|Overall Study|Not specified|1
49763|NCT01223937|190407|P1|Overall Study|Not specified|4
49764|NCT01223937|190406|P2|Overall Study|Protocol Violation|7
49765|NCT01223937|190407|P1|Overall Study|Protocol Violation|8
49766|NCT01223937|190406|P2|Overall Study|Adverse Event|4
49767|NCT01223937|190407|P1|Overall Study|Adverse Event|1
49768|NCT01223937|190406|P2|Overall Study|Lost to Follow-up|4
49769|NCT01223937|190407|P1|Overall Study|Lost to Follow-up|1
49770|NCT01223937|190406|P2|Overall Study|Withdrawal by Subject|2
49771|NCT01223937|190407|P1|Overall Study|Withdrawal by Subject|3
49772|NCT01223196|190455|P2|Overall Study|Withdrawal by Subject|0
49773|NCT01223196|190456|P1|Overall Study|Withdrawal by Subject|1
49774|NCT01223196|190455|P2|Overall Study|Physician Decision|0
49775|NCT01223196|190456|P1|Overall Study|Physician Decision|1
49776|NCT01223196|190455|P2|Overall Study|Lost to Follow-up|0
49777|NCT01223196|190456|P1|Overall Study|Lost to Follow-up|2
49778|NCT01223027|190468|P2|Overall Study|Study terminated by sponsor|8
49779|NCT01223027|190469|P1|Overall Study|Study terminated by sponsor|2
49780|NCT01223027|190468|P2|Overall Study|New therapy for study indication|8
49781|NCT01223027|190469|P1|Overall Study|New therapy for study indication|17
49782|NCT01223027|190468|P2|Overall Study|Subject/guardian decicion|16
49783|NCT01223027|190469|P1|Overall Study|Subject/guardian decicion|18
49784|NCT01223027|190468|P2|Overall Study|Protocol Violation|1
49785|NCT01223027|190469|P1|Overall Study|Protocol Violation|2
49786|NCT01223027|190468|P2|Overall Study|Progressive Disease|183
49787|NCT01223027|190469|P1|Overall Study|Progressive Disease|167
49788|NCT01223027|190468|P2|Overall Study|Physician Decision|8
49789|NCT01223027|190469|P1|Overall Study|Physician Decision|4
49790|NCT01223027|190468|P2|Overall Study|Lost to Follow-up|1
49791|NCT01223027|190469|P1|Overall Study|Lost to Follow-up|2
49792|NCT01223027|190468|P2|Overall Study|Death|42
49793|NCT01223027|190469|P1|Overall Study|Death|42
49794|NCT01223027|190468|P2|Overall Study|Adverse Event|10
49795|NCT01223027|190469|P1|Overall Study|Adverse Event|20
49796|NCT01222533|190539|P1|Overall Study|Other|4
49797|NCT01222533|190539|P1|Overall Study|Withdrawal by Subject|5
49798|NCT01222533|190539|P1|Overall Study|Adverse Event|5
49799|NCT01222520|190678|P2|Double-blind Period|Study medication stolen|0
49800|NCT01222520|190679|P1|Double-blind Period|Study medication stolen|1
49801|NCT01222520|190678|P2|Double-blind Period|Lack of Efficacy|1
49802|NCT01222520|190679|P1|Double-blind Period|Lack of Efficacy|0
49803|NCT01222520|190678|P2|Double-blind Period|Adverse Event|1
49804|NCT01222520|190679|P1|Double-blind Period|Adverse Event|0
49805|NCT01222520|190678|P2|Open-label run-in Period|Number of patients fulfilled|3
49806|NCT01222520|190679|P1|Open-label run-in Period|Number of patients fulfilled|0
49807|NCT01222520|190678|P2|Open-label run-in Period|Blood pressure criteria not met|18
49808|NCT01222520|190679|P1|Open-label run-in Period|Blood pressure criteria not met|0
49809|NCT01222520|190678|P2|Open-label run-in Period|Withdrawal by Subject|2
49810|NCT01222520|190679|P1|Open-label run-in Period|Withdrawal by Subject|0
49811|NCT01222507|190697|P1|Overall Study|Withdrawal by Subject|1
49812|NCT01222507|190697|P1|Overall Study|Physician Decision|1
49813|NCT01222403|190703|P2|Overall Study|Inappropriate enrollment|2
49814|NCT01222403|190704|P1|Overall Study|Inappropriate enrollment|0
49815|NCT01222104|190807|P1|Overall Study|Death|10
49816|NCT01222104|190807|P1|Overall Study|Lost to Follow-up|37
49817|NCT01221948|190821|P1|Overall Study|Protocol Violation|4
49818|NCT01221948|190821|P1|Overall Study|Death|1
49819|NCT01221948|190821|P1|Overall Study|not disclosed|2
49820|NCT01221948|190821|P1|Overall Study|Withdrawal by Subject|2
49821|NCT01221948|190821|P1|Overall Study|Physician Decision|5
49822|NCT01221753|190832|P1|Overall Study|Adverse Event|1
49823|NCT01221727|190839|P2|Overall Study|Withdrawal by Subject|1
49824|NCT01221727|190840|P1|Overall Study|Withdrawal by Subject|1
49825|NCT01221727|190839|P2|Overall Study|Physician Decision|0
49826|NCT01221727|190840|P1|Overall Study|Physician Decision|2
49827|NCT01221623|190861|P2|Overall Study|Other|2
49828|NCT01221623|190862|P1|Overall Study|Other|5
49829|NCT01221623|190861|P2|Overall Study|Death|0
49830|NCT01221623|190862|P1|Overall Study|Death|1
49831|NCT01221623|190861|P2|Overall Study|Adverse Event|3
49832|NCT01221623|190862|P1|Overall Study|Adverse Event|6
49833|NCT01221623|190861|P2|Overall Study|Lost to Follow-up|1
49834|NCT01221623|190862|P1|Overall Study|Lost to Follow-up|7
49835|NCT01221623|190861|P2|Overall Study|Withdrawal by Subject|8
49836|NCT01221623|190862|P1|Overall Study|Withdrawal by Subject|19
49837|NCT01221597|190886|P2|Overall Study|Death|0
49838|NCT01221597|190887|P1|Overall Study|Death|2
49839|NCT01221597|190886|P2|Overall Study|Other|4
49840|NCT01221597|190887|P1|Overall Study|Other|3
49841|NCT01221597|190886|P2|Overall Study|Protocol Violation|0
49842|NCT01221597|190887|P1|Overall Study|Protocol Violation|1
49843|NCT01221597|190886|P2|Overall Study|Lost to Follow-up|5
49844|NCT01221597|190887|P1|Overall Study|Lost to Follow-up|6
49845|NCT01221597|190886|P2|Overall Study|Withdrawal by Subject|6
49846|NCT01221597|190887|P1|Overall Study|Withdrawal by Subject|20
49847|NCT01221597|190886|P2|Overall Study|Adverse Event|1
49848|NCT01221597|190887|P1|Overall Study|Adverse Event|4
49849|NCT01221363|190944|P2|Overall Study|Withdrawal by Subject|5
49850|NCT01221363|190945|P1|Overall Study|Withdrawal by Subject|11
49851|NCT01221363|190944|P2|Overall Study|Pregnancy|0
49852|NCT01221363|190945|P1|Overall Study|Pregnancy|1
49853|NCT01221350|190955|P2|Overall Study|Withdrawal by Subject|2
49854|NCT01221350|190956|P1|Overall Study|Withdrawal by Subject|4
49855|NCT01221350|190955|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
49856|NCT01221350|190956|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
49857|NCT01221350|190955|P2|Overall Study|Discontinued intervention (GERD)|0
49858|NCT01221350|190956|P1|Overall Study|Discontinued intervention (GERD)|1
49859|NCT01221285|191006|P1|Overall Study|Withdrawal by Subject|1
49860|NCT01221272|191015|P2|Period 2|Adverse Event|2
49861|NCT01221272|191016|P1|Period 2|Adverse Event|0
49862|NCT01221272|191015|P2|Period 1|Significant Dosing Noncompliance|1
49863|NCT01221272|191016|P1|Period 1|Significant Dosing Noncompliance|0
49864|NCT01221272|191015|P2|Period 1|Consent Withdrawal|1
49865|NCT01221272|191016|P1|Period 1|Consent Withdrawal|0
49866|NCT01221272|191015|P2|Period 1|Adverse Event|0
49867|NCT01221272|191016|P1|Period 1|Adverse Event|2
49868|NCT01221090|191035|P4|Overall Study|Withdrawal by Subject|2
49869|NCT01221090|191036|P3|Overall Study|Withdrawal by Subject|27
49870|NCT01221090|191037|P2|Overall Study|Withdrawal by Subject|22
49871|NCT01221090|191038|P1|Overall Study|Withdrawal by Subject|0
49872|NCT01221090|191035|P4|Overall Study|Non-Compliant or Unable to Contact|20
49873|NCT01221090|191036|P3|Overall Study|Non-Compliant or Unable to Contact|15
49874|NCT01221090|191037|P2|Overall Study|Non-Compliant or Unable to Contact|12
49875|NCT01221090|191038|P1|Overall Study|Non-Compliant or Unable to Contact|15
49876|NCT01220609|191083|P1|Overall Study|Ineligible-Never treated|1
49877|NCT01220609|191083|P1|Overall Study|Ineligible- Wrong cell type|1
49878|NCT01220609|191083|P1|Overall Study|Ineligible-Wrong primary cancer site|1
49879|NCT01220557|191091|P2|Overall Study|attended less than 6 lessons|2
49880|NCT01220557|191092|P1|Overall Study|attended less than 6 lessons|1
49881|NCT01220557|191091|P2|Overall Study|Lost to Follow-up|3
49882|NCT01220557|191092|P1|Overall Study|Lost to Follow-up|5
49883|NCT01220401|191123|P1|Overall Study|Protocol Violation|1
49884|NCT01220401|191123|P1|Overall Study|Withdrawal by Subject|2
49885|NCT01220180|191133|P1|Overall Study|Randomized but not treated|1
49886|NCT01220180|191133|P1|Overall Study|Death|1
49887|NCT01220180|191133|P1|Overall Study|Lack of Efficacy|22
49888|NCT01220180|191133|P1|Overall Study|Adverse Event|35
49889|NCT01220180|191133|P1|Overall Study|Unspecified|72
49890|NCT01220180|191133|P1|Overall Study|Lost to Follow-up|76
49891|NCT01219985|191156|P1|Overall Study|Physician Decision|20
49892|NCT01219933|191162|P1|Overall Study|Lack of Efficacy|1
49893|NCT01219933|191162|P1|Overall Study|Protocol Violation|8
49894|NCT01219933|191162|P1|Overall Study|Withdrawal by Subject|5
49895|NCT01219933|191162|P1|Overall Study|GC free|1
49896|NCT01219933|191162|P1|Overall Study|Lost to Follow-up|3
49897|NCT01219933|191162|P1|Overall Study|No LDA maintained|7
49898|NCT01219933|191162|P1|Overall Study|No LDA reached|5
49899|NCT01219933|191162|P1|Overall Study|Adverse Event|8
49900|NCT01218867|191372|P11|Overall Study|Death during treatment|0
49901|NCT01218867|191373|P10|Overall Study|Death during treatment|0
49902|NCT01218867|191374|P9|Overall Study|Death during treatment|0
49903|NCT01218867|191375|P8|Overall Study|Death during treatment|0
49904|NCT01218867|191376|P7|Overall Study|Death during treatment|1
49905|NCT01218867|191377|P6|Overall Study|Death during treatment|0
49906|NCT01218867|191378|P5|Overall Study|Death during treatment|0
49907|NCT01218867|191379|P4|Overall Study|Death during treatment|0
49908|NCT01218867|191380|P3|Overall Study|Death during treatment|0
49909|NCT01218867|191381|P2|Overall Study|Death during treatment|0
49910|NCT01218867|191382|P1|Overall Study|Death during treatment|0
49911|NCT01218802|191430|P2|Overall Study|Incarcerated|0
49912|NCT01218802|191431|P1|Overall Study|Incarcerated|2
49913|NCT01218802|191430|P2|Overall Study|Adverse Event|2
49914|NCT01218802|191431|P1|Overall Study|Adverse Event|0
49915|NCT01218802|191430|P2|Overall Study|Withdrawal by Subject|10
49916|NCT01218802|191431|P1|Overall Study|Withdrawal by Subject|3
49917|NCT01218802|191430|P2|Overall Study|Lost to Follow-up|6
49918|NCT01218802|191431|P1|Overall Study|Lost to Follow-up|5
49919|NCT01218646|191443|P4|Overall Study|Protocol Violation|1
49920|NCT01218646|191444|P3|Overall Study|Protocol Violation|1
49921|NCT01218646|191445|P2|Overall Study|Protocol Violation|0
49922|NCT01218646|191446|P1|Overall Study|Protocol Violation|0
49923|NCT01218646|191443|P4|Overall Study|Lost to Follow-up|0
49924|NCT01218646|191444|P3|Overall Study|Lost to Follow-up|0
49925|NCT01218646|191445|P2|Overall Study|Lost to Follow-up|0
49926|NCT01218646|191446|P1|Overall Study|Lost to Follow-up|1
49927|NCT01218646|191443|P4|Overall Study|Adverse Event|0
49928|NCT01218646|191444|P3|Overall Study|Adverse Event|1
49929|NCT01218646|191445|P2|Overall Study|Adverse Event|0
49930|NCT01218646|191446|P1|Overall Study|Adverse Event|0
49931|NCT01218594|191484|P1|Overall Study|Physician Decision|6
49932|NCT01218594|191484|P1|Overall Study|Adverse Event|2
49933|NCT01218594|191484|P1|Overall Study|Withdrawal by Subject|3
49934|NCT01218594|191484|P1|Overall Study|Death|1
49935|NCT01218477|191492|P4|Overall Study|Maximum clinical benefit|0
49936|NCT01218477|191493|P3|Overall Study|Maximum clinical benefit|0
49937|NCT01218477|191494|P2|Overall Study|Maximum clinical benefit|2
49938|NCT01218477|191495|P1|Overall Study|Maximum clinical benefit|0
49939|NCT01218477|191492|P4|Overall Study|Administrative reason by sponsor|0
49940|NCT01218477|191493|P3|Overall Study|Administrative reason by sponsor|1
49941|NCT01218477|191494|P2|Overall Study|Administrative reason by sponsor|0
49942|NCT01218477|191495|P1|Overall Study|Administrative reason by sponsor|0
49943|NCT01218477|191492|P4|Overall Study|Prepared for cell transplantation|0
49944|NCT01218477|191493|P3|Overall Study|Prepared for cell transplantation|1
49945|NCT01218477|191494|P2|Overall Study|Prepared for cell transplantation|1
49946|NCT01218477|191495|P1|Overall Study|Prepared for cell transplantation|0
49947|NCT01218477|191492|P4|Overall Study|Withdrawal by Subject|0
49948|NCT01218477|191493|P3|Overall Study|Withdrawal by Subject|1
49949|NCT01218477|191494|P2|Overall Study|Withdrawal by Subject|0
49950|NCT01218477|191495|P1|Overall Study|Withdrawal by Subject|0
49951|NCT01218477|191492|P4|Overall Study|No longer meets study criteria|0
49952|NCT01218477|191493|P3|Overall Study|No longer meets study criteria|0
49953|NCT01218477|191494|P2|Overall Study|No longer meets study criteria|0
49954|NCT01218477|191495|P1|Overall Study|No longer meets study criteria|1
49955|NCT01218477|191492|P4|Overall Study|Study drug toxicity|0
49956|NCT01218477|191493|P3|Overall Study|Study drug toxicity|5
49957|NCT01218477|191494|P2|Overall Study|Study drug toxicity|2
49958|NCT01218477|191495|P1|Overall Study|Study drug toxicity|0
49959|NCT01218477|191492|P4|Overall Study|Disease progression|2
49960|NCT01218477|191493|P3|Overall Study|Disease progression|6
49961|NCT01218477|191494|P2|Overall Study|Disease progression|3
49962|NCT01218477|191495|P1|Overall Study|Disease progression|2
49963|NCT01218438|191512|P1|Epoch 4|Withdrawal by Subject|2
49964|NCT01218438|191512|P1|Epoch 4|Physician Decision|1
49965|NCT01218438|191512|P1|Epoch 3|Adverse Event|1
49966|NCT01218438|191512|P1|Epoch 3|Withdrawal by Subject|3
49967|NCT01218438|191512|P1|Epoch 1|Adverse Event|1
49968|NCT01218438|191512|P1|Epoch 1|Physician Decision|2
49969|NCT01218308|191667|P2|Overall Study|Unspecified|21
49970|NCT01218308|191668|P1|Overall Study|Unspecified|14
49971|NCT01218308|191667|P2|Overall Study|Lost to Follow-up|31
49972|NCT01218308|191668|P1|Overall Study|Lost to Follow-up|27
49973|NCT01218308|191667|P2|Overall Study|Withdrawal by Subject|64
49974|NCT01218308|191668|P1|Overall Study|Withdrawal by Subject|61
49975|NCT01218308|191667|P2|Overall Study|Protocol Violation|2
49976|NCT01218308|191668|P1|Overall Study|Protocol Violation|0
49977|NCT01218308|191667|P2|Overall Study|Adverse Event|2
49978|NCT01218308|191668|P1|Overall Study|Adverse Event|1
49979|NCT01218243|191712|P2|Overall Study|Protocol Violation|10
49980|NCT01218243|191713|P1|Overall Study|Protocol Violation|5
49981|NCT01218243|191712|P2|Overall Study|Lost to Follow-up|3
49982|NCT01218243|191713|P1|Overall Study|Lost to Follow-up|3
49983|NCT01218243|191712|P2|Overall Study|Lack of Efficacy|1
49984|NCT01218243|191713|P1|Overall Study|Lack of Efficacy|1
49985|NCT01218100|191731|P4|Overall Study|Other Reason|4
49986|NCT01218100|191732|P3|Overall Study|Other Reason|6
49987|NCT01218100|191733|P2|Overall Study|Other Reason|2
49988|NCT01218100|191734|P1|Overall Study|Other Reason|2
49989|NCT01218100|191731|P4|Overall Study|Lost to Follow-up|1
49990|NCT01218100|191732|P3|Overall Study|Lost to Follow-up|2
49991|NCT01218100|191733|P2|Overall Study|Lost to Follow-up|8
49992|NCT01218100|191734|P1|Overall Study|Lost to Follow-up|3
49993|NCT01218100|191731|P4|Overall Study|Withdrawal by Subject|7
49994|NCT01218100|191732|P3|Overall Study|Withdrawal by Subject|6
49995|NCT01218100|191733|P2|Overall Study|Withdrawal by Subject|2
49996|NCT01218100|191734|P1|Overall Study|Withdrawal by Subject|5
49997|NCT01218100|191731|P4|Overall Study|Protocol Violation|1
49998|NCT01218100|191732|P3|Overall Study|Protocol Violation|1
49999|NCT01218100|191733|P2|Overall Study|Protocol Violation|0
50000|NCT01218100|191734|P1|Overall Study|Protocol Violation|0
50001|NCT01218100|191731|P4|Overall Study|Lack of Efficacy|12
50002|NCT01218100|191732|P3|Overall Study|Lack of Efficacy|5
50003|NCT01218100|191733|P2|Overall Study|Lack of Efficacy|6
50004|NCT01218100|191734|P1|Overall Study|Lack of Efficacy|9
50005|NCT01218100|191731|P4|Overall Study|Adverse Event|7
50006|NCT01218100|191732|P3|Overall Study|Adverse Event|6
50007|NCT01218100|191733|P2|Overall Study|Adverse Event|6
50008|NCT01218100|191734|P1|Overall Study|Adverse Event|4
50009|NCT01218100|191731|P4|Overall Study|Did not meet InclusionExclusion criteria|2
50010|NCT01218100|191732|P3|Overall Study|Did not meet InclusionExclusion criteria|1
50011|NCT01218100|191733|P2|Overall Study|Did not meet InclusionExclusion criteria|1
50012|NCT01218100|191734|P1|Overall Study|Did not meet InclusionExclusion criteria|1
50013|NCT01218087|191750|P2|Overall Study|Transferred|5
50014|NCT01218087|191751|P1|Overall Study|Transferred|8
50015|NCT01218087|191750|P2|Overall Study|Withdrawal by Subject|0
50016|NCT01218087|191751|P1|Overall Study|Withdrawal by Subject|5
50017|NCT01218087|191750|P2|Overall Study|Death|1
50018|NCT01218087|191751|P1|Overall Study|Death|2
50019|NCT01218009|191761|P2|Overall Study|Sponsor terminated study|163
50020|NCT01218009|191762|P1|Overall Study|Sponsor terminated study|161
50021|NCT01218009|191761|P2|Overall Study|Withdrawal by Subject|1
50022|NCT01218009|191762|P1|Overall Study|Withdrawal by Subject|3
50023|NCT01218009|191761|P2|Overall Study|Protocol Violation|1
50024|NCT01218009|191762|P1|Overall Study|Protocol Violation|2
50025|NCT01217957|191785|P5|Phase 2|Withdrawal by Patient|1
50026|NCT01217957|191786|P4|Phase 2|Withdrawal by Patient|0
50027|NCT01217957|191787|P3|Phase 2|Withdrawal by Patient|0
50028|NCT01217957|191788|P2|Phase 2|Withdrawal by Patient|0
50029|NCT01217957|191789|P1|Phase 2|Withdrawal by Patient|0
50030|NCT01217957|191785|P5|Phase 1|Withdrawal by Patient|0
50031|NCT01217957|191786|P4|Phase 1|Withdrawal by Patient|1
50032|NCT01217957|191787|P3|Phase 1|Withdrawal by Patient|1
50033|NCT01217957|191788|P2|Phase 1|Withdrawal by Patient|0
50034|NCT01217957|191789|P1|Phase 1|Withdrawal by Patient|1
50035|NCT01217944|191848|P3|Overall Study|Lack of Efficacy|0
50036|NCT01217944|191849|P2|Overall Study|Lack of Efficacy|0
50037|NCT01217944|191850|P1|Overall Study|Lack of Efficacy|1
50038|NCT01217944|191848|P3|Overall Study|Withdrawal by Subject|0
50039|NCT01217944|191849|P2|Overall Study|Withdrawal by Subject|2
50040|NCT01217944|191850|P1|Overall Study|Withdrawal by Subject|1
50041|NCT01217944|191848|P3|Overall Study|Lost to Follow-up|0
50042|NCT01217944|191849|P2|Overall Study|Lost to Follow-up|1
50043|NCT01217944|191850|P1|Overall Study|Lost to Follow-up|3
50044|NCT01217944|191848|P3|Overall Study|Protocol Violation|0
50045|NCT01217944|191849|P2|Overall Study|Protocol Violation|1
50046|NCT01217944|191850|P1|Overall Study|Protocol Violation|1
50047|NCT01217892|191893|P4|Overall Study|Poor/Non-Compliance|0
50048|NCT01217892|191894|P3|Overall Study|Poor/Non-Compliance|1
50049|NCT01217892|191895|P2|Overall Study|Poor/Non-Compliance|0
50050|NCT01217892|191896|P1|Overall Study|Poor/Non-Compliance|0
50051|NCT01217892|191893|P4|Overall Study|Incorrect enrollment|0
50052|NCT01217892|191894|P3|Overall Study|Incorrect enrollment|1
50053|NCT01217892|191895|P2|Overall Study|Incorrect enrollment|1
50054|NCT01217892|191896|P1|Overall Study|Incorrect enrollment|0
50055|NCT01217892|191893|P4|Overall Study|Subject no longer meets study criteria|8
50056|NCT01217892|191894|P3|Overall Study|Subject no longer meets study criteria|4
50057|NCT01217892|191895|P2|Overall Study|Subject no longer meets study criteria|2
50058|NCT01217892|191896|P1|Overall Study|Subject no longer meets study criteria|5
50059|NCT01217892|191893|P4|Overall Study|Lab value|0
50060|NCT01217892|191894|P3|Overall Study|Lab value|1
50061|NCT01217892|191895|P2|Overall Study|Lab value|0
50062|NCT01217892|191896|P1|Overall Study|Lab value|1
50063|NCT01217892|191893|P4|Overall Study|Withdrawal by Subject|0
50064|NCT01217892|191894|P3|Overall Study|Withdrawal by Subject|1
50065|NCT01217892|191895|P2|Overall Study|Withdrawal by Subject|2
50066|NCT01217892|191896|P1|Overall Study|Withdrawal by Subject|0
50067|NCT01217892|191893|P4|Overall Study|Adverse Event|0
50068|NCT01217892|191894|P3|Overall Study|Adverse Event|1
50069|NCT01217892|191895|P2|Overall Study|Adverse Event|1
50070|NCT01217892|191896|P1|Overall Study|Adverse Event|1
50071|NCT01217606|191963|P2|9-Month Masked Extension|Lack of Efficacy|0
50072|NCT01217606|191964|P1|9-Month Masked Extension|Lack of Efficacy|2
50073|NCT01217606|191963|P2|9-Month Masked Extension|Pregnancy|0
50074|NCT01217606|191964|P1|9-Month Masked Extension|Pregnancy|1
50075|NCT01217606|191963|P2|9-Month Masked Extension|Lost to Follow-up|0
50076|NCT01217606|191964|P1|9-Month Masked Extension|Lost to Follow-up|1
50077|NCT01217606|191963|P2|9-Month Masked Extension|Personal Reasons|1
50078|NCT01217606|191964|P1|9-Month Masked Extension|Personal Reasons|2
50079|NCT01217606|191963|P2|9-Month Masked Extension|Other Reasons|4
50080|NCT01217606|191964|P1|9-Month Masked Extension|Other Reasons|4
50081|NCT01217606|191963|P2|9-Month Masked Extension|Adverse Event|6
50082|NCT01217606|191964|P1|9-Month Masked Extension|Adverse Event|3
50083|NCT01217606|191963|P2|Initial Treatment Phase|Adverse Event|6
50084|NCT01217606|191964|P1|Initial Treatment Phase|Adverse Event|10
50085|NCT01217606|191963|P2|Initial Treatment Phase|Lack of Efficacy|0
50086|NCT01217606|191964|P1|Initial Treatment Phase|Lack of Efficacy|1
50087|NCT01217606|191963|P2|Initial Treatment Phase|Personal Reasons|2
50088|NCT01217606|191964|P1|Initial Treatment Phase|Personal Reasons|0
50089|NCT01217606|191963|P2|Initial Treatment Phase|Protocol Violation|2
50090|NCT01217606|191964|P1|Initial Treatment Phase|Protocol Violation|3
50091|NCT01217606|191963|P2|Initial Treatment Phase|Other Reasons|2
50092|NCT01217606|191964|P1|Initial Treatment Phase|Other Reasons|0
50093|NCT01217476|191995|P2|Overall Study|Other|0
50094|NCT01217476|191996|P1|Overall Study|Other|2
50095|NCT01217476|191995|P2|Overall Study|Protocol Deviation|0
50096|NCT01217476|191996|P1|Overall Study|Protocol Deviation|1
50097|NCT01217476|191995|P2|Overall Study|Surgery on the Target Limb|2
50098|NCT01217476|191996|P1|Overall Study|Surgery on the Target Limb|0
50099|NCT01217476|191995|P2|Overall Study|Withdrawal by Subject|3
50100|NCT01217476|191996|P1|Overall Study|Withdrawal by Subject|3
50101|NCT01217476|191995|P2|Overall Study|Physician Decision|1
50102|NCT01217476|191996|P1|Overall Study|Physician Decision|0
50103|NCT01217476|191995|P2|Overall Study|Adverse Event|1
50104|NCT01217476|191996|P1|Overall Study|Adverse Event|6
50105|NCT01217463|192006|P2|Overall Study|Other|1
50106|NCT01217463|192007|P1|Overall Study|Other|1
50107|NCT01217463|192006|P2|Overall Study|Patient Non-compliant|0
50108|NCT01217463|192007|P1|Overall Study|Patient Non-compliant|1
50109|NCT01217463|192006|P2|Overall Study|Surgery on the Target Limb|1
50110|NCT01217463|192007|P1|Overall Study|Surgery on the Target Limb|0
50111|NCT01217463|192006|P2|Overall Study|Withdrawal by Subject|0
50112|NCT01217463|192007|P1|Overall Study|Withdrawal by Subject|3
50113|NCT01217463|192006|P2|Overall Study|Physician Decision|1
50114|NCT01217463|192007|P1|Overall Study|Physician Decision|0
50115|NCT01217463|192006|P2|Overall Study|Adverse Event|5
50116|NCT01217463|192007|P1|Overall Study|Adverse Event|8
50117|NCT01217112|192034|P5|Overall Study|Physician Decision|1
50118|NCT01217112|192035|P4|Overall Study|Physician Decision|0
50119|NCT01217112|192036|P3|Overall Study|Physician Decision|0
50120|NCT01217112|192037|P2|Overall Study|Physician Decision|0
50121|NCT01217112|192038|P1|Overall Study|Physician Decision|0
50122|NCT01217112|192034|P5|Overall Study|Withdrawal by Subject|0
50123|NCT01217112|192035|P4|Overall Study|Withdrawal by Subject|0
50124|NCT01217112|192036|P3|Overall Study|Withdrawal by Subject|1
50125|NCT01217112|192037|P2|Overall Study|Withdrawal by Subject|0
50126|NCT01217112|192038|P1|Overall Study|Withdrawal by Subject|0
50127|NCT01217112|192034|P5|Overall Study|Adverse Event|0
50128|NCT01217112|192035|P4|Overall Study|Adverse Event|2
50129|NCT01217112|192036|P3|Overall Study|Adverse Event|0
50130|NCT01217112|192037|P2|Overall Study|Adverse Event|2
50131|NCT01217112|192038|P1|Overall Study|Adverse Event|0
50132|NCT01217073|192271|P8|Extension Period|Withdrawal by Subject|8
50133|NCT01217073|192272|P7|Extension Period|Withdrawal by Subject|30
50134|NCT01217073|192273|P6|Extension Period|Withdrawal by Subject|0
50135|NCT01217073|192274|P5|Extension Period|Withdrawal by Subject|0
50136|NCT01217073|192275|P4|Extension Period|Withdrawal by Subject|0
50137|NCT01217073|192276|P3|Extension Period|Withdrawal by Subject|0
50138|NCT01217073|192277|P2|Extension Period|Withdrawal by Subject|0
50139|NCT01217073|192278|P1|Extension Period|Withdrawal by Subject|0
50140|NCT01217073|192271|P8|Extension Period|Site discontinued study participation|2
50141|NCT01217073|192272|P7|Extension Period|Site discontinued study participation|7
50142|NCT01217073|192273|P6|Extension Period|Site discontinued study participation|0
50143|NCT01217073|192274|P5|Extension Period|Site discontinued study participation|0
50144|NCT01217073|192275|P4|Extension Period|Site discontinued study participation|0
50145|NCT01217073|192276|P3|Extension Period|Site discontinued study participation|0
50146|NCT01217073|192277|P2|Extension Period|Site discontinued study participation|0
50147|NCT01217073|192278|P1|Extension Period|Site discontinued study participation|0
50148|NCT01217073|192271|P8|Extension Period|Protocol Violation|1
50149|NCT01217073|192272|P7|Extension Period|Protocol Violation|2
50150|NCT01217073|192273|P6|Extension Period|Protocol Violation|0
50151|NCT01217073|192274|P5|Extension Period|Protocol Violation|0
50152|NCT01217073|192275|P4|Extension Period|Protocol Violation|0
50153|NCT01217073|192276|P3|Extension Period|Protocol Violation|0
50154|NCT01217073|192277|P2|Extension Period|Protocol Violation|0
50155|NCT01217073|192278|P1|Extension Period|Protocol Violation|0
50156|NCT01217073|192271|P8|Extension Period|Physician Decision|1
50157|NCT01217073|192272|P7|Extension Period|Physician Decision|4
50158|NCT01217073|192273|P6|Extension Period|Physician Decision|0
50159|NCT01217073|192274|P5|Extension Period|Physician Decision|0
50160|NCT01217073|192275|P4|Extension Period|Physician Decision|0
50161|NCT01217073|192276|P3|Extension Period|Physician Decision|0
50162|NCT01217073|192277|P2|Extension Period|Physician Decision|0
50163|NCT01217073|192278|P1|Extension Period|Physician Decision|0
50164|NCT01217073|192271|P8|Extension Period|Non-compliance with study drug|1
50165|NCT01217073|192272|P7|Extension Period|Non-compliance with study drug|0
50166|NCT01217073|192273|P6|Extension Period|Non-compliance with study drug|0
50167|NCT01217073|192274|P5|Extension Period|Non-compliance with study drug|0
50168|NCT01217073|192275|P4|Extension Period|Non-compliance with study drug|0
50169|NCT01217073|192276|P3|Extension Period|Non-compliance with study drug|0
50170|NCT01217073|192277|P2|Extension Period|Non-compliance with study drug|0
50171|NCT01217073|192278|P1|Extension Period|Non-compliance with study drug|0
50172|NCT01217073|192271|P8|Extension Period|Lost to Follow-up|1
50173|NCT01217073|192272|P7|Extension Period|Lost to Follow-up|9
50174|NCT01217073|192273|P6|Extension Period|Lost to Follow-up|0
50175|NCT01217073|192274|P5|Extension Period|Lost to Follow-up|0
50176|NCT01217073|192275|P4|Extension Period|Lost to Follow-up|0
50177|NCT01217073|192276|P3|Extension Period|Lost to Follow-up|0
50178|NCT01217073|192277|P2|Extension Period|Lost to Follow-up|0
50179|NCT01217073|192278|P1|Extension Period|Lost to Follow-up|0
50180|NCT01217073|192271|P8|Extension Period|Lack of Efficacy|0
50181|NCT01217073|192272|P7|Extension Period|Lack of Efficacy|3
50182|NCT01217073|192273|P6|Extension Period|Lack of Efficacy|0
50183|NCT01217073|192274|P5|Extension Period|Lack of Efficacy|0
50184|NCT01217073|192275|P4|Extension Period|Lack of Efficacy|0
50185|NCT01217073|192276|P3|Extension Period|Lack of Efficacy|0
50186|NCT01217073|192277|P2|Extension Period|Lack of Efficacy|0
50187|NCT01217073|192278|P1|Extension Period|Lack of Efficacy|0
50188|NCT01217073|192271|P8|Extension Period|Excluded medication|0
50189|NCT01217073|192272|P7|Extension Period|Excluded medication|2
50190|NCT01217073|192273|P6|Extension Period|Excluded medication|0
50191|NCT01217073|192274|P5|Extension Period|Excluded medication|0
50192|NCT01217073|192275|P4|Extension Period|Excluded medication|0
50193|NCT01217073|192276|P3|Extension Period|Excluded medication|0
50194|NCT01217073|192277|P2|Extension Period|Excluded medication|0
50195|NCT01217073|192278|P1|Extension Period|Excluded medication|0
50196|NCT01217073|192271|P8|Extension Period|Death|0
50197|NCT01217073|192272|P7|Extension Period|Death|1
50198|NCT01217073|192273|P6|Extension Period|Death|0
50199|NCT01217073|192274|P5|Extension Period|Death|0
50200|NCT01217073|192275|P4|Extension Period|Death|0
50201|NCT01217073|192276|P3|Extension Period|Death|0
50202|NCT01217073|192277|P2|Extension Period|Death|0
50203|NCT01217073|192278|P1|Extension Period|Death|0
50204|NCT01217073|192271|P8|Extension Period|Creatinine/eGFR|1
50205|NCT01217073|192272|P7|Extension Period|Creatinine/eGFR|11
50206|NCT01217073|192273|P6|Extension Period|Creatinine/eGFR|0
50207|NCT01217073|192274|P5|Extension Period|Creatinine/eGFR|0
50208|NCT01217073|192275|P4|Extension Period|Creatinine/eGFR|0
50209|NCT01217073|192276|P3|Extension Period|Creatinine/eGFR|0
50210|NCT01217073|192277|P2|Extension Period|Creatinine/eGFR|0
50211|NCT01217073|192278|P1|Extension Period|Creatinine/eGFR|0
50212|NCT01217073|192271|P8|Extension Period|Contraindication to study medication|0
50213|NCT01217073|192272|P7|Extension Period|Contraindication to study medication|1
50214|NCT01217073|192273|P6|Extension Period|Contraindication to study medication|0
50215|NCT01217073|192274|P5|Extension Period|Contraindication to study medication|0
50216|NCT01217073|192275|P4|Extension Period|Contraindication to study medication|0
50217|NCT01217073|192276|P3|Extension Period|Contraindication to study medication|0
50218|NCT01217073|192277|P2|Extension Period|Contraindication to study medication|0
50219|NCT01217073|192278|P1|Extension Period|Contraindication to study medication|0
50220|NCT01217073|192271|P8|Extension Period|ALT/AST|0
50221|NCT01217073|192272|P7|Extension Period|ALT/AST|2
50222|NCT01217073|192273|P6|Extension Period|ALT/AST|0
50223|NCT01217073|192274|P5|Extension Period|ALT/AST|0
50224|NCT01217073|192275|P4|Extension Period|ALT/AST|0
50225|NCT01217073|192276|P3|Extension Period|ALT/AST|0
50226|NCT01217073|192277|P2|Extension Period|ALT/AST|0
50227|NCT01217073|192278|P1|Extension Period|ALT/AST|0
50228|NCT01217073|192271|P8|Extension Period|Adverse Event|5
50229|NCT01217073|192272|P7|Extension Period|Adverse Event|19
50230|NCT01217073|192273|P6|Extension Period|Adverse Event|0
50231|NCT01217073|192274|P5|Extension Period|Adverse Event|0
50232|NCT01217073|192275|P4|Extension Period|Adverse Event|0
50233|NCT01217073|192276|P3|Extension Period|Adverse Event|0
50234|NCT01217073|192277|P2|Extension Period|Adverse Event|0
50235|NCT01217073|192278|P1|Extension Period|Adverse Event|0
50236|NCT01217073|192271|P8|Base Period|Withdrawal by Subject|0
50237|NCT01217073|192272|P7|Base Period|Withdrawal by Subject|0
50238|NCT01217073|192273|P6|Base Period|Withdrawal by Subject|5
50239|NCT01217073|192274|P5|Base Period|Withdrawal by Subject|5
50240|NCT01217073|192275|P4|Base Period|Withdrawal by Subject|1
50241|NCT01217073|192276|P3|Base Period|Withdrawal by Subject|5
50242|NCT01217073|192277|P2|Base Period|Withdrawal by Subject|5
50243|NCT01217073|192278|P1|Base Period|Withdrawal by Subject|4
50244|NCT01217073|192271|P8|Base Period|Protocol Violation|0
50245|NCT01217073|192272|P7|Base Period|Protocol Violation|0
50246|NCT01217073|192273|P6|Base Period|Protocol Violation|2
50247|NCT01217073|192274|P5|Base Period|Protocol Violation|1
50248|NCT01217073|192275|P4|Base Period|Protocol Violation|0
50249|NCT01217073|192276|P3|Base Period|Protocol Violation|0
50250|NCT01217073|192277|P2|Base Period|Protocol Violation|0
50251|NCT01217073|192278|P1|Base Period|Protocol Violation|1
50252|NCT01217073|192271|P8|Base Period|Physician Decision|0
50253|NCT01217073|192272|P7|Base Period|Physician Decision|0
50254|NCT01217073|192273|P6|Base Period|Physician Decision|0
50255|NCT01217073|192274|P5|Base Period|Physician Decision|1
50256|NCT01217073|192275|P4|Base Period|Physician Decision|0
50257|NCT01217073|192276|P3|Base Period|Physician Decision|0
50258|NCT01217073|192277|P2|Base Period|Physician Decision|0
50259|NCT01217073|192278|P1|Base Period|Physician Decision|0
50260|NCT01217073|192271|P8|Base Period|Lost to Follow-up|0
50261|NCT01217073|192272|P7|Base Period|Lost to Follow-up|0
50262|NCT01217073|192273|P6|Base Period|Lost to Follow-up|0
50263|NCT01217073|192274|P5|Base Period|Lost to Follow-up|3
50264|NCT01217073|192275|P4|Base Period|Lost to Follow-up|1
50265|NCT01217073|192276|P3|Base Period|Lost to Follow-up|1
50266|NCT01217073|192277|P2|Base Period|Lost to Follow-up|0
50267|NCT01217073|192278|P1|Base Period|Lost to Follow-up|0
50268|NCT01217073|192271|P8|Base Period|Lack of Efficacy|0
50269|NCT01217073|192272|P7|Base Period|Lack of Efficacy|0
50270|NCT01217073|192273|P6|Base Period|Lack of Efficacy|1
50271|NCT01217073|192274|P5|Base Period|Lack of Efficacy|0
50272|NCT01217073|192275|P4|Base Period|Lack of Efficacy|0
50273|NCT01217073|192276|P3|Base Period|Lack of Efficacy|0
50274|NCT01217073|192277|P2|Base Period|Lack of Efficacy|0
50275|NCT01217073|192278|P1|Base Period|Lack of Efficacy|0
50276|NCT01217073|192271|P8|Base Period|Excluded medication|0
50277|NCT01217073|192272|P7|Base Period|Excluded medication|0
50278|NCT01217073|192273|P6|Base Period|Excluded medication|0
50279|NCT01217073|192274|P5|Base Period|Excluded medication|1
50280|NCT01217073|192275|P4|Base Period|Excluded medication|0
50281|NCT01217073|192276|P3|Base Period|Excluded medication|0
50282|NCT01217073|192277|P2|Base Period|Excluded medication|0
50283|NCT01217073|192278|P1|Base Period|Excluded medication|0
50284|NCT01217073|192271|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
50285|NCT01217073|192272|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
50286|NCT01217073|192273|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
50287|NCT01217073|192274|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
50288|NCT01217073|192275|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
50289|NCT01217073|192276|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
50290|NCT01217073|192277|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
50291|NCT01217073|192278|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
50292|NCT01217073|192271|P8|Base Period|Adverse Event|0
50293|NCT01217073|192272|P7|Base Period|Adverse Event|0
50294|NCT01217073|192273|P6|Base Period|Adverse Event|1
50295|NCT01217073|192274|P5|Base Period|Adverse Event|4
50296|NCT01217073|192275|P4|Base Period|Adverse Event|0
50297|NCT01217073|192276|P3|Base Period|Adverse Event|1
50298|NCT01217073|192277|P2|Base Period|Adverse Event|0
50299|NCT01217073|192278|P1|Base Period|Adverse Event|1
50300|NCT01216319|192467|P1|Overall Study|Unanticipated chemo for breast cancer|2
50301|NCT01216319|192467|P1|Overall Study|Lost to Follow-up|2
50302|NCT01216163|192484|P3|Overall Study|Withdrawal by Subject|0
50303|NCT01216163|192485|P2|Overall Study|Withdrawal by Subject|1
50304|NCT01216163|192486|P1|Overall Study|Withdrawal by Subject|1
50305|NCT01216072|192538|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
50306|NCT01216072|192539|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
50307|NCT01216072|192538|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
50308|NCT01216072|192539|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
50309|NCT01216072|192538|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
50310|NCT01216072|192539|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
50311|NCT01216072|192538|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
50312|NCT01216072|192539|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
50313|NCT01216072|192538|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
50314|NCT01216072|192539|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
50315|NCT01216072|192538|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
50316|NCT01216072|192539|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
50317|NCT01216072|192538|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
50318|NCT01216072|192539|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
50319|NCT01216072|192538|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
50320|NCT01216072|192539|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
50321|NCT01216072|192538|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
50322|NCT01216072|192539|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
50323|NCT01216072|192538|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
50324|NCT01216072|192539|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
50325|NCT01215981|192567|P2|Overall Study|Withdrawal by Subject|0
50326|NCT01215981|192568|P1|Overall Study|Withdrawal by Subject|1
50327|NCT01215981|192567|P2|Overall Study|Protocol Violation|0
50328|NCT01215981|192568|P1|Overall Study|Protocol Violation|1
50329|NCT01215981|192567|P2|Overall Study|Physician Decision|1
50330|NCT01215981|192568|P1|Overall Study|Physician Decision|0
50331|NCT01215968|192578|P2|Overall Study|Not received study drug|1
50332|NCT01215968|192579|P1|Overall Study|Not received study drug|0
50333|NCT01215968|192578|P2|Overall Study|Protocol Violation|4
50334|NCT01215968|192579|P1|Overall Study|Protocol Violation|2
50335|NCT01215968|192578|P2|Overall Study|Adverse Event|2
50336|NCT01215968|192579|P1|Overall Study|Adverse Event|0
50337|NCT01215955|192599|P4|Overall Study|Quality Issues|2
50338|NCT01215955|192600|P3|Overall Study|Quality Issues|3
50339|NCT01215955|192601|P2|Overall Study|Quality Issues|0
50340|NCT01215955|192602|P1|Overall Study|Quality Issues|0
50341|NCT01215955|192599|P4|Overall Study|Withdrawal by Subject|9
50342|NCT01215955|192600|P3|Overall Study|Withdrawal by Subject|13
50343|NCT01215955|192601|P2|Overall Study|Withdrawal by Subject|15
50344|NCT01215955|192602|P1|Overall Study|Withdrawal by Subject|14
50345|NCT01215955|192599|P4|Overall Study|Sponsor Decision|1
50346|NCT01215955|192600|P3|Overall Study|Sponsor Decision|0
50347|NCT01215955|192601|P2|Overall Study|Sponsor Decision|2
50348|NCT01215955|192602|P1|Overall Study|Sponsor Decision|1
50349|NCT01215955|192599|P4|Overall Study|Protocol Violation|8
50350|NCT01215955|192600|P3|Overall Study|Protocol Violation|8
50351|NCT01215955|192601|P2|Overall Study|Protocol Violation|13
50352|NCT01215955|192602|P1|Overall Study|Protocol Violation|17
50353|NCT01215955|192599|P4|Overall Study|Physician Decision|11
50354|NCT01215955|192600|P3|Overall Study|Physician Decision|8
50355|NCT01215955|192601|P2|Overall Study|Physician Decision|10
50356|NCT01215955|192602|P1|Overall Study|Physician Decision|4
50357|NCT01215955|192599|P4|Overall Study|Lost to Follow-up|9
50358|NCT01215955|192600|P3|Overall Study|Lost to Follow-up|8
50359|NCT01215955|192601|P2|Overall Study|Lost to Follow-up|4
50360|NCT01215955|192602|P1|Overall Study|Lost to Follow-up|4
50361|NCT01215955|192599|P4|Overall Study|Lack of Efficacy|0
50362|NCT01215955|192600|P3|Overall Study|Lack of Efficacy|1
50363|NCT01215955|192601|P2|Overall Study|Lack of Efficacy|2
50364|NCT01215955|192602|P1|Overall Study|Lack of Efficacy|1
50365|NCT01215955|192599|P4|Overall Study|Entry Criteria Not Met|7
50366|NCT01215955|192600|P3|Overall Study|Entry Criteria Not Met|4
50367|NCT01215955|192601|P2|Overall Study|Entry Criteria Not Met|3
50368|NCT01215955|192602|P1|Overall Study|Entry Criteria Not Met|1
50369|NCT01215955|192599|P4|Overall Study|Death|3
50370|NCT01215955|192600|P3|Overall Study|Death|1
50371|NCT01215955|192601|P2|Overall Study|Death|0
50372|NCT01215955|192602|P1|Overall Study|Death|2
50373|NCT01215955|192599|P4|Overall Study|Adverse Event|3
50374|NCT01215955|192600|P3|Overall Study|Adverse Event|2
50375|NCT01215955|192601|P2|Overall Study|Adverse Event|4
50376|NCT01215955|192602|P1|Overall Study|Adverse Event|1
50377|NCT01215851|192683|P6|Follow up Period|Lost to Follow-up|1
50378|NCT01215851|192684|P5|Follow up Period|Lost to Follow-up|0
50379|NCT01215851|192685|P4|Follow up Period|Lost to Follow-up|0
50380|NCT01215851|192686|P3|Follow up Period|Lost to Follow-up|0
50381|NCT01215851|192687|P2|Follow up Period|Lost to Follow-up|0
50382|NCT01215851|192688|P1|Follow up Period|Lost to Follow-up|0
50383|NCT01215851|192683|P6|Treatment Period|Adverse Event|1
50384|NCT01215851|192684|P5|Treatment Period|Adverse Event|0
50385|NCT01215851|192685|P4|Treatment Period|Adverse Event|3
50386|NCT01215851|192686|P3|Treatment Period|Adverse Event|1
50387|NCT01215851|192687|P2|Treatment Period|Adverse Event|1
50388|NCT01215851|192688|P1|Treatment Period|Adverse Event|1
50389|NCT01215734|192747|P2|Overall Study|Death|1
50390|NCT01215734|192748|P1|Overall Study|Death|0
50391|NCT01215721|192756|P1|Overall Study|Adverse Event|2
50392|NCT01215513|192871|P1|Overall Study|Miscellaneous reasons (CS42A)|2
50393|NCT01215513|192871|P1|Overall Study|Withdrawal by subject (CS42A)|5
50394|NCT01215513|192871|P1|Overall Study|Physician decision (CS42A)|6
50395|NCT01215513|192871|P1|Overall Study|Adverse event (CS42A)|2
50396|NCT01215513|192871|P1|Overall Study|Not enrolled from CS42 to CS42A|21
50397|NCT01215513|192871|P1|Overall Study|Not completed CS42|9
50398|NCT01215435|192880|P2|Overall Study|Unclassified|5
50399|NCT01215435|192881|P1|Overall Study|Unclassified|5
50400|NCT01215435|192880|P2|Overall Study|Lost to Follow-up|0
50401|NCT01215435|192881|P1|Overall Study|Lost to Follow-up|3
50402|NCT01215435|192880|P2|Overall Study|Withdrawal Criteria|11
50403|NCT01215435|192881|P1|Overall Study|Withdrawal Criteria|8
50404|NCT01215435|192880|P2|Overall Study|Protocol Violation|0
50405|NCT01215435|192881|P1|Overall Study|Protocol Violation|2
50406|NCT01215435|192880|P2|Overall Study|Adverse Event|0
50407|NCT01215435|192881|P1|Overall Study|Adverse Event|1
50408|NCT01215422|192895|P4|Overall Study|Did not complete all intubations|0
50409|NCT01215422|192896|P3|Overall Study|Did not complete all intubations|0
50410|NCT01215422|192897|P2|Overall Study|Did not complete all intubations|0
50411|NCT01215422|192898|P1|Overall Study|Did not complete all intubations|7
50412|NCT01215422|192895|P4|Overall Study|Failed intubations|8
50413|NCT01215422|192896|P3|Overall Study|Failed intubations|3
50414|NCT01215422|192897|P2|Overall Study|Failed intubations|0
50415|NCT01215422|192898|P1|Overall Study|Failed intubations|0
50416|NCT01215422|192895|P4|Overall Study|Relocation|0
50417|NCT01215422|192896|P3|Overall Study|Relocation|0
50418|NCT01215422|192897|P2|Overall Study|Relocation|0
50419|NCT01215422|192898|P1|Overall Study|Relocation|1
50420|NCT01215357|192920|P1|Overall Study|Protocol Violation|9
50421|NCT01215357|192920|P1|Overall Study|Withdrawal by Subject|3
50422|NCT01215227|193028|P6|Overall Study|Randomized but not treated|1
50423|NCT01215227|193029|P5|Overall Study|Randomized but not treated|0
50424|NCT01215227|193030|P4|Overall Study|Randomized but not treated|1
50425|NCT01215227|193031|P3|Overall Study|Randomized but not treated|1
50426|NCT01215227|193032|P2|Overall Study|Randomized but not treated|0
50427|NCT01215227|193033|P1|Overall Study|Randomized but not treated|0
50428|NCT01215227|193028|P6|Overall Study|Missing Status|0
50429|NCT01215227|193029|P5|Overall Study|Missing Status|0
50430|NCT01215227|193030|P4|Overall Study|Missing Status|0
50431|NCT01215227|193031|P3|Overall Study|Missing Status|0
50432|NCT01215227|193032|P2|Overall Study|Missing Status|1
50433|NCT01215227|193033|P1|Overall Study|Missing Status|0
50434|NCT01215227|193028|P6|Overall Study|Administrative|40
50435|NCT01215227|193029|P5|Overall Study|Administrative|28
50436|NCT01215227|193030|P4|Overall Study|Administrative|24
50437|NCT01215227|193031|P3|Overall Study|Administrative|42
50438|NCT01215227|193032|P2|Overall Study|Administrative|73
50439|NCT01215227|193033|P1|Overall Study|Administrative|83
50440|NCT01215227|193028|P6|Overall Study|Non-Compliance With Protocol|0
50441|NCT01215227|193029|P5|Overall Study|Non-Compliance With Protocol|0
50442|NCT01215227|193030|P4|Overall Study|Non-Compliance With Protocol|0
50443|NCT01215227|193031|P3|Overall Study|Non-Compliance With Protocol|1
50444|NCT01215227|193032|P2|Overall Study|Non-Compliance With Protocol|6
50445|NCT01215227|193033|P1|Overall Study|Non-Compliance With Protocol|2
50446|NCT01215227|193028|P6|Overall Study|Subject Withdrew Consent|8
50447|NCT01215227|193029|P5|Overall Study|Subject Withdrew Consent|11
50448|NCT01215227|193030|P4|Overall Study|Subject Withdrew Consent|10
50449|NCT01215227|193031|P3|Overall Study|Subject Withdrew Consent|7
50450|NCT01215227|193032|P2|Overall Study|Subject Withdrew Consent|20
50451|NCT01215227|193033|P1|Overall Study|Subject Withdrew Consent|16
50452|NCT01215227|193028|P6|Overall Study|Lost to Follow-up|2
50453|NCT01215227|193029|P5|Overall Study|Lost to Follow-up|1
50454|NCT01215227|193030|P4|Overall Study|Lost to Follow-up|1
50455|NCT01215227|193031|P3|Overall Study|Lost to Follow-up|1
50456|NCT01215227|193032|P2|Overall Study|Lost to Follow-up|4
50457|NCT01215227|193033|P1|Overall Study|Lost to Follow-up|1
50458|NCT01215227|193028|P6|Overall Study|Treatment Failure|1
50459|NCT01215227|193029|P5|Overall Study|Treatment Failure|1
50460|NCT01215227|193030|P4|Overall Study|Treatment Failure|5
50461|NCT01215227|193031|P3|Overall Study|Treatment Failure|1
50462|NCT01215227|193032|P2|Overall Study|Treatment Failure|4
50463|NCT01215227|193033|P1|Overall Study|Treatment Failure|8
50464|NCT01215227|193028|P6|Overall Study|Adverse Event|6
50465|NCT01215227|193029|P5|Overall Study|Adverse Event|7
50466|NCT01215227|193030|P4|Overall Study|Adverse Event|8
50467|NCT01215227|193031|P3|Overall Study|Adverse Event|4
50468|NCT01215227|193032|P2|Overall Study|Adverse Event|11
50469|NCT01215227|193033|P1|Overall Study|Adverse Event|11
50470|NCT01215097|193084|P2|Overall Study|patient's private reason|1
50471|NCT01215097|193085|P1|Overall Study|patient's private reason|1
50472|NCT01215097|193084|P2|Overall Study|patient's refusal to come|2
50473|NCT01215097|193085|P1|Overall Study|patient's refusal to come|2
50474|NCT01215097|193084|P2|Overall Study|Lack of Efficacy|3
50475|NCT01215097|193085|P1|Overall Study|Lack of Efficacy|0
50476|NCT01215097|193084|P2|Overall Study|Withdrawal by Subject|3
50477|NCT01215097|193085|P1|Overall Study|Withdrawal by Subject|6
50478|NCT01215097|193084|P2|Overall Study|Lost to Follow-up|0
50479|NCT01215097|193085|P1|Overall Study|Lost to Follow-up|2
50480|NCT01215097|193084|P2|Overall Study|Protocol Violation|2
50481|NCT01215097|193085|P1|Overall Study|Protocol Violation|0
50482|NCT01215097|193084|P2|Overall Study|Adverse Event|3
50483|NCT01215097|193085|P1|Overall Study|Adverse Event|1
50484|NCT01214915|193134|P1|Overall Study|Lack of Efficacy|3
50485|NCT01214915|193134|P1|Overall Study|Adverse Event|8
50486|NCT01214850|193145|P3|Overall Study|Unable to classify|1
50487|NCT01214850|193146|P2|Overall Study|Unable to classify|1
50488|NCT01214850|193147|P1|Overall Study|Unable to classify|2
50489|NCT01214850|193145|P3|Overall Study|Administrative reason|0
50490|NCT01214850|193146|P2|Overall Study|Administrative reason|0
50491|NCT01214850|193147|P1|Overall Study|Administrative reason|1
50492|NCT01214850|193145|P3|Overall Study|Inappropriate enrollment|0
50493|NCT01214850|193146|P2|Overall Study|Inappropriate enrollment|1
50494|NCT01214850|193147|P1|Overall Study|Inappropriate enrollment|2
50495|NCT01214850|193145|P3|Overall Study|Adverse event or death|3
50496|NCT01214850|193146|P2|Overall Study|Adverse event or death|8
50497|NCT01214850|193147|P1|Overall Study|Adverse event or death|11
50498|NCT01214850|193145|P3|Overall Study|Protocol Violation|6
50499|NCT01214850|193146|P2|Overall Study|Protocol Violation|5
50500|NCT01214850|193147|P1|Overall Study|Protocol Violation|5
50501|NCT01214850|193145|P3|Overall Study|Lost to Follow-up|123
50502|NCT01214850|193146|P2|Overall Study|Lost to Follow-up|98
50503|NCT01214850|193147|P1|Overall Study|Lost to Follow-up|124
50504|NCT01214850|193145|P3|Overall Study|Withdrawal by Subject|28
50505|NCT01214850|193146|P2|Overall Study|Withdrawal by Subject|31
50506|NCT01214850|193147|P1|Overall Study|Withdrawal by Subject|38
50507|NCT01214837|193231|P3|Overall Study|Unable to Classify|0
50508|NCT01214837|193232|P2|Overall Study|Unable to Classify|3
50509|NCT01214837|193233|P1|Overall Study|Unable to Classify|1
50510|NCT01214837|193231|P3|Overall Study|Protocol Violation|5
50511|NCT01214837|193232|P2|Overall Study|Protocol Violation|1
50512|NCT01214837|193233|P1|Overall Study|Protocol Violation|3
50513|NCT01214837|193231|P3|Overall Study|Administrative Reason|4
50514|NCT01214837|193232|P2|Overall Study|Administrative Reason|6
50515|NCT01214837|193233|P1|Overall Study|Administrative Reason|2
50516|NCT01214837|193231|P3|Overall Study|Inappropriate Enrolment|2
50517|NCT01214837|193232|P2|Overall Study|Inappropriate Enrolment|1
50518|NCT01214837|193233|P1|Overall Study|Inappropriate Enrolment|0
50519|NCT01214837|193231|P3|Overall Study|Lost to Follow-up|21
50520|NCT01214837|193232|P2|Overall Study|Lost to Follow-up|15
50521|NCT01214837|193233|P1|Overall Study|Lost to Follow-up|20
50522|NCT01214837|193231|P3|Overall Study|Withdrawal by Subject|28
50523|NCT01214837|193232|P2|Overall Study|Withdrawal by Subject|36
50524|NCT01214837|193233|P1|Overall Study|Withdrawal by Subject|27
50525|NCT01214837|193231|P3|Overall Study|Adverse Event|1
50526|NCT01214837|193232|P2|Overall Study|Adverse Event|2
50527|NCT01214837|193233|P1|Overall Study|Adverse Event|1
50528|NCT01214837|193231|P3|Overall Study|Death|1
50529|NCT01214837|193232|P2|Overall Study|Death|0
50530|NCT01214837|193233|P1|Overall Study|Death|0
50531|NCT01214720|193289|P2|Overall Study|Lost to Follow-up|2
50532|NCT01214720|193290|P1|Overall Study|Lost to Follow-up|6
50533|NCT01214720|193289|P2|Overall Study|Alive and in follow-up|48
50534|NCT01214720|193290|P1|Overall Study|Alive and in follow-up|45
50535|NCT01214720|193289|P2|Overall Study|Alive and still on treatment|18
50536|NCT01214720|193290|P1|Overall Study|Alive and still on treatment|34
50537|NCT01214616|193311|P4|Overall Study|Withdrawal by Subject|1
50538|NCT01214616|193312|P3|Overall Study|Withdrawal by Subject|0
50539|NCT01214616|193313|P2|Overall Study|Withdrawal by Subject|0
50540|NCT01214616|193314|P1|Overall Study|Withdrawal by Subject|1
50541|NCT01214616|193311|P4|Overall Study|Other adverse events|1
50542|NCT01214616|193312|P3|Overall Study|Other adverse events|1
50543|NCT01214616|193313|P2|Overall Study|Other adverse events|1
50544|NCT01214616|193314|P1|Overall Study|Other adverse events|0
50545|NCT01214616|193311|P4|Overall Study|Dose limiting toxicity|0
50546|NCT01214616|193312|P3|Overall Study|Dose limiting toxicity|0
50547|NCT01214616|193313|P2|Overall Study|Dose limiting toxicity|2
50548|NCT01214616|193314|P1|Overall Study|Dose limiting toxicity|0
50549|NCT01214616|193311|P4|Overall Study|Progressive disease|4
50550|NCT01214616|193312|P3|Overall Study|Progressive disease|2
50551|NCT01214616|193313|P2|Overall Study|Progressive disease|2
50552|NCT01214616|193314|P1|Overall Study|Progressive disease|2
50553|NCT01214434|193350|P2|Overall Study|Site error|0
50554|NCT01214434|193351|P1|Overall Study|Site error|1
50555|NCT01214434|193350|P2|Overall Study|Lost to Follow-up|2
50556|NCT01214434|193351|P1|Overall Study|Lost to Follow-up|2
50557|NCT01214434|193350|P2|Overall Study|Withdrawal by Subject|0
50558|NCT01214434|193351|P1|Overall Study|Withdrawal by Subject|1
50559|NCT01214395|193367|P1|Overall Study|All patients had infection|5
50560|NCT01214252|193376|P1|Overall Study|Not eligible per protocol|82
50561|NCT01214239|193384|P2|Overall Study|patient's private reason|1
50562|NCT01214239|193385|P1|Overall Study|patient's private reason|1
50563|NCT01214239|193384|P2|Overall Study|Lack of Efficacy|2
50564|NCT01214239|193385|P1|Overall Study|Lack of Efficacy|1
50565|NCT01214239|193384|P2|Overall Study|Withdrawal by Subject|9
50566|NCT01214239|193385|P1|Overall Study|Withdrawal by Subject|4
50567|NCT01214239|193384|P2|Overall Study|Lost to Follow-up|1
50568|NCT01214239|193385|P1|Overall Study|Lost to Follow-up|1
50569|NCT01214239|193384|P2|Overall Study|Protocol Violation|1
50570|NCT01214239|193385|P1|Overall Study|Protocol Violation|2
50571|NCT01214239|193384|P2|Overall Study|Adverse Event|4
50572|NCT01214239|193385|P1|Overall Study|Adverse Event|3
50573|NCT01214174|193420|P3|Overall Study|Withdrawal by Subject|1
50574|NCT01214174|193421|P2|Overall Study|Withdrawal by Subject|0
50575|NCT01214174|193422|P1|Overall Study|Withdrawal by Subject|0
50576|NCT01213966|193539|P4|Overall Study|Protocol Violation|1
50577|NCT01213966|193540|P3|Overall Study|Protocol Violation|3
50578|NCT01213966|193541|P2|Overall Study|Protocol Violation|0
50579|NCT01213966|193542|P1|Overall Study|Protocol Violation|1
50580|NCT01213836|193554|P2|Period 1, First Intervention|Withdrawal by Subject|1
50581|NCT01213836|193555|P1|Period 1, First Intervention|Withdrawal by Subject|1
50582|NCT01213836|193554|P2|Period 1, First Intervention|Protocol Violation|1
50583|NCT01213836|193555|P1|Period 1, First Intervention|Protocol Violation|0
50584|NCT01213836|193554|P2|Period 1, First Intervention|Adverse Event|1
50585|NCT01213836|193555|P1|Period 1, First Intervention|Adverse Event|2
50586|NCT01213264|193668|P3|Overall Study|Lost to Follow-up|6
50587|NCT01213264|193669|P2|Overall Study|Lost to Follow-up|2
50588|NCT01213264|193670|P1|Overall Study|Lost to Follow-up|1
50589|NCT01213264|193668|P3|Overall Study|Adverse Event|0
50590|NCT01213264|193669|P2|Overall Study|Adverse Event|0
50591|NCT01213264|193670|P1|Overall Study|Adverse Event|1
50592|NCT01213251|193690|P3|Overall Study|Missed 18-Month Follow-up|1
50593|NCT01213251|193691|P2|Overall Study|Missed 18-Month Follow-up|0
50594|NCT01213251|193692|P1|Overall Study|Missed 18-Month Follow-up|0
50595|NCT01213251|193690|P3|Overall Study|Protocol Violation|0
50596|NCT01213251|193691|P2|Overall Study|Protocol Violation|1
50597|NCT01213251|193692|P1|Overall Study|Protocol Violation|1
50598|NCT01213251|193690|P3|Overall Study|Exit|8
50599|NCT01213251|193691|P2|Overall Study|Exit|2
50600|NCT01213251|193692|P1|Overall Study|Exit|3
50601|NCT01213251|193690|P3|Overall Study|Death|2
50602|NCT01213251|193691|P2|Overall Study|Death|1
50603|NCT01213251|193692|P1|Overall Study|Death|2
50604|NCT01213173|193719|P2|Overall Study|Incorrect Enrollment|3
50605|NCT01213173|193720|P1|Overall Study|Incorrect Enrollment|1
50606|NCT01213173|193719|P2|Overall Study|Withdrawal by Subject|5
50607|NCT01213173|193720|P1|Overall Study|Withdrawal by Subject|5
50608|NCT01213173|193719|P2|Overall Study|Adverse Event|8
50609|NCT01213173|193720|P1|Overall Study|Adverse Event|4
50610|NCT01213173|193719|P2|Overall Study|Protocol Violation|0
50611|NCT01213173|193720|P1|Overall Study|Protocol Violation|2
50612|NCT01212991|193781|P2|Overall Study|Continuing Treatment|61
50613|NCT01212991|193782|P1|Overall Study|Continuing Treatment|367
50614|NCT01212991|193781|P2|Overall Study|Withdrawal by Subject|14
50615|NCT01212991|193782|P1|Overall Study|Withdrawal by Subject|4
50616|NCT01212991|193781|P2|Overall Study|Death|299
50617|NCT01212991|193782|P1|Overall Study|Death|241
50618|NCT01212991|193781|P2|Overall Study|Lost to Follow-up|0
50619|NCT01212991|193782|P1|Overall Study|Lost to Follow-up|1
50620|NCT01212770|193814|P7|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
50621|NCT01212770|193815|P6|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
50622|NCT01212770|193816|P5|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
50623|NCT01212770|193817|P4|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
50624|NCT01212770|193818|P3|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
50625|NCT01212770|193819|P2|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
50626|NCT01212770|193820|P1|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
50627|NCT01212770|193814|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
50628|NCT01212770|193815|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
50629|NCT01212770|193816|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
50630|NCT01212770|193817|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
50631|NCT01212770|193818|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
50632|NCT01212770|193819|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
50633|NCT01212770|193820|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
50634|NCT01212770|193814|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
50635|NCT01212770|193815|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
50636|NCT01212770|193816|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
50637|NCT01212770|193817|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
50638|NCT01212770|193818|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
50639|NCT01212770|193819|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
50640|NCT01212770|193820|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
50641|NCT01212770|193814|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
50642|NCT01212770|193815|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
50643|NCT01212770|193816|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
50644|NCT01212770|193817|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
50645|NCT01212770|193818|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
50646|NCT01212770|193819|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
50647|NCT01212770|193820|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
50648|NCT01212770|193814|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
50649|NCT01212770|193815|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
50650|NCT01212770|193816|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
50651|NCT01212770|193817|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
50652|NCT01212770|193818|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
50653|NCT01212770|193819|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
50654|NCT01212770|193820|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
50655|NCT01212770|193814|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
50656|NCT01212770|193815|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
50657|NCT01212770|193816|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
50658|NCT01212770|193817|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
50659|NCT01212770|193818|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
50660|NCT01212770|193819|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
50661|NCT01212770|193820|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
50662|NCT01212770|193814|P7|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
50663|NCT01212770|193815|P6|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
50664|NCT01212770|193816|P5|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
50665|NCT01212770|193817|P4|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
50666|NCT01212770|193818|P3|Placebo-controlled Phase (Week 0 - 24)|Unspecified|2
50667|NCT01212770|193819|P2|Placebo-controlled Phase (Week 0 - 24)|Unspecified|1
50668|NCT01212770|193820|P1|Placebo-controlled Phase (Week 0 - 24)|Unspecified|3
50669|NCT01212770|193814|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
50670|NCT01212770|193815|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
50671|NCT01212770|193816|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
50672|NCT01212770|193817|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
50673|NCT01212770|193818|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
50674|NCT01212770|193819|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
50675|NCT01212770|193820|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
50676|NCT01212770|193814|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
50677|NCT01212770|193815|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
50678|NCT01212770|193816|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
50679|NCT01212770|193817|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
50680|NCT01212770|193818|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
50681|NCT01212770|193819|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
50682|NCT01212770|193820|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
50683|NCT01212770|193814|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
50684|NCT01212770|193815|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
50685|NCT01212770|193816|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
50686|NCT01212770|193817|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
50687|NCT01212770|193818|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
50688|NCT01212770|193819|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
50689|NCT01212770|193820|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
50690|NCT01212770|193814|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
50691|NCT01212770|193815|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
50692|NCT01212770|193816|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
50693|NCT01212770|193817|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
50694|NCT01212770|193818|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
50695|NCT01212770|193819|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
50696|NCT01212770|193820|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
50697|NCT01212770|193814|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
50698|NCT01212770|193815|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
50699|NCT01212770|193816|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
50700|NCT01212770|193817|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
50701|NCT01212770|193818|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
50702|NCT01212770|193819|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
50703|NCT01212770|193820|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
50704|NCT01212757|194010|P7|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
50705|NCT01212757|194011|P6|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
50706|NCT01212757|194012|P5|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
50707|NCT01212757|194013|P4|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
50708|NCT01212757|194014|P3|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
50709|NCT01212757|194015|P2|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
50710|NCT01212757|194016|P1|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
50711|NCT01212757|194010|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
50712|NCT01212757|194011|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
50713|NCT01212757|194012|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
50714|NCT01212757|194013|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
50715|NCT01212757|194014|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
50716|NCT01212757|194015|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
50717|NCT01212757|194016|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
50718|NCT01212757|194010|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
50719|NCT01212757|194011|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
50720|NCT01212757|194012|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
50721|NCT01212757|194013|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
50722|NCT01212757|194014|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|7
50723|NCT01212757|194015|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
50724|NCT01212757|194016|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
50725|NCT01212757|194010|P7|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
50726|NCT01212757|194011|P6|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
50727|NCT01212757|194012|P5|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
50728|NCT01212757|194013|P4|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
50729|NCT01212757|194014|P3|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|2
50730|NCT01212757|194015|P2|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
50731|NCT01212757|194016|P1|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
50732|NCT01212757|194010|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
50733|NCT01212757|194011|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
50734|NCT01212757|194012|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
50735|NCT01212757|194013|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
50736|NCT01212757|194014|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
50737|NCT01212757|194015|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
50738|NCT01212757|194016|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
50739|NCT01212757|194010|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
50740|NCT01212757|194011|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
50741|NCT01212757|194012|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
50742|NCT01212757|194013|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
50743|NCT01212757|194014|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|3
50744|NCT01212757|194015|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
50745|NCT01212757|194016|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
50746|NCT01212757|194010|P7|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
50747|NCT01212757|194011|P6|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
50748|NCT01212757|194012|P5|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
50749|NCT01212757|194013|P4|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
50750|NCT01212757|194014|P3|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
50751|NCT01212757|194015|P2|Placebo-controlled Phase (Week 0 - 24)|Unspecified|2
50752|NCT01212757|194016|P1|Placebo-controlled Phase (Week 0 - 24)|Unspecified|1
50753|NCT01212757|194010|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
50754|NCT01212757|194011|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
50755|NCT01212757|194012|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
50756|NCT01212757|194013|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
50757|NCT01212757|194014|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
50758|NCT01212757|194015|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
50759|NCT01212757|194016|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
50760|NCT01212757|194010|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
50761|NCT01212757|194011|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
50762|NCT01212757|194012|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
50763|NCT01212757|194013|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
50764|NCT01212757|194014|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
50765|NCT01212757|194015|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
50766|NCT01212757|194016|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
50767|NCT01212757|194010|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
50768|NCT01212757|194011|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
50769|NCT01212757|194012|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
50770|NCT01212757|194013|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
50771|NCT01212757|194014|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
50772|NCT01212757|194015|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
50773|NCT01212757|194016|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
50774|NCT01212757|194010|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
50775|NCT01212757|194011|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
50776|NCT01212757|194012|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
50777|NCT01212757|194013|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
50778|NCT01212757|194014|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
50779|NCT01212757|194015|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
50780|NCT01212757|194016|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
50781|NCT01212757|194010|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
50782|NCT01212757|194011|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
50783|NCT01212757|194012|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
50784|NCT01212757|194013|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
50785|NCT01212757|194014|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
50786|NCT01212757|194015|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
50787|NCT01212757|194016|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
50788|NCT01212757|194010|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
50789|NCT01212757|194011|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
50790|NCT01212757|194012|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
50791|NCT01212757|194013|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
50792|NCT01212757|194014|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
50793|NCT01212757|194015|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
50794|NCT01212757|194016|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
50795|NCT01212185|194248|P2|Overall Study|Protocol Violation|1
50796|NCT01212185|194249|P1|Overall Study|Protocol Violation|2
50797|NCT01212159|194268|P2|Overall Study|Withdrawal by Subject|12
50798|NCT01212159|194269|P1|Overall Study|Withdrawal by Subject|12
50799|NCT01212094|194282|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
50800|NCT01212094|194283|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
50801|NCT01212094|194284|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
50802|NCT01212094|194282|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
50803|NCT01212094|194283|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
50804|NCT01212094|194284|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
50805|NCT01212094|194282|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
50806|NCT01212094|194283|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
50807|NCT01212094|194284|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
50808|NCT01212094|194282|P3|Year 1: Baseline Monitoring|Started on DMT|0
50809|NCT01212094|194283|P2|Year 1: Baseline Monitoring|Started on DMT|0
50810|NCT01212094|194284|P1|Year 1: Baseline Monitoring|Started on DMT|2
50811|NCT01212094|194282|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
50812|NCT01212094|194283|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
50813|NCT01212094|194284|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
50814|NCT01212094|194282|P3|Year 1: Baseline Monitoring|Study terminated|0
50815|NCT01212094|194283|P2|Year 1: Baseline Monitoring|Study terminated|0
50816|NCT01212094|194284|P1|Year 1: Baseline Monitoring|Study terminated|7
50817|NCT01211769|194331|P4|Overall Study|Adverse Event|1
50818|NCT01211769|194332|P3|Overall Study|Adverse Event|1
50819|NCT01211769|194333|P2|Overall Study|Adverse Event|1
50820|NCT01211769|194334|P1|Overall Study|Adverse Event|0
50821|NCT01211769|194331|P4|Overall Study|Physician Decision|1
50822|NCT01211769|194332|P3|Overall Study|Physician Decision|2
50823|NCT01211769|194333|P2|Overall Study|Physician Decision|0
50824|NCT01211769|194334|P1|Overall Study|Physician Decision|2
50825|NCT01211769|194331|P4|Overall Study|Lost to Follow-up|9
50826|NCT01211769|194332|P3|Overall Study|Lost to Follow-up|5
50827|NCT01211769|194333|P2|Overall Study|Lost to Follow-up|9
50828|NCT01211769|194334|P1|Overall Study|Lost to Follow-up|7
50829|NCT01211665|194373|P2|Overall Study|Death|0
50830|NCT01211665|194374|P1|Overall Study|Death|1
50831|NCT01211665|194373|P2|Overall Study|Withdrawal by Subject|0
50832|NCT01211665|194374|P1|Overall Study|Withdrawal by Subject|1
50833|NCT01211613|194401|P3|Overall Study|Withdrawal by Subject|0
50834|NCT01211613|194402|P2|Overall Study|Withdrawal by Subject|0
50835|NCT01211613|194403|P1|Overall Study|Withdrawal by Subject|1
50836|NCT01211613|194401|P3|Overall Study|Lost to Follow-up|2
50837|NCT01211613|194402|P2|Overall Study|Lost to Follow-up|2
50838|NCT01211613|194403|P1|Overall Study|Lost to Follow-up|2
50839|NCT01211535|194416|P2|Overall Study|Adverse Event|1
50840|NCT01211535|194417|P1|Overall Study|Adverse Event|0
50841|NCT01211197|194423|P6|Washout Period 2 (7 Days)|Adverse Event|0
50842|NCT01211197|194424|P5|Washout Period 2 (7 Days)|Adverse Event|0
50843|NCT01211197|194425|P4|Washout Period 2 (7 Days)|Adverse Event|0
50844|NCT01211197|194426|P3|Washout Period 2 (7 Days)|Adverse Event|0
50845|NCT01211197|194427|P2|Washout Period 2 (7 Days)|Adverse Event|0
50846|NCT01211197|194428|P1|Washout Period 2 (7 Days)|Adverse Event|1
50847|NCT01211197|194423|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
50848|NCT01211197|194424|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
50849|NCT01211197|194425|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
50850|NCT01211197|194426|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
50851|NCT01211197|194427|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
50852|NCT01211197|194428|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
50853|NCT01211184|194475|P3|Overall Study|Withdrawal by Subject|1
50854|NCT01211184|194476|P2|Overall Study|Withdrawal by Subject|2
50855|NCT01211184|194477|P1|Overall Study|Withdrawal by Subject|0
50856|NCT01211145|194492|P4|Overall Study|Patient decision|2
50857|NCT01211145|194493|P3|Overall Study|Patient decision|0
50858|NCT01211145|194494|P2|Overall Study|Patient decision|1
50859|NCT01211145|194495|P1|Overall Study|Patient decision|2
50860|NCT01211145|194492|P4|Overall Study|Eligibility criteria not fulfilled|15
50861|NCT01211145|194493|P3|Overall Study|Eligibility criteria not fulfilled|10
50862|NCT01211145|194494|P2|Overall Study|Eligibility criteria not fulfilled|12
50863|NCT01211145|194495|P1|Overall Study|Eligibility criteria not fulfilled|16
50864|NCT01211145|194492|P4|Overall Study|Severe noncompliance to protocol|0
50865|NCT01211145|194493|P3|Overall Study|Severe noncompliance to protocol|0
50866|NCT01211145|194494|P2|Overall Study|Severe noncompliance to protocol|0
50867|NCT01211145|194495|P1|Overall Study|Severe noncompliance to protocol|1
50868|NCT01211145|194492|P4|Overall Study|Study-specific withdrawal criteria|0
50869|NCT01211145|194493|P3|Overall Study|Study-specific withdrawal criteria|0
50870|NCT01211145|194494|P2|Overall Study|Study-specific withdrawal criteria|0
50871|NCT01211145|194495|P1|Overall Study|Study-specific withdrawal criteria|1
50872|NCT01211145|194492|P4|Overall Study|Lost to Follow-up|2
50873|NCT01211145|194493|P3|Overall Study|Lost to Follow-up|1
50874|NCT01211145|194494|P2|Overall Study|Lost to Follow-up|2
50875|NCT01211145|194495|P1|Overall Study|Lost to Follow-up|3
50876|NCT01211145|194492|P4|Overall Study|Reason not specified|1
50877|NCT01211145|194493|P3|Overall Study|Reason not specified|2
50878|NCT01211145|194494|P2|Overall Study|Reason not specified|2
50879|NCT01211145|194495|P1|Overall Study|Reason not specified|3
50880|NCT01210807|194538|P2|Overall Study|Not implanted bilaterally|1
50881|NCT01210807|194539|P1|Overall Study|Not implanted bilaterally|2
50882|NCT01210807|194538|P2|Overall Study|Lost to Follow-up|2
50883|NCT01210807|194539|P1|Overall Study|Lost to Follow-up|1
50884|NCT01210690|194554|P1|Overall Study|Patient could not take glucose|1
50885|NCT01210690|194554|P1|Overall Study|Patient refused to swallow|1
50886|NCT01210690|194554|P1|Overall Study|Withdrawal by Subject|1
50887|NCT01210690|194554|P1|Overall Study|Disease Remission|1
50888|NCT01210690|194554|P1|Overall Study|Lost to Follow-up|3
50889|NCT01210690|194554|P1|Overall Study|Lack of Efficacy|12
50890|NCT01210690|194554|P1|Overall Study|Adverse Event|7
50891|NCT01210651|194569|P2|Overall Study|Injury outside study|0
50892|NCT01210651|194570|P1|Overall Study|Injury outside study|2
50893|NCT01210651|194569|P2|Overall Study|Withdrawal by Subject|1
50894|NCT01210651|194570|P1|Overall Study|Withdrawal by Subject|1
50895|NCT01210651|194569|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
50896|NCT01210651|194570|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
50897|NCT01210651|194569|P2|Overall Study|schedule conflicts|5
50898|NCT01210651|194570|P1|Overall Study|schedule conflicts|1
50899|NCT01210651|194569|P2|Overall Study|Lost to Follow-up|1
50900|NCT01210651|194570|P1|Overall Study|Lost to Follow-up|1
50901|NCT01210495|194588|P4|Overall Study|Lost to Follow-up|0
50902|NCT01210495|194589|P3|Overall Study|Lost to Follow-up|1
50903|NCT01210495|194590|P2|Overall Study|Lost to Follow-up|0
50904|NCT01210495|194591|P1|Overall Study|Lost to Follow-up|0
50905|NCT01210495|194588|P4|Overall Study|Ongoing on Treatment|1
50906|NCT01210495|194589|P3|Overall Study|Ongoing on Treatment|7
50907|NCT01210495|194590|P2|Overall Study|Ongoing on Treatment|0
50908|NCT01210495|194591|P1|Overall Study|Ongoing on Treatment|0
50909|NCT01210495|194588|P4|Overall Study|Ongoing in Follow-up|13
50910|NCT01210495|194589|P3|Overall Study|Ongoing in Follow-up|14
50911|NCT01210495|194590|P2|Overall Study|Ongoing in Follow-up|1
50912|NCT01210495|194591|P1|Overall Study|Ongoing in Follow-up|0
50913|NCT01210495|194588|P4|Overall Study|Death|52
50914|NCT01210495|194589|P3|Overall Study|Death|101
50915|NCT01210495|194590|P2|Overall Study|Death|6
50916|NCT01210495|194591|P1|Overall Study|Death|14
50917|NCT01210495|194588|P4|Overall Study|Participant Refused Further Follow-Up|2
50918|NCT01210495|194589|P3|Overall Study|Participant Refused Further Follow-Up|11
50919|NCT01210495|194590|P2|Overall Study|Participant Refused Further Follow-Up|0
50920|NCT01210495|194591|P1|Overall Study|Participant Refused Further Follow-Up|1
50921|NCT01210443|194653|P1|Overall Study|Study terminated by sponsor|2
50922|NCT01210144|194677|P2|Overall Study|No transfer|0
50923|NCT01210144|194678|P1|Overall Study|No transfer|1
50924|NCT01210144|194677|P2|Overall Study|No fertilization|0
50925|NCT01210144|194678|P1|Overall Study|No fertilization|1
50926|NCT01210144|194677|P2|Overall Study|Lack of ovarian response|0
50927|NCT01210144|194678|P1|Overall Study|Lack of ovarian response|1
50928|NCT01210118|194700|P2|Overall Study|Spontaneous abortion|3
50929|NCT01210118|194701|P1|Overall Study|Spontaneous abortion|1
50930|NCT01210118|194700|P2|Overall Study|Protocol Violation|1
50931|NCT01210118|194701|P1|Overall Study|Protocol Violation|1
50932|NCT01210118|194700|P2|Overall Study|Lost to Follow-up|1
50933|NCT01210118|194701|P1|Overall Study|Lost to Follow-up|1
50934|NCT01210001|194725|P3|Overall Study|Other reason not defined above|1
50935|NCT01210001|194726|P2|Overall Study|Other reason not defined above|2
50936|NCT01210001|194727|P1|Overall Study|Other reason not defined above|2
50937|NCT01210001|194725|P3|Overall Study|Patient refusal to continue,not due toAE|1
50938|NCT01210001|194726|P2|Overall Study|Patient refusal to continue,not due toAE|2
50939|NCT01210001|194727|P1|Overall Study|Patient refusal to continue,not due toAE|6
50940|NCT01210001|194725|P3|Overall Study|Lost to Follow-up|2
50941|NCT01210001|194726|P2|Overall Study|Lost to Follow-up|3
50942|NCT01210001|194727|P1|Overall Study|Lost to Follow-up|4
50943|NCT01210001|194725|P3|Overall Study|Non compliant with protocol|3
50944|NCT01210001|194726|P2|Overall Study|Non compliant with protocol|2
50945|NCT01210001|194727|P1|Overall Study|Non compliant with protocol|2
50946|NCT01210001|194725|P3|Overall Study|Adverse Event|5
50947|NCT01210001|194726|P2|Overall Study|Adverse Event|2
50948|NCT01210001|194727|P1|Overall Study|Adverse Event|4
50949|NCT01210001|194725|P3|Overall Study|Not treated|0
50950|NCT01210001|194726|P2|Overall Study|Not treated|0
50951|NCT01210001|194727|P1|Overall Study|Not treated|1
50952|NCT01209949|194747|P1|Overall Study|Lost to Follow-up|3
50953|NCT01209780|194757|P5|Overall Study|Inappropriate enrollment|1
50954|NCT01209780|194758|P4|Overall Study|Inappropriate enrollment|0
50955|NCT01209780|194759|P3|Overall Study|Inappropriate enrollment|0
50956|NCT01209780|194760|P2|Overall Study|Inappropriate enrollment|2
50957|NCT01209780|194761|P1|Overall Study|Inappropriate enrollment|0
50958|NCT01209780|194757|P5|Overall Study|Protocol Violation|0
50959|NCT01209780|194758|P4|Overall Study|Protocol Violation|0
50960|NCT01209780|194759|P3|Overall Study|Protocol Violation|0
50961|NCT01209780|194760|P2|Overall Study|Protocol Violation|1
50962|NCT01209780|194761|P1|Overall Study|Protocol Violation|0
50963|NCT01209780|194757|P5|Overall Study|Lost to Follow-up|4
50964|NCT01209780|194758|P4|Overall Study|Lost to Follow-up|9
50965|NCT01209780|194759|P3|Overall Study|Lost to Follow-up|3
50966|NCT01209780|194760|P2|Overall Study|Lost to Follow-up|12
50967|NCT01209780|194761|P1|Overall Study|Lost to Follow-up|17
50968|NCT01209780|194757|P5|Overall Study|Withdrawal by Subject|0
50969|NCT01209780|194758|P4|Overall Study|Withdrawal by Subject|1
50970|NCT01209780|194759|P3|Overall Study|Withdrawal by Subject|1
50971|NCT01209780|194760|P2|Overall Study|Withdrawal by Subject|2
50972|NCT01209780|194761|P1|Overall Study|Withdrawal by Subject|9
50973|NCT01209780|194757|P5|Overall Study|Adverse Event|0
50974|NCT01209780|194758|P4|Overall Study|Adverse Event|0
50975|NCT01209780|194759|P3|Overall Study|Adverse Event|0
50976|NCT01209780|194760|P2|Overall Study|Adverse Event|1
50977|NCT01209780|194761|P1|Overall Study|Adverse Event|0
50978|NCT01209767|194787|P1|Overall Study|Lost to Follow-up|3
50979|NCT01209767|194787|P1|Overall Study|Withdrawal by Subject|1
50980|NCT01209689|194856|P2|Overall Study|Sponsor's Decision to Stop the Study|17
50981|NCT01209689|194857|P1|Overall Study|Sponsor's Decision to Stop the Study|68
50982|NCT01209689|194856|P2|Overall Study|Failure to Return|0
50983|NCT01209689|194857|P1|Overall Study|Failure to Return|3
50984|NCT01209689|194856|P2|Overall Study|Violation of Selection Criteria at Entry|0
50985|NCT01209689|194857|P1|Overall Study|Violation of Selection Criteria at Entry|1
50986|NCT01209689|194856|P2|Overall Study|Adverse Event|0
50987|NCT01209689|194857|P1|Overall Study|Adverse Event|4
50988|NCT01209689|194856|P2|Overall Study|Refused Treatment|3
50989|NCT01209689|194857|P1|Overall Study|Refused Treatment|8
50990|NCT01209689|194856|P2|Overall Study|Insufficient Therapeutic Response|2
50991|NCT01209689|194857|P1|Overall Study|Insufficient Therapeutic Response|7
50992|NCT01209624|194863|P1|Overall Study|Unspecified|4
50993|NCT01209624|194863|P1|Overall Study|Lost to Follow-up|290
50994|NCT01209624|194863|P1|Overall Study|Lack of Efficacy|17
50995|NCT01209624|194863|P1|Overall Study|Adverse Event|13
50996|NCT01209624|194863|P1|Overall Study|Death|2
50997|NCT01209520|194894|P1|Overall Study|Withdrawal by Subject|3
50998|NCT01209286|194902|P3|Overall Study|Other|0
50999|NCT01209286|194903|P2|Overall Study|Other|1
51000|NCT01209286|194904|P1|Overall Study|Other|0
51001|NCT01209286|194902|P3|Overall Study|Physician Decision|0
51002|NCT01209286|194903|P2|Overall Study|Physician Decision|2
51003|NCT01209286|194904|P1|Overall Study|Physician Decision|0
51004|NCT01209286|194902|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
51005|NCT01209286|194903|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
51006|NCT01209286|194904|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
51007|NCT01209286|194902|P3|Overall Study|Hematological Relapse After Remission|1
51008|NCT01209286|194903|P2|Overall Study|Hematological Relapse After Remission|1
51009|NCT01209286|194904|P1|Overall Study|Hematological Relapse After Remission|0
51010|NCT01209286|194902|P3|Overall Study|Adverse Event|1
51011|NCT01209286|194903|P2|Overall Study|Adverse Event|3
51012|NCT01209286|194904|P1|Overall Study|Adverse Event|4
51013|NCT01209143|195013|P2|Overall Study|Disease progression|16
51014|NCT01209143|195014|P1|Overall Study|Disease progression|11
51015|NCT01209143|195013|P2|Overall Study|Withdrawal by Subject|1
51016|NCT01209143|195014|P1|Overall Study|Withdrawal by Subject|2
51017|NCT01209143|195013|P2|Overall Study|Lost to Follow-up|0
51018|NCT01209143|195014|P1|Overall Study|Lost to Follow-up|1
51019|NCT01209143|195013|P2|Overall Study|Physician Decision|1
51020|NCT01209143|195014|P1|Overall Study|Physician Decision|3
51021|NCT01209143|195013|P2|Overall Study|Death|1
51022|NCT01209143|195014|P1|Overall Study|Death|0
51023|NCT01209143|195013|P2|Overall Study|Adverse Event|1
51024|NCT01209143|195014|P1|Overall Study|Adverse Event|2
51025|NCT01208961|195022|P2|High-Fat Period III|Protocol Violation|0
51026|NCT01208961|195023|P1|High-Fat Period III|Protocol Violation|1
51027|NCT01207596|195032|P1|Overall Study|Withdrawal by Subject|1
51028|NCT01207596|195032|P1|Overall Study|Adverse Event|3
51029|NCT01207596|195032|P1|Overall Study|Lack of Efficacy|1
51030|NCT01207596|195032|P1|Overall Study|Physician Decision|4
51031|NCT01207583|195045|P3|Overall Study|Lost to Follow-up|0
51032|NCT01207583|195046|P2|Overall Study|Lost to Follow-up|2
51033|NCT01207583|195047|P1|Overall Study|Lost to Follow-up|0
51034|NCT01207583|195045|P3|Overall Study|Participant failed to return|0
51035|NCT01207583|195046|P2|Overall Study|Participant failed to return|0
51036|NCT01207583|195047|P1|Overall Study|Participant failed to return|1
51037|NCT01207583|195045|P3|Overall Study|Withdrawal by Subject|1
51038|NCT01207583|195046|P2|Overall Study|Withdrawal by Subject|3
51039|NCT01207583|195047|P1|Overall Study|Withdrawal by Subject|0
51040|NCT01208402|195102|P2|Overall Study|Withdrawal by Subject|0
51041|NCT01208402|195103|P1|Overall Study|Withdrawal by Subject|1
51042|NCT01208337|195119|P1|Overall Study|Death|3
51043|NCT01208233|195133|P6|Overall Study|Withdrawal by Subject|2
51044|NCT01208233|195134|P5|Overall Study|Withdrawal by Subject|4
51045|NCT01208233|195135|P4|Overall Study|Withdrawal by Subject|1
51046|NCT01208233|195136|P3|Overall Study|Withdrawal by Subject|1
51047|NCT01208233|195137|P2|Overall Study|Withdrawal by Subject|0
51048|NCT01208233|195138|P1|Overall Study|Withdrawal by Subject|1
51049|NCT01208233|195133|P6|Overall Study|Unspecified|1
51050|NCT01208233|195134|P5|Overall Study|Unspecified|0
51051|NCT01208233|195135|P4|Overall Study|Unspecified|0
51052|NCT01208233|195136|P3|Overall Study|Unspecified|0
51053|NCT01208233|195137|P2|Overall Study|Unspecified|1
51054|NCT01208233|195138|P1|Overall Study|Unspecified|2
51055|NCT01208233|195133|P6|Overall Study|Protocol Violation|0
51056|NCT01208233|195134|P5|Overall Study|Protocol Violation|3
51057|NCT01208233|195135|P4|Overall Study|Protocol Violation|0
51058|NCT01208233|195136|P3|Overall Study|Protocol Violation|0
51059|NCT01208233|195137|P2|Overall Study|Protocol Violation|0
51060|NCT01208233|195138|P1|Overall Study|Protocol Violation|0
51061|NCT01208233|195133|P6|Overall Study|Study terminated by sponsor|7
51062|NCT01208233|195134|P5|Overall Study|Study terminated by sponsor|10
51063|NCT01208233|195135|P4|Overall Study|Study terminated by sponsor|0
51064|NCT01208233|195136|P3|Overall Study|Study terminated by sponsor|0
51065|NCT01208233|195137|P2|Overall Study|Study terminated by sponsor|0
51066|NCT01208233|195138|P1|Overall Study|Study terminated by sponsor|0
51067|NCT01208233|195133|P6|Overall Study|Medication error without adverse event|1
51068|NCT01208233|195134|P5|Overall Study|Medication error without adverse event|0
51069|NCT01208233|195135|P4|Overall Study|Medication error without adverse event|0
51070|NCT01208233|195136|P3|Overall Study|Medication error without adverse event|0
51071|NCT01208233|195137|P2|Overall Study|Medication error without adverse event|0
51072|NCT01208233|195138|P1|Overall Study|Medication error without adverse event|0
51073|NCT01208233|195133|P6|Overall Study|Did not meet entrance criteria|0
51074|NCT01208233|195134|P5|Overall Study|Did not meet entrance criteria|1
51075|NCT01208233|195135|P4|Overall Study|Did not meet entrance criteria|0
51076|NCT01208233|195136|P3|Overall Study|Did not meet entrance criteria|1
51077|NCT01208233|195137|P2|Overall Study|Did not meet entrance criteria|1
51078|NCT01208233|195138|P1|Overall Study|Did not meet entrance criteria|2
51079|NCT01208233|195133|P6|Overall Study|Death|5
51080|NCT01208233|195134|P5|Overall Study|Death|3
51081|NCT01208233|195135|P4|Overall Study|Death|0
51082|NCT01208233|195136|P3|Overall Study|Death|0
51083|NCT01208233|195137|P2|Overall Study|Death|0
51084|NCT01208233|195138|P1|Overall Study|Death|0
51085|NCT01208233|195133|P6|Overall Study|Adverse Event|5
51086|NCT01208233|195134|P5|Overall Study|Adverse Event|3
51087|NCT01208233|195135|P4|Overall Study|Adverse Event|0
51088|NCT01208233|195136|P3|Overall Study|Adverse Event|2
51089|NCT01208233|195137|P2|Overall Study|Adverse Event|1
51090|NCT01208233|195138|P1|Overall Study|Adverse Event|0
51091|NCT01208207|195263|P7|Part II|Technical Problems|0
51092|NCT01208207|195264|P6|Part II|Technical Problems|1
51093|NCT01208207|195265|P5|Part II|Technical Problems|0
51094|NCT01208207|195266|P4|Part II|Technical Problems|1
51095|NCT01208207|195267|P3|Part II|Technical Problems|0
51096|NCT01208207|195268|P2|Part II|Technical Problems|0
51097|NCT01208207|195269|P1|Part II|Technical Problems|0
51098|NCT01208207|195263|P7|Part II|Protocol Violation|0
51099|NCT01208207|195264|P6|Part II|Protocol Violation|0
51100|NCT01208207|195265|P5|Part II|Protocol Violation|0
51101|NCT01208207|195266|P4|Part II|Protocol Violation|1
51102|NCT01208207|195267|P3|Part II|Protocol Violation|0
51103|NCT01208207|195268|P2|Part II|Protocol Violation|0
51104|NCT01208207|195269|P1|Part II|Protocol Violation|0
51105|NCT01208207|195263|P7|Part II|Physician Decision|0
51106|NCT01208207|195264|P6|Part II|Physician Decision|2
51107|NCT01208207|195265|P5|Part II|Physician Decision|0
51108|NCT01208207|195266|P4|Part II|Physician Decision|1
51109|NCT01208207|195267|P3|Part II|Physician Decision|0
51110|NCT01208207|195268|P2|Part II|Physician Decision|0
51111|NCT01208207|195269|P1|Part II|Physician Decision|0
51112|NCT01208207|195263|P7|Part II|Non-Compliance With Study Drug|0
51113|NCT01208207|195264|P6|Part II|Non-Compliance With Study Drug|1
51114|NCT01208207|195265|P5|Part II|Non-Compliance With Study Drug|1
51115|NCT01208207|195266|P4|Part II|Non-Compliance With Study Drug|4
51116|NCT01208207|195267|P3|Part II|Non-Compliance With Study Drug|0
51117|NCT01208207|195268|P2|Part II|Non-Compliance With Study Drug|0
51118|NCT01208207|195269|P1|Part II|Non-Compliance With Study Drug|0
51119|NCT01208207|195263|P7|Part II|Lost to Follow-up|1
51120|NCT01208207|195264|P6|Part II|Lost to Follow-up|2
51121|NCT01208207|195265|P5|Part II|Lost to Follow-up|0
51122|NCT01208207|195266|P4|Part II|Lost to Follow-up|4
51123|NCT01208207|195267|P3|Part II|Lost to Follow-up|0
51124|NCT01208207|195268|P2|Part II|Lost to Follow-up|0
51125|NCT01208207|195269|P1|Part II|Lost to Follow-up|0
51126|NCT01208207|195263|P7|Part II|Lack of Efficacy|3
51127|NCT01208207|195264|P6|Part II|Lack of Efficacy|3
51128|NCT01208207|195265|P5|Part II|Lack of Efficacy|4
51129|NCT01208207|195266|P4|Part II|Lack of Efficacy|6
51130|NCT01208207|195267|P3|Part II|Lack of Efficacy|0
51131|NCT01208207|195268|P2|Part II|Lack of Efficacy|0
51132|NCT01208207|195269|P1|Part II|Lack of Efficacy|0
51133|NCT01208207|195263|P7|Part II|Adverse Event|2
51134|NCT01208207|195264|P6|Part II|Adverse Event|4
51135|NCT01208207|195265|P5|Part II|Adverse Event|9
51136|NCT01208207|195266|P4|Part II|Adverse Event|5
51137|NCT01208207|195267|P3|Part II|Adverse Event|0
51138|NCT01208207|195268|P2|Part II|Adverse Event|0
51139|NCT01208207|195269|P1|Part II|Adverse Event|0
51140|NCT01208207|195263|P7|Part II|Withdrawal by Subject|5
51141|NCT01208207|195264|P6|Part II|Withdrawal by Subject|3
51142|NCT01208207|195265|P5|Part II|Withdrawal by Subject|9
51143|NCT01208207|195266|P4|Part II|Withdrawal by Subject|10
51144|NCT01208207|195267|P3|Part II|Withdrawal by Subject|0
51145|NCT01208207|195268|P2|Part II|Withdrawal by Subject|0
51146|NCT01208207|195269|P1|Part II|Withdrawal by Subject|0
51147|NCT01208207|195263|P7|Part I|Withdrawal by Subject|0
51148|NCT01208207|195264|P6|Part I|Withdrawal by Subject|0
51149|NCT01208207|195265|P5|Part I|Withdrawal by Subject|0
51150|NCT01208207|195266|P4|Part I|Withdrawal by Subject|0
51151|NCT01208207|195267|P3|Part I|Withdrawal by Subject|4
51152|NCT01208207|195268|P2|Part I|Withdrawal by Subject|4
51153|NCT01208207|195269|P1|Part I|Withdrawal by Subject|14
51154|NCT01208207|195263|P7|Part I|Protocol Violation|0
51155|NCT01208207|195264|P6|Part I|Protocol Violation|0
51156|NCT01208207|195265|P5|Part I|Protocol Violation|0
51157|NCT01208207|195266|P4|Part I|Protocol Violation|0
51158|NCT01208207|195267|P3|Part I|Protocol Violation|2
51159|NCT01208207|195268|P2|Part I|Protocol Violation|0
51160|NCT01208207|195269|P1|Part I|Protocol Violation|8
51161|NCT01208207|195263|P7|Part I|Progressive Disease|0
51162|NCT01208207|195264|P6|Part I|Progressive Disease|0
51163|NCT01208207|195265|P5|Part I|Progressive Disease|0
51164|NCT01208207|195266|P4|Part I|Progressive Disease|0
51165|NCT01208207|195267|P3|Part I|Progressive Disease|0
51166|NCT01208207|195268|P2|Part I|Progressive Disease|0
51167|NCT01208207|195269|P1|Part I|Progressive Disease|1
51168|NCT01208207|195263|P7|Part I|Physician Decision|0
51169|NCT01208207|195264|P6|Part I|Physician Decision|0
51170|NCT01208207|195265|P5|Part I|Physician Decision|0
51171|NCT01208207|195266|P4|Part I|Physician Decision|0
51172|NCT01208207|195267|P3|Part I|Physician Decision|0
51173|NCT01208207|195268|P2|Part I|Physician Decision|1
51174|NCT01208207|195269|P1|Part I|Physician Decision|0
51175|NCT01208207|195263|P7|Part I|Non-Compliance With Study Drug|0
51176|NCT01208207|195264|P6|Part I|Non-Compliance With Study Drug|0
51177|NCT01208207|195265|P5|Part I|Non-Compliance With Study Drug|0
51178|NCT01208207|195266|P4|Part I|Non-Compliance With Study Drug|0
51179|NCT01208207|195267|P3|Part I|Non-Compliance With Study Drug|1
51180|NCT01208207|195268|P2|Part I|Non-Compliance With Study Drug|0
51181|NCT01208207|195269|P1|Part I|Non-Compliance With Study Drug|1
51182|NCT01208207|195263|P7|Part I|Lost to Follow-up|0
51183|NCT01208207|195264|P6|Part I|Lost to Follow-up|0
51184|NCT01208207|195265|P5|Part I|Lost to Follow-up|0
51185|NCT01208207|195266|P4|Part I|Lost to Follow-up|0
51186|NCT01208207|195267|P3|Part I|Lost to Follow-up|0
51187|NCT01208207|195268|P2|Part I|Lost to Follow-up|1
51188|NCT01208207|195269|P1|Part I|Lost to Follow-up|6
51189|NCT01208207|195263|P7|Part I|Lack of Efficacy|0
51190|NCT01208207|195264|P6|Part I|Lack of Efficacy|0
51191|NCT01208207|195265|P5|Part I|Lack of Efficacy|0
51192|NCT01208207|195266|P4|Part I|Lack of Efficacy|0
51193|NCT01208207|195267|P3|Part I|Lack of Efficacy|2
51194|NCT01208207|195268|P2|Part I|Lack of Efficacy|3
51195|NCT01208207|195269|P1|Part I|Lack of Efficacy|21
51196|NCT01208207|195263|P7|Part I|Adverse Event|0
51197|NCT01208207|195264|P6|Part I|Adverse Event|0
51198|NCT01208207|195265|P5|Part I|Adverse Event|0
51199|NCT01208207|195266|P4|Part I|Adverse Event|0
51200|NCT01208207|195267|P3|Part I|Adverse Event|6
51201|NCT01208207|195268|P2|Part I|Adverse Event|2
51202|NCT01208207|195269|P1|Part I|Adverse Event|19
51203|NCT01208181|195296|P5|Part 2|Lack of Efficacy|0
51204|NCT01208181|195297|P4|Part 2|Lack of Efficacy|7
51205|NCT01208181|195298|P3|Part 2|Lack of Efficacy|5
51206|NCT01208181|195299|P2|Part 2|Lack of Efficacy|0
51207|NCT01208181|195300|P1|Part 2|Lack of Efficacy|0
51208|NCT01208181|195296|P5|Part 2|Lost to Follow-up|0
51209|NCT01208181|195297|P4|Part 2|Lost to Follow-up|2
51210|NCT01208181|195298|P3|Part 2|Lost to Follow-up|1
51211|NCT01208181|195299|P2|Part 2|Lost to Follow-up|0
51212|NCT01208181|195300|P1|Part 2|Lost to Follow-up|0
51213|NCT01208181|195296|P5|Part 2|Non-compliance with study drug|0
51214|NCT01208181|195297|P4|Part 2|Non-compliance with study drug|1
51215|NCT01208181|195298|P3|Part 2|Non-compliance with study drug|1
51216|NCT01208181|195299|P2|Part 2|Non-compliance with study drug|0
51217|NCT01208181|195300|P1|Part 2|Non-compliance with study drug|0
51218|NCT01208181|195296|P5|Part 2|Physician Decision|0
51219|NCT01208181|195297|P4|Part 2|Physician Decision|2
51220|NCT01208181|195298|P3|Part 2|Physician Decision|1
51221|NCT01208181|195299|P2|Part 2|Physician Decision|0
51222|NCT01208181|195300|P1|Part 2|Physician Decision|0
51223|NCT01208181|195296|P5|Part 2|Protocol Violation|0
51224|NCT01208181|195297|P4|Part 2|Protocol Violation|0
51225|NCT01208181|195298|P3|Part 2|Protocol Violation|1
51226|NCT01208181|195299|P2|Part 2|Protocol Violation|0
51227|NCT01208181|195300|P1|Part 2|Protocol Violation|0
51228|NCT01208181|195296|P5|Part 2|Withdrawal by Subject|0
51229|NCT01208181|195297|P4|Part 2|Withdrawal by Subject|1
51230|NCT01208181|195298|P3|Part 2|Withdrawal by Subject|1
51231|NCT01208181|195299|P2|Part 2|Withdrawal by Subject|0
51232|NCT01208181|195300|P1|Part 2|Withdrawal by Subject|0
51233|NCT01208181|195296|P5|Part 2|Adverse Event|0
51234|NCT01208181|195297|P4|Part 2|Adverse Event|7
51235|NCT01208181|195298|P3|Part 2|Adverse Event|6
51236|NCT01208181|195299|P2|Part 2|Adverse Event|0
51237|NCT01208181|195300|P1|Part 2|Adverse Event|0
51238|NCT01208181|195296|P5|Part 1|Adverse Event|4
51239|NCT01208181|195297|P4|Part 1|Adverse Event|0
51240|NCT01208181|195298|P3|Part 1|Adverse Event|0
51241|NCT01208181|195299|P2|Part 1|Adverse Event|24
51242|NCT01208181|195300|P1|Part 1|Adverse Event|26
51243|NCT01208181|195296|P5|Part 1|Lack of Efficacy|17
51244|NCT01208181|195297|P4|Part 1|Lack of Efficacy|0
51245|NCT01208181|195298|P3|Part 1|Lack of Efficacy|0
51246|NCT01208181|195299|P2|Part 1|Lack of Efficacy|12
51247|NCT01208181|195300|P1|Part 1|Lack of Efficacy|37
51248|NCT01208181|195296|P5|Part 1|Lost to Follow-up|1
51249|NCT01208181|195297|P4|Part 1|Lost to Follow-up|0
51250|NCT01208181|195298|P3|Part 1|Lost to Follow-up|0
51251|NCT01208181|195299|P2|Part 1|Lost to Follow-up|3
51252|NCT01208181|195300|P1|Part 1|Lost to Follow-up|5
51253|NCT01208181|195296|P5|Part 1|Non-compliance with study drug|0
51254|NCT01208181|195297|P4|Part 1|Non-compliance with study drug|0
51255|NCT01208181|195298|P3|Part 1|Non-compliance with study drug|0
51256|NCT01208181|195299|P2|Part 1|Non-compliance with study drug|1
51257|NCT01208181|195300|P1|Part 1|Non-compliance with study drug|1
51258|NCT01208181|195296|P5|Part 1|Physician Decision|0
51259|NCT01208181|195297|P4|Part 1|Physician Decision|0
51260|NCT01208181|195298|P3|Part 1|Physician Decision|0
51261|NCT01208181|195299|P2|Part 1|Physician Decision|0
51262|NCT01208181|195300|P1|Part 1|Physician Decision|4
51263|NCT01208181|195296|P5|Part 1|Protocol Violation|0
51264|NCT01208181|195297|P4|Part 1|Protocol Violation|0
51265|NCT01208181|195298|P3|Part 1|Protocol Violation|0
51266|NCT01208181|195299|P2|Part 1|Protocol Violation|5
51267|NCT01208181|195300|P1|Part 1|Protocol Violation|10
51268|NCT01208181|195296|P5|Part 1|Technical problem|0
51269|NCT01208181|195297|P4|Part 1|Technical problem|0
51270|NCT01208181|195298|P3|Part 1|Technical problem|0
51271|NCT01208181|195299|P2|Part 1|Technical problem|0
51272|NCT01208181|195300|P1|Part 1|Technical problem|5
51273|NCT01208181|195296|P5|Part 1|Withdrawal by Subject|0
51274|NCT01208181|195297|P4|Part 1|Withdrawal by Subject|0
51275|NCT01208181|195298|P3|Part 1|Withdrawal by Subject|0
51276|NCT01208181|195299|P2|Part 1|Withdrawal by Subject|10
51277|NCT01208181|195300|P1|Part 1|Withdrawal by Subject|11
51278|NCT01207492|195365|P1|Overall Study|Toxicity|1
51279|NCT01207492|195365|P1|Overall Study|Progressive disease|3
51280|NCT01207492|195365|P1|Overall Study|Physician Decision|1
51281|NCT01207492|195365|P1|Overall Study|Withdrawal by Subject|9
51282|NCT01207492|195365|P1|Overall Study|Still on study|1
51283|NCT01207453|195380|P2|2nd Intervention|Lost to Follow-up|0
51284|NCT01207453|195381|P1|2nd Intervention|Lost to Follow-up|1
51285|NCT01207453|195380|P2|2nd Intervention|Adverse Event|2
51286|NCT01207453|195381|P1|2nd Intervention|Adverse Event|1
51287|NCT01207453|195380|P2|Washout|Lost to Follow-up|0
51288|NCT01207453|195381|P1|Washout|Lost to Follow-up|1
51289|NCT01207453|195380|P2|Washout|Adverse Event|0
51290|NCT01207453|195381|P1|Washout|Adverse Event|1
51291|NCT01207453|195380|P2|First Intervention|Adverse Event|1
51292|NCT01207453|195381|P1|First Intervention|Adverse Event|2
51293|NCT01207427|195403|P3|Double-blind Treatment Period|Withdrawal by Subject|0
51294|NCT01207427|195404|P2|Double-blind Treatment Period|Withdrawal by Subject|0
51295|NCT01207427|195405|P1|Double-blind Treatment Period|Withdrawal by Subject|1
51296|NCT01207427|195403|P3|Double-blind Treatment Period|Protocol Violation|1
51297|NCT01207427|195404|P2|Double-blind Treatment Period|Protocol Violation|1
51298|NCT01207427|195405|P1|Double-blind Treatment Period|Protocol Violation|2
51299|NCT01207427|195403|P3|Double-blind Treatment Period|Lost to Follow-up|1
51300|NCT01207427|195404|P2|Double-blind Treatment Period|Lost to Follow-up|0
51301|NCT01207427|195405|P1|Double-blind Treatment Period|Lost to Follow-up|0
51302|NCT01207427|195403|P3|Double-blind Treatment Period|Adverse Event|0
51303|NCT01207427|195404|P2|Double-blind Treatment Period|Adverse Event|1
51304|NCT01207427|195405|P1|Double-blind Treatment Period|Adverse Event|0
51305|NCT01207414|195415|P2|Overall Study|Randomized in error|0
51306|NCT01207414|195416|P1|Overall Study|Randomized in error|1
51307|NCT01207414|195415|P2|Overall Study|Protocol deviation|9
51308|NCT01207414|195416|P1|Overall Study|Protocol deviation|12
51309|NCT01207414|195415|P2|Overall Study|Administrative problems|1
51310|NCT01207414|195416|P1|Overall Study|Administrative problems|1
51311|NCT01207414|195415|P2|Overall Study|Lost to Follow-up|17
51312|NCT01207414|195416|P1|Overall Study|Lost to Follow-up|15
51313|NCT01207414|195415|P2|Overall Study|Patient withdrew consent|11
51314|NCT01207414|195416|P1|Overall Study|Patient withdrew consent|14
51315|NCT01207414|195415|P2|Overall Study|Unsatisfactory therapeutic effect|4
51316|NCT01207414|195416|P1|Overall Study|Unsatisfactory therapeutic effect|5
51317|NCT01207414|195415|P2|Overall Study|Abnormal test procedure results|1
51318|NCT01207414|195416|P1|Overall Study|Abnormal test procedure results|0
51319|NCT01207414|195415|P2|Overall Study|Adverse Event|39
51320|NCT01207414|195416|P1|Overall Study|Adverse Event|25
51321|NCT01207388|195441|P1|Overall Study|Other|1
51322|NCT01207388|195441|P1|Overall Study|Physician Decision|2
51323|NCT01207388|195441|P1|Overall Study|Disease Relapse|10
51324|NCT01207388|195441|P1|Overall Study|Adverse Event|20
51325|NCT01207219|195464|P3|Overall Study|Lost to Follow-up|6
51326|NCT01207219|195465|P2|Overall Study|Lost to Follow-up|8
51327|NCT01207219|195466|P1|Overall Study|Lost to Follow-up|6
51328|NCT01207219|195464|P3|Overall Study|changed diagnosis during study period|1
51329|NCT01207219|195465|P2|Overall Study|changed diagnosis during study period|3
51330|NCT01207219|195466|P1|Overall Study|changed diagnosis during study period|5
51331|NCT01207102|195486|P1|Overall Study|Withdrawal by Treating Physician|1
51332|NCT01207102|195486|P1|Overall Study|progression|2
51333|NCT01207102|195486|P1|Overall Study|Adverse Event|2
51334|NCT01207102|195486|P1|Overall Study|Withdrawal by Subject|5
51335|NCT01206777|195491|P1|Overall Study|Adverse Event|1
51336|NCT01206777|195491|P1|Overall Study|Death|1
51337|NCT01206582|195547|P2|Overall Study|Discontinued intervention before week 8|2
51338|NCT01206582|195548|P1|Overall Study|Discontinued intervention before week 8|1
51339|NCT01206582|195547|P2|Overall Study|Withdrew prior to study|0
51340|NCT01206582|195548|P1|Overall Study|Withdrew prior to study|1
51341|NCT01206517|195580|P6|Overall Study|Withdrawal by Subject|0
51342|NCT01206517|195581|P5|Overall Study|Withdrawal by Subject|1
51343|NCT01206517|195582|P4|Overall Study|Withdrawal by Subject|0
51344|NCT01206517|195583|P3|Overall Study|Withdrawal by Subject|2
51345|NCT01206517|195584|P2|Overall Study|Withdrawal by Subject|0
51346|NCT01206517|195585|P1|Overall Study|Withdrawal by Subject|0
51347|NCT01206439|195625|P1|Overall Study|subject did not meet inclusion criteria|1
51348|NCT01206322|195648|P4|Overall Study|Adverse Event|1
51349|NCT01206322|195649|P3|Overall Study|Adverse Event|0
51350|NCT01206322|195650|P2|Overall Study|Adverse Event|0
51351|NCT01206322|195651|P1|Overall Study|Adverse Event|0
51352|NCT01206140|195667|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
51353|NCT01206140|195668|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
51354|NCT01206101|195680|P2|Overall Study|Unclassified|0
51355|NCT01206101|195681|P1|Overall Study|Unclassified|1
51356|NCT01206101|195680|P2|Overall Study|Physician Decision|1
51357|NCT01206101|195681|P1|Overall Study|Physician Decision|0
51358|NCT01206101|195680|P2|Overall Study|Adverse Event|0
51359|NCT01206101|195681|P1|Overall Study|Adverse Event|1
51360|NCT01205685|195705|P1|Overall Study|Withdrawal by Subject|1
51361|NCT01205685|195705|P1|Overall Study|Disease Progression|10
51362|NCT01204671|195717|P5|Overall Study|Physician Decision|0
51363|NCT01204671|195718|P4|Overall Study|Physician Decision|1
51364|NCT01204671|195719|P3|Overall Study|Physician Decision|0
51365|NCT01204671|195720|P2|Overall Study|Physician Decision|0
51366|NCT01204671|195721|P1|Overall Study|Physician Decision|0
51367|NCT01204671|195717|P5|Overall Study|Unknown Completion Status|0
51368|NCT01204671|195718|P4|Overall Study|Unknown Completion Status|0
51369|NCT01204671|195719|P3|Overall Study|Unknown Completion Status|0
51370|NCT01204671|195720|P2|Overall Study|Unknown Completion Status|1
51371|NCT01204671|195721|P1|Overall Study|Unknown Completion Status|1
51372|NCT01204671|195717|P5|Overall Study|Lost to Follow-up|0
51373|NCT01204671|195718|P4|Overall Study|Lost to Follow-up|4
51374|NCT01204671|195719|P3|Overall Study|Lost to Follow-up|6
51375|NCT01204671|195720|P2|Overall Study|Lost to Follow-up|8
51376|NCT01204671|195721|P1|Overall Study|Lost to Follow-up|7
51377|NCT01204671|195717|P5|Overall Study|Withdrawal by Subject|3
51378|NCT01204671|195718|P4|Overall Study|Withdrawal by Subject|5
51379|NCT01204671|195719|P3|Overall Study|Withdrawal by Subject|4
51380|NCT01204671|195720|P2|Overall Study|Withdrawal by Subject|3
51381|NCT01204671|195721|P1|Overall Study|Withdrawal by Subject|2
51382|NCT01204671|195717|P5|Overall Study|Adverse Event|1
51383|NCT01204671|195718|P4|Overall Study|Adverse Event|3
51384|NCT01204671|195719|P3|Overall Study|Adverse Event|3
51385|NCT01204671|195720|P2|Overall Study|Adverse Event|3
51386|NCT01204671|195721|P1|Overall Study|Adverse Event|4
51387|NCT01204658|195783|P4|Primary Phase|Adverse Event|0
51388|NCT01204658|195784|P3|Primary Phase|Adverse Event|1
51389|NCT01204658|195785|P2|Primary Phase|Adverse Event|0
51390|NCT01204658|195786|P1|Primary Phase|Adverse Event|0
51391|NCT01205581|195906|P6|Overall Study|Withdrawal by Subject|0
51392|NCT01205581|195907|P5|Overall Study|Withdrawal by Subject|0
51393|NCT01205581|195908|P4|Overall Study|Withdrawal by Subject|0
51394|NCT01205581|195909|P3|Overall Study|Withdrawal by Subject|0
51395|NCT01205581|195910|P2|Overall Study|Withdrawal by Subject|0
51396|NCT01205581|195911|P1|Overall Study|Withdrawal by Subject|1
51397|NCT01205451|195994|P2|Overall Study|Withdrawal by Subject|9
51398|NCT01205451|195995|P1|Overall Study|Withdrawal by Subject|5
51399|NCT01205451|195994|P2|Overall Study|Lost to Follow-up|1
51400|NCT01205451|195995|P1|Overall Study|Lost to Follow-up|1
51401|NCT01205269|196043|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
51402|NCT01205269|196044|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
51403|NCT01205269|196045|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
51404|NCT01205269|196046|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
51405|NCT01205269|196047|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
51406|NCT01205269|196048|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
51407|NCT01205230|196088|P2|Overall Study|Physician Decision|0
51408|NCT01205230|196089|P1|Overall Study|Physician Decision|1
51409|NCT01205230|196088|P2|Overall Study|Adverse Event|0
51410|NCT01205230|196089|P1|Overall Study|Adverse Event|4
51411|NCT01205126|196134|P2|Maintenance Phase|Withdrawal by Subject|11
51412|NCT01205126|196135|P1|Maintenance Phase|Withdrawal by Subject|8
51413|NCT01205126|196134|P2|Maintenance Phase|Lost to Follow-up|5
51414|NCT01205126|196135|P1|Maintenance Phase|Lost to Follow-up|5
51415|NCT01205126|196134|P2|Maintenance Phase|Unspecified|8
51416|NCT01205126|196135|P1|Maintenance Phase|Unspecified|11
51417|NCT01205126|196134|P2|Maintenance Phase|Prohibited drugs used|0
51418|NCT01205126|196135|P1|Maintenance Phase|Prohibited drugs used|1
51419|NCT01205126|196134|P2|Maintenance Phase|More than the maximum dosage required|5
51420|NCT01205126|196135|P1|Maintenance Phase|More than the maximum dosage required|5
51421|NCT01205126|196134|P2|Maintenance Phase|Death|4
51422|NCT01205126|196135|P1|Maintenance Phase|Death|4
51423|NCT01205126|196134|P2|Maintenance Phase|Adverse Event|7
51424|NCT01205126|196135|P1|Maintenance Phase|Adverse Event|3
51425|NCT01205126|196134|P2|Between Titration & Maintenance Phase|Unspecified|4
51426|NCT01205126|196135|P1|Between Titration & Maintenance Phase|Unspecified|0
51427|NCT01205126|196134|P2|Titration Phase|Unspecified|6
51428|NCT01205126|196135|P1|Titration Phase|Unspecified|8
51429|NCT01205126|196134|P2|Titration Phase|More than maximum dosage required|3
51430|NCT01205126|196135|P1|Titration Phase|More than maximum dosage required|2
51431|NCT01205126|196134|P2|Titration Phase|No stable titration dose|0
51432|NCT01205126|196135|P1|Titration Phase|No stable titration dose|1
51433|NCT01205126|196134|P2|Titration Phase|Lost to Follow-up|2
51434|NCT01205126|196135|P1|Titration Phase|Lost to Follow-up|2
51435|NCT01205126|196134|P2|Titration Phase|Withdrawal by Subject|5
51436|NCT01205126|196135|P1|Titration Phase|Withdrawal by Subject|5
51437|NCT01205126|196134|P2|Titration Phase|Adverse Event|3
51438|NCT01205126|196135|P1|Titration Phase|Adverse Event|5
51439|NCT01205035|196153|P2|Overall Study|Physician Decision|0
51440|NCT01205035|196154|P1|Overall Study|Physician Decision|1
51441|NCT01205035|196153|P2|Overall Study|Withdrawal by Subject|0
51442|NCT01205035|196154|P1|Overall Study|Withdrawal by Subject|1
51443|NCT01204697|196206|P2|Overall Study|Randomized, but not treated|1
51444|NCT01204697|196207|P1|Overall Study|Randomized, but not treated|0
51445|NCT01204697|196206|P2|Overall Study|Withdrawal by Subject|4
51446|NCT01204697|196207|P1|Overall Study|Withdrawal by Subject|2
51447|NCT01204697|196206|P2|Overall Study|Lost to Follow-up|4
51448|NCT01204697|196207|P1|Overall Study|Lost to Follow-up|3
51449|NCT01204697|196206|P2|Overall Study|Death|27
51450|NCT01204697|196207|P1|Overall Study|Death|26
51451|NCT01204398|196223|P1|Overall Study|Adverse Event|1
51452|NCT01204294|196240|P7|Overall Study|Other (house moving)|0
51453|NCT01204294|196241|P6|Overall Study|Other (house moving)|0
51454|NCT01204294|196242|P5|Overall Study|Other (house moving)|0
51455|NCT01204294|196243|P4|Overall Study|Other (house moving)|0
51456|NCT01204294|196244|P3|Overall Study|Other (house moving)|1
51457|NCT01204294|196245|P2|Overall Study|Other (house moving)|0
51458|NCT01204294|196246|P1|Overall Study|Other (house moving)|0
51459|NCT01204294|196240|P7|Overall Study|Lack of Efficacy|0
51460|NCT01204294|196241|P6|Overall Study|Lack of Efficacy|0
51461|NCT01204294|196242|P5|Overall Study|Lack of Efficacy|0
51462|NCT01204294|196243|P4|Overall Study|Lack of Efficacy|2
51463|NCT01204294|196244|P3|Overall Study|Lack of Efficacy|0
51464|NCT01204294|196245|P2|Overall Study|Lack of Efficacy|0
51465|NCT01204294|196246|P1|Overall Study|Lack of Efficacy|0
51466|NCT01204294|196240|P7|Overall Study|Withdrawal by Subject|2
51467|NCT01204294|196241|P6|Overall Study|Withdrawal by Subject|1
51468|NCT01204294|196242|P5|Overall Study|Withdrawal by Subject|1
51469|NCT01204294|196243|P4|Overall Study|Withdrawal by Subject|1
51470|NCT01204294|196244|P3|Overall Study|Withdrawal by Subject|2
51471|NCT01204294|196245|P2|Overall Study|Withdrawal by Subject|2
51472|NCT01204294|196246|P1|Overall Study|Withdrawal by Subject|0
51473|NCT01204294|196240|P7|Overall Study|Protocol Violation|0
51474|NCT01204294|196241|P6|Overall Study|Protocol Violation|0
51475|NCT01204294|196242|P5|Overall Study|Protocol Violation|0
51476|NCT01204294|196243|P4|Overall Study|Protocol Violation|1
51477|NCT01204294|196244|P3|Overall Study|Protocol Violation|2
51478|NCT01204294|196245|P2|Overall Study|Protocol Violation|0
51479|NCT01204294|196246|P1|Overall Study|Protocol Violation|1
51480|NCT01204294|196240|P7|Overall Study|Adverse Event|0
51481|NCT01204294|196241|P6|Overall Study|Adverse Event|4
51482|NCT01204294|196242|P5|Overall Study|Adverse Event|1
51483|NCT01204294|196243|P4|Overall Study|Adverse Event|7
51484|NCT01204294|196244|P3|Overall Study|Adverse Event|0
51485|NCT01204294|196245|P2|Overall Study|Adverse Event|6
51486|NCT01204294|196246|P1|Overall Study|Adverse Event|2
51487|NCT01203956|196273|P2|Second Two-week Period|Non-compliant: no evaluable results|6
51488|NCT01203956|196274|P1|Second Two-week Period|Non-compliant: no evaluable results|5
51489|NCT01203917|196281|P1|Overall Study|Due to EGFR M+I patient|1
51490|NCT01203917|196281|P1|Overall Study|Due to objective disease progression|1
51491|NCT01203917|196281|P1|Overall Study|Withdrawal by Subject|3
51492|NCT01203917|196281|P1|Overall Study|Lost to Follow-up|2
51493|NCT01203917|196281|P1|Overall Study|Death|29
51494|NCT01203878|196294|P3|Overall Study|Adverse Event|2
51495|NCT01203878|196295|P2|Overall Study|Adverse Event|0
51496|NCT01203878|196296|P1|Overall Study|Adverse Event|0
51497|NCT01203878|196294|P3|Overall Study|Withdrawal by Subject|1
51498|NCT01203878|196295|P2|Overall Study|Withdrawal by Subject|0
51499|NCT01203878|196296|P1|Overall Study|Withdrawal by Subject|0
51500|NCT01203852|196307|P1|Washout 2 Weeks|Physician Decision|46
51501|NCT01203852|196307|P1|Metoprolol 8 Weeks|Physician Decision|470
51502|NCT01203787|196316|P2|Overall Study|Adverse Event|15
51503|NCT01203787|196317|P1|Overall Study|Adverse Event|11
51504|NCT01203787|196316|P2|Overall Study|Lost to Follow-up|0
51505|NCT01203787|196317|P1|Overall Study|Lost to Follow-up|2
51506|NCT01203787|196316|P2|Overall Study|Withdrawal by Subject|2
51507|NCT01203787|196317|P1|Overall Study|Withdrawal by Subject|6
51508|NCT01203787|196316|P2|Overall Study|Death|10
51509|NCT01203787|196317|P1|Overall Study|Death|12
51510|NCT01203098|196369|P3|Overall Study|Withdrawal by Subject|3
51511|NCT01203098|196370|P2|Overall Study|Withdrawal by Subject|1
51512|NCT01203098|196371|P1|Overall Study|Withdrawal by Subject|1
51513|NCT01203098|196369|P3|Overall Study|Physician Decision|0
51514|NCT01203098|196370|P2|Overall Study|Physician Decision|2
51515|NCT01203098|196371|P1|Overall Study|Physician Decision|2
51516|NCT01203098|196369|P3|Overall Study|Lost to Follow-up|1
51517|NCT01203098|196370|P2|Overall Study|Lost to Follow-up|0
51518|NCT01203098|196371|P1|Overall Study|Lost to Follow-up|0
51519|NCT01203098|196369|P3|Overall Study|Adverse Event|7
51520|NCT01203098|196370|P2|Overall Study|Adverse Event|1
51521|NCT01203098|196371|P1|Overall Study|Adverse Event|3
51522|NCT01203072|196387|P5|Overall Study|Withdrawal by Subject|3
51523|NCT01203072|196388|P4|Overall Study|Withdrawal by Subject|2
51524|NCT01203072|196389|P3|Overall Study|Withdrawal by Subject|1
51525|NCT01203072|196390|P2|Overall Study|Withdrawal by Subject|2
51526|NCT01203072|196391|P1|Overall Study|Withdrawal by Subject|2
51527|NCT01203072|196387|P5|Overall Study|Protocol Violation|1
51528|NCT01203072|196388|P4|Overall Study|Protocol Violation|0
51529|NCT01203072|196389|P3|Overall Study|Protocol Violation|0
51530|NCT01203072|196390|P2|Overall Study|Protocol Violation|0
51531|NCT01203072|196391|P1|Overall Study|Protocol Violation|2
51532|NCT01203072|196387|P5|Overall Study|Lost to Follow-up|0
51533|NCT01203072|196388|P4|Overall Study|Lost to Follow-up|0
51534|NCT01203072|196389|P3|Overall Study|Lost to Follow-up|0
51535|NCT01203072|196390|P2|Overall Study|Lost to Follow-up|1
51536|NCT01203072|196391|P1|Overall Study|Lost to Follow-up|0
51537|NCT01203072|196387|P5|Overall Study|Lack of Efficacy|0
51538|NCT01203072|196388|P4|Overall Study|Lack of Efficacy|0
51539|NCT01203072|196389|P3|Overall Study|Lack of Efficacy|0
51540|NCT01203072|196390|P2|Overall Study|Lack of Efficacy|0
51541|NCT01203072|196391|P1|Overall Study|Lack of Efficacy|1
51542|NCT01203072|196387|P5|Overall Study|Adverse Event|2
51543|NCT01203072|196388|P4|Overall Study|Adverse Event|4
51544|NCT01203072|196389|P3|Overall Study|Adverse Event|2
51545|NCT01203072|196390|P2|Overall Study|Adverse Event|3
51546|NCT01203072|196391|P1|Overall Study|Adverse Event|5
51547|NCT01202955|196421|P2|Period 1: 10 Days|Withdrawal by Subject|2
51548|NCT01202955|196422|P1|Period 1: 10 Days|Withdrawal by Subject|0
51549|NCT01202903|196434|P2|Overall Study|Withdrawal by Subject|4
51550|NCT01202903|196435|P1|Overall Study|Withdrawal by Subject|4
51551|NCT01202903|196434|P2|Overall Study|Adverse Event|3
51552|NCT01202903|196435|P1|Overall Study|Adverse Event|3
51553|NCT01202903|196434|P2|Overall Study|Lack of Efficacy|3
51554|NCT01202903|196435|P1|Overall Study|Lack of Efficacy|1
51555|NCT01202903|196434|P2|Overall Study|Lost to Follow-up|1
51556|NCT01202903|196435|P1|Overall Study|Lost to Follow-up|1
51557|NCT01202903|196434|P2|Overall Study|Death|0
51558|NCT01202903|196435|P1|Overall Study|Death|1
51559|NCT01202903|196434|P2|Overall Study|Protocol Violation|1
51560|NCT01202903|196435|P1|Overall Study|Protocol Violation|0
51561|NCT01202903|196434|P2|Overall Study|Administrative Probelms|4
51562|NCT01202903|196435|P1|Overall Study|Administrative Probelms|1
51563|NCT01202877|196462|P3|Overall Study|Death|1
51564|NCT01202877|196463|P2|Overall Study|Death|0
51565|NCT01202877|196464|P1|Overall Study|Death|0
51566|NCT01202877|196462|P3|Overall Study|Withdrawal by Subject|1
51567|NCT01202877|196463|P2|Overall Study|Withdrawal by Subject|0
51568|NCT01202877|196464|P1|Overall Study|Withdrawal by Subject|0
51569|NCT01202877|196462|P3|Overall Study|Adverse Event|2
51570|NCT01202877|196463|P2|Overall Study|Adverse Event|0
51571|NCT01202877|196464|P1|Overall Study|Adverse Event|0
51572|NCT01202877|196462|P3|Overall Study|Disease Progression|2
51573|NCT01202877|196463|P2|Overall Study|Disease Progression|1
51574|NCT01202877|196464|P1|Overall Study|Disease Progression|0
51575|NCT01202747|196473|P1|Overall Study|Withdrawal by Subject|1
51576|NCT01202591|196505|P6|Overall Study|Objective Disease Progression|0
51577|NCT01202591|196506|P5|Overall Study|Objective Disease Progression|2
51578|NCT01202591|196507|P4|Overall Study|Objective Disease Progression|0
51579|NCT01202591|196508|P3|Overall Study|Objective Disease Progression|0
51580|NCT01202591|196509|P2|Overall Study|Objective Disease Progression|0
51581|NCT01202591|196510|P1|Overall Study|Objective Disease Progression|0
51582|NCT01202591|196505|P6|Overall Study|Withdrawal by Subject|1
51583|NCT01202591|196506|P5|Overall Study|Withdrawal by Subject|2
51584|NCT01202591|196507|P4|Overall Study|Withdrawal by Subject|0
51585|NCT01202591|196508|P3|Overall Study|Withdrawal by Subject|0
51586|NCT01202591|196509|P2|Overall Study|Withdrawal by Subject|0
51587|NCT01202591|196510|P1|Overall Study|Withdrawal by Subject|0
51588|NCT01202591|196505|P6|Overall Study|Other reason as per investigator|3
51589|NCT01202591|196506|P5|Overall Study|Other reason as per investigator|1
51590|NCT01202591|196507|P4|Overall Study|Other reason as per investigator|3
51591|NCT01202591|196508|P3|Overall Study|Other reason as per investigator|7
51592|NCT01202591|196509|P2|Overall Study|Other reason as per investigator|4
51593|NCT01202591|196510|P1|Overall Study|Other reason as per investigator|3
51594|NCT01202591|196505|P6|Overall Study|Adverse Event|0
51595|NCT01202591|196506|P5|Overall Study|Adverse Event|0
51596|NCT01202591|196507|P4|Overall Study|Adverse Event|4
51597|NCT01202591|196508|P3|Overall Study|Adverse Event|4
51598|NCT01202591|196509|P2|Overall Study|Adverse Event|1
51599|NCT01202591|196510|P1|Overall Study|Adverse Event|2
51600|NCT01202279|196556|P2|Overall Study|study compliance|2
51601|NCT01202279|196557|P1|Overall Study|study compliance|5
51602|NCT01202279|196556|P2|Overall Study|Protocol Violation|1
51603|NCT01202279|196557|P1|Overall Study|Protocol Violation|1
51604|NCT01202279|196556|P2|Overall Study|Lost to Follow-up|7
51605|NCT01202279|196557|P1|Overall Study|Lost to Follow-up|10
51606|NCT01202279|196556|P2|Overall Study|Physician Decision|1
51607|NCT01202279|196557|P1|Overall Study|Physician Decision|0
51608|NCT01202279|196556|P2|Overall Study|Withdrawal by Subject|10
51609|NCT01202279|196557|P1|Overall Study|Withdrawal by Subject|13
51610|NCT01202279|196556|P2|Overall Study|Adverse Event|6
51611|NCT01202279|196557|P1|Overall Study|Adverse Event|8
51612|NCT01202227|196609|P1|Overall Study|Lack of Efficacy|1
51613|NCT01202227|196609|P1|Overall Study|Withdrawal by Subject|2
51614|NCT01202227|196609|P1|Overall Study|Adverse Event|16
51615|NCT01202188|196633|P5|Overall Study|Abnormal test procedure result (s)|0
51616|NCT01202188|196634|P4|Overall Study|Abnormal test procedure result (s)|0
51617|NCT01202188|196635|P3|Overall Study|Abnormal test procedure result (s)|2
51618|NCT01202188|196636|P2|Overall Study|Abnormal test procedure result (s)|0
51619|NCT01202188|196637|P1|Overall Study|Abnormal test procedure result (s)|0
51620|NCT01202188|196633|P5|Overall Study|Death|0
51621|NCT01202188|196634|P4|Overall Study|Death|1
51622|NCT01202188|196635|P3|Overall Study|Death|1
51623|NCT01202188|196636|P2|Overall Study|Death|1
51624|NCT01202188|196637|P1|Overall Study|Death|1
51625|NCT01202188|196633|P5|Overall Study|Lost to Follow-up|1
51626|NCT01202188|196634|P4|Overall Study|Lost to Follow-up|4
51627|NCT01202188|196635|P3|Overall Study|Lost to Follow-up|0
51628|NCT01202188|196636|P2|Overall Study|Lost to Follow-up|1
51629|NCT01202188|196637|P1|Overall Study|Lost to Follow-up|1
51630|NCT01202188|196633|P5|Overall Study|Unsatisfactory therapeutic effect|8
51631|NCT01202188|196634|P4|Overall Study|Unsatisfactory therapeutic effect|5
51632|NCT01202188|196635|P3|Overall Study|Unsatisfactory therapeutic effect|2
51633|NCT01202188|196636|P2|Overall Study|Unsatisfactory therapeutic effect|8
51634|NCT01202188|196637|P1|Overall Study|Unsatisfactory therapeutic effect|2
51635|NCT01202188|196633|P5|Overall Study|Administrative problems|2
51636|NCT01202188|196634|P4|Overall Study|Administrative problems|1
51637|NCT01202188|196635|P3|Overall Study|Administrative problems|1
51638|NCT01202188|196636|P2|Overall Study|Administrative problems|2
51639|NCT01202188|196637|P1|Overall Study|Administrative problems|3
51640|NCT01202188|196633|P5|Overall Study|Adverse Event|10
51641|NCT01202188|196634|P4|Overall Study|Adverse Event|10
51642|NCT01202188|196635|P3|Overall Study|Adverse Event|13
51643|NCT01202188|196636|P2|Overall Study|Adverse Event|23
51644|NCT01202188|196637|P1|Overall Study|Adverse Event|5
51645|NCT01202188|196633|P5|Overall Study|Subject withdrew consent|13
51646|NCT01202188|196634|P4|Overall Study|Subject withdrew consent|11
51647|NCT01202188|196635|P3|Overall Study|Subject withdrew consent|22
51648|NCT01202188|196636|P2|Overall Study|Subject withdrew consent|13
51649|NCT01202188|196637|P1|Overall Study|Subject withdrew consent|12
51650|NCT01202188|196633|P5|Overall Study|Protocol deviation|11
51651|NCT01202188|196634|P4|Overall Study|Protocol deviation|10
51652|NCT01202188|196635|P3|Overall Study|Protocol deviation|12
51653|NCT01202188|196636|P2|Overall Study|Protocol deviation|8
51654|NCT01202188|196637|P1|Overall Study|Protocol deviation|14
51655|NCT01201967|196784|P2|Overall Study|Lost to Follow-up|5
51656|NCT01201967|196785|P1|Overall Study|Lost to Follow-up|6
51657|NCT01201915|196810|P3|Overall Study|Target Lesion Progression|0
51658|NCT01201915|196811|P2|Overall Study|Target Lesion Progression|3
51659|NCT01201915|196812|P1|Overall Study|Target Lesion Progression|0
51660|NCT01201915|196810|P3|Overall Study|Subject Decision|5
51661|NCT01201915|196811|P2|Overall Study|Subject Decision|3
51662|NCT01201915|196812|P1|Overall Study|Subject Decision|3
51663|NCT01201915|196810|P3|Overall Study|Physician Decision|0
51664|NCT01201915|196811|P2|Overall Study|Physician Decision|0
51665|NCT01201915|196812|P1|Overall Study|Physician Decision|3
51666|NCT01201915|196810|P3|Overall Study|Lost to Follow-up|0
51667|NCT01201915|196811|P2|Overall Study|Lost to Follow-up|4
51668|NCT01201915|196812|P1|Overall Study|Lost to Follow-up|0
51669|NCT01201915|196810|P3|Overall Study|Adverse Event|1
51670|NCT01201915|196811|P2|Overall Study|Adverse Event|1
51671|NCT01201915|196812|P1|Overall Study|Adverse Event|2
51672|NCT01201811|196823|P1|Overall Study|Physician Decision|1
51673|NCT01201811|196823|P1|Overall Study|Treatment Failure|2
51674|NCT01201811|196823|P1|Overall Study|Death|4
51675|NCT01201811|196823|P1|Overall Study|Withdrawal by Subject|3
51676|NCT01201811|196823|P1|Overall Study|Disease progression|3
51677|NCT01201811|196823|P1|Overall Study|Adverse Event|6
51678|NCT01201798|196845|P2|Overall Study|Treatment Failure|8
51679|NCT01201798|196846|P1|Overall Study|Treatment Failure|1
51680|NCT01201798|196845|P2|Overall Study|Protocol Violation|1
51681|NCT01201798|196846|P1|Overall Study|Protocol Violation|1
51682|NCT01201798|196845|P2|Overall Study|Noncompliance|0
51683|NCT01201798|196846|P1|Overall Study|Noncompliance|1
51684|NCT01201798|196845|P2|Overall Study|Decision Unrelated to an Adverse Event|1
51685|NCT01201798|196846|P1|Overall Study|Decision Unrelated to an Adverse Event|1
51686|NCT01201798|196845|P2|Overall Study|Lost to Follow-up|5
51687|NCT01201798|196846|P1|Overall Study|Lost to Follow-up|3
51688|NCT01201798|196845|P2|Overall Study|Adverse Event|0
51689|NCT01201798|196846|P1|Overall Study|Adverse Event|2
51690|NCT01201785|196870|P1|Overall Study|Lost to Follow-up|16
51691|NCT01201759|196887|P2|Visit 4 Crossover|Lost to Follow-up|1
51692|NCT01201759|196888|P1|Visit 4 Crossover|Lost to Follow-up|0
51693|NCT01201759|196887|P2|Visit 3 - Washout|Lost to Follow-up|0
51694|NCT01201759|196888|P1|Visit 3 - Washout|Lost to Follow-up|1
51695|NCT01201759|196887|P2|Visit 3 - Washout|Adverse Event|3
51696|NCT01201759|196888|P1|Visit 3 - Washout|Adverse Event|0
51697|NCT01201759|196887|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
51698|NCT01201759|196888|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
51699|NCT01201343|196904|P1|Overall Study|Randomized, not treated|3
51700|NCT01201343|196904|P1|Overall Study|Participant wrongly included in trial|1
51701|NCT01201343|196904|P1|Overall Study|Lack of Efficacy|2
51702|NCT01201343|196904|P1|Overall Study|Lost to Follow-up|2
51703|NCT01201343|196904|P1|Overall Study|Withdrawal by Subject|5
51704|NCT01201343|196904|P1|Overall Study|Adverse Event|6
51705|NCT01201317|196918|P3|Overall Study|Safety, possible history of tuberculosis|1
51706|NCT01201317|196919|P2|Overall Study|Safety, possible history of tuberculosis|0
51707|NCT01201317|196920|P1|Overall Study|Safety, possible history of tuberculosis|0
51708|NCT01201317|196918|P3|Overall Study|Lack of Efficacy|0
51709|NCT01201317|196919|P2|Overall Study|Lack of Efficacy|0
51710|NCT01201317|196920|P1|Overall Study|Lack of Efficacy|1
51711|NCT01201317|196918|P3|Overall Study|Decrease in renal function|0
51712|NCT01201317|196919|P2|Overall Study|Decrease in renal function|1
51713|NCT01201317|196920|P1|Overall Study|Decrease in renal function|0
51714|NCT01201317|196918|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
51715|NCT01201317|196919|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
51716|NCT01201317|196920|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
51717|NCT01201317|196918|P3|Overall Study|Study-specific withdrawal criteria|1
51718|NCT01201317|196919|P2|Overall Study|Study-specific withdrawal criteria|0
51719|NCT01201317|196920|P1|Overall Study|Study-specific withdrawal criteria|0
51720|NCT01201317|196918|P3|Overall Study|Death|0
51721|NCT01201317|196919|P2|Overall Study|Death|1
51722|NCT01201317|196920|P1|Overall Study|Death|0
51723|NCT01201317|196918|P3|Overall Study|Protocol Violation|1
51724|NCT01201317|196919|P2|Overall Study|Protocol Violation|1
51725|NCT01201317|196920|P1|Overall Study|Protocol Violation|0
51726|NCT01201317|196918|P3|Overall Study|Screen failure|0
51727|NCT01201317|196919|P2|Overall Study|Screen failure|1
51728|NCT01201317|196920|P1|Overall Study|Screen failure|1
51729|NCT01201317|196918|P3|Overall Study|Adverse Event|2
51730|NCT01201317|196919|P2|Overall Study|Adverse Event|2
51731|NCT01201317|196920|P1|Overall Study|Adverse Event|2
51732|NCT01201317|196918|P3|Overall Study|Withdrawal by Subject|3
51733|NCT01201317|196919|P2|Overall Study|Withdrawal by Subject|0
51734|NCT01201317|196920|P1|Overall Study|Withdrawal by Subject|5
51735|NCT01201265|196940|P1|Overall Study|Disease Progression|4
51736|NCT01201265|196940|P1|Overall Study|Withdrawal by Subject|7
51737|NCT01201265|196940|P1|Overall Study|Lost to Follow-up|10
51738|NCT01201265|196940|P1|Overall Study|Insufficient Therapeutic Response|3
51739|NCT01201265|196940|P1|Overall Study|Death|14
51740|NCT01200992|196954|P2|Overall Study|Randomized but not treated|0
51741|NCT01200992|196955|P1|Overall Study|Randomized but not treated|2
51742|NCT01200992|196954|P2|Overall Study|Study terminated early|41
51743|NCT01200992|196955|P1|Overall Study|Study terminated early|35
51744|NCT01200810|196967|P2|Overall Study|Sponsor stopped making study drug|3
51745|NCT01200810|196968|P1|Overall Study|Sponsor stopped making study drug|3
51746|NCT01200810|196967|P2|Overall Study|Withdrawal by Subject|2
51747|NCT01200810|196968|P1|Overall Study|Withdrawal by Subject|1
51748|NCT01200810|196967|P2|Overall Study|Physician Decision|0
51749|NCT01200810|196968|P1|Overall Study|Physician Decision|1
51750|NCT01200797|196986|P1|Overall Study|Disease Progression|13
51751|NCT01200797|196986|P1|Overall Study|Adverse Event|4
51752|NCT01200797|196986|P1|Overall Study|symptomatic deterioration|2
51753|NCT01200758|196996|P4|Stage 2|Ongoing Treatment Period|108
51754|NCT01200758|196997|P3|Stage 2|Ongoing Treatment Period|117
51755|NCT01200758|196998|P2|Stage 2|Ongoing Treatment Period|0
51756|NCT01200758|196999|P1|Stage 2|Ongoing Treatment Period|0
51757|NCT01200758|196996|P4|Stage 2|Death|4
51758|NCT01200758|196997|P3|Stage 2|Death|1
51759|NCT01200758|196998|P2|Stage 2|Death|0
51760|NCT01200758|196999|P1|Stage 2|Death|0
51761|NCT01200758|196996|P4|Stage 2|Protocol Violation|4
51762|NCT01200758|196997|P3|Stage 2|Protocol Violation|1
51763|NCT01200758|196998|P2|Stage 2|Protocol Violation|0
51764|NCT01200758|196999|P1|Stage 2|Protocol Violation|0
51765|NCT01200758|196996|P4|Stage 2|Lost to Follow-up|0
51766|NCT01200758|196997|P3|Stage 2|Lost to Follow-up|1
51767|NCT01200758|196998|P2|Stage 2|Lost to Follow-up|0
51768|NCT01200758|196999|P1|Stage 2|Lost to Follow-up|0
51769|NCT01200758|196996|P4|Stage 2|Withdrawal by Subject|1
51770|NCT01200758|196997|P3|Stage 2|Withdrawal by Subject|2
51771|NCT01200758|196998|P2|Stage 2|Withdrawal by Subject|0
51772|NCT01200758|196999|P1|Stage 2|Withdrawal by Subject|0
51773|NCT01200758|196996|P4|Stage 2|Adverse Event|2
51774|NCT01200758|196997|P3|Stage 2|Adverse Event|3
51775|NCT01200758|196998|P2|Stage 2|Adverse Event|0
51776|NCT01200758|196999|P1|Stage 2|Adverse Event|0
51777|NCT01200758|196996|P4|Stage 2|Investigator's Judgement|5
51778|NCT01200758|196997|P3|Stage 2|Investigator's Judgement|4
51779|NCT01200758|196998|P2|Stage 2|Investigator's Judgement|0
51780|NCT01200758|196999|P1|Stage 2|Investigator's Judgement|0
51781|NCT01200758|196996|P4|Stage 2|Lack of Efficacy|2
51782|NCT01200758|196997|P3|Stage 2|Lack of Efficacy|4
51783|NCT01200758|196998|P2|Stage 2|Lack of Efficacy|0
51784|NCT01200758|196999|P1|Stage 2|Lack of Efficacy|0
51785|NCT01200758|196996|P4|Stage 2|Disease Progression|16
51786|NCT01200758|196997|P3|Stage 2|Disease Progression|8
51787|NCT01200758|196998|P2|Stage 2|Disease Progression|0
51788|NCT01200758|196999|P1|Stage 2|Disease Progression|0
51789|NCT01200758|196996|P4|Stage I|Ongoing Treatment Period|0
51790|NCT01200758|196997|P3|Stage I|Ongoing Treatment Period|0
51791|NCT01200758|196998|P2|Stage I|Ongoing Treatment Period|32
51792|NCT01200758|196999|P1|Stage I|Ongoing Treatment Period|30
51793|NCT01200758|196996|P4|Stage I|Disease Progression|0
51794|NCT01200758|196997|P3|Stage I|Disease Progression|0
51795|NCT01200758|196998|P2|Stage I|Disease Progression|7
51796|NCT01200758|196999|P1|Stage I|Disease Progression|9
51797|NCT01200758|196996|P4|Stage I|Withdrawal by Subject|0
51798|NCT01200758|196997|P3|Stage I|Withdrawal by Subject|0
51799|NCT01200758|196998|P2|Stage I|Withdrawal by Subject|2
51800|NCT01200758|196999|P1|Stage I|Withdrawal by Subject|0
51801|NCT01200758|196996|P4|Stage I|Adverse Event|0
51802|NCT01200758|196997|P3|Stage I|Adverse Event|0
51803|NCT01200758|196998|P2|Stage I|Adverse Event|3
51804|NCT01200758|196999|P1|Stage I|Adverse Event|5
51805|NCT01200758|196996|P4|Stage I|Lack of Efficacy|0
51806|NCT01200758|196997|P3|Stage I|Lack of Efficacy|0
51807|NCT01200758|196998|P2|Stage I|Lack of Efficacy|0
51808|NCT01200758|196999|P1|Stage I|Lack of Efficacy|2
51809|NCT01200758|196996|P4|Stage I|Investigator's judgement|0
51810|NCT01200758|196997|P3|Stage I|Investigator's judgement|0
51811|NCT01200758|196998|P2|Stage I|Investigator's judgement|2
51812|NCT01200758|196999|P1|Stage I|Investigator's judgement|1
51813|NCT01200758|196996|P4|Stage I|Death|0
51814|NCT01200758|196997|P3|Stage I|Death|0
51815|NCT01200758|196998|P2|Stage I|Death|1
51816|NCT01200758|196999|P1|Stage I|Death|0
51817|NCT01200524|197061|P3|Overall Study|Non availability of study nurse|1
51818|NCT01200524|197062|P2|Overall Study|Non availability of study nurse|0
51819|NCT01200524|197063|P1|Overall Study|Non availability of study nurse|0
51820|NCT01200524|197061|P3|Overall Study|Adverse Event|0
51821|NCT01200524|197062|P2|Overall Study|Adverse Event|0
51822|NCT01200524|197063|P1|Overall Study|Adverse Event|1
51823|NCT01200524|197061|P3|Overall Study|Withdrawal by Subject|3
51824|NCT01200524|197062|P2|Overall Study|Withdrawal by Subject|1
51825|NCT01200524|197063|P1|Overall Study|Withdrawal by Subject|1
51826|NCT01200368|197113|P3|Toddler Dose|Adverse Event|1
51827|NCT01200368|197114|P2|Toddler Dose|Adverse Event|3
51828|NCT01200368|197115|P1|Toddler Dose|Adverse Event|0
51829|NCT01200368|197113|P3|After Infant Series|Unspecified|2
51830|NCT01200368|197114|P2|After Infant Series|Unspecified|2
51831|NCT01200368|197115|P1|After Infant Series|Unspecified|1
51832|NCT01200368|197113|P3|After Infant Series|Lost to Follow-up|0
51833|NCT01200368|197114|P2|After Infant Series|Lost to Follow-up|0
51834|NCT01200368|197115|P1|After Infant Series|Lost to Follow-up|1
51835|NCT01200368|197113|P3|After Infant Series|Withdrawal by Subject|4
51836|NCT01200368|197114|P2|After Infant Series|Withdrawal by Subject|8
51837|NCT01200368|197115|P1|After Infant Series|Withdrawal by Subject|10
51838|NCT01200368|197113|P3|After Infant Series|Adverse Event|3
51839|NCT01200368|197114|P2|After Infant Series|Adverse Event|6
51840|NCT01200368|197115|P1|After Infant Series|Adverse Event|6
51841|NCT01200368|197113|P3|Infant Series|Unspecified|0
51842|NCT01200368|197114|P2|Infant Series|Unspecified|0
51843|NCT01200368|197115|P1|Infant Series|Unspecified|1
51844|NCT01200368|197113|P3|Infant Series|Randomized, not vaccinated|1
51845|NCT01200368|197114|P2|Infant Series|Randomized, not vaccinated|1
51846|NCT01200368|197115|P1|Infant Series|Randomized, not vaccinated|0
51847|NCT01200368|197113|P3|Infant Series|Did not meet entrance criteria|0
51848|NCT01200368|197114|P2|Infant Series|Did not meet entrance criteria|1
51849|NCT01200368|197115|P1|Infant Series|Did not meet entrance criteria|0
51850|NCT01200368|197113|P3|Infant Series|Withdrawal by Subject|2
51851|NCT01200368|197114|P2|Infant Series|Withdrawal by Subject|2
51852|NCT01200368|197115|P1|Infant Series|Withdrawal by Subject|0
51853|NCT01200368|197113|P3|Infant Series|Adverse Event|3
51854|NCT01200368|197114|P2|Infant Series|Adverse Event|2
51855|NCT01200368|197115|P1|Infant Series|Adverse Event|2
51856|NCT01200342|197179|P1|Overall Study|Disease Progression|1
51857|NCT01200069|197190|P2|Overall Study|Withdrawal by Subject|1
51858|NCT01200069|197191|P1|Overall Study|Withdrawal by Subject|0
51859|NCT01199939|197260|P1|Overall Study|Reached a virologic endpoint|4
51860|NCT01199939|197260|P1|Overall Study|Lost to Follow-up|2
51861|NCT01199939|197260|P1|Overall Study|Protocol Violation|3
51862|NCT01199939|197260|P1|Overall Study|Adverse Event|4
51863|NCT01199861|197292|P2|Overall Study|Adverse Event|0
51864|NCT01199861|197293|P1|Overall Study|Adverse Event|1
51865|NCT01199861|197292|P2|Overall Study|Administrative problems|0
51866|NCT01199861|197293|P1|Overall Study|Administrative problems|1
51867|NCT01199705|197324|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
51868|NCT01199601|197356|P2|Overall Study|Insecurity prevented staff interviewing.|9
51869|NCT01199601|197357|P1|Overall Study|Insecurity prevented staff interviewing.|7
51870|NCT01199601|197356|P2|Overall Study|Withdrawal by Subject|3
51871|NCT01199601|197357|P1|Overall Study|Withdrawal by Subject|15
51872|NCT01199601|197356|P2|Overall Study|Lost to Follow-up|66
51873|NCT01199601|197357|P1|Overall Study|Lost to Follow-up|47
51874|NCT01199471|197367|P1|Overall Study|Physician Decision|1
51875|NCT01199471|197367|P1|Overall Study|Withdrawal by Subject|1
51876|NCT01199471|197367|P1|Overall Study|Protocol Violation|4
51877|NCT01199042|197393|P1|At Home (3 Months)|Lost to Follow-up|1
51878|NCT01199042|197393|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
51879|NCT01198977|197404|P2|Overall Study|Lost to Follow-up|0
51880|NCT01198977|197405|P1|Overall Study|Lost to Follow-up|1
51881|NCT01198873|197417|P2|Overall Study|Other than above|2
51882|NCT01198873|197418|P1|Overall Study|Other than above|4
51883|NCT01198873|197417|P2|Overall Study|Study closure|23
51884|NCT01198873|197418|P1|Overall Study|Study closure|29
51885|NCT01198873|197417|P2|Overall Study|Adverse Event|7
51886|NCT01198873|197418|P1|Overall Study|Adverse Event|4
51887|NCT01198795|197432|P1|Overall Study|Other Reason|4
51888|NCT01198795|197432|P1|Overall Study|Protocol Violation|2
51889|NCT01198795|197432|P1|Overall Study|Lack of Efficacy|5
51890|NCT01198795|197432|P1|Overall Study|Adverse Event|9
51891|NCT01198795|197432|P1|Overall Study|Lost to Follow-up|15
51892|NCT01198795|197432|P1|Overall Study|Withdrawal by Subject|17
51893|NCT01198795|197432|P1|Overall Study|Did not meet InclusionExclusion criteria|30
51894|NCT01198756|197449|P4|Overall Study|Lost to Follow-up|18
51895|NCT01198756|197450|P3|Overall Study|Lost to Follow-up|23
51896|NCT01198756|197451|P2|Overall Study|Lost to Follow-up|36
51897|NCT01198756|197452|P1|Overall Study|Lost to Follow-up|29
51898|NCT01198756|197449|P4|Overall Study|Withdrawal by Subject|5
51899|NCT01198756|197450|P3|Overall Study|Withdrawal by Subject|7
51900|NCT01198756|197451|P2|Overall Study|Withdrawal by Subject|4
51901|NCT01198756|197452|P1|Overall Study|Withdrawal by Subject|9
51902|NCT01198756|197449|P4|Overall Study|Protocol Violation|2
51903|NCT01198756|197450|P3|Overall Study|Protocol Violation|0
51904|NCT01198756|197451|P2|Overall Study|Protocol Violation|0
51905|NCT01198756|197452|P1|Overall Study|Protocol Violation|0
51906|NCT01198756|197449|P4|Overall Study|Adverse Event|1
51907|NCT01198756|197450|P3|Overall Study|Adverse Event|0
51908|NCT01198756|197451|P2|Overall Study|Adverse Event|0
51909|NCT01198756|197452|P1|Overall Study|Adverse Event|0
51910|NCT01198600|197563|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
51911|NCT01198600|197564|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
51912|NCT01198600|197565|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
51913|NCT01198600|197566|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
51914|NCT01198600|197563|P4|Phase 2: 56 Days of Wear|Relocation|0
51915|NCT01198600|197564|P3|Phase 2: 56 Days of Wear|Relocation|2
51916|NCT01198600|197565|P2|Phase 2: 56 Days of Wear|Relocation|0
51917|NCT01198600|197566|P1|Phase 2: 56 Days of Wear|Relocation|0
51918|NCT01198600|197563|P4|Phase 2: 56 Days of Wear|Inconvenience|0
51919|NCT01198600|197564|P3|Phase 2: 56 Days of Wear|Inconvenience|2
51920|NCT01198600|197565|P2|Phase 2: 56 Days of Wear|Inconvenience|0
51921|NCT01198600|197566|P1|Phase 2: 56 Days of Wear|Inconvenience|0
51922|NCT01198600|197563|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
51923|NCT01198600|197564|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
51924|NCT01198600|197565|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
51925|NCT01198600|197566|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
51926|NCT01198600|197563|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
51927|NCT01198600|197564|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
51928|NCT01198600|197565|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
51929|NCT01198600|197566|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
51930|NCT01198600|197563|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
51931|NCT01198600|197564|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
51932|NCT01198600|197565|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
51933|NCT01198600|197566|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
51934|NCT01198600|197563|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
51935|NCT01198600|197564|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
51936|NCT01198600|197565|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
51937|NCT01198600|197566|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
51938|NCT01198574|197592|P4|Overall Study|Resigned from schools|4
51939|NCT01198574|197593|P3|Overall Study|Resigned from schools|1
51940|NCT01198574|197594|P2|Overall Study|Resigned from schools|1
51941|NCT01198574|197595|P1|Overall Study|Resigned from schools|4
51942|NCT01198548|197613|P1|Overall Study|Administrative Decision|1
51943|NCT01198548|197613|P1|Overall Study|Disease Progression|9
51944|NCT01198509|197628|P6|Overall Study|Withdrawal by Subject|0
51945|NCT01198509|197629|P5|Overall Study|Withdrawal by Subject|0
51946|NCT01198509|197630|P4|Overall Study|Withdrawal by Subject|0
51947|NCT01198509|197631|P3|Overall Study|Withdrawal by Subject|0
51948|NCT01198509|197632|P2|Overall Study|Withdrawal by Subject|0
51949|NCT01198509|197633|P1|Overall Study|Withdrawal by Subject|1
51950|NCT01198275|197709|P2|Overall Study|spontaneous return to sinus rhythm|2
51951|NCT01198275|197710|P1|Overall Study|spontaneous return to sinus rhythm|4
51952|NCT01198275|197709|P2|Overall Study|Adverse Event|3
51953|NCT01198275|197710|P1|Overall Study|Adverse Event|2
51954|NCT01197911|197719|P3|Overall Study|Adverse Event|1
51955|NCT01197911|197720|P2|Overall Study|Adverse Event|0
51956|NCT01197911|197721|P1|Overall Study|Adverse Event|0
51957|NCT01197794|197836|P7|Overall Study|Other|4
51958|NCT01197794|197837|P6|Overall Study|Other|2
51959|NCT01197794|197838|P5|Overall Study|Other|2
51960|NCT01197794|197839|P4|Overall Study|Other|0
51961|NCT01197794|197840|P3|Overall Study|Other|3
51962|NCT01197794|197841|P2|Overall Study|Other|1
51963|NCT01197794|197842|P1|Overall Study|Other|1
51964|NCT01197794|197836|P7|Overall Study|Lost to Follow-up|0
51965|NCT01197794|197837|P6|Overall Study|Lost to Follow-up|1
51966|NCT01197794|197838|P5|Overall Study|Lost to Follow-up|0
51967|NCT01197794|197839|P4|Overall Study|Lost to Follow-up|1
51968|NCT01197794|197840|P3|Overall Study|Lost to Follow-up|0
51969|NCT01197794|197841|P2|Overall Study|Lost to Follow-up|1
51970|NCT01197794|197842|P1|Overall Study|Lost to Follow-up|1
51971|NCT01197794|197836|P7|Overall Study|Withdrawal by Subject|6
51972|NCT01197794|197837|P6|Overall Study|Withdrawal by Subject|5
51973|NCT01197794|197838|P5|Overall Study|Withdrawal by Subject|1
51974|NCT01197794|197839|P4|Overall Study|Withdrawal by Subject|1
51975|NCT01197794|197840|P3|Overall Study|Withdrawal by Subject|4
51976|NCT01197794|197841|P2|Overall Study|Withdrawal by Subject|3
51977|NCT01197794|197842|P1|Overall Study|Withdrawal by Subject|3
51978|NCT01197794|197836|P7|Overall Study|Eligibility criteria not fulfilled|6
51979|NCT01197794|197837|P6|Overall Study|Eligibility criteria not fulfilled|9
51980|NCT01197794|197838|P5|Overall Study|Eligibility criteria not fulfilled|5
51981|NCT01197794|197839|P4|Overall Study|Eligibility criteria not fulfilled|5
51982|NCT01197794|197840|P3|Overall Study|Eligibility criteria not fulfilled|2
51983|NCT01197794|197841|P2|Overall Study|Eligibility criteria not fulfilled|8
51984|NCT01197794|197842|P1|Overall Study|Eligibility criteria not fulfilled|5
51985|NCT01197794|197836|P7|Overall Study|Development of study withdrawal criteria|1
51986|NCT01197794|197837|P6|Overall Study|Development of study withdrawal criteria|0
51987|NCT01197794|197838|P5|Overall Study|Development of study withdrawal criteria|0
51988|NCT01197794|197839|P4|Overall Study|Development of study withdrawal criteria|1
51989|NCT01197794|197840|P3|Overall Study|Development of study withdrawal criteria|0
51990|NCT01197794|197841|P2|Overall Study|Development of study withdrawal criteria|0
51991|NCT01197794|197842|P1|Overall Study|Development of study withdrawal criteria|3
51992|NCT01197794|197836|P7|Overall Study|Protocol Violation|1
51993|NCT01197794|197837|P6|Overall Study|Protocol Violation|0
51994|NCT01197794|197838|P5|Overall Study|Protocol Violation|2
51995|NCT01197794|197839|P4|Overall Study|Protocol Violation|0
51996|NCT01197794|197840|P3|Overall Study|Protocol Violation|0
51997|NCT01197794|197841|P2|Overall Study|Protocol Violation|0
51998|NCT01197794|197842|P1|Overall Study|Protocol Violation|0
51999|NCT01197794|197836|P7|Overall Study|Adverse Event|3
52000|NCT01197794|197837|P6|Overall Study|Adverse Event|2
52001|NCT01197794|197838|P5|Overall Study|Adverse Event|4
52002|NCT01197794|197839|P4|Overall Study|Adverse Event|4
52003|NCT01197794|197840|P3|Overall Study|Adverse Event|4
52004|NCT01197794|197841|P2|Overall Study|Adverse Event|2
52005|NCT01197794|197842|P1|Overall Study|Adverse Event|3
52006|NCT01197755|197924|P3|Overall Study|eg, change in circumstances|2
52007|NCT01197755|197925|P2|Overall Study|eg, change in circumstances|3
52008|NCT01197755|197926|P1|Overall Study|eg, change in circumstances|7
52009|NCT01197755|197924|P3|Overall Study|Lost to Follow-up|1
52010|NCT01197755|197925|P2|Overall Study|Lost to Follow-up|0
52011|NCT01197755|197926|P1|Overall Study|Lost to Follow-up|0
52012|NCT01197755|197924|P3|Overall Study|Withdrawal by Subject|0
52013|NCT01197755|197925|P2|Overall Study|Withdrawal by Subject|0
52014|NCT01197755|197926|P1|Overall Study|Withdrawal by Subject|1
52015|NCT01197755|197924|P3|Overall Study|Severe non-compliance to the protocol|2
52016|NCT01197755|197925|P2|Overall Study|Severe non-compliance to the protocol|1
52017|NCT01197755|197926|P1|Overall Study|Severe non-compliance to the protocol|2
52018|NCT01197755|197924|P3|Overall Study|Lack of therapeutic response|4
52019|NCT01197755|197925|P2|Overall Study|Lack of therapeutic response|7
52020|NCT01197755|197926|P1|Overall Study|Lack of therapeutic response|0
52021|NCT01197755|197924|P3|Overall Study|Entered the long-term extension study|35
52022|NCT01197755|197925|P2|Overall Study|Entered the long-term extension study|21
52023|NCT01197755|197926|P1|Overall Study|Entered the long-term extension study|18
52024|NCT01197755|197924|P3|Overall Study|Study-specific discontinuation criteria|0
52025|NCT01197755|197925|P2|Overall Study|Study-specific discontinuation criteria|1
52026|NCT01197755|197926|P1|Overall Study|Study-specific discontinuation criteria|2
52027|NCT01197755|197924|P3|Overall Study|Adverse Event|10
52028|NCT01197755|197925|P2|Overall Study|Adverse Event|10
52029|NCT01197755|197926|P1|Overall Study|Adverse Event|8
52030|NCT01197560|197968|P2|Overall Study|Missing|1
52031|NCT01197560|197969|P1|Overall Study|Missing|0
52032|NCT01197560|197968|P2|Overall Study|Elected to discontinue before cycle end|2
52033|NCT01197560|197969|P1|Overall Study|Elected to discontinue before cycle end|0
52034|NCT01197560|197968|P2|Overall Study|Proceeded to transplant|1
52035|NCT01197560|197969|P1|Overall Study|Proceeded to transplant|1
52036|NCT01197560|197968|P2|Overall Study|Disease progression|35
52037|NCT01197560|197969|P1|Overall Study|Disease progression|39
52038|NCT01197560|197968|P2|Overall Study|Withdrawal by Subject|1
52039|NCT01197560|197969|P1|Overall Study|Withdrawal by Subject|1
52040|NCT01197560|197968|P2|Overall Study|Death|5
52041|NCT01197560|197969|P1|Overall Study|Death|1
52042|NCT01197560|197968|P2|Overall Study|Adverse Event|8
52043|NCT01197560|197969|P1|Overall Study|Adverse Event|4
52044|NCT01197534|197996|P3|Overall Study|Adverse Event|24
52045|NCT01197534|197997|P2|Overall Study|Adverse Event|36
52046|NCT01197534|197998|P1|Overall Study|Adverse Event|35
52047|NCT01197534|197996|P3|Overall Study|Lost to Follow-up|2
52048|NCT01197534|197997|P2|Overall Study|Lost to Follow-up|4
52049|NCT01197534|197998|P1|Overall Study|Lost to Follow-up|1
52050|NCT01197534|197996|P3|Overall Study|Dev. of study specific discont. criteria|2
52051|NCT01197534|197997|P2|Overall Study|Dev. of study specific discont. criteria|6
52052|NCT01197534|197998|P1|Overall Study|Dev. of study specific discont. criteria|13
52053|NCT01197534|197996|P3|Overall Study|Lack of therapeutic response|9
52054|NCT01197534|197997|P2|Overall Study|Lack of therapeutic response|4
52055|NCT01197534|197998|P1|Overall Study|Lack of therapeutic response|9
52056|NCT01197534|197996|P3|Overall Study|Severe non-compliance to protocol|1
52057|NCT01197534|197997|P2|Overall Study|Severe non-compliance to protocol|4
52058|NCT01197534|197998|P1|Overall Study|Severe non-compliance to protocol|3
52059|NCT01197534|197996|P3|Overall Study|Enrolment in long term extension|119
52060|NCT01197534|197997|P2|Overall Study|Enrolment in long term extension|66
52061|NCT01197534|197998|P1|Overall Study|Enrolment in long term extension|57
52062|NCT01197534|197996|P3|Overall Study|Not reported|16
52063|NCT01197534|197997|P2|Overall Study|Not reported|10
52064|NCT01197534|197998|P1|Overall Study|Not reported|16
52065|NCT01197521|198042|P3|Overall Study|Adverse Event|24
52066|NCT01197521|198043|P2|Overall Study|Adverse Event|28
52067|NCT01197521|198044|P1|Overall Study|Adverse Event|25
52068|NCT01197521|198042|P3|Overall Study|Lost to Follow-up|2
52069|NCT01197521|198043|P2|Overall Study|Lost to Follow-up|2
52070|NCT01197521|198044|P1|Overall Study|Lost to Follow-up|3
52071|NCT01197521|198042|P3|Overall Study|Dev. of study specific discont. criteria|2
52072|NCT01197521|198043|P2|Overall Study|Dev. of study specific discont. criteria|16
52073|NCT01197521|198044|P1|Overall Study|Dev. of study specific discont. criteria|6
52074|NCT01197521|198042|P3|Overall Study|Lack of therapeutic response|4
52075|NCT01197521|198043|P2|Overall Study|Lack of therapeutic response|3
52076|NCT01197521|198044|P1|Overall Study|Lack of therapeutic response|2
52077|NCT01197521|198042|P3|Overall Study|Severe non-compliance to protocol|3
52078|NCT01197521|198043|P2|Overall Study|Severe non-compliance to protocol|3
52079|NCT01197521|198044|P1|Overall Study|Severe non-compliance to protocol|1
52080|NCT01197521|198042|P3|Overall Study|Enrolment in long term extension|87
52081|NCT01197521|198043|P2|Overall Study|Enrolment in long term extension|36
52082|NCT01197521|198044|P1|Overall Study|Enrolment in long term extension|42
52083|NCT01197521|198042|P3|Overall Study|Not reported|21
52084|NCT01197521|198043|P2|Overall Study|Not reported|25
52085|NCT01197521|198044|P1|Overall Study|Not reported|24
52086|NCT01197508|198089|P4|Overall Study|Not specified|2
52087|NCT01197508|198090|P3|Overall Study|Not specified|2
52088|NCT01197508|198091|P2|Overall Study|Not specified|3
52089|NCT01197508|198092|P1|Overall Study|Not specified|2
52090|NCT01197508|198089|P4|Overall Study|Lost to Follow-up|0
52091|NCT01197508|198090|P3|Overall Study|Lost to Follow-up|2
52092|NCT01197508|198091|P2|Overall Study|Lost to Follow-up|1
52093|NCT01197508|198092|P1|Overall Study|Lost to Follow-up|1
52094|NCT01197508|198089|P4|Overall Study|Study-specific withdrawal criteria|2
52095|NCT01197508|198090|P3|Overall Study|Study-specific withdrawal criteria|1
52096|NCT01197508|198091|P2|Overall Study|Study-specific withdrawal criteria|0
52097|NCT01197508|198092|P1|Overall Study|Study-specific withdrawal criteria|0
52098|NCT01197508|198089|P4|Overall Study|Lack of Efficacy|1
52099|NCT01197508|198090|P3|Overall Study|Lack of Efficacy|2
52100|NCT01197508|198091|P2|Overall Study|Lack of Efficacy|2
52101|NCT01197508|198092|P1|Overall Study|Lack of Efficacy|1
52102|NCT01197508|198089|P4|Overall Study|Condition under investigation worsened|1
52103|NCT01197508|198090|P3|Overall Study|Condition under investigation worsened|1
52104|NCT01197508|198091|P2|Overall Study|Condition under investigation worsened|1
52105|NCT01197508|198092|P1|Overall Study|Condition under investigation worsened|1
52106|NCT01197508|198089|P4|Overall Study|Severe non-compliance to protocol|3
52107|NCT01197508|198090|P3|Overall Study|Severe non-compliance to protocol|1
52108|NCT01197508|198091|P2|Overall Study|Severe non-compliance to protocol|3
52109|NCT01197508|198092|P1|Overall Study|Severe non-compliance to protocol|0
52110|NCT01197508|198089|P4|Overall Study|Adverse Event|3
52111|NCT01197508|198090|P3|Overall Study|Adverse Event|23
52112|NCT01197508|198091|P2|Overall Study|Adverse Event|13
52113|NCT01197508|198092|P1|Overall Study|Adverse Event|10
52114|NCT01197508|198089|P4|Overall Study|Eligiblity criteria not fulfilled|0
52115|NCT01197508|198090|P3|Overall Study|Eligiblity criteria not fulfilled|2
52116|NCT01197508|198091|P2|Overall Study|Eligiblity criteria not fulfilled|0
52117|NCT01197508|198092|P1|Overall Study|Eligiblity criteria not fulfilled|0
52118|NCT01197508|198089|P4|Overall Study|Withdrawal by Subject|4
52119|NCT01197508|198090|P3|Overall Study|Withdrawal by Subject|15
52120|NCT01197508|198091|P2|Overall Study|Withdrawal by Subject|7
52121|NCT01197508|198092|P1|Overall Study|Withdrawal by Subject|8
52122|NCT01197417|198202|P2|Overall Study|No 25-hour magnesium level|2
52123|NCT01197417|198203|P1|Overall Study|No 25-hour magnesium level|0
52124|NCT01197417|198202|P2|Overall Study|Found to be ineligible|5
52125|NCT01197417|198203|P1|Overall Study|Found to be ineligible|2
52126|NCT01197417|198202|P2|Overall Study|Hypotension|2
52127|NCT01197417|198203|P1|Overall Study|Hypotension|1
52128|NCT01197417|198202|P2|Overall Study|Not consented in time to receive drug|1
52129|NCT01197417|198203|P1|Overall Study|Not consented in time to receive drug|0
52130|NCT01197417|198202|P2|Overall Study|Subject transferred to intensive care|1
52131|NCT01197417|198203|P1|Overall Study|Subject transferred to intensive care|0
52132|NCT01197417|198202|P2|Overall Study|Site miscommunication|1
52133|NCT01197417|198203|P1|Overall Study|Site miscommunication|0
52134|NCT01197417|198202|P2|Overall Study|Withdrawal by Subject|4
52135|NCT01197417|198203|P1|Overall Study|Withdrawal by Subject|2
52136|NCT01197417|198202|P2|Overall Study|Physician Decision|2
52137|NCT01197417|198203|P1|Overall Study|Physician Decision|3
52138|NCT01196988|198236|P4|Overall Study|Unspecified|0
52139|NCT01196988|198237|P3|Overall Study|Unspecified|0
52140|NCT01196988|198238|P2|Overall Study|Unspecified|0
52141|NCT01196988|198239|P1|Overall Study|Unspecified|2
52142|NCT01196988|198236|P4|Overall Study|Lost to Follow-up|1
52143|NCT01196988|198237|P3|Overall Study|Lost to Follow-up|21
52144|NCT01196988|198238|P2|Overall Study|Lost to Follow-up|29
52145|NCT01196988|198239|P1|Overall Study|Lost to Follow-up|16
52146|NCT01196988|198236|P4|Overall Study|Withdrawal by Subject|0
52147|NCT01196988|198237|P3|Overall Study|Withdrawal by Subject|4
52148|NCT01196988|198238|P2|Overall Study|Withdrawal by Subject|1
52149|NCT01196988|198239|P1|Overall Study|Withdrawal by Subject|5
52150|NCT01196988|198236|P4|Overall Study|Adverse Event|0
52151|NCT01196988|198237|P3|Overall Study|Adverse Event|0
52152|NCT01196988|198238|P2|Overall Study|Adverse Event|2
52153|NCT01196988|198239|P1|Overall Study|Adverse Event|1
52154|NCT01196975|198333|P5|Overall Study|Lost to Follow-up|11
52155|NCT01196975|198334|P4|Overall Study|Lost to Follow-up|5
52156|NCT01196975|198335|P3|Overall Study|Lost to Follow-up|5
52157|NCT01196975|198336|P2|Overall Study|Lost to Follow-up|6
52158|NCT01196975|198337|P1|Overall Study|Lost to Follow-up|11
52159|NCT01196975|198333|P5|Overall Study|Withdrawal by Subject|0
52160|NCT01196975|198334|P4|Overall Study|Withdrawal by Subject|1
52161|NCT01196975|198335|P3|Overall Study|Withdrawal by Subject|0
52162|NCT01196975|198336|P2|Overall Study|Withdrawal by Subject|1
52163|NCT01196975|198337|P1|Overall Study|Withdrawal by Subject|2
52164|NCT01196975|198333|P5|Overall Study|Adverse Event|2
52165|NCT01196975|198334|P4|Overall Study|Adverse Event|0
52166|NCT01196975|198335|P3|Overall Study|Adverse Event|0
52167|NCT01196975|198336|P2|Overall Study|Adverse Event|2
52168|NCT01196975|198337|P1|Overall Study|Adverse Event|2
52169|NCT01196741|198475|P2|Overall Study|Protocol Violation|1
52170|NCT01196741|198476|P1|Overall Study|Protocol Violation|2
52171|NCT01196741|198475|P2|Overall Study|Other|2
52172|NCT01196741|198476|P1|Overall Study|Other|3
52173|NCT01196741|198475|P2|Overall Study|Other reason|3
52174|NCT01196741|198476|P1|Overall Study|Other reason|3
52175|NCT01196741|198475|P2|Overall Study|Withdrawal by Subject|0
52176|NCT01196741|198476|P1|Overall Study|Withdrawal by Subject|3
52177|NCT01196741|198475|P2|Overall Study|Dose limiting Adverse Event|1
52178|NCT01196741|198476|P1|Overall Study|Dose limiting Adverse Event|2
52179|NCT01196741|198475|P2|Overall Study|Serious Adverse Event|1
52180|NCT01196741|198476|P1|Overall Study|Serious Adverse Event|3
52181|NCT01196741|198475|P2|Overall Study|Adverse Event|6
52182|NCT01196741|198476|P1|Overall Study|Adverse Event|10
52183|NCT01196741|198475|P2|Overall Study|Disease progression|14
52184|NCT01196741|198476|P1|Overall Study|Disease progression|34
52185|NCT01196104|198502|P2|Overall Study|Various|1
52186|NCT01196104|198503|P1|Overall Study|Various|0
52187|NCT01196104|198502|P2|Overall Study|Withdrawal by Subject|3
52188|NCT01196104|198503|P1|Overall Study|Withdrawal by Subject|3
52189|NCT01196104|198502|P2|Overall Study|Physician Decision|1
52190|NCT01196104|198503|P1|Overall Study|Physician Decision|0
52191|NCT01196104|198502|P2|Overall Study|Lost to Follow-up|0
52192|NCT01196104|198503|P1|Overall Study|Lost to Follow-up|1
52193|NCT01196078|198545|P2|Overall Study|Death|4
52194|NCT01196078|198546|P1|Overall Study|Death|6
52195|NCT01196078|198545|P2|Overall Study|Lost to Follow-up|0
52196|NCT01196078|198546|P1|Overall Study|Lost to Follow-up|1
52197|NCT01196078|198545|P2|Overall Study|Lack of Efficacy|23
52198|NCT01196078|198546|P1|Overall Study|Lack of Efficacy|17
52199|NCT01196078|198545|P2|Overall Study|Protocol Violation|1
52200|NCT01196078|198546|P1|Overall Study|Protocol Violation|2
52201|NCT01196078|198545|P2|Overall Study|Adverse Event|4
52202|NCT01196078|198546|P1|Overall Study|Adverse Event|4
52203|NCT01196078|198545|P2|Overall Study|Withdrawal by Subject|5
52204|NCT01196078|198546|P1|Overall Study|Withdrawal by Subject|3
52205|NCT01196052|198574|P1|Overall Study|Withdrawal by Subject|6
52206|NCT01196052|198574|P1|Overall Study|Reason not Specified|5
52207|NCT01196052|198574|P1|Overall Study|Noncompliance to Protocol Requirements|2
52208|NCT01196052|198574|P1|Overall Study|Lost to Follow-up|1
52209|NCT01196052|198574|P1|Overall Study|Adverse Event|9
52210|NCT01196026|198591|P6|Overall Study|Unspecified|0
52211|NCT01196026|198592|P5|Overall Study|Unspecified|0
52212|NCT01196026|198593|P4|Overall Study|Unspecified|0
52213|NCT01196026|198594|P3|Overall Study|Unspecified|0
52214|NCT01196026|198595|P2|Overall Study|Unspecified|1
52215|NCT01196026|198596|P1|Overall Study|Unspecified|0
52216|NCT01196026|198591|P6|Overall Study|Lost to Follow-up|0
52217|NCT01196026|198592|P5|Overall Study|Lost to Follow-up|1
52218|NCT01196026|198593|P4|Overall Study|Lost to Follow-up|0
52219|NCT01196026|198594|P3|Overall Study|Lost to Follow-up|0
52220|NCT01196026|198595|P2|Overall Study|Lost to Follow-up|3
52221|NCT01196026|198596|P1|Overall Study|Lost to Follow-up|0
52222|NCT01196026|198591|P6|Overall Study|Withdrawal by Subject|0
52223|NCT01196026|198592|P5|Overall Study|Withdrawal by Subject|0
52224|NCT01196026|198593|P4|Overall Study|Withdrawal by Subject|0
52225|NCT01196026|198594|P3|Overall Study|Withdrawal by Subject|0
52226|NCT01196026|198595|P2|Overall Study|Withdrawal by Subject|4
52227|NCT01196026|198596|P1|Overall Study|Withdrawal by Subject|1
52228|NCT01195948|198832|P3|Overall Study|Lost to Follow-up|2
52229|NCT01195948|198833|P2|Overall Study|Lost to Follow-up|1
52230|NCT01195948|198834|P1|Overall Study|Lost to Follow-up|0
52231|NCT01195844|198866|P1|Overall Study|Fecal sample not collected|40
52232|NCT01195831|198883|P2|Overall Study|Protocol Violation|2
52233|NCT01195831|198884|P1|Overall Study|Protocol Violation|0
52234|NCT01195831|198883|P2|Overall Study|Adverse Event|2
52235|NCT01195831|198884|P1|Overall Study|Adverse Event|4
52236|NCT01195831|198883|P2|Overall Study|Withdrawal by Subject|2
52237|NCT01195831|198884|P1|Overall Study|Withdrawal by Subject|2
52238|NCT01195831|198883|P2|Overall Study|Lost to Follow-up|4
52239|NCT01195831|198884|P1|Overall Study|Lost to Follow-up|2
52240|NCT01195675|199124|P1|Overall Study|Withdrawal by Subject|2
52241|NCT01195675|199124|P1|Overall Study|Adverse Event|1
52242|NCT01195662|199157|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
52243|NCT01195662|199158|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
52244|NCT01195662|199159|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
52245|NCT01195662|199157|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
52246|NCT01195662|199158|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
52247|NCT01195662|199159|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
52248|NCT01195662|199157|P3|Double Blind Treatment Period|Missing disposition information|1
52249|NCT01195662|199158|P2|Double Blind Treatment Period|Missing disposition information|1
52250|NCT01195662|199159|P1|Double Blind Treatment Period|Missing disposition information|0
52251|NCT01195662|199157|P3|Double Blind Treatment Period|Non-specified|0
52252|NCT01195662|199158|P2|Double Blind Treatment Period|Non-specified|0
52253|NCT01195662|199159|P1|Double Blind Treatment Period|Non-specified|3
52254|NCT01195662|199157|P3|Double Blind Treatment Period|Lack of Efficacy|0
52255|NCT01195662|199158|P2|Double Blind Treatment Period|Lack of Efficacy|0
52256|NCT01195662|199159|P1|Double Blind Treatment Period|Lack of Efficacy|2
52257|NCT01195662|199157|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
52258|NCT01195662|199158|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
52259|NCT01195662|199159|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
52260|NCT01195662|199157|P3|Double Blind Treatment Period|Requested discontinue treatment|1
52261|NCT01195662|199158|P2|Double Blind Treatment Period|Requested discontinue treatment|0
52262|NCT01195662|199159|P1|Double Blind Treatment Period|Requested discontinue treatment|1
52263|NCT01195662|199157|P3|Double Blind Treatment Period|Administrative reason|1
52264|NCT01195662|199158|P2|Double Blind Treatment Period|Administrative reason|1
52265|NCT01195662|199159|P1|Double Blind Treatment Period|Administrative reason|2
52266|NCT01195662|199157|P3|Double Blind Treatment Period|Lost to Follow-up|3
52267|NCT01195662|199158|P2|Double Blind Treatment Period|Lost to Follow-up|2
52268|NCT01195662|199159|P1|Double Blind Treatment Period|Lost to Follow-up|3
52269|NCT01195662|199157|P3|Double Blind Treatment Period|Withdrawal by Subject|4
52270|NCT01195662|199158|P2|Double Blind Treatment Period|Withdrawal by Subject|4
52271|NCT01195662|199159|P1|Double Blind Treatment Period|Withdrawal by Subject|6
52272|NCT01195662|199157|P3|Double Blind Treatment Period|Adverse Event|2
52273|NCT01195662|199158|P2|Double Blind Treatment Period|Adverse Event|1
52274|NCT01195662|199159|P1|Double Blind Treatment Period|Adverse Event|4
52275|NCT01195636|199189|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
52276|NCT01195636|199190|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
52277|NCT01195636|199189|P2|Second Intervention (3 Weeks)|Adverse Event|1
52278|NCT01195636|199190|P1|Second Intervention (3 Weeks)|Adverse Event|1
52279|NCT01195636|199189|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
52280|NCT01195636|199190|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
52281|NCT01195636|199189|P2|Washout Period (2 Weeks)|Adverse Event|1
52282|NCT01195636|199190|P1|Washout Period (2 Weeks)|Adverse Event|1
52283|NCT01195636|199189|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
52284|NCT01195636|199190|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
52285|NCT01195636|199189|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
52286|NCT01195636|199190|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
52287|NCT01195636|199189|P2|First Intervention (3 Weeks)|Protocol Violation|0
52288|NCT01195636|199190|P1|First Intervention (3 Weeks)|Protocol Violation|1
52289|NCT01195636|199189|P2|First Intervention (3 Weeks)|Adverse Event|3
52290|NCT01195636|199190|P1|First Intervention (3 Weeks)|Adverse Event|2
52291|NCT01195623|199216|P2|Overall Study|Lost to Follow-up|37
52292|NCT01195623|199217|P1|Overall Study|Lost to Follow-up|35
52293|NCT01195415|199251|P1|Overall Study|No repeat biopsy due to progression|2
52294|NCT01195363|199258|P2|Overall Study|incarceration|0
52295|NCT01195363|199259|P1|Overall Study|incarceration|1
52296|NCT01195363|199258|P2|Overall Study|Lack of Efficacy|4
52297|NCT01195363|199259|P1|Overall Study|Lack of Efficacy|0
52298|NCT01195363|199258|P2|Overall Study|Adverse Event|1
52299|NCT01195363|199259|P1|Overall Study|Adverse Event|3
52300|NCT01195363|199258|P2|Overall Study|Lost to Follow-up|4
52301|NCT01195363|199259|P1|Overall Study|Lost to Follow-up|7
52302|NCT01195272|199265|P1|Overall Study|Lack of Efficacy|3
52303|NCT01195272|199265|P1|Overall Study|Adverse Event|1
52304|NCT01195103|199294|P3|Overall Study|Withdrawal by Subject|0
52305|NCT01195103|199295|P2|Overall Study|Withdrawal by Subject|0
52306|NCT01195103|199296|P1|Overall Study|Withdrawal by Subject|1
52307|NCT01195090|199306|P2|Overall Study|Protocol Violation|4
52308|NCT01195090|199307|P1|Overall Study|Protocol Violation|3
52309|NCT01195090|199306|P2|Overall Study|Lost to Follow-up|2
52310|NCT01195090|199307|P1|Overall Study|Lost to Follow-up|2
52311|NCT01195090|199306|P2|Overall Study|Adverse Event|2
52312|NCT01195090|199307|P1|Overall Study|Adverse Event|1
52313|NCT01194999|199376|P1|Overall Study|Lost to Follow-up|17
52314|NCT01194973|199380|P1|Treatment Period (26 Weeks) and Maintena|Pregnancy|1
52315|NCT01194973|199380|P1|Treatment Period (26 Weeks) and Maintena|Lack of Efficacy|1
52316|NCT01194973|199380|P1|Treatment Period (26 Weeks) and Maintena|Adverse Event|1
52317|NCT01194973|199380|P1|Screening Period|Screen Failure|3
52318|NCT01194869|199400|P1|Overall Study|Toxicity|2
52319|NCT01194869|199400|P1|Overall Study|Disease Progression|2
52320|NCT01194830|199408|P2|Overall Study|Other Reason|8
52321|NCT01194830|199409|P1|Overall Study|Other Reason|12
52322|NCT01194830|199408|P2|Overall Study|Non-compliance issues|4
52323|NCT01194830|199409|P1|Overall Study|Non-compliance issues|4
52324|NCT01194830|199408|P2|Overall Study|Lack of Efficacy|1
52325|NCT01194830|199409|P1|Overall Study|Lack of Efficacy|1
52326|NCT01194830|199408|P2|Overall Study|Withdrawal by Subject|1
52327|NCT01194830|199409|P1|Overall Study|Withdrawal by Subject|2
52328|NCT01194830|199408|P2|Overall Study|Lost to Follow-up|7
52329|NCT01194830|199409|P1|Overall Study|Lost to Follow-up|9
52330|NCT01194830|199408|P2|Overall Study|Protocol Violation|4
52331|NCT01194830|199409|P1|Overall Study|Protocol Violation|5
52332|NCT01194830|199408|P2|Overall Study|Adverse Event|2
52333|NCT01194830|199409|P1|Overall Study|Adverse Event|3
52334|NCT01194154|199433|P2|Overall Study|Did not receive study medication|4
52335|NCT01194154|199434|P1|Overall Study|Did not receive study medication|2
52336|NCT01194154|199433|P2|Overall Study|Unspecified|0
52337|NCT01194154|199434|P1|Overall Study|Unspecified|4
52338|NCT01194154|199433|P2|Overall Study|Treatment with prohibited medication|5
52339|NCT01194154|199434|P1|Overall Study|Treatment with prohibited medication|4
52340|NCT01194154|199433|P2|Overall Study|Skipping of CERA treatment at two visits|0
52341|NCT01194154|199434|P1|Overall Study|Skipping of CERA treatment at two visits|3
52342|NCT01194154|199433|P2|Overall Study|Hemoglobin increase|3
52343|NCT01194154|199434|P1|Overall Study|Hemoglobin increase|12
52344|NCT01194154|199433|P2|Overall Study|Hemoglobin decrease|1
52345|NCT01194154|199434|P1|Overall Study|Hemoglobin decrease|0
52346|NCT01194154|199433|P2|Overall Study|Blood pressure increase|3
52347|NCT01194154|199434|P1|Overall Study|Blood pressure increase|5
52348|NCT01194154|199433|P2|Overall Study|Withdrawal by Subject|6
52349|NCT01194154|199434|P1|Overall Study|Withdrawal by Subject|5
52350|NCT01194154|199433|P2|Overall Study|Protocol Violation|1
52351|NCT01194154|199434|P1|Overall Study|Protocol Violation|0
52352|NCT01194154|199433|P2|Overall Study|Lost to Follow-up|3
52353|NCT01194154|199434|P1|Overall Study|Lost to Follow-up|2
52354|NCT01194154|199433|P2|Overall Study|Adverse Event|7
52355|NCT01194154|199434|P1|Overall Study|Adverse Event|12
52356|NCT01194531|199474|P2|Overall Study|Physician Decision|2
52357|NCT01194531|199475|P1|Overall Study|Physician Decision|0
52358|NCT01194531|199474|P2|Overall Study|Protocol Violation|1
52359|NCT01194531|199475|P1|Overall Study|Protocol Violation|4
52360|NCT01194531|199474|P2|Overall Study|Withdrawal by Subject|0
52361|NCT01194531|199475|P1|Overall Study|Withdrawal by Subject|1
52362|NCT01194440|199519|P1|Overall Study|Lost to Follow-up|1
52363|NCT01194440|199519|P1|Overall Study|Withdrawal by Subject|2
52364|NCT01194440|199519|P1|Overall Study|Adverse Event|9
52365|NCT01194414|199529|P4|72 Weeks Open Label Extension|Death|2
52366|NCT01194414|199530|P3|72 Weeks Open Label Extension|Death|0
52367|NCT01194414|199531|P2|72 Weeks Open Label Extension|Death|2
52368|NCT01194414|199532|P1|72 Weeks Open Label Extension|Death|1
52369|NCT01194414|199529|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
52370|NCT01194414|199530|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
52371|NCT01194414|199531|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
52372|NCT01194414|199532|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
52373|NCT01194414|199529|P4|72 Weeks Open Label Extension|Adverse Event|12
52374|NCT01194414|199530|P3|72 Weeks Open Label Extension|Adverse Event|2
52375|NCT01194414|199531|P2|72 Weeks Open Label Extension|Adverse Event|21
52376|NCT01194414|199532|P1|72 Weeks Open Label Extension|Adverse Event|35
52377|NCT01194414|199529|P4|72 Weeks Open Label Extension|Protocol Violation|1
52378|NCT01194414|199530|P3|72 Weeks Open Label Extension|Protocol Violation|0
52379|NCT01194414|199531|P2|72 Weeks Open Label Extension|Protocol Violation|0
52380|NCT01194414|199532|P1|72 Weeks Open Label Extension|Protocol Violation|0
52381|NCT01194414|199529|P4|72 Weeks Open Label Extension|Other|0
52382|NCT01194414|199530|P3|72 Weeks Open Label Extension|Other|0
52383|NCT01194414|199531|P2|72 Weeks Open Label Extension|Other|1
52384|NCT01194414|199532|P1|72 Weeks Open Label Extension|Other|2
52385|NCT01194414|199529|P4|72 Weeks Open Label Extension|Pregnancy|1
52386|NCT01194414|199530|P3|72 Weeks Open Label Extension|Pregnancy|1
52387|NCT01194414|199531|P2|72 Weeks Open Label Extension|Pregnancy|3
52388|NCT01194414|199532|P1|72 Weeks Open Label Extension|Pregnancy|1
52389|NCT01194414|199529|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
52390|NCT01194414|199530|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
52391|NCT01194414|199531|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
52392|NCT01194414|199532|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
52393|NCT01194414|199529|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
52394|NCT01194414|199530|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
52395|NCT01194414|199531|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
52396|NCT01194414|199532|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
52397|NCT01194414|199529|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
52398|NCT01194414|199530|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
52399|NCT01194414|199531|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
52400|NCT01194414|199532|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
52401|NCT01194414|199529|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
52402|NCT01194414|199530|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
52403|NCT01194414|199531|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
52404|NCT01194414|199532|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
52405|NCT01194414|199529|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
52406|NCT01194414|199530|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
52407|NCT01194414|199531|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
52408|NCT01194414|199532|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
52409|NCT01194414|199529|P4|24 Weeks Double Blind Period|Death|0
52410|NCT01194414|199530|P3|24 Weeks Double Blind Period|Death|0
52411|NCT01194414|199531|P2|24 Weeks Double Blind Period|Death|1
52412|NCT01194414|199532|P1|24 Weeks Double Blind Period|Death|0
52413|NCT01194414|199529|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
52414|NCT01194414|199530|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
52415|NCT01194414|199531|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
52416|NCT01194414|199532|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
52417|NCT01194414|199529|P4|24 Weeks Double Blind Period|Adverse Event|0
52418|NCT01194414|199530|P3|24 Weeks Double Blind Period|Adverse Event|0
52419|NCT01194414|199531|P2|24 Weeks Double Blind Period|Adverse Event|40
52420|NCT01194414|199532|P1|24 Weeks Double Blind Period|Adverse Event|28
52421|NCT01194414|199529|P4|24 Weeks Double Blind Period|Other|0
52422|NCT01194414|199530|P3|24 Weeks Double Blind Period|Other|0
52423|NCT01194414|199531|P2|24 Weeks Double Blind Period|Other|1
52424|NCT01194414|199532|P1|24 Weeks Double Blind Period|Other|0
52425|NCT01194414|199529|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
52426|NCT01194414|199530|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
52427|NCT01194414|199531|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
52428|NCT01194414|199532|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
52429|NCT01194414|199529|P4|24 Weeks Double Blind Period|Pregnancy|0
52430|NCT01194414|199530|P3|24 Weeks Double Blind Period|Pregnancy|0
52431|NCT01194414|199531|P2|24 Weeks Double Blind Period|Pregnancy|2
52432|NCT01194414|199532|P1|24 Weeks Double Blind Period|Pregnancy|2
52433|NCT01194414|199529|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
52434|NCT01194414|199530|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
52435|NCT01194414|199531|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
52436|NCT01194414|199532|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
52437|NCT01194414|199529|P4|24 Weeks Double Blind Period|Protocol Violation|0
52438|NCT01194414|199530|P3|24 Weeks Double Blind Period|Protocol Violation|0
52439|NCT01194414|199531|P2|24 Weeks Double Blind Period|Protocol Violation|3
52440|NCT01194414|199532|P1|24 Weeks Double Blind Period|Protocol Violation|5
52441|NCT01194414|199529|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
52442|NCT01194414|199530|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
52443|NCT01194414|199531|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
52444|NCT01194414|199532|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
52445|NCT01194414|199529|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
52446|NCT01194414|199530|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
52447|NCT01194414|199531|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
52448|NCT01194414|199532|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
52449|NCT01194258|199603|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
52450|NCT01194258|199604|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
52451|NCT01194258|199605|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
52452|NCT01194258|199606|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
52453|NCT01194258|199607|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
52454|NCT01194258|199603|P5|Period 2 (12 Weeks)|Adverse Event|0
52455|NCT01194258|199604|P4|Period 2 (12 Weeks)|Adverse Event|0
52456|NCT01194258|199605|P3|Period 2 (12 Weeks)|Adverse Event|0
52457|NCT01194258|199606|P2|Period 2 (12 Weeks)|Adverse Event|1
52458|NCT01194258|199607|P1|Period 2 (12 Weeks)|Adverse Event|0
52459|NCT01194258|199603|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
52460|NCT01194258|199604|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
52461|NCT01194258|199605|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
52462|NCT01194258|199606|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
52463|NCT01194258|199607|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
52464|NCT01194258|199603|P5|Period 1 (12 Weeks)|Death|1
52465|NCT01194258|199604|P4|Period 1 (12 Weeks)|Death|0
52466|NCT01194258|199605|P3|Period 1 (12 Weeks)|Death|0
52467|NCT01194258|199606|P2|Period 1 (12 Weeks)|Death|0
52468|NCT01194258|199607|P1|Period 1 (12 Weeks)|Death|0
52469|NCT01194258|199603|P5|Titration Period|Titration failure|0
52470|NCT01194258|199604|P4|Titration Period|Titration failure|0
52471|NCT01194258|199605|P3|Titration Period|Titration failure|0
52472|NCT01194258|199606|P2|Titration Period|Titration failure|0
52473|NCT01194258|199607|P1|Titration Period|Titration failure|3
52474|NCT01194258|199603|P5|Titration Period|Lost to Follow-up|0
52475|NCT01194258|199604|P4|Titration Period|Lost to Follow-up|0
52476|NCT01194258|199605|P3|Titration Period|Lost to Follow-up|0
52477|NCT01194258|199606|P2|Titration Period|Lost to Follow-up|0
52478|NCT01194258|199607|P1|Titration Period|Lost to Follow-up|2
52479|NCT01194258|199603|P5|Titration Period|Withdrawal by Subject|0
52480|NCT01194258|199604|P4|Titration Period|Withdrawal by Subject|0
52481|NCT01194258|199605|P3|Titration Period|Withdrawal by Subject|0
52482|NCT01194258|199606|P2|Titration Period|Withdrawal by Subject|0
52483|NCT01194258|199607|P1|Titration Period|Withdrawal by Subject|6
52484|NCT01194245|199631|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
52485|NCT01194245|199632|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
52486|NCT01194245|199633|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
52487|NCT01194245|199634|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
52488|NCT01194245|199635|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
52489|NCT01194245|199631|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
52490|NCT01194245|199632|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
52491|NCT01194245|199633|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
52492|NCT01194245|199634|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
52493|NCT01194245|199635|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
52494|NCT01194245|199631|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
52495|NCT01194245|199632|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
52496|NCT01194245|199633|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
52497|NCT01194245|199634|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
52498|NCT01194245|199635|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
52499|NCT01194245|199631|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
52500|NCT01194245|199632|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
52501|NCT01194245|199633|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
52502|NCT01194245|199634|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
52503|NCT01194245|199635|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
52504|NCT01194245|199631|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
52505|NCT01194245|199632|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
52506|NCT01194245|199633|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
52507|NCT01194245|199634|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
52508|NCT01194245|199635|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
52509|NCT01194245|199631|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
52510|NCT01194245|199632|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
52511|NCT01194245|199633|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
52512|NCT01194245|199634|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
52513|NCT01194245|199635|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
52514|NCT01194219|199656|P8|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
52515|NCT01194219|199657|P7|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|1
52516|NCT01194219|199658|P6|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
52517|NCT01194219|199659|P5|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
52518|NCT01194219|199660|P4|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
52519|NCT01194219|199661|P3|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
52520|NCT01194219|199662|P2|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
52521|NCT01194219|199663|P1|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
52522|NCT01194219|199656|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
52523|NCT01194219|199657|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
52524|NCT01194219|199658|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
52525|NCT01194219|199659|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
52526|NCT01194219|199660|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
52527|NCT01194219|199661|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
52528|NCT01194219|199662|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
52529|NCT01194219|199663|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
52530|NCT01194219|199656|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
52531|NCT01194219|199657|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|5
52532|NCT01194219|199658|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
52533|NCT01194219|199659|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
52534|NCT01194219|199660|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
52535|NCT01194219|199661|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
52536|NCT01194219|199662|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
52537|NCT01194219|199663|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
52538|NCT01194219|199656|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|6
52539|NCT01194219|199657|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|12
52540|NCT01194219|199658|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
52541|NCT01194219|199659|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|1
52542|NCT01194219|199660|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
52543|NCT01194219|199661|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
52544|NCT01194219|199662|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
52545|NCT01194219|199663|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
52546|NCT01194219|199656|P8|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
52547|NCT01194219|199657|P7|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|2
52548|NCT01194219|199658|P6|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
52549|NCT01194219|199659|P5|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|1
52550|NCT01194219|199660|P4|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
52551|NCT01194219|199661|P3|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
52552|NCT01194219|199662|P2|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
52553|NCT01194219|199663|P1|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
52554|NCT01194219|199656|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|33
52555|NCT01194219|199657|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|35
52556|NCT01194219|199658|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|1
52557|NCT01194219|199659|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|1
52558|NCT01194219|199660|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
52559|NCT01194219|199661|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
52560|NCT01194219|199662|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
52561|NCT01194219|199663|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
52562|NCT01194219|199656|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|5
52563|NCT01194219|199657|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|6
52564|NCT01194219|199658|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
52565|NCT01194219|199659|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
52566|NCT01194219|199660|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
52567|NCT01194219|199661|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
52568|NCT01194219|199662|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
52569|NCT01194219|199663|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
52570|NCT01194219|199656|P8|Maintenance Phase (Weeks16-32)|Unspecified|0
52571|NCT01194219|199657|P7|Maintenance Phase (Weeks16-32)|Unspecified|0
52572|NCT01194219|199658|P6|Maintenance Phase (Weeks16-32)|Unspecified|0
52573|NCT01194219|199659|P5|Maintenance Phase (Weeks16-32)|Unspecified|0
52574|NCT01194219|199660|P4|Maintenance Phase (Weeks16-32)|Unspecified|1
52575|NCT01194219|199661|P3|Maintenance Phase (Weeks16-32)|Unspecified|2
52576|NCT01194219|199662|P2|Maintenance Phase (Weeks16-32)|Unspecified|0
52577|NCT01194219|199663|P1|Maintenance Phase (Weeks16-32)|Unspecified|0
52578|NCT01194219|199656|P8|Maintenance Phase (Weeks16-32)|Protocol Violation|0
52579|NCT01194219|199657|P7|Maintenance Phase (Weeks16-32)|Protocol Violation|0
52580|NCT01194219|199658|P6|Maintenance Phase (Weeks16-32)|Protocol Violation|0
52581|NCT01194219|199659|P5|Maintenance Phase (Weeks16-32)|Protocol Violation|0
52582|NCT01194219|199660|P4|Maintenance Phase (Weeks16-32)|Protocol Violation|1
52583|NCT01194219|199661|P3|Maintenance Phase (Weeks16-32)|Protocol Violation|0
52584|NCT01194219|199662|P2|Maintenance Phase (Weeks16-32)|Protocol Violation|0
52585|NCT01194219|199663|P1|Maintenance Phase (Weeks16-32)|Protocol Violation|0
52586|NCT01194219|199656|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
52587|NCT01194219|199657|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
52588|NCT01194219|199658|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
52589|NCT01194219|199659|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
52590|NCT01194219|199660|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
52591|NCT01194219|199661|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|9
52592|NCT01194219|199662|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
52593|NCT01194219|199663|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
52594|NCT01194219|199656|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
52595|NCT01194219|199657|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
52596|NCT01194219|199658|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
52597|NCT01194219|199659|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
52598|NCT01194219|199660|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|3
52599|NCT01194219|199661|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|12
52600|NCT01194219|199662|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
52601|NCT01194219|199663|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
52602|NCT01194219|199656|P8|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
52603|NCT01194219|199657|P7|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
52604|NCT01194219|199658|P6|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
52605|NCT01194219|199659|P5|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
52606|NCT01194219|199660|P4|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|1
52607|NCT01194219|199661|P3|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|2
52608|NCT01194219|199662|P2|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
52609|NCT01194219|199663|P1|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
52610|NCT01194219|199656|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
52611|NCT01194219|199657|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
52612|NCT01194219|199658|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
52613|NCT01194219|199659|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
52614|NCT01194219|199660|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|15
52615|NCT01194219|199661|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|37
52616|NCT01194219|199662|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
52617|NCT01194219|199663|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
52618|NCT01194219|199656|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
52619|NCT01194219|199657|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
52620|NCT01194219|199658|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
52621|NCT01194219|199659|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
52622|NCT01194219|199660|P4|Maintenance Phase (Weeks16-32)|Adverse Event|9
52623|NCT01194219|199661|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
52624|NCT01194219|199662|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
52625|NCT01194219|199663|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
52626|NCT01194219|199656|P8|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
52627|NCT01194219|199657|P7|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
52628|NCT01194219|199658|P6|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
52629|NCT01194219|199659|P5|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
52630|NCT01194219|199660|P4|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
52631|NCT01194219|199661|P3|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
52632|NCT01194219|199662|P2|Placebo Controlled Phase (Weeks 0-16)|Unspecified|1
52633|NCT01194219|199663|P1|Placebo Controlled Phase (Weeks 0-16)|Unspecified|1
52634|NCT01194219|199656|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
52635|NCT01194219|199657|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
52636|NCT01194219|199658|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
52637|NCT01194219|199659|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
52638|NCT01194219|199660|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
52639|NCT01194219|199661|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
52640|NCT01194219|199662|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|1
52641|NCT01194219|199663|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|7
52642|NCT01194219|199656|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
52643|NCT01194219|199657|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
52644|NCT01194219|199658|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
52645|NCT01194219|199659|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
52646|NCT01194219|199660|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
52647|NCT01194219|199661|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
52648|NCT01194219|199662|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|9
52649|NCT01194219|199663|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|7
52650|NCT01194219|199656|P8|Placebo Controlled Phase (Weeks 0-16)|Death|0
52651|NCT01194219|199657|P7|Placebo Controlled Phase (Weeks 0-16)|Death|0
52652|NCT01194219|199658|P6|Placebo Controlled Phase (Weeks 0-16)|Death|0
52653|NCT01194219|199659|P5|Placebo Controlled Phase (Weeks 0-16)|Death|0
52654|NCT01194219|199660|P4|Placebo Controlled Phase (Weeks 0-16)|Death|0
52655|NCT01194219|199661|P3|Placebo Controlled Phase (Weeks 0-16)|Death|0
52656|NCT01194219|199662|P2|Placebo Controlled Phase (Weeks 0-16)|Death|1
52657|NCT01194219|199663|P1|Placebo Controlled Phase (Weeks 0-16)|Death|0
52658|NCT01194219|199656|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
52659|NCT01194219|199657|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
52660|NCT01194219|199658|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
52661|NCT01194219|199659|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
52662|NCT01194219|199660|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
52663|NCT01194219|199661|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
52664|NCT01194219|199662|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
52665|NCT01194219|199663|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|12
52666|NCT01194219|199656|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
52667|NCT01194219|199657|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
52668|NCT01194219|199658|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
52669|NCT01194219|199659|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
52670|NCT01194219|199660|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
52671|NCT01194219|199661|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
52672|NCT01194219|199662|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
52673|NCT01194219|199663|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|7
52674|NCT01194219|199656|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
52675|NCT01194219|199657|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
52676|NCT01194219|199658|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
52677|NCT01194219|199659|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
52678|NCT01194219|199660|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
52679|NCT01194219|199661|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
52680|NCT01194219|199662|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|7
52681|NCT01194219|199663|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
52682|NCT01194219|199656|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
52683|NCT01194219|199657|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
52684|NCT01194219|199658|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
52685|NCT01194219|199659|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
52686|NCT01194219|199660|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
52687|NCT01194219|199661|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
52688|NCT01194219|199662|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|5
52689|NCT01194219|199663|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|23
52690|NCT01193920|199703|P10|Overall Study|Unable to classify|0
52691|NCT01193920|199704|P9|Overall Study|Unable to classify|0
52692|NCT01193920|199705|P8|Overall Study|Unable to classify|1
52693|NCT01193920|199706|P7|Overall Study|Unable to classify|0
52694|NCT01193920|199707|P6|Overall Study|Unable to classify|0
52695|NCT01193920|199708|P5|Overall Study|Unable to classify|0
52696|NCT01193920|199709|P4|Overall Study|Unable to classify|1
52697|NCT01193920|199710|P3|Overall Study|Unable to classify|0
52698|NCT01193920|199711|P2|Overall Study|Unable to classify|0
52699|NCT01193920|199712|P1|Overall Study|Unable to classify|0
52700|NCT01193920|199703|P10|Overall Study|Death|4
52701|NCT01193920|199704|P9|Overall Study|Death|2
52702|NCT01193920|199705|P8|Overall Study|Death|3
52703|NCT01193920|199706|P7|Overall Study|Death|2
52704|NCT01193920|199707|P6|Overall Study|Death|0
52705|NCT01193920|199708|P5|Overall Study|Death|0
52706|NCT01193920|199709|P4|Overall Study|Death|1
52707|NCT01193920|199710|P3|Overall Study|Death|0
52708|NCT01193920|199711|P2|Overall Study|Death|0
52709|NCT01193920|199712|P1|Overall Study|Death|0
52710|NCT01193920|199703|P10|Overall Study|Protocol Violation|0
52711|NCT01193920|199704|P9|Overall Study|Protocol Violation|0
52712|NCT01193920|199705|P8|Overall Study|Protocol Violation|0
52713|NCT01193920|199706|P7|Overall Study|Protocol Violation|0
52714|NCT01193920|199707|P6|Overall Study|Protocol Violation|0
52715|NCT01193920|199708|P5|Overall Study|Protocol Violation|0
52716|NCT01193920|199709|P4|Overall Study|Protocol Violation|0
52717|NCT01193920|199710|P3|Overall Study|Protocol Violation|0
52718|NCT01193920|199711|P2|Overall Study|Protocol Violation|0
52719|NCT01193920|199712|P1|Overall Study|Protocol Violation|1
52720|NCT01193920|199703|P10|Overall Study|Lost to Follow-up|3
52721|NCT01193920|199704|P9|Overall Study|Lost to Follow-up|2
52722|NCT01193920|199705|P8|Overall Study|Lost to Follow-up|0
52723|NCT01193920|199706|P7|Overall Study|Lost to Follow-up|1
52724|NCT01193920|199707|P6|Overall Study|Lost to Follow-up|3
52725|NCT01193920|199708|P5|Overall Study|Lost to Follow-up|3
52726|NCT01193920|199709|P4|Overall Study|Lost to Follow-up|1
52727|NCT01193920|199710|P3|Overall Study|Lost to Follow-up|1
52728|NCT01193920|199711|P2|Overall Study|Lost to Follow-up|0
52729|NCT01193920|199712|P1|Overall Study|Lost to Follow-up|1
52730|NCT01193920|199703|P10|Overall Study|Withdrawal by Subject|0
52731|NCT01193920|199704|P9|Overall Study|Withdrawal by Subject|1
52732|NCT01193920|199705|P8|Overall Study|Withdrawal by Subject|0
52733|NCT01193920|199706|P7|Overall Study|Withdrawal by Subject|3
52734|NCT01193920|199707|P6|Overall Study|Withdrawal by Subject|1
52735|NCT01193920|199708|P5|Overall Study|Withdrawal by Subject|3
52736|NCT01193920|199709|P4|Overall Study|Withdrawal by Subject|1
52737|NCT01193920|199710|P3|Overall Study|Withdrawal by Subject|5
52738|NCT01193920|199711|P2|Overall Study|Withdrawal by Subject|0
52739|NCT01193920|199712|P1|Overall Study|Withdrawal by Subject|1
52740|NCT01193686|199805|P2|Overall Study|Removed by Investigators; unable to matc|0
52741|NCT01193686|199806|P1|Overall Study|Removed by Investigators; unable to matc|3
52742|NCT01193686|199805|P2|Overall Study|Withdrawal by Subject|1
52743|NCT01193686|199806|P1|Overall Study|Withdrawal by Subject|4
52744|NCT01193660|199823|P3|Overall Study|Physician Decision|1
52745|NCT01193660|199824|P2|Overall Study|Physician Decision|0
52746|NCT01193660|199825|P1|Overall Study|Physician Decision|1
52747|NCT01193660|199823|P3|Overall Study|Death|0
52748|NCT01193660|199824|P2|Overall Study|Death|0
52749|NCT01193660|199825|P1|Overall Study|Death|1
52750|NCT01193660|199823|P3|Overall Study|Withdrawal by Subject|1
52751|NCT01193660|199824|P2|Overall Study|Withdrawal by Subject|3
52752|NCT01193660|199825|P1|Overall Study|Withdrawal by Subject|2
52753|NCT01193582|199867|P4|12 Month Follow-up|Withdrawal by Subject|11
52754|NCT01193582|199868|P3|12 Month Follow-up|Withdrawal by Subject|3
52755|NCT01193582|199869|P2|12 Month Follow-up|Withdrawal by Subject|0
52756|NCT01193582|199870|P1|12 Month Follow-up|Withdrawal by Subject|6
52757|NCT01193582|199867|P4|12 Month Follow-up|Death|0
52758|NCT01193582|199868|P3|12 Month Follow-up|Death|1
52759|NCT01193582|199869|P2|12 Month Follow-up|Death|0
52760|NCT01193582|199870|P1|12 Month Follow-up|Death|0
52761|NCT01193582|199867|P4|Vaccination Series|Withdrawal by Subject|3
52762|NCT01193582|199868|P3|Vaccination Series|Withdrawal by Subject|8
52763|NCT01193582|199869|P2|Vaccination Series|Withdrawal by Subject|13
52764|NCT01193582|199870|P1|Vaccination Series|Withdrawal by Subject|11
52765|NCT01193556|199900|P2|Overall Study|Study termination|25
52766|NCT01193556|199901|P1|Overall Study|Study termination|26
52767|NCT01193348|199909|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
52768|NCT01193348|199909|P1|Extension Treatment Period|Physician Decision|1
52769|NCT01193348|199909|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
52770|NCT01193348|199909|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
52771|NCT01193348|199909|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
52772|NCT01193348|199909|P1|Screening Period|Screen Failure|5
52773|NCT01193335|199929|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
52774|NCT01193335|199930|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
52775|NCT01193335|199929|P2|2-Year Follow-up|No Longer Willing to Participate|6
52776|NCT01193335|199930|P1|2-Year Follow-up|No Longer Willing to Participate|5
52777|NCT01193335|199929|P2|1-Year Follow-up|Lost to Follow-up|0
52778|NCT01193335|199930|P1|1-Year Follow-up|Lost to Follow-up|4
52779|NCT01193335|199929|P2|1-Year Follow-up|No Longer Willing to Participate|9
52780|NCT01193335|199930|P1|1-Year Follow-up|No Longer Willing to Participate|7
52781|NCT01193335|199929|P2|After Infant Series|No Longer Met Eligibility Criteria|1
52782|NCT01193335|199930|P1|After Infant Series|No Longer Met Eligibility Criteria|0
52783|NCT01193335|199929|P2|After Infant Series|Lost to Follow-up|2
52784|NCT01193335|199930|P1|After Infant Series|Lost to Follow-up|1
52785|NCT01193283|200025|P1|Overall Study|Death|1
52786|NCT01193218|200034|P8|12-52 Weeks|Other reason than above|0
52787|NCT01193218|200035|P7|12-52 Weeks|Other reason than above|0
52788|NCT01193218|200036|P6|12-52 Weeks|Other reason than above|0
52789|NCT01193218|200037|P5|12-52 Weeks|Other reason than above|1
52790|NCT01193218|200038|P4|12-52 Weeks|Other reason than above|1
52791|NCT01193218|200039|P3|12-52 Weeks|Other reason than above|0
52792|NCT01193218|200040|P2|12-52 Weeks|Other reason than above|0
52793|NCT01193218|200041|P1|12-52 Weeks|Other reason than above|1
52794|NCT01193218|200034|P8|12-52 Weeks|Withdrawal by Subject|2
52795|NCT01193218|200035|P7|12-52 Weeks|Withdrawal by Subject|1
52796|NCT01193218|200036|P6|12-52 Weeks|Withdrawal by Subject|2
52797|NCT01193218|200037|P5|12-52 Weeks|Withdrawal by Subject|0
52798|NCT01193218|200038|P4|12-52 Weeks|Withdrawal by Subject|0
52799|NCT01193218|200039|P3|12-52 Weeks|Withdrawal by Subject|3
52800|NCT01193218|200040|P2|12-52 Weeks|Withdrawal by Subject|0
52801|NCT01193218|200041|P1|12-52 Weeks|Withdrawal by Subject|3
52802|NCT01193218|200034|P8|12-52 Weeks|Lack of Efficacy|0
52803|NCT01193218|200035|P7|12-52 Weeks|Lack of Efficacy|1
52804|NCT01193218|200036|P6|12-52 Weeks|Lack of Efficacy|0
52805|NCT01193218|200037|P5|12-52 Weeks|Lack of Efficacy|0
52806|NCT01193218|200038|P4|12-52 Weeks|Lack of Efficacy|0
52807|NCT01193218|200039|P3|12-52 Weeks|Lack of Efficacy|0
52808|NCT01193218|200040|P2|12-52 Weeks|Lack of Efficacy|0
52809|NCT01193218|200041|P1|12-52 Weeks|Lack of Efficacy|0
52810|NCT01193218|200034|P8|12-52 Weeks|Adverse Event|2
52811|NCT01193218|200035|P7|12-52 Weeks|Adverse Event|1
52812|NCT01193218|200036|P6|12-52 Weeks|Adverse Event|3
52813|NCT01193218|200037|P5|12-52 Weeks|Adverse Event|3
52814|NCT01193218|200038|P4|12-52 Weeks|Adverse Event|2
52815|NCT01193218|200039|P3|12-52 Weeks|Adverse Event|1
52816|NCT01193218|200040|P2|12-52 Weeks|Adverse Event|0
52817|NCT01193218|200041|P1|12-52 Weeks|Adverse Event|1
52818|NCT01193218|200034|P8|0-12 Weeks|Withdrawal by Subject|0
52819|NCT01193218|200035|P7|0-12 Weeks|Withdrawal by Subject|1
52820|NCT01193218|200036|P6|0-12 Weeks|Withdrawal by Subject|0
52821|NCT01193218|200037|P5|0-12 Weeks|Withdrawal by Subject|0
52822|NCT01193218|200038|P4|0-12 Weeks|Withdrawal by Subject|0
52823|NCT01193218|200039|P3|0-12 Weeks|Withdrawal by Subject|2
52824|NCT01193218|200040|P2|0-12 Weeks|Withdrawal by Subject|0
52825|NCT01193218|200041|P1|0-12 Weeks|Withdrawal by Subject|3
52826|NCT01193218|200034|P8|0-12 Weeks|Protocol Violation|0
52827|NCT01193218|200035|P7|0-12 Weeks|Protocol Violation|0
52828|NCT01193218|200036|P6|0-12 Weeks|Protocol Violation|1
52829|NCT01193218|200037|P5|0-12 Weeks|Protocol Violation|1
52830|NCT01193218|200038|P4|0-12 Weeks|Protocol Violation|0
52831|NCT01193218|200039|P3|0-12 Weeks|Protocol Violation|0
52832|NCT01193218|200040|P2|0-12 Weeks|Protocol Violation|0
52833|NCT01193218|200041|P1|0-12 Weeks|Protocol Violation|0
52834|NCT01193218|200034|P8|0-12 Weeks|Adverse Event|0
52835|NCT01193218|200035|P7|0-12 Weeks|Adverse Event|2
52836|NCT01193218|200036|P6|0-12 Weeks|Adverse Event|2
52837|NCT01193218|200037|P5|0-12 Weeks|Adverse Event|0
52838|NCT01193218|200038|P4|0-12 Weeks|Adverse Event|0
52839|NCT01193218|200039|P3|0-12 Weeks|Adverse Event|1
52840|NCT01193218|200040|P2|0-12 Weeks|Adverse Event|0
52841|NCT01193218|200041|P1|0-12 Weeks|Adverse Event|6
52842|NCT01193153|200072|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
52843|NCT01193153|200073|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
52844|NCT01193153|200072|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
52845|NCT01193153|200073|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
52846|NCT01193153|200072|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
52847|NCT01193153|200073|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
52848|NCT01193153|200072|P2|Double Blind Relapse Prevention Period|Pregnancy|0
52849|NCT01193153|200073|P1|Double Blind Relapse Prevention Period|Pregnancy|1
52850|NCT01193153|200072|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
52851|NCT01193153|200073|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
52852|NCT01193153|200072|P2|Double Blind Relapse Prevention Period|Death|0
52853|NCT01193153|200073|P1|Double Blind Relapse Prevention Period|Death|2
52854|NCT01193153|200072|P2|Double Blind Relapse Prevention Period|Adverse Event|3
52855|NCT01193153|200073|P1|Double Blind Relapse Prevention Period|Adverse Event|12
52856|NCT01193153|200072|P2|Double Blind Relapse Prevention Period|Unspecified|3
52857|NCT01193153|200073|P1|Double Blind Relapse Prevention Period|Unspecified|2
52858|NCT01193153|200072|P2|Open-label Stabilization Period|Unspecified|0
52859|NCT01193153|200073|P1|Open-label Stabilization Period|Unspecified|8
52860|NCT01193153|200072|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
52861|NCT01193153|200073|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
52862|NCT01193153|200072|P2|Open-label Stabilization Period|Withdrawal by Subject|0
52863|NCT01193153|200073|P1|Open-label Stabilization Period|Withdrawal by Subject|29
52864|NCT01193153|200072|P2|Open-label Stabilization Period|Lack of Efficacy|0
52865|NCT01193153|200073|P1|Open-label Stabilization Period|Lack of Efficacy|5
52866|NCT01193153|200072|P2|Open-label Stabilization Period|Lost to Follow-up|0
52867|NCT01193153|200073|P1|Open-label Stabilization Period|Lost to Follow-up|10
52868|NCT01193153|200072|P2|Open-label Stabilization Period|Death|0
52869|NCT01193153|200073|P1|Open-label Stabilization Period|Death|2
52870|NCT01193153|200072|P2|Open-label Stabilization Period|Adverse Event|0
52871|NCT01193153|200073|P1|Open-label Stabilization Period|Adverse Event|9
52872|NCT01193153|200072|P2|Open-label Lead in Period|Lack of Efficacy|0
52873|NCT01193153|200073|P1|Open-label Lead in Period|Lack of Efficacy|26
52874|NCT01193153|200072|P2|Open-label Lead in Period|Death|0
52875|NCT01193153|200073|P1|Open-label Lead in Period|Death|1
52876|NCT01193153|200072|P2|Open-label Lead in Period|Adverse Event|0
52877|NCT01193153|200073|P1|Open-label Lead in Period|Adverse Event|41
52962|NCT01192178|200684|P2|Overall Study|Lack of Efficacy|2
52878|NCT01193153|200072|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
52879|NCT01193153|200073|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
52880|NCT01193153|200072|P2|Open-label Lead in Period|Unspecified|0
52881|NCT01193153|200073|P1|Open-label Lead in Period|Unspecified|14
52882|NCT01193153|200072|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
52883|NCT01193153|200073|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
52884|NCT01193153|200072|P2|Open-label Lead in Period|Withdrawal by Subject|0
52885|NCT01193153|200073|P1|Open-label Lead in Period|Withdrawal by Subject|69
52886|NCT01193153|200072|P2|Open-label Lead in Period|Pregnancy|0
52887|NCT01193153|200073|P1|Open-label Lead in Period|Pregnancy|1
52888|NCT01193153|200072|P2|Open-label Lead in Period|Lost to Follow-up|0
52889|NCT01193153|200073|P1|Open-label Lead in Period|Lost to Follow-up|32
52890|NCT01193127|200108|P4|Treated|Withdrawal by Subject|1
52891|NCT01193127|200109|P3|Treated|Withdrawal by Subject|0
52892|NCT01193127|200110|P2|Treated|Withdrawal by Subject|0
52893|NCT01193127|200111|P1|Treated|Withdrawal by Subject|0
52894|NCT01193127|200108|P4|Randomized|Surgery Cancelled|1
52895|NCT01193127|200109|P3|Randomized|Surgery Cancelled|0
52896|NCT01193127|200110|P2|Randomized|Surgery Cancelled|0
52897|NCT01193127|200111|P1|Randomized|Surgery Cancelled|0
52898|NCT01193101|200436|P4|Overall Study|Abnormal test procedure results|0
52899|NCT01193101|200437|P3|Overall Study|Abnormal test procedure results|0
52900|NCT01193101|200438|P2|Overall Study|Abnormal test procedure results|1
52901|NCT01193101|200439|P1|Overall Study|Abnormal test procedure results|0
52902|NCT01193101|200436|P4|Overall Study|Administrative problems|0
52903|NCT01193101|200437|P3|Overall Study|Administrative problems|1
52904|NCT01193101|200438|P2|Overall Study|Administrative problems|0
52905|NCT01193101|200439|P1|Overall Study|Administrative problems|0
52906|NCT01193101|200436|P4|Overall Study|Withdrawal by Subject|1
52907|NCT01193101|200437|P3|Overall Study|Withdrawal by Subject|1
52908|NCT01193101|200438|P2|Overall Study|Withdrawal by Subject|4
52909|NCT01193101|200439|P1|Overall Study|Withdrawal by Subject|2
52910|NCT01193101|200436|P4|Overall Study|Lack of Efficacy|8
52911|NCT01193101|200437|P3|Overall Study|Lack of Efficacy|0
52912|NCT01193101|200438|P2|Overall Study|Lack of Efficacy|1
52913|NCT01193101|200439|P1|Overall Study|Lack of Efficacy|3
52914|NCT01193101|200436|P4|Overall Study|Adverse Event|3
52915|NCT01193101|200437|P3|Overall Study|Adverse Event|1
52916|NCT01193101|200438|P2|Overall Study|Adverse Event|1
52917|NCT01193101|200439|P1|Overall Study|Adverse Event|0
52918|NCT01192516|200541|P3|Overall Study|Unable to follow Actiwatch instructions|0
52919|NCT01192516|200542|P2|Overall Study|Unable to follow Actiwatch instructions|2
52920|NCT01192516|200543|P1|Overall Study|Unable to follow Actiwatch instructions|4
52921|NCT01192516|200541|P3|Overall Study|started new treatment|0
52922|NCT01192516|200542|P2|Overall Study|started new treatment|1
52923|NCT01192516|200543|P1|Overall Study|started new treatment|5
52924|NCT01192516|200541|P3|Overall Study|Withdrawal by Subject|1
52925|NCT01192516|200542|P2|Overall Study|Withdrawal by Subject|4
52926|NCT01192516|200543|P1|Overall Study|Withdrawal by Subject|4
52927|NCT01192516|200541|P3|Overall Study|Lost to Follow-up|7
52928|NCT01192516|200542|P2|Overall Study|Lost to Follow-up|10
52929|NCT01192516|200543|P1|Overall Study|Lost to Follow-up|7
52930|NCT01192412|200577|P2|Overall Study|Withdrawal by Subject|1
52931|NCT01192412|200578|P1|Overall Study|Withdrawal by Subject|2
52932|NCT01192412|200577|P2|Overall Study|Lost to Follow-up|1
52933|NCT01192412|200578|P1|Overall Study|Lost to Follow-up|2
52934|NCT01192347|200586|P1|Overall Study|Patient did not show up for visits|1
52935|NCT01192347|200586|P1|Overall Study|Patient not visiting hospital regularly|1
52936|NCT01192347|200586|P1|Overall Study|Patient seen in different hospital|1
52937|NCT01192347|200586|P1|Overall Study|Suspected serious adverse drug reaction|1
52938|NCT01192347|200586|P1|Overall Study|Adverse Event|1
52939|NCT01192347|200586|P1|Overall Study|Withdrawal by Subject|1
52940|NCT01192347|200586|P1|Overall Study|Lost to Follow-up|3
52941|NCT01192347|200586|P1|Overall Study|Death|3
52942|NCT01192295|200609|P2|Overall Study|Administrative|6
52943|NCT01192295|200610|P1|Overall Study|Administrative|4
52944|NCT01192295|200609|P2|Overall Study|Lack of Efficacy|5
52945|NCT01192295|200610|P1|Overall Study|Lack of Efficacy|0
52946|NCT01192295|200609|P2|Overall Study|Lost to Follow-up|1
52947|NCT01192295|200610|P1|Overall Study|Lost to Follow-up|0
52948|NCT01192295|200609|P2|Overall Study|Withdrawal by Subject|4
52949|NCT01192295|200610|P1|Overall Study|Withdrawal by Subject|3
52950|NCT01192295|200609|P2|Overall Study|Adverse Event|7
52951|NCT01192295|200610|P1|Overall Study|Adverse Event|3
52952|NCT01192204|200644|P2|Overall Study|could not keep recall appointments|0
52953|NCT01192204|200645|P1|Overall Study|could not keep recall appointments|1
52954|NCT01192191|200657|P2|Overall Study|Withdrawal by Subject|6
52955|NCT01192191|200658|P1|Overall Study|Withdrawal by Subject|1
52956|NCT01192191|200657|P2|Overall Study|Lost to Follow-up|1
52957|NCT01192191|200658|P1|Overall Study|Lost to Follow-up|0
52958|NCT01192191|200657|P2|Overall Study|Participants Reached Stopping Criteria|2
52959|NCT01192191|200658|P1|Overall Study|Participants Reached Stopping Criteria|3
52960|NCT01192191|200657|P2|Overall Study|Adverse Event|12
52961|NCT01192191|200658|P1|Overall Study|Adverse Event|7
52963|NCT01192178|200685|P1|Overall Study|Lack of Efficacy|1
52964|NCT01192178|200684|P2|Overall Study|Adverse Event|1
52965|NCT01192178|200685|P1|Overall Study|Adverse Event|2
52966|NCT01192178|200684|P2|Overall Study|Lost to Follow-up|3
52967|NCT01192178|200685|P1|Overall Study|Lost to Follow-up|3
52968|NCT01192178|200684|P2|Overall Study|Physician Decision|4
52969|NCT01192178|200685|P1|Overall Study|Physician Decision|2
52970|NCT01192178|200684|P2|Overall Study|Protocol Violation|3
52971|NCT01192178|200685|P1|Overall Study|Protocol Violation|10
52972|NCT01192178|200684|P2|Overall Study|Withdrawal by Subject|10
52973|NCT01192178|200685|P1|Overall Study|Withdrawal by Subject|6
52974|NCT01192152|200705|P2|Period 3|family emergency|0
52975|NCT01192152|200706|P1|Period 3|family emergency|1
52976|NCT01192152|200705|P2|Period 1|left prematurely (while on treatment B)|1
52977|NCT01192152|200706|P1|Period 1|left prematurely (while on treatment B)|0
52978|NCT01192126|200877|P2|First Intervention (1 Week)|Lost to Follow-up|1
52979|NCT01192126|200878|P1|First Intervention (1 Week)|Lost to Follow-up|1
52980|NCT01192126|200877|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
52981|NCT01192126|200878|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
52982|NCT01192022|200890|P5|Overall Study|Parents did not allow all follow up|0
52983|NCT01192022|200891|P4|Overall Study|Parents did not allow all follow up|1
52984|NCT01192022|200892|P3|Overall Study|Parents did not allow all follow up|0
52985|NCT01192022|200893|P2|Overall Study|Parents did not allow all follow up|0
52986|NCT01192022|200894|P1|Overall Study|Parents did not allow all follow up|0
52987|NCT01192022|200890|P5|Overall Study|Patient needed surgery|0
52988|NCT01192022|200891|P4|Overall Study|Patient needed surgery|0
52989|NCT01192022|200892|P3|Overall Study|Patient needed surgery|0
52990|NCT01192022|200893|P2|Overall Study|Patient needed surgery|1
52991|NCT01192022|200894|P1|Overall Study|Patient needed surgery|0
52992|NCT01192022|200890|P5|Overall Study|Patient too sick from chemotherapy|0
52993|NCT01192022|200891|P4|Overall Study|Patient too sick from chemotherapy|0
52994|NCT01192022|200892|P3|Overall Study|Patient too sick from chemotherapy|0
52995|NCT01192022|200893|P2|Overall Study|Patient too sick from chemotherapy|1
52996|NCT01192022|200894|P1|Overall Study|Patient too sick from chemotherapy|0
52997|NCT01192022|200890|P5|Overall Study|Physician withdrew-patient hardship|0
52998|NCT01192022|200891|P4|Overall Study|Physician withdrew-patient hardship|0
52999|NCT01192022|200892|P3|Overall Study|Physician withdrew-patient hardship|0
53000|NCT01192022|200893|P2|Overall Study|Physician withdrew-patient hardship|0
53001|NCT01192022|200894|P1|Overall Study|Physician withdrew-patient hardship|1
53002|NCT01192022|200890|P5|Overall Study|Fatal Adverse Event|1
53003|NCT01192022|200891|P4|Overall Study|Fatal Adverse Event|0
53004|NCT01192022|200892|P3|Overall Study|Fatal Adverse Event|0
53005|NCT01192022|200893|P2|Overall Study|Fatal Adverse Event|6
53006|NCT01192022|200894|P1|Overall Study|Fatal Adverse Event|4
53007|NCT01192022|200890|P5|Overall Study|Adverse Event|0
53008|NCT01192022|200891|P4|Overall Study|Adverse Event|0
53009|NCT01192022|200892|P3|Overall Study|Adverse Event|0
53010|NCT01192022|200893|P2|Overall Study|Adverse Event|0
53011|NCT01192022|200894|P1|Overall Study|Adverse Event|1
53012|NCT01192022|200890|P5|Overall Study|Lost to Follow-up|0
53013|NCT01192022|200891|P4|Overall Study|Lost to Follow-up|1
53014|NCT01192022|200892|P3|Overall Study|Lost to Follow-up|1
53015|NCT01192022|200893|P2|Overall Study|Lost to Follow-up|2
53016|NCT01192022|200894|P1|Overall Study|Lost to Follow-up|4
53017|NCT01192022|200890|P5|Overall Study|Withdrawal of Consent|0
53018|NCT01192022|200891|P4|Overall Study|Withdrawal of Consent|0
53019|NCT01192022|200892|P3|Overall Study|Withdrawal of Consent|0
53020|NCT01192022|200893|P2|Overall Study|Withdrawal of Consent|1
53021|NCT01192022|200894|P1|Overall Study|Withdrawal of Consent|3
53022|NCT01191944|200917|P2|Overall Study|Other|3
53023|NCT01191944|200918|P1|Overall Study|Other|1
53024|NCT01191944|200917|P2|Overall Study|Withdrawal by Subject|2
53025|NCT01191944|200918|P1|Overall Study|Withdrawal by Subject|4
53026|NCT01191944|200917|P2|Overall Study|Protocol Violation|2
53027|NCT01191944|200918|P1|Overall Study|Protocol Violation|1
53028|NCT01191944|200917|P2|Overall Study|Adverse Event|12
53029|NCT01191944|200918|P1|Overall Study|Adverse Event|11
53030|NCT01191788|200973|P2|Overall Study|Lost to Follow-up|22
53031|NCT01191788|200974|P1|Overall Study|Lost to Follow-up|21
53032|NCT01191762|200984|P2|Overall Study|Adverse Event|0
53033|NCT01191762|200985|P1|Overall Study|Adverse Event|1
53034|NCT01191268|201120|P3|Overall Study|Sponsor Decision|0
53035|NCT01191268|201121|P2|Overall Study|Sponsor Decision|2
53036|NCT01191268|201122|P1|Overall Study|Sponsor Decision|0
53037|NCT01191268|201120|P3|Overall Study|Protocol Violation|1
53038|NCT01191268|201121|P2|Overall Study|Protocol Violation|0
53039|NCT01191268|201122|P1|Overall Study|Protocol Violation|1
53040|NCT01191268|201120|P3|Overall Study|Death|3
53041|NCT01191268|201121|P2|Overall Study|Death|1
53042|NCT01191268|201122|P1|Overall Study|Death|0
53043|NCT01191268|201120|P3|Overall Study|Entry Criteria Not Met|1
53044|NCT01191268|201121|P2|Overall Study|Entry Criteria Not Met|1
53045|NCT01191268|201122|P1|Overall Study|Entry Criteria Not Met|3
53046|NCT01191268|201120|P3|Overall Study|Lost to Follow-up|9
53047|NCT01191268|201121|P2|Overall Study|Lost to Follow-up|5
53048|NCT01191268|201122|P1|Overall Study|Lost to Follow-up|8
53049|NCT01191268|201120|P3|Overall Study|Physician Decision|9
53050|NCT01191268|201121|P2|Overall Study|Physician Decision|8
53051|NCT01191268|201122|P1|Overall Study|Physician Decision|6
53052|NCT01191268|201120|P3|Overall Study|Adverse Event|8
53053|NCT01191268|201121|P2|Overall Study|Adverse Event|13
53054|NCT01191268|201122|P1|Overall Study|Adverse Event|21
53055|NCT01191268|201120|P3|Overall Study|Withdrawal by Subject|21
53056|NCT01191268|201121|P2|Overall Study|Withdrawal by Subject|25
53057|NCT01191268|201122|P1|Overall Study|Withdrawal by Subject|19
53058|NCT01191190|201263|P1|Overall Study|Withdrawal by Subject|1
53059|NCT01191086|201274|P1|Overall Study|Other|1
53060|NCT01191086|201274|P1|Overall Study|Discontinuation criterion met|1
53061|NCT01191086|201274|P1|Overall Study|Withdrawal by Subject|24
53062|NCT01191086|201274|P1|Overall Study|Physician Decision|2
53063|NCT01191086|201274|P1|Overall Study|Lost to Follow-up|4
53064|NCT01191086|201274|P1|Overall Study|Lack of Efficacy|10
53065|NCT01191086|201274|P1|Overall Study|Adverse Event|20
53066|NCT01190891|201280|P2|Overall Study|Withdrawal by Subject|0
53067|NCT01190891|201281|P1|Overall Study|Withdrawal by Subject|5
53068|NCT01190891|201280|P2|Overall Study|Protocol Violation|0
53069|NCT01190891|201281|P1|Overall Study|Protocol Violation|1
53070|NCT01190865|201306|P1|Overall Study|Non-compliance|2
53071|NCT01190865|201306|P1|Overall Study|Withdrawal by Subject|1
53072|NCT01190839|201313|P2|Overall Study|Randomized but not treated|4
53073|NCT01190839|201314|P1|Overall Study|Randomized but not treated|2
53074|NCT01190839|201313|P2|Overall Study|Undefined|31
53075|NCT01190839|201314|P1|Overall Study|Undefined|35
53076|NCT01190839|201313|P2|Overall Study|Trial stopped by Sponsor|68
53077|NCT01190839|201314|P1|Overall Study|Trial stopped by Sponsor|71
53078|NCT01190839|201313|P2|Overall Study|Death|0
53079|NCT01190839|201314|P1|Overall Study|Death|1
53080|NCT01190839|201313|P2|Overall Study|Lost to Follow-up|1
53081|NCT01190839|201314|P1|Overall Study|Lost to Follow-up|7
53082|NCT01190839|201313|P2|Overall Study|Protocol Violation|2
53083|NCT01190839|201314|P1|Overall Study|Protocol Violation|2
53084|NCT01190839|201313|P2|Overall Study|Adverse Event|41
53085|NCT01190839|201314|P1|Overall Study|Adverse Event|32
53086|NCT01190813|201328|P2|Overall Study|Adverse Event|1
53087|NCT01190813|201329|P1|Overall Study|Adverse Event|0
53088|NCT01190813|201328|P2|Overall Study|Refused study treatment after randomized|0
53089|NCT01190813|201329|P1|Overall Study|Refused study treatment after randomized|1
53090|NCT01190813|201328|P2|Overall Study|Withdrawal by Subject|1
53091|NCT01190813|201329|P1|Overall Study|Withdrawal by Subject|2
53092|NCT01190813|201328|P2|Overall Study|Lost to Follow-up|2
53093|NCT01190813|201329|P1|Overall Study|Lost to Follow-up|1
53094|NCT01190514|201450|P4|Third Intervention (Period 3)|Adverse Event|0
53095|NCT01190514|201451|P3|Third Intervention (Period 3)|Adverse Event|0
53096|NCT01190514|201452|P2|Third Intervention (Period 3)|Adverse Event|0
53097|NCT01190514|201453|P1|Third Intervention (Period 3)|Adverse Event|1
53098|NCT01190514|201450|P4|First Intervention (Period 1)|Adverse Event|0
53099|NCT01190514|201451|P3|First Intervention (Period 1)|Adverse Event|0
53100|NCT01190514|201452|P2|First Intervention (Period 1)|Adverse Event|0
53101|NCT01190514|201453|P1|First Intervention (Period 1)|Adverse Event|1
53102|NCT01190436|201483|P1|Overall Study|Unspecified|4
53103|NCT01190436|201483|P1|Overall Study|Lost to Follow-up|35
53104|NCT01190267|201508|P2|Overall Study|Protocol Violation|1
53105|NCT01190267|201509|P1|Overall Study|Protocol Violation|8
53106|NCT01190267|201508|P2|Overall Study|Withdrawal by Subject|1
53107|NCT01190267|201509|P1|Overall Study|Withdrawal by Subject|13
53108|NCT01190267|201508|P2|Overall Study|Lost to Follow-up|0
53109|NCT01190267|201509|P1|Overall Study|Lost to Follow-up|2
53110|NCT01190267|201508|P2|Overall Study|Treatment Failure|2
53111|NCT01190267|201509|P1|Overall Study|Treatment Failure|8
53112|NCT01190267|201508|P2|Overall Study|Adverse Event|0
53113|NCT01190267|201509|P1|Overall Study|Adverse Event|10
53114|NCT01190254|201520|P3|Overall Study|Did not meet protocol eligibility|0
53115|NCT01190254|201521|P2|Overall Study|Did not meet protocol eligibility|0
53116|NCT01190254|201522|P1|Overall Study|Did not meet protocol eligibility|1
53117|NCT01190254|201520|P3|Overall Study|Protocol Violation|2
53118|NCT01190254|201521|P2|Overall Study|Protocol Violation|0
53119|NCT01190254|201522|P1|Overall Study|Protocol Violation|2
53120|NCT01190254|201520|P3|Overall Study|Withdrawal by Subject|7
53121|NCT01190254|201521|P2|Overall Study|Withdrawal by Subject|5
53122|NCT01190254|201522|P1|Overall Study|Withdrawal by Subject|4
53123|NCT01190254|201520|P3|Overall Study|Lost to Follow-up|0
53124|NCT01190254|201521|P2|Overall Study|Lost to Follow-up|2
53125|NCT01190254|201522|P1|Overall Study|Lost to Follow-up|4
53126|NCT01190254|201520|P3|Overall Study|Lack of Efficacy|5
53127|NCT01190254|201521|P2|Overall Study|Lack of Efficacy|4
53128|NCT01190254|201522|P1|Overall Study|Lack of Efficacy|7
53129|NCT01190254|201520|P3|Overall Study|Adverse Event|8
53130|NCT01190254|201521|P2|Overall Study|Adverse Event|6
53131|NCT01190254|201522|P1|Overall Study|Adverse Event|3
53132|NCT01190215|201586|P2|Up to Month 6|Lost to Follow-up|0
53133|NCT01190215|201587|P1|Up to Month 6|Lost to Follow-up|2
53134|NCT01190150|201657|P2|Washout|Difficulty in adherence|1
53135|NCT01190150|201658|P1|Washout|Difficulty in adherence|0
53136|NCT01190150|201657|P2|Washout|Withdrawal by Subject|1
53137|NCT01190150|201658|P1|Washout|Withdrawal by Subject|0
53138|NCT01190150|201657|P2|First Treatment|Withdrawal by Subject|0
53139|NCT01190150|201658|P1|First Treatment|Withdrawal by Subject|1
53140|NCT01190124|201685|P3|Overall Study|Lost to Follow-up|0
53141|NCT01190124|201686|P2|Overall Study|Lost to Follow-up|0
53142|NCT01190124|201687|P1|Overall Study|Lost to Follow-up|2
53143|NCT01190124|201685|P3|Overall Study|Therapeutic Failure|1
53144|NCT01190124|201686|P2|Overall Study|Therapeutic Failure|0
53145|NCT01190124|201687|P1|Overall Study|Therapeutic Failure|12
53146|NCT01190124|201685|P3|Overall Study|Death|0
53147|NCT01190124|201686|P2|Overall Study|Death|0
53148|NCT01190124|201687|P1|Overall Study|Death|3
53149|NCT01190098|201725|P2|Overall Study|Other|1
53150|NCT01190098|201726|P1|Overall Study|Other|0
53151|NCT01190098|201725|P2|Overall Study|Lack of transportation|0
53152|NCT01190098|201726|P1|Overall Study|Lack of transportation|1
53153|NCT01190098|201725|P2|Overall Study|Patient coomorbidity|1
53154|NCT01190098|201726|P1|Overall Study|Patient coomorbidity|0
53155|NCT01190098|201725|P2|Overall Study|Adverse Event|0
53156|NCT01190098|201726|P1|Overall Study|Adverse Event|2
53157|NCT01190007|201765|P1|Overall Study|Participant was arrested|1
53158|NCT01190007|201765|P1|Overall Study|Difficulty of visit for complications|1
53159|NCT01190007|201765|P1|Overall Study|Adverse Event|8
53160|NCT01190007|201765|P1|Overall Study|Withdrawal by Subject|4
53161|NCT01189890|201782|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
53162|NCT01189890|201783|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
53163|NCT01189890|201782|P2|Overall Study|Physician Decision|4
53164|NCT01189890|201783|P1|Overall Study|Physician Decision|5
53165|NCT01189890|201782|P2|Overall Study|Non Compliance|1
53166|NCT01189890|201783|P1|Overall Study|Non Compliance|0
53167|NCT01189890|201782|P2|Overall Study|Withdrawal by Subject|11
53168|NCT01189890|201783|P1|Overall Study|Withdrawal by Subject|15
53169|NCT01189890|201782|P2|Overall Study|Protocol Violation|5
53170|NCT01189890|201783|P1|Overall Study|Protocol Violation|1
53171|NCT01189890|201782|P2|Overall Study|Lost to Follow-up|7
53172|NCT01189890|201783|P1|Overall Study|Lost to Follow-up|1
53173|NCT01189890|201782|P2|Overall Study|Lack of Efficacy|2
53174|NCT01189890|201783|P1|Overall Study|Lack of Efficacy|7
53175|NCT01189890|201782|P2|Overall Study|Adverse Event|4
53176|NCT01189890|201783|P1|Overall Study|Adverse Event|3
53177|NCT01189812|201805|P2|Overall Study|Moved out of State|2
53178|NCT01189812|201806|P1|Overall Study|Moved out of State|1
53179|NCT01189812|201805|P2|Overall Study|Out of Window|3
53180|NCT01189812|201806|P1|Overall Study|Out of Window|4
53181|NCT01189812|201805|P2|Overall Study|Adverse Event|0
53182|NCT01189812|201806|P1|Overall Study|Adverse Event|1
53183|NCT01189812|201805|P2|Overall Study|Withdrawal by Subject|3
53184|NCT01189812|201806|P1|Overall Study|Withdrawal by Subject|2
53185|NCT01189604|201890|P7|Overall Study|Withdrawal by Subject|0
53186|NCT01189604|201891|P6|Overall Study|Withdrawal by Subject|0
53187|NCT01189604|201892|P5|Overall Study|Withdrawal by Subject|0
53188|NCT01189604|201893|P4|Overall Study|Withdrawal by Subject|0
53189|NCT01189604|201894|P3|Overall Study|Withdrawal by Subject|0
53190|NCT01189604|201895|P2|Overall Study|Withdrawal by Subject|0
53191|NCT01189604|201896|P1|Overall Study|Withdrawal by Subject|1
53192|NCT01189604|201890|P7|Overall Study|Adverse Event|1
53193|NCT01189604|201891|P6|Overall Study|Adverse Event|0
53194|NCT01189604|201892|P5|Overall Study|Adverse Event|2
53195|NCT01189604|201893|P4|Overall Study|Adverse Event|0
53196|NCT01189604|201894|P3|Overall Study|Adverse Event|0
53197|NCT01189604|201895|P2|Overall Study|Adverse Event|1
53198|NCT01189604|201896|P1|Overall Study|Adverse Event|0
53199|NCT01189604|201890|P7|Overall Study|Impossible to visit|0
53200|NCT01189604|201891|P6|Overall Study|Impossible to visit|1
53201|NCT01189604|201892|P5|Overall Study|Impossible to visit|0
53202|NCT01189604|201893|P4|Overall Study|Impossible to visit|0
53203|NCT01189604|201894|P3|Overall Study|Impossible to visit|0
53204|NCT01189604|201895|P2|Overall Study|Impossible to visit|0
53205|NCT01189604|201896|P1|Overall Study|Impossible to visit|0
53206|NCT01189500|201940|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
53207|NCT01189500|201940|P1|Period 1: TAMOX Alone|Adverse Event|1
53208|NCT01189487|202001|P1|Overall Study|Adverse Event|1
53209|NCT01189487|202001|P1|Overall Study|Lack of Efficacy|2
53210|NCT01189461|202009|P1|Overall Study|Unspecified|8
53211|NCT01189461|202009|P1|Overall Study|Did not meet entrance criteria|3
53212|NCT01189461|202009|P1|Overall Study|Adverse Event|2
53213|NCT01189461|202009|P1|Overall Study|Protocol Violation|1
53214|NCT01189461|202009|P1|Overall Study|Withdrawal by Subject|6
53215|NCT01189461|202009|P1|Overall Study|Lost to Follow-up|1
53216|NCT01189461|202009|P1|Overall Study|Lack of Efficacy|13
53217|NCT01189435|202016|P1|Overall Study|Physician Decision|1
53218|NCT01189435|202016|P1|Overall Study|Withdrawal by Subject|1
53219|NCT01189227|202089|P2|Overall Study|Study terminated due to low accrual|3
53220|NCT01189227|202090|P1|Overall Study|Study terminated due to low accrual|6
53221|NCT01189201|202096|P1|Overall Study|Adverse Event|1
53222|NCT01189032|202199|P3|Overall Study|Protocol Violation|1
53223|NCT01189032|202200|P2|Overall Study|Protocol Violation|1
53224|NCT01189032|202201|P1|Overall Study|Protocol Violation|1
53225|NCT01189032|202199|P3|Overall Study|Withdrawal by Subject|1
53226|NCT01189032|202200|P2|Overall Study|Withdrawal by Subject|0
53227|NCT01189032|202201|P1|Overall Study|Withdrawal by Subject|1
53228|NCT01189032|202199|P3|Overall Study|Lack of Efficacy|0
53229|NCT01189032|202200|P2|Overall Study|Lack of Efficacy|3
53230|NCT01189032|202201|P1|Overall Study|Lack of Efficacy|2
53231|NCT01189032|202199|P3|Overall Study|Adverse Event|4
53232|NCT01189032|202200|P2|Overall Study|Adverse Event|3
53233|NCT01189032|202201|P1|Overall Study|Adverse Event|1
53234|NCT01188967|202211|P2|Overall Study|Lost to Follow-up|2
53235|NCT01188967|202212|P1|Overall Study|Lost to Follow-up|3
53236|NCT01188967|202211|P2|Overall Study|Physician Decision|1
53237|NCT01188967|202212|P1|Overall Study|Physician Decision|1
53238|NCT01188967|202211|P2|Overall Study|Withdrawal by Subject|1
53239|NCT01188967|202212|P1|Overall Study|Withdrawal by Subject|1
53240|NCT01188811|202255|P2|Overall Study|Adverse Event|0
53241|NCT01188811|202256|P1|Overall Study|Adverse Event|6
53242|NCT01188811|202255|P2|Overall Study|Withdrawal by Subject|2
53243|NCT01188811|202256|P1|Overall Study|Withdrawal by Subject|0
53244|NCT01188798|202268|P2|Overall Study|Protocol closure|1
53245|NCT01188798|202269|P1|Overall Study|Protocol closure|1
53246|NCT01188798|202268|P2|Overall Study|Required additional transplant|1
53247|NCT01188798|202269|P1|Overall Study|Required additional transplant|1
53248|NCT01188798|202268|P2|Overall Study|Death|1
53249|NCT01188798|202269|P1|Overall Study|Death|0
53250|NCT01188772|202281|P4|Overall Study|Withdrawal by Subject|0
53251|NCT01188772|202282|P3|Overall Study|Withdrawal by Subject|2
53252|NCT01188772|202283|P2|Overall Study|Withdrawal by Subject|0
53253|NCT01188772|202284|P1|Overall Study|Withdrawal by Subject|0
53254|NCT01188772|202281|P4|Overall Study|Virologic Failure|0
53255|NCT01188772|202282|P3|Overall Study|Virologic Failure|0
53256|NCT01188772|202283|P2|Overall Study|Virologic Failure|0
53257|NCT01188772|202284|P1|Overall Study|Virologic Failure|1
53258|NCT01188772|202281|P4|Overall Study|Treatment Failure|0
53259|NCT01188772|202282|P3|Overall Study|Treatment Failure|1
53260|NCT01188772|202283|P2|Overall Study|Treatment Failure|0
53261|NCT01188772|202284|P1|Overall Study|Treatment Failure|0
53262|NCT01188772|202281|P4|Overall Study|Terminated by Sponsor|0
53263|NCT01188772|202282|P3|Overall Study|Terminated by Sponsor|1
53264|NCT01188772|202283|P2|Overall Study|Terminated by Sponsor|0
53265|NCT01188772|202284|P1|Overall Study|Terminated by Sponsor|0
53266|NCT01188772|202281|P4|Overall Study|Physician Decision|0
53267|NCT01188772|202282|P3|Overall Study|Physician Decision|1
53268|NCT01188772|202283|P2|Overall Study|Physician Decision|0
53269|NCT01188772|202284|P1|Overall Study|Physician Decision|0
53270|NCT01188772|202281|P4|Overall Study|Non-responder|0
53271|NCT01188772|202282|P3|Overall Study|Non-responder|3
53272|NCT01188772|202283|P2|Overall Study|Non-responder|0
53273|NCT01188772|202284|P1|Overall Study|Non-responder|0
53274|NCT01188772|202281|P4|Overall Study|Lost to Follow-up|1
53275|NCT01188772|202282|P3|Overall Study|Lost to Follow-up|1
53276|NCT01188772|202283|P2|Overall Study|Lost to Follow-up|1
53277|NCT01188772|202284|P1|Overall Study|Lost to Follow-up|4
53278|NCT01188772|202281|P4|Overall Study|Adverse Event|0
53279|NCT01188772|202282|P3|Overall Study|Adverse Event|2
53280|NCT01188772|202283|P2|Overall Study|Adverse Event|1
53281|NCT01188772|202284|P1|Overall Study|Adverse Event|0
53282|NCT01188772|202281|P4|Overall Study|Randomized but Not Treated|0
53283|NCT01188772|202282|P3|Overall Study|Randomized but Not Treated|0
53284|NCT01188772|202283|P2|Overall Study|Randomized but Not Treated|1
53285|NCT01188772|202284|P1|Overall Study|Randomized but Not Treated|0
53286|NCT01188681|202343|P4|Overall Study|Withdrawal by Subject|1
53287|NCT01188681|202344|P3|Overall Study|Withdrawal by Subject|0
53288|NCT01188681|202345|P2|Overall Study|Withdrawal by Subject|0
53289|NCT01188681|202346|P1|Overall Study|Withdrawal by Subject|0
53290|NCT01188681|202343|P4|Overall Study|bladder cancer|0
53291|NCT01188681|202344|P3|Overall Study|bladder cancer|1
53292|NCT01188681|202345|P2|Overall Study|bladder cancer|0
53293|NCT01188681|202346|P1|Overall Study|bladder cancer|0
53294|NCT01188668|202360|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
53295|NCT01188668|202360|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
53296|NCT01188668|202360|P1|Period 1: ARIP Alone|Protocol Violation|2
53297|NCT01188655|202393|P1|Overall Study|Unspecified|11
53298|NCT01188655|202393|P1|Overall Study|Lost to Follow-up|1
53299|NCT01188655|202393|P1|Overall Study|Lack of Efficacy|1
53300|NCT01188564|202437|P2|Double-blind Phase|randomized not treated|0
53301|NCT01188564|202438|P1|Double-blind Phase|randomized not treated|1
53302|NCT01188551|202450|P4|Overall Study|Pharmacy issues|0
53303|NCT01188551|202451|P3|Overall Study|Pharmacy issues|0
53304|NCT01188551|202452|P2|Overall Study|Pharmacy issues|0
53305|NCT01188551|202453|P1|Overall Study|Pharmacy issues|1
53306|NCT01188538|202469|P2|Overall Study|Lost to Follow-up|1
53307|NCT01188538|202470|P1|Overall Study|Lost to Follow-up|0
53308|NCT01188343|202507|P3|Overall Study|Withdrawal by Subject|0
53309|NCT01188343|202508|P2|Overall Study|Withdrawal by Subject|24
53310|NCT01188343|202509|P1|Overall Study|Withdrawal by Subject|1
53311|NCT01188343|202507|P3|Overall Study|Not vaccinated|1
53312|NCT01188343|202508|P2|Overall Study|Not vaccinated|2
53313|NCT01188343|202509|P1|Overall Study|Not vaccinated|0
53314|NCT01188226|202535|P1|Overall Study|Withdrawal by Subject|4
53315|NCT01187953|202581|P2|Overall Study|Withdrawal by Subject|3
53316|NCT01187953|202582|P1|Overall Study|Withdrawal by Subject|3
53317|NCT01187953|202581|P2|Overall Study|Lost to Follow-up|3
53318|NCT01187953|202582|P1|Overall Study|Lost to Follow-up|0
53319|NCT01187953|202581|P2|Overall Study|Adverse Event|2
53320|NCT01187953|202582|P1|Overall Study|Adverse Event|1
53321|NCT01187953|202581|P2|Overall Study|Death|13
53322|NCT01187953|202582|P1|Overall Study|Death|11
53323|NCT01187901|202596|P2|Overall Study|Pregnancy|2
53324|NCT01187901|202597|P1|Overall Study|Pregnancy|0
53325|NCT01187901|202596|P2|Overall Study|No Endpoint due to Early Study Halt|3
53326|NCT01187901|202597|P1|Overall Study|No Endpoint due to Early Study Halt|2
53327|NCT01187901|202596|P2|Overall Study|Adverse Event|0
53328|NCT01187901|202597|P1|Overall Study|Adverse Event|3
53329|NCT01187901|202596|P2|Overall Study|Suspected Allergic Reaction|1
53330|NCT01187901|202597|P1|Overall Study|Suspected Allergic Reaction|1
53331|NCT01187901|202596|P2|Overall Study|Unrelated Health Reasons|2
53332|NCT01187901|202597|P1|Overall Study|Unrelated Health Reasons|1
53333|NCT01187901|202596|P2|Overall Study|Lost to Follow-up|2
53334|NCT01187901|202597|P1|Overall Study|Lost to Follow-up|1
53335|NCT01187901|202596|P2|Overall Study|Protocol Violation|0
53336|NCT01187901|202597|P1|Overall Study|Protocol Violation|1
53337|NCT01187550|202615|P2|Overall Study|Randomized but not treated|0
53338|NCT01187550|202616|P1|Overall Study|Randomized but not treated|8
53339|NCT01187550|202615|P2|Overall Study|Unspecified|0
53340|NCT01187550|202616|P1|Overall Study|Unspecified|3
53341|NCT01187550|202615|P2|Overall Study|Protocol Violation|1
53342|NCT01187550|202616|P1|Overall Study|Protocol Violation|3
53343|NCT01187433|202772|P2|Overall Study|Withdrawal by Subject|2
53344|NCT01187433|202773|P1|Overall Study|Withdrawal by Subject|5
53345|NCT01187433|202772|P2|Overall Study|Protocol Violation|2
53346|NCT01187433|202773|P1|Overall Study|Protocol Violation|6
53347|NCT01187043|202817|P5|Overall Study|Unable to make scheduled visits|1
53348|NCT01187043|202818|P4|Overall Study|Unable to make scheduled visits|0
53349|NCT01187043|202819|P3|Overall Study|Unable to make scheduled visits|4
53350|NCT01187043|202820|P2|Overall Study|Unable to make scheduled visits|0
53351|NCT01187043|202821|P1|Overall Study|Unable to make scheduled visits|1
53352|NCT01187043|202817|P5|Overall Study|Adverse Event|1
53353|NCT01187043|202818|P4|Overall Study|Adverse Event|0
53354|NCT01187043|202819|P3|Overall Study|Adverse Event|0
53355|NCT01187043|202820|P2|Overall Study|Adverse Event|0
53356|NCT01187043|202821|P1|Overall Study|Adverse Event|0
53357|NCT01186939|202847|P1|Overall Study|Transformation to AML|1
53358|NCT01186939|202847|P1|Overall Study|Bone marrow transplant|1
53359|NCT01186939|202847|P1|Overall Study|Myocardial infarction|1
53360|NCT01186939|202847|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
53361|NCT01186939|202847|P1|Overall Study|Started additional treatment|1
53362|NCT01186939|202847|P1|Overall Study|Sponsor decision|4
53363|NCT01186939|202847|P1|Overall Study|Program closed|5
53364|NCT01186939|202847|P1|Overall Study|No longer receiving clinical benefit|17
53365|NCT01186939|202847|P1|Overall Study|Withdrawal by Subject|2
53366|NCT01186939|202847|P1|Overall Study|Death|7
53367|NCT01186848|202851|P1|Overall Study|Adverse Event|2
53368|NCT01186848|202851|P1|Overall Study|Withdrawal by Subject|2
53369|NCT01186848|202851|P1|Overall Study|Lost to Follow-up|4
53370|NCT01186796|202859|P2|Overall Study|Protocol Violation|1
53371|NCT01186796|202860|P1|Overall Study|Protocol Violation|0
53372|NCT01186796|202859|P2|Overall Study|Withdrawal by Subject|1
53373|NCT01186796|202860|P1|Overall Study|Withdrawal by Subject|1
53374|NCT01186796|202859|P2|Overall Study|Adverse Event|0
53375|NCT01186796|202860|P1|Overall Study|Adverse Event|3
53376|NCT01186744|202880|P6|Overall Study|Death|0
53377|NCT01186744|202881|P5|Overall Study|Death|0
53378|NCT01186744|202882|P4|Overall Study|Death|0
53379|NCT01186744|202883|P3|Overall Study|Death|0
53380|NCT01186744|202884|P2|Overall Study|Death|0
53381|NCT01186744|202885|P1|Overall Study|Death|1
53382|NCT01186744|202880|P6|Overall Study|Adverse Event|4
53383|NCT01186744|202881|P5|Overall Study|Adverse Event|1
53384|NCT01186744|202882|P4|Overall Study|Adverse Event|0
53385|NCT01186744|202883|P3|Overall Study|Adverse Event|1
53386|NCT01186744|202884|P2|Overall Study|Adverse Event|14
53387|NCT01186744|202885|P1|Overall Study|Adverse Event|10
53388|NCT01186744|202880|P6|Overall Study|Not specified|5
53389|NCT01186744|202881|P5|Overall Study|Not specified|1
53390|NCT01186744|202882|P4|Overall Study|Not specified|2
53391|NCT01186744|202883|P3|Overall Study|Not specified|1
53392|NCT01186744|202884|P2|Overall Study|Not specified|10
53393|NCT01186744|202885|P1|Overall Study|Not specified|9
53394|NCT01186744|202880|P6|Overall Study|Study terminated by Sponsor|0
53395|NCT01186744|202881|P5|Overall Study|Study terminated by Sponsor|0
53396|NCT01186744|202882|P4|Overall Study|Study terminated by Sponsor|0
53397|NCT01186744|202883|P3|Overall Study|Study terminated by Sponsor|0
53398|NCT01186744|202884|P2|Overall Study|Study terminated by Sponsor|0
53399|NCT01186744|202885|P1|Overall Study|Study terminated by Sponsor|1
53400|NCT01186744|202880|P6|Overall Study|Withdrawal by Subject|6
53401|NCT01186744|202881|P5|Overall Study|Withdrawal by Subject|0
53402|NCT01186744|202882|P4|Overall Study|Withdrawal by Subject|5
53403|NCT01186744|202883|P3|Overall Study|Withdrawal by Subject|2
53404|NCT01186744|202884|P2|Overall Study|Withdrawal by Subject|10
53405|NCT01186744|202885|P1|Overall Study|Withdrawal by Subject|14
53406|NCT01186744|202880|P6|Overall Study|Screen failure|0
53407|NCT01186744|202881|P5|Overall Study|Screen failure|0
53408|NCT01186744|202882|P4|Overall Study|Screen failure|1
53409|NCT01186744|202883|P3|Overall Study|Screen failure|0
53410|NCT01186744|202884|P2|Overall Study|Screen failure|1
53411|NCT01186744|202885|P1|Overall Study|Screen failure|1
53412|NCT01186744|202880|P6|Overall Study|Lost to Follow-up|4
53413|NCT01186744|202881|P5|Overall Study|Lost to Follow-up|1
53414|NCT01186744|202882|P4|Overall Study|Lost to Follow-up|1
53415|NCT01186744|202883|P3|Overall Study|Lost to Follow-up|2
53416|NCT01186744|202884|P2|Overall Study|Lost to Follow-up|16
53417|NCT01186744|202885|P1|Overall Study|Lost to Follow-up|15
53418|NCT01186744|202880|P6|Overall Study|Protocol Violation|2
53419|NCT01186744|202881|P5|Overall Study|Protocol Violation|1
53420|NCT01186744|202882|P4|Overall Study|Protocol Violation|1
53421|NCT01186744|202883|P3|Overall Study|Protocol Violation|0
53422|NCT01186744|202884|P2|Overall Study|Protocol Violation|2
53423|NCT01186744|202885|P1|Overall Study|Protocol Violation|1
53424|NCT01186744|202880|P6|Overall Study|Lack of Efficacy|5
53425|NCT01186744|202881|P5|Overall Study|Lack of Efficacy|2
53426|NCT01186744|202882|P4|Overall Study|Lack of Efficacy|2
53427|NCT01186744|202883|P3|Overall Study|Lack of Efficacy|0
53428|NCT01186744|202884|P2|Overall Study|Lack of Efficacy|99
53429|NCT01186744|202885|P1|Overall Study|Lack of Efficacy|156
53430|NCT01186692|203305|P1|Overall Study|Adverse Event|2
53431|NCT01186692|203305|P1|Overall Study|Futher testing contraindicated implant|19
53432|NCT01186692|203305|P1|Overall Study|Not Catheterized|11
53433|NCT01186458|203332|P1|Overall Study|Adverse Event|1
53434|NCT01186419|203341|P2|Overall Study|Not specified|1
53435|NCT01186419|203342|P1|Overall Study|Not specified|1
53436|NCT01186419|203341|P2|Overall Study|Physician Decision|3
53437|NCT01186419|203342|P1|Overall Study|Physician Decision|0
53438|NCT01186419|203341|P2|Overall Study|Adverse Event|2
53439|NCT01186419|203342|P1|Overall Study|Adverse Event|1
53440|NCT01186419|203341|P2|Overall Study|Withdrawal by Subject|3
53441|NCT01186419|203342|P1|Overall Study|Withdrawal by Subject|5
53442|NCT01185834|203377|P1|Overall Study|Early exit - Site error|2
53443|NCT01185834|203377|P1|Overall Study|Time/Job Conflict|2
53444|NCT01185834|203377|P1|Overall Study|Biomicroscopy|4
53445|NCT01185834|203377|P1|Overall Study|Discomfort|4
53446|NCT01185834|203377|P1|Overall Study|Lost to Follow-up|2
53447|NCT01185782|203384|P2|Overall Study|Randomized but not treated|4
53448|NCT01185782|203385|P1|Overall Study|Randomized but not treated|0
53449|NCT01185782|203384|P2|Overall Study|Unspecified|5
53450|NCT01185782|203385|P1|Overall Study|Unspecified|2
53451|NCT01185782|203384|P2|Overall Study|Poor Response to Treatment|1
53452|NCT01185782|203385|P1|Overall Study|Poor Response to Treatment|3
53453|NCT01185782|203384|P2|Overall Study|Protocol Violation|0
53454|NCT01185782|203385|P1|Overall Study|Protocol Violation|1
53455|NCT01185782|203384|P2|Overall Study|Adverse Event|1
53456|NCT01185782|203385|P1|Overall Study|Adverse Event|0
53457|NCT01185704|203413|P2|Overall Study|Ectopic pregnancy|1
53458|NCT01185704|203414|P1|Overall Study|Ectopic pregnancy|0
53459|NCT01185704|203413|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
53460|NCT01185704|203414|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
53461|NCT01185704|203413|P2|Overall Study|Lack of ovarian response|1
53462|NCT01185704|203414|P1|Overall Study|Lack of ovarian response|5
53463|NCT01185704|203413|P2|Overall Study|Randomized but not treated|3
53464|NCT01185704|203414|P1|Overall Study|Randomized but not treated|3
53465|NCT01185600|203450|P2|Overall Study|Hold by DSMB|2
53466|NCT01185600|203451|P1|Overall Study|Hold by DSMB|1
53467|NCT01185600|203450|P2|Overall Study|Withdrawal by Subject|1
53468|NCT01185600|203451|P1|Overall Study|Withdrawal by Subject|1
53469|NCT01185600|203450|P2|Overall Study|Physician Decision|35
53470|NCT01185600|203451|P1|Overall Study|Physician Decision|29
53471|NCT01185600|203450|P2|Overall Study|Lost to Follow-up|5
53472|NCT01185600|203451|P1|Overall Study|Lost to Follow-up|0
53473|NCT01185600|203450|P2|Overall Study|Death|1
53474|NCT01185600|203451|P1|Overall Study|Death|0
53475|NCT01185600|203450|P2|Overall Study|Adverse Event|1
53476|NCT01185600|203451|P1|Overall Study|Adverse Event|1
53477|NCT01185561|203473|P2|Overall Study|Withdrawal by Subject|8
53478|NCT01185561|203474|P1|Overall Study|Withdrawal by Subject|2
53479|NCT01185561|203473|P2|Overall Study|Lost to Follow-up|4
53480|NCT01185561|203474|P1|Overall Study|Lost to Follow-up|0
53481|NCT01185522|203486|P1|Overall Study|Other reasons|12
53482|NCT01185522|203486|P1|Overall Study|Poor tolerance|39
53483|NCT01185522|203486|P1|Overall Study|Withdrawal by Subject|10
53484|NCT01185522|203486|P1|Overall Study|Lost to Follow-up|19
53485|NCT01185522|203486|P1|Overall Study|Lack of Efficacy|28
53486|NCT01185301|203514|P4|Overall Study|Other Reason|2
53487|NCT01185301|203515|P3|Overall Study|Other Reason|2
53488|NCT01185301|203516|P2|Overall Study|Other Reason|2
53489|NCT01185301|203517|P1|Overall Study|Other Reason|3
53490|NCT01185301|203514|P4|Overall Study|Lost to Follow-up|1
53491|NCT01185301|203515|P3|Overall Study|Lost to Follow-up|0
53492|NCT01185301|203516|P2|Overall Study|Lost to Follow-up|0
53493|NCT01185301|203517|P1|Overall Study|Lost to Follow-up|2
53494|NCT01185301|203514|P4|Overall Study|Withdrawal by Subject|3
53495|NCT01185301|203515|P3|Overall Study|Withdrawal by Subject|2
53496|NCT01185301|203516|P2|Overall Study|Withdrawal by Subject|5
53497|NCT01185301|203517|P1|Overall Study|Withdrawal by Subject|7
53498|NCT01185301|203514|P4|Overall Study|Adverse Event|3
53499|NCT01185301|203515|P3|Overall Study|Adverse Event|2
53500|NCT01185301|203516|P2|Overall Study|Adverse Event|0
53501|NCT01185301|203517|P1|Overall Study|Adverse Event|3
53502|NCT01185288|203577|P2|Overall Study|Noncompliance|1
53503|NCT01185288|203578|P1|Overall Study|Noncompliance|0
53504|NCT01185288|203577|P2|Overall Study|Did not meet inclusion criteria|0
53505|NCT01185288|203578|P1|Overall Study|Did not meet inclusion criteria|1
53506|NCT01185288|203577|P2|Overall Study|Investigator discretion|0
53507|NCT01185288|203578|P1|Overall Study|Investigator discretion|1
53508|NCT01185288|203577|P2|Overall Study|Lack of Efficacy|0
53509|NCT01185288|203578|P1|Overall Study|Lack of Efficacy|2
53510|NCT01185288|203577|P2|Overall Study|Lost to Follow-up|5
53511|NCT01185288|203578|P1|Overall Study|Lost to Follow-up|2
53512|NCT01185288|203577|P2|Overall Study|Withdrawal by Subject|4
53513|NCT01185288|203578|P1|Overall Study|Withdrawal by Subject|6
53514|NCT01185288|203577|P2|Overall Study|Adverse Event|6
53515|NCT01185288|203578|P1|Overall Study|Adverse Event|7
53516|NCT01185249|203596|P1|Overall Study|Patients discharged or change in status|42
53517|NCT01185080|203604|P3|Overall Study|Personal reasons|1
53518|NCT01185080|203605|P2|Overall Study|Personal reasons|0
53519|NCT01185080|203606|P1|Overall Study|Personal reasons|0
53520|NCT01185080|203604|P3|Overall Study|Adverse Event|0
53521|NCT01185080|203605|P2|Overall Study|Adverse Event|1
53522|NCT01185080|203606|P1|Overall Study|Adverse Event|1
53523|NCT01184989|203658|P1|Overall Study|Withdrawal by Subject|1
53524|NCT01184989|203658|P1|Overall Study|Adverse Event|11
53525|NCT01184872|203678|P2|Overall Study|Protocol deviation|0
53526|NCT01184872|203679|P1|Overall Study|Protocol deviation|1
53527|NCT01184872|203678|P2|Overall Study|Administrative problems|1
53528|NCT01184872|203679|P1|Overall Study|Administrative problems|1
53529|NCT01184872|203678|P2|Overall Study|Lost to Follow-up|1
53530|NCT01184872|203679|P1|Overall Study|Lost to Follow-up|0
53531|NCT01184872|203678|P2|Overall Study|Withdrawal by Subject|0
53532|NCT01184872|203679|P1|Overall Study|Withdrawal by Subject|2
53533|NCT01184872|203678|P2|Overall Study|Unsatisfactory therapeutic effect|2
53534|NCT01184872|203679|P1|Overall Study|Unsatisfactory therapeutic effect|3
53535|NCT01184872|203678|P2|Overall Study|Adverse Event|4
53536|NCT01184872|203679|P1|Overall Study|Adverse Event|3
53537|NCT01184859|203698|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
53538|NCT01184859|203699|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
53539|NCT01184859|203700|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
53540|NCT01184859|203701|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
53541|NCT01184859|203702|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
53542|NCT01184859|203698|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
53543|NCT01184859|203699|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
53544|NCT01184859|203700|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
53545|NCT01184859|203701|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
53546|NCT01184859|203702|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
53547|NCT01184859|203698|P5|Period 1: Single Dose|Adverse Event|1
53548|NCT01184859|203699|P4|Period 1: Single Dose|Adverse Event|0
53549|NCT01184859|203700|P3|Period 1: Single Dose|Adverse Event|0
53550|NCT01184859|203701|P2|Period 1: Single Dose|Adverse Event|0
53551|NCT01184859|203702|P1|Period 1: Single Dose|Adverse Event|0
53552|NCT01184859|203698|P5|Period 1: Single Dose|Protocol Violation|0
53553|NCT01184859|203699|P4|Period 1: Single Dose|Protocol Violation|0
53554|NCT01184859|203700|P3|Period 1: Single Dose|Protocol Violation|0
53555|NCT01184859|203701|P2|Period 1: Single Dose|Protocol Violation|1
53556|NCT01184859|203702|P1|Period 1: Single Dose|Protocol Violation|0
53557|NCT01184859|203698|P5|Period 1: Single Dose|Insufficient urine production|0
53558|NCT01184859|203699|P4|Period 1: Single Dose|Insufficient urine production|0
53559|NCT01184859|203700|P3|Period 1: Single Dose|Insufficient urine production|0
53560|NCT01184859|203701|P2|Period 1: Single Dose|Insufficient urine production|1
53561|NCT01184859|203702|P1|Period 1: Single Dose|Insufficient urine production|0
53562|NCT01184846|203794|P1|Overall Study|Insufficient response|1
53563|NCT01184846|203794|P1|Overall Study|Adverse Event|2
53564|NCT01184118|203835|P1|Overall Study|Withdrawal by Subject|5
53565|NCT01184118|203835|P1|Overall Study|Exclusionary medical condition|2
53566|NCT01184118|203835|P1|Overall Study|FEV1 <60% predicted|2
53567|NCT01184118|203835|P1|Overall Study|No physiologic confirmation of asthma|8
53568|NCT01184118|203835|P1|Overall Study|Only asthma step 1 - screen fail|1
53569|NCT01184079|203843|P2|Overall Study|Lost to Follow-up|2
53570|NCT01184079|203844|P1|Overall Study|Lost to Follow-up|14
53571|NCT01183975|203863|P1|Overall Study|Lost to Follow-up|73
53572|NCT01183858|203870|P2|Overall Study|Lost to Follow-up|1
53573|NCT01183858|203871|P1|Overall Study|Lost to Follow-up|1
53574|NCT01183858|203870|P2|Overall Study|Death related to Progressive Disease|5
53575|NCT01183858|203871|P1|Overall Study|Death related to Progressive Disease|4
53576|NCT01183858|203870|P2|Overall Study|Progressive Disease|115
53577|NCT01183858|203871|P1|Overall Study|Progressive Disease|112
53578|NCT01183858|203870|P2|Overall Study|Administrative/Other|6
53579|NCT01183858|203871|P1|Overall Study|Administrative/Other|6
53580|NCT01183858|203870|P2|Overall Study|Protocol Violation|0
53581|NCT01183858|203871|P1|Overall Study|Protocol Violation|1
53582|NCT01183858|203870|P2|Overall Study|Discontinued Smoking|1
53583|NCT01183858|203871|P1|Overall Study|Discontinued Smoking|3
53584|NCT01183858|203870|P2|Overall Study|Withdrew Consent|4
53585|NCT01183858|203871|P1|Overall Study|Withdrew Consent|4
53586|NCT01183858|203870|P2|Overall Study|Refused Treatment|4
53587|NCT01183858|203871|P1|Overall Study|Refused Treatment|1
53588|NCT01183858|203870|P2|Overall Study|Insufficient Therapeutic Response|0
53589|NCT01183858|203871|P1|Overall Study|Insufficient Therapeutic Response|2
53590|NCT01183858|203870|P2|Overall Study|Investigator's Decision|3
53591|NCT01183858|203871|P1|Overall Study|Investigator's Decision|0
53592|NCT01183858|203870|P2|Overall Study|Adverse Event|11
53593|NCT01183858|203871|P1|Overall Study|Adverse Event|14
53594|NCT01183858|203870|P2|Overall Study|Death not related to Progressive Disease|6
53595|NCT01183858|203871|P1|Overall Study|Death not related to Progressive Disease|5
53596|NCT01183780|203893|P2|Overall Study|On treatment|16
53597|NCT01183780|203894|P1|Overall Study|On treatment|17
53598|NCT01183780|203893|P2|Overall Study|Lost to Follow-up|11
53599|NCT01183780|203894|P1|Overall Study|Lost to Follow-up|6
53600|NCT01183780|203893|P2|Overall Study|Withdrawal by Subject|13
53601|NCT01183780|203894|P1|Overall Study|Withdrawal by Subject|20
53602|NCT01183468|203954|P4|Overall Study|Withdrawal by Subject|0
53603|NCT01183468|203955|P3|Overall Study|Withdrawal by Subject|0
53604|NCT01183468|203956|P2|Overall Study|Withdrawal by Subject|1
53605|NCT01183468|203957|P1|Overall Study|Withdrawal by Subject|0
53606|NCT01183468|203954|P4|Overall Study|Physician Decision|0
53607|NCT01183468|203955|P3|Overall Study|Physician Decision|0
53608|NCT01183468|203956|P2|Overall Study|Physician Decision|0
53609|NCT01183468|203957|P1|Overall Study|Physician Decision|1
53610|NCT01183468|203954|P4|Overall Study|Lost to Follow-up|0
53611|NCT01183468|203955|P3|Overall Study|Lost to Follow-up|0
53612|NCT01183468|203956|P2|Overall Study|Lost to Follow-up|1
53613|NCT01183468|203957|P1|Overall Study|Lost to Follow-up|2
53614|NCT01183390|203967|P2|First Intervention|Adverse Event|1
53615|NCT01183390|203968|P1|First Intervention|Adverse Event|0
53616|NCT01183234|203999|P2|First Intervention|Adverse Event|0
53617|NCT01183234|204000|P1|First Intervention|Adverse Event|1
53618|NCT01183065|204092|P1|Overall Study|Patient no longer fits eligibility crite|1
53619|NCT01183013|204103|P7|Overall Study|Reasons other than stated above|13
53620|NCT01183013|204104|P6|Overall Study|Reasons other than stated above|15
53621|NCT01183013|204105|P5|Overall Study|Reasons other than stated above|12
53622|NCT01183013|204106|P4|Overall Study|Reasons other than stated above|12
53623|NCT01183013|204107|P3|Overall Study|Reasons other than stated above|17
53624|NCT01183013|204108|P2|Overall Study|Reasons other than stated above|11
53625|NCT01183013|204109|P1|Overall Study|Reasons other than stated above|15
53626|NCT01183013|204103|P7|Overall Study|Withdrawal by Subject|10
53627|NCT01183013|204104|P6|Overall Study|Withdrawal by Subject|9
53628|NCT01183013|204105|P5|Overall Study|Withdrawal by Subject|7
53629|NCT01183013|204106|P4|Overall Study|Withdrawal by Subject|8
53630|NCT01183013|204107|P3|Overall Study|Withdrawal by Subject|10
53631|NCT01183013|204108|P2|Overall Study|Withdrawal by Subject|13
53632|NCT01183013|204109|P1|Overall Study|Withdrawal by Subject|9
53633|NCT01183013|204103|P7|Overall Study|Lost to Follow-up|5
53634|NCT01183013|204104|P6|Overall Study|Lost to Follow-up|6
53635|NCT01183013|204105|P5|Overall Study|Lost to Follow-up|2
53636|NCT01183013|204106|P4|Overall Study|Lost to Follow-up|3
53637|NCT01183013|204107|P3|Overall Study|Lost to Follow-up|4
53638|NCT01183013|204108|P2|Overall Study|Lost to Follow-up|3
53639|NCT01183013|204109|P1|Overall Study|Lost to Follow-up|7
53640|NCT01183013|204103|P7|Overall Study|Protocol Violation|3
53641|NCT01183013|204104|P6|Overall Study|Protocol Violation|3
53642|NCT01183013|204105|P5|Overall Study|Protocol Violation|4
53643|NCT01183013|204106|P4|Overall Study|Protocol Violation|0
53644|NCT01183013|204107|P3|Overall Study|Protocol Violation|4
53645|NCT01183013|204108|P2|Overall Study|Protocol Violation|2
53646|NCT01183013|204109|P1|Overall Study|Protocol Violation|5
53647|NCT01183013|204103|P7|Overall Study|Lack of Efficacy|0
53648|NCT01183013|204104|P6|Overall Study|Lack of Efficacy|2
53649|NCT01183013|204105|P5|Overall Study|Lack of Efficacy|1
53650|NCT01183013|204106|P4|Overall Study|Lack of Efficacy|2
53651|NCT01183013|204107|P3|Overall Study|Lack of Efficacy|1
53652|NCT01183013|204108|P2|Overall Study|Lack of Efficacy|2
53653|NCT01183013|204109|P1|Overall Study|Lack of Efficacy|3
53654|NCT01183013|204103|P7|Overall Study|Adverse Event|6
53655|NCT01183013|204104|P6|Overall Study|Adverse Event|10
53656|NCT01183013|204105|P5|Overall Study|Adverse Event|10
53657|NCT01183013|204106|P4|Overall Study|Adverse Event|5
53658|NCT01183013|204107|P3|Overall Study|Adverse Event|5
53659|NCT01183013|204108|P2|Overall Study|Adverse Event|8
53660|NCT01183013|204109|P1|Overall Study|Adverse Event|6
53661|NCT01182428|204233|P2|Overall Study|Withdrawal by Subject|0
53662|NCT01182428|204234|P1|Overall Study|Withdrawal by Subject|1
53663|NCT01182428|204233|P2|Overall Study|Lost to Follow-up|1
53664|NCT01182428|204234|P1|Overall Study|Lost to Follow-up|9
53665|NCT01182428|204233|P2|Overall Study|Physician Decision|0
53666|NCT01182428|204234|P1|Overall Study|Physician Decision|1
53667|NCT01182337|204309|P2|Overall Study|Lost to Follow-up|1
53668|NCT01182337|204310|P1|Overall Study|Lost to Follow-up|0
53669|NCT01182337|204309|P2|Overall Study|Withdrawal by Subject|1
53670|NCT01182337|204310|P1|Overall Study|Withdrawal by Subject|3
53671|NCT01182298|204328|P1|Overall Study|Withdrawal by Subject|2
53672|NCT01182298|204328|P1|Overall Study|Lack of Efficacy|4
53673|NCT01182285|204332|P3|Third Intervention Week 11-52|Other|2
53674|NCT01182285|204333|P2|Third Intervention Week 11-52|Other|0
53675|NCT01182285|204334|P1|Third Intervention Week 11-52|Other|0
53676|NCT01182285|204332|P3|Third Intervention Week 11-52|Disease Progression|6
53677|NCT01182285|204333|P2|Third Intervention Week 11-52|Disease Progression|0
53678|NCT01182285|204334|P1|Third Intervention Week 11-52|Disease Progression|0
53679|NCT01182285|204332|P3|First Intervention Week 1-10|Non-compliance|0
53680|NCT01182285|204333|P2|First Intervention Week 1-10|Non-compliance|0
53681|NCT01182285|204334|P1|First Intervention Week 1-10|Non-compliance|1
53682|NCT01182285|204332|P3|First Intervention Week 1-10|Adverse Event|0
53683|NCT01182285|204333|P2|First Intervention Week 1-10|Adverse Event|0
53684|NCT01182285|204334|P1|First Intervention Week 1-10|Adverse Event|1
53685|NCT01182285|204332|P3|First Intervention Week 1-10|Disease progression|0
53686|NCT01182285|204333|P2|First Intervention Week 1-10|Disease progression|0
53687|NCT01182285|204334|P1|First Intervention Week 1-10|Disease progression|1
53688|NCT01182207|204344|P2|Second Intervention|Emeses within 1 hour of dosing|0
53689|NCT01182207|204345|P1|Second Intervention|Emeses within 1 hour of dosing|1
53690|NCT01182207|204344|P2|First Intervention|Positive Hepatitis Results|1
53691|NCT01182207|204345|P1|First Intervention|Positive Hepatitis Results|0
53692|NCT01182194|204363|P2|Washout of 28 Days|Withdrawal by Subject|0
53693|NCT01182194|204364|P1|Washout of 28 Days|Withdrawal by Subject|1
53694|NCT01182181|204382|P2|Washout of 21 Days|Withdrawal by Subject|1
53695|NCT01182181|204383|P1|Washout of 21 Days|Withdrawal by Subject|0
53696|NCT01182181|204382|P2|First Intervention|Adverse Event|0
53697|NCT01182181|204383|P1|First Intervention|Adverse Event|1
53698|NCT01181986|204408|P3|Phase 2|Medical condition|0
53699|NCT01181986|204409|P2|Phase 2|Medical condition|1
53700|NCT01181986|204410|P1|Phase 2|Medical condition|0
53701|NCT01181986|204408|P3|Phase 2|Adverse Event|0
53702|NCT01181986|204409|P2|Phase 2|Adverse Event|3
53703|NCT01181986|204410|P1|Phase 2|Adverse Event|0
53704|NCT01181986|204408|P3|Phase 1|Protocol Violation|0
53705|NCT01181986|204409|P2|Phase 1|Protocol Violation|0
53706|NCT01181986|204410|P1|Phase 1|Protocol Violation|1
53707|NCT01181986|204408|P3|Phase 1|Adverse Event|1
53708|NCT01181986|204409|P2|Phase 1|Adverse Event|0
53709|NCT01181986|204410|P1|Phase 1|Adverse Event|0
53710|NCT01181986|204408|P3|Phase 1|Lost to Follow-up|1
53711|NCT01181986|204409|P2|Phase 1|Lost to Follow-up|1
53712|NCT01181986|204410|P1|Phase 1|Lost to Follow-up|0
53713|NCT01181921|204431|P1|Overall Study|Lost to Follow-up|1
53714|NCT01181895|204438|P3|Overall Study|Withdrawal by Subject|5
53715|NCT01181895|204439|P2|Overall Study|Withdrawal by Subject|0
53716|NCT01181895|204440|P1|Overall Study|Withdrawal by Subject|3
53717|NCT01181895|204438|P3|Overall Study|Investigator Discretion|1
53718|NCT01181895|204439|P2|Overall Study|Investigator Discretion|2
53719|NCT01181895|204440|P1|Overall Study|Investigator Discretion|1
53720|NCT01181895|204438|P3|Overall Study|Lost to Follow-up|2
53721|NCT01181895|204439|P2|Overall Study|Lost to Follow-up|1
53722|NCT01181895|204440|P1|Overall Study|Lost to Follow-up|0
53723|NCT01181895|204438|P3|Overall Study|Protocol Violation|0
53724|NCT01181895|204439|P2|Overall Study|Protocol Violation|1
53725|NCT01181895|204440|P1|Overall Study|Protocol Violation|2
53726|NCT01181895|204438|P3|Overall Study|Lack of Efficacy|9
53727|NCT01181895|204439|P2|Overall Study|Lack of Efficacy|9
53728|NCT01181895|204440|P1|Overall Study|Lack of Efficacy|8
53729|NCT01181895|204438|P3|Overall Study|Adverse Event|1
53730|NCT01181895|204439|P2|Overall Study|Adverse Event|1
53731|NCT01181895|204440|P1|Overall Study|Adverse Event|3
53732|NCT01181778|204498|P1|Overall Study|Physician Decision|48
53733|NCT01181726|204506|P2|First Intervention|Adverse Event|0
53734|NCT01181726|204507|P1|First Intervention|Adverse Event|1
53735|NCT01181609|204553|P1|Overall Study|Death|50
53736|NCT01181609|204553|P1|Overall Study|Lost to Follow-up|1
53737|NCT01181609|204553|P1|Overall Study|Withdrawal by Subject|1
53738|NCT01181609|204553|P1|Overall Study|Adverse Event|1
53739|NCT01181531|204566|P2|Overall Study|Adverse Event|1
53740|NCT01181531|204567|P1|Overall Study|Adverse Event|0
53741|NCT01181531|204566|P2|Overall Study|Death|12
53742|NCT01181531|204567|P1|Overall Study|Death|9
53743|NCT01181531|204566|P2|Overall Study|Protocol Violation|6
53744|NCT01181531|204567|P1|Overall Study|Protocol Violation|6
53745|NCT01181531|204566|P2|Overall Study|Withdrawal by Subject|7
53746|NCT01181531|204567|P1|Overall Study|Withdrawal by Subject|8
53747|NCT01181531|204566|P2|Overall Study|Pregnancy|1
53748|NCT01181531|204567|P1|Overall Study|Pregnancy|0
53749|NCT01181531|204566|P2|Overall Study|Protocol Specified Criteria|8
53750|NCT01181531|204567|P1|Overall Study|Protocol Specified Criteria|15
53751|NCT01181531|204566|P2|Overall Study|Ineligibility determined|2
53752|NCT01181531|204567|P1|Overall Study|Ineligibility determined|1
53753|NCT01181531|204566|P2|Overall Study|Noncompliance|2
53754|NCT01181531|204567|P1|Overall Study|Noncompliance|2
53755|NCT01181531|204566|P2|Overall Study|Physician Decision|1
53756|NCT01181531|204567|P1|Overall Study|Physician Decision|3
53757|NCT01181531|204566|P2|Overall Study|Partial consent by subject withdrawn|1
53758|NCT01181531|204567|P1|Overall Study|Partial consent by subject withdrawn|0
53759|NCT01181531|204566|P2|Overall Study|Not known|12
53760|NCT01181531|204567|P1|Overall Study|Not known|17
53761|NCT01181167|204692|P2|Overall Study|Withdrawal by Subject|8
53762|NCT01181167|204693|P1|Overall Study|Withdrawal by Subject|6
53763|NCT01181167|204692|P2|Overall Study|Protocol Violation|0
53764|NCT01181167|204693|P1|Overall Study|Protocol Violation|3
53765|NCT01181167|204692|P2|Overall Study|Physician Decision|3
53766|NCT01181167|204693|P1|Overall Study|Physician Decision|2
53767|NCT01181167|204692|P2|Overall Study|Lost to Follow-up|0
53768|NCT01181167|204693|P1|Overall Study|Lost to Follow-up|1
53769|NCT01181167|204692|P2|Overall Study|Adverse Event|21
53770|NCT01181167|204693|P1|Overall Study|Adverse Event|11
53771|NCT01181141|204703|P2|Overall Study|Withdrawal by Subject|1
53772|NCT01181141|204704|P1|Overall Study|Withdrawal by Subject|3
53773|NCT01181141|204703|P2|Overall Study|Protocol Violation|1
53774|NCT01181141|204704|P1|Overall Study|Protocol Violation|3
53775|NCT01181141|204703|P2|Overall Study|Physician Decision|0
53776|NCT01181141|204704|P1|Overall Study|Physician Decision|2
53777|NCT01181141|204703|P2|Overall Study|Lost to Follow-up|1
53778|NCT01181141|204704|P1|Overall Study|Lost to Follow-up|1
53779|NCT01181141|204703|P2|Overall Study|Lack of Efficacy|0
53780|NCT01181141|204704|P1|Overall Study|Lack of Efficacy|1
53781|NCT01181141|204703|P2|Overall Study|Adverse Event|1
53782|NCT01181141|204704|P1|Overall Study|Adverse Event|2
53783|NCT01181128|204713|P3|Overall Study|Not Specified|1
53784|NCT01181128|204714|P2|Overall Study|Not Specified|1
53785|NCT01181128|204715|P1|Overall Study|Not Specified|1
53786|NCT01181128|204713|P3|Overall Study|Adverse Event|0
53787|NCT01181128|204714|P2|Overall Study|Adverse Event|2
53788|NCT01181128|204715|P1|Overall Study|Adverse Event|0
53789|NCT01181128|204713|P3|Overall Study|Physician Decision|0
53790|NCT01181128|204714|P2|Overall Study|Physician Decision|0
53791|NCT01181128|204715|P1|Overall Study|Physician Decision|2
53792|NCT01181128|204713|P3|Overall Study|Death|0
53793|NCT01181128|204714|P2|Overall Study|Death|0
53794|NCT01181128|204715|P1|Overall Study|Death|1
53795|NCT01181128|204713|P3|Overall Study|Withdrawal by Subject|0
53796|NCT01181128|204714|P2|Overall Study|Withdrawal by Subject|2
53797|NCT01181128|204715|P1|Overall Study|Withdrawal by Subject|2
53798|NCT01181102|204803|P2|Overall Study|Withdrawal by Subject|12
53799|NCT01181102|204804|P1|Overall Study|Withdrawal by Subject|10
53800|NCT01181102|204803|P2|Overall Study|Protocol Violation|6
53801|NCT01181102|204804|P1|Overall Study|Protocol Violation|5
53802|NCT01181102|204803|P2|Overall Study|Physician Decision|1
53803|NCT01181102|204804|P1|Overall Study|Physician Decision|3
53804|NCT01181102|204803|P2|Overall Study|Lost to Follow-up|0
53805|NCT01181102|204804|P1|Overall Study|Lost to Follow-up|2
53806|NCT01181102|204803|P2|Overall Study|Lack of Efficacy|1
53807|NCT01181102|204804|P1|Overall Study|Lack of Efficacy|3
53808|NCT01181102|204803|P2|Overall Study|Adverse Event|26
53809|NCT01181102|204804|P1|Overall Study|Adverse Event|28
53810|NCT01181011|204825|P1|Overall Study|Lost to Follow-up|1
53811|NCT01181011|204825|P1|Overall Study|Adverse Event|2
53812|NCT01180998|204875|P3|Overall Study|Poor lens handling|2
53813|NCT01180998|204876|P2|Overall Study|Poor lens handling|0
53814|NCT01180998|204877|P1|Overall Study|Poor lens handling|0
53815|NCT01180998|204875|P3|Overall Study|Poor comfort|4
53816|NCT01180998|204876|P2|Overall Study|Poor comfort|0
53817|NCT01180998|204877|P1|Overall Study|Poor comfort|3
53818|NCT01180998|204875|P3|Overall Study|Withdrawal by Subject|1
53819|NCT01180998|204876|P2|Overall Study|Withdrawal by Subject|0
53820|NCT01180998|204877|P1|Overall Study|Withdrawal by Subject|0
53821|NCT01180998|204875|P3|Overall Study|Protocol Violation|0
53822|NCT01180998|204876|P2|Overall Study|Protocol Violation|2
53823|NCT01180998|204877|P1|Overall Study|Protocol Violation|1
53824|NCT01180998|204875|P3|Overall Study|Lost to Follow-up|1
53825|NCT01180998|204876|P2|Overall Study|Lost to Follow-up|0
53826|NCT01180998|204877|P1|Overall Study|Lost to Follow-up|0
53827|NCT01180998|204875|P3|Overall Study|Poor Vision|2
53828|NCT01180998|204876|P2|Overall Study|Poor Vision|2
53829|NCT01180998|204877|P1|Overall Study|Poor Vision|0
53830|NCT01180985|204891|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
53831|NCT01180985|204892|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
53832|NCT01180790|204931|P7|Overall Study|Severe coronary atherosclerosis (death)|0
53833|NCT01180790|204932|P6|Overall Study|Severe coronary atherosclerosis (death)|0
53834|NCT01180790|204933|P5|Overall Study|Severe coronary atherosclerosis (death)|0
53835|NCT01180790|204934|P4|Overall Study|Severe coronary atherosclerosis (death)|0
53836|NCT01180790|204935|P3|Overall Study|Severe coronary atherosclerosis (death)|1
53837|NCT01180790|204936|P2|Overall Study|Severe coronary atherosclerosis (death)|0
53838|NCT01180790|204937|P1|Overall Study|Severe coronary atherosclerosis (death)|0
53839|NCT01180790|204931|P7|Overall Study|compliance|0
53840|NCT01180790|204932|P6|Overall Study|compliance|0
53841|NCT01180790|204933|P5|Overall Study|compliance|0
53842|NCT01180790|204934|P4|Overall Study|compliance|0
53843|NCT01180790|204935|P3|Overall Study|compliance|0
53844|NCT01180790|204936|P2|Overall Study|compliance|1
53845|NCT01180790|204937|P1|Overall Study|compliance|0
53846|NCT01180790|204931|P7|Overall Study|Lack of Efficacy|0
53847|NCT01180790|204932|P6|Overall Study|Lack of Efficacy|3
53848|NCT01180790|204933|P5|Overall Study|Lack of Efficacy|1
53849|NCT01180790|204934|P4|Overall Study|Lack of Efficacy|6
53850|NCT01180790|204935|P3|Overall Study|Lack of Efficacy|5
53851|NCT01180790|204936|P2|Overall Study|Lack of Efficacy|2
53852|NCT01180790|204937|P1|Overall Study|Lack of Efficacy|1
53853|NCT01180790|204931|P7|Overall Study|Physician Decision|0
53854|NCT01180790|204932|P6|Overall Study|Physician Decision|0
53855|NCT01180790|204933|P5|Overall Study|Physician Decision|0
53856|NCT01180790|204934|P4|Overall Study|Physician Decision|1
53857|NCT01180790|204935|P3|Overall Study|Physician Decision|0
53858|NCT01180790|204936|P2|Overall Study|Physician Decision|0
53859|NCT01180790|204937|P1|Overall Study|Physician Decision|1
53860|NCT01180790|204931|P7|Overall Study|Lost to Follow-up|1
53861|NCT01180790|204932|P6|Overall Study|Lost to Follow-up|0
53862|NCT01180790|204933|P5|Overall Study|Lost to Follow-up|1
53863|NCT01180790|204934|P4|Overall Study|Lost to Follow-up|2
53864|NCT01180790|204935|P3|Overall Study|Lost to Follow-up|0
53865|NCT01180790|204936|P2|Overall Study|Lost to Follow-up|1
53866|NCT01180790|204937|P1|Overall Study|Lost to Follow-up|3
53867|NCT01180790|204931|P7|Overall Study|Withdrawal by Subject|0
53868|NCT01180790|204932|P6|Overall Study|Withdrawal by Subject|1
53869|NCT01180790|204933|P5|Overall Study|Withdrawal by Subject|2
53870|NCT01180790|204934|P4|Overall Study|Withdrawal by Subject|0
53871|NCT01180790|204935|P3|Overall Study|Withdrawal by Subject|5
53872|NCT01180790|204936|P2|Overall Study|Withdrawal by Subject|0
53873|NCT01180790|204937|P1|Overall Study|Withdrawal by Subject|3
53874|NCT01180790|204931|P7|Overall Study|Adverse Event|0
53875|NCT01180790|204932|P6|Overall Study|Adverse Event|3
53876|NCT01180790|204933|P5|Overall Study|Adverse Event|1
53877|NCT01180790|204934|P4|Overall Study|Adverse Event|0
53878|NCT01180790|204935|P3|Overall Study|Adverse Event|2
53879|NCT01180790|204936|P2|Overall Study|Adverse Event|1
53880|NCT01180790|204937|P1|Overall Study|Adverse Event|1
53881|NCT01180777|205002|P1|Overall Study|Adverse Event|1
53882|NCT01180777|205002|P1|Overall Study|Lost to Follow-up|1
53883|NCT01180777|205002|P1|Overall Study|Poor lens fit|4
53884|NCT01180777|205002|P1|Overall Study|Protocol Violation|6
53885|NCT01180660|205016|P2|Overall Study|Changed to open surgery|0
53886|NCT01180660|205017|P1|Overall Study|Changed to open surgery|1
53887|NCT01180647|205027|P2|Overall Study|Lost to Follow-up|6
53888|NCT01180647|205028|P1|Overall Study|Lost to Follow-up|5
53889|NCT01180400|205046|P2|Overall Study|Not specified|1
53890|NCT01180400|205047|P1|Overall Study|Not specified|0
53891|NCT01180400|205046|P2|Overall Study|Lost to Follow-up|3
53892|NCT01180400|205047|P1|Overall Study|Lost to Follow-up|2
53893|NCT01180400|205046|P2|Overall Study|Study-specific withdrawal criteria|2
53894|NCT01180400|205047|P1|Overall Study|Study-specific withdrawal criteria|1
53895|NCT01180400|205046|P2|Overall Study|Lack of Efficacy|0
53896|NCT01180400|205047|P1|Overall Study|Lack of Efficacy|2
53897|NCT01180400|205046|P2|Overall Study|Condition under investigation worsened|1
53898|NCT01180400|205047|P1|Overall Study|Condition under investigation worsened|2
53899|NCT01180400|205046|P2|Overall Study|Severe non-compliance to protocol|2
53900|NCT01180400|205047|P1|Overall Study|Severe non-compliance to protocol|1
53901|NCT01180400|205046|P2|Overall Study|Adverse Event|10
53902|NCT01180400|205047|P1|Overall Study|Adverse Event|12
53903|NCT01180400|205046|P2|Overall Study|Eligibility criteria not fulfilled|2
53904|NCT01180400|205047|P1|Overall Study|Eligibility criteria not fulfilled|0
53905|NCT01180400|205046|P2|Overall Study|Withdrawal by Subject|6
53906|NCT01180400|205047|P1|Overall Study|Withdrawal by Subject|5
53907|NCT01180296|205095|P2|Overall Study|Protocol Violation|2
53908|NCT01180296|205096|P1|Overall Study|Protocol Violation|1
53909|NCT01180244|205104|P2|Overall Study|Lost to Follow-up|0
53910|NCT01180244|205105|P1|Overall Study|Lost to Follow-up|1
53911|NCT01180244|205104|P2|Overall Study|Protocol Violation|0
53912|NCT01180244|205105|P1|Overall Study|Protocol Violation|1
53913|NCT01180244|205104|P2|Overall Study|Withdrawal by Subject|1
53914|NCT01180244|205105|P1|Overall Study|Withdrawal by Subject|0
53915|NCT01180244|205104|P2|Overall Study|Adverse Event|0
53916|NCT01180244|205105|P1|Overall Study|Adverse Event|1
53917|NCT01180244|205104|P2|Overall Study|Physician Decision|0
53918|NCT01180244|205105|P1|Overall Study|Physician Decision|3
53919|NCT01180244|205104|P2|Overall Study|Lack of Efficacy|7
53920|NCT01180244|205105|P1|Overall Study|Lack of Efficacy|0
53921|NCT01179919|205148|P1|Overall Study|Adverse Event|1
53922|NCT01179919|205148|P1|Overall Study|Protocol Violation|1
53923|NCT01179737|205157|P4|Extension|The study was terminated|0
53924|NCT01179737|205158|P3|Extension|The study was terminated|0
53925|NCT01179737|205159|P2|Extension|The study was terminated|0
53926|NCT01179737|205160|P1|Extension|The study was terminated|3
53927|NCT01179737|205157|P4|Cohort 1 & Cohort 2 Expansion|Death|0
53928|NCT01179737|205158|P3|Cohort 1 & Cohort 2 Expansion|Death|0
53929|NCT01179737|205159|P2|Cohort 1 & Cohort 2 Expansion|Death|0
53930|NCT01179737|205160|P1|Cohort 1 & Cohort 2 Expansion|Death|1
53931|NCT01179737|205157|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
53932|NCT01179737|205158|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
53933|NCT01179737|205159|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
53934|NCT01179737|205160|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
53935|NCT01179737|205157|P4|Cohort 1 & Cohort 2|Death|0
53936|NCT01179737|205158|P3|Cohort 1 & Cohort 2|Death|1
53937|NCT01179737|205159|P2|Cohort 1 & Cohort 2|Death|0
53938|NCT01179737|205160|P1|Cohort 1 & Cohort 2|Death|0
53939|NCT01179737|205157|P4|Cohort 1 & Cohort 2|Administrative problems|4
53940|NCT01179737|205158|P3|Cohort 1 & Cohort 2|Administrative problems|2
53941|NCT01179737|205159|P2|Cohort 1 & Cohort 2|Administrative problems|0
53942|NCT01179737|205160|P1|Cohort 1 & Cohort 2|Administrative problems|0
53943|NCT01179737|205157|P4|Cohort 1 & Cohort 2|Withdrew consent|0
53944|NCT01179737|205158|P3|Cohort 1 & Cohort 2|Withdrew consent|0
53945|NCT01179737|205159|P2|Cohort 1 & Cohort 2|Withdrew consent|0
53946|NCT01179737|205160|P1|Cohort 1 & Cohort 2|Withdrew consent|2
53947|NCT01179737|205157|P4|Cohort 1 & Cohort 2|Adverse Event|0
53948|NCT01179737|205158|P3|Cohort 1 & Cohort 2|Adverse Event|1
53949|NCT01179737|205159|P2|Cohort 1 & Cohort 2|Adverse Event|1
53950|NCT01179737|205160|P1|Cohort 1 & Cohort 2|Adverse Event|3
53951|NCT01179672|205171|P2|Overall Study|Physician Decision|1
53952|NCT01179672|205172|P1|Overall Study|Physician Decision|1
53953|NCT01179672|205171|P2|Overall Study|Protocol Violation|2
53954|NCT01179672|205172|P1|Overall Study|Protocol Violation|2
53955|NCT01179672|205171|P2|Overall Study|Lost to Follow-up|1
53956|NCT01179672|205172|P1|Overall Study|Lost to Follow-up|0
53957|NCT01179672|205171|P2|Overall Study|Entry Criteria Not Met|2
53958|NCT01179672|205172|P1|Overall Study|Entry Criteria Not Met|0
53959|NCT01179672|205171|P2|Overall Study|Withdrawal by Subject|12
53960|NCT01179672|205172|P1|Overall Study|Withdrawal by Subject|10
53961|NCT01179672|205171|P2|Overall Study|Adverse Event|8
53962|NCT01179672|205172|P1|Overall Study|Adverse Event|17
53963|NCT01179516|205228|P3|Overall Study|Other|2
53964|NCT01179516|205229|P2|Overall Study|Other|0
53965|NCT01179516|205230|P1|Overall Study|Other|2
53966|NCT01179516|205228|P3|Overall Study|Lost to Follow-up|3
53967|NCT01179516|205229|P2|Overall Study|Lost to Follow-up|7
53968|NCT01179516|205230|P1|Overall Study|Lost to Follow-up|7
53969|NCT01179516|205228|P3|Overall Study|Withdrawal of Consent|10
53970|NCT01179516|205229|P2|Overall Study|Withdrawal of Consent|6
53971|NCT01179516|205230|P1|Overall Study|Withdrawal of Consent|2
53972|NCT01179516|205228|P3|Overall Study|Protocol Deviations|3
53973|NCT01179516|205229|P2|Overall Study|Protocol Deviations|3
53974|NCT01179516|205230|P1|Overall Study|Protocol Deviations|4
53975|NCT01179516|205228|P3|Overall Study|Noncompliance with Study Drug|1
53976|NCT01179516|205229|P2|Overall Study|Noncompliance with Study Drug|0
53977|NCT01179516|205230|P1|Overall Study|Noncompliance with Study Drug|2
53978|NCT01179516|205228|P3|Overall Study|Lack of Efficacy|0
53979|NCT01179516|205229|P2|Overall Study|Lack of Efficacy|2
53980|NCT01179516|205230|P1|Overall Study|Lack of Efficacy|4
53981|NCT01179516|205228|P3|Overall Study|Pretreatment Event or Adverse Event|12
53982|NCT01179516|205229|P2|Overall Study|Pretreatment Event or Adverse Event|8
53983|NCT01179516|205230|P1|Overall Study|Pretreatment Event or Adverse Event|6
53984|NCT01179399|205274|P1|Overall Study|Withdrawal by Subject|1
53985|NCT01179399|205274|P1|Overall Study|Lack of Efficacy|30
53986|NCT01179399|205274|P1|Overall Study|Adverse Event|1
53987|NCT01179347|205280|P2|Open-label Period (12 Weeks)|Other|4
53988|NCT01179347|205281|P1|Open-label Period (12 Weeks)|Other|7
53989|NCT01179347|205280|P2|Open-label Period (12 Weeks)|Protocol Violation|0
53990|NCT01179347|205281|P1|Open-label Period (12 Weeks)|Protocol Violation|1
53991|NCT01179347|205280|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
53992|NCT01179347|205281|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
53993|NCT01179347|205280|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
53994|NCT01179347|205281|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
53995|NCT01179347|205280|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
53996|NCT01179347|205281|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
53997|NCT01179347|205280|P2|Open-label Period (12 Weeks)|Adverse Event|9
53998|NCT01179347|205281|P1|Open-label Period (12 Weeks)|Adverse Event|5
53999|NCT01179347|205280|P2|Double-blind Period (12 Weeks)|Other|4
54000|NCT01179347|205281|P1|Double-blind Period (12 Weeks)|Other|2
54001|NCT01179347|205280|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
54002|NCT01179347|205281|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
54003|NCT01179347|205280|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
54004|NCT01179347|205281|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
54005|NCT01179347|205280|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
54006|NCT01179347|205281|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
54007|NCT01179347|205280|P2|Double-blind Period (12 Weeks)|Adverse Event|6
54008|NCT01179347|205281|P1|Double-blind Period (12 Weeks)|Adverse Event|2
54009|NCT01179334|205303|P2|Long-term Extension (LTE) Period|Adverse Event|4
54010|NCT01179334|205304|P1|Long-term Extension (LTE) Period|Adverse Event|2
54011|NCT01179334|205303|P2|Long-term Extension (LTE) Period|Death|0
54012|NCT01179334|205304|P1|Long-term Extension (LTE) Period|Death|3
54013|NCT01179334|205303|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
54014|NCT01179334|205304|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
54015|NCT01179334|205303|P2|Treatment Period|Adverse Event|0
54016|NCT01179334|205304|P1|Treatment Period|Adverse Event|1
54017|NCT01179191|205332|P1|Maintenance Phase (8 Weeks)|Unspecified|66
54018|NCT01179191|205332|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
54019|NCT01179191|205332|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
54020|NCT01179191|205332|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
54021|NCT01179191|205332|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
54022|NCT01179191|205332|P1|Titration Phase (up to 6 Weeks)|Unspecified|62
54023|NCT01179191|205332|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
54024|NCT01179191|205332|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
54025|NCT01179191|205332|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
54026|NCT01179191|205332|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
54027|NCT01179191|205332|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
54028|NCT01178853|205364|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
54029|NCT01178853|205365|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
54030|NCT01178853|205364|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
54031|NCT01178853|205365|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
54032|NCT01178853|205364|P2|Period 3 (Warfarin Titration)|Adverse Event|0
54033|NCT01178853|205365|P1|Period 3 (Warfarin Titration)|Adverse Event|1
54034|NCT01178853|205364|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
54035|NCT01178853|205365|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
54036|NCT01178853|205364|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
54037|NCT01178853|205365|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
54038|NCT01178762|205405|P1|Overall Study|Lost to Follow-up|15
54039|NCT01178671|205411|P2|Overall Study|Physician Decision|6
54040|NCT01178671|205412|P1|Overall Study|Physician Decision|4
54041|NCT01178671|205411|P2|Overall Study|Lost to Follow-up|1
54042|NCT01178671|205412|P1|Overall Study|Lost to Follow-up|3
54043|NCT01178671|205411|P2|Overall Study|Lack of Efficacy|1
54044|NCT01178671|205412|P1|Overall Study|Lack of Efficacy|0
54045|NCT01178671|205411|P2|Overall Study|Protocol Violation|1
54046|NCT01178671|205412|P1|Overall Study|Protocol Violation|1
54047|NCT01178671|205411|P2|Overall Study|Adverse Event|6
54048|NCT01178671|205412|P1|Overall Study|Adverse Event|4
54049|NCT01178385|205460|P2|Overall Study|Withdrawal by Subject|0
54050|NCT01178385|205461|P1|Overall Study|Withdrawal by Subject|2
54051|NCT01178294|205530|P1|Overall Study|Completion status could not be verified|1
54052|NCT01178294|205530|P1|Overall Study|Subject status is terminal|1
54053|NCT01178294|205530|P1|Overall Study|Development of inhibitors to OBI-1|1
54054|NCT01178294|205530|P1|Overall Study|Death|1
54055|NCT01178294|205530|P1|Overall Study|Lack of Efficacy|1
54056|NCT01178294|205530|P1|Overall Study|Lost to Follow-up|2
54057|NCT01178294|205530|P1|Overall Study|Adverse Event|4
54058|NCT01178281|205553|P2|Overall Study|Prohibited Medications|2
54059|NCT01178281|205554|P1|Overall Study|Prohibited Medications|0
54060|NCT01178281|205553|P2|Overall Study|Adverse Event|9
54061|NCT01178281|205554|P1|Overall Study|Adverse Event|39
54062|NCT01178281|205553|P2|Overall Study|Withdrawal by Subject|7
54063|NCT01178281|205554|P1|Overall Study|Withdrawal by Subject|18
54064|NCT01178281|205553|P2|Overall Study|Death|5
54065|NCT01178281|205554|P1|Overall Study|Death|4
54066|NCT01178281|205553|P2|Overall Study|Disease Progression|6
54067|NCT01178281|205554|P1|Overall Study|Disease Progression|18
54068|NCT01178281|205553|P2|Overall Study|Non-compliance to study drug|0
54069|NCT01178281|205554|P1|Overall Study|Non-compliance to study drug|1
54070|NCT01178281|205553|P2|Overall Study|Lack of Efficacy|38
54071|NCT01178281|205554|P1|Overall Study|Lack of Efficacy|60
54072|NCT01178281|205553|P2|Overall Study|Loss of Clinical Benefit|7
54073|NCT01178281|205554|P1|Overall Study|Loss of Clinical Benefit|5
54074|NCT01178281|205553|P2|Overall Study|Physician Decision|3
54075|NCT01178281|205554|P1|Overall Study|Physician Decision|4
54076|NCT01178138|205780|P1|Overall Study|Physician Decision|8
54077|NCT01178138|205780|P1|Overall Study|Withdrawal by Subject|7
54078|NCT01178138|205780|P1|Overall Study|Lost to Follow-up|8
54079|NCT01178125|205801|P1|Overall Study|Investigator Decision|5
54080|NCT01178125|205801|P1|Overall Study|Protocol Violation|17
54081|NCT01178125|205801|P1|Overall Study|Sponsor Decision|28
54082|NCT01178125|205801|P1|Overall Study|Other Reason|39
54083|NCT01178125|205801|P1|Overall Study|Pregnancy|55
54084|NCT01178125|205801|P1|Overall Study|Noncompliance|184
54085|NCT01178125|205801|P1|Overall Study|Withdrawal by Subject|209
54086|NCT01178125|205801|P1|Overall Study|Adverse Event|244
54087|NCT01178125|205801|P1|Overall Study|Lost to Follow-up|397
54088|NCT01178099|205832|P2|Overall Study|Physician Decision|1
54089|NCT01178099|205833|P1|Overall Study|Physician Decision|0
54090|NCT01178073|205874|P3|Overall Study|Missing Completion Status|0
54091|NCT01178073|205875|P2|Overall Study|Missing Completion Status|0
54092|NCT01178073|205876|P1|Overall Study|Missing Completion Status|1
54093|NCT01178073|205874|P3|Overall Study|Withdrawal by Subject|8
54094|NCT01178073|205875|P2|Overall Study|Withdrawal by Subject|6
54095|NCT01178073|205876|P1|Overall Study|Withdrawal by Subject|10
54096|NCT01178073|205874|P3|Overall Study|Physician Decision|10
54097|NCT01178073|205875|P2|Overall Study|Physician Decision|10
54098|NCT01178073|205876|P1|Overall Study|Physician Decision|14
54099|NCT01178073|205874|P3|Overall Study|Lost to Follow-up|3
54100|NCT01178073|205875|P2|Overall Study|Lost to Follow-up|0
54101|NCT01178073|205876|P1|Overall Study|Lost to Follow-up|2
54102|NCT01178073|205874|P3|Overall Study|Protocol Violation|1
54103|NCT01178073|205875|P2|Overall Study|Protocol Violation|1
54104|NCT01178073|205876|P1|Overall Study|Protocol Violation|1
54105|NCT01178073|205874|P3|Overall Study|Adverse Event|24
54106|NCT01178073|205875|P2|Overall Study|Adverse Event|27
54107|NCT01178073|205876|P1|Overall Study|Adverse Event|34
54108|NCT01177969|205907|P2|Overall Study|Withdrawal by Subject|2
54109|NCT01177969|205908|P1|Overall Study|Withdrawal by Subject|1
54110|NCT01177969|205907|P2|Overall Study|Protocol Violation|1
54111|NCT01177969|205908|P1|Overall Study|Protocol Violation|2
54112|NCT01177943|205931|P2|First Intervention|Withdrawal by Subject|0
54113|NCT01177943|205932|P1|First Intervention|Withdrawal by Subject|2
54114|NCT01177228|205944|P4|Overall Study|Withdrawal by Subject|0
54115|NCT01177228|205945|P3|Overall Study|Withdrawal by Subject|0
54116|NCT01177228|205946|P2|Overall Study|Withdrawal by Subject|1
54117|NCT01177228|205947|P1|Overall Study|Withdrawal by Subject|0
54118|NCT01177228|205944|P4|Overall Study|Worsening disease activity|0
54119|NCT01177228|205945|P3|Overall Study|Worsening disease activity|0
54120|NCT01177228|205946|P2|Overall Study|Worsening disease activity|0
54121|NCT01177228|205947|P1|Overall Study|Worsening disease activity|1
54122|NCT01177228|205944|P4|Overall Study|Positive tuberculosis test|0
54123|NCT01177228|205945|P3|Overall Study|Positive tuberculosis test|0
54124|NCT01177228|205946|P2|Overall Study|Positive tuberculosis test|1
54125|NCT01177228|205947|P1|Overall Study|Positive tuberculosis test|0
54126|NCT01177813|206009|P5|Overall Study|Other reason not defined above|2
54127|NCT01177813|206010|P4|Overall Study|Other reason not defined above|3
54128|NCT01177813|206011|P3|Overall Study|Other reason not defined above|2
54129|NCT01177813|206012|P2|Overall Study|Other reason not defined above|2
54130|NCT01177813|206013|P1|Overall Study|Other reason not defined above|5
54131|NCT01177813|206009|P5|Overall Study|Withdrawal by Subject|3
54132|NCT01177813|206010|P4|Overall Study|Withdrawal by Subject|5
54133|NCT01177813|206011|P3|Overall Study|Withdrawal by Subject|6
54134|NCT01177813|206012|P2|Overall Study|Withdrawal by Subject|7
54135|NCT01177813|206013|P1|Overall Study|Withdrawal by Subject|12
54136|NCT01177813|206009|P5|Overall Study|Lost to Follow-up|0
54137|NCT01177813|206010|P4|Overall Study|Lost to Follow-up|3
54138|NCT01177813|206011|P3|Overall Study|Lost to Follow-up|6
54139|NCT01177813|206012|P2|Overall Study|Lost to Follow-up|5
54140|NCT01177813|206013|P1|Overall Study|Lost to Follow-up|12
54141|NCT01177813|206009|P5|Overall Study|Protocol Violation|1
54142|NCT01177813|206010|P4|Overall Study|Protocol Violation|0
54143|NCT01177813|206011|P3|Overall Study|Protocol Violation|2
54144|NCT01177813|206012|P2|Overall Study|Protocol Violation|2
54145|NCT01177813|206013|P1|Overall Study|Protocol Violation|3
54146|NCT01177813|206009|P5|Overall Study|Lack of Efficacy|0
54147|NCT01177813|206010|P4|Overall Study|Lack of Efficacy|0
54148|NCT01177813|206011|P3|Overall Study|Lack of Efficacy|0
54149|NCT01177813|206012|P2|Overall Study|Lack of Efficacy|0
54150|NCT01177813|206013|P1|Overall Study|Lack of Efficacy|1
54151|NCT01177813|206009|P5|Overall Study|Adverse Event|3
54152|NCT01177813|206010|P4|Overall Study|Adverse Event|6
54153|NCT01177813|206011|P3|Overall Study|Adverse Event|4
54154|NCT01177813|206012|P2|Overall Study|Adverse Event|2
54155|NCT01177813|206013|P1|Overall Study|Adverse Event|8
54156|NCT01177800|206042|P2|Overall Study|Withdrawal of informed consent|1
54157|NCT01177800|206043|P1|Overall Study|Withdrawal of informed consent|0
54158|NCT01177800|206042|P2|Overall Study|Physician Decision|0
54159|NCT01177800|206043|P1|Overall Study|Physician Decision|1
54160|NCT01177800|206042|P2|Overall Study|Protocol Violation|1
54161|NCT01177800|206043|P1|Overall Study|Protocol Violation|0
54162|NCT01177800|206042|P2|Overall Study|Adverse Event|3
54163|NCT01177800|206043|P1|Overall Study|Adverse Event|9
54164|NCT01177722|206065|P4|Overall Study|Withdrawal by Subject|6
54165|NCT01177722|206066|P3|Overall Study|Withdrawal by Subject|4
54166|NCT01177722|206067|P2|Overall Study|Withdrawal by Subject|6
54167|NCT01177722|206068|P1|Overall Study|Withdrawal by Subject|10
54168|NCT01177722|206065|P4|Overall Study|Lost to Follow-up|1
54169|NCT01177722|206066|P3|Overall Study|Lost to Follow-up|3
54170|NCT01177722|206067|P2|Overall Study|Lost to Follow-up|4
54171|NCT01177722|206068|P1|Overall Study|Lost to Follow-up|3
54172|NCT01177722|206065|P4|Overall Study|Protocol Violation|0
54173|NCT01177722|206066|P3|Overall Study|Protocol Violation|1
54174|NCT01177722|206067|P2|Overall Study|Protocol Violation|0
54175|NCT01177722|206068|P1|Overall Study|Protocol Violation|0
54176|NCT01177722|206065|P4|Overall Study|Serious Adverse Event|0
54177|NCT01177722|206066|P3|Overall Study|Serious Adverse Event|1
54178|NCT01177722|206067|P2|Overall Study|Serious Adverse Event|0
54179|NCT01177722|206068|P1|Overall Study|Serious Adverse Event|0
54180|NCT01177670|206100|P1|Overall Study|Withdrawal by Subject|4
54181|NCT01177670|206100|P1|Overall Study|Physician Decision|50
54182|NCT01177670|206100|P1|Overall Study|Study Terminated|115
54183|NCT01177553|206107|P2|Overall Study|babies not yet 6 months of age|0
54184|NCT01177553|206108|P1|Overall Study|babies not yet 6 months of age|1
54185|NCT01177410|206117|P3|Overall Study|Lost to Follow-up|0
54186|NCT01177410|206118|P2|Overall Study|Lost to Follow-up|1
54187|NCT01177410|206119|P1|Overall Study|Lost to Follow-up|0
54188|NCT01177410|206117|P3|Overall Study|Withdrawal by Subject|3
54189|NCT01177410|206118|P2|Overall Study|Withdrawal by Subject|4
54190|NCT01177410|206119|P1|Overall Study|Withdrawal by Subject|1
54191|NCT01177410|206117|P3|Overall Study|Adverse Event|2
54192|NCT01177410|206118|P2|Overall Study|Adverse Event|2
54193|NCT01177410|206119|P1|Overall Study|Adverse Event|0
54194|NCT01177384|206132|P2|Overall Study|Withdrawal by Subject|12
54195|NCT01177384|206133|P1|Overall Study|Withdrawal by Subject|5
54196|NCT01177384|206132|P2|Overall Study|Protocol Violation|2
54197|NCT01177384|206133|P1|Overall Study|Protocol Violation|0
54198|NCT01177384|206132|P2|Overall Study|Physician Decision|3
54199|NCT01177384|206133|P1|Overall Study|Physician Decision|0
54200|NCT01177384|206132|P2|Overall Study|Lost to Follow-up|4
54201|NCT01177384|206133|P1|Overall Study|Lost to Follow-up|3
54202|NCT01177384|206132|P2|Overall Study|Lack of Efficacy|1
54203|NCT01177384|206133|P1|Overall Study|Lack of Efficacy|0
54204|NCT01177384|206132|P2|Overall Study|Adverse Event|4
54205|NCT01177384|206133|P1|Overall Study|Adverse Event|6
54206|NCT01177293|206145|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
54207|NCT01177293|206146|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
54208|NCT01176968|206162|P2|Overall Study|Reason not defined|3
54209|NCT01176968|206163|P1|Overall Study|Reason not defined|5
54210|NCT01176968|206162|P2|Overall Study|Study terminated by sponsor|1
54211|NCT01176968|206163|P1|Overall Study|Study terminated by sponsor|0
54212|NCT01176968|206162|P2|Overall Study|Did Not Meet Entrance Criteria|0
54213|NCT01176968|206163|P1|Overall Study|Did Not Meet Entrance Criteria|1
54214|NCT01176968|206162|P2|Overall Study|Protocol Violation|1
54215|NCT01176968|206163|P1|Overall Study|Protocol Violation|2
54216|NCT01176968|206162|P2|Overall Study|Withdrawal by Subject|48
54217|NCT01176968|206163|P1|Overall Study|Withdrawal by Subject|48
54218|NCT01176968|206162|P2|Overall Study|Lost to Follow-up|14
54219|NCT01176968|206163|P1|Overall Study|Lost to Follow-up|16
54220|NCT01176968|206162|P2|Overall Study|Lack of Efficacy|1
54221|NCT01176968|206163|P1|Overall Study|Lack of Efficacy|0
54222|NCT01176968|206162|P2|Overall Study|Death|3
54223|NCT01176968|206163|P1|Overall Study|Death|2
54224|NCT01176968|206162|P2|Overall Study|Adverse Event|11
54225|NCT01176968|206163|P1|Overall Study|Adverse Event|10
54226|NCT01176773|206213|P1|Overall Study|Withdrew consent|1
54227|NCT01176773|206213|P1|Overall Study|Screen Failure|2
54228|NCT01176513|206222|P1|Overall Study|Withdrew subjects prior to dosing|3
54229|NCT01176292|206237|P2|Overall Study|Has not scheduled one-year visit yet|2
54230|NCT01176292|206238|P1|Overall Study|Has not scheduled one-year visit yet|2
54231|NCT01176292|206237|P2|Overall Study|Physician Decision|2
54232|NCT01176292|206238|P1|Overall Study|Physician Decision|0
54233|NCT01176292|206237|P2|Overall Study|Adverse Event|1
54234|NCT01176292|206238|P1|Overall Study|Adverse Event|1
54235|NCT01176292|206237|P2|Overall Study|Lost to Follow-up|4
54236|NCT01176292|206238|P1|Overall Study|Lost to Follow-up|2
54237|NCT01176240|206260|P2|Study 306B|withdrew prior to dosing|1
54238|NCT01176240|206261|P1|Study 306B|withdrew prior to dosing|2
54239|NCT01176240|206260|P2|Study 306B|Lost to Follow-up|1
54240|NCT01176240|206261|P1|Study 306B|Lost to Follow-up|0
54241|NCT01176240|206260|P2|Study 306B|Supine Hypertension|2
54242|NCT01176240|206261|P1|Study 306B|Supine Hypertension|1
54243|NCT01176240|206260|P2|Study 306B|Physician Decision|1
54244|NCT01176240|206261|P1|Study 306B|Physician Decision|2
54245|NCT01176240|206260|P2|Study 306B|Withdrawal by Subject|1
54246|NCT01176240|206261|P1|Study 306B|Withdrawal by Subject|4
54247|NCT01176240|206260|P2|Study 306B|Protocol Violation|3
54248|NCT01176240|206261|P1|Study 306B|Protocol Violation|2
54249|NCT01176240|206260|P2|Study 306B|Adverse Event|5
54250|NCT01176240|206261|P1|Study 306B|Adverse Event|10
54251|NCT01176240|206260|P2|Study 306B|Lack of Efficacy|3
54252|NCT01176240|206261|P1|Study 306B|Lack of Efficacy|5
54253|NCT01176240|206260|P2|Study 306A|Stop due to diverse problems|0
54254|NCT01176240|206261|P1|Study 306A|Stop due to diverse problems|1
54255|NCT01176240|206260|P2|Study 306A|Withdrawal by Subject|1
54256|NCT01176240|206261|P1|Study 306A|Withdrawal by Subject|0
54257|NCT01176240|206260|P2|Study 306A|Protocol Violation|1
54258|NCT01176240|206261|P1|Study 306A|Protocol Violation|0
54259|NCT01176240|206260|P2|Study 306A|Lack of Efficacy|1
54260|NCT01176240|206261|P1|Study 306A|Lack of Efficacy|2
54261|NCT01176058|206287|P2|Overall Study|Withdrawal by Subject|0
54262|NCT01176058|206288|P1|Overall Study|Withdrawal by Subject|1
54263|NCT01176058|206287|P2|Overall Study|Insufficient mycological response|1
54264|NCT01176058|206288|P1|Overall Study|Insufficient mycological response|0
54265|NCT01176058|206287|P2|Overall Study|Insufficient clinical response|2
54266|NCT01176058|206288|P1|Overall Study|Insufficient clinical response|2
54267|NCT01176058|206287|P2|Overall Study|Adverse Event|0
54268|NCT01176058|206288|P1|Overall Study|Adverse Event|1
54269|NCT01176032|206312|P2|Overall Study|Not available|0
54270|NCT01176032|206313|P1|Overall Study|Not available|1
54271|NCT01176032|206312|P2|Overall Study|Informed consent withdrawn|0
54272|NCT01176032|206313|P1|Overall Study|Informed consent withdrawn|3
54273|NCT01176032|206312|P2|Overall Study|Protocol Violation|0
54274|NCT01176032|206313|P1|Overall Study|Protocol Violation|1
54275|NCT01176032|206312|P2|Overall Study|Unsatisfactory therapeutic effect|1
54276|NCT01176032|206313|P1|Overall Study|Unsatisfactory therapeutic effect|0
54277|NCT01176032|206312|P2|Overall Study|Adverse Event|0
54278|NCT01176032|206313|P1|Overall Study|Adverse Event|1
54279|NCT01175824|206437|P2|Overall Study|Entry Criteria Not Met|4
54280|NCT01175824|206438|P1|Overall Study|Entry Criteria Not Met|6
54281|NCT01175824|206437|P2|Overall Study|Sponsor Decision|0
54282|NCT01175824|206438|P1|Overall Study|Sponsor Decision|1
54283|NCT01175824|206437|P2|Overall Study|Withdrawal by Subject|7
54284|NCT01175824|206438|P1|Overall Study|Withdrawal by Subject|3
54285|NCT01175824|206437|P2|Overall Study|Protocol Violation|5
54286|NCT01175824|206438|P1|Overall Study|Protocol Violation|2
54287|NCT01175824|206437|P2|Overall Study|Physician Decision|4
54288|NCT01175824|206438|P1|Overall Study|Physician Decision|0
54289|NCT01175824|206437|P2|Overall Study|Lost to Follow-up|1
54290|NCT01175824|206438|P1|Overall Study|Lost to Follow-up|0
54291|NCT01175824|206437|P2|Overall Study|Lack of Efficacy|0
54292|NCT01175824|206438|P1|Overall Study|Lack of Efficacy|2
54293|NCT01175824|206437|P2|Overall Study|Adverse Event|1
54294|NCT01175824|206438|P1|Overall Study|Adverse Event|2
54295|NCT01175811|206472|P2|Overall Study|Withdrawal by Subject|7
54296|NCT01175811|206473|P1|Overall Study|Withdrawal by Subject|6
54297|NCT01175811|206472|P2|Overall Study|Protocol Violation|2
54298|NCT01175811|206473|P1|Overall Study|Protocol Violation|1
54299|NCT01175811|206472|P2|Overall Study|Physician Decision|1
54300|NCT01175811|206473|P1|Overall Study|Physician Decision|1
54301|NCT01175811|206472|P2|Overall Study|Lost to Follow-up|2
54302|NCT01175811|206473|P1|Overall Study|Lost to Follow-up|3
54303|NCT01175811|206472|P2|Overall Study|Lack of Efficacy|0
54304|NCT01175811|206473|P1|Overall Study|Lack of Efficacy|1
54305|NCT01175811|206472|P2|Overall Study|Entry criteria not met|1
54306|NCT01175811|206473|P1|Overall Study|Entry criteria not met|3
54307|NCT01175811|206472|P2|Overall Study|Adverse Event|1
54308|NCT01175811|206473|P1|Overall Study|Adverse Event|1
54309|NCT01175707|206508|P2|Overall Study|Adverse Event|6
54310|NCT01175707|206509|P1|Overall Study|Adverse Event|4
54311|NCT01175668|206545|P2|Overall Study|Withdrawal by Subject|0
54312|NCT01175668|206546|P1|Overall Study|Withdrawal by Subject|2
54313|NCT01175590|206556|P2|Overall Study|Protocol Violation|1
54314|NCT01175590|206557|P1|Overall Study|Protocol Violation|0
54315|NCT01175590|206556|P2|Overall Study|Herpes Simplex Dermatitis|0
54316|NCT01175590|206557|P1|Overall Study|Herpes Simplex Dermatitis|1
54317|NCT01175590|206556|P2|Overall Study|Treated not as randomized|2
54318|NCT01175590|206557|P1|Overall Study|Treated not as randomized|3
54319|NCT01175590|206556|P2|Overall Study|Residual Bacterial Conjunctivitis|0
54320|NCT01175590|206557|P1|Overall Study|Residual Bacterial Conjunctivitis|1
54321|NCT01175590|206556|P2|Overall Study|Lack of Efficacy|1
54322|NCT01175590|206557|P1|Overall Study|Lack of Efficacy|1
54323|NCT01175590|206556|P2|Overall Study|Physician Decision|4
54324|NCT01175590|206557|P1|Overall Study|Physician Decision|1
54325|NCT01175590|206556|P2|Overall Study|Adverse Event|0
54326|NCT01175590|206557|P1|Overall Study|Adverse Event|4
54327|NCT01175590|206556|P2|Overall Study|Withdrawal by Subject|2
54328|NCT01175590|206557|P1|Overall Study|Withdrawal by Subject|0
54329|NCT01175590|206556|P2|Overall Study|Lost to Follow-up|0
54330|NCT01175590|206557|P1|Overall Study|Lost to Follow-up|1
54331|NCT01175473|206591|P2|Overall Study|Adverse Event|2
54332|NCT01175473|206592|P1|Overall Study|Adverse Event|2
54333|NCT01175213|206654|P2|Safety Follow-up|Adverse Event|0
54334|NCT01175213|206655|P1|Safety Follow-up|Adverse Event|1
54335|NCT01175213|206654|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
54336|NCT01175213|206655|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
54337|NCT01175213|206654|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
54338|NCT01175213|206655|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
54339|NCT01175213|206654|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
54340|NCT01175213|206655|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
54341|NCT01175213|206654|P2|IGSC, 10%/rHuPH20|Death|0
54342|NCT01175213|206655|P1|IGSC, 10%/rHuPH20|Death|1
54343|NCT01175213|206654|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
54344|NCT01175213|206655|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
54345|NCT01175018|206710|P2|Overall Study|Adverse Event|1
54346|NCT01175018|206711|P1|Overall Study|Adverse Event|3
54347|NCT01174550|206800|P2|Overall Study|Withdrawal by Subject|289
54348|NCT01174550|206801|P1|Overall Study|Withdrawal by Subject|543
54349|NCT01174550|206800|P2|Overall Study|Lost to Follow-up|510
54350|NCT01174550|206801|P1|Overall Study|Lost to Follow-up|652
54351|NCT01174550|206800|P2|Overall Study|Death|74
54352|NCT01174550|206801|P1|Overall Study|Death|75
54353|NCT01174459|206829|P1|Overall Study|case report form (CRF) not collected|5
54354|NCT01174446|206834|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
54355|NCT01174446|206835|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
54356|NCT01174446|206836|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
54357|NCT01174446|206837|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
54358|NCT01174446|206834|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
54359|NCT01174446|206835|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
54360|NCT01174446|206836|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
54361|NCT01174446|206837|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
54362|NCT01174446|206834|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
54363|NCT01174446|206835|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
54364|NCT01174446|206836|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
54365|NCT01174446|206837|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
54366|NCT01174446|206834|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
54367|NCT01174446|206835|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
54368|NCT01174446|206836|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
54369|NCT01174446|206837|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
54370|NCT01174342|207024|P1|Overall Study|Conversion to cesarean section|4
54371|NCT01174264|207031|P3|Steady-state Pharmacokinetics|Not evaluable|2
54372|NCT01174264|207032|P2|Steady-state Pharmacokinetics|Not evaluable|0
54373|NCT01174264|207033|P1|Steady-state Pharmacokinetics|Not evaluable|6
54374|NCT01174264|207031|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
54375|NCT01174264|207032|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
54376|NCT01174264|207033|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
54377|NCT01174264|207031|P3|Single Dose Pharmacokinetics|Early progressive disease|1
54378|NCT01174264|207032|P2|Single Dose Pharmacokinetics|Early progressive disease|0
54379|NCT01174264|207033|P1|Single Dose Pharmacokinetics|Early progressive disease|1
54380|NCT01174186|207067|P2|Overall Study|Withdrawal by Subject|2
54381|NCT01174186|207068|P1|Overall Study|Withdrawal by Subject|0
54382|NCT01174186|207067|P2|Overall Study|Lost to Follow-up|1
54383|NCT01174186|207068|P1|Overall Study|Lost to Follow-up|0
54384|NCT01174173|207075|P1|Overall Study|drug-drug interaction|1
54385|NCT01174160|207085|P2|Overall Study|Withdrawal by Subject|0
54386|NCT01174160|207086|P1|Overall Study|Withdrawal by Subject|1
54387|NCT01174160|207085|P2|Overall Study|Protocol Violation|6
54388|NCT01174160|207086|P1|Overall Study|Protocol Violation|4
54389|NCT01174160|207085|P2|Overall Study|Physician Decision|0
54390|NCT01174160|207086|P1|Overall Study|Physician Decision|1
54391|NCT01174160|207085|P2|Overall Study|Lost to Follow-up|0
54392|NCT01174160|207086|P1|Overall Study|Lost to Follow-up|1
54393|NCT01174160|207085|P2|Overall Study|Adverse Event|0
54394|NCT01174160|207086|P1|Overall Study|Adverse Event|1
54395|NCT01174043|207092|P1|Overall Study|Withdrawal by Subject|2
54396|NCT01174043|207092|P1|Overall Study|Death|1
54397|NCT01174043|207092|P1|Overall Study|Adverse Event|3
54398|NCT01174043|207092|P1|Overall Study|Disease progression|5
54399|NCT01174004|207131|P2|Overall Study|Physician Decision|0
54400|NCT01174004|207132|P1|Overall Study|Physician Decision|1
54401|NCT01174004|207131|P2|Overall Study|Protocol Violation|1
54402|NCT01174004|207132|P1|Overall Study|Protocol Violation|0
54403|NCT01174004|207131|P2|Overall Study|At Discretion of Sponsor|2
54404|NCT01174004|207132|P1|Overall Study|At Discretion of Sponsor|2
54405|NCT01174004|207131|P2|Overall Study|Withdrawal by Subject|3
54406|NCT01174004|207132|P1|Overall Study|Withdrawal by Subject|2
54407|NCT01174004|207131|P2|Overall Study|Adverse Event|10
54408|NCT01174004|207132|P1|Overall Study|Adverse Event|2
54409|NCT01173718|207140|P1|Overall Study|Abandonment of study graft|27
54410|NCT01173718|207140|P1|Overall Study|Death|17
54411|NCT01173653|207151|P2|Overall Study|Pts unwilling to provide follow-up|41
54412|NCT01173653|207152|P1|Overall Study|Pts unwilling to provide follow-up|53
54413|NCT01173471|207162|P4|Overall Study|Reason given as Other|0
54414|NCT01173471|207163|P3|Overall Study|Reason given as Other|1
54415|NCT01173471|207164|P2|Overall Study|Reason given as Other|0
54416|NCT01173471|207165|P1|Overall Study|Reason given as Other|0
54417|NCT01173471|207162|P4|Overall Study|Lost to Follow-up|0
54418|NCT01173471|207163|P3|Overall Study|Lost to Follow-up|1
54419|NCT01173471|207164|P2|Overall Study|Lost to Follow-up|0
54420|NCT01173471|207165|P1|Overall Study|Lost to Follow-up|0
54421|NCT01173471|207162|P4|Overall Study|Condition under investigation worsened|0
54422|NCT01173471|207163|P3|Overall Study|Condition under investigation worsened|0
54423|NCT01173471|207164|P2|Overall Study|Condition under investigation worsened|0
54424|NCT01173471|207165|P1|Overall Study|Condition under investigation worsened|2
54425|NCT01173471|207162|P4|Overall Study|Eligibility criteria not fulfilled|1
54426|NCT01173471|207163|P3|Overall Study|Eligibility criteria not fulfilled|1
54427|NCT01173471|207164|P2|Overall Study|Eligibility criteria not fulfilled|0
54428|NCT01173471|207165|P1|Overall Study|Eligibility criteria not fulfilled|0
54429|NCT01173120|207295|P1|Overall Study|Switch-Difficulty With Device|12
54430|NCT01173120|207295|P1|Overall Study|Switch-Participant Decision|12
54431|NCT01173120|207295|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
54432|NCT01173120|207295|P1|Overall Study|Participant Decision|2
54433|NCT01173120|207295|P1|Overall Study|Lost to Follow-up|1
54434|NCT01173120|207295|P1|Overall Study|Lack of Efficacy|2
54435|NCT01173055|207313|P2|Period 2 - Day 64 to 112|Adverse Event|1
54436|NCT01173055|207314|P1|Period 2 - Day 64 to 112|Adverse Event|0
54437|NCT01173055|207313|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
54438|NCT01173055|207314|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
54439|NCT01172938|207353|P7|Active Treatment Phase (Weeks 25 - 52)|Not specified|1
54440|NCT01172938|207354|P6|Active Treatment Phase (Weeks 25 - 52)|Not specified|1
54441|NCT01172938|207355|P5|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
54442|NCT01172938|207356|P4|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
54443|NCT01172938|207357|P3|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
54444|NCT01172938|207358|P2|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
54445|NCT01172938|207359|P1|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
54446|NCT01172938|207353|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
54447|NCT01172938|207354|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
54448|NCT01172938|207355|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
54449|NCT01172938|207356|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
54450|NCT01172938|207357|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
54451|NCT01172938|207358|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
54452|NCT01172938|207359|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
54453|NCT01172938|207353|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
54454|NCT01172938|207354|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|9
54455|NCT01172938|207355|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|2
54456|NCT01172938|207356|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|2
54457|NCT01172938|207357|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
54458|NCT01172938|207358|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|5
54459|NCT01172938|207359|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
54460|NCT01172938|207353|P7|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
54461|NCT01172938|207354|P6|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
54462|NCT01172938|207355|P5|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
54463|NCT01172938|207356|P4|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
54464|NCT01172938|207357|P3|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|1
54465|NCT01172938|207358|P2|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
54466|NCT01172938|207359|P1|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
54467|NCT01172938|207353|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
54468|NCT01172938|207354|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|3
54469|NCT01172938|207355|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
54470|NCT01172938|207356|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|3
54471|NCT01172938|207357|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
54472|NCT01172938|207358|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
54473|NCT01172938|207359|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
54474|NCT01172938|207353|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
54475|NCT01172938|207354|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
54476|NCT01172938|207355|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
54477|NCT01172938|207356|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
54478|NCT01172938|207357|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|5
54479|NCT01172938|207358|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
54480|NCT01172938|207359|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
54481|NCT01172938|207353|P7|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
54482|NCT01172938|207354|P6|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
54483|NCT01172938|207355|P5|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
54484|NCT01172938|207356|P4|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
54485|NCT01172938|207357|P3|Placebo-controlled Phase (Week 0 - 24)|Not specified|1
54486|NCT01172938|207358|P2|Placebo-controlled Phase (Week 0 - 24)|Not specified|2
54487|NCT01172938|207359|P1|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
54488|NCT01172938|207353|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
54489|NCT01172938|207354|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
54490|NCT01172938|207355|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
54491|NCT01172938|207356|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
54492|NCT01172938|207357|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
54493|NCT01172938|207358|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
54494|NCT01172938|207359|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
54495|NCT01172938|207353|P7|Placebo-controlled Phase (Week 0 - 24)|Death|0
54496|NCT01172938|207354|P6|Placebo-controlled Phase (Week 0 - 24)|Death|0
54497|NCT01172938|207355|P5|Placebo-controlled Phase (Week 0 - 24)|Death|0
54498|NCT01172938|207356|P4|Placebo-controlled Phase (Week 0 - 24)|Death|0
54499|NCT01172938|207357|P3|Placebo-controlled Phase (Week 0 - 24)|Death|0
54500|NCT01172938|207358|P2|Placebo-controlled Phase (Week 0 - 24)|Death|1
54501|NCT01172938|207359|P1|Placebo-controlled Phase (Week 0 - 24)|Death|0
54502|NCT01172938|207353|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
54503|NCT01172938|207354|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
54504|NCT01172938|207355|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
54505|NCT01172938|207356|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
54506|NCT01172938|207357|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
54507|NCT01172938|207358|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|5
54508|NCT01172938|207359|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|2
54509|NCT01172938|207353|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
54510|NCT01172938|207354|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
54511|NCT01172938|207355|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
54512|NCT01172938|207356|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
54513|NCT01172938|207357|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|2
54514|NCT01172938|207358|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
54515|NCT01172938|207359|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
54516|NCT01172938|207353|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
54517|NCT01172938|207354|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
54518|NCT01172938|207355|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
54519|NCT01172938|207356|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
54520|NCT01172938|207357|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|4
54521|NCT01172938|207358|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
54522|NCT01172938|207359|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|4
54523|NCT01172938|207353|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
54524|NCT01172938|207354|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
54525|NCT01172938|207355|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
54526|NCT01172938|207356|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
54527|NCT01172938|207357|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
54528|NCT01172938|207358|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
54529|NCT01172938|207359|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|11
54530|NCT01172873|207538|P2|Overall Study|Withdrawal by Subject|2
54531|NCT01172873|207539|P1|Overall Study|Withdrawal by Subject|3
54532|NCT01172847|207549|P1|Overall Study|Withdrawal by Subject|3
54533|NCT01172821|207578|P4|Overall Study|Other|3
54534|NCT01172821|207579|P3|Overall Study|Other|5
54535|NCT01172821|207580|P2|Overall Study|Other|4
54536|NCT01172821|207581|P1|Overall Study|Other|3
54537|NCT01172821|207578|P4|Overall Study|Withdrawal by Subject|3
54538|NCT01172821|207579|P3|Overall Study|Withdrawal by Subject|3
54539|NCT01172821|207580|P2|Overall Study|Withdrawal by Subject|3
54540|NCT01172821|207581|P1|Overall Study|Withdrawal by Subject|2
54541|NCT01172821|207578|P4|Overall Study|Lost to Follow-up|2
54542|NCT01172821|207579|P3|Overall Study|Lost to Follow-up|2
54543|NCT01172821|207580|P2|Overall Study|Lost to Follow-up|1
54544|NCT01172821|207581|P1|Overall Study|Lost to Follow-up|4
54545|NCT01172821|207578|P4|Overall Study|Protocol Violation|2
54546|NCT01172821|207579|P3|Overall Study|Protocol Violation|1
54547|NCT01172821|207580|P2|Overall Study|Protocol Violation|2
54548|NCT01172821|207581|P1|Overall Study|Protocol Violation|0
54549|NCT01172821|207578|P4|Overall Study|Adverse Event|7
54550|NCT01172821|207579|P3|Overall Study|Adverse Event|2
54551|NCT01172821|207580|P2|Overall Study|Adverse Event|2
54552|NCT01172821|207581|P1|Overall Study|Adverse Event|5
54553|NCT01172808|207671|P4|Overall Study|Other|7
54554|NCT01172808|207672|P3|Overall Study|Other|9
54555|NCT01172808|207673|P2|Overall Study|Other|5
54556|NCT01172808|207674|P1|Overall Study|Other|6
54557|NCT01172808|207671|P4|Overall Study|Withdrawal by Subject|2
54558|NCT01172808|207672|P3|Overall Study|Withdrawal by Subject|3
54559|NCT01172808|207673|P2|Overall Study|Withdrawal by Subject|1
54560|NCT01172808|207674|P1|Overall Study|Withdrawal by Subject|4
54561|NCT01172808|207671|P4|Overall Study|Lost to Follow-up|3
54562|NCT01172808|207672|P3|Overall Study|Lost to Follow-up|1
54563|NCT01172808|207673|P2|Overall Study|Lost to Follow-up|1
54564|NCT01172808|207674|P1|Overall Study|Lost to Follow-up|0
54565|NCT01172808|207671|P4|Overall Study|Protocol Violation|0
54566|NCT01172808|207672|P3|Overall Study|Protocol Violation|2
54567|NCT01172808|207673|P2|Overall Study|Protocol Violation|2
54568|NCT01172808|207674|P1|Overall Study|Protocol Violation|2
54569|NCT01172808|207671|P4|Overall Study|Lack of Efficacy|0
54570|NCT01172808|207672|P3|Overall Study|Lack of Efficacy|0
54571|NCT01172808|207673|P2|Overall Study|Lack of Efficacy|0
54572|NCT01172808|207674|P1|Overall Study|Lack of Efficacy|1
54573|NCT01172808|207671|P4|Overall Study|Adverse Event|3
54574|NCT01172808|207672|P3|Overall Study|Adverse Event|8
54575|NCT01172808|207673|P2|Overall Study|Adverse Event|4
54576|NCT01172808|207674|P1|Overall Study|Adverse Event|8
54577|NCT01172535|207793|P1|Overall Study|Unwilling to adhere to study requirement|1
54578|NCT01172535|207793|P1|Overall Study|Ineligible at study entry|1
54579|NCT01172535|207793|P1|Overall Study|Lost to Follow-up|1
54580|NCT01172535|207793|P1|Overall Study|Withdrawal by Subject|2
54581|NCT01172535|207793|P1|Overall Study|Death|3
54582|NCT01172288|207838|P2|Overall Study|Protocol Violation|1
54583|NCT01172288|207839|P1|Overall Study|Protocol Violation|0
54584|NCT01172288|207838|P2|Overall Study|Adverse Event|0
54585|NCT01172288|207839|P1|Overall Study|Adverse Event|1
54586|NCT01171976|207885|P3|Overall Study|Adverse Event|5
54587|NCT01171976|207886|P2|Overall Study|Adverse Event|2
54588|NCT01171976|207887|P1|Overall Study|Adverse Event|6
54589|NCT01171976|207885|P3|Overall Study|Abnormal test result|0
54590|NCT01171976|207886|P2|Overall Study|Abnormal test result|0
54591|NCT01171976|207887|P1|Overall Study|Abnormal test result|1
54592|NCT01171976|207885|P3|Overall Study|Withdrawal by Subject|6
54593|NCT01171976|207886|P2|Overall Study|Withdrawal by Subject|5
54594|NCT01171976|207887|P1|Overall Study|Withdrawal by Subject|1
54595|NCT01171976|207885|P3|Overall Study|Lost to Follow-up|2
54596|NCT01171976|207886|P2|Overall Study|Lost to Follow-up|0
54597|NCT01171976|207887|P1|Overall Study|Lost to Follow-up|4
54598|NCT01171976|207885|P3|Overall Study|Death|1
54599|NCT01171976|207886|P2|Overall Study|Death|4
54600|NCT01171976|207887|P1|Overall Study|Death|2
54601|NCT01171976|207885|P3|Overall Study|Protocol Violation|1
54602|NCT01171976|207886|P2|Overall Study|Protocol Violation|0
54603|NCT01171976|207887|P1|Overall Study|Protocol Violation|0
54604|NCT01171963|207924|P2|Overall Study|Withdrawal by Subject|129
54605|NCT01171963|207925|P1|Overall Study|Withdrawal by Subject|114
54606|NCT01171963|207924|P2|Overall Study|Other - diarrhoea|0
54607|NCT01171963|207925|P1|Overall Study|Other - diarrhoea|1
54608|NCT01171963|207924|P2|Overall Study|Lost to Follow-up|24
54609|NCT01171963|207925|P1|Overall Study|Lost to Follow-up|23
54610|NCT01171963|207924|P2|Overall Study|Adverse Event|15
54611|NCT01171963|207925|P1|Overall Study|Adverse Event|10
54612|NCT01171820|207992|P2|Overall Study|1-Year Missed Visit|1
54613|NCT01171820|207993|P1|Overall Study|1-Year Missed Visit|1
54614|NCT01171820|207992|P2|Overall Study|Physician Decision|1
54615|NCT01171820|207993|P1|Overall Study|Physician Decision|0
54616|NCT01171820|207992|P2|Overall Study|Withdrawal by Subject|0
54617|NCT01171820|207993|P1|Overall Study|Withdrawal by Subject|2
54618|NCT01171820|207992|P2|Overall Study|Lost to Follow-up|1
54619|NCT01171820|207993|P1|Overall Study|Lost to Follow-up|0
54620|NCT01171820|207992|P2|Overall Study|Death|3
54621|NCT01171820|207993|P1|Overall Study|Death|3
54622|NCT01171677|208060|P2|Overall Study|completed <70% IntenSati classes|0
54623|NCT01171677|208061|P1|Overall Study|completed <70% IntenSati classes|5
54624|NCT01171677|208060|P2|Overall Study|Adverse Event|0
54625|NCT01171677|208061|P1|Overall Study|Adverse Event|1
54626|NCT01171677|208060|P2|Overall Study|Withdrawal by Subject|3
54627|NCT01171677|208061|P1|Overall Study|Withdrawal by Subject|0
54628|NCT01171612|208093|P1|Overall Study|Lost to Follow-up|51
54629|NCT01171534|208103|P2|Overall Study|screen failure|1
54630|NCT01171534|208104|P1|Overall Study|screen failure|0
54631|NCT01171534|208103|P2|Overall Study|Lost to Follow-up|2
54632|NCT01171534|208104|P1|Overall Study|Lost to Follow-up|0
54633|NCT01171521|208112|P1|Overall Study|screen failure|1
54634|NCT01171521|208112|P1|Overall Study|Lost to Follow-up|5
54635|NCT01171183|208119|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
54636|NCT01171183|208120|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
54637|NCT01171183|208119|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
54638|NCT01171183|208120|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
54639|NCT01171183|208119|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
54640|NCT01171183|208120|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
54641|NCT01171183|208119|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
54642|NCT01171183|208120|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
54643|NCT01171183|208119|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
54644|NCT01171183|208120|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
54645|NCT01171183|208119|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
54646|NCT01171183|208120|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
54647|NCT01169987|208138|P1|Overall Study|Not Specified|4
54648|NCT01169987|208138|P1|Overall Study|Lost to Follow-up|24
54649|NCT01169987|208138|P1|Overall Study|Withdrawal by Subject|3
54650|NCT01170962|208205|P3|Follow up Period|Others|3
54651|NCT01170962|208206|P2|Follow up Period|Others|7
54652|NCT01170962|208207|P1|Follow up Period|Others|10
54653|NCT01170962|208205|P3|Follow up Period|Death|0
54654|NCT01170962|208206|P2|Follow up Period|Death|2
54655|NCT01170962|208207|P1|Follow up Period|Death|2
54656|NCT01170962|208205|P3|Follow up Period|Lost to Follow-up|1
54657|NCT01170962|208206|P2|Follow up Period|Lost to Follow-up|8
54658|NCT01170962|208207|P1|Follow up Period|Lost to Follow-up|13
54659|NCT01170962|208205|P3|Follow up Period|Withdrawal by Subject|2
54660|NCT01170962|208206|P2|Follow up Period|Withdrawal by Subject|10
54661|NCT01170962|208207|P1|Follow up Period|Withdrawal by Subject|14
54662|NCT01170962|208205|P3|Treatment Period|Completed 24 Week treatment period only|0
54663|NCT01170962|208206|P2|Treatment Period|Completed 24 Week treatment period only|2
54664|NCT01170962|208207|P1|Treatment Period|Completed 24 Week treatment period only|10
54665|NCT01170962|208205|P3|Treatment Period|Request to discontinue treatment|1
54666|NCT01170962|208206|P2|Treatment Period|Request to discontinue treatment|3
54667|NCT01170962|208207|P1|Treatment Period|Request to discontinue treatment|7
54668|NCT01170962|208205|P3|Treatment Period|Participant no longer meets criteria|0
54669|NCT01170962|208206|P2|Treatment Period|Participant no longer meets criteria|1
54670|NCT01170962|208207|P1|Treatment Period|Participant no longer meets criteria|0
54671|NCT01170962|208205|P3|Treatment Period|Lost to Follow-up|1
54672|NCT01170962|208206|P2|Treatment Period|Lost to Follow-up|1
54673|NCT01170962|208207|P1|Treatment Period|Lost to Follow-up|1
54674|NCT01170962|208205|P3|Treatment Period|Withdrawal by Subject|0
54675|NCT01170962|208206|P2|Treatment Period|Withdrawal by Subject|1
54676|NCT01170962|208207|P1|Treatment Period|Withdrawal by Subject|2
54677|NCT01170962|208205|P3|Treatment Period|Adverse Event|3
54678|NCT01170962|208206|P2|Treatment Period|Adverse Event|12
54679|NCT01170962|208207|P1|Treatment Period|Adverse Event|11
54680|NCT01170962|208205|P3|Treatment Period|Lack of Efficacy|7
54681|NCT01170962|208206|P2|Treatment Period|Lack of Efficacy|91
54682|NCT01170962|208207|P1|Treatment Period|Lack of Efficacy|96
54683|NCT01170663|208280|P2|Overall Study|Withdrawal of consent without follow-up|11
54684|NCT01170663|208281|P1|Overall Study|Withdrawal of consent without follow-up|8
54685|NCT01170663|208280|P2|Overall Study|Lost to Follow-up|9
54686|NCT01170663|208281|P1|Overall Study|Lost to Follow-up|3
54687|NCT01170663|208280|P2|Overall Study|Alive on treatment at data cut-off date|7
54688|NCT01170663|208281|P1|Overall Study|Alive on treatment at data cut-off date|13
54689|NCT01170598|208309|P1|Overall Study|Refused|1
54690|NCT01170598|208309|P1|Overall Study|Lost to Follow-up|1
54691|NCT01170598|208309|P1|Overall Study|Death|3
54692|NCT01170598|208309|P1|Overall Study|Withdrawal by Subject|1
54693|NCT01170273|208372|P2|Overall Study|Adverse Event|1
54694|NCT01170273|208373|P1|Overall Study|Adverse Event|0
54695|NCT01170273|208372|P2|Overall Study|Death|0
54696|NCT01170273|208373|P1|Overall Study|Death|1
54697|NCT01170273|208372|P2|Overall Study|Protocol Violation|0
54698|NCT01170273|208373|P1|Overall Study|Protocol Violation|1
54699|NCT01170273|208372|P2|Overall Study|Lost to Follow-up|8
54700|NCT01170273|208373|P1|Overall Study|Lost to Follow-up|6
54701|NCT01170221|208381|P2|Overall Study|Randomized but not treated|0
54702|NCT01170221|208382|P1|Overall Study|Randomized but not treated|1
54703|NCT01170221|208381|P2|Overall Study|Subject completed only screening and LFU|0
54704|NCT01170221|208382|P1|Overall Study|Subject completed only screening and LFU|1
54705|NCT01170221|208381|P2|Overall Study|Withdrawal by Subject|7
54706|NCT01170221|208382|P1|Overall Study|Withdrawal by Subject|9
54707|NCT01170221|208381|P2|Overall Study|Lost to Follow-up|21
54708|NCT01170221|208382|P1|Overall Study|Lost to Follow-up|22
54709|NCT01170208|208405|P3|Overall Study|Protocol Violation|1
54710|NCT01170208|208406|P2|Overall Study|Protocol Violation|0
54711|NCT01170208|208407|P1|Overall Study|Protocol Violation|1
54712|NCT01170208|208405|P3|Overall Study|Withdrawal by Subject|1
54713|NCT01170208|208406|P2|Overall Study|Withdrawal by Subject|0
54714|NCT01170208|208407|P1|Overall Study|Withdrawal by Subject|5
54715|NCT01170091|208415|P1|Overall Study|Treatment duration is less than 4 weeks|21
54716|NCT01170091|208415|P1|Overall Study|Missing efficacy evaluation|3
54717|NCT01170039|208424|P2|Overall Study|Lack of funding, drug not available|3
54718|NCT01170039|208425|P1|Overall Study|Lack of funding, drug not available|3
54719|NCT01170039|208424|P2|Overall Study|Withdrawal by Subject|3
54720|NCT01170039|208425|P1|Overall Study|Withdrawal by Subject|5
54721|NCT01169779|208439|P2|Overall Study|Familial and personal reasons|3
54722|NCT01169779|208440|P1|Overall Study|Familial and personal reasons|3
54723|NCT01169779|208439|P2|Overall Study|Withdrawal by Subject|2
54724|NCT01169779|208440|P1|Overall Study|Withdrawal by Subject|3
54725|NCT01169779|208439|P2|Overall Study|Protocol Violation|1
54726|NCT01169779|208440|P1|Overall Study|Protocol Violation|1
54727|NCT01169779|208439|P2|Overall Study|Lack of Efficacy|0
54728|NCT01169779|208440|P1|Overall Study|Lack of Efficacy|1
54729|NCT01169779|208439|P2|Overall Study|Adverse Event|11
54730|NCT01169779|208440|P1|Overall Study|Adverse Event|3
54731|NCT01169701|208475|P2|Overall Study|Sponsor decision|1
54732|NCT01169701|208476|P1|Overall Study|Sponsor decision|0
54733|NCT01169701|208475|P2|Overall Study|Serious adverse event|1
54734|NCT01169701|208476|P1|Overall Study|Serious adverse event|0
54735|NCT01169701|208475|P2|Overall Study|Administrative problems|1
54736|NCT01169701|208476|P1|Overall Study|Administrative problems|0
54737|NCT01169701|208475|P2|Overall Study|Death|1
54738|NCT01169701|208476|P1|Overall Study|Death|0
54739|NCT01169701|208475|P2|Overall Study|Exclusion criteria|0
54740|NCT01169701|208476|P1|Overall Study|Exclusion criteria|2
54741|NCT01169701|208475|P2|Overall Study|Adverse Event|2
54742|NCT01169701|208476|P1|Overall Study|Adverse Event|1
54743|NCT01169701|208475|P2|Overall Study|Withdrawal by Subject|3
54744|NCT01169701|208476|P1|Overall Study|Withdrawal by Subject|1
54745|NCT01169701|208475|P2|Overall Study|Lost to Follow-up|1
54746|NCT01169701|208476|P1|Overall Study|Lost to Follow-up|1
54747|NCT01169675|208513|P5|Overall Study|Other Reason Not Defined Above|1
54748|NCT01169675|208514|P4|Overall Study|Other Reason Not Defined Above|1
54749|NCT01169675|208515|P3|Overall Study|Other Reason Not Defined Above|0
54750|NCT01169675|208516|P2|Overall Study|Other Reason Not Defined Above|0
54751|NCT01169675|208517|P1|Overall Study|Other Reason Not Defined Above|0
54752|NCT01169675|208513|P5|Overall Study|Withdrawal by Subject|2
54753|NCT01169675|208514|P4|Overall Study|Withdrawal by Subject|1
54754|NCT01169675|208515|P3|Overall Study|Withdrawal by Subject|0
54755|NCT01169675|208516|P2|Overall Study|Withdrawal by Subject|0
54756|NCT01169675|208517|P1|Overall Study|Withdrawal by Subject|1
54757|NCT01169675|208513|P5|Overall Study|Adverse Event|0
54758|NCT01169675|208514|P4|Overall Study|Adverse Event|0
54759|NCT01169675|208515|P3|Overall Study|Adverse Event|2
54760|NCT01169675|208516|P2|Overall Study|Adverse Event|1
54761|NCT01169675|208517|P1|Overall Study|Adverse Event|5
54762|NCT01169675|208513|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
54763|NCT01169675|208514|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
54764|NCT01169675|208515|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
54765|NCT01169675|208516|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
54766|NCT01169675|208517|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
54767|NCT01169675|208513|P5|Overall Study|Progressive disease|1
54768|NCT01169675|208514|P4|Overall Study|Progressive disease|15
54769|NCT01169675|208515|P3|Overall Study|Progressive disease|5
54770|NCT01169675|208516|P2|Overall Study|Progressive disease|2
54771|NCT01169675|208517|P1|Overall Study|Progressive disease|13
54772|NCT01169649|208554|P1|Overall Study|Patient Not Treated|3
54773|NCT01169558|208566|P1|Overall Study|Partial response|2
54774|NCT01169558|208566|P1|Overall Study|Protocol Violation|2
54775|NCT01169558|208566|P1|Overall Study|Non-compliance|2
54776|NCT01169558|208566|P1|Overall Study|Need for Surgery|4
54777|NCT01169558|208566|P1|Overall Study|Lost to Follow-up|4
54778|NCT01169558|208566|P1|Overall Study|Stable Disease|4
54779|NCT01169558|208566|P1|Overall Study|Medical Decision|7
54780|NCT01169558|208566|P1|Overall Study|Withdrawal of Consent|8
54781|NCT01169558|208566|P1|Overall Study|Adverse Event|25
54782|NCT01169558|208566|P1|Overall Study|Disease progression|98
54783|NCT01169493|208591|P6|Period 3 (6 Months)|Physician Decision|0
54784|NCT01169493|208592|P5|Period 3 (6 Months)|Physician Decision|0
54785|NCT01169493|208593|P4|Period 3 (6 Months)|Physician Decision|0
54786|NCT01169493|208594|P3|Period 3 (6 Months)|Physician Decision|1
54787|NCT01169493|208595|P2|Period 3 (6 Months)|Physician Decision|1
54788|NCT01169493|208596|P1|Period 3 (6 Months)|Physician Decision|0
54789|NCT01169493|208591|P6|Period 3 (6 Months)|Adverse Event|0
54790|NCT01169493|208592|P5|Period 3 (6 Months)|Adverse Event|0
54791|NCT01169493|208593|P4|Period 3 (6 Months)|Adverse Event|0
54792|NCT01169493|208594|P3|Period 3 (6 Months)|Adverse Event|0
54793|NCT01169493|208595|P2|Period 3 (6 Months)|Adverse Event|1
54794|NCT01169493|208596|P1|Period 3 (6 Months)|Adverse Event|0
54795|NCT01169493|208591|P6|Period 1 (6 Months)|Withdrawal by Subject|3
54796|NCT01169493|208592|P5|Period 1 (6 Months)|Withdrawal by Subject|0
54797|NCT01169493|208593|P4|Period 1 (6 Months)|Withdrawal by Subject|0
54798|NCT01169493|208594|P3|Period 1 (6 Months)|Withdrawal by Subject|2
54799|NCT01169493|208595|P2|Period 1 (6 Months)|Withdrawal by Subject|1
54800|NCT01169493|208596|P1|Period 1 (6 Months)|Withdrawal by Subject|0
54801|NCT01169103|208656|P2|Overall Study|Withdrawal by Subject|1
54802|NCT01169103|208657|P1|Overall Study|Withdrawal by Subject|3
54803|NCT01169103|208656|P2|Overall Study|Lost to Follow-up|3
54804|NCT01169103|208657|P1|Overall Study|Lost to Follow-up|3
54805|NCT01169038|208671|P1|Overall Study|Required antibiotic administration|1
54806|NCT01169038|208671|P1|Overall Study|Adverse Event|5
54807|NCT01169038|208671|P1|Overall Study|Death|1
54808|NCT01168999|208679|P4|Overall Study|Lost to Follow-up|0
54809|NCT01168999|208680|P3|Overall Study|Lost to Follow-up|0
54810|NCT01168999|208681|P2|Overall Study|Lost to Follow-up|1
54811|NCT01168999|208682|P1|Overall Study|Lost to Follow-up|2
54812|NCT01168973|208748|P2|Overall Study|Withdrawal of consent without follow-up|14
54813|NCT01168973|208749|P1|Overall Study|Withdrawal of consent without follow-up|13
54814|NCT01168973|208748|P2|Overall Study|Lost to Follow-up|9
54815|NCT01168973|208749|P1|Overall Study|Lost to Follow-up|10
54816|NCT01168973|208748|P2|Overall Study|Alive on treatment after data-cutoff|10
54817|NCT01168973|208749|P1|Overall Study|Alive on treatment after data-cutoff|11
54818|NCT01168856|208805|P2|Overall Study|Protocol Violation|6
54819|NCT01168856|208806|P1|Overall Study|Protocol Violation|4
54820|NCT01168856|208805|P2|Overall Study|Unspecified|291
54821|NCT01168856|208806|P1|Overall Study|Unspecified|1
54822|NCT01168856|208805|P2|Overall Study|Death|2
54823|NCT01168856|208806|P1|Overall Study|Death|0
54824|NCT01168856|208805|P2|Overall Study|Participant received anti-HCV treatment|0
54825|NCT01168856|208806|P1|Overall Study|Participant received anti-HCV treatment|1
54826|NCT01168856|208805|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
54827|NCT01168856|208806|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
54828|NCT01168856|208805|P2|Overall Study|Physician Decision|1
54829|NCT01168856|208806|P1|Overall Study|Physician Decision|2
54830|NCT01168856|208805|P2|Overall Study|Withdrawal by Subject|8
54831|NCT01168856|208806|P1|Overall Study|Withdrawal by Subject|6
54832|NCT01168856|208805|P2|Overall Study|Lost to Follow-up|34
54833|NCT01168856|208806|P1|Overall Study|Lost to Follow-up|4
54834|NCT01168596|208904|P2|Overall Study|Withdrawal by Subject|1
54835|NCT01168596|208905|P1|Overall Study|Withdrawal by Subject|3
54836|NCT01168427|208949|P1|Overall Study|Patient exited prior to implant|1
54837|NCT01168349|208954|P1|Overall Study|Protocol Violation|76
54838|NCT01168349|208954|P1|Overall Study|Unspecified|22
54839|NCT01168349|208954|P1|Overall Study|Kidney transplantation|3
54840|NCT01168349|208954|P1|Overall Study|Withdrawal by Subject|9
54841|NCT01168349|208954|P1|Overall Study|Lost to Follow-up|34
54842|NCT01168349|208954|P1|Overall Study|Death|157
54843|NCT01168232|209060|P1|Overall Study|Ineligible-Inadequate pathology|1
54844|NCT01168232|209060|P1|Overall Study|Ineligible- Wrong cell type|6
54845|NCT01168232|209060|P1|Overall Study|Ineligible-Second primary cancer site|1
54846|NCT01167881|209084|P2|Overall Study|Other not defined above|55
54847|NCT01167881|209085|P1|Overall Study|Other not defined above|31
54848|NCT01167881|209084|P2|Overall Study|Not treated|0
54849|NCT01167881|209085|P1|Overall Study|Not treated|4
54850|NCT01167881|209084|P2|Overall Study|Patient refusal to cont., not due to AE|40
54851|NCT01167881|209085|P1|Overall Study|Patient refusal to cont., not due to AE|45
54852|NCT01167881|209084|P2|Overall Study|Lost to Follow-up|20
54853|NCT01167881|209085|P1|Overall Study|Lost to Follow-up|19
54854|NCT01167881|209084|P2|Overall Study|Non compliant with protocol|18
54855|NCT01167881|209085|P1|Overall Study|Non compliant with protocol|9
54856|NCT01167881|209084|P2|Overall Study|Lack of Efficacy|7
54857|NCT01167881|209085|P1|Overall Study|Lack of Efficacy|4
54858|NCT01167881|209084|P2|Overall Study|Adverse Event|51
54859|NCT01167881|209085|P1|Overall Study|Adverse Event|47
54860|NCT01167582|209133|P2|Overall Study|Lost to Follow-up|1
54861|NCT01167582|209134|P1|Overall Study|Lost to Follow-up|0
54862|NCT01167426|209156|P1|Overall Study|Sponsor Decision|1
54863|NCT01167426|209156|P1|Overall Study|Withdrawal by Subject|2
54864|NCT01167426|209156|P1|Overall Study|Protocol Violation|1
54865|NCT01167426|209156|P1|Overall Study|Lost to Follow-up|6
54866|NCT01167257|209164|P2|Overall Study|Withdrew consent|1
54867|NCT01167257|209165|P1|Overall Study|Withdrew consent|1
54868|NCT01167257|209164|P2|Overall Study|Lost to Follow-up|2
54869|NCT01167257|209165|P1|Overall Study|Lost to Follow-up|2
54870|NCT01167192|209187|P1|Overall Study|Insurance denial|1
54871|NCT01167192|209187|P1|Overall Study|Withdrawal by Subject|1
54872|NCT01167192|209187|P1|Overall Study|Death|1
54873|NCT01167192|209187|P1|Overall Study|Adverse Event|1
54874|NCT01167153|209204|P2|Overall Study|Subject initiation withdrawal, Other|8
54875|NCT01167153|209205|P1|Overall Study|Subject initiation withdrawal, Other|5
54876|NCT01167153|209204|P2|Overall Study|Withdrawal consent|1
54877|NCT01167153|209205|P1|Overall Study|Withdrawal consent|1
54878|NCT01167153|209204|P2|Overall Study|Investigator initiation withdrawal,Other|1
54879|NCT01167153|209205|P1|Overall Study|Investigator initiation withdrawal,Other|1
54880|NCT01167153|209204|P2|Overall Study|Non-compliance to concomitant medication|2
54881|NCT01167153|209205|P1|Overall Study|Non-compliance to concomitant medication|0
54882|NCT01167153|209204|P2|Overall Study|Lost to Follow-up|9
54883|NCT01167153|209205|P1|Overall Study|Lost to Follow-up|7
54884|NCT01167153|209204|P2|Overall Study|Hypotension|0
54885|NCT01167153|209205|P1|Overall Study|Hypotension|1
54886|NCT01167153|209204|P2|Overall Study|AE including clinical laboratory AE|8
54887|NCT01167153|209205|P1|Overall Study|AE including clinical laboratory AE|2
54888|NCT01167153|209204|P2|Overall Study|Non-effective therapy|4
54889|NCT01167153|209205|P1|Overall Study|Non-effective therapy|1
54890|NCT01167140|209223|P1|Overall Study|Withdrawal by Subject|1
54891|NCT01167023|209231|P3|Overall Study|Withdrawal by Subject|1
54892|NCT01167023|209232|P2|Overall Study|Withdrawal by Subject|0
54893|NCT01167023|209233|P1|Overall Study|Withdrawal by Subject|0
54894|NCT01167023|209231|P3|Overall Study|Sponsor Decision|0
54895|NCT01167023|209232|P2|Overall Study|Sponsor Decision|1
54896|NCT01167023|209233|P1|Overall Study|Sponsor Decision|0
54897|NCT01167023|209231|P3|Overall Study|Screen Failure|0
54898|NCT01167023|209232|P2|Overall Study|Screen Failure|1
54899|NCT01167023|209233|P1|Overall Study|Screen Failure|0
54900|NCT01167023|209231|P3|Overall Study|Lost to Follow-up|1
54901|NCT01167023|209232|P2|Overall Study|Lost to Follow-up|1
54902|NCT01167023|209233|P1|Overall Study|Lost to Follow-up|0
54903|NCT01166958|209273|P2|Overall Study|Withdrawal by Subject|0
54904|NCT01166958|209274|P1|Overall Study|Withdrawal by Subject|1
54905|NCT01166763|209288|P1|Overall Study|Withdrawal by Subject|3
54906|NCT01166750|209296|P2|Overall Study|Lost to Follow-up|0
54907|NCT01166750|209297|P1|Overall Study|Lost to Follow-up|1
54908|NCT01166659|209303|P1|Overall Study|Study Closed at Site|1
54909|NCT01166659|209303|P1|Overall Study|Lost to Follow-up|1
54910|NCT01166659|209303|P1|Overall Study|Death|1
54911|NCT01166659|209303|P1|Overall Study|Investigator Decision|2
54912|NCT01166659|209303|P1|Overall Study|Subject Decision|8
54913|NCT01166646|209312|P2|Overall Study|Adverse Event|0
54914|NCT01166646|209313|P1|Overall Study|Adverse Event|1
54915|NCT01166646|209312|P2|Overall Study|Protocol Violation|1
54916|NCT01166646|209313|P1|Overall Study|Protocol Violation|0
54917|NCT01166282|209331|P3|Open-label Period|Irregular Compliance|1
54918|NCT01166282|209332|P2|Open-label Period|Irregular Compliance|0
54919|NCT01166282|209333|P1|Open-label Period|Irregular Compliance|0
54920|NCT01166282|209331|P3|Open-label Period|Remission|4
54921|NCT01166282|209332|P2|Open-label Period|Remission|0
54922|NCT01166282|209333|P1|Open-label Period|Remission|0
54923|NCT01166282|209331|P3|Open-label Period|Lack of Efficacy|2
54924|NCT01166282|209332|P2|Open-label Period|Lack of Efficacy|0
54925|NCT01166282|209333|P1|Open-label Period|Lack of Efficacy|0
54926|NCT01166282|209331|P3|Open-label Period|Withdrawal by Subject|4
54927|NCT01166282|209332|P2|Open-label Period|Withdrawal by Subject|0
54928|NCT01166282|209333|P1|Open-label Period|Withdrawal by Subject|0
54929|NCT01166282|209331|P3|Open-label Period|Adverse Event|6
54930|NCT01166282|209332|P2|Open-label Period|Adverse Event|0
54931|NCT01166282|209333|P1|Open-label Period|Adverse Event|0
54932|NCT01166178|209372|P2|Overall Study|Study was terminated|8
54933|NCT01166178|209373|P1|Overall Study|Study was terminated|20
54934|NCT01166178|209372|P2|Overall Study|Withdrawal by Subject|0
54935|NCT01166178|209373|P1|Overall Study|Withdrawal by Subject|1
54936|NCT01165996|209406|P1|Overall Study|Physician Decision|1
54937|NCT01165996|209406|P1|Overall Study|Death|1
54938|NCT01165684|209473|P2|Overall Study|Unclassified|22
54939|NCT01165684|209474|P1|Overall Study|Unclassified|16
54940|NCT01165684|209473|P2|Overall Study|Withdrawal Criteria|13
54941|NCT01165684|209474|P1|Overall Study|Withdrawal Criteria|2
54942|NCT01165684|209473|P2|Overall Study|Protocol Violation|15
54943|NCT01165684|209474|P1|Overall Study|Protocol Violation|7
54944|NCT01165684|209473|P2|Overall Study|Lack of Efficacy|1
54945|NCT01165684|209474|P1|Overall Study|Lack of Efficacy|2
54946|NCT01165684|209473|P2|Overall Study|Adverse Event|1
54947|NCT01165684|209474|P1|Overall Study|Adverse Event|1
54948|NCT01165554|209508|P1|Overall Study|Withdrawal by Subject|23
54949|NCT01165424|209531|P1|Overall Study|Participant moved (relocated)|1
54950|NCT01165424|209531|P1|Overall Study|Did not meet entry criteria|1
54951|NCT01165424|209531|P1|Overall Study|Laboratory adverse experiences|1
54952|NCT01165424|209531|P1|Overall Study|Clinical adverse experiences|1
54953|NCT01165320|209538|P3|Overall Study|Reason unknown|0
54954|NCT01165320|209539|P2|Overall Study|Reason unknown|1
54955|NCT01165320|209540|P1|Overall Study|Reason unknown|0
54956|NCT01165320|209538|P3|Overall Study|Lack of Efficacy|0
54957|NCT01165320|209539|P2|Overall Study|Lack of Efficacy|2
54958|NCT01165320|209540|P1|Overall Study|Lack of Efficacy|0
54959|NCT01165320|209538|P3|Overall Study|Laboratory adverse experience|0
54960|NCT01165320|209539|P2|Overall Study|Laboratory adverse experience|0
54961|NCT01165320|209540|P1|Overall Study|Laboratory adverse experience|1
54962|NCT01165320|209538|P3|Overall Study|Clinical adverse experience|0
54963|NCT01165320|209539|P2|Overall Study|Clinical adverse experience|1
54964|NCT01165320|209540|P1|Overall Study|Clinical adverse experience|2
54965|NCT01165307|209550|P2|Overall Study|Subject not available for contact|0
54966|NCT01165307|209551|P1|Overall Study|Subject not available for contact|1
54967|NCT01165307|209550|P2|Overall Study|Withdrawal by Subject|0
54968|NCT01165307|209551|P1|Overall Study|Withdrawal by Subject|2
54969|NCT01165307|209550|P2|Overall Study|Lost to Follow-up|3
54970|NCT01165307|209551|P1|Overall Study|Lost to Follow-up|11
54971|NCT01165281|209581|P2|Overall Study|Other|0
54972|NCT01165281|209582|P1|Overall Study|Other|6
54973|NCT01165281|209581|P2|Overall Study|Progressive Disease|14
54974|NCT01165281|209582|P1|Overall Study|Progressive Disease|10
54975|NCT01165281|209581|P2|Overall Study|Noncompliance with Study Drug|4
54976|NCT01165281|209582|P1|Overall Study|Noncompliance with Study Drug|1
54977|NCT01165281|209581|P2|Overall Study|Withdrawal by Subject|7
54978|NCT01165281|209582|P1|Overall Study|Withdrawal by Subject|8
54979|NCT01165281|209581|P2|Overall Study|Protocol Violation|5
54980|NCT01165281|209582|P1|Overall Study|Protocol Violation|6
54981|NCT01165281|209581|P2|Overall Study|Physician Decision|1
54982|NCT01165281|209582|P1|Overall Study|Physician Decision|8
54983|NCT01165281|209581|P2|Overall Study|Lost to Follow-up|1
54984|NCT01165281|209582|P1|Overall Study|Lost to Follow-up|0
54985|NCT01165281|209581|P2|Overall Study|Lack of Efficacy|1
54986|NCT01165281|209582|P1|Overall Study|Lack of Efficacy|4
54987|NCT01165281|209581|P2|Overall Study|Death|4
54988|NCT01165281|209582|P1|Overall Study|Death|3
54989|NCT01165281|209581|P2|Overall Study|Adverse Event|14
54990|NCT01165281|209582|P1|Overall Study|Adverse Event|12
54991|NCT01165216|209602|P2|Overall Study|Disease progression|3
54992|NCT01165216|209603|P1|Overall Study|Disease progression|1
54993|NCT01165216|209602|P2|Overall Study|Withdrawal by Subject|1
54994|NCT01165216|209603|P1|Overall Study|Withdrawal by Subject|1
54995|NCT01165216|209602|P2|Overall Study|Adverse Event|3
54996|NCT01165216|209603|P1|Overall Study|Adverse Event|6
54997|NCT01165138|209626|P4|Overall Study|Withdrawal by Subject|3
54998|NCT01165138|209627|P3|Overall Study|Withdrawal by Subject|6
54999|NCT01165138|209628|P2|Overall Study|Withdrawal by Subject|6
55000|NCT01165138|209629|P1|Overall Study|Withdrawal by Subject|0
55001|NCT01165138|209626|P4|Overall Study|Physician Decision|6
55002|NCT01165138|209627|P3|Overall Study|Physician Decision|7
55003|NCT01165138|209628|P2|Overall Study|Physician Decision|6
55004|NCT01165138|209629|P1|Overall Study|Physician Decision|0
55005|NCT01165138|209626|P4|Overall Study|Lost to Follow-up|2
55006|NCT01165138|209627|P3|Overall Study|Lost to Follow-up|1
55007|NCT01165138|209628|P2|Overall Study|Lost to Follow-up|0
55008|NCT01165138|209629|P1|Overall Study|Lost to Follow-up|0
55009|NCT01165138|209626|P4|Overall Study|Protocol Violation|2
55010|NCT01165138|209627|P3|Overall Study|Protocol Violation|0
55011|NCT01165138|209628|P2|Overall Study|Protocol Violation|7
55012|NCT01165138|209629|P1|Overall Study|Protocol Violation|0
55013|NCT01165138|209626|P4|Overall Study|Lack of Efficacy|7
55014|NCT01165138|209627|P3|Overall Study|Lack of Efficacy|6
55015|NCT01165138|209628|P2|Overall Study|Lack of Efficacy|32
55016|NCT01165138|209629|P1|Overall Study|Lack of Efficacy|0
55017|NCT01165138|209626|P4|Overall Study|Adverse Event|2
55018|NCT01165138|209627|P3|Overall Study|Adverse Event|0
55019|NCT01165138|209628|P2|Overall Study|Adverse Event|1
55020|NCT01165138|209629|P1|Overall Study|Adverse Event|0
55021|NCT01165021|209692|P1|Overall Study|Death|1
55022|NCT01164891|209700|P1|Overall Study|Adverse Event|1
55023|NCT01164891|209700|P1|Overall Study|Disease Progression|5
55024|NCT01164865|209720|P2|Overall Study|Lost to Follow-up|1
55025|NCT01164865|209721|P1|Overall Study|Lost to Follow-up|2
55026|NCT01164722|209731|P2|Overall Study|enrolled on other study, concomitant med|3
55027|NCT01164722|209732|P1|Overall Study|enrolled on other study, concomitant med|1
55028|NCT01164722|209731|P2|Overall Study|met protocol criteria for non-treatment|1
55029|NCT01164722|209732|P1|Overall Study|met protocol criteria for non-treatment|11
55030|NCT01164722|209731|P2|Overall Study|Lost to Follow-up|6
55031|NCT01164722|209732|P1|Overall Study|Lost to Follow-up|3
55032|NCT01164722|209731|P2|Overall Study|Withdrawal by Subject|4
55033|NCT01164722|209732|P1|Overall Study|Withdrawal by Subject|3
55034|NCT01164722|209731|P2|Overall Study|Adverse Event|1
55035|NCT01164722|209732|P1|Overall Study|Adverse Event|0
55036|NCT01164579|209762|P3|Overall Study|Reason not specified|0
55037|NCT01164579|209763|P2|Overall Study|Reason not specified|0
55038|NCT01164579|209764|P1|Overall Study|Reason not specified|1
55039|NCT01164579|209762|P3|Overall Study|Adverse Event|5
55040|NCT01164579|209763|P2|Overall Study|Adverse Event|2
55041|NCT01164579|209764|P1|Overall Study|Adverse Event|4
55042|NCT01164579|209762|P3|Overall Study|Protocol Violation|2
55043|NCT01164579|209763|P2|Overall Study|Protocol Violation|1
55044|NCT01164579|209764|P1|Overall Study|Protocol Violation|0
55045|NCT01164579|209762|P3|Overall Study|Withdrawal by Subject|3
55046|NCT01164579|209763|P2|Overall Study|Withdrawal by Subject|5
55047|NCT01164579|209764|P1|Overall Study|Withdrawal by Subject|2
55048|NCT01164579|209762|P3|Overall Study|Lost to Follow-up|0
55049|NCT01164579|209763|P2|Overall Study|Lost to Follow-up|1
55050|NCT01164579|209764|P1|Overall Study|Lost to Follow-up|1
55051|NCT01164579|209762|P3|Overall Study|Lack of Efficacy|6
55052|NCT01164579|209763|P2|Overall Study|Lack of Efficacy|0
55053|NCT01164579|209764|P1|Overall Study|Lack of Efficacy|0
55054|NCT01164501|209844|P3|Overall Study|Other reason not defined above|4
55055|NCT01164501|209845|P2|Overall Study|Other reason not defined above|1
55056|NCT01164501|209846|P1|Overall Study|Other reason not defined above|9
55057|NCT01164501|209844|P3|Overall Study|Patient refusal to continue,not due toAE|8
55058|NCT01164501|209845|P2|Overall Study|Patient refusal to continue,not due toAE|4
55059|NCT01164501|209846|P1|Overall Study|Patient refusal to continue,not due toAE|10
55060|NCT01164501|209844|P3|Overall Study|Lost to Follow-up|3
55061|NCT01164501|209845|P2|Overall Study|Lost to Follow-up|0
55062|NCT01164501|209846|P1|Overall Study|Lost to Follow-up|3
55063|NCT01164501|209844|P3|Overall Study|Non compliant with protocol|4
55064|NCT01164501|209845|P2|Overall Study|Non compliant with protocol|1
55065|NCT01164501|209846|P1|Overall Study|Non compliant with protocol|1
55066|NCT01164501|209844|P3|Overall Study|Lack of Efficacy|1
55067|NCT01164501|209845|P2|Overall Study|Lack of Efficacy|0
55068|NCT01164501|209846|P1|Overall Study|Lack of Efficacy|0
55069|NCT01164501|209844|P3|Overall Study|Adverse Event|21
55070|NCT01164501|209845|P2|Overall Study|Adverse Event|4
55071|NCT01164501|209846|P1|Overall Study|Adverse Event|18
55072|NCT01164501|209844|P3|Overall Study|Not treated|1
55073|NCT01164501|209845|P2|Overall Study|Not treated|0
55074|NCT01164501|209846|P1|Overall Study|Not treated|2
55075|NCT01164475|209863|P2|Overall Study|Protocol Violation|0
55076|NCT01164475|209864|P1|Overall Study|Protocol Violation|1
55077|NCT01164475|209863|P2|Overall Study|Progressive disease|1
55078|NCT01164475|209864|P1|Overall Study|Progressive disease|0
55079|NCT01164475|209863|P2|Overall Study|Other|1
55080|NCT01164475|209864|P1|Overall Study|Other|0
55081|NCT01164475|209863|P2|Overall Study|Lack of Efficacy|0
55082|NCT01164475|209864|P1|Overall Study|Lack of Efficacy|1
55083|NCT01163916|209917|P3|Overall Study|Other|16
55084|NCT01163916|209918|P2|Overall Study|Other|4
55085|NCT01163916|209919|P1|Overall Study|Other|24
55086|NCT01163916|209917|P3|Overall Study|Lack of Efficacy|1
55087|NCT01163916|209918|P2|Overall Study|Lack of Efficacy|0
55088|NCT01163916|209919|P1|Overall Study|Lack of Efficacy|2
55089|NCT01163916|209917|P3|Overall Study|Adverse Event|1
55090|NCT01163916|209918|P2|Overall Study|Adverse Event|0
55091|NCT01163916|209919|P1|Overall Study|Adverse Event|2
55092|NCT01163916|209917|P3|Overall Study|Withdrawal by Subject|2
55093|NCT01163916|209918|P2|Overall Study|Withdrawal by Subject|0
55094|NCT01163916|209919|P1|Overall Study|Withdrawal by Subject|2
55095|NCT01163851|209957|P2|Overall Study|Randomized but not treated|0
55096|NCT01163851|209958|P1|Overall Study|Randomized but not treated|1
55097|NCT01163851|209957|P2|Overall Study|Ongoing|1
55098|NCT01163851|209958|P1|Overall Study|Ongoing|0
55099|NCT01163747|210049|P2|Overall Study|Refused Treatment|4
55100|NCT01163747|210050|P1|Overall Study|Refused Treatment|6
55101|NCT01163747|210049|P2|Overall Study|Protocol Violation|1
55102|NCT01163747|210050|P1|Overall Study|Protocol Violation|0
55103|NCT01163747|210049|P2|Overall Study|Insufficient Therapeutic Response|1
55104|NCT01163747|210050|P1|Overall Study|Insufficient Therapeutic Response|0
55105|NCT01163747|210049|P2|Overall Study|Adverse Event|5
55106|NCT01163747|210050|P1|Overall Study|Adverse Event|0
55107|NCT01163721|210070|P2|Overall Study|Physician Decision|1
55108|NCT01163721|210071|P1|Overall Study|Physician Decision|0
55109|NCT01163721|210070|P2|Overall Study|Lost to Follow-up|1
55110|NCT01163721|210071|P1|Overall Study|Lost to Follow-up|0
55111|NCT01163721|210070|P2|Overall Study|Withdrawal by Subject|4
55112|NCT01163721|210071|P1|Overall Study|Withdrawal by Subject|3
55113|NCT01163721|210070|P2|Overall Study|Adverse Event|6
55114|NCT01163721|210071|P1|Overall Study|Adverse Event|5
55115|NCT01163617|210090|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
55116|NCT01163617|210091|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
55117|NCT01163617|210092|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
55118|NCT01163617|210093|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
55196|NCT01163032|210301|P3|Open Label Extension Phase|Adverse Event|3
55119|NCT01163617|210094|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
55120|NCT01163617|210095|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
55121|NCT01163617|210096|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
55122|NCT01163617|210097|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
55123|NCT01163617|210090|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
55124|NCT01163617|210091|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
55125|NCT01163617|210092|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
55126|NCT01163617|210093|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
55127|NCT01163617|210094|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
55128|NCT01163617|210095|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
55129|NCT01163617|210096|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
55130|NCT01163617|210097|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
55131|NCT01163617|210090|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
55132|NCT01163617|210091|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
55133|NCT01163617|210092|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
55134|NCT01163617|210093|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
55135|NCT01163617|210094|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
55136|NCT01163617|210095|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
55137|NCT01163617|210096|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
55138|NCT01163617|210097|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
55139|NCT01163474|210126|P1|Overall Study|Lost to Follow-up|3
55140|NCT01163474|210126|P1|Overall Study|Tech barriers to videoteleconference vis|12
55141|NCT01163474|210126|P1|Overall Study|Withdrawal by Subject|1
55142|NCT01163318|210137|P1|Overall Study|Multiple Reasons Per Participant|224
55143|NCT01163318|210137|P1|Overall Study|Participants Without Case Report Form|7
55144|NCT01163318|210137|P1|Overall Study|History/comorbidity of malignant tumor|3
55145|NCT01163318|210137|P1|Overall Study|Did Not Continue Use of Adalimumab|26
55146|NCT01163318|210137|P1|Overall Study|Off-Label Use of Adalimumab|8
55147|NCT01163292|210146|P2|Overall Study|No further visits|7
55148|NCT01163292|210147|P1|Overall Study|No further visits|5
55149|NCT01163292|210146|P2|Overall Study|Economic reasons|0
55150|NCT01163292|210147|P1|Overall Study|Economic reasons|6
55151|NCT01163292|210146|P2|Overall Study|Refusal to receive adalimumab|0
55152|NCT01163292|210147|P1|Overall Study|Refusal to receive adalimumab|7
55153|NCT01163292|210146|P2|Overall Study|Sufficient response to adalimumab|0
55154|NCT01163292|210147|P1|Overall Study|Sufficient response to adalimumab|8
55155|NCT01163292|210146|P2|Overall Study|Initiation of biological therapy|15
55156|NCT01163292|210147|P1|Overall Study|Initiation of biological therapy|0
55157|NCT01163292|210146|P2|Overall Study|Adverse Event|0
55158|NCT01163292|210147|P1|Overall Study|Adverse Event|6
55159|NCT01163292|210146|P2|Overall Study|Lack of Efficacy|0
55160|NCT01163292|210147|P1|Overall Study|Lack of Efficacy|9
55161|NCT01163279|210163|P2|Overall Study|Withdrawal by Subject|0
55162|NCT01163279|210164|P1|Overall Study|Withdrawal by Subject|2
55163|NCT01163266|210193|P3|Overall Study|Other|2
55164|NCT01163266|210194|P2|Overall Study|Other|1
55165|NCT01163266|210195|P1|Overall Study|Other|1
55166|NCT01163266|210193|P3|Overall Study|Lost to Follow-up|10
55167|NCT01163266|210194|P2|Overall Study|Lost to Follow-up|7
55168|NCT01163266|210195|P1|Overall Study|Lost to Follow-up|7
55169|NCT01163266|210193|P3|Overall Study|Withdrawal of Consent|3
55170|NCT01163266|210194|P2|Overall Study|Withdrawal of Consent|7
55171|NCT01163266|210195|P1|Overall Study|Withdrawal of Consent|5
55172|NCT01163266|210193|P3|Overall Study|Protocol Deviations|5
55173|NCT01163266|210194|P2|Overall Study|Protocol Deviations|2
55174|NCT01163266|210195|P1|Overall Study|Protocol Deviations|2
55175|NCT01163266|210193|P3|Overall Study|Noncompliance with Study Drug|0
55176|NCT01163266|210194|P2|Overall Study|Noncompliance with Study Drug|2
55177|NCT01163266|210195|P1|Overall Study|Noncompliance with Study Drug|0
55178|NCT01163266|210193|P3|Overall Study|Lack of Efficacy|1
55179|NCT01163266|210194|P2|Overall Study|Lack of Efficacy|3
55180|NCT01163266|210195|P1|Overall Study|Lack of Efficacy|1
55181|NCT01163266|210193|P3|Overall Study|Pretreatment Event or Adverse Event|7
55182|NCT01163266|210194|P2|Overall Study|Pretreatment Event or Adverse Event|9
55183|NCT01163266|210195|P1|Overall Study|Pretreatment Event or Adverse Event|2
55184|NCT01163032|210301|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
55185|NCT01163032|210302|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
55186|NCT01163032|210303|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
55187|NCT01163032|210301|P3|Open Label Extension Phase|Study Termination|7
55188|NCT01163032|210302|P2|Open Label Extension Phase|Study Termination|0
55189|NCT01163032|210303|P1|Open Label Extension Phase|Study Termination|0
55190|NCT01163032|210301|P3|Open Label Extension Phase|Protocol Violation|1
55191|NCT01163032|210302|P2|Open Label Extension Phase|Protocol Violation|0
55192|NCT01163032|210303|P1|Open Label Extension Phase|Protocol Violation|0
55193|NCT01163032|210301|P3|Open Label Extension Phase|Withdrawal by Subject|3
55194|NCT01163032|210302|P2|Open Label Extension Phase|Withdrawal by Subject|0
55195|NCT01163032|210303|P1|Open Label Extension Phase|Withdrawal by Subject|0
55197|NCT01163032|210302|P2|Open Label Extension Phase|Adverse Event|0
55198|NCT01163032|210303|P1|Open Label Extension Phase|Adverse Event|0
55199|NCT01163032|210301|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
55200|NCT01163032|210302|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
55201|NCT01163032|210303|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
55202|NCT01163032|210301|P3|Randomization Phase|Various*|0
55203|NCT01163032|210302|P2|Randomization Phase|Various*|4
55204|NCT01163032|210303|P1|Randomization Phase|Various*|5
55205|NCT01163032|210301|P3|Randomization Phase|Protocol Violation|0
55206|NCT01163032|210302|P2|Randomization Phase|Protocol Violation|1
55207|NCT01163032|210303|P1|Randomization Phase|Protocol Violation|0
55208|NCT01163032|210301|P3|Randomization Phase|Adverse Event|0
55209|NCT01163032|210302|P2|Randomization Phase|Adverse Event|3
55210|NCT01163032|210303|P1|Randomization Phase|Adverse Event|3
55211|NCT01163032|210301|P3|Randomization Phase|Withdrawal by Subject|0
55212|NCT01163032|210302|P2|Randomization Phase|Withdrawal by Subject|3
55213|NCT01163032|210303|P1|Randomization Phase|Withdrawal by Subject|2
55214|NCT01162863|210336|P3|Overall Study|Adverse Event|0
55215|NCT01162863|210337|P2|Overall Study|Adverse Event|1
55216|NCT01162863|210338|P1|Overall Study|Adverse Event|0
55217|NCT01162863|210336|P3|Overall Study|Lack of Efficacy|0
55218|NCT01162863|210337|P2|Overall Study|Lack of Efficacy|0
55219|NCT01162863|210338|P1|Overall Study|Lack of Efficacy|1
55220|NCT01162499|210363|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
55221|NCT01162499|210364|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
55222|NCT01162473|210386|P2|Overall Study|Withdrawal by Subject|4
55223|NCT01162473|210387|P1|Overall Study|Withdrawal by Subject|0
55224|NCT01162473|210386|P2|Overall Study|Adverse Event|1
55225|NCT01162473|210387|P1|Overall Study|Adverse Event|2
55226|NCT01162421|210395|P2|Overall Study|Not specified|3
55227|NCT01162421|210396|P1|Overall Study|Not specified|2
55228|NCT01162421|210395|P2|Overall Study|Lack of Efficacy|2
55229|NCT01162421|210396|P1|Overall Study|Lack of Efficacy|2
55230|NCT01162421|210395|P2|Overall Study|Lost to Follow-up|2
55231|NCT01162421|210396|P1|Overall Study|Lost to Follow-up|0
55232|NCT01162421|210395|P2|Overall Study|Adverse Event|5
55233|NCT01162421|210396|P1|Overall Study|Adverse Event|2
55234|NCT01162421|210395|P2|Overall Study|Did not receive study drug|1
55235|NCT01162421|210396|P1|Overall Study|Did not receive study drug|2
55236|NCT01162304|210474|P1|Overall Study|Beck scale to high|11
55237|NCT01162135|210488|P1|Overall Study|Ineligible|1
55238|NCT01162135|210488|P1|Overall Study|Severe back pain|1
55239|NCT01162135|210488|P1|Overall Study|Withdrawal by Subject|1
55240|NCT01162122|210494|P2|Overall Study|Missing primary reason|0
55241|NCT01162122|210495|P1|Overall Study|Missing primary reason|1
55242|NCT01162122|210494|P2|Overall Study|Unable to classify|7
55243|NCT01162122|210495|P1|Overall Study|Unable to classify|3
55244|NCT01162122|210494|P2|Overall Study|Administrative reason|1
55245|NCT01162122|210495|P1|Overall Study|Administrative reason|1
55246|NCT01162122|210494|P2|Overall Study|Inappropriate enrollment|4
55247|NCT01162122|210495|P1|Overall Study|Inappropriate enrollment|5
55248|NCT01162122|210494|P2|Overall Study|Protocol Violation|2
55249|NCT01162122|210495|P1|Overall Study|Protocol Violation|2
55250|NCT01162122|210494|P2|Overall Study|Death|46
55251|NCT01162122|210495|P1|Overall Study|Death|51
55252|NCT01162122|210494|P2|Overall Study|Adverse Event|2
55253|NCT01162122|210495|P1|Overall Study|Adverse Event|3
55254|NCT01162122|210494|P2|Overall Study|Lost to Follow-up|91
55255|NCT01162122|210495|P1|Overall Study|Lost to Follow-up|73
55256|NCT01162122|210494|P2|Overall Study|Withdrawal by Subject|43
55257|NCT01162122|210495|P1|Overall Study|Withdrawal by Subject|52
55258|NCT01161628|210565|P1|Overall Study|Lack of Efficacy|2
55259|NCT01161628|210565|P1|Overall Study|Death|6
55260|NCT01161537|210588|P1|Part B|Withdrawal by Subject|2
55261|NCT01161498|210606|P2|Overall Study|Disease Progression|1
55262|NCT01161498|210607|P1|Overall Study|Disease Progression|0
55263|NCT01161472|210631|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
55264|NCT01161472|210632|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
55265|NCT01161472|210633|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
55266|NCT01161472|210634|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
55267|NCT01161407|210702|P2|Overall Study|Protocol Violation|1
55268|NCT01161407|210703|P1|Overall Study|Protocol Violation|3
55269|NCT01161173|210758|P1|Overall Study|Reasons Not Specified|23
55270|NCT01161173|210758|P1|Overall Study|End of Study|2
55271|NCT01161173|210758|P1|Overall Study|Death|194
55272|NCT01161173|210758|P1|Overall Study|Unacceptable Toxicity|21
55273|NCT01161173|210758|P1|Overall Study|Withdrawal of Consent|5
55274|NCT01161173|210758|P1|Overall Study|Progressive Disease|82
55275|NCT01161173|210758|P1|Overall Study|Lost to Follow-up|7
55276|NCT01161173|210758|P1|Overall Study|Protocol Violation|13
55277|NCT01160822|210799|P7|Overall Study|Protocol deviation|0
55278|NCT01160822|210800|P6|Overall Study|Protocol deviation|0
55279|NCT01160822|210801|P5|Overall Study|Protocol deviation|2
55280|NCT01160822|210802|P4|Overall Study|Protocol deviation|0
55281|NCT01160822|210803|P3|Overall Study|Protocol deviation|0
55282|NCT01160822|210804|P2|Overall Study|Protocol deviation|0
55283|NCT01160822|210805|P1|Overall Study|Protocol deviation|0
55284|NCT01160822|210799|P7|Overall Study|Administrative problems|0
55285|NCT01160822|210800|P6|Overall Study|Administrative problems|0
55286|NCT01160822|210801|P5|Overall Study|Administrative problems|1
55287|NCT01160822|210802|P4|Overall Study|Administrative problems|0
55288|NCT01160822|210803|P3|Overall Study|Administrative problems|0
55289|NCT01160822|210804|P2|Overall Study|Administrative problems|0
55290|NCT01160822|210805|P1|Overall Study|Administrative problems|0
55291|NCT01160822|210799|P7|Overall Study|Lost to Follow-up|0
55292|NCT01160822|210800|P6|Overall Study|Lost to Follow-up|0
55293|NCT01160822|210801|P5|Overall Study|Lost to Follow-up|1
55294|NCT01160822|210802|P4|Overall Study|Lost to Follow-up|0
55295|NCT01160822|210803|P3|Overall Study|Lost to Follow-up|0
55296|NCT01160822|210804|P2|Overall Study|Lost to Follow-up|0
55297|NCT01160822|210805|P1|Overall Study|Lost to Follow-up|0
55298|NCT01160822|210799|P7|Overall Study|Withdrawal by Subject|1
55299|NCT01160822|210800|P6|Overall Study|Withdrawal by Subject|0
55300|NCT01160822|210801|P5|Overall Study|Withdrawal by Subject|0
55301|NCT01160822|210802|P4|Overall Study|Withdrawal by Subject|0
55302|NCT01160822|210803|P3|Overall Study|Withdrawal by Subject|0
55303|NCT01160822|210804|P2|Overall Study|Withdrawal by Subject|0
55304|NCT01160822|210805|P1|Overall Study|Withdrawal by Subject|0
55305|NCT01160822|210799|P7|Overall Study|Unsatisfactory therapeutic effect|3
55306|NCT01160822|210800|P6|Overall Study|Unsatisfactory therapeutic effect|5
55307|NCT01160822|210801|P5|Overall Study|Unsatisfactory therapeutic effect|4
55308|NCT01160822|210802|P4|Overall Study|Unsatisfactory therapeutic effect|0
55309|NCT01160822|210803|P3|Overall Study|Unsatisfactory therapeutic effect|0
55310|NCT01160822|210804|P2|Overall Study|Unsatisfactory therapeutic effect|0
55311|NCT01160822|210805|P1|Overall Study|Unsatisfactory therapeutic effect|0
55312|NCT01160822|210799|P7|Overall Study|Adverse Event|5
55313|NCT01160822|210800|P6|Overall Study|Adverse Event|2
55314|NCT01160822|210801|P5|Overall Study|Adverse Event|1
55315|NCT01160822|210802|P4|Overall Study|Adverse Event|0
55316|NCT01160822|210803|P3|Overall Study|Adverse Event|0
55317|NCT01160822|210804|P2|Overall Study|Adverse Event|0
55318|NCT01160822|210805|P1|Overall Study|Adverse Event|0
55319|NCT01160770|210894|P1|Overall Study|Other Reasons|1
55320|NCT01160770|210894|P1|Overall Study|Lack of Efficacy|15
55321|NCT01160770|210894|P1|Overall Study|Death|9
55322|NCT01160770|210894|P1|Overall Study|Study termination or sponsor request|1
55323|NCT01160770|210894|P1|Overall Study|Lost to Follow-up|7
55324|NCT01160770|210894|P1|Overall Study|Physician Decision|1
55325|NCT01160770|210894|P1|Overall Study|Subject/parent/caregiver request|33
55326|NCT01160770|210894|P1|Overall Study|Protocol Violation|2
55327|NCT01160770|210894|P1|Overall Study|Adverse Event|10
55328|NCT01160744|210907|P4|Overall Study|Alive and Still on Treatment|14
55329|NCT01160744|210908|P3|Overall Study|Alive and Still on Treatment|8
55330|NCT01160744|210909|P2|Overall Study|Alive and Still on Treatment|11
55331|NCT01160744|210910|P1|Overall Study|Alive and Still on Treatment|9
55332|NCT01160744|210907|P4|Overall Study|Not Specified|4
55333|NCT01160744|210908|P3|Overall Study|Not Specified|5
55334|NCT01160744|210909|P2|Overall Study|Not Specified|9
55335|NCT01160744|210910|P1|Overall Study|Not Specified|5
55336|NCT01160744|210907|P4|Overall Study|Not meet inclusion/exclusion criteria|0
55337|NCT01160744|210908|P3|Overall Study|Not meet inclusion/exclusion criteria|1
55338|NCT01160744|210909|P2|Overall Study|Not meet inclusion/exclusion criteria|0
55339|NCT01160744|210910|P1|Overall Study|Not meet inclusion/exclusion criteria|0
55340|NCT01160744|210907|P4|Overall Study|Withdrawal by Subject|4
55341|NCT01160744|210908|P3|Overall Study|Withdrawal by Subject|6
55342|NCT01160744|210909|P2|Overall Study|Withdrawal by Subject|5
55343|NCT01160744|210910|P1|Overall Study|Withdrawal by Subject|6
55344|NCT01160640|210946|P2|Overall Study|Withdrawal by Subject|3
55345|NCT01160640|210947|P1|Overall Study|Withdrawal by Subject|0
55346|NCT01160640|210946|P2|Overall Study|Incarceration|0
55347|NCT01160640|210947|P1|Overall Study|Incarceration|1
55348|NCT01160640|210946|P2|Overall Study|Physician Decision|3
55349|NCT01160640|210947|P1|Overall Study|Physician Decision|3
55350|NCT01160614|210963|P2|Overall Study|Withdrawal by Subject|2
55351|NCT01160614|210964|P1|Overall Study|Withdrawal by Subject|0
55352|NCT01160484|211012|P1|Overall Study|inclusion/exclusion criteria failure|1
55353|NCT01160484|211012|P1|Overall Study|Withdrawal by Subject|2
55354|NCT01160484|211012|P1|Overall Study|Adverse Event|6
55355|NCT01160484|211012|P1|Overall Study|Lack of Efficacy|9
55356|NCT01159938|211090|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
55357|NCT01159938|211091|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
55358|NCT01159938|211092|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
55359|NCT01159938|211093|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
55360|NCT01159938|211094|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
55361|NCT01159912|211157|P3|Overall Study|Withdrawal by Subject|3
55362|NCT01159912|211158|P2|Overall Study|Withdrawal by Subject|3
55363|NCT01159912|211159|P1|Overall Study|Withdrawal by Subject|10
55364|NCT01159912|211157|P3|Overall Study|Physician Decision|3
55365|NCT01159912|211158|P2|Overall Study|Physician Decision|0
55366|NCT01159912|211159|P1|Overall Study|Physician Decision|0
55367|NCT01159912|211157|P3|Overall Study|Lost to Follow-up|0
55368|NCT01159912|211158|P2|Overall Study|Lost to Follow-up|0
55369|NCT01159912|211159|P1|Overall Study|Lost to Follow-up|4
55370|NCT01159912|211157|P3|Overall Study|Protocol Violation|3
55371|NCT01159912|211158|P2|Overall Study|Protocol Violation|2
55372|NCT01159912|211159|P1|Overall Study|Protocol Violation|1
55373|NCT01159912|211157|P3|Overall Study|Lack of Efficacy|14
55374|NCT01159912|211158|P2|Overall Study|Lack of Efficacy|15
55375|NCT01159912|211159|P1|Overall Study|Lack of Efficacy|23
55376|NCT01159912|211157|P3|Overall Study|Adverse Event|3
55377|NCT01159912|211158|P2|Overall Study|Adverse Event|2
55378|NCT01159912|211159|P1|Overall Study|Adverse Event|2
55379|NCT01159769|211182|P1|Overall Study|Adverse Event|1
55380|NCT01159691|211202|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
55381|NCT01159691|211202|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
55382|NCT01159691|211202|P1|Overall Study|Disc. Neupro other & unknown reasons|7
55383|NCT01159691|211202|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
55384|NCT01159691|211202|P1|Overall Study|Discontinued Neupro due to other reasons|1
55385|NCT01159691|211202|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
55386|NCT01159691|211202|P1|Overall Study|Unknown reasons|1
55387|NCT01159691|211202|P1|Overall Study|Lost to Follow-up|2
55388|NCT01159665|211215|P6|Overall Study|Withdrawal by Subject|0
55389|NCT01159665|211216|P5|Overall Study|Withdrawal by Subject|0
55390|NCT01159665|211217|P4|Overall Study|Withdrawal by Subject|0
55391|NCT01159665|211218|P3|Overall Study|Withdrawal by Subject|0
55392|NCT01159665|211219|P2|Overall Study|Withdrawal by Subject|1
55393|NCT01159665|211220|P1|Overall Study|Withdrawal by Subject|0
55394|NCT01159600|211248|P8|Overall Study|Other reason not defined above|3
55395|NCT01159600|211249|P7|Overall Study|Other reason not defined above|3
55396|NCT01159600|211250|P6|Overall Study|Other reason not defined above|7
55397|NCT01159600|211251|P5|Overall Study|Other reason not defined above|5
55398|NCT01159600|211252|P4|Overall Study|Other reason not defined above|2
55399|NCT01159600|211253|P3|Overall Study|Other reason not defined above|4
55400|NCT01159600|211254|P2|Overall Study|Other reason not defined above|0
55401|NCT01159600|211255|P1|Overall Study|Other reason not defined above|3
55402|NCT01159600|211248|P8|Overall Study|Patient refusal to continue,not due toAE|5
55403|NCT01159600|211249|P7|Overall Study|Patient refusal to continue,not due toAE|2
55404|NCT01159600|211250|P6|Overall Study|Patient refusal to continue,not due toAE|4
55405|NCT01159600|211251|P5|Overall Study|Patient refusal to continue,not due toAE|4
55406|NCT01159600|211252|P4|Overall Study|Patient refusal to continue,not due toAE|5
55407|NCT01159600|211253|P3|Overall Study|Patient refusal to continue,not due toAE|4
55408|NCT01159600|211254|P2|Overall Study|Patient refusal to continue,not due toAE|2
55409|NCT01159600|211255|P1|Overall Study|Patient refusal to continue,not due toAE|7
55410|NCT01159600|211248|P8|Overall Study|Lost to Follow-up|2
55411|NCT01159600|211249|P7|Overall Study|Lost to Follow-up|3
55412|NCT01159600|211250|P6|Overall Study|Lost to Follow-up|0
55413|NCT01159600|211251|P5|Overall Study|Lost to Follow-up|3
55414|NCT01159600|211252|P4|Overall Study|Lost to Follow-up|3
55415|NCT01159600|211253|P3|Overall Study|Lost to Follow-up|4
55416|NCT01159600|211254|P2|Overall Study|Lost to Follow-up|3
55417|NCT01159600|211255|P1|Overall Study|Lost to Follow-up|2
55418|NCT01159600|211248|P8|Overall Study|Non compliant with protocol|0
55419|NCT01159600|211249|P7|Overall Study|Non compliant with protocol|2
55420|NCT01159600|211250|P6|Overall Study|Non compliant with protocol|0
55421|NCT01159600|211251|P5|Overall Study|Non compliant with protocol|2
55422|NCT01159600|211252|P4|Overall Study|Non compliant with protocol|0
55423|NCT01159600|211253|P3|Overall Study|Non compliant with protocol|0
55424|NCT01159600|211254|P2|Overall Study|Non compliant with protocol|1
55425|NCT01159600|211255|P1|Overall Study|Non compliant with protocol|2
55426|NCT01159600|211248|P8|Overall Study|Lack of Efficacy|1
55427|NCT01159600|211249|P7|Overall Study|Lack of Efficacy|0
55428|NCT01159600|211250|P6|Overall Study|Lack of Efficacy|0
55429|NCT01159600|211251|P5|Overall Study|Lack of Efficacy|2
55430|NCT01159600|211252|P4|Overall Study|Lack of Efficacy|0
55431|NCT01159600|211253|P3|Overall Study|Lack of Efficacy|0
55432|NCT01159600|211254|P2|Overall Study|Lack of Efficacy|0
55433|NCT01159600|211255|P1|Overall Study|Lack of Efficacy|0
55434|NCT01159600|211248|P8|Overall Study|Adverse Event|5
55435|NCT01159600|211249|P7|Overall Study|Adverse Event|7
55436|NCT01159600|211250|P6|Overall Study|Adverse Event|6
55437|NCT01159600|211251|P5|Overall Study|Adverse Event|8
55438|NCT01159600|211252|P4|Overall Study|Adverse Event|1
55439|NCT01159600|211253|P3|Overall Study|Adverse Event|5
55440|NCT01159600|211254|P2|Overall Study|Adverse Event|2
55441|NCT01159600|211255|P1|Overall Study|Adverse Event|7
55442|NCT01159600|211248|P8|Overall Study|Not treated|2
55443|NCT01159600|211249|P7|Overall Study|Not treated|2
55444|NCT01159600|211250|P6|Overall Study|Not treated|1
55445|NCT01159600|211251|P5|Overall Study|Not treated|0
55446|NCT01159600|211252|P4|Overall Study|Not treated|0
55447|NCT01159600|211253|P3|Overall Study|Not treated|1
55448|NCT01159600|211254|P2|Overall Study|Not treated|0
55449|NCT01159600|211255|P1|Overall Study|Not treated|0
55450|NCT01159431|211312|P2|Overall Study|Lack of Efficacy|3
55451|NCT01159431|211313|P1|Overall Study|Lack of Efficacy|0
55452|NCT01159431|211312|P2|Overall Study|non-compliance|1
55453|NCT01159431|211313|P1|Overall Study|non-compliance|1
55454|NCT01159431|211312|P2|Overall Study|Adverse Event|2
55455|NCT01159431|211313|P1|Overall Study|Adverse Event|1
55456|NCT01159171|211366|P1|Overall Study|Death|1
55457|NCT01159171|211366|P1|Overall Study|Medical Decision|4
55458|NCT01159171|211366|P1|Overall Study|Need for Surgery|5
55459|NCT01159171|211366|P1|Overall Study|Protocol Violation|1
55460|NCT01159171|211366|P1|Overall Study|Progression of Disease|28
55461|NCT01159171|211366|P1|Overall Study|Adverse Event|11
55462|NCT01158924|211383|P2|Overall Study|Lost to Follow-up|1
55463|NCT01158924|211384|P1|Overall Study|Lost to Follow-up|0
55464|NCT01158924|211383|P2|Overall Study|Withdrawal by Subject|2
55465|NCT01158924|211384|P1|Overall Study|Withdrawal by Subject|1
55466|NCT01158534|211426|P1|Overall Study|Other|1
55467|NCT01158534|211426|P1|Overall Study|Death|1
55468|NCT01158534|211426|P1|Overall Study|Withdrawal by Subject|1
55469|NCT01158378|211436|P2|Overall Study|Withdrawal by Subject|0
55470|NCT01158378|211437|P1|Overall Study|Withdrawal by Subject|4
55471|NCT01158378|211436|P2|Overall Study|Lost to Follow-up|4
55472|NCT01158378|211437|P1|Overall Study|Lost to Follow-up|2
55473|NCT01158378|211436|P2|Overall Study|Death|5
55474|NCT01158378|211437|P1|Overall Study|Death|4
55475|NCT01158261|211449|P1|Overall Study|Withdrawal by Subject|1
55476|NCT01158261|211449|P1|Overall Study|Death|7
55477|NCT01158261|211449|P1|Overall Study|Lost to Follow-up|9
55478|NCT01157845|211453|P1|Overall Study|Device malfunction|1
55479|NCT01157845|211453|P1|Overall Study|Study was ended|1
55480|NCT01157845|211453|P1|Overall Study|Protocol Violation|13
55481|NCT01157845|211453|P1|Overall Study|Physician Decision|3
55482|NCT01157845|211453|P1|Overall Study|Withdrawal by Subject|12
55483|NCT01157845|211453|P1|Overall Study|Lost to Follow-up|5
55484|NCT01156532|211462|P1|Overall Study|Lost to Follow-up|1
55485|NCT01156532|211462|P1|Overall Study|Family Reasons|1
55486|NCT01156480|211474|P2|Overall Study|change in diagnosis|1
55487|NCT01156480|211475|P1|Overall Study|change in diagnosis|0
55488|NCT01156376|211486|P3|Overall Study|Withdrawal by Subject|3
55489|NCT01156376|211487|P2|Overall Study|Withdrawal by Subject|0
55490|NCT01156376|211488|P1|Overall Study|Withdrawal by Subject|0
55491|NCT01156376|211486|P3|Overall Study|Adverse Event|1
55492|NCT01156376|211487|P2|Overall Study|Adverse Event|0
55493|NCT01156376|211488|P1|Overall Study|Adverse Event|1
55494|NCT01156363|211709|P1|Overall Study|Unspecified|6
55495|NCT01156363|211709|P1|Overall Study|Refused Treatment|4
55496|NCT01156363|211709|P1|Overall Study|Failure to Return|1
55497|NCT01156363|211709|P1|Overall Study|Insufficient Therapeutic Response|5
55498|NCT01156363|211709|P1|Overall Study|Adverse Event|6
55499|NCT01156311|211731|P4|6-month Add-on Therapy Period|Not Specified|2
55500|NCT01156311|211732|P3|6-month Add-on Therapy Period|Not Specified|1
55501|NCT01156311|211733|P2|6-month Add-on Therapy Period|Not Specified|0
55502|NCT01156311|211734|P1|6-month Add-on Therapy Period|Not Specified|0
55503|NCT01156311|211731|P4|6-month Add-on Therapy Period|Physician Decision|0
55504|NCT01156311|211732|P3|6-month Add-on Therapy Period|Physician Decision|1
55505|NCT01156311|211733|P2|6-month Add-on Therapy Period|Physician Decision|0
55506|NCT01156311|211734|P1|6-month Add-on Therapy Period|Physician Decision|0
55507|NCT01156311|211731|P4|6-month Add-on Therapy Period|Disease Activity|2
55508|NCT01156311|211732|P3|6-month Add-on Therapy Period|Disease Activity|1
55509|NCT01156311|211733|P2|6-month Add-on Therapy Period|Disease Activity|0
55510|NCT01156311|211734|P1|6-month Add-on Therapy Period|Disease Activity|0
55511|NCT01156311|211731|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
55512|NCT01156311|211732|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
55513|NCT01156311|211733|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
55514|NCT01156311|211734|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
55515|NCT01156311|211731|P4|6-month Add-on Therapy Period|Adverse Event|6
55516|NCT01156311|211732|P3|6-month Add-on Therapy Period|Adverse Event|7
55517|NCT01156311|211733|P2|6-month Add-on Therapy Period|Adverse Event|0
55518|NCT01156311|211734|P1|6-month Add-on Therapy Period|Adverse Event|0
55519|NCT01156311|211731|P4|2-Month Monotherapy Period|Not specified|0
55520|NCT01156311|211732|P3|2-Month Monotherapy Period|Not specified|0
55521|NCT01156311|211733|P2|2-Month Monotherapy Period|Not specified|0
55522|NCT01156311|211734|P1|2-Month Monotherapy Period|Not specified|1
55523|NCT01156311|211731|P4|2-Month Monotherapy Period|Physician Decision|0
55524|NCT01156311|211732|P3|2-Month Monotherapy Period|Physician Decision|0
55525|NCT01156311|211733|P2|2-Month Monotherapy Period|Physician Decision|1
55526|NCT01156311|211734|P1|2-Month Monotherapy Period|Physician Decision|0
55527|NCT01156311|211731|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
55528|NCT01156311|211732|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
55529|NCT01156311|211733|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
55530|NCT01156311|211734|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
55531|NCT01157377|211763|P7|Overall Study|Other Miscellaneous Reasons|1
55532|NCT01157377|211764|P6|Overall Study|Other Miscellaneous Reasons|1
55533|NCT01157377|211765|P5|Overall Study|Other Miscellaneous Reasons|1
55534|NCT01157377|211766|P4|Overall Study|Other Miscellaneous Reasons|0
55535|NCT01157377|211767|P3|Overall Study|Other Miscellaneous Reasons|0
55536|NCT01157377|211768|P2|Overall Study|Other Miscellaneous Reasons|2
55537|NCT01157377|211769|P1|Overall Study|Other Miscellaneous Reasons|0
55538|NCT01157377|211763|P7|Overall Study|Lack of Efficacy|1
55539|NCT01157377|211764|P6|Overall Study|Lack of Efficacy|0
55540|NCT01157377|211765|P5|Overall Study|Lack of Efficacy|0
55541|NCT01157377|211766|P4|Overall Study|Lack of Efficacy|0
55542|NCT01157377|211767|P3|Overall Study|Lack of Efficacy|0
55543|NCT01157377|211768|P2|Overall Study|Lack of Efficacy|0
55544|NCT01157377|211769|P1|Overall Study|Lack of Efficacy|0
55545|NCT01157377|211763|P7|Overall Study|Protocol Violation|0
55546|NCT01157377|211764|P6|Overall Study|Protocol Violation|1
55547|NCT01157377|211765|P5|Overall Study|Protocol Violation|0
55548|NCT01157377|211766|P4|Overall Study|Protocol Violation|0
55549|NCT01157377|211767|P3|Overall Study|Protocol Violation|0
55550|NCT01157377|211768|P2|Overall Study|Protocol Violation|0
55551|NCT01157377|211769|P1|Overall Study|Protocol Violation|0
55552|NCT01157377|211763|P7|Overall Study|Personal Reasons|0
55553|NCT01157377|211764|P6|Overall Study|Personal Reasons|0
55554|NCT01157377|211765|P5|Overall Study|Personal Reasons|0
55555|NCT01157377|211766|P4|Overall Study|Personal Reasons|1
55556|NCT01157377|211767|P3|Overall Study|Personal Reasons|0
55557|NCT01157377|211768|P2|Overall Study|Personal Reasons|1
55558|NCT01157377|211769|P1|Overall Study|Personal Reasons|2
55559|NCT01157377|211763|P7|Overall Study|Lost to Follow-up|0
55560|NCT01157377|211764|P6|Overall Study|Lost to Follow-up|1
55561|NCT01157377|211765|P5|Overall Study|Lost to Follow-up|1
55562|NCT01157377|211766|P4|Overall Study|Lost to Follow-up|0
55563|NCT01157377|211767|P3|Overall Study|Lost to Follow-up|1
55564|NCT01157377|211768|P2|Overall Study|Lost to Follow-up|0
55565|NCT01157377|211769|P1|Overall Study|Lost to Follow-up|0
55566|NCT01157351|211787|P2|Overall Study|Randomized but not Treated|2
55567|NCT01157351|211788|P1|Overall Study|Randomized but not Treated|4
55568|NCT01157351|211787|P2|Overall Study|Noncompliance with Study Drug|3
55569|NCT01157351|211788|P1|Overall Study|Noncompliance with Study Drug|0
55570|NCT01157351|211787|P2|Overall Study|Unspecified|36
55571|NCT01157351|211788|P1|Overall Study|Unspecified|32
55572|NCT01157351|211787|P2|Overall Study|Protocol Violation|1
55573|NCT01157351|211788|P1|Overall Study|Protocol Violation|0
55574|NCT01157351|211787|P2|Overall Study|Physician Decision|4
55575|NCT01157351|211788|P1|Overall Study|Physician Decision|5
55576|NCT01157351|211787|P2|Overall Study|Withdrawal by Subject|27
55577|NCT01157351|211788|P1|Overall Study|Withdrawal by Subject|37
55578|NCT01157351|211787|P2|Overall Study|Lost to Follow-up|55
55579|NCT01157351|211788|P1|Overall Study|Lost to Follow-up|53
55580|NCT01157351|211787|P2|Overall Study|Death|0
55581|NCT01157351|211788|P1|Overall Study|Death|1
55582|NCT01157351|211787|P2|Overall Study|Adverse Event|4
55583|NCT01157351|211788|P1|Overall Study|Adverse Event|5
55584|NCT01157234|211806|P2|Overall Study|Withdrawal by Subject|0
55585|NCT01157234|211807|P1|Overall Study|Withdrawal by Subject|1
55586|NCT01157182|211839|P2|Washout of 28 Days|Adverse Event|0
55587|NCT01157182|211840|P1|Washout of 28 Days|Adverse Event|2
55588|NCT01157169|211888|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
55589|NCT01157169|211889|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
55590|NCT01157169|211888|P2|First Intervention|Emesis Within 4 hrs of Administration|2
55591|NCT01157169|211889|P1|First Intervention|Emesis Within 4 hrs of Administration|4
55592|NCT01157169|211888|P2|First Intervention|Protocol Violation|0
55593|NCT01157169|211889|P1|First Intervention|Protocol Violation|0
55594|NCT01157117|211908|P3|Overall Study|Unknown (Pending Final Form Submission)|13
55595|NCT01157117|211909|P2|Overall Study|Unknown (Pending Final Form Submission)|5
55596|NCT01157117|211910|P1|Overall Study|Unknown (Pending Final Form Submission)|4
55597|NCT01157117|211908|P3|Overall Study|Lost to Follow-up|1
55598|NCT01157117|211909|P2|Overall Study|Lost to Follow-up|0
55599|NCT01157117|211910|P1|Overall Study|Lost to Follow-up|0
55600|NCT01157117|211908|P3|Overall Study|Lack of Efficacy|0
55601|NCT01157117|211909|P2|Overall Study|Lack of Efficacy|1
55602|NCT01157117|211910|P1|Overall Study|Lack of Efficacy|1
55603|NCT01157117|211908|P3|Overall Study|Withdrawal by Subject|1
55604|NCT01157117|211909|P2|Overall Study|Withdrawal by Subject|1
55605|NCT01157117|211910|P1|Overall Study|Withdrawal by Subject|4
55606|NCT01157117|211908|P3|Overall Study|Dosing Symptoms|0
55607|NCT01157117|211909|P2|Overall Study|Dosing Symptoms|4
55608|NCT01157117|211910|P1|Overall Study|Dosing Symptoms|0
55609|NCT01157078|211951|P2|Overall Study|Not specified|4
55610|NCT01157078|211952|P1|Overall Study|Not specified|2
55611|NCT01157078|211951|P2|Overall Study|Lost to Follow-up|5
55612|NCT01157078|211952|P1|Overall Study|Lost to Follow-up|7
55613|NCT01157078|211951|P2|Overall Study|Study-specific withdrawal criteria|2
55614|NCT01157078|211952|P1|Overall Study|Study-specific withdrawal criteria|2
55615|NCT01157078|211951|P2|Overall Study|Lack of Efficacy|0
55616|NCT01157078|211952|P1|Overall Study|Lack of Efficacy|2
55617|NCT01157078|211951|P2|Overall Study|Condition under investigation worsened|1
55618|NCT01157078|211952|P1|Overall Study|Condition under investigation worsened|0
55619|NCT01157078|211951|P2|Overall Study|Severe non-compliance to protocol|4
55620|NCT01157078|211952|P1|Overall Study|Severe non-compliance to protocol|2
55621|NCT01157078|211951|P2|Overall Study|Adverse Event|6
55622|NCT01157078|211952|P1|Overall Study|Adverse Event|6
55623|NCT01157078|211951|P2|Overall Study|Eligibility criteria not fulfilled|0
55624|NCT01157078|211952|P1|Overall Study|Eligibility criteria not fulfilled|2
55625|NCT01157078|211951|P2|Overall Study|Withdrawal by Subject|14
55626|NCT01157078|211952|P1|Overall Study|Withdrawal by Subject|12
55627|NCT01157065|212002|P2|Overall Study|Death|1
55628|NCT01157065|212003|P1|Overall Study|Death|0
55629|NCT01156844|212024|P4|Overall Study|Protocol deviation|0
55630|NCT01156844|212025|P3|Overall Study|Protocol deviation|0
55631|NCT01156844|212026|P2|Overall Study|Protocol deviation|0
55632|NCT01156844|212027|P1|Overall Study|Protocol deviation|2
55633|NCT01156844|212024|P4|Overall Study|Administrative problems|1
55634|NCT01156844|212025|P3|Overall Study|Administrative problems|0
55635|NCT01156844|212026|P2|Overall Study|Administrative problems|1
55636|NCT01156844|212027|P1|Overall Study|Administrative problems|0
55637|NCT01156844|212024|P4|Overall Study|Lost to Follow-up|0
55638|NCT01156844|212025|P3|Overall Study|Lost to Follow-up|1
55639|NCT01156844|212026|P2|Overall Study|Lost to Follow-up|0
55640|NCT01156844|212027|P1|Overall Study|Lost to Follow-up|0
55641|NCT01156844|212024|P4|Overall Study|Withdrawal by Subject|2
55642|NCT01156844|212025|P3|Overall Study|Withdrawal by Subject|2
55643|NCT01156844|212026|P2|Overall Study|Withdrawal by Subject|0
55644|NCT01156844|212027|P1|Overall Study|Withdrawal by Subject|0
55645|NCT01156844|212024|P4|Overall Study|Abnormal test procedure result(s)|2
55646|NCT01156844|212025|P3|Overall Study|Abnormal test procedure result(s)|2
55647|NCT01156844|212026|P2|Overall Study|Abnormal test procedure result(s)|1
55648|NCT01156844|212027|P1|Overall Study|Abnormal test procedure result(s)|0
55649|NCT01156844|212024|P4|Overall Study|Adverse Event|1
55650|NCT01156844|212025|P3|Overall Study|Adverse Event|1
55651|NCT01156844|212026|P2|Overall Study|Adverse Event|0
55652|NCT01156844|212027|P1|Overall Study|Adverse Event|0
55653|NCT01156792|212046|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
55654|NCT01156792|212046|P1|Overall Study|Withdrawal by Subject|9
55655|NCT01156792|212046|P1|Overall Study|Physician Decision|3
55656|NCT01156792|212046|P1|Overall Study|Lost to Follow-up|3
55657|NCT01156792|212046|P1|Overall Study|Protocol Violation|6
55658|NCT01156792|212046|P1|Overall Study|Lack of Efficacy|36
55659|NCT01156792|212046|P1|Overall Study|Adverse Event|1
55660|NCT01156116|212176|P2|Overall Study|CPAP intolerance|0
55661|NCT01156116|212177|P1|Overall Study|CPAP intolerance|2
55662|NCT01156116|212176|P2|Overall Study|Withdrawal by Subject|1
55663|NCT01156116|212177|P1|Overall Study|Withdrawal by Subject|3
55664|NCT01156051|212191|P2|Overall Study|patient not compliant with protocol|1
55665|NCT01156051|212192|P1|Overall Study|patient not compliant with protocol|0
55666|NCT01156051|212191|P2|Overall Study|Lost to Follow-up|0
55667|NCT01156051|212192|P1|Overall Study|Lost to Follow-up|1
55668|NCT01156012|212206|P2|Overall Study|Non respect of one of inclusion criteria|1
55669|NCT01156012|212207|P1|Overall Study|Non respect of one of inclusion criteria|2
55670|NCT01156012|212206|P2|Overall Study|use of commercial drug instead of study|1
55671|NCT01156012|212207|P1|Overall Study|use of commercial drug instead of study|0
55672|NCT01156012|212206|P2|Overall Study|Withdrawal by Subject|0
55673|NCT01156012|212207|P1|Overall Study|Withdrawal by Subject|1
55674|NCT01156012|212206|P2|Overall Study|Lost to Follow-up|0
55675|NCT01156012|212207|P1|Overall Study|Lost to Follow-up|1
55676|NCT01156012|212206|P2|Overall Study|Adverse Event|1
55677|NCT01156012|212207|P1|Overall Study|Adverse Event|3
55678|NCT01155869|212224|P2|Overall Study|Lost to Follow-up|1
55679|NCT01155869|212225|P1|Overall Study|Lost to Follow-up|3
55680|NCT01155726|212249|P4|Period 1, 3 Days (Masked)|Inconvenience|0
55681|NCT01155726|212250|P3|Period 1, 3 Days (Masked)|Inconvenience|2
55682|NCT01155726|212251|P2|Period 1, 3 Days (Masked)|Inconvenience|0
55683|NCT01155726|212252|P1|Period 1, 3 Days (Masked)|Inconvenience|1
55684|NCT01155570|212274|P1|Overall Study|Other Reasons|23
55685|NCT01155570|212274|P1|Overall Study|Participant's Economic Reasons + Other|1
55686|NCT01155570|212274|P1|Overall Study|Adverse Event + Other Reasons|7
55687|NCT01155570|212274|P1|Overall Study|Adverse Event + Lack of Efficacy|2
55688|NCT01155570|212274|P1|Overall Study|No Hospital Visits|7
55689|NCT01155570|212274|P1|Overall Study|Participant's Economic Reasons|17
55690|NCT01155570|212274|P1|Overall Study|Lack of Efficacy|46
55691|NCT01155570|212274|P1|Overall Study|Adverse Event|39
55692|NCT01155531|212308|P4|Overall Study|Withdrawal by Subject|0
55693|NCT01155531|212309|P3|Overall Study|Withdrawal by Subject|1
55694|NCT01155531|212310|P2|Overall Study|Withdrawal by Subject|0
55695|NCT01155531|212311|P1|Overall Study|Withdrawal by Subject|1
55696|NCT01155531|212308|P4|Overall Study|Lost to Follow-up|1
55697|NCT01155531|212309|P3|Overall Study|Lost to Follow-up|0
55698|NCT01155531|212310|P2|Overall Study|Lost to Follow-up|0
55699|NCT01155531|212311|P1|Overall Study|Lost to Follow-up|0
55700|NCT01155531|212308|P4|Overall Study|Adverse Event|0
55701|NCT01155531|212309|P3|Overall Study|Adverse Event|1
55702|NCT01155531|212310|P2|Overall Study|Adverse Event|0
55703|NCT01155531|212311|P1|Overall Study|Adverse Event|0
55704|NCT01155479|212334|P5|Part II|Non-Compliance with Protocol|0
55705|NCT01155479|212335|P4|Part II|Non-Compliance with Protocol|2
55706|NCT01155479|212336|P3|Part II|Non-Compliance with Protocol|0
55707|NCT01155479|212337|P2|Part II|Non-Compliance with Protocol|1
55708|NCT01155479|212338|P1|Part II|Non-Compliance with Protocol|0
55709|NCT01155479|212334|P5|Part II|Treatment Failure|1
55710|NCT01155479|212335|P4|Part II|Treatment Failure|0
55711|NCT01155479|212336|P3|Part II|Treatment Failure|2
55712|NCT01155479|212337|P2|Part II|Treatment Failure|1
55713|NCT01155479|212338|P1|Part II|Treatment Failure|0
55714|NCT01155479|212334|P5|Part II|Lost to Follow-up|1
55715|NCT01155479|212335|P4|Part II|Lost to Follow-up|0
55716|NCT01155479|212336|P3|Part II|Lost to Follow-up|0
55717|NCT01155479|212337|P2|Part II|Lost to Follow-up|0
55718|NCT01155479|212338|P1|Part II|Lost to Follow-up|1
55719|NCT01155479|212334|P5|Part II|Withdrawal by Subject|3
55720|NCT01155479|212335|P4|Part II|Withdrawal by Subject|7
55721|NCT01155479|212336|P3|Part II|Withdrawal by Subject|12
55722|NCT01155479|212337|P2|Part II|Withdrawal by Subject|4
55723|NCT01155479|212338|P1|Part II|Withdrawal by Subject|8
55724|NCT01155479|212334|P5|Part II|Administrative|46
55725|NCT01155479|212335|P4|Part II|Administrative|38
55726|NCT01155479|212336|P3|Part II|Administrative|36
55727|NCT01155479|212337|P2|Part II|Administrative|49
55728|NCT01155479|212338|P1|Part II|Administrative|43
55729|NCT01155479|212334|P5|Part II|Adverse Event|4
55730|NCT01155479|212335|P4|Part II|Adverse Event|3
55731|NCT01155479|212336|P3|Part II|Adverse Event|8
55732|NCT01155479|212337|P2|Part II|Adverse Event|6
55733|NCT01155479|212338|P1|Part II|Adverse Event|7
55734|NCT01155479|212334|P5|Part I|Non-Compliance with Protocol|2
55735|NCT01155479|212335|P4|Part I|Non-Compliance with Protocol|3
55736|NCT01155479|212336|P3|Part I|Non-Compliance with Protocol|3
55737|NCT01155479|212337|P2|Part I|Non-Compliance with Protocol|1
55738|NCT01155479|212338|P1|Part I|Non-Compliance with Protocol|2
55739|NCT01155479|212334|P5|Part I|Did Not Receive Treatment|1
55740|NCT01155479|212335|P4|Part I|Did Not Receive Treatment|6
55741|NCT01155479|212336|P3|Part I|Did Not Receive Treatment|2
55742|NCT01155479|212337|P2|Part I|Did Not Receive Treatment|2
55743|NCT01155479|212338|P1|Part I|Did Not Receive Treatment|4
55744|NCT01155479|212334|P5|Part I|Treatment Failure|2
55745|NCT01155479|212335|P4|Part I|Treatment Failure|1
55746|NCT01155479|212336|P3|Part I|Treatment Failure|3
55747|NCT01155479|212337|P2|Part I|Treatment Failure|0
55748|NCT01155479|212338|P1|Part I|Treatment Failure|3
55749|NCT01155479|212334|P5|Part I|Lost to Follow-up|0
55750|NCT01155479|212335|P4|Part I|Lost to Follow-up|1
55751|NCT01155479|212336|P3|Part I|Lost to Follow-up|1
55752|NCT01155479|212337|P2|Part I|Lost to Follow-up|0
55753|NCT01155479|212338|P1|Part I|Lost to Follow-up|0
55754|NCT01155479|212334|P5|Part I|Withdrawal by Subject|9
55755|NCT01155479|212335|P4|Part I|Withdrawal by Subject|8
55756|NCT01155479|212336|P3|Part I|Withdrawal by Subject|8
55757|NCT01155479|212337|P2|Part I|Withdrawal by Subject|13
55758|NCT01155479|212338|P1|Part I|Withdrawal by Subject|11
55759|NCT01155479|212334|P5|Part I|Did Not Meet Protocol Eligibility|3
55760|NCT01155479|212335|P4|Part I|Did Not Meet Protocol Eligibility|1
55761|NCT01155479|212336|P3|Part I|Did Not Meet Protocol Eligibility|2
55762|NCT01155479|212337|P2|Part I|Did Not Meet Protocol Eligibility|1
55763|NCT01155479|212338|P1|Part I|Did Not Meet Protocol Eligibility|3
55764|NCT01155479|212334|P5|Part I|Administrative|0
55765|NCT01155479|212335|P4|Part I|Administrative|0
55766|NCT01155479|212336|P3|Part I|Administrative|2
55767|NCT01155479|212337|P2|Part I|Administrative|2
55768|NCT01155479|212338|P1|Part I|Administrative|2
55769|NCT01155479|212334|P5|Part I|Adverse Event|6
55770|NCT01155479|212335|P4|Part I|Adverse Event|7
55771|NCT01155479|212336|P3|Part I|Adverse Event|18
55772|NCT01155479|212337|P2|Part I|Adverse Event|8
55773|NCT01155479|212338|P1|Part I|Adverse Event|13
55774|NCT01155466|212390|P5|Overall Study|Randomized not treated|2
55775|NCT01155466|212391|P4|Overall Study|Randomized not treated|0
55776|NCT01155466|212392|P3|Overall Study|Randomized not treated|3
55777|NCT01155466|212393|P2|Overall Study|Randomized not treated|2
55778|NCT01155466|212394|P1|Overall Study|Randomized not treated|2
55779|NCT01155466|212390|P5|Overall Study|Administrative|0
55780|NCT01155466|212391|P4|Overall Study|Administrative|0
55781|NCT01155466|212392|P3|Overall Study|Administrative|0
55782|NCT01155466|212393|P2|Overall Study|Administrative|3
55783|NCT01155466|212394|P1|Overall Study|Administrative|0
55784|NCT01155466|212390|P5|Overall Study|Protocol Violation|1
55785|NCT01155466|212391|P4|Overall Study|Protocol Violation|0
55786|NCT01155466|212392|P3|Overall Study|Protocol Violation|2
55787|NCT01155466|212393|P2|Overall Study|Protocol Violation|0
55788|NCT01155466|212394|P1|Overall Study|Protocol Violation|0
55789|NCT01155466|212390|P5|Overall Study|Withdrawal by Subject|4
55790|NCT01155466|212391|P4|Overall Study|Withdrawal by Subject|4
55791|NCT01155466|212392|P3|Overall Study|Withdrawal by Subject|9
55792|NCT01155466|212393|P2|Overall Study|Withdrawal by Subject|5
55793|NCT01155466|212394|P1|Overall Study|Withdrawal by Subject|7
55794|NCT01155466|212390|P5|Overall Study|Lost to Follow-up|2
55795|NCT01155466|212391|P4|Overall Study|Lost to Follow-up|0
55796|NCT01155466|212392|P3|Overall Study|Lost to Follow-up|0
55797|NCT01155466|212393|P2|Overall Study|Lost to Follow-up|0
55798|NCT01155466|212394|P1|Overall Study|Lost to Follow-up|0
55799|NCT01155466|212390|P5|Overall Study|Adverse Event|18
55800|NCT01155466|212391|P4|Overall Study|Adverse Event|17
55801|NCT01155466|212392|P3|Overall Study|Adverse Event|6
55802|NCT01155466|212393|P2|Overall Study|Adverse Event|15
55803|NCT01155466|212394|P1|Overall Study|Adverse Event|13
55804|NCT01155323|212455|P2|Second Intervention|Lost to Follow-up|1
55805|NCT01155323|212456|P1|Second Intervention|Lost to Follow-up|1
55806|NCT01155323|212455|P2|First Intervention|exclusion criteria|1
55807|NCT01155323|212456|P1|First Intervention|exclusion criteria|1
55808|NCT01155219|212474|P2|Overall Study|non-medical reason|2
55809|NCT01155219|212475|P1|Overall Study|non-medical reason|1
55810|NCT01155219|212474|P2|Overall Study|Adverse Event|1
55811|NCT01155219|212475|P1|Overall Study|Adverse Event|3
55812|NCT01155167|212483|P2|Overall Study|Access site changed to femoral artery|0
55813|NCT01155167|212484|P1|Overall Study|Access site changed to femoral artery|1
55814|NCT01155167|212483|P2|Overall Study|Insufficient ultrasound data|0
55815|NCT01155167|212484|P1|Overall Study|Insufficient ultrasound data|2
55816|NCT01155141|212507|P1|Overall Study|Screen Failure|1
55817|NCT01155141|212507|P1|Overall Study|Withdrawal by Subject|1
55818|NCT01155063|212519|P1|Overall Study|Study terminated by sponsor|87
55819|NCT01155063|212519|P1|Overall Study|Withdrawal by Subject|1
55820|NCT01155063|212519|P1|Overall Study|Adverse Event|1
55821|NCT01155024|212529|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
55822|NCT01155024|212530|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
55823|NCT01155024|212529|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
55824|NCT01155024|212530|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
55825|NCT01155024|212529|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
55826|NCT01155024|212530|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
55827|NCT01154673|212559|P2|Overall Study|moved out of province|0
55828|NCT01154673|212560|P1|Overall Study|moved out of province|1
55829|NCT01154673|212559|P2|Overall Study|Lost to Follow-up|0
55830|NCT01154673|212560|P1|Overall Study|Lost to Follow-up|1
55831|NCT01154452|212615|P4|Phase II|Adverse Event|4
55832|NCT01154452|212616|P3|Phase II|Adverse Event|4
55833|NCT01154452|212617|P2|Phase II|Adverse Event|0
55834|NCT01154452|212618|P1|Phase II|Adverse Event|0
55835|NCT01154452|212615|P4|Phase II|Withdrawal by Subject|2
55836|NCT01154452|212616|P3|Phase II|Withdrawal by Subject|1
55837|NCT01154452|212617|P2|Phase II|Withdrawal by Subject|0
55838|NCT01154452|212618|P1|Phase II|Withdrawal by Subject|0
55839|NCT01154452|212615|P4|Phase Ib|Adverse Event|0
55840|NCT01154452|212616|P3|Phase Ib|Adverse Event|0
55841|NCT01154452|212617|P2|Phase Ib|Adverse Event|1
55842|NCT01154452|212618|P1|Phase Ib|Adverse Event|2
55843|NCT01154452|212615|P4|Phase Ib|Not Treated|0
55844|NCT01154452|212616|P3|Phase Ib|Not Treated|0
55845|NCT01154452|212617|P2|Phase Ib|Not Treated|0
55846|NCT01154452|212618|P1|Phase Ib|Not Treated|1
55847|NCT01154296|212648|P2|6-month Follow-up|Declined by Study Coordinator|4
55848|NCT01154296|212649|P1|6-month Follow-up|Declined by Study Coordinator|5
55849|NCT01154296|212648|P2|6-month Follow-up|Death|2
55850|NCT01154296|212649|P1|6-month Follow-up|Death|3
55851|NCT01154296|212648|P2|6-month Follow-up|Withdrew consent|15
55852|NCT01154296|212649|P1|6-month Follow-up|Withdrew consent|14
55853|NCT01154296|212648|P2|6-month Follow-up|Incarcerated|32
55854|NCT01154296|212649|P1|6-month Follow-up|Incarcerated|37
55855|NCT01154296|212648|P2|6-month Follow-up|Lost contact|275
55856|NCT01154296|212649|P1|6-month Follow-up|Lost contact|269
55857|NCT01154296|212648|P2|Randomization and Intervention|Left clinic early|0
55858|NCT01154296|212649|P1|Randomization and Intervention|Left clinic early|2
55859|NCT01154296|212648|P2|Randomization and Intervention|Left before test|1
55860|NCT01154296|212649|P1|Randomization and Intervention|Left before test|0
55861|NCT01154296|212648|P2|Randomization and Intervention|Did not return|0
55862|NCT01154296|212649|P1|Randomization and Intervention|Did not return|1
55863|NCT01154296|212648|P2|Randomization and Intervention|Declined by staff|0
55864|NCT01154296|212649|P1|Randomization and Intervention|Declined by staff|1
55865|NCT01154296|212648|P2|Randomization and Intervention|Decided to decline|1
55866|NCT01154296|212649|P1|Randomization and Intervention|Decided to decline|1
55867|NCT01154283|212667|P2|7-12 Weeks|Withdrawal by Subject|1
55868|NCT01154283|212668|P1|7-12 Weeks|Withdrawal by Subject|0
55869|NCT01154283|212667|P2|7-12 Weeks|Death|0
55870|NCT01154283|212668|P1|7-12 Weeks|Death|1
55871|NCT01154283|212667|P2|0-6 Weeks|Death|1
55872|NCT01154283|212668|P1|0-6 Weeks|Death|0
55873|NCT01154283|212667|P2|0-6 Weeks|Withdrawal by Subject|2
55874|NCT01154283|212668|P1|0-6 Weeks|Withdrawal by Subject|7
55875|NCT01154218|212680|P4|Fourth Intervention Period|Withdrawal by Subject|0
55876|NCT01154218|212681|P3|Fourth Intervention Period|Withdrawal by Subject|0
55877|NCT01154218|212682|P2|Fourth Intervention Period|Withdrawal by Subject|0
55878|NCT01154218|212683|P1|Fourth Intervention Period|Withdrawal by Subject|1
55879|NCT01154218|212680|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
55880|NCT01154218|212681|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
55881|NCT01154218|212682|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
55882|NCT01154218|212683|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
55883|NCT01154218|212680|P4|Third Intervention Period|Adverse Event|0
55884|NCT01154218|212681|P3|Third Intervention Period|Adverse Event|0
55885|NCT01154218|212682|P2|Third Intervention Period|Adverse Event|1
55886|NCT01154218|212683|P1|Third Intervention Period|Adverse Event|0
55887|NCT01154166|212735|P2|Overall Study|Poor Compliance|0
55888|NCT01154166|212736|P1|Overall Study|Poor Compliance|1
55889|NCT01154166|212735|P2|Overall Study|Disease Progression|0
55890|NCT01154166|212736|P1|Overall Study|Disease Progression|1
55891|NCT01154166|212735|P2|Overall Study|Lack of Efficacy|0
55892|NCT01154166|212736|P1|Overall Study|Lack of Efficacy|3
55893|NCT01154166|212735|P2|Overall Study|Withdrawal by Subject|1
55894|NCT01154166|212736|P1|Overall Study|Withdrawal by Subject|10
55895|NCT01154166|212735|P2|Overall Study|Protocol Violation|1
55896|NCT01154166|212736|P1|Overall Study|Protocol Violation|4
55897|NCT01154166|212735|P2|Overall Study|Lost to Follow-up|1
55898|NCT01154166|212736|P1|Overall Study|Lost to Follow-up|1
55899|NCT01154166|212735|P2|Overall Study|Adverse Event|9
55900|NCT01154166|212736|P1|Overall Study|Adverse Event|14
55901|NCT01154153|212768|P2|Overall Study|Withdrew consent|0
55902|NCT01154153|212769|P1|Overall Study|Withdrew consent|1
55903|NCT01154153|212768|P2|Overall Study|Unable to use labs|3
55904|NCT01154153|212769|P1|Overall Study|Unable to use labs|2
55905|NCT01154153|212768|P2|Overall Study|Poor compliance to protocol|0
55906|NCT01154153|212769|P1|Overall Study|Poor compliance to protocol|2
55907|NCT01154140|212787|P2|Overall Study|Randomized but not treated|2
55908|NCT01154140|212788|P1|Overall Study|Randomized but not treated|1
55909|NCT01154140|212787|P2|Overall Study|Ongoing at date of cut-off|115
55910|NCT01154140|212788|P1|Overall Study|Ongoing at date of cut-off|119
55911|NCT01154140|212787|P2|Overall Study|Not specified|1
55912|NCT01154140|212788|P1|Overall Study|Not specified|1
55913|NCT01154140|212787|P2|Overall Study|Withdrawal by Subject|5
55914|NCT01154140|212788|P1|Overall Study|Withdrawal by Subject|7
55915|NCT01154140|212787|P2|Overall Study|Lost to Follow-up|2
55916|NCT01154140|212788|P1|Overall Study|Lost to Follow-up|0
55917|NCT01154140|212787|P2|Overall Study|Death|46
55918|NCT01154140|212788|P1|Overall Study|Death|44
55919|NCT01154127|212837|P2|Period 2 (21 Days)|Protocol Deviation|1
55920|NCT01154127|212838|P1|Period 2 (21 Days)|Protocol Deviation|0
55921|NCT01154127|212837|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
55922|NCT01154127|212838|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
55923|NCT01154127|212837|P2|Washout (14 - 28 Days)|Adverse Event|0
55924|NCT01154127|212838|P1|Washout (14 - 28 Days)|Adverse Event|2
55925|NCT01154127|212837|P2|Period 1 (21 Days)|Withdrawal by Subject|2
55926|NCT01154127|212838|P1|Period 1 (21 Days)|Withdrawal by Subject|0
55927|NCT01154127|212837|P2|Period 1 (21 Days)|Adverse Event|4
55928|NCT01154127|212838|P1|Period 1 (21 Days)|Adverse Event|3
55929|NCT01154036|212863|P8|Phase II|Withdrawal by Subject|4
55930|NCT01154036|212864|P7|Phase II|Withdrawal by Subject|5
55931|NCT01154036|212865|P6|Phase II|Withdrawal by Subject|2
55932|NCT01154036|212866|P5|Phase II|Withdrawal by Subject|4
55933|NCT01154036|212867|P4|Phase II|Withdrawal by Subject|0
55934|NCT01154036|212868|P3|Phase II|Withdrawal by Subject|0
55935|NCT01154036|212869|P2|Phase II|Withdrawal by Subject|0
55936|NCT01154036|212870|P1|Phase II|Withdrawal by Subject|0
55937|NCT01154036|212863|P8|Phase II|Protocol Violation|0
55938|NCT01154036|212864|P7|Phase II|Protocol Violation|0
55939|NCT01154036|212865|P6|Phase II|Protocol Violation|2
55940|NCT01154036|212866|P5|Phase II|Protocol Violation|1
55941|NCT01154036|212867|P4|Phase II|Protocol Violation|0
55942|NCT01154036|212868|P3|Phase II|Protocol Violation|0
55943|NCT01154036|212869|P2|Phase II|Protocol Violation|0
55944|NCT01154036|212870|P1|Phase II|Protocol Violation|0
55945|NCT01154036|212863|P8|Phase II|Lost to Follow-up|1
55946|NCT01154036|212864|P7|Phase II|Lost to Follow-up|2
55947|NCT01154036|212865|P6|Phase II|Lost to Follow-up|0
55948|NCT01154036|212866|P5|Phase II|Lost to Follow-up|2
55949|NCT01154036|212867|P4|Phase II|Lost to Follow-up|1
55950|NCT01154036|212868|P3|Phase II|Lost to Follow-up|0
55951|NCT01154036|212869|P2|Phase II|Lost to Follow-up|0
55952|NCT01154036|212870|P1|Phase II|Lost to Follow-up|0
55953|NCT01154036|212863|P8|Phase II|Physician Decision|0
55954|NCT01154036|212864|P7|Phase II|Physician Decision|1
55955|NCT01154036|212865|P6|Phase II|Physician Decision|0
55956|NCT01154036|212866|P5|Phase II|Physician Decision|0
55957|NCT01154036|212867|P4|Phase II|Physician Decision|0
55958|NCT01154036|212868|P3|Phase II|Physician Decision|0
55959|NCT01154036|212869|P2|Phase II|Physician Decision|0
55960|NCT01154036|212870|P1|Phase II|Physician Decision|0
55961|NCT01154036|212863|P8|Phase II|Adverse Event|1
55962|NCT01154036|212864|P7|Phase II|Adverse Event|1
55963|NCT01154036|212865|P6|Phase II|Adverse Event|1
55964|NCT01154036|212866|P5|Phase II|Adverse Event|1
55965|NCT01154036|212867|P4|Phase II|Adverse Event|0
55966|NCT01154036|212868|P3|Phase II|Adverse Event|0
55967|NCT01154036|212869|P2|Phase II|Adverse Event|0
55968|NCT01154036|212870|P1|Phase II|Adverse Event|0
55969|NCT01154036|212863|P8|Phase I|Adverse Event|0
55970|NCT01154036|212864|P7|Phase I|Adverse Event|0
55971|NCT01154036|212865|P6|Phase I|Adverse Event|0
55972|NCT01154036|212866|P5|Phase I|Adverse Event|0
55973|NCT01154036|212867|P4|Phase I|Adverse Event|0
55974|NCT01154036|212868|P3|Phase I|Adverse Event|12
55975|NCT01154036|212869|P2|Phase I|Adverse Event|11
55976|NCT01154036|212870|P1|Phase I|Adverse Event|1
55977|NCT01154036|212863|P8|Phase I|Withdrawal by Subject|0
55978|NCT01154036|212864|P7|Phase I|Withdrawal by Subject|0
55979|NCT01154036|212865|P6|Phase I|Withdrawal by Subject|0
55980|NCT01154036|212866|P5|Phase I|Withdrawal by Subject|0
55981|NCT01154036|212867|P4|Phase I|Withdrawal by Subject|0
55982|NCT01154036|212868|P3|Phase I|Withdrawal by Subject|29
55983|NCT01154036|212869|P2|Phase I|Withdrawal by Subject|10
55984|NCT01154036|212870|P1|Phase I|Withdrawal by Subject|2
55985|NCT01154036|212863|P8|Phase I|Protocol Violation|0
55986|NCT01154036|212864|P7|Phase I|Protocol Violation|0
55987|NCT01154036|212865|P6|Phase I|Protocol Violation|0
55988|NCT01154036|212866|P5|Phase I|Protocol Violation|0
55989|NCT01154036|212867|P4|Phase I|Protocol Violation|0
55990|NCT01154036|212868|P3|Phase I|Protocol Violation|9
55991|NCT01154036|212869|P2|Phase I|Protocol Violation|3
55992|NCT01154036|212870|P1|Phase I|Protocol Violation|0
55993|NCT01154036|212863|P8|Phase I|Lost to Follow-up|0
55994|NCT01154036|212864|P7|Phase I|Lost to Follow-up|0
55995|NCT01154036|212865|P6|Phase I|Lost to Follow-up|0
55996|NCT01154036|212866|P5|Phase I|Lost to Follow-up|0
55997|NCT01154036|212867|P4|Phase I|Lost to Follow-up|0
55998|NCT01154036|212868|P3|Phase I|Lost to Follow-up|6
55999|NCT01154036|212869|P2|Phase I|Lost to Follow-up|3
56000|NCT01154036|212870|P1|Phase I|Lost to Follow-up|0
56001|NCT01154036|212863|P8|Phase I|Physician Decision|0
56002|NCT01154036|212864|P7|Phase I|Physician Decision|0
56003|NCT01154036|212865|P6|Phase I|Physician Decision|0
56004|NCT01154036|212866|P5|Phase I|Physician Decision|0
56005|NCT01154036|212867|P4|Phase I|Physician Decision|0
56006|NCT01154036|212868|P3|Phase I|Physician Decision|0
56007|NCT01154036|212869|P2|Phase I|Physician Decision|1
56008|NCT01154036|212870|P1|Phase I|Physician Decision|0
56009|NCT01153971|212992|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
56010|NCT01153971|212992|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
56011|NCT01153971|212992|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
56012|NCT01153971|212992|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
56013|NCT01153971|212992|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
56014|NCT01153971|212992|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
56015|NCT01153971|212992|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
56016|NCT01153958|213015|P2|Overall Study|Study Terminated|32
56017|NCT01153958|213016|P1|Overall Study|Study Terminated|36
56018|NCT01153893|213034|P2|Overall Study|Adverse Event|0
56019|NCT01153893|213035|P1|Overall Study|Adverse Event|1
56020|NCT01153815|213061|P2|Overall Study|Withdrawal by Subject|4
56021|NCT01153815|213062|P1|Overall Study|Withdrawal by Subject|6
56022|NCT01153815|213061|P2|Overall Study|Adverse Event|1
56023|NCT01153815|213062|P1|Overall Study|Adverse Event|3
56024|NCT01153763|213084|P1|Overall Study|Ongoing (In follow-up)|24
56025|NCT01153763|213084|P1|Overall Study|Death|29
56026|NCT01153763|213084|P1|Overall Study|Withdrawal by Subject|2
56027|NCT01153763|213084|P1|Overall Study|Physician Decision|2
56028|NCT01153763|213084|P1|Overall Study|Lost to Follow-up|2
56029|NCT01153724|213095|P1|Treatment Period 2|Other reason not defined above|1
56030|NCT01153724|213095|P1|Treatment Period 2|Adverse Event|1
56031|NCT01153724|213095|P1|Treatment Period 1|Withdrawal by Subject|1
56032|NCT01153698|213135|P1|Overall Study|Not treated with Pradaxa|5
56033|NCT01153698|213135|P1|Overall Study|Other|2
56034|NCT01153698|213135|P1|Overall Study|Switch to other anticoagulants|4
56035|NCT01153698|213135|P1|Overall Study|Withdrawal by Subject|2
56036|NCT01153698|213135|P1|Overall Study|Lost to Follow-up|4
56037|NCT01153698|213135|P1|Overall Study|Adverse Event|12
56038|NCT01153633|213184|P2|Overall Study|Therapeutic failure|3
56039|NCT01153633|213185|P1|Overall Study|Therapeutic failure|3
56040|NCT01153633|213184|P2|Overall Study|Protocol Violation|1
56041|NCT01153633|213185|P1|Overall Study|Protocol Violation|1
56042|NCT01153347|213237|P4|Overall Study|Death|0
56043|NCT01153347|213238|P3|Overall Study|Death|0
56044|NCT01153347|213239|P2|Overall Study|Death|0
56045|NCT01153347|213240|P1|Overall Study|Death|1
56046|NCT01153347|213237|P4|Overall Study|Not specified|0
56047|NCT01153347|213238|P3|Overall Study|Not specified|4
56048|NCT01153347|213239|P2|Overall Study|Not specified|5
56049|NCT01153347|213240|P1|Overall Study|Not specified|5
56050|NCT01153347|213237|P4|Overall Study|Lost to Follow-up|8
56051|NCT01153347|213238|P3|Overall Study|Lost to Follow-up|11
56052|NCT01153347|213239|P2|Overall Study|Lost to Follow-up|9
56053|NCT01153347|213240|P1|Overall Study|Lost to Follow-up|4
56054|NCT01153347|213237|P4|Overall Study|Study-specific withdrawal criteria|2
56055|NCT01153347|213238|P3|Overall Study|Study-specific withdrawal criteria|1
56056|NCT01153347|213239|P2|Overall Study|Study-specific withdrawal criteria|3
56057|NCT01153347|213240|P1|Overall Study|Study-specific withdrawal criteria|4
56058|NCT01153347|213237|P4|Overall Study|Lack of Efficacy|4
56059|NCT01153347|213238|P3|Overall Study|Lack of Efficacy|0
56060|NCT01153347|213239|P2|Overall Study|Lack of Efficacy|2
56061|NCT01153347|213240|P1|Overall Study|Lack of Efficacy|2
56062|NCT01153347|213237|P4|Overall Study|Condition under investigation worsened|0
56063|NCT01153347|213238|P3|Overall Study|Condition under investigation worsened|0
56064|NCT01153347|213239|P2|Overall Study|Condition under investigation worsened|1
56065|NCT01153347|213240|P1|Overall Study|Condition under investigation worsened|1
56066|NCT01153347|213237|P4|Overall Study|Severe non-compliance to protocol|3
56067|NCT01153347|213238|P3|Overall Study|Severe non-compliance to protocol|4
56068|NCT01153347|213239|P2|Overall Study|Severe non-compliance to protocol|7
56069|NCT01153347|213240|P1|Overall Study|Severe non-compliance to protocol|6
56070|NCT01153347|213237|P4|Overall Study|Adverse Event|7
56071|NCT01153347|213238|P3|Overall Study|Adverse Event|21
56072|NCT01153347|213239|P2|Overall Study|Adverse Event|9
56073|NCT01153347|213240|P1|Overall Study|Adverse Event|3
56074|NCT01153347|213237|P4|Overall Study|Eligibility criteria not fulfilled|1
56075|NCT01153347|213238|P3|Overall Study|Eligibility criteria not fulfilled|2
56076|NCT01153347|213239|P2|Overall Study|Eligibility criteria not fulfilled|1
56077|NCT01153347|213240|P1|Overall Study|Eligibility criteria not fulfilled|0
56078|NCT01153347|213237|P4|Overall Study|Withdrawal by Subject|7
56079|NCT01153347|213238|P3|Overall Study|Withdrawal by Subject|7
56080|NCT01153347|213239|P2|Overall Study|Withdrawal by Subject|7
56081|NCT01153347|213240|P1|Overall Study|Withdrawal by Subject|7
56082|NCT01153321|213340|P2|Overall Study|Adverse Event|1
56083|NCT01153321|213341|P1|Overall Study|Adverse Event|1
56084|NCT01153321|213340|P2|Overall Study|Withdrawal by Subject|1
56085|NCT01153321|213341|P1|Overall Study|Withdrawal by Subject|0
56086|NCT01153321|213340|P2|Overall Study|Development of study withdrawal criteria|1
56087|NCT01153321|213341|P1|Overall Study|Development of study withdrawal criteria|0
56088|NCT01153269|213453|P1|Overall Study|Antiretroviral therapy break|1
56089|NCT01153269|213453|P1|Overall Study|Withdrawal by Subject|1
56090|NCT01153009|213516|P4|Overall Study|Other|2
56091|NCT01153009|213517|P3|Overall Study|Other|3
56092|NCT01153009|213518|P2|Overall Study|Other|1
56093|NCT01153009|213519|P1|Overall Study|Other|1
56094|NCT01153009|213516|P4|Overall Study|Lost to Follow-up|15
56095|NCT01153009|213517|P3|Overall Study|Lost to Follow-up|11
56096|NCT01153009|213518|P2|Overall Study|Lost to Follow-up|8
56097|NCT01153009|213519|P1|Overall Study|Lost to Follow-up|8
56098|NCT01153009|213516|P4|Overall Study|Withdrawal of Consent|6
56099|NCT01153009|213517|P3|Overall Study|Withdrawal of Consent|4
56100|NCT01153009|213518|P2|Overall Study|Withdrawal of Consent|5
56101|NCT01153009|213519|P1|Overall Study|Withdrawal of Consent|5
56102|NCT01153009|213516|P4|Overall Study|Protocol Deviations|2
56103|NCT01153009|213517|P3|Overall Study|Protocol Deviations|3
56104|NCT01153009|213518|P2|Overall Study|Protocol Deviations|3
56105|NCT01153009|213519|P1|Overall Study|Protocol Deviations|4
56106|NCT01153009|213516|P4|Overall Study|Noncompliance with Study Medication|1
56107|NCT01153009|213517|P3|Overall Study|Noncompliance with Study Medication|4
56108|NCT01153009|213518|P2|Overall Study|Noncompliance with Study Medication|3
56109|NCT01153009|213519|P1|Overall Study|Noncompliance with Study Medication|1
56110|NCT01153009|213516|P4|Overall Study|Lack of Efficacy|1
56111|NCT01153009|213517|P3|Overall Study|Lack of Efficacy|2
56112|NCT01153009|213518|P2|Overall Study|Lack of Efficacy|0
56113|NCT01153009|213519|P1|Overall Study|Lack of Efficacy|9
56114|NCT01153009|213516|P4|Overall Study|Adverse Event|10
56115|NCT01153009|213517|P3|Overall Study|Adverse Event|14
56116|NCT01153009|213518|P2|Overall Study|Adverse Event|14
56117|NCT01153009|213519|P1|Overall Study|Adverse Event|4
56118|NCT01152996|213549|P1|Overall Study|Elevated liver enzymes|1
56119|NCT01152996|213549|P1|Overall Study|Protocol Violation|22
56120|NCT01152996|213549|P1|Overall Study|Other|36
56121|NCT01152996|213549|P1|Overall Study|Noncompliance|41
56122|NCT01152996|213549|P1|Overall Study|Lack of Efficacy|68
56123|NCT01152996|213549|P1|Overall Study|Lost to Follow-up|112
56124|NCT01152996|213549|P1|Overall Study|Adverse Event|115
56125|NCT01152996|213549|P1|Overall Study|Withdrawal by Subject|142
56126|NCT01152814|213562|P1|Overall Study|Lost to Follow-up|2
56127|NCT01152788|213571|P2|Overall Study|No treatment|1
56128|NCT01152788|213572|P1|Overall Study|No treatment|0
56129|NCT01152788|213571|P2|Overall Study|Withdrawal by Subject|3
56130|NCT01152788|213572|P1|Overall Study|Withdrawal by Subject|0
56131|NCT01152580|213609|P2|Overall Study|Withdrawal by Subject|1
56132|NCT01152580|213610|P1|Overall Study|Withdrawal by Subject|0
56133|NCT01152554|213632|P2|Overall Study|Death|1
56134|NCT01152554|213633|P1|Overall Study|Death|1
56135|NCT01152554|213632|P2|Overall Study|Not specified|8
56136|NCT01152554|213633|P1|Overall Study|Not specified|28
56137|NCT01152554|213632|P2|Overall Study|Lost to Follow-up|32
56138|NCT01152554|213633|P1|Overall Study|Lost to Follow-up|87
56139|NCT01152554|213632|P2|Overall Study|Study-specific withdrawal criteria|8
56140|NCT01152554|213633|P1|Overall Study|Study-specific withdrawal criteria|17
56141|NCT01152554|213632|P2|Overall Study|Lack of Efficacy|3
56142|NCT01152554|213633|P1|Overall Study|Lack of Efficacy|20
56143|NCT01152554|213632|P2|Overall Study|Condition under investigation worsened|2
56144|NCT01152554|213633|P1|Overall Study|Condition under investigation worsened|5
56145|NCT01152554|213632|P2|Overall Study|Severe non-compliance to protocol|14
56146|NCT01152554|213633|P1|Overall Study|Severe non-compliance to protocol|36
56147|NCT01152554|213632|P2|Overall Study|Adverse Event|14
56148|NCT01152554|213633|P1|Overall Study|Adverse Event|67
56149|NCT01152554|213632|P2|Overall Study|Eligiblity criteria not fulfilled|1
56150|NCT01152554|213633|P1|Overall Study|Eligiblity criteria not fulfilled|0
56151|NCT01152554|213632|P2|Overall Study|Withdrawal by Subject|28
56152|NCT01152554|213633|P1|Overall Study|Withdrawal by Subject|73
56153|NCT01152450|213655|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
56154|NCT01152450|213656|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
56155|NCT01152450|213657|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
56156|NCT01152450|213658|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
56157|NCT01152450|213659|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
56158|NCT01152450|213660|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
56159|NCT01152450|213655|P6|Period 1 (4 Weeks)|Protocol Violation|0
56160|NCT01152450|213656|P5|Period 1 (4 Weeks)|Protocol Violation|1
56161|NCT01152450|213657|P4|Period 1 (4 Weeks)|Protocol Violation|0
56162|NCT01152450|213658|P3|Period 1 (4 Weeks)|Protocol Violation|0
56163|NCT01152450|213659|P2|Period 1 (4 Weeks)|Protocol Violation|0
56164|NCT01152450|213660|P1|Period 1 (4 Weeks)|Protocol Violation|0
56165|NCT01152450|213655|P6|Period 1 (4 Weeks)|Adverse Event|1
56166|NCT01152450|213656|P5|Period 1 (4 Weeks)|Adverse Event|1
56167|NCT01152450|213657|P4|Period 1 (4 Weeks)|Adverse Event|0
56168|NCT01152450|213658|P3|Period 1 (4 Weeks)|Adverse Event|0
56169|NCT01152450|213659|P2|Period 1 (4 Weeks)|Adverse Event|0
56170|NCT01152450|213660|P1|Period 1 (4 Weeks)|Adverse Event|0
56171|NCT01152437|213731|P3|Overall Study|Refusal to continue taking trial medicat|2
56172|NCT01152437|213732|P2|Overall Study|Refusal to continue taking trial medicat|0
56173|NCT01152437|213733|P1|Overall Study|Refusal to continue taking trial medicat|1
56174|NCT01152437|213731|P3|Overall Study|Progressive disease|32
56175|NCT01152437|213732|P2|Overall Study|Progressive disease|13
56176|NCT01152437|213733|P1|Overall Study|Progressive disease|27
56177|NCT01152437|213731|P3|Overall Study|Not treated|2
56178|NCT01152437|213732|P2|Overall Study|Not treated|1
56179|NCT01152437|213733|P1|Overall Study|Not treated|0
56180|NCT01152437|213731|P3|Overall Study|Other Adverse Event|7
56181|NCT01152437|213732|P2|Overall Study|Other Adverse Event|1
56182|NCT01152437|213733|P1|Overall Study|Other Adverse Event|8
56183|NCT01152385|213753|P4|Overall Study|Unspecified|3
56184|NCT01152385|213754|P3|Overall Study|Unspecified|2
56185|NCT01152385|213755|P2|Overall Study|Unspecified|3
56186|NCT01152385|213756|P1|Overall Study|Unspecified|4
56187|NCT01152385|213753|P4|Overall Study|Study-specific withdrawal criteria|0
56188|NCT01152385|213754|P3|Overall Study|Study-specific withdrawal criteria|2
56189|NCT01152385|213755|P2|Overall Study|Study-specific withdrawal criteria|1
56190|NCT01152385|213756|P1|Overall Study|Study-specific withdrawal criteria|1
56191|NCT01152385|213753|P4|Overall Study|Adverse Event|0
56192|NCT01152385|213754|P3|Overall Study|Adverse Event|0
56193|NCT01152385|213755|P2|Overall Study|Adverse Event|1
56194|NCT01152385|213756|P1|Overall Study|Adverse Event|1
56195|NCT01152385|213753|P4|Overall Study|Protocol Violation|1
56196|NCT01152385|213754|P3|Overall Study|Protocol Violation|0
56197|NCT01152385|213755|P2|Overall Study|Protocol Violation|0
56198|NCT01152385|213756|P1|Overall Study|Protocol Violation|0
56199|NCT01152385|213753|P4|Overall Study|Withdrawal by Subject|1
56200|NCT01152385|213754|P3|Overall Study|Withdrawal by Subject|1
56201|NCT01152385|213755|P2|Overall Study|Withdrawal by Subject|1
56202|NCT01152385|213756|P1|Overall Study|Withdrawal by Subject|3
56203|NCT01152190|213823|P2|Overall Study|Withdrawal by Subject|3
56204|NCT01152190|213824|P1|Overall Study|Withdrawal by Subject|1
56205|NCT01152190|213823|P2|Overall Study|Protocol Violation|1
56206|NCT01152190|213824|P1|Overall Study|Protocol Violation|1
56207|NCT01152190|213823|P2|Overall Study|Death|0
56208|NCT01152190|213824|P1|Overall Study|Death|1
56209|NCT01152190|213823|P2|Overall Study|Adverse Event|4
56210|NCT01152190|213824|P1|Overall Study|Adverse Event|2
56211|NCT01151579|213874|P2|Overall Study|Not meet inclusion criteria|4
56212|NCT01151579|213875|P1|Overall Study|Not meet inclusion criteria|6
56213|NCT01151579|213874|P2|Overall Study|Withdrawal by Subject|2
56214|NCT01151579|213875|P1|Overall Study|Withdrawal by Subject|3
56215|NCT01151579|213874|P2|Overall Study|Physician Decision|1
56216|NCT01151579|213875|P1|Overall Study|Physician Decision|3
56217|NCT01151410|213921|P2|Overall Study|Abnormal laboratory value(s)|1
56218|NCT01151410|213922|P1|Overall Study|Abnormal laboratory value(s)|0
56219|NCT01151410|213921|P2|Overall Study|Unsatisfactory therapeutic effect|1
56220|NCT01151410|213922|P1|Overall Study|Unsatisfactory therapeutic effect|1
56221|NCT01151410|213921|P2|Overall Study|Administrative problems|1
56222|NCT01151410|213922|P1|Overall Study|Administrative problems|1
56223|NCT01151410|213921|P2|Overall Study|Protocol deviation|1
56224|NCT01151410|213922|P1|Overall Study|Protocol deviation|2
56225|NCT01151410|213921|P2|Overall Study|Adverse Event|2
56226|NCT01151410|213922|P1|Overall Study|Adverse Event|1
56227|NCT01151410|213921|P2|Overall Study|Lost to Follow-up|4
56228|NCT01151410|213922|P1|Overall Study|Lost to Follow-up|3
56229|NCT01151410|213921|P2|Overall Study|Withdrawal by Subject|5
56230|NCT01151410|213922|P1|Overall Study|Withdrawal by Subject|3
56231|NCT01151345|213966|P2|First Intervention Period|Protocol Violation|1
56232|NCT01151345|213967|P1|First Intervention Period|Protocol Violation|0
56233|NCT01151280|213981|P1|Overall Study|Lack of Efficacy|3
56234|NCT01151280|213981|P1|Overall Study|Adverse Event|1
56235|NCT01151215|213994|P3|Overall Study|Safety as judged by the investigator|1
56236|NCT01151215|213995|P2|Overall Study|Safety as judged by the investigator|0
56237|NCT01151215|213996|P1|Overall Study|Safety as judged by the investigator|0
56238|NCT01151215|213994|P3|Overall Study|Disease progression|1
56239|NCT01151215|213995|P2|Overall Study|Disease progression|1
56240|NCT01151215|213996|P1|Overall Study|Disease progression|0
56241|NCT01151215|213994|P3|Overall Study|Withdrawal by Subject|2
56242|NCT01151215|213995|P2|Overall Study|Withdrawal by Subject|1
56243|NCT01151215|213996|P1|Overall Study|Withdrawal by Subject|3
56244|NCT01151215|213994|P3|Overall Study|Lost to Follow-up|3
56245|NCT01151215|213995|P2|Overall Study|Lost to Follow-up|0
56246|NCT01151215|213996|P1|Overall Study|Lost to Follow-up|0
56247|NCT01151215|213994|P3|Overall Study|Death|11
56248|NCT01151215|213995|P2|Overall Study|Death|20
56249|NCT01151215|213996|P1|Overall Study|Death|16
56250|NCT01151215|213994|P3|Overall Study|Worsening of condition under study|1
56251|NCT01151215|213995|P2|Overall Study|Worsening of condition under study|1
56252|NCT01151215|213996|P1|Overall Study|Worsening of condition under study|1
56253|NCT01151137|214034|P2|Overall Study|Lost to Follow-up|1
56254|NCT01151137|214035|P1|Overall Study|Lost to Follow-up|1
56255|NCT01151137|214034|P2|Overall Study|Death|27
56256|NCT01151137|214035|P1|Overall Study|Death|15
56257|NCT01151098|214053|P1|Overall Study|Miscellaneous|13
56258|NCT01151098|214053|P1|Overall Study|Protocol Violation|1
56259|NCT01151098|214053|P1|Overall Study|Lack of Efficacy|15
56260|NCT01151098|214053|P1|Overall Study|Lost to Follow-up|6
56261|NCT01151098|214053|P1|Overall Study|Adverse Event|82
56262|NCT01151085|214057|P1|Overall Study|Protocol Violation|25
56263|NCT01151085|214057|P1|Overall Study|Lost to Follow-up|31
56264|NCT01151020|214088|P1|Overall Study|Still be eligible for follow-up|79
56265|NCT01151020|214088|P1|Overall Study|Patients did not receive the device|2
56266|NCT01151020|214088|P1|Overall Study|Withdrawal by Subject|12
56267|NCT01151020|214088|P1|Overall Study|Lost to Follow-up|1
56268|NCT01151020|214088|P1|Overall Study|Conversion to open repair|1
56269|NCT01151020|214088|P1|Overall Study|Death|15
56270|NCT01150474|214167|P2|Overall Study|Surgery Changed|0
56271|NCT01150474|214168|P1|Overall Study|Surgery Changed|1
56272|NCT01150474|214167|P2|Overall Study|Drug not administered|0
56273|NCT01150474|214168|P1|Overall Study|Drug not administered|1
56274|NCT01150474|214167|P2|Overall Study|Drug did not arrive in time|0
56275|NCT01150474|214168|P1|Overall Study|Drug did not arrive in time|1
56276|NCT01150474|214167|P2|Overall Study|Rectotomy|0
56277|NCT01150474|214168|P1|Overall Study|Rectotomy|1
56278|NCT01150474|214167|P2|Overall Study|Multiple Studies|1
56279|NCT01150474|214168|P1|Overall Study|Multiple Studies|0
56280|NCT01150474|214167|P2|Overall Study|Cancer found|0
56281|NCT01150474|214168|P1|Overall Study|Cancer found|1
56282|NCT01150474|214167|P2|Overall Study|Withdrawal by Subject|2
56283|NCT01150474|214168|P1|Overall Study|Withdrawal by Subject|5
56284|NCT01150357|214213|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
56285|NCT01150357|214214|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
56286|NCT01150357|214215|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
56287|NCT01150357|214213|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
56288|NCT01150357|214214|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
56289|NCT01150357|214215|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
56290|NCT01150357|214213|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
56291|NCT01150357|214214|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
56292|NCT01150357|214215|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
56293|NCT01150357|214213|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
56294|NCT01150357|214214|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
56295|NCT01150357|214215|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
56296|NCT01150357|214213|P3|Dose Response Phase (Phase 1)|Adverse Event|1
56297|NCT01150357|214214|P2|Dose Response Phase (Phase 1)|Adverse Event|0
56298|NCT01150357|214215|P1|Dose Response Phase (Phase 1)|Adverse Event|0
56299|NCT01150357|214213|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
56300|NCT01150357|214214|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
56301|NCT01150357|214215|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
56302|NCT01150357|214213|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
56303|NCT01150357|214214|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
56304|NCT01150357|214215|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
56305|NCT01149148|214279|P2|Overall Study|Death|0
56306|NCT01149148|214280|P1|Overall Study|Death|1
56307|NCT01149148|214279|P2|Overall Study|Lost to Follow-up|2
56308|NCT01149148|214280|P1|Overall Study|Lost to Follow-up|1
56309|NCT01150097|214291|P3|Months 24 to 48 Post-transplantation|Death|0
56310|NCT01150097|214292|P2|Months 24 to 48 Post-transplantation|Death|0
56311|NCT01150097|214293|P1|Months 24 to 48 Post-transplantation|Death|2
56312|NCT01150097|214291|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
56313|NCT01150097|214292|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
56314|NCT01150097|214293|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
56315|NCT01150097|214291|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
56316|NCT01150097|214292|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
56317|NCT01150097|214293|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
56318|NCT01150097|214291|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
56319|NCT01150097|214292|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
56320|NCT01150097|214293|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
56321|NCT01150097|214291|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
56322|NCT01150097|214292|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
56323|NCT01150097|214293|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
56324|NCT01150097|214291|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
56325|NCT01150097|214292|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
56326|NCT01150097|214293|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
56327|NCT01150097|214291|P3|Months 24 to 36 Post-transplantation|Death|0
56328|NCT01150097|214292|P2|Months 24 to 36 Post-transplantation|Death|0
56329|NCT01150097|214293|P1|Months 24 to 36 Post-transplantation|Death|2
56330|NCT01149863|214337|P1|Overall Study|Missing data or Not receiveing studydrug|3
56331|NCT01149655|214409|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
56332|NCT01149655|214410|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
56333|NCT01149655|214411|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
56334|NCT01149655|214412|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
56335|NCT01149655|214409|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
56336|NCT01149655|214410|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
56337|NCT01149655|214411|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
56338|NCT01149655|214412|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
56339|NCT01149655|214409|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
56340|NCT01149655|214410|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
56341|NCT01149655|214411|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
56342|NCT01149655|214412|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
56343|NCT01149655|214409|P4|Period 3-DB Maintenance Phase|Physician Decision|0
56344|NCT01149655|214410|P3|Period 3-DB Maintenance Phase|Physician Decision|1
56345|NCT01149655|214411|P2|Period 3-DB Maintenance Phase|Physician Decision|0
56346|NCT01149655|214412|P1|Period 3-DB Maintenance Phase|Physician Decision|0
56347|NCT01149655|214409|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
56348|NCT01149655|214410|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
56349|NCT01149655|214411|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
56350|NCT01149655|214412|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
56351|NCT01149655|214409|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
56352|NCT01149655|214410|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
56353|NCT01149655|214411|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
56354|NCT01149655|214412|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
56355|NCT01149655|214409|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
56356|NCT01149655|214410|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
56357|NCT01149655|214411|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
56358|NCT01149655|214412|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
56359|NCT01149655|214409|P4|Period 2-Stabilization Phase|Physician Decision|0
56360|NCT01149655|214410|P3|Period 2-Stabilization Phase|Physician Decision|0
56361|NCT01149655|214411|P2|Period 2-Stabilization Phase|Physician Decision|3
56362|NCT01149655|214412|P1|Period 2-Stabilization Phase|Physician Decision|0
56363|NCT01149655|214409|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
56364|NCT01149655|214410|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
56365|NCT01149655|214411|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
56366|NCT01149655|214412|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
56367|NCT01149655|214409|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
56368|NCT01149655|214410|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
56369|NCT01149655|214411|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
56370|NCT01149655|214412|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
56371|NCT01149655|214409|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
56372|NCT01149655|214410|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
56373|NCT01149655|214411|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
56374|NCT01149655|214412|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
56375|NCT01149655|214409|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
56376|NCT01149655|214410|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
56377|NCT01149655|214411|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
56378|NCT01149655|214412|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
56379|NCT01149655|214409|P4|Period 1 - Conversion Phase|Physician Decision|0
56380|NCT01149655|214410|P3|Period 1 - Conversion Phase|Physician Decision|0
56381|NCT01149655|214411|P2|Period 1 - Conversion Phase|Physician Decision|0
56382|NCT01149655|214412|P1|Period 1 - Conversion Phase|Physician Decision|2
56383|NCT01149655|214409|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
56384|NCT01149655|214410|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
56385|NCT01149655|214411|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
56386|NCT01149655|214412|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
56387|NCT01149655|214409|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
56388|NCT01149655|214410|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
56389|NCT01149655|214411|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
56390|NCT01149655|214412|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
56391|NCT01149655|214409|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
56392|NCT01149655|214410|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
56393|NCT01149655|214411|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
56394|NCT01149655|214412|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
56395|NCT01149538|214442|P2|Overall Study|Withdrawal by Subject|3
56396|NCT01149538|214443|P1|Overall Study|Withdrawal by Subject|5
56397|NCT01149538|214442|P2|Overall Study|Lost to Follow-up|1
56398|NCT01149538|214443|P1|Overall Study|Lost to Follow-up|0
56399|NCT01149486|214459|P2|First Intervention|Adverse Event|1
56400|NCT01149486|214460|P1|First Intervention|Adverse Event|0
56401|NCT01149473|214484|P2|Washout of 7 Days|Withdrawal by Subject|1
56402|NCT01149473|214485|P1|Washout of 7 Days|Withdrawal by Subject|1
56403|NCT01149473|214484|P2|First Intervention|Adverse Event|1
56404|NCT01149473|214485|P1|First Intervention|Adverse Event|1
56405|NCT01149460|214503|P2|Overall Study|Withdrawal by Subject|2
56406|NCT01149460|214504|P1|Overall Study|Withdrawal by Subject|0
56407|NCT01149421|214537|P3|Overall Study|Protocol Violation|6
56408|NCT01149421|214538|P2|Overall Study|Protocol Violation|2
56409|NCT01149421|214539|P1|Overall Study|Protocol Violation|2
56410|NCT01149421|214537|P3|Overall Study|Entry Criteria Not Met|2
56411|NCT01149421|214538|P2|Overall Study|Entry Criteria Not Met|1
56412|NCT01149421|214539|P1|Overall Study|Entry Criteria Not Met|1
56413|NCT01149421|214537|P3|Overall Study|Physician Decision|6
56414|NCT01149421|214538|P2|Overall Study|Physician Decision|3
56415|NCT01149421|214539|P1|Overall Study|Physician Decision|5
56416|NCT01149421|214537|P3|Overall Study|Lost to Follow-up|5
56417|NCT01149421|214538|P2|Overall Study|Lost to Follow-up|4
56418|NCT01149421|214539|P1|Overall Study|Lost to Follow-up|2
56419|NCT01149421|214537|P3|Overall Study|Sponsor Decision|1
56420|NCT01149421|214538|P2|Overall Study|Sponsor Decision|1
56421|NCT01149421|214539|P1|Overall Study|Sponsor Decision|0
56422|NCT01149421|214537|P3|Overall Study|Withdrawal by Subject|13
56423|NCT01149421|214538|P2|Overall Study|Withdrawal by Subject|12
56424|NCT01149421|214539|P1|Overall Study|Withdrawal by Subject|20
56425|NCT01149421|214537|P3|Overall Study|Adverse Event|11
56426|NCT01149421|214538|P2|Overall Study|Adverse Event|6
56427|NCT01149421|214539|P1|Overall Study|Adverse Event|22
56428|NCT01149057|214618|P1|Overall Study|Unspecified|6
56429|NCT01149057|214618|P1|Overall Study|High Parathyroid Hormone Value|1
56430|NCT01149057|214618|P1|Overall Study|Lost to Follow-up|1
56431|NCT01149057|214618|P1|Overall Study|Participant Non-Compliance|2
56432|NCT01149057|214618|P1|Overall Study|B Cell Depletion|4
56433|NCT01149057|214618|P1|Overall Study|Positive Hepatitis B Core Antibody|5
56434|NCT01149057|214618|P1|Overall Study|Withdrawal by Subject|9
56435|NCT01149057|214618|P1|Overall Study|Adverse Event|13
56436|NCT01149057|214618|P1|Overall Study|Lack of Efficacy|16
56437|NCT01148771|214667|P2|Washout Period|Withdrawal by Subject|1
56438|NCT01148771|214668|P1|Washout Period|Withdrawal by Subject|0
56439|NCT01148693|214688|P2|Overall Study|Attempts for cannulation were failed|10
56440|NCT01148693|214689|P1|Overall Study|Attempts for cannulation were failed|13
56441|NCT01148537|214698|P3|Overall Study|Adverse Event|1
56442|NCT01148537|214699|P2|Overall Study|Adverse Event|0
56443|NCT01148537|214700|P1|Overall Study|Adverse Event|2
56444|NCT01148537|214698|P3|Overall Study|Withdrawal by Subject|2
56445|NCT01148537|214699|P2|Overall Study|Withdrawal by Subject|0
56446|NCT01148537|214700|P1|Overall Study|Withdrawal by Subject|1
56447|NCT01148511|214786|P3|Randomized|Not Specified|1
56448|NCT01148511|214787|P2|Randomized|Not Specified|1
56449|NCT01148511|214788|P1|Randomized|Not Specified|0
56450|NCT01148511|214786|P3|Randomized|Consent withdrawal|3
56451|NCT01148511|214787|P2|Randomized|Consent withdrawal|5
56452|NCT01148511|214788|P1|Randomized|Consent withdrawal|0
56453|NCT01148511|214786|P3|Randomized|Lost to Follow-up|1
56454|NCT01148511|214787|P2|Randomized|Lost to Follow-up|1
56455|NCT01148511|214788|P1|Randomized|Lost to Follow-up|0
56456|NCT01148511|214786|P3|Randomized|Protocol Violation|1
56457|NCT01148511|214787|P2|Randomized|Protocol Violation|2
56458|NCT01148511|214788|P1|Randomized|Protocol Violation|0
56459|NCT01148511|214786|P3|Randomized|Adverse Event|0
56460|NCT01148511|214787|P2|Randomized|Adverse Event|1
56461|NCT01148511|214788|P1|Randomized|Adverse Event|0
56462|NCT01148511|214786|P3|Exposed to Study Drug|Lost to Follow-up|0
56463|NCT01148511|214787|P2|Exposed to Study Drug|Lost to Follow-up|0
56464|NCT01148511|214788|P1|Exposed to Study Drug|Lost to Follow-up|4
56465|NCT01148511|214786|P3|Exposed to Study Drug|Protocol Violation|0
56466|NCT01148511|214787|P2|Exposed to Study Drug|Protocol Violation|0
56467|NCT01148511|214788|P1|Exposed to Study Drug|Protocol Violation|2
56468|NCT01148017|214826|P4|Overall Study|Unable to classify|0
56469|NCT01148017|214827|P3|Overall Study|Unable to classify|0
56470|NCT01148017|214828|P2|Overall Study|Unable to classify|1
56471|NCT01148017|214829|P1|Overall Study|Unable to classify|3
56472|NCT01148017|214826|P4|Overall Study|Administrative reason|0
56473|NCT01148017|214827|P3|Overall Study|Administrative reason|0
56474|NCT01148017|214828|P2|Overall Study|Administrative reason|9
56475|NCT01148017|214829|P1|Overall Study|Administrative reason|22
56476|NCT01148017|214826|P4|Overall Study|Inappropriate enrollment|0
56477|NCT01148017|214827|P3|Overall Study|Inappropriate enrollment|0
56478|NCT01148017|214828|P2|Overall Study|Inappropriate enrollment|0
56479|NCT01148017|214829|P1|Overall Study|Inappropriate enrollment|1
56480|NCT01148017|214826|P4|Overall Study|Lost to Follow-up|0
56481|NCT01148017|214827|P3|Overall Study|Lost to Follow-up|0
56482|NCT01148017|214828|P2|Overall Study|Lost to Follow-up|10
56483|NCT01148017|214829|P1|Overall Study|Lost to Follow-up|23
56484|NCT01148017|214826|P4|Overall Study|Withdrawal by Subject|0
56485|NCT01148017|214827|P3|Overall Study|Withdrawal by Subject|0
56486|NCT01148017|214828|P2|Overall Study|Withdrawal by Subject|14
56487|NCT01148017|214829|P1|Overall Study|Withdrawal by Subject|31
56488|NCT01147926|214868|P2|Overall Study|Colonoscopy result|1
56489|NCT01147926|214869|P1|Overall Study|Colonoscopy result|0
56490|NCT01147926|214868|P2|Overall Study|Went on holiday|1
56491|NCT01147926|214869|P1|Overall Study|Went on holiday|0
56492|NCT01147926|214868|P2|Overall Study|Too busy, no time for study|0
56493|NCT01147926|214869|P1|Overall Study|Too busy, no time for study|1
56494|NCT01147926|214868|P2|Overall Study|Lack of Efficacy|0
56495|NCT01147926|214869|P1|Overall Study|Lack of Efficacy|1
56496|NCT01147926|214868|P2|Overall Study|Sponsor's Decision|1
56497|NCT01147926|214869|P1|Overall Study|Sponsor's Decision|0
56498|NCT01147926|214868|P2|Overall Study|Lost to Follow-up|2
56499|NCT01147926|214869|P1|Overall Study|Lost to Follow-up|0
56500|NCT01147926|214868|P2|Overall Study|Selection criteria not met|1
56501|NCT01147926|214869|P1|Overall Study|Selection criteria not met|3
56502|NCT01147926|214868|P2|Overall Study|Principal investigator left hospital|3
56503|NCT01147926|214869|P1|Overall Study|Principal investigator left hospital|1
56504|NCT01147926|214868|P2|Overall Study|Subject Non-Compliant|4
56505|NCT01147926|214869|P1|Overall Study|Subject Non-Compliant|5
56506|NCT01147926|214868|P2|Overall Study|Adverse Event|6
56507|NCT01147926|214869|P1|Overall Study|Adverse Event|7
56508|NCT01147926|214868|P2|Overall Study|Subject Withdrew Consent|10
56509|NCT01147926|214869|P1|Overall Study|Subject Withdrew Consent|9
56510|NCT01147900|214904|P3|At Year 10|Lost to Follow-up|0
56511|NCT01147900|214905|P2|At Year 10|Lost to Follow-up|1
56512|NCT01147900|214906|P1|At Year 10|Lost to Follow-up|0
56513|NCT01147874|214965|P1|Overall Study|Withdrawal by Subject|24
56514|NCT01147874|214965|P1|Overall Study|Sponsor's Decision|2
56515|NCT01147874|214965|P1|Overall Study|Protocol Violation|5
56516|NCT01147874|214965|P1|Overall Study|Unspecified|5
56517|NCT01147874|214965|P1|Overall Study|Lost to Follow-up|25
56518|NCT01147874|214965|P1|Overall Study|Investigator’s Request|1
56519|NCT01147874|214965|P1|Overall Study|Adverse Event|5
56520|NCT01147848|214973|P3|Randomized Phase|Withdrawal by Subject|9
56521|NCT01147848|214974|P2|Randomized Phase|Withdrawal by Subject|7
56522|NCT01147848|214975|P1|Randomized Phase|Withdrawal by Subject|0
56523|NCT01147848|214973|P3|Randomized Phase|Physician Decision|1
56524|NCT01147848|214974|P2|Randomized Phase|Physician Decision|0
56525|NCT01147848|214975|P1|Randomized Phase|Physician Decision|0
56526|NCT01147848|214973|P3|Randomized Phase|Lost to Follow-up|7
56527|NCT01147848|214974|P2|Randomized Phase|Lost to Follow-up|5
56528|NCT01147848|214975|P1|Randomized Phase|Lost to Follow-up|0
56529|NCT01147848|214973|P3|Randomized Phase|Protocol Violation|10
56530|NCT01147848|214974|P2|Randomized Phase|Protocol Violation|7
56531|NCT01147848|214975|P1|Randomized Phase|Protocol Violation|0
56532|NCT01147848|214973|P3|Randomized Phase|Lack of Efficacy|11
56533|NCT01147848|214974|P2|Randomized Phase|Lack of Efficacy|20
56534|NCT01147848|214975|P1|Randomized Phase|Lack of Efficacy|0
56535|NCT01147848|214973|P3|Randomized Phase|Adverse Event|8
56536|NCT01147848|214974|P2|Randomized Phase|Adverse Event|6
56537|NCT01147848|214975|P1|Randomized Phase|Adverse Event|0
56538|NCT01147848|214973|P3|Run-in Period|Run-in Failure|0
56539|NCT01147848|214974|P2|Run-in Period|Run-in Failure|0
56540|NCT01147848|214975|P1|Run-in Period|Run-in Failure|135
56541|NCT01147848|214973|P3|Run-in Period|Screen Failure|0
56542|NCT01147848|214974|P2|Run-in Period|Screen Failure|0
56543|NCT01147848|214975|P1|Run-in Period|Screen Failure|623
56544|NCT01147822|215007|P2|Overall Study|Not Completed/Ongoing|102
56545|NCT01147822|215008|P1|Overall Study|Not Completed/Ongoing|111
56546|NCT01147822|215007|P2|Overall Study|Withdrawal by Subject|13
56547|NCT01147822|215008|P1|Overall Study|Withdrawal by Subject|8
56548|NCT01147822|215007|P2|Overall Study|Physician Decision|2
56549|NCT01147822|215008|P1|Overall Study|Physician Decision|0
56550|NCT01147822|215007|P2|Overall Study|Lost to Follow-up|2
56551|NCT01147822|215008|P1|Overall Study|Lost to Follow-up|3
56552|NCT01147822|215007|P2|Overall Study|Protocol Violation|1
56553|NCT01147822|215008|P1|Overall Study|Protocol Violation|0
56554|NCT01147822|215007|P2|Overall Study|Death|59
56555|NCT01147822|215008|P1|Overall Study|Death|66
56556|NCT01147809|215028|P6|Phase II (168 Days)|Ongoing|0
56557|NCT01147809|215029|P5|Phase II (168 Days)|Ongoing|1
56558|NCT01147809|215030|P4|Phase II (168 Days)|Ongoing|0
56559|NCT01147809|215031|P3|Phase II (168 Days)|Ongoing|0
56560|NCT01147809|215032|P2|Phase II (168 Days)|Ongoing|0
56561|NCT01147809|215033|P1|Phase II (168 Days)|Ongoing|0
56562|NCT01147809|215028|P6|Phase II (168 Days)|Withdrawal by Subject|15
56563|NCT01147809|215029|P5|Phase II (168 Days)|Withdrawal by Subject|7
56564|NCT01147809|215030|P4|Phase II (168 Days)|Withdrawal by Subject|0
56565|NCT01147809|215031|P3|Phase II (168 Days)|Withdrawal by Subject|0
56566|NCT01147809|215032|P2|Phase II (168 Days)|Withdrawal by Subject|0
56567|NCT01147809|215033|P1|Phase II (168 Days)|Withdrawal by Subject|0
56568|NCT01147809|215028|P6|Phase II (168 Days)|Physician Decision|11
56569|NCT01147809|215029|P5|Phase II (168 Days)|Physician Decision|5
56570|NCT01147809|215030|P4|Phase II (168 Days)|Physician Decision|0
56571|NCT01147809|215031|P3|Phase II (168 Days)|Physician Decision|0
56572|NCT01147809|215032|P2|Phase II (168 Days)|Physician Decision|0
56573|NCT01147809|215033|P1|Phase II (168 Days)|Physician Decision|0
56574|NCT01147809|215028|P6|Phase II (168 Days)|Protocol Violation|1
56575|NCT01147809|215029|P5|Phase II (168 Days)|Protocol Violation|0
56576|NCT01147809|215030|P4|Phase II (168 Days)|Protocol Violation|0
56577|NCT01147809|215031|P3|Phase II (168 Days)|Protocol Violation|0
56578|NCT01147809|215032|P2|Phase II (168 Days)|Protocol Violation|0
56579|NCT01147809|215033|P1|Phase II (168 Days)|Protocol Violation|0
56580|NCT01147809|215028|P6|Phase II (168 Days)|Adverse Event|6
56581|NCT01147809|215029|P5|Phase II (168 Days)|Adverse Event|3
56582|NCT01147809|215030|P4|Phase II (168 Days)|Adverse Event|0
56583|NCT01147809|215031|P3|Phase II (168 Days)|Adverse Event|0
56584|NCT01147809|215032|P2|Phase II (168 Days)|Adverse Event|0
56585|NCT01147809|215033|P1|Phase II (168 Days)|Adverse Event|0
56586|NCT01147809|215028|P6|Phase I (168 Days)|Withdrawal by Subject|0
56587|NCT01147809|215029|P5|Phase I (168 Days)|Withdrawal by Subject|0
56588|NCT01147809|215030|P4|Phase I (168 Days)|Withdrawal by Subject|3
56589|NCT01147809|215031|P3|Phase I (168 Days)|Withdrawal by Subject|0
56590|NCT01147809|215032|P2|Phase I (168 Days)|Withdrawal by Subject|0
56591|NCT01147809|215033|P1|Phase I (168 Days)|Withdrawal by Subject|0
56592|NCT01147809|215028|P6|Phase I (168 Days)|Physician Decision|0
56593|NCT01147809|215029|P5|Phase I (168 Days)|Physician Decision|0
56594|NCT01147809|215030|P4|Phase I (168 Days)|Physician Decision|0
56595|NCT01147809|215031|P3|Phase I (168 Days)|Physician Decision|2
56596|NCT01147809|215032|P2|Phase I (168 Days)|Physician Decision|1
56597|NCT01147809|215033|P1|Phase I (168 Days)|Physician Decision|0
56598|NCT01147809|215028|P6|Phase I (168 Days)|Lost to Follow-up|0
56599|NCT01147809|215029|P5|Phase I (168 Days)|Lost to Follow-up|0
56600|NCT01147809|215030|P4|Phase I (168 Days)|Lost to Follow-up|1
56601|NCT01147809|215031|P3|Phase I (168 Days)|Lost to Follow-up|0
56602|NCT01147809|215032|P2|Phase I (168 Days)|Lost to Follow-up|0
56603|NCT01147809|215033|P1|Phase I (168 Days)|Lost to Follow-up|1
56604|NCT01147809|215028|P6|Phase I (168 Days)|Adverse Event|0
56605|NCT01147809|215029|P5|Phase I (168 Days)|Adverse Event|0
56606|NCT01147809|215030|P4|Phase I (168 Days)|Adverse Event|1
56607|NCT01147809|215031|P3|Phase I (168 Days)|Adverse Event|0
56608|NCT01147809|215032|P2|Phase I (168 Days)|Adverse Event|0
56609|NCT01147809|215033|P1|Phase I (168 Days)|Adverse Event|0
56610|NCT01147640|215149|P2|Overall Study|Didn't meet eligibility criteria|0
56611|NCT01147640|215150|P1|Overall Study|Didn't meet eligibility criteria|1
56612|NCT01147640|215149|P2|Overall Study|Lost to Follow-up|1
56613|NCT01147640|215150|P1|Overall Study|Lost to Follow-up|0
56614|NCT01147640|215149|P2|Overall Study|Withdrawal by Subject|0
56615|NCT01147640|215150|P1|Overall Study|Withdrawal by Subject|1
56616|NCT01147640|215149|P2|Overall Study|Physician Decision|0
56617|NCT01147640|215150|P1|Overall Study|Physician Decision|1
56618|NCT01147640|215149|P2|Overall Study|Adverse Event|0
56619|NCT01147640|215150|P1|Overall Study|Adverse Event|2
56620|NCT01147497|215173|P2|Overall Study|failed insertion|0
56621|NCT01147497|215174|P1|Overall Study|failed insertion|2
56622|NCT01147471|215186|P2|6 Month Follow Up|Lost to Follow-up|2
56623|NCT01147471|215187|P1|6 Month Follow Up|Lost to Follow-up|4
56624|NCT01147471|215186|P2|3 Month Follow Up|Physician Decision|1
56625|NCT01147471|215187|P1|3 Month Follow Up|Physician Decision|0
56626|NCT01147471|215186|P2|3 Month Follow Up|Lost to Follow-up|1
56627|NCT01147471|215187|P1|3 Month Follow Up|Lost to Follow-up|1
56628|NCT01147471|215186|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
56629|NCT01147471|215187|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
56630|NCT01147471|215186|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
56631|NCT01147471|215187|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
56632|NCT01147471|215186|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
56633|NCT01147471|215187|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
56634|NCT01147458|215201|P4|Second Intervention|Unspecified|0
56635|NCT01147458|215202|P3|Second Intervention|Unspecified|1
56636|NCT01147458|215203|P2|Second Intervention|Unspecified|0
56637|NCT01147458|215204|P1|Second Intervention|Unspecified|0
56638|NCT01147458|215201|P4|Second Intervention|Adverse Event|1
56639|NCT01147458|215202|P3|Second Intervention|Adverse Event|1
56640|NCT01147458|215203|P2|Second Intervention|Adverse Event|0
56641|NCT01147458|215204|P1|Second Intervention|Adverse Event|2
56642|NCT01147458|215201|P4|Second Intervention|Withdrawal by Subject|0
56643|NCT01147458|215202|P3|Second Intervention|Withdrawal by Subject|0
56644|NCT01147458|215203|P2|Second Intervention|Withdrawal by Subject|1
56645|NCT01147458|215204|P1|Second Intervention|Withdrawal by Subject|0
56646|NCT01147458|215201|P4|Second Intervention|Protocol Violation|0
56647|NCT01147458|215202|P3|Second Intervention|Protocol Violation|1
56648|NCT01147458|215203|P2|Second Intervention|Protocol Violation|1
56649|NCT01147458|215204|P1|Second Intervention|Protocol Violation|0
56650|NCT01147458|215201|P4|Second Intervention|Study terminated by sponsor|3
56651|NCT01147458|215202|P3|Second Intervention|Study terminated by sponsor|5
56652|NCT01147458|215203|P2|Second Intervention|Study terminated by sponsor|5
56653|NCT01147458|215204|P1|Second Intervention|Study terminated by sponsor|7
56654|NCT01147458|215201|P4|First Intervention|Unspecified|0
56655|NCT01147458|215202|P3|First Intervention|Unspecified|0
56656|NCT01147458|215203|P2|First Intervention|Unspecified|2
56657|NCT01147458|215204|P1|First Intervention|Unspecified|1
56658|NCT01147458|215201|P4|First Intervention|Adverse Event|3
56659|NCT01147458|215202|P3|First Intervention|Adverse Event|2
56660|NCT01147458|215203|P2|First Intervention|Adverse Event|3
56661|NCT01147458|215204|P1|First Intervention|Adverse Event|0
56662|NCT01147458|215201|P4|First Intervention|Withdrawal by Subject|0
56663|NCT01147458|215202|P3|First Intervention|Withdrawal by Subject|1
56664|NCT01147458|215203|P2|First Intervention|Withdrawal by Subject|0
56665|NCT01147458|215204|P1|First Intervention|Withdrawal by Subject|3
56666|NCT01147458|215201|P4|First Intervention|Protocol Violation|3
56667|NCT01147458|215202|P3|First Intervention|Protocol Violation|2
56668|NCT01147458|215203|P2|First Intervention|Protocol Violation|3
56669|NCT01147458|215204|P1|First Intervention|Protocol Violation|2
56670|NCT01147458|215201|P4|First Intervention|Study terminated by sponsor|8
56671|NCT01147458|215202|P3|First Intervention|Study terminated by sponsor|7
56672|NCT01147458|215203|P2|First Intervention|Study terminated by sponsor|8
56673|NCT01147458|215204|P1|First Intervention|Study terminated by sponsor|8
56674|NCT01147341|215296|P2|Open Label Period|Subject moved|0
56675|NCT01147341|215297|P1|Open Label Period|Subject moved|1
56676|NCT01147341|215296|P2|Open Label Period|Lack of Efficacy|0
56677|NCT01147341|215297|P1|Open Label Period|Lack of Efficacy|3
56678|NCT01147341|215296|P2|Double Blind Period|Withdrawal by Subject|1
56679|NCT01147341|215297|P1|Double Blind Period|Withdrawal by Subject|0
56680|NCT01147341|215296|P2|Double Blind Period|Lack of Efficacy|1
56681|NCT01147341|215297|P1|Double Blind Period|Lack of Efficacy|1
56682|NCT01147250|215360|P2|Overall Study|Other than specified|1
56683|NCT01147250|215361|P1|Overall Study|Other than specified|0
56684|NCT01147250|215360|P2|Overall Study|Site termination by sponsor|5
56685|NCT01147250|215361|P1|Overall Study|Site termination by sponsor|13
56686|NCT01147250|215360|P2|Overall Study|Withdrawal by Subject|88
56687|NCT01147250|215361|P1|Overall Study|Withdrawal by Subject|83
56688|NCT01147250|215360|P2|Overall Study|Lost to Follow-up|11
56689|NCT01147250|215361|P1|Overall Study|Lost to Follow-up|14
56690|NCT01147172|215373|P1|Overall Study|Lost to Follow-up|2
56691|NCT01147172|215373|P1|Overall Study|Withdrawal by Subject|2
56692|NCT01147068|215391|P7|Subjects That Completed Safety Follow-up|Ineligible|0
56693|NCT01147068|215392|P6|Subjects That Completed Safety Follow-up|Ineligible|0
56694|NCT01147068|215393|P5|Subjects That Completed Safety Follow-up|Ineligible|0
56695|NCT01147068|215394|P4|Subjects That Completed Safety Follow-up|Ineligible|0
56696|NCT01147068|215395|P3|Subjects That Completed Safety Follow-up|Ineligible|0
56697|NCT01147068|215396|P2|Subjects That Completed Safety Follow-up|Ineligible|1
56698|NCT01147068|215397|P1|Subjects That Completed Safety Follow-up|Ineligible|0
56699|NCT01147068|215391|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
56700|NCT01147068|215392|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
56701|NCT01147068|215393|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
56702|NCT01147068|215394|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
56703|NCT01147068|215395|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
56704|NCT01147068|215396|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
56705|NCT01147068|215397|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
56706|NCT01147068|215391|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
56707|NCT01147068|215392|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
56708|NCT01147068|215393|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
56709|NCT01147068|215394|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
56710|NCT01147068|215395|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
56711|NCT01147068|215396|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
56712|NCT01147068|215397|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
56713|NCT01147068|215391|P7|Subjects That Received 2nd Dose|Other|0
56714|NCT01147068|215392|P6|Subjects That Received 2nd Dose|Other|0
56715|NCT01147068|215393|P5|Subjects That Received 2nd Dose|Other|1
56716|NCT01147068|215394|P4|Subjects That Received 2nd Dose|Other|0
56717|NCT01147068|215395|P3|Subjects That Received 2nd Dose|Other|3
56718|NCT01147068|215396|P2|Subjects That Received 2nd Dose|Other|3
56719|NCT01147068|215397|P1|Subjects That Received 2nd Dose|Other|0
56720|NCT01147068|215391|P7|Subjects That Received 2nd Dose|Did not complete the study|0
56721|NCT01147068|215392|P6|Subjects That Received 2nd Dose|Did not complete the study|1
56722|NCT01147068|215393|P5|Subjects That Received 2nd Dose|Did not complete the study|0
56723|NCT01147068|215394|P4|Subjects That Received 2nd Dose|Did not complete the study|0
56724|NCT01147068|215395|P3|Subjects That Received 2nd Dose|Did not complete the study|0
56725|NCT01147068|215396|P2|Subjects That Received 2nd Dose|Did not complete the study|1
56726|NCT01147068|215397|P1|Subjects That Received 2nd Dose|Did not complete the study|0
56727|NCT01147068|215391|P7|Subjects That Received 2nd Dose|Ineligible|0
56728|NCT01147068|215392|P6|Subjects That Received 2nd Dose|Ineligible|0
56729|NCT01147068|215393|P5|Subjects That Received 2nd Dose|Ineligible|0
56730|NCT01147068|215394|P4|Subjects That Received 2nd Dose|Ineligible|0
56731|NCT01147068|215395|P3|Subjects That Received 2nd Dose|Ineligible|0
56732|NCT01147068|215396|P2|Subjects That Received 2nd Dose|Ineligible|1
56733|NCT01147068|215397|P1|Subjects That Received 2nd Dose|Ineligible|0
56734|NCT01147068|215391|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
56735|NCT01147068|215392|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
56736|NCT01147068|215393|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
56737|NCT01147068|215394|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
56738|NCT01147068|215395|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
56739|NCT01147068|215396|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
56740|NCT01147068|215397|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
56741|NCT01147055|215427|P2|First Intervention Period|Lost to Follow-up|0
56742|NCT01147055|215428|P1|First Intervention Period|Lost to Follow-up|1
56743|NCT01146951|215462|P2|Overall Study|Adverse Event|1
56744|NCT01146951|215463|P1|Overall Study|Adverse Event|4
56745|NCT01146912|215484|P8|Overall Study|Duplicate patient|0
56746|NCT01146912|215485|P7|Overall Study|Duplicate patient|0
56747|NCT01146912|215486|P6|Overall Study|Duplicate patient|0
56748|NCT01146912|215487|P5|Overall Study|Duplicate patient|0
56749|NCT01146912|215488|P4|Overall Study|Duplicate patient|0
56750|NCT01146912|215489|P3|Overall Study|Duplicate patient|1
56751|NCT01146912|215490|P2|Overall Study|Duplicate patient|0
56752|NCT01146912|215491|P1|Overall Study|Duplicate patient|0
56753|NCT01146912|215484|P8|Overall Study|< 14 weeks gestational age|0
56754|NCT01146912|215485|P7|Overall Study|< 14 weeks gestational age|0
56755|NCT01146912|215486|P6|Overall Study|< 14 weeks gestational age|0
56756|NCT01146912|215487|P5|Overall Study|< 14 weeks gestational age|0
56757|NCT01146912|215488|P4|Overall Study|< 14 weeks gestational age|2
56758|NCT01146912|215489|P3|Overall Study|< 14 weeks gestational age|3
56759|NCT01146912|215490|P2|Overall Study|< 14 weeks gestational age|0
56760|NCT01146912|215491|P1|Overall Study|< 14 weeks gestational age|0
56761|NCT01146912|215484|P8|Overall Study|Already received influenza vaccination|0
56762|NCT01146912|215485|P7|Overall Study|Already received influenza vaccination|56
56763|NCT01146912|215486|P6|Overall Study|Already received influenza vaccination|61
56764|NCT01146912|215487|P5|Overall Study|Already received influenza vaccination|41
56765|NCT01146912|215488|P4|Overall Study|Already received influenza vaccination|15
56766|NCT01146912|215489|P3|Overall Study|Already received influenza vaccination|13
56767|NCT01146912|215490|P2|Overall Study|Already received influenza vaccination|822
56768|NCT01146912|215491|P1|Overall Study|Already received influenza vaccination|817
56769|NCT01146873|215513|P2|Overall Study|Transfer out|6
56770|NCT01146873|215514|P1|Overall Study|Transfer out|0
56771|NCT01146860|215530|P2|Overall Study|Withdrawal by Subject|1
56772|NCT01146860|215531|P1|Overall Study|Withdrawal by Subject|0
56773|NCT01146782|215545|P1|Primary Endpoint Cohort|Physician Decision|1
56774|NCT01146782|215545|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
56775|NCT01146782|215545|P1|Safety Cohort|TST <4 hrs|14
56776|NCT01146782|215545|P1|Safety Cohort|Control AHI <5|4
56777|NCT01146782|215545|P1|Safety Cohort|Withdrawal by Subject|4
56778|NCT01146782|215545|P1|Safety Cohort|Screen Failure|61
56779|NCT01146782|215545|P1|Screening Cohort|Withdrawal by Subject|29
56780|NCT01146782|215545|P1|Screening Cohort|Physician Decision|1
56781|NCT01146782|215545|P1|Screening Cohort|Lost to Follow-up|4
56782|NCT01146782|215545|P1|Screening Cohort|Screen Failure|187
56783|NCT01146613|215554|P2|Overall Study|Outpatient detox|0
56784|NCT01146613|215555|P1|Overall Study|Outpatient detox|1
56785|NCT01146613|215554|P2|Overall Study|schedule conflict|0
56786|NCT01146613|215555|P1|Overall Study|schedule conflict|1
56787|NCT01146613|215554|P2|Overall Study|Withdrawal by Subject|3
56788|NCT01146613|215555|P1|Overall Study|Withdrawal by Subject|0
56789|NCT01146613|215554|P2|Overall Study|Physician Decision|0
56790|NCT01146613|215555|P1|Overall Study|Physician Decision|1
56791|NCT01146613|215554|P2|Overall Study|Death|0
56792|NCT01146613|215555|P1|Overall Study|Death|1
56793|NCT01146613|215554|P2|Overall Study|Lack of Efficacy|1
56794|NCT01146613|215555|P1|Overall Study|Lack of Efficacy|0
56795|NCT01146613|215554|P2|Overall Study|Lost to Follow-up|8
56796|NCT01146613|215555|P1|Overall Study|Lost to Follow-up|3
56797|NCT01146288|215608|P2|First Intervention(1 Day)|Adverse Event|1
56798|NCT01146288|215609|P1|First Intervention(1 Day)|Adverse Event|0
56799|NCT01145898|215625|P2|3-year Treatment|medication change by treating physician|16
56800|NCT01145898|215626|P1|3-year Treatment|medication change by treating physician|3
56801|NCT01145755|215660|P3|Overall Study|Positive urine ethanol|0
56802|NCT01145755|215661|P2|Overall Study|Positive urine ethanol|1
56803|NCT01145755|215662|P1|Overall Study|Positive urine ethanol|0
56804|NCT01145755|215660|P3|Overall Study|Withdrawal by Subject|1
56805|NCT01145755|215661|P2|Overall Study|Withdrawal by Subject|0
56806|NCT01145755|215662|P1|Overall Study|Withdrawal by Subject|0
56807|NCT01145755|215660|P3|Overall Study|Patient could not swollow medication|1
56808|NCT01145755|215661|P2|Overall Study|Patient could not swollow medication|0
56809|NCT01145755|215662|P1|Overall Study|Patient could not swollow medication|0
56810|NCT01145755|215660|P3|Overall Study|Lack of Efficacy|0
56811|NCT01145755|215661|P2|Overall Study|Lack of Efficacy|1
56812|NCT01145755|215662|P1|Overall Study|Lack of Efficacy|0
56813|NCT01145755|215660|P3|Overall Study|Study Closure|17
56814|NCT01145755|215661|P2|Overall Study|Study Closure|14
56815|NCT01145755|215662|P1|Overall Study|Study Closure|14
56816|NCT01145755|215660|P3|Overall Study|Protocol Violation|1
56817|NCT01145755|215661|P2|Overall Study|Protocol Violation|3
56818|NCT01145755|215662|P1|Overall Study|Protocol Violation|0
56819|NCT01145755|215660|P3|Overall Study|Lost to Follow-up|1
56820|NCT01145755|215661|P2|Overall Study|Lost to Follow-up|3
56821|NCT01145755|215662|P1|Overall Study|Lost to Follow-up|2
56822|NCT01145755|215660|P3|Overall Study|Withdrawal by Subject|2
56823|NCT01145755|215661|P2|Overall Study|Withdrawal by Subject|2
56824|NCT01145755|215662|P1|Overall Study|Withdrawal by Subject|2
56825|NCT01145755|215660|P3|Overall Study|Adverse Event|2
56826|NCT01145755|215661|P2|Overall Study|Adverse Event|4
56827|NCT01145755|215662|P1|Overall Study|Adverse Event|2
56828|NCT01145625|215689|P2|Overall Study|Pregnancy|1
56829|NCT01145625|215690|P1|Overall Study|Pregnancy|0
56830|NCT01145625|215689|P2|Overall Study|Withdrawal by Subject|16
56831|NCT01145625|215690|P1|Overall Study|Withdrawal by Subject|7
56832|NCT01145625|215689|P2|Overall Study|Protocol Violation|1
56833|NCT01145625|215690|P1|Overall Study|Protocol Violation|3
56834|NCT01145625|215689|P2|Overall Study|Adverse Event|4
56835|NCT01145625|215690|P1|Overall Study|Adverse Event|6
56836|NCT01145625|215689|P2|Overall Study|Lost to Follow-up|9
56837|NCT01145625|215690|P1|Overall Study|Lost to Follow-up|8
56838|NCT01145560|215703|P3|Overall Study|Withdrawal of therapy|1
56839|NCT01145560|215704|P2|Overall Study|Withdrawal of therapy|0
56840|NCT01145560|215705|P1|Overall Study|Withdrawal of therapy|0
56841|NCT01145560|215703|P3|Overall Study|False insurance information|0
56842|NCT01145560|215704|P2|Overall Study|False insurance information|1
56843|NCT01145560|215705|P1|Overall Study|False insurance information|0
56844|NCT01145560|215703|P3|Overall Study|Accidental unblinding of study treatment|0
56845|NCT01145560|215704|P2|Overall Study|Accidental unblinding of study treatment|1
56846|NCT01145560|215705|P1|Overall Study|Accidental unblinding of study treatment|0
56847|NCT01145560|215703|P3|Overall Study|No study drug by 24h after organ failure|0
56848|NCT01145560|215704|P2|Overall Study|No study drug by 24h after organ failure|0
56849|NCT01145560|215705|P1|Overall Study|No study drug by 24h after organ failure|1
56850|NCT01145560|215703|P3|Overall Study|Lost to Follow-up|1
56851|NCT01145560|215704|P2|Overall Study|Lost to Follow-up|1
56852|NCT01145560|215705|P1|Overall Study|Lost to Follow-up|1
56853|NCT01145560|215703|P3|Overall Study|Withdrawal by Subject|0
56854|NCT01145560|215704|P2|Overall Study|Withdrawal by Subject|1
56855|NCT01145560|215705|P1|Overall Study|Withdrawal by Subject|2
56856|NCT01145508|215731|P2|Overall Study|Never started treatment|1
56857|NCT01145508|215732|P1|Overall Study|Never started treatment|1
56858|NCT01145508|215731|P2|Overall Study|Physician Decision|1
56859|NCT01145508|215732|P1|Overall Study|Physician Decision|2
56860|NCT01145508|215731|P2|Overall Study|Death|0
56861|NCT01145508|215732|P1|Overall Study|Death|1
56862|NCT01145508|215731|P2|Overall Study|Adverse Event|0
56863|NCT01145508|215732|P1|Overall Study|Adverse Event|1
56864|NCT01145495|215738|P1|Overall Study|Disease progression after respone|1
56865|NCT01145495|215738|P1|Overall Study|Withdrawal by Subject|5
56866|NCT01145495|215738|P1|Overall Study|Adverse Event|6
56867|NCT01145482|215744|P2|First Intervention (1 Day)|Withdrawal by Subject|1
56868|NCT01145482|215745|P1|First Intervention (1 Day)|Withdrawal by Subject|0
56869|NCT01145417|215755|P2|Overall Study|Unspecified|0
56870|NCT01145417|215756|P1|Overall Study|Unspecified|1
56871|NCT01145417|215755|P2|Overall Study|Study terminated by sponsor|43
56872|NCT01145417|215756|P1|Overall Study|Study terminated by sponsor|35
56873|NCT01145417|215755|P2|Overall Study|Adverse Event|1
56874|NCT01145417|215756|P1|Overall Study|Adverse Event|0
56875|NCT01145417|215755|P2|Overall Study|Pregnancy|0
56876|NCT01145417|215756|P1|Overall Study|Pregnancy|1
56877|NCT01145417|215755|P2|Overall Study|Withdrawal by Subject|2
56878|NCT01145417|215756|P1|Overall Study|Withdrawal by Subject|1
56879|NCT01145417|215755|P2|Overall Study|Lost to Follow-up|1
56880|NCT01145417|215756|P1|Overall Study|Lost to Follow-up|2
56881|NCT01145417|215755|P2|Overall Study|Death|0
56882|NCT01145417|215756|P1|Overall Study|Death|1
56883|NCT01144299|215791|P2|Overall Study|Withdrawal by Subject|0
56884|NCT01144299|215792|P1|Overall Study|Withdrawal by Subject|1
56885|NCT01144299|215791|P2|Overall Study|Lost to Follow-up|0
56886|NCT01144299|215792|P1|Overall Study|Lost to Follow-up|1
56887|NCT01145352|215835|P1|Overall Study|Syringe formulation was used|1
56888|NCT01145352|215835|P1|Overall Study|Treated before marketing approval|4
56889|NCT01145352|215835|P1|Overall Study|Found to have been registered twice|6
56890|NCT01145053|215843|P1|Overall Study|Other|18
56891|NCT01145053|215843|P1|Overall Study|Withdrawal by Subject|25
56892|NCT01145053|215843|P1|Overall Study|Lost to Follow-up|28
56893|NCT01145053|215843|P1|Overall Study|Adverse Event|22
56894|NCT01144715|215895|P2|Overall Study|Adverse Event|1
56895|NCT01144715|215896|P1|Overall Study|Adverse Event|0
56896|NCT01144715|215895|P2|Overall Study|Withdrawal by Subject|1
56897|NCT01144715|215896|P1|Overall Study|Withdrawal by Subject|2
56898|NCT01144715|215895|P2|Overall Study|Lost to Follow-up|1
56899|NCT01144715|215896|P1|Overall Study|Lost to Follow-up|2
56900|NCT01144416|215952|P2|Intervention Period|Other|5
56901|NCT01144416|215953|P1|Intervention Period|Other|7
56902|NCT01144416|215952|P2|Intervention Period|No/too few/bad quality embryos|3
56903|NCT01144416|215953|P1|Intervention Period|No/too few/bad quality embryos|3
56904|NCT01144416|215952|P2|Intervention Period|No or abnormal fertilization|10
56905|NCT01144416|215953|P1|Intervention Period|No or abnormal fertilization|25
56906|NCT01144416|215952|P2|Intervention Period|No/too few/bad oocytes|5
56907|NCT01144416|215953|P1|Intervention Period|No/too few/bad oocytes|7
56908|NCT01144416|215952|P2|Intervention Period|Too high ovarian response|2
56909|NCT01144416|215953|P1|Intervention Period|Too high ovarian response|4
56910|NCT01144416|215952|P2|Intervention Period|Risk of OHSS|1
56911|NCT01144416|215953|P1|Intervention Period|Risk of OHSS|0
56912|NCT01144416|215952|P2|Intervention Period|Insufficient ovarian response|17
56913|NCT01144416|215953|P1|Intervention Period|Insufficient ovarian response|11
56914|NCT01144416|215952|P2|Intervention Period|Adverse Event|6
56915|NCT01144416|215953|P1|Intervention Period|Adverse Event|5
56916|NCT01144403|215969|P1|Overall Study|Adverse Event|1
56917|NCT01144403|215969|P1|Overall Study|Death|1
56918|NCT01144403|215969|P1|Overall Study|Lost to Follow-up|3
56919|NCT01144364|215978|P3|Follow-Up/Maintenance Phase|Physician Decision|1
56920|NCT01144364|215979|P2|Follow-Up/Maintenance Phase|Physician Decision|0
56921|NCT01144364|215980|P1|Follow-Up/Maintenance Phase|Physician Decision|0
56922|NCT01144364|215978|P3|Follow-Up/Maintenance Phase|Relapse|5
56923|NCT01144364|215979|P2|Follow-Up/Maintenance Phase|Relapse|5
56924|NCT01144364|215980|P1|Follow-Up/Maintenance Phase|Relapse|0
56925|NCT01144364|215978|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
56926|NCT01144364|215979|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
56927|NCT01144364|215980|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
56928|NCT01144364|215978|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
56929|NCT01144364|215979|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
56930|NCT01144364|215980|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
56931|NCT01144364|215978|P3|Follow-Up/Maintenance Phase|Death|0
56932|NCT01144364|215979|P2|Follow-Up/Maintenance Phase|Death|2
56933|NCT01144364|215980|P1|Follow-Up/Maintenance Phase|Death|0
56934|NCT01144364|215978|P3|Follow-Up/Maintenance Phase|Adverse Event|1
56935|NCT01144364|215979|P2|Follow-Up/Maintenance Phase|Adverse Event|3
56936|NCT01144364|215980|P1|Follow-Up/Maintenance Phase|Adverse Event|0
56937|NCT01144364|215978|P3|Follow-Up/Maintenance Phase|Disease progression|29
56938|NCT01144364|215979|P2|Follow-Up/Maintenance Phase|Disease progression|23
56939|NCT01144364|215980|P1|Follow-Up/Maintenance Phase|Disease progression|0
56940|NCT01144364|215978|P3|Induction Phase|Protocol Violation|0
56941|NCT01144364|215979|P2|Induction Phase|Protocol Violation|0
56942|NCT01144364|215980|P1|Induction Phase|Protocol Violation|1
56943|NCT01144364|215978|P3|Induction Phase|Secondary neoplasia|0
56944|NCT01144364|215979|P2|Induction Phase|Secondary neoplasia|0
56945|NCT01144364|215980|P1|Induction Phase|Secondary neoplasia|1
56946|NCT01144364|215978|P3|Induction Phase|Stable disease|0
56947|NCT01144364|215979|P2|Induction Phase|Stable disease|0
56948|NCT01144364|215980|P1|Induction Phase|Stable disease|2
56949|NCT01144364|215978|P3|Induction Phase|Physician Decision|0
56950|NCT01144364|215979|P2|Induction Phase|Physician Decision|0
56951|NCT01144364|215980|P1|Induction Phase|Physician Decision|1
56952|NCT01144364|215978|P3|Induction Phase|Lost to Follow-up|0
56953|NCT01144364|215979|P2|Induction Phase|Lost to Follow-up|0
56954|NCT01144364|215980|P1|Induction Phase|Lost to Follow-up|2
56955|NCT01144364|215978|P3|Induction Phase|Withdrawal by Subject|0
56956|NCT01144364|215979|P2|Induction Phase|Withdrawal by Subject|0
56957|NCT01144364|215980|P1|Induction Phase|Withdrawal by Subject|1
56958|NCT01144364|215978|P3|Induction Phase|Death|0
56959|NCT01144364|215979|P2|Induction Phase|Death|0
56960|NCT01144364|215980|P1|Induction Phase|Death|1
56961|NCT01144364|215978|P3|Induction Phase|Adverse Event|0
56962|NCT01144364|215979|P2|Induction Phase|Adverse Event|0
56963|NCT01144364|215980|P1|Induction Phase|Adverse Event|9
56964|NCT01144364|215978|P3|Induction Phase|Disease progression|0
56965|NCT01144364|215979|P2|Induction Phase|Disease progression|0
56966|NCT01144364|215980|P1|Induction Phase|Disease progression|14
56967|NCT01144182|216006|P2|Overall Study|Lost to Follow-up|9
56968|NCT01144182|216007|P1|Overall Study|Lost to Follow-up|9
56969|NCT01144182|216006|P2|Overall Study|Withdrawal by Subject|6
56970|NCT01144182|216007|P1|Overall Study|Withdrawal by Subject|3
56971|NCT01144182|216006|P2|Overall Study|Death|6
56972|NCT01144182|216007|P1|Overall Study|Death|5
56973|NCT01144052|216039|P2|Overall Study|Withdrawal by Subject|1
56974|NCT01144052|216040|P1|Overall Study|Withdrawal by Subject|1
56975|NCT01143896|216071|P2|Overall Study|Death|3
56976|NCT01143896|216072|P1|Overall Study|Death|6
56977|NCT01143896|216071|P2|Overall Study|Withdrawal by Subject|5
56978|NCT01143896|216072|P1|Overall Study|Withdrawal by Subject|13
56979|NCT01143896|216071|P2|Overall Study|Lost to Follow-up|13
56980|NCT01143896|216072|P1|Overall Study|Lost to Follow-up|18
56981|NCT01143896|216071|P2|Overall Study|Did not complete Baseline Interview|4
56982|NCT01143896|216072|P1|Overall Study|Did not complete Baseline Interview|5
56983|NCT01143714|216163|P2|Overall Study|wound size increased|0
56984|NCT01143714|216164|P1|Overall Study|wound size increased|1
56985|NCT01143714|216163|P2|Overall Study|wound closed = deemed healed|0
56986|NCT01143714|216164|P1|Overall Study|wound closed = deemed healed|1
56987|NCT01143714|216163|P2|Overall Study|Subject non-compliance|1
56988|NCT01143714|216164|P1|Overall Study|Subject non-compliance|0
56989|NCT01143714|216163|P2|Overall Study|Withdrawal by Subject|0
56990|NCT01143714|216164|P1|Overall Study|Withdrawal by Subject|1
56991|NCT01143714|216163|P2|Overall Study|Adverse Event|2
56992|NCT01143714|216164|P1|Overall Study|Adverse Event|4
56993|NCT01143337|216196|P3|Overall Study|Other reason|5
56994|NCT01143337|216197|P2|Overall Study|Other reason|0
56995|NCT01143337|216198|P1|Overall Study|Other reason|0
56996|NCT01143337|216196|P3|Overall Study|Withdrawal by Subject|1
56997|NCT01143337|216197|P2|Overall Study|Withdrawal by Subject|0
56998|NCT01143337|216198|P1|Overall Study|Withdrawal by Subject|0
56999|NCT01143337|216196|P3|Overall Study|Protocol Violation|0
57000|NCT01143337|216197|P2|Overall Study|Protocol Violation|0
57001|NCT01143337|216198|P1|Overall Study|Protocol Violation|1
57002|NCT01143337|216196|P3|Overall Study|Lack of Efficacy|1
57003|NCT01143337|216197|P2|Overall Study|Lack of Efficacy|2
57004|NCT01143337|216198|P1|Overall Study|Lack of Efficacy|6
57005|NCT01143337|216196|P3|Overall Study|Adverse Event|5
57006|NCT01143337|216197|P2|Overall Study|Adverse Event|9
57007|NCT01143337|216198|P1|Overall Study|Adverse Event|3
57008|NCT01143324|216212|P1|Overall Study|Explant of the device|4
57009|NCT01143324|216212|P1|Overall Study|Withdrawal by Subject|4
57010|NCT01143324|216212|P1|Overall Study|Lost to Follow-up|11
57011|NCT01143259|216251|P2|Overall Study|Screen Failure|9
57012|NCT01143259|216252|P1|Overall Study|Screen Failure|7
57013|NCT01143259|216251|P2|Overall Study|Protocol Violation|9
57014|NCT01143259|216252|P1|Overall Study|Protocol Violation|13
57015|NCT01143259|216251|P2|Overall Study|Withdrawal by Subject|2
57016|NCT01143259|216252|P1|Overall Study|Withdrawal by Subject|3
57017|NCT01143207|216260|P1|Overall Study|Lost to Follow-up|2
57018|NCT01143090|216280|P1|Overall Study|Administrative|1
57019|NCT01143090|216280|P1|Overall Study|Failure to meet eligibility criteria|1
57020|NCT01143090|216280|P1|Overall Study|Non-compliance with study drug|1
57021|NCT01143090|216280|P1|Overall Study|Withdrawal by Subject|18
57022|NCT01143090|216280|P1|Overall Study|Protocol Violation|2
57023|NCT01143090|216280|P1|Overall Study|Lost to Follow-up|9
57024|NCT01143090|216280|P1|Overall Study|Adverse Event|17
57025|NCT01143090|216280|P1|Overall Study|Lack of Efficacy|2
57026|NCT01143077|216287|P3|Overall Study|Principal Investigator Decision|1
57027|NCT01143077|216288|P2|Overall Study|Principal Investigator Decision|0
57028|NCT01143077|216289|P1|Overall Study|Principal Investigator Decision|2
57029|NCT01143077|216287|P3|Overall Study|Administrative|0
57030|NCT01143077|216288|P2|Overall Study|Administrative|0
57031|NCT01143077|216289|P1|Overall Study|Administrative|1
57032|NCT01143077|216287|P3|Overall Study|Non-compliance with study drug|1
57033|NCT01143077|216288|P2|Overall Study|Non-compliance with study drug|1
57034|NCT01143077|216289|P1|Overall Study|Non-compliance with study drug|0
57035|NCT01143077|216287|P3|Overall Study|Withdrawal by Subject|3
57036|NCT01143077|216288|P2|Overall Study|Withdrawal by Subject|3
57037|NCT01143077|216289|P1|Overall Study|Withdrawal by Subject|4
57038|NCT01143077|216287|P3|Overall Study|Protocol Violation|0
57039|NCT01143077|216288|P2|Overall Study|Protocol Violation|0
57040|NCT01143077|216289|P1|Overall Study|Protocol Violation|2
57041|NCT01143077|216287|P3|Overall Study|Lost to Follow-up|4
57042|NCT01143077|216288|P2|Overall Study|Lost to Follow-up|3
57043|NCT01143077|216289|P1|Overall Study|Lost to Follow-up|2
57044|NCT01143077|216287|P3|Overall Study|Adverse Event|5
57045|NCT01143077|216288|P2|Overall Study|Adverse Event|6
57046|NCT01143077|216289|P1|Overall Study|Adverse Event|5
57047|NCT01143077|216287|P3|Overall Study|Lack of Efficacy|1
57048|NCT01143077|216288|P2|Overall Study|Lack of Efficacy|2
57049|NCT01143077|216289|P1|Overall Study|Lack of Efficacy|0
57050|NCT01143051|216306|P6|3-14 Day Washout|Withdrawal by Subject|1
57051|NCT01143051|216307|P5|3-14 Day Washout|Withdrawal by Subject|0
57052|NCT01143051|216308|P4|3-14 Day Washout|Withdrawal by Subject|0
57053|NCT01143051|216309|P3|3-14 Day Washout|Withdrawal by Subject|0
57054|NCT01143051|216310|P2|3-14 Day Washout|Withdrawal by Subject|0
57055|NCT01143051|216311|P1|3-14 Day Washout|Withdrawal by Subject|0
57056|NCT01143051|216306|P6|3-14 Day Washout|Withdrawal by Subject|0
57057|NCT01143051|216307|P5|3-14 Day Washout|Withdrawal by Subject|0
57058|NCT01143051|216308|P4|3-14 Day Washout|Withdrawal by Subject|0
57059|NCT01143051|216309|P3|3-14 Day Washout|Withdrawal by Subject|1
57060|NCT01143051|216310|P2|3-14 Day Washout|Withdrawal by Subject|0
57061|NCT01143051|216311|P1|3-14 Day Washout|Withdrawal by Subject|0
57062|NCT01143038|216334|P1|Overall Study|Death|1
57063|NCT01143038|216334|P1|Overall Study|Protocol Deviation|1
57064|NCT01143038|216334|P1|Overall Study|Lost to Follow-up|2
57065|NCT01143038|216334|P1|Overall Study|Adverse Event|3
57066|NCT01143038|216334|P1|Overall Study|Requirement for alternative therapy|5
57067|NCT01143038|216334|P1|Overall Study|Withdrawal by Subject|4
57068|NCT01142908|216344|P2|Overall Study|Withdrawal by Subject|0
57069|NCT01142908|216345|P1|Overall Study|Withdrawal by Subject|3
57070|NCT01142908|216344|P2|Overall Study|Excluded - did not meet criteria|5
57071|NCT01142908|216345|P1|Overall Study|Excluded - did not meet criteria|9
57072|NCT01142908|216344|P2|Overall Study|Death|4
57073|NCT01142908|216345|P1|Overall Study|Death|1
57074|NCT01142908|216344|P2|Overall Study|Lost to Follow-up|13
57075|NCT01142908|216345|P1|Overall Study|Lost to Follow-up|19
57076|NCT01142726|216394|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
57077|NCT01142726|216395|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
57078|NCT01142726|216396|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
57079|NCT01142726|216394|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
57080|NCT01142726|216395|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
57081|NCT01142726|216396|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
57082|NCT01142726|216394|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
57083|NCT01142726|216395|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
57084|NCT01142726|216396|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
57085|NCT01142726|216394|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
57086|NCT01142726|216395|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
57087|NCT01142726|216396|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
57088|NCT01142726|216394|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
57089|NCT01142726|216395|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
57090|NCT01142726|216396|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
57091|NCT01142726|216394|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
57092|NCT01142726|216395|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
57093|NCT01142726|216396|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
57094|NCT01142726|216394|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
57095|NCT01142726|216395|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
57096|NCT01142726|216396|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
57097|NCT01142726|216394|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
57098|NCT01142726|216395|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
57099|NCT01142726|216396|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
57100|NCT01142726|216394|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
57101|NCT01142726|216395|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
57102|NCT01142726|216396|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
57103|NCT01142726|216394|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
57104|NCT01142726|216395|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
57105|NCT01142726|216396|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
57106|NCT01142726|216394|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
57107|NCT01142726|216395|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
57108|NCT01142726|216396|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
57109|NCT01142726|216394|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
57110|NCT01142726|216395|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
57111|NCT01142726|216396|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
57112|NCT01142726|216394|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
57113|NCT01142726|216395|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
57114|NCT01142726|216396|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
57115|NCT01142726|216394|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
57116|NCT01142726|216395|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
57117|NCT01142726|216396|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
57118|NCT01142726|216394|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
57119|NCT01142726|216395|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
57120|NCT01142726|216396|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
57121|NCT01142726|216394|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
57122|NCT01142726|216395|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
57123|NCT01142726|216396|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
57124|NCT01142661|216459|P1|Overall Study|Physician Decision|1
57125|NCT01142661|216459|P1|Overall Study|Withdrawal by Subject|1
57126|NCT01142661|216459|P1|Overall Study|Adverse Event|2
57127|NCT01142596|216466|P2|Overall Study|Other reason (not specified)|4
57128|NCT01142596|216467|P1|Overall Study|Other reason (not specified)|5
57129|NCT01142596|216466|P2|Overall Study|Lost to Follow-up|3
57130|NCT01142596|216467|P1|Overall Study|Lost to Follow-up|2
57131|NCT01142596|216466|P2|Overall Study|Lack of Efficacy|9
57132|NCT01142596|216467|P1|Overall Study|Lack of Efficacy|5
57133|NCT01142596|216466|P2|Overall Study|Adverse Event|35
57134|NCT01142596|216467|P1|Overall Study|Adverse Event|8
57135|NCT01142596|216466|P2|Overall Study|Withdrawal by Subject|35
57136|NCT01142596|216467|P1|Overall Study|Withdrawal by Subject|9
57137|NCT01142466|216519|P2|Overall Study|Withdrawal by Subject|1
57138|NCT01142466|216520|P1|Overall Study|Withdrawal by Subject|1
57139|NCT01142466|216519|P2|Overall Study|Adverse Event|1
57140|NCT01142466|216520|P1|Overall Study|Adverse Event|2
57141|NCT01142388|216540|P2|Overall Study|Never started therapy|3
57142|NCT01142388|216541|P1|Overall Study|Never started therapy|7
57143|NCT01142388|216540|P2|Overall Study|Other|1
57144|NCT01142388|216541|P1|Overall Study|Other|1
57145|NCT01142388|216540|P2|Overall Study|Other complications|2
57146|NCT01142388|216541|P1|Overall Study|Other complications|0
57147|NCT01142388|216540|P2|Overall Study|Alternative therapy|0
57148|NCT01142388|216541|P1|Overall Study|Alternative therapy|1
57149|NCT01142388|216540|P2|Overall Study|Withdrawal by Subject|3
57150|NCT01142388|216541|P1|Overall Study|Withdrawal by Subject|5
57151|NCT01142388|216540|P2|Overall Study|Death|2
57152|NCT01142388|216541|P1|Overall Study|Death|3
57153|NCT01142388|216540|P2|Overall Study|Adverse Event|5
57154|NCT01142388|216541|P1|Overall Study|Adverse Event|9
57155|NCT01142388|216540|P2|Overall Study|Lack of Efficacy|31
57156|NCT01142388|216541|P1|Overall Study|Lack of Efficacy|21
57157|NCT01142193|216564|P2|Overall Study|Other|2
57158|NCT01142193|216565|P1|Overall Study|Other|1
57159|NCT01142193|216564|P2|Overall Study|Protocol Discontinuation Criterion Met|0
57160|NCT01142193|216565|P1|Overall Study|Protocol Discontinuation Criterion Met|1
57161|NCT01142193|216564|P2|Overall Study|Withdrawal by Subject|3
57162|NCT01142193|216565|P1|Overall Study|Withdrawal by Subject|4
57163|NCT01142193|216564|P2|Overall Study|Physician Decision|1
57164|NCT01142193|216565|P1|Overall Study|Physician Decision|1
57165|NCT01142193|216564|P2|Overall Study|Lack of Efficacy|1
57166|NCT01142193|216565|P1|Overall Study|Lack of Efficacy|2
57167|NCT01142193|216564|P2|Overall Study|Adverse Event|4
57168|NCT01142193|216565|P1|Overall Study|Adverse Event|12
57169|NCT01142128|216593|P1|Overall Study|Withdrawal by Subject|2
57170|NCT01142128|216593|P1|Overall Study|Lost to Follow-up|1
57171|NCT01142128|216593|P1|Overall Study|Physician Decision|1
57172|NCT01142115|216603|P2|First Intervention|Adverse Event|0
57173|NCT01142115|216604|P1|First Intervention|Adverse Event|1
57174|NCT01142115|216603|P2|First Intervention|Lack of Efficacy|1
57175|NCT01142115|216604|P1|First Intervention|Lack of Efficacy|1
57176|NCT01141660|216621|P2|Overall Study|Physician Decision|12
57177|NCT01141660|216622|P1|Overall Study|Physician Decision|0
57178|NCT01141283|216657|P1|Overall Study|Lack of Efficacy|10
57179|NCT01141283|216657|P1|Overall Study|Administrative|4
57180|NCT01141283|216657|P1|Overall Study|Withdrawal by Subject|14
57181|NCT01141283|216657|P1|Overall Study|Lost to Follow-up|4
57182|NCT01141283|216657|P1|Overall Study|Adverse Event|56
57183|NCT01141205|216663|P2|Overall Study|Withdrawal by Subject|1
57184|NCT01141205|216664|P1|Overall Study|Withdrawal by Subject|1
57185|NCT01141205|216663|P2|Overall Study|Lost to Follow-up|0
57186|NCT01141205|216664|P1|Overall Study|Lost to Follow-up|1
57187|NCT01141205|216663|P2|Overall Study|Physician Decision|1
57188|NCT01141205|216664|P1|Overall Study|Physician Decision|1
57189|NCT01140906|216680|P4|Overall Study|Administrative or other reason|2
57190|NCT01140906|216681|P3|Overall Study|Administrative or other reason|3
57191|NCT01140906|216682|P2|Overall Study|Administrative or other reason|5
57192|NCT01140906|216683|P1|Overall Study|Administrative or other reason|0
57193|NCT01140906|216680|P4|Overall Study|Lost to Follow-up|2
57194|NCT01140906|216681|P3|Overall Study|Lost to Follow-up|0
57195|NCT01140906|216682|P2|Overall Study|Lost to Follow-up|1
57196|NCT01140906|216683|P1|Overall Study|Lost to Follow-up|1
57197|NCT01140906|216680|P4|Overall Study|Withdrawal of consent|2
57198|NCT01140906|216681|P3|Overall Study|Withdrawal of consent|2
57199|NCT01140906|216682|P2|Overall Study|Withdrawal of consent|6
57200|NCT01140906|216683|P1|Overall Study|Withdrawal of consent|6
57201|NCT01140906|216680|P4|Overall Study|Protocol Violation|1
57202|NCT01140906|216681|P3|Overall Study|Protocol Violation|2
57203|NCT01140906|216682|P2|Overall Study|Protocol Violation|3
57204|NCT01140906|216683|P1|Overall Study|Protocol Violation|5
57205|NCT01140906|216680|P4|Overall Study|Non-compliance|1
57206|NCT01140906|216681|P3|Overall Study|Non-compliance|0
57207|NCT01140906|216682|P2|Overall Study|Non-compliance|1
57208|NCT01140906|216683|P1|Overall Study|Non-compliance|0
57209|NCT01140906|216680|P4|Overall Study|Lack of Efficacy|1
57210|NCT01140906|216681|P3|Overall Study|Lack of Efficacy|2
57211|NCT01140906|216682|P2|Overall Study|Lack of Efficacy|8
57212|NCT01140906|216683|P1|Overall Study|Lack of Efficacy|6
57213|NCT01140906|216680|P4|Overall Study|Adverse Event|7
57214|NCT01140906|216681|P3|Overall Study|Adverse Event|17
57215|NCT01140906|216682|P2|Overall Study|Adverse Event|10
57216|NCT01140906|216683|P1|Overall Study|Adverse Event|7
57217|NCT01140880|216723|P2|Overall Study|Protocol Violation|30
57218|NCT01140880|216724|P1|Overall Study|Protocol Violation|0
57219|NCT01140880|216723|P2|Overall Study|Lost to Follow-up|10
57220|NCT01140880|216724|P1|Overall Study|Lost to Follow-up|8
57221|NCT01140880|216723|P2|Overall Study|Withdrawal by Subject|3
57222|NCT01140880|216724|P1|Overall Study|Withdrawal by Subject|6
57223|NCT01140880|216723|P2|Overall Study|Death|1
57224|NCT01140880|216724|P1|Overall Study|Death|0
57225|NCT01140867|216736|P1|Overall Study|Medication Noncompliance|2
57226|NCT01140867|216736|P1|Overall Study|Uncooperative patient|2
57227|NCT01140867|216736|P1|Overall Study|Protocol Violation|1
57228|NCT01140867|216736|P1|Overall Study|Withdrawal by Subject|1
57229|NCT01140867|216736|P1|Overall Study|Lost to Follow-up|2
57230|NCT01140867|216736|P1|Overall Study|Lack of Efficacy|3
57231|NCT01140867|216736|P1|Overall Study|Adverse Event|22
57232|NCT01140646|216776|P1|Overall Study|Refused Further Treatment|5
57233|NCT01140646|216776|P1|Overall Study|Adverse Event|4
57234|NCT01140503|216780|P1|Overall Study|Withdrawal by Subject|1
57235|NCT01140477|216788|P2|Overall Study|Subject explanted|1
57236|NCT01140477|216789|P1|Overall Study|Subject explanted|0
57237|NCT01140477|216788|P2|Overall Study|Death|1
57238|NCT01140477|216789|P1|Overall Study|Death|1
57239|NCT01140477|216788|P2|Overall Study|Surgical complication preventing implant|0
57240|NCT01140477|216789|P1|Overall Study|Surgical complication preventing implant|2
57241|NCT01140477|216788|P2|Overall Study|Withdrawal by Subject|4
57242|NCT01140477|216789|P1|Overall Study|Withdrawal by Subject|1
57243|NCT01140477|216788|P2|Overall Study|Lost to Follow-up|0
57244|NCT01140477|216789|P1|Overall Study|Lost to Follow-up|4
57245|NCT01140347|216800|P2|Overall Study|Withdrawal by Subject|8
57246|NCT01140347|216801|P1|Overall Study|Withdrawal by Subject|13
57247|NCT01140347|216800|P2|Overall Study|Lost to Follow-up|6
57248|NCT01140347|216801|P1|Overall Study|Lost to Follow-up|5
57249|NCT01140061|216845|P10|Extension|Laboratory Adverse Event|1
57250|NCT01140061|216846|P9|Extension|Laboratory Adverse Event|0
57251|NCT01140061|216847|P8|Extension|Laboratory Adverse Event|0
57252|NCT01140061|216848|P7|Extension|Laboratory Adverse Event|0
57253|NCT01140061|216849|P6|Extension|Laboratory Adverse Event|0
57254|NCT01140061|216850|P5|Extension|Laboratory Adverse Event|0
57255|NCT01140061|216851|P4|Extension|Laboratory Adverse Event|0
57256|NCT01140061|216852|P3|Extension|Laboratory Adverse Event|0
57257|NCT01140061|216853|P2|Extension|Laboratory Adverse Event|0
57258|NCT01140061|216854|P1|Extension|Laboratory Adverse Event|0
57259|NCT01140061|216845|P10|Part I|Adverse Event|0
57260|NCT01140061|216846|P9|Part I|Adverse Event|0
57261|NCT01140061|216847|P8|Part I|Adverse Event|0
57262|NCT01140061|216848|P7|Part I|Adverse Event|0
57263|NCT01140061|216849|P6|Part I|Adverse Event|0
57264|NCT01140061|216850|P5|Part I|Adverse Event|0
57265|NCT01140061|216851|P4|Part I|Adverse Event|0
57266|NCT01140061|216852|P3|Part I|Adverse Event|0
57267|NCT01140061|216853|P2|Part I|Adverse Event|0
57268|NCT01140061|216854|P1|Part I|Adverse Event|1
57269|NCT01140048|216881|P1|Overall Study|Lost to Follow-up|31
57270|NCT01140048|216881|P1|Overall Study|Withdrawal by Subject|13
57271|NCT01140048|216881|P1|Overall Study|Physician Decision|1
57272|NCT01139762|216900|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
57273|NCT01139762|216901|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
57274|NCT01139762|216902|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
57275|NCT01139762|216900|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
57276|NCT01139762|216901|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
57277|NCT01139762|216902|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
57278|NCT01139762|216900|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
57279|NCT01139762|216901|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
57280|NCT01139762|216902|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
57281|NCT01139762|216900|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
57282|NCT01139762|216901|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
57283|NCT01139762|216902|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
57284|NCT01139762|216900|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
57285|NCT01139762|216901|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
57286|NCT01139762|216902|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
57287|NCT01139762|216900|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
57288|NCT01139762|216901|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
57289|NCT01139762|216902|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
57290|NCT01139762|216900|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
57291|NCT01139762|216901|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
57292|NCT01139762|216902|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
57293|NCT01139762|216900|P3|Double-Blind Randomized Active Treatment|Death|1
57294|NCT01139762|216901|P2|Double-Blind Randomized Active Treatment|Death|1
57295|NCT01139762|216902|P1|Double-Blind Randomized Active Treatment|Death|0
57296|NCT01139762|216900|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
57297|NCT01139762|216901|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
57298|NCT01139762|216902|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
57299|NCT01139762|216900|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
57300|NCT01139762|216901|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
57301|NCT01139762|216902|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
57302|NCT01139762|216900|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
57303|NCT01139762|216901|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
57304|NCT01139762|216902|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
57305|NCT01139762|216900|P3|Washout and Placebo Lead-In Period|Physician Decision|0
57306|NCT01139762|216901|P2|Washout and Placebo Lead-In Period|Physician Decision|0
57307|NCT01139762|216902|P1|Washout and Placebo Lead-In Period|Physician Decision|12
57308|NCT01139762|216900|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
57309|NCT01139762|216901|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
57310|NCT01139762|216902|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
57311|NCT01139762|216900|P3|Washout and Placebo Lead-In Period|Adverse Event|0
57312|NCT01139762|216901|P2|Washout and Placebo Lead-In Period|Adverse Event|0
57313|NCT01139762|216902|P1|Washout and Placebo Lead-In Period|Adverse Event|1
57314|NCT01139762|216900|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
57315|NCT01139762|216901|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
57316|NCT01139762|216902|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
57317|NCT01139658|216937|P2|Overall Study|Not specified|75
57318|NCT01139658|216938|P1|Overall Study|Not specified|28
57319|NCT01139658|216937|P2|Overall Study|No documentation of treatment|0
57320|NCT01139658|216938|P1|Overall Study|No documentation of treatment|1
57321|NCT01139658|216937|P2|Overall Study|Withdrawal by Subject|4
57322|NCT01139658|216938|P1|Overall Study|Withdrawal by Subject|2
57323|NCT01139658|216937|P2|Overall Study|Lack of Efficacy|7
57324|NCT01139658|216938|P1|Overall Study|Lack of Efficacy|15
57325|NCT01139658|216937|P2|Overall Study|Adverse Event|27
57326|NCT01139658|216938|P1|Overall Study|Adverse Event|10
57327|NCT01139580|216976|P2|Overall Study|Participant Randomization in Error|1
57328|NCT01139580|216977|P1|Overall Study|Participant Randomization in Error|0
57329|NCT01139580|216976|P2|Overall Study|Beginning Study Exclusion Treatment|1
57330|NCT01139580|216977|P1|Overall Study|Beginning Study Exclusion Treatment|0
57331|NCT01139580|216976|P2|Overall Study|Misrandomized|0
57332|NCT01139580|216977|P1|Overall Study|Misrandomized|1
57333|NCT01139580|216976|P2|Overall Study|Did Not Meet Exclusion Criteria|0
57334|NCT01139580|216977|P1|Overall Study|Did Not Meet Exclusion Criteria|1
57335|NCT01139580|216976|P2|Overall Study|Used Excluded Medicine After Enrollment|0
57336|NCT01139580|216977|P1|Overall Study|Used Excluded Medicine After Enrollment|1
57337|NCT01139580|216976|P2|Overall Study|Withdrawal by Subject|9
57338|NCT01139580|216977|P1|Overall Study|Withdrawal by Subject|6
57339|NCT01139580|216976|P2|Overall Study|Lack of Efficacy|2
57340|NCT01139580|216977|P1|Overall Study|Lack of Efficacy|0
57341|NCT01139580|216976|P2|Overall Study|Lost to Follow-up|1
57342|NCT01139580|216977|P1|Overall Study|Lost to Follow-up|9
57343|NCT01139580|216976|P2|Overall Study|Adverse Event|4
57344|NCT01139580|216977|P1|Overall Study|Adverse Event|5
57345|NCT01139450|217025|P3|Overall Study|Adverse Event|3
57346|NCT01139450|217026|P2|Overall Study|Adverse Event|2
57347|NCT01139450|217027|P1|Overall Study|Adverse Event|2
57348|NCT01139450|217025|P3|Overall Study|Administrative|1
57349|NCT01139450|217026|P2|Overall Study|Administrative|0
57350|NCT01139450|217027|P1|Overall Study|Administrative|0
57351|NCT01139450|217025|P3|Overall Study|Lost to Follow-up|11
57352|NCT01139450|217026|P2|Overall Study|Lost to Follow-up|7
57353|NCT01139450|217027|P1|Overall Study|Lost to Follow-up|9
57354|NCT01139450|217025|P3|Overall Study|Protocol Violation|2
57355|NCT01139450|217026|P2|Overall Study|Protocol Violation|5
57356|NCT01139450|217027|P1|Overall Study|Protocol Violation|6
57357|NCT01139450|217025|P3|Overall Study|Lack of Efficacy|8
57358|NCT01139450|217026|P2|Overall Study|Lack of Efficacy|1
57359|NCT01139450|217027|P1|Overall Study|Lack of Efficacy|3
57360|NCT01139450|217025|P3|Overall Study|Withdrawal by Subject|13
57361|NCT01139450|217026|P2|Overall Study|Withdrawal by Subject|10
57362|NCT01139450|217027|P1|Overall Study|Withdrawal by Subject|7
57363|NCT01139164|217068|P3|Overall Study|Withdrawn prior to study start|0
57364|NCT01139164|217069|P2|Overall Study|Withdrawn prior to study start|2
57365|NCT01139164|217070|P1|Overall Study|Withdrawn prior to study start|0
57366|NCT01139125|217084|P1|Overall Study|Withdrawal by Subject|1
57367|NCT01139047|217088|P1|Overall Study|Withdrawal by Subject|1
57368|NCT01139021|217103|P6|Overall Study|Withdrawal by Subject|0
57369|NCT01139021|217104|P5|Overall Study|Withdrawal by Subject|4
57370|NCT01139021|217105|P4|Overall Study|Withdrawal by Subject|1
57371|NCT01139021|217106|P3|Overall Study|Withdrawal by Subject|0
57372|NCT01139021|217107|P2|Overall Study|Withdrawal by Subject|0
57373|NCT01139021|217108|P1|Overall Study|Withdrawal by Subject|0
57374|NCT01139021|217103|P6|Overall Study|Protocol Violation|0
57375|NCT01139021|217104|P5|Overall Study|Protocol Violation|2
57376|NCT01139021|217105|P4|Overall Study|Protocol Violation|0
57377|NCT01139021|217106|P3|Overall Study|Protocol Violation|0
57378|NCT01139021|217107|P2|Overall Study|Protocol Violation|0
57379|NCT01139021|217108|P1|Overall Study|Protocol Violation|1
57380|NCT01139021|217103|P6|Overall Study|Lost to Follow-up|0
57381|NCT01139021|217104|P5|Overall Study|Lost to Follow-up|2
57382|NCT01139021|217105|P4|Overall Study|Lost to Follow-up|0
57383|NCT01139021|217106|P3|Overall Study|Lost to Follow-up|0
57384|NCT01139021|217107|P2|Overall Study|Lost to Follow-up|0
57385|NCT01139021|217108|P1|Overall Study|Lost to Follow-up|0
57386|NCT01139021|217103|P6|Overall Study|Adverse Event|0
57387|NCT01139021|217104|P5|Overall Study|Adverse Event|1
57388|NCT01139021|217105|P4|Overall Study|Adverse Event|0
57389|NCT01139021|217106|P3|Overall Study|Adverse Event|0
57390|NCT01139021|217107|P2|Overall Study|Adverse Event|0
57391|NCT01139021|217108|P1|Overall Study|Adverse Event|0
57392|NCT01139008|217144|P1|Overall Study|Non-compliant, lost product|1
57393|NCT01139008|217144|P1|Overall Study|Withdrawal by Subject|5
57394|NCT01138826|217177|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
57395|NCT01138826|217178|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
57396|NCT01138826|217179|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
57397|NCT01138826|217180|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
57398|NCT01138826|217181|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
57399|NCT01138826|217182|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
57400|NCT01138657|217219|P2|Overall Study|Miscellaneous Reasons|4
57401|NCT01138657|217220|P1|Overall Study|Miscellaneous Reasons|3
57402|NCT01138657|217219|P2|Overall Study|Lost to Follow-up|3
57403|NCT01138657|217220|P1|Overall Study|Lost to Follow-up|0
57404|NCT01138657|217219|P2|Overall Study|Lack of Efficacy|1
57405|NCT01138657|217220|P1|Overall Study|Lack of Efficacy|2
57406|NCT01138657|217219|P2|Overall Study|Adverse Event|10
57407|NCT01138657|217220|P1|Overall Study|Adverse Event|3
57408|NCT01138501|217283|P1|Overall Study|Withdrawal by Subject|3
57409|NCT01138501|217283|P1|Overall Study|Protocol Violation|2
57410|NCT01138150|217290|P2|Overall Study|Physician Decision|0
57411|NCT01138150|217291|P1|Overall Study|Physician Decision|1
57412|NCT01138150|217290|P2|Overall Study|blood unable to be processed|1
57413|NCT01138150|217291|P1|Overall Study|blood unable to be processed|0
57414|NCT01138111|217372|P1|Overall Study|Lost to Follow-up|2
57415|NCT01138111|217372|P1|Overall Study|Death|1
57416|NCT01138111|217372|P1|Overall Study|Adverse Event|1
57417|NCT01138111|217372|P1|Overall Study|Withdrawal by Subject|5
57418|NCT01138046|217426|P1|Overall Study|Withdrawal due to death|6
57419|NCT01138007|217446|P3|Overall Study|Withdrawal by Subject|15
57420|NCT01138007|217447|P2|Overall Study|Withdrawal by Subject|6
57421|NCT01138007|217448|P1|Overall Study|Withdrawal by Subject|5
57422|NCT01138007|217446|P3|Overall Study|Physician Decision|3
57423|NCT01138007|217447|P2|Overall Study|Physician Decision|5
57424|NCT01138007|217448|P1|Overall Study|Physician Decision|0
57425|NCT01138007|217446|P3|Overall Study|Lost to Follow-up|5
57426|NCT01138007|217447|P2|Overall Study|Lost to Follow-up|3
57427|NCT01138007|217448|P1|Overall Study|Lost to Follow-up|3
57428|NCT01138007|217446|P3|Overall Study|Protocol-Defined Stopping Criteria|8
57429|NCT01138007|217447|P2|Overall Study|Protocol-Defined Stopping Criteria|1
57430|NCT01138007|217448|P1|Overall Study|Protocol-Defined Stopping Criteria|6
57431|NCT01138007|217446|P3|Overall Study|Protocol Violation|2
57432|NCT01138007|217447|P2|Overall Study|Protocol Violation|3
57433|NCT01138007|217448|P1|Overall Study|Protocol Violation|2
57434|NCT01138007|217446|P3|Overall Study|Lack of Efficacy|6
57435|NCT01138007|217447|P2|Overall Study|Lack of Efficacy|0
57436|NCT01138007|217448|P1|Overall Study|Lack of Efficacy|2
57437|NCT01138007|217446|P3|Overall Study|Adverse Event|9
57438|NCT01138007|217447|P2|Overall Study|Adverse Event|12
57439|NCT01138007|217448|P1|Overall Study|Adverse Event|4
57440|NCT01137812|217482|P2|Overall Study|Not specified|27
57441|NCT01137812|217483|P1|Overall Study|Not specified|19
57442|NCT01137812|217482|P2|Overall Study|Patient met glycemic withdrawal criteria|85
57443|NCT01137812|217483|P1|Overall Study|Patient met glycemic withdrawal criteria|40
57444|NCT01137812|217482|P2|Overall Study|Death|0
57445|NCT01137812|217483|P1|Overall Study|Death|2
57446|NCT01137812|217482|P2|Overall Study|Withdrawal by Subject|13
57447|NCT01137812|217483|P1|Overall Study|Withdrawal by Subject|5
57448|NCT01137812|217482|P2|Overall Study|Protocol Violation|4
57449|NCT01137812|217483|P1|Overall Study|Protocol Violation|5
57450|NCT01137812|217482|P2|Overall Study|Physician Decision|17
57451|NCT01137812|217483|P1|Overall Study|Physician Decision|25
57452|NCT01137812|217482|P2|Overall Study|Lost to Follow-up|8
57453|NCT01137812|217483|P1|Overall Study|Lost to Follow-up|6
57454|NCT01137812|217482|P2|Overall Study|Adverse Event|14
57455|NCT01137812|217483|P1|Overall Study|Adverse Event|21
57456|NCT01137786|217503|P2|Overall Study|Withdrawal by Subject|1
57457|NCT01137786|217504|P1|Overall Study|Withdrawal by Subject|1
57458|NCT01137786|217503|P2|Overall Study|Lost to Follow-up|2
57459|NCT01137786|217504|P1|Overall Study|Lost to Follow-up|0
57460|NCT01137682|217515|P3|Overall Study|Protocol Violation|1
57461|NCT01137682|217516|P2|Overall Study|Protocol Violation|1
57462|NCT01137682|217517|P1|Overall Study|Protocol Violation|0
57463|NCT01137682|217515|P3|Overall Study|Administrative Problems|0
57464|NCT01137682|217516|P2|Overall Study|Administrative Problems|1
57465|NCT01137682|217517|P1|Overall Study|Administrative Problems|2
57466|NCT01137682|217515|P3|Overall Study|Withdrawal by Subject|2
57467|NCT01137682|217516|P2|Overall Study|Withdrawal by Subject|2
57468|NCT01137682|217517|P1|Overall Study|Withdrawal by Subject|2
57469|NCT01137682|217515|P3|Overall Study|Adverse Event|0
57470|NCT01137682|217516|P2|Overall Study|Adverse Event|4
57471|NCT01137682|217517|P1|Overall Study|Adverse Event|2
57472|NCT01137604|217532|P4|Overall Study|Clinical Decline|1
57473|NCT01137604|217533|P3|Overall Study|Clinical Decline|1
57474|NCT01137604|217534|P2|Overall Study|Clinical Decline|0
57475|NCT01137604|217535|P1|Overall Study|Clinical Decline|0
57476|NCT01137604|217532|P4|Overall Study|Participant's Decision|0
57477|NCT01137604|217533|P3|Overall Study|Participant's Decision|0
57478|NCT01137604|217534|P2|Overall Study|Participant's Decision|0
57479|NCT01137604|217535|P1|Overall Study|Participant's Decision|1
57480|NCT01137604|217532|P4|Overall Study|Clinical Progression|0
57481|NCT01137604|217533|P3|Overall Study|Clinical Progression|1
57482|NCT01137604|217534|P2|Overall Study|Clinical Progression|2
57483|NCT01137604|217535|P1|Overall Study|Clinical Progression|0
57484|NCT01137604|217532|P4|Overall Study|Withdrawal by Subject|1
57485|NCT01137604|217533|P3|Overall Study|Withdrawal by Subject|2
57486|NCT01137604|217534|P2|Overall Study|Withdrawal by Subject|2
57487|NCT01137604|217535|P1|Overall Study|Withdrawal by Subject|0
57488|NCT01137604|217532|P4|Overall Study|Adverse Event|9
57489|NCT01137604|217533|P3|Overall Study|Adverse Event|9
57490|NCT01137604|217534|P2|Overall Study|Adverse Event|6
57491|NCT01137604|217535|P1|Overall Study|Adverse Event|1
57492|NCT01137578|217569|P3|Overall Study|Not Specified|6
57493|NCT01137578|217570|P2|Overall Study|Not Specified|2
57494|NCT01137578|217571|P1|Overall Study|Not Specified|12
57495|NCT01137578|217569|P3|Overall Study|Withdrawal by Subject|0
57496|NCT01137578|217570|P2|Overall Study|Withdrawal by Subject|0
57497|NCT01137578|217571|P1|Overall Study|Withdrawal by Subject|1
57498|NCT01137578|217569|P3|Overall Study|Participant requested to Discontinue|0
57499|NCT01137578|217570|P2|Overall Study|Participant requested to Discontinue|0
57500|NCT01137578|217571|P1|Overall Study|Participant requested to Discontinue|3
57501|NCT01137474|217615|P4|Overall Study|Administrative reason by sponsor|0
57502|NCT01137474|217616|P3|Overall Study|Administrative reason by sponsor|0
57503|NCT01137474|217617|P2|Overall Study|Administrative reason by sponsor|1
57504|NCT01137474|217618|P1|Overall Study|Administrative reason by sponsor|0
57505|NCT01137474|217615|P4|Overall Study|Pregnancy|0
57506|NCT01137474|217616|P3|Overall Study|Pregnancy|0
57507|NCT01137474|217617|P2|Overall Study|Pregnancy|1
57508|NCT01137474|217618|P1|Overall Study|Pregnancy|0
57509|NCT01137474|217615|P4|Overall Study|Not specified|0
57510|NCT01137474|217616|P3|Overall Study|Not specified|0
57511|NCT01137474|217617|P2|Overall Study|Not specified|1
57512|NCT01137474|217618|P1|Overall Study|Not specified|3
57513|NCT01137474|217615|P4|Overall Study|Lack of Efficacy|2
57514|NCT01137474|217616|P3|Overall Study|Lack of Efficacy|0
57515|NCT01137474|217617|P2|Overall Study|Lack of Efficacy|0
57516|NCT01137474|217618|P1|Overall Study|Lack of Efficacy|0
57517|NCT01137474|217615|P4|Overall Study|Lost to Follow-up|2
57518|NCT01137474|217616|P3|Overall Study|Lost to Follow-up|0
57519|NCT01137474|217617|P2|Overall Study|Lost to Follow-up|1
57520|NCT01137474|217618|P1|Overall Study|Lost to Follow-up|5
57521|NCT01137474|217615|P4|Overall Study|No longer met study criteria|5
57522|NCT01137474|217616|P3|Overall Study|No longer met study criteria|0
57523|NCT01137474|217617|P2|Overall Study|No longer met study criteria|1
57524|NCT01137474|217618|P1|Overall Study|No longer met study criteria|6
57525|NCT01137474|217615|P4|Overall Study|Withdrawal by Subject|9
57526|NCT01137474|217616|P3|Overall Study|Withdrawal by Subject|6
57527|NCT01137474|217617|P2|Overall Study|Withdrawal by Subject|2
57528|NCT01137474|217618|P1|Overall Study|Withdrawal by Subject|7
57529|NCT01137474|217615|P4|Overall Study|Adverse Event|3
57530|NCT01137474|217616|P3|Overall Study|Adverse Event|1
57531|NCT01137474|217617|P2|Overall Study|Adverse Event|5
57532|NCT01137474|217618|P1|Overall Study|Adverse Event|3
57533|NCT01137435|217636|P1|Overall Study|Off label usage|4
57534|NCT01137435|217636|P1|Overall Study|Lost to Follow-up|24
57535|NCT01137292|217663|P1|Overall Study|Unspecified|7
57536|NCT01137292|217663|P1|Overall Study|Lost to Follow-up|1
57537|NCT01137292|217663|P1|Overall Study|Lack of Efficacy|13
57538|NCT01137292|217663|P1|Overall Study|Adverse Event|3
57539|NCT01137292|217663|P1|Overall Study|Death|30
57540|NCT01137071|217670|P1|Overall Study|Wrongly Included|1
57541|NCT01137071|217670|P1|Overall Study|Withdrawal by Subject|2
57542|NCT01137071|217670|P1|Overall Study|Disease Progression|11
57543|NCT01136967|217739|P2|Overall Study|Diagnosis of Second Primary Cancer|1
57544|NCT01136967|217740|P1|Overall Study|Diagnosis of Second Primary Cancer|0
57545|NCT01136967|217739|P2|Overall Study|Increase in Lesion Size|2
57546|NCT01136967|217740|P1|Overall Study|Increase in Lesion Size|0
57547|NCT01136967|217739|P2|Overall Study|Investigator's Choice|1
57548|NCT01136967|217740|P1|Overall Study|Investigator's Choice|1
57549|NCT01136967|217739|P2|Overall Study|Non Compliance|0
57550|NCT01136967|217740|P1|Overall Study|Non Compliance|1
57551|NCT01136967|217739|P2|Overall Study|Radiation|0
57552|NCT01136967|217740|P1|Overall Study|Radiation|1
57553|NCT01136967|217739|P2|Overall Study|Clinical Progression|5
57554|NCT01136967|217740|P1|Overall Study|Clinical Progression|3
57555|NCT01136967|217739|P2|Overall Study|Withdrawal by Subject|2
57556|NCT01136967|217740|P1|Overall Study|Withdrawal by Subject|1
57557|NCT01136967|217739|P2|Overall Study|Lost to Follow-up|1
57558|NCT01136967|217740|P1|Overall Study|Lost to Follow-up|0
57559|NCT01136967|217739|P2|Overall Study|Participant Choice|3
57560|NCT01136967|217740|P1|Overall Study|Participant Choice|8
57561|NCT01136967|217739|P2|Overall Study|Adverse Event|12
57562|NCT01136967|217740|P1|Overall Study|Adverse Event|9
57563|NCT01136954|217758|P2|Overall Study|Not Specified|3
57564|NCT01136954|217759|P1|Overall Study|Not Specified|1
57565|NCT01136954|217758|P2|Overall Study|Physician Decision|1
57566|NCT01136954|217759|P1|Overall Study|Physician Decision|0
57567|NCT01136954|217758|P2|Overall Study|Lack of Efficacy|13
57568|NCT01136954|217759|P1|Overall Study|Lack of Efficacy|14
57569|NCT01136954|217758|P2|Overall Study|Withdrawal by Subject|2
57570|NCT01136954|217759|P1|Overall Study|Withdrawal by Subject|6
57571|NCT01136954|217758|P2|Overall Study|Adverse Event|2
57572|NCT01136954|217759|P1|Overall Study|Adverse Event|3
57573|NCT01136915|217773|P2|Overall Study|Exclusion criterion met|1
57574|NCT01136915|217774|P1|Overall Study|Exclusion criterion met|0
57575|NCT01136915|217773|P2|Overall Study|Lost to Follow-up|0
57576|NCT01136915|217774|P1|Overall Study|Lost to Follow-up|2
57577|NCT01136876|217784|P2|Overall Study|Physician Decision|5
57578|NCT01136876|217785|P1|Overall Study|Physician Decision|3
57579|NCT01136876|217784|P2|Overall Study|Lost to Follow-up|1
57580|NCT01136876|217785|P1|Overall Study|Lost to Follow-up|0
57581|NCT01136772|217795|P2|Overall Study|Did not follow up after first injection|2
57582|NCT01136772|217796|P1|Overall Study|Did not follow up after first injection|2
57583|NCT01136772|217795|P2|Overall Study|Did not receive injection|7
57584|NCT01136772|217796|P1|Overall Study|Did not receive injection|10
57585|NCT01136772|217795|P2|Overall Study|Withdrawal by Subject|36
57586|NCT01136772|217796|P1|Overall Study|Withdrawal by Subject|33
57587|NCT01136772|217795|P2|Overall Study|Administrative|12
57588|NCT01136772|217796|P1|Overall Study|Administrative|14
57589|NCT01136772|217795|P2|Overall Study|Lack of Efficacy|39
57590|NCT01136772|217796|P1|Overall Study|Lack of Efficacy|42
57591|NCT01136772|217795|P2|Overall Study|Adverse Event|14
57592|NCT01136772|217796|P1|Overall Study|Adverse Event|15
57593|NCT01136746|217806|P2|Overall Study|Death|0
57594|NCT01136746|217807|P1|Overall Study|Death|1
57595|NCT01136746|217806|P2|Overall Study|Protocol Violation|1
57596|NCT01136746|217807|P1|Overall Study|Protocol Violation|2
57597|NCT01136746|217806|P2|Overall Study|Lost to Follow-up|2
57598|NCT01136746|217807|P1|Overall Study|Lost to Follow-up|0
57599|NCT01136655|217867|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
57600|NCT01136655|217867|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
57601|NCT01136655|217867|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
57602|NCT01136655|217867|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
57603|NCT01136408|217900|P3|Overall Study|Protocol Violation|1
57604|NCT01136408|217901|P2|Overall Study|Protocol Violation|1
57605|NCT01136408|217902|P1|Overall Study|Protocol Violation|1
57606|NCT01136408|217900|P3|Overall Study|Adverse Event|4
57607|NCT01136408|217901|P2|Overall Study|Adverse Event|8
57608|NCT01136408|217902|P1|Overall Study|Adverse Event|4
57609|NCT01136382|217959|P2|Overall Study|Withdrawal by Subject|1
57610|NCT01136382|217960|P1|Overall Study|Withdrawal by Subject|4
57611|NCT01136382|217959|P2|Overall Study|Severe Non-Compliance to Protocol|2
57612|NCT01136382|217960|P1|Overall Study|Severe Non-Compliance to Protocol|0
57613|NCT01136382|217959|P2|Overall Study|Study-Specific Withdrawal Criteria|25
57614|NCT01136382|217960|P1|Overall Study|Study-Specific Withdrawal Criteria|48
57615|NCT01136382|217959|P2|Overall Study|Not Specified|3
57616|NCT01136382|217960|P1|Overall Study|Not Specified|8
57617|NCT01136291|217988|P2|Overall Study|Lost to Follow-up|1
57618|NCT01136291|217989|P1|Overall Study|Lost to Follow-up|1
57619|NCT01136174|218007|P4|Overall Study|Adverse Event|4
57620|NCT01136174|218008|P3|Overall Study|Adverse Event|0
57621|NCT01136174|218009|P2|Overall Study|Adverse Event|0
57622|NCT01136174|218010|P1|Overall Study|Adverse Event|0
57623|NCT01135992|218090|P1|Overall Study|Unclassified|7
57624|NCT01135992|218090|P1|Overall Study|Withdrawal criteria|10
57625|NCT01135992|218090|P1|Overall Study|Protocol Violation|2
57626|NCT01135992|218090|P1|Overall Study|Lack of Efficacy|1
57627|NCT01135992|218090|P1|Overall Study|Adverse Event|1
57628|NCT01135914|218102|P3|Overall Study|Adverse Event|2
57629|NCT01135914|218103|P2|Overall Study|Adverse Event|1
57630|NCT01135914|218104|P1|Overall Study|Adverse Event|0
57631|NCT01135914|218102|P3|Overall Study|Lack of Efficacy|10
57632|NCT01135914|218103|P2|Overall Study|Lack of Efficacy|1
57633|NCT01135914|218104|P1|Overall Study|Lack of Efficacy|2
57634|NCT01135914|218102|P3|Overall Study|Protocol Violation|3
57635|NCT01135914|218103|P2|Overall Study|Protocol Violation|0
57636|NCT01135914|218104|P1|Overall Study|Protocol Violation|0
57637|NCT01135914|218102|P3|Overall Study|Lost to Follow-up|1
57638|NCT01135914|218103|P2|Overall Study|Lost to Follow-up|0
57639|NCT01135914|218104|P1|Overall Study|Lost to Follow-up|1
57640|NCT01135914|218102|P3|Overall Study|Withdrawal by Subject|6
57641|NCT01135914|218103|P2|Overall Study|Withdrawal by Subject|3
57642|NCT01135914|218104|P1|Overall Study|Withdrawal by Subject|1
57643|NCT01135524|218133|P1|Overall Study|Lack of Efficacy|8
57644|NCT01135524|218133|P1|Overall Study|Administrative|151
57645|NCT01135524|218133|P1|Overall Study|Lost to Follow-up|3
57646|NCT01135524|218133|P1|Overall Study|Adverse Event|20
57647|NCT01135524|218133|P1|Overall Study|Withdrawal by Subject|14
57648|NCT01135511|218146|P9|Overall Study|Withdrawal by Subject|1
57649|NCT01135511|218147|P8|Overall Study|Withdrawal by Subject|0
57650|NCT01135511|218148|P7|Overall Study|Withdrawal by Subject|1
57651|NCT01135511|218149|P6|Overall Study|Withdrawal by Subject|0
57652|NCT01135511|218150|P5|Overall Study|Withdrawal by Subject|0
57653|NCT01135511|218151|P4|Overall Study|Withdrawal by Subject|0
57654|NCT01135511|218152|P3|Overall Study|Withdrawal by Subject|0
57655|NCT01135511|218153|P2|Overall Study|Withdrawal by Subject|0
57656|NCT01135511|218154|P1|Overall Study|Withdrawal by Subject|0
57657|NCT01135511|218146|P9|Overall Study|noncompliance with study drug taken|0
57658|NCT01135511|218147|P8|Overall Study|noncompliance with study drug taken|0
57659|NCT01135511|218148|P7|Overall Study|noncompliance with study drug taken|0
57660|NCT01135511|218149|P6|Overall Study|noncompliance with study drug taken|0
57661|NCT01135511|218150|P5|Overall Study|noncompliance with study drug taken|1
57662|NCT01135511|218151|P4|Overall Study|noncompliance with study drug taken|0
57663|NCT01135511|218152|P3|Overall Study|noncompliance with study drug taken|0
57664|NCT01135511|218153|P2|Overall Study|noncompliance with study drug taken|0
57665|NCT01135511|218154|P1|Overall Study|noncompliance with study drug taken|0
57666|NCT01135511|218146|P9|Overall Study|could not visit the clinic|0
57667|NCT01135511|218147|P8|Overall Study|could not visit the clinic|0
57668|NCT01135511|218148|P7|Overall Study|could not visit the clinic|0
57669|NCT01135511|218149|P6|Overall Study|could not visit the clinic|0
57670|NCT01135511|218150|P5|Overall Study|could not visit the clinic|0
57671|NCT01135511|218151|P4|Overall Study|could not visit the clinic|0
57672|NCT01135511|218152|P3|Overall Study|could not visit the clinic|2
57673|NCT01135511|218153|P2|Overall Study|could not visit the clinic|1
57674|NCT01135511|218154|P1|Overall Study|could not visit the clinic|0
57675|NCT01135511|218146|P9|Overall Study|Pregnancy|0
57676|NCT01135511|218147|P8|Overall Study|Pregnancy|0
57677|NCT01135511|218148|P7|Overall Study|Pregnancy|0
57678|NCT01135511|218149|P6|Overall Study|Pregnancy|0
57679|NCT01135511|218150|P5|Overall Study|Pregnancy|0
57680|NCT01135511|218151|P4|Overall Study|Pregnancy|1
57681|NCT01135511|218152|P3|Overall Study|Pregnancy|0
57682|NCT01135511|218153|P2|Overall Study|Pregnancy|0
57683|NCT01135511|218154|P1|Overall Study|Pregnancy|0
57684|NCT01135511|218146|P9|Overall Study|Protocol Violation|0
57685|NCT01135511|218147|P8|Overall Study|Protocol Violation|0
57686|NCT01135511|218148|P7|Overall Study|Protocol Violation|0
57687|NCT01135511|218149|P6|Overall Study|Protocol Violation|0
57688|NCT01135511|218150|P5|Overall Study|Protocol Violation|0
57689|NCT01135511|218151|P4|Overall Study|Protocol Violation|0
57690|NCT01135511|218152|P3|Overall Study|Protocol Violation|3
57691|NCT01135511|218153|P2|Overall Study|Protocol Violation|0
57692|NCT01135511|218154|P1|Overall Study|Protocol Violation|0
57693|NCT01135511|218146|P9|Overall Study|Lack of Efficacy|0
57694|NCT01135511|218147|P8|Overall Study|Lack of Efficacy|0
57695|NCT01135511|218148|P7|Overall Study|Lack of Efficacy|0
57696|NCT01135511|218149|P6|Overall Study|Lack of Efficacy|0
57697|NCT01135511|218150|P5|Overall Study|Lack of Efficacy|0
57698|NCT01135511|218151|P4|Overall Study|Lack of Efficacy|2
57699|NCT01135511|218152|P3|Overall Study|Lack of Efficacy|1
57700|NCT01135511|218153|P2|Overall Study|Lack of Efficacy|1
57701|NCT01135511|218154|P1|Overall Study|Lack of Efficacy|0
57702|NCT01135511|218146|P9|Overall Study|Adverse Event|0
57703|NCT01135511|218147|P8|Overall Study|Adverse Event|1
57704|NCT01135511|218148|P7|Overall Study|Adverse Event|0
57705|NCT01135511|218149|P6|Overall Study|Adverse Event|1
57706|NCT01135511|218150|P5|Overall Study|Adverse Event|0
57707|NCT01135511|218151|P4|Overall Study|Adverse Event|0
57708|NCT01135511|218152|P3|Overall Study|Adverse Event|2
57709|NCT01135511|218153|P2|Overall Study|Adverse Event|1
57710|NCT01135511|218154|P1|Overall Study|Adverse Event|0
57711|NCT01135498|218436|P1|Overall Study|Ongoing at time of analysis|2
57712|NCT01135498|218436|P1|Overall Study|Death|1
57713|NCT01135498|218436|P1|Overall Study|Withdrawal by Subject|4
57714|NCT01135498|218436|P1|Overall Study|Investigator judgement|25
57715|NCT01135498|218436|P1|Overall Study|Progressive disease|38
57716|NCT01135498|218436|P1|Overall Study|Adverse Event|20
57717|NCT01135134|218597|P2|Overall Study|Did not meet protocol eligibility|0
57718|NCT01135134|218598|P1|Overall Study|Did not meet protocol eligibility|1
57719|NCT01135134|218597|P2|Overall Study|Adverse Event|1
57720|NCT01135134|218598|P1|Overall Study|Adverse Event|1
57721|NCT01135017|218621|P2|Overall Study|Other than above|4
57722|NCT01135017|218622|P1|Overall Study|Other than above|3
57723|NCT01135017|218621|P2|Overall Study|Adverse Event|8
57724|NCT01135017|218622|P1|Overall Study|Adverse Event|3
57725|NCT01134939|218660|P8|Overall Study|Termination page not available|0
57726|NCT01134939|218661|P7|Overall Study|Termination page not available|7
57727|NCT01134939|218662|P6|Overall Study|Termination page not available|3
57728|NCT01134939|218663|P5|Overall Study|Termination page not available|0
57729|NCT01134939|218664|P4|Overall Study|Termination page not available|8
57730|NCT01134939|218665|P3|Overall Study|Termination page not available|5
57731|NCT01134939|218666|P2|Overall Study|Termination page not available|6
57732|NCT01134939|218667|P1|Overall Study|Termination page not available|4
57733|NCT01134939|218660|P8|Overall Study|Death|0
57734|NCT01134939|218661|P7|Overall Study|Death|0
57735|NCT01134939|218662|P6|Overall Study|Death|0
57736|NCT01134939|218663|P5|Overall Study|Death|0
57737|NCT01134939|218664|P4|Overall Study|Death|0
57738|NCT01134939|218665|P3|Overall Study|Death|0
57739|NCT01134939|218666|P2|Overall Study|Death|1
57740|NCT01134939|218667|P1|Overall Study|Death|0
57741|NCT01134939|218660|P8|Overall Study|Lost to Follow-up|0
57742|NCT01134939|218661|P7|Overall Study|Lost to Follow-up|0
57743|NCT01134939|218662|P6|Overall Study|Lost to Follow-up|1
57744|NCT01134939|218663|P5|Overall Study|Lost to Follow-up|2
57745|NCT01134939|218664|P4|Overall Study|Lost to Follow-up|1
57746|NCT01134939|218665|P3|Overall Study|Lost to Follow-up|0
57747|NCT01134939|218666|P2|Overall Study|Lost to Follow-up|3
57748|NCT01134939|218667|P1|Overall Study|Lost to Follow-up|2
57749|NCT01134939|218660|P8|Overall Study|Lack of Efficacy|0
57750|NCT01134939|218661|P7|Overall Study|Lack of Efficacy|1
57751|NCT01134939|218662|P6|Overall Study|Lack of Efficacy|0
57752|NCT01134939|218663|P5|Overall Study|Lack of Efficacy|3
57753|NCT01134939|218664|P4|Overall Study|Lack of Efficacy|0
57754|NCT01134939|218665|P3|Overall Study|Lack of Efficacy|1
57755|NCT01134939|218666|P2|Overall Study|Lack of Efficacy|5
57756|NCT01134939|218667|P1|Overall Study|Lack of Efficacy|2
57757|NCT01134939|218660|P8|Overall Study|Adverse Event|0
57758|NCT01134939|218661|P7|Overall Study|Adverse Event|1
57759|NCT01134939|218662|P6|Overall Study|Adverse Event|5
57760|NCT01134939|218663|P5|Overall Study|Adverse Event|5
57761|NCT01134939|218664|P4|Overall Study|Adverse Event|5
57762|NCT01134939|218665|P3|Overall Study|Adverse Event|4
57763|NCT01134939|218666|P2|Overall Study|Adverse Event|3
57764|NCT01134939|218667|P1|Overall Study|Adverse Event|9
57765|NCT01134783|218805|P2|Overall Study|Lost to Follow-up|20
57766|NCT01134783|218806|P1|Overall Study|Lost to Follow-up|5
57767|NCT01134783|218805|P2|Overall Study|Withdrawal by Subject|9
57768|NCT01134783|218806|P1|Overall Study|Withdrawal by Subject|15
57769|NCT01134783|218805|P2|Overall Study|Pregnancy|8
57770|NCT01134783|218806|P1|Overall Study|Pregnancy|16
57771|NCT01134731|218825|P3|Overall Study|Lost to Follow-up|3
57772|NCT01134731|218826|P2|Overall Study|Lost to Follow-up|4
57773|NCT01134731|218827|P1|Overall Study|Lost to Follow-up|5
57774|NCT01134731|218825|P3|Overall Study|Withdrawal by Subject|1
57775|NCT01134731|218826|P2|Overall Study|Withdrawal by Subject|3
57776|NCT01134731|218827|P1|Overall Study|Withdrawal by Subject|3
57777|NCT01134731|218825|P3|Overall Study|Lack of Efficacy|1
57778|NCT01134731|218826|P2|Overall Study|Lack of Efficacy|0
57779|NCT01134731|218827|P1|Overall Study|Lack of Efficacy|0
57780|NCT01134731|218825|P3|Overall Study|Physician Decision|2
57781|NCT01134731|218826|P2|Overall Study|Physician Decision|2
57782|NCT01134731|218827|P1|Overall Study|Physician Decision|2
57783|NCT01134731|218825|P3|Overall Study|Adverse Event|1
57784|NCT01134731|218826|P2|Overall Study|Adverse Event|2
57785|NCT01134731|218827|P1|Overall Study|Adverse Event|3
57786|NCT01134705|218840|P2|Overall Study|Other|6
57787|NCT01134705|218841|P1|Overall Study|Other|1
57788|NCT01134705|218840|P2|Overall Study|Protocol Violation|1
57789|NCT01134705|218841|P1|Overall Study|Protocol Violation|1
57790|NCT01134705|218840|P2|Overall Study|Lost to Follow-up|2
57791|NCT01134705|218841|P1|Overall Study|Lost to Follow-up|5
57792|NCT01134705|218840|P2|Overall Study|Pregnancy|0
57793|NCT01134705|218841|P1|Overall Study|Pregnancy|1
57794|NCT01134705|218840|P2|Overall Study|Withdrawal by Subject|6
57795|NCT01134705|218841|P1|Overall Study|Withdrawal by Subject|6
57796|NCT01134705|218840|P2|Overall Study|Adverse Event|7
57797|NCT01134705|218841|P1|Overall Study|Adverse Event|1
57798|NCT01134627|218853|P2|Overall Study|Unspecified|14
57799|NCT01134627|218854|P1|Overall Study|Unspecified|11
57800|NCT01134627|218853|P2|Overall Study|Planning to become pregnant/pregnancy|0
57801|NCT01134627|218854|P1|Overall Study|Planning to become pregnant/pregnancy|1
57802|NCT01134627|218853|P2|Overall Study|Withdrawal by Subject|3
57803|NCT01134627|218854|P1|Overall Study|Withdrawal by Subject|4
57804|NCT01134627|218853|P2|Overall Study|Lack of Efficacy|12
57805|NCT01134627|218854|P1|Overall Study|Lack of Efficacy|2
57806|NCT01134627|218853|P2|Overall Study|Protocol Violation|5
57807|NCT01134627|218854|P1|Overall Study|Protocol Violation|3
57808|NCT01134627|218853|P2|Overall Study|Lost to Follow-up|2
57809|NCT01134627|218854|P1|Overall Study|Lost to Follow-up|1
57810|NCT01134627|218853|P2|Overall Study|Adverse Event|31
57811|NCT01134627|218854|P1|Overall Study|Adverse Event|47
57812|NCT01134614|218884|P2|Overall Study|Patient in hospice care|1
57813|NCT01134614|218885|P1|Overall Study|Patient in hospice care|0
57814|NCT01134614|218884|P2|Overall Study|Symptomatic deterioration|1
57815|NCT01134614|218885|P1|Overall Study|Symptomatic deterioration|0
57816|NCT01134614|218884|P2|Overall Study|Pt received tx not allowed on study|1
57817|NCT01134614|218885|P1|Overall Study|Pt received tx not allowed on study|0
57818|NCT01134614|218884|P2|Overall Study|Never started treatment|1
57819|NCT01134614|218885|P1|Overall Study|Never started treatment|4
57820|NCT01134614|218884|P2|Overall Study|Physician's decision|1
57821|NCT01134614|218885|P1|Overall Study|Physician's decision|0
57822|NCT01134614|218884|P2|Overall Study|Complicating disease|1
57823|NCT01134614|218885|P1|Overall Study|Complicating disease|2
57824|NCT01134614|218884|P2|Overall Study|Alternative therapy|0
57825|NCT01134614|218885|P1|Overall Study|Alternative therapy|2
57826|NCT01134614|218884|P2|Overall Study|Withdrawal by Subject|2
57827|NCT01134614|218885|P1|Overall Study|Withdrawal by Subject|3
57828|NCT01134614|218884|P2|Overall Study|Death|8
57829|NCT01134614|218885|P1|Overall Study|Death|5
57830|NCT01134614|218884|P2|Overall Study|Adverse Event|39
57831|NCT01134614|218885|P1|Overall Study|Adverse Event|26
57832|NCT01134614|218884|P2|Overall Study|Progressive disease|54
57833|NCT01134614|218885|P1|Overall Study|Progressive disease|60
57834|NCT01134614|218884|P2|Overall Study|Still on treatment as of March 2013|13
57835|NCT01134614|218885|P1|Overall Study|Still on treatment as of March 2013|21
57836|NCT01134393|218910|P1|Overall Study|Other|6
57837|NCT01134393|218910|P1|Overall Study|Withdrawal by Subject|11
57838|NCT01134393|218910|P1|Overall Study|Lost to Follow-up|3
57839|NCT01134393|218910|P1|Overall Study|Protocol Violation|12
57840|NCT01134393|218910|P1|Overall Study|Lack of Efficacy|2
57841|NCT01134393|218910|P1|Overall Study|Adverse Event|18
57842|NCT01134315|218926|P2|Overall Study|Other Reason|17
57843|NCT01134315|218927|P1|Overall Study|Other Reason|8
57844|NCT01134315|218926|P2|Overall Study|Adverse Event|2
57845|NCT01134315|218927|P1|Overall Study|Adverse Event|1
57846|NCT01134107|218962|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
57847|NCT01134107|218963|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
57848|NCT01134107|218962|P2|Period 2-Second Treatment Intervention|Physician Decision|0
57849|NCT01134107|218963|P1|Period 2-Second Treatment Intervention|Physician Decision|1
57850|NCT01134107|218962|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
57851|NCT01134107|218963|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
57852|NCT01134107|218962|P2|Period 1-First Treatment Intervention|Physician Decision|0
57853|NCT01134107|218963|P1|Period 1-First Treatment Intervention|Physician Decision|1
57854|NCT01134107|218962|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
57855|NCT01134107|218963|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
57856|NCT01134107|218962|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
57857|NCT01134107|218963|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
57858|NCT01134107|218962|P2|Period 1-First Treatment Intervention|Adverse Event|0
57859|NCT01134107|218963|P1|Period 1-First Treatment Intervention|Adverse Event|1
57860|NCT01134042|218998|P3|Overall Study|Withdrawal by Subject|7
57861|NCT01134042|218999|P2|Overall Study|Withdrawal by Subject|4
57862|NCT01134042|219000|P1|Overall Study|Withdrawal by Subject|13
57863|NCT01134042|218998|P3|Overall Study|Physician Decision|1
57864|NCT01134042|218999|P2|Overall Study|Physician Decision|8
57865|NCT01134042|219000|P1|Overall Study|Physician Decision|4
57866|NCT01134042|218998|P3|Overall Study|Lost to Follow-up|1
57867|NCT01134042|218999|P2|Overall Study|Lost to Follow-up|0
57868|NCT01134042|219000|P1|Overall Study|Lost to Follow-up|2
57869|NCT01134042|218998|P3|Overall Study|Protocol Violation|5
57870|NCT01134042|218999|P2|Overall Study|Protocol Violation|3
57871|NCT01134042|219000|P1|Overall Study|Protocol Violation|5
57872|NCT01134042|218998|P3|Overall Study|Lack of Efficacy|18
57873|NCT01134042|218999|P2|Overall Study|Lack of Efficacy|6
57874|NCT01134042|219000|P1|Overall Study|Lack of Efficacy|21
57875|NCT01134042|218998|P3|Overall Study|Adverse Event|2
57876|NCT01134042|218999|P2|Overall Study|Adverse Event|7
57877|NCT01134042|219000|P1|Overall Study|Adverse Event|3
57878|NCT01133977|219131|P5|Overall Study|Withdrawal by Subject|1
57879|NCT01133977|219132|P4|Overall Study|Withdrawal by Subject|5
57880|NCT01133977|219133|P3|Overall Study|Withdrawal by Subject|0
57881|NCT01133977|219134|P2|Overall Study|Withdrawal by Subject|0
57882|NCT01133977|219135|P1|Overall Study|Withdrawal by Subject|0
57883|NCT01133977|219131|P5|Overall Study|Lost to Follow-up|1
57884|NCT01133977|219132|P4|Overall Study|Lost to Follow-up|2
57885|NCT01133977|219133|P3|Overall Study|Lost to Follow-up|0
57886|NCT01133977|219134|P2|Overall Study|Lost to Follow-up|0
57887|NCT01133977|219135|P1|Overall Study|Lost to Follow-up|0
57888|NCT01133977|219131|P5|Overall Study|Started a New Line of Therapy|33
57889|NCT01133977|219132|P4|Overall Study|Started a New Line of Therapy|25
57890|NCT01133977|219133|P3|Overall Study|Started a New Line of Therapy|4
57891|NCT01133977|219134|P2|Overall Study|Started a New Line of Therapy|6
57892|NCT01133977|219135|P1|Overall Study|Started a New Line of Therapy|2
57893|NCT01133977|219131|P5|Overall Study|Death|3
57894|NCT01133977|219132|P4|Overall Study|Death|7
57895|NCT01133977|219133|P3|Overall Study|Death|1
57896|NCT01133977|219134|P2|Overall Study|Death|1
57897|NCT01133977|219135|P1|Overall Study|Death|1
57898|NCT01133977|219131|P5|Overall Study|Adverse Event|0
57899|NCT01133977|219132|P4|Overall Study|Adverse Event|0
57900|NCT01133977|219133|P3|Overall Study|Adverse Event|1
57901|NCT01133977|219134|P2|Overall Study|Adverse Event|0
57902|NCT01133977|219135|P1|Overall Study|Adverse Event|0
57903|NCT01133756|219162|P3|Overall Study|Progression of Disease|1
57904|NCT01133756|219163|P2|Overall Study|Progression of Disease|0
57905|NCT01133756|219164|P1|Overall Study|Progression of Disease|0
57906|NCT01133756|219162|P3|Overall Study|Withdrawal by Subject|0
57907|NCT01133756|219163|P2|Overall Study|Withdrawal by Subject|1
57908|NCT01133756|219164|P1|Overall Study|Withdrawal by Subject|0
57909|NCT01133756|219162|P3|Overall Study|Investigator Decision|0
57910|NCT01133756|219163|P2|Overall Study|Investigator Decision|0
57911|NCT01133756|219164|P1|Overall Study|Investigator Decision|1
57912|NCT01133756|219162|P3|Overall Study|Adverse Event|1
57913|NCT01133756|219163|P2|Overall Study|Adverse Event|2
57914|NCT01133756|219164|P1|Overall Study|Adverse Event|1
57915|NCT01133704|219180|P2|Overall Study|Study Closure|0
57916|NCT01133704|219181|P1|Overall Study|Study Closure|1
57917|NCT01133704|219180|P2|Overall Study|Patient refused to continue|0
57918|NCT01133704|219181|P1|Overall Study|Patient refused to continue|4
57919|NCT01133704|219180|P2|Overall Study|Death|26
57920|NCT01133704|219181|P1|Overall Study|Death|44
57921|NCT01133665|219189|P1|Overall Study|Physician Decision|2
57922|NCT01133626|219233|P3|Overall Study|Not specified|0
57923|NCT01133626|219234|P2|Overall Study|Not specified|2
57924|NCT01133626|219235|P1|Overall Study|Not specified|0
57925|NCT01133626|219233|P3|Overall Study|Withdrawal by Subject|2
57926|NCT01133626|219234|P2|Overall Study|Withdrawal by Subject|2
57927|NCT01133626|219235|P1|Overall Study|Withdrawal by Subject|1
57928|NCT01133626|219233|P3|Overall Study|Adverse Event|0
57929|NCT01133626|219234|P2|Overall Study|Adverse Event|1
57930|NCT01133626|219235|P1|Overall Study|Adverse Event|0
57931|NCT01133522|219253|P10|Overall Study|Physician Decision|0
57932|NCT01133522|219254|P9|Overall Study|Physician Decision|0
57933|NCT01133522|219255|P8|Overall Study|Physician Decision|0
57934|NCT01133522|219256|P7|Overall Study|Physician Decision|0
57935|NCT01133522|219257|P6|Overall Study|Physician Decision|0
57936|NCT01133522|219258|P5|Overall Study|Physician Decision|1
57937|NCT01133522|219259|P4|Overall Study|Physician Decision|0
57938|NCT01133522|219260|P3|Overall Study|Physician Decision|0
57939|NCT01133522|219261|P2|Overall Study|Physician Decision|0
57940|NCT01133522|219262|P1|Overall Study|Physician Decision|0
57941|NCT01133522|219253|P10|Overall Study|Withdrawal by Subject|0
57942|NCT01133522|219254|P9|Overall Study|Withdrawal by Subject|0
57943|NCT01133522|219255|P8|Overall Study|Withdrawal by Subject|0
57944|NCT01133522|219256|P7|Overall Study|Withdrawal by Subject|0
57945|NCT01133522|219257|P6|Overall Study|Withdrawal by Subject|0
57946|NCT01133522|219258|P5|Overall Study|Withdrawal by Subject|0
57947|NCT01133522|219259|P4|Overall Study|Withdrawal by Subject|1
57948|NCT01133522|219260|P3|Overall Study|Withdrawal by Subject|0
57949|NCT01133522|219261|P2|Overall Study|Withdrawal by Subject|1
57950|NCT01133522|219262|P1|Overall Study|Withdrawal by Subject|0
57951|NCT01133392|219330|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
57952|NCT01133392|219331|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
57953|NCT01133392|219330|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
57954|NCT01133392|219331|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
57955|NCT01133379|219348|P3|Overall Study|Lost to Follow-up|1
57956|NCT01133379|219349|P2|Overall Study|Lost to Follow-up|1
57957|NCT01133379|219350|P1|Overall Study|Lost to Follow-up|1
57958|NCT01133379|219348|P3|Overall Study|Withdrawal by Subject|1
57959|NCT01133379|219349|P2|Overall Study|Withdrawal by Subject|1
57960|NCT01133379|219350|P1|Overall Study|Withdrawal by Subject|0
57961|NCT01133288|219403|P1|Intervention Allocation|study terminated|2
57962|NCT01133288|219403|P1|Eligibility Assessment|met exclusion criteria|5
57963|NCT01133275|219408|P1|Overall Study|Cerebrovascular accident (CVA)|1
57964|NCT01133275|219408|P1|Overall Study|Withdrawal by Subject|1
57965|NCT01133171|219416|P3|Overall Study|Withdrawal by Subject|0
57966|NCT01133171|219417|P2|Overall Study|Withdrawal by Subject|2
57967|NCT01133171|219418|P1|Overall Study|Withdrawal by Subject|1
57968|NCT01132664|219452|P5|BM Cohort|Withdrawal by Subject|1
57969|NCT01132664|219453|P4|BM Cohort|Withdrawal by Subject|0
57970|NCT01132664|219454|P3|BM Cohort|Withdrawal by Subject|0
57971|NCT01132664|219455|P2|BM Cohort|Withdrawal by Subject|0
57972|NCT01132664|219456|P1|BM Cohort|Withdrawal by Subject|0
57973|NCT01132664|219452|P5|BM Cohort|Adverse Event|1
57974|NCT01132664|219453|P4|BM Cohort|Adverse Event|0
57975|NCT01132664|219454|P3|BM Cohort|Adverse Event|0
57976|NCT01132664|219455|P2|BM Cohort|Adverse Event|0
57977|NCT01132664|219456|P1|BM Cohort|Adverse Event|0
57978|NCT01132664|219452|P5|BM Cohort|Disease progression|4
57979|NCT01132664|219453|P4|BM Cohort|Disease progression|3
57980|NCT01132664|219454|P3|BM Cohort|Disease progression|0
57981|NCT01132664|219455|P2|BM Cohort|Disease progression|0
57982|NCT01132664|219456|P1|BM Cohort|Disease progression|0
57983|NCT01132664|219452|P5|Phase ll|Disease progression|0
57984|NCT01132664|219453|P4|Phase ll|Disease progression|0
57985|NCT01132664|219454|P3|Phase ll|Disease progression|35
57986|NCT01132664|219455|P2|Phase ll|Disease progression|0
57987|NCT01132664|219456|P1|Phase ll|Disease progression|0
57988|NCT01132664|219452|P5|Phase ll|Withdrawal by Subject|0
57989|NCT01132664|219453|P4|Phase ll|Withdrawal by Subject|0
57990|NCT01132664|219454|P3|Phase ll|Withdrawal by Subject|3
57991|NCT01132664|219455|P2|Phase ll|Withdrawal by Subject|0
57992|NCT01132664|219456|P1|Phase ll|Withdrawal by Subject|0
57993|NCT01132664|219452|P5|Phase ll|Adverse Event|0
57994|NCT01132664|219453|P4|Phase ll|Adverse Event|0
57995|NCT01132664|219454|P3|Phase ll|Adverse Event|10
57996|NCT01132664|219455|P2|Phase ll|Adverse Event|0
57997|NCT01132664|219456|P1|Phase ll|Adverse Event|0
57998|NCT01132664|219452|P5|Phase ll|Death|0
57999|NCT01132664|219453|P4|Phase ll|Death|0
58000|NCT01132664|219454|P3|Phase ll|Death|2
58001|NCT01132664|219455|P2|Phase ll|Death|0
58002|NCT01132664|219456|P1|Phase ll|Death|0
58003|NCT01132664|219452|P5|Phase lb|Disease Progression|0
58004|NCT01132664|219453|P4|Phase lb|Disease Progression|0
58005|NCT01132664|219454|P3|Phase lb|Disease Progression|0
58006|NCT01132664|219455|P2|Phase lb|Disease Progression|9
58007|NCT01132664|219456|P1|Phase lb|Disease Progression|4
58008|NCT01132664|219452|P5|Phase lb|Withdrawal by Subject|0
58009|NCT01132664|219453|P4|Phase lb|Withdrawal by Subject|0
58010|NCT01132664|219454|P3|Phase lb|Withdrawal by Subject|0
58011|NCT01132664|219455|P2|Phase lb|Withdrawal by Subject|2
58012|NCT01132664|219456|P1|Phase lb|Withdrawal by Subject|1
58013|NCT01132664|219452|P5|Phase lb|Adverse Event|0
58014|NCT01132664|219453|P4|Phase lb|Adverse Event|0
58015|NCT01132664|219454|P3|Phase lb|Adverse Event|0
58016|NCT01132664|219455|P2|Phase lb|Adverse Event|1
58017|NCT01132664|219456|P1|Phase lb|Adverse Event|0
58018|NCT01132651|219490|P2|Overall Study|Lost to Follow-up|1
58019|NCT01132651|219491|P1|Overall Study|Lost to Follow-up|1
58020|NCT01132547|219501|P2|Overall Study|Death|0
58021|NCT01132547|219502|P1|Overall Study|Death|1
58022|NCT01132547|219501|P2|Overall Study|Withdrawal by Subject|1
58023|NCT01132547|219502|P1|Overall Study|Withdrawal by Subject|3
58024|NCT01132495|219572|P4|Overall Study|Various reasons|12
58025|NCT01132495|219573|P3|Overall Study|Various reasons|20
58026|NCT01132495|219574|P2|Overall Study|Various reasons|38
58027|NCT01132495|219575|P1|Overall Study|Various reasons|40
58028|NCT01132326|219588|P1|Overall Study|Subject Unable to Come To Visits|1
58029|NCT01132326|219588|P1|Overall Study|Death|5
58030|NCT01132326|219588|P1|Overall Study|Caregiver Withdrew Consent|1
58031|NCT01132326|219588|P1|Overall Study|Pregnancy|1
58032|NCT01132326|219588|P1|Overall Study|Declining Health|1
58033|NCT01132326|219588|P1|Overall Study|Study Termination|80
58034|NCT01132326|219588|P1|Overall Study|Physician Decision|10
58035|NCT01132326|219588|P1|Overall Study|Withdrawal by Subject|40
58036|NCT01132326|219588|P1|Overall Study|Lost to Follow-up|16
58037|NCT01132326|219588|P1|Overall Study|Protocol Violation|1
58038|NCT01132326|219588|P1|Overall Study|Adverse Event|37
58039|NCT01132326|219588|P1|Overall Study|Lack of Efficacy|25
58040|NCT01132313|219604|P12|Overall Study|Other reason not defined above|0
58041|NCT01132313|219605|P11|Overall Study|Other reason not defined above|0
58042|NCT01132313|219606|P10|Overall Study|Other reason not defined above|0
58043|NCT01132313|219607|P9|Overall Study|Other reason not defined above|0
58044|NCT01132313|219608|P8|Overall Study|Other reason not defined above|1
58045|NCT01132313|219609|P7|Overall Study|Other reason not defined above|0
58046|NCT01132313|219610|P6|Overall Study|Other reason not defined above|0
58047|NCT01132313|219611|P5|Overall Study|Other reason not defined above|0
58048|NCT01132313|219612|P4|Overall Study|Other reason not defined above|0
58049|NCT01132313|219613|P3|Overall Study|Other reason not defined above|0
58050|NCT01132313|219614|P2|Overall Study|Other reason not defined above|0
58051|NCT01132313|219615|P1|Overall Study|Other reason not defined above|0
58052|NCT01132313|219604|P12|Overall Study|Lack of antiviral response|0
58053|NCT01132313|219605|P11|Overall Study|Lack of antiviral response|1
58054|NCT01132313|219606|P10|Overall Study|Lack of antiviral response|0
58055|NCT01132313|219607|P9|Overall Study|Lack of antiviral response|0
58056|NCT01132313|219608|P8|Overall Study|Lack of antiviral response|0
58057|NCT01132313|219609|P7|Overall Study|Lack of antiviral response|21
58058|NCT01132313|219610|P6|Overall Study|Lack of antiviral response|18
58059|NCT01132313|219611|P5|Overall Study|Lack of antiviral response|18
58060|NCT01132313|219612|P4|Overall Study|Lack of antiviral response|18
58061|NCT01132313|219613|P3|Overall Study|Lack of antiviral response|12
58062|NCT01132313|219614|P2|Overall Study|Lack of antiviral response|0
58063|NCT01132313|219615|P1|Overall Study|Lack of antiviral response|0
58064|NCT01132313|219604|P12|Overall Study|Withdrawal by Subject|0
58065|NCT01132313|219605|P11|Overall Study|Withdrawal by Subject|0
58066|NCT01132313|219606|P10|Overall Study|Withdrawal by Subject|2
58067|NCT01132313|219607|P9|Overall Study|Withdrawal by Subject|0
58068|NCT01132313|219608|P8|Overall Study|Withdrawal by Subject|0
58069|NCT01132313|219609|P7|Overall Study|Withdrawal by Subject|1
58070|NCT01132313|219610|P6|Overall Study|Withdrawal by Subject|0
58071|NCT01132313|219611|P5|Overall Study|Withdrawal by Subject|6
58072|NCT01132313|219612|P4|Overall Study|Withdrawal by Subject|3
58073|NCT01132313|219613|P3|Overall Study|Withdrawal by Subject|3
58074|NCT01132313|219614|P2|Overall Study|Withdrawal by Subject|0
58075|NCT01132313|219615|P1|Overall Study|Withdrawal by Subject|0
58076|NCT01132313|219604|P12|Overall Study|Lost to Follow-up|0
58077|NCT01132313|219605|P11|Overall Study|Lost to Follow-up|0
58078|NCT01132313|219606|P10|Overall Study|Lost to Follow-up|0
58079|NCT01132313|219607|P9|Overall Study|Lost to Follow-up|0
58080|NCT01132313|219608|P8|Overall Study|Lost to Follow-up|1
58081|NCT01132313|219609|P7|Overall Study|Lost to Follow-up|0
58082|NCT01132313|219610|P6|Overall Study|Lost to Follow-up|0
58083|NCT01132313|219611|P5|Overall Study|Lost to Follow-up|0
58084|NCT01132313|219612|P4|Overall Study|Lost to Follow-up|0
58085|NCT01132313|219613|P3|Overall Study|Lost to Follow-up|1
58086|NCT01132313|219614|P2|Overall Study|Lost to Follow-up|0
58087|NCT01132313|219615|P1|Overall Study|Lost to Follow-up|0
58088|NCT01132313|219604|P12|Overall Study|Protocol Violation|0
58089|NCT01132313|219605|P11|Overall Study|Protocol Violation|0
58090|NCT01132313|219606|P10|Overall Study|Protocol Violation|0
58091|NCT01132313|219607|P9|Overall Study|Protocol Violation|0
58092|NCT01132313|219608|P8|Overall Study|Protocol Violation|0
58093|NCT01132313|219609|P7|Overall Study|Protocol Violation|0
58094|NCT01132313|219610|P6|Overall Study|Protocol Violation|0
58095|NCT01132313|219611|P5|Overall Study|Protocol Violation|0
58096|NCT01132313|219612|P4|Overall Study|Protocol Violation|1
58097|NCT01132313|219613|P3|Overall Study|Protocol Violation|0
58098|NCT01132313|219614|P2|Overall Study|Protocol Violation|0
58099|NCT01132313|219615|P1|Overall Study|Protocol Violation|0
58100|NCT01132313|219604|P12|Overall Study|Adverse Event|0
58101|NCT01132313|219605|P11|Overall Study|Adverse Event|0
58102|NCT01132313|219606|P10|Overall Study|Adverse Event|2
58103|NCT01132313|219607|P9|Overall Study|Adverse Event|7
58104|NCT01132313|219608|P8|Overall Study|Adverse Event|3
58105|NCT01132313|219609|P7|Overall Study|Adverse Event|5
58106|NCT01132313|219610|P6|Overall Study|Adverse Event|6
58107|NCT01132313|219611|P5|Overall Study|Adverse Event|19
58108|NCT01132313|219612|P4|Overall Study|Adverse Event|10
58109|NCT01132313|219613|P3|Overall Study|Adverse Event|4
58110|NCT01132313|219614|P2|Overall Study|Adverse Event|0
58111|NCT01132313|219615|P1|Overall Study|Adverse Event|0
58112|NCT01132313|219604|P12|Overall Study|Not treated|0
58113|NCT01132313|219605|P11|Overall Study|Not treated|0
58114|NCT01132313|219606|P10|Overall Study|Not treated|0
58115|NCT01132313|219607|P9|Overall Study|Not treated|0
58116|NCT01132313|219608|P8|Overall Study|Not treated|0
58117|NCT01132313|219609|P7|Overall Study|Not treated|3
58118|NCT01132313|219610|P6|Overall Study|Not treated|1
58119|NCT01132313|219611|P5|Overall Study|Not treated|2
58120|NCT01132313|219612|P4|Overall Study|Not treated|0
58121|NCT01132313|219613|P3|Overall Study|Not treated|0
58122|NCT01132313|219614|P2|Overall Study|Not treated|0
58123|NCT01132313|219615|P1|Overall Study|Not treated|2
58124|NCT01132313|219604|P12|Overall Study|Lack of Efficacy|0
58125|NCT01132313|219605|P11|Overall Study|Lack of Efficacy|0
58126|NCT01132313|219606|P10|Overall Study|Lack of Efficacy|16
58127|NCT01132313|219607|P9|Overall Study|Lack of Efficacy|14
58128|NCT01132313|219608|P8|Overall Study|Lack of Efficacy|3
58129|NCT01132313|219609|P7|Overall Study|Lack of Efficacy|0
58130|NCT01132313|219610|P6|Overall Study|Lack of Efficacy|0
58131|NCT01132313|219611|P5|Overall Study|Lack of Efficacy|0
58132|NCT01132313|219612|P4|Overall Study|Lack of Efficacy|0
58133|NCT01132313|219613|P3|Overall Study|Lack of Efficacy|0
58134|NCT01132313|219614|P2|Overall Study|Lack of Efficacy|0
58135|NCT01132313|219615|P1|Overall Study|Lack of Efficacy|1
58136|NCT01132118|219695|P2|Second Intervention (8 Weeks)|Adverse Event|1
58137|NCT01132118|219696|P1|Second Intervention (8 Weeks)|Adverse Event|0
58138|NCT01132118|219695|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
58139|NCT01132118|219696|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
58140|NCT01132118|219695|P2|First Intervention (8 Weeks)|Adverse Event|0
58141|NCT01132118|219696|P1|First Intervention (8 Weeks)|Adverse Event|1
58142|NCT01131676|219726|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
58143|NCT01131676|219727|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
58144|NCT01131676|219728|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
58145|NCT01131676|219726|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
58146|NCT01131676|219727|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
58147|NCT01131676|219728|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
58148|NCT01131676|219726|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
58149|NCT01131676|219727|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
58150|NCT01131676|219728|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
58151|NCT01131676|219726|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
58152|NCT01131676|219727|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
58153|NCT01131676|219728|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
58154|NCT01131676|219726|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
58155|NCT01131676|219727|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
58156|NCT01131676|219728|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
58157|NCT01131676|219726|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
58158|NCT01131676|219727|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
58159|NCT01131676|219728|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
58160|NCT01131676|219726|P3|Discontinuation From Treatment|Adverse Event|273
58161|NCT01131676|219727|P2|Discontinuation From Treatment|Adverse Event|267
58162|NCT01131676|219728|P1|Discontinuation From Treatment|Adverse Event|303
58163|NCT01131676|219726|P3|Discontinuation From Treatment|Other than those specified|125
58164|NCT01131676|219727|P2|Discontinuation From Treatment|Other than those specified|142
58165|NCT01131676|219728|P1|Discontinuation From Treatment|Other than those specified|162
58166|NCT01131676|219726|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
58167|NCT01131676|219727|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
58168|NCT01131676|219728|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
58169|NCT01131676|219726|P3|Discontinuation From Treatment|Lost to Follow-up|6
58170|NCT01131676|219727|P2|Discontinuation From Treatment|Lost to Follow-up|9
58171|NCT01131676|219728|P1|Discontinuation From Treatment|Lost to Follow-up|15
58172|NCT01131676|219726|P3|Discontinuation From Treatment|Non compliant with protocol|12
58173|NCT01131676|219727|P2|Discontinuation From Treatment|Non compliant with protocol|15
58174|NCT01131676|219728|P1|Discontinuation From Treatment|Non compliant with protocol|15
58175|NCT01131676|219726|P3|Discontinuation From Treatment|Lack of Efficacy|0
58176|NCT01131676|219727|P2|Discontinuation From Treatment|Lack of Efficacy|1
58177|NCT01131676|219728|P1|Discontinuation From Treatment|Lack of Efficacy|11
58178|NCT01131676|219726|P3|Discontinuation From Treatment|Not treated|2
58179|NCT01131676|219727|P2|Discontinuation From Treatment|Not treated|2
58180|NCT01131676|219728|P1|Discontinuation From Treatment|Not treated|4
58181|NCT01131676|219726|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
58182|NCT01131676|219727|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
58183|NCT01131676|219728|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
58184|NCT01131585|219763|P2|Overall Study|Study termination|32
58185|NCT01131585|219764|P1|Overall Study|Study termination|78
58186|NCT01131585|219763|P2|Overall Study|Administrative problems|1
58187|NCT01131585|219764|P1|Overall Study|Administrative problems|1
58188|NCT01131585|219763|P2|Overall Study|Lost to Follow-up|1
58189|NCT01131585|219764|P1|Overall Study|Lost to Follow-up|0
58190|NCT01131585|219763|P2|Overall Study|Withdrawal by Subject|3
58191|NCT01131585|219764|P1|Overall Study|Withdrawal by Subject|3
58192|NCT01131585|219763|P2|Overall Study|Protocol Violation|1
58193|NCT01131585|219764|P1|Overall Study|Protocol Violation|2
58194|NCT01131585|219763|P2|Overall Study|Unsatisfactory therapeutic effect|3
58195|NCT01131585|219764|P1|Overall Study|Unsatisfactory therapeutic effect|0
58196|NCT01131585|219763|P2|Overall Study|Abnormal laboratory value|0
58197|NCT01131585|219764|P1|Overall Study|Abnormal laboratory value|1
58198|NCT01131585|219763|P2|Overall Study|Adverse Event|2
58199|NCT01131585|219764|P1|Overall Study|Adverse Event|0
58200|NCT01131507|219770|P1|Overall Study|Withdrawal by Subject|1
58201|NCT01131507|219770|P1|Overall Study|Lost to Follow-up|1
58202|NCT01131507|219770|P1|Overall Study|Adverse Event|1
58203|NCT01131494|219775|P1|Overall Study|Withdrawal by Subject|2
58204|NCT01131455|219785|P3|Overall Study|Death of PI|0
58205|NCT01131455|219786|P2|Overall Study|Death of PI|4
58206|NCT01131455|219787|P1|Overall Study|Death of PI|6
58207|NCT01131299|219795|P2|Overall Study|Withdrawal by Subject|7
58208|NCT01131299|219796|P1|Overall Study|Withdrawal by Subject|4
58209|NCT01131182|219809|P2|Overall Study|Other Reason|0
58210|NCT01131182|219810|P1|Overall Study|Other Reason|1
58211|NCT01131182|219809|P2|Overall Study|Lost to Follow-up|15
58212|NCT01131182|219810|P1|Overall Study|Lost to Follow-up|14
58213|NCT01131182|219809|P2|Overall Study|Withdrawal by Subject|1
58214|NCT01131182|219810|P1|Overall Study|Withdrawal by Subject|1
58215|NCT01131130|219818|P1|Period 3- Crossover|+ Slit lamp finding|1
58216|NCT01131130|219818|P1|Period 1 - Baseline|Pregnancy|1
58217|NCT01131078|219834|P3|Overall Study|Other|0
58218|NCT01131078|219835|P2|Overall Study|Other|1
58219|NCT01131078|219836|P1|Overall Study|Other|0
58220|NCT01131078|219834|P3|Overall Study|Death|2
58221|NCT01131078|219835|P2|Overall Study|Death|0
58222|NCT01131078|219836|P1|Overall Study|Death|4
58223|NCT01131078|219834|P3|Overall Study|Physician Decision|8
58224|NCT01131078|219835|P2|Overall Study|Physician Decision|6
58225|NCT01131078|219836|P1|Overall Study|Physician Decision|10
58226|NCT01131078|219834|P3|Overall Study|Non-compliance|0
58227|NCT01131078|219835|P2|Overall Study|Non-compliance|0
58228|NCT01131078|219836|P1|Overall Study|Non-compliance|3
58229|NCT01131078|219834|P3|Overall Study|Withdrawal by Subject|3
58230|NCT01131078|219835|P2|Overall Study|Withdrawal by Subject|4
58231|NCT01131078|219836|P1|Overall Study|Withdrawal by Subject|2
58232|NCT01131078|219834|P3|Overall Study|Lost to Follow-up|1
58233|NCT01131078|219835|P2|Overall Study|Lost to Follow-up|1
58234|NCT01131078|219836|P1|Overall Study|Lost to Follow-up|1
58235|NCT01131078|219834|P3|Overall Study|Protocol Violation|0
58236|NCT01131078|219835|P2|Overall Study|Protocol Violation|0
58237|NCT01131078|219836|P1|Overall Study|Protocol Violation|1
58238|NCT01131078|219834|P3|Overall Study|Progressive Disease|71
58239|NCT01131078|219835|P2|Overall Study|Progressive Disease|77
58240|NCT01131078|219836|P1|Overall Study|Progressive Disease|58
58241|NCT01131078|219834|P3|Overall Study|Adverse Event|17
58242|NCT01131078|219835|P2|Overall Study|Adverse Event|12
58243|NCT01131078|219836|P1|Overall Study|Adverse Event|22
58244|NCT01130974|219923|P2|Overall Study|Ineligibility criteria|2
58245|NCT01130974|219924|P1|Overall Study|Ineligibility criteria|5
58246|NCT01130974|219923|P2|Overall Study|Withdrawal by Subject|1
58247|NCT01130974|219924|P1|Overall Study|Withdrawal by Subject|0
58248|NCT01130974|219923|P2|Overall Study|Protocol Violation|10
58249|NCT01130974|219924|P1|Overall Study|Protocol Violation|10
58250|NCT01130883|219944|P1|Overall Study|Adverse Event|3
58251|NCT01130883|219944|P1|Overall Study|Reason Unknown|1
58252|NCT01130883|219944|P1|Overall Study|Patient Noncompliance|6
58253|NCT01130831|220001|P1|Overall Study|Information was missing|3
58254|NCT01130831|220001|P1|Overall Study|Death|4
58255|NCT01130831|220001|P1|Overall Study|Withdrawal by Subject|7
58256|NCT01130597|220040|P1|Overall Study|Protocol Violation|1
58257|NCT01130597|220040|P1|Overall Study|Death|1
58258|NCT01130597|220040|P1|Overall Study|Adverse Event|4
58259|NCT01130597|220040|P1|Overall Study|Protocol-specified (High K+)|1
58260|NCT01130532|220065|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
58261|NCT01130532|220066|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
58262|NCT01130532|220067|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
58263|NCT01130532|220068|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
58264|NCT01130532|220065|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
58265|NCT01130532|220066|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
58266|NCT01130532|220067|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
58267|NCT01130532|220068|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
58268|NCT01130532|220065|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
58269|NCT01130532|220066|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
58270|NCT01130532|220067|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
58271|NCT01130532|220068|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
58272|NCT01130532|220065|P4|Period IV (Weeks 13-16)|Adverse Event|1
58273|NCT01130532|220066|P3|Period IV (Weeks 13-16)|Adverse Event|0
58274|NCT01130532|220067|P2|Period IV (Weeks 13-16)|Adverse Event|0
58275|NCT01130532|220068|P1|Period IV (Weeks 13-16)|Adverse Event|0
58276|NCT01130532|220065|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
58277|NCT01130532|220066|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
58278|NCT01130532|220067|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
58279|NCT01130532|220068|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
58280|NCT01130532|220065|P4|Period III (Weeks 0-12)|Sponsor Decision|0
58281|NCT01130532|220066|P3|Period III (Weeks 0-12)|Sponsor Decision|2
58282|NCT01130532|220067|P2|Period III (Weeks 0-12)|Sponsor Decision|4
58283|NCT01130532|220068|P1|Period III (Weeks 0-12)|Sponsor Decision|3
58284|NCT01130532|220065|P4|Period III (Weeks 0-12)|Protocol Violation|0
58285|NCT01130532|220066|P3|Period III (Weeks 0-12)|Protocol Violation|1
58286|NCT01130532|220067|P2|Period III (Weeks 0-12)|Protocol Violation|0
58287|NCT01130532|220068|P1|Period III (Weeks 0-12)|Protocol Violation|0
58288|NCT01130532|220065|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
58289|NCT01130532|220066|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
58290|NCT01130532|220067|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
58291|NCT01130532|220068|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
58292|NCT01130532|220065|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
58293|NCT01130532|220066|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
58294|NCT01130532|220067|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
58295|NCT01130532|220068|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
58296|NCT01130532|220065|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
58297|NCT01130532|220066|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
58298|NCT01130532|220067|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
58299|NCT01130532|220068|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
58300|NCT01130532|220065|P4|Period III (Weeks 0-12)|Adverse Event|0
58301|NCT01130532|220066|P3|Period III (Weeks 0-12)|Adverse Event|2
58302|NCT01130532|220067|P2|Period III (Weeks 0-12)|Adverse Event|3
58303|NCT01130532|220068|P1|Period III (Weeks 0-12)|Adverse Event|3
58304|NCT01130337|220113|P1|Overall Study|Surgical resection (R2)|1
58305|NCT01130337|220113|P1|Overall Study|Toxicity, AE/intercurrent disease|7
58306|NCT01130337|220113|P1|Overall Study|Disease progression|1
58307|NCT01130337|220113|P1|Overall Study|Death|1
58308|NCT01130337|220113|P1|Overall Study|Principal investigator decision|1
58309|NCT01130337|220113|P1|Overall Study|Withdrawal by Subject|3
58310|NCT01130168|220120|P6|Period 1|Adverse Event|0
58311|NCT01130168|220121|P5|Period 1|Adverse Event|0
58312|NCT01130168|220122|P4|Period 1|Adverse Event|1
58313|NCT01130168|220123|P3|Period 1|Adverse Event|0
58314|NCT01130168|220124|P2|Period 1|Adverse Event|0
58315|NCT01130168|220125|P1|Period 1|Adverse Event|0
58316|NCT01130168|220120|P6|Period 1|Discontinued For Other Reason|0
58317|NCT01130168|220121|P5|Period 1|Discontinued For Other Reason|0
58318|NCT01130168|220122|P4|Period 1|Discontinued For Other Reason|1
58319|NCT01130168|220123|P3|Period 1|Discontinued For Other Reason|1
58320|NCT01130168|220124|P2|Period 1|Discontinued For Other Reason|0
58321|NCT01130168|220125|P1|Period 1|Discontinued For Other Reason|0
58322|NCT01130168|220120|P6|Period 1|Withdrawal by Subject|0
58323|NCT01130168|220121|P5|Period 1|Withdrawal by Subject|0
58324|NCT01130168|220122|P4|Period 1|Withdrawal by Subject|1
58325|NCT01130168|220123|P3|Period 1|Withdrawal by Subject|0
58326|NCT01130168|220124|P2|Period 1|Withdrawal by Subject|1
58327|NCT01130168|220125|P1|Period 1|Withdrawal by Subject|0
58328|NCT01130103|220162|P2|Maintenance Treatment|Withdrawal by Subject|0
58329|NCT01130103|220163|P1|Maintenance Treatment|Withdrawal by Subject|1
58330|NCT01130103|220162|P2|Maintenance Treatment|Lost to Follow-up|1
58331|NCT01130103|220163|P1|Maintenance Treatment|Lost to Follow-up|1
58332|NCT01130103|220162|P2|Maintenance Treatment|Lack of Efficacy|1
58333|NCT01130103|220163|P1|Maintenance Treatment|Lack of Efficacy|0
58334|NCT01130103|220162|P2|Randomized Treatment|Withdrawal by Subject|2
58335|NCT01130103|220163|P1|Randomized Treatment|Withdrawal by Subject|1
58336|NCT01130103|220162|P2|Randomized Treatment|Protocol Violation|2
58337|NCT01130103|220163|P1|Randomized Treatment|Protocol Violation|3
58338|NCT01130103|220162|P2|Randomized Treatment|Lost to Follow-up|0
58339|NCT01130103|220163|P1|Randomized Treatment|Lost to Follow-up|1
58340|NCT01130103|220162|P2|Randomized Treatment|Adverse Event|1
58341|NCT01130103|220163|P1|Randomized Treatment|Adverse Event|1
58342|NCT01130051|220177|P2|Washout Period of 14 Days|Protocol Violation|1
58343|NCT01130051|220178|P1|Washout Period of 14 Days|Protocol Violation|1
58344|NCT01130051|220177|P2|Washout Period of 14 Days|Withdrawal by Subject|1
58345|NCT01130051|220178|P1|Washout Period of 14 Days|Withdrawal by Subject|0
58346|NCT01129960|220192|P4|Overall Study|Pregnancy|0
58347|NCT01129960|220193|P3|Overall Study|Pregnancy|0
58348|NCT01129960|220194|P2|Overall Study|Pregnancy|0
58349|NCT01129960|220195|P1|Overall Study|Pregnancy|1
58350|NCT01129960|220192|P4|Overall Study|Physician Decision|0
58351|NCT01129960|220193|P3|Overall Study|Physician Decision|0
58352|NCT01129960|220194|P2|Overall Study|Physician Decision|0
58353|NCT01129960|220195|P1|Overall Study|Physician Decision|1
58354|NCT01129960|220192|P4|Overall Study|Discontinuation of the study by Sponsor|0
58355|NCT01129960|220193|P3|Overall Study|Discontinuation of the study by Sponsor|0
58356|NCT01129960|220194|P2|Overall Study|Discontinuation of the study by Sponsor|1
58357|NCT01129960|220195|P1|Overall Study|Discontinuation of the study by Sponsor|0
58358|NCT01129960|220192|P4|Overall Study|Lost to Follow-up|3
58359|NCT01129960|220193|P3|Overall Study|Lost to Follow-up|3
58360|NCT01129960|220194|P2|Overall Study|Lost to Follow-up|2
58361|NCT01129960|220195|P1|Overall Study|Lost to Follow-up|0
58362|NCT01129960|220192|P4|Overall Study|Protocol Violation|0
58363|NCT01129960|220193|P3|Overall Study|Protocol Violation|3
58364|NCT01129960|220194|P2|Overall Study|Protocol Violation|2
58365|NCT01129960|220195|P1|Overall Study|Protocol Violation|1
58366|NCT01129960|220192|P4|Overall Study|Adverse Event|7
58367|NCT01129960|220193|P3|Overall Study|Adverse Event|16
58368|NCT01129960|220194|P2|Overall Study|Adverse Event|16
58369|NCT01129960|220195|P1|Overall Study|Adverse Event|23
58370|NCT01129960|220192|P4|Overall Study|Lack of Efficacy|1
58371|NCT01129960|220193|P3|Overall Study|Lack of Efficacy|1
58372|NCT01129960|220194|P2|Overall Study|Lack of Efficacy|1
58373|NCT01129960|220195|P1|Overall Study|Lack of Efficacy|1
58374|NCT01129960|220192|P4|Overall Study|Withdrawal by Subject|2
58375|NCT01129960|220193|P3|Overall Study|Withdrawal by Subject|3
58376|NCT01129960|220194|P2|Overall Study|Withdrawal by Subject|0
58377|NCT01129960|220195|P1|Overall Study|Withdrawal by Subject|3
58378|NCT01129921|220207|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
58379|NCT01129921|220208|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
58380|NCT01129921|220207|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
58381|NCT01129921|220208|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
58382|NCT01129921|220207|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
58383|NCT01129921|220208|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
58384|NCT01129921|220207|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
58385|NCT01129921|220208|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
58386|NCT01129622|220227|P1|Overall Study|Withdrawal by Subject|2
58387|NCT01129583|220234|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
58388|NCT01129583|220235|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
58389|NCT01129583|220234|P2|Overall Study|Lost to Follow-up|1
58390|NCT01129583|220235|P1|Overall Study|Lost to Follow-up|1
58391|NCT01129583|220234|P2|Overall Study|Death|0
58392|NCT01129583|220235|P1|Overall Study|Death|1
58393|NCT01129557|220248|P3|Overall Study|Novartis terminated study early|2
58394|NCT01129557|220249|P2|Overall Study|Novartis terminated study early|3
58395|NCT01129557|220250|P1|Overall Study|Novartis terminated study early|3
58396|NCT01129557|220248|P3|Overall Study|Adverse Event|2
58397|NCT01129557|220249|P2|Overall Study|Adverse Event|2
58398|NCT01129557|220250|P1|Overall Study|Adverse Event|1
58399|NCT01129336|220345|P2|Overall Study|Death|4
58400|NCT01129336|220346|P1|Overall Study|Death|0
58401|NCT01129336|220345|P2|Overall Study|Missing Study Completion Status|3
58402|NCT01129336|220346|P1|Overall Study|Missing Study Completion Status|2
58403|NCT01129336|220345|P2|Overall Study|Adverse Event|1
58404|NCT01129336|220346|P1|Overall Study|Adverse Event|0
58405|NCT01129336|220345|P2|Overall Study|Withdrawal by Subject|4
58406|NCT01129336|220346|P1|Overall Study|Withdrawal by Subject|7
58407|NCT01129336|220345|P2|Overall Study|Lost to Follow-up|0
58408|NCT01129336|220346|P1|Overall Study|Lost to Follow-up|1
58409|NCT01129336|220345|P2|Overall Study|Disease Progression|4
58410|NCT01129336|220346|P1|Overall Study|Disease Progression|1
58411|NCT01129336|220345|P2|Overall Study|Protocol Violation|0
58412|NCT01129336|220346|P1|Overall Study|Protocol Violation|1
58413|NCT01129284|220361|P3|Overall Study|Adverse Event|1
58414|NCT01129284|220362|P2|Overall Study|Adverse Event|0
58415|NCT01129284|220363|P1|Overall Study|Adverse Event|2
58416|NCT01129128|220403|P3|Overall Study|Physician Decision|0
58417|NCT01129128|220404|P2|Overall Study|Physician Decision|0
58418|NCT01129128|220405|P1|Overall Study|Physician Decision|1
58419|NCT01129128|220403|P3|Overall Study|Withdrawal by Subject|3
58420|NCT01129128|220404|P2|Overall Study|Withdrawal by Subject|1
58421|NCT01129128|220405|P1|Overall Study|Withdrawal by Subject|0
58422|NCT01129128|220403|P3|Overall Study|Protocol Violation|0
58423|NCT01129128|220404|P2|Overall Study|Protocol Violation|1
58424|NCT01129128|220405|P1|Overall Study|Protocol Violation|0
58425|NCT01129128|220403|P3|Overall Study|Lost to Follow-up|1
58426|NCT01129128|220404|P2|Overall Study|Lost to Follow-up|2
58427|NCT01129128|220405|P1|Overall Study|Lost to Follow-up|2
58428|NCT01129115|220429|P4|Overall Study|Protocol Violation|2
58429|NCT01129115|220430|P3|Overall Study|Protocol Violation|2
58430|NCT01129115|220431|P2|Overall Study|Protocol Violation|2
58431|NCT01129115|220432|P1|Overall Study|Protocol Violation|0
58432|NCT01129115|220429|P4|Overall Study|Withdrawal by Subject|4
58433|NCT01129115|220430|P3|Overall Study|Withdrawal by Subject|1
58434|NCT01129115|220431|P2|Overall Study|Withdrawal by Subject|3
58435|NCT01129115|220432|P1|Overall Study|Withdrawal by Subject|1
58436|NCT01129115|220429|P4|Overall Study|Adverse Event|3
58437|NCT01129115|220430|P3|Overall Study|Adverse Event|3
58438|NCT01129115|220431|P2|Overall Study|Adverse Event|2
58439|NCT01129115|220432|P1|Overall Study|Adverse Event|1
58440|NCT01129102|220469|P3|Overall Study|Lost to Follow-up|0
58441|NCT01129102|220470|P2|Overall Study|Lost to Follow-up|0
58442|NCT01129102|220471|P1|Overall Study|Lost to Follow-up|2
58443|NCT01129102|220469|P3|Overall Study|Adverse Event|1
58444|NCT01129102|220470|P2|Overall Study|Adverse Event|2
58445|NCT01129102|220471|P1|Overall Study|Adverse Event|2
58446|NCT01129102|220469|P3|Overall Study|Pregnancy|1
58447|NCT01129102|220470|P2|Overall Study|Pregnancy|0
58448|NCT01129102|220471|P1|Overall Study|Pregnancy|0
58449|NCT01129102|220469|P3|Overall Study|Protocol Violation|1
58450|NCT01129102|220470|P2|Overall Study|Protocol Violation|1
58451|NCT01129102|220471|P1|Overall Study|Protocol Violation|0
58452|NCT01129102|220469|P3|Overall Study|Withdrawal by Subject|3
58453|NCT01129102|220470|P2|Overall Study|Withdrawal by Subject|0
58454|NCT01129102|220471|P1|Overall Study|Withdrawal by Subject|2
58455|NCT01129102|220469|P3|Overall Study|No study drug treatment|1
58456|NCT01129102|220470|P2|Overall Study|No study drug treatment|3
58457|NCT01129102|220471|P1|Overall Study|No study drug treatment|2
58458|NCT01129011|220482|P2|Overall Study|misc|4
58459|NCT01129011|220483|P1|Overall Study|misc|7
58460|NCT01129011|220482|P2|Overall Study|Duodenal Ulcer|8
58461|NCT01129011|220483|P1|Overall Study|Duodenal Ulcer|2
58462|NCT01129011|220482|P2|Overall Study|Lost to Follow-up|7
58463|NCT01129011|220483|P1|Overall Study|Lost to Follow-up|6
58464|NCT01129011|220482|P2|Overall Study|Withdrawal by Subject|8
58465|NCT01129011|220483|P1|Overall Study|Withdrawal by Subject|24
58466|NCT01129011|220482|P2|Overall Study|Adverse Event|30
58467|NCT01129011|220483|P1|Overall Study|Adverse Event|20
58468|NCT01128959|220538|P1|Treatment Period|Withdrawal by Subject|1
58469|NCT01128959|220538|P1|Treatment Period|Adverse Event|3
58470|NCT01128959|220538|P1|Lead in Period|Adverse Event|3
58471|NCT01128946|220544|P4|Period III|Protocol Violation|0
58472|NCT01128946|220545|P3|Period III|Protocol Violation|0
58473|NCT01128946|220546|P2|Period III|Protocol Violation|0
58474|NCT01128946|220547|P1|Period III|Protocol Violation|1
58475|NCT01128946|220544|P4|Period II|Withdrawal by Subject|1
58476|NCT01128946|220545|P3|Period II|Withdrawal by Subject|0
58477|NCT01128946|220546|P2|Period II|Withdrawal by Subject|0
58478|NCT01128946|220547|P1|Period II|Withdrawal by Subject|0
58479|NCT01128946|220544|P4|Period II|Protocol Violation|0
58480|NCT01128946|220545|P3|Period II|Protocol Violation|0
58481|NCT01128946|220546|P2|Period II|Protocol Violation|1
58482|NCT01128946|220547|P1|Period II|Protocol Violation|0
58483|NCT01128946|220544|P4|Period I|Withdrawal by Subject|1
58484|NCT01128946|220545|P3|Period I|Withdrawal by Subject|1
58485|NCT01128946|220546|P2|Period I|Withdrawal by Subject|0
58486|NCT01128946|220547|P1|Period I|Withdrawal by Subject|0
58487|NCT01128946|220544|P4|Period I|Protocol Violation|0
58488|NCT01128946|220545|P3|Period I|Protocol Violation|0
58489|NCT01128946|220546|P2|Period I|Protocol Violation|1
58490|NCT01128946|220547|P1|Period I|Protocol Violation|0
58491|NCT01128894|220565|P2|Overall Study|Conflicting HbA1c Results at Screening|0
58492|NCT01128894|220566|P1|Overall Study|Conflicting HbA1c Results at Screening|1
58493|NCT01128894|220565|P2|Overall Study|Physician Decision|1
58494|NCT01128894|220566|P1|Overall Study|Physician Decision|2
58495|NCT01128894|220565|P2|Overall Study|Withdrawal by Subject|12
58496|NCT01128894|220566|P1|Overall Study|Withdrawal by Subject|10
58497|NCT01128894|220565|P2|Overall Study|Lost to Follow-up|8
58498|NCT01128894|220566|P1|Overall Study|Lost to Follow-up|8
58499|NCT01128894|220565|P2|Overall Study|Noncompliance|5
58500|NCT01128894|220566|P1|Overall Study|Noncompliance|4
58501|NCT01128894|220565|P2|Overall Study|Protocol Violation|1
58502|NCT01128894|220566|P1|Overall Study|Protocol Violation|2
58503|NCT01128894|220565|P2|Overall Study|Adverse Event|41
58504|NCT01128894|220566|P1|Overall Study|Adverse Event|31
58505|NCT01128738|220591|P2|Second TP|Withdrawal by Subject|2
58506|NCT01128738|220592|P1|Second TP|Withdrawal by Subject|0
58507|NCT01128738|220591|P2|Second TP|Lost to Follow-up|1
58508|NCT01128738|220592|P1|Second TP|Lost to Follow-up|0
58509|NCT01128738|220591|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
58510|NCT01128738|220592|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
58511|NCT01128738|220591|P2|First Treatment Phase (TP)|Lost to Follow-up|0
58512|NCT01128738|220592|P1|First Treatment Phase (TP)|Lost to Follow-up|1
58513|NCT01128595|220715|P4|Treatment Period 3|Withdrawal by Subject|0
58514|NCT01128595|220716|P3|Treatment Period 3|Withdrawal by Subject|0
58515|NCT01128595|220717|P2|Treatment Period 3|Withdrawal by Subject|1
58516|NCT01128595|220718|P1|Treatment Period 3|Withdrawal by Subject|0
58517|NCT01128569|220748|P6|Treatment Period 2|Withdrawal by Subject|0
58518|NCT01128569|220749|P5|Treatment Period 2|Withdrawal by Subject|0
58519|NCT01128569|220750|P4|Treatment Period 2|Withdrawal by Subject|0
58520|NCT01128569|220751|P3|Treatment Period 2|Withdrawal by Subject|0
58521|NCT01128569|220752|P2|Treatment Period 2|Withdrawal by Subject|1
58522|NCT01128569|220753|P1|Treatment Period 2|Withdrawal by Subject|0
58523|NCT01128569|220748|P6|Washout Period 1|Adverse Event|0
58524|NCT01128569|220749|P5|Washout Period 1|Adverse Event|0
58525|NCT01128569|220750|P4|Washout Period 1|Adverse Event|0
58526|NCT01128569|220751|P3|Washout Period 1|Adverse Event|1
58527|NCT01128569|220752|P2|Washout Period 1|Adverse Event|0
58528|NCT01128569|220753|P1|Washout Period 1|Adverse Event|0
58529|NCT01128543|220770|P1|Overall Study|Protocol Violation|1
58530|NCT01128543|220770|P1|Overall Study|Withdrawal by Subject|3
58531|NCT01128413|220796|P2|Overall Study|Pt made DNR|0
58532|NCT01128413|220797|P1|Overall Study|Pt made DNR|1
58533|NCT01128413|220796|P2|Overall Study|NICOM Monitor Problems|1
58534|NCT01128413|220797|P1|Overall Study|NICOM Monitor Problems|2
58535|NCT01128413|220796|P2|Overall Study|Withdrawal by Subject|0
58536|NCT01128413|220797|P1|Overall Study|Withdrawal by Subject|1
58537|NCT01128400|220806|P3|Overall Study|were not invited to participate on taste|15
58538|NCT01128400|220807|P2|Overall Study|were not invited to participate on taste|0
58539|NCT01128400|220808|P1|Overall Study|were not invited to participate on taste|0
58540|NCT01128400|220806|P3|Overall Study|Screening failure|0
58541|NCT01128400|220807|P2|Overall Study|Screening failure|0
58542|NCT01128400|220808|P1|Overall Study|Screening failure|1
58543|NCT01128400|220806|P3|Overall Study|Lost to Follow-up|1
58544|NCT01128400|220807|P2|Overall Study|Lost to Follow-up|0
58545|NCT01128400|220808|P1|Overall Study|Lost to Follow-up|1
58546|NCT01128244|220832|P1|Overall Study|Scheduling conflict|2
58547|NCT01128244|220832|P1|Overall Study|Adverse Event|1
58548|NCT01128179|220873|P2|Overall Study|Protocol Violation|0
58549|NCT01128179|220874|P1|Overall Study|Protocol Violation|1
58550|NCT01128179|220873|P2|Overall Study|Death|0
58551|NCT01128179|220874|P1|Overall Study|Death|1
58552|NCT01128153|220894|P2|Overall Study|Developed discontinuation criteria|1
58553|NCT01128153|220895|P1|Overall Study|Developed discontinuation criteria|1
58554|NCT01128153|220894|P2|Overall Study|Protocol Violation|0
58555|NCT01128153|220895|P1|Overall Study|Protocol Violation|2
58556|NCT01128153|220894|P2|Overall Study|Incorrect enrolment to study|1
58557|NCT01128153|220895|P1|Overall Study|Incorrect enrolment to study|2
58558|NCT01128153|220894|P2|Overall Study|Withdrawal by Subject|3
58559|NCT01128153|220895|P1|Overall Study|Withdrawal by Subject|2
58560|NCT01128153|220894|P2|Overall Study|Condition under investigation worsened|7
58561|NCT01128153|220895|P1|Overall Study|Condition under investigation worsened|8
58562|NCT01128153|220894|P2|Overall Study|Adverse Event|3
58563|NCT01128153|220895|P1|Overall Study|Adverse Event|1
58564|NCT01128114|220911|P1|Overall Study|Screening Failed|2
58565|NCT01128114|220911|P1|Overall Study|Treatment Withdrawn|6
58566|NCT01127763|220928|P1|Overall Study|Physician Decision|2
58567|NCT01127763|220928|P1|Overall Study|Withdrawal by Subject|1
58568|NCT01127763|220928|P1|Overall Study|Adverse Event|2
58569|NCT01127646|220948|P2|Overall Study|Protocol Violation|1
58570|NCT01127646|220949|P1|Overall Study|Protocol Violation|0
58571|NCT01127646|220948|P2|Overall Study|Entry Criteria Not Met|0
58572|NCT01127646|220949|P1|Overall Study|Entry Criteria Not Met|1
58573|NCT01127607|220983|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
58574|NCT01127607|220984|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
58575|NCT01127607|220983|P2|Phase II (Between Subjects)|Lost to Follow-up|2
58576|NCT01127607|220984|P1|Phase II (Between Subjects)|Lost to Follow-up|0
58577|NCT01127256|221150|P2|Overall Study|Protocol Violation|0
58578|NCT01127256|221151|P1|Overall Study|Protocol Violation|1
58579|NCT01127256|221150|P2|Overall Study|Withdrawal by Subject|9
58580|NCT01127256|221151|P1|Overall Study|Withdrawal by Subject|5
58581|NCT01127256|221150|P2|Overall Study|Lost to Follow-up|17
58582|NCT01127256|221151|P1|Overall Study|Lost to Follow-up|16
58583|NCT01127256|221150|P2|Overall Study|Lack of Efficacy|0
58584|NCT01127256|221151|P1|Overall Study|Lack of Efficacy|4
58585|NCT01127256|221150|P2|Overall Study|Adverse Event|13
58586|NCT01127256|221151|P1|Overall Study|Adverse Event|13
58587|NCT01127165|221163|P2|Overall Study|Protocol Violation|1
58588|NCT01127165|221164|P1|Overall Study|Protocol Violation|0
58589|NCT01127165|221163|P2|Overall Study|Withdrawal by Subject|3
58590|NCT01127165|221164|P1|Overall Study|Withdrawal by Subject|1
58591|NCT01127165|221163|P2|Overall Study|Lost to Follow-up|5
58592|NCT01127165|221164|P1|Overall Study|Lost to Follow-up|3
58593|NCT01127165|221163|P2|Overall Study|Lack of Efficacy|8
58594|NCT01127165|221164|P1|Overall Study|Lack of Efficacy|10
58595|NCT01127165|221163|P2|Overall Study|Adverse Event|2
58596|NCT01127165|221164|P1|Overall Study|Adverse Event|2
58597|NCT01127139|221176|P1|Overall Study|Reason not specified|1
58598|NCT01127139|221176|P1|Overall Study|Lack of Efficacy|4
58599|NCT01127139|221176|P1|Overall Study|Incompliance|12
58600|NCT01127139|221176|P1|Overall Study|Adverse Event|40
58601|NCT01126619|221231|P1|Overall Study|Non-compliance|1
58602|NCT01126619|221231|P1|Overall Study|Withdrawal by Subject|9
58603|NCT01126619|221231|P1|Overall Study|Serious adverse event|1
58604|NCT01126619|221231|P1|Overall Study|Investigator decision|4
58605|NCT01126619|221231|P1|Overall Study|Not eligible for the study|2
58606|NCT01126580|221259|P3|Overall Study|Treatment Non-compliance|3
58607|NCT01126580|221260|P2|Overall Study|Treatment Non-compliance|2
58608|NCT01126580|221261|P1|Overall Study|Treatment Non-compliance|0
58609|NCT01126580|221259|P3|Overall Study|Lost to Follow-up|9
58610|NCT01126580|221260|P2|Overall Study|Lost to Follow-up|13
58611|NCT01126580|221261|P1|Overall Study|Lost to Follow-up|15
58612|NCT01126580|221259|P3|Overall Study|Protocol Violation|2
58613|NCT01126580|221260|P2|Overall Study|Protocol Violation|1
58614|NCT01126580|221261|P1|Overall Study|Protocol Violation|0
58615|NCT01126580|221259|P3|Overall Study|Lack of Efficacy|4
58616|NCT01126580|221260|P2|Overall Study|Lack of Efficacy|3
58617|NCT01126580|221261|P1|Overall Study|Lack of Efficacy|2
58618|NCT01126580|221259|P3|Overall Study|Entry Criteria Not Met|2
58619|NCT01126580|221260|P2|Overall Study|Entry Criteria Not Met|1
58620|NCT01126580|221261|P1|Overall Study|Entry Criteria Not Met|1
58621|NCT01126580|221259|P3|Overall Study|Physician Decision|2
58622|NCT01126580|221260|P2|Overall Study|Physician Decision|1
58623|NCT01126580|221261|P1|Overall Study|Physician Decision|1
58624|NCT01126580|221259|P3|Overall Study|Sponsor Decision|7
58625|NCT01126580|221260|P2|Overall Study|Sponsor Decision|4
58626|NCT01126580|221261|P1|Overall Study|Sponsor Decision|5
58627|NCT01126580|221259|P3|Overall Study|Withdrawal by Subject|14
58628|NCT01126580|221260|P2|Overall Study|Withdrawal by Subject|19
58629|NCT01126580|221261|P1|Overall Study|Withdrawal by Subject|11
58630|NCT01126580|221259|P3|Overall Study|Adverse Event|12
58631|NCT01126580|221260|P2|Overall Study|Adverse Event|8
58632|NCT01126580|221261|P1|Overall Study|Adverse Event|14
58633|NCT01126541|221356|P3|Overall Study|Administrative reason or other|2
58634|NCT01126541|221357|P2|Overall Study|Administrative reason or other|1
58635|NCT01126541|221358|P1|Overall Study|Administrative reason or other|1
58636|NCT01126541|221356|P3|Overall Study|Protocol Violation|1
58637|NCT01126541|221357|P2|Overall Study|Protocol Violation|0
58638|NCT01126541|221358|P1|Overall Study|Protocol Violation|0
58639|NCT01126541|221356|P3|Overall Study|Withdrawal by Subject|6
58640|NCT01126541|221357|P2|Overall Study|Withdrawal by Subject|5
58641|NCT01126541|221358|P1|Overall Study|Withdrawal by Subject|2
58642|NCT01126541|221356|P3|Overall Study|Lost to Follow-up|2
58643|NCT01126541|221357|P2|Overall Study|Lost to Follow-up|2
58644|NCT01126541|221358|P1|Overall Study|Lost to Follow-up|1
58645|NCT01126541|221356|P3|Overall Study|Lack of Efficacy|11
58646|NCT01126541|221357|P2|Overall Study|Lack of Efficacy|1
58647|NCT01126541|221358|P1|Overall Study|Lack of Efficacy|6
58648|NCT01126541|221356|P3|Overall Study|Death|0
58649|NCT01126541|221357|P2|Overall Study|Death|1
58650|NCT01126541|221358|P1|Overall Study|Death|0
58651|NCT01126541|221356|P3|Overall Study|Adverse Event|4
58652|NCT01126541|221357|P2|Overall Study|Adverse Event|2
58653|NCT01126541|221358|P1|Overall Study|Adverse Event|0
58654|NCT01126437|221442|P3|Overall Study|Other reason not specified|178
58655|NCT01126437|221443|P2|Overall Study|Other reason not specified|176
58656|NCT01126437|221444|P1|Overall Study|Other reason not specified|210
58657|NCT01126437|221442|P3|Overall Study|Withdrawal by Subject|319
58658|NCT01126437|221443|P2|Overall Study|Withdrawal by Subject|335
58659|NCT01126437|221444|P1|Overall Study|Withdrawal by Subject|331
58660|NCT01126437|221442|P3|Overall Study|Lost to Follow-up|55
58661|NCT01126437|221443|P2|Overall Study|Lost to Follow-up|63
58662|NCT01126437|221444|P1|Overall Study|Lost to Follow-up|52
58663|NCT01126437|221442|P3|Overall Study|Protocol Violation|41
58664|NCT01126437|221443|P2|Overall Study|Protocol Violation|66
58665|NCT01126437|221444|P1|Overall Study|Protocol Violation|64
58666|NCT01126437|221442|P3|Overall Study|Lack of Efficacy|59
58667|NCT01126437|221443|P2|Overall Study|Lack of Efficacy|60
58668|NCT01126437|221444|P1|Overall Study|Lack of Efficacy|65
58669|NCT01126437|221442|P3|Overall Study|Adverse Event|635
58670|NCT01126437|221443|P2|Overall Study|Adverse Event|606
58671|NCT01126437|221444|P1|Overall Study|Adverse Event|602
58672|NCT01126437|221442|P3|Overall Study|Sites with data irregularities/fraud|7
58673|NCT01126437|221443|P2|Overall Study|Sites with data irregularities/fraud|6
58674|NCT01126437|221444|P1|Overall Study|Sites with data irregularities/fraud|6
58675|NCT01126437|221442|P3|Overall Study|Not treated|19
58676|NCT01126437|221443|P2|Overall Study|Not treated|18
58677|NCT01126437|221444|P1|Overall Study|Not treated|11
58678|NCT01126424|221482|P6|Overall Study|Withdrawal by Subject|0
58679|NCT01126424|221483|P5|Overall Study|Withdrawal by Subject|1
58680|NCT01126424|221484|P4|Overall Study|Withdrawal by Subject|3
58681|NCT01126424|221485|P3|Overall Study|Withdrawal by Subject|1
58682|NCT01126424|221486|P2|Overall Study|Withdrawal by Subject|0
58683|NCT01126424|221487|P1|Overall Study|Withdrawal by Subject|0
58684|NCT01126424|221482|P6|Overall Study|Adverse Event|0
58685|NCT01126424|221483|P5|Overall Study|Adverse Event|1
58686|NCT01126424|221484|P4|Overall Study|Adverse Event|0
58687|NCT01126424|221485|P3|Overall Study|Adverse Event|0
58688|NCT01126424|221486|P2|Overall Study|Adverse Event|0
58689|NCT01126424|221487|P1|Overall Study|Adverse Event|0
58690|NCT01126359|221510|P2|First Intervention (20-minutes)|Physician Decision|1
58691|NCT01126359|221511|P1|First Intervention (20-minutes)|Physician Decision|0
58692|NCT01126268|221523|P1|Overall Study|Adverse Event|1
58693|NCT01126060|221562|P2|Overall Study|Protocol Violation|2
58694|NCT01126060|221563|P1|Overall Study|Protocol Violation|0
58695|NCT01125930|221571|P2|Overall Study|Lost to Follow-up|2
58696|NCT01125930|221572|P1|Overall Study|Lost to Follow-up|0
58697|NCT01125930|221571|P2|Overall Study|Protocol Violation|1
58698|NCT01125930|221572|P1|Overall Study|Protocol Violation|0
58699|NCT01125930|221571|P2|Overall Study|Withdrawal by Subject|6
58700|NCT01125930|221572|P1|Overall Study|Withdrawal by Subject|1
58701|NCT01125930|221571|P2|Overall Study|Adverse Event|1
58702|NCT01125930|221572|P1|Overall Study|Adverse Event|0
58703|NCT01125917|221726|P1|Overall Study|Lack of Efficacy|19
58704|NCT01125917|221726|P1|Overall Study|Administrative|223
58705|NCT01125917|221726|P1|Overall Study|Withdrawal by Subject|31
58706|NCT01125917|221726|P1|Overall Study|Lost to Follow-up|23
58707|NCT01125917|221726|P1|Overall Study|Adverse Event|43
58708|NCT01125813|221730|P1|Overall Study|Screen Failures|4
58709|NCT01125813|221730|P1|Overall Study|Withdrawal by Subject|1
58710|NCT01125813|221730|P1|Overall Study|Death|1
58711|NCT01125800|221740|P5|Phase II|Disease progression|8
58712|NCT01125800|221741|P4|Phase II|Disease progression|1
58713|NCT01125800|221742|P3|Phase II|Disease progression|0
58714|NCT01125800|221743|P2|Phase II|Disease progression|0
58715|NCT01125800|221744|P1|Phase II|Disease progression|0
58716|NCT01125800|221740|P5|Phase II|Adverse Event|2
58717|NCT01125800|221741|P4|Phase II|Adverse Event|0
58718|NCT01125800|221742|P3|Phase II|Adverse Event|0
58719|NCT01125800|221743|P2|Phase II|Adverse Event|0
58720|NCT01125800|221744|P1|Phase II|Adverse Event|0
58721|NCT01125800|221740|P5|Phase II|Protocol Violation|1
58722|NCT01125800|221741|P4|Phase II|Protocol Violation|0
58723|NCT01125800|221742|P3|Phase II|Protocol Violation|0
58724|NCT01125800|221743|P2|Phase II|Protocol Violation|0
58725|NCT01125800|221744|P1|Phase II|Protocol Violation|0
58726|NCT01125800|221740|P5|Phase I|Disease progression|0
58727|NCT01125800|221741|P4|Phase I|Disease progression|3
58728|NCT01125800|221742|P3|Phase I|Disease progression|1
58729|NCT01125800|221743|P2|Phase I|Disease progression|4
58730|NCT01125800|221744|P1|Phase I|Disease progression|5
58731|NCT01125800|221740|P5|Phase I|Withdrawal by Subject|0
58732|NCT01125800|221741|P4|Phase I|Withdrawal by Subject|0
58733|NCT01125800|221742|P3|Phase I|Withdrawal by Subject|1
58734|NCT01125800|221743|P2|Phase I|Withdrawal by Subject|0
58735|NCT01125800|221744|P1|Phase I|Withdrawal by Subject|0
58736|NCT01125800|221740|P5|Phase I|Administrative problems|0
58737|NCT01125800|221741|P4|Phase I|Administrative problems|0
58738|NCT01125800|221742|P3|Phase I|Administrative problems|0
58739|NCT01125800|221743|P2|Phase I|Administrative problems|0
58740|NCT01125800|221744|P1|Phase I|Administrative problems|1
58741|NCT01125800|221740|P5|Phase I|Adverse Event|0
58742|NCT01125800|221741|P4|Phase I|Adverse Event|7
58743|NCT01125800|221742|P3|Phase I|Adverse Event|1
58744|NCT01125800|221743|P2|Phase I|Adverse Event|2
58745|NCT01125800|221744|P1|Phase I|Adverse Event|2
58746|NCT01125800|221740|P5|Phase I|Protocol Violation|0
58747|NCT01125800|221741|P4|Phase I|Protocol Violation|1
58748|NCT01125800|221742|P3|Phase I|Protocol Violation|1
58749|NCT01125800|221743|P2|Phase I|Protocol Violation|3
58750|NCT01125800|221744|P1|Phase I|Protocol Violation|0
58751|NCT01125748|221810|P2|Overall Study|Patient Decision to Withdraw|4
58752|NCT01125748|221811|P1|Overall Study|Patient Decision to Withdraw|2
58753|NCT01125748|221810|P2|Overall Study|Physician Decision|7
58754|NCT01125748|221811|P1|Overall Study|Physician Decision|8
58755|NCT01125748|221810|P2|Overall Study|Lost to Follow-up|1
58756|NCT01125748|221811|P1|Overall Study|Lost to Follow-up|0
58757|NCT01125748|221810|P2|Overall Study|Adverse Event|2
58758|NCT01125748|221811|P1|Overall Study|Adverse Event|0
58759|NCT01125722|221821|P2|Overall Study|Lost to Follow-up|0
58760|NCT01125722|221822|P1|Overall Study|Lost to Follow-up|1
58761|NCT01125722|221821|P2|Overall Study|Withdrawal by Subject|1
58762|NCT01125722|221822|P1|Overall Study|Withdrawal by Subject|2
58763|NCT01125566|221869|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|4
58764|NCT01125566|221870|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
58765|NCT01125566|221871|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
58766|NCT01125566|221869|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|20
58767|NCT01125566|221870|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
58768|NCT01125566|221871|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
58769|NCT01125566|221869|P3|Patients Before the Switch (26Apr2013)|Other than those stated above|0
58770|NCT01125566|221870|P2|Patients Before the Switch (26Apr2013)|Other than those stated above|5
58771|NCT01125566|221871|P1|Patients Before the Switch (26Apr2013)|Other than those stated above|23
58772|NCT01125566|221869|P3|Patients Before the Switch (26Apr2013)|Not treated|0
58773|NCT01125566|221870|P2|Patients Before the Switch (26Apr2013)|Not treated|0
58774|NCT01125566|221871|P1|Patients Before the Switch (26Apr2013)|Not treated|2
58775|NCT01125566|221869|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
58776|NCT01125566|221870|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|21
58777|NCT01125566|221871|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|25
58778|NCT01125566|221869|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
58779|NCT01125566|221870|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|1
58780|NCT01125566|221871|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
58781|NCT01125566|221869|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
58782|NCT01125566|221870|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
58783|NCT01125566|221871|P1|Patients Before the Switch (26Apr2013)|Adverse Event|24
58784|NCT01125566|221869|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
58785|NCT01125566|221870|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|4
58786|NCT01125566|221871|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|5
58787|NCT01125566|221869|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
58788|NCT01125566|221870|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|100
58789|NCT01125566|221871|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|181
58790|NCT01125514|221884|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
58791|NCT01125514|221884|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
58792|NCT01125514|221884|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
58793|NCT01125514|221884|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
58794|NCT01125514|221884|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
58795|NCT01125514|221884|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
58796|NCT01125189|221959|P3|Follow up Period|Other reasons|5
58797|NCT01125189|221960|P2|Follow up Period|Other reasons|4
58798|NCT01125189|221961|P1|Follow up Period|Other reasons|4
58799|NCT01125189|221959|P3|Follow up Period|Lost to Follow-up|6
58800|NCT01125189|221960|P2|Follow up Period|Lost to Follow-up|9
58801|NCT01125189|221961|P1|Follow up Period|Lost to Follow-up|12
58802|NCT01125189|221959|P3|Follow up Period|Death|0
58803|NCT01125189|221960|P2|Follow up Period|Death|0
58804|NCT01125189|221961|P1|Follow up Period|Death|1
58805|NCT01125189|221959|P3|Follow up Period|Withdrawal by Subject|5
58806|NCT01125189|221960|P2|Follow up Period|Withdrawal by Subject|2
58807|NCT01125189|221961|P1|Follow up Period|Withdrawal by Subject|3
58808|NCT01125189|221959|P3|Treatment Period|Completed 24 week treatment period only|2
58809|NCT01125189|221960|P2|Treatment Period|Completed 24 week treatment period only|1
58810|NCT01125189|221961|P1|Treatment Period|Completed 24 week treatment period only|2
58811|NCT01125189|221959|P3|Treatment Period|Other reasons|0
58812|NCT01125189|221960|P2|Treatment Period|Other reasons|1
58813|NCT01125189|221961|P1|Treatment Period|Other reasons|1
58814|NCT01125189|221959|P3|Treatment Period|Participants requested to discontinue|4
58815|NCT01125189|221960|P2|Treatment Period|Participants requested to discontinue|3
58816|NCT01125189|221961|P1|Treatment Period|Participants requested to discontinue|1
58817|NCT01125189|221959|P3|Treatment Period|Poor compliance/noncompliance|0
58818|NCT01125189|221960|P2|Treatment Period|Poor compliance/noncompliance|1
58819|NCT01125189|221961|P1|Treatment Period|Poor compliance/noncompliance|0
58820|NCT01125189|221959|P3|Treatment Period|Lost to Follow-up|1
58821|NCT01125189|221960|P2|Treatment Period|Lost to Follow-up|2
58822|NCT01125189|221961|P1|Treatment Period|Lost to Follow-up|1
58823|NCT01125189|221959|P3|Treatment Period|Death|0
58824|NCT01125189|221960|P2|Treatment Period|Death|0
58825|NCT01125189|221961|P1|Treatment Period|Death|1
58826|NCT01125189|221959|P3|Treatment Period|Withdrawal by Subject|1
58827|NCT01125189|221960|P2|Treatment Period|Withdrawal by Subject|1
58828|NCT01125189|221961|P1|Treatment Period|Withdrawal by Subject|3
58829|NCT01125189|221959|P3|Treatment Period|Adverse Event|8
58830|NCT01125189|221960|P2|Treatment Period|Adverse Event|8
58831|NCT01125189|221961|P1|Treatment Period|Adverse Event|7
58832|NCT01125189|221959|P3|Treatment Period|Lack of Efficacy|25
58833|NCT01125189|221960|P2|Treatment Period|Lack of Efficacy|18
58834|NCT01125189|221961|P1|Treatment Period|Lack of Efficacy|15
58835|NCT01124916|222015|P2|Overall Study|Lost to Follow-up|2
58836|NCT01124916|222016|P1|Overall Study|Lost to Follow-up|3
58837|NCT01124864|222030|P6|Overall Study|Protocol Violation|0
58838|NCT01124864|222031|P5|Overall Study|Protocol Violation|1
58839|NCT01124864|222032|P4|Overall Study|Protocol Violation|0
58840|NCT01124864|222033|P3|Overall Study|Protocol Violation|0
58841|NCT01124864|222034|P2|Overall Study|Protocol Violation|0
58842|NCT01124864|222035|P1|Overall Study|Protocol Violation|1
58843|NCT01124864|222030|P6|Overall Study|Lost to Follow-up|0
58844|NCT01124864|222031|P5|Overall Study|Lost to Follow-up|0
58845|NCT01124864|222032|P4|Overall Study|Lost to Follow-up|1
58846|NCT01124864|222033|P3|Overall Study|Lost to Follow-up|0
58847|NCT01124864|222034|P2|Overall Study|Lost to Follow-up|1
58848|NCT01124864|222035|P1|Overall Study|Lost to Follow-up|1
58849|NCT01124864|222030|P6|Overall Study|Withdrawal by Subject|1
58850|NCT01124864|222031|P5|Overall Study|Withdrawal by Subject|2
58851|NCT01124864|222032|P4|Overall Study|Withdrawal by Subject|0
58852|NCT01124864|222033|P3|Overall Study|Withdrawal by Subject|4
58853|NCT01124864|222034|P2|Overall Study|Withdrawal by Subject|3
58854|NCT01124864|222035|P1|Overall Study|Withdrawal by Subject|2
58855|NCT01124864|222030|P6|Overall Study|Death|0
58856|NCT01124864|222031|P5|Overall Study|Death|1
58857|NCT01124864|222032|P4|Overall Study|Death|2
58858|NCT01124864|222033|P3|Overall Study|Death|6
58859|NCT01124864|222034|P2|Overall Study|Death|9
58860|NCT01124864|222035|P1|Overall Study|Death|6
58861|NCT01124864|222030|P6|Overall Study|Follow up phase competed as per protocol|2
58862|NCT01124864|222031|P5|Overall Study|Follow up phase competed as per protocol|26
58863|NCT01124864|222032|P4|Overall Study|Follow up phase competed as per protocol|18
58864|NCT01124864|222033|P3|Overall Study|Follow up phase competed as per protocol|24
58865|NCT01124864|222034|P2|Overall Study|Follow up phase competed as per protocol|22
58866|NCT01124864|222035|P1|Overall Study|Follow up phase competed as per protocol|18
58867|NCT01124838|222069|P2|Overall Study|Lost to Follow-up|0
58868|NCT01124838|222070|P1|Overall Study|Lost to Follow-up|2
58869|NCT01124838|222069|P2|Overall Study|Withdrawal by Subject|2
58870|NCT01124838|222070|P1|Overall Study|Withdrawal by Subject|3
58871|NCT01124838|222069|P2|Overall Study|Lack of Efficacy|0
58872|NCT01124838|222070|P1|Overall Study|Lack of Efficacy|2
58873|NCT01124838|222069|P2|Overall Study|Adverse Event|11
58874|NCT01124838|222070|P1|Overall Study|Adverse Event|7
58875|NCT01124838|222069|P2|Overall Study|Miscellaneous|2
58876|NCT01124838|222070|P1|Overall Study|Miscellaneous|4
58877|NCT01124643|222137|P1|Overall Study|Death|1
58878|NCT01124617|222151|P2|Overall Study|Unspecified|1
58879|NCT01124617|222152|P1|Overall Study|Unspecified|2
58880|NCT01124617|222151|P2|Overall Study|Withdrawal by Subject|1
58881|NCT01124617|222152|P1|Overall Study|Withdrawal by Subject|9
58882|NCT01124617|222151|P2|Overall Study|Protocol Violation|1
58883|NCT01124617|222152|P1|Overall Study|Protocol Violation|1
58884|NCT01124617|222151|P2|Overall Study|Lack of Efficacy|1
58885|NCT01124617|222152|P1|Overall Study|Lack of Efficacy|2
58886|NCT01124617|222151|P2|Overall Study|Adverse Event|2
58887|NCT01124617|222152|P1|Overall Study|Adverse Event|5
58888|NCT01124604|222184|P2|Overall Study|Disease Progression|1
58889|NCT01124604|222185|P1|Overall Study|Disease Progression|0
58890|NCT01124604|222184|P2|Overall Study|Withdrawal by Subject|0
58891|NCT01124604|222185|P1|Overall Study|Withdrawal by Subject|4
58892|NCT01124604|222184|P2|Overall Study|Lack of Efficacy|0
58893|NCT01124604|222185|P1|Overall Study|Lack of Efficacy|1
58894|NCT01124604|222184|P2|Overall Study|Adverse Event|1
58895|NCT01124604|222185|P1|Overall Study|Adverse Event|10
58896|NCT01124448|222224|P2|Overall Study|Protocol Violation|0
58897|NCT01124448|222225|P1|Overall Study|Protocol Violation|2
58898|NCT01124448|222224|P2|Overall Study|Lost to Follow-up|3
58899|NCT01124448|222225|P1|Overall Study|Lost to Follow-up|0
58900|NCT01124422|222233|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
58901|NCT01124422|222234|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
58902|NCT01124422|222235|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
58903|NCT01124422|222233|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
58904|NCT01124422|222234|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
58905|NCT01124422|222235|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
58906|NCT01124422|222233|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
58907|NCT01124422|222234|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
58908|NCT01124422|222235|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
58909|NCT01124422|222233|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
58910|NCT01124422|222234|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
58911|NCT01124422|222235|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
58912|NCT01124422|222233|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
58913|NCT01124422|222234|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
58914|NCT01124422|222235|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
58915|NCT01124422|222233|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
58916|NCT01124422|222234|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
58917|NCT01124422|222235|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
58918|NCT01124422|222233|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
58919|NCT01124422|222234|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
58920|NCT01124422|222235|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
58921|NCT01124422|222233|P3|4-Week Open-label Run-in Phase|Physician Decision|0
58922|NCT01124422|222234|P2|4-Week Open-label Run-in Phase|Physician Decision|0
58923|NCT01124422|222235|P1|4-Week Open-label Run-in Phase|Physician Decision|4
58924|NCT01124422|222233|P3|4-Week Open-label Run-in Phase|Adverse Event|0
58925|NCT01124422|222234|P2|4-Week Open-label Run-in Phase|Adverse Event|0
58926|NCT01124422|222235|P1|4-Week Open-label Run-in Phase|Adverse Event|7
58927|NCT01124422|222233|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
58928|NCT01124422|222234|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
58929|NCT01124422|222235|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
58930|NCT01124292|222305|P3|Overall Study|piercing track closed|1
58931|NCT01124292|222306|P2|Overall Study|piercing track closed|2
58932|NCT01124292|222307|P1|Overall Study|piercing track closed|0
58933|NCT01124292|222305|P3|Overall Study|medical issue unrelated to the study|2
58934|NCT01124292|222306|P2|Overall Study|medical issue unrelated to the study|0
58935|NCT01124292|222307|P1|Overall Study|medical issue unrelated to the study|0
58936|NCT01124292|222305|P3|Overall Study|Withdrawal by Subject|2
58937|NCT01124292|222306|P2|Overall Study|Withdrawal by Subject|6
58938|NCT01124292|222307|P1|Overall Study|Withdrawal by Subject|0
58939|NCT01124292|222305|P3|Overall Study|Physician Decision|2
58940|NCT01124292|222306|P2|Overall Study|Physician Decision|3
58941|NCT01124292|222307|P1|Overall Study|Physician Decision|0
58942|NCT01124292|222305|P3|Overall Study|Lost to Follow-up|3
58943|NCT01124292|222306|P2|Overall Study|Lost to Follow-up|4
58944|NCT01124292|222307|P1|Overall Study|Lost to Follow-up|2
58945|NCT01124175|222365|P2|Washout of 7 Days|Withdrawal by Subject|2
58946|NCT01124175|222366|P1|Washout of 7 Days|Withdrawal by Subject|0
58947|NCT01124162|222384|P2|Washout of 7 Days|Withdrawal by Subject|0
58948|NCT01124162|222385|P1|Washout of 7 Days|Withdrawal by Subject|1
58949|NCT01124162|222384|P2|First Intervention|Adverse Event|0
58950|NCT01124162|222385|P1|First Intervention|Adverse Event|2
58951|NCT01124149|222401|P1|Maintenance Phase|Non-compliance|1
58952|NCT01124149|222401|P1|Maintenance Phase|Coordinator error|1
58953|NCT01124149|222401|P1|Maintenance Phase|Protocol Violation|5
58954|NCT01124149|222401|P1|Maintenance Phase|Withdrawal by Subject|10
58955|NCT01124149|222401|P1|Maintenance Phase|Lost to Follow-up|15
58956|NCT01124149|222401|P1|Maintenance Phase|Adverse Event|24
58957|NCT01124149|222401|P1|Maintenance Phase|Lack of Efficacy|40
58958|NCT01124149|222401|P1|Acute Phase|Sponsor decision|1
58959|NCT01124149|222401|P1|Acute Phase|Travelling to another country|1
58960|NCT01124149|222401|P1|Acute Phase|Low hemoglobin|1
58961|NCT01124149|222401|P1|Acute Phase|Non-compliance|1
58962|NCT01124149|222401|P1|Acute Phase|UC symptoms not ameliorated|1
58963|NCT01124149|222401|P1|Acute Phase|Sponsor request|1
58964|NCT01124149|222401|P1|Acute Phase|Prolonged antibiotic therapy|1
58965|NCT01124149|222401|P1|Acute Phase|Lost to Follow-up|2
58966|NCT01124149|222401|P1|Acute Phase|Protocol Violation|14
58967|NCT01124149|222401|P1|Acute Phase|Lack of Efficacy|17
58968|NCT01124149|222401|P1|Acute Phase|Adverse Event|21
58969|NCT01124149|222401|P1|Acute Phase|Withdrawal by Subject|22
58970|NCT01124097|222421|P4|Overall Study|Physician Decision|0
58971|NCT01124097|222422|P3|Overall Study|Physician Decision|0
58972|NCT01124097|222423|P2|Overall Study|Physician Decision|1
58973|NCT01124097|222424|P1|Overall Study|Physician Decision|2
58974|NCT01124097|222421|P4|Overall Study|Protocol Violation|1
58975|NCT01124097|222422|P3|Overall Study|Protocol Violation|2
58976|NCT01124097|222423|P2|Overall Study|Protocol Violation|0
58977|NCT01124097|222424|P1|Overall Study|Protocol Violation|2
58978|NCT01124097|222421|P4|Overall Study|Adverse Event|7
58979|NCT01124097|222422|P3|Overall Study|Adverse Event|15
58980|NCT01124097|222423|P2|Overall Study|Adverse Event|15
58981|NCT01124097|222424|P1|Overall Study|Adverse Event|24
58982|NCT01124097|222421|P4|Overall Study|Lack of Efficacy|3
58983|NCT01124097|222422|P3|Overall Study|Lack of Efficacy|1
58984|NCT01124097|222423|P2|Overall Study|Lack of Efficacy|3
58985|NCT01124097|222424|P1|Overall Study|Lack of Efficacy|2
58986|NCT01124097|222421|P4|Overall Study|Withdrawal by Subject|3
58987|NCT01124097|222422|P3|Overall Study|Withdrawal by Subject|2
58988|NCT01124097|222423|P2|Overall Study|Withdrawal by Subject|3
58989|NCT01124097|222424|P1|Overall Study|Withdrawal by Subject|4
58990|NCT01124045|222436|P2|Overall Study|Physician Decision|2
58991|NCT01124045|222437|P1|Overall Study|Physician Decision|0
58992|NCT01124045|222436|P2|Overall Study|Lost to Follow-up|1
58993|NCT01124045|222437|P1|Overall Study|Lost to Follow-up|0
58994|NCT01124006|222470|P3|Overall Study|Other|1
58995|NCT01124006|222471|P2|Overall Study|Other|0
58996|NCT01124006|222472|P1|Overall Study|Other|0
58997|NCT01124006|222470|P3|Overall Study|Lost to Follow-up|1
58998|NCT01124006|222471|P2|Overall Study|Lost to Follow-up|0
58999|NCT01124006|222472|P1|Overall Study|Lost to Follow-up|1
59000|NCT01124006|222470|P3|Overall Study|Withdrawal by Subject|0
59001|NCT01124006|222471|P2|Overall Study|Withdrawal by Subject|2
59002|NCT01124006|222472|P1|Overall Study|Withdrawal by Subject|2
59003|NCT01123980|222500|P2|Overall Study|Unclassified|7
59004|NCT01123980|222501|P1|Overall Study|Unclassified|6
59005|NCT01123980|222500|P2|Overall Study|Withdrawal by Subject|3
59006|NCT01123980|222501|P1|Overall Study|Withdrawal by Subject|5
59007|NCT01123980|222500|P2|Overall Study|Protocol Violation|6
59008|NCT01123980|222501|P1|Overall Study|Protocol Violation|6
59009|NCT01123980|222500|P2|Overall Study|Lost to Follow-up|6
59010|NCT01123980|222501|P1|Overall Study|Lost to Follow-up|0
59011|NCT01123980|222500|P2|Overall Study|Physician Decision|1
59012|NCT01123980|222501|P1|Overall Study|Physician Decision|0
59013|NCT01123980|222500|P2|Overall Study|Lack of Efficacy|0
59014|NCT01123980|222501|P1|Overall Study|Lack of Efficacy|1
59015|NCT01123980|222500|P2|Overall Study|Adverse Event|1
59016|NCT01123980|222501|P1|Overall Study|Adverse Event|1
59017|NCT01123941|222521|P2|Overall Study|Lost to Follow-up|1
59018|NCT01123941|222522|P1|Overall Study|Lost to Follow-up|2
59019|NCT01123889|222557|P2|Overall Study|Lost to Follow-up|1
59020|NCT01123889|222558|P1|Overall Study|Lost to Follow-up|3
59021|NCT01123850|222568|P1|Overall Study|Slow enrollment|45
59022|NCT01123642|222573|P1|Overall Study|ineligible at baseline assessment|36
59023|NCT01123642|222573|P1|Overall Study|Withdrawal by Subject|9
59024|NCT01123642|222573|P1|Overall Study|Lost to Follow-up|23
59025|NCT01123395|222586|P2|Washout Period of 14 Days|Withdrawal by Subject|1
59026|NCT01123395|222587|P1|Washout Period of 14 Days|Withdrawal by Subject|0
59027|NCT01123356|222597|P1|Overall Study|Withdrawal by Subject|1
59028|NCT01123356|222597|P1|Overall Study|Lack of Efficacy|4
59029|NCT01123356|222597|P1|Overall Study|Adverse Event|2
59030|NCT01123148|222605|P1|Overall Study|Didn't meet milestone criteria|1
59031|NCT01123148|222605|P1|Overall Study|Coughing caused unacceptable EEG quality|1
59032|NCT01122927|222609|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
59033|NCT01122927|222610|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
59034|NCT01122927|222609|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
59035|NCT01122927|222610|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
59036|NCT01122927|222609|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
59037|NCT01122927|222610|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
59038|NCT01122927|222609|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
59039|NCT01122927|222610|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
59040|NCT01122927|222609|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
59041|NCT01122927|222610|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
59042|NCT01122927|222609|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
59043|NCT01122927|222610|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
59044|NCT01122927|222609|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
59045|NCT01122927|222610|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
59046|NCT01122927|222609|P2|Period 1 - Conversion Phase|Protocol Deviation|0
59047|NCT01122927|222610|P1|Period 1 - Conversion Phase|Protocol Deviation|1
59048|NCT01122927|222609|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
59049|NCT01122927|222610|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
59050|NCT01122927|222609|P2|Period 1 - Conversion Phase|Physician Decision|0
59051|NCT01122927|222610|P1|Period 1 - Conversion Phase|Physician Decision|2
59052|NCT01122927|222609|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
59053|NCT01122927|222610|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
59054|NCT01122927|222609|P2|Period 1 - Conversion Phase|Adverse Event|0
59055|NCT01122927|222610|P1|Period 1 - Conversion Phase|Adverse Event|3
59056|NCT01122862|222641|P3|Period 2|Adverse Event|1
59057|NCT01122862|222642|P2|Period 2|Adverse Event|0
59058|NCT01122862|222643|P1|Period 2|Adverse Event|0
59059|NCT01122862|222641|P3|Period 1|Protocol Violation|0
59060|NCT01122862|222642|P2|Period 1|Protocol Violation|1
59061|NCT01122862|222643|P1|Period 1|Protocol Violation|0
59062|NCT01122680|222661|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
59063|NCT01122680|222662|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
59064|NCT01122680|222663|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
59065|NCT01122680|222664|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
59066|NCT01122680|222661|P4|Period 3 (4 Weeks)|Adverse Event|0
59067|NCT01122680|222662|P3|Period 3 (4 Weeks)|Adverse Event|0
59068|NCT01122680|222663|P2|Period 3 (4 Weeks)|Adverse Event|0
59069|NCT01122680|222664|P1|Period 3 (4 Weeks)|Adverse Event|1
59070|NCT01122680|222661|P4|Period 2 (4 Weeks)|Other|0
59071|NCT01122680|222662|P3|Period 2 (4 Weeks)|Other|0
59072|NCT01122680|222663|P2|Period 2 (4 Weeks)|Other|0
59073|NCT01122680|222664|P1|Period 2 (4 Weeks)|Other|1
59074|NCT01122680|222661|P4|Period 2 (4 Weeks)|Protocol Violation|1
59075|NCT01122680|222662|P3|Period 2 (4 Weeks)|Protocol Violation|0
59076|NCT01122680|222663|P2|Period 2 (4 Weeks)|Protocol Violation|0
59077|NCT01122680|222664|P1|Period 2 (4 Weeks)|Protocol Violation|0
59078|NCT01122680|222661|P4|Period 1 (4 Weeks)|Other|0
59079|NCT01122680|222662|P3|Period 1 (4 Weeks)|Other|0
59080|NCT01122680|222663|P2|Period 1 (4 Weeks)|Other|1
59081|NCT01122680|222664|P1|Period 1 (4 Weeks)|Other|1
59082|NCT01122680|222661|P4|Period 1 (4 Weeks)|Protocol Violation|0
59083|NCT01122680|222662|P3|Period 1 (4 Weeks)|Protocol Violation|0
59084|NCT01122680|222663|P2|Period 1 (4 Weeks)|Protocol Violation|0
59085|NCT01122680|222664|P1|Period 1 (4 Weeks)|Protocol Violation|1
59086|NCT01122680|222661|P4|Period 1 (4 Weeks)|Adverse Event|0
59087|NCT01122680|222662|P3|Period 1 (4 Weeks)|Adverse Event|0
59088|NCT01122680|222663|P2|Period 1 (4 Weeks)|Adverse Event|0
59089|NCT01122680|222664|P1|Period 1 (4 Weeks)|Adverse Event|1
59090|NCT01122576|222729|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
59091|NCT01122576|222730|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
59092|NCT01122576|222731|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
59093|NCT01122576|222729|P3|Post-Cataract Surgery|Central Macular Edema|1
59094|NCT01122576|222730|P2|Post-Cataract Surgery|Central Macular Edema|0
59095|NCT01122576|222731|P1|Post-Cataract Surgery|Central Macular Edema|0
59096|NCT01122576|222729|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
59097|NCT01122576|222730|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
59098|NCT01122576|222731|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
59099|NCT01122394|222885|P2|Overall Study|Adverse Event|1
59100|NCT01122394|222886|P1|Overall Study|Adverse Event|0
59101|NCT01122394|222885|P2|Overall Study|Lost to Follow-up|2
59102|NCT01122394|222886|P1|Overall Study|Lost to Follow-up|2
59103|NCT01122394|222885|P2|Overall Study|Withdrawal by Subject|1
59104|NCT01122394|222886|P1|Overall Study|Withdrawal by Subject|1
59105|NCT01122381|222902|P2|Overall Study|study terminated early|1
59106|NCT01122381|222903|P1|Overall Study|study terminated early|0
59107|NCT01122264|222912|P3|Overall Study|Lack of Efficacy|1
59108|NCT01122264|222913|P2|Overall Study|Lack of Efficacy|1
59109|NCT01122264|222914|P1|Overall Study|Lack of Efficacy|3
59110|NCT01122264|222912|P3|Overall Study|Physician Decision|1
59111|NCT01122264|222913|P2|Overall Study|Physician Decision|1
59112|NCT01122264|222914|P1|Overall Study|Physician Decision|3
59113|NCT01122264|222912|P3|Overall Study|Withdrawal by Subject|16
59114|NCT01122264|222913|P2|Overall Study|Withdrawal by Subject|6
59115|NCT01122264|222914|P1|Overall Study|Withdrawal by Subject|6
59116|NCT01122264|222912|P3|Overall Study|Protocol Violation|9
59117|NCT01122264|222913|P2|Overall Study|Protocol Violation|7
59118|NCT01122264|222914|P1|Overall Study|Protocol Violation|7
59119|NCT01122264|222912|P3|Overall Study|Entry Criteria Not Met|0
59120|NCT01122264|222913|P2|Overall Study|Entry Criteria Not Met|0
59121|NCT01122264|222914|P1|Overall Study|Entry Criteria Not Met|1
59122|NCT01122264|222912|P3|Overall Study|Lost to Follow-up|13
59123|NCT01122264|222913|P2|Overall Study|Lost to Follow-up|9
59124|NCT01122264|222914|P1|Overall Study|Lost to Follow-up|5
59125|NCT01122264|222912|P3|Overall Study|Death|0
59126|NCT01122264|222913|P2|Overall Study|Death|0
59127|NCT01122264|222914|P1|Overall Study|Death|1
59128|NCT01122264|222912|P3|Overall Study|Adverse Event|7
59129|NCT01122264|222913|P2|Overall Study|Adverse Event|5
59130|NCT01122264|222914|P1|Overall Study|Adverse Event|6
59131|NCT01121991|223041|P1|Overall Study|No Fertilization|1
59132|NCT01121991|223041|P1|Overall Study|No Oocytes Retrieved|3
59133|NCT01121991|223041|P1|Overall Study|Lack of Ovarian Response|2
59134|NCT01121926|223066|P2|Washout Period|Positive pregnancy test|1
59135|NCT01121926|223067|P1|Washout Period|Positive pregnancy test|0
59136|NCT01121926|223066|P2|Washout Period|Adverse Event|1
59137|NCT01121926|223067|P1|Washout Period|Adverse Event|0
59138|NCT01121926|223066|P2|First Intervention Period|Adverse Event|0
59139|NCT01121926|223067|P1|First Intervention Period|Adverse Event|1
59140|NCT01121913|223085|P4|Third Washout Period|Adverse Event|0
59141|NCT01121913|223086|P3|Third Washout Period|Adverse Event|0
59142|NCT01121913|223087|P2|Third Washout Period|Adverse Event|0
59143|NCT01121913|223088|P1|Third Washout Period|Adverse Event|1
59144|NCT01121913|223085|P4|Second Washout Period|Withdrawal by Subject|0
59145|NCT01121913|223086|P3|Second Washout Period|Withdrawal by Subject|1
59146|NCT01121913|223087|P2|Second Washout Period|Withdrawal by Subject|0
59147|NCT01121913|223088|P1|Second Washout Period|Withdrawal by Subject|0
59148|NCT01121913|223085|P4|Second Intervention Period|Adverse Event|0
59149|NCT01121913|223086|P3|Second Intervention Period|Adverse Event|1
59150|NCT01121913|223087|P2|Second Intervention Period|Adverse Event|0
59151|NCT01121913|223088|P1|Second Intervention Period|Adverse Event|0
59152|NCT01121913|223085|P4|First Washout Period|Withdrawal by Subject|0
59153|NCT01121913|223086|P3|First Washout Period|Withdrawal by Subject|0
59154|NCT01121913|223087|P2|First Washout Period|Withdrawal by Subject|0
59155|NCT01121913|223088|P1|First Washout Period|Withdrawal by Subject|1
59156|NCT01121913|223085|P4|First Intervention Period|Adverse Event|0
59157|NCT01121913|223086|P3|First Intervention Period|Adverse Event|1
59158|NCT01121913|223087|P2|First Intervention Period|Adverse Event|0
59159|NCT01121913|223088|P1|First Intervention Period|Adverse Event|0
59160|NCT01121900|223118|P2|Washout Period of 7 Days|Withdrawal by Subject|1
59161|NCT01121900|223119|P1|Washout Period of 7 Days|Withdrawal by Subject|0
59162|NCT01121900|223118|P2|First Intervention Period|Adverse Event|1
59163|NCT01121900|223119|P1|First Intervention Period|Adverse Event|1
59164|NCT01121757|223139|P2|Combination|Disease Progression|0
59165|NCT01121757|223140|P1|Combination|Disease Progression|2
59166|NCT01121757|223139|P2|Combination|Physician Decision|1
59167|NCT01121757|223140|P1|Combination|Physician Decision|0
59168|NCT01121757|223139|P2|First Drug|Disease Progression|2
59169|NCT01121757|223140|P1|First Drug|Disease Progression|0
59170|NCT01121757|223139|P2|First Drug|Death|0
59171|NCT01121757|223140|P1|First Drug|Death|1
59172|NCT01121666|223156|P2|Overall Study|Protocol Violation|10
59173|NCT01121666|223157|P1|Overall Study|Protocol Violation|29
59174|NCT01121575|223213|P6|Overall Study|Death|1
59175|NCT01121575|223214|P5|Overall Study|Death|7
59176|NCT01121575|223215|P4|Overall Study|Death|1
59177|NCT01121575|223216|P3|Overall Study|Death|0
59178|NCT01121575|223217|P2|Overall Study|Death|0
59179|NCT01121575|223218|P1|Overall Study|Death|6
59180|NCT01121575|223213|P6|Overall Study|Unspecified Reasons|10
59181|NCT01121575|223214|P5|Overall Study|Unspecified Reasons|13
59182|NCT01121575|223215|P4|Overall Study|Unspecified Reasons|5
59183|NCT01121575|223216|P3|Overall Study|Unspecified Reasons|7
59184|NCT01121575|223217|P2|Overall Study|Unspecified Reasons|6
59185|NCT01121575|223218|P1|Overall Study|Unspecified Reasons|8
59186|NCT01121575|223213|P6|Overall Study|Participant Refused Further Follow-Up|1
59187|NCT01121575|223214|P5|Overall Study|Participant Refused Further Follow-Up|5
59188|NCT01121575|223215|P4|Overall Study|Participant Refused Further Follow-Up|0
59189|NCT01121575|223216|P3|Overall Study|Participant Refused Further Follow-Up|0
59190|NCT01121575|223217|P2|Overall Study|Participant Refused Further Follow-Up|0
59191|NCT01121575|223218|P1|Overall Study|Participant Refused Further Follow-Up|0
59192|NCT01121562|223342|P1|Overall Study|Met study discontinuation criteria|1
59193|NCT01121562|223342|P1|Overall Study|Sponsor Decision|1
59194|NCT01121562|223342|P1|Overall Study|Adverse Event|1
59195|NCT01121562|223342|P1|Overall Study|Withdrawal by Subject|1
59196|NCT01121562|223342|P1|Overall Study|Objective progression or relapse|8
59197|NCT01121549|223351|P1|Overall Study|Unspecified|58
59198|NCT01121549|223351|P1|Overall Study|Withdrawal by Subject|16
59199|NCT01121549|223351|P1|Overall Study|Protocol Violation|33
59200|NCT01121549|223351|P1|Overall Study|Pregnancy|1
59201|NCT01121549|223351|P1|Overall Study|Study terminated by sponsor|197
59202|NCT01121549|223351|P1|Overall Study|Did not meet entrance criteria|9
59203|NCT01121549|223351|P1|Overall Study|Lost to Follow-up|12
59204|NCT01121549|223351|P1|Overall Study|Lack of Efficacy|11
59205|NCT01121549|223351|P1|Overall Study|Adverse Event|10
59206|NCT01121536|223362|P1|Overall Study|Not specified|118
59207|NCT01121536|223362|P1|Overall Study|Lost to Follow-up|39
59208|NCT01121536|223362|P1|Overall Study|Noncompliance with study procedures|9
59209|NCT01121536|223362|P1|Overall Study|Noncompliance with study medication|12
59210|NCT01121536|223362|P1|Overall Study|Protocol Violation|20
59211|NCT01121536|223362|P1|Overall Study|Withdrawal by Subject|65
59212|NCT01121536|223362|P1|Overall Study|Lack of Efficacy|35
59213|NCT01121536|223362|P1|Overall Study|Adverse Event|63
59214|NCT01121484|223383|P2|Overall Study|Randomized, not treated|4
59215|NCT01121484|223384|P1|Overall Study|Randomized, not treated|1
59216|NCT01121484|223383|P2|Overall Study|unspecified|3
59217|NCT01121484|223384|P1|Overall Study|unspecified|3
59218|NCT01121484|223383|P2|Overall Study|Discontinuation of study by sponsor|1
59219|NCT01121484|223384|P1|Overall Study|Discontinuation of study by sponsor|0
59220|NCT01121484|223383|P2|Overall Study|Withdrawal by Subject|7
59221|NCT01121484|223384|P1|Overall Study|Withdrawal by Subject|8
59222|NCT01121484|223383|P2|Overall Study|Protocol Violation|0
59223|NCT01121484|223384|P1|Overall Study|Protocol Violation|1
59224|NCT01121484|223383|P2|Overall Study|Physician Decision|3
59225|NCT01121484|223384|P1|Overall Study|Physician Decision|0
59226|NCT01121484|223383|P2|Overall Study|Lost to Follow-up|9
59227|NCT01121484|223384|P1|Overall Study|Lost to Follow-up|5
59228|NCT01121484|223383|P2|Overall Study|Lack of Efficacy|11
59229|NCT01121484|223384|P1|Overall Study|Lack of Efficacy|3
59230|NCT01121484|223383|P2|Overall Study|Adverse Event|5
59231|NCT01121484|223384|P1|Overall Study|Adverse Event|12
59232|NCT01121406|223402|P2|Overall Study|Not treated|0
59233|NCT01121406|223403|P1|Overall Study|Not treated|1
59234|NCT01121406|223402|P2|Overall Study|Reason other than specified above|6
59235|NCT01121406|223403|P1|Overall Study|Reason other than specified above|2
59236|NCT01121406|223402|P2|Overall Study|Refused continuation of study med.|2
59237|NCT01121406|223403|P1|Overall Study|Refused continuation of study med.|1
59238|NCT01121406|223402|P2|Overall Study|Lost to Follow-up|1
59239|NCT01121406|223403|P1|Overall Study|Lost to Follow-up|0
59240|NCT01121406|223402|P2|Overall Study|Non−compliant with protocol|2
59241|NCT01121406|223403|P1|Overall Study|Non−compliant with protocol|0
59242|NCT01121406|223402|P2|Overall Study|Other AE|10
59243|NCT01121406|223403|P1|Overall Study|Other AE|3
59244|NCT01121406|223402|P2|Overall Study|Wors. or AE of underlying cancer disease|6
59245|NCT01121406|223403|P1|Overall Study|Wors. or AE of underlying cancer disease|4
59246|NCT01121406|223402|P2|Overall Study|Progressive disease RECIST|28
59247|NCT01121406|223403|P1|Overall Study|Progressive disease RECIST|44
59248|NCT01121393|223453|P2|Overall Study|Not treated|9
59249|NCT01121393|223454|P1|Overall Study|Not treated|3
59250|NCT01121393|223453|P2|Overall Study|Refused cont. medication|7
59251|NCT01121393|223454|P1|Overall Study|Refused cont. medication|7
59252|NCT01121393|223453|P2|Overall Study|Lost to Follow-up|0
59253|NCT01121393|223454|P1|Overall Study|Lost to Follow-up|1
59254|NCT01121393|223453|P2|Overall Study|Non-compliant with protocol|3
59255|NCT01121393|223454|P1|Overall Study|Non-compliant with protocol|0
59256|NCT01121393|223453|P2|Overall Study|Other Adverse events|45
59257|NCT01121393|223454|P1|Overall Study|Other Adverse events|22
59258|NCT01121393|223453|P2|Overall Study|Progressive disease|20
59259|NCT01121393|223454|P1|Overall Study|Progressive disease|186
59260|NCT01121263|223499|P2|Overall Study|Withdrawal by Subject|1
59261|NCT01121263|223500|P1|Overall Study|Withdrawal by Subject|0
59262|NCT01121263|223499|P2|Overall Study|Lost to Follow-up|12
59263|NCT01121263|223500|P1|Overall Study|Lost to Follow-up|22
59264|NCT01121263|223499|P2|Overall Study|Death|2
59265|NCT01121263|223500|P1|Overall Study|Death|3
59266|NCT01121185|223510|P2|Overall Study|Not transplanted|0
59267|NCT01121185|223511|P1|Overall Study|Not transplanted|1
59268|NCT01121185|223510|P2|Overall Study|Not infused|1
59269|NCT01121185|223511|P1|Overall Study|Not infused|0
59270|NCT01121146|223545|P2|Overall Study|Lost to Follow-up|16
59271|NCT01121146|223546|P1|Overall Study|Lost to Follow-up|7
59272|NCT01121146|223545|P2|Overall Study|Adverse Event|11
59273|NCT01121146|223546|P1|Overall Study|Adverse Event|2
59274|NCT01121146|223545|P2|Overall Study|Death|15
59275|NCT01121146|223546|P1|Overall Study|Death|17
59276|NCT01120899|223567|P1|Overall Study|Withdrawal by Subject|3
59277|NCT01120782|223587|P1|Overall Study|Test article shipping error|11
59278|NCT01120717|223593|P2|Overall Study|Abnormal Test Procedure Result(s)|0
59279|NCT01120717|223594|P1|Overall Study|Abnormal Test Procedure Result(s)|1
59280|NCT01120717|223593|P2|Overall Study|Death|1
59281|NCT01120717|223594|P1|Overall Study|Death|3
59282|NCT01120717|223593|P2|Overall Study|Lost to Follow-up|3
59283|NCT01120717|223594|P1|Overall Study|Lost to Follow-up|2
59284|NCT01120717|223593|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
59285|NCT01120717|223594|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
59286|NCT01120717|223593|P2|Overall Study|Protocol Deviation|5
59287|NCT01120717|223594|P1|Overall Study|Protocol Deviation|2
59288|NCT01120717|223593|P2|Overall Study|Adverse Event|6
59289|NCT01120717|223594|P1|Overall Study|Adverse Event|10
59290|NCT01120717|223593|P2|Overall Study|Withdrawal by Subject|6
59291|NCT01120717|223594|P1|Overall Study|Withdrawal by Subject|11
59292|NCT01120691|223700|P3|Overall Study|Abnormal laboratory value(s)|4
59293|NCT01120691|223701|P2|Overall Study|Abnormal laboratory value(s)|3
59294|NCT01120691|223702|P1|Overall Study|Abnormal laboratory value(s)|1
59295|NCT01120691|223700|P3|Overall Study|Patient's inability to use the device|0
59296|NCT01120691|223701|P2|Overall Study|Patient's inability to use the device|1
59297|NCT01120691|223702|P1|Overall Study|Patient's inability to use the device|3
59298|NCT01120691|223700|P3|Overall Study|Abnormal test procedure result(s)|1
59299|NCT01120691|223701|P2|Overall Study|Abnormal test procedure result(s)|2
59300|NCT01120691|223702|P1|Overall Study|Abnormal test procedure result(s)|3
59301|NCT01120691|223700|P3|Overall Study|Lost to Follow-up|4
59302|NCT01120691|223701|P2|Overall Study|Lost to Follow-up|6
59303|NCT01120691|223702|P1|Overall Study|Lost to Follow-up|5
59304|NCT01120691|223700|P3|Overall Study|Protocol deviation|12
59305|NCT01120691|223701|P2|Overall Study|Protocol deviation|12
59306|NCT01120691|223702|P1|Overall Study|Protocol deviation|13
59307|NCT01120691|223700|P3|Overall Study|Administrative problems|9
59308|NCT01120691|223701|P2|Overall Study|Administrative problems|8
59309|NCT01120691|223702|P1|Overall Study|Administrative problems|15
59310|NCT01120691|223700|P3|Overall Study|Unsatisfactory therapeutic effect|38
59311|NCT01120691|223701|P2|Overall Study|Unsatisfactory therapeutic effect|32
59312|NCT01120691|223702|P1|Overall Study|Unsatisfactory therapeutic effect|18
59313|NCT01120691|223700|P3|Overall Study|Death|24
59314|NCT01120691|223701|P2|Overall Study|Death|22
59315|NCT01120691|223702|P1|Overall Study|Death|21
59316|NCT01120691|223700|P3|Overall Study|Subject withdrew consent|44
59317|NCT01120691|223701|P2|Overall Study|Subject withdrew consent|50
59318|NCT01120691|223702|P1|Overall Study|Subject withdrew consent|33
59319|NCT01120691|223700|P3|Overall Study|Adverse Event|47
59320|NCT01120691|223701|P2|Overall Study|Adverse Event|67
59321|NCT01120691|223702|P1|Overall Study|Adverse Event|59
59322|NCT01120626|223746|P2|Overall Study|Withdrawal by Subject|0
59323|NCT01120626|223747|P1|Overall Study|Withdrawal by Subject|1
59324|NCT01120379|223786|P1|Four Year Timepoint|Any other reason for early termination|217
59325|NCT01120379|223786|P1|Four Year Timepoint|Physician Decision|5
59326|NCT01120379|223786|P1|Four Year Timepoint|Death|131
59327|NCT01120379|223786|P1|Four Year Timepoint|Lost to Follow-up|10
59328|NCT01120379|223786|P1|Four Year Timepoint|Withdrawal by Subject|5
59329|NCT01120379|223786|P1|Three Year Timepoint|Any other reason for early termination|17
59330|NCT01120379|223786|P1|Three Year Timepoint|Physician Decision|9
59331|NCT01120379|223786|P1|Three Year Timepoint|Death|120
59332|NCT01120379|223786|P1|Three Year Timepoint|Lost to Follow-up|43
59333|NCT01120379|223786|P1|Three Year Timepoint|Withdrawal by Subject|25
59334|NCT01120379|223786|P1|Two Year Timepoint|Any other reason for early termination|4
59335|NCT01120379|223786|P1|Two Year Timepoint|Physician Decision|12
59336|NCT01120379|223786|P1|Two Year Timepoint|Death|123
59337|NCT01120379|223786|P1|Two Year Timepoint|Lost to Follow-up|87
59338|NCT01120379|223786|P1|Two Year Timepoint|Withdrawal by Subject|11
59339|NCT01120379|223786|P1|One Year Timepoint|Any other reason for early termination|5
59340|NCT01120379|223786|P1|One Year Timepoint|Physician Decision|9
59341|NCT01120379|223786|P1|One Year Timepoint|Death|108
59342|NCT01120379|223786|P1|One Year Timepoint|Lost to Follow-up|115
59343|NCT01120379|223786|P1|One Year Timepoint|Withdrawal by Subject|41
59344|NCT01120275|223822|P1|Overall Study|Not specific|1
59345|NCT01120275|223822|P1|Overall Study|Refusal|1
59346|NCT01120275|223822|P1|Overall Study|Withdrawal by Subject|1
59347|NCT01120275|223822|P1|Overall Study|Ineligible|3
59348|NCT01120275|223822|P1|Overall Study|Progression|27
59349|NCT01120275|223822|P1|Overall Study|Adverse Event|3
59350|NCT01120210|223872|P2|MAIN INFUSION|Withdrawal by Subject|1
59351|NCT01120210|223873|P1|MAIN INFUSION|Withdrawal by Subject|0
59352|NCT01120210|223872|P2|MAIN INFUSION|Adverse Event|0
59353|NCT01120210|223873|P1|MAIN INFUSION|Adverse Event|1
59354|NCT01120093|223920|P5|Treatment Period 5|Adverse Event|0
59355|NCT01120093|223921|P4|Treatment Period 5|Adverse Event|1
59356|NCT01120093|223922|P3|Treatment Period 5|Adverse Event|0
59357|NCT01120093|223923|P2|Treatment Period 5|Adverse Event|1
59358|NCT01120093|223924|P1|Treatment Period 5|Adverse Event|0
59359|NCT01120093|223920|P5|Treatment Period 4|Adverse Event|0
59360|NCT01120093|223921|P4|Treatment Period 4|Adverse Event|0
59361|NCT01120093|223922|P3|Treatment Period 4|Adverse Event|0
59362|NCT01120093|223923|P2|Treatment Period 4|Adverse Event|0
59363|NCT01120093|223924|P1|Treatment Period 4|Adverse Event|1
59364|NCT01120093|223920|P5|Treatment Period 3|Withdrawal by Subject|0
59365|NCT01120093|223921|P4|Treatment Period 3|Withdrawal by Subject|0
59366|NCT01120093|223922|P3|Treatment Period 3|Withdrawal by Subject|1
59367|NCT01120093|223923|P2|Treatment Period 3|Withdrawal by Subject|0
59368|NCT01120093|223924|P1|Treatment Period 3|Withdrawal by Subject|0
59369|NCT01120093|223920|P5|Treatment Period 3|Adverse Event|1
59370|NCT01120093|223921|P4|Treatment Period 3|Adverse Event|0
59371|NCT01120093|223922|P3|Treatment Period 3|Adverse Event|0
59372|NCT01120093|223923|P2|Treatment Period 3|Adverse Event|0
59373|NCT01120093|223924|P1|Treatment Period 3|Adverse Event|0
59374|NCT01120093|223920|P5|Treatment Period 3|Lack of Efficacy|0
59375|NCT01120093|223921|P4|Treatment Period 3|Lack of Efficacy|1
59376|NCT01120093|223922|P3|Treatment Period 3|Lack of Efficacy|0
59377|NCT01120093|223923|P2|Treatment Period 3|Lack of Efficacy|0
59378|NCT01120093|223924|P1|Treatment Period 3|Lack of Efficacy|0
59379|NCT01120093|223920|P5|Treatment Period 2|Withdrawal by Subject|1
59380|NCT01120093|223921|P4|Treatment Period 2|Withdrawal by Subject|0
59381|NCT01120093|223922|P3|Treatment Period 2|Withdrawal by Subject|0
59382|NCT01120093|223923|P2|Treatment Period 2|Withdrawal by Subject|0
59383|NCT01120093|223924|P1|Treatment Period 2|Withdrawal by Subject|0
59384|NCT01120093|223920|P5|Treatment Period 2|Adverse Event|0
59385|NCT01120093|223921|P4|Treatment Period 2|Adverse Event|1
59386|NCT01120093|223922|P3|Treatment Period 2|Adverse Event|0
59387|NCT01120093|223923|P2|Treatment Period 2|Adverse Event|0
59388|NCT01120093|223924|P1|Treatment Period 2|Adverse Event|0
59389|NCT01120093|223920|P5|Treatment Period 1|Withdrawal by Subject|0
59390|NCT01120093|223921|P4|Treatment Period 1|Withdrawal by Subject|0
59391|NCT01120093|223922|P3|Treatment Period 1|Withdrawal by Subject|0
59392|NCT01120093|223923|P2|Treatment Period 1|Withdrawal by Subject|1
59393|NCT01120093|223924|P1|Treatment Period 1|Withdrawal by Subject|0
59394|NCT01120093|223920|P5|Treatment Period 1|Adverse Event|1
59395|NCT01120093|223921|P4|Treatment Period 1|Adverse Event|0
59396|NCT01120093|223922|P3|Treatment Period 1|Adverse Event|1
59397|NCT01120093|223923|P2|Treatment Period 1|Adverse Event|0
59398|NCT01120093|223924|P1|Treatment Period 1|Adverse Event|0
59399|NCT01120067|223953|P2|Overall Study|fail to engage >3 sessions|0
59400|NCT01120067|223954|P1|Overall Study|fail to engage >3 sessions|2
59401|NCT01120067|223953|P2|Overall Study|Lost to Follow-up|1
59402|NCT01120067|223954|P1|Overall Study|Lost to Follow-up|3
59403|NCT01119950|223960|P1|Overall Study|Death|1
59404|NCT01119950|223960|P1|Overall Study|Abnormal lab value|1
59405|NCT01119950|223960|P1|Overall Study|Administrative|2
59406|NCT01119950|223960|P1|Overall Study|Lost to Follow-up|4
59407|NCT01119950|223960|P1|Overall Study|Protocol Violation|5
59408|NCT01119950|223960|P1|Overall Study|Withdrawal by Subject|9
59409|NCT01119950|223960|P1|Overall Study|Adverse Event|25
59410|NCT01119937|224207|P2|Overall Study|Withdrawal by Subject|1
59411|NCT01119937|224208|P1|Overall Study|Withdrawal by Subject|2
59412|NCT01119937|224207|P2|Overall Study|Unsatisfactory therapeutic effect|0
59413|NCT01119937|224208|P1|Overall Study|Unsatisfactory therapeutic effect|3
59414|NCT01119937|224207|P2|Overall Study|Protocol deviation|1
59415|NCT01119937|224208|P1|Overall Study|Protocol deviation|3
59416|NCT01119937|224207|P2|Overall Study|Adverse Event|5
59417|NCT01119937|224208|P1|Overall Study|Adverse Event|11
59418|NCT01119859|224236|P2|Overall Study|Failure to return|0
59419|NCT01119859|224237|P1|Overall Study|Failure to return|3
59420|NCT01119859|224236|P2|Overall Study|Refused treatment|6
59421|NCT01119859|224237|P1|Overall Study|Refused treatment|3
59422|NCT01119859|224236|P2|Overall Study|Insufficient therapeutic response|14
59423|NCT01119859|224237|P1|Overall Study|Insufficient therapeutic response|7
59424|NCT01119859|224236|P2|Overall Study|Death|0
59425|NCT01119859|224237|P1|Overall Study|Death|2
59426|NCT01119859|224236|P2|Overall Study|Adverse Event|10
59427|NCT01119859|224237|P1|Overall Study|Adverse Event|9
59428|NCT01119768|224259|P2|Treatment Period|Lack of Efficacy|25
59429|NCT01119768|224260|P1|Treatment Period|Lack of Efficacy|18
59430|NCT01119703|224316|P2|Overall Study|Adverse Event|1
59431|NCT01119703|224317|P1|Overall Study|Adverse Event|0
59432|NCT01119625|224331|P2|Overall Study|Unspecified|1
59433|NCT01119625|224332|P1|Overall Study|Unspecified|0
59434|NCT01119625|224331|P2|Overall Study|Withdrawal by Subject|1
59435|NCT01119625|224332|P1|Overall Study|Withdrawal by Subject|2
59436|NCT01119625|224331|P2|Overall Study|Lost to Follow-up|2
59437|NCT01119625|224332|P1|Overall Study|Lost to Follow-up|1
59438|NCT01119443|224374|P2|Crossover Period 1 (5 Days)|Adverse Event|1
59439|NCT01119443|224375|P1|Crossover Period 1 (5 Days)|Adverse Event|0
59440|NCT01119287|224418|P6|Overall Study|Patient Decision, not related to AE|0
59441|NCT01119287|224419|P5|Overall Study|Patient Decision, not related to AE|1
59442|NCT01119287|224420|P4|Overall Study|Patient Decision, not related to AE|2
59443|NCT01119287|224421|P3|Overall Study|Patient Decision, not related to AE|2
59444|NCT01119287|224422|P2|Overall Study|Patient Decision, not related to AE|0
59445|NCT01119287|224423|P1|Overall Study|Patient Decision, not related to AE|0
59446|NCT01119131|224480|P3|Overall Study|Physician Decision|1
59447|NCT01119131|224481|P2|Overall Study|Physician Decision|0
59448|NCT01119131|224482|P1|Overall Study|Physician Decision|0
59449|NCT01119131|224480|P3|Overall Study|Non-Compliance|4
59450|NCT01119131|224481|P2|Overall Study|Non-Compliance|0
59451|NCT01119131|224482|P1|Overall Study|Non-Compliance|1
59452|NCT01119131|224480|P3|Overall Study|Adverse Event|1
59453|NCT01119131|224481|P2|Overall Study|Adverse Event|1
59454|NCT01119131|224482|P1|Overall Study|Adverse Event|1
59455|NCT01119118|224511|P1|Overall Study|Adverse Event|1
59456|NCT01119001|224523|P1|Overall Study|Withdrawal by Subject|2
59457|NCT01118975|224567|P2|Overall Study|Adverse Event|1
59458|NCT01118975|224568|P1|Overall Study|Adverse Event|0
59459|NCT01118962|224574|P1|Overall Study|Non-compliance with Medicinal Product|1
59460|NCT01118962|224574|P1|Overall Study|Pregnancy|1
59461|NCT01118962|224574|P1|Overall Study|Withdrawal by Subject|4
59462|NCT01118962|224574|P1|Overall Study|Protocol Violation|1
59463|NCT01118962|224574|P1|Overall Study|Lack of Efficacy|1
59464|NCT01118962|224574|P1|Overall Study|Adverse Event|2
59465|NCT01118949|224579|P1|Overall Study|Withdrawal by Subject|4
59466|NCT01118949|224579|P1|Overall Study|Adverse Event|5
59467|NCT01118780|224609|P2|Overall Study|Withdrawal by Subject|8
59468|NCT01118780|224610|P1|Overall Study|Withdrawal by Subject|13
59469|NCT01118780|224609|P2|Overall Study|Protocol Violation|6
59470|NCT01118780|224610|P1|Overall Study|Protocol Violation|3
59471|NCT01118780|224609|P2|Overall Study|Physician Decision|0
59472|NCT01118780|224610|P1|Overall Study|Physician Decision|2
59473|NCT01118780|224609|P2|Overall Study|Lack of Efficacy|6
59474|NCT01118780|224610|P1|Overall Study|Lack of Efficacy|2
59475|NCT01118780|224609|P2|Overall Study|Death|0
59476|NCT01118780|224610|P1|Overall Study|Death|1
59477|NCT01118780|224609|P2|Overall Study|Adverse Event|15
59478|NCT01118780|224610|P1|Overall Study|Adverse Event|15
59479|NCT01118663|224668|P2|Overall Study|Withdrawal by Subject|1
59480|NCT01118663|224669|P1|Overall Study|Withdrawal by Subject|0
59481|NCT01118663|224668|P2|Overall Study|Adverse Event|1
59482|NCT01118663|224669|P1|Overall Study|Adverse Event|2
59483|NCT01118455|224692|P2|Baseline [Visits 1 & 2]|Adverse Event|0
59484|NCT01118455|224693|P1|Baseline [Visits 1 & 2]|Adverse Event|1
59485|NCT01118377|224721|P1|Overall Study|Failure to Return|3
59486|NCT01118377|224721|P1|Overall Study|Death|38
59487|NCT01118377|224721|P1|Overall Study|Did Not Receive Study Medication|1
59488|NCT01118325|224730|P3|Overall Study|Adverse Event|1
59489|NCT01118325|224731|P2|Overall Study|Adverse Event|0
59490|NCT01118325|224732|P1|Overall Study|Adverse Event|1
59491|NCT01118312|224778|P2|Overall Study|Withdrawal by Subject|3
59492|NCT01118312|224779|P1|Overall Study|Withdrawal by Subject|1
59493|NCT01118312|224778|P2|Overall Study|Lost to Follow-up|32
59494|NCT01118312|224779|P1|Overall Study|Lost to Follow-up|33
59495|NCT01118143|224977|P2|Overall Study|Withdrawal by Subject|5
59496|NCT01118143|224978|P1|Overall Study|Withdrawal by Subject|2
59497|NCT01118117|224988|P2|Overall Study|Missed 12 Month Visit|0
59498|NCT01118117|224989|P1|Overall Study|Missed 12 Month Visit|7
59499|NCT01118117|224988|P2|Overall Study|Lost to Follow-up|0
59500|NCT01118117|224989|P1|Overall Study|Lost to Follow-up|6
59501|NCT01118117|224988|P2|Overall Study|Death|0
59502|NCT01118117|224989|P1|Overall Study|Death|8
59503|NCT01117987|225023|P2|Overall Study|Administrative problems|22
59504|NCT01117987|225024|P1|Overall Study|Administrative problems|25
59505|NCT01117987|225023|P2|Overall Study|Adverse Event|26
59506|NCT01117987|225024|P1|Overall Study|Adverse Event|19
59507|NCT01117987|225023|P2|Overall Study|Withdrawal by Subject|10
59508|NCT01117987|225024|P1|Overall Study|Withdrawal by Subject|5
59509|NCT01117987|225023|P2|Overall Study|Death|10
59510|NCT01117987|225024|P1|Overall Study|Death|5
59511|NCT01117987|225023|P2|Overall Study|Lack of Efficacy|4
59512|NCT01117987|225024|P1|Overall Study|Lack of Efficacy|3
59513|NCT01117987|225023|P2|Overall Study|Abnormal test procedure result|0
59514|NCT01117987|225024|P1|Overall Study|Abnormal test procedure result|2
59515|NCT01117987|225023|P2|Overall Study|Lost to Follow-up|1
59516|NCT01117987|225024|P1|Overall Study|Lost to Follow-up|1
59517|NCT01117987|225023|P2|Overall Study|Subject no longer requires study drug|0
59518|NCT01117987|225024|P1|Overall Study|Subject no longer requires study drug|1
59519|NCT01117987|225023|P2|Overall Study|Protocol deviation|1
59520|NCT01117987|225024|P1|Overall Study|Protocol deviation|0
59521|NCT01117857|225043|P1|Overall Study|Physician Decision|1
59522|NCT01117857|225043|P1|Overall Study|Withdrawal by Subject|4
59523|NCT01117857|225043|P1|Overall Study|Lost to Follow-up|4
59524|NCT01117766|225051|P2|Second Intervention|Withdrawal by Subject|1
59525|NCT01117766|225052|P1|Second Intervention|Withdrawal by Subject|0
59526|NCT01117766|225051|P2|Second Intervention|Adverse Event|2
59527|NCT01117766|225052|P1|Second Intervention|Adverse Event|0
59528|NCT01117766|225051|P2|Second Intervention|Unspecified|2
59529|NCT01117766|225052|P1|Second Intervention|Unspecified|1
59530|NCT01117766|225051|P2|Second Intervention|Lost to Follow-up|0
59531|NCT01117766|225052|P1|Second Intervention|Lost to Follow-up|1
59532|NCT01117766|225051|P2|Washout Period|Protocol Violation|2
59533|NCT01117766|225052|P1|Washout Period|Protocol Violation|0
59534|NCT01117766|225051|P2|First Intervention|Protocol Violation|0
59535|NCT01117766|225052|P1|First Intervention|Protocol Violation|1
59536|NCT01117766|225051|P2|First Intervention|Unspecified|0
59537|NCT01117766|225052|P1|First Intervention|Unspecified|0
59538|NCT01117766|225051|P2|First Intervention|Adverse Event|1
59539|NCT01117766|225052|P1|First Intervention|Adverse Event|0
59540|NCT01117623|225089|P8|Overall Study|Invest. text: completed all planned txs|0
59541|NCT01117623|225090|P7|Overall Study|Invest. text: completed all planned txs|0
59542|NCT01117623|225091|P6|Overall Study|Invest. text: completed all planned txs|1
59543|NCT01117623|225092|P5|Overall Study|Invest. text: completed all planned txs|0
59544|NCT01117623|225093|P4|Overall Study|Invest. text: completed all planned txs|0
59545|NCT01117623|225094|P3|Overall Study|Invest. text: completed all planned txs|0
59546|NCT01117623|225095|P2|Overall Study|Invest. text: completed all planned txs|0
59547|NCT01117623|225096|P1|Overall Study|Invest. text: completed all planned txs|0
59548|NCT01117623|225089|P8|Overall Study|Non-compliance with study medication|1
59549|NCT01117623|225090|P7|Overall Study|Non-compliance with study medication|0
59550|NCT01117623|225091|P6|Overall Study|Non-compliance with study medication|0
59551|NCT01117623|225092|P5|Overall Study|Non-compliance with study medication|0
59552|NCT01117623|225093|P4|Overall Study|Non-compliance with study medication|0
59553|NCT01117623|225094|P3|Overall Study|Non-compliance with study medication|0
59554|NCT01117623|225095|P2|Overall Study|Non-compliance with study medication|0
59555|NCT01117623|225096|P1|Overall Study|Non-compliance with study medication|0
59556|NCT01117623|225089|P8|Overall Study|Withdrawal by Subject|1
59557|NCT01117623|225090|P7|Overall Study|Withdrawal by Subject|1
59558|NCT01117623|225091|P6|Overall Study|Withdrawal by Subject|1
59559|NCT01117623|225092|P5|Overall Study|Withdrawal by Subject|0
59560|NCT01117623|225093|P4|Overall Study|Withdrawal by Subject|0
59561|NCT01117623|225094|P3|Overall Study|Withdrawal by Subject|2
59562|NCT01117623|225095|P2|Overall Study|Withdrawal by Subject|0
59563|NCT01117623|225096|P1|Overall Study|Withdrawal by Subject|0
59564|NCT01117623|225089|P8|Overall Study|Disease progression, recurrence, relapse|22
59565|NCT01117623|225090|P7|Overall Study|Disease progression, recurrence, relapse|5
59566|NCT01117623|225091|P6|Overall Study|Disease progression, recurrence, relapse|14
59567|NCT01117623|225092|P5|Overall Study|Disease progression, recurrence, relapse|8
59568|NCT01117623|225093|P4|Overall Study|Disease progression, recurrence, relapse|6
59569|NCT01117623|225094|P3|Overall Study|Disease progression, recurrence, relapse|5
59570|NCT01117623|225095|P2|Overall Study|Disease progression, recurrence, relapse|6
59571|NCT01117623|225096|P1|Overall Study|Disease progression, recurrence, relapse|3
59572|NCT01117623|225089|P8|Overall Study|Adverse Event|2
59573|NCT01117623|225090|P7|Overall Study|Adverse Event|0
59574|NCT01117623|225091|P6|Overall Study|Adverse Event|0
59575|NCT01117623|225092|P5|Overall Study|Adverse Event|2
59576|NCT01117623|225093|P4|Overall Study|Adverse Event|0
59577|NCT01117623|225094|P3|Overall Study|Adverse Event|4
59578|NCT01117623|225095|P2|Overall Study|Adverse Event|2
59579|NCT01117623|225096|P1|Overall Study|Adverse Event|0
59580|NCT01117480|225248|P1|Overall Study|Did Not Start Adalimumab Therapy|20
59581|NCT01117480|225248|P1|Overall Study|Protocol Violation|8
59582|NCT01117350|225256|P2|Extension Period|Prohibited medication|1
59583|NCT01117350|225257|P1|Extension Period|Prohibited medication|0
59584|NCT01117350|225256|P2|Extension Period|Inclusion criteria not respected|1
59585|NCT01117350|225257|P1|Extension Period|Inclusion criteria not respected|0
59586|NCT01117350|225256|P2|Extension Period|Lack of Efficacy|2
59587|NCT01117350|225257|P1|Extension Period|Lack of Efficacy|0
59588|NCT01117350|225256|P2|Extension Period|Withdrawal by Subject|3
59589|NCT01117350|225257|P1|Extension Period|Withdrawal by Subject|0
59590|NCT01117350|225256|P2|Extension Period|Lost to Follow-up|2
59591|NCT01117350|225257|P1|Extension Period|Lost to Follow-up|0
59592|NCT01117350|225256|P2|Extension Period|Protocol Violation|2
59593|NCT01117350|225257|P1|Extension Period|Protocol Violation|0
59594|NCT01117350|225256|P2|Extension Period|Adverse Event|2
59595|NCT01117350|225257|P1|Extension Period|Adverse Event|0
59596|NCT01117350|225256|P2|Extension Period|Not included in extension, not treated|50
59597|NCT01117350|225257|P1|Extension Period|Not included in extension, not treated|0
59598|NCT01117350|225256|P2|Comparative Period|Move to another city/country|1
59599|NCT01117350|225257|P1|Comparative Period|Move to another city/country|2
59600|NCT01117350|225256|P2|Comparative Period|Physician Decision|1
59601|NCT01117350|225257|P1|Comparative Period|Physician Decision|0
59602|NCT01117350|225256|P2|Comparative Period|Lack of Efficacy|0
59603|NCT01117350|225257|P1|Comparative Period|Lack of Efficacy|1
59604|NCT01117350|225256|P2|Comparative Period|Protocol Violation|12
59605|NCT01117350|225257|P1|Comparative Period|Protocol Violation|8
59606|NCT01117350|225256|P2|Comparative Period|Withdrawal by Subject|13
59607|NCT01117350|225257|P1|Comparative Period|Withdrawal by Subject|9
59608|NCT01117350|225256|P2|Comparative Period|Lost to Follow-up|7
59609|NCT01117350|225257|P1|Comparative Period|Lost to Follow-up|11
59610|NCT01117350|225256|P2|Comparative Period|Adverse Event|33
59611|NCT01117350|225257|P1|Comparative Period|Adverse Event|6
59612|NCT01117350|225256|P2|Comparative Period|Not Treated|8
59613|NCT01117350|225257|P1|Comparative Period|Not Treated|5
59614|NCT01117337|225289|P2|Overall Study|Lost to Follow-up|0
59615|NCT01117337|225290|P1|Overall Study|Lost to Follow-up|4
59616|NCT01117181|225311|P2|Overall Study|Withdrawal by Subject|2
59617|NCT01117181|225312|P1|Overall Study|Withdrawal by Subject|0
59618|NCT01117181|225311|P2|Overall Study|Lost to Follow-up|0
59619|NCT01117181|225312|P1|Overall Study|Lost to Follow-up|1
59620|NCT01117051|225343|P2|Overall Study|Convenience issue|0
59621|NCT01117051|225344|P1|Overall Study|Convenience issue|1
59622|NCT01117051|225343|P2|Overall Study|Randomized by mistake|1
59623|NCT01117051|225344|P1|Overall Study|Randomized by mistake|0
59624|NCT01117051|225343|P2|Overall Study|Surgical procedure|1
59625|NCT01117051|225344|P1|Overall Study|Surgical procedure|0
59626|NCT01117051|225343|P2|Overall Study|Sponsor's decision|1
59627|NCT01117051|225344|P1|Overall Study|Sponsor's decision|3
59628|NCT01117051|225343|P2|Overall Study|Did not meet in-/exclusion criteria|1
59629|NCT01117051|225344|P1|Overall Study|Did not meet in-/exclusion criteria|0
59630|NCT01117051|225343|P2|Overall Study|Lost to Follow-up|1
59631|NCT01117051|225344|P1|Overall Study|Lost to Follow-up|0
59632|NCT01117051|225343|P2|Overall Study|Adverse Event|3
59633|NCT01117051|225344|P1|Overall Study|Adverse Event|4
59634|NCT01117051|225343|P2|Overall Study|Withdrawal by Subject|3
59635|NCT01117051|225344|P1|Overall Study|Withdrawal by Subject|5
59636|NCT01117012|225354|P2|Overall Study|Undefined|3
59637|NCT01117012|225355|P1|Overall Study|Undefined|4
59638|NCT01117012|225354|P2|Overall Study|Withdrawal by Subject|0
59639|NCT01117012|225355|P1|Overall Study|Withdrawal by Subject|3
59640|NCT01117012|225354|P2|Overall Study|Death|1
59641|NCT01117012|225355|P1|Overall Study|Death|1
59642|NCT01117012|225354|P2|Overall Study|Adverse Event|1
59643|NCT01117012|225355|P1|Overall Study|Adverse Event|0
59644|NCT01116882|225477|P2|12-month|Withdrawal by Subject|8
59645|NCT01116882|225478|P1|12-month|Withdrawal by Subject|5
59646|NCT01116882|225477|P2|12-month|Other Reasons|49
59647|NCT01116882|225478|P1|12-month|Other Reasons|151
59648|NCT01116882|225477|P2|12-month|Lost to Follow-up|42
59649|NCT01116882|225478|P1|12-month|Lost to Follow-up|111
59650|NCT01116882|225477|P2|30-day|Other Reasons|6
59651|NCT01116882|225478|P1|30-day|Other Reasons|16
59652|NCT01116882|225477|P2|30-day|Withdrawal by Subject|4
59653|NCT01116882|225478|P1|30-day|Withdrawal by Subject|2
59654|NCT01116882|225477|P2|30-day|Lost to Follow-up|21
59655|NCT01116882|225478|P1|30-day|Lost to Follow-up|50
59656|NCT01116687|225516|P1|Overall Study|Withdrawal by Subject|4
59657|NCT01116427|225533|P2|Extension Phase|Not using appropriate birth control|0
59658|NCT01116427|225534|P1|Extension Phase|Not using appropriate birth control|1
59659|NCT01116427|225533|P2|Extension Phase|Withdrawal by Subject|1
59660|NCT01116427|225534|P1|Extension Phase|Withdrawal by Subject|5
59661|NCT01116427|225533|P2|Extension Phase|Lost to Follow-up|0
59662|NCT01116427|225534|P1|Extension Phase|Lost to Follow-up|2
59663|NCT01116427|225533|P2|Extension Phase|Adverse Event|1
59664|NCT01116427|225534|P1|Extension Phase|Adverse Event|1
59665|NCT01116427|225533|P2|Core Phase|Worsening Multiple Sclerosis|0
59666|NCT01116427|225534|P1|Core Phase|Worsening Multiple Sclerosis|1
59667|NCT01116427|225533|P2|Core Phase|Withdrawal by Subject|0
59668|NCT01116427|225534|P1|Core Phase|Withdrawal by Subject|3
59669|NCT01116427|225533|P2|Core Phase|Lost to Follow-up|0
59670|NCT01116427|225534|P1|Core Phase|Lost to Follow-up|1
59671|NCT01116427|225533|P2|Core Phase|Adverse Event|1
59672|NCT01116427|225534|P1|Core Phase|Adverse Event|0
59673|NCT01116232|225570|P1|Overall Study|Progressive diease|1
59674|NCT01115998|225673|P2|Overall Study|Lost to Follow-up|6
59675|NCT01115998|225674|P1|Overall Study|Lost to Follow-up|6
59676|NCT01115933|225684|P1|Overall Study|Did not receive XIENCE PRIME SV|1
59677|NCT01115855|225781|P2|Overall Study|Unspecified|6
59678|NCT01115855|225782|P1|Overall Study|Unspecified|8
59679|NCT01115855|225781|P2|Overall Study|Withdrawal by Subject|5
59680|NCT01115855|225782|P1|Overall Study|Withdrawal by Subject|5
59681|NCT01115855|225781|P2|Overall Study|Protocol Violation|1
59682|NCT01115855|225782|P1|Overall Study|Protocol Violation|0
59683|NCT01115855|225781|P2|Overall Study|Lab Abnormality|1
59684|NCT01115855|225782|P1|Overall Study|Lab Abnormality|1
59685|NCT01115855|225781|P2|Overall Study|Death|5
59686|NCT01115855|225782|P1|Overall Study|Death|6
59687|NCT01115855|225781|P2|Overall Study|Adverse Event|18
59688|NCT01115855|225782|P1|Overall Study|Adverse Event|16
59689|NCT01115738|225833|P3|Overall Study|Withdrawal by Subject|9
59690|NCT01115738|225834|P2|Overall Study|Withdrawal by Subject|6
59691|NCT01115738|225835|P1|Overall Study|Withdrawal by Subject|6
59692|NCT01115738|225833|P3|Overall Study|Physician Decision|17
59693|NCT01115738|225834|P2|Overall Study|Physician Decision|15
59694|NCT01115738|225835|P1|Overall Study|Physician Decision|18
59695|NCT01115738|225833|P3|Overall Study|Lost to Follow-up|1
59696|NCT01115738|225834|P2|Overall Study|Lost to Follow-up|0
59697|NCT01115738|225835|P1|Overall Study|Lost to Follow-up|0
59698|NCT01115738|225833|P3|Overall Study|Death|0
59699|NCT01115738|225834|P2|Overall Study|Death|0
59700|NCT01115738|225835|P1|Overall Study|Death|1
59701|NCT01115569|226033|P2|Maintenance Phase|Administrative|1
59702|NCT01115569|226034|P1|Maintenance Phase|Administrative|0
59703|NCT01115569|226033|P2|Maintenance Phase|Non-Compliance with Study Drug|48
59704|NCT01115569|226034|P1|Maintenance Phase|Non-Compliance with Study Drug|0
59705|NCT01115569|226033|P2|Maintenance Phase|Withdrawal by Subject|27
59706|NCT01115569|226034|P1|Maintenance Phase|Withdrawal by Subject|0
59707|NCT01115569|226033|P2|Maintenance Phase|Protocol Violation|9
59708|NCT01115569|226034|P1|Maintenance Phase|Protocol Violation|0
59709|NCT01115569|226033|P2|Maintenance Phase|Physician Decision|3
59710|NCT01115569|226034|P1|Maintenance Phase|Physician Decision|0
59711|NCT01115569|226033|P2|Maintenance Phase|Lost to Follow-up|8
59712|NCT01115569|226034|P1|Maintenance Phase|Lost to Follow-up|0
59713|NCT01115569|226033|P2|Maintenance Phase|Adverse Event|43
59714|NCT01115569|226034|P1|Maintenance Phase|Adverse Event|0
59715|NCT01115569|226033|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
59716|NCT01115569|226034|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
59717|NCT01115569|226033|P2|Conversion/Titration Phase|Withdrawal by Subject|0
59718|NCT01115569|226034|P1|Conversion/Titration Phase|Withdrawal by Subject|26
59719|NCT01115569|226033|P2|Conversion/Titration Phase|Protocol Violation|0
59720|NCT01115569|226034|P1|Conversion/Titration Phase|Protocol Violation|68
59721|NCT01115569|226033|P2|Conversion/Titration Phase|Physician Decision|0
59722|NCT01115569|226034|P1|Conversion/Titration Phase|Physician Decision|5
59723|NCT01115569|226033|P2|Conversion/Titration Phase|Lost to Follow-up|0
59724|NCT01115569|226034|P1|Conversion/Titration Phase|Lost to Follow-up|3
59725|NCT01115569|226033|P2|Conversion/Titration Phase|Adverse Event|0
59726|NCT01115569|226034|P1|Conversion/Titration Phase|Adverse Event|59
59727|NCT01115491|226052|P1|Overall Study|Physician Decision|1
59728|NCT01115491|226052|P1|Overall Study|Withdrawal by Subject|1
59729|NCT01115491|226052|P1|Overall Study|Lost to Follow-up|3
59730|NCT01115491|226052|P1|Overall Study|Adverse Event|3
59731|NCT01115491|226052|P1|Overall Study|Death|22
59732|NCT01114880|226214|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
59733|NCT01114880|226215|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
59734|NCT01114880|226214|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
59735|NCT01114880|226215|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
59736|NCT01114880|226214|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
59737|NCT01114880|226215|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
59738|NCT01114880|226214|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
59739|NCT01114880|226215|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
59740|NCT01114880|226214|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
59741|NCT01114880|226215|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
59742|NCT01114880|226214|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
59743|NCT01114880|226215|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
59744|NCT01114828|226267|P2|Overall Study|Withdrawal by Subject|1
59745|NCT01114828|226268|P1|Overall Study|Withdrawal by Subject|0
59746|NCT01114828|226267|P2|Overall Study|Protocol Violation|0
59747|NCT01114828|226268|P1|Overall Study|Protocol Violation|2
59748|NCT01114828|226267|P2|Overall Study|Lack of Efficacy|2
59749|NCT01114828|226268|P1|Overall Study|Lack of Efficacy|0
59750|NCT01114828|226267|P2|Overall Study|Adverse Event|1
59751|NCT01114828|226268|P1|Overall Study|Adverse Event|1
59752|NCT01114737|226278|P2|Open-Label Treatment Period|Difficult Personal Events|0
59753|NCT01114737|226279|P1|Open-Label Treatment Period|Difficult Personal Events|1
59754|NCT01114737|226278|P2|Open-Label Treatment Period|Lost to Follow-up|1
59755|NCT01114737|226279|P1|Open-Label Treatment Period|Lost to Follow-up|3
59756|NCT01114737|226278|P2|Open-Label Treatment Period|Withdrawal by Subject|1
59757|NCT01114737|226279|P1|Open-Label Treatment Period|Withdrawal by Subject|1
59758|NCT01114737|226278|P2|Randomized Treatment Period|Pregnancy|0
59759|NCT01114737|226279|P1|Randomized Treatment Period|Pregnancy|1
59760|NCT01114737|226278|P2|Randomized Treatment Period|Lost to Follow-up|1
59761|NCT01114737|226279|P1|Randomized Treatment Period|Lost to Follow-up|1
59762|NCT01114737|226278|P2|Randomized Treatment Period|Withdrawal by Subject|0
59763|NCT01114737|226279|P1|Randomized Treatment Period|Withdrawal by Subject|1
59764|NCT01114724|226327|P1|Overall Study|Withdrawal by Subject|1
59765|NCT01114724|226327|P1|Overall Study|Lost to Follow-up|1
59766|NCT01114724|226327|P1|Overall Study|Death|8
59767|NCT01114672|226347|P2|Overall Study|transplanted|0
59768|NCT01114672|226348|P1|Overall Study|transplanted|1
59769|NCT01114672|226347|P2|Overall Study|Lost to Follow-up|0
59770|NCT01114672|226348|P1|Overall Study|Lost to Follow-up|1
59771|NCT01114672|226347|P2|Overall Study|Withdrawal by Subject|1
59772|NCT01114672|226348|P1|Overall Study|Withdrawal by Subject|2
59773|NCT01114672|226347|P2|Overall Study|Death|1
59774|NCT01114672|226348|P1|Overall Study|Death|0
59775|NCT01114516|226367|P2|Overall Study|Lost to Follow-up|1
59776|NCT01114516|226368|P1|Overall Study|Lost to Follow-up|2
59777|NCT01114373|226382|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
59778|NCT01114373|226383|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
59779|NCT01114373|226382|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
59780|NCT01114373|226383|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
59781|NCT01114373|226382|P2|Intervention 1 (4 Weeks)|Incarceration|0
59782|NCT01114373|226383|P1|Intervention 1 (4 Weeks)|Incarceration|1
59783|NCT01114373|226382|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
59784|NCT01114373|226383|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
59785|NCT01114360|226415|P2|Intervention 1 (4 Weeks)|Physician Decision|1
59786|NCT01114360|226416|P1|Intervention 1 (4 Weeks)|Physician Decision|0
59787|NCT01113931|226454|P2|Overall Study|Withdrawal by Subject|0
59788|NCT01113931|226455|P1|Overall Study|Withdrawal by Subject|3
59789|NCT01113931|226454|P2|Overall Study|Various|4
59790|NCT01113931|226455|P1|Overall Study|Various|2
59791|NCT01113931|226454|P2|Overall Study|Lost to Follow-up|9
59792|NCT01113931|226455|P1|Overall Study|Lost to Follow-up|12
59793|NCT01113931|226454|P2|Overall Study|Physician Decision|2
59794|NCT01113931|226455|P1|Overall Study|Physician Decision|0
59795|NCT01113931|226454|P2|Overall Study|Adverse Event|2
59796|NCT01113931|226455|P1|Overall Study|Adverse Event|2
59797|NCT01113749|226469|P2|Overall Study|Lost to Follow-up|2
59798|NCT01113749|226470|P1|Overall Study|Lost to Follow-up|1
59799|NCT01113710|226493|P1|Overall Study|Subject Did Not Receive Neupro|3
59800|NCT01113710|226493|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
59801|NCT01113710|226493|P1|Overall Study|Lack of Patient's Compliance/Other|1
59802|NCT01113710|226493|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
59803|NCT01113710|226493|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
59804|NCT01113710|226493|P1|Overall Study|Compliance/Efficacy/AE/Other|1
59805|NCT01113710|226493|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
59806|NCT01113710|226493|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
59807|NCT01113710|226493|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
59808|NCT01113710|226493|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
59809|NCT01113710|226493|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
59810|NCT01113710|226493|P1|Overall Study|Lack of Efficacy/Adverse Event|3
59811|NCT01113710|226493|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
59812|NCT01113710|226493|P1|Overall Study|Lack of Efficacy/Other|4
59813|NCT01113710|226493|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
59814|NCT01113710|226493|P1|Overall Study|Adverse Event/Other|5
59815|NCT01113710|226493|P1|Overall Study|Other|7
59816|NCT01113710|226493|P1|Overall Study|Lack of Patient's Compliance|8
59817|NCT01113710|226493|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
59818|NCT01113710|226493|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
59819|NCT01113710|226493|P1|Overall Study|Lost to Follow-up|20
59820|NCT01113710|226493|P1|Overall Study|Withdrawal by Subject|28
59821|NCT01113710|226493|P1|Overall Study|No Information Available|40
59822|NCT01113710|226493|P1|Overall Study|Lack of Efficacy|41
59823|NCT01113710|226493|P1|Overall Study|Adverse Event|64
59824|NCT01113580|226521|P2|Overall Study|Protocol Violation|0
59825|NCT01113580|226522|P1|Overall Study|Protocol Violation|1
59826|NCT01113541|226536|P1|Overall Study|Adverse Event|4
59827|NCT01113541|226536|P1|Overall Study|Study Terminated by Sponsor|7
59828|NCT01113541|226536|P1|Overall Study|Protocol Violation|1
59829|NCT01113541|226536|P1|Overall Study|Withdrawal by Subject|1
59830|NCT01113463|226569|P1|Overall Study|Physician Decision|5
59831|NCT01112917|226599|P2|Overall Study|Unable to Convert Filter|0
59832|NCT01112917|226600|P1|Overall Study|Unable to Convert Filter|3
59833|NCT01112917|226599|P2|Overall Study|Withdrawal by Subject|3
59834|NCT01112917|226600|P1|Overall Study|Withdrawal by Subject|1
59835|NCT01112917|226599|P2|Overall Study|Lost to Follow-up|1
59836|NCT01112917|226600|P1|Overall Study|Lost to Follow-up|1
59837|NCT01112917|226599|P2|Overall Study|Death|11
59838|NCT01112917|226600|P1|Overall Study|Death|2
59839|NCT01112579|226676|P2|Overall Study|Death|2
59840|NCT01112579|226677|P1|Overall Study|Death|0
59841|NCT01112579|226676|P2|Overall Study|Missed Visit|1
59842|NCT01112579|226677|P1|Overall Study|Missed Visit|1
59843|NCT01112514|226687|P1|Overall Study|Lost to Follow-up|1
59844|NCT01112267|226693|P2|Overall Study|Participants not receive any study drug|2
59845|NCT01112267|226694|P1|Overall Study|Participants not receive any study drug|1
59846|NCT01112267|226693|P2|Overall Study|Participants not compliant|2
59847|NCT01112267|226694|P1|Overall Study|Participants not compliant|1
59848|NCT01112267|226693|P2|Overall Study|Protocol Violation|3
59849|NCT01112267|226694|P1|Overall Study|Protocol Violation|5
59850|NCT01112267|226693|P2|Overall Study|Withdrawal by Subject|5
59851|NCT01112267|226694|P1|Overall Study|Withdrawal by Subject|3
59852|NCT01112267|226693|P2|Overall Study|Adverse Event|6
59853|NCT01112267|226694|P1|Overall Study|Adverse Event|24
59854|NCT01111851|226727|P2|Overall Study|All planned PET scans were not obtained.|0
59855|NCT01111851|226728|P1|Overall Study|All planned PET scans were not obtained.|2
59856|NCT01111838|226740|P1|Overall Study|Other Complicating Disease|1
59857|NCT01111838|226740|P1|Overall Study|Clinical deterioration|1
59858|NCT01111838|226740|P1|Overall Study|Not Treated|3
59859|NCT01111838|226740|P1|Overall Study|Patient Ineligible|2
59860|NCT01111526|226744|P3|Overall Study|GVHD Disease Progression|2
59861|NCT01111526|226745|P2|Overall Study|GVHD Disease Progression|1
59862|NCT01111526|226746|P1|Overall Study|GVHD Disease Progression|0
59863|NCT01111461|226758|P1|Overall Study|Not specified|6
59864|NCT01111461|226758|P1|Overall Study|Withdrawal by Subject|1
59865|NCT01111461|226758|P1|Overall Study|Lost to Follow-up|1
59866|NCT01111461|226758|P1|Overall Study|Participant choice|11
59867|NCT01111461|226758|P1|Overall Study|Adverse Event|32
59868|NCT01111292|226921|P2|Treatment|Physician Decision|1
59869|NCT01111292|226922|P1|Treatment|Physician Decision|1
59870|NCT01111240|226928|P1|Overall Study|Not Specified|312
59871|NCT01111240|226928|P1|Overall Study|Lack of Efficacy and Adverse Event|19
59872|NCT01111240|226928|P1|Overall Study|Lack of Efficacy|545
59873|NCT01111240|226928|P1|Overall Study|Adverse Event|190
59874|NCT01111149|226958|P3|Overall Study|Withdrawal by Subject|2
59875|NCT01111149|226959|P2|Overall Study|Withdrawal by Subject|0
59876|NCT01111149|226960|P1|Overall Study|Withdrawal by Subject|1
59877|NCT01111149|226958|P3|Overall Study|Protocol Violation|2
59878|NCT01111149|226959|P2|Overall Study|Protocol Violation|1
59879|NCT01111149|226960|P1|Overall Study|Protocol Violation|1
59880|NCT01111123|227036|P2|Maintenance Phase|Lost to Follow-up|2
59881|NCT01111123|227037|P1|Maintenance Phase|Lost to Follow-up|0
59882|NCT01111123|227036|P2|Open- Label Phase|Failed to be clear or almost cleared|0
59883|NCT01111123|227037|P1|Open- Label Phase|Failed to be clear or almost cleared|14
59884|NCT01110915|227071|P2|Overall Study|Withdrawal by Subject|1
59885|NCT01110915|227072|P1|Overall Study|Withdrawal by Subject|7
59886|NCT01110915|227071|P2|Overall Study|Lost to Follow-up|0
59887|NCT01110915|227072|P1|Overall Study|Lost to Follow-up|1
59888|NCT01110915|227071|P2|Overall Study|Death|1
59889|NCT01110915|227072|P1|Overall Study|Death|2
59890|NCT01110408|227145|P2|Overall Study|Protocol Violation|0
59891|NCT01110408|227146|P1|Overall Study|Protocol Violation|1
59892|NCT01110382|227166|P2|Overall Study|Protocol Violation|1
59893|NCT01110382|227167|P1|Overall Study|Protocol Violation|0
59894|NCT01110382|227166|P2|Overall Study|Withdrawal by Subject|1
59895|NCT01110382|227167|P1|Overall Study|Withdrawal by Subject|0
59896|NCT01110330|227188|P3|Overall Study|Not specified|1
59897|NCT01110330|227189|P2|Overall Study|Not specified|1
59898|NCT01110330|227190|P1|Overall Study|Not specified|1
59899|NCT01110330|227188|P3|Overall Study|Withdrawal by Subject|2
59900|NCT01110330|227189|P2|Overall Study|Withdrawal by Subject|6
59901|NCT01110330|227190|P1|Overall Study|Withdrawal by Subject|0
59902|NCT01110330|227188|P3|Overall Study|Protocol Violation|4
59903|NCT01110330|227189|P2|Overall Study|Protocol Violation|0
59904|NCT01110330|227190|P1|Overall Study|Protocol Violation|2
59905|NCT01110330|227188|P3|Overall Study|Physician Decision|0
59906|NCT01110330|227189|P2|Overall Study|Physician Decision|1
59907|NCT01110330|227190|P1|Overall Study|Physician Decision|0
59908|NCT01110330|227188|P3|Overall Study|Lost to Follow-up|15
59909|NCT01110330|227189|P2|Overall Study|Lost to Follow-up|10
59910|NCT01110330|227190|P1|Overall Study|Lost to Follow-up|9
59911|NCT01110330|227188|P3|Overall Study|Lack of Efficacy|1
59912|NCT01110330|227189|P2|Overall Study|Lack of Efficacy|1
59913|NCT01110330|227190|P1|Overall Study|Lack of Efficacy|3
59914|NCT01110330|227188|P3|Overall Study|Adverse Event|3
59915|NCT01110330|227189|P2|Overall Study|Adverse Event|4
59916|NCT01110330|227190|P1|Overall Study|Adverse Event|0
59917|NCT01110239|227218|P4|7.5 Min Ischemia|Withdrawal by Subject|0
59918|NCT01110239|227219|P3|7.5 Min Ischemia|Withdrawal by Subject|1
59919|NCT01110239|227220|P2|7.5 Min Ischemia|Withdrawal by Subject|0
59920|NCT01110239|227221|P1|7.5 Min Ischemia|Withdrawal by Subject|0
59921|NCT01110239|227218|P4|Sham Preconditioning|Withdrawal by Subject|0
59922|NCT01110239|227219|P3|Sham Preconditioning|Withdrawal by Subject|1
59923|NCT01110239|227220|P2|Sham Preconditioning|Withdrawal by Subject|0
59924|NCT01110239|227221|P1|Sham Preconditioning|Withdrawal by Subject|0
59925|NCT01110200|227237|P2|Overall Study|Lost to Follow-up|7
59926|NCT01110200|227238|P1|Overall Study|Lost to Follow-up|10
59927|NCT01110200|227237|P2|Overall Study|Physician Decision|17
59928|NCT01110200|227238|P1|Overall Study|Physician Decision|13
59929|NCT01110200|227237|P2|Overall Study|Protocol Violation|12
59930|NCT01110200|227238|P1|Overall Study|Protocol Violation|14
59931|NCT01110200|227237|P2|Overall Study|Lack of Efficacy|25
59932|NCT01110200|227238|P1|Overall Study|Lack of Efficacy|16
59933|NCT01110200|227237|P2|Overall Study|Withdrawal by Subject|32
59934|NCT01110200|227238|P1|Overall Study|Withdrawal by Subject|25
59935|NCT01110200|227237|P2|Overall Study|Adverse Event|28
59936|NCT01110200|227238|P1|Overall Study|Adverse Event|28
59937|NCT01109979|227265|P2|Overall Study|Withdrawal by Subject|1
59938|NCT01109979|227266|P1|Overall Study|Withdrawal by Subject|0
59939|NCT01109979|227265|P2|Overall Study|Physician Decision|0
59940|NCT01109979|227266|P1|Overall Study|Physician Decision|2
59941|NCT01109524|227292|P1|Overall Study|Not specified|5
59942|NCT01109524|227292|P1|Overall Study|Participant requested to end treatment|4
59943|NCT01109524|227292|P1|Overall Study|No longer meets criteria|2
59944|NCT01109524|227292|P1|Overall Study|Death|2
59945|NCT01109524|227292|P1|Overall Study|Maximum clinical benefit|3
59946|NCT01109524|227292|P1|Overall Study|Withdrawal by Subject|2
59947|NCT01109524|227292|P1|Overall Study|Adverse Event|4
59948|NCT01109524|227292|P1|Overall Study|Study Drug toxicity|6
59949|NCT01109524|227292|P1|Overall Study|Disease Progression|29
59950|NCT01109316|227314|P3|Study Period 3|Withdrawal by Subject|1
59951|NCT01109316|227315|P2|Study Period 3|Withdrawal by Subject|1
59952|NCT01109316|227316|P1|Study Period 3|Withdrawal by Subject|0
59953|NCT01109316|227314|P3|Study Period 3|Lost to Follow-up|0
59954|NCT01109316|227315|P2|Study Period 3|Lost to Follow-up|1
59955|NCT01109316|227316|P1|Study Period 3|Lost to Follow-up|0
59956|NCT01109316|227314|P3|Study Period 2|Withdrawal by Subject|0
59957|NCT01109316|227315|P2|Study Period 2|Withdrawal by Subject|1
59958|NCT01109316|227316|P1|Study Period 2|Withdrawal by Subject|1
59959|NCT01109316|227314|P3|Study Period 2|Protocol Violation|0
59960|NCT01109316|227315|P2|Study Period 2|Protocol Violation|1
59961|NCT01109316|227316|P1|Study Period 2|Protocol Violation|0
59962|NCT01109316|227314|P3|Study Period 2|Physician Decision|1
59963|NCT01109316|227315|P2|Study Period 2|Physician Decision|0
59964|NCT01109316|227316|P1|Study Period 2|Physician Decision|0
59965|NCT01109316|227314|P3|Study Period 2|Entry Criteria Not Met|1
59966|NCT01109316|227315|P2|Study Period 2|Entry Criteria Not Met|0
59967|NCT01109316|227316|P1|Study Period 2|Entry Criteria Not Met|0
59968|NCT01109316|227314|P3|Study Period 1|Sponsor Decision|2
59969|NCT01109316|227315|P2|Study Period 1|Sponsor Decision|0
59970|NCT01109316|227316|P1|Study Period 1|Sponsor Decision|0
59971|NCT01109316|227314|P3|Study Period 1|Withdrawal by Subject|2
59972|NCT01109316|227315|P2|Study Period 1|Withdrawal by Subject|1
59973|NCT01109316|227316|P1|Study Period 1|Withdrawal by Subject|0
59974|NCT01109316|227314|P3|Study Period 1|Lost to Follow-up|0
59975|NCT01109316|227315|P2|Study Period 1|Lost to Follow-up|2
59976|NCT01109316|227316|P1|Study Period 1|Lost to Follow-up|0
59977|NCT01109316|227314|P3|Study Period 1|Adverse Event|0
59978|NCT01109316|227315|P2|Study Period 1|Adverse Event|1
59979|NCT01109316|227316|P1|Study Period 1|Adverse Event|0
59980|NCT01109173|227364|P4|Overall Study|Not Specifiied|14
59981|NCT01109173|227365|P3|Overall Study|Not Specifiied|9
59982|NCT01109173|227366|P2|Overall Study|Not Specifiied|4
59983|NCT01109173|227367|P1|Overall Study|Not Specifiied|5
59984|NCT01109173|227364|P4|Overall Study|Patient Did Not Use Study Medication|7
59985|NCT01109173|227365|P3|Overall Study|Patient Did Not Use Study Medication|11
59986|NCT01109173|227366|P2|Overall Study|Patient Did Not Use Study Medication|26
59987|NCT01109173|227367|P1|Overall Study|Patient Did Not Use Study Medication|34
59988|NCT01109173|227364|P4|Overall Study|Protocol Violation|2
59989|NCT01109173|227365|P3|Overall Study|Protocol Violation|1
59990|NCT01109173|227366|P2|Overall Study|Protocol Violation|5
59991|NCT01109173|227367|P1|Overall Study|Protocol Violation|4
59992|NCT01109173|227364|P4|Overall Study|Treatment Failure|64
59993|NCT01109173|227365|P3|Overall Study|Treatment Failure|69
59994|NCT01109173|227366|P2|Overall Study|Treatment Failure|32
59995|NCT01109173|227367|P1|Overall Study|Treatment Failure|25
59996|NCT01109173|227364|P4|Overall Study|Noncompliance|0
59997|NCT01109173|227365|P3|Overall Study|Noncompliance|0
59998|NCT01109173|227366|P2|Overall Study|Noncompliance|1
59999|NCT01109173|227367|P1|Overall Study|Noncompliance|0
60000|NCT01109173|227364|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
60001|NCT01109173|227365|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
60002|NCT01109173|227366|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
60003|NCT01109173|227367|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
60004|NCT01109173|227364|P4|Overall Study|Lost to Follow-up|0
60005|NCT01109173|227365|P3|Overall Study|Lost to Follow-up|0
60006|NCT01109173|227366|P2|Overall Study|Lost to Follow-up|1
60007|NCT01109173|227367|P1|Overall Study|Lost to Follow-up|0
60008|NCT01109173|227364|P4|Overall Study|Adverse Event|6
60009|NCT01109173|227365|P3|Overall Study|Adverse Event|9
60010|NCT01109173|227366|P2|Overall Study|Adverse Event|17
60011|NCT01109173|227367|P1|Overall Study|Adverse Event|15
60012|NCT01108809|227407|P1|Overall Study|Lost to Follow-up|1
60013|NCT01108809|227407|P1|Overall Study|Adverse Event|3
60014|NCT01108796|227424|P2|Overall Study|Lost to Follow-up|6
60015|NCT01108796|227425|P1|Overall Study|Lost to Follow-up|7
60016|NCT01108796|227424|P2|Overall Study|Adverse Event|1
60017|NCT01108796|227425|P1|Overall Study|Adverse Event|0
60018|NCT01108731|227459|P2|Overall Study|Adverse Event|3
60019|NCT01108731|227460|P1|Overall Study|Adverse Event|3
60020|NCT01108731|227459|P2|Overall Study|Withdrawal by Subject|1
60021|NCT01108731|227460|P1|Overall Study|Withdrawal by Subject|1
60022|NCT01108718|227472|P2|Received Control (2 Months)|Withdrawal by Subject|0
60023|NCT01108718|227473|P1|Received Control (2 Months)|Withdrawal by Subject|1
60024|NCT01108523|227478|P1|Overall Study|Protocol Violation|4
60025|NCT01108510|227485|P2|Overall Study|Death|1
60026|NCT01108510|227486|P1|Overall Study|Death|1
60027|NCT01108510|227485|P2|Overall Study|Pregnancy|3
60028|NCT01108510|227486|P1|Overall Study|Pregnancy|0
60029|NCT01108510|227485|P2|Overall Study|Lack of Efficacy|0
60030|NCT01108510|227486|P1|Overall Study|Lack of Efficacy|3
60031|NCT01108510|227485|P2|Overall Study|Participant Noncompliance|7
60032|NCT01108510|227486|P1|Overall Study|Participant Noncompliance|5
60033|NCT01108510|227485|P2|Overall Study|Investigator’s Discretion|10
60034|NCT01108510|227486|P1|Overall Study|Investigator’s Discretion|12
60035|NCT01108510|227485|P2|Overall Study|Withdrew Consent|15
60036|NCT01108510|227486|P1|Overall Study|Withdrew Consent|21
60037|NCT01108510|227485|P2|Overall Study|Lost to Follow-up|17
60038|NCT01108510|227486|P1|Overall Study|Lost to Follow-up|20
60039|NCT01108510|227485|P2|Overall Study|Adverse Event|19
60040|NCT01108510|227486|P1|Overall Study|Adverse Event|26
60041|NCT01108510|227485|P2|Overall Study|Joined Another Gilead-sponsored Study|195
60042|NCT01108510|227486|P1|Overall Study|Joined Another Gilead-sponsored Study|186
60043|NCT01108510|227485|P2|Overall Study|Randomized but Not Treated|1
60044|NCT01108510|227486|P1|Overall Study|Randomized but Not Treated|5
60045|NCT01108341|227549|P1|Overall Study|not specified|1
60046|NCT01108341|227549|P1|Overall Study|Lost to Follow-up|1
60047|NCT01108341|227549|P1|Overall Study|Withdrawal by Subject|1
60048|NCT01108341|227549|P1|Overall Study|Death|2
60049|NCT01108263|227556|P2|Overall Study|Adverse Event|1
60050|NCT01108263|227557|P1|Overall Study|Adverse Event|0
60051|NCT01108237|227567|P2|Overall Study|Did not meet criteria for analysis|0
60052|NCT01108237|227568|P1|Overall Study|Did not meet criteria for analysis|7
60053|NCT01108237|227567|P2|Overall Study|No alignment data|17
60054|NCT01108237|227568|P1|Overall Study|No alignment data|2
60055|NCT01108185|227574|P1|Overall Study|Lost to Follow-up|12
60056|NCT01108185|227574|P1|Overall Study|Non-compliance|15
60057|NCT01107925|227623|P6|Period 2|Withdrawal by Subject|1
60058|NCT01107925|227624|P5|Period 2|Withdrawal by Subject|0
60059|NCT01107925|227625|P4|Period 2|Withdrawal by Subject|0
60060|NCT01107925|227626|P3|Period 2|Withdrawal by Subject|0
60061|NCT01107925|227627|P2|Period 2|Withdrawal by Subject|1
60062|NCT01107925|227628|P1|Period 2|Withdrawal by Subject|0
60063|NCT01107925|227623|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
60064|NCT01107925|227624|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
60065|NCT01107925|227625|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
60066|NCT01107925|227626|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
60067|NCT01107925|227627|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
60068|NCT01107925|227628|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
60069|NCT01107912|227666|P6|Period 3|Withdrawal by Subject|0
60070|NCT01107912|227667|P5|Period 3|Withdrawal by Subject|0
60071|NCT01107912|227668|P4|Period 3|Withdrawal by Subject|1
60072|NCT01107912|227669|P3|Period 3|Withdrawal by Subject|0
60073|NCT01107912|227670|P2|Period 3|Withdrawal by Subject|0
60074|NCT01107912|227671|P1|Period 3|Withdrawal by Subject|0
60075|NCT01107912|227666|P6|Period 3|Adverse Event|0
60076|NCT01107912|227667|P5|Period 3|Adverse Event|0
60077|NCT01107912|227668|P4|Period 3|Adverse Event|0
60078|NCT01107912|227669|P3|Period 3|Adverse Event|1
60079|NCT01107912|227670|P2|Period 3|Adverse Event|1
60080|NCT01107912|227671|P1|Period 3|Adverse Event|0
60081|NCT01107912|227666|P6|Period 2|Physician Decision|0
60082|NCT01107912|227667|P5|Period 2|Physician Decision|0
60083|NCT01107912|227668|P4|Period 2|Physician Decision|0
60084|NCT01107912|227669|P3|Period 2|Physician Decision|1
60085|NCT01107912|227670|P2|Period 2|Physician Decision|0
60086|NCT01107912|227671|P1|Period 2|Physician Decision|0
60087|NCT01107912|227666|P6|Period 1|Withdrawal by Subject|0
60088|NCT01107912|227667|P5|Period 1|Withdrawal by Subject|0
60089|NCT01107912|227668|P4|Period 1|Withdrawal by Subject|0
60090|NCT01107912|227669|P3|Period 1|Withdrawal by Subject|0
60091|NCT01107912|227670|P2|Period 1|Withdrawal by Subject|0
60092|NCT01107912|227671|P1|Period 1|Withdrawal by Subject|1
60093|NCT01107912|227666|P6|Period 1|Physician Decision|0
60094|NCT01107912|227667|P5|Period 1|Physician Decision|1
60095|NCT01107912|227668|P4|Period 1|Physician Decision|0
60096|NCT01107912|227669|P3|Period 1|Physician Decision|0
60097|NCT01107912|227670|P2|Period 1|Physician Decision|0
60098|NCT01107912|227671|P1|Period 1|Physician Decision|0
60099|NCT01107912|227666|P6|Period 1|Adverse Event|0
60100|NCT01107912|227667|P5|Period 1|Adverse Event|2
60101|NCT01107912|227668|P4|Period 1|Adverse Event|0
60102|NCT01107912|227669|P3|Period 1|Adverse Event|0
60103|NCT01107912|227670|P2|Period 1|Adverse Event|0
60104|NCT01107912|227671|P1|Period 1|Adverse Event|0
60105|NCT01107899|227708|P3|Overall Study|Withdrawal by Subject|1
60106|NCT01107899|227709|P2|Overall Study|Withdrawal by Subject|0
60107|NCT01107899|227710|P1|Overall Study|Withdrawal by Subject|0
60108|NCT01107899|227708|P3|Overall Study|Physician Decision|3
60109|NCT01107899|227709|P2|Overall Study|Physician Decision|0
60110|NCT01107899|227710|P1|Overall Study|Physician Decision|5
60111|NCT01107886|227756|P2|Overall Study|Administrative withdrawal of consent|5
60112|NCT01107886|227757|P1|Overall Study|Administrative withdrawal of consent|7
60113|NCT01107886|227756|P2|Overall Study|Withdrawal by Subject|196
60114|NCT01107886|227757|P1|Overall Study|Withdrawal by Subject|180
60115|NCT01107886|227756|P2|Overall Study|Lost to Follow-up|13
60116|NCT01107886|227757|P1|Overall Study|Lost to Follow-up|15
60117|NCT01107743|227786|P1|Overall Study|Protocol Violation|46
60118|NCT01107535|227885|P1|Overall Study|Death|5
60119|NCT01107418|227897|P1|Overall Study|Entered Extension Study|1
60120|NCT01107418|227897|P1|Overall Study|Started Other Therapy|1
60121|NCT01107418|227897|P1|Overall Study|Study Closing|1
60122|NCT01107418|227897|P1|Overall Study|Withdrawal by Subject|1
60123|NCT01107418|227897|P1|Overall Study|Adverse Event|3
60124|NCT01107418|227897|P1|Overall Study|Disease Progression|45
60125|NCT01107405|227970|P5|Overall Study|Protocol Violation|0
60126|NCT01107405|227971|P4|Overall Study|Protocol Violation|1
60127|NCT01107405|227972|P3|Overall Study|Protocol Violation|1
60128|NCT01107405|227973|P2|Overall Study|Protocol Violation|0
60129|NCT01107405|227974|P1|Overall Study|Protocol Violation|0
60130|NCT01107405|227970|P5|Overall Study|Withdrawal by Subject|1
60131|NCT01107405|227971|P4|Overall Study|Withdrawal by Subject|2
60132|NCT01107405|227972|P3|Overall Study|Withdrawal by Subject|1
60133|NCT01107405|227973|P2|Overall Study|Withdrawal by Subject|0
60134|NCT01107405|227974|P1|Overall Study|Withdrawal by Subject|1
60135|NCT01107405|227970|P5|Overall Study|Adverse Event|2
60136|NCT01107405|227971|P4|Overall Study|Adverse Event|0
60137|NCT01107405|227972|P3|Overall Study|Adverse Event|0
60138|NCT01107405|227973|P2|Overall Study|Adverse Event|1
60139|NCT01107405|227974|P1|Overall Study|Adverse Event|1
60140|NCT01107392|228013|P2|Overall Study|Administrative decision|0
60141|NCT01107392|228014|P1|Overall Study|Administrative decision|1
60142|NCT01107392|228013|P2|Overall Study|Personal Reasons|3
60143|NCT01107392|228014|P1|Overall Study|Personal Reasons|2
60144|NCT01107392|228013|P2|Overall Study|Adverse Event|0
60145|NCT01107392|228014|P1|Overall Study|Adverse Event|2
60146|NCT01107379|228026|P1|Overall Study|Lost to Follow-up|3
60147|NCT01107379|228026|P1|Overall Study|Withdrawal by Subject|18
60148|NCT01107353|228037|P2|Overall Study|Positive Drug Screen|0
60149|NCT01107353|228038|P1|Overall Study|Positive Drug Screen|1
60150|NCT01107197|228046|P2|Overall Study|Withdrawal by Subject|5
60151|NCT01107197|228047|P1|Overall Study|Withdrawal by Subject|3
60152|NCT01107197|228046|P2|Overall Study|Lost to Follow-up|8
60153|NCT01107197|228047|P1|Overall Study|Lost to Follow-up|5
60154|NCT01107197|228046|P2|Overall Study|Death|10
60155|NCT01107197|228047|P1|Overall Study|Death|12
60156|NCT01106976|228065|P1|Overall Study|Lost to Follow-up|8
60157|NCT01106911|228079|P1|Overall Study|deemed ineligible after screening|3
60158|NCT01106911|228079|P1|Overall Study|Physician Decision|2
60159|NCT01106846|228124|P2|Overall Study|Change in surgical procedure|1
60160|NCT01106846|228125|P1|Overall Study|Change in surgical procedure|0
60161|NCT01106690|228134|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
60162|NCT01106690|228135|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
60163|NCT01106690|228136|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
60164|NCT01106690|228134|P3|Extension Period: Week 26 to Week 52|Not specified|4
60165|NCT01106690|228135|P2|Extension Period: Week 26 to Week 52|Not specified|3
60166|NCT01106690|228136|P1|Extension Period: Week 26 to Week 52|Not specified|8
60167|NCT01106690|228134|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
60168|NCT01106690|228135|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
60169|NCT01106690|228136|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
60315|NCT01106651|228240|P1|Overall Study|Protocol Violation|1
60170|NCT01106690|228134|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
60171|NCT01106690|228135|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
60172|NCT01106690|228136|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
60173|NCT01106690|228134|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
60174|NCT01106690|228135|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
60175|NCT01106690|228136|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
60176|NCT01106690|228134|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
60177|NCT01106690|228135|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
60178|NCT01106690|228136|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
60179|NCT01106690|228134|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
60180|NCT01106690|228135|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
60181|NCT01106690|228136|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
60182|NCT01106690|228134|P3|Core Period: Baseline to Week 26|Not specified|6
60183|NCT01106690|228135|P2|Core Period: Baseline to Week 26|Not specified|2
60184|NCT01106690|228136|P1|Core Period: Baseline to Week 26|Not specified|10
60185|NCT01106690|228134|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
60186|NCT01106690|228135|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
60187|NCT01106690|228136|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
60188|NCT01106690|228134|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
60189|NCT01106690|228135|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
60190|NCT01106690|228136|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
60191|NCT01106690|228134|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
60192|NCT01106690|228135|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
60193|NCT01106690|228136|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
60194|NCT01106690|228134|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
60195|NCT01106690|228135|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
60196|NCT01106690|228136|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
60197|NCT01106690|228134|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
60198|NCT01106690|228135|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
60199|NCT01106690|228136|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
60200|NCT01106690|228134|P3|Core Period: Baseline to Week 26|Protocol Violation|0
60201|NCT01106690|228135|P2|Core Period: Baseline to Week 26|Protocol Violation|0
60202|NCT01106690|228136|P1|Core Period: Baseline to Week 26|Protocol Violation|1
60203|NCT01106690|228134|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
60204|NCT01106690|228135|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
60205|NCT01106690|228136|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
60206|NCT01106690|228134|P3|Core Period: Baseline to Week 26|Adverse Event|4
60207|NCT01106690|228135|P2|Core Period: Baseline to Week 26|Adverse Event|1
60208|NCT01106690|228136|P1|Core Period: Baseline to Week 26|Adverse Event|6
60209|NCT01106677|228172|P4|Extension Period: Week 26 to Week 52|Not specified|5
60210|NCT01106677|228173|P3|Extension Period: Week 26 to Week 52|Not specified|8
60211|NCT01106677|228174|P2|Extension Period: Week 26 to Week 52|Not specified|5
60212|NCT01106677|228175|P1|Extension Period: Week 26 to Week 52|Not specified|6
60213|NCT01106677|228172|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
60214|NCT01106677|228173|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
60215|NCT01106677|228174|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
60216|NCT01106677|228175|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
60217|NCT01106677|228172|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
60218|NCT01106677|228173|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
60219|NCT01106677|228174|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
60220|NCT01106677|228175|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
60221|NCT01106677|228172|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
60222|NCT01106677|228173|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
60223|NCT01106677|228174|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
60224|NCT01106677|228175|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
60225|NCT01106677|228172|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
60226|NCT01106677|228173|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
60227|NCT01106677|228174|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
60228|NCT01106677|228175|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
60229|NCT01106677|228172|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
60230|NCT01106677|228173|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
60231|NCT01106677|228174|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
60232|NCT01106677|228175|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
60233|NCT01106677|228172|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
60234|NCT01106677|228173|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
60235|NCT01106677|228174|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
60236|NCT01106677|228175|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
60237|NCT01106677|228172|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
60238|NCT01106677|228173|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
60239|NCT01106677|228174|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
60240|NCT01106677|228175|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
60241|NCT01106677|228172|P4|Extension Period: Week 26 to Week 52|Death|1
60242|NCT01106677|228173|P3|Extension Period: Week 26 to Week 52|Death|0
60243|NCT01106677|228174|P2|Extension Period: Week 26 to Week 52|Death|0
60244|NCT01106677|228175|P1|Extension Period: Week 26 to Week 52|Death|0
60245|NCT01106677|228172|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
60246|NCT01106677|228173|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
60247|NCT01106677|228174|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
60248|NCT01106677|228175|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
60249|NCT01106677|228172|P4|Core Period: Baseline to Week 26|Pregnancy|0
60250|NCT01106677|228173|P3|Core Period: Baseline to Week 26|Pregnancy|0
60251|NCT01106677|228174|P2|Core Period: Baseline to Week 26|Pregnancy|1
60252|NCT01106677|228175|P1|Core Period: Baseline to Week 26|Pregnancy|0
60253|NCT01106677|228172|P4|Core Period: Baseline to Week 26|Not specified|23
60254|NCT01106677|228173|P3|Core Period: Baseline to Week 26|Not specified|8
60255|NCT01106677|228174|P2|Core Period: Baseline to Week 26|Not specified|14
60256|NCT01106677|228175|P1|Core Period: Baseline to Week 26|Not specified|8
60257|NCT01106677|228172|P4|Core Period: Baseline to Week 26|Product quality complaint|0
60258|NCT01106677|228173|P3|Core Period: Baseline to Week 26|Product quality complaint|1
60259|NCT01106677|228174|P2|Core Period: Baseline to Week 26|Product quality complaint|1
60260|NCT01106677|228175|P1|Core Period: Baseline to Week 26|Product quality complaint|0
60261|NCT01106677|228172|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
60262|NCT01106677|228173|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
60263|NCT01106677|228174|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
60264|NCT01106677|228175|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
60265|NCT01106677|228172|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
60266|NCT01106677|228173|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
60267|NCT01106677|228174|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
60268|NCT01106677|228175|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
60269|NCT01106677|228172|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
60270|NCT01106677|228173|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
60271|NCT01106677|228174|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
60272|NCT01106677|228175|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
60273|NCT01106677|228172|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
60274|NCT01106677|228173|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
60275|NCT01106677|228174|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
60276|NCT01106677|228175|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
60277|NCT01106677|228172|P4|Core Period: Baseline to Week 26|Protocol Violation|3
60278|NCT01106677|228173|P3|Core Period: Baseline to Week 26|Protocol Violation|0
60279|NCT01106677|228174|P2|Core Period: Baseline to Week 26|Protocol Violation|1
60280|NCT01106677|228175|P1|Core Period: Baseline to Week 26|Protocol Violation|0
60281|NCT01106677|228172|P4|Core Period: Baseline to Week 26|Physician Decision|1
60282|NCT01106677|228173|P3|Core Period: Baseline to Week 26|Physician Decision|3
60283|NCT01106677|228174|P2|Core Period: Baseline to Week 26|Physician Decision|1
60284|NCT01106677|228175|P1|Core Period: Baseline to Week 26|Physician Decision|2
60285|NCT01106677|228172|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
60286|NCT01106677|228173|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
60287|NCT01106677|228174|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
60288|NCT01106677|228175|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
60289|NCT01106677|228172|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
60290|NCT01106677|228173|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
60291|NCT01106677|228174|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
60292|NCT01106677|228175|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
60293|NCT01106677|228172|P4|Core Period: Baseline to Week 26|Death|0
60294|NCT01106677|228173|P3|Core Period: Baseline to Week 26|Death|1
60295|NCT01106677|228174|P2|Core Period: Baseline to Week 26|Death|0
60296|NCT01106677|228175|P1|Core Period: Baseline to Week 26|Death|0
60297|NCT01106677|228172|P4|Core Period: Baseline to Week 26|Adverse Event|8
60298|NCT01106677|228173|P3|Core Period: Baseline to Week 26|Adverse Event|6
60299|NCT01106677|228174|P2|Core Period: Baseline to Week 26|Adverse Event|18
60300|NCT01106677|228175|P1|Core Period: Baseline to Week 26|Adverse Event|7
60301|NCT01106651|228238|P3|Overall Study|Death|0
60302|NCT01106651|228239|P2|Overall Study|Death|3
60303|NCT01106651|228240|P1|Overall Study|Death|0
60304|NCT01106651|228238|P3|Overall Study|Not specified|21
60305|NCT01106651|228239|P2|Overall Study|Not specified|31
60306|NCT01106651|228240|P1|Overall Study|Not specified|34
60307|NCT01106651|228238|P3|Overall Study|Noncompliance with study drug|2
60308|NCT01106651|228239|P2|Overall Study|Noncompliance with study drug|0
60309|NCT01106651|228240|P1|Overall Study|Noncompliance with study drug|1
60310|NCT01106651|228238|P3|Overall Study|Withdrawal by Subject|4
60311|NCT01106651|228239|P2|Overall Study|Withdrawal by Subject|7
60312|NCT01106651|228240|P1|Overall Study|Withdrawal by Subject|14
60313|NCT01106651|228238|P3|Overall Study|Protocol Violation|1
60314|NCT01106651|228239|P2|Overall Study|Protocol Violation|2
60316|NCT01106651|228238|P3|Overall Study|Physician Decision|1
60317|NCT01106651|228239|P2|Overall Study|Physician Decision|3
60318|NCT01106651|228240|P1|Overall Study|Physician Decision|4
60319|NCT01106651|228238|P3|Overall Study|Lost to Follow-up|6
60320|NCT01106651|228239|P2|Overall Study|Lost to Follow-up|2
60321|NCT01106651|228240|P1|Overall Study|Lost to Follow-up|8
60322|NCT01106651|228238|P3|Overall Study|Adverse Event|23
60323|NCT01106651|228239|P2|Overall Study|Adverse Event|9
60324|NCT01106651|228240|P1|Overall Study|Adverse Event|17
60325|NCT01106625|228293|P3|Extension Period: Week 26 to Week 52|Not specified|4
60326|NCT01106625|228294|P2|Extension Period: Week 26 to Week 52|Not specified|5
60327|NCT01106625|228295|P1|Extension Period: Week 26 to Week 52|Not specified|5
60328|NCT01106625|228293|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
60329|NCT01106625|228294|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
60330|NCT01106625|228295|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
60331|NCT01106625|228293|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
60332|NCT01106625|228294|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
60333|NCT01106625|228295|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
60334|NCT01106625|228293|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
60335|NCT01106625|228294|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
60336|NCT01106625|228295|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
60337|NCT01106625|228293|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
60338|NCT01106625|228294|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
60339|NCT01106625|228295|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
60340|NCT01106625|228293|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
60341|NCT01106625|228294|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
60342|NCT01106625|228295|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
60343|NCT01106625|228293|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
60344|NCT01106625|228294|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
60345|NCT01106625|228295|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
60346|NCT01106625|228293|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
60347|NCT01106625|228294|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
60348|NCT01106625|228295|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
60349|NCT01106625|228293|P3|Core Period: Baseline to Week 26|Not specified|4
60350|NCT01106625|228294|P2|Core Period: Baseline to Week 26|Not specified|7
60351|NCT01106625|228295|P1|Core Period: Baseline to Week 26|Not specified|8
60352|NCT01106625|228293|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
60353|NCT01106625|228294|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
60354|NCT01106625|228295|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
60355|NCT01106625|228293|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
60356|NCT01106625|228294|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
60357|NCT01106625|228295|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
60358|NCT01106625|228293|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
60359|NCT01106625|228294|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
60360|NCT01106625|228295|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
60361|NCT01106625|228293|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
60362|NCT01106625|228294|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
60363|NCT01106625|228295|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
60364|NCT01106625|228293|P3|Core Period: Baseline to Week 26|Protocol Violation|3
60365|NCT01106625|228294|P2|Core Period: Baseline to Week 26|Protocol Violation|1
60366|NCT01106625|228295|P1|Core Period: Baseline to Week 26|Protocol Violation|2
60367|NCT01106625|228293|P3|Core Period: Baseline to Week 26|Physician Decision|0
60368|NCT01106625|228294|P2|Core Period: Baseline to Week 26|Physician Decision|0
60369|NCT01106625|228295|P1|Core Period: Baseline to Week 26|Physician Decision|1
60370|NCT01106625|228293|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
60371|NCT01106625|228294|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
60372|NCT01106625|228295|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
60373|NCT01106625|228293|P3|Core Period: Baseline to Week 26|Adverse Event|8
60374|NCT01106625|228294|P2|Core Period: Baseline to Week 26|Adverse Event|8
60375|NCT01106625|228295|P1|Core Period: Baseline to Week 26|Adverse Event|6
60376|NCT01106586|228326|P2|Overall Study|Participant Transferred to Another Study|197
60377|NCT01106586|228327|P1|Overall Study|Participant Transferred to Another Study|212
60378|NCT01106586|228326|P2|Overall Study|Protocol Violation|0
60379|NCT01106586|228327|P1|Overall Study|Protocol Violation|1
60380|NCT01106586|228326|P2|Overall Study|Participant Noncompliance|10
60381|NCT01106586|228327|P1|Overall Study|Participant Noncompliance|12
60382|NCT01106586|228326|P2|Overall Study|Lost to Follow-up|20
60383|NCT01106586|228327|P1|Overall Study|Lost to Follow-up|24
60384|NCT01106586|228326|P2|Overall Study|Withdrew Consent|30
60385|NCT01106586|228327|P1|Overall Study|Withdrew Consent|18
60386|NCT01106586|228326|P2|Overall Study|Investigator's Discretion|8
60387|NCT01106586|228327|P1|Overall Study|Investigator's Discretion|5
60388|NCT01106586|228326|P2|Overall Study|Lack of Efficacy|0
60389|NCT01106586|228327|P1|Overall Study|Lack of Efficacy|1
60390|NCT01106586|228326|P2|Overall Study|Pregnancy|2
60391|NCT01106586|228327|P1|Overall Study|Pregnancy|2
60392|NCT01106586|228326|P2|Overall Study|Death|3
60393|NCT01106586|228327|P1|Overall Study|Death|1
60394|NCT01106586|228326|P2|Overall Study|Adverse Event|15
60395|NCT01106586|228327|P1|Overall Study|Adverse Event|9
60396|NCT01106534|228345|P1|Overall Study|Physician Decision|1
60397|NCT01106534|228345|P1|Overall Study|Death|16
60398|NCT01106534|228345|P1|Overall Study|Lost to Follow-up|2
60399|NCT01106534|228345|P1|Overall Study|Withdrawal by Subject|18
60400|NCT01106430|228368|P2|Overall Study|Withdrawal by Subject|4
60401|NCT01106430|228369|P1|Overall Study|Withdrawal by Subject|8
60402|NCT01106430|228368|P2|Overall Study|Protocol Violation|2
60403|NCT01106430|228369|P1|Overall Study|Protocol Violation|7
60404|NCT01106430|228368|P2|Overall Study|Previous Use Of Marijuana|0
60405|NCT01106430|228369|P1|Overall Study|Previous Use Of Marijuana|1
60406|NCT01106430|228368|P2|Overall Study|Hard Time Swallowing The Pills|0
60407|NCT01106430|228369|P1|Overall Study|Hard Time Swallowing The Pills|1
60408|NCT01106430|228368|P2|Overall Study|Noncompliance|1
60409|NCT01106430|228369|P1|Overall Study|Noncompliance|0
60410|NCT01106430|228368|P2|Overall Study|Refused To Take Medication|1
60411|NCT01106430|228369|P1|Overall Study|Refused To Take Medication|0
60412|NCT01106430|228368|P2|Overall Study|Moved Out Of State|1
60413|NCT01106430|228369|P1|Overall Study|Moved Out Of State|0
60414|NCT01106430|228368|P2|Overall Study|Early Termination Requested By Sponsor|0
60415|NCT01106430|228369|P1|Overall Study|Early Termination Requested By Sponsor|1
60416|NCT01106430|228368|P2|Overall Study|Lost to Follow-up|1
60417|NCT01106430|228369|P1|Overall Study|Lost to Follow-up|5
60418|NCT01106430|228368|P2|Overall Study|Lack of Efficacy|13
60419|NCT01106430|228369|P1|Overall Study|Lack of Efficacy|2
60420|NCT01106430|228368|P2|Overall Study|Adverse Event|10
60421|NCT01106430|228369|P1|Overall Study|Adverse Event|8
60422|NCT01106404|228391|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
60423|NCT01106404|228392|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
60424|NCT01106404|228391|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
60425|NCT01106404|228392|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
60426|NCT01106404|228391|P2|Period I (First 6 Weeks)|Physician Decision|0
60427|NCT01106404|228392|P1|Period I (First 6 Weeks)|Physician Decision|1
60428|NCT01106404|228391|P2|Period I (First 6 Weeks)|Adverse Event|0
60429|NCT01106404|228392|P1|Period I (First 6 Weeks)|Adverse Event|2
60430|NCT01106352|228415|P5|Overall Study|Home hospice since July 2013|0
60431|NCT01106352|228416|P4|Overall Study|Home hospice since July 2013|1
60432|NCT01106352|228417|P3|Overall Study|Home hospice since July 2013|0
60433|NCT01106352|228418|P2|Overall Study|Home hospice since July 2013|0
60434|NCT01106352|228419|P1|Overall Study|Home hospice since July 2013|0
60435|NCT01106352|228415|P5|Overall Study|Subject entered hospice|0
60436|NCT01106352|228416|P4|Overall Study|Subject entered hospice|1
60437|NCT01106352|228417|P3|Overall Study|Subject entered hospice|0
60438|NCT01106352|228418|P2|Overall Study|Subject entered hospice|0
60439|NCT01106352|228419|P1|Overall Study|Subject entered hospice|0
60440|NCT01106352|228415|P5|Overall Study|Went on hospice|0
60441|NCT01106352|228416|P4|Overall Study|Went on hospice|1
60442|NCT01106352|228417|P3|Overall Study|Went on hospice|0
60443|NCT01106352|228418|P2|Overall Study|Went on hospice|0
60444|NCT01106352|228419|P1|Overall Study|Went on hospice|0
60445|NCT01106352|228415|P5|Overall Study|Withdrawal by Subject|2
60446|NCT01106352|228416|P4|Overall Study|Withdrawal by Subject|3
60447|NCT01106352|228417|P3|Overall Study|Withdrawal by Subject|0
60448|NCT01106352|228418|P2|Overall Study|Withdrawal by Subject|0
60449|NCT01106352|228419|P1|Overall Study|Withdrawal by Subject|0
60450|NCT01106352|228415|P5|Overall Study|Disease progression|0
60451|NCT01106352|228416|P4|Overall Study|Disease progression|1
60452|NCT01106352|228417|P3|Overall Study|Disease progression|0
60453|NCT01106352|228418|P2|Overall Study|Disease progression|0
60454|NCT01106352|228419|P1|Overall Study|Disease progression|0
60455|NCT01106352|228415|P5|Overall Study|Death|1
60456|NCT01106352|228416|P4|Overall Study|Death|3
60457|NCT01106352|228417|P3|Overall Study|Death|1
60458|NCT01106352|228418|P2|Overall Study|Death|0
60459|NCT01106352|228419|P1|Overall Study|Death|0
60460|NCT01106352|228415|P5|Overall Study|Lost to Follow-up|1
60461|NCT01106352|228416|P4|Overall Study|Lost to Follow-up|0
60462|NCT01106352|228417|P3|Overall Study|Lost to Follow-up|0
60463|NCT01106352|228418|P2|Overall Study|Lost to Follow-up|0
60464|NCT01106352|228419|P1|Overall Study|Lost to Follow-up|0
60465|NCT01106352|228415|P5|Overall Study|Too ill to come in for the visit|0
60466|NCT01106352|228416|P4|Overall Study|Too ill to come in for the visit|0
60467|NCT01106352|228417|P3|Overall Study|Too ill to come in for the visit|1
60468|NCT01106352|228418|P2|Overall Study|Too ill to come in for the visit|0
60469|NCT01106352|228419|P1|Overall Study|Too ill to come in for the visit|0
60470|NCT01106352|228415|P5|Overall Study|Sponsor Decision|0
60471|NCT01106352|228416|P4|Overall Study|Sponsor Decision|0
60472|NCT01106352|228417|P3|Overall Study|Sponsor Decision|0
60473|NCT01106352|228418|P2|Overall Study|Sponsor Decision|0
60474|NCT01106352|228419|P1|Overall Study|Sponsor Decision|1
60475|NCT01106352|228415|P5|Overall Study|Subjects untreated|4
60476|NCT01106352|228416|P4|Overall Study|Subjects untreated|3
60477|NCT01106352|228417|P3|Overall Study|Subjects untreated|0
60478|NCT01106352|228418|P2|Overall Study|Subjects untreated|0
60479|NCT01106352|228419|P1|Overall Study|Subjects untreated|0
60480|NCT01106287|228515|P4|Overall Study|Adverse Event|0
60481|NCT01106287|228516|P3|Overall Study|Adverse Event|0
60482|NCT01106287|228517|P2|Overall Study|Adverse Event|0
60483|NCT01106287|228518|P1|Overall Study|Adverse Event|1
60484|NCT01106248|228538|P1|Overall Study|Administrative|2
60485|NCT01106248|228538|P1|Overall Study|Adverse Event|1
60486|NCT01106157|228546|P2|Overall Study|Withdrawal by Subject|0
60487|NCT01106157|228547|P1|Overall Study|Withdrawal by Subject|1
60488|NCT01106014|228578|P2|Overall Study|Lost to Follow-up|3
60489|NCT01106014|228579|P1|Overall Study|Lost to Follow-up|2
60490|NCT01106014|228578|P2|Overall Study|Administrative reason|6
60491|NCT01106014|228579|P1|Overall Study|Administrative reason|7
60492|NCT01106014|228578|P2|Overall Study|Withdrawal by Subject|37
60493|NCT01106014|228579|P1|Overall Study|Withdrawal by Subject|43
60494|NCT01106014|228578|P2|Overall Study|Adverse Event|42
60495|NCT01106014|228579|P1|Overall Study|Adverse Event|78
60496|NCT01106014|228578|P2|Overall Study|Morbidity or Mortality primary endpoint|242
60497|NCT01106014|228579|P1|Overall Study|Morbidity or Mortality primary endpoint|155
60498|NCT01105936|228589|P4|Period 3|Protocol Violation|0
60499|NCT01105936|228590|P3|Period 3|Protocol Violation|0
60500|NCT01105936|228591|P2|Period 3|Protocol Violation|2
60501|NCT01105936|228592|P1|Period 3|Protocol Violation|0
60502|NCT01105936|228589|P4|Period 2|Adverse Event|0
60503|NCT01105936|228590|P3|Period 2|Adverse Event|0
60504|NCT01105936|228591|P2|Period 2|Adverse Event|0
60505|NCT01105936|228592|P1|Period 2|Adverse Event|1
60506|NCT01105936|228589|P4|Period 1|Adverse Event|1
60507|NCT01105936|228590|P3|Period 1|Adverse Event|0
60508|NCT01105936|228591|P2|Period 1|Adverse Event|0
60509|NCT01105936|228592|P1|Period 1|Adverse Event|0
60510|NCT01105767|228621|P3|Overall Study|Lost to Follow-up|1184
60511|NCT01105767|228622|P2|Overall Study|Lost to Follow-up|1614
60512|NCT01105767|228623|P1|Overall Study|Lost to Follow-up|1160
60513|NCT01105533|228652|P9|Overall Study|Physician Decision|0
60514|NCT01105533|228653|P8|Overall Study|Physician Decision|1
60515|NCT01105533|228654|P7|Overall Study|Physician Decision|0
60516|NCT01105533|228655|P6|Overall Study|Physician Decision|0
60517|NCT01105533|228656|P5|Overall Study|Physician Decision|0
60518|NCT01105533|228657|P4|Overall Study|Physician Decision|0
60519|NCT01105533|228658|P3|Overall Study|Physician Decision|0
60520|NCT01105533|228659|P2|Overall Study|Physician Decision|0
60521|NCT01105533|228660|P1|Overall Study|Physician Decision|0
60522|NCT01105533|228652|P9|Overall Study|Unspecified|2
60523|NCT01105533|228653|P8|Overall Study|Unspecified|1
60524|NCT01105533|228654|P7|Overall Study|Unspecified|3
60525|NCT01105533|228655|P6|Overall Study|Unspecified|0
60526|NCT01105533|228656|P5|Overall Study|Unspecified|1
60527|NCT01105533|228657|P4|Overall Study|Unspecified|0
60528|NCT01105533|228658|P3|Overall Study|Unspecified|0
60529|NCT01105533|228659|P2|Overall Study|Unspecified|0
60530|NCT01105533|228660|P1|Overall Study|Unspecified|0
60531|NCT01105533|228652|P9|Overall Study|Adverse Event|1
60532|NCT01105533|228653|P8|Overall Study|Adverse Event|0
60533|NCT01105533|228654|P7|Overall Study|Adverse Event|2
60534|NCT01105533|228655|P6|Overall Study|Adverse Event|2
60535|NCT01105533|228656|P5|Overall Study|Adverse Event|1
60536|NCT01105533|228657|P4|Overall Study|Adverse Event|0
60537|NCT01105533|228658|P3|Overall Study|Adverse Event|0
60538|NCT01105533|228659|P2|Overall Study|Adverse Event|0
60539|NCT01105533|228660|P1|Overall Study|Adverse Event|0
60540|NCT01105533|228652|P9|Overall Study|Lack of Efficacy|9
60541|NCT01105533|228653|P8|Overall Study|Lack of Efficacy|2
60542|NCT01105533|228654|P7|Overall Study|Lack of Efficacy|3
60543|NCT01105533|228655|P6|Overall Study|Lack of Efficacy|5
60544|NCT01105533|228656|P5|Overall Study|Lack of Efficacy|4
60545|NCT01105533|228657|P4|Overall Study|Lack of Efficacy|3
60546|NCT01105533|228658|P3|Overall Study|Lack of Efficacy|3
60547|NCT01105533|228659|P2|Overall Study|Lack of Efficacy|1
60548|NCT01105533|228660|P1|Overall Study|Lack of Efficacy|1
60549|NCT01105533|228652|P9|Overall Study|Death|0
60550|NCT01105533|228653|P8|Overall Study|Death|0
60551|NCT01105533|228654|P7|Overall Study|Death|0
60552|NCT01105533|228655|P6|Overall Study|Death|0
60553|NCT01105533|228656|P5|Overall Study|Death|1
60554|NCT01105533|228657|P4|Overall Study|Death|0
60555|NCT01105533|228658|P3|Overall Study|Death|0
60556|NCT01105533|228659|P2|Overall Study|Death|0
60557|NCT01105533|228660|P1|Overall Study|Death|0
60558|NCT01105377|228750|P2|Overall Study|Withdrawal by Subject|1
60559|NCT01105377|228751|P1|Overall Study|Withdrawal by Subject|0
60560|NCT01105130|228778|P3|Overall Study|Multiple Reasons|2
60561|NCT01105130|228779|P2|Overall Study|Multiple Reasons|0
60562|NCT01105130|228780|P1|Overall Study|Multiple Reasons|3
60563|NCT01105130|228778|P3|Overall Study|Toxicity|2
60564|NCT01105130|228779|P2|Overall Study|Toxicity|3
60565|NCT01105130|228780|P1|Overall Study|Toxicity|1
60566|NCT01105130|228778|P3|Overall Study|Never Started|4
60567|NCT01105130|228779|P2|Overall Study|Never Started|2
60568|NCT01105130|228780|P1|Overall Study|Never Started|2
60569|NCT01105130|228778|P3|Overall Study|Withdrawal by Subject|2
60570|NCT01105130|228779|P2|Overall Study|Withdrawal by Subject|6
60571|NCT01105130|228780|P1|Overall Study|Withdrawal by Subject|4
60572|NCT01105091|228810|P2|Overall Study|Death|0
60573|NCT01105091|228811|P1|Overall Study|Death|2
60574|NCT01105065|228835|P1|Overall Study|Technical Problems|1
60575|NCT01105065|228835|P1|Overall Study|Adverse Event|5
60576|NCT01104870|228844|P3|Overall Study|Withdrawal by Subject|1
60577|NCT01104870|228845|P2|Overall Study|Withdrawal by Subject|0
60578|NCT01104870|228846|P1|Overall Study|Withdrawal by Subject|0
60579|NCT01104870|228844|P3|Overall Study|Death|1
60580|NCT01104870|228845|P2|Overall Study|Death|0
60581|NCT01104870|228846|P1|Overall Study|Death|0
60582|NCT01104870|228844|P3|Overall Study|Adverse Event|0
60583|NCT01104870|228845|P2|Overall Study|Adverse Event|1
60584|NCT01104870|228846|P1|Overall Study|Adverse Event|1
60585|NCT01104701|228879|P4|Overall Study|Physician Decision|0
60586|NCT01104701|228880|P3|Overall Study|Physician Decision|0
60587|NCT01104701|228881|P2|Overall Study|Physician Decision|2
60588|NCT01104701|228882|P1|Overall Study|Physician Decision|0
60589|NCT01104701|228879|P4|Overall Study|Adverse Event|1
60590|NCT01104701|228880|P3|Overall Study|Adverse Event|0
60591|NCT01104701|228881|P2|Overall Study|Adverse Event|0
60592|NCT01104701|228882|P1|Overall Study|Adverse Event|0
60593|NCT01104701|228879|P4|Overall Study|Withdrawal by Subject|1
60594|NCT01104701|228880|P3|Overall Study|Withdrawal by Subject|2
60595|NCT01104701|228881|P2|Overall Study|Withdrawal by Subject|1
60596|NCT01104701|228882|P1|Overall Study|Withdrawal by Subject|0
60597|NCT01104662|228944|P8|Overall Study|Randomized but not treated|0
60598|NCT01104662|228945|P7|Overall Study|Randomized but not treated|0
60599|NCT01104662|228946|P6|Overall Study|Randomized but not treated|1
60600|NCT01104662|228947|P5|Overall Study|Randomized but not treated|0
60601|NCT01104662|228948|P4|Overall Study|Randomized but not treated|0
60602|NCT01104662|228949|P3|Overall Study|Randomized but not treated|1
60603|NCT01104662|228950|P2|Overall Study|Randomized but not treated|4
60604|NCT01104662|228951|P1|Overall Study|Randomized but not treated|3
60605|NCT01104662|228944|P8|Overall Study|Reason not specified|0
60606|NCT01104662|228945|P7|Overall Study|Reason not specified|0
60607|NCT01104662|228946|P6|Overall Study|Reason not specified|1
60608|NCT01104662|228947|P5|Overall Study|Reason not specified|0
60609|NCT01104662|228948|P4|Overall Study|Reason not specified|0
60610|NCT01104662|228949|P3|Overall Study|Reason not specified|0
60611|NCT01104662|228950|P2|Overall Study|Reason not specified|3
60612|NCT01104662|228951|P1|Overall Study|Reason not specified|3
60613|NCT01104662|228944|P8|Overall Study|Participant left investigator’s care|0
60614|NCT01104662|228945|P7|Overall Study|Participant left investigator’s care|0
60615|NCT01104662|228946|P6|Overall Study|Participant left investigator’s care|0
60616|NCT01104662|228947|P5|Overall Study|Participant left investigator’s care|0
60617|NCT01104662|228948|P4|Overall Study|Participant left investigator’s care|0
60618|NCT01104662|228949|P3|Overall Study|Participant left investigator’s care|0
60619|NCT01104662|228950|P2|Overall Study|Participant left investigator’s care|1
60620|NCT01104662|228951|P1|Overall Study|Participant left investigator’s care|1
60621|NCT01104662|228944|P8|Overall Study|Clinical Failure|0
60622|NCT01104662|228945|P7|Overall Study|Clinical Failure|0
60623|NCT01104662|228946|P6|Overall Study|Clinical Failure|1
60624|NCT01104662|228947|P5|Overall Study|Clinical Failure|0
60625|NCT01104662|228948|P4|Overall Study|Clinical Failure|0
60626|NCT01104662|228949|P3|Overall Study|Clinical Failure|0
60627|NCT01104662|228950|P2|Overall Study|Clinical Failure|0
60628|NCT01104662|228951|P1|Overall Study|Clinical Failure|1
60629|NCT01104662|228944|P8|Overall Study|Adverse Event|0
60630|NCT01104662|228945|P7|Overall Study|Adverse Event|0
60631|NCT01104662|228946|P6|Overall Study|Adverse Event|1
60632|NCT01104662|228947|P5|Overall Study|Adverse Event|1
60633|NCT01104662|228948|P4|Overall Study|Adverse Event|1
60634|NCT01104662|228949|P3|Overall Study|Adverse Event|0
60635|NCT01104662|228950|P2|Overall Study|Adverse Event|2
60636|NCT01104662|228951|P1|Overall Study|Adverse Event|2
60637|NCT01104636|228977|P1|Overall Study|Ongoing|21
60638|NCT01104636|228977|P1|Overall Study|Adverse Event|40
60639|NCT01104636|228977|P1|Overall Study|Pregnancy|2
60640|NCT01104636|228977|P1|Overall Study|Study terminated by sponsor|1
60641|NCT01104636|228977|P1|Overall Study|Unspecified|43
60642|NCT01104636|228977|P1|Overall Study|Withdrawal by Subject|4
60643|NCT01104636|228977|P1|Overall Study|Lost to Follow-up|24
60644|NCT01104636|228977|P1|Overall Study|Lack of Efficacy|43
60645|NCT01104584|228982|P1|Overall Study|Study prematurely discontinued|2
60646|NCT01104584|228982|P1|Overall Study|Study drug never administered|21
60647|NCT01104558|229052|P1|Overall Study|Missing of genetic analysis results|1
60648|NCT01104558|229052|P1|Overall Study|Missing of primary efficacy assessment|10
60649|NCT01104558|229052|P1|Overall Study|Protocol Violation|6
60650|NCT01104493|229095|P2|Overall Study|Lost to Follow-up|2
60651|NCT01104493|229096|P1|Overall Study|Lost to Follow-up|0
60652|NCT01104376|229114|P1|Overall Study|Consented but excluded after labs|13
60653|NCT01104376|229114|P1|Overall Study|Withdrawal by Subject|15
60654|NCT01104246|229127|P1|Overall Study|did not meet inclusion criteria|4
60655|NCT01104246|229127|P1|Overall Study|Withdrawal by Subject|1
60656|NCT01104155|229133|P2|Overall Study|Not specified|4
60657|NCT01104155|229134|P1|Overall Study|Not specified|3
60658|NCT01104155|229133|P2|Overall Study|Withdrawal of consent|1
60659|NCT01104155|229134|P1|Overall Study|Withdrawal of consent|1
60660|NCT01104155|229133|P2|Overall Study|Participant choice|5
60661|NCT01104155|229134|P1|Overall Study|Participant choice|6
60662|NCT01104155|229133|P2|Overall Study|Adverse Event|8
60663|NCT01104155|229134|P1|Overall Study|Adverse Event|15
60664|NCT01103960|229175|P2|Overall Study|Other|0
60665|NCT01103960|229176|P1|Overall Study|Other|1
60666|NCT01103960|229175|P2|Overall Study|Withdrawal by Subject|1
60667|NCT01103960|229176|P1|Overall Study|Withdrawal by Subject|2
60668|NCT01103960|229175|P2|Overall Study|Adverse Event|1
60669|NCT01103960|229176|P1|Overall Study|Adverse Event|2
60670|NCT01103713|229211|P1|Overall Study|Not specified|1
60671|NCT01103713|229211|P1|Overall Study|Study terminated by sponsor|2
60672|NCT01103713|229211|P1|Overall Study|Withdrawal by Subject|8
60673|NCT01103713|229211|P1|Overall Study|Lost to Follow-up|2
60674|NCT01103479|229244|P3|Overall Study|Saw non-study physician|0
60675|NCT01103479|229245|P2|Overall Study|Saw non-study physician|0
60676|NCT01103479|229246|P1|Overall Study|Saw non-study physician|2
60677|NCT01103479|229244|P3|Overall Study|Active cancer|0
60678|NCT01103479|229245|P2|Overall Study|Active cancer|0
60679|NCT01103479|229246|P1|Overall Study|Active cancer|1
60680|NCT01103479|229244|P3|Overall Study|Family history of CRC|2
60681|NCT01103479|229245|P2|Overall Study|Family history of CRC|0
60682|NCT01103479|229246|P1|Overall Study|Family history of CRC|1
60683|NCT01103479|229244|P3|Overall Study|Up to date with CRC screening|12
60684|NCT01103479|229245|P2|Overall Study|Up to date with CRC screening|9
60685|NCT01103479|229246|P1|Overall Study|Up to date with CRC screening|1
60686|NCT01103466|229259|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
60687|NCT01103466|229260|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
60688|NCT01103466|229261|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
60689|NCT01103466|229259|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
60690|NCT01103466|229260|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
60691|NCT01103466|229261|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
60692|NCT01103466|229259|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
60693|NCT01103466|229260|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
60694|NCT01103466|229261|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
60695|NCT01103466|229259|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
60696|NCT01103466|229260|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
60697|NCT01103466|229261|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
60698|NCT01103466|229259|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
60699|NCT01103466|229260|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
60700|NCT01103466|229261|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
60701|NCT01103466|229259|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
60702|NCT01103466|229260|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
60703|NCT01103466|229261|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
60704|NCT01103362|229340|P1|Overall Study|study terminated|596
60705|NCT01103323|229346|P2|Switched From Placebo to Regorafenib|Adverse Event|1
60706|NCT01103323|229347|P1|Switched From Placebo to Regorafenib|Adverse Event|0
60707|NCT01103323|229346|P2|Without/Before Drug Switch|Switch to Regorafenib|4
60708|NCT01103323|229347|P1|Without/Before Drug Switch|Switch to Regorafenib|0
60709|NCT01103323|229346|P2|Without/Before Drug Switch|did not receive study treatment|2
60710|NCT01103323|229347|P1|Without/Before Drug Switch|did not receive study treatment|5
60711|NCT01103323|229346|P2|Without/Before Drug Switch|Physician Decision|0
60712|NCT01103323|229347|P1|Without/Before Drug Switch|Physician Decision|2
60713|NCT01103323|229346|P2|Without/Before Drug Switch|Protocol Violation|0
60714|NCT01103323|229347|P1|Without/Before Drug Switch|Protocol Violation|2
60715|NCT01103323|229346|P2|Without/Before Drug Switch|Withdrawal by Subject|5
60716|NCT01103323|229347|P1|Without/Before Drug Switch|Withdrawal by Subject|17
60717|NCT01103323|229346|P2|Without/Before Drug Switch|Adverse Event|7
60718|NCT01103323|229347|P1|Without/Before Drug Switch|Adverse Event|50
60719|NCT01103284|229364|P2|Overall Study|Missing CRF entries for study completion|2
60720|NCT01103284|229365|P1|Overall Study|Missing CRF entries for study completion|0
60721|NCT01103284|229364|P2|Overall Study|Not described|1
60722|NCT01103284|229365|P1|Overall Study|Not described|2
60723|NCT01103284|229364|P2|Overall Study|Termination by the Sponsor|1
60724|NCT01103284|229365|P1|Overall Study|Termination by the Sponsor|0
60725|NCT01103284|229364|P2|Overall Study|Dermal Hypersensitivity|1
60726|NCT01103284|229365|P1|Overall Study|Dermal Hypersensitivity|0
60727|NCT01103284|229364|P2|Overall Study|Withdrawal by Subject|18
60728|NCT01103284|229365|P1|Overall Study|Withdrawal by Subject|14
60729|NCT01103284|229364|P2|Overall Study|Adverse Event|5
60730|NCT01103284|229365|P1|Overall Study|Adverse Event|0
60731|NCT01103284|229364|P2|Overall Study|Protocol Violation|5
60732|NCT01103284|229365|P1|Overall Study|Protocol Violation|12
60733|NCT01103284|229364|P2|Overall Study|Pregnancy|1
60734|NCT01103284|229365|P1|Overall Study|Pregnancy|3
60735|NCT01103284|229364|P2|Overall Study|Lost to Follow-up|10
60736|NCT01103284|229365|P1|Overall Study|Lost to Follow-up|9
60737|NCT01103284|229364|P2|Overall Study|Death|0
60738|NCT01103284|229365|P1|Overall Study|Death|2
60739|NCT01103232|229391|P2|Overall Study|Protocol Violation|1
60740|NCT01103232|229392|P1|Overall Study|Protocol Violation|0
60741|NCT01103232|229391|P2|Overall Study|Withdrawal by Subject|1
60742|NCT01103232|229392|P1|Overall Study|Withdrawal by Subject|1
60743|NCT01103063|229400|P2|Overall Study|Death|1
60744|NCT01103063|229401|P1|Overall Study|Death|3
60745|NCT01103063|229400|P2|Overall Study|Study terminated by Sponsor|342
60746|NCT01103063|229401|P1|Overall Study|Study terminated by Sponsor|326
60747|NCT01103063|229400|P2|Overall Study|Protocol Violation|0
60748|NCT01103063|229401|P1|Overall Study|Protocol Violation|1
60749|NCT01103063|229400|P2|Overall Study|Not specified|11
60750|NCT01103063|229401|P1|Overall Study|Not specified|16
60751|NCT01103063|229400|P2|Overall Study|Withdrawal by Subject|15
60752|NCT01103063|229401|P1|Overall Study|Withdrawal by Subject|60
60753|NCT01103063|229400|P2|Overall Study|Lost to Follow-up|51
60754|NCT01103063|229401|P1|Overall Study|Lost to Follow-up|68
60755|NCT01103063|229400|P2|Overall Study|Adverse Event|1
60756|NCT01103063|229401|P1|Overall Study|Adverse Event|3
60757|NCT01102972|229469|P2|Overall Study|Withdrawal by Subject|6
60758|NCT01102972|229470|P1|Overall Study|Withdrawal by Subject|6
60759|NCT01102972|229469|P2|Overall Study|Investigator Discretion|0
60760|NCT01102972|229470|P1|Overall Study|Investigator Discretion|2
60761|NCT01102972|229469|P2|Overall Study|Lost to Follow-up|5
60762|NCT01102972|229470|P1|Overall Study|Lost to Follow-up|10
60763|NCT01102972|229469|P2|Overall Study|Protocol Violation|0
60764|NCT01102972|229470|P1|Overall Study|Protocol Violation|1
60765|NCT01102972|229469|P2|Overall Study|Lack of Efficacy|1
60766|NCT01102972|229470|P1|Overall Study|Lack of Efficacy|2
60767|NCT01102972|229469|P2|Overall Study|Adverse Event|2
60768|NCT01102972|229470|P1|Overall Study|Adverse Event|8
60769|NCT01102803|229534|P2|Post to Follow-Up|Lost to Follow-up|3
60770|NCT01102803|229535|P1|Post to Follow-Up|Lost to Follow-up|1
60771|NCT01102803|229534|P2|Baseline to Post-Treatment|Lost to Follow-up|0
60772|NCT01102803|229535|P1|Baseline to Post-Treatment|Lost to Follow-up|3
60773|NCT01102777|229549|P2|Overall Study|Lost to Follow-up|10
60774|NCT01102777|229550|P1|Overall Study|Lost to Follow-up|7
60775|NCT01102777|229549|P2|Overall Study|Death|6
60776|NCT01102777|229550|P1|Overall Study|Death|2
60777|NCT01102491|229589|P2|Overall Study|Protocol Violation|12
60778|NCT01102491|229590|P1|Overall Study|Protocol Violation|11
60779|NCT01102257|229609|P2|Overall Study|Adverse Event|0
60780|NCT01102257|229610|P1|Overall Study|Adverse Event|1
60781|NCT01102257|229609|P2|Overall Study|Adverse Event|0
60782|NCT01102257|229610|P1|Overall Study|Adverse Event|1
60783|NCT01101841|229649|P2|Overall Study|Eligibility Criteria|2
60784|NCT01101841|229650|P1|Overall Study|Eligibility Criteria|1
60785|NCT01101841|229649|P2|Overall Study|Suicidality Tracking Scale|1
60786|NCT01101841|229650|P1|Overall Study|Suicidality Tracking Scale|3
60787|NCT01101841|229649|P2|Overall Study|Not Specified|1
60788|NCT01101841|229650|P1|Overall Study|Not Specified|0
60789|NCT01101841|229649|P2|Overall Study|Lack of Efficacy|2
60790|NCT01101841|229650|P1|Overall Study|Lack of Efficacy|0
60791|NCT01101841|229649|P2|Overall Study|Physician Decision|2
60792|NCT01101841|229650|P1|Overall Study|Physician Decision|0
60793|NCT01101841|229649|P2|Overall Study|Protocol Violation|1
60794|NCT01101841|229650|P1|Overall Study|Protocol Violation|1
60795|NCT01101841|229649|P2|Overall Study|Withdrawal by Subject|40
60796|NCT01101841|229650|P1|Overall Study|Withdrawal by Subject|21
60797|NCT01101841|229649|P2|Overall Study|Lost to Follow-up|3
60798|NCT01101841|229650|P1|Overall Study|Lost to Follow-up|9
60799|NCT01101841|229649|P2|Overall Study|Adverse Event|15
60800|NCT01101841|229650|P1|Overall Study|Adverse Event|15
60801|NCT01101542|229688|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
60802|NCT01101542|229688|P1|Year 6 Surveillance Period|Pregnancy|1
60803|NCT01101542|229688|P1|Year 6 Surveillance Period|Lost to Follow-up|986
60804|NCT01101542|229688|P1|Year 5 Surveillance Period|Pregnancy|1
60805|NCT01101542|229688|P1|Year 5 Surveillance Period|Lost to Follow-up|140
60806|NCT01101542|229688|P1|Year 4 Surveillance Period|Unspecified|287
60807|NCT01101542|229688|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
60808|NCT01101542|229688|P1|Year 3 Surveillance Period|Lost to Follow-up|7
60809|NCT01101477|229707|P3|Overall Study|Protocol Violation|1
60810|NCT01101477|229708|P2|Overall Study|Protocol Violation|3
60811|NCT01101477|229709|P1|Overall Study|Protocol Violation|5
60812|NCT01101321|229730|P2|Period 1|Adverse Event|3
60813|NCT01101321|229731|P1|Period 1|Adverse Event|3
60814|NCT01101321|229730|P2|Period 1|Withdrawal by Subject|1
60815|NCT01101321|229731|P1|Period 1|Withdrawal by Subject|1
60816|NCT01101308|229741|P2|Period 1|Positive for cotinine|0
60817|NCT01101308|229742|P1|Period 1|Positive for cotinine|1
60818|NCT01101308|229741|P2|Period 1|Adverse Event|1
60819|NCT01101308|229742|P1|Period 1|Adverse Event|2
60820|NCT01101191|229753|P2|Period 1|Adverse Event|2
60821|NCT01101191|229754|P1|Period 1|Adverse Event|1
60822|NCT01101191|229753|P2|Period 1|Withdrawal by Subject|0
60823|NCT01101191|229754|P1|Period 1|Withdrawal by Subject|1
60824|NCT01101178|229765|P2|Period 2|Withdrawal by Subject|1
60825|NCT01101178|229766|P1|Period 2|Withdrawal by Subject|0
60826|NCT01101178|229765|P2|Period 1|Adverse Event|1
60827|NCT01101178|229766|P1|Period 1|Adverse Event|2
60828|NCT01101178|229765|P2|Period 1|Positive drug screen|1
60829|NCT01101178|229766|P1|Period 1|Positive drug screen|1
60830|NCT01101178|229765|P2|Period 1|Withdrawal by Subject|2
60831|NCT01101178|229766|P1|Period 1|Withdrawal by Subject|1
60832|NCT01101165|229777|P2|Period 2|Adverse Event|0
60833|NCT01101165|229778|P1|Period 2|Adverse Event|1
60834|NCT01101165|229777|P2|Period 2|Withdrawal by Subject|1
60835|NCT01101165|229778|P1|Period 2|Withdrawal by Subject|3
60836|NCT01101165|229777|P2|Period 1|Lost to Follow-up|0
60837|NCT01101165|229778|P1|Period 1|Lost to Follow-up|1
60838|NCT01101165|229777|P2|Period 1|Positive Drug Screen|1
60839|NCT01101165|229778|P1|Period 1|Positive Drug Screen|0
60840|NCT01101165|229777|P2|Period 1|Withdrawal by Subject|2
60841|NCT01101165|229778|P1|Period 1|Withdrawal by Subject|0
60842|NCT01101165|229777|P2|Period 1|Adverse Event|2
60843|NCT01101165|229778|P1|Period 1|Adverse Event|1
60844|NCT01101022|229790|P2|Overall Study|Vacation|1
60845|NCT01101022|229791|P1|Overall Study|Vacation|0
60846|NCT01101022|229790|P2|Overall Study|Work schedule|1
60847|NCT01101022|229791|P1|Overall Study|Work schedule|1
60848|NCT01101022|229790|P2|Overall Study|Non-compliance|0
60849|NCT01101022|229791|P1|Overall Study|Non-compliance|1
60850|NCT01101022|229790|P2|Overall Study|Sponsor decision|1
60851|NCT01101022|229791|P1|Overall Study|Sponsor decision|1
60852|NCT01101022|229790|P2|Overall Study|Lack of Efficacy|7
60853|NCT01101022|229791|P1|Overall Study|Lack of Efficacy|0
60854|NCT01101022|229790|P2|Overall Study|Lost to Follow-up|4
60855|NCT01101022|229791|P1|Overall Study|Lost to Follow-up|1
60856|NCT01101022|229790|P2|Overall Study|Withdrawal by Subject|8
60857|NCT01101022|229791|P1|Overall Study|Withdrawal by Subject|3
60858|NCT01101022|229790|P2|Overall Study|Protocol Violation|3
60859|NCT01101022|229791|P1|Overall Study|Protocol Violation|4
60860|NCT01101022|229790|P2|Overall Study|Adverse Event|2
60861|NCT01101022|229791|P1|Overall Study|Adverse Event|6
60862|NCT01100944|229825|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
60863|NCT01100944|229826|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
60864|NCT01100944|229827|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
60865|NCT01100944|229825|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
60866|NCT01100944|229826|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
60867|NCT01100944|229827|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
60868|NCT01100944|229825|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
60869|NCT01100944|229826|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
60870|NCT01100944|229827|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
60871|NCT01100944|229825|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
60872|NCT01100944|229826|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
60873|NCT01100944|229827|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
60874|NCT01100853|229885|P2|Overall Study|Withdrawal by Subject|4
60875|NCT01100853|229886|P1|Overall Study|Withdrawal by Subject|6
60876|NCT01100853|229885|P2|Overall Study|Received <4 study injections|13
60877|NCT01100853|229886|P1|Overall Study|Received <4 study injections|10
60878|NCT01100853|229885|P2|Overall Study|Lost to Follow-up|6
60879|NCT01100853|229886|P1|Overall Study|Lost to Follow-up|11
60880|NCT01100658|229932|P1|Overall Study|Withdrawal by Subject|1
60881|NCT01100502|229964|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
60882|NCT01100502|229965|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
60883|NCT01100502|229964|P2|Long-Term Follow-up|Lost to Follow-up|2
60884|NCT01100502|229965|P1|Long-Term Follow-up|Lost to Follow-up|5
60885|NCT01100502|229964|P2|Long-Term Follow-up|Withdrawal by Subject|8
60886|NCT01100502|229965|P1|Long-Term Follow-up|Withdrawal by Subject|10
60887|NCT01100502|229964|P2|Treatment Period|Progressive Disease|69
60888|NCT01100502|229965|P1|Treatment Period|Progressive Disease|24
60889|NCT01100502|229964|P2|Treatment Period|Withdrawal by Subject|4
60890|NCT01100502|229965|P1|Treatment Period|Withdrawal by Subject|9
60891|NCT01100502|229964|P2|Treatment Period|Adverse Event|10
60892|NCT01100502|229965|P1|Treatment Period|Adverse Event|54
60893|NCT01100437|229975|P3|Maintenance|Sponsor termination of study|1
60894|NCT01100437|229976|P2|Maintenance|Sponsor termination of study|0
60895|NCT01100437|229977|P1|Maintenance|Sponsor termination of study|0
60896|NCT01100437|229975|P3|Maintenance|Withdrawal by Subject|1
60897|NCT01100437|229976|P2|Maintenance|Withdrawal by Subject|0
60898|NCT01100437|229977|P1|Maintenance|Withdrawal by Subject|0
60899|NCT01100437|229975|P3|Titration/Stabilization|Sponsor canceled study|1
60900|NCT01100437|229976|P2|Titration/Stabilization|Sponsor canceled study|0
60901|NCT01100437|229977|P1|Titration/Stabilization|Sponsor canceled study|0
60902|NCT01100437|229975|P3|Titration/Stabilization|Non-compliance|1
60903|NCT01100437|229976|P2|Titration/Stabilization|Non-compliance|0
60904|NCT01100437|229977|P1|Titration/Stabilization|Non-compliance|0
60905|NCT01100437|229975|P3|Titration/Stabilization|Adverse Event|4
60906|NCT01100437|229976|P2|Titration/Stabilization|Adverse Event|0
60907|NCT01100437|229977|P1|Titration/Stabilization|Adverse Event|0
60908|NCT01100320|230014|P2|Period 2|Withdrawal by Subject|1
60909|NCT01100320|230015|P1|Period 2|Withdrawal by Subject|1
60910|NCT01100320|230014|P2|Period 1|Adverse Event|2
60911|NCT01100320|230015|P1|Period 1|Adverse Event|2
60912|NCT01100320|230014|P2|Period 1|Positive Drug Screen|1
60913|NCT01100320|230015|P1|Period 1|Positive Drug Screen|1
60914|NCT01100320|230014|P2|Period 1|Withdrawal by Subject|4
60915|NCT01100320|230015|P1|Period 1|Withdrawal by Subject|2
60916|NCT01100307|230027|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
60917|NCT01100307|230028|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
60918|NCT01100307|230027|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
60919|NCT01100307|230028|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
60920|NCT01100307|230027|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
60921|NCT01100307|230028|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
60922|NCT01100307|230027|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
60923|NCT01100307|230028|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
60924|NCT01100307|230027|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
60925|NCT01100307|230028|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
60926|NCT01100307|230027|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
60927|NCT01100307|230028|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
60928|NCT01100086|230097|P2|Period 1|Withdrawal by Subject|0
60929|NCT01100086|230098|P1|Period 1|Withdrawal by Subject|1
60930|NCT01100073|230108|P1|Overall Study|Missing|5
60931|NCT01100073|230108|P1|Overall Study|not known|8
60932|NCT01100073|230108|P1|Overall Study|Insufficient tolerability +patients wish|8
60933|NCT01100073|230108|P1|Overall Study|Lack of effect + patient's wish|2
60934|NCT01100073|230108|P1|Overall Study|Lost to Follow-up|39
60935|NCT01100073|230108|P1|Overall Study|Withdrawal by Subject|13
60936|NCT01100073|230108|P1|Overall Study|Insufficient Tolerability|21
60937|NCT01100073|230108|P1|Overall Study|Lack of Efficacy|4
60938|NCT01099917|230123|P1|Overall Study|Not Treated|24
60939|NCT01099917|230123|P1|Overall Study|Adverse Event|3
60940|NCT01099709|230185|P2|Period 1|Adverse Event|0
60941|NCT01099709|230186|P1|Period 1|Adverse Event|1
60942|NCT01099709|230185|P2|Period 1|Positive cotinine test|1
60943|NCT01099709|230186|P1|Period 1|Positive cotinine test|0
60944|NCT01099709|230185|P2|Period 1|Withdrawal by Subject|1
60945|NCT01099709|230186|P1|Period 1|Withdrawal by Subject|0
60946|NCT01099579|230212|P3|Stage 2 (ATV Capsules )|Ongoing treatment|15
60947|NCT01099579|230213|P2|Stage 2 (ATV Capsules )|Ongoing treatment|13
60948|NCT01099579|230214|P1|Stage 2 (ATV Capsules )|Ongoing treatment|14
60949|NCT01099579|230212|P3|Stage 2 (ATV Capsules )|Lost to Follow-up|0
60950|NCT01099579|230213|P2|Stage 2 (ATV Capsules )|Lost to Follow-up|1
60951|NCT01099579|230214|P1|Stage 2 (ATV Capsules )|Lost to Follow-up|0
60952|NCT01099579|230212|P3|Stage 2 (ATV Capsules )|No longer met study criteria|0
60953|NCT01099579|230213|P2|Stage 2 (ATV Capsules )|No longer met study criteria|0
60954|NCT01099579|230214|P1|Stage 2 (ATV Capsules )|No longer met study criteria|2
60955|NCT01099579|230212|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
60956|NCT01099579|230213|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
60957|NCT01099579|230214|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
60958|NCT01099579|230212|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
60959|NCT01099579|230213|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
60960|NCT01099579|230214|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
60961|NCT01099579|230212|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
60962|NCT01099579|230213|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
60963|NCT01099579|230214|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
60964|NCT01099579|230212|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
60965|NCT01099579|230213|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
60966|NCT01099579|230214|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
60967|NCT01099397|230283|P1|Overall Study|Withdrawal by Subject|5
60968|NCT01099397|230283|P1|Overall Study|Protocol Violation|4
60969|NCT01099397|230283|P1|Overall Study|Lost to Follow-up|4
60970|NCT01099267|230310|P1|MDS-003 Study|Secondary Malign Disease|1
60971|NCT01099267|230310|P1|MDS-003 Study|Loss of Response|1
60972|NCT01099267|230310|P1|MDS-003 Study|Non-Compliance|2
60973|NCT01099267|230310|P1|MDS-003 Study|Investigator Decision|2
60974|NCT01099267|230310|P1|MDS-003 Study|Disease Progression|7
60975|NCT01099267|230310|P1|MDS-003 Study|Study Closed by Sponsor|2
60976|NCT01099267|230310|P1|MDS-003 Study|Death|11
60977|NCT01099267|230310|P1|MDS-003 Study|Lost to Follow-up|1
60978|NCT01099267|230310|P1|MDS-003 Study|Withdrawal by Subject|8
60979|NCT01099267|230310|P1|MDS-003 Study|Lack of Efficacy|52
60980|NCT01099267|230310|P1|MDS-003 Study|Adverse Event|37
60981|NCT01099215|230320|P2|Overall Study|Adverse Event|1
60982|NCT01099215|230321|P1|Overall Study|Adverse Event|0
60983|NCT01099215|230320|P2|Overall Study|Withdrawal by Subject|0
60984|NCT01099215|230321|P1|Overall Study|Withdrawal by Subject|1
60985|NCT01098851|230391|P2|Overall Study|Equipment failure|0
60986|NCT01098851|230392|P1|Overall Study|Equipment failure|1
60987|NCT01098812|230403|P3|Overall Study|Lost to Follow-up|0
60988|NCT01098812|230404|P2|Overall Study|Lost to Follow-up|1
60989|NCT01098812|230405|P1|Overall Study|Lost to Follow-up|0
60990|NCT01098812|230403|P3|Overall Study|Death|1
60991|NCT01098812|230404|P2|Overall Study|Death|0
60992|NCT01098812|230405|P1|Overall Study|Death|2
60993|NCT01098539|230481|P2|Overall Study|Physician Decision|3
60994|NCT01098539|230482|P1|Overall Study|Physician Decision|5
60995|NCT01098539|230481|P2|Overall Study|Withdrawal by Subject|26
60996|NCT01098539|230482|P1|Overall Study|Withdrawal by Subject|12
60997|NCT01098539|230481|P2|Overall Study|Lost to Follow-up|4
60998|NCT01098539|230482|P1|Overall Study|Lost to Follow-up|4
60999|NCT01098539|230481|P2|Overall Study|Noncompliance|5
61000|NCT01098539|230482|P1|Overall Study|Noncompliance|3
61001|NCT01098539|230481|P2|Overall Study|Protocol Violation|4
61002|NCT01098539|230482|P1|Overall Study|Protocol Violation|1
61003|NCT01098539|230481|P2|Overall Study|Adverse Event|26
61004|NCT01098539|230482|P1|Overall Study|Adverse Event|26
61005|NCT01098487|230533|P1|Overall Study|Physician Decision|1
61006|NCT01098487|230533|P1|Overall Study|Lost to Follow-up|3
61007|NCT01098487|230533|P1|Overall Study|Withdrawal by Subject|7
61008|NCT01098487|230533|P1|Overall Study|Lack of Efficacy|11
61009|NCT01098487|230533|P1|Overall Study|Adverse Event|22
61010|NCT01098461|230549|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
61011|NCT01098461|230550|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
61012|NCT01098461|230551|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
61013|NCT01098461|230552|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
61014|NCT01098461|230549|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
61015|NCT01098461|230550|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
61016|NCT01098461|230551|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
61017|NCT01098461|230552|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
61018|NCT01098461|230549|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
61019|NCT01098461|230550|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
61020|NCT01098461|230551|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
61021|NCT01098461|230552|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
61022|NCT01098461|230549|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
61023|NCT01098461|230550|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
61024|NCT01098461|230551|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
61025|NCT01098461|230552|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
61026|NCT01098461|230549|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
61027|NCT01098461|230550|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
61028|NCT01098461|230551|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
61029|NCT01098461|230552|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
61030|NCT01098461|230549|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
61031|NCT01098461|230550|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
61032|NCT01098461|230551|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
61033|NCT01098461|230552|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
61034|NCT01098461|230549|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
61035|NCT01098461|230550|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
61036|NCT01098461|230551|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
61037|NCT01098461|230552|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
61038|NCT01098305|230597|P2|Overall Study|Lost to Follow-up|33
61039|NCT01098305|230598|P1|Overall Study|Lost to Follow-up|31
61040|NCT01098240|230617|P3|Double-Blind Phase|Adverse Event|3
61041|NCT01098240|230618|P2|Double-Blind Phase|Adverse Event|3
61042|NCT01098240|230619|P1|Double-Blind Phase|Adverse Event|0
61043|NCT01098240|230617|P3|Double-Blind Phase|Withdrawal by Subject|3
61044|NCT01098240|230618|P2|Double-Blind Phase|Withdrawal by Subject|1
61045|NCT01098240|230619|P1|Double-Blind Phase|Withdrawal by Subject|0
61046|NCT01098240|230617|P3|Double-Blind Phase|Insufficient Clinical Response|2
61047|NCT01098240|230618|P2|Double-Blind Phase|Insufficient Clinical Response|1
61048|NCT01098240|230619|P1|Double-Blind Phase|Insufficient Clinical Response|0
61049|NCT01098240|230617|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
61050|NCT01098240|230618|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
61051|NCT01098240|230619|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
61052|NCT01098240|230617|P3|Double-Blind Phase|Unspecified|2
61053|NCT01098240|230618|P2|Double-Blind Phase|Unspecified|2
61054|NCT01098240|230619|P1|Double-Blind Phase|Unspecified|0
61055|NCT01098240|230617|P3|Double-Blind Phase|Lost to Follow-up|0
61056|NCT01098240|230618|P2|Double-Blind Phase|Lost to Follow-up|2
61057|NCT01098240|230619|P1|Double-Blind Phase|Lost to Follow-up|0
61058|NCT01098240|230617|P3|Double-Blind Phase|Protocol Violation|4
61059|NCT01098240|230618|P2|Double-Blind Phase|Protocol Violation|2
61060|NCT01098240|230619|P1|Double-Blind Phase|Protocol Violation|0
61061|NCT01098240|230617|P3|Double-Blind Phase|Study Terminated by Sponsor|8
61062|NCT01098240|230618|P2|Double-Blind Phase|Study Terminated by Sponsor|5
61063|NCT01098240|230619|P1|Double-Blind Phase|Study Terminated by Sponsor|0
61064|NCT01098240|230617|P3|Open-Label Phase|Adverse Event|0
61065|NCT01098240|230618|P2|Open-Label Phase|Adverse Event|0
61066|NCT01098240|230619|P1|Open-Label Phase|Adverse Event|12
61067|NCT01098240|230617|P3|Open-Label Phase|Withdrawal by Subject|0
61068|NCT01098240|230618|P2|Open-Label Phase|Withdrawal by Subject|0
61069|NCT01098240|230619|P1|Open-Label Phase|Withdrawal by Subject|9
61070|NCT01098240|230617|P3|Open-Label Phase|Pregnancy|0
61071|NCT01098240|230618|P2|Open-Label Phase|Pregnancy|0
61072|NCT01098240|230619|P1|Open-Label Phase|Pregnancy|1
61073|NCT01098240|230617|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
61074|NCT01098240|230618|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
61075|NCT01098240|230619|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
61076|NCT01098240|230617|P3|Open-Label Phase|Unspecified|0
61077|NCT01098240|230618|P2|Open-Label Phase|Unspecified|0
61078|NCT01098240|230619|P1|Open-Label Phase|Unspecified|19
61079|NCT01098240|230617|P3|Open-Label Phase|Lost to Follow-up|0
61080|NCT01098240|230618|P2|Open-Label Phase|Lost to Follow-up|0
61081|NCT01098240|230619|P1|Open-Label Phase|Lost to Follow-up|13
61082|NCT01098240|230617|P3|Open-Label Phase|Protocol Violation|0
61083|NCT01098240|230618|P2|Open-Label Phase|Protocol Violation|0
61084|NCT01098240|230619|P1|Open-Label Phase|Protocol Violation|4
61085|NCT01098240|230617|P3|Open-Label Phase|Study Terminated by Sponsor|0
61086|NCT01098240|230618|P2|Open-Label Phase|Study Terminated by Sponsor|0
61087|NCT01098240|230619|P1|Open-Label Phase|Study Terminated by Sponsor|27
61088|NCT01098162|230649|P1|Overall Study|Reason Unknown|26
61089|NCT01098162|230649|P1|Overall Study|Other Reason|1
61090|NCT01098162|230649|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
61091|NCT01098162|230649|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
61092|NCT01098162|230649|P1|Overall Study|Adverse Event & Lost to Follow-up|2
61093|NCT01098162|230649|P1|Overall Study|Adverse Event & Wish of Patient|13
61094|NCT01098162|230649|P1|Overall Study|Adverse Event & Lack of Efficacy|6
61095|NCT01098162|230649|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
61096|NCT01098162|230649|P1|Overall Study|Lost to Follow-up|9
61097|NCT01098162|230649|P1|Overall Study|Wish of Patient|7
61098|NCT01098162|230649|P1|Overall Study|Lack of Efficacy|4
61099|NCT01098162|230649|P1|Overall Study|Adverse Event|37
61100|NCT01098110|230661|P3|Overall Study|Untreated|0
61101|NCT01098110|230662|P2|Overall Study|Untreated|1
61102|NCT01098110|230663|P1|Overall Study|Untreated|1
61103|NCT01098110|230661|P3|Overall Study|Not Specified|5
61104|NCT01098110|230662|P2|Overall Study|Not Specified|7
61105|NCT01098110|230663|P1|Overall Study|Not Specified|4
61106|NCT01098110|230661|P3|Overall Study|Lack of Efficacy|27
61107|NCT01098110|230662|P2|Overall Study|Lack of Efficacy|9
61108|NCT01098110|230663|P1|Overall Study|Lack of Efficacy|13
61109|NCT01098110|230661|P3|Overall Study|Adverse Event|43
61110|NCT01098110|230662|P2|Overall Study|Adverse Event|32
61111|NCT01098110|230663|P1|Overall Study|Adverse Event|30
61112|NCT01098110|230661|P3|Overall Study|Withdrawal by Subject|19
61113|NCT01098110|230662|P2|Overall Study|Withdrawal by Subject|24
61114|NCT01098110|230663|P1|Overall Study|Withdrawal by Subject|14
61115|NCT01098097|230704|P1|Overall Study|No reason reported|31
61116|NCT01098097|230704|P1|Overall Study|Status unknown|16
61117|NCT01098097|230704|P1|Overall Study|Lost to Follow-up|18
61118|NCT01098097|230704|P1|Overall Study|Adverse Event|17
61119|NCT01098071|230713|P1|Overall Study|Lost to Follow-up|13
61120|NCT01098071|230713|P1|Overall Study|Surgery (adenoidectomy)|2
61121|NCT01097863|230755|P3|Overall Study|Did not return for final visit|1
61122|NCT01097863|230756|P2|Overall Study|Did not return for final visit|0
61123|NCT01097863|230757|P1|Overall Study|Did not return for final visit|0
61124|NCT01097863|230755|P3|Overall Study|Discomfort|1
61125|NCT01097863|230756|P2|Overall Study|Discomfort|0
61126|NCT01097863|230757|P1|Overall Study|Discomfort|1
61127|NCT01097668|230778|P2|Overall Study|Lost to Follow-up|0
61128|NCT01097668|230779|P1|Overall Study|Lost to Follow-up|1
61129|NCT01097668|230778|P2|Overall Study|Withdrawal by Subject|2
61130|NCT01097668|230779|P1|Overall Study|Withdrawal by Subject|1
61131|NCT01097629|230792|P8|DB RO Phase|Lost to Follow-up|0
61132|NCT01097629|230793|P7|DB RO Phase|Lost to Follow-up|2
61133|NCT01097629|230794|P6|DB RO Phase|Lost to Follow-up|0
61134|NCT01097629|230795|P5|DB RO Phase|Lost to Follow-up|0
61135|NCT01097629|230796|P4|DB RO Phase|Lost to Follow-up|0
61136|NCT01097629|230797|P3|DB RO Phase|Lost to Follow-up|0
61137|NCT01097629|230798|P2|DB RO Phase|Lost to Follow-up|0
61138|NCT01097629|230799|P1|DB RO Phase|Lost to Follow-up|0
61139|NCT01097629|230792|P8|DB RO Phase|Protocol Violation|0
61140|NCT01097629|230793|P7|DB RO Phase|Protocol Violation|1
61141|NCT01097629|230794|P6|DB RO Phase|Protocol Violation|1
61142|NCT01097629|230795|P5|DB RO Phase|Protocol Violation|0
61143|NCT01097629|230796|P4|DB RO Phase|Protocol Violation|1
61144|NCT01097629|230797|P3|DB RO Phase|Protocol Violation|0
61145|NCT01097629|230798|P2|DB RO Phase|Protocol Violation|0
61146|NCT01097629|230799|P1|DB RO Phase|Protocol Violation|0
61147|NCT01097629|230792|P8|DB RO Phase|Withdrawal by Subject|1
61148|NCT01097629|230793|P7|DB RO Phase|Withdrawal by Subject|0
61149|NCT01097629|230794|P6|DB RO Phase|Withdrawal by Subject|0
61150|NCT01097629|230795|P5|DB RO Phase|Withdrawal by Subject|0
61151|NCT01097629|230796|P4|DB RO Phase|Withdrawal by Subject|0
61152|NCT01097629|230797|P3|DB RO Phase|Withdrawal by Subject|0
61153|NCT01097629|230798|P2|DB RO Phase|Withdrawal by Subject|0
61154|NCT01097629|230799|P1|DB RO Phase|Withdrawal by Subject|0
61155|NCT01097629|230792|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
61156|NCT01097629|230793|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
61157|NCT01097629|230794|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
61158|NCT01097629|230795|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
61159|NCT01097629|230796|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
61160|NCT01097629|230797|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
61161|NCT01097629|230798|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
61162|NCT01097629|230799|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
61163|NCT01097629|230792|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
61164|NCT01097629|230793|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
61165|NCT01097629|230794|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
61166|NCT01097629|230795|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
61167|NCT01097629|230796|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
61168|NCT01097629|230797|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
61169|NCT01097629|230798|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
61170|NCT01097629|230799|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
61171|NCT01097629|230792|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
61172|NCT01097629|230793|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
61173|NCT01097629|230794|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
61174|NCT01097629|230795|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
61175|NCT01097629|230796|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
61176|NCT01097629|230797|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
61177|NCT01097629|230798|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
61178|NCT01097629|230799|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
61179|NCT01097629|230792|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
61180|NCT01097629|230793|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
61181|NCT01097629|230794|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
61182|NCT01097629|230795|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
61183|NCT01097629|230796|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
61184|NCT01097629|230797|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
61185|NCT01097629|230798|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
61186|NCT01097629|230799|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
61187|NCT01097629|230792|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
61188|NCT01097629|230793|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
61189|NCT01097629|230794|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
61190|NCT01097629|230795|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
61191|NCT01097629|230796|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
61192|NCT01097629|230797|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
61193|NCT01097629|230798|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
61194|NCT01097629|230799|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
61195|NCT01097629|230792|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
61196|NCT01097629|230793|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
61197|NCT01097629|230794|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
61198|NCT01097629|230795|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
61199|NCT01097629|230796|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
61200|NCT01097629|230797|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
61201|NCT01097629|230798|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
61202|NCT01097629|230799|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
61203|NCT01097629|230792|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
61204|NCT01097629|230793|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
61205|NCT01097629|230794|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
61206|NCT01097629|230795|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
61207|NCT01097629|230796|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
61208|NCT01097629|230797|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
61209|NCT01097629|230798|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
61210|NCT01097629|230799|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
61211|NCT01097616|230850|P8|DB RO Phase|Not Treated in RO|0
61212|NCT01097616|230851|P7|DB RO Phase|Not Treated in RO|0
61213|NCT01097616|230852|P6|DB RO Phase|Not Treated in RO|1
61214|NCT01097616|230853|P5|DB RO Phase|Not Treated in RO|0
61215|NCT01097616|230854|P4|DB RO Phase|Not Treated in RO|0
61216|NCT01097616|230855|P3|DB RO Phase|Not Treated in RO|0
61217|NCT01097616|230856|P2|DB RO Phase|Not Treated in RO|0
61218|NCT01097616|230857|P1|DB RO Phase|Not Treated in RO|0
61219|NCT01097616|230850|P8|DB RO Phase|Lost to Follow-up|1
61220|NCT01097616|230851|P7|DB RO Phase|Lost to Follow-up|0
61221|NCT01097616|230852|P6|DB RO Phase|Lost to Follow-up|0
61222|NCT01097616|230853|P5|DB RO Phase|Lost to Follow-up|1
61223|NCT01097616|230854|P4|DB RO Phase|Lost to Follow-up|1
61224|NCT01097616|230855|P3|DB RO Phase|Lost to Follow-up|0
61225|NCT01097616|230856|P2|DB RO Phase|Lost to Follow-up|0
61226|NCT01097616|230857|P1|DB RO Phase|Lost to Follow-up|0
61227|NCT01097616|230850|P8|DB RO Phase|Withdrawal by Subject|0
61228|NCT01097616|230851|P7|DB RO Phase|Withdrawal by Subject|0
61229|NCT01097616|230852|P6|DB RO Phase|Withdrawal by Subject|1
61230|NCT01097616|230853|P5|DB RO Phase|Withdrawal by Subject|0
61231|NCT01097616|230854|P4|DB RO Phase|Withdrawal by Subject|0
61232|NCT01097616|230855|P3|DB RO Phase|Withdrawal by Subject|0
61233|NCT01097616|230856|P2|DB RO Phase|Withdrawal by Subject|0
61234|NCT01097616|230857|P1|DB RO Phase|Withdrawal by Subject|0
61235|NCT01097616|230850|P8|DB RO Phase|Adverse Event|0
61236|NCT01097616|230851|P7|DB RO Phase|Adverse Event|1
61237|NCT01097616|230852|P6|DB RO Phase|Adverse Event|0
61238|NCT01097616|230853|P5|DB RO Phase|Adverse Event|0
61239|NCT01097616|230854|P4|DB RO Phase|Adverse Event|0
61240|NCT01097616|230855|P3|DB RO Phase|Adverse Event|0
61241|NCT01097616|230856|P2|DB RO Phase|Adverse Event|0
61242|NCT01097616|230857|P1|DB RO Phase|Adverse Event|0
61243|NCT01097616|230850|P8|Optional DB EXT Phase|Physician Decision|0
61244|NCT01097616|230851|P7|Optional DB EXT Phase|Physician Decision|0
61245|NCT01097616|230852|P6|Optional DB EXT Phase|Physician Decision|0
61246|NCT01097616|230853|P5|Optional DB EXT Phase|Physician Decision|0
61247|NCT01097616|230854|P4|Optional DB EXT Phase|Physician Decision|0
61248|NCT01097616|230855|P3|Optional DB EXT Phase|Physician Decision|0
61249|NCT01097616|230856|P2|Optional DB EXT Phase|Physician Decision|0
61250|NCT01097616|230857|P1|Optional DB EXT Phase|Physician Decision|1
61251|NCT01097616|230850|P8|Optional DB EXT Phase|Lack of Efficacy|0
61252|NCT01097616|230851|P7|Optional DB EXT Phase|Lack of Efficacy|0
61253|NCT01097616|230852|P6|Optional DB EXT Phase|Lack of Efficacy|0
61254|NCT01097616|230853|P5|Optional DB EXT Phase|Lack of Efficacy|0
61255|NCT01097616|230854|P4|Optional DB EXT Phase|Lack of Efficacy|0
61256|NCT01097616|230855|P3|Optional DB EXT Phase|Lack of Efficacy|1
61257|NCT01097616|230856|P2|Optional DB EXT Phase|Lack of Efficacy|1
61258|NCT01097616|230857|P1|Optional DB EXT Phase|Lack of Efficacy|1
61259|NCT01097616|230850|P8|Optional DB EXT Phase|Lost to Follow-up|0
61260|NCT01097616|230851|P7|Optional DB EXT Phase|Lost to Follow-up|0
61261|NCT01097616|230852|P6|Optional DB EXT Phase|Lost to Follow-up|0
61262|NCT01097616|230853|P5|Optional DB EXT Phase|Lost to Follow-up|0
61263|NCT01097616|230854|P4|Optional DB EXT Phase|Lost to Follow-up|0
61264|NCT01097616|230855|P3|Optional DB EXT Phase|Lost to Follow-up|1
61265|NCT01097616|230856|P2|Optional DB EXT Phase|Lost to Follow-up|5
61266|NCT01097616|230857|P1|Optional DB EXT Phase|Lost to Follow-up|1
61267|NCT01097616|230850|P8|Optional DB EXT Phase|Protocol Violation|0
61268|NCT01097616|230851|P7|Optional DB EXT Phase|Protocol Violation|0
61269|NCT01097616|230852|P6|Optional DB EXT Phase|Protocol Violation|0
61270|NCT01097616|230853|P5|Optional DB EXT Phase|Protocol Violation|0
61271|NCT01097616|230854|P4|Optional DB EXT Phase|Protocol Violation|0
61272|NCT01097616|230855|P3|Optional DB EXT Phase|Protocol Violation|3
61273|NCT01097616|230856|P2|Optional DB EXT Phase|Protocol Violation|2
61274|NCT01097616|230857|P1|Optional DB EXT Phase|Protocol Violation|0
61275|NCT01097616|230850|P8|Optional DB EXT Phase|Withdrawal by Subject|0
61276|NCT01097616|230851|P7|Optional DB EXT Phase|Withdrawal by Subject|0
61277|NCT01097616|230852|P6|Optional DB EXT Phase|Withdrawal by Subject|0
61278|NCT01097616|230853|P5|Optional DB EXT Phase|Withdrawal by Subject|0
61279|NCT01097616|230854|P4|Optional DB EXT Phase|Withdrawal by Subject|0
61280|NCT01097616|230855|P3|Optional DB EXT Phase|Withdrawal by Subject|3
61281|NCT01097616|230856|P2|Optional DB EXT Phase|Withdrawal by Subject|6
61282|NCT01097616|230857|P1|Optional DB EXT Phase|Withdrawal by Subject|12
61283|NCT01097616|230850|P8|Optional DB EXT Phase|Adverse Event|0
61284|NCT01097616|230851|P7|Optional DB EXT Phase|Adverse Event|0
61285|NCT01097616|230852|P6|Optional DB EXT Phase|Adverse Event|0
61286|NCT01097616|230853|P5|Optional DB EXT Phase|Adverse Event|0
61287|NCT01097616|230854|P4|Optional DB EXT Phase|Adverse Event|0
61288|NCT01097616|230855|P3|Optional DB EXT Phase|Adverse Event|2
61289|NCT01097616|230856|P2|Optional DB EXT Phase|Adverse Event|7
61290|NCT01097616|230857|P1|Optional DB EXT Phase|Adverse Event|0
61291|NCT01097616|230850|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
61292|NCT01097616|230851|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
61293|NCT01097616|230852|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
61294|NCT01097616|230853|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
61295|NCT01097616|230854|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
61296|NCT01097616|230855|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
61297|NCT01097616|230856|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
61298|NCT01097616|230857|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
61299|NCT01097616|230850|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
61300|NCT01097616|230851|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
61301|NCT01097616|230852|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
61302|NCT01097616|230853|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
61303|NCT01097616|230854|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
61304|NCT01097616|230855|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
61305|NCT01097616|230856|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
61306|NCT01097616|230857|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
61307|NCT01097616|230850|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
61308|NCT01097616|230851|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
61309|NCT01097616|230852|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
61310|NCT01097616|230853|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
61311|NCT01097616|230854|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
61312|NCT01097616|230855|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
61313|NCT01097616|230856|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
61314|NCT01097616|230857|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
61315|NCT01097616|230850|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
61316|NCT01097616|230851|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
61317|NCT01097616|230852|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
61318|NCT01097616|230853|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
61319|NCT01097616|230854|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
61320|NCT01097616|230855|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
61321|NCT01097616|230856|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
61322|NCT01097616|230857|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
61323|NCT01097616|230850|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
61324|NCT01097616|230851|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
61325|NCT01097616|230852|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
61326|NCT01097616|230853|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
61327|NCT01097616|230854|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
61328|NCT01097616|230855|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
61329|NCT01097616|230856|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
61330|NCT01097616|230857|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
61331|NCT01097616|230850|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
61332|NCT01097616|230851|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
61333|NCT01097616|230852|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
61334|NCT01097616|230853|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
61335|NCT01097616|230854|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
61336|NCT01097616|230855|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
61337|NCT01097616|230856|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
61338|NCT01097616|230857|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
61339|NCT01097616|230850|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
61340|NCT01097616|230851|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
61341|NCT01097616|230852|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
61342|NCT01097616|230853|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
61343|NCT01097616|230854|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
61344|NCT01097616|230855|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
61345|NCT01097616|230856|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
61346|NCT01097616|230857|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
61347|NCT01097616|230850|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
61348|NCT01097616|230851|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
61349|NCT01097616|230852|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
61350|NCT01097616|230853|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
61351|NCT01097616|230854|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
61352|NCT01097616|230855|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
61353|NCT01097616|230856|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
61354|NCT01097616|230857|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
61355|NCT01096589|230932|P4|Overall Study|found treatment exhausting|1
61356|NCT01096589|230933|P3|Overall Study|found treatment exhausting|0
61357|NCT01096589|230934|P2|Overall Study|found treatment exhausting|0
61358|NCT01096589|230935|P1|Overall Study|found treatment exhausting|0
61359|NCT01096589|230932|P4|Overall Study|Compliance with protocol|0
61360|NCT01096589|230933|P3|Overall Study|Compliance with protocol|1
61361|NCT01096589|230934|P2|Overall Study|Compliance with protocol|0
61362|NCT01096589|230935|P1|Overall Study|Compliance with protocol|0
61363|NCT01096589|230932|P4|Overall Study|Withdrawal by Subject|1
61364|NCT01096589|230933|P3|Overall Study|Withdrawal by Subject|1
61365|NCT01096589|230934|P2|Overall Study|Withdrawal by Subject|1
61366|NCT01096589|230935|P1|Overall Study|Withdrawal by Subject|2
61367|NCT01096589|230932|P4|Overall Study|Adverse Event|1
61368|NCT01096589|230933|P3|Overall Study|Adverse Event|2
61369|NCT01096589|230934|P2|Overall Study|Adverse Event|1
61370|NCT01096589|230935|P1|Overall Study|Adverse Event|2
61371|NCT01097421|230949|P1|Overall Study|Withdrawal by Subject|3
61372|NCT01097421|230949|P1|Overall Study|Lost to Follow-up|1
61373|NCT01097421|230949|P1|Overall Study|Protocol Violation|2
61374|NCT01097421|230949|P1|Overall Study|Adverse Event|8
61375|NCT01097005|230970|P1|Overall Study|Discontinuance by complication|50
61376|NCT01097005|230970|P1|Overall Study|Adverse Event|14
61377|NCT01097005|230970|P1|Overall Study|Deviation from exclusion criteria|37
61378|NCT01097005|230970|P1|Overall Study|No examination data available|244
61379|NCT01097005|230970|P1|Overall Study|Poor medication compliance|1
61380|NCT01097005|230970|P1|Overall Study|Subjects cannot visit the hospital|1
61381|NCT01097005|230970|P1|Overall Study|Case Report Form not collected|18
61382|NCT01096550|231082|P2|Overall Study|Lost to Follow-up|9
61383|NCT01096550|231083|P1|Overall Study|Lost to Follow-up|12
61384|NCT01096550|231082|P2|Overall Study|non-African American participant|6
61385|NCT01096550|231083|P1|Overall Study|non-African American participant|13
61386|NCT01096550|231082|P2|Overall Study|Withdrawal by Subject|1
61387|NCT01096550|231083|P1|Overall Study|Withdrawal by Subject|0
61388|NCT01096550|231082|P2|Overall Study|clinic readmission|1
61389|NCT01096550|231083|P1|Overall Study|clinic readmission|1
61390|NCT01096550|231082|P2|Overall Study|non-regular treatment track at clinic|1
61391|NCT01096550|231083|P1|Overall Study|non-regular treatment track at clinic|1
61392|NCT01096550|231082|P2|Overall Study|discontinued site|11
61393|NCT01096550|231083|P1|Overall Study|discontinued site|10
61394|NCT01096446|231091|P2|Overall Study|Protocol Violation|0
61395|NCT01096446|231092|P1|Overall Study|Protocol Violation|2
61396|NCT01096446|231091|P2|Overall Study|Death|0
61397|NCT01096446|231092|P1|Overall Study|Death|1
61398|NCT01096342|231097|P1|Overall Study|Protocol Violation|1
61399|NCT01096316|231105|P2|Overall Study|Lost to Follow-up|9
61400|NCT01096316|231106|P1|Overall Study|Lost to Follow-up|15
61401|NCT01096186|231116|P1|Overall Study|Noncompliance with study drug|1
61402|NCT01096186|231116|P1|Overall Study|Physician Decision|1
61403|NCT01096186|231116|P1|Overall Study|Withdrawal by Subject|22
61404|NCT01096186|231116|P1|Overall Study|Lost to Follow-up|2
61405|NCT01096186|231116|P1|Overall Study|Lack of Efficacy|4
61406|NCT01096186|231116|P1|Overall Study|Death|4
61407|NCT01096186|231116|P1|Overall Study|Adverse Event|16
61408|NCT01096056|231124|P2|Overall Study|Lost to Follow-up|1
61409|NCT01096056|231125|P1|Overall Study|Lost to Follow-up|0
61410|NCT01096017|231157|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
61411|NCT01096017|231158|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
61412|NCT01095978|231186|P1|Overall Study|Adverse Event|1
61413|NCT01095978|231186|P1|Overall Study|Did not take Klacid SR|2
61414|NCT01095835|231220|P3|Overall Study|Protocol Violation|0
61415|NCT01095835|231221|P2|Overall Study|Protocol Violation|2
61416|NCT01095835|231222|P1|Overall Study|Protocol Violation|1
61417|NCT01095835|231220|P3|Overall Study|Non study compliance|1
61418|NCT01095835|231221|P2|Overall Study|Non study compliance|0
61419|NCT01095835|231222|P1|Overall Study|Non study compliance|0
61420|NCT01095835|231220|P3|Overall Study|Withdrawal by Subject|0
61421|NCT01095835|231221|P2|Overall Study|Withdrawal by Subject|3
61422|NCT01095835|231222|P1|Overall Study|Withdrawal by Subject|1
61423|NCT01095835|231220|P3|Overall Study|Physician Decision|1
61424|NCT01095835|231221|P2|Overall Study|Physician Decision|0
61425|NCT01095835|231222|P1|Overall Study|Physician Decision|0
61426|NCT01095835|231220|P3|Overall Study|Lack of Efficacy|0
61427|NCT01095835|231221|P2|Overall Study|Lack of Efficacy|1
61428|NCT01095835|231222|P1|Overall Study|Lack of Efficacy|0
61429|NCT01095835|231220|P3|Overall Study|Adverse Event|6
61430|NCT01095835|231221|P2|Overall Study|Adverse Event|6
61431|NCT01095835|231222|P1|Overall Study|Adverse Event|8
61432|NCT01095796|231260|P2|Overall Study|Participant Transferred to Another Study|200
61433|NCT01095796|231261|P1|Overall Study|Participant Transferred to Another Study|215
61434|NCT01095796|231260|P2|Overall Study|Protocol Violation|0
61435|NCT01095796|231261|P1|Overall Study|Protocol Violation|1
61436|NCT01095796|231260|P2|Overall Study|Participant Noncompliance|10
61437|NCT01095796|231261|P1|Overall Study|Participant Noncompliance|5
61438|NCT01095796|231260|P2|Overall Study|Lost to Follow-up|29
61439|NCT01095796|231261|P1|Overall Study|Lost to Follow-up|27
61440|NCT01095796|231260|P2|Overall Study|Withdrew Consent|22
61441|NCT01095796|231261|P1|Overall Study|Withdrew Consent|16
61442|NCT01095796|231260|P2|Overall Study|Investigator's Discretion|2
61443|NCT01095796|231261|P1|Overall Study|Investigator's Discretion|7
61444|NCT01095796|231260|P2|Overall Study|Lack of Efficacy|3
61445|NCT01095796|231261|P1|Overall Study|Lack of Efficacy|5
61446|NCT01095796|231260|P2|Overall Study|Pregnancy|0
61447|NCT01095796|231261|P1|Overall Study|Pregnancy|2
61448|NCT01095796|231260|P2|Overall Study|Death|2
61449|NCT01095796|231261|P1|Overall Study|Death|3
61450|NCT01095796|231260|P2|Overall Study|Adverse Event|19
61451|NCT01095796|231261|P1|Overall Study|Adverse Event|9
61452|NCT01095796|231260|P2|Overall Study|Randomized but Not Treated|2
61453|NCT01095796|231261|P1|Overall Study|Randomized but Not Treated|5
61454|NCT01095653|231291|P3|Overall Study|non-compliance, not met criteria, etc.|5
61455|NCT01095653|231292|P2|Overall Study|non-compliance, not met criteria, etc.|6
61456|NCT01095653|231293|P1|Overall Study|non-compliance, not met criteria, etc.|10
61457|NCT01095653|231291|P3|Overall Study|Withdrawal by Subject|3
61458|NCT01095653|231292|P2|Overall Study|Withdrawal by Subject|5
61459|NCT01095653|231293|P1|Overall Study|Withdrawal by Subject|4
61460|NCT01095653|231291|P3|Overall Study|Lost to Follow-up|4
61461|NCT01095653|231292|P2|Overall Study|Lost to Follow-up|0
61462|NCT01095653|231293|P1|Overall Study|Lost to Follow-up|1
61463|NCT01095653|231291|P3|Overall Study|Adverse Event|4
61464|NCT01095653|231292|P2|Overall Study|Adverse Event|4
61465|NCT01095653|231293|P1|Overall Study|Adverse Event|1
61466|NCT01095653|231291|P3|Overall Study|Lack of Efficacy|0
61467|NCT01095653|231292|P2|Overall Study|Lack of Efficacy|0
61468|NCT01095653|231293|P1|Overall Study|Lack of Efficacy|3
61469|NCT01095250|231351|P4|Overall Study|Withdrawal by Subject|0
61470|NCT01095250|231352|P3|Overall Study|Withdrawal by Subject|1
61471|NCT01095250|231353|P2|Overall Study|Withdrawal by Subject|0
61472|NCT01095250|231354|P1|Overall Study|Withdrawal by Subject|0
61473|NCT01095250|231351|P4|Overall Study|administrative reasons|5
61474|NCT01095250|231352|P3|Overall Study|administrative reasons|7
61475|NCT01095250|231353|P2|Overall Study|administrative reasons|10
61476|NCT01095250|231354|P1|Overall Study|administrative reasons|8
61477|NCT01095094|231384|P1|Overall Study|Physician Decision|1
61478|NCT01095094|231384|P1|Overall Study|Death|1
61479|NCT01095094|231384|P1|Overall Study|Withdrawal by Subject|1
61480|NCT01094886|231389|P1|Overall Study|Withdrawal by Subject|5
61481|NCT01094886|231389|P1|Overall Study|Adverse Event|2
61482|NCT01094808|231399|P3|Overall Study|Withdrawal by Subject|0
61483|NCT01094808|231400|P2|Overall Study|Withdrawal by Subject|1
61484|NCT01094808|231401|P1|Overall Study|Withdrawal by Subject|1
61485|NCT01094743|231436|P1|Period 1|Unsatisfactory comfort at lens fitting|2
61486|NCT01094730|231453|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
61487|NCT01094730|231454|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
61488|NCT01094730|231453|P2|Period 2 (14 Days)|Adverse Event|1
61489|NCT01094730|231454|P1|Period 2 (14 Days)|Adverse Event|0
61490|NCT01094730|231453|P2|Period 2 (14 Days)|No time for the follow-up visit|0
61491|NCT01094730|231454|P1|Period 2 (14 Days)|No time for the follow-up visit|1
61492|NCT01094730|231453|P2|Period 2 (14 Days)|Protocol Violation|0
61493|NCT01094730|231454|P1|Period 2 (14 Days)|Protocol Violation|2
61494|NCT01094730|231453|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
61495|NCT01094730|231454|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
61496|NCT01094730|231453|P2|Period 1 (14 Days)|No time for the follow-up visit|0
61497|NCT01094730|231454|P1|Period 1 (14 Days)|No time for the follow-up visit|1
61498|NCT01094730|231453|P2|Period 1 (14 Days)|Withdrawal by Subject|1
61499|NCT01094730|231454|P1|Period 1 (14 Days)|Withdrawal by Subject|0
61500|NCT01094730|231453|P2|Period 1 (14 Days)|Lost to Follow-up|1
61501|NCT01094730|231454|P1|Period 1 (14 Days)|Lost to Follow-up|0
61502|NCT01093222|231500|P1|Overall Study|Not protocol specified|1
61503|NCT01093222|231500|P1|Overall Study|Death|2
61504|NCT01093222|231500|P1|Overall Study|Progression/relapse|24
61505|NCT01093222|231500|P1|Overall Study|Adverse Event|7
61506|NCT01093222|231500|P1|Overall Study|Ineligible|6
61507|NCT01094171|231507|P1|Overall Study|Unspecified|1
61508|NCT01094171|231507|P1|Overall Study|Migration from the study area|3
61509|NCT01094171|231507|P1|Overall Study|Informed consent withdrawal|4
61510|NCT01094171|231507|P1|Overall Study|Lost to Follow-up|2
61511|NCT01093846|231521|P3|Overall Study|Administrative Problems|15
61512|NCT01093846|231522|P2|Overall Study|Administrative Problems|17
61513|NCT01093846|231523|P1|Overall Study|Administrative Problems|18
61514|NCT01093846|231521|P3|Overall Study|Condition no longer required study drug|1
61515|NCT01093846|231522|P2|Overall Study|Condition no longer required study drug|1
61516|NCT01093846|231523|P1|Overall Study|Condition no longer required study drug|1
61517|NCT01093846|231521|P3|Overall Study|Lack of Efficacy|4
61518|NCT01093846|231522|P2|Overall Study|Lack of Efficacy|0
61519|NCT01093846|231523|P1|Overall Study|Lack of Efficacy|0
61520|NCT01093846|231521|P3|Overall Study|Adverse Event|1
61521|NCT01093846|231522|P2|Overall Study|Adverse Event|0
61522|NCT01093846|231523|P1|Overall Study|Adverse Event|0
61523|NCT01093755|231548|P2|Overall Study|Withdrawal by Subject|4
61524|NCT01093755|231549|P1|Overall Study|Withdrawal by Subject|3
61525|NCT01093625|231589|P2|1-Year Visit|Lost to Follow-up|3
61526|NCT01093625|231590|P1|1-Year Visit|Lost to Follow-up|5
61527|NCT01093625|231589|P2|6-Month Visit|Lost to Follow-up|2
61528|NCT01093625|231590|P1|6-Month Visit|Lost to Follow-up|2
61529|NCT01093625|231589|P2|6-Month Visit|Withdrawal by Subject|7
61530|NCT01093625|231590|P1|6-Month Visit|Withdrawal by Subject|6
61531|NCT01093625|231589|P2|3-Month Visit|Lost to Follow-up|0
61532|NCT01093625|231590|P1|3-Month Visit|Lost to Follow-up|2
61533|NCT01093625|231589|P2|1-Month Visit|Lost to Follow-up|0
61534|NCT01093625|231590|P1|1-Month Visit|Lost to Follow-up|2
61535|NCT01093625|231589|P2|2-Week Visit|Withdrawal by Subject|0
61536|NCT01093625|231590|P1|2-Week Visit|Withdrawal by Subject|1
61537|NCT01093625|231589|P2|Baseline and Dispensed|Withdrawal by Subject|0
61538|NCT01093625|231590|P1|Baseline and Dispensed|Withdrawal by Subject|2
61539|NCT01093599|231610|P2|Overall Study|Lost to Follow-up|46
61540|NCT01093599|231611|P1|Overall Study|Lost to Follow-up|32
61541|NCT01093534|231620|P3|Overall Study|Other|4
61542|NCT01093534|231621|P2|Overall Study|Other|3
61543|NCT01093534|231622|P1|Overall Study|Other|1
61544|NCT01093534|231620|P3|Overall Study|Withdrawal by Subject|2
61545|NCT01093534|231621|P2|Overall Study|Withdrawal by Subject|7
61546|NCT01093534|231622|P1|Overall Study|Withdrawal by Subject|5
61547|NCT01093534|231620|P3|Overall Study|Lack of Efficacy|1
61548|NCT01093534|231621|P2|Overall Study|Lack of Efficacy|1
61549|NCT01093534|231622|P1|Overall Study|Lack of Efficacy|2
61550|NCT01093534|231620|P3|Overall Study|Adverse Event|2
61551|NCT01093534|231621|P2|Overall Study|Adverse Event|5
61552|NCT01093534|231622|P1|Overall Study|Adverse Event|2
61553|NCT01092832|231810|P2|Overall Study|Not specified|0
61554|NCT01092832|231811|P1|Overall Study|Not specified|1
61555|NCT01092780|231823|P4|Washout Period 2|Adverse Event|0
61556|NCT01092780|231824|P3|Washout Period 2|Adverse Event|1
61557|NCT01092780|231825|P2|Washout Period 2|Adverse Event|1
61558|NCT01092780|231826|P1|Washout Period 2|Adverse Event|0
61559|NCT01092780|231823|P4|Washout Period 1|Noncompliance with nCPAP|0
61560|NCT01092780|231824|P3|Washout Period 1|Noncompliance with nCPAP|0
61561|NCT01092780|231825|P2|Washout Period 1|Noncompliance with nCPAP|0
61562|NCT01092780|231826|P1|Washout Period 1|Noncompliance with nCPAP|1
61563|NCT01092780|231823|P4|Washout Period 1|Adverse Event|0
61564|NCT01092780|231824|P3|Washout Period 1|Adverse Event|0
61565|NCT01092780|231825|P2|Washout Period 1|Adverse Event|1
61566|NCT01092780|231826|P1|Washout Period 1|Adverse Event|0
61567|NCT01092728|231862|P2|Overall Study|Prohibited Concomitant Medications|0
61568|NCT01092728|231863|P1|Overall Study|Prohibited Concomitant Medications|1
61569|NCT01092728|231862|P2|Overall Study|Disease Progression|13
61570|NCT01092728|231863|P1|Overall Study|Disease Progression|1
61571|NCT01092728|231862|P2|Overall Study|Adverse Event|1
61572|NCT01092728|231863|P1|Overall Study|Adverse Event|0
61573|NCT01092728|231862|P2|Overall Study|Withdrawal by Subject|0
61574|NCT01092728|231863|P1|Overall Study|Withdrawal by Subject|2
61575|NCT01092702|231871|P1|Overall Study|Lost to Follow-up|2
61576|NCT01092702|231871|P1|Overall Study|Withdrawal by Subject|7
61577|NCT01092663|231877|P2|Overall Study|Protocol Violation|1
61578|NCT01092663|231878|P1|Overall Study|Protocol Violation|0
61579|NCT01092663|231877|P2|Overall Study|Adverse Event|1
61580|NCT01092663|231878|P1|Overall Study|Adverse Event|1
61581|NCT01092663|231877|P2|Overall Study|High fasting triglyceride|0
61582|NCT01092663|231878|P1|Overall Study|High fasting triglyceride|2
61583|NCT01092663|231877|P2|Overall Study|Glucose >300mg/dL|0
61584|NCT01092663|231878|P1|Overall Study|Glucose >300mg/dL|1
61585|NCT01092663|231877|P2|Overall Study|Withdrawal by Subject|2
61586|NCT01092663|231878|P1|Overall Study|Withdrawal by Subject|3
61587|NCT01092637|231926|P2|Overall Study|Death|49
61588|NCT01092637|231927|P1|Overall Study|Death|47
61589|NCT01092546|231942|P1|Overall Study|Subjects withdrawn prior to dosing|4
61590|NCT01092507|231949|P2|Overall Study|Withdrawal by Subject|0
61591|NCT01092507|231950|P1|Overall Study|Withdrawal by Subject|2
61592|NCT01092416|231985|P1|12-Month Follow-up|Data collected after close of 1Y window|2
61593|NCT01092416|231985|P1|12-Month Follow-up|Missed 1-year follow-up|1
61594|NCT01092416|231985|P1|12-Month Follow-up|Withdrawal by Subject|2
61595|NCT01092416|231985|P1|12-Month Follow-up|Lost to Follow-up|4
61596|NCT01092416|231985|P1|12-Month Follow-up|Death|16
61597|NCT01092416|231985|P1|30-Day Follow-up|Data collected after close of 30D window|5
61598|NCT01092416|231985|P1|30-Day Follow-up|Missed 30-day follow-up|3
61599|NCT01092416|231985|P1|30-Day Follow-up|Death|2
61600|NCT01092416|231985|P1|Enrollment|Atherectomy device not inserted|3
61601|NCT01091974|232009|P4|Overall Study|side-effects|2
61602|NCT01091974|232010|P3|Overall Study|side-effects|0
61603|NCT01091974|232011|P2|Overall Study|side-effects|1
61604|NCT01091974|232012|P1|Overall Study|side-effects|1
61605|NCT01091974|232009|P4|Overall Study|Withdrawal by Subject|2
61606|NCT01091974|232010|P3|Overall Study|Withdrawal by Subject|2
61607|NCT01091974|232011|P2|Overall Study|Withdrawal by Subject|3
61608|NCT01091974|232012|P1|Overall Study|Withdrawal by Subject|1
61609|NCT01091974|232009|P4|Overall Study|resumed sleep medication|2
61610|NCT01091974|232010|P3|Overall Study|resumed sleep medication|1
61611|NCT01091974|232011|P2|Overall Study|resumed sleep medication|0
61612|NCT01091974|232012|P1|Overall Study|resumed sleep medication|0
61613|NCT01091974|232009|P4|Overall Study|Did not start intervention|1
61614|NCT01091974|232010|P3|Overall Study|Did not start intervention|3
61615|NCT01091974|232011|P2|Overall Study|Did not start intervention|1
61616|NCT01091974|232012|P1|Overall Study|Did not start intervention|3
61617|NCT01091675|232047|P1|Overall Study|Lack of Efficacy|27
61618|NCT01091675|232047|P1|Overall Study|Adverse Event|7
61619|NCT01091662|232053|P2|Overall Study|unable to swallow capsule|1
61620|NCT01091662|232054|P1|Overall Study|unable to swallow capsule|0
61621|NCT01091662|232053|P2|Overall Study|Protocol Violation|2
61622|NCT01091662|232054|P1|Overall Study|Protocol Violation|0
61623|NCT01091662|232053|P2|Overall Study|Pregnancy|1
61624|NCT01091662|232054|P1|Overall Study|Pregnancy|0
61625|NCT01091662|232053|P2|Overall Study|Lost to Follow-up|1
61626|NCT01091662|232054|P1|Overall Study|Lost to Follow-up|0
61627|NCT01091662|232053|P2|Overall Study|met exclusion criteria|0
61628|NCT01091662|232054|P1|Overall Study|met exclusion criteria|1
61629|NCT01091662|232053|P2|Overall Study|met exit criteria|13
61630|NCT01091662|232054|P1|Overall Study|met exit criteria|7
61631|NCT01091662|232053|P2|Overall Study|Withdrawal by Subject|6
61632|NCT01091662|232054|P1|Overall Study|Withdrawal by Subject|7
61633|NCT01091662|232053|P2|Overall Study|Physician Decision|1
61634|NCT01091662|232054|P1|Overall Study|Physician Decision|1
61635|NCT01091662|232053|P2|Overall Study|Adverse Event|9
61636|NCT01091662|232054|P1|Overall Study|Adverse Event|1
61637|NCT01091519|232092|P2|Overall Study|Randomized not treated|4
61638|NCT01091519|232093|P1|Overall Study|Randomized not treated|4
61639|NCT01091519|232092|P2|Overall Study|Unspecified|8
61640|NCT01091519|232093|P1|Overall Study|Unspecified|6
61641|NCT01091519|232092|P2|Overall Study|Withdrawal by Subject|2
61642|NCT01091519|232093|P1|Overall Study|Withdrawal by Subject|2
61643|NCT01091519|232092|P2|Overall Study|Lost to Follow-up|24
61644|NCT01091519|232093|P1|Overall Study|Lost to Follow-up|14
61645|NCT01091519|232092|P2|Overall Study|Lack of Efficacy|19
61646|NCT01091519|232093|P1|Overall Study|Lack of Efficacy|16
61647|NCT01091519|232092|P2|Overall Study|Death|0
61648|NCT01091519|232093|P1|Overall Study|Death|1
61649|NCT01091519|232092|P2|Overall Study|Adverse Event|16
61650|NCT01091519|232093|P1|Overall Study|Adverse Event|12
61651|NCT01091259|232105|P1|Overall Study|Lack of Efficacy|2
61652|NCT01091259|232105|P1|Overall Study|Adverse Event|3
61653|NCT01091246|232116|P3|Overall Study|Subject not dosed|1
61654|NCT01091246|232117|P2|Overall Study|Subject not dosed|0
61655|NCT01091246|232118|P1|Overall Study|Subject not dosed|2
61656|NCT01091246|232116|P3|Overall Study|Withdrawal by Subject|4
61657|NCT01091246|232117|P2|Overall Study|Withdrawal by Subject|5
61658|NCT01091246|232118|P1|Overall Study|Withdrawal by Subject|9
61659|NCT01091246|232116|P3|Overall Study|Adverse Event|1
61660|NCT01091246|232117|P2|Overall Study|Adverse Event|0
61661|NCT01091246|232118|P1|Overall Study|Adverse Event|1
61662|NCT01091246|232116|P3|Overall Study|Lost to Follow-up|7
61663|NCT01091246|232117|P2|Overall Study|Lost to Follow-up|11
61664|NCT01091246|232118|P1|Overall Study|Lost to Follow-up|23
61665|NCT01091103|232257|P1|Overall Study|Progressive Disease|3
61666|NCT01091103|232257|P1|Overall Study|Adverse Event|1
61667|NCT01090973|232277|P1|Overall Study|Disease progression|1
61668|NCT01090765|232293|P6|Overall Study|Vasovagal reaction with first infusion|0
61669|NCT01090765|232294|P5|Overall Study|Vasovagal reaction with first infusion|1
61670|NCT01090765|232295|P4|Overall Study|Vasovagal reaction with first infusion|0
61671|NCT01090765|232296|P3|Overall Study|Vasovagal reaction with first infusion|0
61672|NCT01090765|232297|P2|Overall Study|Vasovagal reaction with first infusion|0
61673|NCT01090765|232298|P1|Overall Study|Vasovagal reaction with first infusion|0
61674|NCT01090765|232293|P6|Overall Study|Developed a DVT, needed anticoagulation|0
61675|NCT01090765|232294|P5|Overall Study|Developed a DVT, needed anticoagulation|0
61676|NCT01090765|232295|P4|Overall Study|Developed a DVT, needed anticoagulation|1
61677|NCT01090765|232296|P3|Overall Study|Developed a DVT, needed anticoagulation|0
61678|NCT01090765|232297|P2|Overall Study|Developed a DVT, needed anticoagulation|0
61679|NCT01090765|232298|P1|Overall Study|Developed a DVT, needed anticoagulation|0
61680|NCT01090765|232293|P6|Overall Study|Patient withdrew consent|1
61681|NCT01090765|232294|P5|Overall Study|Patient withdrew consent|1
61682|NCT01090765|232295|P4|Overall Study|Patient withdrew consent|0
61683|NCT01090765|232296|P3|Overall Study|Patient withdrew consent|0
61684|NCT01090765|232297|P2|Overall Study|Patient withdrew consent|0
61685|NCT01090765|232298|P1|Overall Study|Patient withdrew consent|0
61686|NCT01090739|232326|P1|36 Month Follow-up|Visit still pending|17
61687|NCT01090739|232326|P1|36 Month Follow-up|Withdrawal by Subject|6
61688|NCT01090739|232326|P1|24 Month Follow-up|Death|1
61689|NCT01090739|232326|P1|24 Month Follow-up|Lost to Follow-up|1
61690|NCT01090739|232326|P1|24 Month Follow-up|Withdrawal by Subject|7
61691|NCT01090739|232326|P1|12 Month Follow-up|Death|1
61692|NCT01090739|232326|P1|12 Month Follow-up|Physician Decision|1
61693|NCT01090739|232326|P1|12 Month Follow-up|Lost to Follow-up|1
61694|NCT01090739|232326|P1|12 Month Follow-up|Withdrawal by Subject|2
61695|NCT01090739|232326|P1|Enrollment|Adverse Event|1
61696|NCT01090739|232326|P1|Enrollment|Study implant limit reached|2
61697|NCT01090739|232326|P1|Enrollment|Sponsor termination of site|4
61698|NCT01090739|232326|P1|Enrollment|Physician Decision|5
61699|NCT01090739|232326|P1|Enrollment|Lost to Follow-up|5
61700|NCT01090739|232326|P1|Enrollment|Protocol Violation|14
61701|NCT01090739|232326|P1|Enrollment|Withdrawal by Subject|24
61702|NCT01090453|232354|P2|Overall Study|Eligibility Criteria|1
61703|NCT01090453|232355|P1|Overall Study|Eligibility Criteria|0
61704|NCT01090453|232354|P2|Overall Study|Unspecified|4
61705|NCT01090453|232355|P1|Overall Study|Unspecified|2
61706|NCT01090453|232354|P2|Overall Study|Protocol Violation|0
61707|NCT01090453|232355|P1|Overall Study|Protocol Violation|2
61708|NCT01090453|232354|P2|Overall Study|Non serious AEs|0
61709|NCT01090453|232355|P1|Overall Study|Non serious AEs|1
61710|NCT01090453|232354|P2|Overall Study|Lost to Follow-up|7
61711|NCT01090453|232355|P1|Overall Study|Lost to Follow-up|7
61712|NCT01090453|232354|P2|Overall Study|Withdrawal by Subject|2
61713|NCT01090453|232355|P1|Overall Study|Withdrawal by Subject|1
61714|NCT01090427|232402|P7|After Controlled Period|Adverse Event|0
61715|NCT01090427|232403|P6|After Controlled Period|Adverse Event|1
61716|NCT01090427|232404|P5|After Controlled Period|Adverse Event|0
61717|NCT01090427|232405|P4|After Controlled Period|Adverse Event|2
61718|NCT01090427|232406|P3|After Controlled Period|Adverse Event|0
61719|NCT01090427|232407|P2|After Controlled Period|Adverse Event|0
61720|NCT01090427|232408|P1|After Controlled Period|Adverse Event|0
61721|NCT01090427|232402|P7|After Controlled Period|Lack of Efficacy|2
61722|NCT01090427|232403|P6|After Controlled Period|Lack of Efficacy|3
61723|NCT01090427|232404|P5|After Controlled Period|Lack of Efficacy|0
61724|NCT01090427|232405|P4|After Controlled Period|Lack of Efficacy|0
61725|NCT01090427|232406|P3|After Controlled Period|Lack of Efficacy|0
61726|NCT01090427|232407|P2|After Controlled Period|Lack of Efficacy|0
61727|NCT01090427|232408|P1|After Controlled Period|Lack of Efficacy|0
61728|NCT01090427|232402|P7|After Controlled Period|Death|0
61729|NCT01090427|232403|P6|After Controlled Period|Death|1
61730|NCT01090427|232404|P5|After Controlled Period|Death|0
61731|NCT01090427|232405|P4|After Controlled Period|Death|0
61732|NCT01090427|232406|P3|After Controlled Period|Death|0
61733|NCT01090427|232407|P2|After Controlled Period|Death|0
61734|NCT01090427|232408|P1|After Controlled Period|Death|0
61735|NCT01090323|232443|P2|Overall Study|Stopped end of extension 1#|1
61736|NCT01090323|232444|P1|Overall Study|Stopped end of extension 1#|3
61737|NCT01090323|232443|P2|Overall Study|Stopped end of core|0
61738|NCT01090323|232444|P1|Overall Study|Stopped end of core|7
61739|NCT01090323|232443|P2|Overall Study|Death|2
61740|NCT01090323|232444|P1|Overall Study|Death|1
61741|NCT01090323|232443|P2|Overall Study|Administrative problems|4
61742|NCT01090323|232444|P1|Overall Study|Administrative problems|6
61743|NCT01090323|232443|P2|Overall Study|Lost to Follow-up|6
61744|NCT01090323|232444|P1|Overall Study|Lost to Follow-up|11
61745|NCT01090323|232443|P2|Overall Study|Withdrew consent|11
61746|NCT01090323|232444|P1|Overall Study|Withdrew consent|33
61747|NCT01090323|232443|P2|Overall Study|Protocol Violation|1
61748|NCT01090323|232444|P1|Overall Study|Protocol Violation|2
61749|NCT01090323|232443|P2|Overall Study|Condition no longer requires drug|4
61750|NCT01090323|232444|P1|Overall Study|Condition no longer requires drug|5
61751|NCT01090323|232443|P2|Overall Study|Unsatisfactory therapeutic effect|2
61752|NCT01090323|232444|P1|Overall Study|Unsatisfactory therapeutic effect|4
61753|NCT01090323|232443|P2|Overall Study|Abnormal Test Procedure Results|0
61754|NCT01090323|232444|P1|Overall Study|Abnormal Test Procedure Results|2
61755|NCT01090323|232443|P2|Overall Study|Abnormal Lab Values|1
61756|NCT01090323|232444|P1|Overall Study|Abnormal Lab Values|3
61757|NCT01090323|232443|P2|Overall Study|Adverse Event|2
61758|NCT01090323|232444|P1|Overall Study|Adverse Event|12
61759|NCT01090310|232456|P4|Extension Study|Subject withdrew consent|0
61760|NCT01090310|232457|P3|Extension Study|Subject withdrew consent|0
61761|NCT01090310|232458|P2|Extension Study|Subject withdrew consent|1
61762|NCT01090310|232459|P1|Extension Study|Subject withdrew consent|0
61763|NCT01090310|232456|P4|Extension Study|Unsatisfactory therapeutic effect|1
61764|NCT01090310|232457|P3|Extension Study|Unsatisfactory therapeutic effect|1
61765|NCT01090310|232458|P2|Extension Study|Unsatisfactory therapeutic effect|0
61766|NCT01090310|232459|P1|Extension Study|Unsatisfactory therapeutic effect|1
61767|NCT01090310|232456|P4|Extension Study|Adverse Event|1
61768|NCT01090310|232457|P3|Extension Study|Adverse Event|0
61769|NCT01090310|232458|P2|Extension Study|Adverse Event|0
61770|NCT01090310|232459|P1|Extension Study|Adverse Event|0
61771|NCT01090310|232456|P4|Extension Study|Aministrative problems|18
61772|NCT01090310|232457|P3|Extension Study|Aministrative problems|14
61773|NCT01090310|232458|P2|Extension Study|Aministrative problems|15
61774|NCT01090310|232459|P1|Extension Study|Aministrative problems|13
61775|NCT01090310|232456|P4|Core Study|Protocol deviation|1
61776|NCT01090310|232457|P3|Core Study|Protocol deviation|0
61777|NCT01090310|232458|P2|Core Study|Protocol deviation|0
61778|NCT01090310|232459|P1|Core Study|Protocol deviation|1
61779|NCT01090310|232456|P4|Core Study|Administrative reasons|4
61780|NCT01090310|232457|P3|Core Study|Administrative reasons|4
61781|NCT01090310|232458|P2|Core Study|Administrative reasons|6
61782|NCT01090310|232459|P1|Core Study|Administrative reasons|5
61783|NCT01090310|232456|P4|Core Study|Abnormal test procedure result|0
61784|NCT01090310|232457|P3|Core Study|Abnormal test procedure result|1
61785|NCT01090310|232458|P2|Core Study|Abnormal test procedure result|0
61786|NCT01090310|232459|P1|Core Study|Abnormal test procedure result|0
61787|NCT01090310|232456|P4|Core Study|Subject withdrew consent|1
61788|NCT01090310|232457|P3|Core Study|Subject withdrew consent|1
61789|NCT01090310|232458|P2|Core Study|Subject withdrew consent|3
61790|NCT01090310|232459|P1|Core Study|Subject withdrew consent|0
61791|NCT01090310|232456|P4|Core Study|Adverse Event|1
61792|NCT01090310|232457|P3|Core Study|Adverse Event|1
61793|NCT01090310|232458|P2|Core Study|Adverse Event|2
61794|NCT01090310|232459|P1|Core Study|Adverse Event|2
61795|NCT01090102|232498|P2|Second 12 Weeks|Withdrawal by Subject|1
61796|NCT01090102|232499|P1|Second 12 Weeks|Withdrawal by Subject|0
61797|NCT01090102|232498|P2|First 12 Weeks|Death|1
61798|NCT01090102|232499|P1|First 12 Weeks|Death|1
61799|NCT01090102|232498|P2|First 12 Weeks|Adverse Event|0
61800|NCT01090102|232499|P1|First 12 Weeks|Adverse Event|2
61801|NCT01090102|232498|P2|First 12 Weeks|Withdrawal by Subject|1
61802|NCT01090102|232499|P1|First 12 Weeks|Withdrawal by Subject|1
61803|NCT01090076|232509|P2|Overall Study|Withdrawal by Subject|1
61804|NCT01090076|232510|P1|Overall Study|Withdrawal by Subject|0
61805|NCT01090076|232509|P2|Overall Study|Death|1
61806|NCT01090076|232510|P1|Overall Study|Death|1
61807|NCT01090063|232520|P1|Treatment|Withdrawal by Subject|4
61808|NCT01090063|232520|P1|Screen|Screen Failed|4
61809|NCT01090050|232536|P2|Overall Study|Physician Decision|1
61810|NCT01090050|232537|P1|Overall Study|Physician Decision|0
61811|NCT01090050|232536|P2|Overall Study|Lack of Efficacy|5
61812|NCT01090050|232537|P1|Overall Study|Lack of Efficacy|1
61813|NCT01090050|232536|P2|Overall Study|Lost to Follow-up|1
61814|NCT01090050|232537|P1|Overall Study|Lost to Follow-up|0
61815|NCT01090011|232557|P1|Overall Study|Other reason not defined above|5
61816|NCT01090011|232557|P1|Overall Study|Refusal to start/continue medication|5
61817|NCT01090011|232557|P1|Overall Study|Protocol Violation|1
61818|NCT01090011|232557|P1|Overall Study|Adverse Event|32
61819|NCT01090011|232557|P1|Overall Study|Progressive disease|128
61820|NCT01089608|232650|P2|Overall Study|Lost to Follow-up|2
61821|NCT01089608|232651|P1|Overall Study|Lost to Follow-up|0
61822|NCT01089608|232650|P2|Overall Study|Adverse Event|4
61823|NCT01089608|232651|P1|Overall Study|Adverse Event|0
61824|NCT01089582|232657|P1|Overall Study|Withdrawal by Subject|1
61825|NCT01089582|232657|P1|Overall Study|Unspecified|4
61826|NCT01089582|232657|P1|Overall Study|Lost to Follow-up|8
61827|NCT01089582|232657|P1|Overall Study|Adverse Event|15
61828|NCT01089582|232657|P1|Overall Study|Death|2
61829|NCT01089556|232669|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
61830|NCT01089556|232670|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
61831|NCT01089556|232671|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
61832|NCT01089556|232672|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
61833|NCT01089556|232673|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
61834|NCT01089556|232674|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
61835|NCT01089556|232669|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
61836|NCT01089556|232670|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
61837|NCT01089556|232671|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
61838|NCT01089556|232672|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
61839|NCT01089556|232673|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
61840|NCT01089556|232674|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
61841|NCT01089556|232669|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
61842|NCT01089556|232670|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
61843|NCT01089556|232671|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
61844|NCT01089556|232672|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
61845|NCT01089556|232673|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
61846|NCT01089556|232674|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
61847|NCT01089556|232669|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
61848|NCT01089556|232670|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
61849|NCT01089556|232671|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
61850|NCT01089556|232672|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
61851|NCT01089556|232673|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
61852|NCT01089556|232674|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
61853|NCT01089556|232669|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
61854|NCT01089556|232670|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
61855|NCT01089556|232671|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
61856|NCT01089556|232672|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
61857|NCT01089556|232673|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
61858|NCT01089556|232674|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
61859|NCT01089556|232669|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
61860|NCT01089556|232670|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
61861|NCT01089556|232671|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
61862|NCT01089556|232672|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
61863|NCT01089556|232673|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
61864|NCT01089556|232674|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
61865|NCT01089556|232669|P6|Study Period III (Weeks 9-16)|Adverse Event|3
61866|NCT01089556|232670|P5|Study Period III (Weeks 9-16)|Adverse Event|4
61867|NCT01089556|232671|P4|Study Period III (Weeks 9-16)|Adverse Event|2
61868|NCT01089556|232672|P3|Study Period III (Weeks 9-16)|Adverse Event|4
61869|NCT01089556|232673|P2|Study Period III (Weeks 9-16)|Adverse Event|0
61870|NCT01089556|232674|P1|Study Period III (Weeks 9-16)|Adverse Event|0
61871|NCT01089556|232669|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
61872|NCT01089556|232670|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
61873|NCT01089556|232671|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
61874|NCT01089556|232672|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
61875|NCT01089556|232673|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
61876|NCT01089556|232674|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
61877|NCT01089556|232669|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
61878|NCT01089556|232670|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
61879|NCT01089556|232671|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
61880|NCT01089556|232672|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
61881|NCT01089556|232673|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
61882|NCT01089556|232674|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
61883|NCT01089556|232669|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
61884|NCT01089556|232670|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
61885|NCT01089556|232671|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
61886|NCT01089556|232672|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
61887|NCT01089556|232673|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
61888|NCT01089556|232674|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
61889|NCT01089556|232669|P6|Study Period II (Weeks 1-8)|Physician Decision|0
61890|NCT01089556|232670|P5|Study Period II (Weeks 1-8)|Physician Decision|0
61891|NCT01089556|232671|P4|Study Period II (Weeks 1-8)|Physician Decision|0
61892|NCT01089556|232672|P3|Study Period II (Weeks 1-8)|Physician Decision|0
61893|NCT01089556|232673|P2|Study Period II (Weeks 1-8)|Physician Decision|0
61894|NCT01089556|232674|P1|Study Period II (Weeks 1-8)|Physician Decision|4
61895|NCT01089556|232669|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
61896|NCT01089556|232670|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
61897|NCT01089556|232671|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
61898|NCT01089556|232672|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
61899|NCT01089556|232673|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
61900|NCT01089556|232674|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
61901|NCT01089556|232669|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
61902|NCT01089556|232670|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
61903|NCT01089556|232671|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
61904|NCT01089556|232672|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
61905|NCT01089556|232673|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
61906|NCT01089556|232674|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
61907|NCT01089556|232669|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
61908|NCT01089556|232670|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
61909|NCT01089556|232671|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
61910|NCT01089556|232672|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
61911|NCT01089556|232673|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
61912|NCT01089556|232674|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
61913|NCT01089556|232669|P6|Study Period II (Weeks 1-8)|Adverse Event|0
61914|NCT01089556|232670|P5|Study Period II (Weeks 1-8)|Adverse Event|0
61915|NCT01089556|232671|P4|Study Period II (Weeks 1-8)|Adverse Event|0
61916|NCT01089556|232672|P3|Study Period II (Weeks 1-8)|Adverse Event|0
61917|NCT01089556|232673|P2|Study Period II (Weeks 1-8)|Adverse Event|39
61918|NCT01089556|232674|P1|Study Period II (Weeks 1-8)|Adverse Event|35
61919|NCT01089543|232748|P4|Overall Study|Adverse Event|0
61920|NCT01089543|232749|P3|Overall Study|Adverse Event|0
61921|NCT01089543|232750|P2|Overall Study|Adverse Event|1
61922|NCT01089543|232751|P1|Overall Study|Adverse Event|0
61923|NCT01089543|232748|P4|Overall Study|Physician Decision|1
61924|NCT01089543|232749|P3|Overall Study|Physician Decision|0
61925|NCT01089543|232750|P2|Overall Study|Physician Decision|0
61926|NCT01089543|232751|P1|Overall Study|Physician Decision|1
61927|NCT01089543|232748|P4|Overall Study|Withdrawal by Subject|1
61928|NCT01089543|232749|P3|Overall Study|Withdrawal by Subject|3
61929|NCT01089543|232750|P2|Overall Study|Withdrawal by Subject|3
61930|NCT01089543|232751|P1|Overall Study|Withdrawal by Subject|2
61931|NCT01089504|232786|P2|Overall Study|Withdrawal by Subject|0
61932|NCT01089504|232787|P1|Overall Study|Withdrawal by Subject|2
61933|NCT01089504|232786|P2|Overall Study|Lost to Follow-up|1
61934|NCT01089504|232787|P1|Overall Study|Lost to Follow-up|1
61935|NCT01089413|232800|P1|Overall Study|Unspecified|71
61936|NCT01089413|232800|P1|Overall Study|Metastasectomy|13
61937|NCT01089413|232800|P1|Overall Study|Death|10
61938|NCT01089413|232800|P1|Overall Study|Unacceptable Toxicity|12
61939|NCT01089413|232800|P1|Overall Study|Participant Withdrew Consent|1
61940|NCT01089413|232800|P1|Overall Study|Progressive Disease|93
61941|NCT01089413|232800|P1|Overall Study|Lost to Follow-up|1
61942|NCT01089127|232848|P6|Overall Study|Protocol deviation|0
61943|NCT01089127|232849|P5|Overall Study|Protocol deviation|1
61944|NCT01089127|232850|P4|Overall Study|Protocol deviation|0
61945|NCT01089127|232851|P3|Overall Study|Protocol deviation|0
61946|NCT01089127|232852|P2|Overall Study|Protocol deviation|1
61947|NCT01089127|232853|P1|Overall Study|Protocol deviation|0
61948|NCT01089127|232848|P6|Overall Study|Lost to Follow-up|0
61949|NCT01089127|232849|P5|Overall Study|Lost to Follow-up|1
61950|NCT01089127|232850|P4|Overall Study|Lost to Follow-up|0
61951|NCT01089127|232851|P3|Overall Study|Lost to Follow-up|0
61952|NCT01089127|232852|P2|Overall Study|Lost to Follow-up|1
61953|NCT01089127|232853|P1|Overall Study|Lost to Follow-up|1
61954|NCT01089127|232848|P6|Overall Study|Abnormal test procedure result(s)|0
61955|NCT01089127|232849|P5|Overall Study|Abnormal test procedure result(s)|0
61956|NCT01089127|232850|P4|Overall Study|Abnormal test procedure result(s)|0
61957|NCT01089127|232851|P3|Overall Study|Abnormal test procedure result(s)|0
61958|NCT01089127|232852|P2|Overall Study|Abnormal test procedure result(s)|1
61959|NCT01089127|232853|P1|Overall Study|Abnormal test procedure result(s)|2
61960|NCT01089127|232848|P6|Overall Study|Subject withdrew consent|2
61961|NCT01089127|232849|P5|Overall Study|Subject withdrew consent|0
61962|NCT01089127|232850|P4|Overall Study|Subject withdrew consent|1
61963|NCT01089127|232851|P3|Overall Study|Subject withdrew consent|1
61964|NCT01089127|232852|P2|Overall Study|Subject withdrew consent|1
61965|NCT01089127|232853|P1|Overall Study|Subject withdrew consent|0
61966|NCT01089127|232848|P6|Overall Study|Adverse Event|1
61967|NCT01089127|232849|P5|Overall Study|Adverse Event|0
61968|NCT01089127|232850|P4|Overall Study|Adverse Event|0
61969|NCT01089127|232851|P3|Overall Study|Adverse Event|1
61970|NCT01089127|232852|P2|Overall Study|Adverse Event|1
61971|NCT01089127|232853|P1|Overall Study|Adverse Event|5
61972|NCT01089023|232907|P1|Overall Study|Lack of Efficacy|1
61973|NCT01089023|232907|P1|Overall Study|Protocol Violation|1
61974|NCT01089023|232907|P1|Overall Study|Withdrawal by Subject|1
61975|NCT01089023|232907|P1|Overall Study|Adverse Event|1
61976|NCT01089023|232907|P1|Overall Study|Lost to Follow-up|3
61977|NCT01088997|232921|P2|Overall Study|Excluded prior to receiving drug|1
61978|NCT01088997|232922|P1|Overall Study|Excluded prior to receiving drug|1
61979|NCT01088997|232921|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
61980|NCT01088997|232922|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
61981|NCT01088997|232921|P2|Overall Study|Physician Decision|1
61982|NCT01088997|232922|P1|Overall Study|Physician Decision|1
61983|NCT01088984|232933|P2|Phase 2|Not Specified|1
61984|NCT01088984|232934|P1|Phase 2|Not Specified|0
61985|NCT01088984|232933|P2|Phase 2|DIsease Progression|25
61986|NCT01088984|232934|P1|Phase 2|DIsease Progression|0
61987|NCT01088984|232933|P2|Phase 2|Withdrawal by Subject|1
61988|NCT01088984|232934|P1|Phase 2|Withdrawal by Subject|0
61989|NCT01088984|232933|P2|Phase 2|Death|5
61990|NCT01088984|232934|P1|Phase 2|Death|0
61991|NCT01088984|232933|P2|Phase 1|Not Specified|1
61992|NCT01088984|232934|P1|Phase 1|Not Specified|1
61993|NCT01088984|232933|P2|Phase 1|Disease Progression|4
61994|NCT01088984|232934|P1|Phase 1|Disease Progression|2
61995|NCT01088984|232933|P2|Phase 1|Death|1
61996|NCT01088984|232934|P1|Phase 1|Death|2
61997|NCT01088529|232995|P2|Overall Study|Did not receive study treatment|1
61998|NCT01088529|232996|P1|Overall Study|Did not receive study treatment|0
61999|NCT01088503|233009|P3|Overall Study|Death|7
62000|NCT01088503|233010|P2|Overall Study|Death|358
62001|NCT01088503|233011|P1|Overall Study|Death|64
62002|NCT01088503|233009|P3|Overall Study|Withdrawal by Subject|10
62003|NCT01088503|233010|P2|Overall Study|Withdrawal by Subject|327
62004|NCT01088503|233011|P1|Overall Study|Withdrawal by Subject|118
62005|NCT01088438|233089|P2|Overall Study|Lost to Follow-up|30
62006|NCT01088438|233090|P1|Overall Study|Lost to Follow-up|18
62007|NCT01088438|233089|P2|Overall Study|Withdrawal by Subject|6
62008|NCT01088438|233090|P1|Overall Study|Withdrawal by Subject|11
62009|NCT01088399|233103|P3|Overall Study|Study summary visit not completed|80
62010|NCT01088399|233104|P2|Overall Study|Study summary visit not completed|283
62011|NCT01088399|233105|P1|Overall Study|Study summary visit not completed|2398
62012|NCT01088399|233103|P3|Overall Study|Enrollment criteria not met|70
62013|NCT01088399|233104|P2|Overall Study|Enrollment criteria not met|119
62014|NCT01088399|233105|P1|Overall Study|Enrollment criteria not met|48
62015|NCT01088399|233103|P3|Overall Study|Protocol Violation|0
62016|NCT01088399|233104|P2|Overall Study|Protocol Violation|1
62017|NCT01088399|233105|P1|Overall Study|Protocol Violation|10
62018|NCT01088399|233103|P3|Overall Study|Sponsor decision|7
62019|NCT01088399|233104|P2|Overall Study|Sponsor decision|298
62020|NCT01088399|233105|P1|Overall Study|Sponsor decision|1573
62021|NCT01088399|233103|P3|Overall Study|Change to or start of somatropin therapy|12
62022|NCT01088399|233104|P2|Overall Study|Change to or start of somatropin therapy|17
62023|NCT01088399|233105|P1|Overall Study|Change to or start of somatropin therapy|234
62024|NCT01088399|233103|P3|Overall Study|Withdrawal by Subject|33
62025|NCT01088399|233104|P2|Overall Study|Withdrawal by Subject|195
62026|NCT01088399|233105|P1|Overall Study|Withdrawal by Subject|544
62027|NCT01088399|233103|P3|Overall Study|Physician Decision|16
62028|NCT01088399|233104|P2|Overall Study|Physician Decision|88
62029|NCT01088399|233105|P1|Overall Study|Physician Decision|531
62030|NCT01088399|233103|P3|Overall Study|Lost to Follow-up|58
62031|NCT01088399|233104|P2|Overall Study|Lost to Follow-up|278
62032|NCT01088399|233105|P1|Overall Study|Lost to Follow-up|1070
62033|NCT01088399|233103|P3|Overall Study|Lack of Efficacy|5
62034|NCT01088399|233104|P2|Overall Study|Lack of Efficacy|7
62035|NCT01088399|233105|P1|Overall Study|Lack of Efficacy|298
62036|NCT01088399|233103|P3|Overall Study|Death|0
62037|NCT01088399|233104|P2|Overall Study|Death|45
62038|NCT01088399|233105|P1|Overall Study|Death|204
62039|NCT01088399|233103|P3|Overall Study|Adverse Event|0
62040|NCT01088399|233104|P2|Overall Study|Adverse Event|16
62041|NCT01088399|233105|P1|Overall Study|Adverse Event|211
62042|NCT01087970|233157|P1|Overall Study|Protocol Violation|2
62043|NCT01087957|233169|P2|Overall Study|Physician Decision|9
62044|NCT01087957|233170|P1|Overall Study|Physician Decision|5
62045|NCT01087957|233169|P2|Overall Study|Withdrawal by Subject|15
62046|NCT01087957|233170|P1|Overall Study|Withdrawal by Subject|18
62047|NCT01087957|233169|P2|Overall Study|Protocol Violation|25
62048|NCT01087957|233170|P1|Overall Study|Protocol Violation|13
62049|NCT01087957|233169|P2|Overall Study|Lost to Follow-up|4
62050|NCT01087957|233170|P1|Overall Study|Lost to Follow-up|3
62051|NCT01087957|233169|P2|Overall Study|Death|2
62052|NCT01087957|233170|P1|Overall Study|Death|2
62053|NCT01087944|233196|P2|Period 2 (Week 4-6)|Adverse Event|2
62054|NCT01087944|233197|P1|Period 2 (Week 4-6)|Adverse Event|0
62055|NCT01087944|233196|P2|Period 1 (Week 1-3)|Adverse Event|0
62056|NCT01087944|233197|P1|Period 1 (Week 1-3)|Adverse Event|1
62057|NCT01087905|233262|P8|Overall Study|Withdrawal by Subject|5
62058|NCT01087905|233263|P7|Overall Study|Withdrawal by Subject|3
62059|NCT01087905|233264|P6|Overall Study|Withdrawal by Subject|3
62060|NCT01087905|233265|P5|Overall Study|Withdrawal by Subject|4
62061|NCT01087905|233266|P4|Overall Study|Withdrawal by Subject|5
62062|NCT01087905|233267|P3|Overall Study|Withdrawal by Subject|4
62063|NCT01087905|233268|P2|Overall Study|Withdrawal by Subject|4
62064|NCT01087905|233269|P1|Overall Study|Withdrawal by Subject|5
62065|NCT01087905|233262|P8|Overall Study|Lost to Follow-up|24
62066|NCT01087905|233263|P7|Overall Study|Lost to Follow-up|20
62067|NCT01087905|233264|P6|Overall Study|Lost to Follow-up|25
62068|NCT01087905|233265|P5|Overall Study|Lost to Follow-up|27
62069|NCT01087905|233266|P4|Overall Study|Lost to Follow-up|31
62070|NCT01087905|233267|P3|Overall Study|Lost to Follow-up|18
62071|NCT01087905|233268|P2|Overall Study|Lost to Follow-up|28
62072|NCT01087905|233269|P1|Overall Study|Lost to Follow-up|24
62073|NCT01087814|233291|P2|Second Intervention (5 Days)|Physician Decision|0
62074|NCT01087814|233292|P1|Second Intervention (5 Days)|Physician Decision|1
62075|NCT01087814|233291|P2|First Intervention (5 Days)|Withdrawal by Subject|1
62076|NCT01087814|233292|P1|First Intervention (5 Days)|Withdrawal by Subject|3
62077|NCT01087788|233310|P3|Open-Label Period (OL-P)|Personal reasons|1
62078|NCT01087788|233311|P2|Open-Label Period (OL-P)|Personal reasons|0
62079|NCT01087788|233312|P1|Open-Label Period (OL-P)|Personal reasons|0
62080|NCT01087788|233310|P3|Open-Label Period (OL-P)|No participation in study extension|1
62081|NCT01087788|233311|P2|Open-Label Period (OL-P)|No participation in study extension|0
62082|NCT01087788|233312|P1|Open-Label Period (OL-P)|No participation in study extension|0
62083|NCT01087788|233310|P3|Open-Label Period (OL-P)|Principal investigator decision|2
62084|NCT01087788|233311|P2|Open-Label Period (OL-P)|Principal investigator decision|1
62085|NCT01087788|233312|P1|Open-Label Period (OL-P)|Principal investigator decision|0
62086|NCT01087788|233310|P3|Open-Label Period (OL-P)|Sponsor request|0
62087|NCT01087788|233311|P2|Open-Label Period (OL-P)|Sponsor request|0
62088|NCT01087788|233312|P1|Open-Label Period (OL-P)|Sponsor request|1
62089|NCT01087788|233310|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
62090|NCT01087788|233311|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
62091|NCT01087788|233312|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
62092|NCT01087788|233310|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
62093|NCT01087788|233311|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
62094|NCT01087788|233312|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
62095|NCT01087788|233310|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
62096|NCT01087788|233311|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
62097|NCT01087788|233312|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
62098|NCT01087788|233310|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
62099|NCT01087788|233311|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
62100|NCT01087788|233312|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
62101|NCT01087788|233310|P3|Open-Label Period (OL-P)|AE, serious fatal|1
62102|NCT01087788|233311|P2|Open-Label Period (OL-P)|AE, serious fatal|0
62103|NCT01087788|233312|P1|Open-Label Period (OL-P)|AE, serious fatal|2
62104|NCT01087788|233310|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
62105|NCT01087788|233311|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
62106|NCT01087788|233312|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
62107|NCT01087788|233310|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
62108|NCT01087788|233311|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
62109|NCT01087788|233312|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
62110|NCT01087788|233310|P3|Open-Label Period (OL-P)|Protocol Violation|0
62111|NCT01087788|233311|P2|Open-Label Period (OL-P)|Protocol Violation|1
62112|NCT01087788|233312|P1|Open-Label Period (OL-P)|Protocol Violation|2
62113|NCT01087788|233310|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
62114|NCT01087788|233311|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
62115|NCT01087788|233312|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
62116|NCT01087788|233310|P3|24-weeks Dose-blind Period|Patient moved|1
62117|NCT01087788|233311|P2|24-weeks Dose-blind Period|Patient moved|0
62118|NCT01087788|233312|P1|24-weeks Dose-blind Period|Patient moved|0
62119|NCT01087788|233310|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
62120|NCT01087788|233311|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
62121|NCT01087788|233312|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
62122|NCT01087788|233310|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
62123|NCT01087788|233311|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
62124|NCT01087788|233312|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
62125|NCT01087788|233310|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
62126|NCT01087788|233311|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
62127|NCT01087788|233312|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
62128|NCT01087788|233310|P3|24-weeks Dose-blind Period|AE, serious fatal|0
62129|NCT01087788|233311|P2|24-weeks Dose-blind Period|AE, serious fatal|1
62130|NCT01087788|233312|P1|24-weeks Dose-blind Period|AE, serious fatal|0
62131|NCT01087788|233310|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
62132|NCT01087788|233311|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
62133|NCT01087788|233312|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
62134|NCT01087788|233310|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
62135|NCT01087788|233311|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
62136|NCT01087788|233312|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
62137|NCT01087788|233310|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
62138|NCT01087788|233311|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
62139|NCT01087788|233312|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
62140|NCT01087788|233310|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
62141|NCT01087788|233311|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
62142|NCT01087788|233312|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
62143|NCT01087788|233310|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
62144|NCT01087788|233311|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
62145|NCT01087788|233312|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
62146|NCT01087788|233310|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
62147|NCT01087788|233311|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
62148|NCT01087788|233312|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
62149|NCT01087788|233310|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
62150|NCT01087788|233311|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
62151|NCT01087788|233312|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
62152|NCT01087788|233310|P3|24-weeks Double-blind Period|AE, unknown type|1
62153|NCT01087788|233311|P2|24-weeks Double-blind Period|AE, unknown type|0
62154|NCT01087788|233312|P1|24-weeks Double-blind Period|AE, unknown type|0
62155|NCT01087788|233310|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
62156|NCT01087788|233311|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
62157|NCT01087788|233312|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
62158|NCT01087788|233310|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
62159|NCT01087788|233311|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
62160|NCT01087788|233312|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
62161|NCT01087788|233310|P3|24-weeks Double-blind Period|AE, serious fatal|1
62162|NCT01087788|233311|P2|24-weeks Double-blind Period|AE, serious fatal|1
62163|NCT01087788|233312|P1|24-weeks Double-blind Period|AE, serious fatal|0
62164|NCT01087788|233310|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
62165|NCT01087788|233311|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
62166|NCT01087788|233312|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
62167|NCT01087788|233310|P3|24-weeks Double-blind Period|Lost to Follow-up|1
62168|NCT01087788|233311|P2|24-weeks Double-blind Period|Lost to Follow-up|1
62169|NCT01087788|233312|P1|24-weeks Double-blind Period|Lost to Follow-up|4
62170|NCT01087788|233310|P3|24-weeks Double-blind Period|Protocol Violation|0
62171|NCT01087788|233311|P2|24-weeks Double-blind Period|Protocol Violation|1
62172|NCT01087788|233312|P1|24-weeks Double-blind Period|Protocol Violation|0
62173|NCT01087788|233310|P3|24-weeks Double-blind Period|Lack of Efficacy|1
62174|NCT01087788|233311|P2|24-weeks Double-blind Period|Lack of Efficacy|0
62175|NCT01087788|233312|P1|24-weeks Double-blind Period|Lack of Efficacy|2
62176|NCT01087762|233342|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
62177|NCT01087762|233343|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
62178|NCT01087762|233344|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
62179|NCT01087762|233345|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
62180|NCT01087762|233346|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
62181|NCT01087762|233342|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
62182|NCT01087762|233343|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
62183|NCT01087762|233344|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
62184|NCT01087762|233345|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
62185|NCT01087762|233346|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
62186|NCT01087762|233342|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
62187|NCT01087762|233343|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
62188|NCT01087762|233344|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
62189|NCT01087762|233345|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
62190|NCT01087762|233346|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
62191|NCT01087762|233342|P5|Open-Label Period (Weeks 48-204)|Unspecified|4
62192|NCT01087762|233343|P4|Open-Label Period (Weeks 48-204)|Unspecified|2
62193|NCT01087762|233344|P3|Open-Label Period (Weeks 48-204)|Unspecified|0
62194|NCT01087762|233345|P2|Open-Label Period (Weeks 48-204)|Unspecified|0
62195|NCT01087762|233346|P1|Open-Label Period (Weeks 48-204)|Unspecified|0
62196|NCT01087762|233342|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
62197|NCT01087762|233343|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
62198|NCT01087762|233344|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
62199|NCT01087762|233345|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
62200|NCT01087762|233346|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
62201|NCT01087762|233342|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
62202|NCT01087762|233343|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
62203|NCT01087762|233344|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
62204|NCT01087762|233345|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
62205|NCT01087762|233346|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
62206|NCT01087762|233342|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
62207|NCT01087762|233343|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
62208|NCT01087762|233344|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
62209|NCT01087762|233345|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
62210|NCT01087762|233346|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
62211|NCT01087762|233342|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
62212|NCT01087762|233343|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
62213|NCT01087762|233344|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
62214|NCT01087762|233345|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
62215|NCT01087762|233346|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
62216|NCT01087762|233342|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
62217|NCT01087762|233343|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
62218|NCT01087762|233344|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
62219|NCT01087762|233345|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
62220|NCT01087762|233346|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
62221|NCT01087762|233342|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
62222|NCT01087762|233343|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
62223|NCT01087762|233344|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
62224|NCT01087762|233345|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
62225|NCT01087762|233346|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
62226|NCT01087762|233342|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
62227|NCT01087762|233343|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
62228|NCT01087762|233344|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
62229|NCT01087762|233345|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
62230|NCT01087762|233346|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
62231|NCT01087762|233342|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
62232|NCT01087762|233343|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
62233|NCT01087762|233344|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
62234|NCT01087762|233345|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
62235|NCT01087762|233346|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
62236|NCT01087762|233342|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
62237|NCT01087762|233343|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
62238|NCT01087762|233344|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
62239|NCT01087762|233345|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
62240|NCT01087762|233346|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
62241|NCT01087736|233394|P2|Overall Study|Withdrawal by Subject|1
62242|NCT01087736|233395|P1|Overall Study|Withdrawal by Subject|0
62243|NCT01087736|233394|P2|Overall Study|Death|1
62244|NCT01087736|233395|P1|Overall Study|Death|0
62245|NCT01087736|233394|P2|Overall Study|Lost to Follow-up|0
62246|NCT01087736|233395|P1|Overall Study|Lost to Follow-up|1
62247|NCT01087723|233405|P2|Overall Study|Reason Not Specified|2
62248|NCT01087723|233406|P1|Overall Study|Reason Not Specified|1
62249|NCT01087723|233405|P2|Overall Study|Lost to Follow-up|4
62250|NCT01087723|233406|P1|Overall Study|Lost to Follow-up|1
62251|NCT01087723|233405|P2|Overall Study|Physician Decision|0
62252|NCT01087723|233406|P1|Overall Study|Physician Decision|2
62253|NCT01087723|233405|P2|Overall Study|Withdrawal by Subject|13
62254|NCT01087723|233406|P1|Overall Study|Withdrawal by Subject|10
62255|NCT01087723|233405|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
62256|NCT01087723|233406|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
62257|NCT01087528|233447|P1|Overall Study|Incomplete CE procedure|6
62258|NCT01087528|233447|P1|Overall Study|Withdrawal by Subject|1
62259|NCT01087502|233453|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
62260|NCT01087502|233454|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
62261|NCT01087502|233453|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
62262|NCT01087502|233454|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
62263|NCT01087502|233453|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
62264|NCT01087502|233454|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
62265|NCT01087502|233453|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
62266|NCT01087502|233454|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
62267|NCT01087502|233453|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
62268|NCT01087502|233454|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
62269|NCT01087502|233453|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
62270|NCT01087502|233454|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
62271|NCT01087502|233453|P2|Up to Final Analysis (Week 52)|Adverse Event|10
62272|NCT01087502|233454|P1|Up to Final Analysis (Week 52)|Adverse Event|17
62273|NCT01087502|233453|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
62274|NCT01087502|233454|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
62275|NCT01087502|233453|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
62276|NCT01087502|233454|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
62277|NCT01087502|233453|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
62278|NCT01087502|233454|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
62279|NCT01087502|233453|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
62280|NCT01087502|233454|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
62281|NCT01087502|233453|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
62282|NCT01087502|233454|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
62283|NCT01087489|233473|P2|Overall Study|unable to survey by telephone|1
62284|NCT01087489|233474|P1|Overall Study|unable to survey by telephone|0
62285|NCT01087489|233473|P2|Overall Study|Death|1
62286|NCT01087489|233474|P1|Overall Study|Death|0
62287|NCT01087489|233473|P2|Overall Study|enrolled in another VA study|1
62288|NCT01087489|233474|P1|Overall Study|enrolled in another VA study|0
62289|NCT01086969|233487|P3|Overall Study|Withdrawal by Subject|0
62290|NCT01086969|233488|P2|Overall Study|Withdrawal by Subject|2
62291|NCT01086969|233489|P1|Overall Study|Withdrawal by Subject|1
62292|NCT01086410|233582|P4|Overall Study|Lost to Follow-up|0
62293|NCT01086410|233583|P3|Overall Study|Lost to Follow-up|1
62294|NCT01086410|233584|P2|Overall Study|Lost to Follow-up|0
62295|NCT01086410|233585|P1|Overall Study|Lost to Follow-up|0
62296|NCT01086410|233582|P4|Overall Study|Protocol Violation|0
62297|NCT01086410|233583|P3|Overall Study|Protocol Violation|0
62298|NCT01086410|233584|P2|Overall Study|Protocol Violation|1
62299|NCT01086410|233585|P1|Overall Study|Protocol Violation|1
62300|NCT01086410|233582|P4|Overall Study|Lack of Efficacy|0
62301|NCT01086410|233583|P3|Overall Study|Lack of Efficacy|0
62302|NCT01086410|233584|P2|Overall Study|Lack of Efficacy|1
62303|NCT01086410|233585|P1|Overall Study|Lack of Efficacy|1
62304|NCT01086410|233582|P4|Overall Study|Adverse Event|2
62305|NCT01086410|233583|P3|Overall Study|Adverse Event|0
62306|NCT01086410|233584|P2|Overall Study|Adverse Event|0
62307|NCT01086410|233585|P1|Overall Study|Adverse Event|1
62308|NCT01086384|233681|P3|Treatment Period|Received Treatment in Error|0
62309|NCT01086384|233682|P2|Treatment Period|Received Treatment in Error|1
62310|NCT01086384|233683|P1|Treatment Period|Received Treatment in Error|0
62311|NCT01086384|233681|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
62312|NCT01086384|233682|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
62313|NCT01086384|233683|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
62314|NCT01086384|233681|P3|Treatment Period|Study Closed/Terminated|8
62315|NCT01086384|233682|P2|Treatment Period|Study Closed/Terminated|7
62316|NCT01086384|233683|P1|Treatment Period|Study Closed/Terminated|0
62317|NCT01086384|233681|P3|Treatment Period|Physician Decision|6
62318|NCT01086384|233682|P2|Treatment Period|Physician Decision|9
62319|NCT01086384|233683|P1|Treatment Period|Physician Decision|0
62320|NCT01086384|233681|P3|Treatment Period|Lost to Follow-up|9
62321|NCT01086384|233682|P2|Treatment Period|Lost to Follow-up|11
62322|NCT01086384|233683|P1|Treatment Period|Lost to Follow-up|0
62323|NCT01086384|233681|P3|Treatment Period|Adverse Event|15
62324|NCT01086384|233682|P2|Treatment Period|Adverse Event|19
62325|NCT01086384|233683|P1|Treatment Period|Adverse Event|0
62326|NCT01086384|233681|P3|Treatment Period|Lack of Efficacy|13
62327|NCT01086384|233682|P2|Treatment Period|Lack of Efficacy|22
62328|NCT01086384|233683|P1|Treatment Period|Lack of Efficacy|0
62329|NCT01086384|233681|P3|Treatment Period|Protocol Violation|17
62330|NCT01086384|233682|P2|Treatment Period|Protocol Violation|26
62331|NCT01086384|233683|P1|Treatment Period|Protocol Violation|0
62332|NCT01086384|233681|P3|Treatment Period|Withdrawal by Subject|55
62333|NCT01086384|233682|P2|Treatment Period|Withdrawal by Subject|53
62334|NCT01086384|233683|P1|Treatment Period|Withdrawal by Subject|0
62335|NCT01086384|233681|P3|2-week Run-in Period|Randomized in Error|0
62336|NCT01086384|233682|P2|2-week Run-in Period|Randomized in Error|0
62337|NCT01086384|233683|P1|2-week Run-in Period|Randomized in Error|1
62338|NCT01086384|233681|P3|2-week Run-in Period|Continuation Criteria Not Met|0
62339|NCT01086384|233682|P2|2-week Run-in Period|Continuation Criteria Not Met|0
62340|NCT01086384|233683|P1|2-week Run-in Period|Continuation Criteria Not Met|92
62341|NCT01086384|233681|P3|2-week Run-in Period|Study Closed/Terminated|0
62342|NCT01086384|233682|P2|2-week Run-in Period|Study Closed/Terminated|0
62343|NCT01086384|233683|P1|2-week Run-in Period|Study Closed/Terminated|42
62344|NCT01086384|233681|P3|2-week Run-in Period|Withdrawal by Subject|0
62345|NCT01086384|233682|P2|2-week Run-in Period|Withdrawal by Subject|0
62346|NCT01086384|233683|P1|2-week Run-in Period|Withdrawal by Subject|19
62347|NCT01086384|233681|P3|2-week Run-in Period|Physician Decision|0
62348|NCT01086384|233682|P2|2-week Run-in Period|Physician Decision|0
62349|NCT01086384|233683|P1|2-week Run-in Period|Physician Decision|6
62350|NCT01086384|233681|P3|2-week Run-in Period|Lost to Follow-up|0
62351|NCT01086384|233682|P2|2-week Run-in Period|Lost to Follow-up|0
62352|NCT01086384|233683|P1|2-week Run-in Period|Lost to Follow-up|1
62353|NCT01086384|233681|P3|2-week Run-in Period|Protocol Violation|0
62354|NCT01086384|233682|P2|2-week Run-in Period|Protocol Violation|0
62355|NCT01086384|233683|P1|2-week Run-in Period|Protocol Violation|1
62356|NCT01086384|233681|P3|2-week Run-in Period|Adverse Event|0
62357|NCT01086384|233682|P2|2-week Run-in Period|Adverse Event|0
62358|NCT01086384|233683|P1|2-week Run-in Period|Adverse Event|1
62359|NCT01086215|233697|P4|Overall Study|Lost to Follow-up|2
62360|NCT01086215|233698|P3|Overall Study|Lost to Follow-up|18
62361|NCT01086215|233699|P2|Overall Study|Lost to Follow-up|39
62362|NCT01086215|233700|P1|Overall Study|Lost to Follow-up|22
62363|NCT01086215|233697|P4|Overall Study|Death|1
62364|NCT01086215|233698|P3|Overall Study|Death|8
62365|NCT01086215|233699|P2|Overall Study|Death|8
62366|NCT01086215|233700|P1|Overall Study|Death|14
62367|NCT01086033|233718|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
62368|NCT01086033|233718|P1|Overall Study|AE and Other Reason|1
62369|NCT01086033|233718|P1|Overall Study|AE and Lost to Follow-up|1
62370|NCT01086033|233718|P1|Overall Study|Death|1
62371|NCT01086033|233718|P1|Overall Study|AE and Lack of Efficacy|4
62372|NCT01086033|233718|P1|Overall Study|Withdrew consent and Other Reason|4
62373|NCT01086033|233718|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
62374|NCT01086033|233718|P1|Overall Study|AE and Withdrew Consent|5
62375|NCT01086033|233718|P1|Overall Study|Other|13
62376|NCT01086033|233718|P1|Overall Study|Other|14
62377|NCT01086033|233718|P1|Overall Study|Withdrawal by Subject|41
62378|NCT01086033|233718|P1|Overall Study|Adverse Event|42
62379|NCT01086033|233718|P1|Overall Study|Lost to Follow-up|86
62380|NCT01086033|233718|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
62381|NCT01085734|233824|P2|Overall Study|Withdrawal by Subject|1
62382|NCT01085734|233825|P1|Overall Study|Withdrawal by Subject|0
62383|NCT01085734|233824|P2|Overall Study|Lost to Follow-up|1
62384|NCT01085734|233825|P1|Overall Study|Lost to Follow-up|0
62385|NCT01085734|233824|P2|Overall Study|Death|0
62386|NCT01085734|233825|P1|Overall Study|Death|1
62387|NCT01085734|233824|P2|Overall Study|Adverse Event|2
62388|NCT01085734|233825|P1|Overall Study|Adverse Event|0
62389|NCT01085682|233837|P2|Overall Study|Withdrawal by Subject|25
62390|NCT01085682|233838|P1|Overall Study|Withdrawal by Subject|25
62391|NCT01085591|233856|P3|Overall Study|Not Properly Consented|0
62392|NCT01085591|233857|P2|Overall Study|Not Properly Consented|0
62393|NCT01085591|233858|P1|Overall Study|Not Properly Consented|1
62394|NCT01085591|233856|P3|Overall Study|Other|0
62395|NCT01085591|233857|P2|Overall Study|Other|1
62396|NCT01085591|233858|P1|Overall Study|Other|0
62397|NCT01085591|233856|P3|Overall Study|Protocol Violation|1
62398|NCT01085591|233857|P2|Overall Study|Protocol Violation|1
62399|NCT01085591|233858|P1|Overall Study|Protocol Violation|1
62400|NCT01085591|233856|P3|Overall Study|Lost to Follow-up|1
62401|NCT01085591|233857|P2|Overall Study|Lost to Follow-up|1
62402|NCT01085591|233858|P1|Overall Study|Lost to Follow-up|0
62403|NCT01085591|233856|P3|Overall Study|Withdrawal by Subject|1
62404|NCT01085591|233857|P2|Overall Study|Withdrawal by Subject|2
62405|NCT01085591|233858|P1|Overall Study|Withdrawal by Subject|0
62406|NCT01085591|233856|P3|Overall Study|Physician Decision|1
62407|NCT01085591|233857|P2|Overall Study|Physician Decision|0
62408|NCT01085591|233858|P1|Overall Study|Physician Decision|1
62409|NCT01085591|233856|P3|Overall Study|Adverse Event|3
62410|NCT01085591|233857|P2|Overall Study|Adverse Event|1
62411|NCT01085591|233858|P1|Overall Study|Adverse Event|0
62412|NCT01085357|233909|P2|Overall Study|Lost to Follow-up|0
62413|NCT01085357|233910|P1|Overall Study|Lost to Follow-up|2
62414|NCT01085357|233909|P2|Overall Study|Death|1
62415|NCT01085357|233910|P1|Overall Study|Death|11
62416|NCT01085357|233909|P2|Overall Study|Investigator Decision|1
62417|NCT01085357|233910|P1|Overall Study|Investigator Decision|1
62418|NCT01085357|233909|P2|Overall Study|Subject Decision|3
62419|NCT01085357|233910|P1|Overall Study|Subject Decision|4
62420|NCT01085357|233909|P2|Overall Study|Adverse Event|1
62421|NCT01085357|233910|P1|Overall Study|Adverse Event|1
62422|NCT01085214|233973|P1|Overall Study|Alternate treatment required|1
62423|NCT01085201|233985|P5|Overall Study|Fond ineligible after consent|0
62424|NCT01085201|233986|P4|Overall Study|Fond ineligible after consent|0
62425|NCT01085201|233987|P3|Overall Study|Fond ineligible after consent|1
62426|NCT01085201|233988|P2|Overall Study|Fond ineligible after consent|1
62427|NCT01085201|233989|P1|Overall Study|Fond ineligible after consent|0
62428|NCT01085201|233985|P5|Overall Study|Unknown- no study drug|0
62429|NCT01085201|233986|P4|Overall Study|Unknown- no study drug|0
62430|NCT01085201|233987|P3|Overall Study|Unknown- no study drug|0
62431|NCT01085201|233988|P2|Overall Study|Unknown- no study drug|0
62432|NCT01085201|233989|P1|Overall Study|Unknown- no study drug|2
62433|NCT01085201|233985|P5|Overall Study|Scheduling conflict|0
62434|NCT01085201|233986|P4|Overall Study|Scheduling conflict|0
62435|NCT01085201|233987|P3|Overall Study|Scheduling conflict|1
62436|NCT01085201|233988|P2|Overall Study|Scheduling conflict|0
62437|NCT01085201|233989|P1|Overall Study|Scheduling conflict|1
62438|NCT01085136|234011|P3|Part B|Not treated|8
62439|NCT01085136|234012|P2|Part B|Not treated|2
62440|NCT01085136|234013|P1|Part B|Not treated|0
62441|NCT01085136|234011|P3|Part B|Other reason not given|3
62442|NCT01085136|234012|P2|Part B|Other reason not given|7
62443|NCT01085136|234013|P1|Part B|Other reason not given|0
62444|NCT01085136|234011|P3|Part B|Refusal to continue trial medication|7
62445|NCT01085136|234012|P2|Part B|Refusal to continue trial medication|12
62446|NCT01085136|234013|P1|Part B|Refusal to continue trial medication|0
62447|NCT01085136|234011|P3|Part B|Adverse Event|8
62448|NCT01085136|234012|P2|Part B|Adverse Event|27
62449|NCT01085136|234013|P1|Part B|Adverse Event|0
62450|NCT01085136|234011|P3|Part A|Other reason not given|0
62451|NCT01085136|234012|P2|Part A|Other reason not given|0
62452|NCT01085136|234013|P1|Part A|Other reason not given|30
62453|NCT01085136|234011|P3|Part A|Refusal to continue trial medication|0
62454|NCT01085136|234012|P2|Part A|Refusal to continue trial medication|0
62455|NCT01085136|234013|P1|Part A|Refusal to continue trial medication|64
62456|NCT01085136|234011|P3|Part A|Lost to Follow-up|0
62457|NCT01085136|234012|P2|Part A|Lost to Follow-up|0
62458|NCT01085136|234013|P1|Part A|Lost to Follow-up|3
62459|NCT01085136|234011|P3|Part A|Protocol Violation|0
62460|NCT01085136|234012|P2|Part A|Protocol Violation|0
62461|NCT01085136|234013|P1|Part A|Protocol Violation|3
62462|NCT01085136|234011|P3|Part A|Adverse Event|0
62463|NCT01085136|234012|P2|Part A|Adverse Event|0
62464|NCT01085136|234013|P1|Part A|Adverse Event|222
62465|NCT01084707|234041|P1|Overall Study|Withdrawal by Subject|6
62466|NCT01084668|234075|P1|Overall Study|Non-compliance|1
62467|NCT01084668|234075|P1|Overall Study|Pregnancy|1
62468|NCT01084668|234075|P1|Overall Study|Withdrawal by Subject|2
62469|NCT01084668|234075|P1|Overall Study|Lack of Efficacy|5
62470|NCT01084603|234084|P1|Washout Period 4|Adverse Event|1
62471|NCT01084603|234084|P1|Oral Nicotine 1|Withdrawal by Subject|1
62472|NCT01084603|234084|P1|Nicorette® Gum|Withdrawal by Subject|1
62473|NCT01084603|234084|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
62474|NCT01084603|234084|P1|Baseline|Withdrawal by Subject|2
62475|NCT01084551|234120|P3|Overall Study|Physician Decision|0
62476|NCT01084551|234121|P2|Overall Study|Physician Decision|0
62477|NCT01084551|234122|P1|Overall Study|Physician Decision|1
62478|NCT01084551|234120|P3|Overall Study|Lost to Follow-up|3
62479|NCT01084551|234121|P2|Overall Study|Lost to Follow-up|0
62480|NCT01084551|234122|P1|Overall Study|Lost to Follow-up|0
62481|NCT01084551|234120|P3|Overall Study|Protocol Violation|0
62482|NCT01084551|234121|P2|Overall Study|Protocol Violation|4
62483|NCT01084551|234122|P1|Overall Study|Protocol Violation|2
62484|NCT01084551|234120|P3|Overall Study|Withdrawal by Subject|0
62485|NCT01084551|234121|P2|Overall Study|Withdrawal by Subject|1
62486|NCT01084551|234122|P1|Overall Study|Withdrawal by Subject|2
62487|NCT01084551|234120|P3|Overall Study|Lack of Efficacy|1
62488|NCT01084551|234121|P2|Overall Study|Lack of Efficacy|0
62489|NCT01084551|234122|P1|Overall Study|Lack of Efficacy|2
62490|NCT01084551|234120|P3|Overall Study|Adverse Event|4
62491|NCT01084551|234121|P2|Overall Study|Adverse Event|9
62492|NCT01084551|234122|P1|Overall Study|Adverse Event|2
62493|NCT01084538|234160|P1|Overall Study|Reason unknown|8
62494|NCT01084538|234160|P1|Overall Study|Over-suppression of parathyroid gland|2
62495|NCT01084538|234160|P1|Overall Study|Change of residence|2
62496|NCT01084538|234160|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
62497|NCT01084538|234160|P1|Overall Study|Hyperphosphatemia|2
62498|NCT01084538|234160|P1|Overall Study|Patient noncompliance|2
62499|NCT01084538|234160|P1|Overall Study|Lack of effectiveness|2
62500|NCT01084538|234160|P1|Overall Study|Serious Adverse Event|3
62501|NCT01084538|234160|P1|Overall Study|Kidney transplant|6
62502|NCT01084538|234160|P1|Overall Study|Adverse Event|9
62503|NCT01084538|234160|P1|Overall Study|Drug not available|30
62504|NCT01084239|234271|P2|28-Day Follow-up|Lost to Follow-up|9
62505|NCT01084239|234272|P1|28-Day Follow-up|Lost to Follow-up|4
62506|NCT01084135|234301|P2|20 Week|Physician Decision|1
62507|NCT01084135|234302|P1|20 Week|Physician Decision|0
62508|NCT01084083|234312|P1|Overall Study|Never started assigned therapy|1
62509|NCT01084083|234312|P1|Overall Study|Other|2
62510|NCT01084083|234312|P1|Overall Study|Complicating disease|1
62511|NCT01084083|234312|P1|Overall Study|Withdrawal by Subject|2
62512|NCT01084083|234312|P1|Overall Study|Death|1
62513|NCT01084083|234312|P1|Overall Study|Adverse Event|5
62514|NCT01084005|234320|P2|Overall Study|Withdrawal by Subject|1
62515|NCT01084005|234321|P1|Overall Study|Withdrawal by Subject|1
62516|NCT01084005|234320|P2|Overall Study|Protocol Violation|7
62517|NCT01084005|234321|P1|Overall Study|Protocol Violation|3
62518|NCT01084005|234320|P2|Overall Study|Adverse Event|8
62519|NCT01084005|234321|P1|Overall Study|Adverse Event|1
62520|NCT01083810|234402|P3|Overall Study|Virologic failure|0
62521|NCT01083810|234403|P2|Overall Study|Virologic failure|8
62522|NCT01083810|234404|P1|Overall Study|Virologic failure|1
62523|NCT01083810|234402|P3|Overall Study|Therapy break|2
62524|NCT01083810|234403|P2|Overall Study|Therapy break|2
62525|NCT01083810|234404|P1|Overall Study|Therapy break|1
62526|NCT01083810|234402|P3|Overall Study|Participation in study|0
62527|NCT01083810|234403|P2|Overall Study|Participation in study|0
62528|NCT01083810|234404|P1|Overall Study|Participation in study|1
62529|NCT01083810|234402|P3|Overall Study|Co-morbidities|0
62530|NCT01083810|234403|P2|Overall Study|Co-morbidities|0
62531|NCT01083810|234404|P1|Overall Study|Co-morbidities|1
62532|NCT01083810|234402|P3|Overall Study|Death|3
62533|NCT01083810|234403|P2|Overall Study|Death|2
62534|NCT01083810|234404|P1|Overall Study|Death|2
62535|NCT01083810|234402|P3|Overall Study|Simplification|0
62536|NCT01083810|234403|P2|Overall Study|Simplification|1
62537|NCT01083810|234404|P1|Overall Study|Simplification|4
62538|NCT01083810|234402|P3|Overall Study|Non-compliance|2
62539|NCT01083810|234403|P2|Overall Study|Non-compliance|7
62540|NCT01083810|234404|P1|Overall Study|Non-compliance|4
62541|NCT01083810|234402|P3|Overall Study|Reason not reported|1
62542|NCT01083810|234403|P2|Overall Study|Reason not reported|1
62543|NCT01083810|234404|P1|Overall Study|Reason not reported|6
62544|NCT01083810|234402|P3|Overall Study|Withdrawal by Subject|4
62545|NCT01083810|234403|P2|Overall Study|Withdrawal by Subject|2
62546|NCT01083810|234404|P1|Overall Study|Withdrawal by Subject|7
62547|NCT01083810|234402|P3|Overall Study|Adverse Event|4
62548|NCT01083810|234403|P2|Overall Study|Adverse Event|11
62549|NCT01083810|234404|P1|Overall Study|Adverse Event|15
62550|NCT01083810|234402|P3|Overall Study|Lost to Follow-up|4
62551|NCT01083810|234403|P2|Overall Study|Lost to Follow-up|11
62552|NCT01083810|234404|P1|Overall Study|Lost to Follow-up|23
62553|NCT01083771|234425|P1|Overall Study|Withdrawal by Subject|3
62554|NCT01083771|234425|P1|Overall Study|non-compliant|2
62555|NCT01083693|234520|P3|Overall Study|Reason unknown|1
62556|NCT01083693|234521|P2|Overall Study|Reason unknown|0
62557|NCT01083693|234522|P1|Overall Study|Reason unknown|0
62558|NCT01083693|234520|P3|Overall Study|Withdrawal by Subject|2
62559|NCT01083693|234521|P2|Overall Study|Withdrawal by Subject|0
62560|NCT01083693|234522|P1|Overall Study|Withdrawal by Subject|3
62561|NCT01083693|234520|P3|Overall Study|Other medical condition/surgery|0
62562|NCT01083693|234521|P2|Overall Study|Other medical condition/surgery|1
62563|NCT01083693|234522|P1|Overall Study|Other medical condition/surgery|1
62564|NCT01083693|234520|P3|Overall Study|Complete remission|0
62565|NCT01083693|234521|P2|Overall Study|Complete remission|1
62566|NCT01083693|234522|P1|Overall Study|Complete remission|0
62567|NCT01083693|234520|P3|Overall Study|Patient Moved|0
62568|NCT01083693|234521|P2|Overall Study|Patient Moved|1
62569|NCT01083693|234522|P1|Overall Study|Patient Moved|0
62570|NCT01083693|234520|P3|Overall Study|Lack of effectiveness|2
62571|NCT01083693|234521|P2|Overall Study|Lack of effectiveness|2
62572|NCT01083693|234522|P1|Overall Study|Lack of effectiveness|13
62573|NCT01083693|234520|P3|Overall Study|Lost to Follow-up|2
62574|NCT01083693|234521|P2|Overall Study|Lost to Follow-up|0
62575|NCT01083693|234522|P1|Overall Study|Lost to Follow-up|2
62576|NCT01083693|234520|P3|Overall Study|Adverse Event|0
62577|NCT01083693|234521|P2|Overall Study|Adverse Event|1
62578|NCT01083693|234522|P1|Overall Study|Adverse Event|1
62579|NCT01083602|234566|P1|Overall Study|Lack of Efficacy|36
62580|NCT01083602|234566|P1|Overall Study|Withdrawal by Subject|5
62581|NCT01083602|234566|P1|Overall Study|Death|1
62582|NCT01083602|234566|P1|Overall Study|New Cancer Therapy|2
62583|NCT01083602|234566|P1|Overall Study|Adverse Event|11
62584|NCT01083576|234577|P2|Overall Study|Treatment Failure|1
62585|NCT01083576|234578|P1|Overall Study|Treatment Failure|6
62586|NCT01083485|234608|P2|Overall Study|Other|0
62587|NCT01083485|234609|P1|Overall Study|Other|1
62588|NCT01083485|234608|P2|Overall Study|Withdrawal by Subject|2
62589|NCT01083485|234609|P1|Overall Study|Withdrawal by Subject|5
62590|NCT01083485|234608|P2|Overall Study|Protocol Violation|0
62591|NCT01083485|234609|P1|Overall Study|Protocol Violation|1
62592|NCT01083485|234608|P2|Overall Study|Adverse Event|1
62593|NCT01083485|234609|P1|Overall Study|Adverse Event|0
62594|NCT01083316|234626|P1|Overall Study|Withdrawal by Subject|1
62595|NCT01083316|234626|P1|Overall Study|Adverse Event|2
62596|NCT01083186|234637|P1|Overall Study|Non-compliance to Study Treatment|1
62597|NCT01083186|234637|P1|Overall Study|Administrative Reasons|2
62598|NCT01083186|234637|P1|Overall Study|Hemodialysis Initiation|28
62599|NCT01083186|234637|P1|Overall Study|Lack of Efficacy|2
62600|NCT01083186|234637|P1|Overall Study|Adverse Event|3
62601|NCT01083186|234637|P1|Overall Study|Death|3
62602|NCT01083186|234637|P1|Overall Study|Consent Withdrawal|7
62603|NCT01083186|234637|P1|Overall Study|Lost to Follow-up|48
62604|NCT01083173|234678|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
62605|NCT01083173|234679|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
62606|NCT01083173|234678|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
62607|NCT01083173|234679|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
62608|NCT01083173|234678|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
62609|NCT01083173|234679|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
62610|NCT01083173|234678|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
62611|NCT01083173|234679|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
62612|NCT01083173|234678|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
62613|NCT01083173|234679|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
62614|NCT01083173|234678|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
62615|NCT01083173|234679|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
62616|NCT01083173|234678|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
62617|NCT01083173|234679|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
62618|NCT01083173|234678|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
62619|NCT01083173|234679|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
62620|NCT01083173|234678|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
62621|NCT01083173|234679|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
62622|NCT01083173|234678|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
62623|NCT01083173|234679|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
62624|NCT01083173|234678|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
62625|NCT01083173|234679|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
62626|NCT01083160|234697|P1|Overall Study|Adverse Event|1
62627|NCT01083121|234704|P1|Overall Study|Use of Humira outside the approved label|81
62628|NCT01082965|234714|P2|Overall Study|Unspecified|1
62629|NCT01082965|234715|P1|Overall Study|Unspecified|1
62630|NCT01082965|234714|P2|Overall Study|Protocol Violation|1
62631|NCT01082965|234715|P1|Overall Study|Protocol Violation|0
62632|NCT01082874|234752|P4|Overall Study|Withdrawal by Subject|3
62633|NCT01082874|234753|P3|Overall Study|Withdrawal by Subject|5
62634|NCT01082874|234754|P2|Overall Study|Withdrawal by Subject|2
62635|NCT01082874|234755|P1|Overall Study|Withdrawal by Subject|1
62636|NCT01082874|234752|P4|Overall Study|Lost to Follow-up|10
62637|NCT01082874|234753|P3|Overall Study|Lost to Follow-up|6
62638|NCT01082874|234754|P2|Overall Study|Lost to Follow-up|10
62639|NCT01082874|234755|P1|Overall Study|Lost to Follow-up|10
62640|NCT01082640|234768|P3|Overall Study|Other|3
62641|NCT01082640|234769|P2|Overall Study|Other|1
62642|NCT01082640|234770|P1|Overall Study|Other|2
62643|NCT01082640|234768|P3|Overall Study|Lost to Follow-up|0
62644|NCT01082640|234769|P2|Overall Study|Lost to Follow-up|3
62645|NCT01082640|234770|P1|Overall Study|Lost to Follow-up|0
62646|NCT01082640|234768|P3|Overall Study|Major protocol deviation|0
62647|NCT01082640|234769|P2|Overall Study|Major protocol deviation|3
62648|NCT01082640|234770|P1|Overall Study|Major protocol deviation|3
62649|NCT01082640|234768|P3|Overall Study|Withdrawal by Subject|2
62650|NCT01082640|234769|P2|Overall Study|Withdrawal by Subject|3
62651|NCT01082640|234770|P1|Overall Study|Withdrawal by Subject|3
62652|NCT01082640|234768|P3|Overall Study|Adverse Event|3
62653|NCT01082640|234769|P2|Overall Study|Adverse Event|5
62654|NCT01082640|234770|P1|Overall Study|Adverse Event|9
62655|NCT01082614|234792|P2|Overall Study|Physician Decision|0
62656|NCT01082614|234793|P1|Overall Study|Physician Decision|2
62657|NCT01082614|234792|P2|Overall Study|Equipment Malfunction|1
62658|NCT01082614|234793|P1|Overall Study|Equipment Malfunction|0
62659|NCT01082614|234792|P2|Overall Study|Adverse Event|4
62660|NCT01082614|234793|P1|Overall Study|Adverse Event|1
62661|NCT01082367|234860|P2|Follow-up (F-U) Period|Adverse Event|1
62662|NCT01082367|234861|P1|Follow-up (F-U) Period|Adverse Event|0
62663|NCT01082367|234860|P2|Follow-up (F-U) Period|Abnormal lab values|0
62664|NCT01082367|234861|P1|Follow-up (F-U) Period|Abnormal lab values|1
62665|NCT01082367|234860|P2|Follow-up (F-U) Period|Administrative problems|0
62666|NCT01082367|234861|P1|Follow-up (F-U) Period|Administrative problems|1
62667|NCT01082367|234860|P2|Double-blind Period|Adverse Event|1
62668|NCT01082367|234861|P1|Double-blind Period|Adverse Event|0
62669|NCT01082367|234860|P2|Double-blind Period|Lack of Efficacy|11
62670|NCT01082367|234861|P1|Double-blind Period|Lack of Efficacy|5
62671|NCT01082367|234860|P2|Double-blind Period|Administrative problems|1
62672|NCT01082367|234861|P1|Double-blind Period|Administrative problems|0
62673|NCT01082328|234875|P1|Overall Study|Adverse Event|1
62674|NCT01082081|234893|P3|Overall Study|Other Reason|0
62675|NCT01082081|234894|P2|Overall Study|Other Reason|1
62676|NCT01082081|234895|P1|Overall Study|Other Reason|0
62677|NCT01082081|234893|P3|Overall Study|Withdrawal by Subject|1
62678|NCT01082081|234894|P2|Overall Study|Withdrawal by Subject|0
62679|NCT01082081|234895|P1|Overall Study|Withdrawal by Subject|0
62680|NCT01082081|234893|P3|Overall Study|Lost to Follow-up|1
62681|NCT01082081|234894|P2|Overall Study|Lost to Follow-up|0
62682|NCT01082081|234895|P1|Overall Study|Lost to Follow-up|0
62683|NCT01081951|234947|P2|Overall Study|Lost to Follow-up|1
62684|NCT01081951|234948|P1|Overall Study|Lost to Follow-up|0
62685|NCT01081951|234947|P2|Overall Study|Allocated treatment but did not take it|1
62686|NCT01081951|234948|P1|Overall Study|Allocated treatment but did not take it|0
62687|NCT01081951|234947|P2|Overall Study|Withdrawal by Subject|6
62688|NCT01081951|234948|P1|Overall Study|Withdrawal by Subject|2
62689|NCT01081951|234947|P2|Overall Study|Death|47
62690|NCT01081951|234948|P1|Overall Study|Death|54
62691|NCT01081912|234958|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
62692|NCT01081912|234959|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
62693|NCT01081912|234960|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
62694|NCT01081912|234958|P3|Maintenance Treatment|Non-Compliance|7
62695|NCT01081912|234959|P2|Maintenance Treatment|Non-Compliance|4
62696|NCT01081912|234960|P1|Maintenance Treatment|Non-Compliance|0
62697|NCT01081912|234958|P3|Maintenance Treatment|Withdrawal by Subject|5
62698|NCT01081912|234959|P2|Maintenance Treatment|Withdrawal by Subject|5
62699|NCT01081912|234960|P1|Maintenance Treatment|Withdrawal by Subject|0
62700|NCT01081912|234958|P3|Maintenance Treatment|Protocol Violation|2
62701|NCT01081912|234959|P2|Maintenance Treatment|Protocol Violation|1
62702|NCT01081912|234960|P1|Maintenance Treatment|Protocol Violation|0
62703|NCT01081912|234958|P3|Maintenance Treatment|Physician Decision|1
62704|NCT01081912|234959|P2|Maintenance Treatment|Physician Decision|0
62705|NCT01081912|234960|P1|Maintenance Treatment|Physician Decision|0
62706|NCT01081912|234958|P3|Maintenance Treatment|Lost to Follow-up|0
62707|NCT01081912|234959|P2|Maintenance Treatment|Lost to Follow-up|1
62708|NCT01081912|234960|P1|Maintenance Treatment|Lost to Follow-up|0
62709|NCT01081912|234958|P3|Maintenance Treatment|Lack of Efficacy|64
62710|NCT01081912|234959|P2|Maintenance Treatment|Lack of Efficacy|14
62711|NCT01081912|234960|P1|Maintenance Treatment|Lack of Efficacy|0
62712|NCT01081912|234958|P3|Maintenance Treatment|Adverse Event|12
62713|NCT01081912|234959|P2|Maintenance Treatment|Adverse Event|2
62714|NCT01081912|234960|P1|Maintenance Treatment|Adverse Event|0
62715|NCT01081912|234958|P3|Conversion/Titration|Non-Compliance|0
62716|NCT01081912|234959|P2|Conversion/Titration|Non-Compliance|0
62717|NCT01081912|234960|P1|Conversion/Titration|Non-Compliance|47
62718|NCT01081912|234958|P3|Conversion/Titration|Withdrawal by Subject|0
62719|NCT01081912|234959|P2|Conversion/Titration|Withdrawal by Subject|0
62720|NCT01081912|234960|P1|Conversion/Titration|Withdrawal by Subject|23
62721|NCT01081912|234958|P3|Conversion/Titration|Protocol Violation|0
62722|NCT01081912|234959|P2|Conversion/Titration|Protocol Violation|0
62723|NCT01081912|234960|P1|Conversion/Titration|Protocol Violation|67
62724|NCT01081912|234958|P3|Conversion/Titration|Physician Decision|0
62725|NCT01081912|234959|P2|Conversion/Titration|Physician Decision|0
62726|NCT01081912|234960|P1|Conversion/Titration|Physician Decision|2
62727|NCT01081912|234958|P3|Conversion/Titration|Lost to Follow-up|0
62728|NCT01081912|234959|P2|Conversion/Titration|Lost to Follow-up|0
62729|NCT01081912|234960|P1|Conversion/Titration|Lost to Follow-up|5
62730|NCT01081912|234958|P3|Conversion/Titration|Lack of Efficacy|0
62731|NCT01081912|234959|P2|Conversion/Titration|Lack of Efficacy|0
62732|NCT01081912|234960|P1|Conversion/Titration|Lack of Efficacy|17
62733|NCT01081912|234958|P3|Conversion/Titration|Adverse Event|0
62734|NCT01081912|234959|P2|Conversion/Titration|Adverse Event|0
62735|NCT01081912|234960|P1|Conversion/Titration|Adverse Event|47
62736|NCT01081886|234969|P2|Overall Study|Study termination|13
62737|NCT01081886|234970|P1|Overall Study|Study termination|11
62738|NCT01081873|234978|P1|Overall Study|Other|47
62739|NCT01081873|234978|P1|Overall Study|Progression of prostate cancer|13
62740|NCT01081873|234978|P1|Overall Study|Lost to Follow-up|142
62741|NCT01081873|234978|P1|Overall Study|Withdrawal by Subject|10
62742|NCT01081873|234978|P1|Overall Study|Death|86
62743|NCT01081834|235050|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
62744|NCT01081834|235051|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
62745|NCT01081834|235052|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
62746|NCT01081834|235053|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
62747|NCT01081834|235054|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
62748|NCT01081834|235050|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
62749|NCT01081834|235051|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
62750|NCT01081834|235052|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
62751|NCT01081834|235053|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
62752|NCT01081834|235054|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
62753|NCT01081834|235050|P5|Extension Period: Week 26 to Week 52|Not specified|0
62754|NCT01081834|235051|P4|Extension Period: Week 26 to Week 52|Not specified|0
62755|NCT01081834|235052|P3|Extension Period: Week 26 to Week 52|Not specified|4
62756|NCT01081834|235053|P2|Extension Period: Week 26 to Week 52|Not specified|5
62757|NCT01081834|235054|P1|Extension Period: Week 26 to Week 52|Not specified|4
62758|NCT01081834|235050|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
62759|NCT01081834|235051|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
62760|NCT01081834|235052|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
62761|NCT01081834|235053|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
62762|NCT01081834|235054|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
62763|NCT01081834|235050|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
62764|NCT01081834|235051|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
62765|NCT01081834|235052|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
62766|NCT01081834|235053|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
62767|NCT01081834|235054|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
62768|NCT01081834|235050|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
62769|NCT01081834|235051|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
62770|NCT01081834|235052|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
62771|NCT01081834|235053|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
62772|NCT01081834|235054|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
62773|NCT01081834|235050|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
62774|NCT01081834|235051|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
62775|NCT01081834|235052|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
62776|NCT01081834|235053|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
62777|NCT01081834|235054|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
62778|NCT01081834|235050|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
62779|NCT01081834|235051|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
62780|NCT01081834|235052|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
62781|NCT01081834|235053|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
62782|NCT01081834|235054|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
62783|NCT01081834|235050|P5|Extension Period: Week 26 to Week 52|Death|0
62784|NCT01081834|235051|P4|Extension Period: Week 26 to Week 52|Death|0
62785|NCT01081834|235052|P3|Extension Period: Week 26 to Week 52|Death|0
62786|NCT01081834|235053|P2|Extension Period: Week 26 to Week 52|Death|0
62787|NCT01081834|235054|P1|Extension Period: Week 26 to Week 52|Death|1
62788|NCT01081834|235050|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
62789|NCT01081834|235051|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
62790|NCT01081834|235052|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
62791|NCT01081834|235053|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
62792|NCT01081834|235054|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
62793|NCT01081834|235050|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
62794|NCT01081834|235051|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
62795|NCT01081834|235052|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
62796|NCT01081834|235053|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
62797|NCT01081834|235054|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
62798|NCT01081834|235050|P5|Core Period: Baseline to Week 26|Not specified|0
62799|NCT01081834|235051|P4|Core Period: Baseline to Week 26|Not specified|1
62800|NCT01081834|235052|P3|Core Period: Baseline to Week 26|Not specified|3
62801|NCT01081834|235053|P2|Core Period: Baseline to Week 26|Not specified|4
62802|NCT01081834|235054|P1|Core Period: Baseline to Week 26|Not specified|4
62803|NCT01081834|235050|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
62804|NCT01081834|235051|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
62805|NCT01081834|235052|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
62806|NCT01081834|235053|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
62807|NCT01081834|235054|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
62808|NCT01081834|235050|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
62809|NCT01081834|235051|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
62810|NCT01081834|235052|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
63055|NCT01079988|235648|P2|Overall Study|Other|0
62811|NCT01081834|235053|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
62812|NCT01081834|235054|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
62813|NCT01081834|235050|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
62814|NCT01081834|235051|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
62815|NCT01081834|235052|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
62816|NCT01081834|235053|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
62817|NCT01081834|235054|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
62818|NCT01081834|235050|P5|Core Period: Baseline to Week 26|Protocol Violation|2
62819|NCT01081834|235051|P4|Core Period: Baseline to Week 26|Protocol Violation|0
62820|NCT01081834|235052|P3|Core Period: Baseline to Week 26|Protocol Violation|0
62821|NCT01081834|235053|P2|Core Period: Baseline to Week 26|Protocol Violation|4
62822|NCT01081834|235054|P1|Core Period: Baseline to Week 26|Protocol Violation|0
62823|NCT01081834|235050|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
62824|NCT01081834|235051|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
62825|NCT01081834|235052|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
62826|NCT01081834|235053|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
62827|NCT01081834|235054|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
62828|NCT01081834|235050|P5|Core Period: Baseline to Week 26|Death|0
62829|NCT01081834|235051|P4|Core Period: Baseline to Week 26|Death|0
62830|NCT01081834|235052|P3|Core Period: Baseline to Week 26|Death|0
62831|NCT01081834|235053|P2|Core Period: Baseline to Week 26|Death|0
62832|NCT01081834|235054|P1|Core Period: Baseline to Week 26|Death|1
62833|NCT01081834|235050|P5|Core Period: Baseline to Week 26|Adverse Event|1
62834|NCT01081834|235051|P4|Core Period: Baseline to Week 26|Adverse Event|1
62835|NCT01081834|235052|P3|Core Period: Baseline to Week 26|Adverse Event|3
62836|NCT01081834|235053|P2|Core Period: Baseline to Week 26|Adverse Event|5
62837|NCT01081834|235054|P1|Core Period: Baseline to Week 26|Adverse Event|2
62838|NCT01081834|235050|P5|Core Period: Baseline to Week 26|Pregnancy|0
62839|NCT01081834|235051|P4|Core Period: Baseline to Week 26|Pregnancy|0
62840|NCT01081834|235052|P3|Core Period: Baseline to Week 26|Pregnancy|0
62841|NCT01081834|235053|P2|Core Period: Baseline to Week 26|Pregnancy|0
62842|NCT01081834|235054|P1|Core Period: Baseline to Week 26|Pregnancy|1
62843|NCT01081795|235115|P3|Overall Study|Unspecified|0
62844|NCT01081795|235116|P2|Overall Study|Unspecified|2
62845|NCT01081795|235117|P1|Overall Study|Unspecified|1
62846|NCT01081795|235115|P3|Overall Study|Using drug with restricted days of use|2
62847|NCT01081795|235116|P2|Overall Study|Using drug with restricted days of use|3
62848|NCT01081795|235117|P1|Overall Study|Using drug with restricted days of use|2
62849|NCT01081795|235115|P3|Overall Study|Use of a prohibited concomitant drug|1
62850|NCT01081795|235116|P2|Overall Study|Use of a prohibited concomitant drug|1
62851|NCT01081795|235117|P1|Overall Study|Use of a prohibited concomitant drug|1
62852|NCT01081795|235115|P3|Overall Study|Ineligible for participation|0
62853|NCT01081795|235116|P2|Overall Study|Ineligible for participation|0
62854|NCT01081795|235117|P1|Overall Study|Ineligible for participation|1
62855|NCT01081795|235115|P3|Overall Study|Revocation of informed consent|0
62856|NCT01081795|235116|P2|Overall Study|Revocation of informed consent|0
62857|NCT01081795|235117|P1|Overall Study|Revocation of informed consent|2
62858|NCT01081795|235115|P3|Overall Study|Subject’s schedule|2
62859|NCT01081795|235116|P2|Overall Study|Subject’s schedule|1
62860|NCT01081795|235117|P1|Overall Study|Subject’s schedule|1
62861|NCT01081795|235115|P3|Overall Study|Lack of Efficacy|19
62862|NCT01081795|235116|P2|Overall Study|Lack of Efficacy|5
62863|NCT01081795|235117|P1|Overall Study|Lack of Efficacy|7
62864|NCT01081795|235115|P3|Overall Study|Adverse Event|6
62865|NCT01081795|235116|P2|Overall Study|Adverse Event|23
62866|NCT01081795|235117|P1|Overall Study|Adverse Event|18
62867|NCT01081769|235154|P2|CORE Intent-To-Treat|Patient Moved|2
62868|NCT01081769|235155|P1|CORE Intent-To-Treat|Patient Moved|2
62869|NCT01081769|235154|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
62870|NCT01081769|235155|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
62871|NCT01081769|235154|P2|CORE Intent-To-Treat|Ineligibility|4
62872|NCT01081769|235155|P1|CORE Intent-To-Treat|Ineligibility|3
62873|NCT01081769|235154|P2|CORE Intent-To-Treat|Other|1
62874|NCT01081769|235155|P1|CORE Intent-To-Treat|Other|0
62875|NCT01081769|235154|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
62876|NCT01081769|235155|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
62877|NCT01081769|235154|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
62878|NCT01081769|235155|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
62879|NCT01081769|235154|P2|CORE Intent-To-Treat|Pregnancy|0
62880|NCT01081769|235155|P1|CORE Intent-To-Treat|Pregnancy|1
62881|NCT01081769|235154|P2|CORE Intent-To-Treat|Lost to Follow-up|5
62882|NCT01081769|235155|P1|CORE Intent-To-Treat|Lost to Follow-up|4
62883|NCT01081769|235154|P2|CORE Intent-To-Treat|Lack of Efficacy|6
62884|NCT01081769|235155|P1|CORE Intent-To-Treat|Lack of Efficacy|2
62885|NCT01081769|235154|P2|CORE Intent-To-Treat|Death|1
62886|NCT01081769|235155|P1|CORE Intent-To-Treat|Death|1
62887|NCT01081769|235154|P2|CORE Intent-To-Treat|Adverse Event|11
62888|NCT01081769|235155|P1|CORE Intent-To-Treat|Adverse Event|14
62889|NCT01081769|235154|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
62890|NCT01081769|235155|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
62891|NCT01081769|235154|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
62892|NCT01081769|235155|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
62893|NCT01081769|235154|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
62894|NCT01081769|235155|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
62895|NCT01081769|235154|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
62896|NCT01081769|235155|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
62897|NCT01081665|235189|P1|Overall Study|Lack of Efficacy|1
62898|NCT01081665|235189|P1|Overall Study|Adverse Event|1
62899|NCT01081665|235189|P1|Overall Study|Change in renal replacement therapy|2
62900|NCT01081665|235189|P1|Overall Study|Regulation of iPTH|5
62901|NCT01081665|235189|P1|Overall Study|Change of dialysis unit|10
62902|NCT01081665|235189|P1|Overall Study|Withdrawal by Subject|17
62903|NCT01081665|235189|P1|Overall Study|Lost to Follow-up|18
62904|NCT01081665|235189|P1|Overall Study|Death|41
62905|NCT01081626|235201|P2|Overall Study|Unspecified|30
62906|NCT01081626|235202|P1|Overall Study|Unspecified|33
62907|NCT01081626|235201|P2|Overall Study|Lost to Follow-up|1
62908|NCT01081626|235202|P1|Overall Study|Lost to Follow-up|0
62909|NCT01081626|235201|P2|Overall Study|Overstimulation|1
62910|NCT01081626|235202|P1|Overall Study|Overstimulation|0
62911|NCT01081626|235201|P2|Overall Study|Low antral follicle count|0
62912|NCT01081626|235202|P1|Overall Study|Low antral follicle count|1
62913|NCT01081626|235201|P2|Overall Study|Missing Estradiol|28
62914|NCT01081626|235202|P1|Overall Study|Missing Estradiol|25
62915|NCT01081626|235201|P2|Overall Study|Dosing error|1
62916|NCT01081626|235202|P1|Overall Study|Dosing error|1
62917|NCT01081301|235228|P1|Overall Study|Lost to Follow-up|4
62918|NCT01081301|235228|P1|Overall Study|Patient too ill|2
62919|NCT01081301|235228|P1|Overall Study|Too busy|5
62920|NCT01081301|235228|P1|Overall Study|Bereaved|3
62921|NCT01081249|235266|P2|Overall Study|Diagnosed with Bipolar Disorder|1
62922|NCT01081249|235267|P1|Overall Study|Diagnosed with Bipolar Disorder|0
62923|NCT01081145|235273|P2|Double-Blind Randomized-Withdrawal Phase|Not specified|3
62924|NCT01081145|235274|P1|Double-Blind Randomized-Withdrawal Phase|Not specified|4
62925|NCT01081145|235273|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
62926|NCT01081145|235274|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
62927|NCT01081145|235273|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
62928|NCT01081145|235274|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
62929|NCT01081145|235273|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
62930|NCT01081145|235274|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
62931|NCT01081145|235273|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
62932|NCT01081145|235274|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
62933|NCT01081145|235273|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
62934|NCT01081145|235274|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
62935|NCT01081145|235273|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
62936|NCT01081145|235274|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
62937|NCT01081145|235273|P2|Open-Label Phase|Protocol Violation|0
62938|NCT01081145|235274|P1|Open-Label Phase|Protocol Violation|4
62939|NCT01081145|235273|P2|Open-Label Phase|Lost to Follow-up|0
62940|NCT01081145|235274|P1|Open-Label Phase|Lost to Follow-up|11
62941|NCT01081145|235273|P2|Open-Label Phase|Not specified|0
62942|NCT01081145|235274|P1|Open-Label Phase|Not specified|12
62943|NCT01081145|235273|P2|Open-Label Phase|Withdrawal by Subject|0
62944|NCT01081145|235274|P1|Open-Label Phase|Withdrawal by Subject|41
62945|NCT01081145|235273|P2|Open-Label Phase|Adverse Event|0
62946|NCT01081145|235274|P1|Open-Label Phase|Adverse Event|42
62947|NCT01081145|235273|P2|Open-Label Phase|Response criteria not met|0
62948|NCT01081145|235274|P1|Open-Label Phase|Response criteria not met|46
62949|NCT01081145|235273|P2|Open-Label Phase|Lack of Efficacy|0
62950|NCT01081145|235274|P1|Open-Label Phase|Lack of Efficacy|56
62951|NCT01081132|235302|P2|Overall Study|Protocol Violation|1
62952|NCT01081132|235303|P1|Overall Study|Protocol Violation|3
62953|NCT01081132|235302|P2|Overall Study|Declined Taper Phase|1
62954|NCT01081132|235303|P1|Overall Study|Declined Taper Phase|0
62955|NCT01081132|235302|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
62956|NCT01081132|235303|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
62957|NCT01081132|235302|P2|Overall Study|Stopped Taking Meds|0
62958|NCT01081132|235303|P1|Overall Study|Stopped Taking Meds|2
62959|NCT01081132|235302|P2|Overall Study|Missed Visits|1
62960|NCT01081132|235303|P1|Overall Study|Missed Visits|1
62961|NCT01081132|235302|P2|Overall Study|Lack Of Compliance|1
62962|NCT01081132|235303|P1|Overall Study|Lack Of Compliance|0
62963|NCT01081132|235302|P2|Overall Study|Non Compliance|2
62964|NCT01081132|235303|P1|Overall Study|Non Compliance|4
62965|NCT01081132|235302|P2|Overall Study|Adverse Event|9
62966|NCT01081132|235303|P1|Overall Study|Adverse Event|3
62967|NCT01081132|235302|P2|Overall Study|Lost to Follow-up|11
62968|NCT01081132|235303|P1|Overall Study|Lost to Follow-up|4
62969|NCT01081132|235302|P2|Overall Study|Withdrawal by Subject|16
62970|NCT01081132|235303|P1|Overall Study|Withdrawal by Subject|13
62971|NCT01081132|235302|P2|Overall Study|Lack of Efficacy|9
62972|NCT01081132|235303|P1|Overall Study|Lack of Efficacy|25
62973|NCT01080807|235376|P2|Overall Study|Moved away without notifying center|0
62974|NCT01080807|235377|P1|Overall Study|Moved away without notifying center|1
62975|NCT01080807|235376|P2|Overall Study|Switched to first shift|0
62976|NCT01080807|235377|P1|Overall Study|Switched to first shift|1
62977|NCT01080807|235376|P2|Overall Study|Work schedule and travel|1
62978|NCT01080807|235377|P1|Overall Study|Work schedule and travel|0
62979|NCT01080807|235376|P2|Overall Study|Work schedule changing|1
62980|NCT01080807|235377|P1|Overall Study|Work schedule changing|1
62981|NCT01080807|235376|P2|Overall Study|Stopped working consistent night shifts|1
62982|NCT01080807|235377|P1|Overall Study|Stopped working consistent night shifts|0
62983|NCT01080807|235376|P2|Overall Study|Laid off or terminated from job|2
62984|NCT01080807|235377|P1|Overall Study|Laid off or terminated from job|1
62985|NCT01080807|235376|P2|Overall Study|Began working day shift|2
62986|NCT01080807|235377|P1|Overall Study|Began working day shift|0
62987|NCT01080807|235376|P2|Overall Study|Noncompliance to study procedures|1
62988|NCT01080807|235377|P1|Overall Study|Noncompliance to study procedures|1
62989|NCT01080807|235376|P2|Overall Study|Noncompliance with drug administration|1
62990|NCT01080807|235377|P1|Overall Study|Noncompliance with drug administration|1
62991|NCT01080807|235376|P2|Overall Study|Lost to Follow-up|4
62992|NCT01080807|235377|P1|Overall Study|Lost to Follow-up|6
62993|NCT01080807|235376|P2|Overall Study|Protocol Violation|6
62994|NCT01080807|235377|P1|Overall Study|Protocol Violation|7
62995|NCT01080807|235376|P2|Overall Study|Withdrawal by Subject|2
62996|NCT01080807|235377|P1|Overall Study|Withdrawal by Subject|7
62997|NCT01080807|235376|P2|Overall Study|Lack of Efficacy|1
62998|NCT01080807|235377|P1|Overall Study|Lack of Efficacy|0
62999|NCT01080807|235376|P2|Overall Study|Adverse Event|1
63000|NCT01080807|235377|P1|Overall Study|Adverse Event|9
63001|NCT01080768|235433|P2|Overall Study|Protocol Deviation|1
63002|NCT01080768|235434|P1|Overall Study|Protocol Deviation|2
63003|NCT01080625|235443|P3|Overall Study|Physician Decision|1
63004|NCT01080625|235444|P2|Overall Study|Physician Decision|2
63005|NCT01080625|235445|P1|Overall Study|Physician Decision|0
63006|NCT01080391|235455|P2|Overall Study|Withdrawal by Subject|10
63007|NCT01080391|235456|P1|Overall Study|Withdrawal by Subject|19
63008|NCT01080391|235455|P2|Overall Study|Lost to Follow-up|3
63009|NCT01080391|235456|P1|Overall Study|Lost to Follow-up|4
63010|NCT01080326|235474|P1|Overall Study|Surgeon decision|1
63011|NCT01080326|235474|P1|Overall Study|Patient deterioration prior to procedure|3
63012|NCT01080300|235480|P2|Overall Study|Reasons not specified|6
63013|NCT01080300|235481|P1|Overall Study|Reasons not specified|4
63014|NCT01080300|235480|P2|Overall Study|Withdrawal by Subject|28
63015|NCT01080300|235481|P1|Overall Study|Withdrawal by Subject|12
63016|NCT01080300|235480|P2|Overall Study|Death|1
63017|NCT01080300|235481|P1|Overall Study|Death|0
63018|NCT01080300|235480|P2|Overall Study|Lost to Follow-up|6
63019|NCT01080300|235481|P1|Overall Study|Lost to Follow-up|10
63020|NCT01080300|235480|P2|Overall Study|Protocol Violation|13
63021|NCT01080300|235481|P1|Overall Study|Protocol Violation|7
63022|NCT01080300|235480|P2|Overall Study|Lack of Efficacy|15
63023|NCT01080300|235481|P1|Overall Study|Lack of Efficacy|12
63024|NCT01080300|235480|P2|Overall Study|Adverse Event|35
63025|NCT01080300|235481|P1|Overall Study|Adverse Event|49
63026|NCT01080131|235549|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
63027|NCT01080131|235550|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
63028|NCT01080131|235549|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
63029|NCT01080131|235550|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
63030|NCT01080131|235549|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
63031|NCT01080131|235550|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
63032|NCT01080131|235549|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
63033|NCT01080131|235550|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
63034|NCT01080131|235549|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
63035|NCT01080131|235550|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
63036|NCT01080131|235549|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
63037|NCT01080131|235550|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
63038|NCT01080131|235549|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
63039|NCT01080131|235550|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
63040|NCT01080131|235549|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
63041|NCT01080131|235550|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
63042|NCT01080131|235549|P2|Core Study (0- 12 Weeks)|Death|0
63043|NCT01080131|235550|P1|Core Study (0- 12 Weeks)|Death|1
63044|NCT01080131|235549|P2|Core Study (0- 12 Weeks)|Administrative problems|1
63045|NCT01080131|235550|P1|Core Study (0- 12 Weeks)|Administrative problems|0
63046|NCT01080131|235549|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
63047|NCT01080131|235550|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
63048|NCT01080131|235549|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
63049|NCT01080131|235550|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
63050|NCT01080131|235549|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
63051|NCT01080131|235550|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
63052|NCT01079988|235645|P5|Overall Study|Other|1
63053|NCT01079988|235646|P4|Overall Study|Other|2
63054|NCT01079988|235647|P3|Overall Study|Other|0
63056|NCT01079988|235649|P1|Overall Study|Other|0
63057|NCT01079988|235645|P5|Overall Study|Lack of Efficacy|0
63058|NCT01079988|235646|P4|Overall Study|Lack of Efficacy|0
63059|NCT01079988|235647|P3|Overall Study|Lack of Efficacy|0
63060|NCT01079988|235648|P2|Overall Study|Lack of Efficacy|0
63061|NCT01079988|235649|P1|Overall Study|Lack of Efficacy|1
63062|NCT01079988|235645|P5|Overall Study|Lost to Follow-up|0
63063|NCT01079988|235646|P4|Overall Study|Lost to Follow-up|1
63064|NCT01079988|235647|P3|Overall Study|Lost to Follow-up|0
63065|NCT01079988|235648|P2|Overall Study|Lost to Follow-up|0
63066|NCT01079988|235649|P1|Overall Study|Lost to Follow-up|0
63067|NCT01079962|235668|P2|Overall Study|Due to arrhythmia/bradycardia|1
63068|NCT01079962|235669|P1|Overall Study|Due to arrhythmia/bradycardia|1
63069|NCT01079962|235668|P2|Overall Study|Participant not returning for next visit|0
63070|NCT01079962|235669|P1|Overall Study|Participant not returning for next visit|1
63071|NCT01079962|235668|P2|Overall Study|Inclusion/exclusion criteria|3
63072|NCT01079962|235669|P1|Overall Study|Inclusion/exclusion criteria|1
63073|NCT01079962|235668|P2|Overall Study|No blood pressure (BP) control|0
63074|NCT01079962|235669|P1|Overall Study|No blood pressure (BP) control|3
63075|NCT01079962|235668|P2|Overall Study|Protocol Violation|2
63076|NCT01079962|235669|P1|Overall Study|Protocol Violation|2
63077|NCT01079962|235668|P2|Overall Study|Withdrawal by Subject|7
63078|NCT01079962|235669|P1|Overall Study|Withdrawal by Subject|5
63079|NCT01079962|235668|P2|Overall Study|Adverse Event|2
63080|NCT01079962|235669|P1|Overall Study|Adverse Event|2
63081|NCT01079949|235697|P2|Overall Study|Randomized but not treated|0
63082|NCT01079949|235698|P1|Overall Study|Randomized but not treated|1
63083|NCT01079949|235697|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
63084|NCT01079949|235698|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
63085|NCT01079949|235697|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
63086|NCT01079949|235698|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
63087|NCT01079949|235697|P2|Overall Study|Withdrawal before r-hCG administration|3
63088|NCT01079949|235698|P1|Overall Study|Withdrawal before r-hCG administration|2
63089|NCT01079936|235744|P5|Phase II|Insurance Issue|1
63090|NCT01079936|235745|P4|Phase II|Insurance Issue|0
63091|NCT01079936|235746|P3|Phase II|Insurance Issue|0
63092|NCT01079936|235747|P2|Phase II|Insurance Issue|0
63093|NCT01079936|235748|P1|Phase II|Insurance Issue|0
63094|NCT01079936|235744|P5|Phase II|Adverse Event|0
63095|NCT01079936|235745|P4|Phase II|Adverse Event|0
63096|NCT01079936|235746|P3|Phase II|Adverse Event|1
63097|NCT01079936|235747|P2|Phase II|Adverse Event|0
63098|NCT01079936|235748|P1|Phase II|Adverse Event|0
63099|NCT01079936|235744|P5|Phase I: MTD|No Stem Cell Transplantation|0
63100|NCT01079936|235745|P4|Phase I: MTD|No Stem Cell Transplantation|0
63101|NCT01079936|235746|P3|Phase I: MTD|No Stem Cell Transplantation|0
63102|NCT01079936|235747|P2|Phase I: MTD|No Stem Cell Transplantation|0
63103|NCT01079936|235748|P1|Phase I: MTD|No Stem Cell Transplantation|2
63104|NCT01079936|235744|P5|Phase I: MTD|First Remission Status|0
63105|NCT01079936|235745|P4|Phase I: MTD|First Remission Status|0
63106|NCT01079936|235746|P3|Phase I: MTD|First Remission Status|0
63107|NCT01079936|235747|P2|Phase I: MTD|First Remission Status|0
63108|NCT01079936|235748|P1|Phase I: MTD|First Remission Status|2
63109|NCT01079832|235767|P1|Overall Study|Withdrawal by Subject|1
63110|NCT01079806|235777|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|2
63111|NCT01079806|235778|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|0
63112|NCT01079806|235777|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
63113|NCT01079806|235778|P1|Day 1 to Week 96|Poor compliance or noncompliance|1
63114|NCT01079806|235777|P2|Day 1 to Week 96|Pregnancy|1
63115|NCT01079806|235778|P1|Day 1 to Week 96|Pregnancy|0
63116|NCT01079806|235777|P2|Day 1 to Week 96|Withdrawal by Subject|1
63117|NCT01079806|235778|P1|Day 1 to Week 96|Withdrawal by Subject|3
63118|NCT01079806|235777|P2|Day 1 to Week 96|Adverse Event|2
63119|NCT01079806|235778|P1|Day 1 to Week 96|Adverse Event|0
63120|NCT01079234|235810|P4|Extension: Week 27 to 52|Unclassified|7
63121|NCT01079234|235811|P3|Extension: Week 27 to 52|Unclassified|4
63122|NCT01079234|235812|P2|Extension: Week 27 to 52|Unclassified|0
63123|NCT01079234|235813|P1|Extension: Week 27 to 52|Unclassified|0
63124|NCT01079234|235810|P4|Extension: Week 27 to 52|Withdrawal criteria|2
63125|NCT01079234|235811|P3|Extension: Week 27 to 52|Withdrawal criteria|4
63126|NCT01079234|235812|P2|Extension: Week 27 to 52|Withdrawal criteria|0
63127|NCT01079234|235813|P1|Extension: Week 27 to 52|Withdrawal criteria|0
63128|NCT01079234|235810|P4|Extension: Week 27 to 52|Protocol Violation|5
63129|NCT01079234|235811|P3|Extension: Week 27 to 52|Protocol Violation|2
63130|NCT01079234|235812|P2|Extension: Week 27 to 52|Protocol Violation|0
63131|NCT01079234|235813|P1|Extension: Week 27 to 52|Protocol Violation|0
63132|NCT01079234|235810|P4|Extension: Week 27 to 52|Lack of Efficacy|2
63133|NCT01079234|235811|P3|Extension: Week 27 to 52|Lack of Efficacy|0
63134|NCT01079234|235812|P2|Extension: Week 27 to 52|Lack of Efficacy|0
63135|NCT01079234|235813|P1|Extension: Week 27 to 52|Lack of Efficacy|0
63136|NCT01079234|235810|P4|Extension: Week 27 to 52|Adverse Event|0
63137|NCT01079234|235811|P3|Extension: Week 27 to 52|Adverse Event|1
63138|NCT01079234|235812|P2|Extension: Week 27 to 52|Adverse Event|0
63139|NCT01079234|235813|P1|Extension: Week 27 to 52|Adverse Event|0
63140|NCT01079234|235810|P4|Main: Week 0 to 26|Unclassified|0
63141|NCT01079234|235811|P3|Main: Week 0 to 26|Unclassified|4
63142|NCT01079234|235812|P2|Main: Week 0 to 26|Unclassified|13
63143|NCT01079234|235813|P1|Main: Week 0 to 26|Unclassified|7
63144|NCT01079234|235810|P4|Main: Week 0 to 26|Withdrawal criteria|0
63145|NCT01079234|235811|P3|Main: Week 0 to 26|Withdrawal criteria|2
63146|NCT01079234|235812|P2|Main: Week 0 to 26|Withdrawal criteria|6
63147|NCT01079234|235813|P1|Main: Week 0 to 26|Withdrawal criteria|6
63148|NCT01079234|235810|P4|Main: Week 0 to 26|Protocol Violation|0
63149|NCT01079234|235811|P3|Main: Week 0 to 26|Protocol Violation|4
63150|NCT01079234|235812|P2|Main: Week 0 to 26|Protocol Violation|2
63151|NCT01079234|235813|P1|Main: Week 0 to 26|Protocol Violation|6
63152|NCT01079234|235810|P4|Main: Week 0 to 26|Lack of Efficacy|0
63153|NCT01079234|235811|P3|Main: Week 0 to 26|Lack of Efficacy|1
63154|NCT01079234|235812|P2|Main: Week 0 to 26|Lack of Efficacy|1
63155|NCT01079234|235813|P1|Main: Week 0 to 26|Lack of Efficacy|2
63156|NCT01079234|235810|P4|Main: Week 0 to 26|Adverse Event|0
63157|NCT01079234|235811|P3|Main: Week 0 to 26|Adverse Event|1
63158|NCT01079234|235812|P2|Main: Week 0 to 26|Adverse Event|4
63159|NCT01079234|235813|P1|Main: Week 0 to 26|Adverse Event|5
63160|NCT01079195|235831|P1|Overall Study|Non-compliance|2
63161|NCT01079195|235831|P1|Overall Study|No Follow-up Documentation Available|4
63162|NCT01079195|235831|P1|Overall Study|Improved Status of Participant|4
63163|NCT01079195|235831|P1|Overall Study|Physician Decision|4
63164|NCT01079195|235831|P1|Overall Study|Lack of Effectiveness|12
63165|NCT01079195|235831|P1|Overall Study|Financial Reasons|15
63166|NCT01079195|235831|P1|Overall Study|Withdrawal by Subject|18
63167|NCT01079195|235831|P1|Overall Study|Reason Unknown|39
63168|NCT01079195|235831|P1|Overall Study|Adverse Event|157
63169|NCT01079195|235831|P1|Overall Study|No Documentation Available|437
63170|NCT01079195|235831|P1|Overall Study|No Documentation of Tarka Therapy|739
63171|NCT01079182|235837|P1|Overall Study|Reasons not Evaluated|271
63172|NCT01079182|235837|P1|Overall Study|ADR and Lack of Effectiveness|39
63173|NCT01079182|235837|P1|Overall Study|Lack of Efficacy|514
63174|NCT01079182|235837|P1|Overall Study|Adverse Drug Reaction (ADR)|261
63175|NCT01079182|235837|P1|Overall Study|Lost to Follow-up|1634
63176|NCT01079130|235945|P6|Overall Study|Lost to Follow-up|0
63177|NCT01079130|235946|P5|Overall Study|Lost to Follow-up|1
63178|NCT01079130|235947|P4|Overall Study|Lost to Follow-up|0
63179|NCT01079130|235948|P3|Overall Study|Lost to Follow-up|0
63180|NCT01079130|235949|P2|Overall Study|Lost to Follow-up|0
63181|NCT01079130|235950|P1|Overall Study|Lost to Follow-up|0
63182|NCT01079130|235945|P6|Overall Study|Unsatisfactory therapeutic effect|0
63183|NCT01079130|235946|P5|Overall Study|Unsatisfactory therapeutic effect|0
63184|NCT01079130|235947|P4|Overall Study|Unsatisfactory therapeutic effect|2
63185|NCT01079130|235948|P3|Overall Study|Unsatisfactory therapeutic effect|0
63186|NCT01079130|235949|P2|Overall Study|Unsatisfactory therapeutic effect|0
63187|NCT01079130|235950|P1|Overall Study|Unsatisfactory therapeutic effect|0
63188|NCT01079130|235945|P6|Overall Study|Abnormal test procedure result(s)|0
63189|NCT01079130|235946|P5|Overall Study|Abnormal test procedure result(s)|1
63190|NCT01079130|235947|P4|Overall Study|Abnormal test procedure result(s)|0
63191|NCT01079130|235948|P3|Overall Study|Abnormal test procedure result(s)|0
63192|NCT01079130|235949|P2|Overall Study|Abnormal test procedure result(s)|0
63193|NCT01079130|235950|P1|Overall Study|Abnormal test procedure result(s)|0
63194|NCT01079130|235945|P6|Overall Study|Protocol deviation|0
63195|NCT01079130|235946|P5|Overall Study|Protocol deviation|0
63196|NCT01079130|235947|P4|Overall Study|Protocol deviation|2
63197|NCT01079130|235948|P3|Overall Study|Protocol deviation|1
63198|NCT01079130|235949|P2|Overall Study|Protocol deviation|2
63199|NCT01079130|235950|P1|Overall Study|Protocol deviation|0
63200|NCT01079130|235945|P6|Overall Study|Withdrawal by Subject|3
63201|NCT01079130|235946|P5|Overall Study|Withdrawal by Subject|1
63202|NCT01079130|235947|P4|Overall Study|Withdrawal by Subject|0
63203|NCT01079130|235948|P3|Overall Study|Withdrawal by Subject|0
63204|NCT01079130|235949|P2|Overall Study|Withdrawal by Subject|1
63205|NCT01079130|235950|P1|Overall Study|Withdrawal by Subject|0
63206|NCT01079130|235945|P6|Overall Study|Administrative problems|1
63207|NCT01079130|235946|P5|Overall Study|Administrative problems|0
63208|NCT01079130|235947|P4|Overall Study|Administrative problems|0
63209|NCT01079130|235948|P3|Overall Study|Administrative problems|0
63210|NCT01079130|235949|P2|Overall Study|Administrative problems|3
63211|NCT01079130|235950|P1|Overall Study|Administrative problems|1
63212|NCT01079130|235945|P6|Overall Study|Adverse Event|1
63213|NCT01079130|235946|P5|Overall Study|Adverse Event|5
63214|NCT01079130|235947|P4|Overall Study|Adverse Event|1
63215|NCT01079130|235948|P3|Overall Study|Adverse Event|0
63216|NCT01079130|235949|P2|Overall Study|Adverse Event|1
63217|NCT01079130|235950|P1|Overall Study|Adverse Event|1
63218|NCT01078974|235970|P1|Overall Study|Adverse Event|3
63219|NCT01078922|235975|P1|Overall Study|Adverse Event|1
63220|NCT01078805|235980|P1|Overall Study|Didn't take study drug|82
63221|NCT01078805|235980|P1|Overall Study|Other|173
63222|NCT01078805|235980|P1|Overall Study|Withdrawal by Subject|739
63223|NCT01078805|235980|P1|Overall Study|Sponsor decision|46
63224|NCT01078805|235980|P1|Overall Study|Serious adverse event|26
63225|NCT01078805|235980|P1|Overall Study|Physician Decision|169
63226|NCT01078805|235980|P1|Overall Study|Lost to Follow-up|676
63227|NCT01078805|235980|P1|Overall Study|Death|134
63228|NCT01078805|235980|P1|Overall Study|Clinically significant abnormal lab|5
63229|NCT01078675|236007|P2|Overall Study|Adverse Event|0
63230|NCT01078675|236008|P1|Overall Study|Adverse Event|3
63231|NCT01078675|236007|P2|Overall Study|Provided in CRF for specific reasons|3
63232|NCT01078675|236008|P1|Overall Study|Provided in CRF for specific reasons|2
63233|NCT01078675|236007|P2|Overall Study|Protocol Violation|0
63234|NCT01078675|236008|P1|Overall Study|Protocol Violation|56
63235|NCT01078675|236007|P2|Overall Study|Withdrawal by Subject|3
63236|NCT01078675|236008|P1|Overall Study|Withdrawal by Subject|7
63237|NCT01078662|236030|P5|Overall Study|Lost to Follow-up|0
63238|NCT01078662|236031|P4|Overall Study|Lost to Follow-up|0
63239|NCT01078662|236032|P3|Overall Study|Lost to Follow-up|0
63240|NCT01078662|236033|P2|Overall Study|Lost to Follow-up|0
63241|NCT01078662|236034|P1|Overall Study|Lost to Follow-up|1
63242|NCT01078662|236030|P5|Overall Study|Protocol Violation|0
63243|NCT01078662|236031|P4|Overall Study|Protocol Violation|0
63244|NCT01078662|236032|P3|Overall Study|Protocol Violation|0
63245|NCT01078662|236033|P2|Overall Study|Protocol Violation|1
63246|NCT01078662|236034|P1|Overall Study|Protocol Violation|0
63247|NCT01078662|236030|P5|Overall Study|Withdrawal by Subject|0
63248|NCT01078662|236031|P4|Overall Study|Withdrawal by Subject|0
63249|NCT01078662|236032|P3|Overall Study|Withdrawal by Subject|1
63250|NCT01078662|236033|P2|Overall Study|Withdrawal by Subject|11
63251|NCT01078662|236034|P1|Overall Study|Withdrawal by Subject|4
63252|NCT01078662|236030|P5|Overall Study|Patients reached data cut-off|3
63253|NCT01078662|236031|P4|Overall Study|Patients reached data cut-off|2
63254|NCT01078662|236032|P3|Overall Study|Patients reached data cut-off|2
63255|NCT01078662|236033|P2|Overall Study|Patients reached data cut-off|53
63256|NCT01078662|236034|P1|Overall Study|Patients reached data cut-off|12
63257|NCT01078662|236030|P5|Overall Study|Death|8
63258|NCT01078662|236031|P4|Overall Study|Death|5
63259|NCT01078662|236032|P3|Overall Study|Death|18
63260|NCT01078662|236033|P2|Overall Study|Death|103
63261|NCT01078662|236034|P1|Overall Study|Death|41
63262|NCT01078623|236073|P20|Treatment Period 4|Withdrawal by Subject|0
63263|NCT01078623|236074|P19|Treatment Period 4|Withdrawal by Subject|0
63264|NCT01078623|236075|P18|Treatment Period 4|Withdrawal by Subject|0
63265|NCT01078623|236076|P17|Treatment Period 4|Withdrawal by Subject|0
63266|NCT01078623|236077|P16|Treatment Period 4|Withdrawal by Subject|1
63267|NCT01078623|236078|P15|Treatment Period 4|Withdrawal by Subject|0
63268|NCT01078623|236079|P14|Treatment Period 4|Withdrawal by Subject|0
63269|NCT01078623|236080|P13|Treatment Period 4|Withdrawal by Subject|0
63270|NCT01078623|236081|P12|Treatment Period 4|Withdrawal by Subject|0
63271|NCT01078623|236082|P11|Treatment Period 4|Withdrawal by Subject|0
63272|NCT01078623|236083|P10|Treatment Period 4|Withdrawal by Subject|0
63273|NCT01078623|236084|P9|Treatment Period 4|Withdrawal by Subject|0
63274|NCT01078623|236085|P8|Treatment Period 4|Withdrawal by Subject|0
63275|NCT01078623|236086|P7|Treatment Period 4|Withdrawal by Subject|0
63276|NCT01078623|236087|P6|Treatment Period 4|Withdrawal by Subject|0
63277|NCT01078623|236088|P5|Treatment Period 4|Withdrawal by Subject|0
63278|NCT01078623|236089|P4|Treatment Period 4|Withdrawal by Subject|0
63279|NCT01078623|236090|P3|Treatment Period 4|Withdrawal by Subject|0
63280|NCT01078623|236091|P2|Treatment Period 4|Withdrawal by Subject|0
63281|NCT01078623|236092|P1|Treatment Period 4|Withdrawal by Subject|0
63282|NCT01078623|236073|P20|Treatment Period 4|Adverse Event|0
63283|NCT01078623|236074|P19|Treatment Period 4|Adverse Event|0
63284|NCT01078623|236075|P18|Treatment Period 4|Adverse Event|0
63285|NCT01078623|236076|P17|Treatment Period 4|Adverse Event|0
63286|NCT01078623|236077|P16|Treatment Period 4|Adverse Event|0
63287|NCT01078623|236078|P15|Treatment Period 4|Adverse Event|0
63288|NCT01078623|236079|P14|Treatment Period 4|Adverse Event|0
63289|NCT01078623|236080|P13|Treatment Period 4|Adverse Event|0
63290|NCT01078623|236081|P12|Treatment Period 4|Adverse Event|0
63291|NCT01078623|236082|P11|Treatment Period 4|Adverse Event|0
63292|NCT01078623|236083|P10|Treatment Period 4|Adverse Event|0
63293|NCT01078623|236084|P9|Treatment Period 4|Adverse Event|0
63294|NCT01078623|236085|P8|Treatment Period 4|Adverse Event|0
63295|NCT01078623|236086|P7|Treatment Period 4|Adverse Event|0
63296|NCT01078623|236087|P6|Treatment Period 4|Adverse Event|0
63297|NCT01078623|236088|P5|Treatment Period 4|Adverse Event|0
63298|NCT01078623|236089|P4|Treatment Period 4|Adverse Event|0
63299|NCT01078623|236090|P3|Treatment Period 4|Adverse Event|1
63300|NCT01078623|236091|P2|Treatment Period 4|Adverse Event|0
63301|NCT01078623|236092|P1|Treatment Period 4|Adverse Event|0
63302|NCT01078623|236073|P20|Treatment Period 3|Adverse Event|0
63303|NCT01078623|236074|P19|Treatment Period 3|Adverse Event|0
63304|NCT01078623|236075|P18|Treatment Period 3|Adverse Event|0
63305|NCT01078623|236076|P17|Treatment Period 3|Adverse Event|0
63306|NCT01078623|236077|P16|Treatment Period 3|Adverse Event|0
63307|NCT01078623|236078|P15|Treatment Period 3|Adverse Event|0
63308|NCT01078623|236079|P14|Treatment Period 3|Adverse Event|1
63309|NCT01078623|236080|P13|Treatment Period 3|Adverse Event|0
63310|NCT01078623|236081|P12|Treatment Period 3|Adverse Event|0
63311|NCT01078623|236082|P11|Treatment Period 3|Adverse Event|0
63312|NCT01078623|236083|P10|Treatment Period 3|Adverse Event|0
63313|NCT01078623|236084|P9|Treatment Period 3|Adverse Event|0
63314|NCT01078623|236085|P8|Treatment Period 3|Adverse Event|0
63315|NCT01078623|236086|P7|Treatment Period 3|Adverse Event|0
63316|NCT01078623|236087|P6|Treatment Period 3|Adverse Event|0
63317|NCT01078623|236088|P5|Treatment Period 3|Adverse Event|1
63318|NCT01078623|236089|P4|Treatment Period 3|Adverse Event|0
63319|NCT01078623|236090|P3|Treatment Period 3|Adverse Event|0
63320|NCT01078623|236091|P2|Treatment Period 3|Adverse Event|0
63321|NCT01078623|236092|P1|Treatment Period 3|Adverse Event|0
63322|NCT01078623|236073|P20|Treatment Period 2|Withdrawal by Subject|0
63323|NCT01078623|236074|P19|Treatment Period 2|Withdrawal by Subject|0
63324|NCT01078623|236075|P18|Treatment Period 2|Withdrawal by Subject|0
63325|NCT01078623|236076|P17|Treatment Period 2|Withdrawal by Subject|0
63326|NCT01078623|236077|P16|Treatment Period 2|Withdrawal by Subject|0
63327|NCT01078623|236078|P15|Treatment Period 2|Withdrawal by Subject|0
63328|NCT01078623|236079|P14|Treatment Period 2|Withdrawal by Subject|0
63329|NCT01078623|236080|P13|Treatment Period 2|Withdrawal by Subject|0
63330|NCT01078623|236081|P12|Treatment Period 2|Withdrawal by Subject|0
63331|NCT01078623|236082|P11|Treatment Period 2|Withdrawal by Subject|0
63332|NCT01078623|236083|P10|Treatment Period 2|Withdrawal by Subject|0
63333|NCT01078623|236084|P9|Treatment Period 2|Withdrawal by Subject|0
63334|NCT01078623|236085|P8|Treatment Period 2|Withdrawal by Subject|0
63335|NCT01078623|236086|P7|Treatment Period 2|Withdrawal by Subject|0
63336|NCT01078623|236087|P6|Treatment Period 2|Withdrawal by Subject|1
63337|NCT01078623|236088|P5|Treatment Period 2|Withdrawal by Subject|0
63338|NCT01078623|236089|P4|Treatment Period 2|Withdrawal by Subject|0
63339|NCT01078623|236090|P3|Treatment Period 2|Withdrawal by Subject|0
63340|NCT01078623|236091|P2|Treatment Period 2|Withdrawal by Subject|0
63341|NCT01078623|236092|P1|Treatment Period 2|Withdrawal by Subject|0
63342|NCT01078623|236073|P20|Treatment Period 2|Adverse Event|0
63343|NCT01078623|236074|P19|Treatment Period 2|Adverse Event|1
63344|NCT01078623|236075|P18|Treatment Period 2|Adverse Event|0
63345|NCT01078623|236076|P17|Treatment Period 2|Adverse Event|0
63346|NCT01078623|236077|P16|Treatment Period 2|Adverse Event|0
63347|NCT01078623|236078|P15|Treatment Period 2|Adverse Event|0
63348|NCT01078623|236079|P14|Treatment Period 2|Adverse Event|0
63349|NCT01078623|236080|P13|Treatment Period 2|Adverse Event|0
63350|NCT01078623|236081|P12|Treatment Period 2|Adverse Event|0
63351|NCT01078623|236082|P11|Treatment Period 2|Adverse Event|0
63352|NCT01078623|236083|P10|Treatment Period 2|Adverse Event|0
63353|NCT01078623|236084|P9|Treatment Period 2|Adverse Event|0
63354|NCT01078623|236085|P8|Treatment Period 2|Adverse Event|0
63355|NCT01078623|236086|P7|Treatment Period 2|Adverse Event|1
63356|NCT01078623|236087|P6|Treatment Period 2|Adverse Event|0
63357|NCT01078623|236088|P5|Treatment Period 2|Adverse Event|0
63358|NCT01078623|236089|P4|Treatment Period 2|Adverse Event|0
63359|NCT01078623|236090|P3|Treatment Period 2|Adverse Event|0
63360|NCT01078623|236091|P2|Treatment Period 2|Adverse Event|0
63361|NCT01078623|236092|P1|Treatment Period 2|Adverse Event|0
63362|NCT01078623|236073|P20|Treatment Period 1|Protocol Violation|0
63363|NCT01078623|236074|P19|Treatment Period 1|Protocol Violation|0
63364|NCT01078623|236075|P18|Treatment Period 1|Protocol Violation|0
63365|NCT01078623|236076|P17|Treatment Period 1|Protocol Violation|0
63366|NCT01078623|236077|P16|Treatment Period 1|Protocol Violation|0
63367|NCT01078623|236078|P15|Treatment Period 1|Protocol Violation|0
63368|NCT01078623|236079|P14|Treatment Period 1|Protocol Violation|0
63369|NCT01078623|236080|P13|Treatment Period 1|Protocol Violation|0
63370|NCT01078623|236081|P12|Treatment Period 1|Protocol Violation|0
63371|NCT01078623|236082|P11|Treatment Period 1|Protocol Violation|0
63372|NCT01078623|236083|P10|Treatment Period 1|Protocol Violation|0
63373|NCT01078623|236084|P9|Treatment Period 1|Protocol Violation|0
63374|NCT01078623|236085|P8|Treatment Period 1|Protocol Violation|0
63375|NCT01078623|236086|P7|Treatment Period 1|Protocol Violation|0
63376|NCT01078623|236087|P6|Treatment Period 1|Protocol Violation|1
63377|NCT01078623|236088|P5|Treatment Period 1|Protocol Violation|0
63378|NCT01078623|236089|P4|Treatment Period 1|Protocol Violation|0
63379|NCT01078623|236090|P3|Treatment Period 1|Protocol Violation|0
63380|NCT01078623|236091|P2|Treatment Period 1|Protocol Violation|0
63381|NCT01078623|236092|P1|Treatment Period 1|Protocol Violation|0
63382|NCT01078623|236073|P20|Treatment Period 1|Withdrawal by Subject|0
63383|NCT01078623|236074|P19|Treatment Period 1|Withdrawal by Subject|0
63384|NCT01078623|236075|P18|Treatment Period 1|Withdrawal by Subject|0
63385|NCT01078623|236076|P17|Treatment Period 1|Withdrawal by Subject|0
63386|NCT01078623|236077|P16|Treatment Period 1|Withdrawal by Subject|0
63387|NCT01078623|236078|P15|Treatment Period 1|Withdrawal by Subject|0
63388|NCT01078623|236079|P14|Treatment Period 1|Withdrawal by Subject|0
63389|NCT01078623|236080|P13|Treatment Period 1|Withdrawal by Subject|0
63390|NCT01078623|236081|P12|Treatment Period 1|Withdrawal by Subject|0
63391|NCT01078623|236082|P11|Treatment Period 1|Withdrawal by Subject|1
63392|NCT01078623|236083|P10|Treatment Period 1|Withdrawal by Subject|0
63393|NCT01078623|236084|P9|Treatment Period 1|Withdrawal by Subject|0
63394|NCT01078623|236085|P8|Treatment Period 1|Withdrawal by Subject|1
63395|NCT01078623|236086|P7|Treatment Period 1|Withdrawal by Subject|0
63396|NCT01078623|236087|P6|Treatment Period 1|Withdrawal by Subject|0
63397|NCT01078623|236088|P5|Treatment Period 1|Withdrawal by Subject|0
63398|NCT01078623|236089|P4|Treatment Period 1|Withdrawal by Subject|0
63399|NCT01078623|236090|P3|Treatment Period 1|Withdrawal by Subject|0
63400|NCT01078623|236091|P2|Treatment Period 1|Withdrawal by Subject|0
63401|NCT01078623|236092|P1|Treatment Period 1|Withdrawal by Subject|0
63402|NCT01078623|236073|P20|Treatment Period 1|Adverse Event|0
63403|NCT01078623|236074|P19|Treatment Period 1|Adverse Event|0
63404|NCT01078623|236075|P18|Treatment Period 1|Adverse Event|0
63405|NCT01078623|236076|P17|Treatment Period 1|Adverse Event|0
63406|NCT01078623|236077|P16|Treatment Period 1|Adverse Event|0
63407|NCT01078623|236078|P15|Treatment Period 1|Adverse Event|0
63408|NCT01078623|236079|P14|Treatment Period 1|Adverse Event|0
63409|NCT01078623|236080|P13|Treatment Period 1|Adverse Event|0
63410|NCT01078623|236081|P12|Treatment Period 1|Adverse Event|0
63411|NCT01078623|236082|P11|Treatment Period 1|Adverse Event|0
63412|NCT01078623|236083|P10|Treatment Period 1|Adverse Event|1
63413|NCT01078623|236084|P9|Treatment Period 1|Adverse Event|1
63414|NCT01078623|236085|P8|Treatment Period 1|Adverse Event|0
63415|NCT01078623|236086|P7|Treatment Period 1|Adverse Event|1
63416|NCT01078623|236087|P6|Treatment Period 1|Adverse Event|0
63417|NCT01078623|236088|P5|Treatment Period 1|Adverse Event|0
63418|NCT01078623|236089|P4|Treatment Period 1|Adverse Event|0
63419|NCT01078623|236090|P3|Treatment Period 1|Adverse Event|1
63420|NCT01078623|236091|P2|Treatment Period 1|Adverse Event|1
63421|NCT01078623|236092|P1|Treatment Period 1|Adverse Event|1
63422|NCT01078584|236114|P1|Overall Study|Multiple Reasons|2
63423|NCT01078584|236114|P1|Overall Study|Serious Adverse Event|27
63424|NCT01078584|236114|P1|Overall Study|Protocol Violation|75
63425|NCT01078584|236114|P1|Overall Study|Lack of Efficacy|98
63426|NCT01078584|236114|P1|Overall Study|Physician Discontinued Patient|12
63427|NCT01078584|236114|P1|Overall Study|Physician Switched Medication|26
63428|NCT01078584|236114|P1|Overall Study|Blood Pressure Controlled|49
63429|NCT01078584|236114|P1|Overall Study|Non-compliance|67
63430|NCT01078584|236114|P1|Overall Study|Physician Withdrew from Study|90
63431|NCT01078584|236114|P1|Overall Study|Withdrawal of Consent|244
63432|NCT01078584|236114|P1|Overall Study|Non-serious Adverse Event|577
63433|NCT01078584|236114|P1|Overall Study|Lost to Follow-up|670
63434|NCT01078584|236114|P1|Overall Study|Final Status Unknown|1073
63435|NCT01078571|236195|P1|Overall Study|Protocol Violation|2
63436|NCT01078571|236195|P1|Overall Study|Lost to Follow-up|8
63437|NCT01078571|236195|P1|Overall Study|Withdrawal by Subject|12
63438|NCT01078571|236195|P1|Overall Study|Reason not reported|21
63439|NCT01078571|236195|P1|Overall Study|Lack of effectiveness|36
63440|NCT01078571|236195|P1|Overall Study|Adverse Event|36
63441|NCT01078545|236211|P1|Overall Study|Participant moved to another physician|1
63442|NCT01078545|236211|P1|Overall Study|Death|3
63443|NCT01078545|236211|P1|Overall Study|Withdrawal by Subject|3
63444|NCT01078545|236211|P1|Overall Study|Physician Decision|6
63445|NCT01078545|236211|P1|Overall Study|Lost to Follow-up|13
63446|NCT01078454|236221|P2|Overall Study|Death|1
63447|NCT01078454|236222|P1|Overall Study|Death|0
63448|NCT01078454|236221|P2|Overall Study|Adverse Event|1
63449|NCT01078454|236222|P1|Overall Study|Adverse Event|1
63450|NCT01078441|236228|P1|Overall Study|Withdrawal by Subject|1
63451|NCT01078389|236268|P2|Overall Study|Other|2
63452|NCT01078389|236269|P1|Overall Study|Other|9
63453|NCT01078389|236268|P2|Overall Study|Voluntary Withdrawal|36
63454|NCT01078389|236269|P1|Overall Study|Voluntary Withdrawal|20
63455|NCT01078389|236268|P2|Overall Study|Lost to Follow-up|23
63456|NCT01078389|236269|P1|Overall Study|Lost to Follow-up|23
63457|NCT01078389|236268|P2|Overall Study|Major Protocol Deviation|0
63458|NCT01078389|236269|P1|Overall Study|Major Protocol Deviation|2
63459|NCT01078389|236268|P2|Overall Study|Adverse Event|6
63460|NCT01078389|236269|P1|Overall Study|Adverse Event|10
63461|NCT01078298|236430|P2|Overall Study|Unspecified|32
63462|NCT01078298|236431|P1|Overall Study|Unspecified|24
63463|NCT01078298|236430|P2|Overall Study|Did not meet entrance criteria|1
63464|NCT01078298|236431|P1|Overall Study|Did not meet entrance criteria|0
63465|NCT01078298|236430|P2|Overall Study|Death|0
63466|NCT01078298|236431|P1|Overall Study|Death|2
63467|NCT01078298|236430|P2|Overall Study|Adverse Event|5
63468|NCT01078298|236431|P1|Overall Study|Adverse Event|6
63469|NCT01078298|236430|P2|Overall Study|Protocol Violation|6
63470|NCT01078298|236431|P1|Overall Study|Protocol Violation|6
63471|NCT01078298|236430|P2|Overall Study|Withdrawal by Subject|33
63472|NCT01078298|236431|P1|Overall Study|Withdrawal by Subject|31
63473|NCT01078298|236430|P2|Overall Study|Lost to Follow-up|13
63474|NCT01078298|236431|P1|Overall Study|Lost to Follow-up|12
63475|NCT01078155|236539|P1|Overall Study|Lost to Follow-up|15
63476|NCT01078155|236539|P1|Overall Study|Participant's Decision|6
63477|NCT01078155|236539|P1|Overall Study|Lack of Efficacy|16
63478|NCT01078155|236539|P1|Overall Study|Adverse Event|7
63479|NCT01078116|236555|P1|Overall Study|Case report form not completed|3
63480|NCT01078116|236555|P1|Overall Study|Lack of effectiveness|15
63481|NCT01078116|236555|P1|Overall Study|Withdrawal by Subject|8
63482|NCT01078116|236555|P1|Overall Study|Adverse Event|5
63483|NCT01078116|236555|P1|Overall Study|Lost to Follow-up|17
63484|NCT01078090|236563|P1|Overall Study|Other|523
63485|NCT01078090|236563|P1|Overall Study|ADR and lack of efficacy|61
63486|NCT01078090|236563|P1|Overall Study|Lack of Efficacy|1193
63487|NCT01078090|236563|P1|Overall Study|Adverse drug reaction (ADR)|453
63488|NCT01078090|236563|P1|Overall Study|Lost to Follow-up|2363
63489|NCT01077960|236657|P1|Overall Study|Reason unspecified|1
63490|NCT01077960|236657|P1|Overall Study|Subject decision|1
63491|NCT01077960|236657|P1|Overall Study|Lost to Follow-up|5
63492|NCT01077960|236657|P1|Overall Study|Protocol Violation|3
63493|NCT01077960|236657|P1|Overall Study|Adverse Event|6
63494|NCT01077804|236907|P1|Overall Study|Other|18
63495|NCT01077804|236907|P1|Overall Study|Refused to continue|79
63496|NCT01077804|236907|P1|Overall Study|Unreachable|102
63497|NCT01077739|236916|P2|Overall Study|Not specified|2
63498|NCT01077739|236917|P1|Overall Study|Not specified|2
63499|NCT01077739|236916|P2|Overall Study|Unacceptable toxicity|2
63500|NCT01077739|236917|P1|Overall Study|Unacceptable toxicity|1
63501|NCT01077739|236916|P2|Overall Study|Death|3
63502|NCT01077739|236917|P1|Overall Study|Death|0
63503|NCT01077739|236916|P2|Overall Study|Withdrawal by Subject|0
63504|NCT01077739|236917|P1|Overall Study|Withdrawal by Subject|1
63505|NCT01077739|236916|P2|Overall Study|Premature withdrawal|3
63506|NCT01077739|236917|P1|Overall Study|Premature withdrawal|1
63507|NCT01077713|236931|P2|Overall Study|Unspecified|2
63508|NCT01077713|236932|P1|Overall Study|Unspecified|4
63509|NCT01077713|236931|P2|Overall Study|Adverse Event|1
63510|NCT01077713|236932|P1|Overall Study|Adverse Event|2
63511|NCT01077713|236931|P2|Overall Study|Lost to Follow-up|1
63512|NCT01077713|236932|P1|Overall Study|Lost to Follow-up|1
63513|NCT01077713|236931|P2|Overall Study|Death|29
63514|NCT01077713|236932|P1|Overall Study|Death|28
63515|NCT01077713|236931|P2|Overall Study|Progressive Disease (PD)|1
63516|NCT01077713|236932|P1|Overall Study|Progressive Disease (PD)|0
63517|NCT01077713|236931|P2|Overall Study|Withdrawal by Subject|2
63518|NCT01077713|236932|P1|Overall Study|Withdrawal by Subject|1
63519|NCT01077622|236956|P1|Overall Study|Withdrawal by Subject|1
63520|NCT01077622|236956|P1|Overall Study|Physician Decision|2
63521|NCT01077544|237076|P2|Overall Study|Disease Progression|1
63522|NCT01077544|237077|P1|Overall Study|Disease Progression|0
63523|NCT01077544|237076|P2|Overall Study|Adverse Event|1
63524|NCT01077544|237077|P1|Overall Study|Adverse Event|0
63525|NCT01077544|237076|P2|Overall Study|New Cancer Therapy|3
63526|NCT01077544|237077|P1|Overall Study|New Cancer Therapy|3
63527|NCT01077375|237105|P2|Overall Study|Other Reason|1
63528|NCT01077375|237106|P1|Overall Study|Other Reason|0
63529|NCT01077375|237105|P2|Overall Study|Lost to Follow-up|5
63530|NCT01077375|237106|P1|Overall Study|Lost to Follow-up|2
63531|NCT01077375|237105|P2|Overall Study|Withdrawal by Subject|6
63532|NCT01077375|237106|P1|Overall Study|Withdrawal by Subject|0
63533|NCT01077375|237105|P2|Overall Study|Lack of Efficacy|8
63534|NCT01077375|237106|P1|Overall Study|Lack of Efficacy|6
63535|NCT01077375|237105|P2|Overall Study|Adverse Event|15
63536|NCT01077375|237106|P1|Overall Study|Adverse Event|2
63537|NCT01077362|237117|P3|Overall Study|Not Specified|2
63538|NCT01077362|237118|P2|Overall Study|Not Specified|1
63539|NCT01077362|237119|P1|Overall Study|Not Specified|0
63540|NCT01077362|237117|P3|Overall Study|Withdrawal by Subject|5
63541|NCT01077362|237118|P2|Overall Study|Withdrawal by Subject|3
63542|NCT01077362|237119|P1|Overall Study|Withdrawal by Subject|5
63543|NCT01077362|237117|P3|Overall Study|Adverse Event|4
63544|NCT01077362|237118|P2|Overall Study|Adverse Event|7
63545|NCT01077362|237119|P1|Overall Study|Adverse Event|12
63546|NCT01077362|237117|P3|Overall Study|Lost to Follow-up|3
63547|NCT01077362|237118|P2|Overall Study|Lost to Follow-up|0
63548|NCT01077362|237119|P1|Overall Study|Lost to Follow-up|1
63549|NCT01077362|237117|P3|Overall Study|Lack of Efficacy|10
63550|NCT01077362|237118|P2|Overall Study|Lack of Efficacy|8
63551|NCT01077362|237119|P1|Overall Study|Lack of Efficacy|13
63552|NCT01077323|237155|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
63553|NCT01077323|237156|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
63554|NCT01077323|237157|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
63555|NCT01077323|237155|P3|Overall Study|Dispensing of drug in baseline period|256446
63556|NCT01077323|237156|P2|Overall Study|Dispensing of drug in baseline period|120229
63557|NCT01077323|237157|P1|Overall Study|Dispensing of drug in baseline period|0
63558|NCT01077323|237155|P3|Overall Study|<9 months enroll before drug dispensed|11655523
63559|NCT01077323|237156|P2|Overall Study|<9 months enroll before drug dispensed|263954
63560|NCT01077323|237157|P1|Overall Study|<9 months enroll before drug dispensed|11226
63561|NCT01077284|237196|P3|Overall Study|Other|1
63562|NCT01077284|237197|P2|Overall Study|Other|0
63563|NCT01077284|237198|P1|Overall Study|Other|0
63564|NCT01077284|237196|P3|Overall Study|Withdrawal by Subject|1
63565|NCT01077284|237197|P2|Overall Study|Withdrawal by Subject|3
63566|NCT01077284|237198|P1|Overall Study|Withdrawal by Subject|2
63567|NCT01077284|237196|P3|Overall Study|Lost to Follow-up|0
63568|NCT01077284|237197|P2|Overall Study|Lost to Follow-up|2
63569|NCT01077284|237198|P1|Overall Study|Lost to Follow-up|1
63570|NCT01077284|237196|P3|Overall Study|Adverse Event|1
63571|NCT01077284|237197|P2|Overall Study|Adverse Event|0
63572|NCT01077284|237198|P1|Overall Study|Adverse Event|2
63573|NCT01077271|237219|P1|Overall Study|Mother unconvinced of the necessity|1
63574|NCT01077271|237219|P1|Overall Study|End of RSV season nearly reached|1
63575|NCT01077271|237219|P1|Overall Study|Parents thought too many injections|2
63576|NCT01077271|237219|P1|Overall Study|Changed doctors|2
63577|NCT01077271|237219|P1|Overall Study|Quota used up (insurance reimb issue)|2
63578|NCT01077271|237219|P1|Overall Study|Noncompliance|2
63579|NCT01077271|237219|P1|Overall Study|Screen failure, did not take palivizumab|4
63580|NCT01077271|237219|P1|Overall Study|Parental desire|8
63581|NCT01077258|237257|P1|Overall Study|Other reasons|260
63582|NCT01077258|237257|P1|Overall Study|Clinical remission|37
63583|NCT01077258|237257|P1|Overall Study|Lack of Efficacy|663
63584|NCT01077258|237257|P1|Overall Study|Adverse drug reaction|218
63585|NCT01077258|237257|P1|Overall Study|Lost to Follow-up|1390
63586|NCT01077193|237293|P1|Overall Study|Study Terminated by Sponsor|40
63587|NCT01077193|237293|P1|Overall Study|Lack of Efficacy|1
63588|NCT01077193|237293|P1|Overall Study|Withdrawal by Subject|2
63589|NCT01077193|237293|P1|Overall Study|Lost to Follow-up|1
63590|NCT01077128|237297|P1|Overall Study|Not available|54
63591|NCT01077128|237297|P1|Overall Study|Lack of efficacy/disease exacerbation|1
63592|NCT01077128|237297|P1|Overall Study|Adverse event and disease exacerbation|1
63593|NCT01077128|237297|P1|Overall Study|Adverse event and consent withdrawal|1
63594|NCT01077128|237297|P1|Overall Study|Disease exacerbation|1
63595|NCT01077128|237297|P1|Overall Study|Lack of Efficacy|1
63596|NCT01077128|237297|P1|Overall Study|Adverse Event|8
63597|NCT01077076|237355|P6|Third Intervention|Death in the participant's family|1
63598|NCT01077076|237356|P5|Third Intervention|Death in the participant's family|0
63599|NCT01077076|237357|P4|Third Intervention|Death in the participant's family|0
63600|NCT01077076|237358|P3|Third Intervention|Death in the participant's family|0
63601|NCT01077076|237359|P2|Third Intervention|Death in the participant's family|0
63602|NCT01077076|237360|P1|Third Intervention|Death in the participant's family|0
63603|NCT01077076|237355|P6|First Intervention|Withdrawal by Subject|0
63604|NCT01077076|237356|P5|First Intervention|Withdrawal by Subject|0
63605|NCT01077076|237357|P4|First Intervention|Withdrawal by Subject|0
63606|NCT01077076|237358|P3|First Intervention|Withdrawal by Subject|0
63607|NCT01077076|237359|P2|First Intervention|Withdrawal by Subject|0
63608|NCT01077076|237360|P1|First Intervention|Withdrawal by Subject|1
63609|NCT01077063|237370|P2|Overall Study|Withdrawal by Subject|2
63610|NCT01077063|237371|P1|Overall Study|Withdrawal by Subject|0
63611|NCT01077063|237370|P2|Overall Study|Death|1
63612|NCT01077063|237371|P1|Overall Study|Death|1
63613|NCT01077063|237370|P2|Overall Study|Adverse Event|0
63614|NCT01077063|237371|P1|Overall Study|Adverse Event|3
63615|NCT01077050|237377|P1|Overall Study|Screen failure|8
63616|NCT01077050|237377|P1|Overall Study|Subjects signed ICF could not be located|1
63617|NCT01077024|237383|P2|Overall Study|unspecified|4
63618|NCT01077024|237384|P1|Overall Study|unspecified|4
63619|NCT01077024|237383|P2|Overall Study|Incarcerated|8
63620|NCT01077024|237384|P1|Overall Study|Incarcerated|7
63621|NCT01077024|237383|P2|Overall Study|Withdrawal by Subject|2
63622|NCT01077024|237384|P1|Overall Study|Withdrawal by Subject|0
63623|NCT01077024|237383|P2|Overall Study|Lost to Follow-up|14
63624|NCT01077024|237384|P1|Overall Study|Lost to Follow-up|20
63625|NCT01076959|237423|P1|Overall Study|Other|119
63626|NCT01076959|237423|P1|Overall Study|Lost to Follow-up|241
63627|NCT01076959|237423|P1|Overall Study|Non-compliance|274
63628|NCT01076959|237423|P1|Overall Study|Lack of Efficacy|849
63629|NCT01076959|237423|P1|Overall Study|Adverse Event|767
63630|NCT01076647|237459|P2|Overall Study|Unclassified|12
63631|NCT01076647|237460|P1|Overall Study|Unclassified|12
63632|NCT01076647|237459|P2|Overall Study|Withdrawal criteria|2
63633|NCT01076647|237460|P1|Overall Study|Withdrawal criteria|2
63634|NCT01076647|237459|P2|Overall Study|Protocol Violation|9
63635|NCT01076647|237460|P1|Overall Study|Protocol Violation|7
63636|NCT01076647|237459|P2|Overall Study|Lack of Efficacy|1
63637|NCT01076647|237460|P1|Overall Study|Lack of Efficacy|0
63638|NCT01076647|237459|P2|Overall Study|Adverse Event|1
63639|NCT01076647|237460|P1|Overall Study|Adverse Event|4
63640|NCT01076361|237491|P1|Overall Study|22 leads were excluded from analysis|21
63641|NCT01076335|237499|P1|Overall Study|Withdrawal without treatment|1
63642|NCT01076335|237499|P1|Overall Study|Withdrawal by Subject|3
63643|NCT01076192|237546|P1|Overall Study|Not specified|197
63644|NCT01076166|237561|P1|Overall Study|Symptoms improved/resolved|6
63645|NCT01076166|237561|P1|Overall Study|Adverse Event|3
63646|NCT01076153|237568|P1|Overall Study|Adverse Event|1
63647|NCT01076153|237568|P1|Overall Study|Symptoms improved/resolved|10
63648|NCT01076088|237582|P6|Overall Study|Other protocol specified criteria|1
63649|NCT01076088|237583|P5|Overall Study|Other protocol specified criteria|0
63650|NCT01076088|237584|P4|Overall Study|Other protocol specified criteria|0
63651|NCT01076088|237585|P3|Overall Study|Other protocol specified criteria|0
63652|NCT01076088|237586|P2|Overall Study|Other protocol specified criteria|0
63653|NCT01076088|237587|P1|Overall Study|Other protocol specified criteria|0
63654|NCT01076088|237582|P6|Overall Study|Withdrawal by Subject|17
63655|NCT01076088|237583|P5|Overall Study|Withdrawal by Subject|11
63656|NCT01076088|237584|P4|Overall Study|Withdrawal by Subject|10
63657|NCT01076088|237585|P3|Overall Study|Withdrawal by Subject|14
63658|NCT01076088|237586|P2|Overall Study|Withdrawal by Subject|8
63659|NCT01076088|237587|P1|Overall Study|Withdrawal by Subject|8
63660|NCT01076088|237582|P6|Overall Study|Physician Decision|0
63661|NCT01076088|237583|P5|Overall Study|Physician Decision|1
63662|NCT01076088|237584|P4|Overall Study|Physician Decision|1
63663|NCT01076088|237585|P3|Overall Study|Physician Decision|0
63664|NCT01076088|237586|P2|Overall Study|Physician Decision|3
63665|NCT01076088|237587|P1|Overall Study|Physician Decision|1
63666|NCT01076088|237582|P6|Overall Study|Non-compliance with study drug|0
63667|NCT01076088|237583|P5|Overall Study|Non-compliance with study drug|0
63668|NCT01076088|237584|P4|Overall Study|Non-compliance with study drug|1
63669|NCT01076088|237585|P3|Overall Study|Non-compliance with study drug|0
63670|NCT01076088|237586|P2|Overall Study|Non-compliance with study drug|0
63671|NCT01076088|237587|P1|Overall Study|Non-compliance with study drug|0
63672|NCT01076088|237582|P6|Overall Study|Lost to Follow-up|2
63673|NCT01076088|237583|P5|Overall Study|Lost to Follow-up|1
63674|NCT01076088|237584|P4|Overall Study|Lost to Follow-up|1
63675|NCT01076088|237585|P3|Overall Study|Lost to Follow-up|0
63676|NCT01076088|237586|P2|Overall Study|Lost to Follow-up|1
63677|NCT01076088|237587|P1|Overall Study|Lost to Follow-up|1
63678|NCT01076088|237582|P6|Overall Study|Adverse Event|3
63679|NCT01076088|237583|P5|Overall Study|Adverse Event|3
63680|NCT01076088|237584|P4|Overall Study|Adverse Event|2
63681|NCT01076088|237585|P3|Overall Study|Adverse Event|3
63682|NCT01076088|237586|P2|Overall Study|Adverse Event|6
63683|NCT01076088|237587|P1|Overall Study|Adverse Event|1
63684|NCT01076075|237615|P2|Overall Study|Withdrawal by Subject|19
63685|NCT01076075|237616|P1|Overall Study|Withdrawal by Subject|8
63686|NCT01076075|237615|P2|Overall Study|Protocol Violation|1
63687|NCT01076075|237616|P1|Overall Study|Protocol Violation|0
63688|NCT01076075|237615|P2|Overall Study|other|9
63689|NCT01076075|237616|P1|Overall Study|other|19
63690|NCT01076075|237615|P2|Overall Study|Lost to Follow-up|5
63691|NCT01076075|237616|P1|Overall Study|Lost to Follow-up|6
63692|NCT01076075|237615|P2|Overall Study|Lack of Efficacy|4
63693|NCT01076075|237616|P1|Overall Study|Lack of Efficacy|5
63694|NCT01076075|237615|P2|Overall Study|Adverse Event|9
63695|NCT01076075|237616|P1|Overall Study|Adverse Event|3
63696|NCT01076036|237630|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
63697|NCT01075984|237640|P5|Follow-up Phase|Treatment failure|4
63698|NCT01075984|237641|P4|Follow-up Phase|Treatment failure|0
63699|NCT01075984|237642|P3|Follow-up Phase|Treatment failure|0
63700|NCT01075984|237643|P2|Follow-up Phase|Treatment failure|0
63701|NCT01075984|237644|P1|Follow-up Phase|Treatment failure|0
63702|NCT01075984|237640|P5|Follow-up Phase|Progression of disease|2
63703|NCT01075984|237641|P4|Follow-up Phase|Progression of disease|0
63704|NCT01075984|237642|P3|Follow-up Phase|Progression of disease|0
63705|NCT01075984|237643|P2|Follow-up Phase|Progression of disease|0
63706|NCT01075984|237644|P1|Follow-up Phase|Progression of disease|0
63707|NCT01075984|237640|P5|Follow-up Phase|Withdrawal by Subject|10
63708|NCT01075984|237641|P4|Follow-up Phase|Withdrawal by Subject|0
63709|NCT01075984|237642|P3|Follow-up Phase|Withdrawal by Subject|0
63710|NCT01075984|237643|P2|Follow-up Phase|Withdrawal by Subject|0
63711|NCT01075984|237644|P1|Follow-up Phase|Withdrawal by Subject|0
63712|NCT01075984|237640|P5|Follow-up Phase|Administrative|1
63713|NCT01075984|237641|P4|Follow-up Phase|Administrative|0
63714|NCT01075984|237642|P3|Follow-up Phase|Administrative|0
63715|NCT01075984|237643|P2|Follow-up Phase|Administrative|0
63716|NCT01075984|237644|P1|Follow-up Phase|Administrative|0
63717|NCT01075984|237640|P5|Follow-up Phase|Adverse Event|27
63718|NCT01075984|237641|P4|Follow-up Phase|Adverse Event|2
63719|NCT01075984|237642|P3|Follow-up Phase|Adverse Event|0
63720|NCT01075984|237643|P2|Follow-up Phase|Adverse Event|0
63721|NCT01075984|237644|P1|Follow-up Phase|Adverse Event|0
63722|NCT01075984|237640|P5|Follow-up Phase|Protocol Violation|3
63723|NCT01075984|237641|P4|Follow-up Phase|Protocol Violation|0
63724|NCT01075984|237642|P3|Follow-up Phase|Protocol Violation|1
63725|NCT01075984|237643|P2|Follow-up Phase|Protocol Violation|0
63726|NCT01075984|237644|P1|Follow-up Phase|Protocol Violation|0
63727|NCT01075984|237640|P5|Treatment Phase|Progression of disease|2
63728|NCT01075984|237641|P4|Treatment Phase|Progression of disease|0
63729|NCT01075984|237642|P3|Treatment Phase|Progression of disease|0
63730|NCT01075984|237643|P2|Treatment Phase|Progression of disease|0
63731|NCT01075984|237644|P1|Treatment Phase|Progression of disease|0
63732|NCT01075984|237640|P5|Treatment Phase|Treatment Failure|5
63733|NCT01075984|237641|P4|Treatment Phase|Treatment Failure|0
63734|NCT01075984|237642|P3|Treatment Phase|Treatment Failure|1
63735|NCT01075984|237643|P2|Treatment Phase|Treatment Failure|0
63736|NCT01075984|237644|P1|Treatment Phase|Treatment Failure|0
63737|NCT01075984|237640|P5|Treatment Phase|Withdrawal by Subject|15
63738|NCT01075984|237641|P4|Treatment Phase|Withdrawal by Subject|0
63739|NCT01075984|237642|P3|Treatment Phase|Withdrawal by Subject|2
63740|NCT01075984|237643|P2|Treatment Phase|Withdrawal by Subject|0
63741|NCT01075984|237644|P1|Treatment Phase|Withdrawal by Subject|0
63742|NCT01075984|237640|P5|Treatment Phase|Protocol Violation|3
63743|NCT01075984|237641|P4|Treatment Phase|Protocol Violation|0
63744|NCT01075984|237642|P3|Treatment Phase|Protocol Violation|1
63745|NCT01075984|237643|P2|Treatment Phase|Protocol Violation|0
63746|NCT01075984|237644|P1|Treatment Phase|Protocol Violation|0
63747|NCT01075984|237640|P5|Treatment Phase|Adverse Event|35
63748|NCT01075984|237641|P4|Treatment Phase|Adverse Event|7
63749|NCT01075984|237642|P3|Treatment Phase|Adverse Event|3
63750|NCT01075984|237643|P2|Treatment Phase|Adverse Event|1
63751|NCT01075984|237644|P1|Treatment Phase|Adverse Event|0
63752|NCT01075958|237702|P1|Overall Study|Blood sample could not be obtained|44
63753|NCT01075815|237718|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
63754|NCT01075815|237719|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
63755|NCT01075815|237718|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
63756|NCT01075815|237719|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
63757|NCT01075815|237718|P2|Overall Study|Withdrawal before r-hCG administration|1
63758|NCT01075815|237719|P1|Overall Study|Withdrawal before r-hCG administration|6
63759|NCT01075763|237757|P2|Overall Study|Withdrawal by Subject|2
63760|NCT01075763|237758|P1|Overall Study|Withdrawal by Subject|2
63761|NCT01075763|237757|P2|Overall Study|Lack of Efficacy|1
63762|NCT01075763|237758|P1|Overall Study|Lack of Efficacy|0
63763|NCT01075763|237757|P2|Overall Study|Lost to Follow-up|1
63764|NCT01075763|237758|P1|Overall Study|Lost to Follow-up|2
63765|NCT01075685|237782|P2|Overall Study|Lost to Follow-up|220
63766|NCT01075685|237783|P1|Overall Study|Lost to Follow-up|563
63767|NCT01075685|237782|P2|Overall Study|Withdrawal by Subject|5
63768|NCT01075685|237783|P1|Overall Study|Withdrawal by Subject|20
63769|NCT01075685|237782|P2|Overall Study|Protocol Violation|1
63770|NCT01075685|237783|P1|Overall Study|Protocol Violation|9
63771|NCT01075646|237799|P4|Overall Study|Lost to Follow-up|2
63772|NCT01075646|237800|P3|Overall Study|Lost to Follow-up|1
63773|NCT01075646|237801|P2|Overall Study|Lost to Follow-up|3
63774|NCT01075646|237802|P1|Overall Study|Lost to Follow-up|4
63775|NCT01075282|237850|P3|Overall Study|Death|2
63776|NCT01075282|237851|P2|Overall Study|Death|1
63777|NCT01075282|237852|P1|Overall Study|Death|0
63778|NCT01075282|237850|P3|Overall Study|Protocol Violation|1
63779|NCT01075282|237851|P2|Overall Study|Protocol Violation|2
63780|NCT01075282|237852|P1|Overall Study|Protocol Violation|0
63781|NCT01075282|237850|P3|Overall Study|Treatment Non-compliance|2
63782|NCT01075282|237851|P2|Overall Study|Treatment Non-compliance|2
63783|NCT01075282|237852|P1|Overall Study|Treatment Non-compliance|1
63784|NCT01075282|237850|P3|Overall Study|Lack of Efficacy|0
63785|NCT01075282|237851|P2|Overall Study|Lack of Efficacy|1
63786|NCT01075282|237852|P1|Overall Study|Lack of Efficacy|1
63787|NCT01075282|237850|P3|Overall Study|Physician Decision|3
63788|NCT01075282|237851|P2|Overall Study|Physician Decision|3
63789|NCT01075282|237852|P1|Overall Study|Physician Decision|3
63790|NCT01075282|237850|P3|Overall Study|Lost to Follow-up|3
63791|NCT01075282|237851|P2|Overall Study|Lost to Follow-up|3
63792|NCT01075282|237852|P1|Overall Study|Lost to Follow-up|3
63793|NCT01075282|237850|P3|Overall Study|Entry Criteria Not Met|0
63794|NCT01075282|237851|P2|Overall Study|Entry Criteria Not Met|2
63795|NCT01075282|237852|P1|Overall Study|Entry Criteria Not Met|3
63796|NCT01075282|237850|P3|Overall Study|Adverse Event|5
63797|NCT01075282|237851|P2|Overall Study|Adverse Event|8
63798|NCT01075282|237852|P1|Overall Study|Adverse Event|9
63799|NCT01075282|237850|P3|Overall Study|Withdrawal by Subject|11
63800|NCT01075282|237851|P2|Overall Study|Withdrawal by Subject|7
63801|NCT01075282|237852|P1|Overall Study|Withdrawal by Subject|11
63802|NCT01075256|237935|P3|Overall Study|Withdrawal by Subject|0
63803|NCT01075256|237936|P2|Overall Study|Withdrawal by Subject|0
63804|NCT01075256|237937|P1|Overall Study|Withdrawal by Subject|1
63805|NCT01075243|237969|P3|Overall Study|Withdrawal by Subject|0
63806|NCT01075243|237970|P2|Overall Study|Withdrawal by Subject|1
63807|NCT01075243|237971|P1|Overall Study|Withdrawal by Subject|1
63808|NCT01075243|237969|P3|Overall Study|Lost to Follow-up|0
63809|NCT01075243|237970|P2|Overall Study|Lost to Follow-up|2
63810|NCT01075243|237971|P1|Overall Study|Lost to Follow-up|5
63811|NCT01075217|238023|P2|Overall Study|Physician Decision|0
63812|NCT01075217|238024|P1|Overall Study|Physician Decision|1
63813|NCT01075217|238023|P2|Overall Study|Adverse Event|1
63814|NCT01075217|238024|P1|Overall Study|Adverse Event|1
63815|NCT01075191|238057|P1|Overall Study|Unknown Reasons|1
63816|NCT01075191|238057|P1|Overall Study|Patient's Wish|2
63817|NCT01075191|238057|P1|Overall Study|Therapy Break|3
63818|NCT01075191|238057|P1|Overall Study|Noncompliance|3
63819|NCT01075191|238057|P1|Overall Study|Adverse Event|4
63820|NCT01075191|238057|P1|Overall Study|Co-morbidities|1
63821|NCT01075191|238057|P1|Overall Study|Intensification|3
63822|NCT01075191|238057|P1|Overall Study|Death|1
63823|NCT01075178|238068|P2|Subject Chart Review|matched partner excluded (reasons above)|3
63824|NCT01075178|238069|P1|Subject Chart Review|matched partner excluded (reasons above)|6
63825|NCT01075178|238068|P2|Subject Chart Review|no data collected due to site closure|4
63826|NCT01075178|238069|P1|Subject Chart Review|no data collected due to site closure|3
63827|NCT01075178|238068|P2|Subject Chart Review|died before chart review period|2
63828|NCT01075178|238069|P1|Subject Chart Review|died before chart review period|0
63829|NCT01075178|238068|P2|Subject Matching|eligible but not matched|403
63830|NCT01075178|238069|P1|Subject Matching|eligible but not matched|130
63831|NCT01075152|238083|P2|Overall Study|Withdrawal by Subject|0
63832|NCT01075152|238084|P1|Overall Study|Withdrawal by Subject|1
63833|NCT01075100|238110|P2|Overall Study|Other|1
63834|NCT01075100|238111|P1|Overall Study|Other|3
63835|NCT01075100|238110|P2|Overall Study|Disease Progression|29
63836|NCT01075100|238111|P1|Overall Study|Disease Progression|25
63837|NCT01075100|238110|P2|Overall Study|Investigator Request|1
63838|NCT01075100|238111|P1|Overall Study|Investigator Request|2
63839|NCT01075100|238110|P2|Overall Study|Patient Request|4
63840|NCT01075100|238111|P1|Overall Study|Patient Request|4
63841|NCT01075100|238110|P2|Overall Study|Adverse Event|18
63842|NCT01075100|238111|P1|Overall Study|Adverse Event|15
63843|NCT01075074|238141|P3|Overall Study|Surgeon changed to open incisional case|2
63844|NCT01075074|238142|P2|Overall Study|Surgeon changed to open incisional case|2
63845|NCT01075074|238143|P1|Overall Study|Surgeon changed to open incisional case|1
63846|NCT01074944|238160|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
63847|NCT01074944|238161|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
63848|NCT01074944|238162|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
63849|NCT01074944|238163|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
63850|NCT01074944|238164|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
63851|NCT01074944|238160|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
63852|NCT01074944|238161|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
63853|NCT01074944|238162|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
63854|NCT01074944|238163|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
63855|NCT01074944|238164|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
63856|NCT01074944|238160|P5|Long Term Treatment|Withdrawal by Subject|0
63857|NCT01074944|238161|P4|Long Term Treatment|Withdrawal by Subject|2
63858|NCT01074944|238162|P3|Long Term Treatment|Withdrawal by Subject|0
63859|NCT01074944|238163|P2|Long Term Treatment|Withdrawal by Subject|0
63860|NCT01074944|238164|P1|Long Term Treatment|Withdrawal by Subject|0
63861|NCT01074944|238160|P5|Long Term Treatment|Entered in Period, But Not Treated|0
63862|NCT01074944|238161|P4|Long Term Treatment|Entered in Period, But Not Treated|1
63863|NCT01074944|238162|P3|Long Term Treatment|Entered in Period, But Not Treated|0
63864|NCT01074944|238163|P2|Long Term Treatment|Entered in Period, But Not Treated|0
63865|NCT01074944|238164|P1|Long Term Treatment|Entered in Period, But Not Treated|0
63866|NCT01074944|238160|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
63867|NCT01074944|238161|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
63868|NCT01074944|238162|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
63869|NCT01074944|238163|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
63870|NCT01074944|238164|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
63871|NCT01074944|238160|P5|Long Term Treatment|Lost to Follow-up|0
63872|NCT01074944|238161|P4|Long Term Treatment|Lost to Follow-up|2
63873|NCT01074944|238162|P3|Long Term Treatment|Lost to Follow-up|0
63874|NCT01074944|238163|P2|Long Term Treatment|Lost to Follow-up|0
63875|NCT01074944|238164|P1|Long Term Treatment|Lost to Follow-up|0
63876|NCT01074944|238160|P5|Long Term Treatment|Adverse Event|0
63877|NCT01074944|238161|P4|Long Term Treatment|Adverse Event|3
63878|NCT01074944|238162|P3|Long Term Treatment|Adverse Event|0
63879|NCT01074944|238163|P2|Long Term Treatment|Adverse Event|0
63880|NCT01074944|238164|P1|Long Term Treatment|Adverse Event|0
63881|NCT01074944|238160|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
63882|NCT01074944|238161|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
63883|NCT01074944|238162|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
63884|NCT01074944|238163|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
63885|NCT01074944|238164|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
63886|NCT01074944|238160|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
63887|NCT01074944|238161|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
63888|NCT01074944|238162|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
63889|NCT01074944|238163|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
63890|NCT01074944|238164|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
63891|NCT01074944|238160|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
63892|NCT01074944|238161|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
63893|NCT01074944|238162|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
63894|NCT01074944|238163|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
63895|NCT01074944|238164|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
63896|NCT01074944|238160|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
63897|NCT01074944|238161|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
63898|NCT01074944|238162|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
63899|NCT01074944|238163|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
63900|NCT01074944|238164|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
63901|NCT01074944|238160|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
63902|NCT01074944|238161|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
63903|NCT01074944|238162|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
63904|NCT01074944|238163|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
63905|NCT01074944|238164|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
63906|NCT01074944|238160|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
63907|NCT01074944|238161|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
63908|NCT01074944|238162|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
63909|NCT01074944|238163|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
63910|NCT01074944|238164|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
63911|NCT01074944|238160|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
63912|NCT01074944|238161|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
63913|NCT01074944|238162|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
63914|NCT01074944|238163|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
63915|NCT01074944|238164|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
63916|NCT01074944|238160|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
63917|NCT01074944|238161|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
63918|NCT01074944|238162|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
63919|NCT01074944|238163|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
63920|NCT01074944|238164|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
63921|NCT01074944|238160|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
63922|NCT01074944|238161|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
63923|NCT01074944|238162|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
63924|NCT01074944|238163|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
63925|NCT01074944|238164|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
63926|NCT01074931|238218|P1|Overall Study|Death|5
63927|NCT01074931|238218|P1|Overall Study|Economic reasons|1
63928|NCT01074658|238230|P1|Overall Study|No implant attempted|19
63929|NCT01074554|238238|P2|Overall Study|Lost to Follow-up|1
63930|NCT01074554|238239|P1|Overall Study|Lost to Follow-up|0
63931|NCT01074554|238238|P2|Overall Study|Adverse Event|3
63932|NCT01074554|238239|P1|Overall Study|Adverse Event|3
63933|NCT01074502|238249|P1|Overall Study|Withdrawal by Subject|1
63934|NCT01074450|238273|P2|Second Intervention|Physician Decision|1
63935|NCT01074450|238274|P1|Second Intervention|Physician Decision|0
63936|NCT01074450|238273|P2|Second Intervention|Protocol Violation|0
63937|NCT01074450|238274|P1|Second Intervention|Protocol Violation|1
63938|NCT01074450|238273|P2|First Intervention|Emesis in Dosing Interval|2
63939|NCT01074450|238274|P1|First Intervention|Emesis in Dosing Interval|0
63940|NCT01074307|238295|P2|Overall Study|Protocol Violation|5
63941|NCT01074307|238296|P1|Overall Study|Protocol Violation|8
63942|NCT01074307|238295|P2|Overall Study|Exclusion criterion|1
63943|NCT01074307|238296|P1|Overall Study|Exclusion criterion|0
63944|NCT01074307|238295|P2|Overall Study|No primary endpoint evaluation|6
63945|NCT01074307|238296|P1|Overall Study|No primary endpoint evaluation|14
63946|NCT01074268|238318|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
63947|NCT01074268|238319|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
63948|NCT01074268|238318|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
63949|NCT01074268|238319|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
63950|NCT01074268|238318|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
63951|NCT01074268|238319|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
63952|NCT01074268|238318|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
63953|NCT01074268|238319|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
63954|NCT01074268|238318|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
63955|NCT01074268|238319|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
63956|NCT01074268|238318|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
63957|NCT01074268|238319|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
63958|NCT01074268|238318|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
63959|NCT01074268|238319|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
63960|NCT01074268|238318|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
63961|NCT01074268|238319|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
63962|NCT01074268|238318|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
63963|NCT01074268|238319|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
63964|NCT01074255|238345|P1|Overall Study|Did not receive EMEND|2
63965|NCT01074242|238349|P1|Overall Study|Duplicate Case Report Form|5
63966|NCT01074242|238349|P1|Overall Study|Violation of vaccine dose or dosage|351
63967|NCT01074242|238349|P1|Overall Study|Case report unclear|6
63968|NCT01074242|238349|P1|Overall Study|Lost to Follow-up|1
63969|NCT01074242|238349|P1|Overall Study|Case report before date of contract|40
63970|NCT01074229|238357|P3|Overall Study|Change to open surgical procedure|4
63971|NCT01074229|238358|P2|Overall Study|Change to open surgical procedure|3
63972|NCT01074229|238359|P1|Overall Study|Change to open surgical procedure|1
63973|NCT01074229|238357|P3|Overall Study|Lost to Follow-up|0
63974|NCT01074229|238358|P2|Overall Study|Lost to Follow-up|0
63975|NCT01074229|238359|P1|Overall Study|Lost to Follow-up|1
63976|NCT01074216|238370|P1|Overall Study|Not Treated|12
63977|NCT01074216|238370|P1|Overall Study|Physician Decision|1
63978|NCT01074047|238427|P2|Survival Follow-Up Phase|Those who remain alive at study closure|3
63979|NCT01074047|238428|P1|Survival Follow-Up Phase|Those who remain alive at study closure|1
63980|NCT01074047|238427|P2|Survival Follow-Up Phase|Death|124
63981|NCT01074047|238428|P1|Survival Follow-Up Phase|Death|116
63982|NCT01074047|238427|P2|Survival Follow-Up Phase|Lost to Follow-up|1
63983|NCT01074047|238428|P1|Survival Follow-Up Phase|Lost to Follow-up|2
63984|NCT01074047|238427|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
63985|NCT01074047|238428|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
63986|NCT01074047|238427|P2|Treatment Phase|Unspecified|39
63987|NCT01074047|238428|P1|Treatment Phase|Unspecified|32
63988|NCT01074047|238427|P2|Treatment Phase|Protocol Violation|1
63989|NCT01074047|238428|P1|Treatment Phase|Protocol Violation|0
63990|NCT01074047|238427|P2|Treatment Phase|Study closure|13
63991|NCT01074047|238428|P1|Treatment Phase|Study closure|24
63992|NCT01074047|238427|P2|Treatment Phase|Lost to Follow-up|1
63993|NCT01074047|238428|P1|Treatment Phase|Lost to Follow-up|0
63994|NCT01074047|238427|P2|Treatment Phase|Death|58
63995|NCT01074047|238428|P1|Treatment Phase|Death|53
63996|NCT01074047|238427|P2|Treatment Phase|Withdrawal by Subject|48
63997|NCT01074047|238428|P1|Treatment Phase|Withdrawal by Subject|27
63998|NCT01074047|238427|P2|Treatment Phase|Disease progression|21
63999|NCT01074047|238428|P1|Treatment Phase|Disease progression|16
64000|NCT01074047|238427|P2|Treatment Phase|Adverse Event|66
64001|NCT01074047|238428|P1|Treatment Phase|Adverse Event|89
64002|NCT01074008|238509|P9|Overall Study|Lost to Follow-up|4
64003|NCT01074008|238510|P8|Overall Study|Lost to Follow-up|0
64004|NCT01074008|238511|P7|Overall Study|Lost to Follow-up|1
64005|NCT01074008|238512|P6|Overall Study|Lost to Follow-up|0
64006|NCT01074008|238513|P5|Overall Study|Lost to Follow-up|1
64007|NCT01074008|238514|P4|Overall Study|Lost to Follow-up|1
64008|NCT01074008|238515|P3|Overall Study|Lost to Follow-up|1
64009|NCT01074008|238516|P2|Overall Study|Lost to Follow-up|1
64010|NCT01074008|238517|P1|Overall Study|Lost to Follow-up|0
64011|NCT01074008|238509|P9|Overall Study|Withdrawal by Subject|0
64012|NCT01074008|238510|P8|Overall Study|Withdrawal by Subject|0
64013|NCT01074008|238511|P7|Overall Study|Withdrawal by Subject|0
64014|NCT01074008|238512|P6|Overall Study|Withdrawal by Subject|0
64015|NCT01074008|238513|P5|Overall Study|Withdrawal by Subject|1
64016|NCT01074008|238514|P4|Overall Study|Withdrawal by Subject|0
64017|NCT01074008|238515|P3|Overall Study|Withdrawal by Subject|1
64018|NCT01074008|238516|P2|Overall Study|Withdrawal by Subject|1
64019|NCT01074008|238517|P1|Overall Study|Withdrawal by Subject|1
64020|NCT01074008|238509|P9|Overall Study|Adverse Event|0
64021|NCT01074008|238510|P8|Overall Study|Adverse Event|0
64022|NCT01074008|238511|P7|Overall Study|Adverse Event|0
64023|NCT01074008|238512|P6|Overall Study|Adverse Event|0
64024|NCT01074008|238513|P5|Overall Study|Adverse Event|0
64025|NCT01074008|238514|P4|Overall Study|Adverse Event|0
64026|NCT01074008|238515|P3|Overall Study|Adverse Event|0
64027|NCT01074008|238516|P2|Overall Study|Adverse Event|1
64028|NCT01074008|238517|P1|Overall Study|Adverse Event|0
64029|NCT01073943|238627|P2|Overall Study|Could not tolerate prep|0
64030|NCT01073943|238628|P1|Overall Study|Could not tolerate prep|1
64031|NCT01073943|238627|P2|Overall Study|Unable to return for follow-up|1
64032|NCT01073943|238628|P1|Overall Study|Unable to return for follow-up|0
64033|NCT01073943|238627|P2|Overall Study|Subject forgot|1
64034|NCT01073943|238628|P1|Overall Study|Subject forgot|0
64035|NCT01073943|238627|P2|Overall Study|Power outage; colonoscopy not done|0
64036|NCT01073943|238628|P1|Overall Study|Power outage; colonoscopy not done|1
64037|NCT01073943|238627|P2|Overall Study|Lost to Follow-up|2
64038|NCT01073943|238628|P1|Overall Study|Lost to Follow-up|0
64039|NCT01073943|238627|P2|Overall Study|Adverse Event|1
64040|NCT01073943|238628|P1|Overall Study|Adverse Event|1
64041|NCT01073943|238627|P2|Overall Study|Protocol Violation|1
64042|NCT01073943|238628|P1|Overall Study|Protocol Violation|2
64043|NCT01073943|238627|P2|Overall Study|Withdrawal by Subject|2
64044|NCT01073943|238628|P1|Overall Study|Withdrawal by Subject|8
64045|NCT01073930|238654|P2|Overall Study|Inadequate prep; unable to do procedure|1
64046|NCT01073930|238655|P1|Overall Study|Inadequate prep; unable to do procedure|0
64047|NCT01073930|238654|P2|Overall Study|Noncompliance with study drug|1
64048|NCT01073930|238655|P1|Overall Study|Noncompliance with study drug|0
64049|NCT01073930|238654|P2|Overall Study|Adverse Event|1
64050|NCT01073930|238655|P1|Overall Study|Adverse Event|0
64051|NCT01073930|238654|P2|Overall Study|Lost to Follow-up|1
64052|NCT01073930|238655|P1|Overall Study|Lost to Follow-up|0
64053|NCT01073930|238654|P2|Overall Study|Withdrawal by Subject|2
64054|NCT01073930|238655|P1|Overall Study|Withdrawal by Subject|3
64055|NCT01073865|238679|P2|Overall Study|Withdrawal by Subject|5
64056|NCT01073865|238680|P1|Overall Study|Withdrawal by Subject|5
64057|NCT01073865|238679|P2|Overall Study|Death|2
64058|NCT01073865|238680|P1|Overall Study|Death|3
64059|NCT01073865|238679|P2|Overall Study|Lost to Follow-up|1
64060|NCT01073865|238680|P1|Overall Study|Lost to Follow-up|1
64061|NCT01073865|238679|P2|Overall Study|Reasons other than below|31
64062|NCT01073865|238680|P1|Overall Study|Reasons other than below|19
64063|NCT01073631|238699|P1|Overall Study|Unspecified|63
64064|NCT01073631|238699|P1|Overall Study|Adverse Event|24
64065|NCT01073631|238699|P1|Overall Study|Death|82
64066|NCT01073618|238704|P1|Overall Study|Unspecified|80
64067|NCT01073618|238704|P1|Overall Study|Adverse Event|19
64068|NCT01073618|238704|P1|Overall Study|Death|208
64069|NCT01073605|238712|P3|Overall Study|Randomized But Not Treated|1
64070|NCT01073605|238713|P2|Overall Study|Randomized But Not Treated|1
64071|NCT01073605|238714|P1|Overall Study|Randomized But Not Treated|0
64072|NCT01073605|238712|P3|Overall Study|Withdrawal by Subject|22
64073|NCT01073605|238713|P2|Overall Study|Withdrawal by Subject|39
64074|NCT01073605|238714|P1|Overall Study|Withdrawal by Subject|31
64075|NCT01073605|238712|P3|Overall Study|Other|29
64076|NCT01073605|238713|P2|Overall Study|Other|21
64077|NCT01073605|238714|P1|Overall Study|Other|25
64078|NCT01073605|238712|P3|Overall Study|Lost to Follow-up|9
64079|NCT01073605|238713|P2|Overall Study|Lost to Follow-up|4
64080|NCT01073605|238714|P1|Overall Study|Lost to Follow-up|3
64081|NCT01073605|238712|P3|Overall Study|Adverse Event|0
64082|NCT01073605|238713|P2|Overall Study|Adverse Event|1
64083|NCT01073605|238714|P1|Overall Study|Adverse Event|2
64084|NCT01073605|238712|P3|Overall Study|Ongoing at Cutoff Date|0
64085|NCT01073605|238713|P2|Overall Study|Ongoing at Cutoff Date|1
64086|NCT01073605|238714|P1|Overall Study|Ongoing at Cutoff Date|1
64087|NCT01073566|238760|P2|Period 2 (6 Weeks)|Adverse Event|0
64088|NCT01073566|238761|P1|Period 2 (6 Weeks)|Adverse Event|1
64089|NCT01073462|238773|P1|Overall Study|Lost to Follow-up|7
64090|NCT01073462|238773|P1|Overall Study|Serious adverse event|2
64091|NCT01073462|238773|P1|Overall Study|Low parathyroid hormone levels|8
64092|NCT01073462|238773|P1|Overall Study|Kidney transplant|10
64093|NCT01073462|238773|P1|Overall Study|Death|14
64094|NCT01073293|238792|P2|Overall Study|Withdrawal by Subject|10
64095|NCT01073293|238793|P1|Overall Study|Withdrawal by Subject|5
64096|NCT01073293|238792|P2|Overall Study|Lost to Follow-up|1
64097|NCT01073293|238793|P1|Overall Study|Lost to Follow-up|0
64098|NCT01073267|238815|P1|Overall Study|Disease Progression|3
64099|NCT01073163|238819|P1|Overall Study|Early termination|1
64100|NCT01073163|238819|P1|Overall Study|Disease Progression|1
64101|NCT01073163|238819|P1|Overall Study|Adverse Event|1
64102|NCT01072929|238842|P3|Overall Study|Not specified|0
64103|NCT01072929|238843|P2|Overall Study|Not specified|3
64104|NCT01072929|238844|P1|Overall Study|Not specified|0
64105|NCT01072929|238842|P3|Overall Study|Noncompliance with study procedures|1
64106|NCT01072929|238843|P2|Overall Study|Noncompliance with study procedures|0
64107|NCT01072929|238844|P1|Overall Study|Noncompliance with study procedures|1
64108|NCT01072929|238842|P3|Overall Study|Noncompliance with study medication|0
64109|NCT01072929|238843|P2|Overall Study|Noncompliance with study medication|3
64110|NCT01072929|238844|P1|Overall Study|Noncompliance with study medication|0
64111|NCT01072929|238842|P3|Overall Study|Lost to Follow-up|1
64112|NCT01072929|238843|P2|Overall Study|Lost to Follow-up|4
64113|NCT01072929|238844|P1|Overall Study|Lost to Follow-up|8
64114|NCT01072929|238842|P3|Overall Study|Protocol Violation|2
64115|NCT01072929|238843|P2|Overall Study|Protocol Violation|11
64116|NCT01072929|238844|P1|Overall Study|Protocol Violation|13
64117|NCT01072929|238842|P3|Overall Study|Withdrawal by Subject|3
64118|NCT01072929|238843|P2|Overall Study|Withdrawal by Subject|15
64119|NCT01072929|238844|P1|Overall Study|Withdrawal by Subject|7
64120|NCT01072929|238842|P3|Overall Study|Lack of Efficacy|0
64121|NCT01072929|238843|P2|Overall Study|Lack of Efficacy|4
64122|NCT01072929|238844|P1|Overall Study|Lack of Efficacy|7
64123|NCT01072929|238842|P3|Overall Study|Adverse Event|2
64124|NCT01072929|238843|P2|Overall Study|Adverse Event|11
64125|NCT01072929|238844|P1|Overall Study|Adverse Event|8
64126|NCT01072877|238923|P5|Overall Study|Lost to Follow-up|0
64127|NCT01072877|238924|P4|Overall Study|Lost to Follow-up|2
64128|NCT01072877|238925|P3|Overall Study|Lost to Follow-up|0
64129|NCT01072877|238926|P2|Overall Study|Lost to Follow-up|1
64130|NCT01072877|238927|P1|Overall Study|Lost to Follow-up|1
64131|NCT01072630|238987|P3|Overall Study|Not specified|1
64132|NCT01072630|238988|P2|Overall Study|Not specified|2
64133|NCT01072630|238989|P1|Overall Study|Not specified|3
64134|NCT01072630|238987|P3|Overall Study|Noncompliance with study procedures|1
64135|NCT01072630|238988|P2|Overall Study|Noncompliance with study procedures|2
64136|NCT01072630|238989|P1|Overall Study|Noncompliance with study procedures|1
64137|NCT01072630|238987|P3|Overall Study|Noncompliance with study medication|1
64138|NCT01072630|238988|P2|Overall Study|Noncompliance with study medication|1
64139|NCT01072630|238989|P1|Overall Study|Noncompliance with study medication|1
64140|NCT01072630|238987|P3|Overall Study|Lost to Follow-up|1
64141|NCT01072630|238988|P2|Overall Study|Lost to Follow-up|11
64142|NCT01072630|238989|P1|Overall Study|Lost to Follow-up|11
64143|NCT01072630|238987|P3|Overall Study|Protocol Violation|4
64144|NCT01072630|238988|P2|Overall Study|Protocol Violation|8
64145|NCT01072630|238989|P1|Overall Study|Protocol Violation|10
64146|NCT01072630|238987|P3|Overall Study|Withdrawal by Subject|2
64147|NCT01072630|238988|P2|Overall Study|Withdrawal by Subject|7
64148|NCT01072630|238989|P1|Overall Study|Withdrawal by Subject|8
64149|NCT01072630|238987|P3|Overall Study|Lack of Efficacy|1
64150|NCT01072630|238988|P2|Overall Study|Lack of Efficacy|10
64151|NCT01072630|238989|P1|Overall Study|Lack of Efficacy|10
64152|NCT01072630|238987|P3|Overall Study|Adverse Event|2
64153|NCT01072630|238988|P2|Overall Study|Adverse Event|19
64154|NCT01072630|238989|P1|Overall Study|Adverse Event|11
64155|NCT01072539|239063|P1|Overall Study|Protocol Violation|2
64156|NCT01072539|239063|P1|Overall Study|Treated prior to the Site Initiation|1
64157|NCT01072500|239087|P2|Overall Study|Withdrawal by Subject|10
64158|NCT01072500|239088|P1|Overall Study|Withdrawal by Subject|17
64159|NCT01072500|239087|P2|Overall Study|Lost to Follow-up|2
64160|NCT01072500|239088|P1|Overall Study|Lost to Follow-up|5
64161|NCT01072500|239087|P2|Overall Study|Death|2
64162|NCT01072500|239088|P1|Overall Study|Death|2
64163|NCT01072448|239098|P2|Overall Study|Death|2
64164|NCT01072448|239099|P1|Overall Study|Death|0
64165|NCT01072448|239098|P2|Overall Study|Abnormal laboratory value(s)|1
64166|NCT01072448|239099|P1|Overall Study|Abnormal laboratory value(s)|0
64167|NCT01072448|239098|P2|Overall Study|Lost to Follow-up|1
64168|NCT01072448|239099|P1|Overall Study|Lost to Follow-up|1
64169|NCT01072448|239098|P2|Overall Study|Unsatisfactory therapeutic effect|3
64170|NCT01072448|239099|P1|Overall Study|Unsatisfactory therapeutic effect|1
64171|NCT01072448|239098|P2|Overall Study|Abnormal test procedure result(s)|0
64172|NCT01072448|239099|P1|Overall Study|Abnormal test procedure result(s)|1
64173|NCT01072448|239098|P2|Overall Study|Protocol deviation|4
64174|NCT01072448|239099|P1|Overall Study|Protocol deviation|3
64175|NCT01072448|239098|P2|Overall Study|Subject withdrew consent|9
64176|NCT01072448|239099|P1|Overall Study|Subject withdrew consent|4
64177|NCT01072448|239098|P2|Overall Study|Adverse Event|10
64178|NCT01072448|239099|P1|Overall Study|Adverse Event|9
64179|NCT01072396|239113|P2|Period Two|Lost to Follow-up|0
64180|NCT01072396|239114|P1|Period Two|Lost to Follow-up|1
64181|NCT01072396|239113|P2|Period Two|Adverse Event|3
64182|NCT01072396|239114|P1|Period Two|Adverse Event|0
64183|NCT01072396|239113|P2|Washout Period|Missing termination information|1
64184|NCT01072396|239114|P1|Washout Period|Missing termination information|0
64185|NCT01072396|239113|P2|Period One|Withdrawal by Subject|0
64186|NCT01072396|239114|P1|Period One|Withdrawal by Subject|2
64187|NCT01072396|239113|P2|Period One|Protocol Violation|1
64188|NCT01072396|239114|P1|Period One|Protocol Violation|2
64189|NCT01072396|239113|P2|Period One|Adverse Event|1
64190|NCT01072396|239114|P1|Period One|Adverse Event|1
64191|NCT01072201|239148|P2|Overall Study|Lost to Follow-up|1
64192|NCT01072201|239149|P1|Overall Study|Lost to Follow-up|0
64193|NCT01072175|239182|P13|Part D (HPMC Capsules)|Ongoing|34
64194|NCT01072175|239183|P12|Part D (HPMC Capsules)|Ongoing|34
64195|NCT01072175|239184|P11|Part D (HPMC Capsules)|Ongoing|12
64196|NCT01072175|239185|P10|Part D (HPMC Capsules)|Ongoing|10
64197|NCT01072175|239186|P9|Part D (HPMC Capsules)|Ongoing|0
64198|NCT01072175|239187|P8|Part D (HPMC Capsules)|Ongoing|0
64199|NCT01072175|239188|P7|Part D (HPMC Capsules)|Ongoing|0
64200|NCT01072175|239189|P6|Part D (HPMC Capsules)|Ongoing|0
64201|NCT01072175|239190|P5|Part D (HPMC Capsules)|Ongoing|0
64202|NCT01072175|239191|P4|Part D (HPMC Capsules)|Ongoing|0
64203|NCT01072175|239192|P3|Part D (HPMC Capsules)|Ongoing|0
64204|NCT01072175|239193|P2|Part D (HPMC Capsules)|Ongoing|0
64205|NCT01072175|239194|P1|Part D (HPMC Capsules)|Ongoing|0
64206|NCT01072175|239182|P13|Part D (HPMC Capsules)|Death|5
64207|NCT01072175|239183|P12|Part D (HPMC Capsules)|Death|6
64208|NCT01072175|239184|P11|Part D (HPMC Capsules)|Death|4
64209|NCT01072175|239185|P10|Part D (HPMC Capsules)|Death|2
64210|NCT01072175|239186|P9|Part D (HPMC Capsules)|Death|0
64211|NCT01072175|239187|P8|Part D (HPMC Capsules)|Death|0
64212|NCT01072175|239188|P7|Part D (HPMC Capsules)|Death|0
64213|NCT01072175|239189|P6|Part D (HPMC Capsules)|Death|0
64214|NCT01072175|239190|P5|Part D (HPMC Capsules)|Death|0
64215|NCT01072175|239191|P4|Part D (HPMC Capsules)|Death|0
64216|NCT01072175|239192|P3|Part D (HPMC Capsules)|Death|0
64217|NCT01072175|239193|P2|Part D (HPMC Capsules)|Death|0
64218|NCT01072175|239194|P1|Part D (HPMC Capsules)|Death|0
64219|NCT01072175|239182|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
64220|NCT01072175|239183|P12|Part D (HPMC Capsules)|Withdrawal by Subject|1
64221|NCT01072175|239184|P11|Part D (HPMC Capsules)|Withdrawal by Subject|0
64222|NCT01072175|239185|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
64223|NCT01072175|239186|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
64224|NCT01072175|239187|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
64225|NCT01072175|239188|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
64226|NCT01072175|239189|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
64227|NCT01072175|239190|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
64228|NCT01072175|239191|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
64229|NCT01072175|239192|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
64230|NCT01072175|239193|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
64231|NCT01072175|239194|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
64232|NCT01072175|239182|P13|Part D (HPMC Capsules)|Lost to Follow-up|0
64233|NCT01072175|239183|P12|Part D (HPMC Capsules)|Lost to Follow-up|2
64234|NCT01072175|239184|P11|Part D (HPMC Capsules)|Lost to Follow-up|0
64235|NCT01072175|239185|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
64236|NCT01072175|239186|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
64237|NCT01072175|239187|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
64238|NCT01072175|239188|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
64239|NCT01072175|239189|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
64240|NCT01072175|239190|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
64241|NCT01072175|239191|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
64242|NCT01072175|239192|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
64243|NCT01072175|239193|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
64244|NCT01072175|239194|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
64245|NCT01072175|239182|P13|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
64246|NCT01072175|239183|P12|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
64247|NCT01072175|239184|P11|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
64248|NCT01072175|239185|P10|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
64249|NCT01072175|239186|P9|Part C (Phase II: Crossover Phase [CP])|Ongoing|28
64250|NCT01072175|239187|P8|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
64251|NCT01072175|239188|P7|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
64252|NCT01072175|239189|P6|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
64253|NCT01072175|239190|P5|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
64254|NCT01072175|239191|P4|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
64255|NCT01072175|239192|P3|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
64256|NCT01072175|239193|P2|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
64257|NCT01072175|239194|P1|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
64258|NCT01072175|239182|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
64259|NCT01072175|239183|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
64260|NCT01072175|239184|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
64261|NCT01072175|239185|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
64262|NCT01072175|239186|P9|Part C (Phase II: Crossover Phase [CP])|Death|15
64263|NCT01072175|239187|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
64264|NCT01072175|239188|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
64265|NCT01072175|239189|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
64266|NCT01072175|239190|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
64267|NCT01072175|239191|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
64268|NCT01072175|239192|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
64269|NCT01072175|239193|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
64270|NCT01072175|239194|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
64271|NCT01072175|239182|P13|Part C (Phase II: Randomized Phase)|Ongoing|0
64272|NCT01072175|239183|P12|Part C (Phase II: Randomized Phase)|Ongoing|0
64273|NCT01072175|239184|P11|Part C (Phase II: Randomized Phase)|Ongoing|0
64274|NCT01072175|239185|P10|Part C (Phase II: Randomized Phase)|Ongoing|0
64275|NCT01072175|239186|P9|Part C (Phase II: Randomized Phase)|Ongoing|0
64276|NCT01072175|239187|P8|Part C (Phase II: Randomized Phase)|Ongoing|40
64277|NCT01072175|239188|P7|Part C (Phase II: Randomized Phase)|Ongoing|32
64278|NCT01072175|239189|P6|Part C (Phase II: Randomized Phase)|Ongoing|35
64279|NCT01072175|239190|P5|Part C (Phase II: Randomized Phase)|Ongoing|0
64280|NCT01072175|239191|P4|Part C (Phase II: Randomized Phase)|Ongoing|0
64281|NCT01072175|239192|P3|Part C (Phase II: Randomized Phase)|Ongoing|0
64282|NCT01072175|239193|P2|Part C (Phase II: Randomized Phase)|Ongoing|0
64283|NCT01072175|239194|P1|Part C (Phase II: Randomized Phase)|Ongoing|0
64284|NCT01072175|239182|P13|Part C (Phase II: Randomized Phase)|Death|0
64285|NCT01072175|239183|P12|Part C (Phase II: Randomized Phase)|Death|0
64286|NCT01072175|239184|P11|Part C (Phase II: Randomized Phase)|Death|0
64287|NCT01072175|239185|P10|Part C (Phase II: Randomized Phase)|Death|0
64288|NCT01072175|239186|P9|Part C (Phase II: Randomized Phase)|Death|0
64289|NCT01072175|239187|P8|Part C (Phase II: Randomized Phase)|Death|14
64290|NCT01072175|239188|P7|Part C (Phase II: Randomized Phase)|Death|18
64291|NCT01072175|239189|P6|Part C (Phase II: Randomized Phase)|Death|19
64292|NCT01072175|239190|P5|Part C (Phase II: Randomized Phase)|Death|0
64293|NCT01072175|239191|P4|Part C (Phase II: Randomized Phase)|Death|0
64294|NCT01072175|239192|P3|Part C (Phase II: Randomized Phase)|Death|0
64295|NCT01072175|239193|P2|Part C (Phase II: Randomized Phase)|Death|0
64296|NCT01072175|239194|P1|Part C (Phase II: Randomized Phase)|Death|0
64297|NCT01072175|239182|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
64298|NCT01072175|239183|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
64299|NCT01072175|239184|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
64300|NCT01072175|239185|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
64301|NCT01072175|239186|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
64302|NCT01072175|239187|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
64303|NCT01072175|239188|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|4
64304|NCT01072175|239189|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
64305|NCT01072175|239190|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
64306|NCT01072175|239191|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
64307|NCT01072175|239192|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
64308|NCT01072175|239193|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
64309|NCT01072175|239194|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
64310|NCT01072175|239182|P13|Part B (Dose Escalation and Expansion)|Ongoing|0
64311|NCT01072175|239183|P12|Part B (Dose Escalation and Expansion)|Ongoing|0
64312|NCT01072175|239184|P11|Part B (Dose Escalation and Expansion)|Ongoing|0
64313|NCT01072175|239185|P10|Part B (Dose Escalation and Expansion)|Ongoing|0
64314|NCT01072175|239186|P9|Part B (Dose Escalation and Expansion)|Ongoing|0
64315|NCT01072175|239187|P8|Part B (Dose Escalation and Expansion)|Ongoing|0
64316|NCT01072175|239188|P7|Part B (Dose Escalation and Expansion)|Ongoing|0
64317|NCT01072175|239189|P6|Part B (Dose Escalation and Expansion)|Ongoing|0
64318|NCT01072175|239190|P5|Part B (Dose Escalation and Expansion)|Ongoing|28
64319|NCT01072175|239191|P4|Part B (Dose Escalation and Expansion)|Ongoing|9
64320|NCT01072175|239192|P3|Part B (Dose Escalation and Expansion)|Ongoing|10
64321|NCT01072175|239193|P2|Part B (Dose Escalation and Expansion)|Ongoing|2
64322|NCT01072175|239194|P1|Part B (Dose Escalation and Expansion)|Ongoing|0
64323|NCT01072175|239182|P13|Part B (Dose Escalation and Expansion)|Death|0
64324|NCT01072175|239183|P12|Part B (Dose Escalation and Expansion)|Death|0
64325|NCT01072175|239184|P11|Part B (Dose Escalation and Expansion)|Death|0
64326|NCT01072175|239185|P10|Part B (Dose Escalation and Expansion)|Death|0
64327|NCT01072175|239186|P9|Part B (Dose Escalation and Expansion)|Death|0
64328|NCT01072175|239187|P8|Part B (Dose Escalation and Expansion)|Death|0
64329|NCT01072175|239188|P7|Part B (Dose Escalation and Expansion)|Death|0
64330|NCT01072175|239189|P6|Part B (Dose Escalation and Expansion)|Death|0
64331|NCT01072175|239190|P5|Part B (Dose Escalation and Expansion)|Death|36
64332|NCT01072175|239191|P4|Part B (Dose Escalation and Expansion)|Death|12
64333|NCT01072175|239192|P3|Part B (Dose Escalation and Expansion)|Death|10
64334|NCT01072175|239193|P2|Part B (Dose Escalation and Expansion)|Death|3
64335|NCT01072175|239194|P1|Part B (Dose Escalation and Expansion)|Death|0
64336|NCT01072175|239182|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
64337|NCT01072175|239183|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
64338|NCT01072175|239184|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
64339|NCT01072175|239185|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
64340|NCT01072175|239186|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
64341|NCT01072175|239187|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
64342|NCT01072175|239188|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
64343|NCT01072175|239189|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
64344|NCT01072175|239190|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
64345|NCT01072175|239191|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
64346|NCT01072175|239192|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
64347|NCT01072175|239193|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
64348|NCT01072175|239194|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
64349|NCT01072175|239182|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
64350|NCT01072175|239183|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
64351|NCT01072175|239184|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
64352|NCT01072175|239185|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
64353|NCT01072175|239186|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
64354|NCT01072175|239187|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
64355|NCT01072175|239188|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
64356|NCT01072175|239189|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
64357|NCT01072175|239190|P5|Part B (Dose Escalation and Expansion)|Physician Decision|13
64358|NCT01072175|239191|P4|Part B (Dose Escalation and Expansion)|Physician Decision|4
64359|NCT01072175|239192|P3|Part B (Dose Escalation and Expansion)|Physician Decision|3
64360|NCT01072175|239193|P2|Part B (Dose Escalation and Expansion)|Physician Decision|1
64361|NCT01072175|239194|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
64362|NCT01072175|239182|P13|Part A (Drug-Drug Interaction)|Death|0
64363|NCT01072175|239183|P12|Part A (Drug-Drug Interaction)|Death|0
64364|NCT01072175|239184|P11|Part A (Drug-Drug Interaction)|Death|0
64365|NCT01072175|239185|P10|Part A (Drug-Drug Interaction)|Death|0
64366|NCT01072175|239186|P9|Part A (Drug-Drug Interaction)|Death|0
64367|NCT01072175|239187|P8|Part A (Drug-Drug Interaction)|Death|0
64368|NCT01072175|239188|P7|Part A (Drug-Drug Interaction)|Death|0
64369|NCT01072175|239189|P6|Part A (Drug-Drug Interaction)|Death|0
64370|NCT01072175|239190|P5|Part A (Drug-Drug Interaction)|Death|0
64371|NCT01072175|239191|P4|Part A (Drug-Drug Interaction)|Death|0
64372|NCT01072175|239192|P3|Part A (Drug-Drug Interaction)|Death|0
64373|NCT01072175|239193|P2|Part A (Drug-Drug Interaction)|Death|0
64374|NCT01072175|239194|P1|Part A (Drug-Drug Interaction)|Death|1
64375|NCT01072175|239182|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
64376|NCT01072175|239183|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
64377|NCT01072175|239184|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
64378|NCT01072175|239185|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
64379|NCT01072175|239186|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
64380|NCT01072175|239187|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
64381|NCT01072175|239188|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
64382|NCT01072175|239189|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
64383|NCT01072175|239190|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
64384|NCT01072175|239191|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
64385|NCT01072175|239192|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
64386|NCT01072175|239193|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
64387|NCT01072175|239194|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
64388|NCT01072175|239182|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
64389|NCT01072175|239183|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
64390|NCT01072175|239184|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
64391|NCT01072175|239185|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
64392|NCT01072175|239186|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
64393|NCT01072175|239187|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
64394|NCT01072175|239188|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
64395|NCT01072175|239189|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
64396|NCT01072175|239190|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
64397|NCT01072175|239191|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
64398|NCT01072175|239192|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
64399|NCT01072175|239193|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
64400|NCT01072175|239194|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
64401|NCT01072149|239377|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64402|NCT01072149|239378|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64403|NCT01072149|239379|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64404|NCT01072149|239380|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64405|NCT01072149|239381|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
64406|NCT01072149|239382|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64407|NCT01072149|239383|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64408|NCT01072149|239384|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64409|NCT01072149|239385|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64410|NCT01072149|239386|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64411|NCT01072149|239387|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64412|NCT01072149|239388|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64413|NCT01072149|239389|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64414|NCT01072149|239390|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64415|NCT01072149|239391|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64416|NCT01072149|239392|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
64417|NCT01072149|239393|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64418|NCT01072149|239394|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
64419|NCT01072149|239377|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
64420|NCT01072149|239378|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
64421|NCT01072149|239379|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
64422|NCT01072149|239380|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
64423|NCT01072149|239381|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
64424|NCT01072149|239382|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
64425|NCT01072149|239383|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
64426|NCT01072149|239384|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
64427|NCT01072149|239385|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
64428|NCT01072149|239386|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
64429|NCT01072149|239387|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
64430|NCT01072149|239388|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
64431|NCT01072149|239389|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
64432|NCT01072149|239390|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
64433|NCT01072149|239391|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
64434|NCT01072149|239392|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
64435|NCT01072149|239393|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
64436|NCT01072149|239394|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
64437|NCT01072149|239377|P18|Washout Period 2 (14 Days)|Adverse Event|0
64438|NCT01072149|239378|P17|Washout Period 2 (14 Days)|Adverse Event|0
64439|NCT01072149|239379|P16|Washout Period 2 (14 Days)|Adverse Event|1
64440|NCT01072149|239380|P15|Washout Period 2 (14 Days)|Adverse Event|0
64441|NCT01072149|239381|P14|Washout Period 2 (14 Days)|Adverse Event|0
64442|NCT01072149|239382|P13|Washout Period 2 (14 Days)|Adverse Event|0
64443|NCT01072149|239383|P12|Washout Period 2 (14 Days)|Adverse Event|0
64444|NCT01072149|239384|P11|Washout Period 2 (14 Days)|Adverse Event|0
64445|NCT01072149|239385|P10|Washout Period 2 (14 Days)|Adverse Event|0
64446|NCT01072149|239386|P9|Washout Period 2 (14 Days)|Adverse Event|0
64447|NCT01072149|239387|P8|Washout Period 2 (14 Days)|Adverse Event|0
64448|NCT01072149|239388|P7|Washout Period 2 (14 Days)|Adverse Event|0
64449|NCT01072149|239389|P6|Washout Period 2 (14 Days)|Adverse Event|0
64450|NCT01072149|239390|P5|Washout Period 2 (14 Days)|Adverse Event|0
64451|NCT01072149|239391|P4|Washout Period 2 (14 Days)|Adverse Event|0
64452|NCT01072149|239392|P3|Washout Period 2 (14 Days)|Adverse Event|0
64453|NCT01072149|239393|P2|Washout Period 2 (14 Days)|Adverse Event|0
64454|NCT01072149|239394|P1|Washout Period 2 (14 Days)|Adverse Event|0
64455|NCT01072149|239377|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64456|NCT01072149|239378|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64457|NCT01072149|239379|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
64458|NCT01072149|239380|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64459|NCT01072149|239381|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64460|NCT01072149|239382|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64461|NCT01072149|239383|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64462|NCT01072149|239384|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64463|NCT01072149|239385|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64464|NCT01072149|239386|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64465|NCT01072149|239387|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64466|NCT01072149|239388|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64467|NCT01072149|239389|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64468|NCT01072149|239390|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64469|NCT01072149|239391|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64470|NCT01072149|239392|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64471|NCT01072149|239393|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64472|NCT01072149|239394|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
64473|NCT01072149|239377|P18|Washout Period 2 (14 Days)|Physician Decision|0
64474|NCT01072149|239378|P17|Washout Period 2 (14 Days)|Physician Decision|0
64475|NCT01072149|239379|P16|Washout Period 2 (14 Days)|Physician Decision|0
64476|NCT01072149|239380|P15|Washout Period 2 (14 Days)|Physician Decision|0
64477|NCT01072149|239381|P14|Washout Period 2 (14 Days)|Physician Decision|0
64478|NCT01072149|239382|P13|Washout Period 2 (14 Days)|Physician Decision|0
64479|NCT01072149|239383|P12|Washout Period 2 (14 Days)|Physician Decision|0
64480|NCT01072149|239384|P11|Washout Period 2 (14 Days)|Physician Decision|0
64481|NCT01072149|239385|P10|Washout Period 2 (14 Days)|Physician Decision|0
64482|NCT01072149|239386|P9|Washout Period 2 (14 Days)|Physician Decision|0
64483|NCT01072149|239387|P8|Washout Period 2 (14 Days)|Physician Decision|0
64484|NCT01072149|239388|P7|Washout Period 2 (14 Days)|Physician Decision|0
64485|NCT01072149|239389|P6|Washout Period 2 (14 Days)|Physician Decision|0
64486|NCT01072149|239390|P5|Washout Period 2 (14 Days)|Physician Decision|0
64487|NCT01072149|239391|P4|Washout Period 2 (14 Days)|Physician Decision|0
64488|NCT01072149|239392|P3|Washout Period 2 (14 Days)|Physician Decision|0
64489|NCT01072149|239393|P2|Washout Period 2 (14 Days)|Physician Decision|0
64490|NCT01072149|239394|P1|Washout Period 2 (14 Days)|Physician Decision|1
64491|NCT01072149|239377|P18|Treatment Period 2 (28 Days)|Physician Decision|0
64492|NCT01072149|239378|P17|Treatment Period 2 (28 Days)|Physician Decision|0
64493|NCT01072149|239379|P16|Treatment Period 2 (28 Days)|Physician Decision|0
64494|NCT01072149|239380|P15|Treatment Period 2 (28 Days)|Physician Decision|0
64495|NCT01072149|239381|P14|Treatment Period 2 (28 Days)|Physician Decision|0
64496|NCT01072149|239382|P13|Treatment Period 2 (28 Days)|Physician Decision|0
64497|NCT01072149|239383|P12|Treatment Period 2 (28 Days)|Physician Decision|0
64498|NCT01072149|239384|P11|Treatment Period 2 (28 Days)|Physician Decision|0
64499|NCT01072149|239385|P10|Treatment Period 2 (28 Days)|Physician Decision|0
64500|NCT01072149|239386|P9|Treatment Period 2 (28 Days)|Physician Decision|0
64501|NCT01072149|239387|P8|Treatment Period 2 (28 Days)|Physician Decision|1
64502|NCT01072149|239388|P7|Treatment Period 2 (28 Days)|Physician Decision|0
64503|NCT01072149|239389|P6|Treatment Period 2 (28 Days)|Physician Decision|0
64504|NCT01072149|239390|P5|Treatment Period 2 (28 Days)|Physician Decision|0
64505|NCT01072149|239391|P4|Treatment Period 2 (28 Days)|Physician Decision|0
64506|NCT01072149|239392|P3|Treatment Period 2 (28 Days)|Physician Decision|0
64507|NCT01072149|239393|P2|Treatment Period 2 (28 Days)|Physician Decision|0
64508|NCT01072149|239394|P1|Treatment Period 2 (28 Days)|Physician Decision|0
64509|NCT01072149|239377|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64510|NCT01072149|239378|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64511|NCT01072149|239379|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64512|NCT01072149|239380|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64513|NCT01072149|239381|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64514|NCT01072149|239382|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64515|NCT01072149|239383|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64516|NCT01072149|239384|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64517|NCT01072149|239385|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64518|NCT01072149|239386|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64519|NCT01072149|239387|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64520|NCT01072149|239388|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64521|NCT01072149|239389|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64522|NCT01072149|239390|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64523|NCT01072149|239391|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64524|NCT01072149|239392|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
64525|NCT01072149|239393|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64526|NCT01072149|239394|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
64527|NCT01072149|239377|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64528|NCT01072149|239378|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64529|NCT01072149|239379|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64530|NCT01072149|239380|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64531|NCT01072149|239381|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64532|NCT01072149|239382|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64533|NCT01072149|239383|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64534|NCT01072149|239384|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64535|NCT01072149|239385|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64536|NCT01072149|239386|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64537|NCT01072149|239387|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64538|NCT01072149|239388|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64539|NCT01072149|239389|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64540|NCT01072149|239390|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64541|NCT01072149|239391|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64542|NCT01072149|239392|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64543|NCT01072149|239393|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
64544|NCT01072149|239394|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
64545|NCT01072149|239377|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64546|NCT01072149|239378|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64547|NCT01072149|239379|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64548|NCT01072149|239380|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64549|NCT01072149|239381|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64550|NCT01072149|239382|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64551|NCT01072149|239383|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64552|NCT01072149|239384|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
64553|NCT01072149|239385|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64554|NCT01072149|239386|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64555|NCT01072149|239387|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64556|NCT01072149|239388|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64557|NCT01072149|239389|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64558|NCT01072149|239390|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64559|NCT01072149|239391|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64560|NCT01072149|239392|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64561|NCT01072149|239393|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64562|NCT01072149|239394|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
64563|NCT01072149|239377|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
64564|NCT01072149|239378|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
64565|NCT01072149|239379|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
64566|NCT01072149|239380|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
64567|NCT01072149|239381|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
64568|NCT01072149|239382|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
64569|NCT01072149|239383|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
64570|NCT01072149|239384|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
64571|NCT01072149|239385|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
64572|NCT01072149|239386|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
64573|NCT01072149|239387|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
64574|NCT01072149|239388|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
64575|NCT01072149|239389|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
64576|NCT01072149|239390|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
64577|NCT01072149|239391|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
64578|NCT01072149|239392|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
64579|NCT01072149|239393|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
64580|NCT01072149|239394|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
64581|NCT01072149|239377|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64582|NCT01072149|239378|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64583|NCT01072149|239379|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64584|NCT01072149|239380|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64585|NCT01072149|239381|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64586|NCT01072149|239382|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64587|NCT01072149|239383|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64588|NCT01072149|239384|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64589|NCT01072149|239385|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64590|NCT01072149|239386|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64591|NCT01072149|239387|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64592|NCT01072149|239388|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64593|NCT01072149|239389|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64594|NCT01072149|239390|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64595|NCT01072149|239391|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64596|NCT01072149|239392|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
64597|NCT01072149|239393|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64598|NCT01072149|239394|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
64599|NCT01071915|239450|P1|Overall Study|Miscellaneous Reasons|2
64600|NCT01071915|239450|P1|Overall Study|Withdrawal by Subject|2
64601|NCT01071915|239450|P1|Overall Study|Physician Decision|2
64602|NCT01071915|239450|P1|Overall Study|Adverse Event|3
64603|NCT01071798|239460|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
64604|NCT01071798|239460|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
64605|NCT01071798|239460|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
64606|NCT01071798|239460|P1|Subpopulation Who Received Two Cycles|Remission|1
64607|NCT01071798|239460|P1|Participants Who Received One Cycle|Severe concomitant disease|2
64608|NCT01071798|239460|P1|Participants Who Received One Cycle|Change of therapy|6
64609|NCT01071798|239460|P1|Participants Who Received One Cycle|Death|5
64610|NCT01071798|239460|P1|Participants Who Received One Cycle|Patient requirement|20
64611|NCT01071798|239460|P1|Participants Who Received One Cycle|Lack of tolerability|14
64612|NCT01071798|239460|P1|Participants Who Received One Cycle|Lack of Efficacy|18
64613|NCT01071395|239492|P2|Overall Study|Adverse Event|1
64614|NCT01071395|239493|P1|Overall Study|Adverse Event|3
64615|NCT01071395|239492|P2|Overall Study|Withdrawal by Subject|1
64616|NCT01071395|239493|P1|Overall Study|Withdrawal by Subject|2
64617|NCT01071278|239499|P1|Overall Study|Completion Status Unknown|459
64618|NCT01071278|239499|P1|Overall Study|Premature Discontinuation|254
64619|NCT01071252|239510|P5|Overall Study|Death|1
64620|NCT01071252|239511|P4|Overall Study|Death|0
64621|NCT01071252|239512|P3|Overall Study|Death|0
64622|NCT01071252|239513|P2|Overall Study|Death|0
64623|NCT01071252|239514|P1|Overall Study|Death|0
64624|NCT01071252|239510|P5|Overall Study|Adverse Event|0
64625|NCT01071252|239511|P4|Overall Study|Adverse Event|1
64626|NCT01071252|239512|P3|Overall Study|Adverse Event|0
64627|NCT01071252|239513|P2|Overall Study|Adverse Event|1
64628|NCT01071252|239514|P1|Overall Study|Adverse Event|1
64629|NCT01071252|239510|P5|Overall Study|Lost to Follow-up|0
64630|NCT01071252|239511|P4|Overall Study|Lost to Follow-up|2
64631|NCT01071252|239512|P3|Overall Study|Lost to Follow-up|1
64632|NCT01071252|239513|P2|Overall Study|Lost to Follow-up|0
64633|NCT01071252|239514|P1|Overall Study|Lost to Follow-up|1
64634|NCT01071252|239510|P5|Overall Study|administrative problems|1
64635|NCT01071252|239511|P4|Overall Study|administrative problems|2
64636|NCT01071252|239512|P3|Overall Study|administrative problems|0
64637|NCT01071252|239513|P2|Overall Study|administrative problems|1
64638|NCT01071252|239514|P1|Overall Study|administrative problems|1
64639|NCT01071252|239510|P5|Overall Study|Withdrawal by Subject|3
64640|NCT01071252|239511|P4|Overall Study|Withdrawal by Subject|2
64641|NCT01071252|239512|P3|Overall Study|Withdrawal by Subject|1
64642|NCT01071252|239513|P2|Overall Study|Withdrawal by Subject|2
64643|NCT01071252|239514|P1|Overall Study|Withdrawal by Subject|8
64644|NCT01071252|239510|P5|Overall Study|unsatisfactory therapeutic effect|6
64645|NCT01071252|239511|P4|Overall Study|unsatisfactory therapeutic effect|0
64646|NCT01071252|239512|P3|Overall Study|unsatisfactory therapeutic effect|2
64647|NCT01071252|239513|P2|Overall Study|unsatisfactory therapeutic effect|6
64648|NCT01071252|239514|P1|Overall Study|unsatisfactory therapeutic effect|4
64649|NCT01071200|239542|P2|Overall Study|No viable embryos|1
64650|NCT01071200|239543|P1|Overall Study|No viable embryos|0
64651|NCT01071200|239542|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
64652|NCT01071200|239543|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
64653|NCT01071200|239542|P2|Overall Study|No oocytes retrieved|1
64654|NCT01071200|239543|P1|Overall Study|No oocytes retrieved|1
64655|NCT01071200|239542|P2|Overall Study|No fertilization|0
64656|NCT01071200|239543|P1|Overall Study|No fertilization|4
64657|NCT01071200|239542|P2|Overall Study|Lack of ovarian response|1
64658|NCT01071200|239543|P1|Overall Study|Lack of ovarian response|1
64659|NCT01071096|239575|P2|First Intervention (90 Days)|Lost to Follow-up|0
64660|NCT01071096|239576|P1|First Intervention (90 Days)|Lost to Follow-up|1
64661|NCT01071083|239600|P5|Overall Study|Subject Refused to Continue|0
64662|NCT01071083|239601|P4|Overall Study|Subject Refused to Continue|0
64663|NCT01071083|239602|P3|Overall Study|Subject Refused to Continue|0
64664|NCT01071083|239603|P2|Overall Study|Subject Refused to Continue|0
64665|NCT01071083|239604|P1|Overall Study|Subject Refused to Continue|1
64666|NCT01071083|239600|P5|Overall Study|Did Not Want Per Protocol Treatment|1
64667|NCT01071083|239601|P4|Overall Study|Did Not Want Per Protocol Treatment|0
64668|NCT01071083|239602|P3|Overall Study|Did Not Want Per Protocol Treatment|1
64669|NCT01071083|239603|P2|Overall Study|Did Not Want Per Protocol Treatment|0
64670|NCT01071083|239604|P1|Overall Study|Did Not Want Per Protocol Treatment|0
64671|NCT01071083|239600|P5|Overall Study|Did Not Meet Eligibility Criteria|1
64672|NCT01071083|239601|P4|Overall Study|Did Not Meet Eligibility Criteria|1
64673|NCT01071083|239602|P3|Overall Study|Did Not Meet Eligibility Criteria|1
64674|NCT01071083|239603|P2|Overall Study|Did Not Meet Eligibility Criteria|0
64675|NCT01071083|239604|P1|Overall Study|Did Not Meet Eligibility Criteria|0
64676|NCT01071083|239600|P5|Overall Study|Images Not Usable (Motion)|0
64677|NCT01071083|239601|P4|Overall Study|Images Not Usable (Motion)|0
64678|NCT01071083|239602|P3|Overall Study|Images Not Usable (Motion)|0
64679|NCT01071083|239603|P2|Overall Study|Images Not Usable (Motion)|1
64680|NCT01071083|239604|P1|Overall Study|Images Not Usable (Motion)|0
64681|NCT01071083|239600|P5|Overall Study|Subject Moved|0
64682|NCT01071083|239601|P4|Overall Study|Subject Moved|0
64683|NCT01071083|239602|P3|Overall Study|Subject Moved|0
64684|NCT01071083|239603|P2|Overall Study|Subject Moved|1
64685|NCT01071083|239604|P1|Overall Study|Subject Moved|0
64686|NCT01071083|239600|P5|Overall Study|Early Rescue|1
64687|NCT01071083|239601|P4|Overall Study|Early Rescue|0
64688|NCT01071083|239602|P3|Overall Study|Early Rescue|0
64689|NCT01071083|239603|P2|Overall Study|Early Rescue|0
64690|NCT01071083|239604|P1|Overall Study|Early Rescue|1
64691|NCT01071083|239600|P5|Overall Study|Physician Decision|1
64692|NCT01071083|239601|P4|Overall Study|Physician Decision|1
64693|NCT01071083|239602|P3|Overall Study|Physician Decision|0
64694|NCT01071083|239603|P2|Overall Study|Physician Decision|0
64695|NCT01071083|239604|P1|Overall Study|Physician Decision|1
64696|NCT01071083|239600|P5|Overall Study|Withdrawal by Subject|3
64697|NCT01071083|239601|P4|Overall Study|Withdrawal by Subject|0
64698|NCT01071083|239602|P3|Overall Study|Withdrawal by Subject|2
64699|NCT01071083|239603|P2|Overall Study|Withdrawal by Subject|0
64700|NCT01071083|239604|P1|Overall Study|Withdrawal by Subject|3
64701|NCT01071083|239600|P5|Overall Study|Adverse Event|1
64702|NCT01071083|239601|P4|Overall Study|Adverse Event|0
64703|NCT01071083|239602|P3|Overall Study|Adverse Event|1
64704|NCT01071083|239603|P2|Overall Study|Adverse Event|0
64705|NCT01071083|239604|P1|Overall Study|Adverse Event|1
64706|NCT01071070|239623|P2|Overall Study|Hypercalcemia|0
64707|NCT01071070|239624|P1|Overall Study|Hypercalcemia|1
64708|NCT01071070|239623|P2|Overall Study|Missed 3 consecutive doses of study drug|0
64709|NCT01071070|239624|P1|Overall Study|Missed 3 consecutive doses of study drug|2
64710|NCT01071070|239623|P2|Overall Study|Withdrawal by Subject|0
64711|NCT01071070|239624|P1|Overall Study|Withdrawal by Subject|1
64712|NCT01071070|239623|P2|Overall Study|Adverse Event|3
64713|NCT01071070|239624|P1|Overall Study|Adverse Event|0
64714|NCT01070979|239670|P3|Overall Study|No study drug taken|0
64715|NCT01070979|239671|P2|Overall Study|No study drug taken|1
64716|NCT01070979|239672|P1|Overall Study|No study drug taken|0
64717|NCT01070979|239670|P3|Overall Study|Withdrawal by Subject|1
64718|NCT01070979|239671|P2|Overall Study|Withdrawal by Subject|1
64719|NCT01070979|239672|P1|Overall Study|Withdrawal by Subject|3
64720|NCT01070979|239670|P3|Overall Study|Surgery, moving, personal, abn. labs|2
64721|NCT01070979|239671|P2|Overall Study|Surgery, moving, personal, abn. labs|4
64722|NCT01070979|239672|P1|Overall Study|Surgery, moving, personal, abn. labs|4
64723|NCT01070979|239670|P3|Overall Study|Protocol Violation|6
64724|NCT01070979|239671|P2|Overall Study|Protocol Violation|2
64725|NCT01070979|239672|P1|Overall Study|Protocol Violation|0
64726|NCT01070979|239670|P3|Overall Study|Lost to Follow-up|1
64727|NCT01070979|239671|P2|Overall Study|Lost to Follow-up|1
64728|NCT01070979|239672|P1|Overall Study|Lost to Follow-up|2
64729|NCT01070979|239670|P3|Overall Study|Adverse Event|3
64730|NCT01070979|239671|P2|Overall Study|Adverse Event|3
64731|NCT01070979|239672|P1|Overall Study|Adverse Event|2
64732|NCT01070966|239698|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
64733|NCT01070966|239698|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
64734|NCT01070966|239698|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
64735|NCT01070966|239698|P1|Participants for Safety Evaluation|TMT given before date of contract|3
64736|NCT01070966|239698|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
64737|NCT01070966|239698|P1|Participants for Safety Evaluation|Duplicate Participants|4
64738|NCT01070966|239698|P1|Participants for Safety Evaluation|Off-label use|9
64739|NCT01070966|239698|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
64740|NCT01070953|239709|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
64741|NCT01070953|239709|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
64742|NCT01070953|239709|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
64743|NCT01070953|239709|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
64744|NCT01070953|239709|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
64745|NCT01070953|239709|P1|Participants for Safety Evaluation|Uncontracted participants|4
64746|NCT01070953|239709|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
64747|NCT01070953|239709|P1|Participants for Safety Evaluation|Duplicated participants|22
64748|NCT01070953|239709|P1|Participants for Safety Evaluation|Off-label use|283
64749|NCT01070953|239709|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
64750|NCT01070888|239722|P2|Washout (14 Days)|Physician Decision|0
64751|NCT01070888|239723|P1|Washout (14 Days)|Physician Decision|1
64752|NCT01070888|239722|P2|First Intervention (14 Days)|Lost to Follow-up|1
64753|NCT01070888|239723|P1|First Intervention (14 Days)|Lost to Follow-up|0
64754|NCT01070888|239722|P2|First Intervention (14 Days)|Adverse Event|1
64755|NCT01070888|239723|P1|First Intervention (14 Days)|Adverse Event|0
64756|NCT01070784|239731|P2|Overall Study|Adverse Event|9
64757|NCT01070784|239732|P1|Overall Study|Adverse Event|14
64758|NCT01070784|239731|P2|Overall Study|Withdrawal by Subject|9
64759|NCT01070784|239732|P1|Overall Study|Withdrawal by Subject|6
64760|NCT01070771|239820|P1|Overall Study|Protocol Violation|1
64761|NCT01070771|239820|P1|Overall Study|Adverse Event|2
64762|NCT01070550|239840|P6|Overall Study|Withdrawal by Subject|0
64763|NCT01070550|239841|P5|Overall Study|Withdrawal by Subject|0
64764|NCT01070550|239842|P4|Overall Study|Withdrawal by Subject|0
64765|NCT01070550|239843|P3|Overall Study|Withdrawal by Subject|3
64766|NCT01070550|239844|P2|Overall Study|Withdrawal by Subject|0
64767|NCT01070550|239845|P1|Overall Study|Withdrawal by Subject|35
64768|NCT01070550|239840|P6|Overall Study|Other|0
64769|NCT01070550|239841|P5|Overall Study|Other|0
64770|NCT01070550|239842|P4|Overall Study|Other|1
64771|NCT01070550|239843|P3|Overall Study|Other|0
64772|NCT01070550|239844|P2|Overall Study|Other|0
64773|NCT01070550|239845|P1|Overall Study|Other|5
64774|NCT01070550|239840|P6|Overall Study|Treatment was stopped early|0
64775|NCT01070550|239841|P5|Overall Study|Treatment was stopped early|0
64776|NCT01070550|239842|P4|Overall Study|Treatment was stopped early|0
64777|NCT01070550|239843|P3|Overall Study|Treatment was stopped early|0
64778|NCT01070550|239844|P2|Overall Study|Treatment was stopped early|0
64779|NCT01070550|239845|P1|Overall Study|Treatment was stopped early|7
64780|NCT01070550|239840|P6|Overall Study|Treatment unavailable|0
64781|NCT01070550|239841|P5|Overall Study|Treatment unavailable|0
64782|NCT01070550|239842|P4|Overall Study|Treatment unavailable|0
64783|NCT01070550|239843|P3|Overall Study|Treatment unavailable|0
64784|NCT01070550|239844|P2|Overall Study|Treatment unavailable|0
64785|NCT01070550|239845|P1|Overall Study|Treatment unavailable|1
64786|NCT01070550|239840|P6|Overall Study|Treatment stopped|0
64787|NCT01070550|239841|P5|Overall Study|Treatment stopped|0
64788|NCT01070550|239842|P4|Overall Study|Treatment stopped|0
64789|NCT01070550|239843|P3|Overall Study|Treatment stopped|0
64790|NCT01070550|239844|P2|Overall Study|Treatment stopped|0
64791|NCT01070550|239845|P1|Overall Study|Treatment stopped|3
64792|NCT01070550|239840|P6|Overall Study|Treatment restarted|0
64793|NCT01070550|239841|P5|Overall Study|Treatment restarted|0
64794|NCT01070550|239842|P4|Overall Study|Treatment restarted|0
64795|NCT01070550|239843|P3|Overall Study|Treatment restarted|0
64796|NCT01070550|239844|P2|Overall Study|Treatment restarted|1
64797|NCT01070550|239845|P1|Overall Study|Treatment restarted|0
64798|NCT01070550|239840|P6|Overall Study|Treatment not started|0
64799|NCT01070550|239841|P5|Overall Study|Treatment not started|0
64800|NCT01070550|239842|P4|Overall Study|Treatment not started|0
64801|NCT01070550|239843|P3|Overall Study|Treatment not started|4
64802|NCT01070550|239844|P2|Overall Study|Treatment not started|2
64803|NCT01070550|239845|P1|Overall Study|Treatment not started|14
64804|NCT01070550|239840|P6|Overall Study|Treatment interrupted|0
64805|NCT01070550|239841|P5|Overall Study|Treatment interrupted|0
64806|NCT01070550|239842|P4|Overall Study|Treatment interrupted|1
64807|NCT01070550|239843|P3|Overall Study|Treatment interrupted|1
64808|NCT01070550|239844|P2|Overall Study|Treatment interrupted|0
64809|NCT01070550|239845|P1|Overall Study|Treatment interrupted|7
64810|NCT01070550|239840|P6|Overall Study|Treatment duration shortened|0
64811|NCT01070550|239841|P5|Overall Study|Treatment duration shortened|0
64812|NCT01070550|239842|P4|Overall Study|Treatment duration shortened|0
64813|NCT01070550|239843|P3|Overall Study|Treatment duration shortened|0
64814|NCT01070550|239844|P2|Overall Study|Treatment duration shortened|0
64815|NCT01070550|239845|P1|Overall Study|Treatment duration shortened|1
64816|NCT01070550|239840|P6|Overall Study|Sponsor decision|0
64817|NCT01070550|239841|P5|Overall Study|Sponsor decision|0
64818|NCT01070550|239842|P4|Overall Study|Sponsor decision|0
64819|NCT01070550|239843|P3|Overall Study|Sponsor decision|0
64820|NCT01070550|239844|P2|Overall Study|Sponsor decision|0
64821|NCT01070550|239845|P1|Overall Study|Sponsor decision|1
64822|NCT01070550|239840|P6|Overall Study|Screen failure|0
64823|NCT01070550|239841|P5|Overall Study|Screen failure|0
64824|NCT01070550|239842|P4|Overall Study|Screen failure|0
64825|NCT01070550|239843|P3|Overall Study|Screen failure|0
64826|NCT01070550|239844|P2|Overall Study|Screen failure|0
64827|NCT01070550|239845|P1|Overall Study|Screen failure|1
64828|NCT01070550|239840|P6|Overall Study|Result not available|0
64829|NCT01070550|239841|P5|Overall Study|Result not available|0
64830|NCT01070550|239842|P4|Overall Study|Result not available|0
64831|NCT01070550|239843|P3|Overall Study|Result not available|3
64832|NCT01070550|239844|P2|Overall Study|Result not available|1
64833|NCT01070550|239845|P1|Overall Study|Result not available|3
64834|NCT01070550|239840|P6|Overall Study|Relapse|0
64835|NCT01070550|239841|P5|Overall Study|Relapse|0
64836|NCT01070550|239842|P4|Overall Study|Relapse|4
64837|NCT01070550|239843|P3|Overall Study|Relapse|14
64838|NCT01070550|239844|P2|Overall Study|Relapse|5
64839|NCT01070550|239845|P1|Overall Study|Relapse|44
64840|NCT01070550|239840|P6|Overall Study|Protocol Violation|0
64841|NCT01070550|239841|P5|Overall Study|Protocol Violation|0
64842|NCT01070550|239842|P4|Overall Study|Protocol Violation|1
64843|NCT01070550|239843|P3|Overall Study|Protocol Violation|1
64844|NCT01070550|239844|P2|Overall Study|Protocol Violation|1
64845|NCT01070550|239845|P1|Overall Study|Protocol Violation|15
64846|NCT01070550|239840|P6|Overall Study|Not categorized|1
64847|NCT01070550|239841|P5|Overall Study|Not categorized|0
64848|NCT01070550|239842|P4|Overall Study|Not categorized|1
64849|NCT01070550|239843|P3|Overall Study|Not categorized|6
64850|NCT01070550|239844|P2|Overall Study|Not categorized|2
64851|NCT01070550|239845|P1|Overall Study|Not categorized|33
64852|NCT01070550|239840|P6|Overall Study|Non-responders|2
64853|NCT01070550|239841|P5|Overall Study|Non-responders|0
64854|NCT01070550|239842|P4|Overall Study|Non-responders|20
64855|NCT01070550|239843|P3|Overall Study|Non-responders|21
64856|NCT01070550|239844|P2|Overall Study|Non-responders|4
64857|NCT01070550|239845|P1|Overall Study|Non-responders|493
64858|NCT01070550|239840|P6|Overall Study|New treatment started|0
64859|NCT01070550|239841|P5|Overall Study|New treatment started|0
64860|NCT01070550|239842|P4|Overall Study|New treatment started|2
64861|NCT01070550|239843|P3|Overall Study|New treatment started|0
64862|NCT01070550|239844|P2|Overall Study|New treatment started|1
64863|NCT01070550|239845|P1|Overall Study|New treatment started|3
64864|NCT01070550|239840|P6|Overall Study|Miscellaneous|0
64865|NCT01070550|239841|P5|Overall Study|Miscellaneous|0
64866|NCT01070550|239842|P4|Overall Study|Miscellaneous|1
64867|NCT01070550|239843|P3|Overall Study|Miscellaneous|3
64868|NCT01070550|239844|P2|Overall Study|Miscellaneous|2
64869|NCT01070550|239845|P1|Overall Study|Miscellaneous|12
64870|NCT01070550|239840|P6|Overall Study|Lack of Efficacy|1
64871|NCT01070550|239841|P5|Overall Study|Lack of Efficacy|0
64872|NCT01070550|239842|P4|Overall Study|Lack of Efficacy|5
64873|NCT01070550|239843|P3|Overall Study|Lack of Efficacy|5
64874|NCT01070550|239844|P2|Overall Study|Lack of Efficacy|1
64875|NCT01070550|239845|P1|Overall Study|Lack of Efficacy|65
64876|NCT01070550|239840|P6|Overall Study|Lab test not done|1
64877|NCT01070550|239841|P5|Overall Study|Lab test not done|0
64878|NCT01070550|239842|P4|Overall Study|Lab test not done|1
64879|NCT01070550|239843|P3|Overall Study|Lab test not done|4
64880|NCT01070550|239844|P2|Overall Study|Lab test not done|3
64881|NCT01070550|239845|P1|Overall Study|Lab test not done|22
64882|NCT01070550|239840|P6|Overall Study|Incomplete treatment|0
64883|NCT01070550|239841|P5|Overall Study|Incomplete treatment|0
64884|NCT01070550|239842|P4|Overall Study|Incomplete treatment|0
64885|NCT01070550|239843|P3|Overall Study|Incomplete treatment|0
64886|NCT01070550|239844|P2|Overall Study|Incomplete treatment|0
64887|NCT01070550|239845|P1|Overall Study|Incomplete treatment|2
64888|NCT01070550|239840|P6|Overall Study|Failed to return|2
64889|NCT01070550|239841|P5|Overall Study|Failed to return|1
64890|NCT01070550|239842|P4|Overall Study|Failed to return|40
64891|NCT01070550|239843|P3|Overall Study|Failed to return|144
64892|NCT01070550|239844|P2|Overall Study|Failed to return|33
64893|NCT01070550|239845|P1|Overall Study|Failed to return|450
64894|NCT01070550|239840|P6|Overall Study|Early termination|0
64895|NCT01070550|239841|P5|Overall Study|Early termination|0
64896|NCT01070550|239842|P4|Overall Study|Early termination|0
64897|NCT01070550|239843|P3|Overall Study|Early termination|0
64898|NCT01070550|239844|P2|Overall Study|Early termination|0
64899|NCT01070550|239845|P1|Overall Study|Early termination|3
64900|NCT01070550|239840|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
64901|NCT01070550|239841|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
64902|NCT01070550|239842|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
64903|NCT01070550|239843|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
64904|NCT01070550|239844|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
64905|NCT01070550|239845|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
64906|NCT01070550|239840|P6|Overall Study|Death|0
64907|NCT01070550|239841|P5|Overall Study|Death|0
64908|NCT01070550|239842|P4|Overall Study|Death|0
64909|NCT01070550|239843|P3|Overall Study|Death|3
64910|NCT01070550|239844|P2|Overall Study|Death|4
64911|NCT01070550|239845|P1|Overall Study|Death|20
64912|NCT01070550|239840|P6|Overall Study|Adverse Event|0
64913|NCT01070550|239841|P5|Overall Study|Adverse Event|0
64914|NCT01070550|239842|P4|Overall Study|Adverse Event|0
64915|NCT01070550|239843|P3|Overall Study|Adverse Event|3
64916|NCT01070550|239844|P2|Overall Study|Adverse Event|1
64917|NCT01070550|239845|P1|Overall Study|Adverse Event|43
64918|NCT01070394|239985|P1|Overall Study|Withdrawal by Subject|1
64919|NCT01070394|239985|P1|Overall Study|Adverse Event|6
64920|NCT01070381|239996|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
64921|NCT01070381|239997|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
64922|NCT01070381|239996|P2|Period 2, 1 Week of Wear|Handling|1
64923|NCT01070381|239997|P1|Period 2, 1 Week of Wear|Handling|0
64924|NCT01070329|240005|P2|Overall Study|Sponsor Decision|1
64925|NCT01070329|240006|P1|Overall Study|Sponsor Decision|0
64926|NCT01070329|240005|P2|Overall Study|Entry Criteria Not Met|0
64927|NCT01070329|240006|P1|Overall Study|Entry Criteria Not Met|1
64928|NCT01070329|240005|P2|Overall Study|Physician Decision|1
64929|NCT01070329|240006|P1|Overall Study|Physician Decision|2
64930|NCT01070329|240005|P2|Overall Study|Lack of Efficacy|6
64931|NCT01070329|240006|P1|Overall Study|Lack of Efficacy|2
64932|NCT01070329|240005|P2|Overall Study|Protocol Violation|8
64933|NCT01070329|240006|P1|Overall Study|Protocol Violation|3
64934|NCT01070329|240005|P2|Overall Study|Withdrawal by Subject|11
64935|NCT01070329|240006|P1|Overall Study|Withdrawal by Subject|9
64936|NCT01070329|240005|P2|Overall Study|Lost to Follow-up|12
64937|NCT01070329|240006|P1|Overall Study|Lost to Follow-up|22
64938|NCT01070329|240005|P2|Overall Study|Adverse Event|10
64939|NCT01070329|240006|P1|Overall Study|Adverse Event|13
64940|NCT01070316|240038|P1|Extension Phase|Withdrawal by Subject|1
64941|NCT01070316|240038|P1|Extension Phase|Lack of Efficacy|3
64942|NCT01070303|240045|P1|Overall Study|Other|18
64943|NCT01070303|240045|P1|Overall Study|Administrative Reason|1
64944|NCT01070303|240045|P1|Overall Study|Lack of Efficacy|2
64945|NCT01070303|240045|P1|Overall Study|Protocol Violation|0
64946|NCT01070303|240045|P1|Overall Study|Lost to Follow-up|9
64947|NCT01070303|240045|P1|Overall Study|Withdrawal by Subject|20
64948|NCT01070303|240045|P1|Overall Study|Adverse Event|39
64949|NCT01070043|240119|P3|Double-Blind Treatment|Adverse Event|2
64950|NCT01070043|240120|P2|Double-Blind Treatment|Adverse Event|0
64951|NCT01070043|240121|P1|Double-Blind Treatment|Adverse Event|0
64952|NCT01070043|240119|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
64953|NCT01070043|240120|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
64954|NCT01070043|240121|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
64955|NCT01069939|240137|P2|Randomised and Included in the Analyses|Removal|0
64956|NCT01069939|240138|P1|Randomised and Included in the Analyses|Removal|1
64957|NCT01069939|240137|P2|Randomised and Included in the Analyses|Physician Decision|2
64958|NCT01069939|240138|P1|Randomised and Included in the Analyses|Physician Decision|0
64959|NCT01069939|240137|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
64960|NCT01069939|240138|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
64961|NCT01069939|240137|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
64962|NCT01069939|240138|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
64963|NCT01069939|240137|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
64964|NCT01069939|240138|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
64965|NCT01069939|240137|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
64966|NCT01069939|240138|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
64967|NCT01069939|240137|P2|Randomised and Included in the Analyses|Protocol Violation|1
64968|NCT01069939|240138|P1|Randomised and Included in the Analyses|Protocol Violation|0
64969|NCT01069939|240137|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
64970|NCT01069939|240138|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
64971|NCT01069939|240137|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
64972|NCT01069939|240138|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
64973|NCT01069939|240137|P2|Randomised and Included in the Analyses|Adverse Event|22
64974|NCT01069939|240138|P1|Randomised and Included in the Analyses|Adverse Event|17
64975|NCT01069900|240164|P2|Overall Study|Insufficient Therapeutic effect|0
64976|NCT01069900|240165|P1|Overall Study|Insufficient Therapeutic effect|1
64977|NCT01069900|240164|P2|Overall Study|Protocol Violation|1
64978|NCT01069900|240165|P1|Overall Study|Protocol Violation|4
64979|NCT01069900|240164|P2|Overall Study|Withdrawal by Subject|1
64980|NCT01069900|240165|P1|Overall Study|Withdrawal by Subject|6
64981|NCT01069900|240164|P2|Overall Study|Lost to Follow-up|1
64982|NCT01069900|240165|P1|Overall Study|Lost to Follow-up|7
64983|NCT01069900|240164|P2|Overall Study|Technical problems|1
64984|NCT01069900|240165|P1|Overall Study|Technical problems|0
64985|NCT01069861|240209|P1|Overall Study|Did not meet entrance criteria|1
64986|NCT01069861|240209|P1|Overall Study|Adverse Event|1
64987|NCT01069861|240209|P1|Overall Study|Death|1
64988|NCT01069627|240222|P1|Overall Study|Protocol Violation|1
64989|NCT01069627|240222|P1|Overall Study|Adverse Event|12
64990|NCT01069627|240222|P1|Overall Study|Disease progression|7
64991|NCT01069523|240272|P2|Overall Study|Withdrawal by Subject|7
64992|NCT01069523|240273|P1|Overall Study|Withdrawal by Subject|4
64993|NCT01069484|240283|P2|Overall Study|Illness mother or child|1
64994|NCT01069484|240284|P1|Overall Study|Illness mother or child|3
64995|NCT01069484|240283|P2|Overall Study|No specific reason|2
64996|NCT01069484|240284|P1|Overall Study|No specific reason|8
64997|NCT01069484|240283|P2|Overall Study|Death-in-near-family|0
64998|NCT01069484|240284|P1|Overall Study|Death-in-near-family|1
64999|NCT01069419|240292|P1|Overall Study|Missing termination information|13
65000|NCT01069419|240292|P1|Overall Study|Other Reason|43
65001|NCT01069419|240292|P1|Overall Study|Withdrawal by Subject|34
65002|NCT01069419|240292|P1|Overall Study|Remission of disease|11
65003|NCT01069419|240292|P1|Overall Study|Lost to Follow-up|49
65004|NCT01069419|240292|P1|Overall Study|Lack of Efficacy|332
65005|NCT01069419|240292|P1|Overall Study|Adverse Event|233
65006|NCT01069341|240299|P1|Overall Study|Lost to Follow-up|1
65007|NCT01069289|240312|P2|Overall Study|Due to deteriorating health condition|0
65008|NCT01069289|240313|P1|Overall Study|Due to deteriorating health condition|1
65009|NCT01069289|240312|P2|Overall Study|Severe non-compliance to protocol|2
65010|NCT01069289|240313|P1|Overall Study|Severe non-compliance to protocol|3
65011|NCT01069289|240312|P2|Overall Study|Eligibility criteria not fulfilled|0
65012|NCT01069289|240313|P1|Overall Study|Eligibility criteria not fulfilled|2
65013|NCT01069289|240312|P2|Overall Study|Adverse Event|28
65014|NCT01069289|240313|P1|Overall Study|Adverse Event|21
65015|NCT01069289|240312|P2|Overall Study|Withdrawal by Subject|26
65016|NCT01069289|240313|P1|Overall Study|Withdrawal by Subject|15
65017|NCT01069172|240351|P2|Overall Study|Withdrawal by Subject|0
65018|NCT01069172|240352|P1|Overall Study|Withdrawal by Subject|1
65019|NCT01069120|240362|P1|Overall Study|Study prematurely terminated|27
65020|NCT01068912|240399|P3|Overall Study|other underlying illness|3
65021|NCT01068912|240400|P2|Overall Study|other underlying illness|3
65022|NCT01068912|240401|P1|Overall Study|other underlying illness|0
65023|NCT01068912|240399|P3|Overall Study|aggravation influenza|1
65024|NCT01068912|240400|P2|Overall Study|aggravation influenza|1
65025|NCT01068912|240401|P1|Overall Study|aggravation influenza|1
65026|NCT01068912|240399|P3|Overall Study|Protocol Violation|0
65027|NCT01068912|240400|P2|Overall Study|Protocol Violation|2
65028|NCT01068912|240401|P1|Overall Study|Protocol Violation|0
65029|NCT01068912|240399|P3|Overall Study|Lost to Follow-up|3
65030|NCT01068912|240400|P2|Overall Study|Lost to Follow-up|7
65031|NCT01068912|240401|P1|Overall Study|Lost to Follow-up|3
65032|NCT01068912|240399|P3|Overall Study|Withdrawal by Subject|6
65033|NCT01068912|240400|P2|Overall Study|Withdrawal by Subject|6
65034|NCT01068912|240401|P1|Overall Study|Withdrawal by Subject|5
65035|NCT01068912|240399|P3|Overall Study|Adverse Event|2
65036|NCT01068912|240400|P2|Overall Study|Adverse Event|3
65037|NCT01068912|240401|P1|Overall Study|Adverse Event|2
65038|NCT01068860|240419|P10|Overall Study|Lost to Follow-up|0
65039|NCT01068860|240420|P9|Overall Study|Lost to Follow-up|0
65040|NCT01068860|240421|P8|Overall Study|Lost to Follow-up|0
65041|NCT01068860|240422|P7|Overall Study|Lost to Follow-up|0
65042|NCT01068860|240423|P6|Overall Study|Lost to Follow-up|0
65043|NCT01068860|240424|P5|Overall Study|Lost to Follow-up|0
65044|NCT01068860|240425|P4|Overall Study|Lost to Follow-up|0
65045|NCT01068860|240426|P3|Overall Study|Lost to Follow-up|0
65046|NCT01068860|240427|P2|Overall Study|Lost to Follow-up|1
65047|NCT01068860|240428|P1|Overall Study|Lost to Follow-up|0
65048|NCT01068860|240419|P10|Overall Study|Administrative problems; misrandomized|1
65049|NCT01068860|240420|P9|Overall Study|Administrative problems; misrandomized|0
65050|NCT01068860|240421|P8|Overall Study|Administrative problems; misrandomized|0
65051|NCT01068860|240422|P7|Overall Study|Administrative problems; misrandomized|0
65052|NCT01068860|240423|P6|Overall Study|Administrative problems; misrandomized|0
65053|NCT01068860|240424|P5|Overall Study|Administrative problems; misrandomized|0
65054|NCT01068860|240425|P4|Overall Study|Administrative problems; misrandomized|1
65055|NCT01068860|240426|P3|Overall Study|Administrative problems; misrandomized|0
65056|NCT01068860|240427|P2|Overall Study|Administrative problems; misrandomized|0
65057|NCT01068860|240428|P1|Overall Study|Administrative problems; misrandomized|0
65058|NCT01068860|240419|P10|Overall Study|Withdrawal by Subject|3
65059|NCT01068860|240420|P9|Overall Study|Withdrawal by Subject|0
65060|NCT01068860|240421|P8|Overall Study|Withdrawal by Subject|0
65061|NCT01068860|240422|P7|Overall Study|Withdrawal by Subject|0
65062|NCT01068860|240423|P6|Overall Study|Withdrawal by Subject|2
65063|NCT01068860|240424|P5|Overall Study|Withdrawal by Subject|0
65064|NCT01068860|240425|P4|Overall Study|Withdrawal by Subject|0
65065|NCT01068860|240426|P3|Overall Study|Withdrawal by Subject|0
65066|NCT01068860|240427|P2|Overall Study|Withdrawal by Subject|0
65067|NCT01068860|240428|P1|Overall Study|Withdrawal by Subject|0
65068|NCT01068769|240611|P1|Overall Study|Ineligible|1
65069|NCT01068743|240616|P4|Period 3|Adverse Event|0
65070|NCT01068743|240617|P3|Period 3|Adverse Event|0
65071|NCT01068743|240618|P2|Period 3|Adverse Event|1
65072|NCT01068743|240619|P1|Period 3|Adverse Event|0
65073|NCT01068730|240693|P4|Period 4|Family emergency|0
65074|NCT01068730|240694|P3|Period 4|Family emergency|0
65075|NCT01068730|240695|P2|Period 4|Family emergency|1
65076|NCT01068730|240696|P1|Period 4|Family emergency|0
65077|NCT01068730|240693|P4|Period 3|Personal reason|0
65078|NCT01068730|240694|P3|Period 3|Personal reason|0
65079|NCT01068730|240695|P2|Period 3|Personal reason|0
65080|NCT01068730|240696|P1|Period 3|Personal reason|1
65081|NCT01068717|240750|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
65082|NCT01068717|240751|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
65083|NCT01068717|240752|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
65084|NCT01068717|240753|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
65085|NCT01068678|240809|P2|Overall Study|Unclassified|15
65086|NCT01068678|240810|P1|Overall Study|Unclassified|18
65087|NCT01068678|240809|P2|Overall Study|Withdrawal criteria|6
65088|NCT01068678|240810|P1|Overall Study|Withdrawal criteria|12
65089|NCT01068678|240809|P2|Overall Study|Protocol Violation|1
65090|NCT01068678|240810|P1|Overall Study|Protocol Violation|5
65091|NCT01068678|240809|P2|Overall Study|Lack of Efficacy|2
65092|NCT01068678|240810|P1|Overall Study|Lack of Efficacy|3
65093|NCT01068665|240820|P2|Overall Study|Other|12
65094|NCT01068665|240821|P1|Overall Study|Other|17
65095|NCT01068665|240820|P2|Overall Study|Withdrawal Criteria|9
65096|NCT01068665|240821|P1|Overall Study|Withdrawal Criteria|3
65097|NCT01068665|240820|P2|Overall Study|Protocol Violation|2
65098|NCT01068665|240821|P1|Overall Study|Protocol Violation|5
65099|NCT01068665|240820|P2|Overall Study|Lack of Efficacy|2
65100|NCT01068665|240821|P1|Overall Study|Lack of Efficacy|0
65101|NCT01068665|240820|P2|Overall Study|Adverse Event|4
65102|NCT01068665|240821|P1|Overall Study|Adverse Event|5
65103|NCT01068652|240831|P2|Overall Study|Unclassified|4
65104|NCT01068652|240832|P1|Overall Study|Unclassified|7
65105|NCT01068652|240831|P2|Overall Study|Patient was not eligible|0
65106|NCT01068652|240832|P1|Overall Study|Patient was not eligible|1
65107|NCT01068652|240831|P2|Overall Study|Withdrawal criteria|2
65108|NCT01068652|240832|P1|Overall Study|Withdrawal criteria|1
65109|NCT01068652|240831|P2|Overall Study|Protocol Violation|6
65110|NCT01068652|240832|P1|Overall Study|Protocol Violation|3
65111|NCT01068652|240831|P2|Overall Study|Lost to Follow-up|1
65112|NCT01068652|240832|P1|Overall Study|Lost to Follow-up|2
65113|NCT01068652|240831|P2|Overall Study|Lack of Efficacy|2
65114|NCT01068652|240832|P1|Overall Study|Lack of Efficacy|0
65115|NCT01068652|240831|P2|Overall Study|Adverse Event|0
65116|NCT01068652|240832|P1|Overall Study|Adverse Event|4
65117|NCT01068626|240872|P2|Overall Study|Withdrawal by Subject|2
65118|NCT01068626|240873|P1|Overall Study|Withdrawal by Subject|0
65119|NCT01068626|240872|P2|Overall Study|Adverse Event|0
65120|NCT01068626|240873|P1|Overall Study|Adverse Event|3
65121|NCT01068600|240891|P2|Overall Study|Administrative problems|1
65122|NCT01068600|240892|P1|Overall Study|Administrative problems|0
65123|NCT01068600|240891|P2|Overall Study|Unsatisfactory therapeutic effect|4
65124|NCT01068600|240892|P1|Overall Study|Unsatisfactory therapeutic effect|0
65125|NCT01068600|240891|P2|Overall Study|Protocol deviation|1
65126|NCT01068600|240892|P1|Overall Study|Protocol deviation|1
65127|NCT01068600|240891|P2|Overall Study|Lost to Follow-up|2
65128|NCT01068600|240892|P1|Overall Study|Lost to Follow-up|1
65129|NCT01068600|240891|P2|Overall Study|Abnormal laboratory value(s)|0
65130|NCT01068600|240892|P1|Overall Study|Abnormal laboratory value(s)|1
65131|NCT01068600|240891|P2|Overall Study|Adverse Event|3
65132|NCT01068600|240892|P1|Overall Study|Adverse Event|3
65133|NCT01068600|240891|P2|Overall Study|Withdrawal by Subject|6
65134|NCT01068600|240892|P1|Overall Study|Withdrawal by Subject|5
65135|NCT01068509|240912|P3|Overall Study|Reason Not Specified|0
65136|NCT01068509|240913|P2|Overall Study|Reason Not Specified|1
65137|NCT01068509|240914|P1|Overall Study|Reason Not Specified|0
65138|NCT01068509|240912|P3|Overall Study|Withdrew Consent|2
65139|NCT01068509|240913|P2|Overall Study|Withdrew Consent|1
65140|NCT01068509|240914|P1|Overall Study|Withdrew Consent|0
65141|NCT01068509|240912|P3|Overall Study|Lost to Follow-up|0
65142|NCT01068509|240913|P2|Overall Study|Lost to Follow-up|0
65143|NCT01068509|240914|P1|Overall Study|Lost to Follow-up|1
65144|NCT01068509|240912|P3|Overall Study|Disease Progression|18
65145|NCT01068509|240913|P2|Overall Study|Disease Progression|20
65146|NCT01068509|240914|P1|Overall Study|Disease Progression|5
65147|NCT01068509|240912|P3|Overall Study|Death|1
65148|NCT01068509|240913|P2|Overall Study|Death|0
65149|NCT01068509|240914|P1|Overall Study|Death|0
65150|NCT01068418|240927|P1|Overall Study|Physician Decision|12
65151|NCT01068158|240934|P2|Overall Study|Protocol Violation|2
65152|NCT01068158|240935|P1|Overall Study|Protocol Violation|0
65153|NCT01068158|240934|P2|Overall Study|Lost to Follow-up|0
65154|NCT01068158|240935|P1|Overall Study|Lost to Follow-up|7
65155|NCT01068158|240934|P2|Overall Study|Withdrawal by Subject|2
65156|NCT01068158|240935|P1|Overall Study|Withdrawal by Subject|1
65157|NCT01067976|240947|P1|Overall Study|Study prematurely discontinued|2
65158|NCT01067976|240947|P1|Overall Study|Study drug never administered|20
65159|NCT01067846|241008|P2|Overall Study|participation in other tx study|0
65160|NCT01067846|241009|P1|Overall Study|participation in other tx study|1
65161|NCT01067846|241008|P2|Overall Study|Withdrawal by Subject|0
65162|NCT01067846|241009|P1|Overall Study|Withdrawal by Subject|1
65163|NCT01067846|241008|P2|Overall Study|Lost to Follow-up|19
65164|NCT01067846|241009|P1|Overall Study|Lost to Follow-up|17
65165|NCT01067352|241077|P3|Overall Study|Physician Decision|0
65166|NCT01067352|241078|P2|Overall Study|Physician Decision|1
65167|NCT01067352|241079|P1|Overall Study|Physician Decision|0
65168|NCT01067352|241077|P3|Overall Study|Withdrawal by Subject|1
65169|NCT01067352|241078|P2|Overall Study|Withdrawal by Subject|2
65170|NCT01067352|241079|P1|Overall Study|Withdrawal by Subject|1
65171|NCT01067326|241095|P2|Overall Study|Early Study Termination|1
65172|NCT01067326|241096|P1|Overall Study|Early Study Termination|1
65173|NCT01067326|241095|P2|Overall Study|Withdrawal by Subject|0
65174|NCT01067326|241096|P1|Overall Study|Withdrawal by Subject|1
65175|NCT01067326|241095|P2|Overall Study|Adverse Event|2
65176|NCT01067326|241096|P1|Overall Study|Adverse Event|0
65177|NCT01067105|241108|P1|Overall Study|Other|31
65178|NCT01067105|241108|P1|Overall Study|Physician Decision|6
65179|NCT01067105|241108|P1|Overall Study|Lost to Follow-up|6
65180|NCT01067105|241108|P1|Overall Study|Withdrawal by Subject|36
65181|NCT01067105|241108|P1|Overall Study|Protocol Violation|48
65182|NCT01067105|241108|P1|Overall Study|Adverse Event|14
65183|NCT01066923|241129|P4|Overall Study|Withdrawal by Subject|8
65184|NCT01066923|241130|P3|Overall Study|Withdrawal by Subject|8
65185|NCT01066923|241131|P2|Overall Study|Withdrawal by Subject|3
65186|NCT01066923|241132|P1|Overall Study|Withdrawal by Subject|3
65187|NCT01066871|241150|P4|Overall Study|Unspecified|2
65188|NCT01066871|241151|P3|Overall Study|Unspecified|1
65189|NCT01066871|241152|P2|Overall Study|Unspecified|2
65190|NCT01066871|241153|P1|Overall Study|Unspecified|0
65191|NCT01066871|241150|P4|Overall Study|Withdrawal by Subject|0
65192|NCT01066871|241151|P3|Overall Study|Withdrawal by Subject|0
65193|NCT01066871|241152|P2|Overall Study|Withdrawal by Subject|1
65194|NCT01066871|241153|P1|Overall Study|Withdrawal by Subject|3
65195|NCT01066871|241150|P4|Overall Study|Lack of Efficacy|1
65196|NCT01066871|241151|P3|Overall Study|Lack of Efficacy|0
65197|NCT01066871|241152|P2|Overall Study|Lack of Efficacy|0
65198|NCT01066871|241153|P1|Overall Study|Lack of Efficacy|0
65199|NCT01066871|241150|P4|Overall Study|Protocol Violation|2
65200|NCT01066871|241151|P3|Overall Study|Protocol Violation|3
65201|NCT01066871|241152|P2|Overall Study|Protocol Violation|0
65202|NCT01066871|241153|P1|Overall Study|Protocol Violation|1
65203|NCT01066871|241150|P4|Overall Study|Lost to Follow-up|0
65204|NCT01066871|241151|P3|Overall Study|Lost to Follow-up|2
65205|NCT01066871|241152|P2|Overall Study|Lost to Follow-up|2
65206|NCT01066871|241153|P1|Overall Study|Lost to Follow-up|0
65207|NCT01066819|241217|P6|Overall Study|Other|0
65208|NCT01066819|241218|P5|Overall Study|Other|0
65209|NCT01066819|241219|P4|Overall Study|Other|0
65210|NCT01066819|241220|P3|Overall Study|Other|1
65211|NCT01066819|241221|P2|Overall Study|Other|1
65212|NCT01066819|241222|P1|Overall Study|Other|5
65213|NCT01066819|241217|P6|Overall Study|Treatment stopped|0
65214|NCT01066819|241218|P5|Overall Study|Treatment stopped|0
65215|NCT01066819|241219|P4|Overall Study|Treatment stopped|1
65216|NCT01066819|241220|P3|Overall Study|Treatment stopped|2
65217|NCT01066819|241221|P2|Overall Study|Treatment stopped|1
65218|NCT01066819|241222|P1|Overall Study|Treatment stopped|12
65219|NCT01066819|241217|P6|Overall Study|Treatment never started|2
65220|NCT01066819|241218|P5|Overall Study|Treatment never started|2
65221|NCT01066819|241219|P4|Overall Study|Treatment never started|3
65222|NCT01066819|241220|P3|Overall Study|Treatment never started|19
65223|NCT01066819|241221|P2|Overall Study|Treatment never started|19
65224|NCT01066819|241222|P1|Overall Study|Treatment never started|85
65225|NCT01066819|241217|P6|Overall Study|Spontaneous cure|0
65226|NCT01066819|241218|P5|Overall Study|Spontaneous cure|0
65227|NCT01066819|241219|P4|Overall Study|Spontaneous cure|0
65228|NCT01066819|241220|P3|Overall Study|Spontaneous cure|0
65229|NCT01066819|241221|P2|Overall Study|Spontaneous cure|0
65230|NCT01066819|241222|P1|Overall Study|Spontaneous cure|1
65231|NCT01066819|241217|P6|Overall Study|Screen failure|0
65232|NCT01066819|241218|P5|Overall Study|Screen failure|0
65233|NCT01066819|241219|P4|Overall Study|Screen failure|0
65234|NCT01066819|241220|P3|Overall Study|Screen failure|0
65235|NCT01066819|241221|P2|Overall Study|Screen failure|0
65236|NCT01066819|241222|P1|Overall Study|Screen failure|1
65237|NCT01066819|241217|P6|Overall Study|Results not available|0
65238|NCT01066819|241218|P5|Overall Study|Results not available|0
65239|NCT01066819|241219|P4|Overall Study|Results not available|0
65240|NCT01066819|241220|P3|Overall Study|Results not available|0
65241|NCT01066819|241221|P2|Overall Study|Results not available|0
65242|NCT01066819|241222|P1|Overall Study|Results not available|1
65243|NCT01066819|241217|P6|Overall Study|Relapse|0
65244|NCT01066819|241218|P5|Overall Study|Relapse|0
65245|NCT01066819|241219|P4|Overall Study|Relapse|0
65246|NCT01066819|241220|P3|Overall Study|Relapse|3
65247|NCT01066819|241221|P2|Overall Study|Relapse|4
65248|NCT01066819|241222|P1|Overall Study|Relapse|16
65249|NCT01066819|241217|P6|Overall Study|Not categorised|0
65250|NCT01066819|241218|P5|Overall Study|Not categorised|0
65251|NCT01066819|241219|P4|Overall Study|Not categorised|1
65252|NCT01066819|241220|P3|Overall Study|Not categorised|6
65253|NCT01066819|241221|P2|Overall Study|Not categorised|2
65254|NCT01066819|241222|P1|Overall Study|Not categorised|9
65255|NCT01066819|241217|P6|Overall Study|Non responders|1
65256|NCT01066819|241218|P5|Overall Study|Non responders|0
65257|NCT01066819|241219|P4|Overall Study|Non responders|2
65258|NCT01066819|241220|P3|Overall Study|Non responders|7
65259|NCT01066819|241221|P2|Overall Study|Non responders|2
65260|NCT01066819|241222|P1|Overall Study|Non responders|123
65261|NCT01066819|241217|P6|Overall Study|Miscellaneous|0
65262|NCT01066819|241218|P5|Overall Study|Miscellaneous|0
65263|NCT01066819|241219|P4|Overall Study|Miscellaneous|1
65264|NCT01066819|241220|P3|Overall Study|Miscellaneous|18
65265|NCT01066819|241221|P2|Overall Study|Miscellaneous|10
65266|NCT01066819|241222|P1|Overall Study|Miscellaneous|28
65267|NCT01066819|241217|P6|Overall Study|Lab test not done|0
65268|NCT01066819|241218|P5|Overall Study|Lab test not done|0
65269|NCT01066819|241219|P4|Overall Study|Lab test not done|1
65270|NCT01066819|241220|P3|Overall Study|Lab test not done|2
65271|NCT01066819|241221|P2|Overall Study|Lab test not done|0
65272|NCT01066819|241222|P1|Overall Study|Lab test not done|9
65273|NCT01066819|241217|P6|Overall Study|Failed to return|3
65274|NCT01066819|241218|P5|Overall Study|Failed to return|2
65275|NCT01066819|241219|P4|Overall Study|Failed to return|7
65276|NCT01066819|241220|P3|Overall Study|Failed to return|68
65277|NCT01066819|241221|P2|Overall Study|Failed to return|107
65278|NCT01066819|241222|P1|Overall Study|Failed to return|298
65279|NCT01066819|241217|P6|Overall Study|Early termination|0
65280|NCT01066819|241218|P5|Overall Study|Early termination|0
65281|NCT01066819|241219|P4|Overall Study|Early termination|0
65282|NCT01066819|241220|P3|Overall Study|Early termination|0
65283|NCT01066819|241221|P2|Overall Study|Early termination|0
65284|NCT01066819|241222|P1|Overall Study|Early termination|2
65285|NCT01066819|241217|P6|Overall Study|Not met inclusion/exclusion criteria|0
65286|NCT01066819|241218|P5|Overall Study|Not met inclusion/exclusion criteria|0
65287|NCT01066819|241219|P4|Overall Study|Not met inclusion/exclusion criteria|0
65288|NCT01066819|241220|P3|Overall Study|Not met inclusion/exclusion criteria|0
65289|NCT01066819|241221|P2|Overall Study|Not met inclusion/exclusion criteria|0
65290|NCT01066819|241222|P1|Overall Study|Not met inclusion/exclusion criteria|1
65291|NCT01066819|241217|P6|Overall Study|Administrative|0
65292|NCT01066819|241218|P5|Overall Study|Administrative|0
65293|NCT01066819|241219|P4|Overall Study|Administrative|0
65294|NCT01066819|241220|P3|Overall Study|Administrative|2
65295|NCT01066819|241221|P2|Overall Study|Administrative|4
65296|NCT01066819|241222|P1|Overall Study|Administrative|6
65297|NCT01066819|241217|P6|Overall Study|Withdrawal by Subject|0
65298|NCT01066819|241218|P5|Overall Study|Withdrawal by Subject|0
65299|NCT01066819|241219|P4|Overall Study|Withdrawal by Subject|0
65300|NCT01066819|241220|P3|Overall Study|Withdrawal by Subject|6
65301|NCT01066819|241221|P2|Overall Study|Withdrawal by Subject|11
65302|NCT01066819|241222|P1|Overall Study|Withdrawal by Subject|29
65303|NCT01066819|241217|P6|Overall Study|Protocol Violation|0
65304|NCT01066819|241218|P5|Overall Study|Protocol Violation|0
65305|NCT01066819|241219|P4|Overall Study|Protocol Violation|0
65306|NCT01066819|241220|P3|Overall Study|Protocol Violation|0
65307|NCT01066819|241221|P2|Overall Study|Protocol Violation|6
65308|NCT01066819|241222|P1|Overall Study|Protocol Violation|12
65309|NCT01066819|241217|P6|Overall Study|Physician Decision|0
65310|NCT01066819|241218|P5|Overall Study|Physician Decision|0
65311|NCT01066819|241219|P4|Overall Study|Physician Decision|0
65312|NCT01066819|241220|P3|Overall Study|Physician Decision|3
65313|NCT01066819|241221|P2|Overall Study|Physician Decision|2
65314|NCT01066819|241222|P1|Overall Study|Physician Decision|6
65315|NCT01066819|241217|P6|Overall Study|Lack of Efficacy|0
65316|NCT01066819|241218|P5|Overall Study|Lack of Efficacy|0
65317|NCT01066819|241219|P4|Overall Study|Lack of Efficacy|1
65318|NCT01066819|241220|P3|Overall Study|Lack of Efficacy|2
65319|NCT01066819|241221|P2|Overall Study|Lack of Efficacy|1
65320|NCT01066819|241222|P1|Overall Study|Lack of Efficacy|22
65321|NCT01066819|241217|P6|Overall Study|Death|0
65322|NCT01066819|241218|P5|Overall Study|Death|0
65323|NCT01066819|241219|P4|Overall Study|Death|0
65324|NCT01066819|241220|P3|Overall Study|Death|1
65325|NCT01066819|241221|P2|Overall Study|Death|0
65326|NCT01066819|241222|P1|Overall Study|Death|5
65327|NCT01066819|241217|P6|Overall Study|Adverse Event|0
65328|NCT01066819|241218|P5|Overall Study|Adverse Event|0
65329|NCT01066819|241219|P4|Overall Study|Adverse Event|0
65330|NCT01066819|241220|P3|Overall Study|Adverse Event|6
65331|NCT01066819|241221|P2|Overall Study|Adverse Event|1
65332|NCT01066819|241222|P1|Overall Study|Adverse Event|18
65333|NCT01066793|241363|P6|Overall Study|Treatment Stopped|0
65334|NCT01066793|241364|P5|Overall Study|Treatment Stopped|0
65335|NCT01066793|241365|P4|Overall Study|Treatment Stopped|1
65336|NCT01066793|241366|P3|Overall Study|Treatment Stopped|0
65337|NCT01066793|241367|P2|Overall Study|Treatment Stopped|1
65338|NCT01066793|241368|P1|Overall Study|Treatment Stopped|2
65339|NCT01066793|241363|P6|Overall Study|Treatment Never Started|0
65340|NCT01066793|241364|P5|Overall Study|Treatment Never Started|0
65341|NCT01066793|241365|P4|Overall Study|Treatment Never Started|1
65342|NCT01066793|241366|P3|Overall Study|Treatment Never Started|4
65343|NCT01066793|241367|P2|Overall Study|Treatment Never Started|5
65344|NCT01066793|241368|P1|Overall Study|Treatment Never Started|18
65345|NCT01066793|241363|P6|Overall Study|Treatment Interrupted|0
65346|NCT01066793|241364|P5|Overall Study|Treatment Interrupted|0
65347|NCT01066793|241365|P4|Overall Study|Treatment Interrupted|0
65348|NCT01066793|241366|P3|Overall Study|Treatment Interrupted|0
65349|NCT01066793|241367|P2|Overall Study|Treatment Interrupted|1
65350|NCT01066793|241368|P1|Overall Study|Treatment Interrupted|1
65351|NCT01066793|241363|P6|Overall Study|Result Not Available|0
65352|NCT01066793|241364|P5|Overall Study|Result Not Available|0
65353|NCT01066793|241365|P4|Overall Study|Result Not Available|0
65354|NCT01066793|241366|P3|Overall Study|Result Not Available|0
65355|NCT01066793|241367|P2|Overall Study|Result Not Available|0
65356|NCT01066793|241368|P1|Overall Study|Result Not Available|1
65357|NCT01066793|241363|P6|Overall Study|Relapse|0
65358|NCT01066793|241364|P5|Overall Study|Relapse|0
65359|NCT01066793|241365|P4|Overall Study|Relapse|3
65360|NCT01066793|241366|P3|Overall Study|Relapse|2
65361|NCT01066793|241367|P2|Overall Study|Relapse|8
65362|NCT01066793|241368|P1|Overall Study|Relapse|20
65363|NCT01066793|241363|P6|Overall Study|Other|0
65364|NCT01066793|241364|P5|Overall Study|Other|0
65365|NCT01066793|241365|P4|Overall Study|Other|2
65366|NCT01066793|241366|P3|Overall Study|Other|6
65367|NCT01066793|241367|P2|Overall Study|Other|5
65368|NCT01066793|241368|P1|Overall Study|Other|15
65369|NCT01066793|241363|P6|Overall Study|Non-responders|0
65370|NCT01066793|241364|P5|Overall Study|Non-responders|0
65371|NCT01066793|241365|P4|Overall Study|Non-responders|25
65372|NCT01066793|241366|P3|Overall Study|Non-responders|11
65373|NCT01066793|241367|P2|Overall Study|Non-responders|5
65374|NCT01066793|241368|P1|Overall Study|Non-responders|104
65375|NCT01066793|241363|P6|Overall Study|Miscellaneous|0
65376|NCT01066793|241364|P5|Overall Study|Miscellaneous|0
65377|NCT01066793|241365|P4|Overall Study|Miscellaneous|0
65378|NCT01066793|241366|P3|Overall Study|Miscellaneous|6
65379|NCT01066793|241367|P2|Overall Study|Miscellaneous|5
65380|NCT01066793|241368|P1|Overall Study|Miscellaneous|4
65381|NCT01066793|241363|P6|Overall Study|Lab test not done|0
65382|NCT01066793|241364|P5|Overall Study|Lab test not done|0
65383|NCT01066793|241365|P4|Overall Study|Lab test not done|1
65384|NCT01066793|241366|P3|Overall Study|Lab test not done|0
65385|NCT01066793|241367|P2|Overall Study|Lab test not done|0
65386|NCT01066793|241368|P1|Overall Study|Lab test not done|7
65387|NCT01066793|241363|P6|Overall Study|Early Termination|0
65388|NCT01066793|241364|P5|Overall Study|Early Termination|0
65389|NCT01066793|241365|P4|Overall Study|Early Termination|0
65390|NCT01066793|241366|P3|Overall Study|Early Termination|0
65391|NCT01066793|241367|P2|Overall Study|Early Termination|0
65392|NCT01066793|241368|P1|Overall Study|Early Termination|3
65393|NCT01066793|241363|P6|Overall Study|Withdrawal by Subject|0
65394|NCT01066793|241364|P5|Overall Study|Withdrawal by Subject|0
65395|NCT01066793|241365|P4|Overall Study|Withdrawal by Subject|0
65396|NCT01066793|241366|P3|Overall Study|Withdrawal by Subject|1
65397|NCT01066793|241367|P2|Overall Study|Withdrawal by Subject|4
65398|NCT01066793|241368|P1|Overall Study|Withdrawal by Subject|7
65399|NCT01066793|241363|P6|Overall Study|Protocol Violation|0
65400|NCT01066793|241364|P5|Overall Study|Protocol Violation|0
65401|NCT01066793|241365|P4|Overall Study|Protocol Violation|0
65402|NCT01066793|241366|P3|Overall Study|Protocol Violation|2
65403|NCT01066793|241367|P2|Overall Study|Protocol Violation|2
65404|NCT01066793|241368|P1|Overall Study|Protocol Violation|3
65405|NCT01066793|241363|P6|Overall Study|Physician Decision|0
65406|NCT01066793|241364|P5|Overall Study|Physician Decision|0
65407|NCT01066793|241365|P4|Overall Study|Physician Decision|0
65408|NCT01066793|241366|P3|Overall Study|Physician Decision|0
65409|NCT01066793|241367|P2|Overall Study|Physician Decision|0
65410|NCT01066793|241368|P1|Overall Study|Physician Decision|3
65411|NCT01066793|241363|P6|Overall Study|Lost to Follow-up|1
65412|NCT01066793|241364|P5|Overall Study|Lost to Follow-up|0
65413|NCT01066793|241365|P4|Overall Study|Lost to Follow-up|16
65414|NCT01066793|241366|P3|Overall Study|Lost to Follow-up|82
65415|NCT01066793|241367|P2|Overall Study|Lost to Follow-up|39
65416|NCT01066793|241368|P1|Overall Study|Lost to Follow-up|180
65417|NCT01066793|241363|P6|Overall Study|Lack of Efficacy|0
65418|NCT01066793|241364|P5|Overall Study|Lack of Efficacy|0
65419|NCT01066793|241365|P4|Overall Study|Lack of Efficacy|0
65420|NCT01066793|241366|P3|Overall Study|Lack of Efficacy|0
65421|NCT01066793|241367|P2|Overall Study|Lack of Efficacy|1
65422|NCT01066793|241368|P1|Overall Study|Lack of Efficacy|2
65423|NCT01066793|241363|P6|Overall Study|Death|0
65424|NCT01066793|241364|P5|Overall Study|Death|0
65425|NCT01066793|241365|P4|Overall Study|Death|0
65426|NCT01066793|241366|P3|Overall Study|Death|1
65427|NCT01066793|241367|P2|Overall Study|Death|1
65428|NCT01066793|241368|P1|Overall Study|Death|4
65429|NCT01066780|241508|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
65430|NCT01066780|241509|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
65431|NCT01066585|241528|P2|Overall Study|Withdrawal by Subject|3
65432|NCT01066585|241529|P1|Overall Study|Withdrawal by Subject|0
65433|NCT01066585|241528|P2|Overall Study|Protocol Violation|0
65434|NCT01066585|241529|P1|Overall Study|Protocol Violation|1
65435|NCT01066546|241541|P1|Overall Study|Study terminated by sponsor|5
65436|NCT01066039|241571|P1|Overall Study|Drug/Dose Adjustment Required|1
65437|NCT01066039|241571|P1|Overall Study|Failure to Control Blood Pressure|1
65438|NCT01066039|241571|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
65439|NCT01066039|241571|P1|Overall Study|Additional Antihypertensive Required|4
65440|NCT01066039|241571|P1|Overall Study|Dropout due to Insulin Administration|1
65441|NCT01066039|241571|P1|Overall Study|Investigator’s Request|1
65442|NCT01066039|241571|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
65443|NCT01066039|241571|P1|Overall Study|Protocol Violation|2
65444|NCT01066039|241571|P1|Overall Study|Withdrawal by Subject|17
65445|NCT01066039|241571|P1|Overall Study|Adverse Event|6
65446|NCT01066000|241584|P1|Overall Study|Adverse Event|1
65447|NCT01066000|241584|P1|Overall Study|Withdrawal by Subject|1
65448|NCT01066000|241584|P1|Overall Study|Death|3
65449|NCT01066000|241584|P1|Overall Study|Protocol Violation|4
65450|NCT01065844|241595|P1|Overall Study|Adverse Event|5
65451|NCT01065779|241599|P1|Overall Study|Inclusion Criteria Violation|7
65452|NCT01065779|241599|P1|Overall Study|Failed to Follow-up|10
65453|NCT01065779|241599|P1|Overall Study|Not Administered With Study Drug|17
65454|NCT01065779|241599|P1|Overall Study|Non-enrollment Period Administration|10
65455|NCT01065779|241599|P1|Overall Study|Investigation Before Contract Date|37
65456|NCT01065779|241599|P1|Overall Study|Duplicate Investigation|1
65457|NCT01065766|241610|P1|Overall Study|Violated dosage/administration|25
65458|NCT01065766|241610|P1|Overall Study|Contraindication to administration|6
65459|NCT01065766|241610|P1|Overall Study|Assessed before the contracted date|1
65460|NCT01065597|241629|P1|Overall Study|Adverse Event|1
65461|NCT01065454|241654|P4|Follow up|study ongoing|41
65462|NCT01065454|241655|P3|Follow up|study ongoing|15
65463|NCT01065454|241656|P2|Follow up|study ongoing|22
65464|NCT01065454|241657|P1|Follow up|study ongoing|37
65465|NCT01065454|241654|P4|Follow up|Withdrawal by Subject|0
65466|NCT01065454|241655|P3|Follow up|Withdrawal by Subject|1
65467|NCT01065454|241656|P2|Follow up|Withdrawal by Subject|1
65468|NCT01065454|241657|P1|Follow up|Withdrawal by Subject|1
65469|NCT01065454|241654|P4|Follow up|Progressive disease|1
65470|NCT01065454|241655|P3|Follow up|Progressive disease|0
65471|NCT01065454|241656|P2|Follow up|Progressive disease|0
65472|NCT01065454|241657|P1|Follow up|Progressive disease|0
65473|NCT01065454|241654|P4|Follow up|Lost to Follow-up|1
65474|NCT01065454|241655|P3|Follow up|Lost to Follow-up|0
65475|NCT01065454|241656|P2|Follow up|Lost to Follow-up|0
65476|NCT01065454|241657|P1|Follow up|Lost to Follow-up|0
65477|NCT01065454|241654|P4|Follow up|Death|0
65478|NCT01065454|241655|P3|Follow up|Death|1
65479|NCT01065454|241656|P2|Follow up|Death|1
65480|NCT01065454|241657|P1|Follow up|Death|0
65481|NCT01065454|241654|P4|Follow up|Adverse Event|1
65482|NCT01065454|241655|P3|Follow up|Adverse Event|0
65483|NCT01065454|241656|P2|Follow up|Adverse Event|0
65484|NCT01065454|241657|P1|Follow up|Adverse Event|1
65485|NCT01065454|241654|P4|Treatment|Withdrawal by Subject|3
65486|NCT01065454|241655|P3|Treatment|Withdrawal by Subject|2
65487|NCT01065454|241656|P2|Treatment|Withdrawal by Subject|1
65488|NCT01065454|241657|P1|Treatment|Withdrawal by Subject|3
65489|NCT01065454|241654|P4|Treatment|Protocol Violation|0
65490|NCT01065454|241655|P3|Treatment|Protocol Violation|1
65491|NCT01065454|241656|P2|Treatment|Protocol Violation|0
65492|NCT01065454|241657|P1|Treatment|Protocol Violation|1
65493|NCT01065454|241654|P4|Treatment|Protocol Decision|2
65494|NCT01065454|241655|P3|Treatment|Protocol Decision|3
65495|NCT01065454|241656|P2|Treatment|Protocol Decision|0
65496|NCT01065454|241657|P1|Treatment|Protocol Decision|0
65497|NCT01065454|241654|P4|Treatment|Non-compliance|1
65498|NCT01065454|241655|P3|Treatment|Non-compliance|0
65499|NCT01065454|241656|P2|Treatment|Non-compliance|0
65500|NCT01065454|241657|P1|Treatment|Non-compliance|1
65501|NCT01065454|241654|P4|Treatment|Death|0
65502|NCT01065454|241655|P3|Treatment|Death|0
65503|NCT01065454|241656|P2|Treatment|Death|0
65504|NCT01065454|241657|P1|Treatment|Death|1
65505|NCT01065454|241654|P4|Treatment|Adverse Event|6
65506|NCT01065454|241655|P3|Treatment|Adverse Event|3
65507|NCT01065454|241656|P2|Treatment|Adverse Event|4
65508|NCT01065454|241657|P1|Treatment|Adverse Event|7
65509|NCT01065350|241780|P2|Overall Study|Received incorrect drug allocation|1
65510|NCT01065350|241781|P1|Overall Study|Received incorrect drug allocation|0
65511|NCT01064947|241842|P1|Overall Study|negative culture|41
65512|NCT01064856|241883|P4|Open-label (OL) Period|Not specified|7
65513|NCT01064856|241884|P3|Open-label (OL) Period|Not specified|7
65514|NCT01064856|241885|P2|Open-label (OL) Period|Not specified|0
65515|NCT01064856|241886|P1|Open-label (OL) Period|Not specified|0
65516|NCT01064856|241883|P4|Open-label (OL) Period|Lost to Follow-up|1
65517|NCT01064856|241884|P3|Open-label (OL) Period|Lost to Follow-up|2
65518|NCT01064856|241885|P2|Open-label (OL) Period|Lost to Follow-up|0
65519|NCT01064856|241886|P1|Open-label (OL) Period|Lost to Follow-up|0
65520|NCT01064856|241883|P4|Open-label (OL) Period|Consent withdrawn by participant|6
65521|NCT01064856|241884|P3|Open-label (OL) Period|Consent withdrawn by participant|5
65522|NCT01064856|241885|P2|Open-label (OL) Period|Consent withdrawn by participant|0
65523|NCT01064856|241886|P1|Open-label (OL) Period|Consent withdrawn by participant|0
65524|NCT01064856|241883|P4|Open-label (OL) Period|Adverse Event|6
65525|NCT01064856|241884|P3|Open-label (OL) Period|Adverse Event|12
65526|NCT01064856|241885|P2|Open-label (OL) Period|Adverse Event|0
65527|NCT01064856|241886|P1|Open-label (OL) Period|Adverse Event|0
65528|NCT01064856|241883|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
65529|NCT01064856|241884|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
65530|NCT01064856|241885|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
65531|NCT01064856|241886|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
65532|NCT01064856|241883|P4|Double-blind (DB) Period|Adverse Event|0
65533|NCT01064856|241884|P3|Double-blind (DB) Period|Adverse Event|0
65534|NCT01064856|241885|P2|Double-blind (DB) Period|Adverse Event|0
65535|NCT01064856|241886|P1|Double-blind (DB) Period|Adverse Event|1
65536|NCT01064817|241930|P2|Study Completion|Withdrawal by Subject|0
65537|NCT01064817|241931|P1|Study Completion|Withdrawal by Subject|1
65538|NCT01064817|241930|P2|Study Completion|Physician Decision|0
65539|NCT01064817|241931|P1|Study Completion|Physician Decision|1
65540|NCT01064739|241943|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
65541|NCT01064687|242003|P4|Overall Study|Treatment Noncompliance|0
65542|NCT01064687|242004|P3|Overall Study|Treatment Noncompliance|1
65543|NCT01064687|242005|P2|Overall Study|Treatment Noncompliance|1
65544|NCT01064687|242006|P1|Overall Study|Treatment Noncompliance|1
65545|NCT01064687|242003|P4|Overall Study|Withdrawal by Subject|5
65546|NCT01064687|242004|P3|Overall Study|Withdrawal by Subject|12
65547|NCT01064687|242005|P2|Overall Study|Withdrawal by Subject|7
65548|NCT01064687|242006|P1|Overall Study|Withdrawal by Subject|9
65549|NCT01064687|242003|P4|Overall Study|Sponsor Decision|0
65550|NCT01064687|242004|P3|Overall Study|Sponsor Decision|3
65551|NCT01064687|242005|P2|Overall Study|Sponsor Decision|0
65552|NCT01064687|242006|P1|Overall Study|Sponsor Decision|0
65553|NCT01064687|242003|P4|Overall Study|Protocol Violation|1
65554|NCT01064687|242004|P3|Overall Study|Protocol Violation|0
65555|NCT01064687|242005|P2|Overall Study|Protocol Violation|1
65556|NCT01064687|242006|P1|Overall Study|Protocol Violation|1
65557|NCT01064687|242003|P4|Overall Study|Physician Decision|0
65558|NCT01064687|242004|P3|Overall Study|Physician Decision|0
65559|NCT01064687|242005|P2|Overall Study|Physician Decision|2
65560|NCT01064687|242006|P1|Overall Study|Physician Decision|2
65561|NCT01064687|242003|P4|Overall Study|Lost to Follow-up|5
65562|NCT01064687|242004|P3|Overall Study|Lost to Follow-up|13
65563|NCT01064687|242005|P2|Overall Study|Lost to Follow-up|10
65564|NCT01064687|242006|P1|Overall Study|Lost to Follow-up|7
65565|NCT01064687|242003|P4|Overall Study|Lack of Efficacy|3
65566|NCT01064687|242004|P3|Overall Study|Lack of Efficacy|2
65567|NCT01064687|242005|P2|Overall Study|Lack of Efficacy|0
65568|NCT01064687|242006|P1|Overall Study|Lack of Efficacy|1
65569|NCT01064687|242003|P4|Overall Study|Entry Criteria Not Met|0
65570|NCT01064687|242004|P3|Overall Study|Entry Criteria Not Met|0
65571|NCT01064687|242005|P2|Overall Study|Entry Criteria Not Met|0
65572|NCT01064687|242006|P1|Overall Study|Entry Criteria Not Met|3
65573|NCT01064687|242003|P4|Overall Study|Death|0
65574|NCT01064687|242004|P3|Overall Study|Death|0
65575|NCT01064687|242005|P2|Overall Study|Death|1
65576|NCT01064687|242006|P1|Overall Study|Death|1
65577|NCT01064687|242003|P4|Overall Study|Adverse Event|3
65578|NCT01064687|242004|P3|Overall Study|Adverse Event|10
65579|NCT01064687|242005|P2|Overall Study|Adverse Event|4
65580|NCT01064687|242006|P1|Overall Study|Adverse Event|9
65581|NCT01064622|242186|P2|Randomized Phase II|Protocol Violation|1
65582|NCT01064622|242187|P1|Randomized Phase II|Protocol Violation|0
65583|NCT01064622|242186|P2|Randomized Phase II|Withdrawal by Subject|2
65584|NCT01064622|242187|P1|Randomized Phase II|Withdrawal by Subject|2
65585|NCT01064414|242211|P3|Extension Period: Week 26 to Week 52|Not specified|1
65586|NCT01064414|242212|P2|Extension Period: Week 26 to Week 52|Not specified|2
65587|NCT01064414|242213|P1|Extension Period: Week 26 to Week 52|Not specified|5
65588|NCT01064414|242211|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
65589|NCT01064414|242212|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
65590|NCT01064414|242213|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
65591|NCT01064414|242211|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
65592|NCT01064414|242212|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
65593|NCT01064414|242213|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
65594|NCT01064414|242211|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
65595|NCT01064414|242212|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
65596|NCT01064414|242213|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
65597|NCT01064414|242211|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
65598|NCT01064414|242212|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
65599|NCT01064414|242213|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
65600|NCT01064414|242211|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
65601|NCT01064414|242212|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
65602|NCT01064414|242213|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
65603|NCT01064414|242211|P3|Extension Period: Week 26 to Week 52|Death|0
65604|NCT01064414|242212|P2|Extension Period: Week 26 to Week 52|Death|1
65605|NCT01064414|242213|P1|Extension Period: Week 26 to Week 52|Death|0
65606|NCT01064414|242211|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
65607|NCT01064414|242212|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
65608|NCT01064414|242213|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
65609|NCT01064414|242211|P3|Core Period: Baseline to Week 26|Not specified|2
65610|NCT01064414|242212|P2|Core Period: Baseline to Week 26|Not specified|7
65611|NCT01064414|242213|P1|Core Period: Baseline to Week 26|Not specified|4
65612|NCT01064414|242211|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
65613|NCT01064414|242212|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
65614|NCT01064414|242213|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
65615|NCT01064414|242211|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
65616|NCT01064414|242212|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
65617|NCT01064414|242213|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
65618|NCT01064414|242211|P3|Core Period: Baseline to Week 26|Protocol Violation|1
65619|NCT01064414|242212|P2|Core Period: Baseline to Week 26|Protocol Violation|0
65620|NCT01064414|242213|P1|Core Period: Baseline to Week 26|Protocol Violation|1
65621|NCT01064414|242211|P3|Core Period: Baseline to Week 26|Death|0
65622|NCT01064414|242212|P2|Core Period: Baseline to Week 26|Death|1
65623|NCT01064414|242213|P1|Core Period: Baseline to Week 26|Death|0
65624|NCT01064414|242211|P3|Core Period: Baseline to Week 26|Adverse Event|2
65625|NCT01064414|242212|P2|Core Period: Baseline to Week 26|Adverse Event|4
65626|NCT01064414|242213|P1|Core Period: Baseline to Week 26|Adverse Event|4
65627|NCT01064401|242232|P2|Overall Study|Not Specified|1
65628|NCT01064401|242233|P1|Overall Study|Not Specified|2
65629|NCT01064401|242232|P2|Overall Study|Site Closure|5
65630|NCT01064401|242233|P1|Overall Study|Site Closure|4
65631|NCT01064401|242232|P2|Overall Study|Noncompliance|8
65632|NCT01064401|242233|P1|Overall Study|Noncompliance|7
65633|NCT01064401|242232|P2|Overall Study|Pregnancy|7
65634|NCT01064401|242233|P1|Overall Study|Pregnancy|4
65635|NCT01064401|242232|P2|Overall Study|Death|0
65636|NCT01064401|242233|P1|Overall Study|Death|4
65637|NCT01064401|242232|P2|Overall Study|Investigator Decision|6
65638|NCT01064401|242233|P1|Overall Study|Investigator Decision|4
65639|NCT01064401|242232|P2|Overall Study|Consent Withdrawn|80
65640|NCT01064401|242233|P1|Overall Study|Consent Withdrawn|98
65641|NCT01064401|242232|P2|Overall Study|Lost to Follow-up|9
65642|NCT01064401|242233|P1|Overall Study|Lost to Follow-up|12
65643|NCT01064401|242232|P2|Overall Study|Lack of Efficacy|23
65644|NCT01064401|242233|P1|Overall Study|Lack of Efficacy|46
65645|NCT01064401|242232|P2|Overall Study|Adverse Event|56
65646|NCT01064401|242233|P1|Overall Study|Adverse Event|47
65647|NCT01064310|242260|P2|Period 2|Lack of Efficacy|4
65648|NCT01064310|242261|P1|Period 2|Lack of Efficacy|1
65649|NCT01064310|242260|P2|Period 2|Entered Open-label Period|0
65650|NCT01064310|242261|P1|Period 2|Entered Open-label Period|1
65651|NCT01064310|242260|P2|Period 2|Physician Decision|1
65652|NCT01064310|242261|P1|Period 2|Physician Decision|0
65653|NCT01064310|242260|P2|Period 2|Adverse Event|1
65654|NCT01064310|242261|P1|Period 2|Adverse Event|2
65655|NCT01064310|242260|P2|Period 1|Entered Open-label Period|1
65656|NCT01064310|242261|P1|Period 1|Entered Open-label Period|1
65657|NCT01064310|242260|P2|Period 1|Lack of Efficacy|5
65658|NCT01064310|242261|P1|Period 1|Lack of Efficacy|3
65659|NCT01064310|242260|P2|Period 1|Withdrawal by Subject|2
65660|NCT01064310|242261|P1|Period 1|Withdrawal by Subject|2
65661|NCT01064310|242260|P2|Period 1|Physician Decision|0
65662|NCT01064310|242261|P1|Period 1|Physician Decision|1
65663|NCT01064310|242260|P2|Period 1|Adverse Event|10
65664|NCT01064310|242261|P1|Period 1|Adverse Event|7
65665|NCT01064297|242290|P3|Overall Study|Lost to Follow-up|133
65666|NCT01064297|242291|P2|Overall Study|Lost to Follow-up|48
65667|NCT01064297|242292|P1|Overall Study|Lost to Follow-up|791
65668|NCT01064167|242338|P2|Overall Study|Protocol Violation|15
65669|NCT01064167|242339|P1|Overall Study|Protocol Violation|14
65670|NCT01063881|242381|P3|Overall Study|Reason for not completed not specified|0
65671|NCT01063881|242382|P2|Overall Study|Reason for not completed not specified|1
65672|NCT01063881|242383|P1|Overall Study|Reason for not completed not specified|5
65673|NCT01063881|242381|P3|Overall Study|Withdrawal by Subject|0
65674|NCT01063881|242382|P2|Overall Study|Withdrawal by Subject|1
65675|NCT01063881|242383|P1|Overall Study|Withdrawal by Subject|25
65676|NCT01063881|242381|P3|Overall Study|Lost to Follow-up|1
65677|NCT01063881|242382|P2|Overall Study|Lost to Follow-up|7
65678|NCT01063881|242383|P1|Overall Study|Lost to Follow-up|13
65679|NCT01063881|242381|P3|Overall Study|Adverse Event|0
65680|NCT01063881|242382|P2|Overall Study|Adverse Event|2
65681|NCT01063881|242383|P1|Overall Study|Adverse Event|12
65682|NCT01063868|242407|P2|Overall Study|Study Terminated By Sponsor|4
65683|NCT01063868|242408|P1|Overall Study|Study Terminated By Sponsor|23
65684|NCT01063868|242407|P2|Overall Study|Withdrawal by Subject|1
65685|NCT01063868|242408|P1|Overall Study|Withdrawal by Subject|3
65686|NCT01063868|242407|P2|Overall Study|Adverse Event|7
65687|NCT01063868|242408|P1|Overall Study|Adverse Event|9
65688|NCT01063855|242416|P2|Overall Study|Reason not specified|11
65689|NCT01063855|242417|P1|Overall Study|Reason not specified|13
65690|NCT01063855|242416|P2|Overall Study|Withdrawal by Subject|8
65691|NCT01063855|242417|P1|Overall Study|Withdrawal by Subject|11
65692|NCT01063855|242416|P2|Overall Study|Lack of Efficacy|1
65693|NCT01063855|242417|P1|Overall Study|Lack of Efficacy|0
65694|NCT01063855|242416|P2|Overall Study|Pregnancy|0
65695|NCT01063855|242417|P1|Overall Study|Pregnancy|1
65696|NCT01063855|242416|P2|Overall Study|Lost to Follow-up|4
65697|NCT01063855|242417|P1|Overall Study|Lost to Follow-up|8
65698|NCT01063855|242416|P2|Overall Study|Death|1
65699|NCT01063855|242417|P1|Overall Study|Death|0
65700|NCT01063855|242416|P2|Overall Study|Adverse Event|4
65701|NCT01063855|242417|P1|Overall Study|Adverse Event|4
65702|NCT01063764|242439|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
65703|NCT01063764|242439|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
65704|NCT01063764|242439|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
65705|NCT01063764|242439|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
65706|NCT01063764|242439|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
65707|NCT01063764|242439|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
65708|NCT01063764|242439|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
65709|NCT01063595|242458|P2|First Intervention|Reason not Specified|1
65710|NCT01063595|242459|P1|First Intervention|Reason not Specified|0
65711|NCT01063595|242458|P2|First Intervention|Withdrawal by Subject|0
65712|NCT01063595|242459|P1|First Intervention|Withdrawal by Subject|1
65713|NCT01063595|242458|P2|First Intervention|Adverse Event|4
65714|NCT01063595|242459|P1|First Intervention|Adverse Event|1
65715|NCT01063595|242458|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
65716|NCT01063595|242459|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
65717|NCT01063595|242458|P2|Enrolled in Study and Randomized|Adverse Event|1
65718|NCT01063595|242459|P1|Enrolled in Study and Randomized|Adverse Event|0
65719|NCT01063595|242458|P2|Enrolled in Study and Randomized|Reason not Specified|0
65720|NCT01063595|242459|P1|Enrolled in Study and Randomized|Reason not Specified|1
65721|NCT01063517|242471|P2|Overall Study|Death|48
65722|NCT01063517|242472|P1|Overall Study|Death|33
65723|NCT01063517|242471|P2|Overall Study|Withdrawal by Subject|2
65724|NCT01063517|242472|P1|Overall Study|Withdrawal by Subject|1
65725|NCT01063517|242471|P2|Overall Study|Lost to Follow-up|3
65726|NCT01063517|242472|P1|Overall Study|Lost to Follow-up|4
65727|NCT01063517|242471|P2|Overall Study|Study reached data cut-off|7
65728|NCT01063517|242472|P1|Overall Study|Study reached data cut-off|19
65729|NCT01063517|242471|P2|Overall Study|Consent withdrawal|0
65730|NCT01063517|242472|P1|Overall Study|Consent withdrawal|1
65731|NCT01063348|242512|P2|Overall Study|Lost to Follow-up|10
65732|NCT01063348|242513|P1|Overall Study|Lost to Follow-up|3
65733|NCT01063153|242523|P2|Overall Study|Physician Decision|4
65734|NCT01063153|242524|P1|Overall Study|Physician Decision|0
65735|NCT01063153|242523|P2|Overall Study|Withdrawal by Subject|1
65736|NCT01063153|242524|P1|Overall Study|Withdrawal by Subject|0
65737|NCT01063153|242523|P2|Overall Study|Lost to Follow-up|7
65738|NCT01063153|242524|P1|Overall Study|Lost to Follow-up|0
65739|NCT01063153|242523|P2|Overall Study|Found Ineligible During Screening|0
65740|NCT01063153|242524|P1|Overall Study|Found Ineligible During Screening|2
65741|NCT01063062|242551|P2|Overall Study|Miscellaneous reason|1
65742|NCT01063062|242552|P1|Overall Study|Miscellaneous reason|0
65743|NCT01063062|242551|P2|Overall Study|Lost to Follow-up|2
65744|NCT01063062|242552|P1|Overall Study|Lost to Follow-up|0
65745|NCT01063062|242551|P2|Overall Study|Investigator's request|0
65746|NCT01063062|242552|P1|Overall Study|Investigator's request|1
65747|NCT01063062|242551|P2|Overall Study|Protocol Violation|4
65748|NCT01063062|242552|P1|Overall Study|Protocol Violation|5
65749|NCT01063062|242551|P2|Overall Study|Adverse Event|4
65750|NCT01063062|242552|P1|Overall Study|Adverse Event|2
65751|NCT01063062|242551|P2|Overall Study|Patient withdrew consent|1
65752|NCT01063062|242552|P1|Overall Study|Patient withdrew consent|0
65753|NCT01063036|242606|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
65754|NCT01063036|242606|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
65755|NCT01063036|242606|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
65756|NCT01063036|242606|P1|Participants Treated With Study Drug|Pregnancy|1
65757|NCT01063036|242606|P1|Participants Treated With Study Drug|Lost to Follow-up|1
65758|NCT01063036|242606|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
65759|NCT01063036|242606|P1|Participants Treated With Study Drug|Protocol Violation|1
65760|NCT01063036|242606|P1|Participants Treated With Study Drug|Adverse Event|1
65761|NCT01062841|242622|P2|Overall Study|Withdrawal by Study|0
65762|NCT01062841|242623|P1|Overall Study|Withdrawal by Study|3
65763|NCT01062841|242622|P2|Overall Study|Withdrawal by Subject|0
65764|NCT01062841|242623|P1|Overall Study|Withdrawal by Subject|2
65765|NCT01062841|242622|P2|Overall Study|Death|5
65766|NCT01062841|242623|P1|Overall Study|Death|3
65767|NCT01062841|242622|P2|Overall Study|Indwelling Device Removed|48
65768|NCT01062841|242623|P1|Overall Study|Indwelling Device Removed|41
65769|NCT01062763|242653|P2|Overall Study|Adverse Event|4
65770|NCT01062763|242654|P1|Overall Study|Adverse Event|3
65771|NCT01062425|242666|P2|Overall Study|Protocol Violation|6
65772|NCT01062425|242667|P1|Overall Study|Protocol Violation|3
65773|NCT01062256|242704|P3|Overall Study|Administrative|0
65774|NCT01062256|242705|P2|Overall Study|Administrative|2
65775|NCT01062256|242706|P1|Overall Study|Administrative|0
65776|NCT01062256|242704|P3|Overall Study|Ineligible|3
65777|NCT01062256|242705|P2|Overall Study|Ineligible|4
65778|NCT01062256|242706|P1|Overall Study|Ineligible|1
65779|NCT01062256|242704|P3|Overall Study|Withdrawal by Subject|1
65780|NCT01062256|242705|P2|Overall Study|Withdrawal by Subject|1
65781|NCT01062256|242706|P1|Overall Study|Withdrawal by Subject|1
65782|NCT01062256|242704|P3|Overall Study|Adverse Event|0
65783|NCT01062256|242705|P2|Overall Study|Adverse Event|0
65784|NCT01062256|242706|P1|Overall Study|Adverse Event|1
65785|NCT01062113|242740|P3|Overall Study|Withdrawal by Subject|0
65786|NCT01062113|242741|P2|Overall Study|Withdrawal by Subject|0
65787|NCT01062113|242742|P1|Overall Study|Withdrawal by Subject|1
65788|NCT01062113|242740|P3|Overall Study|Lack of Efficacy|31
65789|NCT01062113|242741|P2|Overall Study|Lack of Efficacy|22
65790|NCT01062113|242742|P1|Overall Study|Lack of Efficacy|38
65791|NCT01062113|242740|P3|Overall Study|Adverse Event|0
65792|NCT01062113|242741|P2|Overall Study|Adverse Event|0
65793|NCT01062113|242742|P1|Overall Study|Adverse Event|1
65794|NCT01062061|242760|P1|Overall Study|Failed to meet inclusion criteria|2
65795|NCT01062061|242760|P1|Overall Study|Outside chief indications|10
65796|NCT01062061|242760|P1|Overall Study|Investigated before study start|13
65797|NCT01062061|242760|P1|Overall Study|Enrolled more than once|2
65798|NCT01061866|242774|P1|Overall Study|Adverse Event|2
65799|NCT01061775|242778|P1|Overall Study|Lost to Follow-up|1
65800|NCT01061775|242778|P1|Overall Study|Physician Decision|2
65801|NCT01061710|242785|P1|Overall Study|Protocol Violation|14
65802|NCT01061671|242795|P2|Overall Study|Death|30
65803|NCT01061671|242796|P1|Overall Study|Death|28
65804|NCT01061671|242795|P2|Overall Study|Lost to Follow-up|5
65805|NCT01061671|242796|P1|Overall Study|Lost to Follow-up|3
65806|NCT01061671|242795|P2|Overall Study|Withdrawal by Subject|20
65807|NCT01061671|242796|P1|Overall Study|Withdrawal by Subject|16
65808|NCT01061606|242808|P1|Overall Study|alternative therapy|2
65809|NCT01061606|242808|P1|Overall Study|Disease Progression|4
65810|NCT01061606|242808|P1|Overall Study|Death|1
65811|NCT01061606|242808|P1|Overall Study|Adverse Event|1
65812|NCT01061567|242817|P1|Overall Study|Other reason than stated above|3
65813|NCT01061567|242817|P1|Overall Study|Withdrawal by Subject|11
65814|NCT01061567|242817|P1|Overall Study|Protocol Violation|1
65815|NCT01061567|242817|P1|Overall Study|Lost to Follow-up|24
65816|NCT01061567|242817|P1|Overall Study|Lack of Efficacy|3
65817|NCT01061567|242817|P1|Overall Study|Death|2
65818|NCT01061567|242817|P1|Overall Study|Adverse Event|32
65819|NCT01061385|242832|P2|Overall Study|subject decision not related to AE|1
65820|NCT01061385|242833|P1|Overall Study|subject decision not related to AE|0
65821|NCT01061385|242832|P2|Overall Study|Lost to Follow-up|0
65822|NCT01061385|242833|P1|Overall Study|Lost to Follow-up|1
65823|NCT01061359|242841|P1|Overall Study|Secondary neoplasm|11
65824|NCT01061359|242841|P1|Overall Study|Relapse|187
65825|NCT01061359|242841|P1|Overall Study|Lost to Follow-up|1072
65826|NCT01061359|242841|P1|Overall Study|Death|32
65827|NCT01061333|242847|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
65828|NCT01061333|242848|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
65829|NCT01061008|242893|P2|Overall Study|Adverse Event|1
65830|NCT01061008|242894|P1|Overall Study|Adverse Event|0
65831|NCT01061008|242893|P2|Overall Study|Unable to exercise following surgery|0
65832|NCT01061008|242894|P1|Overall Study|Unable to exercise following surgery|1
65833|NCT01061008|242893|P2|Overall Study|Withdrawal by Subject|3
65834|NCT01061008|242894|P1|Overall Study|Withdrawal by Subject|1
65835|NCT01061008|242893|P2|Overall Study|Death|0
65836|NCT01061008|242894|P1|Overall Study|Death|1
65837|NCT01061008|242893|P2|Overall Study|Badiocephalic fistula failed|2
65838|NCT01061008|242894|P1|Overall Study|Badiocephalic fistula failed|3
65839|NCT01060670|242902|P2|Run In|screen failure|238
65840|NCT01060670|242903|P1|Run In|screen failure|0
65841|NCT01060553|242938|P2|Overall Study|Lack of Efficacy|0
65842|NCT01060553|242939|P1|Overall Study|Lack of Efficacy|1
65843|NCT01060553|242938|P2|Overall Study|Withdrawal by Subject|5
65844|NCT01060553|242939|P1|Overall Study|Withdrawal by Subject|5
65845|NCT01060553|242938|P2|Overall Study|Lost to Follow-up|5
65846|NCT01060553|242939|P1|Overall Study|Lost to Follow-up|3
65847|NCT01060540|242946|P2|Overall Study|Physician Decision|1
65848|NCT01060540|242947|P1|Overall Study|Physician Decision|0
65849|NCT01060540|242946|P2|Overall Study|Death|1
65850|NCT01060540|242947|P1|Overall Study|Death|2
65851|NCT01060540|242946|P2|Overall Study|Lost to Follow-up|43
65852|NCT01060540|242947|P1|Overall Study|Lost to Follow-up|52
65853|NCT01060540|242946|P2|Overall Study|Withdrawal by Subject|20
65854|NCT01060540|242947|P1|Overall Study|Withdrawal by Subject|10
65855|NCT01060150|242961|P1|Overall Study|Enrolled, but not treated|2
65856|NCT01060150|242961|P1|Overall Study|Withdrawal by Subject|8
65857|NCT01060150|242961|P1|Overall Study|Protocol Violation|6
65858|NCT01060150|242961|P1|Overall Study|Lost to Follow-up|1
65859|NCT01060150|242961|P1|Overall Study|Adverse Event|6
65860|NCT01060124|242976|P1|Overall Study|Withdrawal by Subject|7
65861|NCT01060124|242976|P1|Overall Study|Adverse Event|14
65862|NCT01060124|242976|P1|Overall Study|Unspecified|16
65863|NCT01060111|242987|P3|Overall Study|Unspecified|4
65864|NCT01060111|242988|P2|Overall Study|Unspecified|3
65865|NCT01060111|242989|P1|Overall Study|Unspecified|2
65866|NCT01060111|242987|P3|Overall Study|Participants' non-cooperation|0
65867|NCT01060111|242988|P2|Overall Study|Participants' non-cooperation|0
65868|NCT01060111|242989|P1|Overall Study|Participants' non-cooperation|1
65869|NCT01060111|242987|P3|Overall Study|Adverse event and insufficient effect|0
65870|NCT01060111|242988|P2|Overall Study|Adverse event and insufficient effect|1
65871|NCT01060111|242989|P1|Overall Study|Adverse event and insufficient effect|0
65872|NCT01060111|242987|P3|Overall Study|Participants' non-cooperation|6
65873|NCT01060111|242988|P2|Overall Study|Participants' non-cooperation|6
65874|NCT01060111|242989|P1|Overall Study|Participants' non-cooperation|8
65875|NCT01060111|242987|P3|Overall Study|Participants' evasion for hospital visit|2
65876|NCT01060111|242988|P2|Overall Study|Participants' evasion for hospital visit|3
65877|NCT01060111|242989|P1|Overall Study|Participants' evasion for hospital visit|0
65878|NCT01060111|242987|P3|Overall Study|Inappropriate participant|5
65879|NCT01060111|242988|P2|Overall Study|Inappropriate participant|4
65880|NCT01060111|242989|P1|Overall Study|Inappropriate participant|5
65881|NCT01060111|242987|P3|Overall Study|Lack of Efficacy|0
65882|NCT01060111|242988|P2|Overall Study|Lack of Efficacy|1
65883|NCT01060111|242989|P1|Overall Study|Lack of Efficacy|2
65884|NCT01060111|242987|P3|Overall Study|Adverse Event|18
65885|NCT01060111|242988|P2|Overall Study|Adverse Event|5
65886|NCT01060111|242989|P1|Overall Study|Adverse Event|9
65887|NCT01060072|243008|P2|Overall Study|Excluded Medications|1
65888|NCT01060072|243009|P1|Overall Study|Excluded Medications|0
65889|NCT01060072|243008|P2|Overall Study|Acute cholecystitis|0
65890|NCT01060072|243009|P1|Overall Study|Acute cholecystitis|1
65891|NCT01060072|243008|P2|Overall Study|Protocol Violation|1
65892|NCT01060072|243009|P1|Overall Study|Protocol Violation|0
65893|NCT01060072|243008|P2|Overall Study|Physician Decision|2
65894|NCT01060072|243009|P1|Overall Study|Physician Decision|0
65895|NCT01060072|243008|P2|Overall Study|Adverse Event|1
65896|NCT01060072|243009|P1|Overall Study|Adverse Event|1
65897|NCT01060059|243025|P2|Overall Study|lack of compliance|2
65898|NCT01060059|243026|P1|Overall Study|lack of compliance|5
65899|NCT01060059|243025|P2|Overall Study|lack of glycemic control|1
65900|NCT01060059|243026|P1|Overall Study|lack of glycemic control|2
65901|NCT01060059|243025|P2|Overall Study|Withdrawal by Subject|23
65902|NCT01060059|243026|P1|Overall Study|Withdrawal by Subject|35
65903|NCT01060059|243025|P2|Overall Study|entry criteria not met|3
65904|NCT01060059|243026|P1|Overall Study|entry criteria not met|4
65905|NCT01060059|243025|P2|Overall Study|Lost to Follow-up|34
65906|NCT01060059|243026|P1|Overall Study|Lost to Follow-up|18
65907|NCT01060059|243025|P2|Overall Study|Death|3
65908|NCT01060059|243026|P1|Overall Study|Death|2
65909|NCT01060059|243025|P2|Overall Study|Adverse Event|1
65910|NCT01060059|243026|P1|Overall Study|Adverse Event|1
65911|NCT01060007|243076|P1|Overall Study|Inevaluable for response at surgery|3
65912|NCT01060007|243076|P1|Overall Study|Inevaluable for primary objective|1
65913|NCT01059903|243110|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
65914|NCT01059903|243111|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
65915|NCT01059864|243145|P3|Double-Blind Treatment Phase|Adverse Event|3
65916|NCT01059864|243146|P2|Double-Blind Treatment Phase|Adverse Event|3
65917|NCT01059864|243147|P1|Double-Blind Treatment Phase|Adverse Event|0
65918|NCT01059864|243145|P3|Open-Label Run-In Phase|Protocol Violation|0
65919|NCT01059864|243146|P2|Open-Label Run-In Phase|Protocol Violation|0
65920|NCT01059864|243147|P1|Open-Label Run-In Phase|Protocol Violation|2
65921|NCT01059864|243145|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
65922|NCT01059864|243146|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
65923|NCT01059864|243147|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
65924|NCT01059864|243145|P3|Open-Label Run-In Phase|Lost to Follow-up|0
65925|NCT01059864|243146|P2|Open-Label Run-In Phase|Lost to Follow-up|0
65926|NCT01059864|243147|P1|Open-Label Run-In Phase|Lost to Follow-up|2
65927|NCT01059864|243145|P3|Open-Label Run-In Phase|Lack of Efficacy|0
65928|NCT01059864|243146|P2|Open-Label Run-In Phase|Lack of Efficacy|0
65929|NCT01059864|243147|P1|Open-Label Run-In Phase|Lack of Efficacy|1
65930|NCT01059864|243145|P3|Open-Label Run-In Phase|Adverse Event|0
65931|NCT01059864|243146|P2|Open-Label Run-In Phase|Adverse Event|0
65932|NCT01059864|243147|P1|Open-Label Run-In Phase|Adverse Event|7
65933|NCT01059812|243217|P2|Overall Study|Unclassified|4
65934|NCT01059812|243218|P1|Overall Study|Unclassified|14
65935|NCT01059812|243217|P2|Overall Study|Withdrawal Criteria|4
65936|NCT01059812|243218|P1|Overall Study|Withdrawal Criteria|9
65937|NCT01059812|243217|P2|Overall Study|Protocol Violation|1
65938|NCT01059812|243218|P1|Overall Study|Protocol Violation|3
65939|NCT01059812|243217|P2|Overall Study|Lack of Efficacy|2
65940|NCT01059812|243218|P1|Overall Study|Lack of Efficacy|2
65941|NCT01059812|243217|P2|Overall Study|Adverse Event|5
65942|NCT01059812|243218|P1|Overall Study|Adverse Event|9
65943|NCT01059799|243234|P2|Overall Study|Other|3
65944|NCT01059799|243235|P1|Overall Study|Other|12
65945|NCT01059799|243234|P2|Overall Study|Withdrawal criteria|2
65946|NCT01059799|243235|P1|Overall Study|Withdrawal criteria|13
65947|NCT01059799|243234|P2|Overall Study|Protocol Violation|2
65948|NCT01059799|243235|P1|Overall Study|Protocol Violation|3
65949|NCT01059799|243234|P2|Overall Study|Lack of Efficacy|0
65950|NCT01059799|243235|P1|Overall Study|Lack of Efficacy|1
65951|NCT01059799|243234|P2|Overall Study|Adverse Event|3
65952|NCT01059799|243235|P1|Overall Study|Adverse Event|2
65953|NCT01059773|243249|P2|Overall Study|Other|3
65954|NCT01059773|243250|P1|Overall Study|Other|1
65955|NCT01059773|243249|P2|Overall Study|Ineligible follow TB screening criteria|1
65956|NCT01059773|243250|P1|Overall Study|Ineligible follow TB screening criteria|0
65957|NCT01059773|243249|P2|Overall Study|Malignancy including squamous cell skin|1
65958|NCT01059773|243250|P1|Overall Study|Malignancy including squamous cell skin|0
65959|NCT01059773|243249|P2|Overall Study|Death|1
65960|NCT01059773|243250|P1|Overall Study|Death|0
65961|NCT01059773|243249|P2|Overall Study|Lack of Efficacy|3
65962|NCT01059773|243250|P1|Overall Study|Lack of Efficacy|3
65963|NCT01059773|243249|P2|Overall Study|Physician Decision|4
65964|NCT01059773|243250|P1|Overall Study|Physician Decision|5
65965|NCT01059773|243249|P2|Overall Study|Protocol Violation|2
65966|NCT01059773|243250|P1|Overall Study|Protocol Violation|6
65967|NCT01059773|243249|P2|Overall Study|Pregnancy|1
65968|NCT01059773|243250|P1|Overall Study|Pregnancy|1
65969|NCT01059773|243249|P2|Overall Study|Lost to Follow-up|1
65970|NCT01059773|243250|P1|Overall Study|Lost to Follow-up|1
65971|NCT01059773|243249|P2|Overall Study|Withdrawal by Subject|5
65972|NCT01059773|243250|P1|Overall Study|Withdrawal by Subject|1
65973|NCT01059773|243249|P2|Overall Study|Adverse Event|2
65974|NCT01059773|243250|P1|Overall Study|Adverse Event|2
65975|NCT01059630|243282|P2|Maintenance Period (up to 2 Years)|Unspecified|3
65976|NCT01059630|243283|P1|Maintenance Period (up to 2 Years)|Unspecified|0
65977|NCT01059630|243282|P2|Maintenance Period (up to 2 Years)|Physician Decision|2
65978|NCT01059630|243283|P1|Maintenance Period (up to 2 Years)|Physician Decision|0
65979|NCT01059630|243282|P2|Maintenance Period (up to 2 Years)|Death|2
65980|NCT01059630|243283|P1|Maintenance Period (up to 2 Years)|Death|0
65981|NCT01059630|243282|P2|Maintenance Period (up to 2 Years)|Withdrawal by Subject|3
65982|NCT01059630|243283|P1|Maintenance Period (up to 2 Years)|Withdrawal by Subject|0
65983|NCT01059630|243282|P2|Maintenance Period (up to 2 Years)|Progressive Disease|44
65984|NCT01059630|243283|P1|Maintenance Period (up to 2 Years)|Progressive Disease|0
65985|NCT01059630|243282|P2|Maintenance Period (up to 2 Years)|Adverse Event|8
65986|NCT01059630|243283|P1|Maintenance Period (up to 2 Years)|Adverse Event|0
65987|NCT01059630|243282|P2|Maintenance Period (up to 2 Years)|Maintenance ongoing|46
65988|NCT01059630|243283|P1|Maintenance Period (up to 2 Years)|Maintenance ongoing|0
65989|NCT01059630|243282|P2|Induction Period (6 Months)|Randomized but not Treated|0
65990|NCT01059630|243283|P1|Induction Period (6 Months)|Randomized but not Treated|4
65991|NCT01059630|243282|P2|Induction Period (6 Months)|Unspecified|0
65992|NCT01059630|243283|P1|Induction Period (6 Months)|Unspecified|1
65993|NCT01059630|243282|P2|Induction Period (6 Months)|Physician Decision|4
65994|NCT01059630|243283|P1|Induction Period (6 Months)|Physician Decision|2
65995|NCT01059630|243282|P2|Induction Period (6 Months)|Death|2
65996|NCT01059630|243283|P1|Induction Period (6 Months)|Death|2
65997|NCT01059630|243282|P2|Induction Period (6 Months)|Withdrawal by Subject|2
65998|NCT01059630|243283|P1|Induction Period (6 Months)|Withdrawal by Subject|7
65999|NCT01059630|243282|P2|Induction Period (6 Months)|Progressive Disease|9
66000|NCT01059630|243283|P1|Induction Period (6 Months)|Progressive Disease|14
66001|NCT01059630|243282|P2|Induction Period (6 Months)|Adverse Event|15
66002|NCT01059630|243283|P1|Induction Period (6 Months)|Adverse Event|30
66003|NCT01059630|243282|P2|Induction Period (6 Months)|Induction ongoing|6
66004|NCT01059630|243283|P1|Induction Period (6 Months)|Induction ongoing|13
66005|NCT01059617|243343|P4|Overall Study|Unspecified|6
66006|NCT01059617|243344|P3|Overall Study|Unspecified|8
66007|NCT01059617|243345|P2|Overall Study|Unspecified|1
66008|NCT01059617|243346|P1|Overall Study|Unspecified|7
66009|NCT01059565|243522|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
66010|NCT01059565|243523|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
66011|NCT01059565|243522|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
66012|NCT01059565|243523|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
66013|NCT01059565|243522|P2|24-Week Open-Label Phase|Subject noncompliance|0
66014|NCT01059565|243523|P1|24-Week Open-Label Phase|Subject noncompliance|1
66015|NCT01059565|243522|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
66016|NCT01059565|243523|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
66017|NCT01059565|243522|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
66018|NCT01059565|243523|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
66019|NCT01059565|243522|P2|24-Week Open-Label Phase|Adverse Event|0
66020|NCT01059565|243523|P1|24-Week Open-Label Phase|Adverse Event|2
66021|NCT01059565|243522|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
66022|NCT01059565|243523|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
66023|NCT01059565|243522|P2|24-Week Randomized Phase|Lost to Follow-up|1
66024|NCT01059565|243523|P1|24-Week Randomized Phase|Lost to Follow-up|0
66025|NCT01059565|243522|P2|24-Week Randomized Phase|Withdrawal by Subject|1
66026|NCT01059565|243523|P1|24-Week Randomized Phase|Withdrawal by Subject|3
66027|NCT01059565|243522|P2|24-Week Randomized Phase|Adverse Event|0
66028|NCT01059565|243523|P1|24-Week Randomized Phase|Adverse Event|5
66029|NCT01059565|243522|P2|24-Week Randomized Phase|Randomized but not treated|0
66030|NCT01059565|243523|P1|24-Week Randomized Phase|Randomized but not treated|1
66031|NCT01059526|243559|P2|Overall Study|Patient found to be dermatographic|0
66032|NCT01059526|243560|P1|Overall Study|Patient found to be dermatographic|1
66033|NCT01059526|243559|P2|Overall Study|Lost to Follow-up|1
66034|NCT01059526|243560|P1|Overall Study|Lost to Follow-up|4
66035|NCT01059526|243559|P2|Overall Study|Withdrawal by Subject|1
66036|NCT01059526|243560|P1|Overall Study|Withdrawal by Subject|3
66037|NCT01059526|243559|P2|Overall Study|Protocol Violation|1
66038|NCT01059526|243560|P1|Overall Study|Protocol Violation|0
66039|NCT01059526|243559|P2|Overall Study|Adverse Event|2
66040|NCT01059526|243560|P1|Overall Study|Adverse Event|2
66041|NCT01059526|243559|P2|Overall Study|Patient enrolled but not treated|17
66042|NCT01059526|243560|P1|Overall Study|Patient enrolled but not treated|20
66043|NCT01059071|243568|P4|Overall Study|Physician Decision|1
66044|NCT01059071|243569|P3|Overall Study|Physician Decision|0
66045|NCT01059071|243570|P2|Overall Study|Physician Decision|0
66046|NCT01059071|243571|P1|Overall Study|Physician Decision|0
66047|NCT01059071|243568|P4|Overall Study|Withdrawal by Subject|2
66048|NCT01059071|243569|P3|Overall Study|Withdrawal by Subject|0
66049|NCT01059071|243570|P2|Overall Study|Withdrawal by Subject|0
66050|NCT01059071|243571|P1|Overall Study|Withdrawal by Subject|1
66051|NCT01059071|243568|P4|Overall Study|Lack of Efficacy|3
66052|NCT01059071|243569|P3|Overall Study|Lack of Efficacy|2
66053|NCT01059071|243570|P2|Overall Study|Lack of Efficacy|4
66054|NCT01059071|243571|P1|Overall Study|Lack of Efficacy|1
66055|NCT01058863|243587|P1|Overall Study|Randomized in error|1
66056|NCT01058863|243587|P1|Overall Study|Sponsor requested withdrawal|1
66057|NCT01058863|243587|P1|Overall Study|Withdrawal by Subject|1
66058|NCT01058863|243587|P1|Overall Study|Lost to Follow-up|1
66059|NCT01058642|243609|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
66060|NCT01058642|243610|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
66061|NCT01058642|243611|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
66062|NCT01058642|243612|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
66063|NCT01058642|243609|P4|Treatment Period 1|Protocol Violation|1
66064|NCT01058642|243610|P3|Treatment Period 1|Protocol Violation|0
66065|NCT01058642|243611|P2|Treatment Period 1|Protocol Violation|0
66066|NCT01058642|243612|P1|Treatment Period 1|Protocol Violation|0
66067|NCT01058642|243609|P4|Treatment Period 1|Lack of Efficacy|1
66068|NCT01058642|243610|P3|Treatment Period 1|Lack of Efficacy|0
66069|NCT01058642|243611|P2|Treatment Period 1|Lack of Efficacy|0
66070|NCT01058642|243612|P1|Treatment Period 1|Lack of Efficacy|0
66071|NCT01058642|243609|P4|Treatment Period 1|Withdrawal by Subject|0
66072|NCT01058642|243610|P3|Treatment Period 1|Withdrawal by Subject|0
66073|NCT01058642|243611|P2|Treatment Period 1|Withdrawal by Subject|0
66074|NCT01058642|243612|P1|Treatment Period 1|Withdrawal by Subject|1
66075|NCT01058642|243609|P4|Treatment Period 1|Physician Decision|0
66076|NCT01058642|243610|P3|Treatment Period 1|Physician Decision|1
66077|NCT01058642|243611|P2|Treatment Period 1|Physician Decision|0
66078|NCT01058642|243612|P1|Treatment Period 1|Physician Decision|0
66079|NCT01058642|243609|P4|Treatment Period 1|Adverse Event|0
66080|NCT01058642|243610|P3|Treatment Period 1|Adverse Event|1
66081|NCT01058642|243611|P2|Treatment Period 1|Adverse Event|1
66082|NCT01058642|243612|P1|Treatment Period 1|Adverse Event|0
66083|NCT01058356|243620|P1|Overall Study|Lost to Follow-up|4
66084|NCT01058356|243620|P1|Overall Study|Withdrawal by Subject|21
66085|NCT01058356|243620|P1|Overall Study|Administration of contraindicated drugs|12
66086|NCT01058356|243620|P1|Overall Study|Adverse Event|5
66087|NCT01058304|243627|P2|Overall Study|Developed exclusion criterion|12
66088|NCT01058304|243628|P1|Overall Study|Developed exclusion criterion|6
66089|NCT01058304|243627|P2|Overall Study|Lost to Follow-up|16
66090|NCT01058304|243628|P1|Overall Study|Lost to Follow-up|13
66091|NCT01058304|243627|P2|Overall Study|Withdrawal by Subject|5
66092|NCT01058304|243628|P1|Overall Study|Withdrawal by Subject|8
66093|NCT01058265|243638|P2|Overall Study|Lost to Follow-up|12
66094|NCT01058265|243639|P1|Overall Study|Lost to Follow-up|11
66095|NCT01058005|243655|P3|Overall Study|Reason Missing|1
66096|NCT01058005|243656|P2|Overall Study|Reason Missing|3
66097|NCT01058005|243657|P1|Overall Study|Reason Missing|5
66098|NCT01058005|243655|P3|Overall Study|Withdrawn Due to Study Termination|7
66099|NCT01058005|243656|P2|Overall Study|Withdrawn Due to Study Termination|13
66100|NCT01058005|243657|P1|Overall Study|Withdrawn Due to Study Termination|27
66101|NCT01058005|243655|P3|Overall Study|Withdrawal by Subject|11
66102|NCT01058005|243656|P2|Overall Study|Withdrawal by Subject|5
66103|NCT01058005|243657|P1|Overall Study|Withdrawal by Subject|4
66104|NCT01058005|243655|P3|Overall Study|Physician Decision|0
66105|NCT01058005|243656|P2|Overall Study|Physician Decision|2
66106|NCT01058005|243657|P1|Overall Study|Physician Decision|2
66107|NCT01058005|243655|P3|Overall Study|Adverse Event|1
66108|NCT01058005|243656|P2|Overall Study|Adverse Event|2
66109|NCT01058005|243657|P1|Overall Study|Adverse Event|0
66110|NCT01057810|243692|P2|Overall Study|Unspecified|14
66111|NCT01057810|243693|P1|Overall Study|Unspecified|7
66112|NCT01057810|243692|P2|Overall Study|No longer met study criteria|1
66113|NCT01057810|243693|P1|Overall Study|No longer met study criteria|0
66114|NCT01057810|243692|P2|Overall Study|Poor/non-compliance|1
66115|NCT01057810|243693|P1|Overall Study|Poor/non-compliance|0
66116|NCT01057810|243692|P2|Overall Study|Maximum clinical benefit|5
66117|NCT01057810|243693|P1|Overall Study|Maximum clinical benefit|5
66118|NCT01057810|243692|P2|Overall Study|Death|12
66119|NCT01057810|243693|P1|Overall Study|Death|2
66120|NCT01057810|243692|P2|Overall Study|Withdrawal by Subject|25
66121|NCT01057810|243693|P1|Overall Study|Withdrawal by Subject|10
66122|NCT01057810|243692|P2|Overall Study|Adverse event unrelated to study drug|29
66123|NCT01057810|243693|P1|Overall Study|Adverse event unrelated to study drug|13
66124|NCT01057810|243692|P2|Overall Study|Study drug toxicity|114
66125|NCT01057810|243693|P1|Overall Study|Study drug toxicity|5
66126|NCT01057810|243692|P2|Overall Study|Disease progression|197
66127|NCT01057810|243693|P1|Overall Study|Disease progression|156
66128|NCT01057693|243709|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
66129|NCT01057693|243710|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
66130|NCT01057693|243711|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
66131|NCT01057693|243709|P3|Double-Blind Phase (Week 7 to Week 19)|Unspecified|0
66132|NCT01057693|243710|P2|Double-Blind Phase (Week 7 to Week 19)|Unspecified|1
66133|NCT01057693|243711|P1|Double-Blind Phase (Week 7 to Week 19)|Unspecified|0
66134|NCT01057693|243709|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
66135|NCT01057693|243710|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
66136|NCT01057693|243711|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
66137|NCT01057693|243709|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
66138|NCT01057693|243710|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
66139|NCT01057693|243711|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
66140|NCT01057693|243709|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
66141|NCT01057693|243710|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
66142|NCT01057693|243711|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
66143|NCT01057693|243709|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
66144|NCT01057693|243710|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
66145|NCT01057693|243711|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
66146|NCT01057693|243709|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
66147|NCT01057693|243710|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
66148|NCT01057693|243711|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
66149|NCT01057693|243709|P3|Between Single-Blind and Double-Blind|Unspecified|0
66150|NCT01057693|243710|P2|Between Single-Blind and Double-Blind|Unspecified|0
66151|NCT01057693|243711|P1|Between Single-Blind and Double-Blind|Unspecified|6
66152|NCT01057693|243709|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
66153|NCT01057693|243710|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
66154|NCT01057693|243711|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
66155|NCT01057693|243709|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
66156|NCT01057693|243710|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
66157|NCT01057693|243711|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
66158|NCT01057693|243709|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
66159|NCT01057693|243710|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
66160|NCT01057693|243711|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
66161|NCT01057693|243709|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
66162|NCT01057693|243710|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
66163|NCT01057693|243711|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
66164|NCT01057693|243709|P3|Between Single-Blind and Double-Blind|Adverse Event|0
66165|NCT01057693|243710|P2|Between Single-Blind and Double-Blind|Adverse Event|0
66166|NCT01057693|243711|P1|Between Single-Blind and Double-Blind|Adverse Event|5
66167|NCT01057693|243709|P3|Single-Blind Phase (Up to Week 6)|Unspecified|0
66168|NCT01057693|243710|P2|Single-Blind Phase (Up to Week 6)|Unspecified|0
66169|NCT01057693|243711|P1|Single-Blind Phase (Up to Week 6)|Unspecified|2
66170|NCT01057693|243709|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
66171|NCT01057693|243710|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
66172|NCT01057693|243711|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
66173|NCT01057693|243709|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
66174|NCT01057693|243710|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
66175|NCT01057693|243711|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
66176|NCT01057693|243709|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
66177|NCT01057693|243710|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
66178|NCT01057693|243711|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
66179|NCT01057693|243709|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
66180|NCT01057693|243710|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
66181|NCT01057693|243711|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
66182|NCT01057693|243709|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
66183|NCT01057693|243710|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
66184|NCT01057693|243711|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
66185|NCT01057589|243757|P1|Overall Study|Lost to Follow-up|1
66186|NCT01057589|243757|P1|Overall Study|Death|8
66187|NCT01057589|243757|P1|Overall Study|Sponsor Decision|1
66188|NCT01057589|243757|P1|Overall Study|Withdrawal by Subject|3
66189|NCT01057589|243757|P1|Overall Study|Physician Decision|8
66190|NCT01057589|243757|P1|Overall Study|Adverse Event|10
66191|NCT01057589|243757|P1|Overall Study|Disease Progression|35
66192|NCT01057433|243766|P1|Overall Study|Adverse Event|1
66193|NCT01057394|243770|P2|Overall Study|Not eligible|2
66194|NCT01057394|243771|P1|Overall Study|Not eligible|0
66195|NCT01057251|243781|P2|Overall Study|Other Reason|1
66196|NCT01057251|243782|P1|Overall Study|Other Reason|1
66197|NCT01057251|243781|P2|Overall Study|Lost to Follow-up|6
66198|NCT01057251|243782|P1|Overall Study|Lost to Follow-up|7
66199|NCT01057251|243781|P2|Overall Study|Withdrawal by Subject|5
66200|NCT01057251|243782|P1|Overall Study|Withdrawal by Subject|4
66201|NCT01057251|243781|P2|Overall Study|Protocol Violation|2
66202|NCT01057251|243782|P1|Overall Study|Protocol Violation|6
66203|NCT01057251|243781|P2|Overall Study|Lack of Efficacy|11
66204|NCT01057251|243782|P1|Overall Study|Lack of Efficacy|2
66205|NCT01057251|243781|P2|Overall Study|Adverse Event|2
66206|NCT01057251|243782|P1|Overall Study|Adverse Event|4
66207|NCT01057251|243781|P2|Overall Study|Did not meet InclusionExclusion criteria|2
66208|NCT01057251|243782|P1|Overall Study|Did not meet InclusionExclusion criteria|4
66209|NCT01056822|243860|P2|Overall Study|Lost to Follow-up|0
66210|NCT01056822|243861|P1|Overall Study|Lost to Follow-up|1
66211|NCT01056822|243860|P2|Overall Study|Withdrawal by Subject|1
66212|NCT01056822|243861|P1|Overall Study|Withdrawal by Subject|1
66213|NCT01056822|243860|P2|Overall Study|Protocol Violation|5
66214|NCT01056822|243861|P1|Overall Study|Protocol Violation|6
66215|NCT01056822|243860|P2|Overall Study|Adverse Event|1
66216|NCT01056822|243861|P1|Overall Study|Adverse Event|0
66217|NCT01056718|243910|P1|Overall Study|Ischemia on baseline stress test|1
66218|NCT01056718|243910|P1|Overall Study|Withdrawal by Subject|2
66219|NCT01056640|243942|P2|Overall Study|Death|4
66220|NCT01056640|243943|P1|Overall Study|Death|15
66221|NCT01056640|243942|P2|Overall Study|Withdrawal by Subject|8
66222|NCT01056640|243943|P1|Overall Study|Withdrawal by Subject|11
66223|NCT01056523|243955|P7|Overall Study|Death|1
66224|NCT01056523|243956|P6|Overall Study|Death|0
66225|NCT01056523|243957|P5|Overall Study|Death|0
66226|NCT01056523|243958|P4|Overall Study|Death|3
66227|NCT01056523|243959|P3|Overall Study|Death|2
66228|NCT01056523|243960|P2|Overall Study|Death|0
66229|NCT01056523|243961|P1|Overall Study|Death|1
66230|NCT01056510|243971|P2|Overall Study|Missing|1
66231|NCT01056510|243972|P1|Overall Study|Missing|0
66232|NCT01056510|243971|P2|Overall Study|Not Specified|12
66233|NCT01056510|243972|P1|Overall Study|Not Specified|10
66234|NCT01056510|243971|P2|Overall Study|Lost to Follow-up|6
66235|NCT01056510|243972|P1|Overall Study|Lost to Follow-up|5
66236|NCT01056510|243971|P2|Overall Study|Physician Decision|5
66237|NCT01056510|243972|P1|Overall Study|Physician Decision|4
66238|NCT01056510|243971|P2|Overall Study|Noncompliance|3
66239|NCT01056510|243972|P1|Overall Study|Noncompliance|1
66240|NCT01056510|243971|P2|Overall Study|Death|34
66241|NCT01056510|243972|P1|Overall Study|Death|29
66242|NCT01056510|243971|P2|Overall Study|Withdrawal by Subject|2
66243|NCT01056510|243972|P1|Overall Study|Withdrawal by Subject|4
66244|NCT01056510|243971|P2|Overall Study|Dropout Before Start of Treatment|1
66245|NCT01056510|243972|P1|Overall Study|Dropout Before Start of Treatment|1
66246|NCT01056484|244018|P2|Follow up - Non-randomized|Withdrawal by Subject|2
66247|NCT01056484|244019|P1|Follow up - Non-randomized|Withdrawal by Subject|0
66248|NCT01056484|244018|P2|Randomized Controlled Trial|Physician Decision|0
66249|NCT01056484|244019|P1|Randomized Controlled Trial|Physician Decision|1
66250|NCT01056484|244018|P2|Randomized Controlled Trial|Withdrawal by Subject|1
66251|NCT01056484|244019|P1|Randomized Controlled Trial|Withdrawal by Subject|6
66252|NCT01056341|244038|P5|Overall Study|Other reasons|5
66253|NCT01056341|244039|P4|Overall Study|Other reasons|9
66254|NCT01056341|244040|P3|Overall Study|Other reasons|8
66255|NCT01056341|244041|P2|Overall Study|Other reasons|4
66256|NCT01056341|244042|P1|Overall Study|Other reasons|4
66257|NCT01056341|244038|P5|Overall Study|Lack of Efficacy|9
66258|NCT01056341|244039|P4|Overall Study|Lack of Efficacy|25
66259|NCT01056341|244040|P3|Overall Study|Lack of Efficacy|7
66260|NCT01056341|244041|P2|Overall Study|Lack of Efficacy|30
66261|NCT01056341|244042|P1|Overall Study|Lack of Efficacy|32
66262|NCT01056341|244038|P5|Overall Study|Treatment Intolerance|0
66263|NCT01056341|244039|P4|Overall Study|Treatment Intolerance|2
66264|NCT01056341|244040|P3|Overall Study|Treatment Intolerance|0
66265|NCT01056341|244041|P2|Overall Study|Treatment Intolerance|2
66266|NCT01056341|244042|P1|Overall Study|Treatment Intolerance|0
66267|NCT01056289|244115|P4|Double-blind Phase|Physician Decision|0
66268|NCT01056289|244116|P3|Double-blind Phase|Physician Decision|1
66269|NCT01056289|244117|P2|Double-blind Phase|Physician Decision|0
66270|NCT01056289|244118|P1|Double-blind Phase|Physician Decision|0
66271|NCT01056289|244115|P4|Double-blind Phase|Discontinuation symptom|2
66272|NCT01056289|244116|P3|Double-blind Phase|Discontinuation symptom|2
66273|NCT01056289|244117|P2|Double-blind Phase|Discontinuation symptom|1
66274|NCT01056289|244118|P1|Double-blind Phase|Discontinuation symptom|0
66275|NCT01056289|244115|P4|Double-blind Phase|Withdrawal by Subject|2
66276|NCT01056289|244116|P3|Double-blind Phase|Withdrawal by Subject|4
66277|NCT01056289|244117|P2|Double-blind Phase|Withdrawal by Subject|0
66278|NCT01056289|244118|P1|Double-blind Phase|Withdrawal by Subject|0
66279|NCT01056289|244115|P4|Double-blind Phase|Protocol Violation|1
66280|NCT01056289|244116|P3|Double-blind Phase|Protocol Violation|1
66281|NCT01056289|244117|P2|Double-blind Phase|Protocol Violation|0
66282|NCT01056289|244118|P1|Double-blind Phase|Protocol Violation|0
66283|NCT01056289|244115|P4|Double-blind Phase|Unspecified|2
66284|NCT01056289|244116|P3|Double-blind Phase|Unspecified|1
66285|NCT01056289|244117|P2|Double-blind Phase|Unspecified|0
66286|NCT01056289|244118|P1|Double-blind Phase|Unspecified|0
66287|NCT01056289|244115|P4|Double-blind Phase|Lost to Follow-up|2
66288|NCT01056289|244116|P3|Double-blind Phase|Lost to Follow-up|2
66289|NCT01056289|244117|P2|Double-blind Phase|Lost to Follow-up|2
66290|NCT01056289|244118|P1|Double-blind Phase|Lost to Follow-up|0
66291|NCT01056289|244115|P4|Double-blind Phase|Adverse Event|1
66292|NCT01056289|244116|P3|Double-blind Phase|Adverse Event|2
66293|NCT01056289|244117|P2|Double-blind Phase|Adverse Event|1
66294|NCT01056289|244118|P1|Double-blind Phase|Adverse Event|0
66295|NCT01056289|244115|P4|Open-label Phase|Not randomized to Double-blind phase|0
66296|NCT01056289|244116|P3|Open-label Phase|Not randomized to Double-blind phase|0
66297|NCT01056289|244117|P2|Open-label Phase|Not randomized to Double-blind phase|0
66298|NCT01056289|244118|P1|Open-label Phase|Not randomized to Double-blind phase|1
66299|NCT01056289|244115|P4|Open-label Phase|Lack of Efficacy|0
66300|NCT01056289|244116|P3|Open-label Phase|Lack of Efficacy|0
66301|NCT01056289|244117|P2|Open-label Phase|Lack of Efficacy|0
66302|NCT01056289|244118|P1|Open-label Phase|Lack of Efficacy|18
66303|NCT01056289|244115|P4|Open-label Phase|Withdrawal by Subject|0
66304|NCT01056289|244116|P3|Open-label Phase|Withdrawal by Subject|0
66305|NCT01056289|244117|P2|Open-label Phase|Withdrawal by Subject|0
66306|NCT01056289|244118|P1|Open-label Phase|Withdrawal by Subject|26
66307|NCT01056289|244115|P4|Open-label Phase|Protocol Violation|0
66308|NCT01056289|244116|P3|Open-label Phase|Protocol Violation|0
66309|NCT01056289|244117|P2|Open-label Phase|Protocol Violation|0
66310|NCT01056289|244118|P1|Open-label Phase|Protocol Violation|6
66311|NCT01056289|244115|P4|Open-label Phase|Unspecified|0
66312|NCT01056289|244116|P3|Open-label Phase|Unspecified|0
66313|NCT01056289|244117|P2|Open-label Phase|Unspecified|0
66314|NCT01056289|244118|P1|Open-label Phase|Unspecified|9
66315|NCT01056289|244115|P4|Open-label Phase|Lost to Follow-up|0
66316|NCT01056289|244116|P3|Open-label Phase|Lost to Follow-up|0
66317|NCT01056289|244117|P2|Open-label Phase|Lost to Follow-up|0
66318|NCT01056289|244118|P1|Open-label Phase|Lost to Follow-up|30
66319|NCT01056289|244115|P4|Open-label Phase|Adverse Event|0
66320|NCT01056289|244116|P3|Open-label Phase|Adverse Event|0
66321|NCT01056289|244117|P2|Open-label Phase|Adverse Event|0
66322|NCT01056289|244118|P1|Open-label Phase|Adverse Event|29
66323|NCT01056263|244133|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
66324|NCT01056263|244133|P1|Overall Study|Objective progression or relapse|1
66325|NCT01056263|244133|P1|Overall Study|Neoplasm progression|1
66326|NCT01056263|244133|P1|Overall Study|Progressive disease|2
66327|NCT01056263|244133|P1|Overall Study|Lack of Efficacy|29
66328|NCT01056263|244133|P1|Overall Study|Withdrawal by Subject|1
66329|NCT01056263|244133|P1|Overall Study|Death|1
66330|NCT01056263|244133|P1|Overall Study|Adverse Event|12
66331|NCT01056107|244156|P4|Overall Study|Withdrawal by Subject|0
66332|NCT01056107|244157|P3|Overall Study|Withdrawal by Subject|3
66333|NCT01056107|244158|P2|Overall Study|Withdrawal by Subject|1
66334|NCT01056107|244159|P1|Overall Study|Withdrawal by Subject|0
66335|NCT01055886|244216|P2|Overall Study|Withdrawal by PI|1
66336|NCT01055886|244217|P1|Overall Study|Withdrawal by PI|0
66337|NCT01055886|244216|P2|Overall Study|Lost to Follow-up|1
66338|NCT01055886|244217|P1|Overall Study|Lost to Follow-up|1
66339|NCT01055886|244216|P2|Overall Study|Withdrawal by Subject|9
66340|NCT01055886|244217|P1|Overall Study|Withdrawal by Subject|4
66341|NCT01055834|244229|P2|Treatment Period I|Adverse Event|0
66342|NCT01055834|244230|P1|Treatment Period I|Adverse Event|1
66343|NCT01055639|244315|P2|Overall Study|Withdrawal by Subject|11
66344|NCT01055639|244316|P1|Overall Study|Withdrawal by Subject|8
66345|NCT01055639|244315|P2|Overall Study|Protocol Violation|5
66346|NCT01055639|244316|P1|Overall Study|Protocol Violation|5
66347|NCT01055639|244315|P2|Overall Study|Lost to Follow-up|11
66348|NCT01055639|244316|P1|Overall Study|Lost to Follow-up|8
66349|NCT01055639|244315|P2|Overall Study|Lack of Efficacy|1
66350|NCT01055639|244316|P1|Overall Study|Lack of Efficacy|0
66351|NCT01055639|244315|P2|Overall Study|Adverse Event|1
66352|NCT01055639|244316|P1|Overall Study|Adverse Event|0
66353|NCT01055613|244340|P2|Overall Study|Subject Disinterest|1
66354|NCT01055613|244341|P1|Overall Study|Subject Disinterest|1
66355|NCT01055613|244340|P2|Overall Study|Protocol Violation|1
66356|NCT01055613|244341|P1|Overall Study|Protocol Violation|1
66357|NCT01055613|244340|P2|Overall Study|Lost to Follow-up|1
66358|NCT01055613|244341|P1|Overall Study|Lost to Follow-up|1
66359|NCT01055613|244340|P2|Overall Study|Discomfort|1
66360|NCT01055613|244341|P1|Overall Study|Discomfort|2
66361|NCT01055613|244340|P2|Overall Study|Unacceptable lens fit|0
66362|NCT01055613|244341|P1|Overall Study|Unacceptable lens fit|1
66363|NCT01055613|244340|P2|Overall Study|No Longer Meets Eligibility Criteria|0
66364|NCT01055613|244341|P1|Overall Study|No Longer Meets Eligibility Criteria|3
66365|NCT01055457|244349|P10|Overall Study|Adverse Event|0
66366|NCT01055457|244350|P9|Overall Study|Adverse Event|0
66367|NCT01055457|244351|P8|Overall Study|Adverse Event|0
66368|NCT01055457|244352|P7|Overall Study|Adverse Event|0
66369|NCT01055457|244353|P6|Overall Study|Adverse Event|0
66370|NCT01055457|244354|P5|Overall Study|Adverse Event|0
66371|NCT01055457|244355|P4|Overall Study|Adverse Event|1
66372|NCT01055457|244356|P3|Overall Study|Adverse Event|0
66373|NCT01055457|244357|P2|Overall Study|Adverse Event|0
66374|NCT01055457|244358|P1|Overall Study|Adverse Event|0
66375|NCT01055457|244349|P10|Overall Study|Pregnancy|0
66376|NCT01055457|244350|P9|Overall Study|Pregnancy|0
66377|NCT01055457|244351|P8|Overall Study|Pregnancy|0
66378|NCT01055457|244352|P7|Overall Study|Pregnancy|0
66379|NCT01055457|244353|P6|Overall Study|Pregnancy|0
66380|NCT01055457|244354|P5|Overall Study|Pregnancy|0
66381|NCT01055457|244355|P4|Overall Study|Pregnancy|1
66382|NCT01055457|244356|P3|Overall Study|Pregnancy|0
66383|NCT01055457|244357|P2|Overall Study|Pregnancy|0
66384|NCT01055457|244358|P1|Overall Study|Pregnancy|0
66385|NCT01055457|244349|P10|Overall Study|Discomfort|0
66386|NCT01055457|244350|P9|Overall Study|Discomfort|0
66387|NCT01055457|244351|P8|Overall Study|Discomfort|0
66388|NCT01055457|244352|P7|Overall Study|Discomfort|0
66389|NCT01055457|244353|P6|Overall Study|Discomfort|0
66390|NCT01055457|244354|P5|Overall Study|Discomfort|1
66391|NCT01055457|244355|P4|Overall Study|Discomfort|0
66392|NCT01055457|244356|P3|Overall Study|Discomfort|0
66393|NCT01055457|244357|P2|Overall Study|Discomfort|0
66394|NCT01055457|244358|P1|Overall Study|Discomfort|0
66395|NCT01055457|244349|P10|Overall Study|Subject Ineligible|0
66396|NCT01055457|244350|P9|Overall Study|Subject Ineligible|0
66397|NCT01055457|244351|P8|Overall Study|Subject Ineligible|0
66398|NCT01055457|244352|P7|Overall Study|Subject Ineligible|0
66399|NCT01055457|244353|P6|Overall Study|Subject Ineligible|0
66400|NCT01055457|244354|P5|Overall Study|Subject Ineligible|1
66401|NCT01055457|244355|P4|Overall Study|Subject Ineligible|0
66402|NCT01055457|244356|P3|Overall Study|Subject Ineligible|1
66403|NCT01055457|244357|P2|Overall Study|Subject Ineligible|0
66404|NCT01055457|244358|P1|Overall Study|Subject Ineligible|1
66405|NCT01055457|244349|P10|Overall Study|Subject Disinterest|0
66406|NCT01055457|244350|P9|Overall Study|Subject Disinterest|0
66407|NCT01055457|244351|P8|Overall Study|Subject Disinterest|1
66408|NCT01055457|244352|P7|Overall Study|Subject Disinterest|0
66409|NCT01055457|244353|P6|Overall Study|Subject Disinterest|0
66410|NCT01055457|244354|P5|Overall Study|Subject Disinterest|0
66411|NCT01055457|244355|P4|Overall Study|Subject Disinterest|0
66412|NCT01055457|244356|P3|Overall Study|Subject Disinterest|0
66413|NCT01055457|244357|P2|Overall Study|Subject Disinterest|0
66414|NCT01055457|244358|P1|Overall Study|Subject Disinterest|0
66415|NCT01055457|244349|P10|Overall Study|Protocol Violation|1
66416|NCT01055457|244350|P9|Overall Study|Protocol Violation|0
66417|NCT01055457|244351|P8|Overall Study|Protocol Violation|0
66418|NCT01055457|244352|P7|Overall Study|Protocol Violation|1
66419|NCT01055457|244353|P6|Overall Study|Protocol Violation|2
66420|NCT01055457|244354|P5|Overall Study|Protocol Violation|1
66421|NCT01055457|244355|P4|Overall Study|Protocol Violation|1
66422|NCT01055457|244356|P3|Overall Study|Protocol Violation|1
66423|NCT01055457|244357|P2|Overall Study|Protocol Violation|0
66424|NCT01055457|244358|P1|Overall Study|Protocol Violation|0
66425|NCT01055457|244349|P10|Overall Study|Lost to Follow-up|0
66426|NCT01055457|244350|P9|Overall Study|Lost to Follow-up|0
66427|NCT01055457|244351|P8|Overall Study|Lost to Follow-up|0
66428|NCT01055457|244352|P7|Overall Study|Lost to Follow-up|0
66429|NCT01055457|244353|P6|Overall Study|Lost to Follow-up|1
66430|NCT01055457|244354|P5|Overall Study|Lost to Follow-up|0
66431|NCT01055457|244355|P4|Overall Study|Lost to Follow-up|0
66432|NCT01055457|244356|P3|Overall Study|Lost to Follow-up|0
66433|NCT01055457|244357|P2|Overall Study|Lost to Follow-up|1
66434|NCT01055457|244358|P1|Overall Study|Lost to Follow-up|0
66435|NCT01055262|244390|P1|Overall Study|Uncooperativeness|1
66436|NCT01055262|244390|P1|Overall Study|Protocol Violation|3
66437|NCT01055262|244390|P1|Overall Study|Adverse Event|5
66438|NCT01055197|244431|P2|Overall Study|Withdrawal by Subject|0
66439|NCT01055197|244432|P1|Overall Study|Withdrawal by Subject|2
66440|NCT01055197|244431|P2|Overall Study|Protocol Violation|2
66441|NCT01055197|244432|P1|Overall Study|Protocol Violation|7
66442|NCT01055132|244459|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
66443|NCT01055132|244460|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
66444|NCT01055132|244459|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
66445|NCT01055132|244460|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
66446|NCT01054976|244471|P1|Overall Study|Not specified|8
66447|NCT01054976|244471|P1|Overall Study|Withdrawal by Subject|4
66448|NCT01054976|244471|P1|Overall Study|Uncooperative participations to study|7
66449|NCT01054976|244471|P1|Overall Study|Adverse Event|16
66450|NCT01054885|244492|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
66451|NCT01054885|244493|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
66452|NCT01054885|244494|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
66453|NCT01054885|244495|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
66454|NCT01054885|244496|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
66455|NCT01054885|244497|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
66456|NCT01054885|244498|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
66457|NCT01054885|244492|P7|24-week, Double-blind Treatment Period|Physician Decision|1
66458|NCT01054885|244493|P6|24-week, Double-blind Treatment Period|Physician Decision|1
66459|NCT01054885|244494|P5|24-week, Double-blind Treatment Period|Physician Decision|3
66460|NCT01054885|244495|P4|24-week, Double-blind Treatment Period|Physician Decision|6
66461|NCT01054885|244496|P3|24-week, Double-blind Treatment Period|Physician Decision|1
66462|NCT01054885|244497|P2|24-week, Double-blind Treatment Period|Physician Decision|4
66463|NCT01054885|244498|P1|24-week, Double-blind Treatment Period|Physician Decision|0
66464|NCT01054885|244492|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
66465|NCT01054885|244493|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
66466|NCT01054885|244494|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
66467|NCT01054885|244495|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
66468|NCT01054885|244496|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
66469|NCT01054885|244497|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
66470|NCT01054885|244498|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
66471|NCT01054885|244492|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
66472|NCT01054885|244493|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
66473|NCT01054885|244494|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
66474|NCT01054885|244495|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
66475|NCT01054885|244496|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
66476|NCT01054885|244497|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
66477|NCT01054885|244498|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
66478|NCT01054885|244492|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
66479|NCT01054885|244493|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
66480|NCT01054885|244494|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
66481|NCT01054885|244495|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
66482|NCT01054885|244496|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
66483|NCT01054885|244497|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
66484|NCT01054885|244498|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
66485|NCT01054885|244492|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
66486|NCT01054885|244493|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
66487|NCT01054885|244494|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
66488|NCT01054885|244495|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
66489|NCT01054885|244496|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
66490|NCT01054885|244497|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
66491|NCT01054885|244498|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
66492|NCT01054885|244492|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
66493|NCT01054885|244493|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
66494|NCT01054885|244494|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
66495|NCT01054885|244495|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
66496|NCT01054885|244496|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
66497|NCT01054885|244497|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
66498|NCT01054885|244498|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
66499|NCT01054885|244492|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
66500|NCT01054885|244493|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
66501|NCT01054885|244494|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
66502|NCT01054885|244495|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
66503|NCT01054885|244496|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
66504|NCT01054885|244497|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
66505|NCT01054885|244498|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
66506|NCT01054885|244492|P7|24-week, Double-blind Treatment Period|Adverse Event|19
66507|NCT01054885|244493|P6|24-week, Double-blind Treatment Period|Adverse Event|17
66508|NCT01054885|244494|P5|24-week, Double-blind Treatment Period|Adverse Event|15
66509|NCT01054885|244495|P4|24-week, Double-blind Treatment Period|Adverse Event|15
66510|NCT01054885|244496|P3|24-week, Double-blind Treatment Period|Adverse Event|12
66511|NCT01054885|244497|P2|24-week, Double-blind Treatment Period|Adverse Event|18
66512|NCT01054885|244498|P1|24-week, Double-blind Treatment Period|Adverse Event|0
66513|NCT01054885|244492|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
66514|NCT01054885|244493|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
66515|NCT01054885|244494|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
66516|NCT01054885|244495|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
66517|NCT01054885|244496|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
66518|NCT01054885|244497|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
66519|NCT01054885|244498|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
66520|NCT01054885|244492|P7|2-week, Single-blind Run-In Period|Adverse Event|0
66521|NCT01054885|244493|P6|2-week, Single-blind Run-In Period|Adverse Event|0
66522|NCT01054885|244494|P5|2-week, Single-blind Run-In Period|Adverse Event|0
66523|NCT01054885|244495|P4|2-week, Single-blind Run-In Period|Adverse Event|0
66524|NCT01054885|244496|P3|2-week, Single-blind Run-In Period|Adverse Event|0
66525|NCT01054885|244497|P2|2-week, Single-blind Run-In Period|Adverse Event|0
66526|NCT01054885|244498|P1|2-week, Single-blind Run-In Period|Adverse Event|7
66527|NCT01054885|244492|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
66528|NCT01054885|244493|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
66529|NCT01054885|244494|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
66530|NCT01054885|244495|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
66531|NCT01054885|244496|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
66532|NCT01054885|244497|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
66533|NCT01054885|244498|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
66534|NCT01054885|244492|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
66535|NCT01054885|244493|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
66536|NCT01054885|244494|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
66537|NCT01054885|244495|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
66538|NCT01054885|244496|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
66539|NCT01054885|244497|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
66540|NCT01054885|244498|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
66541|NCT01054885|244492|P7|2-week, Single-blind Run-In Period|Physician Decision|0
66542|NCT01054885|244493|P6|2-week, Single-blind Run-In Period|Physician Decision|0
66543|NCT01054885|244494|P5|2-week, Single-blind Run-In Period|Physician Decision|0
66544|NCT01054885|244495|P4|2-week, Single-blind Run-In Period|Physician Decision|0
66545|NCT01054885|244496|P3|2-week, Single-blind Run-In Period|Physician Decision|0
66546|NCT01054885|244497|P2|2-week, Single-blind Run-In Period|Physician Decision|0
66547|NCT01054885|244498|P1|2-week, Single-blind Run-In Period|Physician Decision|6
66548|NCT01054885|244492|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
66549|NCT01054885|244493|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
66550|NCT01054885|244494|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
66551|NCT01054885|244495|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
66552|NCT01054885|244496|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
66553|NCT01054885|244497|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
66554|NCT01054885|244498|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
66555|NCT01054846|244538|P2|Overall Study|Lost to Follow-up|17
66556|NCT01054846|244539|P1|Overall Study|Lost to Follow-up|76
66557|NCT01054820|244546|P1|Overall Study|Withdrawal by Subject|2
66558|NCT01054729|244568|P4|Overall Study|Lack of Efficacy|1
66559|NCT01054729|244569|P3|Overall Study|Lack of Efficacy|0
66560|NCT01054729|244570|P2|Overall Study|Lack of Efficacy|0
66561|NCT01054729|244571|P1|Overall Study|Lack of Efficacy|0
66562|NCT01054729|244568|P4|Overall Study|Subject moved|0
66563|NCT01054729|244569|P3|Overall Study|Subject moved|1
66564|NCT01054729|244570|P2|Overall Study|Subject moved|0
66565|NCT01054729|244571|P1|Overall Study|Subject moved|0
66566|NCT01054729|244568|P4|Overall Study|Personal/Obligations|0
66567|NCT01054729|244569|P3|Overall Study|Personal/Obligations|0
66568|NCT01054729|244570|P2|Overall Study|Personal/Obligations|1
66569|NCT01054729|244571|P1|Overall Study|Personal/Obligations|0
66570|NCT01054729|244568|P4|Overall Study|PEG/RBV Non-responder|0
66571|NCT01054729|244569|P3|Overall Study|PEG/RBV Non-responder|1
66572|NCT01054729|244570|P2|Overall Study|PEG/RBV Non-responder|0
66573|NCT01054729|244571|P1|Overall Study|PEG/RBV Non-responder|1
66574|NCT01054729|244568|P4|Overall Study|Non-responder|1
66575|NCT01054729|244569|P3|Overall Study|Non-responder|1
66576|NCT01054729|244570|P2|Overall Study|Non-responder|0
66577|NCT01054729|244571|P1|Overall Study|Non-responder|1
66578|NCT01054729|244568|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
66579|NCT01054729|244569|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
66580|NCT01054729|244570|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
66581|NCT01054729|244571|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
66582|NCT01054729|244568|P4|Overall Study|Lost to Follow-up|0
66583|NCT01054729|244569|P3|Overall Study|Lost to Follow-up|0
66584|NCT01054729|244570|P2|Overall Study|Lost to Follow-up|1
66585|NCT01054729|244571|P1|Overall Study|Lost to Follow-up|0
66586|NCT01054729|244568|P4|Overall Study|Withdrawal by Subject|0
66587|NCT01054729|244569|P3|Overall Study|Withdrawal by Subject|1
66588|NCT01054729|244570|P2|Overall Study|Withdrawal by Subject|0
66589|NCT01054729|244571|P1|Overall Study|Withdrawal by Subject|1
66590|NCT01054729|244568|P4|Overall Study|Adverse Event|1
66591|NCT01054729|244569|P3|Overall Study|Adverse Event|2
66592|NCT01054729|244570|P2|Overall Study|Adverse Event|1
66593|NCT01054729|244571|P1|Overall Study|Adverse Event|1
66594|NCT01054729|244568|P4|Overall Study|Randomized but Not Treated|0
66595|NCT01054729|244569|P3|Overall Study|Randomized but Not Treated|0
66596|NCT01054729|244570|P2|Overall Study|Randomized but Not Treated|1
66597|NCT01054729|244571|P1|Overall Study|Randomized but Not Treated|0
66598|NCT01054573|244766|P4|Overall Study|Withdrawal by Subject|1
66599|NCT01054573|244767|P3|Overall Study|Withdrawal by Subject|2
66600|NCT01054573|244768|P2|Overall Study|Withdrawal by Subject|2
66601|NCT01054573|244769|P1|Overall Study|Withdrawal by Subject|0
66602|NCT01054573|244766|P4|Overall Study|Lost to Follow-up|0
66603|NCT01054573|244767|P3|Overall Study|Lost to Follow-up|0
66604|NCT01054573|244768|P2|Overall Study|Lost to Follow-up|2
66605|NCT01054573|244769|P1|Overall Study|Lost to Follow-up|0
66606|NCT01054573|244766|P4|Overall Study|Adverse Event|1
66607|NCT01054573|244767|P3|Overall Study|Adverse Event|1
66608|NCT01054573|244768|P2|Overall Study|Adverse Event|0
66609|NCT01054573|244769|P1|Overall Study|Adverse Event|1
66610|NCT01054560|244815|P2|Overall Study|Physician Decision|0
66611|NCT01054560|244816|P1|Overall Study|Physician Decision|1
66612|NCT01054560|244815|P2|Overall Study|Withdrawal by Subject|2
66613|NCT01054560|244816|P1|Overall Study|Withdrawal by Subject|0
66614|NCT01054560|244815|P2|Overall Study|Lost to Follow-up|5
66615|NCT01054560|244816|P1|Overall Study|Lost to Follow-up|2
66616|NCT01054560|244815|P2|Overall Study|Death|21
66617|NCT01054560|244816|P1|Overall Study|Death|10
66618|NCT01054222|244866|P1|Overall Study|Withdrawal by Subject|6
66619|NCT01054222|244866|P1|Overall Study|Lost to Follow-up|4
66620|NCT01054222|244866|P1|Overall Study|Lack of Efficacy|1
66621|NCT01054170|244898|P2|Overall Study|Adverse Event|4
66622|NCT01054170|244899|P1|Overall Study|Adverse Event|0
66623|NCT01054170|244898|P2|Overall Study|Withdrawal by Subject|2
66624|NCT01054170|244899|P1|Overall Study|Withdrawal by Subject|3
66625|NCT01054170|244898|P2|Overall Study|Protocol Violation|0
66626|NCT01054170|244899|P1|Overall Study|Protocol Violation|1
66627|NCT01053988|244960|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
66628|NCT01053988|244961|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
66629|NCT01053988|244962|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
66630|NCT01053988|244963|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
66631|NCT01053988|244964|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
66632|NCT01053988|244965|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
66633|NCT01053988|244960|P6|24-week, Double-blind Treatment Period|Physician Decision|4
66634|NCT01053988|244961|P5|24-week, Double-blind Treatment Period|Physician Decision|5
66635|NCT01053988|244962|P4|24-week, Double-blind Treatment Period|Physician Decision|5
66636|NCT01053988|244963|P3|24-week, Double-blind Treatment Period|Physician Decision|2
66637|NCT01053988|244964|P2|24-week, Double-blind Treatment Period|Physician Decision|5
66638|NCT01053988|244965|P1|24-week, Double-blind Treatment Period|Physician Decision|0
66639|NCT01053988|244960|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
66640|NCT01053988|244961|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
66641|NCT01053988|244962|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
66642|NCT01053988|244963|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
66643|NCT01053988|244964|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
66644|NCT01053988|244965|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
66645|NCT01053988|244960|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
66646|NCT01053988|244961|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
66647|NCT01053988|244962|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
66648|NCT01053988|244963|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
66649|NCT01053988|244964|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
66650|NCT01053988|244965|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
66651|NCT01053988|244960|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
66652|NCT01053988|244961|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
66653|NCT01053988|244962|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
66654|NCT01053988|244963|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
66655|NCT01053988|244964|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
66656|NCT01053988|244965|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
66657|NCT01053988|244960|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
66658|NCT01053988|244961|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
66659|NCT01053988|244962|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
66660|NCT01053988|244963|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
66661|NCT01053988|244964|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
66662|NCT01053988|244965|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
66663|NCT01053988|244960|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
66664|NCT01053988|244961|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
66665|NCT01053988|244962|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
66666|NCT01053988|244963|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
66667|NCT01053988|244964|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
66668|NCT01053988|244965|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
66669|NCT01053988|244960|P6|24-week, Double-blind Treatment Period|Adverse Event|14
66670|NCT01053988|244961|P5|24-week, Double-blind Treatment Period|Adverse Event|17
66671|NCT01053988|244962|P4|24-week, Double-blind Treatment Period|Adverse Event|24
66672|NCT01053988|244963|P3|24-week, Double-blind Treatment Period|Adverse Event|23
66673|NCT01053988|244964|P2|24-week, Double-blind Treatment Period|Adverse Event|15
66674|NCT01053988|244965|P1|24-week, Double-blind Treatment Period|Adverse Event|0
66675|NCT01053988|244960|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
66676|NCT01053988|244961|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
66677|NCT01053988|244962|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
66678|NCT01053988|244963|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
66679|NCT01053988|244964|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
66680|NCT01053988|244965|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
66681|NCT01053988|244960|P6|2-week, Single-blind Run-In Period|Physician Decision|0
66682|NCT01053988|244961|P5|2-week, Single-blind Run-In Period|Physician Decision|0
66683|NCT01053988|244962|P4|2-week, Single-blind Run-In Period|Physician Decision|0
66684|NCT01053988|244963|P3|2-week, Single-blind Run-In Period|Physician Decision|0
66685|NCT01053988|244964|P2|2-week, Single-blind Run-In Period|Physician Decision|0
66686|NCT01053988|244965|P1|2-week, Single-blind Run-In Period|Physician Decision|5
66687|NCT01053988|244960|P6|2-week, Single-blind Run-In Period|Adverse Event|0
66688|NCT01053988|244961|P5|2-week, Single-blind Run-In Period|Adverse Event|0
66689|NCT01053988|244962|P4|2-week, Single-blind Run-In Period|Adverse Event|0
66690|NCT01053988|244963|P3|2-week, Single-blind Run-In Period|Adverse Event|0
66691|NCT01053988|244964|P2|2-week, Single-blind Run-In Period|Adverse Event|0
66692|NCT01053988|244965|P1|2-week, Single-blind Run-In Period|Adverse Event|6
66693|NCT01053988|244960|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
66694|NCT01053988|244961|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
66695|NCT01053988|244962|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
66696|NCT01053988|244963|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
66697|NCT01053988|244964|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
66698|NCT01053988|244965|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
66699|NCT01053988|244960|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
66700|NCT01053988|244961|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
66701|NCT01053988|244962|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
66702|NCT01053988|244963|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
66703|NCT01053988|244964|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
66704|NCT01053988|244965|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
66705|NCT01053988|244960|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
66706|NCT01053988|244961|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
66707|NCT01053988|244962|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
66708|NCT01053988|244963|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
66709|NCT01053988|244964|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
66710|NCT01053988|244965|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
66711|NCT01053663|245016|P1|Overall Study|Negative Influenza Diagnosis|1
66712|NCT01053663|245016|P1|Overall Study|Transferred to Another Hospital|1
66713|NCT01053663|245016|P1|Overall Study|Poor IV Access|1
66714|NCT01053663|245016|P1|Overall Study|Lost to Follow-up|1
66715|NCT01053663|245016|P1|Overall Study|Death|2
66716|NCT01053429|245074|P1|Overall Study|Unspecified|309
66717|NCT01053429|245074|P1|Overall Study|Adverse Event|64
66718|NCT01053247|245104|P3|Overall Study|Adverse Event|3
66719|NCT01053247|245105|P2|Overall Study|Adverse Event|9
66720|NCT01053247|245106|P1|Overall Study|Adverse Event|0
66721|NCT01053247|245104|P3|Overall Study|Lost to Follow-up|7
66722|NCT01053247|245105|P2|Overall Study|Lost to Follow-up|5
66723|NCT01053247|245106|P1|Overall Study|Lost to Follow-up|8
66724|NCT01053247|245104|P3|Overall Study|Protocol Violation|2
66725|NCT01053247|245105|P2|Overall Study|Protocol Violation|1
66726|NCT01053247|245106|P1|Overall Study|Protocol Violation|2
66727|NCT01053247|245104|P3|Overall Study|Lack of Efficacy|1
66728|NCT01053247|245105|P2|Overall Study|Lack of Efficacy|0
66729|NCT01053247|245106|P1|Overall Study|Lack of Efficacy|1
66730|NCT01053247|245104|P3|Overall Study|Withdrawal by Subject|15
66731|NCT01053247|245105|P2|Overall Study|Withdrawal by Subject|4
66732|NCT01053247|245106|P1|Overall Study|Withdrawal by Subject|9
66733|NCT01052844|245200|P2|Overall Study|Adverse Event|1
66734|NCT01052844|245201|P1|Overall Study|Adverse Event|0
66735|NCT01052662|245223|P3|Overall Study|Administrative|0
66736|NCT01052662|245224|P2|Overall Study|Administrative|3
66737|NCT01052662|245225|P1|Overall Study|Administrative|0
66738|NCT01052662|245223|P3|Overall Study|Legal Problem|0
66739|NCT01052662|245224|P2|Overall Study|Legal Problem|0
66740|NCT01052662|245225|P1|Overall Study|Legal Problem|2
66741|NCT01052662|245223|P3|Overall Study|Adverse Event|0
66742|NCT01052662|245224|P2|Overall Study|Adverse Event|1
66743|NCT01052662|245225|P1|Overall Study|Adverse Event|1
66744|NCT01052662|245223|P3|Overall Study|Pharmacy issue|3
66745|NCT01052662|245224|P2|Overall Study|Pharmacy issue|3
66746|NCT01052662|245225|P1|Overall Study|Pharmacy issue|1
66747|NCT01052662|245223|P3|Overall Study|Withdrawal by Subject|1
66748|NCT01052662|245224|P2|Overall Study|Withdrawal by Subject|2
66749|NCT01052662|245225|P1|Overall Study|Withdrawal by Subject|3
66750|NCT01052662|245223|P3|Overall Study|Lost to Follow-up|18
66751|NCT01052662|245224|P2|Overall Study|Lost to Follow-up|13
66752|NCT01052662|245225|P1|Overall Study|Lost to Follow-up|15
66753|NCT01052428|245256|P2|Overall Study|Withdrawal by Subject|1
66754|NCT01052428|245257|P1|Overall Study|Withdrawal by Subject|0
66755|NCT01052428|245256|P2|Overall Study|Death|0
66756|NCT01052428|245257|P1|Overall Study|Death|1
66757|NCT01052272|245279|P4|Overall Study|decline in health|0
66758|NCT01052272|245280|P3|Overall Study|decline in health|1
66759|NCT01052272|245281|P2|Overall Study|decline in health|0
66760|NCT01052272|245282|P1|Overall Study|decline in health|0
66761|NCT01052272|245279|P4|Overall Study|placed in long-term care|0
66762|NCT01052272|245280|P3|Overall Study|placed in long-term care|1
66763|NCT01052272|245281|P2|Overall Study|placed in long-term care|0
66764|NCT01052272|245282|P1|Overall Study|placed in long-term care|0
66765|NCT01052272|245279|P4|Overall Study|Withdrawal by Subject|2
66766|NCT01052272|245280|P3|Overall Study|Withdrawal by Subject|3
66767|NCT01052272|245281|P2|Overall Study|Withdrawal by Subject|2
66768|NCT01052272|245282|P1|Overall Study|Withdrawal by Subject|0
66769|NCT01052272|245279|P4|Overall Study|patient refuses follow-up|4
66770|NCT01052272|245280|P3|Overall Study|patient refuses follow-up|2
66771|NCT01052272|245281|P2|Overall Study|patient refuses follow-up|4
66772|NCT01052272|245282|P1|Overall Study|patient refuses follow-up|5
66773|NCT01052272|245279|P4|Overall Study|Physician Decision|0
66774|NCT01052272|245280|P3|Overall Study|Physician Decision|0
66775|NCT01052272|245281|P2|Overall Study|Physician Decision|1
66776|NCT01052272|245282|P1|Overall Study|Physician Decision|0
66777|NCT01052272|245279|P4|Overall Study|Death|1
66778|NCT01052272|245280|P3|Overall Study|Death|1
66779|NCT01052272|245281|P2|Overall Study|Death|0
66780|NCT01052272|245282|P1|Overall Study|Death|0
66781|NCT01052116|245327|P2|Overall Study|Spirometry not performed|4
66782|NCT01052116|245328|P1|Overall Study|Spirometry not performed|0
66783|NCT01052116|245327|P2|Overall Study|Withdrawal by Subject|6
66784|NCT01052116|245328|P1|Overall Study|Withdrawal by Subject|3
66785|NCT01052116|245327|P2|Overall Study|Lost to Follow-up|17
66786|NCT01052116|245328|P1|Overall Study|Lost to Follow-up|11
66787|NCT01052077|245336|P4|Phase A+|Withdrawal by Subject|7
66788|NCT01052077|245337|P3|Phase A+|Withdrawal by Subject|0
66789|NCT01052077|245338|P2|Phase A+|Withdrawal by Subject|0
66790|NCT01052077|245339|P1|Phase A+|Withdrawal by Subject|0
66791|NCT01052077|245336|P4|Phase A+|Met Withdrawal Criteria|2
66792|NCT01052077|245337|P3|Phase A+|Met Withdrawal Criteria|0
66793|NCT01052077|245338|P2|Phase A+|Met Withdrawal Criteria|0
66794|NCT01052077|245339|P1|Phase A+|Met Withdrawal Criteria|0
66795|NCT01052077|245336|P4|Phase A+|Adverse Event|4
66796|NCT01052077|245337|P3|Phase A+|Adverse Event|0
66797|NCT01052077|245338|P2|Phase A+|Adverse Event|0
66798|NCT01052077|245339|P1|Phase A+|Adverse Event|0
66799|NCT01052077|245336|P4|Phase A+|Lost to Follow-up|8
66800|NCT01052077|245337|P3|Phase A+|Lost to Follow-up|0
66801|NCT01052077|245338|P2|Phase A+|Lost to Follow-up|0
66802|NCT01052077|245339|P1|Phase A+|Lost to Follow-up|0
66803|NCT01052077|245336|P4|Phase B|Lack of Efficacy|0
66804|NCT01052077|245337|P3|Phase B|Lack of Efficacy|0
66805|NCT01052077|245338|P2|Phase B|Lack of Efficacy|1
66806|NCT01052077|245339|P1|Phase B|Lack of Efficacy|0
66807|NCT01052077|245336|P4|Phase B|Protocol Deviation|0
66808|NCT01052077|245337|P3|Phase B|Protocol Deviation|4
66809|NCT01052077|245338|P2|Phase B|Protocol Deviation|3
66810|NCT01052077|245339|P1|Phase B|Protocol Deviation|0
66811|NCT01052077|245336|P4|Phase B|Withdrawal by Subject|0
66812|NCT01052077|245337|P3|Phase B|Withdrawal by Subject|5
66813|NCT01052077|245338|P2|Phase B|Withdrawal by Subject|0
66814|NCT01052077|245339|P1|Phase B|Withdrawal by Subject|0
66815|NCT01052077|245336|P4|Phase B|Physician Decision|0
66816|NCT01052077|245337|P3|Phase B|Physician Decision|1
66817|NCT01052077|245338|P2|Phase B|Physician Decision|1
66818|NCT01052077|245339|P1|Phase B|Physician Decision|0
66819|NCT01052077|245336|P4|Phase B|Met Withdrawal Criteria|0
66820|NCT01052077|245337|P3|Phase B|Met Withdrawal Criteria|1
66821|NCT01052077|245338|P2|Phase B|Met Withdrawal Criteria|2
66822|NCT01052077|245339|P1|Phase B|Met Withdrawal Criteria|0
66823|NCT01052077|245336|P4|Phase B|Adverse Event|0
66824|NCT01052077|245337|P3|Phase B|Adverse Event|2
66825|NCT01052077|245338|P2|Phase B|Adverse Event|9
66826|NCT01052077|245339|P1|Phase B|Adverse Event|0
66827|NCT01052077|245336|P4|Phase B|Lost to Follow-up|0
66828|NCT01052077|245337|P3|Phase B|Lost to Follow-up|3
66829|NCT01052077|245338|P2|Phase B|Lost to Follow-up|2
66830|NCT01052077|245339|P1|Phase B|Lost to Follow-up|0
66831|NCT01052077|245336|P4|Phase A|Protocol Deviation|0
66832|NCT01052077|245337|P3|Phase A|Protocol Deviation|0
66833|NCT01052077|245338|P2|Phase A|Protocol Deviation|0
66834|NCT01052077|245339|P1|Phase A|Protocol Deviation|27
66835|NCT01052077|245336|P4|Phase A|Withdrawal by Subject|0
66836|NCT01052077|245337|P3|Phase A|Withdrawal by Subject|0
66837|NCT01052077|245338|P2|Phase A|Withdrawal by Subject|0
66838|NCT01052077|245339|P1|Phase A|Withdrawal by Subject|29
66839|NCT01052077|245336|P4|Phase A|Physician Decision|0
66840|NCT01052077|245337|P3|Phase A|Physician Decision|0
66841|NCT01052077|245338|P2|Phase A|Physician Decision|0
66842|NCT01052077|245339|P1|Phase A|Physician Decision|10
66843|NCT01052077|245336|P4|Phase A|Met Withdrawal Criteria|0
66844|NCT01052077|245337|P3|Phase A|Met Withdrawal Criteria|0
66845|NCT01052077|245338|P2|Phase A|Met Withdrawal Criteria|0
66846|NCT01052077|245339|P1|Phase A|Met Withdrawal Criteria|26
66847|NCT01052077|245336|P4|Phase A|Adverse Event|0
66848|NCT01052077|245337|P3|Phase A|Adverse Event|0
66849|NCT01052077|245338|P2|Phase A|Adverse Event|0
66850|NCT01052077|245339|P1|Phase A|Adverse Event|32
66851|NCT01052077|245336|P4|Phase A|Lost to Follow-up|0
66852|NCT01052077|245337|P3|Phase A|Lost to Follow-up|0
66853|NCT01052077|245338|P2|Phase A|Lost to Follow-up|0
66854|NCT01052077|245339|P1|Phase A|Lost to Follow-up|22
66855|NCT01052038|245366|P3|Overall Study|Protocol Violation|3
66856|NCT01052038|245367|P2|Overall Study|Protocol Violation|3
66857|NCT01052038|245368|P1|Overall Study|Protocol Violation|2
66858|NCT01052038|245366|P3|Overall Study|Lost to Follow-up|1
66859|NCT01052038|245367|P2|Overall Study|Lost to Follow-up|3
66860|NCT01052038|245368|P1|Overall Study|Lost to Follow-up|2
66861|NCT01051986|245390|P2|Overall Study|Protocol Violation|3
66862|NCT01051986|245391|P1|Overall Study|Protocol Violation|2
66863|NCT01051986|245390|P2|Overall Study|Withdrawal by Subject|1
66864|NCT01051986|245391|P1|Overall Study|Withdrawal by Subject|2
66865|NCT01051986|245390|P2|Overall Study|Death|0
66866|NCT01051986|245391|P1|Overall Study|Death|1
66867|NCT01051921|245405|P1|Overall Study|patient moved|1
66868|NCT01051921|245405|P1|Overall Study|virological failure|1
66869|NCT01051921|245405|P1|Overall Study|Lost to Follow-up|4
66870|NCT01051921|245405|P1|Overall Study|Withdrawal by Subject|7
66871|NCT01051921|245405|P1|Overall Study|Adverse Event|8
66872|NCT01051921|245405|P1|Overall Study|Physician Decision|9
66873|NCT01051856|245412|P2|Overall Study|Withdrawal by Subject|0
66874|NCT01051856|245413|P1|Overall Study|Withdrawal by Subject|1
66875|NCT01051817|245423|P2|Overall Study|Protocol Violation|1
66876|NCT01051817|245424|P1|Overall Study|Protocol Violation|0
66877|NCT01051817|245423|P2|Overall Study|Withdrawal by Subject|5
66878|NCT01051817|245424|P1|Overall Study|Withdrawal by Subject|3
66879|NCT01051817|245423|P2|Overall Study|Abnormal Test Proceedure reults|1
66880|NCT01051817|245424|P1|Overall Study|Abnormal Test Proceedure reults|0
66881|NCT01051817|245423|P2|Overall Study|Adverse Event|2
66882|NCT01051817|245424|P1|Overall Study|Adverse Event|0
66883|NCT01051739|245445|P2|Overall Study|Withdrawal by Subject|10
66884|NCT01051739|245446|P1|Overall Study|Withdrawal by Subject|25
66885|NCT01051739|245445|P2|Overall Study|Death|3
66886|NCT01051739|245446|P1|Overall Study|Death|3
66887|NCT01051557|245463|P7|Overall Study|Adverse Event|4
66888|NCT01051557|245464|P6|Overall Study|Adverse Event|3
66889|NCT01051557|245465|P5|Overall Study|Adverse Event|1
66890|NCT01051557|245466|P4|Overall Study|Adverse Event|1
66891|NCT01051557|245467|P3|Overall Study|Adverse Event|0
66892|NCT01051557|245468|P2|Overall Study|Adverse Event|0
66893|NCT01051557|245469|P1|Overall Study|Adverse Event|0
66894|NCT01051557|245463|P7|Overall Study|Withdrawal by Subject|1
66895|NCT01051557|245464|P6|Overall Study|Withdrawal by Subject|0
66896|NCT01051557|245465|P5|Overall Study|Withdrawal by Subject|2
66897|NCT01051557|245466|P4|Overall Study|Withdrawal by Subject|0
66898|NCT01051557|245467|P3|Overall Study|Withdrawal by Subject|1
66899|NCT01051557|245468|P2|Overall Study|Withdrawal by Subject|0
66900|NCT01051557|245469|P1|Overall Study|Withdrawal by Subject|0
66901|NCT01051557|245463|P7|Overall Study|disease progression|1
66902|NCT01051557|245464|P6|Overall Study|disease progression|3
66903|NCT01051557|245465|P5|Overall Study|disease progression|4
66904|NCT01051557|245466|P4|Overall Study|disease progression|2
66905|NCT01051557|245467|P3|Overall Study|disease progression|5
66906|NCT01051557|245468|P2|Overall Study|disease progression|3
66907|NCT01051557|245469|P1|Overall Study|disease progression|3
66908|NCT01051557|245463|P7|Overall Study|Physician Decision|0
66909|NCT01051557|245464|P6|Overall Study|Physician Decision|0
66910|NCT01051557|245465|P5|Overall Study|Physician Decision|0
66911|NCT01051557|245466|P4|Overall Study|Physician Decision|0
66912|NCT01051557|245467|P3|Overall Study|Physician Decision|0
66913|NCT01051557|245468|P2|Overall Study|Physician Decision|0
66914|NCT01051557|245469|P1|Overall Study|Physician Decision|1
66915|NCT01051466|245481|P2|Overall Study|Physician Decision|0
66916|NCT01051466|245482|P1|Overall Study|Physician Decision|1
66917|NCT01051466|245481|P2|Overall Study|Entry Criteria Not Met|3
66918|NCT01051466|245482|P1|Overall Study|Entry Criteria Not Met|0
66919|NCT01051466|245481|P2|Overall Study|Withdrawal by Subject|1
66920|NCT01051466|245482|P1|Overall Study|Withdrawal by Subject|5
66921|NCT01051466|245481|P2|Overall Study|Lost to Follow-up|1
66922|NCT01051466|245482|P1|Overall Study|Lost to Follow-up|1
66923|NCT01051466|245481|P2|Overall Study|Adverse Event|0
66924|NCT01051466|245482|P1|Overall Study|Adverse Event|1
66925|NCT01051323|245529|P1|Overall Study|Missing|37
66926|NCT01051323|245529|P1|Overall Study|Unspecified|148
66927|NCT01051323|245529|P1|Overall Study|Hospitalization|28
66928|NCT01051323|245529|P1|Overall Study|Death|129
66929|NCT01051323|245529|P1|Overall Study|Lost to Follow-up|31
66930|NCT01051323|245529|P1|Overall Study|Withdrawal by Subject|13
66931|NCT01051323|245529|P1|Overall Study|Dialysis dependency|22
66932|NCT01051323|245529|P1|Overall Study|Transplantation|28
66933|NCT01051323|245529|P1|Overall Study|Discontinuation of treatment|103
66934|NCT01050998|245556|P5|Overall Study|Data integrity issues|4
66935|NCT01050998|245557|P4|Overall Study|Data integrity issues|1
66936|NCT01050998|245558|P3|Overall Study|Data integrity issues|1
66937|NCT01050998|245559|P2|Overall Study|Data integrity issues|0
66938|NCT01050998|245560|P1|Overall Study|Data integrity issues|0
66939|NCT01050998|245556|P5|Overall Study|Unspecified|5
66940|NCT01050998|245557|P4|Overall Study|Unspecified|1
66941|NCT01050998|245558|P3|Overall Study|Unspecified|1
66942|NCT01050998|245559|P2|Overall Study|Unspecified|2
66943|NCT01050998|245560|P1|Overall Study|Unspecified|3
66944|NCT01050998|245556|P5|Overall Study|Withdrawal by Subject|3
66945|NCT01050998|245557|P4|Overall Study|Withdrawal by Subject|1
66946|NCT01050998|245558|P3|Overall Study|Withdrawal by Subject|0
66947|NCT01050998|245559|P2|Overall Study|Withdrawal by Subject|0
66948|NCT01050998|245560|P1|Overall Study|Withdrawal by Subject|0
66949|NCT01050998|245556|P5|Overall Study|Adverse Event|2
66950|NCT01050998|245557|P4|Overall Study|Adverse Event|0
66951|NCT01050998|245558|P3|Overall Study|Adverse Event|1
66952|NCT01050998|245559|P2|Overall Study|Adverse Event|0
66953|NCT01050998|245560|P1|Overall Study|Adverse Event|1
66954|NCT01050816|245894|P1|Overall Study|patient's refusal|2
66955|NCT01050816|245894|P1|Overall Study|Lost to Follow-up|2
66956|NCT01050790|245900|P1|Overall Study|Adverse Event|1
66957|NCT01050673|245912|P2|Overall Study|Physician Decision|5
66958|NCT01050673|245913|P1|Overall Study|Physician Decision|4
66959|NCT01050634|245962|P1|Overall Study|Ongoing at Date of Cut-Off|5
66960|NCT01050634|245962|P1|Overall Study|Other|21
66961|NCT01050634|245962|P1|Overall Study|Lost to Follow-up|2
66962|NCT01050634|245962|P1|Overall Study|Adverse Event|42
66963|NCT01050634|245962|P1|Overall Study|Death|2
66964|NCT01050634|245962|P1|Overall Study|Enrolled, but Not Treated|56
66965|NCT01050569|245986|P3|Overall Study|Physician Decision|3
66966|NCT01050569|245987|P2|Overall Study|Physician Decision|3
66967|NCT01050569|245988|P1|Overall Study|Physician Decision|3
66968|NCT01050569|245986|P3|Overall Study|Adverse Event|0
66969|NCT01050569|245987|P2|Overall Study|Adverse Event|0
66970|NCT01050569|245988|P1|Overall Study|Adverse Event|1
66971|NCT01050569|245986|P3|Overall Study|Lack of Efficacy|3
66972|NCT01050569|245987|P2|Overall Study|Lack of Efficacy|4
66973|NCT01050569|245988|P1|Overall Study|Lack of Efficacy|5
66974|NCT01050569|245986|P3|Overall Study|Withdrawal by Subject|11
66975|NCT01050569|245987|P2|Overall Study|Withdrawal by Subject|3
66976|NCT01050569|245988|P1|Overall Study|Withdrawal by Subject|9
66977|NCT01050569|245986|P3|Overall Study|Lost to Follow-up|16
66978|NCT01050569|245987|P2|Overall Study|Lost to Follow-up|14
66979|NCT01050569|245988|P1|Overall Study|Lost to Follow-up|20
66980|NCT01050543|246007|P2|Overall Study|Administrative|1
66981|NCT01050543|246008|P1|Overall Study|Administrative|4
66982|NCT01050543|246007|P2|Overall Study|Protocol Violation|1
66983|NCT01050543|246008|P1|Overall Study|Protocol Violation|0
66984|NCT01050543|246007|P2|Overall Study|Withdrawal by Subject|2
66985|NCT01050543|246008|P1|Overall Study|Withdrawal by Subject|0
66986|NCT01050530|246016|P2|Overall Study|Protocol Violation|0
66987|NCT01050530|246017|P1|Overall Study|Protocol Violation|1
66988|NCT01050530|246016|P2|Overall Study|Withdrawal by Subject|3
66989|NCT01050530|246017|P1|Overall Study|Withdrawal by Subject|0
66990|NCT01050530|246016|P2|Overall Study|Lack of Efficacy|4
66991|NCT01050530|246017|P1|Overall Study|Lack of Efficacy|1
66992|NCT01050530|246016|P2|Overall Study|Adverse Event|3
66993|NCT01050530|246017|P1|Overall Study|Adverse Event|6
66994|NCT01050257|246028|P3|Overall Study|Death|1
66995|NCT01050257|246029|P2|Overall Study|Death|0
66996|NCT01050257|246030|P1|Overall Study|Death|0
66997|NCT01050257|246028|P3|Overall Study|Failure to return|0
66998|NCT01050257|246029|P2|Overall Study|Failure to return|2
66999|NCT01050257|246030|P1|Overall Study|Failure to return|0
67000|NCT01050257|246028|P3|Overall Study|Violation criteria|0
67001|NCT01050257|246029|P2|Overall Study|Violation criteria|1
67002|NCT01050257|246030|P1|Overall Study|Violation criteria|0
67003|NCT01050257|246028|P3|Overall Study|Refused treatment/ Did not Cooperate|0
67004|NCT01050257|246029|P2|Overall Study|Refused treatment/ Did not Cooperate|1
67005|NCT01050257|246030|P1|Overall Study|Refused treatment/ Did not Cooperate|1
67006|NCT01050257|246028|P3|Overall Study|No reason specified|2
67007|NCT01050257|246029|P2|Overall Study|No reason specified|0
67008|NCT01050257|246030|P1|Overall Study|No reason specified|0
67009|NCT01050257|246028|P3|Overall Study|Withdrawal by Subject|0
67010|NCT01050257|246029|P2|Overall Study|Withdrawal by Subject|3
67011|NCT01050257|246030|P1|Overall Study|Withdrawal by Subject|0
67012|NCT01050257|246028|P3|Overall Study|Admin/Other (did not switch to oral)|2
67013|NCT01050257|246029|P2|Overall Study|Admin/Other (did not switch to oral)|2
67014|NCT01050257|246030|P1|Overall Study|Admin/Other (did not switch to oral)|6
67015|NCT01050257|246028|P3|Overall Study|Adverse Event|2
67016|NCT01050257|246029|P2|Overall Study|Adverse Event|4
67017|NCT01050257|246030|P1|Overall Study|Adverse Event|4
67018|NCT01050218|246065|P1|Overall Study|Family emergency|1
67019|NCT01050218|246065|P1|Overall Study|Serious Adverse Event|1
67020|NCT01050218|246065|P1|Overall Study|Failed to return|7
67021|NCT01050218|246065|P1|Overall Study|Compliance|2
67022|NCT01050218|246065|P1|Overall Study|Discontinued by sponsor|18
67023|NCT01050218|246065|P1|Overall Study|Withdrawal by Subject|18
67024|NCT01050218|246065|P1|Overall Study|Protocol Violation|3
67025|NCT01050218|246065|P1|Overall Study|Lack of Efficacy|8
67026|NCT01050218|246065|P1|Overall Study|Adverse Event|37
67027|NCT01050062|246098|P2|Overall Study|Others|11
67028|NCT01050062|246099|P1|Overall Study|Others|17
67029|NCT01050062|246098|P2|Overall Study|Physician Decision|9
67030|NCT01050062|246099|P1|Overall Study|Physician Decision|74
67031|NCT01050062|246098|P2|Overall Study|Lack of Efficacy|35
67032|NCT01050062|246099|P1|Overall Study|Lack of Efficacy|22
67033|NCT01050062|246098|P2|Overall Study|Lost to Follow-up|35
67034|NCT01050062|246099|P1|Overall Study|Lost to Follow-up|83
67035|NCT01050062|246098|P2|Overall Study|Adverse Event|22
67036|NCT01050062|246099|P1|Overall Study|Adverse Event|75
67037|NCT01049984|246121|P2|Overall Study|Treatment failure|2
67038|NCT01049984|246122|P1|Overall Study|Treatment failure|0
67039|NCT01049984|246121|P2|Overall Study|Adverse Event|7
67040|NCT01049984|246122|P1|Overall Study|Adverse Event|13
67041|NCT01049984|246121|P2|Overall Study|Lost to Follow-up|1
67042|NCT01049984|246122|P1|Overall Study|Lost to Follow-up|2
67043|NCT01049984|246121|P2|Overall Study|Protocol Violation|4
67044|NCT01049984|246122|P1|Overall Study|Protocol Violation|3
67045|NCT01049984|246121|P2|Overall Study|Withdrawal by Subject|5
67046|NCT01049984|246122|P1|Overall Study|Withdrawal by Subject|1
67047|NCT01049581|246182|P2|Overall Study|Lost to Follow-up|1
67048|NCT01049581|246183|P1|Overall Study|Lost to Follow-up|2
67049|NCT01049503|246198|P6|Overall Study|Lost to Follow-up|8
67050|NCT01049503|246199|P5|Overall Study|Lost to Follow-up|27
67051|NCT01049503|246200|P4|Overall Study|Lost to Follow-up|26
67052|NCT01049503|246201|P3|Overall Study|Lost to Follow-up|24
67053|NCT01049503|246202|P2|Overall Study|Lost to Follow-up|12
67054|NCT01049503|246203|P1|Overall Study|Lost to Follow-up|11
67055|NCT01049373|246234|P2|Overall Study|Non-cooperation|1
67056|NCT01049373|246235|P1|Overall Study|Non-cooperation|0
67057|NCT01049373|246234|P2|Overall Study|Not specified|1
67058|NCT01049373|246235|P1|Overall Study|Not specified|1
67059|NCT01049373|246234|P2|Overall Study|no evaluable study values|21
67060|NCT01049373|246235|P1|Overall Study|no evaluable study values|9
67061|NCT01049373|246234|P2|Overall Study|Lost to Follow-up|4
67062|NCT01049373|246235|P1|Overall Study|Lost to Follow-up|9
67063|NCT01049373|246234|P2|Overall Study|Adverse Event|3
67064|NCT01049373|246235|P1|Overall Study|Adverse Event|3
67065|NCT01049373|246234|P2|Overall Study|Withdrawal by Subject|5
67066|NCT01049373|246235|P1|Overall Study|Withdrawal by Subject|8
67067|NCT01049373|246234|P2|Overall Study|Protocol Violation|9
67068|NCT01049373|246235|P1|Overall Study|Protocol Violation|9
67069|NCT01049360|246249|P20|Period 4|Withdrawal by Subject|0
67070|NCT01049360|246250|P19|Period 4|Withdrawal by Subject|0
67071|NCT01049360|246251|P18|Period 4|Withdrawal by Subject|0
67072|NCT01049360|246252|P17|Period 4|Withdrawal by Subject|0
67073|NCT01049360|246253|P16|Period 4|Withdrawal by Subject|0
67074|NCT01049360|246254|P15|Period 4|Withdrawal by Subject|0
67075|NCT01049360|246255|P14|Period 4|Withdrawal by Subject|0
67076|NCT01049360|246256|P13|Period 4|Withdrawal by Subject|0
67077|NCT01049360|246257|P12|Period 4|Withdrawal by Subject|0
67078|NCT01049360|246258|P11|Period 4|Withdrawal by Subject|0
67079|NCT01049360|246259|P10|Period 4|Withdrawal by Subject|0
67080|NCT01049360|246260|P9|Period 4|Withdrawal by Subject|0
67081|NCT01049360|246261|P8|Period 4|Withdrawal by Subject|0
67082|NCT01049360|246262|P7|Period 4|Withdrawal by Subject|0
67083|NCT01049360|246263|P6|Period 4|Withdrawal by Subject|0
67084|NCT01049360|246264|P5|Period 4|Withdrawal by Subject|0
67085|NCT01049360|246265|P4|Period 4|Withdrawal by Subject|1
67086|NCT01049360|246266|P3|Period 4|Withdrawal by Subject|0
67087|NCT01049360|246267|P2|Period 4|Withdrawal by Subject|0
67088|NCT01049360|246268|P1|Period 4|Withdrawal by Subject|0
67089|NCT01049360|246249|P20|Period 4|Protocol Violation|0
67090|NCT01049360|246250|P19|Period 4|Protocol Violation|0
67091|NCT01049360|246251|P18|Period 4|Protocol Violation|1
67092|NCT01049360|246252|P17|Period 4|Protocol Violation|0
67093|NCT01049360|246253|P16|Period 4|Protocol Violation|0
67094|NCT01049360|246254|P15|Period 4|Protocol Violation|0
67095|NCT01049360|246255|P14|Period 4|Protocol Violation|0
67096|NCT01049360|246256|P13|Period 4|Protocol Violation|0
67097|NCT01049360|246257|P12|Period 4|Protocol Violation|0
67098|NCT01049360|246258|P11|Period 4|Protocol Violation|0
67099|NCT01049360|246259|P10|Period 4|Protocol Violation|0
67100|NCT01049360|246260|P9|Period 4|Protocol Violation|0
67101|NCT01049360|246261|P8|Period 4|Protocol Violation|0
67102|NCT01049360|246262|P7|Period 4|Protocol Violation|0
67103|NCT01049360|246263|P6|Period 4|Protocol Violation|0
67104|NCT01049360|246264|P5|Period 4|Protocol Violation|0
67105|NCT01049360|246265|P4|Period 4|Protocol Violation|0
67106|NCT01049360|246266|P3|Period 4|Protocol Violation|0
67107|NCT01049360|246267|P2|Period 4|Protocol Violation|0
67108|NCT01049360|246268|P1|Period 4|Protocol Violation|0
67109|NCT01049360|246249|P20|Period 2|Lack of Efficacy|0
67110|NCT01049360|246250|P19|Period 2|Lack of Efficacy|0
67111|NCT01049360|246251|P18|Period 2|Lack of Efficacy|0
67112|NCT01049360|246252|P17|Period 2|Lack of Efficacy|0
67113|NCT01049360|246253|P16|Period 2|Lack of Efficacy|0
67114|NCT01049360|246254|P15|Period 2|Lack of Efficacy|0
67115|NCT01049360|246255|P14|Period 2|Lack of Efficacy|0
67116|NCT01049360|246256|P13|Period 2|Lack of Efficacy|0
67117|NCT01049360|246257|P12|Period 2|Lack of Efficacy|0
67118|NCT01049360|246258|P11|Period 2|Lack of Efficacy|0
67119|NCT01049360|246259|P10|Period 2|Lack of Efficacy|0
67120|NCT01049360|246260|P9|Period 2|Lack of Efficacy|0
67121|NCT01049360|246261|P8|Period 2|Lack of Efficacy|0
67122|NCT01049360|246262|P7|Period 2|Lack of Efficacy|0
67123|NCT01049360|246263|P6|Period 2|Lack of Efficacy|1
67124|NCT01049360|246264|P5|Period 2|Lack of Efficacy|0
67125|NCT01049360|246265|P4|Period 2|Lack of Efficacy|0
67126|NCT01049360|246266|P3|Period 2|Lack of Efficacy|0
67127|NCT01049360|246267|P2|Period 2|Lack of Efficacy|0
67128|NCT01049360|246268|P1|Period 2|Lack of Efficacy|0
67129|NCT01049360|246249|P20|Period 2|Withdrawal by Subject|1
67130|NCT01049360|246250|P19|Period 2|Withdrawal by Subject|0
67131|NCT01049360|246251|P18|Period 2|Withdrawal by Subject|0
67132|NCT01049360|246252|P17|Period 2|Withdrawal by Subject|0
67133|NCT01049360|246253|P16|Period 2|Withdrawal by Subject|0
67134|NCT01049360|246254|P15|Period 2|Withdrawal by Subject|1
67135|NCT01049360|246255|P14|Period 2|Withdrawal by Subject|0
67136|NCT01049360|246256|P13|Period 2|Withdrawal by Subject|0
67137|NCT01049360|246257|P12|Period 2|Withdrawal by Subject|0
67138|NCT01049360|246258|P11|Period 2|Withdrawal by Subject|0
67139|NCT01049360|246259|P10|Period 2|Withdrawal by Subject|0
67140|NCT01049360|246260|P9|Period 2|Withdrawal by Subject|0
67141|NCT01049360|246261|P8|Period 2|Withdrawal by Subject|0
67142|NCT01049360|246262|P7|Period 2|Withdrawal by Subject|0
67143|NCT01049360|246263|P6|Period 2|Withdrawal by Subject|0
67144|NCT01049360|246264|P5|Period 2|Withdrawal by Subject|0
67145|NCT01049360|246265|P4|Period 2|Withdrawal by Subject|1
67146|NCT01049360|246266|P3|Period 2|Withdrawal by Subject|0
67147|NCT01049360|246267|P2|Period 2|Withdrawal by Subject|0
67148|NCT01049360|246268|P1|Period 2|Withdrawal by Subject|0
67149|NCT01049360|246249|P20|Period 2|Adverse Event|1
67150|NCT01049360|246250|P19|Period 2|Adverse Event|0
67151|NCT01049360|246251|P18|Period 2|Adverse Event|0
67152|NCT01049360|246252|P17|Period 2|Adverse Event|0
67153|NCT01049360|246253|P16|Period 2|Adverse Event|0
67154|NCT01049360|246254|P15|Period 2|Adverse Event|0
67155|NCT01049360|246255|P14|Period 2|Adverse Event|0
67156|NCT01049360|246256|P13|Period 2|Adverse Event|0
67157|NCT01049360|246257|P12|Period 2|Adverse Event|0
67158|NCT01049360|246258|P11|Period 2|Adverse Event|0
67159|NCT01049360|246259|P10|Period 2|Adverse Event|0
67160|NCT01049360|246260|P9|Period 2|Adverse Event|1
67161|NCT01049360|246261|P8|Period 2|Adverse Event|0
67162|NCT01049360|246262|P7|Period 2|Adverse Event|0
67163|NCT01049360|246263|P6|Period 2|Adverse Event|0
67164|NCT01049360|246264|P5|Period 2|Adverse Event|0
67165|NCT01049360|246265|P4|Period 2|Adverse Event|0
67166|NCT01049360|246266|P3|Period 2|Adverse Event|0
67167|NCT01049360|246267|P2|Period 2|Adverse Event|1
67168|NCT01049360|246268|P1|Period 2|Adverse Event|0
67169|NCT01049360|246249|P20|Period 2|Protocol Violation|0
67170|NCT01049360|246250|P19|Period 2|Protocol Violation|0
67171|NCT01049360|246251|P18|Period 2|Protocol Violation|0
67172|NCT01049360|246252|P17|Period 2|Protocol Violation|0
67173|NCT01049360|246253|P16|Period 2|Protocol Violation|1
67174|NCT01049360|246254|P15|Period 2|Protocol Violation|1
67175|NCT01049360|246255|P14|Period 2|Protocol Violation|0
67176|NCT01049360|246256|P13|Period 2|Protocol Violation|0
67177|NCT01049360|246257|P12|Period 2|Protocol Violation|0
67178|NCT01049360|246258|P11|Period 2|Protocol Violation|0
67179|NCT01049360|246259|P10|Period 2|Protocol Violation|0
67180|NCT01049360|246260|P9|Period 2|Protocol Violation|0
67181|NCT01049360|246261|P8|Period 2|Protocol Violation|0
67182|NCT01049360|246262|P7|Period 2|Protocol Violation|0
67183|NCT01049360|246263|P6|Period 2|Protocol Violation|0
67184|NCT01049360|246264|P5|Period 2|Protocol Violation|0
67185|NCT01049360|246265|P4|Period 2|Protocol Violation|1
67186|NCT01049360|246266|P3|Period 2|Protocol Violation|0
67187|NCT01049360|246267|P2|Period 2|Protocol Violation|0
67188|NCT01049360|246268|P1|Period 2|Protocol Violation|0
67189|NCT01049360|246249|P20|Period 1|Withdrawal by Subject|0
67190|NCT01049360|246250|P19|Period 1|Withdrawal by Subject|0
67191|NCT01049360|246251|P18|Period 1|Withdrawal by Subject|0
67192|NCT01049360|246252|P17|Period 1|Withdrawal by Subject|0
67193|NCT01049360|246253|P16|Period 1|Withdrawal by Subject|0
67194|NCT01049360|246254|P15|Period 1|Withdrawal by Subject|0
67195|NCT01049360|246255|P14|Period 1|Withdrawal by Subject|0
67196|NCT01049360|246256|P13|Period 1|Withdrawal by Subject|1
67197|NCT01049360|246257|P12|Period 1|Withdrawal by Subject|0
67198|NCT01049360|246258|P11|Period 1|Withdrawal by Subject|1
67199|NCT01049360|246259|P10|Period 1|Withdrawal by Subject|0
67200|NCT01049360|246260|P9|Period 1|Withdrawal by Subject|1
67201|NCT01049360|246261|P8|Period 1|Withdrawal by Subject|0
67202|NCT01049360|246262|P7|Period 1|Withdrawal by Subject|0
67203|NCT01049360|246263|P6|Period 1|Withdrawal by Subject|0
67204|NCT01049360|246264|P5|Period 1|Withdrawal by Subject|0
67205|NCT01049360|246265|P4|Period 1|Withdrawal by Subject|0
67206|NCT01049360|246266|P3|Period 1|Withdrawal by Subject|0
67207|NCT01049360|246267|P2|Period 1|Withdrawal by Subject|0
67208|NCT01049360|246268|P1|Period 1|Withdrawal by Subject|0
67209|NCT01049360|246249|P20|Period 1|Did not meet inc/exc criteria|0
67210|NCT01049360|246250|P19|Period 1|Did not meet inc/exc criteria|0
67211|NCT01049360|246251|P18|Period 1|Did not meet inc/exc criteria|0
67212|NCT01049360|246252|P17|Period 1|Did not meet inc/exc criteria|0
67213|NCT01049360|246253|P16|Period 1|Did not meet inc/exc criteria|0
67214|NCT01049360|246254|P15|Period 1|Did not meet inc/exc criteria|0
67215|NCT01049360|246255|P14|Period 1|Did not meet inc/exc criteria|0
67216|NCT01049360|246256|P13|Period 1|Did not meet inc/exc criteria|0
67217|NCT01049360|246257|P12|Period 1|Did not meet inc/exc criteria|0
67218|NCT01049360|246258|P11|Period 1|Did not meet inc/exc criteria|0
67219|NCT01049360|246259|P10|Period 1|Did not meet inc/exc criteria|0
67220|NCT01049360|246260|P9|Period 1|Did not meet inc/exc criteria|1
67221|NCT01049360|246261|P8|Period 1|Did not meet inc/exc criteria|1
67222|NCT01049360|246262|P7|Period 1|Did not meet inc/exc criteria|0
67223|NCT01049360|246263|P6|Period 1|Did not meet inc/exc criteria|0
67224|NCT01049360|246264|P5|Period 1|Did not meet inc/exc criteria|0
67225|NCT01049360|246265|P4|Period 1|Did not meet inc/exc criteria|0
67226|NCT01049360|246266|P3|Period 1|Did not meet inc/exc criteria|0
67227|NCT01049360|246267|P2|Period 1|Did not meet inc/exc criteria|0
67228|NCT01049360|246268|P1|Period 1|Did not meet inc/exc criteria|0
67229|NCT01049360|246249|P20|Period 1|Adverse Event|0
67230|NCT01049360|246250|P19|Period 1|Adverse Event|1
67231|NCT01049360|246251|P18|Period 1|Adverse Event|0
67232|NCT01049360|246252|P17|Period 1|Adverse Event|1
67233|NCT01049360|246253|P16|Period 1|Adverse Event|0
67234|NCT01049360|246254|P15|Period 1|Adverse Event|0
67235|NCT01049360|246255|P14|Period 1|Adverse Event|1
67236|NCT01049360|246256|P13|Period 1|Adverse Event|1
67237|NCT01049360|246257|P12|Period 1|Adverse Event|0
67238|NCT01049360|246258|P11|Period 1|Adverse Event|0
67239|NCT01049360|246259|P10|Period 1|Adverse Event|0
67240|NCT01049360|246260|P9|Period 1|Adverse Event|0
67241|NCT01049360|246261|P8|Period 1|Adverse Event|1
67242|NCT01049360|246262|P7|Period 1|Adverse Event|0
67243|NCT01049360|246263|P6|Period 1|Adverse Event|0
67244|NCT01049360|246264|P5|Period 1|Adverse Event|0
67245|NCT01049360|246265|P4|Period 1|Adverse Event|1
67246|NCT01049360|246266|P3|Period 1|Adverse Event|0
67247|NCT01049360|246267|P2|Period 1|Adverse Event|1
67248|NCT01049360|246268|P1|Period 1|Adverse Event|0
67249|NCT01049308|246290|P1|Pill Counts|Withdrawal by Subject|83
67250|NCT01049217|246303|P2|Overall Study|Randomized but not Treated|2
67251|NCT01049217|246304|P1|Overall Study|Randomized but not Treated|0
67252|NCT01049217|246303|P2|Overall Study|Unspecified|2
67253|NCT01049217|246304|P1|Overall Study|Unspecified|1
67254|NCT01049217|246303|P2|Overall Study|Study Terminated by Sponsor|43
67255|NCT01049217|246304|P1|Overall Study|Study Terminated by Sponsor|43
67256|NCT01049217|246303|P2|Overall Study|Pregnancy|0
67257|NCT01049217|246304|P1|Overall Study|Pregnancy|1
67258|NCT01049217|246303|P2|Overall Study|Protocol Violation|3
67259|NCT01049217|246304|P1|Overall Study|Protocol Violation|1
67260|NCT01049217|246303|P2|Overall Study|Withdrawal by Subject|3
67261|NCT01049217|246304|P1|Overall Study|Withdrawal by Subject|4
67262|NCT01049217|246303|P2|Overall Study|Lost to Follow-up|8
67263|NCT01049217|246304|P1|Overall Study|Lost to Follow-up|3
67264|NCT01049217|246303|P2|Overall Study|Lack of Efficacy|1
67265|NCT01049217|246304|P1|Overall Study|Lack of Efficacy|1
67266|NCT01049217|246303|P2|Overall Study|Adverse Event|1
67267|NCT01049217|246304|P1|Overall Study|Adverse Event|2
67268|NCT01049009|246376|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
67269|NCT01049009|246377|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
67270|NCT01049009|246376|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
67271|NCT01049009|246377|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
67272|NCT01049009|246376|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
67273|NCT01049009|246377|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
67274|NCT01049009|246376|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
67275|NCT01049009|246377|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
67276|NCT01048944|246389|P4|Overall Study|Protocol Violation|2
67277|NCT01048944|246390|P3|Overall Study|Protocol Violation|10
67278|NCT01048944|246391|P2|Overall Study|Protocol Violation|10
67279|NCT01048944|246392|P1|Overall Study|Protocol Violation|8
67280|NCT01048788|246425|P3|Overall Study|Withdrawal by Subject|0
67281|NCT01048788|246426|P2|Overall Study|Withdrawal by Subject|1
67282|NCT01048788|246427|P1|Overall Study|Withdrawal by Subject|0
67283|NCT01048788|246425|P3|Overall Study|Lack of Efficacy|1
67284|NCT01048788|246426|P2|Overall Study|Lack of Efficacy|0
67285|NCT01048788|246427|P1|Overall Study|Lack of Efficacy|0
67286|NCT01048788|246425|P3|Overall Study|Adverse Event|1
67287|NCT01048788|246426|P2|Overall Study|Adverse Event|1
67288|NCT01048788|246427|P1|Overall Study|Adverse Event|5
67289|NCT01048671|246449|P3|Overall Study|Protocol Violation|1
67290|NCT01048671|246450|P2|Overall Study|Protocol Violation|1
67291|NCT01048671|246451|P1|Overall Study|Protocol Violation|0
67292|NCT01048541|246502|P2|Overall Study|Withdrawal by Subject|0
67293|NCT01048541|246503|P1|Overall Study|Withdrawal by Subject|1
67294|NCT01048502|246513|P4|Overall Study|Physician Decision|1
67295|NCT01048502|246514|P3|Overall Study|Physician Decision|0
67296|NCT01048502|246515|P2|Overall Study|Physician Decision|3
67297|NCT01048502|246516|P1|Overall Study|Physician Decision|0
67298|NCT01048502|246513|P4|Overall Study|Withdrawal by Subject|3
67299|NCT01048502|246514|P3|Overall Study|Withdrawal by Subject|5
67300|NCT01048502|246515|P2|Overall Study|Withdrawal by Subject|4
67301|NCT01048502|246516|P1|Overall Study|Withdrawal by Subject|1
67302|NCT01048502|246513|P4|Overall Study|Adverse Event|0
67303|NCT01048502|246514|P3|Overall Study|Adverse Event|0
67304|NCT01048502|246515|P2|Overall Study|Adverse Event|0
67305|NCT01048502|246516|P1|Overall Study|Adverse Event|1
67306|NCT01048502|246513|P4|Overall Study|Lost to Follow-up|0
67307|NCT01048502|246514|P3|Overall Study|Lost to Follow-up|0
67308|NCT01048502|246515|P2|Overall Study|Lost to Follow-up|0
67309|NCT01048502|246516|P1|Overall Study|Lost to Follow-up|2
67310|NCT01048333|246552|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
67311|NCT01048333|246553|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
67312|NCT01048333|246554|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
67313|NCT01048333|246555|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
67314|NCT01048333|246556|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
67315|NCT01048333|246557|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
67316|NCT01048099|246586|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
67317|NCT01048099|246586|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
67318|NCT01047553|246616|P2|Overall Study|PI's decision|1
67319|NCT01047553|246617|P1|Overall Study|PI's decision|0
67320|NCT01047553|246616|P2|Overall Study|Sever Non-Compliance to Protocol|0
67321|NCT01047553|246617|P1|Overall Study|Sever Non-Compliance to Protocol|1
67322|NCT01047553|246616|P2|Overall Study|Lost to Follow-up|0
67323|NCT01047553|246617|P1|Overall Study|Lost to Follow-up|1
67324|NCT01047553|246616|P2|Overall Study|Development of Study-Specific Withdrawal|1
67325|NCT01047553|246617|P1|Overall Study|Development of Study-Specific Withdrawal|1
67326|NCT01047553|246616|P2|Overall Study|Withdrawal by Subject|2
67327|NCT01047553|246617|P1|Overall Study|Withdrawal by Subject|4
67328|NCT01047553|246616|P2|Overall Study|Adverse Event|5
67329|NCT01047553|246617|P1|Overall Study|Adverse Event|10
67330|NCT01047436|246724|P2|Overall Study|Protocol Violation|0
67331|NCT01047436|246725|P1|Overall Study|Protocol Violation|1
67332|NCT01047345|246750|P3|Extension|Lost to Follow-up|5
67333|NCT01047345|246751|P2|Extension|Lost to Follow-up|0
67334|NCT01047345|246752|P1|Extension|Lost to Follow-up|0
67335|NCT01047345|246750|P3|Extension|Withdrawal by Subject|1
67336|NCT01047345|246751|P2|Extension|Withdrawal by Subject|0
67337|NCT01047345|246752|P1|Extension|Withdrawal by Subject|0
67338|NCT01047345|246750|P3|Base Study|Withdrawal by Subject|0
67339|NCT01047345|246751|P2|Base Study|Withdrawal by Subject|4
67340|NCT01047345|246752|P1|Base Study|Withdrawal by Subject|12
67341|NCT01047345|246750|P3|Base Study|Protocol Violation|0
67342|NCT01047345|246751|P2|Base Study|Protocol Violation|1
67343|NCT01047345|246752|P1|Base Study|Protocol Violation|3
67344|NCT01047345|246750|P3|Base Study|Lost to Follow-up|0
67345|NCT01047345|246751|P2|Base Study|Lost to Follow-up|1
67346|NCT01047345|246752|P1|Base Study|Lost to Follow-up|4
67347|NCT01047345|246750|P3|Base Study|Adverse Event|0
67348|NCT01047345|246751|P2|Base Study|Adverse Event|0
67349|NCT01047345|246752|P1|Base Study|Adverse Event|3
67350|NCT01047306|246774|P2|Overall Study|Lost to Follow-up|0
67351|NCT01047306|246775|P1|Overall Study|Lost to Follow-up|1
67352|NCT01047306|246774|P2|Overall Study|Withdrawal by Subject|0
67353|NCT01047306|246775|P1|Overall Study|Withdrawal by Subject|2
67354|NCT01046903|246869|P1|Overall Study|Unspecified|5
67355|NCT01046903|246869|P1|Overall Study|Withdrawal by Subject|3
67356|NCT01046903|246869|P1|Overall Study|Adverse Event|4
67357|NCT01046903|246869|P1|Overall Study|Lost to Follow-up|16
67358|NCT01046877|246882|P1|Overall Study|Exited voluntarily after tube extrusion|11
67359|NCT01046877|246882|P1|Overall Study|Exited voluntarily before tube extrusion|7
67360|NCT01046695|246898|P2|Overall Study|TENS interfered with the cardiac monitor|1
67361|NCT01046695|246899|P1|Overall Study|TENS interfered with the cardiac monitor|0
67362|NCT01046695|246898|P2|Overall Study|Subject had a pacemaker|1
67363|NCT01046695|246899|P1|Overall Study|Subject had a pacemaker|0
67364|NCT01046682|246911|P2|Overall Study|Adverse Event|0
67365|NCT01046682|246912|P1|Overall Study|Adverse Event|2
67366|NCT01046643|246920|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
67367|NCT01046643|246921|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
67368|NCT01046643|246922|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
67369|NCT01046643|246923|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
67370|NCT01046565|246945|P1|Overall Study|Withdrawal by Subject|7
67371|NCT01046565|246945|P1|Overall Study|Adverse Event|2
67372|NCT01046396|246954|P1|Overall Study|Withdrawal by Subject|5
67373|NCT01046253|246965|P2|Second Intervention|Protocol Violation|1
67374|NCT01046253|246966|P1|Second Intervention|Protocol Violation|0
67375|NCT01046253|246965|P2|Second Intervention|Adverse Event|1
67376|NCT01046253|246966|P1|Second Intervention|Adverse Event|0
67377|NCT01046136|246978|P2|Overall Study|Lost to Follow-up|3
67378|NCT01046136|246979|P1|Overall Study|Lost to Follow-up|3
67379|NCT01046136|246978|P2|Overall Study|Physician Decision|1
67380|NCT01046136|246979|P1|Overall Study|Physician Decision|1
67381|NCT01046136|246978|P2|Overall Study|Withdrawal by Subject|4
67382|NCT01046136|246979|P1|Overall Study|Withdrawal by Subject|0
67383|NCT01046110|246991|P2|Overall Study|Unclassified|35
67384|NCT01046110|246992|P1|Overall Study|Unclassified|36
67385|NCT01046110|246991|P2|Overall Study|Withdrawal Criteria|5
67386|NCT01046110|246992|P1|Overall Study|Withdrawal Criteria|3
67387|NCT01046110|246991|P2|Overall Study|Protocol Violation|12
67388|NCT01046110|246992|P1|Overall Study|Protocol Violation|7
67389|NCT01046110|246991|P2|Overall Study|Lack of Efficacy|1
67390|NCT01046110|246992|P1|Overall Study|Lack of Efficacy|0
67391|NCT01046110|246991|P2|Overall Study|Adverse Event|2
67392|NCT01046110|246992|P1|Overall Study|Adverse Event|9
67393|NCT01046084|247002|P2|Third Washout of 7 Days|Withdrawal by Subject|0
67394|NCT01046084|247003|P1|Third Washout of 7 Days|Withdrawal by Subject|2
67395|NCT01045993|247017|P4|Overall Study|Treated-later found eligibility not met|0
67396|NCT01045993|247018|P3|Overall Study|Treated-later found eligibility not met|0
67397|NCT01045993|247019|P2|Overall Study|Treated-later found eligibility not met|1
67398|NCT01045993|247020|P1|Overall Study|Treated-later found eligibility not met|0
67399|NCT01045967|247096|P2|Second Intervention|Protocol Violation|1
67400|NCT01045967|247097|P1|Second Intervention|Protocol Violation|0
67401|NCT01045798|247109|P2|Overall Study|Received Systemic Antifungal Prestudy|1
67402|NCT01045798|247110|P1|Overall Study|Received Systemic Antifungal Prestudy|0
67403|NCT01045798|247109|P2|Overall Study|Changed to Other Antifungal Therapy|2
67404|NCT01045798|247110|P1|Overall Study|Changed to Other Antifungal Therapy|1
67405|NCT01045798|247109|P2|Overall Study|Invasive Fungal Infection at Baseline|1
67406|NCT01045798|247110|P1|Overall Study|Invasive Fungal Infection at Baseline|0
67407|NCT01045798|247109|P2|Overall Study|Changed to Open-Label Caspofungin|0
67408|NCT01045798|247110|P1|Overall Study|Changed to Open-Label Caspofungin|1
67409|NCT01045707|247118|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
67410|NCT01045707|247119|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
67411|NCT01045707|247118|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
67412|NCT01045707|247119|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
67413|NCT01045707|247118|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
67414|NCT01045707|247119|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
67415|NCT01045707|247118|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
67416|NCT01045707|247119|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
67417|NCT01045707|247118|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
67418|NCT01045707|247119|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
67419|NCT01045707|247118|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
67420|NCT01045707|247119|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
67421|NCT01045707|247118|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
67422|NCT01045707|247119|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
67423|NCT01045707|247118|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
67424|NCT01045707|247119|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
67425|NCT01045707|247118|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
67426|NCT01045707|247119|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
67427|NCT01045447|247145|P2|Overall Study|Unclassified|13
67428|NCT01045447|247146|P1|Overall Study|Unclassified|17
67429|NCT01045447|247145|P2|Overall Study|Withdrawal Criteria|10
67430|NCT01045447|247146|P1|Overall Study|Withdrawal Criteria|10
67431|NCT01045447|247145|P2|Overall Study|Protocol Violation|3
67432|NCT01045447|247146|P1|Overall Study|Protocol Violation|6
67433|NCT01045447|247145|P2|Overall Study|Lack of Efficacy|1
67434|NCT01045447|247146|P1|Overall Study|Lack of Efficacy|3
67435|NCT01045447|247145|P2|Overall Study|Adverse Event|1
67436|NCT01045447|247146|P1|Overall Study|Adverse Event|0
67437|NCT01045421|247160|P11|Phase 2|Other|1
67438|NCT01045421|247161|P10|Phase 2|Other|0
67439|NCT01045421|247162|P9|Phase 2|Other|0
67440|NCT01045421|247163|P8|Phase 2|Other|3
67441|NCT01045421|247164|P7|Phase 2|Other|0
67442|NCT01045421|247165|P6|Phase 2|Other|0
67443|NCT01045421|247166|P5|Phase 2|Other|0
67444|NCT01045421|247167|P4|Phase 2|Other|0
67445|NCT01045421|247168|P3|Phase 2|Other|0
67446|NCT01045421|247169|P2|Phase 2|Other|0
67447|NCT01045421|247170|P1|Phase 2|Other|0
67448|NCT01045421|247160|P11|Phase 2|Death|0
67449|NCT01045421|247161|P10|Phase 2|Death|2
67450|NCT01045421|247162|P9|Phase 2|Death|1
67451|NCT01045421|247163|P8|Phase 2|Death|1
67452|NCT01045421|247164|P7|Phase 2|Death|0
67453|NCT01045421|247165|P6|Phase 2|Death|0
67454|NCT01045421|247166|P5|Phase 2|Death|0
67455|NCT01045421|247167|P4|Phase 2|Death|0
67456|NCT01045421|247168|P3|Phase 2|Death|0
67457|NCT01045421|247169|P2|Phase 2|Death|0
67458|NCT01045421|247170|P1|Phase 2|Death|0
67459|NCT01045421|247160|P11|Phase 2|Progressive Disease|1
67460|NCT01045421|247161|P10|Phase 2|Progressive Disease|1
67461|NCT01045421|247162|P9|Phase 2|Progressive Disease|1
67462|NCT01045421|247163|P8|Phase 2|Progressive Disease|1
67463|NCT01045421|247164|P7|Phase 2|Progressive Disease|0
67464|NCT01045421|247165|P6|Phase 2|Progressive Disease|0
67465|NCT01045421|247166|P5|Phase 2|Progressive Disease|0
67466|NCT01045421|247167|P4|Phase 2|Progressive Disease|0
67467|NCT01045421|247168|P3|Phase 2|Progressive Disease|0
67468|NCT01045421|247169|P2|Phase 2|Progressive Disease|0
67469|NCT01045421|247170|P1|Phase 2|Progressive Disease|0
67470|NCT01045421|247160|P11|Phase 1|Withdrawal by Subject|0
67471|NCT01045421|247161|P10|Phase 1|Withdrawal by Subject|0
67472|NCT01045421|247162|P9|Phase 1|Withdrawal by Subject|0
67473|NCT01045421|247163|P8|Phase 1|Withdrawal by Subject|0
67474|NCT01045421|247164|P7|Phase 1|Withdrawal by Subject|0
67475|NCT01045421|247165|P6|Phase 1|Withdrawal by Subject|0
67476|NCT01045421|247166|P5|Phase 1|Withdrawal by Subject|0
67477|NCT01045421|247167|P4|Phase 1|Withdrawal by Subject|1
67478|NCT01045421|247168|P3|Phase 1|Withdrawal by Subject|0
67479|NCT01045421|247169|P2|Phase 1|Withdrawal by Subject|0
67480|NCT01045421|247170|P1|Phase 1|Withdrawal by Subject|0
67481|NCT01045421|247160|P11|Phase 1|Progressive Disease|0
67482|NCT01045421|247161|P10|Phase 1|Progressive Disease|0
67483|NCT01045421|247162|P9|Phase 1|Progressive Disease|0
67484|NCT01045421|247163|P8|Phase 1|Progressive Disease|0
67485|NCT01045421|247164|P7|Phase 1|Progressive Disease|0
67486|NCT01045421|247165|P6|Phase 1|Progressive Disease|0
67487|NCT01045421|247166|P5|Phase 1|Progressive Disease|1
67488|NCT01045421|247167|P4|Phase 1|Progressive Disease|0
67489|NCT01045421|247168|P3|Phase 1|Progressive Disease|0
67490|NCT01045421|247169|P2|Phase 1|Progressive Disease|0
67491|NCT01045421|247170|P1|Phase 1|Progressive Disease|0
67492|NCT01045161|247264|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
67493|NCT01045161|247265|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
67494|NCT01045161|247266|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
67495|NCT01045161|247264|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
67496|NCT01045161|247265|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
67497|NCT01045161|247266|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
67498|NCT01045161|247264|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
67499|NCT01045161|247265|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
67500|NCT01045161|247266|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
67501|NCT01045161|247264|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
67502|NCT01045161|247265|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
67503|NCT01045161|247266|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
67504|NCT01045161|247264|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
67505|NCT01045161|247265|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
67506|NCT01045161|247266|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
67507|NCT01045161|247264|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
67508|NCT01045161|247265|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
67509|NCT01045161|247266|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
67510|NCT01045161|247264|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
67511|NCT01045161|247265|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
67512|NCT01045161|247266|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
67513|NCT01045161|247264|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
67514|NCT01045161|247265|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
67515|NCT01045161|247266|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
67516|NCT01045161|247264|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
67517|NCT01045161|247265|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
67518|NCT01045161|247266|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
67519|NCT01045161|247264|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
67520|NCT01045161|247265|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
67521|NCT01045161|247266|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
67522|NCT01045161|247264|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
67523|NCT01045161|247265|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
67524|NCT01045161|247266|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
67525|NCT01045161|247264|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
67526|NCT01045161|247265|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
67527|NCT01045161|247266|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
67528|NCT01045161|247264|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
67529|NCT01045161|247265|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
67530|NCT01045161|247266|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
67531|NCT01045161|247264|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
67532|NCT01045161|247265|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
67533|NCT01045161|247266|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
67534|NCT01045096|247296|P3|Overall Study|Other|0
67535|NCT01045096|247297|P2|Overall Study|Other|0
67536|NCT01045096|247298|P1|Overall Study|Other|1
67537|NCT01045096|247296|P3|Overall Study|Withdrawal by Subject|0
67538|NCT01045096|247297|P2|Overall Study|Withdrawal by Subject|0
67539|NCT01045096|247298|P1|Overall Study|Withdrawal by Subject|2
67540|NCT01044732|247373|P2|Overall Study|Technical error or malfunction|14
67541|NCT01044732|247374|P1|Overall Study|Technical error or malfunction|15
67542|NCT01044732|247373|P2|Overall Study|Inability to reach cecum|2
67543|NCT01044732|247374|P1|Overall Study|Inability to reach cecum|5
67544|NCT01044732|247373|P2|Overall Study|Inadequate bowel preparation|17
67545|NCT01044732|247374|P1|Overall Study|Inadequate bowel preparation|11
67546|NCT01044732|247373|P2|Overall Study|Withdrawal by Subject|1
67547|NCT01044732|247374|P1|Overall Study|Withdrawal by Subject|0
67548|NCT01044732|247373|P2|Overall Study|Protocol Violation|12
67549|NCT01044732|247374|P1|Overall Study|Protocol Violation|11
67550|NCT01044732|247373|P2|Overall Study|Physician Decision|3
67551|NCT01044732|247374|P1|Overall Study|Physician Decision|5
67552|NCT01044732|247373|P2|Overall Study|Lost to Follow-up|1
67553|NCT01044732|247374|P1|Overall Study|Lost to Follow-up|2
67554|NCT01044498|247432|P2|Overall Study|Not specified|0
67555|NCT01044498|247433|P1|Overall Study|Not specified|1
67556|NCT01044498|247432|P2|Overall Study|Adverse Event|1
67557|NCT01044498|247433|P1|Overall Study|Adverse Event|1
67558|NCT01044498|247432|P2|Overall Study|Withdrew consent|1
67559|NCT01044498|247433|P1|Overall Study|Withdrew consent|1
67560|NCT01044459|247459|P2|Overall Study|Lost to Follow-up|12
67561|NCT01044459|247460|P1|Overall Study|Lost to Follow-up|18
67562|NCT01044459|247459|P2|Overall Study|COPD exacerbation|8
67563|NCT01044459|247460|P1|Overall Study|COPD exacerbation|9
67564|NCT01044459|247459|P2|Overall Study|Other Reason|14
67565|NCT01044459|247460|P1|Overall Study|Other Reason|7
67566|NCT01044459|247459|P2|Overall Study|Protocol Violation|16
67567|NCT01044459|247460|P1|Overall Study|Protocol Violation|11
67568|NCT01044459|247459|P2|Overall Study|Lack of Efficacy|12
67569|NCT01044459|247460|P1|Overall Study|Lack of Efficacy|23
67570|NCT01044459|247459|P2|Overall Study|Adverse Event|20
67571|NCT01044459|247460|P1|Overall Study|Adverse Event|22
67572|NCT01044459|247459|P2|Overall Study|Terminated by Sponsor|21
67573|NCT01044459|247460|P1|Overall Study|Terminated by Sponsor|22
67574|NCT01044459|247459|P2|Overall Study|Withdrawal by Subject|28
67575|NCT01044459|247460|P1|Overall Study|Withdrawal by Subject|21
67576|NCT01044303|247468|P1|Overall Study|Lost to Follow-up|2
67577|NCT01044290|247478|P3|Follow-Up 2|Withdrawal by Subject|1
67578|NCT01044290|247479|P2|Follow-Up 2|Withdrawal by Subject|1
67579|NCT01044290|247480|P1|Follow-Up 2|Withdrawal by Subject|0
67580|NCT01044290|247478|P3|Follow-Up 2|Death|1
67581|NCT01044290|247479|P2|Follow-Up 2|Death|1
67582|NCT01044290|247480|P1|Follow-Up 2|Death|0
67583|NCT01044290|247478|P3|Follow-up 1|Withdrawal by Subject|0
67584|NCT01044290|247479|P2|Follow-up 1|Withdrawal by Subject|2
67585|NCT01044290|247480|P1|Follow-up 1|Withdrawal by Subject|2
67586|NCT01044290|247478|P3|Follow-up 1|Death|1
67587|NCT01044290|247479|P2|Follow-up 1|Death|3
67588|NCT01044290|247480|P1|Follow-up 1|Death|3
67589|NCT01043874|247596|P1|Overall Study|Administrative Problems|1
67590|NCT01043874|247596|P1|Overall Study|Lack of Efficacy|1
67591|NCT01043874|247596|P1|Overall Study|Withdrawal by Subject|1
67592|NCT01043874|247596|P1|Overall Study|Adverse Event|3
67593|NCT01043705|247606|P3|Overall Study|Unspecified|25
67594|NCT01043705|247607|P2|Overall Study|Unspecified|19
67595|NCT01043705|247608|P1|Overall Study|Unspecified|0
67596|NCT01043705|247606|P3|Overall Study|Screen Fail|0
67597|NCT01043705|247607|P2|Overall Study|Screen Fail|0
67598|NCT01043705|247608|P1|Overall Study|Screen Fail|21
67599|NCT01043705|247606|P3|Overall Study|Adverse Event|0
67600|NCT01043705|247607|P2|Overall Study|Adverse Event|2
67601|NCT01043705|247608|P1|Overall Study|Adverse Event|0
67602|NCT01043705|247606|P3|Overall Study|Subsequent Procedure|29
67603|NCT01043705|247607|P2|Overall Study|Subsequent Procedure|24
67604|NCT01043705|247608|P1|Overall Study|Subsequent Procedure|9
67605|NCT01043705|247606|P3|Overall Study|Site Closure|0
67606|NCT01043705|247607|P2|Overall Study|Site Closure|0
67607|NCT01043705|247608|P1|Overall Study|Site Closure|8
67608|NCT01043705|247606|P3|Overall Study|Withdrawal by Subject|0
67609|NCT01043705|247607|P2|Overall Study|Withdrawal by Subject|6
67610|NCT01043705|247608|P1|Overall Study|Withdrawal by Subject|8
67611|NCT01043705|247606|P3|Overall Study|Protocol Violation|0
67612|NCT01043705|247607|P2|Overall Study|Protocol Violation|1
67613|NCT01043705|247608|P1|Overall Study|Protocol Violation|2
67614|NCT01043705|247606|P3|Overall Study|Multiple Reasons|0
67615|NCT01043705|247607|P2|Overall Study|Multiple Reasons|7
67616|NCT01043705|247608|P1|Overall Study|Multiple Reasons|4
67617|NCT01043705|247606|P3|Overall Study|Lost to Follow-up|0
67618|NCT01043705|247607|P2|Overall Study|Lost to Follow-up|12
67619|NCT01043705|247608|P1|Overall Study|Lost to Follow-up|27
67620|NCT01043705|247606|P3|Overall Study|Death|26
67621|NCT01043705|247607|P2|Overall Study|Death|60
67622|NCT01043705|247608|P1|Overall Study|Death|28
67623|NCT01043185|247675|P10|Period 6 - Third Washout Period|Protocol Violation|0
67624|NCT01043185|247676|P9|Period 6 - Third Washout Period|Protocol Violation|1
67625|NCT01043185|247677|P8|Period 6 - Third Washout Period|Protocol Violation|0
67626|NCT01043185|247678|P7|Period 6 - Third Washout Period|Protocol Violation|0
67627|NCT01043185|247679|P6|Period 6 - Third Washout Period|Protocol Violation|0
67628|NCT01043185|247680|P5|Period 6 - Third Washout Period|Protocol Violation|0
67629|NCT01043185|247681|P4|Period 6 - Third Washout Period|Protocol Violation|0
67630|NCT01043185|247682|P3|Period 6 - Third Washout Period|Protocol Violation|0
67631|NCT01043185|247683|P2|Period 6 - Third Washout Period|Protocol Violation|0
67632|NCT01043185|247684|P1|Period 6 - Third Washout Period|Protocol Violation|0
67633|NCT01042977|247760|P2|Overall Study|Various|0
67634|NCT01042977|247761|P1|Overall Study|Various|3
67635|NCT01042977|247760|P2|Overall Study|Administrative reason by sponsor|1
67636|NCT01042977|247761|P1|Overall Study|Administrative reason by sponsor|0
67637|NCT01042977|247760|P2|Overall Study|Safety|2
67638|NCT01042977|247761|P1|Overall Study|Safety|0
67639|NCT01042977|247760|P2|Overall Study|Incorrect enrollment|4
67640|NCT01042977|247761|P1|Overall Study|Incorrect enrollment|6
67641|NCT01042977|247760|P2|Overall Study|Subject no longer meets study criteria|13
67642|NCT01042977|247761|P1|Overall Study|Subject no longer meets study criteria|15
67643|NCT01042977|247760|P2|Overall Study|Poor/non-compliance|4
67644|NCT01042977|247761|P1|Overall Study|Poor/non-compliance|3
67645|NCT01042977|247760|P2|Overall Study|Lost to Follow-up|2
67646|NCT01042977|247761|P1|Overall Study|Lost to Follow-up|0
67647|NCT01042977|247760|P2|Overall Study|Withdrawal by Subject|16
67648|NCT01042977|247761|P1|Overall Study|Withdrawal by Subject|8
67649|NCT01042977|247760|P2|Overall Study|Death|1
67650|NCT01042977|247761|P1|Overall Study|Death|2
67651|NCT01042977|247760|P2|Overall Study|Adverse Event|12
67652|NCT01042977|247761|P1|Overall Study|Adverse Event|4
67653|NCT01042938|247781|P2|Overall Study|Ineligible: RTOG study conflict|0
67654|NCT01042938|247782|P1|Overall Study|Ineligible: RTOG study conflict|1
67655|NCT01042938|247781|P2|Overall Study|Protocol Violation|1
67656|NCT01042938|247782|P1|Overall Study|Protocol Violation|1
67657|NCT01042938|247781|P2|Overall Study|Withdrawal by Subject|1
67658|NCT01042938|247782|P1|Overall Study|Withdrawal by Subject|1
67659|NCT01042678|247797|P6|Overall Study|Physician Decision|0
67660|NCT01042678|247798|P5|Overall Study|Physician Decision|0
67661|NCT01042678|247799|P4|Overall Study|Physician Decision|0
67662|NCT01042678|247800|P3|Overall Study|Physician Decision|0
67663|NCT01042678|247801|P2|Overall Study|Physician Decision|0
67664|NCT01042678|247802|P1|Overall Study|Physician Decision|1
67665|NCT01042600|247840|P2|Overall Study|Ineligible|0
67666|NCT01042600|247841|P1|Overall Study|Ineligible|1
67667|NCT01042535|247849|P1|Overall Study|complications from other disease|2
67668|NCT01042535|247849|P1|Overall Study|disease progression during treatment|3
67669|NCT01042535|247849|P1|Overall Study|disease progression prior to treatment|3
67670|NCT01042392|247883|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
67671|NCT01042392|247884|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
67672|NCT01042392|247885|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
67673|NCT01042392|247886|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
67674|NCT01042392|247883|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
67675|NCT01042392|247884|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
67676|NCT01042392|247885|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
67677|NCT01042392|247886|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
67678|NCT01042392|247883|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
67679|NCT01042392|247884|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
67680|NCT01042392|247885|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
67681|NCT01042392|247886|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
67682|NCT01042392|247883|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
67683|NCT01042392|247884|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
67684|NCT01042392|247885|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
67685|NCT01042392|247886|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
67686|NCT01042392|247883|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
67687|NCT01042392|247884|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
67688|NCT01042392|247885|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
67689|NCT01042392|247886|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
67690|NCT01042392|247883|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
67691|NCT01042392|247884|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
67692|NCT01042392|247885|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
67693|NCT01042392|247886|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
67694|NCT01042392|247883|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
67695|NCT01042392|247884|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
67696|NCT01042392|247885|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
67697|NCT01042392|247886|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
67780|NCT01041859|248019|P3|Open-Label Titration|Lack of Efficacy|0
67698|NCT01042392|247883|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
67699|NCT01042392|247884|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
67700|NCT01042392|247885|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
67701|NCT01042392|247886|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
67702|NCT01042392|247883|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
67703|NCT01042392|247884|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
67704|NCT01042392|247885|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
67705|NCT01042392|247886|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
67706|NCT01042236|247920|P6|Treatment Period 3|Protocol Violation|0
67707|NCT01042236|247921|P5|Treatment Period 3|Protocol Violation|0
67708|NCT01042236|247922|P4|Treatment Period 3|Protocol Violation|1
67709|NCT01042236|247923|P3|Treatment Period 3|Protocol Violation|0
67710|NCT01042236|247924|P2|Treatment Period 3|Protocol Violation|0
67711|NCT01042236|247925|P1|Treatment Period 3|Protocol Violation|0
67712|NCT01042236|247920|P6|Treatment Period 3|Adverse Event|0
67713|NCT01042236|247921|P5|Treatment Period 3|Adverse Event|0
67714|NCT01042236|247922|P4|Treatment Period 3|Adverse Event|1
67715|NCT01042236|247923|P3|Treatment Period 3|Adverse Event|0
67716|NCT01042236|247924|P2|Treatment Period 3|Adverse Event|0
67717|NCT01042236|247925|P1|Treatment Period 3|Adverse Event|0
67718|NCT01042236|247920|P6|Treatment Period 1|Adverse Event|0
67719|NCT01042236|247921|P5|Treatment Period 1|Adverse Event|1
67720|NCT01042236|247922|P4|Treatment Period 1|Adverse Event|0
67721|NCT01042236|247923|P3|Treatment Period 1|Adverse Event|0
67722|NCT01042236|247924|P2|Treatment Period 1|Adverse Event|1
67723|NCT01042236|247925|P1|Treatment Period 1|Adverse Event|0
67724|NCT01042093|247985|P4|Overall Study|Withdrawal by Subject|1
67725|NCT01042093|247986|P3|Overall Study|Withdrawal by Subject|0
67726|NCT01042093|247987|P2|Overall Study|Withdrawal by Subject|0
67727|NCT01042093|247988|P1|Overall Study|Withdrawal by Subject|0
67728|NCT01042093|247985|P4|Overall Study|Protocol Violation|3
67729|NCT01042093|247986|P3|Overall Study|Protocol Violation|2
67730|NCT01042093|247987|P2|Overall Study|Protocol Violation|2
67731|NCT01042093|247988|P1|Overall Study|Protocol Violation|2
67732|NCT01041976|248008|P2|Overall Study|Death|4
67733|NCT01041976|248009|P1|Overall Study|Death|0
67734|NCT01041976|248008|P2|Overall Study|Incarceration|0
67735|NCT01041976|248009|P1|Overall Study|Incarceration|2
67736|NCT01041976|248008|P2|Overall Study|Withdrawal by Subject|0
67737|NCT01041976|248009|P1|Overall Study|Withdrawal by Subject|3
67738|NCT01041859|248019|P3|Double-Blind Maintenance|Withdrawal by Subject|9
67739|NCT01041859|248020|P2|Double-Blind Maintenance|Withdrawal by Subject|8
67740|NCT01041859|248021|P1|Double-Blind Maintenance|Withdrawal by Subject|0
67741|NCT01041859|248019|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
67742|NCT01041859|248020|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
67743|NCT01041859|248021|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
67744|NCT01041859|248019|P3|Double-Blind Maintenance|Other|2
67745|NCT01041859|248020|P2|Double-Blind Maintenance|Other|6
67746|NCT01041859|248021|P1|Double-Blind Maintenance|Other|0
67747|NCT01041859|248019|P3|Double-Blind Maintenance|Protocol Violation|3
67748|NCT01041859|248020|P2|Double-Blind Maintenance|Protocol Violation|1
67749|NCT01041859|248021|P1|Double-Blind Maintenance|Protocol Violation|0
67750|NCT01041859|248019|P3|Double-Blind Maintenance|Physician Decision|1
67751|NCT01041859|248020|P2|Double-Blind Maintenance|Physician Decision|2
67752|NCT01041859|248021|P1|Double-Blind Maintenance|Physician Decision|0
67753|NCT01041859|248019|P3|Double-Blind Maintenance|Lost to Follow-up|0
67754|NCT01041859|248020|P2|Double-Blind Maintenance|Lost to Follow-up|1
67755|NCT01041859|248021|P1|Double-Blind Maintenance|Lost to Follow-up|0
67756|NCT01041859|248019|P3|Double-Blind Maintenance|Lack of Efficacy|11
67757|NCT01041859|248020|P2|Double-Blind Maintenance|Lack of Efficacy|3
67758|NCT01041859|248021|P1|Double-Blind Maintenance|Lack of Efficacy|0
67759|NCT01041859|248019|P3|Double-Blind Maintenance|Adverse Event|13
67760|NCT01041859|248020|P2|Double-Blind Maintenance|Adverse Event|23
67761|NCT01041859|248021|P1|Double-Blind Maintenance|Adverse Event|0
67762|NCT01041859|248019|P3|Open-Label Titration|Withdrawal by Subject|0
67763|NCT01041859|248020|P2|Open-Label Titration|Withdrawal by Subject|0
67764|NCT01041859|248021|P1|Open-Label Titration|Withdrawal by Subject|11
67765|NCT01041859|248019|P3|Open-Label Titration|Noncompliance With Study Drug|0
67766|NCT01041859|248020|P2|Open-Label Titration|Noncompliance With Study Drug|0
67767|NCT01041859|248021|P1|Open-Label Titration|Noncompliance With Study Drug|8
67768|NCT01041859|248019|P3|Open-Label Titration|Other|0
67769|NCT01041859|248020|P2|Open-Label Titration|Other|0
67770|NCT01041859|248021|P1|Open-Label Titration|Other|7
67771|NCT01041859|248019|P3|Open-Label Titration|Protocol Violation|0
67772|NCT01041859|248020|P2|Open-Label Titration|Protocol Violation|0
67773|NCT01041859|248021|P1|Open-Label Titration|Protocol Violation|1
67774|NCT01041859|248019|P3|Open-Label Titration|Physician Decision|0
67775|NCT01041859|248020|P2|Open-Label Titration|Physician Decision|0
67776|NCT01041859|248021|P1|Open-Label Titration|Physician Decision|1
67777|NCT01041859|248019|P3|Open-Label Titration|Lost to Follow-up|0
67778|NCT01041859|248020|P2|Open-Label Titration|Lost to Follow-up|0
67779|NCT01041859|248021|P1|Open-Label Titration|Lost to Follow-up|1
67781|NCT01041859|248020|P2|Open-Label Titration|Lack of Efficacy|0
67782|NCT01041859|248021|P1|Open-Label Titration|Lack of Efficacy|3
67783|NCT01041859|248019|P3|Open-Label Titration|Adverse Event|0
67784|NCT01041859|248020|P2|Open-Label Titration|Adverse Event|0
67785|NCT01041859|248021|P1|Open-Label Titration|Adverse Event|69
67786|NCT01041638|248036|P1|Overall Study|Withdrawal by Subject|11
67787|NCT01041638|248036|P1|Overall Study|Physician Decision|4
67788|NCT01041638|248036|P1|Overall Study|Lack of Efficacy|7
67789|NCT01041638|248036|P1|Overall Study|Death|1
67790|NCT01041638|248036|P1|Overall Study|Adverse Event|4
67791|NCT01041573|248044|P4|Overall Study|positive to anti-HCV|0
67792|NCT01041573|248045|P3|Overall Study|positive to anti-HCV|0
67793|NCT01041573|248046|P2|Overall Study|positive to anti-HCV|0
67794|NCT01041573|248047|P1|Overall Study|positive to anti-HCV|1
67795|NCT01041573|248044|P4|Overall Study|further blood extraction|0
67796|NCT01041573|248045|P3|Overall Study|further blood extraction|0
67797|NCT01041573|248046|P2|Overall Study|further blood extraction|1
67798|NCT01041573|248047|P1|Overall Study|further blood extraction|0
67799|NCT01041573|248044|P4|Overall Study|relocation|1
67800|NCT01041573|248045|P3|Overall Study|relocation|3
67801|NCT01041573|248046|P2|Overall Study|relocation|4
67802|NCT01041573|248047|P1|Overall Study|relocation|1
67803|NCT01041573|248044|P4|Overall Study|Adverse Event|0
67804|NCT01041573|248045|P3|Overall Study|Adverse Event|0
67805|NCT01041573|248046|P2|Overall Study|Adverse Event|2
67806|NCT01041573|248047|P1|Overall Study|Adverse Event|0
67807|NCT01041573|248044|P4|Overall Study|Lost to Follow-up|1
67808|NCT01041573|248045|P3|Overall Study|Lost to Follow-up|2
67809|NCT01041573|248046|P2|Overall Study|Lost to Follow-up|1
67810|NCT01041573|248047|P1|Overall Study|Lost to Follow-up|0
67811|NCT01041573|248044|P4|Overall Study|Death|0
67812|NCT01041573|248045|P3|Overall Study|Death|0
67813|NCT01041573|248046|P2|Overall Study|Death|0
67814|NCT01041573|248047|P1|Overall Study|Death|1
67815|NCT01041573|248044|P4|Overall Study|Withdrawal by Subject|0
67816|NCT01041573|248045|P3|Overall Study|Withdrawal by Subject|2
67817|NCT01041573|248046|P2|Overall Study|Withdrawal by Subject|5
67818|NCT01041573|248047|P1|Overall Study|Withdrawal by Subject|2
67819|NCT01041417|248059|P2|Overall Study|Death|0
67820|NCT01041417|248060|P1|Overall Study|Death|1
67821|NCT01041417|248059|P2|Overall Study|Lost to Follow-up|1
67822|NCT01041417|248060|P1|Overall Study|Lost to Follow-up|1
67823|NCT01041417|248059|P2|Overall Study|Adverse Event|2
67824|NCT01041417|248060|P1|Overall Study|Adverse Event|5
67825|NCT01041404|248098|P2|Overall Study|Not Specified|23
67826|NCT01041404|248099|P1|Overall Study|Not Specified|11
67827|NCT01041404|248098|P2|Overall Study|Failure to Return|2
67828|NCT01041404|248099|P1|Overall Study|Failure to Return|1
67829|NCT01041404|248098|P2|Overall Study|Withdrawal by Subject|23
67830|NCT01041404|248099|P1|Overall Study|Withdrawal by Subject|29
67831|NCT01041404|248098|P2|Overall Study|Protocol Violation|0
67832|NCT01041404|248099|P1|Overall Study|Protocol Violation|4
67833|NCT01041404|248098|P2|Overall Study|Violation of Selection Criteria|1
67834|NCT01041404|248099|P1|Overall Study|Violation of Selection Criteria|0
67835|NCT01041404|248098|P2|Overall Study|Lack of Efficacy|210
67836|NCT01041404|248099|P1|Overall Study|Lack of Efficacy|200
67837|NCT01041404|248098|P2|Overall Study|Adverse Event|35
67838|NCT01041404|248099|P1|Overall Study|Adverse Event|45
67839|NCT01041287|248140|P2|Treatment Period 2 (3 Months)|Adverse Event|2
67840|NCT01041287|248141|P1|Treatment Period 2 (3 Months)|Adverse Event|0
67841|NCT01041287|248140|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
67842|NCT01041287|248141|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
67843|NCT01040871|248164|P2|Overall Study|Randomized and Not Treated|1
67844|NCT01040871|248165|P1|Overall Study|Randomized and Not Treated|2
67845|NCT01040871|248164|P2|Overall Study|drug supply issue|0
67846|NCT01040871|248165|P1|Overall Study|drug supply issue|1
67847|NCT01040871|248164|P2|Overall Study|Lack of Efficacy|1
67848|NCT01040871|248165|P1|Overall Study|Lack of Efficacy|1
67849|NCT01040871|248164|P2|Overall Study|Death|3
67850|NCT01040871|248165|P1|Overall Study|Death|1
67851|NCT01040871|248164|P2|Overall Study|Withdrawal by Subject|0
67852|NCT01040871|248165|P1|Overall Study|Withdrawal by Subject|2
67853|NCT01040871|248164|P2|Overall Study|Adverse Event|2
67854|NCT01040871|248165|P1|Overall Study|Adverse Event|6
67855|NCT01040845|248216|P2|Overall Study|Physician Decision|0
67856|NCT01040845|248217|P1|Overall Study|Physician Decision|1
67857|NCT01040845|248216|P2|Overall Study|Withdrawal by Subject|1
67858|NCT01040845|248217|P1|Overall Study|Withdrawal by Subject|1
67859|NCT01040832|248232|P2|Overall Study|Unspecified|1
67860|NCT01040832|248233|P1|Overall Study|Unspecified|2
67861|NCT01040832|248232|P2|Overall Study|Symptomatic deterioration|5
67862|NCT01040832|248233|P1|Overall Study|Symptomatic deterioration|2
67863|NCT01040832|248232|P2|Overall Study|Progressive disease|17
67864|NCT01040832|248233|P1|Overall Study|Progressive disease|32
67865|NCT01040832|248232|P2|Overall Study|Withdrawal by Subject|3
67866|NCT01040832|248233|P1|Overall Study|Withdrawal by Subject|2
67867|NCT01040832|248232|P2|Overall Study|Death|6
67868|NCT01040832|248233|P1|Overall Study|Death|4
67869|NCT01040832|248232|P2|Overall Study|Adverse Event|5
67870|NCT01040832|248233|P1|Overall Study|Adverse Event|4
67871|NCT01040793|248256|P6|Overall Study|Other reasons not listed above|0
67872|NCT01040793|248257|P5|Overall Study|Other reasons not listed above|1
67873|NCT01040793|248258|P4|Overall Study|Other reasons not listed above|0
67874|NCT01040793|248259|P3|Overall Study|Other reasons not listed above|1
67875|NCT01040793|248260|P2|Overall Study|Other reasons not listed above|0
67876|NCT01040793|248261|P1|Overall Study|Other reasons not listed above|0
67877|NCT01040793|248256|P6|Overall Study|Withdrawal by Subject|0
67878|NCT01040793|248257|P5|Overall Study|Withdrawal by Subject|0
67879|NCT01040793|248258|P4|Overall Study|Withdrawal by Subject|2
67880|NCT01040793|248259|P3|Overall Study|Withdrawal by Subject|0
67881|NCT01040793|248260|P2|Overall Study|Withdrawal by Subject|0
67882|NCT01040793|248261|P1|Overall Study|Withdrawal by Subject|0
67883|NCT01040793|248256|P6|Overall Study|Lost to Follow-up|0
67884|NCT01040793|248257|P5|Overall Study|Lost to Follow-up|0
67885|NCT01040793|248258|P4|Overall Study|Lost to Follow-up|0
67886|NCT01040793|248259|P3|Overall Study|Lost to Follow-up|1
67887|NCT01040793|248260|P2|Overall Study|Lost to Follow-up|1
67888|NCT01040793|248261|P1|Overall Study|Lost to Follow-up|0
67889|NCT01040793|248256|P6|Overall Study|Protocol Violation|0
67890|NCT01040793|248257|P5|Overall Study|Protocol Violation|1
67891|NCT01040793|248258|P4|Overall Study|Protocol Violation|0
67892|NCT01040793|248259|P3|Overall Study|Protocol Violation|1
67893|NCT01040793|248260|P2|Overall Study|Protocol Violation|1
67894|NCT01040793|248261|P1|Overall Study|Protocol Violation|1
67895|NCT01040793|248256|P6|Overall Study|Adverse Event|1
67896|NCT01040793|248257|P5|Overall Study|Adverse Event|2
67897|NCT01040793|248258|P4|Overall Study|Adverse Event|2
67898|NCT01040793|248259|P3|Overall Study|Adverse Event|0
67899|NCT01040793|248260|P2|Overall Study|Adverse Event|3
67900|NCT01040793|248261|P1|Overall Study|Adverse Event|5
67901|NCT01040780|248340|P2|Overall Study|Protocol Violation|3
67902|NCT01040780|248341|P1|Overall Study|Protocol Violation|1
67903|NCT01040728|248355|P4|Overall Study|Other reasons not listed above|0
67904|NCT01040728|248356|P3|Overall Study|Other reasons not listed above|0
67905|NCT01040728|248357|P2|Overall Study|Other reasons not listed above|1
67906|NCT01040728|248358|P1|Overall Study|Other reasons not listed above|0
67907|NCT01040728|248355|P4|Overall Study|Lack of Efficacy|1
67908|NCT01040728|248356|P3|Overall Study|Lack of Efficacy|0
67909|NCT01040728|248357|P2|Overall Study|Lack of Efficacy|1
67910|NCT01040728|248358|P1|Overall Study|Lack of Efficacy|0
67911|NCT01040728|248355|P4|Overall Study|Protocol Violation|1
67912|NCT01040728|248356|P3|Overall Study|Protocol Violation|0
67913|NCT01040728|248357|P2|Overall Study|Protocol Violation|0
67914|NCT01040728|248358|P1|Overall Study|Protocol Violation|0
67915|NCT01040728|248355|P4|Overall Study|Withdrawal by Subject|0
67916|NCT01040728|248356|P3|Overall Study|Withdrawal by Subject|1
67917|NCT01040728|248357|P2|Overall Study|Withdrawal by Subject|1
67918|NCT01040728|248358|P1|Overall Study|Withdrawal by Subject|0
67919|NCT01040728|248355|P4|Overall Study|Adverse Event|4
67920|NCT01040728|248356|P3|Overall Study|Adverse Event|0
67921|NCT01040728|248357|P2|Overall Study|Adverse Event|8
67922|NCT01040728|248358|P1|Overall Study|Adverse Event|4
67923|NCT01040689|248428|P4|Overall Study|Other reasons not listed above|0
67924|NCT01040689|248429|P3|Overall Study|Other reasons not listed above|0
67925|NCT01040689|248430|P2|Overall Study|Other reasons not listed above|1
67926|NCT01040689|248431|P1|Overall Study|Other reasons not listed above|0
67927|NCT01040689|248428|P4|Overall Study|Withdrawal by Subject|0
67928|NCT01040689|248429|P3|Overall Study|Withdrawal by Subject|1
67929|NCT01040689|248430|P2|Overall Study|Withdrawal by Subject|1
67930|NCT01040689|248431|P1|Overall Study|Withdrawal by Subject|2
67931|NCT01040689|248428|P4|Overall Study|Lost to Follow-up|0
67932|NCT01040689|248429|P3|Overall Study|Lost to Follow-up|0
67933|NCT01040689|248430|P2|Overall Study|Lost to Follow-up|0
67934|NCT01040689|248431|P1|Overall Study|Lost to Follow-up|1
67935|NCT01040689|248428|P4|Overall Study|Lack of Efficacy|0
67936|NCT01040689|248429|P3|Overall Study|Lack of Efficacy|1
67937|NCT01040689|248430|P2|Overall Study|Lack of Efficacy|0
67938|NCT01040689|248431|P1|Overall Study|Lack of Efficacy|0
67939|NCT01040689|248428|P4|Overall Study|Adverse Event|4
67940|NCT01040689|248429|P3|Overall Study|Adverse Event|2
67941|NCT01040689|248430|P2|Overall Study|Adverse Event|0
67942|NCT01040689|248431|P1|Overall Study|Adverse Event|0
67943|NCT01039519|248510|P1|Survival Follow-up|Sponsor decision|4
67944|NCT01039519|248510|P1|Survival Follow-up|Death|23
67945|NCT01039519|248510|P1|Treatment|Physician Decision|2
67946|NCT01039519|248510|P1|Treatment|Adverse Event|3
67947|NCT01039519|248510|P1|Treatment|Treatment failure|2
67948|NCT01039519|248510|P1|Treatment|Progressive disease|20
67949|NCT01040403|248519|P1|Overall Study|Other reason not defined above|6
67950|NCT01040403|248519|P1|Overall Study|Not treated|1
67951|NCT01040403|248519|P1|Overall Study|Lost to Follow-up|1
67952|NCT01040403|248519|P1|Overall Study|Protocol Violation|2
67953|NCT01040403|248519|P1|Overall Study|Adverse Event|10
67954|NCT01040351|248707|P2|Overall Study|poor ovarian response|2
67955|NCT01040351|248708|P1|Overall Study|poor ovarian response|1
67956|NCT01040169|248746|P2|Overall Study|Lost to Follow-up|8
67957|NCT01040169|248747|P1|Overall Study|Lost to Follow-up|3
67958|NCT01040130|248755|P6|Overall Study|Other reasons not listed above|0
67959|NCT01040130|248756|P5|Overall Study|Other reasons not listed above|0
67960|NCT01040130|248757|P4|Overall Study|Other reasons not listed above|0
67961|NCT01040130|248758|P3|Overall Study|Other reasons not listed above|0
67962|NCT01040130|248759|P2|Overall Study|Other reasons not listed above|0
67963|NCT01040130|248760|P1|Overall Study|Other reasons not listed above|2
67964|NCT01040130|248755|P6|Overall Study|Withdrawal by Subject|1
67965|NCT01040130|248756|P5|Overall Study|Withdrawal by Subject|0
67966|NCT01040130|248757|P4|Overall Study|Withdrawal by Subject|0
67967|NCT01040130|248758|P3|Overall Study|Withdrawal by Subject|0
67968|NCT01040130|248759|P2|Overall Study|Withdrawal by Subject|2
67969|NCT01040130|248760|P1|Overall Study|Withdrawal by Subject|0
67970|NCT01040130|248755|P6|Overall Study|Protocol Violation|0
67971|NCT01040130|248756|P5|Overall Study|Protocol Violation|0
67972|NCT01040130|248757|P4|Overall Study|Protocol Violation|0
67973|NCT01040130|248758|P3|Overall Study|Protocol Violation|2
67974|NCT01040130|248759|P2|Overall Study|Protocol Violation|0
67975|NCT01040130|248760|P1|Overall Study|Protocol Violation|0
67976|NCT01040130|248755|P6|Overall Study|Adverse Event|3
67977|NCT01040130|248756|P5|Overall Study|Adverse Event|0
67978|NCT01040130|248757|P4|Overall Study|Adverse Event|5
67979|NCT01040130|248758|P3|Overall Study|Adverse Event|0
67980|NCT01040130|248759|P2|Overall Study|Adverse Event|1
67981|NCT01040130|248760|P1|Overall Study|Adverse Event|1
67982|NCT01039675|248843|P2|Overall Study|Physician Decision|1
67983|NCT01039675|248844|P1|Overall Study|Physician Decision|0
67984|NCT01039675|248843|P2|Overall Study|Lost to Follow-up|1
67985|NCT01039675|248844|P1|Overall Study|Lost to Follow-up|0
67986|NCT01039675|248843|P2|Overall Study|Withdrawal by Subject|1
67987|NCT01039675|248844|P1|Overall Study|Withdrawal by Subject|0
67988|NCT01039675|248843|P2|Overall Study|Lack of Efficacy|2
67989|NCT01039675|248844|P1|Overall Study|Lack of Efficacy|0
67990|NCT01039675|248843|P2|Overall Study|Adverse Event|2
67991|NCT01039675|248844|P1|Overall Study|Adverse Event|0
67992|NCT01039584|248857|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
67993|NCT01039584|248858|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
67994|NCT01039584|248859|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
67995|NCT01039584|248857|P3|Overall Study|Pap smear with significant pathology|3
67996|NCT01039584|248858|P2|Overall Study|Pap smear with significant pathology|10
67997|NCT01039584|248859|P1|Overall Study|Pap smear with significant pathology|10
67998|NCT01039584|248857|P3|Overall Study|other|1
67999|NCT01039584|248858|P2|Overall Study|other|3
68000|NCT01039584|248859|P1|Overall Study|other|1
68001|NCT01039584|248857|P3|Overall Study|Lack of Efficacy|10
68002|NCT01039584|248858|P2|Overall Study|Lack of Efficacy|6
68003|NCT01039584|248859|P1|Overall Study|Lack of Efficacy|7
68004|NCT01039584|248857|P3|Overall Study|Negative Baseline culture for Candida|24
68005|NCT01039584|248858|P2|Overall Study|Negative Baseline culture for Candida|59
68006|NCT01039584|248859|P1|Overall Study|Negative Baseline culture for Candida|59
68007|NCT01039584|248857|P3|Overall Study|Lost to Follow-up|4
68008|NCT01039584|248858|P2|Overall Study|Lost to Follow-up|3
68009|NCT01039584|248859|P1|Overall Study|Lost to Follow-up|5
68010|NCT01039584|248857|P3|Overall Study|Protocol Violation|6
68011|NCT01039584|248858|P2|Overall Study|Protocol Violation|4
68012|NCT01039584|248859|P1|Overall Study|Protocol Violation|10
68013|NCT01039584|248857|P3|Overall Study|Withdrawal by Subject|1
68014|NCT01039584|248858|P2|Overall Study|Withdrawal by Subject|2
68015|NCT01039584|248859|P1|Overall Study|Withdrawal by Subject|4
68016|NCT01039428|248875|P2|Overall Study|Withdrawal by Subject|0
68017|NCT01039428|248876|P1|Overall Study|Withdrawal by Subject|1
68018|NCT01039428|248875|P2|Overall Study|Protocol Violation|0
68019|NCT01039428|248876|P1|Overall Study|Protocol Violation|1
68020|NCT01039376|248900|P2|Overall Study|Ongoing|182
68021|NCT01039376|248901|P1|Overall Study|Ongoing|189
68022|NCT01039376|248900|P2|Overall Study|Withdrawal by Subject|17
68023|NCT01039376|248901|P1|Overall Study|Withdrawal by Subject|11
68024|NCT01039376|248900|P2|Overall Study|Physician Decision|2
68025|NCT01039376|248901|P1|Overall Study|Physician Decision|4
68026|NCT01039376|248900|P2|Overall Study|Lost to Follow-up|1
68027|NCT01039376|248901|P1|Overall Study|Lost to Follow-up|2
68028|NCT01038921|248961|P2|Overall Study|Physician Decision|0
68029|NCT01038921|248962|P1|Overall Study|Physician Decision|1
68030|NCT01038921|248961|P2|Overall Study|Withdrawal by Subject|0
68031|NCT01038921|248962|P1|Overall Study|Withdrawal by Subject|1
68032|NCT01038869|248968|P1|Overall Study|Lost to Follow-up|6
68033|NCT01038869|248968|P1|Overall Study|Withdrawal by Subject|1
68034|NCT01038752|248978|P2|Overall Study|Lost to Follow-up|3
68035|NCT01038752|248979|P1|Overall Study|Lost to Follow-up|3
68036|NCT01038752|248978|P2|Overall Study|Tumor Progression|2
68037|NCT01038752|248979|P1|Overall Study|Tumor Progression|2
68038|NCT01038713|249002|P3|Overall Study|Autoimmune Pancreatitis|0
68039|NCT01038713|249003|P2|Overall Study|Autoimmune Pancreatitis|0
68040|NCT01038713|249004|P1|Overall Study|Autoimmune Pancreatitis|1
68041|NCT01038713|249002|P3|Overall Study|died from PEP|0
68042|NCT01038713|249003|P2|Overall Study|died from PEP|1
68043|NCT01038713|249004|P1|Overall Study|died from PEP|0
68044|NCT01038713|249002|P3|Overall Study|Neuroendocrine Tumor|0
68045|NCT01038713|249003|P2|Overall Study|Neuroendocrine Tumor|1
68046|NCT01038713|249004|P1|Overall Study|Neuroendocrine Tumor|0
68047|NCT01038713|249002|P3|Overall Study|Lost to Follow-up|0
68048|NCT01038713|249003|P2|Overall Study|Lost to Follow-up|0
68049|NCT01038713|249004|P1|Overall Study|Lost to Follow-up|3
68050|NCT01038713|249002|P3|Overall Study|Patient to hospice|1
68051|NCT01038713|249003|P2|Overall Study|Patient to hospice|1
68052|NCT01038713|249004|P1|Overall Study|Patient to hospice|1
68053|NCT01038635|249033|P9|Overall Study|Death|2
68054|NCT01038635|249034|P8|Overall Study|Death|1
68055|NCT01038635|249035|P7|Overall Study|Death|1
68056|NCT01038635|249036|P6|Overall Study|Death|0
68057|NCT01038635|249037|P5|Overall Study|Death|1
68058|NCT01038635|249038|P4|Overall Study|Death|0
68059|NCT01038635|249039|P3|Overall Study|Death|0
68060|NCT01038635|249040|P2|Overall Study|Death|0
68061|NCT01038635|249041|P1|Overall Study|Death|0
68062|NCT01038635|249033|P9|Overall Study|Disease Progression|0
68063|NCT01038635|249034|P8|Overall Study|Disease Progression|4
68064|NCT01038635|249035|P7|Overall Study|Disease Progression|1
68065|NCT01038635|249036|P6|Overall Study|Disease Progression|0
68066|NCT01038635|249037|P5|Overall Study|Disease Progression|0
68067|NCT01038635|249038|P4|Overall Study|Disease Progression|0
68068|NCT01038635|249039|P3|Overall Study|Disease Progression|0
68069|NCT01038635|249040|P2|Overall Study|Disease Progression|0
68070|NCT01038635|249041|P1|Overall Study|Disease Progression|2
68071|NCT01038609|249067|P5|Overall Study|Refusal of Blood Draws|0
68072|NCT01038609|249068|P4|Overall Study|Refusal of Blood Draws|0
68073|NCT01038609|249069|P3|Overall Study|Refusal of Blood Draws|0
68074|NCT01038609|249070|P2|Overall Study|Refusal of Blood Draws|1
68075|NCT01038609|249071|P1|Overall Study|Refusal of Blood Draws|0
68076|NCT01038609|249067|P5|Overall Study|Death in the Family|0
68077|NCT01038609|249068|P4|Overall Study|Death in the Family|0
68078|NCT01038609|249069|P3|Overall Study|Death in the Family|0
68079|NCT01038609|249070|P2|Overall Study|Death in the Family|0
68080|NCT01038609|249071|P1|Overall Study|Death in the Family|1
68081|NCT01038609|249067|P5|Overall Study|Dosing Error|1
68082|NCT01038609|249068|P4|Overall Study|Dosing Error|1
68083|NCT01038609|249069|P3|Overall Study|Dosing Error|0
68084|NCT01038609|249070|P2|Overall Study|Dosing Error|0
68085|NCT01038609|249071|P1|Overall Study|Dosing Error|0
68086|NCT01038609|249067|P5|Overall Study|Adverse Event|0
68087|NCT01038609|249068|P4|Overall Study|Adverse Event|0
68088|NCT01038609|249069|P3|Overall Study|Adverse Event|1
68089|NCT01038609|249070|P2|Overall Study|Adverse Event|0
68090|NCT01038609|249071|P1|Overall Study|Adverse Event|0
68091|NCT01038323|249150|P3|Overall Study|Withdrawal by Subject|4
68092|NCT01038323|249151|P2|Overall Study|Withdrawal by Subject|2
68093|NCT01038323|249152|P1|Overall Study|Withdrawal by Subject|3
68094|NCT01038128|249163|P1|Overall Study|Withdrawal by Subject|2
68095|NCT01038128|249163|P1|Overall Study|Lost to Follow-up|1
68096|NCT01038128|249163|P1|Overall Study|Lack of Efficacy|1
68097|NCT01037244|249247|P4|Overall Study|Various|1
68098|NCT01037244|249248|P3|Overall Study|Various|1
68099|NCT01037244|249249|P2|Overall Study|Various|2
68100|NCT01037244|249250|P1|Overall Study|Various|3
68101|NCT01037244|249247|P4|Overall Study|Partner Withdrew Consent|0
68102|NCT01037244|249248|P3|Overall Study|Partner Withdrew Consent|0
68103|NCT01037244|249249|P2|Overall Study|Partner Withdrew Consent|1
68104|NCT01037244|249250|P1|Overall Study|Partner Withdrew Consent|2
68105|NCT01037244|249247|P4|Overall Study|Withdrawal by Subject|5
68106|NCT01037244|249248|P3|Overall Study|Withdrawal by Subject|3
68107|NCT01037244|249249|P2|Overall Study|Withdrawal by Subject|5
68108|NCT01037244|249250|P1|Overall Study|Withdrawal by Subject|1
68109|NCT01037244|249247|P4|Overall Study|Lost to Follow-up|4
68110|NCT01037244|249248|P3|Overall Study|Lost to Follow-up|4
68111|NCT01037244|249249|P2|Overall Study|Lost to Follow-up|3
68112|NCT01037244|249250|P1|Overall Study|Lost to Follow-up|3
68113|NCT01037244|249247|P4|Overall Study|Lack of Efficacy|1
68114|NCT01037244|249248|P3|Overall Study|Lack of Efficacy|0
68115|NCT01037244|249249|P2|Overall Study|Lack of Efficacy|1
68116|NCT01037244|249250|P1|Overall Study|Lack of Efficacy|1
68117|NCT01037244|249247|P4|Overall Study|Adverse Event|3
68118|NCT01037244|249248|P3|Overall Study|Adverse Event|6
68119|NCT01037244|249249|P2|Overall Study|Adverse Event|2
68120|NCT01037244|249250|P1|Overall Study|Adverse Event|3
68121|NCT01037218|249312|P4|Overall Study|Various|1
68122|NCT01037218|249313|P3|Overall Study|Various|3
68123|NCT01037218|249314|P2|Overall Study|Various|2
68124|NCT01037218|249315|P1|Overall Study|Various|3
68125|NCT01037218|249312|P4|Overall Study|Protocol Violation|2
68126|NCT01037218|249313|P3|Overall Study|Protocol Violation|2
68127|NCT01037218|249314|P2|Overall Study|Protocol Violation|0
68128|NCT01037218|249315|P1|Overall Study|Protocol Violation|0
68129|NCT01037218|249312|P4|Overall Study|Partner Withdrew Consent|1
68130|NCT01037218|249313|P3|Overall Study|Partner Withdrew Consent|2
68131|NCT01037218|249314|P2|Overall Study|Partner Withdrew Consent|3
68132|NCT01037218|249315|P1|Overall Study|Partner Withdrew Consent|0
68133|NCT01037218|249312|P4|Overall Study|Withdrawal by Subject|4
68134|NCT01037218|249313|P3|Overall Study|Withdrawal by Subject|7
68135|NCT01037218|249314|P2|Overall Study|Withdrawal by Subject|7
68136|NCT01037218|249315|P1|Overall Study|Withdrawal by Subject|6
68137|NCT01037218|249312|P4|Overall Study|Lost to Follow-up|2
68138|NCT01037218|249313|P3|Overall Study|Lost to Follow-up|4
68139|NCT01037218|249314|P2|Overall Study|Lost to Follow-up|5
68140|NCT01037218|249315|P1|Overall Study|Lost to Follow-up|3
68141|NCT01037218|249312|P4|Overall Study|Lack of Efficacy|5
68142|NCT01037218|249313|P3|Overall Study|Lack of Efficacy|1
68143|NCT01037218|249314|P2|Overall Study|Lack of Efficacy|2
68144|NCT01037218|249315|P1|Overall Study|Lack of Efficacy|0
68145|NCT01037218|249312|P4|Overall Study|Adverse Event|1
68146|NCT01037218|249313|P3|Overall Study|Adverse Event|2
68147|NCT01037218|249314|P2|Overall Study|Adverse Event|2
68148|NCT01037218|249315|P1|Overall Study|Adverse Event|4
68149|NCT01037127|249386|P2|Overall Study|Study Closed Terminated|17
68150|NCT01037127|249387|P1|Overall Study|Study Closed Terminated|2
68151|NCT01037127|249386|P2|Overall Study|Physician Decision|0
68152|NCT01037127|249387|P1|Overall Study|Physician Decision|1
68153|NCT01037127|249386|P2|Overall Study|Lost to Follow-up|4
68154|NCT01037127|249387|P1|Overall Study|Lost to Follow-up|2
68155|NCT01037114|249419|P1|Year 20|Others|1
68156|NCT01037088|249432|P1|Overall Study|Withdrawal by Subject|3
68157|NCT01036763|249461|P1|Overall Study|Other reason (not specified)|40
68158|NCT01036763|249461|P1|Overall Study|Lost to Follow-up|28
68159|NCT01036763|249461|P1|Overall Study|Adverse Event|25
68160|NCT01036724|249473|P2|Overall Study|Protocol Violation|5
68161|NCT01036724|249474|P1|Overall Study|Protocol Violation|4
68162|NCT01036724|249473|P2|Overall Study|Lack of Efficacy|1
68163|NCT01036724|249474|P1|Overall Study|Lack of Efficacy|1
68164|NCT01036724|249473|P2|Overall Study|Adverse Event|2
68165|NCT01036724|249474|P1|Overall Study|Adverse Event|1
68166|NCT01036529|249484|P2|Overall Study|Sponsor study termination|12
68167|NCT01036529|249485|P1|Overall Study|Sponsor study termination|11
68168|NCT01036529|249484|P2|Overall Study|Withdrawal by Subject|1
68169|NCT01036529|249485|P1|Overall Study|Withdrawal by Subject|1
68170|NCT01036529|249484|P2|Overall Study|Physician Decision|0
68171|NCT01036529|249485|P1|Overall Study|Physician Decision|1
68172|NCT01036529|249484|P2|Overall Study|Lost to Follow-up|1
68173|NCT01036529|249485|P1|Overall Study|Lost to Follow-up|0
68174|NCT01036529|249484|P2|Overall Study|Adverse Event|1
68175|NCT01036529|249485|P1|Overall Study|Adverse Event|0
68176|NCT01036438|249512|P2|Overall Study|No effect of study treatment|1
68177|NCT01036438|249513|P1|Overall Study|No effect of study treatment|3
68178|NCT01036438|249512|P2|Overall Study|Death|1
68179|NCT01036438|249513|P1|Overall Study|Death|0
68180|NCT01036438|249512|P2|Overall Study|Adverse Event|8
68181|NCT01036438|249513|P1|Overall Study|Adverse Event|7
68182|NCT01036321|249521|P2|Overall Study|Adverse Event|1
68183|NCT01036321|249522|P1|Overall Study|Adverse Event|2
68184|NCT01036321|249521|P2|Overall Study|Withdrawal by Subject|2
68185|NCT01036321|249522|P1|Overall Study|Withdrawal by Subject|3
68186|NCT01036321|249521|P2|Overall Study|Ineligible after randomization|1
68187|NCT01036321|249522|P1|Overall Study|Ineligible after randomization|0
68188|NCT01036165|249546|P1|Overall Study|Problems finding proper area to inject|1
68189|NCT01036165|249546|P1|Overall Study|Device Related Issues|3
68190|NCT01036165|249546|P1|Overall Study|Withdrawal by Subject|3
68191|NCT01036165|249546|P1|Overall Study|Lost to Follow-up|2
68192|NCT01036165|249546|P1|Overall Study|Adverse Event|6
68193|NCT01035905|249587|P2|Overall Study|Lack of Efficacy|1
68194|NCT01035905|249588|P1|Overall Study|Lack of Efficacy|1
68195|NCT01035255|249786|P2|Overall Study|patient's request|13
68196|NCT01035255|249787|P1|Overall Study|patient's request|15
68197|NCT01035255|249786|P2|Overall Study|Lost to Follow-up|5
68198|NCT01035255|249787|P1|Overall Study|Lost to Follow-up|2
68199|NCT01035255|249786|P2|Overall Study|Death|844
68200|NCT01035255|249787|P1|Overall Study|Death|724
68201|NCT01035229|249805|P2|Overall Study|Disease Progression|152
68202|NCT01035229|249806|P1|Overall Study|Disease Progression|261
68203|NCT01035229|249805|P2|Overall Study|Sponsor's decision to end study|3
68204|NCT01035229|249806|P1|Overall Study|Sponsor's decision to end study|3
68205|NCT01035229|249805|P2|Overall Study|Protocol Violation|2
68206|NCT01035229|249806|P1|Overall Study|Protocol Violation|0
68207|NCT01035229|249805|P2|Overall Study|New cancer therapy|0
68208|NCT01035229|249806|P1|Overall Study|New cancer therapy|2
68209|NCT01035229|249805|P2|Overall Study|Death|5
68210|NCT01035229|249806|P1|Overall Study|Death|13
68211|NCT01035229|249805|P2|Overall Study|Administrative problems|1
68212|NCT01035229|249806|P1|Overall Study|Administrative problems|1
68213|NCT01035229|249805|P2|Overall Study|Lost to Follow-up|0
68214|NCT01035229|249806|P1|Overall Study|Lost to Follow-up|1
68215|NCT01035229|249805|P2|Overall Study|Withdrawal by Subject|7
68216|NCT01035229|249806|P1|Overall Study|Withdrawal by Subject|20
68217|NCT01035229|249805|P2|Overall Study|Adverse Event|14
68218|NCT01035229|249806|P1|Overall Study|Adverse Event|61
68219|NCT01035138|249827|P3|Overall Study|Lost to Follow-up|1
68220|NCT01035138|249828|P2|Overall Study|Lost to Follow-up|0
68221|NCT01035138|249829|P1|Overall Study|Lost to Follow-up|0
68222|NCT01035138|249827|P3|Overall Study|Sponsor Decision|42
68223|NCT01035138|249828|P2|Overall Study|Sponsor Decision|60
68224|NCT01035138|249829|P1|Overall Study|Sponsor Decision|66
68225|NCT01035138|249827|P3|Overall Study|Physician Decision|1
68226|NCT01035138|249828|P2|Overall Study|Physician Decision|0
68227|NCT01035138|249829|P1|Overall Study|Physician Decision|0
68228|NCT01035138|249827|P3|Overall Study|Withdrawal by Subject|0
68229|NCT01035138|249828|P2|Overall Study|Withdrawal by Subject|0
68230|NCT01035138|249829|P1|Overall Study|Withdrawal by Subject|1
68231|NCT01035138|249827|P3|Overall Study|Caregiver Decision|1
68232|NCT01035138|249828|P2|Overall Study|Caregiver Decision|0
68233|NCT01035138|249829|P1|Overall Study|Caregiver Decision|2
68234|NCT01035138|249827|P3|Overall Study|Adverse Event|2
68235|NCT01035138|249828|P2|Overall Study|Adverse Event|0
68236|NCT01035138|249829|P1|Overall Study|Adverse Event|4
68237|NCT01035060|249885|P2|Overall Study|Physician Decision|0
68238|NCT01035060|249886|P1|Overall Study|Physician Decision|2
68239|NCT01035060|249885|P2|Overall Study|Withdrawal by Subject|6
68240|NCT01035060|249886|P1|Overall Study|Withdrawal by Subject|8
68241|NCT01035060|249885|P2|Overall Study|Did not quality after 2nd screening|1
68242|NCT01035060|249886|P1|Overall Study|Did not quality after 2nd screening|14
68243|NCT01035060|249885|P2|Overall Study|Lost to Follow-up|7
68244|NCT01035060|249886|P1|Overall Study|Lost to Follow-up|0
68245|NCT01034709|249911|P2|Overall Study|Protocol Violation|16
68246|NCT01034709|249912|P1|Overall Study|Protocol Violation|9
68247|NCT01034657|249918|P3|Randomized Phase|Adverse Event|1
68248|NCT01034657|249919|P2|Randomized Phase|Adverse Event|2
68249|NCT01034657|249920|P1|Randomized Phase|Adverse Event|0
68250|NCT01034657|249918|P3|Randomized Phase|Abnormal laboratory value|0
68251|NCT01034657|249919|P2|Randomized Phase|Abnormal laboratory value|1
68252|NCT01034657|249920|P1|Randomized Phase|Abnormal laboratory value|0
68253|NCT01034657|249918|P3|Randomized Phase|Lack of Efficacy|0
68254|NCT01034657|249919|P2|Randomized Phase|Lack of Efficacy|1
68255|NCT01034657|249920|P1|Randomized Phase|Lack of Efficacy|5
68256|NCT01034657|249918|P3|Randomized Phase|Withdrawal by Subject|0
68257|NCT01034657|249919|P2|Randomized Phase|Withdrawal by Subject|2
68258|NCT01034657|249920|P1|Randomized Phase|Withdrawal by Subject|0
68259|NCT01034657|249918|P3|Core Phase|Protocol Violation|0
68260|NCT01034657|249919|P2|Core Phase|Protocol Violation|0
68261|NCT01034657|249920|P1|Core Phase|Protocol Violation|2
68262|NCT01034657|249918|P3|Core Phase|Adverse Event|0
68263|NCT01034657|249919|P2|Core Phase|Adverse Event|0
68264|NCT01034657|249920|P1|Core Phase|Adverse Event|8
68265|NCT01034657|249918|P3|Core Phase|Abnormal laboratory value|0
68266|NCT01034657|249919|P2|Core Phase|Abnormal laboratory value|0
68267|NCT01034657|249920|P1|Core Phase|Abnormal laboratory value|1
68268|NCT01034657|249918|P3|Core Phase|Lack of Efficacy|0
68269|NCT01034657|249919|P2|Core Phase|Lack of Efficacy|0
68270|NCT01034657|249920|P1|Core Phase|Lack of Efficacy|2
68271|NCT01034657|249918|P3|Core Phase|Withdrawal by Subject|0
68272|NCT01034657|249919|P2|Core Phase|Withdrawal by Subject|0
68273|NCT01034657|249920|P1|Core Phase|Withdrawal by Subject|1
68274|NCT01034540|250000|P2|Overall Study|Adverse Event|1
68275|NCT01034540|250001|P1|Overall Study|Adverse Event|0
68276|NCT01034462|250011|P2|Overall Study|Other reasons|2
68277|NCT01034462|250012|P1|Overall Study|Other reasons|1
68278|NCT01034462|250011|P2|Overall Study|Lost to Follow-up|16
68279|NCT01034462|250012|P1|Overall Study|Lost to Follow-up|14
68280|NCT01034462|250011|P2|Overall Study|Withdrawal by Subject|8
68281|NCT01034462|250012|P1|Overall Study|Withdrawal by Subject|9
68282|NCT01034462|250011|P2|Overall Study|Protocol Violation|7
68283|NCT01034462|250012|P1|Overall Study|Protocol Violation|10
68284|NCT01034462|250011|P2|Overall Study|Lack of Efficacy|4
68285|NCT01034462|250012|P1|Overall Study|Lack of Efficacy|4
68286|NCT01034462|250011|P2|Overall Study|Adverse Event|17
68287|NCT01034462|250012|P1|Overall Study|Adverse Event|7
68288|NCT01034397|250022|P2|Overall Study|Not specified|1
68289|NCT01034397|250023|P1|Overall Study|Not specified|0
68290|NCT01034397|250022|P2|Overall Study|Adverse Event|0
68291|NCT01034397|250023|P1|Overall Study|Adverse Event|4
68292|NCT01034397|250022|P2|Overall Study|Lack of Efficacy|0
68293|NCT01034397|250023|P1|Overall Study|Lack of Efficacy|3
68294|NCT01034397|250022|P2|Overall Study|Lack of compliance|1
68295|NCT01034397|250023|P1|Overall Study|Lack of compliance|0
68296|NCT01034358|250172|P1|Overall Study|Protocol Violation|1
68297|NCT01034358|250172|P1|Overall Study|Withdrawal by Subject|1
68298|NCT01034306|250178|P2|Overall Study|Noncomplience|0
68299|NCT01034306|250179|P1|Overall Study|Noncomplience|1
68300|NCT01034306|250178|P2|Overall Study|hospitalized and decided to stop|0
68301|NCT01034306|250179|P1|Overall Study|hospitalized and decided to stop|1
68302|NCT01034306|250178|P2|Overall Study|Withdrawal by Subject|2
68303|NCT01034306|250179|P1|Overall Study|Withdrawal by Subject|2
68304|NCT01034306|250178|P2|Overall Study|Lost to Follow-up|1
68305|NCT01034306|250179|P1|Overall Study|Lost to Follow-up|0
68306|NCT01034306|250178|P2|Overall Study|Adverse Event|0
68307|NCT01034306|250179|P1|Overall Study|Adverse Event|1
68308|NCT01034163|250187|P2|Overall Study|Abnormal laboratory value|0
68309|NCT01034163|250188|P1|Overall Study|Abnormal laboratory value|1
68310|NCT01034163|250187|P2|Overall Study|Administrative problems|1
68311|NCT01034163|250188|P1|Overall Study|Administrative problems|0
68312|NCT01034163|250187|P2|Overall Study|Adverse Event|0
68313|NCT01034163|250188|P1|Overall Study|Adverse Event|6
68314|NCT01034163|250187|P2|Overall Study|Disease progression|4
68315|NCT01034163|250188|P1|Overall Study|Disease progression|3
68316|NCT01034163|250187|P2|Overall Study|Protocol deviation|0
68317|NCT01034163|250188|P1|Overall Study|Protocol deviation|1
68318|NCT01034163|250187|P2|Overall Study|Withdrawal by Subject|2
68319|NCT01034163|250188|P1|Overall Study|Withdrawal by Subject|8
68320|NCT01034163|250187|P2|Overall Study|Treatment completed as per protocol|7
68321|NCT01034163|250188|P1|Overall Study|Treatment completed as per protocol|8
68322|NCT01034137|250197|P3|Overall Study|Administrative or other|4
68323|NCT01034137|250198|P2|Overall Study|Administrative or other|3
68324|NCT01034137|250199|P1|Overall Study|Administrative or other|2
68325|NCT01034137|250197|P3|Overall Study|Refused treatment or did not cooperate|1
68326|NCT01034137|250198|P2|Overall Study|Refused treatment or did not cooperate|0
68327|NCT01034137|250199|P1|Overall Study|Refused treatment or did not cooperate|2
68328|NCT01034137|250197|P3|Overall Study|Protocol Violation|1
68329|NCT01034137|250198|P2|Overall Study|Protocol Violation|2
68330|NCT01034137|250199|P1|Overall Study|Protocol Violation|2
68331|NCT01034137|250197|P3|Overall Study|Lack of Efficacy|13
68332|NCT01034137|250198|P2|Overall Study|Lack of Efficacy|4
68333|NCT01034137|250199|P1|Overall Study|Lack of Efficacy|9
68334|NCT01034137|250197|P3|Overall Study|Withdrawal by Subject|3
68335|NCT01034137|250198|P2|Overall Study|Withdrawal by Subject|3
68336|NCT01034137|250199|P1|Overall Study|Withdrawal by Subject|4
68337|NCT01034137|250197|P3|Overall Study|Adverse Event|8
68338|NCT01034137|250198|P2|Overall Study|Adverse Event|10
68339|NCT01034137|250199|P1|Overall Study|Adverse Event|9
68340|NCT01033851|250363|P2|Overall Study|Withdrawal by Subject|7
68341|NCT01033851|250364|P1|Overall Study|Withdrawal by Subject|3
68342|NCT01033825|250379|P7|Overall Study|Other|0
68343|NCT01033825|250380|P6|Overall Study|Other|0
68344|NCT01033825|250381|P5|Overall Study|Other|1
68345|NCT01033825|250382|P4|Overall Study|Other|0
68346|NCT01033825|250383|P3|Overall Study|Other|0
68347|NCT01033825|250384|P2|Overall Study|Other|0
68348|NCT01033825|250385|P1|Overall Study|Other|0
68349|NCT01033825|250379|P7|Overall Study|Protocol Violation|0
68350|NCT01033825|250380|P6|Overall Study|Protocol Violation|0
68351|NCT01033825|250381|P5|Overall Study|Protocol Violation|0
68352|NCT01033825|250382|P4|Overall Study|Protocol Violation|0
68353|NCT01033825|250383|P3|Overall Study|Protocol Violation|0
68354|NCT01033825|250384|P2|Overall Study|Protocol Violation|0
68355|NCT01033825|250385|P1|Overall Study|Protocol Violation|1
68356|NCT01033825|250379|P7|Overall Study|Adverse Event|0
68357|NCT01033825|250380|P6|Overall Study|Adverse Event|0
68358|NCT01033825|250381|P5|Overall Study|Adverse Event|0
68359|NCT01033825|250382|P4|Overall Study|Adverse Event|1
68360|NCT01033825|250383|P3|Overall Study|Adverse Event|0
68361|NCT01033825|250384|P2|Overall Study|Adverse Event|0
68362|NCT01033825|250385|P1|Overall Study|Adverse Event|0
68363|NCT01033825|250379|P7|Overall Study|Withdrawal by Subject|0
68364|NCT01033825|250380|P6|Overall Study|Withdrawal by Subject|0
68365|NCT01033825|250381|P5|Overall Study|Withdrawal by Subject|1
68366|NCT01033825|250382|P4|Overall Study|Withdrawal by Subject|1
68367|NCT01033825|250383|P3|Overall Study|Withdrawal by Subject|2
68368|NCT01033825|250384|P2|Overall Study|Withdrawal by Subject|3
68369|NCT01033825|250385|P1|Overall Study|Withdrawal by Subject|2
68370|NCT01033747|250606|P2|Overall Study|Stopped at end of Extension 1|0
68371|NCT01033747|250607|P1|Overall Study|Stopped at end of Extension 1|2
68372|NCT01033747|250606|P2|Overall Study|Stopped at end of prolongation visit 1|0
68373|NCT01033747|250607|P1|Overall Study|Stopped at end of prolongation visit 1|1
68374|NCT01033747|250606|P2|Overall Study|Withdrawal by Subject|6
68375|NCT01033747|250607|P1|Overall Study|Withdrawal by Subject|9
68376|NCT01033747|250606|P2|Overall Study|Protocol Violation|0
68377|NCT01033747|250607|P1|Overall Study|Protocol Violation|1
68378|NCT01033747|250606|P2|Overall Study|Unsatisfactory therapeutic effect|4
68379|NCT01033747|250607|P1|Overall Study|Unsatisfactory therapeutic effect|14
68380|NCT01033747|250606|P2|Overall Study|Abnormal test procedure|1
68381|NCT01033747|250607|P1|Overall Study|Abnormal test procedure|0
68382|NCT01033747|250606|P2|Overall Study|Abnormal Laboratory Value|0
68383|NCT01033747|250607|P1|Overall Study|Abnormal Laboratory Value|1
68384|NCT01033747|250606|P2|Overall Study|Adverse Event|4
68385|NCT01033747|250607|P1|Overall Study|Adverse Event|9
68386|NCT01033734|250615|P1|Overall Study|Withdrawal by Subject|1
68387|NCT01033487|250671|P10|Fourth Intervention Period|Adverse Event|0
68388|NCT01033487|250672|P9|Fourth Intervention Period|Adverse Event|1
68389|NCT01033487|250673|P8|Fourth Intervention Period|Adverse Event|0
68390|NCT01033487|250674|P7|Fourth Intervention Period|Adverse Event|0
68391|NCT01033487|250675|P6|Fourth Intervention Period|Adverse Event|0
68392|NCT01033487|250676|P5|Fourth Intervention Period|Adverse Event|0
68393|NCT01033487|250677|P4|Fourth Intervention Period|Adverse Event|0
68394|NCT01033487|250678|P3|Fourth Intervention Period|Adverse Event|0
68395|NCT01033487|250679|P2|Fourth Intervention Period|Adverse Event|0
68396|NCT01033487|250680|P1|Fourth Intervention Period|Adverse Event|0
68397|NCT01033071|250771|P3|Overall Study|Other|3
68398|NCT01033071|250772|P2|Overall Study|Other|4
68399|NCT01033071|250773|P1|Overall Study|Other|6
68400|NCT01033071|250771|P3|Overall Study|Lack of Efficacy|1
68401|NCT01033071|250772|P2|Overall Study|Lack of Efficacy|1
68402|NCT01033071|250773|P1|Overall Study|Lack of Efficacy|0
68403|NCT01033071|250771|P3|Overall Study|Withdrawal by Subject|11
68404|NCT01033071|250772|P2|Overall Study|Withdrawal by Subject|14
68405|NCT01033071|250773|P1|Overall Study|Withdrawal by Subject|17
68406|NCT01033071|250771|P3|Overall Study|Lost to Follow-up|5
68407|NCT01033071|250772|P2|Overall Study|Lost to Follow-up|5
68408|NCT01033071|250773|P1|Overall Study|Lost to Follow-up|4
68409|NCT01033071|250771|P3|Overall Study|Protocol Violation|1
68410|NCT01033071|250772|P2|Overall Study|Protocol Violation|2
68411|NCT01033071|250773|P1|Overall Study|Protocol Violation|0
68412|NCT01033071|250771|P3|Overall Study|Adverse Event|26
68413|NCT01033071|250772|P2|Overall Study|Adverse Event|51
68414|NCT01033071|250773|P1|Overall Study|Adverse Event|28
68415|NCT01033019|250844|P2|Overall Study|Withdrawal by Subject|0
68416|NCT01033019|250845|P1|Overall Study|Withdrawal by Subject|1
68417|NCT01032915|250883|P4|Overall Study|Protocol Violation|1
68418|NCT01032915|250884|P3|Overall Study|Protocol Violation|0
68419|NCT01032915|250885|P2|Overall Study|Protocol Violation|0
68420|NCT01032915|250886|P1|Overall Study|Protocol Violation|1
68421|NCT01032915|250883|P4|Overall Study|Administrative reasons|4
68422|NCT01032915|250884|P3|Overall Study|Administrative reasons|4
68423|NCT01032915|250885|P2|Overall Study|Administrative reasons|6
68424|NCT01032915|250886|P1|Overall Study|Administrative reasons|5
68425|NCT01032915|250883|P4|Overall Study|Withdrawal by Subject|1
68426|NCT01032915|250884|P3|Overall Study|Withdrawal by Subject|1
68427|NCT01032915|250885|P2|Overall Study|Withdrawal by Subject|3
68428|NCT01032915|250886|P1|Overall Study|Withdrawal by Subject|0
68429|NCT01032915|250883|P4|Overall Study|Abnormal test procedure result|0
68430|NCT01032915|250884|P3|Overall Study|Abnormal test procedure result|1
68431|NCT01032915|250885|P2|Overall Study|Abnormal test procedure result|0
68432|NCT01032915|250886|P1|Overall Study|Abnormal test procedure result|0
68433|NCT01032915|250883|P4|Overall Study|Adverse Event|1
68434|NCT01032915|250884|P3|Overall Study|Adverse Event|1
68435|NCT01032915|250885|P2|Overall Study|Adverse Event|2
68436|NCT01032915|250886|P1|Overall Study|Adverse Event|2
68437|NCT01032889|250911|P3|Overall Study|Miscellaneous Reasons|1
68438|NCT01032889|250912|P2|Overall Study|Miscellaneous Reasons|1
68439|NCT01032889|250913|P1|Overall Study|Miscellaneous Reasons|2
68440|NCT01032889|250911|P3|Overall Study|Lack of Submental Fat|1
68441|NCT01032889|250912|P2|Overall Study|Lack of Submental Fat|8
68442|NCT01032889|250913|P1|Overall Study|Lack of Submental Fat|2
68443|NCT01032889|250911|P3|Overall Study|Lost to Follow-up|0
68444|NCT01032889|250912|P2|Overall Study|Lost to Follow-up|1
68445|NCT01032889|250913|P1|Overall Study|Lost to Follow-up|1
68446|NCT01032889|250911|P3|Overall Study|Patient Request|0
68447|NCT01032889|250912|P2|Overall Study|Patient Request|1
68448|NCT01032889|250913|P1|Overall Study|Patient Request|0
68449|NCT01032889|250911|P3|Overall Study|Withdrawal of Consent|1
68450|NCT01032889|250912|P2|Overall Study|Withdrawal of Consent|2
68451|NCT01032889|250913|P1|Overall Study|Withdrawal of Consent|1
68452|NCT01032889|250911|P3|Overall Study|Adverse Event|0
68453|NCT01032889|250912|P2|Overall Study|Adverse Event|2
68454|NCT01032889|250913|P1|Overall Study|Adverse Event|2
68455|NCT01032837|250944|P4|Overall Study|Refused treatment|1
68456|NCT01032837|250945|P3|Overall Study|Refused treatment|0
68457|NCT01032837|250946|P2|Overall Study|Refused treatment|0
68458|NCT01032837|250947|P1|Overall Study|Refused treatment|0
68459|NCT01032837|250944|P4|Overall Study|Failed to return|0
68460|NCT01032837|250945|P3|Overall Study|Failed to return|1
68461|NCT01032837|250946|P2|Overall Study|Failed to return|0
68462|NCT01032837|250947|P1|Overall Study|Failed to return|0
68463|NCT01032837|250944|P4|Overall Study|Withdrew consent|1
68464|NCT01032837|250945|P3|Overall Study|Withdrew consent|0
68465|NCT01032837|250946|P2|Overall Study|Withdrew consent|2
68466|NCT01032837|250947|P1|Overall Study|Withdrew consent|0
68467|NCT01032837|250944|P4|Overall Study|Adverse event/internal illness|1
68468|NCT01032837|250945|P3|Overall Study|Adverse event/internal illness|0
68469|NCT01032837|250946|P2|Overall Study|Adverse event/internal illness|1
68470|NCT01032837|250947|P1|Overall Study|Adverse event/internal illness|0
68471|NCT01032382|251052|P2|Overall Study|Index lesion relapse|3
68472|NCT01032382|251053|P1|Overall Study|Index lesion relapse|1
68473|NCT01032382|251052|P2|Overall Study|Treatment failure|1
68474|NCT01032382|251053|P1|Overall Study|Treatment failure|3
68475|NCT01032382|251052|P2|Overall Study|Disease dissemination|1
68476|NCT01032382|251053|P1|Overall Study|Disease dissemination|1
68477|NCT01032291|251082|P3|Proof of Concept|Never Received Study Drug|0
68478|NCT01032291|251083|P2|Proof of Concept|Never Received Study Drug|1
68479|NCT01032291|251084|P1|Proof of Concept|Never Received Study Drug|0
68480|NCT01032291|251082|P3|Proof of Concept|Lack of Efficacy|0
68481|NCT01032291|251083|P2|Proof of Concept|Lack of Efficacy|1
68482|NCT01032291|251084|P1|Proof of Concept|Lack of Efficacy|0
68483|NCT01032291|251082|P3|Proof of Concept|Death|2
68484|NCT01032291|251083|P2|Proof of Concept|Death|1
68485|NCT01032291|251084|P1|Proof of Concept|Death|0
68486|NCT01032291|251082|P3|Proof of Concept|Adverse Event|1
68487|NCT01032291|251083|P2|Proof of Concept|Adverse Event|5
68488|NCT01032291|251084|P1|Proof of Concept|Adverse Event|0
68489|NCT01032291|251082|P3|Safety Lead-in|Death|0
68490|NCT01032291|251083|P2|Safety Lead-in|Death|0
68491|NCT01032291|251084|P1|Safety Lead-in|Death|1
68492|NCT01032291|251082|P3|Safety Lead-in|Adverse Event|0
68493|NCT01032291|251083|P2|Safety Lead-in|Adverse Event|0
68494|NCT01032291|251084|P1|Safety Lead-in|Adverse Event|1
68495|NCT01032200|251131|P2|Overall Study|Multiple|1
68496|NCT01032200|251132|P1|Overall Study|Multiple|1
68497|NCT01032200|251131|P2|Overall Study|Progression|0
68498|NCT01032200|251132|P1|Overall Study|Progression|1
68499|NCT01032200|251131|P2|Overall Study|Toxicity|2
68500|NCT01032200|251132|P1|Overall Study|Toxicity|0
68501|NCT01032200|251131|P2|Overall Study|Withdrawal by Subject|3
68502|NCT01032200|251132|P1|Overall Study|Withdrawal by Subject|1
68503|NCT01032200|251131|P2|Overall Study|Death|1
68504|NCT01032200|251132|P1|Overall Study|Death|1
68505|NCT01032174|251148|P2|Overall Study|Adverse Event|1
68506|NCT01032174|251149|P1|Overall Study|Adverse Event|0
68507|NCT01032070|251161|P2|Overall Study|Withdrawal by Subject|2
68508|NCT01032070|251162|P1|Overall Study|Withdrawal by Subject|0
68509|NCT01032070|251161|P2|Overall Study|Medical or ethical reasons|2
68510|NCT01032070|251162|P1|Overall Study|Medical or ethical reasons|0
68511|NCT01032070|251161|P2|Overall Study|Disease progression|8
68512|NCT01032070|251162|P1|Overall Study|Disease progression|13
68513|NCT01032044|251191|P2|Overall Study|Lost to Follow-up|11
68514|NCT01032044|251192|P1|Overall Study|Lost to Follow-up|11
68515|NCT01032044|251191|P2|Overall Study|Adverse Event|1
68516|NCT01032044|251192|P1|Overall Study|Adverse Event|0
68517|NCT01032044|251191|P2|Overall Study|Protocol Violation|8
68518|NCT01032044|251192|P1|Overall Study|Protocol Violation|14
68519|NCT01032018|251200|P2|Overall Study|Death|1
68520|NCT01032018|251201|P1|Overall Study|Death|0
68521|NCT01032018|251200|P2|Overall Study|Lost to Follow-up|5
68522|NCT01032018|251201|P1|Overall Study|Lost to Follow-up|6
68523|NCT01031706|251235|P2|Overall Study|Withdrawal by Subject|1
68524|NCT01031706|251236|P1|Overall Study|Withdrawal by Subject|1
68525|NCT01031706|251235|P2|Overall Study|Adverse Event|0
68526|NCT01031706|251236|P1|Overall Study|Adverse Event|1
68527|NCT01031680|251246|P2|Overall Study|Various|2
68528|NCT01031680|251247|P1|Overall Study|Various|0
68529|NCT01031680|251246|P2|Overall Study|Administrative Reason by Sponsor|1
68530|NCT01031680|251247|P1|Overall Study|Administrative Reason by Sponsor|0
68531|NCT01031680|251246|P2|Overall Study|Incorrect Enrolment|2
68532|NCT01031680|251247|P1|Overall Study|Incorrect Enrolment|1
68533|NCT01031680|251246|P2|Overall Study|Safety|0
68534|NCT01031680|251247|P1|Overall Study|Safety|1
68535|NCT01031680|251246|P2|Overall Study|Poor/Non-compliance|6
68536|NCT01031680|251247|P1|Overall Study|Poor/Non-compliance|5
68537|NCT01031680|251246|P2|Overall Study|Subject No Longer Meets Study Criteria|17
68538|NCT01031680|251247|P1|Overall Study|Subject No Longer Meets Study Criteria|26
68539|NCT01031680|251246|P2|Overall Study|Death|1
68540|NCT01031680|251247|P1|Overall Study|Death|2
68541|NCT01031680|251246|P2|Overall Study|Withdrawal by Subject|16
68542|NCT01031680|251247|P1|Overall Study|Withdrawal by Subject|12
68543|NCT01031680|251246|P2|Overall Study|Lost to Follow-up|10
68544|NCT01031680|251247|P1|Overall Study|Lost to Follow-up|2
68545|NCT01031680|251246|P2|Overall Study|Adverse Event|3
68546|NCT01031680|251247|P1|Overall Study|Adverse Event|8
68547|NCT01031628|251267|P4|Overall Study|Study terminated early|0
68548|NCT01031628|251268|P3|Overall Study|Study terminated early|3
68549|NCT01031628|251269|P2|Overall Study|Study terminated early|1
68550|NCT01031628|251270|P1|Overall Study|Study terminated early|0
68551|NCT01031446|251308|P1|Overall Study|Still on treatment|1
68552|NCT01031446|251308|P1|Overall Study|Withdrawal by Subject|3
68553|NCT01031446|251308|P1|Overall Study|Physician Decision|4
68554|NCT01031446|251308|P1|Overall Study|Adverse Event|9
68555|NCT01031446|251308|P1|Overall Study|Disease Progression|38
68556|NCT01031381|251317|P1|Overall Study|Withdrawal by Subject|6
68557|NCT01031381|251317|P1|Overall Study|Physician Decision|3
68558|NCT01031004|251337|P2|Overall Study|Lost to Follow-up|0
68559|NCT01031004|251338|P1|Overall Study|Lost to Follow-up|1
68560|NCT01031004|251337|P2|Overall Study|Protocol Violation|1
68561|NCT01031004|251338|P1|Overall Study|Protocol Violation|0
68562|NCT01030965|251382|P4|Overall Study|Withdrawal by Subject|2
68563|NCT01030965|251383|P3|Overall Study|Withdrawal by Subject|0
68564|NCT01030965|251384|P2|Overall Study|Withdrawal by Subject|1
68565|NCT01030965|251385|P1|Overall Study|Withdrawal by Subject|0
68566|NCT01030965|251382|P4|Overall Study|Protocol-defined Stopping Criteria|0
68567|NCT01030965|251383|P3|Overall Study|Protocol-defined Stopping Criteria|1
68568|NCT01030965|251384|P2|Overall Study|Protocol-defined Stopping Criteria|1
68569|NCT01030965|251385|P1|Overall Study|Protocol-defined Stopping Criteria|0
68570|NCT01030965|251382|P4|Overall Study|Adverse Event|1
68571|NCT01030965|251383|P3|Overall Study|Adverse Event|2
68572|NCT01030965|251384|P2|Overall Study|Adverse Event|1
68573|NCT01030965|251385|P1|Overall Study|Adverse Event|0
68574|NCT01030965|251382|P4|Overall Study|Protocol Violation|1
68575|NCT01030965|251383|P3|Overall Study|Protocol Violation|1
68576|NCT01030965|251384|P2|Overall Study|Protocol Violation|1
68577|NCT01030965|251385|P1|Overall Study|Protocol Violation|1
68578|NCT01030965|251382|P4|Overall Study|Lack of Efficacy|3
68579|NCT01030965|251383|P3|Overall Study|Lack of Efficacy|0
68580|NCT01030965|251384|P2|Overall Study|Lack of Efficacy|2
68581|NCT01030965|251385|P1|Overall Study|Lack of Efficacy|3
68582|NCT01030952|251405|P2|Overall Study|Unexplained|1
68583|NCT01030952|251406|P1|Overall Study|Unexplained|1
68584|NCT01030952|251405|P2|Overall Study|Lost to Follow-up|1
68585|NCT01030952|251406|P1|Overall Study|Lost to Follow-up|0
68586|NCT01030952|251405|P2|Overall Study|Informed consent withdrawal|0
68587|NCT01030952|251406|P1|Overall Study|Informed consent withdrawal|1
68588|NCT01030952|251405|P2|Overall Study|Protocol Violation|1
68589|NCT01030952|251406|P1|Overall Study|Protocol Violation|0
68590|NCT01030718|251448|P3|Study CA180-036 Only|Other Reasons|0
68591|NCT01030718|251449|P2|Study CA180-036 Only|Other Reasons|2
68592|NCT01030718|251450|P1|Study CA180-036 Only|Other Reasons|0
68593|NCT01030718|251448|P3|Study CA180-036 Only|Death|0
68594|NCT01030718|251449|P2|Study CA180-036 Only|Death|1
68595|NCT01030718|251450|P1|Study CA180-036 Only|Death|0
68596|NCT01030718|251448|P3|Study CA180-036 Only|Adverse Event|0
68597|NCT01030718|251449|P2|Study CA180-036 Only|Adverse Event|3
68598|NCT01030718|251450|P1|Study CA180-036 Only|Adverse Event|2
68599|NCT01030718|251448|P3|Study CA180-036 Only|insufficient effect|5
68600|NCT01030718|251449|P2|Study CA180-036 Only|insufficient effect|1
68601|NCT01030718|251450|P1|Study CA180-036 Only|insufficient effect|1
68602|NCT01030718|251448|P3|Studies CA180-031 and -036 Combined|other reasons|0
68603|NCT01030718|251449|P2|Studies CA180-031 and -036 Combined|other reasons|2
68604|NCT01030718|251450|P1|Studies CA180-031 and -036 Combined|other reasons|0
68605|NCT01030718|251448|P3|Studies CA180-031 and -036 Combined|Death|0
68606|NCT01030718|251449|P2|Studies CA180-031 and -036 Combined|Death|1
68607|NCT01030718|251450|P1|Studies CA180-031 and -036 Combined|Death|0
68608|NCT01030718|251448|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
68609|NCT01030718|251449|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
68610|NCT01030718|251450|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
68611|NCT01030718|251448|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
68612|NCT01030718|251449|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
68613|NCT01030718|251450|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
68614|NCT01030666|251511|P2|Overall Study|Lost to Follow-up|2
68615|NCT01030666|251512|P1|Overall Study|Lost to Follow-up|3
68616|NCT01030458|251534|P2|Overall Study|Side effect of medication|1
68617|NCT01030458|251535|P1|Overall Study|Side effect of medication|1
68618|NCT01030458|251534|P2|Overall Study|Moved or changed job|13
68619|NCT01030458|251535|P1|Overall Study|Moved or changed job|6
68620|NCT01030458|251534|P2|Overall Study|Logistical reasons|5
68621|NCT01030458|251535|P1|Overall Study|Logistical reasons|9
68622|NCT01030458|251534|P2|Overall Study|Withdrawal by Subject|3
68623|NCT01030458|251535|P1|Overall Study|Withdrawal by Subject|2
68624|NCT01030458|251534|P2|Overall Study|Lost to Follow-up|10
68625|NCT01030458|251535|P1|Overall Study|Lost to Follow-up|9
68626|NCT01029925|251547|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
68627|NCT01029925|251547|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
68628|NCT01029925|251547|P1|Completion of Cycle 1 (28 Days)|Death|2
68629|NCT01029886|251553|P2|Overall Study|Loss Glucose Control|1
68630|NCT01029886|251554|P1|Overall Study|Loss Glucose Control|7
68631|NCT01029886|251553|P2|Overall Study|Sponsor Decision|0
68632|NCT01029886|251554|P1|Overall Study|Sponsor Decision|1
68633|NCT01029886|251553|P2|Overall Study|Entry Criteria Not Met|5
68634|NCT01029886|251554|P1|Overall Study|Entry Criteria Not Met|13
68635|NCT01029886|251553|P2|Overall Study|Withdrawal by Subject|18
68636|NCT01029886|251554|P1|Overall Study|Withdrawal by Subject|8
68637|NCT01029886|251553|P2|Overall Study|Protocol Violation|5
68638|NCT01029886|251554|P1|Overall Study|Protocol Violation|17
68639|NCT01029886|251553|P2|Overall Study|Physician Decision|6
68640|NCT01029886|251554|P1|Overall Study|Physician Decision|2
68641|NCT01029886|251553|P2|Overall Study|Lost to Follow-up|0
68642|NCT01029886|251554|P1|Overall Study|Lost to Follow-up|1
68643|NCT01029886|251553|P2|Overall Study|Adverse Event|25
68644|NCT01029886|251554|P1|Overall Study|Adverse Event|12
68645|NCT01029795|251582|P2|Overall Study|Withdrawal by Subject|3
68646|NCT01029795|251583|P1|Overall Study|Withdrawal by Subject|1
68647|NCT01029795|251582|P2|Overall Study|Sponsor Decision|17
68648|NCT01029795|251583|P1|Overall Study|Sponsor Decision|11
68649|NCT01029795|251582|P2|Overall Study|Physician Decision|1
68650|NCT01029795|251583|P1|Overall Study|Physician Decision|2
68651|NCT01029795|251582|P2|Overall Study|Entry Criteria Not Met|1
68652|NCT01029795|251583|P1|Overall Study|Entry Criteria Not Met|2
68653|NCT01029652|251680|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
68654|NCT01029652|251681|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
68655|NCT01029652|251680|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
68656|NCT01029652|251681|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
68657|NCT01029652|251680|P2|Extension Study 2 (25-72 Weeks)|Death|1
68658|NCT01029652|251681|P1|Extension Study 2 (25-72 Weeks)|Death|1
68659|NCT01029652|251680|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
68660|NCT01029652|251681|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
68661|NCT01029652|251680|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
68662|NCT01029652|251681|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
68663|NCT01029652|251680|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
68664|NCT01029652|251681|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
68665|NCT01029652|251680|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
68666|NCT01029652|251681|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
68667|NCT01029652|251680|P2|Core Study (0-12 Weeks)|Death|1
68668|NCT01029652|251681|P1|Core Study (0-12 Weeks)|Death|0
68669|NCT01029652|251680|P2|Core Study (0-12 Weeks)|Administrative problems|1
68670|NCT01029652|251681|P1|Core Study (0-12 Weeks)|Administrative problems|2
68671|NCT01029652|251680|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
68672|NCT01029652|251681|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
68673|NCT01029652|251680|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
68674|NCT01029652|251681|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
68675|NCT01029652|251680|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
68676|NCT01029652|251681|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
68677|NCT01029535|251759|P1|Overall Study|Death|1
68678|NCT01029535|251759|P1|Overall Study|Use of Another Treatment|1
68679|NCT01029535|251759|P1|Overall Study|Adverse Event|1
68680|NCT01029535|251759|P1|Overall Study|Participant Withdrew Consent|2
68681|NCT01029535|251759|P1|Overall Study|Protocol Violation|2
68682|NCT01029535|251759|P1|Overall Study|Lost to Follow-up|24
68683|NCT01029340|251789|P6|Extension Period|Physician Decision|1
68684|NCT01029340|251790|P5|Extension Period|Physician Decision|0
68685|NCT01029340|251791|P4|Extension Period|Physician Decision|0
68686|NCT01029340|251792|P3|Extension Period|Physician Decision|0
68687|NCT01029340|251793|P2|Extension Period|Physician Decision|0
68688|NCT01029340|251794|P1|Extension Period|Physician Decision|0
68689|NCT01029340|251789|P6|Extension Period|Withdrawal by Subject|1
68690|NCT01029340|251790|P5|Extension Period|Withdrawal by Subject|0
68691|NCT01029340|251791|P4|Extension Period|Withdrawal by Subject|0
68692|NCT01029340|251792|P3|Extension Period|Withdrawal by Subject|0
68693|NCT01029340|251793|P2|Extension Period|Withdrawal by Subject|0
68694|NCT01029340|251794|P1|Extension Period|Withdrawal by Subject|0
68695|NCT01029340|251789|P6|Extension Period|non-compliance|1
68696|NCT01029340|251790|P5|Extension Period|non-compliance|0
68697|NCT01029340|251791|P4|Extension Period|non-compliance|0
68698|NCT01029340|251792|P3|Extension Period|non-compliance|0
68699|NCT01029340|251793|P2|Extension Period|non-compliance|0
68700|NCT01029340|251794|P1|Extension Period|non-compliance|0
68701|NCT01029340|251789|P6|Extension Period|starting another study|8
68702|NCT01029340|251790|P5|Extension Period|starting another study|0
68703|NCT01029340|251791|P4|Extension Period|starting another study|0
68704|NCT01029340|251792|P3|Extension Period|starting another study|0
68705|NCT01029340|251793|P2|Extension Period|starting another study|0
68706|NCT01029340|251794|P1|Extension Period|starting another study|0
68707|NCT01029340|251789|P6|Extension Period|Adverse Event|1
68708|NCT01029340|251790|P5|Extension Period|Adverse Event|0
68709|NCT01029340|251791|P4|Extension Period|Adverse Event|0
68710|NCT01029340|251792|P3|Extension Period|Adverse Event|0
68711|NCT01029340|251793|P2|Extension Period|Adverse Event|0
68712|NCT01029340|251794|P1|Extension Period|Adverse Event|0
68713|NCT01029340|251789|P6|Part B Treatment Period|Protocol Violation|0
68714|NCT01029340|251790|P5|Part B Treatment Period|Protocol Violation|0
68715|NCT01029340|251791|P4|Part B Treatment Period|Protocol Violation|0
68716|NCT01029340|251792|P3|Part B Treatment Period|Protocol Violation|1
68717|NCT01029340|251793|P2|Part B Treatment Period|Protocol Violation|0
68718|NCT01029340|251794|P1|Part B Treatment Period|Protocol Violation|0
68719|NCT01029340|251789|P6|Part B Treatment Period|Withdrawal by Subject|0
68720|NCT01029340|251790|P5|Part B Treatment Period|Withdrawal by Subject|0
68721|NCT01029340|251791|P4|Part B Treatment Period|Withdrawal by Subject|0
68722|NCT01029340|251792|P3|Part B Treatment Period|Withdrawal by Subject|1
68723|NCT01029340|251793|P2|Part B Treatment Period|Withdrawal by Subject|0
68724|NCT01029340|251794|P1|Part B Treatment Period|Withdrawal by Subject|0
68725|NCT01029262|251825|P2|Overall Study|Unspecified|5
68726|NCT01029262|251826|P1|Overall Study|Unspecified|1
68727|NCT01029262|251825|P2|Overall Study|Protocol Violation|3
68728|NCT01029262|251826|P1|Overall Study|Protocol Violation|2
68729|NCT01029262|251825|P2|Overall Study|Withdrawal by Subject|16
68730|NCT01029262|251826|P1|Overall Study|Withdrawal by Subject|10
68731|NCT01029262|251825|P2|Overall Study|Lack of therapeutic effect|69
68732|NCT01029262|251826|P1|Overall Study|Lack of therapeutic effect|56
68733|NCT01029262|251825|P2|Overall Study|Adverse Event|52
68734|NCT01029262|251826|P1|Overall Study|Adverse Event|9
68735|NCT01027364|251969|P4|Overall Study|Withdrawal by Subject|0
68736|NCT01027364|251970|P3|Overall Study|Withdrawal by Subject|0
68737|NCT01027364|251971|P2|Overall Study|Withdrawal by Subject|2
68738|NCT01027364|251972|P1|Overall Study|Withdrawal by Subject|1
68739|NCT01027364|251969|P4|Overall Study|Protocol Violation|1
68740|NCT01027364|251970|P3|Overall Study|Protocol Violation|0
68741|NCT01027364|251971|P2|Overall Study|Protocol Violation|0
68742|NCT01027364|251972|P1|Overall Study|Protocol Violation|1
68743|NCT01027364|251969|P4|Overall Study|Lost to Follow-up|0
68744|NCT01027364|251970|P3|Overall Study|Lost to Follow-up|0
68745|NCT01027364|251971|P2|Overall Study|Lost to Follow-up|0
68746|NCT01027364|251972|P1|Overall Study|Lost to Follow-up|1
68747|NCT01027364|251969|P4|Overall Study|Adverse Event|0
68748|NCT01027364|251970|P3|Overall Study|Adverse Event|1
68749|NCT01027364|251971|P2|Overall Study|Adverse Event|0
68750|NCT01027364|251972|P1|Overall Study|Adverse Event|1
68751|NCT01027351|252067|P6|Overall Study|Protocol Violation|0
68752|NCT01027351|252068|P5|Overall Study|Protocol Violation|1
68753|NCT01027351|252069|P4|Overall Study|Protocol Violation|1
68754|NCT01027351|252070|P3|Overall Study|Protocol Violation|0
68755|NCT01027351|252071|P2|Overall Study|Protocol Violation|0
68756|NCT01027351|252072|P1|Overall Study|Protocol Violation|1
68757|NCT01027351|252067|P6|Overall Study|Inappropriate enrollment|0
68758|NCT01027351|252068|P5|Overall Study|Inappropriate enrollment|1
68759|NCT01027351|252069|P4|Overall Study|Inappropriate enrollment|0
68760|NCT01027351|252070|P3|Overall Study|Inappropriate enrollment|0
68761|NCT01027351|252071|P2|Overall Study|Inappropriate enrollment|0
68762|NCT01027351|252072|P1|Overall Study|Inappropriate enrollment|0
68763|NCT01027351|252067|P6|Overall Study|Lost to Follow-up|0
68764|NCT01027351|252068|P5|Overall Study|Lost to Follow-up|6
68765|NCT01027351|252069|P4|Overall Study|Lost to Follow-up|1
68766|NCT01027351|252070|P3|Overall Study|Lost to Follow-up|0
68767|NCT01027351|252071|P2|Overall Study|Lost to Follow-up|1
68768|NCT01027351|252072|P1|Overall Study|Lost to Follow-up|1
68769|NCT01027351|252067|P6|Overall Study|Withdrawal by Subject|5
68770|NCT01027351|252068|P5|Overall Study|Withdrawal by Subject|3
68771|NCT01027351|252069|P4|Overall Study|Withdrawal by Subject|0
68772|NCT01027351|252070|P3|Overall Study|Withdrawal by Subject|1
68773|NCT01027351|252071|P2|Overall Study|Withdrawal by Subject|0
68774|NCT01027351|252072|P1|Overall Study|Withdrawal by Subject|1
68775|NCT01027286|252156|P2|Overall Study|Lost to Follow-up|1
68776|NCT01027286|252157|P1|Overall Study|Lost to Follow-up|0
68777|NCT01027286|252156|P2|Overall Study|Unable to Obtain Required Blood Volume|0
68778|NCT01027286|252157|P1|Overall Study|Unable to Obtain Required Blood Volume|1
68779|NCT01027273|252177|P2|Overall Study|Death|2
68780|NCT01027273|252178|P1|Overall Study|Death|2
68781|NCT01027273|252177|P2|Overall Study|Lost to Follow-up|31
68782|NCT01027273|252178|P1|Overall Study|Lost to Follow-up|57
68783|NCT01028391|252196|P2|Overall Study|Needed excluded medication|1
68784|NCT01028391|252197|P1|Overall Study|Needed excluded medication|1
68785|NCT01028391|252196|P2|Overall Study|Withdrawal by Subject|3
68786|NCT01028391|252197|P1|Overall Study|Withdrawal by Subject|6
68787|NCT01028391|252196|P2|Overall Study|Physician Decision|1
68788|NCT01028391|252197|P1|Overall Study|Physician Decision|0
68789|NCT01028391|252196|P2|Overall Study|Lost to Follow-up|4
68790|NCT01028391|252197|P1|Overall Study|Lost to Follow-up|3
68791|NCT01028391|252196|P2|Overall Study|Lack of Efficacy|2
68792|NCT01028391|252197|P1|Overall Study|Lack of Efficacy|0
68793|NCT01028391|252196|P2|Overall Study|Adverse Event|0
68794|NCT01028391|252197|P1|Overall Study|Adverse Event|4
68795|NCT01028378|252205|P1|Overall Study|Adminstrative Reasons|4
68796|NCT01028378|252205|P1|Overall Study|Withdrawal by Subject|1
68797|NCT01028378|252205|P1|Overall Study|Lost to Follow-up|12
68798|NCT01028352|252217|P1|Overall Study|Withdrawal by Subject|1
68799|NCT01028352|252217|P1|Overall Study|Ineligible due to baseline average pain|5
68800|NCT01028300|252222|P1|Overall Study|Study Terminated|4
68801|NCT01028222|252231|P2|Overall Study|Adverse Event|0
68802|NCT01028222|252232|P1|Overall Study|Adverse Event|2
68803|NCT01028222|252231|P2|Overall Study|Crossover to nilotinib w/out progression|2
68804|NCT01028222|252232|P1|Overall Study|Crossover to nilotinib w/out progression|0
68805|NCT01028222|252231|P2|Overall Study|Withdrawal by Subject|0
68806|NCT01028222|252232|P1|Overall Study|Withdrawal by Subject|1
68807|NCT01028222|252231|P2|Overall Study|Lost to Follow-up|1
68808|NCT01028222|252232|P1|Overall Study|Lost to Follow-up|0
68809|NCT01028222|252231|P2|Overall Study|Administrative problems|1
68810|NCT01028222|252232|P1|Overall Study|Administrative problems|1
68811|NCT01028222|252231|P2|Overall Study|Disease progression|9
68812|NCT01028222|252232|P1|Overall Study|Disease progression|33
68813|NCT01028222|252231|P2|Overall Study|Protocol deviation|0
68814|NCT01028222|252232|P1|Overall Study|Protocol deviation|1
68815|NCT01028053|252274|P1|Overall Study|Various reasons|4
68816|NCT01028053|252274|P1|Overall Study|Terminated by Sponsor|1
68817|NCT01028053|252274|P1|Overall Study|Technical Problem|1
68818|NCT01028053|252274|P1|Overall Study|Physician Decision|2
68819|NCT01028053|252274|P1|Overall Study|Protocol Violation|1
68820|NCT01028053|252274|P1|Overall Study|Patient Request|11
68821|NCT01028053|252274|P1|Overall Study|Screen Failure|113
68822|NCT01028027|252282|P2|Overall Study|Lack of Efficacy|1
68823|NCT01028027|252283|P1|Overall Study|Lack of Efficacy|0
68824|NCT01028027|252282|P2|Overall Study|Protocol Violation|1
68825|NCT01028027|252283|P1|Overall Study|Protocol Violation|3
68826|NCT01028027|252282|P2|Overall Study|Adverse Event|7
68827|NCT01028027|252283|P1|Overall Study|Adverse Event|4
68828|NCT01028027|252282|P2|Overall Study|Withdrawal by Subject|3
68829|NCT01028027|252283|P1|Overall Study|Withdrawal by Subject|5
68830|NCT01028027|252282|P2|Overall Study|Lost to Follow-up|1
68831|NCT01028027|252283|P1|Overall Study|Lost to Follow-up|4
68832|NCT01028014|252305|P6|Overall Study|Lost to Follow-up|2
68833|NCT01028014|252306|P5|Overall Study|Lost to Follow-up|1
68834|NCT01028014|252307|P4|Overall Study|Lost to Follow-up|1
68835|NCT01028014|252308|P3|Overall Study|Lost to Follow-up|0
68836|NCT01028014|252309|P2|Overall Study|Lost to Follow-up|2
68837|NCT01028014|252310|P1|Overall Study|Lost to Follow-up|1
68838|NCT01027897|252351|P1|Overall Study|Withdrawal by Subject|1
68839|NCT01027897|252351|P1|Overall Study|Protocol Violation|1
68840|NCT01027884|252359|P2|Overall Study|Spinal fixation surgery|3
68841|NCT01027884|252360|P1|Overall Study|Spinal fixation surgery|0
68842|NCT01027884|252359|P2|Overall Study|Lost to Follow-up|1
68843|NCT01027884|252360|P1|Overall Study|Lost to Follow-up|0
68844|NCT01027884|252359|P2|Overall Study|Withdrawal by Subject|1
68845|NCT01027884|252360|P1|Overall Study|Withdrawal by Subject|0
68846|NCT01027884|252359|P2|Overall Study|Non-compliance|1
68847|NCT01027884|252360|P1|Overall Study|Non-compliance|1
68848|NCT01027884|252359|P2|Overall Study|Protocol Violation|0
68849|NCT01027884|252360|P1|Overall Study|Protocol Violation|1
68850|NCT01027884|252359|P2|Overall Study|Adverse Event|1
68851|NCT01027884|252360|P1|Overall Study|Adverse Event|2
68852|NCT01027650|252404|P8|Overall Study|Lack of Efficacy|0
68853|NCT01027650|252405|P7|Overall Study|Lack of Efficacy|0
68854|NCT01027650|252406|P6|Overall Study|Lack of Efficacy|1
68855|NCT01027650|252407|P5|Overall Study|Lack of Efficacy|0
68856|NCT01027650|252408|P4|Overall Study|Lack of Efficacy|0
68857|NCT01027650|252409|P3|Overall Study|Lack of Efficacy|0
68858|NCT01027650|252410|P2|Overall Study|Lack of Efficacy|0
68859|NCT01027650|252411|P1|Overall Study|Lack of Efficacy|0
68860|NCT01027650|252404|P8|Overall Study|Lost to Follow-up|0
68861|NCT01027650|252405|P7|Overall Study|Lost to Follow-up|1
68862|NCT01027650|252406|P6|Overall Study|Lost to Follow-up|0
68863|NCT01027650|252407|P5|Overall Study|Lost to Follow-up|0
68864|NCT01027650|252408|P4|Overall Study|Lost to Follow-up|0
68865|NCT01027650|252409|P3|Overall Study|Lost to Follow-up|0
68866|NCT01027650|252410|P2|Overall Study|Lost to Follow-up|0
68867|NCT01027650|252411|P1|Overall Study|Lost to Follow-up|0
68868|NCT01027650|252404|P8|Overall Study|Personal Reasons|0
68869|NCT01027650|252405|P7|Overall Study|Personal Reasons|0
68870|NCT01027650|252406|P6|Overall Study|Personal Reasons|1
68871|NCT01027650|252407|P5|Overall Study|Personal Reasons|2
68872|NCT01027650|252408|P4|Overall Study|Personal Reasons|0
68873|NCT01027650|252409|P3|Overall Study|Personal Reasons|0
68874|NCT01027650|252410|P2|Overall Study|Personal Reasons|0
68875|NCT01027650|252411|P1|Overall Study|Personal Reasons|0
68876|NCT01026974|252497|P4|Overall Study|Inappropriate enrollment|0
68877|NCT01026974|252498|P3|Overall Study|Inappropriate enrollment|1
68878|NCT01026974|252499|P2|Overall Study|Inappropriate enrollment|0
68879|NCT01026974|252500|P1|Overall Study|Inappropriate enrollment|0
68880|NCT01026974|252497|P4|Overall Study|Adverse Event|1
68881|NCT01026974|252498|P3|Overall Study|Adverse Event|0
68882|NCT01026974|252499|P2|Overall Study|Adverse Event|0
68883|NCT01026974|252500|P1|Overall Study|Adverse Event|0
68884|NCT01026974|252497|P4|Overall Study|Lost to Follow-up|0
68885|NCT01026974|252498|P3|Overall Study|Lost to Follow-up|4
68886|NCT01026974|252499|P2|Overall Study|Lost to Follow-up|1
68887|NCT01026974|252500|P1|Overall Study|Lost to Follow-up|1
68888|NCT01026974|252497|P4|Overall Study|Withdrawal by Subject|2
68889|NCT01026974|252498|P3|Overall Study|Withdrawal by Subject|7
68890|NCT01026974|252499|P2|Overall Study|Withdrawal by Subject|1
68891|NCT01026974|252500|P1|Overall Study|Withdrawal by Subject|0
68892|NCT01026948|252557|P1|Overall Study|Physician Decision|8
68893|NCT01026831|252590|P2|Overall Study|Withdrawal by Subject|5
68894|NCT01026831|252591|P1|Overall Study|Withdrawal by Subject|7
68895|NCT01026831|252590|P2|Overall Study|Protocol Violation|2
68896|NCT01026831|252591|P1|Overall Study|Protocol Violation|0
68897|NCT01026831|252590|P2|Overall Study|Physician Decision|1
68898|NCT01026831|252591|P1|Overall Study|Physician Decision|1
68899|NCT01026831|252590|P2|Overall Study|Lost to Follow-up|0
68900|NCT01026831|252591|P1|Overall Study|Lost to Follow-up|2
68901|NCT01026831|252590|P2|Overall Study|Adverse Event|3
68902|NCT01026831|252591|P1|Overall Study|Adverse Event|4
68903|NCT01026818|252602|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
68904|NCT01026818|252603|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
68905|NCT01026818|252604|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
68906|NCT01026818|252605|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
68907|NCT01026818|252602|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
68908|NCT01026818|252603|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
68909|NCT01026818|252604|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
68910|NCT01026818|252605|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
68911|NCT01026818|252602|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
68912|NCT01026818|252603|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
68913|NCT01026818|252604|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
68914|NCT01026818|252605|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
68915|NCT01026818|252602|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
68916|NCT01026818|252603|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
68917|NCT01026818|252604|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
68918|NCT01026818|252605|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
68919|NCT01026818|252602|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
68920|NCT01026818|252603|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
68921|NCT01026818|252604|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
68922|NCT01026818|252605|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
68923|NCT01026818|252602|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
68924|NCT01026818|252603|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
68925|NCT01026818|252604|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
68926|NCT01026818|252605|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
68927|NCT01026818|252602|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
68928|NCT01026818|252603|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
68929|NCT01026818|252604|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
68930|NCT01026818|252605|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
68931|NCT01026818|252602|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
68932|NCT01026818|252603|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
68933|NCT01026818|252604|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
68934|NCT01026818|252605|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
68935|NCT01026818|252602|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
68936|NCT01026818|252603|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
68937|NCT01026818|252604|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
68938|NCT01026818|252605|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
68939|NCT01026818|252602|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
68940|NCT01026818|252603|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
68941|NCT01026818|252604|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
68942|NCT01026818|252605|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
68943|NCT01026818|252602|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
68944|NCT01026818|252603|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
68945|NCT01026818|252604|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
68946|NCT01026818|252605|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
68947|NCT01026818|252602|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
68948|NCT01026818|252603|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
68949|NCT01026818|252604|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
68950|NCT01026818|252605|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
68951|NCT01026818|252602|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
68952|NCT01026818|252603|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
68953|NCT01026818|252604|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
68954|NCT01026818|252605|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
68955|NCT01026818|252602|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
68956|NCT01026818|252603|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
68957|NCT01026818|252604|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
68958|NCT01026818|252605|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
68959|NCT01026818|252602|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
68960|NCT01026818|252603|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
68961|NCT01026818|252604|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
68962|NCT01026818|252605|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
68963|NCT01026818|252602|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
68964|NCT01026818|252603|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
68965|NCT01026818|252604|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
68966|NCT01026818|252605|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
68967|NCT01026818|252602|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
68968|NCT01026818|252603|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
68969|NCT01026818|252604|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
68970|NCT01026818|252605|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
68971|NCT01026818|252602|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
68972|NCT01026818|252603|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
68973|NCT01026818|252604|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
68974|NCT01026818|252605|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
68975|NCT01026818|252602|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
68976|NCT01026818|252603|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
68977|NCT01026818|252604|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
68978|NCT01026818|252605|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
68979|NCT01026818|252602|P4|Screening Period|Physician Decision|0
68980|NCT01026818|252603|P3|Screening Period|Physician Decision|0
68981|NCT01026818|252604|P2|Screening Period|Physician Decision|0
68982|NCT01026818|252605|P1|Screening Period|Physician Decision|1
68983|NCT01026818|252602|P4|Screening Period|Adverse Event|0
68984|NCT01026818|252603|P3|Screening Period|Adverse Event|0
68985|NCT01026818|252604|P2|Screening Period|Adverse Event|0
68986|NCT01026818|252605|P1|Screening Period|Adverse Event|2
68987|NCT01026818|252602|P4|Screening Period|Protocol Deviation|0
68988|NCT01026818|252603|P3|Screening Period|Protocol Deviation|0
68989|NCT01026818|252604|P2|Screening Period|Protocol Deviation|0
68990|NCT01026818|252605|P1|Screening Period|Protocol Deviation|3
68991|NCT01026818|252602|P4|Screening Period|Withdrawal by Subject|0
68992|NCT01026818|252603|P3|Screening Period|Withdrawal by Subject|0
68993|NCT01026818|252604|P2|Screening Period|Withdrawal by Subject|0
68994|NCT01026818|252605|P1|Screening Period|Withdrawal by Subject|49
68995|NCT01026818|252602|P4|Screening Period|Entry Criteria Not Met|0
68996|NCT01026818|252603|P3|Screening Period|Entry Criteria Not Met|0
68997|NCT01026818|252604|P2|Screening Period|Entry Criteria Not Met|0
68998|NCT01026818|252605|P1|Screening Period|Entry Criteria Not Met|105
68999|NCT01026792|252693|P1|Overall Study|Protocol Violation|1
69000|NCT01026454|252699|P2|Second Intervention|Pregnancy|1
69001|NCT01026454|252700|P1|Second Intervention|Pregnancy|1
69002|NCT01026389|253049|P2|Overall Study|change of treatment, patient moved|2
69003|NCT01026389|253050|P1|Overall Study|change of treatment, patient moved|4
69004|NCT01026389|253049|P2|Overall Study|Withdrawal by Subject|3
69005|NCT01026389|253050|P1|Overall Study|Withdrawal by Subject|1
69006|NCT01026324|253065|P3|Follow up/Survival|Withdrawal by Subject|0
69007|NCT01026324|253066|P2|Follow up/Survival|Withdrawal by Subject|0
69008|NCT01026324|253067|P1|Follow up/Survival|Withdrawal by Subject|1
69009|NCT01026194|253077|P2|Period 2：Open-label Period|Withdrawal by Subject|4
69010|NCT01026194|253078|P1|Period 2：Open-label Period|Withdrawal by Subject|0
69011|NCT01026194|253077|P2|Period 2：Open-label Period|Physician Decision|1
69012|NCT01026194|253078|P1|Period 2：Open-label Period|Physician Decision|3
69013|NCT01026194|253077|P2|Period 2：Open-label Period|Adverse Event|5
69014|NCT01026194|253078|P1|Period 2：Open-label Period|Adverse Event|4
69015|NCT01026194|253077|P2|Period 1：Double Blind Period|Physician Decision|4
69016|NCT01026194|253078|P1|Period 1：Double Blind Period|Physician Decision|0
69017|NCT01026194|253077|P2|Period 1：Double Blind Period|Lack of Efficacy|0
69018|NCT01026194|253078|P1|Period 1：Double Blind Period|Lack of Efficacy|1
69019|NCT01026194|253077|P2|Period 1：Double Blind Period|Adverse Event|1
69020|NCT01026194|253078|P1|Period 1：Double Blind Period|Adverse Event|2
69021|NCT01026142|253094|P2|Overall Study|Reasons not specified|23
69022|NCT01026142|253095|P1|Overall Study|Reasons not specified|25
69023|NCT01026142|253094|P2|Overall Study|Death|98
69024|NCT01026142|253095|P1|Overall Study|Death|114
69025|NCT01026103|253117|P1|Overall Study|did not receive study device bc of error|1
69026|NCT01026103|253117|P1|Overall Study|Physician Decision|1
69027|NCT01026038|253127|P3|Overall Study|Lost to Follow-up|0
69028|NCT01026038|253128|P2|Overall Study|Lost to Follow-up|1
69029|NCT01026038|253129|P1|Overall Study|Lost to Follow-up|1
69030|NCT01025843|253178|P10|Washout 4|Withdrawal by Subject|0
69031|NCT01025843|253179|P9|Washout 4|Withdrawal by Subject|0
69032|NCT01025843|253180|P8|Washout 4|Withdrawal by Subject|0
69033|NCT01025843|253181|P7|Washout 4|Withdrawal by Subject|0
69034|NCT01025843|253182|P6|Washout 4|Withdrawal by Subject|0
69035|NCT01025843|253183|P5|Washout 4|Withdrawal by Subject|0
69036|NCT01025843|253184|P4|Washout 4|Withdrawal by Subject|1
69037|NCT01025843|253185|P3|Washout 4|Withdrawal by Subject|1
69038|NCT01025843|253186|P2|Washout 4|Withdrawal by Subject|0
69039|NCT01025843|253187|P1|Washout 4|Withdrawal by Subject|0
69040|NCT01025817|253281|P2|Completed Study|Lost to Follow-up|1
69041|NCT01025817|253282|P1|Completed Study|Lost to Follow-up|0
69042|NCT01025817|253281|P2|Completed Study|Missing|0
69043|NCT01025817|253282|P1|Completed Study|Missing|2
69044|NCT01025817|253281|P2|Completed Study|Death|5
69045|NCT01025817|253282|P1|Completed Study|Death|6
69046|NCT01025817|253281|P2|Completed Study|Withdrawal by Subject|16
69047|NCT01025817|253282|P1|Completed Study|Withdrawal by Subject|8
69048|NCT01025817|253281|P2|Completed Study Medication|Lost to Follow-up|1
69049|NCT01025817|253282|P1|Completed Study Medication|Lost to Follow-up|0
69050|NCT01025817|253281|P2|Completed Study Medication|Subject no longer required study drug|1
69051|NCT01025817|253282|P1|Completed Study Medication|Subject no longer required study drug|0
69052|NCT01025817|253281|P2|Completed Study Medication|Abnormal lab values|2
69053|NCT01025817|253282|P1|Completed Study Medication|Abnormal lab values|0
69054|NCT01025817|253281|P2|Completed Study Medication|Death|2
69055|NCT01025817|253282|P1|Completed Study Medication|Death|2
69056|NCT01025817|253281|P2|Completed Study Medication|Graft loss|5
69057|NCT01025817|253282|P1|Completed Study Medication|Graft loss|2
69058|NCT01025817|253281|P2|Completed Study Medication|Abnormal test procedure|0
69059|NCT01025817|253282|P1|Completed Study Medication|Abnormal test procedure|4
69060|NCT01025817|253281|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
69061|NCT01025817|253282|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
69062|NCT01025817|253281|P2|Completed Study Medication|Administrative problems|5
69063|NCT01025817|253282|P1|Completed Study Medication|Administrative problems|7
69064|NCT01025817|253281|P2|Completed Study Medication|Withdrawal by Subject|9
69065|NCT01025817|253282|P1|Completed Study Medication|Withdrawal by Subject|8
69066|NCT01025817|253281|P2|Completed Study Medication|Protocol Deviation|8
69067|NCT01025817|253282|P1|Completed Study Medication|Protocol Deviation|9
69068|NCT01025817|253281|P2|Completed Study Medication|Adverse Event|39
69069|NCT01025817|253282|P1|Completed Study Medication|Adverse Event|66
69070|NCT01025635|253302|P2|Overall Study|Reason not known|2
69071|NCT01025635|253303|P1|Overall Study|Reason not known|4
69072|NCT01025635|253302|P2|Overall Study|Lost to Follow-up|13
69073|NCT01025635|253303|P1|Overall Study|Lost to Follow-up|9
69074|NCT01025635|253302|P2|Overall Study|Lack of Efficacy|1
69075|NCT01025635|253303|P1|Overall Study|Lack of Efficacy|0
69076|NCT01025635|253302|P2|Overall Study|Protocol Violation|2
69077|NCT01025635|253303|P1|Overall Study|Protocol Violation|4
69078|NCT01025635|253302|P2|Overall Study|Withdrawal by Subject|7
69079|NCT01025635|253303|P1|Overall Study|Withdrawal by Subject|6
69080|NCT01025336|253324|P5|Overall Study|Protocol Violation|0
69081|NCT01025336|253325|P4|Overall Study|Protocol Violation|2
69082|NCT01025336|253326|P3|Overall Study|Protocol Violation|0
69083|NCT01025336|253327|P2|Overall Study|Protocol Violation|0
69084|NCT01025336|253328|P1|Overall Study|Protocol Violation|0
69085|NCT01025232|253387|P2|Overall Study|Study drug no longer available|6
69086|NCT01025232|253388|P1|Overall Study|Study drug no longer available|3
69087|NCT01025154|253406|P1|Overall Study|Withdrawal by Subject|1
69088|NCT01025154|253406|P1|Overall Study|Lost to Follow-up|1
69089|NCT01025037|253415|P1|Overall Study|Withdrawal by Subject|1
69090|NCT01025037|253415|P1|Overall Study|Lost to Follow-up|7
69091|NCT01025037|253415|P1|Overall Study|Adverse Event|3
69092|NCT01024959|253437|P1|Overall Study|missing results required for analysis|17
69093|NCT01024959|253437|P1|Overall Study|results not evaluable|12
69094|NCT01024959|253437|P1|Overall Study|ineligible|12
69095|NCT01024946|253446|P1|Overall Study|Adverse Event|1
69096|NCT01024946|253446|P1|Overall Study|Withdrawal by Subject|1
69097|NCT01024946|253446|P1|Overall Study|Screen Failure|3
69098|NCT01024855|253450|P1|Overall Study|Inclusion/exclusion criteria|1
69099|NCT01024751|253457|P2|Eligible Participants|Ineligible|1
69100|NCT01024751|253458|P1|Eligible Participants|Ineligible|0
69101|NCT01024751|253457|P2|Eligible Participants|Lost to Follow-up|1
69102|NCT01024751|253458|P1|Eligible Participants|Lost to Follow-up|0
69103|NCT01024751|253457|P2|Eligible Participants|Withdrawal by Subject|1
69104|NCT01024751|253458|P1|Eligible Participants|Withdrawal by Subject|0
69105|NCT01024751|253457|P2|Enrolled Participants|Ineligible at baseline|4
69106|NCT01024751|253458|P1|Enrolled Participants|Ineligible at baseline|3
69107|NCT01024608|253481|P2|Overall Study|Never received study treatment|0
69108|NCT01024608|253482|P1|Overall Study|Never received study treatment|2
69109|NCT01024608|253481|P2|Overall Study|Protocol Violation|3
69110|NCT01024608|253482|P1|Overall Study|Protocol Violation|0
69111|NCT01024608|253481|P2|Overall Study|Lost to Follow-up|1
69112|NCT01024608|253482|P1|Overall Study|Lost to Follow-up|0
69113|NCT01024608|253481|P2|Overall Study|Withdrawal by Subject|0
69114|NCT01024608|253482|P1|Overall Study|Withdrawal by Subject|1
69115|NCT01024608|253481|P2|Overall Study|Adverse Event|0
69116|NCT01024608|253482|P1|Overall Study|Adverse Event|1
69117|NCT01024465|253494|P1|Overall Study|Physician Decision|1
69118|NCT01024465|253494|P1|Overall Study|Adverse Event|2
69119|NCT01024309|253511|P2|Overall Study|Withdrawal by Subject|4
69120|NCT01024309|253512|P1|Overall Study|Withdrawal by Subject|4
69121|NCT01024309|253511|P2|Overall Study|Physician Decision|0
69122|NCT01024309|253512|P1|Overall Study|Physician Decision|4
69123|NCT01024244|253539|P5|Overall Study|Withdrawal by Subject|0
69124|NCT01024244|253540|P4|Overall Study|Withdrawal by Subject|0
69125|NCT01024244|253541|P3|Overall Study|Withdrawal by Subject|0
69126|NCT01024244|253542|P2|Overall Study|Withdrawal by Subject|1
69127|NCT01024244|253543|P1|Overall Study|Withdrawal by Subject|0
69128|NCT01024244|253539|P5|Overall Study|Sponsor Decision|10
69129|NCT01024244|253540|P4|Overall Study|Sponsor Decision|12
69130|NCT01024244|253541|P3|Overall Study|Sponsor Decision|14
69131|NCT01024244|253542|P2|Overall Study|Sponsor Decision|7
69132|NCT01024244|253543|P1|Overall Study|Sponsor Decision|14
69133|NCT01024244|253539|P5|Overall Study|Protocol Violation|2
69134|NCT01024244|253540|P4|Overall Study|Protocol Violation|0
69135|NCT01024244|253541|P3|Overall Study|Protocol Violation|0
69136|NCT01024244|253542|P2|Overall Study|Protocol Violation|0
69137|NCT01024244|253543|P1|Overall Study|Protocol Violation|1
69138|NCT01024244|253539|P5|Overall Study|Lack of Efficacy|0
69139|NCT01024244|253540|P4|Overall Study|Lack of Efficacy|0
69140|NCT01024244|253541|P3|Overall Study|Lack of Efficacy|0
69141|NCT01024244|253542|P2|Overall Study|Lack of Efficacy|0
69142|NCT01024244|253543|P1|Overall Study|Lack of Efficacy|1
69143|NCT01024244|253539|P5|Overall Study|Entry Criteria Not Met|0
69144|NCT01024244|253540|P4|Overall Study|Entry Criteria Not Met|0
69145|NCT01024244|253541|P3|Overall Study|Entry Criteria Not Met|0
69146|NCT01024244|253542|P2|Overall Study|Entry Criteria Not Met|1
69147|NCT01024244|253543|P1|Overall Study|Entry Criteria Not Met|0
69148|NCT01024244|253539|P5|Overall Study|Adverse Event|2
69149|NCT01024244|253540|P4|Overall Study|Adverse Event|1
69150|NCT01024244|253541|P3|Overall Study|Adverse Event|0
69151|NCT01024244|253542|P2|Overall Study|Adverse Event|2
69152|NCT01024244|253543|P1|Overall Study|Adverse Event|1
69153|NCT01024036|253657|P2|Unblinded Treatment|Lack of Efficacy|0
69154|NCT01024036|253658|P1|Unblinded Treatment|Lack of Efficacy|2
69155|NCT01024036|253657|P2|Unblinded Treatment|Adverse Event|0
69156|NCT01024036|253658|P1|Unblinded Treatment|Adverse Event|1
69157|NCT01024036|253657|P2|Blinded Treatment|Withdrawal by Subject|3
69158|NCT01024036|253658|P1|Blinded Treatment|Withdrawal by Subject|4
69159|NCT01024036|253657|P2|Blinded Treatment|Death|2
69160|NCT01024036|253658|P1|Blinded Treatment|Death|0
69161|NCT01024036|253657|P2|Blinded Treatment|Physician Decision|0
69162|NCT01024036|253658|P1|Blinded Treatment|Physician Decision|1
69163|NCT01024036|253657|P2|Blinded Treatment|Lack of Efficacy|14
69164|NCT01024036|253658|P1|Blinded Treatment|Lack of Efficacy|16
69165|NCT01024036|253657|P2|Blinded Treatment|Adverse Event|1
69166|NCT01024036|253658|P1|Blinded Treatment|Adverse Event|1
69167|NCT01023815|253707|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
69168|NCT01023815|253708|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
69169|NCT01023815|253709|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
69170|NCT01023815|253710|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
69171|NCT01023815|253707|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
69172|NCT01023815|253708|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
69173|NCT01023815|253709|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
69174|NCT01023815|253710|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
69175|NCT01023815|253707|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
69176|NCT01023815|253708|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
69177|NCT01023815|253709|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
69178|NCT01023815|253710|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
69179|NCT01023815|253707|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
69180|NCT01023815|253708|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
69181|NCT01023815|253709|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
69182|NCT01023815|253710|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
69183|NCT01023815|253707|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
69184|NCT01023815|253708|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
69185|NCT01023815|253709|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
69186|NCT01023815|253710|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
69187|NCT01023672|253748|P1|Overall Study|Death|1
69188|NCT01023672|253748|P1|Overall Study|Worsening disease|2
69189|NCT01023659|253755|P3|Overall Study|Lost to Follow-up|102
69190|NCT01023659|253756|P2|Overall Study|Lost to Follow-up|251
69191|NCT01023659|253757|P1|Overall Study|Lost to Follow-up|73
69192|NCT01023581|253773|P7|Overall Study|Other|0
69193|NCT01023581|253774|P6|Overall Study|Other|0
69194|NCT01023581|253775|P5|Overall Study|Other|1
69195|NCT01023581|253776|P4|Overall Study|Other|0
69196|NCT01023581|253777|P3|Overall Study|Other|1
69197|NCT01023581|253778|P2|Overall Study|Other|0
69198|NCT01023581|253779|P1|Overall Study|Other|1
69199|NCT01023581|253773|P7|Overall Study|Physician Decision|1
69200|NCT01023581|253774|P6|Overall Study|Physician Decision|1
69201|NCT01023581|253775|P5|Overall Study|Physician Decision|1
69202|NCT01023581|253776|P4|Overall Study|Physician Decision|1
69203|NCT01023581|253777|P3|Overall Study|Physician Decision|2
69204|NCT01023581|253778|P2|Overall Study|Physician Decision|0
69205|NCT01023581|253779|P1|Overall Study|Physician Decision|2
69206|NCT01023581|253773|P7|Overall Study|Lack of Efficacy|1
69207|NCT01023581|253774|P6|Overall Study|Lack of Efficacy|2
69208|NCT01023581|253775|P5|Overall Study|Lack of Efficacy|1
69209|NCT01023581|253776|P4|Overall Study|Lack of Efficacy|2
69210|NCT01023581|253777|P3|Overall Study|Lack of Efficacy|6
69211|NCT01023581|253778|P2|Overall Study|Lack of Efficacy|3
69212|NCT01023581|253779|P1|Overall Study|Lack of Efficacy|9
69213|NCT01023581|253773|P7|Overall Study|Pregnancy|0
69214|NCT01023581|253774|P6|Overall Study|Pregnancy|1
69215|NCT01023581|253775|P5|Overall Study|Pregnancy|0
69216|NCT01023581|253776|P4|Overall Study|Pregnancy|2
69217|NCT01023581|253777|P3|Overall Study|Pregnancy|0
69218|NCT01023581|253778|P2|Overall Study|Pregnancy|0
69219|NCT01023581|253779|P1|Overall Study|Pregnancy|0
69220|NCT01023581|253773|P7|Overall Study|Withdrawal by Subject|5
69221|NCT01023581|253774|P6|Overall Study|Withdrawal by Subject|8
69222|NCT01023581|253775|P5|Overall Study|Withdrawal by Subject|6
69223|NCT01023581|253776|P4|Overall Study|Withdrawal by Subject|10
69224|NCT01023581|253777|P3|Overall Study|Withdrawal by Subject|16
69225|NCT01023581|253778|P2|Overall Study|Withdrawal by Subject|8
69226|NCT01023581|253779|P1|Overall Study|Withdrawal by Subject|13
69227|NCT01023581|253773|P7|Overall Study|Lost to Follow-up|2
69228|NCT01023581|253774|P6|Overall Study|Lost to Follow-up|2
69229|NCT01023581|253775|P5|Overall Study|Lost to Follow-up|5
69230|NCT01023581|253776|P4|Overall Study|Lost to Follow-up|2
69231|NCT01023581|253777|P3|Overall Study|Lost to Follow-up|7
69232|NCT01023581|253778|P2|Overall Study|Lost to Follow-up|8
69233|NCT01023581|253779|P1|Overall Study|Lost to Follow-up|4
69234|NCT01023581|253773|P7|Overall Study|Major protocol deviation|0
69235|NCT01023581|253774|P6|Overall Study|Major protocol deviation|0
69236|NCT01023581|253775|P5|Overall Study|Major protocol deviation|0
69237|NCT01023581|253776|P4|Overall Study|Major protocol deviation|0
69238|NCT01023581|253777|P3|Overall Study|Major protocol deviation|3
69239|NCT01023581|253778|P2|Overall Study|Major protocol deviation|0
69240|NCT01023581|253779|P1|Overall Study|Major protocol deviation|2
69241|NCT01023581|253773|P7|Overall Study|Adverse Event|11
69242|NCT01023581|253774|P6|Overall Study|Adverse Event|5
69243|NCT01023581|253775|P5|Overall Study|Adverse Event|2
69244|NCT01023581|253776|P4|Overall Study|Adverse Event|3
69245|NCT01023581|253777|P3|Overall Study|Adverse Event|7
69246|NCT01023581|253778|P2|Overall Study|Adverse Event|4
69247|NCT01023581|253779|P1|Overall Study|Adverse Event|4
69248|NCT01023516|253836|P2|Overall Study|Incorrect enrolment|2
69249|NCT01023516|253837|P1|Overall Study|Incorrect enrolment|4
69250|NCT01023516|253836|P2|Overall Study|Study-specific criteria|2
69251|NCT01023516|253837|P1|Overall Study|Study-specific criteria|4
69252|NCT01023516|253836|P2|Overall Study|Safety reason|3
69253|NCT01023516|253837|P1|Overall Study|Safety reason|0
69254|NCT01023516|253836|P2|Overall Study|Adverse Event|6
69255|NCT01023516|253837|P1|Overall Study|Adverse Event|9
69256|NCT01023516|253836|P2|Overall Study|Voluntary discontinuation|5
69257|NCT01023516|253837|P1|Overall Study|Voluntary discontinuation|7
69258|NCT01023308|253919|P2|Overall Study|Withdrawal by Subject|18
69259|NCT01023308|253920|P1|Overall Study|Withdrawal by Subject|34
69260|NCT01023308|253919|P2|Overall Study|Lost to Follow-up|0
69261|NCT01023308|253920|P1|Overall Study|Lost to Follow-up|1
69262|NCT01023308|253919|P2|Overall Study|Untreated|5
69263|NCT01023308|253920|P1|Overall Study|Untreated|5
69264|NCT01023308|253919|P2|Overall Study|Protocol Violation|4
69265|NCT01023308|253920|P1|Overall Study|Protocol Violation|3
69266|NCT01023308|253919|P2|Overall Study|New Cancer therapy|7
69267|NCT01023308|253920|P1|Overall Study|New Cancer therapy|4
69268|NCT01023308|253919|P2|Overall Study|Disease progression|153
69269|NCT01023308|253920|P1|Overall Study|Disease progression|82
69270|NCT01023308|253919|P2|Overall Study|Death|17
69271|NCT01023308|253920|P1|Overall Study|Death|21
69272|NCT01023308|253919|P2|Overall Study|Adverse Event|66
69273|NCT01023308|253920|P1|Overall Study|Adverse Event|130
69274|NCT01023308|253919|P2|Overall Study|Administrative problems|1
69275|NCT01023308|253920|P1|Overall Study|Administrative problems|2
69276|NCT01023308|253919|P2|Overall Study|Abnormal test proceedure results|8
69277|NCT01023308|253920|P1|Overall Study|Abnormal test proceedure results|3
69278|NCT01023256|253950|P4|Overall Study|Withdrawal by Subject|2
69279|NCT01023256|253951|P3|Overall Study|Withdrawal by Subject|0
69280|NCT01023256|253952|P2|Overall Study|Withdrawal by Subject|0
69281|NCT01023256|253953|P1|Overall Study|Withdrawal by Subject|0
69282|NCT01023256|253950|P4|Overall Study|Adverse Event|1
69283|NCT01023256|253951|P3|Overall Study|Adverse Event|0
69284|NCT01023256|253952|P2|Overall Study|Adverse Event|0
69285|NCT01023256|253953|P1|Overall Study|Adverse Event|0
69286|NCT01023256|253950|P4|Overall Study|Not specified|2
69287|NCT01023256|253951|P3|Overall Study|Not specified|0
69288|NCT01023256|253952|P2|Overall Study|Not specified|0
69289|NCT01023256|253953|P1|Overall Study|Not specified|1
69290|NCT01023256|253950|P4|Overall Study|Randomized but not treated|0
69291|NCT01023256|253951|P3|Overall Study|Randomized but not treated|1
69292|NCT01023256|253952|P2|Overall Study|Randomized but not treated|0
69293|NCT01023256|253953|P1|Overall Study|Randomized but not treated|1
69294|NCT01023256|253950|P4|Overall Study|Protocol Violation|0
69295|NCT01023256|253951|P3|Overall Study|Protocol Violation|0
69296|NCT01023256|253952|P2|Overall Study|Protocol Violation|3
69297|NCT01023256|253953|P1|Overall Study|Protocol Violation|2
69298|NCT01023217|253995|P2|Overall Study|Withdrawal by Subject|0
69299|NCT01023217|253996|P1|Overall Study|Withdrawal by Subject|1
69300|NCT01023035|254037|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
69301|NCT01023035|254038|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
69302|NCT01023035|254039|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
69303|NCT01023035|254037|P3|Follow-up Period (up to Week 72)|Adverse Event|1
69304|NCT01023035|254038|P2|Follow-up Period (up to Week 72)|Adverse Event|0
69305|NCT01023035|254039|P1|Follow-up Period (up to Week 72)|Adverse Event|2
69306|NCT01023035|254037|P3|Treatment Period|Treatment Failure|24
69307|NCT01023035|254038|P2|Treatment Period|Treatment Failure|31
69308|NCT01023035|254039|P1|Treatment Period|Treatment Failure|26
69309|NCT01023035|254037|P3|Treatment Period|Non-Medical Reasons|44
69310|NCT01023035|254038|P2|Treatment Period|Non-Medical Reasons|22
69311|NCT01023035|254039|P1|Treatment Period|Non-Medical Reasons|19
69312|NCT01023035|254037|P3|Treatment Period|Adverse Event|50
69313|NCT01023035|254038|P2|Treatment Period|Adverse Event|32
69314|NCT01023035|254039|P1|Treatment Period|Adverse Event|27
69315|NCT01023022|254049|P1|Overall Study|due to technical issues|2
69316|NCT01023022|254049|P1|Overall Study|Lost to Follow-up|7
69317|NCT01023022|254049|P1|Overall Study|Death|5
69318|NCT01022502|254055|P1|Overall Study|Withdrawal by Subject|1
69319|NCT01022502|254055|P1|Overall Study|employment related reasons|1
69320|NCT01022502|254055|P1|Overall Study|Adverse Event|1
69321|NCT01022996|254069|P1|Overall Study|Protocol Violation|1
69322|NCT01022996|254069|P1|Overall Study|Disease Progression|32
69323|NCT01022996|254069|P1|Overall Study|Administrative problems|6
69324|NCT01022996|254069|P1|Overall Study|Lost to Follow-up|1
69325|NCT01022996|254069|P1|Overall Study|Withdrawal by Subject|3
69326|NCT01022996|254069|P1|Overall Study|Adverse Event|14
69327|NCT01022762|254080|P2|Overall Study|Unclassified|20
69328|NCT01022762|254081|P1|Overall Study|Unclassified|12
69329|NCT01022762|254080|P2|Overall Study|Protocol Violation|6
69330|NCT01022762|254081|P1|Overall Study|Protocol Violation|7
69331|NCT01022762|254080|P2|Overall Study|Lack of Efficacy|1
69332|NCT01022762|254081|P1|Overall Study|Lack of Efficacy|0
69333|NCT01022762|254080|P2|Overall Study|Adverse Event|1
69334|NCT01022762|254081|P1|Overall Study|Adverse Event|3
69335|NCT01022398|254109|P2|Overall Study|Study terminated|2
69336|NCT01022398|254110|P1|Overall Study|Study terminated|2
69337|NCT01022203|254135|P2|Follow-Up Assessment|Lost to Follow-up|2
69338|NCT01022203|254136|P1|Follow-Up Assessment|Lost to Follow-up|2
69339|NCT01022203|254135|P2|Post Treatment Assessment|Adverse Event|2
69340|NCT01022203|254136|P1|Post Treatment Assessment|Adverse Event|0
69341|NCT01022203|254135|P2|Post Treatment Assessment|Physician Decision|0
69342|NCT01022203|254136|P1|Post Treatment Assessment|Physician Decision|2
69343|NCT01022203|254135|P2|Post Treatment Assessment|Withdrawal by Subject|12
69344|NCT01022203|254136|P1|Post Treatment Assessment|Withdrawal by Subject|12
69345|NCT01022112|254155|P5|Overall Study|Fasting plasma glucose level increased|7
69346|NCT01022112|254156|P4|Overall Study|Fasting plasma glucose level increased|0
69347|NCT01022112|254157|P3|Overall Study|Fasting plasma glucose level increased|0
69348|NCT01022112|254158|P2|Overall Study|Fasting plasma glucose level increased|0
69349|NCT01022112|254159|P1|Overall Study|Fasting plasma glucose level increased|1
69350|NCT01022112|254155|P5|Overall Study|Withdrawal by Subject|1
69351|NCT01022112|254156|P4|Overall Study|Withdrawal by Subject|2
69352|NCT01022112|254157|P3|Overall Study|Withdrawal by Subject|2
69353|NCT01022112|254158|P2|Overall Study|Withdrawal by Subject|1
69354|NCT01022112|254159|P1|Overall Study|Withdrawal by Subject|0
69355|NCT01022112|254155|P5|Overall Study|Physician Decision|1
69356|NCT01022112|254156|P4|Overall Study|Physician Decision|0
69357|NCT01022112|254157|P3|Overall Study|Physician Decision|1
69358|NCT01022112|254158|P2|Overall Study|Physician Decision|0
69359|NCT01022112|254159|P1|Overall Study|Physician Decision|0
69360|NCT01022112|254155|P5|Overall Study|Lack of Efficacy|1
69361|NCT01022112|254156|P4|Overall Study|Lack of Efficacy|0
69362|NCT01022112|254157|P3|Overall Study|Lack of Efficacy|0
69363|NCT01022112|254158|P2|Overall Study|Lack of Efficacy|0
69364|NCT01022112|254159|P1|Overall Study|Lack of Efficacy|1
69365|NCT01022112|254155|P5|Overall Study|Adverse Event|0
69366|NCT01022112|254156|P4|Overall Study|Adverse Event|1
69367|NCT01022112|254157|P3|Overall Study|Adverse Event|0
69368|NCT01022112|254158|P2|Overall Study|Adverse Event|2
69369|NCT01022112|254159|P1|Overall Study|Adverse Event|1
69370|NCT01021878|254182|P2|Overall Study|Transplantation|1
69371|NCT01021878|254183|P1|Overall Study|Transplantation|6
69372|NCT01021878|254182|P2|Overall Study|Adverse Event|5
69373|NCT01021878|254183|P1|Overall Study|Adverse Event|6
69374|NCT01021878|254182|P2|Overall Study|Death|1
69375|NCT01021878|254183|P1|Overall Study|Death|0
69376|NCT01021878|254182|P2|Overall Study|Lost to Follow-up|3
69377|NCT01021878|254183|P1|Overall Study|Lost to Follow-up|4
69378|NCT01021852|254205|P8|Treatment Period 2|Withdrawal by Subject|2
69379|NCT01021852|254206|P7|Treatment Period 2|Withdrawal by Subject|1
69380|NCT01021852|254207|P6|Treatment Period 2|Withdrawal by Subject|0
69381|NCT01021852|254208|P5|Treatment Period 2|Withdrawal by Subject|0
69382|NCT01021852|254209|P4|Treatment Period 2|Withdrawal by Subject|0
69383|NCT01021852|254210|P3|Treatment Period 2|Withdrawal by Subject|0
69384|NCT01021852|254211|P2|Treatment Period 2|Withdrawal by Subject|0
69385|NCT01021852|254212|P1|Treatment Period 2|Withdrawal by Subject|0
69386|NCT01021852|254205|P8|Treatment Period 2|Protocol Violation|0
69387|NCT01021852|254206|P7|Treatment Period 2|Protocol Violation|1
69388|NCT01021852|254207|P6|Treatment Period 2|Protocol Violation|0
69389|NCT01021852|254208|P5|Treatment Period 2|Protocol Violation|1
69390|NCT01021852|254209|P4|Treatment Period 2|Protocol Violation|0
69391|NCT01021852|254210|P3|Treatment Period 2|Protocol Violation|0
69392|NCT01021852|254211|P2|Treatment Period 2|Protocol Violation|0
69393|NCT01021852|254212|P1|Treatment Period 2|Protocol Violation|0
69394|NCT01021852|254205|P8|Treatment Period 2|Physician Decision|0
69395|NCT01021852|254206|P7|Treatment Period 2|Physician Decision|0
69396|NCT01021852|254207|P6|Treatment Period 2|Physician Decision|0
69397|NCT01021852|254208|P5|Treatment Period 2|Physician Decision|0
69398|NCT01021852|254209|P4|Treatment Period 2|Physician Decision|0
69399|NCT01021852|254210|P3|Treatment Period 2|Physician Decision|1
69400|NCT01021852|254211|P2|Treatment Period 2|Physician Decision|0
69401|NCT01021852|254212|P1|Treatment Period 2|Physician Decision|0
69402|NCT01021852|254205|P8|Treatment Period 2|Lack of Efficacy|0
69403|NCT01021852|254206|P7|Treatment Period 2|Lack of Efficacy|0
69404|NCT01021852|254207|P6|Treatment Period 2|Lack of Efficacy|1
69405|NCT01021852|254208|P5|Treatment Period 2|Lack of Efficacy|0
69406|NCT01021852|254209|P4|Treatment Period 2|Lack of Efficacy|0
69407|NCT01021852|254210|P3|Treatment Period 2|Lack of Efficacy|0
69408|NCT01021852|254211|P2|Treatment Period 2|Lack of Efficacy|0
69409|NCT01021852|254212|P1|Treatment Period 2|Lack of Efficacy|0
69410|NCT01021852|254205|P8|Treatment Period 2|Adverse Event|0
69411|NCT01021852|254206|P7|Treatment Period 2|Adverse Event|1
69412|NCT01021852|254207|P6|Treatment Period 2|Adverse Event|0
69413|NCT01021852|254208|P5|Treatment Period 2|Adverse Event|1
69414|NCT01021852|254209|P4|Treatment Period 2|Adverse Event|0
69415|NCT01021852|254210|P3|Treatment Period 2|Adverse Event|0
69416|NCT01021852|254211|P2|Treatment Period 2|Adverse Event|1
69417|NCT01021852|254212|P1|Treatment Period 2|Adverse Event|0
69418|NCT01021852|254205|P8|Washout Period-No Drug|Adverse Event|0
69419|NCT01021852|254206|P7|Washout Period-No Drug|Adverse Event|0
69420|NCT01021852|254207|P6|Washout Period-No Drug|Adverse Event|1
69421|NCT01021852|254208|P5|Washout Period-No Drug|Adverse Event|0
69422|NCT01021852|254209|P4|Washout Period-No Drug|Adverse Event|0
69423|NCT01021852|254210|P3|Washout Period-No Drug|Adverse Event|0
69424|NCT01021852|254211|P2|Washout Period-No Drug|Adverse Event|0
69425|NCT01021852|254212|P1|Washout Period-No Drug|Adverse Event|1
69426|NCT01021852|254205|P8|Washout Period-Placebo|Protocol Violation|0
69427|NCT01021852|254206|P7|Washout Period-Placebo|Protocol Violation|1
69428|NCT01021852|254207|P6|Washout Period-Placebo|Protocol Violation|0
69429|NCT01021852|254208|P5|Washout Period-Placebo|Protocol Violation|0
69430|NCT01021852|254209|P4|Washout Period-Placebo|Protocol Violation|0
69431|NCT01021852|254210|P3|Washout Period-Placebo|Protocol Violation|0
69432|NCT01021852|254211|P2|Washout Period-Placebo|Protocol Violation|0
69433|NCT01021852|254212|P1|Washout Period-Placebo|Protocol Violation|0
69434|NCT01021852|254205|P8|Washout Period-Placebo|Lost to Follow-up|0
69435|NCT01021852|254206|P7|Washout Period-Placebo|Lost to Follow-up|0
69436|NCT01021852|254207|P6|Washout Period-Placebo|Lost to Follow-up|0
69437|NCT01021852|254208|P5|Washout Period-Placebo|Lost to Follow-up|1
69438|NCT01021852|254209|P4|Washout Period-Placebo|Lost to Follow-up|0
69439|NCT01021852|254210|P3|Washout Period-Placebo|Lost to Follow-up|0
69440|NCT01021852|254211|P2|Washout Period-Placebo|Lost to Follow-up|0
69441|NCT01021852|254212|P1|Washout Period-Placebo|Lost to Follow-up|0
69442|NCT01021852|254205|P8|Washout Period-Placebo|Adverse Event|0
69443|NCT01021852|254206|P7|Washout Period-Placebo|Adverse Event|0
69444|NCT01021852|254207|P6|Washout Period-Placebo|Adverse Event|1
69445|NCT01021852|254208|P5|Washout Period-Placebo|Adverse Event|0
69446|NCT01021852|254209|P4|Washout Period-Placebo|Adverse Event|1
69447|NCT01021852|254210|P3|Washout Period-Placebo|Adverse Event|0
69448|NCT01021852|254211|P2|Washout Period-Placebo|Adverse Event|0
69449|NCT01021852|254212|P1|Washout Period-Placebo|Adverse Event|0
69450|NCT01021852|254205|P8|Treatment Period 1|Not Treated|0
69451|NCT01021852|254206|P7|Treatment Period 1|Not Treated|0
69452|NCT01021852|254207|P6|Treatment Period 1|Not Treated|0
69453|NCT01021852|254208|P5|Treatment Period 1|Not Treated|0
69454|NCT01021852|254209|P4|Treatment Period 1|Not Treated|2
69455|NCT01021852|254210|P3|Treatment Period 1|Not Treated|0
69456|NCT01021852|254211|P2|Treatment Period 1|Not Treated|0
69457|NCT01021852|254212|P1|Treatment Period 1|Not Treated|0
69458|NCT01021852|254205|P8|Treatment Period 1|Withdrawal by Subject|1
69459|NCT01021852|254206|P7|Treatment Period 1|Withdrawal by Subject|0
69460|NCT01021852|254207|P6|Treatment Period 1|Withdrawal by Subject|0
69461|NCT01021852|254208|P5|Treatment Period 1|Withdrawal by Subject|1
69462|NCT01021852|254209|P4|Treatment Period 1|Withdrawal by Subject|0
69463|NCT01021852|254210|P3|Treatment Period 1|Withdrawal by Subject|0
69464|NCT01021852|254211|P2|Treatment Period 1|Withdrawal by Subject|0
69465|NCT01021852|254212|P1|Treatment Period 1|Withdrawal by Subject|0
69466|NCT01021852|254205|P8|Treatment Period 1|Pregnancy|0
69467|NCT01021852|254206|P7|Treatment Period 1|Pregnancy|0
69468|NCT01021852|254207|P6|Treatment Period 1|Pregnancy|0
69469|NCT01021852|254208|P5|Treatment Period 1|Pregnancy|0
69470|NCT01021852|254209|P4|Treatment Period 1|Pregnancy|0
69471|NCT01021852|254210|P3|Treatment Period 1|Pregnancy|1
69472|NCT01021852|254211|P2|Treatment Period 1|Pregnancy|0
69473|NCT01021852|254212|P1|Treatment Period 1|Pregnancy|0
69474|NCT01021852|254205|P8|Treatment Period 1|Adverse Event|0
69475|NCT01021852|254206|P7|Treatment Period 1|Adverse Event|0
69476|NCT01021852|254207|P6|Treatment Period 1|Adverse Event|2
69477|NCT01021852|254208|P5|Treatment Period 1|Adverse Event|2
69478|NCT01021852|254209|P4|Treatment Period 1|Adverse Event|0
69479|NCT01021852|254210|P3|Treatment Period 1|Adverse Event|1
69480|NCT01021852|254211|P2|Treatment Period 1|Adverse Event|1
69481|NCT01021852|254212|P1|Treatment Period 1|Adverse Event|3
69482|NCT01021813|254248|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
69483|NCT01021813|254249|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
69484|NCT01021813|254250|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
69485|NCT01021813|254251|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
69486|NCT01021813|254252|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
69487|NCT01021813|254248|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
69488|NCT01021813|254249|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
69489|NCT01021813|254250|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
69490|NCT01021813|254251|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
69491|NCT01021813|254252|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
69492|NCT01021813|254248|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
69493|NCT01021813|254249|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
69494|NCT01021813|254250|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
69495|NCT01021813|254251|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
69496|NCT01021813|254252|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
69497|NCT01021813|254248|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
69498|NCT01021813|254249|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
69499|NCT01021813|254250|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
69500|NCT01021813|254251|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
69501|NCT01021813|254252|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
69502|NCT01021813|254248|P5|DB Randomized Discontinuation Phase|Adverse Event|1
69503|NCT01021813|254249|P4|DB Randomized Discontinuation Phase|Adverse Event|3
69504|NCT01021813|254250|P3|DB Randomized Discontinuation Phase|Adverse Event|0
69505|NCT01021813|254251|P2|DB Randomized Discontinuation Phase|Adverse Event|0
69506|NCT01021813|254252|P1|DB Randomized Discontinuation Phase|Adverse Event|0
69507|NCT01021813|254248|P5|DB Treatment Phase|Withdrawal by Subject|0
69508|NCT01021813|254249|P4|DB Treatment Phase|Withdrawal by Subject|0
69509|NCT01021813|254250|P3|DB Treatment Phase|Withdrawal by Subject|0
69510|NCT01021813|254251|P2|DB Treatment Phase|Withdrawal by Subject|24
69511|NCT01021813|254252|P1|DB Treatment Phase|Withdrawal by Subject|60
69512|NCT01021813|254248|P5|DB Treatment Phase|Protocol Violation|0
69513|NCT01021813|254249|P4|DB Treatment Phase|Protocol Violation|0
69514|NCT01021813|254250|P3|DB Treatment Phase|Protocol Violation|0
69515|NCT01021813|254251|P2|DB Treatment Phase|Protocol Violation|3
69516|NCT01021813|254252|P1|DB Treatment Phase|Protocol Violation|4
69517|NCT01021813|254248|P5|DB Treatment Phase|Pregnancy|0
69518|NCT01021813|254249|P4|DB Treatment Phase|Pregnancy|0
69519|NCT01021813|254250|P3|DB Treatment Phase|Pregnancy|0
69520|NCT01021813|254251|P2|DB Treatment Phase|Pregnancy|0
69521|NCT01021813|254252|P1|DB Treatment Phase|Pregnancy|1
69522|NCT01021813|254248|P5|DB Treatment Phase|Physician Decision|0
69523|NCT01021813|254249|P4|DB Treatment Phase|Physician Decision|0
69524|NCT01021813|254250|P3|DB Treatment Phase|Physician Decision|0
69525|NCT01021813|254251|P2|DB Treatment Phase|Physician Decision|8
69526|NCT01021813|254252|P1|DB Treatment Phase|Physician Decision|17
69527|NCT01021813|254248|P5|DB Treatment Phase|Lost to Follow-up|0
69528|NCT01021813|254249|P4|DB Treatment Phase|Lost to Follow-up|0
69529|NCT01021813|254250|P3|DB Treatment Phase|Lost to Follow-up|0
69530|NCT01021813|254251|P2|DB Treatment Phase|Lost to Follow-up|12
69531|NCT01021813|254252|P1|DB Treatment Phase|Lost to Follow-up|14
69532|NCT01021813|254248|P5|DB Treatment Phase|Lack of Efficacy|0
69533|NCT01021813|254249|P4|DB Treatment Phase|Lack of Efficacy|0
69534|NCT01021813|254250|P3|DB Treatment Phase|Lack of Efficacy|0
69535|NCT01021813|254251|P2|DB Treatment Phase|Lack of Efficacy|28
69536|NCT01021813|254252|P1|DB Treatment Phase|Lack of Efficacy|44
69537|NCT01021813|254248|P5|DB Treatment Phase|Adverse Event|0
69538|NCT01021813|254249|P4|DB Treatment Phase|Adverse Event|0
69539|NCT01021813|254250|P3|DB Treatment Phase|Adverse Event|0
69540|NCT01021813|254251|P2|DB Treatment Phase|Adverse Event|22
69541|NCT01021813|254252|P1|DB Treatment Phase|Adverse Event|60
69542|NCT01021683|254304|P1|Overall Study|unspecified|8
69543|NCT01021683|254304|P1|Overall Study|Recovery of neutrophil count|51
69544|NCT01021683|254304|P1|Overall Study|Lack of Efficacy|12
69545|NCT01020526|254327|P1|Overall Study|Adverse Event|2
69546|NCT01020526|254327|P1|Overall Study|Lost to Follow-up|1
69547|NCT01020526|254327|P1|Overall Study|Insufficient clinical response|3
69548|NCT01020526|254327|P1|Overall Study|Other reasons|3
69549|NCT01020526|254327|P1|Overall Study|Withdrawal by Subject|5
69550|NCT01020474|254333|P2|Overall Study|Insufficient Clinical Response|3
69551|NCT01020474|254334|P1|Overall Study|Insufficient Clinical Response|0
69552|NCT01020474|254333|P2|Overall Study|Other Reasons|1
69553|NCT01020474|254334|P1|Overall Study|Other Reasons|1
69554|NCT01020474|254333|P2|Overall Study|Withdrawal by Subject|7
69555|NCT01020474|254334|P1|Overall Study|Withdrawal by Subject|5
69556|NCT01020474|254333|P2|Overall Study|Protocol Violation|2
69557|NCT01020474|254334|P1|Overall Study|Protocol Violation|0
69558|NCT01020474|254333|P2|Overall Study|Adverse Event|4
69559|NCT01020474|254334|P1|Overall Study|Adverse Event|4
69560|NCT01020448|254354|P1|Treatment|Lost to Follow-up|2
69561|NCT01020448|254354|P1|Treatment|Lack of Efficacy|8
69562|NCT01020448|254354|P1|Treatment|Disease Progression|2
69563|NCT01020448|254354|P1|Treatment|Consent Withdrawn|3
69564|NCT01020448|254354|P1|Treatment|Adverse Event|11
69565|NCT01020448|254354|P1|Pre-assignment|Does Not Meet Entry Criteria|2
69566|NCT01020448|254354|P1|Pre-assignment|Withdrawal by Subject|5
69567|NCT01020448|254354|P1|Pre-assignment|Adverse Event|6
69568|NCT01021423|254365|P2|Overall Study|Study terminated|5
69569|NCT01021423|254366|P1|Overall Study|Study terminated|4
69570|NCT01021332|254382|P1|Overall Study|Miscellaneous|3
69571|NCT01021332|254382|P1|Overall Study|Protocol Violation|9
69572|NCT01021332|254382|P1|Overall Study|Lost to Follow-up|4
69573|NCT01021332|254382|P1|Overall Study|Withdrawal of Consent|23
69574|NCT01021332|254382|P1|Overall Study|Lack of Efficacy|19
69575|NCT01021332|254382|P1|Overall Study|Adverse Event|43
69576|NCT01021332|254382|P1|Overall Study|Not fulfilling incl./excl.criteria|5
69577|NCT01021215|254443|P2|Overall Study|Lost to Follow-up|0
69578|NCT01021215|254444|P1|Overall Study|Lost to Follow-up|3
69579|NCT01021020|254454|P1|14 Day Washout Period A|Physician Decision|1
69580|NCT01021020|254454|P1|Period I|Withdrawal by Subject|1
69581|NCT01021020|254454|P1|Period I|Protocol Violation|1
69582|NCT01021007|254470|P2|Overall Study|Adverse Event|3
69583|NCT01021007|254471|P1|Overall Study|Adverse Event|1
69584|NCT01021007|254470|P2|Overall Study|Lost to Follow-up|1
69585|NCT01021007|254471|P1|Overall Study|Lost to Follow-up|1
69586|NCT01020981|254483|P2|Overall Study|Participant declined to complete survey|0
69587|NCT01020981|254484|P1|Overall Study|Participant declined to complete survey|2
69588|NCT01020981|254483|P2|Overall Study|Survey returned undeliverable|32
69589|NCT01020981|254484|P1|Overall Study|Survey returned undeliverable|8
69590|NCT01020981|254483|P2|Overall Study|Did not return mailed survey|58
69591|NCT01020981|254484|P1|Overall Study|Did not return mailed survey|74
69592|NCT01020877|254505|P2|Second Intervention|Withdrawal by Subject|0
69593|NCT01020877|254506|P1|Second Intervention|Withdrawal by Subject|1
69594|NCT01020838|254516|P1|Overall Study|Most common: Study ended by sponsor|77
69595|NCT01020838|254516|P1|Overall Study|Lost to Follow-up|6
69596|NCT01020838|254516|P1|Overall Study|Withdrawal by Subject|9
69597|NCT01020838|254516|P1|Overall Study|Adverse Event|1
69598|NCT01020838|254516|P1|Overall Study|Death|90
69599|NCT01020812|254531|P1|Overall Study|Protocol Violation|1
69600|NCT01020812|254531|P1|Overall Study|Withdrawal by Subject|1
69601|NCT01020812|254531|P1|Overall Study|Physician Decision|1
69602|NCT01020799|254541|P3|Overall Study|Lost to Follow-up|2
69603|NCT01020799|254542|P2|Overall Study|Lost to Follow-up|4
69604|NCT01020799|254543|P1|Overall Study|Lost to Follow-up|6
69605|NCT01020799|254541|P3|Overall Study|Withdrawal by Subject|3
69606|NCT01020799|254542|P2|Overall Study|Withdrawal by Subject|2
69607|NCT01020799|254543|P1|Overall Study|Withdrawal by Subject|2
69608|NCT01020799|254541|P3|Overall Study|Protocol Violation|0
69609|NCT01020799|254542|P2|Overall Study|Protocol Violation|2
69610|NCT01020799|254543|P1|Overall Study|Protocol Violation|3
69611|NCT01020799|254541|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
69612|NCT01020799|254542|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
69613|NCT01020799|254543|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
69614|NCT01020799|254541|P3|Overall Study|Adverse Event|2
69615|NCT01020799|254542|P2|Overall Study|Adverse Event|3
69616|NCT01020799|254543|P1|Overall Study|Adverse Event|4
69617|NCT01020786|254566|P1|Maintenance Period|Sponsor Decision|1
69618|NCT01020786|254566|P1|Maintenance Period|Withdrawal by Subject|8
69619|NCT01020786|254566|P1|Maintenance Period|Progressive Disease|43
69620|NCT01020786|254566|P1|Maintenance Period|Adverse Event|8
69621|NCT01020786|254566|P1|Induction Period|Withdrawal by Subject|3
69622|NCT01020786|254566|P1|Induction Period|Investigator Decision|3
69623|NCT01020786|254566|P1|Induction Period|Progressive Disease|31
69624|NCT01020786|254566|P1|Induction Period|Adverse Event|10
69625|NCT01020786|254566|P1|Induction Period|Entry Criteria Not Met|2
69626|NCT01020773|254580|P2|Overall Study|Withdrawal by Subject|3
69627|NCT01020773|254581|P1|Overall Study|Withdrawal by Subject|4
69628|NCT01020747|254587|P1|Overall Study|Withdrawal by Subject|1
69629|NCT01020305|254592|P1|Overall Study|Adverse Event|2
69630|NCT01020123|254603|P7|Extention Period|Lost to Follow-up|0
69631|NCT01020123|254604|P6|Extention Period|Lost to Follow-up|2
69632|NCT01020123|254605|P5|Extention Period|Lost to Follow-up|0
69633|NCT01020123|254606|P4|Extention Period|Lost to Follow-up|0
69634|NCT01020123|254607|P3|Extention Period|Lost to Follow-up|0
69635|NCT01020123|254608|P2|Extention Period|Lost to Follow-up|0
69636|NCT01020123|254609|P1|Extention Period|Lost to Follow-up|0
69637|NCT01020123|254603|P7|Extention Period|Protocol Violation|1
69638|NCT01020123|254604|P6|Extention Period|Protocol Violation|0
69639|NCT01020123|254605|P5|Extention Period|Protocol Violation|0
69640|NCT01020123|254606|P4|Extention Period|Protocol Violation|0
69641|NCT01020123|254607|P3|Extention Period|Protocol Violation|1
69642|NCT01020123|254608|P2|Extention Period|Protocol Violation|1
69643|NCT01020123|254609|P1|Extention Period|Protocol Violation|1
69644|NCT01020123|254603|P7|Extention Period|Adverse Event|0
69645|NCT01020123|254604|P6|Extention Period|Adverse Event|0
69646|NCT01020123|254605|P5|Extention Period|Adverse Event|0
69647|NCT01020123|254606|P4|Extention Period|Adverse Event|1
69648|NCT01020123|254607|P3|Extention Period|Adverse Event|0
69649|NCT01020123|254608|P2|Extention Period|Adverse Event|0
69650|NCT01020123|254609|P1|Extention Period|Adverse Event|0
69651|NCT01020123|254603|P7|Extention Period|Withdrawal by Subject|0
69652|NCT01020123|254604|P6|Extention Period|Withdrawal by Subject|0
69653|NCT01020123|254605|P5|Extention Period|Withdrawal by Subject|0
69654|NCT01020123|254606|P4|Extention Period|Withdrawal by Subject|0
69655|NCT01020123|254607|P3|Extention Period|Withdrawal by Subject|1
69656|NCT01020123|254608|P2|Extention Period|Withdrawal by Subject|1
69657|NCT01020123|254609|P1|Extention Period|Withdrawal by Subject|2
69658|NCT01020123|254603|P7|Main Period|Unclasified|6
69659|NCT01020123|254604|P6|Main Period|Unclasified|3
69660|NCT01020123|254605|P5|Main Period|Unclasified|1
69661|NCT01020123|254606|P4|Main Period|Unclasified|0
69662|NCT01020123|254607|P3|Main Period|Unclasified|1
69663|NCT01020123|254608|P2|Main Period|Unclasified|0
69664|NCT01020123|254609|P1|Main Period|Unclasified|2
69665|NCT01020123|254603|P7|Main Period|Lost to Follow-up|0
69666|NCT01020123|254604|P6|Main Period|Lost to Follow-up|0
69667|NCT01020123|254605|P5|Main Period|Lost to Follow-up|0
69668|NCT01020123|254606|P4|Main Period|Lost to Follow-up|0
69669|NCT01020123|254607|P3|Main Period|Lost to Follow-up|0
69670|NCT01020123|254608|P2|Main Period|Lost to Follow-up|2
69671|NCT01020123|254609|P1|Main Period|Lost to Follow-up|0
69672|NCT01020123|254603|P7|Main Period|Protocol Violation|2
69673|NCT01020123|254604|P6|Main Period|Protocol Violation|3
69674|NCT01020123|254605|P5|Main Period|Protocol Violation|2
69675|NCT01020123|254606|P4|Main Period|Protocol Violation|5
69676|NCT01020123|254607|P3|Main Period|Protocol Violation|2
69677|NCT01020123|254608|P2|Main Period|Protocol Violation|4
69678|NCT01020123|254609|P1|Main Period|Protocol Violation|4
69679|NCT01020123|254603|P7|Main Period|Adverse Event|1
69680|NCT01020123|254604|P6|Main Period|Adverse Event|2
69681|NCT01020123|254605|P5|Main Period|Adverse Event|1
69682|NCT01020123|254606|P4|Main Period|Adverse Event|1
69683|NCT01020123|254607|P3|Main Period|Adverse Event|2
69684|NCT01020123|254608|P2|Main Period|Adverse Event|2
69685|NCT01020123|254609|P1|Main Period|Adverse Event|5
69686|NCT01020123|254603|P7|Main Period|Eligibility Criteria not fullfilled|0
69687|NCT01020123|254604|P6|Main Period|Eligibility Criteria not fullfilled|0
69688|NCT01020123|254605|P5|Main Period|Eligibility Criteria not fullfilled|1
69689|NCT01020123|254606|P4|Main Period|Eligibility Criteria not fullfilled|0
69690|NCT01020123|254607|P3|Main Period|Eligibility Criteria not fullfilled|0
69691|NCT01020123|254608|P2|Main Period|Eligibility Criteria not fullfilled|1
69692|NCT01020123|254609|P1|Main Period|Eligibility Criteria not fullfilled|0
69693|NCT01020123|254603|P7|Main Period|Withdrawal by Subject|2
69694|NCT01020123|254604|P6|Main Period|Withdrawal by Subject|3
69695|NCT01020123|254605|P5|Main Period|Withdrawal by Subject|6
69696|NCT01020123|254606|P4|Main Period|Withdrawal by Subject|1
69697|NCT01020123|254607|P3|Main Period|Withdrawal by Subject|3
69698|NCT01020123|254608|P2|Main Period|Withdrawal by Subject|5
69699|NCT01020123|254609|P1|Main Period|Withdrawal by Subject|6
69700|NCT01020019|254804|P2|Overall Study|moving|2
69701|NCT01020019|254805|P1|Overall Study|moving|0
69702|NCT01020019|254804|P2|Overall Study|not interested in treatment|4
69703|NCT01020019|254805|P1|Overall Study|not interested in treatment|4
69704|NCT01020019|254804|P2|Overall Study|Adverse Event|5
69705|NCT01020019|254805|P1|Overall Study|Adverse Event|1
69706|NCT01020019|254804|P2|Overall Study|Lost to Follow-up|18
69707|NCT01020019|254805|P1|Overall Study|Lost to Follow-up|21
69708|NCT01019980|254826|P2|Overall Study|Drug not available.|0
69709|NCT01019980|254827|P1|Overall Study|Drug not available.|2
69710|NCT01019694|254890|P3|Overall Study|Other reason (not specified)|6
69711|NCT01019694|254891|P2|Overall Study|Other reason (not specified)|5
69712|NCT01019694|254892|P1|Overall Study|Other reason (not specified)|1
69713|NCT01019694|254890|P3|Overall Study|Not treated|3
69714|NCT01019694|254891|P2|Overall Study|Not treated|2
69715|NCT01019694|254892|P1|Overall Study|Not treated|0
69716|NCT01019694|254890|P3|Overall Study|Withdrawal by Subject|12
69717|NCT01019694|254891|P2|Overall Study|Withdrawal by Subject|6
69718|NCT01019694|254892|P1|Overall Study|Withdrawal by Subject|4
69719|NCT01019694|254890|P3|Overall Study|Lost to Follow-up|3
69720|NCT01019694|254891|P2|Overall Study|Lost to Follow-up|3
69721|NCT01019694|254892|P1|Overall Study|Lost to Follow-up|5
69722|NCT01019694|254890|P3|Overall Study|Protocol Violation|4
69723|NCT01019694|254891|P2|Overall Study|Protocol Violation|6
69724|NCT01019694|254892|P1|Overall Study|Protocol Violation|2
69725|NCT01019694|254890|P3|Overall Study|Adverse Event|19
69726|NCT01019694|254891|P2|Overall Study|Adverse Event|16
69727|NCT01019694|254892|P1|Overall Study|Adverse Event|12
69728|NCT01019486|255017|P3|Overall Study|Withdrawal by Subject|1
69729|NCT01019486|255018|P2|Overall Study|Withdrawal by Subject|1
69730|NCT01019486|255019|P1|Overall Study|Withdrawal by Subject|1
69731|NCT01019369|255033|P2|Overall Study|Withdrawal by Subject|1
69732|NCT01019369|255034|P1|Overall Study|Withdrawal by Subject|0
69733|NCT01019369|255033|P2|Overall Study|Lost to Follow-up|6
69734|NCT01019369|255034|P1|Overall Study|Lost to Follow-up|10
69735|NCT01019317|255040|P1|Overall Study|Not Eligible|4
69736|NCT01019135|255047|P3|Overall Study|Did not attend CR|6
69737|NCT01019135|255048|P2|Overall Study|Did not attend CR|13
69738|NCT01019135|255049|P1|Overall Study|Did not attend CR|8
69739|NCT01019135|255047|P3|Overall Study|Did not receive allocated intervention|25
69740|NCT01019135|255048|P2|Overall Study|Did not receive allocated intervention|6
69741|NCT01019135|255049|P1|Overall Study|Did not receive allocated intervention|12
69742|NCT01018992|255077|P2|Overall Study|Lost to Follow-up|1
69743|NCT01018992|255078|P1|Overall Study|Lost to Follow-up|5
69744|NCT01018992|255077|P2|Overall Study|Protocol Violation|4
69745|NCT01018992|255078|P1|Overall Study|Protocol Violation|0
69746|NCT01018992|255077|P2|Overall Study|Withdrawal by Subject|8
69747|NCT01018992|255078|P1|Overall Study|Withdrawal by Subject|3
69748|NCT01018992|255077|P2|Overall Study|Adverse Event|3
69749|NCT01018992|255078|P1|Overall Study|Adverse Event|8
69750|NCT01018979|255092|P2|Overall Study|Not received at least one dose|1
69751|NCT01018979|255093|P1|Overall Study|Not received at least one dose|0
69752|NCT01018979|255092|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
69753|NCT01018979|255093|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
69754|NCT01018953|255123|P1|Overall Study|Study termination by sponsor|5
69755|NCT01018953|255123|P1|Overall Study|Withdrawal by Subject|1
69756|NCT01018953|255123|P1|Overall Study|Adverse Event|2
69757|NCT01018862|255136|P3|Overall Study|administrative problems|4
69758|NCT01018862|255137|P2|Overall Study|administrative problems|4
69759|NCT01018862|255138|P1|Overall Study|administrative problems|5
69760|NCT01018862|255136|P3|Overall Study|Withdrawal by Subject|1
69761|NCT01018862|255137|P2|Overall Study|Withdrawal by Subject|2
69762|NCT01018862|255138|P1|Overall Study|Withdrawal by Subject|1
69763|NCT01018862|255136|P3|Overall Study|Protocol Violation|3
69764|NCT01018862|255137|P2|Overall Study|Protocol Violation|3
69765|NCT01018862|255138|P1|Overall Study|Protocol Violation|1
69766|NCT01018862|255136|P3|Overall Study|Lost to Follow-up|0
69767|NCT01018862|255137|P2|Overall Study|Lost to Follow-up|1
69768|NCT01018862|255138|P1|Overall Study|Lost to Follow-up|3
69769|NCT01018862|255136|P3|Overall Study|Lack of Efficacy|2
69770|NCT01018862|255137|P2|Overall Study|Lack of Efficacy|0
69771|NCT01018862|255138|P1|Overall Study|Lack of Efficacy|1
69772|NCT01018862|255136|P3|Overall Study|Adverse Event|6
69773|NCT01018862|255137|P2|Overall Study|Adverse Event|0
69774|NCT01018862|255138|P1|Overall Study|Adverse Event|2
69775|NCT01018810|255160|P5|Overall Study|Sponsor Decision|1
69776|NCT01018810|255161|P4|Overall Study|Sponsor Decision|1
69777|NCT01018810|255162|P3|Overall Study|Sponsor Decision|1
69778|NCT01018810|255163|P2|Overall Study|Sponsor Decision|0
69779|NCT01018810|255164|P1|Overall Study|Sponsor Decision|2
69780|NCT01018810|255160|P5|Overall Study|Withdrawal by Subject|0
69781|NCT01018810|255161|P4|Overall Study|Withdrawal by Subject|0
69782|NCT01018810|255162|P3|Overall Study|Withdrawal by Subject|0
69783|NCT01018810|255163|P2|Overall Study|Withdrawal by Subject|1
69784|NCT01018810|255164|P1|Overall Study|Withdrawal by Subject|0
69785|NCT01018732|255224|P3|Overall Study|Unable to Classify|1
69786|NCT01018732|255225|P2|Overall Study|Unable to Classify|0
69787|NCT01018732|255226|P1|Overall Study|Unable to Classify|0
69788|NCT01018732|255224|P3|Overall Study|Inappropriate Enrollment|0
69789|NCT01018732|255225|P2|Overall Study|Inappropriate Enrollment|1
69790|NCT01018732|255226|P1|Overall Study|Inappropriate Enrollment|0
69791|NCT01018732|255224|P3|Overall Study|Protocol Violation|0
69792|NCT01018732|255225|P2|Overall Study|Protocol Violation|1
69793|NCT01018732|255226|P1|Overall Study|Protocol Violation|1
69794|NCT01018732|255224|P3|Overall Study|Lost to Follow-up|3
69795|NCT01018732|255225|P2|Overall Study|Lost to Follow-up|0
69796|NCT01018732|255226|P1|Overall Study|Lost to Follow-up|0
69797|NCT01018680|255260|P2|Overall Study|Physician Decision|1
69798|NCT01018680|255261|P1|Overall Study|Physician Decision|3
69799|NCT01018680|255260|P2|Overall Study|Entry Criteria Not Met|4
69800|NCT01018680|255261|P1|Overall Study|Entry Criteria Not Met|1
69801|NCT01018680|255260|P2|Overall Study|Lost to Follow-up|3
69802|NCT01018680|255261|P1|Overall Study|Lost to Follow-up|5
69803|NCT01018680|255260|P2|Overall Study|Lack of Efficacy|2
69804|NCT01018680|255261|P1|Overall Study|Lack of Efficacy|8
69805|NCT01018680|255260|P2|Overall Study|Sponsor Decision|7
69806|NCT01018680|255261|P1|Overall Study|Sponsor Decision|6
69807|NCT01018680|255260|P2|Overall Study|Protocol Violation|8
69808|NCT01018680|255261|P1|Overall Study|Protocol Violation|5
69809|NCT01018680|255260|P2|Overall Study|Withdrawal by Subject|10
69810|NCT01018680|255261|P1|Overall Study|Withdrawal by Subject|10
69811|NCT01018680|255260|P2|Overall Study|Adverse Event|40
69812|NCT01018680|255261|P1|Overall Study|Adverse Event|23
69813|NCT01018511|255305|P4|Overall Study|Miscellaneous|0
69814|NCT01018511|255306|P3|Overall Study|Miscellaneous|0
69815|NCT01018511|255307|P2|Overall Study|Miscellaneous|2
69816|NCT01018511|255308|P1|Overall Study|Miscellaneous|0
69817|NCT01018511|255305|P4|Overall Study|Protocol Violation|9
69818|NCT01018511|255306|P3|Overall Study|Protocol Violation|7
69819|NCT01018511|255307|P2|Overall Study|Protocol Violation|8
69820|NCT01018511|255308|P1|Overall Study|Protocol Violation|5
69821|NCT01018511|255305|P4|Overall Study|Lost to Follow-up|0
69822|NCT01018511|255306|P3|Overall Study|Lost to Follow-up|1
69823|NCT01018511|255307|P2|Overall Study|Lost to Follow-up|0
69824|NCT01018511|255308|P1|Overall Study|Lost to Follow-up|0
69825|NCT01018511|255305|P4|Overall Study|Withdrawal by Subject|9
69826|NCT01018511|255306|P3|Overall Study|Withdrawal by Subject|11
69827|NCT01018511|255307|P2|Overall Study|Withdrawal by Subject|5
69828|NCT01018511|255308|P1|Overall Study|Withdrawal by Subject|6
69829|NCT01018511|255305|P4|Overall Study|Lack of Efficacy|2
69830|NCT01018511|255306|P3|Overall Study|Lack of Efficacy|1
69831|NCT01018511|255307|P2|Overall Study|Lack of Efficacy|1
69832|NCT01018511|255308|P1|Overall Study|Lack of Efficacy|4
69833|NCT01018511|255305|P4|Overall Study|Adverse Event|10
69834|NCT01018511|255306|P3|Overall Study|Adverse Event|13
69835|NCT01018511|255307|P2|Overall Study|Adverse Event|9
69836|NCT01018511|255308|P1|Overall Study|Adverse Event|5
69837|NCT01018511|255305|P4|Overall Study|Not fulfilling eligibility criteria|3
69838|NCT01018511|255306|P3|Overall Study|Not fulfilling eligibility criteria|7
69839|NCT01018511|255307|P2|Overall Study|Not fulfilling eligibility criteria|7
69840|NCT01018511|255308|P1|Overall Study|Not fulfilling eligibility criteria|6
69841|NCT01018394|255505|P2|Overall Study|Lost to Follow-up|3
69842|NCT01018394|255506|P1|Overall Study|Lost to Follow-up|4
69843|NCT01018394|255505|P2|Overall Study|Withdrawal by Subject|5
69844|NCT01018394|255506|P1|Overall Study|Withdrawal by Subject|5
69845|NCT01018264|255516|P2|Overall Study|Lost to Follow-up|1
69846|NCT01018264|255517|P1|Overall Study|Lost to Follow-up|0
69847|NCT01018264|255516|P2|Overall Study|Withdrawal by Subject|0
69848|NCT01018264|255517|P1|Overall Study|Withdrawal by Subject|1
69849|NCT01018186|255534|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
69850|NCT01018186|255535|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
69851|NCT01018186|255536|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
69852|NCT01018186|255537|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
69853|NCT01018186|255534|P4|52-week Double-blind Treatment Period|Physician Decision|3
69854|NCT01018186|255535|P3|52-week Double-blind Treatment Period|Physician Decision|0
69855|NCT01018186|255536|P2|52-week Double-blind Treatment Period|Physician Decision|1
69856|NCT01018186|255537|P1|52-week Double-blind Treatment Period|Physician Decision|0
69857|NCT01018186|255534|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
69858|NCT01018186|255535|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
69859|NCT01018186|255536|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
69860|NCT01018186|255537|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
69861|NCT01018186|255534|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
69862|NCT01018186|255535|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
69863|NCT01018186|255536|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
69864|NCT01018186|255537|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
69865|NCT01018186|255534|P4|52-week Double-blind Treatment Period|Protocol Violation|2
69866|NCT01018186|255535|P3|52-week Double-blind Treatment Period|Protocol Violation|8
69867|NCT01018186|255536|P2|52-week Double-blind Treatment Period|Protocol Violation|8
69868|NCT01018186|255537|P1|52-week Double-blind Treatment Period|Protocol Violation|0
69869|NCT01018186|255534|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
69870|NCT01018186|255535|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
69871|NCT01018186|255536|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
69872|NCT01018186|255537|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
69873|NCT01018186|255534|P4|52-week Double-blind Treatment Period|Adverse Event|6
69874|NCT01018186|255535|P3|52-week Double-blind Treatment Period|Adverse Event|3
69875|NCT01018186|255536|P2|52-week Double-blind Treatment Period|Adverse Event|5
69876|NCT01018186|255537|P1|52-week Double-blind Treatment Period|Adverse Event|0
69877|NCT01018186|255534|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
69878|NCT01018186|255535|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
69879|NCT01018186|255536|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
69880|NCT01018186|255537|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
69881|NCT01018186|255534|P4|2-week Run-in Period|Withdrawal by Subject|0
69882|NCT01018186|255535|P3|2-week Run-in Period|Withdrawal by Subject|0
69883|NCT01018186|255536|P2|2-week Run-in Period|Withdrawal by Subject|0
69884|NCT01018186|255537|P1|2-week Run-in Period|Withdrawal by Subject|11
69885|NCT01018186|255534|P4|2-week Run-in Period|Physician Decision|0
69886|NCT01018186|255535|P3|2-week Run-in Period|Physician Decision|0
69887|NCT01018186|255536|P2|2-week Run-in Period|Physician Decision|0
69888|NCT01018186|255537|P1|2-week Run-in Period|Physician Decision|3
69889|NCT01018186|255534|P4|2-week Run-in Period|Lost to Follow-up|0
69890|NCT01018186|255535|P3|2-week Run-in Period|Lost to Follow-up|0
69891|NCT01018186|255536|P2|2-week Run-in Period|Lost to Follow-up|0
69892|NCT01018186|255537|P1|2-week Run-in Period|Lost to Follow-up|2
69893|NCT01018186|255534|P4|2-week Run-in Period|Protocol Violation|0
69894|NCT01018186|255535|P3|2-week Run-in Period|Protocol Violation|0
69895|NCT01018186|255536|P2|2-week Run-in Period|Protocol Violation|0
69896|NCT01018186|255537|P1|2-week Run-in Period|Protocol Violation|1
69897|NCT01018030|255723|P3|Overall Study|Did Not Receive Study Drug|0
69898|NCT01018030|255724|P2|Overall Study|Did Not Receive Study Drug|3
69899|NCT01018030|255725|P1|Overall Study|Did Not Receive Study Drug|1
69900|NCT01018030|255723|P3|Overall Study|Lack of Efficacy|0
69901|NCT01018030|255724|P2|Overall Study|Lack of Efficacy|0
69902|NCT01018030|255725|P1|Overall Study|Lack of Efficacy|1
69903|NCT01018030|255723|P3|Overall Study|Physician Decision|1
69904|NCT01018030|255724|P2|Overall Study|Physician Decision|0
69905|NCT01018030|255725|P1|Overall Study|Physician Decision|1
69906|NCT01018030|255723|P3|Overall Study|Protocol Violation|0
69907|NCT01018030|255724|P2|Overall Study|Protocol Violation|1
69908|NCT01018030|255725|P1|Overall Study|Protocol Violation|2
69909|NCT01018030|255723|P3|Overall Study|Lost to Follow-up|3
69910|NCT01018030|255724|P2|Overall Study|Lost to Follow-up|0
69911|NCT01018030|255725|P1|Overall Study|Lost to Follow-up|2
69912|NCT01018030|255723|P3|Overall Study|Withdrawal by Subject|4
69913|NCT01018030|255724|P2|Overall Study|Withdrawal by Subject|2
69914|NCT01018030|255725|P1|Overall Study|Withdrawal by Subject|2
69915|NCT01018030|255723|P3|Overall Study|Adverse Event|5
69916|NCT01018030|255724|P2|Overall Study|Adverse Event|5
69917|NCT01018030|255725|P1|Overall Study|Adverse Event|10
69918|NCT01017952|255776|P5|52-week, Double-blind Treatment Period|Physician Decision|7
69919|NCT01017952|255777|P4|52-week, Double-blind Treatment Period|Physician Decision|9
69920|NCT01017952|255778|P3|52-week, Double-blind Treatment Period|Physician Decision|8
69921|NCT01017952|255779|P2|52-week, Double-blind Treatment Period|Physician Decision|10
69922|NCT01017952|255780|P1|52-week, Double-blind Treatment Period|Physician Decision|0
69923|NCT01017952|255776|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
69924|NCT01017952|255777|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
69925|NCT01017952|255778|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
69926|NCT01017952|255779|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
69927|NCT01017952|255780|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
69928|NCT01017952|255776|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
69929|NCT01017952|255777|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
69930|NCT01017952|255778|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
69931|NCT01017952|255779|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
69932|NCT01017952|255780|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
69933|NCT01017952|255776|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
69934|NCT01017952|255777|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
69935|NCT01017952|255778|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
69936|NCT01017952|255779|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
69937|NCT01017952|255780|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
69938|NCT01017952|255776|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
69939|NCT01017952|255777|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
69940|NCT01017952|255778|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
69941|NCT01017952|255779|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
69942|NCT01017952|255780|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
69943|NCT01017952|255776|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
69944|NCT01017952|255777|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
69945|NCT01017952|255778|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
69946|NCT01017952|255779|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
69947|NCT01017952|255780|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
69948|NCT01017952|255776|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
69949|NCT01017952|255777|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
69950|NCT01017952|255778|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
69951|NCT01017952|255779|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
69952|NCT01017952|255780|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
69953|NCT01017952|255776|P5|52-week, Double-blind Treatment Period|Adverse Event|30
69954|NCT01017952|255777|P4|52-week, Double-blind Treatment Period|Adverse Event|35
69955|NCT01017952|255778|P3|52-week, Double-blind Treatment Period|Adverse Event|32
69956|NCT01017952|255779|P2|52-week, Double-blind Treatment Period|Adverse Event|25
69957|NCT01017952|255780|P1|52-week, Double-blind Treatment Period|Adverse Event|0
69958|NCT01017952|255776|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
69959|NCT01017952|255777|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
69960|NCT01017952|255778|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
69961|NCT01017952|255779|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
69962|NCT01017952|255780|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
69963|NCT01017952|255776|P5|4-week, Open-label Run-In Period|Physician Decision|0
69964|NCT01017952|255777|P4|4-week, Open-label Run-In Period|Physician Decision|0
69965|NCT01017952|255778|P3|4-week, Open-label Run-In Period|Physician Decision|0
69966|NCT01017952|255779|P2|4-week, Open-label Run-In Period|Physician Decision|0
69967|NCT01017952|255780|P1|4-week, Open-label Run-In Period|Physician Decision|10
69968|NCT01017952|255776|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
69969|NCT01017952|255777|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
69970|NCT01017952|255778|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
69971|NCT01017952|255779|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
69972|NCT01017952|255780|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
69973|NCT01017952|255776|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
69974|NCT01017952|255777|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
69975|NCT01017952|255778|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
69976|NCT01017952|255779|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
69977|NCT01017952|255780|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
69978|NCT01017952|255776|P5|4-week, Open-label Run-In Period|Adverse Event|0
69979|NCT01017952|255777|P4|4-week, Open-label Run-In Period|Adverse Event|0
69980|NCT01017952|255778|P3|4-week, Open-label Run-In Period|Adverse Event|0
69981|NCT01017952|255779|P2|4-week, Open-label Run-In Period|Adverse Event|0
69982|NCT01017952|255780|P1|4-week, Open-label Run-In Period|Adverse Event|23
69983|NCT01017952|255776|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
69984|NCT01017952|255777|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
69985|NCT01017952|255778|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
69986|NCT01017952|255779|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
69987|NCT01017952|255780|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
69988|NCT01017874|255804|P2|Overall Study|Physician Decision|3
69989|NCT01017874|255805|P1|Overall Study|Physician Decision|1
69990|NCT01017874|255804|P2|Overall Study|Lost to Follow-up|2
69991|NCT01017874|255805|P1|Overall Study|Lost to Follow-up|3
69992|NCT01017874|255804|P2|Overall Study|Sponsor decision|1
69993|NCT01017874|255805|P1|Overall Study|Sponsor decision|3
69994|NCT01017874|255804|P2|Overall Study|Withdrawal by Subject|20
69995|NCT01017874|255805|P1|Overall Study|Withdrawal by Subject|23
69996|NCT01017731|255823|P1|Overall Study|Adverse Event|1
69997|NCT01017731|255823|P1|Overall Study|Physician Decision|2
69998|NCT01017731|255823|P1|Overall Study|Withdrawal by Subject|3
69999|NCT01017731|255823|P1|Overall Study|Lost to Follow-up|2
70000|NCT01017575|255855|P5|Overall Study|Withdrawal by Subject|0
70001|NCT01017575|255856|P4|Overall Study|Withdrawal by Subject|0
70002|NCT01017575|255857|P3|Overall Study|Withdrawal by Subject|0
70003|NCT01017575|255858|P2|Overall Study|Withdrawal by Subject|0
70004|NCT01017575|255859|P1|Overall Study|Withdrawal by Subject|1
70005|NCT01017575|255855|P5|Overall Study|Adverse Event|2
70006|NCT01017575|255856|P4|Overall Study|Adverse Event|0
70007|NCT01017575|255857|P3|Overall Study|Adverse Event|0
70008|NCT01017575|255858|P2|Overall Study|Adverse Event|1
70009|NCT01017575|255859|P1|Overall Study|Adverse Event|0
70010|NCT01017575|255855|P5|Overall Study|Lack of Efficacy|1
70011|NCT01017575|255856|P4|Overall Study|Lack of Efficacy|1
70012|NCT01017575|255857|P3|Overall Study|Lack of Efficacy|0
70013|NCT01017575|255858|P2|Overall Study|Lack of Efficacy|1
70014|NCT01017575|255859|P1|Overall Study|Lack of Efficacy|0
70015|NCT01017549|255896|P1|One-year Follow-up|Withdrawal by Subject|5
70016|NCT01017549|255896|P1|One-year Follow-up|Lost to Follow-up|2
70017|NCT01017549|255896|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
70018|NCT01017263|255927|P1|Overall Study|not eligible|12
70019|NCT01017146|256008|P2|Overall Study|Change in Work Situation|0
70020|NCT01017146|256009|P1|Overall Study|Change in Work Situation|1
70021|NCT01017146|256008|P2|Overall Study|Did Not Meet Eligibility Criteria|2
70022|NCT01017146|256009|P1|Overall Study|Did Not Meet Eligibility Criteria|1
70023|NCT01017146|256008|P2|Overall Study|Took Excluded Medication|0
70024|NCT01017146|256009|P1|Overall Study|Took Excluded Medication|2
70025|NCT01017146|256008|P2|Overall Study|Protocol Violation|0
70026|NCT01017146|256009|P1|Overall Study|Protocol Violation|2
70027|NCT01017146|256008|P2|Overall Study|Pregnancy|1
70028|NCT01017146|256009|P1|Overall Study|Pregnancy|2
70029|NCT01017146|256008|P2|Overall Study|Relocation|4
70030|NCT01017146|256009|P1|Overall Study|Relocation|0
70031|NCT01017146|256008|P2|Overall Study|Withdrawal by Subject|16
70032|NCT01017146|256009|P1|Overall Study|Withdrawal by Subject|32
70033|NCT01017146|256008|P2|Overall Study|Noncompliance with Study Product|1
70034|NCT01017146|256009|P1|Overall Study|Noncompliance with Study Product|1
70035|NCT01017146|256008|P2|Overall Study|Lost to Follow-up|14
70036|NCT01017146|256009|P1|Overall Study|Lost to Follow-up|14
70037|NCT01017146|256008|P2|Overall Study|Adverse Event|1
70038|NCT01017146|256009|P1|Overall Study|Adverse Event|11
70039|NCT01017120|256047|P2|Overall Study|Parent Unable to Provide Transportation|0
70040|NCT01017120|256048|P1|Overall Study|Parent Unable to Provide Transportation|1
70041|NCT01017120|256047|P2|Overall Study|Protocol Violation|0
70042|NCT01017120|256048|P1|Overall Study|Protocol Violation|1
70043|NCT01017120|256047|P2|Overall Study|Relocated Out of Town|2
70044|NCT01017120|256048|P1|Overall Study|Relocated Out of Town|0
70045|NCT01017120|256047|P2|Overall Study|Did Not Meet Eligibility Criteria|0
70046|NCT01017120|256048|P1|Overall Study|Did Not Meet Eligibility Criteria|1
70047|NCT01017120|256047|P2|Overall Study|Pregnancy|1
70048|NCT01017120|256048|P1|Overall Study|Pregnancy|1
70049|NCT01017120|256047|P2|Overall Study|Withdrawal by Subject|21
70050|NCT01017120|256048|P1|Overall Study|Withdrawal by Subject|39
70051|NCT01017120|256047|P2|Overall Study|Lack of Efficacy|0
70052|NCT01017120|256048|P1|Overall Study|Lack of Efficacy|1
70053|NCT01017120|256047|P2|Overall Study|Lost to Follow-up|11
70054|NCT01017120|256048|P1|Overall Study|Lost to Follow-up|13
70055|NCT01017120|256047|P2|Overall Study|Adverse Event|0
70056|NCT01017120|256048|P1|Overall Study|Adverse Event|9
70057|NCT01017029|256109|P2|Overall Study|Death|1
70058|NCT01017029|256110|P1|Overall Study|Death|3
70059|NCT01017029|256109|P2|Overall Study|Administrative problem|1
70060|NCT01017029|256110|P1|Overall Study|Administrative problem|0
70061|NCT01017029|256109|P2|Overall Study|Lost to Follow-up|0
70062|NCT01017029|256110|P1|Overall Study|Lost to Follow-up|1
70063|NCT01016977|256138|P2|Overall Study|Withdrawal by Subject|2
70064|NCT01016977|256139|P1|Overall Study|Withdrawal by Subject|2
70065|NCT01016977|256138|P2|Overall Study|Lost to Follow-up|0
70066|NCT01016977|256139|P1|Overall Study|Lost to Follow-up|1
70067|NCT01016964|256175|P2|Overall Study|Lost to Follow-up|3
70068|NCT01016964|256176|P1|Overall Study|Lost to Follow-up|3
70069|NCT01016912|256192|P5|Follow-up Period|Other reason|0
70070|NCT01016912|256193|P4|Follow-up Period|Other reason|1
70071|NCT01016912|256194|P3|Follow-up Period|Other reason|1
70072|NCT01016912|256195|P2|Follow-up Period|Other reason|0
70073|NCT01016912|256196|P1|Follow-up Period|Other reason|0
70074|NCT01016912|256192|P5|End of Treatment Period|Completed double-blind period only|0
70075|NCT01016912|256193|P4|End of Treatment Period|Completed double-blind period only|0
70076|NCT01016912|256194|P3|End of Treatment Period|Completed double-blind period only|0
70077|NCT01016912|256195|P2|End of Treatment Period|Completed double-blind period only|1
70078|NCT01016912|256196|P1|End of Treatment Period|Completed double-blind period only|0
70079|NCT01016912|256192|P5|End of Treatment Period|Adverse Event|0
70080|NCT01016912|256193|P4|End of Treatment Period|Adverse Event|0
70081|NCT01016912|256194|P3|End of Treatment Period|Adverse Event|1
70082|NCT01016912|256195|P2|End of Treatment Period|Adverse Event|1
70083|NCT01016912|256196|P1|End of Treatment Period|Adverse Event|0
70084|NCT01016912|256192|P5|End of Treatment Period|Lack of Efficacy|4
70085|NCT01016912|256193|P4|End of Treatment Period|Lack of Efficacy|4
70086|NCT01016912|256194|P3|End of Treatment Period|Lack of Efficacy|0
70087|NCT01016912|256195|P2|End of Treatment Period|Lack of Efficacy|1
70088|NCT01016912|256196|P1|End of Treatment Period|Lack of Efficacy|0
70089|NCT01016600|256357|P4|Overall Study|Did not start treatment|0
70090|NCT01016600|256358|P3|Overall Study|Did not start treatment|0
70091|NCT01016600|256359|P2|Overall Study|Did not start treatment|0
70092|NCT01016600|256360|P1|Overall Study|Did not start treatment|1
70093|NCT01016132|256423|P1|Overall Study|Discomfort|1
70094|NCT01016067|256438|P2|Overall Study|Withdrew due to Relocation|1
70095|NCT01016067|256439|P1|Overall Study|Withdrew due to Relocation|0
70096|NCT01016067|256438|P2|Overall Study|Physician Decision|1
70097|NCT01016067|256439|P1|Overall Study|Physician Decision|1
70098|NCT01016067|256438|P2|Overall Study|Lost to Follow-up|2
70099|NCT01016067|256439|P1|Overall Study|Lost to Follow-up|1
70100|NCT01016015|256457|P1|Overall Study|Adverse Event|15
70101|NCT01016015|256457|P1|Overall Study|Withdrawal by Subject|1
70102|NCT01016015|256457|P1|Overall Study|Not Treated|3
70103|NCT01015820|256468|P2|Overall Study|Suboptimal measurements|0
70104|NCT01015820|256469|P1|Overall Study|Suboptimal measurements|1
70105|NCT01015703|256491|P5|Overall Study|Protocol Violation|0
70106|NCT01015703|256492|P4|Overall Study|Protocol Violation|0
70107|NCT01015703|256493|P3|Overall Study|Protocol Violation|0
70108|NCT01015703|256494|P2|Overall Study|Protocol Violation|0
70109|NCT01015703|256495|P1|Overall Study|Protocol Violation|1
70110|NCT01015703|256491|P5|Overall Study|Adverse Event|0
70111|NCT01015703|256492|P4|Overall Study|Adverse Event|0
70112|NCT01015703|256493|P3|Overall Study|Adverse Event|0
70113|NCT01015703|256494|P2|Overall Study|Adverse Event|0
70114|NCT01015703|256495|P1|Overall Study|Adverse Event|1
70115|NCT01015703|256491|P5|Overall Study|Withdrawal by Subject|0
70116|NCT01015703|256492|P4|Overall Study|Withdrawal by Subject|0
70117|NCT01015703|256493|P3|Overall Study|Withdrawal by Subject|0
70118|NCT01015703|256494|P2|Overall Study|Withdrawal by Subject|1
70119|NCT01015703|256495|P1|Overall Study|Withdrawal by Subject|0
70120|NCT01015677|256510|P3|Overall Study|Withdrawal by Subject|0
70121|NCT01015677|256511|P2|Overall Study|Withdrawal by Subject|1
70122|NCT01015677|256512|P1|Overall Study|Withdrawal by Subject|1
70123|NCT01015677|256510|P3|Overall Study|Protocol Violation|0
70124|NCT01015677|256511|P2|Overall Study|Protocol Violation|1
70125|NCT01015677|256512|P1|Overall Study|Protocol Violation|0
70126|NCT01015677|256510|P3|Overall Study|Lack of Efficacy|0
70127|NCT01015677|256511|P2|Overall Study|Lack of Efficacy|1
70128|NCT01015677|256512|P1|Overall Study|Lack of Efficacy|0
70129|NCT01015677|256510|P3|Overall Study|Adverse Event|0
70130|NCT01015677|256511|P2|Overall Study|Adverse Event|1
70131|NCT01015677|256512|P1|Overall Study|Adverse Event|0
70132|NCT01015638|256534|P2|Overall Study|Withdrawal by Subject|0
70133|NCT01015638|256535|P1|Overall Study|Withdrawal by Subject|1
70134|NCT01015560|256563|P1|Overall Study|Withdrawal by Subject|1
70135|NCT01015560|256563|P1|Overall Study|Not protocol specified|1
70136|NCT01015560|256563|P1|Overall Study|Adverse Event|1
70137|NCT01015287|256612|P2|Overall Study|Protocol Violation|1
70138|NCT01015287|256613|P1|Overall Study|Protocol Violation|1
70139|NCT01015287|256612|P2|Overall Study|Lost to Follow-up|1
70140|NCT01015287|256613|P1|Overall Study|Lost to Follow-up|2
70141|NCT01015287|256612|P2|Overall Study|Entry Criteria not Met|14
70142|NCT01015287|256613|P1|Overall Study|Entry Criteria not Met|11
70143|NCT01015287|256612|P2|Overall Study|Withdrawal by Subject|19
70144|NCT01015287|256613|P1|Overall Study|Withdrawal by Subject|14
70145|NCT01015287|256612|P2|Overall Study|Physician Decision|21
70146|NCT01015287|256613|P1|Overall Study|Physician Decision|19
70147|NCT01015287|256612|P2|Overall Study|Sponsor Decision|7
70148|NCT01015287|256613|P1|Overall Study|Sponsor Decision|3
70149|NCT01015287|256612|P2|Overall Study|Adverse Event|0
70150|NCT01015287|256613|P1|Overall Study|Adverse Event|1
70151|NCT01015287|256612|P2|Overall Study|Death|16
70152|NCT01015287|256613|P1|Overall Study|Death|21
70153|NCT01015131|256639|P1|Overall Study|Other Protocol Specified Criteria|4
70154|NCT01015131|256639|P1|Overall Study|Withdrawal by Subject|2
70155|NCT01015131|256639|P1|Overall Study|Protocol Violation|1
70156|NCT01015131|256639|P1|Overall Study|Physician Decision|1
70157|NCT01015118|256655|P2|Overall Study|Other than stated above|17
70158|NCT01015118|256656|P1|Overall Study|Other than stated above|32
70159|NCT01015118|256655|P2|Overall Study|Not treated|5
70160|NCT01015118|256656|P1|Overall Study|Not treated|9
70161|NCT01015118|256655|P2|Overall Study|Progressive disease|225
70162|NCT01015118|256656|P1|Overall Study|Progressive disease|354
70163|NCT01015118|256655|P2|Overall Study|Other Adverse Event|32
70164|NCT01015118|256656|P1|Overall Study|Other Adverse Event|138
70165|NCT01015118|256655|P2|Overall Study|Withdrawal by Subject|26
70166|NCT01015118|256656|P1|Overall Study|Withdrawal by Subject|98
70167|NCT01015118|256655|P2|Overall Study|Lost to Follow-up|0
70168|NCT01015118|256656|P1|Overall Study|Lost to Follow-up|1
70169|NCT01015118|256655|P2|Overall Study|Protocol Violation|5
70170|NCT01015118|256656|P1|Overall Study|Protocol Violation|4
70171|NCT01015118|256655|P2|Overall Study|Worsening or AE of underlying disease|4
70172|NCT01015118|256656|P1|Overall Study|Worsening or AE of underlying disease|5
70173|NCT01014975|256674|P3|Overall Study|Lost to Follow-up|1
70174|NCT01014975|256675|P2|Overall Study|Lost to Follow-up|0
70175|NCT01014975|256676|P1|Overall Study|Lost to Follow-up|0
70176|NCT01014975|256674|P3|Overall Study|Death|4
70177|NCT01014975|256675|P2|Overall Study|Death|3
70178|NCT01014975|256676|P1|Overall Study|Death|3
70179|NCT01014975|256674|P3|Overall Study|Withdrawal by Subject|1
70180|NCT01014975|256675|P2|Overall Study|Withdrawal by Subject|0
70181|NCT01014975|256676|P1|Overall Study|Withdrawal by Subject|1
70182|NCT01014910|256686|P2|Overall Study|Withdrawal by Subject|2
70183|NCT01014910|256687|P1|Overall Study|Withdrawal by Subject|0
70184|NCT01014689|256716|P2|Overall Study|Pregnancy|0
70185|NCT01014689|256717|P1|Overall Study|Pregnancy|1
70186|NCT01014689|256716|P2|Overall Study|Lost to Follow-up|7
70187|NCT01014689|256717|P1|Overall Study|Lost to Follow-up|3
70188|NCT01014689|256716|P2|Overall Study|Protocol Violation|1
70189|NCT01014689|256717|P1|Overall Study|Protocol Violation|1
70190|NCT01014689|256716|P2|Overall Study|Withdrawal by Subject|4
70191|NCT01014689|256717|P1|Overall Study|Withdrawal by Subject|5
70192|NCT01014689|256716|P2|Overall Study|Adverse Event|0
70193|NCT01014689|256717|P1|Overall Study|Adverse Event|3
70194|NCT01014689|256716|P2|Overall Study|Lack of Efficacy|1
70195|NCT01014689|256717|P1|Overall Study|Lack of Efficacy|0
70196|NCT01014585|256752|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
70197|NCT01014585|256753|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
70198|NCT01014585|256754|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
70199|NCT01014585|256755|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
70200|NCT01014585|256752|P4|Overall Study|Lost to Follow-up|2
70201|NCT01014585|256753|P3|Overall Study|Lost to Follow-up|0
70202|NCT01014585|256754|P2|Overall Study|Lost to Follow-up|0
70203|NCT01014585|256755|P1|Overall Study|Lost to Follow-up|0
70204|NCT01014585|256752|P4|Overall Study|Withdrawal by Subject|3
70205|NCT01014585|256753|P3|Overall Study|Withdrawal by Subject|1
70206|NCT01014585|256754|P2|Overall Study|Withdrawal by Subject|0
70207|NCT01014585|256755|P1|Overall Study|Withdrawal by Subject|2
70208|NCT01014585|256752|P4|Overall Study|Adverse Event|3
70209|NCT01014585|256753|P3|Overall Study|Adverse Event|0
70210|NCT01014585|256754|P2|Overall Study|Adverse Event|2
70211|NCT01014585|256755|P1|Overall Study|Adverse Event|0
70212|NCT01014442|256784|P2|Overall Study|Unspecified Reason|1
70213|NCT01014442|256785|P1|Overall Study|Unspecified Reason|1
70214|NCT01014442|256784|P2|Overall Study|Lack of Compliance|1
70215|NCT01014442|256785|P1|Overall Study|Lack of Compliance|0
70216|NCT01014442|256784|P2|Overall Study|Protocol Violation|5
70217|NCT01014442|256785|P1|Overall Study|Protocol Violation|2
70218|NCT01014442|256784|P2|Overall Study|Withdrawal by Subject|4
70219|NCT01014442|256785|P1|Overall Study|Withdrawal by Subject|4
70220|NCT01014442|256784|P2|Overall Study|Adverse Event|8
70221|NCT01014442|256785|P1|Overall Study|Adverse Event|0
70222|NCT01014208|256905|P2|Overall Study|Study Closed/terminated|83
70223|NCT01014208|256906|P1|Overall Study|Study Closed/terminated|78
70224|NCT01014208|256905|P2|Overall Study|Did Not Receive Study Drug|0
70225|NCT01014208|256906|P1|Overall Study|Did Not Receive Study Drug|2
70226|NCT01014208|256905|P2|Overall Study|Participant Withdrew Consent|12
70227|NCT01014208|256906|P1|Overall Study|Participant Withdrew Consent|12
70228|NCT01014208|256905|P2|Overall Study|Lost to Follow-up|5
70229|NCT01014208|256906|P1|Overall Study|Lost to Follow-up|2
70230|NCT01014143|256948|P3|Second Intervention|Lost to Follow-up|0
70231|NCT01014143|256949|P2|Second Intervention|Lost to Follow-up|0
70232|NCT01014143|256950|P1|Second Intervention|Lost to Follow-up|2
70233|NCT01014013|256960|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
70234|NCT01014013|256961|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
70235|NCT01014013|256960|P2|Overall Study|Appendectomy|0
70236|NCT01014013|256961|P1|Overall Study|Appendectomy|1
70237|NCT01014013|256960|P2|Overall Study|Another antibiotic therapy required|1
70238|NCT01014013|256961|P1|Overall Study|Another antibiotic therapy required|0
70239|NCT01014013|256960|P2|Overall Study|Physician Decision|1
70240|NCT01014013|256961|P1|Overall Study|Physician Decision|0
70241|NCT01014013|256960|P2|Overall Study|Pathogen resistant|4
70242|NCT01014013|256961|P1|Overall Study|Pathogen resistant|7
70243|NCT01014013|256960|P2|Overall Study|Negative urine culture|0
70244|NCT01014013|256961|P1|Overall Study|Negative urine culture|2
70245|NCT01014013|256960|P2|Overall Study|Pathogen culture = no growth|34
70246|NCT01014013|256961|P1|Overall Study|Pathogen culture = no growth|26
70247|NCT01014013|256960|P2|Overall Study|Clinical/microbiologic failure|2
70248|NCT01014013|256961|P1|Overall Study|Clinical/microbiologic failure|1
70249|NCT01014013|256960|P2|Overall Study|Withdrawal by Subject|4
70250|NCT01014013|256961|P1|Overall Study|Withdrawal by Subject|7
70251|NCT01014013|256960|P2|Overall Study|Protocol Violation|3
70252|NCT01014013|256961|P1|Overall Study|Protocol Violation|1
70253|NCT01014013|256960|P2|Overall Study|Laboratory adverse experience|1
70254|NCT01014013|256961|P1|Overall Study|Laboratory adverse experience|1
70255|NCT01014013|256960|P2|Overall Study|Clinical adverse experience|2
70256|NCT01014013|256961|P1|Overall Study|Clinical adverse experience|4
70257|NCT01014013|256960|P2|Overall Study|Inclusion/Exclusion criteria not met|3
70258|NCT01014013|256961|P1|Overall Study|Inclusion/Exclusion criteria not met|1
70259|NCT01013961|256973|P2|Overall Study|Physician Decision|1
70260|NCT01013961|256974|P1|Overall Study|Physician Decision|0
70261|NCT01013961|256973|P2|Overall Study|Withdrawal by Subject|0
70262|NCT01013961|256974|P1|Overall Study|Withdrawal by Subject|1
70263|NCT01013961|256973|P2|Overall Study|Adverse Event|2
70264|NCT01013961|256974|P1|Overall Study|Adverse Event|2
70265|NCT01013883|256992|P2|Overall Study|Lost to Follow-up|2
70266|NCT01013883|256993|P1|Overall Study|Lost to Follow-up|2
70267|NCT01013870|257005|P2|Overall Study|Lost to Follow-up|3
70268|NCT01013870|257006|P1|Overall Study|Lost to Follow-up|1
70269|NCT01013792|257055|P2|Overall Study|Lost to Follow-up|1
70270|NCT01013792|257056|P1|Overall Study|Lost to Follow-up|0
70271|NCT01013792|257055|P2|Overall Study|Adverse Event|3
70272|NCT01013792|257056|P1|Overall Study|Adverse Event|0
70273|NCT01013792|257055|P2|Overall Study|Study suspended|1
70274|NCT01013792|257056|P1|Overall Study|Study suspended|2
70275|NCT01013753|257062|P1|Overall Study|Other|2
70276|NCT01013753|257062|P1|Overall Study|Withdrawal by Subject|2
70277|NCT01013753|257062|P1|Overall Study|Lost to Follow-up|1
70278|NCT01013753|257062|P1|Overall Study|Protocol Violation|3
70279|NCT01013753|257062|P1|Overall Study|Adverse Event|8
70280|NCT01013740|257258|P2|Overall Study|Ongoing|45
70281|NCT01013740|257259|P1|Overall Study|Ongoing|24
70282|NCT01013740|257258|P2|Overall Study|Withdrawal by Subject|3
70283|NCT01013740|257259|P1|Overall Study|Withdrawal by Subject|0
70284|NCT01013740|257258|P2|Overall Study|Physician Decision|0
70285|NCT01013740|257259|P1|Overall Study|Physician Decision|1
70286|NCT01013740|257258|P2|Overall Study|Lost to Follow-up|5
70287|NCT01013740|257259|P1|Overall Study|Lost to Follow-up|0
70288|NCT01013597|257283|P1|Overall Study|Withdrawal by Subject|1
70289|NCT01013207|257293|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
70290|NCT01012973|257313|P2|Overall Study|Withdrawal by Subject|6
70291|NCT01012973|257314|P1|Overall Study|Withdrawal by Subject|4
70292|NCT01012973|257313|P2|Overall Study|Protocol Violation|2
70293|NCT01012973|257314|P1|Overall Study|Protocol Violation|5
70294|NCT01012973|257313|P2|Overall Study|Increase in vis. acuity, never injected|1
70295|NCT01012973|257314|P1|Overall Study|Increase in vis. acuity, never injected|0
70296|NCT01012973|257313|P2|Overall Study|(Overseas travel - indefinite period)|0
70297|NCT01012973|257314|P1|Overall Study|(Overseas travel - indefinite period)|1
70298|NCT01012973|257313|P2|Overall Study|Lost to Follow-up|0
70299|NCT01012973|257314|P1|Overall Study|Lost to Follow-up|1
70300|NCT01012973|257313|P2|Overall Study|Lack of Efficacy|5
70301|NCT01012973|257314|P1|Overall Study|Lack of Efficacy|0
70302|NCT01012973|257313|P2|Overall Study|Adverse Event|5
70303|NCT01012973|257314|P1|Overall Study|Adverse Event|5
70304|NCT01012947|257339|P5|Overall Study|Lost to Follow-up|142
70305|NCT01012947|257340|P4|Overall Study|Lost to Follow-up|118
70306|NCT01012947|257341|P3|Overall Study|Lost to Follow-up|130
70307|NCT01012947|257342|P2|Overall Study|Lost to Follow-up|135
70308|NCT01012947|257343|P1|Overall Study|Lost to Follow-up|131
70309|NCT01012765|257355|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
70310|NCT01012765|257356|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
70311|NCT01012765|257357|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
70312|NCT01012765|257358|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
70313|NCT01012765|257359|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
70314|NCT01012765|257360|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
70315|NCT01012765|257355|P6|Treatment Period 2|Adverse Event|0
70316|NCT01012765|257356|P5|Treatment Period 2|Adverse Event|0
70317|NCT01012765|257357|P4|Treatment Period 2|Adverse Event|0
70318|NCT01012765|257358|P3|Treatment Period 2|Adverse Event|1
70319|NCT01012765|257359|P2|Treatment Period 2|Adverse Event|1
70320|NCT01012765|257360|P1|Treatment Period 2|Adverse Event|0
70321|NCT01012765|257355|P6|Treatment Period 2|Abnormal laboratory value(s)|1
70322|NCT01012765|257356|P5|Treatment Period 2|Abnormal laboratory value(s)|0
70323|NCT01012765|257357|P4|Treatment Period 2|Abnormal laboratory value(s)|0
70324|NCT01012765|257358|P3|Treatment Period 2|Abnormal laboratory value(s)|0
70325|NCT01012765|257359|P2|Treatment Period 2|Abnormal laboratory value(s)|0
70326|NCT01012765|257360|P1|Treatment Period 2|Abnormal laboratory value(s)|0
70327|NCT01012765|257355|P6|Treatment Period 2|Withdrawal by Subject|0
70328|NCT01012765|257356|P5|Treatment Period 2|Withdrawal by Subject|1
70329|NCT01012765|257357|P4|Treatment Period 2|Withdrawal by Subject|0
70330|NCT01012765|257358|P3|Treatment Period 2|Withdrawal by Subject|1
70331|NCT01012765|257359|P2|Treatment Period 2|Withdrawal by Subject|0
70332|NCT01012765|257360|P1|Treatment Period 2|Withdrawal by Subject|1
70333|NCT01012765|257355|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
70334|NCT01012765|257356|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
70335|NCT01012765|257357|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
70336|NCT01012765|257358|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
70337|NCT01012765|257359|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
70338|NCT01012765|257360|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
70339|NCT01012765|257355|P6|Treatment Period 1|Protocol Violation|0
70340|NCT01012765|257356|P5|Treatment Period 1|Protocol Violation|1
70341|NCT01012765|257357|P4|Treatment Period 1|Protocol Violation|2
70342|NCT01012765|257358|P3|Treatment Period 1|Protocol Violation|0
70343|NCT01012765|257359|P2|Treatment Period 1|Protocol Violation|0
70344|NCT01012765|257360|P1|Treatment Period 1|Protocol Violation|0
70345|NCT01012765|257355|P6|Treatment Period 1|Administrative problems|0
70346|NCT01012765|257356|P5|Treatment Period 1|Administrative problems|1
70347|NCT01012765|257357|P4|Treatment Period 1|Administrative problems|1
70348|NCT01012765|257358|P3|Treatment Period 1|Administrative problems|1
70349|NCT01012765|257359|P2|Treatment Period 1|Administrative problems|0
70350|NCT01012765|257360|P1|Treatment Period 1|Administrative problems|0
70351|NCT01012765|257355|P6|Treatment Period 1|Withdrawal by Subject|0
70352|NCT01012765|257356|P5|Treatment Period 1|Withdrawal by Subject|0
70353|NCT01012765|257357|P4|Treatment Period 1|Withdrawal by Subject|0
70354|NCT01012765|257358|P3|Treatment Period 1|Withdrawal by Subject|0
70355|NCT01012765|257359|P2|Treatment Period 1|Withdrawal by Subject|0
70356|NCT01012765|257360|P1|Treatment Period 1|Withdrawal by Subject|2
70357|NCT01012765|257355|P6|Treatment Period 1|Adverse Event|0
70358|NCT01012765|257356|P5|Treatment Period 1|Adverse Event|0
70359|NCT01012765|257357|P4|Treatment Period 1|Adverse Event|0
70360|NCT01012765|257358|P3|Treatment Period 1|Adverse Event|1
70361|NCT01012765|257359|P2|Treatment Period 1|Adverse Event|0
70362|NCT01012765|257360|P1|Treatment Period 1|Adverse Event|1
70363|NCT01012739|257389|P4|Treatment Period 2|Abnormal test procedure results|1
70364|NCT01012739|257390|P3|Treatment Period 2|Abnormal test procedure results|0
70365|NCT01012739|257391|P2|Treatment Period 2|Abnormal test procedure results|0
70366|NCT01012739|257392|P1|Treatment Period 2|Abnormal test procedure results|0
70367|NCT01012739|257389|P4|Treatment Period 1|Adverse Event|1
70368|NCT01012739|257390|P3|Treatment Period 1|Adverse Event|0
70369|NCT01012739|257391|P2|Treatment Period 1|Adverse Event|0
70370|NCT01012739|257392|P1|Treatment Period 1|Adverse Event|0
70371|NCT01012713|257420|P1|Overall Study|Lack of Efficacy|3
70372|NCT01012622|257446|P1|Overall Study|withdrawal of consent by a parent|2
70373|NCT01012622|257446|P1|Overall Study|screening failure|1
70374|NCT01012622|257446|P1|Overall Study|unspecified|1
70375|NCT01012622|257446|P1|Overall Study|non-compliance with the drug|9
70376|NCT01012622|257446|P1|Overall Study|Adverse Event|7
70377|NCT01012622|257446|P1|Overall Study|Lost to Follow-up|5
70378|NCT01012622|257446|P1|Overall Study|Withdrawal by Subject|6
70379|NCT01012440|257465|P1|Overall Study|Withdrawal by Subject|2
70380|NCT01012414|257469|P1|Overall Study|Trial was stopped before completed|7
70381|NCT01012414|257469|P1|Overall Study|Lost to Follow-up|1
70382|NCT01012414|257469|P1|Overall Study|Withdrawal by Subject|2
70383|NCT01012258|257485|P1|Overall Study|Ongoing|29
70384|NCT01012258|257485|P1|Overall Study|Another Tumor Discovered|1
70385|NCT01012258|257485|P1|Overall Study|Another Anti-cancer Drug Received|1
70386|NCT01012258|257485|P1|Overall Study|Symptomatic Deterioration|1
70387|NCT01012258|257485|P1|Overall Study|Progressive Disease (PD)|18
70388|NCT01012258|257485|P1|Overall Study|Adverse Event|1
70389|NCT01012258|257485|P1|Overall Study|Lost to Follow-up|1
70390|NCT01012258|257485|P1|Overall Study|Death|14
70391|NCT01012219|257532|P1|Period 2|Withdrawal by Subject|1
70392|NCT01012219|257532|P1|Period 1|Withdrawal by Subject|1
70393|NCT01012037|257542|P3|Overall Study|Other reason (not specified)|1
70394|NCT01012037|257543|P2|Overall Study|Other reason (not specified)|1
70395|NCT01012037|257544|P1|Overall Study|Other reason (not specified)|1
70396|NCT01012037|257542|P3|Overall Study|Withdrawal by Subject|1
70397|NCT01012037|257543|P2|Overall Study|Withdrawal by Subject|4
70398|NCT01012037|257544|P1|Overall Study|Withdrawal by Subject|0
70399|NCT01012037|257542|P3|Overall Study|Protocol Violation|5
70400|NCT01012037|257543|P2|Overall Study|Protocol Violation|3
70401|NCT01012037|257544|P1|Overall Study|Protocol Violation|0
70402|NCT01012037|257542|P3|Overall Study|Adverse Event|3
70403|NCT01012037|257543|P2|Overall Study|Adverse Event|8
70404|NCT01012037|257544|P1|Overall Study|Adverse Event|0
70405|NCT01011946|257579|P1|Overall Study|No pathological lab value|1
70406|NCT01011946|257579|P1|Overall Study|Transferred to another hospital|2
70407|NCT01011933|257583|P1|Overall Study|Never treated|1
70408|NCT01011933|257583|P1|Overall Study|Inadequate pathology|1
70409|NCT01011933|257583|P1|Overall Study|Improper pre-protocol Rx|1
70410|NCT01011933|257583|P1|Overall Study|Wrong cell type|1
70411|NCT01011907|257592|P2|Overall Study|Adverse Event|4
70412|NCT01011907|257593|P1|Overall Study|Adverse Event|1
70413|NCT01011907|257592|P2|Overall Study|Withdrawal by Subject|11
70414|NCT01011907|257593|P1|Overall Study|Withdrawal by Subject|13
70415|NCT01011868|257606|P3|After Week 78 Follow-up|Other reason not defined above|16
70416|NCT01011868|257607|P2|After Week 78 Follow-up|Other reason not defined above|5
70417|NCT01011868|257608|P1|After Week 78 Follow-up|Other reason not defined above|5
70418|NCT01011868|257606|P3|After Week 78 Follow-up|Withdrawal by Subject|1
70419|NCT01011868|257607|P2|After Week 78 Follow-up|Withdrawal by Subject|8
70420|NCT01011868|257608|P1|After Week 78 Follow-up|Withdrawal by Subject|9
70421|NCT01011868|257606|P3|After Week 78 Follow-up|Lost to Follow-up|4
70422|NCT01011868|257607|P2|After Week 78 Follow-up|Lost to Follow-up|6
70423|NCT01011868|257608|P1|After Week 78 Follow-up|Lost to Follow-up|11
70424|NCT01011868|257606|P3|After Week 78 Follow-up|Protocol Violation|2
70425|NCT01011868|257607|P2|After Week 78 Follow-up|Protocol Violation|1
70426|NCT01011868|257608|P1|After Week 78 Follow-up|Protocol Violation|9
70427|NCT01011868|257606|P3|After Week 78 Follow-up|Lack of Efficacy|0
70428|NCT01011868|257607|P2|After Week 78 Follow-up|Lack of Efficacy|0
70429|NCT01011868|257608|P1|After Week 78 Follow-up|Lack of Efficacy|4
70430|NCT01011868|257606|P3|After Week 78 Follow-up|Adverse Event|21
70431|NCT01011868|257607|P2|After Week 78 Follow-up|Adverse Event|18
70432|NCT01011868|257608|P1|After Week 78 Follow-up|Adverse Event|14
70433|NCT01011868|257606|P3|After Week 18 Follow-up|Other reason not defined above|12
70434|NCT01011868|257607|P2|After Week 18 Follow-up|Other reason not defined above|3
70435|NCT01011868|257608|P1|After Week 18 Follow-up|Other reason not defined above|2
70436|NCT01011868|257606|P3|After Week 18 Follow-up|Withdrawal by Subject|0
70437|NCT01011868|257607|P2|After Week 18 Follow-up|Withdrawal by Subject|3
70438|NCT01011868|257608|P1|After Week 18 Follow-up|Withdrawal by Subject|6
70439|NCT01011868|257606|P3|After Week 18 Follow-up|Lost to Follow-up|0
70440|NCT01011868|257607|P2|After Week 18 Follow-up|Lost to Follow-up|3
70441|NCT01011868|257608|P1|After Week 18 Follow-up|Lost to Follow-up|5
70442|NCT01011868|257606|P3|After Week 18 Follow-up|Protocol Violation|1
70443|NCT01011868|257607|P2|After Week 18 Follow-up|Protocol Violation|1
70444|NCT01011868|257608|P1|After Week 18 Follow-up|Protocol Violation|1
70445|NCT01011868|257606|P3|After Week 18 Follow-up|Lack of Efficacy|0
70446|NCT01011868|257607|P2|After Week 18 Follow-up|Lack of Efficacy|0
70447|NCT01011868|257608|P1|After Week 18 Follow-up|Lack of Efficacy|1
70448|NCT01011868|257606|P3|After Week 18 Follow-up|Adverse Event|13
70449|NCT01011868|257607|P2|After Week 18 Follow-up|Adverse Event|6
70450|NCT01011868|257608|P1|After Week 18 Follow-up|Adverse Event|8
70451|NCT01011738|257670|P3|Overall Study|Unknown reasons|17
70452|NCT01011738|257671|P2|Overall Study|Unknown reasons|291
70453|NCT01011738|257672|P1|Overall Study|Unknown reasons|312
70454|NCT01011738|257670|P3|Overall Study|Death|0
70455|NCT01011738|257671|P2|Overall Study|Death|3
70456|NCT01011738|257672|P1|Overall Study|Death|12
70457|NCT01011673|257712|P2|24 Hour Follow-up|Lost to Follow-up|3
70458|NCT01011673|257713|P1|24 Hour Follow-up|Lost to Follow-up|3
70459|NCT01011673|257712|P2|Randomized|Secondary headache|1
70460|NCT01011673|257713|P1|Randomized|Secondary headache|2
70461|NCT01011556|257736|P4|Overall Study|Inclusion/exclusion criteria not met|5
70462|NCT01011556|257737|P3|Overall Study|Inclusion/exclusion criteria not met|3
70463|NCT01011556|257738|P2|Overall Study|Inclusion/exclusion criteria not met|1
70464|NCT01011556|257739|P1|Overall Study|Inclusion/exclusion criteria not met|2
70465|NCT01011556|257736|P4|Overall Study|Sponsor decision|2
70466|NCT01011556|257737|P3|Overall Study|Sponsor decision|1
70467|NCT01011556|257738|P2|Overall Study|Sponsor decision|1
70468|NCT01011556|257739|P1|Overall Study|Sponsor decision|0
70469|NCT01011556|257736|P4|Overall Study|Withdrawal by Subject|4
70470|NCT01011556|257737|P3|Overall Study|Withdrawal by Subject|4
70471|NCT01011556|257738|P2|Overall Study|Withdrawal by Subject|2
70472|NCT01011556|257739|P1|Overall Study|Withdrawal by Subject|1
70473|NCT01011556|257736|P4|Overall Study|Protocol Violation|0
70474|NCT01011556|257737|P3|Overall Study|Protocol Violation|0
70475|NCT01011556|257738|P2|Overall Study|Protocol Violation|1
70476|NCT01011556|257739|P1|Overall Study|Protocol Violation|0
70477|NCT01011556|257736|P4|Overall Study|Physician Decision|1
70478|NCT01011556|257737|P3|Overall Study|Physician Decision|0
70479|NCT01011556|257738|P2|Overall Study|Physician Decision|0
70480|NCT01011556|257739|P1|Overall Study|Physician Decision|1
70481|NCT01011556|257736|P4|Overall Study|Lost to Follow-up|0
70482|NCT01011556|257737|P3|Overall Study|Lost to Follow-up|0
70483|NCT01011556|257738|P2|Overall Study|Lost to Follow-up|0
70484|NCT01011556|257739|P1|Overall Study|Lost to Follow-up|1
70485|NCT01011556|257736|P4|Overall Study|Adverse Event|1
70486|NCT01011556|257737|P3|Overall Study|Adverse Event|2
70487|NCT01011556|257738|P2|Overall Study|Adverse Event|3
70488|NCT01011556|257739|P1|Overall Study|Adverse Event|1
70489|NCT01011465|257817|P8|Overall Study|Withdrawal by Subject|0
70490|NCT01011465|257818|P7|Overall Study|Withdrawal by Subject|1
70491|NCT01011465|257819|P6|Overall Study|Withdrawal by Subject|0
70492|NCT01011465|257820|P5|Overall Study|Withdrawal by Subject|1
70493|NCT01011465|257821|P4|Overall Study|Withdrawal by Subject|0
70494|NCT01011465|257822|P3|Overall Study|Withdrawal by Subject|0
70495|NCT01011465|257823|P2|Overall Study|Withdrawal by Subject|1
70496|NCT01011465|257824|P1|Overall Study|Withdrawal by Subject|2
70497|NCT01011387|257852|P1|Overall Study|Protocol Violation|1
70498|NCT01011387|257852|P1|Overall Study|Adverse Event|2
70499|NCT01011387|257852|P1|Overall Study|Withdrawal by Subject|3
70500|NCT01011309|257859|P3|Overall Study|Protocol Violation|3
70501|NCT01011309|257860|P2|Overall Study|Protocol Violation|1
70502|NCT01011309|257861|P1|Overall Study|Protocol Violation|0
70503|NCT01011309|257859|P3|Overall Study|Lack of Efficacy|0
70504|NCT01011309|257860|P2|Overall Study|Lack of Efficacy|1
70505|NCT01011309|257861|P1|Overall Study|Lack of Efficacy|0
70506|NCT01011309|257859|P3|Overall Study|Adverse Event|2
70507|NCT01011309|257860|P2|Overall Study|Adverse Event|1
70508|NCT01011309|257861|P1|Overall Study|Adverse Event|2
70509|NCT01011283|257877|P2|Overall Study|Not Specified|2
70510|NCT01011283|257878|P1|Overall Study|Not Specified|2
70511|NCT01011283|257877|P2|Overall Study|Terminated by Sponsor|5
70512|NCT01011283|257878|P1|Overall Study|Terminated by Sponsor|5
70513|NCT01011283|257877|P2|Overall Study|Progressive Disease|2
70514|NCT01011283|257878|P1|Overall Study|Progressive Disease|0
70515|NCT01011283|257877|P2|Overall Study|Adverse Event|2
70516|NCT01011283|257878|P1|Overall Study|Adverse Event|4
70517|NCT01011153|257898|P3|Overall Study|Less than 78 cases completed|9
70518|NCT01011153|257899|P2|Overall Study|Less than 78 cases completed|11
70519|NCT01011153|257900|P1|Overall Study|Less than 78 cases completed|8
70520|NCT01011049|257929|P4|Overall Study|Withdrawal by Subject|0
70521|NCT01011049|257930|P3|Overall Study|Withdrawal by Subject|1
70522|NCT01011049|257931|P2|Overall Study|Withdrawal by Subject|0
70523|NCT01011049|257932|P1|Overall Study|Withdrawal by Subject|0
70524|NCT01011049|257929|P4|Overall Study|Lost to Follow-up|0
70525|NCT01011049|257930|P3|Overall Study|Lost to Follow-up|1
70526|NCT01011049|257931|P2|Overall Study|Lost to Follow-up|2
70527|NCT01011049|257932|P1|Overall Study|Lost to Follow-up|1
70528|NCT01011049|257929|P4|Overall Study|Protocol Violation|0
70529|NCT01011049|257930|P3|Overall Study|Protocol Violation|2
70530|NCT01011049|257931|P2|Overall Study|Protocol Violation|0
70531|NCT01011049|257932|P1|Overall Study|Protocol Violation|0
70532|NCT01010971|257957|P3|Overall Study|Other|2
70533|NCT01010971|257958|P2|Overall Study|Other|0
70534|NCT01010971|257959|P1|Overall Study|Other|1
70535|NCT01010971|257957|P3|Overall Study|Lost to Follow-up|3
70536|NCT01010971|257958|P2|Overall Study|Lost to Follow-up|2
70537|NCT01010971|257959|P1|Overall Study|Lost to Follow-up|0
70538|NCT01010971|257957|P3|Overall Study|Withdrawal by Subject|5
70539|NCT01010971|257958|P2|Overall Study|Withdrawal by Subject|2
70540|NCT01010971|257959|P1|Overall Study|Withdrawal by Subject|0
70541|NCT01010971|257957|P3|Overall Study|Adverse Event|3
70542|NCT01010971|257958|P2|Overall Study|Adverse Event|4
70543|NCT01010971|257959|P1|Overall Study|Adverse Event|2
70544|NCT01010776|258087|P1|Extension Phase|Not specified|3
70545|NCT01010776|258087|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
70546|NCT01010776|258087|P1|Main Phase|Did not received study medication|5
70547|NCT01010776|258087|P1|Main Phase|Not specified|1
70548|NCT01010776|258087|P1|Main Phase|Inform consent withdrawal|1
70549|NCT01010776|258087|P1|Main Phase|Selection failure|2
70550|NCT01010776|258087|P1|Main Phase|Non-compliance to study medication|5
70551|NCT01010776|258087|P1|Main Phase|Lost to Follow-up|6
70552|NCT01010776|258087|P1|Main Phase|Adverse Event|7
70553|NCT01010776|258087|P1|Main Phase|Lack of Efficacy|8
70554|NCT01010776|258087|P1|Main Phase|Withdrawal by Subject|14
70555|NCT01010750|258115|P6|Second Intervention|Adverse Event|0
70556|NCT01010750|258116|P5|Second Intervention|Adverse Event|0
70557|NCT01010750|258117|P4|Second Intervention|Adverse Event|0
70558|NCT01010750|258118|P3|Second Intervention|Adverse Event|0
70559|NCT01010750|258119|P2|Second Intervention|Adverse Event|1
70560|NCT01010750|258120|P1|Second Intervention|Adverse Event|0
70561|NCT01010633|258145|P2|Overall Study|Investigator decision|1
70562|NCT01010633|258146|P1|Overall Study|Investigator decision|0
70563|NCT01010633|258145|P2|Overall Study|Withdrawal by Subject|1
70564|NCT01010633|258146|P1|Overall Study|Withdrawal by Subject|2
70565|NCT01010633|258145|P2|Overall Study|Protocol Violation|2
70566|NCT01010633|258146|P1|Overall Study|Protocol Violation|1
70567|NCT01010633|258145|P2|Overall Study|Adverse Event|1
70568|NCT01010633|258146|P1|Overall Study|Adverse Event|1
70569|NCT01010503|258173|P1|Overall Study|Death|1
70570|NCT01010503|258173|P1|Overall Study|Adverse Event|1
70571|NCT01010230|258232|P2|Overall Study|Lost to Follow-up|2
70572|NCT01010230|258233|P1|Overall Study|Lost to Follow-up|4
70573|NCT01010230|258232|P2|Overall Study|Withdrawal by Subject|5
70574|NCT01010230|258233|P1|Overall Study|Withdrawal by Subject|6
70575|NCT01010204|258265|P2|Overall Study|psychiatric hospitalization|1
70576|NCT01010204|258266|P1|Overall Study|psychiatric hospitalization|2
70577|NCT01010204|258265|P2|Overall Study|Withdrawal by Subject|3
70578|NCT01010204|258266|P1|Overall Study|Withdrawal by Subject|2
70579|NCT01010204|258265|P2|Overall Study|Adverse Event|3
70580|NCT01010204|258266|P1|Overall Study|Adverse Event|1
70581|NCT01010204|258265|P2|Overall Study|Lost to Follow-up|2
70582|NCT01010204|258266|P1|Overall Study|Lost to Follow-up|2
70583|NCT01010061|258276|P2|Overall Study|Failure to Return|2
70584|NCT01010061|258277|P1|Overall Study|Failure to Return|3
70585|NCT01010061|258276|P2|Overall Study|Refused Treatment/Did Not Cooperate|1
70586|NCT01010061|258277|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
70587|NCT01010061|258276|P2|Overall Study|Administrative/Other|14
70588|NCT01010061|258277|P1|Overall Study|Administrative/Other|19
70589|NCT01010061|258276|P2|Overall Study|Death|7
70590|NCT01010061|258277|P1|Overall Study|Death|23
70591|NCT01010061|258276|P2|Overall Study|Withdrew Consent|4
70592|NCT01010061|258277|P1|Overall Study|Withdrew Consent|9
70593|NCT01010061|258276|P2|Overall Study|Progression of Disease|63
70594|NCT01010061|258277|P1|Overall Study|Progression of Disease|71
70595|NCT01010061|258276|P2|Overall Study|Adverse Events or Intercurrent Illness|4
70596|NCT01010061|258277|P1|Overall Study|Adverse Events or Intercurrent Illness|7
70597|NCT01009983|258327|P1|Overall Study|necessary scans not completed|1
70598|NCT01009840|258337|P1|Overall Study|Subject Withdrew Consent to Participate|1
70599|NCT01009840|258337|P1|Overall Study|Subject was Withdrawn by Investigator|1
70600|NCT01009840|258337|P1|Overall Study|Subject Met Withdrawal Criteria|7
70601|NCT01009840|258337|P1|Overall Study|Adverse Event|4
70602|NCT01009840|258337|P1|Overall Study|Lost to Follow-up|1
70603|NCT01009645|258367|P4|Overall Study|Lost to Follow-up|5
70604|NCT01009645|258368|P3|Overall Study|Lost to Follow-up|4
70605|NCT01009645|258369|P2|Overall Study|Lost to Follow-up|8
70606|NCT01009645|258370|P1|Overall Study|Lost to Follow-up|2
70607|NCT01009580|258407|P2|Overall Study|Unclassified|21
70608|NCT01009580|258408|P1|Overall Study|Unclassified|17
70609|NCT01009580|258407|P2|Overall Study|Withdrawal Criteria|6
70610|NCT01009580|258408|P1|Overall Study|Withdrawal Criteria|4
70611|NCT01009580|258407|P2|Overall Study|Protocol Violation|3
70612|NCT01009580|258408|P1|Overall Study|Protocol Violation|2
70613|NCT01009580|258407|P2|Overall Study|Lack of Efficacy|1
70614|NCT01009580|258408|P1|Overall Study|Lack of Efficacy|0
70615|NCT01009580|258407|P2|Overall Study|Adverse Event|4
70616|NCT01009580|258408|P1|Overall Study|Adverse Event|4
70617|NCT01009554|258422|P2|Overall Study|Noncompliant with Study Product|3
70618|NCT01009554|258423|P1|Overall Study|Noncompliant with Study Product|0
70619|NCT01009554|258422|P2|Overall Study|Withdrawal by Subject|3
70620|NCT01009554|258423|P1|Overall Study|Withdrawal by Subject|1
70621|NCT01009554|258422|P2|Overall Study|Adverse Event|1
70622|NCT01009554|258423|P1|Overall Study|Adverse Event|1
70623|NCT01009515|258555|P1|Overall Study|Withdrawal by Subject|3
70624|NCT01009463|258566|P5|52-week, Double-blind Treatment Period|Physician Decision|8
70625|NCT01009463|258567|P4|52-week, Double-blind Treatment Period|Physician Decision|6
70626|NCT01009463|258568|P3|52-week, Double-blind Treatment Period|Physician Decision|6
70627|NCT01009463|258569|P2|52-week, Double-blind Treatment Period|Physician Decision|4
70628|NCT01009463|258570|P1|52-week, Double-blind Treatment Period|Physician Decision|0
70629|NCT01009463|258566|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
70630|NCT01009463|258567|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
70631|NCT01009463|258568|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
70632|NCT01009463|258569|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
70633|NCT01009463|258570|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
70634|NCT01009463|258566|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
70635|NCT01009463|258567|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
70636|NCT01009463|258568|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
70637|NCT01009463|258569|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
70638|NCT01009463|258570|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
70639|NCT01009463|258566|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
70640|NCT01009463|258567|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
70641|NCT01009463|258568|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
70642|NCT01009463|258569|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
70643|NCT01009463|258570|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
70644|NCT01009463|258566|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
70645|NCT01009463|258567|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
70646|NCT01009463|258568|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
70647|NCT01009463|258569|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
70648|NCT01009463|258570|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
70649|NCT01009463|258566|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
70650|NCT01009463|258567|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
70651|NCT01009463|258568|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
70652|NCT01009463|258569|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
70653|NCT01009463|258570|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
70654|NCT01009463|258566|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
70655|NCT01009463|258567|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
70656|NCT01009463|258568|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
70657|NCT01009463|258569|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
70658|NCT01009463|258570|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
70659|NCT01009463|258566|P5|52-week, Double-blind Treatment Period|Adverse Event|31
70660|NCT01009463|258567|P4|52-week, Double-blind Treatment Period|Adverse Event|29
70661|NCT01009463|258568|P3|52-week, Double-blind Treatment Period|Adverse Event|25
70662|NCT01009463|258569|P2|52-week, Double-blind Treatment Period|Adverse Event|22
70663|NCT01009463|258570|P1|52-week, Double-blind Treatment Period|Adverse Event|0
70664|NCT01009463|258566|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
70665|NCT01009463|258567|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
70666|NCT01009463|258568|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
70667|NCT01009463|258569|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
70668|NCT01009463|258570|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
70669|NCT01009463|258566|P5|4-week, Open-label Run-In Period|Physician Decision|0
70670|NCT01009463|258567|P4|4-week, Open-label Run-In Period|Physician Decision|0
70671|NCT01009463|258568|P3|4-week, Open-label Run-In Period|Physician Decision|0
70672|NCT01009463|258569|P2|4-week, Open-label Run-In Period|Physician Decision|0
70673|NCT01009463|258570|P1|4-week, Open-label Run-In Period|Physician Decision|10
70674|NCT01009463|258566|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
70675|NCT01009463|258567|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
70676|NCT01009463|258568|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
70677|NCT01009463|258569|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
70678|NCT01009463|258570|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
70679|NCT01009463|258566|P5|4-week, Open-label Run-In Period|Adverse Event|0
70680|NCT01009463|258567|P4|4-week, Open-label Run-In Period|Adverse Event|0
70681|NCT01009463|258568|P3|4-week, Open-label Run-In Period|Adverse Event|0
70682|NCT01009463|258569|P2|4-week, Open-label Run-In Period|Adverse Event|0
70683|NCT01009463|258570|P1|4-week, Open-label Run-In Period|Adverse Event|10
70684|NCT01009463|258566|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
70685|NCT01009463|258567|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
70686|NCT01009463|258568|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
70687|NCT01009463|258569|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
70688|NCT01009463|258570|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
70689|NCT01009203|258615|P1|Overall Study|Treatment-unrelated death|1
70690|NCT01009203|258615|P1|Overall Study|Adverse Event|5
70691|NCT01009203|258615|P1|Overall Study|Withdrawal by Subject|1
70692|NCT01009099|258655|P2|Overall Study|Death|1
70693|NCT01009099|258656|P1|Overall Study|Death|0
70694|NCT01009099|258655|P2|Overall Study|Withdrawal by Subject|1
70695|NCT01009099|258656|P1|Overall Study|Withdrawal by Subject|1
70696|NCT01009099|258655|P2|Overall Study|Physician Decision|2
70697|NCT01009099|258656|P1|Overall Study|Physician Decision|3
70698|NCT01009099|258655|P2|Overall Study|Lost to Follow-up|0
70699|NCT01009099|258656|P1|Overall Study|Lost to Follow-up|1
70700|NCT01009086|258665|P3|Overall Study|Unspecified|1
70701|NCT01009086|258666|P2|Overall Study|Unspecified|5
70702|NCT01009086|258667|P1|Overall Study|Unspecified|3
70703|NCT01009086|258665|P3|Overall Study|Withdrawal by Subject|13
70704|NCT01009086|258666|P2|Overall Study|Withdrawal by Subject|11
70705|NCT01009086|258667|P1|Overall Study|Withdrawal by Subject|9
70706|NCT01009086|258665|P3|Overall Study|Adverse Event|8
70707|NCT01009086|258666|P2|Overall Study|Adverse Event|11
70708|NCT01009086|258667|P1|Overall Study|Adverse Event|12
70709|NCT01009086|258665|P3|Overall Study|Lost to Follow-up|3
70710|NCT01009086|258666|P2|Overall Study|Lost to Follow-up|5
70711|NCT01009086|258667|P1|Overall Study|Lost to Follow-up|4
70712|NCT01009086|258665|P3|Overall Study|Lack of Efficacy|9
70713|NCT01009086|258666|P2|Overall Study|Lack of Efficacy|15
70714|NCT01009086|258667|P1|Overall Study|Lack of Efficacy|16
70715|NCT01009047|258702|P2|Overall Study|Unspecified|2
70716|NCT01009047|258703|P1|Overall Study|Unspecified|3
70717|NCT01009047|258702|P2|Overall Study|Withdrawal by consent|11
70718|NCT01009047|258703|P1|Overall Study|Withdrawal by consent|16
70719|NCT01009047|258702|P2|Overall Study|Lack of Efficacy|11
70720|NCT01009047|258703|P1|Overall Study|Lack of Efficacy|4
70721|NCT01009047|258702|P2|Overall Study|Lost to Follow-up|2
70722|NCT01009047|258703|P1|Overall Study|Lost to Follow-up|0
70723|NCT01009047|258702|P2|Overall Study|Adverse Event|0
70724|NCT01009047|258703|P1|Overall Study|Adverse Event|5
70725|NCT01009034|258725|P1|Overall Study|Withdrawal by Subject|2
70726|NCT01009034|258725|P1|Overall Study|Lost to Follow-up|2
70727|NCT01008995|258733|P4|After Controlled Period|Not specified|0
70728|NCT01008995|258734|P3|After Controlled Period|Not specified|1
70729|NCT01008995|258735|P2|After Controlled Period|Not specified|0
70730|NCT01008995|258736|P1|After Controlled Period|Not specified|0
70731|NCT01008995|258733|P4|After Controlled Period|Adverse Event|1
70732|NCT01008995|258734|P3|After Controlled Period|Adverse Event|1
70733|NCT01008995|258735|P2|After Controlled Period|Adverse Event|0
70734|NCT01008995|258736|P1|After Controlled Period|Adverse Event|0
70735|NCT01008995|258733|P4|Controlled Period|Not specified|0
70736|NCT01008995|258734|P3|Controlled Period|Not specified|0
70737|NCT01008995|258735|P2|Controlled Period|Not specified|1
70738|NCT01008995|258736|P1|Controlled Period|Not specified|2
70739|NCT01008995|258733|P4|Controlled Period|Adverse Event|0
70740|NCT01008995|258734|P3|Controlled Period|Adverse Event|0
70741|NCT01008995|258735|P2|Controlled Period|Adverse Event|2
70742|NCT01008995|258736|P1|Controlled Period|Adverse Event|1
70743|NCT01008943|258753|P1|Overall Study|Withdrawal by Subject|1
70744|NCT01008904|258760|P1|Overall Study|unexpected unrelated surgery|1
70745|NCT01008904|258760|P1|Overall Study|Adverse Event|2
70746|NCT01008904|258760|P1|Overall Study|Lost to Follow-up|1
70747|NCT01008696|258778|P2|Overall Study|Other|2
70748|NCT01008696|258779|P1|Overall Study|Other|0
70749|NCT01008696|258778|P2|Overall Study|Unspecified|3
70750|NCT01008696|258779|P1|Overall Study|Unspecified|2
70751|NCT01008696|258778|P2|Overall Study|Participants' non-cooperation|3
70752|NCT01008696|258779|P1|Overall Study|Participants' non-cooperation|2
70753|NCT01008696|258778|P2|Overall Study|Adverse Event|0
70754|NCT01008696|258779|P1|Overall Study|Adverse Event|1
70755|NCT01008696|258778|P2|Overall Study|Physician Decision|1
70756|NCT01008696|258779|P1|Overall Study|Physician Decision|5
70757|NCT01008696|258778|P2|Overall Study|Withdrawal by Subject|4
70758|NCT01008696|258779|P1|Overall Study|Withdrawal by Subject|2
70759|NCT01008696|258778|P2|Overall Study|Participant's evasion of hospital visit|4
70760|NCT01008696|258779|P1|Overall Study|Participant's evasion of hospital visit|5
70761|NCT01008618|258789|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
70762|NCT01008618|258790|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
70763|NCT01008618|258791|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
70764|NCT01008618|258789|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
70765|NCT01008618|258790|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
70766|NCT01008618|258791|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
70998|NCT01006616|259190|P3|Period 1 (6 Months)|Lack of Efficacy|0
70767|NCT01008618|258789|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
70768|NCT01008618|258790|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
70769|NCT01008618|258791|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
70770|NCT01008618|258789|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
70771|NCT01008618|258790|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
70772|NCT01008618|258791|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
70773|NCT01008618|258789|P3|Period 2 (Double-Blind Period)|Physician Decision|0
70774|NCT01008618|258790|P2|Period 2 (Double-Blind Period)|Physician Decision|1
70775|NCT01008618|258791|P1|Period 2 (Double-Blind Period)|Physician Decision|0
70776|NCT01008618|258789|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
70777|NCT01008618|258790|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
70778|NCT01008618|258791|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
70779|NCT01008618|258789|P3|Period 2 (Double-Blind Period)|Adverse Event|2
70780|NCT01008618|258790|P2|Period 2 (Double-Blind Period)|Adverse Event|11
70781|NCT01008618|258791|P1|Period 2 (Double-Blind Period)|Adverse Event|0
70782|NCT01008618|258789|P3|Period 1 (Titration Period)|Aggravated symptom|0
70783|NCT01008618|258790|P2|Period 1 (Titration Period)|Aggravated symptom|0
70784|NCT01008618|258791|P1|Period 1 (Titration Period)|Aggravated symptom|2
70785|NCT01008618|258789|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
70786|NCT01008618|258790|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
70787|NCT01008618|258791|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
70788|NCT01008618|258789|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
70789|NCT01008618|258790|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
70790|NCT01008618|258791|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
70791|NCT01008618|258789|P3|Period 1 (Titration Period)|Adverse Event|0
70792|NCT01008618|258790|P2|Period 1 (Titration Period)|Adverse Event|0
70793|NCT01008618|258791|P1|Period 1 (Titration Period)|Adverse Event|33
70794|NCT01008618|258789|P3|Period 1 (Titration Period)|Physician Decision|0
70795|NCT01008618|258790|P2|Period 1 (Titration Period)|Physician Decision|0
70796|NCT01008618|258791|P1|Period 1 (Titration Period)|Physician Decision|2
70797|NCT01008553|258840|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
70798|NCT01008553|258841|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
70799|NCT01008553|258842|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
70800|NCT01008553|258840|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
70801|NCT01008553|258841|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
70802|NCT01008553|258842|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
70803|NCT01008553|258840|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
70804|NCT01008553|258841|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
70805|NCT01008553|258842|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
70806|NCT01008553|258840|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
70807|NCT01008553|258841|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
70808|NCT01008553|258842|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
70809|NCT01008553|258840|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
70810|NCT01008553|258841|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
70811|NCT01008553|258842|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
70812|NCT01008553|258840|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
70813|NCT01008553|258841|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
70814|NCT01008553|258842|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
70815|NCT01008553|258840|P3|Period 2 (Double-Blind Period)|Adverse Event|4
70816|NCT01008553|258841|P2|Period 2 (Double-Blind Period)|Adverse Event|14
70817|NCT01008553|258842|P1|Period 2 (Double-Blind Period)|Adverse Event|0
70818|NCT01008553|258840|P3|Period 2 (Double-Blind Period)|Physician Decision|2
70819|NCT01008553|258841|P2|Period 2 (Double-Blind Period)|Physician Decision|1
70820|NCT01008553|258842|P1|Period 2 (Double-Blind Period)|Physician Decision|0
70821|NCT01008553|258840|P3|Period 1 (Titration Period)|Not appropriate for this study|0
70822|NCT01008553|258841|P2|Period 1 (Titration Period)|Not appropriate for this study|0
70823|NCT01008553|258842|P1|Period 1 (Titration Period)|Not appropriate for this study|1
70824|NCT01008553|258840|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
70825|NCT01008553|258841|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
70826|NCT01008553|258842|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
70827|NCT01008553|258840|P3|Period 1 (Titration Period)|Determined to increase dosage|0
70828|NCT01008553|258841|P2|Period 1 (Titration Period)|Determined to increase dosage|0
70829|NCT01008553|258842|P1|Period 1 (Titration Period)|Determined to increase dosage|3
70830|NCT01008553|258840|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
70831|NCT01008553|258841|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
70832|NCT01008553|258842|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
70833|NCT01008553|258840|P3|Period 1 (Titration Period)|Adverse Event|0
70834|NCT01008553|258841|P2|Period 1 (Titration Period)|Adverse Event|0
70835|NCT01008553|258842|P1|Period 1 (Titration Period)|Adverse Event|33
70836|NCT01008553|258840|P3|Period 1 (Titration Period)|Physician Decision|0
70837|NCT01008553|258841|P2|Period 1 (Titration Period)|Physician Decision|0
70838|NCT01008553|258842|P1|Period 1 (Titration Period)|Physician Decision|2
70839|NCT01008475|258874|P7|Overall Study|Ongoing treatment at data cut-off date|4
70840|NCT01008475|258875|P6|Overall Study|Ongoing treatment at data cut-off date|6
70841|NCT01008475|258876|P5|Overall Study|Ongoing treatment at data cut-off date|5
70842|NCT01008475|258877|P4|Overall Study|Ongoing treatment at data cut-off date|0
70843|NCT01008475|258878|P3|Overall Study|Ongoing treatment at data cut-off date|0
70844|NCT01008475|258879|P2|Overall Study|Ongoing treatment at data cut-off date|0
70845|NCT01008475|258880|P1|Overall Study|Ongoing treatment at data cut-off date|0
70846|NCT01008449|258910|P2|Overall Study|Lost to Follow-up|19
70847|NCT01008449|258911|P1|Overall Study|Lost to Follow-up|29
70848|NCT01007916|258944|P2|Period 2, 4 Weeks of Wear|Relocation|0
70849|NCT01007916|258945|P1|Period 2, 4 Weeks of Wear|Relocation|1
70850|NCT01007916|258944|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
70851|NCT01007916|258945|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
70852|NCT01007838|258955|P4|Overall Study|Started home haemodialysis|0
70853|NCT01007838|258956|P3|Overall Study|Started home haemodialysis|0
70854|NCT01007838|258957|P2|Overall Study|Started home haemodialysis|0
70855|NCT01007838|258958|P1|Overall Study|Started home haemodialysis|1
70856|NCT01007838|258955|P4|Overall Study|Physician Decision|0
70857|NCT01007838|258956|P3|Overall Study|Physician Decision|0
70858|NCT01007838|258957|P2|Overall Study|Physician Decision|0
70859|NCT01007838|258958|P1|Overall Study|Physician Decision|1
70860|NCT01007838|258955|P4|Overall Study|Withdrawal by Subject|0
70861|NCT01007838|258956|P3|Overall Study|Withdrawal by Subject|0
70862|NCT01007838|258957|P2|Overall Study|Withdrawal by Subject|0
70863|NCT01007838|258958|P1|Overall Study|Withdrawal by Subject|1
70864|NCT01007812|258968|P2|Period 1, One Week|Discomfort|0
70865|NCT01007812|258969|P1|Period 1, One Week|Discomfort|1
70866|NCT01007812|258968|P2|Period 1, One Week|Lost to Follow-up|1
70867|NCT01007812|258969|P1|Period 1, One Week|Lost to Follow-up|0
70868|NCT01007435|259006|P4|Overall Study|Reason not Specified|1
70869|NCT01007435|259007|P3|Overall Study|Reason not Specified|2
70870|NCT01007435|259008|P2|Overall Study|Reason not Specified|1
70871|NCT01007435|259009|P1|Overall Study|Reason not Specified|1
70872|NCT01007435|259006|P4|Overall Study|Failure to Return|6
70873|NCT01007435|259007|P3|Overall Study|Failure to Return|3
70874|NCT01007435|259008|P2|Overall Study|Failure to Return|4
70875|NCT01007435|259009|P1|Overall Study|Failure to Return|5
70876|NCT01007435|259006|P4|Overall Study|Refused Treatment|8
70877|NCT01007435|259007|P3|Overall Study|Refused Treatment|5
70878|NCT01007435|259008|P2|Overall Study|Refused Treatment|13
70879|NCT01007435|259009|P1|Overall Study|Refused Treatment|13
70880|NCT01007435|259006|P4|Overall Study|Other Protocol Violation|0
70881|NCT01007435|259007|P3|Overall Study|Other Protocol Violation|1
70882|NCT01007435|259008|P2|Overall Study|Other Protocol Violation|0
70883|NCT01007435|259009|P1|Overall Study|Other Protocol Violation|2
70884|NCT01007435|259006|P4|Overall Study|Violation of Selection Criteria at Entry|0
70885|NCT01007435|259007|P3|Overall Study|Violation of Selection Criteria at Entry|2
70886|NCT01007435|259008|P2|Overall Study|Violation of Selection Criteria at Entry|5
70887|NCT01007435|259009|P1|Overall Study|Violation of Selection Criteria at Entry|3
70888|NCT01007435|259006|P4|Overall Study|Insufficient Therapeutic Response|9
70889|NCT01007435|259007|P3|Overall Study|Insufficient Therapeutic Response|2
70890|NCT01007435|259008|P2|Overall Study|Insufficient Therapeutic Response|7
70891|NCT01007435|259009|P1|Overall Study|Insufficient Therapeutic Response|21
70892|NCT01007435|259006|P4|Overall Study|Death|1
70893|NCT01007435|259007|P3|Overall Study|Death|2
70894|NCT01007435|259008|P2|Overall Study|Death|4
70895|NCT01007435|259009|P1|Overall Study|Death|2
70896|NCT01007435|259006|P4|Overall Study|Adverse Event|31
70897|NCT01007435|259007|P3|Overall Study|Adverse Event|47
70898|NCT01007435|259008|P2|Overall Study|Adverse Event|25
70899|NCT01007435|259009|P1|Overall Study|Adverse Event|16
70900|NCT01007396|259051|P1|Overall Study|Lost to Follow-up|47
70901|NCT01007253|259056|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
70902|NCT01007253|259057|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
70903|NCT01007253|259058|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
70904|NCT01007253|259059|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
70905|NCT01007149|259091|P2|Overall Study|Administrative problems|1
70906|NCT01007149|259092|P1|Overall Study|Administrative problems|0
70907|NCT01006980|259133|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
70908|NCT01006980|259134|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
70909|NCT01006980|259133|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
70910|NCT01006980|259134|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
70911|NCT01006980|259133|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
70912|NCT01006980|259134|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
70913|NCT01006980|259133|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
70914|NCT01006980|259134|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
70915|NCT01006980|259133|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
70916|NCT01006980|259134|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
70917|NCT01006980|259133|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
70918|NCT01006980|259134|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
70919|NCT01006980|259133|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
70920|NCT01006980|259134|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
70921|NCT01006980|259133|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
70922|NCT01006980|259134|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
70923|NCT01006980|259133|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
70924|NCT01006980|259134|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
70925|NCT01006980|259133|P2|Vemurafenib and Dacarbazine|Progression|218
70926|NCT01006980|259134|P1|Vemurafenib and Dacarbazine|Progression|257
70927|NCT01006980|259133|P2|Vemurafenib and Dacarbazine|Death|12
70928|NCT01006980|259134|P1|Vemurafenib and Dacarbazine|Death|13
70929|NCT01006980|259133|P2|Vemurafenib and Dacarbazine|Adverse Event|5
70930|NCT01006980|259134|P1|Vemurafenib and Dacarbazine|Adverse Event|25
70931|NCT01006980|259133|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
70932|NCT01006980|259134|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
70933|NCT01006889|259154|P1|Overall Study|Withdrawal by Subject|3
70934|NCT01006629|259174|P1|Overall Study|Parent unable to perform site visit|4
70935|NCT01006629|259174|P1|Overall Study|Parent refused to continue participation|1
70936|NCT01006629|259174|P1|Overall Study|Adverse Event|1
70937|NCT01006616|259189|P4|Period 2 (18 Months)|Study Terminated|70
70938|NCT01006616|259190|P3|Period 2 (18 Months)|Study Terminated|44
70939|NCT01006616|259191|P2|Period 2 (18 Months)|Study Terminated|46
70940|NCT01006616|259192|P1|Period 2 (18 Months)|Study Terminated|63
70941|NCT01006616|259189|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
70942|NCT01006616|259190|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
70943|NCT01006616|259191|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
70944|NCT01006616|259192|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
70945|NCT01006616|259189|P4|Period 2 (18 Months)|Withdrawal by Subject|1
70946|NCT01006616|259190|P3|Period 2 (18 Months)|Withdrawal by Subject|0
70947|NCT01006616|259191|P2|Period 2 (18 Months)|Withdrawal by Subject|4
70948|NCT01006616|259192|P1|Period 2 (18 Months)|Withdrawal by Subject|1
70949|NCT01006616|259189|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
70950|NCT01006616|259190|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
70951|NCT01006616|259191|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
70952|NCT01006616|259192|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
70953|NCT01006616|259189|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
70954|NCT01006616|259190|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
70955|NCT01006616|259191|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
70956|NCT01006616|259192|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
70957|NCT01006616|259189|P4|Period 2 (18 Months)|Lost to Follow-up|0
70958|NCT01006616|259190|P3|Period 2 (18 Months)|Lost to Follow-up|0
70959|NCT01006616|259191|P2|Period 2 (18 Months)|Lost to Follow-up|0
70960|NCT01006616|259192|P1|Period 2 (18 Months)|Lost to Follow-up|2
70961|NCT01006616|259189|P4|Period 2 (18 Months)|Lack of Efficacy|2
70962|NCT01006616|259190|P3|Period 2 (18 Months)|Lack of Efficacy|1
70963|NCT01006616|259191|P2|Period 2 (18 Months)|Lack of Efficacy|0
70964|NCT01006616|259192|P1|Period 2 (18 Months)|Lack of Efficacy|0
70965|NCT01006616|259189|P4|Period 2 (18 Months)|Adverse Event|4
70966|NCT01006616|259190|P3|Period 2 (18 Months)|Adverse Event|6
70967|NCT01006616|259191|P2|Period 2 (18 Months)|Adverse Event|6
70968|NCT01006616|259192|P1|Period 2 (18 Months)|Adverse Event|6
70969|NCT01006616|259189|P4|Period 1 (6 Months)|Not Treated|1
70970|NCT01006616|259190|P3|Period 1 (6 Months)|Not Treated|1
70971|NCT01006616|259191|P2|Period 1 (6 Months)|Not Treated|0
70972|NCT01006616|259192|P1|Period 1 (6 Months)|Not Treated|0
70973|NCT01006616|259189|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
70974|NCT01006616|259190|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
70975|NCT01006616|259191|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
70976|NCT01006616|259192|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
70977|NCT01006616|259189|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
70978|NCT01006616|259190|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
70979|NCT01006616|259191|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
70980|NCT01006616|259192|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
70981|NCT01006616|259189|P4|Period 1 (6 Months)|Withdrawal by Subject|0
70982|NCT01006616|259190|P3|Period 1 (6 Months)|Withdrawal by Subject|2
70983|NCT01006616|259191|P2|Period 1 (6 Months)|Withdrawal by Subject|2
70984|NCT01006616|259192|P1|Period 1 (6 Months)|Withdrawal by Subject|2
70985|NCT01006616|259189|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
70986|NCT01006616|259190|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
70987|NCT01006616|259191|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
70988|NCT01006616|259192|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
70989|NCT01006616|259189|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
70990|NCT01006616|259190|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
70991|NCT01006616|259191|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
70992|NCT01006616|259192|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
70993|NCT01006616|259189|P4|Period 1 (6 Months)|Lost to Follow-up|0
70994|NCT01006616|259190|P3|Period 1 (6 Months)|Lost to Follow-up|1
70995|NCT01006616|259191|P2|Period 1 (6 Months)|Lost to Follow-up|0
70996|NCT01006616|259192|P1|Period 1 (6 Months)|Lost to Follow-up|0
70997|NCT01006616|259189|P4|Period 1 (6 Months)|Lack of Efficacy|4
70999|NCT01006616|259191|P2|Period 1 (6 Months)|Lack of Efficacy|4
71000|NCT01006616|259192|P1|Period 1 (6 Months)|Lack of Efficacy|3
71001|NCT01006616|259189|P4|Period 1 (6 Months)|Adverse Event|9
71002|NCT01006616|259190|P3|Period 1 (6 Months)|Adverse Event|37
71003|NCT01006616|259191|P2|Period 1 (6 Months)|Adverse Event|31
71004|NCT01006616|259192|P1|Period 1 (6 Months)|Adverse Event|10
71005|NCT01006603|259328|P2|Overall Study|Other|7
71006|NCT01006603|259329|P1|Overall Study|Other|3
71007|NCT01006603|259328|P2|Overall Study|Study specific discontinuation criteria|34
71008|NCT01006603|259329|P1|Overall Study|Study specific discontinuation criteria|33
71009|NCT01006603|259328|P2|Overall Study|Death|1
71010|NCT01006603|259329|P1|Overall Study|Death|1
71011|NCT01006603|259328|P2|Overall Study|Adverse Event|7
71012|NCT01006603|259329|P1|Overall Study|Adverse Event|15
71013|NCT01006603|259328|P2|Overall Study|Incorrect enrolment|2
71014|NCT01006603|259329|P1|Overall Study|Incorrect enrolment|0
71015|NCT01006603|259328|P2|Overall Study|Protocol Violation|3
71016|NCT01006603|259329|P1|Overall Study|Protocol Violation|1
71017|NCT01006603|259328|P2|Overall Study|Safety reason|1
71018|NCT01006603|259329|P1|Overall Study|Safety reason|1
71019|NCT01006603|259328|P2|Overall Study|Lost to Follow-up|1
71020|NCT01006603|259329|P1|Overall Study|Lost to Follow-up|0
71021|NCT01006603|259328|P2|Overall Study|Withdrawal by Subject|19
71022|NCT01006603|259329|P1|Overall Study|Withdrawal by Subject|17
71023|NCT01006590|259349|P2|Overall Study|Not specified|2
71024|NCT01006590|259350|P1|Overall Study|Not specified|3
71025|NCT01006590|259349|P2|Overall Study|Study specific discontinuation criteria|23
71026|NCT01006590|259350|P1|Overall Study|Study specific discontinuation criteria|16
71027|NCT01006590|259349|P2|Overall Study|Withdrawal by Subject|2
71028|NCT01006590|259350|P1|Overall Study|Withdrawal by Subject|4
71029|NCT01006590|259349|P2|Overall Study|Protocol Violation|0
71030|NCT01006590|259350|P1|Overall Study|Protocol Violation|1
71031|NCT01006590|259349|P2|Overall Study|Lost to Follow-up|1
71032|NCT01006590|259350|P1|Overall Study|Lost to Follow-up|1
71033|NCT01006590|259349|P2|Overall Study|Death|1
71034|NCT01006590|259350|P1|Overall Study|Death|1
71035|NCT01006590|259349|P2|Overall Study|Adverse Event|3
71036|NCT01006590|259350|P1|Overall Study|Adverse Event|2
71037|NCT01006356|259366|P1|Overall Study|unspecified|23
71038|NCT01006356|259366|P1|Overall Study|Protocol Violation|3
71039|NCT01006356|259366|P1|Overall Study|Choice by participants|2
71040|NCT01006356|259366|P1|Overall Study|Withdrawal by Subject|1
71041|NCT01006356|259366|P1|Overall Study|Paticipants did not cooperate|6
71042|NCT01006356|259366|P1|Overall Study|Physician Decision|1
71043|NCT01006356|259366|P1|Overall Study|Adverse Event|6
71044|NCT01006291|259381|P3|Overall Study|Other|17
71045|NCT01006291|259382|P2|Overall Study|Other|14
71046|NCT01006291|259383|P1|Overall Study|Other|14
71047|NCT01006291|259381|P3|Overall Study|Withdrawal criteria|4
71048|NCT01006291|259382|P2|Overall Study|Withdrawal criteria|4
71049|NCT01006291|259383|P1|Overall Study|Withdrawal criteria|5
71050|NCT01006291|259381|P3|Overall Study|Protocol Violation|3
71051|NCT01006291|259382|P2|Overall Study|Protocol Violation|3
71052|NCT01006291|259383|P1|Overall Study|Protocol Violation|3
71053|NCT01006291|259381|P3|Overall Study|Lack of Efficacy|1
71054|NCT01006291|259382|P2|Overall Study|Lack of Efficacy|2
71055|NCT01006291|259383|P1|Overall Study|Lack of Efficacy|2
71056|NCT01006291|259381|P3|Overall Study|Adverse Event|2
71057|NCT01006291|259382|P2|Overall Study|Adverse Event|1
71058|NCT01006291|259383|P1|Overall Study|Adverse Event|2
71059|NCT01006135|259400|P1|Overall Study|Other|72
71060|NCT01006135|259400|P1|Overall Study|Lost to Follow-up|32
71061|NCT01006135|259400|P1|Overall Study|Protocol Violation|14
71062|NCT01006135|259400|P1|Overall Study|Adverse Event|22
71063|NCT01006122|259407|P2|Second Double-blind Intervention Period|Death|1
71064|NCT01006122|259408|P1|Second Double-blind Intervention Period|Death|0
71065|NCT01006122|259407|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
71066|NCT01006122|259408|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
71067|NCT01006122|259407|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
71068|NCT01006122|259408|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
71069|NCT01006122|259407|P2|Second Double-blind Intervention Period|Protocol Violation|0
71070|NCT01006122|259408|P1|Second Double-blind Intervention Period|Protocol Violation|1
71071|NCT01006122|259407|P2|Second Double-blind Intervention Period|Adverse Event|1
71072|NCT01006122|259408|P1|Second Double-blind Intervention Period|Adverse Event|1
71073|NCT01006122|259407|P2|First Double-blind Intervention Period|Adverse Event|4
71074|NCT01006122|259408|P1|First Double-blind Intervention Period|Adverse Event|0
71075|NCT01006122|259407|P2|First Double-blind Intervention Period|Unspecified|0
71076|NCT01006122|259408|P1|First Double-blind Intervention Period|Unspecified|3
71077|NCT01006122|259407|P2|First Double-blind Intervention Period|Lack of Efficacy|1
71078|NCT01006122|259408|P1|First Double-blind Intervention Period|Lack of Efficacy|2
71079|NCT01006122|259407|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
71080|NCT01006122|259408|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
71081|NCT01006122|259407|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
71082|NCT01006122|259408|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
71083|NCT01006122|259407|P2|First Double-blind Intervention Period|Pregnancy|1
71084|NCT01006122|259408|P1|First Double-blind Intervention Period|Pregnancy|0
71085|NCT01006122|259407|P2|First Double-blind Intervention Period|Protocol Violation|1
71086|NCT01006122|259408|P1|First Double-blind Intervention Period|Protocol Violation|1
71087|NCT01006122|259407|P2|First Double-blind Intervention Period|Lost to Follow-up|2
71088|NCT01006122|259408|P1|First Double-blind Intervention Period|Lost to Follow-up|0
71089|NCT01005966|259459|P5|Treatment Period 4 (14 Days)|Other Reason|1
71090|NCT01005966|259460|P4|Treatment Period 4 (14 Days)|Other Reason|0
71091|NCT01005966|259461|P3|Treatment Period 4 (14 Days)|Other Reason|0
71092|NCT01005966|259462|P2|Treatment Period 4 (14 Days)|Other Reason|0
71093|NCT01005966|259463|P1|Treatment Period 4 (14 Days)|Other Reason|0
71094|NCT01005966|259459|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
71095|NCT01005966|259460|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
71096|NCT01005966|259461|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
71097|NCT01005966|259462|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
71098|NCT01005966|259463|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
71099|NCT01005966|259459|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
71100|NCT01005966|259460|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
71101|NCT01005966|259461|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
71102|NCT01005966|259462|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
71103|NCT01005966|259463|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
71104|NCT01005966|259459|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
71105|NCT01005966|259460|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
71106|NCT01005966|259461|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
71107|NCT01005966|259462|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
71108|NCT01005966|259463|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
71109|NCT01005966|259459|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
71110|NCT01005966|259460|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
71111|NCT01005966|259461|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
71112|NCT01005966|259462|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
71113|NCT01005966|259463|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
71114|NCT01005966|259459|P5|Treatment Period 2 (14 Days)|Adverse Event|0
71115|NCT01005966|259460|P4|Treatment Period 2 (14 Days)|Adverse Event|0
71116|NCT01005966|259461|P3|Treatment Period 2 (14 Days)|Adverse Event|1
71117|NCT01005966|259462|P2|Treatment Period 2 (14 Days)|Adverse Event|1
71118|NCT01005966|259463|P1|Treatment Period 2 (14 Days)|Adverse Event|0
71119|NCT01005966|259459|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
71120|NCT01005966|259460|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
71121|NCT01005966|259461|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
71122|NCT01005966|259462|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
71123|NCT01005966|259463|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
71124|NCT01005966|259459|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
71125|NCT01005966|259460|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
71126|NCT01005966|259461|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
71127|NCT01005966|259462|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
71128|NCT01005966|259463|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
71129|NCT01005966|259459|P5|Treatment Period 1 (14 Days)|Adverse Event|0
71130|NCT01005966|259460|P4|Treatment Period 1 (14 Days)|Adverse Event|0
71131|NCT01005966|259461|P3|Treatment Period 1 (14 Days)|Adverse Event|0
71132|NCT01005966|259462|P2|Treatment Period 1 (14 Days)|Adverse Event|0
71133|NCT01005966|259463|P1|Treatment Period 1 (14 Days)|Adverse Event|1
71134|NCT01005914|259483|P1|Overall Study|Withdrawal by Subject|1
71135|NCT01005914|259483|P1|Overall Study|Lack of Efficacy|1
71136|NCT01005914|259483|P1|Overall Study|Death|4
71137|NCT01005914|259483|P1|Overall Study|Adverse Event|4
71138|NCT01005901|259489|P2|Overall Study|No longer requires study drug|1
71139|NCT01005901|259490|P1|Overall Study|No longer requires study drug|0
71140|NCT01005901|259489|P2|Overall Study|Patient's inability to use the device|1
71141|NCT01005901|259490|P1|Overall Study|Patient's inability to use the device|1
71142|NCT01005901|259489|P2|Overall Study|Lost to Follow-up|2
71143|NCT01005901|259490|P1|Overall Study|Lost to Follow-up|1
71144|NCT01005901|259489|P2|Overall Study|Death|3
71145|NCT01005901|259490|P1|Overall Study|Death|2
71146|NCT01005901|259489|P2|Overall Study|Protocol Violation|3
71147|NCT01005901|259490|P1|Overall Study|Protocol Violation|4
71148|NCT01005901|259489|P2|Overall Study|Unsatisfactory therapeutic effect|5
71149|NCT01005901|259490|P1|Overall Study|Unsatisfactory therapeutic effect|5
71150|NCT01005901|259489|P2|Overall Study|Administrative problems|13
71151|NCT01005901|259490|P1|Overall Study|Administrative problems|21
71152|NCT01005901|259489|P2|Overall Study|Adverse Event|16
71153|NCT01005901|259490|P1|Overall Study|Adverse Event|30
71154|NCT01005901|259489|P2|Overall Study|Withdrawal by Subject|14
71155|NCT01005901|259490|P1|Overall Study|Withdrawal by Subject|38
71156|NCT01005875|259553|P1|Overall Study|Death|3
71157|NCT01005745|259561|P1|Overall Study|Inappropriate antidiuretic hormone|1
71158|NCT01005745|259561|P1|Overall Study|Death prior to treatment|1
71159|NCT01005745|259561|P1|Overall Study|Disease progressed during TIL growth|3
71160|NCT01005745|259561|P1|Overall Study|No TIL growth|1
71161|NCT01005732|259566|P1|Overall Study|Death|1
71162|NCT01005732|259566|P1|Overall Study|Lost to Follow-up|10
71163|NCT01005719|259582|P6|Period 2|Adverse Event|1
71164|NCT01005719|259583|P5|Period 2|Adverse Event|1
71165|NCT01005719|259584|P4|Period 2|Adverse Event|0
71166|NCT01005719|259585|P3|Period 2|Adverse Event|0
71167|NCT01005719|259586|P2|Period 2|Adverse Event|0
71168|NCT01005719|259587|P1|Period 2|Adverse Event|0
71169|NCT01005719|259582|P6|Period 1|Delay in completing study procedures|1
71170|NCT01005719|259583|P5|Period 1|Delay in completing study procedures|0
71171|NCT01005719|259584|P4|Period 1|Delay in completing study procedures|0
71172|NCT01005719|259585|P3|Period 1|Delay in completing study procedures|0
71173|NCT01005719|259586|P2|Period 1|Delay in completing study procedures|0
71174|NCT01005719|259587|P1|Period 1|Delay in completing study procedures|0
71175|NCT01005719|259582|P6|Period 1|Adverse Event|0
71176|NCT01005719|259583|P5|Period 1|Adverse Event|0
71177|NCT01005719|259584|P4|Period 1|Adverse Event|1
71178|NCT01005719|259585|P3|Period 1|Adverse Event|0
71179|NCT01005719|259586|P2|Period 1|Adverse Event|0
71180|NCT01005719|259587|P1|Period 1|Adverse Event|0
71181|NCT01005680|259654|P2|Overall Study|Physician Decision|1
71182|NCT01005680|259655|P1|Overall Study|Physician Decision|1
71183|NCT01005680|259654|P2|Overall Study|Withdrawal by Subject|4
71184|NCT01005680|259655|P1|Overall Study|Withdrawal by Subject|1
71185|NCT01005680|259654|P2|Overall Study|Lost to Follow-up|6
71186|NCT01005680|259655|P1|Overall Study|Lost to Follow-up|4
71187|NCT01005602|259679|P2|Overall Study|Excluded due to unreliable clinical data|0
71188|NCT01005602|259680|P1|Overall Study|Excluded due to unreliable clinical data|1
71189|NCT01005329|259740|P1|Overall Study|Ineligible or received no protocol trt.|4
71190|NCT01005251|259759|P5|Overall Study|Lack of Efficacy|0
71191|NCT01005251|259760|P4|Overall Study|Lack of Efficacy|1
71192|NCT01005251|259761|P3|Overall Study|Lack of Efficacy|1
71193|NCT01005251|259762|P2|Overall Study|Lack of Efficacy|0
71194|NCT01005251|259763|P1|Overall Study|Lack of Efficacy|0
71195|NCT01005251|259759|P5|Overall Study|Randomized in error|0
71196|NCT01005251|259760|P4|Overall Study|Randomized in error|1
71197|NCT01005251|259761|P3|Overall Study|Randomized in error|1
71198|NCT01005251|259762|P2|Overall Study|Randomized in error|0
71199|NCT01005251|259763|P1|Overall Study|Randomized in error|0
71200|NCT01005251|259759|P5|Overall Study|Wrong drug dispensed|0
71201|NCT01005251|259760|P4|Overall Study|Wrong drug dispensed|0
71202|NCT01005251|259761|P3|Overall Study|Wrong drug dispensed|0
71203|NCT01005251|259762|P2|Overall Study|Wrong drug dispensed|1
71204|NCT01005251|259763|P1|Overall Study|Wrong drug dispensed|0
71205|NCT01005251|259759|P5|Overall Study|Patient moved|0
71206|NCT01005251|259760|P4|Overall Study|Patient moved|0
71207|NCT01005251|259761|P3|Overall Study|Patient moved|0
71208|NCT01005251|259762|P2|Overall Study|Patient moved|0
71209|NCT01005251|259763|P1|Overall Study|Patient moved|1
71210|NCT01005251|259759|P5|Overall Study|Physician Decision|2
71211|NCT01005251|259760|P4|Overall Study|Physician Decision|0
71212|NCT01005251|259761|P3|Overall Study|Physician Decision|0
71213|NCT01005251|259762|P2|Overall Study|Physician Decision|0
71214|NCT01005251|259763|P1|Overall Study|Physician Decision|0
71215|NCT01005251|259759|P5|Overall Study|Lost to Follow-up|0
71216|NCT01005251|259760|P4|Overall Study|Lost to Follow-up|0
71217|NCT01005251|259761|P3|Overall Study|Lost to Follow-up|2
71218|NCT01005251|259762|P2|Overall Study|Lost to Follow-up|4
71219|NCT01005251|259763|P1|Overall Study|Lost to Follow-up|1
71220|NCT01005251|259759|P5|Overall Study|Developed study-specific withdrawal crit|1
71221|NCT01005251|259760|P4|Overall Study|Developed study-specific withdrawal crit|0
71222|NCT01005251|259761|P3|Overall Study|Developed study-specific withdrawal crit|3
71223|NCT01005251|259762|P2|Overall Study|Developed study-specific withdrawal crit|0
71224|NCT01005251|259763|P1|Overall Study|Developed study-specific withdrawal crit|2
71225|NCT01005251|259759|P5|Overall Study|Protocol Violation|2
71226|NCT01005251|259760|P4|Overall Study|Protocol Violation|0
71227|NCT01005251|259761|P3|Overall Study|Protocol Violation|0
71228|NCT01005251|259762|P2|Overall Study|Protocol Violation|0
71229|NCT01005251|259763|P1|Overall Study|Protocol Violation|1
71230|NCT01005251|259759|P5|Overall Study|Adverse Event|4
71231|NCT01005251|259760|P4|Overall Study|Adverse Event|5
71232|NCT01005251|259761|P3|Overall Study|Adverse Event|8
71233|NCT01005251|259762|P2|Overall Study|Adverse Event|6
71234|NCT01005251|259763|P1|Overall Study|Adverse Event|2
71235|NCT01005251|259759|P5|Overall Study|Eligibility criteria not fulfilled|0
71236|NCT01005251|259760|P4|Overall Study|Eligibility criteria not fulfilled|1
71237|NCT01005251|259761|P3|Overall Study|Eligibility criteria not fulfilled|4
71238|NCT01005251|259762|P2|Overall Study|Eligibility criteria not fulfilled|0
71239|NCT01005251|259763|P1|Overall Study|Eligibility criteria not fulfilled|4
71240|NCT01005251|259759|P5|Overall Study|Withdrawal by Subject|9
71241|NCT01005251|259760|P4|Overall Study|Withdrawal by Subject|4
71242|NCT01005251|259761|P3|Overall Study|Withdrawal by Subject|3
71243|NCT01005251|259762|P2|Overall Study|Withdrawal by Subject|5
71244|NCT01005251|259763|P1|Overall Study|Withdrawal by Subject|2
71245|NCT01004848|259832|P2|Overall Study|Lost to Follow-up|45
71246|NCT01004848|259833|P1|Overall Study|Lost to Follow-up|55
71247|NCT01004822|259871|P8|Overall Study|Unspecified|0
71248|NCT01004822|259872|P7|Overall Study|Unspecified|0
71249|NCT01004822|259873|P6|Overall Study|Unspecified|1
71250|NCT01004822|259874|P5|Overall Study|Unspecified|0
71251|NCT01004822|259875|P4|Overall Study|Unspecified|1
71252|NCT01004822|259876|P3|Overall Study|Unspecified|4
71253|NCT01004822|259877|P2|Overall Study|Unspecified|0
71254|NCT01004822|259878|P1|Overall Study|Unspecified|0
71255|NCT01004822|259871|P8|Overall Study|Adverse Event|1
71256|NCT01004822|259872|P7|Overall Study|Adverse Event|1
71257|NCT01004822|259873|P6|Overall Study|Adverse Event|0
71258|NCT01004822|259874|P5|Overall Study|Adverse Event|0
71259|NCT01004822|259875|P4|Overall Study|Adverse Event|0
71260|NCT01004822|259876|P3|Overall Study|Adverse Event|0
71261|NCT01004822|259877|P2|Overall Study|Adverse Event|0
71262|NCT01004822|259878|P1|Overall Study|Adverse Event|0
71263|NCT01004822|259871|P8|Overall Study|No longer willing to continue|0
71264|NCT01004822|259872|P7|Overall Study|No longer willing to continue|1
71265|NCT01004822|259873|P6|Overall Study|No longer willing to continue|1
71266|NCT01004822|259874|P5|Overall Study|No longer willing to continue|2
71267|NCT01004822|259875|P4|Overall Study|No longer willing to continue|1
71268|NCT01004822|259876|P3|Overall Study|No longer willing to continue|0
71269|NCT01004822|259877|P2|Overall Study|No longer willing to continue|0
71270|NCT01004822|259878|P1|Overall Study|No longer willing to continue|0
71271|NCT01004822|259871|P8|Overall Study|Global deterioration of health status|0
71272|NCT01004822|259872|P7|Overall Study|Global deterioration of health status|1
71273|NCT01004822|259873|P6|Overall Study|Global deterioration of health status|0
71274|NCT01004822|259874|P5|Overall Study|Global deterioration of health status|0
71275|NCT01004822|259875|P4|Overall Study|Global deterioration of health status|1
71276|NCT01004822|259876|P3|Overall Study|Global deterioration of health status|0
71277|NCT01004822|259877|P2|Overall Study|Global deterioration of health status|0
71278|NCT01004822|259878|P1|Overall Study|Global deterioration of health status|0
71279|NCT01004822|259871|P8|Overall Study|Objective progression or relapse|4
71280|NCT01004822|259872|P7|Overall Study|Objective progression or relapse|1
71281|NCT01004822|259873|P6|Overall Study|Objective progression or relapse|2
71282|NCT01004822|259874|P5|Overall Study|Objective progression or relapse|2
71283|NCT01004822|259875|P4|Overall Study|Objective progression or relapse|1
71284|NCT01004822|259876|P3|Overall Study|Objective progression or relapse|0
71285|NCT01004822|259877|P2|Overall Study|Objective progression or relapse|3
71286|NCT01004822|259878|P1|Overall Study|Objective progression or relapse|3
71287|NCT01004614|260043|P4|Washout|Withdrawal by Subject|0
71288|NCT01004614|260044|P3|Washout|Withdrawal by Subject|0
71289|NCT01004614|260045|P2|Washout|Withdrawal by Subject|1
71290|NCT01004614|260046|P1|Washout|Withdrawal by Subject|0
71291|NCT01004510|260080|P1|Overall Study|Adverse Event|1
71292|NCT01004432|260084|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
71293|NCT01004432|260085|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
71294|NCT01004432|260086|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
71295|NCT01004432|260087|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
71296|NCT01004432|260088|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
71297|NCT01004432|260084|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
71298|NCT01004432|260085|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
71299|NCT01004432|260086|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
71300|NCT01004432|260087|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
71301|NCT01004432|260088|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
71302|NCT01004432|260084|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
71303|NCT01004432|260085|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
71304|NCT01004432|260086|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
71305|NCT01004432|260087|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
71306|NCT01004432|260088|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
71307|NCT01004432|260084|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
71308|NCT01004432|260085|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
71309|NCT01004432|260086|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
71310|NCT01004432|260087|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
71311|NCT01004432|260088|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
71312|NCT01004432|260084|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
71313|NCT01004432|260085|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
71314|NCT01004432|260086|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
71315|NCT01004432|260087|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
71316|NCT01004432|260088|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
71317|NCT01004432|260084|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
71318|NCT01004432|260085|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
71319|NCT01004432|260086|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
71320|NCT01004432|260087|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
71321|NCT01004432|260088|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
71322|NCT01004432|260084|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
71323|NCT01004432|260085|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
71324|NCT01004432|260086|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
71325|NCT01004432|260087|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
71326|NCT01004432|260088|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
71327|NCT01004432|260084|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
71328|NCT01004432|260085|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
71329|NCT01004432|260086|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
71330|NCT01004432|260087|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
71331|NCT01004432|260088|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
71332|NCT01004432|260084|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
71333|NCT01004432|260085|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
71334|NCT01004432|260086|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
71335|NCT01004432|260087|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
71336|NCT01004432|260088|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
71337|NCT01004432|260084|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
71338|NCT01004432|260085|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
71339|NCT01004432|260086|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
71340|NCT01004432|260087|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
71341|NCT01004432|260088|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
71342|NCT01004432|260084|P5|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
71343|NCT01004432|260085|P4|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
71344|NCT01004432|260086|P3|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
71345|NCT01004432|260087|P2|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
71346|NCT01004432|260088|P1|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|2
71347|NCT01004432|260084|P5|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
71348|NCT01004432|260085|P4|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
71349|NCT01004432|260086|P3|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
71350|NCT01004432|260087|P2|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
71351|NCT01004432|260088|P1|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|15
71352|NCT01004432|260084|P5|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
71353|NCT01004432|260085|P4|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
71354|NCT01004432|260086|P3|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
71355|NCT01004432|260087|P2|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
71356|NCT01004432|260088|P1|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|17
71357|NCT01004432|260084|P5|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
71358|NCT01004432|260085|P4|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
71359|NCT01004432|260086|P3|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
71360|NCT01004432|260087|P2|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
71361|NCT01004432|260088|P1|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|29
71362|NCT01004432|260084|P5|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
71363|NCT01004432|260085|P4|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
71364|NCT01004432|260086|P3|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
71365|NCT01004432|260087|P2|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
71366|NCT01004432|260088|P1|Open-label (OL) Period (Week 0 – 16)|Adverse Event|20
71367|NCT01004263|260123|P1|Overall Study|Lack of Qualifying Event|2
71368|NCT01004263|260123|P1|Overall Study|Physician Decision|15
71369|NCT01004263|260123|P1|Overall Study|Pregnancy|2
71370|NCT01004263|260123|P1|Overall Study|Lack of Efficacy|13
71371|NCT01004263|260123|P1|Overall Study|Lost to Follow-up|64
71372|NCT01004263|260123|P1|Overall Study|Protocol Violation|10
71373|NCT01004263|260123|P1|Overall Study|Withdrawal by Subject|58
71374|NCT01004263|260123|P1|Overall Study|Adverse Event|15
71375|NCT01004250|260131|P1|Follow-Up (FU) Period|Lost to Follow-up|1
71376|NCT01004250|260131|P1|Maintenance Therapy Period|Physician Decision|4
71377|NCT01004250|260131|P1|Maintenance Therapy Period|Withdrawal by Subject|5
71378|NCT01004250|260131|P1|Maintenance Therapy Period|Protocol Violation|1
71379|NCT01004250|260131|P1|Maintenance Therapy Period|Lost to Follow-up|1
71380|NCT01004250|260131|P1|Maintenance Therapy Period|Adverse Event|15
71381|NCT01004250|260131|P1|Induction Therapy Period|Physician Decision|2
71382|NCT01004250|260131|P1|Induction Therapy Period|Withdrawal by Subject|2
71383|NCT01004250|260131|P1|Induction Therapy Period|Entry Criteria Not Met|1
71384|NCT01004250|260131|P1|Induction Therapy Period|Adverse Event|10
71385|NCT01004185|260143|P2|Overall Study|Withdrawal by Subject|1
71386|NCT01004185|260144|P1|Overall Study|Withdrawal by Subject|2
71387|NCT01004185|260143|P2|Overall Study|Sponsor Terminated Study|5
71388|NCT01004185|260144|P1|Overall Study|Sponsor Terminated Study|4
71389|NCT01004185|260143|P2|Overall Study|Lack of Efficacy|1
71390|NCT01004185|260144|P1|Overall Study|Lack of Efficacy|2
71391|NCT01004185|260143|P2|Overall Study|Lost to Follow-up|1
71392|NCT01004185|260144|P1|Overall Study|Lost to Follow-up|0
71393|NCT01004185|260143|P2|Overall Study|Adverse Event|1
71394|NCT01004185|260144|P1|Overall Study|Adverse Event|1
71395|NCT01004159|260152|P1|Overall Study|Disease Progression|18
71396|NCT01004159|260152|P1|Overall Study|Adverse Event|2
71397|NCT01004146|260159|P2|Overall Study|Withdrawal by Subject|5
71398|NCT01004146|260160|P1|Overall Study|Withdrawal by Subject|4
71399|NCT01004003|260175|P9|Overall Study|Other|0
71400|NCT01004003|260176|P8|Overall Study|Other|0
71401|NCT01004003|260177|P7|Overall Study|Other|0
71402|NCT01004003|260178|P6|Overall Study|Other|1
71403|NCT01004003|260179|P5|Overall Study|Other|0
71404|NCT01004003|260180|P4|Overall Study|Other|0
71405|NCT01004003|260181|P3|Overall Study|Other|0
71406|NCT01004003|260182|P2|Overall Study|Other|0
71407|NCT01004003|260183|P1|Overall Study|Other|0
71408|NCT01004003|260175|P9|Overall Study|Refused to continue taking trial med.|2
71409|NCT01004003|260176|P8|Overall Study|Refused to continue taking trial med.|0
71410|NCT01004003|260177|P7|Overall Study|Refused to continue taking trial med.|0
71411|NCT01004003|260178|P6|Overall Study|Refused to continue taking trial med.|0
71412|NCT01004003|260179|P5|Overall Study|Refused to continue taking trial med.|0
71413|NCT01004003|260180|P4|Overall Study|Refused to continue taking trial med.|0
71414|NCT01004003|260181|P3|Overall Study|Refused to continue taking trial med.|0
71415|NCT01004003|260182|P2|Overall Study|Refused to continue taking trial med.|0
71416|NCT01004003|260183|P1|Overall Study|Refused to continue taking trial med.|0
71417|NCT01004003|260175|P9|Overall Study|Adverse Event|6
71418|NCT01004003|260176|P8|Overall Study|Adverse Event|21
71419|NCT01004003|260177|P7|Overall Study|Adverse Event|7
71420|NCT01004003|260178|P6|Overall Study|Adverse Event|2
71421|NCT01004003|260179|P5|Overall Study|Adverse Event|2
71422|NCT01004003|260180|P4|Overall Study|Adverse Event|3
71423|NCT01004003|260181|P3|Overall Study|Adverse Event|3
71424|NCT01004003|260182|P2|Overall Study|Adverse Event|2
71425|NCT01004003|260183|P1|Overall Study|Adverse Event|4
71426|NCT01004003|260175|P9|Overall Study|Progressive disease|22
71427|NCT01004003|260176|P8|Overall Study|Progressive disease|39
71428|NCT01004003|260177|P7|Overall Study|Progressive disease|1
71429|NCT01004003|260178|P6|Overall Study|Progressive disease|1
71430|NCT01004003|260179|P5|Overall Study|Progressive disease|2
71431|NCT01004003|260180|P4|Overall Study|Progressive disease|0
71432|NCT01004003|260181|P3|Overall Study|Progressive disease|1
71433|NCT01004003|260182|P2|Overall Study|Progressive disease|1
71434|NCT01004003|260183|P1|Overall Study|Progressive disease|2
71435|NCT01003899|260220|P1|Overall Study|Progressive disease|34
71436|NCT01003899|260220|P1|Overall Study|Not treated|1
71437|NCT01003899|260220|P1|Overall Study|Not entered|4
71438|NCT01003899|260220|P1|Overall Study|Other Adverse Event|8
71439|NCT01003886|260229|P1|Overall Study|Adverse Event|3
71440|NCT01003886|260229|P1|Overall Study|Unspecified|14
71441|NCT01003886|260229|P1|Overall Study|Withdrawal by Subject|39
71442|NCT01003886|260229|P1|Overall Study|Lost to Follow-up|169
71443|NCT01003886|260229|P1|Overall Study|Lack of Efficacy|5
71444|NCT01002742|260240|P2|Overall Study|Determined to be ineligible|1
71445|NCT01002742|260241|P1|Overall Study|Determined to be ineligible|0
71446|NCT01003210|260302|P2|Overall Study|Lost to Follow-up|3
71447|NCT01003210|260303|P1|Overall Study|Lost to Follow-up|1
71448|NCT01003184|260313|P2|Overall Study|Physician Decision|0
71449|NCT01003184|260314|P1|Overall Study|Physician Decision|1
71450|NCT01003184|260313|P2|Overall Study|Withdrawal by Subject|6
71451|NCT01003184|260314|P1|Overall Study|Withdrawal by Subject|1
71452|NCT01003184|260313|P2|Overall Study|Protocol Violation|0
71453|NCT01003184|260314|P1|Overall Study|Protocol Violation|3
71454|NCT01003184|260313|P2|Overall Study|Loss of glucose control|1
71455|NCT01003184|260314|P1|Overall Study|Loss of glucose control|1
71456|NCT01003184|260313|P2|Overall Study|Lost to Follow-up|0
71457|NCT01003184|260314|P1|Overall Study|Lost to Follow-up|1
71458|NCT01003184|260313|P2|Overall Study|Adverse Event|5
71459|NCT01003184|260314|P1|Overall Study|Adverse Event|12
71460|NCT01002989|260388|P1|Overall Study|exclusion criteria, no consent|5
71461|NCT01002573|260397|P2|Overall Study|Subject did not receive at least 1 dose|7
71462|NCT01002573|260398|P1|Overall Study|Subject did not receive at least 1 dose|11
71463|NCT01002482|260418|P2|Overall Study|Included twice|0
71464|NCT01002482|260419|P1|Overall Study|Included twice|1
71465|NCT01002482|260418|P2|Overall Study|Withdrawal by Subject|21
71466|NCT01002482|260419|P1|Overall Study|Withdrawal by Subject|14
71467|NCT01002339|260453|P3|Overall Study|Randomized. Not transplanted|1
71468|NCT01002339|260454|P2|Overall Study|Randomized. Not transplanted|0
71469|NCT01002339|260455|P1|Overall Study|Randomized. Not transplanted|0
71470|NCT01002339|260453|P3|Overall Study|Lung cancer detected before transplant|1
71471|NCT01002339|260454|P2|Overall Study|Lung cancer detected before transplant|0
71472|NCT01002339|260455|P1|Overall Study|Lung cancer detected before transplant|0
71473|NCT01002339|260453|P3|Overall Study|Protocol Violation|2
71474|NCT01002339|260454|P2|Overall Study|Protocol Violation|0
71475|NCT01002339|260455|P1|Overall Study|Protocol Violation|0
71476|NCT01002339|260453|P3|Overall Study|Incorrect treatment assignment|1
71477|NCT01002339|260454|P2|Overall Study|Incorrect treatment assignment|0
71478|NCT01002339|260455|P1|Overall Study|Incorrect treatment assignment|0
71479|NCT01002339|260453|P3|Overall Study|Withdrawal by Subject|0
71480|NCT01002339|260454|P2|Overall Study|Withdrawal by Subject|1
71481|NCT01002339|260455|P1|Overall Study|Withdrawal by Subject|0
71482|NCT01002105|260525|P2|Overall Study|condition worsened|2
71483|NCT01002105|260526|P1|Overall Study|condition worsened|4
71484|NCT01002105|260525|P2|Overall Study|non compliance|3
71485|NCT01002105|260526|P1|Overall Study|non compliance|5
71486|NCT01002105|260525|P2|Overall Study|Lost to Follow-up|16
71487|NCT01002105|260526|P1|Overall Study|Lost to Follow-up|10
71488|NCT01001832|260555|P2|Follow-up Period|Not specified|1
71489|NCT01001832|260556|P1|Follow-up Period|Not specified|2
71490|NCT01001832|260555|P2|Follow-up Period|Follow-up no longer required /protocol|20
71491|NCT01001832|260556|P1|Follow-up Period|Follow-up no longer required /protocol|15
71492|NCT01001832|260555|P2|Follow-up Period|Withdrawal by Subject|0
71493|NCT01001832|260556|P1|Follow-up Period|Withdrawal by Subject|1
71494|NCT01001832|260555|P2|Long-term Period|Not specified|2
71495|NCT01001832|260556|P1|Long-term Period|Not specified|1
71496|NCT01001832|260555|P2|Long-term Period|Lack of Efficacy|2
71497|NCT01001832|260556|P1|Long-term Period|Lack of Efficacy|0
71498|NCT01001832|260555|P2|Long-term Period|Withdrawal by Subject|0
71499|NCT01001832|260556|P1|Long-term Period|Withdrawal by Subject|1
71500|NCT01001832|260555|P2|Long-term Period|Adverse Event|1
71501|NCT01001832|260556|P1|Long-term Period|Adverse Event|2
71502|NCT01001832|260555|P2|Short-term Period|Adverse Event|3
71503|NCT01001832|260556|P1|Short-term Period|Adverse Event|2
71504|NCT01001767|260614|P2|Overall Study|Physician Decision|0
71505|NCT01001767|260615|P1|Overall Study|Physician Decision|1
71506|NCT01001767|260614|P2|Overall Study|Lost to Follow-up|0
71507|NCT01001767|260615|P1|Overall Study|Lost to Follow-up|1
71508|NCT01001767|260614|P2|Overall Study|Protocol Violation|0
71509|NCT01001767|260615|P1|Overall Study|Protocol Violation|1
71510|NCT01001767|260614|P2|Overall Study|no baseline study performed|0
71511|NCT01001767|260615|P1|Overall Study|no baseline study performed|1
71512|NCT01001702|260621|P1|Overall Study|Lack of Efficacy per Investigator|3
71513|NCT01001702|260621|P1|Overall Study|Withdrawal by Subject|19
71514|NCT01001702|260621|P1|Overall Study|Investigator withdrew Subject|10
71515|NCT01001702|260621|P1|Overall Study|Subject met Withdrawal Criteria|22
71516|NCT01001702|260621|P1|Overall Study|Sponsor Discontinued Study|4
71517|NCT01001702|260621|P1|Overall Study|Adverse Event|7
71518|NCT01001702|260621|P1|Overall Study|Lost to Follow-up|7
71519|NCT01001572|260634|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
71520|NCT01001572|260635|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
71521|NCT01001572|260636|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
71522|NCT01001572|260634|P3|Double-Blind Treatment Phase|Protocol deviation|1
71523|NCT01001572|260635|P2|Double-Blind Treatment Phase|Protocol deviation|0
71524|NCT01001572|260636|P1|Double-Blind Treatment Phase|Protocol deviation|0
71525|NCT01001572|260634|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
71526|NCT01001572|260635|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
71527|NCT01001572|260636|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
71528|NCT01001572|260634|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
71529|NCT01001572|260635|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
71530|NCT01001572|260636|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
71531|NCT01001572|260634|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
71532|NCT01001572|260635|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
71533|NCT01001572|260636|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
71534|NCT01001572|260634|P3|Double-Blind Treatment Phase|Adverse Event|2
71535|NCT01001572|260635|P2|Double-Blind Treatment Phase|Adverse Event|2
71536|NCT01001572|260636|P1|Double-Blind Treatment Phase|Adverse Event|0
71537|NCT01001572|260634|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
71538|NCT01001572|260635|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
71539|NCT01001572|260636|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
71540|NCT01001572|260634|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
71541|NCT01001572|260635|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
71542|NCT01001572|260636|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
71543|NCT01001572|260634|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
71544|NCT01001572|260635|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
71545|NCT01001572|260636|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
71546|NCT01001572|260634|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
71547|NCT01001572|260635|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
71548|NCT01001572|260636|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
71549|NCT01001572|260634|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
71550|NCT01001572|260635|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
71551|NCT01001572|260636|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
71552|NCT01001572|260634|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
71553|NCT01001572|260635|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
71554|NCT01001572|260636|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
71555|NCT01001572|260634|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
71556|NCT01001572|260635|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
71557|NCT01001572|260636|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
71558|NCT01001572|260634|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
71559|NCT01001572|260635|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
71560|NCT01001572|260636|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
71561|NCT01001520|260674|P2|Medication Period 2|Withdrawal by Subject|3
71562|NCT01001520|260675|P1|Medication Period 2|Withdrawal by Subject|0
71563|NCT01001520|260674|P2|Washout Period|Withdrawal by Subject|1
71564|NCT01001520|260675|P1|Washout Period|Withdrawal by Subject|2
71565|NCT01001520|260674|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
71566|NCT01001520|260675|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
71567|NCT01001520|260674|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
71568|NCT01001520|260675|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
71569|NCT01001520|260674|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
71570|NCT01001520|260675|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
71571|NCT01001520|260674|P2|Medication Period 1|Withdrawal by Subject|2
71572|NCT01001520|260675|P1|Medication Period 1|Withdrawal by Subject|2
71573|NCT01001494|260702|P3|Overall Study|Other|3
71574|NCT01001494|260703|P2|Overall Study|Other|1
71575|NCT01001494|260704|P1|Overall Study|Other|0
71576|NCT01001494|260702|P3|Overall Study|Lack of Efficacy|8
71577|NCT01001494|260703|P2|Overall Study|Lack of Efficacy|0
71578|NCT01001494|260704|P1|Overall Study|Lack of Efficacy|2
71579|NCT01001494|260702|P3|Overall Study|COPD exacerbation|5
71580|NCT01001494|260703|P2|Overall Study|COPD exacerbation|4
71581|NCT01001494|260704|P1|Overall Study|COPD exacerbation|3
71582|NCT01001494|260702|P3|Overall Study|Withdrawal by Subject|17
71583|NCT01001494|260703|P2|Overall Study|Withdrawal by Subject|7
71584|NCT01001494|260704|P1|Overall Study|Withdrawal by Subject|9
71585|NCT01001494|260702|P3|Overall Study|Lost to Follow-up|1
71586|NCT01001494|260703|P2|Overall Study|Lost to Follow-up|0
71587|NCT01001494|260704|P1|Overall Study|Lost to Follow-up|2
71588|NCT01001494|260702|P3|Overall Study|Protocol Violation|1
71589|NCT01001494|260703|P2|Overall Study|Protocol Violation|1
71590|NCT01001494|260704|P1|Overall Study|Protocol Violation|0
71591|NCT01001494|260702|P3|Overall Study|Adverse Event|6
71592|NCT01001494|260703|P2|Overall Study|Adverse Event|4
71593|NCT01001494|260704|P1|Overall Study|Adverse Event|8
71594|NCT01001390|260733|P2|Overall Study|Failure to wear AFO device|0
71595|NCT01001390|260734|P1|Overall Study|Failure to wear AFO device|2
71596|NCT01001377|260742|P2|Overall Study|Death|384
71597|NCT01001377|260743|P1|Overall Study|Death|391
71598|NCT01001377|260742|P2|Overall Study|Lost to Follow-up|17
71599|NCT01001377|260743|P1|Overall Study|Lost to Follow-up|14
71600|NCT01001377|260742|P2|Overall Study|Withdrawal by Subject|20
71601|NCT01001377|260743|P1|Overall Study|Withdrawal by Subject|19
71602|NCT01001377|260742|P2|Overall Study|Ineligibility determined|0
71603|NCT01001377|260743|P1|Overall Study|Ineligibility determined|2
71604|NCT01001325|260773|P2|Overall Study|Protocol Violation|0
71605|NCT01001325|260774|P1|Overall Study|Protocol Violation|2
71606|NCT01001325|260773|P2|Overall Study|Lost to Follow-up|10
71607|NCT01001325|260774|P1|Overall Study|Lost to Follow-up|16
71608|NCT01001299|260780|P1|Overall Study|Withdrew Consent|1
71609|NCT01001299|260780|P1|Overall Study|Began Taking Commercially Available Drug|2
71610|NCT01001299|260780|P1|Overall Study|Death|1
71611|NCT01001299|260780|P1|Overall Study|Adverse event or Intercurrent Illness|1
71612|NCT01001299|260780|P1|Overall Study|Insufficient Therapeutic Response|20
71613|NCT01001234|260809|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
71614|NCT01001234|260810|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
71615|NCT01001234|260811|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
71616|NCT01001234|260812|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
71617|NCT01001234|260813|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
71618|NCT01001234|260809|P5|Overall Study|Not Treated: Physician Decision|0
71619|NCT01001234|260810|P4|Overall Study|Not Treated: Physician Decision|0
71620|NCT01001234|260811|P3|Overall Study|Not Treated: Physician Decision|0
71621|NCT01001234|260812|P2|Overall Study|Not Treated: Physician Decision|4
71622|NCT01001234|260813|P1|Overall Study|Not Treated: Physician Decision|37
71623|NCT01001234|260809|P5|Overall Study|Not Treated: Pregnancy|0
71624|NCT01001234|260810|P4|Overall Study|Not Treated: Pregnancy|0
71625|NCT01001234|260811|P3|Overall Study|Not Treated: Pregnancy|0
71626|NCT01001234|260812|P2|Overall Study|Not Treated: Pregnancy|0
71627|NCT01001234|260813|P1|Overall Study|Not Treated: Pregnancy|3
71628|NCT01001234|260809|P5|Overall Study|Not Treated: Lost to Follow-up|0
71629|NCT01001234|260810|P4|Overall Study|Not Treated: Lost to Follow-up|5
71630|NCT01001234|260811|P3|Overall Study|Not Treated: Lost to Follow-up|7
71631|NCT01001234|260812|P2|Overall Study|Not Treated: Lost to Follow-up|4
71632|NCT01001234|260813|P1|Overall Study|Not Treated: Lost to Follow-up|53
71633|NCT01001234|260809|P5|Overall Study|Not Treated: Protocol Violation|0
71634|NCT01001234|260810|P4|Overall Study|Not Treated: Protocol Violation|0
71635|NCT01001234|260811|P3|Overall Study|Not Treated: Protocol Violation|0
71636|NCT01001234|260812|P2|Overall Study|Not Treated: Protocol Violation|0
71637|NCT01001234|260813|P1|Overall Study|Not Treated: Protocol Violation|3
71638|NCT01001234|260809|P5|Overall Study|Not Treated: Withdrawal by Subject|0
71639|NCT01001234|260810|P4|Overall Study|Not Treated: Withdrawal by Subject|0
71640|NCT01001234|260811|P3|Overall Study|Not Treated: Withdrawal by Subject|2
71641|NCT01001234|260812|P2|Overall Study|Not Treated: Withdrawal by Subject|2
71642|NCT01001234|260813|P1|Overall Study|Not Treated: Withdrawal by Subject|23
71643|NCT01001234|260809|P5|Overall Study|Not Treated: Adverse Event|0
71644|NCT01001234|260810|P4|Overall Study|Not Treated: Adverse Event|0
71645|NCT01001234|260811|P3|Overall Study|Not Treated: Adverse Event|0
71646|NCT01001234|260812|P2|Overall Study|Not Treated: Adverse Event|0
71647|NCT01001234|260813|P1|Overall Study|Not Treated: Adverse Event|1
71648|NCT01001234|260809|P5|Overall Study|Physician Decision|0
71649|NCT01001234|260810|P4|Overall Study|Physician Decision|0
71650|NCT01001234|260811|P3|Overall Study|Physician Decision|0
71651|NCT01001234|260812|P2|Overall Study|Physician Decision|0
71652|NCT01001234|260813|P1|Overall Study|Physician Decision|1
71653|NCT01001234|260809|P5|Overall Study|Lost to Follow-up|0
71654|NCT01001234|260810|P4|Overall Study|Lost to Follow-up|2
71655|NCT01001234|260811|P3|Overall Study|Lost to Follow-up|1
71656|NCT01001234|260812|P2|Overall Study|Lost to Follow-up|0
71657|NCT01001234|260813|P1|Overall Study|Lost to Follow-up|0
71658|NCT01001234|260809|P5|Overall Study|Protocol Violation|0
71659|NCT01001234|260810|P4|Overall Study|Protocol Violation|18
71660|NCT01001234|260811|P3|Overall Study|Protocol Violation|19
71661|NCT01001234|260812|P2|Overall Study|Protocol Violation|3
71662|NCT01001234|260813|P1|Overall Study|Protocol Violation|34
71663|NCT01001234|260809|P5|Overall Study|Withdrawal by Subject|0
71664|NCT01001234|260810|P4|Overall Study|Withdrawal by Subject|0
71665|NCT01001234|260811|P3|Overall Study|Withdrawal by Subject|3
71666|NCT01001234|260812|P2|Overall Study|Withdrawal by Subject|0
71667|NCT01001234|260813|P1|Overall Study|Withdrawal by Subject|2
71668|NCT01001221|260829|P5|Overall Study|Not treated; protocol exclusion|0
71669|NCT01001221|260830|P4|Overall Study|Not treated; protocol exclusion|0
71670|NCT01001221|260831|P3|Overall Study|Not treated; protocol exclusion|1
71671|NCT01001221|260832|P2|Overall Study|Not treated; protocol exclusion|0
71672|NCT01001221|260833|P1|Overall Study|Not treated; protocol exclusion|0
71673|NCT01001221|260829|P5|Overall Study|Not specified|0
71674|NCT01001221|260830|P4|Overall Study|Not specified|0
71675|NCT01001221|260831|P3|Overall Study|Not specified|0
71676|NCT01001221|260832|P2|Overall Study|Not specified|1
71677|NCT01001221|260833|P1|Overall Study|Not specified|1
71678|NCT01001221|260829|P5|Overall Study|Disease progression|0
71679|NCT01001221|260830|P4|Overall Study|Disease progression|4
71680|NCT01001221|260831|P3|Overall Study|Disease progression|2
71681|NCT01001221|260832|P2|Overall Study|Disease progression|2
71682|NCT01001221|260833|P1|Overall Study|Disease progression|3
71683|NCT01001221|260829|P5|Overall Study|Adverse Event|0
71684|NCT01001221|260830|P4|Overall Study|Adverse Event|2
71685|NCT01001221|260831|P3|Overall Study|Adverse Event|0
71686|NCT01001221|260832|P2|Overall Study|Adverse Event|2
71687|NCT01001221|260833|P1|Overall Study|Adverse Event|1
71688|NCT01001208|261008|P2|Overall Study|Other|2
71689|NCT01001208|261009|P1|Overall Study|Other|0
71690|NCT01001208|261008|P2|Overall Study|Disease Progression|3
71691|NCT01001208|261009|P1|Overall Study|Disease Progression|0
71692|NCT01001208|261008|P2|Overall Study|Noncompliance|7
71693|NCT01001208|261009|P1|Overall Study|Noncompliance|4
71694|NCT01001208|261008|P2|Overall Study|Ineligibility Determined|2
71695|NCT01001208|261009|P1|Overall Study|Ineligibility Determined|4
71696|NCT01001208|261008|P2|Overall Study|Withdrawal by Subject|5
71697|NCT01001208|261009|P1|Overall Study|Withdrawal by Subject|4
71698|NCT01001208|261008|P2|Overall Study|Physician Decision|0
71699|NCT01001208|261009|P1|Overall Study|Physician Decision|1
71700|NCT01001208|261008|P2|Overall Study|Lost to Follow-up|9
71701|NCT01001208|261009|P1|Overall Study|Lost to Follow-up|5
71702|NCT01001208|261008|P2|Overall Study|Adverse Event|5
71703|NCT01001208|261009|P1|Overall Study|Adverse Event|10
71704|NCT01001104|261054|P4|Overall Study|Withdrawal by Subject|2
71705|NCT01001104|261055|P3|Overall Study|Withdrawal by Subject|0
71706|NCT01001104|261056|P2|Overall Study|Withdrawal by Subject|0
71707|NCT01001104|261057|P1|Overall Study|Withdrawal by Subject|0
71708|NCT01001104|261054|P4|Overall Study|Entry Criteria Not Met|1
71709|NCT01001104|261055|P3|Overall Study|Entry Criteria Not Met|0
71710|NCT01001104|261056|P2|Overall Study|Entry Criteria Not Met|0
71711|NCT01001104|261057|P1|Overall Study|Entry Criteria Not Met|0
71712|NCT01001104|261054|P4|Overall Study|Lost to Follow-up|0
71713|NCT01001104|261055|P3|Overall Study|Lost to Follow-up|1
71714|NCT01001104|261056|P2|Overall Study|Lost to Follow-up|0
71715|NCT01001104|261057|P1|Overall Study|Lost to Follow-up|0
71716|NCT01001104|261054|P4|Overall Study|Adverse Event|0
71717|NCT01001104|261055|P3|Overall Study|Adverse Event|0
71718|NCT01001104|261056|P2|Overall Study|Adverse Event|1
71719|NCT01001104|261057|P1|Overall Study|Adverse Event|2
71720|NCT01000974|261135|P3|Booster Vaccination Phase|Unspecified|4
71721|NCT01000974|261136|P2|Booster Vaccination Phase|Unspecified|6
71722|NCT01000974|261137|P1|Booster Vaccination Phase|Unspecified|24
71723|NCT01000974|261135|P3|Booster Vaccination Phase|Lost to Follow-up|7
71724|NCT01000974|261136|P2|Booster Vaccination Phase|Lost to Follow-up|5
71725|NCT01000974|261137|P1|Booster Vaccination Phase|Lost to Follow-up|40
71726|NCT01000974|261135|P3|Booster Vaccination Phase|Withdrawal by Subject|1
71727|NCT01000974|261136|P2|Booster Vaccination Phase|Withdrawal by Subject|1
71728|NCT01000974|261137|P1|Booster Vaccination Phase|Withdrawal by Subject|3
71729|NCT01000974|261135|P3|Booster Vaccination Phase|Protocol Violation|2
71730|NCT01000974|261136|P2|Booster Vaccination Phase|Protocol Violation|0
71731|NCT01000974|261137|P1|Booster Vaccination Phase|Protocol Violation|0
71732|NCT01000974|261135|P3|Primary Vaccination Phase|Unspecified|12
71733|NCT01000974|261136|P2|Primary Vaccination Phase|Unspecified|9
71734|NCT01000974|261137|P1|Primary Vaccination Phase|Unspecified|4
71735|NCT01000974|261135|P3|Primary Vaccination Phase|Adverse Event|2
71736|NCT01000974|261136|P2|Primary Vaccination Phase|Adverse Event|2
71737|NCT01000974|261137|P1|Primary Vaccination Phase|Adverse Event|14
71738|NCT01000974|261135|P3|Primary Vaccination Phase|Protocol Violation|2
71739|NCT01000974|261136|P2|Primary Vaccination Phase|Protocol Violation|3
71740|NCT01000974|261137|P1|Primary Vaccination Phase|Protocol Violation|40
71741|NCT01000974|261135|P3|Primary Vaccination Phase|Lost to Follow-up|26
71742|NCT01000974|261136|P2|Primary Vaccination Phase|Lost to Follow-up|19
71743|NCT01000974|261137|P1|Primary Vaccination Phase|Lost to Follow-up|171
71744|NCT01000974|261135|P3|Primary Vaccination Phase|Withdrawal by Subject|21
71745|NCT01000974|261136|P2|Primary Vaccination Phase|Withdrawal by Subject|17
71746|NCT01000974|261137|P1|Primary Vaccination Phase|Withdrawal by Subject|109
71747|NCT01000961|261214|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
71748|NCT01000961|261215|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
71749|NCT01000961|261214|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
71750|NCT01000961|261215|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
71751|NCT01000805|261238|P2|Overall Study|Sponsor Decision|1
71752|NCT01000805|261239|P1|Overall Study|Sponsor Decision|0
71753|NCT01000805|261238|P2|Overall Study|Withdrawal by Subject|6
71754|NCT01000805|261239|P1|Overall Study|Withdrawal by Subject|16
71755|NCT01000805|261238|P2|Overall Study|Protocol Violation|8
71756|NCT01000805|261239|P1|Overall Study|Protocol Violation|12
71757|NCT01000805|261238|P2|Overall Study|Physician Decision|1
71758|NCT01000805|261239|P1|Overall Study|Physician Decision|0
71759|NCT01000805|261238|P2|Overall Study|Lost to Follow-up|21
71760|NCT01000805|261239|P1|Overall Study|Lost to Follow-up|16
71761|NCT01000805|261238|P2|Overall Study|Lack of Efficacy|16
71762|NCT01000805|261239|P1|Overall Study|Lack of Efficacy|5
71763|NCT01000805|261238|P2|Overall Study|Adverse Event|9
71764|NCT01000805|261239|P1|Overall Study|Adverse Event|21
71765|NCT01000610|261280|P1|Overall Study|Treatment failure|1
71766|NCT01000610|261280|P1|Overall Study|Lost to Follow-up|4
71767|NCT01000610|261280|P1|Overall Study|Adverse Event|1
71768|NCT01000506|261291|P4|Overall Study|Withdrawal by Subject|7
71769|NCT01000506|261292|P3|Overall Study|Withdrawal by Subject|2
71770|NCT01000506|261293|P2|Overall Study|Withdrawal by Subject|8
71771|NCT01000506|261294|P1|Overall Study|Withdrawal by Subject|11
71772|NCT01000506|261291|P4|Overall Study|Physician Decision|3
71773|NCT01000506|261292|P3|Overall Study|Physician Decision|3
71774|NCT01000506|261293|P2|Overall Study|Physician Decision|3
71775|NCT01000506|261294|P1|Overall Study|Physician Decision|1
71776|NCT01000506|261291|P4|Overall Study|Lost to Follow-up|0
71777|NCT01000506|261292|P3|Overall Study|Lost to Follow-up|4
71778|NCT01000506|261293|P2|Overall Study|Lost to Follow-up|1
71779|NCT01000506|261294|P1|Overall Study|Lost to Follow-up|1
71780|NCT01000506|261291|P4|Overall Study|Protocol Violation|0
71781|NCT01000506|261292|P3|Overall Study|Protocol Violation|0
71782|NCT01000506|261293|P2|Overall Study|Protocol Violation|1
71783|NCT01000506|261294|P1|Overall Study|Protocol Violation|1
71784|NCT01000506|261291|P4|Overall Study|Lack of Efficacy|4
71785|NCT01000506|261292|P3|Overall Study|Lack of Efficacy|4
71786|NCT01000506|261293|P2|Overall Study|Lack of Efficacy|6
71787|NCT01000506|261294|P1|Overall Study|Lack of Efficacy|8
71788|NCT01000506|261291|P4|Overall Study|Adverse Event|9
71789|NCT01000506|261292|P3|Overall Study|Adverse Event|8
71790|NCT01000506|261293|P2|Overall Study|Adverse Event|5
71791|NCT01000506|261294|P1|Overall Study|Adverse Event|6
71792|NCT01000480|261336|P1|Concurrent Therapy Phase|Physician Decision|1
71793|NCT01000480|261336|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
71794|NCT01000480|261336|P1|Concurrent Therapy Phase|Protocol Violation|2
71795|NCT01000480|261336|P1|Concurrent Therapy Phase|Adverse Event|4
71796|NCT01000480|261336|P1|Induction Phase|Entry Criteria Not Met|3
71797|NCT01000480|261336|P1|Induction Phase|Physician Decision|1
71798|NCT01000480|261336|P1|Induction Phase|Lost to Follow-up|1
71799|NCT01000480|261336|P1|Induction Phase|Adverse Event|2
71800|NCT01000376|261344|P2|Cycle 1 Day 1|Progressive Disease|0
71801|NCT01000376|261345|P1|Cycle 1 Day 1|Progressive Disease|1
71802|NCT01000376|261344|P2|Cycle 1 Day 1|Adverse Event|0
71803|NCT01000376|261345|P1|Cycle 1 Day 1|Adverse Event|1
71804|NCT01000337|261355|P2|Overall Study|Lost to Follow-up|3
71805|NCT01000337|261356|P1|Overall Study|Lost to Follow-up|4
71806|NCT01000311|261374|P2|Overall Study|Administrative reason|15
71807|NCT01000311|261375|P1|Overall Study|Administrative reason|9
71808|NCT01000311|261374|P2|Overall Study|Inappropriate enrollment|0
71809|NCT01000311|261375|P1|Overall Study|Inappropriate enrollment|2
71810|NCT01000311|261374|P2|Overall Study|Protocol Violation|2
71811|NCT01000311|261375|P1|Overall Study|Protocol Violation|1
71812|NCT01000311|261374|P2|Overall Study|Lost to Follow-up|24
71813|NCT01000311|261375|P1|Overall Study|Lost to Follow-up|15
71814|NCT01000311|261374|P2|Overall Study|Withdrawal by Subject|24
71815|NCT01000311|261375|P1|Overall Study|Withdrawal by Subject|16
71816|NCT01000311|261374|P2|Overall Study|Adverse Event|5
71817|NCT01000311|261375|P1|Overall Study|Adverse Event|2
71818|NCT01000155|261425|P1|Overall Study|Adverse Event|1
71819|NCT01000155|261425|P1|Overall Study|Withdrawal by Subject|1
71820|NCT01000025|261431|P2|Overall Study|Intercurrent Illness|7
71821|NCT01000025|261432|P1|Overall Study|Intercurrent Illness|26
71822|NCT01000025|261431|P2|Overall Study|Lack of Efficacy|208
71823|NCT01000025|261432|P1|Overall Study|Lack of Efficacy|363
71824|NCT01000025|261431|P2|Overall Study|Death|13
71825|NCT01000025|261432|P1|Overall Study|Death|23
71826|NCT01000025|261431|P2|Overall Study|Withdrawal by Subject|8
71827|NCT01000025|261432|P1|Overall Study|Withdrawal by Subject|13
71828|NCT01000025|261431|P2|Overall Study|Adverse Event|2
71829|NCT01000025|261432|P1|Overall Study|Adverse Event|43
71830|NCT00999921|261450|P2|Overall Study|Lost to Follow-up|19
71831|NCT00999921|261451|P1|Overall Study|Lost to Follow-up|10
71832|NCT00999908|261461|P3|Treatment Period 2|Protocol Violation|0
71833|NCT00999908|261462|P2|Treatment Period 2|Protocol Violation|0
71834|NCT00999908|261463|P1|Treatment Period 2|Protocol Violation|1
71835|NCT00999908|261461|P3|Treatment Period 1|Subject withdrew consent|0
71836|NCT00999908|261462|P2|Treatment Period 1|Subject withdrew consent|0
71837|NCT00999908|261463|P1|Treatment Period 1|Subject withdrew consent|2
71838|NCT00999804|261492|P2|Overall Study|Ineligible|0
71839|NCT00999804|261493|P1|Overall Study|Ineligible|3
71840|NCT00999804|261492|P2|Overall Study|Death|0
71841|NCT00999804|261493|P1|Overall Study|Death|1
71842|NCT00999804|261492|P2|Overall Study|Withdrawal by Subject|0
71843|NCT00999804|261493|P1|Overall Study|Withdrawal by Subject|4
71844|NCT00999804|261492|P2|Overall Study|Adverse Event|3
71845|NCT00999804|261493|P1|Overall Study|Adverse Event|4
71846|NCT00999804|261492|P2|Overall Study|Lack of Efficacy|2
71847|NCT00999804|261493|P1|Overall Study|Lack of Efficacy|9
71848|NCT00999687|261505|P1|Second Intervention|Lack of Efficacy|1
71849|NCT00999687|261505|P1|Second Intervention|Withdrawal by Subject|2
71850|NCT00999687|261505|P1|First Intervention|Withdrawal by Subject|1
71851|NCT00999661|261512|P1|Overall Study|Not meeting eligibility criteria|9
71852|NCT00999661|261512|P1|Overall Study|Withdrawal by Subject|1
71853|NCT00999661|261512|P1|Overall Study|Adverse Event|1
71854|NCT00999661|261512|P1|Overall Study|Lost to Follow-up|59
71855|NCT00999596|261518|P1|Overall Study|Statistical population not required|101
71856|NCT00999544|261523|P1|Overall Study|Withdrawal by Subject|1
71857|NCT00999466|261544|P3|Main Part|Adverse Event|2
71858|NCT00999466|261545|P2|Main Part|Adverse Event|4
71859|NCT00999466|261546|P1|Main Part|Adverse Event|0
71860|NCT00999466|261544|P3|Main Part|Withdrawal by Subject|2
71861|NCT00999466|261545|P2|Main Part|Withdrawal by Subject|0
71862|NCT00999466|261546|P1|Main Part|Withdrawal by Subject|0
71863|NCT00999167|261823|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
71864|NCT00999167|261824|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
71865|NCT00999167|261825|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
71866|NCT00999167|261823|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
71867|NCT00999167|261824|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
71868|NCT00999167|261825|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
71869|NCT00999167|261823|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
71870|NCT00999167|261824|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
71871|NCT00999167|261825|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
71872|NCT00999167|261823|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
71873|NCT00999167|261824|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
71874|NCT00999167|261825|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
71875|NCT00999167|261823|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
71876|NCT00999167|261824|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
71877|NCT00999167|261825|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
71878|NCT00999167|261823|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
71879|NCT00999167|261824|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
71880|NCT00999167|261825|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
71881|NCT00999167|261823|P3|Part A: Open Label Safety run-in|Adverse Event|0
71882|NCT00999167|261824|P2|Part A: Open Label Safety run-in|Adverse Event|0
71883|NCT00999167|261825|P1|Part A: Open Label Safety run-in|Adverse Event|3
71884|NCT00999167|261823|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
71885|NCT00999167|261824|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
71886|NCT00999167|261825|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
71887|NCT00998985|261935|P14|Overall Study|Protocol Violation|0
71888|NCT00998985|261936|P13|Overall Study|Protocol Violation|0
71889|NCT00998985|261937|P12|Overall Study|Protocol Violation|0
71890|NCT00998985|261938|P11|Overall Study|Protocol Violation|0
71891|NCT00998985|261939|P10|Overall Study|Protocol Violation|0
71892|NCT00998985|261940|P9|Overall Study|Protocol Violation|0
71893|NCT00998985|261941|P8|Overall Study|Protocol Violation|0
71894|NCT00998985|261942|P7|Overall Study|Protocol Violation|0
71895|NCT00998985|261943|P6|Overall Study|Protocol Violation|1
71896|NCT00998985|261944|P5|Overall Study|Protocol Violation|0
71897|NCT00998985|261945|P4|Overall Study|Protocol Violation|0
71898|NCT00998985|261946|P3|Overall Study|Protocol Violation|0
71899|NCT00998985|261947|P2|Overall Study|Protocol Violation|0
71900|NCT00998985|261948|P1|Overall Study|Protocol Violation|0
71901|NCT00998985|261935|P14|Overall Study|Withdrawal by Subject|0
71902|NCT00998985|261936|P13|Overall Study|Withdrawal by Subject|0
71903|NCT00998985|261937|P12|Overall Study|Withdrawal by Subject|0
71904|NCT00998985|261938|P11|Overall Study|Withdrawal by Subject|0
71905|NCT00998985|261939|P10|Overall Study|Withdrawal by Subject|0
71906|NCT00998985|261940|P9|Overall Study|Withdrawal by Subject|1
71907|NCT00998985|261941|P8|Overall Study|Withdrawal by Subject|0
71908|NCT00998985|261942|P7|Overall Study|Withdrawal by Subject|0
71909|NCT00998985|261943|P6|Overall Study|Withdrawal by Subject|0
71910|NCT00998985|261944|P5|Overall Study|Withdrawal by Subject|0
71911|NCT00998985|261945|P4|Overall Study|Withdrawal by Subject|0
71912|NCT00998985|261946|P3|Overall Study|Withdrawal by Subject|0
71913|NCT00998985|261947|P2|Overall Study|Withdrawal by Subject|0
71914|NCT00998985|261948|P1|Overall Study|Withdrawal by Subject|0
71915|NCT00998881|262016|P2|Overall Study|Personal matter|0
71916|NCT00998881|262017|P1|Overall Study|Personal matter|1
71917|NCT00998881|262016|P2|Overall Study|Withdrawal by Subject|0
71918|NCT00998881|262017|P1|Overall Study|Withdrawal by Subject|1
71919|NCT00998881|262016|P2|Overall Study|Physician Decision|0
71920|NCT00998881|262017|P1|Overall Study|Physician Decision|3
71921|NCT00998881|262016|P2|Overall Study|Lack of Efficacy|0
71922|NCT00998881|262017|P1|Overall Study|Lack of Efficacy|1
71923|NCT00998881|262016|P2|Overall Study|Adverse Event|2
71924|NCT00998881|262017|P1|Overall Study|Adverse Event|2
71925|NCT00998764|262038|P2|Overall Study|Recurrent Episode of vasogenic edema|0
71926|NCT00998764|262039|P1|Overall Study|Recurrent Episode of vasogenic edema|1
71927|NCT00998764|262038|P2|Overall Study|Not specified|4
71928|NCT00998764|262039|P1|Overall Study|Not specified|4
71929|NCT00998764|262038|P2|Overall Study|Loss of Caregiver|3
71930|NCT00998764|262039|P1|Overall Study|Loss of Caregiver|0
71931|NCT00998764|262038|P2|Overall Study|Lost to Follow-up|1
71932|NCT00998764|262039|P1|Overall Study|Lost to Follow-up|1
71933|NCT00998764|262038|P2|Overall Study|Failed to Return|1
71934|NCT00998764|262039|P1|Overall Study|Failed to Return|1
71935|NCT00998764|262038|P2|Overall Study|Protocol Violation|1
71936|NCT00998764|262039|P1|Overall Study|Protocol Violation|0
71937|NCT00998764|262038|P2|Overall Study|Discontinuation of Study by Sponsor|217
71938|NCT00998764|262039|P1|Overall Study|Discontinuation of Study by Sponsor|164
71939|NCT00998764|262038|P2|Overall Study|Death|1
71940|NCT00998764|262039|P1|Overall Study|Death|3
71941|NCT00998764|262038|P2|Overall Study|Physician Decision|3
71942|NCT00998764|262039|P1|Overall Study|Physician Decision|3
71943|NCT00998764|262038|P2|Overall Study|Withdrawal by Subject|25
71944|NCT00998764|262039|P1|Overall Study|Withdrawal by Subject|19
71945|NCT00998764|262038|P2|Overall Study|Adverse Event|12
71946|NCT00998764|262039|P1|Overall Study|Adverse Event|17
71947|NCT00998764|262038|P2|Overall Study|Lack of Efficacy|6
71948|NCT00998764|262039|P1|Overall Study|Lack of Efficacy|3
71949|NCT00998738|262061|P1|Overall Study|Uknown|1
71950|NCT00998335|262144|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
71951|NCT00998335|262145|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
71952|NCT00998309|262173|P1|Overall Study|Protocol Violation|4
71953|NCT00998296|262240|P11|Overall Study|Reason other than those specified above|0
71954|NCT00998296|262241|P10|Overall Study|Reason other than those specified above|1
71955|NCT00998296|262242|P9|Overall Study|Reason other than those specified above|0
71956|NCT00998296|262243|P8|Overall Study|Reason other than those specified above|0
71957|NCT00998296|262244|P7|Overall Study|Reason other than those specified above|0
71958|NCT00998296|262245|P6|Overall Study|Reason other than those specified above|0
71959|NCT00998296|262246|P5|Overall Study|Reason other than those specified above|0
71960|NCT00998296|262247|P4|Overall Study|Reason other than those specified above|0
71961|NCT00998296|262248|P3|Overall Study|Reason other than those specified above|0
71962|NCT00998296|262249|P2|Overall Study|Reason other than those specified above|0
71963|NCT00998296|262250|P1|Overall Study|Reason other than those specified above|0
71964|NCT00998296|262240|P11|Overall Study|Refused to continue taking trial med.|0
71965|NCT00998296|262241|P10|Overall Study|Refused to continue taking trial med.|2
71966|NCT00998296|262242|P9|Overall Study|Refused to continue taking trial med.|0
71967|NCT00998296|262243|P8|Overall Study|Refused to continue taking trial med.|0
71968|NCT00998296|262244|P7|Overall Study|Refused to continue taking trial med.|0
71969|NCT00998296|262245|P6|Overall Study|Refused to continue taking trial med.|0
71970|NCT00998296|262246|P5|Overall Study|Refused to continue taking trial med.|0
71971|NCT00998296|262247|P4|Overall Study|Refused to continue taking trial med.|0
71972|NCT00998296|262248|P3|Overall Study|Refused to continue taking trial med.|0
71973|NCT00998296|262249|P2|Overall Study|Refused to continue taking trial med.|0
71974|NCT00998296|262250|P1|Overall Study|Refused to continue taking trial med.|0
71975|NCT00998296|262240|P11|Overall Study|Other adverse event|2
71976|NCT00998296|262241|P10|Overall Study|Other adverse event|1
71977|NCT00998296|262242|P9|Overall Study|Other adverse event|0
71978|NCT00998296|262243|P8|Overall Study|Other adverse event|0
71979|NCT00998296|262244|P7|Overall Study|Other adverse event|0
71980|NCT00998296|262245|P6|Overall Study|Other adverse event|0
71981|NCT00998296|262246|P5|Overall Study|Other adverse event|1
71982|NCT00998296|262247|P4|Overall Study|Other adverse event|0
71983|NCT00998296|262248|P3|Overall Study|Other adverse event|0
71984|NCT00998296|262249|P2|Overall Study|Other adverse event|0
71985|NCT00998296|262250|P1|Overall Study|Other adverse event|0
71986|NCT00998296|262240|P11|Overall Study|Dose limiting or dose reducing toxicity|0
71987|NCT00998296|262241|P10|Overall Study|Dose limiting or dose reducing toxicity|0
71988|NCT00998296|262242|P9|Overall Study|Dose limiting or dose reducing toxicity|2
71989|NCT00998296|262243|P8|Overall Study|Dose limiting or dose reducing toxicity|2
71990|NCT00998296|262244|P7|Overall Study|Dose limiting or dose reducing toxicity|0
71991|NCT00998296|262245|P6|Overall Study|Dose limiting or dose reducing toxicity|0
71992|NCT00998296|262246|P5|Overall Study|Dose limiting or dose reducing toxicity|1
71993|NCT00998296|262247|P4|Overall Study|Dose limiting or dose reducing toxicity|0
71994|NCT00998296|262248|P3|Overall Study|Dose limiting or dose reducing toxicity|0
71995|NCT00998296|262249|P2|Overall Study|Dose limiting or dose reducing toxicity|0
71996|NCT00998296|262250|P1|Overall Study|Dose limiting or dose reducing toxicity|0
71997|NCT00998296|262240|P11|Overall Study|Progressive disease|5
71998|NCT00998296|262241|P10|Overall Study|Progressive disease|14
71999|NCT00998296|262242|P9|Overall Study|Progressive disease|0
72000|NCT00998296|262243|P8|Overall Study|Progressive disease|0
72001|NCT00998296|262244|P7|Overall Study|Progressive disease|1
72002|NCT00998296|262245|P6|Overall Study|Progressive disease|0
72003|NCT00998296|262246|P5|Overall Study|Progressive disease|0
72004|NCT00998296|262247|P4|Overall Study|Progressive disease|0
72005|NCT00998296|262248|P3|Overall Study|Progressive disease|0
72006|NCT00998296|262249|P2|Overall Study|Progressive disease|1
72007|NCT00998296|262250|P1|Overall Study|Progressive disease|0
72008|NCT00997984|262340|P3|Overall Study|Work schedule|2
72009|NCT00997984|262341|P2|Overall Study|Work schedule|0
72010|NCT00997984|262342|P1|Overall Study|Work schedule|0
72011|NCT00997984|262340|P3|Overall Study|Suicidal ideation|1
72012|NCT00997984|262341|P2|Overall Study|Suicidal ideation|0
72013|NCT00997984|262342|P1|Overall Study|Suicidal ideation|0
72014|NCT00997984|262340|P3|Overall Study|Wrong medication dispensed|0
72015|NCT00997984|262341|P2|Overall Study|Wrong medication dispensed|1
72016|NCT00997984|262342|P1|Overall Study|Wrong medication dispensed|0
72017|NCT00997984|262340|P3|Overall Study|non-compliance|3
72018|NCT00997984|262341|P2|Overall Study|non-compliance|2
72019|NCT00997984|262342|P1|Overall Study|non-compliance|0
72020|NCT00997984|262340|P3|Overall Study|Met exclusion criteria|0
72021|NCT00997984|262341|P2|Overall Study|Met exclusion criteria|0
72022|NCT00997984|262342|P1|Overall Study|Met exclusion criteria|1
72023|NCT00997984|262340|P3|Overall Study|Lack of Efficacy|3
72024|NCT00997984|262341|P2|Overall Study|Lack of Efficacy|6
72025|NCT00997984|262342|P1|Overall Study|Lack of Efficacy|20
72026|NCT00997984|262340|P3|Overall Study|Lost to Follow-up|4
72027|NCT00997984|262341|P2|Overall Study|Lost to Follow-up|5
72028|NCT00997984|262342|P1|Overall Study|Lost to Follow-up|8
72029|NCT00997984|262340|P3|Overall Study|Withdrawal by Subject|5
72030|NCT00997984|262341|P2|Overall Study|Withdrawal by Subject|9
72031|NCT00997984|262342|P1|Overall Study|Withdrawal by Subject|6
72032|NCT00997984|262340|P3|Overall Study|Protocol Violation|0
72033|NCT00997984|262341|P2|Overall Study|Protocol Violation|3
72034|NCT00997984|262342|P1|Overall Study|Protocol Violation|1
72035|NCT00997984|262340|P3|Overall Study|Adverse Event|8
72036|NCT00997984|262341|P2|Overall Study|Adverse Event|8
72037|NCT00997984|262342|P1|Overall Study|Adverse Event|1
72038|NCT00997503|262476|P1|Overall Study|Other reason|13
72039|NCT00997503|262476|P1|Overall Study|Missed 12-month follow-up|85
72040|NCT00997503|262476|P1|Overall Study|Physician Decision|10
72041|NCT00997503|262476|P1|Overall Study|Adverse Event|3
72042|NCT00997503|262476|P1|Overall Study|Lost to Follow-up|33
72043|NCT00997503|262476|P1|Overall Study|Withdrawal by Subject|76
72044|NCT00997503|262476|P1|Overall Study|Death|53
72045|NCT00997438|262519|P3|Overall Study|Exclusion criteria at visit 1|3
72046|NCT00997438|262520|P2|Overall Study|Exclusion criteria at visit 1|2
72047|NCT00997438|262521|P1|Overall Study|Exclusion criteria at visit 1|2
72048|NCT00997438|262519|P3|Overall Study|Withdrawal by Subject|0
72049|NCT00997438|262520|P2|Overall Study|Withdrawal by Subject|1
72050|NCT00997438|262521|P1|Overall Study|Withdrawal by Subject|1
72051|NCT00997438|262519|P3|Overall Study|Blood draw difficulty|1
72052|NCT00997438|262520|P2|Overall Study|Blood draw difficulty|0
72053|NCT00997438|262521|P1|Overall Study|Blood draw difficulty|2
72054|NCT00997373|262563|P2|Overall Study|could not have hysterectomy|0
72055|NCT00997373|262564|P1|Overall Study|could not have hysterectomy|6
72056|NCT00997373|262563|P2|Overall Study|wrong tumor type|0
72057|NCT00997373|262564|P1|Overall Study|wrong tumor type|4
72058|NCT00997373|262563|P2|Overall Study|Withdrawal by Subject|0
72059|NCT00997373|262564|P1|Overall Study|Withdrawal by Subject|5
72060|NCT00997321|262572|P2|Overall Study|did not undergo sedation after enrollmen|3
72061|NCT00997321|262573|P1|Overall Study|did not undergo sedation after enrollmen|0
72062|NCT00997243|262585|P1|Overall Study|Early termination of study by sponsor|7
72063|NCT00997126|262617|P2|Overall Study|Physician Decision|11
72064|NCT00997126|262618|P1|Overall Study|Physician Decision|7
72065|NCT00996996|262645|P1|Overall Study|Did Not Receive Study Medications|1
72066|NCT00996996|262645|P1|Overall Study|Death|5
72067|NCT00996996|262645|P1|Overall Study|Lost to Follow-up|9
72068|NCT00996996|262645|P1|Overall Study|Non-compliance|8
72069|NCT00996996|262645|P1|Overall Study|Progressive Disease|10
72070|NCT00996944|262679|P2|Long-term Treatment Period|Study Closed/Terminated|5
72071|NCT00996944|262680|P1|Long-term Treatment Period|Study Closed/Terminated|12
72072|NCT00996944|262679|P2|Double-blind Treatment Period|Withdrawal by Subject|1
72073|NCT00996944|262680|P1|Double-blind Treatment Period|Withdrawal by Subject|1
72074|NCT00996944|262679|P2|Double-blind Treatment Period|Study Closed/Terminated|5
72075|NCT00996944|262680|P1|Double-blind Treatment Period|Study Closed/Terminated|6
72076|NCT00996944|262679|P2|Double-blind Treatment Period|Protocol Violation|0
72077|NCT00996944|262680|P1|Double-blind Treatment Period|Protocol Violation|1
72078|NCT00996944|262679|P2|Double-blind Treatment Period|Adverse Event|1
72079|NCT00996944|262680|P1|Double-blind Treatment Period|Adverse Event|2
72080|NCT00996918|262732|P5|Overall Study|Not Specified|0
72081|NCT00996918|262733|P4|Overall Study|Not Specified|0
72082|NCT00996918|262734|P3|Overall Study|Not Specified|0
72083|NCT00996918|262735|P2|Overall Study|Not Specified|1
72084|NCT00996918|262736|P1|Overall Study|Not Specified|3
72085|NCT00996918|262732|P5|Overall Study|Loss of Caregiver|0
72086|NCT00996918|262733|P4|Overall Study|Loss of Caregiver|0
72087|NCT00996918|262734|P3|Overall Study|Loss of Caregiver|0
72088|NCT00996918|262735|P2|Overall Study|Loss of Caregiver|1
72089|NCT00996918|262736|P1|Overall Study|Loss of Caregiver|0
72090|NCT00996918|262732|P5|Overall Study|Discontinuation of Study by Sponsor|2
72091|NCT00996918|262733|P4|Overall Study|Discontinuation of Study by Sponsor|45
72092|NCT00996918|262734|P3|Overall Study|Discontinuation of Study by Sponsor|30
72093|NCT00996918|262735|P2|Overall Study|Discontinuation of Study by Sponsor|54
72094|NCT00996918|262736|P1|Overall Study|Discontinuation of Study by Sponsor|31
72095|NCT00996918|262732|P5|Overall Study|Physician Decision|0
72096|NCT00996918|262733|P4|Overall Study|Physician Decision|0
72097|NCT00996918|262734|P3|Overall Study|Physician Decision|0
72098|NCT00996918|262735|P2|Overall Study|Physician Decision|0
72099|NCT00996918|262736|P1|Overall Study|Physician Decision|1
72100|NCT00996918|262732|P5|Overall Study|Withdrawal by Subject|2
72101|NCT00996918|262733|P4|Overall Study|Withdrawal by Subject|3
72102|NCT00996918|262734|P3|Overall Study|Withdrawal by Subject|3
72103|NCT00996918|262735|P2|Overall Study|Withdrawal by Subject|4
72104|NCT00996918|262736|P1|Overall Study|Withdrawal by Subject|1
72105|NCT00996918|262732|P5|Overall Study|Adverse Event|0
72106|NCT00996918|262733|P4|Overall Study|Adverse Event|6
72107|NCT00996918|262734|P3|Overall Study|Adverse Event|2
72108|NCT00996918|262735|P2|Overall Study|Adverse Event|5
72109|NCT00996918|262736|P1|Overall Study|Adverse Event|2
72110|NCT00996918|262732|P5|Overall Study|Lack of Efficacy|0
72111|NCT00996918|262733|P4|Overall Study|Lack of Efficacy|2
72112|NCT00996918|262734|P3|Overall Study|Lack of Efficacy|2
72113|NCT00996918|262735|P2|Overall Study|Lack of Efficacy|1
72114|NCT00996918|262736|P1|Overall Study|Lack of Efficacy|1
72115|NCT00996892|262780|P20|Expansion Stage 2A|Disease Progression|31
72116|NCT00996892|262781|P19|Expansion Stage 2A|Disease Progression|0
72117|NCT00996892|262782|P18|Expansion Stage 2A|Disease Progression|0
72118|NCT00996892|262783|P17|Expansion Stage 2A|Disease Progression|0
72119|NCT00996892|262784|P16|Expansion Stage 2A|Disease Progression|0
72120|NCT00996892|262785|P15|Expansion Stage 2A|Disease Progression|0
72121|NCT00996892|262786|P14|Expansion Stage 2A|Disease Progression|0
72122|NCT00996892|262787|P13|Expansion Stage 2A|Disease Progression|0
72123|NCT00996892|262788|P12|Expansion Stage 2A|Disease Progression|0
72124|NCT00996892|262789|P11|Expansion Stage 2A|Disease Progression|0
72125|NCT00996892|262790|P10|Expansion Stage 2A|Disease Progression|0
72126|NCT00996892|262791|P9|Expansion Stage 2A|Disease Progression|0
72127|NCT00996892|262792|P8|Expansion Stage 2A|Disease Progression|0
72128|NCT00996892|262793|P7|Expansion Stage 2A|Disease Progression|0
72129|NCT00996892|262794|P6|Expansion Stage 2A|Disease Progression|0
72130|NCT00996892|262795|P5|Expansion Stage 2A|Disease Progression|0
72131|NCT00996892|262796|P4|Expansion Stage 2A|Disease Progression|0
72132|NCT00996892|262797|P3|Expansion Stage 2A|Disease Progression|0
72133|NCT00996892|262798|P2|Expansion Stage 2A|Disease Progression|0
72134|NCT00996892|262799|P1|Expansion Stage 2A|Disease Progression|0
72135|NCT00996892|262780|P20|Expansion Stage 2A|Withdrawal by Subject|4
72136|NCT00996892|262781|P19|Expansion Stage 2A|Withdrawal by Subject|0
72137|NCT00996892|262782|P18|Expansion Stage 2A|Withdrawal by Subject|0
72138|NCT00996892|262783|P17|Expansion Stage 2A|Withdrawal by Subject|0
72139|NCT00996892|262784|P16|Expansion Stage 2A|Withdrawal by Subject|0
72140|NCT00996892|262785|P15|Expansion Stage 2A|Withdrawal by Subject|0
72141|NCT00996892|262786|P14|Expansion Stage 2A|Withdrawal by Subject|0
72142|NCT00996892|262787|P13|Expansion Stage 2A|Withdrawal by Subject|0
72143|NCT00996892|262788|P12|Expansion Stage 2A|Withdrawal by Subject|0
72144|NCT00996892|262789|P11|Expansion Stage 2A|Withdrawal by Subject|0
72145|NCT00996892|262790|P10|Expansion Stage 2A|Withdrawal by Subject|0
72146|NCT00996892|262791|P9|Expansion Stage 2A|Withdrawal by Subject|0
72147|NCT00996892|262792|P8|Expansion Stage 2A|Withdrawal by Subject|0
72148|NCT00996892|262793|P7|Expansion Stage 2A|Withdrawal by Subject|0
72149|NCT00996892|262794|P6|Expansion Stage 2A|Withdrawal by Subject|0
72150|NCT00996892|262795|P5|Expansion Stage 2A|Withdrawal by Subject|0
72151|NCT00996892|262796|P4|Expansion Stage 2A|Withdrawal by Subject|0
72152|NCT00996892|262797|P3|Expansion Stage 2A|Withdrawal by Subject|0
72153|NCT00996892|262798|P2|Expansion Stage 2A|Withdrawal by Subject|0
72154|NCT00996892|262799|P1|Expansion Stage 2A|Withdrawal by Subject|0
72155|NCT00996892|262780|P20|Expansion Stage 2A|Physician Decision|2
72156|NCT00996892|262781|P19|Expansion Stage 2A|Physician Decision|0
72157|NCT00996892|262782|P18|Expansion Stage 2A|Physician Decision|0
72158|NCT00996892|262783|P17|Expansion Stage 2A|Physician Decision|0
72159|NCT00996892|262784|P16|Expansion Stage 2A|Physician Decision|0
72160|NCT00996892|262785|P15|Expansion Stage 2A|Physician Decision|0
72161|NCT00996892|262786|P14|Expansion Stage 2A|Physician Decision|0
72162|NCT00996892|262787|P13|Expansion Stage 2A|Physician Decision|0
72163|NCT00996892|262788|P12|Expansion Stage 2A|Physician Decision|0
72164|NCT00996892|262789|P11|Expansion Stage 2A|Physician Decision|0
72165|NCT00996892|262790|P10|Expansion Stage 2A|Physician Decision|0
72166|NCT00996892|262791|P9|Expansion Stage 2A|Physician Decision|0
72167|NCT00996892|262792|P8|Expansion Stage 2A|Physician Decision|0
72168|NCT00996892|262793|P7|Expansion Stage 2A|Physician Decision|0
72169|NCT00996892|262794|P6|Expansion Stage 2A|Physician Decision|0
72170|NCT00996892|262795|P5|Expansion Stage 2A|Physician Decision|0
72171|NCT00996892|262796|P4|Expansion Stage 2A|Physician Decision|0
72172|NCT00996892|262797|P3|Expansion Stage 2A|Physician Decision|0
72173|NCT00996892|262798|P2|Expansion Stage 2A|Physician Decision|0
72174|NCT00996892|262799|P1|Expansion Stage 2A|Physician Decision|0
72175|NCT00996892|262780|P20|Expansion Stage 2A|Adverse Event|8
72176|NCT00996892|262781|P19|Expansion Stage 2A|Adverse Event|0
72177|NCT00996892|262782|P18|Expansion Stage 2A|Adverse Event|0
72178|NCT00996892|262783|P17|Expansion Stage 2A|Adverse Event|0
72179|NCT00996892|262784|P16|Expansion Stage 2A|Adverse Event|0
72180|NCT00996892|262785|P15|Expansion Stage 2A|Adverse Event|0
72181|NCT00996892|262786|P14|Expansion Stage 2A|Adverse Event|0
72182|NCT00996892|262787|P13|Expansion Stage 2A|Adverse Event|0
72183|NCT00996892|262788|P12|Expansion Stage 2A|Adverse Event|0
72184|NCT00996892|262789|P11|Expansion Stage 2A|Adverse Event|0
72185|NCT00996892|262790|P10|Expansion Stage 2A|Adverse Event|0
72186|NCT00996892|262791|P9|Expansion Stage 2A|Adverse Event|0
72187|NCT00996892|262792|P8|Expansion Stage 2A|Adverse Event|0
72188|NCT00996892|262793|P7|Expansion Stage 2A|Adverse Event|0
72189|NCT00996892|262794|P6|Expansion Stage 2A|Adverse Event|0
72190|NCT00996892|262795|P5|Expansion Stage 2A|Adverse Event|0
72191|NCT00996892|262796|P4|Expansion Stage 2A|Adverse Event|0
72192|NCT00996892|262797|P3|Expansion Stage 2A|Adverse Event|0
72193|NCT00996892|262798|P2|Expansion Stage 2A|Adverse Event|0
72194|NCT00996892|262799|P1|Expansion Stage 2A|Adverse Event|0
72195|NCT00996892|262780|P20|Expansion Stage 2|Disease Progression|0
72196|NCT00996892|262781|P19|Expansion Stage 2|Disease Progression|28
72197|NCT00996892|262782|P18|Expansion Stage 2|Disease Progression|0
72198|NCT00996892|262783|P17|Expansion Stage 2|Disease Progression|0
72199|NCT00996892|262784|P16|Expansion Stage 2|Disease Progression|0
72200|NCT00996892|262785|P15|Expansion Stage 2|Disease Progression|0
72201|NCT00996892|262786|P14|Expansion Stage 2|Disease Progression|0
72202|NCT00996892|262787|P13|Expansion Stage 2|Disease Progression|0
72203|NCT00996892|262788|P12|Expansion Stage 2|Disease Progression|0
72204|NCT00996892|262789|P11|Expansion Stage 2|Disease Progression|0
72205|NCT00996892|262790|P10|Expansion Stage 2|Disease Progression|0
72206|NCT00996892|262791|P9|Expansion Stage 2|Disease Progression|0
72207|NCT00996892|262792|P8|Expansion Stage 2|Disease Progression|0
72208|NCT00996892|262793|P7|Expansion Stage 2|Disease Progression|0
72209|NCT00996892|262794|P6|Expansion Stage 2|Disease Progression|0
72210|NCT00996892|262795|P5|Expansion Stage 2|Disease Progression|0
72211|NCT00996892|262796|P4|Expansion Stage 2|Disease Progression|0
72212|NCT00996892|262797|P3|Expansion Stage 2|Disease Progression|0
72213|NCT00996892|262798|P2|Expansion Stage 2|Disease Progression|0
72214|NCT00996892|262799|P1|Expansion Stage 2|Disease Progression|0
72215|NCT00996892|262780|P20|Expansion Stage 2|Withdrawal by Subject|0
72216|NCT00996892|262781|P19|Expansion Stage 2|Withdrawal by Subject|1
72217|NCT00996892|262782|P18|Expansion Stage 2|Withdrawal by Subject|0
72218|NCT00996892|262783|P17|Expansion Stage 2|Withdrawal by Subject|0
72219|NCT00996892|262784|P16|Expansion Stage 2|Withdrawal by Subject|0
72220|NCT00996892|262785|P15|Expansion Stage 2|Withdrawal by Subject|0
72221|NCT00996892|262786|P14|Expansion Stage 2|Withdrawal by Subject|0
72222|NCT00996892|262787|P13|Expansion Stage 2|Withdrawal by Subject|0
72223|NCT00996892|262788|P12|Expansion Stage 2|Withdrawal by Subject|0
72224|NCT00996892|262789|P11|Expansion Stage 2|Withdrawal by Subject|0
72225|NCT00996892|262790|P10|Expansion Stage 2|Withdrawal by Subject|0
72226|NCT00996892|262791|P9|Expansion Stage 2|Withdrawal by Subject|0
72227|NCT00996892|262792|P8|Expansion Stage 2|Withdrawal by Subject|0
72228|NCT00996892|262793|P7|Expansion Stage 2|Withdrawal by Subject|0
72229|NCT00996892|262794|P6|Expansion Stage 2|Withdrawal by Subject|0
72230|NCT00996892|262795|P5|Expansion Stage 2|Withdrawal by Subject|0
72231|NCT00996892|262796|P4|Expansion Stage 2|Withdrawal by Subject|0
72232|NCT00996892|262797|P3|Expansion Stage 2|Withdrawal by Subject|0
72233|NCT00996892|262798|P2|Expansion Stage 2|Withdrawal by Subject|0
72234|NCT00996892|262799|P1|Expansion Stage 2|Withdrawal by Subject|0
72235|NCT00996892|262780|P20|Expansion Stage 2|Physician Decision|0
72236|NCT00996892|262781|P19|Expansion Stage 2|Physician Decision|1
72237|NCT00996892|262782|P18|Expansion Stage 2|Physician Decision|0
72238|NCT00996892|262783|P17|Expansion Stage 2|Physician Decision|0
72239|NCT00996892|262784|P16|Expansion Stage 2|Physician Decision|0
72240|NCT00996892|262785|P15|Expansion Stage 2|Physician Decision|0
72241|NCT00996892|262786|P14|Expansion Stage 2|Physician Decision|0
72242|NCT00996892|262787|P13|Expansion Stage 2|Physician Decision|0
72243|NCT00996892|262788|P12|Expansion Stage 2|Physician Decision|0
72244|NCT00996892|262789|P11|Expansion Stage 2|Physician Decision|0
72245|NCT00996892|262790|P10|Expansion Stage 2|Physician Decision|0
72246|NCT00996892|262791|P9|Expansion Stage 2|Physician Decision|0
72247|NCT00996892|262792|P8|Expansion Stage 2|Physician Decision|0
72248|NCT00996892|262793|P7|Expansion Stage 2|Physician Decision|0
72249|NCT00996892|262794|P6|Expansion Stage 2|Physician Decision|0
72250|NCT00996892|262795|P5|Expansion Stage 2|Physician Decision|0
72251|NCT00996892|262796|P4|Expansion Stage 2|Physician Decision|0
72252|NCT00996892|262797|P3|Expansion Stage 2|Physician Decision|0
72253|NCT00996892|262798|P2|Expansion Stage 2|Physician Decision|0
72254|NCT00996892|262799|P1|Expansion Stage 2|Physician Decision|0
72255|NCT00996892|262780|P20|Expansion Stage 2|Death|0
72256|NCT00996892|262781|P19|Expansion Stage 2|Death|2
72257|NCT00996892|262782|P18|Expansion Stage 2|Death|0
72258|NCT00996892|262783|P17|Expansion Stage 2|Death|0
72259|NCT00996892|262784|P16|Expansion Stage 2|Death|0
72260|NCT00996892|262785|P15|Expansion Stage 2|Death|0
72261|NCT00996892|262786|P14|Expansion Stage 2|Death|0
72262|NCT00996892|262787|P13|Expansion Stage 2|Death|0
72263|NCT00996892|262788|P12|Expansion Stage 2|Death|0
72264|NCT00996892|262789|P11|Expansion Stage 2|Death|0
72265|NCT00996892|262790|P10|Expansion Stage 2|Death|0
72266|NCT00996892|262791|P9|Expansion Stage 2|Death|0
72267|NCT00996892|262792|P8|Expansion Stage 2|Death|0
72268|NCT00996892|262793|P7|Expansion Stage 2|Death|0
72269|NCT00996892|262794|P6|Expansion Stage 2|Death|0
72270|NCT00996892|262795|P5|Expansion Stage 2|Death|0
72271|NCT00996892|262796|P4|Expansion Stage 2|Death|0
72272|NCT00996892|262797|P3|Expansion Stage 2|Death|0
72273|NCT00996892|262798|P2|Expansion Stage 2|Death|0
72274|NCT00996892|262799|P1|Expansion Stage 2|Death|0
72275|NCT00996892|262780|P20|Expansion Stage 2|Adverse Event|0
72276|NCT00996892|262781|P19|Expansion Stage 2|Adverse Event|3
72277|NCT00996892|262782|P18|Expansion Stage 2|Adverse Event|0
72278|NCT00996892|262783|P17|Expansion Stage 2|Adverse Event|0
72279|NCT00996892|262784|P16|Expansion Stage 2|Adverse Event|0
72280|NCT00996892|262785|P15|Expansion Stage 2|Adverse Event|0
72281|NCT00996892|262786|P14|Expansion Stage 2|Adverse Event|0
72282|NCT00996892|262787|P13|Expansion Stage 2|Adverse Event|0
72283|NCT00996892|262788|P12|Expansion Stage 2|Adverse Event|0
72284|NCT00996892|262789|P11|Expansion Stage 2|Adverse Event|0
72285|NCT00996892|262790|P10|Expansion Stage 2|Adverse Event|0
72286|NCT00996892|262791|P9|Expansion Stage 2|Adverse Event|0
72287|NCT00996892|262792|P8|Expansion Stage 2|Adverse Event|0
72288|NCT00996892|262793|P7|Expansion Stage 2|Adverse Event|0
72289|NCT00996892|262794|P6|Expansion Stage 2|Adverse Event|0
72290|NCT00996892|262795|P5|Expansion Stage 2|Adverse Event|0
72291|NCT00996892|262796|P4|Expansion Stage 2|Adverse Event|0
72292|NCT00996892|262797|P3|Expansion Stage 2|Adverse Event|0
72293|NCT00996892|262798|P2|Expansion Stage 2|Adverse Event|0
72294|NCT00996892|262799|P1|Expansion Stage 2|Adverse Event|0
72295|NCT00996892|262780|P20|Dose-Escalation Stage 1B|Disease Progression|0
72296|NCT00996892|262781|P19|Dose-Escalation Stage 1B|Disease Progression|0
72297|NCT00996892|262782|P18|Dose-Escalation Stage 1B|Disease Progression|3
72298|NCT00996892|262783|P17|Dose-Escalation Stage 1B|Disease Progression|3
72299|NCT00996892|262784|P16|Dose-Escalation Stage 1B|Disease Progression|3
72300|NCT00996892|262785|P15|Dose-Escalation Stage 1B|Disease Progression|4
72301|NCT00996892|262786|P14|Dose-Escalation Stage 1B|Disease Progression|0
72302|NCT00996892|262787|P13|Dose-Escalation Stage 1B|Disease Progression|0
72303|NCT00996892|262788|P12|Dose-Escalation Stage 1B|Disease Progression|0
72304|NCT00996892|262789|P11|Dose-Escalation Stage 1B|Disease Progression|0
72305|NCT00996892|262790|P10|Dose-Escalation Stage 1B|Disease Progression|0
72306|NCT00996892|262791|P9|Dose-Escalation Stage 1B|Disease Progression|0
72307|NCT00996892|262792|P8|Dose-Escalation Stage 1B|Disease Progression|0
72308|NCT00996892|262793|P7|Dose-Escalation Stage 1B|Disease Progression|0
72309|NCT00996892|262794|P6|Dose-Escalation Stage 1B|Disease Progression|0
72310|NCT00996892|262795|P5|Dose-Escalation Stage 1B|Disease Progression|0
72311|NCT00996892|262796|P4|Dose-Escalation Stage 1B|Disease Progression|0
72312|NCT00996892|262797|P3|Dose-Escalation Stage 1B|Disease Progression|0
72313|NCT00996892|262798|P2|Dose-Escalation Stage 1B|Disease Progression|0
72314|NCT00996892|262799|P1|Dose-Escalation Stage 1B|Disease Progression|0
72315|NCT00996892|262780|P20|Dose-Escalation Stage 1B|Physician Decision|0
72316|NCT00996892|262781|P19|Dose-Escalation Stage 1B|Physician Decision|0
72317|NCT00996892|262782|P18|Dose-Escalation Stage 1B|Physician Decision|2
72318|NCT00996892|262783|P17|Dose-Escalation Stage 1B|Physician Decision|0
72319|NCT00996892|262784|P16|Dose-Escalation Stage 1B|Physician Decision|0
72320|NCT00996892|262785|P15|Dose-Escalation Stage 1B|Physician Decision|0
72321|NCT00996892|262786|P14|Dose-Escalation Stage 1B|Physician Decision|0
72322|NCT00996892|262787|P13|Dose-Escalation Stage 1B|Physician Decision|0
72323|NCT00996892|262788|P12|Dose-Escalation Stage 1B|Physician Decision|0
72324|NCT00996892|262789|P11|Dose-Escalation Stage 1B|Physician Decision|0
72325|NCT00996892|262790|P10|Dose-Escalation Stage 1B|Physician Decision|0
72326|NCT00996892|262791|P9|Dose-Escalation Stage 1B|Physician Decision|0
72327|NCT00996892|262792|P8|Dose-Escalation Stage 1B|Physician Decision|0
72328|NCT00996892|262793|P7|Dose-Escalation Stage 1B|Physician Decision|0
72329|NCT00996892|262794|P6|Dose-Escalation Stage 1B|Physician Decision|0
72330|NCT00996892|262795|P5|Dose-Escalation Stage 1B|Physician Decision|0
72331|NCT00996892|262796|P4|Dose-Escalation Stage 1B|Physician Decision|0
72332|NCT00996892|262797|P3|Dose-Escalation Stage 1B|Physician Decision|0
72333|NCT00996892|262798|P2|Dose-Escalation Stage 1B|Physician Decision|0
72334|NCT00996892|262799|P1|Dose-Escalation Stage 1B|Physician Decision|0
72335|NCT00996892|262780|P20|Dose-Escalation Stage 1A|Disease Progression|0
72336|NCT00996892|262781|P19|Dose-Escalation Stage 1A|Disease Progression|0
72337|NCT00996892|262782|P18|Dose-Escalation Stage 1A|Disease Progression|0
72338|NCT00996892|262783|P17|Dose-Escalation Stage 1A|Disease Progression|0
72339|NCT00996892|262784|P16|Dose-Escalation Stage 1A|Disease Progression|0
72340|NCT00996892|262785|P15|Dose-Escalation Stage 1A|Disease Progression|0
72341|NCT00996892|262786|P14|Dose-Escalation Stage 1A|Disease Progression|4
72342|NCT00996892|262787|P13|Dose-Escalation Stage 1A|Disease Progression|6
72343|NCT00996892|262788|P12|Dose-Escalation Stage 1A|Disease Progression|7
72344|NCT00996892|262789|P11|Dose-Escalation Stage 1A|Disease Progression|5
72345|NCT00996892|262790|P10|Dose-Escalation Stage 1A|Disease Progression|1
72346|NCT00996892|262791|P9|Dose-Escalation Stage 1A|Disease Progression|3
72347|NCT00996892|262792|P8|Dose-Escalation Stage 1A|Disease Progression|2
72348|NCT00996892|262793|P7|Dose-Escalation Stage 1A|Disease Progression|0
72349|NCT00996892|262794|P6|Dose-Escalation Stage 1A|Disease Progression|0
72350|NCT00996892|262795|P5|Dose-Escalation Stage 1A|Disease Progression|0
72351|NCT00996892|262796|P4|Dose-Escalation Stage 1A|Disease Progression|0
72352|NCT00996892|262797|P3|Dose-Escalation Stage 1A|Disease Progression|0
72353|NCT00996892|262798|P2|Dose-Escalation Stage 1A|Disease Progression|0
72354|NCT00996892|262799|P1|Dose-Escalation Stage 1A|Disease Progression|0
72355|NCT00996892|262780|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72356|NCT00996892|262781|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72357|NCT00996892|262782|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72358|NCT00996892|262783|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72359|NCT00996892|262784|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72360|NCT00996892|262785|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72361|NCT00996892|262786|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72362|NCT00996892|262787|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
72363|NCT00996892|262788|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
72364|NCT00996892|262789|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
72365|NCT00996892|262790|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
72366|NCT00996892|262791|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72367|NCT00996892|262792|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72368|NCT00996892|262793|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72369|NCT00996892|262794|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72370|NCT00996892|262795|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72371|NCT00996892|262796|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72372|NCT00996892|262797|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72373|NCT00996892|262798|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72374|NCT00996892|262799|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
72375|NCT00996892|262780|P20|Dose-Escalation Stage 1A|Physician Decision|0
72376|NCT00996892|262781|P19|Dose-Escalation Stage 1A|Physician Decision|0
72377|NCT00996892|262782|P18|Dose-Escalation Stage 1A|Physician Decision|0
72378|NCT00996892|262783|P17|Dose-Escalation Stage 1A|Physician Decision|0
72379|NCT00996892|262784|P16|Dose-Escalation Stage 1A|Physician Decision|0
72380|NCT00996892|262785|P15|Dose-Escalation Stage 1A|Physician Decision|0
72381|NCT00996892|262786|P14|Dose-Escalation Stage 1A|Physician Decision|0
72382|NCT00996892|262787|P13|Dose-Escalation Stage 1A|Physician Decision|0
72383|NCT00996892|262788|P12|Dose-Escalation Stage 1A|Physician Decision|0
72384|NCT00996892|262789|P11|Dose-Escalation Stage 1A|Physician Decision|0
72385|NCT00996892|262790|P10|Dose-Escalation Stage 1A|Physician Decision|0
72386|NCT00996892|262791|P9|Dose-Escalation Stage 1A|Physician Decision|0
72387|NCT00996892|262792|P8|Dose-Escalation Stage 1A|Physician Decision|1
72388|NCT00996892|262793|P7|Dose-Escalation Stage 1A|Physician Decision|0
72389|NCT00996892|262794|P6|Dose-Escalation Stage 1A|Physician Decision|0
72390|NCT00996892|262795|P5|Dose-Escalation Stage 1A|Physician Decision|0
72391|NCT00996892|262796|P4|Dose-Escalation Stage 1A|Physician Decision|0
72392|NCT00996892|262797|P3|Dose-Escalation Stage 1A|Physician Decision|0
72393|NCT00996892|262798|P2|Dose-Escalation Stage 1A|Physician Decision|0
72394|NCT00996892|262799|P1|Dose-Escalation Stage 1A|Physician Decision|0
72395|NCT00996892|262780|P20|Dose-Escalation Stage 1A|Death|0
72396|NCT00996892|262781|P19|Dose-Escalation Stage 1A|Death|0
72397|NCT00996892|262782|P18|Dose-Escalation Stage 1A|Death|0
72398|NCT00996892|262783|P17|Dose-Escalation Stage 1A|Death|0
72399|NCT00996892|262784|P16|Dose-Escalation Stage 1A|Death|0
72400|NCT00996892|262785|P15|Dose-Escalation Stage 1A|Death|0
72401|NCT00996892|262786|P14|Dose-Escalation Stage 1A|Death|0
72402|NCT00996892|262787|P13|Dose-Escalation Stage 1A|Death|1
72403|NCT00996892|262788|P12|Dose-Escalation Stage 1A|Death|1
72404|NCT00996892|262789|P11|Dose-Escalation Stage 1A|Death|0
72405|NCT00996892|262790|P10|Dose-Escalation Stage 1A|Death|2
72406|NCT00996892|262791|P9|Dose-Escalation Stage 1A|Death|0
72407|NCT00996892|262792|P8|Dose-Escalation Stage 1A|Death|0
72408|NCT00996892|262793|P7|Dose-Escalation Stage 1A|Death|0
72409|NCT00996892|262794|P6|Dose-Escalation Stage 1A|Death|0
72410|NCT00996892|262795|P5|Dose-Escalation Stage 1A|Death|0
72411|NCT00996892|262796|P4|Dose-Escalation Stage 1A|Death|0
72412|NCT00996892|262797|P3|Dose-Escalation Stage 1A|Death|0
72413|NCT00996892|262798|P2|Dose-Escalation Stage 1A|Death|0
72414|NCT00996892|262799|P1|Dose-Escalation Stage 1A|Death|0
72415|NCT00996892|262780|P20|Dose-Escalation Stage 1A|Adverse Event|0
72416|NCT00996892|262781|P19|Dose-Escalation Stage 1A|Adverse Event|0
72417|NCT00996892|262782|P18|Dose-Escalation Stage 1A|Adverse Event|0
72418|NCT00996892|262783|P17|Dose-Escalation Stage 1A|Adverse Event|0
72419|NCT00996892|262784|P16|Dose-Escalation Stage 1A|Adverse Event|0
72420|NCT00996892|262785|P15|Dose-Escalation Stage 1A|Adverse Event|0
72421|NCT00996892|262786|P14|Dose-Escalation Stage 1A|Adverse Event|1
72422|NCT00996892|262787|P13|Dose-Escalation Stage 1A|Adverse Event|0
72423|NCT00996892|262788|P12|Dose-Escalation Stage 1A|Adverse Event|0
72424|NCT00996892|262789|P11|Dose-Escalation Stage 1A|Adverse Event|1
72425|NCT00996892|262790|P10|Dose-Escalation Stage 1A|Adverse Event|0
72426|NCT00996892|262791|P9|Dose-Escalation Stage 1A|Adverse Event|0
72427|NCT00996892|262792|P8|Dose-Escalation Stage 1A|Adverse Event|0
72428|NCT00996892|262793|P7|Dose-Escalation Stage 1A|Adverse Event|0
72429|NCT00996892|262794|P6|Dose-Escalation Stage 1A|Adverse Event|0
72430|NCT00996892|262795|P5|Dose-Escalation Stage 1A|Adverse Event|0
72431|NCT00996892|262796|P4|Dose-Escalation Stage 1A|Adverse Event|0
72432|NCT00996892|262797|P3|Dose-Escalation Stage 1A|Adverse Event|0
72433|NCT00996892|262798|P2|Dose-Escalation Stage 1A|Adverse Event|0
72434|NCT00996892|262799|P1|Dose-Escalation Stage 1A|Adverse Event|0
72435|NCT00996892|262780|P20|Dose-Escalation Stage 1|Disease Progression|0
72436|NCT00996892|262781|P19|Dose-Escalation Stage 1|Disease Progression|0
72437|NCT00996892|262782|P18|Dose-Escalation Stage 1|Disease Progression|0
72438|NCT00996892|262783|P17|Dose-Escalation Stage 1|Disease Progression|0
72439|NCT00996892|262784|P16|Dose-Escalation Stage 1|Disease Progression|0
72440|NCT00996892|262785|P15|Dose-Escalation Stage 1|Disease Progression|0
72441|NCT00996892|262786|P14|Dose-Escalation Stage 1|Disease Progression|0
72442|NCT00996892|262787|P13|Dose-Escalation Stage 1|Disease Progression|0
72443|NCT00996892|262788|P12|Dose-Escalation Stage 1|Disease Progression|0
72444|NCT00996892|262789|P11|Dose-Escalation Stage 1|Disease Progression|0
72445|NCT00996892|262790|P10|Dose-Escalation Stage 1|Disease Progression|0
72446|NCT00996892|262791|P9|Dose-Escalation Stage 1|Disease Progression|0
72447|NCT00996892|262792|P8|Dose-Escalation Stage 1|Disease Progression|0
72448|NCT00996892|262793|P7|Dose-Escalation Stage 1|Disease Progression|0
72449|NCT00996892|262794|P6|Dose-Escalation Stage 1|Disease Progression|7
72450|NCT00996892|262795|P5|Dose-Escalation Stage 1|Disease Progression|10
72451|NCT00996892|262796|P4|Dose-Escalation Stage 1|Disease Progression|4
72452|NCT00996892|262797|P3|Dose-Escalation Stage 1|Disease Progression|3
72453|NCT00996892|262798|P2|Dose-Escalation Stage 1|Disease Progression|2
72454|NCT00996892|262799|P1|Dose-Escalation Stage 1|Disease Progression|2
72455|NCT00996892|262780|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
72456|NCT00996892|262781|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
72457|NCT00996892|262782|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
72458|NCT00996892|262783|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
72459|NCT00996892|262784|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
72460|NCT00996892|262785|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
72461|NCT00996892|262786|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
72462|NCT00996892|262787|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
72463|NCT00996892|262788|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
72464|NCT00996892|262789|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
72465|NCT00996892|262790|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
72466|NCT00996892|262791|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
72467|NCT00996892|262792|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
72468|NCT00996892|262793|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
72469|NCT00996892|262794|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
72470|NCT00996892|262795|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
72471|NCT00996892|262796|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
72472|NCT00996892|262797|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
72473|NCT00996892|262798|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
72474|NCT00996892|262799|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
72475|NCT00996892|262780|P20|Dose-Escalation Stage 1|Physician Decision|0
72476|NCT00996892|262781|P19|Dose-Escalation Stage 1|Physician Decision|0
72477|NCT00996892|262782|P18|Dose-Escalation Stage 1|Physician Decision|0
72478|NCT00996892|262783|P17|Dose-Escalation Stage 1|Physician Decision|0
72479|NCT00996892|262784|P16|Dose-Escalation Stage 1|Physician Decision|0
72480|NCT00996892|262785|P15|Dose-Escalation Stage 1|Physician Decision|0
72481|NCT00996892|262786|P14|Dose-Escalation Stage 1|Physician Decision|0
72482|NCT00996892|262787|P13|Dose-Escalation Stage 1|Physician Decision|0
72483|NCT00996892|262788|P12|Dose-Escalation Stage 1|Physician Decision|0
72484|NCT00996892|262789|P11|Dose-Escalation Stage 1|Physician Decision|0
72485|NCT00996892|262790|P10|Dose-Escalation Stage 1|Physician Decision|0
72486|NCT00996892|262791|P9|Dose-Escalation Stage 1|Physician Decision|0
72487|NCT00996892|262792|P8|Dose-Escalation Stage 1|Physician Decision|0
72488|NCT00996892|262793|P7|Dose-Escalation Stage 1|Physician Decision|2
72489|NCT00996892|262794|P6|Dose-Escalation Stage 1|Physician Decision|1
72490|NCT00996892|262795|P5|Dose-Escalation Stage 1|Physician Decision|0
72491|NCT00996892|262796|P4|Dose-Escalation Stage 1|Physician Decision|1
72492|NCT00996892|262797|P3|Dose-Escalation Stage 1|Physician Decision|0
72493|NCT00996892|262798|P2|Dose-Escalation Stage 1|Physician Decision|0
72494|NCT00996892|262799|P1|Dose-Escalation Stage 1|Physician Decision|1
72495|NCT00996892|262780|P20|Dose-Escalation Stage 1|Death|0
72496|NCT00996892|262781|P19|Dose-Escalation Stage 1|Death|0
72497|NCT00996892|262782|P18|Dose-Escalation Stage 1|Death|0
72498|NCT00996892|262783|P17|Dose-Escalation Stage 1|Death|0
72499|NCT00996892|262784|P16|Dose-Escalation Stage 1|Death|0
72500|NCT00996892|262785|P15|Dose-Escalation Stage 1|Death|0
72501|NCT00996892|262786|P14|Dose-Escalation Stage 1|Death|0
72502|NCT00996892|262787|P13|Dose-Escalation Stage 1|Death|0
72503|NCT00996892|262788|P12|Dose-Escalation Stage 1|Death|0
72504|NCT00996892|262789|P11|Dose-Escalation Stage 1|Death|0
72505|NCT00996892|262790|P10|Dose-Escalation Stage 1|Death|0
72506|NCT00996892|262791|P9|Dose-Escalation Stage 1|Death|0
72507|NCT00996892|262792|P8|Dose-Escalation Stage 1|Death|0
72508|NCT00996892|262793|P7|Dose-Escalation Stage 1|Death|0
72509|NCT00996892|262794|P6|Dose-Escalation Stage 1|Death|1
72510|NCT00996892|262795|P5|Dose-Escalation Stage 1|Death|0
72511|NCT00996892|262796|P4|Dose-Escalation Stage 1|Death|0
72512|NCT00996892|262797|P3|Dose-Escalation Stage 1|Death|0
72513|NCT00996892|262798|P2|Dose-Escalation Stage 1|Death|0
72514|NCT00996892|262799|P1|Dose-Escalation Stage 1|Death|1
72515|NCT00996892|262780|P20|Dose-Escalation Stage 1|Adverse Event|0
72516|NCT00996892|262781|P19|Dose-Escalation Stage 1|Adverse Event|0
72517|NCT00996892|262782|P18|Dose-Escalation Stage 1|Adverse Event|0
72518|NCT00996892|262783|P17|Dose-Escalation Stage 1|Adverse Event|0
72519|NCT00996892|262784|P16|Dose-Escalation Stage 1|Adverse Event|0
72520|NCT00996892|262785|P15|Dose-Escalation Stage 1|Adverse Event|0
72521|NCT00996892|262786|P14|Dose-Escalation Stage 1|Adverse Event|0
72522|NCT00996892|262787|P13|Dose-Escalation Stage 1|Adverse Event|0
72523|NCT00996892|262788|P12|Dose-Escalation Stage 1|Adverse Event|0
72524|NCT00996892|262789|P11|Dose-Escalation Stage 1|Adverse Event|0
72525|NCT00996892|262790|P10|Dose-Escalation Stage 1|Adverse Event|0
72526|NCT00996892|262791|P9|Dose-Escalation Stage 1|Adverse Event|0
72527|NCT00996892|262792|P8|Dose-Escalation Stage 1|Adverse Event|0
72528|NCT00996892|262793|P7|Dose-Escalation Stage 1|Adverse Event|1
72529|NCT00996892|262794|P6|Dose-Escalation Stage 1|Adverse Event|0
72530|NCT00996892|262795|P5|Dose-Escalation Stage 1|Adverse Event|0
72531|NCT00996892|262796|P4|Dose-Escalation Stage 1|Adverse Event|2
72532|NCT00996892|262797|P3|Dose-Escalation Stage 1|Adverse Event|0
72533|NCT00996892|262798|P2|Dose-Escalation Stage 1|Adverse Event|0
72534|NCT00996892|262799|P1|Dose-Escalation Stage 1|Adverse Event|0
72535|NCT00996801|263394|P6|Overall Study|Withdrawal by Subject|9
72536|NCT00996801|263395|P5|Overall Study|Withdrawal by Subject|5
72537|NCT00996801|263396|P4|Overall Study|Withdrawal by Subject|5
72538|NCT00996801|263397|P3|Overall Study|Withdrawal by Subject|9
72539|NCT00996801|263398|P2|Overall Study|Withdrawal by Subject|6
72540|NCT00996801|263399|P1|Overall Study|Withdrawal by Subject|8
72541|NCT00996801|263394|P6|Overall Study|Study Terminated by Sponsor|0
72542|NCT00996801|263395|P5|Overall Study|Study Terminated by Sponsor|46
72543|NCT00996801|263396|P4|Overall Study|Study Terminated by Sponsor|0
72544|NCT00996801|263397|P3|Overall Study|Study Terminated by Sponsor|0
72545|NCT00996801|263398|P2|Overall Study|Study Terminated by Sponsor|1
72546|NCT00996801|263399|P1|Overall Study|Study Terminated by Sponsor|0
72547|NCT00996801|263394|P6|Overall Study|Protocol Violation|4
72548|NCT00996801|263395|P5|Overall Study|Protocol Violation|3
72549|NCT00996801|263396|P4|Overall Study|Protocol Violation|2
72550|NCT00996801|263397|P3|Overall Study|Protocol Violation|1
72551|NCT00996801|263398|P2|Overall Study|Protocol Violation|4
72552|NCT00996801|263399|P1|Overall Study|Protocol Violation|3
72553|NCT00996801|263394|P6|Overall Study|Progressive Disease|0
72554|NCT00996801|263395|P5|Overall Study|Progressive Disease|0
72555|NCT00996801|263396|P4|Overall Study|Progressive Disease|0
72556|NCT00996801|263397|P3|Overall Study|Progressive Disease|0
72557|NCT00996801|263398|P2|Overall Study|Progressive Disease|1
72558|NCT00996801|263399|P1|Overall Study|Progressive Disease|0
72559|NCT00996801|263394|P6|Overall Study|Physician Decision|0
72560|NCT00996801|263395|P5|Overall Study|Physician Decision|0
72561|NCT00996801|263396|P4|Overall Study|Physician Decision|1
72562|NCT00996801|263397|P3|Overall Study|Physician Decision|0
72563|NCT00996801|263398|P2|Overall Study|Physician Decision|0
72564|NCT00996801|263399|P1|Overall Study|Physician Decision|0
72565|NCT00996801|263394|P6|Overall Study|Lost to Follow-up|2
72566|NCT00996801|263395|P5|Overall Study|Lost to Follow-up|3
72567|NCT00996801|263396|P4|Overall Study|Lost to Follow-up|3
72568|NCT00996801|263397|P3|Overall Study|Lost to Follow-up|0
72569|NCT00996801|263398|P2|Overall Study|Lost to Follow-up|0
72570|NCT00996801|263399|P1|Overall Study|Lost to Follow-up|0
72571|NCT00996801|263394|P6|Overall Study|Lack of Efficacy|1
72572|NCT00996801|263395|P5|Overall Study|Lack of Efficacy|0
72573|NCT00996801|263396|P4|Overall Study|Lack of Efficacy|3
72574|NCT00996801|263397|P3|Overall Study|Lack of Efficacy|1
72575|NCT00996801|263398|P2|Overall Study|Lack of Efficacy|0
72576|NCT00996801|263399|P1|Overall Study|Lack of Efficacy|3
72577|NCT00996801|263394|P6|Overall Study|Adverse Event|3
72578|NCT00996801|263395|P5|Overall Study|Adverse Event|31
72579|NCT00996801|263396|P4|Overall Study|Adverse Event|17
72580|NCT00996801|263397|P3|Overall Study|Adverse Event|12
72581|NCT00996801|263398|P2|Overall Study|Adverse Event|4
72582|NCT00996801|263399|P1|Overall Study|Adverse Event|6
72583|NCT00996736|263511|P2|Overall Study|Visit not within 3-month window|3
72584|NCT00996736|263512|P1|Overall Study|Visit not within 3-month window|5
72585|NCT00996736|263511|P2|Overall Study|Lost to Follow-up|14
72586|NCT00996736|263512|P1|Overall Study|Lost to Follow-up|15
72587|NCT00996736|263511|P2|Overall Study|Death|1
72588|NCT00996736|263512|P1|Overall Study|Death|1
72589|NCT00996658|263532|P2|Overall Study|Other|7
72590|NCT00996658|263533|P1|Overall Study|Other|9
72591|NCT00996658|263532|P2|Overall Study|Non-compliance issues|3
72592|NCT00996658|263533|P1|Overall Study|Non-compliance issues|3
72593|NCT00996658|263532|P2|Overall Study|Lost to Follow-up|5
72594|NCT00996658|263533|P1|Overall Study|Lost to Follow-up|2
72595|NCT00996658|263532|P2|Overall Study|Protocol Violation|1
72596|NCT00996658|263533|P1|Overall Study|Protocol Violation|0
72597|NCT00996658|263532|P2|Overall Study|Adverse Event|5
72598|NCT00996658|263533|P1|Overall Study|Adverse Event|2
72599|NCT00996632|263561|P2|Overall Study|Physician Decision|0
72600|NCT00996632|263562|P1|Overall Study|Physician Decision|0
72601|NCT00996606|263570|P1|Overall Study|Withdrawal by Subject|3
72602|NCT00996606|263570|P1|Overall Study|Protocol Violation|1
72603|NCT00996606|263570|P1|Overall Study|Insufficient Therapeutic Response|2
72604|NCT00996606|263570|P1|Overall Study|Adverse Event or Intercurrent Illness|2
72605|NCT00996593|263664|P1|Long-Term Follow-Up|Site Closed|1
72606|NCT00996593|263664|P1|Long-Term Follow-Up|Withdrawal by Subject|2
72607|NCT00996593|263664|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
72608|NCT00996593|263664|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
72609|NCT00996593|263664|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
72610|NCT00996593|263664|P1|Dosimetric and Therapeutic Treatment|Death|1
72611|NCT00996593|263664|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
72612|NCT00996593|263664|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
72613|NCT00996593|263664|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
72614|NCT00996580|263692|P1|Overall Study|Not specified|29
72615|NCT00996580|263692|P1|Overall Study|Withdrawal by Subject|217
72616|NCT00996580|263692|P1|Overall Study|Sponsor requested participant withdrawal|35
72617|NCT00996580|263692|P1|Overall Study|Protocol Violation|16
72618|NCT00996580|263692|P1|Overall Study|Pregnancy|68
72619|NCT00996580|263692|P1|Overall Study|Physician Decision|5
72620|NCT00996580|263692|P1|Overall Study|Noncompliance with the protocol|137
72621|NCT00996580|263692|P1|Overall Study|Lost to Follow-up|480
72622|NCT00996580|263692|P1|Overall Study|Adverse Event|466
72623|NCT00996476|263729|P5|Overall Study|Adverse Event|1
72624|NCT00996476|263730|P4|Overall Study|Adverse Event|0
72625|NCT00996476|263731|P3|Overall Study|Adverse Event|0
72626|NCT00996476|263732|P2|Overall Study|Adverse Event|1
72627|NCT00996476|263733|P1|Overall Study|Adverse Event|0
72628|NCT00996476|263729|P5|Overall Study|Withdrawal by Subject|1
72629|NCT00996476|263730|P4|Overall Study|Withdrawal by Subject|0
72630|NCT00996476|263731|P3|Overall Study|Withdrawal by Subject|1
72631|NCT00996476|263732|P2|Overall Study|Withdrawal by Subject|2
72632|NCT00996476|263733|P1|Overall Study|Withdrawal by Subject|1
72633|NCT00996437|263801|P2|Overall Study|Missed|5
72634|NCT00996437|263802|P1|Overall Study|Missed|2
72635|NCT00996437|263801|P2|Overall Study|Dropped|2
72636|NCT00996437|263802|P1|Overall Study|Dropped|2
72637|NCT00996437|263801|P2|Overall Study|Death|0
72638|NCT00996437|263802|P1|Overall Study|Death|1
72639|NCT00996333|263847|P1|Overall Study|Other|5
72640|NCT00996333|263847|P1|Overall Study|Physician Decision|1
72641|NCT00996333|263847|P1|Overall Study|Adverse Event|1
72642|NCT00996333|263847|P1|Overall Study|Death|4
72643|NCT00996333|263847|P1|Overall Study|Withdrawal by Subject|1
72644|NCT00996333|263847|P1|Overall Study|Screen failure|1
72645|NCT00996307|263857|P4|Overall Study|Unable to classify|1
72646|NCT00996307|263858|P3|Overall Study|Unable to classify|2
72647|NCT00996307|263859|P2|Overall Study|Unable to classify|0
72648|NCT00996307|263860|P1|Overall Study|Unable to classify|4
72649|NCT00996307|263857|P4|Overall Study|Administrative reason|0
72650|NCT00996307|263858|P3|Overall Study|Administrative reason|0
72651|NCT00996307|263859|P2|Overall Study|Administrative reason|1
72652|NCT00996307|263860|P1|Overall Study|Administrative reason|0
72653|NCT00996307|263857|P4|Overall Study|Lost to Follow-up|15
72654|NCT00996307|263858|P3|Overall Study|Lost to Follow-up|7
72655|NCT00996307|263859|P2|Overall Study|Lost to Follow-up|13
72656|NCT00996307|263860|P1|Overall Study|Lost to Follow-up|13
72657|NCT00996307|263857|P4|Overall Study|Withdrawal by Subject|5
72658|NCT00996307|263858|P3|Overall Study|Withdrawal by Subject|5
72659|NCT00996307|263859|P2|Overall Study|Withdrawal by Subject|2
72660|NCT00996307|263860|P1|Overall Study|Withdrawal by Subject|3
72661|NCT00996307|263857|P4|Overall Study|Adverse Event|0
72662|NCT00996307|263858|P3|Overall Study|Adverse Event|0
72663|NCT00996307|263859|P2|Overall Study|Adverse Event|1
72664|NCT00996307|263860|P1|Overall Study|Adverse Event|0
72665|NCT00996281|263924|P2|Overall Study|Other|7
72666|NCT00996281|263925|P1|Overall Study|Other|5
72667|NCT00996281|263924|P2|Overall Study|Lack of Efficacy|2
72668|NCT00996281|263925|P1|Overall Study|Lack of Efficacy|0
72669|NCT00996281|263924|P2|Overall Study|Withdrawal by Subject|20
72670|NCT00996281|263925|P1|Overall Study|Withdrawal by Subject|31
72671|NCT00996281|263924|P2|Overall Study|Lost to Follow-up|16
72672|NCT00996281|263925|P1|Overall Study|Lost to Follow-up|14
72673|NCT00996281|263924|P2|Overall Study|Major Protocol Deviation|7
72674|NCT00996281|263925|P1|Overall Study|Major Protocol Deviation|6
72675|NCT00996281|263924|P2|Overall Study|Adverse Event|37
72676|NCT00996281|263925|P1|Overall Study|Adverse Event|75
72677|NCT00996216|263933|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
72678|NCT00996216|263933|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
72679|NCT00996216|263933|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
72680|NCT00996203|263949|P1|Overall Study|Protocol Violation|2
72681|NCT00996203|263949|P1|Overall Study|Lack of Efficacy|1
72682|NCT00996203|263949|P1|Overall Study|Lost to Follow-up|1
72683|NCT00996203|263949|P1|Overall Study|Adverse Event|3
72684|NCT00996125|263981|P2|Overall Study|Withdrawal by Subject|3
72685|NCT00996125|263982|P1|Overall Study|Withdrawal by Subject|4
72686|NCT00996125|263981|P2|Overall Study|Lost to Follow-up|6
72687|NCT00996125|263982|P1|Overall Study|Lost to Follow-up|1
72688|NCT00996125|263981|P2|Overall Study|Adverse Event|2
72689|NCT00996125|263982|P1|Overall Study|Adverse Event|0
72690|NCT00996034|264002|P1|Overall Study|withdrawn by PI|1
72691|NCT00996034|264002|P1|Overall Study|Lost to Follow-up|2
72692|NCT00995930|264008|P2|Overall Study|Adverse Event|14
72693|NCT00995930|264009|P1|Overall Study|Adverse Event|11
72694|NCT00995930|264008|P2|Overall Study|Withdrawal by Subject|4
72695|NCT00995930|264009|P1|Overall Study|Withdrawal by Subject|3
72696|NCT00995930|264008|P2|Overall Study|Lost to Follow-up|2
72697|NCT00995930|264009|P1|Overall Study|Lost to Follow-up|1
72698|NCT00995930|264008|P2|Overall Study|Administrative problems|2
72699|NCT00995930|264009|P1|Overall Study|Administrative problems|4
72700|NCT00995930|264008|P2|Overall Study|Death|1
72701|NCT00995930|264009|P1|Overall Study|Death|0
72702|NCT00995930|264008|P2|Overall Study|Protocol deviation|5
72703|NCT00995930|264009|P1|Overall Study|Protocol deviation|2
72704|NCT00995865|264060|P3|Overall Study|Lost to Follow-up|1
72705|NCT00995865|264061|P2|Overall Study|Lost to Follow-up|0
72706|NCT00995865|264062|P1|Overall Study|Lost to Follow-up|0
72707|NCT00995865|264060|P3|Overall Study|Protocol Violation|0
72708|NCT00995865|264061|P2|Overall Study|Protocol Violation|0
72709|NCT00995865|264062|P1|Overall Study|Protocol Violation|2
72710|NCT00995774|264084|P2|Training Period 2|Withdrawal by Subject|0
72711|NCT00995774|264085|P1|Training Period 2|Withdrawal by Subject|2
72712|NCT00995709|264117|P3|Overall Study|Protocol Violation|0
72713|NCT00995709|264118|P2|Overall Study|Protocol Violation|1
72714|NCT00995709|264119|P1|Overall Study|Protocol Violation|2
72715|NCT00995709|264117|P3|Overall Study|Death|0
72716|NCT00995709|264118|P2|Overall Study|Death|1
72717|NCT00995709|264119|P1|Overall Study|Death|0
72718|NCT00995709|264117|P3|Overall Study|Lost to Follow-up|0
72719|NCT00995709|264118|P2|Overall Study|Lost to Follow-up|0
72720|NCT00995709|264119|P1|Overall Study|Lost to Follow-up|1
72721|NCT00995709|264117|P3|Overall Study|Withdrawal by Subject|1
72722|NCT00995709|264118|P2|Overall Study|Withdrawal by Subject|4
72723|NCT00995709|264119|P1|Overall Study|Withdrawal by Subject|0
72724|NCT00995709|264117|P3|Overall Study|Lack of Efficacy|4
72725|NCT00995709|264118|P2|Overall Study|Lack of Efficacy|1
72726|NCT00995709|264119|P1|Overall Study|Lack of Efficacy|0
72727|NCT00995709|264117|P3|Overall Study|Adverse Event|0
72728|NCT00995709|264118|P2|Overall Study|Adverse Event|2
72729|NCT00995709|264119|P1|Overall Study|Adverse Event|4
72730|NCT00995670|264145|P3|Overall Study|Failed arterial cannulation|3
72731|NCT00995670|264146|P2|Overall Study|Failed arterial cannulation|0
72732|NCT00995670|264147|P1|Overall Study|Failed arterial cannulation|1
72733|NCT00995566|264155|P1|Overall Study|Early study termination|52
72734|NCT00995566|264155|P1|Overall Study|Adverse Event|2
72735|NCT00995553|264169|P2|Overall Study|Withdrawal by Subject|6
72736|NCT00995553|264170|P1|Overall Study|Withdrawal by Subject|2
72737|NCT00995488|264178|P1|Overall Study|Withdrawal by Subject|1
72738|NCT00995436|264201|P3|Overall Study|Withdrawal by Subject|0
72739|NCT00995436|264202|P2|Overall Study|Withdrawal by Subject|5
72740|NCT00995436|264203|P1|Overall Study|Withdrawal by Subject|2
72741|NCT00995410|264211|P1|Overall Study|Misc|28
72742|NCT00995410|264211|P1|Overall Study|Lost to Follow-up|2
72743|NCT00995410|264211|P1|Overall Study|Withdrawal by Subject|7
72744|NCT00995410|264211|P1|Overall Study|Adverse Event|51
72745|NCT00995371|264218|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
72746|NCT00995371|264219|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
72747|NCT00995345|264237|P5|Overall Study|all other reasons combined|3
72748|NCT00995345|264238|P4|Overall Study|all other reasons combined|1
72749|NCT00995345|264239|P3|Overall Study|all other reasons combined|2
72750|NCT00995345|264240|P2|Overall Study|all other reasons combined|2
72751|NCT00995345|264241|P1|Overall Study|all other reasons combined|2
72752|NCT00995345|264237|P5|Overall Study|Lost to Follow-up|0
72753|NCT00995345|264238|P4|Overall Study|Lost to Follow-up|1
72754|NCT00995345|264239|P3|Overall Study|Lost to Follow-up|2
72755|NCT00995345|264240|P2|Overall Study|Lost to Follow-up|2
72756|NCT00995345|264241|P1|Overall Study|Lost to Follow-up|2
72757|NCT00995345|264237|P5|Overall Study|Adverse Event|1
72758|NCT00995345|264238|P4|Overall Study|Adverse Event|0
72759|NCT00995345|264239|P3|Overall Study|Adverse Event|2
72760|NCT00995345|264240|P2|Overall Study|Adverse Event|1
72761|NCT00995345|264241|P1|Overall Study|Adverse Event|3
72762|NCT00995345|264237|P5|Overall Study|Withdrawal by Subject|1
72763|NCT00995345|264238|P4|Overall Study|Withdrawal by Subject|3
72764|NCT00995345|264239|P3|Overall Study|Withdrawal by Subject|1
72765|NCT00995345|264240|P2|Overall Study|Withdrawal by Subject|2
72766|NCT00995345|264241|P1|Overall Study|Withdrawal by Subject|4
72767|NCT00995085|264268|P1|Overall Study|Withdrawal by Subject|5
72768|NCT00995020|264274|P2|Overall Study|specimen fragmentation, thermal damage|2
72769|NCT00995020|264275|P1|Overall Study|specimen fragmentation, thermal damage|1
72770|NCT00995020|264274|P2|Overall Study|margin analysis not performed|5
72771|NCT00995020|264275|P1|Overall Study|margin analysis not performed|2
72772|NCT00995007|264285|P2|Overall Study|Toxicity|0
72773|NCT00995007|264286|P1|Overall Study|Toxicity|8
72774|NCT00995007|264285|P2|Overall Study|Refused further treatment|2
72775|NCT00995007|264286|P1|Overall Study|Refused further treatment|8
72776|NCT00995007|264285|P2|Overall Study|Withdrew consent|0
72777|NCT00995007|264286|P1|Overall Study|Withdrew consent|1
72778|NCT00994461|264357|P3|Overall Study|Adverse Event|0
72779|NCT00994461|264358|P2|Overall Study|Adverse Event|1
72780|NCT00994461|264359|P1|Overall Study|Adverse Event|2
72781|NCT00994448|264387|P2|Overall Study|Physician Decision|0
72782|NCT00994448|264388|P1|Overall Study|Physician Decision|1
72783|NCT00994448|264387|P2|Overall Study|Withdrawal by Subject|1
72784|NCT00994448|264388|P1|Overall Study|Withdrawal by Subject|1
72785|NCT00994448|264387|P2|Overall Study|Lost to Follow-up|1
72786|NCT00994448|264388|P1|Overall Study|Lost to Follow-up|5
72787|NCT00994448|264387|P2|Overall Study|Adverse Event|0
72788|NCT00994448|264388|P1|Overall Study|Adverse Event|1
72789|NCT00994422|264396|P2|Overall Study|Lost to Follow-up|1
72790|NCT00994422|264397|P1|Overall Study|Lost to Follow-up|7
72791|NCT00994240|264431|P2|Overall Study|study termination|3
72792|NCT00994240|264432|P1|Overall Study|study termination|2
72793|NCT00994240|264431|P2|Overall Study|Withdrawal by Subject|0
72794|NCT00994240|264432|P1|Overall Study|Withdrawal by Subject|1
72795|NCT00994240|264431|P2|Overall Study|Lost to Follow-up|2
72796|NCT00994240|264432|P1|Overall Study|Lost to Follow-up|3
72797|NCT00994214|264442|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
72798|NCT00994214|264443|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
72799|NCT00994214|264444|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
72800|NCT00994214|264445|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
72801|NCT00994214|264442|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
72802|NCT00994214|264443|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
72803|NCT00994214|264444|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
72804|NCT00994214|264445|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
72805|NCT00994214|264442|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
72806|NCT00994214|264443|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
72807|NCT00994214|264444|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
72808|NCT00994214|264445|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
72809|NCT00994214|264442|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
72810|NCT00994214|264443|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
72811|NCT00994214|264444|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
72812|NCT00994214|264445|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
72813|NCT00994214|264442|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
72814|NCT00994214|264443|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
72815|NCT00994214|264444|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
72816|NCT00994214|264445|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
72817|NCT00994214|264442|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
72818|NCT00994214|264443|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
72819|NCT00994214|264444|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
72820|NCT00994214|264445|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
72821|NCT00994110|264515|P2|Overall Study|Pt not eligible|5
72822|NCT00994110|264516|P1|Overall Study|Pt not eligible|10
72823|NCT00994110|264515|P2|Overall Study|Patient not resected|52
72824|NCT00994110|264516|P1|Overall Study|Patient not resected|41
72825|NCT00994110|264515|P2|Overall Study|Adverse Event|0
72826|NCT00994110|264516|P1|Overall Study|Adverse Event|1
72827|NCT00994110|264515|P2|Overall Study|Not Treated|8
72828|NCT00994110|264516|P1|Overall Study|Not Treated|4
72829|NCT00994110|264515|P2|Overall Study|Withdrawal by Subject|9
72830|NCT00994110|264516|P1|Overall Study|Withdrawal by Subject|9
72831|NCT00993954|264524|P2|Overall Study|Protocol Violation|2
72832|NCT00993954|264525|P1|Overall Study|Protocol Violation|21
72833|NCT00993915|264536|P1|Overall Study|Ongoing|3
72834|NCT00993915|264536|P1|Overall Study|Not specified|1
72835|NCT00993915|264536|P1|Overall Study|Withdrawal by Subject|2
72836|NCT00993915|264536|P1|Overall Study|Insufficient clinical response|3
72837|NCT00993668|264562|P2|Open-Label Period|Lost to Follow-up|1
72838|NCT00993668|264563|P1|Open-Label Period|Lost to Follow-up|6
72839|NCT00993668|264562|P2|Open-Label Period|Withdrawal by Subject|3
72840|NCT00993668|264563|P1|Open-Label Period|Withdrawal by Subject|4
72841|NCT00993668|264562|P2|Open-Label Period|Lack of Efficacy|3
72842|NCT00993668|264563|P1|Open-Label Period|Lack of Efficacy|4
72843|NCT00993668|264562|P2|Open-Label Period|Adverse Event|8
72844|NCT00993668|264563|P1|Open-Label Period|Adverse Event|9
72845|NCT00993668|264562|P2|Single-Blind Period|Lost to Follow-up|1
72846|NCT00993668|264563|P1|Single-Blind Period|Lost to Follow-up|3
72847|NCT00993668|264562|P2|Single-Blind Period|Lack of Efficacy|1
72848|NCT00993668|264563|P1|Single-Blind Period|Lack of Efficacy|0
72849|NCT00993668|264562|P2|Single-Blind Period|Adverse Event|1
72850|NCT00993668|264563|P1|Single-Blind Period|Adverse Event|1
72851|NCT00993616|264588|P1|Overall Study|Never treated|1
72852|NCT00993616|264588|P1|Overall Study|No tumor at entry|1
72853|NCT00993499|264598|P6|Discontinued After Starting Course 3|Other adverse event|0
72854|NCT00993499|264599|P5|Discontinued After Starting Course 3|Other adverse event|0
72855|NCT00993499|264600|P4|Discontinued After Starting Course 3|Other adverse event|0
72856|NCT00993499|264601|P3|Discontinued After Starting Course 3|Other adverse event|1
72857|NCT00993499|264602|P2|Discontinued After Starting Course 3|Other adverse event|0
72858|NCT00993499|264603|P1|Discontinued After Starting Course 3|Other adverse event|1
72859|NCT00993499|264598|P6|Discontinued After Starting Course 3|DLT|0
72860|NCT00993499|264599|P5|Discontinued After Starting Course 3|DLT|0
72861|NCT00993499|264600|P4|Discontinued After Starting Course 3|DLT|1
72862|NCT00993499|264601|P3|Discontinued After Starting Course 3|DLT|2
72863|NCT00993499|264602|P2|Discontinued After Starting Course 3|DLT|0
72864|NCT00993499|264603|P1|Discontinued After Starting Course 3|DLT|1
72865|NCT00993499|264598|P6|Discontinued After Starting Course 3|Progressive Disease|3
72866|NCT00993499|264599|P5|Discontinued After Starting Course 3|Progressive Disease|3
72867|NCT00993499|264600|P4|Discontinued After Starting Course 3|Progressive Disease|1
72868|NCT00993499|264601|P3|Discontinued After Starting Course 3|Progressive Disease|3
72869|NCT00993499|264602|P2|Discontinued After Starting Course 3|Progressive Disease|4
72870|NCT00993499|264603|P1|Discontinued After Starting Course 3|Progressive Disease|6
72871|NCT00993499|264598|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
72872|NCT00993499|264599|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
72873|NCT00993499|264600|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
72874|NCT00993499|264601|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
72875|NCT00993499|264602|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
72876|NCT00993499|264603|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
72877|NCT00993499|264598|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
72878|NCT00993499|264599|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
72879|NCT00993499|264600|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
72880|NCT00993499|264601|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
72881|NCT00993499|264602|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
72882|NCT00993499|264603|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
72883|NCT00993499|264598|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
72884|NCT00993499|264599|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
72885|NCT00993499|264600|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
72886|NCT00993499|264601|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
72887|NCT00993499|264602|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
72888|NCT00993499|264603|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
72889|NCT00993499|264598|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
72890|NCT00993499|264599|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
72891|NCT00993499|264600|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
72892|NCT00993499|264601|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
72893|NCT00993499|264602|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
72894|NCT00993499|264603|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
72895|NCT00993499|264598|P6|Discontinued Before Starting Course 3|Progressive Disease|0
72896|NCT00993499|264599|P5|Discontinued Before Starting Course 3|Progressive Disease|0
72897|NCT00993499|264600|P4|Discontinued Before Starting Course 3|Progressive Disease|0
72898|NCT00993499|264601|P3|Discontinued Before Starting Course 3|Progressive Disease|0
72899|NCT00993499|264602|P2|Discontinued Before Starting Course 3|Progressive Disease|2
72900|NCT00993499|264603|P1|Discontinued Before Starting Course 3|Progressive Disease|2
72901|NCT00993499|264598|P6|Run-in Period (8 Days)|Progressive disease|0
72902|NCT00993499|264599|P5|Run-in Period (8 Days)|Progressive disease|0
72903|NCT00993499|264600|P4|Run-in Period (8 Days)|Progressive disease|0
72904|NCT00993499|264601|P3|Run-in Period (8 Days)|Progressive disease|1
72905|NCT00993499|264602|P2|Run-in Period (8 Days)|Progressive disease|1
72906|NCT00993499|264603|P1|Run-in Period (8 Days)|Progressive disease|0
72907|NCT00993499|264598|P6|Run-in Period (8 Days)|Consent withdrawn|0
72908|NCT00993499|264599|P5|Run-in Period (8 Days)|Consent withdrawn|0
72909|NCT00993499|264600|P4|Run-in Period (8 Days)|Consent withdrawn|0
72910|NCT00993499|264601|P3|Run-in Period (8 Days)|Consent withdrawn|0
72911|NCT00993499|264602|P2|Run-in Period (8 Days)|Consent withdrawn|1
72912|NCT00993499|264603|P1|Run-in Period (8 Days)|Consent withdrawn|0
72913|NCT00993499|264598|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
72914|NCT00993499|264599|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
72915|NCT00993499|264600|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
72916|NCT00993499|264601|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
72917|NCT00993499|264602|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
72918|NCT00993499|264603|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
72919|NCT00993499|264598|P6|Run-in Period (8 Days)|Adverse Event|0
72920|NCT00993499|264599|P5|Run-in Period (8 Days)|Adverse Event|0
72921|NCT00993499|264600|P4|Run-in Period (8 Days)|Adverse Event|0
72922|NCT00993499|264601|P3|Run-in Period (8 Days)|Adverse Event|0
72923|NCT00993499|264602|P2|Run-in Period (8 Days)|Adverse Event|1
72924|NCT00993499|264603|P1|Run-in Period (8 Days)|Adverse Event|0
72925|NCT00993473|264685|P2|Overall Study|Family event|0
72926|NCT00993473|264686|P1|Overall Study|Family event|1
72927|NCT00993473|264685|P2|Overall Study|Technical problem with CGM device|1
72928|NCT00993473|264686|P1|Overall Study|Technical problem with CGM device|0
72929|NCT00993473|264685|P2|Overall Study|Withdrawal by Subject|5
72930|NCT00993473|264686|P1|Overall Study|Withdrawal by Subject|1
72931|NCT00993473|264685|P2|Overall Study|Lost to Follow-up|0
72932|NCT00993473|264686|P1|Overall Study|Lost to Follow-up|1
72933|NCT00993473|264685|P2|Overall Study|Protocol Violation|2
72934|NCT00993473|264686|P1|Overall Study|Protocol Violation|1
72935|NCT00993473|264685|P2|Overall Study|Adverse Event|2
72936|NCT00993473|264686|P1|Overall Study|Adverse Event|0
72937|NCT00993447|264724|P2|Overall Study|Adverse Event|0
72938|NCT00993447|264725|P1|Overall Study|Adverse Event|1
72939|NCT00993447|264724|P2|Overall Study|Lost to Follow-up|3
72940|NCT00993447|264725|P1|Overall Study|Lost to Follow-up|1
72941|NCT00993447|264724|P2|Overall Study|Protocol Violation|8
72942|NCT00993447|264725|P1|Overall Study|Protocol Violation|12
72943|NCT00993447|264724|P2|Overall Study|Withdrawal by Subject|8
72944|NCT00993447|264725|P1|Overall Study|Withdrawal by Subject|23
72945|NCT00993421|264762|P7|Overall Study|Protocol Violation|1
72946|NCT00993421|264763|P6|Overall Study|Protocol Violation|2
72947|NCT00993421|264764|P5|Overall Study|Protocol Violation|0
72948|NCT00993421|264765|P4|Overall Study|Protocol Violation|0
72949|NCT00993421|264766|P3|Overall Study|Protocol Violation|0
72950|NCT00993421|264767|P2|Overall Study|Protocol Violation|0
72951|NCT00993421|264768|P1|Overall Study|Protocol Violation|0
72952|NCT00993421|264762|P7|Overall Study|Physician Decision|1
72953|NCT00993421|264763|P6|Overall Study|Physician Decision|1
72954|NCT00993421|264764|P5|Overall Study|Physician Decision|0
72955|NCT00993421|264765|P4|Overall Study|Physician Decision|0
72956|NCT00993421|264766|P3|Overall Study|Physician Decision|0
72957|NCT00993421|264767|P2|Overall Study|Physician Decision|0
72958|NCT00993421|264768|P1|Overall Study|Physician Decision|0
72959|NCT00993421|264762|P7|Overall Study|Entry Criteria Exclusion|0
72960|NCT00993421|264763|P6|Overall Study|Entry Criteria Exclusion|1
72961|NCT00993421|264764|P5|Overall Study|Entry Criteria Exclusion|0
72962|NCT00993421|264765|P4|Overall Study|Entry Criteria Exclusion|3
72963|NCT00993421|264766|P3|Overall Study|Entry Criteria Exclusion|1
72964|NCT00993421|264767|P2|Overall Study|Entry Criteria Exclusion|0
72965|NCT00993421|264768|P1|Overall Study|Entry Criteria Exclusion|0
72966|NCT00993421|264762|P7|Overall Study|Death|1
72967|NCT00993421|264763|P6|Overall Study|Death|0
72968|NCT00993421|264764|P5|Overall Study|Death|0
72969|NCT00993421|264765|P4|Overall Study|Death|0
72970|NCT00993421|264766|P3|Overall Study|Death|0
72971|NCT00993421|264767|P2|Overall Study|Death|0
72972|NCT00993421|264768|P1|Overall Study|Death|0
72973|NCT00993421|264762|P7|Overall Study|Withdrawal by Subject|3
72974|NCT00993421|264763|P6|Overall Study|Withdrawal by Subject|5
72975|NCT00993421|264764|P5|Overall Study|Withdrawal by Subject|3
72976|NCT00993421|264765|P4|Overall Study|Withdrawal by Subject|3
72977|NCT00993421|264766|P3|Overall Study|Withdrawal by Subject|3
72978|NCT00993421|264767|P2|Overall Study|Withdrawal by Subject|2
72979|NCT00993421|264768|P1|Overall Study|Withdrawal by Subject|3
72980|NCT00993421|264762|P7|Overall Study|Lost to Follow-up|6
72981|NCT00993421|264763|P6|Overall Study|Lost to Follow-up|0
72982|NCT00993421|264764|P5|Overall Study|Lost to Follow-up|0
72983|NCT00993421|264765|P4|Overall Study|Lost to Follow-up|0
72984|NCT00993421|264766|P3|Overall Study|Lost to Follow-up|5
72985|NCT00993421|264767|P2|Overall Study|Lost to Follow-up|5
72986|NCT00993421|264768|P1|Overall Study|Lost to Follow-up|3
72987|NCT00993421|264762|P7|Overall Study|Sponsor Decision|29
72988|NCT00993421|264763|P6|Overall Study|Sponsor Decision|30
72989|NCT00993421|264764|P5|Overall Study|Sponsor Decision|38
72990|NCT00993421|264765|P4|Overall Study|Sponsor Decision|30
72991|NCT00993421|264766|P3|Overall Study|Sponsor Decision|28
72992|NCT00993421|264767|P2|Overall Study|Sponsor Decision|31
72993|NCT00993421|264768|P1|Overall Study|Sponsor Decision|36
72994|NCT00993421|264762|P7|Overall Study|Adverse Event|1
72995|NCT00993421|264763|P6|Overall Study|Adverse Event|7
72996|NCT00993421|264764|P5|Overall Study|Adverse Event|5
72997|NCT00993421|264765|P4|Overall Study|Adverse Event|9
72998|NCT00993421|264766|P3|Overall Study|Adverse Event|6
72999|NCT00993421|264767|P2|Overall Study|Adverse Event|7
73000|NCT00993421|264768|P1|Overall Study|Adverse Event|2
73001|NCT00993317|264919|P2|Overall Study|Early study termination at the site|0
73002|NCT00993317|264920|P1|Overall Study|Early study termination at the site|1
73003|NCT00993317|264919|P2|Overall Study|Investigator's opinion|1
73004|NCT00993317|264920|P1|Overall Study|Investigator's opinion|0
73005|NCT00993317|264919|P2|Overall Study|Withdrawal by Subject|2
73006|NCT00993317|264920|P1|Overall Study|Withdrawal by Subject|0
73007|NCT00993317|264919|P2|Overall Study|Lack of Efficacy|18
73008|NCT00993317|264920|P1|Overall Study|Lack of Efficacy|18
73009|NCT00993317|264919|P2|Overall Study|Adverse Event|4
73010|NCT00993317|264920|P1|Overall Study|Adverse Event|2
73011|NCT00993291|264938|P1|Overall Study|Withdrawal by Subject|1
73012|NCT00993265|264944|P2|Overall Study|Non-compliant with study medication|0
73013|NCT00993265|264945|P1|Overall Study|Non-compliant with study medication|1
73014|NCT00993265|264944|P2|Overall Study|Changed dose of concomitant drug|0
73015|NCT00993265|264945|P1|Overall Study|Changed dose of concomitant drug|2
73016|NCT00993265|264944|P2|Overall Study|Adverse Event|0
73017|NCT00993265|264945|P1|Overall Study|Adverse Event|1
73018|NCT00993148|264997|P1|Overall Study|never initiated treatment|1
73019|NCT00993148|264997|P1|Overall Study|Lost to Follow-up|2
73020|NCT00993044|265009|P1|Irinotecan 50 mg|Physician Decision|1
73021|NCT00992992|265014|P1|Overall Study|Sponsor Closed the Study|4
73022|NCT00992992|265014|P1|Overall Study|GlaxoSmithKline Closed the Study|2
73023|NCT00992992|265014|P1|Overall Study|Death|16
73024|NCT00992992|265014|P1|Overall Study|Lost to Follow-up|3
73025|NCT00992836|265045|P1|Overall Study|Protocol Violation|2
73026|NCT00992836|265045|P1|Overall Study|Withdrawal by Subject|2
73027|NCT00992836|265045|P1|Overall Study|Lost to Follow-up|1
73028|NCT00992784|265060|P3|Overall Study|Withdrawal by Subject|1
73029|NCT00992784|265061|P2|Overall Study|Withdrawal by Subject|1
73030|NCT00992784|265062|P1|Overall Study|Withdrawal by Subject|1
73031|NCT00992784|265060|P3|Overall Study|Adverse Event|0
73032|NCT00992784|265061|P2|Overall Study|Adverse Event|1
73033|NCT00992784|265062|P1|Overall Study|Adverse Event|2
73034|NCT00992589|265169|P4|Double-Blind Phase|Not specified|3
73035|NCT00992589|265170|P3|Double-Blind Phase|Not specified|6
73036|NCT00992589|265171|P2|Double-Blind Phase|Not specified|1
73037|NCT00992589|265172|P1|Double-Blind Phase|Not specified|0
73038|NCT00992589|265169|P4|Double-Blind Phase|Lost to Follow-up|2
73039|NCT00992589|265170|P3|Double-Blind Phase|Lost to Follow-up|0
73040|NCT00992589|265171|P2|Double-Blind Phase|Lost to Follow-up|0
73041|NCT00992589|265172|P1|Double-Blind Phase|Lost to Follow-up|0
73042|NCT00992589|265169|P4|Double-Blind Phase|Withdrawal by Subject|2
73043|NCT00992589|265170|P3|Double-Blind Phase|Withdrawal by Subject|5
73044|NCT00992589|265171|P2|Double-Blind Phase|Withdrawal by Subject|6
73045|NCT00992589|265172|P1|Double-Blind Phase|Withdrawal by Subject|0
73046|NCT00992589|265169|P4|Double-Blind Phase|Adverse Event|3
73047|NCT00992589|265170|P3|Double-Blind Phase|Adverse Event|2
73048|NCT00992589|265171|P2|Double-Blind Phase|Adverse Event|6
73049|NCT00992589|265172|P1|Double-Blind Phase|Adverse Event|0
73050|NCT00992589|265169|P4|Open-Label Phase|Not specified|0
73051|NCT00992589|265170|P3|Open-Label Phase|Not specified|0
73052|NCT00992589|265171|P2|Open-Label Phase|Not specified|0
73053|NCT00992589|265172|P1|Open-Label Phase|Not specified|45
73054|NCT00992589|265169|P4|Open-Label Phase|Physician Decision|0
73055|NCT00992589|265170|P3|Open-Label Phase|Physician Decision|0
73056|NCT00992589|265171|P2|Open-Label Phase|Physician Decision|0
73057|NCT00992589|265172|P1|Open-Label Phase|Physician Decision|4
73058|NCT00992589|265169|P4|Open-Label Phase|Protocol Violation|0
73059|NCT00992589|265170|P3|Open-Label Phase|Protocol Violation|0
73060|NCT00992589|265171|P2|Open-Label Phase|Protocol Violation|0
73061|NCT00992589|265172|P1|Open-Label Phase|Protocol Violation|3
73062|NCT00992589|265169|P4|Open-Label Phase|Lost to Follow-up|0
73063|NCT00992589|265170|P3|Open-Label Phase|Lost to Follow-up|0
73064|NCT00992589|265171|P2|Open-Label Phase|Lost to Follow-up|0
73065|NCT00992589|265172|P1|Open-Label Phase|Lost to Follow-up|1
73066|NCT00992589|265169|P4|Open-Label Phase|Withdrawal by Subject|0
73067|NCT00992589|265170|P3|Open-Label Phase|Withdrawal by Subject|0
73068|NCT00992589|265171|P2|Open-Label Phase|Withdrawal by Subject|0
73069|NCT00992589|265172|P1|Open-Label Phase|Withdrawal by Subject|20
73070|NCT00992589|265169|P4|Open-Label Phase|Adverse Event|0
73071|NCT00992589|265170|P3|Open-Label Phase|Adverse Event|0
73072|NCT00992589|265171|P2|Open-Label Phase|Adverse Event|0
73073|NCT00992589|265172|P1|Open-Label Phase|Adverse Event|4
73074|NCT00992459|265216|P2|Overall Study|Adverse Event|0
73075|NCT00992459|265217|P1|Overall Study|Adverse Event|1
73076|NCT00992459|265216|P2|Overall Study|Withdrawal by Subject|1
73077|NCT00992459|265217|P1|Overall Study|Withdrawal by Subject|0
73078|NCT00992407|265308|P2|Overall Study|Study medication not administered|13
73079|NCT00992407|265309|P1|Overall Study|Study medication not administered|17
73080|NCT00992407|265308|P2|Overall Study|Loss of follow-up & Adverse events|1
73081|NCT00992407|265309|P1|Overall Study|Loss of follow-up & Adverse events|2
73082|NCT00992407|265308|P2|Overall Study|Unspecified|0
73083|NCT00992407|265309|P1|Overall Study|Unspecified|2
73084|NCT00992407|265308|P2|Overall Study|protocol Violation & Adverse events|4
73085|NCT00992407|265309|P1|Overall Study|protocol Violation & Adverse events|2
73086|NCT00992407|265308|P2|Overall Study|Adverse Event|2
73087|NCT00992407|265309|P1|Overall Study|Adverse Event|3
73088|NCT00992407|265308|P2|Overall Study|Lost to Follow-up|3
73089|NCT00992407|265309|P1|Overall Study|Lost to Follow-up|3
73090|NCT00992407|265308|P2|Overall Study|Protocol Violation|1
73091|NCT00992407|265309|P1|Overall Study|Protocol Violation|2
73092|NCT00992394|265359|P2|Overall Study|Other event|0
73093|NCT00992394|265360|P1|Overall Study|Other event|1
73094|NCT00992394|265359|P2|Overall Study|Lost to Follow-up|0
73095|NCT00992394|265360|P1|Overall Study|Lost to Follow-up|2
73096|NCT00992394|265359|P2|Overall Study|Protocol Violation|4
73097|NCT00992394|265360|P1|Overall Study|Protocol Violation|2
73098|NCT00992394|265359|P2|Overall Study|Physician Decision|0
73099|NCT00992394|265360|P1|Overall Study|Physician Decision|1
73100|NCT00992394|265359|P2|Overall Study|Withdrawal by Subject|2
73101|NCT00992394|265360|P1|Overall Study|Withdrawal by Subject|8
73102|NCT00992394|265359|P2|Overall Study|Adverse Event|5
73103|NCT00992394|265360|P1|Overall Study|Adverse Event|4
73104|NCT00992394|265359|P2|Overall Study|Lack of Efficacy|3
73105|NCT00992394|265360|P1|Overall Study|Lack of Efficacy|6
73106|NCT00992186|265447|P1|Overall Study|Refusal To Receive Study Agent|3
73107|NCT00992186|265447|P1|Overall Study|Progressive Disease|30
73108|NCT00992186|265447|P1|Overall Study|Adverse Event|9
73109|NCT00992186|265447|P1|Overall Study|Physician Decision|1
73110|NCT00992186|265447|P1|Overall Study|Protocol Violation|1
73111|NCT00992186|265447|P1|Overall Study|Withdrawal by Subject|2
73112|NCT00992108|265466|P2|Overall Study|Lost to Follow-up|1
73113|NCT00992108|265467|P1|Overall Study|Lost to Follow-up|0
73114|NCT00992056|265481|P2|Washout Period (2 Weeks)|Physician Decision|0
73115|NCT00992056|265482|P1|Washout Period (2 Weeks)|Physician Decision|1
73116|NCT00992056|265481|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
73117|NCT00992056|265482|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
73118|NCT00992017|265488|P1|Overall Study|Not adhere to study requirements|1
73119|NCT00992017|265488|P1|Overall Study|Unable to get to clinic|5
73120|NCT00992017|265488|P1|Overall Study|Withdrawal by Subject|2
73121|NCT00992017|265488|P1|Overall Study|Lost to Follow-up|2
73122|NCT00991952|265503|P2|Overall Study|Adverse Event|1
73123|NCT00991952|265504|P1|Overall Study|Adverse Event|0
73124|NCT00991939|265512|P2|Overall Study|Entire study terminated|1
73125|NCT00991939|265513|P1|Overall Study|Entire study terminated|4
73126|NCT00991939|265512|P2|Overall Study|Withdrawal by Subject|0
73127|NCT00991939|265513|P1|Overall Study|Withdrawal by Subject|1
73128|NCT00991939|265512|P2|Overall Study|Lost to Follow-up|1
73129|NCT00991939|265513|P1|Overall Study|Lost to Follow-up|0
73130|NCT00991510|265556|P2|Period III (Days 29-112)|Adverse Event|1
73131|NCT00991510|265557|P1|Period III (Days 29-112)|Adverse Event|1
73132|NCT00991510|265556|P2|Period I (Days 1-14)|Adverse Event|0
73133|NCT00991510|265557|P1|Period I (Days 1-14)|Adverse Event|1
73134|NCT00991341|265603|P2|Overall Study|Withdrawal by Subject|4
73135|NCT00991341|265604|P1|Overall Study|Withdrawal by Subject|3
73136|NCT00991341|265603|P2|Overall Study|Physician Decision|2
73137|NCT00991341|265604|P1|Overall Study|Physician Decision|1
73138|NCT00991341|265603|P2|Overall Study|no RBCs received 96hrs after randomized|155
73139|NCT00991341|265604|P1|Overall Study|no RBCs received 96hrs after randomized|186
73140|NCT00991341|265603|P2|Overall Study|Death|0
73141|NCT00991341|265604|P1|Overall Study|Death|3
73142|NCT00991341|265603|P2|Overall Study|no surgery w/in 30 days of randomization|18
73143|NCT00991341|265604|P1|Overall Study|no surgery w/in 30 days of randomization|11
73144|NCT00991302|265642|P2|Overall Study|Lost to Follow-up|12
73145|NCT00991302|265643|P1|Overall Study|Lost to Follow-up|14
73146|NCT00991302|265642|P2|Overall Study|Death|1
73147|NCT00991302|265643|P1|Overall Study|Death|0
73148|NCT00991289|265659|P1|Overall Study|Protocol Violation|2
73149|NCT00991289|265659|P1|Overall Study|Lost to Follow-up|4
73150|NCT00991289|265659|P1|Overall Study|Withdrawal by Subject|3
73151|NCT00991289|265659|P1|Overall Study|Physician Decision|2
73152|NCT00991289|265659|P1|Overall Study|Adverse Event|1
73153|NCT00991276|265679|P6|Third Intervention Period|Withdrawal by Subject|0
73154|NCT00991276|265680|P5|Third Intervention Period|Withdrawal by Subject|0
73155|NCT00991276|265681|P4|Third Intervention Period|Withdrawal by Subject|1
73156|NCT00991276|265682|P3|Third Intervention Period|Withdrawal by Subject|0
73157|NCT00991276|265683|P2|Third Intervention Period|Withdrawal by Subject|0
73158|NCT00991276|265684|P1|Third Intervention Period|Withdrawal by Subject|0
73159|NCT00991276|265679|P6|Third Intervention Period|Adverse Event|0
73160|NCT00991276|265680|P5|Third Intervention Period|Adverse Event|0
73161|NCT00991276|265681|P4|Third Intervention Period|Adverse Event|0
73162|NCT00991276|265682|P3|Third Intervention Period|Adverse Event|1
73163|NCT00991276|265683|P2|Third Intervention Period|Adverse Event|0
73164|NCT00991276|265684|P1|Third Intervention Period|Adverse Event|0
73165|NCT00991276|265679|P6|Third Intervention Period|Unspecified|1
73166|NCT00991276|265680|P5|Third Intervention Period|Unspecified|0
73167|NCT00991276|265681|P4|Third Intervention Period|Unspecified|0
73168|NCT00991276|265682|P3|Third Intervention Period|Unspecified|0
73169|NCT00991276|265683|P2|Third Intervention Period|Unspecified|0
73170|NCT00991276|265684|P1|Third Intervention Period|Unspecified|0
73171|NCT00991276|265679|P6|Third Intervention Period|Protocol Violation|0
73172|NCT00991276|265680|P5|Third Intervention Period|Protocol Violation|0
73173|NCT00991276|265681|P4|Third Intervention Period|Protocol Violation|0
73174|NCT00991276|265682|P3|Third Intervention Period|Protocol Violation|0
73175|NCT00991276|265683|P2|Third Intervention Period|Protocol Violation|0
73176|NCT00991276|265684|P1|Third Intervention Period|Protocol Violation|1
73177|NCT00991276|265679|P6|Second Intervention Period|Unspecified|1
73178|NCT00991276|265680|P5|Second Intervention Period|Unspecified|0
73179|NCT00991276|265681|P4|Second Intervention Period|Unspecified|1
73180|NCT00991276|265682|P3|Second Intervention Period|Unspecified|0
73181|NCT00991276|265683|P2|Second Intervention Period|Unspecified|0
73182|NCT00991276|265684|P1|Second Intervention Period|Unspecified|0
73183|NCT00991276|265679|P6|Second Intervention Period|Protocol Violation|0
73184|NCT00991276|265680|P5|Second Intervention Period|Protocol Violation|0
73185|NCT00991276|265681|P4|Second Intervention Period|Protocol Violation|0
73186|NCT00991276|265682|P3|Second Intervention Period|Protocol Violation|0
73187|NCT00991276|265683|P2|Second Intervention Period|Protocol Violation|0
73188|NCT00991276|265684|P1|Second Intervention Period|Protocol Violation|1
73189|NCT00991276|265679|P6|Second Intervention Period|Adverse Event|0
73190|NCT00991276|265680|P5|Second Intervention Period|Adverse Event|1
73191|NCT00991276|265681|P4|Second Intervention Period|Adverse Event|1
73192|NCT00991276|265682|P3|Second Intervention Period|Adverse Event|0
73193|NCT00991276|265683|P2|Second Intervention Period|Adverse Event|2
73194|NCT00991276|265684|P1|Second Intervention Period|Adverse Event|0
73195|NCT00991276|265679|P6|First Intervention Period|Lost to Follow-up|0
73196|NCT00991276|265680|P5|First Intervention Period|Lost to Follow-up|0
73197|NCT00991276|265681|P4|First Intervention Period|Lost to Follow-up|1
73198|NCT00991276|265682|P3|First Intervention Period|Lost to Follow-up|0
73199|NCT00991276|265683|P2|First Intervention Period|Lost to Follow-up|1
73200|NCT00991276|265684|P1|First Intervention Period|Lost to Follow-up|0
73201|NCT00991276|265679|P6|First Intervention Period|Withdrawal by Subject|1
73202|NCT00991276|265680|P5|First Intervention Period|Withdrawal by Subject|0
73203|NCT00991276|265681|P4|First Intervention Period|Withdrawal by Subject|1
73204|NCT00991276|265682|P3|First Intervention Period|Withdrawal by Subject|0
73205|NCT00991276|265683|P2|First Intervention Period|Withdrawal by Subject|1
73206|NCT00991276|265684|P1|First Intervention Period|Withdrawal by Subject|0
73207|NCT00991276|265679|P6|First Intervention Period|Unspecified|0
73208|NCT00991276|265680|P5|First Intervention Period|Unspecified|1
73209|NCT00991276|265681|P4|First Intervention Period|Unspecified|1
73210|NCT00991276|265682|P3|First Intervention Period|Unspecified|0
73211|NCT00991276|265683|P2|First Intervention Period|Unspecified|0
73212|NCT00991276|265684|P1|First Intervention Period|Unspecified|0
73213|NCT00991276|265679|P6|First Intervention Period|Insufficient clinical response|0
73214|NCT00991276|265680|P5|First Intervention Period|Insufficient clinical response|1
73215|NCT00991276|265681|P4|First Intervention Period|Insufficient clinical response|0
73216|NCT00991276|265682|P3|First Intervention Period|Insufficient clinical response|0
73217|NCT00991276|265683|P2|First Intervention Period|Insufficient clinical response|0
73218|NCT00991276|265684|P1|First Intervention Period|Insufficient clinical response|0
73219|NCT00991276|265679|P6|First Intervention Period|Protocol Violation|0
73220|NCT00991276|265680|P5|First Intervention Period|Protocol Violation|2
73221|NCT00991276|265681|P4|First Intervention Period|Protocol Violation|0
73222|NCT00991276|265682|P3|First Intervention Period|Protocol Violation|0
73223|NCT00991276|265683|P2|First Intervention Period|Protocol Violation|0
73224|NCT00991276|265684|P1|First Intervention Period|Protocol Violation|0
73225|NCT00991276|265679|P6|First Intervention Period|Adverse Event|0
73226|NCT00991276|265680|P5|First Intervention Period|Adverse Event|0
73227|NCT00991276|265681|P4|First Intervention Period|Adverse Event|1
73228|NCT00991276|265682|P3|First Intervention Period|Adverse Event|0
73229|NCT00991276|265683|P2|First Intervention Period|Adverse Event|1
73230|NCT00991276|265684|P1|First Intervention Period|Adverse Event|0
73231|NCT00990821|265841|P14|Overall Study|Withdrawal by Subject|1
73232|NCT00990821|265842|P13|Overall Study|Withdrawal by Subject|2
73233|NCT00990821|265843|P12|Overall Study|Withdrawal by Subject|5
73234|NCT00990821|265844|P11|Overall Study|Withdrawal by Subject|3
73235|NCT00990821|265845|P10|Overall Study|Withdrawal by Subject|1
73236|NCT00990821|265846|P9|Overall Study|Withdrawal by Subject|0
73237|NCT00990821|265847|P8|Overall Study|Withdrawal by Subject|0
73238|NCT00990821|265848|P7|Overall Study|Withdrawal by Subject|1
73239|NCT00990821|265849|P6|Overall Study|Withdrawal by Subject|3
73240|NCT00990821|265850|P5|Overall Study|Withdrawal by Subject|3
73241|NCT00990821|265851|P4|Overall Study|Withdrawal by Subject|0
73242|NCT00990821|265852|P3|Overall Study|Withdrawal by Subject|0
73243|NCT00990821|265853|P2|Overall Study|Withdrawal by Subject|2
73244|NCT00990821|265854|P1|Overall Study|Withdrawal by Subject|0
73245|NCT00990704|265886|P2|Overall Study|Physician Decision|1
73246|NCT00990704|265887|P1|Overall Study|Physician Decision|0
73247|NCT00990704|265886|P2|Overall Study|Adverse Event|1
73248|NCT00990704|265887|P1|Overall Study|Adverse Event|1
73249|NCT00990652|265907|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
73250|NCT00990652|265907|P1|Pre-surgical Bortezomib|Adverse Event|1
73251|NCT00990340|265941|P2|First 14-day Treatment|Protocol Violation|2
73252|NCT00990340|265942|P1|First 14-day Treatment|Protocol Violation|2
73253|NCT00990340|265941|P2|First 14-day Treatment|Lost to Follow-up|1
73254|NCT00990340|265942|P1|First 14-day Treatment|Lost to Follow-up|2
73255|NCT00990340|265941|P2|First 14-day Treatment|Not Compliant|1
73256|NCT00990340|265942|P1|First 14-day Treatment|Not Compliant|2
73257|NCT00990184|265956|P1|Overall Study|Physician Decision|1
73258|NCT00990106|265964|P2|Overall Study|scheduling conflicts|2
73259|NCT00990106|265965|P1|Overall Study|scheduling conflicts|0
73260|NCT00990106|265964|P2|Overall Study|planned major surgery|1
73261|NCT00990106|265965|P1|Overall Study|planned major surgery|0
73262|NCT00990106|265964|P2|Overall Study|started exclusionary medication|1
73263|NCT00990106|265965|P1|Overall Study|started exclusionary medication|0
73264|NCT00990106|265964|P2|Overall Study|relocation/deployment|1
73265|NCT00990106|265965|P1|Overall Study|relocation/deployment|4
73266|NCT00990106|265964|P2|Overall Study|opted for open label prazosin|1
73267|NCT00990106|265965|P1|Overall Study|opted for open label prazosin|1
73268|NCT00990106|265964|P2|Overall Study|Withdrawal by Subject|1
73269|NCT00990106|265965|P1|Overall Study|Withdrawal by Subject|2
73270|NCT00990106|265964|P2|Overall Study|Lost to Follow-up|3
73271|NCT00990106|265965|P1|Overall Study|Lost to Follow-up|1
73272|NCT00990106|265964|P2|Overall Study|"too busy to continue"|2
73273|NCT00990106|265965|P1|Overall Study|"too busy to continue"|1
73274|NCT00990093|265975|P2|Test Period 2 (15-28 Days)|Not specified|1
73275|NCT00990093|265976|P1|Test Period 2 (15-28 Days)|Not specified|0
73276|NCT00990093|265975|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
73277|NCT00990093|265976|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
73278|NCT00990093|265975|P2|Test Period 2 (15-28 Days)|Adverse Event|0
73279|NCT00990093|265976|P1|Test Period 2 (15-28 Days)|Adverse Event|1
73280|NCT00990093|265975|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
73281|NCT00990093|265976|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
73282|NCT00990093|265975|P2|Test Period 1 (1-14 Days)|Not Specified|0
73283|NCT00990093|265976|P1|Test Period 1 (1-14 Days)|Not Specified|1
73284|NCT00990093|265975|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
73285|NCT00990093|265976|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
73286|NCT00990093|265975|P2|Test Period 1 (1-14 Days)|Adverse Event|0
73287|NCT00990093|265976|P1|Test Period 1 (1-14 Days)|Adverse Event|1
73288|NCT00989950|266029|P4|Randomized Phase|Adverse Event|0
73289|NCT00989950|266030|P3|Randomized Phase|Adverse Event|0
73290|NCT00989950|266031|P2|Randomized Phase|Adverse Event|1
73291|NCT00989950|266032|P1|Randomized Phase|Adverse Event|0
73292|NCT00989950|266029|P4|Randomized Phase|Protocol Violation|0
73293|NCT00989950|266030|P3|Randomized Phase|Protocol Violation|0
73294|NCT00989950|266031|P2|Randomized Phase|Protocol Violation|0
73295|NCT00989950|266032|P1|Randomized Phase|Protocol Violation|1
73296|NCT00989833|266049|P3|Overall Study|Incorrectly randomized|0
73297|NCT00989833|266050|P2|Overall Study|Incorrectly randomized|0
73298|NCT00989833|266051|P1|Overall Study|Incorrectly randomized|1
73299|NCT00989833|266049|P3|Overall Study|Withdrawal by Subject|1
73300|NCT00989833|266050|P2|Overall Study|Withdrawal by Subject|0
73301|NCT00989833|266051|P1|Overall Study|Withdrawal by Subject|0
73302|NCT00989833|266049|P3|Overall Study|Protocol Violation|1
73303|NCT00989833|266050|P2|Overall Study|Protocol Violation|2
73304|NCT00989833|266051|P1|Overall Study|Protocol Violation|1
73305|NCT00989833|266049|P3|Overall Study|Lost to Follow-up|0
73306|NCT00989833|266050|P2|Overall Study|Lost to Follow-up|1
73307|NCT00989833|266051|P1|Overall Study|Lost to Follow-up|0
73308|NCT00989664|266091|P1|Long-Term Follow-Up|Death|3
73309|NCT00989664|266091|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
73310|NCT00989664|266091|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
73311|NCT00989664|266091|P1|Dosimetric and Therapeutic Treatment|Death|1
73312|NCT00989664|266091|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
73313|NCT00989664|266091|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
73314|NCT00989664|266091|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
73315|NCT00989235|266137|P2|Overall Study|Lost to Follow-up|1
73316|NCT00989235|266138|P1|Overall Study|Lost to Follow-up|0
73317|NCT00989235|266137|P2|Overall Study|Randomized by Mistake|2
73318|NCT00989235|266138|P1|Overall Study|Randomized by Mistake|0
73319|NCT00989235|266137|P2|Overall Study|Desire to Become Pregnant|0
73320|NCT00989235|266138|P1|Overall Study|Desire to Become Pregnant|1
73321|NCT00989235|266137|P2|Overall Study|Withdrawal of Consent|1
73322|NCT00989235|266138|P1|Overall Study|Withdrawal of Consent|1
73323|NCT00989235|266137|P2|Overall Study|Lack of Efficacy|0
73324|NCT00989235|266138|P1|Overall Study|Lack of Efficacy|1
73325|NCT00989235|266137|P2|Overall Study|Adverse Event|1
73326|NCT00989235|266138|P1|Overall Study|Adverse Event|0
73327|NCT00989235|266137|P2|Overall Study|Death|1
73328|NCT00989235|266138|P1|Overall Study|Death|0
73329|NCT00989196|266183|P2|Treatment Period|Lost to Follow-up|0
73330|NCT00989196|266184|P1|Treatment Period|Lost to Follow-up|1
73331|NCT00989092|266222|P2|Overall Study|Did not receive study drug|0
73332|NCT00989092|266223|P1|Overall Study|Did not receive study drug|2
73333|NCT00989092|266222|P2|Overall Study|Erythropoietin therapy initiated|0
73334|NCT00989092|266223|P1|Overall Study|Erythropoietin therapy initiated|2
73335|NCT00989092|266222|P2|Overall Study|Protocol deviation|0
73336|NCT00989092|266223|P1|Overall Study|Protocol deviation|2
73337|NCT00989092|266222|P2|Overall Study|Other|1
73338|NCT00989092|266223|P1|Overall Study|Other|3
73339|NCT00989092|266222|P2|Overall Study|Lost to Follow-up|2
73340|NCT00989092|266223|P1|Overall Study|Lost to Follow-up|6
73341|NCT00989092|266222|P2|Overall Study|Ineligibility determined|3
73342|NCT00989092|266223|P1|Overall Study|Ineligibility determined|3
73343|NCT00989092|266222|P2|Overall Study|Death|2
73344|NCT00989092|266223|P1|Overall Study|Death|14
73345|NCT00989092|266222|P2|Overall Study|Withdrawal by Subject|9
73346|NCT00989092|266223|P1|Overall Study|Withdrawal by Subject|17
73347|NCT00989092|266222|P2|Overall Study|Chemotherapy initiated|4
73348|NCT00989092|266223|P1|Overall Study|Chemotherapy initiated|12
73349|NCT00989092|266222|P2|Overall Study|Adverse Event|1
73350|NCT00989092|266223|P1|Overall Study|Adverse Event|20
73351|NCT00989092|266222|P2|Overall Study|Physician Decision|6
73352|NCT00989092|266223|P1|Overall Study|Physician Decision|9
73353|NCT00988884|266275|P2|Overall Study|Withdrawal by Subject|18
73354|NCT00988884|266276|P1|Overall Study|Withdrawal by Subject|15
73355|NCT00988884|266275|P2|Overall Study|Protocol Violation|1
73356|NCT00988884|266276|P1|Overall Study|Protocol Violation|0
73357|NCT00988884|266275|P2|Overall Study|Lost to Follow-up|16
73358|NCT00988884|266276|P1|Overall Study|Lost to Follow-up|20
73359|NCT00988884|266275|P2|Overall Study|Adverse Event|1
73360|NCT00988884|266276|P1|Overall Study|Adverse Event|0
73361|NCT00988637|266335|P2|Overall Study|non-compliance with study drug|1
73362|NCT00988637|266336|P1|Overall Study|non-compliance with study drug|0
73363|NCT00988637|266335|P2|Overall Study|Withdrawal by Subject|1
73364|NCT00988637|266336|P1|Overall Study|Withdrawal by Subject|1
73365|NCT00988637|266335|P2|Overall Study|Lost to Follow-up|1
73366|NCT00988637|266336|P1|Overall Study|Lost to Follow-up|2
73367|NCT00988533|266366|P1|Overall Study|Lost to Follow-up|3
73368|NCT00988429|266381|P3|Overall Study|other reasons|1
73369|NCT00988429|266382|P2|Overall Study|other reasons|8
73370|NCT00988429|266383|P1|Overall Study|other reasons|8
73371|NCT00988429|266381|P3|Overall Study|Administrative Reasons|1
73372|NCT00988429|266382|P2|Overall Study|Administrative Reasons|2
73373|NCT00988429|266383|P1|Overall Study|Administrative Reasons|1
73374|NCT00988429|266381|P3|Overall Study|Withdrawal by Subject|12
73375|NCT00988429|266382|P2|Overall Study|Withdrawal by Subject|7
73376|NCT00988429|266383|P1|Overall Study|Withdrawal by Subject|7
73377|NCT00988429|266381|P3|Overall Study|Protocol Violation|3
73378|NCT00988429|266382|P2|Overall Study|Protocol Violation|3
73379|NCT00988429|266383|P1|Overall Study|Protocol Violation|4
73380|NCT00988429|266381|P3|Overall Study|Pregnancy|0
73381|NCT00988429|266382|P2|Overall Study|Pregnancy|1
73382|NCT00988429|266383|P1|Overall Study|Pregnancy|2
73383|NCT00988429|266381|P3|Overall Study|Physician Decision|3
73384|NCT00988429|266382|P2|Overall Study|Physician Decision|0
73385|NCT00988429|266383|P1|Overall Study|Physician Decision|1
73386|NCT00988429|266381|P3|Overall Study|Non-Compliance with Study Drug|3
73387|NCT00988429|266382|P2|Overall Study|Non-Compliance with Study Drug|1
73388|NCT00988429|266383|P1|Overall Study|Non-Compliance with Study Drug|5
73389|NCT00988429|266381|P3|Overall Study|Lack of Efficacy|1
73390|NCT00988429|266382|P2|Overall Study|Lack of Efficacy|0
73391|NCT00988429|266383|P1|Overall Study|Lack of Efficacy|0
73392|NCT00988429|266381|P3|Overall Study|Adverse Event|45
73393|NCT00988429|266382|P2|Overall Study|Adverse Event|21
73394|NCT00988429|266383|P1|Overall Study|Adverse Event|9
73395|NCT00988351|266396|P2|Overall Study|not using CPAP|3
73396|NCT00988351|266397|P1|Overall Study|not using CPAP|5
73397|NCT00988351|266396|P2|Overall Study|Lost to Follow-up|9
73398|NCT00988351|266397|P1|Overall Study|Lost to Follow-up|6
73399|NCT00988351|266396|P2|Overall Study|Withdrawal by Subject|0
73400|NCT00988351|266397|P1|Overall Study|Withdrawal by Subject|8
73401|NCT00988247|266413|P2|Overall Study|Not specified|0
73402|NCT00988247|266414|P1|Overall Study|Not specified|3
73403|NCT00988247|266413|P2|Overall Study|Sponsor requested withdrawal|1
73404|NCT00988247|266414|P1|Overall Study|Sponsor requested withdrawal|3
73405|NCT00988247|266413|P2|Overall Study|Protocol Violation|5
73406|NCT00988247|266414|P1|Overall Study|Protocol Violation|4
73407|NCT00988247|266413|P2|Overall Study|Lost to Follow-up|2
73408|NCT00988247|266414|P1|Overall Study|Lost to Follow-up|11
73409|NCT00988247|266413|P2|Overall Study|Pregnancy|2
73410|NCT00988247|266414|P1|Overall Study|Pregnancy|1
73411|NCT00988247|266413|P2|Overall Study|Withdrawal by Subject|13
73412|NCT00988247|266414|P1|Overall Study|Withdrawal by Subject|44
73413|NCT00988247|266413|P2|Overall Study|Adverse Event|3
73414|NCT00988247|266414|P1|Overall Study|Adverse Event|17
73415|NCT00988221|266433|P4|Part III|Refused Treatment|0
73416|NCT00988221|266434|P3|Part III|Refused Treatment|1
73417|NCT00988221|266435|P2|Part III|Refused Treatment|0
73418|NCT00988221|266436|P1|Part III|Refused Treatment|0
73419|NCT00988221|266433|P4|Part III|Insufficient Therapeutic Response|0
73420|NCT00988221|266434|P3|Part III|Insufficient Therapeutic Response|1
73421|NCT00988221|266435|P2|Part III|Insufficient Therapeutic Response|1
73422|NCT00988221|266436|P1|Part III|Insufficient Therapeutic Response|0
73423|NCT00988221|266433|P4|Part III|Adverse Event|0
73424|NCT00988221|266434|P3|Part III|Adverse Event|1
73425|NCT00988221|266435|P2|Part III|Adverse Event|0
73426|NCT00988221|266436|P1|Part III|Adverse Event|1
73427|NCT00988221|266433|P4|Part II|Reason not Specified|0
73428|NCT00988221|266434|P3|Part II|Reason not Specified|1
73429|NCT00988221|266435|P2|Part II|Reason not Specified|0
73430|NCT00988221|266436|P1|Part II|Reason not Specified|0
73431|NCT00988221|266433|P4|Part II|Withdrawal by Subject|2
73432|NCT00988221|266434|P3|Part II|Withdrawal by Subject|2
73433|NCT00988221|266435|P2|Part II|Withdrawal by Subject|0
73434|NCT00988221|266436|P1|Part II|Withdrawal by Subject|0
73435|NCT00988221|266433|P4|Part II|Adverse Event|1
73436|NCT00988221|266434|P3|Part II|Adverse Event|0
73437|NCT00988221|266435|P2|Part II|Adverse Event|0
73438|NCT00988221|266436|P1|Part II|Adverse Event|1
73439|NCT00988221|266433|P4|Part I|Lost to Follow-up|0
73440|NCT00988221|266434|P3|Part I|Lost to Follow-up|0
73441|NCT00988221|266435|P2|Part I|Lost to Follow-up|1
73442|NCT00988221|266436|P1|Part I|Lost to Follow-up|0
73443|NCT00988221|266433|P4|Part I|Refused Treatment|0
73444|NCT00988221|266434|P3|Part I|Refused Treatment|1
73445|NCT00988221|266435|P2|Part I|Refused Treatment|2
73446|NCT00988221|266436|P1|Part I|Refused Treatment|0
73447|NCT00988221|266433|P4|Part I|Insufficient Therapeutic Response|0
73448|NCT00988221|266434|P3|Part I|Insufficient Therapeutic Response|5
73449|NCT00988221|266435|P2|Part I|Insufficient Therapeutic Response|6
73450|NCT00988221|266436|P1|Part I|Insufficient Therapeutic Response|4
73451|NCT00988221|266433|P4|Part I|Adverse Event|0
73452|NCT00988221|266434|P3|Part I|Adverse Event|2
73453|NCT00988221|266435|P2|Part I|Adverse Event|1
73454|NCT00988221|266436|P1|Part I|Adverse Event|0
73455|NCT00988208|266609|P2|Overall Study|Unspecified|3
73456|NCT00988208|266610|P1|Overall Study|Unspecified|8
73457|NCT00988208|266609|P2|Overall Study|Subject decision/investigator discretion|32
73458|NCT00988208|266610|P1|Overall Study|Subject decision/investigator discretion|32
73459|NCT00988208|266609|P2|Overall Study|Clinical Deterioration|14
73460|NCT00988208|266610|P1|Overall Study|Clinical Deterioration|7
73461|NCT00988208|266609|P2|Overall Study|Biochemical Progression|7
73462|NCT00988208|266610|P1|Overall Study|Biochemical Progression|21
73463|NCT00988208|266609|P2|Overall Study|Clinical Progression|16
73464|NCT00988208|266610|P1|Overall Study|Clinical Progression|17
73465|NCT00988208|266609|P2|Overall Study|Sponsor Decision|78
73466|NCT00988208|266610|P1|Overall Study|Sponsor Decision|102
73467|NCT00988208|266609|P2|Overall Study|Protocol Violation|2
73468|NCT00988208|266610|P1|Overall Study|Protocol Violation|9
73469|NCT00988208|266609|P2|Overall Study|Lost to Follow-up|3
73470|NCT00988208|266610|P1|Overall Study|Lost to Follow-up|2
73471|NCT00988208|266609|P2|Overall Study|Death|15
73472|NCT00988208|266610|P1|Overall Study|Death|9
73473|NCT00988208|266609|P2|Overall Study|Withdrawal by Subject|57
73474|NCT00988208|266610|P1|Overall Study|Withdrawal by Subject|50
73475|NCT00988208|266609|P2|Overall Study|Disease Progression|89
73476|NCT00988208|266610|P1|Overall Study|Disease Progression|103
73477|NCT00988208|266609|P2|Overall Study|Adverse Event|122
73478|NCT00988208|266610|P1|Overall Study|Adverse Event|71
73479|NCT00988169|266622|P1|Overall Study|Withdrawal by Subject|1
73480|NCT00988117|266674|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
73481|NCT00988117|266674|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
73482|NCT00988091|266683|P2|Open-label Period|Not specified|3
73483|NCT00988091|266684|P1|Open-label Period|Not specified|2
73484|NCT00988091|266683|P2|Open-label Period|Lost to Follow-up|5
73485|NCT00988091|266684|P1|Open-label Period|Lost to Follow-up|3
73486|NCT00988091|266683|P2|Open-label Period|Withdrawal by Subject|16
73487|NCT00988091|266684|P1|Open-label Period|Withdrawal by Subject|10
73488|NCT00988091|266683|P2|Open-label Period|Protocol Violation|1
73489|NCT00988091|266684|P1|Open-label Period|Protocol Violation|1
73490|NCT00988091|266683|P2|Open-label Period|Use of exclusionary medication|1
73491|NCT00988091|266684|P1|Open-label Period|Use of exclusionary medication|1
73492|NCT00988091|266683|P2|Open-label Period|Adverse Event|7
73493|NCT00988091|266684|P1|Open-label Period|Adverse Event|4
73494|NCT00988091|266683|P2|Double-blind Period|Use of exclusionary medication|3
73495|NCT00988091|266684|P1|Double-blind Period|Use of exclusionary medication|2
73496|NCT00988091|266683|P2|Double-blind Period|Adverse Event|9
73497|NCT00988091|266684|P1|Double-blind Period|Adverse Event|6
73498|NCT00988091|266683|P2|Double-blind Period|Not specified|8
73499|NCT00988091|266684|P1|Double-blind Period|Not specified|8
73500|NCT00988091|266683|P2|Double-blind Period|Lost to Follow-up|14
73501|NCT00988091|266684|P1|Double-blind Period|Lost to Follow-up|12
73502|NCT00988091|266683|P2|Double-blind Period|Withdrawal by Subject|13
73503|NCT00988091|266684|P1|Double-blind Period|Withdrawal by Subject|15
73504|NCT00988065|266706|P3|Overall Study|Noncompliance with protocol|9
73505|NCT00988065|266707|P2|Overall Study|Noncompliance with protocol|6
73506|NCT00988065|266708|P1|Overall Study|Noncompliance with protocol|5
73507|NCT00988065|266706|P3|Overall Study|Subject withdrew consent|2
73508|NCT00988065|266707|P2|Overall Study|Subject withdrew consent|5
73509|NCT00988065|266708|P1|Overall Study|Subject withdrew consent|3
73510|NCT00988065|266706|P3|Overall Study|Lost to Follow-up|2
73511|NCT00988065|266707|P2|Overall Study|Lost to Follow-up|2
73512|NCT00988065|266708|P1|Overall Study|Lost to Follow-up|1
73513|NCT00988065|266706|P3|Overall Study|Adverse Event|2
73514|NCT00988065|266707|P2|Overall Study|Adverse Event|10
73515|NCT00988065|266708|P1|Overall Study|Adverse Event|4
73516|NCT00987935|266737|P9|Overall Study|Reason other than those specified above|1
73517|NCT00987935|266738|P8|Overall Study|Reason other than those specified above|0
73518|NCT00987935|266739|P7|Overall Study|Reason other than those specified above|0
73519|NCT00987935|266740|P6|Overall Study|Reason other than those specified above|0
73520|NCT00987935|266741|P5|Overall Study|Reason other than those specified above|0
73521|NCT00987935|266742|P4|Overall Study|Reason other than those specified above|0
73522|NCT00987935|266743|P3|Overall Study|Reason other than those specified above|0
73523|NCT00987935|266744|P2|Overall Study|Reason other than those specified above|0
73524|NCT00987935|266745|P1|Overall Study|Reason other than those specified above|0
73525|NCT00987935|266737|P9|Overall Study|Refused to continue taking trial med.|2
73526|NCT00987935|266738|P8|Overall Study|Refused to continue taking trial med.|4
73527|NCT00987935|266739|P7|Overall Study|Refused to continue taking trial med.|4
73528|NCT00987935|266740|P6|Overall Study|Refused to continue taking trial med.|0
73529|NCT00987935|266741|P5|Overall Study|Refused to continue taking trial med.|1
73530|NCT00987935|266742|P4|Overall Study|Refused to continue taking trial med.|0
73531|NCT00987935|266743|P3|Overall Study|Refused to continue taking trial med.|0
73532|NCT00987935|266744|P2|Overall Study|Refused to continue taking trial med.|0
73533|NCT00987935|266745|P1|Overall Study|Refused to continue taking trial med.|1
73534|NCT00987935|266737|P9|Overall Study|Adverse Event|6
73535|NCT00987935|266738|P8|Overall Study|Adverse Event|10
73536|NCT00987935|266739|P7|Overall Study|Adverse Event|2
73537|NCT00987935|266740|P6|Overall Study|Adverse Event|0
73538|NCT00987935|266741|P5|Overall Study|Adverse Event|1
73539|NCT00987935|266742|P4|Overall Study|Adverse Event|1
73540|NCT00987935|266743|P3|Overall Study|Adverse Event|0
73541|NCT00987935|266744|P2|Overall Study|Adverse Event|1
73542|NCT00987935|266745|P1|Overall Study|Adverse Event|0
73543|NCT00987935|266737|P9|Overall Study|Progressive disease|23
73544|NCT00987935|266738|P8|Overall Study|Progressive disease|48
73545|NCT00987935|266739|P7|Overall Study|Progressive disease|9
73546|NCT00987935|266740|P6|Overall Study|Progressive disease|3
73547|NCT00987935|266741|P5|Overall Study|Progressive disease|5
73548|NCT00987935|266742|P4|Overall Study|Progressive disease|2
73549|NCT00987935|266743|P3|Overall Study|Progressive disease|3
73550|NCT00987935|266744|P2|Overall Study|Progressive disease|2
73551|NCT00987935|266745|P1|Overall Study|Progressive disease|3
73552|NCT00987831|266801|P3|Overall Study|Lost to Follow-up|0
73553|NCT00987831|266802|P2|Overall Study|Lost to Follow-up|3
73554|NCT00987831|266803|P1|Overall Study|Lost to Follow-up|0
73555|NCT00987831|266801|P3|Overall Study|Never flared in 12 months|0
73556|NCT00987831|266802|P2|Overall Study|Never flared in 12 months|0
73557|NCT00987831|266803|P1|Overall Study|Never flared in 12 months|1
73558|NCT00987623|266825|P2|Overall Study|Influenza|1
73559|NCT00987623|266826|P1|Overall Study|Influenza|0
73560|NCT00987623|266825|P2|Overall Study|Biomicroscopy|1
73561|NCT00987623|266826|P1|Overall Study|Biomicroscopy|0
73562|NCT00987623|266825|P2|Overall Study|Discomfort|0
73563|NCT00987623|266826|P1|Overall Study|Discomfort|1
73564|NCT00987623|266825|P2|Overall Study|Time/job conflict|0
73565|NCT00987623|266826|P1|Overall Study|Time/job conflict|2
73566|NCT00987623|266825|P2|Overall Study|Lost to Follow-up|1
73567|NCT00987623|266826|P1|Overall Study|Lost to Follow-up|2
73568|NCT00987467|266846|P1|Overall Study|Lost to Follow-up|2
73569|NCT00987402|266870|P2|Overall Study|Insufficient data entry|98
73570|NCT00987402|266871|P1|Overall Study|Insufficient data entry|86
73571|NCT00987337|266880|P3|Overall Study|Participant Relapsed|5
73572|NCT00987337|266881|P2|Overall Study|Participant Relapsed|20
73573|NCT00987337|266882|P1|Overall Study|Participant Relapsed|18
73574|NCT00987337|266880|P3|Overall Study|Protocol Violation|2
73575|NCT00987337|266881|P2|Overall Study|Protocol Violation|0
73576|NCT00987337|266882|P1|Overall Study|Protocol Violation|1
73577|NCT00987337|266880|P3|Overall Study|Unspecified|5
73578|NCT00987337|266881|P2|Overall Study|Unspecified|2
73579|NCT00987337|266882|P1|Overall Study|Unspecified|0
73580|NCT00987337|266880|P3|Overall Study|Withdrawal by Subject|9
73581|NCT00987337|266881|P2|Overall Study|Withdrawal by Subject|9
73582|NCT00987337|266882|P1|Overall Study|Withdrawal by Subject|6
73583|NCT00987337|266880|P3|Overall Study|Lost to Follow-up|2
73584|NCT00987337|266881|P2|Overall Study|Lost to Follow-up|6
73585|NCT00987337|266882|P1|Overall Study|Lost to Follow-up|10
73586|NCT00987337|266880|P3|Overall Study|Virologic Breakthrough|8
73587|NCT00987337|266881|P2|Overall Study|Virologic Breakthrough|2
73588|NCT00987337|266882|P1|Overall Study|Virologic Breakthrough|2
73589|NCT00987337|266880|P3|Overall Study|Insufficient Virologic Response|12
73590|NCT00987337|266881|P2|Overall Study|Insufficient Virologic Response|7
73591|NCT00987337|266882|P1|Overall Study|Insufficient Virologic Response|10
73592|NCT00987337|266880|P3|Overall Study|Adverse Event|8
73593|NCT00987337|266881|P2|Overall Study|Adverse Event|9
73594|NCT00987337|266882|P1|Overall Study|Adverse Event|10
73595|NCT00986986|266937|P2|Overall Study|Lost to Follow-up|1
73596|NCT00986986|266938|P1|Overall Study|Lost to Follow-up|0
73597|NCT00986973|266948|P1|Overall Study|Withdrawn by study team|1
73598|NCT00986921|266969|P2|Overall Study|Physician Decision|0
73599|NCT00986921|266970|P1|Overall Study|Physician Decision|1
73600|NCT00986674|267006|P3|Overall Study|unknown/not specify|9
73601|NCT00986674|267007|P2|Overall Study|unknown/not specify|7
73602|NCT00986674|267008|P1|Overall Study|unknown/not specify|0
73603|NCT00986674|267006|P3|Overall Study|not start protocol therapy|1
73604|NCT00986674|267007|P2|Overall Study|not start protocol therapy|3
73605|NCT00986674|267008|P1|Overall Study|not start protocol therapy|4
73606|NCT00986674|267006|P3|Overall Study|alternative therapy|1
73607|NCT00986674|267007|P2|Overall Study|alternative therapy|0
73608|NCT00986674|267008|P1|Overall Study|alternative therapy|0
73609|NCT00986674|267006|P3|Overall Study|Withdrawal by Subject|1
73610|NCT00986674|267007|P2|Overall Study|Withdrawal by Subject|2
73611|NCT00986674|267008|P1|Overall Study|Withdrawal by Subject|6
73612|NCT00986674|267006|P3|Overall Study|Death|4
73613|NCT00986674|267007|P2|Overall Study|Death|0
73614|NCT00986674|267008|P1|Overall Study|Death|5
73615|NCT00986674|267006|P3|Overall Study|Adverse Event|9
73616|NCT00986674|267007|P2|Overall Study|Adverse Event|8
73617|NCT00986674|267008|P1|Overall Study|Adverse Event|4
73618|NCT00986674|267006|P3|Overall Study|Lack of Efficacy|23
73619|NCT00986674|267007|P2|Overall Study|Lack of Efficacy|25
73620|NCT00986674|267008|P1|Overall Study|Lack of Efficacy|28
73621|NCT00986570|267041|P1|Overall Study|Potential bias for objective assessment|1
73622|NCT00986570|267041|P1|Overall Study|Lost to Follow-up|6
73623|NCT00986479|267058|P2|Period 1|Administrative reasons|0
73624|NCT00986479|267059|P1|Period 1|Administrative reasons|1
73625|NCT00986479|267058|P2|Period 1|Improved mood|0
73626|NCT00986479|267059|P1|Period 1|Improved mood|1
73627|NCT00986427|267105|P2|Overall Study|Withdrawal by Subject|0
73628|NCT00986427|267106|P1|Overall Study|Withdrawal by Subject|1
73629|NCT00986427|267105|P2|Overall Study|Lack of Efficacy|0
73630|NCT00986427|267106|P1|Overall Study|Lack of Efficacy|1
73631|NCT00986427|267105|P2|Overall Study|Lost to Follow-up|0
73632|NCT00986427|267106|P1|Overall Study|Lost to Follow-up|2
73633|NCT00986362|267134|P2|Overall Study|Lost to Follow-up|1
73634|NCT00986362|267135|P1|Overall Study|Lost to Follow-up|0
73635|NCT00986362|267134|P2|Overall Study|Death|0
73636|NCT00986362|267135|P1|Overall Study|Death|2
73637|NCT00986349|267141|P1|Overall Study|device migration|1
73638|NCT00986349|267141|P1|Overall Study|Physician Decision|1
73639|NCT00986349|267141|P1|Overall Study|Adverse Event|2
73640|NCT00986349|267141|P1|Overall Study|Unsuccessful implant procedure|3
73641|NCT00986258|267154|P1|Maintenance Period|Withdrawal by Subject|2
73642|NCT00986258|267154|P1|Maintenance Period|Lack of Efficacy|2
73643|NCT00986258|267154|P1|Maintenance Period|Adverse Event|5
73644|NCT00986258|267154|P1|Titration and Optimal Dose Period|Other|1
73645|NCT00986258|267154|P1|Titration and Optimal Dose Period|Non-Compliance|1
73646|NCT00986258|267154|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
73647|NCT00986258|267154|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
73648|NCT00986258|267154|P1|Titration and Optimal Dose Period|Adverse Event|15
73649|NCT00986258|267154|P1|Observation Period|Not eligible to be dosed|11
73650|NCT00986245|267182|P2|Second Intervention|Protocol Violation|1
73651|NCT00986245|267183|P1|Second Intervention|Protocol Violation|0
73652|NCT00986245|267182|P2|Second Intervention|Lost to Follow-up|0
73653|NCT00986245|267183|P1|Second Intervention|Lost to Follow-up|1
73654|NCT00986245|267182|P2|Second Intervention|Poor compliance|0
73655|NCT00986245|267183|P1|Second Intervention|Poor compliance|1
73656|NCT00986245|267182|P2|First Intervention|Out of indication|0
73657|NCT00986245|267183|P1|First Intervention|Out of indication|1
73658|NCT00986245|267182|P2|First Intervention|Protocol Violation|1
73659|NCT00986245|267183|P1|First Intervention|Protocol Violation|0
73660|NCT00986245|267182|P2|First Intervention|Withdrawal by Subject|1
73661|NCT00986245|267183|P1|First Intervention|Withdrawal by Subject|0
73662|NCT00986245|267182|P2|First Intervention|Lack of Efficacy|2
73663|NCT00986245|267183|P1|First Intervention|Lack of Efficacy|1
73664|NCT00986245|267182|P2|First Intervention|Poor compliance|4
73665|NCT00986245|267183|P1|First Intervention|Poor compliance|8
73666|NCT00986232|267220|P4|Overall Study|Incomplete safety follow-up|2
73667|NCT00986232|267221|P3|Overall Study|Incomplete safety follow-up|2
73668|NCT00986232|267222|P2|Overall Study|Incomplete safety follow-up|7
73669|NCT00986232|267223|P1|Overall Study|Incomplete safety follow-up|3
73670|NCT00986232|267220|P4|Overall Study|Missed one or more bleeds|7
73671|NCT00986232|267221|P3|Overall Study|Missed one or more bleeds|6
73672|NCT00986232|267222|P2|Overall Study|Missed one or more bleeds|10
73673|NCT00986232|267223|P1|Overall Study|Missed one or more bleeds|13
73674|NCT00986232|267220|P4|Overall Study|Withdrawal by Subject|3
73675|NCT00986232|267221|P3|Overall Study|Withdrawal by Subject|12
73676|NCT00986232|267222|P2|Overall Study|Withdrawal by Subject|16
73677|NCT00986232|267223|P1|Overall Study|Withdrawal by Subject|13
73678|NCT00986232|267220|P4|Overall Study|Protocol Violation|1
73679|NCT00986232|267221|P3|Overall Study|Protocol Violation|0
73680|NCT00986232|267222|P2|Overall Study|Protocol Violation|3
73681|NCT00986232|267223|P1|Overall Study|Protocol Violation|2
73682|NCT00986232|267220|P4|Overall Study|Lost to Follow-up|7
73683|NCT00986232|267221|P3|Overall Study|Lost to Follow-up|12
73684|NCT00986232|267222|P2|Overall Study|Lost to Follow-up|12
73685|NCT00986232|267223|P1|Overall Study|Lost to Follow-up|19
73686|NCT00986232|267220|P4|Overall Study|Adverse Event|0
73687|NCT00986232|267221|P3|Overall Study|Adverse Event|3
73688|NCT00986232|267222|P2|Overall Study|Adverse Event|2
73689|NCT00986232|267223|P1|Overall Study|Adverse Event|1
73690|NCT00986180|267297|P2|Overall Study|Miscellanies|11
73691|NCT00986180|267298|P1|Overall Study|Miscellanies|10
73692|NCT00986180|267297|P2|Overall Study|Withdrawal by Subject|9
73693|NCT00986180|267298|P1|Overall Study|Withdrawal by Subject|1
73694|NCT00986180|267297|P2|Overall Study|Protocol Violation|0
73695|NCT00986180|267298|P1|Overall Study|Protocol Violation|2
73696|NCT00986180|267297|P2|Overall Study|Physician Decision|3
73697|NCT00986180|267298|P1|Overall Study|Physician Decision|1
73698|NCT00986180|267297|P2|Overall Study|Lost to Follow-up|7
73699|NCT00986180|267298|P1|Overall Study|Lost to Follow-up|5
73700|NCT00986180|267297|P2|Overall Study|Lack of Efficacy|3
73701|NCT00986180|267298|P1|Overall Study|Lack of Efficacy|4
73702|NCT00986180|267297|P2|Overall Study|Adverse Event|23
73703|NCT00986180|267298|P1|Overall Study|Adverse Event|21
73704|NCT00986154|267376|P2|Overall Study|never received study drug|27
73705|NCT00986154|267377|P1|Overall Study|never received study drug|25
73706|NCT00986154|267376|P2|Overall Study|investigator/subject decide not continue|3
73707|NCT00986154|267377|P1|Overall Study|investigator/subject decide not continue|6
73708|NCT00986154|267376|P2|Overall Study|Withdrawal by Subject|33
73709|NCT00986154|267377|P1|Overall Study|Withdrawal by Subject|32
73710|NCT00986154|267376|P2|Overall Study|Lost to Follow-up|4
73711|NCT00986154|267377|P1|Overall Study|Lost to Follow-up|7
73712|NCT00986154|267376|P2|Overall Study|Death|127
73713|NCT00986154|267377|P1|Overall Study|Death|136
73714|NCT00986102|267391|P4|Overall Study|Withdrawal by Subject|0
73715|NCT00986102|267392|P3|Overall Study|Withdrawal by Subject|0
73716|NCT00986102|267393|P2|Overall Study|Withdrawal by Subject|1
73717|NCT00986102|267394|P1|Overall Study|Withdrawal by Subject|1
73718|NCT00986102|267391|P4|Overall Study|Lost to Follow-up|1
73719|NCT00986102|267392|P3|Overall Study|Lost to Follow-up|0
73720|NCT00986102|267393|P2|Overall Study|Lost to Follow-up|1
73721|NCT00986102|267394|P1|Overall Study|Lost to Follow-up|0
73722|NCT00985985|267444|P4|Overall Study|Other Reason|2
73723|NCT00985985|267445|P3|Overall Study|Other Reason|4
73724|NCT00985985|267446|P2|Overall Study|Other Reason|1
73725|NCT00985985|267447|P1|Overall Study|Other Reason|6
73726|NCT00985985|267444|P4|Overall Study|Withdrawal by Subject|2
73727|NCT00985985|267445|P3|Overall Study|Withdrawal by Subject|2
73728|NCT00985985|267446|P2|Overall Study|Withdrawal by Subject|2
73729|NCT00985985|267447|P1|Overall Study|Withdrawal by Subject|4
73730|NCT00985985|267444|P4|Overall Study|Lack of Efficacy|3
73731|NCT00985985|267445|P3|Overall Study|Lack of Efficacy|1
73732|NCT00985985|267446|P2|Overall Study|Lack of Efficacy|6
73733|NCT00985985|267447|P1|Overall Study|Lack of Efficacy|5
73734|NCT00985985|267444|P4|Overall Study|Protocol Violation|1
73735|NCT00985985|267445|P3|Overall Study|Protocol Violation|0
73736|NCT00985985|267446|P2|Overall Study|Protocol Violation|2
73737|NCT00985985|267447|P1|Overall Study|Protocol Violation|1
73738|NCT00985985|267444|P4|Overall Study|Lost to Follow-up|3
73739|NCT00985985|267445|P3|Overall Study|Lost to Follow-up|2
73740|NCT00985985|267446|P2|Overall Study|Lost to Follow-up|11
73741|NCT00985985|267447|P1|Overall Study|Lost to Follow-up|4
73742|NCT00985985|267444|P4|Overall Study|Adverse Event|2
73743|NCT00985985|267445|P3|Overall Study|Adverse Event|2
73744|NCT00985985|267446|P2|Overall Study|Adverse Event|2
73745|NCT00985985|267447|P1|Overall Study|Adverse Event|4
73746|NCT00985959|267488|P3|Overall Study|Unspecified|11
73747|NCT00985959|267489|P2|Overall Study|Unspecified|0
73748|NCT00985959|267490|P1|Overall Study|Unspecified|0
73749|NCT00985959|267488|P3|Overall Study|Complete response observed over 2 cycles|4
73750|NCT00985959|267489|P2|Overall Study|Complete response observed over 2 cycles|1
73751|NCT00985959|267490|P1|Overall Study|Complete response observed over 2 cycles|0
73752|NCT00985959|267488|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
73753|NCT00985959|267489|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
73754|NCT00985959|267490|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
73755|NCT00985959|267488|P3|Overall Study|Unrecovered toxicity|7
73756|NCT00985959|267489|P2|Overall Study|Unrecovered toxicity|0
73757|NCT00985959|267490|P1|Overall Study|Unrecovered toxicity|0
73758|NCT00985959|267488|P3|Overall Study|Progressive disease|8
73759|NCT00985959|267489|P2|Overall Study|Progressive disease|2
73760|NCT00985959|267490|P1|Overall Study|Progressive disease|1
73761|NCT00985959|267488|P3|Overall Study|Withdrawal by Subject|8
73762|NCT00985959|267489|P2|Overall Study|Withdrawal by Subject|0
73763|NCT00985959|267490|P1|Overall Study|Withdrawal by Subject|0
73764|NCT00985959|267488|P3|Overall Study|Adverse Event|19
73765|NCT00985959|267489|P2|Overall Study|Adverse Event|0
73766|NCT00985959|267490|P1|Overall Study|Adverse Event|0
73767|NCT00985790|267524|P2|Overall Study|Lost to Follow-up|7
73768|NCT00985790|267525|P1|Overall Study|Lost to Follow-up|6
73769|NCT00985790|267524|P2|Overall Study|Withdrawal by Subject|1
73770|NCT00985790|267525|P1|Overall Study|Withdrawal by Subject|1
73771|NCT00985738|267563|P2|Overall Study|Study closed prematurely|8
73772|NCT00985738|267564|P1|Overall Study|Study closed prematurely|8
73773|NCT00985725|267572|P2|Overall Study|Out-of-window visits|1
73774|NCT00985725|267573|P1|Overall Study|Out-of-window visits|0
73775|NCT00985725|267572|P2|Overall Study|Non-compliance|2
73776|NCT00985725|267573|P1|Overall Study|Non-compliance|1
73777|NCT00985725|267572|P2|Overall Study|Lack of Efficacy|1
73778|NCT00985725|267573|P1|Overall Study|Lack of Efficacy|0
73779|NCT00985725|267572|P2|Overall Study|Lost to Follow-up|1
73780|NCT00985725|267573|P1|Overall Study|Lost to Follow-up|1
73781|NCT00985725|267572|P2|Overall Study|Withdrawal by Subject|4
73782|NCT00985725|267573|P1|Overall Study|Withdrawal by Subject|4
73783|NCT00985725|267572|P2|Overall Study|Protocol Violation|3
73784|NCT00985725|267573|P1|Overall Study|Protocol Violation|1
73785|NCT00985725|267572|P2|Overall Study|Adverse Event|1
73786|NCT00985725|267573|P1|Overall Study|Adverse Event|4
73787|NCT00985712|267609|P2|Overall Study|Sponsor decision|2
73788|NCT00985712|267610|P1|Overall Study|Sponsor decision|0
73789|NCT00985712|267609|P2|Overall Study|Withdrawal by Subject|1
73790|NCT00985712|267610|P1|Overall Study|Withdrawal by Subject|4
73791|NCT00985712|267609|P2|Overall Study|Protocol Violation|1
73792|NCT00985712|267610|P1|Overall Study|Protocol Violation|0
73793|NCT00985712|267609|P2|Overall Study|Lost to Follow-up|2
73794|NCT00985712|267610|P1|Overall Study|Lost to Follow-up|2
73795|NCT00985712|267609|P2|Overall Study|Adverse Event|1
73796|NCT00985712|267610|P1|Overall Study|Adverse Event|0
73797|NCT00985686|267628|P4|Overall Study|Lost to Follow-up|2
73798|NCT00985686|267629|P3|Overall Study|Lost to Follow-up|0
73799|NCT00985686|267630|P2|Overall Study|Lost to Follow-up|1
73800|NCT00985686|267631|P1|Overall Study|Lost to Follow-up|1
73801|NCT00985673|267645|P6|Overall Study|Unspecified|0
73802|NCT00985673|267646|P5|Overall Study|Unspecified|1
73803|NCT00985673|267647|P4|Overall Study|Unspecified|0
73804|NCT00985673|267648|P3|Overall Study|Unspecified|1
73805|NCT00985673|267649|P2|Overall Study|Unspecified|0
73806|NCT00985673|267650|P1|Overall Study|Unspecified|1
73807|NCT00985673|267645|P6|Overall Study|Withdrawal by Subject|3
73808|NCT00985673|267646|P5|Overall Study|Withdrawal by Subject|2
73809|NCT00985673|267647|P4|Overall Study|Withdrawal by Subject|2
73810|NCT00985673|267648|P3|Overall Study|Withdrawal by Subject|5
73811|NCT00985673|267649|P2|Overall Study|Withdrawal by Subject|4
73812|NCT00985673|267650|P1|Overall Study|Withdrawal by Subject|0
73813|NCT00985673|267645|P6|Overall Study|Lost to Follow-up|3
73814|NCT00985673|267646|P5|Overall Study|Lost to Follow-up|5
73815|NCT00985673|267647|P4|Overall Study|Lost to Follow-up|10
73816|NCT00985673|267648|P3|Overall Study|Lost to Follow-up|6
73817|NCT00985673|267649|P2|Overall Study|Lost to Follow-up|7
73818|NCT00985673|267650|P1|Overall Study|Lost to Follow-up|6
73819|NCT00985504|267912|P2|Optimization Period|Withdrawal by Subject|8
73820|NCT00985504|267913|P1|Optimization Period|Withdrawal by Subject|10
73821|NCT00985504|267912|P2|Optimization Period|Protocol Violation|1
73822|NCT00985504|267913|P1|Optimization Period|Protocol Violation|3
73823|NCT00985504|267912|P2|Optimization Period|Physician Decision|0
73824|NCT00985504|267913|P1|Optimization Period|Physician Decision|1
73825|NCT00985504|267912|P2|Optimization Period|Lost to Follow-up|1
73826|NCT00985504|267913|P1|Optimization Period|Lost to Follow-up|0
73827|NCT00985504|267912|P2|Optimization Period|Lack of Efficacy|3
73828|NCT00985504|267913|P1|Optimization Period|Lack of Efficacy|5
73829|NCT00985504|267912|P2|Optimization Period|Death|1
73830|NCT00985504|267913|P1|Optimization Period|Death|0
73831|NCT00985504|267912|P2|Optimization Period|Adverse Event|9
73832|NCT00985504|267913|P1|Optimization Period|Adverse Event|7
73833|NCT00985504|267912|P2|Acute Treatment Period|Withdrawal by Subject|5
73834|NCT00985504|267913|P1|Acute Treatment Period|Withdrawal by Subject|9
73835|NCT00985504|267912|P2|Acute Treatment Period|Sponsor Decision|1
73836|NCT00985504|267913|P1|Acute Treatment Period|Sponsor Decision|0
73837|NCT00985504|267912|P2|Acute Treatment Period|Protocol Violation|0
73838|NCT00985504|267913|P1|Acute Treatment Period|Protocol Violation|2
73839|NCT00985504|267912|P2|Acute Treatment Period|Entry Criteria Not Met|2
73840|NCT00985504|267913|P1|Acute Treatment Period|Entry Criteria Not Met|1
73841|NCT00985504|267912|P2|Acute Treatment Period|Adverse Event|4
73842|NCT00985504|267913|P1|Acute Treatment Period|Adverse Event|3
73843|NCT00985491|267939|P1|Overall Study|implant failure|3
73844|NCT00985491|267939|P1|Overall Study|Withdrawal by Subject|1
73845|NCT00985491|267939|P1|Overall Study|device migration|7
73846|NCT00985491|267939|P1|Overall Study|Adverse Event|8
73847|NCT00985439|267948|P4|Overall Study|Adverse Event|0
73848|NCT00985439|267949|P3|Overall Study|Adverse Event|1
73849|NCT00985439|267950|P2|Overall Study|Adverse Event|0
73850|NCT00985439|267951|P1|Overall Study|Adverse Event|0
73851|NCT00985231|267967|P2|Overall Study|Study related symptoms & complaints|2
73852|NCT00985231|267968|P1|Overall Study|Study related symptoms & complaints|0
73853|NCT00985231|267967|P2|Overall Study|Lost to Follow-up|1
73854|NCT00985231|267968|P1|Overall Study|Lost to Follow-up|0
73855|NCT00985231|267967|P2|Overall Study|Withdrawal by Subject|0
73856|NCT00985231|267968|P1|Overall Study|Withdrawal by Subject|1
73857|NCT00985231|267967|P2|Overall Study|Protocol Violation|0
73858|NCT00985231|267968|P1|Overall Study|Protocol Violation|1
73859|NCT00985231|267967|P2|Overall Study|ineligible|0
73860|NCT00985231|267968|P1|Overall Study|ineligible|1
73861|NCT00985192|267976|P1|Overall Study|Determined to be Ineligible During Trial|2
73862|NCT00985192|267976|P1|Overall Study|Disease Progression|1
73863|NCT00985192|267976|P1|Overall Study|Withdrawal by Subject|1
73864|NCT00985166|267988|P3|Overall Study|Unspecified|1
73865|NCT00985166|267989|P2|Overall Study|Unspecified|0
73866|NCT00985166|267990|P1|Overall Study|Unspecified|1
73867|NCT00985166|267988|P3|Overall Study|Test not done|4
73868|NCT00985166|267989|P2|Overall Study|Test not done|0
73869|NCT00985166|267990|P1|Overall Study|Test not done|2
73870|NCT00985166|267988|P3|Overall Study|Withdrawal by Subject|0
73871|NCT00985166|267989|P2|Overall Study|Withdrawal by Subject|2
73872|NCT00985166|267990|P1|Overall Study|Withdrawal by Subject|3
73873|NCT00985166|267988|P3|Overall Study|Lost to Follow-up|2
73874|NCT00985166|267989|P2|Overall Study|Lost to Follow-up|2
73875|NCT00985166|267990|P1|Overall Study|Lost to Follow-up|3
73876|NCT00985153|268010|P4|Overall Study|Incomplete Safety Follow-up|4
73877|NCT00985153|268011|P3|Overall Study|Incomplete Safety Follow-up|4
73878|NCT00985153|268012|P2|Overall Study|Incomplete Safety Follow-up|5
73879|NCT00985153|268013|P1|Overall Study|Incomplete Safety Follow-up|3
73880|NCT00985153|268010|P4|Overall Study|Missed One or More Bleeds|10
73881|NCT00985153|268011|P3|Overall Study|Missed One or More Bleeds|8
73882|NCT00985153|268012|P2|Overall Study|Missed One or More Bleeds|7
73883|NCT00985153|268013|P1|Overall Study|Missed One or More Bleeds|7
73884|NCT00985153|268010|P4|Overall Study|Withdrawal by Subject|10
73885|NCT00985153|268011|P3|Overall Study|Withdrawal by Subject|11
73886|NCT00985153|268012|P2|Overall Study|Withdrawal by Subject|11
73887|NCT00985153|268013|P1|Overall Study|Withdrawal by Subject|6
73888|NCT00985153|268010|P4|Overall Study|Protocol Violation|3
73889|NCT00985153|268011|P3|Overall Study|Protocol Violation|4
73890|NCT00985153|268012|P2|Overall Study|Protocol Violation|2
73891|NCT00985153|268013|P1|Overall Study|Protocol Violation|3
73892|NCT00985153|268010|P4|Overall Study|Lost to Follow-up|20
73893|NCT00985153|268011|P3|Overall Study|Lost to Follow-up|17
73894|NCT00985153|268012|P2|Overall Study|Lost to Follow-up|19
73895|NCT00985153|268013|P1|Overall Study|Lost to Follow-up|16
73896|NCT00985114|268057|P2|Overall Study|Withdrawal by Subject|2
73897|NCT00985114|268058|P1|Overall Study|Withdrawal by Subject|0
73898|NCT00985114|268057|P2|Overall Study|Adverse Event|0
73899|NCT00985114|268058|P1|Overall Study|Adverse Event|1
73900|NCT00984867|268077|P2|Overall Study|lack of efficacy and subject compliance|0
73901|NCT00984867|268078|P1|Overall Study|lack of efficacy and subject compliance|1
73902|NCT00984867|268077|P2|Overall Study|site closing|0
73903|NCT00984867|268078|P1|Overall Study|site closing|1
73904|NCT00984867|268077|P2|Overall Study|Subject no longer meets study criteria|1
73905|NCT00984867|268078|P1|Overall Study|Subject no longer meets study criteria|1
73906|NCT00984867|268077|P2|Overall Study|Poor/non-compliance|1
73907|NCT00984867|268078|P1|Overall Study|Poor/non-compliance|0
73908|NCT00984867|268077|P2|Overall Study|Lost to Follow-up|4
73909|NCT00984867|268078|P1|Overall Study|Lost to Follow-up|3
73910|NCT00984867|268077|P2|Overall Study|Withdrawal by Subject|4
73911|NCT00984867|268078|P1|Overall Study|Withdrawal by Subject|13
73912|NCT00984867|268077|P2|Overall Study|Death|0
73913|NCT00984867|268078|P1|Overall Study|Death|1
73914|NCT00984867|268077|P2|Overall Study|Adverse Event|7
73915|NCT00984867|268078|P1|Overall Study|Adverse Event|3
73916|NCT00984659|268118|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
73917|NCT00984659|268119|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
73918|NCT00984659|268120|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
73919|NCT00984659|268121|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
73920|NCT00984659|268118|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
73921|NCT00984659|268119|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
73922|NCT00984659|268120|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
73923|NCT00984659|268121|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
73924|NCT00984659|268118|P4|6-week Double-blind Treatment Period|Protocol Violation|4
73925|NCT00984659|268119|P3|6-week Double-blind Treatment Period|Protocol Violation|0
73926|NCT00984659|268120|P2|6-week Double-blind Treatment Period|Protocol Violation|0
73927|NCT00984659|268121|P1|6-week Double-blind Treatment Period|Protocol Violation|0
73928|NCT00984659|268118|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
73929|NCT00984659|268119|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
73930|NCT00984659|268120|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
73931|NCT00984659|268121|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
73932|NCT00984659|268118|P4|6-week Double-blind Treatment Period|Adverse Event|7
73933|NCT00984659|268119|P3|6-week Double-blind Treatment Period|Adverse Event|3
73934|NCT00984659|268120|P2|6-week Double-blind Treatment Period|Adverse Event|3
73935|NCT00984659|268121|P1|6-week Double-blind Treatment Period|Adverse Event|0
73936|NCT00984659|268118|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
73937|NCT00984659|268119|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
73938|NCT00984659|268120|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
73939|NCT00984659|268121|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
73940|NCT00984659|268118|P4|2-week Run-in Period|Withdrawal by Subject|0
73941|NCT00984659|268119|P3|2-week Run-in Period|Withdrawal by Subject|0
73942|NCT00984659|268120|P2|2-week Run-in Period|Withdrawal by Subject|0
73943|NCT00984659|268121|P1|2-week Run-in Period|Withdrawal by Subject|10
73944|NCT00984659|268118|P4|2-week Run-in Period|Physician Decision|0
73945|NCT00984659|268119|P3|2-week Run-in Period|Physician Decision|0
73946|NCT00984659|268120|P2|2-week Run-in Period|Physician Decision|0
73947|NCT00984659|268121|P1|2-week Run-in Period|Physician Decision|10
73948|NCT00984659|268118|P4|2-week Run-in Period|Lost to Follow-up|0
73949|NCT00984659|268119|P3|2-week Run-in Period|Lost to Follow-up|0
73950|NCT00984659|268120|P2|2-week Run-in Period|Lost to Follow-up|0
73951|NCT00984659|268121|P1|2-week Run-in Period|Lost to Follow-up|3
73952|NCT00984659|268118|P4|2-week Run-in Period|Study Closed/Terminated|0
73953|NCT00984659|268119|P3|2-week Run-in Period|Study Closed/Terminated|0
73954|NCT00984659|268120|P2|2-week Run-in Period|Study Closed/Terminated|0
73955|NCT00984659|268121|P1|2-week Run-in Period|Study Closed/Terminated|2
73956|NCT00984659|268118|P4|2-week Run-in Period|Protocol Violation|0
73957|NCT00984659|268119|P3|2-week Run-in Period|Protocol Violation|0
73958|NCT00984659|268120|P2|2-week Run-in Period|Protocol Violation|0
73959|NCT00984659|268121|P1|2-week Run-in Period|Protocol Violation|5
73960|NCT00984659|268118|P4|2-week Run-in Period|Adverse Event|0
73961|NCT00984659|268119|P3|2-week Run-in Period|Adverse Event|0
73962|NCT00984659|268120|P2|2-week Run-in Period|Adverse Event|0
73963|NCT00984659|268121|P1|2-week Run-in Period|Adverse Event|8
73964|NCT00984620|268148|P2|Overall Study|reason other than listed above|4
73965|NCT00984620|268149|P1|Overall Study|reason other than listed above|0
73966|NCT00984620|268148|P2|Overall Study|Withdrawal by Subject|2
73967|NCT00984620|268149|P1|Overall Study|Withdrawal by Subject|0
73968|NCT00984620|268148|P2|Overall Study|Lost to Follow-up|1
73969|NCT00984620|268149|P1|Overall Study|Lost to Follow-up|1
73970|NCT00984620|268148|P2|Overall Study|Adverse Event|5
73971|NCT00984620|268149|P1|Overall Study|Adverse Event|5
73972|NCT00984594|268187|P2|Overall Study|Withdrawal by Subject|1
73973|NCT00984594|268188|P1|Overall Study|Withdrawal by Subject|0
73974|NCT00984594|268187|P2|Overall Study|Lost to Follow-up|0
73975|NCT00984594|268188|P1|Overall Study|Lost to Follow-up|1
73976|NCT00984568|268204|P2|Overall Study|Unknown Reason|3
73977|NCT00984568|268205|P1|Overall Study|Unknown Reason|1
73978|NCT00984568|268204|P2|Overall Study|Opportunistic Infection|0
73979|NCT00984568|268205|P1|Overall Study|Opportunistic Infection|1
73980|NCT00984568|268204|P2|Overall Study|Lost to Follow-up|1
73981|NCT00984568|268205|P1|Overall Study|Lost to Follow-up|0
73982|NCT00984568|268204|P2|Overall Study|Did Not Meet Randomization Criteria|0
73983|NCT00984568|268205|P1|Overall Study|Did Not Meet Randomization Criteria|1
73984|NCT00984568|268204|P2|Overall Study|Adverse Event|0
73985|NCT00984568|268205|P1|Overall Study|Adverse Event|2
73986|NCT00984568|268204|P2|Overall Study|Lack of Efficacy|0
73987|NCT00984568|268205|P1|Overall Study|Lack of Efficacy|2
73988|NCT00984568|268204|P2|Overall Study|Withdrawal by Subject|2
73989|NCT00984568|268205|P1|Overall Study|Withdrawal by Subject|1
73990|NCT00984542|268213|P1|Overall Study|clinical deterioration|2
73991|NCT00984542|268213|P1|Overall Study|Withdrawal by Subject|3
73992|NCT00984542|268213|P1|Overall Study|complicating disease|3
73993|NCT00984542|268213|P1|Overall Study|Death|7
73994|NCT00984542|268213|P1|Overall Study|toxicity|7
73995|NCT00984542|268213|P1|Overall Study|disease progression|19
73996|NCT00984295|268263|P3|Overall Study|Incomplete safety follow-up|3
73997|NCT00984295|268264|P2|Overall Study|Incomplete safety follow-up|2
73998|NCT00984295|268265|P1|Overall Study|Incomplete safety follow-up|11
73999|NCT00984295|268263|P3|Overall Study|Missed one or more blood samplings|2
74000|NCT00984295|268264|P2|Overall Study|Missed one or more blood samplings|7
74001|NCT00984295|268265|P1|Overall Study|Missed one or more blood samplings|3
74002|NCT00984295|268263|P3|Overall Study|CAE – discontinued test vaccine|3
74003|NCT00984295|268264|P2|Overall Study|CAE – discontinued test vaccine|1
74004|NCT00984295|268265|P1|Overall Study|CAE – discontinued test vaccine|0
74005|NCT00984295|268263|P3|Overall Study|Withdrawal by Subject|12
74006|NCT00984295|268264|P2|Overall Study|Withdrawal by Subject|9
74007|NCT00984295|268265|P1|Overall Study|Withdrawal by Subject|18
74008|NCT00984295|268263|P3|Overall Study|Protocol Violation|4
74009|NCT00984295|268264|P2|Overall Study|Protocol Violation|1
74010|NCT00984295|268265|P1|Overall Study|Protocol Violation|2
74011|NCT00984295|268263|P3|Overall Study|Lost to Follow-up|13
74012|NCT00984295|268264|P2|Overall Study|Lost to Follow-up|12
74013|NCT00984295|268265|P1|Overall Study|Lost to Follow-up|31
74014|NCT00984282|268332|P2|Long Term Follow-up|Ongoing with treatment|46
74015|NCT00984282|268333|P1|Long Term Follow-up|Ongoing with treatment|66
74016|NCT00984282|268332|P2|Long Term Follow-up|Participant convenience|0
74017|NCT00984282|268333|P1|Long Term Follow-up|Participant convenience|1
74018|NCT00984282|268332|P2|Long Term Follow-up|Lost to Follow-up|1
74019|NCT00984282|268333|P1|Long Term Follow-up|Lost to Follow-up|5
74020|NCT00984282|268332|P2|Long Term Follow-up|Progression, recurrence or relapse|0
74021|NCT00984282|268333|P1|Long Term Follow-up|Progression, recurrence or relapse|1
74022|NCT00984282|268332|P2|Long Term Follow-up|Death|34
74023|NCT00984282|268333|P1|Long Term Follow-up|Death|36
74024|NCT00984282|268332|P2|Long Term Follow-up|Withdrawal by Subject|10
74025|NCT00984282|268333|P1|Long Term Follow-up|Withdrawal by Subject|14
74026|NCT00984282|268332|P2|Open-label Treatment|Not receive treatment|14
74027|NCT00984282|268333|P1|Open-label Treatment|Not receive treatment|34
74028|NCT00984282|268332|P2|Open-label Treatment|Ongoing with treatment|53
74029|NCT00984282|268333|P1|Open-label Treatment|Ongoing with treatment|12
74030|NCT00984282|268332|P2|Open-label Treatment|Lost to Follow-up|1
74031|NCT00984282|268333|P1|Open-label Treatment|Lost to Follow-up|0
74032|NCT00984282|268332|P2|Open-label Treatment|Progression, recurrence or relapse|49
74033|NCT00984282|268333|P1|Open-label Treatment|Progression, recurrence or relapse|32
74034|NCT00984282|268332|P2|Open-label Treatment|Death|10
74035|NCT00984282|268333|P1|Open-label Treatment|Death|2
74036|NCT00984282|268332|P2|Open-label Treatment|Withdrawal by Subject|13
74037|NCT00984282|268333|P1|Open-label Treatment|Withdrawal by Subject|4
74038|NCT00984282|268332|P2|Open-label Treatment|Adverse Event|24
74039|NCT00984282|268333|P1|Open-label Treatment|Adverse Event|5
74040|NCT00984282|268332|P2|Double Blind Treatment|Not treated|1
74041|NCT00984282|268333|P1|Double Blind Treatment|Not treated|0
74042|NCT00984282|268332|P2|Double Blind Treatment|Ongoing with treatment|23
74043|NCT00984282|268333|P1|Double Blind Treatment|Ongoing with treatment|43
74044|NCT00984282|268332|P2|Double Blind Treatment|Death|2
74045|NCT00984282|268333|P1|Double Blind Treatment|Death|6
74046|NCT00984282|268332|P2|Double Blind Treatment|Lost to Follow-up|1
74047|NCT00984282|268333|P1|Double Blind Treatment|Lost to Follow-up|3
74048|NCT00984282|268332|P2|Double Blind Treatment|Withdrawal by Subject|10
74049|NCT00984282|268333|P1|Double Blind Treatment|Withdrawal by Subject|12
74050|NCT00984282|268332|P2|Double Blind Treatment|Progression by clinical judgment|0
74051|NCT00984282|268333|P1|Double Blind Treatment|Progression by clinical judgment|1
74052|NCT00984282|268332|P2|Double Blind Treatment|Noncompliance with study medication|0
74053|NCT00984282|268333|P1|Double Blind Treatment|Noncompliance with study medication|1
74054|NCT00984282|268332|P2|Double Blind Treatment|Physician Decision|1
74055|NCT00984282|268333|P1|Double Blind Treatment|Physician Decision|1
74056|NCT00984282|268332|P2|Double Blind Treatment|Progression, recurrence or relapse|3
74057|NCT00984282|268333|P1|Double Blind Treatment|Progression, recurrence or relapse|20
74058|NCT00984282|268332|P2|Double Blind Treatment|Adverse Event|5
74059|NCT00984282|268333|P1|Double Blind Treatment|Adverse Event|31
74060|NCT00984256|268356|P2|Overall Study|Withdrawal by Subject|1
74061|NCT00984256|268357|P1|Overall Study|Withdrawal by Subject|0
74062|NCT00984204|268377|P1|Overall Study|Lack of Efficacy|10
74063|NCT00984204|268377|P1|Overall Study|Lost to Follow-up|4
74064|NCT00984204|268377|P1|Overall Study|Death|1
74065|NCT00984165|268387|P4|Overall Study|removed with a pair recipient|1
74066|NCT00984165|268388|P3|Overall Study|removed with a pair recipient|0
74067|NCT00984165|268389|P2|Overall Study|removed with a pair recipient|0
74068|NCT00984165|268390|P1|Overall Study|removed with a pair recipient|0
74069|NCT00984165|268387|P4|Overall Study|P+/donor pair removed from protocol|1
74070|NCT00984165|268388|P3|Overall Study|P+/donor pair removed from protocol|0
74071|NCT00984165|268389|P2|Overall Study|P+/donor pair removed from protocol|0
74072|NCT00984165|268390|P1|Overall Study|P+/donor pair removed from protocol|0
74073|NCT00984165|268387|P4|Overall Study|New protocol|1
74074|NCT00984165|268388|P3|Overall Study|New protocol|0
74075|NCT00984165|268389|P2|Overall Study|New protocol|0
74076|NCT00984165|268390|P1|Overall Study|New protocol|0
74077|NCT00984165|268387|P4|Overall Study|Death of recipient|1
74078|NCT00984165|268388|P3|Overall Study|Death of recipient|0
74079|NCT00984165|268389|P2|Overall Study|Death of recipient|0
74080|NCT00984165|268390|P1|Overall Study|Death of recipient|0
74081|NCT00984165|268387|P4|Overall Study|Disease progression on study|0
74082|NCT00984165|268388|P3|Overall Study|Disease progression on study|0
74083|NCT00984165|268389|P2|Overall Study|Disease progression on study|1
74084|NCT00984165|268390|P1|Overall Study|Disease progression on study|5
74085|NCT00984165|268387|P4|Overall Study|Death on study|0
74086|NCT00984165|268388|P3|Overall Study|Death on study|0
74087|NCT00984165|268389|P2|Overall Study|Death on study|0
74088|NCT00984165|268390|P1|Overall Study|Death on study|2
74089|NCT00984061|268415|P1|Clarithromycin Alone|Protocol Violation|1
74090|NCT00984022|268428|P2|Overall Study|Lost to Follow-up|14
74091|NCT00984022|268429|P1|Overall Study|Lost to Follow-up|10
74092|NCT00984009|268439|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
74093|NCT00983957|268472|P1|Overall Study|Personal Reasons|1
74094|NCT00983957|268472|P1|Overall Study|Adverse Event|1
74095|NCT00983931|268506|P1|14 Day Washout Period|Physician Decision|1
74096|NCT00983918|268520|P4|Overall Study|conversion to open cholecystectomy|2
74097|NCT00983918|268521|P3|Overall Study|conversion to open cholecystectomy|2
74098|NCT00983918|268522|P2|Overall Study|conversion to open cholecystectomy|2
74099|NCT00983918|268523|P1|Overall Study|conversion to open cholecystectomy|0
74100|NCT00983905|268533|P1|Colchicine Alone|Adverse Event|2
74101|NCT00983905|268533|P1|Theophylline Alone|Adverse Event|1
74102|NCT00983892|268546|P2|Overall Study|Withdrawal by Subject|12
74103|NCT00983892|268547|P1|Overall Study|Withdrawal by Subject|10
74104|NCT00983853|268559|P6|Overall Study|Unable to come to study follow-up visits|0
74105|NCT00983853|268560|P5|Overall Study|Unable to come to study follow-up visits|0
74106|NCT00983853|268561|P4|Overall Study|Unable to come to study follow-up visits|0
74107|NCT00983853|268562|P3|Overall Study|Unable to come to study follow-up visits|0
74108|NCT00983853|268563|P2|Overall Study|Unable to come to study follow-up visits|1
74109|NCT00983853|268564|P1|Overall Study|Unable to come to study follow-up visits|0
74110|NCT00983853|268559|P6|Overall Study|Withdrawal by Subject|0
74111|NCT00983853|268560|P5|Overall Study|Withdrawal by Subject|1
74112|NCT00983853|268561|P4|Overall Study|Withdrawal by Subject|0
74113|NCT00983853|268562|P3|Overall Study|Withdrawal by Subject|1
74114|NCT00983853|268563|P2|Overall Study|Withdrawal by Subject|0
74115|NCT00983853|268564|P1|Overall Study|Withdrawal by Subject|0
74116|NCT00983853|268559|P6|Overall Study|Lost to Follow-up|1
74117|NCT00983853|268560|P5|Overall Study|Lost to Follow-up|2
74118|NCT00983853|268561|P4|Overall Study|Lost to Follow-up|2
74119|NCT00983853|268562|P3|Overall Study|Lost to Follow-up|2
74120|NCT00983853|268563|P2|Overall Study|Lost to Follow-up|1
74121|NCT00983853|268564|P1|Overall Study|Lost to Follow-up|1
74122|NCT00983827|268592|P1|Overall Study|Withdrawal by Subject|1
74123|NCT00983749|268610|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
74124|NCT00983749|268611|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
74125|NCT00983515|268644|P1|Colchicine With Ritonavir|Lost to Follow-up|1
74126|NCT00983515|268644|P1|Ritonavir Alone|liver panel out of range|6
74127|NCT00983476|268671|P3|Overall Study|Did not receive intervention|0
74128|NCT00983476|268672|P2|Overall Study|Did not receive intervention|22
74129|NCT00983476|268673|P1|Overall Study|Did not receive intervention|17
74130|NCT00983437|268705|P1|Overall Study|Other Reason|26
74131|NCT00983437|268705|P1|Overall Study|Lost to Follow-up|2
74132|NCT00983437|268705|P1|Overall Study|Noncompliance to Study Procedures|1
74133|NCT00983437|268705|P1|Overall Study|Withdrawal by Subject|8
74134|NCT00983437|268705|P1|Overall Study|Lack of Efficacy|1
74135|NCT00983437|268705|P1|Overall Study|Adverse Event|9
74136|NCT00983385|268724|P1|Observation Period|Not Evaluable due to Non Compliance|12
74137|NCT00983385|268724|P1|Observation Period|Not eligible to be dosed|20
74138|NCT00983372|268769|P1|Diltiazem ER Alone|Adverse Event|1
74139|NCT00983372|268769|P1|Diltiazem ER Alone|missed diltiazem dose|2
74140|NCT00983372|268769|P1|14 Day Washout Period|Withdrawal by Subject|1
74141|NCT00983294|268792|P1|Colchicine With Azithromycin|Adverse Event|1
74142|NCT00983294|268792|P1|14 Day Washout Period|Withdrawal by Subject|2
74143|NCT00983073|268834|P1|Maintenance Period|Other Reason|7
74144|NCT00983073|268834|P1|Maintenance Period|Lack of Efficacy|2
74145|NCT00983073|268834|P1|Maintenance Period|Withdrawal by Subject|2
74146|NCT00983073|268834|P1|Maintenance Period|Adverse Event|5
74147|NCT00983073|268834|P1|Titration and Optimal Dose Period|Other reason|4
74148|NCT00983073|268834|P1|Titration and Optimal Dose Period|Non-Compliance|1
74149|NCT00983073|268834|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
74150|NCT00983073|268834|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
74151|NCT00983073|268834|P1|Titration and Optimal Dose Period|Adverse Event|19
74152|NCT00982735|268860|P1|Overall Study|Patient ineligible for trial|224
74153|NCT00982735|268860|P1|Overall Study|Lost to Follow-up|6
74154|NCT00982657|268870|P4|Overall Study|On going at date of cut-off|1
74155|NCT00982657|268871|P3|Overall Study|On going at date of cut-off|0
74156|NCT00982657|268872|P2|Overall Study|On going at date of cut-off|0
74157|NCT00982657|268873|P1|Overall Study|On going at date of cut-off|0
74158|NCT00982657|268870|P4|Overall Study|Unspecified|4
74159|NCT00982657|268871|P3|Overall Study|Unspecified|0
74160|NCT00982657|268872|P2|Overall Study|Unspecified|0
74161|NCT00982657|268873|P1|Overall Study|Unspecified|0
74162|NCT00982657|268870|P4|Overall Study|Withdrawal by Subject|3
74163|NCT00982657|268871|P3|Overall Study|Withdrawal by Subject|1
74164|NCT00982657|268872|P2|Overall Study|Withdrawal by Subject|0
74165|NCT00982657|268873|P1|Overall Study|Withdrawal by Subject|0
74166|NCT00982657|268870|P4|Overall Study|Death|1
74167|NCT00982657|268871|P3|Overall Study|Death|1
74168|NCT00982657|268872|P2|Overall Study|Death|0
74169|NCT00982657|268873|P1|Overall Study|Death|1
74170|NCT00982644|268914|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
74171|NCT00982644|268915|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
74172|NCT00982644|268914|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
74173|NCT00982644|268915|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
74174|NCT00982644|268914|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
74175|NCT00982644|268915|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
74176|NCT00982644|268914|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
74177|NCT00982644|268915|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
74178|NCT00982644|268914|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
74179|NCT00982644|268915|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
74180|NCT00982644|268914|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
74181|NCT00982644|268915|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
74182|NCT00982644|268914|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
74183|NCT00982644|268915|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
74184|NCT00982644|268914|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
74185|NCT00982644|268915|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
74186|NCT00982644|268914|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
74187|NCT00982644|268915|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
74353|NCT00981292|269322|P3|Day 2|Protocol Violation|0
74188|NCT00982644|268914|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
74189|NCT00982644|268915|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
74190|NCT00982488|268966|P5|Overall Study|Withdrawal by Subject|0
74191|NCT00982488|268967|P4|Overall Study|Withdrawal by Subject|0
74192|NCT00982488|268968|P3|Overall Study|Withdrawal by Subject|1
74193|NCT00982488|268969|P2|Overall Study|Withdrawal by Subject|1
74194|NCT00982488|268970|P1|Overall Study|Withdrawal by Subject|5
74195|NCT00982488|268966|P5|Overall Study|Study drug toxicity|0
74196|NCT00982488|268967|P4|Overall Study|Study drug toxicity|0
74197|NCT00982488|268968|P3|Overall Study|Study drug toxicity|6
74198|NCT00982488|268969|P2|Overall Study|Study drug toxicity|1
74199|NCT00982488|268970|P1|Overall Study|Study drug toxicity|34
74200|NCT00982488|268966|P5|Overall Study|Stem cell transplant|0
74201|NCT00982488|268967|P4|Overall Study|Stem cell transplant|1
74202|NCT00982488|268968|P3|Overall Study|Stem cell transplant|0
74203|NCT00982488|268969|P2|Overall Study|Stem cell transplant|0
74204|NCT00982488|268970|P1|Overall Study|Stem cell transplant|2
74205|NCT00982488|268966|P5|Overall Study|Poor compliance/noncompliance|0
74206|NCT00982488|268967|P4|Overall Study|Poor compliance/noncompliance|0
74207|NCT00982488|268968|P3|Overall Study|Poor compliance/noncompliance|0
74208|NCT00982488|268969|P2|Overall Study|Poor compliance/noncompliance|1
74209|NCT00982488|268970|P1|Overall Study|Poor compliance/noncompliance|0
74210|NCT00982488|268966|P5|Overall Study|Not specified|0
74211|NCT00982488|268967|P4|Overall Study|Not specified|1
74212|NCT00982488|268968|P3|Overall Study|Not specified|3
74213|NCT00982488|268969|P2|Overall Study|Not specified|1
74214|NCT00982488|268970|P1|Overall Study|Not specified|15
74215|NCT00982488|268966|P5|Overall Study|Maximum clinical benefit|0
74216|NCT00982488|268967|P4|Overall Study|Maximum clinical benefit|0
74217|NCT00982488|268968|P3|Overall Study|Maximum clinical benefit|1
74218|NCT00982488|268969|P2|Overall Study|Maximum clinical benefit|1
74219|NCT00982488|268970|P1|Overall Study|Maximum clinical benefit|1
74220|NCT00982488|268966|P5|Overall Study|Lost to Follow-up|0
74221|NCT00982488|268967|P4|Overall Study|Lost to Follow-up|0
74222|NCT00982488|268968|P3|Overall Study|Lost to Follow-up|0
74223|NCT00982488|268969|P2|Overall Study|Lost to Follow-up|0
74224|NCT00982488|268970|P1|Overall Study|Lost to Follow-up|1
74225|NCT00982488|268966|P5|Overall Study|Disease progression|1
74226|NCT00982488|268967|P4|Overall Study|Disease progression|1
74227|NCT00982488|268968|P3|Overall Study|Disease progression|10
74228|NCT00982488|268969|P2|Overall Study|Disease progression|5
74229|NCT00982488|268970|P1|Overall Study|Disease progression|30
74230|NCT00982488|268966|P5|Overall Study|Death|0
74231|NCT00982488|268967|P4|Overall Study|Death|0
74232|NCT00982488|268968|P3|Overall Study|Death|2
74233|NCT00982488|268969|P2|Overall Study|Death|0
74234|NCT00982488|268970|P1|Overall Study|Death|11
74235|NCT00982488|268966|P5|Overall Study|Adverse event unrelated to study drug|0
74236|NCT00982488|268967|P4|Overall Study|Adverse event unrelated to study drug|0
74237|NCT00982488|268968|P3|Overall Study|Adverse event unrelated to study drug|0
74238|NCT00982488|268969|P2|Overall Study|Adverse event unrelated to study drug|1
74239|NCT00982488|268970|P1|Overall Study|Adverse event unrelated to study drug|5
74240|NCT00982488|268966|P5|Overall Study|Administrative reason by sponsor|0
74241|NCT00982488|268967|P4|Overall Study|Administrative reason by sponsor|0
74242|NCT00982488|268968|P3|Overall Study|Administrative reason by sponsor|11
74243|NCT00982488|268969|P2|Overall Study|Administrative reason by sponsor|3
74244|NCT00982488|268970|P1|Overall Study|Administrative reason by sponsor|81
74245|NCT00982410|269003|P2|12-month Follow-up Assessment|scheduled, no-show|0
74246|NCT00982410|269004|P1|12-month Follow-up Assessment|scheduled, no-show|1
74247|NCT00982410|269003|P2|12-month Follow-up Assessment|incarceration|1
74248|NCT00982410|269004|P1|12-month Follow-up Assessment|incarceration|2
74249|NCT00982410|269003|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
74250|NCT00982410|269004|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
74251|NCT00982410|269003|P2|12-month Follow-up Assessment|could not reach to schedule|5
74252|NCT00982410|269004|P1|12-month Follow-up Assessment|could not reach to schedule|6
74253|NCT00982410|269003|P2|12-month Follow-up Assessment|Death|2
74254|NCT00982410|269004|P1|12-month Follow-up Assessment|Death|0
74255|NCT00982410|269003|P2|6-month Follow-up Assessment|scheduled, no-show|1
74256|NCT00982410|269004|P1|6-month Follow-up Assessment|scheduled, no-show|0
74257|NCT00982410|269003|P2|6-month Follow-up Assessment|patent surgery|1
74258|NCT00982410|269004|P1|6-month Follow-up Assessment|patent surgery|0
74259|NCT00982410|269003|P2|6-month Follow-up Assessment|incarceration|2
74260|NCT00982410|269004|P1|6-month Follow-up Assessment|incarceration|0
74261|NCT00982410|269003|P2|6-month Follow-up Assessment|participant no transportation|0
74262|NCT00982410|269004|P1|6-month Follow-up Assessment|participant no transportation|1
74263|NCT00982410|269003|P2|6-month Follow-up Assessment|Could not reach to schedule|7
74264|NCT00982410|269004|P1|6-month Follow-up Assessment|Could not reach to schedule|5
74265|NCT00982410|269003|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
74266|NCT00982410|269004|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
74267|NCT00982410|269003|P2|3-month Follow-up Assessment|Scheduled, no-show|2
74268|NCT00982410|269004|P1|3-month Follow-up Assessment|Scheduled, no-show|1
74269|NCT00982410|269003|P2|3-month Follow-up Assessment|Could not reach to schedule|9
74270|NCT00982410|269004|P1|3-month Follow-up Assessment|Could not reach to schedule|8
74271|NCT00982280|269030|P1|Maintenance Period|Adverse Event|1
74272|NCT00982280|269030|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
74273|NCT00982280|269030|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
74274|NCT00982280|269030|P1|Titration and Optimal Dose Period|Adverse Event|5
74275|NCT00982280|269030|P1|Observation Period|Not eligible to be dosed|19
74276|NCT00982228|269055|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
74277|NCT00982228|269056|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
74278|NCT00982228|269055|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
74279|NCT00982228|269056|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
74280|NCT00982228|269055|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
74281|NCT00982228|269056|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
74282|NCT00982228|269055|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
74283|NCT00982228|269056|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
74284|NCT00982228|269055|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
74285|NCT00982228|269056|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
74286|NCT00982228|269055|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
74287|NCT00982228|269056|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
74288|NCT00982228|269055|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
74289|NCT00982228|269056|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
74290|NCT00982228|269055|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
74291|NCT00982228|269056|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
74292|NCT00982228|269055|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
74293|NCT00982228|269056|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
74294|NCT00982228|269055|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
74295|NCT00982228|269056|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
74296|NCT00982137|269109|P4|Overall Study|Withdrawal by Subject|0
74297|NCT00982137|269110|P3|Overall Study|Withdrawal by Subject|0
74298|NCT00982137|269111|P2|Overall Study|Withdrawal by Subject|1
74299|NCT00982137|269112|P1|Overall Study|Withdrawal by Subject|0
74300|NCT00982137|269109|P4|Overall Study|Lost to Follow-up|1
74301|NCT00982137|269110|P3|Overall Study|Lost to Follow-up|0
74302|NCT00982137|269111|P2|Overall Study|Lost to Follow-up|0
74303|NCT00982137|269112|P1|Overall Study|Lost to Follow-up|0
74304|NCT00982111|269144|P2|Overall Study|Withdrawal by Subject|17
74305|NCT00982111|269145|P1|Overall Study|Withdrawal by Subject|16
74306|NCT00982111|269144|P2|Overall Study|On Study Treatment at Conclusion|0
74307|NCT00982111|269145|P1|Overall Study|On Study Treatment at Conclusion|7
74308|NCT00982111|269144|P2|Overall Study|New Anti-Cancer Therapy|5
74309|NCT00982111|269145|P1|Overall Study|New Anti-Cancer Therapy|5
74310|NCT00982111|269144|P2|Overall Study|Lost to Follow-up|6
74311|NCT00982111|269145|P1|Overall Study|Lost to Follow-up|9
74312|NCT00982111|269144|P2|Overall Study|Progressive Disease|37
74313|NCT00982111|269145|P1|Overall Study|Progressive Disease|37
74314|NCT00982111|269144|P2|Overall Study|Adverse Event|1
74315|NCT00982111|269145|P1|Overall Study|Adverse Event|1
74316|NCT00982020|269169|P2|Overall Study|Clinical Relapse|1
74317|NCT00982020|269170|P1|Overall Study|Clinical Relapse|0
74318|NCT00982020|269169|P2|Overall Study|Protocol Violation|2
74319|NCT00982020|269170|P1|Overall Study|Protocol Violation|0
74320|NCT00982020|269169|P2|Overall Study|Entry Criteria Not Met|1
74321|NCT00982020|269170|P1|Overall Study|Entry Criteria Not Met|2
74322|NCT00982020|269169|P2|Overall Study|Physician Decision|5
74323|NCT00982020|269170|P1|Overall Study|Physician Decision|2
74324|NCT00982020|269169|P2|Overall Study|Treatment Non-compliance|6
74325|NCT00982020|269170|P1|Overall Study|Treatment Non-compliance|3
74326|NCT00982020|269169|P2|Overall Study|Parent/Caregiver Decision|5
74327|NCT00982020|269170|P1|Overall Study|Parent/Caregiver Decision|5
74328|NCT00982020|269169|P2|Overall Study|Lack of Efficacy|4
74329|NCT00982020|269170|P1|Overall Study|Lack of Efficacy|10
74330|NCT00982020|269169|P2|Overall Study|Lost to Follow-up|11
74331|NCT00982020|269170|P1|Overall Study|Lost to Follow-up|5
74332|NCT00982020|269169|P2|Overall Study|Withdrawal by Subject|14
74333|NCT00982020|269170|P1|Overall Study|Withdrawal by Subject|11
74334|NCT00982020|269169|P2|Overall Study|Adverse Event|15
74335|NCT00982020|269170|P1|Overall Study|Adverse Event|19
74336|NCT00981461|269270|P2|Overall Study|Lost to Follow-up|2
74337|NCT00981461|269271|P1|Overall Study|Lost to Follow-up|5
74338|NCT00981409|269279|P2|Overall Study|Prostate Cancer Treatment before Trial|0
74339|NCT00981409|269280|P1|Overall Study|Prostate Cancer Treatment before Trial|2
74340|NCT00981409|269279|P2|Overall Study|Protocol Violation|1
74341|NCT00981409|269280|P1|Overall Study|Protocol Violation|0
74342|NCT00981409|269279|P2|Overall Study|Adverse Event|0
74343|NCT00981409|269280|P1|Overall Study|Adverse Event|4
74344|NCT00981292|269319|P6|Day 3|Protocol Violation|1
74345|NCT00981292|269320|P5|Day 3|Protocol Violation|0
74346|NCT00981292|269321|P4|Day 3|Protocol Violation|0
74347|NCT00981292|269322|P3|Day 3|Protocol Violation|0
74348|NCT00981292|269323|P2|Day 3|Protocol Violation|0
74349|NCT00981292|269324|P1|Day 3|Protocol Violation|0
74350|NCT00981292|269319|P6|Day 2|Protocol Violation|0
74351|NCT00981292|269320|P5|Day 2|Protocol Violation|0
74352|NCT00981292|269321|P4|Day 2|Protocol Violation|0
74354|NCT00981292|269323|P2|Day 2|Protocol Violation|0
74355|NCT00981292|269324|P1|Day 2|Protocol Violation|2
74356|NCT00981292|269319|P6|Day 1|Protocol Violation|2
74357|NCT00981292|269320|P5|Day 1|Protocol Violation|0
74358|NCT00981292|269321|P4|Day 1|Protocol Violation|0
74359|NCT00981292|269322|P3|Day 1|Protocol Violation|0
74360|NCT00981292|269323|P2|Day 1|Protocol Violation|0
74361|NCT00981292|269324|P1|Day 1|Protocol Violation|1
74362|NCT00981175|269387|P2|Booster Dose Vaccination|Lost to Follow-up|3
74363|NCT00981175|269388|P1|Booster Dose Vaccination|Lost to Follow-up|2
74364|NCT00981175|269387|P2|Primary Dose Vaccination|Lost to Follow-up|1
74365|NCT00981175|269388|P1|Primary Dose Vaccination|Lost to Follow-up|2
74366|NCT00981175|269387|P2|Primary Dose Vaccination|Protocol Violation|1
74367|NCT00981175|269388|P1|Primary Dose Vaccination|Protocol Violation|0
74368|NCT00981175|269387|P2|Primary Dose Vaccination|Adverse Event|0
74369|NCT00981175|269388|P1|Primary Dose Vaccination|Adverse Event|1
74370|NCT00981084|269413|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
74371|NCT00981084|269414|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
74372|NCT00981084|269413|P2|Post Intervention (Data Analysis)|poor effort|1
74373|NCT00981084|269414|P1|Post Intervention (Data Analysis)|poor effort|1
74374|NCT00981058|269430|P2|Overall Study|On study treatment at conclusion|0
74375|NCT00981058|269431|P1|Overall Study|On study treatment at conclusion|9
74376|NCT00981058|269430|P2|Overall Study|Withdrawal by Subject|23
74377|NCT00981058|269431|P1|Overall Study|Withdrawal by Subject|25
74378|NCT00981058|269430|P2|Overall Study|Randomization Error|2
74379|NCT00981058|269431|P1|Overall Study|Randomization Error|1
74380|NCT00981058|269430|P2|Overall Study|Radiologist Error|1
74381|NCT00981058|269431|P1|Overall Study|Radiologist Error|0
74382|NCT00981058|269430|P2|Overall Study|Noncompliance|0
74383|NCT00981058|269431|P1|Overall Study|Noncompliance|1
74384|NCT00981058|269430|P2|Overall Study|New Anticancer Therapy|6
74385|NCT00981058|269431|P1|Overall Study|New Anticancer Therapy|6
74386|NCT00981058|269430|P2|Overall Study|Lost to Follow-up|15
74387|NCT00981058|269431|P1|Overall Study|Lost to Follow-up|16
74388|NCT00981058|269430|P2|Overall Study|Progressive Disease|49
74389|NCT00981058|269431|P1|Overall Study|Progressive Disease|61
74390|NCT00981058|269430|P2|Overall Study|Adverse Event|1
74391|NCT00981058|269431|P1|Overall Study|Adverse Event|1
74392|NCT00981019|269462|P1|Overall Study|Hit the survey after closure|79
74393|NCT00981019|269462|P1|Overall Study|Inadvertent exclusion|239
74394|NCT00981019|269462|P1|Overall Study|Did not match target population|94
74395|NCT00981019|269462|P1|Overall Study|Did not respond|65
74396|NCT00980980|269469|P3|Overall Study|Withdrawal by Hospital|0
74397|NCT00980980|269470|P2|Overall Study|Withdrawal by Hospital|1
74398|NCT00980980|269471|P1|Overall Study|Withdrawal by Hospital|0
74399|NCT00980798|269496|P2|Overall Study|Other|1
74400|NCT00980798|269497|P1|Overall Study|Other|0
74401|NCT00980798|269496|P2|Overall Study|Withdrawal by Subject|11
74402|NCT00980798|269497|P1|Overall Study|Withdrawal by Subject|8
74403|NCT00980798|269496|P2|Overall Study|Physician Decision|1
74404|NCT00980798|269497|P1|Overall Study|Physician Decision|2
74405|NCT00980798|269496|P2|Overall Study|Lost to Follow-up|1
74406|NCT00980798|269497|P1|Overall Study|Lost to Follow-up|0
74407|NCT00980798|269496|P2|Overall Study|Lack of Efficacy|5
74408|NCT00980798|269497|P1|Overall Study|Lack of Efficacy|16
74409|NCT00980798|269496|P2|Overall Study|Adverse Event|36
74410|NCT00980798|269497|P1|Overall Study|Adverse Event|7
74411|NCT00980655|269538|P2|Overall Study|Unspecified|1
74412|NCT00980655|269539|P1|Overall Study|Unspecified|0
74413|NCT00980655|269538|P2|Overall Study|Parent/legal guardian request|0
74414|NCT00980655|269539|P1|Overall Study|Parent/legal guardian request|1
74415|NCT00980655|269538|P2|Overall Study|Lost to Follow-up|1
74416|NCT00980655|269539|P1|Overall Study|Lost to Follow-up|0
74417|NCT00980655|269538|P2|Overall Study|Withdrawal by Subject|4
74418|NCT00980655|269539|P1|Overall Study|Withdrawal by Subject|0
74419|NCT00980655|269538|P2|Overall Study|Protocol Violation|7
74420|NCT00980655|269539|P1|Overall Study|Protocol Violation|2
74421|NCT00980655|269538|P2|Overall Study|Death|7
74422|NCT00980655|269539|P1|Overall Study|Death|0
74423|NCT00980655|269538|P2|Overall Study|Adverse Event|31
74424|NCT00980655|269539|P1|Overall Study|Adverse Event|13
74425|NCT00980330|269607|P7|Overall Study|(not specified)|0
74426|NCT00980330|269608|P6|Overall Study|(not specified)|1
74427|NCT00980330|269609|P5|Overall Study|(not specified)|1
74428|NCT00980330|269610|P4|Overall Study|(not specified)|1
74429|NCT00980330|269611|P3|Overall Study|(not specified)|0
74430|NCT00980330|269612|P2|Overall Study|(not specified)|0
74431|NCT00980330|269613|P1|Overall Study|(not specified)|2
74432|NCT00980330|269607|P7|Overall Study|Withdrawal by Subject|5
74433|NCT00980330|269608|P6|Overall Study|Withdrawal by Subject|2
74434|NCT00980330|269609|P5|Overall Study|Withdrawal by Subject|3
74435|NCT00980330|269610|P4|Overall Study|Withdrawal by Subject|1
74436|NCT00980330|269611|P3|Overall Study|Withdrawal by Subject|4
74437|NCT00980330|269612|P2|Overall Study|Withdrawal by Subject|4
74438|NCT00980330|269613|P1|Overall Study|Withdrawal by Subject|2
74439|NCT00980330|269607|P7|Overall Study|Lost to Follow-up|2
74440|NCT00980330|269608|P6|Overall Study|Lost to Follow-up|1
74441|NCT00980330|269609|P5|Overall Study|Lost to Follow-up|1
74442|NCT00980330|269610|P4|Overall Study|Lost to Follow-up|2
74443|NCT00980330|269611|P3|Overall Study|Lost to Follow-up|4
74444|NCT00980330|269612|P2|Overall Study|Lost to Follow-up|1
74445|NCT00980330|269613|P1|Overall Study|Lost to Follow-up|1
74446|NCT00980330|269607|P7|Overall Study|Adverse Event|0
74447|NCT00980330|269608|P6|Overall Study|Adverse Event|0
74448|NCT00980330|269609|P5|Overall Study|Adverse Event|0
74449|NCT00980330|269610|P4|Overall Study|Adverse Event|1
74450|NCT00980330|269611|P3|Overall Study|Adverse Event|0
74451|NCT00980330|269612|P2|Overall Study|Adverse Event|0
74452|NCT00980330|269613|P1|Overall Study|Adverse Event|0
74453|NCT00980200|269728|P5|7-day Treatment Period 3|Lack of Efficacy|1
74454|NCT00980200|269729|P4|7-day Treatment Period 3|Lack of Efficacy|0
74455|NCT00980200|269730|P3|7-day Treatment Period 3|Lack of Efficacy|0
74456|NCT00980200|269731|P2|7-day Treatment Period 3|Lack of Efficacy|1
74457|NCT00980200|269732|P1|7-day Treatment Period 3|Lack of Efficacy|0
74458|NCT00980200|269728|P5|7-day Treatment Period 1|Withdrawal by Subject|0
74459|NCT00980200|269729|P4|7-day Treatment Period 1|Withdrawal by Subject|0
74460|NCT00980200|269730|P3|7-day Treatment Period 1|Withdrawal by Subject|0
74461|NCT00980200|269731|P2|7-day Treatment Period 1|Withdrawal by Subject|1
74462|NCT00980200|269732|P1|7-day Treatment Period 1|Withdrawal by Subject|0
74463|NCT00980174|269751|P2|Overall Study|Other|1
74464|NCT00980174|269752|P1|Overall Study|Other|0
74465|NCT00980174|269751|P2|Overall Study|Death|1
74466|NCT00980174|269752|P1|Overall Study|Death|1
74467|NCT00980174|269751|P2|Overall Study|Ineligibility determined|1
74468|NCT00980174|269752|P1|Overall Study|Ineligibility determined|2
74469|NCT00980174|269751|P2|Overall Study|Adverse Event|3
74470|NCT00980174|269752|P1|Overall Study|Adverse Event|0
74471|NCT00980174|269751|P2|Overall Study|Withdrawal by Subject|4
74472|NCT00980174|269752|P1|Overall Study|Withdrawal by Subject|1
74473|NCT00980148|269770|P2|Overall Study|Various other reasons|9
74474|NCT00980148|269771|P1|Overall Study|Various other reasons|8
74475|NCT00980148|269770|P2|Overall Study|Negative for chlamydia at enrollment|9
74476|NCT00980148|269771|P1|Overall Study|Negative for chlamydia at enrollment|12
74477|NCT00980148|269770|P2|Overall Study|Received other antichlamydia treatment|14
74478|NCT00980148|269771|P1|Overall Study|Received other antichlamydia treatment|20
74479|NCT00980148|269770|P2|Overall Study|Discharged from facility|96
74480|NCT00980148|269771|P1|Overall Study|Discharged from facility|89
74481|NCT00980044|269780|P3|Overall Study|Protocol Violation|2
74482|NCT00980044|269781|P2|Overall Study|Protocol Violation|0
74483|NCT00980044|269782|P1|Overall Study|Protocol Violation|0
74484|NCT00980044|269780|P3|Overall Study|Withdrawal by Subject|3
74485|NCT00980044|269781|P2|Overall Study|Withdrawal by Subject|7
74486|NCT00980044|269782|P1|Overall Study|Withdrawal by Subject|5
74487|NCT00980005|269801|P2|Overall Study|Unspecified|3
74488|NCT00980005|269802|P1|Overall Study|Unspecified|4
74489|NCT00980005|269801|P2|Overall Study|Lost to Follow-up|43
74490|NCT00980005|269802|P1|Overall Study|Lost to Follow-up|37
74491|NCT00980005|269801|P2|Overall Study|Withdrawal by Subject|17
74492|NCT00980005|269802|P1|Overall Study|Withdrawal by Subject|6
74493|NCT00979953|269846|P4|Overall Study|Protocol Violation|2
74494|NCT00979953|269847|P3|Overall Study|Protocol Violation|2
74495|NCT00979953|269848|P2|Overall Study|Protocol Violation|0
74496|NCT00979953|269849|P1|Overall Study|Protocol Violation|1
74497|NCT00979953|269846|P4|Overall Study|Withdrawal by Subject|1
74498|NCT00979953|269847|P3|Overall Study|Withdrawal by Subject|2
74499|NCT00979953|269848|P2|Overall Study|Withdrawal by Subject|0
74500|NCT00979953|269849|P1|Overall Study|Withdrawal by Subject|0
74501|NCT00979953|269846|P4|Overall Study|Lost to Follow-up|0
74502|NCT00979953|269847|P3|Overall Study|Lost to Follow-up|1
74503|NCT00979953|269848|P2|Overall Study|Lost to Follow-up|1
74504|NCT00979953|269849|P1|Overall Study|Lost to Follow-up|1
74505|NCT00979953|269846|P4|Overall Study|Lack of Efficacy|0
74506|NCT00979953|269847|P3|Overall Study|Lack of Efficacy|0
74507|NCT00979953|269848|P2|Overall Study|Lack of Efficacy|2
74508|NCT00979953|269849|P1|Overall Study|Lack of Efficacy|1
74509|NCT00979953|269846|P4|Overall Study|Adverse Event|4
74510|NCT00979953|269847|P3|Overall Study|Adverse Event|17
74511|NCT00979953|269848|P2|Overall Study|Adverse Event|2
74512|NCT00979953|269849|P1|Overall Study|Adverse Event|5
74513|NCT00979901|269872|P4|Overall Study|Treatment Group Terminated by Sponsor|112
74514|NCT00979901|269873|P3|Overall Study|Treatment Group Terminated by Sponsor|0
74515|NCT00979901|269874|P2|Overall Study|Treatment Group Terminated by Sponsor|0
74516|NCT00979901|269875|P1|Overall Study|Treatment Group Terminated by Sponsor|0
74517|NCT00979901|269872|P4|Overall Study|Left Country|0
74518|NCT00979901|269873|P3|Overall Study|Left Country|1
74519|NCT00979901|269874|P2|Overall Study|Left Country|0
74520|NCT00979901|269875|P1|Overall Study|Left Country|0
74521|NCT00979901|269872|P4|Overall Study|Discontinued in Error|0
74522|NCT00979901|269873|P3|Overall Study|Discontinued in Error|0
74523|NCT00979901|269874|P2|Overall Study|Discontinued in Error|1
74524|NCT00979901|269875|P1|Overall Study|Discontinued in Error|0
74525|NCT00979901|269872|P4|Overall Study|elevated lab values pre-randomization|0
74526|NCT00979901|269873|P3|Overall Study|elevated lab values pre-randomization|0
74527|NCT00979901|269874|P2|Overall Study|elevated lab values pre-randomization|0
74528|NCT00979901|269875|P1|Overall Study|elevated lab values pre-randomization|1
74529|NCT00979901|269872|P4|Overall Study|vacation|0
74530|NCT00979901|269873|P3|Overall Study|vacation|0
74531|NCT00979901|269874|P2|Overall Study|vacation|0
74532|NCT00979901|269875|P1|Overall Study|vacation|1
74533|NCT00979901|269872|P4|Overall Study|out-of-state|0
74534|NCT00979901|269873|P3|Overall Study|out-of-state|0
74535|NCT00979901|269874|P2|Overall Study|out-of-state|0
74536|NCT00979901|269875|P1|Overall Study|out-of-state|1
74537|NCT00979901|269872|P4|Overall Study|Noncompliance|0
74538|NCT00979901|269873|P3|Overall Study|Noncompliance|0
74539|NCT00979901|269874|P2|Overall Study|Noncompliance|0
74540|NCT00979901|269875|P1|Overall Study|Noncompliance|1
74541|NCT00979901|269872|P4|Overall Study|Withdrawal by Subject|1
74542|NCT00979901|269873|P3|Overall Study|Withdrawal by Subject|1
74543|NCT00979901|269874|P2|Overall Study|Withdrawal by Subject|1
74544|NCT00979901|269875|P1|Overall Study|Withdrawal by Subject|2
74545|NCT00979901|269872|P4|Overall Study|Protocol Violation|1
74546|NCT00979901|269873|P3|Overall Study|Protocol Violation|7
74547|NCT00979901|269874|P2|Overall Study|Protocol Violation|2
74548|NCT00979901|269875|P1|Overall Study|Protocol Violation|2
74549|NCT00979901|269872|P4|Overall Study|Lost to Follow-up|0
74550|NCT00979901|269873|P3|Overall Study|Lost to Follow-up|2
74551|NCT00979901|269874|P2|Overall Study|Lost to Follow-up|1
74552|NCT00979901|269875|P1|Overall Study|Lost to Follow-up|1
74553|NCT00979901|269872|P4|Overall Study|Lack of Efficacy|0
74554|NCT00979901|269873|P3|Overall Study|Lack of Efficacy|9
74555|NCT00979901|269874|P2|Overall Study|Lack of Efficacy|4
74556|NCT00979901|269875|P1|Overall Study|Lack of Efficacy|8
74557|NCT00979901|269872|P4|Overall Study|Adverse Event|2
74558|NCT00979901|269873|P3|Overall Study|Adverse Event|9
74559|NCT00979901|269874|P2|Overall Study|Adverse Event|3
74560|NCT00979901|269875|P1|Overall Study|Adverse Event|1
74561|NCT00979654|269948|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
74562|NCT00979654|269948|P1|Overall Study|Serious Adverse Event|1
74563|NCT00979654|269948|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
74564|NCT00979654|269948|P1|Overall Study|Per Principal Investigator’s Discretion|1
74565|NCT00979654|269948|P1|Overall Study|Adverse Event of Diverticulitis|1
74566|NCT00979654|269948|P1|Overall Study|Adverse Event|1
74567|NCT00979654|269948|P1|Overall Study|Lack of Efficacy|6
74568|NCT00979654|269948|P1|Overall Study|Death|1
74569|NCT00979654|269948|P1|Overall Study|Withdrawal by Subject|22
74570|NCT00979654|269948|P1|Overall Study|Lost to Follow-up|1
74571|NCT00979628|269963|P3|Overall Study|transferred to ICU|1
74572|NCT00979628|269964|P2|Overall Study|transferred to ICU|2
74573|NCT00979628|269965|P1|Overall Study|transferred to ICU|1
74574|NCT00979628|269963|P3|Overall Study|received steroids|0
74575|NCT00979628|269964|P2|Overall Study|received steroids|1
74576|NCT00979628|269965|P1|Overall Study|received steroids|1
74577|NCT00979628|269963|P3|Overall Study|received regimen < 24 hours|5
74578|NCT00979628|269964|P2|Overall Study|received regimen < 24 hours|6
74579|NCT00979628|269965|P1|Overall Study|received regimen < 24 hours|7
74580|NCT00979576|269993|P3|Combination Followed by Monotherapy|Progressive Disease|1
74581|NCT00979576|269994|P2|Combination Followed by Monotherapy|Progressive Disease|2
74582|NCT00979576|269995|P1|Combination Followed by Monotherapy|Progressive Disease|0
74583|NCT00979576|269993|P3|Combination Treatment Phase|Adverse Event|2
74584|NCT00979576|269994|P2|Combination Treatment Phase|Adverse Event|2
74585|NCT00979576|269995|P1|Combination Treatment Phase|Adverse Event|0
74586|NCT00979576|269993|P3|Combination Treatment Phase|Dose limiting toxicity|2
74587|NCT00979576|269994|P2|Combination Treatment Phase|Dose limiting toxicity|3
74588|NCT00979576|269995|P1|Combination Treatment Phase|Dose limiting toxicity|0
74589|NCT00979576|269993|P3|Combination Treatment Phase|Progressive disease|5
74590|NCT00979576|269994|P2|Combination Treatment Phase|Progressive disease|1
74591|NCT00979576|269995|P1|Combination Treatment Phase|Progressive disease|3
74592|NCT00978627|270028|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
74593|NCT00978627|270029|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
74594|NCT00978627|270028|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
74595|NCT00978627|270029|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
74596|NCT00978627|270028|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
74597|NCT00978627|270029|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
74598|NCT00978627|270028|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
74599|NCT00978627|270029|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
74600|NCT00978627|270028|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
74601|NCT00978627|270029|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
74602|NCT00978627|270028|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
74603|NCT00978627|270029|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
74604|NCT00978627|270028|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
74605|NCT00978627|270029|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
74606|NCT00978627|270028|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
74607|NCT00978627|270029|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
74608|NCT00978627|270028|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
74609|NCT00978627|270029|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
74610|NCT00979420|270068|P4|Overall Study|Other reasons not related to Viramune|1
74611|NCT00979420|270069|P3|Overall Study|Other reasons not related to Viramune|0
74612|NCT00979420|270070|P2|Overall Study|Other reasons not related to Viramune|0
74613|NCT00979420|270071|P1|Overall Study|Other reasons not related to Viramune|3
74614|NCT00979420|270068|P4|Overall Study|Lack of Efficacy|1
74615|NCT00979420|270069|P3|Overall Study|Lack of Efficacy|1
74616|NCT00979420|270070|P2|Overall Study|Lack of Efficacy|0
74617|NCT00979420|270071|P1|Overall Study|Lack of Efficacy|3
74618|NCT00979420|270068|P4|Overall Study|Adverse Event|0
74619|NCT00979420|270069|P3|Overall Study|Adverse Event|0
74620|NCT00979420|270070|P2|Overall Study|Adverse Event|0
74621|NCT00979420|270071|P1|Overall Study|Adverse Event|1
74622|NCT00979212|270141|P2|Overall Study|No protocol therapy received|0
74623|NCT00979212|270142|P1|Overall Study|No protocol therapy received|1
74624|NCT00979212|270141|P2|Overall Study|Protocol Violation|8
74625|NCT00979212|270142|P1|Overall Study|Protocol Violation|1
74626|NCT00978757|270196|P2|Overall Study|Physician Decision|3
74627|NCT00978757|270197|P1|Overall Study|Physician Decision|1
74628|NCT00978731|270207|P4|Overall Study|No response|0
74629|NCT00978731|270208|P3|Overall Study|No response|0
74630|NCT00978731|270209|P2|Overall Study|No response|0
74631|NCT00978731|270210|P1|Overall Study|No response|1
74632|NCT00978731|270207|P4|Overall Study|Study closure|1
74633|NCT00978731|270208|P3|Overall Study|Study closure|1
74634|NCT00978731|270209|P2|Overall Study|Study closure|4
74635|NCT00978731|270210|P1|Overall Study|Study closure|3
74636|NCT00978731|270207|P4|Overall Study|Disease progression/relapse|2
74637|NCT00978731|270208|P3|Overall Study|Disease progression/relapse|2
74638|NCT00978731|270209|P2|Overall Study|Disease progression/relapse|4
74639|NCT00978731|270210|P1|Overall Study|Disease progression/relapse|5
74640|NCT00978731|270207|P4|Overall Study|Deterioration without progression|0
74641|NCT00978731|270208|P3|Overall Study|Deterioration without progression|0
74642|NCT00978731|270209|P2|Overall Study|Deterioration without progression|1
74643|NCT00978731|270210|P1|Overall Study|Deterioration without progression|0
74644|NCT00978731|270207|P4|Overall Study|Administrative reason|0
74645|NCT00978731|270208|P3|Overall Study|Administrative reason|1
74646|NCT00978731|270209|P2|Overall Study|Administrative reason|3
74647|NCT00978731|270210|P1|Overall Study|Administrative reason|3
74648|NCT00978731|270207|P4|Overall Study|Participant's request|0
74649|NCT00978731|270208|P3|Overall Study|Participant's request|0
74650|NCT00978731|270209|P2|Overall Study|Participant's request|0
74651|NCT00978731|270210|P1|Overall Study|Participant's request|1
74652|NCT00978731|270207|P4|Overall Study|Adverse Event|0
74653|NCT00978731|270208|P3|Overall Study|Adverse Event|0
74654|NCT00978731|270209|P2|Overall Study|Adverse Event|2
74655|NCT00978731|270210|P1|Overall Study|Adverse Event|5
74656|NCT00978731|270207|P4|Overall Study|Lost to Follow-up|1
74657|NCT00978731|270208|P3|Overall Study|Lost to Follow-up|0
74658|NCT00978731|270209|P2|Overall Study|Lost to Follow-up|0
74659|NCT00978731|270210|P1|Overall Study|Lost to Follow-up|0
74660|NCT00978731|270207|P4|Overall Study|Death|0
74661|NCT00978731|270208|P3|Overall Study|Death|1
74662|NCT00978731|270209|P2|Overall Study|Death|1
74663|NCT00978731|270210|P1|Overall Study|Death|4
74664|NCT00978432|270259|P3|Overall Study|Adverse Event|1
74665|NCT00978432|270260|P2|Overall Study|Adverse Event|0
74666|NCT00978432|270261|P1|Overall Study|Adverse Event|2
74667|NCT00978432|270259|P3|Overall Study|Lack of Efficacy|3
74668|NCT00978432|270260|P2|Overall Study|Lack of Efficacy|1
74669|NCT00978432|270261|P1|Overall Study|Lack of Efficacy|1
74670|NCT00978432|270259|P3|Overall Study|Withdrawal by Subject|1
74671|NCT00978432|270260|P2|Overall Study|Withdrawal by Subject|0
74672|NCT00978432|270261|P1|Overall Study|Withdrawal by Subject|0
74673|NCT00978380|270281|P1|Overall Study|Unclassified|8
74674|NCT00978380|270281|P1|Overall Study|Withdrawal criteria|9
74675|NCT00978380|270281|P1|Overall Study|Protocol Violation|2
74676|NCT00978341|270287|P2|Washout Period of 2 Weeks|Adverse Event|0
74677|NCT00978341|270288|P1|Washout Period of 2 Weeks|Adverse Event|1
74678|NCT00978120|270310|P4|Overall Study|Moved out of state|1
74679|NCT00978120|270311|P3|Overall Study|Moved out of state|0
74680|NCT00978120|270312|P2|Overall Study|Moved out of state|0
74681|NCT00978120|270313|P1|Overall Study|Moved out of state|0
74682|NCT00978120|270310|P4|Overall Study|Withdrawal by Subject|0
74683|NCT00978120|270311|P3|Overall Study|Withdrawal by Subject|0
74684|NCT00978120|270312|P2|Overall Study|Withdrawal by Subject|0
74685|NCT00978120|270313|P1|Overall Study|Withdrawal by Subject|2
74686|NCT00978120|270310|P4|Overall Study|Lost to Follow-up|0
74687|NCT00978120|270311|P3|Overall Study|Lost to Follow-up|3
74688|NCT00978120|270312|P2|Overall Study|Lost to Follow-up|0
74689|NCT00978120|270313|P1|Overall Study|Lost to Follow-up|0
74690|NCT00978120|270310|P4|Overall Study|Death|1
74691|NCT00978120|270311|P3|Overall Study|Death|0
74692|NCT00978120|270312|P2|Overall Study|Death|0
74693|NCT00978120|270313|P1|Overall Study|Death|0
74694|NCT00978042|270365|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
74695|NCT00978042|270366|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
74696|NCT00978042|270365|P2|Initial Treatment Period|Consent withdrawn|9
74697|NCT00978042|270366|P1|Initial Treatment Period|Consent withdrawn|22
74698|NCT00978042|270365|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
74699|NCT00978042|270366|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
74700|NCT00978042|270365|P2|Initial Treatment Period|Adverse Event|0
74701|NCT00978042|270366|P1|Initial Treatment Period|Adverse Event|2
74702|NCT00978042|270365|P2|Initial Treatment Period|Lost to Follow-up|3
74703|NCT00978042|270366|P1|Initial Treatment Period|Lost to Follow-up|21
74704|NCT00978042|270365|P2|Initial Treatment Period|Ineligibility|0
74705|NCT00978042|270366|P1|Initial Treatment Period|Ineligibility|1
74706|NCT00978042|270365|P2|Initial Treatment Period|Treated in Error|3
74707|NCT00978042|270366|P1|Initial Treatment Period|Treated in Error|0
74708|NCT00978029|270379|P3|Overall Study|Protocol Violation|0
74709|NCT00978029|270380|P2|Overall Study|Protocol Violation|1
74710|NCT00978029|270381|P1|Overall Study|Protocol Violation|0
74711|NCT00978029|270379|P3|Overall Study|Withdrawal by Subject|1
74712|NCT00978029|270380|P2|Overall Study|Withdrawal by Subject|0
74713|NCT00978029|270381|P1|Overall Study|Withdrawal by Subject|0
74714|NCT00978029|270379|P3|Overall Study|Adverse Event|5
74715|NCT00978029|270380|P2|Overall Study|Adverse Event|2
74716|NCT00978029|270381|P1|Overall Study|Adverse Event|1
74717|NCT00977938|270408|P4|Observation (30-33 mo. Post Procedure)|Other|0
74718|NCT00977938|270409|P3|Observation (30-33 mo. Post Procedure)|Other|0
74719|NCT00977938|270410|P2|Observation (30-33 mo. Post Procedure)|Other|4
74720|NCT00977938|270411|P1|Observation (30-33 mo. Post Procedure)|Other|8
74721|NCT00977938|270408|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
74722|NCT00977938|270409|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
74723|NCT00977938|270410|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
74724|NCT00977938|270411|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
74725|NCT00977938|270408|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
74726|NCT00977938|270409|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
74727|NCT00977938|270410|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
74728|NCT00977938|270411|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
74729|NCT00977938|270408|P4|Treatment (12-30 mo. Post Procedure)|Other|4
74730|NCT00977938|270409|P3|Treatment (12-30 mo. Post Procedure)|Other|3
74731|NCT00977938|270410|P2|Treatment (12-30 mo. Post Procedure)|Other|18
74732|NCT00977938|270411|P1|Treatment (12-30 mo. Post Procedure)|Other|17
74733|NCT00977938|270408|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
74734|NCT00977938|270409|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
74735|NCT00977938|270410|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
74736|NCT00977938|270411|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
74737|NCT00977938|270408|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
74738|NCT00977938|270409|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
74739|NCT00977938|270410|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
74740|NCT00977938|270411|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
74741|NCT00977665|270475|P2|Overall Study|Treatment failure|1
74742|NCT00977665|270476|P1|Overall Study|Treatment failure|0
74743|NCT00977665|270475|P2|Overall Study|Adverse Event|7
74744|NCT00977665|270476|P1|Overall Study|Adverse Event|14
74745|NCT00977665|270475|P2|Overall Study|Death|2
74746|NCT00977665|270476|P1|Overall Study|Death|3
74747|NCT00977665|270475|P2|Overall Study|Lost to Follow-up|0
74748|NCT00977665|270476|P1|Overall Study|Lost to Follow-up|1
74749|NCT00977665|270475|P2|Overall Study|Sponsor requested withdrawal|1
74750|NCT00977665|270476|P1|Overall Study|Sponsor requested withdrawal|0
74751|NCT00977665|270475|P2|Overall Study|Physician Decision|1
74752|NCT00977665|270476|P1|Overall Study|Physician Decision|2
74753|NCT00977665|270475|P2|Overall Study|Withdrawal by Subject|3
74754|NCT00977665|270476|P1|Overall Study|Withdrawal by Subject|1
74755|NCT00977613|270508|P1|Overall Study|Lost to Follow-up|16
74756|NCT00977561|270514|P2|Overall Study|Unspecified|0
74757|NCT00977561|270515|P1|Overall Study|Unspecified|2
74758|NCT00977561|270514|P2|Overall Study|Study terminated|2
74759|NCT00977561|270515|P1|Overall Study|Study terminated|0
74760|NCT00977561|270514|P2|Overall Study|Death|2
74761|NCT00977561|270515|P1|Overall Study|Death|3
74762|NCT00977548|270542|P1|Overall Study|Withdrawal by Subject|1
74763|NCT00977548|270542|P1|Overall Study|Adverse Event|8
74764|NCT00977548|270542|P1|Overall Study|Ineligible|4
74765|NCT00977379|270551|P2|Overall Study|Randomization Error|1
74766|NCT00977379|270552|P1|Overall Study|Randomization Error|0
74767|NCT00977379|270551|P2|Overall Study|Participant Moving House|1
74768|NCT00977379|270552|P1|Overall Study|Participant Moving House|0
74769|NCT00977379|270551|P2|Overall Study|Premature Study Termination|0
74770|NCT00977379|270552|P1|Overall Study|Premature Study Termination|4
74771|NCT00977379|270551|P2|Overall Study|Death|9
74772|NCT00977379|270552|P1|Overall Study|Death|7
74773|NCT00977379|270551|P2|Overall Study|Withdrawal by Subject|1
74774|NCT00977379|270552|P1|Overall Study|Withdrawal by Subject|1
74775|NCT00977314|270588|P2|Overall Study|Physician Decision|0
74776|NCT00977314|270589|P1|Overall Study|Physician Decision|1
74777|NCT00977314|270588|P2|Overall Study|Withdrawal by Subject|0
74778|NCT00977314|270589|P1|Overall Study|Withdrawal by Subject|1
74779|NCT00977197|270597|P2|Overall Study|Nonadherence|1
74780|NCT00977197|270598|P1|Overall Study|Nonadherence|1
74781|NCT00977197|270597|P2|Overall Study|Lost to Follow-up|3
74782|NCT00977197|270598|P1|Overall Study|Lost to Follow-up|1
74783|NCT00977197|270597|P2|Overall Study|Lack of Efficacy|0
74784|NCT00977197|270598|P1|Overall Study|Lack of Efficacy|1
74785|NCT00977197|270597|P2|Overall Study|Adverse Event|1
74786|NCT00977197|270598|P1|Overall Study|Adverse Event|3
74787|NCT00977197|270597|P2|Overall Study|Withdrawal by Subject|4
74788|NCT00977197|270598|P1|Overall Study|Withdrawal by Subject|3
74789|NCT00977106|270661|P2|Overall Study|Not specified|0
74790|NCT00977106|270662|P1|Overall Study|Not specified|1
74791|NCT00977106|270661|P2|Overall Study|Protocol Violation|1
74792|NCT00977106|270662|P1|Overall Study|Protocol Violation|0
74793|NCT00977106|270661|P2|Overall Study|Lack of Efficacy|2
74794|NCT00977106|270662|P1|Overall Study|Lack of Efficacy|2
74795|NCT00977106|270661|P2|Overall Study|Withdrawal by Subject|2
74796|NCT00977106|270662|P1|Overall Study|Withdrawal by Subject|2
74797|NCT00977106|270661|P2|Overall Study|Adverse Event|6
74798|NCT00977106|270662|P1|Overall Study|Adverse Event|5
74799|NCT00977080|270754|P4|Overall Study|Travel for family reasons|0
74800|NCT00977080|270755|P3|Overall Study|Travel for family reasons|0
74801|NCT00977080|270756|P2|Overall Study|Travel for family reasons|0
74802|NCT00977080|270757|P1|Overall Study|Travel for family reasons|1
74803|NCT00977080|270754|P4|Overall Study|Required kidney transplantation|1
74804|NCT00977080|270755|P3|Overall Study|Required kidney transplantation|3
74805|NCT00977080|270756|P2|Overall Study|Required kidney transplantation|3
74806|NCT00977080|270757|P1|Overall Study|Required kidney transplantation|1
74807|NCT00977080|270754|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
74808|NCT00977080|270755|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
74809|NCT00977080|270756|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
74810|NCT00977080|270757|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
74811|NCT00977080|270754|P4|Overall Study|Noncompliance|0
74812|NCT00977080|270755|P3|Overall Study|Noncompliance|1
74813|NCT00977080|270756|P2|Overall Study|Noncompliance|2
74814|NCT00977080|270757|P1|Overall Study|Noncompliance|0
74815|NCT00977080|270754|P4|Overall Study|Protocol Violation|3
74816|NCT00977080|270755|P3|Overall Study|Protocol Violation|4
74817|NCT00977080|270756|P2|Overall Study|Protocol Violation|3
74818|NCT00977080|270757|P1|Overall Study|Protocol Violation|7
74819|NCT00977080|270754|P4|Overall Study|Withdrawal by Subject|5
74820|NCT00977080|270755|P3|Overall Study|Withdrawal by Subject|1
74821|NCT00977080|270756|P2|Overall Study|Withdrawal by Subject|5
74822|NCT00977080|270757|P1|Overall Study|Withdrawal by Subject|1
74823|NCT00977080|270754|P4|Overall Study|Adverse Event|7
74824|NCT00977080|270755|P3|Overall Study|Adverse Event|7
74825|NCT00977080|270756|P2|Overall Study|Adverse Event|7
74826|NCT00977080|270757|P1|Overall Study|Adverse Event|2
74827|NCT00976989|270790|P3|Overall Study|Unspecified|1
74828|NCT00976989|270791|P2|Overall Study|Unspecified|0
74829|NCT00976989|270792|P1|Overall Study|Unspecified|1
74830|NCT00976989|270790|P3|Overall Study|Recurrence of Disease|0
74831|NCT00976989|270791|P2|Overall Study|Recurrence of Disease|1
74832|NCT00976989|270792|P1|Overall Study|Recurrence of Disease|0
74833|NCT00976989|270790|P3|Overall Study|Failure to Return|0
74834|NCT00976989|270791|P2|Overall Study|Failure to Return|1
74835|NCT00976989|270792|P1|Overall Study|Failure to Return|2
74836|NCT00976989|270790|P3|Overall Study|Refused Treatment|5
74837|NCT00976989|270791|P2|Overall Study|Refused Treatment|3
74838|NCT00976989|270792|P1|Overall Study|Refused Treatment|4
74839|NCT00976989|270790|P3|Overall Study|Death|10
74840|NCT00976989|270791|P2|Overall Study|Death|7
74841|NCT00976989|270792|P1|Overall Study|Death|5
74842|NCT00976989|270790|P3|Overall Study|Violation of Selection Criteria at Entry|1
74843|NCT00976989|270791|P2|Overall Study|Violation of Selection Criteria at Entry|0
74844|NCT00976989|270792|P1|Overall Study|Violation of Selection Criteria at Entry|1
74845|NCT00976950|270833|P1|Overall Study|Events with no relationship to Aptivus|3
74846|NCT00976950|270833|P1|Overall Study|Adverse Event|3
74847|NCT00976937|270841|P2|Overall Study|Personal and Familial Reason|2
74848|NCT00976937|270842|P1|Overall Study|Personal and Familial Reason|2
74849|NCT00976937|270841|P2|Overall Study|Poor compliance to protocol|0
74850|NCT00976937|270842|P1|Overall Study|Poor compliance to protocol|3
74851|NCT00976937|270841|P2|Overall Study|Withdrawal by Subject|3
74852|NCT00976937|270842|P1|Overall Study|Withdrawal by Subject|5
74853|NCT00976937|270841|P2|Overall Study|Lost to Follow-up|1
74854|NCT00976937|270842|P1|Overall Study|Lost to Follow-up|2
74855|NCT00976937|270841|P2|Overall Study|Adverse Event|5
74856|NCT00976937|270842|P1|Overall Study|Adverse Event|4
74857|NCT00976911|270884|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
74858|NCT00976911|270885|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
74859|NCT00976911|270884|P2|Overall Study|Not Specified|9
74860|NCT00976911|270885|P1|Overall Study|Not Specified|8
74861|NCT00976911|270884|P2|Overall Study|Protocol Violation|0
74862|NCT00976911|270885|P1|Overall Study|Protocol Violation|2
74863|NCT00976911|270884|P2|Overall Study|Adverse Event|1
74864|NCT00976911|270885|P1|Overall Study|Adverse Event|0
74865|NCT00976911|270884|P2|Overall Study|Death|126
74866|NCT00976911|270885|P1|Overall Study|Death|138
74867|NCT00976911|270884|P2|Overall Study|Withdrawal by Subject|6
74868|NCT00976911|270885|P1|Overall Study|Withdrawal by Subject|4
74869|NCT00976716|270903|P1|Overall Study|Adverse Event|1
74870|NCT00976703|270921|P2|Overall Study|ineligible for study|2
74871|NCT00976703|270922|P1|Overall Study|ineligible for study|2
74872|NCT00976703|270921|P2|Overall Study|Physician Decision|1
74873|NCT00976703|270922|P1|Overall Study|Physician Decision|1
74874|NCT00976677|270936|P2|Overall Study|Unknown/Missing|0
74875|NCT00976677|270937|P1|Overall Study|Unknown/Missing|1
74876|NCT00976677|270936|P2|Overall Study|Trial unblinded|2
74877|NCT00976677|270937|P1|Overall Study|Trial unblinded|2
74878|NCT00976677|270936|P2|Overall Study|Disease progression|1
74879|NCT00976677|270937|P1|Overall Study|Disease progression|1
74880|NCT00976677|270936|P2|Overall Study|Withdrawal by Subject|2
74881|NCT00976677|270937|P1|Overall Study|Withdrawal by Subject|0
74882|NCT00976677|270936|P2|Overall Study|Adverse Event|0
74883|NCT00976677|270937|P1|Overall Study|Adverse Event|1
74884|NCT00976508|271164|P2|Overall Study|Terminated by the Sponsor|1
74885|NCT00976508|271165|P1|Overall Study|Terminated by the Sponsor|0
74886|NCT00976508|271164|P2|Overall Study|Subject Enrolled in Hospice|0
74887|NCT00976508|271165|P1|Overall Study|Subject Enrolled in Hospice|1
74888|NCT00976508|271164|P2|Overall Study|Disease Progression|4
74889|NCT00976508|271165|P1|Overall Study|Disease Progression|4
74890|NCT00976508|271164|P2|Overall Study|Withdrawal by Subject|0
74891|NCT00976508|271165|P1|Overall Study|Withdrawal by Subject|1
74892|NCT00976508|271164|P2|Overall Study|Lost to Follow-up|0
74893|NCT00976508|271165|P1|Overall Study|Lost to Follow-up|1
74894|NCT00976508|271164|P2|Overall Study|Death|1
74895|NCT00976508|271165|P1|Overall Study|Death|7
74896|NCT00976482|271195|P1|Overall Study|Protocol Violation|5
74897|NCT00976482|271195|P1|Overall Study|Center terminated|1
74898|NCT00976482|271195|P1|Overall Study|Withdrawal by Subject|45
74899|NCT00976482|271195|P1|Overall Study|Death|208
74900|NCT00976456|271201|P2|Overall Study|screening failure, unknown|4
74901|NCT00976456|271202|P1|Overall Study|screening failure, unknown|11
74902|NCT00976456|271201|P2|Overall Study|Withdrawal by Subject|1
74903|NCT00976456|271202|P1|Overall Study|Withdrawal by Subject|3
74904|NCT00976456|271201|P2|Overall Study|Lack of Efficacy|2
74905|NCT00976456|271202|P1|Overall Study|Lack of Efficacy|5
74906|NCT00976456|271201|P2|Overall Study|Death|9
74907|NCT00976456|271202|P1|Overall Study|Death|7
74908|NCT00976456|271201|P2|Overall Study|Adverse Event|22
74909|NCT00976456|271202|P1|Overall Study|Adverse Event|17
74910|NCT00976391|271229|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
74911|NCT00976391|271230|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
74912|NCT00976391|271229|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
74913|NCT00976391|271230|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
74914|NCT00976391|271229|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
74915|NCT00976391|271230|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
74916|NCT00976391|271229|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
74917|NCT00976391|271230|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
74918|NCT00976391|271229|P2|Follow-up Period (8 Weeks)|Noncompliance|2
74919|NCT00976391|271230|P1|Follow-up Period (8 Weeks)|Noncompliance|2
74920|NCT00976391|271229|P2|Follow-up Period (8 Weeks)|Adverse Event|1
74921|NCT00976391|271230|P1|Follow-up Period (8 Weeks)|Adverse Event|3
74922|NCT00976391|271229|P2|Treatment Period (52 Weeks)|Pregnancy|0
74923|NCT00976391|271230|P1|Treatment Period (52 Weeks)|Pregnancy|1
74924|NCT00976391|271229|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
74925|NCT00976391|271230|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
74926|NCT00976391|271229|P2|Treatment Period (52 Weeks)|Physician Decision|1
74927|NCT00976391|271230|P1|Treatment Period (52 Weeks)|Physician Decision|1
74928|NCT00976391|271229|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
74929|NCT00976391|271230|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
74930|NCT00976391|271229|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
74931|NCT00976391|271230|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
74932|NCT00976391|271229|P2|Treatment Period (52 Weeks)|Noncompliance|4
74933|NCT00976391|271230|P1|Treatment Period (52 Weeks)|Noncompliance|4
74934|NCT00976391|271229|P2|Treatment Period (52 Weeks)|Protocol Violation|1
74935|NCT00976391|271230|P1|Treatment Period (52 Weeks)|Protocol Violation|1
74936|NCT00976391|271229|P2|Treatment Period (52 Weeks)|Adverse Event|2
74937|NCT00976391|271230|P1|Treatment Period (52 Weeks)|Adverse Event|16
74938|NCT00976274|271256|P2|Overall Study|Physician Decision|2
74939|NCT00976274|271257|P1|Overall Study|Physician Decision|1
74940|NCT00976274|271256|P2|Overall Study|Withdrawal by Subject|1
74941|NCT00976274|271257|P1|Overall Study|Withdrawal by Subject|1
74942|NCT00976274|271256|P2|Overall Study|Lost to Follow-up|5
74943|NCT00976274|271257|P1|Overall Study|Lost to Follow-up|5
74944|NCT00976209|271273|P2|Treatment Period 2|Lost to Follow-up|1
74945|NCT00976209|271274|P1|Treatment Period 2|Lost to Follow-up|0
74946|NCT00976209|271273|P2|Treatment Period 2|Withdrawal by Subject|1
74947|NCT00976209|271274|P1|Treatment Period 2|Withdrawal by Subject|0
74948|NCT00976209|271273|P2|Wash-out Period|Unspecified|0
74949|NCT00976209|271274|P1|Wash-out Period|Unspecified|1
74950|NCT00976209|271273|P2|Wash-out Period|Protocol Violation|0
74951|NCT00976209|271274|P1|Wash-out Period|Protocol Violation|1
74952|NCT00976209|271273|P2|Wash-out Period|Lost to Follow-up|0
74953|NCT00976209|271274|P1|Wash-out Period|Lost to Follow-up|1
74954|NCT00976209|271273|P2|Wash-out Period|Adverse Event|2
74955|NCT00976209|271274|P1|Wash-out Period|Adverse Event|1
74956|NCT00976209|271273|P2|Treatment Period 1|Unspecified|1
74957|NCT00976209|271274|P1|Treatment Period 1|Unspecified|0
74958|NCT00976209|271273|P2|Treatment Period 1|Lost to Follow-up|0
74959|NCT00976209|271274|P1|Treatment Period 1|Lost to Follow-up|2
74960|NCT00976209|271273|P2|Treatment Period 1|Protocol Violation|0
74961|NCT00976209|271274|P1|Treatment Period 1|Protocol Violation|1
74962|NCT00976027|271282|P2|Overall Study|Withdrawal by Subject|66
74963|NCT00976027|271283|P1|Overall Study|Withdrawal by Subject|107
74964|NCT00976027|271282|P2|Overall Study|Lost to Follow-up|103
74965|NCT00976027|271283|P1|Overall Study|Lost to Follow-up|208
74966|NCT00976027|271282|P2|Overall Study|Protocol Violation|27
74967|NCT00976027|271283|P1|Overall Study|Protocol Violation|60
74968|NCT00976027|271282|P2|Overall Study|Adverse Event|2
74969|NCT00976027|271283|P1|Overall Study|Adverse Event|0
74970|NCT00976027|271282|P2|Overall Study|Serious Adverse Event|17
74971|NCT00976027|271283|P1|Overall Study|Serious Adverse Event|36
74972|NCT00975975|271295|P1|Overall Study|Death|6
74973|NCT00975923|271303|P2|Overall Study|Withdrawal by Subject|1
74974|NCT00975923|271304|P1|Overall Study|Withdrawal by Subject|0
74975|NCT00975806|271315|P3|Overall Study|Physician decision and disease related|1
74976|NCT00975806|271316|P2|Overall Study|Physician decision and disease related|0
74977|NCT00975806|271317|P1|Overall Study|Physician decision and disease related|1
74978|NCT00975806|271315|P3|Overall Study|Death|0
74979|NCT00975806|271316|P2|Overall Study|Death|1
74980|NCT00975806|271317|P1|Overall Study|Death|0
74981|NCT00975806|271315|P3|Overall Study|Withdrawal by Subject|0
74982|NCT00975806|271316|P2|Overall Study|Withdrawal by Subject|0
74983|NCT00975806|271317|P1|Overall Study|Withdrawal by Subject|1
74984|NCT00975806|271315|P3|Overall Study|Disease Progression|1
74985|NCT00975806|271316|P2|Overall Study|Disease Progression|5
74986|NCT00975806|271317|P1|Overall Study|Disease Progression|1
74987|NCT00975806|271315|P3|Overall Study|Adverse Event|2
74988|NCT00975806|271316|P2|Overall Study|Adverse Event|1
74989|NCT00975806|271317|P1|Overall Study|Adverse Event|2
74990|NCT00975780|271341|P2|Follow Up|Discharged from Facility|12
74991|NCT00975780|271342|P1|Follow Up|Discharged from Facility|7
74992|NCT00975780|271341|P2|Follow Up|Facility Withdrawal|23
74993|NCT00975780|271342|P1|Follow Up|Facility Withdrawal|7
74994|NCT00975780|271341|P2|Follow Up|Death|122
74995|NCT00975780|271342|P1|Follow Up|Death|88
74996|NCT00975715|271352|P2|Maintenance Period|Adverse Event|1
74997|NCT00975715|271353|P1|Maintenance Period|Adverse Event|2
74998|NCT00975715|271352|P2|Titration Period|Protocol Violation|0
74999|NCT00975715|271353|P1|Titration Period|Protocol Violation|1
75000|NCT00975715|271352|P2|Titration Period|Adverse Event|0
75001|NCT00975715|271353|P1|Titration Period|Adverse Event|6
75002|NCT00975689|271369|P2|Overall Study|Physician Decision|0
75003|NCT00975689|271370|P1|Overall Study|Physician Decision|1
75004|NCT00975689|271369|P2|Overall Study|Withdrawal by Subject|0
75005|NCT00975689|271370|P1|Overall Study|Withdrawal by Subject|1
75006|NCT00975689|271369|P2|Overall Study|Adverse Event|3
75007|NCT00975689|271370|P1|Overall Study|Adverse Event|0
75008|NCT00975611|271402|P1|Overall Study|Physician Decision|1
75009|NCT00975611|271402|P1|Overall Study|Screen Fail|16
75010|NCT00975585|271408|P2|Overall Study|Lens issue|2
75011|NCT00975585|271409|P1|Overall Study|Lens issue|2
75012|NCT00975585|271408|P2|Overall Study|Withdrawal by Subject|1
75013|NCT00975585|271409|P1|Overall Study|Withdrawal by Subject|2
75014|NCT00975585|271408|P2|Overall Study|Lost to Follow-up|5
75015|NCT00975585|271409|P1|Overall Study|Lost to Follow-up|3
75016|NCT00975585|271408|P2|Overall Study|Adverse Event|4
75017|NCT00975585|271409|P1|Overall Study|Adverse Event|0
75018|NCT00975507|271429|P2|Overall Study|Withdrawal by Subject|3
75019|NCT00975507|271430|P1|Overall Study|Withdrawal by Subject|10
75020|NCT00975507|271429|P2|Overall Study|Protocol Violation|0
75021|NCT00975507|271430|P1|Overall Study|Protocol Violation|2
75022|NCT00975507|271429|P2|Overall Study|Lost to Follow-up|1
75023|NCT00975507|271430|P1|Overall Study|Lost to Follow-up|7
75024|NCT00975507|271429|P2|Overall Study|Adverse Event|0
75025|NCT00975507|271430|P1|Overall Study|Adverse Event|1
75026|NCT00975481|271450|P6|Fifth Intervention Period|Withdrawal by Subject|0
75027|NCT00975481|271451|P5|Fifth Intervention Period|Withdrawal by Subject|1
75028|NCT00975481|271452|P4|Fifth Intervention Period|Withdrawal by Subject|0
75029|NCT00975481|271453|P3|Fifth Intervention Period|Withdrawal by Subject|0
75030|NCT00975481|271454|P2|Fifth Intervention Period|Withdrawal by Subject|0
75031|NCT00975481|271455|P1|Fifth Intervention Period|Withdrawal by Subject|0
75032|NCT00975481|271450|P6|Fourth Intervention Period|Withdrawal by Subject|0
75033|NCT00975481|271451|P5|Fourth Intervention Period|Withdrawal by Subject|0
75034|NCT00975481|271452|P4|Fourth Intervention Period|Withdrawal by Subject|1
75035|NCT00975481|271453|P3|Fourth Intervention Period|Withdrawal by Subject|1
75036|NCT00975481|271454|P2|Fourth Intervention Period|Withdrawal by Subject|0
75037|NCT00975481|271455|P1|Fourth Intervention Period|Withdrawal by Subject|0
75038|NCT00975481|271450|P6|Second Intervention Period|Withdrawal by Subject|0
75039|NCT00975481|271451|P5|Second Intervention Period|Withdrawal by Subject|0
75040|NCT00975481|271452|P4|Second Intervention Period|Withdrawal by Subject|0
75041|NCT00975481|271453|P3|Second Intervention Period|Withdrawal by Subject|1
75042|NCT00975481|271454|P2|Second Intervention Period|Withdrawal by Subject|0
75043|NCT00975481|271455|P1|Second Intervention Period|Withdrawal by Subject|0
75044|NCT00975481|271450|P6|Second Intervention Period|Adverse Event|0
75045|NCT00975481|271451|P5|Second Intervention Period|Adverse Event|0
75046|NCT00975481|271452|P4|Second Intervention Period|Adverse Event|0
75047|NCT00975481|271453|P3|Second Intervention Period|Adverse Event|0
75048|NCT00975481|271454|P2|Second Intervention Period|Adverse Event|1
75049|NCT00975481|271455|P1|Second Intervention Period|Adverse Event|2
75050|NCT00975416|271555|P2|Overall Study|early discharge from tx|5
75051|NCT00975416|271556|P1|Overall Study|early discharge from tx|3
75052|NCT00975286|271565|P2|Overall Study|Sponsor Decision|2
75053|NCT00975286|271566|P1|Overall Study|Sponsor Decision|0
75054|NCT00975286|271565|P2|Overall Study|Poor Compliance to Protocol|2
75055|NCT00975286|271566|P1|Overall Study|Poor Compliance to Protocol|0
75056|NCT00975286|271565|P2|Overall Study|Familial and Personal Reasons|2
75057|NCT00975286|271566|P1|Overall Study|Familial and Personal Reasons|2
75058|NCT00975286|271565|P2|Overall Study|Withdrawal by Subject|2
75059|NCT00975286|271566|P1|Overall Study|Withdrawal by Subject|0
75060|NCT00975286|271565|P2|Overall Study|Protocol Violation|2
75061|NCT00975286|271566|P1|Overall Study|Protocol Violation|1
75062|NCT00975286|271565|P2|Overall Study|Adverse Event|19
75063|NCT00975286|271566|P1|Overall Study|Adverse Event|9
75064|NCT00975221|271598|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
75065|NCT00975221|271599|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
75066|NCT00975221|271598|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
75067|NCT00975221|271599|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
75068|NCT00975221|271598|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
75069|NCT00975221|271599|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
75070|NCT00975221|271598|P2|Titration Phase (Weeks 1-12)|Other|1
75071|NCT00975221|271599|P1|Titration Phase (Weeks 1-12)|Other|0
75072|NCT00975221|271598|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
75073|NCT00975221|271599|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
75074|NCT00975221|271598|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
75075|NCT00975221|271599|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
75076|NCT00975195|271615|P2|Overall Study|Not treated|2
75077|NCT00975195|271616|P1|Overall Study|Not treated|1
75078|NCT00975195|271615|P2|Overall Study|Other reason not defined above|33
75079|NCT00975195|271616|P1|Overall Study|Other reason not defined above|29
75080|NCT00975195|271615|P2|Overall Study|Withdrawal by Subject|61
75081|NCT00975195|271616|P1|Overall Study|Withdrawal by Subject|48
75082|NCT00975195|271615|P2|Overall Study|Lost to Follow-up|7
75083|NCT00975195|271616|P1|Overall Study|Lost to Follow-up|9
75084|NCT00975195|271615|P2|Overall Study|Protocol Violation|23
75085|NCT00975195|271616|P1|Overall Study|Protocol Violation|27
75086|NCT00975195|271615|P2|Overall Study|Lack of Efficacy|6
75087|NCT00975195|271616|P1|Overall Study|Lack of Efficacy|6
75088|NCT00975195|271615|P2|Overall Study|Adverse Event|101
75089|NCT00975195|271616|P1|Overall Study|Adverse Event|108
75090|NCT00975156|271676|P2|Overall Study|Protocol Violation|1
75091|NCT00975156|271677|P1|Overall Study|Protocol Violation|0
75092|NCT00975143|271689|P2|Overall Study|Details not available|4
75093|NCT00975143|271690|P1|Overall Study|Details not available|10
75094|NCT00975143|271689|P2|Overall Study|Physician Decision|2
75095|NCT00975143|271690|P1|Overall Study|Physician Decision|1
75096|NCT00975143|271689|P2|Overall Study|Non-compliance|8
75097|NCT00975143|271690|P1|Overall Study|Non-compliance|5
75098|NCT00975143|271689|P2|Overall Study|Lost to Follow-up|16
75099|NCT00975143|271690|P1|Overall Study|Lost to Follow-up|20
75100|NCT00975143|271689|P2|Overall Study|Withdrawal by Subject|15
75101|NCT00975143|271690|P1|Overall Study|Withdrawal by Subject|15
75102|NCT00975143|271689|P2|Overall Study|Adverse Event|15
75103|NCT00975143|271690|P1|Overall Study|Adverse Event|19
75104|NCT00975130|271700|P3|Study Part 2|Protocol Violation|1
75105|NCT00975130|271701|P2|Study Part 2|Protocol Violation|0
75106|NCT00975130|271702|P1|Study Part 2|Protocol Violation|0
75107|NCT00975130|271700|P3|Study Part 2|Administrative|0
75108|NCT00975130|271701|P2|Study Part 2|Administrative|1
75109|NCT00975130|271702|P1|Study Part 2|Administrative|0
75110|NCT00975130|271700|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
75111|NCT00975130|271701|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
75112|NCT00975130|271702|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
75113|NCT00975130|271700|P3|Study Part 2|Withdrew Consent|2
75114|NCT00975130|271701|P2|Study Part 2|Withdrew Consent|6
75115|NCT00975130|271702|P1|Study Part 2|Withdrew Consent|0
75116|NCT00975130|271700|P3|Study Part 2|Withdrawal by Subject|5
75117|NCT00975130|271701|P2|Study Part 2|Withdrawal by Subject|13
75118|NCT00975130|271702|P1|Study Part 2|Withdrawal by Subject|0
75119|NCT00975130|271700|P3|Study Part 2|Lost to Follow-up|1
75120|NCT00975130|271701|P2|Study Part 2|Lost to Follow-up|0
75121|NCT00975130|271702|P1|Study Part 2|Lost to Follow-up|0
75122|NCT00975130|271700|P3|Study Part 2|Adverse Event|7
75123|NCT00975130|271701|P2|Study Part 2|Adverse Event|14
75124|NCT00975130|271702|P1|Study Part 2|Adverse Event|0
75125|NCT00975130|271700|P3|Study Part 1|Withdrew Consent|0
75126|NCT00975130|271701|P2|Study Part 1|Withdrew Consent|0
75127|NCT00975130|271702|P1|Study Part 1|Withdrew Consent|24
75128|NCT00975130|271700|P3|Study Part 1|Administrative|0
75129|NCT00975130|271701|P2|Study Part 1|Administrative|0
75130|NCT00975130|271702|P1|Study Part 1|Administrative|4
75131|NCT00975130|271700|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
75132|NCT00975130|271701|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
75133|NCT00975130|271702|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
75134|NCT00975130|271700|P3|Study Part 1|Protocol Violation|0
75135|NCT00975130|271701|P2|Study Part 1|Protocol Violation|0
75136|NCT00975130|271702|P1|Study Part 1|Protocol Violation|13
75137|NCT00975130|271700|P3|Study Part 1|Withdrawal by Subject|0
75138|NCT00975130|271701|P2|Study Part 1|Withdrawal by Subject|0
75139|NCT00975130|271702|P1|Study Part 1|Withdrawal by Subject|61
75140|NCT00975130|271700|P3|Study Part 1|Lost to Follow-up|0
75141|NCT00975130|271701|P2|Study Part 1|Lost to Follow-up|0
75142|NCT00975130|271702|P1|Study Part 1|Lost to Follow-up|19
75143|NCT00975130|271700|P3|Study Part 1|Adverse Event|0
75144|NCT00975130|271701|P2|Study Part 1|Adverse Event|0
75145|NCT00975130|271702|P1|Study Part 1|Adverse Event|150
75146|NCT00975000|271886|P2|Overall Study|Non-compliance|1
75147|NCT00975000|271887|P1|Overall Study|Non-compliance|0
75148|NCT00975000|271886|P2|Overall Study|Protocol-specified Criteria|0
75149|NCT00975000|271887|P1|Overall Study|Protocol-specified Criteria|1
75150|NCT00975000|271886|P2|Overall Study|Lost to Follow-up|1
75151|NCT00975000|271887|P1|Overall Study|Lost to Follow-up|0
75152|NCT00975000|271886|P2|Overall Study|Withdrawal by Subject|2
75153|NCT00975000|271887|P1|Overall Study|Withdrawal by Subject|2
75154|NCT00975000|271886|P2|Overall Study|Adverse Event|1
75155|NCT00975000|271887|P1|Overall Study|Adverse Event|1
75156|NCT00975000|271886|P2|Overall Study|Other|0
75157|NCT00975000|271887|P1|Overall Study|Other|1
75158|NCT00974974|271911|P2|Maintenance - Double Blind Treatment|Various|0
75159|NCT00974974|271912|P1|Maintenance - Double Blind Treatment|Various|4
75160|NCT00974974|271911|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
75161|NCT00974974|271912|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
75162|NCT00974974|271911|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
75163|NCT00974974|271912|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
75164|NCT00974974|271911|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
75165|NCT00974974|271912|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
75166|NCT00974974|271911|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
75167|NCT00974974|271912|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
75168|NCT00974974|271911|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
75169|NCT00974974|271912|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
75170|NCT00974974|271911|P2|Maintenance - Double Blind Treatment|Adverse Event|3
75171|NCT00974974|271912|P1|Maintenance - Double Blind Treatment|Adverse Event|3
75172|NCT00974974|271911|P2|IPX066 Dose Conversion|Protocol Violation|0
75173|NCT00974974|271912|P1|IPX066 Dose Conversion|Protocol Violation|4
75174|NCT00974974|271911|P2|IPX066 Dose Conversion|Various|0
75175|NCT00974974|271912|P1|IPX066 Dose Conversion|Various|3
75176|NCT00974974|271911|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
75177|NCT00974974|271912|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
75178|NCT00974974|271911|P2|IPX066 Dose Conversion|Lack of Efficacy|0
75179|NCT00974974|271912|P1|IPX066 Dose Conversion|Lack of Efficacy|13
75180|NCT00974974|271911|P2|IPX066 Dose Conversion|Death|0
75181|NCT00974974|271912|P1|IPX066 Dose Conversion|Death|2
75182|NCT00974974|271911|P2|IPX066 Dose Conversion|Adverse Event|0
75183|NCT00974974|271912|P1|IPX066 Dose Conversion|Adverse Event|23
75184|NCT00974974|271911|P2|IR CD-LD Dose Adjustment|Various|9
75185|NCT00974974|271912|P1|IR CD-LD Dose Adjustment|Various|0
75186|NCT00974974|271911|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
75187|NCT00974974|271912|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
75188|NCT00974974|271911|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
75189|NCT00974974|271912|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
75190|NCT00974974|271911|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
75191|NCT00974974|271912|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
75192|NCT00974974|271911|P2|IR CD-LD Dose Adjustment|Adverse Event|3
75193|NCT00974974|271912|P1|IR CD-LD Dose Adjustment|Adverse Event|0
75194|NCT00974571|271934|P3|Overall Study|Unspecified|10
75195|NCT00974571|271935|P2|Overall Study|Unspecified|0
75196|NCT00974571|271936|P1|Overall Study|Unspecified|4
75197|NCT00974571|271934|P3|Overall Study|Patient Moved|1
75198|NCT00974571|271935|P2|Overall Study|Patient Moved|0
75199|NCT00974571|271936|P1|Overall Study|Patient Moved|1
75200|NCT00974571|271934|P3|Overall Study|Withdrawal by Subject|16
75201|NCT00974571|271935|P2|Overall Study|Withdrawal by Subject|5
75202|NCT00974571|271936|P1|Overall Study|Withdrawal by Subject|14
75203|NCT00974571|271934|P3|Overall Study|Protocol Violation|18
75204|NCT00974571|271935|P2|Overall Study|Protocol Violation|4
75205|NCT00974571|271936|P1|Overall Study|Protocol Violation|13
75206|NCT00974571|271934|P3|Overall Study|Lost to Follow-up|2
75207|NCT00974571|271935|P2|Overall Study|Lost to Follow-up|1
75208|NCT00974571|271936|P1|Overall Study|Lost to Follow-up|2
75209|NCT00974571|271934|P3|Overall Study|Lack of Efficacy|9
75210|NCT00974571|271935|P2|Overall Study|Lack of Efficacy|2
75211|NCT00974571|271936|P1|Overall Study|Lack of Efficacy|3
75212|NCT00974571|271934|P3|Overall Study|Adverse Event|27
75213|NCT00974571|271935|P2|Overall Study|Adverse Event|4
75214|NCT00974571|271936|P1|Overall Study|Adverse Event|31
75215|NCT00974311|272001|P2|Overall Study|Continuing Treatment|19
75216|NCT00974311|272002|P1|Overall Study|Continuing Treatment|231
75217|NCT00974311|272001|P2|Overall Study|Withdrawal of consent|5
75218|NCT00974311|272002|P1|Overall Study|Withdrawal of consent|9
75219|NCT00974311|272001|P2|Overall Study|Death|211
75220|NCT00974311|272002|P1|Overall Study|Death|305
75221|NCT00974311|272001|P2|Overall Study|Lost to Follow-up|1
75222|NCT00974311|272002|P1|Overall Study|Lost to Follow-up|1
75223|NCT00974220|272030|P2|Treatment Period 1|noncompliant subjects|1
75224|NCT00974220|272031|P1|Treatment Period 1|noncompliant subjects|0
75225|NCT00974220|272030|P2|Treatment Period 1|Adverse Event|1
75226|NCT00974220|272031|P1|Treatment Period 1|Adverse Event|2
75227|NCT00974090|272041|P2|Period 2: Open-label Period|Withdrawal by Subject|0
75228|NCT00974090|272042|P1|Period 2: Open-label Period|Withdrawal by Subject|1
75229|NCT00974090|272041|P2|Period 2: Open-label Period|Physician Decision|3
75230|NCT00974090|272042|P1|Period 2: Open-label Period|Physician Decision|0
75231|NCT00974090|272041|P2|Period 2: Open-label Period|Lack of Efficacy|1
75232|NCT00974090|272042|P1|Period 2: Open-label Period|Lack of Efficacy|3
75233|NCT00974090|272041|P2|Period 2: Open-label Period|Adverse Event|6
75234|NCT00974090|272042|P1|Period 2: Open-label Period|Adverse Event|4
75235|NCT00974090|272041|P2|Period 1: Double Blind Period|Physician Decision|0
75236|NCT00974090|272042|P1|Period 1: Double Blind Period|Physician Decision|1
75237|NCT00974090|272041|P2|Period 1: Double Blind Period|Adverse Event|1
75238|NCT00974090|272042|P1|Period 1: Double Blind Period|Adverse Event|2
75239|NCT00973921|272076|P1|Overall Study|IVUS results were not available|9
75240|NCT00973765|272085|P2|Overall Study|Lost to Follow-up|14
75241|NCT00973765|272086|P1|Overall Study|Lost to Follow-up|8
75242|NCT00973700|272104|P5|Overall Study|Unable to Classify|1
75243|NCT00973700|272105|P4|Overall Study|Unable to Classify|2
75244|NCT00973700|272106|P3|Overall Study|Unable to Classify|1
75245|NCT00973700|272107|P2|Overall Study|Unable to Classify|0
75246|NCT00973700|272108|P1|Overall Study|Unable to Classify|0
75247|NCT00973700|272104|P5|Overall Study|Inappropriate enrolment|0
75248|NCT00973700|272105|P4|Overall Study|Inappropriate enrolment|4
75249|NCT00973700|272106|P3|Overall Study|Inappropriate enrolment|0
75250|NCT00973700|272107|P2|Overall Study|Inappropriate enrolment|0
75251|NCT00973700|272108|P1|Overall Study|Inappropriate enrolment|0
75252|NCT00973700|272104|P5|Overall Study|Lost to Follow-up|5
75253|NCT00973700|272105|P4|Overall Study|Lost to Follow-up|8
75254|NCT00973700|272106|P3|Overall Study|Lost to Follow-up|1
75255|NCT00973700|272107|P2|Overall Study|Lost to Follow-up|0
75256|NCT00973700|272108|P1|Overall Study|Lost to Follow-up|5
75257|NCT00973700|272104|P5|Overall Study|Withdrawal by Subject|4
75258|NCT00973700|272105|P4|Overall Study|Withdrawal by Subject|4
75259|NCT00973700|272106|P3|Overall Study|Withdrawal by Subject|8
75260|NCT00973700|272107|P2|Overall Study|Withdrawal by Subject|2
75261|NCT00973700|272108|P1|Overall Study|Withdrawal by Subject|2
75262|NCT00973622|272157|P2|Overall Study|did not complete rTMS sessions|2
75263|NCT00973622|272158|P1|Overall Study|did not complete rTMS sessions|11
75264|NCT00973622|272157|P2|Overall Study|did not pass MRI screen|0
75265|NCT00973622|272158|P1|Overall Study|did not pass MRI screen|6
75266|NCT00973622|272157|P2|Overall Study|did not attend MRI|3
75267|NCT00973622|272158|P1|Overall Study|did not attend MRI|14
75268|NCT00973479|272166|P2|Overall Study|Not Specified|7
75269|NCT00973479|272167|P1|Overall Study|Not Specified|1
75270|NCT00973479|272166|P2|Overall Study|Protocol Violation|2
75271|NCT00973479|272167|P1|Overall Study|Protocol Violation|2
75272|NCT00973479|272166|P2|Overall Study|Adverse Event|32
75273|NCT00973479|272167|P1|Overall Study|Adverse Event|12
75274|NCT00973479|272166|P2|Overall Study|Lack of Efficacy|7
75275|NCT00973479|272167|P1|Overall Study|Lack of Efficacy|5
75276|NCT00973479|272166|P2|Overall Study|Withdrawal by Subject|16
75277|NCT00973479|272167|P1|Overall Study|Withdrawal by Subject|15
75278|NCT00973479|272166|P2|Overall Study|Death|2
75279|NCT00973479|272167|P1|Overall Study|Death|2
75280|NCT00973479|272166|P2|Overall Study|Lost to Follow-up|3
75281|NCT00973479|272167|P1|Overall Study|Lost to Follow-up|0
75282|NCT00973362|272185|P2|3-Year Follow-up|Lost to Follow-up|0
75283|NCT00973362|272186|P1|3-Year Follow-up|Lost to Follow-up|17
75284|NCT00973362|272185|P2|Baseline Evaluation|Inevaluable|223
75285|NCT00973362|272186|P1|Baseline Evaluation|Inevaluable|686
75286|NCT00973362|272185|P2|Baseline Evaluation|No colposcopy visit|0
75287|NCT00973362|272186|P1|Baseline Evaluation|No colposcopy visit|62
75288|NCT00973362|272185|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
75289|NCT00973362|272186|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
75290|NCT00973349|272211|P16|Overall Study|Unable to classify|0
75291|NCT00973349|272212|P15|Overall Study|Unable to classify|0
75292|NCT00973349|272213|P14|Overall Study|Unable to classify|0
75293|NCT00973349|272214|P13|Overall Study|Unable to classify|0
75294|NCT00973349|272215|P12|Overall Study|Unable to classify|0
75295|NCT00973349|272216|P11|Overall Study|Unable to classify|0
75296|NCT00973349|272217|P10|Overall Study|Unable to classify|1
75297|NCT00973349|272218|P9|Overall Study|Unable to classify|0
75298|NCT00973349|272219|P8|Overall Study|Unable to classify|0
75299|NCT00973349|272220|P7|Overall Study|Unable to classify|0
75300|NCT00973349|272221|P6|Overall Study|Unable to classify|1
75301|NCT00973349|272222|P5|Overall Study|Unable to classify|1
75302|NCT00973349|272223|P4|Overall Study|Unable to classify|0
75303|NCT00973349|272224|P3|Overall Study|Unable to classify|0
75304|NCT00973349|272225|P2|Overall Study|Unable to classify|0
75305|NCT00973349|272226|P1|Overall Study|Unable to classify|0
75306|NCT00973349|272211|P16|Overall Study|Protocol Violation|0
75307|NCT00973349|272212|P15|Overall Study|Protocol Violation|0
75308|NCT00973349|272213|P14|Overall Study|Protocol Violation|0
75309|NCT00973349|272214|P13|Overall Study|Protocol Violation|0
75310|NCT00973349|272215|P12|Overall Study|Protocol Violation|0
75311|NCT00973349|272216|P11|Overall Study|Protocol Violation|0
75312|NCT00973349|272217|P10|Overall Study|Protocol Violation|0
75313|NCT00973349|272218|P9|Overall Study|Protocol Violation|1
75314|NCT00973349|272219|P8|Overall Study|Protocol Violation|0
75315|NCT00973349|272220|P7|Overall Study|Protocol Violation|0
75316|NCT00973349|272221|P6|Overall Study|Protocol Violation|0
75317|NCT00973349|272222|P5|Overall Study|Protocol Violation|0
75318|NCT00973349|272223|P4|Overall Study|Protocol Violation|0
75319|NCT00973349|272224|P3|Overall Study|Protocol Violation|0
75320|NCT00973349|272225|P2|Overall Study|Protocol Violation|0
75321|NCT00973349|272226|P1|Overall Study|Protocol Violation|0
75322|NCT00973349|272211|P16|Overall Study|Inappropriate enrolment|1
75323|NCT00973349|272212|P15|Overall Study|Inappropriate enrolment|1
75324|NCT00973349|272213|P14|Overall Study|Inappropriate enrolment|0
75325|NCT00973349|272214|P13|Overall Study|Inappropriate enrolment|1
75326|NCT00973349|272215|P12|Overall Study|Inappropriate enrolment|0
75327|NCT00973349|272216|P11|Overall Study|Inappropriate enrolment|0
75328|NCT00973349|272217|P10|Overall Study|Inappropriate enrolment|2
75329|NCT00973349|272218|P9|Overall Study|Inappropriate enrolment|0
75330|NCT00973349|272219|P8|Overall Study|Inappropriate enrolment|0
75331|NCT00973349|272220|P7|Overall Study|Inappropriate enrolment|0
75332|NCT00973349|272221|P6|Overall Study|Inappropriate enrolment|0
75333|NCT00973349|272222|P5|Overall Study|Inappropriate enrolment|0
75334|NCT00973349|272223|P4|Overall Study|Inappropriate enrolment|0
75335|NCT00973349|272224|P3|Overall Study|Inappropriate enrolment|1
75336|NCT00973349|272225|P2|Overall Study|Inappropriate enrolment|0
75337|NCT00973349|272226|P1|Overall Study|Inappropriate enrolment|0
75338|NCT00973349|272211|P16|Overall Study|Lost to Follow-up|1
75339|NCT00973349|272212|P15|Overall Study|Lost to Follow-up|0
75340|NCT00973349|272213|P14|Overall Study|Lost to Follow-up|0
75341|NCT00973349|272214|P13|Overall Study|Lost to Follow-up|0
75342|NCT00973349|272215|P12|Overall Study|Lost to Follow-up|1
75343|NCT00973349|272216|P11|Overall Study|Lost to Follow-up|0
75344|NCT00973349|272217|P10|Overall Study|Lost to Follow-up|1
75345|NCT00973349|272218|P9|Overall Study|Lost to Follow-up|2
75346|NCT00973349|272219|P8|Overall Study|Lost to Follow-up|1
75347|NCT00973349|272220|P7|Overall Study|Lost to Follow-up|0
75348|NCT00973349|272221|P6|Overall Study|Lost to Follow-up|3
75349|NCT00973349|272222|P5|Overall Study|Lost to Follow-up|1
75350|NCT00973349|272223|P4|Overall Study|Lost to Follow-up|2
75351|NCT00973349|272224|P3|Overall Study|Lost to Follow-up|2
75352|NCT00973349|272225|P2|Overall Study|Lost to Follow-up|1
75353|NCT00973349|272226|P1|Overall Study|Lost to Follow-up|3
75354|NCT00973349|272211|P16|Overall Study|Withdrawal by Subject|0
75355|NCT00973349|272212|P15|Overall Study|Withdrawal by Subject|0
75356|NCT00973349|272213|P14|Overall Study|Withdrawal by Subject|0
75357|NCT00973349|272214|P13|Overall Study|Withdrawal by Subject|0
75358|NCT00973349|272215|P12|Overall Study|Withdrawal by Subject|1
75359|NCT00973349|272216|P11|Overall Study|Withdrawal by Subject|0
75360|NCT00973349|272217|P10|Overall Study|Withdrawal by Subject|2
75361|NCT00973349|272218|P9|Overall Study|Withdrawal by Subject|0
75362|NCT00973349|272219|P8|Overall Study|Withdrawal by Subject|2
75363|NCT00973349|272220|P7|Overall Study|Withdrawal by Subject|2
75364|NCT00973349|272221|P6|Overall Study|Withdrawal by Subject|0
75365|NCT00973349|272222|P5|Overall Study|Withdrawal by Subject|2
75366|NCT00973349|272223|P4|Overall Study|Withdrawal by Subject|3
75367|NCT00973349|272224|P3|Overall Study|Withdrawal by Subject|2
75368|NCT00973349|272225|P2|Overall Study|Withdrawal by Subject|2
75369|NCT00973349|272226|P1|Overall Study|Withdrawal by Subject|1
75370|NCT00973349|272211|P16|Overall Study|Adverse Event|0
75371|NCT00973349|272212|P15|Overall Study|Adverse Event|1
75372|NCT00973349|272213|P14|Overall Study|Adverse Event|0
75373|NCT00973349|272214|P13|Overall Study|Adverse Event|0
75374|NCT00973349|272215|P12|Overall Study|Adverse Event|0
75375|NCT00973349|272216|P11|Overall Study|Adverse Event|0
75376|NCT00973349|272217|P10|Overall Study|Adverse Event|0
75377|NCT00973349|272218|P9|Overall Study|Adverse Event|1
75378|NCT00973349|272219|P8|Overall Study|Adverse Event|0
75379|NCT00973349|272220|P7|Overall Study|Adverse Event|0
75380|NCT00973349|272221|P6|Overall Study|Adverse Event|0
75381|NCT00973349|272222|P5|Overall Study|Adverse Event|1
75382|NCT00973349|272223|P4|Overall Study|Adverse Event|0
75383|NCT00973349|272224|P3|Overall Study|Adverse Event|0
75384|NCT00973349|272225|P2|Overall Study|Adverse Event|0
75385|NCT00973349|272226|P1|Overall Study|Adverse Event|0
75386|NCT00972816|272347|P8|Overall Study|Unable to classify|0
75387|NCT00972816|272348|P7|Overall Study|Unable to classify|0
75388|NCT00972816|272349|P6|Overall Study|Unable to classify|0
75389|NCT00972816|272350|P5|Overall Study|Unable to classify|1
75390|NCT00972816|272351|P4|Overall Study|Unable to classify|0
75391|NCT00972816|272352|P3|Overall Study|Unable to classify|0
75392|NCT00972816|272353|P2|Overall Study|Unable to classify|0
75393|NCT00972816|272354|P1|Overall Study|Unable to classify|2
75394|NCT00972816|272347|P8|Overall Study|Inappropriate enrolment|0
75395|NCT00972816|272348|P7|Overall Study|Inappropriate enrolment|2
75396|NCT00972816|272349|P6|Overall Study|Inappropriate enrolment|0
75397|NCT00972816|272350|P5|Overall Study|Inappropriate enrolment|0
75398|NCT00972816|272351|P4|Overall Study|Inappropriate enrolment|0
75399|NCT00972816|272352|P3|Overall Study|Inappropriate enrolment|0
75400|NCT00972816|272353|P2|Overall Study|Inappropriate enrolment|0
75401|NCT00972816|272354|P1|Overall Study|Inappropriate enrolment|0
75402|NCT00972816|272347|P8|Overall Study|Lost to Follow-up|7
75403|NCT00972816|272348|P7|Overall Study|Lost to Follow-up|7
75404|NCT00972816|272349|P6|Overall Study|Lost to Follow-up|10
75405|NCT00972816|272350|P5|Overall Study|Lost to Follow-up|11
75406|NCT00972816|272351|P4|Overall Study|Lost to Follow-up|5
75407|NCT00972816|272352|P3|Overall Study|Lost to Follow-up|7
75408|NCT00972816|272353|P2|Overall Study|Lost to Follow-up|9
75409|NCT00972816|272354|P1|Overall Study|Lost to Follow-up|11
75410|NCT00972816|272347|P8|Overall Study|Withdrawal by Subject|2
75411|NCT00972816|272348|P7|Overall Study|Withdrawal by Subject|1
75412|NCT00972816|272349|P6|Overall Study|Withdrawal by Subject|1
75413|NCT00972816|272350|P5|Overall Study|Withdrawal by Subject|0
75414|NCT00972816|272351|P4|Overall Study|Withdrawal by Subject|3
75415|NCT00972816|272352|P3|Overall Study|Withdrawal by Subject|1
75416|NCT00972816|272353|P2|Overall Study|Withdrawal by Subject|2
75417|NCT00972816|272354|P1|Overall Study|Withdrawal by Subject|4
75418|NCT00972816|272347|P8|Overall Study|Adverse Event|0
75419|NCT00972816|272348|P7|Overall Study|Adverse Event|0
75420|NCT00972816|272349|P6|Overall Study|Adverse Event|0
75421|NCT00972816|272350|P5|Overall Study|Adverse Event|0
75422|NCT00972816|272351|P4|Overall Study|Adverse Event|0
75423|NCT00972816|272352|P3|Overall Study|Adverse Event|1
75424|NCT00972816|272353|P2|Overall Study|Adverse Event|0
75425|NCT00972816|272354|P1|Overall Study|Adverse Event|0
75426|NCT00972777|272438|P2|Overall Study|Missed visit|0
75427|NCT00972777|272439|P1|Overall Study|Missed visit|1
75428|NCT00972777|272438|P2|Overall Study|Screening Failure|1
75429|NCT00972777|272439|P1|Overall Study|Screening Failure|2
75430|NCT00972777|272438|P2|Overall Study|Protocol Violation|2
75431|NCT00972777|272439|P1|Overall Study|Protocol Violation|0
75432|NCT00972777|272438|P2|Overall Study|Physician Decision|0
75433|NCT00972777|272439|P1|Overall Study|Physician Decision|4
75434|NCT00972777|272438|P2|Overall Study|Withdrawal by Subject|5
75435|NCT00972777|272439|P1|Overall Study|Withdrawal by Subject|4
75436|NCT00972777|272438|P2|Overall Study|Lost to Follow-up|4
75437|NCT00972777|272439|P1|Overall Study|Lost to Follow-up|0
75438|NCT00972777|272438|P2|Overall Study|Adverse Event|2
75439|NCT00972777|272439|P1|Overall Study|Adverse Event|3
75440|NCT00972738|272454|P3|Overall Study|Unspecified|1
75441|NCT00972738|272455|P2|Overall Study|Unspecified|2
75442|NCT00972738|272456|P1|Overall Study|Unspecified|1
75443|NCT00972738|272454|P3|Overall Study|Moved|1
75444|NCT00972738|272455|P2|Overall Study|Moved|0
75445|NCT00972738|272456|P1|Overall Study|Moved|0
75446|NCT00972738|272454|P3|Overall Study|Withdrawal by Subject|4
75447|NCT00972738|272455|P2|Overall Study|Withdrawal by Subject|1
75448|NCT00972738|272456|P1|Overall Study|Withdrawal by Subject|5
75449|NCT00972738|272454|P3|Overall Study|Lack of Efficacy|11
75450|NCT00972738|272455|P2|Overall Study|Lack of Efficacy|1
75451|NCT00972738|272456|P1|Overall Study|Lack of Efficacy|5
75452|NCT00972738|272454|P3|Overall Study|Lost to Follow-up|1
75453|NCT00972738|272455|P2|Overall Study|Lost to Follow-up|0
75454|NCT00972738|272456|P1|Overall Study|Lost to Follow-up|1
75455|NCT00972738|272454|P3|Overall Study|Protocol Violation|3
75456|NCT00972738|272455|P2|Overall Study|Protocol Violation|1
75457|NCT00972738|272456|P1|Overall Study|Protocol Violation|2
75458|NCT00972738|272454|P3|Overall Study|Adverse Event|8
75459|NCT00972738|272455|P2|Overall Study|Adverse Event|1
75460|NCT00972738|272456|P1|Overall Study|Adverse Event|7
75461|NCT00972595|272490|P2|Period 1|Adverse Event|0
75462|NCT00972595|272491|P1|Period 1|Adverse Event|1
75463|NCT00972543|272501|P2|Overall Study|Early study termination by sponsor|1
75464|NCT00972543|272502|P1|Overall Study|Early study termination by sponsor|4
75465|NCT00972543|272501|P2|Overall Study|Adverse Event|0
75466|NCT00972543|272502|P1|Overall Study|Adverse Event|1
75467|NCT00972478|272587|P2|Overall Study|Not start protocol treatment|2
75468|NCT00972478|272588|P1|Overall Study|Not start protocol treatment|1
75469|NCT00972478|272587|P2|Overall Study|Ineligible|7
75470|NCT00972478|272588|P1|Overall Study|Ineligible|1
75471|NCT00972478|272587|P2|Overall Study|Not protocol specified|1
75472|NCT00972478|272588|P1|Overall Study|Not protocol specified|1
75473|NCT00972478|272587|P2|Overall Study|Death|2
75474|NCT00972478|272588|P1|Overall Study|Death|0
75475|NCT00972478|272587|P2|Overall Study|Progression/Relapse|2
75476|NCT00972478|272588|P1|Overall Study|Progression/Relapse|0
75477|NCT00972478|272587|P2|Overall Study|Withdrawal by Subject|8
75478|NCT00972478|272588|P1|Overall Study|Withdrawal by Subject|1
75479|NCT00972478|272587|P2|Overall Study|Adverse Event|16
75480|NCT00972478|272588|P1|Overall Study|Adverse Event|3
75481|NCT00972322|272624|P2|Overall Study|Consistently high glucose values|0
75482|NCT00972322|272625|P1|Overall Study|Consistently high glucose values|1
75483|NCT00972322|272624|P2|Overall Study|Lost to Follow-up|1
75484|NCT00972322|272625|P1|Overall Study|Lost to Follow-up|0
75485|NCT00972322|272624|P2|Overall Study|Positive drug screen|1
75486|NCT00972322|272625|P1|Overall Study|Positive drug screen|0
75487|NCT00972322|272624|P2|Overall Study|Adverse Event|1
75488|NCT00972322|272625|P1|Overall Study|Adverse Event|2
75489|NCT00972283|272637|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
75490|NCT00972283|272638|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
75491|NCT00972283|272637|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
75492|NCT00972283|272638|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
75493|NCT00972283|272637|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
75494|NCT00972283|272638|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
75495|NCT00972283|272637|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
75496|NCT00972283|272638|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
75497|NCT00972283|272637|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
75498|NCT00972283|272638|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
75499|NCT00972283|272637|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
75500|NCT00972283|272638|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
75501|NCT00972283|272637|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
75502|NCT00972283|272638|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
75503|NCT00972283|272637|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
75504|NCT00972283|272638|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
75505|NCT00972283|272637|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
75506|NCT00972283|272638|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
75507|NCT00972283|272637|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
75508|NCT00972283|272638|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
75509|NCT00972244|272665|P5|Overall Study|Various|2
75510|NCT00972244|272666|P4|Overall Study|Various|0
75511|NCT00972244|272667|P3|Overall Study|Various|0
75512|NCT00972244|272668|P2|Overall Study|Various|0
75513|NCT00972244|272669|P1|Overall Study|Various|0
75514|NCT00972244|272665|P5|Overall Study|Death|0
75515|NCT00972244|272666|P4|Overall Study|Death|0
75516|NCT00972244|272667|P3|Overall Study|Death|0
75517|NCT00972244|272668|P2|Overall Study|Death|0
75518|NCT00972244|272669|P1|Overall Study|Death|1
75519|NCT00972244|272665|P5|Overall Study|Safety|1
75520|NCT00972244|272666|P4|Overall Study|Safety|0
75521|NCT00972244|272667|P3|Overall Study|Safety|0
75522|NCT00972244|272668|P2|Overall Study|Safety|0
75523|NCT00972244|272669|P1|Overall Study|Safety|0
75524|NCT00972244|272665|P5|Overall Study|Withdrawal by Subject|1
75525|NCT00972244|272666|P4|Overall Study|Withdrawal by Subject|0
75526|NCT00972244|272667|P3|Overall Study|Withdrawal by Subject|1
75527|NCT00972244|272668|P2|Overall Study|Withdrawal by Subject|2
75528|NCT00972244|272669|P1|Overall Study|Withdrawal by Subject|1
75529|NCT00972244|272665|P5|Overall Study|Subject No Longer Meets Study Criteria|5
75530|NCT00972244|272666|P4|Overall Study|Subject No Longer Meets Study Criteria|0
75531|NCT00972244|272667|P3|Overall Study|Subject No Longer Meets Study Criteria|0
75532|NCT00972244|272668|P2|Overall Study|Subject No Longer Meets Study Criteria|2
75533|NCT00972244|272669|P1|Overall Study|Subject No Longer Meets Study Criteria|2
75534|NCT00972244|272665|P5|Overall Study|Adverse Event|0
75535|NCT00972244|272666|P4|Overall Study|Adverse Event|0
75536|NCT00972244|272667|P3|Overall Study|Adverse Event|1
75537|NCT00972244|272668|P2|Overall Study|Adverse Event|1
75538|NCT00972244|272669|P1|Overall Study|Adverse Event|0
75539|NCT00972244|272665|P5|Overall Study|Incorrect Enrolment|0
75540|NCT00972244|272666|P4|Overall Study|Incorrect Enrolment|0
75541|NCT00972244|272667|P3|Overall Study|Incorrect Enrolment|0
75542|NCT00972244|272668|P2|Overall Study|Incorrect Enrolment|0
75543|NCT00972244|272669|P1|Overall Study|Incorrect Enrolment|1
75544|NCT00972153|272701|P3|Overall Study|Equipment malfunction during case|0
75545|NCT00972153|272702|P2|Overall Study|Equipment malfunction during case|1
75546|NCT00972153|272703|P1|Overall Study|Equipment malfunction during case|0
75547|NCT00972023|272718|P1|Overall Study|Withdrawal by Subject|1
75548|NCT00971997|272725|P1|Overall Study|Physician Decision|7
75549|NCT00971997|272725|P1|Overall Study|Withdrawal by Subject|5
75550|NCT00971997|272725|P1|Overall Study|Protocol Violation|4
75551|NCT00971997|272725|P1|Overall Study|Death|1
75552|NCT00971997|272725|P1|Overall Study|Adverse Event|2
75553|NCT00971932|272743|P1|Overall Study|Ongoing|4
75554|NCT00971932|272743|P1|Overall Study|Investigator's decision|2
75555|NCT00971932|272743|P1|Overall Study|Withdrawal by Subject|1
75556|NCT00971620|272790|P2|Overall Study|Refused further treatment|1
75557|NCT00971620|272791|P1|Overall Study|Refused further treatment|0
75558|NCT00971620|272790|P2|Overall Study|Subj lost to F/U after the primary endpt|0
75559|NCT00971620|272791|P1|Overall Study|Subj lost to F/U after the primary endpt|1
75560|NCT00971425|272801|P2|Overall Study|Withdrawal by Subject|1
75561|NCT00971425|272802|P1|Overall Study|Withdrawal by Subject|0
75562|NCT00971425|272801|P2|Overall Study|Adverse Event|1
75563|NCT00971425|272802|P1|Overall Study|Adverse Event|1
75564|NCT00971243|272866|P5|Open-label Period|Other reason|2
75565|NCT00971243|272867|P4|Open-label Period|Other reason|0
75566|NCT00971243|272868|P3|Open-label Period|Other reason|0
75567|NCT00971243|272869|P2|Open-label Period|Other reason|0
75568|NCT00971243|272870|P1|Open-label Period|Other reason|0
75569|NCT00971243|272866|P5|Open-label Period|Withdrawal by Subject|1
75570|NCT00971243|272867|P4|Open-label Period|Withdrawal by Subject|2
75571|NCT00971243|272868|P3|Open-label Period|Withdrawal by Subject|0
75572|NCT00971243|272869|P2|Open-label Period|Withdrawal by Subject|0
75573|NCT00971243|272870|P1|Open-label Period|Withdrawal by Subject|1
75574|NCT00971243|272866|P5|Open-label Period|Protocol Violation|1
75575|NCT00971243|272867|P4|Open-label Period|Protocol Violation|0
75576|NCT00971243|272868|P3|Open-label Period|Protocol Violation|1
75577|NCT00971243|272869|P2|Open-label Period|Protocol Violation|1
75578|NCT00971243|272870|P1|Open-label Period|Protocol Violation|1
75579|NCT00971243|272866|P5|Open-label Period|Physician Decision|2
75580|NCT00971243|272867|P4|Open-label Period|Physician Decision|7
75581|NCT00971243|272868|P3|Open-label Period|Physician Decision|3
75582|NCT00971243|272869|P2|Open-label Period|Physician Decision|9
75583|NCT00971243|272870|P1|Open-label Period|Physician Decision|5
75584|NCT00971243|272866|P5|Open-label Period|Adverse Event|0
75585|NCT00971243|272867|P4|Open-label Period|Adverse Event|1
75586|NCT00971243|272868|P3|Open-label Period|Adverse Event|1
75587|NCT00971243|272869|P2|Open-label Period|Adverse Event|0
75588|NCT00971243|272870|P1|Open-label Period|Adverse Event|1
75589|NCT00971243|272866|P5|Double Blind Period|Other reasons|1
75590|NCT00971243|272867|P4|Double Blind Period|Other reasons|0
75591|NCT00971243|272868|P3|Double Blind Period|Other reasons|2
75592|NCT00971243|272869|P2|Double Blind Period|Other reasons|0
75593|NCT00971243|272870|P1|Double Blind Period|Other reasons|1
75594|NCT00971243|272866|P5|Double Blind Period|Withdrawal by Subject|4
75595|NCT00971243|272867|P4|Double Blind Period|Withdrawal by Subject|4
75596|NCT00971243|272868|P3|Double Blind Period|Withdrawal by Subject|4
75597|NCT00971243|272869|P2|Double Blind Period|Withdrawal by Subject|1
75598|NCT00971243|272870|P1|Double Blind Period|Withdrawal by Subject|4
75599|NCT00971243|272866|P5|Double Blind Period|Protocol Violation|2
75600|NCT00971243|272867|P4|Double Blind Period|Protocol Violation|2
75601|NCT00971243|272868|P3|Double Blind Period|Protocol Violation|3
75602|NCT00971243|272869|P2|Double Blind Period|Protocol Violation|0
75603|NCT00971243|272870|P1|Double Blind Period|Protocol Violation|2
75604|NCT00971243|272866|P5|Double Blind Period|Physician Decision|7
75605|NCT00971243|272867|P4|Double Blind Period|Physician Decision|6
75606|NCT00971243|272868|P3|Double Blind Period|Physician Decision|7
75607|NCT00971243|272869|P2|Double Blind Period|Physician Decision|6
75608|NCT00971243|272870|P1|Double Blind Period|Physician Decision|10
75609|NCT00971243|272866|P5|Double Blind Period|Lost to Follow-up|1
75610|NCT00971243|272867|P4|Double Blind Period|Lost to Follow-up|0
75611|NCT00971243|272868|P3|Double Blind Period|Lost to Follow-up|1
75612|NCT00971243|272869|P2|Double Blind Period|Lost to Follow-up|1
75613|NCT00971243|272870|P1|Double Blind Period|Lost to Follow-up|0
75614|NCT00971243|272866|P5|Double Blind Period|Adverse Event|3
75615|NCT00971243|272867|P4|Double Blind Period|Adverse Event|2
75616|NCT00971243|272868|P3|Double Blind Period|Adverse Event|2
75617|NCT00971243|272869|P2|Double Blind Period|Adverse Event|3
75618|NCT00971243|272870|P1|Double Blind Period|Adverse Event|2
75619|NCT00971204|272887|P1|Overall Study|Lost to Follow-up|10
75620|NCT00971204|272887|P1|Overall Study|Did not meet all criteria-not treated|14
75621|NCT00971048|272895|P4|Overall Study|Physician Decision|1
75622|NCT00971048|272896|P3|Overall Study|Physician Decision|0
75623|NCT00971048|272897|P2|Overall Study|Physician Decision|0
75624|NCT00971048|272898|P1|Overall Study|Physician Decision|0
75625|NCT00971048|272895|P4|Overall Study|Adverse Event|0
75626|NCT00971048|272896|P3|Overall Study|Adverse Event|1
75627|NCT00971048|272897|P2|Overall Study|Adverse Event|0
75628|NCT00971048|272898|P1|Overall Study|Adverse Event|0
75629|NCT00971048|272895|P4|Overall Study|Protocol Violation|1
75630|NCT00971048|272896|P3|Overall Study|Protocol Violation|0
75631|NCT00971048|272897|P2|Overall Study|Protocol Violation|2
75632|NCT00971048|272898|P1|Overall Study|Protocol Violation|1
75633|NCT00970944|272922|P2|Overall Study|Physician Decision|2
75634|NCT00970944|272923|P1|Overall Study|Physician Decision|0
75635|NCT00970944|272922|P2|Overall Study|Death|0
75636|NCT00970944|272923|P1|Overall Study|Death|1
75637|NCT00970684|272975|P1|Overall Study|Withdrawal by Subject|1
75638|NCT00970684|272975|P1|Overall Study|Adverse Event|4
75639|NCT00970684|272975|P1|Overall Study|Lack of Efficacy|5
75640|NCT00970632|272984|P3|Overall Study|Sponsor decision|1
75641|NCT00970632|272985|P2|Overall Study|Sponsor decision|0
75642|NCT00970632|272986|P1|Overall Study|Sponsor decision|1
75643|NCT00970632|272984|P3|Overall Study|Entry criteria not met|2
75644|NCT00970632|272985|P2|Overall Study|Entry criteria not met|2
75645|NCT00970632|272986|P1|Overall Study|Entry criteria not met|0
75646|NCT00970632|272984|P3|Overall Study|Withdrawal by Subject|4
75647|NCT00970632|272985|P2|Overall Study|Withdrawal by Subject|6
75648|NCT00970632|272986|P1|Overall Study|Withdrawal by Subject|7
75649|NCT00970632|272984|P3|Overall Study|Protocol Violation|8
75650|NCT00970632|272985|P2|Overall Study|Protocol Violation|5
75651|NCT00970632|272986|P1|Overall Study|Protocol Violation|8
75652|NCT00970632|272984|P3|Overall Study|Lost to Follow-up|2
75653|NCT00970632|272985|P2|Overall Study|Lost to Follow-up|0
75654|NCT00970632|272986|P1|Overall Study|Lost to Follow-up|3
75655|NCT00970632|272984|P3|Overall Study|Lack of Efficacy|0
75656|NCT00970632|272985|P2|Overall Study|Lack of Efficacy|0
75657|NCT00970632|272986|P1|Overall Study|Lack of Efficacy|3
75658|NCT00970632|272984|P3|Overall Study|Adverse Event|1
75659|NCT00970632|272985|P2|Overall Study|Adverse Event|2
75660|NCT00970632|272986|P1|Overall Study|Adverse Event|2
75661|NCT00970294|273072|P1|Overall Study|Withdrawal by Subject|1
75662|NCT00970294|273072|P1|Overall Study|Physician Decision|4
75663|NCT00970281|273080|P2|Overall Study|Physician Decision|1
75664|NCT00970281|273081|P1|Overall Study|Physician Decision|1
75665|NCT00970281|273080|P2|Overall Study|Withdrawal by Subject|1
75666|NCT00970281|273081|P1|Overall Study|Withdrawal by Subject|0
75667|NCT00970281|273080|P2|Overall Study|Lack of Efficacy|14
75668|NCT00970281|273081|P1|Overall Study|Lack of Efficacy|1
75669|NCT00970268|273099|P2|Overall Study|Inclusion/Exclusion Criteria|0
75670|NCT00970268|273100|P1|Overall Study|Inclusion/Exclusion Criteria|1
75671|NCT00970268|273099|P2|Overall Study|Lost to Follow-up|2
75672|NCT00970268|273100|P1|Overall Study|Lost to Follow-up|1
75673|NCT00970268|273099|P2|Overall Study|COPD Exacerbation|2
75674|NCT00970268|273100|P1|Overall Study|COPD Exacerbation|4
75675|NCT00970268|273099|P2|Overall Study|Other Reason|1
75676|NCT00970268|273100|P1|Overall Study|Other Reason|3
75677|NCT00970268|273099|P2|Overall Study|Protocol Violation|7
75678|NCT00970268|273100|P1|Overall Study|Protocol Violation|4
75679|NCT00970268|273099|P2|Overall Study|Lack of Efficacy|6
75680|NCT00970268|273100|P1|Overall Study|Lack of Efficacy|3
75681|NCT00970268|273099|P2|Overall Study|Adverse Event|12
75682|NCT00970268|273100|P1|Overall Study|Adverse Event|15
75683|NCT00970268|273099|P2|Overall Study|Withdrawal by Subject|19
75684|NCT00970268|273100|P1|Overall Study|Withdrawal by Subject|12
75685|NCT00969709|273133|P4|Overall Study|Other reasons|0
75686|NCT00969709|273134|P3|Overall Study|Other reasons|3
75687|NCT00969709|273135|P2|Overall Study|Other reasons|0
75688|NCT00969709|273136|P1|Overall Study|Other reasons|0
75689|NCT00969709|273133|P4|Overall Study|Lost to Follow-up|15
75690|NCT00969709|273134|P3|Overall Study|Lost to Follow-up|8
75691|NCT00969709|273135|P2|Overall Study|Lost to Follow-up|14
75692|NCT00969709|273136|P1|Overall Study|Lost to Follow-up|10
75693|NCT00969709|273133|P4|Overall Study|Withdrawal by Subject|23
75694|NCT00969709|273134|P3|Overall Study|Withdrawal by Subject|11
75695|NCT00969709|273135|P2|Overall Study|Withdrawal by Subject|12
75696|NCT00969709|273136|P1|Overall Study|Withdrawal by Subject|9
75697|NCT00969709|273133|P4|Overall Study|Protocol Violation|10
75698|NCT00969709|273134|P3|Overall Study|Protocol Violation|9
75699|NCT00969709|273135|P2|Overall Study|Protocol Violation|5
75700|NCT00969709|273136|P1|Overall Study|Protocol Violation|9
75701|NCT00969709|273133|P4|Overall Study|Lack of Efficacy|3
75702|NCT00969709|273134|P3|Overall Study|Lack of Efficacy|1
75703|NCT00969709|273135|P2|Overall Study|Lack of Efficacy|4
75704|NCT00969709|273136|P1|Overall Study|Lack of Efficacy|7
75705|NCT00969709|273133|P4|Overall Study|Adverse Event|12
75706|NCT00969709|273134|P3|Overall Study|Adverse Event|26
75707|NCT00969709|273135|P2|Overall Study|Adverse Event|13
75708|NCT00969709|273136|P1|Overall Study|Adverse Event|3
75709|NCT00969618|273150|P1|Overall Study|Withdrawal by Subject|27
75710|NCT00969618|273150|P1|Overall Study|Protocol Violation|9
75711|NCT00969618|273150|P1|Overall Study|Physician Decision|1
75712|NCT00969618|273150|P1|Overall Study|Lost to Follow-up|7
75713|NCT00969618|273150|P1|Overall Study|Lack of Efficacy|2
75714|NCT00969618|273150|P1|Overall Study|Entry Criteria Not Met|3
75715|NCT00969618|273150|P1|Overall Study|Adverse Event|29
75716|NCT00969540|273163|P2|Overall Study|Lost to Follow-up|1
75717|NCT00969540|273164|P1|Overall Study|Lost to Follow-up|1
75718|NCT00969280|273188|P2|Overall Study|infection of influenza A(H1N1)|1
75719|NCT00969280|273189|P1|Overall Study|infection of influenza A(H1N1)|0
75720|NCT00969280|273188|P2|Overall Study|Withdrawal by Subject|1
75721|NCT00969280|273189|P1|Overall Study|Withdrawal by Subject|0
75722|NCT00969280|273188|P2|Overall Study|Protocol Violation|1
75723|NCT00969280|273189|P1|Overall Study|Protocol Violation|2
75724|NCT00969228|273197|P2|Overall Study|Porcine circovirus detection in vaccine|14
75725|NCT00969228|273198|P1|Overall Study|Porcine circovirus detection in vaccine|38
75726|NCT00969228|273197|P2|Overall Study|Withdrawal by Subject|0
75727|NCT00969228|273198|P1|Overall Study|Withdrawal by Subject|4
75728|NCT00969228|273197|P2|Overall Study|Adverse Event|0
75729|NCT00969228|273198|P1|Overall Study|Adverse Event|1
75730|NCT00969150|273216|P2|Overall Study|Other reasons|0
75731|NCT00969150|273217|P1|Overall Study|Other reasons|1
75732|NCT00969150|273216|P2|Overall Study|Lost to Follow-up|4
75733|NCT00969150|273217|P1|Overall Study|Lost to Follow-up|5
75734|NCT00969150|273216|P2|Overall Study|Withdrawal by Subject|9
75735|NCT00969150|273217|P1|Overall Study|Withdrawal by Subject|13
75736|NCT00969150|273216|P2|Overall Study|Protocol Violation|12
75737|NCT00969150|273217|P1|Overall Study|Protocol Violation|9
75738|NCT00969150|273216|P2|Overall Study|Lack of Efficacy|1
75739|NCT00969150|273217|P1|Overall Study|Lack of Efficacy|1
75740|NCT00969150|273216|P2|Overall Study|Adverse Event|14
75741|NCT00969150|273217|P1|Overall Study|Adverse Event|4
75742|NCT00968981|273228|P3|Overall Study|Withdrawal by Subject|3
75743|NCT00968981|273229|P2|Overall Study|Withdrawal by Subject|3
75744|NCT00968981|273230|P1|Overall Study|Withdrawal by Subject|1
75745|NCT00968981|273228|P3|Overall Study|Physician Decision|5
75746|NCT00968981|273229|P2|Overall Study|Physician Decision|3
75747|NCT00968981|273230|P1|Overall Study|Physician Decision|5
75748|NCT00968981|273228|P3|Overall Study|Lost to Follow-up|1
75749|NCT00968981|273229|P2|Overall Study|Lost to Follow-up|0
75750|NCT00968981|273230|P1|Overall Study|Lost to Follow-up|0
75751|NCT00968981|273228|P3|Overall Study|Disease Progression|13
75752|NCT00968981|273229|P2|Overall Study|Disease Progression|16
75753|NCT00968981|273230|P1|Overall Study|Disease Progression|14
75754|NCT00968981|273228|P3|Overall Study|Adverse Event|0
75755|NCT00968981|273229|P2|Overall Study|Adverse Event|0
75756|NCT00968981|273230|P1|Overall Study|Adverse Event|2
75757|NCT00968812|273309|P3|Overall Study|Not specified|40
75758|NCT00968812|273310|P2|Overall Study|Not specified|37
75759|NCT00968812|273311|P1|Overall Study|Not specified|25
75760|NCT00968812|273309|P3|Overall Study|Unable to take rescue therapy|17
75761|NCT00968812|273310|P2|Overall Study|Unable to take rescue therapy|12
75762|NCT00968812|273311|P1|Overall Study|Unable to take rescue therapy|12
75763|NCT00968812|273309|P3|Overall Study|Noncompliance with study drug|6
75764|NCT00968812|273310|P2|Overall Study|Noncompliance with study drug|1
75765|NCT00968812|273311|P1|Overall Study|Noncompliance with study drug|4
75766|NCT00968812|273309|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
75767|NCT00968812|273310|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
75768|NCT00968812|273311|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
75769|NCT00968812|273309|P3|Overall Study|Withdrawal by Subject|25
75770|NCT00968812|273310|P2|Overall Study|Withdrawal by Subject|23
75771|NCT00968812|273311|P1|Overall Study|Withdrawal by Subject|17
75772|NCT00968812|273309|P3|Overall Study|Protocol Violation|3
75773|NCT00968812|273310|P2|Overall Study|Protocol Violation|4
75774|NCT00968812|273311|P1|Overall Study|Protocol Violation|7
75775|NCT00968812|273309|P3|Overall Study|Physician Decision|9
75776|NCT00968812|273310|P2|Overall Study|Physician Decision|5
75777|NCT00968812|273311|P1|Overall Study|Physician Decision|8
75778|NCT00968812|273309|P3|Overall Study|Lost to Follow-up|11
75779|NCT00968812|273310|P2|Overall Study|Lost to Follow-up|12
75780|NCT00968812|273311|P1|Overall Study|Lost to Follow-up|17
75781|NCT00968812|273309|P3|Overall Study|Lack of Efficacy|16
75782|NCT00968812|273310|P2|Overall Study|Lack of Efficacy|7
75783|NCT00968812|273311|P1|Overall Study|Lack of Efficacy|9
75784|NCT00968812|273309|P3|Overall Study|Death|1
75785|NCT00968812|273310|P2|Overall Study|Death|2
75786|NCT00968812|273311|P1|Overall Study|Death|2
75787|NCT00968812|273309|P3|Overall Study|Adverse Event|33
75788|NCT00968812|273310|P2|Overall Study|Adverse Event|46
75789|NCT00968812|273311|P1|Overall Study|Adverse Event|30
75790|NCT00968799|273331|P1|Overall Study|Advanced disease, HIPEC not applicable|2
75791|NCT00968708|273341|P2|Overall Study|Other|34
75792|NCT00968708|273342|P1|Overall Study|Other|26
75793|NCT00968708|273341|P2|Overall Study|Investigator Discretion|1
75794|NCT00968708|273342|P1|Overall Study|Investigator Discretion|0
75795|NCT00968708|273341|P2|Overall Study|Voluntary Withdrawal|101
75796|NCT00968708|273342|P1|Overall Study|Voluntary Withdrawal|104
75797|NCT00968708|273341|P2|Overall Study|Lost to Follow-up|11
75798|NCT00968708|273342|P1|Overall Study|Lost to Follow-up|19
75799|NCT00968708|273341|P2|Overall Study|Major Protocol Deviation|1
75800|NCT00968708|273342|P1|Overall Study|Major Protocol Deviation|0
75801|NCT00968708|273341|P2|Overall Study|Adverse Event|150
75802|NCT00968708|273342|P1|Overall Study|Adverse Event|169
75803|NCT00968669|273354|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
75804|NCT00968669|273355|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
75805|NCT00968669|273356|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
75806|NCT00968669|273357|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
75807|NCT00968669|273354|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
75808|NCT00968669|273355|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
75809|NCT00968669|273356|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
75810|NCT00968669|273357|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
75811|NCT00968669|273354|P4|Overall Study|SUBJECT INCARCERATED|0
75812|NCT00968669|273355|P3|Overall Study|SUBJECT INCARCERATED|0
75813|NCT00968669|273356|P2|Overall Study|SUBJECT INCARCERATED|1
75814|NCT00968669|273357|P1|Overall Study|SUBJECT INCARCERATED|0
75815|NCT00968669|273354|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
75816|NCT00968669|273355|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
75817|NCT00968669|273356|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
75818|NCT00968669|273357|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
75819|NCT00968669|273354|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
75820|NCT00968669|273355|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
75821|NCT00968669|273356|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
75822|NCT00968669|273357|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
75823|NCT00968669|273354|P4|Overall Study|SPONSOR DECISION|0
75824|NCT00968669|273355|P3|Overall Study|SPONSOR DECISION|0
75825|NCT00968669|273356|P2|Overall Study|SPONSOR DECISION|1
75826|NCT00968669|273357|P1|Overall Study|SPONSOR DECISION|0
75827|NCT00968669|273354|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
75828|NCT00968669|273355|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
75829|NCT00968669|273356|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
75830|NCT00968669|273357|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
75831|NCT00968669|273354|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
75832|NCT00968669|273355|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
75833|NCT00968669|273356|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
75834|NCT00968669|273357|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
75835|NCT00968669|273354|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
75836|NCT00968669|273355|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
75837|NCT00968669|273356|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
75838|NCT00968669|273357|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
75839|NCT00968669|273354|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
75840|NCT00968669|273355|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
75841|NCT00968669|273356|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
75842|NCT00968669|273357|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
75843|NCT00968669|273354|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
75844|NCT00968669|273355|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
75845|NCT00968669|273356|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
75846|NCT00968669|273357|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
75847|NCT00968669|273354|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
75848|NCT00968669|273355|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
75849|NCT00968669|273356|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
75850|NCT00968669|273357|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
75851|NCT00968669|273354|P4|Overall Study|EARLY WITHDRAWAL|0
75852|NCT00968669|273355|P3|Overall Study|EARLY WITHDRAWAL|0
75853|NCT00968669|273356|P2|Overall Study|EARLY WITHDRAWAL|1
75854|NCT00968669|273357|P1|Overall Study|EARLY WITHDRAWAL|0
75855|NCT00968669|273354|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
75856|NCT00968669|273355|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
75857|NCT00968669|273356|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
75858|NCT00968669|273357|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
75859|NCT00968669|273354|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
75860|NCT00968669|273355|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
75861|NCT00968669|273356|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
75862|NCT00968669|273357|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
75863|NCT00968669|273354|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
75864|NCT00968669|273355|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
75865|NCT00968669|273356|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
75866|NCT00968669|273357|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
75867|NCT00968669|273354|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
75868|NCT00968669|273355|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
75869|NCT00968669|273356|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
75870|NCT00968669|273357|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
75871|NCT00968669|273354|P4|Overall Study|AE|0
75872|NCT00968669|273355|P3|Overall Study|AE|0
75873|NCT00968669|273356|P2|Overall Study|AE|0
75874|NCT00968669|273357|P1|Overall Study|AE|1
75875|NCT00968669|273354|P4|Overall Study|Pregnancy|0
75876|NCT00968669|273355|P3|Overall Study|Pregnancy|2
75877|NCT00968669|273356|P2|Overall Study|Pregnancy|0
75878|NCT00968669|273357|P1|Overall Study|Pregnancy|0
75879|NCT00968669|273354|P4|Overall Study|Withdrawal by Subject|3
75880|NCT00968669|273355|P3|Overall Study|Withdrawal by Subject|5
75881|NCT00968669|273356|P2|Overall Study|Withdrawal by Subject|7
75882|NCT00968669|273357|P1|Overall Study|Withdrawal by Subject|9
75883|NCT00968669|273354|P4|Overall Study|Lost to Follow-up|4
75884|NCT00968669|273355|P3|Overall Study|Lost to Follow-up|1
75885|NCT00968669|273356|P2|Overall Study|Lost to Follow-up|2
75886|NCT00968669|273357|P1|Overall Study|Lost to Follow-up|5
75887|NCT00968617|273447|P1|Overall Study|Study terminated by sponsor|6
75888|NCT00968201|273461|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
75889|NCT00968201|273462|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
75890|NCT00968201|273463|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
75891|NCT00968201|273461|P3|Extension Study - (Period III)|Not Specified|2
75892|NCT00968201|273462|P2|Extension Study - (Period III)|Not Specified|0
75893|NCT00968201|273463|P1|Extension Study - (Period III)|Not Specified|0
75894|NCT00968201|273461|P3|Extension Study - (Period III)|Noncompliance|3
75895|NCT00968201|273462|P2|Extension Study - (Period III)|Noncompliance|0
75896|NCT00968201|273463|P1|Extension Study - (Period III)|Noncompliance|0
75897|NCT00968201|273461|P3|Extension Study - (Period III)|Patient Relocated|1
75898|NCT00968201|273462|P2|Extension Study - (Period III)|Patient Relocated|1
75899|NCT00968201|273463|P1|Extension Study - (Period III)|Patient Relocated|0
75900|NCT00968201|273461|P3|Extension Study - (Period III)|Withdrawal by Subject|40
75901|NCT00968201|273462|P2|Extension Study - (Period III)|Withdrawal by Subject|20
75902|NCT00968201|273463|P1|Extension Study - (Period III)|Withdrawal by Subject|0
75903|NCT00968201|273461|P3|Extension Study - (Period III)|Protocol Violation|14
75904|NCT00968201|273462|P2|Extension Study - (Period III)|Protocol Violation|17
75905|NCT00968201|273463|P1|Extension Study - (Period III)|Protocol Violation|0
75906|NCT00968201|273461|P3|Extension Study - (Period III)|Lost to Follow-up|13
75907|NCT00968201|273462|P2|Extension Study - (Period III)|Lost to Follow-up|7
75908|NCT00968201|273463|P1|Extension Study - (Period III)|Lost to Follow-up|0
75909|NCT00968201|273461|P3|Extension Study - (Period III)|Adverse Event|22
75910|NCT00968201|273462|P2|Extension Study - (Period III)|Adverse Event|5
75911|NCT00968201|273463|P1|Extension Study - (Period III)|Adverse Event|0
75912|NCT00968201|273461|P3|Base Study - (Period II)|Site Error|1
75913|NCT00968201|273462|P2|Base Study - (Period II)|Site Error|0
75914|NCT00968201|273463|P1|Base Study - (Period II)|Site Error|0
75915|NCT00968201|273461|P3|Base Study - (Period II)|Withdrawal by Subject|8
75916|NCT00968201|273462|P2|Base Study - (Period II)|Withdrawal by Subject|0
75917|NCT00968201|273463|P1|Base Study - (Period II)|Withdrawal by Subject|4
75918|NCT00968201|273461|P3|Base Study - (Period II)|Protocol Violation|12
75919|NCT00968201|273462|P2|Base Study - (Period II)|Protocol Violation|0
75920|NCT00968201|273463|P1|Base Study - (Period II)|Protocol Violation|12
75921|NCT00968201|273461|P3|Base Study - (Period II)|Lost to Follow-up|7
75922|NCT00968201|273462|P2|Base Study - (Period II)|Lost to Follow-up|0
75923|NCT00968201|273463|P1|Base Study - (Period II)|Lost to Follow-up|2
75924|NCT00968201|273461|P3|Base Study - (Period II)|Lack of Efficacy|1
75925|NCT00968201|273462|P2|Base Study - (Period II)|Lack of Efficacy|0
75926|NCT00968201|273463|P1|Base Study - (Period II)|Lack of Efficacy|0
75927|NCT00968201|273461|P3|Base Study - (Period II)|Adverse Event|16
75928|NCT00968201|273462|P2|Base Study - (Period II)|Adverse Event|0
75929|NCT00968201|273463|P1|Base Study - (Period II)|Adverse Event|8
75930|NCT00968149|273524|P2|Overall Study|Withdrawal by Subject|0
75931|NCT00968149|273525|P1|Overall Study|Withdrawal by Subject|2
75932|NCT00968149|273524|P2|Overall Study|Protocol Violation|0
75933|NCT00968149|273525|P1|Overall Study|Protocol Violation|4
75934|NCT00968149|273524|P2|Overall Study|Lost to Follow-up|1
75935|NCT00968149|273525|P1|Overall Study|Lost to Follow-up|0
75936|NCT00968149|273524|P2|Overall Study|Lack of Efficacy|4
75937|NCT00968149|273525|P1|Overall Study|Lack of Efficacy|0
75938|NCT00968149|273524|P2|Overall Study|Adverse Event|1
75939|NCT00968149|273525|P1|Overall Study|Adverse Event|5
75940|NCT00967694|273578|P1|Overall Study|Withdrawal by Subject|6
75941|NCT00967668|273585|P3|Overall Study|Pregnancy|0
75942|NCT00967668|273586|P2|Overall Study|Pregnancy|0
75943|NCT00967668|273587|P1|Overall Study|Pregnancy|1
75944|NCT00967668|273585|P3|Overall Study|Refused 12-mo assessment|9
75945|NCT00967668|273586|P2|Overall Study|Refused 12-mo assessment|1
75946|NCT00967668|273587|P1|Overall Study|Refused 12-mo assessment|3
75947|NCT00967668|273585|P3|Overall Study|Lost to Follow-up|16
75948|NCT00967668|273586|P2|Overall Study|Lost to Follow-up|9
75949|NCT00967668|273587|P1|Overall Study|Lost to Follow-up|15
75950|NCT00967668|273585|P3|Overall Study|Lost to follow-up at 12-mo|26
75951|NCT00967668|273586|P2|Overall Study|Lost to follow-up at 12-mo|29
75952|NCT00967668|273587|P1|Overall Study|Lost to follow-up at 12-mo|27
75953|NCT00967668|273585|P3|Overall Study|Refused Year 2|4
75954|NCT00967668|273586|P2|Overall Study|Refused Year 2|6
75955|NCT00967668|273587|P1|Overall Study|Refused Year 2|11
75956|NCT00967668|273585|P3|Overall Study|Removed due to behavior|2
75957|NCT00967668|273586|P2|Overall Study|Removed due to behavior|1
75958|NCT00967668|273587|P1|Overall Study|Removed due to behavior|1
75959|NCT00967668|273585|P3|Overall Study|Death|4
75960|NCT00967668|273586|P2|Overall Study|Death|2
75961|NCT00967668|273587|P1|Overall Study|Death|0
75962|NCT00967668|273585|P3|Overall Study|Withdrawal by Subject|8
75963|NCT00967668|273586|P2|Overall Study|Withdrawal by Subject|8
75964|NCT00967668|273587|P1|Overall Study|Withdrawal by Subject|13
75965|NCT00967330|273633|P2|Overall Study|Severe protocol deviation|1
75966|NCT00967330|273634|P1|Overall Study|Severe protocol deviation|0
75967|NCT00967330|273633|P2|Overall Study|Death|51
75968|NCT00967330|273634|P1|Overall Study|Death|102
75969|NCT00967330|273633|P2|Overall Study|Lost to Follow-up|1
75970|NCT00967330|273634|P1|Overall Study|Lost to Follow-up|1
75971|NCT00967330|273633|P2|Overall Study|Withdrawal by Subject|0
75972|NCT00967330|273634|P1|Overall Study|Withdrawal by Subject|6
75973|NCT00967330|273633|P2|Overall Study|Regular|3
75974|NCT00967330|273634|P1|Overall Study|Regular|10
75975|NCT00967330|273633|P2|Overall Study|Protocol Violation|4
75976|NCT00967330|273634|P1|Overall Study|Protocol Violation|3
75977|NCT00967226|273664|P2|Overall Study|Physician Decision|1
75978|NCT00967226|273665|P1|Overall Study|Physician Decision|0
75979|NCT00967226|273664|P2|Overall Study|Protocol Violation|0
75980|NCT00967226|273665|P1|Overall Study|Protocol Violation|2
75981|NCT00967226|273664|P2|Overall Study|Adverse Event|5
75982|NCT00967226|273665|P1|Overall Study|Adverse Event|0
75983|NCT00967018|273699|P1|Overall Study|Miscellaneous Reasons|9
75984|NCT00967018|273699|P1|Overall Study|Withdrawal by Subject|1
75985|NCT00967018|273699|P1|Overall Study|Lost to Follow-up|2
75986|NCT00967018|273699|P1|Overall Study|Physician Decision|7
75987|NCT00967018|273699|P1|Overall Study|Adverse Event|2
75988|NCT00966940|273740|P2|Period 1, First 6 Weeks|Protocol Violation|0
75989|NCT00966940|273741|P1|Period 1, First 6 Weeks|Protocol Violation|1
75990|NCT00966940|273740|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
75991|NCT00966940|273741|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
75992|NCT00966875|273768|P9|Part B|Entry Criteria|1
75993|NCT00966875|273769|P8|Part B|Entry Criteria|0
75994|NCT00966875|273770|P7|Part B|Entry Criteria|1
75995|NCT00966875|273771|P6|Part B|Entry Criteria|0
75996|NCT00966875|273772|P5|Part B|Entry Criteria|0
75997|NCT00966875|273773|P4|Part B|Entry Criteria|0
75998|NCT00966875|273774|P3|Part B|Entry Criteria|0
75999|NCT00966875|273775|P2|Part B|Entry Criteria|0
76000|NCT00966875|273776|P1|Part B|Entry Criteria|0
76001|NCT00966875|273768|P9|Part B|Withdrawal by Subject|5
76002|NCT00966875|273769|P8|Part B|Withdrawal by Subject|5
76003|NCT00966875|273770|P7|Part B|Withdrawal by Subject|4
76004|NCT00966875|273771|P6|Part B|Withdrawal by Subject|1
76005|NCT00966875|273772|P5|Part B|Withdrawal by Subject|2
76006|NCT00966875|273773|P4|Part B|Withdrawal by Subject|1
76007|NCT00966875|273774|P3|Part B|Withdrawal by Subject|2
76008|NCT00966875|273775|P2|Part B|Withdrawal by Subject|1
76009|NCT00966875|273776|P1|Part B|Withdrawal by Subject|2
76010|NCT00966875|273768|P9|Part B|Sponsor Decision|1
76011|NCT00966875|273769|P8|Part B|Sponsor Decision|2
76012|NCT00966875|273770|P7|Part B|Sponsor Decision|0
76013|NCT00966875|273771|P6|Part B|Sponsor Decision|1
76014|NCT00966875|273772|P5|Part B|Sponsor Decision|0
76015|NCT00966875|273773|P4|Part B|Sponsor Decision|0
76016|NCT00966875|273774|P3|Part B|Sponsor Decision|0
76017|NCT00966875|273775|P2|Part B|Sponsor Decision|0
76018|NCT00966875|273776|P1|Part B|Sponsor Decision|1
76019|NCT00966875|273768|P9|Part B|Physician Decision|2
76020|NCT00966875|273769|P8|Part B|Physician Decision|0
76021|NCT00966875|273770|P7|Part B|Physician Decision|0
76022|NCT00966875|273771|P6|Part B|Physician Decision|1
76023|NCT00966875|273772|P5|Part B|Physician Decision|2
76024|NCT00966875|273773|P4|Part B|Physician Decision|0
76025|NCT00966875|273774|P3|Part B|Physician Decision|1
76026|NCT00966875|273775|P2|Part B|Physician Decision|0
76027|NCT00966875|273776|P1|Part B|Physician Decision|0
76028|NCT00966875|273768|P9|Part B|Lost to Follow-up|1
76029|NCT00966875|273769|P8|Part B|Lost to Follow-up|0
76030|NCT00966875|273770|P7|Part B|Lost to Follow-up|0
76031|NCT00966875|273771|P6|Part B|Lost to Follow-up|0
76032|NCT00966875|273772|P5|Part B|Lost to Follow-up|0
76033|NCT00966875|273773|P4|Part B|Lost to Follow-up|1
76034|NCT00966875|273774|P3|Part B|Lost to Follow-up|0
76035|NCT00966875|273775|P2|Part B|Lost to Follow-up|0
76036|NCT00966875|273776|P1|Part B|Lost to Follow-up|0
76037|NCT00966875|273768|P9|Part B|Lack of Efficacy|6
76038|NCT00966875|273769|P8|Part B|Lack of Efficacy|9
76039|NCT00966875|273770|P7|Part B|Lack of Efficacy|12
76040|NCT00966875|273771|P6|Part B|Lack of Efficacy|3
76041|NCT00966875|273772|P5|Part B|Lack of Efficacy|2
76042|NCT00966875|273773|P4|Part B|Lack of Efficacy|1
76043|NCT00966875|273774|P3|Part B|Lack of Efficacy|1
76044|NCT00966875|273775|P2|Part B|Lack of Efficacy|1
76045|NCT00966875|273776|P1|Part B|Lack of Efficacy|2
76046|NCT00966875|273768|P9|Part B|Death|0
76047|NCT00966875|273769|P8|Part B|Death|1
76048|NCT00966875|273770|P7|Part B|Death|0
76049|NCT00966875|273771|P6|Part B|Death|0
76050|NCT00966875|273772|P5|Part B|Death|0
76051|NCT00966875|273773|P4|Part B|Death|0
76052|NCT00966875|273774|P3|Part B|Death|1
76053|NCT00966875|273775|P2|Part B|Death|0
76054|NCT00966875|273776|P1|Part B|Death|0
76055|NCT00966875|273768|P9|Part B|Adverse Event|2
76056|NCT00966875|273769|P8|Part B|Adverse Event|2
76057|NCT00966875|273770|P7|Part B|Adverse Event|5
76058|NCT00966875|273771|P6|Part B|Adverse Event|0
76059|NCT00966875|273772|P5|Part B|Adverse Event|1
76060|NCT00966875|273773|P4|Part B|Adverse Event|0
76061|NCT00966875|273774|P3|Part B|Adverse Event|1
76062|NCT00966875|273775|P2|Part B|Adverse Event|1
76063|NCT00966875|273776|P1|Part B|Adverse Event|0
76064|NCT00966875|273768|P9|Part A|Protocol Violation|1
76065|NCT00966875|273769|P8|Part A|Protocol Violation|1
76066|NCT00966875|273770|P7|Part A|Protocol Violation|2
76067|NCT00966875|273771|P6|Part A|Protocol Violation|0
76068|NCT00966875|273772|P5|Part A|Protocol Violation|0
76069|NCT00966875|273773|P4|Part A|Protocol Violation|0
76070|NCT00966875|273774|P3|Part A|Protocol Violation|0
76071|NCT00966875|273775|P2|Part A|Protocol Violation|0
76072|NCT00966875|273776|P1|Part A|Protocol Violation|0
76073|NCT00966875|273768|P9|Part A|Withdrawal by Subject|1
76074|NCT00966875|273769|P8|Part A|Withdrawal by Subject|1
76075|NCT00966875|273770|P7|Part A|Withdrawal by Subject|5
76076|NCT00966875|273771|P6|Part A|Withdrawal by Subject|0
76077|NCT00966875|273772|P5|Part A|Withdrawal by Subject|3
76078|NCT00966875|273773|P4|Part A|Withdrawal by Subject|1
76079|NCT00966875|273774|P3|Part A|Withdrawal by Subject|1
76080|NCT00966875|273775|P2|Part A|Withdrawal by Subject|2
76081|NCT00966875|273776|P1|Part A|Withdrawal by Subject|2
76082|NCT00966875|273768|P9|Part A|Sponsor Decision|1
76083|NCT00966875|273769|P8|Part A|Sponsor Decision|2
76084|NCT00966875|273770|P7|Part A|Sponsor Decision|0
76085|NCT00966875|273771|P6|Part A|Sponsor Decision|0
76086|NCT00966875|273772|P5|Part A|Sponsor Decision|1
76087|NCT00966875|273773|P4|Part A|Sponsor Decision|0
76088|NCT00966875|273774|P3|Part A|Sponsor Decision|1
76089|NCT00966875|273775|P2|Part A|Sponsor Decision|0
76090|NCT00966875|273776|P1|Part A|Sponsor Decision|0
76091|NCT00966875|273768|P9|Part A|Physician Decision|2
76092|NCT00966875|273769|P8|Part A|Physician Decision|0
76093|NCT00966875|273770|P7|Part A|Physician Decision|1
76094|NCT00966875|273771|P6|Part A|Physician Decision|0
76095|NCT00966875|273772|P5|Part A|Physician Decision|1
76096|NCT00966875|273773|P4|Part A|Physician Decision|0
76097|NCT00966875|273774|P3|Part A|Physician Decision|0
76098|NCT00966875|273775|P2|Part A|Physician Decision|0
76099|NCT00966875|273776|P1|Part A|Physician Decision|0
76100|NCT00966875|273768|P9|Part A|Parent/Caregiver Decision|0
76101|NCT00966875|273769|P8|Part A|Parent/Caregiver Decision|0
76102|NCT00966875|273770|P7|Part A|Parent/Caregiver Decision|0
76103|NCT00966875|273771|P6|Part A|Parent/Caregiver Decision|0
76104|NCT00966875|273772|P5|Part A|Parent/Caregiver Decision|0
76105|NCT00966875|273773|P4|Part A|Parent/Caregiver Decision|1
76106|NCT00966875|273774|P3|Part A|Parent/Caregiver Decision|0
76107|NCT00966875|273775|P2|Part A|Parent/Caregiver Decision|0
76108|NCT00966875|273776|P1|Part A|Parent/Caregiver Decision|0
76109|NCT00966875|273768|P9|Part A|Lost to Follow-up|0
76110|NCT00966875|273769|P8|Part A|Lost to Follow-up|0
76111|NCT00966875|273770|P7|Part A|Lost to Follow-up|0
76112|NCT00966875|273771|P6|Part A|Lost to Follow-up|1
76113|NCT00966875|273772|P5|Part A|Lost to Follow-up|0
76114|NCT00966875|273773|P4|Part A|Lost to Follow-up|0
76115|NCT00966875|273774|P3|Part A|Lost to Follow-up|0
76116|NCT00966875|273775|P2|Part A|Lost to Follow-up|0
76117|NCT00966875|273776|P1|Part A|Lost to Follow-up|2
76118|NCT00966875|273768|P9|Part A|Lack of Efficacy|0
76119|NCT00966875|273769|P8|Part A|Lack of Efficacy|0
76120|NCT00966875|273770|P7|Part A|Lack of Efficacy|4
76121|NCT00966875|273771|P6|Part A|Lack of Efficacy|0
76122|NCT00966875|273772|P5|Part A|Lack of Efficacy|0
76123|NCT00966875|273773|P4|Part A|Lack of Efficacy|0
76124|NCT00966875|273774|P3|Part A|Lack of Efficacy|0
76125|NCT00966875|273775|P2|Part A|Lack of Efficacy|1
76126|NCT00966875|273776|P1|Part A|Lack of Efficacy|0
76127|NCT00966875|273768|P9|Part A|Entry Criteria|0
76128|NCT00966875|273769|P8|Part A|Entry Criteria|0
76129|NCT00966875|273770|P7|Part A|Entry Criteria|0
76130|NCT00966875|273771|P6|Part A|Entry Criteria|2
76131|NCT00966875|273772|P5|Part A|Entry Criteria|0
76132|NCT00966875|273773|P4|Part A|Entry Criteria|0
76133|NCT00966875|273774|P3|Part A|Entry Criteria|0
76134|NCT00966875|273775|P2|Part A|Entry Criteria|0
76135|NCT00966875|273776|P1|Part A|Entry Criteria|0
76136|NCT00966875|273768|P9|Part A|Adverse Event|3
76137|NCT00966875|273769|P8|Part A|Adverse Event|3
76138|NCT00966875|273770|P7|Part A|Adverse Event|0
76139|NCT00966875|273771|P6|Part A|Adverse Event|1
76140|NCT00966875|273772|P5|Part A|Adverse Event|0
76141|NCT00966875|273773|P4|Part A|Adverse Event|1
76142|NCT00966875|273774|P3|Part A|Adverse Event|0
76143|NCT00966875|273775|P2|Part A|Adverse Event|1
76144|NCT00966875|273776|P1|Part A|Adverse Event|2
76145|NCT00966277|274132|P2|Overall Study|Treatment Plan Changed|1
76146|NCT00966277|274133|P1|Overall Study|Treatment Plan Changed|0
76147|NCT00966277|274132|P2|Overall Study|Ineligible|3
76148|NCT00966277|274133|P1|Overall Study|Ineligible|1
76149|NCT00966277|274132|P2|Overall Study|Withdrawal by Subject|0
76150|NCT00966277|274133|P1|Overall Study|Withdrawal by Subject|3
76151|NCT00966264|274141|P2|Overall Study|Lost to Follow-up|3
76152|NCT00966264|274142|P1|Overall Study|Lost to Follow-up|4
76153|NCT00965848|274188|P3|Overall Study|Unspecified|1
76154|NCT00965848|274189|P2|Overall Study|Unspecified|0
76155|NCT00965848|274190|P1|Overall Study|Unspecified|5
76156|NCT00965848|274188|P3|Overall Study|Not Clinically Evaluable|1
76157|NCT00965848|274189|P2|Overall Study|Not Clinically Evaluable|1
76158|NCT00965848|274190|P1|Overall Study|Not Clinically Evaluable|7
76159|NCT00965848|274188|P3|Overall Study|Indeterminate Clinical Outcome|1
76160|NCT00965848|274189|P2|Overall Study|Indeterminate Clinical Outcome|0
76161|NCT00965848|274190|P1|Overall Study|Indeterminate Clinical Outcome|2
76162|NCT00965848|274188|P3|Overall Study|Withdrawal by Subject|0
76163|NCT00965848|274189|P2|Overall Study|Withdrawal by Subject|0
76164|NCT00965848|274190|P1|Overall Study|Withdrawal by Subject|1
76165|NCT00965848|274188|P3|Overall Study|Lost to Follow-up|1
76166|NCT00965848|274189|P2|Overall Study|Lost to Follow-up|0
76167|NCT00965848|274190|P1|Overall Study|Lost to Follow-up|0
76168|NCT00965848|274188|P3|Overall Study|Death|5
76169|NCT00965848|274189|P2|Overall Study|Death|1
76170|NCT00965848|274190|P1|Overall Study|Death|11
76171|NCT00965848|274188|P3|Overall Study|Protocol Violation|1
76172|NCT00965848|274189|P2|Overall Study|Protocol Violation|0
76173|NCT00965848|274190|P1|Overall Study|Protocol Violation|3
76174|NCT00965757|274209|P4|Extension Phase|Not Specified|1
76175|NCT00965757|274210|P3|Extension Phase|Not Specified|2
76176|NCT00965757|274211|P2|Extension Phase|Not Specified|0
76177|NCT00965757|274212|P1|Extension Phase|Not Specified|0
76178|NCT00965757|274209|P4|Extension Phase|Protocol Violation|1
76179|NCT00965757|274210|P3|Extension Phase|Protocol Violation|0
76180|NCT00965757|274211|P2|Extension Phase|Protocol Violation|0
76181|NCT00965757|274212|P1|Extension Phase|Protocol Violation|0
76182|NCT00965757|274209|P4|Extension Phase|Ineligible after Taking Study Drug|3
76183|NCT00965757|274210|P3|Extension Phase|Ineligible after Taking Study Drug|3
76184|NCT00965757|274211|P2|Extension Phase|Ineligible after Taking Study Drug|0
76185|NCT00965757|274212|P1|Extension Phase|Ineligible after Taking Study Drug|0
76186|NCT00965757|274209|P4|Extension Phase|Lost to Follow-up|1
76187|NCT00965757|274210|P3|Extension Phase|Lost to Follow-up|0
76188|NCT00965757|274211|P2|Extension Phase|Lost to Follow-up|0
76189|NCT00965757|274212|P1|Extension Phase|Lost to Follow-up|0
76190|NCT00965757|274209|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
76191|NCT00965757|274210|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
76192|NCT00965757|274211|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
76193|NCT00965757|274212|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
76194|NCT00965757|274209|P4|Extension Phase|Lack of Efficacy|12
76195|NCT00965757|274210|P3|Extension Phase|Lack of Efficacy|8
76196|NCT00965757|274211|P2|Extension Phase|Lack of Efficacy|0
76197|NCT00965757|274212|P1|Extension Phase|Lack of Efficacy|0
76198|NCT00965757|274209|P4|Extension Phase|Abnormal Laboratory Value|1
76199|NCT00965757|274210|P3|Extension Phase|Abnormal Laboratory Value|6
76200|NCT00965757|274211|P2|Extension Phase|Abnormal Laboratory Value|0
76201|NCT00965757|274212|P1|Extension Phase|Abnormal Laboratory Value|0
76202|NCT00965757|274209|P4|Extension Phase|Adverse drug reaction|3
76203|NCT00965757|274210|P3|Extension Phase|Adverse drug reaction|6
76204|NCT00965757|274211|P2|Extension Phase|Adverse drug reaction|0
76205|NCT00965757|274212|P1|Extension Phase|Adverse drug reaction|0
76206|NCT00965757|274209|P4|Extension Phase|Progression of concomitant disease|2
76207|NCT00965757|274210|P3|Extension Phase|Progression of concomitant disease|4
76208|NCT00965757|274211|P2|Extension Phase|Progression of concomitant disease|0
76209|NCT00965757|274212|P1|Extension Phase|Progression of concomitant disease|0
76210|NCT00965757|274209|P4|Double-blind Phase|Not specified|0
76211|NCT00965757|274210|P3|Double-blind Phase|Not specified|0
76212|NCT00965757|274211|P2|Double-blind Phase|Not specified|0
76213|NCT00965757|274212|P1|Double-blind Phase|Not specified|1
76214|NCT00965757|274209|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
76215|NCT00965757|274210|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
76216|NCT00965757|274211|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
76217|NCT00965757|274212|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
76218|NCT00965757|274209|P4|Double-blind Phase|Lost to Follow-up|0
76219|NCT00965757|274210|P3|Double-blind Phase|Lost to Follow-up|0
76220|NCT00965757|274211|P2|Double-blind Phase|Lost to Follow-up|1
76221|NCT00965757|274212|P1|Double-blind Phase|Lost to Follow-up|0
76222|NCT00965757|274209|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
76223|NCT00965757|274210|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
76224|NCT00965757|274211|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
76225|NCT00965757|274212|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
76226|NCT00965757|274209|P4|Double-blind Phase|Lack of Efficacy|0
76227|NCT00965757|274210|P3|Double-blind Phase|Lack of Efficacy|0
76228|NCT00965757|274211|P2|Double-blind Phase|Lack of Efficacy|11
76229|NCT00965757|274212|P1|Double-blind Phase|Lack of Efficacy|7
76230|NCT00965757|274209|P4|Double-blind Phase|Abnormal Laboratory Value|0
76231|NCT00965757|274210|P3|Double-blind Phase|Abnormal Laboratory Value|0
76232|NCT00965757|274211|P2|Double-blind Phase|Abnormal Laboratory Value|0
76233|NCT00965757|274212|P1|Double-blind Phase|Abnormal Laboratory Value|2
76234|NCT00965757|274209|P4|Double-blind Phase|Adverse drug reaction|0
76235|NCT00965757|274210|P3|Double-blind Phase|Adverse drug reaction|0
76236|NCT00965757|274211|P2|Double-blind Phase|Adverse drug reaction|1
76237|NCT00965757|274212|P1|Double-blind Phase|Adverse drug reaction|2
76238|NCT00965757|274209|P4|Double-blind Phase|Progression of concomitant disease|0
76239|NCT00965757|274210|P3|Double-blind Phase|Progression of concomitant disease|0
76240|NCT00965757|274211|P2|Double-blind Phase|Progression of concomitant disease|2
76241|NCT00965757|274212|P1|Double-blind Phase|Progression of concomitant disease|1
76242|NCT00965731|274246|P2|Overall Study|Not specified|15
76243|NCT00965731|274247|P1|Overall Study|Not specified|7
76244|NCT00965731|274246|P2|Overall Study|Withdrawal by Subject|1
76245|NCT00965731|274247|P1|Overall Study|Withdrawal by Subject|0
76246|NCT00965731|274246|P2|Overall Study|Death|4
76247|NCT00965731|274247|P1|Overall Study|Death|0
76248|NCT00965718|274311|P1|Overall Study|Withdrawal by Subject|4
76249|NCT00965562|274324|P3|Overall Study|Withdrawal by Subject|0
76250|NCT00965562|274325|P2|Overall Study|Withdrawal by Subject|2
76251|NCT00965562|274326|P1|Overall Study|Withdrawal by Subject|2
76252|NCT00965562|274324|P3|Overall Study|Lost to Follow-up|3
76253|NCT00965562|274325|P2|Overall Study|Lost to Follow-up|2
76254|NCT00965562|274326|P1|Overall Study|Lost to Follow-up|1
76255|NCT00965523|274364|P1|Study 224|Physician Decision|1
76256|NCT00965523|274364|P1|Study 224|Progressive Disease|5
76257|NCT00965523|274364|P1|Study 221|Physician Decision|3
76258|NCT00965523|274364|P1|Study 221|Progressive Disease|4
76259|NCT00965497|274369|P1|Overall Study|Physician Decision|1
76260|NCT00965484|274374|P1|Overall Study|Withdrawal by Subject|1
76261|NCT00965484|274374|P1|Overall Study|Protocol Violation|1
76262|NCT00965458|274383|P2|Overall Study|Withdrawal by Subject|1
76263|NCT00965458|274384|P1|Overall Study|Withdrawal by Subject|0
76264|NCT00965458|274383|P2|Overall Study|Lost to Follow-up|3
76265|NCT00965458|274384|P1|Overall Study|Lost to Follow-up|1
76266|NCT00965458|274383|P2|Overall Study|Adverse Event|0
76267|NCT00965458|274384|P1|Overall Study|Adverse Event|1
76268|NCT00965341|274402|P2|Overall Study|Transportation issues|3
76269|NCT00965341|274403|P1|Overall Study|Transportation issues|4
76270|NCT00965341|274402|P2|Overall Study|Lost to Follow-up|0
76271|NCT00965341|274403|P1|Overall Study|Lost to Follow-up|1
76272|NCT00965341|274402|P2|Overall Study|Withdrew consent|5
76273|NCT00965341|274403|P1|Overall Study|Withdrew consent|1
76274|NCT00965185|274441|P2|Overall Study|Withdrawal by Subject|1
76275|NCT00965185|274442|P1|Overall Study|Withdrawal by Subject|0
76276|NCT00965185|274441|P2|Overall Study|Lost to Follow-up|0
76277|NCT00965185|274442|P1|Overall Study|Lost to Follow-up|2
76278|NCT00965146|274458|P1|Overall Study|Overall Study Termination|145
76279|NCT00965146|274458|P1|Overall Study|Revision / Removal of Study Implant|6
76280|NCT00965146|274458|P1|Overall Study|Intercurrent illness|1
76281|NCT00965146|274458|P1|Overall Study|Unwilling to return|11
76282|NCT00965146|274458|P1|Overall Study|Unable to return|1
76283|NCT00965146|274458|P1|Overall Study|Withdrawal by Subject|17
76284|NCT00965146|274458|P1|Overall Study|Lost to Follow-up|22
76285|NCT00965146|274458|P1|Overall Study|Death|7
76286|NCT00965094|274464|P2|Overall Study|Lost to Follow-up|1
76287|NCT00965094|274465|P1|Overall Study|Lost to Follow-up|0
76288|NCT00965094|274464|P2|Overall Study|Adverse Event|0
76289|NCT00965094|274465|P1|Overall Study|Adverse Event|5
76290|NCT00965081|274481|P2|Overall Study|Switched to Rescue Arm|12
76291|NCT00965081|274482|P1|Overall Study|Switched to Rescue Arm|5
76292|NCT00965081|274481|P2|Overall Study|Withdrawal by Subject|7
76293|NCT00965081|274482|P1|Overall Study|Withdrawal by Subject|4
76294|NCT00965081|274481|P2|Overall Study|Sponsor Decision|0
76295|NCT00965081|274482|P1|Overall Study|Sponsor Decision|1
76296|NCT00965081|274481|P2|Overall Study|Protocol Violation|5
76297|NCT00965081|274482|P1|Overall Study|Protocol Violation|2
76298|NCT00965081|274481|P2|Overall Study|Physician Decision|0
76299|NCT00965081|274482|P1|Overall Study|Physician Decision|2
76300|NCT00965081|274481|P2|Overall Study|Lost to Follow-up|5
76301|NCT00965081|274482|P1|Overall Study|Lost to Follow-up|4
76302|NCT00965081|274481|P2|Overall Study|Lack of Efficacy|5
76303|NCT00965081|274482|P1|Overall Study|Lack of Efficacy|2
76304|NCT00965081|274481|P2|Overall Study|Adverse Event|9
76305|NCT00965081|274482|P1|Overall Study|Adverse Event|14
76306|NCT00964886|274509|P4|Overall Study|Protocol Violation|0
76307|NCT00964886|274510|P3|Overall Study|Protocol Violation|0
76308|NCT00964886|274511|P2|Overall Study|Protocol Violation|2
76309|NCT00964886|274512|P1|Overall Study|Protocol Violation|0
76310|NCT00964886|274509|P4|Overall Study|Adverse Event|2
76311|NCT00964886|274510|P3|Overall Study|Adverse Event|5
76312|NCT00964886|274511|P2|Overall Study|Adverse Event|1
76313|NCT00964886|274512|P1|Overall Study|Adverse Event|3
76314|NCT00964886|274509|P4|Overall Study|Withdrawal by Subject|3
76315|NCT00964886|274510|P3|Overall Study|Withdrawal by Subject|5
76316|NCT00964886|274511|P2|Overall Study|Withdrawal by Subject|2
76317|NCT00964886|274512|P1|Overall Study|Withdrawal by Subject|6
76318|NCT00964886|274509|P4|Overall Study|Lost to Follow-up|4
76319|NCT00964886|274510|P3|Overall Study|Lost to Follow-up|6
76320|NCT00964886|274511|P2|Overall Study|Lost to Follow-up|2
76321|NCT00964886|274512|P1|Overall Study|Lost to Follow-up|2
76322|NCT00964860|274528|P2|Overall Study|Withdrawal by Subject|1
76323|NCT00964860|274529|P1|Overall Study|Withdrawal by Subject|0
76324|NCT00964795|274537|P1|Overall Study|Other|23
76325|NCT00964795|274537|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
76326|NCT00964795|274537|P1|Overall Study|Termination of Study by Sponsor|169
76327|NCT00964795|274537|P1|Overall Study|Lost to Follow-up|7
76328|NCT00964795|274537|P1|Overall Study|Death|14
76329|NCT00964795|274537|P1|Overall Study|Adverse Event|12
76330|NCT00964795|274537|P1|Overall Study|Withdrawal by Subject|79
76331|NCT00964743|274544|P1|Overall Study|Neither patient completed 8 weeks of tre|2
76332|NCT00963235|274607|P1|Overall Study|Unspecified|1
76333|NCT00963235|274607|P1|Overall Study|Physician Decision|2
76334|NCT00963235|274607|P1|Overall Study|Adverse Event|5
76335|NCT00963235|274607|P1|Overall Study|Protocol Violation|7
76336|NCT00963235|274607|P1|Overall Study|Failed to return|9
76337|NCT00963235|274607|P1|Overall Study|Lost to Follow-up|14
76338|NCT00963235|274607|P1|Overall Study|Withdrawal by Subject|22
76339|NCT00964366|274628|P2|Overall Study|Withdrawal by Subject|1
76340|NCT00964366|274629|P1|Overall Study|Withdrawal by Subject|0
76341|NCT00964366|274628|P2|Overall Study|Did not qualify at Day 1|0
76342|NCT00964366|274629|P1|Overall Study|Did not qualify at Day 1|1
76343|NCT00964223|274643|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
76344|NCT00963937|274715|P3|Overall Study|Physician Decision|4
76345|NCT00963937|274716|P2|Overall Study|Physician Decision|10
76346|NCT00963937|274717|P1|Overall Study|Physician Decision|18
76347|NCT00963937|274715|P3|Overall Study|Protocol Violation|0
76348|NCT00963937|274716|P2|Overall Study|Protocol Violation|1
76349|NCT00963937|274717|P1|Overall Study|Protocol Violation|1
76350|NCT00963924|274755|P2|Overall Study|Lost to Follow-up|1
76351|NCT00963924|274756|P1|Overall Study|Lost to Follow-up|0
76352|NCT00963924|274755|P2|Overall Study|Changed antipsychotic|1
76353|NCT00963924|274756|P1|Overall Study|Changed antipsychotic|0
76354|NCT00963924|274755|P2|Overall Study|Withdrawal by Subject|1
76355|NCT00963924|274756|P1|Overall Study|Withdrawal by Subject|0
76356|NCT00963924|274755|P2|Overall Study|Adverse Event|0
76357|NCT00963924|274756|P1|Overall Study|Adverse Event|1
76358|NCT00963820|274824|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
76359|NCT00963820|274825|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
76360|NCT00963820|274826|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
76361|NCT00963820|274827|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
76362|NCT00963820|274828|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
76363|NCT00963820|274829|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
76364|NCT00963820|274830|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
76365|NCT00963820|274831|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
76366|NCT00963820|274832|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
76367|NCT00963820|274833|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
76368|NCT00963820|274834|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
76369|NCT00963820|274835|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
76370|NCT00963820|274824|P12|Expansion Phase|Withdrawal by Subject|1
76371|NCT00963820|274825|P11|Expansion Phase|Withdrawal by Subject|1
76372|NCT00963820|274826|P10|Expansion Phase|Withdrawal by Subject|0
76373|NCT00963820|274827|P9|Expansion Phase|Withdrawal by Subject|1
76374|NCT00963820|274828|P8|Expansion Phase|Withdrawal by Subject|0
76375|NCT00963820|274829|P7|Expansion Phase|Withdrawal by Subject|0
76376|NCT00963820|274830|P6|Expansion Phase|Withdrawal by Subject|0
76377|NCT00963820|274831|P5|Expansion Phase|Withdrawal by Subject|0
76378|NCT00963820|274832|P4|Expansion Phase|Withdrawal by Subject|0
76379|NCT00963820|274833|P3|Expansion Phase|Withdrawal by Subject|0
76380|NCT00963820|274834|P2|Expansion Phase|Withdrawal by Subject|0
76381|NCT00963820|274835|P1|Expansion Phase|Withdrawal by Subject|0
76382|NCT00963820|274824|P12|Expansion Phase|Adverse Event|0
76383|NCT00963820|274825|P11|Expansion Phase|Adverse Event|0
76384|NCT00963820|274826|P10|Expansion Phase|Adverse Event|3
76385|NCT00963820|274827|P9|Expansion Phase|Adverse Event|1
76386|NCT00963820|274828|P8|Expansion Phase|Adverse Event|0
76387|NCT00963820|274829|P7|Expansion Phase|Adverse Event|0
76388|NCT00963820|274830|P6|Expansion Phase|Adverse Event|0
76389|NCT00963820|274831|P5|Expansion Phase|Adverse Event|0
76390|NCT00963820|274832|P4|Expansion Phase|Adverse Event|0
76391|NCT00963820|274833|P3|Expansion Phase|Adverse Event|0
76392|NCT00963820|274834|P2|Expansion Phase|Adverse Event|0
76393|NCT00963820|274835|P1|Expansion Phase|Adverse Event|0
76394|NCT00963820|274824|P12|Expansion Phase|Progressive Disease|2
76395|NCT00963820|274825|P11|Expansion Phase|Progressive Disease|4
76396|NCT00963820|274826|P10|Expansion Phase|Progressive Disease|6
76397|NCT00963820|274827|P9|Expansion Phase|Progressive Disease|8
76398|NCT00963820|274828|P8|Expansion Phase|Progressive Disease|0
76399|NCT00963820|274829|P7|Expansion Phase|Progressive Disease|0
76400|NCT00963820|274830|P6|Expansion Phase|Progressive Disease|0
76401|NCT00963820|274831|P5|Expansion Phase|Progressive Disease|0
76402|NCT00963820|274832|P4|Expansion Phase|Progressive Disease|0
76403|NCT00963820|274833|P3|Expansion Phase|Progressive Disease|0
76404|NCT00963820|274834|P2|Expansion Phase|Progressive Disease|0
76405|NCT00963820|274835|P1|Expansion Phase|Progressive Disease|0
76406|NCT00963820|274824|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
76407|NCT00963820|274825|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
76408|NCT00963820|274826|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
76409|NCT00963820|274827|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
76410|NCT00963820|274828|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
76411|NCT00963820|274829|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
76412|NCT00963820|274830|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
76413|NCT00963820|274831|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
76414|NCT00963820|274832|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
76415|NCT00963820|274833|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
76416|NCT00963820|274834|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
76417|NCT00963820|274835|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
76418|NCT00963820|274824|P12|Dose Escalation Phase|Withdrawal by Subject|0
76419|NCT00963820|274825|P11|Dose Escalation Phase|Withdrawal by Subject|0
76420|NCT00963820|274826|P10|Dose Escalation Phase|Withdrawal by Subject|0
76421|NCT00963820|274827|P9|Dose Escalation Phase|Withdrawal by Subject|0
76422|NCT00963820|274828|P8|Dose Escalation Phase|Withdrawal by Subject|2
76423|NCT00963820|274829|P7|Dose Escalation Phase|Withdrawal by Subject|1
76424|NCT00963820|274830|P6|Dose Escalation Phase|Withdrawal by Subject|0
76425|NCT00963820|274831|P5|Dose Escalation Phase|Withdrawal by Subject|0
76426|NCT00963820|274832|P4|Dose Escalation Phase|Withdrawal by Subject|0
76427|NCT00963820|274833|P3|Dose Escalation Phase|Withdrawal by Subject|0
76428|NCT00963820|274834|P2|Dose Escalation Phase|Withdrawal by Subject|0
76429|NCT00963820|274835|P1|Dose Escalation Phase|Withdrawal by Subject|0
76430|NCT00963820|274824|P12|Dose Escalation Phase|Adverse Event|0
76431|NCT00963820|274825|P11|Dose Escalation Phase|Adverse Event|0
76432|NCT00963820|274826|P10|Dose Escalation Phase|Adverse Event|0
76433|NCT00963820|274827|P9|Dose Escalation Phase|Adverse Event|0
76434|NCT00963820|274828|P8|Dose Escalation Phase|Adverse Event|1
76435|NCT00963820|274829|P7|Dose Escalation Phase|Adverse Event|3
76436|NCT00963820|274830|P6|Dose Escalation Phase|Adverse Event|0
76437|NCT00963820|274831|P5|Dose Escalation Phase|Adverse Event|0
76438|NCT00963820|274832|P4|Dose Escalation Phase|Adverse Event|0
76439|NCT00963820|274833|P3|Dose Escalation Phase|Adverse Event|0
76440|NCT00963820|274834|P2|Dose Escalation Phase|Adverse Event|0
76441|NCT00963820|274835|P1|Dose Escalation Phase|Adverse Event|0
76442|NCT00963820|274824|P12|Dose Escalation Phase|Progressive Disease|0
76443|NCT00963820|274825|P11|Dose Escalation Phase|Progressive Disease|0
76444|NCT00963820|274826|P10|Dose Escalation Phase|Progressive Disease|0
76445|NCT00963820|274827|P9|Dose Escalation Phase|Progressive Disease|0
76446|NCT00963820|274828|P8|Dose Escalation Phase|Progressive Disease|2
76447|NCT00963820|274829|P7|Dose Escalation Phase|Progressive Disease|3
76448|NCT00963820|274830|P6|Dose Escalation Phase|Progressive Disease|3
76449|NCT00963820|274831|P5|Dose Escalation Phase|Progressive Disease|4
76450|NCT00963820|274832|P4|Dose Escalation Phase|Progressive Disease|3
76451|NCT00963820|274833|P3|Dose Escalation Phase|Progressive Disease|3
76452|NCT00963820|274834|P2|Dose Escalation Phase|Progressive Disease|3
76453|NCT00963820|274835|P1|Dose Escalation Phase|Progressive Disease|3
76454|NCT00963599|274995|P4|Overall Study|Withdrawal by Subject|3
76455|NCT00963599|274996|P3|Overall Study|Withdrawal by Subject|3
76456|NCT00963599|274997|P2|Overall Study|Withdrawal by Subject|1
76457|NCT00963599|274998|P1|Overall Study|Withdrawal by Subject|2
76458|NCT00963599|274995|P4|Overall Study|Protocol Violation|4
76459|NCT00963599|274996|P3|Overall Study|Protocol Violation|3
76460|NCT00963599|274997|P2|Overall Study|Protocol Violation|2
76461|NCT00963599|274998|P1|Overall Study|Protocol Violation|2
76462|NCT00963599|274995|P4|Overall Study|Lost to Follow-up|1
76463|NCT00963599|274996|P3|Overall Study|Lost to Follow-up|1
76464|NCT00963599|274997|P2|Overall Study|Lost to Follow-up|1
76465|NCT00963599|274998|P1|Overall Study|Lost to Follow-up|0
76466|NCT00963599|274995|P4|Overall Study|Lack of Efficacy|4
76467|NCT00963599|274996|P3|Overall Study|Lack of Efficacy|1
76468|NCT00963599|274997|P2|Overall Study|Lack of Efficacy|2
76469|NCT00963599|274998|P1|Overall Study|Lack of Efficacy|0
76470|NCT00963599|274995|P4|Overall Study|Adverse Event|2
76471|NCT00963599|274996|P3|Overall Study|Adverse Event|1
76472|NCT00963599|274997|P2|Overall Study|Adverse Event|0
76473|NCT00963599|274998|P1|Overall Study|Adverse Event|2
76474|NCT00963469|275088|P3|Overall Study|Site closed (local pollen Season ended)|3
76475|NCT00963469|275089|P2|Overall Study|Site closed (local pollen Season ended)|1
76476|NCT00963469|275090|P1|Overall Study|Site closed (local pollen Season ended)|4
76477|NCT00963469|275088|P3|Overall Study|Moved|0
76478|NCT00963469|275089|P2|Overall Study|Moved|0
76479|NCT00963469|275090|P1|Overall Study|Moved|1
76480|NCT00963469|275088|P3|Overall Study|Pre-randomization Adverse Event|0
76481|NCT00963469|275089|P2|Overall Study|Pre-randomization Adverse Event|2
76482|NCT00963469|275090|P1|Overall Study|Pre-randomization Adverse Event|1
76483|NCT00963469|275088|P3|Overall Study|Withdrawal by Subject|1
76484|NCT00963469|275089|P2|Overall Study|Withdrawal by Subject|1
76485|NCT00963469|275090|P1|Overall Study|Withdrawal by Subject|4
76486|NCT00963469|275088|P3|Overall Study|Protocol Violation|3
76487|NCT00963469|275089|P2|Overall Study|Protocol Violation|5
76488|NCT00963469|275090|P1|Overall Study|Protocol Violation|5
76489|NCT00963469|275088|P3|Overall Study|Lost to Follow-up|0
76490|NCT00963469|275089|P2|Overall Study|Lost to Follow-up|1
76491|NCT00963469|275090|P1|Overall Study|Lost to Follow-up|1
76492|NCT00963469|275088|P3|Overall Study|Lack of Efficacy|2
76493|NCT00963469|275089|P2|Overall Study|Lack of Efficacy|7
76494|NCT00963469|275090|P1|Overall Study|Lack of Efficacy|10
76495|NCT00963469|275088|P3|Overall Study|Adverse Event|1
76496|NCT00963469|275089|P2|Overall Study|Adverse Event|11
76497|NCT00963469|275090|P1|Overall Study|Adverse Event|15
76498|NCT00962780|275381|P2|Overall Study|Unspecified|1
76499|NCT00962780|275382|P1|Overall Study|Unspecified|0
76500|NCT00962780|275381|P2|Overall Study|Withdrawal by Subject|8
76501|NCT00962780|275382|P1|Overall Study|Withdrawal by Subject|1
76502|NCT00962780|275381|P2|Overall Study|Protocol Violation|4
76503|NCT00962780|275382|P1|Overall Study|Protocol Violation|9
76504|NCT00962780|275381|P2|Overall Study|Death|1
76505|NCT00962780|275382|P1|Overall Study|Death|0
76506|NCT00962741|275457|P1|Overall Study|drug ineffective+prohibited drug taken|1
76507|NCT00962741|275457|P1|Overall Study|Lack of Efficacy|1
76508|NCT00962741|275457|P1|Overall Study|Withdrawal by Subject|1
76509|NCT00962741|275457|P1|Overall Study|Lost to Follow-up|2
76510|NCT00962741|275457|P1|Overall Study|Failed to return|3
76511|NCT00962650|275548|P1|Overall Study|Transgastric DP was not completed|2
76512|NCT00962585|275556|P4|Overall Study|Withdrew Consent|0
76513|NCT00962585|275557|P3|Overall Study|Withdrew Consent|0
76514|NCT00962585|275558|P2|Overall Study|Withdrew Consent|0
76515|NCT00962585|275559|P1|Overall Study|Withdrew Consent|2
76516|NCT00962585|275556|P4|Overall Study|Withdrawal by Subject|0
76517|NCT00962585|275557|P3|Overall Study|Withdrawal by Subject|0
76518|NCT00962585|275558|P2|Overall Study|Withdrawal by Subject|0
76519|NCT00962585|275559|P1|Overall Study|Withdrawal by Subject|1
76520|NCT00962585|275556|P4|Overall Study|Protocol Violation|0
76521|NCT00962585|275557|P3|Overall Study|Protocol Violation|1
76522|NCT00962585|275558|P2|Overall Study|Protocol Violation|0
76523|NCT00962585|275559|P1|Overall Study|Protocol Violation|0
76524|NCT00962585|275556|P4|Overall Study|Lost to Follow-up|0
76525|NCT00962585|275557|P3|Overall Study|Lost to Follow-up|1
76526|NCT00962585|275558|P2|Overall Study|Lost to Follow-up|0
76527|NCT00962585|275559|P1|Overall Study|Lost to Follow-up|3
76528|NCT00962585|275556|P4|Overall Study|Adverse Event|0
76529|NCT00962585|275557|P3|Overall Study|Adverse Event|1
76530|NCT00962585|275558|P2|Overall Study|Adverse Event|2
76531|NCT00962585|275559|P1|Overall Study|Adverse Event|0
76532|NCT00962208|275619|P2|Overall Study|Lost to Follow-up|9
76533|NCT00962208|275620|P1|Overall Study|Lost to Follow-up|0
76534|NCT00962208|275619|P2|Overall Study|Contraindicated to continue study|1
76535|NCT00962208|275620|P1|Overall Study|Contraindicated to continue study|5
76536|NCT00962208|275619|P2|Overall Study|Could not achieve good vision|0
76537|NCT00962208|275620|P1|Overall Study|Could not achieve good vision|9
76538|NCT00962104|275628|P2|Overall Study|Other|0
76539|NCT00962104|275629|P1|Overall Study|Other|2
76540|NCT00962104|275628|P2|Overall Study|Withdrawal by Subject|6
76541|NCT00962104|275629|P1|Overall Study|Withdrawal by Subject|10
76542|NCT00962104|275628|P2|Overall Study|Sponsor Decision|1
76543|NCT00962104|275629|P1|Overall Study|Sponsor Decision|0
76544|NCT00962104|275628|P2|Overall Study|Protocol Violation|8
76545|NCT00962104|275629|P1|Overall Study|Protocol Violation|6
76546|NCT00962104|275628|P2|Overall Study|Physician Decision|0
76547|NCT00962104|275629|P1|Overall Study|Physician Decision|1
76548|NCT00962104|275628|P2|Overall Study|Lost to Follow-up|4
76549|NCT00962104|275629|P1|Overall Study|Lost to Follow-up|10
76550|NCT00962104|275628|P2|Overall Study|Lack of Efficacy|1
76551|NCT00962104|275629|P1|Overall Study|Lack of Efficacy|0
76552|NCT00962104|275628|P2|Overall Study|Entry Criteria Not Met|2
76553|NCT00962104|275629|P1|Overall Study|Entry Criteria Not Met|1
76554|NCT00962104|275628|P2|Overall Study|Adverse Event|3
76555|NCT00962104|275629|P1|Overall Study|Adverse Event|10
76556|NCT00962013|275683|P1|Overall Study|No 5 year evaluation|6
76557|NCT00962013|275683|P1|Overall Study|Site Termination|24
76558|NCT00962013|275683|P1|Overall Study|Removal of study device|3
76559|NCT00962013|275683|P1|Overall Study|Withdrawal by Subject|8
76560|NCT00962013|275683|P1|Overall Study|Unable/Unwilling to return|6
76561|NCT00962013|275683|P1|Overall Study|Lost to Follow-up|12
76562|NCT00962013|275683|P1|Overall Study|Death|8
76563|NCT00962013|275683|P1|Overall Study|Did not have surgery|1
76564|NCT00961896|275706|P3|Overall Study|Abnormal laboratory value|1
76565|NCT00961896|275707|P2|Overall Study|Abnormal laboratory value|0
76566|NCT00961896|275708|P1|Overall Study|Abnormal laboratory value|0
76567|NCT00961649|275775|P4|Overall Study|Study terminated by sponsor|1
76568|NCT00961649|275776|P3|Overall Study|Study terminated by sponsor|4
76569|NCT00961649|275777|P2|Overall Study|Study terminated by sponsor|4
76570|NCT00961649|275778|P1|Overall Study|Study terminated by sponsor|4
76571|NCT00961649|275775|P4|Overall Study|Patient left to Mexico-family emergency|0
76572|NCT00961649|275776|P3|Overall Study|Patient left to Mexico-family emergency|0
76573|NCT00961649|275777|P2|Overall Study|Patient left to Mexico-family emergency|0
76574|NCT00961649|275778|P1|Overall Study|Patient left to Mexico-family emergency|1
76575|NCT00961649|275775|P4|Overall Study|Patient has travel plans during holidays|0
76576|NCT00961649|275776|P3|Overall Study|Patient has travel plans during holidays|1
76577|NCT00961649|275777|P2|Overall Study|Patient has travel plans during holidays|0
76578|NCT00961649|275778|P1|Overall Study|Patient has travel plans during holidays|0
76579|NCT00961649|275775|P4|Overall Study|Inadequate control of IOP|1
76580|NCT00961649|275776|P3|Overall Study|Inadequate control of IOP|0
76581|NCT00961649|275777|P2|Overall Study|Inadequate control of IOP|0
76582|NCT00961649|275778|P1|Overall Study|Inadequate control of IOP|0
76583|NCT00961649|275775|P4|Overall Study|Adverse Event|2
76584|NCT00961649|275776|P3|Overall Study|Adverse Event|0
76585|NCT00961649|275777|P2|Overall Study|Adverse Event|0
76586|NCT00961649|275778|P1|Overall Study|Adverse Event|4
76587|NCT00961636|275792|P3|Overall Study|Withdrawal by Subject|13
76588|NCT00961636|275793|P2|Overall Study|Withdrawal by Subject|22
76589|NCT00961636|275794|P1|Overall Study|Withdrawal by Subject|29
76590|NCT00961636|275792|P3|Overall Study|Protocol Violation|1
76591|NCT00961636|275793|P2|Overall Study|Protocol Violation|5
76592|NCT00961636|275794|P1|Overall Study|Protocol Violation|9
76593|NCT00961636|275792|P3|Overall Study|Physician Decision|1
76594|NCT00961636|275793|P2|Overall Study|Physician Decision|1
76595|NCT00961636|275794|P1|Overall Study|Physician Decision|3
76596|NCT00961636|275792|P3|Overall Study|Lost to Follow-up|1
76597|NCT00961636|275793|P2|Overall Study|Lost to Follow-up|3
76598|NCT00961636|275794|P1|Overall Study|Lost to Follow-up|2
76599|NCT00961636|275792|P3|Overall Study|Flushing Symptoms|3
76600|NCT00961636|275793|P2|Overall Study|Flushing Symptoms|46
76601|NCT00961636|275794|P1|Overall Study|Flushing Symptoms|29
76602|NCT00961636|275792|P3|Overall Study|Adverse Event|13
76603|NCT00961636|275793|P2|Overall Study|Adverse Event|54
76604|NCT00961636|275794|P1|Overall Study|Adverse Event|35
76605|NCT00961415|275829|P3|Maintenance Treatment Phase|Other reason|3
76606|NCT00961415|275830|P2|Maintenance Treatment Phase|Other reason|1
76607|NCT00961415|275831|P1|Maintenance Treatment Phase|Other reason|0
76608|NCT00961415|275829|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
76609|NCT00961415|275830|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
76610|NCT00961415|275831|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
76611|NCT00961415|275829|P3|Maintenance Treatment Phase|Investigators decision|0
76612|NCT00961415|275830|P2|Maintenance Treatment Phase|Investigators decision|2
76613|NCT00961415|275831|P1|Maintenance Treatment Phase|Investigators decision|0
76614|NCT00961415|275829|P3|Maintenance Treatment Phase|Death|34
76615|NCT00961415|275830|P2|Maintenance Treatment Phase|Death|42
76616|NCT00961415|275831|P1|Maintenance Treatment Phase|Death|0
76617|NCT00961415|275829|P3|Induction Treatment Phase|Other Reason|0
76618|NCT00961415|275830|P2|Induction Treatment Phase|Other Reason|0
76619|NCT00961415|275831|P1|Induction Treatment Phase|Other Reason|5
76620|NCT00961415|275829|P3|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
76621|NCT00961415|275830|P2|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
76622|NCT00961415|275831|P1|Induction Treatment Phase|Didn’t meet maintenance phase criteria|27
76623|NCT00961415|275829|P3|Induction Treatment Phase|Physician Decision|0
76624|NCT00961415|275830|P2|Induction Treatment Phase|Physician Decision|0
76625|NCT00961415|275831|P1|Induction Treatment Phase|Physician Decision|2
76626|NCT00961415|275829|P3|Induction Treatment Phase|Protocol Violation|0
76627|NCT00961415|275830|P2|Induction Treatment Phase|Protocol Violation|0
76628|NCT00961415|275831|P1|Induction Treatment Phase|Protocol Violation|1
76629|NCT00961415|275829|P3|Induction Treatment Phase|Death|0
76630|NCT00961415|275830|P2|Induction Treatment Phase|Death|0
76631|NCT00961415|275831|P1|Induction Treatment Phase|Death|77
76632|NCT00961415|275829|P3|Induction Treatment Phase|Withdrawal by Subject|0
76633|NCT00961415|275830|P2|Induction Treatment Phase|Withdrawal by Subject|0
76634|NCT00961415|275831|P1|Induction Treatment Phase|Withdrawal by Subject|11
76635|NCT00961350|275871|P2|Overall Study|Misc|21
76636|NCT00961350|275872|P1|Overall Study|Misc|16
76637|NCT00961350|275871|P2|Overall Study|Lost to Follow-up|3
76638|NCT00961350|275872|P1|Overall Study|Lost to Follow-up|3
76639|NCT00961350|275871|P2|Overall Study|Withdrawal by Subject|10
76640|NCT00961350|275872|P1|Overall Study|Withdrawal by Subject|10
76641|NCT00961350|275871|P2|Overall Study|Adverse Event|33
76642|NCT00961350|275872|P1|Overall Study|Adverse Event|18
76643|NCT00961298|275893|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
76644|NCT00961298|275893|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
76645|NCT00961298|275893|P1|Two Week Placebo Run in|Withdrawal by Subject|1
76646|NCT00961259|275900|P3|Washout Period of 7 Days|due to concomitant medication used|0
76647|NCT00961259|275901|P2|Washout Period of 7 Days|due to concomitant medication used|1
76648|NCT00961259|275902|P1|Washout Period of 7 Days|due to concomitant medication used|0
76649|NCT00961220|275930|P1|Overall Study|Complete Response prior to 12 courses|1
76650|NCT00961220|275930|P1|Overall Study|O6BG no longer supplied|1
76651|NCT00961220|275930|P1|Overall Study|No IV access for O6BG|1
76652|NCT00961220|275930|P1|Overall Study|Lack of Efficacy|1
76653|NCT00961220|275930|P1|Overall Study|Adverse Event|3
76654|NCT00961181|275946|P1|Overall Study|Lost to Follow-up|1
76655|NCT00961181|275946|P1|Overall Study|Withdrawal by Subject|2
76656|NCT00961181|275946|P1|Overall Study|Death|2
76657|NCT00961116|275959|P2|Washout Period of 7 Days|Protocol Violation|1
76658|NCT00961116|275960|P1|Washout Period of 7 Days|Protocol Violation|0
76659|NCT00961116|275959|P2|Washout Period of 7 Days|Withdrawal by Subject|1
76660|NCT00961116|275960|P1|Washout Period of 7 Days|Withdrawal by Subject|1
76661|NCT00961116|275959|P2|Washout Period of 7 Days|Adverse Event|1
76662|NCT00961116|275960|P1|Washout Period of 7 Days|Adverse Event|1
76663|NCT00960999|275983|P2|Overall Study|RT dose constraints not met|0
76664|NCT00960999|275984|P1|Overall Study|RT dose constraints not met|2
76665|NCT00960999|275983|P2|Overall Study|Protocol Violation|2
76666|NCT00960999|275984|P1|Overall Study|Protocol Violation|5
76667|NCT00960999|275983|P2|Overall Study|Withdrawal by Subject|0
76668|NCT00960999|275984|P1|Overall Study|Withdrawal by Subject|1
76669|NCT00960986|275994|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
76670|NCT00960986|275995|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
76671|NCT00960986|275996|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
76672|NCT00960986|275997|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
76673|NCT00960986|275994|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
76674|NCT00960986|275995|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
76675|NCT00960986|275996|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
76676|NCT00960986|275997|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
76677|NCT00960986|275994|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
76678|NCT00960986|275995|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
76679|NCT00960986|275996|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
76680|NCT00960986|275997|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
76681|NCT00960986|275994|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
76682|NCT00960986|275995|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
76683|NCT00960986|275996|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
76684|NCT00960986|275997|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
76685|NCT00960986|275994|P4|Period 3 (7-week Therapy Period)|Death|0
76686|NCT00960986|275995|P3|Period 3 (7-week Therapy Period)|Death|1
76687|NCT00960986|275996|P2|Period 3 (7-week Therapy Period)|Death|0
76688|NCT00960986|275997|P1|Period 3 (7-week Therapy Period)|Death|0
76689|NCT00960986|275994|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
76690|NCT00960986|275995|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
76691|NCT00960986|275996|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
76692|NCT00960986|275997|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
76693|NCT00960986|275994|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
76694|NCT00960986|275995|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
76695|NCT00960986|275996|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
76696|NCT00960986|275997|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
76697|NCT00960986|275994|P4|Period 1 (Screening and Washout)|Protocol Violation|0
76698|NCT00960986|275995|P3|Period 1 (Screening and Washout)|Protocol Violation|0
76699|NCT00960986|275996|P2|Period 1 (Screening and Washout)|Protocol Violation|0
76700|NCT00960986|275997|P1|Period 1 (Screening and Washout)|Protocol Violation|1
76701|NCT00960986|275994|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
76702|NCT00960986|275995|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
76703|NCT00960986|275996|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
76704|NCT00960986|275997|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
76705|NCT00960986|275994|P4|Period 1 (Screening and Washout)|Adverse Event|1
76706|NCT00960986|275995|P3|Period 1 (Screening and Washout)|Adverse Event|1
76707|NCT00960986|275996|P2|Period 1 (Screening and Washout)|Adverse Event|2
76708|NCT00960986|275997|P1|Period 1 (Screening and Washout)|Adverse Event|1
76709|NCT00960934|276073|P6|Overall Study|Study Terminated by Sponsor|49
76710|NCT00960934|276074|P5|Overall Study|Study Terminated by Sponsor|49
76711|NCT00960934|276075|P4|Overall Study|Study Terminated by Sponsor|50
76712|NCT00960934|276076|P3|Overall Study|Study Terminated by Sponsor|52
76713|NCT00960934|276077|P2|Overall Study|Study Terminated by Sponsor|46
76714|NCT00960934|276078|P1|Overall Study|Study Terminated by Sponsor|50
76715|NCT00960934|276073|P6|Overall Study|Withdrawal by Subject|7
76716|NCT00960934|276074|P5|Overall Study|Withdrawal by Subject|5
76717|NCT00960934|276075|P4|Overall Study|Withdrawal by Subject|5
76718|NCT00960934|276076|P3|Overall Study|Withdrawal by Subject|4
76719|NCT00960934|276077|P2|Overall Study|Withdrawal by Subject|6
76720|NCT00960934|276078|P1|Overall Study|Withdrawal by Subject|5
76721|NCT00960934|276073|P6|Overall Study|Protocol Violation|2
76722|NCT00960934|276074|P5|Overall Study|Protocol Violation|3
76723|NCT00960934|276075|P4|Overall Study|Protocol Violation|3
76724|NCT00960934|276076|P3|Overall Study|Protocol Violation|0
76725|NCT00960934|276077|P2|Overall Study|Protocol Violation|4
76726|NCT00960934|276078|P1|Overall Study|Protocol Violation|3
76727|NCT00960934|276073|P6|Overall Study|Progressive Disease|1
76728|NCT00960934|276074|P5|Overall Study|Progressive Disease|1
76729|NCT00960934|276075|P4|Overall Study|Progressive Disease|0
76730|NCT00960934|276076|P3|Overall Study|Progressive Disease|0
76731|NCT00960934|276077|P2|Overall Study|Progressive Disease|1
76732|NCT00960934|276078|P1|Overall Study|Progressive Disease|1
76733|NCT00960934|276073|P6|Overall Study|Physician Decision|0
76734|NCT00960934|276074|P5|Overall Study|Physician Decision|0
76735|NCT00960934|276075|P4|Overall Study|Physician Decision|0
76736|NCT00960934|276076|P3|Overall Study|Physician Decision|0
76737|NCT00960934|276077|P2|Overall Study|Physician Decision|1
76738|NCT00960934|276078|P1|Overall Study|Physician Decision|0
76739|NCT00960934|276073|P6|Overall Study|Not Specified|2
76740|NCT00960934|276074|P5|Overall Study|Not Specified|2
76741|NCT00960934|276075|P4|Overall Study|Not Specified|4
76742|NCT00960934|276076|P3|Overall Study|Not Specified|5
76743|NCT00960934|276077|P2|Overall Study|Not Specified|1
76744|NCT00960934|276078|P1|Overall Study|Not Specified|2
76745|NCT00960934|276073|P6|Overall Study|Lost to Follow-up|0
76746|NCT00960934|276074|P5|Overall Study|Lost to Follow-up|0
76747|NCT00960934|276075|P4|Overall Study|Lost to Follow-up|0
76748|NCT00960934|276076|P3|Overall Study|Lost to Follow-up|0
76749|NCT00960934|276077|P2|Overall Study|Lost to Follow-up|1
76750|NCT00960934|276078|P1|Overall Study|Lost to Follow-up|0
76751|NCT00960934|276073|P6|Overall Study|Lack of Efficacy|0
76752|NCT00960934|276074|P5|Overall Study|Lack of Efficacy|0
76753|NCT00960934|276075|P4|Overall Study|Lack of Efficacy|0
76754|NCT00960934|276076|P3|Overall Study|Lack of Efficacy|0
76755|NCT00960934|276077|P2|Overall Study|Lack of Efficacy|0
76756|NCT00960934|276078|P1|Overall Study|Lack of Efficacy|1
76757|NCT00960934|276073|P6|Overall Study|Adverse Event|3
76758|NCT00960934|276074|P5|Overall Study|Adverse Event|4
76759|NCT00960934|276075|P4|Overall Study|Adverse Event|2
76760|NCT00960934|276076|P3|Overall Study|Adverse Event|3
76761|NCT00960934|276077|P2|Overall Study|Adverse Event|3
76762|NCT00960934|276078|P1|Overall Study|Adverse Event|2
76763|NCT00960869|276190|P2|Overall Study|Misc|18
76764|NCT00960869|276191|P1|Overall Study|Misc|19
76765|NCT00960869|276190|P2|Overall Study|Lost to Follow-up|4
76766|NCT00960869|276191|P1|Overall Study|Lost to Follow-up|1
76767|NCT00960869|276190|P2|Overall Study|Withdrawal by Subject|14
76768|NCT00960869|276191|P1|Overall Study|Withdrawal by Subject|16
76769|NCT00960869|276190|P2|Overall Study|Adverse Event|26
76770|NCT00960869|276191|P1|Overall Study|Adverse Event|17
76771|NCT00960856|276205|P4|Washout Period of 7 Days|Adverse Event|0
76772|NCT00960856|276206|P3|Washout Period of 7 Days|Adverse Event|1
76773|NCT00960856|276207|P2|Washout Period of 7 Days|Adverse Event|0
76774|NCT00960856|276208|P1|Washout Period of 7 Days|Adverse Event|0
76775|NCT00960856|276205|P4|Washout Period of 7 Days|Withdrawal by Subject|0
76776|NCT00960856|276206|P3|Washout Period of 7 Days|Withdrawal by Subject|0
76777|NCT00960856|276207|P2|Washout Period of 7 Days|Withdrawal by Subject|2
76778|NCT00960856|276208|P1|Washout Period of 7 Days|Withdrawal by Subject|0
76779|NCT00960843|276228|P2|Overall Study|Repeated needle dislodgment|1
76780|NCT00960843|276229|P1|Overall Study|Repeated needle dislodgment|0
76781|NCT00960843|276228|P2|Overall Study|Protocol Violation|4
76782|NCT00960843|276229|P1|Overall Study|Protocol Violation|0
76783|NCT00960843|276228|P2|Overall Study|Lost to Follow-up|0
76784|NCT00960843|276229|P1|Overall Study|Lost to Follow-up|2
76785|NCT00960687|276239|P2|Washout Period of 7 Days|Withdrawal by Subject|1
76786|NCT00960687|276240|P1|Washout Period of 7 Days|Withdrawal by Subject|1
76787|NCT00960687|276239|P2|Washout Period of 7 Days|Adverse Event|2
76788|NCT00960687|276240|P1|Washout Period of 7 Days|Adverse Event|3
76789|NCT00960661|276252|P3|Interventional Phase|Lack of Efficacy|0
76790|NCT00960661|276253|P2|Interventional Phase|Lack of Efficacy|2
76791|NCT00960661|276254|P1|Interventional Phase|Lack of Efficacy|0
76792|NCT00960661|276252|P3|Interventional Phase|sponsor decision|0
76793|NCT00960661|276253|P2|Interventional Phase|sponsor decision|1
76794|NCT00960661|276254|P1|Interventional Phase|sponsor decision|0
76795|NCT00960661|276252|P3|Interventional Phase|Physician Decision|5
76796|NCT00960661|276253|P2|Interventional Phase|Physician Decision|3
76797|NCT00960661|276254|P1|Interventional Phase|Physician Decision|0
76798|NCT00960661|276252|P3|Interventional Phase|Withdrawal by Subject|29
76799|NCT00960661|276253|P2|Interventional Phase|Withdrawal by Subject|18
76800|NCT00960661|276254|P1|Interventional Phase|Withdrawal by Subject|0
76801|NCT00960661|276252|P3|Interventional Phase|Protocol Violation|2
76802|NCT00960661|276253|P2|Interventional Phase|Protocol Violation|7
76803|NCT00960661|276254|P1|Interventional Phase|Protocol Violation|0
76804|NCT00960661|276252|P3|Interventional Phase|entry criteria not met|0
76805|NCT00960661|276253|P2|Interventional Phase|entry criteria not met|3
76806|NCT00960661|276254|P1|Interventional Phase|entry criteria not met|0
76807|NCT00960661|276252|P3|Interventional Phase|Lost to Follow-up|2
76808|NCT00960661|276253|P2|Interventional Phase|Lost to Follow-up|0
76809|NCT00960661|276254|P1|Interventional Phase|Lost to Follow-up|0
76810|NCT00960661|276252|P3|Interventional Phase|Death|0
76811|NCT00960661|276253|P2|Interventional Phase|Death|1
76812|NCT00960661|276254|P1|Interventional Phase|Death|0
76813|NCT00960661|276252|P3|Interventional Phase|Adverse Event|8
76814|NCT00960661|276253|P2|Interventional Phase|Adverse Event|17
76815|NCT00960661|276254|P1|Interventional Phase|Adverse Event|0
76816|NCT00960661|276252|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
76817|NCT00960661|276253|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
76818|NCT00960661|276254|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
76819|NCT00960661|276252|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
76820|NCT00960661|276253|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
76821|NCT00960661|276254|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
76822|NCT00960661|276252|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
76823|NCT00960661|276253|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
76824|NCT00960661|276254|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
76825|NCT00960661|276252|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
76826|NCT00960661|276253|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
76827|NCT00960661|276254|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
76828|NCT00960661|276252|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
76829|NCT00960661|276253|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
76830|NCT00960661|276254|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
76831|NCT00960661|276252|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
76832|NCT00960661|276253|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
76833|NCT00960661|276254|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
76834|NCT00960570|276293|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
76835|NCT00960570|276293|P1|1 Day Period Between Dosing|Adverse Event|2
76836|NCT00960570|276293|P1|21 Day Washout Period|Withdrawal by Subject|1
76837|NCT00960570|276293|P1|21 Day Washout Period|Adverse Event|1
76838|NCT00960531|276314|P10|Overall Study|Reason not Specified|1
76839|NCT00960531|276315|P9|Overall Study|Reason not Specified|8
76840|NCT00960531|276316|P8|Overall Study|Reason not Specified|0
76841|NCT00960531|276317|P7|Overall Study|Reason not Specified|16
76842|NCT00960531|276318|P6|Overall Study|Reason not Specified|0
76843|NCT00960531|276319|P5|Overall Study|Reason not Specified|2
76844|NCT00960531|276320|P4|Overall Study|Reason not Specified|1
76845|NCT00960531|276321|P3|Overall Study|Reason not Specified|13
76846|NCT00960531|276322|P2|Overall Study|Reason not Specified|1
76847|NCT00960531|276323|P1|Overall Study|Reason not Specified|2
76848|NCT00960531|276314|P10|Overall Study|Adverse Event (AE)|0
76849|NCT00960531|276315|P9|Overall Study|Adverse Event (AE)|2
76850|NCT00960531|276316|P8|Overall Study|Adverse Event (AE)|0
76851|NCT00960531|276317|P7|Overall Study|Adverse Event (AE)|2
76852|NCT00960531|276318|P6|Overall Study|Adverse Event (AE)|1
76853|NCT00960531|276319|P5|Overall Study|Adverse Event (AE)|0
76854|NCT00960531|276320|P4|Overall Study|Adverse Event (AE)|0
76855|NCT00960531|276321|P3|Overall Study|Adverse Event (AE)|0
76856|NCT00960531|276322|P2|Overall Study|Adverse Event (AE)|0
76857|NCT00960531|276323|P1|Overall Study|Adverse Event (AE)|2
76858|NCT00960531|276314|P10|Overall Study|Failed to Return|0
76859|NCT00960531|276315|P9|Overall Study|Failed to Return|0
76860|NCT00960531|276316|P8|Overall Study|Failed to Return|2
76861|NCT00960531|276317|P7|Overall Study|Failed to Return|0
76862|NCT00960531|276318|P6|Overall Study|Failed to Return|0
76863|NCT00960531|276319|P5|Overall Study|Failed to Return|0
76864|NCT00960531|276320|P4|Overall Study|Failed to Return|0
76865|NCT00960531|276321|P3|Overall Study|Failed to Return|0
76866|NCT00960531|276322|P2|Overall Study|Failed to Return|0
76867|NCT00960531|276323|P1|Overall Study|Failed to Return|2
76868|NCT00960531|276314|P10|Overall Study|Lost to Follow-up|0
76869|NCT00960531|276315|P9|Overall Study|Lost to Follow-up|0
76870|NCT00960531|276316|P8|Overall Study|Lost to Follow-up|0
76871|NCT00960531|276317|P7|Overall Study|Lost to Follow-up|1
76872|NCT00960531|276318|P6|Overall Study|Lost to Follow-up|0
76873|NCT00960531|276319|P5|Overall Study|Lost to Follow-up|0
76874|NCT00960531|276320|P4|Overall Study|Lost to Follow-up|0
76875|NCT00960531|276321|P3|Overall Study|Lost to Follow-up|1
76876|NCT00960531|276322|P2|Overall Study|Lost to Follow-up|0
76877|NCT00960531|276323|P1|Overall Study|Lost to Follow-up|0
76878|NCT00960531|276314|P10|Overall Study|Discontinuation of Study by Sponsor|0
76879|NCT00960531|276315|P9|Overall Study|Discontinuation of Study by Sponsor|0
76880|NCT00960531|276316|P8|Overall Study|Discontinuation of Study by Sponsor|1
76881|NCT00960531|276317|P7|Overall Study|Discontinuation of Study by Sponsor|0
76882|NCT00960531|276318|P6|Overall Study|Discontinuation of Study by Sponsor|0
76883|NCT00960531|276319|P5|Overall Study|Discontinuation of Study by Sponsor|0
76884|NCT00960531|276320|P4|Overall Study|Discontinuation of Study by Sponsor|0
76885|NCT00960531|276321|P3|Overall Study|Discontinuation of Study by Sponsor|0
76886|NCT00960531|276322|P2|Overall Study|Discontinuation of Study by Sponsor|0
76887|NCT00960531|276323|P1|Overall Study|Discontinuation of Study by Sponsor|0
76888|NCT00960531|276314|P10|Overall Study|Investigator Request|0
76889|NCT00960531|276315|P9|Overall Study|Investigator Request|0
76890|NCT00960531|276316|P8|Overall Study|Investigator Request|0
76891|NCT00960531|276317|P7|Overall Study|Investigator Request|0
76892|NCT00960531|276318|P6|Overall Study|Investigator Request|0
76893|NCT00960531|276319|P5|Overall Study|Investigator Request|0
76894|NCT00960531|276320|P4|Overall Study|Investigator Request|0
76895|NCT00960531|276321|P3|Overall Study|Investigator Request|1
76896|NCT00960531|276322|P2|Overall Study|Investigator Request|0
76897|NCT00960531|276323|P1|Overall Study|Investigator Request|0
76898|NCT00960531|276314|P10|Overall Study|Caregiver Request|0
76899|NCT00960531|276315|P9|Overall Study|Caregiver Request|3
76900|NCT00960531|276316|P8|Overall Study|Caregiver Request|1
76901|NCT00960531|276317|P7|Overall Study|Caregiver Request|3
76902|NCT00960531|276318|P6|Overall Study|Caregiver Request|2
76903|NCT00960531|276319|P5|Overall Study|Caregiver Request|0
76904|NCT00960531|276320|P4|Overall Study|Caregiver Request|5
76905|NCT00960531|276321|P3|Overall Study|Caregiver Request|6
76906|NCT00960531|276322|P2|Overall Study|Caregiver Request|0
76907|NCT00960531|276323|P1|Overall Study|Caregiver Request|2
76908|NCT00960531|276314|P10|Overall Study|Withdrawal by Subject|0
76909|NCT00960531|276315|P9|Overall Study|Withdrawal by Subject|1
76910|NCT00960531|276316|P8|Overall Study|Withdrawal by Subject|0
76911|NCT00960531|276317|P7|Overall Study|Withdrawal by Subject|2
76912|NCT00960531|276318|P6|Overall Study|Withdrawal by Subject|0
76913|NCT00960531|276319|P5|Overall Study|Withdrawal by Subject|0
76914|NCT00960531|276320|P4|Overall Study|Withdrawal by Subject|2
76915|NCT00960531|276321|P3|Overall Study|Withdrawal by Subject|5
76916|NCT00960531|276322|P2|Overall Study|Withdrawal by Subject|0
76917|NCT00960531|276323|P1|Overall Study|Withdrawal by Subject|1
76918|NCT00960531|276314|P10|Overall Study|Lack of Efficacy|0
76919|NCT00960531|276315|P9|Overall Study|Lack of Efficacy|0
76920|NCT00960531|276316|P8|Overall Study|Lack of Efficacy|0
76921|NCT00960531|276317|P7|Overall Study|Lack of Efficacy|0
76922|NCT00960531|276318|P6|Overall Study|Lack of Efficacy|0
76923|NCT00960531|276319|P5|Overall Study|Lack of Efficacy|0
76924|NCT00960531|276320|P4|Overall Study|Lack of Efficacy|0
76925|NCT00960531|276321|P3|Overall Study|Lack of Efficacy|0
76926|NCT00960531|276322|P2|Overall Study|Lack of Efficacy|0
76927|NCT00960531|276323|P1|Overall Study|Lack of Efficacy|1
76928|NCT00960440|276371|P4|Overall Study|Unspecified|0
76929|NCT00960440|276372|P3|Overall Study|Unspecified|1
76930|NCT00960440|276373|P2|Overall Study|Unspecified|1
76931|NCT00960440|276374|P1|Overall Study|Unspecified|1
76932|NCT00960440|276371|P4|Overall Study|Withdrawal by Subject|1
76933|NCT00960440|276372|P3|Overall Study|Withdrawal by Subject|2
76934|NCT00960440|276373|P2|Overall Study|Withdrawal by Subject|5
76935|NCT00960440|276374|P1|Overall Study|Withdrawal by Subject|9
76936|NCT00960440|276371|P4|Overall Study|Protocol Violation|4
76937|NCT00960440|276372|P3|Overall Study|Protocol Violation|3
76938|NCT00960440|276373|P2|Overall Study|Protocol Violation|8
76939|NCT00960440|276374|P1|Overall Study|Protocol Violation|2
76940|NCT00960440|276371|P4|Overall Study|Lack of Efficacy|8
76941|NCT00960440|276372|P3|Overall Study|Lack of Efficacy|3
76942|NCT00960440|276373|P2|Overall Study|Lack of Efficacy|5
76943|NCT00960440|276374|P1|Overall Study|Lack of Efficacy|2
76944|NCT00960440|276371|P4|Overall Study|Adverse Event|4
76945|NCT00960440|276372|P3|Overall Study|Adverse Event|4
76946|NCT00960440|276373|P2|Overall Study|Adverse Event|12
76947|NCT00960440|276374|P1|Overall Study|Adverse Event|12
76948|NCT00960440|276371|P4|Overall Study|Death|1
76949|NCT00960440|276372|P3|Overall Study|Death|0
76950|NCT00960440|276373|P2|Overall Study|Death|0
76951|NCT00960440|276374|P1|Overall Study|Death|0
76952|NCT00960375|276546|P2|Overall Study|Lost to Follow-up|22
76953|NCT00960375|276547|P1|Overall Study|Lost to Follow-up|20
76954|NCT00960323|276555|P1|Atorvastatin Alone|Withdrawal by Subject|1
76955|NCT00960297|276566|P1|Overall Study|Disease progression|1
76956|NCT00960297|276566|P1|Overall Study|Venous port infection|1
76957|NCT00960297|276566|P1|Overall Study|Physician Decision|1
76958|NCT00960206|276573|P3|Overall Study|Missing 10 year data|1
76959|NCT00960206|276574|P2|Overall Study|Missing 10 year data|1
76960|NCT00960206|276575|P1|Overall Study|Missing 10 year data|20
76961|NCT00960206|276573|P3|Overall Study|Revision of study component|2
76962|NCT00960206|276574|P2|Overall Study|Revision of study component|2
76963|NCT00960206|276575|P1|Overall Study|Revision of study component|2
76964|NCT00960206|276573|P3|Overall Study|Withdrawal by Subject|0
76965|NCT00960206|276574|P2|Overall Study|Withdrawal by Subject|4
76966|NCT00960206|276575|P1|Overall Study|Withdrawal by Subject|2
76967|NCT00960206|276573|P3|Overall Study|Lost to Follow-up|8
76968|NCT00960206|276574|P2|Overall Study|Lost to Follow-up|14
76969|NCT00960206|276575|P1|Overall Study|Lost to Follow-up|8
76970|NCT00960206|276573|P3|Overall Study|Unwilling/Unable to return|0
76971|NCT00960206|276574|P2|Overall Study|Unwilling/Unable to return|2
76972|NCT00960206|276575|P1|Overall Study|Unwilling/Unable to return|1
76973|NCT00960206|276573|P3|Overall Study|Death|1
76974|NCT00960206|276574|P2|Overall Study|Death|4
76975|NCT00960206|276575|P1|Overall Study|Death|7
76976|NCT00960193|276593|P1|14 Day Washout Period|Withdrawal by Subject|1
76977|NCT00960154|276606|P2|Overall Study|Study termination|25
76978|NCT00960154|276607|P1|Overall Study|Study termination|25
76979|NCT00960141|276618|P3|Overall Study|Withdrawal by Subject|1
76980|NCT00960141|276619|P2|Overall Study|Withdrawal by Subject|2
76981|NCT00960141|276620|P1|Overall Study|Withdrawal by Subject|1
76982|NCT00960141|276618|P3|Overall Study|Protocol Violation|2
76983|NCT00960141|276619|P2|Overall Study|Protocol Violation|3
76984|NCT00960141|276620|P1|Overall Study|Protocol Violation|1
76985|NCT00960141|276618|P3|Overall Study|Lost to Follow-up|0
76986|NCT00960141|276619|P2|Overall Study|Lost to Follow-up|0
76987|NCT00960141|276620|P1|Overall Study|Lost to Follow-up|1
76988|NCT00960141|276618|P3|Overall Study|Lack of Efficacy|2
76989|NCT00960141|276619|P2|Overall Study|Lack of Efficacy|4
76990|NCT00960141|276620|P1|Overall Study|Lack of Efficacy|3
76991|NCT00960141|276618|P3|Overall Study|Adverse Event|2
76992|NCT00960141|276619|P2|Overall Study|Adverse Event|8
76993|NCT00960141|276620|P1|Overall Study|Adverse Event|4
76994|NCT00960115|276645|P2|Overall Study|Ongoing treatment at data cut-off date|15
76995|NCT00960115|276646|P1|Overall Study|Ongoing treatment at data cut-off date|19
76996|NCT00960076|276660|P2|Overall Study|Did not attend the termination visit|1
76997|NCT00960076|276661|P1|Overall Study|Did not attend the termination visit|0
76998|NCT00960076|276660|P2|Overall Study|Hyperglycemia|5
76999|NCT00960076|276661|P1|Overall Study|Hyperglycemia|1
77000|NCT00960076|276660|P2|Overall Study|Severe non-compliance to protocol|2
77001|NCT00960076|276661|P1|Overall Study|Severe non-compliance to protocol|1
77002|NCT00960076|276660|P2|Overall Study|Lost to Follow-up|3
77003|NCT00960076|276661|P1|Overall Study|Lost to Follow-up|3
77004|NCT00960076|276660|P2|Overall Study|Withdrawal by Subject|2
77005|NCT00960076|276661|P1|Overall Study|Withdrawal by Subject|1
77006|NCT00960076|276660|P2|Overall Study|No longer met study criteria|5
77007|NCT00960076|276661|P1|Overall Study|No longer met study criteria|1
77008|NCT00960076|276660|P2|Overall Study|Adverse Event|7
77009|NCT00960076|276661|P1|Overall Study|Adverse Event|1
77010|NCT00960063|276676|P3|Overall Study|Progression of Disease|3
77011|NCT00960063|276677|P2|Overall Study|Progression of Disease|0
77012|NCT00960063|276678|P1|Overall Study|Progression of Disease|0
77013|NCT00960063|276676|P3|Overall Study|Adverse Event|0
77014|NCT00960063|276677|P2|Overall Study|Adverse Event|0
77015|NCT00960063|276678|P1|Overall Study|Adverse Event|1
77016|NCT00959946|276724|P8|Overall Study|Withdrawal by Subject|0
77017|NCT00959946|276725|P7|Overall Study|Withdrawal by Subject|0
77018|NCT00959946|276726|P6|Overall Study|Withdrawal by Subject|1
77019|NCT00959946|276727|P5|Overall Study|Withdrawal by Subject|0
77020|NCT00959946|276728|P4|Overall Study|Withdrawal by Subject|0
77021|NCT00959946|276729|P3|Overall Study|Withdrawal by Subject|0
77022|NCT00959946|276730|P2|Overall Study|Withdrawal by Subject|0
77023|NCT00959946|276731|P1|Overall Study|Withdrawal by Subject|0
77024|NCT00959946|276724|P8|Overall Study|Disease Progression|2
77025|NCT00959946|276725|P7|Overall Study|Disease Progression|2
77026|NCT00959946|276726|P6|Overall Study|Disease Progression|6
77027|NCT00959946|276727|P5|Overall Study|Disease Progression|4
77028|NCT00959946|276728|P4|Overall Study|Disease Progression|4
77029|NCT00959946|276729|P3|Overall Study|Disease Progression|2
77030|NCT00959946|276730|P2|Overall Study|Disease Progression|4
77031|NCT00959946|276731|P1|Overall Study|Disease Progression|2
77032|NCT00959946|276724|P8|Overall Study|Death|0
77033|NCT00959946|276725|P7|Overall Study|Death|0
77034|NCT00959946|276726|P6|Overall Study|Death|1
77035|NCT00959946|276727|P5|Overall Study|Death|0
77036|NCT00959946|276728|P4|Overall Study|Death|0
77037|NCT00959946|276729|P3|Overall Study|Death|0
77038|NCT00959946|276730|P2|Overall Study|Death|0
77039|NCT00959946|276731|P1|Overall Study|Death|0
77040|NCT00959946|276724|P8|Overall Study|Adverse Event|0
77041|NCT00959946|276725|P7|Overall Study|Adverse Event|0
77042|NCT00959946|276726|P6|Overall Study|Adverse Event|1
77043|NCT00959946|276727|P5|Overall Study|Adverse Event|0
77044|NCT00959946|276728|P4|Overall Study|Adverse Event|1
77045|NCT00959946|276729|P3|Overall Study|Adverse Event|2
77046|NCT00959946|276730|P2|Overall Study|Adverse Event|0
77047|NCT00959946|276731|P1|Overall Study|Adverse Event|0
77048|NCT00959907|276793|P2|Overall Study|Withdrawal by Subject|0
77049|NCT00959907|276794|P1|Overall Study|Withdrawal by Subject|2
77050|NCT00959907|276793|P2|Overall Study|Adverse Event|0
77051|NCT00959907|276794|P1|Overall Study|Adverse Event|1
77052|NCT00959907|276793|P2|Overall Study|Protocol Violation|1
77053|NCT00959907|276794|P1|Overall Study|Protocol Violation|0
77054|NCT00959894|276804|P1|Overall Study|Subject moved out of town|1
77055|NCT00959894|276804|P1|Overall Study|Need for contraindicated medication|1
77056|NCT00959894|276804|P1|Overall Study|Withdrawal by Subject|1
77057|NCT00959894|276804|P1|Overall Study|Adverse Event|3
77058|NCT00959894|276804|P1|Overall Study|Lost to Follow-up|10
77059|NCT00959751|276853|P2|Overall Study|No migraine headache without aura|7
77060|NCT00959751|276854|P1|Overall Study|No migraine headache without aura|7
77061|NCT00959751|276853|P2|Overall Study|Non-compliance to Study Procedures|1
77062|NCT00959751|276854|P1|Overall Study|Non-compliance to Study Procedures|0
77063|NCT00959751|276853|P2|Overall Study|Consent Withdrawn|1
77064|NCT00959751|276854|P1|Overall Study|Consent Withdrawn|0
77065|NCT00959751|276853|P2|Overall Study|Lost to Follow-up|3
77066|NCT00959751|276854|P1|Overall Study|Lost to Follow-up|2
77067|NCT00959699|276876|P2|Follow-up Period|Withdrawal by Subject|4
77068|NCT00959699|276877|P1|Follow-up Period|Withdrawal by Subject|3
77069|NCT00959699|276876|P2|Follow-up Period|Lost to Follow-up|2
77070|NCT00959699|276877|P1|Follow-up Period|Lost to Follow-up|3
77071|NCT00959699|276876|P2|Treatment Period|Futility/crossover to boceprevir|0
77072|NCT00959699|276877|P1|Treatment Period|Futility/crossover to boceprevir|4
77073|NCT00959699|276876|P2|Treatment Period|Did not receive treatment|1
77074|NCT00959699|276877|P1|Treatment Period|Did not receive treatment|0
77075|NCT00959699|276876|P2|Treatment Period|Non-Compliance with Protocol|1
77076|NCT00959699|276877|P1|Treatment Period|Non-Compliance with Protocol|0
77077|NCT00959699|276876|P2|Treatment Period|Withdrawal by Subject|3
77078|NCT00959699|276877|P1|Treatment Period|Withdrawal by Subject|1
77079|NCT00959699|276876|P2|Treatment Period|Lost to Follow-up|1
77080|NCT00959699|276877|P1|Treatment Period|Lost to Follow-up|0
77081|NCT00959699|276876|P2|Treatment Period|Lack of Efficacy|6
77082|NCT00959699|276877|P1|Treatment Period|Lack of Efficacy|15
77083|NCT00959699|276876|P2|Treatment Period|Adverse Event|13
77084|NCT00959699|276877|P1|Treatment Period|Adverse Event|3
77085|NCT00959647|276894|P1|Overall Study|Withdrawal by Subject|7
77086|NCT00959647|276894|P1|Overall Study|Study terminated by sponsor|4
77087|NCT00959647|276894|P1|Overall Study|Progressive disease|6
77088|NCT00959647|276894|P1|Overall Study|Adverse Event|2
77089|NCT00959374|276899|P1|Overall Study|Physician Decision|1
77090|NCT00959374|276899|P1|Overall Study|Implant Removed/Not Replaced|4
77091|NCT00959374|276899|P1|Overall Study|Protocol Violation|1
77092|NCT00959374|276899|P1|Overall Study|Death|1
77093|NCT00959374|276899|P1|Overall Study|Lost to Follow-up|14
77094|NCT00959374|276899|P1|Overall Study|Withdrawal by Subject|2
77095|NCT00959192|276913|P4|Overall Study|Caregiver Request|1
77096|NCT00959192|276914|P3|Overall Study|Caregiver Request|2
77097|NCT00959192|276915|P2|Overall Study|Caregiver Request|0
77098|NCT00959192|276916|P1|Overall Study|Caregiver Request|0
77099|NCT00959192|276913|P4|Overall Study|Investigator Request|0
77100|NCT00959192|276914|P3|Overall Study|Investigator Request|0
77101|NCT00959192|276915|P2|Overall Study|Investigator Request|0
77102|NCT00959192|276916|P1|Overall Study|Investigator Request|1
77103|NCT00959192|276913|P4|Overall Study|Adverse Event|0
77104|NCT00959192|276914|P3|Overall Study|Adverse Event|1
77105|NCT00959192|276915|P2|Overall Study|Adverse Event|1
77106|NCT00959192|276916|P1|Overall Study|Adverse Event|1
77107|NCT00959049|276964|P6|Overall Study|Withdrawal by Subject|0
77108|NCT00959049|276965|P5|Overall Study|Withdrawal by Subject|0
77109|NCT00959049|276966|P4|Overall Study|Withdrawal by Subject|0
77110|NCT00959049|276967|P3|Overall Study|Withdrawal by Subject|0
77111|NCT00959049|276968|P2|Overall Study|Withdrawal by Subject|2
77112|NCT00959049|276969|P1|Overall Study|Withdrawal by Subject|0
77113|NCT00959049|276964|P6|Overall Study|Contraindicated medication|0
77114|NCT00959049|276965|P5|Overall Study|Contraindicated medication|0
77115|NCT00959049|276966|P4|Overall Study|Contraindicated medication|1
77116|NCT00959049|276967|P3|Overall Study|Contraindicated medication|0
77117|NCT00959049|276968|P2|Overall Study|Contraindicated medication|0
77118|NCT00959049|276969|P1|Overall Study|Contraindicated medication|0
77119|NCT00959049|276964|P6|Overall Study|Lost to Follow-up|1
77120|NCT00959049|276965|P5|Overall Study|Lost to Follow-up|9
77121|NCT00959049|276966|P4|Overall Study|Lost to Follow-up|10
77122|NCT00959049|276967|P3|Overall Study|Lost to Follow-up|1
77123|NCT00959049|276968|P2|Overall Study|Lost to Follow-up|5
77124|NCT00959049|276969|P1|Overall Study|Lost to Follow-up|17
77125|NCT00959049|276964|P6|Overall Study|Adverse Event|0
77126|NCT00959049|276965|P5|Overall Study|Adverse Event|0
77127|NCT00959049|276966|P4|Overall Study|Adverse Event|0
77128|NCT00959049|276967|P3|Overall Study|Adverse Event|0
77129|NCT00959049|276968|P2|Overall Study|Adverse Event|0
77130|NCT00959049|276969|P1|Overall Study|Adverse Event|1
77131|NCT00958893|277034|P1|Overall Study|Study prematurely terminated|4
77132|NCT00958880|277040|P2|Overall Study|Lost to Follow-up|2
77133|NCT00958880|277041|P1|Overall Study|Lost to Follow-up|2
77134|NCT00958841|277049|P1|Overall Study|Discontinued prior to M*|28
77135|NCT00958841|277049|P1|Overall Study|Completed M6/did not enter extension|27
77136|NCT00958841|277049|P1|Overall Study|Unsatisfactory therapeutic effect|22
77137|NCT00958841|277049|P1|Overall Study|Withdrawal by Subject|1
77138|NCT00958841|277049|P1|Overall Study|New cancer therapy|5
77139|NCT00958841|277049|P1|Overall Study|Adverse Event|8
77140|NCT00958841|277049|P1|Overall Study|Administrative problems|1
77141|NCT00958841|277049|P1|Overall Study|Abnormal test procedure result(s)|3
77142|NCT00958841|277049|P1|Overall Study|Abnormal laboratory value(s)|1
77143|NCT00958828|277067|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
77144|NCT00958828|277068|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
77145|NCT00958828|277067|P2|Period 1, 1 Week of Wear|Randomization break|1
77146|NCT00958828|277068|P1|Period 1, 1 Week of Wear|Randomization break|0
77147|NCT00958776|277076|P2|Overall Study|Missing|1
77148|NCT00958776|277077|P1|Overall Study|Missing|1
77149|NCT00958776|277076|P2|Overall Study|Noncompliance; Protocol Deviations|3
77150|NCT00958776|277077|P1|Overall Study|Noncompliance; Protocol Deviations|2
77151|NCT00958776|277076|P2|Overall Study|Death|1
77152|NCT00958776|277077|P1|Overall Study|Death|2
77153|NCT00958776|277076|P2|Overall Study|Protocol Violation|1
77154|NCT00958776|277077|P1|Overall Study|Protocol Violation|1
77155|NCT00958776|277076|P2|Overall Study|Withdrawal by Subject|16
77156|NCT00958776|277077|P1|Overall Study|Withdrawal by Subject|7
77157|NCT00958776|277076|P2|Overall Study|Lost to Follow-up|6
77158|NCT00958776|277077|P1|Overall Study|Lost to Follow-up|2
77159|NCT00958776|277076|P2|Overall Study|Physician Decision|0
77160|NCT00958776|277077|P1|Overall Study|Physician Decision|1
77161|NCT00958776|277076|P2|Overall Study|Adverse Event|1
77162|NCT00958776|277077|P1|Overall Study|Adverse Event|0
77163|NCT00958568|277107|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
77164|NCT00958568|277108|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
77165|NCT00958568|277109|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
77166|NCT00958568|277110|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
77167|NCT00958568|277107|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
77168|NCT00958568|277108|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
77169|NCT00958568|277109|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
77170|NCT00958568|277110|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
77171|NCT00958568|277107|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
77172|NCT00958568|277108|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
77173|NCT00958568|277109|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
77174|NCT00958568|277110|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
77175|NCT00958568|277107|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
77176|NCT00958568|277108|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
77177|NCT00958568|277109|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
77178|NCT00958568|277110|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
77179|NCT00958568|277107|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
77180|NCT00958568|277108|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
77181|NCT00958568|277109|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
77182|NCT00958568|277110|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
77183|NCT00958568|277107|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
77184|NCT00958568|277108|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
77185|NCT00958568|277109|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
77186|NCT00958568|277110|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
77187|NCT00958568|277107|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
77188|NCT00958568|277108|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
77189|NCT00958568|277109|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
77190|NCT00958568|277110|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
77191|NCT00958568|277107|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
77192|NCT00958568|277108|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
77193|NCT00958568|277109|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
77194|NCT00958568|277110|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
77195|NCT00958568|277107|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
77196|NCT00958568|277108|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
77351|NCT00958126|277361|P6|Overall Study|Moved away from study area|0
77197|NCT00958568|277109|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
77198|NCT00958568|277110|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
77199|NCT00958568|277107|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
77200|NCT00958568|277108|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
77201|NCT00958568|277109|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
77202|NCT00958568|277110|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
77203|NCT00958568|277107|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
77204|NCT00958568|277108|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
77205|NCT00958568|277109|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
77206|NCT00958568|277110|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
77207|NCT00958568|277107|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
77208|NCT00958568|277108|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
77209|NCT00958568|277109|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
77210|NCT00958568|277110|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
77211|NCT00958568|277107|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
77212|NCT00958568|277108|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
77213|NCT00958568|277109|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
77214|NCT00958568|277110|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
77215|NCT00958568|277107|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
77216|NCT00958568|277108|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
77217|NCT00958568|277109|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
77218|NCT00958568|277110|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
77219|NCT00958568|277107|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
77220|NCT00958568|277108|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
77221|NCT00958568|277109|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
77222|NCT00958568|277110|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
77223|NCT00958568|277107|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
77224|NCT00958568|277108|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
77225|NCT00958568|277109|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
77226|NCT00958568|277110|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
77227|NCT00958568|277107|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
77228|NCT00958568|277108|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
77229|NCT00958568|277109|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
77230|NCT00958568|277110|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
77231|NCT00958568|277107|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
77232|NCT00958568|277108|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
77233|NCT00958568|277109|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
77234|NCT00958568|277110|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
77235|NCT00958568|277107|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
77236|NCT00958568|277108|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
77237|NCT00958568|277109|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
77238|NCT00958568|277110|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
77239|NCT00958568|277107|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
77240|NCT00958568|277108|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
77241|NCT00958568|277109|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
77242|NCT00958568|277110|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
77243|NCT00958568|277107|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
77244|NCT00958568|277108|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
77245|NCT00958568|277109|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
77246|NCT00958568|277110|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
77247|NCT00958568|277107|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
77248|NCT00958568|277108|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
77249|NCT00958568|277109|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
77250|NCT00958568|277110|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
77251|NCT00958568|277107|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
77252|NCT00958568|277108|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
77253|NCT00958568|277109|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
77254|NCT00958568|277110|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
77255|NCT00958568|277107|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
77256|NCT00958568|277108|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
77257|NCT00958568|277109|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
77258|NCT00958568|277110|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
77259|NCT00958568|277107|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
77260|NCT00958568|277108|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
77261|NCT00958568|277109|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
77262|NCT00958568|277110|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
77263|NCT00958568|277107|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
77264|NCT00958568|277108|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
77265|NCT00958568|277109|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
77266|NCT00958568|277110|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
77267|NCT00958568|277107|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
77268|NCT00958568|277108|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
77269|NCT00958568|277109|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
77270|NCT00958568|277110|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
77271|NCT00958568|277107|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
77272|NCT00958568|277108|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
77273|NCT00958568|277109|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
77274|NCT00958568|277110|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
77275|NCT00958568|277107|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
77276|NCT00958568|277108|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
77277|NCT00958568|277109|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
77278|NCT00958568|277110|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
77279|NCT00958360|277193|P2|Overall Study|Lost to Follow-up|1
77280|NCT00958360|277194|P1|Overall Study|Lost to Follow-up|0
77281|NCT00958360|277193|P2|Overall Study|Physician Decision|1
77282|NCT00958360|277194|P1|Overall Study|Physician Decision|2
77283|NCT00958360|277193|P2|Overall Study|Death|7
77284|NCT00958360|277194|P1|Overall Study|Death|6
77285|NCT00958360|277193|P2|Overall Study|Withdrawal by Subject|1
77286|NCT00958360|277194|P1|Overall Study|Withdrawal by Subject|3
77287|NCT00958347|277208|P1|Overall Study|study termination|135
77288|NCT00958347|277208|P1|Overall Study|revision/removal|10
77289|NCT00958347|277208|P1|Overall Study|Lost to Follow-up|15
77290|NCT00958347|277208|P1|Overall Study|Withdrawal by Subject|23
77291|NCT00958347|277208|P1|Overall Study|Death|43
77292|NCT00958256|277249|P1|Overall Study|Adverse Event|3
77293|NCT00958243|277259|P6|Overall Study|Lost to Follow-up|5
77294|NCT00958243|277260|P5|Overall Study|Lost to Follow-up|8
77295|NCT00958243|277261|P4|Overall Study|Lost to Follow-up|2
77296|NCT00958243|277262|P3|Overall Study|Lost to Follow-up|11
77297|NCT00958243|277263|P2|Overall Study|Lost to Follow-up|5
77298|NCT00958243|277264|P1|Overall Study|Lost to Follow-up|2
77299|NCT00958243|277259|P6|Overall Study|Withdrawal by Subject|5
77300|NCT00958243|277260|P5|Overall Study|Withdrawal by Subject|1
77301|NCT00958243|277261|P4|Overall Study|Withdrawal by Subject|1
77302|NCT00958243|277262|P3|Overall Study|Withdrawal by Subject|3
77303|NCT00958243|277263|P2|Overall Study|Withdrawal by Subject|1
77304|NCT00958243|277264|P1|Overall Study|Withdrawal by Subject|0
77305|NCT00958217|277322|P2|Overall Study|Inpatient hospitalization|1
77306|NCT00958217|277323|P1|Overall Study|Inpatient hospitalization|0
77307|NCT00958217|277322|P2|Overall Study|Moved out of area|1
77308|NCT00958217|277323|P1|Overall Study|Moved out of area|1
77309|NCT00958217|277322|P2|Overall Study|Lost to Follow-up|19
77310|NCT00958217|277323|P1|Overall Study|Lost to Follow-up|17
77311|NCT00958217|277322|P2|Overall Study|Withdrawal by Subject|3
77312|NCT00958217|277323|P1|Overall Study|Withdrawal by Subject|4
77313|NCT00958217|277322|P2|Overall Study|Death|1
77314|NCT00958217|277323|P1|Overall Study|Death|2
77315|NCT00958191|277334|P1|Overall Study|No 5 yr x-rays|56
77316|NCT00958191|277334|P1|Overall Study|Site termination|11
77317|NCT00958191|277334|P1|Overall Study|Revision of study device|4
77318|NCT00958191|277334|P1|Overall Study|Did not receive study device|1
77319|NCT00958191|277334|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
77320|NCT00958191|277334|P1|Overall Study|Inadequate 5 yr x-ray quality|10
77321|NCT00958191|277334|P1|Overall Study|Lost to Follow-up|5
77322|NCT00958191|277334|P1|Overall Study|Death|4
77323|NCT00958165|277347|P1|Overall Study|Not eligible|9
77324|NCT00958165|277347|P1|Overall Study|Lost to Follow-up|5
77325|NCT00958126|277359|P8|Overall Study|Other Reason|0
77326|NCT00958126|277360|P7|Overall Study|Other Reason|0
77327|NCT00958126|277361|P6|Overall Study|Other Reason|1
77328|NCT00958126|277362|P5|Overall Study|Other Reason|0
77329|NCT00958126|277363|P4|Overall Study|Other Reason|1
77330|NCT00958126|277364|P3|Overall Study|Other Reason|0
77331|NCT00958126|277365|P2|Overall Study|Other Reason|0
77332|NCT00958126|277366|P1|Overall Study|Other Reason|0
77333|NCT00958126|277359|P8|Overall Study|Sponsor/Investigator decision|0
77334|NCT00958126|277360|P7|Overall Study|Sponsor/Investigator decision|0
77335|NCT00958126|277361|P6|Overall Study|Sponsor/Investigator decision|0
77336|NCT00958126|277362|P5|Overall Study|Sponsor/Investigator decision|0
77337|NCT00958126|277363|P4|Overall Study|Sponsor/Investigator decision|1
77338|NCT00958126|277364|P3|Overall Study|Sponsor/Investigator decision|0
77339|NCT00958126|277365|P2|Overall Study|Sponsor/Investigator decision|0
77340|NCT00958126|277366|P1|Overall Study|Sponsor/Investigator decision|0
77341|NCT00958126|277359|P8|Overall Study|Lost to Follow-up|0
77342|NCT00958126|277360|P7|Overall Study|Lost to Follow-up|0
77343|NCT00958126|277361|P6|Overall Study|Lost to Follow-up|0
77344|NCT00958126|277362|P5|Overall Study|Lost to Follow-up|0
77345|NCT00958126|277363|P4|Overall Study|Lost to Follow-up|8
77346|NCT00958126|277364|P3|Overall Study|Lost to Follow-up|9
77347|NCT00958126|277365|P2|Overall Study|Lost to Follow-up|5
77348|NCT00958126|277366|P1|Overall Study|Lost to Follow-up|1
77349|NCT00958126|277359|P8|Overall Study|Moved away from study area|0
77350|NCT00958126|277360|P7|Overall Study|Moved away from study area|0
77352|NCT00958126|277362|P5|Overall Study|Moved away from study area|0
77353|NCT00958126|277363|P4|Overall Study|Moved away from study area|1
77354|NCT00958126|277364|P3|Overall Study|Moved away from study area|1
77355|NCT00958126|277365|P2|Overall Study|Moved away from study area|0
77356|NCT00958126|277366|P1|Overall Study|Moved away from study area|0
77357|NCT00958126|277359|P8|Overall Study|Withdrawal by Subject|0
77358|NCT00958126|277360|P7|Overall Study|Withdrawal by Subject|0
77359|NCT00958126|277361|P6|Overall Study|Withdrawal by Subject|0
77360|NCT00958126|277362|P5|Overall Study|Withdrawal by Subject|0
77361|NCT00958126|277363|P4|Overall Study|Withdrawal by Subject|0
77362|NCT00958126|277364|P3|Overall Study|Withdrawal by Subject|0
77363|NCT00958126|277365|P2|Overall Study|Withdrawal by Subject|2
77364|NCT00958126|277366|P1|Overall Study|Withdrawal by Subject|0
77365|NCT00958126|277359|P8|Overall Study|Serious Adverse Event|0
77366|NCT00958126|277360|P7|Overall Study|Serious Adverse Event|1
77367|NCT00958126|277361|P6|Overall Study|Serious Adverse Event|0
77368|NCT00958126|277362|P5|Overall Study|Serious Adverse Event|0
77369|NCT00958126|277363|P4|Overall Study|Serious Adverse Event|0
77370|NCT00958126|277364|P3|Overall Study|Serious Adverse Event|0
77371|NCT00958126|277365|P2|Overall Study|Serious Adverse Event|2
77372|NCT00958126|277366|P1|Overall Study|Serious Adverse Event|0
77373|NCT00958074|277438|P2|Overall Study|Withdrawal by Subject|1
77374|NCT00958074|277439|P1|Overall Study|Withdrawal by Subject|0
77375|NCT00958009|277454|P1|Overall Study|Subject found device difficult to use|1
77376|NCT00958009|277454|P1|Overall Study|Adverse Event|1
77377|NCT00957996|277461|P2|Overall Study|Noncompliance; Protocol Deviations|6
77378|NCT00957996|277462|P1|Overall Study|Noncompliance; Protocol Deviations|5
77379|NCT00957996|277461|P2|Overall Study|Missing|0
77380|NCT00957996|277462|P1|Overall Study|Missing|1
77381|NCT00957996|277461|P2|Overall Study|Influenza-related complication|1
77382|NCT00957996|277462|P1|Overall Study|Influenza-related complication|0
77383|NCT00957996|277461|P2|Overall Study|Physician Decision|1
77384|NCT00957996|277462|P1|Overall Study|Physician Decision|1
77385|NCT00957996|277461|P2|Overall Study|Adverse Event|1
77386|NCT00957996|277462|P1|Overall Study|Adverse Event|2
77387|NCT00957996|277461|P2|Overall Study|Withdrawal by Subject|2
77388|NCT00957996|277462|P1|Overall Study|Withdrawal by Subject|9
77389|NCT00957996|277461|P2|Overall Study|Lost to Follow-up|7
77390|NCT00957996|277462|P1|Overall Study|Lost to Follow-up|4
77391|NCT00957996|277461|P2|Overall Study|Death|10
77392|NCT00957996|277462|P1|Overall Study|Death|4
77393|NCT00957944|277494|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
77394|NCT00957944|277495|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
77395|NCT00957723|277529|P1|Overall Study|2yr ROM Data Not Evaluable|25
77396|NCT00957723|277529|P1|Overall Study|Intercurrent Illness|2
77397|NCT00957723|277529|P1|Overall Study|Investigative Site Terminated|55
77398|NCT00957723|277529|P1|Overall Study|Did not undergo surgery|3
77399|NCT00957723|277529|P1|Overall Study|Withdrawal by Subject|23
77400|NCT00957723|277529|P1|Overall Study|Lost to Follow-up|7
77401|NCT00957723|277529|P1|Overall Study|Revision/ Removal of Study Implant|3
77402|NCT00957723|277529|P1|Overall Study|Death|3
77403|NCT00957658|277558|P1|Overall Study|Protocol Violation|5
77404|NCT00957658|277558|P1|Overall Study|surgery cancelled|2
77405|NCT00957658|277558|P1|Overall Study|unwilling/unable to return|2
77406|NCT00957658|277558|P1|Overall Study|Site termination|10
77407|NCT00957658|277558|P1|Overall Study|Incomplete 2 yr data|28
77408|NCT00957658|277558|P1|Overall Study|Revision|1
77409|NCT00957658|277558|P1|Overall Study|Withdrawal by Subject|12
77410|NCT00957658|277558|P1|Overall Study|Lost to Follow-up|4
77411|NCT00957658|277558|P1|Overall Study|Death|1
77412|NCT00957528|277612|P3|Overall Study|Withdrawal by Subject|1
77413|NCT00957528|277613|P2|Overall Study|Withdrawal by Subject|0
77414|NCT00957528|277614|P1|Overall Study|Withdrawal by Subject|0
77415|NCT00957528|277612|P3|Overall Study|Protocol Violation|0
77416|NCT00957528|277613|P2|Overall Study|Protocol Violation|1
77417|NCT00957528|277614|P1|Overall Study|Protocol Violation|0
77418|NCT00957424|277637|P1|Overall Study|Withdrawal by Subject|1
77419|NCT00957424|277637|P1|Overall Study|Protocol Violation|3
77420|NCT00957424|277637|P1|Overall Study|Lost to Follow-up|19
77421|NCT00957372|277647|P4|PART II|Patient non-compliance|4
77422|NCT00957372|277648|P3|PART II|Patient non-compliance|0
77423|NCT00957372|277649|P2|PART II|Patient non-compliance|0
77424|NCT00957372|277650|P1|PART II|Patient non-compliance|0
77425|NCT00957372|277647|P4|PART II|Adverse Event|10
77426|NCT00957372|277648|P3|PART II|Adverse Event|0
77427|NCT00957372|277649|P2|PART II|Adverse Event|0
77428|NCT00957372|277650|P1|PART II|Adverse Event|0
77429|NCT00957372|277647|P4|PART II|Not Know|20
77430|NCT00957372|277648|P3|PART II|Not Know|0
77431|NCT00957372|277649|P2|PART II|Not Know|0
77432|NCT00957372|277650|P1|PART II|Not Know|0
77433|NCT00957372|277647|P4|PART II|Pregnancy|1
77434|NCT00957372|277648|P3|PART II|Pregnancy|0
77435|NCT00957372|277649|P2|PART II|Pregnancy|0
77436|NCT00957372|277650|P1|PART II|Pregnancy|0
77437|NCT00957372|277647|P4|PART II|Physician Decision|1
77438|NCT00957372|277648|P3|PART II|Physician Decision|0
77439|NCT00957372|277649|P2|PART II|Physician Decision|0
77440|NCT00957372|277650|P1|PART II|Physician Decision|0
77441|NCT00957372|277647|P4|PART II|Withdrawal by Subject|8
77442|NCT00957372|277648|P3|PART II|Withdrawal by Subject|0
77443|NCT00957372|277649|P2|PART II|Withdrawal by Subject|0
77444|NCT00957372|277650|P1|PART II|Withdrawal by Subject|0
77445|NCT00957372|277647|P4|PART I|Lost to Follow-up|0
77446|NCT00957372|277648|P3|PART I|Lost to Follow-up|1
77447|NCT00957372|277649|P2|PART I|Lost to Follow-up|0
77448|NCT00957372|277650|P1|PART I|Lost to Follow-up|0
77449|NCT00957268|277675|P5|Overall Study|Voluntary Withdrawal|0
77450|NCT00957268|277676|P4|Overall Study|Voluntary Withdrawal|0
77451|NCT00957268|277677|P3|Overall Study|Voluntary Withdrawal|1
77452|NCT00957268|277678|P2|Overall Study|Voluntary Withdrawal|0
77453|NCT00957268|277679|P1|Overall Study|Voluntary Withdrawal|0
77454|NCT00957034|277801|P3|Overall Study|Withdrawal by Subject|0
77455|NCT00957034|277802|P2|Overall Study|Withdrawal by Subject|2
77456|NCT00957034|277803|P1|Overall Study|Withdrawal by Subject|0
77457|NCT00957034|277801|P3|Overall Study|Sponsor Terminated Study|5
77458|NCT00957034|277802|P2|Overall Study|Sponsor Terminated Study|1
77459|NCT00957034|277803|P1|Overall Study|Sponsor Terminated Study|6
77460|NCT00957034|277801|P3|Overall Study|Adverse Event|1
77461|NCT00957034|277802|P2|Overall Study|Adverse Event|1
77462|NCT00957034|277803|P1|Overall Study|Adverse Event|0
77463|NCT00957021|277826|P1|Overall Study|Termination due to language issue|2
77464|NCT00957021|277826|P1|Overall Study|Surgery Cancelled|9
77465|NCT00957021|277826|P1|Overall Study|Site Termination by the 2 yr visit|16
77466|NCT00957021|277826|P1|Overall Study|Revised study component by 2 yr visit|8
77467|NCT00957021|277826|P1|Overall Study|No 2 yr ROM data|35
77468|NCT00957021|277826|P1|Overall Study|Withdrawal by Subject|34
77469|NCT00957021|277826|P1|Overall Study|Lost to Follow-up|8
77470|NCT00957021|277826|P1|Overall Study|Death|5
77471|NCT00957008|277839|P4|Overall Study|Relocated; Family conflict|3
77472|NCT00957008|277840|P3|Overall Study|Relocated; Family conflict|1
77473|NCT00957008|277841|P2|Overall Study|Relocated; Family conflict|1
77474|NCT00957008|277842|P1|Overall Study|Relocated; Family conflict|4
77475|NCT00957008|277839|P4|Overall Study|Physician Decision|1
77476|NCT00957008|277840|P3|Overall Study|Physician Decision|1
77477|NCT00957008|277841|P2|Overall Study|Physician Decision|0
77478|NCT00957008|277842|P1|Overall Study|Physician Decision|1
77479|NCT00957008|277839|P4|Overall Study|Lost to Follow-up|4
77480|NCT00957008|277840|P3|Overall Study|Lost to Follow-up|3
77481|NCT00957008|277841|P2|Overall Study|Lost to Follow-up|1
77482|NCT00957008|277842|P1|Overall Study|Lost to Follow-up|3
77483|NCT00957008|277839|P4|Overall Study|Withdrawal by Subject|16
77484|NCT00957008|277840|P3|Overall Study|Withdrawal by Subject|12
77485|NCT00957008|277841|P2|Overall Study|Withdrawal by Subject|10
77486|NCT00957008|277842|P1|Overall Study|Withdrawal by Subject|13
77487|NCT00956943|277858|P2|Overall Study|Lost to Follow-up|10
77488|NCT00956943|277859|P1|Overall Study|Lost to Follow-up|9
77489|NCT00956839|277870|P3|Overall Study|Lost to Follow-up|3
77490|NCT00956839|277871|P2|Overall Study|Lost to Follow-up|0
77491|NCT00956839|277872|P1|Overall Study|Lost to Follow-up|3
77492|NCT00956592|277891|P2|Overall Study|Protocol Violation|3
77493|NCT00956592|277892|P1|Overall Study|Protocol Violation|1
77494|NCT00956293|277917|P3|Follow-up Period|Follow-up period was terminated.|0
77495|NCT00956293|277918|P2|Follow-up Period|Follow-up period was terminated.|32
77496|NCT00956293|277919|P1|Follow-up Period|Follow-up period was terminated.|20
77497|NCT00956293|277917|P3|Main Period (Randomization)|Adverse Event|0
77498|NCT00956293|277918|P2|Main Period (Randomization)|Adverse Event|15
77499|NCT00956293|277919|P1|Main Period (Randomization)|Adverse Event|0
77500|NCT00956293|277917|P3|Main Period (Randomization)|Lack of Efficacy|0
77501|NCT00956293|277918|P2|Main Period (Randomization)|Lack of Efficacy|10
77502|NCT00956293|277919|P1|Main Period (Randomization)|Lack of Efficacy|1
77503|NCT00956293|277917|P3|Main Period (Randomization)|Abnormal laboratory value|0
77504|NCT00956293|277918|P2|Main Period (Randomization)|Abnormal laboratory value|2
77505|NCT00956293|277919|P1|Main Period (Randomization)|Abnormal laboratory value|0
77506|NCT00956293|277917|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
77507|NCT00956293|277918|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
77508|NCT00956293|277919|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
77509|NCT00956293|277917|P3|Main Period (Pre-randomization)|Adverse Event|36
77510|NCT00956293|277918|P2|Main Period (Pre-randomization)|Adverse Event|0
77511|NCT00956293|277919|P1|Main Period (Pre-randomization)|Adverse Event|0
77512|NCT00956293|277917|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
77513|NCT00956293|277918|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
77514|NCT00956293|277919|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
77515|NCT00956293|277917|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
77516|NCT00956293|277918|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
77517|NCT00956293|277919|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
77518|NCT00956293|277917|P3|Main Period (Pre-randomization)|Graft loss|7
77519|NCT00956293|277918|P2|Main Period (Pre-randomization)|Graft loss|0
77520|NCT00956293|277919|P1|Main Period (Pre-randomization)|Graft loss|0
77521|NCT00956293|277917|P3|Main Period (Pre-randomization)|Administrative problems|6
77522|NCT00956293|277918|P2|Main Period (Pre-randomization)|Administrative problems|0
77523|NCT00956293|277919|P1|Main Period (Pre-randomization)|Administrative problems|0
77524|NCT00956293|277917|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
77525|NCT00956293|277918|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
77526|NCT00956293|277919|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
77527|NCT00956293|277917|P3|Main Period (Pre-randomization)|Protocol Violation|1
77528|NCT00956293|277918|P2|Main Period (Pre-randomization)|Protocol Violation|0
77529|NCT00956293|277919|P1|Main Period (Pre-randomization)|Protocol Violation|0
77530|NCT00956293|277917|P3|Main Period (Pre-randomization)|Death|1
77531|NCT00956293|277918|P2|Main Period (Pre-randomization)|Death|0
77532|NCT00956293|277919|P1|Main Period (Pre-randomization)|Death|0
77533|NCT00956293|277917|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
77534|NCT00956293|277918|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
77535|NCT00956293|277919|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
77536|NCT00955955|277971|P3|Overall Study|Lost to Follow-up|0
77537|NCT00955955|277972|P2|Overall Study|Lost to Follow-up|0
77538|NCT00955955|277973|P1|Overall Study|Lost to Follow-up|2
77539|NCT00955825|277995|P2|Overall Study|Any other reason not above-mentioned|9
77540|NCT00955825|277996|P1|Overall Study|Any other reason not above-mentioned|7
77541|NCT00955825|277995|P2|Overall Study|Withdrawal by Subject|6
77542|NCT00955825|277996|P1|Overall Study|Withdrawal by Subject|4
77543|NCT00955825|277995|P2|Overall Study|Adverse Event|2
77544|NCT00955825|277996|P1|Overall Study|Adverse Event|15
77545|NCT00955721|278013|P2|Overall Study|Withdrawal by Subject|0
77546|NCT00955721|278014|P1|Overall Study|Withdrawal by Subject|1
77547|NCT00955721|278013|P2|Overall Study|Death|0
77548|NCT00955721|278014|P1|Overall Study|Death|1
77549|NCT00955721|278013|P2|Overall Study|Physician Decision|0
77550|NCT00955721|278014|P1|Overall Study|Physician Decision|1
77551|NCT00955617|278022|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
77552|NCT00955617|278023|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
77553|NCT00955617|278022|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
77554|NCT00955617|278023|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
77555|NCT00955617|278022|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
77556|NCT00955617|278023|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
77557|NCT00955617|278022|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
77558|NCT00955617|278023|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
77559|NCT00955474|278048|P2|Overall Study|Study Terminated|13
77560|NCT00955474|278049|P1|Overall Study|Study Terminated|12
77561|NCT00955357|278059|P2|Maintenance Phase|Non compliance to study procedures|0
77562|NCT00955357|278060|P1|Maintenance Phase|Non compliance to study procedures|1
77563|NCT00955357|278059|P2|Maintenance Phase|Patient moving out of area|1
77564|NCT00955357|278060|P1|Maintenance Phase|Patient moving out of area|0
77565|NCT00955357|278059|P2|Maintenance Phase|Withdrawal by Subject|4
77566|NCT00955357|278060|P1|Maintenance Phase|Withdrawal by Subject|4
77567|NCT00955357|278059|P2|Maintenance Phase|Lost to Follow-up|7
77568|NCT00955357|278060|P1|Maintenance Phase|Lost to Follow-up|2
77569|NCT00955357|278059|P2|Maintenance Phase|Protocol Violation|6
77570|NCT00955357|278060|P1|Maintenance Phase|Protocol Violation|2
77571|NCT00955357|278059|P2|Maintenance Phase|Lack of Efficacy|4
77572|NCT00955357|278060|P1|Maintenance Phase|Lack of Efficacy|0
77573|NCT00955357|278059|P2|Maintenance Phase|Adverse Event|23
77574|NCT00955357|278060|P1|Maintenance Phase|Adverse Event|3
77575|NCT00955357|278059|P2|Titration Phase|Non compliance to study procedures|1
77576|NCT00955357|278060|P1|Titration Phase|Non compliance to study procedures|0
77577|NCT00955357|278059|P2|Titration Phase|Study medication not tolerated|1
77578|NCT00955357|278060|P1|Titration Phase|Study medication not tolerated|0
77579|NCT00955357|278059|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
77580|NCT00955357|278060|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
77581|NCT00955357|278059|P2|Titration Phase|Withdrawal by Subject|5
77582|NCT00955357|278060|P1|Titration Phase|Withdrawal by Subject|3
77583|NCT00955357|278059|P2|Titration Phase|Lost to Follow-up|3
77584|NCT00955357|278060|P1|Titration Phase|Lost to Follow-up|1
77585|NCT00955357|278059|P2|Titration Phase|Protocol Violation|7
77586|NCT00955357|278060|P1|Titration Phase|Protocol Violation|3
77587|NCT00955357|278059|P2|Titration Phase|Lack of Efficacy|2
77588|NCT00955357|278060|P1|Titration Phase|Lack of Efficacy|0
77589|NCT00955357|278059|P2|Titration Phase|Adverse Event|46
77590|NCT00955357|278060|P1|Titration Phase|Adverse Event|9
77591|NCT00955305|278068|P2|Overall Study|Ineligible|7
77592|NCT00955305|278069|P1|Overall Study|Ineligible|5
77593|NCT00955305|278068|P2|Overall Study|Never started protocol treatment|5
77594|NCT00955305|278069|P1|Overall Study|Never started protocol treatment|5
77595|NCT00955305|278068|P2|Overall Study|No off-treatment reason submitted|0
77596|NCT00955305|278069|P1|Overall Study|No off-treatment reason submitted|1
77597|NCT00955305|278068|P2|Overall Study|Lost to Follow-up|1
77598|NCT00955305|278069|P1|Overall Study|Lost to Follow-up|0
77599|NCT00955305|278068|P2|Overall Study|Maximum response achieved|1
77600|NCT00955305|278069|P1|Overall Study|Maximum response achieved|0
77601|NCT00955305|278068|P2|Overall Study|Functional decline|0
77602|NCT00955305|278069|P1|Overall Study|Functional decline|2
77603|NCT00955305|278068|P2|Overall Study|Continued presence of residual disease|1
77604|NCT00955305|278069|P1|Overall Study|Continued presence of residual disease|0
77605|NCT00955305|278068|P2|Overall Study|Physician Decision|0
77606|NCT00955305|278069|P1|Overall Study|Physician Decision|1
77607|NCT00955305|278068|P2|Overall Study|Other complicating disease|4
77608|NCT00955305|278069|P1|Overall Study|Other complicating disease|2
77609|NCT00955305|278068|P2|Overall Study|Alternative therapy|0
77610|NCT00955305|278069|P1|Overall Study|Alternative therapy|4
77611|NCT00955305|278068|P2|Overall Study|Withdrawal by Subject|4
77612|NCT00955305|278069|P1|Overall Study|Withdrawal by Subject|5
77613|NCT00955305|278068|P2|Overall Study|Death|1
77614|NCT00955305|278069|P1|Overall Study|Death|2
77615|NCT00955305|278068|P2|Overall Study|Adverse Event|22
77616|NCT00955305|278069|P1|Overall Study|Adverse Event|22
77617|NCT00955305|278068|P2|Overall Study|Disease progression|41
77618|NCT00955305|278069|P1|Overall Study|Disease progression|39
77619|NCT00955279|278082|P3|Overall Study|Withdrawal by Subject|3
77620|NCT00955279|278083|P2|Overall Study|Withdrawal by Subject|0
77621|NCT00955279|278084|P1|Overall Study|Withdrawal by Subject|2
77622|NCT00955279|278082|P3|Overall Study|Lost to Follow-up|1
77623|NCT00955279|278083|P2|Overall Study|Lost to Follow-up|3
77624|NCT00955279|278084|P1|Overall Study|Lost to Follow-up|0
77625|NCT00955279|278082|P3|Overall Study|Death|1
77626|NCT00955279|278083|P2|Overall Study|Death|1
77627|NCT00955279|278084|P1|Overall Study|Death|1
77628|NCT00955279|278082|P3|Overall Study|Unspecified|3
77629|NCT00955279|278083|P2|Overall Study|Unspecified|0
77630|NCT00955279|278084|P1|Overall Study|Unspecified|0
77631|NCT00955110|278104|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
77632|NCT00955110|278104|P1|Treatment Phase|Non-compliance with study restrictions|1
77633|NCT00955110|278104|P1|Treatment Phase|Administrative reasons|2
77634|NCT00955110|278104|P1|Treatment Phase|Adverse Event|2
77635|NCT00955110|278104|P1|Qualification Phase|Did not meet eligibility criteria|24
77636|NCT00954941|278151|P2|Overall Study|Adverse Event|1
77637|NCT00954941|278152|P1|Overall Study|Adverse Event|0
77638|NCT00954941|278151|P2|Overall Study|Ineligible|2
77639|NCT00954941|278152|P1|Overall Study|Ineligible|2
77640|NCT00954941|278151|P2|Overall Study|Physician Decision|2
77641|NCT00954941|278152|P1|Overall Study|Physician Decision|2
77642|NCT00954941|278151|P2|Overall Study|Insurance Denial|2
77643|NCT00954941|278152|P1|Overall Study|Insurance Denial|2
77644|NCT00954941|278151|P2|Overall Study|Withdrawal by Subject|0
77645|NCT00954941|278152|P1|Overall Study|Withdrawal by Subject|1
77646|NCT00954941|278151|P2|Overall Study|Received treatment at home|0
77647|NCT00954941|278152|P1|Overall Study|Received treatment at home|1
77648|NCT00954733|278168|P1|Overall Study|blood gas machine did not work|1
77649|NCT00954707|278172|P1|Overall Study|Lost to Follow-up|33
77650|NCT00954707|278172|P1|Overall Study|Withdrawal by Subject|100
77651|NCT00954707|278172|P1|Overall Study|Death|34
77652|NCT00954538|278190|P6|Part III|Withdrawal by Subject|0
77653|NCT00954538|278191|P5|Part III|Withdrawal by Subject|1
77654|NCT00954538|278192|P4|Part III|Withdrawal by Subject|0
77655|NCT00954538|278193|P3|Part III|Withdrawal by Subject|0
77656|NCT00954538|278194|P2|Part III|Withdrawal by Subject|0
77657|NCT00954538|278195|P1|Part III|Withdrawal by Subject|0
77658|NCT00954512|278212|P6|Overall Study|Progression of Disease|1
77659|NCT00954512|278213|P5|Overall Study|Progression of Disease|1
77660|NCT00954512|278214|P4|Overall Study|Progression of Disease|1
77661|NCT00954512|278215|P3|Overall Study|Progression of Disease|0
77662|NCT00954512|278216|P2|Overall Study|Progression of Disease|1
77663|NCT00954512|278217|P1|Overall Study|Progression of Disease|2
77664|NCT00954512|278212|P6|Overall Study|Symptomatic Deterioration|0
77665|NCT00954512|278213|P5|Overall Study|Symptomatic Deterioration|2
77666|NCT00954512|278214|P4|Overall Study|Symptomatic Deterioration|0
77667|NCT00954512|278215|P3|Overall Study|Symptomatic Deterioration|0
77668|NCT00954512|278216|P2|Overall Study|Symptomatic Deterioration|1
77669|NCT00954512|278217|P1|Overall Study|Symptomatic Deterioration|0
77670|NCT00954512|278212|P6|Overall Study|Physician Decision|0
77671|NCT00954512|278213|P5|Overall Study|Physician Decision|0
77672|NCT00954512|278214|P4|Overall Study|Physician Decision|1
77673|NCT00954512|278215|P3|Overall Study|Physician Decision|0
77674|NCT00954512|278216|P2|Overall Study|Physician Decision|1
77675|NCT00954512|278217|P1|Overall Study|Physician Decision|0
77676|NCT00954512|278212|P6|Overall Study|Adverse Event|2
77677|NCT00954512|278213|P5|Overall Study|Adverse Event|1
77678|NCT00954512|278214|P4|Overall Study|Adverse Event|0
77679|NCT00954512|278215|P3|Overall Study|Adverse Event|0
77680|NCT00954512|278216|P2|Overall Study|Adverse Event|0
77681|NCT00954512|278217|P1|Overall Study|Adverse Event|0
77682|NCT00954512|278212|P6|Overall Study|Withdrawal by Subject|1
77683|NCT00954512|278213|P5|Overall Study|Withdrawal by Subject|0
77684|NCT00954512|278214|P4|Overall Study|Withdrawal by Subject|0
77685|NCT00954512|278215|P3|Overall Study|Withdrawal by Subject|0
77686|NCT00954512|278216|P2|Overall Study|Withdrawal by Subject|0
77687|NCT00954512|278217|P1|Overall Study|Withdrawal by Subject|0
77688|NCT00954447|278238|P2|Overall Study|Other|18
77689|NCT00954447|278239|P1|Overall Study|Other|21
77690|NCT00954447|278238|P2|Overall Study|Withdrawal by Subject|21
77691|NCT00954447|278239|P1|Overall Study|Withdrawal by Subject|26
77692|NCT00954447|278238|P2|Overall Study|Lost to Follow-up|14
77693|NCT00954447|278239|P1|Overall Study|Lost to Follow-up|8
77694|NCT00954447|278238|P2|Overall Study|Protocol Violation|7
77695|NCT00954447|278239|P1|Overall Study|Protocol Violation|5
77696|NCT00954447|278238|P2|Overall Study|Lack of Efficacy|3
77697|NCT00954447|278239|P1|Overall Study|Lack of Efficacy|17
77698|NCT00954447|278238|P2|Overall Study|Adverse Event|25
77699|NCT00954447|278239|P1|Overall Study|Adverse Event|33
77700|NCT00954421|278275|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
77701|NCT00954421|278275|P1|6 Months of DBS|Withdrawal by Subject|1
77702|NCT00954421|278275|P1|Screening|screen failures|3
77703|NCT00954122|278321|P1|Overall Study|Safety Reason|1
77704|NCT00954122|278321|P1|Overall Study|Adverse Event|1
77705|NCT00954122|278321|P1|Overall Study|Withdrawal by Subject|5
77706|NCT00953927|278338|P2|Overall Study|Other study discontinuation|1
77707|NCT00953927|278339|P1|Overall Study|Other study discontinuation|1
77708|NCT00953927|278338|P2|Overall Study|Death|4
77709|NCT00953927|278339|P1|Overall Study|Death|7
77710|NCT00953927|278338|P2|Overall Study|Withdrawal by Subject|25
77711|NCT00953927|278339|P1|Overall Study|Withdrawal by Subject|36
77712|NCT00953927|278338|P2|Overall Study|Lost to Follow-up|65
77713|NCT00953927|278339|P1|Overall Study|Lost to Follow-up|61
77714|NCT00953706|278417|P4|Part B (96-Week Open-Label Extension)|Unspecified|2
77715|NCT00953706|278418|P3|Part B (96-Week Open-Label Extension)|Unspecified|0
77716|NCT00953706|278419|P2|Part B (96-Week Open-Label Extension)|Unspecified|0
77717|NCT00953706|278420|P1|Part B (96-Week Open-Label Extension)|Unspecified|0
77718|NCT00953706|278417|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
77719|NCT00953706|278418|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
77720|NCT00953706|278419|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
77721|NCT00953706|278420|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
77722|NCT00953706|278417|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
77723|NCT00953706|278418|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
77724|NCT00953706|278419|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
77725|NCT00953706|278420|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
77726|NCT00953706|278417|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
77727|NCT00953706|278418|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
77728|NCT00953706|278419|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
77729|NCT00953706|278420|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
77730|NCT00953706|278417|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
77731|NCT00953706|278418|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
77732|NCT00953706|278419|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
77733|NCT00953706|278420|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
77734|NCT00953706|278417|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
77735|NCT00953706|278418|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
77736|NCT00953706|278419|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
77737|NCT00953706|278420|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
77738|NCT00953706|278417|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
77739|NCT00953706|278418|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
77740|NCT00953706|278419|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
77741|NCT00953706|278420|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
77742|NCT00953706|278417|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
77743|NCT00953706|278418|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
77744|NCT00953706|278419|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
77745|NCT00953706|278420|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
77746|NCT00953706|278417|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
77747|NCT00953706|278418|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
77748|NCT00953706|278419|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
77749|NCT00953706|278420|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
77750|NCT00953706|278417|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
77751|NCT00953706|278418|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
77752|NCT00953706|278419|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
77753|NCT00953706|278420|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
77754|NCT00953706|278417|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
77755|NCT00953706|278418|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
77756|NCT00953706|278419|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
77757|NCT00953706|278420|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
77758|NCT00953680|278452|P2|Period 1|Withdrawal by Subject|1
77759|NCT00953680|278453|P1|Period 1|Withdrawal by Subject|0
77760|NCT00953667|278465|P1|Overall Study|poor venous access,unable to draw blood|4
77761|NCT00953667|278465|P1|Overall Study|Adverse Event|10
77762|NCT00953667|278465|P1|Overall Study|Withdrawal by Subject|63
77763|NCT00953667|278465|P1|Overall Study|Physician Decision|35
77764|NCT00953667|278465|P1|Overall Study|Lost to Follow-up|11
77765|NCT00953615|278486|P1|Overall Study|Adverse Event|1
77766|NCT00953524|278497|P4|Overall Study|Withdrawal by Subject|0
77767|NCT00953524|278498|P3|Overall Study|Withdrawal by Subject|1
77768|NCT00953524|278499|P2|Overall Study|Withdrawal by Subject|4
77769|NCT00953524|278500|P1|Overall Study|Withdrawal by Subject|2
77770|NCT00953524|278497|P4|Overall Study|Lost to Follow-up|0
77771|NCT00953524|278498|P3|Overall Study|Lost to Follow-up|1
77772|NCT00953524|278499|P2|Overall Study|Lost to Follow-up|1
77773|NCT00953524|278500|P1|Overall Study|Lost to Follow-up|0
77774|NCT00953524|278497|P4|Overall Study|Protocol Violation|6
77775|NCT00953524|278498|P3|Overall Study|Protocol Violation|11
77776|NCT00953524|278499|P2|Overall Study|Protocol Violation|10
77777|NCT00953524|278500|P1|Overall Study|Protocol Violation|18
77778|NCT00953524|278497|P4|Overall Study|Adverse Event|2
77779|NCT00953524|278498|P3|Overall Study|Adverse Event|1
77780|NCT00953524|278499|P2|Overall Study|Adverse Event|0
77781|NCT00953524|278500|P1|Overall Study|Adverse Event|2
77782|NCT00953407|278543|P5|Overall Study|Lost to Follow-up|0
77783|NCT00953407|278544|P4|Overall Study|Lost to Follow-up|1
77784|NCT00953407|278545|P3|Overall Study|Lost to Follow-up|0
77785|NCT00953407|278546|P2|Overall Study|Lost to Follow-up|0
77786|NCT00953407|278547|P1|Overall Study|Lost to Follow-up|0
77787|NCT00953407|278543|P5|Overall Study|Failed inclusion criteria|1
77788|NCT00953407|278544|P4|Overall Study|Failed inclusion criteria|1
77789|NCT00953407|278545|P3|Overall Study|Failed inclusion criteria|1
77790|NCT00953407|278546|P2|Overall Study|Failed inclusion criteria|1
77791|NCT00953407|278547|P1|Overall Study|Failed inclusion criteria|1
77792|NCT00953329|278559|P1|Overall Study|Lack of Efficacy|1
77793|NCT00953225|278572|P2|Overall Study|Withdrawal by Subject|0
77794|NCT00953225|278573|P1|Overall Study|Withdrawal by Subject|2
77795|NCT00953160|278581|P1|Overall Study|Withdrawal by Subject|4
77796|NCT00953160|278581|P1|Overall Study|Lost to Follow-up|23
77797|NCT00953147|278590|P3|Overall Study|Other|13
77798|NCT00953147|278591|P2|Overall Study|Other|11
77799|NCT00953147|278592|P1|Overall Study|Other|4
77800|NCT00953147|278590|P3|Overall Study|Physician Decision|3
77801|NCT00953147|278591|P2|Overall Study|Physician Decision|7
77802|NCT00953147|278592|P1|Overall Study|Physician Decision|2
77803|NCT00953147|278590|P3|Overall Study|Lost to Follow-up|4
77804|NCT00953147|278591|P2|Overall Study|Lost to Follow-up|9
77805|NCT00953147|278592|P1|Overall Study|Lost to Follow-up|8
77806|NCT00953147|278590|P3|Overall Study|Withdrawal by Subject|12
77807|NCT00953147|278591|P2|Overall Study|Withdrawal by Subject|15
77808|NCT00953147|278592|P1|Overall Study|Withdrawal by Subject|13
77809|NCT00953147|278590|P3|Overall Study|Protocol Violation|4
77810|NCT00953147|278591|P2|Overall Study|Protocol Violation|8
77811|NCT00953147|278592|P1|Overall Study|Protocol Violation|2
77812|NCT00953147|278590|P3|Overall Study|Adverse Event|6
77813|NCT00953147|278591|P2|Overall Study|Adverse Event|16
77814|NCT00953147|278592|P1|Overall Study|Adverse Event|8
77815|NCT00953056|278670|P6|Overall Study|Serious Adverse Event|1
77816|NCT00953056|278671|P5|Overall Study|Serious Adverse Event|0
77817|NCT00953056|278672|P4|Overall Study|Serious Adverse Event|0
77818|NCT00953056|278673|P3|Overall Study|Serious Adverse Event|0
77819|NCT00953056|278674|P2|Overall Study|Serious Adverse Event|0
77820|NCT00953056|278675|P1|Overall Study|Serious Adverse Event|0
77821|NCT00953056|278670|P6|Overall Study|Withdrew Consent|3
77822|NCT00953056|278671|P5|Overall Study|Withdrew Consent|2
77823|NCT00953056|278672|P4|Overall Study|Withdrew Consent|0
77824|NCT00953056|278673|P3|Overall Study|Withdrew Consent|0
77825|NCT00953056|278674|P2|Overall Study|Withdrew Consent|0
77826|NCT00953056|278675|P1|Overall Study|Withdrew Consent|0
77827|NCT00953043|278699|P2|Overall Study|Physician Decision|2
77828|NCT00953043|278700|P1|Overall Study|Physician Decision|0
77829|NCT00953043|278699|P2|Overall Study|Withdrawal by Subject|0
77830|NCT00953043|278700|P1|Overall Study|Withdrawal by Subject|4
77831|NCT00953017|278724|P4|Overall Study|Brown stool prior to procedure|0
77832|NCT00953017|278725|P3|Overall Study|Brown stool prior to procedure|1
77833|NCT00953017|278726|P2|Overall Study|Brown stool prior to procedure|0
77834|NCT00953017|278727|P1|Overall Study|Brown stool prior to procedure|0
77835|NCT00953017|278724|P4|Overall Study|Procedure incomplete due to pain/looping|1
77836|NCT00953017|278725|P3|Overall Study|Procedure incomplete due to pain/looping|0
77837|NCT00953017|278726|P2|Overall Study|Procedure incomplete due to pain/looping|1
77838|NCT00953017|278727|P1|Overall Study|Procedure incomplete due to pain/looping|0
77839|NCT00953017|278724|P4|Overall Study|Incomplete data|0
77840|NCT00953017|278725|P3|Overall Study|Incomplete data|0
77841|NCT00953017|278726|P2|Overall Study|Incomplete data|1
77842|NCT00953017|278727|P1|Overall Study|Incomplete data|1
77843|NCT00953017|278724|P4|Overall Study|DId not show up for colonoscopy|4
77844|NCT00953017|278725|P3|Overall Study|DId not show up for colonoscopy|5
77845|NCT00953017|278726|P2|Overall Study|DId not show up for colonoscopy|4
77846|NCT00953017|278727|P1|Overall Study|DId not show up for colonoscopy|4
77847|NCT00952848|278749|P1|Overall Study|Withdrawal by Subject|4
77848|NCT00952822|278756|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
77849|NCT00952822|278757|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
77850|NCT00952822|278758|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
77851|NCT00952822|278759|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
77852|NCT00952822|278756|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
77853|NCT00952822|278757|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
77854|NCT00952822|278758|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
77855|NCT00952822|278759|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
77856|NCT00952731|278791|P2|Overall Study|Drug supply expired|0
77857|NCT00952731|278792|P1|Overall Study|Drug supply expired|1
77858|NCT00952705|278811|P3|Overall Study|Exclusion criteria not met pre dose|0
77859|NCT00952705|278812|P2|Overall Study|Exclusion criteria not met pre dose|1
77860|NCT00952705|278813|P1|Overall Study|Exclusion criteria not met pre dose|0
77861|NCT00952705|278811|P3|Overall Study|Incarcerated post dose|0
77862|NCT00952705|278812|P2|Overall Study|Incarcerated post dose|0
77863|NCT00952705|278813|P1|Overall Study|Incarcerated post dose|5
77864|NCT00952705|278811|P3|Overall Study|Death|0
77865|NCT00952705|278812|P2|Overall Study|Death|0
77866|NCT00952705|278813|P1|Overall Study|Death|2
77867|NCT00952705|278811|P3|Overall Study|Withdrawal by Subject|1
77868|NCT00952705|278812|P2|Overall Study|Withdrawal by Subject|1
77869|NCT00952705|278813|P1|Overall Study|Withdrawal by Subject|2
77870|NCT00952705|278811|P3|Overall Study|Lost to Follow-up|9
77871|NCT00952705|278812|P2|Overall Study|Lost to Follow-up|8
77872|NCT00952705|278813|P1|Overall Study|Lost to Follow-up|24
77873|NCT00952614|278900|P1|Overall Study|other reason|1
77874|NCT00952614|278900|P1|Overall Study|Lost to Follow-up|3
77875|NCT00952614|278900|P1|Overall Study|Death|3
77876|NCT00952588|278907|P2|Overall Study|Lack of Efficacy|2
77877|NCT00952588|278908|P1|Overall Study|Lack of Efficacy|2
77878|NCT00952588|278907|P2|Overall Study|Physician Decision|1
77879|NCT00952588|278908|P1|Overall Study|Physician Decision|0
77880|NCT00952588|278907|P2|Overall Study|Lost to Follow-up|0
77881|NCT00952588|278908|P1|Overall Study|Lost to Follow-up|2
77882|NCT00952588|278907|P2|Overall Study|Adverse Event|3
77883|NCT00952588|278908|P1|Overall Study|Adverse Event|2
77884|NCT00952588|278907|P2|Overall Study|Withdrawal by Subject|5
77885|NCT00952588|278908|P1|Overall Study|Withdrawal by Subject|2
77886|NCT00952588|278907|P2|Overall Study|Death|13
77887|NCT00952588|278908|P1|Overall Study|Death|28
77888|NCT00952523|278926|P1|Overall Study|Withdrawal by Subject|7
77889|NCT00952484|278935|P3|Overall Study|Withdrawal by Subject|0
77890|NCT00952484|278936|P2|Overall Study|Withdrawal by Subject|1
77891|NCT00952484|278937|P1|Overall Study|Withdrawal by Subject|0
77892|NCT00952419|278964|P3|Overall Study|Withdrawal by Subject|0
77893|NCT00952419|278965|P2|Overall Study|Withdrawal by Subject|3
77894|NCT00952419|278966|P1|Overall Study|Withdrawal by Subject|1
77895|NCT00952419|278964|P3|Overall Study|Protocol Violation|0
77896|NCT00952419|278965|P2|Overall Study|Protocol Violation|7
77897|NCT00952419|278966|P1|Overall Study|Protocol Violation|3
77898|NCT00952419|278964|P3|Overall Study|Adverse Event|0
77899|NCT00952419|278965|P2|Overall Study|Adverse Event|0
77900|NCT00952419|278966|P1|Overall Study|Adverse Event|2
77901|NCT00952367|279002|P1|Overall Study|Protocol Violation|3
77902|NCT00952367|279002|P1|Overall Study|Noncoordination|1
77903|NCT00952367|279002|P1|Overall Study|Withdrawal by Subject|2
77904|NCT00952341|279017|P2|Cycle 2|Progressive Disease|1
77905|NCT00952341|279018|P1|Cycle 2|Progressive Disease|0
77906|NCT00952341|279017|P2|Cycle 2|Physician Decision|1
77907|NCT00952341|279018|P1|Cycle 2|Physician Decision|1
77908|NCT00952341|279017|P2|Cycle 2|Lost to Follow-up|9
77909|NCT00952341|279018|P1|Cycle 2|Lost to Follow-up|6
77910|NCT00952341|279017|P2|Cycle 2|Protocol Violation|0
77911|NCT00952341|279018|P1|Cycle 2|Protocol Violation|1
77912|NCT00952341|279017|P2|Cycle 2|Withdrawal by Subject|1
77913|NCT00952341|279018|P1|Cycle 2|Withdrawal by Subject|1
77914|NCT00952341|279017|P2|Cycle 1|Physician Decision|1
77915|NCT00952341|279018|P1|Cycle 1|Physician Decision|0
77916|NCT00952341|279017|P2|Cycle 1|Lost to Follow-up|2
77917|NCT00952341|279018|P1|Cycle 1|Lost to Follow-up|11
77918|NCT00952341|279017|P2|Cycle 1|Protocol Violation|1
77919|NCT00952341|279018|P1|Cycle 1|Protocol Violation|2
77920|NCT00952341|279017|P2|Cycle 1|Withdrawal by Subject|8
77921|NCT00952341|279018|P1|Cycle 1|Withdrawal by Subject|3
77922|NCT00952341|279017|P2|Cycle 1|Adverse Event|1
77923|NCT00952341|279018|P1|Cycle 1|Adverse Event|4
77924|NCT00952289|279040|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
77925|NCT00952289|279041|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
77926|NCT00952289|279040|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
77927|NCT00952289|279041|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
77928|NCT00952289|279040|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
77929|NCT00952289|279041|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
77930|NCT00952289|279040|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
77931|NCT00952289|279041|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
77932|NCT00952289|279040|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
77933|NCT00952289|279041|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
77934|NCT00952289|279040|P2|All Participants|Data lost during site relocation|1
77935|NCT00952289|279041|P1|All Participants|Data lost during site relocation|0
77936|NCT00952289|279040|P2|All Participants|Withdrawal by Subject|10
77937|NCT00952289|279041|P1|All Participants|Withdrawal by Subject|1
77938|NCT00952289|279040|P2|All Participants|Disease progression|12
77939|NCT00952289|279041|P1|All Participants|Disease progression|3
77940|NCT00952289|279040|P2|All Participants|Adverse Event|8
77941|NCT00952289|279041|P1|All Participants|Adverse Event|8
77942|NCT00952289|279040|P2|All Participants|Death|9
77943|NCT00952289|279041|P1|All Participants|Death|9
77944|NCT00952276|279070|P5|Overall Study|Withdrawal by Subject|0
77945|NCT00952276|279071|P4|Overall Study|Withdrawal by Subject|1
77946|NCT00952276|279072|P3|Overall Study|Withdrawal by Subject|0
77947|NCT00952276|279073|P2|Overall Study|Withdrawal by Subject|0
77948|NCT00952276|279074|P1|Overall Study|Withdrawal by Subject|1
77949|NCT00952068|279160|P1|Overall Study|Withdrawal by Subject|4
77950|NCT00952068|279160|P1|Overall Study|Adverse Event|3
77951|NCT00951912|279171|P3|Overall Study|Other: Stroke|0
77952|NCT00951912|279172|P2|Overall Study|Other: Stroke|1
77953|NCT00951912|279173|P1|Overall Study|Other: Stroke|0
77954|NCT00951912|279171|P3|Overall Study|Other: Colon cancer|0
77955|NCT00951912|279172|P2|Overall Study|Other: Colon cancer|0
77956|NCT00951912|279173|P1|Overall Study|Other: Colon cancer|1
77957|NCT00951912|279171|P3|Overall Study|Other:Depression|0
77958|NCT00951912|279172|P2|Overall Study|Other:Depression|0
77959|NCT00951912|279173|P1|Overall Study|Other:Depression|1
77960|NCT00951912|279171|P3|Overall Study|Withdrawal by Subject|0
77961|NCT00951912|279172|P2|Overall Study|Withdrawal by Subject|1
77962|NCT00951912|279173|P1|Overall Study|Withdrawal by Subject|1
77963|NCT00951912|279171|P3|Overall Study|Physician Decision|1
77964|NCT00951912|279172|P2|Overall Study|Physician Decision|0
77965|NCT00951912|279173|P1|Overall Study|Physician Decision|1
77966|NCT00951912|279171|P3|Overall Study|Lost to Follow-up|0
77967|NCT00951912|279172|P2|Overall Study|Lost to Follow-up|2
77968|NCT00951912|279173|P1|Overall Study|Lost to Follow-up|2
77969|NCT00951912|279171|P3|Overall Study|Adverse Event|1
77970|NCT00951912|279172|P2|Overall Study|Adverse Event|1
77971|NCT00951912|279173|P1|Overall Study|Adverse Event|0
77972|NCT00951912|279171|P3|Overall Study|Lack of Efficacy|0
77973|NCT00951912|279172|P2|Overall Study|Lack of Efficacy|0
77974|NCT00951912|279173|P1|Overall Study|Lack of Efficacy|1
77975|NCT00951665|279273|P6|Phase 2a|Disease Progression|5
77976|NCT00951665|279274|P5|Phase 2a|Disease Progression|6
77977|NCT00951665|279275|P4|Phase 2a|Disease Progression|0
77978|NCT00951665|279276|P3|Phase 2a|Disease Progression|0
77979|NCT00951665|279277|P2|Phase 2a|Disease Progression|0
77980|NCT00951665|279278|P1|Phase 2a|Disease Progression|0
77981|NCT00951665|279273|P6|Phase 2a|Withdrawal by Subject|0
77982|NCT00951665|279274|P5|Phase 2a|Withdrawal by Subject|2
77983|NCT00951665|279275|P4|Phase 2a|Withdrawal by Subject|0
77984|NCT00951665|279276|P3|Phase 2a|Withdrawal by Subject|0
77985|NCT00951665|279277|P2|Phase 2a|Withdrawal by Subject|0
77986|NCT00951665|279278|P1|Phase 2a|Withdrawal by Subject|0
77987|NCT00951665|279273|P6|Phase 2a|Physician Decision|1
77988|NCT00951665|279274|P5|Phase 2a|Physician Decision|0
77989|NCT00951665|279275|P4|Phase 2a|Physician Decision|0
77990|NCT00951665|279276|P3|Phase 2a|Physician Decision|0
77991|NCT00951665|279277|P2|Phase 2a|Physician Decision|0
77992|NCT00951665|279278|P1|Phase 2a|Physician Decision|0
77993|NCT00951665|279273|P6|Phase 2a|Lost to Follow-up|0
77994|NCT00951665|279274|P5|Phase 2a|Lost to Follow-up|1
77995|NCT00951665|279275|P4|Phase 2a|Lost to Follow-up|0
77996|NCT00951665|279276|P3|Phase 2a|Lost to Follow-up|0
77997|NCT00951665|279277|P2|Phase 2a|Lost to Follow-up|0
77998|NCT00951665|279278|P1|Phase 2a|Lost to Follow-up|0
77999|NCT00951665|279273|P6|Phase 2a|Death|1
78000|NCT00951665|279274|P5|Phase 2a|Death|1
78001|NCT00951665|279275|P4|Phase 2a|Death|0
78002|NCT00951665|279276|P3|Phase 2a|Death|0
78003|NCT00951665|279277|P2|Phase 2a|Death|0
78004|NCT00951665|279278|P1|Phase 2a|Death|0
78005|NCT00951665|279273|P6|Phase 2a|Adverse Event|0
78006|NCT00951665|279274|P5|Phase 2a|Adverse Event|2
78007|NCT00951665|279275|P4|Phase 2a|Adverse Event|0
78008|NCT00951665|279276|P3|Phase 2a|Adverse Event|0
78009|NCT00951665|279277|P2|Phase 2a|Adverse Event|0
78010|NCT00951665|279278|P1|Phase 2a|Adverse Event|0
78011|NCT00951665|279273|P6|Phase 1b|Protocol Violation|0
78012|NCT00951665|279274|P5|Phase 1b|Protocol Violation|0
78013|NCT00951665|279275|P4|Phase 1b|Protocol Violation|0
78014|NCT00951665|279276|P3|Phase 1b|Protocol Violation|0
78015|NCT00951665|279277|P2|Phase 1b|Protocol Violation|0
78016|NCT00951665|279278|P1|Phase 1b|Protocol Violation|2
78017|NCT00951665|279273|P6|Phase 1b|Disease Progression|0
78018|NCT00951665|279274|P5|Phase 1b|Disease Progression|0
78019|NCT00951665|279275|P4|Phase 1b|Disease Progression|0
78020|NCT00951665|279276|P3|Phase 1b|Disease Progression|14
78021|NCT00951665|279277|P2|Phase 1b|Disease Progression|2
78022|NCT00951665|279278|P1|Phase 1b|Disease Progression|13
78023|NCT00951665|279273|P6|Phase 1b|Withdrawal by Subject|0
78024|NCT00951665|279274|P5|Phase 1b|Withdrawal by Subject|0
78025|NCT00951665|279275|P4|Phase 1b|Withdrawal by Subject|0
78026|NCT00951665|279276|P3|Phase 1b|Withdrawal by Subject|0
78027|NCT00951665|279277|P2|Phase 1b|Withdrawal by Subject|1
78028|NCT00951665|279278|P1|Phase 1b|Withdrawal by Subject|0
78029|NCT00951665|279273|P6|Phase 1b|Physician Decision|0
78030|NCT00951665|279274|P5|Phase 1b|Physician Decision|0
78031|NCT00951665|279275|P4|Phase 1b|Physician Decision|0
78032|NCT00951665|279276|P3|Phase 1b|Physician Decision|1
78033|NCT00951665|279277|P2|Phase 1b|Physician Decision|0
78034|NCT00951665|279278|P1|Phase 1b|Physician Decision|4
78035|NCT00951665|279273|P6|Phase 1b|Death|0
78036|NCT00951665|279274|P5|Phase 1b|Death|0
78037|NCT00951665|279275|P4|Phase 1b|Death|0
78038|NCT00951665|279276|P3|Phase 1b|Death|2
78039|NCT00951665|279277|P2|Phase 1b|Death|0
78040|NCT00951665|279278|P1|Phase 1b|Death|1
78041|NCT00951665|279273|P6|Phase 1b|Adverse Event|0
78042|NCT00951665|279274|P5|Phase 1b|Adverse Event|0
78043|NCT00951665|279275|P4|Phase 1b|Adverse Event|1
78044|NCT00951665|279276|P3|Phase 1b|Adverse Event|0
78045|NCT00951665|279277|P2|Phase 1b|Adverse Event|1
78046|NCT00951665|279278|P1|Phase 1b|Adverse Event|2
78047|NCT00951509|279387|P1|Overall Study|Withdrawal by Subject|2
78048|NCT00951483|279397|P2|Overall Study|Withdrawal by Subject|0
78049|NCT00951483|279398|P1|Overall Study|Withdrawal by Subject|15
78050|NCT00951483|279397|P2|Overall Study|Physician Decision|0
78051|NCT00951483|279398|P1|Overall Study|Physician Decision|4
78052|NCT00951379|279418|P2|Overall Study|Disease Progression|1
78053|NCT00951379|279419|P1|Overall Study|Disease Progression|0
78054|NCT00951379|279418|P2|Overall Study|Noncompliance|0
78055|NCT00951379|279419|P1|Overall Study|Noncompliance|1
78056|NCT00951379|279418|P2|Overall Study|Withdrawal by Subject|0
78057|NCT00951379|279419|P1|Overall Study|Withdrawal by Subject|1
78058|NCT00951379|279418|P2|Overall Study|Adverse Event|1
78059|NCT00951379|279419|P1|Overall Study|Adverse Event|4
78060|NCT00951275|279461|P1|Overall Study|Protocol Violation|1
78061|NCT00951275|279461|P1|Overall Study|Withdrawal by Subject|4
78062|NCT00951275|279461|P1|Overall Study|Adverse Event|7
78063|NCT00951275|279461|P1|Overall Study|Administrative Reason|1
78064|NCT00951171|279493|P2|Overall Study|Adverse Event|0
78065|NCT00951171|279494|P1|Overall Study|Adverse Event|2
78066|NCT00951015|279528|P4|Overall Study|Ongoing|8
78067|NCT00951015|279529|P3|Overall Study|Ongoing|46
78068|NCT00951015|279530|P2|Overall Study|Ongoing|45
78069|NCT00951015|279531|P1|Overall Study|Ongoing|47
78070|NCT00951015|279528|P4|Overall Study|Withdrawal by Subject|2
78071|NCT00951015|279529|P3|Overall Study|Withdrawal by Subject|1
78072|NCT00951015|279530|P2|Overall Study|Withdrawal by Subject|1
78073|NCT00951015|279531|P1|Overall Study|Withdrawal by Subject|3
78074|NCT00951015|279528|P4|Overall Study|Lost to Follow-up|2
78075|NCT00951015|279529|P3|Overall Study|Lost to Follow-up|1
78076|NCT00951015|279530|P2|Overall Study|Lost to Follow-up|2
78077|NCT00951015|279531|P1|Overall Study|Lost to Follow-up|0
78078|NCT00951015|279528|P4|Overall Study|Protocol-Defined Stopping Criteria|1
78079|NCT00951015|279529|P3|Overall Study|Protocol-Defined Stopping Criteria|0
78080|NCT00951015|279530|P2|Overall Study|Protocol-Defined Stopping Criteria|0
78081|NCT00951015|279531|P1|Overall Study|Protocol-Defined Stopping Criteria|0
78082|NCT00951015|279528|P4|Overall Study|Protocol Violation|0
78083|NCT00951015|279529|P3|Overall Study|Protocol Violation|1
78084|NCT00951015|279530|P2|Overall Study|Protocol Violation|1
78085|NCT00951015|279531|P1|Overall Study|Protocol Violation|1
78086|NCT00951015|279528|P4|Overall Study|Lack of Efficacy|0
78087|NCT00951015|279529|P3|Overall Study|Lack of Efficacy|0
78088|NCT00951015|279530|P2|Overall Study|Lack of Efficacy|1
78089|NCT00951015|279531|P1|Overall Study|Lack of Efficacy|1
78090|NCT00951015|279528|P4|Overall Study|Adverse Event|5
78091|NCT00951015|279529|P3|Overall Study|Adverse Event|2
78092|NCT00951015|279530|P2|Overall Study|Adverse Event|1
78093|NCT00951015|279531|P1|Overall Study|Adverse Event|1
78094|NCT00950963|279627|P2|Overall Study|Lost to Follow-up|24
78095|NCT00950963|279628|P1|Overall Study|Lost to Follow-up|29
78096|NCT00950911|279663|P2|Overall Study|Poor performance status|1
78097|NCT00950911|279664|P1|Overall Study|Poor performance status|0
78098|NCT00950911|279663|P2|Overall Study|Noncompliance|0
78099|NCT00950911|279664|P1|Overall Study|Noncompliance|1
78100|NCT00950911|279663|P2|Overall Study|Ineligibility determined|0
78101|NCT00950911|279664|P1|Overall Study|Ineligibility determined|1
78102|NCT00950911|279663|P2|Overall Study|Administrative decision|1
78103|NCT00950911|279664|P1|Overall Study|Administrative decision|3
78104|NCT00950911|279663|P2|Overall Study|Consent withdrawn|3
78105|NCT00950911|279664|P1|Overall Study|Consent withdrawn|1
78106|NCT00950911|279663|P2|Overall Study|Disease progression|2
78107|NCT00950911|279664|P1|Overall Study|Disease progression|2
78108|NCT00950911|279663|P2|Overall Study|Death|6
78109|NCT00950911|279664|P1|Overall Study|Death|4
78110|NCT00950911|279663|P2|Overall Study|Adverse Event|2
78111|NCT00950911|279664|P1|Overall Study|Adverse Event|0
78112|NCT00950872|279670|P1|Overall Study|Did not have surgery|2
78113|NCT00950872|279670|P1|Overall Study|Withdrawal by Subject|1
78114|NCT00950859|279679|P2|Overall Study|Lost to Follow-up|3
78115|NCT00950859|279680|P1|Overall Study|Lost to Follow-up|0
78116|NCT00950859|279679|P2|Overall Study|Protocol Violation|1
78117|NCT00950859|279680|P1|Overall Study|Protocol Violation|1
78118|NCT00950859|279679|P2|Overall Study|Insufficient Viral Load Response|3
78119|NCT00950859|279680|P1|Overall Study|Insufficient Viral Load Response|12
78120|NCT00950859|279679|P2|Overall Study|Adverse Event|3
78121|NCT00950859|279680|P1|Overall Study|Adverse Event|3
78122|NCT00950807|279720|P10|Treatment Period 3|Adverse Event|0
78123|NCT00950807|279721|P9|Treatment Period 3|Adverse Event|0
78124|NCT00950807|279722|P8|Treatment Period 3|Adverse Event|0
78125|NCT00950807|279723|P7|Treatment Period 3|Adverse Event|1
78126|NCT00950807|279724|P6|Treatment Period 3|Adverse Event|0
78127|NCT00950807|279725|P5|Treatment Period 3|Adverse Event|0
78128|NCT00950807|279726|P4|Treatment Period 3|Adverse Event|0
78129|NCT00950807|279727|P3|Treatment Period 3|Adverse Event|0
78130|NCT00950807|279728|P2|Treatment Period 3|Adverse Event|0
78131|NCT00950807|279729|P1|Treatment Period 3|Adverse Event|0
78132|NCT00950807|279720|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
78133|NCT00950807|279721|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
78134|NCT00950807|279722|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
78135|NCT00950807|279723|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
78136|NCT00950807|279724|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
78137|NCT00950807|279725|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
78138|NCT00950807|279726|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
78139|NCT00950807|279727|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
78140|NCT00950807|279728|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
78141|NCT00950807|279729|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
78142|NCT00950807|279720|P10|Treatment Period 3|Withdrawal by Subject|1
78143|NCT00950807|279721|P9|Treatment Period 3|Withdrawal by Subject|0
78144|NCT00950807|279722|P8|Treatment Period 3|Withdrawal by Subject|0
78145|NCT00950807|279723|P7|Treatment Period 3|Withdrawal by Subject|0
78146|NCT00950807|279724|P6|Treatment Period 3|Withdrawal by Subject|0
78147|NCT00950807|279725|P5|Treatment Period 3|Withdrawal by Subject|0
78148|NCT00950807|279726|P4|Treatment Period 3|Withdrawal by Subject|0
78149|NCT00950807|279727|P3|Treatment Period 3|Withdrawal by Subject|0
78150|NCT00950807|279728|P2|Treatment Period 3|Withdrawal by Subject|0
78151|NCT00950807|279729|P1|Treatment Period 3|Withdrawal by Subject|0
78152|NCT00950807|279720|P10|Washout Period 2|Adverse Event|0
78153|NCT00950807|279721|P9|Washout Period 2|Adverse Event|0
78154|NCT00950807|279722|P8|Washout Period 2|Adverse Event|0
78155|NCT00950807|279723|P7|Washout Period 2|Adverse Event|0
78156|NCT00950807|279724|P6|Washout Period 2|Adverse Event|0
78157|NCT00950807|279725|P5|Washout Period 2|Adverse Event|0
78158|NCT00950807|279726|P4|Washout Period 2|Adverse Event|1
78159|NCT00950807|279727|P3|Washout Period 2|Adverse Event|0
78160|NCT00950807|279728|P2|Washout Period 2|Adverse Event|0
78161|NCT00950807|279729|P1|Washout Period 2|Adverse Event|3
78162|NCT00950807|279720|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
78163|NCT00950807|279721|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
78164|NCT00950807|279722|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
78165|NCT00950807|279723|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
78166|NCT00950807|279724|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
78167|NCT00950807|279725|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
78168|NCT00950807|279726|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
78169|NCT00950807|279727|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
78170|NCT00950807|279728|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
78171|NCT00950807|279729|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
78172|NCT00950807|279720|P10|Washout Period 2|Lack of Efficacy|0
78173|NCT00950807|279721|P9|Washout Period 2|Lack of Efficacy|0
78174|NCT00950807|279722|P8|Washout Period 2|Lack of Efficacy|0
78175|NCT00950807|279723|P7|Washout Period 2|Lack of Efficacy|0
78176|NCT00950807|279724|P6|Washout Period 2|Lack of Efficacy|0
78177|NCT00950807|279725|P5|Washout Period 2|Lack of Efficacy|0
78178|NCT00950807|279726|P4|Washout Period 2|Lack of Efficacy|0
78179|NCT00950807|279727|P3|Washout Period 2|Lack of Efficacy|0
78180|NCT00950807|279728|P2|Washout Period 2|Lack of Efficacy|0
78181|NCT00950807|279729|P1|Washout Period 2|Lack of Efficacy|1
78182|NCT00950807|279720|P10|Treatment Period 2|Adverse Event|0
78183|NCT00950807|279721|P9|Treatment Period 2|Adverse Event|0
78184|NCT00950807|279722|P8|Treatment Period 2|Adverse Event|1
78185|NCT00950807|279723|P7|Treatment Period 2|Adverse Event|0
78186|NCT00950807|279724|P6|Treatment Period 2|Adverse Event|1
78187|NCT00950807|279725|P5|Treatment Period 2|Adverse Event|0
78188|NCT00950807|279726|P4|Treatment Period 2|Adverse Event|1
78189|NCT00950807|279727|P3|Treatment Period 2|Adverse Event|0
78190|NCT00950807|279728|P2|Treatment Period 2|Adverse Event|1
78191|NCT00950807|279729|P1|Treatment Period 2|Adverse Event|0
78192|NCT00950807|279720|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
78193|NCT00950807|279721|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
78194|NCT00950807|279722|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
78195|NCT00950807|279723|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
78196|NCT00950807|279724|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
78197|NCT00950807|279725|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
78198|NCT00950807|279726|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
78199|NCT00950807|279727|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
78200|NCT00950807|279728|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
78201|NCT00950807|279729|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
78202|NCT00950807|279720|P10|Treatment Period 2|Withdrawal by Subject|0
78203|NCT00950807|279721|P9|Treatment Period 2|Withdrawal by Subject|0
78204|NCT00950807|279722|P8|Treatment Period 2|Withdrawal by Subject|2
78205|NCT00950807|279723|P7|Treatment Period 2|Withdrawal by Subject|1
78206|NCT00950807|279724|P6|Treatment Period 2|Withdrawal by Subject|0
78207|NCT00950807|279725|P5|Treatment Period 2|Withdrawal by Subject|0
78208|NCT00950807|279726|P4|Treatment Period 2|Withdrawal by Subject|0
78209|NCT00950807|279727|P3|Treatment Period 2|Withdrawal by Subject|0
78210|NCT00950807|279728|P2|Treatment Period 2|Withdrawal by Subject|0
78211|NCT00950807|279729|P1|Treatment Period 2|Withdrawal by Subject|0
78212|NCT00950807|279720|P10|Treatment Period 2|Lack of Efficacy|0
78213|NCT00950807|279721|P9|Treatment Period 2|Lack of Efficacy|0
78214|NCT00950807|279722|P8|Treatment Period 2|Lack of Efficacy|0
78215|NCT00950807|279723|P7|Treatment Period 2|Lack of Efficacy|0
78216|NCT00950807|279724|P6|Treatment Period 2|Lack of Efficacy|0
78217|NCT00950807|279725|P5|Treatment Period 2|Lack of Efficacy|0
78218|NCT00950807|279726|P4|Treatment Period 2|Lack of Efficacy|0
78219|NCT00950807|279727|P3|Treatment Period 2|Lack of Efficacy|0
78220|NCT00950807|279728|P2|Treatment Period 2|Lack of Efficacy|0
78221|NCT00950807|279729|P1|Treatment Period 2|Lack of Efficacy|1
78222|NCT00950807|279720|P10|Washout Period 1|Adverse Event|0
78223|NCT00950807|279721|P9|Washout Period 1|Adverse Event|0
78224|NCT00950807|279722|P8|Washout Period 1|Adverse Event|0
78225|NCT00950807|279723|P7|Washout Period 1|Adverse Event|0
78226|NCT00950807|279724|P6|Washout Period 1|Adverse Event|0
78227|NCT00950807|279725|P5|Washout Period 1|Adverse Event|1
78228|NCT00950807|279726|P4|Washout Period 1|Adverse Event|1
78229|NCT00950807|279727|P3|Washout Period 1|Adverse Event|0
78230|NCT00950807|279728|P2|Washout Period 1|Adverse Event|0
78231|NCT00950807|279729|P1|Washout Period 1|Adverse Event|2
78232|NCT00950807|279720|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
78233|NCT00950807|279721|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
78234|NCT00950807|279722|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
78235|NCT00950807|279723|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
78236|NCT00950807|279724|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
78237|NCT00950807|279725|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
78238|NCT00950807|279726|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
78239|NCT00950807|279727|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
78240|NCT00950807|279728|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
78241|NCT00950807|279729|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
78242|NCT00950807|279720|P10|Washout Period 1|Withdrawal by Subject|0
78243|NCT00950807|279721|P9|Washout Period 1|Withdrawal by Subject|1
78244|NCT00950807|279722|P8|Washout Period 1|Withdrawal by Subject|0
78245|NCT00950807|279723|P7|Washout Period 1|Withdrawal by Subject|0
78246|NCT00950807|279724|P6|Washout Period 1|Withdrawal by Subject|0
78247|NCT00950807|279725|P5|Washout Period 1|Withdrawal by Subject|0
78248|NCT00950807|279726|P4|Washout Period 1|Withdrawal by Subject|0
78249|NCT00950807|279727|P3|Washout Period 1|Withdrawal by Subject|0
78250|NCT00950807|279728|P2|Washout Period 1|Withdrawal by Subject|0
78251|NCT00950807|279729|P1|Washout Period 1|Withdrawal by Subject|0
78252|NCT00950807|279720|P10|Washout Period 1|Lack of Efficacy|0
78253|NCT00950807|279721|P9|Washout Period 1|Lack of Efficacy|0
78254|NCT00950807|279722|P8|Washout Period 1|Lack of Efficacy|0
78255|NCT00950807|279723|P7|Washout Period 1|Lack of Efficacy|1
78256|NCT00950807|279724|P6|Washout Period 1|Lack of Efficacy|0
78257|NCT00950807|279725|P5|Washout Period 1|Lack of Efficacy|0
78258|NCT00950807|279726|P4|Washout Period 1|Lack of Efficacy|0
78259|NCT00950807|279727|P3|Washout Period 1|Lack of Efficacy|0
78260|NCT00950807|279728|P2|Washout Period 1|Lack of Efficacy|0
78261|NCT00950807|279729|P1|Washout Period 1|Lack of Efficacy|0
78262|NCT00950807|279720|P10|Treatment Period 1|Adverse Event|0
78263|NCT00950807|279721|P9|Treatment Period 1|Adverse Event|0
78264|NCT00950807|279722|P8|Treatment Period 1|Adverse Event|0
78265|NCT00950807|279723|P7|Treatment Period 1|Adverse Event|0
78266|NCT00950807|279724|P6|Treatment Period 1|Adverse Event|1
78267|NCT00950807|279725|P5|Treatment Period 1|Adverse Event|0
78268|NCT00950807|279726|P4|Treatment Period 1|Adverse Event|0
78269|NCT00950807|279727|P3|Treatment Period 1|Adverse Event|0
78270|NCT00950807|279728|P2|Treatment Period 1|Adverse Event|0
78271|NCT00950807|279729|P1|Treatment Period 1|Adverse Event|0
78272|NCT00950807|279720|P10|Treatment Period 1|Withdrawal by Subject|0
78273|NCT00950807|279721|P9|Treatment Period 1|Withdrawal by Subject|1
78274|NCT00950807|279722|P8|Treatment Period 1|Withdrawal by Subject|0
78275|NCT00950807|279723|P7|Treatment Period 1|Withdrawal by Subject|0
78276|NCT00950807|279724|P6|Treatment Period 1|Withdrawal by Subject|0
78277|NCT00950807|279725|P5|Treatment Period 1|Withdrawal by Subject|1
78278|NCT00950807|279726|P4|Treatment Period 1|Withdrawal by Subject|0
78279|NCT00950807|279727|P3|Treatment Period 1|Withdrawal by Subject|0
78280|NCT00950807|279728|P2|Treatment Period 1|Withdrawal by Subject|0
78281|NCT00950807|279729|P1|Treatment Period 1|Withdrawal by Subject|1
78282|NCT00950807|279720|P10|Treatment Period 1|Lost to Follow-up|0
78283|NCT00950807|279721|P9|Treatment Period 1|Lost to Follow-up|0
78284|NCT00950807|279722|P8|Treatment Period 1|Lost to Follow-up|0
78285|NCT00950807|279723|P7|Treatment Period 1|Lost to Follow-up|0
78286|NCT00950807|279724|P6|Treatment Period 1|Lost to Follow-up|0
78287|NCT00950807|279725|P5|Treatment Period 1|Lost to Follow-up|0
78288|NCT00950807|279726|P4|Treatment Period 1|Lost to Follow-up|0
78289|NCT00950807|279727|P3|Treatment Period 1|Lost to Follow-up|1
78290|NCT00950807|279728|P2|Treatment Period 1|Lost to Follow-up|0
78291|NCT00950807|279729|P1|Treatment Period 1|Lost to Follow-up|0
78292|NCT00950807|279720|P10|Treatment Period 1|Protocol Violation|0
78293|NCT00950807|279721|P9|Treatment Period 1|Protocol Violation|0
78294|NCT00950807|279722|P8|Treatment Period 1|Protocol Violation|0
78295|NCT00950807|279723|P7|Treatment Period 1|Protocol Violation|0
78296|NCT00950807|279724|P6|Treatment Period 1|Protocol Violation|0
78297|NCT00950807|279725|P5|Treatment Period 1|Protocol Violation|0
78298|NCT00950807|279726|P4|Treatment Period 1|Protocol Violation|0
78299|NCT00950807|279727|P3|Treatment Period 1|Protocol Violation|0
78300|NCT00950807|279728|P2|Treatment Period 1|Protocol Violation|0
78301|NCT00950807|279729|P1|Treatment Period 1|Protocol Violation|1
78302|NCT00950807|279720|P10|Treatment Period 1|Lack of Efficacy|0
78303|NCT00950807|279721|P9|Treatment Period 1|Lack of Efficacy|0
78304|NCT00950807|279722|P8|Treatment Period 1|Lack of Efficacy|0
78305|NCT00950807|279723|P7|Treatment Period 1|Lack of Efficacy|0
78306|NCT00950807|279724|P6|Treatment Period 1|Lack of Efficacy|1
78307|NCT00950807|279725|P5|Treatment Period 1|Lack of Efficacy|0
78308|NCT00950807|279726|P4|Treatment Period 1|Lack of Efficacy|0
78309|NCT00950807|279727|P3|Treatment Period 1|Lack of Efficacy|0
78310|NCT00950807|279728|P2|Treatment Period 1|Lack of Efficacy|0
78311|NCT00950807|279729|P1|Treatment Period 1|Lack of Efficacy|1
78312|NCT00950755|279771|P1|Long-Term Follow-Up|Death|8
78313|NCT00950755|279771|P1|Long-Term Follow-Up|Lost to Follow-up|1
78314|NCT00950755|279771|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
78315|NCT00950755|279771|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
78316|NCT00950755|279771|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
78317|NCT00950755|279771|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
78318|NCT00950755|279771|P1|Dosimetric and Therapeutic Treatment|Death|1
78319|NCT00950755|279771|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
78320|NCT00950755|279771|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
78321|NCT00950755|279771|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
78322|NCT00950742|279797|P2|Overall Study|Dose limiting toxicity|0
78323|NCT00950742|279798|P1|Overall Study|Dose limiting toxicity|6
78324|NCT00950742|279797|P2|Overall Study|Progressive Disease|2
78325|NCT00950742|279798|P1|Overall Study|Progressive Disease|6
78326|NCT00950742|279797|P2|Overall Study|Withdrawal by Subject|0
78327|NCT00950742|279798|P1|Overall Study|Withdrawal by Subject|3
78328|NCT00950742|279797|P2|Overall Study|Other Adverse Event|0
78329|NCT00950742|279798|P1|Overall Study|Other Adverse Event|1
78330|NCT00950690|279819|P1|Overall Study|Not known|163
78331|NCT00950690|279819|P1|Overall Study|Lost to Follow-up|40
78332|NCT00950690|279819|P1|Overall Study|Lack of Efficacy|22
78333|NCT00950690|279819|P1|Overall Study|Adverse Event|15
78334|NCT00950690|279819|P1|Overall Study|Death|4
78335|NCT00950664|279826|P2|First Intervention|Withdrawal by Subject|2
78336|NCT00950664|279827|P1|First Intervention|Withdrawal by Subject|2
78337|NCT00950664|279826|P2|First Intervention|Lost to Follow-up|3
78338|NCT00950664|279827|P1|First Intervention|Lost to Follow-up|1
78339|NCT00950651|279847|P2|Overall Study|Withdrawal by Subject|9
78340|NCT00950651|279848|P1|Overall Study|Withdrawal by Subject|8
78341|NCT00950651|279847|P2|Overall Study|Protocol Violation|4
78342|NCT00950651|279848|P1|Overall Study|Protocol Violation|3
78343|NCT00950651|279847|P2|Overall Study|Lack of Efficacy|2
78344|NCT00950651|279848|P1|Overall Study|Lack of Efficacy|2
78345|NCT00950651|279847|P2|Overall Study|Death|0
78346|NCT00950651|279848|P1|Overall Study|Death|1
78347|NCT00950651|279847|P2|Overall Study|Adverse Event|20
78348|NCT00950651|279848|P1|Overall Study|Adverse Event|17
78349|NCT00950599|279941|P10|Follow-Up Period|Subject withdrew Consent|1
78350|NCT00950599|279942|P9|Follow-Up Period|Subject withdrew Consent|2
78351|NCT00950599|279943|P8|Follow-Up Period|Subject withdrew Consent|0
78352|NCT00950599|279944|P7|Follow-Up Period|Subject withdrew Consent|0
78353|NCT00950599|279945|P6|Follow-Up Period|Subject withdrew Consent|0
78354|NCT00950599|279946|P5|Follow-Up Period|Subject withdrew Consent|0
78355|NCT00950599|279947|P4|Follow-Up Period|Subject withdrew Consent|0
78356|NCT00950599|279948|P3|Follow-Up Period|Subject withdrew Consent|0
78357|NCT00950599|279949|P2|Follow-Up Period|Subject withdrew Consent|0
78358|NCT00950599|279950|P1|Follow-Up Period|Subject withdrew Consent|0
78359|NCT00950599|279941|P10|Follow-Up Period|Poor/Noncompliance|0
78360|NCT00950599|279942|P9|Follow-Up Period|Poor/Noncompliance|1
78361|NCT00950599|279943|P8|Follow-Up Period|Poor/Noncompliance|0
78362|NCT00950599|279944|P7|Follow-Up Period|Poor/Noncompliance|0
78363|NCT00950599|279945|P6|Follow-Up Period|Poor/Noncompliance|0
78364|NCT00950599|279946|P5|Follow-Up Period|Poor/Noncompliance|0
78365|NCT00950599|279947|P4|Follow-Up Period|Poor/Noncompliance|0
78366|NCT00950599|279948|P3|Follow-Up Period|Poor/Noncompliance|0
78367|NCT00950599|279949|P2|Follow-Up Period|Poor/Noncompliance|0
78368|NCT00950599|279950|P1|Follow-Up Period|Poor/Noncompliance|0
78369|NCT00950599|279941|P10|Follow-Up Period|Physician Decision|0
78370|NCT00950599|279942|P9|Follow-Up Period|Physician Decision|1
78371|NCT00950599|279943|P8|Follow-Up Period|Physician Decision|0
78372|NCT00950599|279944|P7|Follow-Up Period|Physician Decision|0
78373|NCT00950599|279945|P6|Follow-Up Period|Physician Decision|0
78374|NCT00950599|279946|P5|Follow-Up Period|Physician Decision|0
78375|NCT00950599|279947|P4|Follow-Up Period|Physician Decision|0
78376|NCT00950599|279948|P3|Follow-Up Period|Physician Decision|0
78377|NCT00950599|279949|P2|Follow-Up Period|Physician Decision|0
78378|NCT00950599|279950|P1|Follow-Up Period|Physician Decision|0
78379|NCT00950599|279941|P10|Follow-Up Period|Lost to Follow-up|1
78380|NCT00950599|279942|P9|Follow-Up Period|Lost to Follow-up|5
78381|NCT00950599|279943|P8|Follow-Up Period|Lost to Follow-up|0
78382|NCT00950599|279944|P7|Follow-Up Period|Lost to Follow-up|0
78383|NCT00950599|279945|P6|Follow-Up Period|Lost to Follow-up|0
78384|NCT00950599|279946|P5|Follow-Up Period|Lost to Follow-up|0
78385|NCT00950599|279947|P4|Follow-Up Period|Lost to Follow-up|0
78386|NCT00950599|279948|P3|Follow-Up Period|Lost to Follow-up|0
78387|NCT00950599|279949|P2|Follow-Up Period|Lost to Follow-up|0
78388|NCT00950599|279950|P1|Follow-Up Period|Lost to Follow-up|0
78389|NCT00950599|279941|P10|Follow-Up Period|Lack of Efficacy|0
78390|NCT00950599|279942|P9|Follow-Up Period|Lack of Efficacy|3
78391|NCT00950599|279943|P8|Follow-Up Period|Lack of Efficacy|0
78392|NCT00950599|279944|P7|Follow-Up Period|Lack of Efficacy|0
78393|NCT00950599|279945|P6|Follow-Up Period|Lack of Efficacy|0
78394|NCT00950599|279946|P5|Follow-Up Period|Lack of Efficacy|0
78395|NCT00950599|279947|P4|Follow-Up Period|Lack of Efficacy|0
78396|NCT00950599|279948|P3|Follow-Up Period|Lack of Efficacy|0
78397|NCT00950599|279949|P2|Follow-Up Period|Lack of Efficacy|0
78398|NCT00950599|279950|P1|Follow-Up Period|Lack of Efficacy|0
78399|NCT00950599|279941|P10|Follow-Up Period|Adverse Event|0
78400|NCT00950599|279942|P9|Follow-Up Period|Adverse Event|1
78401|NCT00950599|279943|P8|Follow-Up Period|Adverse Event|0
78402|NCT00950599|279944|P7|Follow-Up Period|Adverse Event|0
78403|NCT00950599|279945|P6|Follow-Up Period|Adverse Event|0
78404|NCT00950599|279946|P5|Follow-Up Period|Adverse Event|0
78405|NCT00950599|279947|P4|Follow-Up Period|Adverse Event|0
78406|NCT00950599|279948|P3|Follow-Up Period|Adverse Event|0
78407|NCT00950599|279949|P2|Follow-Up Period|Adverse Event|0
78408|NCT00950599|279950|P1|Follow-Up Period|Adverse Event|0
78409|NCT00950599|279941|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
78410|NCT00950599|279942|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
78411|NCT00950599|279943|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
78412|NCT00950599|279944|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
78413|NCT00950599|279945|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
78414|NCT00950599|279946|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
78415|NCT00950599|279947|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
78416|NCT00950599|279948|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
78417|NCT00950599|279949|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
78418|NCT00950599|279950|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
78419|NCT00950599|279941|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
78420|NCT00950599|279942|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
78421|NCT00950599|279943|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
78422|NCT00950599|279944|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
78423|NCT00950599|279945|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
78424|NCT00950599|279946|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
78425|NCT00950599|279947|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
78426|NCT00950599|279948|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
78427|NCT00950599|279949|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
78428|NCT00950599|279950|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
78429|NCT00950599|279941|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
78430|NCT00950599|279942|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
78431|NCT00950599|279943|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
78432|NCT00950599|279944|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
78433|NCT00950599|279945|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
78434|NCT00950599|279946|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
78435|NCT00950599|279947|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
78436|NCT00950599|279948|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
78437|NCT00950599|279949|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
78438|NCT00950599|279950|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
78439|NCT00950599|279941|P10|Double-Blind Treatment Period|Lost to Follow-up|0
78440|NCT00950599|279942|P9|Double-Blind Treatment Period|Lost to Follow-up|0
78441|NCT00950599|279943|P8|Double-Blind Treatment Period|Lost to Follow-up|1
78442|NCT00950599|279944|P7|Double-Blind Treatment Period|Lost to Follow-up|0
78443|NCT00950599|279945|P6|Double-Blind Treatment Period|Lost to Follow-up|2
78444|NCT00950599|279946|P5|Double-Blind Treatment Period|Lost to Follow-up|1
78445|NCT00950599|279947|P4|Double-Blind Treatment Period|Lost to Follow-up|1
78446|NCT00950599|279948|P3|Double-Blind Treatment Period|Lost to Follow-up|0
78447|NCT00950599|279949|P2|Double-Blind Treatment Period|Lost to Follow-up|0
78448|NCT00950599|279950|P1|Double-Blind Treatment Period|Lost to Follow-up|0
78449|NCT00950599|279941|P10|Double-Blind Treatment Period|Lack of Efficacy|0
78450|NCT00950599|279942|P9|Double-Blind Treatment Period|Lack of Efficacy|0
78451|NCT00950599|279943|P8|Double-Blind Treatment Period|Lack of Efficacy|1
78452|NCT00950599|279944|P7|Double-Blind Treatment Period|Lack of Efficacy|0
78453|NCT00950599|279945|P6|Double-Blind Treatment Period|Lack of Efficacy|6
78454|NCT00950599|279946|P5|Double-Blind Treatment Period|Lack of Efficacy|3
78455|NCT00950599|279947|P4|Double-Blind Treatment Period|Lack of Efficacy|7
78456|NCT00950599|279948|P3|Double-Blind Treatment Period|Lack of Efficacy|5
78457|NCT00950599|279949|P2|Double-Blind Treatment Period|Lack of Efficacy|5
78458|NCT00950599|279950|P1|Double-Blind Treatment Period|Lack of Efficacy|2
78459|NCT00950599|279941|P10|Double-Blind Treatment Period|Adverse Event|0
78460|NCT00950599|279942|P9|Double-Blind Treatment Period|Adverse Event|0
78461|NCT00950599|279943|P8|Double-Blind Treatment Period|Adverse Event|0
78462|NCT00950599|279944|P7|Double-Blind Treatment Period|Adverse Event|0
78463|NCT00950599|279945|P6|Double-Blind Treatment Period|Adverse Event|1
78464|NCT00950599|279946|P5|Double-Blind Treatment Period|Adverse Event|1
78465|NCT00950599|279947|P4|Double-Blind Treatment Period|Adverse Event|1
78466|NCT00950599|279948|P3|Double-Blind Treatment Period|Adverse Event|1
78467|NCT00950599|279949|P2|Double-Blind Treatment Period|Adverse Event|1
78468|NCT00950599|279950|P1|Double-Blind Treatment Period|Adverse Event|0
78469|NCT00950599|279941|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
78470|NCT00950599|279942|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
78471|NCT00950599|279943|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
78472|NCT00950599|279944|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
78473|NCT00950599|279945|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
78474|NCT00950599|279946|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
78475|NCT00950599|279947|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
78476|NCT00950599|279948|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
78477|NCT00950599|279949|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
78478|NCT00950599|279950|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
78479|NCT00950300|280523|P2|SFU Period|Participant Refusal/Withdrawal|6
78480|NCT00950300|280524|P1|SFU Period|Participant Refusal/Withdrawal|2
78481|NCT00950300|280523|P2|SFU Period|Lost to Follow-up|9
78482|NCT00950300|280524|P1|SFU Period|Lost to Follow-up|11
78483|NCT00950300|280523|P2|SFU Period|Death|21
78484|NCT00950300|280524|P1|SFU Period|Death|28
78485|NCT00950300|280523|P2|SFU Period|Ongoing in SFU|18
78486|NCT00950300|280524|P1|SFU Period|Ongoing in SFU|12
78487|NCT00950300|280523|P2|TFFU Period|Not Specified|1
78488|NCT00950300|280524|P1|TFFU Period|Not Specified|1
78489|NCT00950300|280523|P2|TFFU Period|Recurrence of Disease|55
78490|NCT00950300|280524|P1|TFFU Period|Recurrence of Disease|48
78491|NCT00950300|280523|P2|TFFU Period|Lost to Follow-up|4
78492|NCT00950300|280524|P1|TFFU Period|Lost to Follow-up|6
78493|NCT00950300|280523|P2|TFFU Period|Participant Refusal/Withdrawal|8
78494|NCT00950300|280524|P1|TFFU Period|Participant Refusal/Withdrawal|5
78495|NCT00950300|280523|P2|TFFU Period|Death|0
78496|NCT00950300|280524|P1|TFFU Period|Death|1
78497|NCT00950300|280523|P2|TFFU Period|Adverse Event or Intercurrent Illness|1
78498|NCT00950300|280524|P1|TFFU Period|Adverse Event or Intercurrent Illness|1
78499|NCT00950300|280523|P2|TFFU Period|Ongoing in TFFU|183
78500|NCT00950300|280524|P1|TFFU Period|Ongoing in TFFU|192
78501|NCT00950300|280523|P2|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
78502|NCT00950300|280524|P1|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
78503|NCT00950300|280523|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
78504|NCT00950300|280524|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
78505|NCT00950300|280523|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
78506|NCT00950300|280524|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
78507|NCT00950300|280523|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
78508|NCT00950300|280524|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
78509|NCT00950300|280523|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
78510|NCT00950300|280524|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
78511|NCT00950300|280523|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
78512|NCT00950300|280524|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
78513|NCT00950300|280523|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
78514|NCT00950300|280524|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
78515|NCT00950300|280523|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
78516|NCT00950300|280524|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
78517|NCT00950300|280523|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
78518|NCT00950300|280524|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
78519|NCT00950300|280523|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
78520|NCT00950300|280524|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
78521|NCT00949975|280602|P4|Overall Study|Other|0
78522|NCT00949975|280603|P3|Overall Study|Other|0
78523|NCT00949975|280604|P2|Overall Study|Other|0
78524|NCT00949975|280605|P1|Overall Study|Other|1
78525|NCT00949975|280602|P4|Overall Study|Lost to Follow-up|3
78526|NCT00949975|280603|P3|Overall Study|Lost to Follow-up|1
78527|NCT00949975|280604|P2|Overall Study|Lost to Follow-up|0
78528|NCT00949975|280605|P1|Overall Study|Lost to Follow-up|1
78529|NCT00949975|280602|P4|Overall Study|Severe non-compliance|2
78530|NCT00949975|280603|P3|Overall Study|Severe non-compliance|0
78531|NCT00949975|280604|P2|Overall Study|Severe non-compliance|1
78532|NCT00949975|280605|P1|Overall Study|Severe non-compliance|3
78533|NCT00949975|280602|P4|Overall Study|Incorrect enrolment|7
78534|NCT00949975|280603|P3|Overall Study|Incorrect enrolment|4
78535|NCT00949975|280604|P2|Overall Study|Incorrect enrolment|10
78536|NCT00949975|280605|P1|Overall Study|Incorrect enrolment|5
78537|NCT00949975|280602|P4|Overall Study|Study-specific criteria|0
78538|NCT00949975|280603|P3|Overall Study|Study-specific criteria|1
78539|NCT00949975|280604|P2|Overall Study|Study-specific criteria|1
78540|NCT00949975|280605|P1|Overall Study|Study-specific criteria|0
78541|NCT00949975|280602|P4|Overall Study|Safety reason|0
78542|NCT00949975|280603|P3|Overall Study|Safety reason|0
78543|NCT00949975|280604|P2|Overall Study|Safety reason|1
78544|NCT00949975|280605|P1|Overall Study|Safety reason|0
78545|NCT00949975|280602|P4|Overall Study|Adverse Event|10
78546|NCT00949975|280603|P3|Overall Study|Adverse Event|10
78547|NCT00949975|280604|P2|Overall Study|Adverse Event|11
78548|NCT00949975|280605|P1|Overall Study|Adverse Event|11
78549|NCT00949975|280602|P4|Overall Study|Voluntary discontinuation|6
78550|NCT00949975|280603|P3|Overall Study|Voluntary discontinuation|3
78551|NCT00949975|280604|P2|Overall Study|Voluntary discontinuation|5
78552|NCT00949975|280605|P1|Overall Study|Voluntary discontinuation|6
78553|NCT00949910|280723|P1|Overall Study|No Data|9
78554|NCT00949910|280723|P1|Overall Study|Other|4
78555|NCT00949910|280723|P1|Overall Study|Physician/Participant Decision|7
78556|NCT00949910|280723|P1|Overall Study|Serious Adverse Event|6
78557|NCT00949910|280723|P1|Overall Study|Adverse Event|83
78558|NCT00949910|280723|P1|Overall Study|Prolonged Dosing Interruption|4
78559|NCT00949910|280723|P1|Overall Study|Non-Compliance|10
78560|NCT00949910|280723|P1|Overall Study|Logistical Reasons|13
78561|NCT00949910|280723|P1|Overall Study|Violation of Eligibility|23
78562|NCT00949910|280723|P1|Overall Study|Switched to Commercial Treatment|4
78563|NCT00949910|280723|P1|Overall Study|Switched to Compassionate/Other Use|174
78564|NCT00949910|280723|P1|Overall Study|Unspecified Progression/Deterioration|13
78565|NCT00949910|280723|P1|Overall Study|Death from Unknown Cause|5
78566|NCT00949910|280723|P1|Overall Study|Death Due to Toxicity|3
78567|NCT00949910|280723|P1|Overall Study|Death Due to Adverse Event|115
78568|NCT00949910|280723|P1|Overall Study|Death Due to Progression/Deterioration|4
78569|NCT00949910|280723|P1|Overall Study|Death Due to Malignant Disease|456
78570|NCT00949910|280723|P1|Overall Study|Participant Refusal|390
78571|NCT00949910|280723|P1|Overall Study|Study Drug-Related Adverse Event|315
78572|NCT00949910|280723|P1|Overall Study|Lost to Follow-up|100
78573|NCT00949910|280723|P1|Overall Study|Symptomatic Deterioration|1088
78574|NCT00949910|280723|P1|Overall Study|Progressive Disease|3750
78575|NCT00949884|280736|P3|Overall Study|Study terminated by sponsor|1
78576|NCT00949884|280737|P2|Overall Study|Study terminated by sponsor|0
78577|NCT00949884|280738|P1|Overall Study|Study terminated by sponsor|0
78578|NCT00949884|280736|P3|Overall Study|Lack of Efficacy|7
78579|NCT00949884|280737|P2|Overall Study|Lack of Efficacy|2
78580|NCT00949884|280738|P1|Overall Study|Lack of Efficacy|4
78581|NCT00949884|280736|P3|Overall Study|Withdrawal by Subject|16
78582|NCT00949884|280737|P2|Overall Study|Withdrawal by Subject|4
78583|NCT00949884|280738|P1|Overall Study|Withdrawal by Subject|13
78584|NCT00949884|280736|P3|Overall Study|Treatment non-compliance|8
78585|NCT00949884|280737|P2|Overall Study|Treatment non-compliance|0
78586|NCT00949884|280738|P1|Overall Study|Treatment non-compliance|5
78587|NCT00949884|280736|P3|Overall Study|Physician Decision|6
78588|NCT00949884|280737|P2|Overall Study|Physician Decision|0
78589|NCT00949884|280738|P1|Overall Study|Physician Decision|5
78590|NCT00949884|280736|P3|Overall Study|Lost to Follow-up|5
78591|NCT00949884|280737|P2|Overall Study|Lost to Follow-up|5
78592|NCT00949884|280738|P1|Overall Study|Lost to Follow-up|7
78593|NCT00949884|280736|P3|Overall Study|Did not meet inclusion/exclusion|3
78594|NCT00949884|280737|P2|Overall Study|Did not meet inclusion/exclusion|1
78595|NCT00949884|280738|P1|Overall Study|Did not meet inclusion/exclusion|2
78596|NCT00949884|280736|P3|Overall Study|Adverse Event|12
78597|NCT00949884|280737|P2|Overall Study|Adverse Event|3
78598|NCT00949884|280738|P1|Overall Study|Adverse Event|14
78599|NCT00949715|280793|P2|Overall Study|Missing 24 month LVEF measurement|0
78600|NCT00949715|280794|P1|Overall Study|Missing 24 month LVEF measurement|2
78601|NCT00949715|280793|P2|Overall Study|Lost to Follow-up|0
78602|NCT00949715|280794|P1|Overall Study|Lost to Follow-up|1
78603|NCT00949715|280793|P2|Overall Study|Physician Decision|0
78604|NCT00949715|280794|P1|Overall Study|Physician Decision|1
78605|NCT00949702|280805|P1|Overall Study|Withdrawal of consent|1
78606|NCT00949702|280805|P1|Overall Study|Disease progression|7
78607|NCT00949702|280805|P1|Overall Study|Death|40
78608|NCT00949650|280822|P2|Overall Study|Other|0
78609|NCT00949650|280823|P1|Overall Study|Other|1
78610|NCT00949650|280822|P2|Overall Study|Not treated|4
78611|NCT00949650|280823|P1|Overall Study|Not treated|1
78612|NCT00949650|280822|P2|Overall Study|Withdrawal by Subject|11
78613|NCT00949650|280823|P1|Overall Study|Withdrawal by Subject|6
78614|NCT00949650|280822|P2|Overall Study|Protocol Violation|4
78615|NCT00949650|280823|P1|Overall Study|Protocol Violation|1
78616|NCT00949650|280822|P2|Overall Study|Other Adverse Event|17
78617|NCT00949650|280823|P1|Overall Study|Other Adverse Event|23
78618|NCT00949650|280822|P2|Overall Study|Progressive disease|19
78619|NCT00949650|280823|P1|Overall Study|Progressive disease|133
78620|NCT00949533|280861|P2|Overall Study|Lost to Follow-up|1
78621|NCT00949533|280862|P1|Overall Study|Lost to Follow-up|0
78622|NCT00949117|280876|P2|Overall Study|Adverse Event|1
78623|NCT00949117|280877|P1|Overall Study|Adverse Event|0
78624|NCT00949117|280876|P2|Overall Study|Protocol Violation|1
78625|NCT00949117|280877|P1|Overall Study|Protocol Violation|1
78626|NCT00949117|280876|P2|Overall Study|Lack of Efficacy|3
78627|NCT00949117|280877|P1|Overall Study|Lack of Efficacy|2
78628|NCT00948896|280899|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
78629|NCT00948896|280900|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
78630|NCT00948896|280901|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
78631|NCT00948896|280902|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
78632|NCT00948896|280903|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
78633|NCT00948896|280904|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
78634|NCT00948896|280905|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
78635|NCT00948896|280906|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
78636|NCT00948896|280899|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
78637|NCT00948896|280900|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
78638|NCT00948896|280901|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
78639|NCT00948896|280902|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
78640|NCT00948896|280903|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
78641|NCT00948896|280904|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
78642|NCT00948896|280905|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
78643|NCT00948896|280906|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
78644|NCT00948896|280899|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
78645|NCT00948896|280900|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
78646|NCT00948896|280901|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
78647|NCT00948896|280902|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
78648|NCT00948896|280903|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
78649|NCT00948896|280904|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
78650|NCT00948896|280905|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
78651|NCT00948896|280906|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
78652|NCT00948896|280899|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
78653|NCT00948896|280900|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
78654|NCT00948896|280901|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
78655|NCT00948896|280902|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
78656|NCT00948896|280903|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
78657|NCT00948896|280904|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
78658|NCT00948896|280905|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
78659|NCT00948896|280906|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
78660|NCT00948896|280899|P8|24 Months of Age to 36 Months of Age|Death|0
78661|NCT00948896|280900|P7|24 Months of Age to 36 Months of Age|Death|0
78662|NCT00948896|280901|P6|24 Months of Age to 36 Months of Age|Death|1
78663|NCT00948896|280902|P5|24 Months of Age to 36 Months of Age|Death|0
78664|NCT00948896|280903|P4|24 Months of Age to 36 Months of Age|Death|0
78665|NCT00948896|280904|P3|24 Months of Age to 36 Months of Age|Death|2
78666|NCT00948896|280905|P2|24 Months of Age to 36 Months of Age|Death|2
78667|NCT00948896|280906|P1|24 Months of Age to 36 Months of Age|Death|0
78668|NCT00948896|280899|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
78669|NCT00948896|280900|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
78670|NCT00948896|280901|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
78671|NCT00948896|280902|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
78672|NCT00948896|280903|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
78673|NCT00948896|280904|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
78674|NCT00948896|280905|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
78675|NCT00948896|280906|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
78676|NCT00948896|280899|P8|Randomization to 24 Months of Age|Protocol Violation|1
78677|NCT00948896|280900|P7|Randomization to 24 Months of Age|Protocol Violation|1
78678|NCT00948896|280901|P6|Randomization to 24 Months of Age|Protocol Violation|0
78679|NCT00948896|280902|P5|Randomization to 24 Months of Age|Protocol Violation|0
78680|NCT00948896|280903|P4|Randomization to 24 Months of Age|Protocol Violation|1
78681|NCT00948896|280904|P3|Randomization to 24 Months of Age|Protocol Violation|0
78682|NCT00948896|280905|P2|Randomization to 24 Months of Age|Protocol Violation|1
78683|NCT00948896|280906|P1|Randomization to 24 Months of Age|Protocol Violation|0
78684|NCT00948896|280899|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
78685|NCT00948896|280900|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
78686|NCT00948896|280901|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
78687|NCT00948896|280902|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
78688|NCT00948896|280903|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
78689|NCT00948896|280904|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
78690|NCT00948896|280905|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
78691|NCT00948896|280906|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
78692|NCT00948896|280899|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
78693|NCT00948896|280900|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
78694|NCT00948896|280901|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
78695|NCT00948896|280902|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
78696|NCT00948896|280903|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
78697|NCT00948896|280904|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
78698|NCT00948896|280905|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
78699|NCT00948896|280906|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
78700|NCT00948896|280899|P8|Randomization to 24 Months of Age|Death|1
78701|NCT00948896|280900|P7|Randomization to 24 Months of Age|Death|2
78702|NCT00948896|280901|P6|Randomization to 24 Months of Age|Death|1
78703|NCT00948896|280902|P5|Randomization to 24 Months of Age|Death|2
78704|NCT00948896|280903|P4|Randomization to 24 Months of Age|Death|0
78705|NCT00948896|280904|P3|Randomization to 24 Months of Age|Death|0
78706|NCT00948896|280905|P2|Randomization to 24 Months of Age|Death|0
78707|NCT00948896|280906|P1|Randomization to 24 Months of Age|Death|1
78708|NCT00948857|280942|P2|Overall Study|Lost to Follow-up|0
78709|NCT00948857|280943|P1|Overall Study|Lost to Follow-up|1
78710|NCT00948818|280951|P2|Overall Study|Other Reason|5
78711|NCT00948818|280952|P1|Overall Study|Other Reason|4
78712|NCT00948818|280951|P2|Overall Study|Lack of Efficacy|5
78713|NCT00948818|280952|P1|Overall Study|Lack of Efficacy|4
78714|NCT00948818|280951|P2|Overall Study|Lost to Follow-up|17
78715|NCT00948818|280952|P1|Overall Study|Lost to Follow-up|10
78716|NCT00948818|280951|P2|Overall Study|Withdrawal by Subject|25
78717|NCT00948818|280952|P1|Overall Study|Withdrawal by Subject|25
78718|NCT00948818|280951|P2|Overall Study|Protocol Violation|10
78719|NCT00948818|280952|P1|Overall Study|Protocol Violation|9
78720|NCT00948818|280951|P2|Overall Study|Adverse Event|32
78721|NCT00948818|280952|P1|Overall Study|Adverse Event|10
78722|NCT00948766|280999|P2|Extension Study|Death|0
78723|NCT00948766|281000|P1|Extension Study|Death|4
78724|NCT00948766|280999|P2|Extension Study|Administrative Problems|0
78725|NCT00948766|281000|P1|Extension Study|Administrative Problems|1
78726|NCT00948766|280999|P2|Extension Study|Lost to Follow-up|0
78727|NCT00948766|281000|P1|Extension Study|Lost to Follow-up|8
78728|NCT00948766|280999|P2|Extension Study|Patient Withdrew Consent|0
78729|NCT00948766|281000|P1|Extension Study|Patient Withdrew Consent|32
78730|NCT00948766|280999|P2|Extension Study|Study Drug No Longer Required|0
78731|NCT00948766|281000|P1|Extension Study|Study Drug No Longer Required|1
78732|NCT00948766|280999|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
78733|NCT00948766|281000|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
78734|NCT00948766|280999|P2|Extension Study|Adverse Event|0
78735|NCT00948766|281000|P1|Extension Study|Adverse Event|43
78736|NCT00948766|280999|P2|Core Study|Protocol Deviation|10
78737|NCT00948766|281000|P1|Core Study|Protocol Deviation|8
78738|NCT00948766|280999|P2|Core Study|Death|1
78739|NCT00948766|281000|P1|Core Study|Death|1
78740|NCT00948766|280999|P2|Core Study|Administrative Problems|2
78741|NCT00948766|281000|P1|Core Study|Administrative Problems|2
78742|NCT00948766|280999|P2|Core Study|Lost to Follow-up|2
78743|NCT00948766|281000|P1|Core Study|Lost to Follow-up|3
78744|NCT00948766|280999|P2|Core Study|Patient Withdrew Consent|46
78745|NCT00948766|281000|P1|Core Study|Patient Withdrew Consent|27
78746|NCT00948766|280999|P2|Core Study|Unsatisfactory Therapeutic Effect|14
78747|NCT00948766|281000|P1|Core Study|Unsatisfactory Therapeutic Effect|13
78748|NCT00948766|280999|P2|Core Study|Adverse Event|51
78749|NCT00948766|281000|P1|Core Study|Adverse Event|73
78750|NCT00948675|281018|P2|Overall Study|Treatment ongoing|4
78751|NCT00948675|281019|P1|Overall Study|Treatment ongoing|5
78752|NCT00948675|281018|P2|Overall Study|Lost to Follow-up|0
78753|NCT00948675|281019|P1|Overall Study|Lost to Follow-up|2
78754|NCT00948506|281035|P2|Overall Study|Withdrawal by Subject|1
78755|NCT00948506|281036|P1|Overall Study|Withdrawal by Subject|3
78756|NCT00948441|281056|P2|Overall Study|no longer meet inclusion criteria|4
78757|NCT00948441|281057|P1|Overall Study|no longer meet inclusion criteria|1
78758|NCT00948389|281070|P5|Overall Study|Both Progression and Toxicity|0
78759|NCT00948389|281071|P4|Overall Study|Both Progression and Toxicity|0
78760|NCT00948389|281072|P3|Overall Study|Both Progression and Toxicity|0
78761|NCT00948389|281073|P2|Overall Study|Both Progression and Toxicity|0
78762|NCT00948389|281074|P1|Overall Study|Both Progression and Toxicity|1
78763|NCT00948389|281070|P5|Overall Study|Thrombocytopenia, Grade 4|0
78764|NCT00948389|281071|P4|Overall Study|Thrombocytopenia, Grade 4|1
78765|NCT00948389|281072|P3|Overall Study|Thrombocytopenia, Grade 4|0
78766|NCT00948389|281073|P2|Overall Study|Thrombocytopenia, Grade 4|0
78767|NCT00948389|281074|P1|Overall Study|Thrombocytopenia, Grade 4|2
78768|NCT00948389|281070|P5|Overall Study|Disease Progression/Relapse/Death|1
78769|NCT00948389|281071|P4|Overall Study|Disease Progression/Relapse/Death|8
78770|NCT00948389|281072|P3|Overall Study|Disease Progression/Relapse/Death|7
78771|NCT00948389|281073|P2|Overall Study|Disease Progression/Relapse/Death|3
78772|NCT00948389|281074|P1|Overall Study|Disease Progression/Relapse/Death|3
78773|NCT00948246|281111|P1|Overall Study|Withdrawal by Subject|1
78774|NCT00948246|281111|P1|Overall Study|Death|1
78775|NCT00948246|281111|P1|Overall Study|Adverse Event|11
78776|NCT00948246|281111|P1|Overall Study|Lost to Follow-up|11
78777|NCT00948155|281120|P2|Washout 14 Days|Lost to Follow-up|2
78778|NCT00948155|281121|P1|Washout 14 Days|Lost to Follow-up|1
78779|NCT00948155|281120|P2|First Intervention 21 Days|Lost to Follow-up|2
78780|NCT00948155|281121|P1|First Intervention 21 Days|Lost to Follow-up|2
78781|NCT00948064|281168|P3|Phase II|Withdrawal by Subject|0
78782|NCT00948064|281169|P2|Phase II|Withdrawal by Subject|1
78783|NCT00948064|281170|P1|Phase II|Withdrawal by Subject|0
78784|NCT00948064|281168|P3|Phase II|Physician Decision|1
78785|NCT00948064|281169|P2|Phase II|Physician Decision|0
78786|NCT00948064|281170|P1|Phase II|Physician Decision|0
78787|NCT00948064|281168|P3|Phase I|No treatment received|0
78788|NCT00948064|281169|P2|Phase I|No treatment received|0
78789|NCT00948064|281170|P1|Phase I|No treatment received|1
78790|NCT00947882|281185|P4|Overall Study|Trial Terminated by Sponsor|70
78791|NCT00947882|281186|P3|Overall Study|Trial Terminated by Sponsor|62
78792|NCT00947882|281187|P2|Overall Study|Trial Terminated by Sponsor|61
78793|NCT00947882|281188|P1|Overall Study|Trial Terminated by Sponsor|62
78794|NCT00947882|281185|P4|Overall Study|Other/Unknown|6
78795|NCT00947882|281186|P3|Overall Study|Other/Unknown|3
78796|NCT00947882|281187|P2|Overall Study|Other/Unknown|13
78797|NCT00947882|281188|P1|Overall Study|Other/Unknown|10
78798|NCT00947882|281185|P4|Overall Study|Lost to Follow-up|0
78799|NCT00947882|281186|P3|Overall Study|Lost to Follow-up|1
78800|NCT00947882|281187|P2|Overall Study|Lost to Follow-up|2
78801|NCT00947882|281188|P1|Overall Study|Lost to Follow-up|0
78802|NCT00947882|281185|P4|Overall Study|Protocol Violation|0
78803|NCT00947882|281186|P3|Overall Study|Protocol Violation|1
78804|NCT00947882|281187|P2|Overall Study|Protocol Violation|0
78805|NCT00947882|281188|P1|Overall Study|Protocol Violation|0
78806|NCT00947882|281185|P4|Overall Study|Withdrawal by Subject|2
78807|NCT00947882|281186|P3|Overall Study|Withdrawal by Subject|8
78808|NCT00947882|281187|P2|Overall Study|Withdrawal by Subject|0
78809|NCT00947882|281188|P1|Overall Study|Withdrawal by Subject|2
78810|NCT00947882|281185|P4|Overall Study|Adverse Event|4
78811|NCT00947882|281186|P3|Overall Study|Adverse Event|4
78812|NCT00947882|281187|P2|Overall Study|Adverse Event|1
78813|NCT00947882|281188|P1|Overall Study|Adverse Event|0
78814|NCT00947856|281216|P2|Follow-up Period|Withdrawal by Subject|0
78815|NCT00947856|281217|P1|Follow-up Period|Withdrawal by Subject|1
78816|NCT00947856|281216|P2|Follow-up Period|Patient unavailable for site visits|0
78817|NCT00947856|281217|P1|Follow-up Period|Patient unavailable for site visits|1
78818|NCT00947856|281216|P2|Follow-up Period|Lost to Follow-up|0
78819|NCT00947856|281217|P1|Follow-up Period|Lost to Follow-up|7
78820|NCT00947856|281216|P2|Follow-up Period|Re-enrolled for Retreatment|3
78821|NCT00947856|281217|P1|Follow-up Period|Re-enrolled for Retreatment|2
78822|NCT00947856|281216|P2|Follow-up Period|Study Stopped by Sponsor|20
78823|NCT00947856|281217|P1|Follow-up Period|Study Stopped by Sponsor|40
78824|NCT00947856|281216|P2|Treatment Period|Withdrawal by Subject|1
78825|NCT00947856|281217|P1|Treatment Period|Withdrawal by Subject|12
78826|NCT00947856|281216|P2|Treatment Period|Study Stopped by Sponsor|4
78827|NCT00947856|281217|P1|Treatment Period|Study Stopped by Sponsor|4
78828|NCT00947856|281216|P2|Treatment Period|Physician Decision|6
78829|NCT00947856|281217|P1|Treatment Period|Physician Decision|14
78830|NCT00947856|281216|P2|Treatment Period|Adverse Event|9
78831|NCT00947856|281217|P1|Treatment Period|Adverse Event|15
78832|NCT00947856|281216|P2|Treatment Period|Progressive Disease|12
78833|NCT00947856|281217|P1|Treatment Period|Progressive Disease|33
78834|NCT00947544|281287|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
78835|NCT00947544|281288|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
78836|NCT00947531|281314|P2|Overall Study|Other|1
78837|NCT00947531|281315|P1|Overall Study|Other|1
78838|NCT00947531|281314|P2|Overall Study|Lack of Efficacy|0
78839|NCT00947531|281315|P1|Overall Study|Lack of Efficacy|1
78840|NCT00947531|281314|P2|Overall Study|Adverse Event|2
78841|NCT00947531|281315|P1|Overall Study|Adverse Event|2
78842|NCT00947531|281314|P2|Overall Study|Administrative Reason|1
78843|NCT00947531|281315|P1|Overall Study|Administrative Reason|0
78844|NCT00947531|281314|P2|Overall Study|Withdrawal by Subject|7
78845|NCT00947531|281315|P1|Overall Study|Withdrawal by Subject|10
78846|NCT00947427|281339|P2|Overall Study|Protocol Violation|1
78847|NCT00947427|281340|P1|Overall Study|Protocol Violation|0
78848|NCT00947427|281339|P2|Overall Study|Withdrawal by Subject|3
78849|NCT00947427|281340|P1|Overall Study|Withdrawal by Subject|1
78850|NCT00947349|281350|P4|Overall Study Standard of Care|not specified|1
78851|NCT00947349|281351|P3|Overall Study Standard of Care|not specified|0
78852|NCT00947349|281352|P2|Overall Study Standard of Care|not specified|0
78853|NCT00947349|281353|P1|Overall Study Standard of Care|not specified|0
78854|NCT00947349|281350|P4|Overall Study Standard of Care|Withdrawal by Subject|0
78855|NCT00947349|281351|P3|Overall Study Standard of Care|Withdrawal by Subject|1
78856|NCT00947349|281352|P2|Overall Study Standard of Care|Withdrawal by Subject|0
78857|NCT00947349|281353|P1|Overall Study Standard of Care|Withdrawal by Subject|0
78858|NCT00947349|281350|P4|Overall Study Standard of Care|Lack of Efficacy|1
78859|NCT00947349|281351|P3|Overall Study Standard of Care|Lack of Efficacy|1
78860|NCT00947349|281352|P2|Overall Study Standard of Care|Lack of Efficacy|0
78861|NCT00947349|281353|P1|Overall Study Standard of Care|Lack of Efficacy|0
78862|NCT00947349|281350|P4|Triple Treatment Combination Period|Adverse Event|0
78863|NCT00947349|281351|P3|Triple Treatment Combination Period|Adverse Event|0
78864|NCT00947349|281352|P2|Triple Treatment Combination Period|Adverse Event|1
78865|NCT00947349|281353|P1|Triple Treatment Combination Period|Adverse Event|0
78866|NCT00947154|281562|P1|Overall Study|Lost to Follow-up|1
78867|NCT00947115|281572|P3|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|8
78868|NCT00947115|281573|P2|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|12
78869|NCT00947115|281574|P1|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|11
78870|NCT00947115|281572|P3|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|4
78871|NCT00947115|281573|P2|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|3
78872|NCT00947115|281574|P1|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|1
78873|NCT00947115|281572|P3|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
78874|NCT00947115|281573|P2|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
78875|NCT00947115|281574|P1|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|2
78876|NCT00947115|281572|P3|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
78877|NCT00947115|281573|P2|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
78878|NCT00947115|281574|P1|Year 0 (Month 0) - Year 10 (Month 120)|Death|0
78879|NCT00947115|281572|P3|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
78880|NCT00947115|281573|P2|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|2
78881|NCT00947115|281574|P1|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
78882|NCT00947115|281572|P3|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|2
78883|NCT00947115|281573|P2|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|4
78884|NCT00947115|281574|P1|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|3
78885|NCT00946985|281636|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
78886|NCT00946985|281636|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
78887|NCT00946985|281636|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
78888|NCT00946985|281636|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
78889|NCT00946985|281636|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
78890|NCT00946985|281636|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
78891|NCT00946985|281636|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
78892|NCT00946985|281636|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
78893|NCT00946985|281636|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
78894|NCT00946920|281642|P2|Overall Study|Miscellaneous reasons|3
78895|NCT00946920|281643|P1|Overall Study|Miscellaneous reasons|18
78896|NCT00946920|281642|P2|Overall Study|Protocol Violation|8
78897|NCT00946920|281643|P1|Overall Study|Protocol Violation|16
78898|NCT00946920|281642|P2|Overall Study|Adverse Event|14
78899|NCT00946920|281643|P1|Overall Study|Adverse Event|41
78900|NCT00946920|281642|P2|Overall Study|Physician Decision|2
78901|NCT00946920|281643|P1|Overall Study|Physician Decision|5
78902|NCT00946920|281642|P2|Overall Study|Lost to Follow-up|2
78903|NCT00946920|281643|P1|Overall Study|Lost to Follow-up|2
78904|NCT00946920|281642|P2|Overall Study|Withdrawal by Subject|15
78905|NCT00946920|281643|P1|Overall Study|Withdrawal by Subject|28
78906|NCT00946322|281676|P1|Post-treatment|participant failure to follow up|2
78907|NCT00946322|281676|P1|Pre-treatment|participant failure to follow up|1
78908|NCT00946309|281689|P2|Overall Study|Procedure cancelled/discontinued|3
78909|NCT00946309|281690|P1|Overall Study|Procedure cancelled/discontinued|0
78910|NCT00946309|281689|P2|Overall Study|Lost to Follow-up|1
78911|NCT00946309|281690|P1|Overall Study|Lost to Follow-up|0
78912|NCT00946309|281689|P2|Overall Study|Protocol Violation|0
78913|NCT00946309|281690|P1|Overall Study|Protocol Violation|1
78914|NCT00946296|281708|P2|Overall Study|Physician Decision|0
78915|NCT00946296|281709|P1|Overall Study|Physician Decision|3
78916|NCT00946114|281717|P2|Overall Study|Withdrawal by Subject|0
78917|NCT00946114|281718|P1|Overall Study|Withdrawal by Subject|2
78918|NCT00946114|281717|P2|Overall Study|Unspecified|0
78919|NCT00946114|281718|P1|Overall Study|Unspecified|1
78920|NCT00946114|281717|P2|Overall Study|Death|2
78921|NCT00946114|281718|P1|Overall Study|Death|5
78922|NCT00946101|281726|P2|Overall Study|Physician Decision|1
78923|NCT00946101|281727|P1|Overall Study|Physician Decision|0
78924|NCT00946101|281726|P2|Overall Study|Withdrawal of consent|0
78925|NCT00946101|281727|P1|Overall Study|Withdrawal of consent|2
78926|NCT00946101|281726|P2|Overall Study|Lost to Follow-up|1
78927|NCT00946101|281727|P1|Overall Study|Lost to Follow-up|2
78928|NCT00945945|281823|P2|Overall Study|Entry Criteria Not Met|1
78929|NCT00945945|281824|P1|Overall Study|Entry Criteria Not Met|0
78930|NCT00945945|281823|P2|Overall Study|Protocol Violation|2
78931|NCT00945945|281824|P1|Overall Study|Protocol Violation|4
78932|NCT00945945|281823|P2|Overall Study|Lack of Efficacy|2
78933|NCT00945945|281824|P1|Overall Study|Lack of Efficacy|6
78934|NCT00945945|281823|P2|Overall Study|Lost to Follow-up|5
78935|NCT00945945|281824|P1|Overall Study|Lost to Follow-up|4
78936|NCT00945945|281823|P2|Overall Study|Withdrawal by Subject|10
78937|NCT00945945|281824|P1|Overall Study|Withdrawal by Subject|7
78938|NCT00945945|281823|P2|Overall Study|Adverse Event|35
78939|NCT00945945|281824|P1|Overall Study|Adverse Event|15
78940|NCT00945906|281850|P1|Overall Study|Moved to another country|2
78941|NCT00945906|281850|P1|Overall Study|Unable to return for last visit|2
78942|NCT00945906|281850|P1|Overall Study|Did not want to return for last visit|2
78943|NCT00945906|281850|P1|Overall Study|Withdrawal by Subject|1
78944|NCT00945893|281861|P2|Overall Study|Withdrawal of consent|2
78945|NCT00945893|281862|P1|Overall Study|Withdrawal of consent|1
78946|NCT00945893|281861|P2|Overall Study|Lost to Follow-up|8
78947|NCT00945893|281862|P1|Overall Study|Lost to Follow-up|2
78948|NCT00945815|281939|P1|Overall Study|Did not begin protocol therapy|1
78949|NCT00945815|281939|P1|Overall Study|Ineligible|3
78950|NCT00945815|281939|P1|Overall Study|Not protocol specified|1
78951|NCT00945815|281939|P1|Overall Study|Death|3
78952|NCT00945555|281968|P1|Overall Study|Other|1
78953|NCT00945555|281968|P1|Overall Study|Death|18
78954|NCT00945555|281968|P1|Overall Study|Participant continued treatment at home|1
78955|NCT00945555|281968|P1|Overall Study|Withdrawal by Subject|2
78956|NCT00945555|281968|P1|Overall Study|Worsening condition, intensive care unit|1
78957|NCT00945555|281968|P1|Overall Study|Referred to another hospital|5
78958|NCT00945477|281979|P1|Overall Study|Withdrawal by Subject|1
78959|NCT00945477|281979|P1|Overall Study|Lack of Efficacy|2
78960|NCT00945477|281979|P1|Overall Study|Adverse Event|3
78961|NCT00945321|281995|P6|Period 4|Lost to Follow-up|1
78962|NCT00945321|281996|P5|Period 4|Lost to Follow-up|0
78963|NCT00945321|281997|P4|Period 4|Lost to Follow-up|0
78964|NCT00945321|281998|P3|Period 4|Lost to Follow-up|0
78965|NCT00945321|281999|P2|Period 4|Lost to Follow-up|0
78966|NCT00945321|282000|P1|Period 4|Lost to Follow-up|0
78967|NCT00945321|281995|P6|Period 1|Adverse Event|0
78968|NCT00945321|281996|P5|Period 1|Adverse Event|1
78969|NCT00945321|281997|P4|Period 1|Adverse Event|0
78970|NCT00945321|281998|P3|Period 1|Adverse Event|0
78971|NCT00945321|281999|P2|Period 1|Adverse Event|0
78972|NCT00945321|282000|P1|Period 1|Adverse Event|0
78973|NCT00945243|282052|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
78974|NCT00944697|282204|P2|Overall Study|Administrative|1
78975|NCT00944697|282205|P1|Overall Study|Administrative|1
78976|NCT00944697|282204|P2|Overall Study|Adverse Event|3
78977|NCT00944697|282205|P1|Overall Study|Adverse Event|0
78978|NCT00944697|282204|P2|Overall Study|Withdrawal by Subject|1
78979|NCT00944697|282205|P1|Overall Study|Withdrawal by Subject|1
78980|NCT00944645|282235|P2|Period 2|Withdrawal by Subject|6
78981|NCT00944645|282236|P1|Period 2|Withdrawal by Subject|7
78982|NCT00944645|282235|P2|Period 2|Lost to Follow-up|3
78983|NCT00944645|282236|P1|Period 2|Lost to Follow-up|0
78984|NCT00944645|282235|P2|Period 2|Adverse Event|0
78985|NCT00944645|282236|P1|Period 2|Adverse Event|1
78986|NCT00944229|282257|P1|Overall Study|Physician Decision|14
78987|NCT00944229|282257|P1|Overall Study|Withdrawal by Subject|11
78988|NCT00944125|282263|P2|6 Months to Study Completion|Withdrawal by Subject|2
78989|NCT00944125|282264|P1|6 Months to Study Completion|Withdrawal by Subject|0
78990|NCT00944125|282263|P2|3 to 6 Months|Withdrawal by Subject|2
78991|NCT00944125|282264|P1|3 to 6 Months|Withdrawal by Subject|0
78992|NCT00944034|282363|P12|Overall Study|Administrative reason|0
78993|NCT00944034|282364|P11|Overall Study|Administrative reason|0
78994|NCT00944034|282365|P10|Overall Study|Administrative reason|0
78995|NCT00944034|282366|P9|Overall Study|Administrative reason|0
78996|NCT00944034|282367|P8|Overall Study|Administrative reason|0
78997|NCT00944034|282368|P7|Overall Study|Administrative reason|1
78998|NCT00944034|282369|P6|Overall Study|Administrative reason|0
78999|NCT00944034|282370|P5|Overall Study|Administrative reason|0
79000|NCT00944034|282371|P4|Overall Study|Administrative reason|0
79001|NCT00944034|282372|P3|Overall Study|Administrative reason|0
79002|NCT00944034|282373|P2|Overall Study|Administrative reason|0
79003|NCT00944034|282374|P1|Overall Study|Administrative reason|0
79004|NCT00944034|282363|P12|Overall Study|Unable to classify|0
79005|NCT00944034|282364|P11|Overall Study|Unable to classify|0
79006|NCT00944034|282365|P10|Overall Study|Unable to classify|0
79007|NCT00944034|282366|P9|Overall Study|Unable to classify|0
79008|NCT00944034|282367|P8|Overall Study|Unable to classify|1
79009|NCT00944034|282368|P7|Overall Study|Unable to classify|1
79010|NCT00944034|282369|P6|Overall Study|Unable to classify|1
79011|NCT00944034|282370|P5|Overall Study|Unable to classify|0
79012|NCT00944034|282371|P4|Overall Study|Unable to classify|0
79013|NCT00944034|282372|P3|Overall Study|Unable to classify|0
79014|NCT00944034|282373|P2|Overall Study|Unable to classify|0
79015|NCT00944034|282374|P1|Overall Study|Unable to classify|0
79016|NCT00944034|282363|P12|Overall Study|Protocol Violation|0
79017|NCT00944034|282364|P11|Overall Study|Protocol Violation|0
79018|NCT00944034|282365|P10|Overall Study|Protocol Violation|4
79019|NCT00944034|282366|P9|Overall Study|Protocol Violation|1
79020|NCT00944034|282367|P8|Overall Study|Protocol Violation|1
79021|NCT00944034|282368|P7|Overall Study|Protocol Violation|0
79022|NCT00944034|282369|P6|Overall Study|Protocol Violation|3
79023|NCT00944034|282370|P5|Overall Study|Protocol Violation|2
79024|NCT00944034|282371|P4|Overall Study|Protocol Violation|1
79025|NCT00944034|282372|P3|Overall Study|Protocol Violation|0
79026|NCT00944034|282373|P2|Overall Study|Protocol Violation|0
79027|NCT00944034|282374|P1|Overall Study|Protocol Violation|2
79028|NCT00944034|282363|P12|Overall Study|Death|0
79029|NCT00944034|282364|P11|Overall Study|Death|0
79030|NCT00944034|282365|P10|Overall Study|Death|0
79031|NCT00944034|282366|P9|Overall Study|Death|0
79032|NCT00944034|282367|P8|Overall Study|Death|0
79033|NCT00944034|282368|P7|Overall Study|Death|0
79034|NCT00944034|282369|P6|Overall Study|Death|0
79035|NCT00944034|282370|P5|Overall Study|Death|0
79036|NCT00944034|282371|P4|Overall Study|Death|0
79037|NCT00944034|282372|P3|Overall Study|Death|1
79038|NCT00944034|282373|P2|Overall Study|Death|0
79039|NCT00944034|282374|P1|Overall Study|Death|0
79040|NCT00944034|282363|P12|Overall Study|Lost to Follow-up|0
79041|NCT00944034|282364|P11|Overall Study|Lost to Follow-up|1
79042|NCT00944034|282365|P10|Overall Study|Lost to Follow-up|1
79043|NCT00944034|282366|P9|Overall Study|Lost to Follow-up|5
79044|NCT00944034|282367|P8|Overall Study|Lost to Follow-up|1
79045|NCT00944034|282368|P7|Overall Study|Lost to Follow-up|0
79046|NCT00944034|282369|P6|Overall Study|Lost to Follow-up|7
79047|NCT00944034|282370|P5|Overall Study|Lost to Follow-up|5
79048|NCT00944034|282371|P4|Overall Study|Lost to Follow-up|0
79049|NCT00944034|282372|P3|Overall Study|Lost to Follow-up|2
79050|NCT00944034|282373|P2|Overall Study|Lost to Follow-up|4
79051|NCT00944034|282374|P1|Overall Study|Lost to Follow-up|0
79052|NCT00944034|282363|P12|Overall Study|Withdrawal by Subject|4
79053|NCT00944034|282364|P11|Overall Study|Withdrawal by Subject|0
79054|NCT00944034|282365|P10|Overall Study|Withdrawal by Subject|4
79055|NCT00944034|282366|P9|Overall Study|Withdrawal by Subject|3
79056|NCT00944034|282367|P8|Overall Study|Withdrawal by Subject|2
79057|NCT00944034|282368|P7|Overall Study|Withdrawal by Subject|2
79058|NCT00944034|282369|P6|Overall Study|Withdrawal by Subject|8
79059|NCT00944034|282370|P5|Overall Study|Withdrawal by Subject|5
79060|NCT00944034|282371|P4|Overall Study|Withdrawal by Subject|2
79061|NCT00944034|282372|P3|Overall Study|Withdrawal by Subject|6
79062|NCT00944034|282373|P2|Overall Study|Withdrawal by Subject|2
79063|NCT00944034|282374|P1|Overall Study|Withdrawal by Subject|3
79064|NCT00944034|282363|P12|Overall Study|Inappropriate enrollment|0
79065|NCT00944034|282364|P11|Overall Study|Inappropriate enrollment|0
79066|NCT00944034|282365|P10|Overall Study|Inappropriate enrollment|1
79067|NCT00944034|282366|P9|Overall Study|Inappropriate enrollment|1
79068|NCT00944034|282367|P8|Overall Study|Inappropriate enrollment|0
79069|NCT00944034|282368|P7|Overall Study|Inappropriate enrollment|0
79070|NCT00944034|282369|P6|Overall Study|Inappropriate enrollment|1
79071|NCT00944034|282370|P5|Overall Study|Inappropriate enrollment|2
79072|NCT00944034|282371|P4|Overall Study|Inappropriate enrollment|1
79073|NCT00944034|282372|P3|Overall Study|Inappropriate enrollment|0
79074|NCT00944034|282373|P2|Overall Study|Inappropriate enrollment|1
79075|NCT00944034|282374|P1|Overall Study|Inappropriate enrollment|0
79076|NCT00943917|282520|P15|Stage II Continuation|A1C elevation|0
79077|NCT00943917|282521|P14|Stage II Continuation|A1C elevation|1
79078|NCT00943917|282522|P13|Stage II Continuation|A1C elevation|0
79079|NCT00943917|282523|P12|Stage II Continuation|A1C elevation|0
79080|NCT00943917|282524|P11|Stage II Continuation|A1C elevation|0
79081|NCT00943917|282525|P10|Stage II Continuation|A1C elevation|0
79082|NCT00943917|282526|P9|Stage II Continuation|A1C elevation|0
79083|NCT00943917|282527|P8|Stage II Continuation|A1C elevation|0
79084|NCT00943917|282528|P7|Stage II Continuation|A1C elevation|0
79085|NCT00943917|282529|P6|Stage II Continuation|A1C elevation|0
79086|NCT00943917|282530|P5|Stage II Continuation|A1C elevation|0
79087|NCT00943917|282531|P4|Stage II Continuation|A1C elevation|0
79088|NCT00943917|282532|P3|Stage II Continuation|A1C elevation|0
79089|NCT00943917|282533|P2|Stage II Continuation|A1C elevation|0
79090|NCT00943917|282534|P1|Stage II Continuation|A1C elevation|0
79091|NCT00943917|282520|P15|Stage II Continuation|hypoglycemia|0
79092|NCT00943917|282521|P14|Stage II Continuation|hypoglycemia|0
79093|NCT00943917|282522|P13|Stage II Continuation|hypoglycemia|1
79094|NCT00943917|282523|P12|Stage II Continuation|hypoglycemia|0
79095|NCT00943917|282524|P11|Stage II Continuation|hypoglycemia|0
79096|NCT00943917|282525|P10|Stage II Continuation|hypoglycemia|0
79097|NCT00943917|282526|P9|Stage II Continuation|hypoglycemia|0
79098|NCT00943917|282527|P8|Stage II Continuation|hypoglycemia|0
79099|NCT00943917|282528|P7|Stage II Continuation|hypoglycemia|0
79100|NCT00943917|282529|P6|Stage II Continuation|hypoglycemia|0
79101|NCT00943917|282530|P5|Stage II Continuation|hypoglycemia|0
79102|NCT00943917|282531|P4|Stage II Continuation|hypoglycemia|0
79103|NCT00943917|282532|P3|Stage II Continuation|hypoglycemia|0
79104|NCT00943917|282533|P2|Stage II Continuation|hypoglycemia|0
79105|NCT00943917|282534|P1|Stage II Continuation|hypoglycemia|0
79106|NCT00943917|282520|P15|Stage II Continuation|Protocol Violation|0
79107|NCT00943917|282521|P14|Stage II Continuation|Protocol Violation|0
79108|NCT00943917|282522|P13|Stage II Continuation|Protocol Violation|0
79109|NCT00943917|282523|P12|Stage II Continuation|Protocol Violation|1
79110|NCT00943917|282524|P11|Stage II Continuation|Protocol Violation|0
79111|NCT00943917|282525|P10|Stage II Continuation|Protocol Violation|1
79112|NCT00943917|282526|P9|Stage II Continuation|Protocol Violation|0
79113|NCT00943917|282527|P8|Stage II Continuation|Protocol Violation|0
79114|NCT00943917|282528|P7|Stage II Continuation|Protocol Violation|0
79115|NCT00943917|282529|P6|Stage II Continuation|Protocol Violation|0
79116|NCT00943917|282530|P5|Stage II Continuation|Protocol Violation|0
79117|NCT00943917|282531|P4|Stage II Continuation|Protocol Violation|0
79118|NCT00943917|282532|P3|Stage II Continuation|Protocol Violation|0
79119|NCT00943917|282533|P2|Stage II Continuation|Protocol Violation|0
79120|NCT00943917|282534|P1|Stage II Continuation|Protocol Violation|0
79121|NCT00943917|282520|P15|Stage II Continuation|Withdrawal by Subject|3
79122|NCT00943917|282521|P14|Stage II Continuation|Withdrawal by Subject|1
79123|NCT00943917|282522|P13|Stage II Continuation|Withdrawal by Subject|0
79124|NCT00943917|282523|P12|Stage II Continuation|Withdrawal by Subject|0
79125|NCT00943917|282524|P11|Stage II Continuation|Withdrawal by Subject|0
79126|NCT00943917|282525|P10|Stage II Continuation|Withdrawal by Subject|0
79127|NCT00943917|282526|P9|Stage II Continuation|Withdrawal by Subject|0
79128|NCT00943917|282527|P8|Stage II Continuation|Withdrawal by Subject|0
79129|NCT00943917|282528|P7|Stage II Continuation|Withdrawal by Subject|0
79130|NCT00943917|282529|P6|Stage II Continuation|Withdrawal by Subject|0
79131|NCT00943917|282530|P5|Stage II Continuation|Withdrawal by Subject|0
79132|NCT00943917|282531|P4|Stage II Continuation|Withdrawal by Subject|0
79133|NCT00943917|282532|P3|Stage II Continuation|Withdrawal by Subject|0
79134|NCT00943917|282533|P2|Stage II Continuation|Withdrawal by Subject|0
79135|NCT00943917|282534|P1|Stage II Continuation|Withdrawal by Subject|0
79136|NCT00943917|282520|P15|Stage II Continuation|Adverse Event|1
79137|NCT00943917|282521|P14|Stage II Continuation|Adverse Event|1
79138|NCT00943917|282522|P13|Stage II Continuation|Adverse Event|2
79139|NCT00943917|282523|P12|Stage II Continuation|Adverse Event|1
79140|NCT00943917|282524|P11|Stage II Continuation|Adverse Event|0
79141|NCT00943917|282525|P10|Stage II Continuation|Adverse Event|0
79142|NCT00943917|282526|P9|Stage II Continuation|Adverse Event|0
79143|NCT00943917|282527|P8|Stage II Continuation|Adverse Event|0
79144|NCT00943917|282528|P7|Stage II Continuation|Adverse Event|0
79145|NCT00943917|282529|P6|Stage II Continuation|Adverse Event|0
79146|NCT00943917|282530|P5|Stage II Continuation|Adverse Event|0
79147|NCT00943917|282531|P4|Stage II Continuation|Adverse Event|0
79148|NCT00943917|282532|P3|Stage II Continuation|Adverse Event|0
79149|NCT00943917|282533|P2|Stage II Continuation|Adverse Event|0
79150|NCT00943917|282534|P1|Stage II Continuation|Adverse Event|0
79151|NCT00943917|282520|P15|Stage II|Pregnancy|0
79152|NCT00943917|282521|P14|Stage II|Pregnancy|0
79153|NCT00943917|282522|P13|Stage II|Pregnancy|0
79154|NCT00943917|282523|P12|Stage II|Pregnancy|0
79155|NCT00943917|282524|P11|Stage II|Pregnancy|0
79156|NCT00943917|282525|P10|Stage II|Pregnancy|0
79157|NCT00943917|282526|P9|Stage II|Pregnancy|0
79158|NCT00943917|282527|P8|Stage II|Pregnancy|0
79159|NCT00943917|282528|P7|Stage II|Pregnancy|0
79160|NCT00943917|282529|P6|Stage II|Pregnancy|1
79161|NCT00943917|282530|P5|Stage II|Pregnancy|0
79162|NCT00943917|282531|P4|Stage II|Pregnancy|0
79163|NCT00943917|282532|P3|Stage II|Pregnancy|0
79164|NCT00943917|282533|P2|Stage II|Pregnancy|0
79165|NCT00943917|282534|P1|Stage II|Pregnancy|0
79166|NCT00943917|282520|P15|Stage II|Withdrawal by Subject|0
79167|NCT00943917|282521|P14|Stage II|Withdrawal by Subject|0
79168|NCT00943917|282522|P13|Stage II|Withdrawal by Subject|0
79169|NCT00943917|282523|P12|Stage II|Withdrawal by Subject|0
79170|NCT00943917|282524|P11|Stage II|Withdrawal by Subject|0
79171|NCT00943917|282525|P10|Stage II|Withdrawal by Subject|0
79172|NCT00943917|282526|P9|Stage II|Withdrawal by Subject|0
79173|NCT00943917|282527|P8|Stage II|Withdrawal by Subject|0
79174|NCT00943917|282528|P7|Stage II|Withdrawal by Subject|0
79175|NCT00943917|282529|P6|Stage II|Withdrawal by Subject|1
79176|NCT00943917|282530|P5|Stage II|Withdrawal by Subject|0
79177|NCT00943917|282531|P4|Stage II|Withdrawal by Subject|0
79178|NCT00943917|282532|P3|Stage II|Withdrawal by Subject|0
79179|NCT00943917|282533|P2|Stage II|Withdrawal by Subject|0
79180|NCT00943917|282534|P1|Stage II|Withdrawal by Subject|0
79181|NCT00943917|282520|P15|Stage II|Adverse Event|0
79182|NCT00943917|282521|P14|Stage II|Adverse Event|0
79183|NCT00943917|282522|P13|Stage II|Adverse Event|0
79184|NCT00943917|282523|P12|Stage II|Adverse Event|0
79185|NCT00943917|282524|P11|Stage II|Adverse Event|0
79186|NCT00943917|282525|P10|Stage II|Adverse Event|0
79187|NCT00943917|282526|P9|Stage II|Adverse Event|1
79188|NCT00943917|282527|P8|Stage II|Adverse Event|0
79189|NCT00943917|282528|P7|Stage II|Adverse Event|3
79190|NCT00943917|282529|P6|Stage II|Adverse Event|1
79191|NCT00943917|282530|P5|Stage II|Adverse Event|0
79192|NCT00943917|282531|P4|Stage II|Adverse Event|0
79193|NCT00943917|282532|P3|Stage II|Adverse Event|0
79194|NCT00943917|282533|P2|Stage II|Adverse Event|0
79195|NCT00943917|282534|P1|Stage II|Adverse Event|0
79196|NCT00943917|282520|P15|Stage I|Withdrawal by Subject|0
79197|NCT00943917|282521|P14|Stage I|Withdrawal by Subject|0
79198|NCT00943917|282522|P13|Stage I|Withdrawal by Subject|0
79199|NCT00943917|282523|P12|Stage I|Withdrawal by Subject|0
79200|NCT00943917|282524|P11|Stage I|Withdrawal by Subject|0
79201|NCT00943917|282525|P10|Stage I|Withdrawal by Subject|0
79202|NCT00943917|282526|P9|Stage I|Withdrawal by Subject|0
79203|NCT00943917|282527|P8|Stage I|Withdrawal by Subject|0
79204|NCT00943917|282528|P7|Stage I|Withdrawal by Subject|0
79205|NCT00943917|282529|P6|Stage I|Withdrawal by Subject|0
79206|NCT00943917|282530|P5|Stage I|Withdrawal by Subject|0
79207|NCT00943917|282531|P4|Stage I|Withdrawal by Subject|0
79208|NCT00943917|282532|P3|Stage I|Withdrawal by Subject|2
79209|NCT00943917|282533|P2|Stage I|Withdrawal by Subject|1
79210|NCT00943917|282534|P1|Stage I|Withdrawal by Subject|2
79211|NCT00943917|282520|P15|Stage I|A1C elevation|0
79212|NCT00943917|282521|P14|Stage I|A1C elevation|0
79213|NCT00943917|282522|P13|Stage I|A1C elevation|0
79214|NCT00943917|282523|P12|Stage I|A1C elevation|0
79215|NCT00943917|282524|P11|Stage I|A1C elevation|0
79216|NCT00943917|282525|P10|Stage I|A1C elevation|0
79217|NCT00943917|282526|P9|Stage I|A1C elevation|0
79218|NCT00943917|282527|P8|Stage I|A1C elevation|0
79219|NCT00943917|282528|P7|Stage I|A1C elevation|0
79220|NCT00943917|282529|P6|Stage I|A1C elevation|0
79221|NCT00943917|282530|P5|Stage I|A1C elevation|0
79222|NCT00943917|282531|P4|Stage I|A1C elevation|0
79223|NCT00943917|282532|P3|Stage I|A1C elevation|0
79224|NCT00943917|282533|P2|Stage I|A1C elevation|0
79225|NCT00943917|282534|P1|Stage I|A1C elevation|1
79226|NCT00943917|282520|P15|Stage I|hyperglycemia|0
79227|NCT00943917|282521|P14|Stage I|hyperglycemia|0
79228|NCT00943917|282522|P13|Stage I|hyperglycemia|0
79229|NCT00943917|282523|P12|Stage I|hyperglycemia|0
79230|NCT00943917|282524|P11|Stage I|hyperglycemia|0
79231|NCT00943917|282525|P10|Stage I|hyperglycemia|0
79232|NCT00943917|282526|P9|Stage I|hyperglycemia|0
79233|NCT00943917|282527|P8|Stage I|hyperglycemia|0
79234|NCT00943917|282528|P7|Stage I|hyperglycemia|0
79235|NCT00943917|282529|P6|Stage I|hyperglycemia|0
79236|NCT00943917|282530|P5|Stage I|hyperglycemia|0
79237|NCT00943917|282531|P4|Stage I|hyperglycemia|0
79238|NCT00943917|282532|P3|Stage I|hyperglycemia|1
79239|NCT00943917|282533|P2|Stage I|hyperglycemia|0
79240|NCT00943917|282534|P1|Stage I|hyperglycemia|0
79241|NCT00943917|282520|P15|Stage I|Lost to Follow-up|0
79242|NCT00943917|282521|P14|Stage I|Lost to Follow-up|0
79243|NCT00943917|282522|P13|Stage I|Lost to Follow-up|0
79244|NCT00943917|282523|P12|Stage I|Lost to Follow-up|0
79245|NCT00943917|282524|P11|Stage I|Lost to Follow-up|0
79246|NCT00943917|282525|P10|Stage I|Lost to Follow-up|0
79247|NCT00943917|282526|P9|Stage I|Lost to Follow-up|0
79248|NCT00943917|282527|P8|Stage I|Lost to Follow-up|0
79249|NCT00943917|282528|P7|Stage I|Lost to Follow-up|0
79250|NCT00943917|282529|P6|Stage I|Lost to Follow-up|0
79251|NCT00943917|282530|P5|Stage I|Lost to Follow-up|0
79252|NCT00943917|282531|P4|Stage I|Lost to Follow-up|0
79253|NCT00943917|282532|P3|Stage I|Lost to Follow-up|1
79254|NCT00943917|282533|P2|Stage I|Lost to Follow-up|0
79255|NCT00943917|282534|P1|Stage I|Lost to Follow-up|0
79256|NCT00943917|282520|P15|Stage I|Adverse Event|0
79257|NCT00943917|282521|P14|Stage I|Adverse Event|0
79258|NCT00943917|282522|P13|Stage I|Adverse Event|0
79259|NCT00943917|282523|P12|Stage I|Adverse Event|0
79260|NCT00943917|282524|P11|Stage I|Adverse Event|0
79261|NCT00943917|282525|P10|Stage I|Adverse Event|0
79262|NCT00943917|282526|P9|Stage I|Adverse Event|0
79263|NCT00943917|282527|P8|Stage I|Adverse Event|0
79264|NCT00943917|282528|P7|Stage I|Adverse Event|0
79265|NCT00943917|282529|P6|Stage I|Adverse Event|0
79266|NCT00943917|282530|P5|Stage I|Adverse Event|0
79267|NCT00943917|282531|P4|Stage I|Adverse Event|0
79268|NCT00943917|282532|P3|Stage I|Adverse Event|2
79269|NCT00943917|282533|P2|Stage I|Adverse Event|2
79270|NCT00943917|282534|P1|Stage I|Adverse Event|1
79271|NCT00943852|282710|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
79272|NCT00943852|282711|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
79273|NCT00943852|282712|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
79274|NCT00943852|282713|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
79275|NCT00943852|282714|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
79276|NCT00943852|282715|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
79277|NCT00943852|282716|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
79278|NCT00943852|282717|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
79279|NCT00943852|282718|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
79280|NCT00943852|282719|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
79281|NCT00943852|282710|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
79282|NCT00943852|282711|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
79283|NCT00943852|282712|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
79284|NCT00943852|282713|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
79285|NCT00943852|282714|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
79286|NCT00943852|282715|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
79287|NCT00943852|282716|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
79288|NCT00943852|282717|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
79289|NCT00943852|282718|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
79290|NCT00943852|282719|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
79291|NCT00943852|282710|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
79292|NCT00943852|282711|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
79293|NCT00943852|282712|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
79294|NCT00943852|282713|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
79295|NCT00943852|282714|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
79296|NCT00943852|282715|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
79297|NCT00943852|282716|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
79298|NCT00943852|282717|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
79299|NCT00943852|282718|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
79300|NCT00943852|282719|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
79301|NCT00943852|282710|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
79302|NCT00943852|282711|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
79303|NCT00943852|282712|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
79304|NCT00943852|282713|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
79305|NCT00943852|282714|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
79306|NCT00943852|282715|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
79307|NCT00943852|282716|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
79308|NCT00943852|282717|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
79309|NCT00943852|282718|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
79310|NCT00943852|282719|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
79311|NCT00943852|282710|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
79312|NCT00943852|282711|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
79313|NCT00943852|282712|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
79314|NCT00943852|282713|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
79315|NCT00943852|282714|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
79316|NCT00943852|282715|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
79317|NCT00943852|282716|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
79318|NCT00943852|282717|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
79319|NCT00943852|282718|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
79320|NCT00943852|282719|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
79321|NCT00943826|282732|P2|Monotherapy Phase|Failure to return|1
79322|NCT00943826|282733|P1|Monotherapy Phase|Failure to return|2
79323|NCT00943826|282732|P2|Monotherapy Phase|Withdrew Consent|3
79324|NCT00943826|282733|P1|Monotherapy Phase|Withdrew Consent|3
79325|NCT00943826|282732|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
79326|NCT00943826|282733|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|5
79327|NCT00943826|282732|P2|Monotherapy Phase|Administrative reasons|4
79328|NCT00943826|282733|P1|Monotherapy Phase|Administrative reasons|8
79329|NCT00943826|282732|P2|Monotherapy Phase|Adverse Event|3
79330|NCT00943826|282733|P1|Monotherapy Phase|Adverse Event|33
79331|NCT00943826|282732|P2|Maintenance Phase|Failure to return|1
79332|NCT00943826|282733|P1|Maintenance Phase|Failure to return|0
79333|NCT00943826|282732|P2|Maintenance Phase|Administrative reasons|2
79334|NCT00943826|282733|P1|Maintenance Phase|Administrative reasons|4
79335|NCT00943826|282732|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
79336|NCT00943826|282733|P1|Maintenance Phase|Refused treatment/Did not cooperate|4
79337|NCT00943826|282732|P2|Maintenance Phase|Withdrew consent|5
79338|NCT00943826|282733|P1|Maintenance Phase|Withdrew consent|4
79339|NCT00943826|282732|P2|Maintenance Phase|Adverse Event|30
79340|NCT00943826|282733|P1|Maintenance Phase|Adverse Event|31
79341|NCT00943826|282732|P2|Concurrent Phase|Protocol Violation|0
79342|NCT00943826|282733|P1|Concurrent Phase|Protocol Violation|1
79343|NCT00943826|282732|P2|Concurrent Phase|Administrative reasons|1
79344|NCT00943826|282733|P1|Concurrent Phase|Administrative reasons|2
79345|NCT00943826|282732|P2|Concurrent Phase|Refused treatment/Did not cooperate|6
79346|NCT00943826|282733|P1|Concurrent Phase|Refused treatment/Did not cooperate|4
79347|NCT00943826|282732|P2|Concurrent Phase|Withdrew consent|8
79348|NCT00943826|282733|P1|Concurrent Phase|Withdrew consent|4
79349|NCT00943826|282732|P2|Concurrent Phase|Adverse Event|27
79350|NCT00943826|282733|P1|Concurrent Phase|Adverse Event|50
79351|NCT00943787|282747|P1|Overall Study|Withdrawal by Subject|3
79352|NCT00943787|282747|P1|Overall Study|Physician Decision|4
79353|NCT00943761|282754|P2|Overall Study|Withdrawal by Subject|1
79354|NCT00943761|282755|P1|Overall Study|Withdrawal by Subject|2
79355|NCT00943761|282754|P2|Overall Study|Lost to Follow-up|0
79356|NCT00943761|282755|P1|Overall Study|Lost to Follow-up|2
79357|NCT00943735|282767|P1|Overall Study|Other|3
79358|NCT00943735|282767|P1|Overall Study|Unspecified|8
79359|NCT00943735|282767|P1|Overall Study|Death|1
79360|NCT00943735|282767|P1|Overall Study|Withdrawal by Subject|8
79361|NCT00943735|282767|P1|Overall Study|Adverse Event|12
79362|NCT00943722|282805|P5|Overall Study|Withdrawal by Subject|8
79363|NCT00943722|282806|P4|Overall Study|Withdrawal by Subject|13
79364|NCT00943722|282807|P3|Overall Study|Withdrawal by Subject|2
79365|NCT00943722|282808|P2|Overall Study|Withdrawal by Subject|13
79366|NCT00943722|282809|P1|Overall Study|Withdrawal by Subject|12
79367|NCT00943722|282805|P5|Overall Study|Protocol Violation|2
79368|NCT00943722|282806|P4|Overall Study|Protocol Violation|0
79369|NCT00943722|282807|P3|Overall Study|Protocol Violation|0
79370|NCT00943722|282808|P2|Overall Study|Protocol Violation|1
79371|NCT00943722|282809|P1|Overall Study|Protocol Violation|0
79372|NCT00943722|282805|P5|Overall Study|Pregnancy|0
79373|NCT00943722|282806|P4|Overall Study|Pregnancy|0
79374|NCT00943722|282807|P3|Overall Study|Pregnancy|1
79375|NCT00943722|282808|P2|Overall Study|Pregnancy|0
79376|NCT00943722|282809|P1|Overall Study|Pregnancy|0
79377|NCT00943722|282805|P5|Overall Study|Physician Decision|1
79378|NCT00943722|282806|P4|Overall Study|Physician Decision|0
79379|NCT00943722|282807|P3|Overall Study|Physician Decision|0
79380|NCT00943722|282808|P2|Overall Study|Physician Decision|0
79381|NCT00943722|282809|P1|Overall Study|Physician Decision|1
79382|NCT00943722|282805|P5|Overall Study|Lost to Follow-up|11
79383|NCT00943722|282806|P4|Overall Study|Lost to Follow-up|8
79384|NCT00943722|282807|P3|Overall Study|Lost to Follow-up|10
79385|NCT00943722|282808|P2|Overall Study|Lost to Follow-up|8
79386|NCT00943722|282809|P1|Overall Study|Lost to Follow-up|12
79387|NCT00943722|282805|P5|Overall Study|Adverse Event|0
79388|NCT00943722|282806|P4|Overall Study|Adverse Event|1
79389|NCT00943722|282807|P3|Overall Study|Adverse Event|0
79390|NCT00943722|282808|P2|Overall Study|Adverse Event|0
79391|NCT00943722|282809|P1|Overall Study|Adverse Event|0
79392|NCT00943683|282839|P2|Overall Study|Patient Moved|0
79393|NCT00943683|282840|P1|Overall Study|Patient Moved|1
79394|NCT00943683|282839|P2|Overall Study|Withdrawal by Subject|0
79395|NCT00943683|282840|P1|Overall Study|Withdrawal by Subject|1
79396|NCT00943683|282839|P2|Overall Study|Protocol Violation|2
79397|NCT00943683|282840|P1|Overall Study|Protocol Violation|1
79398|NCT00943683|282839|P2|Overall Study|Lost to Follow-up|1
79399|NCT00943683|282840|P1|Overall Study|Lost to Follow-up|1
79400|NCT00943683|282839|P2|Overall Study|Adverse Event|3
79401|NCT00943683|282840|P1|Overall Study|Adverse Event|3
79402|NCT00943670|282846|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
79403|NCT00943670|282846|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
79404|NCT00943670|282846|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
79405|NCT00943670|282846|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
79406|NCT00943670|282846|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
79407|NCT00943670|282846|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
79408|NCT00943670|282846|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
79409|NCT00943670|282846|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
79410|NCT00943670|282846|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
79411|NCT00943670|282846|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
79412|NCT00943605|282935|P2|Overall Study|Study termination|30
79413|NCT00943605|282936|P1|Overall Study|Study termination|30
79414|NCT00943592|282946|P1|Overall Study|Death|3
79415|NCT00943579|282959|P2|Overall Study|Lack of Efficacy|2
79416|NCT00943579|282960|P1|Overall Study|Lack of Efficacy|2
79417|NCT00943579|282959|P2|Overall Study|Adverse Event|3
79418|NCT00943579|282960|P1|Overall Study|Adverse Event|4
79419|NCT00943397|283054|P2|Overall Study|Site terminated and other|56
79420|NCT00943397|283055|P1|Overall Study|Site terminated and other|12
79421|NCT00943397|283054|P2|Overall Study|Withdrawal by Subject|1
79422|NCT00943397|283055|P1|Overall Study|Withdrawal by Subject|1
79423|NCT00943397|283054|P2|Overall Study|Protocol Violation|5
79424|NCT00943397|283055|P1|Overall Study|Protocol Violation|2
79425|NCT00943397|283054|P2|Overall Study|Lost to Follow-up|4
79426|NCT00943397|283055|P1|Overall Study|Lost to Follow-up|0
79427|NCT00943397|283054|P2|Overall Study|Adverse Event|6
79428|NCT00943397|283055|P1|Overall Study|Adverse Event|0
79429|NCT00943384|283061|P1|Overall Study|Withdrawal by Subject|5
79430|NCT00943384|283061|P1|Overall Study|Lost to Follow-up|16
79431|NCT00943384|283061|P1|Overall Study|Treated off protocol-protocol violation|5
79432|NCT00943384|283061|P1|Overall Study|Dispositioned prior to treatment|23
79433|NCT00943124|283320|P2|Period 1|Personal Reasons|1
79434|NCT00943124|283321|P1|Period 1|Personal Reasons|0
79435|NCT00943124|283320|P2|Period 1|Did Not Follow Study Procedures|0
79436|NCT00943124|283321|P1|Period 1|Did Not Follow Study Procedures|1
79437|NCT00943124|283320|P2|Period 1|Withdrawal by Subject|1
79438|NCT00943124|283321|P1|Period 1|Withdrawal by Subject|1
79439|NCT00943111|283343|P3|5 Years Long-term Treatment Period|Other than specified above|2
79440|NCT00943111|283344|P2|5 Years Long-term Treatment Period|Other than specified above|0
79441|NCT00943111|283345|P1|5 Years Long-term Treatment Period|Other than specified above|0
79442|NCT00943111|283343|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
79443|NCT00943111|283344|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
79444|NCT00943111|283345|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
79445|NCT00943111|283343|P3|5 Years Long-term Treatment Period|Pregnancy|4
79446|NCT00943111|283344|P2|5 Years Long-term Treatment Period|Pregnancy|0
79447|NCT00943111|283345|P1|5 Years Long-term Treatment Period|Pregnancy|0
79448|NCT00943111|283343|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
79449|NCT00943111|283344|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
79450|NCT00943111|283345|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
79451|NCT00943111|283343|P3|5 Years Long-term Treatment Period|Adverse Event|9
79452|NCT00943111|283344|P2|5 Years Long-term Treatment Period|Adverse Event|0
79453|NCT00943111|283345|P1|5 Years Long-term Treatment Period|Adverse Event|0
79533|NCT00942604|283524|P1|Overall Study|Adverse Event|0
79454|NCT00943111|283343|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
79455|NCT00943111|283344|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
79456|NCT00943111|283345|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
79457|NCT00943111|283343|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
79458|NCT00943111|283344|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
79459|NCT00943111|283345|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
79460|NCT00943111|283343|P3|52-Weeks Primary Analysis Period|Adverse Event|0
79461|NCT00943111|283344|P2|52-Weeks Primary Analysis Period|Adverse Event|1
79462|NCT00943111|283345|P1|52-Weeks Primary Analysis Period|Adverse Event|2
79463|NCT00943072|283413|P2|Overall Study|Other|1
79464|NCT00943072|283414|P1|Overall Study|Other|1
79465|NCT00943072|283413|P2|Overall Study|Lack of Efficacy|4
79466|NCT00943072|283414|P1|Overall Study|Lack of Efficacy|0
79467|NCT00943072|283413|P2|Overall Study|Lost to Follow-up|2
79468|NCT00943072|283414|P1|Overall Study|Lost to Follow-up|1
79469|NCT00943072|283413|P2|Overall Study|Protocol Violation|1
79470|NCT00943072|283414|P1|Overall Study|Protocol Violation|0
79471|NCT00943072|283413|P2|Overall Study|Withdrawal by Subject|1
79472|NCT00943072|283414|P1|Overall Study|Withdrawal by Subject|3
79473|NCT00943072|283413|P2|Overall Study|Death|2
79474|NCT00943072|283414|P1|Overall Study|Death|0
79475|NCT00943072|283413|P2|Overall Study|Adverse Event|3
79476|NCT00943072|283414|P1|Overall Study|Adverse Event|0
79477|NCT00942994|283432|P2|Overall Study|Protocol deviation|2
79478|NCT00942994|283433|P1|Overall Study|Protocol deviation|1
79479|NCT00942994|283432|P2|Overall Study|Lost to Follow-up|4
79480|NCT00942994|283433|P1|Overall Study|Lost to Follow-up|1
79481|NCT00942994|283432|P2|Overall Study|Patient withdrew consent|8
79482|NCT00942994|283433|P1|Overall Study|Patient withdrew consent|5
79483|NCT00942994|283432|P2|Overall Study|Unsatisfactory therapeutic effect|1
79484|NCT00942994|283433|P1|Overall Study|Unsatisfactory therapeutic effect|1
79485|NCT00942994|283432|P2|Overall Study|Abnormal laboratory value(s)|0
79486|NCT00942994|283433|P1|Overall Study|Abnormal laboratory value(s)|1
79487|NCT00942994|283432|P2|Overall Study|Adverse Event|4
79488|NCT00942994|283433|P1|Overall Study|Adverse Event|7
79489|NCT00941863|283463|P5|Continued After PCD|Disease progression, recurrence, relapse|18
79490|NCT00941863|283464|P4|Continued After PCD|Disease progression, recurrence, relapse|0
79491|NCT00941863|283465|P3|Continued After PCD|Disease progression, recurrence, relapse|0
79492|NCT00941863|283466|P2|Continued After PCD|Disease progression, recurrence, relapse|0
79493|NCT00941863|283467|P1|Continued After PCD|Disease progression, recurrence, relapse|0
79494|NCT00941863|283463|P5|Continued After PCD|Withdrawal by Subject|1
79495|NCT00941863|283464|P4|Continued After PCD|Withdrawal by Subject|0
79496|NCT00941863|283465|P3|Continued After PCD|Withdrawal by Subject|0
79497|NCT00941863|283466|P2|Continued After PCD|Withdrawal by Subject|0
79498|NCT00941863|283467|P1|Continued After PCD|Withdrawal by Subject|0
79499|NCT00941863|283463|P5|Until Primary Completion Date (PCD)|Disease progression|73
79500|NCT00941863|283464|P4|Until Primary Completion Date (PCD)|Disease progression|14
79501|NCT00941863|283465|P3|Until Primary Completion Date (PCD)|Disease progression|8
79502|NCT00941863|283466|P2|Until Primary Completion Date (PCD)|Disease progression|1
79503|NCT00941863|283467|P1|Until Primary Completion Date (PCD)|Disease progression|6
79504|NCT00941863|283463|P5|Until Primary Completion Date (PCD)|Death|7
79505|NCT00941863|283464|P4|Until Primary Completion Date (PCD)|Death|2
79506|NCT00941863|283465|P3|Until Primary Completion Date (PCD)|Death|1
79507|NCT00941863|283466|P2|Until Primary Completion Date (PCD)|Death|0
79508|NCT00941863|283467|P1|Until Primary Completion Date (PCD)|Death|0
79509|NCT00941863|283463|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
79510|NCT00941863|283464|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
79511|NCT00941863|283465|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
79512|NCT00941863|283466|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
79513|NCT00941863|283467|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
79514|NCT00941863|283463|P5|Until Primary Completion Date (PCD)|Physician Decision|1
79515|NCT00941863|283464|P4|Until Primary Completion Date (PCD)|Physician Decision|0
79516|NCT00941863|283465|P3|Until Primary Completion Date (PCD)|Physician Decision|0
79517|NCT00941863|283466|P2|Until Primary Completion Date (PCD)|Physician Decision|0
79518|NCT00941863|283467|P1|Until Primary Completion Date (PCD)|Physician Decision|0
79519|NCT00941863|283463|P5|Until Primary Completion Date (PCD)|Adverse Event|5
79520|NCT00941863|283464|P4|Until Primary Completion Date (PCD)|Adverse Event|1
79521|NCT00941863|283465|P3|Until Primary Completion Date (PCD)|Adverse Event|2
79522|NCT00941863|283466|P2|Until Primary Completion Date (PCD)|Adverse Event|2
79523|NCT00941863|283467|P1|Until Primary Completion Date (PCD)|Adverse Event|1
79524|NCT00942734|283517|P1|Overall Study|Physician Decision|1
79525|NCT00942734|283517|P1|Overall Study|Disease Progression|2
79526|NCT00942734|283517|P1|Overall Study|Protocol Violation|3
79527|NCT00942734|283517|P1|Overall Study|Adverse Event|2
79528|NCT00942604|283523|P2|Overall Study|Patient relocation|1
79529|NCT00942604|283524|P1|Overall Study|Patient relocation|1
79530|NCT00942604|283523|P2|Overall Study|Withdrawal by Subject|1
79531|NCT00942604|283524|P1|Overall Study|Withdrawal by Subject|0
79532|NCT00942604|283523|P2|Overall Study|Adverse Event|1
79534|NCT00942604|283523|P2|Overall Study|Protocol Violation|1
79535|NCT00942604|283524|P1|Overall Study|Protocol Violation|1
79536|NCT00942422|283601|P1|Overall Study|Progressive diease|1
79537|NCT00942422|283601|P1|Overall Study|Death|1
79538|NCT00942422|283601|P1|Overall Study|Withdrawal by Subject|1
79539|NCT00942409|283605|P1|Overall Study|study drug unavailable|2
79540|NCT00942409|283605|P1|Overall Study|Lack of Efficacy|1
79541|NCT00942266|283611|P2|Overall Study|medical deterioration (pneumonia)|1
79542|NCT00942266|283612|P1|Overall Study|medical deterioration (pneumonia)|0
79543|NCT00942266|283611|P2|Overall Study|Physician Decision|0
79544|NCT00942266|283612|P1|Overall Study|Physician Decision|2
79545|NCT00942266|283611|P2|Overall Study|Intercurrent illness|1
79546|NCT00942266|283612|P1|Overall Study|Intercurrent illness|0
79547|NCT00942266|283611|P2|Overall Study|Failure to thrive and pt withdrawal|1
79548|NCT00942266|283612|P1|Overall Study|Failure to thrive and pt withdrawal|0
79549|NCT00942266|283611|P2|Overall Study|Disease Progression|11
79550|NCT00942266|283612|P1|Overall Study|Disease Progression|38
79551|NCT00942266|283611|P2|Overall Study|Adverse Event|1
79552|NCT00942266|283612|P1|Overall Study|Adverse Event|2
79553|NCT00942266|283611|P2|Overall Study|Withdrawal by Subject|0
79554|NCT00942266|283612|P1|Overall Study|Withdrawal by Subject|1
79555|NCT00942175|283634|P4|Overall Study|Low Platelet Count|0
79556|NCT00942175|283635|P3|Overall Study|Low Platelet Count|0
79557|NCT00942175|283636|P2|Overall Study|Low Platelet Count|2
79558|NCT00942175|283637|P1|Overall Study|Low Platelet Count|0
79559|NCT00942175|283634|P4|Overall Study|Elevated Alanine Amino Transferase|1
79560|NCT00942175|283635|P3|Overall Study|Elevated Alanine Amino Transferase|0
79561|NCT00942175|283636|P2|Overall Study|Elevated Alanine Amino Transferase|0
79562|NCT00942175|283637|P1|Overall Study|Elevated Alanine Amino Transferase|0
79563|NCT00942175|283634|P4|Overall Study|Pregnancy|1
79564|NCT00942175|283635|P3|Overall Study|Pregnancy|0
79565|NCT00942175|283636|P2|Overall Study|Pregnancy|0
79566|NCT00942175|283637|P1|Overall Study|Pregnancy|0
79567|NCT00942175|283634|P4|Overall Study|Protocol Violation|0
79568|NCT00942175|283635|P3|Overall Study|Protocol Violation|2
79569|NCT00942175|283636|P2|Overall Study|Protocol Violation|1
79570|NCT00942175|283637|P1|Overall Study|Protocol Violation|0
79571|NCT00942175|283634|P4|Overall Study|Adverse Event|0
79572|NCT00942175|283635|P3|Overall Study|Adverse Event|0
79573|NCT00942175|283636|P2|Overall Study|Adverse Event|1
79574|NCT00942175|283637|P1|Overall Study|Adverse Event|2
79575|NCT00942084|283691|P1|Overall Study|Death|2
79576|NCT00941928|283708|P1|Overall Study|Disease Progression|1
79577|NCT00941928|283708|P1|Overall Study|Withdrawal by Subject|1
79578|NCT00941798|283714|P2|Overall Study|Death|1
79579|NCT00941798|283715|P1|Overall Study|Death|0
79580|NCT00941798|283714|P2|Overall Study|Abnormal laboratory values|2
79581|NCT00941798|283715|P1|Overall Study|Abnormal laboratory values|1
79582|NCT00941798|283714|P2|Overall Study|Abnormal test procedure results|1
79583|NCT00941798|283715|P1|Overall Study|Abnormal test procedure results|3
79584|NCT00941798|283714|P2|Overall Study|Patient's inability to use device|1
79585|NCT00941798|283715|P1|Overall Study|Patient's inability to use device|6
79586|NCT00941798|283714|P2|Overall Study|Lack of Efficacy|17
79587|NCT00941798|283715|P1|Overall Study|Lack of Efficacy|10
79588|NCT00941798|283714|P2|Overall Study|Administrative problems|23
79589|NCT00941798|283715|P1|Overall Study|Administrative problems|13
79590|NCT00941798|283714|P2|Overall Study|Protocol Violation|20
79591|NCT00941798|283715|P1|Overall Study|Protocol Violation|17
79592|NCT00941798|283714|P2|Overall Study|Lost to Follow-up|23
79593|NCT00941798|283715|P1|Overall Study|Lost to Follow-up|29
79594|NCT00941798|283714|P2|Overall Study|Adverse Event|23
79595|NCT00941798|283715|P1|Overall Study|Adverse Event|43
79596|NCT00941798|283714|P2|Overall Study|Withdrawal by Subject|74
79597|NCT00941798|283715|P1|Overall Study|Withdrawal by Subject|72
79598|NCT00941733|283745|P2|Overall Study|Protocol Violation|6
79599|NCT00941733|283746|P1|Overall Study|Protocol Violation|15
79600|NCT00941733|283745|P2|Overall Study|Lost to Follow-up|2
79601|NCT00941733|283746|P1|Overall Study|Lost to Follow-up|1
79602|NCT00941733|283745|P2|Overall Study|Adverse Event|4
79603|NCT00941733|283746|P1|Overall Study|Adverse Event|20
79604|NCT00941733|283745|P2|Overall Study|Withdrawal by Subject|6
79605|NCT00941733|283746|P1|Overall Study|Withdrawal by Subject|14
79606|NCT00941733|283745|P2|Overall Study|Death|10
79607|NCT00941733|283746|P1|Overall Study|Death|24
79608|NCT00941720|283786|P1|Overall Study|ineligible|2
79609|NCT00941720|283786|P1|Overall Study|Insurance denied participation|11
79610|NCT00941720|283786|P1|Overall Study|Withdrawal by Subject|1
79611|NCT00941655|283833|P2|Overall Study|off study prior to trmt/noncompliance|1
79612|NCT00941655|283834|P1|Overall Study|off study prior to trmt/noncompliance|0
79613|NCT00941655|283833|P2|Overall Study|withdrew consent|3
79614|NCT00941655|283834|P1|Overall Study|withdrew consent|0
79615|NCT00941655|283833|P2|Overall Study|stopped chemo/decided to have surgery|1
79616|NCT00941655|283834|P1|Overall Study|stopped chemo/decided to have surgery|0
79617|NCT00941655|283833|P2|Overall Study|progressed while on chemo|2
79618|NCT00941655|283834|P1|Overall Study|progressed while on chemo|0
79619|NCT00941655|283833|P2|Overall Study|not meet criteria for chemo foll surgery|0
79620|NCT00941655|283834|P1|Overall Study|not meet criteria for chemo foll surgery|4
79621|NCT00941655|283833|P2|Overall Study|received some chemo, 4 and 9 cycles|0
79622|NCT00941655|283834|P1|Overall Study|received some chemo, 4 and 9 cycles|2
79623|NCT00941603|283848|P6|Overall Study|Did not meet protocol eligibility|0
79624|NCT00941603|283849|P5|Overall Study|Did not meet protocol eligibility|0
79625|NCT00941603|283850|P4|Overall Study|Did not meet protocol eligibility|0
79626|NCT00941603|283851|P3|Overall Study|Did not meet protocol eligibility|0
79627|NCT00941603|283852|P2|Overall Study|Did not meet protocol eligibility|0
79628|NCT00941603|283853|P1|Overall Study|Did not meet protocol eligibility|1
79629|NCT00941603|283848|P6|Overall Study|Protocol Violation|0
79630|NCT00941603|283849|P5|Overall Study|Protocol Violation|0
79631|NCT00941603|283850|P4|Overall Study|Protocol Violation|0
79632|NCT00941603|283851|P3|Overall Study|Protocol Violation|0
79633|NCT00941603|283852|P2|Overall Study|Protocol Violation|1
79634|NCT00941603|283853|P1|Overall Study|Protocol Violation|0
79635|NCT00941603|283848|P6|Overall Study|Withdrawal by Subject|1
79636|NCT00941603|283849|P5|Overall Study|Withdrawal by Subject|0
79637|NCT00941603|283850|P4|Overall Study|Withdrawal by Subject|2
79638|NCT00941603|283851|P3|Overall Study|Withdrawal by Subject|0
79639|NCT00941603|283852|P2|Overall Study|Withdrawal by Subject|0
79640|NCT00941603|283853|P1|Overall Study|Withdrawal by Subject|0
79641|NCT00941603|283848|P6|Overall Study|Lost to Follow-up|2
79642|NCT00941603|283849|P5|Overall Study|Lost to Follow-up|0
79643|NCT00941603|283850|P4|Overall Study|Lost to Follow-up|1
79644|NCT00941603|283851|P3|Overall Study|Lost to Follow-up|0
79645|NCT00941603|283852|P2|Overall Study|Lost to Follow-up|0
79646|NCT00941603|283853|P1|Overall Study|Lost to Follow-up|0
79647|NCT00941603|283848|P6|Overall Study|Adverse Event|0
79648|NCT00941603|283849|P5|Overall Study|Adverse Event|4
79649|NCT00941603|283850|P4|Overall Study|Adverse Event|1
79650|NCT00941603|283851|P3|Overall Study|Adverse Event|5
79651|NCT00941603|283852|P2|Overall Study|Adverse Event|15
79652|NCT00941603|283853|P1|Overall Study|Adverse Event|10
79653|NCT00941304|283878|P5|Overall Study|Lost to Follow-up|0
79654|NCT00941304|283879|P4|Overall Study|Lost to Follow-up|0
79655|NCT00941304|283880|P3|Overall Study|Lost to Follow-up|0
79656|NCT00941304|283881|P2|Overall Study|Lost to Follow-up|0
79657|NCT00941304|283882|P1|Overall Study|Lost to Follow-up|1
79658|NCT00941070|283944|P1|Overall Study|Patient non-compliant|1
79659|NCT00941031|283962|P7|Maintenance Period|Lack of Efficacy|13
79660|NCT00941031|283963|P6|Maintenance Period|Lack of Efficacy|0
79661|NCT00941031|283964|P5|Maintenance Period|Lack of Efficacy|0
79662|NCT00941031|283965|P4|Maintenance Period|Lack of Efficacy|0
79663|NCT00941031|283966|P3|Maintenance Period|Lack of Efficacy|0
79664|NCT00941031|283967|P2|Maintenance Period|Lack of Efficacy|0
79665|NCT00941031|283968|P1|Maintenance Period|Lack of Efficacy|0
79666|NCT00941031|283962|P7|Maintenance Period|Lost to Follow-up|7
79667|NCT00941031|283963|P6|Maintenance Period|Lost to Follow-up|2
79668|NCT00941031|283964|P5|Maintenance Period|Lost to Follow-up|2
79669|NCT00941031|283965|P4|Maintenance Period|Lost to Follow-up|0
79670|NCT00941031|283966|P3|Maintenance Period|Lost to Follow-up|0
79671|NCT00941031|283967|P2|Maintenance Period|Lost to Follow-up|0
79672|NCT00941031|283968|P1|Maintenance Period|Lost to Follow-up|0
79673|NCT00941031|283962|P7|Maintenance Period|Adverse Event|8
79674|NCT00941031|283963|P6|Maintenance Period|Adverse Event|2
79675|NCT00941031|283964|P5|Maintenance Period|Adverse Event|0
79676|NCT00941031|283965|P4|Maintenance Period|Adverse Event|0
79677|NCT00941031|283966|P3|Maintenance Period|Adverse Event|0
79678|NCT00941031|283967|P2|Maintenance Period|Adverse Event|0
79679|NCT00941031|283968|P1|Maintenance Period|Adverse Event|0
79680|NCT00941031|283962|P7|Maintenance Period|Protocol Violation|1
79681|NCT00941031|283963|P6|Maintenance Period|Protocol Violation|0
79682|NCT00941031|283964|P5|Maintenance Period|Protocol Violation|0
79683|NCT00941031|283965|P4|Maintenance Period|Protocol Violation|0
79684|NCT00941031|283966|P3|Maintenance Period|Protocol Violation|0
79685|NCT00941031|283967|P2|Maintenance Period|Protocol Violation|0
79686|NCT00941031|283968|P1|Maintenance Period|Protocol Violation|0
79687|NCT00941031|283962|P7|Maintenance Period|Administrative Problems|1
79688|NCT00941031|283963|P6|Maintenance Period|Administrative Problems|0
79689|NCT00941031|283964|P5|Maintenance Period|Administrative Problems|1
79690|NCT00941031|283965|P4|Maintenance Period|Administrative Problems|0
79691|NCT00941031|283966|P3|Maintenance Period|Administrative Problems|0
79692|NCT00941031|283967|P2|Maintenance Period|Administrative Problems|0
79693|NCT00941031|283968|P1|Maintenance Period|Administrative Problems|0
79694|NCT00941031|283962|P7|Maintenance Period|Withdrawal by Subject|13
79695|NCT00941031|283963|P6|Maintenance Period|Withdrawal by Subject|2
79696|NCT00941031|283964|P5|Maintenance Period|Withdrawal by Subject|6
79697|NCT00941031|283965|P4|Maintenance Period|Withdrawal by Subject|0
79698|NCT00941031|283966|P3|Maintenance Period|Withdrawal by Subject|0
79699|NCT00941031|283967|P2|Maintenance Period|Withdrawal by Subject|0
79700|NCT00941031|283968|P1|Maintenance Period|Withdrawal by Subject|0
79701|NCT00941031|283962|P7|Induction Period|Adverse Event|0
79702|NCT00941031|283963|P6|Induction Period|Adverse Event|0
79703|NCT00941031|283964|P5|Induction Period|Adverse Event|0
79704|NCT00941031|283965|P4|Induction Period|Adverse Event|2
79705|NCT00941031|283966|P3|Induction Period|Adverse Event|3
79706|NCT00941031|283967|P2|Induction Period|Adverse Event|0
79707|NCT00941031|283968|P1|Induction Period|Adverse Event|1
79708|NCT00941031|283962|P7|Induction Period|Adminstative Problems|0
79709|NCT00941031|283963|P6|Induction Period|Adminstative Problems|0
79710|NCT00941031|283964|P5|Induction Period|Adminstative Problems|0
79711|NCT00941031|283965|P4|Induction Period|Adminstative Problems|0
79712|NCT00941031|283966|P3|Induction Period|Adminstative Problems|1
79713|NCT00941031|283967|P2|Induction Period|Adminstative Problems|1
79714|NCT00941031|283968|P1|Induction Period|Adminstative Problems|1
79715|NCT00941031|283962|P7|Induction Period|Withdrawal by Subject|0
79716|NCT00941031|283963|P6|Induction Period|Withdrawal by Subject|0
79717|NCT00941031|283964|P5|Induction Period|Withdrawal by Subject|0
79718|NCT00941031|283965|P4|Induction Period|Withdrawal by Subject|2
79719|NCT00941031|283966|P3|Induction Period|Withdrawal by Subject|2
79720|NCT00941031|283967|P2|Induction Period|Withdrawal by Subject|2
79721|NCT00941031|283968|P1|Induction Period|Withdrawal by Subject|1
79722|NCT00941031|283962|P7|Induction Period|Lack of Efficacy|0
79723|NCT00941031|283963|P6|Induction Period|Lack of Efficacy|0
79724|NCT00941031|283964|P5|Induction Period|Lack of Efficacy|0
79725|NCT00941031|283965|P4|Induction Period|Lack of Efficacy|5
79726|NCT00941031|283966|P3|Induction Period|Lack of Efficacy|0
79727|NCT00941031|283967|P2|Induction Period|Lack of Efficacy|1
79728|NCT00941031|283968|P1|Induction Period|Lack of Efficacy|2
79729|NCT00940992|283994|P3|Overall Study|Lost to Follow-up|1
79730|NCT00940992|283995|P2|Overall Study|Lost to Follow-up|1
79731|NCT00940992|283996|P1|Overall Study|Lost to Follow-up|0
79732|NCT00940992|283994|P3|Overall Study|subject request|0
79733|NCT00940992|283995|P2|Overall Study|subject request|1
79734|NCT00940992|283996|P1|Overall Study|subject request|2
79735|NCT00940992|283994|P3|Overall Study|Adverse Event|1
79736|NCT00940992|283995|P2|Overall Study|Adverse Event|0
79737|NCT00940992|283996|P1|Overall Study|Adverse Event|2
79738|NCT00940875|284014|P2|Post-Study Treatment|Disease Progression|2
79739|NCT00940875|284015|P1|Post-Study Treatment|Disease Progression|0
79740|NCT00940875|284014|P2|Post-Study Treatment|Death|1
79741|NCT00940875|284015|P1|Post-Study Treatment|Death|0
79742|NCT00940875|284014|P2|Treatment Phase|Physician Decision|0
79743|NCT00940875|284015|P1|Treatment Phase|Physician Decision|1
79744|NCT00940875|284014|P2|Treatment Phase|Disease progression|11
79745|NCT00940875|284015|P1|Treatment Phase|Disease progression|9
79746|NCT00940875|284014|P2|Treatment Phase|Withdrawal by Subject|0
79747|NCT00940875|284015|P1|Treatment Phase|Withdrawal by Subject|3
79748|NCT00940875|284014|P2|Treatment Phase|Lack of Efficacy|0
79749|NCT00940875|284015|P1|Treatment Phase|Lack of Efficacy|1
79750|NCT00940875|284014|P2|Treatment Phase|Death|5
79751|NCT00940875|284015|P1|Treatment Phase|Death|3
79752|NCT00940875|284014|P2|Treatment Phase|Adverse Event|3
79753|NCT00940875|284015|P1|Treatment Phase|Adverse Event|9
79754|NCT00940485|284055|P2|Overall Study|Others|1
79755|NCT00940485|284056|P1|Overall Study|Others|1
79756|NCT00940485|284055|P2|Overall Study|Withdrawal by Subject|1
79757|NCT00940485|284056|P1|Overall Study|Withdrawal by Subject|1
79758|NCT00940485|284055|P2|Overall Study|Adverse Event|0
79759|NCT00940485|284056|P1|Overall Study|Adverse Event|8
79760|NCT00940485|284055|P2|Overall Study|Lost to Follow-up|3
79761|NCT00940485|284056|P1|Overall Study|Lost to Follow-up|2
79762|NCT00940485|284055|P2|Overall Study|HBeAb positive at Baseline|2
79763|NCT00940485|284056|P1|Overall Study|HBeAb positive at Baseline|3
79764|NCT00940108|284101|P4|Overall Study|Diagnosed with H1N1|1
79765|NCT00940108|284102|P3|Overall Study|Diagnosed with H1N1|0
79766|NCT00940108|284103|P2|Overall Study|Diagnosed with H1N1|0
79767|NCT00940108|284104|P1|Overall Study|Diagnosed with H1N1|0
79768|NCT00940108|284101|P4|Overall Study|Viral illness after Dose 1|0
79769|NCT00940108|284102|P3|Overall Study|Viral illness after Dose 1|0
79770|NCT00940108|284103|P2|Overall Study|Viral illness after Dose 1|1
79771|NCT00940108|284104|P1|Overall Study|Viral illness after Dose 1|0
79772|NCT00940108|284101|P4|Overall Study|Refused - pyrexia after Dose 1|0
79773|NCT00940108|284102|P3|Overall Study|Refused - pyrexia after Dose 1|0
79774|NCT00940108|284103|P2|Overall Study|Refused - pyrexia after Dose 1|1
79775|NCT00940108|284104|P1|Overall Study|Refused - pyrexia after Dose 1|0
79776|NCT00940108|284101|P4|Overall Study|Declined further vaccination|0
79777|NCT00940108|284102|P3|Overall Study|Declined further vaccination|3
79778|NCT00940108|284103|P2|Overall Study|Declined further vaccination|1
79779|NCT00940108|284104|P1|Overall Study|Declined further vaccination|0
79780|NCT00940108|284101|P4|Overall Study|Dose 2 contraindicated|1
79781|NCT00940108|284102|P3|Overall Study|Dose 2 contraindicated|0
79782|NCT00940108|284103|P2|Overall Study|Dose 2 contraindicated|1
79783|NCT00940108|284104|P1|Overall Study|Dose 2 contraindicated|1
79784|NCT00940108|284101|P4|Overall Study|Withdrew Consent|1
79785|NCT00940108|284102|P3|Overall Study|Withdrew Consent|0
79786|NCT00940108|284103|P2|Overall Study|Withdrew Consent|1
79787|NCT00940108|284104|P1|Overall Study|Withdrew Consent|2
79788|NCT00940108|284101|P4|Overall Study|Adverse Event|2
79789|NCT00940108|284102|P3|Overall Study|Adverse Event|0
79790|NCT00940108|284103|P2|Overall Study|Adverse Event|4
79791|NCT00940108|284104|P1|Overall Study|Adverse Event|2
79792|NCT00940017|284154|P1|Overall Study|Adverse Event|1
79793|NCT00940017|284154|P1|Overall Study|did not meet entrance criteria|3
79794|NCT00939809|284210|P1|Overall Study|Death|1
79795|NCT00939809|284210|P1|Overall Study|Adverse Event|2
79796|NCT00939783|284224|P1|Overall Study|Enrolled but not treated|1
79797|NCT00939783|284224|P1|Overall Study|Protocol Violation|3
79798|NCT00939783|284224|P1|Overall Study|Lost to Follow-up|8
79799|NCT00939783|284224|P1|Overall Study|Unspecified|16
79800|NCT00939783|284224|P1|Overall Study|Withdrawal by Subject|78
79801|NCT00939783|284224|P1|Overall Study|Study Terminated by Sponsor|498
79802|NCT00939783|284224|P1|Overall Study|Adverse Event|39
79803|NCT00939783|284224|P1|Overall Study|Death|6
79804|NCT00939692|284265|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
79805|NCT00939692|284266|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
79806|NCT00939692|284265|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
79807|NCT00939692|284266|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
79808|NCT00939627|284278|P3|Overall Study|No off-tx reason given|0
79809|NCT00939627|284279|P2|Overall Study|No off-tx reason given|2
79810|NCT00939627|284280|P1|Overall Study|No off-tx reason given|0
79811|NCT00939627|284278|P3|Overall Study|Not compliant|0
79812|NCT00939627|284279|P2|Overall Study|Not compliant|0
79813|NCT00939627|284280|P1|Overall Study|Not compliant|2
79814|NCT00939627|284278|P3|Overall Study|Other complicating disease|0
79815|NCT00939627|284279|P2|Overall Study|Other complicating disease|1
79816|NCT00939627|284280|P1|Overall Study|Other complicating disease|1
79817|NCT00939627|284278|P3|Overall Study|Withdrawal by Subject|0
79818|NCT00939627|284279|P2|Overall Study|Withdrawal by Subject|4
79819|NCT00939627|284280|P1|Overall Study|Withdrawal by Subject|2
79820|NCT00939627|284278|P3|Overall Study|Death|0
79821|NCT00939627|284279|P2|Overall Study|Death|2
79822|NCT00939627|284280|P1|Overall Study|Death|0
79823|NCT00939627|284278|P3|Overall Study|Adverse Event|0
79824|NCT00939627|284279|P2|Overall Study|Adverse Event|7
79825|NCT00939627|284280|P1|Overall Study|Adverse Event|6
79826|NCT00939627|284278|P3|Overall Study|Disease Progression|0
79827|NCT00939627|284279|P2|Overall Study|Disease Progression|12
79828|NCT00939627|284280|P1|Overall Study|Disease Progression|16
79829|NCT00939510|284316|P1|Overall Study|Withdrawal by Subject|1
79830|NCT00939484|284325|P3|Overall Study|Progression/Relapse|3
79831|NCT00939484|284326|P2|Overall Study|Progression/Relapse|20
79832|NCT00939484|284327|P1|Overall Study|Progression/Relapse|8
79833|NCT00939393|284353|P2|Overall Study|Lost to Follow-up|0
79834|NCT00939393|284354|P1|Overall Study|Lost to Follow-up|3
79835|NCT00939393|284353|P2|Overall Study|Withdrawal by Subject|0
79836|NCT00939393|284354|P1|Overall Study|Withdrawal by Subject|1
79837|NCT00939341|284385|P1|Overall Study|Incorrect enrolment|8
79838|NCT00939341|284385|P1|Overall Study|Protocol Violation|6
79839|NCT00939341|284385|P1|Overall Study|Withdrawal by Subject|13
79840|NCT00939341|284385|P1|Overall Study|Lost to Follow-up|23
79841|NCT00939341|284385|P1|Overall Study|Pregnancy|1
79842|NCT00939341|284385|P1|Overall Study|Adverse Event|15
79843|NCT00939185|284467|P1|Overall Study|Randomized But Did Not Receive Treatment|10
79844|NCT00939185|284467|P1|Overall Study|Withdrawal by Subject|2
79845|NCT00939185|284467|P1|Overall Study|Unspecified|3
79846|NCT00939185|284467|P1|Overall Study|Lost to Follow-up|6
79847|NCT00939185|284467|P1|Overall Study|Lack of Efficacy|1
79848|NCT00939185|284467|P1|Overall Study|Adverse Event|3
79849|NCT00939107|284505|P2|Overall Study|Lost to Follow-up|12
79850|NCT00939107|284506|P1|Overall Study|Lost to Follow-up|14
79851|NCT00939094|284520|P2|Overall Study|Abnormal ECG findings|0
79852|NCT00939094|284521|P1|Overall Study|Abnormal ECG findings|1
79853|NCT00939094|284520|P2|Overall Study|Study stopped by sponsor|2
79854|NCT00939094|284521|P1|Overall Study|Study stopped by sponsor|0
79855|NCT00939094|284520|P2|Overall Study|Severe non-compliance to protocol|1
79856|NCT00939094|284521|P1|Overall Study|Severe non-compliance to protocol|0
79857|NCT00939094|284520|P2|Overall Study|Eligibility criteria not fulfilled|0
79858|NCT00939094|284521|P1|Overall Study|Eligibility criteria not fulfilled|2
79859|NCT00939094|284520|P2|Overall Study|Lost to Follow-up|1
79860|NCT00939094|284521|P1|Overall Study|Lost to Follow-up|1
79861|NCT00939094|284520|P2|Overall Study|Withdrawal by Subject|6
79862|NCT00939094|284521|P1|Overall Study|Withdrawal by Subject|1
79863|NCT00939094|284520|P2|Overall Study|Adverse Event|0
79864|NCT00939094|284521|P1|Overall Study|Adverse Event|9
79865|NCT00939055|284543|P2|Overall Study|Discontinuation prior to procedure|0
79866|NCT00939055|284544|P1|Overall Study|Discontinuation prior to procedure|4
79867|NCT00939029|284554|P2|Overall Study|Adverse Event|1
79868|NCT00939029|284555|P1|Overall Study|Adverse Event|0
79869|NCT00939029|284554|P2|Overall Study|Lost to Follow-up|4
79870|NCT00939029|284555|P1|Overall Study|Lost to Follow-up|3
79871|NCT00939029|284554|P2|Overall Study|Withdrawal by Subject|7
79872|NCT00939029|284555|P1|Overall Study|Withdrawal by Subject|3
79873|NCT00939003|284567|P2|Open-label Treatment Period|Site Closure|4
79874|NCT00939003|284568|P1|Open-label Treatment Period|Site Closure|3
79875|NCT00939003|284567|P2|Open-label Treatment Period|Exclusion Criteria|0
79876|NCT00939003|284568|P1|Open-label Treatment Period|Exclusion Criteria|1
79877|NCT00939003|284567|P2|Open-label Treatment Period|Pregnancy|1
79878|NCT00939003|284568|P1|Open-label Treatment Period|Pregnancy|1
79879|NCT00939003|284567|P2|Open-label Treatment Period|Lack of Efficacy|9
79880|NCT00939003|284568|P1|Open-label Treatment Period|Lack of Efficacy|6
79881|NCT00939003|284567|P2|Open-label Treatment Period|Withdrawal by Subject|7
79882|NCT00939003|284568|P1|Open-label Treatment Period|Withdrawal by Subject|14
79883|NCT00939003|284567|P2|Open-label Treatment Period|Adverse Event|8
79884|NCT00939003|284568|P1|Open-label Treatment Period|Adverse Event|4
79885|NCT00939003|284567|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
79886|NCT00939003|284568|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
79887|NCT00939003|284567|P2|Double-blind Treatment Period|Pregnancy|1
79888|NCT00939003|284568|P1|Double-blind Treatment Period|Pregnancy|0
79889|NCT00939003|284567|P2|Double-blind Treatment Period|Lack of Efficacy|1
79890|NCT00939003|284568|P1|Double-blind Treatment Period|Lack of Efficacy|0
79891|NCT00939003|284567|P2|Double-blind Treatment Period|Adverse Event|1
79892|NCT00939003|284568|P1|Double-blind Treatment Period|Adverse Event|1
79893|NCT00938860|284605|P2|Overall Study|Protocol Violation|1
79894|NCT00938860|284606|P1|Overall Study|Protocol Violation|3
79895|NCT00938860|284605|P2|Overall Study|Death|1
79896|NCT00938860|284606|P1|Overall Study|Death|1
79897|NCT00938860|284605|P2|Overall Study|Administration problems|0
79898|NCT00938860|284606|P1|Overall Study|Administration problems|2
79899|NCT00938860|284605|P2|Overall Study|Lost to Follow-up|4
79900|NCT00938860|284606|P1|Overall Study|Lost to Follow-up|4
79901|NCT00938860|284605|P2|Overall Study|Withdrawal by Subject|8
79902|NCT00938860|284606|P1|Overall Study|Withdrawal by Subject|11
79903|NCT00938860|284605|P2|Overall Study|Abnormal laboratory values|2
79904|NCT00938860|284606|P1|Overall Study|Abnormal laboratory values|2
79905|NCT00938860|284605|P2|Overall Study|Adverse Event|1
79906|NCT00938860|284606|P1|Overall Study|Adverse Event|2
79907|NCT00938717|284639|P2|Overall Study|Other reason|2
79908|NCT00938717|284640|P1|Overall Study|Other reason|5
79909|NCT00938717|284639|P2|Overall Study|Lack of Efficacy|15
79910|NCT00938717|284640|P1|Overall Study|Lack of Efficacy|33
79911|NCT00938717|284639|P2|Overall Study|Lost to Follow-up|18
79912|NCT00938717|284640|P1|Overall Study|Lost to Follow-up|13
79913|NCT00938717|284639|P2|Overall Study|Withdrawal by Subject|24
79914|NCT00938717|284640|P1|Overall Study|Withdrawal by Subject|26
79915|NCT00938717|284639|P2|Overall Study|Protocol Violation|8
79916|NCT00938717|284640|P1|Overall Study|Protocol Violation|11
79917|NCT00938717|284639|P2|Overall Study|Adverse Event|41
79918|NCT00938717|284640|P1|Overall Study|Adverse Event|10
79919|NCT00938639|284691|P2|Overall Study|Participant noncompliance|0
79920|NCT00938639|284692|P1|Overall Study|Participant noncompliance|1
79921|NCT00938639|284691|P2|Overall Study|Family issues|1
79922|NCT00938639|284692|P1|Overall Study|Family issues|1
79923|NCT00938639|284691|P2|Overall Study|Lost to Follow-up|2
79924|NCT00938639|284692|P1|Overall Study|Lost to Follow-up|1
79925|NCT00938639|284691|P2|Overall Study|Moved away from study area|1
79926|NCT00938639|284692|P1|Overall Study|Moved away from study area|0
79927|NCT00938431|284789|P3|Overall Study|Reached maximum dose early|1
79928|NCT00938431|284790|P2|Overall Study|Reached maximum dose early|0
79929|NCT00938431|284791|P1|Overall Study|Reached maximum dose early|0
79930|NCT00938431|284789|P3|Overall Study|Dosing compliance issue|1
79931|NCT00938431|284790|P2|Overall Study|Dosing compliance issue|0
79932|NCT00938431|284791|P1|Overall Study|Dosing compliance issue|0
79933|NCT00938431|284789|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
79934|NCT00938431|284790|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
79935|NCT00938431|284791|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
79936|NCT00938431|284789|P3|Overall Study|Lack of Efficacy|0
79937|NCT00938431|284790|P2|Overall Study|Lack of Efficacy|1
79938|NCT00938431|284791|P1|Overall Study|Lack of Efficacy|0
79939|NCT00938431|284789|P3|Overall Study|Adverse Event|6
79940|NCT00938431|284790|P2|Overall Study|Adverse Event|8
79941|NCT00938431|284791|P1|Overall Study|Adverse Event|5
79942|NCT00938392|284818|P2|Overall Study|Lost to Follow-up|2
79943|NCT00938392|284819|P1|Overall Study|Lost to Follow-up|2
79944|NCT00938392|284818|P2|Overall Study|Withdrawal by Subject|1
79945|NCT00938392|284819|P1|Overall Study|Withdrawal by Subject|0
79946|NCT00938392|284818|P2|Overall Study|Adverse Event|1
79947|NCT00938392|284819|P1|Overall Study|Adverse Event|0
79948|NCT00938366|284845|P2|Overall Study|Withdrawal by Subject|0
79949|NCT00938366|284846|P1|Overall Study|Withdrawal by Subject|1
79950|NCT00938327|284866|P1|Overall Study|Vaccine not received as out of stock|9
79951|NCT00938327|284866|P1|Overall Study|2nd dose received outside of the study|7
79952|NCT00938327|284866|P1|Overall Study|Lost to Follow-up|37
79953|NCT00938327|284866|P1|Overall Study|Withdrawal by Subject|4
79954|NCT00938327|284866|P1|Overall Study|Protocol Violation|1
79955|NCT00938327|284866|P1|Overall Study|Adverse Event|2
79956|NCT00938041|284934|P1|Overall Study|Adrenal Insufficiency|3
79957|NCT00938041|284934|P1|Overall Study|Death|12
79958|NCT00938041|284934|P1|Overall Study|Progressive Disease|5
79959|NCT00938041|284934|P1|Overall Study|Received Alternative Therapy|1
79960|NCT00938041|284934|P1|Overall Study|Lost to Follow-up|6
79961|NCT00938015|284943|P1|Overall Study|Reason not related to Etanercept|29
79962|NCT00938015|284943|P1|Overall Study|Non-responder|52
79963|NCT00938015|284943|P1|Overall Study|Adverse Event|32
79964|NCT00938015|284943|P1|Overall Study|Lost to Follow-up|32
79965|NCT00938015|284943|P1|Overall Study|Death|2
79966|NCT00937950|284959|P1|Overall Study|Others|18
79967|NCT00937950|284959|P1|Overall Study|Missing confirmed|4
79968|NCT00937950|284959|P1|Overall Study|Lost to Follow-up|144
79969|NCT00937950|284959|P1|Overall Study|Migrated/moved from study area|27
79970|NCT00937950|284959|P1|Overall Study|Withdrawal by Subject|23
79971|NCT00937937|284975|P1|Overall Study|Not specified|2
79972|NCT00937937|284975|P1|Overall Study|Death|1
79973|NCT00937937|284975|P1|Overall Study|Progression/relapse|61
79974|NCT00937937|284975|P1|Overall Study|Withdrawal by Subject|2
79975|NCT00937937|284975|P1|Overall Study|Adverse Event|6
79976|NCT00937833|284984|P2|Overall Study|Withdrawal by Subject|6
79977|NCT00937833|284985|P1|Overall Study|Withdrawal by Subject|4
79978|NCT00937833|284984|P2|Overall Study|Lost to Follow-up|8
79979|NCT00937833|284985|P1|Overall Study|Lost to Follow-up|10
79980|NCT00937833|284984|P2|Overall Study|Procedure delayed; enrollment closed|1
79981|NCT00937833|284985|P1|Overall Study|Procedure delayed; enrollment closed|0
79982|NCT00937833|284984|P2|Overall Study|Protocol Violation|2
79983|NCT00937833|284985|P1|Overall Study|Protocol Violation|1
79984|NCT00937768|284998|P2|Overall Study|No Further Funding|4
79985|NCT00937768|284999|P1|Overall Study|No Further Funding|4
79986|NCT00937768|284998|P2|Overall Study|Alternate Treatment|1
79987|NCT00937768|284999|P1|Overall Study|Alternate Treatment|0
79988|NCT00937768|284998|P2|Overall Study|Disease Progression|1
79989|NCT00937768|284999|P1|Overall Study|Disease Progression|1
79990|NCT00937768|284998|P2|Overall Study|Refused Further Treatment|2
79991|NCT00937768|284999|P1|Overall Study|Refused Further Treatment|3
79992|NCT00937560|285005|P1|Maintenance Treatment|According to protocol|1
79993|NCT00937560|285005|P1|Maintenance Treatment|Withdraw consent|5
79994|NCT00937560|285005|P1|Maintenance Treatment|Death|12
79995|NCT00937560|285005|P1|Initial Treatment|No end of study page|10
79996|NCT00937560|285005|P1|Initial Treatment|Lost to Follow-up|1
79997|NCT00937560|285005|P1|Initial Treatment|Adverse Event|1
79998|NCT00937560|285005|P1|Initial Treatment|Withdraw consent|3
79999|NCT00937560|285005|P1|Initial Treatment|Death|6
80000|NCT00937547|285016|P3|Overall Study|misdiagnosis|7
80001|NCT00937547|285017|P2|Overall Study|misdiagnosis|6
80002|NCT00937547|285018|P1|Overall Study|misdiagnosis|1
80003|NCT00937521|285055|P8|Booster Phase|Protocol Deviation|0
80004|NCT00937521|285056|P7|Booster Phase|Protocol Deviation|1
80005|NCT00937521|285057|P6|Booster Phase|Protocol Deviation|0
80006|NCT00937521|285058|P5|Booster Phase|Protocol Deviation|0
80007|NCT00937521|285059|P4|Booster Phase|Protocol Deviation|0
80008|NCT00937521|285060|P3|Booster Phase|Protocol Deviation|0
80009|NCT00937521|285061|P2|Booster Phase|Protocol Deviation|0
80010|NCT00937521|285062|P1|Booster Phase|Protocol Deviation|0
80011|NCT00937521|285055|P8|Booster Phase|Administrative Reason|0
80012|NCT00937521|285056|P7|Booster Phase|Administrative Reason|0
80013|NCT00937521|285057|P6|Booster Phase|Administrative Reason|1
80014|NCT00937521|285058|P5|Booster Phase|Administrative Reason|1
80015|NCT00937521|285059|P4|Booster Phase|Administrative Reason|0
80016|NCT00937521|285060|P3|Booster Phase|Administrative Reason|1
80017|NCT00937521|285061|P2|Booster Phase|Administrative Reason|0
80018|NCT00937521|285062|P1|Booster Phase|Administrative Reason|0
80019|NCT00937521|285055|P8|Booster Phase|Lost to Follow-up|0
80020|NCT00937521|285056|P7|Booster Phase|Lost to Follow-up|3
80021|NCT00937521|285057|P6|Booster Phase|Lost to Follow-up|4
80022|NCT00937521|285058|P5|Booster Phase|Lost to Follow-up|4
80023|NCT00937521|285059|P4|Booster Phase|Lost to Follow-up|2
80024|NCT00937521|285060|P3|Booster Phase|Lost to Follow-up|4
80025|NCT00937521|285061|P2|Booster Phase|Lost to Follow-up|2
80026|NCT00937521|285062|P1|Booster Phase|Lost to Follow-up|2
80027|NCT00937521|285055|P8|Booster Phase|Withdrawal by Subject|2
80028|NCT00937521|285056|P7|Booster Phase|Withdrawal by Subject|0
80029|NCT00937521|285057|P6|Booster Phase|Withdrawal by Subject|0
80030|NCT00937521|285058|P5|Booster Phase|Withdrawal by Subject|0
80031|NCT00937521|285059|P4|Booster Phase|Withdrawal by Subject|1
80032|NCT00937521|285060|P3|Booster Phase|Withdrawal by Subject|0
80033|NCT00937521|285061|P2|Booster Phase|Withdrawal by Subject|0
80034|NCT00937521|285062|P1|Booster Phase|Withdrawal by Subject|1
80035|NCT00937521|285055|P8|Booster Phase|Adverse Event|0
80036|NCT00937521|285056|P7|Booster Phase|Adverse Event|1
80037|NCT00937521|285057|P6|Booster Phase|Adverse Event|0
80038|NCT00937521|285058|P5|Booster Phase|Adverse Event|0
80039|NCT00937521|285059|P4|Booster Phase|Adverse Event|0
80040|NCT00937521|285060|P3|Booster Phase|Adverse Event|0
80041|NCT00937521|285061|P2|Booster Phase|Adverse Event|0
80042|NCT00937521|285062|P1|Booster Phase|Adverse Event|0
80043|NCT00937521|285055|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
80044|NCT00937521|285056|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
80045|NCT00937521|285057|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
80046|NCT00937521|285058|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
80047|NCT00937521|285059|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
80048|NCT00937521|285060|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
80049|NCT00937521|285061|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
80050|NCT00937521|285062|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
80051|NCT00937521|285055|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
80052|NCT00937521|285056|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
80053|NCT00937521|285057|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
80054|NCT00937521|285058|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
80055|NCT00937521|285059|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
80056|NCT00937521|285060|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
80057|NCT00937521|285061|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
80058|NCT00937521|285062|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
80059|NCT00937521|285055|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
80060|NCT00937521|285056|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
80061|NCT00937521|285057|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
80062|NCT00937521|285058|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
80063|NCT00937521|285059|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
80064|NCT00937521|285060|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
80065|NCT00937521|285061|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
80066|NCT00937521|285062|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
80067|NCT00937521|285055|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
80068|NCT00937521|285056|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
80069|NCT00937521|285057|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
80070|NCT00937521|285058|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
80071|NCT00937521|285059|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
80072|NCT00937521|285060|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
80073|NCT00937521|285061|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
80074|NCT00937521|285062|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
80075|NCT00937521|285055|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
80076|NCT00937521|285056|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
80077|NCT00937521|285057|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
80078|NCT00937521|285058|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
80079|NCT00937521|285059|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
80080|NCT00937521|285060|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
80081|NCT00937521|285061|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
80082|NCT00937521|285062|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
80083|NCT00937495|285168|P1|Overall Study|Protocol Violation|2
80084|NCT00937391|285176|P1|Stage 2|Withdrawal by Subject|1
80085|NCT00937157|285227|P1|Overall Study|Lost to Follow-up|3
80086|NCT00937157|285227|P1|Overall Study|Pregnancy|1
80087|NCT00937040|285258|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
80088|NCT00937040|285259|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
80089|NCT00937040|285258|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
80090|NCT00937040|285259|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
80091|NCT00937040|285258|P2|Overall Study|Withdrawal by Subject|7
80092|NCT00937040|285259|P1|Overall Study|Withdrawal by Subject|13
80093|NCT00937040|285258|P2|Overall Study|Protocol Violation|0
80094|NCT00937040|285259|P1|Overall Study|Protocol Violation|3
80095|NCT00937040|285258|P2|Overall Study|Lost to Follow-up|12
80096|NCT00937040|285259|P1|Overall Study|Lost to Follow-up|12
80097|NCT00937040|285258|P2|Overall Study|Adverse Event|8
80098|NCT00937040|285259|P1|Overall Study|Adverse Event|5
80099|NCT00936975|285301|P1|Overall Study|Post-Tx scan uninterpretable|2
80100|NCT00936975|285301|P1|Overall Study|Disease progression|3
80101|NCT00936975|285301|P1|Overall Study|Withdrawal by Subject|1
80102|NCT00936897|285312|P2|Overall Study|Death|1
80103|NCT00936897|285313|P1|Overall Study|Death|0
80104|NCT00936897|285312|P2|Overall Study|Noncompliance|2
80105|NCT00936897|285313|P1|Overall Study|Noncompliance|0
80106|NCT00936897|285312|P2|Overall Study|Ineligibility Determined|3
80107|NCT00936897|285313|P1|Overall Study|Ineligibility Determined|0
80108|NCT00936897|285312|P2|Overall Study|Protocol Violation|1
80109|NCT00936897|285313|P1|Overall Study|Protocol Violation|1
80110|NCT00936897|285312|P2|Overall Study|Administrative Decision|2
80111|NCT00936897|285313|P1|Overall Study|Administrative Decision|1
80112|NCT00936897|285312|P2|Overall Study|Lost to Follow-up|10
80113|NCT00936897|285313|P1|Overall Study|Lost to Follow-up|1
80114|NCT00936897|285312|P2|Overall Study|Other|9
80115|NCT00936897|285313|P1|Overall Study|Other|3
80116|NCT00936897|285312|P2|Overall Study|Adverse Event|13
80117|NCT00936897|285313|P1|Overall Study|Adverse Event|4
80118|NCT00936897|285312|P2|Overall Study|Withdrawal by Subject|19
80119|NCT00936897|285313|P1|Overall Study|Withdrawal by Subject|9
80120|NCT00936702|285330|P1|Overall Study|Unspecified|1
80121|NCT00936702|285330|P1|Overall Study|Alternative Treatment|1
80122|NCT00936702|285330|P1|Overall Study|Withdrawal by Subject|2
80123|NCT00936702|285330|P1|Overall Study|Adverse Event|8
80124|NCT00936702|285330|P1|Overall Study|Disease progression|34
80125|NCT00936598|285340|P2|Overall Study|Ineligible after consent|0
80126|NCT00936598|285341|P1|Overall Study|Ineligible after consent|1
80127|NCT00936598|285340|P2|Overall Study|Withdrawal by Subject|0
80128|NCT00936598|285341|P1|Overall Study|Withdrawal by Subject|1
80129|NCT00936221|285430|P2|Overall Study|Withdrawal by Subject|1
80130|NCT00936221|285431|P1|Overall Study|Withdrawal by Subject|1
80131|NCT00936208|285445|P2|Overall Study|Protocol Violation|22
80132|NCT00936208|285446|P1|Overall Study|Protocol Violation|37
80133|NCT00936117|285464|P1|Overall Study|Unable to continue oral medication|3
80134|NCT00936117|285464|P1|Overall Study|Adverse Event|7
80135|NCT00936065|285472|P3|Overall Study|Withdrawal by Subject|4
80136|NCT00936065|285473|P2|Overall Study|Withdrawal by Subject|2
80137|NCT00936065|285474|P1|Overall Study|Withdrawal by Subject|0
80138|NCT00936065|285472|P3|Overall Study|Protocol Violation|1
80139|NCT00936065|285473|P2|Overall Study|Protocol Violation|2
80140|NCT00936065|285474|P1|Overall Study|Protocol Violation|1
80141|NCT00936065|285472|P3|Overall Study|Lost to Follow-up|0
80142|NCT00936065|285473|P2|Overall Study|Lost to Follow-up|0
80143|NCT00936065|285474|P1|Overall Study|Lost to Follow-up|1
80144|NCT00936065|285472|P3|Overall Study|Lack of Efficacy|1
80145|NCT00936065|285473|P2|Overall Study|Lack of Efficacy|0
80146|NCT00936065|285474|P1|Overall Study|Lack of Efficacy|1
80147|NCT00936065|285472|P3|Overall Study|Adverse Event|1
80148|NCT00936065|285473|P2|Overall Study|Adverse Event|0
80149|NCT00936065|285474|P1|Overall Study|Adverse Event|1
80150|NCT00935883|285580|P2|Treatment Period|Withdrawal by Subject|2
80151|NCT00935883|285581|P1|Treatment Period|Withdrawal by Subject|0
80152|NCT00935883|285580|P2|Treatment Period|Physician Decision|0
80153|NCT00935883|285581|P1|Treatment Period|Physician Decision|1
80154|NCT00935818|285608|P2|Overall Study|Physician Decision|1
80155|NCT00935818|285609|P1|Overall Study|Physician Decision|0
80156|NCT00935818|285608|P2|Overall Study|Adverse Event|7
80157|NCT00935818|285609|P1|Overall Study|Adverse Event|6
80158|NCT00935818|285608|P2|Overall Study|Lost to Follow-up|42
80159|NCT00935818|285609|P1|Overall Study|Lost to Follow-up|40
80160|NCT00935818|285608|P2|Overall Study|Withdrawal by Subject|50
80161|NCT00935818|285609|P1|Overall Study|Withdrawal by Subject|45
80162|NCT00935701|285660|P1|Overall Study|Failure to Transition to Acupuncture|1
80163|NCT00935584|285677|P2|Overall Study|Provider dropped out of study|4
80164|NCT00935584|285678|P1|Overall Study|Provider dropped out of study|14
80165|NCT00935584|285677|P2|Overall Study|Patient changed provider|0
80166|NCT00935584|285678|P1|Overall Study|Patient changed provider|3
80167|NCT00935584|285677|P2|Overall Study|Relocated|0
80168|NCT00935584|285678|P1|Overall Study|Relocated|3
80169|NCT00935584|285677|P2|Overall Study|No show|0
80170|NCT00935584|285678|P1|Overall Study|No show|9
80171|NCT00935584|285677|P2|Overall Study|Lost to Follow-up|0
80172|NCT00935584|285678|P1|Overall Study|Lost to Follow-up|8
80173|NCT00935584|285677|P2|Overall Study|Death|0
80174|NCT00935584|285678|P1|Overall Study|Death|3
80175|NCT00935584|285677|P2|Overall Study|Withdrawal by Subject|0
80176|NCT00935584|285678|P1|Overall Study|Withdrawal by Subject|9
80177|NCT00935532|285690|P2|Overall Study|Loss Glucose Control|0
80178|NCT00935532|285691|P1|Overall Study|Loss Glucose Control|4
80179|NCT00935532|285690|P2|Overall Study|Sponsor Decision|1
80180|NCT00935532|285691|P1|Overall Study|Sponsor Decision|0
80181|NCT00935532|285690|P2|Overall Study|Subject Decision|1
80182|NCT00935532|285691|P1|Overall Study|Subject Decision|2
80183|NCT00935532|285690|P2|Overall Study|Protocol Violation|1
80184|NCT00935532|285691|P1|Overall Study|Protocol Violation|2
80185|NCT00935532|285690|P2|Overall Study|Physician Decision|2
80186|NCT00935532|285691|P1|Overall Study|Physician Decision|1
80187|NCT00935532|285690|P2|Overall Study|Lost to Follow-up|0
80188|NCT00935532|285691|P1|Overall Study|Lost to Follow-up|1
80189|NCT00935532|285690|P2|Overall Study|Death|0
80190|NCT00935532|285691|P1|Overall Study|Death|1
80191|NCT00935532|285690|P2|Overall Study|Adverse Event|6
80192|NCT00935532|285691|P1|Overall Study|Adverse Event|11
80193|NCT00935493|285720|P3|Overall Study|Treatment Discontinued|0
80194|NCT00935493|285721|P2|Overall Study|Treatment Discontinued|1
80195|NCT00935493|285722|P1|Overall Study|Treatment Discontinued|0
80196|NCT00935493|285720|P3|Overall Study|Lost to Follow-up|1
80197|NCT00935493|285721|P2|Overall Study|Lost to Follow-up|1
80198|NCT00935493|285722|P1|Overall Study|Lost to Follow-up|1
80199|NCT00935272|285760|P2|Overall Study|Protocol Violation|1
80200|NCT00935272|285761|P1|Overall Study|Protocol Violation|0
80201|NCT00935272|285760|P2|Overall Study|Physician Decision|0
80202|NCT00935272|285761|P1|Overall Study|Physician Decision|1
80203|NCT00935272|285760|P2|Overall Study|Withdrawal by Subject|2
80204|NCT00935272|285761|P1|Overall Study|Withdrawal by Subject|8
80205|NCT00935272|285760|P2|Overall Study|Lost to Follow-up|3
80206|NCT00935272|285761|P1|Overall Study|Lost to Follow-up|10
80207|NCT00935259|285770|P2|Period 1|Administrative (scheduling conflict)|1
80208|NCT00935259|285771|P1|Period 1|Administrative (scheduling conflict)|1
80209|NCT00935220|285785|P1|Overall Study|Other reason (not specified)|1
80210|NCT00935220|285785|P1|Overall Study|Adverse Event|1
80211|NCT00934947|285816|P2|Overall Study|Adverse Event|2
80212|NCT00934947|285817|P1|Overall Study|Adverse Event|0
80213|NCT00934843|285836|P2|Overall Study|Protocol Violation|1
80214|NCT00934843|285837|P1|Overall Study|Protocol Violation|0
80215|NCT00934791|285853|P2|Overall Study|Withdrawal by Subject|0
80216|NCT00934791|285854|P1|Overall Study|Withdrawal by Subject|1
80217|NCT00934648|285860|P1|Overall Study|Withdrawal by Subject|1
80218|NCT00934648|285860|P1|Overall Study|Failure to return|8
80219|NCT00934622|285904|P1|Overall Study|2nd Intraoperative exclusion criteria|1
80220|NCT00934622|285904|P1|Overall Study|Lost to Follow-up|7
80221|NCT00934544|285942|P2|Overall Study|Entered Extension phase INC424|18
80222|NCT00934544|285943|P1|Overall Study|Entered Extension phase INC424|29
80223|NCT00934544|285942|P2|Overall Study|Other Reasons|7
80224|NCT00934544|285943|P1|Overall Study|Other Reasons|7
80225|NCT00934544|285942|P2|Overall Study|Non-compliance with study procedures|1
80226|NCT00934544|285943|P1|Overall Study|Non-compliance with study procedures|0
80227|NCT00934544|285942|P2|Overall Study|Non-compliance with study Medication|0
80228|NCT00934544|285943|P1|Overall Study|Non-compliance with study Medication|2
80229|NCT00934544|285942|P2|Overall Study|Disease Progression|3
80230|NCT00934544|285943|P1|Overall Study|Disease Progression|1
80231|NCT00934544|285942|P2|Overall Study|Protocol Violation|0
80232|NCT00934544|285943|P1|Overall Study|Protocol Violation|2
80233|NCT00934544|285942|P2|Overall Study|Withdrawal by Subject|9
80234|NCT00934544|285943|P1|Overall Study|Withdrawal by Subject|2
80235|NCT00934544|285942|P2|Overall Study|Adverse Event|4
80236|NCT00934544|285943|P1|Overall Study|Adverse Event|12
80237|NCT00934362|285968|P2|Overall Study|Adverse Event|0
80238|NCT00934362|285969|P1|Overall Study|Adverse Event|1
80239|NCT00934128|286019|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
80240|NCT00934128|286020|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
80241|NCT00934128|286019|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
80242|NCT00934128|286020|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
80243|NCT00934128|286019|P2|Washout Period (1 Hour)|Too tired|0
80244|NCT00934128|286020|P1|Washout Period (1 Hour)|Too tired|1
80245|NCT00934128|286019|P2|Washout Period (1 Hour)|Pain|0
80246|NCT00934128|286020|P1|Washout Period (1 Hour)|Pain|1
80247|NCT00934128|286019|P2|Washout Period (1 Hour)|Patient preference|3
80248|NCT00934128|286020|P1|Washout Period (1 Hour)|Patient preference|1
80249|NCT00934128|286019|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
80250|NCT00934128|286020|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
80251|NCT00934128|286019|P2|First Intervention (2 Hours)|Adverse Event|1
80252|NCT00934128|286020|P1|First Intervention (2 Hours)|Adverse Event|4
80253|NCT00934128|286019|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
80254|NCT00934128|286020|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
80255|NCT00934102|286028|P3|Period 1, One Night of Wear|Personal Reasons|0
80256|NCT00934102|286029|P2|Period 1, One Night of Wear|Personal Reasons|0
80257|NCT00934102|286030|P1|Period 1, One Night of Wear|Personal Reasons|1
80258|NCT00934050|286044|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
80259|NCT00934050|286045|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
80260|NCT00934050|286046|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
80261|NCT00934050|286047|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
80262|NCT00934050|286048|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
80263|NCT00934050|286049|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
80264|NCT00934050|286044|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
80265|NCT00934050|286045|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
80266|NCT00934050|286046|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
80267|NCT00934050|286047|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
80268|NCT00934050|286048|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
80269|NCT00934050|286049|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
80270|NCT00934050|286044|P6|Enrolled After 15 Dec 2009|Death|1
80271|NCT00934050|286045|P5|Enrolled After 15 Dec 2009|Death|0
80272|NCT00934050|286046|P4|Enrolled After 15 Dec 2009|Death|0
80273|NCT00934050|286047|P3|Enrolled After 15 Dec 2009|Death|0
80274|NCT00934050|286048|P2|Enrolled After 15 Dec 2009|Death|0
80275|NCT00934050|286049|P1|Enrolled After 15 Dec 2009|Death|0
80276|NCT00934050|286044|P6|Enrolled After 15 Dec 2009|Adverse Event|0
80277|NCT00934050|286045|P5|Enrolled After 15 Dec 2009|Adverse Event|3
80278|NCT00934050|286046|P4|Enrolled After 15 Dec 2009|Adverse Event|0
80279|NCT00934050|286047|P3|Enrolled After 15 Dec 2009|Adverse Event|0
80280|NCT00934050|286048|P2|Enrolled After 15 Dec 2009|Adverse Event|0
80281|NCT00934050|286049|P1|Enrolled After 15 Dec 2009|Adverse Event|0
80282|NCT00934050|286044|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
80283|NCT00934050|286045|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
80284|NCT00934050|286046|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
80285|NCT00934050|286047|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
80286|NCT00934050|286048|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
80287|NCT00934050|286049|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
80288|NCT00934050|286044|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
80289|NCT00934050|286045|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
80290|NCT00934050|286046|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
80291|NCT00934050|286047|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
80292|NCT00934050|286048|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
80293|NCT00934050|286049|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
80294|NCT00934050|286044|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
80295|NCT00934050|286045|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
80296|NCT00934050|286046|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
80297|NCT00934050|286047|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
80298|NCT00934050|286048|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
80299|NCT00934050|286049|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
80300|NCT00933933|286064|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
80301|NCT00933933|286065|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
80302|NCT00933933|286066|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
80391|NCT00932373|286566|P4|Overall Study|Lack of Efficacy|0
80303|NCT00933933|286064|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
80304|NCT00933933|286065|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
80305|NCT00933933|286066|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
80306|NCT00933686|286084|P2|Overall Study|Failure to show up at endpoint visits|2
80307|NCT00933686|286085|P1|Overall Study|Failure to show up at endpoint visits|0
80308|NCT00933686|286084|P2|Overall Study|Physician Decision|0
80309|NCT00933686|286085|P1|Overall Study|Physician Decision|1
80310|NCT00933686|286084|P2|Overall Study|Adverse Event|1
80311|NCT00933686|286085|P1|Overall Study|Adverse Event|1
80312|NCT00933686|286084|P2|Overall Study|Withdrawal by Subject|5
80313|NCT00933686|286085|P1|Overall Study|Withdrawal by Subject|6
80314|NCT00933686|286084|P2|Overall Study|Lost to Follow-up|2
80315|NCT00933686|286085|P1|Overall Study|Lost to Follow-up|2
80316|NCT00933686|286084|P2|Overall Study|Protocol Violation|1
80317|NCT00933686|286085|P1|Overall Study|Protocol Violation|0
80318|NCT00933608|286105|P2|Overall Study|Physician Decision|0
80319|NCT00933608|286106|P1|Overall Study|Physician Decision|1
80320|NCT00933608|286105|P2|Overall Study|Adverse Event|2
80321|NCT00933608|286106|P1|Overall Study|Adverse Event|4
80322|NCT00933543|286114|P2|Overall Study|Not known|1
80323|NCT00933543|286115|P1|Overall Study|Not known|1
80324|NCT00933543|286114|P2|Overall Study|Lack of Efficacy|3
80325|NCT00933543|286115|P1|Overall Study|Lack of Efficacy|0
80326|NCT00933543|286114|P2|Overall Study|Withdrawal by Subject|1
80327|NCT00933543|286115|P1|Overall Study|Withdrawal by Subject|0
80328|NCT00933543|286114|P2|Overall Study|Lost to Follow-up|1
80329|NCT00933543|286115|P1|Overall Study|Lost to Follow-up|0
80330|NCT00933543|286114|P2|Overall Study|Adverse Event|1
80331|NCT00933543|286115|P1|Overall Study|Adverse Event|2
80332|NCT00933335|286184|P2|Overall Study|Co-morbid Illness|0
80333|NCT00933335|286185|P1|Overall Study|Co-morbid Illness|1
80334|NCT00933335|286184|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
80335|NCT00933335|286185|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
80336|NCT00933335|286184|P2|Overall Study|Progressive Disease|11
80337|NCT00933335|286185|P1|Overall Study|Progressive Disease|0
80338|NCT00933335|286184|P2|Overall Study|Withdrawal by Subject|1
80339|NCT00933335|286185|P1|Overall Study|Withdrawal by Subject|0
80340|NCT00933335|286184|P2|Overall Study|Lost to Follow-up|3
80341|NCT00933335|286185|P1|Overall Study|Lost to Follow-up|1
80342|NCT00933270|286255|P1|Overall Study|Moved or would not return|10
80343|NCT00933270|286255|P1|Overall Study|Death|24
80344|NCT00933270|286255|P1|Overall Study|Missed Visit|2
80345|NCT00933270|286255|P1|Overall Study|Adverse Event|1
80346|NCT00933270|286255|P1|Overall Study|Lost to Follow-up|14
80347|NCT00933270|286255|P1|Overall Study|Insufficient Follow-up|10
80348|NCT00933270|286255|P1|Overall Study|Withdrawal by Subject|26
80349|NCT00933244|286349|P3|Overall Study|Withdrawal by Subject|3
80350|NCT00933244|286350|P2|Overall Study|Withdrawal by Subject|1
80351|NCT00933244|286351|P1|Overall Study|Withdrawal by Subject|5
80352|NCT00933166|286368|P1|Overall Study|Withdrawal by Subject|1
80353|NCT00933166|286368|P1|Overall Study|Unavailable|4
80354|NCT00933166|286368|P1|Overall Study|Lack of Efficacy|9
80355|NCT00933166|286368|P1|Overall Study|Lost to Follow-up|4
80356|NCT00932893|286374|P2|Overall Study|Unspecified|144
80357|NCT00932893|286375|P1|Overall Study|Unspecified|5
80358|NCT00932893|286374|P2|Overall Study|Withdrawal by Subject|2
80359|NCT00932893|286375|P1|Overall Study|Withdrawal by Subject|5
80360|NCT00932893|286374|P2|Overall Study|Lost to Follow-up|0
80361|NCT00932893|286375|P1|Overall Study|Lost to Follow-up|8
80362|NCT00932893|286374|P2|Overall Study|Death|24
80363|NCT00932893|286375|P1|Overall Study|Death|115
80364|NCT00932646|286411|P4|Overall Study|Withdrawal by Subject|0
80365|NCT00932646|286412|P3|Overall Study|Withdrawal by Subject|3
80366|NCT00932646|286413|P2|Overall Study|Withdrawal by Subject|1
80367|NCT00932646|286414|P1|Overall Study|Withdrawal by Subject|1
80368|NCT00932646|286411|P4|Overall Study|Lost to Follow-up|0
80369|NCT00932646|286412|P3|Overall Study|Lost to Follow-up|0
80370|NCT00932646|286413|P2|Overall Study|Lost to Follow-up|1
80371|NCT00932646|286414|P1|Overall Study|Lost to Follow-up|2
80372|NCT00932646|286411|P4|Overall Study|Adverse Event|1
80373|NCT00932646|286412|P3|Overall Study|Adverse Event|1
80374|NCT00932646|286413|P2|Overall Study|Adverse Event|1
80375|NCT00932646|286414|P1|Overall Study|Adverse Event|2
80376|NCT00932451|286501|P1|Overall Study|Other reasons|5
80377|NCT00932451|286501|P1|Overall Study|Death|726
80378|NCT00932451|286501|P1|Overall Study|Lost to Follow-up|22
80379|NCT00932451|286501|P1|Overall Study|Withdrawal by Subject|69
80380|NCT00932425|286525|P2|Overall Study|Withdrawal by Subject|1
80381|NCT00932425|286526|P1|Overall Study|Withdrawal by Subject|0
80382|NCT00932425|286525|P2|Overall Study|Lost to Follow-up|1
80383|NCT00932425|286526|P1|Overall Study|Lost to Follow-up|0
80384|NCT00932373|286559|P11|Overall Study|Lack of Efficacy|0
80385|NCT00932373|286560|P10|Overall Study|Lack of Efficacy|1
80386|NCT00932373|286561|P9|Overall Study|Lack of Efficacy|0
80387|NCT00932373|286562|P8|Overall Study|Lack of Efficacy|0
80388|NCT00932373|286563|P7|Overall Study|Lack of Efficacy|0
80389|NCT00932373|286564|P6|Overall Study|Lack of Efficacy|0
80390|NCT00932373|286565|P5|Overall Study|Lack of Efficacy|0
80392|NCT00932373|286567|P3|Overall Study|Lack of Efficacy|0
80393|NCT00932373|286568|P2|Overall Study|Lack of Efficacy|0
80394|NCT00932373|286569|P1|Overall Study|Lack of Efficacy|0
80395|NCT00932373|286559|P11|Overall Study|Clinical progression|0
80396|NCT00932373|286560|P10|Overall Study|Clinical progression|0
80397|NCT00932373|286561|P9|Overall Study|Clinical progression|0
80398|NCT00932373|286562|P8|Overall Study|Clinical progression|0
80399|NCT00932373|286563|P7|Overall Study|Clinical progression|1
80400|NCT00932373|286564|P6|Overall Study|Clinical progression|0
80401|NCT00932373|286565|P5|Overall Study|Clinical progression|0
80402|NCT00932373|286566|P4|Overall Study|Clinical progression|0
80403|NCT00932373|286567|P3|Overall Study|Clinical progression|0
80404|NCT00932373|286568|P2|Overall Study|Clinical progression|0
80405|NCT00932373|286569|P1|Overall Study|Clinical progression|0
80406|NCT00932373|286559|P11|Overall Study|Withdrawal by Subject|0
80407|NCT00932373|286560|P10|Overall Study|Withdrawal by Subject|0
80408|NCT00932373|286561|P9|Overall Study|Withdrawal by Subject|1
80409|NCT00932373|286562|P8|Overall Study|Withdrawal by Subject|0
80410|NCT00932373|286563|P7|Overall Study|Withdrawal by Subject|0
80411|NCT00932373|286564|P6|Overall Study|Withdrawal by Subject|0
80412|NCT00932373|286565|P5|Overall Study|Withdrawal by Subject|0
80413|NCT00932373|286566|P4|Overall Study|Withdrawal by Subject|0
80414|NCT00932373|286567|P3|Overall Study|Withdrawal by Subject|0
80415|NCT00932373|286568|P2|Overall Study|Withdrawal by Subject|0
80416|NCT00932373|286569|P1|Overall Study|Withdrawal by Subject|0
80417|NCT00932373|286559|P11|Overall Study|Dose limiting toxicity|0
80418|NCT00932373|286560|P10|Overall Study|Dose limiting toxicity|0
80419|NCT00932373|286561|P9|Overall Study|Dose limiting toxicity|0
80420|NCT00932373|286562|P8|Overall Study|Dose limiting toxicity|0
80421|NCT00932373|286563|P7|Overall Study|Dose limiting toxicity|0
80422|NCT00932373|286564|P6|Overall Study|Dose limiting toxicity|1
80423|NCT00932373|286565|P5|Overall Study|Dose limiting toxicity|0
80424|NCT00932373|286566|P4|Overall Study|Dose limiting toxicity|0
80425|NCT00932373|286567|P3|Overall Study|Dose limiting toxicity|0
80426|NCT00932373|286568|P2|Overall Study|Dose limiting toxicity|0
80427|NCT00932373|286569|P1|Overall Study|Dose limiting toxicity|0
80428|NCT00932373|286559|P11|Overall Study|Physician Decision|0
80429|NCT00932373|286560|P10|Overall Study|Physician Decision|1
80430|NCT00932373|286561|P9|Overall Study|Physician Decision|0
80431|NCT00932373|286562|P8|Overall Study|Physician Decision|0
80432|NCT00932373|286563|P7|Overall Study|Physician Decision|0
80433|NCT00932373|286564|P6|Overall Study|Physician Decision|0
80434|NCT00932373|286565|P5|Overall Study|Physician Decision|2
80435|NCT00932373|286566|P4|Overall Study|Physician Decision|0
80436|NCT00932373|286567|P3|Overall Study|Physician Decision|1
80437|NCT00932373|286568|P2|Overall Study|Physician Decision|0
80438|NCT00932373|286569|P1|Overall Study|Physician Decision|0
80439|NCT00932373|286559|P11|Overall Study|Adverse Event|1
80440|NCT00932373|286560|P10|Overall Study|Adverse Event|2
80441|NCT00932373|286561|P9|Overall Study|Adverse Event|0
80442|NCT00932373|286562|P8|Overall Study|Adverse Event|1
80443|NCT00932373|286563|P7|Overall Study|Adverse Event|0
80444|NCT00932373|286564|P6|Overall Study|Adverse Event|1
80445|NCT00932373|286565|P5|Overall Study|Adverse Event|2
80446|NCT00932373|286566|P4|Overall Study|Adverse Event|0
80447|NCT00932373|286567|P3|Overall Study|Adverse Event|0
80448|NCT00932373|286568|P2|Overall Study|Adverse Event|0
80449|NCT00932373|286569|P1|Overall Study|Adverse Event|0
80450|NCT00932373|286559|P11|Overall Study|Progressive disease|2
80451|NCT00932373|286560|P10|Overall Study|Progressive disease|9
80452|NCT00932373|286561|P9|Overall Study|Progressive disease|1
80453|NCT00932373|286562|P8|Overall Study|Progressive disease|2
80454|NCT00932373|286563|P7|Overall Study|Progressive disease|0
80455|NCT00932373|286564|P6|Overall Study|Progressive disease|1
80456|NCT00932373|286565|P5|Overall Study|Progressive disease|10
80457|NCT00932373|286566|P4|Overall Study|Progressive disease|0
80458|NCT00932373|286567|P3|Overall Study|Progressive disease|0
80459|NCT00932373|286568|P2|Overall Study|Progressive disease|1
80460|NCT00932373|286569|P1|Overall Study|Progressive disease|3
80461|NCT00932165|286680|P1|Overall Study|Lost to Follow-up|1
80462|NCT00932126|286698|P8|Overall Study|Other|2
80463|NCT00932126|286699|P7|Overall Study|Other|1
80464|NCT00932126|286700|P6|Overall Study|Other|0
80465|NCT00932126|286701|P5|Overall Study|Other|1
80466|NCT00932126|286702|P4|Overall Study|Other|0
80467|NCT00932126|286703|P3|Overall Study|Other|0
80468|NCT00932126|286704|P2|Overall Study|Other|0
80469|NCT00932126|286705|P1|Overall Study|Other|0
80470|NCT00932126|286698|P8|Overall Study|Objective progression or relapse|5
80471|NCT00932126|286699|P7|Overall Study|Objective progression or relapse|3
80472|NCT00932126|286700|P6|Overall Study|Objective progression or relapse|3
80473|NCT00932126|286701|P5|Overall Study|Objective progression or relapse|3
80474|NCT00932126|286702|P4|Overall Study|Objective progression or relapse|3
80475|NCT00932126|286703|P3|Overall Study|Objective progression or relapse|2
80476|NCT00932126|286704|P2|Overall Study|Objective progression or relapse|3
80477|NCT00932126|286705|P1|Overall Study|Objective progression or relapse|3
80478|NCT00932126|286698|P8|Overall Study|Withdrawal by Subject|1
80479|NCT00932126|286699|P7|Overall Study|Withdrawal by Subject|0
80480|NCT00932126|286700|P6|Overall Study|Withdrawal by Subject|0
80481|NCT00932126|286701|P5|Overall Study|Withdrawal by Subject|0
80482|NCT00932126|286702|P4|Overall Study|Withdrawal by Subject|0
80483|NCT00932126|286703|P3|Overall Study|Withdrawal by Subject|1
80484|NCT00932126|286704|P2|Overall Study|Withdrawal by Subject|0
80485|NCT00932126|286705|P1|Overall Study|Withdrawal by Subject|0
80486|NCT00932126|286698|P8|Overall Study|Protocol Violation|0
80487|NCT00932126|286699|P7|Overall Study|Protocol Violation|0
80488|NCT00932126|286700|P6|Overall Study|Protocol Violation|0
80489|NCT00932126|286701|P5|Overall Study|Protocol Violation|1
80490|NCT00932126|286702|P4|Overall Study|Protocol Violation|0
80491|NCT00932126|286703|P3|Overall Study|Protocol Violation|0
80492|NCT00932126|286704|P2|Overall Study|Protocol Violation|0
80493|NCT00932126|286705|P1|Overall Study|Protocol Violation|0
80494|NCT00932126|286698|P8|Overall Study|Adverse Event|2
80495|NCT00932126|286699|P7|Overall Study|Adverse Event|1
80496|NCT00932126|286700|P6|Overall Study|Adverse Event|0
80497|NCT00932126|286701|P5|Overall Study|Adverse Event|0
80498|NCT00932126|286702|P4|Overall Study|Adverse Event|0
80499|NCT00932126|286703|P3|Overall Study|Adverse Event|0
80500|NCT00932126|286704|P2|Overall Study|Adverse Event|0
80501|NCT00932126|286705|P1|Overall Study|Adverse Event|0
80502|NCT00931918|286764|P2|Overall Study|Did not receive study drug|2
80503|NCT00931918|286765|P1|Overall Study|Did not receive study drug|3
80504|NCT00931918|286764|P2|Overall Study|Other Reason not Specified|4
80505|NCT00931918|286765|P1|Overall Study|Other Reason not Specified|4
80506|NCT00931918|286764|P2|Overall Study|Withdrawal by Patient|4
80507|NCT00931918|286765|P1|Overall Study|Withdrawal by Patient|3
80508|NCT00931918|286764|P2|Overall Study|Symptomatic Deterioration|0
80509|NCT00931918|286765|P1|Overall Study|Symptomatic Deterioration|1
80510|NCT00931918|286764|P2|Overall Study|Progressive Disease|1
80511|NCT00931918|286765|P1|Overall Study|Progressive Disease|2
80512|NCT00931918|286764|P2|Overall Study|Adverse Event|6
80513|NCT00931918|286765|P1|Overall Study|Adverse Event|4
80514|NCT00931801|286792|P3|Overall Study|Confirmed Virologic Failure|3
80515|NCT00931801|286793|P2|Overall Study|Confirmed Virologic Failure|0
80516|NCT00931801|286794|P1|Overall Study|Confirmed Virologic Failure|0
80517|NCT00931801|286792|P3|Overall Study|Withdrawal by Subject|0
80518|NCT00931801|286793|P2|Overall Study|Withdrawal by Subject|0
80519|NCT00931801|286794|P1|Overall Study|Withdrawal by Subject|1
80520|NCT00931801|286792|P3|Overall Study|Lost to Follow-up|0
80521|NCT00931801|286793|P2|Overall Study|Lost to Follow-up|1
80522|NCT00931801|286794|P1|Overall Study|Lost to Follow-up|0
80523|NCT00931801|286792|P3|Overall Study|Adverse Event|1
80524|NCT00931801|286793|P2|Overall Study|Adverse Event|0
80525|NCT00931801|286794|P1|Overall Study|Adverse Event|0
80526|NCT00931723|286817|P2|Overall Study|Late hospital discharge|0
80527|NCT00931723|286818|P1|Overall Study|Late hospital discharge|1
80528|NCT00931723|286817|P2|Overall Study|Sponsor decision|0
80529|NCT00931723|286818|P1|Overall Study|Sponsor decision|1
80530|NCT00931723|286817|P2|Overall Study|Lack or insufficient theraputic response|5
80531|NCT00931723|286818|P1|Overall Study|Lack or insufficient theraputic response|2
80532|NCT00931723|286817|P2|Overall Study|Took prohibited concomitant medication|1
80533|NCT00931723|286818|P1|Overall Study|Took prohibited concomitant medication|0
80534|NCT00931723|286817|P2|Overall Study|Safety reasons|1
80535|NCT00931723|286818|P1|Overall Study|Safety reasons|0
80536|NCT00931723|286817|P2|Overall Study|Severe non-compliance to protocol|0
80537|NCT00931723|286818|P1|Overall Study|Severe non-compliance to protocol|2
80538|NCT00931723|286817|P2|Overall Study|Study-specific discontinuation criteria|1
80539|NCT00931723|286818|P1|Overall Study|Study-specific discontinuation criteria|1
80540|NCT00931723|286817|P2|Overall Study|Lost to Follow-up|2
80541|NCT00931723|286818|P1|Overall Study|Lost to Follow-up|1
80542|NCT00931723|286817|P2|Overall Study|Condition under investigation worsened|2
80543|NCT00931723|286818|P1|Overall Study|Condition under investigation worsened|1
80544|NCT00931723|286817|P2|Overall Study|Lithium found in blood|1
80545|NCT00931723|286818|P1|Overall Study|Lithium found in blood|0
80546|NCT00931723|286817|P2|Overall Study|Adverse Event|13
80547|NCT00931723|286818|P1|Overall Study|Adverse Event|6
80548|NCT00931723|286817|P2|Overall Study|Withdrawal by Subject|13
80549|NCT00931723|286818|P1|Overall Study|Withdrawal by Subject|11
80550|NCT00931710|286866|P2|Overall Study|Protocol deviation|2
80551|NCT00931710|286867|P1|Overall Study|Protocol deviation|1
80552|NCT00931710|286866|P2|Overall Study|Lost to Follow-up|5
80553|NCT00931710|286867|P1|Overall Study|Lost to Follow-up|6
80554|NCT00931710|286866|P2|Overall Study|Patient withdrew consent|9
80555|NCT00931710|286867|P1|Overall Study|Patient withdrew consent|4
80556|NCT00931710|286866|P2|Overall Study|Unsatisfactory therapeutic effects|12
80557|NCT00931710|286867|P1|Overall Study|Unsatisfactory therapeutic effects|5
80558|NCT00931710|286866|P2|Overall Study|Abnormal test procedure results|0
80559|NCT00931710|286867|P1|Overall Study|Abnormal test procedure results|2
80560|NCT00931710|286866|P2|Overall Study|Adverse Event|10
80561|NCT00931710|286867|P1|Overall Study|Adverse Event|16
80562|NCT00931632|286885|P2|Overall Study|Adverse Event|15
80563|NCT00931632|286886|P1|Overall Study|Adverse Event|19
80564|NCT00931632|286885|P2|Overall Study|Withdrawal by Subject|3
80565|NCT00931632|286886|P1|Overall Study|Withdrawal by Subject|2
80566|NCT00931528|286894|P2|Overall Study|Assessment outside of Time Frame|23
80567|NCT00931528|286895|P1|Overall Study|Assessment outside of Time Frame|22
80568|NCT00931528|286894|P2|Overall Study|Lost to Follow-up|13
80569|NCT00931528|286895|P1|Overall Study|Lost to Follow-up|6
80570|NCT00931528|286894|P2|Overall Study|Withdrawal by Subject|12
80571|NCT00931528|286895|P1|Overall Study|Withdrawal by Subject|4
80572|NCT00931528|286894|P2|Overall Study|Protocol Violation|12
80573|NCT00931528|286895|P1|Overall Study|Protocol Violation|9
80574|NCT00931515|286903|P2|Overall Study|Lost to Follow-up|5
80575|NCT00931515|286904|P1|Overall Study|Lost to Follow-up|2
80576|NCT00931463|286912|P2|Overall Study|Lost to Follow-up|1
80577|NCT00931463|286913|P1|Overall Study|Lost to Follow-up|4
80578|NCT00931463|286912|P2|Overall Study|Withdrawal by Subject|0
80579|NCT00931463|286913|P1|Overall Study|Withdrawal by Subject|5
80580|NCT00931463|286912|P2|Overall Study|Death|4
80581|NCT00931463|286913|P1|Overall Study|Death|8
80582|NCT00931411|286929|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
80583|NCT00931411|286930|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
80584|NCT00931411|286929|P2|First Intervention - 42 Days|Lost to Follow-up|0
80585|NCT00931411|286930|P1|First Intervention - 42 Days|Lost to Follow-up|2
80586|NCT00931411|286929|P2|First Intervention - 42 Days|Adverse Event|3
80587|NCT00931411|286930|P1|First Intervention - 42 Days|Adverse Event|2
80588|NCT00931385|286951|P4|Overall Study|Lost to Follow-up|1
80589|NCT00931385|286952|P3|Overall Study|Lost to Follow-up|0
80590|NCT00931385|286953|P2|Overall Study|Lost to Follow-up|0
80591|NCT00931385|286954|P1|Overall Study|Lost to Follow-up|0
80592|NCT00931385|286951|P4|Overall Study|Withdrawal by Subject|1
80593|NCT00931385|286952|P3|Overall Study|Withdrawal by Subject|0
80594|NCT00931385|286953|P2|Overall Study|Withdrawal by Subject|1
80595|NCT00931385|286954|P1|Overall Study|Withdrawal by Subject|0
80596|NCT00931385|286951|P4|Overall Study|Protocol Violation|0
80597|NCT00931385|286952|P3|Overall Study|Protocol Violation|1
80598|NCT00931385|286953|P2|Overall Study|Protocol Violation|0
80599|NCT00931385|286954|P1|Overall Study|Protocol Violation|0
80600|NCT00931385|286951|P4|Overall Study|Adverse Event|3
80601|NCT00931385|286952|P3|Overall Study|Adverse Event|0
80602|NCT00931385|286953|P2|Overall Study|Adverse Event|1
80603|NCT00931385|286954|P1|Overall Study|Adverse Event|2
80604|NCT00931307|287023|P1|Overall Study|Biomicroscopy|1
80605|NCT00931307|287023|P1|Overall Study|Lack of Efficacy|12
80606|NCT00931268|287027|P1|Overall Study|Lost to Follow-up|6
80607|NCT00930982|287052|P2|Overall Study|Withdrawal by Subject|1
80608|NCT00930982|287053|P1|Overall Study|Withdrawal by Subject|1
80609|NCT00930982|287052|P2|Overall Study|Protocol Violation|5
80610|NCT00930982|287053|P1|Overall Study|Protocol Violation|1
80611|NCT00930982|287052|P2|Overall Study|Adverse Event|23
80612|NCT00930982|287053|P1|Overall Study|Adverse Event|19
80613|NCT00930969|287087|P1|Overall Study|Withdrawal by Subject|19
80614|NCT00930969|287087|P1|Overall Study|Physician Decision|13
80615|NCT00930969|287087|P1|Overall Study|Lost to Follow-up|1
80616|NCT00930969|287087|P1|Overall Study|Death|5
80617|NCT00930930|287097|P2|Overall Study|patients not compliant|1
80618|NCT00930930|287098|P1|Overall Study|patients not compliant|1
80619|NCT00930930|287097|P2|Overall Study|excessive lapse btw txs, not eligible|1
80620|NCT00930930|287098|P1|Overall Study|excessive lapse btw txs, not eligible|0
80621|NCT00930930|287097|P2|Overall Study|Disease progression|3
80622|NCT00930930|287098|P1|Overall Study|Disease progression|2
80623|NCT00930930|287097|P2|Overall Study|Withdrawal by Subject|1
80624|NCT00930930|287098|P1|Overall Study|Withdrawal by Subject|3
80625|NCT00930930|287097|P2|Overall Study|Adverse Event|3
80626|NCT00930930|287098|P1|Overall Study|Adverse Event|13
80627|NCT00930930|287097|P2|Overall Study|Physician Decision|0
80628|NCT00930930|287098|P1|Overall Study|Physician Decision|1
80629|NCT00930930|287097|P2|Overall Study|Death|0
80630|NCT00930930|287098|P1|Overall Study|Death|1
80631|NCT00930813|287112|P2|Overall Study|Lost to Follow-up|4
80632|NCT00930813|287113|P1|Overall Study|Lost to Follow-up|2
80633|NCT00930813|287112|P2|Overall Study|Withdrawal by Subject|5
80634|NCT00930813|287113|P1|Overall Study|Withdrawal by Subject|2
80635|NCT00930813|287112|P2|Overall Study|Death|5
80636|NCT00930813|287113|P1|Overall Study|Death|4
80637|NCT00930774|287134|P4|Overall Study|Withdrawal by Subject|0
80638|NCT00930774|287135|P3|Overall Study|Withdrawal by Subject|2
80639|NCT00930774|287136|P2|Overall Study|Withdrawal by Subject|9
80640|NCT00930774|287137|P1|Overall Study|Withdrawal by Subject|1
80641|NCT00930761|287177|P2|Overall Study|less than 3 music therapy sessions|3
80642|NCT00930761|287178|P1|Overall Study|less than 3 music therapy sessions|0
80643|NCT00930761|287177|P2|Overall Study|3 newborns died; 1 mother quit the study|0
80644|NCT00930761|287178|P1|Overall Study|3 newborns died; 1 mother quit the study|4
80645|NCT00930722|287190|P1|Overall Study|Study terminated by sponsor|2
80646|NCT00930722|287190|P1|Overall Study|No longer willing to participate|9
80647|NCT00930722|287190|P1|Overall Study|Lost to Follow-up|16
80648|NCT00930644|287205|P1|Overall Study|Adverse Event|16
80649|NCT00930644|287205|P1|Overall Study|Death|1
80650|NCT00930644|287205|P1|Overall Study|Physician Decision|2
80651|NCT00930644|287205|P1|Overall Study|Withdrawal by Subject|4
80652|NCT00930176|287229|P1|Overall Study|Death|1
80653|NCT00929864|287246|P2|Overall Study|Non-specified|7
80654|NCT00929864|287247|P1|Overall Study|Non-specified|2
80655|NCT00929864|287246|P2|Overall Study|Administrative reason by Sponsor|1
80656|NCT00929864|287247|P1|Overall Study|Administrative reason by Sponsor|1
80657|NCT00929864|287246|P2|Overall Study|Pregnancy|3
80658|NCT00929864|287247|P1|Overall Study|Pregnancy|0
80659|NCT00929864|287246|P2|Overall Study|Poor or non-compliance|3
80660|NCT00929864|287247|P1|Overall Study|Poor or non-compliance|3
80661|NCT00929864|287246|P2|Overall Study|No longer met criteria|1
80662|NCT00929864|287247|P1|Overall Study|No longer met criteria|2
80663|NCT00929864|287246|P2|Overall Study|Withdrawal by Subject|9
80664|NCT00929864|287247|P1|Overall Study|Withdrawal by Subject|20
80665|NCT00929864|287246|P2|Overall Study|Lost to Follow-up|12
80666|NCT00929864|287247|P1|Overall Study|Lost to Follow-up|7
80667|NCT00929864|287246|P2|Overall Study|Lack of Efficacy|16
80668|NCT00929864|287247|P1|Overall Study|Lack of Efficacy|19
80669|NCT00929864|287246|P2|Overall Study|Adverse Event|30
80670|NCT00929864|287247|P1|Overall Study|Adverse Event|11
80671|NCT00929864|287246|P2|Overall Study|Death|1
80672|NCT00929864|287247|P1|Overall Study|Death|1
80673|NCT00929734|287286|P2|Overall Study|Withdrawal by Subject|2
80674|NCT00929734|287287|P1|Overall Study|Withdrawal by Subject|0
80675|NCT00929734|287286|P2|Overall Study|Lost to Follow-up|1
80676|NCT00929734|287287|P1|Overall Study|Lost to Follow-up|2
80677|NCT00929708|287304|P5|Overall Study|Lost to Follow-up|0
80678|NCT00929708|287305|P4|Overall Study|Lost to Follow-up|1
80679|NCT00929708|287306|P3|Overall Study|Lost to Follow-up|0
80680|NCT00929708|287307|P2|Overall Study|Lost to Follow-up|0
80681|NCT00929708|287308|P1|Overall Study|Lost to Follow-up|0
80682|NCT00929708|287304|P5|Overall Study|Physician Decision|1
80683|NCT00929708|287305|P4|Overall Study|Physician Decision|2
80684|NCT00929708|287306|P3|Overall Study|Physician Decision|2
80685|NCT00929708|287307|P2|Overall Study|Physician Decision|2
80686|NCT00929708|287308|P1|Overall Study|Physician Decision|0
80687|NCT00929708|287304|P5|Overall Study|Adverse Event|3
80688|NCT00929708|287305|P4|Overall Study|Adverse Event|0
80689|NCT00929708|287306|P3|Overall Study|Adverse Event|0
80690|NCT00929708|287307|P2|Overall Study|Adverse Event|0
80691|NCT00929708|287308|P1|Overall Study|Adverse Event|0
80692|NCT00929708|287304|P5|Overall Study|Withdrawal by Subject|1
80693|NCT00929708|287305|P4|Overall Study|Withdrawal by Subject|2
80694|NCT00929708|287306|P3|Overall Study|Withdrawal by Subject|0
80695|NCT00929708|287307|P2|Overall Study|Withdrawal by Subject|0
80696|NCT00929708|287308|P1|Overall Study|Withdrawal by Subject|2
80697|NCT00929708|287304|P5|Overall Study|Protocol Violation|1
80698|NCT00929708|287305|P4|Overall Study|Protocol Violation|1
80699|NCT00929708|287306|P3|Overall Study|Protocol Violation|1
80700|NCT00929708|287307|P2|Overall Study|Protocol Violation|1
80701|NCT00929708|287308|P1|Overall Study|Protocol Violation|2
80702|NCT00929695|287362|P2|Overall Study|incorrect stratification|0
80703|NCT00929695|287363|P1|Overall Study|incorrect stratification|2
80704|NCT00929695|287362|P2|Overall Study|discharge home|3
80705|NCT00929695|287363|P1|Overall Study|discharge home|4
80706|NCT00929695|287362|P2|Overall Study|Withdrawal by Subject|2
80707|NCT00929695|287363|P1|Overall Study|Withdrawal by Subject|0
80708|NCT00929695|287362|P2|Overall Study|Death|1
80709|NCT00929695|287363|P1|Overall Study|Death|2
80710|NCT00929643|287393|P1|Overall Study|Protocol Violation|2
80711|NCT00929526|287415|P2|Overall Study|Unspecified|6
80712|NCT00929526|287416|P1|Overall Study|Unspecified|8
80713|NCT00929526|287415|P2|Overall Study|Lost to Follow-up|12
80714|NCT00929526|287416|P1|Overall Study|Lost to Follow-up|8
80715|NCT00929526|287415|P2|Overall Study|Withdrawal by Subject|11
80716|NCT00929526|287416|P1|Overall Study|Withdrawal by Subject|1
80717|NCT00929240|287536|P3|Maintenance Phase|Participant not treated|0
80718|NCT00929240|287537|P2|Maintenance Phase|Participant not treated|2
80719|NCT00929240|287538|P1|Maintenance Phase|Participant not treated|0
80720|NCT00929240|287536|P3|Maintenance Phase|Treatment ongoing at study closure|10
80721|NCT00929240|287537|P2|Maintenance Phase|Treatment ongoing at study closure|0
80722|NCT00929240|287538|P1|Maintenance Phase|Treatment ongoing at study closure|0
80723|NCT00929240|287536|P3|Maintenance Phase|Change of treatment|0
80724|NCT00929240|287537|P2|Maintenance Phase|Change of treatment|4
80725|NCT00929240|287538|P1|Maintenance Phase|Change of treatment|0
80726|NCT00929240|287536|P3|Maintenance Phase|Physician Decision|1
80727|NCT00929240|287537|P2|Maintenance Phase|Physician Decision|2
80728|NCT00929240|287538|P1|Maintenance Phase|Physician Decision|0
80729|NCT00929240|287536|P3|Maintenance Phase|Health authority/Study termination|2
80730|NCT00929240|287537|P2|Maintenance Phase|Health authority/Study termination|1
80731|NCT00929240|287538|P1|Maintenance Phase|Health authority/Study termination|0
80732|NCT00929240|287536|P3|Maintenance Phase|Protocol Violation|0
80733|NCT00929240|287537|P2|Maintenance Phase|Protocol Violation|1
80734|NCT00929240|287538|P1|Maintenance Phase|Protocol Violation|0
80735|NCT00929240|287536|P3|Maintenance Phase|Withdrawal by Subject|6
80736|NCT00929240|287537|P2|Maintenance Phase|Withdrawal by Subject|2
80737|NCT00929240|287538|P1|Maintenance Phase|Withdrawal by Subject|0
80738|NCT00929240|287536|P3|Maintenance Phase|Adverse Event|12
80739|NCT00929240|287537|P2|Maintenance Phase|Adverse Event|9
80740|NCT00929240|287538|P1|Maintenance Phase|Adverse Event|0
80741|NCT00929240|287536|P3|Maintenance Phase|Disease progression|60
80742|NCT00929240|287537|P2|Maintenance Phase|Disease progression|73
80743|NCT00929240|287538|P1|Maintenance Phase|Disease progression|0
80744|NCT00929240|287536|P3|Initial Treatment Phase|Physician Decision|0
80745|NCT00929240|287537|P2|Initial Treatment Phase|Physician Decision|0
80746|NCT00929240|287538|P1|Initial Treatment Phase|Physician Decision|4
80747|NCT00929240|287536|P3|Initial Treatment Phase|Health authority/Study termination|0
80748|NCT00929240|287537|P2|Initial Treatment Phase|Health authority/Study termination|0
80749|NCT00929240|287538|P1|Initial Treatment Phase|Health authority/Study termination|3
80750|NCT00929240|287536|P3|Initial Treatment Phase|Death|0
80751|NCT00929240|287537|P2|Initial Treatment Phase|Death|0
80752|NCT00929240|287538|P1|Initial Treatment Phase|Death|2
80753|NCT00929240|287536|P3|Initial Treatment Phase|Protocol Violation|0
80754|NCT00929240|287537|P2|Initial Treatment Phase|Protocol Violation|0
80755|NCT00929240|287538|P1|Initial Treatment Phase|Protocol Violation|5
80756|NCT00929240|287536|P3|Initial Treatment Phase|Withdrawal by Subject|0
80757|NCT00929240|287537|P2|Initial Treatment Phase|Withdrawal by Subject|0
80758|NCT00929240|287538|P1|Initial Treatment Phase|Withdrawal by Subject|13
80759|NCT00929240|287536|P3|Initial Treatment Phase|Disease progression|0
80760|NCT00929240|287537|P2|Initial Treatment Phase|Disease progression|0
80761|NCT00929240|287538|P1|Initial Treatment Phase|Disease progression|41
80762|NCT00929240|287536|P3|Initial Treatment Phase|Adverse Event|0
80763|NCT00929240|287537|P2|Initial Treatment Phase|Adverse Event|0
80764|NCT00929240|287538|P1|Initial Treatment Phase|Adverse Event|31
80765|NCT00929201|287565|P2|Period 1|Withdrawal by Subject|1
80766|NCT00929201|287566|P1|Period 1|Withdrawal by Subject|0
80767|NCT00929162|287576|P2|Overall Study|Other termination reason|6
80768|NCT00929162|287577|P1|Overall Study|Other termination reason|5
80769|NCT00929162|287576|P2|Overall Study|Protocol Violation|30
80770|NCT00929162|287577|P1|Overall Study|Protocol Violation|32
80771|NCT00929162|287576|P2|Overall Study|Withdrawal by Subject|1
80772|NCT00929162|287577|P1|Overall Study|Withdrawal by Subject|3
80773|NCT00929162|287576|P2|Overall Study|Adverse Event|5
80774|NCT00929162|287577|P1|Overall Study|Adverse Event|8
80775|NCT00929110|287590|P3|Overall Study|Patient inability to use the device|0
80776|NCT00929110|287591|P2|Overall Study|Patient inability to use the device|1
80777|NCT00929110|287592|P1|Overall Study|Patient inability to use the device|0
80778|NCT00929110|287590|P3|Overall Study|Abnormal test procedure result(s)|1
80779|NCT00929110|287591|P2|Overall Study|Abnormal test procedure result(s)|1
80780|NCT00929110|287592|P1|Overall Study|Abnormal test procedure result(s)|0
80781|NCT00929110|287590|P3|Overall Study|Abnormal laboratory value(s)|0
80782|NCT00929110|287591|P2|Overall Study|Abnormal laboratory value(s)|1
80783|NCT00929110|287592|P1|Overall Study|Abnormal laboratory value(s)|0
80784|NCT00929110|287590|P3|Overall Study|Death|2
80785|NCT00929110|287591|P2|Overall Study|Death|2
80786|NCT00929110|287592|P1|Overall Study|Death|2
80787|NCT00929110|287590|P3|Overall Study|Administrative problems|2
80788|NCT00929110|287591|P2|Overall Study|Administrative problems|1
80789|NCT00929110|287592|P1|Overall Study|Administrative problems|4
80790|NCT00929110|287590|P3|Overall Study|Protocol deviation|4
80791|NCT00929110|287591|P2|Overall Study|Protocol deviation|2
80792|NCT00929110|287592|P1|Overall Study|Protocol deviation|5
80793|NCT00929110|287590|P3|Overall Study|Lost to Follow-up|3
80794|NCT00929110|287591|P2|Overall Study|Lost to Follow-up|7
80795|NCT00929110|287592|P1|Overall Study|Lost to Follow-up|7
80796|NCT00929110|287590|P3|Overall Study|Unsatisfactory therapeutic effect|6
80797|NCT00929110|287591|P2|Overall Study|Unsatisfactory therapeutic effect|9
80798|NCT00929110|287592|P1|Overall Study|Unsatisfactory therapeutic effect|20
80799|NCT00929110|287590|P3|Overall Study|Subject withdrew consent|26
80800|NCT00929110|287591|P2|Overall Study|Subject withdrew consent|23
80801|NCT00929110|287592|P1|Overall Study|Subject withdrew consent|40
80802|NCT00929110|287590|P3|Overall Study|Adverse Event|18
80803|NCT00929110|287591|P2|Overall Study|Adverse Event|29
80804|NCT00929110|287592|P1|Overall Study|Adverse Event|40
80805|NCT00928889|287675|P2|Overall Study|Other|0
80806|NCT00928889|287676|P1|Overall Study|Other|1
80807|NCT00928889|287675|P2|Overall Study|Adverse Event|0
80808|NCT00928889|287676|P1|Overall Study|Adverse Event|1
80809|NCT00928889|287675|P2|Overall Study|Protocol Violation|1
80810|NCT00928889|287676|P1|Overall Study|Protocol Violation|0
80811|NCT00928889|287675|P2|Overall Study|Lost to Follow-up|1
80812|NCT00928889|287676|P1|Overall Study|Lost to Follow-up|3
80813|NCT00928746|287700|P1|Overall Study|Other|2
80814|NCT00928746|287700|P1|Overall Study|Withdrawal by Subject|1
80815|NCT00928746|287700|P1|Overall Study|Protocol Violation|1
80816|NCT00928746|287700|P1|Overall Study|Adverse Event|2
80817|NCT00928668|287742|P5|Overall Study|Other reasons not listed above|0
80818|NCT00928668|287743|P4|Overall Study|Other reasons not listed above|1
80819|NCT00928668|287744|P3|Overall Study|Other reasons not listed above|0
80820|NCT00928668|287745|P2|Overall Study|Other reasons not listed above|0
80821|NCT00928668|287746|P1|Overall Study|Other reasons not listed above|0
80822|NCT00928668|287742|P5|Overall Study|Withdrawal by Subject|0
80823|NCT00928668|287743|P4|Overall Study|Withdrawal by Subject|0
80824|NCT00928668|287744|P3|Overall Study|Withdrawal by Subject|1
80825|NCT00928668|287745|P2|Overall Study|Withdrawal by Subject|1
80826|NCT00928668|287746|P1|Overall Study|Withdrawal by Subject|0
80827|NCT00928668|287742|P5|Overall Study|Protocol Violation|1
80828|NCT00928668|287743|P4|Overall Study|Protocol Violation|0
80829|NCT00928668|287744|P3|Overall Study|Protocol Violation|0
80830|NCT00928668|287745|P2|Overall Study|Protocol Violation|0
80831|NCT00928668|287746|P1|Overall Study|Protocol Violation|0
80832|NCT00928668|287742|P5|Overall Study|Adverse Event|0
80833|NCT00928668|287743|P4|Overall Study|Adverse Event|0
80834|NCT00928668|287744|P3|Overall Study|Adverse Event|0
80835|NCT00928668|287745|P2|Overall Study|Adverse Event|0
80836|NCT00928668|287746|P1|Overall Study|Adverse Event|1
80837|NCT00928512|287802|P5|Overall Study|Administrative Problems|0
80838|NCT00928512|287803|P4|Overall Study|Administrative Problems|0
80839|NCT00928512|287804|P3|Overall Study|Administrative Problems|0
80840|NCT00928512|287805|P2|Overall Study|Administrative Problems|1
80841|NCT00928512|287806|P1|Overall Study|Administrative Problems|0
80842|NCT00928512|287802|P5|Overall Study|Lost to Follow-up|3
80843|NCT00928512|287803|P4|Overall Study|Lost to Follow-up|1
80844|NCT00928512|287804|P3|Overall Study|Lost to Follow-up|2
80845|NCT00928512|287805|P2|Overall Study|Lost to Follow-up|1
80846|NCT00928512|287806|P1|Overall Study|Lost to Follow-up|1
80847|NCT00928512|287802|P5|Overall Study|Withdrawal by Subject|0
80848|NCT00928512|287803|P4|Overall Study|Withdrawal by Subject|4
80849|NCT00928512|287804|P3|Overall Study|Withdrawal by Subject|3
80850|NCT00928512|287805|P2|Overall Study|Withdrawal by Subject|0
80851|NCT00928512|287806|P1|Overall Study|Withdrawal by Subject|3
80852|NCT00928512|287802|P5|Overall Study|Protocol Violation|3
80853|NCT00928512|287803|P4|Overall Study|Protocol Violation|1
80854|NCT00928512|287804|P3|Overall Study|Protocol Violation|0
80855|NCT00928512|287805|P2|Overall Study|Protocol Violation|1
80856|NCT00928512|287806|P1|Overall Study|Protocol Violation|0
80857|NCT00928512|287802|P5|Overall Study|Lack of Efficacy|3
80858|NCT00928512|287803|P4|Overall Study|Lack of Efficacy|7
80859|NCT00928512|287804|P3|Overall Study|Lack of Efficacy|4
80860|NCT00928512|287805|P2|Overall Study|Lack of Efficacy|0
80861|NCT00928512|287806|P1|Overall Study|Lack of Efficacy|2
80862|NCT00928512|287802|P5|Overall Study|Adverse Event|6
80863|NCT00928512|287803|P4|Overall Study|Adverse Event|8
80864|NCT00928512|287804|P3|Overall Study|Adverse Event|2
80865|NCT00928512|287805|P2|Overall Study|Adverse Event|3
80866|NCT00928512|287806|P1|Overall Study|Adverse Event|4
80867|NCT00928486|287907|P1|Overall Study|Withdrawal by Subject|1
80868|NCT00928486|287907|P1|Overall Study|Disease Progression|7
80869|NCT00928486|287907|P1|Overall Study|Adverse Event|2
80870|NCT00928434|287916|P3|Overall Study|Other (not meeting above criteria)|2
80871|NCT00928434|287917|P2|Overall Study|Other (not meeting above criteria)|1
80872|NCT00928434|287918|P1|Overall Study|Other (not meeting above criteria)|5
80873|NCT00928434|287916|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
80874|NCT00928434|287917|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
80875|NCT00928434|287918|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
80876|NCT00928434|287916|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
80877|NCT00928434|287917|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
80878|NCT00928434|287918|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
80879|NCT00928434|287916|P3|Overall Study|Withdrawal by Subject|2
80880|NCT00928434|287917|P2|Overall Study|Withdrawal by Subject|3
80881|NCT00928434|287918|P1|Overall Study|Withdrawal by Subject|5
80882|NCT00928434|287916|P3|Overall Study|Lost to Follow-up|3
80883|NCT00928434|287917|P2|Overall Study|Lost to Follow-up|0
80884|NCT00928434|287918|P1|Overall Study|Lost to Follow-up|1
80885|NCT00928434|287916|P3|Overall Study|Physician Decision|3
80886|NCT00928434|287917|P2|Overall Study|Physician Decision|0
80887|NCT00928434|287918|P1|Overall Study|Physician Decision|2
80888|NCT00928434|287916|P3|Overall Study|Protocol Violation|8
80889|NCT00928434|287917|P2|Overall Study|Protocol Violation|0
80890|NCT00928434|287918|P1|Overall Study|Protocol Violation|5
80891|NCT00928434|287916|P3|Overall Study|Adverse Event|18
80892|NCT00928434|287917|P2|Overall Study|Adverse Event|5
80893|NCT00928434|287918|P1|Overall Study|Adverse Event|14
80894|NCT00928408|287994|P1|Overall Study|Lost to Follow-up|12
80895|NCT00928408|287994|P1|Overall Study|Death|5
80896|NCT00928408|287994|P1|Overall Study|Withdrawal by Subject|4
80897|NCT00928408|287994|P1|Overall Study|Other|2
80898|NCT00928187|288043|P3|Overall Study|Protocol Violation|0
80899|NCT00928187|288044|P2|Overall Study|Protocol Violation|1
80900|NCT00928187|288045|P1|Overall Study|Protocol Violation|0
80901|NCT00928187|288043|P3|Overall Study|Withdrawal by Subject|1
80902|NCT00928187|288044|P2|Overall Study|Withdrawal by Subject|1
80903|NCT00928187|288045|P1|Overall Study|Withdrawal by Subject|0
80904|NCT00928187|288043|P3|Overall Study|Lost to Follow-up|1
80905|NCT00928187|288044|P2|Overall Study|Lost to Follow-up|2
80906|NCT00928187|288045|P1|Overall Study|Lost to Follow-up|1
80907|NCT00928187|288043|P3|Overall Study|Death|3
80908|NCT00928187|288044|P2|Overall Study|Death|2
80909|NCT00928187|288045|P1|Overall Study|Death|1
80910|NCT00928070|288215|P2|Overall Study|Unspecified|5
80911|NCT00928070|288216|P1|Overall Study|Unspecified|5
80912|NCT00928070|288215|P2|Overall Study|Randomized but not treated|2
80913|NCT00928070|288216|P1|Overall Study|Randomized but not treated|2
80914|NCT00928070|288215|P2|Overall Study|Protocol Violation|5
80915|NCT00928070|288216|P1|Overall Study|Protocol Violation|6
80916|NCT00928070|288215|P2|Overall Study|Did not meet entrance criteria|9
80917|NCT00928070|288216|P1|Overall Study|Did not meet entrance criteria|16
80918|NCT00928070|288215|P2|Overall Study|Lack of Efficacy|5
80919|NCT00928070|288216|P1|Overall Study|Lack of Efficacy|9
80920|NCT00928070|288215|P2|Overall Study|Adverse Event|26
80921|NCT00928070|288216|P1|Overall Study|Adverse Event|14
80922|NCT00928070|288215|P2|Overall Study|Withdrawal by Subject|3
80923|NCT00928070|288216|P1|Overall Study|Withdrawal by Subject|10
80924|NCT00928070|288215|P2|Overall Study|Lost to Follow-up|2
80925|NCT00928070|288216|P1|Overall Study|Lost to Follow-up|1
80926|NCT00928057|288274|P2|Overall Study|Protocol Violation|1
80927|NCT00928057|288275|P1|Overall Study|Protocol Violation|0
80928|NCT00928057|288274|P2|Overall Study|Lost to Follow-up|1
80929|NCT00928057|288275|P1|Overall Study|Lost to Follow-up|0
80930|NCT00928057|288274|P2|Overall Study|Withdrawal by Subject|0
80931|NCT00928057|288275|P1|Overall Study|Withdrawal by Subject|1
80932|NCT00928057|288274|P2|Overall Study|Adverse Event|2
80933|NCT00928057|288275|P1|Overall Study|Adverse Event|1
80934|NCT00928018|288300|P2|Overall Study|Withdrawal by Subject|0
80935|NCT00928018|288301|P1|Overall Study|Withdrawal by Subject|1
80936|NCT00927953|288331|P2|Overall Study|Death|1
80937|NCT00927953|288332|P1|Overall Study|Death|2
80938|NCT00927940|288346|P1|Overall Study|Death|1
80939|NCT00927927|288366|P15|Overall Study|Withdrawal by Subject|0
80940|NCT00927927|288367|P14|Overall Study|Withdrawal by Subject|0
80941|NCT00927927|288368|P13|Overall Study|Withdrawal by Subject|0
80942|NCT00927927|288369|P12|Overall Study|Withdrawal by Subject|2
80943|NCT00927927|288370|P11|Overall Study|Withdrawal by Subject|0
80944|NCT00927927|288371|P10|Overall Study|Withdrawal by Subject|0
80945|NCT00927927|288372|P9|Overall Study|Withdrawal by Subject|0
80946|NCT00927927|288373|P8|Overall Study|Withdrawal by Subject|2
80947|NCT00927927|288374|P7|Overall Study|Withdrawal by Subject|0
80948|NCT00927927|288375|P6|Overall Study|Withdrawal by Subject|0
80949|NCT00927927|288376|P5|Overall Study|Withdrawal by Subject|0
80950|NCT00927927|288377|P4|Overall Study|Withdrawal by Subject|0
80951|NCT00927927|288378|P3|Overall Study|Withdrawal by Subject|0
80952|NCT00927927|288379|P2|Overall Study|Withdrawal by Subject|0
80953|NCT00927927|288380|P1|Overall Study|Withdrawal by Subject|0
80954|NCT00927901|288427|P4|Treatment Period 4|Subject withdrew consent|0
80955|NCT00927901|288428|P3|Treatment Period 4|Subject withdrew consent|1
80956|NCT00927901|288429|P2|Treatment Period 4|Subject withdrew consent|0
80957|NCT00927901|288430|P1|Treatment Period 4|Subject withdrew consent|0
80958|NCT00927901|288427|P4|Treatment Period 4|Adverse Event|1
80959|NCT00927901|288428|P3|Treatment Period 4|Adverse Event|0
80960|NCT00927901|288429|P2|Treatment Period 4|Adverse Event|0
80961|NCT00927901|288430|P1|Treatment Period 4|Adverse Event|0
80962|NCT00927901|288427|P4|Treatment Period 1|Subject withdrew consent|0
80963|NCT00927901|288428|P3|Treatment Period 1|Subject withdrew consent|1
80964|NCT00927901|288429|P2|Treatment Period 1|Subject withdrew consent|0
80965|NCT00927901|288430|P1|Treatment Period 1|Subject withdrew consent|0
80966|NCT00927862|288471|P2|Overall Study|Missing data needed for endpt analyses|45
80967|NCT00927862|288472|P1|Overall Study|Missing data needed for endpt analyses|27
80968|NCT00927823|288507|P4|Continuous Dosing Period|Unspecified|3
80969|NCT00927823|288508|P3|Continuous Dosing Period|Unspecified|9
80970|NCT00927823|288509|P2|Continuous Dosing Period|Unspecified|2
80971|NCT00927823|288510|P1|Continuous Dosing Period|Unspecified|1
80972|NCT00927823|288507|P4|Continuous Dosing Period|Withdrawal by Subject|2
80973|NCT00927823|288508|P3|Continuous Dosing Period|Withdrawal by Subject|2
80974|NCT00927823|288509|P2|Continuous Dosing Period|Withdrawal by Subject|0
80975|NCT00927823|288510|P1|Continuous Dosing Period|Withdrawal by Subject|1
80976|NCT00927823|288507|P4|Continuous Dosing Period|Lost to Follow-up|0
80977|NCT00927823|288508|P3|Continuous Dosing Period|Lost to Follow-up|9
80978|NCT00927823|288509|P2|Continuous Dosing Period|Lost to Follow-up|1
80979|NCT00927823|288510|P1|Continuous Dosing Period|Lost to Follow-up|1
80980|NCT00927823|288507|P4|Continuous Dosing Period|Death|0
80981|NCT00927823|288508|P3|Continuous Dosing Period|Death|6
80982|NCT00927823|288509|P2|Continuous Dosing Period|Death|0
80983|NCT00927823|288510|P1|Continuous Dosing Period|Death|0
80984|NCT00927758|288574|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
80985|NCT00927758|288575|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
80986|NCT00927758|288576|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
80987|NCT00927758|288577|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
80988|NCT00927758|288578|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
80989|NCT00927758|288579|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
80990|NCT00927758|288574|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
80991|NCT00927758|288575|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
80992|NCT00927758|288576|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
80993|NCT00927758|288577|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
80994|NCT00927758|288578|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
80995|NCT00927758|288579|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
80996|NCT00927589|288587|P1|Overall Study|Non-compliance|1
80997|NCT00927589|288587|P1|Overall Study|Disease Progression|8
80998|NCT00927589|288587|P1|Overall Study|Adverse Event|2
80999|NCT00927589|288587|P1|Overall Study|Withdrawal by Subject|3
81000|NCT00927589|288587|P1|Overall Study|Physician Decision|1
81001|NCT00927589|288587|P1|Overall Study|Death|1
81002|NCT00927563|288617|P1|Overall Study|Withdrawal by Subject|1
81003|NCT00927563|288617|P1|Overall Study|Lost to Follow-up|1
81004|NCT00927472|288625|P2|Overall Study|Post treatment Assessment out of window|4
81005|NCT00927472|288626|P1|Overall Study|Post treatment Assessment out of window|0
81006|NCT00927472|288625|P2|Overall Study|Protocol Violation|1
81007|NCT00927472|288626|P1|Overall Study|Protocol Violation|0
81008|NCT00927472|288625|P2|Overall Study|Lost to Follow-up|6
81009|NCT00927472|288626|P1|Overall Study|Lost to Follow-up|1
81010|NCT00927472|288625|P2|Overall Study|Withdrawal by Subject|11
81011|NCT00927472|288626|P1|Overall Study|Withdrawal by Subject|10
81012|NCT00927394|288652|P2|Overall Study|Randomized in error|1
81013|NCT00927394|288653|P1|Overall Study|Randomized in error|0
81014|NCT00927394|288652|P2|Overall Study|Protocol deviation|13
81015|NCT00927394|288653|P1|Overall Study|Protocol deviation|16
81016|NCT00927394|288652|P2|Overall Study|Death|1
81017|NCT00927394|288653|P1|Overall Study|Death|1
81018|NCT00927394|288652|P2|Overall Study|Administrative Problem|0
81019|NCT00927394|288653|P1|Overall Study|Administrative Problem|1
81020|NCT00927394|288652|P2|Overall Study|Lost to Follow-up|14
81021|NCT00927394|288653|P1|Overall Study|Lost to Follow-up|8
81022|NCT00927394|288652|P2|Overall Study|Withdrawal by Subject|24
81023|NCT00927394|288653|P1|Overall Study|Withdrawal by Subject|20
81024|NCT00927394|288652|P2|Overall Study|Unsatisfactory therapeutic effect|23
81025|NCT00927394|288653|P1|Overall Study|Unsatisfactory therapeutic effect|17
81026|NCT00927394|288652|P2|Overall Study|Adverse Event|9
81027|NCT00927394|288653|P1|Overall Study|Adverse Event|14
81028|NCT00927368|288684|P3|Overall Study|cancellation of surgery|2
81029|NCT00927368|288685|P2|Overall Study|cancellation of surgery|1
81030|NCT00927368|288686|P1|Overall Study|cancellation of surgery|0
81031|NCT00927368|288684|P3|Overall Study|ineligible post randomization|1
81032|NCT00927368|288685|P2|Overall Study|ineligible post randomization|3
81033|NCT00927368|288686|P1|Overall Study|ineligible post randomization|0
81034|NCT00927368|288684|P3|Overall Study|equipment failure|0
81035|NCT00927368|288685|P2|Overall Study|equipment failure|0
81036|NCT00927368|288686|P1|Overall Study|equipment failure|1
81037|NCT00927368|288684|P3|Overall Study|Lost to Follow-up|0
81038|NCT00927368|288685|P2|Overall Study|Lost to Follow-up|0
81039|NCT00927368|288686|P1|Overall Study|Lost to Follow-up|4
81040|NCT00927368|288684|P3|Overall Study|enrollment in another study|2
81041|NCT00927368|288685|P2|Overall Study|enrollment in another study|1
81042|NCT00927368|288686|P1|Overall Study|enrollment in another study|1
81043|NCT00927355|288702|P2|Overall Study|Adverse Event|1
81044|NCT00927355|288703|P1|Overall Study|Adverse Event|1
81045|NCT00927251|288721|P1|Overall Study|Patients not implanted with 4296 lead|8
81046|NCT00927186|288727|P2|12 Months Primary Study|Withdrawal by Subject|1
81047|NCT00927186|288728|P1|12 Months Primary Study|Withdrawal by Subject|1
81048|NCT00927186|288727|P2|12 Months Primary Study|Protocol Violation|1
81049|NCT00927186|288728|P1|12 Months Primary Study|Protocol Violation|0
81050|NCT00927186|288727|P2|12 Months Primary Study|Lost to Follow-up|0
81051|NCT00927186|288728|P1|12 Months Primary Study|Lost to Follow-up|1
81052|NCT00927186|288727|P2|12 Months Primary Study|Adverse Event|2
81053|NCT00927186|288728|P1|12 Months Primary Study|Adverse Event|5
81054|NCT00927095|288858|P3|Overall Study|Physician Decision|1
81055|NCT00927095|288859|P2|Overall Study|Physician Decision|2
81056|NCT00927095|288860|P1|Overall Study|Physician Decision|1
81057|NCT00927095|288858|P3|Overall Study|Withdrawal by Subject|1
81058|NCT00927095|288859|P2|Overall Study|Withdrawal by Subject|1
81059|NCT00927095|288860|P1|Overall Study|Withdrawal by Subject|2
81060|NCT00927095|288858|P3|Overall Study|Adverse Event|0
81061|NCT00927095|288859|P2|Overall Study|Adverse Event|1
81062|NCT00927095|288860|P1|Overall Study|Adverse Event|3
81063|NCT00927082|288872|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
81064|NCT00927082|288873|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
81065|NCT00927082|288874|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
81066|NCT00927082|288875|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
81067|NCT00927082|288872|P4|Overall Study|Death|0
81068|NCT00927082|288873|P3|Overall Study|Death|1
81069|NCT00927082|288874|P2|Overall Study|Death|0
81070|NCT00927082|288875|P1|Overall Study|Death|0
81071|NCT00927082|288872|P4|Overall Study|Withdrawal by Subject|2
81072|NCT00927082|288873|P3|Overall Study|Withdrawal by Subject|7
81073|NCT00927082|288874|P2|Overall Study|Withdrawal by Subject|2
81074|NCT00927082|288875|P1|Overall Study|Withdrawal by Subject|3
81075|NCT00927082|288872|P4|Overall Study|Lost to Follow-up|16
81076|NCT00927082|288873|P3|Overall Study|Lost to Follow-up|12
81077|NCT00927082|288874|P2|Overall Study|Lost to Follow-up|8
81078|NCT00927082|288875|P1|Overall Study|Lost to Follow-up|9
81079|NCT00927069|288939|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
81080|NCT00927069|288940|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
81081|NCT00927069|288941|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
81082|NCT00927069|288942|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
81083|NCT00927069|288939|P4|Week 12 to Week 24|Withdrawal by Subject|0
81084|NCT00927069|288940|P3|Week 12 to Week 24|Withdrawal by Subject|0
81085|NCT00927069|288941|P2|Week 12 to Week 24|Withdrawal by Subject|0
81086|NCT00927069|288942|P1|Week 12 to Week 24|Withdrawal by Subject|1
81087|NCT00927069|288939|P4|Week 12 to Week 24|Lost to Follow-up|0
81088|NCT00927069|288940|P3|Week 12 to Week 24|Lost to Follow-up|1
81089|NCT00927069|288941|P2|Week 12 to Week 24|Lost to Follow-up|0
81090|NCT00927069|288942|P1|Week 12 to Week 24|Lost to Follow-up|0
81091|NCT00927069|288939|P4|Week 12 to Week 24|Lack of Efficacy|3
81092|NCT00927069|288940|P3|Week 12 to Week 24|Lack of Efficacy|2
81093|NCT00927069|288941|P2|Week 12 to Week 24|Lack of Efficacy|0
81094|NCT00927069|288942|P1|Week 12 to Week 24|Lack of Efficacy|0
81095|NCT00927069|288939|P4|Week 0 to Week 12|Worsening of psoriasis|0
81096|NCT00927069|288940|P3|Week 0 to Week 12|Worsening of psoriasis|0
81097|NCT00927069|288941|P2|Week 0 to Week 12|Worsening of psoriasis|1
81098|NCT00927069|288942|P1|Week 0 to Week 12|Worsening of psoriasis|1
81099|NCT00926796|288979|P2|Overall Study|Withdrawal by Subject|0
81100|NCT00926796|288980|P1|Overall Study|Withdrawal by Subject|1
81101|NCT00926796|288979|P2|Overall Study|Protocol Violation|11
81102|NCT00926796|288980|P1|Overall Study|Protocol Violation|15
81103|NCT00926796|288979|P2|Overall Study|Lost to Follow-up|13
81104|NCT00926796|288980|P1|Overall Study|Lost to Follow-up|22
81105|NCT00926796|288979|P2|Overall Study|Adverse Event|14
81106|NCT00926796|288980|P1|Overall Study|Adverse Event|7
81107|NCT00926796|288979|P2|Overall Study|Ineligible, but positive for gonorrhea|1
81108|NCT00926796|288980|P1|Overall Study|Ineligible, but positive for gonorrhea|1
81109|NCT00926796|288979|P2|Overall Study|Ineligible, negative for gonorrhea|60
81110|NCT00926796|288980|P1|Overall Study|Ineligible, negative for gonorrhea|57
81111|NCT00926796|288979|P2|Overall Study|Did not receive randomized treatment|7
81112|NCT00926796|288980|P1|Overall Study|Did not receive randomized treatment|4
81113|NCT00926783|289001|P2|Overall Study|Incomplete CFAE Procedures|3
81114|NCT00926783|289002|P1|Overall Study|Incomplete CFAE Procedures|3
81115|NCT00926575|289029|P2|Overall Study|Withdrawal by Subject|9
81116|NCT00926575|289030|P1|Overall Study|Withdrawal by Subject|8
81117|NCT00926575|289029|P2|Overall Study|Protocol Violation|0
81118|NCT00926575|289030|P1|Overall Study|Protocol Violation|1
81119|NCT00926575|289029|P2|Overall Study|Physician Decision|2
81120|NCT00926575|289030|P1|Overall Study|Physician Decision|1
81121|NCT00926575|289029|P2|Overall Study|Lost to Follow-up|1
81122|NCT00926575|289030|P1|Overall Study|Lost to Follow-up|1
81123|NCT00926575|289029|P2|Overall Study|Death|4
81124|NCT00926575|289030|P1|Overall Study|Death|4
81125|NCT00926575|289029|P2|Overall Study|Adverse Event|1
81126|NCT00926575|289030|P1|Overall Study|Adverse Event|1
81127|NCT00926536|289042|P2|Overall Study|Physician Decision|2
81128|NCT00926536|289043|P1|Overall Study|Physician Decision|1
81129|NCT00926393|289064|P2|Overall Study|Adverse Event|1
81130|NCT00926393|289065|P1|Overall Study|Adverse Event|1
81131|NCT00926393|289064|P2|Overall Study|Withdrawal by Subject|2
81132|NCT00926393|289065|P1|Overall Study|Withdrawal by Subject|1
81133|NCT00926367|289097|P2|Overall Study|Skin Irritation|2
81134|NCT00926367|289098|P1|Overall Study|Skin Irritation|1
81135|NCT00926367|289097|P2|Overall Study|Lost to Follow-up|0
81136|NCT00926367|289098|P1|Overall Study|Lost to Follow-up|1
81137|NCT00926367|289097|P2|Overall Study|Withdrawal by Subject|1
81138|NCT00926367|289098|P1|Overall Study|Withdrawal by Subject|0
81139|NCT00926328|289140|P2|Overall Study|Lost to Follow-up|14
81140|NCT00926328|289141|P1|Overall Study|Lost to Follow-up|12
81141|NCT00926289|289151|P2|Overall Study|not specified|3
81142|NCT00926289|289152|P1|Overall Study|not specified|1
81143|NCT00926289|289151|P2|Overall Study|Withdrawal by Subject|4
81144|NCT00926289|289152|P1|Overall Study|Withdrawal by Subject|4
81145|NCT00926289|289151|P2|Overall Study|Lost to Follow-up|6
81146|NCT00926289|289152|P1|Overall Study|Lost to Follow-up|3
81147|NCT00926289|289151|P2|Overall Study|Protocol Violation|12
81148|NCT00926289|289152|P1|Overall Study|Protocol Violation|8
81149|NCT00926289|289151|P2|Overall Study|Adverse Event|11
81150|NCT00926289|289152|P1|Overall Study|Adverse Event|9
81151|NCT00926211|289220|P1|Overall Study|Lost to Follow-up|1
81152|NCT00926029|289230|P3|Overall Study|Lost to Follow-up|1
81153|NCT00926029|289231|P2|Overall Study|Lost to Follow-up|1
81154|NCT00926029|289232|P1|Overall Study|Lost to Follow-up|2
81155|NCT00925990|289245|P2|Overall Study|moved out of state, missed medication|2
81156|NCT00925990|289246|P1|Overall Study|moved out of state, missed medication|0
81157|NCT00925990|289245|P2|Overall Study|Physician Decision|1
81158|NCT00925990|289246|P1|Overall Study|Physician Decision|1
81159|NCT00925990|289245|P2|Overall Study|Lost to Follow-up|3
81160|NCT00925990|289246|P1|Overall Study|Lost to Follow-up|1
81161|NCT00925990|289245|P2|Overall Study|Withdrawal by Subject|2
81162|NCT00925990|289246|P1|Overall Study|Withdrawal by Subject|2
81163|NCT00925990|289245|P2|Overall Study|Adverse Event|3
81164|NCT00925990|289246|P1|Overall Study|Adverse Event|1
81165|NCT00925769|289289|P6|Overall Study|Adverse Event|0
81166|NCT00925769|289290|P5|Overall Study|Adverse Event|1
81167|NCT00925769|289291|P4|Overall Study|Adverse Event|0
81168|NCT00925769|289292|P3|Overall Study|Adverse Event|0
81169|NCT00925769|289293|P2|Overall Study|Adverse Event|0
81170|NCT00925769|289294|P1|Overall Study|Adverse Event|0
81171|NCT00925769|289289|P6|Overall Study|Participant is unable to swallow drug|0
81172|NCT00925769|289290|P5|Overall Study|Participant is unable to swallow drug|0
81173|NCT00925769|289291|P4|Overall Study|Participant is unable to swallow drug|1
81174|NCT00925769|289292|P3|Overall Study|Participant is unable to swallow drug|0
81175|NCT00925769|289293|P2|Overall Study|Participant is unable to swallow drug|0
81176|NCT00925769|289294|P1|Overall Study|Participant is unable to swallow drug|0
81177|NCT00925769|289289|P6|Overall Study|End of study visit not done|0
81178|NCT00925769|289290|P5|Overall Study|End of study visit not done|0
81179|NCT00925769|289291|P4|Overall Study|End of study visit not done|0
81180|NCT00925769|289292|P3|Overall Study|End of study visit not done|1
81181|NCT00925769|289293|P2|Overall Study|End of study visit not done|0
81182|NCT00925769|289294|P1|Overall Study|End of study visit not done|0
81183|NCT00925769|289289|P6|Overall Study|Missing documentation|0
81184|NCT00925769|289290|P5|Overall Study|Missing documentation|0
81185|NCT00925769|289291|P4|Overall Study|Missing documentation|0
81186|NCT00925769|289292|P3|Overall Study|Missing documentation|0
81187|NCT00925769|289293|P2|Overall Study|Missing documentation|1
81188|NCT00925769|289294|P1|Overall Study|Missing documentation|0
81189|NCT00925769|289289|P6|Overall Study|Physician Decision|0
81190|NCT00925769|289290|P5|Overall Study|Physician Decision|0
81191|NCT00925769|289291|P4|Overall Study|Physician Decision|0
81192|NCT00925769|289292|P3|Overall Study|Physician Decision|0
81193|NCT00925769|289293|P2|Overall Study|Physician Decision|0
81194|NCT00925769|289294|P1|Overall Study|Physician Decision|1
81195|NCT00925769|289289|P6|Overall Study|Death|0
81196|NCT00925769|289290|P5|Overall Study|Death|0
81197|NCT00925769|289291|P4|Overall Study|Death|0
81198|NCT00925769|289292|P3|Overall Study|Death|1
81199|NCT00925769|289293|P2|Overall Study|Death|0
81200|NCT00925769|289294|P1|Overall Study|Death|0
81201|NCT00925769|289289|P6|Overall Study|Disease progression|3
81202|NCT00925769|289290|P5|Overall Study|Disease progression|2
81203|NCT00925769|289291|P4|Overall Study|Disease progression|4
81204|NCT00925769|289292|P3|Overall Study|Disease progression|3
81205|NCT00925769|289293|P2|Overall Study|Disease progression|5
81206|NCT00925769|289294|P1|Overall Study|Disease progression|4
81207|NCT00925769|289289|P6|Overall Study|Major toxicity|0
81208|NCT00925769|289290|P5|Overall Study|Major toxicity|0
81209|NCT00925769|289291|P4|Overall Study|Major toxicity|1
81210|NCT00925769|289292|P3|Overall Study|Major toxicity|1
81211|NCT00925769|289293|P2|Overall Study|Major toxicity|0
81212|NCT00925769|289294|P1|Overall Study|Major toxicity|1
81213|NCT00925704|289362|P6|Third Intervention|Withdrew consent|1
81214|NCT00925704|289363|P5|Third Intervention|Withdrew consent|0
81215|NCT00925704|289364|P4|Third Intervention|Withdrew consent|0
81216|NCT00925704|289365|P3|Third Intervention|Withdrew consent|0
81217|NCT00925704|289366|P2|Third Intervention|Withdrew consent|0
81218|NCT00925704|289367|P1|Third Intervention|Withdrew consent|0
81219|NCT00925704|289362|P6|Second Intervention|Withdrawal by Subject|0
81220|NCT00925704|289363|P5|Second Intervention|Withdrawal by Subject|1
81221|NCT00925704|289364|P4|Second Intervention|Withdrawal by Subject|0
81222|NCT00925704|289365|P3|Second Intervention|Withdrawal by Subject|0
81223|NCT00925704|289366|P2|Second Intervention|Withdrawal by Subject|0
81224|NCT00925704|289367|P1|Second Intervention|Withdrawal by Subject|1
81225|NCT00925704|289362|P6|First Intervention|Withdrew consent|0
81226|NCT00925704|289363|P5|First Intervention|Withdrew consent|1
81227|NCT00925704|289364|P4|First Intervention|Withdrew consent|1
81228|NCT00925704|289365|P3|First Intervention|Withdrew consent|0
81229|NCT00925704|289366|P2|First Intervention|Withdrew consent|0
81230|NCT00925704|289367|P1|First Intervention|Withdrew consent|0
81231|NCT00925587|289380|P2|Overall Study|Lost to Follow-up|1
81232|NCT00925587|289381|P1|Overall Study|Lost to Follow-up|0
81233|NCT00925587|289380|P2|Overall Study|Adverse Event|2
81234|NCT00925587|289381|P1|Overall Study|Adverse Event|6
81235|NCT00925587|289380|P2|Overall Study|Death|5
81236|NCT00925587|289381|P1|Overall Study|Death|5
81237|NCT00925587|289380|P2|Overall Study|Withdrawal by Subject|6
81238|NCT00925587|289381|P1|Overall Study|Withdrawal by Subject|9
81239|NCT00925587|289380|P2|Overall Study|Protocol Violation|4
81240|NCT00925587|289381|P1|Overall Study|Protocol Violation|6
81241|NCT00925587|289380|P2|Overall Study|Physician Decision|1
81242|NCT00925587|289381|P1|Overall Study|Physician Decision|4
81243|NCT00925587|289380|P2|Overall Study|Protocol Specified Criteria|6
81244|NCT00925587|289381|P1|Overall Study|Protocol Specified Criteria|6
81245|NCT00925548|289495|P2|Overall Study|Discontinuation of trial by sponsor|5
81246|NCT00925548|289496|P1|Overall Study|Discontinuation of trial by sponsor|10
81247|NCT00925353|289526|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
81248|NCT00925288|289532|P2|Overall Study|Lost to Follow-up|7
81249|NCT00925288|289533|P1|Overall Study|Lost to Follow-up|9
81250|NCT00924950|289545|P1|Overall Study|Lost to Follow-up|2
81251|NCT00924781|289577|P2|Overall Study|Study terminated by sponsor|10
81252|NCT00924781|289578|P1|Overall Study|Study terminated by sponsor|12
81253|NCT00924729|289612|P2|Overall Study|Protocol Violation|0
81254|NCT00924729|289613|P1|Overall Study|Protocol Violation|1
81255|NCT00924729|289612|P2|Overall Study|insufficient volume for analysis|0
81256|NCT00924729|289613|P1|Overall Study|insufficient volume for analysis|1
81257|NCT00924638|289621|P2|Overall Study|Physician Decision|3
81258|NCT00924638|289622|P1|Overall Study|Physician Decision|3
81259|NCT00924638|289621|P2|Overall Study|Withdrawal by Subject|7
81260|NCT00924638|289622|P1|Overall Study|Withdrawal by Subject|5
81261|NCT00924638|289621|P2|Overall Study|Lost to Follow-up|1
81262|NCT00924638|289622|P1|Overall Study|Lost to Follow-up|1
81263|NCT00924638|289621|P2|Overall Study|Death|2
81264|NCT00924638|289622|P1|Overall Study|Death|3
81265|NCT00924560|289644|P3|Overall Study|Miscellaneous Reasons|10
81266|NCT00924560|289645|P2|Overall Study|Miscellaneous Reasons|10
81267|NCT00924560|289646|P1|Overall Study|Miscellaneous Reasons|13
81268|NCT00924560|289644|P3|Overall Study|Lost to Follow-up|45
81269|NCT00924560|289645|P2|Overall Study|Lost to Follow-up|94
81270|NCT00924560|289646|P1|Overall Study|Lost to Follow-up|78
81271|NCT00924560|289644|P3|Overall Study|Pregnancy|1
81272|NCT00924560|289645|P2|Overall Study|Pregnancy|7
81273|NCT00924560|289646|P1|Overall Study|Pregnancy|5
81274|NCT00924560|289644|P3|Overall Study|Adverse Event|0
81275|NCT00924560|289645|P2|Overall Study|Adverse Event|33
81276|NCT00924560|289646|P1|Overall Study|Adverse Event|39
81277|NCT00924560|289644|P3|Overall Study|Withdrawal by Subject|18
81278|NCT00924560|289645|P2|Overall Study|Withdrawal by Subject|44
81279|NCT00924560|289646|P1|Overall Study|Withdrawal by Subject|50
81280|NCT00924560|289644|P3|Overall Study|Physician Decision|4
81281|NCT00924560|289645|P2|Overall Study|Physician Decision|3
81282|NCT00924560|289646|P1|Overall Study|Physician Decision|2
81283|NCT00924560|289644|P3|Overall Study|Non Compliance with the Protocol|4
81284|NCT00924560|289645|P2|Overall Study|Non Compliance with the Protocol|15
81285|NCT00924560|289646|P1|Overall Study|Non Compliance with the Protocol|20
81286|NCT00924560|289644|P3|Overall Study|Did Not Meet Protocol Requirements|1
81287|NCT00924560|289645|P2|Overall Study|Did Not Meet Protocol Requirements|2
81288|NCT00924560|289646|P1|Overall Study|Did Not Meet Protocol Requirements|4
81289|NCT00924508|289690|P1|Overall Study|Withdrawal by Subject|3
81290|NCT00924469|289704|P2|Overall Study|Lost to Follow-up|1
81291|NCT00924469|289705|P1|Overall Study|Lost to Follow-up|0
81292|NCT00924469|289704|P2|Overall Study|Withdrawal by Subject|1
81293|NCT00924469|289705|P1|Overall Study|Withdrawal by Subject|0
81294|NCT00924469|289704|P2|Overall Study|Adverse Event|0
81295|NCT00924469|289705|P1|Overall Study|Adverse Event|2
81296|NCT00924443|289727|P1|Overall Study|Protocol Violation|1
81297|NCT00924443|289727|P1|Overall Study|Physician Decision|2
81298|NCT00924313|289749|P1|Overall Study|not imaged due to failed tracer imaging|1
81299|NCT00924287|289754|P1|Overall Study|Death|1
81300|NCT00923975|289841|P1|Overall Study|Did not meet inclusion criteria|1
81301|NCT00923845|289868|P2|Induction Therapy|Poor performance status|2
81302|NCT00923845|289869|P1|Induction Therapy|Poor performance status|0
81303|NCT00923351|289883|P3|Overall Study|no apheresis/adequate tumor sample|12
81304|NCT00923351|289884|P2|Overall Study|no apheresis/adequate tumor sample|0
81305|NCT00923351|289885|P1|Overall Study|no apheresis/adequate tumor sample|0
81306|NCT00923273|289898|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
81307|NCT00923273|289899|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
81308|NCT00923273|289900|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
81309|NCT00923273|289901|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
81310|NCT00923273|289902|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
81311|NCT00923273|289898|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
81312|NCT00923273|289899|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
81313|NCT00923273|289900|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
81314|NCT00923273|289901|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
81315|NCT00923273|289902|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
81316|NCT00923260|289927|P2|Overall Study|Lost to Follow-up|1
81317|NCT00923260|289928|P1|Overall Study|Lost to Follow-up|1
81318|NCT00923195|290062|P2|Overall Study|Death|1
81319|NCT00923195|290063|P1|Overall Study|Death|0
81320|NCT00923156|290074|P3|Overall Study|Lack of Efficacy|1
81321|NCT00923156|290075|P2|Overall Study|Lack of Efficacy|0
81322|NCT00923156|290076|P1|Overall Study|Lack of Efficacy|0
81323|NCT00923156|290074|P3|Overall Study|Death|0
81324|NCT00923156|290075|P2|Overall Study|Death|1
81325|NCT00923156|290076|P1|Overall Study|Death|0
81326|NCT00923156|290074|P3|Overall Study|Withdrawal by Subject|0
81327|NCT00923156|290075|P2|Overall Study|Withdrawal by Subject|1
81328|NCT00923156|290076|P1|Overall Study|Withdrawal by Subject|0
81329|NCT00923156|290074|P3|Overall Study|Abnormal laboratory values|1
81330|NCT00923156|290075|P2|Overall Study|Abnormal laboratory values|0
81331|NCT00923156|290076|P1|Overall Study|Abnormal laboratory values|0
81332|NCT00923156|290074|P3|Overall Study|Adverse Event|1
81333|NCT00923156|290075|P2|Overall Study|Adverse Event|2
81334|NCT00923156|290076|P1|Overall Study|Adverse Event|0
81335|NCT00923091|290121|P13|Period VI (Open-Label)|Other Reason|0
81336|NCT00923091|290122|P12|Period VI (Open-Label)|Other Reason|0
81337|NCT00923091|290123|P11|Period VI (Open-Label)|Other Reason|0
81338|NCT00923091|290124|P10|Period VI (Open-Label)|Other Reason|0
81339|NCT00923091|290125|P9|Period VI (Open-Label)|Other Reason|0
81340|NCT00923091|290126|P8|Period VI (Open-Label)|Other Reason|0
81341|NCT00923091|290127|P7|Period VI (Open-Label)|Other Reason|0
81342|NCT00923091|290128|P6|Period VI (Open-Label)|Other Reason|0
81343|NCT00923091|290129|P5|Period VI (Open-Label)|Other Reason|1
81344|NCT00923091|290130|P4|Period VI (Open-Label)|Other Reason|1
81345|NCT00923091|290131|P3|Period VI (Open-Label)|Other Reason|0
81346|NCT00923091|290132|P2|Period VI (Open-Label)|Other Reason|0
81347|NCT00923091|290133|P1|Period VI (Open-Label)|Other Reason|0
81348|NCT00923091|290121|P13|Period VI (Open-Label)|Lost to Follow-up|0
81349|NCT00923091|290122|P12|Period VI (Open-Label)|Lost to Follow-up|0
81350|NCT00923091|290123|P11|Period VI (Open-Label)|Lost to Follow-up|0
81351|NCT00923091|290124|P10|Period VI (Open-Label)|Lost to Follow-up|0
81352|NCT00923091|290125|P9|Period VI (Open-Label)|Lost to Follow-up|0
81353|NCT00923091|290126|P8|Period VI (Open-Label)|Lost to Follow-up|0
81354|NCT00923091|290127|P7|Period VI (Open-Label)|Lost to Follow-up|0
81355|NCT00923091|290128|P6|Period VI (Open-Label)|Lost to Follow-up|0
81356|NCT00923091|290129|P5|Period VI (Open-Label)|Lost to Follow-up|0
81357|NCT00923091|290130|P4|Period VI (Open-Label)|Lost to Follow-up|0
81358|NCT00923091|290131|P3|Period VI (Open-Label)|Lost to Follow-up|1
81359|NCT00923091|290132|P2|Period VI (Open-Label)|Lost to Follow-up|0
81360|NCT00923091|290133|P1|Period VI (Open-Label)|Lost to Follow-up|1
81361|NCT00923091|290121|P13|Period VI (Open-Label)|Protocol Violation|0
81362|NCT00923091|290122|P12|Period VI (Open-Label)|Protocol Violation|0
81363|NCT00923091|290123|P11|Period VI (Open-Label)|Protocol Violation|0
81364|NCT00923091|290124|P10|Period VI (Open-Label)|Protocol Violation|0
81365|NCT00923091|290125|P9|Period VI (Open-Label)|Protocol Violation|0
81366|NCT00923091|290126|P8|Period VI (Open-Label)|Protocol Violation|0
81367|NCT00923091|290127|P7|Period VI (Open-Label)|Protocol Violation|0
81368|NCT00923091|290128|P6|Period VI (Open-Label)|Protocol Violation|0
81369|NCT00923091|290129|P5|Period VI (Open-Label)|Protocol Violation|4
81370|NCT00923091|290130|P4|Period VI (Open-Label)|Protocol Violation|1
81371|NCT00923091|290131|P3|Period VI (Open-Label)|Protocol Violation|3
81372|NCT00923091|290132|P2|Period VI (Open-Label)|Protocol Violation|1
81373|NCT00923091|290133|P1|Period VI (Open-Label)|Protocol Violation|6
81374|NCT00923091|290121|P13|Period VI (Open-Label)|Withdrawal by Subject|0
81375|NCT00923091|290122|P12|Period VI (Open-Label)|Withdrawal by Subject|0
81376|NCT00923091|290123|P11|Period VI (Open-Label)|Withdrawal by Subject|0
81377|NCT00923091|290124|P10|Period VI (Open-Label)|Withdrawal by Subject|0
81378|NCT00923091|290125|P9|Period VI (Open-Label)|Withdrawal by Subject|0
81379|NCT00923091|290126|P8|Period VI (Open-Label)|Withdrawal by Subject|0
81380|NCT00923091|290127|P7|Period VI (Open-Label)|Withdrawal by Subject|0
81381|NCT00923091|290128|P6|Period VI (Open-Label)|Withdrawal by Subject|0
81382|NCT00923091|290129|P5|Period VI (Open-Label)|Withdrawal by Subject|1
81383|NCT00923091|290130|P4|Period VI (Open-Label)|Withdrawal by Subject|0
81384|NCT00923091|290131|P3|Period VI (Open-Label)|Withdrawal by Subject|5
81385|NCT00923091|290132|P2|Period VI (Open-Label)|Withdrawal by Subject|7
81386|NCT00923091|290133|P1|Period VI (Open-Label)|Withdrawal by Subject|15
81387|NCT00923091|290121|P13|Period VI (Open-Label)|Adverse Event|0
81388|NCT00923091|290122|P12|Period VI (Open-Label)|Adverse Event|0
81389|NCT00923091|290123|P11|Period VI (Open-Label)|Adverse Event|0
81390|NCT00923091|290124|P10|Period VI (Open-Label)|Adverse Event|0
81391|NCT00923091|290125|P9|Period VI (Open-Label)|Adverse Event|0
81392|NCT00923091|290126|P8|Period VI (Open-Label)|Adverse Event|0
81393|NCT00923091|290127|P7|Period VI (Open-Label)|Adverse Event|0
81394|NCT00923091|290128|P6|Period VI (Open-Label)|Adverse Event|0
81395|NCT00923091|290129|P5|Period VI (Open-Label)|Adverse Event|1
81396|NCT00923091|290130|P4|Period VI (Open-Label)|Adverse Event|1
81397|NCT00923091|290131|P3|Period VI (Open-Label)|Adverse Event|4
81398|NCT00923091|290132|P2|Period VI (Open-Label)|Adverse Event|0
81399|NCT00923091|290133|P1|Period VI (Open-Label)|Adverse Event|17
81400|NCT00923091|290121|P13|Period V (Double -Blind)|Lost to Follow-up|0
81401|NCT00923091|290122|P12|Period V (Double -Blind)|Lost to Follow-up|0
81402|NCT00923091|290123|P11|Period V (Double -Blind)|Lost to Follow-up|1
81403|NCT00923091|290124|P10|Period V (Double -Blind)|Lost to Follow-up|0
81404|NCT00923091|290125|P9|Period V (Double -Blind)|Lost to Follow-up|0
81405|NCT00923091|290126|P8|Period V (Double -Blind)|Lost to Follow-up|0
81406|NCT00923091|290127|P7|Period V (Double -Blind)|Lost to Follow-up|0
81407|NCT00923091|290128|P6|Period V (Double -Blind)|Lost to Follow-up|0
81408|NCT00923091|290129|P5|Period V (Double -Blind)|Lost to Follow-up|0
81409|NCT00923091|290130|P4|Period V (Double -Blind)|Lost to Follow-up|0
81410|NCT00923091|290131|P3|Period V (Double -Blind)|Lost to Follow-up|0
81411|NCT00923091|290132|P2|Period V (Double -Blind)|Lost to Follow-up|0
81412|NCT00923091|290133|P1|Period V (Double -Blind)|Lost to Follow-up|0
81413|NCT00923091|290121|P13|Period V (Double -Blind)|Protocol Violation|1
81414|NCT00923091|290122|P12|Period V (Double -Blind)|Protocol Violation|0
81415|NCT00923091|290123|P11|Period V (Double -Blind)|Protocol Violation|0
81416|NCT00923091|290124|P10|Period V (Double -Blind)|Protocol Violation|0
81417|NCT00923091|290125|P9|Period V (Double -Blind)|Protocol Violation|0
81418|NCT00923091|290126|P8|Period V (Double -Blind)|Protocol Violation|0
81419|NCT00923091|290127|P7|Period V (Double -Blind)|Protocol Violation|0
81420|NCT00923091|290128|P6|Period V (Double -Blind)|Protocol Violation|0
81421|NCT00923091|290129|P5|Period V (Double -Blind)|Protocol Violation|0
81422|NCT00923091|290130|P4|Period V (Double -Blind)|Protocol Violation|0
81423|NCT00923091|290131|P3|Period V (Double -Blind)|Protocol Violation|0
81424|NCT00923091|290132|P2|Period V (Double -Blind)|Protocol Violation|0
81425|NCT00923091|290133|P1|Period V (Double -Blind)|Protocol Violation|0
81426|NCT00923091|290121|P13|Period V (Double -Blind)|Withdrawal by Subject|1
81427|NCT00923091|290122|P12|Period V (Double -Blind)|Withdrawal by Subject|0
81428|NCT00923091|290123|P11|Period V (Double -Blind)|Withdrawal by Subject|0
81429|NCT00923091|290124|P10|Period V (Double -Blind)|Withdrawal by Subject|0
81430|NCT00923091|290125|P9|Period V (Double -Blind)|Withdrawal by Subject|1
81431|NCT00923091|290126|P8|Period V (Double -Blind)|Withdrawal by Subject|0
81432|NCT00923091|290127|P7|Period V (Double -Blind)|Withdrawal by Subject|0
81433|NCT00923091|290128|P6|Period V (Double -Blind)|Withdrawal by Subject|0
81434|NCT00923091|290129|P5|Period V (Double -Blind)|Withdrawal by Subject|0
81435|NCT00923091|290130|P4|Period V (Double -Blind)|Withdrawal by Subject|0
81436|NCT00923091|290131|P3|Period V (Double -Blind)|Withdrawal by Subject|0
81437|NCT00923091|290132|P2|Period V (Double -Blind)|Withdrawal by Subject|0
81438|NCT00923091|290133|P1|Period V (Double -Blind)|Withdrawal by Subject|0
81439|NCT00923091|290121|P13|Period IV (Double-Blind)|Protocol Violation|0
81440|NCT00923091|290122|P12|Period IV (Double-Blind)|Protocol Violation|0
81441|NCT00923091|290123|P11|Period IV (Double-Blind)|Protocol Violation|0
81442|NCT00923091|290124|P10|Period IV (Double-Blind)|Protocol Violation|0
81443|NCT00923091|290125|P9|Period IV (Double-Blind)|Protocol Violation|0
81444|NCT00923091|290126|P8|Period IV (Double-Blind)|Protocol Violation|0
81445|NCT00923091|290127|P7|Period IV (Double-Blind)|Protocol Violation|0
81446|NCT00923091|290128|P6|Period IV (Double-Blind)|Protocol Violation|0
81447|NCT00923091|290129|P5|Period IV (Double-Blind)|Protocol Violation|0
81448|NCT00923091|290130|P4|Period IV (Double-Blind)|Protocol Violation|0
81449|NCT00923091|290131|P3|Period IV (Double-Blind)|Protocol Violation|0
81450|NCT00923091|290132|P2|Period IV (Double-Blind)|Protocol Violation|1
81451|NCT00923091|290133|P1|Period IV (Double-Blind)|Protocol Violation|0
81452|NCT00923091|290121|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
81453|NCT00923091|290122|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
81454|NCT00923091|290123|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
81455|NCT00923091|290124|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
81456|NCT00923091|290125|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
81457|NCT00923091|290126|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
81458|NCT00923091|290127|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
81459|NCT00923091|290128|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
81460|NCT00923091|290129|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
81461|NCT00923091|290130|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
81462|NCT00923091|290131|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
81463|NCT00923091|290132|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
81464|NCT00923091|290133|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
81465|NCT00923091|290121|P13|Period IV (Double-Blind)|Adverse Event|0
81466|NCT00923091|290122|P12|Period IV (Double-Blind)|Adverse Event|0
81467|NCT00923091|290123|P11|Period IV (Double-Blind)|Adverse Event|0
81468|NCT00923091|290124|P10|Period IV (Double-Blind)|Adverse Event|0
81469|NCT00923091|290125|P9|Period IV (Double-Blind)|Adverse Event|0
81470|NCT00923091|290126|P8|Period IV (Double-Blind)|Adverse Event|0
81471|NCT00923091|290127|P7|Period IV (Double-Blind)|Adverse Event|0
81472|NCT00923091|290128|P6|Period IV (Double-Blind)|Adverse Event|0
81473|NCT00923091|290129|P5|Period IV (Double-Blind)|Adverse Event|0
81474|NCT00923091|290130|P4|Period IV (Double-Blind)|Adverse Event|0
81475|NCT00923091|290131|P3|Period IV (Double-Blind)|Adverse Event|0
81476|NCT00923091|290132|P2|Period IV (Double-Blind)|Adverse Event|0
81477|NCT00923091|290133|P1|Period IV (Double-Blind)|Adverse Event|2
81478|NCT00923091|290121|P13|Period III (Single-Blind)|Lost to Follow-up|0
81479|NCT00923091|290122|P12|Period III (Single-Blind)|Lost to Follow-up|0
81480|NCT00923091|290123|P11|Period III (Single-Blind)|Lost to Follow-up|0
81481|NCT00923091|290124|P10|Period III (Single-Blind)|Lost to Follow-up|0
81482|NCT00923091|290125|P9|Period III (Single-Blind)|Lost to Follow-up|0
81483|NCT00923091|290126|P8|Period III (Single-Blind)|Lost to Follow-up|0
81484|NCT00923091|290127|P7|Period III (Single-Blind)|Lost to Follow-up|0
81485|NCT00923091|290128|P6|Period III (Single-Blind)|Lost to Follow-up|0
81486|NCT00923091|290129|P5|Period III (Single-Blind)|Lost to Follow-up|0
81487|NCT00923091|290130|P4|Period III (Single-Blind)|Lost to Follow-up|0
81488|NCT00923091|290131|P3|Period III (Single-Blind)|Lost to Follow-up|0
81489|NCT00923091|290132|P2|Period III (Single-Blind)|Lost to Follow-up|0
81490|NCT00923091|290133|P1|Period III (Single-Blind)|Lost to Follow-up|2
81491|NCT00923091|290121|P13|Period III (Single-Blind)|Protocol Violation|0
81492|NCT00923091|290122|P12|Period III (Single-Blind)|Protocol Violation|0
81493|NCT00923091|290123|P11|Period III (Single-Blind)|Protocol Violation|0
81494|NCT00923091|290124|P10|Period III (Single-Blind)|Protocol Violation|0
81495|NCT00923091|290125|P9|Period III (Single-Blind)|Protocol Violation|0
81496|NCT00923091|290126|P8|Period III (Single-Blind)|Protocol Violation|0
81497|NCT00923091|290127|P7|Period III (Single-Blind)|Protocol Violation|0
81498|NCT00923091|290128|P6|Period III (Single-Blind)|Protocol Violation|0
81499|NCT00923091|290129|P5|Period III (Single-Blind)|Protocol Violation|0
81500|NCT00923091|290130|P4|Period III (Single-Blind)|Protocol Violation|0
81501|NCT00923091|290131|P3|Period III (Single-Blind)|Protocol Violation|0
81502|NCT00923091|290132|P2|Period III (Single-Blind)|Protocol Violation|0
81503|NCT00923091|290133|P1|Period III (Single-Blind)|Protocol Violation|3
81504|NCT00923091|290121|P13|Period III (Single-Blind)|Withdrawal by Subject|0
81505|NCT00923091|290122|P12|Period III (Single-Blind)|Withdrawal by Subject|0
81506|NCT00923091|290123|P11|Period III (Single-Blind)|Withdrawal by Subject|0
81507|NCT00923091|290124|P10|Period III (Single-Blind)|Withdrawal by Subject|0
81508|NCT00923091|290125|P9|Period III (Single-Blind)|Withdrawal by Subject|0
81509|NCT00923091|290126|P8|Period III (Single-Blind)|Withdrawal by Subject|0
81510|NCT00923091|290127|P7|Period III (Single-Blind)|Withdrawal by Subject|0
81511|NCT00923091|290128|P6|Period III (Single-Blind)|Withdrawal by Subject|0
81512|NCT00923091|290129|P5|Period III (Single-Blind)|Withdrawal by Subject|0
81513|NCT00923091|290130|P4|Period III (Single-Blind)|Withdrawal by Subject|0
81514|NCT00923091|290131|P3|Period III (Single-Blind)|Withdrawal by Subject|0
81515|NCT00923091|290132|P2|Period III (Single-Blind)|Withdrawal by Subject|0
81516|NCT00923091|290133|P1|Period III (Single-Blind)|Withdrawal by Subject|10
81517|NCT00923091|290121|P13|Period III (Single-Blind)|Adverse Event|0
81518|NCT00923091|290122|P12|Period III (Single-Blind)|Adverse Event|0
81519|NCT00923091|290123|P11|Period III (Single-Blind)|Adverse Event|0
81520|NCT00923091|290124|P10|Period III (Single-Blind)|Adverse Event|0
81521|NCT00923091|290125|P9|Period III (Single-Blind)|Adverse Event|0
81522|NCT00923091|290126|P8|Period III (Single-Blind)|Adverse Event|0
81523|NCT00923091|290127|P7|Period III (Single-Blind)|Adverse Event|0
81524|NCT00923091|290128|P6|Period III (Single-Blind)|Adverse Event|0
81525|NCT00923091|290129|P5|Period III (Single-Blind)|Adverse Event|0
81526|NCT00923091|290130|P4|Period III (Single-Blind)|Adverse Event|0
81527|NCT00923091|290131|P3|Period III (Single-Blind)|Adverse Event|0
81528|NCT00923091|290132|P2|Period III (Single-Blind)|Adverse Event|0
81529|NCT00923091|290133|P1|Period III (Single-Blind)|Adverse Event|5
81530|NCT00923091|290121|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
81531|NCT00923091|290122|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
81532|NCT00923091|290123|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
81533|NCT00923091|290124|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
81534|NCT00923091|290125|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
81535|NCT00923091|290126|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
81536|NCT00923091|290127|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
81537|NCT00923091|290128|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
81538|NCT00923091|290129|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
81539|NCT00923091|290130|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
81540|NCT00923091|290131|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
81541|NCT00923091|290132|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
81542|NCT00923091|290133|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
81543|NCT00923091|290121|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
81544|NCT00923091|290122|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
81545|NCT00923091|290123|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
81546|NCT00923091|290124|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
81547|NCT00923091|290125|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
81548|NCT00923091|290126|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
81549|NCT00923091|290127|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
81550|NCT00923091|290128|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
81551|NCT00923091|290129|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
81552|NCT00923091|290130|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
81553|NCT00923091|290131|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
81554|NCT00923091|290132|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
81555|NCT00923091|290133|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
81556|NCT00923091|290121|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
81557|NCT00923091|290122|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
81558|NCT00923091|290123|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
81559|NCT00923091|290124|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
81560|NCT00923091|290125|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
81561|NCT00923091|290126|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
81562|NCT00923091|290127|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
81563|NCT00923091|290128|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
81564|NCT00923091|290129|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
81565|NCT00923091|290130|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
81566|NCT00923091|290131|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
81567|NCT00923091|290132|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
81568|NCT00923091|290133|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
81569|NCT00923091|290121|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
81570|NCT00923091|290122|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
81571|NCT00923091|290123|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
81572|NCT00923091|290124|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
81573|NCT00923091|290125|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
81574|NCT00923091|290126|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
81575|NCT00923091|290127|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
81576|NCT00923091|290128|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
81577|NCT00923091|290129|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
81578|NCT00923091|290130|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
81664|NCT00922272|290417|P1|Double-blind Phase|Noncompliance|1
81579|NCT00923091|290131|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
81580|NCT00923091|290132|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
81581|NCT00923091|290133|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
81582|NCT00923091|290121|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
81583|NCT00923091|290122|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
81584|NCT00923091|290123|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
81585|NCT00923091|290124|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
81586|NCT00923091|290125|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
81587|NCT00923091|290126|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
81588|NCT00923091|290127|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
81589|NCT00923091|290128|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
81590|NCT00923091|290129|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
81591|NCT00923091|290130|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
81592|NCT00923091|290131|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
81593|NCT00923091|290132|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
81594|NCT00923091|290133|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
81595|NCT00922987|290180|P1|Overall Study|Adverse Event|1
81596|NCT00922987|290180|P1|Overall Study|Protocol Violation|2
81597|NCT00922987|290180|P1|Overall Study|Insufficient clinical response|1
81598|NCT00922935|290195|P3|Overall Study|Lost to Follow-up|0
81599|NCT00922935|290196|P2|Overall Study|Lost to Follow-up|1
81600|NCT00922935|290197|P1|Overall Study|Lost to Follow-up|0
81601|NCT00922935|290195|P3|Overall Study|Physician Decision|0
81602|NCT00922935|290196|P2|Overall Study|Physician Decision|1
81603|NCT00922935|290197|P1|Overall Study|Physician Decision|1
81604|NCT00922935|290195|P3|Overall Study|Protocol Violation|0
81605|NCT00922935|290196|P2|Overall Study|Protocol Violation|3
81606|NCT00922935|290197|P1|Overall Study|Protocol Violation|0
81607|NCT00922779|290205|P1|Overall Study|Missing|1874
81608|NCT00922779|290205|P1|Overall Study|Unspecified|27
81609|NCT00922779|290205|P1|Overall Study|Lost to Follow-up|44
81610|NCT00922779|290205|P1|Overall Study|Withdrawal by Subject|308
81611|NCT00922779|290205|P1|Overall Study|Pregnancy|7
81612|NCT00922779|290205|P1|Overall Study|Adverse Event|67
81613|NCT00922766|290212|P1|Overall Study|Adverse Event|1
81614|NCT00922766|290212|P1|Overall Study|Unspecified|1
81615|NCT00922766|290212|P1|Overall Study|Withdrawal by Subject|2
81616|NCT00922766|290212|P1|Overall Study|Death|3
81617|NCT00922636|290230|P5|Overall Study|Lost to Follow-up|4
81618|NCT00922636|290231|P4|Overall Study|Lost to Follow-up|2
81619|NCT00922636|290232|P3|Overall Study|Lost to Follow-up|2
81620|NCT00922636|290233|P2|Overall Study|Lost to Follow-up|2
81621|NCT00922636|290234|P1|Overall Study|Lost to Follow-up|1
81622|NCT00922636|290230|P5|Overall Study|Parent/Caregiver Decision|2
81623|NCT00922636|290231|P4|Overall Study|Parent/Caregiver Decision|5
81624|NCT00922636|290232|P3|Overall Study|Parent/Caregiver Decision|3
81625|NCT00922636|290233|P2|Overall Study|Parent/Caregiver Decision|4
81626|NCT00922636|290234|P1|Overall Study|Parent/Caregiver Decision|2
81627|NCT00922636|290230|P5|Overall Study|Entry Criteria Not Met|0
81628|NCT00922636|290231|P4|Overall Study|Entry Criteria Not Met|1
81629|NCT00922636|290232|P3|Overall Study|Entry Criteria Not Met|1
81630|NCT00922636|290233|P2|Overall Study|Entry Criteria Not Met|0
81631|NCT00922636|290234|P1|Overall Study|Entry Criteria Not Met|0
81632|NCT00922636|290230|P5|Overall Study|Protocol Violation|0
81633|NCT00922636|290231|P4|Overall Study|Protocol Violation|2
81634|NCT00922636|290232|P3|Overall Study|Protocol Violation|2
81635|NCT00922636|290233|P2|Overall Study|Protocol Violation|0
81636|NCT00922636|290234|P1|Overall Study|Protocol Violation|0
81637|NCT00922636|290230|P5|Overall Study|Withdrawal by Subject|4
81638|NCT00922636|290231|P4|Overall Study|Withdrawal by Subject|2
81639|NCT00922636|290232|P3|Overall Study|Withdrawal by Subject|5
81640|NCT00922636|290233|P2|Overall Study|Withdrawal by Subject|0
81641|NCT00922636|290234|P1|Overall Study|Withdrawal by Subject|0
81642|NCT00922636|290230|P5|Overall Study|Sponsor Decision|0
81643|NCT00922636|290231|P4|Overall Study|Sponsor Decision|0
81644|NCT00922636|290232|P3|Overall Study|Sponsor Decision|2
81645|NCT00922636|290233|P2|Overall Study|Sponsor Decision|0
81646|NCT00922636|290234|P1|Overall Study|Sponsor Decision|0
81647|NCT00922636|290230|P5|Overall Study|Lack of Efficacy|4
81648|NCT00922636|290231|P4|Overall Study|Lack of Efficacy|2
81649|NCT00922636|290232|P3|Overall Study|Lack of Efficacy|3
81650|NCT00922636|290233|P2|Overall Study|Lack of Efficacy|7
81651|NCT00922636|290234|P1|Overall Study|Lack of Efficacy|1
81652|NCT00922636|290230|P5|Overall Study|Adverse Event|2
81653|NCT00922636|290231|P4|Overall Study|Adverse Event|3
81654|NCT00922636|290232|P3|Overall Study|Adverse Event|2
81655|NCT00922636|290233|P2|Overall Study|Adverse Event|3
81656|NCT00922636|290234|P1|Overall Study|Adverse Event|3
81657|NCT00922623|290381|P1|Overall Study|Lost to Follow-up|1
81658|NCT00922623|290381|P1|Overall Study|Other|4
81659|NCT00922428|290387|P1|Overall Study|no medication use or questionable use|13
81660|NCT00922428|290387|P1|Overall Study|retrospective/extremely implausible data|2
81661|NCT00922272|290416|P2|Double-blind Phase|Positive urine drug screen|1
81662|NCT00922272|290417|P1|Double-blind Phase|Positive urine drug screen|1
81663|NCT00922272|290416|P2|Double-blind Phase|Noncompliance|1
81665|NCT00922272|290416|P2|Double-blind Phase|Withdrawal criteria met|1
81666|NCT00922272|290417|P1|Double-blind Phase|Withdrawal criteria met|1
81667|NCT00922272|290416|P2|Double-blind Phase|Lost to Follow-up|1
81668|NCT00922272|290417|P1|Double-blind Phase|Lost to Follow-up|2
81669|NCT00922272|290416|P2|Double-blind Phase|Withdrawal by Subject|1
81670|NCT00922272|290417|P1|Double-blind Phase|Withdrawal by Subject|1
81671|NCT00922272|290416|P2|Double-blind Phase|Adverse Event|1
81672|NCT00922272|290417|P1|Double-blind Phase|Adverse Event|1
81673|NCT00922272|290416|P2|Open-label Phase|Withdrawal criteria met|0
81674|NCT00922272|290417|P1|Open-label Phase|Withdrawal criteria met|5
81675|NCT00922272|290416|P2|Open-label Phase|Failure to meet randomization criteria|0
81676|NCT00922272|290417|P1|Open-label Phase|Failure to meet randomization criteria|1
81677|NCT00922272|290416|P2|Open-label Phase|Withdrawal by Subject|0
81678|NCT00922272|290417|P1|Open-label Phase|Withdrawal by Subject|11
81679|NCT00922272|290416|P2|Open-label Phase|Protocol Violation|0
81680|NCT00922272|290417|P1|Open-label Phase|Protocol Violation|1
81681|NCT00922272|290416|P2|Open-label Phase|Adverse Event|0
81682|NCT00922272|290417|P1|Open-label Phase|Adverse Event|5
81683|NCT00922207|290482|P3|Overall Study|Abnormality of Laboratory Test|1
81684|NCT00922207|290483|P2|Overall Study|Abnormality of Laboratory Test|1
81685|NCT00922207|290484|P1|Overall Study|Abnormality of Laboratory Test|0
81686|NCT00922207|290482|P3|Overall Study|Withdrew Consent|2
81687|NCT00922207|290483|P2|Overall Study|Withdrew Consent|5
81688|NCT00922207|290484|P1|Overall Study|Withdrew Consent|2
81689|NCT00922207|290482|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
81690|NCT00922207|290483|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
81691|NCT00922207|290484|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
81692|NCT00922207|290482|P3|Overall Study|Violation of Selection Criteria at Entry|0
81693|NCT00922207|290483|P2|Overall Study|Violation of Selection Criteria at Entry|1
81694|NCT00922207|290484|P1|Overall Study|Violation of Selection Criteria at Entry|0
81695|NCT00922207|290482|P3|Overall Study|Insufficient Therapeutic Response|1
81696|NCT00922207|290483|P2|Overall Study|Insufficient Therapeutic Response|0
81697|NCT00922207|290484|P1|Overall Study|Insufficient Therapeutic Response|0
81698|NCT00922207|290482|P3|Overall Study|Adverse Event/Intercurrent Illness|0
81699|NCT00922207|290483|P2|Overall Study|Adverse Event/Intercurrent Illness|0
81700|NCT00922207|290484|P1|Overall Study|Adverse Event/Intercurrent Illness|3
81701|NCT00922116|290520|P1|Overall Study|Unspecified|5
81702|NCT00922116|290520|P1|Overall Study|Withdrawal by Subject|4
81703|NCT00922116|290520|P1|Overall Study|Lost to Follow-up|1
81704|NCT00922116|290520|P1|Overall Study|Death|1
81705|NCT00922116|290520|P1|Overall Study|Adverse Event|4
81706|NCT00921024|290602|P2|Overall Study|Withdrawal by Subject|3
81707|NCT00921024|290603|P1|Overall Study|Withdrawal by Subject|0
81708|NCT00921024|290602|P2|Overall Study|Received concomittant therapy|0
81709|NCT00921024|290603|P1|Overall Study|Received concomittant therapy|2
81710|NCT00921024|290602|P2|Overall Study|Lost to Follow-up|0
81711|NCT00921024|290603|P1|Overall Study|Lost to Follow-up|2
81712|NCT00920907|290613|P2|Maintenance Period|Adverse Event|1
81713|NCT00920907|290614|P1|Maintenance Period|Adverse Event|0
81714|NCT00920907|290613|P2|Maintenance Period|Withdrawal by Subject|0
81715|NCT00920907|290614|P1|Maintenance Period|Withdrawal by Subject|1
81716|NCT00920907|290613|P2|Maintenance Period|Death|1
81717|NCT00920907|290614|P1|Maintenance Period|Death|1
81718|NCT00920907|290613|P2|Maintenance Period|Study Drug Toxicity|2
81719|NCT00920907|290614|P1|Maintenance Period|Study Drug Toxicity|0
81720|NCT00920907|290613|P2|Maintenance Period|Administrative (study closure)|2
81721|NCT00920907|290614|P1|Maintenance Period|Administrative (study closure)|7
81722|NCT00920907|290613|P2|Maintenance Period|Disease Progression|7
81723|NCT00920907|290614|P1|Maintenance Period|Disease Progression|3
81724|NCT00920907|290613|P2|Induction Period|Withdrawal by Subject|1
81725|NCT00920907|290614|P1|Induction Period|Withdrawal by Subject|1
81726|NCT00920907|290613|P2|Induction Period|No longer meets study criteria|1
81727|NCT00920907|290614|P1|Induction Period|No longer meets study criteria|0
81728|NCT00920907|290613|P2|Induction Period|Study Drug Toxicity|6
81729|NCT00920907|290614|P1|Induction Period|Study Drug Toxicity|8
81730|NCT00920907|290613|P2|Induction Period|Disease Progression|11
81731|NCT00920907|290614|P1|Induction Period|Disease Progression|12
81732|NCT00920907|290613|P2|Induction Period|Death|1
81733|NCT00920907|290614|P1|Induction Period|Death|1
81734|NCT00920907|290613|P2|Induction Period|Adverse Event|2
81735|NCT00920907|290614|P1|Induction Period|Adverse Event|0
81736|NCT00920855|290655|P3|Overall Study|Response plateau; started maintenance|1
81737|NCT00920855|290656|P2|Overall Study|Response plateau; started maintenance|0
81738|NCT00920855|290657|P1|Overall Study|Response plateau; started maintenance|0
81739|NCT00920855|290655|P3|Overall Study|Noncompliance to study medication|1
81740|NCT00920855|290656|P2|Overall Study|Noncompliance to study medication|0
81741|NCT00920855|290657|P1|Overall Study|Noncompliance to study medication|0
81742|NCT00920855|290655|P3|Overall Study|Disease progression|10
81743|NCT00920855|290656|P2|Overall Study|Disease progression|1
81744|NCT00920855|290657|P1|Overall Study|Disease progression|2
81745|NCT00920855|290655|P3|Overall Study|Withdrawal by Subject|6
81746|NCT00920855|290656|P2|Overall Study|Withdrawal by Subject|1
81747|NCT00920855|290657|P1|Overall Study|Withdrawal by Subject|2
81748|NCT00920855|290655|P3|Overall Study|Adverse Event|4
81749|NCT00920855|290656|P2|Overall Study|Adverse Event|1
81750|NCT00920855|290657|P1|Overall Study|Adverse Event|1
81751|NCT00920816|290683|P4|Overall Study|Ongoing|36
81752|NCT00920816|290684|P3|Overall Study|Ongoing|70
81753|NCT00920816|290685|P2|Overall Study|Ongoing|56
81754|NCT00920816|290686|P1|Overall Study|Ongoing|106
81755|NCT00920816|290683|P4|Overall Study|Withdrawal by Subject|1
81756|NCT00920816|290684|P3|Overall Study|Withdrawal by Subject|1
81757|NCT00920816|290685|P2|Overall Study|Withdrawal by Subject|2
81758|NCT00920816|290686|P1|Overall Study|Withdrawal by Subject|7
81759|NCT00920816|290683|P4|Overall Study|Objective progression or relapse|0
81760|NCT00920816|290684|P3|Overall Study|Objective progression or relapse|2
81761|NCT00920816|290685|P2|Overall Study|Objective progression or relapse|0
81762|NCT00920816|290686|P1|Overall Study|Objective progression or relapse|0
81763|NCT00920816|290683|P4|Overall Study|Lost to Follow-up|4
81764|NCT00920816|290684|P3|Overall Study|Lost to Follow-up|3
81765|NCT00920816|290685|P2|Overall Study|Lost to Follow-up|2
81766|NCT00920816|290686|P1|Overall Study|Lost to Follow-up|1
81767|NCT00920816|290683|P4|Overall Study|Adverse Event|0
81768|NCT00920816|290684|P3|Overall Study|Adverse Event|1
81769|NCT00920816|290685|P2|Overall Study|Adverse Event|0
81770|NCT00920816|290686|P1|Overall Study|Adverse Event|1
81771|NCT00920816|290683|P4|Overall Study|Death|28
81772|NCT00920816|290684|P3|Overall Study|Death|58
81773|NCT00920816|290685|P2|Overall Study|Death|36
81774|NCT00920816|290686|P1|Overall Study|Death|77
81775|NCT00920790|290724|P1|Overall Study|aggravation of general condition|14
81776|NCT00920686|290736|P3|Overall Study|Study drug dosing criteria not met|12
81777|NCT00920686|290737|P2|Overall Study|Study drug dosing criteria not met|19
81778|NCT00920686|290738|P1|Overall Study|Study drug dosing criteria not met|17
81779|NCT00920686|290736|P3|Overall Study|Lost to Follow-up|1
81780|NCT00920686|290737|P2|Overall Study|Lost to Follow-up|3
81781|NCT00920686|290738|P1|Overall Study|Lost to Follow-up|2
81782|NCT00920140|290867|P5|Phase 2|Withdrawal by Subject|1
81783|NCT00920140|290868|P4|Phase 2|Withdrawal by Subject|2
81784|NCT00920140|290869|P3|Phase 2|Withdrawal by Subject|4
81785|NCT00920140|290870|P2|Phase 2|Withdrawal by Subject|0
81786|NCT00920140|290871|P1|Phase 2|Withdrawal by Subject|0
81787|NCT00920140|290867|P5|Phase 2|Physician Decision|2
81788|NCT00920140|290868|P4|Phase 2|Physician Decision|3
81789|NCT00920140|290869|P3|Phase 2|Physician Decision|3
81790|NCT00920140|290870|P2|Phase 2|Physician Decision|0
81791|NCT00920140|290871|P1|Phase 2|Physician Decision|0
81792|NCT00920140|290867|P5|Phase 2|Lost to Follow-up|0
81793|NCT00920140|290868|P4|Phase 2|Lost to Follow-up|1
81794|NCT00920140|290869|P3|Phase 2|Lost to Follow-up|0
81795|NCT00920140|290870|P2|Phase 2|Lost to Follow-up|0
81796|NCT00920140|290871|P1|Phase 2|Lost to Follow-up|0
81797|NCT00920140|290867|P5|Phase 2|Lack of Efficacy|5
81798|NCT00920140|290868|P4|Phase 2|Lack of Efficacy|14
81799|NCT00920140|290869|P3|Phase 2|Lack of Efficacy|29
81800|NCT00920140|290870|P2|Phase 2|Lack of Efficacy|0
81801|NCT00920140|290871|P1|Phase 2|Lack of Efficacy|0
81802|NCT00920140|290867|P5|Phase 2|Adverse Event|3
81803|NCT00920140|290868|P4|Phase 2|Adverse Event|2
81804|NCT00920140|290869|P3|Phase 2|Adverse Event|14
81805|NCT00920140|290870|P2|Phase 2|Adverse Event|0
81806|NCT00920140|290871|P1|Phase 2|Adverse Event|0
81807|NCT00920140|290867|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
81808|NCT00920140|290868|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
81809|NCT00920140|290869|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
81810|NCT00920140|290870|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
81811|NCT00920140|290871|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
81812|NCT00920140|290867|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
81813|NCT00920140|290868|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
81814|NCT00920140|290869|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
81815|NCT00920140|290870|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
81816|NCT00920140|290871|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
81817|NCT00920140|290867|P5|Phase 1 (Dose Escalation)|Adverse Event|0
81818|NCT00920140|290868|P4|Phase 1 (Dose Escalation)|Adverse Event|0
81819|NCT00920140|290869|P3|Phase 1 (Dose Escalation)|Adverse Event|0
81820|NCT00920140|290870|P2|Phase 1 (Dose Escalation)|Adverse Event|3
81821|NCT00920140|290871|P1|Phase 1 (Dose Escalation)|Adverse Event|3
81822|NCT00919893|290928|P2|Overall Study|Protocol Violation|9
81823|NCT00919893|290929|P1|Overall Study|Protocol Violation|19
81824|NCT00919867|290941|P6|First Intervention|Physician Decision|1
81825|NCT00919867|290942|P5|First Intervention|Physician Decision|0
81826|NCT00919867|290943|P4|First Intervention|Physician Decision|0
81827|NCT00919867|290944|P3|First Intervention|Physician Decision|0
81828|NCT00919867|290945|P2|First Intervention|Physician Decision|0
81829|NCT00919867|290946|P1|First Intervention|Physician Decision|0
81830|NCT00919867|290941|P6|First Intervention|Withdrawal by Subject|0
81831|NCT00919867|290942|P5|First Intervention|Withdrawal by Subject|0
81832|NCT00919867|290943|P4|First Intervention|Withdrawal by Subject|0
81833|NCT00919867|290944|P3|First Intervention|Withdrawal by Subject|1
81834|NCT00919867|290945|P2|First Intervention|Withdrawal by Subject|0
81835|NCT00919867|290946|P1|First Intervention|Withdrawal by Subject|0
81836|NCT00919854|290967|P1|Overall Study|Adverse Event|1
81837|NCT00919711|290996|P2|Overall Study|Noncompliance|0
81838|NCT00919711|290997|P1|Overall Study|Noncompliance|1
81839|NCT00919711|290996|P2|Overall Study|Death|0
81840|NCT00919711|290997|P1|Overall Study|Death|1
81841|NCT00919711|290996|P2|Overall Study|Lost to Follow-up|0
81842|NCT00919711|290997|P1|Overall Study|Lost to Follow-up|2
81843|NCT00919711|290996|P2|Overall Study|Administrative Decision|1
81844|NCT00919711|290997|P1|Overall Study|Administrative Decision|0
81845|NCT00919711|290996|P2|Overall Study|Other|2
81846|NCT00919711|290997|P1|Overall Study|Other|1
81847|NCT00919711|290996|P2|Overall Study|Adverse Event|3
81848|NCT00919711|290997|P1|Overall Study|Adverse Event|13
81849|NCT00919711|290996|P2|Overall Study|Withdrawal by Subject|7
81850|NCT00919711|290997|P1|Overall Study|Withdrawal by Subject|15
81851|NCT00919633|291013|P4|Overall Study|Viral rebound outside protocol timepoint|0
81852|NCT00919633|291014|P3|Overall Study|Viral rebound outside protocol timepoint|1
81853|NCT00919633|291015|P2|Overall Study|Viral rebound outside protocol timepoint|0
81854|NCT00919633|291016|P1|Overall Study|Viral rebound outside protocol timepoint|0
81855|NCT00919633|291013|P4|Overall Study|Request of withdrawal w/o future contact|0
81856|NCT00919633|291014|P3|Overall Study|Request of withdrawal w/o future contact|1
81857|NCT00919633|291015|P2|Overall Study|Request of withdrawal w/o future contact|0
81858|NCT00919633|291016|P1|Overall Study|Request of withdrawal w/o future contact|0
81859|NCT00919633|291013|P4|Overall Study|Physician Decision|1
81860|NCT00919633|291014|P3|Overall Study|Physician Decision|0
81861|NCT00919633|291015|P2|Overall Study|Physician Decision|0
81862|NCT00919633|291016|P1|Overall Study|Physician Decision|0
81863|NCT00919633|291013|P4|Overall Study|Protocol Violation|1
81864|NCT00919633|291014|P3|Overall Study|Protocol Violation|0
81865|NCT00919633|291015|P2|Overall Study|Protocol Violation|0
81866|NCT00919633|291016|P1|Overall Study|Protocol Violation|0
81867|NCT00919633|291013|P4|Overall Study|Withdraw consent post transition to SOC|1
81868|NCT00919633|291014|P3|Overall Study|Withdraw consent post transition to SOC|1
81869|NCT00919633|291015|P2|Overall Study|Withdraw consent post transition to SOC|0
81870|NCT00919633|291016|P1|Overall Study|Withdraw consent post transition to SOC|0
81871|NCT00919633|291013|P4|Overall Study|Lost to Follow-up|2
81872|NCT00919633|291014|P3|Overall Study|Lost to Follow-up|0
81873|NCT00919633|291015|P2|Overall Study|Lost to Follow-up|1
81874|NCT00919633|291016|P1|Overall Study|Lost to Follow-up|3
81875|NCT00919633|291013|P4|Overall Study|Withdrawal by Subject|3
81876|NCT00919633|291014|P3|Overall Study|Withdrawal by Subject|4
81877|NCT00919633|291015|P2|Overall Study|Withdrawal by Subject|2
81878|NCT00919633|291016|P1|Overall Study|Withdrawal by Subject|1
81879|NCT00919633|291013|P4|Overall Study|Lack of Efficacy|3
81880|NCT00919633|291014|P3|Overall Study|Lack of Efficacy|2
81881|NCT00919633|291015|P2|Overall Study|Lack of Efficacy|3
81882|NCT00919633|291016|P1|Overall Study|Lack of Efficacy|17
81883|NCT00919633|291013|P4|Overall Study|Death|0
81884|NCT00919633|291014|P3|Overall Study|Death|2
81885|NCT00919633|291015|P2|Overall Study|Death|0
81886|NCT00919633|291016|P1|Overall Study|Death|0
81887|NCT00919633|291013|P4|Overall Study|Adverse Event|10
81888|NCT00919633|291014|P3|Overall Study|Adverse Event|12
81889|NCT00919633|291015|P2|Overall Study|Adverse Event|9
81890|NCT00919633|291016|P1|Overall Study|Adverse Event|1
81891|NCT00919061|291101|P1|Overall Study|Withdrawal by Subject|1
81892|NCT00919061|291101|P1|Overall Study|Adverse Event|1
81893|NCT00918957|291114|P2|Overall Study|Withdrawal by Subject|0
81894|NCT00918957|291115|P1|Overall Study|Withdrawal by Subject|1
81895|NCT00918957|291114|P2|Overall Study|Adverse Event|0
81896|NCT00918957|291115|P1|Overall Study|Adverse Event|2
81897|NCT00918879|291148|P2|Overall Study|Severe non-compliance to protocol|1
81898|NCT00918879|291149|P1|Overall Study|Severe non-compliance to protocol|1
81899|NCT00918879|291148|P2|Overall Study|Lost to Follow-up|1
81900|NCT00918879|291149|P1|Overall Study|Lost to Follow-up|1
81901|NCT00918879|291148|P2|Overall Study|Withdrawal by Subject|4
81902|NCT00918879|291149|P1|Overall Study|Withdrawal by Subject|4
81903|NCT00918749|291181|P3|Overall Study|No Study Medication Taken|0
81904|NCT00918749|291182|P2|Overall Study|No Study Medication Taken|0
81905|NCT00918749|291183|P1|Overall Study|No Study Medication Taken|1
81906|NCT00918749|291181|P3|Overall Study|Withdrawal by Subject|5
81907|NCT00918749|291182|P2|Overall Study|Withdrawal by Subject|3
81908|NCT00918749|291183|P1|Overall Study|Withdrawal by Subject|5
81909|NCT00918749|291181|P3|Overall Study|Lost to Follow-up|1
81910|NCT00918749|291182|P2|Overall Study|Lost to Follow-up|0
81911|NCT00918749|291183|P1|Overall Study|Lost to Follow-up|0
81912|NCT00918749|291181|P3|Overall Study|Adverse Event|1
81913|NCT00918749|291182|P2|Overall Study|Adverse Event|0
81914|NCT00918749|291183|P1|Overall Study|Adverse Event|1
81915|NCT00918736|291215|P1|Overall Study|Withdrawal by Subject|4
81916|NCT00918580|291224|P1|After 6-month FU to 1-year FU|Failed to Return|2
81917|NCT00918580|291224|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
81918|NCT00918580|291224|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
81919|NCT00918580|291224|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
81920|NCT00918580|291224|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
81921|NCT00918580|291224|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
81922|NCT00918580|291224|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
81923|NCT00918385|291244|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
81924|NCT00918385|291245|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
81925|NCT00918385|291244|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
81926|NCT00918385|291245|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
81927|NCT00918385|291244|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
81928|NCT00918385|291245|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
81929|NCT00918385|291244|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
81930|NCT00918385|291245|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
81931|NCT00918385|291244|P2|Monotherapy|Complicating illness|0
81932|NCT00918385|291245|P1|Monotherapy|Complicating illness|1
81933|NCT00918385|291244|P2|Monotherapy|Adverse Event|6
81934|NCT00918385|291245|P1|Monotherapy|Adverse Event|1
81935|NCT00918346|291254|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
81936|NCT00918346|291255|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
81937|NCT00918281|291269|P1|Overall Study|Physician Decision|29
81938|NCT00918255|291279|P3|Overall Study|Investigator discretion|0
81939|NCT00918255|291280|P2|Overall Study|Investigator discretion|0
81940|NCT00918255|291281|P1|Overall Study|Investigator discretion|1
81941|NCT00918255|291279|P3|Overall Study|Non-compliance|0
81942|NCT00918255|291280|P2|Overall Study|Non-compliance|0
81943|NCT00918255|291281|P1|Overall Study|Non-compliance|1
81944|NCT00918255|291279|P3|Overall Study|Exceeded allowed number of interventions|1
81945|NCT00918255|291280|P2|Overall Study|Exceeded allowed number of interventions|0
81946|NCT00918255|291281|P1|Overall Study|Exceeded allowed number of interventions|0
81947|NCT00918255|291279|P3|Overall Study|Lost to Follow-up|2
81948|NCT00918255|291280|P2|Overall Study|Lost to Follow-up|0
81949|NCT00918255|291281|P1|Overall Study|Lost to Follow-up|1
81950|NCT00918255|291279|P3|Overall Study|Lack of Efficacy|0
81951|NCT00918255|291280|P2|Overall Study|Lack of Efficacy|0
81952|NCT00918255|291281|P1|Overall Study|Lack of Efficacy|1
81953|NCT00918255|291279|P3|Overall Study|Withdrawal by Subject|2
81954|NCT00918255|291280|P2|Overall Study|Withdrawal by Subject|0
81955|NCT00918255|291281|P1|Overall Study|Withdrawal by Subject|1
81956|NCT00918255|291279|P3|Overall Study|Adverse Event|0
81957|NCT00918255|291280|P2|Overall Study|Adverse Event|0
81958|NCT00918255|291281|P1|Overall Study|Adverse Event|1
81959|NCT00918203|291309|P3|Crossover to Olaratumab Monotherapy|Other Therapy Started|1
81960|NCT00918203|291310|P2|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
81961|NCT00918203|291311|P1|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
81962|NCT00918203|291309|P3|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|2
81963|NCT00918203|291310|P2|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
81964|NCT00918203|291311|P1|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
81965|NCT00918203|291309|P3|Treatment With or Without Olaratumab|On Treatment|0
81966|NCT00918203|291310|P2|Treatment With or Without Olaratumab|On Treatment|0
81967|NCT00918203|291311|P1|Treatment With or Without Olaratumab|On Treatment|1
81968|NCT00918203|291309|P3|Treatment With or Without Olaratumab|Physician Decision|0
81969|NCT00918203|291310|P2|Treatment With or Without Olaratumab|Physician Decision|1
81970|NCT00918203|291311|P1|Treatment With or Without Olaratumab|Physician Decision|0
81971|NCT00918203|291309|P3|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
81972|NCT00918203|291310|P2|Treatment With or Without Olaratumab|Off Study Treatment/Alive|1
81973|NCT00918203|291311|P1|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
81974|NCT00918203|291309|P3|Treatment With or Without Olaratumab|Never Treated|0
81975|NCT00918203|291310|P2|Treatment With or Without Olaratumab|Never Treated|1
81976|NCT00918203|291311|P1|Treatment With or Without Olaratumab|Never Treated|2
81977|NCT00918203|291309|P3|Treatment With or Without Olaratumab|Adverse Event|0
81978|NCT00918203|291310|P2|Treatment With or Without Olaratumab|Adverse Event|1
81979|NCT00918203|291311|P1|Treatment With or Without Olaratumab|Adverse Event|1
81980|NCT00918203|291309|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
81981|NCT00918203|291310|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
81982|NCT00918203|291311|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
81983|NCT00918203|291309|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
81984|NCT00918203|291310|P2|Treatment With or Without Olaratumab|Lost to Follow-up|0
81985|NCT00918203|291311|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
81986|NCT00918203|291309|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
81987|NCT00918203|291310|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|9
81988|NCT00918203|291311|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|0
81989|NCT00918138|291342|P2|Overall Study|Death|0
81990|NCT00918138|291343|P1|Overall Study|Death|1
81991|NCT00918138|291342|P2|Overall Study|Subject withdrew consent|1
81992|NCT00918138|291343|P1|Overall Study|Subject withdrew consent|1
81993|NCT00917852|291382|P1|Overall Study|Death|6
81994|NCT00917644|291399|P2|Period 2: Second Intervention|family emergency|0
81995|NCT00917644|291400|P1|Period 2: Second Intervention|family emergency|1
81996|NCT00917644|291399|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
81997|NCT00917644|291400|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
81998|NCT00917644|291399|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
81999|NCT00917644|291400|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
82000|NCT00917579|291414|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
82001|NCT00917579|291415|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
82002|NCT00917579|291414|P2|Washout >= 2 Weeks|Adverse Event|0
82003|NCT00917579|291415|P1|Washout >= 2 Weeks|Adverse Event|1
82004|NCT00917501|291431|P2|Overall Study|trouble swollowing capsules|1
82005|NCT00917501|291432|P1|Overall Study|trouble swollowing capsules|0
82006|NCT00917501|291431|P2|Overall Study|Lack of Efficacy|2
82007|NCT00917501|291432|P1|Overall Study|Lack of Efficacy|1
82008|NCT00917501|291431|P2|Overall Study|Withdrawal by Subject|1
82009|NCT00917501|291432|P1|Overall Study|Withdrawal by Subject|3
82010|NCT00917501|291431|P2|Overall Study|Lost to Follow-up|1
82011|NCT00917501|291432|P1|Overall Study|Lost to Follow-up|4
82012|NCT00917384|291440|P2|Overall Study|Withdrawal by Subject|2
82013|NCT00917384|291441|P1|Overall Study|Withdrawal by Subject|10
82014|NCT00917384|291440|P2|Overall Study|Lost to Follow-up|2
82015|NCT00917384|291441|P1|Overall Study|Lost to Follow-up|4
82016|NCT00917267|291465|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
82017|NCT00917267|291466|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
82018|NCT00917267|291465|P2|Overall Study|Sponsor Decision|5
82019|NCT00917267|291466|P1|Overall Study|Sponsor Decision|5
82020|NCT00917267|291465|P2|Overall Study|Entry Criteria Not Met|0
82021|NCT00917267|291466|P1|Overall Study|Entry Criteria Not Met|1
82022|NCT00917267|291465|P2|Overall Study|Lost to follow up|2
82023|NCT00917267|291466|P1|Overall Study|Lost to follow up|0
82024|NCT00917267|291465|P2|Overall Study|Withdrawal by Subject|12
82025|NCT00917267|291466|P1|Overall Study|Withdrawal by Subject|5
82026|NCT00917267|291465|P2|Overall Study|Protocol Violation|18
82027|NCT00917267|291466|P1|Overall Study|Protocol Violation|9
82028|NCT00917267|291465|P2|Overall Study|Physician Decision|4
82029|NCT00917267|291466|P1|Overall Study|Physician Decision|2
82030|NCT00917267|291465|P2|Overall Study|Adverse Event|36
82031|NCT00917267|291466|P1|Overall Study|Adverse Event|15
82032|NCT00917124|291494|P2|Overall Study|Protocol Violation|6
82033|NCT00917124|291495|P1|Overall Study|Protocol Violation|4
82034|NCT00916929|291505|P2|Overall Study|Device unable to process impedance data|7
82035|NCT00916929|291506|P1|Overall Study|Device unable to process impedance data|0
82036|NCT00916929|291505|P2|Overall Study|Moved to another state|1
82037|NCT00916929|291506|P1|Overall Study|Moved to another state|0
82038|NCT00916929|291505|P2|Overall Study|System explant|0
82039|NCT00916929|291506|P1|Overall Study|System explant|1
82040|NCT00916929|291505|P2|Overall Study|Transferred to hospice care|1
82041|NCT00916929|291506|P1|Overall Study|Transferred to hospice care|1
82042|NCT00916929|291505|P2|Overall Study|Left ventricular epicardial lead|2
82043|NCT00916929|291506|P1|Overall Study|Left ventricular epicardial lead|1
82044|NCT00916929|291505|P2|Overall Study|Withdrawal by Subject|5
82045|NCT00916929|291506|P1|Overall Study|Withdrawal by Subject|1
82046|NCT00916929|291505|P2|Overall Study|Death|10
82047|NCT00916929|291506|P1|Overall Study|Death|5
82048|NCT00916929|291505|P2|Overall Study|Lost to Follow-up|3
82049|NCT00916929|291506|P1|Overall Study|Lost to Follow-up|1
82050|NCT00916721|291516|P2|Overall Study|Protocol Violation|4
82051|NCT00916721|291517|P1|Overall Study|Protocol Violation|2
82052|NCT00916721|291516|P2|Overall Study|Withdrawal by Subject|2
82053|NCT00916721|291517|P1|Overall Study|Withdrawal by Subject|2
82054|NCT00916721|291516|P2|Overall Study|Adverse Event|3
82055|NCT00916721|291517|P1|Overall Study|Adverse Event|6
82056|NCT00916721|291516|P2|Overall Study|Lost to Follow-up|1
82057|NCT00916721|291517|P1|Overall Study|Lost to Follow-up|0
82058|NCT00916383|291536|P1|Overall Study|Protocol Violation|1
82059|NCT00916383|291536|P1|Overall Study|Death|1
82060|NCT00916383|291536|P1|Overall Study|Adverse Event|1
82061|NCT00916370|291564|P2|Overall Study|Physician Decision|1
82062|NCT00916370|291565|P1|Overall Study|Physician Decision|0
82063|NCT00916370|291564|P2|Overall Study|Withdrawal by Subject|0
82064|NCT00916370|291565|P1|Overall Study|Withdrawal by Subject|2
82065|NCT00916370|291564|P2|Overall Study|Death|1
82066|NCT00916370|291565|P1|Overall Study|Death|3
82067|NCT00916357|291739|P6|Period 2|Weight loss > 3 kilograms (kg)|0
82068|NCT00916357|291740|P5|Period 2|Weight loss > 3 kilograms (kg)|0
82069|NCT00916357|291741|P4|Period 2|Weight loss > 3 kilograms (kg)|1
82070|NCT00916357|291742|P3|Period 2|Weight loss > 3 kilograms (kg)|0
82071|NCT00916357|291743|P2|Period 2|Weight loss > 3 kilograms (kg)|0
82072|NCT00916357|291744|P1|Period 2|Weight loss > 3 kilograms (kg)|0
82073|NCT00916357|291739|P6|Period 1|Withdrawal by Subject|0
82074|NCT00916357|291740|P5|Period 1|Withdrawal by Subject|0
82075|NCT00916357|291741|P4|Period 1|Withdrawal by Subject|0
82076|NCT00916357|291742|P3|Period 1|Withdrawal by Subject|0
82077|NCT00916357|291743|P2|Period 1|Withdrawal by Subject|0
82078|NCT00916357|291744|P1|Period 1|Withdrawal by Subject|1
82079|NCT00916344|291782|P1|Overall Study|Drop-out|5
82080|NCT00916344|291782|P1|Overall Study|ICD upgrade|1
82081|NCT00916344|291782|P1|Overall Study|Death|2
82082|NCT00916305|291789|P2|Overall Study|Withdrawal by Subject|1
82083|NCT00916305|291790|P1|Overall Study|Withdrawal by Subject|0
82084|NCT00916305|291789|P2|Overall Study|Lost to Follow-up|27
82085|NCT00916305|291790|P1|Overall Study|Lost to Follow-up|21
82086|NCT00916279|291798|P1|Overall Study|Lost to Follow-up|2
82087|NCT00916279|291798|P1|Overall Study|Death|2
82088|NCT00916006|291860|P2|Overall Study|Protocol Violation|1
82089|NCT00916006|291861|P1|Overall Study|Protocol Violation|0
82090|NCT00916006|291860|P2|Overall Study|Withdrawal by Subject|5
82091|NCT00916006|291861|P1|Overall Study|Withdrawal by Subject|2
82092|NCT00916006|291860|P2|Overall Study|Adverse Event|1
82093|NCT00916006|291861|P1|Overall Study|Adverse Event|1
82094|NCT00915876|291882|P2|Overall Study|Adverse Event|1
82095|NCT00915876|291883|P1|Overall Study|Adverse Event|0
82096|NCT00915772|291919|P3|Overall Study|Any other reason|7
82097|NCT00915772|291920|P2|Overall Study|Any other reason|7
82098|NCT00915772|291921|P1|Overall Study|Any other reason|4
82099|NCT00915772|291919|P3|Overall Study|Refused to continue trial medication|4
82100|NCT00915772|291920|P2|Overall Study|Refused to continue trial medication|8
82101|NCT00915772|291921|P1|Overall Study|Refused to continue trial medication|6
82102|NCT00915772|291919|P3|Overall Study|Lack of Efficacy|3
82103|NCT00915772|291920|P2|Overall Study|Lack of Efficacy|15
82104|NCT00915772|291921|P1|Overall Study|Lack of Efficacy|9
82105|NCT00915772|291919|P3|Overall Study|Lost to Follow-up|2
82106|NCT00915772|291920|P2|Overall Study|Lost to Follow-up|2
82107|NCT00915772|291921|P1|Overall Study|Lost to Follow-up|1
82108|NCT00915772|291919|P3|Overall Study|Protocol Violation|2
82109|NCT00915772|291920|P2|Overall Study|Protocol Violation|1
82110|NCT00915772|291921|P1|Overall Study|Protocol Violation|4
82111|NCT00915772|291919|P3|Overall Study|Adverse Event|11
82112|NCT00915772|291920|P2|Overall Study|Adverse Event|13
82113|NCT00915772|291921|P1|Overall Study|Adverse Event|12
82114|NCT00915551|292000|P2|Overall Study|Withdrawal by Subject|1
82115|NCT00915551|292001|P1|Overall Study|Withdrawal by Subject|0
82116|NCT00915525|292011|P2|Overall Study|Patient Moved|9
82117|NCT00915525|292012|P1|Overall Study|Patient Moved|15
82118|NCT00915525|292011|P2|Overall Study|Non-Compliance|1
82119|NCT00915525|292012|P1|Overall Study|Non-Compliance|3
82120|NCT00915525|292011|P2|Overall Study|Study Burden|12
82121|NCT00915525|292012|P1|Overall Study|Study Burden|28
82122|NCT00915525|292011|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
82123|NCT00915525|292012|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
82124|NCT00915525|292011|P2|Overall Study|Site Closed|9
82125|NCT00915525|292012|P1|Overall Study|Site Closed|27
82126|NCT00915525|292011|P2|Overall Study|Other Reason|12
82127|NCT00915525|292012|P1|Overall Study|Other Reason|35
82128|NCT00915525|292011|P2|Overall Study|Missing|1
82129|NCT00915525|292012|P1|Overall Study|Missing|12
82130|NCT00915525|292011|P2|Overall Study|Adverse Event|13
82131|NCT00915525|292012|P1|Overall Study|Adverse Event|29
82132|NCT00915525|292011|P2|Overall Study|Lack of Efficacy|32
82133|NCT00915525|292012|P1|Overall Study|Lack of Efficacy|15
82134|NCT00915525|292011|P2|Overall Study|Pregnancy|0
82135|NCT00915525|292012|P1|Overall Study|Pregnancy|2
82136|NCT00915525|292011|P2|Overall Study|Lost to Follow-up|16
82137|NCT00915525|292012|P1|Overall Study|Lost to Follow-up|27
82138|NCT00915525|292011|P2|Overall Study|Withdrawal by Subject|21
82139|NCT00915525|292012|P1|Overall Study|Withdrawal by Subject|59
82140|NCT00915525|292011|P2|Overall Study|Protocol Violation|4
82141|NCT00915525|292012|P1|Overall Study|Protocol Violation|9
82142|NCT00915473|292126|P2|4-week Follow Up|Lost to Follow-up|5
82143|NCT00915473|292127|P1|4-week Follow Up|Lost to Follow-up|1
82144|NCT00915473|292126|P2|Screening|Withdrawal by Subject|0
82145|NCT00915473|292127|P1|Screening|Withdrawal by Subject|1
82146|NCT00915356|292144|P5|Overall Study|Withdrawal by Subject|0
82147|NCT00915356|292145|P4|Overall Study|Withdrawal by Subject|0
82148|NCT00915356|292146|P3|Overall Study|Withdrawal by Subject|0
82149|NCT00915356|292147|P2|Overall Study|Withdrawal by Subject|0
82150|NCT00915356|292148|P1|Overall Study|Withdrawal by Subject|1
82151|NCT00915343|292210|P3|Part B - Open Label Period|Did not attend the last visit|1
82152|NCT00915343|292211|P2|Part B - Open Label Period|Did not attend the last visit|0
82153|NCT00915343|292212|P1|Part B - Open Label Period|Did not attend the last visit|0
82154|NCT00915343|292210|P3|Part B - Open Label Period|Treatment switch|1
82155|NCT00915343|292211|P2|Part B - Open Label Period|Treatment switch|0
82156|NCT00915343|292212|P1|Part B - Open Label Period|Treatment switch|0
82157|NCT00915278|292297|P6|Overall Study|Admission to hospice|0
82158|NCT00915278|292298|P5|Overall Study|Admission to hospice|0
82159|NCT00915278|292299|P4|Overall Study|Admission to hospice|0
82160|NCT00915278|292300|P3|Overall Study|Admission to hospice|1
82161|NCT00915278|292301|P2|Overall Study|Admission to hospice|0
82162|NCT00915278|292302|P1|Overall Study|Admission to hospice|0
82163|NCT00915278|292297|P6|Overall Study|Infusion related AEs|2
82164|NCT00915278|292298|P5|Overall Study|Infusion related AEs|0
82165|NCT00915278|292299|P4|Overall Study|Infusion related AEs|0
82166|NCT00915278|292300|P3|Overall Study|Infusion related AEs|0
82167|NCT00915278|292301|P2|Overall Study|Infusion related AEs|0
82168|NCT00915278|292302|P1|Overall Study|Infusion related AEs|0
82169|NCT00915278|292297|P6|Overall Study|Progressive disease/clinical progression|2
82170|NCT00915278|292298|P5|Overall Study|Progressive disease/clinical progression|1
82171|NCT00915278|292299|P4|Overall Study|Progressive disease/clinical progression|3
82172|NCT00915278|292300|P3|Overall Study|Progressive disease/clinical progression|0
82173|NCT00915278|292301|P2|Overall Study|Progressive disease/clinical progression|0
82174|NCT00915278|292302|P1|Overall Study|Progressive disease/clinical progression|0
82175|NCT00915278|292297|P6|Overall Study|Adverse Event|0
82176|NCT00915278|292298|P5|Overall Study|Adverse Event|0
82177|NCT00915278|292299|P4|Overall Study|Adverse Event|0
82178|NCT00915278|292300|P3|Overall Study|Adverse Event|0
82179|NCT00915278|292301|P2|Overall Study|Adverse Event|1
82180|NCT00915278|292302|P1|Overall Study|Adverse Event|4
82181|NCT00915278|292297|P6|Overall Study|Withdrawal by Subject|4
82182|NCT00915278|292298|P5|Overall Study|Withdrawal by Subject|1
82183|NCT00915278|292299|P4|Overall Study|Withdrawal by Subject|0
82184|NCT00915278|292300|P3|Overall Study|Withdrawal by Subject|0
82185|NCT00915278|292301|P2|Overall Study|Withdrawal by Subject|1
82186|NCT00915278|292302|P1|Overall Study|Withdrawal by Subject|0
82187|NCT00915278|292297|P6|Overall Study|Lost to Follow-up|0
82188|NCT00915278|292298|P5|Overall Study|Lost to Follow-up|0
82189|NCT00915278|292299|P4|Overall Study|Lost to Follow-up|0
82190|NCT00915278|292300|P3|Overall Study|Lost to Follow-up|0
82191|NCT00915278|292301|P2|Overall Study|Lost to Follow-up|1
82192|NCT00915278|292302|P1|Overall Study|Lost to Follow-up|0
82193|NCT00915278|292297|P6|Overall Study|Death|0
82194|NCT00915278|292298|P5|Overall Study|Death|0
82195|NCT00915278|292299|P4|Overall Study|Death|0
82196|NCT00915278|292300|P3|Overall Study|Death|0
82197|NCT00915278|292301|P2|Overall Study|Death|0
82198|NCT00915278|292302|P1|Overall Study|Death|1
82199|NCT00914966|292453|P1|Step 2: 2000 Units|Withdrawal by Subject|1
82200|NCT00914966|292453|P1|Step 1: 1500 Units|Physician Decision|1
82201|NCT00914966|292453|P1|Step 1: 1500 Units|Withdrawal by Subject|1
82202|NCT00914849|292548|P2|Overall Study|Not eligible|1
82203|NCT00914849|292549|P1|Overall Study|Not eligible|0
82204|NCT00914849|292548|P2|Overall Study|Withdrawal by Subject|0
82205|NCT00914849|292549|P1|Overall Study|Withdrawal by Subject|1
82206|NCT00914810|292581|P2|Overall Study|Hospitalized and unable to follow up.|1
82207|NCT00914810|292582|P1|Overall Study|Hospitalized and unable to follow up.|0
82208|NCT00914810|292581|P2|Overall Study|Relocated out of state|0
82209|NCT00914810|292582|P1|Overall Study|Relocated out of state|1
82210|NCT00914810|292581|P2|Overall Study|Withdrawal by Subject|0
82211|NCT00914810|292582|P1|Overall Study|Withdrawal by Subject|1
82212|NCT00914589|292593|P3|Overall Study|Death|1
82213|NCT00914589|292594|P2|Overall Study|Death|1
82214|NCT00914589|292595|P1|Overall Study|Death|0
82215|NCT00914589|292593|P3|Overall Study|unclassified|7
82216|NCT00914589|292594|P2|Overall Study|unclassified|9
82217|NCT00914589|292595|P1|Overall Study|unclassified|16
82218|NCT00914589|292593|P3|Overall Study|Protocol Violation|3
82219|NCT00914589|292594|P2|Overall Study|Protocol Violation|6
82220|NCT00914589|292595|P1|Overall Study|Protocol Violation|8
82221|NCT00914589|292593|P3|Overall Study|Adverse Event|1
82222|NCT00914589|292594|P2|Overall Study|Adverse Event|0
82223|NCT00914589|292595|P1|Overall Study|Adverse Event|1
82224|NCT00914459|292621|P2|Overall Study|Parent/Legal guardian request|0
82225|NCT00914459|292622|P1|Overall Study|Parent/Legal guardian request|1
82226|NCT00914459|292621|P2|Overall Study|Protocol Violation|1
82227|NCT00914459|292622|P1|Overall Study|Protocol Violation|0
82228|NCT00913770|292697|P3|Overall Study|Refused|8
82229|NCT00913770|292698|P2|Overall Study|Refused|10
82230|NCT00913770|292699|P1|Overall Study|Refused|11
82231|NCT00913770|292697|P3|Overall Study|Unable to contact|13
82232|NCT00913770|292698|P2|Overall Study|Unable to contact|19
82233|NCT00913770|292699|P1|Overall Study|Unable to contact|24
82234|NCT00913744|292712|P2|Overall Study|Death|0
82235|NCT00913744|292713|P1|Overall Study|Death|1
82236|NCT00913744|292712|P2|Overall Study|Withdrawal by Subject|1
82237|NCT00913744|292713|P1|Overall Study|Withdrawal by Subject|2
82238|NCT00913744|292712|P2|Overall Study|Adverse Event|0
82239|NCT00913744|292713|P1|Overall Study|Adverse Event|2
82240|NCT00913692|292719|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
82241|NCT00913692|292719|P1|Screening (4 Months)|Not eligible after screening phase.|6
82242|NCT00913692|292719|P1|Screening (4 Months)|Physician Decision|3
82243|NCT00913523|292732|P3|Overall Study|Inadequate Number of Tampons Used|3
82244|NCT00913523|292733|P2|Overall Study|Inadequate Number of Tampons Used|2
82245|NCT00913523|292734|P1|Overall Study|Inadequate Number of Tampons Used|7
82246|NCT00913523|292732|P3|Overall Study|Pregnancy|0
82247|NCT00913523|292733|P2|Overall Study|Pregnancy|3
82248|NCT00913523|292734|P1|Overall Study|Pregnancy|1
82249|NCT00913523|292732|P3|Overall Study|Protocol Violation|8
82250|NCT00913523|292733|P2|Overall Study|Protocol Violation|8
82251|NCT00913523|292734|P1|Overall Study|Protocol Violation|5
82252|NCT00913523|292732|P3|Overall Study|Adverse Event|0
82253|NCT00913523|292733|P2|Overall Study|Adverse Event|0
82254|NCT00913523|292734|P1|Overall Study|Adverse Event|1
82255|NCT00913523|292732|P3|Overall Study|Lost to Follow-up|1
82256|NCT00913523|292733|P2|Overall Study|Lost to Follow-up|1
82257|NCT00913523|292734|P1|Overall Study|Lost to Follow-up|1
82258|NCT00913523|292732|P3|Overall Study|Withdrawal by Subject|2
82259|NCT00913523|292733|P2|Overall Study|Withdrawal by Subject|2
82260|NCT00913523|292734|P1|Overall Study|Withdrawal by Subject|3
82261|NCT00913458|292766|P7|Phase 3|Unsatisfactory Response per Investigator|4
82262|NCT00913458|292767|P6|Phase 3|Unsatisfactory Response per Investigator|11
82263|NCT00913458|292768|P5|Phase 3|Unsatisfactory Response per Investigator|14
82264|NCT00913458|292769|P4|Phase 3|Unsatisfactory Response per Investigator|0
82265|NCT00913458|292770|P3|Phase 3|Unsatisfactory Response per Investigator|0
82266|NCT00913458|292771|P2|Phase 3|Unsatisfactory Response per Investigator|0
82267|NCT00913458|292772|P1|Phase 3|Unsatisfactory Response per Investigator|0
82268|NCT00913458|292766|P7|Phase 3|Withdrawal by Subject|0
82269|NCT00913458|292767|P6|Phase 3|Withdrawal by Subject|2
82270|NCT00913458|292768|P5|Phase 3|Withdrawal by Subject|1
82271|NCT00913458|292769|P4|Phase 3|Withdrawal by Subject|0
82272|NCT00913458|292770|P3|Phase 3|Withdrawal by Subject|0
82273|NCT00913458|292771|P2|Phase 3|Withdrawal by Subject|0
82274|NCT00913458|292772|P1|Phase 3|Withdrawal by Subject|0
82275|NCT00913458|292766|P7|Phase 3|Non-Responder|3
82276|NCT00913458|292767|P6|Phase 3|Non-Responder|1
82277|NCT00913458|292768|P5|Phase 3|Non-Responder|0
82278|NCT00913458|292769|P4|Phase 3|Non-Responder|0
82279|NCT00913458|292770|P3|Phase 3|Non-Responder|0
82280|NCT00913458|292771|P2|Phase 3|Non-Responder|0
82281|NCT00913458|292772|P1|Phase 3|Non-Responder|0
82282|NCT00913458|292766|P7|Phase 3|Lost to Follow-up|0
82283|NCT00913458|292767|P6|Phase 3|Lost to Follow-up|0
82284|NCT00913458|292768|P5|Phase 3|Lost to Follow-up|2
82285|NCT00913458|292769|P4|Phase 3|Lost to Follow-up|0
82286|NCT00913458|292770|P3|Phase 3|Lost to Follow-up|0
82287|NCT00913458|292771|P2|Phase 3|Lost to Follow-up|0
82288|NCT00913458|292772|P1|Phase 3|Lost to Follow-up|0
82289|NCT00913458|292766|P7|Phase 3|Adverse Event|1
82290|NCT00913458|292767|P6|Phase 3|Adverse Event|4
82291|NCT00913458|292768|P5|Phase 3|Adverse Event|5
82292|NCT00913458|292769|P4|Phase 3|Adverse Event|0
82293|NCT00913458|292770|P3|Phase 3|Adverse Event|0
82294|NCT00913458|292771|P2|Phase 3|Adverse Event|0
82295|NCT00913458|292772|P1|Phase 3|Adverse Event|0
82296|NCT00913458|292766|P7|Phase 2|Unsatisfactory Response per Investigator|0
82297|NCT00913458|292767|P6|Phase 2|Unsatisfactory Response per Investigator|0
82298|NCT00913458|292768|P5|Phase 2|Unsatisfactory Response per Investigator|0
82299|NCT00913458|292769|P4|Phase 2|Unsatisfactory Response per Investigator|17
82300|NCT00913458|292770|P3|Phase 2|Unsatisfactory Response per Investigator|11
82301|NCT00913458|292771|P2|Phase 2|Unsatisfactory Response per Investigator|0
82302|NCT00913458|292772|P1|Phase 2|Unsatisfactory Response per Investigator|0
82303|NCT00913458|292766|P7|Phase 2|Protocol Violation|0
82304|NCT00913458|292767|P6|Phase 2|Protocol Violation|0
82305|NCT00913458|292768|P5|Phase 2|Protocol Violation|0
82306|NCT00913458|292769|P4|Phase 2|Protocol Violation|0
82307|NCT00913458|292770|P3|Phase 2|Protocol Violation|0
82308|NCT00913458|292771|P2|Phase 2|Protocol Violation|2
82309|NCT00913458|292772|P1|Phase 2|Protocol Violation|0
82310|NCT00913458|292766|P7|Phase 2|Lost to Follow-up|0
82311|NCT00913458|292767|P6|Phase 2|Lost to Follow-up|0
82312|NCT00913458|292768|P5|Phase 2|Lost to Follow-up|0
82313|NCT00913458|292769|P4|Phase 2|Lost to Follow-up|1
82314|NCT00913458|292770|P3|Phase 2|Lost to Follow-up|0
82315|NCT00913458|292771|P2|Phase 2|Lost to Follow-up|0
82316|NCT00913458|292772|P1|Phase 2|Lost to Follow-up|0
82317|NCT00913458|292766|P7|Phase 2|Adverse Event|0
82318|NCT00913458|292767|P6|Phase 2|Adverse Event|0
82319|NCT00913458|292768|P5|Phase 2|Adverse Event|0
82320|NCT00913458|292769|P4|Phase 2|Adverse Event|1
82321|NCT00913458|292770|P3|Phase 2|Adverse Event|0
82322|NCT00913458|292771|P2|Phase 2|Adverse Event|3
82323|NCT00913458|292772|P1|Phase 2|Adverse Event|0
82324|NCT00913458|292766|P7|Phase 2|Subject Request|0
82325|NCT00913458|292767|P6|Phase 2|Subject Request|0
82326|NCT00913458|292768|P5|Phase 2|Subject Request|0
82327|NCT00913458|292769|P4|Phase 2|Subject Request|2
82328|NCT00913458|292770|P3|Phase 2|Subject Request|1
82329|NCT00913458|292771|P2|Phase 2|Subject Request|0
82330|NCT00913458|292772|P1|Phase 2|Subject Request|0
82331|NCT00913458|292766|P7|Phase 2|Non-Responder|0
82332|NCT00913458|292767|P6|Phase 2|Non-Responder|0
82333|NCT00913458|292768|P5|Phase 2|Non-Responder|0
82334|NCT00913458|292769|P4|Phase 2|Non-Responder|12
82335|NCT00913458|292770|P3|Phase 2|Non-Responder|7
82336|NCT00913458|292771|P2|Phase 2|Non-Responder|5
82337|NCT00913458|292772|P1|Phase 2|Non-Responder|0
82338|NCT00913458|292766|P7|Phase 1|Unsatisfactory Response per Investigator|0
82339|NCT00913458|292767|P6|Phase 1|Unsatisfactory Response per Investigator|0
82340|NCT00913458|292768|P5|Phase 1|Unsatisfactory Response per Investigator|0
82341|NCT00913458|292769|P4|Phase 1|Unsatisfactory Response per Investigator|0
82342|NCT00913458|292770|P3|Phase 1|Unsatisfactory Response per Investigator|0
82343|NCT00913458|292771|P2|Phase 1|Unsatisfactory Response per Investigator|0
82344|NCT00913458|292772|P1|Phase 1|Unsatisfactory Response per Investigator|7
82345|NCT00913458|292766|P7|Phase 1|Sponsor|0
82346|NCT00913458|292767|P6|Phase 1|Sponsor|0
82347|NCT00913458|292768|P5|Phase 1|Sponsor|0
82348|NCT00913458|292769|P4|Phase 1|Sponsor|0
82349|NCT00913458|292770|P3|Phase 1|Sponsor|0
82350|NCT00913458|292771|P2|Phase 1|Sponsor|0
82351|NCT00913458|292772|P1|Phase 1|Sponsor|2
82352|NCT00913458|292766|P7|Phase 1|Protocol Violation|0
82353|NCT00913458|292767|P6|Phase 1|Protocol Violation|0
82354|NCT00913458|292768|P5|Phase 1|Protocol Violation|0
82355|NCT00913458|292769|P4|Phase 1|Protocol Violation|0
82356|NCT00913458|292770|P3|Phase 1|Protocol Violation|0
82357|NCT00913458|292771|P2|Phase 1|Protocol Violation|0
82358|NCT00913458|292772|P1|Phase 1|Protocol Violation|10
82359|NCT00913458|292766|P7|Phase 1|Lost to Follow-up|0
82360|NCT00913458|292767|P6|Phase 1|Lost to Follow-up|0
82361|NCT00913458|292768|P5|Phase 1|Lost to Follow-up|0
82362|NCT00913458|292769|P4|Phase 1|Lost to Follow-up|0
82363|NCT00913458|292770|P3|Phase 1|Lost to Follow-up|0
82364|NCT00913458|292771|P2|Phase 1|Lost to Follow-up|0
82365|NCT00913458|292772|P1|Phase 1|Lost to Follow-up|2
82366|NCT00913458|292766|P7|Phase 1|Adverse Event|0
82367|NCT00913458|292767|P6|Phase 1|Adverse Event|0
82368|NCT00913458|292768|P5|Phase 1|Adverse Event|0
82369|NCT00913458|292769|P4|Phase 1|Adverse Event|0
82370|NCT00913458|292770|P3|Phase 1|Adverse Event|0
82371|NCT00913458|292771|P2|Phase 1|Adverse Event|0
82372|NCT00913458|292772|P1|Phase 1|Adverse Event|20
82373|NCT00913458|292766|P7|Phase 1|Subject Request|0
82374|NCT00913458|292767|P6|Phase 1|Subject Request|0
82375|NCT00913458|292768|P5|Phase 1|Subject Request|0
82376|NCT00913458|292769|P4|Phase 1|Subject Request|0
82377|NCT00913458|292770|P3|Phase 1|Subject Request|0
82378|NCT00913458|292771|P2|Phase 1|Subject Request|0
82379|NCT00913458|292772|P1|Phase 1|Subject Request|17
82380|NCT00913458|292766|P7|Phase 1|Non-Responder|0
82381|NCT00913458|292767|P6|Phase 1|Non-Responder|0
82382|NCT00913458|292768|P5|Phase 1|Non-Responder|0
82383|NCT00913458|292769|P4|Phase 1|Non-Responder|0
82384|NCT00913458|292770|P3|Phase 1|Non-Responder|0
82385|NCT00913458|292771|P2|Phase 1|Non-Responder|0
82386|NCT00913458|292772|P1|Phase 1|Non-Responder|54
82387|NCT00913380|292865|P2|Clinical Outcomes|Lost to Follow-up|6
82388|NCT00913380|292866|P1|Clinical Outcomes|Lost to Follow-up|6
82389|NCT00912964|292932|P3|Overall Study|Randomized but never received study drug|0
82390|NCT00912964|292933|P2|Overall Study|Randomized but never received study drug|1
82391|NCT00912964|292934|P1|Overall Study|Randomized but never received study drug|0
82392|NCT00912964|292932|P3|Overall Study|Violation of exclusion criterion|2
82393|NCT00912964|292933|P2|Overall Study|Violation of exclusion criterion|0
82394|NCT00912964|292934|P1|Overall Study|Violation of exclusion criterion|0
82395|NCT00912964|292932|P3|Overall Study|Non-compliance with study procedures|0
82396|NCT00912964|292933|P2|Overall Study|Non-compliance with study procedures|0
82397|NCT00912964|292934|P1|Overall Study|Non-compliance with study procedures|2
82398|NCT00912964|292932|P3|Overall Study|Medical History|0
82399|NCT00912964|292933|P2|Overall Study|Medical History|0
82400|NCT00912964|292934|P1|Overall Study|Medical History|1
82401|NCT00912964|292932|P3|Overall Study|Taking exclusionary medications|8
82402|NCT00912964|292933|P2|Overall Study|Taking exclusionary medications|4
82403|NCT00912964|292934|P1|Overall Study|Taking exclusionary medications|7
82404|NCT00912964|292932|P3|Overall Study|Protocol Violation|8
82405|NCT00912964|292933|P2|Overall Study|Protocol Violation|3
82406|NCT00912964|292934|P1|Overall Study|Protocol Violation|5
82407|NCT00912964|292932|P3|Overall Study|Lost to Follow-up|3
82408|NCT00912964|292933|P2|Overall Study|Lost to Follow-up|3
82409|NCT00912964|292934|P1|Overall Study|Lost to Follow-up|4
82410|NCT00912964|292932|P3|Overall Study|Withdrawal by Subject|18
82411|NCT00912964|292933|P2|Overall Study|Withdrawal by Subject|12
82412|NCT00912964|292934|P1|Overall Study|Withdrawal by Subject|20
82413|NCT00912964|292932|P3|Overall Study|Lack of Efficacy|3
82414|NCT00912964|292933|P2|Overall Study|Lack of Efficacy|4
82415|NCT00912964|292934|P1|Overall Study|Lack of Efficacy|11
82416|NCT00912964|292932|P3|Overall Study|Adverse Event|12
82417|NCT00912964|292933|P2|Overall Study|Adverse Event|18
82418|NCT00912964|292934|P1|Overall Study|Adverse Event|15
82419|NCT00912964|292932|P3|Overall Study|Eligibility criterion not met|0
82420|NCT00912964|292933|P2|Overall Study|Eligibility criterion not met|1
82421|NCT00912964|292934|P1|Overall Study|Eligibility criterion not met|1
82422|NCT00912912|293077|P1|Overall Study|Disease Progression|3
82423|NCT00912912|293077|P1|Overall Study|Withdrawal by Subject|1
82424|NCT00912782|293109|P2|Overall Study|Relocated before study completion|1
82425|NCT00912782|293110|P1|Overall Study|Relocated before study completion|0
82426|NCT00912782|293109|P2|Overall Study|Did not receive vascular access type|2
82427|NCT00912782|293110|P1|Overall Study|Did not receive vascular access type|1
82428|NCT00912782|293109|P2|Overall Study|Lost to Follow-up|1
82429|NCT00912782|293110|P1|Overall Study|Lost to Follow-up|0
82430|NCT00912782|293109|P2|Overall Study|Death|1
82431|NCT00912782|293110|P1|Overall Study|Death|2
82432|NCT00912743|293120|P2|Overall Study|End of treatment form was not collected|0
82433|NCT00912743|293121|P1|Overall Study|End of treatment form was not collected|1
82434|NCT00912743|293120|P2|Overall Study|Toxicity|1
82435|NCT00912743|293121|P1|Overall Study|Toxicity|0
82436|NCT00912743|293120|P2|Overall Study|Lack of Efficacy|18
82437|NCT00912743|293121|P1|Overall Study|Lack of Efficacy|9
82438|NCT00912743|293120|P2|Overall Study|Adverse Event|1
82439|NCT00912743|293121|P1|Overall Study|Adverse Event|3
82440|NCT00912509|293133|P2|Overall Study|Lack of Efficacy|3
82441|NCT00912509|293134|P1|Overall Study|Lack of Efficacy|4
82442|NCT00912509|293133|P2|Overall Study|Lost to Follow-up|0
82443|NCT00912509|293134|P1|Overall Study|Lost to Follow-up|1
82444|NCT00912405|293140|P1|Overall Study|Lost to Follow-up|5
82445|NCT00912288|293174|P2|Overall Study|Unspecified|0
82446|NCT00912288|293175|P1|Overall Study|Unspecified|1
82447|NCT00912288|293174|P2|Overall Study|Study terminated by sponsor|35
82448|NCT00912288|293175|P1|Overall Study|Study terminated by sponsor|34
82449|NCT00912288|293174|P2|Overall Study|Withdrawal by Subject|3
82450|NCT00912288|293175|P1|Overall Study|Withdrawal by Subject|3
82451|NCT00912288|293174|P2|Overall Study|Protocol Violation|0
82452|NCT00912288|293175|P1|Overall Study|Protocol Violation|1
82453|NCT00912288|293174|P2|Overall Study|Lost to Follow-up|0
82454|NCT00912288|293175|P1|Overall Study|Lost to Follow-up|1
82455|NCT00912288|293174|P2|Overall Study|Adverse Event|1
82456|NCT00912288|293175|P1|Overall Study|Adverse Event|1
82457|NCT00912288|293174|P2|Overall Study|Death|1
82458|NCT00912288|293175|P1|Overall Study|Death|0
82459|NCT00912223|293197|P1|Overall Study|Transformed disease|1
82460|NCT00912223|293197|P1|Overall Study|Not transplanted|1
82461|NCT00912223|293197|P1|Overall Study|Withdrawal by Subject|1
82462|NCT00912093|293228|P5|The Controlled Phase|Lost to Follow-up|1
82463|NCT00912093|293229|P4|The Controlled Phase|Lost to Follow-up|0
82464|NCT00912093|293230|P3|The Controlled Phase|Lost to Follow-up|0
82465|NCT00912093|293231|P2|The Controlled Phase|Lost to Follow-up|0
82466|NCT00912093|293232|P1|The Controlled Phase|Lost to Follow-up|0
82467|NCT00912093|293228|P5|The Controlled Phase|Medical Condition|0
82468|NCT00912093|293229|P4|The Controlled Phase|Medical Condition|0
82469|NCT00912093|293230|P3|The Controlled Phase|Medical Condition|0
82470|NCT00912093|293231|P2|The Controlled Phase|Medical Condition|1
82471|NCT00912093|293232|P1|The Controlled Phase|Medical Condition|0
82472|NCT00912093|293228|P5|The Controlled Phase|Death|0
82473|NCT00912093|293229|P4|The Controlled Phase|Death|0
82474|NCT00912093|293230|P3|The Controlled Phase|Death|0
82475|NCT00912093|293231|P2|The Controlled Phase|Death|1
82476|NCT00912093|293232|P1|The Controlled Phase|Death|0
82477|NCT00912028|293251|P5|Overall Study|Withdrawal by Subject|0
82478|NCT00912028|293252|P4|Overall Study|Withdrawal by Subject|0
82479|NCT00912028|293253|P3|Overall Study|Withdrawal by Subject|0
82480|NCT00912028|293254|P2|Overall Study|Withdrawal by Subject|0
82481|NCT00912028|293255|P1|Overall Study|Withdrawal by Subject|3
82482|NCT00912028|293251|P5|Overall Study|Lost to Follow-up|3
82483|NCT00912028|293252|P4|Overall Study|Lost to Follow-up|1
82484|NCT00912028|293253|P3|Overall Study|Lost to Follow-up|0
82485|NCT00912028|293254|P2|Overall Study|Lost to Follow-up|3
82486|NCT00912028|293255|P1|Overall Study|Lost to Follow-up|2
82487|NCT00912015|293284|P4|Overall Study|Adverse Event|1
82488|NCT00912015|293285|P3|Overall Study|Adverse Event|0
82489|NCT00912015|293286|P2|Overall Study|Adverse Event|0
82490|NCT00912015|293287|P1|Overall Study|Adverse Event|6
82491|NCT00912015|293284|P4|Overall Study|Protocol Violation|1
82492|NCT00912015|293285|P3|Overall Study|Protocol Violation|0
82493|NCT00912015|293286|P2|Overall Study|Protocol Violation|0
82494|NCT00912015|293287|P1|Overall Study|Protocol Violation|1
82495|NCT00912015|293284|P4|Overall Study|Withdrawal by Subject|0
82496|NCT00912015|293285|P3|Overall Study|Withdrawal by Subject|3
82497|NCT00912015|293286|P2|Overall Study|Withdrawal by Subject|8
82498|NCT00912015|293287|P1|Overall Study|Withdrawal by Subject|8
82499|NCT00912015|293284|P4|Overall Study|Lack of Efficacy|0
82500|NCT00912015|293285|P3|Overall Study|Lack of Efficacy|0
82501|NCT00912015|293286|P2|Overall Study|Lack of Efficacy|0
82502|NCT00912015|293287|P1|Overall Study|Lack of Efficacy|1
82503|NCT00911989|293303|P1|Overall Study|Adverse Event|1
82504|NCT00911937|293309|P2|Overall Study|Unspecified|5
82505|NCT00911937|293310|P1|Overall Study|Unspecified|9
82506|NCT00911937|293309|P2|Overall Study|Randomized but not treated|13
82507|NCT00911937|293310|P1|Overall Study|Randomized but not treated|13
82508|NCT00911937|293309|P2|Overall Study|Protocol Violation|23
82509|NCT00911937|293310|P1|Overall Study|Protocol Violation|14
82510|NCT00911937|293309|P2|Overall Study|Did not meet inclusion criteria|11
82511|NCT00911937|293310|P1|Overall Study|Did not meet inclusion criteria|9
82512|NCT00911937|293309|P2|Overall Study|Lack of Efficacy|6
82513|NCT00911937|293310|P1|Overall Study|Lack of Efficacy|11
82514|NCT00911937|293309|P2|Overall Study|Adverse Event|25
82515|NCT00911937|293310|P1|Overall Study|Adverse Event|11
82516|NCT00911937|293309|P2|Overall Study|Withdrawn due to pregnancy|0
82517|NCT00911937|293310|P1|Overall Study|Withdrawn due to pregnancy|1
82518|NCT00911937|293309|P2|Overall Study|Withdrawal by Subject|7
82519|NCT00911937|293310|P1|Overall Study|Withdrawal by Subject|10
82520|NCT00911937|293309|P2|Overall Study|Lost to Follow-up|5
82521|NCT00911937|293310|P1|Overall Study|Lost to Follow-up|8
82522|NCT00911937|293309|P2|Overall Study|Death|0
82523|NCT00911937|293310|P1|Overall Study|Death|1
82524|NCT00911859|293377|P3|Follow-up Period|Study terminated by sponsor|27
82525|NCT00911859|293378|P2|Follow-up Period|Study terminated by sponsor|33
82526|NCT00911859|293379|P1|Follow-up Period|Study terminated by sponsor|5
82527|NCT00911859|293377|P3|Follow-up Period|Withdrawal by Subject|4
82528|NCT00911859|293378|P2|Follow-up Period|Withdrawal by Subject|4
82529|NCT00911859|293379|P1|Follow-up Period|Withdrawal by Subject|0
82530|NCT00911859|293377|P3|Follow-up Period|Lost to Follow-up|0
82531|NCT00911859|293378|P2|Follow-up Period|Lost to Follow-up|1
82532|NCT00911859|293379|P1|Follow-up Period|Lost to Follow-up|1
82533|NCT00911859|293377|P3|Follow-up Period|Death|10
82534|NCT00911859|293378|P2|Follow-up Period|Death|8
82535|NCT00911859|293379|P1|Follow-up Period|Death|5
82536|NCT00911859|293377|P3|Maintainance Period|Withdrawal by Subject|3
82537|NCT00911859|293378|P2|Maintainance Period|Withdrawal by Subject|0
82538|NCT00911859|293379|P1|Maintainance Period|Withdrawal by Subject|0
82539|NCT00911859|293377|P3|Maintainance Period|Physician Decision|9
82540|NCT00911859|293378|P2|Maintainance Period|Physician Decision|0
82541|NCT00911859|293379|P1|Maintainance Period|Physician Decision|0
82542|NCT00911859|293377|P3|Maintainance Period|Lack of Efficacy|9
82543|NCT00911859|293378|P2|Maintainance Period|Lack of Efficacy|0
82544|NCT00911859|293379|P1|Maintainance Period|Lack of Efficacy|0
82545|NCT00911859|293377|P3|Treatment Period|Did not receive study treatment|0
82546|NCT00911859|293378|P2|Treatment Period|Did not receive study treatment|1
82547|NCT00911859|293379|P1|Treatment Period|Did not receive study treatment|0
82548|NCT00911859|293377|P3|Treatment Period|Withdrawal by Subject|5
82549|NCT00911859|293378|P2|Treatment Period|Withdrawal by Subject|4
82550|NCT00911859|293379|P1|Treatment Period|Withdrawal by Subject|0
82551|NCT00911859|293377|P3|Treatment Period|Physician Decision|3
82552|NCT00911859|293378|P2|Treatment Period|Physician Decision|3
82553|NCT00911859|293379|P1|Treatment Period|Physician Decision|3
82554|NCT00911859|293377|P3|Treatment Period|Lack of Efficacy|5
82555|NCT00911859|293378|P2|Treatment Period|Lack of Efficacy|7
82556|NCT00911859|293379|P1|Treatment Period|Lack of Efficacy|1
82557|NCT00911859|293377|P3|Treatment Period|Death|5
82558|NCT00911859|293378|P2|Treatment Period|Death|3
82559|NCT00911859|293379|P1|Treatment Period|Death|1
82560|NCT00911859|293377|P3|Treatment Period|Adverse Event|7
82561|NCT00911859|293378|P2|Treatment Period|Adverse Event|3
82562|NCT00911859|293379|P1|Treatment Period|Adverse Event|3
82563|NCT00911807|293406|P3|Overall Study|Organizational reasons|1
82564|NCT00911807|293407|P2|Overall Study|Organizational reasons|3
82565|NCT00911807|293408|P1|Overall Study|Organizational reasons|1
82566|NCT00911807|293406|P3|Overall Study|Withdrawal by Subject|7
82567|NCT00911807|293407|P2|Overall Study|Withdrawal by Subject|10
82568|NCT00911807|293408|P1|Overall Study|Withdrawal by Subject|8
82569|NCT00911807|293406|P3|Overall Study|Protocol Violation|9
82570|NCT00911807|293407|P2|Overall Study|Protocol Violation|4
82571|NCT00911807|293408|P1|Overall Study|Protocol Violation|6
82572|NCT00911807|293406|P3|Overall Study|Death|1
82573|NCT00911807|293407|P2|Overall Study|Death|0
82574|NCT00911807|293408|P1|Overall Study|Death|0
82575|NCT00911807|293406|P3|Overall Study|Adverse Event|5
82576|NCT00911807|293407|P2|Overall Study|Adverse Event|1
82577|NCT00911807|293408|P1|Overall Study|Adverse Event|2
82578|NCT00911768|293418|P2|Overall Study|Withdrawal by Subject|0
82579|NCT00911768|293419|P1|Overall Study|Withdrawal by Subject|1
82580|NCT00911768|293418|P2|Overall Study|Protocol Violation|4
82581|NCT00911768|293419|P1|Overall Study|Protocol Violation|5
82582|NCT00911547|293467|P4|Overall Study|Withdrawal by Subject|8
82583|NCT00911547|293468|P3|Overall Study|Withdrawal by Subject|4
82584|NCT00911547|293469|P2|Overall Study|Withdrawal by Subject|10
82585|NCT00911547|293470|P1|Overall Study|Withdrawal by Subject|3
82586|NCT00911547|293467|P4|Overall Study|Protocol Violation|1
82587|NCT00911547|293468|P3|Overall Study|Protocol Violation|5
82588|NCT00911547|293469|P2|Overall Study|Protocol Violation|5
82589|NCT00911547|293470|P1|Overall Study|Protocol Violation|0
82590|NCT00911547|293467|P4|Overall Study|Lost to Follow-up|1
82591|NCT00911547|293468|P3|Overall Study|Lost to Follow-up|2
82592|NCT00911547|293469|P2|Overall Study|Lost to Follow-up|0
82593|NCT00911547|293470|P1|Overall Study|Lost to Follow-up|0
82594|NCT00911547|293467|P4|Overall Study|Adverse Event|6
82595|NCT00911547|293468|P3|Overall Study|Adverse Event|11
82596|NCT00911547|293469|P2|Overall Study|Adverse Event|27
82597|NCT00911547|293470|P1|Overall Study|Adverse Event|8
82598|NCT00911534|293498|P2|Overall Study|Not specified|2
82599|NCT00911534|293499|P1|Overall Study|Not specified|2
82600|NCT00911534|293498|P2|Overall Study|Withdrawal of consent|4
82601|NCT00911534|293499|P1|Overall Study|Withdrawal of consent|1
82602|NCT00911534|293498|P2|Overall Study|Lack of Efficacy|1
82603|NCT00911534|293499|P1|Overall Study|Lack of Efficacy|4
82604|NCT00911534|293498|P2|Overall Study|Withdrawal by Subject|1
82605|NCT00911534|293499|P1|Overall Study|Withdrawal by Subject|2
82606|NCT00911534|293498|P2|Overall Study|Lost to Follow-up|4
82607|NCT00911534|293499|P1|Overall Study|Lost to Follow-up|2
82608|NCT00911534|293498|P2|Overall Study|Adverse Event|4
82609|NCT00911534|293499|P1|Overall Study|Adverse Event|4
82610|NCT00911300|293554|P2|Overall Study|Randomized; No Study Medication Received|2
82611|NCT00911300|293555|P1|Overall Study|Randomized; No Study Medication Received|0
82612|NCT00911300|293554|P2|Overall Study|Treatment Stopped by Mistake|1
82613|NCT00911300|293555|P1|Overall Study|Treatment Stopped by Mistake|0
82614|NCT00911300|293554|P2|Overall Study|Physician Decision|1
82615|NCT00911300|293555|P1|Overall Study|Physician Decision|0
82616|NCT00911300|293554|P2|Overall Study|Underlying Disease (Myocarditis)|1
82617|NCT00911300|293555|P1|Overall Study|Underlying Disease (Myocarditis)|0
82618|NCT00911300|293554|P2|Overall Study|Participant Refused Hospital Consulation|1
82619|NCT00911300|293555|P1|Overall Study|Participant Refused Hospital Consulation|0
82620|NCT00911300|293554|P2|Overall Study|International Normalized Ratio Too High|1
82621|NCT00911300|293555|P1|Overall Study|International Normalized Ratio Too High|0
82622|NCT00911300|293554|P2|Overall Study|Investigator's Decision; New AF Episode|1
82623|NCT00911300|293555|P1|Overall Study|Investigator's Decision; New AF Episode|0
82624|NCT00911300|293554|P2|Overall Study|Participant Could Not Stay in Hospital|1
82625|NCT00911300|293555|P1|Overall Study|Participant Could Not Stay in Hospital|0
82626|NCT00911300|293554|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
82627|NCT00911300|293555|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
82628|NCT00911300|293554|P2|Overall Study|Nurse Unavailable in Participant's City|0
82629|NCT00911300|293555|P1|Overall Study|Nurse Unavailable in Participant's City|1
82630|NCT00911300|293554|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
82631|NCT00911300|293555|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
82632|NCT00911300|293554|P2|Overall Study|Recurrent Tachyarrhythmia|1
82633|NCT00911300|293555|P1|Overall Study|Recurrent Tachyarrhythmia|1
82634|NCT00911300|293554|P2|Overall Study|Received Commercial Treatment|0
82635|NCT00911300|293555|P1|Overall Study|Received Commercial Treatment|1
82636|NCT00911300|293554|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
82637|NCT00911300|293555|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
82638|NCT00911300|293554|P2|Overall Study|Coronary Angiography Performed|0
82639|NCT00911300|293555|P1|Overall Study|Coronary Angiography Performed|1
82640|NCT00911300|293554|P2|Overall Study|Consent Withdrawn|12
82641|NCT00911300|293555|P1|Overall Study|Consent Withdrawn|4
82642|NCT00911300|293554|P2|Overall Study|Protocol Violation|2
82643|NCT00911300|293555|P1|Overall Study|Protocol Violation|3
82644|NCT00911300|293554|P2|Overall Study|Adverse Event|6
82645|NCT00911300|293555|P1|Overall Study|Adverse Event|14
82646|NCT00911300|293554|P2|Overall Study|Thrombus Persistant in Second TEE|7
82647|NCT00911300|293555|P1|Overall Study|Thrombus Persistant in Second TEE|3
82648|NCT00911300|293554|P2|Overall Study|Death|0
82649|NCT00911300|293555|P1|Overall Study|Death|1
82650|NCT00911300|293554|P2|Overall Study|Primary Endpoint Component Occurred|2
82651|NCT00911300|293555|P1|Overall Study|Primary Endpoint Component Occurred|1
82652|NCT00911170|293592|P2|Long Term Follow-Up|Death|121
82653|NCT00911170|293593|P1|Long Term Follow-Up|Death|116
82654|NCT00911170|293592|P2|Long Term Follow-Up|Lost to Follow-up|7
82655|NCT00911170|293593|P1|Long Term Follow-Up|Lost to Follow-up|8
82656|NCT00911170|293592|P2|Long Term Follow-Up|Physician Decision|4
82657|NCT00911170|293593|P1|Long Term Follow-Up|Physician Decision|5
82658|NCT00911170|293592|P2|Long Term Follow-Up|Withdrawal by Subject|21
82659|NCT00911170|293593|P1|Long Term Follow-Up|Withdrawal by Subject|20
82660|NCT00911170|293592|P2|Long Term Follow-Up|Continuing in study|269
82661|NCT00911170|293593|P1|Long Term Follow-Up|Continuing in study|274
82662|NCT00911170|293592|P2|Treatment Period|Death|9
82663|NCT00911170|293593|P1|Treatment Period|Death|6
82664|NCT00911170|293592|P2|Treatment Period|Lost to Follow-up|1
82665|NCT00911170|293593|P1|Treatment Period|Lost to Follow-up|0
82666|NCT00911170|293592|P2|Treatment Period|Physician Decision|5
82667|NCT00911170|293593|P1|Treatment Period|Physician Decision|5
82668|NCT00911170|293592|P2|Treatment Period|Disease progression|2
82669|NCT00911170|293593|P1|Treatment Period|Disease progression|0
82670|NCT00911170|293592|P2|Treatment Period|Withdrawal by Subject|4
82671|NCT00911170|293593|P1|Treatment Period|Withdrawal by Subject|4
82672|NCT00911170|293592|P2|Treatment Period|Adverse Event|10
82673|NCT00911170|293593|P1|Treatment Period|Adverse Event|9
82674|NCT00911170|293592|P2|Treatment Period|Protocol deviation|2
82675|NCT00911170|293593|P1|Treatment Period|Protocol deviation|1
82676|NCT00911170|293592|P2|Treatment Period|Ineligibility determined|3
82677|NCT00911170|293593|P1|Treatment Period|Ineligibility determined|1
82678|NCT00911170|293592|P2|Treatment Period|Randomized in error|1
82679|NCT00911170|293593|P1|Treatment Period|Randomized in error|1
82680|NCT00911157|293617|P2|Overall Study|Need to treat for lung cancer|0
82681|NCT00911157|293618|P1|Overall Study|Need to treat for lung cancer|1
82682|NCT00911157|293617|P2|Overall Study|Need for prohibited drug (heparin)|0
82683|NCT00911157|293618|P1|Overall Study|Need for prohibited drug (heparin)|1
82684|NCT00911157|293617|P2|Overall Study|Withdrawal by Subject|1
82685|NCT00911157|293618|P1|Overall Study|Withdrawal by Subject|1
82686|NCT00911157|293617|P2|Overall Study|Adverse Event|1
82687|NCT00911157|293618|P1|Overall Study|Adverse Event|4
82688|NCT00911144|293634|P2|Overall Study|Withdrawal by Subject|5
82689|NCT00911144|293635|P1|Overall Study|Withdrawal by Subject|16
82690|NCT00910988|293663|P4|Overall Study|Lost to Follow-up|0
82691|NCT00910988|293664|P3|Overall Study|Lost to Follow-up|3
82692|NCT00910988|293665|P2|Overall Study|Lost to Follow-up|4
82693|NCT00910988|293666|P1|Overall Study|Lost to Follow-up|2
82694|NCT00910910|293710|P2|Overall Study|Untreated before cycle 1|2
82695|NCT00910910|293711|P1|Overall Study|Untreated before cycle 1|1
82696|NCT00910910|293710|P2|Overall Study|Unspecified|32
82697|NCT00910910|293711|P1|Overall Study|Unspecified|114
82698|NCT00910910|293710|P2|Overall Study|Completed 13 cycles of treatment|118
82699|NCT00910910|293711|P1|Overall Study|Completed 13 cycles of treatment|0
82700|NCT00910910|293710|P2|Overall Study|Protocol Violation|2
82701|NCT00910910|293711|P1|Overall Study|Protocol Violation|2
82702|NCT00910910|293710|P2|Overall Study|Death|3
82703|NCT00910910|293711|P1|Overall Study|Death|9
82704|NCT00910910|293710|P2|Overall Study|Lost to Follow-up|2
82705|NCT00910910|293711|P1|Overall Study|Lost to Follow-up|2
82706|NCT00910910|293710|P2|Overall Study|Withdrawal by Subject|5
82707|NCT00910910|293711|P1|Overall Study|Withdrawal by Subject|7
82708|NCT00910910|293710|P2|Overall Study|PD with histologic change|2
82709|NCT00910910|293711|P1|Overall Study|PD with histologic change|0
82710|NCT00910910|293710|P2|Overall Study|PD without histologic change|23
82711|NCT00910910|293711|P1|Overall Study|PD without histologic change|27
82712|NCT00910910|293710|P2|Overall Study|Adverse Event|35
82713|NCT00910910|293711|P1|Overall Study|Adverse Event|63
82714|NCT00910871|293745|P1|Overall Study|Undefined|1
82715|NCT00910871|293745|P1|Overall Study|Subject didn’t meet eligibility criteria|5
82716|NCT00910871|293745|P1|Overall Study|Withdrawal by Subject|12
82717|NCT00910871|293745|P1|Overall Study|Protocol Violation|11
82718|NCT00910871|293745|P1|Overall Study|Lost to Follow-up|8
82719|NCT00910871|293745|P1|Overall Study|Death|12
82720|NCT00910871|293745|P1|Overall Study|Adverse Event|5
82721|NCT00910858|293753|P3|Combined Treatment Phase|Other|1
82722|NCT00910858|293754|P2|Combined Treatment Phase|Other|2
82723|NCT00910858|293755|P1|Combined Treatment Phase|Other|0
82724|NCT00910858|293753|P3|Combined Treatment Phase|Protocol Violation|0
82725|NCT00910858|293754|P2|Combined Treatment Phase|Protocol Violation|0
82726|NCT00910858|293755|P1|Combined Treatment Phase|Protocol Violation|1
82727|NCT00910858|293753|P3|Combined Treatment Phase|Withdrawal by Subject|0
82728|NCT00910858|293754|P2|Combined Treatment Phase|Withdrawal by Subject|2
82729|NCT00910858|293755|P1|Combined Treatment Phase|Withdrawal by Subject|0
82730|NCT00910858|293753|P3|Combined Treatment Phase|Lack of therapeutic effect|3
82731|NCT00910858|293754|P2|Combined Treatment Phase|Lack of therapeutic effect|6
82732|NCT00910858|293755|P1|Combined Treatment Phase|Lack of therapeutic effect|8
82733|NCT00910858|293753|P3|Monotherapy Phase|Other|2
82734|NCT00910858|293754|P2|Monotherapy Phase|Other|4
82735|NCT00910858|293755|P1|Monotherapy Phase|Other|3
82736|NCT00910858|293753|P3|Monotherapy Phase|Protocol Violation|0
82737|NCT00910858|293754|P2|Monotherapy Phase|Protocol Violation|0
82738|NCT00910858|293755|P1|Monotherapy Phase|Protocol Violation|1
82739|NCT00910858|293753|P3|Monotherapy Phase|Withdrawal by Subject|1
82740|NCT00910858|293754|P2|Monotherapy Phase|Withdrawal by Subject|3
82741|NCT00910858|293755|P1|Monotherapy Phase|Withdrawal by Subject|1
82742|NCT00910858|293753|P3|Monotherapy Phase|Lack of therapeutic effect|4
82743|NCT00910858|293754|P2|Monotherapy Phase|Lack of therapeutic effect|6
82744|NCT00910858|293755|P1|Monotherapy Phase|Lack of therapeutic effect|9
82745|NCT00910858|293753|P3|Monotherapy Phase|Adverse Event|0
82746|NCT00910858|293754|P2|Monotherapy Phase|Adverse Event|2
82747|NCT00910858|293755|P1|Monotherapy Phase|Adverse Event|3
82748|NCT00910858|293753|P3|Pharmacokinetic Phase|Adverse Event|0
82749|NCT00910858|293754|P2|Pharmacokinetic Phase|Adverse Event|0
82750|NCT00910858|293755|P1|Pharmacokinetic Phase|Adverse Event|1
82751|NCT00910715|293794|P3|Overall Study|Lost to Follow-up|0
82752|NCT00910715|293795|P2|Overall Study|Lost to Follow-up|26
82753|NCT00910715|293796|P1|Overall Study|Lost to Follow-up|22
82754|NCT00910689|293810|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
82755|NCT00910689|293811|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
82756|NCT00910689|293812|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
82757|NCT00910689|293813|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
82758|NCT00910689|293810|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
82759|NCT00910689|293811|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
82760|NCT00910689|293812|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
82761|NCT00910689|293813|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
82762|NCT00910689|293810|P4|Months 11- 16: Evaluation Period II|Time Demands|0
82763|NCT00910689|293811|P3|Months 11- 16: Evaluation Period II|Time Demands|0
82764|NCT00910689|293812|P2|Months 11- 16: Evaluation Period II|Time Demands|1
82765|NCT00910689|293813|P1|Months 11- 16: Evaluation Period II|Time Demands|2
82766|NCT00910689|293810|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
82767|NCT00910689|293811|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
82768|NCT00910689|293812|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
82769|NCT00910689|293813|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
82770|NCT00910689|293810|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
82771|NCT00910689|293811|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
82772|NCT00910689|293812|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
82773|NCT00910689|293813|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
82774|NCT00910689|293810|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
82775|NCT00910689|293811|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
82776|NCT00910689|293812|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
82777|NCT00910689|293813|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
82778|NCT00910689|293810|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
82779|NCT00910689|293811|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
82780|NCT00910689|293812|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
82781|NCT00910689|293813|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
82782|NCT00910689|293810|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
82783|NCT00910689|293811|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
82784|NCT00910689|293812|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
82785|NCT00910689|293813|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
82786|NCT00910689|293810|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
82787|NCT00910689|293811|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
82788|NCT00910689|293812|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
82789|NCT00910689|293813|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
82790|NCT00910689|293810|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
82791|NCT00910689|293811|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
82792|NCT00910689|293812|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
82793|NCT00910689|293813|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
82794|NCT00910689|293810|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
82795|NCT00910689|293811|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
82796|NCT00910689|293812|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
82797|NCT00910689|293813|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
82798|NCT00910689|293810|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
82799|NCT00910689|293811|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
82800|NCT00910689|293812|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
82801|NCT00910689|293813|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
82802|NCT00910689|293810|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
82803|NCT00910689|293811|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
82804|NCT00910689|293812|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
82805|NCT00910689|293813|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
82806|NCT00910689|293810|P4|Month 2- 4: Treatment Period|Protocol Violation|0
82807|NCT00910689|293811|P3|Month 2- 4: Treatment Period|Protocol Violation|0
82808|NCT00910689|293812|P2|Month 2- 4: Treatment Period|Protocol Violation|0
82809|NCT00910689|293813|P1|Month 2- 4: Treatment Period|Protocol Violation|1
82810|NCT00910689|293810|P4|Month 2- 4: Treatment Period|Pregnancy|0
82811|NCT00910689|293811|P3|Month 2- 4: Treatment Period|Pregnancy|0
82812|NCT00910689|293812|P2|Month 2- 4: Treatment Period|Pregnancy|2
82813|NCT00910689|293813|P1|Month 2- 4: Treatment Period|Pregnancy|0
82814|NCT00910689|293810|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
82815|NCT00910689|293811|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
82816|NCT00910689|293812|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
82817|NCT00910689|293813|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
82818|NCT00910689|293810|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
82819|NCT00910689|293811|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
82820|NCT00910689|293812|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
82821|NCT00910689|293813|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
82822|NCT00910689|293810|P4|Month 2- 4: Treatment Period|Time Demands|8
82823|NCT00910689|293811|P3|Month 2- 4: Treatment Period|Time Demands|4
82824|NCT00910689|293812|P2|Month 2- 4: Treatment Period|Time Demands|0
82825|NCT00910689|293813|P1|Month 2- 4: Treatment Period|Time Demands|1
82826|NCT00910689|293810|P4|Month 2- 4: Treatment Period|Adverse Event|0
82827|NCT00910689|293811|P3|Month 2- 4: Treatment Period|Adverse Event|2
82828|NCT00910689|293812|P2|Month 2- 4: Treatment Period|Adverse Event|3
82829|NCT00910689|293813|P1|Month 2- 4: Treatment Period|Adverse Event|2
82830|NCT00910689|293810|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
82831|NCT00910689|293811|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
82832|NCT00910689|293812|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
82833|NCT00910689|293813|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
82834|NCT00910689|293810|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
82835|NCT00910689|293811|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
82836|NCT00910689|293812|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
82837|NCT00910689|293813|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
82838|NCT00910663|293845|P2|Period 1|Withdrawal by Subject|1
82839|NCT00910663|293846|P1|Period 1|Withdrawal by Subject|0
82840|NCT00910624|293860|P4|Follow-Up Phase|Administrative|0
82841|NCT00910624|293861|P3|Follow-Up Phase|Administrative|1
82842|NCT00910624|293862|P2|Follow-Up Phase|Administrative|1
82843|NCT00910624|293863|P1|Follow-Up Phase|Administrative|0
82844|NCT00910624|293860|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
82845|NCT00910624|293861|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
82846|NCT00910624|293862|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
82847|NCT00910624|293863|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
82848|NCT00910624|293860|P4|Follow-Up Phase|Withdrawal by Subject|0
82849|NCT00910624|293861|P3|Follow-Up Phase|Withdrawal by Subject|0
82850|NCT00910624|293862|P2|Follow-Up Phase|Withdrawal by Subject|0
82851|NCT00910624|293863|P1|Follow-Up Phase|Withdrawal by Subject|1
82852|NCT00910624|293860|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
82853|NCT00910624|293861|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
82854|NCT00910624|293862|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
82855|NCT00910624|293863|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
82856|NCT00910624|293860|P4|Follow-Up Phase|Lost to Follow-up|0
82857|NCT00910624|293861|P3|Follow-Up Phase|Lost to Follow-up|2
82858|NCT00910624|293862|P2|Follow-Up Phase|Lost to Follow-up|1
82859|NCT00910624|293863|P1|Follow-Up Phase|Lost to Follow-up|3
82860|NCT00910624|293860|P4|Follow-Up Phase|Adverse Event|0
82861|NCT00910624|293861|P3|Follow-Up Phase|Adverse Event|1
82862|NCT00910624|293862|P2|Follow-Up Phase|Adverse Event|0
82863|NCT00910624|293863|P1|Follow-Up Phase|Adverse Event|0
82864|NCT00910624|293860|P4|Treatment Phase|Non-Compliance With Protocol|0
82865|NCT00910624|293861|P3|Treatment Phase|Non-Compliance With Protocol|1
82866|NCT00910624|293862|P2|Treatment Phase|Non-Compliance With Protocol|1
82867|NCT00910624|293863|P1|Treatment Phase|Non-Compliance With Protocol|0
82868|NCT00910624|293860|P4|Treatment Phase|Withdrawal by Subject|0
82869|NCT00910624|293861|P3|Treatment Phase|Withdrawal by Subject|0
82870|NCT00910624|293862|P2|Treatment Phase|Withdrawal by Subject|1
82871|NCT00910624|293863|P1|Treatment Phase|Withdrawal by Subject|2
82872|NCT00910624|293860|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
82873|NCT00910624|293861|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
82874|NCT00910624|293862|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
82875|NCT00910624|293863|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
82876|NCT00910624|293860|P4|Treatment Phase|Lost to Follow-up|0
82877|NCT00910624|293861|P3|Treatment Phase|Lost to Follow-up|1
82878|NCT00910624|293862|P2|Treatment Phase|Lost to Follow-up|0
82879|NCT00910624|293863|P1|Treatment Phase|Lost to Follow-up|0
82880|NCT00910624|293860|P4|Treatment Phase|Treatment Failure|0
82881|NCT00910624|293861|P3|Treatment Phase|Treatment Failure|0
82882|NCT00910624|293862|P2|Treatment Phase|Treatment Failure|10
82883|NCT00910624|293863|P1|Treatment Phase|Treatment Failure|23
82884|NCT00910624|293860|P4|Treatment Phase|Adverse Event|0
82885|NCT00910624|293861|P3|Treatment Phase|Adverse Event|6
82886|NCT00910624|293862|P2|Treatment Phase|Adverse Event|6
82887|NCT00910624|293863|P1|Treatment Phase|Adverse Event|2
82888|NCT00910299|293890|P2|Overall Study|Didn't receive any study drug|1
82889|NCT00910299|293891|P1|Overall Study|Didn't receive any study drug|2
82890|NCT00910299|293890|P2|Overall Study|Sponsor Decision|60
82891|NCT00910299|293891|P1|Overall Study|Sponsor Decision|58
82892|NCT00910299|293890|P2|Overall Study|Withdrawal by Subject|13
82893|NCT00910299|293891|P1|Overall Study|Withdrawal by Subject|16
82894|NCT00910273|293903|P2|Overall Study|Lost to Follow-up|1
82895|NCT00910273|293904|P1|Overall Study|Lost to Follow-up|1
82896|NCT00910273|293903|P2|Overall Study|Protocol Violation|0
82897|NCT00910273|293904|P1|Overall Study|Protocol Violation|1
82898|NCT00910273|293903|P2|Overall Study|Discontinuation of study by sponsor|2
82899|NCT00910273|293904|P1|Overall Study|Discontinuation of study by sponsor|8
82900|NCT00910273|293903|P2|Overall Study|Withdrawal by Subject|0
82901|NCT00910273|293904|P1|Overall Study|Withdrawal by Subject|1
82902|NCT00910273|293903|P2|Overall Study|Adverse Event|1
82903|NCT00910273|293904|P1|Overall Study|Adverse Event|1
82904|NCT00910273|293903|P2|Overall Study|Lack of Efficacy|9
82905|NCT00910273|293904|P1|Overall Study|Lack of Efficacy|6
82906|NCT00910091|293956|P2|Treatment and Survival|Adverse Event|0
82907|NCT00910091|293957|P1|Treatment and Survival|Adverse Event|1
82908|NCT00910091|293956|P2|Treatment and Survival|Withdrawal by Subject|4
82909|NCT00910091|293957|P1|Treatment and Survival|Withdrawal by Subject|3
82910|NCT00910091|293956|P2|Pre-assignment|Withdrawal by Subject|2
82911|NCT00910091|293957|P1|Pre-assignment|Withdrawal by Subject|0
82912|NCT00910039|293985|P1|Overall Study|Physician Decision|1
82913|NCT00910000|294002|P6|Overall Study|Withdrawal by Subject|0
82914|NCT00910000|294003|P5|Overall Study|Withdrawal by Subject|1
82915|NCT00910000|294004|P4|Overall Study|Withdrawal by Subject|0
82916|NCT00910000|294005|P3|Overall Study|Withdrawal by Subject|1
82917|NCT00910000|294006|P2|Overall Study|Withdrawal by Subject|0
82918|NCT00910000|294007|P1|Overall Study|Withdrawal by Subject|0
82919|NCT00910000|294002|P6|Overall Study|Adverse Event|1
82920|NCT00910000|294003|P5|Overall Study|Adverse Event|0
82921|NCT00910000|294004|P4|Overall Study|Adverse Event|2
82922|NCT00910000|294005|P3|Overall Study|Adverse Event|2
82923|NCT00910000|294006|P2|Overall Study|Adverse Event|3
82924|NCT00910000|294007|P1|Overall Study|Adverse Event|0
82925|NCT00909870|294025|P2|Overall Study|Other|5
82926|NCT00909870|294026|P1|Overall Study|Other|1
82927|NCT00909870|294025|P2|Overall Study|Physician Decision|2
82928|NCT00909870|294026|P1|Overall Study|Physician Decision|0
82929|NCT00909870|294025|P2|Overall Study|Lost to Follow-up|3
82930|NCT00909870|294026|P1|Overall Study|Lost to Follow-up|3
82931|NCT00909870|294025|P2|Overall Study|Withdrawal by Subject|8
82932|NCT00909870|294026|P1|Overall Study|Withdrawal by Subject|5
82933|NCT00909870|294025|P2|Overall Study|Protocol Violation|2
82934|NCT00909870|294026|P1|Overall Study|Protocol Violation|1
82935|NCT00909870|294025|P2|Overall Study|Adverse Event|7
82936|NCT00909870|294026|P1|Overall Study|Adverse Event|13
82937|NCT00909857|294038|P2|Overall Study|Did not receive study medication|24
82938|NCT00909857|294039|P1|Overall Study|Did not receive study medication|19
82939|NCT00909857|294038|P2|Overall Study|Other|0
82940|NCT00909857|294039|P1|Overall Study|Other|1
82941|NCT00909857|294038|P2|Overall Study|Pregnancy|0
82942|NCT00909857|294039|P1|Overall Study|Pregnancy|1
82943|NCT00909857|294038|P2|Overall Study|Protocol Violation|1
82944|NCT00909857|294039|P1|Overall Study|Protocol Violation|2
82945|NCT00909857|294038|P2|Overall Study|Lost to Follow-up|5
82946|NCT00909857|294039|P1|Overall Study|Lost to Follow-up|2
82947|NCT00909857|294038|P2|Overall Study|Adverse Event|5
82948|NCT00909857|294039|P1|Overall Study|Adverse Event|5
82949|NCT00909857|294038|P2|Overall Study|Withdrawal by Subject|10
82950|NCT00909857|294039|P1|Overall Study|Withdrawal by Subject|6
82951|NCT00909792|294179|P2|Period 2|Lost to Follow-up|1
82952|NCT00909792|294180|P1|Period 2|Lost to Follow-up|0
82953|NCT00909792|294179|P2|Period 2|Biomicroscopy|0
82954|NCT00909792|294180|P1|Period 2|Biomicroscopy|1
82955|NCT00909792|294179|P2|Period 1|Did not meet inclusion criteria|1
82956|NCT00909792|294180|P1|Period 1|Did not meet inclusion criteria|0
82957|NCT00909779|294188|P2|Overall Study|Randomized in error|1
82958|NCT00909779|294189|P1|Overall Study|Randomized in error|1
82959|NCT00909779|294188|P2|Overall Study|Noncompliance|1
82960|NCT00909779|294189|P1|Overall Study|Noncompliance|1
82961|NCT00909779|294188|P2|Overall Study|Medical Monitor Decision|0
82962|NCT00909779|294189|P1|Overall Study|Medical Monitor Decision|1
82963|NCT00909779|294188|P2|Overall Study|Site Ceasing Operation|2
82964|NCT00909779|294189|P1|Overall Study|Site Ceasing Operation|2
82965|NCT00909779|294188|P2|Overall Study|Withdrawal by Subject|80
82966|NCT00909779|294189|P1|Overall Study|Withdrawal by Subject|116
82967|NCT00909779|294188|P2|Overall Study|Protocol Violation|5
82968|NCT00909779|294189|P1|Overall Study|Protocol Violation|2
82969|NCT00909779|294188|P2|Overall Study|Physician Decision|2
82970|NCT00909779|294189|P1|Overall Study|Physician Decision|8
82971|NCT00909779|294188|P2|Overall Study|Lost to Follow-up|15
82972|NCT00909779|294189|P1|Overall Study|Lost to Follow-up|19
82973|NCT00909779|294188|P2|Overall Study|Lack of Efficacy|4
82974|NCT00909779|294189|P1|Overall Study|Lack of Efficacy|7
82975|NCT00909779|294188|P2|Overall Study|Adverse Event|55
82976|NCT00909779|294189|P1|Overall Study|Adverse Event|53
82977|NCT00909753|294213|P2|Period: Second Intervention|Protocol Violation|0
82978|NCT00909753|294214|P1|Period: Second Intervention|Protocol Violation|1
82979|NCT00909753|294213|P2|Period: Washout of 28 Days|Protocol Violation|3
82980|NCT00909753|294214|P1|Period: Washout of 28 Days|Protocol Violation|2
82981|NCT00909727|294234|P2|Overall Study|Prohibited Medication|0
82982|NCT00909727|294235|P1|Overall Study|Prohibited Medication|1
82983|NCT00909727|294234|P2|Overall Study|Withdrawal of Consent|0
82984|NCT00909727|294235|P1|Overall Study|Withdrawal of Consent|1
82985|NCT00909727|294234|P2|Overall Study|Wrong Genotype|0
82986|NCT00909727|294235|P1|Overall Study|Wrong Genotype|1
82987|NCT00909727|294234|P2|Overall Study|Adverse Event|0
82988|NCT00909727|294235|P1|Overall Study|Adverse Event|1
82989|NCT00909610|294258|P2|Period: Second Intervention|Adverse Event|0
82990|NCT00909610|294259|P1|Period: Second Intervention|Adverse Event|1
82991|NCT00909610|294258|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
82992|NCT00909610|294259|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
82993|NCT00909610|294258|P2|Period: First Intervention|Adverse Event|1
82994|NCT00909610|294259|P1|Period: First Intervention|Adverse Event|0
82995|NCT00909532|294420|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
82996|NCT00909532|294421|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
82997|NCT00909532|294420|P2|Overall Study|Wrong Genotype|0
82998|NCT00909532|294421|P1|Overall Study|Wrong Genotype|1
82999|NCT00909532|294420|P2|Overall Study|Physician Decision|0
83000|NCT00909532|294421|P1|Overall Study|Physician Decision|1
83001|NCT00909532|294420|P2|Overall Study|Noncompliance with Study Requirements|2
83002|NCT00909532|294421|P1|Overall Study|Noncompliance with Study Requirements|0
83003|NCT00909532|294420|P2|Overall Study|Withdrawal of Consent|1
83004|NCT00909532|294421|P1|Overall Study|Withdrawal of Consent|1
83005|NCT00909532|294420|P2|Overall Study|Prohibited Medication|1
83006|NCT00909532|294421|P1|Overall Study|Prohibited Medication|2
83007|NCT00909532|294420|P2|Overall Study|Pregnancy|1
83008|NCT00909532|294421|P1|Overall Study|Pregnancy|0
83009|NCT00909532|294420|P2|Overall Study|Adverse Event|1
83010|NCT00909532|294421|P1|Overall Study|Adverse Event|4
83011|NCT00909480|294439|P2|Overall Study|Unclassified|19
83012|NCT00909480|294440|P1|Overall Study|Unclassified|18
83013|NCT00909480|294439|P2|Overall Study|Withdrawal criteria|11
83014|NCT00909480|294440|P1|Overall Study|Withdrawal criteria|9
83015|NCT00909480|294439|P2|Overall Study|Protocol Violation|8
83016|NCT00909480|294440|P1|Overall Study|Protocol Violation|6
83017|NCT00909480|294439|P2|Overall Study|Adverse Event|3
83018|NCT00909480|294440|P1|Overall Study|Adverse Event|5
83019|NCT00909389|294472|P1|Overall Study|No Information|103
83020|NCT00909389|294472|P1|Overall Study|Lost to Follow-up|4
83021|NCT00909389|294472|P1|Overall Study|Poor Compliance|16
83022|NCT00909389|294472|P1|Overall Study|Death|4
83023|NCT00909389|294472|P1|Overall Study|Adverse Event|6
83024|NCT00909181|294492|P3|Overall Study|Lost to Follow-up|33
83025|NCT00909181|294493|P2|Overall Study|Lost to Follow-up|18
83026|NCT00909181|294494|P1|Overall Study|Lost to Follow-up|39
83027|NCT00909038|294515|P1|Overall Study|Non-evaluable Subjects|230
83028|NCT00909038|294515|P1|Overall Study|Protocol Violation|187
83029|NCT00908960|294527|P3|Overall Study|excluded from analysis|2
83030|NCT00908960|294528|P2|Overall Study|excluded from analysis|1
83031|NCT00908960|294529|P1|Overall Study|excluded from analysis|1
83032|NCT00908895|294545|P2|Overall Study|Adverse Event|1
83033|NCT00908895|294546|P1|Overall Study|Adverse Event|1
83034|NCT00908895|294545|P2|Overall Study|algodystrophy|2
83035|NCT00908895|294546|P1|Overall Study|algodystrophy|2
83036|NCT00908895|294545|P2|Overall Study|Lost to Follow-up|3
83037|NCT00908895|294546|P1|Overall Study|Lost to Follow-up|1
83038|NCT00908596|294619|P4|Overall Study|Withdrawal by Subject|1
83039|NCT00908596|294620|P3|Overall Study|Withdrawal by Subject|3
83040|NCT00908596|294621|P2|Overall Study|Withdrawal by Subject|1
83041|NCT00908596|294622|P1|Overall Study|Withdrawal by Subject|0
83042|NCT00908596|294619|P4|Overall Study|Protocol Violation|0
83043|NCT00908596|294620|P3|Overall Study|Protocol Violation|0
83044|NCT00908596|294621|P2|Overall Study|Protocol Violation|0
83045|NCT00908596|294622|P1|Overall Study|Protocol Violation|1
83046|NCT00908596|294619|P4|Overall Study|Death|32
83047|NCT00908596|294620|P3|Overall Study|Death|57
83048|NCT00908596|294621|P2|Overall Study|Death|5
83049|NCT00908596|294622|P1|Overall Study|Death|0
83050|NCT00908596|294619|P4|Overall Study|Lost to Follow-up|4
83051|NCT00908596|294620|P3|Overall Study|Lost to Follow-up|12
83052|NCT00908596|294621|P2|Overall Study|Lost to Follow-up|1
83053|NCT00908596|294622|P1|Overall Study|Lost to Follow-up|0
83054|NCT00908596|294619|P4|Overall Study|Other reasons|0
83055|NCT00908596|294620|P3|Overall Study|Other reasons|2
83056|NCT00908596|294621|P2|Overall Study|Other reasons|6
83057|NCT00908596|294622|P1|Overall Study|Other reasons|46
83058|NCT00908583|294652|P1|Phase 5|Adverse Event|3
83059|NCT00908583|294652|P1|Phase 4|Physician Decision|1
83060|NCT00908583|294652|P1|Phase 4|Adverse Event|1
83061|NCT00908583|294652|P1|Phase 3|Adverse Event|2
83062|NCT00908583|294652|P1|Phase 2|Adverse Event|1
83063|NCT00908583|294652|P1|Phase 2|Physician Decision|1
83064|NCT00908583|294652|P1|Phase 1|Adverse Event|4
83065|NCT00908583|294652|P1|Phase 1|Withdrawal by Subject|1
83066|NCT00908375|294680|P2|Overall Study|Lost to Follow-up|6
83067|NCT00908375|294681|P1|Overall Study|Lost to Follow-up|8
83068|NCT00908375|294680|P2|Overall Study|Withdrawal by Subject|4
83069|NCT00908375|294681|P1|Overall Study|Withdrawal by Subject|2
83070|NCT00908310|294691|P1|Overall Study|Other reasons|4
83071|NCT00908310|294691|P1|Overall Study|Screening failure|5
83072|NCT00908310|294691|P1|Overall Study|Lost to Follow-up|7
83073|NCT00908310|294691|P1|Overall Study|Withdrawal by Subject|7
83074|NCT00908310|294691|P1|Overall Study|Death|37
83075|NCT00908232|294695|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
83076|NCT00908232|294696|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
83077|NCT00908232|294697|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
83078|NCT00908232|294698|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
83079|NCT00908232|294695|P4|Randomization (Cycle 5) to Cycle 8|Other|0
83080|NCT00908232|294696|P3|Randomization (Cycle 5) to Cycle 8|Other|0
83081|NCT00908232|294697|P2|Randomization (Cycle 5) to Cycle 8|Other|1
83082|NCT00908232|294698|P1|Randomization (Cycle 5) to Cycle 8|Other|3
83083|NCT00908232|294695|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
83084|NCT00908232|294696|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
83085|NCT00908232|294697|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
83086|NCT00908232|294698|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
83087|NCT00908232|294695|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
83088|NCT00908232|294696|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
83089|NCT00908232|294697|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
83090|NCT00908232|294698|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
83091|NCT00908232|294695|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
83092|NCT00908232|294696|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
83093|NCT00908232|294697|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
83094|NCT00908232|294698|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
83095|NCT00908232|294695|P4|Randomization (Cycle 5) to Cycle 8|Death|0
83096|NCT00908232|294696|P3|Randomization (Cycle 5) to Cycle 8|Death|0
83097|NCT00908232|294697|P2|Randomization (Cycle 5) to Cycle 8|Death|0
83098|NCT00908232|294698|P1|Randomization (Cycle 5) to Cycle 8|Death|2
83099|NCT00908232|294695|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
83100|NCT00908232|294696|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
83101|NCT00908232|294697|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
83102|NCT00908232|294698|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
83103|NCT00908232|294695|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
83104|NCT00908232|294696|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
83105|NCT00908232|294697|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
83106|NCT00908232|294698|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
83107|NCT00908232|294695|P4|Cycle 1 to 4|not specified|0
83108|NCT00908232|294696|P3|Cycle 1 to 4|not specified|0
83109|NCT00908232|294697|P2|Cycle 1 to 4|not specified|0
83110|NCT00908232|294698|P1|Cycle 1 to 4|not specified|1
83111|NCT00908232|294695|P4|Cycle 1 to 4|Adverse Event|0
83112|NCT00908232|294696|P3|Cycle 1 to 4|Adverse Event|0
83113|NCT00908232|294697|P2|Cycle 1 to 4|Adverse Event|0
83114|NCT00908232|294698|P1|Cycle 1 to 4|Adverse Event|12
83115|NCT00908232|294695|P4|Cycle 1 to 4|Progressive Disease|0
83116|NCT00908232|294696|P3|Cycle 1 to 4|Progressive Disease|0
83117|NCT00908232|294697|P2|Cycle 1 to 4|Progressive Disease|0
83118|NCT00908232|294698|P1|Cycle 1 to 4|Progressive Disease|6
83119|NCT00908232|294695|P4|Cycle 1 to 4|Withdrawal by Subject|0
83120|NCT00908232|294696|P3|Cycle 1 to 4|Withdrawal by Subject|0
83121|NCT00908232|294697|P2|Cycle 1 to 4|Withdrawal by Subject|0
83122|NCT00908232|294698|P1|Cycle 1 to 4|Withdrawal by Subject|4
83123|NCT00908232|294695|P4|Cycle 1 to 4|Death|0
83124|NCT00908232|294696|P3|Cycle 1 to 4|Death|0
83125|NCT00908232|294697|P2|Cycle 1 to 4|Death|0
83126|NCT00908232|294698|P1|Cycle 1 to 4|Death|5
83127|NCT00908141|294716|P2|Overall Study|Withdrawal by Subject|1
83128|NCT00908141|294717|P1|Overall Study|Withdrawal by Subject|0
83129|NCT00908115|294734|P1|Overall Study|Unspecified|14
83130|NCT00908076|294742|P2|Overall Study|Lack of Efficacy|1
83131|NCT00908076|294743|P1|Overall Study|Lack of Efficacy|1
83132|NCT00908037|294756|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
83133|NCT00908037|294757|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
83134|NCT00908037|294758|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
83135|NCT00908037|294759|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
83136|NCT00908037|294760|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
83137|NCT00908037|294761|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
83138|NCT00908037|294762|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
83139|NCT00908037|294763|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
83140|NCT00908037|294764|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
83141|NCT00908037|294765|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
83142|NCT00908037|294766|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
83143|NCT00908037|294767|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
83144|NCT00908037|294756|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
83145|NCT00908037|294757|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
83146|NCT00908037|294758|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
83147|NCT00908037|294759|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
83148|NCT00908037|294760|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
83149|NCT00908037|294761|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
83150|NCT00908037|294762|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
83151|NCT00908037|294763|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
83152|NCT00908037|294764|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
83153|NCT00908037|294765|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
83154|NCT00908037|294766|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
83155|NCT00908037|294767|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
83156|NCT00908037|294756|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
83157|NCT00908037|294757|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
83158|NCT00908037|294758|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
83159|NCT00908037|294759|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
83160|NCT00908037|294760|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
83161|NCT00908037|294761|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
83162|NCT00908037|294762|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
83163|NCT00908037|294763|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
83164|NCT00908037|294764|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
83165|NCT00908037|294765|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
83166|NCT00908037|294766|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
83167|NCT00908037|294767|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
83168|NCT00908037|294756|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
83169|NCT00908037|294757|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
83170|NCT00908037|294758|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
83171|NCT00908037|294759|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
83172|NCT00908037|294760|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
83173|NCT00908037|294761|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
83174|NCT00908037|294762|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
83175|NCT00908037|294763|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
83176|NCT00908037|294764|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
83177|NCT00908037|294765|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
83178|NCT00908037|294766|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
83179|NCT00908037|294767|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
83180|NCT00908037|294756|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
83181|NCT00908037|294757|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
83182|NCT00908037|294758|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
83183|NCT00908037|294759|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
83184|NCT00908037|294760|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
83185|NCT00908037|294761|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
83186|NCT00908037|294762|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
83187|NCT00908037|294763|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
83188|NCT00908037|294764|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
83189|NCT00908037|294765|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
83190|NCT00908037|294766|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
83191|NCT00908037|294767|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
83192|NCT00908037|294756|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
83193|NCT00908037|294757|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
83194|NCT00908037|294758|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
83195|NCT00908037|294759|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
83196|NCT00908037|294760|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
83197|NCT00908037|294761|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
83198|NCT00908037|294762|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
83199|NCT00908037|294763|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
83200|NCT00908037|294764|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
83201|NCT00908037|294765|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
83202|NCT00908037|294766|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
83203|NCT00908037|294767|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
83204|NCT00908037|294756|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
83205|NCT00908037|294757|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
83206|NCT00908037|294758|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
83207|NCT00908037|294759|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
83208|NCT00908037|294760|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
83209|NCT00908037|294761|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
83210|NCT00908037|294762|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
83211|NCT00908037|294763|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
83212|NCT00908037|294764|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
83213|NCT00908037|294765|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
83214|NCT00908037|294766|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
83215|NCT00908037|294767|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
83216|NCT00908037|294756|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
83217|NCT00908037|294757|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
83218|NCT00908037|294758|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
83219|NCT00908037|294759|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
83220|NCT00908037|294760|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
83221|NCT00908037|294761|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
83222|NCT00908037|294762|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
83223|NCT00908037|294763|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
83224|NCT00908037|294764|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
83225|NCT00908037|294765|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
83226|NCT00908037|294766|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
83227|NCT00908037|294767|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
83228|NCT00908037|294756|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
83229|NCT00908037|294757|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
83230|NCT00908037|294758|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
83231|NCT00908037|294759|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
83232|NCT00908037|294760|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
83233|NCT00908037|294761|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
83234|NCT00908037|294762|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
83235|NCT00908037|294763|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
83236|NCT00908037|294764|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
83237|NCT00908037|294765|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
83238|NCT00908037|294766|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
83239|NCT00908037|294767|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
83240|NCT00908011|294916|P2|Overall Study|Withdrawal by Subject|2
83241|NCT00908011|294917|P1|Overall Study|Withdrawal by Subject|2
83242|NCT00907881|294934|P1|Overall Study|Missing discontinuation information|15
83243|NCT00907881|294934|P1|Overall Study|Protocol Violation|1
83244|NCT00907881|294934|P1|Overall Study|Withdrawal by Subject|5
83245|NCT00907881|294934|P1|Overall Study|Noncompliance|5
83246|NCT00907881|294934|P1|Overall Study|Lost to Follow-up|59
83247|NCT00907803|294944|P3|Overall Study|Protocol Violation|0
83248|NCT00907803|294945|P2|Overall Study|Protocol Violation|1
83249|NCT00907803|294946|P1|Overall Study|Protocol Violation|0
83250|NCT00907803|294944|P3|Overall Study|Lost to Follow-up|0
83251|NCT00907803|294945|P2|Overall Study|Lost to Follow-up|1
83252|NCT00907803|294946|P1|Overall Study|Lost to Follow-up|0
83253|NCT00907803|294944|P3|Overall Study|Withdrawal by Subject|0
83254|NCT00907803|294945|P2|Overall Study|Withdrawal by Subject|1
83255|NCT00907803|294946|P1|Overall Study|Withdrawal by Subject|0
83256|NCT00907803|294944|P3|Overall Study|Adverse Event|0
83257|NCT00907803|294945|P2|Overall Study|Adverse Event|0
83258|NCT00907803|294946|P1|Overall Study|Adverse Event|2
83259|NCT00907803|294944|P3|Overall Study|Withdrawal of consent - long commute|0
83260|NCT00907803|294945|P2|Overall Study|Withdrawal of consent - long commute|0
83261|NCT00907803|294946|P1|Overall Study|Withdrawal of consent - long commute|1
83262|NCT00907777|294977|P2|Overall Study|Withdrawal by Subject|1
83263|NCT00907777|294978|P1|Overall Study|Withdrawal by Subject|0
83264|NCT00907738|295005|P5|Overall Study|Disease progression|2
83265|NCT00907738|295006|P4|Overall Study|Disease progression|4
83266|NCT00907738|295007|P3|Overall Study|Disease progression|6
83267|NCT00907738|295008|P2|Overall Study|Disease progression|1
83268|NCT00907738|295009|P1|Overall Study|Disease progression|8
83269|NCT00907738|295005|P5|Overall Study|not specified or withdrew consent|0
83270|NCT00907738|295006|P4|Overall Study|not specified or withdrew consent|0
83271|NCT00907738|295007|P3|Overall Study|not specified or withdrew consent|0
83272|NCT00907738|295008|P2|Overall Study|not specified or withdrew consent|0
83273|NCT00907738|295009|P1|Overall Study|not specified or withdrew consent|3
83274|NCT00907738|295005|P5|Overall Study|Adverse Event|0
83275|NCT00907738|295006|P4|Overall Study|Adverse Event|0
83276|NCT00907738|295007|P3|Overall Study|Adverse Event|1
83277|NCT00907738|295008|P2|Overall Study|Adverse Event|0
83278|NCT00907738|295009|P1|Overall Study|Adverse Event|2
83279|NCT00907621|295027|P2|Overall Study|intercurrent febrile illness|1
83280|NCT00907621|295028|P1|Overall Study|intercurrent febrile illness|1
83281|NCT00907621|295027|P2|Overall Study|Lost to Follow-up|3
83282|NCT00907621|295028|P1|Overall Study|Lost to Follow-up|6
83283|NCT00907517|295041|P5|Overall Study|Symptomatic Deterioration|1
83284|NCT00907517|295042|P4|Overall Study|Symptomatic Deterioration|0
83285|NCT00907517|295043|P3|Overall Study|Symptomatic Deterioration|0
83286|NCT00907517|295044|P2|Overall Study|Symptomatic Deterioration|0
83287|NCT00907517|295045|P1|Overall Study|Symptomatic Deterioration|0
83288|NCT00907517|295041|P5|Overall Study|Progressive Disease|4
83289|NCT00907517|295042|P4|Overall Study|Progressive Disease|4
83290|NCT00907517|295043|P3|Overall Study|Progressive Disease|4
83291|NCT00907517|295044|P2|Overall Study|Progressive Disease|3
83292|NCT00907517|295045|P1|Overall Study|Progressive Disease|3
83293|NCT00907478|295070|P3|Overall Study|Other|1
83294|NCT00907478|295071|P2|Overall Study|Other|0
83295|NCT00907478|295072|P1|Overall Study|Other|3
83296|NCT00907478|295070|P3|Overall Study|Lost to Follow-up|0
83297|NCT00907478|295071|P2|Overall Study|Lost to Follow-up|0
83298|NCT00907478|295072|P1|Overall Study|Lost to Follow-up|1
83299|NCT00907478|295070|P3|Overall Study|Pregnancy|1
83300|NCT00907478|295071|P2|Overall Study|Pregnancy|1
83301|NCT00907478|295072|P1|Overall Study|Pregnancy|0
83302|NCT00907478|295070|P3|Overall Study|Protocol-specified criteria|3
83303|NCT00907478|295071|P2|Overall Study|Protocol-specified criteria|2
83304|NCT00907478|295072|P1|Overall Study|Protocol-specified criteria|5
83305|NCT00907478|295070|P3|Overall Study|Death|1
83306|NCT00907478|295071|P2|Overall Study|Death|2
83307|NCT00907478|295072|P1|Overall Study|Death|4
83308|NCT00907478|295070|P3|Overall Study|Physician Decision|3
83309|NCT00907478|295071|P2|Overall Study|Physician Decision|0
83310|NCT00907478|295072|P1|Overall Study|Physician Decision|2
83311|NCT00907478|295070|P3|Overall Study|Requirement for alternative therapy|3
83312|NCT00907478|295071|P2|Overall Study|Requirement for alternative therapy|2
83313|NCT00907478|295072|P1|Overall Study|Requirement for alternative therapy|1
83314|NCT00907478|295070|P3|Overall Study|Withdrawal by Subject|6
83315|NCT00907478|295071|P2|Overall Study|Withdrawal by Subject|9
83316|NCT00907478|295072|P1|Overall Study|Withdrawal by Subject|8
83317|NCT00907478|295070|P3|Overall Study|Adverse Event|2
83318|NCT00907478|295071|P2|Overall Study|Adverse Event|1
83319|NCT00907478|295072|P1|Overall Study|Adverse Event|3
83320|NCT00907478|295070|P3|Overall Study|Noncompliance|1
83321|NCT00907478|295071|P2|Overall Study|Noncompliance|0
83322|NCT00907478|295072|P1|Overall Study|Noncompliance|0
83323|NCT00907478|295070|P3|Overall Study|Ineligibility determined|1
83324|NCT00907478|295071|P2|Overall Study|Ineligibility determined|0
83325|NCT00907478|295072|P1|Overall Study|Ineligibility determined|0
83326|NCT00907374|295122|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
83327|NCT00907374|295123|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
83328|NCT00907335|295137|P2|Overall Study|Lost to Follow-up|0
83329|NCT00907335|295138|P1|Overall Study|Lost to Follow-up|2
83330|NCT00907335|295137|P2|Overall Study|Adverse Event|1
83331|NCT00907335|295138|P1|Overall Study|Adverse Event|4
83332|NCT00907335|295137|P2|Overall Study|Withdrawal by Subject|0
83333|NCT00907335|295138|P1|Overall Study|Withdrawal by Subject|2
83334|NCT00907257|295156|P2|Overall Study|Personal Reasons|1
83335|NCT00907257|295157|P1|Overall Study|Personal Reasons|6
83336|NCT00907257|295156|P2|Overall Study|Moved|0
83337|NCT00907257|295157|P1|Overall Study|Moved|1
83338|NCT00907257|295156|P2|Overall Study|Per IRB-Subject became vulnerable|0
83339|NCT00907257|295157|P1|Overall Study|Per IRB-Subject became vulnerable|1
83340|NCT00907257|295156|P2|Overall Study|Withdrawal by Subject|2
83341|NCT00907257|295157|P1|Overall Study|Withdrawal by Subject|1
83342|NCT00907257|295156|P2|Overall Study|Lost to Follow-up|3
83343|NCT00907257|295157|P1|Overall Study|Lost to Follow-up|3
83344|NCT00907257|295156|P2|Overall Study|Protocol Violation|2
83345|NCT00907257|295157|P1|Overall Study|Protocol Violation|1
83346|NCT00907257|295156|P2|Overall Study|Adverse Event|4
83347|NCT00907257|295157|P1|Overall Study|Adverse Event|0
83348|NCT00906971|295190|P2|Overall Study|Lost to Follow-up|1
83349|NCT00906971|295191|P1|Overall Study|Lost to Follow-up|0
83350|NCT00906971|295190|P2|Overall Study|Withdrawal by Subject|2
83351|NCT00906971|295191|P1|Overall Study|Withdrawal by Subject|8
83352|NCT00906698|295232|P6|Overall Study|incl. non compliance, lost to follow-up|0
83353|NCT00906698|295233|P5|Overall Study|incl. non compliance, lost to follow-up|0
83354|NCT00906698|295234|P4|Overall Study|incl. non compliance, lost to follow-up|0
83355|NCT00906698|295235|P3|Overall Study|incl. non compliance, lost to follow-up|0
83356|NCT00906698|295236|P2|Overall Study|incl. non compliance, lost to follow-up|1
83357|NCT00906698|295237|P1|Overall Study|incl. non compliance, lost to follow-up|0
83358|NCT00906698|295232|P6|Overall Study|Withdrawal by Subject|0
83359|NCT00906698|295233|P5|Overall Study|Withdrawal by Subject|1
83360|NCT00906698|295234|P4|Overall Study|Withdrawal by Subject|0
83361|NCT00906698|295235|P3|Overall Study|Withdrawal by Subject|0
83362|NCT00906698|295236|P2|Overall Study|Withdrawal by Subject|0
83363|NCT00906698|295237|P1|Overall Study|Withdrawal by Subject|0
83364|NCT00906698|295232|P6|Overall Study|Disease progression|4
83365|NCT00906698|295233|P5|Overall Study|Disease progression|12
83366|NCT00906698|295234|P4|Overall Study|Disease progression|4
83367|NCT00906698|295235|P3|Overall Study|Disease progression|4
83368|NCT00906698|295236|P2|Overall Study|Disease progression|12
83369|NCT00906698|295237|P1|Overall Study|Disease progression|3
83370|NCT00906698|295232|P6|Overall Study|Adverse Event|1
83371|NCT00906698|295233|P5|Overall Study|Adverse Event|4
83372|NCT00906698|295234|P4|Overall Study|Adverse Event|0
83373|NCT00906698|295235|P3|Overall Study|Adverse Event|2
83374|NCT00906698|295236|P2|Overall Study|Adverse Event|0
83375|NCT00906698|295237|P1|Overall Study|Adverse Event|0
83376|NCT00906698|295232|P6|Overall Study|Dose-limiting toxicity (DLT)|0
83377|NCT00906698|295233|P5|Overall Study|Dose-limiting toxicity (DLT)|1
83378|NCT00906698|295234|P4|Overall Study|Dose-limiting toxicity (DLT)|0
83379|NCT00906698|295235|P3|Overall Study|Dose-limiting toxicity (DLT)|0
83380|NCT00906698|295236|P2|Overall Study|Dose-limiting toxicity (DLT)|6
83381|NCT00906698|295237|P1|Overall Study|Dose-limiting toxicity (DLT)|0
83382|NCT00906399|295339|P7|Year 2|Not specified|0
83383|NCT00906399|295340|P6|Year 2|Not specified|1
83384|NCT00906399|295341|P5|Year 2|Not specified|3
83385|NCT00906399|295342|P4|Year 2|Not specified|2
83386|NCT00906399|295343|P3|Year 2|Not specified|0
83387|NCT00906399|295344|P2|Year 2|Not specified|0
83388|NCT00906399|295345|P1|Year 2|Not specified|0
83389|NCT00906399|295339|P7|Year 2|Death|3
83390|NCT00906399|295340|P6|Year 2|Death|0
83391|NCT00906399|295341|P5|Year 2|Death|0
83392|NCT00906399|295342|P4|Year 2|Death|1
83393|NCT00906399|295343|P3|Year 2|Death|0
83394|NCT00906399|295344|P2|Year 2|Death|0
83395|NCT00906399|295345|P1|Year 2|Death|0
83396|NCT00906399|295339|P7|Year 2|Physician Decision|3
83397|NCT00906399|295340|P6|Year 2|Physician Decision|6
83398|NCT00906399|295341|P5|Year 2|Physician Decision|2
83399|NCT00906399|295342|P4|Year 2|Physician Decision|0
83400|NCT00906399|295343|P3|Year 2|Physician Decision|0
83401|NCT00906399|295344|P2|Year 2|Physician Decision|0
83402|NCT00906399|295345|P1|Year 2|Physician Decision|0
83403|NCT00906399|295339|P7|Year 2|Withdrawal by Subject|13
83404|NCT00906399|295340|P6|Year 2|Withdrawal by Subject|27
83405|NCT00906399|295341|P5|Year 2|Withdrawal by Subject|18
83406|NCT00906399|295342|P4|Year 2|Withdrawal by Subject|17
83407|NCT00906399|295343|P3|Year 2|Withdrawal by Subject|0
83408|NCT00906399|295344|P2|Year 2|Withdrawal by Subject|0
83409|NCT00906399|295345|P1|Year 2|Withdrawal by Subject|0
83410|NCT00906399|295339|P7|Year 2|Lost to Follow-up|4
83411|NCT00906399|295340|P6|Year 2|Lost to Follow-up|2
83412|NCT00906399|295341|P5|Year 2|Lost to Follow-up|4
83413|NCT00906399|295342|P4|Year 2|Lost to Follow-up|1
83414|NCT00906399|295343|P3|Year 2|Lost to Follow-up|0
83415|NCT00906399|295344|P2|Year 2|Lost to Follow-up|0
83416|NCT00906399|295345|P1|Year 2|Lost to Follow-up|0
83417|NCT00906399|295339|P7|Year 2|Adverse Event|6
83418|NCT00906399|295340|P6|Year 2|Adverse Event|11
83419|NCT00906399|295341|P5|Year 2|Adverse Event|8
83420|NCT00906399|295342|P4|Year 2|Adverse Event|9
83421|NCT00906399|295343|P3|Year 2|Adverse Event|0
83422|NCT00906399|295344|P2|Year 2|Adverse Event|0
83423|NCT00906399|295345|P1|Year 2|Adverse Event|0
83424|NCT00906399|295339|P7|Year 1|Not specified|0
83425|NCT00906399|295340|P6|Year 1|Not specified|0
83426|NCT00906399|295341|P5|Year 1|Not specified|0
83427|NCT00906399|295342|P4|Year 1|Not specified|0
83428|NCT00906399|295343|P3|Year 1|Not specified|7
83429|NCT00906399|295344|P2|Year 1|Not specified|2
83430|NCT00906399|295345|P1|Year 1|Not specified|4
83431|NCT00906399|295339|P7|Year 1|Death|0
83432|NCT00906399|295340|P6|Year 1|Death|0
83433|NCT00906399|295341|P5|Year 1|Death|0
83434|NCT00906399|295342|P4|Year 1|Death|0
83435|NCT00906399|295343|P3|Year 1|Death|1
83436|NCT00906399|295344|P2|Year 1|Death|1
83437|NCT00906399|295345|P1|Year 1|Death|2
83438|NCT00906399|295339|P7|Year 1|Physician Decision|0
83439|NCT00906399|295340|P6|Year 1|Physician Decision|0
83440|NCT00906399|295341|P5|Year 1|Physician Decision|0
83441|NCT00906399|295342|P4|Year 1|Physician Decision|0
83442|NCT00906399|295343|P3|Year 1|Physician Decision|3
83443|NCT00906399|295344|P2|Year 1|Physician Decision|1
83444|NCT00906399|295345|P1|Year 1|Physician Decision|0
83445|NCT00906399|295339|P7|Year 1|Withdrawal by Subject|0
83446|NCT00906399|295340|P6|Year 1|Withdrawal by Subject|0
83447|NCT00906399|295341|P5|Year 1|Withdrawal by Subject|0
83448|NCT00906399|295342|P4|Year 1|Withdrawal by Subject|0
83449|NCT00906399|295343|P3|Year 1|Withdrawal by Subject|36
83450|NCT00906399|295344|P2|Year 1|Withdrawal by Subject|32
83451|NCT00906399|295345|P1|Year 1|Withdrawal by Subject|30
83452|NCT00906399|295339|P7|Year 1|Lost to Follow-up|0
83453|NCT00906399|295340|P6|Year 1|Lost to Follow-up|0
83454|NCT00906399|295341|P5|Year 1|Lost to Follow-up|0
83455|NCT00906399|295342|P4|Year 1|Lost to Follow-up|0
83456|NCT00906399|295343|P3|Year 1|Lost to Follow-up|2
83457|NCT00906399|295344|P2|Year 1|Lost to Follow-up|4
83458|NCT00906399|295345|P1|Year 1|Lost to Follow-up|4
83459|NCT00906399|295339|P7|Year 1|Adverse Event|0
83460|NCT00906399|295340|P6|Year 1|Adverse Event|0
83461|NCT00906399|295341|P5|Year 1|Adverse Event|0
83462|NCT00906399|295342|P4|Year 1|Adverse Event|0
83463|NCT00906399|295343|P3|Year 1|Adverse Event|24
83464|NCT00906399|295344|P2|Year 1|Adverse Event|22
83465|NCT00906399|295345|P1|Year 1|Adverse Event|4
83466|NCT00906399|295339|P7|Year 1|Randomized But Not Treated|0
83467|NCT00906399|295340|P6|Year 1|Randomized But Not Treated|0
83468|NCT00906399|295341|P5|Year 1|Randomized But Not Treated|0
83469|NCT00906399|295342|P4|Year 1|Randomized But Not Treated|0
83470|NCT00906399|295343|P3|Year 1|Randomized But Not Treated|3
83471|NCT00906399|295344|P2|Year 1|Randomized But Not Treated|1
83472|NCT00906399|295345|P1|Year 1|Randomized But Not Treated|0
83473|NCT00906347|295368|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
83474|NCT00906347|295369|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
83475|NCT00906347|295368|P2|Received Study Drug|Refused study drug|0
83476|NCT00906347|295369|P1|Received Study Drug|Refused study drug|1
83477|NCT00906347|295368|P2|Received Study Drug|Nonreassuring fetal heart rate|1
83478|NCT00906347|295369|P1|Received Study Drug|Nonreassuring fetal heart rate|13
83479|NCT00906347|295368|P2|Received Study Drug|8 cm prior to initiation of study drug|30
83480|NCT00906347|295369|P1|Received Study Drug|8 cm prior to initiation of study drug|18
83481|NCT00906204|295395|P2|Secondary Endpoints (Long-term Safety)|Death|1
83482|NCT00906204|295396|P1|Secondary Endpoints (Long-term Safety)|Death|0
83483|NCT00906204|295395|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
83484|NCT00906204|295396|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
83485|NCT00906204|295395|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
83486|NCT00906204|295396|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
83487|NCT00906204|295395|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
83488|NCT00906204|295396|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
83489|NCT00906204|295395|P2|Primary Endpoint (Early Safety)|Physician Decision|0
83490|NCT00906204|295396|P1|Primary Endpoint (Early Safety)|Physician Decision|1
83491|NCT00905840|295454|P1|Overall Study|Adverse Event|1
83492|NCT00905840|295454|P1|Overall Study|Withdrawal by Subject|1
83493|NCT00905840|295454|P1|Overall Study|Death|3
83494|NCT00905840|295454|P1|Overall Study|Lost to Follow-up|11
83495|NCT00905632|295485|P7|Overall Study|Adverse Event|4
83496|NCT00905632|295486|P6|Overall Study|Adverse Event|1
83497|NCT00905632|295487|P5|Overall Study|Adverse Event|0
83498|NCT00905632|295488|P4|Overall Study|Adverse Event|0
83499|NCT00905632|295489|P3|Overall Study|Adverse Event|0
83500|NCT00905632|295490|P2|Overall Study|Adverse Event|0
83501|NCT00905632|295491|P1|Overall Study|Adverse Event|0
83502|NCT00905606|295629|P2|Washout|Withdrawal by Subject|0
83503|NCT00905606|295630|P1|Washout|Withdrawal by Subject|1
83504|NCT00905606|295629|P2|Period 1|Adverse Event|1
83505|NCT00905606|295630|P1|Period 1|Adverse Event|0
83506|NCT00905567|295655|P2|Washout|Withdrawal by Subject|1
83507|NCT00905567|295656|P1|Washout|Withdrawal by Subject|0
83508|NCT00905489|295688|P1|Optional Extension Phase (OEP)|Adverse Event|1
83509|NCT00905489|295688|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
83510|NCT00905489|295688|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
83511|NCT00905437|295737|P2|Overall Study|Unspecified|6
83512|NCT00905437|295738|P1|Overall Study|Unspecified|5
83513|NCT00905437|295737|P2|Overall Study|Withdrawal by Subject|1
83514|NCT00905437|295738|P1|Overall Study|Withdrawal by Subject|0
83515|NCT00905437|295737|P2|Overall Study|Lost to Follow-up|1
83516|NCT00905437|295738|P1|Overall Study|Lost to Follow-up|0
83517|NCT00905437|295737|P2|Overall Study|Adverse Event|2
83518|NCT00905437|295738|P1|Overall Study|Adverse Event|3
83519|NCT00905424|295758|P2|Overall Study|Non-adherence to visit schedule|1
83520|NCT00905424|295759|P1|Overall Study|Non-adherence to visit schedule|0
83521|NCT00905424|295758|P2|Overall Study|Positive urine drug screen|1
83522|NCT00905424|295759|P1|Overall Study|Positive urine drug screen|0
83523|NCT00905424|295758|P2|Overall Study|Sponsor decision|0
83524|NCT00905424|295759|P1|Overall Study|Sponsor decision|1
83525|NCT00905424|295758|P2|Overall Study|Non-compliance with study medication|0
83526|NCT00905424|295759|P1|Overall Study|Non-compliance with study medication|2
83527|NCT00905424|295758|P2|Overall Study|Adverse Event|2
83528|NCT00905424|295759|P1|Overall Study|Adverse Event|4
83529|NCT00905424|295758|P2|Overall Study|Withdrawal by Subject|2
83530|NCT00905424|295759|P1|Overall Study|Withdrawal by Subject|1
83531|NCT00905424|295758|P2|Overall Study|Lost to Follow-up|3
83532|NCT00905424|295759|P1|Overall Study|Lost to Follow-up|3
83533|NCT00905359|295801|P2|Overall Study|Withdrawal consent|6
83534|NCT00905359|295802|P1|Overall Study|Withdrawal consent|5
83535|NCT00905359|295801|P2|Overall Study|Death|0
83536|NCT00905359|295802|P1|Overall Study|Death|2
83537|NCT00905359|295801|P2|Overall Study|Lost to Follow-up|10
83538|NCT00905359|295802|P1|Overall Study|Lost to Follow-up|17
83539|NCT00905346|295838|P2|Period 1|Withdrawal by Subject|0
83540|NCT00905346|295839|P1|Period 1|Withdrawal by Subject|1
83541|NCT00905307|295853|P6|Overall Study|Lack of Efficacy|8
83542|NCT00905307|295854|P5|Overall Study|Lack of Efficacy|4
83543|NCT00905307|295855|P4|Overall Study|Lack of Efficacy|4
83544|NCT00905307|295856|P3|Overall Study|Lack of Efficacy|5
83545|NCT00905307|295857|P2|Overall Study|Lack of Efficacy|3
83546|NCT00905307|295858|P1|Overall Study|Lack of Efficacy|6
83547|NCT00905307|295853|P6|Overall Study|Protocol Violation|0
83548|NCT00905307|295854|P5|Overall Study|Protocol Violation|0
83549|NCT00905307|295855|P4|Overall Study|Protocol Violation|0
83550|NCT00905307|295856|P3|Overall Study|Protocol Violation|1
83551|NCT00905307|295857|P2|Overall Study|Protocol Violation|0
83552|NCT00905307|295858|P1|Overall Study|Protocol Violation|1
83553|NCT00905307|295853|P6|Overall Study|Withdrawal by Subject|13
83554|NCT00905307|295854|P5|Overall Study|Withdrawal by Subject|4
83555|NCT00905307|295855|P4|Overall Study|Withdrawal by Subject|11
83556|NCT00905307|295856|P3|Overall Study|Withdrawal by Subject|15
83557|NCT00905307|295857|P2|Overall Study|Withdrawal by Subject|13
83558|NCT00905307|295858|P1|Overall Study|Withdrawal by Subject|5
83559|NCT00905307|295853|P6|Overall Study|Adverse Event|5
83560|NCT00905307|295854|P5|Overall Study|Adverse Event|3
83561|NCT00905307|295855|P4|Overall Study|Adverse Event|11
83562|NCT00905307|295856|P3|Overall Study|Adverse Event|5
83563|NCT00905307|295857|P2|Overall Study|Adverse Event|4
83564|NCT00905307|295858|P1|Overall Study|Adverse Event|3
83565|NCT00905307|295853|P6|Overall Study|Lost to Follow-up|1
83566|NCT00905307|295854|P5|Overall Study|Lost to Follow-up|1
83567|NCT00905307|295855|P4|Overall Study|Lost to Follow-up|0
83568|NCT00905307|295856|P3|Overall Study|Lost to Follow-up|0
83569|NCT00905307|295857|P2|Overall Study|Lost to Follow-up|0
83570|NCT00905307|295858|P1|Overall Study|Lost to Follow-up|0
83571|NCT00905307|295853|P6|Overall Study|Switched to Open Label Rescue|15
83572|NCT00905307|295854|P5|Overall Study|Switched to Open Label Rescue|4
83573|NCT00905307|295855|P4|Overall Study|Switched to Open Label Rescue|11
83574|NCT00905307|295856|P3|Overall Study|Switched to Open Label Rescue|11
83575|NCT00905307|295857|P2|Overall Study|Switched to Open Label Rescue|17
83576|NCT00905307|295858|P1|Overall Study|Switched to Open Label Rescue|7
83577|NCT00905255|295953|P2|Overall Study|Familial and Personal Reasons|0
83578|NCT00905255|295954|P1|Overall Study|Familial and Personal Reasons|1
83579|NCT00905255|295953|P2|Overall Study|Withdrawal by Subject|4
83580|NCT00905255|295954|P1|Overall Study|Withdrawal by Subject|5
83581|NCT00905255|295953|P2|Overall Study|Adverse Event|5
83582|NCT00905255|295954|P1|Overall Study|Adverse Event|7
83583|NCT00905164|295972|P2|Period 1|Protocol Violation|1
83584|NCT00905164|295973|P1|Period 1|Protocol Violation|0
83585|NCT00905034|296020|P1|Overall Study|Withdrawal by Subject|1
83586|NCT00905021|296024|P1|Overall Study|Adverse Event|2
83587|NCT00904917|296053|P4|Overall Study|Lost to Follow-up|2
83588|NCT00904917|296054|P3|Overall Study|Lost to Follow-up|2
83589|NCT00904917|296055|P2|Overall Study|Lost to Follow-up|2
83590|NCT00904917|296056|P1|Overall Study|Lost to Follow-up|2
83591|NCT00904839|296074|P3|Overall Study|Other than above|7
83592|NCT00904839|296075|P2|Overall Study|Other than above|9
83593|NCT00904839|296076|P1|Overall Study|Other than above|0
83594|NCT00904839|296074|P3|Overall Study|Not treated|1
83595|NCT00904839|296075|P2|Overall Study|Not treated|0
83596|NCT00904839|296076|P1|Overall Study|Not treated|1
83597|NCT00904839|296074|P3|Overall Study|Withdrawal by Subject|0
83598|NCT00904839|296075|P2|Overall Study|Withdrawal by Subject|2
83599|NCT00904839|296076|P1|Overall Study|Withdrawal by Subject|0
83600|NCT00904839|296074|P3|Overall Study|Lost to Follow-up|2
83601|NCT00904839|296075|P2|Overall Study|Lost to Follow-up|1
83602|NCT00904839|296076|P1|Overall Study|Lost to Follow-up|0
83603|NCT00904839|296074|P3|Overall Study|Protocol Violation|1
83604|NCT00904839|296075|P2|Overall Study|Protocol Violation|1
83605|NCT00904839|296076|P1|Overall Study|Protocol Violation|0
83606|NCT00904839|296074|P3|Overall Study|Adverse Event|4
83607|NCT00904839|296075|P2|Overall Study|Adverse Event|5
83608|NCT00904839|296076|P1|Overall Study|Adverse Event|0
83609|NCT00904748|296122|P6|Overall Study|Adverse Event|0
83610|NCT00904748|296123|P5|Overall Study|Adverse Event|1
83611|NCT00904748|296124|P4|Overall Study|Adverse Event|0
83612|NCT00904748|296125|P3|Overall Study|Adverse Event|0
83613|NCT00904748|296126|P2|Overall Study|Adverse Event|0
83614|NCT00904748|296127|P1|Overall Study|Adverse Event|0
83615|NCT00904748|296122|P6|Overall Study|Withdrawal by Subject|0
83616|NCT00904748|296123|P5|Overall Study|Withdrawal by Subject|0
83617|NCT00904748|296124|P4|Overall Study|Withdrawal by Subject|2
83618|NCT00904748|296125|P3|Overall Study|Withdrawal by Subject|1
83619|NCT00904748|296126|P2|Overall Study|Withdrawal by Subject|1
83620|NCT00904748|296127|P1|Overall Study|Withdrawal by Subject|1
83621|NCT00904722|296151|P1|Overall Study|Physician Decision|1
83622|NCT00904670|296156|P2|Open Label Phase|Lost to Follow-up|0
83623|NCT00904670|296157|P1|Open Label Phase|Lost to Follow-up|1
83624|NCT00904670|296156|P2|Open Label Phase|Lack of Efficacy|0
83625|NCT00904670|296157|P1|Open Label Phase|Lack of Efficacy|1
83626|NCT00904670|296156|P2|Open Label Phase|Adverse Event|0
83627|NCT00904670|296157|P1|Open Label Phase|Adverse Event|2
83628|NCT00904670|296156|P2|Open Label Phase|Withdrawal by Subject|0
83629|NCT00904670|296157|P1|Open Label Phase|Withdrawal by Subject|2
83630|NCT00904371|296194|P1|Overall Study|Continued with Tritace|1
83631|NCT00904371|296194|P1|Overall Study|Discontinued at target blood pressure|2
83632|NCT00904371|296194|P1|Overall Study|Lost to Follow-up|4
83633|NCT00904371|296194|P1|Overall Study|Adverse Event|2
83634|NCT00904215|296208|P1|Overall Study|Other|28
83635|NCT00904215|296208|P1|Overall Study|Withdrawal by Subject|9
83636|NCT00904215|296208|P1|Overall Study|Lost to Follow-up|63
83637|NCT00904215|296208|P1|Overall Study|Protocol Violation|10
83638|NCT00904215|296208|P1|Overall Study|Adverse Event|25
83639|NCT00904150|296222|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
83640|NCT00904150|296223|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
83641|NCT00904150|296222|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
83642|NCT00904150|296223|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
83643|NCT00903929|296250|P4|Overall Study|Adverse Event|1
83644|NCT00903929|296251|P3|Overall Study|Adverse Event|0
83645|NCT00903929|296252|P2|Overall Study|Adverse Event|0
83646|NCT00903929|296253|P1|Overall Study|Adverse Event|0
83647|NCT00903929|296250|P4|Overall Study|Withdrawal by Subject|2
83648|NCT00903929|296251|P3|Overall Study|Withdrawal by Subject|1
83649|NCT00903929|296252|P2|Overall Study|Withdrawal by Subject|0
83650|NCT00903929|296253|P1|Overall Study|Withdrawal by Subject|0
83651|NCT00903695|296261|P2|Overall Study|lung cancer|0
83652|NCT00903695|296262|P1|Overall Study|lung cancer|1
83653|NCT00903695|296261|P2|Overall Study|medical exclusion after 1st testing|0
83654|NCT00903695|296262|P1|Overall Study|medical exclusion after 1st testing|1
83655|NCT00903682|296284|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
83656|NCT00903682|296285|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
83657|NCT00903682|296284|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
83658|NCT00903682|296285|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
83659|NCT00903682|296284|P2|Overall Study|Subject Non-Compliant|0
83660|NCT00903682|296285|P1|Overall Study|Subject Non-Compliant|1
83661|NCT00903682|296284|P2|Overall Study|Subject Reached A Virologic Endpoint|1
83662|NCT00903682|296285|P1|Overall Study|Subject Reached A Virologic Endpoint|1
83663|NCT00903682|296284|P2|Overall Study|Pregnancy|1
83664|NCT00903682|296285|P1|Overall Study|Pregnancy|0
83665|NCT00903682|296284|P2|Overall Study|Withdrawal by Subject|0
83666|NCT00903682|296285|P1|Overall Study|Withdrawal by Subject|5
83667|NCT00903682|296284|P2|Overall Study|Lost to Follow-up|0
83668|NCT00903682|296285|P1|Overall Study|Lost to Follow-up|1
83669|NCT00903682|296284|P2|Overall Study|Adverse Event|13
83670|NCT00903682|296285|P1|Overall Study|Adverse Event|6
83671|NCT00903630|296306|P3|Phase 2|Adverse Event|1
83672|NCT00903630|296307|P2|Phase 2|Adverse Event|0
83673|NCT00903630|296308|P1|Phase 2|Adverse Event|0
83674|NCT00903409|296331|P2|Overall Study|Lost to Follow-up|6
83675|NCT00903409|296332|P1|Overall Study|Lost to Follow-up|2
83676|NCT00903409|296331|P2|Overall Study|Not specified|3
83677|NCT00903409|296332|P1|Overall Study|Not specified|2
83678|NCT00903409|296331|P2|Overall Study|Withdrawal by Subject|8
83679|NCT00903409|296332|P1|Overall Study|Withdrawal by Subject|8
83680|NCT00903409|296331|P2|Overall Study|Laboratory Abnormality|0
83681|NCT00903409|296332|P1|Overall Study|Laboratory Abnormality|2
83682|NCT00903409|296331|P2|Overall Study|Non-compliance with Protocol|1
83683|NCT00903409|296332|P1|Overall Study|Non-compliance with Protocol|1
83684|NCT00903409|296331|P2|Overall Study|Adverse Event|9
83685|NCT00903409|296332|P1|Overall Study|Adverse Event|11
83686|NCT00903383|296383|P4|Overall Study|Patient Decision|1
83687|NCT00903383|296384|P3|Overall Study|Patient Decision|0
83688|NCT00903383|296385|P2|Overall Study|Patient Decision|0
83689|NCT00903383|296386|P1|Overall Study|Patient Decision|0
83690|NCT00903383|296383|P4|Overall Study|Patient Decision - Lack of Efficacy|0
83691|NCT00903383|296384|P3|Overall Study|Patient Decision - Lack of Efficacy|0
83692|NCT00903383|296385|P2|Overall Study|Patient Decision - Lack of Efficacy|1
83693|NCT00903383|296386|P1|Overall Study|Patient Decision - Lack of Efficacy|0
83694|NCT00903383|296383|P4|Overall Study|Withdrawal by Subject|2
83695|NCT00903383|296384|P3|Overall Study|Withdrawal by Subject|0
83696|NCT00903383|296385|P2|Overall Study|Withdrawal by Subject|1
83697|NCT00903383|296386|P1|Overall Study|Withdrawal by Subject|4
83698|NCT00903383|296383|P4|Overall Study|Decision of Sponsor|0
83699|NCT00903383|296384|P3|Overall Study|Decision of Sponsor|0
83700|NCT00903383|296385|P2|Overall Study|Decision of Sponsor|0
83701|NCT00903383|296386|P1|Overall Study|Decision of Sponsor|1
83702|NCT00903383|296383|P4|Overall Study|Lost to Follow-up|1
83703|NCT00903383|296384|P3|Overall Study|Lost to Follow-up|0
83704|NCT00903383|296385|P2|Overall Study|Lost to Follow-up|0
83705|NCT00903383|296386|P1|Overall Study|Lost to Follow-up|0
83706|NCT00903383|296383|P4|Overall Study|Physician Decision|0
83707|NCT00903383|296384|P3|Overall Study|Physician Decision|0
83708|NCT00903383|296385|P2|Overall Study|Physician Decision|2
83709|NCT00903383|296386|P1|Overall Study|Physician Decision|1
83710|NCT00903383|296383|P4|Overall Study|Adverse Event|1
83711|NCT00903383|296384|P3|Overall Study|Adverse Event|3
83712|NCT00903383|296385|P2|Overall Study|Adverse Event|2
83713|NCT00903383|296386|P1|Overall Study|Adverse Event|1
83714|NCT00903370|296418|P2|Overall Study|Lost to Follow-up|8
83715|NCT00903370|296419|P1|Overall Study|Lost to Follow-up|6
83716|NCT00903370|296418|P2|Overall Study|Withdrawal by Subject|6
83717|NCT00903370|296419|P1|Overall Study|Withdrawal by Subject|9
83718|NCT00903370|296418|P2|Overall Study|Death|10
83719|NCT00903370|296419|P1|Overall Study|Death|13
83720|NCT00903357|296427|P2|Second Intervention|Lost to Follow-up|0
83721|NCT00903357|296428|P1|Second Intervention|Lost to Follow-up|1
83722|NCT00903357|296427|P2|Wash Out Period of 2 Weeks|Flu|1
83723|NCT00903357|296428|P1|Wash Out Period of 2 Weeks|Flu|0
83724|NCT00903357|296427|P2|First Intervention|Flu|1
83725|NCT00903357|296428|P1|First Intervention|Flu|0
83726|NCT00903357|296427|P2|First Intervention|Withdrawal by Subject|3
83727|NCT00903357|296428|P1|First Intervention|Withdrawal by Subject|5
83728|NCT00903344|296440|P2|Overall Study|Lost to Follow-up|0
83729|NCT00903344|296441|P1|Overall Study|Lost to Follow-up|3
83730|NCT00903344|296440|P2|Overall Study|Pregnancy|3
83731|NCT00903344|296441|P1|Overall Study|Pregnancy|2
83732|NCT00903331|296459|P2|Overall Study|Lung transplant|2
83733|NCT00903331|296460|P1|Overall Study|Lung transplant|0
83734|NCT00903331|296459|P2|Overall Study|Withdrawal of consent|8
83735|NCT00903331|296460|P1|Overall Study|Withdrawal of consent|1
83736|NCT00903331|296459|P2|Overall Study|Death|8
83737|NCT00903331|296460|P1|Overall Study|Death|4
83738|NCT00903175|296470|P2|Period 2 - Second Line|Death|2
83739|NCT00903175|296471|P1|Period 2 - Second Line|Death|5
83740|NCT00903175|296470|P2|Period 2 - Second Line|Administrative problems|9
83741|NCT00903175|296471|P1|Period 2 - Second Line|Administrative problems|19
83742|NCT00903175|296470|P2|Period 2 - Second Line|Lost to Follow-up|0
83743|NCT00903175|296471|P1|Period 2 - Second Line|Lost to Follow-up|1
83744|NCT00903175|296470|P2|Period 2 - Second Line|Withdrawal by Subject|5
83745|NCT00903175|296471|P1|Period 2 - Second Line|Withdrawal by Subject|7
83746|NCT00903175|296470|P2|Period 2 - Second Line|Adverse Event|20
83747|NCT00903175|296471|P1|Period 2 - Second Line|Adverse Event|16
83748|NCT00903175|296470|P2|Period 2 - Second Line|Missing|0
83749|NCT00903175|296471|P1|Period 2 - Second Line|Missing|1
83750|NCT00903175|296470|P2|Period 1 - First Line|Death|10
83751|NCT00903175|296471|P1|Period 1 - First Line|Death|17
83752|NCT00903175|296470|P2|Period 1 - First Line|Administrative problems|13
83753|NCT00903175|296471|P1|Period 1 - First Line|Administrative problems|12
83754|NCT00903175|296470|P2|Period 1 - First Line|Withdrawal by Subject|12
83755|NCT00903175|296471|P1|Period 1 - First Line|Withdrawal by Subject|8
83756|NCT00903175|296470|P2|Period 1 - First Line|Protocol Violation|3
83757|NCT00903175|296471|P1|Period 1 - First Line|Protocol Violation|3
83758|NCT00903175|296470|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
83759|NCT00903175|296471|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
83760|NCT00903175|296470|P2|Period 1 - First Line|Abnormal lab value(s)|1
83761|NCT00903175|296471|P1|Period 1 - First Line|Abnormal lab value(s)|0
83762|NCT00903175|296470|P2|Period 1 - First Line|Adverse Event|50
83763|NCT00903175|296471|P1|Period 1 - First Line|Adverse Event|36
83764|NCT00903032|296509|P2|Overall Study|Lost to Follow-up|2
83765|NCT00903032|296510|P1|Overall Study|Lost to Follow-up|2
83766|NCT00903032|296509|P2|Overall Study|Withdrawal by Subject|3
83767|NCT00903032|296510|P1|Overall Study|Withdrawal by Subject|5
83768|NCT00903006|296520|P4|Overall Study|Progressive Disease|0
83769|NCT00903006|296521|P3|Overall Study|Progressive Disease|1
83770|NCT00903006|296522|P2|Overall Study|Progressive Disease|3
83771|NCT00903006|296523|P1|Overall Study|Progressive Disease|0
83772|NCT00903006|296520|P4|Overall Study|Withdrawal by Subject|0
83773|NCT00903006|296521|P3|Overall Study|Withdrawal by Subject|0
83774|NCT00903006|296522|P2|Overall Study|Withdrawal by Subject|0
83775|NCT00903006|296523|P1|Overall Study|Withdrawal by Subject|2
83776|NCT00902850|296535|P2|Overall Study|Physician Decision|2
83777|NCT00902850|296536|P1|Overall Study|Physician Decision|2
83778|NCT00902746|296542|P1|Overall Study|Physician Decision|2
83779|NCT00902746|296542|P1|Overall Study|Lost to Follow-up|3
83780|NCT00902746|296542|P1|Overall Study|Adverse Event|8
83781|NCT00902746|296542|P1|Overall Study|Withdrawal by Subject|16
83782|NCT00902746|296542|P1|Overall Study|Protocol Violation|7
83783|NCT00902668|296547|P1|Overall Study|Protocol stopped due to slow accrual.|3
83784|NCT00902564|296551|P1|Overall Study|Withdrawal by Subject|2
83785|NCT00902538|296566|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
83786|NCT00902538|296567|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
83787|NCT00902538|296568|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
83788|NCT00902538|296569|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
83789|NCT00902538|296570|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
83790|NCT00902538|296571|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
83791|NCT00902538|296566|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
83792|NCT00902538|296567|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
83793|NCT00902538|296568|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
83794|NCT00902538|296569|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
83795|NCT00902538|296570|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
83796|NCT00902538|296571|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
83797|NCT00902538|296566|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
83798|NCT00902538|296567|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
83799|NCT00902538|296568|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
83800|NCT00902538|296569|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
83801|NCT00902538|296570|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
83802|NCT00902538|296571|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
83803|NCT00902538|296566|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
83804|NCT00902538|296567|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
83805|NCT00902538|296568|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
83806|NCT00902538|296569|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
83807|NCT00902538|296570|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
83808|NCT00902538|296571|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
83809|NCT00902538|296566|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
83810|NCT00902538|296567|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
83811|NCT00902538|296568|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
83812|NCT00902538|296569|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
83813|NCT00902538|296570|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
83814|NCT00902538|296571|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
83815|NCT00902538|296566|P6|3-Single-blind, Single Treatment|Protocol Violation|0
83816|NCT00902538|296567|P5|3-Single-blind, Single Treatment|Protocol Violation|0
83817|NCT00902538|296568|P4|3-Single-blind, Single Treatment|Protocol Violation|0
83818|NCT00902538|296569|P3|3-Single-blind, Single Treatment|Protocol Violation|0
83819|NCT00902538|296570|P2|3-Single-blind, Single Treatment|Protocol Violation|5
83820|NCT00902538|296571|P1|3-Single-blind, Single Treatment|Protocol Violation|0
83821|NCT00902538|296566|P6|3-Single-blind, Single Treatment|Adverse Event|0
83822|NCT00902538|296567|P5|3-Single-blind, Single Treatment|Adverse Event|0
83823|NCT00902538|296568|P4|3-Single-blind, Single Treatment|Adverse Event|0
83824|NCT00902538|296569|P3|3-Single-blind, Single Treatment|Adverse Event|0
83825|NCT00902538|296570|P2|3-Single-blind, Single Treatment|Adverse Event|5
83826|NCT00902538|296571|P1|3-Single-blind, Single Treatment|Adverse Event|0
83827|NCT00902538|296566|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
83828|NCT00902538|296567|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
83829|NCT00902538|296568|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
83830|NCT00902538|296569|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
83831|NCT00902538|296570|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
83832|NCT00902538|296571|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
83833|NCT00902538|296566|P6|2-Randomized Double-blind 3 Treatments|Other|0
83834|NCT00902538|296567|P5|2-Randomized Double-blind 3 Treatments|Other|0
83835|NCT00902538|296568|P4|2-Randomized Double-blind 3 Treatments|Other|0
83836|NCT00902538|296569|P3|2-Randomized Double-blind 3 Treatments|Other|0
83837|NCT00902538|296570|P2|2-Randomized Double-blind 3 Treatments|Other|1
83838|NCT00902538|296571|P1|2-Randomized Double-blind 3 Treatments|Other|2
83839|NCT00902538|296566|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
83840|NCT00902538|296567|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
83841|NCT00902538|296568|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
83842|NCT00902538|296569|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
83843|NCT00902538|296570|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
83844|NCT00902538|296571|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
83845|NCT00902538|296566|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
83846|NCT00902538|296567|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
83847|NCT00902538|296568|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
83848|NCT00902538|296569|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
83849|NCT00902538|296570|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
83850|NCT00902538|296571|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
83851|NCT00902538|296566|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
83852|NCT00902538|296567|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
83853|NCT00902538|296568|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
83854|NCT00902538|296569|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
83855|NCT00902538|296570|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
83856|NCT00902538|296571|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
83857|NCT00902538|296566|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
83858|NCT00902538|296567|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
83859|NCT00902538|296568|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
83860|NCT00902538|296569|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
83861|NCT00902538|296570|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
83862|NCT00902538|296571|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
83863|NCT00902538|296566|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
83864|NCT00902538|296567|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
83865|NCT00902538|296568|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
83866|NCT00902538|296569|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
83867|NCT00902538|296570|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
83868|NCT00902538|296571|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
83869|NCT00902538|296566|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
83870|NCT00902538|296567|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
83871|NCT00902538|296568|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
83872|NCT00902538|296569|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
83873|NCT00902538|296570|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
83874|NCT00902538|296571|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
83875|NCT00902538|296566|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
83876|NCT00902538|296567|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
83877|NCT00902538|296568|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
83878|NCT00902538|296569|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
83879|NCT00902538|296570|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
83880|NCT00902538|296571|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
83881|NCT00902538|296566|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
83882|NCT00902538|296567|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
83883|NCT00902538|296568|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
83884|NCT00902538|296569|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
83885|NCT00902538|296570|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
83886|NCT00902538|296571|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
83887|NCT00902330|296603|P2|Overall Study|No post baseline data|0
83888|NCT00902330|296604|P1|Overall Study|No post baseline data|1
83889|NCT00902330|296603|P2|Overall Study|Adverse Event|0
83890|NCT00902330|296604|P1|Overall Study|Adverse Event|1
83891|NCT00902330|296603|P2|Overall Study|Too overwhelmed by treatment|5
83892|NCT00902330|296604|P1|Overall Study|Too overwhelmed by treatment|2
83893|NCT00902304|296641|P3|Overall Study|includes pregnancy|2
83894|NCT00902304|296642|P2|Overall Study|includes pregnancy|9
83895|NCT00902304|296643|P1|Overall Study|includes pregnancy|3
83896|NCT00902304|296641|P3|Overall Study|Withdrawal by Subject|43
83897|NCT00902304|296642|P2|Overall Study|Withdrawal by Subject|22
83898|NCT00902304|296643|P1|Overall Study|Withdrawal by Subject|32
83899|NCT00902304|296641|P3|Overall Study|Protocol Violation|20
83900|NCT00902304|296642|P2|Overall Study|Protocol Violation|18
83901|NCT00902304|296643|P1|Overall Study|Protocol Violation|9
83902|NCT00902304|296641|P3|Overall Study|Lost to Follow-up|7
83903|NCT00902304|296642|P2|Overall Study|Lost to Follow-up|7
83904|NCT00902304|296643|P1|Overall Study|Lost to Follow-up|7
83905|NCT00902304|296641|P3|Overall Study|Investigator discretion|13
83906|NCT00902304|296642|P2|Overall Study|Investigator discretion|5
83907|NCT00902304|296643|P1|Overall Study|Investigator discretion|3
83908|NCT00902304|296641|P3|Overall Study|Adverse Event|25
83909|NCT00902304|296642|P2|Overall Study|Adverse Event|10
83910|NCT00902304|296643|P1|Overall Study|Adverse Event|4
83911|NCT00902265|296688|P1|Overall Study|Protocol Violation|1
83912|NCT00902265|296688|P1|Overall Study|Lack of Efficacy|2
83913|NCT00902265|296688|P1|Overall Study|Adverse Event|2
83914|NCT00902265|296688|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
83915|NCT00902174|296712|P2|Overall Study|Administration problem|1
83916|NCT00902174|296713|P1|Overall Study|Administration problem|0
83917|NCT00902174|296712|P2|Overall Study|Protocol Violation|1
83918|NCT00902174|296713|P1|Overall Study|Protocol Violation|1
83919|NCT00902174|296712|P2|Overall Study|Abnormal labs|1
83920|NCT00902174|296713|P1|Overall Study|Abnormal labs|1
83921|NCT00902174|296712|P2|Overall Study|Withdrawal by Subject|1
83922|NCT00902174|296713|P1|Overall Study|Withdrawal by Subject|2
83923|NCT00902174|296712|P2|Overall Study|Death|2
83924|NCT00902174|296713|P1|Overall Study|Death|2
83925|NCT00902174|296712|P2|Overall Study|Lack of Efficacy|5
83926|NCT00902174|296713|P1|Overall Study|Lack of Efficacy|1
83927|NCT00902174|296712|P2|Overall Study|Adverse Event|7
83928|NCT00902174|296713|P1|Overall Study|Adverse Event|27
83929|NCT00901901|296770|P2|Follow-up Period|Lost to Follow-up|8
83930|NCT00901901|296771|P1|Follow-up Period|Lost to Follow-up|12
83931|NCT00901901|296770|P2|Follow-up Period|Withdrawal by Subject|9
83932|NCT00901901|296771|P1|Follow-up Period|Withdrawal by Subject|6
83933|NCT00901901|296770|P2|Follow-up Period|Protocol driven decision point|35
83934|NCT00901901|296771|P1|Follow-up Period|Protocol driven decision point|47
83935|NCT00901901|296770|P2|Follow-up Period|Death|207
83936|NCT00901901|296771|P1|Follow-up Period|Death|181
83937|NCT00901901|296770|P2|Treatment Period|Never treated|3
83938|NCT00901901|296771|P1|Treatment Period|Never treated|0
83939|NCT00901901|296770|P2|Treatment Period|Missing|1
83940|NCT00901901|296771|P1|Treatment Period|Missing|1
83941|NCT00901901|296770|P2|Treatment Period|Protocol Violation|9
83942|NCT00901901|296771|P1|Treatment Period|Protocol Violation|4
83943|NCT00901901|296770|P2|Treatment Period|Noncompliance with study medication|1
83944|NCT00901901|296771|P1|Treatment Period|Noncompliance with study medication|4
83945|NCT00901901|296770|P2|Treatment Period|Lost to Follow-up|5
83946|NCT00901901|296771|P1|Treatment Period|Lost to Follow-up|3
83947|NCT00901901|296770|P2|Treatment Period|Physician Decision|2
83948|NCT00901901|296771|P1|Treatment Period|Physician Decision|2
83949|NCT00901901|296770|P2|Treatment Period|Withdrawal by Subject|24
83950|NCT00901901|296771|P1|Treatment Period|Withdrawal by Subject|26
83951|NCT00901901|296770|P2|Treatment Period|Adverse Event|123
83952|NCT00901901|296771|P1|Treatment Period|Adverse Event|117
83953|NCT00901628|296793|P2|Overall Study|peroneal nerve palsy|1
83954|NCT00901628|296794|P1|Overall Study|peroneal nerve palsy|0
83955|NCT00901628|296793|P2|Overall Study|disconnection of drain|1
83956|NCT00901628|296794|P1|Overall Study|disconnection of drain|0
83957|NCT00901628|296793|P2|Overall Study|disconnection of catheter|8
83958|NCT00901628|296794|P1|Overall Study|disconnection of catheter|4
83959|NCT00901576|296816|P6|Second Intervention|Physician Decision|0
83960|NCT00901576|296817|P5|Second Intervention|Physician Decision|0
83961|NCT00901576|296818|P4|Second Intervention|Physician Decision|0
83962|NCT00901576|296819|P3|Second Intervention|Physician Decision|0
83963|NCT00901576|296820|P2|Second Intervention|Physician Decision|0
83964|NCT00901576|296821|P1|Second Intervention|Physician Decision|1
83965|NCT00901576|296816|P6|Second Intervention|Withdrawal by Subject|1
83966|NCT00901576|296817|P5|Second Intervention|Withdrawal by Subject|0
83967|NCT00901576|296818|P4|Second Intervention|Withdrawal by Subject|1
83968|NCT00901576|296819|P3|Second Intervention|Withdrawal by Subject|0
83969|NCT00901576|296820|P2|Second Intervention|Withdrawal by Subject|0
83970|NCT00901576|296821|P1|Second Intervention|Withdrawal by Subject|0
83971|NCT00901459|296842|P1|Overall Study|Withdrawal by Subject|6
83972|NCT00901186|296873|P2|Overall Study|Protocol deviations|4
83973|NCT00901186|296874|P1|Overall Study|Protocol deviations|5
83974|NCT00901186|296873|P2|Overall Study|Administration problems|1
83975|NCT00901186|296874|P1|Overall Study|Administration problems|0
83976|NCT00901186|296873|P2|Overall Study|Adverse Event|4
83977|NCT00901186|296874|P1|Overall Study|Adverse Event|2
83978|NCT00901186|296873|P2|Overall Study|Lost to Follow-up|0
83979|NCT00901186|296874|P1|Overall Study|Lost to Follow-up|2
83980|NCT00901186|296873|P2|Overall Study|Abnormal laboratory values|1
83981|NCT00901186|296874|P1|Overall Study|Abnormal laboratory values|0
83982|NCT00901186|296873|P2|Overall Study|Lack of Efficacy|1
83983|NCT00901186|296874|P1|Overall Study|Lack of Efficacy|0
83984|NCT00900796|296914|P1|Phase 2|Lost to Follow-up|5
83985|NCT00900796|296914|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
83986|NCT00900796|296914|P1|Phase 1|Missing information at Week 16|7
83987|NCT00900796|296914|P1|Phase 1|Lacked sufficient information|4
83988|NCT00900757|296924|P1|Overall Study|screen failure|19
83989|NCT00900731|296934|P2|Overall Study|Death|2
83990|NCT00900731|296935|P1|Overall Study|Death|0
83991|NCT00900731|296934|P2|Overall Study|Lack of Efficacy|3
83992|NCT00900731|296935|P1|Overall Study|Lack of Efficacy|1
83993|NCT00900731|296934|P2|Overall Study|Lost to Follow-up|3
83994|NCT00900731|296935|P1|Overall Study|Lost to Follow-up|2
83995|NCT00900731|296934|P2|Overall Study|Abnormal Laboratory Value(s)|4
83996|NCT00900731|296935|P1|Overall Study|Abnormal Laboratory Value(s)|2
83997|NCT00900731|296934|P2|Overall Study|Abnormal Test Procedure Result(s)|0
83998|NCT00900731|296935|P1|Overall Study|Abnormal Test Procedure Result(s)|3
83999|NCT00900731|296934|P2|Overall Study|Administrative Problems|4
84000|NCT00900731|296935|P1|Overall Study|Administrative Problems|5
84001|NCT00900731|296934|P2|Overall Study|Protocol Deviation|11
84002|NCT00900731|296935|P1|Overall Study|Protocol Deviation|8
84003|NCT00900731|296934|P2|Overall Study|Withdrawal by Subject|7
84004|NCT00900731|296935|P1|Overall Study|Withdrawal by Subject|8
84005|NCT00900731|296934|P2|Overall Study|Adverse Event|27
84006|NCT00900731|296935|P1|Overall Study|Adverse Event|31
84007|NCT00900627|296972|P6|Overall Study|Death|24
84008|NCT00900627|296973|P5|Overall Study|Death|28
84009|NCT00900627|296974|P4|Overall Study|Death|0
84010|NCT00900627|296975|P3|Overall Study|Death|0
84011|NCT00900627|296976|P2|Overall Study|Death|0
84012|NCT00900627|296977|P1|Overall Study|Death|0
84013|NCT00900627|296972|P6|Overall Study|Adverse Event|0
84014|NCT00900627|296973|P5|Overall Study|Adverse Event|0
84015|NCT00900627|296974|P4|Overall Study|Adverse Event|3
84016|NCT00900627|296975|P3|Overall Study|Adverse Event|0
84017|NCT00900627|296976|P2|Overall Study|Adverse Event|2
84018|NCT00900627|296977|P1|Overall Study|Adverse Event|1
84019|NCT00900627|296972|P6|Overall Study|Withdrawal by Subject|2
84020|NCT00900627|296973|P5|Overall Study|Withdrawal by Subject|1
84021|NCT00900627|296974|P4|Overall Study|Withdrawal by Subject|0
84022|NCT00900627|296975|P3|Overall Study|Withdrawal by Subject|1
84023|NCT00900627|296976|P2|Overall Study|Withdrawal by Subject|0
84024|NCT00900627|296977|P1|Overall Study|Withdrawal by Subject|1
84025|NCT00900627|296972|P6|Overall Study|Condition under investigation worsened|0
84026|NCT00900627|296973|P5|Overall Study|Condition under investigation worsened|0
84027|NCT00900627|296974|P4|Overall Study|Condition under investigation worsened|3
84028|NCT00900627|296975|P3|Overall Study|Condition under investigation worsened|5
84029|NCT00900627|296976|P2|Overall Study|Condition under investigation worsened|0
84030|NCT00900627|296977|P1|Overall Study|Condition under investigation worsened|4
84031|NCT00900146|297011|P5|Intermediate: Period III|Administrative problems|163
84032|NCT00900146|297012|P4|Intermediate: Period III|Administrative problems|90
84033|NCT00900146|297013|P3|Intermediate: Period III|Administrative problems|84
84034|NCT00900146|297014|P2|Intermediate: Period III|Administrative problems|92
84035|NCT00900146|297015|P1|Intermediate: Period III|Administrative problems|85
84036|NCT00900146|297011|P5|Intermediate: Period III|Lost to Follow-up|1
84037|NCT00900146|297012|P4|Intermediate: Period III|Lost to Follow-up|0
84038|NCT00900146|297013|P3|Intermediate: Period III|Lost to Follow-up|0
84039|NCT00900146|297014|P2|Intermediate: Period III|Lost to Follow-up|0
84040|NCT00900146|297015|P1|Intermediate: Period III|Lost to Follow-up|2
84041|NCT00900146|297011|P5|Intermediate: Period III|Withdrawal by Subject|3
84042|NCT00900146|297012|P4|Intermediate: Period III|Withdrawal by Subject|0
84043|NCT00900146|297013|P3|Intermediate: Period III|Withdrawal by Subject|0
84044|NCT00900146|297014|P2|Intermediate: Period III|Withdrawal by Subject|1
84045|NCT00900146|297015|P1|Intermediate: Period III|Withdrawal by Subject|0
84046|NCT00900146|297011|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
84047|NCT00900146|297012|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
84048|NCT00900146|297013|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
84049|NCT00900146|297014|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
84050|NCT00900146|297015|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
84051|NCT00900146|297011|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
84052|NCT00900146|297012|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
84053|NCT00900146|297013|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
84054|NCT00900146|297014|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
84055|NCT00900146|297015|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
84056|NCT00900146|297011|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
84057|NCT00900146|297012|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
84058|NCT00900146|297013|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
84059|NCT00900146|297014|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
84060|NCT00900146|297015|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
84061|NCT00900029|297132|P5|Overall Study|Death|0
84062|NCT00900029|297133|P4|Overall Study|Death|1
84063|NCT00900029|297134|P3|Overall Study|Death|0
84064|NCT00900029|297135|P2|Overall Study|Death|0
84065|NCT00900029|297136|P1|Overall Study|Death|1
84066|NCT00900029|297132|P5|Overall Study|Adverse Event|1
84067|NCT00900029|297133|P4|Overall Study|Adverse Event|1
84068|NCT00900029|297134|P3|Overall Study|Adverse Event|1
84069|NCT00900029|297135|P2|Overall Study|Adverse Event|0
84070|NCT00900029|297136|P1|Overall Study|Adverse Event|0
84071|NCT00900029|297132|P5|Overall Study|Withdrawal by Subject|1
84072|NCT00900029|297133|P4|Overall Study|Withdrawal by Subject|1
84073|NCT00900029|297134|P3|Overall Study|Withdrawal by Subject|1
84074|NCT00900029|297135|P2|Overall Study|Withdrawal by Subject|2
84075|NCT00900029|297136|P1|Overall Study|Withdrawal by Subject|2
84076|NCT00900029|297132|P5|Overall Study|Lost to Follow-up|4
84077|NCT00900029|297133|P4|Overall Study|Lost to Follow-up|4
84078|NCT00900029|297134|P3|Overall Study|Lost to Follow-up|1
84079|NCT00900029|297135|P2|Overall Study|Lost to Follow-up|2
84080|NCT00900029|297136|P1|Overall Study|Lost to Follow-up|0
84081|NCT00899678|297173|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
84082|NCT00899678|297174|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
84083|NCT00899678|297175|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
84084|NCT00899678|297173|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
84085|NCT00899678|297174|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
84086|NCT00899678|297175|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
84087|NCT00899678|297173|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
84088|NCT00899678|297174|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
84089|NCT00899678|297175|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
84090|NCT00899678|297173|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
84091|NCT00899678|297174|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
84092|NCT00899678|297175|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
84093|NCT00899678|297173|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
84094|NCT00899678|297174|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
84095|NCT00899678|297175|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
84096|NCT00899678|297173|P3|Induction Period (Weeks 0 to 6)|Other reason|0
84097|NCT00899678|297174|P2|Induction Period (Weeks 0 to 6)|Other reason|0
84098|NCT00899678|297175|P1|Induction Period (Weeks 0 to 6)|Other reason|1
84099|NCT00899678|297173|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
84100|NCT00899678|297174|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
84101|NCT00899678|297175|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
84102|NCT00899678|297173|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
84103|NCT00899678|297174|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
84104|NCT00899678|297175|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
84105|NCT00899678|297173|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
84106|NCT00899678|297174|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
84107|NCT00899678|297175|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
84108|NCT00899392|297298|P2|Overall Study|Subject didn't finish/partial pilot data|24
84109|NCT00899392|297299|P1|Overall Study|Subject didn't finish/partial pilot data|21
84110|NCT00899379|297316|P5|Overall Study|Inc/Exc Criteria Not Met|0
84111|NCT00899379|297317|P4|Overall Study|Inc/Exc Criteria Not Met|0
84112|NCT00899379|297318|P3|Overall Study|Inc/Exc Criteria Not Met|1
84113|NCT00899379|297319|P2|Overall Study|Inc/Exc Criteria Not Met|0
84114|NCT00899379|297320|P1|Overall Study|Inc/Exc Criteria Not Met|0
84115|NCT00899379|297316|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
84116|NCT00899379|297317|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
84117|NCT00899379|297318|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
84118|NCT00899379|297319|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
84119|NCT00899379|297320|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
84120|NCT00899379|297316|P5|Overall Study|No Attack Pretreatment|4
84121|NCT00899379|297317|P4|Overall Study|No Attack Pretreatment|6
84122|NCT00899379|297318|P3|Overall Study|No Attack Pretreatment|5
84123|NCT00899379|297319|P2|Overall Study|No Attack Pretreatment|5
84124|NCT00899379|297320|P1|Overall Study|No Attack Pretreatment|3
84125|NCT00899379|297316|P5|Overall Study|Abnormal Baseline ECG|0
84126|NCT00899379|297317|P4|Overall Study|Abnormal Baseline ECG|1
84127|NCT00899379|297318|P3|Overall Study|Abnormal Baseline ECG|1
84128|NCT00899379|297319|P2|Overall Study|Abnormal Baseline ECG|0
84129|NCT00899379|297320|P1|Overall Study|Abnormal Baseline ECG|0
84130|NCT00899379|297316|P5|Overall Study|Abnormal Prestudy Labs|2
84131|NCT00899379|297317|P4|Overall Study|Abnormal Prestudy Labs|0
84132|NCT00899379|297318|P3|Overall Study|Abnormal Prestudy Labs|0
84133|NCT00899379|297319|P2|Overall Study|Abnormal Prestudy Labs|0
84134|NCT00899379|297320|P1|Overall Study|Abnormal Prestudy Labs|0
84135|NCT00899379|297316|P5|Overall Study|Patient Uncooperative|0
84136|NCT00899379|297317|P4|Overall Study|Patient Uncooperative|1
84137|NCT00899379|297318|P3|Overall Study|Patient Uncooperative|0
84138|NCT00899379|297319|P2|Overall Study|Patient Uncooperative|0
84139|NCT00899379|297320|P1|Overall Study|Patient Uncooperative|0
84140|NCT00899379|297316|P5|Overall Study|Pregnancy|0
84141|NCT00899379|297317|P4|Overall Study|Pregnancy|0
84142|NCT00899379|297318|P3|Overall Study|Pregnancy|0
84143|NCT00899379|297319|P2|Overall Study|Pregnancy|0
84144|NCT00899379|297320|P1|Overall Study|Pregnancy|1
84145|NCT00899379|297316|P5|Overall Study|Withdrawal by Subject|2
84146|NCT00899379|297317|P4|Overall Study|Withdrawal by Subject|7
84147|NCT00899379|297318|P3|Overall Study|Withdrawal by Subject|4
84148|NCT00899379|297319|P2|Overall Study|Withdrawal by Subject|7
84149|NCT00899379|297320|P1|Overall Study|Withdrawal by Subject|4
84150|NCT00899379|297316|P5|Overall Study|Lost to Follow-up|5
84151|NCT00899379|297317|P4|Overall Study|Lost to Follow-up|2
84152|NCT00899379|297318|P3|Overall Study|Lost to Follow-up|0
84153|NCT00899379|297319|P2|Overall Study|Lost to Follow-up|1
84154|NCT00899379|297320|P1|Overall Study|Lost to Follow-up|3
84155|NCT00899379|297316|P5|Overall Study|Study Terminated|1
84156|NCT00899379|297317|P4|Overall Study|Study Terminated|3
84157|NCT00899379|297318|P3|Overall Study|Study Terminated|3
84158|NCT00899379|297319|P2|Overall Study|Study Terminated|0
84159|NCT00899379|297320|P1|Overall Study|Study Terminated|3
84160|NCT00899379|297316|P5|Overall Study|Not Completed/Entered Extn|3
84161|NCT00899379|297317|P4|Overall Study|Not Completed/Entered Extn|4
84162|NCT00899379|297318|P3|Overall Study|Not Completed/Entered Extn|6
84163|NCT00899379|297319|P2|Overall Study|Not Completed/Entered Extn|1
84164|NCT00899379|297320|P1|Overall Study|Not Completed/Entered Extn|5
84165|NCT00899379|297316|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
84166|NCT00899379|297317|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
84167|NCT00899379|297318|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
84168|NCT00899379|297319|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
84169|NCT00899379|297320|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
84170|NCT00899379|297316|P5|Overall Study|Abnormal Baseline ECG|0
84171|NCT00899379|297317|P4|Overall Study|Abnormal Baseline ECG|1
84172|NCT00899379|297318|P3|Overall Study|Abnormal Baseline ECG|0
84173|NCT00899379|297319|P2|Overall Study|Abnormal Baseline ECG|0
84174|NCT00899379|297320|P1|Overall Study|Abnormal Baseline ECG|0
84175|NCT00899379|297316|P5|Overall Study|Patient Uncooperative|2
84176|NCT00899379|297317|P4|Overall Study|Patient Uncooperative|1
84177|NCT00899379|297318|P3|Overall Study|Patient Uncooperative|0
84178|NCT00899379|297319|P2|Overall Study|Patient Uncooperative|1
84179|NCT00899379|297320|P1|Overall Study|Patient Uncooperative|0
84180|NCT00899379|297316|P5|Overall Study|Pregnancy|1
84181|NCT00899379|297317|P4|Overall Study|Pregnancy|0
84182|NCT00899379|297318|P3|Overall Study|Pregnancy|1
84183|NCT00899379|297319|P2|Overall Study|Pregnancy|0
84184|NCT00899379|297320|P1|Overall Study|Pregnancy|0
84185|NCT00899379|297316|P5|Overall Study|Withdrawal by Subject|6
84186|NCT00899379|297317|P4|Overall Study|Withdrawal by Subject|3
84187|NCT00899379|297318|P3|Overall Study|Withdrawal by Subject|2
84188|NCT00899379|297319|P2|Overall Study|Withdrawal by Subject|4
84189|NCT00899379|297320|P1|Overall Study|Withdrawal by Subject|2
84190|NCT00899379|297316|P5|Overall Study|Protocol Violation|0
84191|NCT00899379|297317|P4|Overall Study|Protocol Violation|1
84192|NCT00899379|297318|P3|Overall Study|Protocol Violation|1
84193|NCT00899379|297319|P2|Overall Study|Protocol Violation|0
84194|NCT00899379|297320|P1|Overall Study|Protocol Violation|0
84195|NCT00899379|297316|P5|Overall Study|Lost to Follow-up|2
84196|NCT00899379|297317|P4|Overall Study|Lost to Follow-up|6
84197|NCT00899379|297318|P3|Overall Study|Lost to Follow-up|0
84198|NCT00899379|297319|P2|Overall Study|Lost to Follow-up|3
84199|NCT00899379|297320|P1|Overall Study|Lost to Follow-up|9
84200|NCT00899379|297316|P5|Overall Study|Lack of Efficacy|1
84201|NCT00899379|297317|P4|Overall Study|Lack of Efficacy|0
84202|NCT00899379|297318|P3|Overall Study|Lack of Efficacy|3
84203|NCT00899379|297319|P2|Overall Study|Lack of Efficacy|4
84204|NCT00899379|297320|P1|Overall Study|Lack of Efficacy|0
84205|NCT00899379|297316|P5|Overall Study|Adverse Event|2
84206|NCT00899379|297317|P4|Overall Study|Adverse Event|1
84207|NCT00899379|297318|P3|Overall Study|Adverse Event|1
84208|NCT00899379|297319|P2|Overall Study|Adverse Event|2
84209|NCT00899379|297320|P1|Overall Study|Adverse Event|2
84210|NCT00899353|297332|P1|Overall Study|Withdrawal by Subject|2
84211|NCT00899353|297332|P1|Overall Study|Lost to Follow-up|1
84212|NCT00899353|297332|P1|Overall Study|Adverse Event|2
84213|NCT00898807|297355|P2|Overall Study|Death|1
84214|NCT00898807|297356|P1|Overall Study|Death|0
84215|NCT00898807|297355|P2|Overall Study|Lost to Follow-up|3
84216|NCT00898807|297356|P1|Overall Study|Lost to Follow-up|1
84217|NCT00898807|297355|P2|Overall Study|Family pressure to discontinue|2
84218|NCT00898807|297356|P1|Overall Study|Family pressure to discontinue|2
84219|NCT00898807|297355|P2|Overall Study|Withdrawal by Subject|3
84220|NCT00898807|297356|P1|Overall Study|Withdrawal by Subject|5
84221|NCT00898677|297372|P4|Overall Study|Not Treated: Other (Not Specified)|0
84222|NCT00898677|297373|P3|Overall Study|Not Treated: Other (Not Specified)|2
84223|NCT00898677|297374|P2|Overall Study|Not Treated: Other (Not Specified)|0
84224|NCT00898677|297375|P1|Overall Study|Not Treated: Other (Not Specified)|0
84225|NCT00898677|297372|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
84226|NCT00898677|297373|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
84227|NCT00898677|297374|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
84228|NCT00898677|297375|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
84229|NCT00898677|297372|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
84230|NCT00898677|297373|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
84231|NCT00898677|297374|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
84232|NCT00898677|297375|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
84233|NCT00898677|297372|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
84234|NCT00898677|297373|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
84235|NCT00898677|297374|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
84236|NCT00898677|297375|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
84237|NCT00898677|297372|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
84238|NCT00898677|297373|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
84239|NCT00898677|297374|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
84240|NCT00898677|297375|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
84241|NCT00898677|297372|P4|Overall Study|Not Treated: Patient uncooperative|0
84242|NCT00898677|297373|P3|Overall Study|Not Treated: Patient uncooperative|1
84243|NCT00898677|297374|P2|Overall Study|Not Treated: Patient uncooperative|3
84244|NCT00898677|297375|P1|Overall Study|Not Treated: Patient uncooperative|2
84245|NCT00898677|297372|P4|Overall Study|Not Treated: Withdraw by Subject|3
84246|NCT00898677|297373|P3|Overall Study|Not Treated: Withdraw by Subject|11
84247|NCT00898677|297374|P2|Overall Study|Not Treated: Withdraw by Subject|16
84248|NCT00898677|297375|P1|Overall Study|Not Treated: Withdraw by Subject|2
84249|NCT00898677|297372|P4|Overall Study|Not Treated: Protocol Violation|0
84250|NCT00898677|297373|P3|Overall Study|Not Treated: Protocol Violation|2
84251|NCT00898677|297374|P2|Overall Study|Not Treated: Protocol Violation|0
84252|NCT00898677|297375|P1|Overall Study|Not Treated: Protocol Violation|2
84253|NCT00898677|297372|P4|Overall Study|Not Treated: Pregnancy|0
84254|NCT00898677|297373|P3|Overall Study|Not Treated: Pregnancy|1
84255|NCT00898677|297374|P2|Overall Study|Not Treated: Pregnancy|0
84256|NCT00898677|297375|P1|Overall Study|Not Treated: Pregnancy|0
84257|NCT00898677|297372|P4|Overall Study|Not Treated: Lost to Follow-Up|2
84258|NCT00898677|297373|P3|Overall Study|Not Treated: Lost to Follow-Up|5
84259|NCT00898677|297374|P2|Overall Study|Not Treated: Lost to Follow-Up|5
84260|NCT00898677|297375|P1|Overall Study|Not Treated: Lost to Follow-Up|0
84261|NCT00898677|297372|P4|Overall Study|Not Treated: Adverse Event|0
84262|NCT00898677|297373|P3|Overall Study|Not Treated: Adverse Event|1
84263|NCT00898677|297374|P2|Overall Study|Not Treated: Adverse Event|2
84264|NCT00898677|297375|P1|Overall Study|Not Treated: Adverse Event|0
84265|NCT00898677|297372|P4|Overall Study|Withdrawal by Subject|1
84266|NCT00898677|297373|P3|Overall Study|Withdrawal by Subject|0
84267|NCT00898677|297374|P2|Overall Study|Withdrawal by Subject|0
84268|NCT00898677|297375|P1|Overall Study|Withdrawal by Subject|0
84269|NCT00898677|297372|P4|Overall Study|Protocol Violation|0
84270|NCT00898677|297373|P3|Overall Study|Protocol Violation|2
84271|NCT00898677|297374|P2|Overall Study|Protocol Violation|1
84272|NCT00898677|297375|P1|Overall Study|Protocol Violation|1
84273|NCT00898677|297372|P4|Overall Study|Lost to Follow-up|0
84274|NCT00898677|297373|P3|Overall Study|Lost to Follow-up|2
84275|NCT00898677|297374|P2|Overall Study|Lost to Follow-up|0
84276|NCT00898677|297375|P1|Overall Study|Lost to Follow-up|0
84277|NCT00898677|297372|P4|Overall Study|Adverse Event|0
84278|NCT00898677|297373|P3|Overall Study|Adverse Event|1
84279|NCT00898677|297374|P2|Overall Study|Adverse Event|0
84280|NCT00898677|297375|P1|Overall Study|Adverse Event|0
84281|NCT00898443|297413|P2|Overall Study|Withdrawal by Subject|0
84282|NCT00898443|297414|P1|Overall Study|Withdrawal by Subject|1
84283|NCT00897949|297429|P3|Overall Study|Did not take study drug|4
84284|NCT00897949|297430|P2|Overall Study|Did not take study drug|3
84285|NCT00897949|297431|P1|Overall Study|Did not take study drug|9
84286|NCT00897949|297429|P3|Overall Study|Lack of Migraine Attack|19
84287|NCT00897949|297430|P2|Overall Study|Lack of Migraine Attack|30
84288|NCT00897949|297431|P1|Overall Study|Lack of Migraine Attack|29
84289|NCT00897949|297429|P3|Overall Study|Need for Concom. Med.|1
84290|NCT00897949|297430|P2|Overall Study|Need for Concom. Med.|1
84291|NCT00897949|297431|P1|Overall Study|Need for Concom. Med.|0
84292|NCT00897949|297429|P3|Overall Study|Abnormal Baseline ECG|4
84293|NCT00897949|297430|P2|Overall Study|Abnormal Baseline ECG|2
84294|NCT00897949|297431|P1|Overall Study|Abnormal Baseline ECG|2
84295|NCT00897949|297429|P3|Overall Study|Abnormal Prestudy Labs|4
84296|NCT00897949|297430|P2|Overall Study|Abnormal Prestudy Labs|3
84297|NCT00897949|297431|P1|Overall Study|Abnormal Prestudy Labs|2
84298|NCT00897949|297429|P3|Overall Study|Withdrawal by Subject|17
84299|NCT00897949|297430|P2|Overall Study|Withdrawal by Subject|31
84300|NCT00897949|297431|P1|Overall Study|Withdrawal by Subject|24
84301|NCT00897949|297429|P3|Overall Study|Lost to Follow-up|17
84302|NCT00897949|297430|P2|Overall Study|Lost to Follow-up|23
84303|NCT00897949|297431|P1|Overall Study|Lost to Follow-up|30
84304|NCT00897949|297429|P3|Overall Study|Patient Uncoorperative|1
84305|NCT00897949|297430|P2|Overall Study|Patient Uncoorperative|2
84306|NCT00897949|297431|P1|Overall Study|Patient Uncoorperative|0
84307|NCT00897949|297429|P3|Overall Study|Withdrawal by Subject|0
84308|NCT00897949|297430|P2|Overall Study|Withdrawal by Subject|2
84309|NCT00897949|297431|P1|Overall Study|Withdrawal by Subject|1
84310|NCT00897949|297429|P3|Overall Study|Protocol Violation|1
84311|NCT00897949|297430|P2|Overall Study|Protocol Violation|3
84312|NCT00897949|297431|P1|Overall Study|Protocol Violation|6
84313|NCT00897949|297429|P3|Overall Study|Lost to Follow-up|1
84314|NCT00897949|297430|P2|Overall Study|Lost to Follow-up|2
84315|NCT00897949|297431|P1|Overall Study|Lost to Follow-up|0
84316|NCT00897949|297429|P3|Overall Study|Adverse Event|0
84317|NCT00897949|297430|P2|Overall Study|Adverse Event|1
84318|NCT00897949|297431|P1|Overall Study|Adverse Event|1
84319|NCT00897715|297465|P2|Overall Study|increased risk of infection|0
84320|NCT00897715|297466|P1|Overall Study|increased risk of infection|1
84321|NCT00897715|297465|P2|Overall Study|Physician Decision|0
84322|NCT00897715|297466|P1|Overall Study|Physician Decision|1
84323|NCT00897715|297465|P2|Overall Study|Lost to Follow-up|1
84324|NCT00897715|297466|P1|Overall Study|Lost to Follow-up|0
84325|NCT00897390|297474|P1|Overall Study|Did not Return for the Clinic Visit|2
84326|NCT00897390|297474|P1|Overall Study|Personal Reasons|1
84327|NCT00897390|297474|P1|Overall Study|No Longer Met Study Criteria|1
84328|NCT00897390|297474|P1|Overall Study|Adverse Event|2
84329|NCT00897104|297564|P3|Overall Study|Withdrawal by Subject|1
84330|NCT00897104|297565|P2|Overall Study|Withdrawal by Subject|0
84331|NCT00897104|297566|P1|Overall Study|Withdrawal by Subject|0
84332|NCT00897104|297564|P3|Overall Study|Protocol Violation|0
84333|NCT00897104|297565|P2|Overall Study|Protocol Violation|0
84334|NCT00897104|297566|P1|Overall Study|Protocol Violation|1
84335|NCT00897104|297564|P3|Overall Study|Not Specified|0
84336|NCT00897104|297565|P2|Overall Study|Not Specified|0
84337|NCT00897104|297566|P1|Overall Study|Not Specified|3
84338|NCT00897104|297564|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
84339|NCT00897104|297565|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
84340|NCT00897104|297566|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
84341|NCT00897104|297564|P3|Overall Study|Lack of Migraine Attack|1
84342|NCT00897104|297565|P2|Overall Study|Lack of Migraine Attack|22
84343|NCT00897104|297566|P1|Overall Study|Lack of Migraine Attack|20
84344|NCT00897104|297564|P3|Overall Study|Need for Concom. Med.|1
84345|NCT00897104|297565|P2|Overall Study|Need for Concom. Med.|1
84346|NCT00897104|297566|P1|Overall Study|Need for Concom. Med.|0
84347|NCT00897104|297564|P3|Overall Study|Abnormal Baseline ECG|0
84348|NCT00897104|297565|P2|Overall Study|Abnormal Baseline ECG|2
84349|NCT00897104|297566|P1|Overall Study|Abnormal Baseline ECG|2
84350|NCT00897104|297564|P3|Overall Study|Abnormal Prestudy Labs|0
84351|NCT00897104|297565|P2|Overall Study|Abnormal Prestudy Labs|0
84352|NCT00897104|297566|P1|Overall Study|Abnormal Prestudy Labs|2
84353|NCT00897104|297564|P3|Overall Study|Withdrawal by Subject|3
84354|NCT00897104|297565|P2|Overall Study|Withdrawal by Subject|27
84355|NCT00897104|297566|P1|Overall Study|Withdrawal by Subject|23
84356|NCT00897104|297564|P3|Overall Study|Protocol Violation|0
84357|NCT00897104|297565|P2|Overall Study|Protocol Violation|1
84358|NCT00897104|297566|P1|Overall Study|Protocol Violation|0
84359|NCT00897104|297564|P3|Overall Study|Pregnancy|0
84360|NCT00897104|297565|P2|Overall Study|Pregnancy|1
84361|NCT00897104|297566|P1|Overall Study|Pregnancy|0
84362|NCT00897104|297564|P3|Overall Study|Lost to Follow-up|2
84363|NCT00897104|297565|P2|Overall Study|Lost to Follow-up|17
84364|NCT00897104|297566|P1|Overall Study|Lost to Follow-up|12
84365|NCT00896649|297601|P1|Overall Study|technical difficulties|2
84366|NCT00896649|297601|P1|Overall Study|missing documentation|1
84367|NCT00896649|297601|P1|Overall Study|Pregnancy|1
84368|NCT00896649|297601|P1|Overall Study|Physician Decision|1
84369|NCT00896454|297606|P1|Overall Study|Withdrawal by Subject|1
84370|NCT00896454|297606|P1|Overall Study|Ongoing in study|2
84371|NCT00896454|297606|P1|Overall Study|Requirement for alternative therapy|3
84372|NCT00896454|297606|P1|Overall Study|Other|4
84373|NCT00896454|297606|P1|Overall Study|Disease Progression|5
84374|NCT00896454|297606|P1|Overall Study|Adverse Event|8
84375|NCT00896454|297606|P1|Overall Study|Death|10
84376|NCT00896337|297618|P1|Overall Study|Lost to Follow-up|11
84377|NCT00896337|297618|P1|Overall Study|Withdrawal by Subject|7
84378|NCT00896337|297618|P1|Overall Study|Death|7
84379|NCT00896233|297685|P1|Overall Study|Claustrophobia during MRI|1
84380|NCT00896168|297698|P2|Overall Study|Unspecified|1
84381|NCT00896168|297699|P1|Overall Study|Unspecified|1
84382|NCT00896168|297698|P2|Overall Study|Lost to Follow-up|1
84383|NCT00896168|297699|P1|Overall Study|Lost to Follow-up|1
84384|NCT00896168|297698|P2|Overall Study|Treatment failure|10
84385|NCT00896168|297699|P1|Overall Study|Treatment failure|8
84386|NCT00896168|297698|P2|Overall Study|Adverse Event|7
84387|NCT00896168|297699|P1|Overall Study|Adverse Event|4
84388|NCT00896051|297729|P2|Overall Study|Not specified|1
84389|NCT00896051|297730|P1|Overall Study|Not specified|1
84390|NCT00896051|297729|P2|Overall Study|Subject noncompliant|3
84391|NCT00896051|297730|P1|Overall Study|Subject noncompliant|1
84392|NCT00896051|297729|P2|Overall Study|Withdrawal by Subject|2
84393|NCT00896051|297730|P1|Overall Study|Withdrawal by Subject|3
84394|NCT00896051|297729|P2|Overall Study|Lost to Follow-up|2
84395|NCT00896051|297730|P1|Overall Study|Lost to Follow-up|3
84396|NCT00896051|297729|P2|Overall Study|Adverse Event|1
84397|NCT00896051|297730|P1|Overall Study|Adverse Event|2
84398|NCT00895947|297817|P2|Overall Study|Withdrawal by Subject|0
84399|NCT00895947|297818|P1|Overall Study|Withdrawal by Subject|2
84400|NCT00895947|297817|P2|Overall Study|Protocol Violation|2
84401|NCT00895947|297818|P1|Overall Study|Protocol Violation|4
84402|NCT00895947|297817|P2|Overall Study|Lost to Follow-up|4
84403|NCT00895947|297818|P1|Overall Study|Lost to Follow-up|3
84404|NCT00895947|297817|P2|Overall Study|Adverse Event|4
84405|NCT00895947|297818|P1|Overall Study|Adverse Event|3
84406|NCT00895934|297836|P2|Overall Study|ineligible|0
84407|NCT00895934|297837|P1|Overall Study|ineligible|1
84408|NCT00895934|297836|P2|Overall Study|Death|1
84409|NCT00895934|297837|P1|Overall Study|Death|0
84410|NCT00895934|297836|P2|Overall Study|Lack of Efficacy|24
84411|NCT00895934|297837|P1|Overall Study|Lack of Efficacy|5
84412|NCT00895895|297848|P5|Period 2|unsatisfactory response-efficacy|0
84413|NCT00895895|297849|P4|Period 2|unsatisfactory response-efficacy|0
84414|NCT00895895|297850|P3|Period 2|unsatisfactory response-efficacy|0
84415|NCT00895895|297851|P2|Period 2|unsatisfactory response-efficacy|1
84416|NCT00895895|297852|P1|Period 2|unsatisfactory response-efficacy|2
84417|NCT00895895|297848|P5|Period 2|Withdrawal by Subject|5
84418|NCT00895895|297849|P4|Period 2|Withdrawal by Subject|3
84419|NCT00895895|297850|P3|Period 2|Withdrawal by Subject|0
84420|NCT00895895|297851|P2|Period 2|Withdrawal by Subject|2
84421|NCT00895895|297852|P1|Period 2|Withdrawal by Subject|0
84422|NCT00895895|297848|P5|Period 2|Protocol Violation|1
84423|NCT00895895|297849|P4|Period 2|Protocol Violation|1
84424|NCT00895895|297850|P3|Period 2|Protocol Violation|1
84425|NCT00895895|297851|P2|Period 2|Protocol Violation|0
84426|NCT00895895|297852|P1|Period 2|Protocol Violation|1
84427|NCT00895895|297848|P5|Period 2|unspecified|1
84428|NCT00895895|297849|P4|Period 2|unspecified|1
84429|NCT00895895|297850|P3|Period 2|unspecified|3
84430|NCT00895895|297851|P2|Period 2|unspecified|1
84431|NCT00895895|297852|P1|Period 2|unspecified|1
84432|NCT00895895|297848|P5|Period 2|Lost to Follow-up|0
84433|NCT00895895|297849|P4|Period 2|Lost to Follow-up|1
84434|NCT00895895|297850|P3|Period 2|Lost to Follow-up|1
84435|NCT00895895|297851|P2|Period 2|Lost to Follow-up|2
84436|NCT00895895|297852|P1|Period 2|Lost to Follow-up|1
84437|NCT00895895|297848|P5|Period 2|investigator request|0
84438|NCT00895895|297849|P4|Period 2|investigator request|0
84439|NCT00895895|297850|P3|Period 2|investigator request|0
84440|NCT00895895|297851|P2|Period 2|investigator request|0
84441|NCT00895895|297852|P1|Period 2|investigator request|2
84442|NCT00895895|297848|P5|Period 2|failed to return|0
84443|NCT00895895|297849|P4|Period 2|failed to return|0
84444|NCT00895895|297850|P3|Period 2|failed to return|0
84445|NCT00895895|297851|P2|Period 2|failed to return|0
84446|NCT00895895|297852|P1|Period 2|failed to return|2
84447|NCT00895895|297848|P5|Period 2|discontinued by sponsor|37
84448|NCT00895895|297849|P4|Period 2|discontinued by sponsor|46
84449|NCT00895895|297850|P3|Period 2|discontinued by sponsor|38
84450|NCT00895895|297851|P2|Period 2|discontinued by sponsor|44
84451|NCT00895895|297852|P1|Period 2|discontinued by sponsor|44
84452|NCT00895895|297848|P5|Period 2|Death|0
84453|NCT00895895|297849|P4|Period 2|Death|0
84454|NCT00895895|297850|P3|Period 2|Death|1
84455|NCT00895895|297851|P2|Period 2|Death|0
84456|NCT00895895|297852|P1|Period 2|Death|0
84457|NCT00895895|297848|P5|Period 2|Adverse Event|5
84458|NCT00895895|297849|P4|Period 2|Adverse Event|2
84459|NCT00895895|297850|P3|Period 2|Adverse Event|5
84460|NCT00895895|297851|P2|Period 2|Adverse Event|3
84461|NCT00895895|297852|P1|Period 2|Adverse Event|3
84462|NCT00895895|297848|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
84463|NCT00895895|297849|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
84464|NCT00895895|297850|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
84465|NCT00895895|297851|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
84466|NCT00895895|297852|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
84467|NCT00895895|297848|P5|After Period 1, Prior to Period 2|Protocol Violation|1
84468|NCT00895895|297849|P4|After Period 1, Prior to Period 2|Protocol Violation|0
84469|NCT00895895|297850|P3|After Period 1, Prior to Period 2|Protocol Violation|0
84470|NCT00895895|297851|P2|After Period 1, Prior to Period 2|Protocol Violation|0
84471|NCT00895895|297852|P1|After Period 1, Prior to Period 2|Protocol Violation|0
84472|NCT00895895|297848|P5|After Period 1, Prior to Period 2|unspecified|0
84473|NCT00895895|297849|P4|After Period 1, Prior to Period 2|unspecified|0
84474|NCT00895895|297850|P3|After Period 1, Prior to Period 2|unspecified|1
84475|NCT00895895|297851|P2|After Period 1, Prior to Period 2|unspecified|0
84476|NCT00895895|297852|P1|After Period 1, Prior to Period 2|unspecified|0
84477|NCT00895895|297848|P5|After Period 1, Prior to Period 2|Adverse Event|0
84478|NCT00895895|297849|P4|After Period 1, Prior to Period 2|Adverse Event|0
84479|NCT00895895|297850|P3|After Period 1, Prior to Period 2|Adverse Event|1
84480|NCT00895895|297851|P2|After Period 1, Prior to Period 2|Adverse Event|0
84481|NCT00895895|297852|P1|After Period 1, Prior to Period 2|Adverse Event|0
84482|NCT00895895|297848|P5|Period 1|randomized and not treated|2
84483|NCT00895895|297849|P4|Period 1|randomized and not treated|1
84484|NCT00895895|297850|P3|Period 1|randomized and not treated|1
84485|NCT00895895|297851|P2|Period 1|randomized and not treated|3
84486|NCT00895895|297852|P1|Period 1|randomized and not treated|1
84487|NCT00895895|297848|P5|Period 1|unsatisfactory response-efficacy|0
84488|NCT00895895|297849|P4|Period 1|unsatisfactory response-efficacy|0
84489|NCT00895895|297850|P3|Period 1|unsatisfactory response-efficacy|0
84490|NCT00895895|297851|P2|Period 1|unsatisfactory response-efficacy|0
84491|NCT00895895|297852|P1|Period 1|unsatisfactory response-efficacy|2
84492|NCT00895895|297848|P5|Period 1|Withdrawal by Subject|4
84493|NCT00895895|297849|P4|Period 1|Withdrawal by Subject|2
84494|NCT00895895|297850|P3|Period 1|Withdrawal by Subject|8
84495|NCT00895895|297851|P2|Period 1|Withdrawal by Subject|6
84496|NCT00895895|297852|P1|Period 1|Withdrawal by Subject|6
84497|NCT00895895|297848|P5|Period 1|Protocol Violation|0
84498|NCT00895895|297849|P4|Period 1|Protocol Violation|0
84499|NCT00895895|297850|P3|Period 1|Protocol Violation|0
84500|NCT00895895|297851|P2|Period 1|Protocol Violation|1
84501|NCT00895895|297852|P1|Period 1|Protocol Violation|0
84502|NCT00895895|297848|P5|Period 1|unspecified|1
84503|NCT00895895|297849|P4|Period 1|unspecified|1
84504|NCT00895895|297850|P3|Period 1|unspecified|1
84505|NCT00895895|297851|P2|Period 1|unspecified|2
84506|NCT00895895|297852|P1|Period 1|unspecified|1
84507|NCT00895895|297848|P5|Period 1|Lost to Follow-up|3
84508|NCT00895895|297849|P4|Period 1|Lost to Follow-up|2
84509|NCT00895895|297850|P3|Period 1|Lost to Follow-up|3
84510|NCT00895895|297851|P2|Period 1|Lost to Follow-up|1
84511|NCT00895895|297852|P1|Period 1|Lost to Follow-up|2
84512|NCT00895895|297848|P5|Period 1|investigator request|0
84513|NCT00895895|297849|P4|Period 1|investigator request|0
84514|NCT00895895|297850|P3|Period 1|investigator request|0
84515|NCT00895895|297851|P2|Period 1|investigator request|1
84516|NCT00895895|297852|P1|Period 1|investigator request|0
84517|NCT00895895|297848|P5|Period 1|failed to return|1
84518|NCT00895895|297849|P4|Period 1|failed to return|0
84519|NCT00895895|297850|P3|Period 1|failed to return|1
84520|NCT00895895|297851|P2|Period 1|failed to return|0
84521|NCT00895895|297852|P1|Period 1|failed to return|0
84522|NCT00895895|297848|P5|Period 1|discontinued by sponsor|1
84523|NCT00895895|297849|P4|Period 1|discontinued by sponsor|1
84524|NCT00895895|297850|P3|Period 1|discontinued by sponsor|2
84525|NCT00895895|297851|P2|Period 1|discontinued by sponsor|1
84526|NCT00895895|297852|P1|Period 1|discontinued by sponsor|2
84527|NCT00895895|297848|P5|Period 1|Death|1
84528|NCT00895895|297849|P4|Period 1|Death|0
84529|NCT00895895|297850|P3|Period 1|Death|0
84530|NCT00895895|297851|P2|Period 1|Death|0
84531|NCT00895895|297852|P1|Period 1|Death|0
84532|NCT00895895|297848|P5|Period 1|Adverse Event|7
84533|NCT00895895|297849|P4|Period 1|Adverse Event|6
84534|NCT00895895|297850|P3|Period 1|Adverse Event|4
84535|NCT00895895|297851|P2|Period 1|Adverse Event|6
84536|NCT00895895|297852|P1|Period 1|Adverse Event|7
84537|NCT00895843|297966|P2|Overall Study|Protocol Violation|12
84538|NCT00895843|297967|P1|Overall Study|Protocol Violation|12
84539|NCT00895583|298005|P2|Overall Study|Not specified|1
84540|NCT00895583|298006|P1|Overall Study|Not specified|0
84541|NCT00895583|298005|P2|Overall Study|Lack of Efficacy|0
84542|NCT00895583|298006|P1|Overall Study|Lack of Efficacy|5
84543|NCT00895583|298005|P2|Overall Study|Withdrawal by Subject|2
84544|NCT00895583|298006|P1|Overall Study|Withdrawal by Subject|4
84545|NCT00895583|298005|P2|Overall Study|Protocol Violation|0
84546|NCT00895583|298006|P1|Overall Study|Protocol Violation|1
84547|NCT00895583|298005|P2|Overall Study|Lost to Follow-up|3
84548|NCT00895583|298006|P1|Overall Study|Lost to Follow-up|1
84549|NCT00895583|298005|P2|Overall Study|Physician Decision|1
84550|NCT00895583|298006|P1|Overall Study|Physician Decision|3
84551|NCT00895583|298005|P2|Overall Study|Death|1
84552|NCT00895583|298006|P1|Overall Study|Death|2
84553|NCT00895583|298005|P2|Overall Study|Adverse Event|4
84554|NCT00895583|298006|P1|Overall Study|Adverse Event|28
84555|NCT00895453|298087|P3|Overall Study|Lost to Follow-up|23
84556|NCT00895453|298088|P2|Overall Study|Lost to Follow-up|25
84557|NCT00895453|298089|P1|Overall Study|Lost to Follow-up|25
84558|NCT00895310|298097|P1|Overall Study|Withdrawal by Subject|1
84559|NCT00895011|298164|P3|Overall Study|schedule conflict|0
84560|NCT00895011|298165|P2|Overall Study|schedule conflict|0
84561|NCT00895011|298166|P1|Overall Study|schedule conflict|1
84562|NCT00895011|298164|P3|Overall Study|Adverse Event|2
84563|NCT00895011|298165|P2|Overall Study|Adverse Event|2
84564|NCT00895011|298166|P1|Overall Study|Adverse Event|1
84565|NCT00895011|298164|P3|Overall Study|Protocol Violation|3
84566|NCT00895011|298165|P2|Overall Study|Protocol Violation|1
84567|NCT00895011|298166|P1|Overall Study|Protocol Violation|3
84568|NCT00895011|298164|P3|Overall Study|Lost to Follow-up|1
84569|NCT00895011|298165|P2|Overall Study|Lost to Follow-up|4
84570|NCT00895011|298166|P1|Overall Study|Lost to Follow-up|5
84571|NCT00895011|298164|P3|Overall Study|Withdrawal by Subject|2
84572|NCT00895011|298165|P2|Overall Study|Withdrawal by Subject|7
84573|NCT00895011|298166|P1|Overall Study|Withdrawal by Subject|14
84574|NCT00894803|298182|P2|Overall Study|Lost to Follow-up|1
84575|NCT00894803|298183|P1|Overall Study|Lost to Follow-up|0
84576|NCT00894803|298182|P2|Overall Study|Death|4
84577|NCT00894803|298183|P1|Overall Study|Death|20
84578|NCT00894790|298219|P2|Overall Study|Did not meet entrance criteria|0
84579|NCT00894790|298220|P1|Overall Study|Did not meet entrance criteria|1
84580|NCT00894790|298219|P2|Overall Study|Lost to Follow-up|1
84581|NCT00894790|298220|P1|Overall Study|Lost to Follow-up|0
84582|NCT00894790|298219|P2|Overall Study|Protocol Violation|1
84583|NCT00894790|298220|P1|Overall Study|Protocol Violation|0
84584|NCT00894647|298253|P2|Overall Study|Other, not due to AE|2
84585|NCT00894647|298254|P1|Overall Study|Other, not due to AE|1
84586|NCT00894647|298253|P2|Overall Study|Non-compliance with study procedures|2
84587|NCT00894647|298254|P1|Overall Study|Non-compliance with study procedures|0
84588|NCT00894647|298253|P2|Overall Study|Lost to Follow-up|2
84589|NCT00894647|298254|P1|Overall Study|Lost to Follow-up|0
84590|NCT00894647|298253|P2|Overall Study|Withdrawal by Subject|4
84591|NCT00894647|298254|P1|Overall Study|Withdrawal by Subject|4
84592|NCT00894647|298253|P2|Overall Study|Adverse Event|4
84593|NCT00894647|298254|P1|Overall Study|Adverse Event|5
84594|NCT00894556|298267|P4|Treatment Phase|Lack of Qualifying Event|0
84595|NCT00894556|298268|P3|Treatment Phase|Lack of Qualifying Event|0
84596|NCT00894556|298269|P2|Treatment Phase|Lack of Qualifying Event|1
84597|NCT00894556|298270|P1|Treatment Phase|Lack of Qualifying Event|2
84598|NCT00894556|298267|P4|Treatment Phase|Lost to Follow-up|0
84599|NCT00894556|298268|P3|Treatment Phase|Lost to Follow-up|1
84600|NCT00894556|298269|P2|Treatment Phase|Lost to Follow-up|3
84601|NCT00894556|298270|P1|Treatment Phase|Lost to Follow-up|2
84602|NCT00894556|298267|P4|Baseline Phase|Did not meet Randomization Criteria|85
84603|NCT00894556|298268|P3|Baseline Phase|Did not meet Randomization Criteria|0
84604|NCT00894556|298269|P2|Baseline Phase|Did not meet Randomization Criteria|0
84605|NCT00894556|298270|P1|Baseline Phase|Did not meet Randomization Criteria|0
84606|NCT00894543|298281|P2|Week 4 to Week 8|No diary or lost or withdrew|2
84607|NCT00894543|298282|P1|Week 4 to Week 8|No diary or lost or withdrew|4
84608|NCT00894543|298281|P2|Baseline to Week 4|No diary or lost or withdrew|2
84609|NCT00894543|298282|P1|Baseline to Week 4|No diary or lost or withdrew|3
84610|NCT00894387|298348|P2|Overall Study|GCP non-compliance|2
84611|NCT00894387|298349|P1|Overall Study|GCP non-compliance|0
84612|NCT00894387|298348|P2|Overall Study|Mis-randomized|9
84613|NCT00894387|298349|P1|Overall Study|Mis-randomized|13
84614|NCT00894387|298348|P2|Overall Study|Other (Missing)|3
84615|NCT00894387|298349|P1|Overall Study|Other (Missing)|5
84616|NCT00894387|298348|P2|Overall Study|Patient's request|30
84617|NCT00894387|298349|P1|Overall Study|Patient's request|25
84618|NCT00894387|298348|P2|Overall Study|Protocol Deviation|0
84619|NCT00894387|298349|P1|Overall Study|Protocol Deviation|4
84620|NCT00894387|298348|P2|Overall Study|Death|76
84621|NCT00894387|298349|P1|Overall Study|Death|77
84622|NCT00894387|298348|P2|Overall Study|Administrative problems|2
84623|NCT00894387|298349|P1|Overall Study|Administrative problems|2
84624|NCT00894387|298348|P2|Overall Study|Lost to Follow-up|5
84625|NCT00894387|298349|P1|Overall Study|Lost to Follow-up|3
84626|NCT00894387|298348|P2|Overall Study|Unsatisfactory therapeutic effect|1
84627|NCT00894387|298349|P1|Overall Study|Unsatisfactory therapeutic effect|0
84628|NCT00894387|298348|P2|Overall Study|Abnormal Laboratory values|2
84629|NCT00894387|298349|P1|Overall Study|Abnormal Laboratory values|2
84630|NCT00894387|298348|P2|Overall Study|Adverse Event|45
84631|NCT00894387|298349|P1|Overall Study|Adverse Event|44
84632|NCT00894361|298369|P2|Overall Study|deaths and less than 2 yr followup|64
84633|NCT00894361|298370|P1|Overall Study|deaths and less than 2 yr followup|24
84634|NCT00894322|298379|P3|Overall Study|Withdrawal by Subject|0
84635|NCT00894322|298380|P2|Overall Study|Withdrawal by Subject|0
84636|NCT00894322|298381|P1|Overall Study|Withdrawal by Subject|1
84637|NCT00894166|298432|P8|Overall Study|Death|0
84638|NCT00894166|298433|P7|Overall Study|Death|0
84639|NCT00894166|298434|P6|Overall Study|Death|0
84640|NCT00894166|298435|P5|Overall Study|Death|0
84641|NCT00894166|298436|P4|Overall Study|Death|1
84642|NCT00894166|298437|P3|Overall Study|Death|0
84643|NCT00894166|298438|P2|Overall Study|Death|0
84644|NCT00894166|298439|P1|Overall Study|Death|0
84645|NCT00894166|298432|P8|Overall Study|Withdrew or Lost to Follow-Up|34
84646|NCT00894166|298433|P7|Overall Study|Withdrew or Lost to Follow-Up|16
84647|NCT00894166|298434|P6|Overall Study|Withdrew or Lost to Follow-Up|16
84648|NCT00894166|298435|P5|Overall Study|Withdrew or Lost to Follow-Up|24
84649|NCT00894166|298436|P4|Overall Study|Withdrew or Lost to Follow-Up|68
84650|NCT00894166|298437|P3|Overall Study|Withdrew or Lost to Follow-Up|62
84651|NCT00894166|298438|P2|Overall Study|Withdrew or Lost to Follow-Up|63
84652|NCT00894166|298439|P1|Overall Study|Withdrew or Lost to Follow-Up|61
84653|NCT00893789|298482|P4|Overall Study|Lost to Follow-up|1
84654|NCT00893789|298483|P3|Overall Study|Lost to Follow-up|0
84655|NCT00893789|298484|P2|Overall Study|Lost to Follow-up|0
84656|NCT00893789|298485|P1|Overall Study|Lost to Follow-up|0
84657|NCT00893789|298482|P4|Overall Study|Protocol Violation|4
84658|NCT00893789|298483|P3|Overall Study|Protocol Violation|1
84659|NCT00893789|298484|P2|Overall Study|Protocol Violation|1
84660|NCT00893789|298485|P1|Overall Study|Protocol Violation|0
84661|NCT00893789|298482|P4|Overall Study|Adverse Event|5
84662|NCT00893789|298483|P3|Overall Study|Adverse Event|1
84663|NCT00893789|298484|P2|Overall Study|Adverse Event|2
84664|NCT00893789|298485|P1|Overall Study|Adverse Event|0
84665|NCT00893789|298482|P4|Overall Study|Taking Excluded Concomitant Medication|0
84666|NCT00893789|298483|P3|Overall Study|Taking Excluded Concomitant Medication|1
84667|NCT00893789|298484|P2|Overall Study|Taking Excluded Concomitant Medication|0
84668|NCT00893789|298485|P1|Overall Study|Taking Excluded Concomitant Medication|1
84669|NCT00893789|298482|P4|Overall Study|Noncompliance With Study Procedures|0
84670|NCT00893789|298483|P3|Overall Study|Noncompliance With Study Procedures|0
84671|NCT00893789|298484|P2|Overall Study|Noncompliance With Study Procedures|0
84672|NCT00893789|298485|P1|Overall Study|Noncompliance With Study Procedures|1
84673|NCT00893789|298482|P4|Overall Study|Noncompliance With Study Drug|2
84674|NCT00893789|298483|P3|Overall Study|Noncompliance With Study Drug|1
84675|NCT00893789|298484|P2|Overall Study|Noncompliance With Study Drug|0
84676|NCT00893789|298485|P1|Overall Study|Noncompliance With Study Drug|1
84677|NCT00893789|298482|P4|Overall Study|Withdrawal by Subject|1
84678|NCT00893789|298483|P3|Overall Study|Withdrawal by Subject|3
84679|NCT00893789|298484|P2|Overall Study|Withdrawal by Subject|1
84680|NCT00893789|298485|P1|Overall Study|Withdrawal by Subject|3
84681|NCT00893763|298569|P2|Overall Study|extubated|110
84682|NCT00893763|298570|P1|Overall Study|extubated|110
84683|NCT00893737|298578|P1|Overall Study|Lost to Follow-up|6
84684|NCT00893737|298578|P1|Overall Study|Withdrawal by Subject|2
84685|NCT00893737|298578|P1|Overall Study|Adverse Event|4
84686|NCT00893464|298592|P8|Overall Study|Did not complete therapy/experience PD|2
84687|NCT00893464|298593|P7|Overall Study|Did not complete therapy/experience PD|2
84688|NCT00893464|298594|P6|Overall Study|Did not complete therapy/experience PD|0
84689|NCT00893464|298595|P5|Overall Study|Did not complete therapy/experience PD|0
84690|NCT00893464|298596|P4|Overall Study|Did not complete therapy/experience PD|0
84691|NCT00893464|298597|P3|Overall Study|Did not complete therapy/experience PD|0
84692|NCT00893464|298598|P2|Overall Study|Did not complete therapy/experience PD|0
84693|NCT00893464|298599|P1|Overall Study|Did not complete therapy/experience PD|0
84694|NCT00892437|298717|P2|Open-Label Extension Phase|Withdrew Consent|1
84695|NCT00892437|298718|P1|Open-Label Extension Phase|Withdrew Consent|3
84696|NCT00892437|298717|P2|Open-Label Extension Phase|Investigator's Discretion|0
84697|NCT00892437|298718|P1|Open-Label Extension Phase|Investigator's Discretion|1
84698|NCT00892437|298717|P2|Open-Label Extension Phase|Lost to Follow-up|1
84699|NCT00892437|298718|P1|Open-Label Extension Phase|Lost to Follow-up|3
84700|NCT00892437|298717|P2|Open-Label Extension Phase|Lack of Efficacy|0
84701|NCT00892437|298718|P1|Open-Label Extension Phase|Lack of Efficacy|1
84702|NCT00892437|298717|P2|Open-Label Extension Phase|Adverse Event|2
84703|NCT00892437|298718|P1|Open-Label Extension Phase|Adverse Event|4
84704|NCT00892437|298717|P2|Randomized Phase|Withdrew Consent|0
84705|NCT00892437|298718|P1|Randomized Phase|Withdrew Consent|1
84706|NCT00892437|298717|P2|Randomized Phase|Investigator’s Discretion|0
84707|NCT00892437|298718|P1|Randomized Phase|Investigator’s Discretion|1
84708|NCT00892437|298717|P2|Randomized Phase|Lost to Follow-up|3
84709|NCT00892437|298718|P1|Randomized Phase|Lost to Follow-up|1
84710|NCT00892437|298717|P2|Randomized Phase|Adverse Event|2
84711|NCT00892437|298718|P1|Randomized Phase|Adverse Event|2
84712|NCT00892437|298717|P2|Randomized Phase|Randomized but not treated|0
84713|NCT00892437|298718|P1|Randomized Phase|Randomized but not treated|6
84714|NCT00893113|298746|P2|Overall Study|Withdrew Consent|7
84715|NCT00893113|298747|P1|Overall Study|Withdrew Consent|8
84716|NCT00893113|298746|P2|Overall Study|Early Termination|1
84717|NCT00893113|298747|P1|Overall Study|Early Termination|1
84718|NCT00893113|298746|P2|Overall Study|Lost to Follow-up|8
84719|NCT00893113|298747|P1|Overall Study|Lost to Follow-up|4
84720|NCT00892957|298759|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
84721|NCT00892957|298760|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
84722|NCT00892957|298759|P2|Between Postoperative Day 1 and Day 14|Death|2
84723|NCT00892957|298760|P1|Between Postoperative Day 1 and Day 14|Death|0
84724|NCT00892723|298849|P3|Overall Study|Withdrawal by Subject|1
84725|NCT00892723|298850|P2|Overall Study|Withdrawal by Subject|1
84726|NCT00892723|298851|P1|Overall Study|Withdrawal by Subject|1
84727|NCT00892723|298849|P3|Overall Study|Lost to Follow-up|1
84728|NCT00892723|298850|P2|Overall Study|Lost to Follow-up|3
84729|NCT00892723|298851|P1|Overall Study|Lost to Follow-up|1
84730|NCT00892281|298927|P2|Overall Study|Visit 4 date out of window|0
84731|NCT00892281|298928|P1|Overall Study|Visit 4 date out of window|1
84732|NCT00892281|298927|P2|Overall Study|Rash on hand|0
84733|NCT00892281|298928|P1|Overall Study|Rash on hand|1
84734|NCT00892281|298927|P2|Overall Study|Subject had history of drug abuse|0
84735|NCT00892281|298928|P1|Overall Study|Subject had history of drug abuse|1
84736|NCT00892281|298927|P2|Overall Study|Non-compliant with visits as scheduled|0
84737|NCT00892281|298928|P1|Overall Study|Non-compliant with visits as scheduled|1
84738|NCT00892281|298927|P2|Overall Study|Missed visits rescheduled out of window|0
84739|NCT00892281|298928|P1|Overall Study|Missed visits rescheduled out of window|1
84740|NCT00892281|298927|P2|Overall Study|Missed multiple visits|0
84741|NCT00892281|298928|P1|Overall Study|Missed multiple visits|1
84742|NCT00892281|298927|P2|Overall Study|No show Visit 2; prescription not filled|0
84743|NCT00892281|298928|P1|Overall Study|No show Visit 2; prescription not filled|1
84744|NCT00892281|298927|P2|Overall Study|Subject not seen by PI at final visit|0
84745|NCT00892281|298928|P1|Overall Study|Subject not seen by PI at final visit|1
84746|NCT00892281|298927|P2|Overall Study|Lack of efficacy of study product|0
84747|NCT00892281|298928|P1|Overall Study|Lack of efficacy of study product|2
84748|NCT00892281|298927|P2|Overall Study|Death in family|0
84749|NCT00892281|298928|P1|Overall Study|Death in family|1
84750|NCT00892281|298927|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
84751|NCT00892281|298928|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
84752|NCT00892281|298927|P2|Overall Study|Subject lost interest in program|1
84753|NCT00892281|298928|P1|Overall Study|Subject lost interest in program|0
84754|NCT00892281|298927|P2|Overall Study|PI complained of inadequate compensation|0
84755|NCT00892281|298928|P1|Overall Study|PI complained of inadequate compensation|3
84756|NCT00892281|298927|P2|Overall Study|Scheduled for knee replacement|1
84757|NCT00892281|298928|P1|Overall Study|Scheduled for knee replacement|0
84758|NCT00892281|298927|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
84759|NCT00892281|298928|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
84760|NCT00892281|298927|P2|Overall Study|Subject missed several visits/lost meds|0
84761|NCT00892281|298928|P1|Overall Study|Subject missed several visits/lost meds|1
84762|NCT00892281|298927|P2|Overall Study|Subject did not return for any visits|0
84763|NCT00892281|298928|P1|Overall Study|Subject did not return for any visits|1
84764|NCT00892281|298927|P2|Overall Study|Subject not good candidate for study|0
84765|NCT00892281|298928|P1|Overall Study|Subject not good candidate for study|1
84766|NCT00892281|298927|P2|Overall Study|Unable to redeem the drug voucher|0
84767|NCT00892281|298928|P1|Overall Study|Unable to redeem the drug voucher|1
84768|NCT00892281|298927|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
84769|NCT00892281|298928|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
84770|NCT00892281|298927|P2|Overall Study|Did not meet incl/excl criteria|0
84771|NCT00892281|298928|P1|Overall Study|Did not meet incl/excl criteria|1
84772|NCT00892281|298927|P2|Overall Study|Last visit not done - death in family|0
84773|NCT00892281|298928|P1|Overall Study|Last visit not done - death in family|1
84774|NCT00892281|298927|P2|Overall Study|Family emergency|0
84775|NCT00892281|298928|P1|Overall Study|Family emergency|1
84776|NCT00892281|298927|P2|Overall Study|Subject completed day after study closed|0
84777|NCT00892281|298928|P1|Overall Study|Subject completed day after study closed|1
84778|NCT00892281|298927|P2|Overall Study|Final visit completed 4 weeks late|1
84779|NCT00892281|298928|P1|Overall Study|Final visit completed 4 weeks late|0
84780|NCT00892281|298927|P2|Overall Study|Subject unable to keep follow-up visits|0
84781|NCT00892281|298928|P1|Overall Study|Subject unable to keep follow-up visits|1
84782|NCT00892281|298927|P2|Overall Study|Subject failed to return for final visit|0
84783|NCT00892281|298928|P1|Overall Study|Subject failed to return for final visit|2
84784|NCT00892281|298927|P2|Overall Study|Withdrawal by Subject|14
84785|NCT00892281|298928|P1|Overall Study|Withdrawal by Subject|86
84786|NCT00892281|298927|P2|Overall Study|Protocol Violation|2
84787|NCT00892281|298928|P1|Overall Study|Protocol Violation|7
84788|NCT00892281|298927|P2|Overall Study|Pregnancy|0
84789|NCT00892281|298928|P1|Overall Study|Pregnancy|1
84790|NCT00892281|298927|P2|Overall Study|Lost to Follow-up|8
84791|NCT00892281|298928|P1|Overall Study|Lost to Follow-up|81
84792|NCT00892281|298927|P2|Overall Study|Adverse Event|8
84793|NCT00892281|298928|P1|Overall Study|Adverse Event|65
84794|NCT00892151|298938|P1|Overall Study|Protocol Violation|1
84795|NCT00892099|298947|P3|Overall Study|Lost to Follow-up|1
84796|NCT00892099|298948|P2|Overall Study|Lost to Follow-up|0
84797|NCT00892099|298949|P1|Overall Study|Lost to Follow-up|0
84798|NCT00892099|298947|P3|Overall Study|investigator decision|1
84799|NCT00892099|298948|P2|Overall Study|investigator decision|0
84800|NCT00892099|298949|P1|Overall Study|investigator decision|0
84801|NCT00892099|298947|P3|Overall Study|kidney function recovered|0
84802|NCT00892099|298948|P2|Overall Study|kidney function recovered|1
84803|NCT00892099|298949|P1|Overall Study|kidney function recovered|0
84804|NCT00892099|298947|P3|Overall Study|no further details|1
84805|NCT00892099|298948|P2|Overall Study|no further details|0
84806|NCT00892099|298949|P1|Overall Study|no further details|1
84807|NCT00892099|298947|P3|Overall Study|Prolonged hospitalization|1
84808|NCT00892099|298948|P2|Overall Study|Prolonged hospitalization|0
84809|NCT00892099|298949|P1|Overall Study|Prolonged hospitalization|1
84810|NCT00892099|298947|P3|Overall Study|replocated|2
84811|NCT00892099|298948|P2|Overall Study|replocated|0
84812|NCT00892099|298949|P1|Overall Study|replocated|1
84813|NCT00892099|298947|P3|Overall Study|Adverse Event|0
84814|NCT00892099|298948|P2|Overall Study|Adverse Event|0
84815|NCT00892099|298949|P1|Overall Study|Adverse Event|1
84816|NCT00892099|298947|P3|Overall Study|Death|1
84817|NCT00892099|298948|P2|Overall Study|Death|0
84818|NCT00892099|298949|P1|Overall Study|Death|1
84819|NCT00892047|298959|P2|Overall Study|Lack of Efficacy|2
84820|NCT00892047|298960|P1|Overall Study|Lack of Efficacy|0
84821|NCT00892047|298959|P2|Overall Study|subject burden|3
84822|NCT00892047|298960|P1|Overall Study|subject burden|2
84823|NCT00892047|298959|P2|Overall Study|Adverse Event|2
84824|NCT00892047|298960|P1|Overall Study|Adverse Event|2
84825|NCT00892008|298976|P1|Overall Study|Adverse Event|37
84826|NCT00892008|298976|P1|Overall Study|unspecified|378
84827|NCT00892008|298976|P1|Overall Study|Lost to Follow-up|142
84828|NCT00892008|298976|P1|Overall Study|Lack of Efficacy|3
84829|NCT00892008|298976|P1|Overall Study|Death|5
84830|NCT00891930|299062|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
84831|NCT00891930|299062|P1|Part 2: Panitumumab + Ganitumab|Death|30
84832|NCT00891930|299062|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
84833|NCT00891930|299062|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
84834|NCT00891930|299062|P1|Part 1: Panitumumab +Irinotecan|Death|38
84835|NCT00891904|299083|P1|Overall Study|Adverse Event|1
84836|NCT00891904|299083|P1|Overall Study|Death|1
84837|NCT00891839|299090|P1|Overall Study|Disease progression|3
84838|NCT00891839|299090|P1|Overall Study|Withdrawal by Subject|2
84839|NCT00891839|299090|P1|Overall Study|Adverse Event|2
84840|NCT00891813|299099|P1|Overall Study|Protocol Violation|2
84841|NCT00891813|299099|P1|Overall Study|Patient Noncompliance|6
84842|NCT00891813|299099|P1|Overall Study|Withdrawal by Subject|1
84843|NCT00891813|299099|P1|Overall Study|Adverse Event|3
84844|NCT00891774|299105|P1|Overall Study|Protocol Violation|4
84845|NCT00891774|299105|P1|Overall Study|Withdrawal by Subject|2
84846|NCT00891774|299105|P1|Overall Study|Illness (Self/Mother)|3
84847|NCT00891774|299105|P1|Overall Study|Lost to Follow-up|5
84848|NCT00891735|299113|P4|Overall Study|Patient's decision to withdraw|8
84849|NCT00891735|299114|P3|Overall Study|Patient's decision to withdraw|4
84850|NCT00891735|299115|P2|Overall Study|Patient's decision to withdraw|9
84851|NCT00891735|299116|P1|Overall Study|Patient's decision to withdraw|4
84852|NCT00891735|299113|P4|Overall Study|Physician's decision to withdraw patient|0
84853|NCT00891735|299114|P3|Overall Study|Physician's decision to withdraw patient|0
84854|NCT00891735|299115|P2|Overall Study|Physician's decision to withdraw patient|0
84855|NCT00891735|299116|P1|Overall Study|Physician's decision to withdraw patient|1
84856|NCT00891735|299113|P4|Overall Study|Lost to Follow-up|2
84857|NCT00891735|299114|P3|Overall Study|Lost to Follow-up|2
84858|NCT00891735|299115|P2|Overall Study|Lost to Follow-up|2
84859|NCT00891735|299116|P1|Overall Study|Lost to Follow-up|2
84860|NCT00891735|299113|P4|Overall Study|Death|5
84861|NCT00891735|299114|P3|Overall Study|Death|4
84862|NCT00891735|299115|P2|Overall Study|Death|5
84863|NCT00891735|299116|P1|Overall Study|Death|8
84864|NCT00891735|299113|P4|Overall Study|Adverse Event|0
84865|NCT00891735|299114|P3|Overall Study|Adverse Event|2
84866|NCT00891735|299115|P2|Overall Study|Adverse Event|0
84867|NCT00891735|299116|P1|Overall Study|Adverse Event|2
84868|NCT00891657|299156|P2|Overall Study|Withdrawal by Subject|1
84869|NCT00891657|299157|P1|Overall Study|Withdrawal by Subject|1
84870|NCT00891618|299169|P1|Overall Study|Withdrawal by Subject|1
84871|NCT00891462|299176|P3|Overall Study|Lost to Follow-up|0
84872|NCT00891462|299177|P2|Overall Study|Lost to Follow-up|2
84873|NCT00891462|299178|P1|Overall Study|Lost to Follow-up|0
84874|NCT00891462|299176|P3|Overall Study|Inclusion/exclusion criteria|2
84875|NCT00891462|299177|P2|Overall Study|Inclusion/exclusion criteria|2
84876|NCT00891462|299178|P1|Overall Study|Inclusion/exclusion criteria|0
84877|NCT00891462|299176|P3|Overall Study|Protocol Violation|3
84878|NCT00891462|299177|P2|Overall Study|Protocol Violation|1
84879|NCT00891462|299178|P1|Overall Study|Protocol Violation|2
84880|NCT00891462|299176|P3|Overall Study|Other Reason|3
84881|NCT00891462|299177|P2|Overall Study|Other Reason|5
84882|NCT00891462|299178|P1|Overall Study|Other Reason|2
84883|NCT00891462|299176|P3|Overall Study|COPD exacerbation|1
84884|NCT00891462|299177|P2|Overall Study|COPD exacerbation|4
84885|NCT00891462|299178|P1|Overall Study|COPD exacerbation|7
84886|NCT00891462|299176|P3|Overall Study|Lack of Efficacy|1
84887|NCT00891462|299177|P2|Overall Study|Lack of Efficacy|5
84888|NCT00891462|299178|P1|Overall Study|Lack of Efficacy|10
84889|NCT00891462|299176|P3|Overall Study|Adverse Event|7
84890|NCT00891462|299177|P2|Overall Study|Adverse Event|8
84891|NCT00891462|299178|P1|Overall Study|Adverse Event|7
84892|NCT00891462|299176|P3|Overall Study|Withdrawal by Subject|7
84893|NCT00891462|299177|P2|Overall Study|Withdrawal by Subject|6
84894|NCT00891462|299178|P1|Overall Study|Withdrawal by Subject|9
84895|NCT00891371|299200|P1|Treatment|Lost to Follow-up|1
84896|NCT00891371|299200|P1|Treatment|Death|1
84897|NCT00891371|299200|P1|Treatment|Adverse Event|2
84898|NCT00891371|299200|P1|Treatment|Lack of Efficacy|5
84899|NCT00891371|299200|P1|Pre-assignment|Consent withdrawal|1
84900|NCT00891371|299200|P1|Pre-assignment|Inclusion/exclusion|5
84901|NCT00891293|299209|P1|Overall Study|Sponsor termination|62
84902|NCT00891293|299209|P1|Overall Study|Subject withdrew consent|7
84903|NCT00891293|299209|P1|Overall Study|Lost to Follow-up|7
84904|NCT00891293|299209|P1|Overall Study|Laboratory abnormality|4
84905|NCT00891293|299209|P1|Overall Study|Protocol Violation|2
84906|NCT00891293|299209|P1|Overall Study|Adverse Event|2
84907|NCT00891202|299223|P2|Overall Study|Withdrawal by Subject|0
84908|NCT00891202|299224|P1|Overall Study|Withdrawal by Subject|1
84909|NCT00891020|299374|P3|Long-term Extension Period|Administrative|2
84910|NCT00891020|299375|P2|Long-term Extension Period|Administrative|2
84911|NCT00891020|299376|P1|Long-term Extension Period|Administrative|1
84912|NCT00891020|299374|P3|Long-term Extension Period|Failure to return|3
84913|NCT00891020|299375|P2|Long-term Extension Period|Failure to return|2
84914|NCT00891020|299376|P1|Long-term Extension Period|Failure to return|0
84915|NCT00891020|299374|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
84916|NCT00891020|299375|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
84917|NCT00891020|299376|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
84918|NCT00891020|299374|P3|Long-term Extension Period|Protocol Violation|1
84919|NCT00891020|299375|P2|Long-term Extension Period|Protocol Violation|1
84920|NCT00891020|299376|P1|Long-term Extension Period|Protocol Violation|0
84921|NCT00891020|299374|P3|Long-term Extension Period|Insufficient therapeutic response|2
84922|NCT00891020|299375|P2|Long-term Extension Period|Insufficient therapeutic response|2
84923|NCT00891020|299376|P1|Long-term Extension Period|Insufficient therapeutic response|3
84924|NCT00891020|299374|P3|Long-term Extension Period|Death|1
84925|NCT00891020|299375|P2|Long-term Extension Period|Death|0
84926|NCT00891020|299376|P1|Long-term Extension Period|Death|0
84927|NCT00891020|299374|P3|Long-term Extension Period|Adverse Event|10
84928|NCT00891020|299375|P2|Long-term Extension Period|Adverse Event|11
84929|NCT00891020|299376|P1|Long-term Extension Period|Adverse Event|1
84930|NCT00891020|299374|P3|24 Week Treatment Period|Administrative/Other|1
84931|NCT00891020|299375|P2|24 Week Treatment Period|Administrative/Other|6
84932|NCT00891020|299376|P1|24 Week Treatment Period|Administrative/Other|5
84933|NCT00891020|299374|P3|24 Week Treatment Period|Withdrew consent|15
84934|NCT00891020|299375|P2|24 Week Treatment Period|Withdrew consent|3
84935|NCT00891020|299376|P1|24 Week Treatment Period|Withdrew consent|6
84936|NCT00891020|299374|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
84937|NCT00891020|299375|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
84938|NCT00891020|299376|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
84939|NCT00891020|299374|P3|24 Week Treatment Period|Other protocol violation|2
84940|NCT00891020|299375|P2|24 Week Treatment Period|Other protocol violation|1
84941|NCT00891020|299376|P1|24 Week Treatment Period|Other protocol violation|1
84942|NCT00891020|299374|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
84943|NCT00891020|299375|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
84944|NCT00891020|299376|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
84945|NCT00891020|299374|P3|24 Week Treatment Period|Failure to return|5
84946|NCT00891020|299375|P2|24 Week Treatment Period|Failure to return|5
84947|NCT00891020|299376|P1|24 Week Treatment Period|Failure to return|4
84948|NCT00891020|299374|P3|24 Week Treatment Period|Insufficient therapeutic response|15
84949|NCT00891020|299375|P2|24 Week Treatment Period|Insufficient therapeutic response|9
84950|NCT00891020|299376|P1|24 Week Treatment Period|Insufficient therapeutic response|6
84951|NCT00891020|299374|P3|24 Week Treatment Period|Death|0
84952|NCT00891020|299375|P2|24 Week Treatment Period|Death|2
84953|NCT00891020|299376|P1|24 Week Treatment Period|Death|0
84954|NCT00891020|299374|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
84955|NCT00891020|299375|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
84956|NCT00891020|299376|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
84957|NCT00890929|299440|P1|Overall Study|Physician Decision|1
84958|NCT00890929|299440|P1|Overall Study|Withdrawal by Subject|3
84959|NCT00890929|299440|P1|Overall Study|Death before treatment|2
84960|NCT00890695|299467|P2|Overall Study|Protocol Violation|0
84961|NCT00890695|299468|P1|Overall Study|Protocol Violation|1
84962|NCT00890591|299497|P1|Overall Study|Lack of Efficacy|20
84963|NCT00890409|299505|P2|Overall Study|Lost to Follow-up|21
84964|NCT00890409|299506|P1|Overall Study|Lost to Follow-up|20
84965|NCT00890201|299516|P2|Overall Study|Protocol Violation|56
84966|NCT00890201|299517|P1|Overall Study|Protocol Violation|5
84967|NCT00890097|299526|P3|Overall Study|Protocol Deviation|1
84968|NCT00890097|299527|P2|Overall Study|Protocol Deviation|1
84969|NCT00890097|299528|P1|Overall Study|Protocol Deviation|1
84970|NCT00890097|299526|P3|Overall Study|Subject Moved|0
84971|NCT00890097|299527|P2|Overall Study|Subject Moved|4
84972|NCT00890097|299528|P1|Overall Study|Subject Moved|0
84973|NCT00890097|299526|P3|Overall Study|Transportation|0
84974|NCT00890097|299527|P2|Overall Study|Transportation|2
84975|NCT00890097|299528|P1|Overall Study|Transportation|0
84976|NCT00890097|299526|P3|Overall Study|Failed inclusion criteria|0
84977|NCT00890097|299527|P2|Overall Study|Failed inclusion criteria|4
84978|NCT00890097|299528|P1|Overall Study|Failed inclusion criteria|3
84979|NCT00890097|299526|P3|Overall Study|Randomization Error|0
84980|NCT00890097|299527|P2|Overall Study|Randomization Error|0
84981|NCT00890097|299528|P1|Overall Study|Randomization Error|2
84982|NCT00890097|299526|P3|Overall Study|Subject Decision|6
84983|NCT00890097|299527|P2|Overall Study|Subject Decision|2
84984|NCT00890097|299528|P1|Overall Study|Subject Decision|3
84985|NCT00890097|299526|P3|Overall Study|Did not attend final visit|0
84986|NCT00890097|299527|P2|Overall Study|Did not attend final visit|3
84987|NCT00890097|299528|P1|Overall Study|Did not attend final visit|2
84988|NCT00890097|299526|P3|Overall Study|Sponsor Decision|7
84989|NCT00890097|299527|P2|Overall Study|Sponsor Decision|11
84990|NCT00890097|299528|P1|Overall Study|Sponsor Decision|7
84991|NCT00890097|299526|P3|Overall Study|Noncompliance|4
84992|NCT00890097|299527|P2|Overall Study|Noncompliance|4
84993|NCT00890097|299528|P1|Overall Study|Noncompliance|0
84994|NCT00890097|299526|P3|Overall Study|Lost to Follow-up|5
84995|NCT00890097|299527|P2|Overall Study|Lost to Follow-up|5
84996|NCT00890097|299528|P1|Overall Study|Lost to Follow-up|5
84997|NCT00890097|299526|P3|Overall Study|Withdrew Consent|9
84998|NCT00890097|299527|P2|Overall Study|Withdrew Consent|6
84999|NCT00890097|299528|P1|Overall Study|Withdrew Consent|9
85000|NCT00890097|299526|P3|Overall Study|Decision Unrelated to an Adverse Event|17
85001|NCT00890097|299527|P2|Overall Study|Decision Unrelated to an Adverse Event|12
85002|NCT00890097|299528|P1|Overall Study|Decision Unrelated to an Adverse Event|15
85003|NCT00890097|299526|P3|Overall Study|Adverse Event|28
85004|NCT00890097|299527|P2|Overall Study|Adverse Event|32
85005|NCT00890097|299528|P1|Overall Study|Adverse Event|21
85006|NCT00890084|299536|P1|Overall Study|Lost to Follow-up|126
85007|NCT00890084|299536|P1|Overall Study|Adverse Event|16
85008|NCT00889863|299576|P2|Part II: Randomized Double Blind|Protocol deviation|1
85009|NCT00889863|299577|P1|Part II: Randomized Double Blind|Protocol deviation|0
85010|NCT00889863|299576|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
85011|NCT00889863|299577|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
85012|NCT00889863|299576|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
85013|NCT00889863|299577|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
85014|NCT00889863|299576|P2|Part II: Randomized Double Blind|Adverse Event|4
85015|NCT00889863|299577|P1|Part II: Randomized Double Blind|Adverse Event|0
85016|NCT00889863|299576|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
85017|NCT00889863|299577|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
85018|NCT00889863|299576|P2|Part I: Open Label|Adverse Event|0
85019|NCT00889863|299577|P1|Part I: Open Label|Adverse Event|4
85020|NCT00889863|299576|P2|Part I: Open Label|Death|0
85021|NCT00889863|299577|P1|Part I: Open Label|Death|1
85022|NCT00889720|299603|P1|Overall Study|Unspecified|4
85023|NCT00889720|299603|P1|Overall Study|Withdrawal by Subject|4
85024|NCT00889707|299630|P2|Overall Study|Lack of Efficacy|5
85025|NCT00889707|299631|P1|Overall Study|Lack of Efficacy|2
85026|NCT00889707|299630|P2|Overall Study|Lost to Follow-up|2
85027|NCT00889707|299631|P1|Overall Study|Lost to Follow-up|0
85028|NCT00889707|299630|P2|Overall Study|Withdrawal by Subject|3
85029|NCT00889707|299631|P1|Overall Study|Withdrawal by Subject|4
85030|NCT00889707|299630|P2|Overall Study|Adverse Event|0
85031|NCT00889707|299631|P1|Overall Study|Adverse Event|1
85032|NCT00889681|299639|P1|Overall Study|Insurance disapproval|1
85033|NCT00889681|299639|P1|Overall Study|Not meeting qualification Criteria|2
85034|NCT00889603|299646|P1|Overall Study|Not Specified|4
85035|NCT00889603|299646|P1|Overall Study|No longer willing to participant in stud|4
85036|NCT00889603|299646|P1|Overall Study|Lost to Follow-up|19
85037|NCT00889603|299646|P1|Overall Study|Death|3
85038|NCT00889603|299646|P1|Overall Study|Adverse Event|7
85039|NCT00889421|299668|P1|Overall Study|Lack of Efficacy|3
85040|NCT00889265|299709|P1|Overall Study|Protocol Violation|1
85041|NCT00889265|299709|P1|Overall Study|Lost to Follow-up|5
85042|NCT00889265|299709|P1|Overall Study|Adverse Event|1
85043|NCT00889252|299716|P2|Overall Study|Protocol Violation|0
85044|NCT00889252|299717|P1|Overall Study|Protocol Violation|2
85045|NCT00889252|299716|P2|Overall Study|Withdrawal by Subject|0
85046|NCT00889252|299717|P1|Overall Study|Withdrawal by Subject|3
85047|NCT00889252|299716|P2|Overall Study|Adverse Event|4
85048|NCT00889252|299717|P1|Overall Study|Adverse Event|2
85049|NCT00888940|299771|P2|Overall Study|Randomized Not Treated|13
85050|NCT00888940|299772|P1|Overall Study|Randomized Not Treated|11
85051|NCT00888940|299771|P2|Overall Study|Lost to Follow-up|5
85052|NCT00888940|299772|P1|Overall Study|Lost to Follow-up|5
85053|NCT00888940|299771|P2|Overall Study|Adverse Event|3
85054|NCT00888940|299772|P1|Overall Study|Adverse Event|12
85055|NCT00888849|299782|P2|Overall Study|Lost to Follow-up|2
85056|NCT00888849|299783|P1|Overall Study|Lost to Follow-up|1
85057|NCT00888849|299782|P2|Overall Study|Death|7
85058|NCT00888849|299783|P1|Overall Study|Death|4
85059|NCT00888654|299793|P1|Overall Study|Stopped meds due to headaches|1
85060|NCT00888654|299793|P1|Overall Study|Change in surg date|1
85061|NCT00888654|299793|P1|Overall Study|Inelig. due to contraindication of med|1
85062|NCT00888654|299793|P1|Overall Study|Withdrawal by Subject|1
85063|NCT00888654|299793|P1|Overall Study|Surgery aborted|2
85064|NCT00888654|299793|P1|Overall Study|Not enough oral meds before surgery|3
85065|NCT00888654|299793|P1|Overall Study|Problems swallowing oral meds.|1
85066|NCT00888433|299812|P2|Overall Study|Missed Visit|1
85067|NCT00888433|299813|P1|Overall Study|Missed Visit|2
85068|NCT00888433|299812|P2|Overall Study|Withdrawal by Subject|2
85069|NCT00888433|299813|P1|Overall Study|Withdrawal by Subject|1
85070|NCT00888381|299821|P2|Overall Study|Lost to Follow-up|1
85071|NCT00888381|299822|P1|Overall Study|Lost to Follow-up|0
85072|NCT00888355|299842|P4|Overall Study|Withdrawal by Subject|3
85073|NCT00888355|299843|P3|Overall Study|Withdrawal by Subject|1
85074|NCT00888355|299844|P2|Overall Study|Withdrawal by Subject|3
85075|NCT00888355|299845|P1|Overall Study|Withdrawal by Subject|0
85076|NCT00888355|299842|P4|Overall Study|Protocol Violation|2
85077|NCT00888355|299843|P3|Overall Study|Protocol Violation|1
85078|NCT00888355|299844|P2|Overall Study|Protocol Violation|2
85079|NCT00888355|299845|P1|Overall Study|Protocol Violation|3
85080|NCT00888355|299842|P4|Overall Study|Lost to Follow-up|0
85081|NCT00888355|299843|P3|Overall Study|Lost to Follow-up|2
85082|NCT00888355|299844|P2|Overall Study|Lost to Follow-up|2
85083|NCT00888355|299845|P1|Overall Study|Lost to Follow-up|0
85084|NCT00888355|299842|P4|Overall Study|Lack of Efficacy|2
85085|NCT00888355|299843|P3|Overall Study|Lack of Efficacy|5
85086|NCT00888355|299844|P2|Overall Study|Lack of Efficacy|2
85087|NCT00888355|299845|P1|Overall Study|Lack of Efficacy|9
85088|NCT00888355|299842|P4|Overall Study|Adverse Event|3
85089|NCT00888355|299843|P3|Overall Study|Adverse Event|3
85090|NCT00888355|299844|P2|Overall Study|Adverse Event|0
85091|NCT00888355|299845|P1|Overall Study|Adverse Event|10
85092|NCT00888329|299901|P2|Overall Study|Physician Decision|9
85093|NCT00888329|299902|P1|Overall Study|Physician Decision|6
85094|NCT00888238|299908|P3|Washout Period After Period 2|Adverse Event|1
85095|NCT00888238|299909|P2|Washout Period After Period 2|Adverse Event|0
85096|NCT00888238|299910|P1|Washout Period After Period 2|Adverse Event|0
85097|NCT00888134|299918|P1|Follow-up|being followed for long-term survival|1
85098|NCT00888134|299918|P1|Treatment With Study Drug|Withdrawal by Subject|1
85099|NCT00887978|299928|P2|Overall Study|Lost to Follow-up|1
85100|NCT00887978|299929|P1|Overall Study|Lost to Follow-up|0
85101|NCT00887978|299928|P2|Overall Study|Withdrawal by Subject|2
85102|NCT00887978|299929|P1|Overall Study|Withdrawal by Subject|1
85103|NCT00887978|299928|P2|Overall Study|Death|3
85104|NCT00887978|299929|P1|Overall Study|Death|2
85105|NCT00887978|299928|P2|Overall Study|Clinical Worsening|4
85106|NCT00887978|299929|P1|Overall Study|Clinical Worsening|4
85107|NCT00887978|299928|P2|Overall Study|Adverse Event|5
85108|NCT00887978|299929|P1|Overall Study|Adverse Event|18
85109|NCT00887913|299995|P1|Overall Study|Withdrawal by Subject|6
85110|NCT00887809|300003|P2|Overall Study|Death|0
85111|NCT00887809|300004|P1|Overall Study|Death|1
85112|NCT00887809|300003|P2|Overall Study|Patient Not Treated|0
85113|NCT00887809|300004|P1|Overall Study|Patient Not Treated|3
85114|NCT00887744|300010|P1|Overall Study|Various reasons|9
85115|NCT00887744|300010|P1|Overall Study|Withdrawal by Subject|18
85116|NCT00887744|300010|P1|Overall Study|Lost to Follow-up|3
85117|NCT00887744|300010|P1|Overall Study|Death|1
85118|NCT00887744|300010|P1|Overall Study|Adverse Event|3
85119|NCT00887679|300019|P1|Overall Study|Physician Decision|5
85120|NCT00887679|300019|P1|Overall Study|Lost to Follow-up|4
85121|NCT00887679|300019|P1|Overall Study|Withdrawal by Subject|1
85122|NCT00887588|300049|P2|Extension Period|Lost to Follow-up|0
85123|NCT00887588|300050|P1|Extension Period|Lost to Follow-up|1
85124|NCT00887588|300049|P2|Extension Period|Protocol deviation|0
85125|NCT00887588|300050|P1|Extension Period|Protocol deviation|1
85126|NCT00887588|300049|P2|Extension Period|Death|1
85127|NCT00887588|300050|P1|Extension Period|Death|0
85128|NCT00887588|300049|P2|Extension Period|Adverse Event|4
85129|NCT00887588|300050|P1|Extension Period|Adverse Event|4
85130|NCT00887588|300049|P2|Core Period|Adverse Event|11
85131|NCT00887588|300050|P1|Core Period|Adverse Event|9
85132|NCT00887588|300049|P2|Core Period|Withdrawal by Subject|8
85133|NCT00887588|300050|P1|Core Period|Withdrawal by Subject|6
85134|NCT00887588|300049|P2|Core Period|Lost to Follow-up|1
85135|NCT00887588|300050|P1|Core Period|Lost to Follow-up|3
85136|NCT00887588|300049|P2|Core Period|Death|1
85137|NCT00887588|300050|P1|Core Period|Death|1
85138|NCT00887549|300131|P1|Maintenance Therapy|Death due to adverse event|1
85139|NCT00887549|300131|P1|Maintenance Therapy|Progressive Disease|25
85140|NCT00887549|300131|P1|Maintenance Therapy|Physician Decision|1
85141|NCT00887549|300131|P1|Maintenance Therapy|Adverse Event|16
85142|NCT00887549|300131|P1|Induction Therapy|Death due to Study Drug Toxicity|1
85143|NCT00887549|300131|P1|Induction Therapy|Death due to Study Disease|4
85144|NCT00887549|300131|P1|Induction Therapy|Progressive Disease|13
85145|NCT00887549|300131|P1|Induction Therapy|Physician Decision|1
85146|NCT00887549|300131|P1|Induction Therapy|Adverse Event|8
85147|NCT00887484|300149|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
85148|NCT00887484|300149|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
85149|NCT00887484|300149|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
85150|NCT00887354|300235|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
85151|NCT00887354|300236|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
85152|NCT00887354|300235|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
85153|NCT00887354|300236|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
85154|NCT00887354|300235|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
85155|NCT00887354|300236|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
85156|NCT00887354|300235|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
85157|NCT00887354|300236|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
85158|NCT00887354|300235|P2|Open Label Phase (Week 26 to Week 78)|Death|2
85159|NCT00887354|300236|P1|Open Label Phase (Week 26 to Week 78)|Death|0
85160|NCT00887354|300235|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
85161|NCT00887354|300236|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
85162|NCT00887354|300235|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
85163|NCT00887354|300236|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
85164|NCT00887354|300235|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
85165|NCT00887354|300236|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
85166|NCT00887354|300235|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
85167|NCT00887354|300236|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
85168|NCT00887354|300235|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
85169|NCT00887354|300236|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
85170|NCT00887354|300235|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
85171|NCT00887354|300236|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
85172|NCT00887354|300235|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
85173|NCT00887354|300236|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
85174|NCT00887354|300235|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
85175|NCT00887354|300236|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
85176|NCT00887354|300235|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
85177|NCT00887354|300236|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
85178|NCT00887354|300235|P2|Treatment Phase (Week 0 to Week 26)|Death|1
85179|NCT00887354|300236|P1|Treatment Phase (Week 0 to Week 26)|Death|0
85180|NCT00887341|300256|P2|Overall Study|Lost to Follow-up|1
85181|NCT00887341|300257|P1|Overall Study|Lost to Follow-up|0
85182|NCT00887341|300256|P2|Overall Study|Adverse Event|1
85183|NCT00887341|300257|P1|Overall Study|Adverse Event|0
85184|NCT00887341|300256|P2|Overall Study|Withdrawal by Subject|1
85185|NCT00887341|300257|P1|Overall Study|Withdrawal by Subject|1
85186|NCT00887341|300256|P2|Overall Study|Refused treatment|0
85187|NCT00887341|300257|P1|Overall Study|Refused treatment|1
85188|NCT00887315|300293|P2|Overall Study|Study termination|4
85189|NCT00887315|300294|P1|Overall Study|Study termination|7
85190|NCT00887289|300302|P1|Overall Study|not specified|20
85191|NCT00887289|300302|P1|Overall Study|Lost to Follow-up|8
85192|NCT00887289|300302|P1|Overall Study|Withdrawal by Subject|26
85193|NCT00887289|300302|P1|Overall Study|Adverse Event|27
85194|NCT00887289|300302|P1|Overall Study|Lack of Efficacy|14
85195|NCT00887250|300314|P3|Overall Study|Patient uncooperative|1
85196|NCT00887250|300315|P2|Overall Study|Patient uncooperative|0
85197|NCT00887250|300316|P1|Overall Study|Patient uncooperative|0
85198|NCT00887250|300314|P3|Overall Study|Withdrawal by Subject|2
85199|NCT00887250|300315|P2|Overall Study|Withdrawal by Subject|1
85200|NCT00887250|300316|P1|Overall Study|Withdrawal by Subject|2
85201|NCT00887250|300314|P3|Overall Study|Protocol Violation|1
85202|NCT00887250|300315|P2|Overall Study|Protocol Violation|2
85203|NCT00887250|300316|P1|Overall Study|Protocol Violation|2
85204|NCT00887250|300314|P3|Overall Study|Lost to Follow-up|1
85205|NCT00887250|300315|P2|Overall Study|Lost to Follow-up|3
85206|NCT00887250|300316|P1|Overall Study|Lost to Follow-up|2
85207|NCT00887250|300314|P3|Overall Study|Lack of Efficacy|1
85208|NCT00887250|300315|P2|Overall Study|Lack of Efficacy|6
85209|NCT00887250|300316|P1|Overall Study|Lack of Efficacy|9
85210|NCT00887250|300314|P3|Overall Study|Adverse Event|7
85211|NCT00887250|300315|P2|Overall Study|Adverse Event|0
85212|NCT00887250|300316|P1|Overall Study|Adverse Event|3
85213|NCT00887224|300339|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
85214|NCT00887224|300340|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
85215|NCT00887224|300341|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
85216|NCT00887224|300339|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
85217|NCT00887224|300340|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
85218|NCT00887224|300341|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
85219|NCT00887224|300339|P3|DB Taper Phase / Post Study Follow Up|Unspecified|12
85220|NCT00887224|300340|P2|DB Taper Phase / Post Study Follow Up|Unspecified|11
85221|NCT00887224|300341|P1|DB Taper Phase / Post Study Follow Up|Unspecified|0
85222|NCT00887224|300339|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
85223|NCT00887224|300340|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
85224|NCT00887224|300341|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
85225|NCT00887224|300339|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
85226|NCT00887224|300340|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
85227|NCT00887224|300341|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
85228|NCT00887224|300339|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
85229|NCT00887224|300340|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
85230|NCT00887224|300341|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
85231|NCT00887224|300339|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
85232|NCT00887224|300340|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
85233|NCT00887224|300341|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
85234|NCT00887224|300339|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
85235|NCT00887224|300340|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
85236|NCT00887224|300341|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
85237|NCT00887224|300339|P3|Double-blind (DB) Phase|Protocol Violation|5
85238|NCT00887224|300340|P2|Double-blind (DB) Phase|Protocol Violation|8
85239|NCT00887224|300341|P1|Double-blind (DB) Phase|Protocol Violation|0
85240|NCT00887224|300339|P3|Double-blind (DB) Phase|Unspecified|0
85241|NCT00887224|300340|P2|Double-blind (DB) Phase|Unspecified|2
85242|NCT00887224|300341|P1|Double-blind (DB) Phase|Unspecified|0
85243|NCT00887224|300339|P3|Double-blind (DB) Phase|Lost to Follow-up|8
85244|NCT00887224|300340|P2|Double-blind (DB) Phase|Lost to Follow-up|8
85245|NCT00887224|300341|P1|Double-blind (DB) Phase|Lost to Follow-up|0
85246|NCT00887224|300339|P3|Double-blind (DB) Phase|Lack of Efficacy|33
85247|NCT00887224|300340|P2|Double-blind (DB) Phase|Lack of Efficacy|67
85248|NCT00887224|300341|P1|Double-blind (DB) Phase|Lack of Efficacy|0
85249|NCT00887224|300339|P3|Double-blind (DB) Phase|Failed to return|2
85250|NCT00887224|300340|P2|Double-blind (DB) Phase|Failed to return|2
85251|NCT00887224|300341|P1|Double-blind (DB) Phase|Failed to return|0
85252|NCT00887224|300339|P3|Double-blind (DB) Phase|Adverse Event|2
85253|NCT00887224|300340|P2|Double-blind (DB) Phase|Adverse Event|7
85254|NCT00887224|300341|P1|Double-blind (DB) Phase|Adverse Event|0
85255|NCT00887224|300339|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
85256|NCT00887224|300340|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
85257|NCT00887224|300341|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
85258|NCT00887224|300339|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
85259|NCT00887224|300340|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
85260|NCT00887224|300341|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
85261|NCT00887224|300339|P3|OL Taper Phase / OL Follow Up|Unspecified|0
85262|NCT00887224|300340|P2|OL Taper Phase / OL Follow Up|Unspecified|0
85263|NCT00887224|300341|P1|OL Taper Phase / OL Follow Up|Unspecified|30
85264|NCT00887224|300339|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
85265|NCT00887224|300340|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
85266|NCT00887224|300341|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
85267|NCT00887224|300339|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
85268|NCT00887224|300340|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
85269|NCT00887224|300341|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
85270|NCT00887224|300339|P3|OL Taper Phase / OL Follow Up|Failed to return|0
85271|NCT00887224|300340|P2|OL Taper Phase / OL Follow Up|Failed to return|0
85272|NCT00887224|300341|P1|OL Taper Phase / OL Follow Up|Failed to return|17
85273|NCT00887224|300339|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
85274|NCT00887224|300340|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
85275|NCT00887224|300341|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
85276|NCT00887224|300339|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
85277|NCT00887224|300340|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
85278|NCT00887224|300341|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
85279|NCT00887224|300339|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
85280|NCT00887224|300340|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
85281|NCT00887224|300341|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
85282|NCT00887224|300339|P3|Open-label Stability (OLS) Phase|Unspecified|0
85283|NCT00887224|300340|P2|Open-label Stability (OLS) Phase|Unspecified|0
85284|NCT00887224|300341|P1|Open-label Stability (OLS) Phase|Unspecified|1
85285|NCT00887224|300339|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
85286|NCT00887224|300340|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
85287|NCT00887224|300341|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
85288|NCT00887224|300339|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
85289|NCT00887224|300340|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
85290|NCT00887224|300341|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
85291|NCT00887224|300339|P3|Open-label Stability (OLS) Phase|Failed to return|0
85292|NCT00887224|300340|P2|Open-label Stability (OLS) Phase|Failed to return|0
85293|NCT00887224|300341|P1|Open-label Stability (OLS) Phase|Failed to return|3
85294|NCT00887224|300339|P3|Open-label Stability (OLS) Phase|Adverse Event|0
85295|NCT00887224|300340|P2|Open-label Stability (OLS) Phase|Adverse Event|0
85296|NCT00887224|300341|P1|Open-label Stability (OLS) Phase|Adverse Event|22
85297|NCT00887224|300339|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
85298|NCT00887224|300340|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
85299|NCT00887224|300341|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
85300|NCT00887224|300339|P3|Open-label Response (OLR) Phase|Protocol Violation|0
85301|NCT00887224|300340|P2|Open-label Response (OLR) Phase|Protocol Violation|0
85302|NCT00887224|300341|P1|Open-label Response (OLR) Phase|Protocol Violation|12
85303|NCT00887224|300339|P3|Open-label Response (OLR) Phase|Unspecified|0
85304|NCT00887224|300340|P2|Open-label Response (OLR) Phase|Unspecified|0
85305|NCT00887224|300341|P1|Open-label Response (OLR) Phase|Unspecified|1
85306|NCT00887224|300339|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
85307|NCT00887224|300340|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
85308|NCT00887224|300341|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
85309|NCT00887224|300339|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
85310|NCT00887224|300340|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
85311|NCT00887224|300341|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
85312|NCT00887224|300339|P3|Open-label Response (OLR) Phase|Failed to return|0
85313|NCT00887224|300340|P2|Open-label Response (OLR) Phase|Failed to return|0
85314|NCT00887224|300341|P1|Open-label Response (OLR) Phase|Failed to return|6
85315|NCT00887224|300339|P3|Open-label Response (OLR) Phase|Adverse Event|0
85316|NCT00887224|300340|P2|Open-label Response (OLR) Phase|Adverse Event|0
85317|NCT00887224|300341|P1|Open-label Response (OLR) Phase|Adverse Event|46
85318|NCT00887198|300368|P2|Overall Study|Lost to Follow-up|3
85319|NCT00887198|300369|P1|Overall Study|Lost to Follow-up|4
85320|NCT00887198|300368|P2|Overall Study|Withdrawal by Subject|41
85321|NCT00887198|300369|P1|Overall Study|Withdrawal by Subject|28
85322|NCT00887198|300368|P2|Overall Study|Death|387
85323|NCT00887198|300369|P1|Overall Study|Death|352
85324|NCT00887159|300400|P3|Overall Study|Never started assigned therapy|4
85325|NCT00887159|300401|P2|Overall Study|Never started assigned therapy|3
85326|NCT00887159|300402|P1|Overall Study|Never started assigned therapy|3
85327|NCT00887159|300400|P3|Overall Study|Ineligible|0
85328|NCT00887159|300401|P2|Overall Study|Ineligible|1
85329|NCT00887159|300402|P1|Overall Study|Ineligible|5
85330|NCT00887159|300400|P3|Overall Study|Received more tx instead of observation|0
85331|NCT00887159|300401|P2|Overall Study|Received more tx instead of observation|0
85332|NCT00887159|300402|P1|Overall Study|Received more tx instead of observation|1
85333|NCT00887159|300400|P3|Overall Study|Pt had PD but was SD when re-measured|0
85334|NCT00887159|300401|P2|Overall Study|Pt had PD but was SD when re-measured|1
85335|NCT00887159|300402|P1|Overall Study|Pt had PD but was SD when re-measured|0
85336|NCT00887159|300400|P3|Overall Study|Treatment delayed|0
85337|NCT00887159|300401|P2|Overall Study|Treatment delayed|1
85338|NCT00887159|300402|P1|Overall Study|Treatment delayed|1
85339|NCT00887159|300400|P3|Overall Study|Sympomatic deterioration|0
85340|NCT00887159|300401|P2|Overall Study|Sympomatic deterioration|0
85341|NCT00887159|300402|P1|Overall Study|Sympomatic deterioration|1
85342|NCT00887159|300400|P3|Overall Study|Physician Decision|0
85343|NCT00887159|300401|P2|Overall Study|Physician Decision|1
85344|NCT00887159|300402|P1|Overall Study|Physician Decision|1
85345|NCT00887159|300400|P3|Overall Study|Alternative therapy|0
85346|NCT00887159|300401|P2|Overall Study|Alternative therapy|0
85347|NCT00887159|300402|P1|Overall Study|Alternative therapy|2
85348|NCT00887159|300400|P3|Overall Study|Withdrawal by Subject|2
85349|NCT00887159|300401|P2|Overall Study|Withdrawal by Subject|4
85350|NCT00887159|300402|P1|Overall Study|Withdrawal by Subject|4
85351|NCT00887159|300400|P3|Overall Study|Death|0
85352|NCT00887159|300401|P2|Overall Study|Death|2
85353|NCT00887159|300402|P1|Overall Study|Death|2
85354|NCT00887159|300400|P3|Overall Study|Adverse Event|17
85355|NCT00887159|300401|P2|Overall Study|Adverse Event|4
85356|NCT00887159|300402|P1|Overall Study|Adverse Event|3
85357|NCT00887159|300400|P3|Overall Study|Disease progression|33
85358|NCT00887159|300401|P2|Overall Study|Disease progression|39
85359|NCT00887159|300402|P1|Overall Study|Disease progression|6
85360|NCT00886938|300418|P1|Overall Study|Withdrawal by Subject|1
85361|NCT00886938|300418|P1|Overall Study|Adverse Event|1
85362|NCT00886834|300431|P2|Overall Study|Protocol Violation|3
85363|NCT00886834|300432|P1|Overall Study|Protocol Violation|0
85364|NCT00886795|300440|P1|Overall Study|Lack of Efficacy|1
85365|NCT00886769|300447|P2|Overall Study|Unsatisfactory therapeutic effect|37
85366|NCT00886769|300448|P1|Overall Study|Unsatisfactory therapeutic effect|6
85367|NCT00886639|300483|P1|Overall Study|non-compliance|2
85368|NCT00886639|300483|P1|Overall Study|acute exacerbation|14
85369|NCT00886613|300497|P3|Overall Study|Subject withdrew consent (Part A)|2
85370|NCT00886613|300498|P2|Overall Study|Subject withdrew consent (Part A)|0
85371|NCT00886613|300499|P1|Overall Study|Subject withdrew consent (Part A)|0
85372|NCT00886613|300497|P3|Overall Study|Lost to follow-up (Part B)|1
85373|NCT00886613|300498|P2|Overall Study|Lost to follow-up (Part B)|0
85374|NCT00886613|300499|P1|Overall Study|Lost to follow-up (Part B)|1
85375|NCT00886613|300497|P3|Overall Study|Protocol deviation (Part B)|0
85376|NCT00886613|300498|P2|Overall Study|Protocol deviation (Part B)|0
85377|NCT00886613|300499|P1|Overall Study|Protocol deviation (Part B)|1
85378|NCT00886600|300521|P4|Combination Therapy Period|Protocol Violation|0
85379|NCT00886600|300522|P3|Combination Therapy Period|Protocol Violation|1
85380|NCT00886600|300523|P2|Combination Therapy Period|Protocol Violation|0
85381|NCT00886600|300524|P1|Combination Therapy Period|Protocol Violation|0
85382|NCT00886600|300521|P4|Combination Therapy Period|Adverse Event|0
85383|NCT00886600|300522|P3|Combination Therapy Period|Adverse Event|1
85384|NCT00886600|300523|P2|Combination Therapy Period|Adverse Event|0
85385|NCT00886600|300524|P1|Combination Therapy Period|Adverse Event|0
85386|NCT00886600|300521|P4|Double-blind Monotherapy|Withdrawal by Subject|0
85387|NCT00886600|300522|P3|Double-blind Monotherapy|Withdrawal by Subject|0
85388|NCT00886600|300523|P2|Double-blind Monotherapy|Withdrawal by Subject|0
85389|NCT00886600|300524|P1|Double-blind Monotherapy|Withdrawal by Subject|1
85390|NCT00886600|300521|P4|Double-blind Monotherapy|Protocol Violation|1
85391|NCT00886600|300522|P3|Double-blind Monotherapy|Protocol Violation|0
85392|NCT00886600|300523|P2|Double-blind Monotherapy|Protocol Violation|0
85393|NCT00886600|300524|P1|Double-blind Monotherapy|Protocol Violation|0
85394|NCT00886600|300521|P4|Double-blind Monotherapy|Adverse Event|1
85395|NCT00886600|300522|P3|Double-blind Monotherapy|Adverse Event|1
85396|NCT00886600|300523|P2|Double-blind Monotherapy|Adverse Event|1
85397|NCT00886600|300524|P1|Double-blind Monotherapy|Adverse Event|1
85398|NCT00886483|300548|P2|Overall Study|Distance to center, poor grades|0
85399|NCT00886483|300549|P1|Overall Study|Distance to center, poor grades|1
85400|NCT00886483|300548|P2|Overall Study|Pursue medications|2
85401|NCT00886483|300549|P1|Overall Study|Pursue medications|1
85402|NCT00886483|300548|P2|Overall Study|Lost to Follow-up|1
85403|NCT00886483|300549|P1|Overall Study|Lost to Follow-up|0
85404|NCT00886340|300567|P2|Overall Study|Withdrawal by Subject|7
85405|NCT00886340|300568|P1|Overall Study|Withdrawal by Subject|0
85406|NCT00886288|300576|P2|Overall Study|Lost to Follow-up|0
85407|NCT00886288|300577|P1|Overall Study|Lost to Follow-up|86
85408|NCT00886288|300576|P2|Overall Study|no respect of the 12 weeks period|227
85409|NCT00886288|300577|P1|Overall Study|no respect of the 12 weeks period|657
85410|NCT00886119|300599|P2|Period 1|Did not meet inclusion criteria|0
85411|NCT00886119|300600|P1|Period 1|Did not meet inclusion criteria|1
85412|NCT00885846|300609|P3|Overall Study|Withdrawal by Subject|2
85413|NCT00885846|300610|P2|Overall Study|Withdrawal by Subject|5
85414|NCT00885846|300611|P1|Overall Study|Withdrawal by Subject|2
85415|NCT00885755|300626|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
85416|NCT00885755|300627|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
85417|NCT00885755|300628|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
85418|NCT00885755|300626|P3|Part I: Trastuzumab+Taxane|Death|1
85419|NCT00885755|300627|P2|Part I: Trastuzumab+Taxane|Death|0
85420|NCT00885755|300628|P1|Part I: Trastuzumab+Taxane|Death|0
85421|NCT00885755|300626|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
85422|NCT00885755|300627|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
85423|NCT00885755|300628|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
85424|NCT00885755|300626|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
85425|NCT00885755|300627|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
85426|NCT00885755|300628|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
85427|NCT00885755|300626|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
85428|NCT00885755|300627|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
85429|NCT00885755|300628|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
85430|NCT00885534|300672|P1|Overall Study|Patient deemed ineligible|1
85431|NCT00885482|300676|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
85432|NCT00885482|300676|P1|Overall Study|Death|1
85433|NCT00885482|300676|P1|Overall Study|Lack of Efficacy|1
85434|NCT00885482|300676|P1|Overall Study|Pregnancy|1
85435|NCT00885378|300682|P2|Overall Study|Protocol Violation|0
85436|NCT00885378|300683|P1|Overall Study|Protocol Violation|2
85437|NCT00885378|300682|P2|Overall Study|Poor/Noncompliance|2
85438|NCT00885378|300683|P1|Overall Study|Poor/Noncompliance|2
85439|NCT00885378|300682|P2|Overall Study|Lost to Follow-up|2
85440|NCT00885378|300683|P1|Overall Study|Lost to Follow-up|1
85441|NCT00885378|300682|P2|Overall Study|Withdrawal by Subject|2
85442|NCT00885378|300683|P1|Overall Study|Withdrawal by Subject|1
85443|NCT00885378|300682|P2|Overall Study|Lack of Efficacy|2
85444|NCT00885378|300683|P1|Overall Study|Lack of Efficacy|2
85445|NCT00885365|300713|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
85446|NCT00885365|300714|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
85447|NCT00885365|300713|P2|4 Weeks ON Treatment|Protocol Violation|2
85448|NCT00885365|300714|P1|4 Weeks ON Treatment|Protocol Violation|1
85449|NCT00885365|300713|P2|4 Weeks ON Treatment|Adverse Event|4
85450|NCT00885365|300714|P1|4 Weeks ON Treatment|Adverse Event|2
85451|NCT00885352|300750|P2|Overall Study|Lab abnormalities|1
85452|NCT00885352|300751|P1|Overall Study|Lab abnormalities|1
85453|NCT00885352|300750|P2|Overall Study|Excluded medication|2
85454|NCT00885352|300751|P1|Overall Study|Excluded medication|2
85455|NCT00885352|300750|P2|Overall Study|Contradiction to study medication|2
85456|NCT00885352|300751|P1|Overall Study|Contradiction to study medication|0
85457|NCT00885352|300750|P2|Overall Study|Withdrawal by Subject|5
85458|NCT00885352|300751|P1|Overall Study|Withdrawal by Subject|1
85459|NCT00885352|300750|P2|Overall Study|Protocol Violation|2
85460|NCT00885352|300751|P1|Overall Study|Protocol Violation|0
85461|NCT00885352|300750|P2|Overall Study|Physician Decision|3
85462|NCT00885352|300751|P1|Overall Study|Physician Decision|0
85463|NCT00885352|300750|P2|Overall Study|Lost to Follow-up|2
85464|NCT00885352|300751|P1|Overall Study|Lost to Follow-up|2
85465|NCT00885352|300750|P2|Overall Study|Adverse Event|3
85466|NCT00885352|300751|P1|Overall Study|Adverse Event|2
85467|NCT00885118|300766|P5|Overall Study|Other reason not defined above|0
85468|NCT00885118|300767|P4|Overall Study|Other reason not defined above|0
85469|NCT00885118|300768|P3|Overall Study|Other reason not defined above|1
85470|NCT00885118|300769|P2|Overall Study|Other reason not defined above|0
85471|NCT00885118|300770|P1|Overall Study|Other reason not defined above|0
85472|NCT00885118|300766|P5|Overall Study|Withdrawal by Subject|1
85473|NCT00885118|300767|P4|Overall Study|Withdrawal by Subject|0
85474|NCT00885118|300768|P3|Overall Study|Withdrawal by Subject|0
85475|NCT00885118|300769|P2|Overall Study|Withdrawal by Subject|0
85476|NCT00885118|300770|P1|Overall Study|Withdrawal by Subject|0
85477|NCT00885118|300766|P5|Overall Study|Adverse Event|0
85478|NCT00885118|300767|P4|Overall Study|Adverse Event|0
85479|NCT00885118|300768|P3|Overall Study|Adverse Event|0
85480|NCT00885118|300769|P2|Overall Study|Adverse Event|0
85481|NCT00885118|300770|P1|Overall Study|Adverse Event|1
85482|NCT00885105|300909|P2|Overall Study|Protocol Violation|2
85483|NCT00885105|300910|P1|Overall Study|Protocol Violation|0
85484|NCT00885105|300909|P2|Overall Study|Adverse Event|0
85485|NCT00885105|300910|P1|Overall Study|Adverse Event|1
85486|NCT00885105|300909|P2|Overall Study|Withdrawal by Subject|8
85487|NCT00885105|300910|P1|Overall Study|Withdrawal by Subject|0
85488|NCT00884949|300950|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
85489|NCT00884949|300950|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
85490|NCT00884832|300974|P2|Overall Study|Withdrawal by Subject|1
85491|NCT00884832|300975|P1|Overall Study|Withdrawal by Subject|0
85492|NCT00884793|301010|P1|Overall Study|Withdrawal by Subject|1
85493|NCT00884741|301029|P4|Randomization|Protocol Violation|8
85494|NCT00884741|301030|P3|Randomization|Protocol Violation|8
85495|NCT00884741|301031|P2|Randomization|Protocol Violation|0
85496|NCT00884741|301032|P1|Randomization|Protocol Violation|0
85497|NCT00884741|301029|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
85498|NCT00884741|301030|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
85499|NCT00884741|301031|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
85500|NCT00884741|301032|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
85501|NCT00884741|301029|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
85502|NCT00884741|301030|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
85503|NCT00884741|301031|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
85504|NCT00884741|301032|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
85505|NCT00884741|301029|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
85506|NCT00884741|301030|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
85507|NCT00884741|301031|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
85508|NCT00884741|301032|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
85509|NCT00884741|301029|P4|Step 2 Registration: Tissue Analysis|Death|0
85510|NCT00884741|301030|P3|Step 2 Registration: Tissue Analysis|Death|0
85511|NCT00884741|301031|P2|Step 2 Registration: Tissue Analysis|Death|1
85512|NCT00884741|301032|P1|Step 2 Registration: Tissue Analysis|Death|0
85513|NCT00884741|301029|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
85514|NCT00884741|301030|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
85515|NCT00884741|301031|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
85516|NCT00884741|301032|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
85517|NCT00884741|301029|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
85518|NCT00884741|301030|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
85519|NCT00884741|301031|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
85520|NCT00884741|301032|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
85521|NCT00884741|301029|P4|Step 1 Registration: Tissue Screening|Disease progression|0
85522|NCT00884741|301030|P3|Step 1 Registration: Tissue Screening|Disease progression|0
85523|NCT00884741|301031|P2|Step 1 Registration: Tissue Screening|Disease progression|0
85524|NCT00884741|301032|P1|Step 1 Registration: Tissue Screening|Disease progression|12
85525|NCT00884741|301029|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
85526|NCT00884741|301030|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
85527|NCT00884741|301031|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
85528|NCT00884741|301032|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
85529|NCT00884741|301029|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
85530|NCT00884741|301030|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
85531|NCT00884741|301031|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
85532|NCT00884741|301032|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
85533|NCT00884741|301029|P4|Step 1 Registration: Tissue Screening|Death|0
85534|NCT00884741|301030|P3|Step 1 Registration: Tissue Screening|Death|0
85535|NCT00884741|301031|P2|Step 1 Registration: Tissue Screening|Death|0
85536|NCT00884741|301032|P1|Step 1 Registration: Tissue Screening|Death|3
85537|NCT00884741|301029|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
85538|NCT00884741|301030|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
85539|NCT00884741|301031|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
85540|NCT00884741|301032|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
85541|NCT00884390|301060|P2|Overall Study|Not specified|1
85542|NCT00884390|301061|P1|Overall Study|Not specified|11
85543|NCT00884390|301060|P2|Overall Study|Discontinuation of Study by Sponsor|2
85544|NCT00884390|301061|P1|Overall Study|Discontinuation of Study by Sponsor|2
85545|NCT00884390|301060|P2|Overall Study|Withdrawal by Subject|1
85546|NCT00884390|301061|P1|Overall Study|Withdrawal by Subject|4
85547|NCT00884390|301060|P2|Overall Study|Protocol Violation|1
85548|NCT00884390|301061|P1|Overall Study|Protocol Violation|4
85549|NCT00884390|301060|P2|Overall Study|Physician Decision|1
85550|NCT00884390|301061|P1|Overall Study|Physician Decision|2
85551|NCT00884390|301060|P2|Overall Study|Lost to Follow-up|1
85552|NCT00884390|301061|P1|Overall Study|Lost to Follow-up|0
85553|NCT00884390|301060|P2|Overall Study|Adverse Event|1
85554|NCT00884390|301061|P1|Overall Study|Adverse Event|0
85555|NCT00884325|301079|P2|Overall Study|Not provided|0
85556|NCT00884325|301080|P1|Overall Study|Not provided|1
85557|NCT00884325|301079|P2|Overall Study|Withdrawal by Subject|1
85558|NCT00884325|301080|P1|Overall Study|Withdrawal by Subject|1
85559|NCT00884325|301079|P2|Overall Study|Lack of Efficacy|1
85560|NCT00884325|301080|P1|Overall Study|Lack of Efficacy|0
85561|NCT00884325|301079|P2|Overall Study|Lost to Follow-up|2
85562|NCT00884325|301080|P1|Overall Study|Lost to Follow-up|1
85563|NCT00884273|301090|P2|Overall Study|Practical reasons|0
85564|NCT00884273|301091|P1|Overall Study|Practical reasons|1
85565|NCT00884273|301090|P2|Overall Study|Protocol Violation|3
85566|NCT00884273|301091|P1|Overall Study|Protocol Violation|1
85567|NCT00884273|301090|P2|Overall Study|Adverse Event|2
85568|NCT00884273|301091|P1|Overall Study|Adverse Event|0
85569|NCT00884221|301117|P2|Overall Study|Cancellation of Cycle and Other Reason|13
85570|NCT00884221|301118|P1|Overall Study|Cancellation of Cycle and Other Reason|12
85571|NCT00884221|301117|P2|Overall Study|Protocol Violation|13
85572|NCT00884221|301118|P1|Overall Study|Protocol Violation|16
85573|NCT00884221|301117|P2|Overall Study|Adverse Event|3
85574|NCT00884221|301118|P1|Overall Study|Adverse Event|6
85575|NCT00884221|301117|P2|Overall Study|Withdrawal by Subject|3
85576|NCT00884221|301118|P1|Overall Study|Withdrawal by Subject|0
85577|NCT00884117|301154|P1|Overall Study|Not Specified|12
85578|NCT00884117|301154|P1|Overall Study|Lost to Follow-up|143
85579|NCT00884117|301154|P1|Overall Study|Death|3
85580|NCT00884117|301154|P1|Overall Study|Withdrawal by Subject|89
85581|NCT00884117|301154|P1|Overall Study|Adverse Event|2
85582|NCT00884039|301217|P2|Overall Study|Lack of Efficacy|0
85583|NCT00884039|301218|P1|Overall Study|Lack of Efficacy|2
85584|NCT00884039|301217|P2|Overall Study|Withdrawal by Subject|1
85585|NCT00884039|301218|P1|Overall Study|Withdrawal by Subject|0
85586|NCT00883779|301226|P2|Off-study Phase|Unspecified|21
85587|NCT00883779|301227|P1|Off-study Phase|Unspecified|18
85588|NCT00883779|301226|P2|Off-study Phase|Failure to return|6
85589|NCT00883779|301227|P1|Off-study Phase|Failure to return|5
85590|NCT00883779|301226|P2|Off-study Phase|Refused treatment|1
85591|NCT00883779|301227|P1|Off-study Phase|Refused treatment|1
85592|NCT00883779|301226|P2|Off-study Phase|Death|174
85593|NCT00883779|301227|P1|Off-study Phase|Death|185
85594|NCT00883779|301226|P2|Post-Study Treatment Phase|Ongoing in the study|6
85595|NCT00883779|301227|P1|Post-Study Treatment Phase|Ongoing in the study|0
85596|NCT00883779|301226|P2|Post-Study Treatment Phase|Unspecified|0
85597|NCT00883779|301227|P1|Post-Study Treatment Phase|Unspecified|3
85598|NCT00883779|301226|P2|Post-Study Treatment Phase|Disease progression|122
85599|NCT00883779|301227|P1|Post-Study Treatment Phase|Disease progression|103
85600|NCT00883779|301226|P2|Post-Study Treatment Phase|Refused Treatment|0
85601|NCT00883779|301227|P1|Post-Study Treatment Phase|Refused Treatment|3
85602|NCT00883779|301226|P2|Post-Study Treatment Phase|Protocol Violation|1
85603|NCT00883779|301227|P1|Post-Study Treatment Phase|Protocol Violation|0
85604|NCT00883779|301226|P2|Post-Study Treatment Phase|Death|3
85605|NCT00883779|301227|P1|Post-Study Treatment Phase|Death|1
85606|NCT00883779|301226|P2|Post-Study Treatment Phase|Adverse Event|3
85607|NCT00883779|301227|P1|Post-Study Treatment Phase|Adverse Event|2
85608|NCT00883779|301226|P2|Primary Study Treatment Phase|Unspecified|0
85609|NCT00883779|301227|P1|Primary Study Treatment Phase|Unspecified|3
85610|NCT00883779|301226|P2|Primary Study Treatment Phase|Refused Treatment|4
85611|NCT00883779|301227|P1|Primary Study Treatment Phase|Refused Treatment|5
85612|NCT00883779|301226|P2|Primary Study Treatment Phase|Death|3
85613|NCT00883779|301227|P1|Primary Study Treatment Phase|Death|2
85614|NCT00883779|301226|P2|Primary Study Treatment Phase|Adverse Event|16
85615|NCT00883779|301227|P1|Primary Study Treatment Phase|Adverse Event|16
85616|NCT00883779|301226|P2|Primary Study Treatment Phase|Disease progression|59
85617|NCT00883779|301227|P1|Primary Study Treatment Phase|Disease progression|75
85618|NCT00883779|301226|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
85619|NCT00883779|301227|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
85620|NCT00883753|301263|P1|Overall Study|Administrative/Other|8
85621|NCT00883753|301263|P1|Overall Study|Investigator's decision|17
85622|NCT00883753|301263|P1|Overall Study|Withdrew consent|10
85623|NCT00883753|301263|P1|Overall Study|Refused treatment|4
85624|NCT00883753|301263|P1|Overall Study|Protocol Violation|2
85625|NCT00883753|301263|P1|Overall Study|Violation of selection criteria at entry|7
85626|NCT00883753|301263|P1|Overall Study|Lost to Follow-up|4
85627|NCT00883753|301263|P1|Overall Study|Insufficient therapeutic response|16
85628|NCT00883753|301263|P1|Overall Study|Death|2
85629|NCT00883753|301263|P1|Overall Study|Adverse Event|37
85630|NCT00883740|301303|P2|Second Intervention|No longer willing to participate|1
85631|NCT00883740|301304|P1|Second Intervention|No longer willing to participate|0
85632|NCT00883740|301303|P2|Second Intervention|Protocol Violation|0
85633|NCT00883740|301304|P1|Second Intervention|Protocol Violation|1
85634|NCT00883740|301303|P2|First Intervention|Adverse Event|2
85635|NCT00883740|301304|P1|First Intervention|Adverse Event|1
85636|NCT00883740|301303|P2|First Intervention|Protocol Violation|6
85637|NCT00883740|301304|P1|First Intervention|Protocol Violation|3
85638|NCT00883740|301303|P2|First Intervention|No longer willing to participate|0
85639|NCT00883740|301304|P1|First Intervention|No longer willing to participate|2
85640|NCT00883740|301303|P2|First Intervention|Lost to Follow-up|0
85641|NCT00883740|301304|P1|First Intervention|Lost to Follow-up|1
85642|NCT00883558|301348|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
85643|NCT00883558|301349|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
85644|NCT00883558|301350|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
85645|NCT00883558|301348|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
85646|NCT00883558|301349|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
85647|NCT00883558|301350|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
85648|NCT00883558|301348|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
85649|NCT00883558|301349|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
85650|NCT00883558|301350|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
85651|NCT00883558|301348|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
85652|NCT00883558|301349|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
85653|NCT00883558|301350|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
85654|NCT00883558|301348|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
85655|NCT00883558|301349|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
85656|NCT00883558|301350|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
85657|NCT00883493|301362|P2|Overall Study|Not specified|3
85658|NCT00883493|301363|P1|Overall Study|Not specified|5
85659|NCT00883493|301362|P2|Overall Study|Study specific disc. criteria|0
85660|NCT00883493|301363|P1|Overall Study|Study specific disc. criteria|2
85661|NCT00883493|301362|P2|Overall Study|Eligibility Criteria not fullfilled|6
85662|NCT00883493|301363|P1|Overall Study|Eligibility Criteria not fullfilled|6
85663|NCT00883493|301362|P2|Overall Study|Withdrawal by Subject|20
85664|NCT00883493|301363|P1|Overall Study|Withdrawal by Subject|11
85665|NCT00883493|301362|P2|Overall Study|Lost to Follow-up|6
85666|NCT00883493|301363|P1|Overall Study|Lost to Follow-up|7
85667|NCT00883493|301362|P2|Overall Study|Lack of Efficacy|3
85668|NCT00883493|301363|P1|Overall Study|Lack of Efficacy|4
85669|NCT00883493|301362|P2|Overall Study|Adverse Event|12
85670|NCT00883493|301363|P1|Overall Study|Adverse Event|11
85671|NCT00883337|301394|P3|Extension Treatment Period|Other than above|5
85672|NCT00883337|301395|P2|Extension Treatment Period|Other than above|9
85673|NCT00883337|301396|P1|Extension Treatment Period|Other than above|10
85674|NCT00883337|301394|P3|Extension Treatment Period|Lost to Follow-up|0
85675|NCT00883337|301395|P2|Extension Treatment Period|Lost to Follow-up|0
85676|NCT00883337|301396|P1|Extension Treatment Period|Lost to Follow-up|1
85677|NCT00883337|301394|P3|Extension Treatment Period|Poor compliance to protocol|1
85678|NCT00883337|301395|P2|Extension Treatment Period|Poor compliance to protocol|1
85679|NCT00883337|301396|P1|Extension Treatment Period|Poor compliance to protocol|1
85680|NCT00883337|301394|P3|Extension Treatment Period|Lack of Efficacy|8
85681|NCT00883337|301395|P2|Extension Treatment Period|Lack of Efficacy|8
85682|NCT00883337|301396|P1|Extension Treatment Period|Lack of Efficacy|8
85683|NCT00883337|301394|P3|Extension Treatment Period|Adverse Event|5
85684|NCT00883337|301395|P2|Extension Treatment Period|Adverse Event|5
85685|NCT00883337|301396|P1|Extension Treatment Period|Adverse Event|8
85686|NCT00883337|301394|P3|Core Treatment Period|Other than above|1
85687|NCT00883337|301395|P2|Core Treatment Period|Other than above|1
85688|NCT00883337|301396|P1|Core Treatment Period|Other than above|0
85689|NCT00883337|301394|P3|Core Treatment Period|Poor compliance to protocol|1
85690|NCT00883337|301395|P2|Core Treatment Period|Poor compliance to protocol|0
85691|NCT00883337|301396|P1|Core Treatment Period|Poor compliance to protocol|0
85692|NCT00883337|301394|P3|Core Treatment Period|Wish to be pregnant|1
85693|NCT00883337|301395|P2|Core Treatment Period|Wish to be pregnant|2
85694|NCT00883337|301396|P1|Core Treatment Period|Wish to be pregnant|1
85695|NCT00883337|301394|P3|Core Treatment Period|Withdrawal by Subject|6
85696|NCT00883337|301395|P2|Core Treatment Period|Withdrawal by Subject|2
85697|NCT00883337|301396|P1|Core Treatment Period|Withdrawal by Subject|2
85698|NCT00883337|301394|P3|Core Treatment Period|Lost to Follow-up|0
85699|NCT00883337|301395|P2|Core Treatment Period|Lost to Follow-up|1
85700|NCT00883337|301396|P1|Core Treatment Period|Lost to Follow-up|1
85701|NCT00883337|301394|P3|Core Treatment Period|Lack of Efficacy|2
85702|NCT00883337|301395|P2|Core Treatment Period|Lack of Efficacy|4
85703|NCT00883337|301396|P1|Core Treatment Period|Lack of Efficacy|7
85704|NCT00883337|301394|P3|Core Treatment Period|Adverse Event|22
85705|NCT00883337|301395|P2|Core Treatment Period|Adverse Event|12
85706|NCT00883337|301396|P1|Core Treatment Period|Adverse Event|9
85707|NCT00883181|301463|P1|Overall Study|Noncompliance|3
85708|NCT00883181|301463|P1|Overall Study|Protocol Deviation|3
85709|NCT00883181|301463|P1|Overall Study|Other|38
85710|NCT00883181|301463|P1|Overall Study|Death|31
85711|NCT00883181|301463|P1|Overall Study|Withdrawal by Subject|4
85712|NCT00883181|301463|P1|Overall Study|Administrative Reason|24
85713|NCT00883181|301463|P1|Overall Study|Disease Progression|94
85714|NCT00883181|301463|P1|Overall Study|Non-hematological Adverse Event|55
85715|NCT00883181|301463|P1|Overall Study|Hematological Adverse Event|26
85716|NCT00883129|301699|P2|Overall Study|Defined Treatment Failure|2
85717|NCT00883129|301700|P1|Overall Study|Defined Treatment Failure|0
85718|NCT00883129|301699|P2|Overall Study|Death|2
85719|NCT00883129|301700|P1|Overall Study|Death|1
85720|NCT00883129|301699|P2|Overall Study|Lost to Follow-up|2
85721|NCT00883129|301700|P1|Overall Study|Lost to Follow-up|1
85722|NCT00883129|301699|P2|Overall Study|Non-compliance|6
85723|NCT00883129|301700|P1|Overall Study|Non-compliance|3
85724|NCT00883129|301699|P2|Overall Study|Withdrawal by Subject|9
85725|NCT00883129|301700|P1|Overall Study|Withdrawal by Subject|8
85726|NCT00883129|301699|P2|Overall Study|Adverse Event|15
85727|NCT00883129|301700|P1|Overall Study|Adverse Event|7
85728|NCT00883116|301724|P2|Overall Study|No longer meets study criteria|2
85729|NCT00883116|301725|P1|Overall Study|No longer meets study criteria|2
85730|NCT00883116|301724|P2|Overall Study|Withdrawal by Subject|8
85731|NCT00883116|301725|P1|Overall Study|Withdrawal by Subject|14
85732|NCT00883116|301724|P2|Overall Study|Study drug toxicity|16
85733|NCT00883116|301725|P1|Overall Study|Study drug toxicity|36
85734|NCT00883116|301724|P2|Overall Study|Not identified|6
85735|NCT00883116|301725|P1|Overall Study|Not identified|3
85736|NCT00883116|301724|P2|Overall Study|Maximum clinical benefit|46
85737|NCT00883116|301725|P1|Overall Study|Maximum clinical benefit|13
85738|NCT00883116|301724|P2|Overall Study|Lost to Follow-up|1
85739|NCT00883116|301725|P1|Overall Study|Lost to Follow-up|0
85740|NCT00883116|301724|P2|Overall Study|Disease progression|128
85741|NCT00883116|301725|P1|Overall Study|Disease progression|130
85742|NCT00883116|301724|P2|Overall Study|Death|2
85743|NCT00883116|301725|P1|Overall Study|Death|6
85744|NCT00883116|301724|P2|Overall Study|Adverse event unrelated to study drug|10
85745|NCT00883116|301725|P1|Overall Study|Adverse event unrelated to study drug|5
85746|NCT00883090|301747|P1|Overall Study|Withdrawal by Subject|1
85747|NCT00883090|301747|P1|Overall Study|Sponsor's decision|1
85748|NCT00882921|301762|P1|Overall Study|Withdrawal Of Consent|1
85749|NCT00882921|301762|P1|Overall Study|Termination By Investigator|3
85750|NCT00882921|301762|P1|Overall Study|Lost to Follow-up|2
85751|NCT00882921|301762|P1|Overall Study|Not specified|3
85752|NCT00882921|301762|P1|Overall Study|Death|2
85753|NCT00882908|301772|P5|Overall Study|Study terminated in error|0
85754|NCT00882908|301773|P4|Overall Study|Study terminated in error|1
85755|NCT00882908|301774|P3|Overall Study|Study terminated in error|0
85756|NCT00882908|301775|P2|Overall Study|Study terminated in error|0
85757|NCT00882908|301776|P1|Overall Study|Study terminated in error|0
85758|NCT00882908|301772|P5|Overall Study|Subject reached a virologic endpoint|1
85759|NCT00882908|301773|P4|Overall Study|Subject reached a virologic endpoint|0
85760|NCT00882908|301774|P3|Overall Study|Subject reached a virologic endpoint|0
85761|NCT00882908|301775|P2|Overall Study|Subject reached a virologic endpoint|0
85762|NCT00882908|301776|P1|Overall Study|Subject reached a virologic endpoint|0
85763|NCT00882908|301772|P5|Overall Study|Withdrawal by Subject|2
85764|NCT00882908|301773|P4|Overall Study|Withdrawal by Subject|5
85765|NCT00882908|301774|P3|Overall Study|Withdrawal by Subject|3
85766|NCT00882908|301775|P2|Overall Study|Withdrawal by Subject|0
85767|NCT00882908|301776|P1|Overall Study|Withdrawal by Subject|0
85768|NCT00882908|301772|P5|Overall Study|Protocol Violation|0
85769|NCT00882908|301773|P4|Overall Study|Protocol Violation|0
85770|NCT00882908|301774|P3|Overall Study|Protocol Violation|0
85771|NCT00882908|301775|P2|Overall Study|Protocol Violation|1
85772|NCT00882908|301776|P1|Overall Study|Protocol Violation|0
85773|NCT00882908|301772|P5|Overall Study|Lost to Follow-up|2
85774|NCT00882908|301773|P4|Overall Study|Lost to Follow-up|1
85775|NCT00882908|301774|P3|Overall Study|Lost to Follow-up|3
85776|NCT00882908|301775|P2|Overall Study|Lost to Follow-up|5
85777|NCT00882908|301776|P1|Overall Study|Lost to Follow-up|3
85778|NCT00882908|301772|P5|Overall Study|Adverse Event|1
85779|NCT00882908|301773|P4|Overall Study|Adverse Event|0
85780|NCT00882908|301774|P3|Overall Study|Adverse Event|1
85781|NCT00882908|301775|P2|Overall Study|Adverse Event|0
85782|NCT00882908|301776|P1|Overall Study|Adverse Event|0
85783|NCT00882713|301882|P1|Overall Study|Other - Reasons|2
85784|NCT00882713|301882|P1|Overall Study|Failure to return|2
85785|NCT00882713|301882|P1|Overall Study|Insufficient therapeutic response|3
85786|NCT00882713|301882|P1|Overall Study|Blood transfusion|2
85787|NCT00882713|301882|P1|Overall Study|refused treatment/withdrew consent|4
85788|NCT00882713|301882|P1|Overall Study|Administrative reasons|4
85789|NCT00882713|301882|P1|Overall Study|Death|3
85790|NCT00882713|301882|P1|Overall Study|Adverse Event|2
85791|NCT00882557|301906|P2|Overall Study|Randomized Not Treated|1
85792|NCT00882557|301907|P1|Overall Study|Randomized Not Treated|0
85793|NCT00882557|301906|P2|Overall Study|Trouble with Vein Access|0
85794|NCT00882557|301907|P1|Overall Study|Trouble with Vein Access|1
85795|NCT00882557|301906|P2|Overall Study|Withdrawal by Subject|0
85796|NCT00882557|301907|P1|Overall Study|Withdrawal by Subject|1
85797|NCT00882518|301927|P2|Overall Study|Allocating random number by mistake|1
85798|NCT00882518|301928|P1|Overall Study|Allocating random number by mistake|0
85799|NCT00882518|301927|P2|Overall Study|Central lab closure for National day|0
85800|NCT00882518|301928|P1|Overall Study|Central lab closure for National day|1
85801|NCT00882518|301927|P2|Overall Study|Incorrect enrolment|2
85802|NCT00882518|301928|P1|Overall Study|Incorrect enrolment|4
85803|NCT00882518|301927|P2|Overall Study|Severe non-compliance to protocol|1
85804|NCT00882518|301928|P1|Overall Study|Severe non-compliance to protocol|3
85805|NCT00882518|301927|P2|Overall Study|Lack of Efficacy|9
85806|NCT00882518|301928|P1|Overall Study|Lack of Efficacy|12
85807|NCT00882518|301927|P2|Overall Study|Withdrawal by Subject|13
85808|NCT00882518|301928|P1|Overall Study|Withdrawal by Subject|9
85809|NCT00882518|301927|P2|Overall Study|Adverse Event|18
85810|NCT00882518|301928|P1|Overall Study|Adverse Event|9
85811|NCT00882440|301957|P7|Overall Study|Patient Uncooperative|0
85812|NCT00882440|301958|P6|Overall Study|Patient Uncooperative|0
85813|NCT00882440|301959|P5|Overall Study|Patient Uncooperative|1
85814|NCT00882440|301960|P4|Overall Study|Patient Uncooperative|0
85815|NCT00882440|301961|P3|Overall Study|Patient Uncooperative|0
85816|NCT00882440|301962|P2|Overall Study|Patient Uncooperative|0
85817|NCT00882440|301963|P1|Overall Study|Patient Uncooperative|2
85818|NCT00882440|301957|P7|Overall Study|Withdrawal by Subject|1
85819|NCT00882440|301958|P6|Overall Study|Withdrawal by Subject|0
85820|NCT00882440|301959|P5|Overall Study|Withdrawal by Subject|6
85821|NCT00882440|301960|P4|Overall Study|Withdrawal by Subject|0
85822|NCT00882440|301961|P3|Overall Study|Withdrawal by Subject|1
85823|NCT00882440|301962|P2|Overall Study|Withdrawal by Subject|1
85824|NCT00882440|301963|P1|Overall Study|Withdrawal by Subject|2
85825|NCT00882440|301957|P7|Overall Study|Protocol Violation|0
85826|NCT00882440|301958|P6|Overall Study|Protocol Violation|0
85827|NCT00882440|301959|P5|Overall Study|Protocol Violation|1
85828|NCT00882440|301960|P4|Overall Study|Protocol Violation|1
85829|NCT00882440|301961|P3|Overall Study|Protocol Violation|1
85830|NCT00882440|301962|P2|Overall Study|Protocol Violation|0
85831|NCT00882440|301963|P1|Overall Study|Protocol Violation|0
85832|NCT00882440|301957|P7|Overall Study|Lost to Follow-up|1
85833|NCT00882440|301958|P6|Overall Study|Lost to Follow-up|0
85834|NCT00882440|301959|P5|Overall Study|Lost to Follow-up|1
85835|NCT00882440|301960|P4|Overall Study|Lost to Follow-up|1
85836|NCT00882440|301961|P3|Overall Study|Lost to Follow-up|1
85837|NCT00882440|301962|P2|Overall Study|Lost to Follow-up|0
85838|NCT00882440|301963|P1|Overall Study|Lost to Follow-up|2
85839|NCT00882440|301957|P7|Overall Study|Lack of Efficacy|0
85840|NCT00882440|301958|P6|Overall Study|Lack of Efficacy|3
85841|NCT00882440|301959|P5|Overall Study|Lack of Efficacy|0
85842|NCT00882440|301960|P4|Overall Study|Lack of Efficacy|0
85843|NCT00882440|301961|P3|Overall Study|Lack of Efficacy|2
85844|NCT00882440|301962|P2|Overall Study|Lack of Efficacy|5
85845|NCT00882440|301963|P1|Overall Study|Lack of Efficacy|3
85846|NCT00882440|301957|P7|Overall Study|Adverse Event|2
85847|NCT00882440|301958|P6|Overall Study|Adverse Event|4
85848|NCT00882440|301959|P5|Overall Study|Adverse Event|1
85849|NCT00882440|301960|P4|Overall Study|Adverse Event|1
85850|NCT00882440|301961|P3|Overall Study|Adverse Event|2
85851|NCT00882440|301962|P2|Overall Study|Adverse Event|2
85852|NCT00882440|301963|P1|Overall Study|Adverse Event|2
85853|NCT00882362|301988|P2|Overall Study|change of residence or other commitments|0
85854|NCT00882362|301989|P1|Overall Study|change of residence or other commitments|5
85855|NCT00882362|301988|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
85856|NCT00882362|301989|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
85857|NCT00882362|301988|P2|Overall Study|Physician Decision|1
85858|NCT00882362|301989|P1|Overall Study|Physician Decision|5
85859|NCT00882362|301988|P2|Overall Study|Pregnancy|0
85860|NCT00882362|301989|P1|Overall Study|Pregnancy|1
85861|NCT00882362|301988|P2|Overall Study|Protocol Violation|2
85862|NCT00882362|301989|P1|Overall Study|Protocol Violation|7
85863|NCT00882362|301988|P2|Overall Study|Lack of Efficacy|0
85864|NCT00882362|301989|P1|Overall Study|Lack of Efficacy|3
85865|NCT00882362|301988|P2|Overall Study|Withdrawal by Subject|10
85866|NCT00882362|301989|P1|Overall Study|Withdrawal by Subject|13
85867|NCT00882362|301988|P2|Overall Study|Adverse Event|10
85868|NCT00882362|301989|P1|Overall Study|Adverse Event|13
85869|NCT00882310|301995|P1|Overall Study|Adverse Event|1
85870|NCT00882310|301995|P1|Overall Study|Progression of disease|4
85871|NCT00882310|301995|P1|Overall Study|Death|6
85872|NCT00882310|301995|P1|Overall Study|Never received treatment|1
85873|NCT00882310|301995|P1|Overall Study|Screen Failure|10
85874|NCT00881959|302014|P2|Overall Study|Lost to Follow-up|4
85875|NCT00881959|302015|P1|Overall Study|Lost to Follow-up|2
85876|NCT00881894|302023|P2|Overall Study|Other reasons for premature termination|2
85877|NCT00881894|302024|P1|Overall Study|Other reasons for premature termination|1
85878|NCT00881894|302023|P2|Overall Study|Consent withdrawn|1
85879|NCT00881894|302024|P1|Overall Study|Consent withdrawn|0
85880|NCT00881868|302056|P2|Overall Study|Protocol Violation|0
85881|NCT00881868|302057|P1|Overall Study|Protocol Violation|2
85882|NCT00881868|302056|P2|Overall Study|Physician Decision|0
85883|NCT00881868|302057|P1|Overall Study|Physician Decision|4
85884|NCT00881868|302056|P2|Overall Study|Lost to Follow-up|1
85885|NCT00881868|302057|P1|Overall Study|Lost to Follow-up|2
85886|NCT00881868|302056|P2|Overall Study|Adverse Event|1
85887|NCT00881868|302057|P1|Overall Study|Adverse Event|0
85888|NCT00881712|302072|P3|Overall Study|Withdrawal by Subject|0
85889|NCT00881712|302073|P2|Overall Study|Withdrawal by Subject|0
85890|NCT00881712|302074|P1|Overall Study|Withdrawal by Subject|1
85891|NCT00881712|302072|P3|Overall Study|Death|0
85892|NCT00881712|302073|P2|Overall Study|Death|0
85893|NCT00881712|302074|P1|Overall Study|Death|1
85894|NCT00881608|302112|P1|Overall Study|Study prematurely terminated|11
85895|NCT00881530|302135|P6|Overall Study|Other reason not defined above|2
85896|NCT00881530|302136|P5|Overall Study|Other reason not defined above|0
85897|NCT00881530|302137|P4|Overall Study|Other reason not defined above|0
85898|NCT00881530|302138|P3|Overall Study|Other reason not defined above|2
85899|NCT00881530|302139|P2|Overall Study|Other reason not defined above|1
85900|NCT00881530|302140|P1|Overall Study|Other reason not defined above|1
85901|NCT00881530|302135|P6|Overall Study|Refused to continue medication|0
85902|NCT00881530|302136|P5|Overall Study|Refused to continue medication|0
85903|NCT00881530|302137|P4|Overall Study|Refused to continue medication|2
85904|NCT00881530|302138|P3|Overall Study|Refused to continue medication|1
85905|NCT00881530|302139|P2|Overall Study|Refused to continue medication|2
85906|NCT00881530|302140|P1|Overall Study|Refused to continue medication|7
85907|NCT00881530|302135|P6|Overall Study|Lost to Follow-up|0
85908|NCT00881530|302136|P5|Overall Study|Lost to Follow-up|1
85909|NCT00881530|302137|P4|Overall Study|Lost to Follow-up|3
85910|NCT00881530|302138|P3|Overall Study|Lost to Follow-up|1
85911|NCT00881530|302139|P2|Overall Study|Lost to Follow-up|1
85912|NCT00881530|302140|P1|Overall Study|Lost to Follow-up|0
85913|NCT00881530|302135|P6|Overall Study|Not compliant with the protocol|0
85914|NCT00881530|302136|P5|Overall Study|Not compliant with the protocol|2
85915|NCT00881530|302137|P4|Overall Study|Not compliant with the protocol|0
85916|NCT00881530|302138|P3|Overall Study|Not compliant with the protocol|0
85917|NCT00881530|302139|P2|Overall Study|Not compliant with the protocol|0
85918|NCT00881530|302140|P1|Overall Study|Not compliant with the protocol|0
85919|NCT00881530|302135|P6|Overall Study|Lack of Efficacy|1
85920|NCT00881530|302136|P5|Overall Study|Lack of Efficacy|1
85921|NCT00881530|302137|P4|Overall Study|Lack of Efficacy|0
85922|NCT00881530|302138|P3|Overall Study|Lack of Efficacy|0
85923|NCT00881530|302139|P2|Overall Study|Lack of Efficacy|0
85924|NCT00881530|302140|P1|Overall Study|Lack of Efficacy|1
85925|NCT00881530|302135|P6|Overall Study|Adverse Event|2
85926|NCT00881530|302136|P5|Overall Study|Adverse Event|10
85927|NCT00881530|302137|P4|Overall Study|Adverse Event|4
85928|NCT00881530|302138|P3|Overall Study|Adverse Event|1
85929|NCT00881530|302139|P2|Overall Study|Adverse Event|1
85930|NCT00881530|302140|P1|Overall Study|Adverse Event|5
85931|NCT00881504|302196|P1|Overall Study|Withdrawal by Subject|1
85932|NCT00881335|302216|P2|Overall Study|Lost to Follow-up|2
85933|NCT00881335|302217|P1|Overall Study|Lost to Follow-up|3
85934|NCT00881205|302237|P2|Overall Study|Condition no longer requires drug|0
85935|NCT00881205|302238|P1|Overall Study|Condition no longer requires drug|1
85936|NCT00881205|302237|P2|Overall Study|Administrative problems|1
85937|NCT00881205|302238|P1|Overall Study|Administrative problems|1
85938|NCT00881205|302237|P2|Overall Study|Lost to Follow-up|1
85939|NCT00881205|302238|P1|Overall Study|Lost to Follow-up|0
85940|NCT00881205|302237|P2|Overall Study|Withdrawal by Subject|2
85941|NCT00881205|302238|P1|Overall Study|Withdrawal by Subject|1
85942|NCT00881205|302237|P2|Overall Study|Adverse Event|3
85943|NCT00881205|302238|P1|Overall Study|Adverse Event|8
85944|NCT00880906|302284|P2|Overall Study|Did not meet criteria following patholog|6
85945|NCT00880906|302285|P1|Overall Study|Did not meet criteria following patholog|12
85946|NCT00880906|302284|P2|Overall Study|Lost to Follow-up|1
85947|NCT00880906|302285|P1|Overall Study|Lost to Follow-up|0
85948|NCT00880763|302295|P4|Extension Period (Part 2)|Lack of Efficacy|1
85949|NCT00880763|302296|P3|Extension Period (Part 2)|Lack of Efficacy|0
85950|NCT00880763|302297|P2|Extension Period (Part 2)|Lack of Efficacy|0
85951|NCT00880763|302298|P1|Extension Period (Part 2)|Lack of Efficacy|0
85952|NCT00880763|302295|P4|Extension Period (Part 2)|Physician Decision|0
85953|NCT00880763|302296|P3|Extension Period (Part 2)|Physician Decision|1
85954|NCT00880763|302297|P2|Extension Period (Part 2)|Physician Decision|1
85955|NCT00880763|302298|P1|Extension Period (Part 2)|Physician Decision|0
85956|NCT00880763|302295|P4|Extension Period (Part 2)|Withdrawal by Subject|1
85957|NCT00880763|302296|P3|Extension Period (Part 2)|Withdrawal by Subject|1
85958|NCT00880763|302297|P2|Extension Period (Part 2)|Withdrawal by Subject|2
85959|NCT00880763|302298|P1|Extension Period (Part 2)|Withdrawal by Subject|0
85960|NCT00880763|302295|P4|Extension Period (Part 2)|Adverse Event|1
85961|NCT00880763|302296|P3|Extension Period (Part 2)|Adverse Event|1
85962|NCT00880763|302297|P2|Extension Period (Part 2)|Adverse Event|0
85963|NCT00880763|302298|P1|Extension Period (Part 2)|Adverse Event|0
85964|NCT00880750|302330|P2|Second Intervention|Unable to collect urine|0
85965|NCT00880750|302331|P1|Second Intervention|Unable to collect urine|1
85966|NCT00880750|302330|P2|Second Intervention|Protocol Violation|0
85967|NCT00880750|302331|P1|Second Intervention|Protocol Violation|1
85968|NCT00880750|302330|P2|Second Intervention|Withdrawal by Subject|2
85969|NCT00880750|302331|P1|Second Intervention|Withdrawal by Subject|2
85970|NCT00880750|302330|P2|First Intervention|Lost to Follow-up|0
85971|NCT00880750|302331|P1|First Intervention|Lost to Follow-up|2
85972|NCT00880750|302330|P2|First Intervention|Withdrawal by Subject|0
85973|NCT00880750|302331|P1|First Intervention|Withdrawal by Subject|2
85974|NCT00880750|302330|P2|First Intervention|Non-compliance with meals|1
85975|NCT00880750|302331|P1|First Intervention|Non-compliance with meals|0
85976|NCT00880750|302330|P2|First Intervention|Unable to collect urine|0
85977|NCT00880750|302331|P1|First Intervention|Unable to collect urine|4
85978|NCT00880750|302330|P2|First Intervention|Adverse Event|0
85979|NCT00880750|302331|P1|First Intervention|Adverse Event|1
85980|NCT00880698|302349|P4|Overall Study|Lost to Follow-up|1
85981|NCT00880698|302350|P3|Overall Study|Lost to Follow-up|0
85982|NCT00880698|302351|P2|Overall Study|Lost to Follow-up|3
85983|NCT00880698|302352|P1|Overall Study|Lost to Follow-up|1
85984|NCT00880698|302349|P4|Overall Study|Death|2
85985|NCT00880698|302350|P3|Overall Study|Death|1
85986|NCT00880698|302351|P2|Overall Study|Death|0
85987|NCT00880698|302352|P1|Overall Study|Death|0
85988|NCT00880685|302378|P1|Memantine 20mg|Withdrawal by Subject|1
85989|NCT00880685|302378|P1|Memantine 10mg|Lost to Follow-up|2
85990|NCT00880620|302390|P4|Overall Study|Not specified|2
85991|NCT00880620|302391|P3|Overall Study|Not specified|2
85992|NCT00880620|302392|P2|Overall Study|Not specified|1
85993|NCT00880620|302393|P1|Overall Study|Not specified|1
85994|NCT00880620|302390|P4|Overall Study|Noncompliance|1
85995|NCT00880620|302391|P3|Overall Study|Noncompliance|1
85996|NCT00880620|302392|P2|Overall Study|Noncompliance|0
85997|NCT00880620|302393|P1|Overall Study|Noncompliance|0
85998|NCT00880620|302390|P4|Overall Study|Withdrawal by Subject|3
85999|NCT00880620|302391|P3|Overall Study|Withdrawal by Subject|1
86000|NCT00880620|302392|P2|Overall Study|Withdrawal by Subject|3
86001|NCT00880620|302393|P1|Overall Study|Withdrawal by Subject|4
86002|NCT00880620|302390|P4|Overall Study|Protocol Violation|2
86003|NCT00880620|302391|P3|Overall Study|Protocol Violation|0
86004|NCT00880620|302392|P2|Overall Study|Protocol Violation|1
86005|NCT00880620|302393|P1|Overall Study|Protocol Violation|0
86006|NCT00880620|302390|P4|Overall Study|Lost to Follow-up|0
86007|NCT00880620|302391|P3|Overall Study|Lost to Follow-up|1
86008|NCT00880620|302392|P2|Overall Study|Lost to Follow-up|1
86009|NCT00880620|302393|P1|Overall Study|Lost to Follow-up|0
86010|NCT00880620|302390|P4|Overall Study|Lack of Efficacy|1
86011|NCT00880620|302391|P3|Overall Study|Lack of Efficacy|0
86012|NCT00880620|302392|P2|Overall Study|Lack of Efficacy|4
86013|NCT00880620|302393|P1|Overall Study|Lack of Efficacy|12
86014|NCT00880620|302390|P4|Overall Study|Death|0
86015|NCT00880620|302391|P3|Overall Study|Death|1
86016|NCT00880620|302392|P2|Overall Study|Death|0
86017|NCT00880620|302393|P1|Overall Study|Death|0
86018|NCT00880620|302390|P4|Overall Study|Adverse Event|15
86019|NCT00880620|302391|P3|Overall Study|Adverse Event|15
86020|NCT00880620|302392|P2|Overall Study|Adverse Event|5
86021|NCT00880620|302393|P1|Overall Study|Adverse Event|4
86022|NCT00880568|302412|P9|Overall Study|Withdrawal by Subject|0
86023|NCT00880568|302413|P8|Overall Study|Withdrawal by Subject|1
86024|NCT00880568|302414|P7|Overall Study|Withdrawal by Subject|0
86025|NCT00880568|302415|P6|Overall Study|Withdrawal by Subject|0
86026|NCT00880568|302416|P5|Overall Study|Withdrawal by Subject|0
86027|NCT00880568|302417|P4|Overall Study|Withdrawal by Subject|0
86028|NCT00880568|302418|P3|Overall Study|Withdrawal by Subject|0
86029|NCT00880568|302419|P2|Overall Study|Withdrawal by Subject|0
86030|NCT00880568|302420|P1|Overall Study|Withdrawal by Subject|0
86031|NCT00880568|302412|P9|Overall Study|Adverse Event|0
86032|NCT00880568|302413|P8|Overall Study|Adverse Event|1
86033|NCT00880568|302414|P7|Overall Study|Adverse Event|1
86034|NCT00880568|302415|P6|Overall Study|Adverse Event|0
86035|NCT00880568|302416|P5|Overall Study|Adverse Event|0
86036|NCT00880568|302417|P4|Overall Study|Adverse Event|0
86037|NCT00880568|302418|P3|Overall Study|Adverse Event|0
86038|NCT00880568|302419|P2|Overall Study|Adverse Event|0
86039|NCT00880568|302420|P1|Overall Study|Adverse Event|0
86040|NCT00880568|302412|P9|Overall Study|Disease progression|3
86041|NCT00880568|302413|P8|Overall Study|Disease progression|0
86042|NCT00880568|302414|P7|Overall Study|Disease progression|5
86043|NCT00880568|302415|P6|Overall Study|Disease progression|3
86044|NCT00880568|302416|P5|Overall Study|Disease progression|3
86045|NCT00880568|302417|P4|Overall Study|Disease progression|1
86046|NCT00880568|302418|P3|Overall Study|Disease progression|3
86047|NCT00880568|302419|P2|Overall Study|Disease progression|3
86048|NCT00880568|302420|P1|Overall Study|Disease progression|3
86049|NCT00880555|302466|P6|Overall Study|Lost to Follow-up|0
86050|NCT00880555|302467|P5|Overall Study|Lost to Follow-up|0
86051|NCT00880555|302468|P4|Overall Study|Lost to Follow-up|0
86052|NCT00880555|302469|P3|Overall Study|Lost to Follow-up|0
86053|NCT00880555|302470|P2|Overall Study|Lost to Follow-up|1
86054|NCT00880555|302471|P1|Overall Study|Lost to Follow-up|0
86055|NCT00880555|302466|P6|Overall Study|Death|1
86056|NCT00880555|302467|P5|Overall Study|Death|0
86057|NCT00880555|302468|P4|Overall Study|Death|0
86058|NCT00880555|302469|P3|Overall Study|Death|0
86059|NCT00880555|302470|P2|Overall Study|Death|0
86060|NCT00880555|302471|P1|Overall Study|Death|0
86061|NCT00880555|302466|P6|Overall Study|Lack of resources (hired rater)|0
86062|NCT00880555|302467|P5|Overall Study|Lack of resources (hired rater)|0
86063|NCT00880555|302468|P4|Overall Study|Lack of resources (hired rater)|0
86064|NCT00880555|302469|P3|Overall Study|Lack of resources (hired rater)|5
86065|NCT00880555|302470|P2|Overall Study|Lack of resources (hired rater)|7
86066|NCT00880555|302471|P1|Overall Study|Lack of resources (hired rater)|9
86067|NCT00880555|302466|P6|Overall Study|Withdrawal by Subject|0
86068|NCT00880555|302467|P5|Overall Study|Withdrawal by Subject|0
86069|NCT00880555|302468|P4|Overall Study|Withdrawal by Subject|0
86070|NCT00880555|302469|P3|Overall Study|Withdrawal by Subject|0
86071|NCT00880555|302470|P2|Overall Study|Withdrawal by Subject|1
86072|NCT00880555|302471|P1|Overall Study|Withdrawal by Subject|1
86073|NCT00880555|302466|P6|Overall Study|Physician Decision|0
86074|NCT00880555|302467|P5|Overall Study|Physician Decision|1
86075|NCT00880555|302468|P4|Overall Study|Physician Decision|2
86076|NCT00880555|302469|P3|Overall Study|Physician Decision|0
86077|NCT00880555|302470|P2|Overall Study|Physician Decision|8
86078|NCT00880555|302471|P1|Overall Study|Physician Decision|0
86079|NCT00880542|302482|P1|REP: Surgical Resection|progressive disease|1
86080|NCT00880542|302482|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
86081|NCT00880542|302482|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
86082|NCT00880334|302502|P2|Overall Study|Brain Metastasis|1
86083|NCT00880334|302503|P1|Overall Study|Brain Metastasis|0
86084|NCT00880334|302502|P2|Overall Study|Inadequate Labs|1
86085|NCT00880334|302503|P1|Overall Study|Inadequate Labs|1
86086|NCT00880334|302502|P2|Overall Study|Withdrawal by Subject|1
86087|NCT00880334|302503|P1|Overall Study|Withdrawal by Subject|2
86088|NCT00880334|302502|P2|Overall Study|Physician Decision|0
86089|NCT00880334|302503|P1|Overall Study|Physician Decision|1
86090|NCT00880269|302519|P2|Overall Study|Adverse Event|9
86091|NCT00880269|302520|P1|Overall Study|Adverse Event|10
86092|NCT00880269|302519|P2|Overall Study|Withdrawal by Subject|4
86093|NCT00880269|302520|P1|Overall Study|Withdrawal by Subject|3
86094|NCT00880269|302519|P2|Overall Study|Lost to Follow-up|1
86095|NCT00880269|302520|P1|Overall Study|Lost to Follow-up|0
86096|NCT00880269|302519|P2|Overall Study|Death|2
86097|NCT00880269|302520|P1|Overall Study|Death|4
86098|NCT00880269|302519|P2|Overall Study|New Cancer Therapy|0
86099|NCT00880269|302520|P1|Overall Study|New Cancer Therapy|1
86100|NCT00880269|302519|P2|Overall Study|Disease Progression|11
86101|NCT00880269|302520|P1|Overall Study|Disease Progression|13
86102|NCT00880269|302519|P2|Overall Study|Protocol Violation|0
86103|NCT00880269|302520|P1|Overall Study|Protocol Violation|1
86104|NCT00880256|302536|P1|Overall Study|Lost to Follow-up|28
86105|NCT00880191|302563|P2|Overall Study|Hospitalization/efficacy|1
86106|NCT00880191|302564|P1|Overall Study|Hospitalization/efficacy|1
86107|NCT00880191|302563|P2|Overall Study|Adverse Event|6
86108|NCT00880191|302564|P1|Overall Study|Adverse Event|8
86109|NCT00880191|302563|P2|Overall Study|Refused further treatment|1
86110|NCT00880191|302564|P1|Overall Study|Refused further treatment|4
86111|NCT00880165|302584|P2|Overall Study|Lost to follow|15
86112|NCT00880165|302585|P1|Overall Study|Lost to follow|9
86113|NCT00880165|302584|P2|Overall Study|Required BIPAP or oxygen treatment|4
86114|NCT00880165|302585|P1|Overall Study|Required BIPAP or oxygen treatment|12
86115|NCT00880165|302584|P2|Overall Study|Not diagnosed with OSA|8
86116|NCT00880165|302585|P1|Overall Study|Not diagnosed with OSA|14
86117|NCT00880165|302584|P2|Overall Study|Withdrawal by Subject|23
86118|NCT00880165|302585|P1|Overall Study|Withdrawal by Subject|27
86119|NCT00880100|302595|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
86120|NCT00880100|302595|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
86121|NCT00880100|302595|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
86122|NCT00880009|302615|P1|Overall Study|Protocol Violation|1
86123|NCT00880009|302615|P1|Overall Study|Withdrawal by Subject|1
86124|NCT00880009|302615|P1|Overall Study|Study terminated by sponsor|14
86125|NCT00879996|302639|P2|Overall Study|put on parole|0
86126|NCT00879996|302640|P1|Overall Study|put on parole|1
86127|NCT00879996|302639|P2|Overall Study|psychiatric problem|1
86128|NCT00879996|302640|P1|Overall Study|psychiatric problem|0
86129|NCT00879996|302639|P2|Overall Study|Physician Decision|2
86130|NCT00879996|302640|P1|Overall Study|Physician Decision|1
86131|NCT00879996|302639|P2|Overall Study|non-compliance|4
86132|NCT00879996|302640|P1|Overall Study|non-compliance|6
86133|NCT00879996|302639|P2|Overall Study|Lost to Follow-up|6
86134|NCT00879996|302640|P1|Overall Study|Lost to Follow-up|7
86135|NCT00879970|302655|P5|Period 2 Vitamin D Randomization|Death|0
86136|NCT00879970|302656|P4|Period 2 Vitamin D Randomization|Death|2
86137|NCT00879970|302657|P3|Period 2 Vitamin D Randomization|Death|0
86138|NCT00879970|302658|P2|Period 2 Vitamin D Randomization|Death|0
86139|NCT00879970|302659|P1|Period 2 Vitamin D Randomization|Death|0
86140|NCT00879970|302655|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
86141|NCT00879970|302656|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
86142|NCT00879970|302657|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
86143|NCT00879970|302658|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
86144|NCT00879970|302659|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
86145|NCT00879970|302655|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
86146|NCT00879970|302656|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
86147|NCT00879970|302657|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
86148|NCT00879970|302658|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
86149|NCT00879970|302659|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
86150|NCT00879970|302655|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
86151|NCT00879970|302656|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
86152|NCT00879970|302657|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
86153|NCT00879970|302658|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
86154|NCT00879970|302659|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
86155|NCT00879970|302655|P5|Period 1 TZD Randomization|Death|0
86156|NCT00879970|302656|P4|Period 1 TZD Randomization|Death|0
86157|NCT00879970|302657|P3|Period 1 TZD Randomization|Death|0
86158|NCT00879970|302658|P2|Period 1 TZD Randomization|Death|1
86159|NCT00879970|302659|P1|Period 1 TZD Randomization|Death|2
86160|NCT00879970|302655|P5|Period 1 TZD Randomization|Lost to Follow-up|0
86161|NCT00879970|302656|P4|Period 1 TZD Randomization|Lost to Follow-up|0
86162|NCT00879970|302657|P3|Period 1 TZD Randomization|Lost to Follow-up|1
86163|NCT00879970|302658|P2|Period 1 TZD Randomization|Lost to Follow-up|0
86164|NCT00879970|302659|P1|Period 1 TZD Randomization|Lost to Follow-up|1
86165|NCT00879970|302655|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
86166|NCT00879970|302656|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
86167|NCT00879970|302657|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
86168|NCT00879970|302658|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
86169|NCT00879970|302659|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
86170|NCT00879879|302741|P1|Overall Study|Physician Decision|1
86171|NCT00879879|302741|P1|Overall Study|Withdrawal by Subject|1
86172|NCT00879879|302741|P1|Overall Study|Death|1
86173|NCT00879814|302749|P4|Overall Study|Unspecified|0
86174|NCT00879814|302750|P3|Overall Study|Unspecified|1
86175|NCT00879814|302751|P2|Overall Study|Unspecified|0
86176|NCT00879814|302752|P1|Overall Study|Unspecified|0
86177|NCT00879814|302749|P4|Overall Study|Physician Decision|0
86178|NCT00879814|302750|P3|Overall Study|Physician Decision|1
86179|NCT00879814|302751|P2|Overall Study|Physician Decision|0
86180|NCT00879814|302752|P1|Overall Study|Physician Decision|0
86181|NCT00879814|302749|P4|Overall Study|Withdrawal by Subject|2
86182|NCT00879814|302750|P3|Overall Study|Withdrawal by Subject|1
86183|NCT00879814|302751|P2|Overall Study|Withdrawal by Subject|1
86184|NCT00879814|302752|P1|Overall Study|Withdrawal by Subject|3
86185|NCT00879814|302749|P4|Overall Study|Participant Failed to Return|1
86186|NCT00879814|302750|P3|Overall Study|Participant Failed to Return|0
86187|NCT00879814|302751|P2|Overall Study|Participant Failed to Return|0
86188|NCT00879814|302752|P1|Overall Study|Participant Failed to Return|0
86189|NCT00879814|302749|P4|Overall Study|Lost to Follow-up|2
86190|NCT00879814|302750|P3|Overall Study|Lost to Follow-up|0
86191|NCT00879814|302751|P2|Overall Study|Lost to Follow-up|0
86192|NCT00879814|302752|P1|Overall Study|Lost to Follow-up|1
86193|NCT00879814|302749|P4|Overall Study|Adverse Event|0
86194|NCT00879814|302750|P3|Overall Study|Adverse Event|0
86195|NCT00879814|302751|P2|Overall Study|Adverse Event|1
86196|NCT00879814|302752|P1|Overall Study|Adverse Event|0
86197|NCT00879775|302860|P2|Overall Study|Lost to Follow-up|1
86198|NCT00879775|302861|P1|Overall Study|Lost to Follow-up|2
86199|NCT00879710|302877|P4|Phase 1 - 6 Weeks|Adverse Event|0
86200|NCT00879710|302878|P3|Phase 1 - 6 Weeks|Adverse Event|1
86201|NCT00879710|302879|P2|Phase 1 - 6 Weeks|Adverse Event|0
86202|NCT00879710|302880|P1|Phase 1 - 6 Weeks|Adverse Event|0
86203|NCT00879710|302877|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
86204|NCT00879710|302878|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
86205|NCT00879710|302879|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
86206|NCT00879710|302880|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
86207|NCT00879697|302890|P2|Overall Study|Physician Decision|2
86208|NCT00879697|302891|P1|Overall Study|Physician Decision|2
86209|NCT00879684|302897|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
86210|NCT00879684|302898|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
86211|NCT00879684|302899|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
86212|NCT00879684|302900|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
86213|NCT00879684|302901|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
86214|NCT00879684|302902|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
86215|NCT00879684|302903|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
86216|NCT00879684|302897|P7|Stage 2: Expanded Cohort|Progressive Disease|11
86217|NCT00879684|302898|P6|Stage 2: Expanded Cohort|Progressive Disease|0
86218|NCT00879684|302899|P5|Stage 2: Expanded Cohort|Progressive Disease|0
86219|NCT00879684|302900|P4|Stage 2: Expanded Cohort|Progressive Disease|0
86220|NCT00879684|302901|P3|Stage 2: Expanded Cohort|Progressive Disease|0
86221|NCT00879684|302902|P2|Stage 2: Expanded Cohort|Progressive Disease|0
86222|NCT00879684|302903|P1|Stage 2: Expanded Cohort|Progressive Disease|0
86223|NCT00879684|302897|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
86224|NCT00879684|302898|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
86225|NCT00879684|302899|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
86226|NCT00879684|302900|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
86227|NCT00879684|302901|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
86228|NCT00879684|302902|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
86229|NCT00879684|302903|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
86230|NCT00879684|302897|P7|Stage 1: Dose Escalation|Death|0
86231|NCT00879684|302898|P6|Stage 1: Dose Escalation|Death|0
86232|NCT00879684|302899|P5|Stage 1: Dose Escalation|Death|0
86233|NCT00879684|302900|P4|Stage 1: Dose Escalation|Death|0
86234|NCT00879684|302901|P3|Stage 1: Dose Escalation|Death|1
86235|NCT00879684|302902|P2|Stage 1: Dose Escalation|Death|0
86236|NCT00879684|302903|P1|Stage 1: Dose Escalation|Death|0
86237|NCT00879684|302897|P7|Stage 1: Dose Escalation|Investigator declined participation|0
86238|NCT00879684|302898|P6|Stage 1: Dose Escalation|Investigator declined participation|0
86239|NCT00879684|302899|P5|Stage 1: Dose Escalation|Investigator declined participation|0
86240|NCT00879684|302900|P4|Stage 1: Dose Escalation|Investigator declined participation|2
86241|NCT00879684|302901|P3|Stage 1: Dose Escalation|Investigator declined participation|2
86242|NCT00879684|302902|P2|Stage 1: Dose Escalation|Investigator declined participation|0
86243|NCT00879684|302903|P1|Stage 1: Dose Escalation|Investigator declined participation|0
86244|NCT00879684|302897|P7|Stage 1: Dose Escalation|Progressive Disease|0
86245|NCT00879684|302898|P6|Stage 1: Dose Escalation|Progressive Disease|3
86246|NCT00879684|302899|P5|Stage 1: Dose Escalation|Progressive Disease|3
86247|NCT00879684|302900|P4|Stage 1: Dose Escalation|Progressive Disease|4
86248|NCT00879684|302901|P3|Stage 1: Dose Escalation|Progressive Disease|0
86249|NCT00879684|302902|P2|Stage 1: Dose Escalation|Progressive Disease|3
86250|NCT00879684|302903|P1|Stage 1: Dose Escalation|Progressive Disease|2
86251|NCT00879684|302897|P7|Stage 1: Dose Escalation|Adverse Event|0
86252|NCT00879684|302898|P6|Stage 1: Dose Escalation|Adverse Event|0
86253|NCT00879684|302899|P5|Stage 1: Dose Escalation|Adverse Event|0
86254|NCT00879684|302900|P4|Stage 1: Dose Escalation|Adverse Event|0
86255|NCT00879684|302901|P3|Stage 1: Dose Escalation|Adverse Event|0
86256|NCT00879684|302902|P2|Stage 1: Dose Escalation|Adverse Event|0
86257|NCT00879684|302903|P1|Stage 1: Dose Escalation|Adverse Event|1
86258|NCT00879645|302969|P4|Overall Study|Adverse Event|0
86259|NCT00879645|302970|P3|Overall Study|Adverse Event|0
86260|NCT00879645|302971|P2|Overall Study|Adverse Event|0
86261|NCT00879645|302972|P1|Overall Study|Adverse Event|1
86262|NCT00879411|302999|P1|Overall Study|lost to follow-up (non-AE)|162
86263|NCT00879398|303005|P1|Overall Study|Other Reasons|171
86264|NCT00879398|303005|P1|Overall Study|Adverse Event|41
86265|NCT00879398|303005|P1|Overall Study|Lack of Efficacy|64
86266|NCT00879398|303005|P1|Overall Study|Visit Stop|399
86267|NCT00879333|303017|P2|Overall Study|Protocol Violation|1
86268|NCT00879333|303018|P1|Overall Study|Protocol Violation|1
86269|NCT00879333|303017|P2|Overall Study|Disease Progression|169
86270|NCT00879333|303018|P1|Overall Study|Disease Progression|292
86271|NCT00879333|303017|P2|Overall Study|Death|5
86272|NCT00879333|303018|P1|Overall Study|Death|16
86273|NCT00879333|303017|P2|Overall Study|Administrative Problems|0
86274|NCT00879333|303018|P1|Overall Study|Administrative Problems|2
86275|NCT00879333|303017|P2|Overall Study|Lost to Follow-up|1
86276|NCT00879333|303018|P1|Overall Study|Lost to Follow-up|2
86277|NCT00879333|303017|P2|Overall Study|Withdrawal by Subject|7
86278|NCT00879333|303018|P1|Overall Study|Withdrawal by Subject|20
86279|NCT00879333|303017|P2|Overall Study|Abnormal Laboratory Value|0
86280|NCT00879333|303018|P1|Overall Study|Abnormal Laboratory Value|1
86281|NCT00879333|303017|P2|Overall Study|Adverse Event|34
86282|NCT00879333|303018|P1|Overall Study|Adverse Event|94
86283|NCT00879229|303051|P2|Overall Study|Other|0
86284|NCT00879229|303052|P1|Overall Study|Other|1
86285|NCT00879229|303051|P2|Overall Study|Clinical status did not improve|0
86286|NCT00879229|303052|P1|Overall Study|Clinical status did not improve|1
86287|NCT00879229|303051|P2|Overall Study|Withdrawal by Subject|0
86288|NCT00879229|303052|P1|Overall Study|Withdrawal by Subject|1
86289|NCT00879229|303051|P2|Overall Study|Adverse Event|0
86290|NCT00879229|303052|P1|Overall Study|Adverse Event|2
86291|NCT00879229|303051|P2|Overall Study|Death|2
86292|NCT00879229|303052|P1|Overall Study|Death|4
86293|NCT00879229|303051|P2|Overall Study|Study terminated by Sponsor|12
86294|NCT00879229|303052|P1|Overall Study|Study terminated by Sponsor|13
86295|NCT00878969|303079|P3|Overall Study|Pregnancy|0
86296|NCT00878969|303080|P2|Overall Study|Pregnancy|1
86297|NCT00878969|303081|P1|Overall Study|Pregnancy|0
86298|NCT00878969|303079|P3|Overall Study|Death|2
86299|NCT00878969|303080|P2|Overall Study|Death|0
86300|NCT00878969|303081|P1|Overall Study|Death|0
86301|NCT00878969|303079|P3|Overall Study|Protocol Violation|0
86302|NCT00878969|303080|P2|Overall Study|Protocol Violation|0
86303|NCT00878969|303081|P1|Overall Study|Protocol Violation|2
86304|NCT00878969|303079|P3|Overall Study|Lost to Follow-up|0
86305|NCT00878969|303080|P2|Overall Study|Lost to Follow-up|1
86306|NCT00878969|303081|P1|Overall Study|Lost to Follow-up|2
86307|NCT00878969|303079|P3|Overall Study|Adverse Event|2
86308|NCT00878969|303080|P2|Overall Study|Adverse Event|1
86309|NCT00878969|303081|P1|Overall Study|Adverse Event|3
86310|NCT00878969|303079|P3|Overall Study|kidney transplant|2
86311|NCT00878969|303080|P2|Overall Study|kidney transplant|3
86312|NCT00878969|303081|P1|Overall Study|kidney transplant|2
86313|NCT00878969|303079|P3|Overall Study|Withdrawal by Subject|3
86314|NCT00878969|303080|P2|Overall Study|Withdrawal by Subject|6
86315|NCT00878969|303081|P1|Overall Study|Withdrawal by Subject|1
86316|NCT00878969|303079|P3|Overall Study|Physician Decision|2
86317|NCT00878969|303080|P2|Overall Study|Physician Decision|3
86318|NCT00878969|303081|P1|Overall Study|Physician Decision|5
86319|NCT00878800|303129|P5|Overall Study|Other|1
86320|NCT00878800|303130|P4|Overall Study|Other|0
86321|NCT00878800|303131|P3|Overall Study|Other|0
86322|NCT00878800|303132|P2|Overall Study|Other|1
86323|NCT00878800|303133|P1|Overall Study|Other|1
86324|NCT00878800|303129|P5|Overall Study|Death|0
86325|NCT00878800|303130|P4|Overall Study|Death|0
86326|NCT00878800|303131|P3|Overall Study|Death|1
86327|NCT00878800|303132|P2|Overall Study|Death|0
86328|NCT00878800|303133|P1|Overall Study|Death|0
86329|NCT00878800|303129|P5|Overall Study|Withdrew consent|1
86330|NCT00878800|303130|P4|Overall Study|Withdrew consent|1
86331|NCT00878800|303131|P3|Overall Study|Withdrew consent|0
86332|NCT00878800|303132|P2|Overall Study|Withdrew consent|1
86333|NCT00878800|303133|P1|Overall Study|Withdrew consent|1
86334|NCT00878800|303129|P5|Overall Study|Progressive disease|13
86335|NCT00878800|303130|P4|Overall Study|Progressive disease|5
86336|NCT00878800|303131|P3|Overall Study|Progressive disease|6
86337|NCT00878800|303132|P2|Overall Study|Progressive disease|5
86338|NCT00878800|303133|P1|Overall Study|Progressive disease|1
86339|NCT00878800|303129|P5|Overall Study|Adverse Event|1
86340|NCT00878800|303130|P4|Overall Study|Adverse Event|0
86341|NCT00878800|303131|P3|Overall Study|Adverse Event|2
86342|NCT00878800|303132|P2|Overall Study|Adverse Event|0
86343|NCT00878800|303133|P1|Overall Study|Adverse Event|0
86344|NCT00878722|303168|P8|Overall Study|Relapse|0
86345|NCT00878722|303169|P7|Overall Study|Relapse|0
86346|NCT00878722|303170|P6|Overall Study|Relapse|0
86347|NCT00878722|303171|P5|Overall Study|Relapse|0
86348|NCT00878722|303172|P4|Overall Study|Relapse|1
86349|NCT00878722|303173|P3|Overall Study|Relapse|0
86350|NCT00878722|303174|P2|Overall Study|Relapse|0
86351|NCT00878722|303175|P1|Overall Study|Relapse|0
86352|NCT00878722|303168|P8|Overall Study|Withdrawal by Subject|2
86353|NCT00878722|303169|P7|Overall Study|Withdrawal by Subject|0
86354|NCT00878722|303170|P6|Overall Study|Withdrawal by Subject|0
86355|NCT00878722|303171|P5|Overall Study|Withdrawal by Subject|0
86356|NCT00878722|303172|P4|Overall Study|Withdrawal by Subject|0
86357|NCT00878722|303173|P3|Overall Study|Withdrawal by Subject|0
86358|NCT00878722|303174|P2|Overall Study|Withdrawal by Subject|0
86359|NCT00878722|303175|P1|Overall Study|Withdrawal by Subject|0
86360|NCT00878722|303168|P8|Overall Study|Adverse Event|0
86361|NCT00878722|303169|P7|Overall Study|Adverse Event|2
86362|NCT00878722|303170|P6|Overall Study|Adverse Event|0
86363|NCT00878722|303171|P5|Overall Study|Adverse Event|0
86364|NCT00878722|303172|P4|Overall Study|Adverse Event|0
86365|NCT00878722|303173|P3|Overall Study|Adverse Event|0
86366|NCT00878722|303174|P2|Overall Study|Adverse Event|0
86367|NCT00878722|303175|P1|Overall Study|Adverse Event|0
86368|NCT00878722|303168|P8|Overall Study|Death|2
86369|NCT00878722|303169|P7|Overall Study|Death|0
86370|NCT00878722|303170|P6|Overall Study|Death|1
86371|NCT00878722|303171|P5|Overall Study|Death|0
86372|NCT00878722|303172|P4|Overall Study|Death|1
86373|NCT00878722|303173|P3|Overall Study|Death|0
86374|NCT00878722|303174|P2|Overall Study|Death|0
86375|NCT00878722|303175|P1|Overall Study|Death|0
86376|NCT00878722|303168|P8|Overall Study|Progressive disease|3
86377|NCT00878722|303169|P7|Overall Study|Progressive disease|4
86378|NCT00878722|303170|P6|Overall Study|Progressive disease|1
86379|NCT00878722|303171|P5|Overall Study|Progressive disease|7
86380|NCT00878722|303172|P4|Overall Study|Progressive disease|7
86381|NCT00878722|303173|P3|Overall Study|Progressive disease|3
86382|NCT00878722|303174|P2|Overall Study|Progressive disease|3
86383|NCT00878722|303175|P1|Overall Study|Progressive disease|3
86384|NCT00878553|303279|P5|PK Study|Withdrawal by Subject|0
86385|NCT00878553|303280|P4|PK Study|Withdrawal by Subject|1
86386|NCT00878553|303281|P3|PK Study|Withdrawal by Subject|0
86387|NCT00878553|303282|P2|PK Study|Withdrawal by Subject|0
86388|NCT00878553|303283|P1|PK Study|Withdrawal by Subject|0
86389|NCT00878553|303279|P5|Sleep Study|family emergency|0
86390|NCT00878553|303280|P4|Sleep Study|family emergency|0
86391|NCT00878553|303281|P3|Sleep Study|family emergency|0
86392|NCT00878553|303282|P2|Sleep Study|family emergency|0
86393|NCT00878553|303283|P1|Sleep Study|family emergency|1
86394|NCT00878553|303279|P5|Sleep Study|car accident|0
86395|NCT00878553|303280|P4|Sleep Study|car accident|0
86396|NCT00878553|303281|P3|Sleep Study|car accident|0
86397|NCT00878553|303282|P2|Sleep Study|car accident|0
86398|NCT00878553|303283|P1|Sleep Study|car accident|1
86399|NCT00878553|303279|P5|Sleep Study|Lost to Follow-up|0
86400|NCT00878553|303280|P4|Sleep Study|Lost to Follow-up|0
86401|NCT00878553|303281|P3|Sleep Study|Lost to Follow-up|0
86402|NCT00878553|303282|P2|Sleep Study|Lost to Follow-up|0
86403|NCT00878553|303283|P1|Sleep Study|Lost to Follow-up|1
86404|NCT00878553|303279|P5|Sleep Study|Withdrawal by Subject|0
86405|NCT00878553|303280|P4|Sleep Study|Withdrawal by Subject|0
86406|NCT00878553|303281|P3|Sleep Study|Withdrawal by Subject|0
86407|NCT00878553|303282|P2|Sleep Study|Withdrawal by Subject|0
86408|NCT00878553|303283|P1|Sleep Study|Withdrawal by Subject|2
86409|NCT00878501|303342|P3|Overall Study|Administrative|1
86410|NCT00878501|303343|P2|Overall Study|Administrative|0
86411|NCT00878501|303344|P1|Overall Study|Administrative|0
86412|NCT00878501|303342|P3|Overall Study|Mis-randomisation of patient|0
86413|NCT00878501|303343|P2|Overall Study|Mis-randomisation of patient|0
86414|NCT00878501|303344|P1|Overall Study|Mis-randomisation of patient|1
86493|NCT00877487|303563|P2|Open-label Treatment Phase|Lost to Follow-up|0
86415|NCT00878501|303342|P3|Overall Study|Intake of prohibited concom. medication|1
86416|NCT00878501|303343|P2|Overall Study|Intake of prohibited concom. medication|0
86417|NCT00878501|303344|P1|Overall Study|Intake of prohibited concom. medication|0
86418|NCT00878501|303342|P3|Overall Study|Incorrect enrolment|0
86419|NCT00878501|303343|P2|Overall Study|Incorrect enrolment|2
86420|NCT00878501|303344|P1|Overall Study|Incorrect enrolment|1
86421|NCT00878501|303342|P3|Overall Study|Protocol Violation|1
86422|NCT00878501|303343|P2|Overall Study|Protocol Violation|0
86423|NCT00878501|303344|P1|Overall Study|Protocol Violation|0
86424|NCT00878501|303342|P3|Overall Study|Withdrawal by Subject|2
86425|NCT00878501|303343|P2|Overall Study|Withdrawal by Subject|1
86426|NCT00878501|303344|P1|Overall Study|Withdrawal by Subject|2
86427|NCT00878501|303342|P3|Overall Study|Lack of Efficacy|0
86428|NCT00878501|303343|P2|Overall Study|Lack of Efficacy|1
86429|NCT00878501|303344|P1|Overall Study|Lack of Efficacy|2
86430|NCT00878501|303342|P3|Overall Study|Adverse Event|3
86431|NCT00878501|303343|P2|Overall Study|Adverse Event|3
86432|NCT00878501|303344|P1|Overall Study|Adverse Event|11
86433|NCT00877929|303376|P2|Overall Study|Other reason (not specified)|6
86434|NCT00877929|303377|P1|Overall Study|Other reason (not specified)|2
86435|NCT00877929|303376|P2|Overall Study|Lack of Efficacy|1
86436|NCT00877929|303377|P1|Overall Study|Lack of Efficacy|0
86437|NCT00877929|303376|P2|Overall Study|Withdrawal by Subject|4
86438|NCT00877929|303377|P1|Overall Study|Withdrawal by Subject|4
86439|NCT00877929|303376|P2|Overall Study|Lost to Follow-up|1
86440|NCT00877929|303377|P1|Overall Study|Lost to Follow-up|0
86441|NCT00877929|303376|P2|Overall Study|Protocol Violation|3
86442|NCT00877929|303377|P1|Overall Study|Protocol Violation|3
86443|NCT00877929|303376|P2|Overall Study|Adverse Event|20
86444|NCT00877929|303377|P1|Overall Study|Adverse Event|11
86445|NCT00877890|303465|P2|Overall Study|Loss of Glucose Control|4
86446|NCT00877890|303466|P1|Overall Study|Loss of Glucose Control|3
86447|NCT00877890|303465|P2|Overall Study|Investigator Decision|2
86448|NCT00877890|303466|P1|Overall Study|Investigator Decision|0
86449|NCT00877890|303465|P2|Overall Study|Withdrawal of Consent|12
86450|NCT00877890|303466|P1|Overall Study|Withdrawal of Consent|6
86451|NCT00877890|303465|P2|Overall Study|Protocol Violation|1
86452|NCT00877890|303466|P1|Overall Study|Protocol Violation|0
86453|NCT00877890|303465|P2|Overall Study|Lost to Follow-up|5
86454|NCT00877890|303466|P1|Overall Study|Lost to Follow-up|5
86455|NCT00877890|303465|P2|Overall Study|Adverse Event|6
86456|NCT00877890|303466|P1|Overall Study|Adverse Event|6
86457|NCT00877799|303531|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
86458|NCT00877799|303532|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
86459|NCT00877799|303533|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
86460|NCT00877799|303534|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
86461|NCT00877799|303535|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
86462|NCT00877799|303531|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
86463|NCT00877799|303532|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
86464|NCT00877799|303533|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
86465|NCT00877799|303534|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
86466|NCT00877799|303535|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
86467|NCT00877799|303531|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
86468|NCT00877799|303532|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
86469|NCT00877799|303533|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
86470|NCT00877799|303534|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
86471|NCT00877799|303535|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
86472|NCT00877799|303531|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
86473|NCT00877799|303532|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
86474|NCT00877799|303533|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
86475|NCT00877799|303534|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
86476|NCT00877799|303535|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
86477|NCT00877799|303531|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
86478|NCT00877799|303532|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
86479|NCT00877799|303533|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
86480|NCT00877799|303534|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
86481|NCT00877799|303535|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
86482|NCT00877773|303550|P1|Overall Study|Disease Progression|44
86483|NCT00877487|303563|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
86484|NCT00877487|303564|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
86485|NCT00877487|303563|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
86486|NCT00877487|303564|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
86487|NCT00877487|303563|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
86488|NCT00877487|303564|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
86489|NCT00877487|303563|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
86490|NCT00877487|303564|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
86491|NCT00877487|303563|P2|Open-label Treatment Phase|Out of country for business|0
86492|NCT00877487|303564|P1|Open-label Treatment Phase|Out of country for business|1
86494|NCT00877487|303564|P1|Open-label Treatment Phase|Lost to Follow-up|1
86495|NCT00877487|303563|P2|Open-label Treatment Phase|Withdrawal by Subject|0
86496|NCT00877487|303564|P1|Open-label Treatment Phase|Withdrawal by Subject|1
86497|NCT00877487|303563|P2|Open-label Treatment Phase|Protocol Violation|0
86498|NCT00877487|303564|P1|Open-label Treatment Phase|Protocol Violation|3
86499|NCT00877487|303563|P2|Open-label Treatment Phase|Adverse Event|0
86500|NCT00877487|303564|P1|Open-label Treatment Phase|Adverse Event|1
86501|NCT00877383|303612|P2|Overall Study|Death|2
86502|NCT00877383|303613|P1|Overall Study|Death|1
86503|NCT00877383|303612|P2|Overall Study|Unsatisfactory therapeutic effect|0
86504|NCT00877383|303613|P1|Overall Study|Unsatisfactory therapeutic effect|1
86505|NCT00877383|303612|P2|Overall Study|Protocol deviation|6
86506|NCT00877383|303613|P1|Overall Study|Protocol deviation|2
86507|NCT00877383|303612|P2|Overall Study|Administrative problems|0
86508|NCT00877383|303613|P1|Overall Study|Administrative problems|2
86509|NCT00877383|303612|P2|Overall Study|Subject no longer requires study drug|0
86510|NCT00877383|303613|P1|Overall Study|Subject no longer requires study drug|2
86511|NCT00877383|303612|P2|Overall Study|Subject withdrew consent|12
86512|NCT00877383|303613|P1|Overall Study|Subject withdrew consent|3
86513|NCT00877383|303612|P2|Overall Study|Lost to Follow-up|3
86514|NCT00877383|303613|P1|Overall Study|Lost to Follow-up|5
86515|NCT00877383|303612|P2|Overall Study|Adverse Event|14
86516|NCT00877383|303613|P1|Overall Study|Adverse Event|13
86517|NCT00875017|303639|P6|Fourth Intervention|Inability to comply with fasting|1
86518|NCT00875017|303640|P5|Fourth Intervention|Inability to comply with fasting|0
86519|NCT00875017|303641|P4|Fourth Intervention|Inability to comply with fasting|0
86520|NCT00875017|303642|P3|Fourth Intervention|Inability to comply with fasting|0
86521|NCT00875017|303643|P2|Fourth Intervention|Inability to comply with fasting|0
86522|NCT00875017|303644|P1|Fourth Intervention|Inability to comply with fasting|0
86523|NCT00875017|303639|P6|Washout|Withdrawal by Subject|0
86524|NCT00875017|303640|P5|Washout|Withdrawal by Subject|1
86525|NCT00875017|303641|P4|Washout|Withdrawal by Subject|0
86526|NCT00875017|303642|P3|Washout|Withdrawal by Subject|0
86527|NCT00875017|303643|P2|Washout|Withdrawal by Subject|0
86528|NCT00875017|303644|P1|Washout|Withdrawal by Subject|0
86529|NCT00875017|303639|P6|Third Intervention|Adverse Event|0
86530|NCT00875017|303640|P5|Third Intervention|Adverse Event|0
86531|NCT00875017|303641|P4|Third Intervention|Adverse Event|0
86532|NCT00875017|303642|P3|Third Intervention|Adverse Event|1
86533|NCT00875017|303643|P2|Third Intervention|Adverse Event|1
86534|NCT00875017|303644|P1|Third Intervention|Adverse Event|0
86535|NCT00875017|303639|P6|Washout|Problems collecting rectal effluent|0
86536|NCT00875017|303640|P5|Washout|Problems collecting rectal effluent|0
86537|NCT00875017|303641|P4|Washout|Problems collecting rectal effluent|0
86538|NCT00875017|303642|P3|Washout|Problems collecting rectal effluent|0
86539|NCT00875017|303643|P2|Washout|Problems collecting rectal effluent|1
86540|NCT00875017|303644|P1|Washout|Problems collecting rectal effluent|0
86541|NCT00875017|303639|P6|Second Intervention|Adverse Event|0
86542|NCT00875017|303640|P5|Second Intervention|Adverse Event|0
86543|NCT00875017|303641|P4|Second Intervention|Adverse Event|1
86544|NCT00875017|303642|P3|Second Intervention|Adverse Event|0
86545|NCT00875017|303643|P2|Second Intervention|Adverse Event|0
86546|NCT00875017|303644|P1|Second Intervention|Adverse Event|0
86547|NCT00875017|303639|P6|Washout|Problem collecting rectal effluent|0
86548|NCT00875017|303640|P5|Washout|Problem collecting rectal effluent|0
86549|NCT00875017|303641|P4|Washout|Problem collecting rectal effluent|0
86550|NCT00875017|303642|P3|Washout|Problem collecting rectal effluent|1
86551|NCT00875017|303643|P2|Washout|Problem collecting rectal effluent|0
86552|NCT00875017|303644|P1|Washout|Problem collecting rectal effluent|0
86553|NCT00875017|303639|P6|First Intervention|Intolerance to nasogastric tube|0
86554|NCT00875017|303640|P5|First Intervention|Intolerance to nasogastric tube|1
86555|NCT00875017|303641|P4|First Intervention|Intolerance to nasogastric tube|0
86556|NCT00875017|303642|P3|First Intervention|Intolerance to nasogastric tube|0
86557|NCT00875017|303643|P2|First Intervention|Intolerance to nasogastric tube|0
86558|NCT00875017|303644|P1|First Intervention|Intolerance to nasogastric tube|0
86559|NCT00875017|303639|P6|First Intervention|Problems collecting rectal effluent|0
86560|NCT00875017|303640|P5|First Intervention|Problems collecting rectal effluent|0
86561|NCT00875017|303641|P4|First Intervention|Problems collecting rectal effluent|0
86562|NCT00875017|303642|P3|First Intervention|Problems collecting rectal effluent|0
86563|NCT00875017|303643|P2|First Intervention|Problems collecting rectal effluent|0
86564|NCT00875017|303644|P1|First Intervention|Problems collecting rectal effluent|1
86565|NCT00875017|303639|P6|First Intervention|Adverse Event|0
86566|NCT00875017|303640|P5|First Intervention|Adverse Event|0
86567|NCT00875017|303641|P4|First Intervention|Adverse Event|1
86568|NCT00875017|303642|P3|First Intervention|Adverse Event|0
86569|NCT00875017|303643|P2|First Intervention|Adverse Event|0
86570|NCT00875017|303644|P1|First Intervention|Adverse Event|0
86571|NCT00875017|303639|P6|First Intervention|Withdrawal by Subject|0
86572|NCT00875017|303640|P5|First Intervention|Withdrawal by Subject|0
86573|NCT00875017|303641|P4|First Intervention|Withdrawal by Subject|0
86574|NCT00875017|303642|P3|First Intervention|Withdrawal by Subject|1
86575|NCT00875017|303643|P2|First Intervention|Withdrawal by Subject|0
86576|NCT00875017|303644|P1|First Intervention|Withdrawal by Subject|1
86577|NCT00877071|303658|P1|Overall Study|disease progression|2
86578|NCT00877032|303691|P7|Overall Study|Did not meet entrance criteria|2
86579|NCT00877032|303692|P6|Overall Study|Did not meet entrance criteria|0
86580|NCT00877032|303693|P5|Overall Study|Did not meet entrance criteria|0
86581|NCT00877032|303694|P4|Overall Study|Did not meet entrance criteria|1
86582|NCT00877032|303695|P3|Overall Study|Did not meet entrance criteria|0
86583|NCT00877032|303696|P2|Overall Study|Did not meet entrance criteria|0
86584|NCT00877032|303697|P1|Overall Study|Did not meet entrance criteria|0
86585|NCT00877006|303798|P2|Treatment Period|Randomized but Not Treated|8
86586|NCT00877006|303799|P1|Treatment Period|Randomized but Not Treated|3
86587|NCT00877006|303798|P2|Treatment Period|Not Specified|4
86588|NCT00877006|303799|P1|Treatment Period|Not Specified|4
86589|NCT00877006|303798|P2|Treatment Period|Started New Treatment Regimen|5
86590|NCT00877006|303799|P1|Treatment Period|Started New Treatment Regimen|1
86591|NCT00877006|303798|P2|Treatment Period|Disease Progression|2
86592|NCT00877006|303799|P1|Treatment Period|Disease Progression|0
86593|NCT00877006|303798|P2|Treatment Period|Lost to Follow-up|1
86594|NCT00877006|303799|P1|Treatment Period|Lost to Follow-up|0
86595|NCT00877006|303798|P2|Treatment Period|Protocol Violation|0
86596|NCT00877006|303799|P1|Treatment Period|Protocol Violation|1
86597|NCT00877006|303798|P2|Treatment Period|Withdrawal by Subject|3
86598|NCT00877006|303799|P1|Treatment Period|Withdrawal by Subject|2
86599|NCT00877006|303798|P2|Treatment Period|Adverse Event|3
86600|NCT00877006|303799|P1|Treatment Period|Adverse Event|9
86601|NCT00877006|303798|P2|Treatment Period|Death|1
86602|NCT00877006|303799|P1|Treatment Period|Death|1
86603|NCT00876928|303827|P2|Overall Study|Hypokalemia-affects insulin secretion|0
86604|NCT00876928|303828|P1|Overall Study|Hypokalemia-affects insulin secretion|1
86605|NCT00876928|303827|P2|Overall Study|Lost to Follow-up|5
86606|NCT00876928|303828|P1|Overall Study|Lost to Follow-up|2
86607|NCT00876733|303865|P4|Overall Study|Data not available|1
86608|NCT00876733|303866|P3|Overall Study|Data not available|7
86609|NCT00876733|303867|P2|Overall Study|Data not available|3
86610|NCT00876733|303868|P1|Overall Study|Data not available|14
86611|NCT00876733|303865|P4|Overall Study|Lost to Follow-up|2
86612|NCT00876733|303866|P3|Overall Study|Lost to Follow-up|3
86613|NCT00876733|303867|P2|Overall Study|Lost to Follow-up|10
86614|NCT00876733|303868|P1|Overall Study|Lost to Follow-up|26
86615|NCT00876733|303865|P4|Overall Study|Lack of Efficacy|1
86616|NCT00876733|303866|P3|Overall Study|Lack of Efficacy|10
86617|NCT00876733|303867|P2|Overall Study|Lack of Efficacy|9
86618|NCT00876733|303868|P1|Overall Study|Lack of Efficacy|17
86619|NCT00876733|303865|P4|Overall Study|Adverse Event|3
86620|NCT00876733|303866|P3|Overall Study|Adverse Event|10
86621|NCT00876733|303867|P2|Overall Study|Adverse Event|20
86622|NCT00876733|303868|P1|Overall Study|Adverse Event|34
86623|NCT00876694|303976|P2|Overall Study|Death|0
86624|NCT00876694|303977|P1|Overall Study|Death|1
86625|NCT00876694|303976|P2|Overall Study|Administrative problems|1
86626|NCT00876694|303977|P1|Overall Study|Administrative problems|1
86627|NCT00876694|303976|P2|Overall Study|Abnormal test procedure result(s)|0
86628|NCT00876694|303977|P1|Overall Study|Abnormal test procedure result(s)|1
86629|NCT00876694|303976|P2|Overall Study|Unsatisfactory therapeutic effect|0
86630|NCT00876694|303977|P1|Overall Study|Unsatisfactory therapeutic effect|2
86631|NCT00876694|303976|P2|Overall Study|Subject withdrew consent|4
86632|NCT00876694|303977|P1|Overall Study|Subject withdrew consent|6
86633|NCT00876694|303976|P2|Overall Study|Adverse Event|7
86634|NCT00876694|303977|P1|Overall Study|Adverse Event|10
86635|NCT00876460|304003|P8|Mono Therapy Phase|Adverse Event|0
86636|NCT00876460|304004|P7|Mono Therapy Phase|Adverse Event|0
86637|NCT00876460|304005|P6|Mono Therapy Phase|Adverse Event|0
86638|NCT00876460|304006|P5|Mono Therapy Phase|Adverse Event|0
86639|NCT00876460|304007|P4|Mono Therapy Phase|Adverse Event|1
86640|NCT00876460|304008|P3|Mono Therapy Phase|Adverse Event|0
86641|NCT00876460|304009|P2|Mono Therapy Phase|Adverse Event|0
86642|NCT00876460|304010|P1|Mono Therapy Phase|Adverse Event|0
86643|NCT00876460|304003|P8|Mono Therapy Phase|Withdrawal by Subject|0
86644|NCT00876460|304004|P7|Mono Therapy Phase|Withdrawal by Subject|0
86645|NCT00876460|304005|P6|Mono Therapy Phase|Withdrawal by Subject|0
86646|NCT00876460|304006|P5|Mono Therapy Phase|Withdrawal by Subject|0
86647|NCT00876460|304007|P4|Mono Therapy Phase|Withdrawal by Subject|0
86648|NCT00876460|304008|P3|Mono Therapy Phase|Withdrawal by Subject|0
86649|NCT00876460|304009|P2|Mono Therapy Phase|Withdrawal by Subject|1
86650|NCT00876460|304010|P1|Mono Therapy Phase|Withdrawal by Subject|0
86651|NCT00876460|304003|P8|Mono Therapy Phase|Progressive disease|3
86652|NCT00876460|304004|P7|Mono Therapy Phase|Progressive disease|1
86653|NCT00876460|304005|P6|Mono Therapy Phase|Progressive disease|0
86654|NCT00876460|304006|P5|Mono Therapy Phase|Progressive disease|2
86655|NCT00876460|304007|P4|Mono Therapy Phase|Progressive disease|0
86656|NCT00876460|304008|P3|Mono Therapy Phase|Progressive disease|0
86657|NCT00876460|304009|P2|Mono Therapy Phase|Progressive disease|0
86658|NCT00876460|304010|P1|Mono Therapy Phase|Progressive disease|0
86659|NCT00876460|304003|P8|Combination Therapy Phase|Not treated|0
86660|NCT00876460|304004|P7|Combination Therapy Phase|Not treated|1
86661|NCT00876460|304005|P6|Combination Therapy Phase|Not treated|0
86662|NCT00876460|304006|P5|Combination Therapy Phase|Not treated|0
86663|NCT00876460|304007|P4|Combination Therapy Phase|Not treated|0
86664|NCT00876460|304008|P3|Combination Therapy Phase|Not treated|0
86665|NCT00876460|304009|P2|Combination Therapy Phase|Not treated|0
86666|NCT00876460|304010|P1|Combination Therapy Phase|Not treated|0
86667|NCT00876460|304003|P8|Combination Therapy Phase|Other reason not defined above|2
86668|NCT00876460|304004|P7|Combination Therapy Phase|Other reason not defined above|1
86669|NCT00876460|304005|P6|Combination Therapy Phase|Other reason not defined above|0
86670|NCT00876460|304006|P5|Combination Therapy Phase|Other reason not defined above|0
86671|NCT00876460|304007|P4|Combination Therapy Phase|Other reason not defined above|0
86672|NCT00876460|304008|P3|Combination Therapy Phase|Other reason not defined above|0
86673|NCT00876460|304009|P2|Combination Therapy Phase|Other reason not defined above|0
86674|NCT00876460|304010|P1|Combination Therapy Phase|Other reason not defined above|0
86675|NCT00876460|304003|P8|Combination Therapy Phase|Withdrawal by Subject|0
86676|NCT00876460|304004|P7|Combination Therapy Phase|Withdrawal by Subject|0
86677|NCT00876460|304005|P6|Combination Therapy Phase|Withdrawal by Subject|0
86678|NCT00876460|304006|P5|Combination Therapy Phase|Withdrawal by Subject|1
86679|NCT00876460|304007|P4|Combination Therapy Phase|Withdrawal by Subject|0
86680|NCT00876460|304008|P3|Combination Therapy Phase|Withdrawal by Subject|0
86681|NCT00876460|304009|P2|Combination Therapy Phase|Withdrawal by Subject|1
86682|NCT00876460|304010|P1|Combination Therapy Phase|Withdrawal by Subject|1
86683|NCT00876460|304003|P8|Combination Therapy Phase|Adverse Event|2
86684|NCT00876460|304004|P7|Combination Therapy Phase|Adverse Event|3
86685|NCT00876460|304005|P6|Combination Therapy Phase|Adverse Event|0
86686|NCT00876460|304006|P5|Combination Therapy Phase|Adverse Event|2
86687|NCT00876460|304007|P4|Combination Therapy Phase|Adverse Event|2
86688|NCT00876460|304008|P3|Combination Therapy Phase|Adverse Event|0
86689|NCT00876460|304009|P2|Combination Therapy Phase|Adverse Event|2
86690|NCT00876460|304010|P1|Combination Therapy Phase|Adverse Event|0
86691|NCT00876460|304003|P8|Combination Therapy Phase|Dose limiting toxicity|1
86692|NCT00876460|304004|P7|Combination Therapy Phase|Dose limiting toxicity|2
86693|NCT00876460|304005|P6|Combination Therapy Phase|Dose limiting toxicity|2
86694|NCT00876460|304006|P5|Combination Therapy Phase|Dose limiting toxicity|1
86695|NCT00876460|304007|P4|Combination Therapy Phase|Dose limiting toxicity|1
86696|NCT00876460|304008|P3|Combination Therapy Phase|Dose limiting toxicity|0
86697|NCT00876460|304009|P2|Combination Therapy Phase|Dose limiting toxicity|1
86698|NCT00876460|304010|P1|Combination Therapy Phase|Dose limiting toxicity|0
86699|NCT00876460|304003|P8|Combination Therapy Phase|Progressive disease|1
86700|NCT00876460|304004|P7|Combination Therapy Phase|Progressive disease|1
86701|NCT00876460|304005|P6|Combination Therapy Phase|Progressive disease|1
86702|NCT00876460|304006|P5|Combination Therapy Phase|Progressive disease|3
86703|NCT00876460|304007|P4|Combination Therapy Phase|Progressive disease|3
86704|NCT00876460|304008|P3|Combination Therapy Phase|Progressive disease|3
86705|NCT00876460|304009|P2|Combination Therapy Phase|Progressive disease|3
86706|NCT00876460|304010|P1|Combination Therapy Phase|Progressive disease|2
86707|NCT00876447|304082|P2|Overall Study|Adverse Event|8
86708|NCT00876447|304083|P1|Overall Study|Adverse Event|4
86709|NCT00876447|304082|P2|Overall Study|Lack of Efficacy|3
86710|NCT00876447|304083|P1|Overall Study|Lack of Efficacy|5
86711|NCT00876447|304082|P2|Overall Study|Pregnancy|2
86712|NCT00876447|304083|P1|Overall Study|Pregnancy|4
86713|NCT00876447|304082|P2|Overall Study|Lost to Follow-up|15
86714|NCT00876447|304083|P1|Overall Study|Lost to Follow-up|6
86715|NCT00876447|304082|P2|Overall Study|Personal reasons|28
86716|NCT00876447|304083|P1|Overall Study|Personal reasons|30
86717|NCT00876447|304082|P2|Overall Study|Protocol Violation|3
86718|NCT00876447|304083|P1|Overall Study|Protocol Violation|9
86719|NCT00876447|304082|P2|Overall Study|Site closure|14
86720|NCT00876447|304083|P1|Overall Study|Site closure|19
86721|NCT00876447|304082|P2|Overall Study|Other miscellaneous reasons|8
86722|NCT00876447|304083|P1|Overall Study|Other miscellaneous reasons|3
86723|NCT00876343|304144|P3|Overall Study|Change of residence or other commitments|3
86724|NCT00876343|304145|P2|Overall Study|Change of residence or other commitments|2
86725|NCT00876343|304146|P1|Overall Study|Change of residence or other commitments|2
86726|NCT00876343|304144|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
86727|NCT00876343|304145|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
86728|NCT00876343|304146|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
86729|NCT00876343|304144|P3|Overall Study|Physician Decision|1
86730|NCT00876343|304145|P2|Overall Study|Physician Decision|1
86731|NCT00876343|304146|P1|Overall Study|Physician Decision|0
86732|NCT00876343|304144|P3|Overall Study|Protocol Violation|1
86733|NCT00876343|304145|P2|Overall Study|Protocol Violation|1
86734|NCT00876343|304146|P1|Overall Study|Protocol Violation|4
86735|NCT00876343|304144|P3|Overall Study|Lack of Efficacy|1
86736|NCT00876343|304145|P2|Overall Study|Lack of Efficacy|0
86737|NCT00876343|304146|P1|Overall Study|Lack of Efficacy|0
86738|NCT00876343|304144|P3|Overall Study|Withdrawal by Subject|3
86739|NCT00876343|304145|P2|Overall Study|Withdrawal by Subject|4
86740|NCT00876343|304146|P1|Overall Study|Withdrawal by Subject|4
86741|NCT00876343|304144|P3|Overall Study|Adverse Event|2
86742|NCT00876343|304145|P2|Overall Study|Adverse Event|8
86743|NCT00876343|304146|P1|Overall Study|Adverse Event|7
86744|NCT00876265|304160|P1|Overall Study|Withdrawal by Subject|2
86745|NCT00876265|304160|P1|Overall Study|Lost to Follow-up|6
86746|NCT00876265|304160|P1|Overall Study|Miscellaneous reasons|4
86747|NCT00875979|304168|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
86748|NCT00875979|304169|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
86749|NCT00875979|304168|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
86750|NCT00875979|304169|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
86751|NCT00875979|304168|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
86752|NCT00875979|304169|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
86753|NCT00875979|304168|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
86754|NCT00875979|304169|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
86755|NCT00875979|304168|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
86756|NCT00875979|304169|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
86757|NCT00875979|304168|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
86758|NCT00875979|304169|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
86759|NCT00875979|304168|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
86760|NCT00875979|304169|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
86761|NCT00875979|304168|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
86762|NCT00875979|304169|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
86763|NCT00875979|304168|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
86764|NCT00875979|304169|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
86765|NCT00875810|304192|P1|Overall Study|Device explanted|1
86766|NCT00875810|304192|P1|Overall Study|Patient enroled but not implanted|2
86767|NCT00875810|304192|P1|Overall Study|Lost to Follow-up|39
86768|NCT00875810|304192|P1|Overall Study|Physician Decision|3
86769|NCT00875810|304192|P1|Overall Study|Withdrawal by Subject|1
86770|NCT00875797|304201|P2|Overall Study|Protocol Violation|3
86771|NCT00875797|304202|P1|Overall Study|Protocol Violation|6
86772|NCT00875706|304215|P3|Overall Study|Withdrawal by Subject|0
86773|NCT00875706|304216|P2|Overall Study|Withdrawal by Subject|0
86774|NCT00875706|304217|P1|Overall Study|Withdrawal by Subject|1
86775|NCT00875615|304234|P1|Overall Study|Withdrawal by Subject|1
86776|NCT00875563|304248|P1|Overall Study|Still be eligible for follow-up|7
86777|NCT00875563|304248|P1|Overall Study|No long-term (3-5 year) consent|6
86778|NCT00875563|304248|P1|Overall Study|Withdrawal by Subject|7
86779|NCT00875563|304248|P1|Overall Study|Death|4
86780|NCT00875485|304273|P2|Challenge Dose Epoch|Pregnancy|0
86781|NCT00875485|304274|P1|Challenge Dose Epoch|Pregnancy|1
86782|NCT00875433|304314|P1|Overall Study|Not specified|3
86783|NCT00875433|304314|P1|Overall Study|Withdrawal by Subject|2
86784|NCT00875433|304314|P1|Overall Study|Other Adverse Event|14
86785|NCT00875433|304314|P1|Overall Study|Progressive disease|41
86786|NCT00875420|304344|P5|Overall Study|Withdrawal by Subject|0
86787|NCT00875420|304345|P4|Overall Study|Withdrawal by Subject|0
86788|NCT00875420|304346|P3|Overall Study|Withdrawal by Subject|1
86789|NCT00875420|304347|P2|Overall Study|Withdrawal by Subject|0
86790|NCT00875420|304348|P1|Overall Study|Withdrawal by Subject|0
86791|NCT00875420|304344|P5|Overall Study|Sponsor decision|0
86792|NCT00875420|304345|P4|Overall Study|Sponsor decision|0
86793|NCT00875420|304346|P3|Overall Study|Sponsor decision|0
86794|NCT00875420|304347|P2|Overall Study|Sponsor decision|1
86795|NCT00875420|304348|P1|Overall Study|Sponsor decision|0
86796|NCT00875420|304344|P5|Overall Study|Prohibited medication|0
86797|NCT00875420|304345|P4|Overall Study|Prohibited medication|1
86798|NCT00875420|304346|P3|Overall Study|Prohibited medication|0
86799|NCT00875420|304347|P2|Overall Study|Prohibited medication|0
86800|NCT00875420|304348|P1|Overall Study|Prohibited medication|0
86801|NCT00875420|304344|P5|Overall Study|Personal reason|1
86802|NCT00875420|304345|P4|Overall Study|Personal reason|0
86803|NCT00875420|304346|P3|Overall Study|Personal reason|0
86804|NCT00875420|304347|P2|Overall Study|Personal reason|0
86805|NCT00875420|304348|P1|Overall Study|Personal reason|0
86806|NCT00875420|304344|P5|Overall Study|Lost to Follow-up|0
86807|NCT00875420|304345|P4|Overall Study|Lost to Follow-up|0
86808|NCT00875420|304346|P3|Overall Study|Lost to Follow-up|0
86809|NCT00875420|304347|P2|Overall Study|Lost to Follow-up|0
86810|NCT00875420|304348|P1|Overall Study|Lost to Follow-up|1
86811|NCT00875420|304344|P5|Overall Study|Inability to complete study procedures|1
86812|NCT00875420|304345|P4|Overall Study|Inability to complete study procedures|1
86813|NCT00875420|304346|P3|Overall Study|Inability to complete study procedures|1
86814|NCT00875420|304347|P2|Overall Study|Inability to complete study procedures|0
86815|NCT00875420|304348|P1|Overall Study|Inability to complete study procedures|1
86816|NCT00875420|304344|P5|Overall Study|Adverse Event|0
86817|NCT00875420|304345|P4|Overall Study|Adverse Event|0
86818|NCT00875420|304346|P3|Overall Study|Adverse Event|1
86819|NCT00875420|304347|P2|Overall Study|Adverse Event|1
86820|NCT00875420|304348|P1|Overall Study|Adverse Event|0
86821|NCT00874939|304403|P1|Overall Study|Study terminated|4
86822|NCT00874848|304436|P2|Overall Study|Physician Decision|2
86823|NCT00874848|304437|P1|Overall Study|Physician Decision|0
86824|NCT00874848|304436|P2|Overall Study|Failure to comply with protocol|1
86825|NCT00874848|304437|P1|Overall Study|Failure to comply with protocol|0
86826|NCT00874848|304436|P2|Overall Study|Noncompliance|1
86827|NCT00874848|304437|P1|Overall Study|Noncompliance|1
86828|NCT00874848|304436|P2|Overall Study|Withdrawal by Subject|4
86829|NCT00874848|304437|P1|Overall Study|Withdrawal by Subject|7
86830|NCT00874848|304436|P2|Overall Study|Progressive neoplastic disease|18
86831|NCT00874848|304437|P1|Overall Study|Progressive neoplastic disease|38
86832|NCT00874848|304436|P2|Overall Study|Adverse Event|2
86833|NCT00874848|304437|P1|Overall Study|Adverse Event|13
86834|NCT00874822|304453|P1|Overall Study|excluded by criteria|8
86835|NCT00874770|304461|P4|Overall Study|Subject no Longer Meets Study Criteria|0
86836|NCT00874770|304462|P3|Overall Study|Subject no Longer Meets Study Criteria|0
86837|NCT00874770|304463|P2|Overall Study|Subject no Longer Meets Study Criteria|0
86838|NCT00874770|304464|P1|Overall Study|Subject no Longer Meets Study Criteria|1
86839|NCT00874770|304461|P4|Overall Study|Lost to Follow-up|1
86840|NCT00874770|304462|P3|Overall Study|Lost to Follow-up|0
86841|NCT00874770|304463|P2|Overall Study|Lost to Follow-up|0
86842|NCT00874770|304464|P1|Overall Study|Lost to Follow-up|1
86843|NCT00874770|304461|P4|Overall Study|Adverse Event|2
86844|NCT00874770|304462|P3|Overall Study|Adverse Event|4
86845|NCT00874770|304463|P2|Overall Study|Adverse Event|1
86846|NCT00874770|304464|P1|Overall Study|Adverse Event|1
86847|NCT00874770|304461|P4|Overall Study|Lack of Efficacy|2
86848|NCT00874770|304462|P3|Overall Study|Lack of Efficacy|0
86849|NCT00874770|304463|P2|Overall Study|Lack of Efficacy|0
86850|NCT00874770|304464|P1|Overall Study|Lack of Efficacy|2
86851|NCT00874549|304502|P4|Overall Study|Withdrawal by Subject|1
86852|NCT00874549|304503|P3|Overall Study|Withdrawal by Subject|0
86853|NCT00874549|304504|P2|Overall Study|Withdrawal by Subject|1
86854|NCT00874549|304505|P1|Overall Study|Withdrawal by Subject|0
86855|NCT00874549|304502|P4|Overall Study|Lost to Follow-up|0
86856|NCT00874549|304503|P3|Overall Study|Lost to Follow-up|1
86857|NCT00874549|304504|P2|Overall Study|Lost to Follow-up|0
86858|NCT00874549|304505|P1|Overall Study|Lost to Follow-up|0
86859|NCT00874549|304502|P4|Overall Study|Protocol Violation|1
86860|NCT00874549|304503|P3|Overall Study|Protocol Violation|2
86861|NCT00874549|304504|P2|Overall Study|Protocol Violation|0
86862|NCT00874549|304505|P1|Overall Study|Protocol Violation|1
86863|NCT00874549|304502|P4|Overall Study|Adverse Event|0
86864|NCT00874549|304503|P3|Overall Study|Adverse Event|1
86865|NCT00874549|304504|P2|Overall Study|Adverse Event|0
86866|NCT00874549|304505|P1|Overall Study|Adverse Event|0
86867|NCT00874276|304582|P2|Overall Study|Withdrawal by Subject|1
86868|NCT00874276|304583|P1|Overall Study|Withdrawal by Subject|1
86869|NCT00874120|304603|P2|Second Intervention|Protocol Violation|0
86870|NCT00874120|304604|P1|Second Intervention|Protocol Violation|1
86871|NCT00874120|304603|P2|Second Intervention|Withdrawal by Subject|0
86872|NCT00874120|304604|P1|Second Intervention|Withdrawal by Subject|1
86873|NCT00874120|304603|P2|First Intervention|positive drug test|0
86874|NCT00874120|304604|P1|First Intervention|positive drug test|1
86875|NCT00874120|304603|P2|First Intervention|Protocol Violation|0
86876|NCT00874120|304604|P1|First Intervention|Protocol Violation|3
86877|NCT00874120|304603|P2|First Intervention|Lost to Follow-up|1
86878|NCT00874120|304604|P1|First Intervention|Lost to Follow-up|0
86879|NCT00874120|304603|P2|First Intervention|Withdrawal by Subject|0
86880|NCT00874120|304604|P1|First Intervention|Withdrawal by Subject|2
86881|NCT00874120|304603|P2|First Intervention|Adverse Event|1
86882|NCT00874120|304604|P1|First Intervention|Adverse Event|0
86883|NCT00874029|304617|P1|Overall Study|Lost to Follow-up|5
86884|NCT00874029|304617|P1|Overall Study|Adverse Event|1
86885|NCT00874029|304617|P1|Overall Study|Physician Decision|1
86886|NCT00874029|304617|P1|Overall Study|Pregnancy|4
86887|NCT00874029|304617|P1|Overall Study|Withdrawal by Subject|10
86888|NCT00873912|304633|P2|Overall Study|Lost to Follow-up|0
86889|NCT00873912|304634|P1|Overall Study|Lost to Follow-up|2
86890|NCT00873912|304633|P2|Overall Study|Withdrawal by Subject|0
86891|NCT00873912|304634|P1|Overall Study|Withdrawal by Subject|1
86892|NCT00873730|304688|P2|Overall Study|Sponsor decision|0
86893|NCT00873730|304689|P1|Overall Study|Sponsor decision|1
86894|NCT00873730|304688|P2|Overall Study|Withdrawal by Subject|1
86895|NCT00873730|304689|P1|Overall Study|Withdrawal by Subject|0
86896|NCT00873730|304688|P2|Overall Study|Adverse Event|2
86897|NCT00873730|304689|P1|Overall Study|Adverse Event|0
86898|NCT00873730|304688|P2|Overall Study|Protocol Deviation|2
86899|NCT00873730|304689|P1|Overall Study|Protocol Deviation|5
86900|NCT00873119|304738|P2|Overall Study|Not treated|0
86901|NCT00873119|304739|P1|Overall Study|Not treated|2
86902|NCT00873119|304738|P2|Overall Study|Other|5
86903|NCT00873119|304739|P1|Overall Study|Other|2
86904|NCT00873119|304738|P2|Overall Study|Death|1
86905|NCT00873119|304739|P1|Overall Study|Death|2
86906|NCT00873119|304738|P2|Overall Study|Progressive disease|18
86907|NCT00873119|304739|P1|Overall Study|Progressive disease|26
86908|NCT00873119|304738|P2|Overall Study|Adverse Event|0
86909|NCT00873119|304739|P1|Overall Study|Adverse Event|8
86910|NCT00873119|304738|P2|Overall Study|Patient request|2
86911|NCT00873119|304739|P1|Overall Study|Patient request|4
86912|NCT00873093|304760|P5|Overall Study|Ineligible|0
86913|NCT00873093|304761|P4|Overall Study|Ineligible|1
86914|NCT00873093|304762|P3|Overall Study|Ineligible|0
86915|NCT00873093|304763|P2|Overall Study|Ineligible|1
86916|NCT00873093|304764|P1|Overall Study|Ineligible|0
86917|NCT00873093|304760|P5|Overall Study|Withdrawal by Subject|0
86918|NCT00873093|304761|P4|Overall Study|Withdrawal by Subject|0
86919|NCT00873093|304762|P3|Overall Study|Withdrawal by Subject|4
86920|NCT00873093|304763|P2|Overall Study|Withdrawal by Subject|4
86921|NCT00873093|304764|P1|Overall Study|Withdrawal by Subject|1
86922|NCT00873093|304760|P5|Overall Study|Physician Decision|2
86923|NCT00873093|304761|P4|Overall Study|Physician Decision|10
86924|NCT00873093|304762|P3|Overall Study|Physician Decision|10
86925|NCT00873093|304763|P2|Overall Study|Physician Decision|17
86926|NCT00873093|304764|P1|Overall Study|Physician Decision|0
86927|NCT00873093|304760|P5|Overall Study|Death|0
86928|NCT00873093|304761|P4|Overall Study|Death|0
86929|NCT00873093|304762|P3|Overall Study|Death|2
86930|NCT00873093|304763|P2|Overall Study|Death|3
86931|NCT00873093|304764|P1|Overall Study|Death|0
86932|NCT00873093|304760|P5|Overall Study|Adverse Event|0
86933|NCT00873093|304761|P4|Overall Study|Adverse Event|0
86934|NCT00873093|304762|P3|Overall Study|Adverse Event|0
86935|NCT00873093|304763|P2|Overall Study|Adverse Event|2
86936|NCT00873093|304764|P1|Overall Study|Adverse Event|0
86937|NCT00873041|304821|P3|Extension Study|Administrative reasons|1
86938|NCT00873041|304822|P2|Extension Study|Administrative reasons|0
86939|NCT00873041|304823|P1|Extension Study|Administrative reasons|0
86940|NCT00873041|304821|P3|Extension Study|Adverse Event|1
86941|NCT00873041|304822|P2|Extension Study|Adverse Event|0
86942|NCT00873041|304823|P1|Extension Study|Adverse Event|1
86943|NCT00873041|304821|P3|Core Study|Protocol deviation|1
86944|NCT00873041|304822|P2|Core Study|Protocol deviation|0
86945|NCT00873041|304823|P1|Core Study|Protocol deviation|1
86946|NCT00873041|304821|P3|Core Study|Abnormal laboratory value|1
86947|NCT00873041|304822|P2|Core Study|Abnormal laboratory value|0
86948|NCT00873041|304823|P1|Core Study|Abnormal laboratory value|0
86949|NCT00873041|304821|P3|Core Study|Lost to Follow-up|0
86950|NCT00873041|304822|P2|Core Study|Lost to Follow-up|1
86951|NCT00873041|304823|P1|Core Study|Lost to Follow-up|3
86952|NCT00873041|304821|P3|Core Study|Withdrawal by Subject|2
86953|NCT00873041|304822|P2|Core Study|Withdrawal by Subject|2
86954|NCT00873041|304823|P1|Core Study|Withdrawal by Subject|1
86955|NCT00873041|304821|P3|Core Study|Adverse Event|1
86956|NCT00873041|304822|P2|Core Study|Adverse Event|3
86957|NCT00873041|304823|P1|Core Study|Adverse Event|2
86958|NCT00873015|304881|P4|Overall Study|Withdrawal by Subject|0
86959|NCT00873015|304882|P3|Overall Study|Withdrawal by Subject|0
86960|NCT00873015|304883|P2|Overall Study|Withdrawal by Subject|1
86961|NCT00873015|304884|P1|Overall Study|Withdrawal by Subject|0
86962|NCT00872989|304893|P2|Overall Study|Not protocol specified|8
86963|NCT00872989|304894|P1|Overall Study|Not protocol specified|3
86964|NCT00872989|304893|P2|Overall Study|Progression/relapse|35
86965|NCT00872989|304894|P1|Overall Study|Progression/relapse|47
86966|NCT00872989|304893|P2|Overall Study|Withdrawal by Subject|5
86967|NCT00872989|304894|P1|Overall Study|Withdrawal by Subject|8
86968|NCT00872989|304893|P2|Overall Study|Adverse Event|15
86969|NCT00872989|304894|P1|Overall Study|Adverse Event|7
86970|NCT00872898|304913|P2|Part Two - Double Blind|Other reasons|0
86971|NCT00872898|304914|P1|Part Two - Double Blind|Other reasons|2
86972|NCT00872898|304913|P2|Part Two - Double Blind|Lost to Follow-up|2
86973|NCT00872898|304914|P1|Part Two - Double Blind|Lost to Follow-up|0
86974|NCT00872898|304913|P2|Part Two - Double Blind|Withdrawal by Subject|1
86975|NCT00872898|304914|P1|Part Two - Double Blind|Withdrawal by Subject|3
86976|NCT00872898|304913|P2|Part Two - Double Blind|Protocol Violation|0
86977|NCT00872898|304914|P1|Part Two - Double Blind|Protocol Violation|1
86978|NCT00872898|304913|P2|Part Two - Double Blind|Lack of Efficacy|0
86979|NCT00872898|304914|P1|Part Two - Double Blind|Lack of Efficacy|1
86980|NCT00872898|304913|P2|Part Two - Double Blind|Adverse Event|3
86981|NCT00872898|304914|P1|Part Two - Double Blind|Adverse Event|4
86982|NCT00872599|304988|P2|Second Washout Period|Adverse Event|1
86983|NCT00872599|304989|P1|Second Washout Period|Adverse Event|1
86984|NCT00872521|305009|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
86985|NCT00872521|305010|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
86986|NCT00872521|305011|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
86987|NCT00872521|305009|P3|Completed 3-month Follow up|Physician Decision|0
86988|NCT00872521|305010|P2|Completed 3-month Follow up|Physician Decision|1
86989|NCT00872521|305011|P1|Completed 3-month Follow up|Physician Decision|0
86990|NCT00872521|305009|P3|Completed 3-month Follow up|Not specified|0
86991|NCT00872521|305010|P2|Completed 3-month Follow up|Not specified|2
86992|NCT00872521|305011|P1|Completed 3-month Follow up|Not specified|0
86993|NCT00872521|305009|P3|Primary Endpoint Analysis|Patient response missing|1
86994|NCT00872521|305010|P2|Primary Endpoint Analysis|Patient response missing|0
86995|NCT00872521|305011|P1|Primary Endpoint Analysis|Patient response missing|0
86996|NCT00872521|305009|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
86997|NCT00872521|305010|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
86998|NCT00872521|305011|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
86999|NCT00872521|305009|P3|Primary Endpoint Analysis|Patient choice|0
87000|NCT00872521|305010|P2|Primary Endpoint Analysis|Patient choice|1
87001|NCT00872521|305011|P1|Primary Endpoint Analysis|Patient choice|0
87002|NCT00872521|305009|P3|Primary Endpoint Analysis|Not specified|0
87003|NCT00872521|305010|P2|Primary Endpoint Analysis|Not specified|2
87004|NCT00872521|305011|P1|Primary Endpoint Analysis|Not specified|1
87005|NCT00872521|305009|P3|Completed PAD Induction|Death|0
87006|NCT00872521|305010|P2|Completed PAD Induction|Death|1
87007|NCT00872521|305011|P1|Completed PAD Induction|Death|1
87008|NCT00872521|305009|P3|Completed PAD Induction|Adverse Event|0
87009|NCT00872521|305010|P2|Completed PAD Induction|Adverse Event|0
87010|NCT00872521|305011|P1|Completed PAD Induction|Adverse Event|4
87011|NCT00872521|305009|P3|Completed PAD Induction|Disease progression|0
87012|NCT00872521|305010|P2|Completed PAD Induction|Disease progression|2
87013|NCT00872521|305011|P1|Completed PAD Induction|Disease progression|0
87014|NCT00872521|305009|P3|Completed PAD Induction|Patient choice|0
87015|NCT00872521|305010|P2|Completed PAD Induction|Patient choice|1
87016|NCT00872521|305011|P1|Completed PAD Induction|Patient choice|0
87017|NCT00872170|305082|P2|Overall Study|Adverse Event|0
87018|NCT00872170|305083|P1|Overall Study|Adverse Event|1
87019|NCT00872001|305104|P2|Overall Study|Administrative|15
87020|NCT00872001|305105|P1|Overall Study|Administrative|23
87021|NCT00872001|305104|P2|Overall Study|Did Not Meet Protocol Eligibility|36
87022|NCT00872001|305105|P1|Overall Study|Did Not Meet Protocol Eligibility|38
87023|NCT00872001|305104|P2|Overall Study|Protocol Violation|8
87024|NCT00872001|305105|P1|Overall Study|Protocol Violation|5
87025|NCT00872001|305104|P2|Overall Study|Withdrawal by Subject|30
87026|NCT00872001|305105|P1|Overall Study|Withdrawal by Subject|18
87027|NCT00872001|305104|P2|Overall Study|Lost to Follow-up|12
87028|NCT00872001|305105|P1|Overall Study|Lost to Follow-up|13
87029|NCT00872001|305104|P2|Overall Study|Protocol Defined Clinical Event|7
87030|NCT00872001|305105|P1|Overall Study|Protocol Defined Clinical Event|5
87031|NCT00872001|305104|P2|Overall Study|Adverse Event|23
87032|NCT00872001|305105|P1|Overall Study|Adverse Event|34
87033|NCT00871975|305113|P1|Overall Study|Motion artifact, tracing uninterpretable|5
87034|NCT00871975|305113|P1|Overall Study|Patient unable to void/insufficient vol|13
87035|NCT00871975|305113|P1|Overall Study|Catheters could not be inserted|1
87036|NCT00871975|305113|P1|Overall Study|Technical difficulty w155-1ith equipment|3
87037|NCT00871871|305119|P4|Part II|Protocol Violation|1
87038|NCT00871871|305120|P3|Part II|Protocol Violation|0
87039|NCT00871871|305121|P2|Part II|Protocol Violation|0
87040|NCT00871871|305122|P1|Part II|Protocol Violation|0
87041|NCT00871871|305119|P4|Part II|Adverse Event|2
87042|NCT00871871|305120|P3|Part II|Adverse Event|1
87043|NCT00871871|305121|P2|Part II|Adverse Event|0
87044|NCT00871871|305122|P1|Part II|Adverse Event|0
87045|NCT00871871|305119|P4|Part II|Withdrawal by Subject|1
87046|NCT00871871|305120|P3|Part II|Withdrawal by Subject|2
87047|NCT00871871|305121|P2|Part II|Withdrawal by Subject|0
87048|NCT00871871|305122|P1|Part II|Withdrawal by Subject|0
87049|NCT00871871|305119|P4|Part II|Lack of Efficacy|0
87050|NCT00871871|305120|P3|Part II|Lack of Efficacy|1
87051|NCT00871871|305121|P2|Part II|Lack of Efficacy|0
87052|NCT00871871|305122|P1|Part II|Lack of Efficacy|0
87053|NCT00871871|305119|P4|Part I|Laboratory abnormality|0
87054|NCT00871871|305120|P3|Part I|Laboratory abnormality|0
87055|NCT00871871|305121|P2|Part I|Laboratory abnormality|1
87056|NCT00871871|305122|P1|Part I|Laboratory abnormality|0
87057|NCT00871871|305119|P4|Part I|Withdrawal by Subject|0
87058|NCT00871871|305120|P3|Part I|Withdrawal by Subject|0
87059|NCT00871871|305121|P2|Part I|Withdrawal by Subject|0
87060|NCT00871871|305122|P1|Part I|Withdrawal by Subject|3
87061|NCT00871871|305119|P4|Part I|Adverse Event|0
87062|NCT00871871|305120|P3|Part I|Adverse Event|0
87063|NCT00871871|305121|P2|Part I|Adverse Event|2
87064|NCT00871871|305122|P1|Part I|Adverse Event|0
87065|NCT00871780|305146|P1|Overall Study|Physician Decision|1
87066|NCT00871780|305146|P1|Overall Study|Death|1
87067|NCT00871780|305146|P1|Overall Study|Voluntary Discontinuation|4
87068|NCT00871780|305146|P1|Overall Study|Adverse Event|6
87069|NCT00871780|305146|P1|Overall Study|Withdrawal by Subject|9
87070|NCT00871780|305146|P1|Overall Study|Enrolled But Not Treated|6
87071|NCT00871728|305164|P1|Overall Study|Withdrawal of Informed Consent|5
87072|NCT00871728|305164|P1|Overall Study|Participant Non-compliance|1
87073|NCT00871728|305164|P1|Overall Study|Failed to Visit Hospital|4
87074|NCT00871728|305164|P1|Overall Study|Lost to Follow-up|2
87075|NCT00871728|305164|P1|Overall Study|Protocol Violation|7
87076|NCT00871728|305164|P1|Overall Study|Adverse Event|1
87077|NCT00871715|305177|P3|Overall Study|Lost to Follow-up|9
87078|NCT00871715|305178|P2|Overall Study|Lost to Follow-up|6
87079|NCT00871715|305179|P1|Overall Study|Lost to Follow-up|3
87080|NCT00871715|305177|P3|Overall Study|Physician Decision|2
87081|NCT00871715|305178|P2|Overall Study|Physician Decision|0
87082|NCT00871715|305179|P1|Overall Study|Physician Decision|6
87083|NCT00871715|305177|P3|Overall Study|Withdrawal by Subject|15
87084|NCT00871715|305178|P2|Overall Study|Withdrawal by Subject|10
87085|NCT00871715|305179|P1|Overall Study|Withdrawal by Subject|6
87086|NCT00871494|305217|P1|Overall Study|Lost to Follow-up|1
87087|NCT00871494|305217|P1|Overall Study|Adverse Event|4
87088|NCT00871494|305217|P1|Overall Study|Lack of Efficacy|4
87089|NCT00871494|305217|P1|Overall Study|Protocol Violation|5
87090|NCT00871429|305224|P1|Overall Study|Questionnaire not completed|1
87091|NCT00871429|305224|P1|Overall Study|Withdrawal by Subject|17
87092|NCT00871429|305224|P1|Overall Study|Lost to Follow-up|6
87093|NCT00871403|305235|P3|Monotherapy Treatment Phase|Adverse Event|0
87094|NCT00871403|305236|P2|Monotherapy Treatment Phase|Adverse Event|4
87095|NCT00871403|305237|P1|Monotherapy Treatment Phase|Adverse Event|0
87096|NCT00871403|305235|P3|Monotherapy Treatment Phase|Disease Progression|1
87097|NCT00871403|305236|P2|Monotherapy Treatment Phase|Disease Progression|9
87098|NCT00871403|305237|P1|Monotherapy Treatment Phase|Disease Progression|0
87099|NCT00871403|305235|P3|Combination Treatment Phase|Physician Decision|3
87100|NCT00871403|305236|P2|Combination Treatment Phase|Physician Decision|1
87101|NCT00871403|305237|P1|Combination Treatment Phase|Physician Decision|0
87102|NCT00871403|305235|P3|Combination Treatment Phase|Withdrawal by Subject|1
87103|NCT00871403|305236|P2|Combination Treatment Phase|Withdrawal by Subject|3
87104|NCT00871403|305237|P1|Combination Treatment Phase|Withdrawal by Subject|0
87105|NCT00871403|305235|P3|Combination Treatment Phase|Disease Progression|5
87106|NCT00871403|305236|P2|Combination Treatment Phase|Disease Progression|8
87107|NCT00871403|305237|P1|Combination Treatment Phase|Disease Progression|0
87108|NCT00871403|305235|P3|Combination Treatment Phase|Adverse Event|2
87109|NCT00871403|305236|P2|Combination Treatment Phase|Adverse Event|17
87110|NCT00871403|305237|P1|Combination Treatment Phase|Adverse Event|0
87111|NCT00871403|305235|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
87112|NCT00871403|305236|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
87113|NCT00871403|305237|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
87114|NCT00871403|305235|P3|Combination Treatment Phase|Randomized but Not Treated|1
87115|NCT00871403|305236|P2|Combination Treatment Phase|Randomized but Not Treated|1
87116|NCT00871403|305237|P1|Combination Treatment Phase|Randomized but Not Treated|1
87117|NCT00871377|305250|P6|Third Intervention (10 Weeks)|Death|0
87118|NCT00871377|305251|P5|Third Intervention (10 Weeks)|Death|0
87119|NCT00871377|305252|P4|Third Intervention (10 Weeks)|Death|1
87120|NCT00871377|305253|P3|Third Intervention (10 Weeks)|Death|0
87121|NCT00871377|305254|P2|Third Intervention (10 Weeks)|Death|0
87122|NCT00871377|305255|P1|Third Intervention (10 Weeks)|Death|0
87123|NCT00871377|305250|P6|Washout (6 Weeks)|Withdrawal by Subject|1
87124|NCT00871377|305251|P5|Washout (6 Weeks)|Withdrawal by Subject|0
87125|NCT00871377|305252|P4|Washout (6 Weeks)|Withdrawal by Subject|0
87126|NCT00871377|305253|P3|Washout (6 Weeks)|Withdrawal by Subject|0
87127|NCT00871377|305254|P2|Washout (6 Weeks)|Withdrawal by Subject|0
87128|NCT00871377|305255|P1|Washout (6 Weeks)|Withdrawal by Subject|0
87129|NCT00871377|305250|P6|Washout (6 Weeks)|Withdrawal by Subject|0
87130|NCT00871377|305251|P5|Washout (6 Weeks)|Withdrawal by Subject|0
87131|NCT00871377|305252|P4|Washout (6 Weeks)|Withdrawal by Subject|0
87132|NCT00871377|305253|P3|Washout (6 Weeks)|Withdrawal by Subject|0
87133|NCT00871377|305254|P2|Washout (6 Weeks)|Withdrawal by Subject|0
87134|NCT00871377|305255|P1|Washout (6 Weeks)|Withdrawal by Subject|1
87135|NCT00871377|305250|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
87136|NCT00871377|305251|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
87137|NCT00871377|305252|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
87138|NCT00871377|305253|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
87139|NCT00871377|305254|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
87140|NCT00871377|305255|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
87141|NCT00871377|305250|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
87142|NCT00871377|305251|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
87143|NCT00871377|305252|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
87144|NCT00871377|305253|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
87145|NCT00871377|305254|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
87146|NCT00871377|305255|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
87147|NCT00871351|305266|P3|Overall Study|Adverse Event|0
87148|NCT00871351|305267|P2|Overall Study|Adverse Event|1
87149|NCT00871351|305268|P1|Overall Study|Adverse Event|3
87150|NCT00871351|305266|P3|Overall Study|Withdrawal by Subject|0
87151|NCT00871351|305267|P2|Overall Study|Withdrawal by Subject|0
87152|NCT00871351|305268|P1|Overall Study|Withdrawal by Subject|1
87153|NCT00871338|305290|P2|Prior to Booster|Lost to Follow-up|0
87154|NCT00871338|305291|P1|Prior to Booster|Lost to Follow-up|1
87155|NCT00871338|305290|P2|Prior to Booster|Withdrawal by Subject|3
87156|NCT00871338|305291|P1|Prior to Booster|Withdrawal by Subject|1
87157|NCT00871234|305380|P1|Overall Study|Lost to Follow-up|3
87158|NCT00871234|305380|P1|Overall Study|Adverse Event|2
87159|NCT00871169|305384|P1|Overall Study|Patient did not receive study treatment|2
87160|NCT00871169|305384|P1|Overall Study|Protocol Violation|1
87161|NCT00871117|305412|P2|Overall Study|Lost to Follow-up|10
87162|NCT00871117|305413|P1|Overall Study|Lost to Follow-up|5
87163|NCT00870740|305455|P6|Overall Study|Not Specified|5
87164|NCT00870740|305456|P5|Overall Study|Not Specified|3
87165|NCT00870740|305457|P4|Overall Study|Not Specified|4
87166|NCT00870740|305458|P3|Overall Study|Not Specified|2
87167|NCT00870740|305459|P2|Overall Study|Not Specified|5
87168|NCT00870740|305460|P1|Overall Study|Not Specified|2
87169|NCT00870740|305455|P6|Overall Study|Death|0
87170|NCT00870740|305456|P5|Overall Study|Death|1
87171|NCT00870740|305457|P4|Overall Study|Death|0
87172|NCT00870740|305458|P3|Overall Study|Death|0
87173|NCT00870740|305459|P2|Overall Study|Death|0
87174|NCT00870740|305460|P1|Overall Study|Death|0
87175|NCT00870740|305455|P6|Overall Study|Subject Non-compliance|1
87176|NCT00870740|305456|P5|Overall Study|Subject Non-compliance|0
87177|NCT00870740|305457|P4|Overall Study|Subject Non-compliance|0
87178|NCT00870740|305458|P3|Overall Study|Subject Non-compliance|0
87179|NCT00870740|305459|P2|Overall Study|Subject Non-compliance|0
87180|NCT00870740|305460|P1|Overall Study|Subject Non-compliance|0
87181|NCT00870740|305455|P6|Overall Study|Investigator Decision|0
87182|NCT00870740|305456|P5|Overall Study|Investigator Decision|0
87183|NCT00870740|305457|P4|Overall Study|Investigator Decision|0
87184|NCT00870740|305458|P3|Overall Study|Investigator Decision|1
87185|NCT00870740|305459|P2|Overall Study|Investigator Decision|0
87186|NCT00870740|305460|P1|Overall Study|Investigator Decision|2
87187|NCT00870740|305455|P6|Overall Study|Consent Withdrawn|5
87188|NCT00870740|305456|P5|Overall Study|Consent Withdrawn|6
87189|NCT00870740|305457|P4|Overall Study|Consent Withdrawn|6
87190|NCT00870740|305458|P3|Overall Study|Consent Withdrawn|4
87191|NCT00870740|305459|P2|Overall Study|Consent Withdrawn|3
87192|NCT00870740|305460|P1|Overall Study|Consent Withdrawn|6
87193|NCT00870740|305455|P6|Overall Study|Adverse Event|6
87194|NCT00870740|305456|P5|Overall Study|Adverse Event|1
87195|NCT00870740|305457|P4|Overall Study|Adverse Event|2
87196|NCT00870740|305458|P3|Overall Study|Adverse Event|3
87197|NCT00870740|305459|P2|Overall Study|Adverse Event|1
87198|NCT00870740|305460|P1|Overall Study|Adverse Event|2
87199|NCT00870688|305534|P1|Overall Study|Granules in the Stools|1
87200|NCT00870688|305534|P1|Overall Study|Death, Unrelated|1
87201|NCT00870688|305534|P1|Overall Study|Lost to Follow-up|2
87202|NCT00870584|305539|P2|Overall Study|Protocol Deviation|2
87203|NCT00870584|305540|P1|Overall Study|Protocol Deviation|2
87204|NCT00870584|305539|P2|Overall Study|Lost to Follow-up|1
87205|NCT00870584|305540|P1|Overall Study|Lost to Follow-up|5
87206|NCT00870584|305539|P2|Overall Study|Withdrawal by Subject|7
87207|NCT00870584|305540|P1|Overall Study|Withdrawal by Subject|6
87208|NCT00870584|305539|P2|Overall Study|Adverse Event|3
87209|NCT00870584|305540|P1|Overall Study|Adverse Event|3
87210|NCT00870194|305651|P2|Overall Study|Subject Decision|2
87211|NCT00870194|305652|P1|Overall Study|Subject Decision|7
87212|NCT00870194|305651|P2|Overall Study|Entry Criteria Not Met|2
87213|NCT00870194|305652|P1|Overall Study|Entry Criteria Not Met|1
87214|NCT00870194|305651|P2|Overall Study|Protocol Violation|3
87215|NCT00870194|305652|P1|Overall Study|Protocol Violation|3
87216|NCT00870194|305651|P2|Overall Study|Physician Decision|1
87217|NCT00870194|305652|P1|Overall Study|Physician Decision|3
87218|NCT00870194|305651|P2|Overall Study|Lost to Follow-up|0
87219|NCT00870194|305652|P1|Overall Study|Lost to Follow-up|2
87220|NCT00870194|305651|P2|Overall Study|Lack of Efficacy|1
87221|NCT00870194|305652|P1|Overall Study|Lack of Efficacy|0
87222|NCT00870194|305651|P2|Overall Study|Adverse Event|5
87223|NCT00870194|305652|P1|Overall Study|Adverse Event|10
87224|NCT00870103|305690|P1|Overall Study|Lost to Follow-up|2
87225|NCT00870103|305690|P1|Overall Study|Physician Decision|2
87226|NCT00869999|305695|P1|Overall Study|removed prior to starting therapy|1
87227|NCT00869999|305695|P1|Overall Study|Withdrawal by Subject|1
87228|NCT00869960|305701|P1|Overall Study|Lost to Follow-up|2
87229|NCT00869778|305731|P3|Overall Study|Unblinding|0
87230|NCT00869778|305732|P2|Overall Study|Unblinding|0
87231|NCT00869778|305733|P1|Overall Study|Unblinding|1
87232|NCT00869778|305731|P3|Overall Study|Protocol Violation|5
87233|NCT00869778|305732|P2|Overall Study|Protocol Violation|3
87234|NCT00869778|305733|P1|Overall Study|Protocol Violation|5
87235|NCT00869778|305731|P3|Overall Study|Pregnancy|0
87236|NCT00869778|305732|P2|Overall Study|Pregnancy|0
87237|NCT00869778|305733|P1|Overall Study|Pregnancy|1
87238|NCT00869778|305731|P3|Overall Study|Withdrawal by Subject|5
87239|NCT00869778|305732|P2|Overall Study|Withdrawal by Subject|4
87240|NCT00869778|305733|P1|Overall Study|Withdrawal by Subject|3
87241|NCT00869778|305731|P3|Overall Study|Adverse Event|0
87242|NCT00869778|305732|P2|Overall Study|Adverse Event|0
87243|NCT00869778|305733|P1|Overall Study|Adverse Event|2
87244|NCT00869557|305808|P2|Extension Phase|Withdrew Consent|0
87245|NCT00869557|305809|P1|Extension Phase|Withdrew Consent|2
87246|NCT00869557|305808|P2|Extension Phase|Investigator's Discretion|0
87247|NCT00869557|305809|P1|Extension Phase|Investigator's Discretion|2
87248|NCT00869557|305808|P2|Extension Phase|Lost to Follow-up|1
87249|NCT00869557|305809|P1|Extension Phase|Lost to Follow-up|3
87250|NCT00869557|305808|P2|Extension Phase|Lack of Efficacy|0
87251|NCT00869557|305809|P1|Extension Phase|Lack of Efficacy|1
87252|NCT00869557|305808|P2|Extension Phase|Adverse Event|2
87253|NCT00869557|305809|P1|Extension Phase|Adverse Event|2
87254|NCT00869557|305808|P2|Randomized Phase|Withdrew Consent|1
87255|NCT00869557|305809|P1|Randomized Phase|Withdrew Consent|0
87256|NCT00869557|305808|P2|Randomized Phase|Investigator's Discretion|0
87257|NCT00869557|305809|P1|Randomized Phase|Investigator's Discretion|1
87258|NCT00869557|305808|P2|Randomized Phase|Lost to Follow-up|1
87259|NCT00869557|305809|P1|Randomized Phase|Lost to Follow-up|2
87260|NCT00869518|305828|P2|Overall Study|Lost to Follow-up|1
87261|NCT00869518|305829|P1|Overall Study|Lost to Follow-up|1
87262|NCT00869362|305854|P2|Overall Study|Lost to Follow-up|3
87263|NCT00869362|305855|P1|Overall Study|Lost to Follow-up|1
87264|NCT00869362|305854|P2|Overall Study|Death|2
87265|NCT00869362|305855|P1|Overall Study|Death|0
87266|NCT00869258|305863|P1|Overall Study|Physician Decision|1
87267|NCT00869128|305897|P2|Overall Study|lack of Compliance|6
87268|NCT00869128|305898|P1|Overall Study|lack of Compliance|6
87269|NCT00869089|305902|P1|Overall Study|Screen Fail|1
87270|NCT00869089|305902|P1|Overall Study|Withdrawal by Subject|1
87271|NCT00869089|305902|P1|Overall Study|Lost to Follow-up|1
87272|NCT00869050|305906|P1|Overall Study|Screen Failure|3
87273|NCT00868998|305911|P1|Overall Study|Death|1
87274|NCT00868998|305911|P1|Overall Study|Progression of disease|2
87275|NCT00868998|305911|P1|Overall Study|Withdrawal by Subject|1
87276|NCT00868998|305911|P1|Overall Study|Screen Failure|1
87277|NCT00868790|305922|P14|Post-study|Excluded Medication|0
87278|NCT00868790|305923|P13|Post-study|Excluded Medication|0
87279|NCT00868790|305924|P12|Post-study|Excluded Medication|0
87280|NCT00868790|305925|P11|Post-study|Excluded Medication|0
87281|NCT00868790|305926|P10|Post-study|Excluded Medication|1
87282|NCT00868790|305927|P9|Post-study|Excluded Medication|0
87283|NCT00868790|305928|P8|Post-study|Excluded Medication|2
87284|NCT00868790|305929|P7|Post-study|Excluded Medication|0
87285|NCT00868790|305930|P6|Post-study|Excluded Medication|0
87286|NCT00868790|305931|P5|Post-study|Excluded Medication|0
87287|NCT00868790|305932|P4|Post-study|Excluded Medication|0
87288|NCT00868790|305933|P3|Post-study|Excluded Medication|0
87289|NCT00868790|305934|P2|Post-study|Excluded Medication|0
87290|NCT00868790|305935|P1|Post-study|Excluded Medication|0
87291|NCT00868790|305922|P14|Post-study|Withdrawal by Subject|0
87292|NCT00868790|305923|P13|Post-study|Withdrawal by Subject|0
87293|NCT00868790|305924|P12|Post-study|Withdrawal by Subject|0
87294|NCT00868790|305925|P11|Post-study|Withdrawal by Subject|0
87295|NCT00868790|305926|P10|Post-study|Withdrawal by Subject|0
87296|NCT00868790|305927|P9|Post-study|Withdrawal by Subject|0
87297|NCT00868790|305928|P8|Post-study|Withdrawal by Subject|0
87298|NCT00868790|305929|P7|Post-study|Withdrawal by Subject|0
87299|NCT00868790|305930|P6|Post-study|Withdrawal by Subject|0
87300|NCT00868790|305931|P5|Post-study|Withdrawal by Subject|1
87301|NCT00868790|305932|P4|Post-study|Withdrawal by Subject|0
87302|NCT00868790|305933|P3|Post-study|Withdrawal by Subject|0
87303|NCT00868790|305934|P2|Post-study|Withdrawal by Subject|0
87304|NCT00868790|305935|P1|Post-study|Withdrawal by Subject|0
87305|NCT00868790|305922|P14|Period 4|Abnormal ALT/AST|0
87306|NCT00868790|305923|P13|Period 4|Abnormal ALT/AST|0
87307|NCT00868790|305924|P12|Period 4|Abnormal ALT/AST|0
87308|NCT00868790|305925|P11|Period 4|Abnormal ALT/AST|0
87309|NCT00868790|305926|P10|Period 4|Abnormal ALT/AST|0
87310|NCT00868790|305927|P9|Period 4|Abnormal ALT/AST|0
87311|NCT00868790|305928|P8|Period 4|Abnormal ALT/AST|0
87312|NCT00868790|305929|P7|Period 4|Abnormal ALT/AST|0
87313|NCT00868790|305930|P6|Period 4|Abnormal ALT/AST|0
87314|NCT00868790|305931|P5|Period 4|Abnormal ALT/AST|0
87315|NCT00868790|305932|P4|Period 4|Abnormal ALT/AST|0
87316|NCT00868790|305933|P3|Period 4|Abnormal ALT/AST|1
87317|NCT00868790|305934|P2|Period 4|Abnormal ALT/AST|0
87318|NCT00868790|305935|P1|Period 4|Abnormal ALT/AST|0
87319|NCT00868790|305922|P14|Period 4|Study Terminated by Sponsor|1
87320|NCT00868790|305923|P13|Period 4|Study Terminated by Sponsor|0
87321|NCT00868790|305924|P12|Period 4|Study Terminated by Sponsor|1
87322|NCT00868790|305925|P11|Period 4|Study Terminated by Sponsor|2
87323|NCT00868790|305926|P10|Period 4|Study Terminated by Sponsor|0
87324|NCT00868790|305927|P9|Period 4|Study Terminated by Sponsor|2
87325|NCT00868790|305928|P8|Period 4|Study Terminated by Sponsor|1
87326|NCT00868790|305929|P7|Period 4|Study Terminated by Sponsor|0
87327|NCT00868790|305930|P6|Period 4|Study Terminated by Sponsor|0
87328|NCT00868790|305931|P5|Period 4|Study Terminated by Sponsor|0
87329|NCT00868790|305932|P4|Period 4|Study Terminated by Sponsor|0
87330|NCT00868790|305933|P3|Period 4|Study Terminated by Sponsor|0
87331|NCT00868790|305934|P2|Period 4|Study Terminated by Sponsor|0
87332|NCT00868790|305935|P1|Period 4|Study Terminated by Sponsor|2
87333|NCT00868790|305922|P14|Period 4|Lost to Follow-up|0
87334|NCT00868790|305923|P13|Period 4|Lost to Follow-up|0
87335|NCT00868790|305924|P12|Period 4|Lost to Follow-up|0
87336|NCT00868790|305925|P11|Period 4|Lost to Follow-up|0
87337|NCT00868790|305926|P10|Period 4|Lost to Follow-up|0
87338|NCT00868790|305927|P9|Period 4|Lost to Follow-up|0
87339|NCT00868790|305928|P8|Period 4|Lost to Follow-up|1
87340|NCT00868790|305929|P7|Period 4|Lost to Follow-up|0
87341|NCT00868790|305930|P6|Period 4|Lost to Follow-up|0
87342|NCT00868790|305931|P5|Period 4|Lost to Follow-up|0
87343|NCT00868790|305932|P4|Period 4|Lost to Follow-up|0
87344|NCT00868790|305933|P3|Period 4|Lost to Follow-up|0
87345|NCT00868790|305934|P2|Period 4|Lost to Follow-up|0
87346|NCT00868790|305935|P1|Period 4|Lost to Follow-up|0
87347|NCT00868790|305922|P14|Period 4|Adverse Event|0
87348|NCT00868790|305923|P13|Period 4|Adverse Event|1
87349|NCT00868790|305924|P12|Period 4|Adverse Event|0
87350|NCT00868790|305925|P11|Period 4|Adverse Event|1
87351|NCT00868790|305926|P10|Period 4|Adverse Event|0
87352|NCT00868790|305927|P9|Period 4|Adverse Event|0
87353|NCT00868790|305928|P8|Period 4|Adverse Event|1
87354|NCT00868790|305929|P7|Period 4|Adverse Event|0
87355|NCT00868790|305930|P6|Period 4|Adverse Event|0
87356|NCT00868790|305931|P5|Period 4|Adverse Event|0
87357|NCT00868790|305932|P4|Period 4|Adverse Event|0
87358|NCT00868790|305933|P3|Period 4|Adverse Event|0
87359|NCT00868790|305934|P2|Period 4|Adverse Event|0
87360|NCT00868790|305935|P1|Period 4|Adverse Event|0
87361|NCT00868790|305922|P14|Period 3|Study Terminated by Sponsor|0
87362|NCT00868790|305923|P13|Period 3|Study Terminated by Sponsor|0
87363|NCT00868790|305924|P12|Period 3|Study Terminated by Sponsor|0
87364|NCT00868790|305925|P11|Period 3|Study Terminated by Sponsor|0
87365|NCT00868790|305926|P10|Period 3|Study Terminated by Sponsor|0
87366|NCT00868790|305927|P9|Period 3|Study Terminated by Sponsor|0
87367|NCT00868790|305928|P8|Period 3|Study Terminated by Sponsor|0
87368|NCT00868790|305929|P7|Period 3|Study Terminated by Sponsor|0
87369|NCT00868790|305930|P6|Period 3|Study Terminated by Sponsor|0
87370|NCT00868790|305931|P5|Period 3|Study Terminated by Sponsor|0
87371|NCT00868790|305932|P4|Period 3|Study Terminated by Sponsor|1
87372|NCT00868790|305933|P3|Period 3|Study Terminated by Sponsor|0
87373|NCT00868790|305934|P2|Period 3|Study Terminated by Sponsor|0
87374|NCT00868790|305935|P1|Period 3|Study Terminated by Sponsor|0
87375|NCT00868790|305922|P14|Period 3|Protocol Violation|0
87376|NCT00868790|305923|P13|Period 3|Protocol Violation|0
87377|NCT00868790|305924|P12|Period 3|Protocol Violation|0
87378|NCT00868790|305925|P11|Period 3|Protocol Violation|1
87379|NCT00868790|305926|P10|Period 3|Protocol Violation|0
87380|NCT00868790|305927|P9|Period 3|Protocol Violation|0
87381|NCT00868790|305928|P8|Period 3|Protocol Violation|0
87382|NCT00868790|305929|P7|Period 3|Protocol Violation|0
87383|NCT00868790|305930|P6|Period 3|Protocol Violation|0
87384|NCT00868790|305931|P5|Period 3|Protocol Violation|0
87385|NCT00868790|305932|P4|Period 3|Protocol Violation|0
87386|NCT00868790|305933|P3|Period 3|Protocol Violation|0
87387|NCT00868790|305934|P2|Period 3|Protocol Violation|0
87388|NCT00868790|305935|P1|Period 3|Protocol Violation|0
87389|NCT00868790|305922|P14|Period 3|Adverse Event|0
87390|NCT00868790|305923|P13|Period 3|Adverse Event|0
87391|NCT00868790|305924|P12|Period 3|Adverse Event|0
87392|NCT00868790|305925|P11|Period 3|Adverse Event|0
87393|NCT00868790|305926|P10|Period 3|Adverse Event|1
87394|NCT00868790|305927|P9|Period 3|Adverse Event|0
87395|NCT00868790|305928|P8|Period 3|Adverse Event|0
87396|NCT00868790|305929|P7|Period 3|Adverse Event|0
87397|NCT00868790|305930|P6|Period 3|Adverse Event|0
87398|NCT00868790|305931|P5|Period 3|Adverse Event|0
87399|NCT00868790|305932|P4|Period 3|Adverse Event|0
87400|NCT00868790|305933|P3|Period 3|Adverse Event|0
87401|NCT00868790|305934|P2|Period 3|Adverse Event|0
87402|NCT00868790|305935|P1|Period 3|Adverse Event|0
87403|NCT00868790|305922|P14|Period 2|Withdrawal by Subject|1
87404|NCT00868790|305923|P13|Period 2|Withdrawal by Subject|0
87405|NCT00868790|305924|P12|Period 2|Withdrawal by Subject|0
87406|NCT00868790|305925|P11|Period 2|Withdrawal by Subject|0
87407|NCT00868790|305926|P10|Period 2|Withdrawal by Subject|0
87408|NCT00868790|305927|P9|Period 2|Withdrawal by Subject|1
87409|NCT00868790|305928|P8|Period 2|Withdrawal by Subject|0
87410|NCT00868790|305929|P7|Period 2|Withdrawal by Subject|0
87411|NCT00868790|305930|P6|Period 2|Withdrawal by Subject|0
87412|NCT00868790|305931|P5|Period 2|Withdrawal by Subject|0
87413|NCT00868790|305932|P4|Period 2|Withdrawal by Subject|0
87414|NCT00868790|305933|P3|Period 2|Withdrawal by Subject|0
87415|NCT00868790|305934|P2|Period 2|Withdrawal by Subject|0
87416|NCT00868790|305935|P1|Period 2|Withdrawal by Subject|0
87417|NCT00868790|305922|P14|Period 2|Lost to Follow-up|0
87418|NCT00868790|305923|P13|Period 2|Lost to Follow-up|0
87419|NCT00868790|305924|P12|Period 2|Lost to Follow-up|0
87420|NCT00868790|305925|P11|Period 2|Lost to Follow-up|0
87421|NCT00868790|305926|P10|Period 2|Lost to Follow-up|0
87422|NCT00868790|305927|P9|Period 2|Lost to Follow-up|0
87423|NCT00868790|305928|P8|Period 2|Lost to Follow-up|0
87424|NCT00868790|305929|P7|Period 2|Lost to Follow-up|0
87425|NCT00868790|305930|P6|Period 2|Lost to Follow-up|1
87426|NCT00868790|305931|P5|Period 2|Lost to Follow-up|0
87427|NCT00868790|305932|P4|Period 2|Lost to Follow-up|0
87428|NCT00868790|305933|P3|Period 2|Lost to Follow-up|0
87429|NCT00868790|305934|P2|Period 2|Lost to Follow-up|1
87430|NCT00868790|305935|P1|Period 2|Lost to Follow-up|0
87431|NCT00868790|305922|P14|Period 2|Adverse Event|0
87432|NCT00868790|305923|P13|Period 2|Adverse Event|0
87433|NCT00868790|305924|P12|Period 2|Adverse Event|0
87434|NCT00868790|305925|P11|Period 2|Adverse Event|0
87435|NCT00868790|305926|P10|Period 2|Adverse Event|0
87436|NCT00868790|305927|P9|Period 2|Adverse Event|1
87437|NCT00868790|305928|P8|Period 2|Adverse Event|0
87438|NCT00868790|305929|P7|Period 2|Adverse Event|0
87439|NCT00868790|305930|P6|Period 2|Adverse Event|0
87440|NCT00868790|305931|P5|Period 2|Adverse Event|0
87441|NCT00868790|305932|P4|Period 2|Adverse Event|0
87442|NCT00868790|305933|P3|Period 2|Adverse Event|0
87443|NCT00868790|305934|P2|Period 2|Adverse Event|0
87444|NCT00868790|305935|P1|Period 2|Adverse Event|0
87445|NCT00868790|305922|P14|Period 1|Lost to Follow-up|0
87446|NCT00868790|305923|P13|Period 1|Lost to Follow-up|0
87447|NCT00868790|305924|P12|Period 1|Lost to Follow-up|0
87448|NCT00868790|305925|P11|Period 1|Lost to Follow-up|0
87449|NCT00868790|305926|P10|Period 1|Lost to Follow-up|0
87450|NCT00868790|305927|P9|Period 1|Lost to Follow-up|0
87451|NCT00868790|305928|P8|Period 1|Lost to Follow-up|0
87452|NCT00868790|305929|P7|Period 1|Lost to Follow-up|0
87453|NCT00868790|305930|P6|Period 1|Lost to Follow-up|1
87454|NCT00868790|305931|P5|Period 1|Lost to Follow-up|0
87455|NCT00868790|305932|P4|Period 1|Lost to Follow-up|0
87456|NCT00868790|305933|P3|Period 1|Lost to Follow-up|0
87457|NCT00868790|305934|P2|Period 1|Lost to Follow-up|0
87458|NCT00868790|305935|P1|Period 1|Lost to Follow-up|0
87459|NCT00868790|305922|P14|Period 1|Abnormal Triglycerides|0
87460|NCT00868790|305923|P13|Period 1|Abnormal Triglycerides|0
87461|NCT00868790|305924|P12|Period 1|Abnormal Triglycerides|0
87462|NCT00868790|305925|P11|Period 1|Abnormal Triglycerides|0
87463|NCT00868790|305926|P10|Period 1|Abnormal Triglycerides|0
87464|NCT00868790|305927|P9|Period 1|Abnormal Triglycerides|0
87465|NCT00868790|305928|P8|Period 1|Abnormal Triglycerides|0
87466|NCT00868790|305929|P7|Period 1|Abnormal Triglycerides|0
87467|NCT00868790|305930|P6|Period 1|Abnormal Triglycerides|0
87468|NCT00868790|305931|P5|Period 1|Abnormal Triglycerides|1
87469|NCT00868790|305932|P4|Period 1|Abnormal Triglycerides|0
87470|NCT00868790|305933|P3|Period 1|Abnormal Triglycerides|0
87471|NCT00868790|305934|P2|Period 1|Abnormal Triglycerides|0
87472|NCT00868790|305935|P1|Period 1|Abnormal Triglycerides|0
87473|NCT00868790|305922|P14|Period 1|Withdrawal by Subject|1
87474|NCT00868790|305923|P13|Period 1|Withdrawal by Subject|0
87475|NCT00868790|305924|P12|Period 1|Withdrawal by Subject|0
87476|NCT00868790|305925|P11|Period 1|Withdrawal by Subject|0
87477|NCT00868790|305926|P10|Period 1|Withdrawal by Subject|0
87478|NCT00868790|305927|P9|Period 1|Withdrawal by Subject|0
87479|NCT00868790|305928|P8|Period 1|Withdrawal by Subject|0
87480|NCT00868790|305929|P7|Period 1|Withdrawal by Subject|0
87481|NCT00868790|305930|P6|Period 1|Withdrawal by Subject|0
87482|NCT00868790|305931|P5|Period 1|Withdrawal by Subject|0
87483|NCT00868790|305932|P4|Period 1|Withdrawal by Subject|0
87484|NCT00868790|305933|P3|Period 1|Withdrawal by Subject|0
87485|NCT00868790|305934|P2|Period 1|Withdrawal by Subject|1
87486|NCT00868790|305935|P1|Period 1|Withdrawal by Subject|0
87487|NCT00868790|305922|P14|Period 1|Protocol Violation|0
87488|NCT00868790|305923|P13|Period 1|Protocol Violation|0
87489|NCT00868790|305924|P12|Period 1|Protocol Violation|0
87490|NCT00868790|305925|P11|Period 1|Protocol Violation|0
87491|NCT00868790|305926|P10|Period 1|Protocol Violation|0
87492|NCT00868790|305927|P9|Period 1|Protocol Violation|0
87493|NCT00868790|305928|P8|Period 1|Protocol Violation|0
87494|NCT00868790|305929|P7|Period 1|Protocol Violation|0
87495|NCT00868790|305930|P6|Period 1|Protocol Violation|0
87496|NCT00868790|305931|P5|Period 1|Protocol Violation|0
87497|NCT00868790|305932|P4|Period 1|Protocol Violation|0
87498|NCT00868790|305933|P3|Period 1|Protocol Violation|0
87499|NCT00868790|305934|P2|Period 1|Protocol Violation|0
87500|NCT00868790|305935|P1|Period 1|Protocol Violation|1
87501|NCT00868790|305922|P14|Period 1|Adverse Event|1
87502|NCT00868790|305923|P13|Period 1|Adverse Event|0
87503|NCT00868790|305924|P12|Period 1|Adverse Event|0
87504|NCT00868790|305925|P11|Period 1|Adverse Event|0
87505|NCT00868790|305926|P10|Period 1|Adverse Event|0
87506|NCT00868790|305927|P9|Period 1|Adverse Event|1
87507|NCT00868790|305928|P8|Period 1|Adverse Event|3
87508|NCT00868790|305929|P7|Period 1|Adverse Event|0
87509|NCT00868790|305930|P6|Period 1|Adverse Event|0
87510|NCT00868790|305931|P5|Period 1|Adverse Event|0
87511|NCT00868790|305932|P4|Period 1|Adverse Event|0
87512|NCT00868790|305933|P3|Period 1|Adverse Event|0
87513|NCT00868790|305934|P2|Period 1|Adverse Event|0
87514|NCT00868790|305935|P1|Period 1|Adverse Event|1
87515|NCT00868530|306007|P1|Overall Study|Lost to Follow-up|1
87516|NCT00868530|306007|P1|Overall Study|Adverse Event|3
87517|NCT00868517|306022|P3|Overall Study|Protocol Violation|0
87518|NCT00868517|306023|P2|Overall Study|Protocol Violation|1
87519|NCT00868517|306024|P1|Overall Study|Protocol Violation|1
87520|NCT00868517|306022|P3|Overall Study|Withdrawal by Subject|2
87521|NCT00868517|306023|P2|Overall Study|Withdrawal by Subject|3
87522|NCT00868517|306024|P1|Overall Study|Withdrawal by Subject|3
87523|NCT00868439|306062|P2|Overall Study|Withdrawal by Subject|1
87524|NCT00868439|306063|P1|Overall Study|Withdrawal by Subject|0
87525|NCT00868439|306062|P2|Overall Study|Physician Decision|0
87526|NCT00868439|306063|P1|Overall Study|Physician Decision|1
87527|NCT00868439|306062|P2|Overall Study|Protocol Violation|1
87528|NCT00868439|306063|P1|Overall Study|Protocol Violation|1
87529|NCT00868439|306062|P2|Overall Study|Death|1
87530|NCT00868439|306063|P1|Overall Study|Death|0
87531|NCT00868439|306062|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
87532|NCT00868439|306063|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
87533|NCT00868439|306062|P2|Overall Study|Adverse Event|3
87534|NCT00868439|306063|P1|Overall Study|Adverse Event|4
87535|NCT00868296|306120|P2|Overall Study|Withdrawal by Subject|1
87536|NCT00868296|306121|P1|Overall Study|Withdrawal by Subject|0
87537|NCT00868296|306120|P2|Overall Study|Adverse Event|2
87538|NCT00868296|306121|P1|Overall Study|Adverse Event|0
87539|NCT00868231|306129|P6|Treatment Period 3|Adverse Event|0
87540|NCT00868231|306130|P5|Treatment Period 3|Adverse Event|0
87541|NCT00868231|306131|P4|Treatment Period 3|Adverse Event|0
87542|NCT00868231|306132|P3|Treatment Period 3|Adverse Event|1
87543|NCT00868231|306133|P2|Treatment Period 3|Adverse Event|0
87544|NCT00868231|306134|P1|Treatment Period 3|Adverse Event|0
87545|NCT00868231|306129|P6|Treatment Period 2|Adverse Event|0
87546|NCT00868231|306130|P5|Treatment Period 2|Adverse Event|0
87547|NCT00868231|306131|P4|Treatment Period 2|Adverse Event|0
87548|NCT00868231|306132|P3|Treatment Period 2|Adverse Event|0
87549|NCT00868231|306133|P2|Treatment Period 2|Adverse Event|0
87550|NCT00868231|306134|P1|Treatment Period 2|Adverse Event|1
87551|NCT00868231|306129|P6|Treatment Period 1|Adverse Event|0
87552|NCT00868231|306130|P5|Treatment Period 1|Adverse Event|1
87553|NCT00868231|306131|P4|Treatment Period 1|Adverse Event|0
87554|NCT00868231|306132|P3|Treatment Period 1|Adverse Event|0
87555|NCT00868231|306133|P2|Treatment Period 1|Adverse Event|0
87556|NCT00868231|306134|P1|Treatment Period 1|Adverse Event|0
87557|NCT00868192|306200|P1|Overall Study|Ineligible|4
87558|NCT00867568|306254|P1|Overall Study|Withdrawal by Subject|1
87559|NCT00867568|306254|P1|Overall Study|Adverse Event|4
87560|NCT00867568|306254|P1|Overall Study|Lack of Efficacy|10
87561|NCT00867503|306263|P1|Overall Study|Withdrawal by Subject|1
87562|NCT00867490|306269|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
87563|NCT00867490|306269|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
87564|NCT00867490|306269|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
87565|NCT00867490|306269|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
87566|NCT00867490|306269|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
87567|NCT00867165|306311|P2|Overall Study|Withdrawal by Subject|0
87568|NCT00867165|306312|P1|Overall Study|Withdrawal by Subject|1
87569|NCT00867165|306311|P2|Overall Study|Adverse Event|0
87570|NCT00867165|306312|P1|Overall Study|Adverse Event|3
87571|NCT00867035|306462|P2|Baseline to 1 Week|Withdrawal by Subject|0
87572|NCT00867035|306463|P1|Baseline to 1 Week|Withdrawal by Subject|1
87573|NCT00867035|306462|P2|Baseline to 1 Hour|Withdrawal by Subject|1
87574|NCT00867035|306463|P1|Baseline to 1 Hour|Withdrawal by Subject|1
87575|NCT00867009|306489|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
87576|NCT00867009|306489|P1|Induction Period|Progressive Disease (PD)|25
87577|NCT00867009|306489|P1|Induction Period|Physician Decision|3
87578|NCT00867009|306489|P1|Induction Period|Withdrawal by Subject|8
87579|NCT00867009|306489|P1|Induction Period|Protocol Violation|1
87580|NCT00867009|306489|P1|Induction Period|Death due to Study Disease|4
87581|NCT00867009|306489|P1|Induction Period|Death due to serious adverse event|6
87582|NCT00867009|306489|P1|Induction Period|Serious Adverse Event|10
87583|NCT00867009|306489|P1|Induction Period|Nonserious Adverse Event|5
87584|NCT00866814|306501|P1|Overall Study|Moved to area without study site|1
87585|NCT00866814|306501|P1|Overall Study|Unable to meet follow-up requirements|2
87586|NCT00866814|306501|P1|Overall Study|No longer wished to participate|1
87587|NCT00866814|306501|P1|Overall Study|Death|1
87588|NCT00866814|306501|P1|Overall Study|Physician Decision|1
87589|NCT00866814|306501|P1|Overall Study|Adverse Event|2
87590|NCT00866814|306501|P1|Overall Study|Lost to Follow-up|12
87591|NCT00866788|306514|P4|Overall Study|Physician Decision|1
87592|NCT00866788|306515|P3|Overall Study|Physician Decision|1
87593|NCT00866788|306516|P2|Overall Study|Physician Decision|0
87594|NCT00866788|306517|P1|Overall Study|Physician Decision|0
87595|NCT00866788|306514|P4|Overall Study|Disease progression|0
87596|NCT00866788|306515|P3|Overall Study|Disease progression|1
87597|NCT00866788|306516|P2|Overall Study|Disease progression|1
87598|NCT00866788|306517|P1|Overall Study|Disease progression|3
87599|NCT00866788|306514|P4|Overall Study|Pregnancy|0
87600|NCT00866788|306515|P3|Overall Study|Pregnancy|0
87601|NCT00866788|306516|P2|Overall Study|Pregnancy|1
87602|NCT00866788|306517|P1|Overall Study|Pregnancy|0
87603|NCT00866788|306514|P4|Overall Study|Withdrawal by Subject|1
87604|NCT00866788|306515|P3|Overall Study|Withdrawal by Subject|0
87605|NCT00866788|306516|P2|Overall Study|Withdrawal by Subject|1
87606|NCT00866788|306517|P1|Overall Study|Withdrawal by Subject|2
87607|NCT00866788|306514|P4|Overall Study|Lost to Follow-up|2
87608|NCT00866788|306515|P3|Overall Study|Lost to Follow-up|0
87609|NCT00866788|306516|P2|Overall Study|Lost to Follow-up|1
87610|NCT00866788|306517|P1|Overall Study|Lost to Follow-up|1
87611|NCT00866788|306514|P4|Overall Study|Adverse Event|1
87612|NCT00866788|306515|P3|Overall Study|Adverse Event|0
87613|NCT00866788|306516|P2|Overall Study|Adverse Event|2
87614|NCT00866788|306517|P1|Overall Study|Adverse Event|0
87615|NCT00866775|306565|P2|Overall Study|discontinued due to communication error|1
87616|NCT00866775|306566|P1|Overall Study|discontinued due to communication error|0
87617|NCT00866775|306565|P2|Overall Study|met exit criteria|17
87618|NCT00866775|306566|P1|Overall Study|met exit criteria|23
87619|NCT00866775|306565|P2|Overall Study|Withdrawal by Subject|4
87620|NCT00866775|306566|P1|Overall Study|Withdrawal by Subject|4
87621|NCT00866775|306565|P2|Overall Study|Protocol Violation|4
87622|NCT00866775|306566|P1|Overall Study|Protocol Violation|3
87623|NCT00866775|306565|P2|Overall Study|Physician Decision|3
87624|NCT00866775|306566|P1|Overall Study|Physician Decision|0
87625|NCT00866775|306565|P2|Overall Study|Lost to Follow-up|4
87626|NCT00866775|306566|P1|Overall Study|Lost to Follow-up|0
87627|NCT00866775|306565|P2|Overall Study|Death|0
87628|NCT00866775|306566|P1|Overall Study|Death|1
87629|NCT00866775|306565|P2|Overall Study|Adverse Event|19
87630|NCT00866775|306566|P1|Overall Study|Adverse Event|5
87631|NCT00866723|306602|P1|Overall Study|Disease Progression|4
87632|NCT00866723|306602|P1|Overall Study|Withdrawal by Subject|1
87633|NCT00866697|306609|P2|Overall Study|Ongoing|312
87634|NCT00866697|306610|P1|Overall Study|Ongoing|335
87635|NCT00866697|306609|P2|Overall Study|Withdrawal by Subject|53
87636|NCT00866697|306610|P1|Overall Study|Withdrawal by Subject|28
87637|NCT00866697|306609|P2|Overall Study|Physician Decision|4
87638|NCT00866697|306610|P1|Overall Study|Physician Decision|3
87639|NCT00866697|306609|P2|Overall Study|Lost to Follow-up|8
87640|NCT00866697|306610|P1|Overall Study|Lost to Follow-up|7
87641|NCT00866658|306654|P2|Overall Study|Familial and Personal Reasons|5
87642|NCT00866658|306655|P1|Overall Study|Familial and Personal Reasons|4
87643|NCT00866658|306654|P2|Overall Study|Protocol Violation|1
87644|NCT00866658|306655|P1|Overall Study|Protocol Violation|1
87645|NCT00866658|306654|P2|Overall Study|Withdrawal by Subject|0
87646|NCT00866658|306655|P1|Overall Study|Withdrawal by Subject|1
87647|NCT00866658|306654|P2|Overall Study|Lack of Efficacy|1
87648|NCT00866658|306655|P1|Overall Study|Lack of Efficacy|2
87649|NCT00866658|306654|P2|Overall Study|Adverse Event|14
87650|NCT00866658|306655|P1|Overall Study|Adverse Event|5
87651|NCT00866606|306683|P1|Overall Study|Adverse Event|1
87652|NCT00866606|306683|P1|Overall Study|Lost to Follow-up|3
87653|NCT00866359|306697|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
87654|NCT00866359|306698|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
87655|NCT00866359|306699|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
87656|NCT00866359|306700|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
87657|NCT00866359|306697|P4|Treatment Phase (Days 1 to 85)|Unspecified|0
87658|NCT00866359|306698|P3|Treatment Phase (Days 1 to 85)|Unspecified|0
87659|NCT00866359|306699|P2|Treatment Phase (Days 1 to 85)|Unspecified|0
87660|NCT00866359|306700|P1|Treatment Phase (Days 1 to 85)|Unspecified|1
87661|NCT00866359|306697|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
87662|NCT00866359|306698|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
87663|NCT00866359|306699|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
87664|NCT00866359|306700|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
87665|NCT00866359|306697|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
87666|NCT00866359|306698|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
87667|NCT00866359|306699|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
87668|NCT00866359|306700|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
87669|NCT00866359|306697|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
87670|NCT00866359|306698|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
87671|NCT00866359|306699|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
87672|NCT00866359|306700|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
87673|NCT00866359|306697|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
87674|NCT00866359|306698|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
87675|NCT00866359|306699|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
87676|NCT00866359|306700|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
87677|NCT00866320|306753|P1|Overall Study|Death|2
87678|NCT00866320|306753|P1|Overall Study|Withdrawal by Subject|4
87679|NCT00866307|306760|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
87680|NCT00866307|306761|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
87681|NCT00866307|306762|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
87682|NCT00866307|306760|P3|Consolidation/Maintenance|Non-compliance|1
87683|NCT00866307|306761|P2|Consolidation/Maintenance|Non-compliance|0
87684|NCT00866307|306762|P1|Consolidation/Maintenance|Non-compliance|0
87685|NCT00866307|306760|P3|Consolidation/Maintenance|Therapy error|0
87686|NCT00866307|306761|P2|Consolidation/Maintenance|Therapy error|1
87687|NCT00866307|306762|P1|Consolidation/Maintenance|Therapy error|0
87688|NCT00866307|306760|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
87689|NCT00866307|306761|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
87690|NCT00866307|306762|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
87691|NCT00866307|306760|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
87692|NCT00866307|306761|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
87693|NCT00866307|306762|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
87694|NCT00866307|306760|P3|Consolidation/Maintenance|Withdrawal by Subject|1
87695|NCT00866307|306761|P2|Consolidation/Maintenance|Withdrawal by Subject|1
87696|NCT00866307|306762|P1|Consolidation/Maintenance|Withdrawal by Subject|0
87697|NCT00866307|306760|P3|Consolidation/Maintenance|Physician Decision|2
87698|NCT00866307|306761|P2|Consolidation/Maintenance|Physician Decision|3
87699|NCT00866307|306762|P1|Consolidation/Maintenance|Physician Decision|0
87700|NCT00866307|306760|P3|Consolidation/Maintenance|Death|1
87701|NCT00866307|306761|P2|Consolidation/Maintenance|Death|0
87702|NCT00866307|306762|P1|Consolidation/Maintenance|Death|0
87703|NCT00866307|306760|P3|Consolidation/Maintenance|Adverse Event|8
87704|NCT00866307|306761|P2|Consolidation/Maintenance|Adverse Event|0
87705|NCT00866307|306762|P1|Consolidation/Maintenance|Adverse Event|0
87706|NCT00866307|306760|P3|Induction|Study was closed at the time|0
87707|NCT00866307|306761|P2|Induction|Study was closed at the time|0
87708|NCT00866307|306762|P1|Induction|Study was closed at the time|1
87709|NCT00866307|306760|P3|Induction|Improper post-induction consent|0
87710|NCT00866307|306761|P2|Induction|Improper post-induction consent|0
87711|NCT00866307|306762|P1|Induction|Improper post-induction consent|2
87712|NCT00866307|306760|P3|Induction|Inadequate cytognetic samples th|0
87713|NCT00866307|306761|P2|Induction|Inadequate cytognetic samples th|0
87714|NCT00866307|306762|P1|Induction|Inadequate cytognetic samples th|1
87715|NCT00866307|306760|P3|Induction|Identification of Patients with Day 29 M|0
87716|NCT00866307|306761|P2|Induction|Identification of Patients with Day 29 M|0
87717|NCT00866307|306762|P1|Induction|Identification of Patients with Day 29 M|3
87718|NCT00866307|306760|P3|Induction|Progressive Disease|0
87719|NCT00866307|306761|P2|Induction|Progressive Disease|0
87720|NCT00866307|306762|P1|Induction|Progressive Disease|1
87721|NCT00866307|306760|P3|Induction|Physician Decision|0
87722|NCT00866307|306761|P2|Induction|Physician Decision|0
87723|NCT00866307|306762|P1|Induction|Physician Decision|5
87724|NCT00866307|306760|P3|Induction|Death|0
87725|NCT00866307|306761|P2|Induction|Death|0
87726|NCT00866307|306762|P1|Induction|Death|2
87727|NCT00866307|306760|P3|Induction|Adverse Event|0
87728|NCT00866307|306761|P2|Induction|Adverse Event|0
87729|NCT00866307|306762|P1|Induction|Adverse Event|5
87730|NCT00866294|306772|P3|Overall Study|Physician Decision|1
87731|NCT00866294|306773|P2|Overall Study|Physician Decision|2
87732|NCT00866294|306774|P1|Overall Study|Physician Decision|6
87733|NCT00866294|306772|P3|Overall Study|Lost to Follow-up|0
87734|NCT00866294|306773|P2|Overall Study|Lost to Follow-up|3
87735|NCT00866294|306774|P1|Overall Study|Lost to Follow-up|1
87736|NCT00866294|306772|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
87737|NCT00866294|306773|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
87738|NCT00866294|306774|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
87739|NCT00866294|306772|P3|Overall Study|Protocol Violation|0
87740|NCT00866294|306773|P2|Overall Study|Protocol Violation|0
87741|NCT00866294|306774|P1|Overall Study|Protocol Violation|2
87742|NCT00866294|306772|P3|Overall Study|Lack of Efficacy|0
87743|NCT00866294|306773|P2|Overall Study|Lack of Efficacy|1
87744|NCT00866294|306774|P1|Overall Study|Lack of Efficacy|7
87745|NCT00866294|306772|P3|Overall Study|Adverse Event|9
87746|NCT00866294|306773|P2|Overall Study|Adverse Event|13
87747|NCT00866294|306774|P1|Overall Study|Adverse Event|12
87748|NCT00866281|306803|P2|Overall Study|New cancer therapy|4
87749|NCT00866281|306804|P1|Overall Study|New cancer therapy|0
87750|NCT00866281|306803|P2|Overall Study|Disease progression|11
87751|NCT00866281|306804|P1|Overall Study|Disease progression|3
87752|NCT00866281|306803|P2|Overall Study|Withdrawal by participants|0
87753|NCT00866281|306804|P1|Overall Study|Withdrawal by participants|3
87754|NCT00866281|306803|P2|Overall Study|Adverse Event|0
87755|NCT00866281|306804|P1|Overall Study|Adverse Event|1
87756|NCT00866177|306820|P1|Overall Study|Not Treated|151
87757|NCT00866177|306820|P1|Overall Study|Withdrawal by Subject|1
87758|NCT00866047|306824|P1|Follow-up Period|Continuing in follow-up|31
87759|NCT00866047|306824|P1|Treatment Period|Continuing on treatment|9
87760|NCT00866047|306824|P1|Treatment Period|Withdrawal by Subject|5
87761|NCT00866047|306824|P1|Treatment Period|Physician Decision|14
87762|NCT00866047|306824|P1|Treatment Period|Adverse Event|14
87763|NCT00866047|306824|P1|Treatment Period|Progressive disease|13
87764|NCT00865904|306856|P5|Overall Study|Randomized but not Treated|1
87765|NCT00865904|306857|P4|Overall Study|Randomized but not Treated|1
87766|NCT00865904|306858|P3|Overall Study|Randomized but not Treated|0
87767|NCT00865904|306859|P2|Overall Study|Randomized but not Treated|0
87768|NCT00865904|306860|P1|Overall Study|Randomized but not Treated|2
87769|NCT00865709|306917|P2|Treatment|Surgery|3
87770|NCT00865709|306918|P1|Treatment|Surgery|8
87771|NCT00865709|306917|P2|Treatment|Physician Decision|2
87772|NCT00865709|306918|P1|Treatment|Physician Decision|3
87773|NCT00865709|306917|P2|Treatment|Withdrawal by Subject|7
87774|NCT00865709|306918|P1|Treatment|Withdrawal by Subject|10
87775|NCT00865709|306917|P2|Treatment|Adverse Event|6
87776|NCT00865709|306918|P1|Treatment|Adverse Event|9
87777|NCT00865514|306934|P1|Overall Study|Infusion cost exceeded funding|2
87778|NCT00865345|306939|P1|Overall Study|Withdrawal by Subject|2
87779|NCT00865306|306946|P2|Controlled Trial|Withdrawal by Subject|1
87780|NCT00865306|306947|P1|Controlled Trial|Withdrawal by Subject|0
87781|NCT00865306|306946|P2|Controlled Trial|Sought treatment for conduct disorder|0
87782|NCT00865306|306947|P1|Controlled Trial|Sought treatment for conduct disorder|1
87783|NCT00865306|306946|P2|Controlled Trial|Improved btw baseline and first session|0
87784|NCT00865306|306947|P1|Controlled Trial|Improved btw baseline and first session|1
87785|NCT00865306|306946|P2|Controlled Trial|Difficulty commuting|0
87786|NCT00865306|306947|P1|Controlled Trial|Difficulty commuting|2
87787|NCT00865306|306946|P2|Controlled Trial|Lost to Follow-up|1
87788|NCT00865306|306947|P1|Controlled Trial|Lost to Follow-up|1
87789|NCT00865098|306957|P1|Overall Study|Progressive disease|1
87790|NCT00865046|306969|P3|Overall Study|Withdrawal by Subject|0
87791|NCT00865046|306970|P2|Overall Study|Withdrawal by Subject|0
87792|NCT00865046|306971|P1|Overall Study|Withdrawal by Subject|5
87793|NCT00865046|306969|P3|Overall Study|Death|1
87794|NCT00865046|306970|P2|Overall Study|Death|1
87795|NCT00865046|306971|P1|Overall Study|Death|0
87796|NCT00865046|306969|P3|Overall Study|Lost to Follow-up|0
87797|NCT00865046|306970|P2|Overall Study|Lost to Follow-up|4
87798|NCT00865046|306971|P1|Overall Study|Lost to Follow-up|1
87799|NCT00865020|306981|P2|Overall Study|Randomized but discontinued|4
87800|NCT00865020|306982|P1|Overall Study|Randomized but discontinued|2
87801|NCT00865020|306981|P2|Overall Study|Death|1
87802|NCT00865020|306982|P1|Overall Study|Death|0
87803|NCT00865020|306981|P2|Overall Study|Abnormal laboratory value(s)|1
87804|NCT00865020|306982|P1|Overall Study|Abnormal laboratory value(s)|0
87805|NCT00865020|306981|P2|Overall Study|Administrative problems|2
87806|NCT00865020|306982|P1|Overall Study|Administrative problems|0
87807|NCT00865020|306981|P2|Overall Study|Protocol deviation|1
87808|NCT00865020|306982|P1|Overall Study|Protocol deviation|4
87809|NCT00865020|306981|P2|Overall Study|Lost to Follow-up|4
87810|NCT00865020|306982|P1|Overall Study|Lost to Follow-up|6
87811|NCT00865020|306981|P2|Overall Study|Abnormal test procedure result(s)|8
87812|NCT00865020|306982|P1|Overall Study|Abnormal test procedure result(s)|6
87813|NCT00865020|306981|P2|Overall Study|Adverse Event|14
87814|NCT00865020|306982|P1|Overall Study|Adverse Event|9
87815|NCT00865020|306981|P2|Overall Study|Withdrawal by Subject|16
87816|NCT00865020|306982|P1|Overall Study|Withdrawal by Subject|22
87817|NCT00864916|306998|P2|Overall Study|Withdrawal by Subject|0
87818|NCT00864916|306999|P1|Overall Study|Withdrawal by Subject|1
87819|NCT00864916|306998|P2|Overall Study|Protocol Violation|0
87820|NCT00864916|306999|P1|Overall Study|Protocol Violation|1
87821|NCT00864916|306998|P2|Overall Study|Lost to Follow-up|4
87822|NCT00864916|306999|P1|Overall Study|Lost to Follow-up|4
87823|NCT00864851|307008|P3|Overall Study|Patient uncooperative|0
87824|NCT00864851|307009|P2|Overall Study|Patient uncooperative|0
87825|NCT00864851|307010|P1|Overall Study|Patient uncooperative|1
87826|NCT00864851|307008|P3|Overall Study|Death|0
87827|NCT00864851|307009|P2|Overall Study|Death|0
87828|NCT00864851|307010|P1|Overall Study|Death|1
87829|NCT00864851|307008|P3|Overall Study|Physician Decision|0
87830|NCT00864851|307009|P2|Overall Study|Physician Decision|0
87831|NCT00864851|307010|P1|Overall Study|Physician Decision|1
87832|NCT00864851|307008|P3|Overall Study|Withdrawal by Subject|0
87833|NCT00864851|307009|P2|Overall Study|Withdrawal by Subject|1
87834|NCT00864851|307010|P1|Overall Study|Withdrawal by Subject|0
87835|NCT00864682|307056|P3|Overall Study|Protocol Violation|2
87836|NCT00864682|307057|P2|Overall Study|Protocol Violation|1
87837|NCT00864682|307058|P1|Overall Study|Protocol Violation|2
87838|NCT00864513|307097|P1|Overall Study|Withdrawal by Subject|3
87839|NCT00864253|307143|P2|Overall Study|Untreated|7
87840|NCT00864253|307144|P1|Overall Study|Untreated|7
87841|NCT00864253|307143|P2|Overall Study|Ongoing|3
87842|NCT00864253|307144|P1|Overall Study|Ongoing|2
87843|NCT00864253|307143|P2|Overall Study|Death|0
87844|NCT00864253|307144|P1|Overall Study|Death|1
87845|NCT00864253|307143|P2|Overall Study|Withdrawal by Subject|18
87846|NCT00864253|307144|P1|Overall Study|Withdrawal by Subject|18
87847|NCT00864253|307143|P2|Overall Study|Lost to Follow-up|1
87848|NCT00864253|307144|P1|Overall Study|Lost to Follow-up|1
87849|NCT00864253|307143|P2|Overall Study|Protocol Violation|2
87850|NCT00864253|307144|P1|Overall Study|Protocol Violation|0
87851|NCT00864253|307143|P2|Overall Study|Physician Decision|15
87852|NCT00864253|307144|P1|Overall Study|Physician Decision|11
87853|NCT00864253|307143|P2|Overall Study|Unrelated Adverse Event|1
87854|NCT00864253|307144|P1|Overall Study|Unrelated Adverse Event|3
87855|NCT00864253|307143|P2|Overall Study|Adverse Event|11
87856|NCT00864253|307144|P1|Overall Study|Adverse Event|56
87857|NCT00864227|307174|P1|Overall Study|Disease Relapse/Progression|3
87858|NCT00864227|307174|P1|Overall Study|Withdrawal by Subject|1
87859|NCT00863798|307236|P3|Overall Study|Randomized not treated|3
87860|NCT00863798|307237|P2|Overall Study|Randomized not treated|2
87861|NCT00863798|307238|P1|Overall Study|Randomized not treated|4
87862|NCT00863798|307236|P3|Overall Study|Withdrawal by Subject|4
87863|NCT00863798|307237|P2|Overall Study|Withdrawal by Subject|7
87864|NCT00863798|307238|P1|Overall Study|Withdrawal by Subject|8
87865|NCT00863798|307236|P3|Overall Study|Protocol Violation|1
87866|NCT00863798|307237|P2|Overall Study|Protocol Violation|1
87867|NCT00863798|307238|P1|Overall Study|Protocol Violation|0
87868|NCT00863798|307236|P3|Overall Study|Unspecified|1
87869|NCT00863798|307237|P2|Overall Study|Unspecified|3
87870|NCT00863798|307238|P1|Overall Study|Unspecified|2
87871|NCT00863798|307236|P3|Overall Study|Lost to Follow-up|5
87872|NCT00863798|307237|P2|Overall Study|Lost to Follow-up|9
87873|NCT00863798|307238|P1|Overall Study|Lost to Follow-up|6
87874|NCT00863798|307236|P3|Overall Study|Lack of Efficacy|6
87875|NCT00863798|307237|P2|Overall Study|Lack of Efficacy|3
87876|NCT00863798|307238|P1|Overall Study|Lack of Efficacy|4
87877|NCT00863798|307236|P3|Overall Study|Investigator request|1
87878|NCT00863798|307237|P2|Overall Study|Investigator request|2
87879|NCT00863798|307238|P1|Overall Study|Investigator request|1
87880|NCT00863798|307236|P3|Overall Study|Participant failed to return|0
87881|NCT00863798|307237|P2|Overall Study|Participant failed to return|1
87882|NCT00863798|307238|P1|Overall Study|Participant failed to return|2
87883|NCT00863798|307236|P3|Overall Study|Adverse Event|4
87884|NCT00863798|307237|P2|Overall Study|Adverse Event|2
87885|NCT00863798|307238|P1|Overall Study|Adverse Event|5
87886|NCT00863746|307290|P2|Survival Follow up|Consent Withdrawn|8
87887|NCT00863746|307291|P1|Survival Follow up|Consent Withdrawn|7
87888|NCT00863746|307290|P2|Survival Follow up|Lost to Follow-up|1
87889|NCT00863746|307291|P1|Survival Follow up|Lost to Follow-up|2
87890|NCT00863746|307290|P2|Survival Follow up|Death|271
87891|NCT00863746|307291|P1|Survival Follow up|Death|244
87892|NCT00863746|307290|P2|Treatment|not available|0
87893|NCT00863746|307291|P1|Treatment|not available|1
87894|NCT00863746|307290|P2|Treatment|Protocol Violation|3
87895|NCT00863746|307291|P1|Treatment|Protocol Violation|5
87896|NCT00863746|307290|P2|Treatment|Lost to Follow-up|0
87897|NCT00863746|307291|P1|Treatment|Lost to Follow-up|1
87898|NCT00863746|307290|P2|Treatment|Consent withdrawn|14
87899|NCT00863746|307291|P1|Treatment|Consent withdrawn|15
87900|NCT00863746|307290|P2|Treatment|non-compliant with study medication|0
87901|NCT00863746|307291|P1|Treatment|non-compliant with study medication|4
87902|NCT00863746|307290|P2|Treatment|Adverse Event|16
87903|NCT00863746|307291|P1|Treatment|Adverse Event|41
87904|NCT00863746|307290|P2|Treatment|Not treated|2
87905|NCT00863746|307291|P1|Treatment|Not treated|4
87906|NCT00863707|307317|P2|Overall Study|Randomized, but drug not received|3
87907|NCT00863707|307318|P1|Overall Study|Randomized, but drug not received|4
87908|NCT00863655|307326|P2|Overall Study|Ongoing|69
87909|NCT00863655|307327|P1|Overall Study|Ongoing|227
87910|NCT00863330|307360|P1|Overall Study|study terminated early due to administra|6
87911|NCT00863317|307366|P2|Overall Study|Lost to Follow-up|9
87912|NCT00863317|307367|P1|Overall Study|Lost to Follow-up|8
87913|NCT00863057|307390|P4|Period 2 (Weeks 6-10)|Physician Decision|1
87914|NCT00863057|307391|P3|Period 2 (Weeks 6-10)|Physician Decision|0
87915|NCT00863057|307392|P2|Period 2 (Weeks 6-10)|Physician Decision|0
87916|NCT00863057|307393|P1|Period 2 (Weeks 6-10)|Physician Decision|0
87917|NCT00863057|307390|P4|Period 2 (Weeks 6-10)|Adverse Event|0
87918|NCT00863057|307391|P3|Period 2 (Weeks 6-10)|Adverse Event|1
87919|NCT00863057|307392|P2|Period 2 (Weeks 6-10)|Adverse Event|1
87920|NCT00863057|307393|P1|Period 2 (Weeks 6-10)|Adverse Event|0
87921|NCT00863057|307390|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
87922|NCT00863057|307391|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
87923|NCT00863057|307392|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
87924|NCT00863057|307393|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
87925|NCT00863057|307390|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
87926|NCT00863057|307391|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
87927|NCT00863057|307392|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
87928|NCT00863057|307393|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
87929|NCT00862940|307435|P2|Overall Study|Administrative or other reason(s)|3
87930|NCT00862940|307436|P1|Overall Study|Administrative or other reason(s)|4
87931|NCT00862940|307435|P2|Overall Study|Lost to Follow-up|1
87932|NCT00862940|307436|P1|Overall Study|Lost to Follow-up|0
87933|NCT00862940|307435|P2|Overall Study|Non-compliance|0
87934|NCT00862940|307436|P1|Overall Study|Non-compliance|4
87935|NCT00862940|307435|P2|Overall Study|Withdrawal by Subject|6
87936|NCT00862940|307436|P1|Overall Study|Withdrawal by Subject|4
87937|NCT00862940|307435|P2|Overall Study|Protocol Violation|5
87938|NCT00862940|307436|P1|Overall Study|Protocol Violation|2
87939|NCT00862940|307435|P2|Overall Study|Lack of Efficacy|3
87940|NCT00862940|307436|P1|Overall Study|Lack of Efficacy|1
87941|NCT00862940|307435|P2|Overall Study|Adverse Event|12
87942|NCT00862940|307436|P1|Overall Study|Adverse Event|15
87943|NCT00862849|307448|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
87944|NCT00862849|307449|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
87945|NCT00862849|307450|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
87946|NCT00862849|307451|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
87947|NCT00862849|307452|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
87948|NCT00862849|307453|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
87949|NCT00862849|307448|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
87950|NCT00862849|307449|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
87951|NCT00862849|307450|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
87952|NCT00862849|307451|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
87953|NCT00862849|307452|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
87954|NCT00862849|307453|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
87955|NCT00862836|307476|P1|Overall Study|Withdrawal by Subject|1
87956|NCT00862823|307487|P2|First Intervention|Withdrawal by Subject|1
87957|NCT00862823|307488|P1|First Intervention|Withdrawal by Subject|1
87958|NCT00862719|307537|P4|Overall Study|Veno-Occlusive Disease|0
87959|NCT00862719|307538|P3|Overall Study|Veno-Occlusive Disease|1
87960|NCT00862719|307539|P2|Overall Study|Veno-Occlusive Disease|0
87961|NCT00862719|307540|P1|Overall Study|Veno-Occlusive Disease|0
87962|NCT00862719|307537|P4|Overall Study|Engraftment failure|0
87963|NCT00862719|307538|P3|Overall Study|Engraftment failure|1
87964|NCT00862719|307539|P2|Overall Study|Engraftment failure|0
87965|NCT00862719|307540|P1|Overall Study|Engraftment failure|0
87966|NCT00862719|307537|P4|Overall Study|Death|1
87967|NCT00862719|307538|P3|Overall Study|Death|1
87968|NCT00862719|307539|P2|Overall Study|Death|6
87969|NCT00862719|307540|P1|Overall Study|Death|5
87970|NCT00862719|307537|P4|Overall Study|Disease Progression|0
87971|NCT00862719|307538|P3|Overall Study|Disease Progression|1
87972|NCT00862719|307539|P2|Overall Study|Disease Progression|0
87973|NCT00862719|307540|P1|Overall Study|Disease Progression|5
87974|NCT00862654|307563|P4|Overall Study|Included after end of inclusions|0
87975|NCT00862654|307564|P3|Overall Study|Included after end of inclusions|1
87976|NCT00862654|307565|P2|Overall Study|Included after end of inclusions|0
87977|NCT00862654|307566|P1|Overall Study|Included after end of inclusions|0
87978|NCT00862654|307563|P4|Overall Study|Never used study drugs|0
87979|NCT00862654|307564|P3|Overall Study|Never used study drugs|0
87980|NCT00862654|307565|P2|Overall Study|Never used study drugs|0
87981|NCT00862654|307566|P1|Overall Study|Never used study drugs|1
87982|NCT00862654|307563|P4|Overall Study|Familly constraint|0
87983|NCT00862654|307564|P3|Overall Study|Familly constraint|0
87984|NCT00862654|307565|P2|Overall Study|Familly constraint|1
87985|NCT00862654|307566|P1|Overall Study|Familly constraint|0
87986|NCT00862654|307563|P4|Overall Study|Subject mistake|0
87987|NCT00862654|307564|P3|Overall Study|Subject mistake|0
87988|NCT00862654|307565|P2|Overall Study|Subject mistake|1
87989|NCT00862654|307566|P1|Overall Study|Subject mistake|0
87990|NCT00862654|307563|P4|Overall Study|Withdrawal by Subject|3
87991|NCT00862654|307564|P3|Overall Study|Withdrawal by Subject|2
87992|NCT00862654|307565|P2|Overall Study|Withdrawal by Subject|2
87993|NCT00862654|307566|P1|Overall Study|Withdrawal by Subject|2
87994|NCT00862654|307563|P4|Overall Study|Pregnancy|0
87995|NCT00862654|307564|P3|Overall Study|Pregnancy|0
87996|NCT00862654|307565|P2|Overall Study|Pregnancy|1
87997|NCT00862654|307566|P1|Overall Study|Pregnancy|1
87998|NCT00862654|307563|P4|Overall Study|Adverse Event|0
87999|NCT00862654|307564|P3|Overall Study|Adverse Event|1
88000|NCT00862654|307565|P2|Overall Study|Adverse Event|1
88001|NCT00862654|307566|P1|Overall Study|Adverse Event|0
88002|NCT00862654|307563|P4|Overall Study|Lost to Follow-up|3
88003|NCT00862654|307564|P3|Overall Study|Lost to Follow-up|1
88004|NCT00862654|307565|P2|Overall Study|Lost to Follow-up|2
88005|NCT00862654|307566|P1|Overall Study|Lost to Follow-up|1
88006|NCT00862654|307563|P4|Overall Study|Lack of Efficacy|0
88007|NCT00862654|307564|P3|Overall Study|Lack of Efficacy|1
88008|NCT00862654|307565|P2|Overall Study|Lack of Efficacy|0
88009|NCT00862654|307566|P1|Overall Study|Lack of Efficacy|1
88010|NCT00862641|307580|P4|Overall Study|Randomized, but drug not received|4
88011|NCT00862641|307581|P3|Overall Study|Randomized, but drug not received|1
88012|NCT00862641|307582|P2|Overall Study|Randomized, but drug not received|4
88013|NCT00862641|307583|P1|Overall Study|Randomized, but drug not received|1
88014|NCT00862459|307677|P3|Overall Study|Administrative problems|0
88015|NCT00862459|307678|P2|Overall Study|Administrative problems|1
88016|NCT00862459|307679|P1|Overall Study|Administrative problems|0
88017|NCT00862459|307677|P3|Overall Study|Inclusion/exclusion criteria not met|0
88018|NCT00862459|307678|P2|Overall Study|Inclusion/exclusion criteria not met|1
88019|NCT00862459|307679|P1|Overall Study|Inclusion/exclusion criteria not met|0
88020|NCT00862459|307677|P3|Overall Study|Unable to hold still for imaging|0
88021|NCT00862459|307678|P2|Overall Study|Unable to hold still for imaging|1
88022|NCT00862459|307679|P1|Overall Study|Unable to hold still for imaging|0
88023|NCT00862459|307677|P3|Overall Study|Intravenous (IV) site problems|1
88024|NCT00862459|307678|P2|Overall Study|Intravenous (IV) site problems|0
88025|NCT00862459|307679|P1|Overall Study|Intravenous (IV) site problems|1
88026|NCT00862459|307677|P3|Overall Study|Operation|0
88027|NCT00862459|307678|P2|Overall Study|Operation|1
88028|NCT00862459|307679|P1|Overall Study|Operation|1
88029|NCT00862459|307677|P3|Overall Study|Personal reasons|0
88030|NCT00862459|307678|P2|Overall Study|Personal reasons|0
88031|NCT00862459|307679|P1|Overall Study|Personal reasons|1
88032|NCT00862459|307677|P3|Overall Study|Adverse Event|0
88033|NCT00862459|307678|P2|Overall Study|Adverse Event|1
88034|NCT00862459|307679|P1|Overall Study|Adverse Event|0
88035|NCT00862459|307677|P3|Overall Study|Withdrawal by Subject|3
88036|NCT00862459|307678|P2|Overall Study|Withdrawal by Subject|1
88037|NCT00862459|307679|P1|Overall Study|Withdrawal by Subject|1
88038|NCT00862459|307677|P3|Overall Study|Protocol Violation|0
88039|NCT00862459|307678|P2|Overall Study|Protocol Violation|0
88040|NCT00862459|307679|P1|Overall Study|Protocol Violation|1
88041|NCT00862459|307677|P3|Overall Study|Lost to Follow-up|2
88042|NCT00862459|307678|P2|Overall Study|Lost to Follow-up|2
88043|NCT00862459|307679|P1|Overall Study|Lost to Follow-up|1
88044|NCT00862277|307826|P3|Overall Study|Protocol Violation|5
88045|NCT00862277|307827|P2|Overall Study|Protocol Violation|2
88046|NCT00862277|307828|P1|Overall Study|Protocol Violation|1
88047|NCT00862251|307842|P3|Overall Study|Withdrawal by Subject|6
88048|NCT00862251|307843|P2|Overall Study|Withdrawal by Subject|2
88049|NCT00862251|307844|P1|Overall Study|Withdrawal by Subject|9
88050|NCT00862251|307842|P3|Overall Study|Protocol Violation|1
88051|NCT00862251|307843|P2|Overall Study|Protocol Violation|0
88052|NCT00862251|307844|P1|Overall Study|Protocol Violation|2
88053|NCT00862251|307842|P3|Overall Study|Lost to Follow-up|1
88054|NCT00862251|307843|P2|Overall Study|Lost to Follow-up|0
88055|NCT00862251|307844|P1|Overall Study|Lost to Follow-up|0
88056|NCT00862251|307842|P3|Overall Study|Adverse Event|1
88057|NCT00862251|307843|P2|Overall Study|Adverse Event|3
88058|NCT00862251|307844|P1|Overall Study|Adverse Event|8
88059|NCT00862134|307904|P2|Overall Study|Withdrew prior to dosing|0
88060|NCT00862134|307905|P1|Overall Study|Withdrew prior to dosing|2
88061|NCT00862134|307904|P2|Overall Study|Adverse Event|2
88062|NCT00862134|307905|P1|Overall Study|Adverse Event|2
88063|NCT00862134|307904|P2|Overall Study|Sponsor terminated study|7
88064|NCT00862134|307905|P1|Overall Study|Sponsor terminated study|5
88065|NCT00862134|307904|P2|Overall Study|Withdrawal by Subject|2
88066|NCT00862134|307905|P1|Overall Study|Withdrawal by Subject|1
88067|NCT00862134|307904|P2|Overall Study|Physician Decision|1
88068|NCT00862134|307905|P1|Overall Study|Physician Decision|0
88069|NCT00862134|307904|P2|Overall Study|Death|0
88070|NCT00862134|307905|P1|Overall Study|Death|1
88071|NCT00862121|307917|P2|Overall Study|Incorrect randomisation|1
88072|NCT00862121|307918|P1|Overall Study|Incorrect randomisation|0
88073|NCT00862121|307917|P2|Overall Study|Exclusion criterion violation|1
88074|NCT00862121|307918|P1|Overall Study|Exclusion criterion violation|0
88075|NCT00862121|307917|P2|Overall Study|Protocol Violation|1
88076|NCT00862121|307918|P1|Overall Study|Protocol Violation|0
88077|NCT00862121|307917|P2|Overall Study|Lack of Efficacy|3
88078|NCT00862121|307918|P1|Overall Study|Lack of Efficacy|0
88079|NCT00862121|307917|P2|Overall Study|Adverse Event|2
88080|NCT00862121|307918|P1|Overall Study|Adverse Event|1
88081|NCT00862082|307936|P2|Overall Study|Withdrawal by Subject|1
88082|NCT00862082|307937|P1|Overall Study|Withdrawal by Subject|0
88083|NCT00862082|307936|P2|Overall Study|Sponsor decision to terminate the study|0
88084|NCT00862082|307937|P1|Overall Study|Sponsor decision to terminate the study|5
88085|NCT00861757|307992|P4|Overall Study|Withdrawal by Subject|2
88086|NCT00861757|307993|P3|Overall Study|Withdrawal by Subject|5
88087|NCT00861757|307994|P2|Overall Study|Withdrawal by Subject|5
88088|NCT00861757|307995|P1|Overall Study|Withdrawal by Subject|1
88089|NCT00861757|307992|P4|Overall Study|Protocol Violation|1
88090|NCT00861757|307993|P3|Overall Study|Protocol Violation|4
88091|NCT00861757|307994|P2|Overall Study|Protocol Violation|2
88092|NCT00861757|307995|P1|Overall Study|Protocol Violation|2
88093|NCT00861757|307992|P4|Overall Study|Physician Decision|1
88094|NCT00861757|307993|P3|Overall Study|Physician Decision|0
88095|NCT00861757|307994|P2|Overall Study|Physician Decision|0
88096|NCT00861757|307995|P1|Overall Study|Physician Decision|0
88097|NCT00861757|307992|P4|Overall Study|Lost to Follow-up|1
88098|NCT00861757|307993|P3|Overall Study|Lost to Follow-up|1
88099|NCT00861757|307994|P2|Overall Study|Lost to Follow-up|0
88100|NCT00861757|307995|P1|Overall Study|Lost to Follow-up|1
88101|NCT00861757|307992|P4|Overall Study|Lack of Efficacy|1
88102|NCT00861757|307993|P3|Overall Study|Lack of Efficacy|0
88103|NCT00861757|307994|P2|Overall Study|Lack of Efficacy|1
88104|NCT00861757|307995|P1|Overall Study|Lack of Efficacy|3
88105|NCT00861757|307992|P4|Overall Study|Entry Criteria Not Met|1
88106|NCT00861757|307993|P3|Overall Study|Entry Criteria Not Met|1
88107|NCT00861757|307994|P2|Overall Study|Entry Criteria Not Met|2
88108|NCT00861757|307995|P1|Overall Study|Entry Criteria Not Met|1
88109|NCT00861757|307992|P4|Overall Study|Adverse Event|2
88110|NCT00861757|307993|P3|Overall Study|Adverse Event|7
88111|NCT00861757|307994|P2|Overall Study|Adverse Event|5
88112|NCT00861757|307995|P1|Overall Study|Adverse Event|1
88113|NCT00861744|308053|P4|Overall Study|Blood draws|1
88114|NCT00861744|308054|P3|Overall Study|Blood draws|0
88115|NCT00861744|308055|P2|Overall Study|Blood draws|0
88116|NCT00861744|308056|P1|Overall Study|Blood draws|0
88117|NCT00861744|308053|P4|Overall Study|Migration from study area|0
88118|NCT00861744|308054|P3|Overall Study|Migration from study area|1
88119|NCT00861744|308055|P2|Overall Study|Migration from study area|3
88120|NCT00861744|308056|P1|Overall Study|Migration from study area|0
88121|NCT00861744|308053|P4|Overall Study|Protocol Violation|0
88122|NCT00861744|308054|P3|Overall Study|Protocol Violation|0
88123|NCT00861744|308055|P2|Overall Study|Protocol Violation|1
88124|NCT00861744|308056|P1|Overall Study|Protocol Violation|0
88125|NCT00861744|308053|P4|Overall Study|Withdrawal by Subject|19
88126|NCT00861744|308054|P3|Overall Study|Withdrawal by Subject|6
88127|NCT00861744|308055|P2|Overall Study|Withdrawal by Subject|6
88128|NCT00861744|308056|P1|Overall Study|Withdrawal by Subject|10
88129|NCT00861744|308053|P4|Overall Study|Lost to Follow-up|12
88130|NCT00861744|308054|P3|Overall Study|Lost to Follow-up|17
88131|NCT00861744|308055|P2|Overall Study|Lost to Follow-up|19
88132|NCT00861744|308056|P1|Overall Study|Lost to Follow-up|7
88133|NCT00861744|308053|P4|Overall Study|Adverse Event|1
88134|NCT00861744|308054|P3|Overall Study|Adverse Event|0
88135|NCT00861744|308055|P2|Overall Study|Adverse Event|0
88136|NCT00861744|308056|P1|Overall Study|Adverse Event|0
88137|NCT00861705|308238|P4|Overall Study|Never Began Treatment|1
88138|NCT00861705|308239|P3|Overall Study|Never Began Treatment|0
88139|NCT00861705|308240|P2|Overall Study|Never Began Treatment|3
88140|NCT00861705|308241|P1|Overall Study|Never Began Treatment|7
88141|NCT00861692|308257|P1|Overall Study|Death|6
88142|NCT00861614|308269|P2|Overall Study|Unspecified|22
88143|NCT00861614|308270|P1|Overall Study|Unspecified|17
88144|NCT00861614|308269|P2|Overall Study|Withdrawal by Subject|35
88145|NCT00861614|308270|P1|Overall Study|Withdrawal by Subject|34
88146|NCT00861614|308269|P2|Overall Study|Adverse Event|23
88147|NCT00861614|308270|P1|Overall Study|Adverse Event|27
88148|NCT00861614|308269|P2|Overall Study|Death|19
88149|NCT00861614|308270|P1|Overall Study|Death|32
88150|NCT00861614|308269|P2|Overall Study|Study Drug Toxicity|6
88151|NCT00861614|308270|P1|Overall Study|Study Drug Toxicity|79
88152|NCT00861614|308269|P2|Overall Study|Disease Progression|263
88153|NCT00861614|308270|P1|Overall Study|Disease Progression|182
88154|NCT00861471|308355|P1|Overall Study|Physician Decision|2
88155|NCT00861471|308355|P1|Overall Study|treatment for lumbar laminectomy|1
88156|NCT00861471|308355|P1|Overall Study|Lack of Efficacy|3
88157|NCT00861471|308355|P1|Overall Study|Adverse Event|2
88158|NCT00861471|308355|P1|Overall Study|Withdrawal by Subject|1
88159|NCT00861341|308363|P1|Overall Study|Withdrawal by Subject|2
88160|NCT00861198|308372|P1|Overall Study|SpyGlass Failed|5
88161|NCT00860951|308389|P1|Overall Study|Lost to Follow-up|5
88162|NCT00860951|308389|P1|Overall Study|Withdrawal by Subject|2
88163|NCT00860743|308431|P2|Overall Study|Withdrawal by Subject|0
88164|NCT00860743|308432|P1|Overall Study|Withdrawal by Subject|3
88165|NCT00860470|308445|P2|Overall Study|Lost to Follow-up|39
88166|NCT00860470|308446|P1|Overall Study|Lost to Follow-up|34
88167|NCT00860470|308445|P2|Overall Study|Moved away|10
88168|NCT00860470|308446|P1|Overall Study|Moved away|8
88169|NCT00860470|308445|P2|Overall Study|Death|10
88170|NCT00860470|308446|P1|Overall Study|Death|6
88171|NCT00860405|308476|P2|Overall Study|Main reason: Follow-up data not complete|4
88172|NCT00860405|308477|P1|Overall Study|Main reason: Follow-up data not complete|5
88173|NCT00860262|308517|P3|Overall Study|Not Specified|1
88174|NCT00860262|308518|P2|Overall Study|Not Specified|3
88175|NCT00860262|308519|P1|Overall Study|Not Specified|5
88176|NCT00860262|308517|P3|Overall Study|Lack of Efficacy|3
88177|NCT00860262|308518|P2|Overall Study|Lack of Efficacy|4
88178|NCT00860262|308519|P1|Overall Study|Lack of Efficacy|0
88179|NCT00860262|308517|P3|Overall Study|Withdrawal by Subject|6
88180|NCT00860262|308518|P2|Overall Study|Withdrawal by Subject|8
88181|NCT00860262|308519|P1|Overall Study|Withdrawal by Subject|4
88182|NCT00860262|308517|P3|Overall Study|Lost to Follow-up|1
88183|NCT00860262|308518|P2|Overall Study|Lost to Follow-up|0
88184|NCT00860262|308519|P1|Overall Study|Lost to Follow-up|2
88185|NCT00860262|308517|P3|Overall Study|Protocol Violation|0
88186|NCT00860262|308518|P2|Overall Study|Protocol Violation|1
88187|NCT00860262|308519|P1|Overall Study|Protocol Violation|0
88188|NCT00860262|308517|P3|Overall Study|Adverse Event|7
88189|NCT00860262|308518|P2|Overall Study|Adverse Event|6
88190|NCT00860262|308519|P1|Overall Study|Adverse Event|9
88191|NCT00860249|308632|P3|Overall Study|trial was terminated prior to completion|21
88192|NCT00860249|308633|P2|Overall Study|trial was terminated prior to completion|18
88193|NCT00860249|308634|P1|Overall Study|trial was terminated prior to completion|21
88194|NCT00860158|308645|P1|Overall Study|Study Terminated|1
88195|NCT00860067|308656|P3|Overall Study|Pregnancy|0
88196|NCT00860067|308657|P2|Overall Study|Pregnancy|0
88197|NCT00860067|308658|P1|Overall Study|Pregnancy|1
88198|NCT00860067|308656|P3|Overall Study|Withdrawal by Subject|0
88199|NCT00860067|308657|P2|Overall Study|Withdrawal by Subject|0
88200|NCT00860067|308658|P1|Overall Study|Withdrawal by Subject|4
88201|NCT00860067|308656|P3|Overall Study|Lost to Follow-up|9
88202|NCT00860067|308657|P2|Overall Study|Lost to Follow-up|9
88203|NCT00860067|308658|P1|Overall Study|Lost to Follow-up|46
88204|NCT00860028|308718|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
88205|NCT00860028|308719|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
88206|NCT00859937|308731|P2|Overall Study|Protocol Violation|0
88207|NCT00859937|308732|P1|Overall Study|Protocol Violation|1
88208|NCT00859898|308747|P3|Overall Study|non-specified|1
88209|NCT00859898|308748|P2|Overall Study|non-specified|1
88210|NCT00859898|308749|P1|Overall Study|non-specified|1
88211|NCT00859898|308747|P3|Overall Study|No longer meets criteria|0
88212|NCT00859898|308748|P2|Overall Study|No longer meets criteria|1
88213|NCT00859898|308749|P1|Overall Study|No longer meets criteria|0
88214|NCT00859898|308747|P3|Overall Study|poor/non-compliance|0
88215|NCT00859898|308748|P2|Overall Study|poor/non-compliance|0
88216|NCT00859898|308749|P1|Overall Study|poor/non-compliance|2
88217|NCT00859898|308747|P3|Overall Study|Lost to Follow-up|5
88218|NCT00859898|308748|P2|Overall Study|Lost to Follow-up|11
88219|NCT00859898|308749|P1|Overall Study|Lost to Follow-up|10
88220|NCT00859898|308747|P3|Overall Study|Death|1
88221|NCT00859898|308748|P2|Overall Study|Death|0
88222|NCT00859898|308749|P1|Overall Study|Death|0
88223|NCT00859898|308747|P3|Overall Study|Withdrawal by Subject|11
88224|NCT00859898|308748|P2|Overall Study|Withdrawal by Subject|8
88225|NCT00859898|308749|P1|Overall Study|Withdrawal by Subject|11
88226|NCT00859898|308747|P3|Overall Study|Adverse Event|8
88227|NCT00859898|308748|P2|Overall Study|Adverse Event|9
88228|NCT00859898|308749|P1|Overall Study|Adverse Event|4
88229|NCT00859898|308747|P3|Overall Study|Lack of Efficacy|1
88230|NCT00859898|308748|P2|Overall Study|Lack of Efficacy|1
88231|NCT00859898|308749|P1|Overall Study|Lack of Efficacy|0
88232|NCT00859638|308797|P2|Overall Study|Ill health|1
88233|NCT00859638|308798|P1|Overall Study|Ill health|1
88234|NCT00859638|308797|P2|Overall Study|Withdrawal by Subject|2
88235|NCT00859638|308798|P1|Overall Study|Withdrawal by Subject|3
88236|NCT00859638|308797|P2|Overall Study|Lost to Follow-up|1
88237|NCT00859638|308798|P1|Overall Study|Lost to Follow-up|6
88238|NCT00859586|308804|P1|Overall Study|Donors|4
88239|NCT00859573|308810|P2|Overall Study|Physician Decision|1
88240|NCT00859573|308811|P1|Overall Study|Physician Decision|1
88241|NCT00859573|308810|P2|Overall Study|Withdrawal by Subject|1
88242|NCT00859573|308811|P1|Overall Study|Withdrawal by Subject|4
88243|NCT00859547|308817|P1|Overall Study|Parent withdrew consent|1
88244|NCT00859547|308817|P1|Overall Study|Lost to Follow-up|1
88245|NCT00859521|308830|P2|Washout|Withdrawal by Subject|1
88246|NCT00859521|308831|P1|Washout|Withdrawal by Subject|0
88247|NCT00859469|308848|P1|Overall Study|Death|16
88248|NCT00859469|308848|P1|Overall Study|Withdrawal by Subject|1
88249|NCT00859469|308848|P1|Overall Study|Lack of Efficacy|9
88250|NCT00859469|308848|P1|Overall Study|Adverse Event|2
88251|NCT00859430|308856|P2|First Intervention|Withdrawal by Subject|1
88252|NCT00859430|308857|P1|First Intervention|Withdrawal by Subject|0
88253|NCT00859313|308873|P1|Overall Study|staff error|1
88254|NCT00859313|308873|P1|Overall Study|Adverse Event|1
88255|NCT00859313|308873|P1|Overall Study|Lack of Efficacy|2
88256|NCT00859222|308880|P5|Overall Study|DLT|0
88257|NCT00859222|308881|P4|Overall Study|DLT|0
88258|NCT00859222|308882|P3|Overall Study|DLT|0
88259|NCT00859222|308883|P2|Overall Study|DLT|0
88260|NCT00859222|308884|P1|Overall Study|DLT|1
88261|NCT00859222|308880|P5|Overall Study|Adverse Event|15
88262|NCT00859222|308881|P4|Overall Study|Adverse Event|24
88263|NCT00859222|308882|P3|Overall Study|Adverse Event|6
88264|NCT00859222|308883|P2|Overall Study|Adverse Event|3
88265|NCT00859222|308884|P1|Overall Study|Adverse Event|2
88266|NCT00859014|309003|P1|Overall Study|Lost to Follow-up|1
88267|NCT00859014|309003|P1|Overall Study|Death|4
88268|NCT00858845|309016|P1|Overall Study|Patient underwent heart transplant.|1
88269|NCT00858832|309022|P2|Overall Study|Adverse Event|1
88270|NCT00858832|309023|P1|Overall Study|Adverse Event|0
88271|NCT00858832|309022|P2|Overall Study|became ineligible: delivered vaginally|0
88272|NCT00858832|309023|P1|Overall Study|became ineligible: delivered vaginally|1
88273|NCT00858780|309029|P5|OL Re-Treatment (Failure to Week 48)|Unspecified|1
88274|NCT00858780|309030|P4|OL Re-Treatment (Failure to Week 48)|Unspecified|0
88275|NCT00858780|309031|P3|OL Re-Treatment (Failure to Week 48)|Unspecified|0
88276|NCT00858780|309032|P2|OL Re-Treatment (Failure to Week 48)|Unspecified|0
88277|NCT00858780|309033|P1|OL Re-Treatment (Failure to Week 48)|Unspecified|0
88278|NCT00858780|309029|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
88279|NCT00858780|309030|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
88280|NCT00858780|309031|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
88281|NCT00858780|309032|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
88282|NCT00858780|309033|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
88283|NCT00858780|309029|P5|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
88284|NCT00858780|309030|P4|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
88285|NCT00858780|309031|P3|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
88286|NCT00858780|309032|P2|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|1
88287|NCT00858780|309033|P1|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
88288|NCT00858780|309029|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
88289|NCT00858780|309030|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
88290|NCT00858780|309031|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
88291|NCT00858780|309032|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
88292|NCT00858780|309033|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
88293|NCT00858780|309029|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
88294|NCT00858780|309030|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
88295|NCT00858780|309031|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
88296|NCT00858780|309032|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
88297|NCT00858780|309033|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
88298|NCT00858780|309029|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
88299|NCT00858780|309030|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
88300|NCT00858780|309031|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
88301|NCT00858780|309032|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
88302|NCT00858780|309033|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
88303|NCT00858702|309108|P2|Overall Study|Withdrawal by Subject|0
88304|NCT00858702|309109|P1|Overall Study|Withdrawal by Subject|1
88305|NCT00858702|309108|P2|Overall Study|Other|1
88306|NCT00858702|309109|P1|Overall Study|Other|2
88307|NCT00858702|309108|P2|Overall Study|Protocol Violation|1
88308|NCT00858702|309109|P1|Overall Study|Protocol Violation|1
88309|NCT00858702|309108|P2|Overall Study|Lack of Efficacy|0
88310|NCT00858702|309109|P1|Overall Study|Lack of Efficacy|1
88311|NCT00858637|309126|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
88312|NCT00858637|309127|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
88313|NCT00858637|309128|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
88314|NCT00858637|309129|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
88315|NCT00858637|309130|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
88316|NCT00858637|309131|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
88317|NCT00858637|309126|P6|Placebo-controlled Withdrawal Phase|Death|0
88318|NCT00858637|309127|P5|Placebo-controlled Withdrawal Phase|Death|1
88319|NCT00858637|309128|P4|Placebo-controlled Withdrawal Phase|Death|0
88320|NCT00858637|309129|P3|Placebo-controlled Withdrawal Phase|Death|1
88321|NCT00858637|309130|P2|Placebo-controlled Withdrawal Phase|Death|0
88322|NCT00858637|309131|P1|Placebo-controlled Withdrawal Phase|Death|0
88323|NCT00858637|309126|P6|Active Comparison Phase|Other Reasons|0
88324|NCT00858637|309127|P5|Active Comparison Phase|Other Reasons|0
88325|NCT00858637|309128|P4|Active Comparison Phase|Other Reasons|1
88326|NCT00858637|309129|P3|Active Comparison Phase|Other Reasons|0
88327|NCT00858637|309130|P2|Active Comparison Phase|Other Reasons|0
88328|NCT00858637|309131|P1|Active Comparison Phase|Other Reasons|1
88329|NCT00858637|309126|P6|Active Comparison Phase|Withdrawal by Subject|0
88330|NCT00858637|309127|P5|Active Comparison Phase|Withdrawal by Subject|0
88331|NCT00858637|309128|P4|Active Comparison Phase|Withdrawal by Subject|6
88332|NCT00858637|309129|P3|Active Comparison Phase|Withdrawal by Subject|0
88333|NCT00858637|309130|P2|Active Comparison Phase|Withdrawal by Subject|0
88334|NCT00858637|309131|P1|Active Comparison Phase|Withdrawal by Subject|7
88335|NCT00858637|309126|P6|Active Comparison Phase|Physician Decision|0
88336|NCT00858637|309127|P5|Active Comparison Phase|Physician Decision|0
88337|NCT00858637|309128|P4|Active Comparison Phase|Physician Decision|1
88338|NCT00858637|309129|P3|Active Comparison Phase|Physician Decision|0
88339|NCT00858637|309130|P2|Active Comparison Phase|Physician Decision|0
88340|NCT00858637|309131|P1|Active Comparison Phase|Physician Decision|1
88341|NCT00858637|309126|P6|Active Comparison Phase|Death|0
88342|NCT00858637|309127|P5|Active Comparison Phase|Death|0
88343|NCT00858637|309128|P4|Active Comparison Phase|Death|1
88344|NCT00858637|309129|P3|Active Comparison Phase|Death|0
88345|NCT00858637|309130|P2|Active Comparison Phase|Death|0
88346|NCT00858637|309131|P1|Active Comparison Phase|Death|1
88347|NCT00858637|309126|P6|Active Comparison Phase|Adverse Event|0
88348|NCT00858637|309127|P5|Active Comparison Phase|Adverse Event|0
88349|NCT00858637|309128|P4|Active Comparison Phase|Adverse Event|9
88350|NCT00858637|309129|P3|Active Comparison Phase|Adverse Event|0
88351|NCT00858637|309130|P2|Active Comparison Phase|Adverse Event|0
88352|NCT00858637|309131|P1|Active Comparison Phase|Adverse Event|14
88353|NCT00858442|309172|P2|Compression:Start to Finish|Lost to Follow-up|3
88354|NCT00858442|309173|P1|Compression:Start to Finish|Lost to Follow-up|1
88355|NCT00858403|309183|P1|Overall Study|Disease Progression|1
88356|NCT00858403|309183|P1|Overall Study|Death|3
88357|NCT00858403|309183|P1|Overall Study|Withdrawal by Subject|1
88358|NCT00858247|309204|P2|Week 12 Follow-up|Withdrawal by Subject|1
88359|NCT00858247|309205|P1|Week 12 Follow-up|Withdrawal by Subject|0
88360|NCT00858247|309204|P2|Baseline Assessment|Protocol Violation|1
88361|NCT00858247|309205|P1|Baseline Assessment|Protocol Violation|0
88362|NCT00858247|309204|P2|Baseline Assessment|Poor IV access|0
88363|NCT00858247|309205|P1|Baseline Assessment|Poor IV access|1
88364|NCT00858247|309204|P2|Baseline Assessment|Withdrawal by Subject|1
88365|NCT00858247|309205|P1|Baseline Assessment|Withdrawal by Subject|1
88366|NCT00858208|309221|P1|Overall Study|Unspecified|10
88367|NCT00858208|309221|P1|Overall Study|Participant refused|40
88368|NCT00858208|309221|P1|Overall Study|Lost to Follow-up|26
88369|NCT00858208|309221|P1|Overall Study|Adverse Event|3
88370|NCT00858143|309238|P1|Overall Study|Other|23
88371|NCT00858143|309238|P1|Overall Study|Death|7
88372|NCT00858143|309238|P1|Overall Study|Lack of Efficacy|4
88373|NCT00858143|309238|P1|Overall Study|Adverse Event|16
88374|NCT00857948|309325|P4|Overall Study|Protocol Violation|0
88375|NCT00857948|309326|P3|Overall Study|Protocol Violation|1
88376|NCT00857948|309327|P2|Overall Study|Protocol Violation|0
88377|NCT00857948|309328|P1|Overall Study|Protocol Violation|1
88378|NCT00857948|309325|P4|Overall Study|Withdrawal by Subject|0
88379|NCT00857948|309326|P3|Overall Study|Withdrawal by Subject|0
88380|NCT00857948|309327|P2|Overall Study|Withdrawal by Subject|0
88381|NCT00857948|309328|P1|Overall Study|Withdrawal by Subject|2
88382|NCT00857896|309350|P1|Baseline to Week 4|Withdrawal by Subject|1
88383|NCT00857818|309364|P2|Overall Study|Investigator decision|0
88384|NCT00857818|309365|P1|Overall Study|Investigator decision|1
88385|NCT00857818|309364|P2|Overall Study|Sponsor terminated study|4
88386|NCT00857818|309365|P1|Overall Study|Sponsor terminated study|6
88387|NCT00857818|309364|P2|Overall Study|Withdrawal by Subject|4
88388|NCT00857818|309365|P1|Overall Study|Withdrawal by Subject|0
88389|NCT00857818|309364|P2|Overall Study|Adverse Event|0
88390|NCT00857818|309365|P1|Overall Study|Adverse Event|3
88391|NCT00857818|309364|P2|Overall Study|Lack of Efficacy|0
88392|NCT00857818|309365|P1|Overall Study|Lack of Efficacy|1
88393|NCT00857792|309393|P1|Overall Study|inadequate image quality for analysis|12
88394|NCT00857766|309399|P2|Overall Study|Participant Withdrew Consent|4
88395|NCT00857766|309400|P1|Overall Study|Participant Withdrew Consent|4
88396|NCT00857766|309399|P2|Overall Study|Investigator Discretion|3
88397|NCT00857766|309400|P1|Overall Study|Investigator Discretion|2
88398|NCT00857766|309399|P2|Overall Study|Lost to Follow-up|0
88399|NCT00857766|309400|P1|Overall Study|Lost to Follow-up|1
88400|NCT00857766|309399|P2|Overall Study|Protocol Violation|11
88401|NCT00857766|309400|P1|Overall Study|Protocol Violation|11
88402|NCT00857766|309399|P2|Overall Study|Adverse Event|12
88403|NCT00857766|309400|P1|Overall Study|Adverse Event|13
88404|NCT00857649|309417|P2|Overall Study|Other Reasons|3
88405|NCT00857649|309418|P1|Overall Study|Other Reasons|1
88406|NCT00857649|309417|P2|Overall Study|Nursing Home Placement|9
88407|NCT00857649|309418|P1|Overall Study|Nursing Home Placement|2
88408|NCT00857649|309417|P2|Overall Study|Withdrawal of Consent|7
88409|NCT00857649|309418|P1|Overall Study|Withdrawal of Consent|10
88410|NCT00857649|309417|P2|Overall Study|Protocol Violation|2
88411|NCT00857649|309418|P1|Overall Study|Protocol Violation|2
88412|NCT00857649|309417|P2|Overall Study|Non-compliance|1
88413|NCT00857649|309418|P1|Overall Study|Non-compliance|1
88414|NCT00857649|309417|P2|Overall Study|Adverse Event|10
88415|NCT00857649|309418|P1|Overall Study|Adverse Event|15
88416|NCT00857623|309434|P2|Overall Study|Positive for HEP C|1
88417|NCT00857623|309435|P1|Overall Study|Positive for HEP C|0
88418|NCT00857623|309434|P2|Overall Study|Intake of prohibited medication|1
88419|NCT00857623|309435|P1|Overall Study|Intake of prohibited medication|0
88420|NCT00857623|309434|P2|Overall Study|Severe non-compliance to protocol|1
88421|NCT00857623|309435|P1|Overall Study|Severe non-compliance to protocol|1
88422|NCT00857623|309434|P2|Overall Study|Lack of Efficacy|1
88423|NCT00857623|309435|P1|Overall Study|Lack of Efficacy|1
88424|NCT00857623|309434|P2|Overall Study|Withdrawal by Subject|1
88425|NCT00857623|309435|P1|Overall Study|Withdrawal by Subject|2
88426|NCT00857623|309434|P2|Overall Study|Study-specific discontinuation criteria|3
88427|NCT00857623|309435|P1|Overall Study|Study-specific discontinuation criteria|5
88428|NCT00857623|309434|P2|Overall Study|Adverse Event|2
88429|NCT00857623|309435|P1|Overall Study|Adverse Event|5
88430|NCT00857584|309459|P2|Overall Study|Physician Decision|1
88431|NCT00857584|309460|P1|Overall Study|Physician Decision|1
88432|NCT00857584|309459|P2|Overall Study|Adverse Event|2
88433|NCT00857584|309460|P1|Overall Study|Adverse Event|2
88434|NCT00857584|309459|P2|Overall Study|Lack of Efficacy|2
88435|NCT00857584|309460|P1|Overall Study|Lack of Efficacy|1
88436|NCT00857454|309539|P1|Overall Study|MTE09 enrollment criteria not met|6
88437|NCT00857454|309539|P1|Overall Study|Total Testosterone <300 ng/dL|8
88438|NCT00857454|309539|P1|Overall Study|Total Testosterone >1050 ng/dL|1
88439|NCT00857454|309539|P1|Overall Study|Adverse Event|2
88440|NCT00857454|309539|P1|Overall Study|Lost to Follow-up|1
88441|NCT00857454|309539|P1|Overall Study|Withdrawal by Subject|2
88442|NCT00857415|309552|P2|Overall Study|Deceased with no autopsy|0
88443|NCT00857415|309553|P1|Overall Study|Deceased with no autopsy|2
88444|NCT00857415|309552|P2|Overall Study|Subject still living at end of study|0
88445|NCT00857415|309553|P1|Overall Study|Subject still living at end of study|110
88446|NCT00857415|309552|P2|Overall Study|Invalid image or not imaged|0
88447|NCT00857415|309553|P1|Overall Study|Invalid image or not imaged|3
88448|NCT00857415|309552|P2|Overall Study|Image acquisition failure|0
88449|NCT00857415|309553|P1|Overall Study|Image acquisition failure|2
88450|NCT00857311|309564|P4|Overall Study|Lost to Follow-up|0
88451|NCT00857311|309565|P3|Overall Study|Lost to Follow-up|0
88452|NCT00857311|309566|P2|Overall Study|Lost to Follow-up|0
88453|NCT00857311|309567|P1|Overall Study|Lost to Follow-up|1
88454|NCT00857285|309579|P2|Overall Study|Randomization criteria not met|1
88455|NCT00857285|309580|P1|Overall Study|Randomization criteria not met|1
88456|NCT00857285|309579|P2|Overall Study|Withdrawal by Subject|0
88457|NCT00857285|309580|P1|Overall Study|Withdrawal by Subject|4
88458|NCT00857285|309579|P2|Overall Study|Protocol Violation|1
88459|NCT00857285|309580|P1|Overall Study|Protocol Violation|3
88460|NCT00857285|309579|P2|Overall Study|Lack of Efficacy|2
88461|NCT00857285|309580|P1|Overall Study|Lack of Efficacy|0
88462|NCT00857285|309579|P2|Overall Study|Adverse Event|2
88463|NCT00857285|309580|P1|Overall Study|Adverse Event|4
88464|NCT00857259|309596|P3|Overall Study|Protocol Violation|1
88465|NCT00857259|309597|P2|Overall Study|Protocol Violation|0
88466|NCT00857259|309598|P1|Overall Study|Protocol Violation|1
88467|NCT00857246|309608|P1|ChemoRT|Adverse Event|2
88468|NCT00857246|309608|P1|ChemoRT|Withdrawal by Subject|1
88469|NCT00857246|309608|P1|Surgery (Curative)|disease progression|6
88470|NCT00857246|309608|P1|Induction Regimen|Withdrawal by Subject|1
88471|NCT00857246|309608|P1|Induction Regimen|disease-related complications|1
88472|NCT00857246|309608|P1|Induction Regimen|Adverse Event|1
88473|NCT00857233|309618|P1|Overall Study|Other Reasons|2
88474|NCT00857233|309618|P1|Overall Study|Nursing Home Placement|14
88475|NCT00857233|309618|P1|Overall Study|Lost to Follow-up|4
88476|NCT00857233|309618|P1|Overall Study|Withdrawal of Consent|9
88477|NCT00857233|309618|P1|Overall Study|Non-compliance|1
88478|NCT00857233|309618|P1|Overall Study|Lack of Efficacy|1
88479|NCT00857233|309618|P1|Overall Study|Adverse Event|24
88480|NCT00857220|309627|P1|Overall Study|Miscellaneous|8
88481|NCT00857220|309627|P1|Overall Study|Site Closed|5
88482|NCT00857220|309627|P1|Overall Study|Clinical Hold|6
88483|NCT00857220|309627|P1|Overall Study|Withdrawal by Subject|67
88484|NCT00857220|309627|P1|Overall Study|Protocol Violation|16
88485|NCT00857220|309627|P1|Overall Study|Physician Decision|4
88486|NCT00857220|309627|P1|Overall Study|Lost to Follow-up|30
88487|NCT00857220|309627|P1|Overall Study|Lack of Efficacy|11
88488|NCT00857220|309627|P1|Overall Study|Death|1
88489|NCT00857220|309627|P1|Overall Study|Adverse Event|35
88490|NCT00856986|309649|P5|Extension Period, Weeks 26-52|Unclassified|0
88491|NCT00856986|309650|P4|Extension Period, Weeks 26-52|Unclassified|0
88492|NCT00856986|309651|P3|Extension Period, Weeks 26-52|Unclassified|11
88493|NCT00856986|309652|P2|Extension Period, Weeks 26-52|Unclassified|2
88494|NCT00856986|309653|P1|Extension Period, Weeks 26-52|Unclassified|4
88495|NCT00856986|309649|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
88496|NCT00856986|309650|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
88497|NCT00856986|309651|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
88498|NCT00856986|309652|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
88499|NCT00856986|309653|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
88500|NCT00856986|309649|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
88501|NCT00856986|309650|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
88502|NCT00856986|309651|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
88503|NCT00856986|309652|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
88504|NCT00856986|309653|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
88505|NCT00856986|309649|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
88506|NCT00856986|309650|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
88507|NCT00856986|309651|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
88508|NCT00856986|309652|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
88509|NCT00856986|309653|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
88510|NCT00856986|309649|P5|Extension Period, Weeks 26-52|Protocol Violation|0
88511|NCT00856986|309650|P4|Extension Period, Weeks 26-52|Protocol Violation|0
88512|NCT00856986|309651|P3|Extension Period, Weeks 26-52|Protocol Violation|5
88513|NCT00856986|309652|P2|Extension Period, Weeks 26-52|Protocol Violation|2
88514|NCT00856986|309653|P1|Extension Period, Weeks 26-52|Protocol Violation|6
88515|NCT00856986|309649|P5|Extension Period, Weeks 26-52|Adverse Event|0
88516|NCT00856986|309650|P4|Extension Period, Weeks 26-52|Adverse Event|0
88517|NCT00856986|309651|P3|Extension Period, Weeks 26-52|Adverse Event|10
88518|NCT00856986|309652|P2|Extension Period, Weeks 26-52|Adverse Event|3
88519|NCT00856986|309653|P1|Extension Period, Weeks 26-52|Adverse Event|3
88520|NCT00856986|309649|P5|Main Period, Weeks 0-26|Unclassified|0
88521|NCT00856986|309650|P4|Main Period, Weeks 0-26|Unclassified|0
88522|NCT00856986|309651|P3|Main Period, Weeks 0-26|Unclassified|7
88523|NCT00856986|309652|P2|Main Period, Weeks 0-26|Unclassified|6
88524|NCT00856986|309653|P1|Main Period, Weeks 0-26|Unclassified|7
88525|NCT00856986|309649|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
88526|NCT00856986|309650|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
88527|NCT00856986|309651|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
88528|NCT00856986|309652|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
88529|NCT00856986|309653|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
88530|NCT00856986|309649|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
88531|NCT00856986|309650|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
88532|NCT00856986|309651|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
88533|NCT00856986|309652|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
88534|NCT00856986|309653|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
88535|NCT00856986|309649|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
88536|NCT00856986|309650|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
88537|NCT00856986|309651|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
88538|NCT00856986|309652|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
88539|NCT00856986|309653|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
88540|NCT00856986|309649|P5|Main Period, Weeks 0-26|Protocol Violation|0
88541|NCT00856986|309650|P4|Main Period, Weeks 0-26|Protocol Violation|0
88542|NCT00856986|309651|P3|Main Period, Weeks 0-26|Protocol Violation|7
88543|NCT00856986|309652|P2|Main Period, Weeks 0-26|Protocol Violation|5
88544|NCT00856986|309653|P1|Main Period, Weeks 0-26|Protocol Violation|4
88545|NCT00856986|309649|P5|Main Period, Weeks 0-26|Adverse Event|0
88546|NCT00856986|309650|P4|Main Period, Weeks 0-26|Adverse Event|0
88547|NCT00856986|309651|P3|Main Period, Weeks 0-26|Adverse Event|9
88548|NCT00856986|309652|P2|Main Period, Weeks 0-26|Adverse Event|4
88549|NCT00856986|309653|P1|Main Period, Weeks 0-26|Adverse Event|6
88550|NCT00856986|309649|P5|Run-in Period, Weeks -12-0|Unclassified|0
88551|NCT00856986|309650|P4|Run-in Period, Weeks -12-0|Unclassified|24
88552|NCT00856986|309651|P3|Run-in Period, Weeks -12-0|Unclassified|0
88553|NCT00856986|309652|P2|Run-in Period, Weeks -12-0|Unclassified|0
88554|NCT00856986|309653|P1|Run-in Period, Weeks -12-0|Unclassified|0
88555|NCT00856986|309649|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
88556|NCT00856986|309650|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
88557|NCT00856986|309651|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
88558|NCT00856986|309652|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
88559|NCT00856986|309653|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
88560|NCT00856986|309649|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
88561|NCT00856986|309650|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
88562|NCT00856986|309651|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
88563|NCT00856986|309652|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
88564|NCT00856986|309653|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
88565|NCT00856986|309649|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
88566|NCT00856986|309650|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
88567|NCT00856986|309651|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
88568|NCT00856986|309652|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
88569|NCT00856986|309653|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
88570|NCT00856986|309649|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
88571|NCT00856986|309650|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
88572|NCT00856986|309651|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
88573|NCT00856986|309652|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
88574|NCT00856986|309653|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
88575|NCT00856986|309649|P5|Run-in Period, Weeks -12-0|Adverse Event|0
88576|NCT00856986|309650|P4|Run-in Period, Weeks -12-0|Adverse Event|92
88577|NCT00856986|309651|P3|Run-in Period, Weeks -12-0|Adverse Event|0
88578|NCT00856986|309652|P2|Run-in Period, Weeks -12-0|Adverse Event|0
88579|NCT00856986|309653|P1|Run-in Period, Weeks -12-0|Adverse Event|0
88580|NCT00856973|309823|P3|Overall Study|Other|13
88581|NCT00856973|309824|P2|Overall Study|Other|12
88582|NCT00856973|309825|P1|Overall Study|Other|11
88583|NCT00856973|309823|P3|Overall Study|Withdrawal by Subject|15
88584|NCT00856973|309824|P2|Overall Study|Withdrawal by Subject|16
88585|NCT00856973|309825|P1|Overall Study|Withdrawal by Subject|13
88586|NCT00856973|309823|P3|Overall Study|Protocol Violation|1
88587|NCT00856973|309824|P2|Overall Study|Protocol Violation|2
88588|NCT00856973|309825|P1|Overall Study|Protocol Violation|1
88589|NCT00856973|309823|P3|Overall Study|Physician Decision|1
88590|NCT00856973|309824|P2|Overall Study|Physician Decision|3
88591|NCT00856973|309825|P1|Overall Study|Physician Decision|0
88592|NCT00856973|309823|P3|Overall Study|Lost to Follow-up|5
88593|NCT00856973|309824|P2|Overall Study|Lost to Follow-up|3
88594|NCT00856973|309825|P1|Overall Study|Lost to Follow-up|6
88595|NCT00856973|309823|P3|Overall Study|Adverse Event|3
88596|NCT00856973|309824|P2|Overall Study|Adverse Event|5
88597|NCT00856973|309825|P1|Overall Study|Adverse Event|5
88598|NCT00856908|309905|P2|Overall Study|Lost to Follow-up|0
88599|NCT00856908|309906|P1|Overall Study|Lost to Follow-up|1
88600|NCT00856843|309933|P2|Overall Study|Lack of Efficacy|0
88601|NCT00856843|309934|P1|Overall Study|Lack of Efficacy|1
88602|NCT00856843|309933|P2|Overall Study|Withdrawal by Subject|5
88603|NCT00856843|309934|P1|Overall Study|Withdrawal by Subject|1
88604|NCT00856778|309971|P1|Overall Study|Lost to Follow-up|5
88605|NCT00856778|309971|P1|Overall Study|Study deviation|2
88606|NCT00856778|309971|P1|Overall Study|Withdrawal by Subject|10
88607|NCT00856778|309971|P1|Overall Study|Adverse Event|7
88608|NCT00856661|310005|P2|Overall Study|Physician Judgement|5
88609|NCT00856661|310006|P1|Overall Study|Physician Judgement|8
88610|NCT00856661|310005|P2|Overall Study|Lost to Follow-up|3
88611|NCT00856661|310006|P1|Overall Study|Lost to Follow-up|1
88612|NCT00856661|310005|P2|Overall Study|Withdrawal by Subject|2
88613|NCT00856661|310006|P1|Overall Study|Withdrawal by Subject|1
88614|NCT00856661|310005|P2|Overall Study|Protocol Violation|1
88615|NCT00856661|310006|P1|Overall Study|Protocol Violation|2
88616|NCT00856661|310005|P2|Overall Study|Death|18
88617|NCT00856661|310006|P1|Overall Study|Death|15
88618|NCT00856635|310020|P2|Overall Study|Discontinued at Randomization|2
88619|NCT00856635|310021|P1|Overall Study|Discontinued at Randomization|2
88620|NCT00856635|310020|P2|Overall Study|Other|0
88621|NCT00856635|310021|P1|Overall Study|Other|1
88622|NCT00856635|310020|P2|Overall Study|Serious Adverse Event|0
88623|NCT00856635|310021|P1|Overall Study|Serious Adverse Event|1
88624|NCT00856635|310020|P2|Overall Study|Withdrawal by Subject|1
88625|NCT00856635|310021|P1|Overall Study|Withdrawal by Subject|3
88626|NCT00856635|310020|P2|Overall Study|Pregnancy|0
88627|NCT00856635|310021|P1|Overall Study|Pregnancy|1
88628|NCT00856635|310020|P2|Overall Study|Lost to Follow-up|5
88629|NCT00856635|310021|P1|Overall Study|Lost to Follow-up|2
88630|NCT00856583|310029|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
88631|NCT00856583|310030|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
88632|NCT00856583|310029|P2|Overall Study|Other|104
88633|NCT00856583|310030|P1|Overall Study|Other|92
88634|NCT00856583|310029|P2|Overall Study|Pregnancy|5
88635|NCT00856583|310030|P1|Overall Study|Pregnancy|14
88636|NCT00856583|310029|P2|Overall Study|Physician Decision|82
88637|NCT00856583|310030|P1|Overall Study|Physician Decision|59
88638|NCT00856583|310029|P2|Overall Study|Withdrawal by Subject|919
88639|NCT00856583|310030|P1|Overall Study|Withdrawal by Subject|1092
88640|NCT00856583|310029|P2|Overall Study|Non-compliance|262
88641|NCT00856583|310030|P1|Overall Study|Non-compliance|305
88642|NCT00856583|310029|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
88643|NCT00856583|310030|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
88644|NCT00856583|310029|P2|Overall Study|Serious Adverse Event (SAE)|65
88645|NCT00856583|310030|P1|Overall Study|Serious Adverse Event (SAE)|99
88646|NCT00856583|310029|P2|Overall Study|Lack of Efficacy|377
88647|NCT00856583|310030|P1|Overall Study|Lack of Efficacy|389
88648|NCT00856557|310060|P2|Overall Study|No patients with contextual flags|16
88649|NCT00856557|310061|P1|Overall Study|No patients with contextual flags|12
88650|NCT00856544|310075|P4|Overall Study|Withdrawal by Subject|1
88651|NCT00856544|310076|P3|Overall Study|Withdrawal by Subject|0
88652|NCT00856544|310077|P2|Overall Study|Withdrawal by Subject|5
88653|NCT00856544|310078|P1|Overall Study|Withdrawal by Subject|8
88654|NCT00856544|310075|P4|Overall Study|Lost to Follow-up|0
88655|NCT00856544|310076|P3|Overall Study|Lost to Follow-up|2
88656|NCT00856544|310077|P2|Overall Study|Lost to Follow-up|2
88657|NCT00856544|310078|P1|Overall Study|Lost to Follow-up|1
88658|NCT00856544|310075|P4|Overall Study|Unspecified|6
88659|NCT00856544|310076|P3|Overall Study|Unspecified|1
88660|NCT00856544|310077|P2|Overall Study|Unspecified|16
88661|NCT00856544|310078|P1|Overall Study|Unspecified|9
88662|NCT00856544|310075|P4|Overall Study|Lack of Efficacy|3
88663|NCT00856544|310076|P3|Overall Study|Lack of Efficacy|3
88664|NCT00856544|310077|P2|Overall Study|Lack of Efficacy|12
88665|NCT00856544|310078|P1|Overall Study|Lack of Efficacy|16
88666|NCT00856544|310075|P4|Overall Study|Adverse Event|3
88667|NCT00856544|310076|P3|Overall Study|Adverse Event|2
88668|NCT00856544|310077|P2|Overall Study|Adverse Event|29
88669|NCT00856544|310078|P1|Overall Study|Adverse Event|20
88670|NCT00856544|310075|P4|Overall Study|Death|0
88671|NCT00856544|310076|P3|Overall Study|Death|0
88672|NCT00856544|310077|P2|Overall Study|Death|2
88673|NCT00856544|310078|P1|Overall Study|Death|0
88674|NCT00856544|310075|P4|Overall Study|Randomized but not treated|0
88675|NCT00856544|310076|P3|Overall Study|Randomized but not treated|0
88676|NCT00856544|310077|P2|Overall Study|Randomized but not treated|0
88677|NCT00856544|310078|P1|Overall Study|Randomized but not treated|3
88678|NCT00856518|310257|P2|Overall Study|Lost to Follow-up|2
88679|NCT00856518|310258|P1|Overall Study|Lost to Follow-up|4
88680|NCT00856388|310276|P1|Overall Study|Not Specified|1
88681|NCT00856349|310287|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
88682|NCT00856349|310287|P1|Overall Study|Site closure|78
88683|NCT00856349|310287|P1|Overall Study|Device explant|33
88684|NCT00856349|310287|P1|Overall Study|Subject relocation|104
88685|NCT00856349|310287|P1|Overall Study|Physician Decision|13
88686|NCT00856349|310287|P1|Overall Study|Protocol Violation|38
88687|NCT00856349|310287|P1|Overall Study|Lost to Follow-up|91
88688|NCT00856349|310287|P1|Overall Study|Withdrawal by Subject|116
88689|NCT00856349|310287|P1|Overall Study|Death|418
88690|NCT00856323|310296|P1|Overall Study|Withdrawal by Subject|2
88691|NCT00856297|310308|P5|Overall Study|Unable to classify|0
88692|NCT00856297|310309|P4|Overall Study|Unable to classify|0
88693|NCT00856297|310310|P3|Overall Study|Unable to classify|0
88694|NCT00856297|310311|P2|Overall Study|Unable to classify|0
88695|NCT00856297|310312|P1|Overall Study|Unable to classify|2
88696|NCT00856284|310345|P3|Overall Study|Randomized in error|1
88697|NCT00856284|310346|P2|Overall Study|Randomized in error|0
88698|NCT00856284|310347|P1|Overall Study|Randomized in error|0
88699|NCT00856284|310345|P3|Overall Study|Other|14
88700|NCT00856284|310346|P2|Overall Study|Other|17
88701|NCT00856284|310347|P1|Overall Study|Other|15
88702|NCT00856284|310345|P3|Overall Study|Investigator discretion|10
88703|NCT00856284|310346|P2|Overall Study|Investigator discretion|8
88704|NCT00856284|310347|P1|Overall Study|Investigator discretion|9
88705|NCT00856284|310345|P3|Overall Study|Pregnancy|0
88706|NCT00856284|310346|P2|Overall Study|Pregnancy|2
88707|NCT00856284|310347|P1|Overall Study|Pregnancy|1
88708|NCT00856284|310345|P3|Overall Study|Voluntary withdrawal|62
88709|NCT00856284|310346|P2|Overall Study|Voluntary withdrawal|52
88710|NCT00856284|310347|P1|Overall Study|Voluntary withdrawal|48
88711|NCT00856284|310345|P3|Overall Study|Lost to Follow-up|28
88712|NCT00856284|310346|P2|Overall Study|Lost to Follow-up|22
88713|NCT00856284|310347|P1|Overall Study|Lost to Follow-up|20
88714|NCT00856284|310345|P3|Overall Study|Major protocol deviation|15
88715|NCT00856284|310346|P2|Overall Study|Major protocol deviation|16
88716|NCT00856284|310347|P1|Overall Study|Major protocol deviation|24
88717|NCT00856284|310345|P3|Overall Study|Adverse Event|82
88718|NCT00856284|310346|P2|Overall Study|Adverse Event|74
88719|NCT00856284|310347|P1|Overall Study|Adverse Event|60
88720|NCT00856284|310345|P3|Overall Study|Hyperglycemic rescue|235
88721|NCT00856284|310346|P2|Overall Study|Hyperglycemic rescue|201
88722|NCT00856284|310347|P1|Overall Study|Hyperglycemic rescue|231
88723|NCT00856193|310389|P2|Period 2|Lost to Follow-up|1
88724|NCT00856193|310390|P1|Period 2|Lost to Follow-up|0
88725|NCT00856193|310389|P2|Period 2|Abnormal test procedure results|1
88726|NCT00856193|310390|P1|Period 2|Abnormal test procedure results|0
88727|NCT00856180|310402|P1|Overall Study|Progressive Disease|16
88728|NCT00856180|310402|P1|Overall Study|Adverse Event|4
88729|NCT00855959|310427|P1|Overall Study|Incorrect enrolment|1
88730|NCT00855959|310427|P1|Overall Study|Pregnancy|1
88731|NCT00855959|310427|P1|Overall Study|Withdrawal by Subject|3
88732|NCT00855959|310427|P1|Overall Study|Lost to Follow-up|2
88733|NCT00855959|310427|P1|Overall Study|Adverse Event|2
88734|NCT00855933|310444|P2|Overall Study|Withdrawal by Subject|1
88735|NCT00855933|310445|P1|Overall Study|Withdrawal by Subject|0
88736|NCT00855894|310451|P1|Overall Study|Disease progression|1
88737|NCT00855894|310451|P1|Overall Study|Patient's decision|1
88738|NCT00855894|310451|P1|Overall Study|Death|31
88739|NCT00855816|310474|P2|Overall Study|Became ineligible|1
88740|NCT00855816|310475|P1|Overall Study|Became ineligible|0
88741|NCT00855816|310474|P2|Overall Study|Death|0
88742|NCT00855816|310475|P1|Overall Study|Death|1
88743|NCT00855816|310474|P2|Overall Study|Lost to Follow-up|5
88744|NCT00855816|310475|P1|Overall Study|Lost to Follow-up|3
88745|NCT00855816|310474|P2|Overall Study|Withdrawal by Subject|15
88746|NCT00855816|310475|P1|Overall Study|Withdrawal by Subject|22
88747|NCT00855738|310481|P1|Overall Study|Death|1
88748|NCT00855738|310481|P1|Overall Study|Subject Defaulted|1
88749|NCT00855738|310481|P1|Overall Study|Adverse Event|1
88750|NCT00855738|310481|P1|Overall Study|Lost to Follow-up|2
88751|NCT00855595|310509|P2|Overall Study|patient left country|1
88752|NCT00855595|310510|P1|Overall Study|patient left country|0
88753|NCT00855595|310509|P2|Overall Study|patient moved out of state|0
88754|NCT00855595|310510|P1|Overall Study|patient moved out of state|1
88755|NCT00855595|310509|P2|Overall Study|Adverse Event|1
88756|NCT00855595|310510|P1|Overall Study|Adverse Event|1
88757|NCT00855595|310509|P2|Overall Study|Lost to Follow-up|3
88758|NCT00855595|310510|P1|Overall Study|Lost to Follow-up|3
88759|NCT00855595|310509|P2|Overall Study|Withdrawal by Subject|2
88760|NCT00855595|310510|P1|Overall Study|Withdrawal by Subject|1
88761|NCT00855582|310549|P3|Overall Study|Withdrawal by Subject|8
88762|NCT00855582|310550|P2|Overall Study|Withdrawal by Subject|4
88763|NCT00855582|310551|P1|Overall Study|Withdrawal by Subject|7
88764|NCT00855582|310549|P3|Overall Study|Entry Criteria Not Met|3
88765|NCT00855582|310550|P2|Overall Study|Entry Criteria Not Met|6
88766|NCT00855582|310551|P1|Overall Study|Entry Criteria Not Met|8
88767|NCT00855582|310549|P3|Overall Study|Protocol Violation|6
88768|NCT00855582|310550|P2|Overall Study|Protocol Violation|2
88769|NCT00855582|310551|P1|Overall Study|Protocol Violation|6
88770|NCT00855582|310549|P3|Overall Study|Physician Decision|1
88771|NCT00855582|310550|P2|Overall Study|Physician Decision|0
88772|NCT00855582|310551|P1|Overall Study|Physician Decision|0
88773|NCT00855582|310549|P3|Overall Study|Lost to Follow-up|1
88774|NCT00855582|310550|P2|Overall Study|Lost to Follow-up|3
88775|NCT00855582|310551|P1|Overall Study|Lost to Follow-up|1
88776|NCT00855582|310549|P3|Overall Study|Lack of Efficacy|8
88777|NCT00855582|310550|P2|Overall Study|Lack of Efficacy|3
88778|NCT00855582|310551|P1|Overall Study|Lack of Efficacy|1
88779|NCT00855582|310549|P3|Overall Study|Death|0
88780|NCT00855582|310550|P2|Overall Study|Death|0
88781|NCT00855582|310551|P1|Overall Study|Death|1
88782|NCT00855582|310549|P3|Overall Study|Adverse Event|3
88783|NCT00855582|310550|P2|Overall Study|Adverse Event|6
88784|NCT00855582|310551|P1|Overall Study|Adverse Event|2
88785|NCT00855465|310640|P2|Follow-up Period (FUP)|Missing|0
88786|NCT00855465|310641|P1|Follow-up Period (FUP)|Missing|1
88787|NCT00855465|310640|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
88788|NCT00855465|310641|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
88789|NCT00855465|310640|P2|Follow-up Period (FUP)|Lost to Follow-up|0
88790|NCT00855465|310641|P1|Follow-up Period (FUP)|Lost to Follow-up|3
88791|NCT00855465|310640|P2|Follow-up Period (FUP)|Death|1
88792|NCT00855465|310641|P1|Follow-up Period (FUP)|Death|0
88793|NCT00855465|310640|P2|Follow-up Period (FUP)|Adverse Event|1
88794|NCT00855465|310641|P1|Follow-up Period (FUP)|Adverse Event|0
88795|NCT00855465|310640|P2|Treatment Period|Not treated|0
88796|NCT00855465|310641|P1|Treatment Period|Not treated|1
88797|NCT00855465|310640|P2|Treatment Period|Withdrawal by Subject|0
88798|NCT00855465|310641|P1|Treatment Period|Withdrawal by Subject|2
88799|NCT00855465|310640|P2|Treatment Period|Protocol Violation|0
88800|NCT00855465|310641|P1|Treatment Period|Protocol Violation|2
88801|NCT00855465|310640|P2|Treatment Period|Non-compliance|0
88802|NCT00855465|310641|P1|Treatment Period|Non-compliance|1
88803|NCT00855465|310640|P2|Treatment Period|Lack of Efficacy|1
88804|NCT00855465|310641|P1|Treatment Period|Lack of Efficacy|2
88805|NCT00855465|310640|P2|Treatment Period|Death|2
88806|NCT00855465|310641|P1|Treatment Period|Death|2
88807|NCT00855465|310640|P2|Treatment Period|Adverse Event|2
88808|NCT00855465|310641|P1|Treatment Period|Adverse Event|4
88809|NCT00855439|310731|P2|Overall Study|Pregnancy|0
88810|NCT00855439|310732|P1|Overall Study|Pregnancy|1
88811|NCT00855439|310731|P2|Overall Study|Withdrawal by Subject|0
88812|NCT00855439|310732|P1|Overall Study|Withdrawal by Subject|2
88813|NCT00855309|310746|P2|Overall Study|patient never recieved drug|0
88814|NCT00855309|310747|P1|Overall Study|patient never recieved drug|1
88815|NCT00855218|310755|P2|Overall Study|Still treated with study medication|21
88816|NCT00855218|310756|P1|Overall Study|Still treated with study medication|24
88817|NCT00855218|310755|P2|Overall Study|technical problems|1
88818|NCT00855218|310756|P1|Overall Study|technical problems|2
88819|NCT00855218|310755|P2|Overall Study|patient convenience|0
88820|NCT00855218|310756|P1|Overall Study|patient convenience|2
88821|NCT00855218|310755|P2|Overall Study|non-compliant with study drug|1
88822|NCT00855218|310756|P1|Overall Study|non-compliant with study drug|3
88823|NCT00855218|310755|P2|Overall Study|Protocol Violation|9
88824|NCT00855218|310756|P1|Overall Study|Protocol Violation|5
88825|NCT00855218|310755|P2|Overall Study|Lost to Follow-up|1
88826|NCT00855218|310756|P1|Overall Study|Lost to Follow-up|0
88827|NCT00855218|310755|P2|Overall Study|Physician Decision|11
88828|NCT00855218|310756|P1|Overall Study|Physician Decision|17
88829|NCT00855218|310755|P2|Overall Study|Withdrawal by Subject|6
88830|NCT00855218|310756|P1|Overall Study|Withdrawal by Subject|10
88831|NCT00855218|310755|P2|Overall Study|Adverse Event|26
88832|NCT00855218|310756|P1|Overall Study|Adverse Event|41
88833|NCT00855166|310774|P2|Overall Study|Subject no longer meets study criteria|1
88834|NCT00855166|310775|P1|Overall Study|Subject no longer meets study criteria|1
88835|NCT00855166|310774|P2|Overall Study|Administrative reasons by sponsor|0
88836|NCT00855166|310775|P1|Overall Study|Administrative reasons by sponsor|1
88837|NCT00855166|310774|P2|Overall Study|Poor/non-compliance|0
88838|NCT00855166|310775|P1|Overall Study|Poor/non-compliance|2
88839|NCT00855166|310774|P2|Overall Study|Withdrawal by Subject|4
88840|NCT00855166|310775|P1|Overall Study|Withdrawal by Subject|1
88841|NCT00855166|310774|P2|Overall Study|Death|1
88842|NCT00855166|310775|P1|Overall Study|Death|0
88843|NCT00855166|310774|P2|Overall Study|Adverse Event|2
88844|NCT00855166|310775|P1|Overall Study|Adverse Event|0
88845|NCT00855062|310795|P2|Step2|Initiation of antiretroviral therapy/ART|1
88846|NCT00855062|310796|P1|Step2|Initiation of antiretroviral therapy/ART|0
88847|NCT00855062|310795|P2|Step2|Adverse Event|3
88848|NCT00855062|310796|P1|Step2|Adverse Event|0
88849|NCT00855062|310795|P2|Step2|Early Study Closure|2
88850|NCT00855062|310796|P1|Step2|Early Study Closure|6
88851|NCT00855062|310795|P2|Step1|Withdrawal by Subject|3
88852|NCT00855062|310796|P1|Step1|Withdrawal by Subject|2
88853|NCT00855062|310795|P2|Step1|Pregnancy|0
88854|NCT00855062|310796|P1|Step1|Pregnancy|1
88855|NCT00855062|310795|P2|Step1|Protocol Violation|0
88856|NCT00855062|310796|P1|Step1|Protocol Violation|1
88857|NCT00855062|310795|P2|Step1|Adverse Event|1
88858|NCT00855062|310796|P1|Step1|Adverse Event|1
88859|NCT00855062|310795|P2|Step1|Early Study Closure|7
88860|NCT00855062|310796|P1|Step1|Early Study Closure|5
88861|NCT00854906|310820|P1|Overall Study|One person had no ocular history|1
88862|NCT00854724|310829|P2|Second Intervention|Physician Decision|1
88863|NCT00854724|310830|P1|Second Intervention|Physician Decision|0
88864|NCT00854724|310829|P2|Second Intervention|Protocol Violation|0
88865|NCT00854724|310830|P1|Second Intervention|Protocol Violation|1
88866|NCT00854724|310829|P2|Washout|Withdrawal by Subject|1
88867|NCT00854724|310830|P1|Washout|Withdrawal by Subject|0
88868|NCT00854724|310829|P2|Washout|Protocol Violation|0
88869|NCT00854724|310830|P1|Washout|Protocol Violation|1
88870|NCT00854724|310829|P2|First Intervention|Withdrawal by Subject|1
88871|NCT00854724|310830|P1|First Intervention|Withdrawal by Subject|1
88872|NCT00854620|310836|P1|Overall Study|Adverse Event|1
88873|NCT00854607|310840|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
88874|NCT00854373|310895|P2|Overall Study|Forgot to take study drug|1
88875|NCT00854373|310896|P1|Overall Study|Forgot to take study drug|1
88876|NCT00854373|310895|P2|Overall Study|Withdrawal by Subject|3
88877|NCT00854373|310896|P1|Overall Study|Withdrawal by Subject|1
88878|NCT00854360|310910|P4|Overall Study|Other|3
88879|NCT00854360|310911|P3|Overall Study|Other|0
88880|NCT00854360|310912|P2|Overall Study|Other|0
88881|NCT00854360|310913|P1|Overall Study|Other|0
88882|NCT00854360|310910|P4|Overall Study|Lack of Efficacy|0
88883|NCT00854360|310911|P3|Overall Study|Lack of Efficacy|0
88884|NCT00854360|310912|P2|Overall Study|Lack of Efficacy|1
88885|NCT00854360|310913|P1|Overall Study|Lack of Efficacy|2
88886|NCT00854360|310910|P4|Overall Study|Pregnancy|0
88887|NCT00854360|310911|P3|Overall Study|Pregnancy|0
88888|NCT00854360|310912|P2|Overall Study|Pregnancy|1
88889|NCT00854360|310913|P1|Overall Study|Pregnancy|0
88890|NCT00854360|310910|P4|Overall Study|Withdrawal by Subject|1
88891|NCT00854360|310911|P3|Overall Study|Withdrawal by Subject|0
88892|NCT00854360|310912|P2|Overall Study|Withdrawal by Subject|0
88893|NCT00854360|310913|P1|Overall Study|Withdrawal by Subject|0
88894|NCT00854360|310910|P4|Overall Study|Adverse Event|6
88895|NCT00854360|310911|P3|Overall Study|Adverse Event|2
88896|NCT00854360|310912|P2|Overall Study|Adverse Event|1
88897|NCT00854360|310913|P1|Overall Study|Adverse Event|0
88898|NCT00854308|310945|P2|Overall Study|Sponsor's decision to terminate study|1
88899|NCT00854308|310946|P1|Overall Study|Sponsor's decision to terminate study|0
88900|NCT00854308|310945|P2|Overall Study|Withdrawal by Subject|2
88901|NCT00854308|310946|P1|Overall Study|Withdrawal by Subject|4
88902|NCT00854308|310945|P2|Overall Study|Physician Decision|6
88903|NCT00854308|310946|P1|Overall Study|Physician Decision|6
88904|NCT00854308|310945|P2|Overall Study|Death|5
88905|NCT00854308|310946|P1|Overall Study|Death|2
88906|NCT00854308|310945|P2|Overall Study|Adverse Event|3
88907|NCT00854308|310946|P1|Overall Study|Adverse Event|8
88908|NCT00854308|310945|P2|Overall Study|Disease progression|50
88909|NCT00854308|310946|P1|Overall Study|Disease progression|42
88910|NCT00854113|310971|P11|Overall Study|Withdrawal by Subject|0
88911|NCT00854113|310972|P10|Overall Study|Withdrawal by Subject|0
88912|NCT00854113|310973|P9|Overall Study|Withdrawal by Subject|1
88913|NCT00854113|310974|P8|Overall Study|Withdrawal by Subject|1
88914|NCT00854113|310975|P7|Overall Study|Withdrawal by Subject|0
88915|NCT00854113|310976|P6|Overall Study|Withdrawal by Subject|0
88916|NCT00854113|310977|P5|Overall Study|Withdrawal by Subject|0
88917|NCT00854113|310978|P4|Overall Study|Withdrawal by Subject|0
88918|NCT00854113|310979|P3|Overall Study|Withdrawal by Subject|0
88919|NCT00854113|310980|P2|Overall Study|Withdrawal by Subject|0
88920|NCT00854113|310981|P1|Overall Study|Withdrawal by Subject|0
88921|NCT00854113|310971|P11|Overall Study|Adverse Event|0
88922|NCT00854113|310972|P10|Overall Study|Adverse Event|0
88923|NCT00854113|310973|P9|Overall Study|Adverse Event|0
88924|NCT00854113|310974|P8|Overall Study|Adverse Event|2
88925|NCT00854113|310975|P7|Overall Study|Adverse Event|0
88926|NCT00854113|310976|P6|Overall Study|Adverse Event|0
88927|NCT00854113|310977|P5|Overall Study|Adverse Event|0
88928|NCT00854113|310978|P4|Overall Study|Adverse Event|0
88929|NCT00854113|310979|P3|Overall Study|Adverse Event|0
88930|NCT00854113|310980|P2|Overall Study|Adverse Event|0
88931|NCT00854113|310981|P1|Overall Study|Adverse Event|0
88932|NCT00853970|311093|P2|Overall Study|Cancelled surgery|2
88933|NCT00853970|311094|P1|Overall Study|Cancelled surgery|4
88934|NCT00853970|311093|P2|Overall Study|Withdrawal by Subject|1
88935|NCT00853970|311094|P1|Overall Study|Withdrawal by Subject|2
88936|NCT00853957|311104|P2|Overall Study|Protocol deviation|3
88937|NCT00853957|311105|P1|Overall Study|Protocol deviation|0
88938|NCT00853957|311104|P2|Overall Study|Lost to Follow-up|6
88939|NCT00853957|311105|P1|Overall Study|Lost to Follow-up|1
88940|NCT00853957|311104|P2|Overall Study|Subject withdrew consent|5
88941|NCT00853957|311105|P1|Overall Study|Subject withdrew consent|4
88942|NCT00853957|311104|P2|Overall Study|Unsatisfactory therapeutic effect|2
88943|NCT00853957|311105|P1|Overall Study|Unsatisfactory therapeutic effect|0
88944|NCT00853957|311104|P2|Overall Study|Adverse Event|3
88945|NCT00853957|311105|P1|Overall Study|Adverse Event|9
88946|NCT00853905|311123|P2|Overall Study|never had surgery|0
88947|NCT00853905|311124|P1|Overall Study|never had surgery|1
88948|NCT00853905|311123|P2|Overall Study|Withdrawal by Subject|1
88949|NCT00853905|311124|P1|Overall Study|Withdrawal by Subject|0
88950|NCT00853905|311123|P2|Overall Study|Lost to Follow-up|3
88951|NCT00853905|311124|P1|Overall Study|Lost to Follow-up|1
88952|NCT00853827|311148|P2|Double Blind Period (103 Weeks)|Death|6
88953|NCT00853827|311149|P1|Double Blind Period (103 Weeks)|Death|1
88954|NCT00853827|311148|P2|Double Blind Period (103 Weeks)|Administrative problems|56
88955|NCT00853827|311149|P1|Double Blind Period (103 Weeks)|Administrative problems|45
88956|NCT00853827|311148|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
88957|NCT00853827|311149|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
88958|NCT00853827|311148|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
88959|NCT00853827|311149|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
88960|NCT00853827|311148|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
88961|NCT00853827|311149|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
88962|NCT00853827|311148|P2|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|1
88963|NCT00853827|311149|P1|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|3
88964|NCT00853827|311148|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
88965|NCT00853827|311149|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
88966|NCT00853827|311148|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
88967|NCT00853827|311149|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
88968|NCT00853827|311148|P2|Double Blind Period (103 Weeks)|Adverse Event|14
88969|NCT00853827|311149|P1|Double Blind Period (103 Weeks)|Adverse Event|25
88970|NCT00853827|311148|P2|Single Blind Period (1 Week)|Protocol Violation|0
88971|NCT00853827|311149|P1|Single Blind Period (1 Week)|Protocol Violation|12
88972|NCT00853827|311148|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
88973|NCT00853827|311149|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
88974|NCT00853827|311148|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
88975|NCT00853827|311149|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
88976|NCT00853827|311148|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
88977|NCT00853827|311149|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
88978|NCT00853827|311148|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
88979|NCT00853827|311149|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
88980|NCT00853827|311148|P2|Single Blind Period (1 Week)|Adverse Event|0
88981|NCT00853827|311149|P1|Single Blind Period (1 Week)|Adverse Event|9
88982|NCT00853827|311148|P2|Single Blind Period (1 Week)|Other|0
88983|NCT00853827|311149|P1|Single Blind Period (1 Week)|Other|4
88984|NCT00853762|311165|P4|Overall Study|Randomised but not Treated|0
88985|NCT00853762|311166|P3|Overall Study|Randomised but not Treated|2
88986|NCT00853762|311167|P2|Overall Study|Randomised but not Treated|2
88987|NCT00853762|311168|P1|Overall Study|Randomised but not Treated|0
88988|NCT00853762|311165|P4|Overall Study|Unspecified|0
88989|NCT00853762|311166|P3|Overall Study|Unspecified|0
88990|NCT00853762|311167|P2|Overall Study|Unspecified|2
88991|NCT00853762|311168|P1|Overall Study|Unspecified|0
88992|NCT00853762|311165|P4|Overall Study|Withdrawal by Subject|0
88993|NCT00853762|311166|P3|Overall Study|Withdrawal by Subject|1
88994|NCT00853762|311167|P2|Overall Study|Withdrawal by Subject|0
88995|NCT00853762|311168|P1|Overall Study|Withdrawal by Subject|0
88996|NCT00853762|311165|P4|Overall Study|Protocol Violation|1
88997|NCT00853762|311166|P3|Overall Study|Protocol Violation|0
88998|NCT00853762|311167|P2|Overall Study|Protocol Violation|0
88999|NCT00853762|311168|P1|Overall Study|Protocol Violation|0
89000|NCT00853762|311165|P4|Overall Study|Premature Termination|21
89001|NCT00853762|311166|P3|Overall Study|Premature Termination|14
89002|NCT00853762|311167|P2|Overall Study|Premature Termination|15
89003|NCT00853762|311168|P1|Overall Study|Premature Termination|16
89004|NCT00853749|311236|P2|Overall Study|Lost to Follow-up|1
89005|NCT00853749|311237|P1|Overall Study|Lost to Follow-up|0
89006|NCT00853723|311258|P3|Overall Study|Protocol Violation|1
89007|NCT00853723|311259|P2|Overall Study|Protocol Violation|2
89008|NCT00853723|311260|P1|Overall Study|Protocol Violation|1
89009|NCT00853723|311258|P3|Overall Study|Withdrawal by Subject|0
89010|NCT00853723|311259|P2|Overall Study|Withdrawal by Subject|1
89011|NCT00853723|311260|P1|Overall Study|Withdrawal by Subject|2
89012|NCT00853723|311258|P3|Overall Study|Adverse Event|1
89013|NCT00853723|311259|P2|Overall Study|Adverse Event|4
89014|NCT00853723|311260|P1|Overall Study|Adverse Event|3
89015|NCT00853658|311307|P3|Overall Study|Missing study completion information|6
89016|NCT00853658|311308|P2|Overall Study|Missing study completion information|4
89017|NCT00853658|311309|P1|Overall Study|Missing study completion information|5
89018|NCT00853658|311307|P3|Overall Study|Patient's request|11
89019|NCT00853658|311308|P2|Overall Study|Patient's request|17
89020|NCT00853658|311309|P1|Overall Study|Patient's request|21
89021|NCT00853658|311307|P3|Overall Study|Vital Status at study end N/A|10
89022|NCT00853658|311308|P2|Overall Study|Vital Status at study end N/A|10
89023|NCT00853658|311309|P1|Overall Study|Vital Status at study end N/A|8
89024|NCT00853658|311307|P3|Overall Study|Vital Status unknown at study end|0
89025|NCT00853658|311308|P2|Overall Study|Vital Status unknown at study end|1
89026|NCT00853658|311309|P1|Overall Study|Vital Status unknown at study end|1
89027|NCT00853658|311307|P3|Overall Study|Vital Status known (alive) at study end|3
89028|NCT00853658|311308|P2|Overall Study|Vital Status known (alive) at study end|3
89029|NCT00853658|311309|P1|Overall Study|Vital Status known (alive) at study end|2
89030|NCT00853658|311307|P3|Overall Study|IRB request|2
89031|NCT00853658|311308|P2|Overall Study|IRB request|0
89032|NCT00853658|311309|P1|Overall Study|IRB request|0
89033|NCT00853658|311307|P3|Overall Study|H.A. Request|19
89034|NCT00853658|311308|P2|Overall Study|H.A. Request|23
89035|NCT00853658|311309|P1|Overall Study|H.A. Request|26
89036|NCT00853658|311307|P3|Overall Study|Lost to Follow-up|11
89037|NCT00853658|311308|P2|Overall Study|Lost to Follow-up|6
89038|NCT00853658|311309|P1|Overall Study|Lost to Follow-up|11
89039|NCT00853658|311307|P3|Overall Study|Death|753
89040|NCT00853658|311308|P2|Overall Study|Death|768
89041|NCT00853658|311309|P1|Overall Study|Death|713
89042|NCT00853593|311329|P1|Overall Study|Implant not attempted|4
89043|NCT00853593|311329|P1|Overall Study|Model 4396 lead not attempted|29
89044|NCT00853593|311329|P1|Overall Study|Subjects did not receive a 4396 lead|12
89045|NCT00853567|311357|P1|Overall Study|Study prematurely terminated|71
89046|NCT00853385|311370|P5|Overall Study|Unspecified|12
89047|NCT00853385|311371|P4|Overall Study|Unspecified|4
89048|NCT00853385|311372|P3|Overall Study|Unspecified|4
89049|NCT00853385|311373|P2|Overall Study|Unspecified|9
89050|NCT00853385|311374|P1|Overall Study|Unspecified|18
89051|NCT00853385|311370|P5|Overall Study|Withdrawal by Subject|1
89052|NCT00853385|311371|P4|Overall Study|Withdrawal by Subject|1
89053|NCT00853385|311372|P3|Overall Study|Withdrawal by Subject|0
89054|NCT00853385|311373|P2|Overall Study|Withdrawal by Subject|2
89055|NCT00853385|311374|P1|Overall Study|Withdrawal by Subject|4
89056|NCT00853385|311370|P5|Overall Study|Lost to Follow-up|0
89057|NCT00853385|311371|P4|Overall Study|Lost to Follow-up|0
89058|NCT00853385|311372|P3|Overall Study|Lost to Follow-up|0
89059|NCT00853385|311373|P2|Overall Study|Lost to Follow-up|1
89060|NCT00853385|311374|P1|Overall Study|Lost to Follow-up|2
89061|NCT00853385|311370|P5|Overall Study|Lack of Efficacy|6
89062|NCT00853385|311371|P4|Overall Study|Lack of Efficacy|3
89063|NCT00853385|311372|P3|Overall Study|Lack of Efficacy|3
89064|NCT00853385|311373|P2|Overall Study|Lack of Efficacy|7
89065|NCT00853385|311374|P1|Overall Study|Lack of Efficacy|6
89066|NCT00853385|311370|P5|Overall Study|Adverse Event|22
89067|NCT00853385|311371|P4|Overall Study|Adverse Event|5
89068|NCT00853385|311372|P3|Overall Study|Adverse Event|2
89069|NCT00853385|311373|P2|Overall Study|Adverse Event|24
89070|NCT00853385|311374|P1|Overall Study|Adverse Event|24
89071|NCT00853385|311370|P5|Overall Study|Death|1
89072|NCT00853385|311371|P4|Overall Study|Death|0
89073|NCT00853385|311372|P3|Overall Study|Death|0
89074|NCT00853385|311373|P2|Overall Study|Death|0
89075|NCT00853385|311374|P1|Overall Study|Death|0
89076|NCT00853242|311607|P7|Overall Study|Unspecified|2
89077|NCT00853242|311608|P6|Overall Study|Unspecified|1
89078|NCT00853242|311609|P5|Overall Study|Unspecified|0
89079|NCT00853242|311610|P4|Overall Study|Unspecified|0
89080|NCT00853242|311611|P3|Overall Study|Unspecified|2
89081|NCT00853242|311612|P2|Overall Study|Unspecified|0
89082|NCT00853242|311613|P1|Overall Study|Unspecified|2
89083|NCT00853242|311607|P7|Overall Study|Withdrawal by Subject|2
89084|NCT00853242|311608|P6|Overall Study|Withdrawal by Subject|0
89085|NCT00853242|311609|P5|Overall Study|Withdrawal by Subject|0
89086|NCT00853242|311610|P4|Overall Study|Withdrawal by Subject|4
89087|NCT00853242|311611|P3|Overall Study|Withdrawal by Subject|0
89088|NCT00853242|311612|P2|Overall Study|Withdrawal by Subject|2
89089|NCT00853242|311613|P1|Overall Study|Withdrawal by Subject|1
89090|NCT00853242|311607|P7|Overall Study|Noncompliant|0
89091|NCT00853242|311608|P6|Overall Study|Noncompliant|0
89092|NCT00853242|311609|P5|Overall Study|Noncompliant|1
89093|NCT00853242|311610|P4|Overall Study|Noncompliant|0
89094|NCT00853242|311611|P3|Overall Study|Noncompliant|0
89095|NCT00853242|311612|P2|Overall Study|Noncompliant|0
89096|NCT00853242|311613|P1|Overall Study|Noncompliant|0
89097|NCT00853242|311607|P7|Overall Study|Adverse Event|1
89098|NCT00853242|311608|P6|Overall Study|Adverse Event|1
89099|NCT00853242|311609|P5|Overall Study|Adverse Event|3
89100|NCT00853242|311610|P4|Overall Study|Adverse Event|0
89101|NCT00853242|311611|P3|Overall Study|Adverse Event|1
89102|NCT00853242|311612|P2|Overall Study|Adverse Event|1
89103|NCT00853242|311613|P1|Overall Study|Adverse Event|0
89104|NCT00853151|311657|P4|Overall Study|Sponsor Decision|0
89105|NCT00853151|311658|P3|Overall Study|Sponsor Decision|0
89106|NCT00853151|311659|P2|Overall Study|Sponsor Decision|3
89107|NCT00853151|311660|P1|Overall Study|Sponsor Decision|0
89108|NCT00853151|311657|P4|Overall Study|Physician Decision|0
89109|NCT00853151|311658|P3|Overall Study|Physician Decision|1
89110|NCT00853151|311659|P2|Overall Study|Physician Decision|2
89111|NCT00853151|311660|P1|Overall Study|Physician Decision|0
89112|NCT00853151|311657|P4|Overall Study|Withdrawal by Subject|1
89113|NCT00853151|311658|P3|Overall Study|Withdrawal by Subject|2
89114|NCT00853151|311659|P2|Overall Study|Withdrawal by Subject|4
89115|NCT00853151|311660|P1|Overall Study|Withdrawal by Subject|5
89116|NCT00853151|311657|P4|Overall Study|Protocol Violation|1
89117|NCT00853151|311658|P3|Overall Study|Protocol Violation|0
89118|NCT00853151|311659|P2|Overall Study|Protocol Violation|0
89119|NCT00853151|311660|P1|Overall Study|Protocol Violation|0
89120|NCT00853151|311657|P4|Overall Study|Death|1
89121|NCT00853151|311658|P3|Overall Study|Death|0
89122|NCT00853151|311659|P2|Overall Study|Death|0
89123|NCT00853151|311660|P1|Overall Study|Death|1
89124|NCT00853151|311657|P4|Overall Study|Lost to Follow-up|0
89125|NCT00853151|311658|P3|Overall Study|Lost to Follow-up|3
89126|NCT00853151|311659|P2|Overall Study|Lost to Follow-up|0
89127|NCT00853151|311660|P1|Overall Study|Lost to Follow-up|2
89128|NCT00853151|311657|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
89129|NCT00853151|311658|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
89130|NCT00853151|311659|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
89131|NCT00853151|311660|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
89132|NCT00853151|311657|P4|Overall Study|Adverse Event|0
89133|NCT00853151|311658|P3|Overall Study|Adverse Event|2
89134|NCT00853151|311659|P2|Overall Study|Adverse Event|4
89135|NCT00853151|311660|P1|Overall Study|Adverse Event|1
89136|NCT00853099|311805|P4|Double-blind + Open-label Periods|Not Specified|6
89137|NCT00853099|311806|P3|Double-blind + Open-label Periods|Not Specified|0
89138|NCT00853099|311807|P2|Double-blind + Open-label Periods|Not Specified|0
89139|NCT00853099|311808|P1|Double-blind + Open-label Periods|Not Specified|0
89140|NCT00853099|311805|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
89141|NCT00853099|311806|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
89142|NCT00853099|311807|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
89143|NCT00853099|311808|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
89144|NCT00853099|311805|P4|Double-blind + Open-label Periods|Adverse Event|47
89145|NCT00853099|311806|P3|Double-blind + Open-label Periods|Adverse Event|0
89146|NCT00853099|311807|P2|Double-blind + Open-label Periods|Adverse Event|0
89147|NCT00853099|311808|P1|Double-blind + Open-label Periods|Adverse Event|0
89148|NCT00853099|311805|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
89149|NCT00853099|311806|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
89150|NCT00853099|311807|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
89151|NCT00853099|311808|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
89152|NCT00853099|311805|P4|Double-blind Period|Mistreated with rescue study drug|0
89153|NCT00853099|311806|P3|Double-blind Period|Mistreated with rescue study drug|1
89154|NCT00853099|311807|P2|Double-blind Period|Mistreated with rescue study drug|0
89155|NCT00853099|311808|P1|Double-blind Period|Mistreated with rescue study drug|0
89156|NCT00853099|311805|P4|Double-blind Period|Not Specified|0
89157|NCT00853099|311806|P3|Double-blind Period|Not Specified|1
89158|NCT00853099|311807|P2|Double-blind Period|Not Specified|0
89159|NCT00853099|311808|P1|Double-blind Period|Not Specified|0
89160|NCT00853099|311805|P4|Double-blind Period|Lack of Efficacy|0
89161|NCT00853099|311806|P3|Double-blind Period|Lack of Efficacy|16
89162|NCT00853099|311807|P2|Double-blind Period|Lack of Efficacy|17
89163|NCT00853099|311808|P1|Double-blind Period|Lack of Efficacy|14
89164|NCT00853099|311805|P4|Double-blind Period|Withdrawal by Subject|0
89165|NCT00853099|311806|P3|Double-blind Period|Withdrawal by Subject|0
89166|NCT00853099|311807|P2|Double-blind Period|Withdrawal by Subject|3
89167|NCT00853099|311808|P1|Double-blind Period|Withdrawal by Subject|2
89168|NCT00853099|311805|P4|Double-blind Period|Adverse Event|0
89169|NCT00853099|311806|P3|Double-blind Period|Adverse Event|13
89170|NCT00853099|311807|P2|Double-blind Period|Adverse Event|9
89171|NCT00853099|311808|P1|Double-blind Period|Adverse Event|7
89172|NCT00853073|311850|P2|Overall Study|Withdrawal by Subject|2
89173|NCT00853073|311851|P1|Overall Study|Withdrawal by Subject|3
89174|NCT00853021|311857|P1|Overall Study|Death|1
89175|NCT00853021|311857|P1|Overall Study|Withdrawal by Subject|2
89176|NCT00853021|311857|P1|Overall Study|Adverse Event|2
89177|NCT00852995|311869|P5|Overall Study|Moved Out of Area|0
89178|NCT00852995|311870|P4|Overall Study|Moved Out of Area|0
89179|NCT00852995|311871|P3|Overall Study|Moved Out of Area|0
89180|NCT00852995|311872|P2|Overall Study|Moved Out of Area|0
89181|NCT00852995|311873|P1|Overall Study|Moved Out of Area|1
89182|NCT00852995|311869|P5|Overall Study|Protocol Violation|1
89183|NCT00852995|311870|P4|Overall Study|Protocol Violation|0
89184|NCT00852995|311871|P3|Overall Study|Protocol Violation|0
89185|NCT00852995|311872|P2|Overall Study|Protocol Violation|0
89186|NCT00852995|311873|P1|Overall Study|Protocol Violation|0
89187|NCT00852995|311869|P5|Overall Study|Physician Decision|0
89188|NCT00852995|311870|P4|Overall Study|Physician Decision|0
89189|NCT00852995|311871|P3|Overall Study|Physician Decision|0
89190|NCT00852995|311872|P2|Overall Study|Physician Decision|0
89191|NCT00852995|311873|P1|Overall Study|Physician Decision|1
89192|NCT00852995|311869|P5|Overall Study|Progressive Disease|1
89193|NCT00852995|311870|P4|Overall Study|Progressive Disease|2
89194|NCT00852995|311871|P3|Overall Study|Progressive Disease|0
89195|NCT00852995|311872|P2|Overall Study|Progressive Disease|0
89196|NCT00852995|311873|P1|Overall Study|Progressive Disease|1
89197|NCT00852995|311869|P5|Overall Study|Non-Compliance|0
89198|NCT00852995|311870|P4|Overall Study|Non-Compliance|2
89199|NCT00852995|311871|P3|Overall Study|Non-Compliance|0
89200|NCT00852995|311872|P2|Overall Study|Non-Compliance|0
89201|NCT00852995|311873|P1|Overall Study|Non-Compliance|0
89202|NCT00852995|311869|P5|Overall Study|Withdrawal by Subject|2
89203|NCT00852995|311870|P4|Overall Study|Withdrawal by Subject|1
89204|NCT00852995|311871|P3|Overall Study|Withdrawal by Subject|0
89205|NCT00852995|311872|P2|Overall Study|Withdrawal by Subject|0
89206|NCT00852995|311873|P1|Overall Study|Withdrawal by Subject|4
89207|NCT00852995|311869|P5|Overall Study|Lost to Follow-up|0
89208|NCT00852995|311870|P4|Overall Study|Lost to Follow-up|0
89209|NCT00852995|311871|P3|Overall Study|Lost to Follow-up|1
89210|NCT00852995|311872|P2|Overall Study|Lost to Follow-up|1
89211|NCT00852995|311873|P1|Overall Study|Lost to Follow-up|0
89212|NCT00852995|311869|P5|Overall Study|Adverse Event|0
89213|NCT00852995|311870|P4|Overall Study|Adverse Event|0
89214|NCT00852995|311871|P3|Overall Study|Adverse Event|4
89215|NCT00852995|311872|P2|Overall Study|Adverse Event|0
89216|NCT00852995|311873|P1|Overall Study|Adverse Event|1
89217|NCT00852969|311917|P2|Overall Study|Lost to Follow-up|1
89218|NCT00852969|311918|P1|Overall Study|Lost to Follow-up|0
89219|NCT00852969|311917|P2|Overall Study|Adverse Event|1
89220|NCT00852969|311918|P1|Overall Study|Adverse Event|0
89221|NCT00852930|311929|P3|Overall Study|Physician Decision|1
89222|NCT00852930|311930|P2|Overall Study|Physician Decision|0
89223|NCT00852930|311931|P1|Overall Study|Physician Decision|0
89224|NCT00852930|311929|P3|Overall Study|Withdrawal by Subject|1
89225|NCT00852930|311930|P2|Overall Study|Withdrawal by Subject|1
89226|NCT00852930|311931|P1|Overall Study|Withdrawal by Subject|1
89227|NCT00852917|311952|P4|Overall Study|Death|1
89228|NCT00852917|311953|P3|Overall Study|Death|0
89229|NCT00852917|311954|P2|Overall Study|Death|0
89230|NCT00852917|311955|P1|Overall Study|Death|0
89231|NCT00852917|311952|P4|Overall Study|Physician Decision|19
89232|NCT00852917|311953|P3|Overall Study|Physician Decision|2
89233|NCT00852917|311954|P2|Overall Study|Physician Decision|7
89234|NCT00852917|311955|P1|Overall Study|Physician Decision|6
89235|NCT00852917|311952|P4|Overall Study|Withdrawal by Subject|9
89236|NCT00852917|311953|P3|Overall Study|Withdrawal by Subject|10
89237|NCT00852917|311954|P2|Overall Study|Withdrawal by Subject|8
89238|NCT00852917|311955|P1|Overall Study|Withdrawal by Subject|4
89239|NCT00852917|311952|P4|Overall Study|Lack of Efficacy|47
89240|NCT00852917|311953|P3|Overall Study|Lack of Efficacy|11
89241|NCT00852917|311954|P2|Overall Study|Lack of Efficacy|11
89242|NCT00852917|311955|P1|Overall Study|Lack of Efficacy|21
89243|NCT00852917|311952|P4|Overall Study|Adverse Event|17
89244|NCT00852917|311953|P3|Overall Study|Adverse Event|35
89245|NCT00852917|311954|P2|Overall Study|Adverse Event|20
89246|NCT00852917|311955|P1|Overall Study|Adverse Event|13
89247|NCT00851786|312040|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
89248|NCT00851786|312041|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
89249|NCT00851786|312040|P2|Overall Study|Site Closure|0
89250|NCT00851786|312041|P1|Overall Study|Site Closure|1
89251|NCT00851786|312040|P2|Overall Study|Incarceration|0
89252|NCT00851786|312041|P1|Overall Study|Incarceration|1
89253|NCT00851786|312040|P2|Overall Study|Lost to Follow-up|0
89254|NCT00851786|312041|P1|Overall Study|Lost to Follow-up|1
89255|NCT00851786|312040|P2|Overall Study|Protocol Violation|1
89256|NCT00851786|312041|P1|Overall Study|Protocol Violation|0
89257|NCT00851786|312040|P2|Overall Study|Withdrawal by Subject|1
89258|NCT00851786|312041|P1|Overall Study|Withdrawal by Subject|0
89259|NCT00851721|312051|P2|Overall Study|Adverse Event|1
89260|NCT00851721|312052|P1|Overall Study|Adverse Event|0
89261|NCT00851721|312051|P2|Overall Study|Death|0
89262|NCT00851721|312052|P1|Overall Study|Death|1
89263|NCT00851721|312051|P2|Overall Study|planned surgery|0
89264|NCT00851721|312052|P1|Overall Study|planned surgery|1
89265|NCT00851682|312142|P2|Overall Study|screen failure|0
89266|NCT00851682|312143|P1|Overall Study|screen failure|5
89267|NCT00851643|312157|P6|Extension Study (Up to 36 Months)|Moved|1
89268|NCT00851643|312158|P5|Extension Study (Up to 36 Months)|Moved|0
89269|NCT00851643|312159|P4|Extension Study (Up to 36 Months)|Moved|1
89270|NCT00851643|312160|P3|Extension Study (Up to 36 Months)|Moved|1
89271|NCT00851643|312161|P2|Extension Study (Up to 36 Months)|Moved|2
89272|NCT00851643|312162|P1|Extension Study (Up to 36 Months)|Moved|0
89273|NCT00851643|312157|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
89274|NCT00851643|312158|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
89275|NCT00851643|312159|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
89276|NCT00851643|312160|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
89277|NCT00851643|312161|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
89278|NCT00851643|312162|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
89279|NCT00851643|312157|P6|Base Study (Up to 12 Months)|Unspecified|1
89280|NCT00851643|312158|P5|Base Study (Up to 12 Months)|Unspecified|0
89281|NCT00851643|312159|P4|Base Study (Up to 12 Months)|Unspecified|0
89282|NCT00851643|312160|P3|Base Study (Up to 12 Months)|Unspecified|0
89283|NCT00851643|312161|P2|Base Study (Up to 12 Months)|Unspecified|0
89284|NCT00851643|312162|P1|Base Study (Up to 12 Months)|Unspecified|0
89285|NCT00851643|312157|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
89286|NCT00851643|312158|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
89287|NCT00851643|312159|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
89288|NCT00851643|312160|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
89289|NCT00851643|312161|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
89290|NCT00851643|312162|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
89291|NCT00851630|312183|P2|Overall Study|Clinical failure|1
89292|NCT00851630|312184|P1|Overall Study|Clinical failure|0
89293|NCT00851630|312183|P2|Overall Study|Death|1
89294|NCT00851630|312184|P1|Overall Study|Death|2
89295|NCT00852540|312215|P2|Overall Study|Did Not Receive Study Drug|3
89296|NCT00852540|312216|P1|Overall Study|Did Not Receive Study Drug|3
89297|NCT00852540|312215|P2|Overall Study|Withdrawal by Subject|1
89298|NCT00852540|312216|P1|Overall Study|Withdrawal by Subject|3
89299|NCT00852540|312215|P2|Overall Study|Investigator Discretion|3
89300|NCT00852540|312216|P1|Overall Study|Investigator Discretion|2
89301|NCT00852540|312215|P2|Overall Study|Lost to Follow-up|3
89302|NCT00852540|312216|P1|Overall Study|Lost to Follow-up|2
89303|NCT00852540|312215|P2|Overall Study|Protocol Violation|2
89304|NCT00852540|312216|P1|Overall Study|Protocol Violation|1
89305|NCT00852540|312215|P2|Overall Study|Lack of Efficacy|3
89306|NCT00852540|312216|P1|Overall Study|Lack of Efficacy|15
89307|NCT00852540|312215|P2|Overall Study|Adverse Event|3
89308|NCT00852540|312216|P1|Overall Study|Adverse Event|10
89309|NCT00852475|312250|P2|Overall Study|Lost to Follow-up|4
89310|NCT00852475|312251|P1|Overall Study|Lost to Follow-up|3
89311|NCT00852397|312262|P3|Overall Study|Protocol Violation|1
89312|NCT00852397|312263|P2|Overall Study|Protocol Violation|0
89313|NCT00852397|312264|P1|Overall Study|Protocol Violation|0
89314|NCT00852397|312262|P3|Overall Study|Difficulty in study site visit|0
89315|NCT00852397|312263|P2|Overall Study|Difficulty in study site visit|0
89316|NCT00852397|312264|P1|Overall Study|Difficulty in study site visit|1
89317|NCT00852397|312262|P3|Overall Study|Study terminated by sponsor|6
89318|NCT00852397|312263|P2|Overall Study|Study terminated by sponsor|1
89319|NCT00852397|312264|P1|Overall Study|Study terminated by sponsor|2
89320|NCT00852397|312262|P3|Overall Study|Withdrawal by Subject|2
89321|NCT00852397|312263|P2|Overall Study|Withdrawal by Subject|1
89322|NCT00852397|312264|P1|Overall Study|Withdrawal by Subject|4
89323|NCT00852397|312262|P3|Overall Study|Death|1
89324|NCT00852397|312263|P2|Overall Study|Death|0
89325|NCT00852397|312264|P1|Overall Study|Death|0
89326|NCT00852397|312262|P3|Overall Study|Adverse Event|4
89327|NCT00852397|312263|P2|Overall Study|Adverse Event|6
89328|NCT00852397|312264|P1|Overall Study|Adverse Event|4
89329|NCT00851903|312324|P1|Overall Study|Withdrawal by Subject|2
89330|NCT00851890|312338|P4|Overall Study|Lost to Follow-up|1
89331|NCT00851890|312339|P3|Overall Study|Lost to Follow-up|0
89332|NCT00851890|312340|P2|Overall Study|Lost to Follow-up|1
89333|NCT00851890|312341|P1|Overall Study|Lost to Follow-up|0
89334|NCT00851799|312401|P3|Overall Study|Completed protocol due to pregnancy|1
89335|NCT00851799|312402|P2|Overall Study|Completed protocol due to pregnancy|0
89336|NCT00851799|312403|P1|Overall Study|Completed protocol due to pregnancy|0
89337|NCT00851799|312401|P3|Overall Study|Severe Debilitation|0
89338|NCT00851799|312402|P2|Overall Study|Severe Debilitation|1
89339|NCT00851799|312403|P1|Overall Study|Severe Debilitation|0
89340|NCT00851799|312401|P3|Overall Study|Withdrew consent prior study completion|1
89341|NCT00851799|312402|P2|Overall Study|Withdrew consent prior study completion|2
89342|NCT00851799|312403|P1|Overall Study|Withdrew consent prior study completion|1
89343|NCT00851799|312401|P3|Overall Study|Not willing to adhere to requirements|2
89344|NCT00851799|312402|P2|Overall Study|Not willing to adhere to requirements|2
89345|NCT00851799|312403|P1|Overall Study|Not willing to adhere to requirements|1
89346|NCT00851799|312401|P3|Overall Study|Not able to get to clinic|9
89347|NCT00851799|312402|P2|Overall Study|Not able to get to clinic|5
89348|NCT00851799|312403|P1|Overall Study|Not able to get to clinic|8
89349|NCT00851799|312401|P3|Overall Study|Lost to Follow-up|10
89350|NCT00851799|312402|P2|Overall Study|Lost to Follow-up|3
89351|NCT00851799|312403|P1|Overall Study|Lost to Follow-up|5
89352|NCT00851799|312401|P3|Overall Study|Death|1
89353|NCT00851799|312402|P2|Overall Study|Death|0
89354|NCT00851799|312403|P1|Overall Study|Death|1
89355|NCT00851591|312491|P2|Overall Study|Withdrawal by Subject|0
89356|NCT00851591|312492|P1|Overall Study|Withdrawal by Subject|2
89357|NCT00851552|312498|P1|Overall Study|Disease Progression|4
89358|NCT00851552|312498|P1|Overall Study|Adverse Event|1
89359|NCT00851552|312498|P1|Overall Study|Death|2
89360|NCT00851318|312512|P4|Overall Study|Physician Decision|1
89361|NCT00851318|312513|P3|Overall Study|Physician Decision|1
89362|NCT00851318|312514|P2|Overall Study|Physician Decision|0
89363|NCT00851318|312515|P1|Overall Study|Physician Decision|0
89364|NCT00851318|312512|P4|Overall Study|Non-compliance with Study Procedures|0
89365|NCT00851318|312513|P3|Overall Study|Non-compliance with Study Procedures|1
89366|NCT00851318|312514|P2|Overall Study|Non-compliance with Study Procedures|0
89367|NCT00851318|312515|P1|Overall Study|Non-compliance with Study Procedures|2
89368|NCT00851318|312512|P4|Overall Study|Lack of Efficacy|2
89369|NCT00851318|312513|P3|Overall Study|Lack of Efficacy|4
89370|NCT00851318|312514|P2|Overall Study|Lack of Efficacy|2
89371|NCT00851318|312515|P1|Overall Study|Lack of Efficacy|8
89372|NCT00851318|312512|P4|Overall Study|Pregnancy|1
89373|NCT00851318|312513|P3|Overall Study|Pregnancy|1
89374|NCT00851318|312514|P2|Overall Study|Pregnancy|0
89375|NCT00851318|312515|P1|Overall Study|Pregnancy|0
89376|NCT00851318|312512|P4|Overall Study|Adverse Event|12
89377|NCT00851318|312513|P3|Overall Study|Adverse Event|9
89378|NCT00851318|312514|P2|Overall Study|Adverse Event|2
89379|NCT00851318|312515|P1|Overall Study|Adverse Event|13
89380|NCT00851318|312512|P4|Overall Study|Withdrawal by Subject|3
89381|NCT00851318|312513|P3|Overall Study|Withdrawal by Subject|5
89382|NCT00851318|312514|P2|Overall Study|Withdrawal by Subject|1
89383|NCT00851318|312515|P1|Overall Study|Withdrawal by Subject|7
89384|NCT00851084|312551|P2|Overall Study|Not specified|1
89385|NCT00851084|312552|P1|Overall Study|Not specified|7
89386|NCT00851084|312551|P2|Overall Study|Metastatic surgery|6
89387|NCT00851084|312552|P1|Overall Study|Metastatic surgery|6
89388|NCT00851084|312551|P2|Overall Study|Withdrawal by Subject|12
89389|NCT00851084|312552|P1|Overall Study|Withdrawal by Subject|11
89390|NCT00851084|312551|P2|Overall Study|Consent withdrawn|2
89391|NCT00851084|312552|P1|Overall Study|Consent withdrawn|0
89392|NCT00851084|312551|P2|Overall Study|Physician Decision|14
89393|NCT00851084|312552|P1|Overall Study|Physician Decision|13
89394|NCT00851084|312551|P2|Overall Study|Poor compliance to protocol|1
89395|NCT00851084|312552|P1|Overall Study|Poor compliance to protocol|1
89396|NCT00851084|312551|P2|Overall Study|Disease progression|47
89397|NCT00851084|312552|P1|Overall Study|Disease progression|52
89398|NCT00851084|312551|P2|Overall Study|Adverse Event|36
89399|NCT00851084|312552|P1|Overall Study|Adverse Event|26
89400|NCT00851084|312551|P2|Overall Study|Randomized but not treated|0
89401|NCT00851084|312552|P1|Overall Study|Randomized but not treated|1
89402|NCT00850759|312612|P4|Overall Study|Lost to Follow-up|3
89403|NCT00850759|312613|P3|Overall Study|Lost to Follow-up|5
89404|NCT00850759|312614|P2|Overall Study|Lost to Follow-up|5
89405|NCT00850759|312615|P1|Overall Study|Lost to Follow-up|7
89406|NCT00850564|312660|P1|Overall Study|Withdrawal by Subject|2
89407|NCT00850538|312665|P1|Overall Study|Protocol Violation|2
89408|NCT00850538|312665|P1|Overall Study|radiology error|2
89409|NCT00850538|312665|P1|Overall Study|Withdrawal by Subject|3
89410|NCT00850538|312665|P1|Overall Study|specimen unusable|7
89411|NCT00850538|312665|P1|Overall Study|specimen missed due to scheduling error|14
89412|NCT00850538|312665|P1|Overall Study|unable/unwilling to complete MRI|13
89413|NCT00850499|312671|P2|Overall Study|Lack of Efficacy|1
89414|NCT00850499|312672|P1|Overall Study|Lack of Efficacy|0
89415|NCT00850499|312671|P2|Overall Study|Adverse Event|1
89416|NCT00850499|312672|P1|Overall Study|Adverse Event|3
89417|NCT00850460|312682|P2|Overall Study|Lost to Follow-up|4
89418|NCT00850460|312683|P1|Overall Study|Lost to Follow-up|4
89419|NCT00849524|312691|P1|Overall Study|Lack of Efficacy|3
89420|NCT00850395|312712|P1|Overall Study|Unspecified|5
89421|NCT00850395|312712|P1|Overall Study|Insufficient clinical response|3
89422|NCT00850395|312712|P1|Overall Study|Adverse Event|1
89423|NCT00850395|312712|P1|Overall Study|Death|1
89424|NCT00850343|312732|P4|Overall Study|Physician Decision|1
89425|NCT00850343|312733|P3|Overall Study|Physician Decision|1
89426|NCT00850343|312734|P2|Overall Study|Physician Decision|1
89427|NCT00850343|312735|P1|Overall Study|Physician Decision|2
89428|NCT00850343|312732|P4|Overall Study|Non-compliance with Study Procedures|1
89429|NCT00850343|312733|P3|Overall Study|Non-compliance with Study Procedures|1
89430|NCT00850343|312734|P2|Overall Study|Non-compliance with Study Procedures|0
89431|NCT00850343|312735|P1|Overall Study|Non-compliance with Study Procedures|1
89432|NCT00850343|312732|P4|Overall Study|Lack of Efficacy|2
89433|NCT00850343|312733|P3|Overall Study|Lack of Efficacy|3
89434|NCT00850343|312734|P2|Overall Study|Lack of Efficacy|0
89435|NCT00850343|312735|P1|Overall Study|Lack of Efficacy|17
89436|NCT00850343|312732|P4|Overall Study|Pregnancy|1
89437|NCT00850343|312733|P3|Overall Study|Pregnancy|0
89438|NCT00850343|312734|P2|Overall Study|Pregnancy|0
89439|NCT00850343|312735|P1|Overall Study|Pregnancy|0
89440|NCT00850343|312732|P4|Overall Study|Adverse Event|6
89441|NCT00850343|312733|P3|Overall Study|Adverse Event|6
89442|NCT00850343|312734|P2|Overall Study|Adverse Event|2
89443|NCT00850343|312735|P1|Overall Study|Adverse Event|15
89444|NCT00850343|312732|P4|Overall Study|Withdrawal by Subject|2
89445|NCT00850343|312733|P3|Overall Study|Withdrawal by Subject|3
89446|NCT00850343|312734|P2|Overall Study|Withdrawal by Subject|0
89447|NCT00850343|312735|P1|Overall Study|Withdrawal by Subject|11
89448|NCT00850200|312765|P1|Overall Study|Withdrawal by Subject|1
89449|NCT00850174|312773|P2|Second Intervention|Withdrawal by Subject|0
89450|NCT00850174|312774|P1|Second Intervention|Withdrawal by Subject|1
89451|NCT00850174|312773|P2|Washout: One Week|Withdrawal by Subject|2
89452|NCT00850174|312774|P1|Washout: One Week|Withdrawal by Subject|0
89453|NCT00850135|312788|P1|Overall Study|Physician Decision|1
89454|NCT00850070|312807|P2|Overall Study|Adverse Event|0
89455|NCT00850070|312808|P1|Overall Study|Adverse Event|2
89456|NCT00850070|312807|P2|Overall Study|Lack of Efficacy|1
89457|NCT00850070|312808|P1|Overall Study|Lack of Efficacy|1
89458|NCT00849940|312829|P1|Overall Study|Physician Decision|4
89459|NCT00849901|312840|P3|Extension Phase|Lack of Efficacy|1
89460|NCT00849901|312841|P2|Extension Phase|Lack of Efficacy|4
89461|NCT00849901|312842|P1|Extension Phase|Lack of Efficacy|2
89462|NCT00849901|312840|P3|Extension Phase|Physician Decision|0
89463|NCT00849901|312841|P2|Extension Phase|Physician Decision|2
89464|NCT00849901|312842|P1|Extension Phase|Physician Decision|1
89465|NCT00849901|312840|P3|Extension Phase|Parent or Caregiver Decision|4
89466|NCT00849901|312841|P2|Extension Phase|Parent or Caregiver Decision|4
89467|NCT00849901|312842|P1|Extension Phase|Parent or Caregiver Decision|10
89468|NCT00849901|312840|P3|Extension Phase|Withdrawal by Subject|3
89469|NCT00849901|312841|P2|Extension Phase|Withdrawal by Subject|6
89470|NCT00849901|312842|P1|Extension Phase|Withdrawal by Subject|7
89471|NCT00849901|312840|P3|Extension Phase|Protocol Violation|4
89472|NCT00849901|312841|P2|Extension Phase|Protocol Violation|2
89473|NCT00849901|312842|P1|Extension Phase|Protocol Violation|2
89474|NCT00849901|312840|P3|Extension Phase|Lost to Follow-up|1
89475|NCT00849901|312841|P2|Extension Phase|Lost to Follow-up|0
89476|NCT00849901|312842|P1|Extension Phase|Lost to Follow-up|3
89477|NCT00849901|312840|P3|Extension Phase|Adverse Event|4
89478|NCT00849901|312841|P2|Extension Phase|Adverse Event|8
89479|NCT00849901|312842|P1|Extension Phase|Adverse Event|2
89480|NCT00849901|312840|P3|Acute Treatment Phase|Lack of Efficacy|2
89481|NCT00849901|312841|P2|Acute Treatment Phase|Lack of Efficacy|3
89482|NCT00849901|312842|P1|Acute Treatment Phase|Lack of Efficacy|2
89483|NCT00849901|312840|P3|Acute Treatment Phase|Sponsor Decision|0
89484|NCT00849901|312841|P2|Acute Treatment Phase|Sponsor Decision|0
89485|NCT00849901|312842|P1|Acute Treatment Phase|Sponsor Decision|1
89486|NCT00849901|312840|P3|Acute Treatment Phase|Physician Decision|1
89487|NCT00849901|312841|P2|Acute Treatment Phase|Physician Decision|1
89488|NCT00849901|312842|P1|Acute Treatment Phase|Physician Decision|1
89489|NCT00849901|312840|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
89490|NCT00849901|312841|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
89491|NCT00849901|312842|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
89492|NCT00849901|312840|P3|Acute Treatment Phase|Withdrawal by Subject|4
89493|NCT00849901|312841|P2|Acute Treatment Phase|Withdrawal by Subject|10
89494|NCT00849901|312842|P1|Acute Treatment Phase|Withdrawal by Subject|4
89495|NCT00849901|312840|P3|Acute Treatment Phase|Protocol Violation|1
89496|NCT00849901|312841|P2|Acute Treatment Phase|Protocol Violation|2
89497|NCT00849901|312842|P1|Acute Treatment Phase|Protocol Violation|0
89498|NCT00849901|312840|P3|Acute Treatment Phase|Lost to Follow-up|1
89499|NCT00849901|312841|P2|Acute Treatment Phase|Lost to Follow-up|4
89500|NCT00849901|312842|P1|Acute Treatment Phase|Lost to Follow-up|2
89501|NCT00849901|312840|P3|Acute Treatment Phase|Adverse Event|3
89502|NCT00849901|312841|P2|Acute Treatment Phase|Adverse Event|1
89503|NCT00849901|312842|P1|Acute Treatment Phase|Adverse Event|9
89504|NCT00849797|312903|P2|Washout: One Week|Withdrawal by Subject|2
89505|NCT00849797|312904|P1|Washout: One Week|Withdrawal by Subject|0
89506|NCT00849797|312903|P2|First Intervention|Adverse Event|1
89507|NCT00849797|312904|P1|First Intervention|Adverse Event|0
89508|NCT00849797|312903|P2|First Intervention|bad veins|0
89509|NCT00849797|312904|P1|First Intervention|bad veins|1
89510|NCT00849693|312922|P4|Extension Phase|Lack of Efficacy|1
89511|NCT00849693|312923|P3|Extension Phase|Lack of Efficacy|2
89512|NCT00849693|312924|P2|Extension Phase|Lack of Efficacy|2
89513|NCT00849693|312925|P1|Extension Phase|Lack of Efficacy|2
89514|NCT00849693|312922|P4|Extension Phase|Sponsor decision|1
89515|NCT00849693|312923|P3|Extension Phase|Sponsor decision|0
89516|NCT00849693|312924|P2|Extension Phase|Sponsor decision|0
89517|NCT00849693|312925|P1|Extension Phase|Sponsor decision|1
89518|NCT00849693|312922|P4|Extension Phase|Physician Decision|0
89519|NCT00849693|312923|P3|Extension Phase|Physician Decision|2
89520|NCT00849693|312924|P2|Extension Phase|Physician Decision|1
89521|NCT00849693|312925|P1|Extension Phase|Physician Decision|1
89522|NCT00849693|312922|P4|Extension Phase|Parent or caregiver decision|5
89523|NCT00849693|312923|P3|Extension Phase|Parent or caregiver decision|10
89524|NCT00849693|312924|P2|Extension Phase|Parent or caregiver decision|4
89525|NCT00849693|312925|P1|Extension Phase|Parent or caregiver decision|9
89526|NCT00849693|312922|P4|Extension Phase|Withdrawal by Subject|15
89527|NCT00849693|312923|P3|Extension Phase|Withdrawal by Subject|10
89528|NCT00849693|312924|P2|Extension Phase|Withdrawal by Subject|9
89529|NCT00849693|312925|P1|Extension Phase|Withdrawal by Subject|6
89530|NCT00849693|312922|P4|Extension Phase|Protocol Violation|3
89531|NCT00849693|312923|P3|Extension Phase|Protocol Violation|2
89532|NCT00849693|312924|P2|Extension Phase|Protocol Violation|3
89533|NCT00849693|312925|P1|Extension Phase|Protocol Violation|0
89534|NCT00849693|312922|P4|Extension Phase|Lost to Follow-up|6
89535|NCT00849693|312923|P3|Extension Phase|Lost to Follow-up|6
89536|NCT00849693|312924|P2|Extension Phase|Lost to Follow-up|5
89537|NCT00849693|312925|P1|Extension Phase|Lost to Follow-up|7
89538|NCT00849693|312922|P4|Extension Phase|Adverse Event|7
89539|NCT00849693|312923|P3|Extension Phase|Adverse Event|3
89540|NCT00849693|312924|P2|Extension Phase|Adverse Event|6
89541|NCT00849693|312925|P1|Extension Phase|Adverse Event|4
89542|NCT00849693|312922|P4|Acute Treatment Phase|Lack of Efficacy|2
89543|NCT00849693|312923|P3|Acute Treatment Phase|Lack of Efficacy|1
89544|NCT00849693|312924|P2|Acute Treatment Phase|Lack of Efficacy|3
89545|NCT00849693|312925|P1|Acute Treatment Phase|Lack of Efficacy|1
89546|NCT00849693|312922|P4|Acute Treatment Phase|Sponsor decision|0
89547|NCT00849693|312923|P3|Acute Treatment Phase|Sponsor decision|1
89548|NCT00849693|312924|P2|Acute Treatment Phase|Sponsor decision|0
89549|NCT00849693|312925|P1|Acute Treatment Phase|Sponsor decision|0
89550|NCT00849693|312922|P4|Acute Treatment Phase|Physician Decision|1
89551|NCT00849693|312923|P3|Acute Treatment Phase|Physician Decision|2
89552|NCT00849693|312924|P2|Acute Treatment Phase|Physician Decision|1
89553|NCT00849693|312925|P1|Acute Treatment Phase|Physician Decision|2
89554|NCT00849693|312922|P4|Acute Treatment Phase|Parent or caregiver decision|7
89555|NCT00849693|312923|P3|Acute Treatment Phase|Parent or caregiver decision|7
89556|NCT00849693|312924|P2|Acute Treatment Phase|Parent or caregiver decision|6
89557|NCT00849693|312925|P1|Acute Treatment Phase|Parent or caregiver decision|7
89558|NCT00849693|312922|P4|Acute Treatment Phase|Withdrawal by Subject|8
89559|NCT00849693|312923|P3|Acute Treatment Phase|Withdrawal by Subject|3
89560|NCT00849693|312924|P2|Acute Treatment Phase|Withdrawal by Subject|5
89561|NCT00849693|312925|P1|Acute Treatment Phase|Withdrawal by Subject|5
89562|NCT00849693|312922|P4|Acute Treatment Phase|Protocol Violation|6
89563|NCT00849693|312923|P3|Acute Treatment Phase|Protocol Violation|2
89564|NCT00849693|312924|P2|Acute Treatment Phase|Protocol Violation|5
89565|NCT00849693|312925|P1|Acute Treatment Phase|Protocol Violation|1
89566|NCT00849693|312922|P4|Acute Treatment Phase|Lost to Follow-up|9
89567|NCT00849693|312923|P3|Acute Treatment Phase|Lost to Follow-up|11
89568|NCT00849693|312924|P2|Acute Treatment Phase|Lost to Follow-up|8
89569|NCT00849693|312925|P1|Acute Treatment Phase|Lost to Follow-up|5
89570|NCT00849693|312922|P4|Acute Treatment Phase|Adverse Event|4
89571|NCT00849693|312923|P3|Acute Treatment Phase|Adverse Event|6
89572|NCT00849693|312924|P2|Acute Treatment Phase|Adverse Event|7
89573|NCT00849693|312925|P1|Acute Treatment Phase|Adverse Event|12
89574|NCT00849680|312992|P8|Overall Study|Subject unable to comply with protocol|0
89575|NCT00849680|312993|P7|Overall Study|Subject unable to comply with protocol|0
89576|NCT00849680|312994|P6|Overall Study|Subject unable to comply with protocol|0
89577|NCT00849680|312995|P5|Overall Study|Subject unable to comply with protocol|0
89578|NCT00849680|312996|P4|Overall Study|Subject unable to comply with protocol|0
89579|NCT00849680|312997|P3|Overall Study|Subject unable to comply with protocol|0
89580|NCT00849680|312998|P2|Overall Study|Subject unable to comply with protocol|0
89581|NCT00849680|312999|P1|Overall Study|Subject unable to comply with protocol|1
89582|NCT00849680|312992|P8|Overall Study|Withdrawal by Subject|1
89583|NCT00849680|312993|P7|Overall Study|Withdrawal by Subject|1
89584|NCT00849680|312994|P6|Overall Study|Withdrawal by Subject|2
89585|NCT00849680|312995|P5|Overall Study|Withdrawal by Subject|2
89586|NCT00849680|312996|P4|Overall Study|Withdrawal by Subject|2
89587|NCT00849680|312997|P3|Overall Study|Withdrawal by Subject|0
89588|NCT00849680|312998|P2|Overall Study|Withdrawal by Subject|0
89589|NCT00849680|312999|P1|Overall Study|Withdrawal by Subject|2
89590|NCT00849680|312992|P8|Overall Study|Subject moved|2
89591|NCT00849680|312993|P7|Overall Study|Subject moved|2
89592|NCT00849680|312994|P6|Overall Study|Subject moved|2
89593|NCT00849680|312995|P5|Overall Study|Subject moved|0
89594|NCT00849680|312996|P4|Overall Study|Subject moved|1
89595|NCT00849680|312997|P3|Overall Study|Subject moved|3
89596|NCT00849680|312998|P2|Overall Study|Subject moved|0
89597|NCT00849680|312999|P1|Overall Study|Subject moved|1
89598|NCT00849680|312992|P8|Overall Study|Lost to Follow-up|5
89599|NCT00849680|312993|P7|Overall Study|Lost to Follow-up|12
89600|NCT00849680|312994|P6|Overall Study|Lost to Follow-up|11
89601|NCT00849680|312995|P5|Overall Study|Lost to Follow-up|8
89602|NCT00849680|312996|P4|Overall Study|Lost to Follow-up|11
89603|NCT00849680|312997|P3|Overall Study|Lost to Follow-up|12
89604|NCT00849680|312998|P2|Overall Study|Lost to Follow-up|3
89605|NCT00849680|312999|P1|Overall Study|Lost to Follow-up|7
89606|NCT00849680|312992|P8|Overall Study|Adverse Event|0
89607|NCT00849680|312993|P7|Overall Study|Adverse Event|2
89608|NCT00849680|312994|P6|Overall Study|Adverse Event|0
89609|NCT00849680|312995|P5|Overall Study|Adverse Event|0
89610|NCT00849680|312996|P4|Overall Study|Adverse Event|0
89611|NCT00849680|312997|P3|Overall Study|Adverse Event|0
89612|NCT00849680|312998|P2|Overall Study|Adverse Event|0
89613|NCT00849680|312999|P1|Overall Study|Adverse Event|0
89614|NCT00849472|313041|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
89615|NCT00849472|313041|P1|Pazopanib Postsurgery Treatment|Moved|1
89616|NCT00849472|313041|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
89617|NCT00849472|313041|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
89618|NCT00849472|313041|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
89619|NCT00849472|313041|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
89620|NCT00849472|313041|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
89621|NCT00849472|313041|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
89622|NCT00849472|313041|P1|Weekly Paclitaxel|Physician Decision|3
89623|NCT00849472|313041|P1|Weekly Paclitaxel|Withdrawal by Subject|1
89624|NCT00849472|313041|P1|Weekly Paclitaxel|Adverse Event|11
89625|NCT00849472|313041|P1|Weekly Paclitaxel|Disease Progression|1
89626|NCT00849472|313041|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
89627|NCT00849472|313041|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
89628|NCT00849472|313041|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
89629|NCT00849472|313041|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
89630|NCT00849472|313041|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
89631|NCT00849381|313055|P1|Overall Study|Unspecified|4
89632|NCT00849381|313055|P1|Overall Study|Withdrawal by Subject|6
89633|NCT00849381|313055|P1|Overall Study|Protocol Violation|5
89634|NCT00849381|313055|P1|Overall Study|Lost to Follow-up|129
89635|NCT00849381|313055|P1|Overall Study|Adverse Event|1
89636|NCT00849290|313061|P1|Overall Study|Disease Progression|20
89637|NCT00849290|313061|P1|Overall Study|Protocol Violation|5
89638|NCT00849290|313061|P1|Overall Study|Lost to Follow-up|2
89639|NCT00849290|313061|P1|Overall Study|Withdrawal by Subject|11
89640|NCT00849290|313061|P1|Overall Study|Death|14
89641|NCT00849290|313061|P1|Overall Study|Adverse Event|3
89642|NCT00849212|313065|P1|Overall Study|Miscellaneous|1
89643|NCT00849212|313065|P1|Overall Study|Adverse Event|2
89644|NCT00849212|313065|P1|Overall Study|Withdrawal by Subject|3
89645|NCT00849212|313065|P1|Overall Study|Lack of Efficacy|1
89646|NCT00849186|313070|P1|Overall Study|Other|1
89647|NCT00849186|313070|P1|Overall Study|not treated|6
89648|NCT00849186|313070|P1|Overall Study|Withdrawal by Subject|1
89649|NCT00849186|313070|P1|Overall Study|Adverse Event|2
89650|NCT00849147|313076|P1|Overall Study|Disease Relapse/Progression|2
89651|NCT00849147|313076|P1|Overall Study|Protocol Violation|2
89652|NCT00849147|313076|P1|Overall Study|Withdrawal by Subject|1
89653|NCT00849108|313109|P2|Cohort 2 Efficacy|Not specified|9
89654|NCT00849108|313110|P1|Cohort 2 Efficacy|Not specified|0
89655|NCT00849108|313109|P2|Cohort 2 Efficacy|Adverse Event|1
89656|NCT00849108|313110|P1|Cohort 2 Efficacy|Adverse Event|0
89657|NCT00849108|313109|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
89658|NCT00849108|313110|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
89659|NCT00849056|313120|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
89660|NCT00849056|313121|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
89661|NCT00849056|313120|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
89662|NCT00849056|313121|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
89663|NCT00849056|313120|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
89664|NCT00849056|313121|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
89665|NCT00849056|313120|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
89666|NCT00849056|313121|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
89667|NCT00849056|313120|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
89668|NCT00849056|313121|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
89669|NCT00849056|313120|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
89670|NCT00849056|313121|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
89671|NCT00849056|313120|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
89672|NCT00849056|313121|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
89673|NCT00849056|313120|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
89674|NCT00849056|313121|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
89675|NCT00849056|313120|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
89676|NCT00849056|313121|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
89677|NCT00849056|313120|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
89678|NCT00849056|313121|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
89679|NCT00849056|313120|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
89680|NCT00849056|313121|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
89681|NCT00849056|313120|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
89682|NCT00849056|313121|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
89683|NCT00849056|313120|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
89684|NCT00849056|313121|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
89685|NCT00849056|313120|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
89686|NCT00849056|313121|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
89687|NCT00849056|313120|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
89688|NCT00849056|313121|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
89689|NCT00849056|313120|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
89690|NCT00849056|313121|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
89691|NCT00849017|313146|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
89692|NCT00849017|313147|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
89693|NCT00849017|313148|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
89694|NCT00849017|313146|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
89695|NCT00849017|313147|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
89696|NCT00849017|313148|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
89697|NCT00849017|313146|P3|Follow-up Period (8 Weeks)|Physician Decision|1
89698|NCT00849017|313147|P2|Follow-up Period (8 Weeks)|Physician Decision|1
89699|NCT00849017|313148|P1|Follow-up Period (8 Weeks)|Physician Decision|0
89700|NCT00849017|313146|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
89701|NCT00849017|313147|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
89702|NCT00849017|313148|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
89703|NCT00849017|313146|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
89704|NCT00849017|313147|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
89705|NCT00849017|313148|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
89706|NCT00849017|313146|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
89707|NCT00849017|313147|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
89708|NCT00849017|313148|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
89709|NCT00849017|313146|P3|Follow-up Period (8 Weeks)|Noncompliance|0
89710|NCT00849017|313147|P2|Follow-up Period (8 Weeks)|Noncompliance|1
89711|NCT00849017|313148|P1|Follow-up Period (8 Weeks)|Noncompliance|2
89712|NCT00849017|313146|P3|Follow-up Period (8 Weeks)|Adverse Event|0
89713|NCT00849017|313147|P2|Follow-up Period (8 Weeks)|Adverse Event|0
89714|NCT00849017|313148|P1|Follow-up Period (8 Weeks)|Adverse Event|1
89715|NCT00849017|313146|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
89716|NCT00849017|313147|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
89717|NCT00849017|313148|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
89718|NCT00849017|313146|P3|Treatment Period (156 Weeks)|Pregnancy|1
89719|NCT00849017|313147|P2|Treatment Period (156 Weeks)|Pregnancy|0
89720|NCT00849017|313148|P1|Treatment Period (156 Weeks)|Pregnancy|1
89721|NCT00849017|313146|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
89722|NCT00849017|313147|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
89723|NCT00849017|313148|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
89724|NCT00849017|313146|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
89725|NCT00849017|313147|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
89726|NCT00849017|313148|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
89727|NCT00849017|313146|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
89728|NCT00849017|313147|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
89729|NCT00849017|313148|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
89730|NCT00849017|313146|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
89731|NCT00849017|313147|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
89732|NCT00849017|313148|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
89733|NCT00849017|313146|P3|Treatment Period (156 Weeks)|Physician Decision|1
89734|NCT00849017|313147|P2|Treatment Period (156 Weeks)|Physician Decision|2
89735|NCT00849017|313148|P1|Treatment Period (156 Weeks)|Physician Decision|0
89736|NCT00849017|313146|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
89737|NCT00849017|313147|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
89738|NCT00849017|313148|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
89739|NCT00849017|313146|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
89740|NCT00849017|313147|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
89741|NCT00849017|313148|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
89742|NCT00849017|313146|P3|Treatment Period (156 Weeks)|Noncompliance|4
89743|NCT00849017|313147|P2|Treatment Period (156 Weeks)|Noncompliance|3
89744|NCT00849017|313148|P1|Treatment Period (156 Weeks)|Noncompliance|3
89745|NCT00849017|313146|P3|Treatment Period (156 Weeks)|Adverse Event|15
89746|NCT00849017|313147|P2|Treatment Period (156 Weeks)|Adverse Event|6
89747|NCT00849017|313148|P1|Treatment Period (156 Weeks)|Adverse Event|5
89748|NCT00848965|313191|P1|Overall Study|Withdrawal by Subject|1
89749|NCT00848965|313191|P1|Overall Study|Adverse Event|1
89750|NCT00848926|313233|P1|Follow-up Period|Not specified|2
89751|NCT00848926|313233|P1|Follow-up Period|Withdrawal by Subject|3
89752|NCT00848926|313233|P1|Follow-up Period|Lost to Follow-up|7
89753|NCT00848926|313233|P1|Treatment Period|Withdrawal by Subject|7
89754|NCT00848926|313233|P1|Treatment Period|Physician Decision|12
89755|NCT00848926|313233|P1|Treatment Period|Adverse Event|20
89756|NCT00848926|313233|P1|Treatment Period|Progressive disease|45
89757|NCT00848549|313267|P2|E2090-E044-314 (Extension Study)|Not Specified|6
89758|NCT00848549|313268|P1|E2090-E044-314 (Extension Study)|Not Specified|5
89759|NCT00848549|313267|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
89760|NCT00848549|313268|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
89761|NCT00848549|313267|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
89762|NCT00848549|313268|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
89763|NCT00848549|313267|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
89764|NCT00848549|313268|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
89765|NCT00848549|313267|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
89766|NCT00848549|313268|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
89767|NCT00848549|313267|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
89768|NCT00848549|313268|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
89769|NCT00848549|313267|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
89770|NCT00848549|313268|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
89771|NCT00848549|313267|P2|E2090-E044-310 (Base Study) Disposition|Not Specified|3
89772|NCT00848549|313268|P1|E2090-E044-310 (Base Study) Disposition|Not Specified|4
89773|NCT00848549|313267|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
89774|NCT00848549|313268|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
89775|NCT00848549|313267|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
89776|NCT00848549|313268|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
89777|NCT00848549|313267|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
89778|NCT00848549|313268|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
89779|NCT00848549|313267|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
89780|NCT00848549|313268|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
89781|NCT00848549|313267|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
89782|NCT00848549|313268|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
89783|NCT00848549|313267|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
89784|NCT00848549|313268|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
89785|NCT00848536|313286|P2|Overall Study|Patient Moved|2
89786|NCT00848536|313287|P1|Overall Study|Patient Moved|0
89787|NCT00848536|313286|P2|Overall Study|Inadequate Control of IOP|1
89788|NCT00848536|313287|P1|Overall Study|Inadequate Control of IOP|1
89789|NCT00848536|313286|P2|Overall Study|Noncompliance|0
89790|NCT00848536|313287|P1|Overall Study|Noncompliance|1
89791|NCT00848536|313286|P2|Overall Study|Protocol Violation|1
89792|NCT00848536|313287|P1|Overall Study|Protocol Violation|0
89793|NCT00848536|313286|P2|Overall Study|Withdrawal by Subject|1
89794|NCT00848536|313287|P1|Overall Study|Withdrawal by Subject|0
89795|NCT00848536|313286|P2|Overall Study|Adverse Event|2
89796|NCT00848536|313287|P1|Overall Study|Adverse Event|2
89797|NCT00848497|313352|P2|Overall Study|Withdrawal by Subject|1
89798|NCT00848497|313353|P1|Overall Study|Withdrawal by Subject|0
89799|NCT00848497|313352|P2|Overall Study|Screen failure|0
89800|NCT00848497|313353|P1|Overall Study|Screen failure|2
89801|NCT00848484|313367|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
89802|NCT00848484|313368|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
89803|NCT00848484|313367|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
89804|NCT00848484|313368|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
89805|NCT00848484|313367|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
89806|NCT00848484|313368|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
89807|NCT00848484|313367|P2|First Intervention (Treatment Period 1)|Physician Decision|1
89808|NCT00848484|313368|P1|First Intervention (Treatment Period 1)|Physician Decision|0
89809|NCT00848484|313367|P2|First Intervention (Treatment Period 1)|Adverse Event|1
89810|NCT00848484|313368|P1|First Intervention (Treatment Period 1)|Adverse Event|2
89811|NCT00848354|313397|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
89812|NCT00848354|313398|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
89813|NCT00848354|313397|P2|Phase 2 Year 2|Subject Request|1
89814|NCT00848354|313398|P1|Phase 2 Year 2|Subject Request|1
89815|NCT00848354|313397|P2|Phase 2 Year 2|Protocol Violation|1
89816|NCT00848354|313398|P1|Phase 2 Year 2|Protocol Violation|1
89817|NCT00848354|313397|P2|Phase 2 Year 2|Unspecified Reason|0
89818|NCT00848354|313398|P1|Phase 2 Year 2|Unspecified Reason|1
89819|NCT00848354|313397|P2|Phase 2 Year 2|Lost to Follow-up|3
89820|NCT00848354|313398|P1|Phase 2 Year 2|Lost to Follow-up|1
89821|NCT00848354|313397|P2|Phase 2 Year 2|Failed to return|0
89822|NCT00848354|313398|P1|Phase 2 Year 2|Failed to return|3
89823|NCT00848354|313397|P2|Phase 2 Year 2|Death|0
89824|NCT00848354|313398|P1|Phase 2 Year 2|Death|2
89825|NCT00848354|313397|P2|Phase 2 Year 2|Adverse Event|2
89826|NCT00848354|313398|P1|Phase 2 Year 2|Adverse Event|12
89827|NCT00848354|313397|P2|Phase 2 Year 1|Subject Request|2
89828|NCT00848354|313398|P1|Phase 2 Year 1|Subject Request|1
89829|NCT00848354|313397|P2|Phase 2 Year 1|Protocol Violation|1
89830|NCT00848354|313398|P1|Phase 2 Year 1|Protocol Violation|4
89831|NCT00848354|313397|P2|Phase 2 Year 1|Unspecified Reason|0
89832|NCT00848354|313398|P1|Phase 2 Year 1|Unspecified Reason|3
89833|NCT00848354|313397|P2|Phase 2 Year 1|Lost to Follow-up|0
89834|NCT00848354|313398|P1|Phase 2 Year 1|Lost to Follow-up|1
89835|NCT00848354|313397|P2|Phase 2 Year 1|Failed to Return|1
89836|NCT00848354|313398|P1|Phase 2 Year 1|Failed to Return|1
89837|NCT00848354|313397|P2|Phase 2 Year 1|Death|0
89838|NCT00848354|313398|P1|Phase 2 Year 1|Death|1
89839|NCT00848354|313397|P2|Phase 2 Year 1|Adverse Event|2
89840|NCT00848354|313398|P1|Phase 2 Year 1|Adverse Event|7
89841|NCT00848354|313397|P2|Phase 1|Lack of Efficacy|1
89842|NCT00848354|313398|P1|Phase 1|Lack of Efficacy|0
89843|NCT00848354|313397|P2|Phase 1|Withdrawal by Subject|4
89844|NCT00848354|313398|P1|Phase 1|Withdrawal by Subject|2
89845|NCT00848354|313397|P2|Phase 1|Protocol Violation|1
89846|NCT00848354|313398|P1|Phase 1|Protocol Violation|1
89847|NCT00848354|313397|P2|Phase 1|Unspecified Reason|1
89848|NCT00848354|313398|P1|Phase 1|Unspecified Reason|1
89849|NCT00848354|313397|P2|Phase 1|Lost to Follow-up|1
89850|NCT00848354|313398|P1|Phase 1|Lost to Follow-up|1
89851|NCT00848354|313397|P2|Phase 1|Failed to return|1
89852|NCT00848354|313398|P1|Phase 1|Failed to return|0
89853|NCT00848354|313397|P2|Phase 1|Discontinuation of study by sponsor|1
89854|NCT00848354|313398|P1|Phase 1|Discontinuation of study by sponsor|2
89855|NCT00848354|313397|P2|Phase 1|Adverse Event|4
89856|NCT00848354|313398|P1|Phase 1|Adverse Event|5
89857|NCT00848211|313561|P4|Overall Study|Adverse Event|0
89858|NCT00848211|313562|P3|Overall Study|Adverse Event|0
89859|NCT00848211|313563|P2|Overall Study|Adverse Event|0
89860|NCT00848211|313564|P1|Overall Study|Adverse Event|0
89861|NCT00848211|313561|P4|Overall Study|Protocol Violation|0
89862|NCT00848211|313562|P3|Overall Study|Protocol Violation|1
89863|NCT00848211|313563|P2|Overall Study|Protocol Violation|1
89864|NCT00848211|313564|P1|Overall Study|Protocol Violation|0
89865|NCT00848198|313582|P1|Overall Study|Incomplete Case Report Forms|15
89866|NCT00848120|313634|P1|Overall Study|Adverse Event|1
89867|NCT00848107|313646|P1|Overall Study|Pregnancy|1
89868|NCT00848107|313646|P1|Overall Study|Death|1
89869|NCT00848107|313646|P1|Overall Study|Adverse Event|9
89870|NCT00848107|313646|P1|Overall Study|Withdrawal by Subject|8
89871|NCT00848107|313646|P1|Overall Study|Lost to Follow-up|2
89872|NCT00848081|313656|P2|Overall Study|Withdrawal by Subject|3
89873|NCT00848081|313657|P1|Overall Study|Withdrawal by Subject|5
89874|NCT00848081|313656|P2|Overall Study|Physician Decision|3
89875|NCT00848081|313657|P1|Overall Study|Physician Decision|0
89876|NCT00848081|313656|P2|Overall Study|Lost to Follow-up|0
89877|NCT00848081|313657|P1|Overall Study|Lost to Follow-up|1
89878|NCT00848081|313656|P2|Overall Study|Protocol Violation|5
89879|NCT00848081|313657|P1|Overall Study|Protocol Violation|8
89880|NCT00848081|313656|P2|Overall Study|Adverse Event|7
89881|NCT00848081|313657|P1|Overall Study|Adverse Event|6
89882|NCT00848042|313674|P3|Overall Study|Other Therapy|0
89883|NCT00848042|313675|P2|Overall Study|Other Therapy|0
89884|NCT00848042|313676|P1|Overall Study|Other Therapy|3
89885|NCT00848042|313674|P3|Overall Study|Death|0
89886|NCT00848042|313675|P2|Overall Study|Death|2
89887|NCT00848042|313676|P1|Overall Study|Death|1
89888|NCT00847886|313695|P2|Overall Study|Adverse Event|1
89889|NCT00847886|313696|P1|Overall Study|Adverse Event|0
89890|NCT00847808|313722|P1|Overall Study|Participant Took Excluded Medication|1
89891|NCT00847808|313722|P1|Overall Study|Participant Reported Lack of Efficacy|1
89892|NCT00847808|313722|P1|Overall Study|Withdrawal by Subject|4
89893|NCT00847808|313722|P1|Overall Study|Lost to Follow-up|1
89894|NCT00847808|313722|P1|Overall Study|Protocol Violation|1
89895|NCT00847808|313722|P1|Overall Study|Adverse Event|7
89896|NCT00847704|313739|P1|Overall Study|Withdrawal by Subject|1
89897|NCT00847665|313750|P2|Overall Study|Withdrawal by Subject|0
89898|NCT00847665|313751|P1|Overall Study|Withdrawal by Subject|1
89899|NCT00847626|313774|P11|Overall Study|Other|3
89900|NCT00847626|313775|P10|Overall Study|Other|1
89901|NCT00847626|313776|P9|Overall Study|Other|1
89902|NCT00847626|313777|P8|Overall Study|Other|3
89903|NCT00847626|313778|P7|Overall Study|Other|2
89904|NCT00847626|313779|P6|Overall Study|Other|2
89905|NCT00847626|313780|P5|Overall Study|Other|2
89906|NCT00847626|313781|P4|Overall Study|Other|1
89907|NCT00847626|313782|P3|Overall Study|Other|4
89908|NCT00847626|313783|P2|Overall Study|Other|5
89909|NCT00847626|313784|P1|Overall Study|Other|1
89910|NCT00847626|313774|P11|Overall Study|Lack of Efficacy|7
89911|NCT00847626|313775|P10|Overall Study|Lack of Efficacy|1
89912|NCT00847626|313776|P9|Overall Study|Lack of Efficacy|5
89913|NCT00847626|313777|P8|Overall Study|Lack of Efficacy|2
89914|NCT00847626|313778|P7|Overall Study|Lack of Efficacy|6
89915|NCT00847626|313779|P6|Overall Study|Lack of Efficacy|0
89916|NCT00847626|313780|P5|Overall Study|Lack of Efficacy|2
89917|NCT00847626|313781|P4|Overall Study|Lack of Efficacy|1
89918|NCT00847626|313782|P3|Overall Study|Lack of Efficacy|0
89919|NCT00847626|313783|P2|Overall Study|Lack of Efficacy|1
89920|NCT00847626|313784|P1|Overall Study|Lack of Efficacy|3
89921|NCT00847626|313774|P11|Overall Study|Withdrawal by Subject|2
89922|NCT00847626|313775|P10|Overall Study|Withdrawal by Subject|5
89923|NCT00847626|313776|P9|Overall Study|Withdrawal by Subject|4
89924|NCT00847626|313777|P8|Overall Study|Withdrawal by Subject|4
89925|NCT00847626|313778|P7|Overall Study|Withdrawal by Subject|8
89926|NCT00847626|313779|P6|Overall Study|Withdrawal by Subject|9
89927|NCT00847626|313780|P5|Overall Study|Withdrawal by Subject|12
89928|NCT00847626|313781|P4|Overall Study|Withdrawal by Subject|8
89929|NCT00847626|313782|P3|Overall Study|Withdrawal by Subject|3
89930|NCT00847626|313783|P2|Overall Study|Withdrawal by Subject|5
89931|NCT00847626|313784|P1|Overall Study|Withdrawal by Subject|5
89932|NCT00847626|313774|P11|Overall Study|Lost to Follow-up|1
89933|NCT00847626|313775|P10|Overall Study|Lost to Follow-up|0
89934|NCT00847626|313776|P9|Overall Study|Lost to Follow-up|1
89935|NCT00847626|313777|P8|Overall Study|Lost to Follow-up|3
89936|NCT00847626|313778|P7|Overall Study|Lost to Follow-up|1
89937|NCT00847626|313779|P6|Overall Study|Lost to Follow-up|3
89938|NCT00847626|313780|P5|Overall Study|Lost to Follow-up|0
89939|NCT00847626|313781|P4|Overall Study|Lost to Follow-up|1
89940|NCT00847626|313782|P3|Overall Study|Lost to Follow-up|1
89941|NCT00847626|313783|P2|Overall Study|Lost to Follow-up|1
89942|NCT00847626|313784|P1|Overall Study|Lost to Follow-up|0
89943|NCT00847626|313774|P11|Overall Study|Protocol Violation|1
89944|NCT00847626|313775|P10|Overall Study|Protocol Violation|1
89945|NCT00847626|313776|P9|Overall Study|Protocol Violation|0
89946|NCT00847626|313777|P8|Overall Study|Protocol Violation|1
89947|NCT00847626|313778|P7|Overall Study|Protocol Violation|1
89948|NCT00847626|313779|P6|Overall Study|Protocol Violation|1
89949|NCT00847626|313780|P5|Overall Study|Protocol Violation|1
89950|NCT00847626|313781|P4|Overall Study|Protocol Violation|1
89951|NCT00847626|313782|P3|Overall Study|Protocol Violation|2
89952|NCT00847626|313783|P2|Overall Study|Protocol Violation|1
89953|NCT00847626|313784|P1|Overall Study|Protocol Violation|2
89954|NCT00847626|313774|P11|Overall Study|Adverse Event|6
89955|NCT00847626|313775|P10|Overall Study|Adverse Event|6
89956|NCT00847626|313776|P9|Overall Study|Adverse Event|3
89957|NCT00847626|313777|P8|Overall Study|Adverse Event|6
89958|NCT00847626|313778|P7|Overall Study|Adverse Event|4
89959|NCT00847626|313779|P6|Overall Study|Adverse Event|22
89960|NCT00847626|313780|P5|Overall Study|Adverse Event|11
89961|NCT00847626|313781|P4|Overall Study|Adverse Event|19
89962|NCT00847626|313782|P3|Overall Study|Adverse Event|6
89963|NCT00847626|313783|P2|Overall Study|Adverse Event|10
89964|NCT00847626|313784|P1|Overall Study|Adverse Event|10
89965|NCT00847613|313983|P4|Overall Study|Unspecified|0
89966|NCT00847613|313984|P3|Overall Study|Unspecified|2
89967|NCT00847613|313985|P2|Overall Study|Unspecified|1
89968|NCT00847613|313986|P1|Overall Study|Unspecified|1
89969|NCT00847613|313983|P4|Overall Study|Randomized, but not treated|0
89970|NCT00847613|313984|P3|Overall Study|Randomized, but not treated|0
89971|NCT00847613|313985|P2|Overall Study|Randomized, but not treated|3
89972|NCT00847613|313986|P1|Overall Study|Randomized, but not treated|0
89973|NCT00847613|313983|P4|Overall Study|Sponsor request|0
89974|NCT00847613|313984|P3|Overall Study|Sponsor request|0
89975|NCT00847613|313985|P2|Overall Study|Sponsor request|1
89976|NCT00847613|313986|P1|Overall Study|Sponsor request|0
89977|NCT00847613|313983|P4|Overall Study|Participant moved|0
89978|NCT00847613|313984|P3|Overall Study|Participant moved|0
89979|NCT00847613|313985|P2|Overall Study|Participant moved|1
89980|NCT00847613|313986|P1|Overall Study|Participant moved|4
89981|NCT00847613|313983|P4|Overall Study|Withdrawal by Subject|2
89982|NCT00847613|313984|P3|Overall Study|Withdrawal by Subject|2
89983|NCT00847613|313985|P2|Overall Study|Withdrawal by Subject|11
89984|NCT00847613|313986|P1|Overall Study|Withdrawal by Subject|8
89985|NCT00847613|313983|P4|Overall Study|Site closure|1
89986|NCT00847613|313984|P3|Overall Study|Site closure|0
89987|NCT00847613|313985|P2|Overall Study|Site closure|0
89988|NCT00847613|313986|P1|Overall Study|Site closure|1
89989|NCT00847613|313983|P4|Overall Study|Pregnancy|0
89990|NCT00847613|313984|P3|Overall Study|Pregnancy|0
89991|NCT00847613|313985|P2|Overall Study|Pregnancy|1
89992|NCT00847613|313986|P1|Overall Study|Pregnancy|1
89993|NCT00847613|313983|P4|Overall Study|Protocol Violation|1
89994|NCT00847613|313984|P3|Overall Study|Protocol Violation|3
89995|NCT00847613|313985|P2|Overall Study|Protocol Violation|6
89996|NCT00847613|313986|P1|Overall Study|Protocol Violation|6
89997|NCT00847613|313983|P4|Overall Study|Lost to Follow-up|3
89998|NCT00847613|313984|P3|Overall Study|Lost to Follow-up|0
89999|NCT00847613|313985|P2|Overall Study|Lost to Follow-up|0
90000|NCT00847613|313986|P1|Overall Study|Lost to Follow-up|5
90001|NCT00847613|313983|P4|Overall Study|Study terminated by Sponsor|1
90002|NCT00847613|313984|P3|Overall Study|Study terminated by Sponsor|2
90003|NCT00847613|313985|P2|Overall Study|Study terminated by Sponsor|0
90004|NCT00847613|313986|P1|Overall Study|Study terminated by Sponsor|1
90005|NCT00847613|313983|P4|Overall Study|Lack of Efficacy|1
90006|NCT00847613|313984|P3|Overall Study|Lack of Efficacy|3
90007|NCT00847613|313985|P2|Overall Study|Lack of Efficacy|3
90008|NCT00847613|313986|P1|Overall Study|Lack of Efficacy|7
90009|NCT00847613|313983|P4|Overall Study|Adverse Event|6
90010|NCT00847613|313984|P3|Overall Study|Adverse Event|5
90011|NCT00847613|313985|P2|Overall Study|Adverse Event|26
90012|NCT00847613|313986|P1|Overall Study|Adverse Event|36
90013|NCT00847613|313983|P4|Overall Study|Death|0
90014|NCT00847613|313984|P3|Overall Study|Death|0
90015|NCT00847613|313985|P2|Overall Study|Death|1
90016|NCT00847613|313986|P1|Overall Study|Death|1
90017|NCT00847613|313983|P4|Overall Study|Ongoing at cut-off date|64
90018|NCT00847613|313984|P3|Overall Study|Ongoing at cut-off date|64
90019|NCT00847613|313985|P2|Overall Study|Ongoing at cut-off date|265
90020|NCT00847613|313986|P1|Overall Study|Ongoing at cut-off date|250
90021|NCT00847561|314237|P2|Overall Study|Unable to schedule|1
90022|NCT00847561|314238|P1|Overall Study|Unable to schedule|9
90023|NCT00847561|314237|P2|Overall Study|Withdrawal by Subject|3
90024|NCT00847561|314238|P1|Overall Study|Withdrawal by Subject|4
90025|NCT00847535|314244|P3|Overall Study|Lost to Follow-up|0
90026|NCT00847535|314245|P2|Overall Study|Lost to Follow-up|1
90027|NCT00847535|314246|P1|Overall Study|Lost to Follow-up|0
90028|NCT00847535|314244|P3|Overall Study|Withdrawal by Subject|1
90029|NCT00847535|314245|P2|Overall Study|Withdrawal by Subject|1
90030|NCT00847535|314246|P1|Overall Study|Withdrawal by Subject|2
90031|NCT00847405|314260|P2|Washout of 7 Days|Withdrawal by Subject|0
90032|NCT00847405|314261|P1|Washout of 7 Days|Withdrawal by Subject|1
90033|NCT00847405|314260|P2|First Intervention|Adverse Event|1
90034|NCT00847405|314261|P1|First Intervention|Adverse Event|0
90035|NCT00847301|314269|P1|Overall Study|Other reason not defined above|1
90036|NCT00847301|314269|P1|Overall Study|No prescription after hospital discharge|1
90037|NCT00847301|314269|P1|Overall Study|Lost to Follow-up|1
90038|NCT00847301|314269|P1|Overall Study|Switch to other anticoagulants|16
90039|NCT00847301|314269|P1|Overall Study|Adverse Event|35
90040|NCT00847197|314317|P2|Overall Study|Withdrawal by Subject|1
90041|NCT00847197|314318|P1|Overall Study|Withdrawal by Subject|3
90042|NCT00847197|314317|P2|Overall Study|Protocol Violation|1
90043|NCT00847197|314318|P1|Overall Study|Protocol Violation|0
90044|NCT00847197|314317|P2|Overall Study|Adverse Event|3
90045|NCT00847197|314318|P1|Overall Study|Adverse Event|21
90046|NCT00847145|314336|P8|Overall Study|Protocol Violation|1
90047|NCT00847145|314337|P7|Overall Study|Protocol Violation|0
90048|NCT00847145|314338|P6|Overall Study|Protocol Violation|0
90049|NCT00847145|314339|P5|Overall Study|Protocol Violation|1
90050|NCT00847145|314340|P4|Overall Study|Protocol Violation|0
90051|NCT00847145|314341|P3|Overall Study|Protocol Violation|3
90052|NCT00847145|314342|P2|Overall Study|Protocol Violation|0
90053|NCT00847145|314343|P1|Overall Study|Protocol Violation|0
90054|NCT00847145|314336|P8|Overall Study|Inappropriate enrollment|0
90055|NCT00847145|314337|P7|Overall Study|Inappropriate enrollment|0
90056|NCT00847145|314338|P6|Overall Study|Inappropriate enrollment|0
90057|NCT00847145|314339|P5|Overall Study|Inappropriate enrollment|1
90058|NCT00847145|314340|P4|Overall Study|Inappropriate enrollment|0
90059|NCT00847145|314341|P3|Overall Study|Inappropriate enrollment|0
90060|NCT00847145|314342|P2|Overall Study|Inappropriate enrollment|0
90061|NCT00847145|314343|P1|Overall Study|Inappropriate enrollment|0
90062|NCT00847145|314336|P8|Overall Study|Lost to Follow-up|2
90063|NCT00847145|314337|P7|Overall Study|Lost to Follow-up|8
90064|NCT00847145|314338|P6|Overall Study|Lost to Follow-up|4
90065|NCT00847145|314339|P5|Overall Study|Lost to Follow-up|4
90066|NCT00847145|314340|P4|Overall Study|Lost to Follow-up|0
90067|NCT00847145|314341|P3|Overall Study|Lost to Follow-up|1
90068|NCT00847145|314342|P2|Overall Study|Lost to Follow-up|1
90069|NCT00847145|314343|P1|Overall Study|Lost to Follow-up|3
90070|NCT00847145|314336|P8|Overall Study|Withdrawal by Subject|1
90071|NCT00847145|314337|P7|Overall Study|Withdrawal by Subject|1
90072|NCT00847145|314338|P6|Overall Study|Withdrawal by Subject|0
90073|NCT00847145|314339|P5|Overall Study|Withdrawal by Subject|0
90074|NCT00847145|314340|P4|Overall Study|Withdrawal by Subject|1
90075|NCT00847145|314341|P3|Overall Study|Withdrawal by Subject|6
90076|NCT00847145|314342|P2|Overall Study|Withdrawal by Subject|4
90077|NCT00847145|314343|P1|Overall Study|Withdrawal by Subject|3
90078|NCT00847145|314336|P8|Overall Study|AE or Death|0
90079|NCT00847145|314337|P7|Overall Study|AE or Death|0
90080|NCT00847145|314338|P6|Overall Study|AE or Death|0
90081|NCT00847145|314339|P5|Overall Study|AE or Death|0
90082|NCT00847145|314340|P4|Overall Study|AE or Death|0
90083|NCT00847145|314341|P3|Overall Study|AE or Death|1
90084|NCT00847145|314342|P2|Overall Study|AE or Death|1
90085|NCT00847145|314343|P1|Overall Study|AE or Death|0
90086|NCT00847015|314400|P1|Overall Study|partial cystectomy vs radical cystectomy|1
90087|NCT00847015|314400|P1|Overall Study|declined any surgery|1
90088|NCT00847015|314400|P1|Overall Study|Withdrawal by Subject|1
90089|NCT00846846|314428|P1|Overall Study|Withdrawal by Subject|19
90090|NCT00846846|314428|P1|Overall Study|Death|56
90091|NCT00846807|314433|P1|Overall Study|Other|60
90092|NCT00846807|314433|P1|Overall Study|No prescription after hospital discharge|56
90093|NCT00846807|314433|P1|Overall Study|Switch to other anticoagulants|89
90094|NCT00846807|314433|P1|Overall Study|Non compliant with European label|7
90095|NCT00846807|314433|P1|Overall Study|Withdrawal by Subject|56
90096|NCT00846807|314433|P1|Overall Study|Lost to Follow-up|94
90097|NCT00846807|314433|P1|Overall Study|Adverse Event|270
90098|NCT00846768|314441|P4|Overall Study|Adverse Event|0
90099|NCT00846768|314442|P3|Overall Study|Adverse Event|0
90100|NCT00846768|314443|P2|Overall Study|Adverse Event|1
90101|NCT00846768|314444|P1|Overall Study|Adverse Event|0
90102|NCT00846586|314533|P2|Overall Study|Unsatisfactory therapeutic effect|1
90103|NCT00846586|314534|P1|Overall Study|Unsatisfactory therapeutic effect|0
90104|NCT00846586|314533|P2|Overall Study|Lost to Follow-up|4
90105|NCT00846586|314534|P1|Overall Study|Lost to Follow-up|1
90106|NCT00846586|314533|P2|Overall Study|Abnormal test procedure result(s)|0
90107|NCT00846586|314534|P1|Overall Study|Abnormal test procedure result(s)|1
90108|NCT00846586|314533|P2|Overall Study|Protocol deviation|6
90109|NCT00846586|314534|P1|Overall Study|Protocol deviation|2
90110|NCT00846586|314533|P2|Overall Study|Death|0
90111|NCT00846586|314534|P1|Overall Study|Death|2
90112|NCT00846586|314533|P2|Overall Study|Administrative problems|4
90113|NCT00846586|314534|P1|Overall Study|Administrative problems|5
90114|NCT00846586|314533|P2|Overall Study|Subject withdrew consent|10
90115|NCT00846586|314534|P1|Overall Study|Subject withdrew consent|8
90116|NCT00846586|314533|P2|Overall Study|Adverse Event|10
90117|NCT00846586|314534|P1|Overall Study|Adverse Event|20
90118|NCT00846521|314568|P1|Overall Study|Protocol Violation|1
90119|NCT00846521|314568|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
90120|NCT00846521|314568|P1|Overall Study|Withdrawal by Subject|5
90121|NCT00846495|314575|P2|Overall Study|Physician Decision|0
90122|NCT00846495|314576|P1|Overall Study|Physician Decision|1
90123|NCT00846495|314575|P2|Overall Study|Lack of Efficacy|2
90124|NCT00846495|314576|P1|Overall Study|Lack of Efficacy|1
90125|NCT00846495|314575|P2|Overall Study|Adverse Event|1
90126|NCT00846495|314576|P1|Overall Study|Adverse Event|5
90127|NCT00846495|314575|P2|Overall Study|Lost to Follow-up|0
90128|NCT00846495|314576|P1|Overall Study|Lost to Follow-up|1
90129|NCT00846391|314599|P3|Overall Study|Study Terminated by Sponsor|2
90130|NCT00846391|314600|P2|Overall Study|Study Terminated by Sponsor|2
90131|NCT00846391|314601|P1|Overall Study|Study Terminated by Sponsor|1
90132|NCT00846391|314599|P3|Overall Study|Physician Decision|1
90133|NCT00846391|314600|P2|Overall Study|Physician Decision|0
90134|NCT00846391|314601|P1|Overall Study|Physician Decision|0
90135|NCT00846365|314612|P3|Overall Study|Other|6
90136|NCT00846365|314613|P2|Overall Study|Other|1
90137|NCT00846365|314614|P1|Overall Study|Other|9
90138|NCT00846365|314612|P3|Overall Study|Lack of Efficacy|2
90139|NCT00846365|314613|P2|Overall Study|Lack of Efficacy|1
90140|NCT00846365|314614|P1|Overall Study|Lack of Efficacy|1
90141|NCT00846365|314612|P3|Overall Study|Pregnancy|0
90142|NCT00846365|314613|P2|Overall Study|Pregnancy|0
90143|NCT00846365|314614|P1|Overall Study|Pregnancy|1
90144|NCT00846365|314612|P3|Overall Study|Withdrawal by Subject|9
90145|NCT00846365|314613|P2|Overall Study|Withdrawal by Subject|11
90146|NCT00846365|314614|P1|Overall Study|Withdrawal by Subject|11
90147|NCT00846365|314612|P3|Overall Study|Lost to Follow-up|5
90148|NCT00846365|314613|P2|Overall Study|Lost to Follow-up|2
90149|NCT00846365|314614|P1|Overall Study|Lost to Follow-up|8
90150|NCT00846365|314612|P3|Overall Study|Protocol Violation|0
90151|NCT00846365|314613|P2|Overall Study|Protocol Violation|4
90152|NCT00846365|314614|P1|Overall Study|Protocol Violation|5
90153|NCT00846365|314612|P3|Overall Study|Adverse Event|11
90154|NCT00846365|314613|P2|Overall Study|Adverse Event|30
90155|NCT00846365|314614|P1|Overall Study|Adverse Event|20
90156|NCT00846027|314693|P1|Overall Study|Subject Not Treated|7
90157|NCT00846027|314693|P1|Overall Study|Protocol Violation|2
90158|NCT00846027|314693|P1|Overall Study|Investigator Discretion|29
90159|NCT00846027|314693|P1|Overall Study|Patient Decision|7
90160|NCT00846027|314693|P1|Overall Study|Toxicity|12
90161|NCT00846027|314693|P1|Overall Study|Disease Progression|30
90162|NCT00846027|314693|P1|Overall Study|Death|3
90163|NCT00845897|314716|P3|Overall Study|Too ill to participate|0
90164|NCT00845897|314717|P2|Overall Study|Too ill to participate|1
90165|NCT00845897|314718|P1|Overall Study|Too ill to participate|0
90166|NCT00845897|314716|P3|Overall Study|Ulcer did not heal|1
90167|NCT00845897|314717|P2|Overall Study|Ulcer did not heal|0
90168|NCT00845897|314718|P1|Overall Study|Ulcer did not heal|1
90169|NCT00845897|314716|P3|Overall Study|Withdrawal by Subject|2
90170|NCT00845897|314717|P2|Overall Study|Withdrawal by Subject|3
90171|NCT00845897|314718|P1|Overall Study|Withdrawal by Subject|0
90172|NCT00845897|314716|P3|Overall Study|Lost to Follow-up|0
90173|NCT00845897|314717|P2|Overall Study|Lost to Follow-up|1
90174|NCT00845897|314718|P1|Overall Study|Lost to Follow-up|1
90175|NCT00845858|314732|P3|Overall Study|not eligible|2
90176|NCT00845858|314733|P2|Overall Study|not eligible|3
90177|NCT00845858|314734|P1|Overall Study|not eligible|0
90178|NCT00845858|314732|P3|Overall Study|Protocol Violation|1
90179|NCT00845858|314733|P2|Overall Study|Protocol Violation|0
90180|NCT00845858|314734|P1|Overall Study|Protocol Violation|0
90181|NCT00845858|314732|P3|Overall Study|Adverse Event|4
90182|NCT00845858|314733|P2|Overall Study|Adverse Event|8
90183|NCT00845858|314734|P1|Overall Study|Adverse Event|3
90184|NCT00845858|314732|P3|Overall Study|Withdrawal by Subject|1
90185|NCT00845858|314733|P2|Overall Study|Withdrawal by Subject|1
90186|NCT00845858|314734|P1|Overall Study|Withdrawal by Subject|5
90187|NCT00845845|314747|P2|Overall Study|Lost to Follow-up|4
90188|NCT00845845|314748|P1|Overall Study|Lost to Follow-up|0
90189|NCT00845832|314759|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
90190|NCT00845832|314760|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
90191|NCT00845832|314761|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
90192|NCT00845832|314759|P3|Safety Follow-Up|Withdrawal by Subject|0
90193|NCT00845832|314760|P2|Safety Follow-Up|Withdrawal by Subject|0
90194|NCT00845832|314761|P1|Safety Follow-Up|Withdrawal by Subject|1
90195|NCT00845832|314759|P3|Treatment Period|Protocol Violation|0
90196|NCT00845832|314760|P2|Treatment Period|Protocol Violation|1
90197|NCT00845832|314761|P1|Treatment Period|Protocol Violation|1
90198|NCT00845832|314759|P3|Treatment Period|Adverse Event|0
90199|NCT00845832|314760|P2|Treatment Period|Adverse Event|2
90200|NCT00845832|314761|P1|Treatment Period|Adverse Event|0
90201|NCT00845728|314807|P2|Overall Study|Withdrawal by Subject|108
90202|NCT00845728|314808|P1|Overall Study|Withdrawal by Subject|105
90203|NCT00845728|314807|P2|Overall Study|Adverse Event|96
90204|NCT00845728|314808|P1|Overall Study|Adverse Event|101
90205|NCT00845728|314807|P2|Overall Study|Lack of Efficacy|39
90206|NCT00845728|314808|P1|Overall Study|Lack of Efficacy|51
90207|NCT00845728|314807|P2|Overall Study|Protocol Violation|24
90208|NCT00845728|314808|P1|Overall Study|Protocol Violation|36
90209|NCT00845728|314807|P2|Overall Study|Administrative Problems|26
90210|NCT00845728|314808|P1|Overall Study|Administrative Problems|34
90211|NCT00845728|314807|P2|Overall Study|Death|26
90212|NCT00845728|314808|P1|Overall Study|Death|24
90213|NCT00845728|314807|P2|Overall Study|Lost to Follow-up|13
90214|NCT00845728|314808|P1|Overall Study|Lost to Follow-up|22
90215|NCT00845728|314807|P2|Overall Study|Abnormal test procedure result (s)|2
90216|NCT00845728|314808|P1|Overall Study|Abnormal test procedure result (s)|7
90217|NCT00845728|314807|P2|Overall Study|Patient's inability to use the device|6
90218|NCT00845728|314808|P1|Overall Study|Patient's inability to use the device|4
90219|NCT00845728|314807|P2|Overall Study|Abnormal laboratory value (s)|2
90220|NCT00845728|314808|P1|Overall Study|Abnormal laboratory value (s)|2
90221|NCT00845676|314822|P1|Overall Study|Adverse Event|1
90222|NCT00845676|314822|P1|Overall Study|Virologic breakthrough at week 20|1
90223|NCT00845429|314880|P3|Overall Study|Serious adverse event|1
90224|NCT00845429|314881|P2|Overall Study|Serious adverse event|0
90225|NCT00845429|314882|P1|Overall Study|Serious adverse event|0
90226|NCT00845429|314880|P3|Overall Study|Withdrawal by Subject|2
90227|NCT00845429|314881|P2|Overall Study|Withdrawal by Subject|2
90228|NCT00845429|314882|P1|Overall Study|Withdrawal by Subject|2
90229|NCT00845429|314880|P3|Overall Study|Lost to Follow-up|10
90230|NCT00845429|314881|P2|Overall Study|Lost to Follow-up|9
90231|NCT00845429|314882|P1|Overall Study|Lost to Follow-up|7
90232|NCT00845429|314880|P3|Overall Study|Protocol Violation|7
90233|NCT00845429|314881|P2|Overall Study|Protocol Violation|4
90234|NCT00845429|314882|P1|Overall Study|Protocol Violation|5
90235|NCT00845182|314917|P3|Overall Study|Physician Decision|1
90236|NCT00845182|314918|P2|Overall Study|Physician Decision|0
90237|NCT00845182|314919|P1|Overall Study|Physician Decision|0
90238|NCT00845182|314917|P3|Overall Study|Adverse Event|1
90239|NCT00845182|314918|P2|Overall Study|Adverse Event|1
90240|NCT00845182|314919|P1|Overall Study|Adverse Event|0
90241|NCT00845182|314917|P3|Overall Study|Lost to Follow-up|4
90242|NCT00845182|314918|P2|Overall Study|Lost to Follow-up|3
90243|NCT00845182|314919|P1|Overall Study|Lost to Follow-up|3
90244|NCT00845065|314943|P2|Overall Study|Non-Medical Reasons|11
90245|NCT00845065|314944|P1|Overall Study|Non-Medical Reasons|1
90246|NCT00845065|314943|P2|Overall Study|Lack of Efficacy|21
90247|NCT00845065|314944|P1|Overall Study|Lack of Efficacy|43
90248|NCT00845065|314943|P2|Overall Study|Adverse Event|23
90249|NCT00845065|314944|P1|Overall Study|Adverse Event|3
90250|NCT00844896|314988|P2|Overall Study|Parents did not have time to complete|1
90251|NCT00844896|314989|P1|Overall Study|Parents did not have time to complete|0
90252|NCT00844896|314988|P2|Overall Study|Lost to Follow-up|16
90253|NCT00844896|314989|P1|Overall Study|Lost to Follow-up|12
90254|NCT00844857|315013|P2|Overall Study|Good Clinical Practice Violations|11
90255|NCT00844857|315014|P1|Overall Study|Good Clinical Practice Violations|21
90256|NCT00844857|315013|P2|Overall Study|Did Not Take Study Drug|1
90257|NCT00844857|315014|P1|Overall Study|Did Not Take Study Drug|3
90258|NCT00844857|315013|P2|Overall Study|Lost to Follow-up|3
90259|NCT00844857|315014|P1|Overall Study|Lost to Follow-up|2
90260|NCT00844857|315013|P2|Overall Study|Entry Criteria Not Met|1
90261|NCT00844857|315014|P1|Overall Study|Entry Criteria Not Met|0
90262|NCT00844857|315013|P2|Overall Study|Clinical Relapse|1
90263|NCT00844857|315014|P1|Overall Study|Clinical Relapse|0
90264|NCT00844857|315013|P2|Overall Study|Lack of Efficacy|5
90265|NCT00844857|315014|P1|Overall Study|Lack of Efficacy|5
90266|NCT00844857|315013|P2|Overall Study|Protocol Violation|0
90267|NCT00844857|315014|P1|Overall Study|Protocol Violation|6
90268|NCT00844857|315013|P2|Overall Study|Withdrawal by Subject|7
90269|NCT00844857|315014|P1|Overall Study|Withdrawal by Subject|8
90270|NCT00844857|315013|P2|Overall Study|Parent/Caregiver Decision|2
90271|NCT00844857|315014|P1|Overall Study|Parent/Caregiver Decision|6
90272|NCT00844857|315013|P2|Overall Study|Physician Decision|0
90273|NCT00844857|315014|P1|Overall Study|Physician Decision|2
90274|NCT00844857|315013|P2|Overall Study|Sponsor Decision|1
90275|NCT00844857|315014|P1|Overall Study|Sponsor Decision|1
90276|NCT00844857|315013|P2|Overall Study|Adverse Event|5
90277|NCT00844857|315014|P1|Overall Study|Adverse Event|24
90278|NCT00844844|315058|P1|Post Treatment Period|Withdrawal by Subject|1
90279|NCT00844844|315058|P1|Extension Treatment Period|Adverse Event|2
90280|NCT00844844|315058|P1|Treatment Period (26 Weeks)|Protocol Violation|1
90281|NCT00844844|315058|P1|Treatment Period (26 Weeks)|Adverse Event|1
90282|NCT00844805|315074|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
90283|NCT00844805|315075|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
90284|NCT00844805|315076|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
90285|NCT00844805|315077|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
90286|NCT00844805|315074|P4|Follow-Up Phase|Relapse/Recurrence|4
90287|NCT00844805|315075|P3|Follow-Up Phase|Relapse/Recurrence|2
90288|NCT00844805|315076|P2|Follow-Up Phase|Relapse/Recurrence|0
90289|NCT00844805|315077|P1|Follow-Up Phase|Relapse/Recurrence|0
90290|NCT00844805|315074|P4|Follow-Up Phase|Noncompliance With Protocol|1
90291|NCT00844805|315075|P3|Follow-Up Phase|Noncompliance With Protocol|0
90292|NCT00844805|315076|P2|Follow-Up Phase|Noncompliance With Protocol|0
90293|NCT00844805|315077|P1|Follow-Up Phase|Noncompliance With Protocol|0
90294|NCT00844805|315074|P4|Follow-Up Phase|Withdrawal by Subject|3
90295|NCT00844805|315075|P3|Follow-Up Phase|Withdrawal by Subject|6
90296|NCT00844805|315076|P2|Follow-Up Phase|Withdrawal by Subject|0
90297|NCT00844805|315077|P1|Follow-Up Phase|Withdrawal by Subject|0
90298|NCT00844805|315074|P4|Follow-Up Phase|Adverse Event|0
90299|NCT00844805|315075|P3|Follow-Up Phase|Adverse Event|1
90300|NCT00844805|315076|P2|Follow-Up Phase|Adverse Event|0
90301|NCT00844805|315077|P1|Follow-Up Phase|Adverse Event|0
90302|NCT00844805|315074|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
90303|NCT00844805|315075|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
90304|NCT00844805|315076|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
90305|NCT00844805|315077|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
90306|NCT00844805|315074|P4|Treatment Phase|Noncompliance With Protocol|0
90307|NCT00844805|315075|P3|Treatment Phase|Noncompliance With Protocol|0
90308|NCT00844805|315076|P2|Treatment Phase|Noncompliance With Protocol|0
90309|NCT00844805|315077|P1|Treatment Phase|Noncompliance With Protocol|1
90310|NCT00844805|315074|P4|Treatment Phase|Withdrawal by Subject|0
90311|NCT00844805|315075|P3|Treatment Phase|Withdrawal by Subject|0
90312|NCT00844805|315076|P2|Treatment Phase|Withdrawal by Subject|4
90313|NCT00844805|315077|P1|Treatment Phase|Withdrawal by Subject|3
90314|NCT00844805|315074|P4|Treatment Phase|Adverse Event|0
90315|NCT00844805|315075|P3|Treatment Phase|Adverse Event|0
90316|NCT00844805|315076|P2|Treatment Phase|Adverse Event|1
90317|NCT00844805|315077|P1|Treatment Phase|Adverse Event|5
90318|NCT00844753|315121|P4|Overall Study|Withdrawal by Subject|3
90319|NCT00844753|315122|P3|Overall Study|Withdrawal by Subject|0
90320|NCT00844753|315123|P2|Overall Study|Withdrawal by Subject|0
90321|NCT00844753|315124|P1|Overall Study|Withdrawal by Subject|1
90322|NCT00844753|315121|P4|Overall Study|could not swallow medication|0
90323|NCT00844753|315122|P3|Overall Study|could not swallow medication|0
90324|NCT00844753|315123|P2|Overall Study|could not swallow medication|0
90325|NCT00844753|315124|P1|Overall Study|could not swallow medication|2
90326|NCT00844753|315121|P4|Overall Study|Lost to Follow-up|1
90327|NCT00844753|315122|P3|Overall Study|Lost to Follow-up|0
90328|NCT00844753|315123|P2|Overall Study|Lost to Follow-up|1
90329|NCT00844753|315124|P1|Overall Study|Lost to Follow-up|1
90330|NCT00844753|315121|P4|Overall Study|Adverse Event|5
90331|NCT00844753|315122|P3|Overall Study|Adverse Event|5
90332|NCT00844753|315123|P2|Overall Study|Adverse Event|2
90333|NCT00844753|315124|P1|Overall Study|Adverse Event|3
90334|NCT00844753|315121|P4|Overall Study|Lack of Efficacy|2
90335|NCT00844753|315122|P3|Overall Study|Lack of Efficacy|2
90336|NCT00844753|315123|P2|Overall Study|Lack of Efficacy|0
90337|NCT00844753|315124|P1|Overall Study|Lack of Efficacy|1
90338|NCT00844649|315142|P2|Overall Study|Withdrew prior to starting treatment|27
90339|NCT00844649|315143|P1|Overall Study|Withdrew prior to starting treatment|11
90340|NCT00844649|315142|P2|Overall Study|Unspecified|10
90341|NCT00844649|315143|P1|Overall Study|Unspecified|7
90342|NCT00844649|315142|P2|Overall Study|Withdrawal by Subject|39
90343|NCT00844649|315143|P1|Overall Study|Withdrawal by Subject|28
90344|NCT00844649|315142|P2|Overall Study|Protocol Violation|6
90345|NCT00844649|315143|P1|Overall Study|Protocol Violation|10
90346|NCT00844649|315142|P2|Overall Study|Physician Decision|18
90347|NCT00844649|315143|P1|Overall Study|Physician Decision|25
90348|NCT00844649|315142|P2|Overall Study|Adverse Event|73
90349|NCT00844649|315143|P1|Overall Study|Adverse Event|128
90350|NCT00844649|315142|P2|Overall Study|Progressive Disease|245
90351|NCT00844649|315143|P1|Overall Study|Progressive Disease|196
90352|NCT00844597|315167|P6|Overall Study|Adverse Event|0
90353|NCT00844597|315168|P5|Overall Study|Adverse Event|0
90354|NCT00844597|315169|P4|Overall Study|Adverse Event|1
90355|NCT00844597|315170|P3|Overall Study|Adverse Event|0
90356|NCT00844597|315171|P2|Overall Study|Adverse Event|0
90357|NCT00844597|315172|P1|Overall Study|Adverse Event|0
90358|NCT00844558|315192|P2|Overall Study|Physician Decision|0
90359|NCT00844558|315193|P1|Overall Study|Physician Decision|1
90360|NCT00844558|315192|P2|Overall Study|Lost to Follow-up|1
90361|NCT00844558|315193|P1|Overall Study|Lost to Follow-up|0
90362|NCT00844558|315192|P2|Overall Study|Protocol Violation|1
90363|NCT00844558|315193|P1|Overall Study|Protocol Violation|1
90364|NCT00844558|315192|P2|Overall Study|Death|0
90365|NCT00844558|315193|P1|Overall Study|Death|1
90366|NCT00844558|315192|P2|Overall Study|Withdrawal by Subject|2
90367|NCT00844558|315193|P1|Overall Study|Withdrawal by Subject|9
90368|NCT00844545|315209|P1|Post Treatment Period|Withdrawal by Subject|1
90369|NCT00844545|315209|P1|Extension Treatment Period|Adverse Event|2
90370|NCT00844545|315209|P1|Treatment Period (26 Weeks)|Protocol Violation|1
90371|NCT00844545|315209|P1|Treatment Period (26 Weeks)|Adverse Event|1
90372|NCT00844532|315223|P1|Overall Study|Lost to Follow-up|7
90373|NCT00844532|315223|P1|Overall Study|Withdrawal by Subject|16
90374|NCT00844532|315223|P1|Overall Study|Death|16
90375|NCT00844519|315309|P2|Overall Study|Adverse Event|0
90376|NCT00844519|315310|P1|Overall Study|Adverse Event|1
90377|NCT00844519|315309|P2|Overall Study|Withdrawal by Subject|1
90378|NCT00844519|315310|P1|Overall Study|Withdrawal by Subject|1
90379|NCT00844428|315316|P1|Post Treatment Period (Patients Who Disc|Death|1
90380|NCT00844428|315316|P1|Extension Treatment Period|Death|1
90381|NCT00844428|315316|P1|Screening Period|Screen Failure|3
90382|NCT00844415|315332|P1|Overall Study|Withdrawal by Subject|1
90383|NCT00844376|315346|P2|Period 1: First Intervention|Withdrawal by Subject|0
90384|NCT00844376|315347|P1|Period 1: First Intervention|Withdrawal by Subject|1
90385|NCT00844194|315371|P2|Overall Study|Other reason (not specified)|0
90386|NCT00844194|315372|P1|Overall Study|Other reason (not specified)|1
90387|NCT00844194|315371|P2|Overall Study|Lack of Efficacy|0
90388|NCT00844194|315372|P1|Overall Study|Lack of Efficacy|3
90389|NCT00844194|315371|P2|Overall Study|Withdrawal by Subject|1
90390|NCT00844194|315372|P1|Overall Study|Withdrawal by Subject|2
90391|NCT00844194|315371|P2|Overall Study|Lost to Follow-up|1
90392|NCT00844194|315372|P1|Overall Study|Lost to Follow-up|1
90393|NCT00844194|315371|P2|Overall Study|Protocol Violation|1
90394|NCT00844194|315372|P1|Overall Study|Protocol Violation|1
90395|NCT00844194|315371|P2|Overall Study|Adverse Event|5
90396|NCT00844194|315372|P1|Overall Study|Adverse Event|17
90397|NCT00843843|315627|P2|Overall Study|Protocol Violation|1
90398|NCT00843843|315628|P1|Overall Study|Protocol Violation|1
90399|NCT00843843|315627|P2|Overall Study|Physician Decision|1
90400|NCT00843843|315628|P1|Overall Study|Physician Decision|1
90401|NCT00843778|315641|P1|Overall Study|Withdrawal by Subject|4
90402|NCT00843778|315641|P1|Overall Study|Loss of efficacy|2
90403|NCT00843778|315641|P1|Overall Study|Lack of Efficacy|14
90404|NCT00843778|315641|P1|Overall Study|Adverse Event|15
90405|NCT00843635|315686|P3|Overall Study|Adverse Event|0
90406|NCT00843635|315687|P2|Overall Study|Adverse Event|2
90407|NCT00843635|315688|P1|Overall Study|Adverse Event|2
90408|NCT00843492|315717|P2|Overall Study|Deep-vein Thrombosis|0
90409|NCT00843492|315718|P1|Overall Study|Deep-vein Thrombosis|1
90410|NCT00843492|315717|P2|Overall Study|Visit Not Performed|0
90411|NCT00843492|315718|P1|Overall Study|Visit Not Performed|1
90412|NCT00843492|315717|P2|Overall Study|Orthopedic Surgery|2
90413|NCT00843492|315718|P1|Overall Study|Orthopedic Surgery|0
90414|NCT00843492|315717|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
90415|NCT00843492|315718|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
90416|NCT00843492|315717|P2|Overall Study|Immobilization Stopped|0
90417|NCT00843492|315718|P1|Overall Study|Immobilization Stopped|1
90418|NCT00843492|315717|P2|Overall Study|Withdrawal by Subject|4
90419|NCT00843492|315718|P1|Overall Study|Withdrawal by Subject|0
90420|NCT00843492|315717|P2|Overall Study|Lost to Follow-up|4
90421|NCT00843492|315718|P1|Overall Study|Lost to Follow-up|4
90422|NCT00843492|315717|P2|Overall Study|Adverse Event|3
90423|NCT00843492|315718|P1|Overall Study|Adverse Event|0
90424|NCT00843284|315783|P1|Overall Study|Death|3
90425|NCT00843284|315783|P1|Overall Study|Withdrawal by Subject|4
90426|NCT00843284|315783|P1|Overall Study|Other|10
90427|NCT00843284|315783|P1|Overall Study|Lost to Follow-up|11
90428|NCT00843284|315783|P1|Overall Study|Lack of Efficacy|5
90429|NCT00843284|315783|P1|Overall Study|Adverse Event|39
90430|NCT00843167|315808|P2|Treatment Period|Withdrawal by Subject|3
90431|NCT00843167|315809|P1|Treatment Period|Withdrawal by Subject|2
90432|NCT00843167|315808|P2|Treatment Period|Adverse Event|5
90433|NCT00843167|315809|P1|Treatment Period|Adverse Event|1
90434|NCT00843115|315822|P1|Overall Study|Syndrome De Glissement|1
90435|NCT00843115|315822|P1|Overall Study|week 12 not done|1
90436|NCT00843115|315822|P1|Overall Study|hospitalized due to deterioration|1
90437|NCT00843115|315822|P1|Overall Study|patient never took the medication|1
90438|NCT00843115|315822|P1|Overall Study|patient took for 2 days then stopped|1
90439|NCT00843115|315822|P1|Overall Study|Family discontinued meds|1
90440|NCT00843115|315822|P1|Overall Study|Physician Decision|1
90441|NCT00843115|315822|P1|Overall Study|Does not meet entrance criteria|1
90442|NCT00843115|315822|P1|Overall Study|Patient forgot to take meds|1
90443|NCT00843115|315822|P1|Overall Study|Family does not want continuation|1
90444|NCT00843115|315822|P1|Overall Study|Family wanted meds stopped|1
90445|NCT00843115|315822|P1|Overall Study|Withdrawal by Subject|17
90446|NCT00843115|315822|P1|Overall Study|Lost to Follow-up|4
90447|NCT00843115|315822|P1|Overall Study|Adverse Event|30
90448|NCT00843115|315822|P1|Overall Study|Death|4
90449|NCT00843024|315878|P6|Double-blind Treatment Phase|Lack of Efficacy|0
90450|NCT00843024|315879|P5|Double-blind Treatment Phase|Lack of Efficacy|1
90451|NCT00843024|315880|P4|Double-blind Treatment Phase|Lack of Efficacy|0
90452|NCT00843024|315881|P3|Double-blind Treatment Phase|Lack of Efficacy|0
90453|NCT00843024|315882|P2|Double-blind Treatment Phase|Lack of Efficacy|0
90454|NCT00843024|315883|P1|Double-blind Treatment Phase|Lack of Efficacy|0
90455|NCT00843024|315878|P6|Double-blind Treatment Phase|Adverse Event|1
90456|NCT00843024|315879|P5|Double-blind Treatment Phase|Adverse Event|1
90457|NCT00843024|315880|P4|Double-blind Treatment Phase|Adverse Event|0
90458|NCT00843024|315881|P3|Double-blind Treatment Phase|Adverse Event|0
90459|NCT00843024|315882|P2|Double-blind Treatment Phase|Adverse Event|0
90460|NCT00843024|315883|P1|Double-blind Treatment Phase|Adverse Event|0
90461|NCT00843024|315878|P6|Double-blind Treatment Phase|Physician Decision|1
90462|NCT00843024|315879|P5|Double-blind Treatment Phase|Physician Decision|1
90463|NCT00843024|315880|P4|Double-blind Treatment Phase|Physician Decision|3
90464|NCT00843024|315881|P3|Double-blind Treatment Phase|Physician Decision|0
90465|NCT00843024|315882|P2|Double-blind Treatment Phase|Physician Decision|0
90466|NCT00843024|315883|P1|Double-blind Treatment Phase|Physician Decision|0
90467|NCT00843024|315878|P6|Double-blind Treatment Phase|Protocol Violation|3
90468|NCT00843024|315879|P5|Double-blind Treatment Phase|Protocol Violation|0
90469|NCT00843024|315880|P4|Double-blind Treatment Phase|Protocol Violation|0
90470|NCT00843024|315881|P3|Double-blind Treatment Phase|Protocol Violation|3
90471|NCT00843024|315882|P2|Double-blind Treatment Phase|Protocol Violation|0
90472|NCT00843024|315883|P1|Double-blind Treatment Phase|Protocol Violation|0
90473|NCT00843024|315878|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
90474|NCT00843024|315879|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
90475|NCT00843024|315880|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
90476|NCT00843024|315881|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
90477|NCT00843024|315882|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
90478|NCT00843024|315883|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
90479|NCT00843024|315878|P6|Double-blind Treatment Phase|Lost to Follow-up|4
90480|NCT00843024|315879|P5|Double-blind Treatment Phase|Lost to Follow-up|4
90481|NCT00843024|315880|P4|Double-blind Treatment Phase|Lost to Follow-up|4
90482|NCT00843024|315881|P3|Double-blind Treatment Phase|Lost to Follow-up|8
90483|NCT00843024|315882|P2|Double-blind Treatment Phase|Lost to Follow-up|0
90484|NCT00843024|315883|P1|Double-blind Treatment Phase|Lost to Follow-up|0
90485|NCT00843024|315878|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
90486|NCT00843024|315879|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
90487|NCT00843024|315880|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
90488|NCT00843024|315881|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
90489|NCT00843024|315882|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
90490|NCT00843024|315883|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
90491|NCT00843024|315878|P6|Single-blind Placebo Run-In Phase|Other|0
90492|NCT00843024|315879|P5|Single-blind Placebo Run-In Phase|Other|0
90493|NCT00843024|315880|P4|Single-blind Placebo Run-In Phase|Other|0
90494|NCT00843024|315881|P3|Single-blind Placebo Run-In Phase|Other|0
90495|NCT00843024|315882|P2|Single-blind Placebo Run-In Phase|Other|1
90496|NCT00843024|315883|P1|Single-blind Placebo Run-In Phase|Other|0
90497|NCT00843024|315878|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
90498|NCT00843024|315879|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
90499|NCT00843024|315880|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
90500|NCT00843024|315881|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
90501|NCT00843024|315882|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
90502|NCT00843024|315883|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
90503|NCT00843024|315878|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
90504|NCT00843024|315879|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
90505|NCT00843024|315880|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
90506|NCT00843024|315881|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
90507|NCT00843024|315882|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
90508|NCT00843024|315883|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
90509|NCT00843024|315878|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
90510|NCT00843024|315879|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
90511|NCT00843024|315880|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
90512|NCT00843024|315881|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
90513|NCT00843024|315882|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
90514|NCT00843024|315883|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
90515|NCT00843024|315878|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
90516|NCT00843024|315879|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
90517|NCT00843024|315880|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
90518|NCT00843024|315881|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
90519|NCT00843024|315882|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
90520|NCT00843024|315883|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
90521|NCT00843024|315878|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
90522|NCT00843024|315879|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
90523|NCT00843024|315880|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
90524|NCT00843024|315881|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
90525|NCT00843024|315882|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
90526|NCT00843024|315883|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
90527|NCT00843024|315878|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
90528|NCT00843024|315879|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
90529|NCT00843024|315880|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
90530|NCT00843024|315881|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
90531|NCT00843024|315882|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
90532|NCT00843024|315883|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
90533|NCT00842985|315948|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
90534|NCT00842985|315948|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
90535|NCT00842985|315948|P1|First Intervention|Protocol Violation|3
90536|NCT00842985|315948|P1|First Intervention|Withdrawal by Subject|3
90537|NCT00842985|315948|P1|Screening|Did not meet entrance requirements|27
90538|NCT00842829|315966|P3|Continuation Period|Non-compliance to study drug|1
90539|NCT00842829|315967|P2|Continuation Period|Non-compliance to study drug|0
90540|NCT00842829|315968|P1|Continuation Period|Non-compliance to study drug|0
90541|NCT00842829|315966|P3|Continuation Period|Non-compliance to study procedures|2
90542|NCT00842829|315967|P2|Continuation Period|Non-compliance to study procedures|0
90543|NCT00842829|315968|P1|Continuation Period|Non-compliance to study procedures|0
90544|NCT00842829|315966|P3|Continuation Period|Not specified|7
90545|NCT00842829|315967|P2|Continuation Period|Not specified|0
90546|NCT00842829|315968|P1|Continuation Period|Not specified|0
90547|NCT00842829|315966|P3|Continuation Period|Withdrawal by Subject|10
90548|NCT00842829|315967|P2|Continuation Period|Withdrawal by Subject|0
90549|NCT00842829|315968|P1|Continuation Period|Withdrawal by Subject|0
90550|NCT00842829|315966|P3|Continuation Period|Unstable persistent cancer pain|3
90551|NCT00842829|315967|P2|Continuation Period|Unstable persistent cancer pain|0
90552|NCT00842829|315968|P1|Continuation Period|Unstable persistent cancer pain|0
90553|NCT00842829|315966|P3|Continuation Period|Lack of Efficacy|6
90554|NCT00842829|315967|P2|Continuation Period|Lack of Efficacy|0
90555|NCT00842829|315968|P1|Continuation Period|Lack of Efficacy|0
90556|NCT00842829|315966|P3|Continuation Period|Adverse Event|32
90557|NCT00842829|315967|P2|Continuation Period|Adverse Event|0
90558|NCT00842829|315968|P1|Continuation Period|Adverse Event|0
90559|NCT00842829|315966|P3|Treatment Period|Unclear completion status|1
90560|NCT00842829|315967|P2|Treatment Period|Unclear completion status|0
90561|NCT00842829|315968|P1|Treatment Period|Unclear completion status|0
90562|NCT00842829|315966|P3|Treatment Period|Non-compliance to study procedures|4
90563|NCT00842829|315967|P2|Treatment Period|Non-compliance to study procedures|0
90564|NCT00842829|315968|P1|Treatment Period|Non-compliance to study procedures|0
90565|NCT00842829|315966|P3|Treatment Period|Not specified|18
90566|NCT00842829|315967|P2|Treatment Period|Not specified|0
90567|NCT00842829|315968|P1|Treatment Period|Not specified|0
90568|NCT00842829|315966|P3|Treatment Period|Protocol Violation|2
90569|NCT00842829|315967|P2|Treatment Period|Protocol Violation|0
90570|NCT00842829|315968|P1|Treatment Period|Protocol Violation|0
90571|NCT00842829|315966|P3|Treatment Period|Consistently >4 BTP episodes daily|1
90572|NCT00842829|315967|P2|Treatment Period|Consistently >4 BTP episodes daily|0
90573|NCT00842829|315968|P1|Treatment Period|Consistently >4 BTP episodes daily|0
90574|NCT00842829|315966|P3|Treatment Period|Withdrawal by Subject|11
90575|NCT00842829|315967|P2|Treatment Period|Withdrawal by Subject|0
90576|NCT00842829|315968|P1|Treatment Period|Withdrawal by Subject|0
90577|NCT00842829|315966|P3|Treatment Period|Unstable persistent cancer pain|5
90578|NCT00842829|315967|P2|Treatment Period|Unstable persistent cancer pain|0
90579|NCT00842829|315968|P1|Treatment Period|Unstable persistent cancer pain|0
90580|NCT00842829|315966|P3|Treatment Period|Lack of Efficacy|6
90581|NCT00842829|315967|P2|Treatment Period|Lack of Efficacy|0
90582|NCT00842829|315968|P1|Treatment Period|Lack of Efficacy|0
90583|NCT00842829|315966|P3|Treatment Period|Adverse Event|15
90584|NCT00842829|315967|P2|Treatment Period|Adverse Event|0
90585|NCT00842829|315968|P1|Treatment Period|Adverse Event|0
90586|NCT00842829|315966|P3|Dose Titration Period|Non-compliance to study drug|0
90587|NCT00842829|315967|P2|Dose Titration Period|Non-compliance to study drug|1
90588|NCT00842829|315968|P1|Dose Titration Period|Non-compliance to study drug|2
90589|NCT00842829|315966|P3|Dose Titration Period|Non-compliance to study procedures|0
90590|NCT00842829|315967|P2|Dose Titration Period|Non-compliance to study procedures|1
90591|NCT00842829|315968|P1|Dose Titration Period|Non-compliance to study procedures|1
90592|NCT00842829|315966|P3|Dose Titration Period|Not specified|0
90593|NCT00842829|315967|P2|Dose Titration Period|Not specified|4
90594|NCT00842829|315968|P1|Dose Titration Period|Not specified|5
90595|NCT00842829|315966|P3|Dose Titration Period|Withdrawal by Subject|0
90596|NCT00842829|315967|P2|Dose Titration Period|Withdrawal by Subject|6
90597|NCT00842829|315968|P1|Dose Titration Period|Withdrawal by Subject|2
90598|NCT00842829|315966|P3|Dose Titration Period|Unstable persistent cancer pain|0
90599|NCT00842829|315967|P2|Dose Titration Period|Unstable persistent cancer pain|0
90600|NCT00842829|315968|P1|Dose Titration Period|Unstable persistent cancer pain|1
90601|NCT00842829|315966|P3|Dose Titration Period|Lack of Efficacy|0
90602|NCT00842829|315967|P2|Dose Titration Period|Lack of Efficacy|1
90603|NCT00842829|315968|P1|Dose Titration Period|Lack of Efficacy|4
90604|NCT00842829|315966|P3|Dose Titration Period|Adverse Event|0
90605|NCT00842829|315967|P2|Dose Titration Period|Adverse Event|10
90606|NCT00842829|315968|P1|Dose Titration Period|Adverse Event|11
90607|NCT00842712|316023|P7|Randomized Part|Ongoing at cut-off date|2
90608|NCT00842712|316024|P6|Randomized Part|Ongoing at cut-off date|0
90609|NCT00842712|316025|P5|Randomized Part|Ongoing at cut-off date|0
90610|NCT00842712|316026|P4|Randomized Part|Ongoing at cut-off date|0
90611|NCT00842712|316027|P3|Randomized Part|Ongoing at cut-off date|0
90612|NCT00842712|316028|P2|Randomized Part|Ongoing at cut-off date|0
90613|NCT00842712|316029|P1|Randomized Part|Ongoing at cut-off date|0
90614|NCT00842712|316023|P7|Randomized Part|Randomized but not treated|4
90615|NCT00842712|316024|P6|Randomized Part|Randomized but not treated|1
90616|NCT00842712|316025|P5|Randomized Part|Randomized but not treated|0
90617|NCT00842712|316026|P4|Randomized Part|Randomized but not treated|0
90618|NCT00842712|316027|P3|Randomized Part|Randomized but not treated|0
90619|NCT00842712|316028|P2|Randomized Part|Randomized but not treated|0
90620|NCT00842712|316029|P1|Randomized Part|Randomized but not treated|0
90621|NCT00842712|316023|P7|Safety Run-in Part|Progressive disease|0
90622|NCT00842712|316024|P6|Safety Run-in Part|Progressive disease|0
90623|NCT00842712|316025|P5|Safety Run-in Part|Progressive disease|0
90624|NCT00842712|316026|P4|Safety Run-in Part|Progressive disease|1
90625|NCT00842712|316027|P3|Safety Run-in Part|Progressive disease|0
90626|NCT00842712|316028|P2|Safety Run-in Part|Progressive disease|1
90627|NCT00842712|316029|P1|Safety Run-in Part|Progressive disease|3
90628|NCT00842712|316023|P7|Safety Run-in Part|Adverse Event|0
90629|NCT00842712|316024|P6|Safety Run-in Part|Adverse Event|0
90630|NCT00842712|316025|P5|Safety Run-in Part|Adverse Event|0
90631|NCT00842712|316026|P4|Safety Run-in Part|Adverse Event|0
90632|NCT00842712|316027|P3|Safety Run-in Part|Adverse Event|0
90633|NCT00842712|316028|P2|Safety Run-in Part|Adverse Event|1
90634|NCT00842712|316029|P1|Safety Run-in Part|Adverse Event|0
90635|NCT00842543|316061|P4|Overall Study|Withdrawal by Subject|4
90636|NCT00842543|316062|P3|Overall Study|Withdrawal by Subject|3
90637|NCT00842543|316063|P2|Overall Study|Withdrawal by Subject|0
90638|NCT00842543|316064|P1|Overall Study|Withdrawal by Subject|2
90639|NCT00842361|316078|P2|Overall Study|Unclassified|2
90640|NCT00842361|316079|P1|Overall Study|Unclassified|0
90641|NCT00842361|316078|P2|Overall Study|Protocol Violation|0
90642|NCT00842361|316079|P1|Overall Study|Protocol Violation|1
90643|NCT00842348|316099|P2|Study 729|Surgical resection|0
90644|NCT00842348|316100|P1|Study 729|Surgical resection|1
90645|NCT00842348|316099|P2|Study 729|Sponsor's decision|0
90646|NCT00842348|316100|P1|Study 729|Sponsor's decision|1
90647|NCT00842348|316099|P2|Study 729|Due to non-availability of IP|1
90648|NCT00842348|316100|P1|Study 729|Due to non-availability of IP|0
90649|NCT00842348|316099|P2|Study 729|Due to Sponsor stopping the study|1
90650|NCT00842348|316100|P1|Study 729|Due to Sponsor stopping the study|1
90651|NCT00842348|316099|P2|Study 729|Withdrawal by Subject|4
90652|NCT00842348|316100|P1|Study 729|Withdrawal by Subject|2
90653|NCT00842348|316099|P2|Study 729|Protocol Violation|1
90654|NCT00842348|316100|P1|Study 729|Protocol Violation|1
90655|NCT00842348|316099|P2|Study 729|Adverse Event|1
90656|NCT00842348|316100|P1|Study 729|Adverse Event|1
90657|NCT00842348|316099|P2|Study 729|Disease progression/death|30
90658|NCT00842348|316100|P1|Study 729|Disease progression/death|19
90659|NCT00842348|316099|P2|Patients Randomised in Study 726|Did not enter Study 729|56
90660|NCT00842348|316100|P1|Patients Randomised in Study 726|Did not enter Study 729|59
90661|NCT00842244|316117|P1|Overall Study|Unspecified|17
90662|NCT00842244|316117|P1|Overall Study|Withdrawal by Subject|1
90663|NCT00842244|316117|P1|Overall Study|Death|3
90664|NCT00842153|316144|P2|Overall Study|Lost to Follow-up|2
90665|NCT00842153|316145|P1|Overall Study|Lost to Follow-up|1
90666|NCT00842153|316144|P2|Overall Study|Adverse Event|1
90667|NCT00842153|316145|P1|Overall Study|Adverse Event|0
90668|NCT00841906|316220|P2|Overall Study|Withdrawal by Subject|0
90669|NCT00841906|316221|P1|Overall Study|Withdrawal by Subject|2
90670|NCT00841815|316235|P2|Washout|Withdrawal by Subject|1
90671|NCT00841815|316236|P1|Washout|Withdrawal by Subject|0
90672|NCT00841776|316246|P2|Overall Study|Withdrawal by Subject|1
90673|NCT00841776|316247|P1|Overall Study|Withdrawal by Subject|0
90674|NCT00841776|316246|P2|Overall Study|Lost to Follow-up|1
90675|NCT00841776|316247|P1|Overall Study|Lost to Follow-up|2
90676|NCT00841776|316246|P2|Overall Study|Lack of Efficacy|1
90677|NCT00841776|316247|P1|Overall Study|Lack of Efficacy|0
90678|NCT00841763|316265|P4|Overall Study|Unable to Classify|0
90679|NCT00841763|316266|P3|Overall Study|Unable to Classify|0
90680|NCT00841763|316267|P2|Overall Study|Unable to Classify|1
90681|NCT00841763|316268|P1|Overall Study|Unable to Classify|7
90682|NCT00841763|316265|P4|Overall Study|Administrative Reasons|0
90683|NCT00841763|316266|P3|Overall Study|Administrative Reasons|0
90684|NCT00841763|316267|P2|Overall Study|Administrative Reasons|1
90685|NCT00841763|316268|P1|Overall Study|Administrative Reasons|3
90686|NCT00841763|316265|P4|Overall Study|Protocol Violation|0
90687|NCT00841763|316266|P3|Overall Study|Protocol Violation|1
90688|NCT00841763|316267|P2|Overall Study|Protocol Violation|3
90689|NCT00841763|316268|P1|Overall Study|Protocol Violation|20
90690|NCT00841763|316265|P4|Overall Study|Lost to Follow-up|0
90691|NCT00841763|316266|P3|Overall Study|Lost to Follow-up|0
90692|NCT00841763|316267|P2|Overall Study|Lost to Follow-up|25
90693|NCT00841763|316268|P1|Overall Study|Lost to Follow-up|63
90694|NCT00841763|316265|P4|Overall Study|Adverse Event|2
90695|NCT00841763|316266|P3|Overall Study|Adverse Event|3
90696|NCT00841763|316267|P2|Overall Study|Adverse Event|10
90697|NCT00841763|316268|P1|Overall Study|Adverse Event|9
90698|NCT00841763|316265|P4|Overall Study|Withdrawal by Subject|1
90699|NCT00841763|316266|P3|Overall Study|Withdrawal by Subject|4
90700|NCT00841763|316267|P2|Overall Study|Withdrawal by Subject|17
90701|NCT00841763|316268|P1|Overall Study|Withdrawal by Subject|60
90702|NCT00841698|316330|P2|First Intervention|Withdrawal by Subject|0
90703|NCT00841698|316331|P1|First Intervention|Withdrawal by Subject|1
90704|NCT00841672|316341|P2|Overall Study|Protocol Deviation|1
90705|NCT00841672|316342|P1|Overall Study|Protocol Deviation|0
90706|NCT00841672|316341|P2|Overall Study|Misrandomized|0
90707|NCT00841672|316342|P1|Overall Study|Misrandomized|1
90708|NCT00841672|316341|P2|Overall Study|Administrative problems|9
90709|NCT00841672|316342|P1|Overall Study|Administrative problems|9
90710|NCT00841672|316341|P2|Overall Study|Lost to Follow-up|1
90711|NCT00841672|316342|P1|Overall Study|Lost to Follow-up|1
90712|NCT00841672|316341|P2|Overall Study|Subject withdrew consent|4
90713|NCT00841672|316342|P1|Overall Study|Subject withdrew consent|2
90714|NCT00841672|316341|P2|Overall Study|Abnormal test procedure result(s)|1
90715|NCT00841672|316342|P1|Overall Study|Abnormal test procedure result(s)|0
90716|NCT00841672|316341|P2|Overall Study|Adverse Event|16
90717|NCT00841672|316342|P1|Overall Study|Adverse Event|7
90718|NCT00841659|316358|P2|Washout: 2 Weeks|Protocol Violation|0
90719|NCT00841659|316359|P1|Washout: 2 Weeks|Protocol Violation|1
90720|NCT00841542|316375|P2|Period 1|Adverse Event|0
90721|NCT00841542|316376|P1|Period 1|Adverse Event|1
90722|NCT00841321|316391|P2|Overall Study|Adverse Event|2
90723|NCT00841321|316392|P1|Overall Study|Adverse Event|0
90724|NCT00841321|316391|P2|Overall Study|Lost to Follow-up|1
90725|NCT00841321|316392|P1|Overall Study|Lost to Follow-up|1
90726|NCT00841035|316442|P1|Phase 1 Overall Study|Physician Decision|13
90727|NCT00840996|316449|P2|Overall Study|Withdrawal by Subject|0
90728|NCT00840996|316450|P1|Overall Study|Withdrawal by Subject|1
90729|NCT00840879|316470|P2|Second Intervention|Withdrawal by Subject|0
90730|NCT00840879|316471|P1|Second Intervention|Withdrawal by Subject|1
90731|NCT00840658|316511|P4|Overall Study|Lost to Follow-up|1
90732|NCT00840658|316512|P3|Overall Study|Lost to Follow-up|2
90733|NCT00840658|316513|P2|Overall Study|Lost to Follow-up|1
90734|NCT00840658|316514|P1|Overall Study|Lost to Follow-up|3
90735|NCT00840658|316511|P4|Overall Study|Death|3
90736|NCT00840658|316512|P3|Overall Study|Death|3
90737|NCT00840658|316513|P2|Overall Study|Death|2
90738|NCT00840658|316514|P1|Overall Study|Death|2
90739|NCT00840632|316526|P2|Washout|Withdrawal by Subject|1
90740|NCT00840632|316527|P1|Washout|Withdrawal by Subject|1
90741|NCT00840632|316526|P2|First Intervention|Withdrawal by Subject|1
90742|NCT00840632|316527|P1|First Intervention|Withdrawal by Subject|0
90743|NCT00840450|316552|P1|Overall Study|Lack of Efficacy|2
90744|NCT00840450|316552|P1|Overall Study|Adverse Event|1
90745|NCT00840411|316560|P2|Washout|Withdrawal by Subject|0
90746|NCT00840411|316561|P1|Washout|Withdrawal by Subject|1
90747|NCT00840411|316560|P2|First Intervention|Adverse Event|0
90748|NCT00840411|316561|P1|First Intervention|Adverse Event|1
90749|NCT00840294|316571|P2|Overall Study|Illness|1
90750|NCT00840294|316572|P1|Overall Study|Illness|0
90751|NCT00840294|316571|P2|Overall Study|Protocol Violation|3
90752|NCT00840294|316572|P1|Overall Study|Protocol Violation|1
90753|NCT00840294|316571|P2|Overall Study|Withdrawal by Subject|1
90754|NCT00840294|316572|P1|Overall Study|Withdrawal by Subject|2
90755|NCT00840216|316593|P2|Washout: 7 Days|Withdrawal by Subject|0
90756|NCT00840216|316594|P1|Washout: 7 Days|Withdrawal by Subject|1
90757|NCT00840203|316604|P2|Washout|Protocol Violation|0
90758|NCT00840203|316605|P1|Washout|Protocol Violation|1
90759|NCT00840203|316604|P2|First Intervention|Protocol Violation|1
90760|NCT00840203|316605|P1|First Intervention|Protocol Violation|1
90761|NCT00840086|316636|P1|Overall Study|Lost to Follow-up|1
90762|NCT00840086|316636|P1|Overall Study|Protocol Violation|2
90763|NCT00840086|316636|P1|Overall Study|Adverse Event|1
90764|NCT00840073|316645|P2|Second Intervention|Missed 72 hour blood draw|1
90765|NCT00840073|316646|P1|Second Intervention|Missed 72 hour blood draw|1
90766|NCT00840060|316660|P2|Overall Study|Change in emotional/behavioral status|1
90767|NCT00840060|316661|P1|Overall Study|Change in emotional/behavioral status|0
90768|NCT00840060|316660|P2|Overall Study|Withdrawal by Subject|0
90769|NCT00840060|316661|P1|Overall Study|Withdrawal by Subject|1
90770|NCT00839917|316682|P2|Overall Study|Did not receive vaccine|1
90771|NCT00839917|316683|P1|Overall Study|Did not receive vaccine|0
90772|NCT00839917|316682|P2|Overall Study|Lost to Follow-up|0
90773|NCT00839917|316683|P1|Overall Study|Lost to Follow-up|1
90774|NCT00839800|316721|P2|Overall Study|Severe Non-Compliance to Protocol|7
90775|NCT00839800|316722|P1|Overall Study|Severe Non-Compliance to Protocol|7
90776|NCT00839800|316721|P2|Overall Study|Not Specified|14
90777|NCT00839800|316722|P1|Overall Study|Not Specified|8
90778|NCT00839800|316721|P2|Overall Study|Safety Reasons|1
90779|NCT00839800|316722|P1|Overall Study|Safety Reasons|2
90780|NCT00839800|316721|P2|Overall Study|Study-Specific Discontinuation Criteria|13
90781|NCT00839800|316722|P1|Overall Study|Study-Specific Discontinuation Criteria|6
90782|NCT00839800|316721|P2|Overall Study|Incorrect Enrolment|3
90783|NCT00839800|316722|P1|Overall Study|Incorrect Enrolment|3
90784|NCT00839800|316721|P2|Overall Study|Withdrawal by Subject|34
90785|NCT00839800|316722|P1|Overall Study|Withdrawal by Subject|28
90786|NCT00839800|316721|P2|Overall Study|Lost to Follow-up|26
90787|NCT00839800|316722|P1|Overall Study|Lost to Follow-up|31
90788|NCT00839800|316721|P2|Overall Study|Adverse Event|12
90789|NCT00839800|316722|P1|Overall Study|Adverse Event|8
90790|NCT00839527|316768|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
90791|NCT00839527|316769|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
90792|NCT00839527|316770|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
90793|NCT00839527|316768|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
90794|NCT00839527|316769|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
90795|NCT00839527|316770|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
90796|NCT00839527|316768|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
90797|NCT00839527|316769|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
90798|NCT00839527|316770|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
90799|NCT00839527|316768|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
90800|NCT00839527|316769|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
90801|NCT00839527|316770|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
90802|NCT00839527|316768|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
90803|NCT00839527|316769|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
90804|NCT00839527|316770|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
90805|NCT00839527|316768|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
90806|NCT00839527|316769|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
90807|NCT00839527|316770|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
90808|NCT00839527|316768|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
90809|NCT00839527|316769|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
90810|NCT00839527|316770|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
90811|NCT00839527|316768|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
90812|NCT00839527|316769|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
90813|NCT00839527|316770|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
90814|NCT00839527|316768|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
90815|NCT00839527|316769|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
90816|NCT00839527|316770|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
90817|NCT00839527|316768|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
90818|NCT00839527|316769|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
90819|NCT00839527|316770|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
90820|NCT00839527|316768|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
90821|NCT00839527|316769|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
90822|NCT00839527|316770|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
90823|NCT00839527|316768|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
90824|NCT00839527|316769|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
90825|NCT00839527|316770|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
90826|NCT00839527|316768|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
90827|NCT00839527|316769|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
90828|NCT00839527|316770|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
90829|NCT00839527|316768|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
90830|NCT00839527|316769|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
90831|NCT00839527|316770|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
90832|NCT00839527|316768|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
90833|NCT00839527|316769|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
90834|NCT00839527|316770|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
90835|NCT00839527|316768|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
90836|NCT00839527|316769|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
90837|NCT00839527|316770|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
90838|NCT00839527|316768|P3|Treatment Period (TP) (156 Weeks)|Missing|0
90839|NCT00839527|316769|P2|Treatment Period (TP) (156 Weeks)|Missing|1
90840|NCT00839527|316770|P1|Treatment Period (TP) (156 Weeks)|Missing|0
90841|NCT00839527|316768|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
90842|NCT00839527|316769|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
90843|NCT00839527|316770|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
90844|NCT00839527|316768|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
90845|NCT00839527|316769|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
90846|NCT00839527|316770|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
90847|NCT00839527|316768|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
90848|NCT00839527|316769|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
90849|NCT00839527|316770|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
90850|NCT00839527|316768|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
90851|NCT00839527|316769|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
90852|NCT00839527|316770|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
90853|NCT00839527|316768|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
90854|NCT00839527|316769|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
90855|NCT00839527|316770|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
90856|NCT00839527|316768|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
90857|NCT00839527|316769|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
90858|NCT00839527|316770|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
90859|NCT00839527|316768|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
90860|NCT00839527|316769|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
90861|NCT00839527|316770|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
90862|NCT00839436|316805|P3|Overall Study|Study drug no longer available|1
90863|NCT00839436|316806|P2|Overall Study|Study drug no longer available|0
90864|NCT00839436|316807|P1|Overall Study|Study drug no longer available|0
90865|NCT00839436|316805|P3|Overall Study|Withdrawal by Subject|0
90866|NCT00839436|316806|P2|Overall Study|Withdrawal by Subject|1
90867|NCT00839436|316807|P1|Overall Study|Withdrawal by Subject|0
90868|NCT00839436|316805|P3|Overall Study|Developed exclusionary condition|0
90869|NCT00839436|316806|P2|Overall Study|Developed exclusionary condition|0
90870|NCT00839436|316807|P1|Overall Study|Developed exclusionary condition|1
90871|NCT00839423|316819|P4|Overall Study|Administrative or other reasons|0
90872|NCT00839423|316820|P3|Overall Study|Administrative or other reasons|1
90873|NCT00839423|316821|P2|Overall Study|Administrative or other reasons|0
90874|NCT00839423|316822|P1|Overall Study|Administrative or other reasons|3
90875|NCT00839423|316819|P4|Overall Study|Lost to Follow-up|0
90876|NCT00839423|316820|P3|Overall Study|Lost to Follow-up|1
90877|NCT00839423|316821|P2|Overall Study|Lost to Follow-up|0
90878|NCT00839423|316822|P1|Overall Study|Lost to Follow-up|1
90879|NCT00839423|316819|P4|Overall Study|Withdrawal of consent|1
90880|NCT00839423|316820|P3|Overall Study|Withdrawal of consent|4
90881|NCT00839423|316821|P2|Overall Study|Withdrawal of consent|0
90882|NCT00839423|316822|P1|Overall Study|Withdrawal of consent|4
90883|NCT00839423|316819|P4|Overall Study|Protocol Violation|0
90884|NCT00839423|316820|P3|Overall Study|Protocol Violation|2
90885|NCT00839423|316821|P2|Overall Study|Protocol Violation|1
90886|NCT00839423|316822|P1|Overall Study|Protocol Violation|0
90887|NCT00839423|316819|P4|Overall Study|Non-compliance|1
90888|NCT00839423|316820|P3|Overall Study|Non-compliance|0
90889|NCT00839423|316821|P2|Overall Study|Non-compliance|0
90890|NCT00839423|316822|P1|Overall Study|Non-compliance|0
90891|NCT00839423|316819|P4|Overall Study|Lack of Efficacy|2
90892|NCT00839423|316820|P3|Overall Study|Lack of Efficacy|3
90893|NCT00839423|316821|P2|Overall Study|Lack of Efficacy|6
90894|NCT00839423|316822|P1|Overall Study|Lack of Efficacy|6
90895|NCT00839423|316819|P4|Overall Study|Adverse Event|16
90896|NCT00839423|316820|P3|Overall Study|Adverse Event|7
90897|NCT00839423|316821|P2|Overall Study|Adverse Event|3
90898|NCT00839423|316822|P1|Overall Study|Adverse Event|4
90899|NCT00839306|316898|P2|Overall Study|Not specified|18
90900|NCT00839306|316899|P1|Overall Study|Not specified|6
90901|NCT00839306|316898|P2|Overall Study|Lack of Efficacy|4
90902|NCT00839306|316899|P1|Overall Study|Lack of Efficacy|5
90903|NCT00839306|316898|P2|Overall Study|Withdrawal by Subject|7
90904|NCT00839306|316899|P1|Overall Study|Withdrawal by Subject|5
90905|NCT00839306|316898|P2|Overall Study|Lost to Follow-up|9
90906|NCT00839306|316899|P1|Overall Study|Lost to Follow-up|6
90907|NCT00839306|316898|P2|Overall Study|Adverse Event|5
90908|NCT00839306|316899|P1|Overall Study|Adverse Event|3
90909|NCT00839098|316997|P3|Overall Study|Withdrawal by Subject|7
90910|NCT00839098|316998|P2|Overall Study|Withdrawal by Subject|1
90911|NCT00839098|316999|P1|Overall Study|Withdrawal by Subject|2
90912|NCT00839072|317025|P2|Second Intervention Period|Withdrawal by Subject|0
90913|NCT00839072|317026|P1|Second Intervention Period|Withdrawal by Subject|1
90914|NCT00839072|317025|P2|First Intervention Period|Adverse Event|1
90915|NCT00839072|317026|P1|First Intervention Period|Adverse Event|1
90916|NCT00839072|317025|P2|First Intervention Period|Withdrawal by Subject|0
90917|NCT00839072|317026|P1|First Intervention Period|Withdrawal by Subject|1
90918|NCT00838929|317045|P3|Overall Study|Disease progression|1
90919|NCT00838929|317046|P2|Overall Study|Disease progression|2
90920|NCT00838929|317047|P1|Overall Study|Disease progression|0
90921|NCT00838929|317045|P3|Overall Study|Protocol Violation|0
90922|NCT00838929|317046|P2|Overall Study|Protocol Violation|1
90923|NCT00838929|317047|P1|Overall Study|Protocol Violation|0
90924|NCT00838916|317055|P2|Follow-up Period (8 Weeks)|Missing|0
90925|NCT00838916|317056|P1|Follow-up Period (8 Weeks)|Missing|3
90926|NCT00838916|317055|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
90927|NCT00838916|317056|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
90928|NCT00838916|317055|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
90929|NCT00838916|317056|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
90930|NCT00838916|317055|P2|Follow-up Period (8 Weeks)|Physician Decision|0
90931|NCT00838916|317056|P1|Follow-up Period (8 Weeks)|Physician Decision|2
90932|NCT00838916|317055|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
90933|NCT00838916|317056|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
90934|NCT00838916|317055|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
90935|NCT00838916|317056|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
90936|NCT00838916|317055|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
90937|NCT00838916|317056|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
90938|NCT00838916|317055|P2|Follow-up Period (8 Weeks)|Noncompliance|5
90939|NCT00838916|317056|P1|Follow-up Period (8 Weeks)|Noncompliance|6
90940|NCT00838916|317055|P2|Follow-up Period (8 Weeks)|Adverse Event|5
90941|NCT00838916|317056|P1|Follow-up Period (8 Weeks)|Adverse Event|10
90942|NCT00838916|317055|P2|Treatment Period (156 Weeks)|Pregnancy|0
90943|NCT00838916|317056|P1|Treatment Period (156 Weeks)|Pregnancy|2
90944|NCT00838916|317055|P2|Treatment Period (156 Weeks)|Missing|1
90945|NCT00838916|317056|P1|Treatment Period (156 Weeks)|Missing|3
90946|NCT00838916|317055|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
91021|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Site closed|0
90947|NCT00838916|317056|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
90948|NCT00838916|317055|P2|Treatment Period (156 Weeks)|Physician Decision|1
90949|NCT00838916|317056|P1|Treatment Period (156 Weeks)|Physician Decision|6
90950|NCT00838916|317055|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
90951|NCT00838916|317056|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
90952|NCT00838916|317055|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
90953|NCT00838916|317056|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
90954|NCT00838916|317055|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
90955|NCT00838916|317056|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
90956|NCT00838916|317055|P2|Treatment Period (156 Weeks)|Noncompliance|14
90957|NCT00838916|317056|P1|Treatment Period (156 Weeks)|Noncompliance|21
90958|NCT00838916|317055|P2|Treatment Period (156 Weeks)|Protocol Violation|3
90959|NCT00838916|317056|P1|Treatment Period (156 Weeks)|Protocol Violation|12
90960|NCT00838916|317055|P2|Treatment Period (156 Weeks)|Adverse Event|11
90961|NCT00838916|317056|P1|Treatment Period (156 Weeks)|Adverse Event|50
90962|NCT00838903|317085|P4|Follow-up Period (8 Weeks)|Missing|1
90963|NCT00838903|317086|P3|Follow-up Period (8 Weeks)|Missing|1
90964|NCT00838903|317087|P2|Follow-up Period (8 Weeks)|Missing|2
90965|NCT00838903|317088|P1|Follow-up Period (8 Weeks)|Missing|1
90966|NCT00838903|317085|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
90967|NCT00838903|317086|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
90968|NCT00838903|317087|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
90969|NCT00838903|317088|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
90970|NCT00838903|317085|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
90971|NCT00838903|317086|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
90972|NCT00838903|317087|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
90973|NCT00838903|317088|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
90974|NCT00838903|317085|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
90975|NCT00838903|317086|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
90976|NCT00838903|317087|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
90977|NCT00838903|317088|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
90978|NCT00838903|317085|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
90979|NCT00838903|317086|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
90980|NCT00838903|317087|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
90981|NCT00838903|317088|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
90982|NCT00838903|317085|P4|Follow-up Period (8 Weeks)|Physician Decision|1
90983|NCT00838903|317086|P3|Follow-up Period (8 Weeks)|Physician Decision|1
90984|NCT00838903|317087|P2|Follow-up Period (8 Weeks)|Physician Decision|1
90985|NCT00838903|317088|P1|Follow-up Period (8 Weeks)|Physician Decision|1
90986|NCT00838903|317085|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
90987|NCT00838903|317086|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
90988|NCT00838903|317087|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
90989|NCT00838903|317088|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
90990|NCT00838903|317085|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
90991|NCT00838903|317086|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
90992|NCT00838903|317087|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
90993|NCT00838903|317088|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
90994|NCT00838903|317085|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
90995|NCT00838903|317086|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
90996|NCT00838903|317087|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
90997|NCT00838903|317088|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
90998|NCT00838903|317085|P4|Follow-up Period (8 Weeks)|Noncompliance|5
90999|NCT00838903|317086|P3|Follow-up Period (8 Weeks)|Noncompliance|5
91000|NCT00838903|317087|P2|Follow-up Period (8 Weeks)|Noncompliance|8
91001|NCT00838903|317088|P1|Follow-up Period (8 Weeks)|Noncompliance|2
91002|NCT00838903|317085|P4|Follow-up Period (8 Weeks)|Adverse Event|1
91003|NCT00838903|317086|P3|Follow-up Period (8 Weeks)|Adverse Event|3
91004|NCT00838903|317087|P2|Follow-up Period (8 Weeks)|Adverse Event|0
91005|NCT00838903|317088|P1|Follow-up Period (8 Weeks)|Adverse Event|0
91006|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
91007|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
91008|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
91009|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
91010|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
91011|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
91012|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
91013|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
91014|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
91015|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
91016|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
91017|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
91018|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Site closed|0
91019|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Site closed|1
91020|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Site closed|0
91022|NCT00838903|317085|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
91023|NCT00838903|317086|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
91024|NCT00838903|317087|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
91025|NCT00838903|317088|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
91026|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Pregnancy|0
91027|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Pregnancy|1
91028|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Pregnancy|0
91029|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Pregnancy|0
91030|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
91031|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
91032|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
91033|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
91034|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
91035|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
91036|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
91037|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
91038|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
91039|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
91040|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
91041|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
91042|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
91043|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
91044|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
91045|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
91046|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Physician Decision|2
91047|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Physician Decision|1
91048|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Physician Decision|2
91049|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Physician Decision|1
91050|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
91051|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
91052|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
91053|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
91054|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
91055|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
91056|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
91057|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
91058|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
91059|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
91060|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
91061|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
91062|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Noncompliance|6
91063|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Noncompliance|12
91064|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Noncompliance|13
91065|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Noncompliance|9
91066|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Protocol Violation|5
91067|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Protocol Violation|6
91068|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Protocol Violation|6
91069|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Protocol Violation|1
91070|NCT00838903|317085|P4|Treatment Period (156 Weeks)|Adverse Event|25
91071|NCT00838903|317086|P3|Treatment Period (156 Weeks)|Adverse Event|17
91072|NCT00838903|317087|P2|Treatment Period (156 Weeks)|Adverse Event|13
91073|NCT00838903|317088|P1|Treatment Period (156 Weeks)|Adverse Event|5
91074|NCT00838682|317132|P2|Overall Study|Withdrawal by Subject|1
91075|NCT00838682|317133|P1|Overall Study|Withdrawal by Subject|0
91076|NCT00838682|317132|P2|Overall Study|Protocol Violation|1
91077|NCT00838682|317133|P1|Overall Study|Protocol Violation|0
91078|NCT00838682|317132|P2|Overall Study|detection of exclusion criteria|3
91079|NCT00838682|317133|P1|Overall Study|detection of exclusion criteria|4
91080|NCT00838682|317132|P2|Overall Study|Lost to Follow-up|14
91081|NCT00838682|317133|P1|Overall Study|Lost to Follow-up|21
91082|NCT00838630|317151|P2|Washout: 7 Days|Protocol Violation|0
91083|NCT00838630|317152|P1|Washout: 7 Days|Protocol Violation|1
91084|NCT00838630|317151|P2|First Intervention|Adverse Event|0
91085|NCT00838630|317152|P1|First Intervention|Adverse Event|1
91086|NCT00838578|317160|P1|Overall Study|Protocol Violation|2
91087|NCT00838526|317170|P2|Overall Study|Not specified|7
91088|NCT00838526|317171|P1|Overall Study|Not specified|11
91089|NCT00838526|317170|P2|Overall Study|Lack of Efficacy|3
91090|NCT00838526|317171|P1|Overall Study|Lack of Efficacy|2
91091|NCT00838526|317170|P2|Overall Study|Withdrawal by Subject|5
91092|NCT00838526|317171|P1|Overall Study|Withdrawal by Subject|4
91093|NCT00838526|317170|P2|Overall Study|Lost to Follow-up|12
91094|NCT00838526|317171|P1|Overall Study|Lost to Follow-up|4
91095|NCT00838526|317170|P2|Overall Study|Adverse Event|12
91096|NCT00838526|317171|P1|Overall Study|Adverse Event|3
91097|NCT00838513|317179|P1|Post Treatment Period (Patients Who Disc|Death|1
91098|NCT00838513|317179|P1|Extension Treatment Period|Death|1
91099|NCT00838513|317179|P1|Screening Period|Screen Failure|3
91100|NCT00838331|317195|P1|Aged Blood Transfusion|Withdrawal by Subject|9
91101|NCT00838279|317201|P2|Washout|Withdrawal by Subject|1
91102|NCT00838279|317202|P1|Washout|Withdrawal by Subject|0
91103|NCT00838279|317201|P2|Washout|Protocol Violation|0
91104|NCT00838279|317202|P1|Washout|Protocol Violation|1
91105|NCT00838201|317212|P2|Overall Study|Death|13
91106|NCT00838201|317213|P1|Overall Study|Death|11
91107|NCT00838201|317212|P2|Overall Study|Adverse Event|9
91108|NCT00838201|317213|P1|Overall Study|Adverse Event|5
91109|NCT00838201|317212|P2|Overall Study|Lost to Follow-up|3
91110|NCT00838201|317213|P1|Overall Study|Lost to Follow-up|4
91111|NCT00838201|317212|P2|Overall Study|Consetn withdrawn|19
91112|NCT00838201|317213|P1|Overall Study|Consetn withdrawn|16
91113|NCT00838201|317212|P2|Overall Study|Disease progression|3
91114|NCT00838201|317213|P1|Overall Study|Disease progression|3
91115|NCT00838201|317212|P2|Overall Study|Administrative decision|2
91116|NCT00838201|317213|P1|Overall Study|Administrative decision|1
91117|NCT00838201|317212|P2|Overall Study|Noncompliance|1
91118|NCT00838201|317213|P1|Overall Study|Noncompliance|0
91119|NCT00838201|317212|P2|Overall Study|Investigator decision, or other reasons|3
91120|NCT00838201|317213|P1|Overall Study|Investigator decision, or other reasons|2
91121|NCT00838110|317281|P4|Overall Study|Randomized but not treated|0
91122|NCT00838110|317282|P3|Overall Study|Randomized but not treated|0
91123|NCT00838110|317283|P2|Overall Study|Randomized but not treated|1
91124|NCT00838110|317284|P1|Overall Study|Randomized but not treated|0
91125|NCT00838110|317281|P4|Overall Study|Did not meet eligibility criteria|2
91126|NCT00838110|317282|P3|Overall Study|Did not meet eligibility criteria|1
91127|NCT00838110|317283|P2|Overall Study|Did not meet eligibility criteria|0
91128|NCT00838110|317284|P1|Overall Study|Did not meet eligibility criteria|0
91129|NCT00838110|317281|P4|Overall Study|Lost to Follow-up|0
91130|NCT00838110|317282|P3|Overall Study|Lost to Follow-up|0
91131|NCT00838110|317283|P2|Overall Study|Lost to Follow-up|0
91132|NCT00838110|317284|P1|Overall Study|Lost to Follow-up|3
91133|NCT00838110|317281|P4|Overall Study|Protocol Violation|1
91134|NCT00838110|317282|P3|Overall Study|Protocol Violation|1
91135|NCT00838110|317283|P2|Overall Study|Protocol Violation|2
91136|NCT00838110|317284|P1|Overall Study|Protocol Violation|0
91137|NCT00838110|317281|P4|Overall Study|Unspecified|2
91138|NCT00838110|317282|P3|Overall Study|Unspecified|3
91139|NCT00838110|317283|P2|Overall Study|Unspecified|3
91140|NCT00838110|317284|P1|Overall Study|Unspecified|3
91141|NCT00838110|317281|P4|Overall Study|Withdrawal by Subject|4
91142|NCT00838110|317282|P3|Overall Study|Withdrawal by Subject|3
91143|NCT00838110|317283|P2|Overall Study|Withdrawal by Subject|6
91144|NCT00838110|317284|P1|Overall Study|Withdrawal by Subject|5
91145|NCT00838110|317281|P4|Overall Study|Adverse Event|7
91146|NCT00838110|317282|P3|Overall Study|Adverse Event|8
91147|NCT00838110|317283|P2|Overall Study|Adverse Event|10
91148|NCT00838110|317284|P1|Overall Study|Adverse Event|11
91149|NCT00838110|317281|P4|Overall Study|Death|2
91150|NCT00838110|317282|P3|Overall Study|Death|1
91151|NCT00838110|317283|P2|Overall Study|Death|0
91152|NCT00838110|317284|P1|Overall Study|Death|0
91153|NCT00838097|317304|P1|Overall Study|Protocol-specified criteria|142
91154|NCT00838097|317304|P1|Overall Study|Death|6
91155|NCT00838097|317304|P1|Overall Study|Lost to Follow-up|11
91156|NCT00838097|317304|P1|Overall Study|Physician Decision|4
91157|NCT00838097|317304|P1|Overall Study|Requirement for alternative therapy|2
91158|NCT00838097|317304|P1|Overall Study|Withdrawal by Subject|3
91159|NCT00838097|317304|P1|Overall Study|Adverse Event|2
91160|NCT00838097|317304|P1|Overall Study|Ineligibility determined|6
91161|NCT00837967|317312|P2|Washout Period of 7 - 14 Days|Adverse Event|0
91162|NCT00837967|317313|P1|Washout Period of 7 - 14 Days|Adverse Event|2
91163|NCT00837876|317329|P1|Overall Study|disease progression|24
91164|NCT00837876|317329|P1|Overall Study|Withdrawal by Subject|3
91165|NCT00837876|317329|P1|Overall Study|Physician Decision|1
91166|NCT00837876|317329|P1|Overall Study|Adverse Event|7
91167|NCT00837876|317329|P1|Overall Study|Death|2
91168|NCT00837759|317348|P1|Overall Study|Lost to Follow-up|1
91169|NCT00837759|317348|P1|Overall Study|Protocol Violation|3
91170|NCT00837616|317359|P2|Overall Study|Withdrawal by Subject|1
91171|NCT00837616|317360|P1|Overall Study|Withdrawal by Subject|0
91172|NCT00837577|317386|P2|Open-label Period|Other Reason|1
91173|NCT00837577|317387|P1|Open-label Period|Other Reason|1
91174|NCT00837577|317386|P2|Open-label Period|Withdrawal by Subject|2
91175|NCT00837577|317387|P1|Open-label Period|Withdrawal by Subject|1
91176|NCT00837577|317386|P2|Open-label Period|Lack of Efficacy|3
91177|NCT00837577|317387|P1|Open-label Period|Lack of Efficacy|4
91178|NCT00837577|317386|P2|Open-label Period|Laboratory Adverse Event|1
91179|NCT00837577|317387|P1|Open-label Period|Laboratory Adverse Event|0
91180|NCT00837577|317386|P2|Open-label Period|Clinical Adverse Event|2
91181|NCT00837577|317387|P1|Open-label Period|Clinical Adverse Event|2
91182|NCT00837577|317386|P2|Double-blind Period|Withdrawal by Subject|0
91183|NCT00837577|317387|P1|Double-blind Period|Withdrawal by Subject|1
91184|NCT00837577|317386|P2|Double-blind Period|Clinical Adverse Event|0
91185|NCT00837577|317387|P1|Double-blind Period|Clinical Adverse Event|1
91186|NCT00837486|317407|P2|Long-term Follow-up Phase - Open Label|Death|0
91187|NCT00837486|317408|P1|Long-term Follow-up Phase - Open Label|Death|1
91188|NCT00837486|317407|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
91189|NCT00837486|317408|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
91190|NCT00837486|317407|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
91191|NCT00837486|317408|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
91192|NCT00837486|317407|P2|Blinded-treatment Phase|Physician Decision|0
91193|NCT00837486|317408|P1|Blinded-treatment Phase|Physician Decision|1
91194|NCT00837434|317427|P2|Overall Study|Unable to obtain study drug|0
91195|NCT00837434|317428|P1|Overall Study|Unable to obtain study drug|1
91196|NCT00837434|317427|P2|Overall Study|Baseline assessments not done in time|0
91197|NCT00837434|317428|P1|Overall Study|Baseline assessments not done in time|1
91198|NCT00837434|317427|P2|Overall Study|Noncompliant|0
91199|NCT00837434|317428|P1|Overall Study|Noncompliant|2
91200|NCT00837434|317427|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
91201|NCT00837434|317428|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
91202|NCT00837434|317427|P2|Overall Study|Lost to Follow-up|1
91203|NCT00837434|317428|P1|Overall Study|Lost to Follow-up|1
91204|NCT00837434|317427|P2|Overall Study|Physician Decision|0
91205|NCT00837434|317428|P1|Overall Study|Physician Decision|3
91206|NCT00837330|317448|P2|Overall Study|Lost to Follow-up|3
91207|NCT00837330|317449|P1|Overall Study|Lost to Follow-up|1
91208|NCT00837213|317472|P2|Overall Study|not stated|1
91209|NCT00837213|317473|P1|Overall Study|not stated|1
91210|NCT00837213|317472|P2|Overall Study|Withdrawal by Subject|2
91211|NCT00837213|317473|P1|Overall Study|Withdrawal by Subject|2
91212|NCT00837213|317472|P2|Overall Study|Lost to Follow-up|2
91213|NCT00837213|317473|P1|Overall Study|Lost to Follow-up|3
91214|NCT00837161|317499|P1|Overall Study|refused hysterectomy|2
91215|NCT00837148|317507|P1|Overall Study|Death|1
91216|NCT00837148|317507|P1|Overall Study|Adverse Event|1
91217|NCT00836953|317517|P1|Overall Study|Lost to Follow-up|1
91218|NCT00836953|317517|P1|Overall Study|Withdrawal by Subject|1
91219|NCT00836901|317525|P2|First Intervention|Withdrawal by Subject|0
91220|NCT00836901|317526|P1|First Intervention|Withdrawal by Subject|1
91221|NCT00836875|317542|P2|Overall Study|Withdrawal by Subject|1
91222|NCT00836875|317543|P1|Overall Study|Withdrawal by Subject|0
91223|NCT00836875|317542|P2|Overall Study|Death|2
91224|NCT00836875|317543|P1|Overall Study|Death|3
91225|NCT00836745|317557|P1|Overall Study|Unspecified|2
91226|NCT00836745|317557|P1|Overall Study|Objective progression or relapse|4
91227|NCT00836745|317557|P1|Overall Study|Adverse Event|3
91228|NCT00836745|317557|P1|Overall Study|Lost to Follow-up|10
91229|NCT00836745|317557|P1|Overall Study|Death|2
91230|NCT00836706|317571|P2|Washout: 7 Days|Withdrawal by Subject|1
91231|NCT00836706|317572|P1|Washout: 7 Days|Withdrawal by Subject|0
91232|NCT00836693|317582|P2|Overall Study|Lost to Follow-up|0
91233|NCT00836693|317583|P1|Overall Study|Lost to Follow-up|1
91234|NCT00836693|317582|P2|Overall Study|Protocol Violation|0
91235|NCT00836693|317583|P1|Overall Study|Protocol Violation|1
91236|NCT00836693|317582|P2|Overall Study|Withdrawal by Subject|4
91237|NCT00836693|317583|P1|Overall Study|Withdrawal by Subject|9
91238|NCT00836693|317582|P2|Overall Study|Physician Decision|0
91239|NCT00836693|317583|P1|Overall Study|Physician Decision|2
91240|NCT00836693|317582|P2|Overall Study|Sponsor Decision|1
91241|NCT00836693|317583|P1|Overall Study|Sponsor Decision|0
91242|NCT00836693|317582|P2|Overall Study|Adverse Event|1
91243|NCT00836693|317583|P1|Overall Study|Adverse Event|4
91244|NCT00836498|317635|P2|Overall Study|Withdrawal by Subject|1
91245|NCT00836498|317636|P1|Overall Study|Withdrawal by Subject|2
91246|NCT00836498|317635|P2|Overall Study|Lost to Follow-up|0
91247|NCT00836498|317636|P1|Overall Study|Lost to Follow-up|1
91248|NCT00836498|317635|P2|Overall Study|Adverse Event|0
91249|NCT00836498|317636|P1|Overall Study|Adverse Event|1
91250|NCT00836472|317668|P2|Washout|Withdrawal by Subject|1
91251|NCT00836472|317669|P1|Washout|Withdrawal by Subject|1
91252|NCT00836472|317668|P2|Washout|Adverse Event|2
91253|NCT00836472|317669|P1|Washout|Adverse Event|1
91254|NCT00836277|317746|P1|Overall Study|Not evaluable for response|6
91255|NCT00836095|317756|P2|Overall Study|Physician Decision|3
91256|NCT00836095|317757|P1|Overall Study|Physician Decision|0
91257|NCT00836056|317767|P2|First Intervention|Adverse Event|0
91258|NCT00836056|317768|P1|First Intervention|Adverse Event|1
91259|NCT00835991|317797|P2|Washout|Withdrawal by Subject|1
91260|NCT00835991|317798|P1|Washout|Withdrawal by Subject|3
91261|NCT00835991|317797|P2|Washout|Protocol Violation|2
91262|NCT00835991|317798|P1|Washout|Protocol Violation|0
91263|NCT00835991|317797|P2|First Intervention|Adverse Event|1
91264|NCT00835991|317798|P1|First Intervention|Adverse Event|0
91265|NCT00835978|317816|P4|Overall Study|Study ongoing|1
91266|NCT00835978|317817|P3|Overall Study|Study ongoing|54
91267|NCT00835978|317818|P2|Overall Study|Study ongoing|28
91268|NCT00835978|317819|P1|Overall Study|Study ongoing|31
91269|NCT00835978|317816|P4|Overall Study|Withdrawal by Subject|2
91270|NCT00835978|317817|P3|Overall Study|Withdrawal by Subject|0
91271|NCT00835978|317818|P2|Overall Study|Withdrawal by Subject|0
91272|NCT00835978|317819|P1|Overall Study|Withdrawal by Subject|0
91273|NCT00835978|317816|P4|Overall Study|Adverse Event|1
91274|NCT00835978|317817|P3|Overall Study|Adverse Event|0
91275|NCT00835978|317818|P2|Overall Study|Adverse Event|0
91276|NCT00835978|317819|P1|Overall Study|Adverse Event|1
91277|NCT00835978|317816|P4|Overall Study|Objective progression or relapse|0
91278|NCT00835978|317817|P3|Overall Study|Objective progression or relapse|0
91279|NCT00835978|317818|P2|Overall Study|Objective progression or relapse|1
91280|NCT00835978|317819|P1|Overall Study|Objective progression or relapse|1
91281|NCT00835978|317816|P4|Overall Study|Not Specified|2
91282|NCT00835978|317817|P3|Overall Study|Not Specified|4
91283|NCT00835978|317818|P2|Overall Study|Not Specified|3
91284|NCT00835978|317819|P1|Overall Study|Not Specified|0
91285|NCT00835978|317816|P4|Overall Study|Lost to Follow-up|0
91286|NCT00835978|317817|P3|Overall Study|Lost to Follow-up|2
91287|NCT00835978|317818|P2|Overall Study|Lost to Follow-up|4
91288|NCT00835978|317819|P1|Overall Study|Lost to Follow-up|2
91289|NCT00835978|317816|P4|Overall Study|Death|4
91290|NCT00835978|317817|P3|Overall Study|Death|31
91291|NCT00835978|317818|P2|Overall Study|Death|20
91292|NCT00835978|317819|P1|Overall Study|Death|21
91293|NCT00835796|317916|P2|First Intervention|Withdrawal by Subject|1
91294|NCT00835796|317917|P1|First Intervention|Withdrawal by Subject|0
91295|NCT00835731|317927|P2|Overall Study|Physician Decision|1
91296|NCT00835731|317928|P1|Overall Study|Physician Decision|1
91297|NCT00835731|317927|P2|Overall Study|Withdrawal by Subject|0
91298|NCT00835731|317928|P1|Overall Study|Withdrawal by Subject|1
91299|NCT00835705|317944|P2|Second Intervention|Difficulty with vein|0
91300|NCT00835705|317945|P1|Second Intervention|Difficulty with vein|1
91301|NCT00835705|317944|P2|First Intervention|Difficulty with vein|0
91302|NCT00835705|317945|P1|First Intervention|Difficulty with vein|1
91303|NCT00835692|317961|P2|First Intervention|Withdrawal by Subject|0
91304|NCT00835692|317962|P1|First Intervention|Withdrawal by Subject|1
91305|NCT00835679|317974|P4|Overall Study|Withdrawal by Subject|0
91306|NCT00835679|317975|P3|Overall Study|Withdrawal by Subject|0
91307|NCT00835679|317976|P2|Overall Study|Withdrawal by Subject|0
91308|NCT00835679|317977|P1|Overall Study|Withdrawal by Subject|1
91309|NCT00835666|318001|P2|Washout|Withdrawal by Subject|0
91310|NCT00835666|318002|P1|Washout|Withdrawal by Subject|1
91311|NCT00835666|318001|P2|Washout|Protocol Violation|0
91312|NCT00835666|318002|P1|Washout|Protocol Violation|1
91313|NCT00835640|318012|P2|Second Intervention|Protocol Violation|0
91314|NCT00835640|318013|P1|Second Intervention|Protocol Violation|1
91315|NCT00835575|318045|P2|Washout of 14 Days|Withdrawal by Subject|0
91316|NCT00835575|318046|P1|Washout of 14 Days|Withdrawal by Subject|1
91317|NCT00835549|318056|P2|Washout of 7 Days|Withdrawal by Subject|0
91318|NCT00835549|318057|P1|Washout of 7 Days|Withdrawal by Subject|2
91319|NCT00835536|318067|P2|Washout of 5 Weeks|Withdrawal by Subject|0
91320|NCT00835536|318068|P1|Washout of 5 Weeks|Withdrawal by Subject|1
91321|NCT00835406|318129|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
91322|NCT00835406|318130|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
91323|NCT00835406|318129|P2|Period: First Intervention|Withdrawal by Subject|0
91324|NCT00835406|318130|P1|Period: First Intervention|Withdrawal by Subject|2
91325|NCT00835406|318129|P2|Period: First Intervention|Adverse Event|1
91326|NCT00835406|318130|P1|Period: First Intervention|Adverse Event|0
91327|NCT00835380|318136|P1|Overall Study|Withdrawal by Subject|2
91328|NCT00835367|318143|P2|Second Intervention|Adverse Event|1
91329|NCT00835367|318144|P1|Second Intervention|Adverse Event|1
91330|NCT00835367|318143|P2|Washout|Withdrawal by Subject|0
91331|NCT00835367|318144|P1|Washout|Withdrawal by Subject|1
91332|NCT00835367|318143|P2|Washout|Adverse Event|0
91333|NCT00835367|318144|P1|Washout|Adverse Event|2
91334|NCT00835354|318166|P2|First Intervention|Adverse Event|1
91335|NCT00835354|318167|P1|First Intervention|Adverse Event|0
91336|NCT00835341|318177|P2|Overall Study|Lost to Follow-up|12
91337|NCT00835341|318178|P1|Overall Study|Lost to Follow-up|3
91338|NCT00835263|318197|P2|Second Intervention|Adverse Event|0
91339|NCT00835263|318198|P1|Second Intervention|Adverse Event|1
91340|NCT00835237|318208|P2|Overall Study|Withdrawal by Subject|0
91341|NCT00835237|318209|P1|Overall Study|Withdrawal by Subject|2
91342|NCT00835237|318208|P2|Overall Study|Lost to Follow-up|0
91343|NCT00835237|318209|P1|Overall Study|Lost to Follow-up|4
91344|NCT00835211|318249|P2|Washout: 7 Days|Withdrawal by Subject|0
91345|NCT00835211|318250|P1|Washout: 7 Days|Withdrawal by Subject|1
91346|NCT00835211|318249|P2|Washout: 7 Days|Adverse Event|1
91347|NCT00835211|318250|P1|Washout: 7 Days|Adverse Event|2
91348|NCT00835211|318249|P2|First Intervention|Withdrawal by Subject|1
91349|NCT00835211|318250|P1|First Intervention|Withdrawal by Subject|0
91350|NCT00835172|318296|P2|Washout|Protocol Violation|1
91351|NCT00835172|318297|P1|Washout|Protocol Violation|0
91352|NCT00835120|318323|P1|Overall Study|Withdrawal by Subject|2
91353|NCT00835120|318323|P1|Overall Study|Adverse Event|2
91354|NCT00835120|318323|P1|Overall Study|Lost to Follow-up|3
91355|NCT00835120|318323|P1|Overall Study|Lack of Efficacy|1
91356|NCT00835081|318333|P2|Washout of 7 Days|Withdrawal by Subject|0
91357|NCT00835081|318334|P1|Washout of 7 Days|Withdrawal by Subject|1
91358|NCT00835068|318344|P2|Overall Study|Withdrawal by Subject|0
91359|NCT00835068|318345|P1|Overall Study|Withdrawal by Subject|1
91360|NCT00835068|318344|P2|Overall Study|Unspecified|0
91361|NCT00835068|318345|P1|Overall Study|Unspecified|8
91362|NCT00835068|318344|P2|Overall Study|Adverse Event|1
91363|NCT00835068|318345|P1|Overall Study|Adverse Event|0
91364|NCT00835068|318344|P2|Overall Study|Death|0
91365|NCT00835068|318345|P1|Overall Study|Death|1
91366|NCT00835042|318365|P2|Washout of 21 Days|Withdrawal by Subject|2
91367|NCT00835042|318366|P1|Washout of 21 Days|Withdrawal by Subject|0
91368|NCT00835042|318365|P2|First Intervention|Adverse Event|2
91369|NCT00835042|318366|P1|First Intervention|Adverse Event|1
91370|NCT00835042|318365|P2|First Intervention|Withdrawal by Subject|0
91371|NCT00835042|318366|P1|First Intervention|Withdrawal by Subject|3
91372|NCT00834912|318452|P6|Treatment Period 2|Withdrawal by Subject|0
91373|NCT00834912|318453|P5|Treatment Period 2|Withdrawal by Subject|1
91374|NCT00834912|318454|P4|Treatment Period 2|Withdrawal by Subject|0
91375|NCT00834912|318455|P3|Treatment Period 2|Withdrawal by Subject|1
91376|NCT00834912|318456|P2|Treatment Period 2|Withdrawal by Subject|0
91377|NCT00834912|318457|P1|Treatment Period 2|Withdrawal by Subject|0
91378|NCT00834912|318452|P6|Treatment Period 1|Adverse Event|0
91379|NCT00834912|318453|P5|Treatment Period 1|Adverse Event|0
91380|NCT00834912|318454|P4|Treatment Period 1|Adverse Event|1
91381|NCT00834912|318455|P3|Treatment Period 1|Adverse Event|0
91382|NCT00834912|318456|P2|Treatment Period 1|Adverse Event|1
91383|NCT00834912|318457|P1|Treatment Period 1|Adverse Event|0
91384|NCT00834899|318479|P2|Overall Study|Withdrawal by Subject|1
91385|NCT00834899|318480|P1|Overall Study|Withdrawal by Subject|1
91386|NCT00834873|318519|P2|First Intervention|Adverse Event|1
91387|NCT00834873|318520|P1|First Intervention|Adverse Event|0
91388|NCT00834795|318555|P2|Second Intervention|Adverse Event|0
91389|NCT00834795|318556|P1|Second Intervention|Adverse Event|1
91390|NCT00834795|318555|P2|Washout: 7 Days|Withdrawal by Subject|1
91391|NCT00834795|318556|P1|Washout: 7 Days|Withdrawal by Subject|0
91392|NCT00833794|318566|P2|Double-blind Phase|Administrative reason|3
91393|NCT00833794|318567|P1|Double-blind Phase|Administrative reason|1
91394|NCT00833794|318566|P2|Double-blind Phase|Physician Decision|7
91395|NCT00833794|318567|P1|Double-blind Phase|Physician Decision|4
91396|NCT00833794|318566|P2|Double-blind Phase|Withdrawal by Subject|6
91397|NCT00833794|318567|P1|Double-blind Phase|Withdrawal by Subject|23
91398|NCT00833794|318566|P2|Double-blind Phase|Lack of Efficacy|22
91399|NCT00833794|318567|P1|Double-blind Phase|Lack of Efficacy|34
91400|NCT00833794|318566|P2|Double-blind Phase|Adverse Event|11
91401|NCT00833794|318567|P1|Double-blind Phase|Adverse Event|44
91402|NCT00833794|318566|P2|Open-label Phase|enrolled in error (immediately D/C)|0
91403|NCT00833794|318567|P1|Open-label Phase|enrolled in error (immediately D/C)|1
91404|NCT00833794|318566|P2|Open-label Phase|Did not complete wash-out period|0
91405|NCT00833794|318567|P1|Open-label Phase|Did not complete wash-out period|12
91406|NCT00833794|318566|P2|Open-label Phase|Protocol Violation|0
91407|NCT00833794|318567|P1|Open-label Phase|Protocol Violation|47
91408|NCT00833794|318566|P2|Open-label Phase|Administrative reason|0
91409|NCT00833794|318567|P1|Open-label Phase|Administrative reason|1
91410|NCT00833794|318566|P2|Open-label Phase|Physician Decision|0
91411|NCT00833794|318567|P1|Open-label Phase|Physician Decision|20
91412|NCT00833794|318566|P2|Open-label Phase|Withdrawal by Subject|0
91413|NCT00833794|318567|P1|Open-label Phase|Withdrawal by Subject|48
91414|NCT00833794|318566|P2|Open-label Phase|Lack of Efficacy|0
91415|NCT00833794|318567|P1|Open-label Phase|Lack of Efficacy|28
91416|NCT00833794|318566|P2|Open-label Phase|Adverse Event|0
91417|NCT00833794|318567|P1|Open-label Phase|Adverse Event|225
91418|NCT00833755|318611|P4|Overall Study|Subject had scheduling issues|0
91419|NCT00833755|318612|P3|Overall Study|Subject had scheduling issues|0
91420|NCT00833755|318613|P2|Overall Study|Subject had scheduling issues|1
91421|NCT00833755|318614|P1|Overall Study|Subject had scheduling issues|0
91422|NCT00833755|318611|P4|Overall Study|Physician Decision|6
91423|NCT00833755|318612|P3|Overall Study|Physician Decision|2
91424|NCT00833755|318613|P2|Overall Study|Physician Decision|4
91425|NCT00833755|318614|P1|Overall Study|Physician Decision|4
91426|NCT00833703|318634|P2|Overall Study|Parent(s)/guardian(s)'s request|1
91427|NCT00833703|318635|P1|Overall Study|Parent(s)/guardian(s)'s request|0
91428|NCT00833690|318648|P3|Overall Study|Discontinued study drug|0
91429|NCT00833690|318649|P2|Overall Study|Discontinued study drug|2
91430|NCT00833690|318650|P1|Overall Study|Discontinued study drug|3
91431|NCT00833690|318648|P3|Overall Study|Withdrawal by Subject|0
91432|NCT00833690|318649|P2|Overall Study|Withdrawal by Subject|0
91433|NCT00833690|318650|P1|Overall Study|Withdrawal by Subject|1
91434|NCT00833638|318786|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
91435|NCT00833638|318787|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
91436|NCT00833638|318788|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
91437|NCT00833638|318786|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
91438|NCT00833638|318787|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
91439|NCT00833638|318788|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
91440|NCT00833638|318786|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
91441|NCT00833638|318787|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
91442|NCT00833638|318788|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
91443|NCT00833638|318786|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
91527|NCT00833976|319222|P1|Overall Study|Physician Decision|1
91444|NCT00833638|318787|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
91445|NCT00833638|318788|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
91446|NCT00833638|318786|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
91447|NCT00833638|318787|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
91448|NCT00833638|318788|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
91449|NCT00833638|318786|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
91450|NCT00833638|318787|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
91451|NCT00833638|318788|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
91452|NCT00833638|318786|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
91453|NCT00833638|318787|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
91454|NCT00833638|318788|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
91455|NCT00833638|318786|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
91456|NCT00833638|318787|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
91457|NCT00833638|318788|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
91458|NCT00833638|318786|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
91459|NCT00833638|318787|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
91460|NCT00833638|318788|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
91461|NCT00833560|318839|P1|Overall Study|Not specified|5
91462|NCT00833560|318839|P1|Overall Study|Pregression of other disease|1
91463|NCT00833560|318839|P1|Overall Study|Death|2
91464|NCT00833560|318839|P1|Overall Study|Lack of Efficacy|4
91465|NCT00833560|318839|P1|Overall Study|Protocol Violation|6
91466|NCT00833560|318839|P1|Overall Study|Adverse Event|11
91467|NCT00833560|318839|P1|Overall Study|Toxicity|13
91468|NCT00833547|318848|P2|Overall Study|Withdrawal by Subject|2
91469|NCT00833547|318849|P1|Overall Study|Withdrawal by Subject|2
91470|NCT00834756|318859|P2|Washout: 21 Days|Withdrawal by Subject|0
91471|NCT00834756|318860|P1|Washout: 21 Days|Withdrawal by Subject|1
91472|NCT00834756|318859|P2|First Intervention|Adverse Event|0
91473|NCT00834756|318860|P1|First Intervention|Adverse Event|1
91474|NCT00834743|318870|P2|Second Intervention|Withdrawal by Subject|0
91475|NCT00834743|318871|P1|Second Intervention|Withdrawal by Subject|1
91476|NCT00834717|318881|P2|First Intervention|Withdrawal by Subject|1
91477|NCT00834717|318882|P1|First Intervention|Withdrawal by Subject|0
91478|NCT00834717|318881|P2|First Intervention|Adverse Event|0
91479|NCT00834717|318882|P1|First Intervention|Adverse Event|1
91480|NCT00834639|318903|P2|Second Intervention|Physician Decision|2
91481|NCT00834639|318904|P1|Second Intervention|Physician Decision|0
91482|NCT00834613|318921|P2|First Intervention|Protocol Violation|0
91483|NCT00834613|318922|P1|First Intervention|Protocol Violation|1
91484|NCT00834587|318932|P2|Washout: 7 Days|Withdrawal by Subject|0
91485|NCT00834587|318933|P1|Washout: 7 Days|Withdrawal by Subject|1
91486|NCT00834522|318982|P2|Washout|Withdrawal by Subject|1
91487|NCT00834522|318983|P1|Washout|Withdrawal by Subject|2
91488|NCT00834522|318982|P2|Washout|Adverse Event|0
91489|NCT00834522|318983|P1|Washout|Adverse Event|1
91490|NCT00834444|319006|P2|Second Intervention|Adverse Event|0
91491|NCT00834444|319007|P1|Second Intervention|Adverse Event|1
91492|NCT00834444|319006|P2|Washout of 7 Days|Withdrawal by Subject|1
91493|NCT00834444|319007|P1|Washout of 7 Days|Withdrawal by Subject|0
91494|NCT00834444|319006|P2|First Intervention|Intolerance to Venopuncture|1
91495|NCT00834444|319007|P1|First Intervention|Intolerance to Venopuncture|0
91496|NCT00834444|319006|P2|First Intervention|Adverse Event|0
91497|NCT00834444|319007|P1|First Intervention|Adverse Event|1
91498|NCT00834431|319017|P2|Washout of 7 Days|Withdrawal by Subject|1
91499|NCT00834431|319018|P1|Washout of 7 Days|Withdrawal by Subject|0
91500|NCT00834431|319017|P2|First Intervention|Adverse Event|1
91501|NCT00834431|319018|P1|First Intervention|Adverse Event|0
91502|NCT00834418|319028|P2|Overall Study|Adverse Event|2
91503|NCT00834418|319029|P1|Overall Study|Adverse Event|0
91504|NCT00834366|319046|P2|Treatment Period 1|Adverse Event|1
91505|NCT00834366|319047|P1|Treatment Period 1|Adverse Event|1
91506|NCT00834340|319063|P2|Washout|Withdrawal by Subject|0
91507|NCT00834340|319064|P1|Washout|Withdrawal by Subject|1
91508|NCT00834340|319063|P2|Washout|Adverse Event|0
91509|NCT00834340|319064|P1|Washout|Adverse Event|1
91510|NCT00834249|319108|P2|Second Intervention|Adverse Event|0
91511|NCT00834249|319109|P1|Second Intervention|Adverse Event|1
91512|NCT00834249|319108|P2|Washout: 7 Days|Withdrawal by Subject|1
91513|NCT00834249|319109|P1|Washout: 7 Days|Withdrawal by Subject|1
91514|NCT00834080|319178|P1|Overall Study|Subject Relocated|1
91515|NCT00834080|319178|P1|Overall Study|Physician Decision|1
91516|NCT00834080|319178|P1|Overall Study|Other - False positive tests of the UDS|1
91517|NCT00834080|319178|P1|Overall Study|Other - Pregnancy|1
91518|NCT00834080|319178|P1|Overall Study|Withdrawal by Subject|5
91519|NCT00834080|319178|P1|Overall Study|Lost to Follow-up|7
91520|NCT00834080|319178|P1|Overall Study|Adverse Event|7
91521|NCT00834067|319184|P2|Washout of 21 Days|Protocol Violation|1
91522|NCT00834067|319185|P1|Washout of 21 Days|Protocol Violation|0
91523|NCT00834041|319207|P2|Overall Study|Lost to Follow-up|1
91524|NCT00834041|319208|P1|Overall Study|Lost to Follow-up|0
91525|NCT00834041|319207|P2|Overall Study|Withdrawal by Subject|0
91526|NCT00834041|319208|P1|Overall Study|Withdrawal by Subject|1
91528|NCT00833976|319222|P1|Overall Study|Did not meet eligibility criteria|41
91529|NCT00833976|319222|P1|Overall Study|Lost to Follow-up|4
91530|NCT00833976|319222|P1|Overall Study|Withdrawal by Subject|5
91531|NCT00833937|319228|P2|Washout|Withdrawal by Subject|0
91532|NCT00833937|319229|P1|Washout|Withdrawal by Subject|1
91533|NCT00833924|319237|P1|Overall Study|In study follow-up|71
91534|NCT00833924|319237|P1|Overall Study|Withdrawal by Subject|13
91535|NCT00833924|319237|P1|Overall Study|Lost to Follow-up|2
91536|NCT00833924|319237|P1|Overall Study|Conversion|2
91537|NCT00833924|319237|P1|Overall Study|Death|21
91538|NCT00833911|319242|P1|Maintenance Phase II|Lack of Efficacy|1
91539|NCT00833911|319242|P1|Maintenance Phase II|Withdrawal by Subject|1
91540|NCT00833911|319242|P1|Maintenance Phase II|Physician Decision|2
91541|NCT00833911|319242|P1|Maintenance Phase II|Adverse Event|6
91542|NCT00833911|319242|P1|Maintenance Phase I|Lack of Efficacy|4
91543|NCT00833911|319242|P1|Maintenance Phase I|Physician Decision|10
91544|NCT00833911|319242|P1|Maintenance Phase I|Withdrawal by Subject|11
91545|NCT00833911|319242|P1|Maintenance Phase I|Adverse Event|73
91546|NCT00833911|319242|P1|Titration|Withdrawal by Subject|3
91547|NCT00833911|319242|P1|Titration|Adverse Event|18
91548|NCT00833898|319252|P2|Overall Study|Patient did not receive transplant|2
91549|NCT00833898|319253|P1|Overall Study|Patient did not receive transplant|0
91550|NCT00833898|319252|P2|Overall Study|Lost to Follow-up|7
91551|NCT00833898|319253|P1|Overall Study|Lost to Follow-up|7
91552|NCT00833898|319252|P2|Overall Study|Withdrawal by Subject|27
91553|NCT00833898|319253|P1|Overall Study|Withdrawal by Subject|33
91554|NCT00833833|319309|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
91555|NCT00833833|319310|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
91556|NCT00833833|319311|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
91557|NCT00833833|319312|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
91558|NCT00833833|319313|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
91559|NCT00833833|319314|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
91560|NCT00833833|319309|P6|Phase 2 (as of 01 April 2011)|Unspecified|3
91561|NCT00833833|319310|P5|Phase 2 (as of 01 April 2011)|Unspecified|4
91562|NCT00833833|319311|P4|Phase 2 (as of 01 April 2011)|Unspecified|0
91563|NCT00833833|319312|P3|Phase 2 (as of 01 April 2011)|Unspecified|0
91564|NCT00833833|319313|P2|Phase 2 (as of 01 April 2011)|Unspecified|0
91565|NCT00833833|319314|P1|Phase 2 (as of 01 April 2011)|Unspecified|0
91566|NCT00833833|319309|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
91567|NCT00833833|319310|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
91568|NCT00833833|319311|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
91569|NCT00833833|319312|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
91570|NCT00833833|319313|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
91571|NCT00833833|319314|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
91572|NCT00833833|319309|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
91573|NCT00833833|319310|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
91574|NCT00833833|319311|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
91575|NCT00833833|319312|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
91576|NCT00833833|319313|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
91577|NCT00833833|319314|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
91578|NCT00833833|319309|P6|Phase 2 (as of 01 April 2011)|Death|9
91579|NCT00833833|319310|P5|Phase 2 (as of 01 April 2011)|Death|8
91580|NCT00833833|319311|P4|Phase 2 (as of 01 April 2011)|Death|0
91581|NCT00833833|319312|P3|Phase 2 (as of 01 April 2011)|Death|0
91582|NCT00833833|319313|P2|Phase 2 (as of 01 April 2011)|Death|0
91583|NCT00833833|319314|P1|Phase 2 (as of 01 April 2011)|Death|0
91584|NCT00833833|319309|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
91585|NCT00833833|319310|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
91586|NCT00833833|319311|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
91587|NCT00833833|319312|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
91588|NCT00833833|319313|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
91589|NCT00833833|319314|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
91590|NCT00833833|319309|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
91591|NCT00833833|319310|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
91592|NCT00833833|319311|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
91593|NCT00833833|319312|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
91594|NCT00833833|319313|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
91595|NCT00833833|319314|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
91596|NCT00833833|319309|P6|Phase 1 (as of 01 April 2011)|Unspecified|0
91597|NCT00833833|319310|P5|Phase 1 (as of 01 April 2011)|Unspecified|0
91598|NCT00833833|319311|P4|Phase 1 (as of 01 April 2011)|Unspecified|1
91599|NCT00833833|319312|P3|Phase 1 (as of 01 April 2011)|Unspecified|0
91600|NCT00833833|319313|P2|Phase 1 (as of 01 April 2011)|Unspecified|3
91601|NCT00833833|319314|P1|Phase 1 (as of 01 April 2011)|Unspecified|1
91602|NCT00833833|319309|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
91603|NCT00833833|319310|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
91604|NCT00833833|319311|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
91605|NCT00833833|319312|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
91606|NCT00833833|319313|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
91607|NCT00833833|319314|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
91608|NCT00833833|319309|P6|Phase 1 (as of 01 April 2011)|Death|0
91609|NCT00833833|319310|P5|Phase 1 (as of 01 April 2011)|Death|0
91610|NCT00833833|319311|P4|Phase 1 (as of 01 April 2011)|Death|0
91611|NCT00833833|319312|P3|Phase 1 (as of 01 April 2011)|Death|2
91612|NCT00833833|319313|P2|Phase 1 (as of 01 April 2011)|Death|1
91613|NCT00833833|319314|P1|Phase 1 (as of 01 April 2011)|Death|0
91614|NCT00833833|319309|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
91615|NCT00833833|319310|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
91616|NCT00833833|319311|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
91617|NCT00833833|319312|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
91618|NCT00833833|319313|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
91619|NCT00833833|319314|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
91620|NCT00833833|319309|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
91621|NCT00833833|319310|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
91622|NCT00833833|319311|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
91623|NCT00833833|319312|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
91624|NCT00833833|319313|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
91625|NCT00833833|319314|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
91626|NCT00833833|319309|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
91627|NCT00833833|319310|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
91628|NCT00833833|319311|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
91629|NCT00833833|319312|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
91630|NCT00833833|319313|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
91631|NCT00833833|319314|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
91632|NCT00833482|319365|P6|Days 21-30|Withdrawal by Subject|0
91633|NCT00833482|319366|P5|Days 21-30|Withdrawal by Subject|1
91634|NCT00833482|319367|P4|Days 21-30|Withdrawal by Subject|0
91635|NCT00833482|319368|P3|Days 21-30|Withdrawal by Subject|0
91636|NCT00833482|319369|P2|Days 21-30|Withdrawal by Subject|0
91637|NCT00833482|319370|P1|Days 21-30|Withdrawal by Subject|0
91638|NCT00833482|319365|P6|Days 21-30|Adverse Event|0
91639|NCT00833482|319366|P5|Days 21-30|Adverse Event|0
91640|NCT00833482|319367|P4|Days 21-30|Adverse Event|0
91641|NCT00833482|319368|P3|Days 21-30|Adverse Event|1
91642|NCT00833482|319369|P2|Days 21-30|Adverse Event|0
91643|NCT00833482|319370|P1|Days 21-30|Adverse Event|0
91644|NCT00833482|319365|P6|Days 11-20|Withdrawal by Subject|0
91645|NCT00833482|319366|P5|Days 11-20|Withdrawal by Subject|0
91646|NCT00833482|319367|P4|Days 11-20|Withdrawal by Subject|0
91647|NCT00833482|319368|P3|Days 11-20|Withdrawal by Subject|0
91648|NCT00833482|319369|P2|Days 11-20|Withdrawal by Subject|1
91649|NCT00833482|319370|P1|Days 11-20|Withdrawal by Subject|0
91650|NCT00833482|319365|P6|Days 11-20|Adverse Event|0
91651|NCT00833482|319366|P5|Days 11-20|Adverse Event|0
91652|NCT00833482|319367|P4|Days 11-20|Adverse Event|0
91653|NCT00833482|319368|P3|Days 11-20|Adverse Event|0
91654|NCT00833482|319369|P2|Days 11-20|Adverse Event|2
91655|NCT00833482|319370|P1|Days 11-20|Adverse Event|0
91656|NCT00833469|319426|P1|Overall Study|Lost to Follow-up|1
91657|NCT00833469|319426|P1|Overall Study|Withdrawal by Subject|1
91658|NCT00833417|319449|P2|Overall Study|Reason Not Specified|1
91659|NCT00833417|319450|P1|Overall Study|Reason Not Specified|0
91660|NCT00833417|319449|P2|Overall Study|Disease Progression|17
91661|NCT00833417|319450|P1|Overall Study|Disease Progression|18
91662|NCT00833417|319449|P2|Overall Study|Sponsor Decision to Terminate Study|2
91663|NCT00833417|319450|P1|Overall Study|Sponsor Decision to Terminate Study|1
91664|NCT00833417|319449|P2|Overall Study|Patient Decision to Withdraw|23
91665|NCT00833417|319450|P1|Overall Study|Patient Decision to Withdraw|4
91666|NCT00833417|319449|P2|Overall Study|Physician Decision to Withdraw Patient|7
91667|NCT00833417|319450|P1|Overall Study|Physician Decision to Withdraw Patient|3
91668|NCT00833417|319449|P2|Overall Study|Lost to Follow-up|2
91669|NCT00833417|319450|P1|Overall Study|Lost to Follow-up|1
91670|NCT00833417|319449|P2|Overall Study|Death|3
91671|NCT00833417|319450|P1|Overall Study|Death|1
91672|NCT00833417|319449|P2|Overall Study|Adverse Event|16
91673|NCT00833417|319450|P1|Overall Study|Adverse Event|5
91674|NCT00833248|319476|P2|Overall Study|Withdrawal by Subject|1
91675|NCT00833248|319477|P1|Overall Study|Withdrawal by Subject|0
91676|NCT00833248|319476|P2|Overall Study|Protocol Violation|2
91677|NCT00833248|319477|P1|Overall Study|Protocol Violation|1
91678|NCT00833248|319476|P2|Overall Study|Adverse Event|0
91679|NCT00833248|319477|P1|Overall Study|Adverse Event|3
91680|NCT00833092|319501|P2|Overall Study|constipation|1
91681|NCT00833092|319502|P1|Overall Study|constipation|0
91682|NCT00833092|319501|P2|Overall Study|Diarrhea|2
91683|NCT00833092|319502|P1|Overall Study|Diarrhea|0
91684|NCT00833092|319501|P2|Overall Study|Protocol Violation|1
91685|NCT00833092|319502|P1|Overall Study|Protocol Violation|2
91686|NCT00833092|319501|P2|Overall Study|Withdrawal by Subject|3
91687|NCT00833092|319502|P1|Overall Study|Withdrawal by Subject|2
91688|NCT00833053|319510|P2|Overall Study|Protocol Violation|1
91689|NCT00833053|319511|P1|Overall Study|Protocol Violation|2
91690|NCT00833053|319510|P2|Overall Study|Withdrawal by Subject|1
91691|NCT00833053|319511|P1|Overall Study|Withdrawal by Subject|0
91692|NCT00833053|319510|P2|Overall Study|Treatment Failure|1
91693|NCT00833053|319511|P1|Overall Study|Treatment Failure|3
91694|NCT00833053|319510|P2|Overall Study|Adverse Event|0
91695|NCT00833053|319511|P1|Overall Study|Adverse Event|4
91696|NCT00833040|319529|P6|Overall Study|Adverse Event|1
91697|NCT00833040|319530|P5|Overall Study|Adverse Event|0
91698|NCT00833040|319531|P4|Overall Study|Adverse Event|0
91699|NCT00833040|319532|P3|Overall Study|Adverse Event|0
91700|NCT00833040|319533|P2|Overall Study|Adverse Event|0
91701|NCT00833040|319534|P1|Overall Study|Adverse Event|0
91702|NCT00833027|319539|P1|Overall Study|Missing|10
91703|NCT00833027|319539|P1|Overall Study|Withdrawal by Subject|16
91704|NCT00833027|319539|P1|Overall Study|Protocol Violation|115
91705|NCT00833027|319539|P1|Overall Study|Lost to Follow-up|24
91706|NCT00833027|319539|P1|Overall Study|Lack of Efficacy|12
91707|NCT00833027|319539|P1|Overall Study|Death|1
91708|NCT00833027|319539|P1|Overall Study|Adverse Event|33
91709|NCT00832975|319544|P1|Overall Study|Other reasons|14
91710|NCT00832975|319544|P1|Overall Study|Withdrawal by Subject|3
91711|NCT00832975|319544|P1|Overall Study|Physician Decision|4
91712|NCT00832975|319544|P1|Overall Study|Death|5
91713|NCT00832975|319544|P1|Overall Study|Protocol Violation|6
91714|NCT00832975|319544|P1|Overall Study|Lost to Follow-up|7
91715|NCT00832819|319558|P3|Overall Study|Protocol Violation|1
91716|NCT00832819|319559|P2|Overall Study|Protocol Violation|0
91717|NCT00832819|319560|P1|Overall Study|Protocol Violation|0
91718|NCT00832819|319558|P3|Overall Study|Adverse Event|0
91719|NCT00832819|319559|P2|Overall Study|Adverse Event|1
91720|NCT00832819|319560|P1|Overall Study|Adverse Event|0
91721|NCT00832650|319569|P3|Overall Study|Randomized but not treated|1
91722|NCT00832650|319570|P2|Overall Study|Randomized but not treated|0
91723|NCT00832650|319571|P1|Overall Study|Randomized but not treated|0
91724|NCT00832624|319611|P1|Overall Study|Study Terminated|10
91725|NCT00832585|319615|P1|Overall Study|Lost to Follow-up|1
91726|NCT00832585|319615|P1|Overall Study|Withdrawal by Subject|1
91727|NCT00832455|319639|P1|Overall Study|Patient moved|1
91728|NCT00832455|319639|P1|Overall Study|No improvement|3
91729|NCT00832455|319639|P1|Overall Study|Parent dissatisfied|1
91730|NCT00832455|319639|P1|Overall Study|Parent misunderstood study|1
91731|NCT00832455|319639|P1|Overall Study|Stopped Medication|4
91732|NCT00832455|319639|P1|Overall Study|Screening Failure|2
91733|NCT00832455|319639|P1|Overall Study|Withdrawal by Subject|17
91734|NCT00832455|319639|P1|Overall Study|Protocol Violation|4
91735|NCT00832455|319639|P1|Overall Study|Lost to Follow-up|26
91736|NCT00832455|319639|P1|Overall Study|Adverse Event|13
91737|NCT00832416|319663|P4|Overall Study|Death|0
91738|NCT00832416|319664|P3|Overall Study|Death|0
91739|NCT00832416|319665|P2|Overall Study|Death|0
91740|NCT00832416|319666|P1|Overall Study|Death|1
91741|NCT00832416|319663|P4|Overall Study|Adverse Event|10
91742|NCT00832416|319664|P3|Overall Study|Adverse Event|41
91743|NCT00832416|319665|P2|Overall Study|Adverse Event|19
91744|NCT00832416|319666|P1|Overall Study|Adverse Event|21
91745|NCT00832416|319663|P4|Overall Study|Administrative|1
91746|NCT00832416|319664|P3|Overall Study|Administrative|0
91747|NCT00832416|319665|P2|Overall Study|Administrative|0
91748|NCT00832416|319666|P1|Overall Study|Administrative|0
91749|NCT00832416|319663|P4|Overall Study|Physician Decision|10
91750|NCT00832416|319664|P3|Overall Study|Physician Decision|5
91751|NCT00832416|319665|P2|Overall Study|Physician Decision|12
91752|NCT00832416|319666|P1|Overall Study|Physician Decision|2
91753|NCT00832416|319663|P4|Overall Study|Withdrawal by Subject|10
91754|NCT00832416|319664|P3|Overall Study|Withdrawal by Subject|2
91755|NCT00832416|319665|P2|Overall Study|Withdrawal by Subject|7
91756|NCT00832416|319666|P1|Overall Study|Withdrawal by Subject|5
91757|NCT00832416|319663|P4|Overall Study|Lack of Efficacy|52
91758|NCT00832416|319664|P3|Overall Study|Lack of Efficacy|13
91759|NCT00832416|319665|P2|Overall Study|Lack of Efficacy|15
91760|NCT00832416|319666|P1|Overall Study|Lack of Efficacy|17
91761|NCT00832377|319717|P1|Overall Study|Protocol Violation|1
91762|NCT00832117|319758|P1|Overall Study|Disease Progression|11
91763|NCT00832117|319758|P1|Overall Study|Death|1
91764|NCT00832091|319777|P2|Overall Study|Prohibited Medication|0
91765|NCT00832091|319778|P1|Overall Study|Prohibited Medication|1
91766|NCT00832091|319777|P2|Overall Study|Withdrawal by Subject|1
91767|NCT00832091|319778|P1|Overall Study|Withdrawal by Subject|2
91768|NCT00832091|319777|P2|Overall Study|Protocol Violation|0
91769|NCT00832091|319778|P1|Overall Study|Protocol Violation|1
91770|NCT00832091|319777|P2|Overall Study|Adverse Event|1
91771|NCT00832091|319778|P1|Overall Study|Adverse Event|1
91772|NCT00832078|319786|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
91773|NCT00832078|319787|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
91774|NCT00832078|319786|P2|Test Day 1-2 Period|Lack of Efficacy|2
91775|NCT00832078|319787|P1|Test Day 1-2 Period|Lack of Efficacy|0
91776|NCT00832000|319793|P2|Overall Study|No calls to IVR in period 2|0
91777|NCT00832000|319794|P1|Overall Study|No calls to IVR in period 2|2
91778|NCT00832000|319793|P2|Overall Study|No calls to IVR in either period|1
91779|NCT00832000|319794|P1|Overall Study|No calls to IVR in either period|1
91780|NCT00832000|319793|P2|Overall Study|Withdrawal by Subject|0
91781|NCT00832000|319794|P1|Overall Study|Withdrawal by Subject|1
91782|NCT00832000|319793|P2|Overall Study|Adverse Event|0
91783|NCT00832000|319794|P1|Overall Study|Adverse Event|2
91784|NCT00831844|319855|P10|Overall Study|Ineligible|0
91785|NCT00831844|319856|P9|Overall Study|Ineligible|0
91786|NCT00831844|319857|P8|Overall Study|Ineligible|0
91787|NCT00831844|319858|P7|Overall Study|Ineligible|0
91788|NCT00831844|319859|P6|Overall Study|Ineligible|0
91789|NCT00831844|319860|P5|Overall Study|Ineligible|1
91790|NCT00831844|319861|P4|Overall Study|Ineligible|0
91791|NCT00831844|319862|P3|Overall Study|Ineligible|1
91792|NCT00831844|319863|P2|Overall Study|Ineligible|1
91793|NCT00831844|319864|P1|Overall Study|Ineligible|0
91794|NCT00831844|319855|P10|Overall Study|Withdrawal by Subject|0
91795|NCT00831844|319856|P9|Overall Study|Withdrawal by Subject|1
91796|NCT00831844|319857|P8|Overall Study|Withdrawal by Subject|1
91797|NCT00831844|319858|P7|Overall Study|Withdrawal by Subject|0
91798|NCT00831844|319859|P6|Overall Study|Withdrawal by Subject|0
91799|NCT00831844|319860|P5|Overall Study|Withdrawal by Subject|0
91800|NCT00831844|319861|P4|Overall Study|Withdrawal by Subject|0
91801|NCT00831844|319862|P3|Overall Study|Withdrawal by Subject|1
91802|NCT00831844|319863|P2|Overall Study|Withdrawal by Subject|0
91803|NCT00831844|319864|P1|Overall Study|Withdrawal by Subject|0
91804|NCT00831844|319855|P10|Overall Study|Physician Decision|0
91805|NCT00831844|319856|P9|Overall Study|Physician Decision|1
91806|NCT00831844|319857|P8|Overall Study|Physician Decision|0
91807|NCT00831844|319858|P7|Overall Study|Physician Decision|0
91808|NCT00831844|319859|P6|Overall Study|Physician Decision|1
91809|NCT00831844|319860|P5|Overall Study|Physician Decision|1
91810|NCT00831844|319861|P4|Overall Study|Physician Decision|1
91811|NCT00831844|319862|P3|Overall Study|Physician Decision|3
91812|NCT00831844|319863|P2|Overall Study|Physician Decision|1
91813|NCT00831844|319864|P1|Overall Study|Physician Decision|0
91814|NCT00831844|319855|P10|Overall Study|Lack of Efficacy|0
91815|NCT00831844|319856|P9|Overall Study|Lack of Efficacy|7
91816|NCT00831844|319857|P8|Overall Study|Lack of Efficacy|9
91817|NCT00831844|319858|P7|Overall Study|Lack of Efficacy|8
91818|NCT00831844|319859|P6|Overall Study|Lack of Efficacy|17
91819|NCT00831844|319860|P5|Overall Study|Lack of Efficacy|11
91820|NCT00831844|319861|P4|Overall Study|Lack of Efficacy|8
91821|NCT00831844|319862|P3|Overall Study|Lack of Efficacy|15
91822|NCT00831844|319863|P2|Overall Study|Lack of Efficacy|10
91823|NCT00831844|319864|P1|Overall Study|Lack of Efficacy|8
91824|NCT00831844|319855|P10|Overall Study|Death|0
91825|NCT00831844|319856|P9|Overall Study|Death|0
91826|NCT00831844|319857|P8|Overall Study|Death|0
91827|NCT00831844|319858|P7|Overall Study|Death|0
91828|NCT00831844|319859|P6|Overall Study|Death|0
91829|NCT00831844|319860|P5|Overall Study|Death|0
91830|NCT00831844|319861|P4|Overall Study|Death|1
91831|NCT00831844|319862|P3|Overall Study|Death|0
91832|NCT00831844|319863|P2|Overall Study|Death|0
91833|NCT00831844|319864|P1|Overall Study|Death|0
91834|NCT00831844|319855|P10|Overall Study|Adverse Event|0
91835|NCT00831844|319856|P9|Overall Study|Adverse Event|0
91836|NCT00831844|319857|P8|Overall Study|Adverse Event|0
91837|NCT00831844|319858|P7|Overall Study|Adverse Event|2
91838|NCT00831844|319859|P6|Overall Study|Adverse Event|1
91839|NCT00831844|319860|P5|Overall Study|Adverse Event|1
91840|NCT00831844|319861|P4|Overall Study|Adverse Event|0
91841|NCT00831844|319862|P3|Overall Study|Adverse Event|0
91842|NCT00831844|319863|P2|Overall Study|Adverse Event|0
91843|NCT00831844|319864|P1|Overall Study|Adverse Event|2
91844|NCT00831701|319912|P2|Overall Study|Lost to Follow-up|3
91845|NCT00831701|319913|P1|Overall Study|Lost to Follow-up|1
91846|NCT00831701|319912|P2|Overall Study|Stone expulsion before first medication|2
91847|NCT00831701|319913|P1|Overall Study|Stone expulsion before first medication|2
91848|NCT00831701|319912|P2|Overall Study|Withdrawal by Subject|0
91849|NCT00831701|319913|P1|Overall Study|Withdrawal by Subject|2
91850|NCT00831493|319942|P1|Overall Study|Intractable nausea and vomiting|1
91851|NCT00831441|319952|P2|Follow Up (30 Days)|missing end of study status|1
91852|NCT00831441|319953|P1|Follow Up (30 Days)|missing end of study status|0
91853|NCT00831441|319952|P2|Follow Up (30 Days)|non-specified|26
91854|NCT00831441|319953|P1|Follow Up (30 Days)|non-specified|16
91855|NCT00831441|319952|P2|Follow Up (30 Days)|Death|86
91856|NCT00831441|319953|P1|Follow Up (30 Days)|Death|63
91857|NCT00831441|319952|P2|Follow Up (30 Days)|Lost to Follow-up|27
91858|NCT00831441|319953|P1|Follow Up (30 Days)|Lost to Follow-up|13
91859|NCT00831441|319952|P2|Follow Up (30 Days)|Withdrawal by Subject|34
91860|NCT00831441|319953|P1|Follow Up (30 Days)|Withdrawal by Subject|41
91861|NCT00831441|319952|P2|Randomized|non-specified|266
91862|NCT00831441|319953|P1|Randomized|non-specified|276
91863|NCT00831441|319952|P2|Randomized|poor/non-compliance|38
91864|NCT00831441|319953|P1|Randomized|poor/non-compliance|30
91865|NCT00831441|319952|P2|Randomized|Administrative reason by sponsor|2671
91866|NCT00831441|319953|P1|Randomized|Administrative reason by sponsor|2780
91867|NCT00831441|319952|P2|Randomized|Lost to Follow-up|35
91868|NCT00831441|319953|P1|Randomized|Lost to Follow-up|26
91869|NCT00831441|319952|P2|Randomized|Withdrawal by Subject|212
91870|NCT00831441|319953|P1|Randomized|Withdrawal by Subject|178
91871|NCT00831441|319952|P2|Randomized|No longer met criteria|19
91872|NCT00831441|319953|P1|Randomized|No longer met criteria|13
91873|NCT00831441|319952|P2|Randomized|Physician Decision|35
91874|NCT00831441|319953|P1|Randomized|Physician Decision|26
91875|NCT00831441|319952|P2|Randomized|Elective procedure|25
91876|NCT00831441|319953|P1|Randomized|Elective procedure|26
91877|NCT00831441|319952|P2|Randomized|Emergency procedure|2
91878|NCT00831441|319953|P1|Randomized|Emergency procedure|2
91879|NCT00831441|319952|P2|Randomized|Adverse Event|321
91880|NCT00831441|319953|P1|Randomized|Adverse Event|248
91881|NCT00831441|319952|P2|Randomized|Death|81
91882|NCT00831441|319953|P1|Randomized|Death|82
91883|NCT00831415|319985|P1|Overall Study|Death|1
91884|NCT00831415|319985|P1|Overall Study|Unsatisfactory response - Efficacy|4
91885|NCT00831415|319985|P1|Overall Study|Withdrawal by Subject|35
91886|NCT00831415|319985|P1|Overall Study|Protocol Violation|3
91887|NCT00831415|319985|P1|Overall Study|Lost to Follow-up|9
91888|NCT00831415|319985|P1|Overall Study|Physician Decision|6
91889|NCT00831415|319985|P1|Overall Study|Failed to return|3
91890|NCT00831415|319985|P1|Overall Study|Adverse Event|14
91891|NCT00831389|319992|P1|Overall Study|Withdrawal by Subject|1
91892|NCT00831311|320018|P2|Overall Study|Withdrawal by Subject|4
91893|NCT00831311|320019|P1|Overall Study|Withdrawal by Subject|6
91894|NCT00831311|320018|P2|Overall Study|Physician Decision|1
91895|NCT00831311|320019|P1|Overall Study|Physician Decision|0
91896|NCT00831311|320018|P2|Overall Study|Lost to Follow-up|0
91897|NCT00831311|320019|P1|Overall Study|Lost to Follow-up|3
91898|NCT00831311|320018|P2|Overall Study|Definitive Contraindication|3
91899|NCT00831311|320019|P1|Overall Study|Definitive Contraindication|3
91900|NCT00831233|320039|P2|Overall Study|Selection Criteria Not Met|0
91901|NCT00831233|320040|P1|Overall Study|Selection Criteria Not Met|2
91902|NCT00831233|320039|P2|Overall Study|Protocol Violation|0
91903|NCT00831233|320040|P1|Overall Study|Protocol Violation|1
91904|NCT00831233|320039|P2|Overall Study|Adverse Event|1
91905|NCT00831233|320040|P1|Overall Study|Adverse Event|0
91906|NCT00831129|320066|P2|Overall Study|9 lost to follow-up reasons uknown|9
91907|NCT00831129|320067|P1|Overall Study|9 lost to follow-up reasons uknown|0
91908|NCT00831129|320066|P2|Overall Study|Adverse Event|1
91909|NCT00831129|320067|P1|Overall Study|Adverse Event|0
91910|NCT00830960|320109|P6|Overall Study|No study drug received|7
91911|NCT00830960|320110|P5|Overall Study|No study drug received|5
91912|NCT00830960|320111|P4|Overall Study|No study drug received|3
91913|NCT00830960|320112|P3|Overall Study|No study drug received|4
91914|NCT00830960|320113|P2|Overall Study|No study drug received|2
91915|NCT00830960|320114|P1|Overall Study|No study drug received|7
91916|NCT00830960|320109|P6|Overall Study|Sponsor Decision|7
91917|NCT00830960|320110|P5|Overall Study|Sponsor Decision|5
91918|NCT00830960|320111|P4|Overall Study|Sponsor Decision|4
91919|NCT00830960|320112|P3|Overall Study|Sponsor Decision|3
91920|NCT00830960|320113|P2|Overall Study|Sponsor Decision|2
91921|NCT00830960|320114|P1|Overall Study|Sponsor Decision|1
91922|NCT00830960|320109|P6|Overall Study|Withdrawal by Subject|21
91923|NCT00830960|320110|P5|Overall Study|Withdrawal by Subject|16
91924|NCT00830960|320111|P4|Overall Study|Withdrawal by Subject|23
91925|NCT00830960|320112|P3|Overall Study|Withdrawal by Subject|18
91926|NCT00830960|320113|P2|Overall Study|Withdrawal by Subject|19
91927|NCT00830960|320114|P1|Overall Study|Withdrawal by Subject|19
91928|NCT00830960|320109|P6|Overall Study|Lost to Follow-up|1
91929|NCT00830960|320110|P5|Overall Study|Lost to Follow-up|0
91930|NCT00830960|320111|P4|Overall Study|Lost to Follow-up|0
91931|NCT00830960|320112|P3|Overall Study|Lost to Follow-up|1
91932|NCT00830960|320113|P2|Overall Study|Lost to Follow-up|1
91933|NCT00830960|320114|P1|Overall Study|Lost to Follow-up|1
91934|NCT00830960|320109|P6|Overall Study|Death|1
91935|NCT00830960|320110|P5|Overall Study|Death|6
91936|NCT00830960|320111|P4|Overall Study|Death|2
91937|NCT00830960|320112|P3|Overall Study|Death|3
91938|NCT00830960|320113|P2|Overall Study|Death|4
91939|NCT00830960|320114|P1|Overall Study|Death|5
91940|NCT00830947|320230|P2|Overall Study|Lost to Follow-up|4
91941|NCT00830947|320231|P1|Overall Study|Lost to Follow-up|4
91942|NCT00830804|320237|P1|Overall Study|Unwilling to adhere to study requirement|1
91943|NCT00830804|320237|P1|Overall Study|Consent withdrawn|2
91944|NCT00830804|320237|P1|Overall Study|Unable to get to clinic|7
91945|NCT00830804|320237|P1|Overall Study|Death|1
91946|NCT00830804|320237|P1|Overall Study|Lost to Follow-up|4
91947|NCT00830765|320317|P2|Overall Study|Protocol Violation|2
91948|NCT00830765|320318|P1|Overall Study|Protocol Violation|3
91949|NCT00830375|320329|P1|Overall Study|Lost to Follow-up|1
91950|NCT00830336|320344|P2|Washout: 21 Days|Withdrawal by Subject|0
91951|NCT00830336|320345|P1|Washout: 21 Days|Withdrawal by Subject|1
91952|NCT00830258|320372|P2|Washout: 7 Days|Protocol Violation|0
91953|NCT00830258|320373|P1|Washout: 7 Days|Protocol Violation|1
91954|NCT00830258|320372|P2|First Intervention|Adverse Event|0
91955|NCT00830258|320373|P1|First Intervention|Adverse Event|1
91956|NCT00830219|320392|P2|Washout of 7 Days|Withdrawal by Subject|1
91957|NCT00830219|320393|P1|Washout of 7 Days|Withdrawal by Subject|1
91958|NCT00830206|320403|P2|Washout: 21 Days|Withdrawal by Subject|1
91959|NCT00830206|320404|P1|Washout: 21 Days|Withdrawal by Subject|1
91960|NCT00830167|320414|P2|Overall Study|Other|2
91961|NCT00830167|320415|P1|Overall Study|Other|2
91962|NCT00830167|320414|P2|Overall Study|Protocol Violation|1
91963|NCT00830167|320415|P1|Overall Study|Protocol Violation|0
91964|NCT00830167|320414|P2|Overall Study|Lost to Follow-up|1
91965|NCT00830167|320415|P1|Overall Study|Lost to Follow-up|0
91966|NCT00830167|320414|P2|Overall Study|Withdrawal by Subject|0
91967|NCT00830167|320415|P1|Overall Study|Withdrawal by Subject|2
91968|NCT00830167|320414|P2|Overall Study|Not meeting entrance criteria|5
91969|NCT00830167|320415|P1|Overall Study|Not meeting entrance criteria|2
91970|NCT00830167|320414|P2|Overall Study|Adverse Event|24
91971|NCT00830167|320415|P1|Overall Study|Adverse Event|8
91972|NCT00830167|320414|P2|Overall Study|Lack of Efficacy|10
91973|NCT00830167|320415|P1|Overall Study|Lack of Efficacy|26
91974|NCT00830128|320485|P1|Overall Study|Operating a vehicle|1
91975|NCT00830128|320485|P1|Overall Study|Work obligation|1
91976|NCT00830128|320485|P1|Overall Study|Relocation|1
91977|NCT00830128|320485|P1|Overall Study|Family obligation|1
91978|NCT00830128|320485|P1|Overall Study|Withdrawal by Subject|2
91979|NCT00830128|320485|P1|Overall Study|Protocol Violation|1
91980|NCT00830128|320485|P1|Overall Study|Lack of Efficacy|7
91981|NCT00830128|320485|P1|Overall Study|Adverse Event|5
91982|NCT00830115|320500|P1|Overall Study|Improvement/recovery|1
91983|NCT00830115|320500|P1|Overall Study|Adverse Event|2
91984|NCT00830037|320527|P2|Overall Study|Active when terminated by DSMB|14
91985|NCT00830037|320528|P1|Overall Study|Active when terminated by DSMB|15
91986|NCT00830037|320527|P2|Overall Study|Lost to Follow-up|2
91987|NCT00830037|320528|P1|Overall Study|Lost to Follow-up|1
91988|NCT00830037|320527|P2|Overall Study|Withdrawal by Subject|3
91989|NCT00830037|320528|P1|Overall Study|Withdrawal by Subject|2
91990|NCT00830024|320538|P2|Washout: 7 Days|Withdrawal by Subject|0
91991|NCT00830024|320539|P1|Washout: 7 Days|Withdrawal by Subject|1
91992|NCT00829998|320549|P2|Washout|Adverse Event|1
91993|NCT00829998|320550|P1|Washout|Adverse Event|0
91994|NCT00829933|320579|P4|Overall Study|withdrew before treatment started|9
91995|NCT00829933|320580|P3|Overall Study|withdrew before treatment started|2
91996|NCT00829933|320581|P2|Overall Study|withdrew before treatment started|1
91997|NCT00829933|320582|P1|Overall Study|withdrew before treatment started|5
91998|NCT00829933|320579|P4|Overall Study|Protocol Violation|0
91999|NCT00829933|320580|P3|Overall Study|Protocol Violation|0
92000|NCT00829933|320581|P2|Overall Study|Protocol Violation|1
92001|NCT00829933|320582|P1|Overall Study|Protocol Violation|2
92002|NCT00829933|320579|P4|Overall Study|Pregnancy|2
92003|NCT00829933|320580|P3|Overall Study|Pregnancy|0
92004|NCT00829933|320581|P2|Overall Study|Pregnancy|0
92005|NCT00829933|320582|P1|Overall Study|Pregnancy|0
92006|NCT00829933|320579|P4|Overall Study|Physician Decision|1
92007|NCT00829933|320580|P3|Overall Study|Physician Decision|8
92008|NCT00829933|320581|P2|Overall Study|Physician Decision|7
92009|NCT00829933|320582|P1|Overall Study|Physician Decision|5
92010|NCT00829933|320579|P4|Overall Study|Lack of Efficacy|0
92011|NCT00829933|320580|P3|Overall Study|Lack of Efficacy|0
92012|NCT00829933|320581|P2|Overall Study|Lack of Efficacy|1
92013|NCT00829933|320582|P1|Overall Study|Lack of Efficacy|0
92014|NCT00829933|320579|P4|Overall Study|Death|1
92015|NCT00829933|320580|P3|Overall Study|Death|1
92016|NCT00829933|320581|P2|Overall Study|Death|0
92017|NCT00829933|320582|P1|Overall Study|Death|0
92018|NCT00829933|320579|P4|Overall Study|Adverse Event|1
92019|NCT00829933|320580|P3|Overall Study|Adverse Event|2
92020|NCT00829933|320581|P2|Overall Study|Adverse Event|3
92021|NCT00829933|320582|P1|Overall Study|Adverse Event|2
92022|NCT00829868|320594|P2|Washout|Physician Decision|0
92023|NCT00829868|320595|P1|Washout|Physician Decision|1
92024|NCT00829790|320605|P2|Washout of 14 Days|Withdrawal by Subject|1
92025|NCT00829790|320606|P1|Washout of 14 Days|Withdrawal by Subject|0
92026|NCT00829764|320616|P2|First Intervention|Withdrawal by Subject|1
92027|NCT00829764|320617|P1|First Intervention|Withdrawal by Subject|1
92028|NCT00829764|320616|P2|First Intervention|Adverse Event|0
92029|NCT00829764|320617|P1|First Intervention|Adverse Event|1
92030|NCT00829712|320643|P2|Washout of 7 Days|Withdrawal by Subject|1
92031|NCT00829712|320644|P1|Washout of 7 Days|Withdrawal by Subject|0
92032|NCT00829673|320663|P2|Washout of 7 Days|Withdrawal by Subject|0
92033|NCT00829673|320664|P1|Washout of 7 Days|Withdrawal by Subject|1
92034|NCT00829621|320674|P2|Overall Study|Lost to Follow-up|4
92035|NCT00829621|320675|P1|Overall Study|Lost to Follow-up|3
92036|NCT00829621|320674|P2|Overall Study|Death|0
92037|NCT00829621|320675|P1|Overall Study|Death|1
92038|NCT00829530|320683|P2|Second Intervention|Intolerance to Venopuncture|0
92039|NCT00829530|320684|P1|Second Intervention|Intolerance to Venopuncture|1
92040|NCT00829530|320683|P2|First Intervention|Intolerance to Venopuncture|1
92041|NCT00829530|320684|P1|First Intervention|Intolerance to Venopuncture|0
92042|NCT00829530|320683|P2|First Intervention|Adverse Event|1
92043|NCT00829530|320684|P1|First Intervention|Adverse Event|0
92044|NCT00829504|320698|P2|Second Intervention|Physician Decision|0
92045|NCT00829504|320699|P1|Second Intervention|Physician Decision|1
92046|NCT00829504|320698|P2|Washout of 7 Days|Withdrawal by Subject|0
92047|NCT00829504|320699|P1|Washout of 7 Days|Withdrawal by Subject|1
92048|NCT00829504|320698|P2|First Intervention|Adverse Event|0
92049|NCT00829504|320699|P1|First Intervention|Adverse Event|1
92050|NCT00829452|320709|P2|Second Intervention|Physician Decision|1
92051|NCT00829452|320710|P1|Second Intervention|Physician Decision|0
92052|NCT00829452|320709|P2|Washout of 42 Days|Withdrawal by Subject|1
92053|NCT00829452|320710|P1|Washout of 42 Days|Withdrawal by Subject|0
92054|NCT00829452|320709|P2|First Intervention|Withdrawal by Subject|1
92055|NCT00829452|320710|P1|First Intervention|Withdrawal by Subject|0
92056|NCT00829439|320722|P4|Overall Study|Adverse Event|0
92057|NCT00829439|320723|P3|Overall Study|Adverse Event|1
92058|NCT00829439|320724|P2|Overall Study|Adverse Event|0
92059|NCT00829439|320725|P1|Overall Study|Adverse Event|0
92060|NCT00829426|320731|P2|Washout: 7 Days|Withdrawal by Subject|0
92061|NCT00829426|320732|P1|Washout: 7 Days|Withdrawal by Subject|1
92062|NCT00829387|320742|P2|Overall Study|Disqualified by PI|0
92063|NCT00829387|320743|P1|Overall Study|Disqualified by PI|1
92064|NCT00829387|320742|P2|Overall Study|Withdrawal by Subject|3
92065|NCT00829387|320743|P1|Overall Study|Withdrawal by Subject|2
92066|NCT00829309|320761|P2|Washout: 7 Days|Protocol Violation|0
92067|NCT00829309|320762|P1|Washout: 7 Days|Protocol Violation|1
92068|NCT00829296|320772|P2|Overall Study|Adverse Event|4
92069|NCT00829296|320773|P1|Overall Study|Adverse Event|5
92070|NCT00829283|320787|P2|Overall Study|Lost to Follow-up|25
92071|NCT00829283|320788|P1|Overall Study|Lost to Follow-up|7
92072|NCT00829244|320798|P2|Overall Study|No embryo cleavage|2
92073|NCT00829244|320799|P1|Overall Study|No embryo cleavage|0
92074|NCT00829244|320798|P2|Overall Study|All embryos discarded|3
92075|NCT00829244|320799|P1|Overall Study|All embryos discarded|0
92076|NCT00829244|320798|P2|Overall Study|No fertilization|2
92077|NCT00829244|320799|P1|Overall Study|No fertilization|2
92078|NCT00829244|320798|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
92079|NCT00829244|320799|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
92080|NCT00829244|320798|P2|Overall Study|Lack of ovarian response to stimulation|5
92081|NCT00829244|320799|P1|Overall Study|Lack of ovarian response to stimulation|9
92082|NCT00829244|320798|P2|Overall Study|Protocol Violation|0
92083|NCT00829244|320799|P1|Overall Study|Protocol Violation|1
92084|NCT00829244|320798|P2|Overall Study|Adverse Event|3
92085|NCT00829244|320799|P1|Overall Study|Adverse Event|1
92086|NCT00829179|320829|P1|Overall Study|Withdrawal by Subject|1
92087|NCT00829166|320835|P2|Overall Study|Reason Not Specified|3
92088|NCT00829166|320836|P1|Overall Study|Reason Not Specified|3
92089|NCT00829166|320835|P2|Overall Study|Sponsor’s Decision|98
92090|NCT00829166|320836|P1|Overall Study|Sponsor’s Decision|137
92091|NCT00829166|320835|P2|Overall Study|Subject's Decision|55
92092|NCT00829166|320836|P1|Overall Study|Subject's Decision|41
92093|NCT00829166|320835|P2|Overall Study|Physician's Decision|3
92094|NCT00829166|320836|P1|Overall Study|Physician's Decision|4
92095|NCT00829166|320835|P2|Overall Study|Lost to Follow-up|4
92096|NCT00829166|320836|P1|Overall Study|Lost to Follow-up|5
92097|NCT00829166|320835|P2|Overall Study|Death|333
92098|NCT00829166|320836|P1|Overall Study|Death|305
92099|NCT00829010|320899|P5|Overall Study|Migrated/Moved from study area|0
92100|NCT00829010|320900|P4|Overall Study|Migrated/Moved from study area|5
92101|NCT00829010|320901|P3|Overall Study|Migrated/Moved from study area|0
92102|NCT00829010|320902|P2|Overall Study|Migrated/Moved from study area|4
92103|NCT00829010|320903|P1|Overall Study|Migrated/Moved from study area|3
92104|NCT00829010|320899|P5|Overall Study|Fatality|0
92105|NCT00829010|320900|P4|Overall Study|Fatality|3
92106|NCT00829010|320901|P3|Overall Study|Fatality|0
92107|NCT00829010|320902|P2|Overall Study|Fatality|4
92108|NCT00829010|320903|P1|Overall Study|Fatality|5
92109|NCT00829010|320899|P5|Overall Study|Lost to Follow-up|0
92110|NCT00829010|320900|P4|Overall Study|Lost to Follow-up|0
92111|NCT00829010|320901|P3|Overall Study|Lost to Follow-up|2
92112|NCT00829010|320902|P2|Overall Study|Lost to Follow-up|0
92113|NCT00829010|320903|P1|Overall Study|Lost to Follow-up|1
92114|NCT00829010|320899|P5|Overall Study|Withdrawal by Subject|2
92115|NCT00829010|320900|P4|Overall Study|Withdrawal by Subject|0
92116|NCT00829010|320901|P3|Overall Study|Withdrawal by Subject|1
92117|NCT00829010|320902|P2|Overall Study|Withdrawal by Subject|1
92118|NCT00829010|320903|P1|Overall Study|Withdrawal by Subject|0
92119|NCT00829010|320899|P5|Overall Study|Adverse Event|0
92120|NCT00829010|320900|P4|Overall Study|Adverse Event|0
92121|NCT00829010|320901|P3|Overall Study|Adverse Event|0
92122|NCT00829010|320902|P2|Overall Study|Adverse Event|0
92123|NCT00829010|320903|P1|Overall Study|Adverse Event|1
92124|NCT00828984|321068|P3|Overall Study|ConMed|1
92125|NCT00828984|321069|P2|Overall Study|ConMed|1
92126|NCT00828984|321070|P1|Overall Study|ConMed|1
92127|NCT00828984|321068|P3|Overall Study|Noncompliant|3
92128|NCT00828984|321069|P2|Overall Study|Noncompliant|2
92129|NCT00828984|321070|P1|Overall Study|Noncompliant|1
92130|NCT00828984|321068|P3|Overall Study|Medical Contraindication|0
92131|NCT00828984|321069|P2|Overall Study|Medical Contraindication|1
92132|NCT00828984|321070|P1|Overall Study|Medical Contraindication|0
92133|NCT00828984|321068|P3|Overall Study|Ineligable|0
92134|NCT00828984|321069|P2|Overall Study|Ineligable|2
92135|NCT00828984|321070|P1|Overall Study|Ineligable|1
92136|NCT00828984|321068|P3|Overall Study|Withdrawal by Subject|4
92137|NCT00828984|321069|P2|Overall Study|Withdrawal by Subject|4
92138|NCT00828984|321070|P1|Overall Study|Withdrawal by Subject|4
92139|NCT00828984|321068|P3|Overall Study|Lost to Follow-up|1
92140|NCT00828984|321069|P2|Overall Study|Lost to Follow-up|3
92141|NCT00828984|321070|P1|Overall Study|Lost to Follow-up|5
92142|NCT00828984|321068|P3|Overall Study|Adverse Event|0
92143|NCT00828984|321069|P2|Overall Study|Adverse Event|3
92144|NCT00828984|321070|P1|Overall Study|Adverse Event|2
92145|NCT00828945|321093|P1|Overall Study|Unspecified|36
92146|NCT00828945|321093|P1|Overall Study|Participant was missing|1
92147|NCT00828945|321093|P1|Overall Study|Death|4
92148|NCT00828750|321125|P1|Overall Study|Normal PC Remained While No Treatment|1
92149|NCT00828750|321125|P1|Overall Study|Lack of Efficacy|3
92150|NCT00828711|321139|P3|Overall Study|Lost to Follow-up|0
92151|NCT00828711|321140|P2|Overall Study|Lost to Follow-up|0
92152|NCT00828711|321141|P1|Overall Study|Lost to Follow-up|1
92153|NCT00828568|321173|P3|Treated - Received at Least One Dose|Protocol Violation|3
92154|NCT00828568|321174|P2|Treated - Received at Least One Dose|Protocol Violation|5
92155|NCT00828568|321175|P1|Treated - Received at Least One Dose|Protocol Violation|9
92156|NCT00828568|321173|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
92157|NCT00828568|321174|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
92158|NCT00828568|321175|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
92159|NCT00828568|321173|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
92160|NCT00828568|321174|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
92161|NCT00828568|321175|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
92162|NCT00828568|321173|P3|Treated - Received at Least One Dose|Adverse Event|1
92163|NCT00828568|321174|P2|Treated - Received at Least One Dose|Adverse Event|8
92164|NCT00828568|321175|P1|Treated - Received at Least One Dose|Adverse Event|11
92165|NCT00828568|321173|P3|Randomized|Withdrawal by Subject|2
92166|NCT00828568|321174|P2|Randomized|Withdrawal by Subject|0
92167|NCT00828568|321175|P1|Randomized|Withdrawal by Subject|1
92168|NCT00828516|321188|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
92169|NCT00828464|321193|P1|Overall Study|Withdrawal by Subject|1
92170|NCT00828321|321230|P2|Second Intervention|Protocol Violation|1
92171|NCT00828321|321231|P1|Second Intervention|Protocol Violation|0
92172|NCT00828321|321230|P2|Washout of 42 Days|Withdrawal by Subject|0
92173|NCT00828321|321231|P1|Washout of 42 Days|Withdrawal by Subject|2
92174|NCT00828204|321260|P2|Extension Study|Physician Decision|2
92175|NCT00828204|321261|P1|Extension Study|Physician Decision|0
92176|NCT00828204|321260|P2|Extension Study|Lost to Follow-up|1
92177|NCT00828204|321261|P1|Extension Study|Lost to Follow-up|0
92178|NCT00828204|321260|P2|Main Study: After Study Restart|Noncompliance|1
92179|NCT00828204|321261|P1|Main Study: After Study Restart|Noncompliance|0
92180|NCT00828204|321260|P2|Main Study: After Study Restart|Adverse Event|2
92181|NCT00828204|321261|P1|Main Study: After Study Restart|Adverse Event|0
92182|NCT00828204|321260|P2|Main Study: Prior to Study Suspension|Study Suspension|0
92183|NCT00828204|321261|P1|Main Study: Prior to Study Suspension|Study Suspension|11
92184|NCT00828204|321260|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
92185|NCT00828204|321261|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
92186|NCT00828204|321260|P2|Main Study: Prior to Study Suspension|Adverse Event|0
92187|NCT00828204|321261|P1|Main Study: Prior to Study Suspension|Adverse Event|1
92188|NCT00828139|321308|P4|Overall Study|Not specified|2
92189|NCT00828139|321309|P3|Overall Study|Not specified|5
92190|NCT00828139|321310|P2|Overall Study|Not specified|2
92191|NCT00828139|321311|P1|Overall Study|Not specified|4
92192|NCT00828139|321308|P4|Overall Study|Disease Progression|39
92193|NCT00828139|321309|P3|Overall Study|Disease Progression|35
92194|NCT00828139|321310|P2|Overall Study|Disease Progression|33
92195|NCT00828139|321311|P1|Overall Study|Disease Progression|24
92196|NCT00828139|321308|P4|Overall Study|Refusal unrelated to toxicity|3
92197|NCT00828139|321309|P3|Overall Study|Refusal unrelated to toxicity|5
92198|NCT00828139|321310|P2|Overall Study|Refusal unrelated to toxicity|4
92199|NCT00828139|321311|P1|Overall Study|Refusal unrelated to toxicity|3
92200|NCT00828139|321308|P4|Overall Study|Death|2
92201|NCT00828139|321309|P3|Overall Study|Death|0
92202|NCT00828139|321310|P2|Overall Study|Death|1
92203|NCT00828139|321311|P1|Overall Study|Death|2
92204|NCT00828139|321308|P4|Overall Study|Adverse Event|5
92205|NCT00828139|321309|P3|Overall Study|Adverse Event|10
92206|NCT00828139|321310|P2|Overall Study|Adverse Event|1
92207|NCT00828139|321311|P1|Overall Study|Adverse Event|8
92208|NCT00828113|321331|P2|Overall Study|Lost to Follow-up|5
92209|NCT00828113|321332|P1|Overall Study|Lost to Follow-up|3
92210|NCT00828113|321331|P2|Overall Study|Withdrawal by Subject|26
92211|NCT00828113|321332|P1|Overall Study|Withdrawal by Subject|27
92212|NCT00827931|321390|P2|Overall Study|Unspecified|0
92213|NCT00827931|321391|P1|Overall Study|Unspecified|1
92214|NCT00827931|321390|P2|Overall Study|Withdrawal by Subject|1
92215|NCT00827931|321391|P1|Overall Study|Withdrawal by Subject|0
92216|NCT00827931|321390|P2|Overall Study|Lost to Follow-up|0
92217|NCT00827931|321391|P1|Overall Study|Lost to Follow-up|1
92218|NCT00827931|321390|P2|Overall Study|Adverse Event|0
92219|NCT00827931|321391|P1|Overall Study|Adverse Event|1
92220|NCT00827931|321390|P2|Overall Study|Death|5
92221|NCT00827931|321391|P1|Overall Study|Death|3
92222|NCT00827918|321412|P3|Overall Study|Withdrawal by Subject|6
92223|NCT00827918|321413|P2|Overall Study|Withdrawal by Subject|2
92224|NCT00827918|321414|P1|Overall Study|Withdrawal by Subject|6
92225|NCT00827918|321412|P3|Overall Study|Protocol Violation|0
92226|NCT00827918|321413|P2|Overall Study|Protocol Violation|1
92227|NCT00827918|321414|P1|Overall Study|Protocol Violation|0
92228|NCT00827918|321412|P3|Overall Study|Progressive Disease|0
92229|NCT00827918|321413|P2|Overall Study|Progressive Disease|1
92230|NCT00827918|321414|P1|Overall Study|Progressive Disease|1
92231|NCT00827918|321412|P3|Overall Study|Pregnancy|0
92232|NCT00827918|321413|P2|Overall Study|Pregnancy|1
92233|NCT00827918|321414|P1|Overall Study|Pregnancy|0
92234|NCT00827918|321412|P3|Overall Study|Physician Decision|0
92235|NCT00827918|321413|P2|Overall Study|Physician Decision|0
92236|NCT00827918|321414|P1|Overall Study|Physician Decision|1
92237|NCT00827918|321412|P3|Overall Study|Lack of Efficacy|15
92238|NCT00827918|321413|P2|Overall Study|Lack of Efficacy|4
92239|NCT00827918|321414|P1|Overall Study|Lack of Efficacy|16
92240|NCT00827918|321412|P3|Overall Study|Adverse Event|0
92241|NCT00827918|321413|P2|Overall Study|Adverse Event|0
92242|NCT00827918|321414|P1|Overall Study|Adverse Event|4
92243|NCT00827827|321442|P2|Overall Study|Burned with water at home|0
92244|NCT00827827|321443|P1|Overall Study|Burned with water at home|1
92245|NCT00827827|321442|P2|Overall Study|Transportation issues|0
92246|NCT00827827|321443|P1|Overall Study|Transportation issues|1
92247|NCT00827827|321442|P2|Overall Study|Gout|0
92248|NCT00827827|321443|P1|Overall Study|Gout|1
92249|NCT00827827|321442|P2|Overall Study|Another cerebrovascular accident (CVA)|0
92250|NCT00827827|321443|P1|Overall Study|Another cerebrovascular accident (CVA)|1
92251|NCT00827827|321442|P2|Overall Study|Fall at home- hospitalization|0
92252|NCT00827827|321443|P1|Overall Study|Fall at home- hospitalization|1
92253|NCT00827827|321442|P2|Overall Study|Lost to Follow-up|0
92254|NCT00827827|321443|P1|Overall Study|Lost to Follow-up|3
92255|NCT00827632|321487|P2|Overall Study|Early withdrawal|11
92256|NCT00827632|321488|P1|Overall Study|Early withdrawal|14
92257|NCT00827632|321487|P2|Overall Study|Lost to Follow-up|12
92258|NCT00827632|321488|P1|Overall Study|Lost to Follow-up|8
92259|NCT00827606|321496|P2|Overall Study|Adverse Event|2
92260|NCT00827606|321497|P1|Overall Study|Adverse Event|4
92261|NCT00827606|321496|P2|Overall Study|LDL below 2.59 mmol/L|12
92262|NCT00827606|321497|P1|Overall Study|LDL below 2.59 mmol/L|4
92263|NCT00827606|321496|P2|Overall Study|Not specified|13
92264|NCT00827606|321497|P1|Overall Study|Not specified|5
92265|NCT00827606|321496|P2|Overall Study|Pregnancy|1
92266|NCT00827606|321497|P1|Overall Study|Pregnancy|0
92267|NCT00827606|321496|P2|Overall Study|Withdrawal by Subject|6
92268|NCT00827606|321497|P1|Overall Study|Withdrawal by Subject|7
92269|NCT00827606|321496|P2|Overall Study|Lost to Follow-up|1
92270|NCT00827606|321497|P1|Overall Study|Lost to Follow-up|3
92271|NCT00827606|321496|P2|Overall Study|Protocol Violation|3
92272|NCT00827606|321497|P1|Overall Study|Protocol Violation|4
92273|NCT00827567|321558|P1|Overall Study|Progression of Disease/Screen Failure|4
92274|NCT00827541|321564|P2|Overall Study|Lack of effectiveness|0
92275|NCT00827541|321565|P1|Overall Study|Lack of effectiveness|1
92276|NCT00827541|321564|P2|Overall Study|Pathogen not susceptible|0
92277|NCT00827541|321565|P1|Overall Study|Pathogen not susceptible|1
92278|NCT00827541|321564|P2|Overall Study|Unspecified|3
92279|NCT00827541|321565|P1|Overall Study|Unspecified|1
92280|NCT00827541|321564|P2|Overall Study|Exitus|8
92281|NCT00827541|321565|P1|Overall Study|Exitus|1
92282|NCT00827502|321577|P1|Overall Study|Withdrawal by Subject|5
92283|NCT00827502|321577|P1|Overall Study|Lost to Follow-up|4
92284|NCT00827502|321577|P1|Overall Study|Adverse Event|1
92285|NCT00827502|321577|P1|Overall Study|randomized but not treated|11
92286|NCT00827372|321583|P1|Overall Study|Lack of Efficacy|3
92287|NCT00827372|321583|P1|Overall Study|Adverse Event|5
92288|NCT00827242|321598|P2|Overall Study|Lack of Efficacy|0
92289|NCT00827242|321599|P1|Overall Study|Lack of Efficacy|1
92290|NCT00827242|321598|P2|Overall Study|Death|0
92291|NCT00827242|321599|P1|Overall Study|Death|1
92292|NCT00827242|321598|P2|Overall Study|Physician Decision|0
92293|NCT00827242|321599|P1|Overall Study|Physician Decision|2
92294|NCT00827242|321598|P2|Overall Study|Entry Criteria Not Met|1
92295|NCT00827242|321599|P1|Overall Study|Entry Criteria Not Met|4
92296|NCT00827242|321598|P2|Overall Study|Adverse Event Excluding Death|1
92297|NCT00827242|321599|P1|Overall Study|Adverse Event Excluding Death|2
92298|NCT00827242|321598|P2|Overall Study|Lost to Follow-up|3
92299|NCT00827242|321599|P1|Overall Study|Lost to Follow-up|0
92300|NCT00827242|321598|P2|Overall Study|Protocol Violation|3
92301|NCT00827242|321599|P1|Overall Study|Protocol Violation|1
92302|NCT00827242|321598|P2|Overall Study|Withdrawal by Subject|4
92303|NCT00827242|321599|P1|Overall Study|Withdrawal by Subject|2
92304|NCT00827112|321637|P2|Overall Study|Unspecified|3
92305|NCT00827112|321638|P1|Overall Study|Unspecified|1
92306|NCT00827112|321637|P2|Overall Study|Randomized but not treated|3
92307|NCT00827112|321638|P1|Overall Study|Randomized but not treated|5
92308|NCT00827112|321637|P2|Overall Study|Withdrawal by Subject|1
92309|NCT00827112|321638|P1|Overall Study|Withdrawal by Subject|2
92310|NCT00827112|321637|P2|Overall Study|Protocol Violation|2
92311|NCT00827112|321638|P1|Overall Study|Protocol Violation|0
92312|NCT00827112|321637|P2|Overall Study|Pregnancy|1
92313|NCT00827112|321638|P1|Overall Study|Pregnancy|0
92314|NCT00827112|321637|P2|Overall Study|Lost to Follow-up|2
92315|NCT00827112|321638|P1|Overall Study|Lost to Follow-up|3
92316|NCT00827112|321637|P2|Overall Study|Lack of Efficacy|0
92317|NCT00827112|321638|P1|Overall Study|Lack of Efficacy|2
92318|NCT00827112|321637|P2|Overall Study|Adverse Event|0
92319|NCT00827112|321638|P1|Overall Study|Adverse Event|2
92320|NCT00826943|321691|P6|Overall Study|Withdrawal by Subject|0
92321|NCT00826943|321692|P5|Overall Study|Withdrawal by Subject|1
92322|NCT00826943|321693|P4|Overall Study|Withdrawal by Subject|0
92323|NCT00826943|321694|P3|Overall Study|Withdrawal by Subject|0
92324|NCT00826943|321695|P2|Overall Study|Withdrawal by Subject|0
92325|NCT00826943|321696|P1|Overall Study|Withdrawal by Subject|0
92326|NCT00826618|321714|P1|Overall Study|Withdrawal by Subject|1
92327|NCT00826540|321718|P1|Overall Study|Withdrawal by Subject|1
92328|NCT00826540|321718|P1|Overall Study|ineligible|3
92329|NCT00826449|321724|P1|Overall Study|Withdrawal by Subject|1
92330|NCT00826449|321724|P1|Overall Study|Disease Progression|4
92331|NCT00826280|321733|P3|Overall Study|One or more non-interpretable scan|1
92332|NCT00826280|321734|P2|Overall Study|One or more non-interpretable scan|1
92333|NCT00826280|321735|P1|Overall Study|One or more non-interpretable scan|0
92334|NCT00826280|321733|P3|Overall Study|Machine Failure|0
92335|NCT00826280|321734|P2|Overall Study|Machine Failure|1
92336|NCT00826280|321735|P1|Overall Study|Machine Failure|1
92337|NCT00826280|321733|P3|Overall Study|Interpretation Failure|0
92338|NCT00826280|321734|P2|Overall Study|Interpretation Failure|0
92339|NCT00826280|321735|P1|Overall Study|Interpretation Failure|1
92340|NCT00826280|321733|P3|Overall Study|Reversible ischemic defect not present|44
92341|NCT00826280|321734|P2|Overall Study|Reversible ischemic defect not present|40
92342|NCT00826280|321735|P1|Overall Study|Reversible ischemic defect not present|43
92343|NCT00826280|321733|P3|Overall Study|Sponsor discontinued subject or study|0
92344|NCT00826280|321734|P2|Overall Study|Sponsor discontinued subject or study|0
92345|NCT00826280|321735|P1|Overall Study|Sponsor discontinued subject or study|1
92346|NCT00826280|321733|P3|Overall Study|Lost to Follow-up|0
92347|NCT00826280|321734|P2|Overall Study|Lost to Follow-up|1
92348|NCT00826280|321735|P1|Overall Study|Lost to Follow-up|0
92349|NCT00826280|321733|P3|Overall Study|Adverse Event|0
92350|NCT00826280|321734|P2|Overall Study|Adverse Event|3
92351|NCT00826280|321735|P1|Overall Study|Adverse Event|1
92352|NCT00826280|321733|P3|Overall Study|Randomized but drug not received|1
92353|NCT00826280|321734|P2|Overall Study|Randomized but drug not received|0
92354|NCT00826280|321735|P1|Overall Study|Randomized but drug not received|1
92355|NCT00826267|321764|P3|Overall Study|Other Adverse Event|0
92356|NCT00826267|321765|P2|Overall Study|Other Adverse Event|0
92357|NCT00826267|321766|P1|Overall Study|Other Adverse Event|1
92358|NCT00826228|321784|P1|Overall Study|Withdrawal by Subject|1
92359|NCT00826176|321806|P2|Overall Study|Administrative|0
92360|NCT00826176|321807|P1|Overall Study|Administrative|9
92361|NCT00826176|321806|P2|Overall Study|Subject Withdrew Consent|0
92362|NCT00826176|321807|P1|Overall Study|Subject Withdrew Consent|3
92363|NCT00826176|321806|P2|Overall Study|Lost to Follow-up|0
92364|NCT00826176|321807|P1|Overall Study|Lost to Follow-up|1
92365|NCT00826111|321819|P2|Overall Study|Physician Decision|1
92366|NCT00826111|321820|P1|Overall Study|Physician Decision|1
92367|NCT00826111|321819|P2|Overall Study|Withdrawal by Subject|0
92368|NCT00826111|321820|P1|Overall Study|Withdrawal by Subject|5
92369|NCT00826111|321819|P2|Overall Study|Protocol Violation|0
92370|NCT00826111|321820|P1|Overall Study|Protocol Violation|1
92371|NCT00826111|321819|P2|Overall Study|Lost to Follow-up|1
92372|NCT00826111|321820|P1|Overall Study|Lost to Follow-up|0
92373|NCT00825994|321850|P1|Overall Study|Placebo Responder at V2|1
92374|NCT00825994|321850|P1|Overall Study|Protocol Violation|1
92375|NCT00825994|321850|P1|Overall Study|Lost to Follow-up|1
92376|NCT00825994|321850|P1|Overall Study|Withdrawal by Subject|2
92377|NCT00825916|321858|P3|Overall Study|Lost to Follow-up|1
92378|NCT00825916|321859|P2|Overall Study|Lost to Follow-up|2
92379|NCT00825916|321860|P1|Overall Study|Lost to Follow-up|4
92380|NCT00825825|321901|P6|Third Medication Period (14 Days)|poor data quality|0
92381|NCT00825825|321902|P5|Third Medication Period (14 Days)|poor data quality|0
92382|NCT00825825|321903|P4|Third Medication Period (14 Days)|poor data quality|0
92383|NCT00825825|321904|P3|Third Medication Period (14 Days)|poor data quality|0
92384|NCT00825825|321905|P2|Third Medication Period (14 Days)|poor data quality|1
92385|NCT00825825|321906|P1|Third Medication Period (14 Days)|poor data quality|0
92386|NCT00825825|321901|P6|Third Medication Period (14 Days)|Protocol Violation|2
92387|NCT00825825|321902|P5|Third Medication Period (14 Days)|Protocol Violation|0
92388|NCT00825825|321903|P4|Third Medication Period (14 Days)|Protocol Violation|0
92389|NCT00825825|321904|P3|Third Medication Period (14 Days)|Protocol Violation|0
92390|NCT00825825|321905|P2|Third Medication Period (14 Days)|Protocol Violation|0
92391|NCT00825825|321906|P1|Third Medication Period (14 Days)|Protocol Violation|0
92392|NCT00825825|321901|P6|Third Medication Period (14 Days)|Adverse Event|0
92393|NCT00825825|321902|P5|Third Medication Period (14 Days)|Adverse Event|0
92394|NCT00825825|321903|P4|Third Medication Period (14 Days)|Adverse Event|0
92395|NCT00825825|321904|P3|Third Medication Period (14 Days)|Adverse Event|0
92396|NCT00825825|321905|P2|Third Medication Period (14 Days)|Adverse Event|1
92397|NCT00825825|321906|P1|Third Medication Period (14 Days)|Adverse Event|0
92398|NCT00825825|321901|P6|Second Medication Period (14 Days)|Protocol Violation|0
92399|NCT00825825|321902|P5|Second Medication Period (14 Days)|Protocol Violation|1
92400|NCT00825825|321903|P4|Second Medication Period (14 Days)|Protocol Violation|0
92401|NCT00825825|321904|P3|Second Medication Period (14 Days)|Protocol Violation|0
92402|NCT00825825|321905|P2|Second Medication Period (14 Days)|Protocol Violation|0
92403|NCT00825825|321906|P1|Second Medication Period (14 Days)|Protocol Violation|1
92404|NCT00825825|321901|P6|Second Medication Period (14 Days)|Physician Decision|0
92405|NCT00825825|321902|P5|Second Medication Period (14 Days)|Physician Decision|0
92406|NCT00825825|321903|P4|Second Medication Period (14 Days)|Physician Decision|2
92407|NCT00825825|321904|P3|Second Medication Period (14 Days)|Physician Decision|0
92408|NCT00825825|321905|P2|Second Medication Period (14 Days)|Physician Decision|0
92409|NCT00825825|321906|P1|Second Medication Period (14 Days)|Physician Decision|1
92410|NCT00825825|321901|P6|First Medication Period (14 Days)|Physician Decision|1
92411|NCT00825825|321902|P5|First Medication Period (14 Days)|Physician Decision|0
92412|NCT00825825|321903|P4|First Medication Period (14 Days)|Physician Decision|0
92413|NCT00825825|321904|P3|First Medication Period (14 Days)|Physician Decision|1
92414|NCT00825825|321905|P2|First Medication Period (14 Days)|Physician Decision|0
92415|NCT00825825|321906|P1|First Medication Period (14 Days)|Physician Decision|2
92416|NCT00825825|321901|P6|First Medication Period (14 Days)|Adverse Event|1
92417|NCT00825825|321902|P5|First Medication Period (14 Days)|Adverse Event|0
92418|NCT00825825|321903|P4|First Medication Period (14 Days)|Adverse Event|0
92419|NCT00825825|321904|P3|First Medication Period (14 Days)|Adverse Event|0
92420|NCT00825825|321905|P2|First Medication Period (14 Days)|Adverse Event|0
92421|NCT00825825|321906|P1|First Medication Period (14 Days)|Adverse Event|1
92422|NCT00825812|321922|P4|Overall Study|Administrative|5
92423|NCT00825812|321923|P3|Overall Study|Administrative|3
92424|NCT00825812|321924|P2|Overall Study|Administrative|1
92425|NCT00825812|321925|P1|Overall Study|Administrative|0
92426|NCT00825812|321922|P4|Overall Study|Non-compliance with protocol|1
92427|NCT00825812|321923|P3|Overall Study|Non-compliance with protocol|0
92428|NCT00825812|321924|P2|Overall Study|Non-compliance with protocol|0
92429|NCT00825812|321925|P1|Overall Study|Non-compliance with protocol|0
92430|NCT00825812|321922|P4|Overall Study|Subject withdrew consent|2
92431|NCT00825812|321923|P3|Overall Study|Subject withdrew consent|3
92432|NCT00825812|321924|P2|Overall Study|Subject withdrew consent|0
92433|NCT00825812|321925|P1|Overall Study|Subject withdrew consent|0
92434|NCT00825812|321922|P4|Overall Study|Adverse Event|1
92435|NCT00825812|321923|P3|Overall Study|Adverse Event|0
92436|NCT00825812|321924|P2|Overall Study|Adverse Event|0
92437|NCT00825812|321925|P1|Overall Study|Adverse Event|0
92438|NCT00825812|321922|P4|Overall Study|Never entered follow up|1
92439|NCT00825812|321923|P3|Overall Study|Never entered follow up|0
92440|NCT00825812|321924|P2|Overall Study|Never entered follow up|0
92441|NCT00825812|321925|P1|Overall Study|Never entered follow up|0
92442|NCT00825682|321951|P2|Overall Study|personal reasons/ inconvenience|5
92443|NCT00825682|321952|P1|Overall Study|personal reasons/ inconvenience|13
92444|NCT00825305|322007|P2|Overall Study|Can not be classified|1
92445|NCT00825305|322008|P1|Overall Study|Can not be classified|0
92446|NCT00825305|322007|P2|Overall Study|Protocol Violation|9
92447|NCT00825305|322008|P1|Overall Study|Protocol Violation|9
92448|NCT00825305|322007|P2|Overall Study|Inappropriate inclusion|0
92449|NCT00825305|322008|P1|Overall Study|Inappropriate inclusion|1
92450|NCT00825305|322007|P2|Overall Study|Withdrawal by Subject|12
92451|NCT00825305|322008|P1|Overall Study|Withdrawal by Subject|6
92452|NCT00825305|322007|P2|Overall Study|Adverse Event|1
92453|NCT00825305|322008|P1|Overall Study|Adverse Event|1
92454|NCT00825175|322031|P2|Overall Study|Withdrawal by Subject|5
92455|NCT00825175|322032|P1|Overall Study|Withdrawal by Subject|0
92456|NCT00825162|322041|P3|Overall Study|Unable to attend the study visit|0
92457|NCT00825162|322042|P2|Overall Study|Unable to attend the study visit|2
92458|NCT00825162|322043|P1|Overall Study|Unable to attend the study visit|5
92459|NCT00825162|322041|P3|Overall Study|Move away from the study area|0
92460|NCT00825162|322042|P2|Overall Study|Move away from the study area|0
92461|NCT00825162|322043|P1|Overall Study|Move away from the study area|1
92462|NCT00825162|322041|P3|Overall Study|Physician Decision|0
92463|NCT00825162|322042|P2|Overall Study|Physician Decision|0
92464|NCT00825162|322043|P1|Overall Study|Physician Decision|2
92465|NCT00825162|322041|P3|Overall Study|Lost to Follow-up|3
92466|NCT00825162|322042|P2|Overall Study|Lost to Follow-up|6
92467|NCT00825162|322043|P1|Overall Study|Lost to Follow-up|9
92468|NCT00825162|322041|P3|Overall Study|Withdrawal by Subject|3
92469|NCT00825162|322042|P2|Overall Study|Withdrawal by Subject|13
92470|NCT00825162|322043|P1|Overall Study|Withdrawal by Subject|11
92471|NCT00824850|322069|P2|Overall Study|Withdrawal by Subject|1
92472|NCT00824850|322070|P1|Overall Study|Withdrawal by Subject|0
92473|NCT00824772|322123|P1|Overall Study|Withdrawal by Subject|8
92474|NCT00824720|322143|P3|Overall Study|Protocol Violation|1
92475|NCT00824720|322144|P2|Overall Study|Protocol Violation|0
92476|NCT00824720|322145|P1|Overall Study|Protocol Violation|0
92477|NCT00824720|322143|P3|Overall Study|failed plug insertion|0
92478|NCT00824720|322144|P2|Overall Study|failed plug insertion|1
92479|NCT00824720|322145|P1|Overall Study|failed plug insertion|3
92480|NCT00824655|322161|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
92569|NCT00824408|322410|P1|Run-in Phase|Other reason not defined above|0
92481|NCT00824655|322162|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
92482|NCT00824655|322161|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
92483|NCT00824655|322162|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
92484|NCT00824616|322182|P2|Overall Study|Withdrawal by Subject|1
92485|NCT00824616|322183|P1|Overall Study|Withdrawal by Subject|1
92486|NCT00824616|322182|P2|Overall Study|Lost to Follow-up|1
92487|NCT00824616|322183|P1|Overall Study|Lost to Follow-up|0
92488|NCT00824616|322182|P2|Overall Study|Lack of Efficacy|1
92489|NCT00824616|322183|P1|Overall Study|Lack of Efficacy|2
92490|NCT00824616|322182|P2|Overall Study|Hyperglycemia|1
92491|NCT00824616|322183|P1|Overall Study|Hyperglycemia|1
92492|NCT00824616|322182|P2|Overall Study|Creatinine/Creatinine Clearance|2
92493|NCT00824616|322183|P1|Overall Study|Creatinine/Creatinine Clearance|0
92494|NCT00824616|322182|P2|Overall Study|Adverse Event|1
92495|NCT00824616|322183|P1|Overall Study|Adverse Event|2
92496|NCT00824564|322193|P2|Overall Study|Randomized, but not treated|0
92497|NCT00824564|322194|P1|Overall Study|Randomized, but not treated|1
92498|NCT00824564|322193|P2|Overall Study|Unspecified|2
92499|NCT00824564|322194|P1|Overall Study|Unspecified|1
92500|NCT00824564|322193|P2|Overall Study|Withdrawal by Subject|1
92501|NCT00824564|322194|P1|Overall Study|Withdrawal by Subject|1
92502|NCT00824564|322193|P2|Overall Study|Lost to Follow-up|7
92503|NCT00824564|322194|P1|Overall Study|Lost to Follow-up|5
92504|NCT00824473|322271|P2|Overall Study|Other|1
92505|NCT00824473|322272|P1|Overall Study|Other|1
92506|NCT00824473|322271|P2|Overall Study|Withdrawal by Subject|3
92507|NCT00824473|322272|P1|Overall Study|Withdrawal by Subject|2
92508|NCT00824473|322271|P2|Overall Study|Non-Compliance|2
92509|NCT00824473|322272|P1|Overall Study|Non-Compliance|4
92510|NCT00824473|322271|P2|Overall Study|Protocol Violation|0
92511|NCT00824473|322272|P1|Overall Study|Protocol Violation|2
92512|NCT00824473|322271|P2|Overall Study|Lack of Efficacy|2
92513|NCT00824473|322272|P1|Overall Study|Lack of Efficacy|2
92514|NCT00824473|322271|P2|Overall Study|Adverse Event|5
92515|NCT00824473|322272|P1|Overall Study|Adverse Event|4
92516|NCT00824421|322353|P3|Overall Study|Unspecified|0
92517|NCT00824421|322354|P2|Overall Study|Unspecified|1
92518|NCT00824421|322355|P1|Overall Study|Unspecified|0
92519|NCT00824421|322353|P3|Overall Study|Randomized but not Treated|0
92520|NCT00824421|322354|P2|Overall Study|Randomized but not Treated|1
92521|NCT00824421|322355|P1|Overall Study|Randomized but not Treated|1
92522|NCT00824421|322353|P3|Overall Study|Withdrawal by Subject|3
92523|NCT00824421|322354|P2|Overall Study|Withdrawal by Subject|3
92524|NCT00824421|322355|P1|Overall Study|Withdrawal by Subject|2
92525|NCT00824421|322353|P3|Overall Study|Pregnancy|1
92526|NCT00824421|322354|P2|Overall Study|Pregnancy|0
92527|NCT00824421|322355|P1|Overall Study|Pregnancy|1
92528|NCT00824421|322353|P3|Overall Study|Lost to Follow-up|0
92529|NCT00824421|322354|P2|Overall Study|Lost to Follow-up|3
92530|NCT00824421|322355|P1|Overall Study|Lost to Follow-up|2
92531|NCT00824421|322353|P3|Overall Study|Lack of Efficacy|4
92532|NCT00824421|322354|P2|Overall Study|Lack of Efficacy|7
92533|NCT00824421|322355|P1|Overall Study|Lack of Efficacy|5
92534|NCT00824421|322353|P3|Overall Study|Death|0
92535|NCT00824421|322354|P2|Overall Study|Death|1
92536|NCT00824421|322355|P1|Overall Study|Death|0
92537|NCT00824421|322353|P3|Overall Study|Adverse Event|6
92538|NCT00824421|322354|P2|Overall Study|Adverse Event|6
92539|NCT00824421|322355|P1|Overall Study|Adverse Event|6
92540|NCT00824408|322406|P5|Randomized Phase|Other reason not defined above|4
92541|NCT00824408|322407|P4|Randomized Phase|Other reason not defined above|2
92542|NCT00824408|322408|P3|Randomized Phase|Other reason not defined above|4
92543|NCT00824408|322409|P2|Randomized Phase|Other reason not defined above|0
92544|NCT00824408|322410|P1|Randomized Phase|Other reason not defined above|0
92545|NCT00824408|322406|P5|Randomized Phase|Refused to continue medication|2
92546|NCT00824408|322407|P4|Randomized Phase|Refused to continue medication|2
92547|NCT00824408|322408|P3|Randomized Phase|Refused to continue medication|2
92548|NCT00824408|322409|P2|Randomized Phase|Refused to continue medication|0
92549|NCT00824408|322410|P1|Randomized Phase|Refused to continue medication|0
92550|NCT00824408|322406|P5|Randomized Phase|Adverse Event|5
92551|NCT00824408|322407|P4|Randomized Phase|Adverse Event|5
92552|NCT00824408|322408|P3|Randomized Phase|Adverse Event|4
92553|NCT00824408|322409|P2|Randomized Phase|Adverse Event|0
92554|NCT00824408|322410|P1|Randomized Phase|Adverse Event|0
92555|NCT00824408|322406|P5|Randomized Phase|Progressive disease|34
92556|NCT00824408|322407|P4|Randomized Phase|Progressive disease|36
92557|NCT00824408|322408|P3|Randomized Phase|Progressive disease|25
92558|NCT00824408|322409|P2|Randomized Phase|Progressive disease|0
92559|NCT00824408|322410|P1|Randomized Phase|Progressive disease|0
92560|NCT00824408|322406|P5|Randomized Phase|Not treated|1
92561|NCT00824408|322407|P4|Randomized Phase|Not treated|1
92562|NCT00824408|322408|P3|Randomized Phase|Not treated|1
92563|NCT00824408|322409|P2|Randomized Phase|Not treated|0
92564|NCT00824408|322410|P1|Randomized Phase|Not treated|0
92565|NCT00824408|322406|P5|Run-in Phase|Other reason not defined above|0
92566|NCT00824408|322407|P4|Run-in Phase|Other reason not defined above|0
92567|NCT00824408|322408|P3|Run-in Phase|Other reason not defined above|0
92568|NCT00824408|322409|P2|Run-in Phase|Other reason not defined above|1
92570|NCT00824408|322406|P5|Run-in Phase|Refused to continue medication|0
92571|NCT00824408|322407|P4|Run-in Phase|Refused to continue medication|0
92572|NCT00824408|322408|P3|Run-in Phase|Refused to continue medication|0
92573|NCT00824408|322409|P2|Run-in Phase|Refused to continue medication|0
92574|NCT00824408|322410|P1|Run-in Phase|Refused to continue medication|1
92575|NCT00824408|322406|P5|Run-in Phase|Adverse Event|0
92576|NCT00824408|322407|P4|Run-in Phase|Adverse Event|0
92577|NCT00824408|322408|P3|Run-in Phase|Adverse Event|0
92578|NCT00824408|322409|P2|Run-in Phase|Adverse Event|1
92579|NCT00824408|322410|P1|Run-in Phase|Adverse Event|1
92580|NCT00824408|322406|P5|Run-in Phase|Progressive disease|0
92581|NCT00824408|322407|P4|Run-in Phase|Progressive disease|0
92582|NCT00824408|322408|P3|Run-in Phase|Progressive disease|0
92583|NCT00824408|322409|P2|Run-in Phase|Progressive disease|4
92584|NCT00824408|322410|P1|Run-in Phase|Progressive disease|4
92585|NCT00824382|322462|P4|Overall Study|Investigator's decision|0
92586|NCT00824382|322463|P3|Overall Study|Investigator's decision|2
92587|NCT00824382|322464|P2|Overall Study|Investigator's decision|1
92588|NCT00824382|322465|P1|Overall Study|Investigator's decision|0
92589|NCT00824382|322462|P4|Overall Study|Protocol Violation|1
92590|NCT00824382|322463|P3|Overall Study|Protocol Violation|0
92591|NCT00824382|322464|P2|Overall Study|Protocol Violation|0
92592|NCT00824382|322465|P1|Overall Study|Protocol Violation|1
92593|NCT00824382|322462|P4|Overall Study|Adverse Event|4
92594|NCT00824382|322463|P3|Overall Study|Adverse Event|1
92595|NCT00824382|322464|P2|Overall Study|Adverse Event|1
92596|NCT00824382|322465|P1|Overall Study|Adverse Event|4
92597|NCT00824369|322541|P6|Overall Study|Lost to Follow-up|0
92598|NCT00824369|322542|P5|Overall Study|Lost to Follow-up|1
92599|NCT00824369|322543|P4|Overall Study|Lost to Follow-up|0
92600|NCT00824369|322544|P3|Overall Study|Lost to Follow-up|0
92601|NCT00824369|322545|P2|Overall Study|Lost to Follow-up|0
92602|NCT00824369|322546|P1|Overall Study|Lost to Follow-up|0
92603|NCT00824369|322541|P6|Overall Study|Nolonger willing to participate in study|1
92604|NCT00824369|322542|P5|Overall Study|Nolonger willing to participate in study|0
92605|NCT00824369|322543|P4|Overall Study|Nolonger willing to participate in study|2
92606|NCT00824369|322544|P3|Overall Study|Nolonger willing to participate in study|1
92607|NCT00824369|322545|P2|Overall Study|Nolonger willing to participate in study|0
92608|NCT00824369|322546|P1|Overall Study|Nolonger willing to participate in study|1
92609|NCT00824291|322586|P2|Overall Study|Participant on prohibited medication|0
92610|NCT00824291|322587|P1|Overall Study|Participant on prohibited medication|1
92611|NCT00824291|322586|P2|Overall Study|Lack of Efficacy|8
92612|NCT00824291|322587|P1|Overall Study|Lack of Efficacy|7
92613|NCT00824291|322586|P2|Overall Study|Withdrawal by Subject|8
92614|NCT00824291|322587|P1|Overall Study|Withdrawal by Subject|14
92615|NCT00824291|322586|P2|Overall Study|Protocol Violation|1
92616|NCT00824291|322587|P1|Overall Study|Protocol Violation|4
92617|NCT00824291|322586|P2|Overall Study|Non-compliance|1
92618|NCT00824291|322587|P1|Overall Study|Non-compliance|1
92619|NCT00824291|322586|P2|Overall Study|Lost to Follow-up|9
92620|NCT00824291|322587|P1|Overall Study|Lost to Follow-up|11
92621|NCT00824291|322586|P2|Overall Study|Discontinuation of Study by Sponsor|2
92622|NCT00824291|322587|P1|Overall Study|Discontinuation of Study by Sponsor|1
92623|NCT00824291|322586|P2|Overall Study|Adverse Event|6
92624|NCT00824291|322587|P1|Overall Study|Adverse Event|15
92625|NCT00824265|322609|P2|Overall Study|Withdrawal by Subject|15
92626|NCT00824265|322610|P1|Overall Study|Withdrawal by Subject|6
92627|NCT00824265|322609|P2|Overall Study|Physician Decision|12
92628|NCT00824265|322610|P1|Overall Study|Physician Decision|6
92629|NCT00824265|322609|P2|Overall Study|Lost to Follow-up|1
92630|NCT00824265|322610|P1|Overall Study|Lost to Follow-up|1
92631|NCT00824265|322609|P2|Overall Study|Protocol Violation|0
92632|NCT00824265|322610|P1|Overall Study|Protocol Violation|1
92633|NCT00824265|322609|P2|Overall Study|Adverse Event,non-fatal|52
92634|NCT00824265|322610|P1|Overall Study|Adverse Event,non-fatal|50
92635|NCT00824161|322669|P1|Overall Study|Screen Failure|1
92636|NCT00824161|322669|P1|Overall Study|Withdrawal by Subject|1
92637|NCT00823264|322699|P2|Overall Study|Protocol Violation|0
92638|NCT00823264|322700|P1|Overall Study|Protocol Violation|2
92639|NCT00822172|322782|P2|Overall Study|Other|1
92640|NCT00822172|322783|P1|Overall Study|Other|0
92641|NCT00822172|322782|P2|Overall Study|site closed|1
92642|NCT00822172|322783|P1|Overall Study|site closed|0
92643|NCT00822172|322782|P2|Overall Study|Withdrawal by Subject|4
92644|NCT00822172|322783|P1|Overall Study|Withdrawal by Subject|1
92645|NCT00822172|322782|P2|Overall Study|Lost to Follow-up|1
92646|NCT00822172|322783|P1|Overall Study|Lost to Follow-up|3
92647|NCT00822172|322782|P2|Overall Study|Death|0
92648|NCT00822172|322783|P1|Overall Study|Death|1
92649|NCT00822172|322782|P2|Overall Study|Adverse Event|12
92650|NCT00822172|322783|P1|Overall Study|Adverse Event|10
92651|NCT00824005|322791|P2|Overall Study|Lost to Follow-up|1
92652|NCT00824005|322792|P1|Overall Study|Lost to Follow-up|0
92653|NCT00824005|322791|P2|Overall Study|Death|1
92654|NCT00824005|322792|P1|Overall Study|Death|0
92655|NCT00823979|322827|P3|Overall Study|Study Terminated by Sponsor|7
92656|NCT00823979|322828|P2|Overall Study|Study Terminated by Sponsor|5
92657|NCT00823979|322829|P1|Overall Study|Study Terminated by Sponsor|5
92658|NCT00823979|322827|P3|Overall Study|Randomized but not Treated|1
92659|NCT00823979|322828|P2|Overall Study|Randomized but not Treated|3
92660|NCT00823979|322829|P1|Overall Study|Randomized but not Treated|4
92661|NCT00823979|322827|P3|Overall Study|Unspecified|1
92662|NCT00823979|322828|P2|Overall Study|Unspecified|0
92663|NCT00823979|322829|P1|Overall Study|Unspecified|2
92664|NCT00823979|322827|P3|Overall Study|Adverse Event|4
92665|NCT00823979|322828|P2|Overall Study|Adverse Event|2
92666|NCT00823979|322829|P1|Overall Study|Adverse Event|0
92667|NCT00823979|322827|P3|Overall Study|Pregnancy|0
92668|NCT00823979|322828|P2|Overall Study|Pregnancy|1
92669|NCT00823979|322829|P1|Overall Study|Pregnancy|0
92670|NCT00823979|322827|P3|Overall Study|Protocol Violation|0
92671|NCT00823979|322828|P2|Overall Study|Protocol Violation|1
92672|NCT00823979|322829|P1|Overall Study|Protocol Violation|1
92673|NCT00823979|322827|P3|Overall Study|Withdrawal by Subject|2
92674|NCT00823979|322828|P2|Overall Study|Withdrawal by Subject|3
92675|NCT00823979|322829|P1|Overall Study|Withdrawal by Subject|2
92676|NCT00823979|322827|P3|Overall Study|Lost to Follow-up|0
92677|NCT00823979|322828|P2|Overall Study|Lost to Follow-up|1
92678|NCT00823979|322829|P1|Overall Study|Lost to Follow-up|2
92679|NCT00823979|322827|P3|Overall Study|Lack of Efficacy|9
92680|NCT00823979|322828|P2|Overall Study|Lack of Efficacy|16
92681|NCT00823979|322829|P1|Overall Study|Lack of Efficacy|13
92682|NCT00823901|322874|P2|Overall Study|Lost to Follow-up|1
92683|NCT00823901|322875|P1|Overall Study|Lost to Follow-up|2
92684|NCT00823901|322874|P2|Overall Study|Lack of Efficacy|0
92685|NCT00823901|322875|P1|Overall Study|Lack of Efficacy|1
92686|NCT00823901|322874|P2|Overall Study|Adverse Event|1
92687|NCT00823901|322875|P1|Overall Study|Adverse Event|1
92688|NCT00823836|322883|P2|Long-term Phase|Withdrawal by Subject|1
92689|NCT00823836|322884|P1|Long-term Phase|Withdrawal by Subject|1
92690|NCT00823836|322883|P2|Long-term Phase|Physician Decision|2
92691|NCT00823836|322884|P1|Long-term Phase|Physician Decision|1
92692|NCT00823836|322883|P2|Long-term Phase|Adverse Event|2
92693|NCT00823836|322884|P1|Long-term Phase|Adverse Event|3
92694|NCT00823836|322883|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
92695|NCT00823836|322884|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
92696|NCT00823836|322883|P2|NV and PR/XR Switching Phases|Physician Decision|2
92697|NCT00823836|322884|P1|NV and PR/XR Switching Phases|Physician Decision|5
92698|NCT00823836|322883|P2|NV and PR/XR Switching Phases|Protocol Violation|1
92699|NCT00823836|322884|P1|NV and PR/XR Switching Phases|Protocol Violation|1
92700|NCT00823836|322883|P2|NV and PR/XR Switching Phases|Adverse Event|21
92701|NCT00823836|322884|P1|NV and PR/XR Switching Phases|Adverse Event|22
92702|NCT00823823|322990|P2|Overall Study|Protocol Violation|5
92703|NCT00823823|322991|P1|Overall Study|Protocol Violation|5
92704|NCT00823823|322990|P2|Overall Study|Lost to Follow-up|1
92705|NCT00823823|322991|P1|Overall Study|Lost to Follow-up|3
92706|NCT00823719|323001|P2|Overall Study|Disease Progression|4
92707|NCT00823719|323002|P1|Overall Study|Disease Progression|4
92708|NCT00823719|323001|P2|Overall Study|Withdrawal by Subject|1
92709|NCT00823719|323002|P1|Overall Study|Withdrawal by Subject|0
92710|NCT00823719|323001|P2|Overall Study|Physician Decision|4
92711|NCT00823719|323002|P1|Overall Study|Physician Decision|1
92712|NCT00823719|323001|P2|Overall Study|Adverse Event|2
92713|NCT00823719|323002|P1|Overall Study|Adverse Event|1
92714|NCT00823615|323055|P2|Period 2|Time/Job Conflict|2
92715|NCT00823615|323056|P1|Period 2|Time/Job Conflict|1
92716|NCT00823615|323055|P2|Period 2|Lost to Follow-up|0
92717|NCT00823615|323056|P1|Period 2|Lost to Follow-up|2
92718|NCT00823472|323066|P2|Overall Study|Physician Decision|28
92719|NCT00823472|323067|P1|Overall Study|Physician Decision|24
92720|NCT00823212|323086|P2|Overall Study|Missed 12-month visit|21
92721|NCT00823212|323087|P1|Overall Study|Missed 12-month visit|21
92722|NCT00823212|323086|P2|Overall Study|Incarcerated|1
92723|NCT00823212|323087|P1|Overall Study|Incarcerated|0
92724|NCT00823212|323086|P2|Overall Study|Withdrawal by Subject|1
92725|NCT00823212|323087|P1|Overall Study|Withdrawal by Subject|6
92726|NCT00823212|323086|P2|Overall Study|Death|10
92727|NCT00823212|323087|P1|Overall Study|Death|8
92728|NCT00823199|323169|P1|Overall Study|Withdrawal by Subject|2
92729|NCT00822900|323238|P2|Overall Study|Became a ward of the state|1
92730|NCT00822900|323239|P1|Overall Study|Became a ward of the state|2
92731|NCT00822900|323238|P2|Overall Study|Death|69
92732|NCT00822900|323239|P1|Overall Study|Death|83
92733|NCT00822900|323238|P2|Overall Study|Lost to Follow-up|9
92734|NCT00822900|323239|P1|Overall Study|Lost to Follow-up|9
92735|NCT00822900|323238|P2|Overall Study|Withdrawal by Subject|14
92736|NCT00822900|323239|P1|Overall Study|Withdrawal by Subject|14
92737|NCT00822692|323286|P2|Overall Study|Lost to Follow-up|25
92738|NCT00822692|323287|P1|Overall Study|Lost to Follow-up|17
92739|NCT00822237|323425|P2|Dose 2 Vaccination|Lost to Follow-up|9
92740|NCT00822237|323426|P1|Dose 2 Vaccination|Lost to Follow-up|2
92741|NCT00822237|323425|P2|Dose 2 Vaccination|Withdrawal by Subject|2
92742|NCT00822237|323426|P1|Dose 2 Vaccination|Withdrawal by Subject|2
92743|NCT00822237|323425|P2|Dose 1 Vaccination|Lost to Follow-up|12
92744|NCT00822237|323426|P1|Dose 1 Vaccination|Lost to Follow-up|9
92745|NCT00822237|323425|P2|Dose 1 Vaccination|Withdrawal by Subject|14
92746|NCT00822237|323426|P1|Dose 1 Vaccination|Withdrawal by Subject|13
92747|NCT00822237|323425|P2|Dose 1 Vaccination|Not vaccinated|0
92748|NCT00822237|323426|P1|Dose 1 Vaccination|Not vaccinated|3
92749|NCT00821873|323442|P1|Overall Study|Lost to Follow-up|4
92750|NCT00821678|323463|P2|Overall Study|Death|2
92751|NCT00821678|323464|P1|Overall Study|Death|0
92752|NCT00821678|323463|P2|Overall Study|Lost to Follow-up|12
92753|NCT00821678|323464|P1|Overall Study|Lost to Follow-up|13
92754|NCT00821678|323463|P2|Overall Study|Withdrawal by Subject|0
92755|NCT00821678|323464|P1|Overall Study|Withdrawal by Subject|8
92756|NCT00821587|323482|P2|Overall Study|Physician Decision|1
92757|NCT00821587|323483|P1|Overall Study|Physician Decision|0
92758|NCT00821509|323492|P3|Overall Study|Withdrawal by Subject|34
92759|NCT00821509|323493|P2|Overall Study|Withdrawal by Subject|11
92760|NCT00821509|323494|P1|Overall Study|Withdrawal by Subject|12
92761|NCT00821431|323507|P2|Overall Study|Physician Decision|1
92762|NCT00821431|323508|P1|Overall Study|Physician Decision|0
92763|NCT00821431|323507|P2|Overall Study|Protocol Violation|1
92764|NCT00821431|323508|P1|Overall Study|Protocol Violation|3
92765|NCT00821431|323507|P2|Overall Study|Lost to Follow-up|0
92766|NCT00821431|323508|P1|Overall Study|Lost to Follow-up|1
92767|NCT00821431|323507|P2|Overall Study|Withdrawal by Subject|0
92768|NCT00821431|323508|P1|Overall Study|Withdrawal by Subject|5
92769|NCT00821431|323507|P2|Overall Study|Adverse Event|3
92770|NCT00821431|323508|P1|Overall Study|Adverse Event|6
92771|NCT00821327|323516|P1|Overall Study|Other/Unknown|5
92772|NCT00821327|323516|P1|Overall Study|Disease Progression|13
92773|NCT00821327|323516|P1|Overall Study|Sponsor Request|1
92774|NCT00821327|323516|P1|Overall Study|Investigator Request|2
92775|NCT00821327|323516|P1|Overall Study|Patient Request|1
92776|NCT00821327|323516|P1|Overall Study|Adverse Event|13
92777|NCT00821236|323525|P1|Overall Study|Lost to Follow-up|3
92778|NCT00821093|323563|P2|Overall Study|Administrative problems|2
92779|NCT00821093|323564|P1|Overall Study|Administrative problems|1
92780|NCT00821093|323563|P2|Overall Study|Abnormal test procedure result(s)|1
92781|NCT00821093|323564|P1|Overall Study|Abnormal test procedure result(s)|1
92782|NCT00821093|323563|P2|Overall Study|Death|1
92783|NCT00821093|323564|P1|Overall Study|Death|2
92784|NCT00821093|323563|P2|Overall Study|Lack of Efficacy|2
92785|NCT00821093|323564|P1|Overall Study|Lack of Efficacy|2
92786|NCT00821093|323563|P2|Overall Study|Abnormal laboratory value(s)|0
92787|NCT00821093|323564|P1|Overall Study|Abnormal laboratory value(s)|2
92788|NCT00821093|323563|P2|Overall Study|Protocol deviation|6
92789|NCT00821093|323564|P1|Overall Study|Protocol deviation|3
92790|NCT00821093|323563|P2|Overall Study|Lost to Follow-up|3
92791|NCT00821093|323564|P1|Overall Study|Lost to Follow-up|9
92792|NCT00821093|323563|P2|Overall Study|Withdrawal by Subject|13
92793|NCT00821093|323564|P1|Overall Study|Withdrawal by Subject|9
92794|NCT00821093|323563|P2|Overall Study|Adverse Event|12
92795|NCT00821093|323564|P1|Overall Study|Adverse Event|20
92796|NCT00820755|323583|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
92797|NCT00820755|323584|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
92798|NCT00820755|323585|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
92799|NCT00820755|323583|P3|Period 1: Combination Therapy Phase|Unspecified|0
92800|NCT00820755|323584|P2|Period 1: Combination Therapy Phase|Unspecified|0
92801|NCT00820755|323585|P1|Period 1: Combination Therapy Phase|Unspecified|11
92802|NCT00820755|323583|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
92803|NCT00820755|323584|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
92804|NCT00820755|323585|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
92805|NCT00820755|323583|P3|Period 1: Combination Therapy Phase|Progressive disease|0
92806|NCT00820755|323584|P2|Period 1: Combination Therapy Phase|Progressive disease|0
92807|NCT00820755|323585|P1|Period 1: Combination Therapy Phase|Progressive disease|114
92808|NCT00820755|323583|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
92809|NCT00820755|323584|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
92810|NCT00820755|323585|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
92811|NCT00820755|323583|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
92812|NCT00820755|323584|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
92813|NCT00820755|323585|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
92814|NCT00820755|323583|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
92815|NCT00820755|323584|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
92816|NCT00820755|323585|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
92817|NCT00820755|323583|P3|Period 1: Combination Therapy Phase|Death|0
92818|NCT00820755|323584|P2|Period 1: Combination Therapy Phase|Death|0
92819|NCT00820755|323585|P1|Period 1: Combination Therapy Phase|Death|28
92820|NCT00820755|323583|P3|Period 1: Combination Therapy Phase|Adverse Event|0
92821|NCT00820755|323584|P2|Period 1: Combination Therapy Phase|Adverse Event|0
92822|NCT00820755|323585|P1|Period 1: Combination Therapy Phase|Adverse Event|77
92823|NCT00820222|323678|P2|Overall Study|Ongoing|191
92824|NCT00820222|323679|P1|Overall Study|Ongoing|185
92825|NCT00820222|323678|P2|Overall Study|Sponsor Terminated Study|1
92826|NCT00820222|323679|P1|Overall Study|Sponsor Terminated Study|0
92827|NCT00820222|323678|P2|Overall Study|Physician Decision|6
92828|NCT00820222|323679|P1|Overall Study|Physician Decision|4
92829|NCT00820222|323678|P2|Overall Study|Withdrawal by Subject|9
92830|NCT00820222|323679|P1|Overall Study|Withdrawal by Subject|8
92831|NCT00820222|323678|P2|Overall Study|Lost to Follow-up|4
92832|NCT00820222|323679|P1|Overall Study|Lost to Follow-up|4
92833|NCT00819156|323746|P6|Overall Study|Prostate-specific antigen progression|0
92834|NCT00819156|323747|P5|Overall Study|Prostate-specific antigen progression|1
92835|NCT00819156|323748|P4|Overall Study|Prostate-specific antigen progression|0
92836|NCT00819156|323749|P3|Overall Study|Prostate-specific antigen progression|0
92837|NCT00819156|323750|P2|Overall Study|Prostate-specific antigen progression|0
92838|NCT00819156|323751|P1|Overall Study|Prostate-specific antigen progression|0
92839|NCT00819156|323746|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
92840|NCT00819156|323747|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
92841|NCT00819156|323748|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
92842|NCT00819156|323749|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
92843|NCT00819156|323750|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
92844|NCT00819156|323751|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
92845|NCT00819156|323746|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
92846|NCT00819156|323747|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
92847|NCT00819156|323748|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
92848|NCT00819156|323749|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
92849|NCT00819156|323750|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
92850|NCT00819156|323751|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
92851|NCT00819156|323746|P6|Overall Study|Lost to Follow-up|2
92852|NCT00819156|323747|P5|Overall Study|Lost to Follow-up|0
92853|NCT00819156|323748|P4|Overall Study|Lost to Follow-up|0
92854|NCT00819156|323749|P3|Overall Study|Lost to Follow-up|0
92855|NCT00819156|323750|P2|Overall Study|Lost to Follow-up|1
92856|NCT00819156|323751|P1|Overall Study|Lost to Follow-up|0
92857|NCT00819156|323746|P6|Overall Study|Protocol Violation|1
92858|NCT00819156|323747|P5|Overall Study|Protocol Violation|0
92859|NCT00819156|323748|P4|Overall Study|Protocol Violation|0
92860|NCT00819156|323749|P3|Overall Study|Protocol Violation|1
92861|NCT00819156|323750|P2|Overall Study|Protocol Violation|0
92862|NCT00819156|323751|P1|Overall Study|Protocol Violation|1
92863|NCT00819156|323746|P6|Overall Study|Withdrawal by Subject|0
92864|NCT00819156|323747|P5|Overall Study|Withdrawal by Subject|1
92865|NCT00819156|323748|P4|Overall Study|Withdrawal by Subject|0
92866|NCT00819156|323749|P3|Overall Study|Withdrawal by Subject|2
92867|NCT00819156|323750|P2|Overall Study|Withdrawal by Subject|3
92868|NCT00819156|323751|P1|Overall Study|Withdrawal by Subject|0
92869|NCT00819156|323746|P6|Overall Study|Adverse Event|3
92870|NCT00819156|323747|P5|Overall Study|Adverse Event|2
92871|NCT00819156|323748|P4|Overall Study|Adverse Event|1
92872|NCT00819156|323749|P3|Overall Study|Adverse Event|2
92873|NCT00819156|323750|P2|Overall Study|Adverse Event|4
92874|NCT00819156|323751|P1|Overall Study|Adverse Event|1
92875|NCT00819910|323843|P4|Overall Study|Lost to Follow-up|0
92876|NCT00819910|323844|P3|Overall Study|Lost to Follow-up|0
92877|NCT00819910|323845|P2|Overall Study|Lost to Follow-up|0
92878|NCT00819910|323846|P1|Overall Study|Lost to Follow-up|1
92879|NCT00819910|323843|P4|Overall Study|Withdrawal by Subject|0
92880|NCT00819910|323844|P3|Overall Study|Withdrawal by Subject|1
92881|NCT00819910|323845|P2|Overall Study|Withdrawal by Subject|1
92882|NCT00819910|323846|P1|Overall Study|Withdrawal by Subject|1
92883|NCT00819910|323843|P4|Overall Study|Adverse Event|1
92884|NCT00819910|323844|P3|Overall Study|Adverse Event|2
92885|NCT00819910|323845|P2|Overall Study|Adverse Event|0
92886|NCT00819910|323846|P1|Overall Study|Adverse Event|0
92887|NCT00819832|323878|P6|Overall Study|Sponsor Termination of Study|0
92888|NCT00819832|323879|P5|Overall Study|Sponsor Termination of Study|0
92889|NCT00819832|323880|P4|Overall Study|Sponsor Termination of Study|0
92890|NCT00819832|323881|P3|Overall Study|Sponsor Termination of Study|0
92891|NCT00819832|323882|P2|Overall Study|Sponsor Termination of Study|0
92892|NCT00819832|323883|P1|Overall Study|Sponsor Termination of Study|3
92893|NCT00819780|323899|P2|Overall Study|Still in treatment|17
92894|NCT00819780|323900|P1|Overall Study|Still in treatment|25
92895|NCT00819780|323899|P2|Overall Study|Did not receive study drug|4
92896|NCT00819780|323900|P1|Overall Study|Did not receive study drug|3
92897|NCT00819767|323934|P2|Overall Study|Unsatisfactory therapeutic effect|2
92898|NCT00819767|323935|P1|Overall Study|Unsatisfactory therapeutic effect|1
92899|NCT00819741|323947|P2|Overall Study|Reasons unknown|3
92900|NCT00819741|323948|P1|Overall Study|Reasons unknown|3
92901|NCT00819741|323947|P2|Overall Study|Unclassified|0
92902|NCT00819741|323948|P1|Overall Study|Unclassified|6
92903|NCT00819741|323947|P2|Overall Study|Withdrawal by Subject|2
92904|NCT00819741|323948|P1|Overall Study|Withdrawal by Subject|2
92905|NCT00819741|323947|P2|Overall Study|Protocol Violation|4
92906|NCT00819741|323948|P1|Overall Study|Protocol Violation|3
92907|NCT00819741|323947|P2|Overall Study|Lost to Follow-up|1
92908|NCT00819741|323948|P1|Overall Study|Lost to Follow-up|3
92909|NCT00819741|323947|P2|Overall Study|Lack of Efficacy|2
92910|NCT00819741|323948|P1|Overall Study|Lack of Efficacy|0
92911|NCT00819741|323947|P2|Overall Study|Adverse Event|2
92912|NCT00819741|323948|P1|Overall Study|Adverse Event|5
92913|NCT00819585|324002|P7|Overall Study|Protocol Violation|3
92914|NCT00819585|324003|P6|Overall Study|Protocol Violation|1
92915|NCT00819585|324004|P5|Overall Study|Protocol Violation|0
92916|NCT00819585|324005|P4|Overall Study|Protocol Violation|0
92917|NCT00819585|324006|P3|Overall Study|Protocol Violation|1
92918|NCT00819585|324007|P2|Overall Study|Protocol Violation|0
92919|NCT00819585|324008|P1|Overall Study|Protocol Violation|0
92920|NCT00819585|324002|P7|Overall Study|Death|1
92921|NCT00819585|324003|P6|Overall Study|Death|0
92922|NCT00819585|324004|P5|Overall Study|Death|0
92923|NCT00819585|324005|P4|Overall Study|Death|0
92924|NCT00819585|324006|P3|Overall Study|Death|0
92925|NCT00819585|324007|P2|Overall Study|Death|0
92926|NCT00819585|324008|P1|Overall Study|Death|0
92927|NCT00819585|324002|P7|Overall Study|Administrative problems|2
92928|NCT00819585|324003|P6|Overall Study|Administrative problems|0
92929|NCT00819585|324004|P5|Overall Study|Administrative problems|0
92930|NCT00819585|324005|P4|Overall Study|Administrative problems|0
92931|NCT00819585|324006|P3|Overall Study|Administrative problems|0
92932|NCT00819585|324007|P2|Overall Study|Administrative problems|0
92933|NCT00819585|324008|P1|Overall Study|Administrative problems|0
92934|NCT00819585|324002|P7|Overall Study|Lost to Follow-up|1
92935|NCT00819585|324003|P6|Overall Study|Lost to Follow-up|1
92936|NCT00819585|324004|P5|Overall Study|Lost to Follow-up|1
92937|NCT00819585|324005|P4|Overall Study|Lost to Follow-up|0
92938|NCT00819585|324006|P3|Overall Study|Lost to Follow-up|2
92939|NCT00819585|324007|P2|Overall Study|Lost to Follow-up|1
92940|NCT00819585|324008|P1|Overall Study|Lost to Follow-up|2
92941|NCT00819585|324002|P7|Overall Study|Subject withdrew consent|3
92942|NCT00819585|324003|P6|Overall Study|Subject withdrew consent|0
92943|NCT00819585|324004|P5|Overall Study|Subject withdrew consent|0
92944|NCT00819585|324005|P4|Overall Study|Subject withdrew consent|1
92945|NCT00819585|324006|P3|Overall Study|Subject withdrew consent|2
92946|NCT00819585|324007|P2|Overall Study|Subject withdrew consent|3
92947|NCT00819585|324008|P1|Overall Study|Subject withdrew consent|0
92948|NCT00819585|324002|P7|Overall Study|Subject no longer requires study drug|0
92949|NCT00819585|324003|P6|Overall Study|Subject no longer requires study drug|0
92950|NCT00819585|324004|P5|Overall Study|Subject no longer requires study drug|1
92951|NCT00819585|324005|P4|Overall Study|Subject no longer requires study drug|0
92952|NCT00819585|324006|P3|Overall Study|Subject no longer requires study drug|0
92953|NCT00819585|324007|P2|Overall Study|Subject no longer requires study drug|0
92954|NCT00819585|324008|P1|Overall Study|Subject no longer requires study drug|0
92955|NCT00819585|324002|P7|Overall Study|Unsatisfactory therapeutic effect|1
92956|NCT00819585|324003|P6|Overall Study|Unsatisfactory therapeutic effect|0
92957|NCT00819585|324004|P5|Overall Study|Unsatisfactory therapeutic effect|0
92958|NCT00819585|324005|P4|Overall Study|Unsatisfactory therapeutic effect|0
92959|NCT00819585|324006|P3|Overall Study|Unsatisfactory therapeutic effect|0
92960|NCT00819585|324007|P2|Overall Study|Unsatisfactory therapeutic effect|1
92961|NCT00819585|324008|P1|Overall Study|Unsatisfactory therapeutic effect|0
92962|NCT00819585|324002|P7|Overall Study|Abnormal laboratory value(s)|0
92963|NCT00819585|324003|P6|Overall Study|Abnormal laboratory value(s)|0
92964|NCT00819585|324004|P5|Overall Study|Abnormal laboratory value(s)|0
92965|NCT00819585|324005|P4|Overall Study|Abnormal laboratory value(s)|0
92966|NCT00819585|324006|P3|Overall Study|Abnormal laboratory value(s)|0
92967|NCT00819585|324007|P2|Overall Study|Abnormal laboratory value(s)|0
92968|NCT00819585|324008|P1|Overall Study|Abnormal laboratory value(s)|2
92969|NCT00819585|324002|P7|Overall Study|Adverse Event|2
92970|NCT00819585|324003|P6|Overall Study|Adverse Event|0
92971|NCT00819585|324004|P5|Overall Study|Adverse Event|1
92972|NCT00819585|324005|P4|Overall Study|Adverse Event|4
92973|NCT00819585|324006|P3|Overall Study|Adverse Event|1
92974|NCT00819585|324007|P2|Overall Study|Adverse Event|1
92975|NCT00819585|324008|P1|Overall Study|Adverse Event|2
92976|NCT00819390|324080|P4|Overall Study|Adverse Event|0
92977|NCT00819390|324081|P3|Overall Study|Adverse Event|1
92978|NCT00819390|324082|P2|Overall Study|Adverse Event|0
92979|NCT00819390|324083|P1|Overall Study|Adverse Event|0
92980|NCT00819390|324080|P4|Overall Study|Withdrawal by Subject|0
92981|NCT00819390|324081|P3|Overall Study|Withdrawal by Subject|0
92982|NCT00819390|324082|P2|Overall Study|Withdrawal by Subject|0
92983|NCT00819390|324083|P1|Overall Study|Withdrawal by Subject|2
92984|NCT00819390|324080|P4|Overall Study|Lost to Follow-up|0
92985|NCT00819390|324081|P3|Overall Study|Lost to Follow-up|0
92986|NCT00819390|324082|P2|Overall Study|Lost to Follow-up|1
92987|NCT00819390|324083|P1|Overall Study|Lost to Follow-up|1
92988|NCT00819247|324219|P3|Overall Study|not specified|0
92989|NCT00819247|324220|P2|Overall Study|not specified|0
92990|NCT00819247|324221|P1|Overall Study|not specified|1
92991|NCT00819247|324219|P3|Overall Study|Bad prostate-specific antigen response|0
92992|NCT00819247|324220|P2|Overall Study|Bad prostate-specific antigen response|2
92993|NCT00819247|324221|P1|Overall Study|Bad prostate-specific antigen response|3
92994|NCT00819247|324219|P3|Overall Study|Mistakenly withdrawn|0
92995|NCT00819247|324220|P2|Overall Study|Mistakenly withdrawn|1
92996|NCT00819247|324221|P1|Overall Study|Mistakenly withdrawn|0
92997|NCT00819247|324219|P3|Overall Study|Protocol Violation|1
92998|NCT00819247|324220|P2|Overall Study|Protocol Violation|0
92999|NCT00819247|324221|P1|Overall Study|Protocol Violation|1
93000|NCT00819247|324219|P3|Overall Study|Withdrawal by Subject|0
93001|NCT00819247|324220|P2|Overall Study|Withdrawal by Subject|0
93002|NCT00819247|324221|P1|Overall Study|Withdrawal by Subject|1
93003|NCT00819247|324219|P3|Overall Study|Insufficient testosterone response|10
93004|NCT00819247|324220|P2|Overall Study|Insufficient testosterone response|8
93005|NCT00819247|324221|P1|Overall Study|Insufficient testosterone response|5
93006|NCT00819247|324219|P3|Overall Study|Adverse Event|3
93007|NCT00819247|324220|P2|Overall Study|Adverse Event|5
93008|NCT00819247|324221|P1|Overall Study|Adverse Event|0
93009|NCT00819234|324247|P10|Overall Study|Lost to Follow-up|2
93010|NCT00819234|324248|P9|Overall Study|Lost to Follow-up|1
93011|NCT00819234|324249|P8|Overall Study|Lost to Follow-up|1
93012|NCT00819234|324250|P7|Overall Study|Lost to Follow-up|1
93013|NCT00819234|324251|P6|Overall Study|Lost to Follow-up|1
93014|NCT00819234|324252|P5|Overall Study|Lost to Follow-up|1
93015|NCT00819234|324253|P4|Overall Study|Lost to Follow-up|2
93016|NCT00819234|324254|P3|Overall Study|Lost to Follow-up|0
93017|NCT00819234|324255|P2|Overall Study|Lost to Follow-up|2
93018|NCT00819234|324256|P1|Overall Study|Lost to Follow-up|2
93019|NCT00819234|324247|P10|Overall Study|Protocol Violation|0
93020|NCT00819234|324248|P9|Overall Study|Protocol Violation|0
93021|NCT00819234|324249|P8|Overall Study|Protocol Violation|0
93022|NCT00819234|324250|P7|Overall Study|Protocol Violation|0
93023|NCT00819234|324251|P6|Overall Study|Protocol Violation|0
93024|NCT00819234|324252|P5|Overall Study|Protocol Violation|0
93025|NCT00819234|324253|P4|Overall Study|Protocol Violation|0
93026|NCT00819234|324254|P3|Overall Study|Protocol Violation|1
93027|NCT00819234|324255|P2|Overall Study|Protocol Violation|0
93028|NCT00819234|324256|P1|Overall Study|Protocol Violation|0
93029|NCT00819234|324247|P10|Overall Study|Physician Decision|2
93030|NCT00819234|324248|P9|Overall Study|Physician Decision|0
93031|NCT00819234|324249|P8|Overall Study|Physician Decision|0
93032|NCT00819234|324250|P7|Overall Study|Physician Decision|0
93033|NCT00819234|324251|P6|Overall Study|Physician Decision|0
93034|NCT00819234|324252|P5|Overall Study|Physician Decision|0
93035|NCT00819234|324253|P4|Overall Study|Physician Decision|1
93036|NCT00819234|324254|P3|Overall Study|Physician Decision|0
93037|NCT00819234|324255|P2|Overall Study|Physician Decision|0
93038|NCT00819234|324256|P1|Overall Study|Physician Decision|0
93039|NCT00819234|324247|P10|Overall Study|Adverse Event|0
93040|NCT00819234|324248|P9|Overall Study|Adverse Event|0
93041|NCT00819234|324249|P8|Overall Study|Adverse Event|0
93042|NCT00819234|324250|P7|Overall Study|Adverse Event|0
93043|NCT00819234|324251|P6|Overall Study|Adverse Event|2
93044|NCT00819234|324252|P5|Overall Study|Adverse Event|0
93045|NCT00819234|324253|P4|Overall Study|Adverse Event|0
93046|NCT00819234|324254|P3|Overall Study|Adverse Event|1
93047|NCT00819234|324255|P2|Overall Study|Adverse Event|0
93048|NCT00819234|324256|P1|Overall Study|Adverse Event|0
93049|NCT00819234|324247|P10|Overall Study|Withdrawal by Subject|3
93050|NCT00819234|324248|P9|Overall Study|Withdrawal by Subject|5
93051|NCT00819234|324249|P8|Overall Study|Withdrawal by Subject|8
93052|NCT00819234|324250|P7|Overall Study|Withdrawal by Subject|4
93053|NCT00819234|324251|P6|Overall Study|Withdrawal by Subject|4
93054|NCT00819234|324252|P5|Overall Study|Withdrawal by Subject|0
93055|NCT00819234|324253|P4|Overall Study|Withdrawal by Subject|3
93056|NCT00819234|324254|P3|Overall Study|Withdrawal by Subject|6
93057|NCT00819234|324255|P2|Overall Study|Withdrawal by Subject|13
93058|NCT00819234|324256|P1|Overall Study|Withdrawal by Subject|8
93059|NCT00819091|324416|P2|Overall Study|Not Specified|2
93060|NCT00819091|324417|P1|Overall Study|Not Specified|1
93061|NCT00819091|324416|P2|Overall Study|Withdrawal by Subject|2
93062|NCT00819091|324417|P1|Overall Study|Withdrawal by Subject|1
93063|NCT00819091|324416|P2|Overall Study|Lost to Follow-up|0
93064|NCT00819091|324417|P1|Overall Study|Lost to Follow-up|2
93065|NCT00819091|324416|P2|Overall Study|Protocol Violation|1
93066|NCT00819091|324417|P1|Overall Study|Protocol Violation|0
93067|NCT00819091|324416|P2|Overall Study|Adverse Event|5
93068|NCT00819091|324417|P1|Overall Study|Adverse Event|3
93069|NCT00819052|324443|P2|Overall Study|Death or events leading to death|0
93070|NCT00819052|324444|P1|Overall Study|Death or events leading to death|1
93071|NCT00819052|324443|P2|Overall Study|Pregnancy|2
93072|NCT00819052|324444|P1|Overall Study|Pregnancy|1
93073|NCT00819052|324443|P2|Overall Study|Lack of Efficacy|1
93074|NCT00819052|324444|P1|Overall Study|Lack of Efficacy|1
93075|NCT00819052|324443|P2|Overall Study|Withdrawal by Subject|2
93076|NCT00819052|324444|P1|Overall Study|Withdrawal by Subject|1
93077|NCT00819052|324443|P2|Overall Study|Lost to Follow-up|2
93078|NCT00819052|324444|P1|Overall Study|Lost to Follow-up|1
93079|NCT00819052|324443|P2|Overall Study|Protocol Violation|2
93080|NCT00819052|324444|P1|Overall Study|Protocol Violation|1
93081|NCT00819052|324443|P2|Overall Study|Adverse Event|5
93082|NCT00819052|324444|P1|Overall Study|Adverse Event|0
93083|NCT00819039|324559|P3|Overall Study|Protocol Violation|0
93084|NCT00819039|324560|P2|Overall Study|Protocol Violation|0
93085|NCT00819039|324561|P1|Overall Study|Protocol Violation|1
93086|NCT00819039|324559|P3|Overall Study|Physician Decision|1
93087|NCT00819039|324560|P2|Overall Study|Physician Decision|0
93088|NCT00819039|324561|P1|Overall Study|Physician Decision|1
93089|NCT00819013|324591|P4|Overall Study|Death|1
93090|NCT00819013|324592|P3|Overall Study|Death|0
93091|NCT00819013|324593|P2|Overall Study|Death|0
93092|NCT00819013|324594|P1|Overall Study|Death|0
93093|NCT00819013|324591|P4|Overall Study|Lost to Follow-up|2
93094|NCT00819013|324592|P3|Overall Study|Lost to Follow-up|1
93095|NCT00819013|324593|P2|Overall Study|Lost to Follow-up|0
93096|NCT00819013|324594|P1|Overall Study|Lost to Follow-up|0
93097|NCT00819013|324591|P4|Overall Study|Withdrawal by Subject|0
93098|NCT00819013|324592|P3|Overall Study|Withdrawal by Subject|1
93099|NCT00819013|324593|P2|Overall Study|Withdrawal by Subject|0
93100|NCT00819013|324594|P1|Overall Study|Withdrawal by Subject|1
93101|NCT00819013|324591|P4|Overall Study|Adverse Event|0
93102|NCT00819013|324592|P3|Overall Study|Adverse Event|1
93103|NCT00819013|324593|P2|Overall Study|Adverse Event|0
93104|NCT00819013|324594|P1|Overall Study|Adverse Event|0
93105|NCT00819013|324591|P4|Overall Study|Not meeting continuing study eligibility|1
93106|NCT00819013|324592|P3|Overall Study|Not meeting continuing study eligibility|2
93107|NCT00819013|324593|P2|Overall Study|Not meeting continuing study eligibility|1
93108|NCT00819013|324594|P1|Overall Study|Not meeting continuing study eligibility|2
93109|NCT00818883|324660|P2|Overall Study|Other|7
93110|NCT00818883|324661|P1|Overall Study|Other|2
93111|NCT00818883|324660|P2|Overall Study|Lack of Efficacy|2
93112|NCT00818883|324661|P1|Overall Study|Lack of Efficacy|0
93113|NCT00818883|324660|P2|Overall Study|Withdrawal by Subject|14
93114|NCT00818883|324661|P1|Overall Study|Withdrawal by Subject|16
93115|NCT00818883|324660|P2|Overall Study|Lost to Follow-up|2
93116|NCT00818883|324661|P1|Overall Study|Lost to Follow-up|3
93117|NCT00818883|324660|P2|Overall Study|Protocol Violation|2
93118|NCT00818883|324661|P1|Overall Study|Protocol Violation|2
93119|NCT00818883|324660|P2|Overall Study|Adverse Event|19
93120|NCT00818883|324661|P1|Overall Study|Adverse Event|28
93121|NCT00818779|324708|P2|Overall Study|Adverse Event|1
93122|NCT00818779|324709|P1|Overall Study|Adverse Event|4
93123|NCT00818779|324708|P2|Overall Study|Lost to Follow-up|0
93124|NCT00818779|324709|P1|Overall Study|Lost to Follow-up|1
93125|NCT00818779|324708|P2|Overall Study|Protocol Violation|0
93126|NCT00818779|324709|P1|Overall Study|Protocol Violation|1
93127|NCT00818753|324718|P3|Overall Study|Randomised and not treated|0
93128|NCT00818753|324719|P2|Overall Study|Randomised and not treated|0
93129|NCT00818753|324720|P1|Overall Study|Randomised and not treated|2
93130|NCT00818753|324718|P3|Overall Study|Other reason (not specified)|1
93131|NCT00818753|324719|P2|Overall Study|Other reason (not specified)|0
93132|NCT00818753|324720|P1|Overall Study|Other reason (not specified)|0
93133|NCT00818753|324718|P3|Overall Study|Protocol Violation|0
93134|NCT00818753|324719|P2|Overall Study|Protocol Violation|0
93135|NCT00818753|324720|P1|Overall Study|Protocol Violation|1
93136|NCT00818662|324744|P4|Overall Study|Admitted to long term nursing care|0
93137|NCT00818662|324745|P3|Overall Study|Admitted to long term nursing care|0
93138|NCT00818662|324746|P2|Overall Study|Admitted to long term nursing care|1
93139|NCT00818662|324747|P1|Overall Study|Admitted to long term nursing care|0
93140|NCT00818662|324744|P4|Overall Study|Study partner decision|1
93141|NCT00818662|324745|P3|Overall Study|Study partner decision|0
93142|NCT00818662|324746|P2|Overall Study|Study partner decision|0
93143|NCT00818662|324747|P1|Overall Study|Study partner decision|0
93144|NCT00818662|324744|P4|Overall Study|Change in living situation|1
93145|NCT00818662|324745|P3|Overall Study|Change in living situation|0
93146|NCT00818662|324746|P2|Overall Study|Change in living situation|0
93147|NCT00818662|324747|P1|Overall Study|Change in living situation|0
93148|NCT00818662|324744|P4|Overall Study|Declined move to another study site|0
93149|NCT00818662|324745|P3|Overall Study|Declined move to another study site|0
93150|NCT00818662|324746|P2|Overall Study|Declined move to another study site|0
93151|NCT00818662|324747|P1|Overall Study|Declined move to another study site|1
93152|NCT00818662|324744|P4|Overall Study|Moving out of state|1
93153|NCT00818662|324745|P3|Overall Study|Moving out of state|0
93154|NCT00818662|324746|P2|Overall Study|Moving out of state|0
93155|NCT00818662|324747|P1|Overall Study|Moving out of state|0
93156|NCT00818662|324744|P4|Overall Study|Caregiver to pursue other treatment|0
93157|NCT00818662|324745|P3|Overall Study|Caregiver to pursue other treatment|0
93158|NCT00818662|324746|P2|Overall Study|Caregiver to pursue other treatment|1
93159|NCT00818662|324747|P1|Overall Study|Caregiver to pursue other treatment|0
93160|NCT00818662|324744|P4|Overall Study|Participant's health declined|1
93161|NCT00818662|324745|P3|Overall Study|Participant's health declined|0
93162|NCT00818662|324746|P2|Overall Study|Participant's health declined|0
93163|NCT00818662|324747|P1|Overall Study|Participant's health declined|0
93164|NCT00818662|324744|P4|Overall Study|Study Partner Unwilling or Unable|1
93165|NCT00818662|324745|P3|Overall Study|Study Partner Unwilling or Unable|1
93166|NCT00818662|324746|P2|Overall Study|Study Partner Unwilling or Unable|2
93167|NCT00818662|324747|P1|Overall Study|Study Partner Unwilling or Unable|3
93168|NCT00818662|324744|P4|Overall Study|Safety Risk|1
93169|NCT00818662|324745|P3|Overall Study|Safety Risk|0
93170|NCT00818662|324746|P2|Overall Study|Safety Risk|1
93171|NCT00818662|324747|P1|Overall Study|Safety Risk|1
93172|NCT00818662|324744|P4|Overall Study|Requires a Prohibited Medication|0
93173|NCT00818662|324745|P3|Overall Study|Requires a Prohibited Medication|0
93174|NCT00818662|324746|P2|Overall Study|Requires a Prohibited Medication|0
93175|NCT00818662|324747|P1|Overall Study|Requires a Prohibited Medication|1
93176|NCT00818662|324744|P4|Overall Study|Protocol Violation|0
93177|NCT00818662|324745|P3|Overall Study|Protocol Violation|0
93178|NCT00818662|324746|P2|Overall Study|Protocol Violation|1
93179|NCT00818662|324747|P1|Overall Study|Protocol Violation|1
93180|NCT00818662|324744|P4|Overall Study|Unwilling or Unable to Participate|4
93181|NCT00818662|324745|P3|Overall Study|Unwilling or Unable to Participate|2
93182|NCT00818662|324746|P2|Overall Study|Unwilling or Unable to Participate|6
93183|NCT00818662|324747|P1|Overall Study|Unwilling or Unable to Participate|4
93184|NCT00818662|324744|P4|Overall Study|Lost to Follow-up|1
93185|NCT00818662|324745|P3|Overall Study|Lost to Follow-up|0
93186|NCT00818662|324746|P2|Overall Study|Lost to Follow-up|0
93187|NCT00818662|324747|P1|Overall Study|Lost to Follow-up|0
93188|NCT00818662|324744|P4|Overall Study|Physician Decision|0
93189|NCT00818662|324745|P3|Overall Study|Physician Decision|0
93190|NCT00818662|324746|P2|Overall Study|Physician Decision|0
93191|NCT00818662|324747|P1|Overall Study|Physician Decision|1
93192|NCT00818662|324744|P4|Overall Study|Death|0
93193|NCT00818662|324745|P3|Overall Study|Death|0
93194|NCT00818662|324746|P2|Overall Study|Death|3
93195|NCT00818662|324747|P1|Overall Study|Death|1
93196|NCT00818662|324744|P4|Overall Study|Withdrawal by Subject|2
93197|NCT00818662|324745|P3|Overall Study|Withdrawal by Subject|2
93198|NCT00818662|324746|P2|Overall Study|Withdrawal by Subject|4
93199|NCT00818662|324747|P1|Overall Study|Withdrawal by Subject|5
93200|NCT00818662|324744|P4|Overall Study|Adverse Event|3
93201|NCT00818662|324745|P3|Overall Study|Adverse Event|4
93202|NCT00818662|324746|P2|Overall Study|Adverse Event|14
93203|NCT00818662|324747|P1|Overall Study|Adverse Event|5
93204|NCT00818649|324833|P1|Overall Study|Adverse Event|1
93205|NCT00818649|324833|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
93206|NCT00818649|324833|P1|Overall Study|Declining performance status|2
93207|NCT00818623|324845|P8|Overall Study|Disease progression|0
93208|NCT00818623|324846|P7|Overall Study|Disease progression|1
93209|NCT00818623|324847|P6|Overall Study|Disease progression|0
93210|NCT00818623|324848|P5|Overall Study|Disease progression|0
93211|NCT00818623|324849|P4|Overall Study|Disease progression|0
93212|NCT00818623|324850|P3|Overall Study|Disease progression|0
93213|NCT00818623|324851|P2|Overall Study|Disease progression|0
93214|NCT00818623|324852|P1|Overall Study|Disease progression|0
93215|NCT00818623|324845|P8|Overall Study|Lack of trial drug at site|0
93216|NCT00818623|324846|P7|Overall Study|Lack of trial drug at site|1
93217|NCT00818623|324847|P6|Overall Study|Lack of trial drug at site|0
93218|NCT00818623|324848|P5|Overall Study|Lack of trial drug at site|2
93219|NCT00818623|324849|P4|Overall Study|Lack of trial drug at site|0
93220|NCT00818623|324850|P3|Overall Study|Lack of trial drug at site|0
93221|NCT00818623|324851|P2|Overall Study|Lack of trial drug at site|0
93222|NCT00818623|324852|P1|Overall Study|Lack of trial drug at site|0
93223|NCT00818623|324845|P8|Overall Study|Need of additional treatment|0
93224|NCT00818623|324846|P7|Overall Study|Need of additional treatment|0
93225|NCT00818623|324847|P6|Overall Study|Need of additional treatment|0
93226|NCT00818623|324848|P5|Overall Study|Need of additional treatment|1
93227|NCT00818623|324849|P4|Overall Study|Need of additional treatment|0
93228|NCT00818623|324850|P3|Overall Study|Need of additional treatment|0
93229|NCT00818623|324851|P2|Overall Study|Need of additional treatment|0
93230|NCT00818623|324852|P1|Overall Study|Need of additional treatment|0
93231|NCT00818623|324845|P8|Overall Study|Protocol Violation|0
93232|NCT00818623|324846|P7|Overall Study|Protocol Violation|1
93233|NCT00818623|324847|P6|Overall Study|Protocol Violation|0
93234|NCT00818623|324848|P5|Overall Study|Protocol Violation|1
93235|NCT00818623|324849|P4|Overall Study|Protocol Violation|0
93236|NCT00818623|324850|P3|Overall Study|Protocol Violation|0
93237|NCT00818623|324851|P2|Overall Study|Protocol Violation|0
93238|NCT00818623|324852|P1|Overall Study|Protocol Violation|1
93239|NCT00818623|324845|P8|Overall Study|Withdrawal by Subject|1
93240|NCT00818623|324846|P7|Overall Study|Withdrawal by Subject|1
93241|NCT00818623|324847|P6|Overall Study|Withdrawal by Subject|1
93242|NCT00818623|324848|P5|Overall Study|Withdrawal by Subject|0
93243|NCT00818623|324849|P4|Overall Study|Withdrawal by Subject|0
93244|NCT00818623|324850|P3|Overall Study|Withdrawal by Subject|1
93245|NCT00818623|324851|P2|Overall Study|Withdrawal by Subject|1
93246|NCT00818623|324852|P1|Overall Study|Withdrawal by Subject|0
93247|NCT00818623|324845|P8|Overall Study|Bad prostate specific antigen response|0
93248|NCT00818623|324846|P7|Overall Study|Bad prostate specific antigen response|0
93249|NCT00818623|324847|P6|Overall Study|Bad prostate specific antigen response|1
93250|NCT00818623|324848|P5|Overall Study|Bad prostate specific antigen response|0
93251|NCT00818623|324849|P4|Overall Study|Bad prostate specific antigen response|5
93252|NCT00818623|324850|P3|Overall Study|Bad prostate specific antigen response|2
93253|NCT00818623|324851|P2|Overall Study|Bad prostate specific antigen response|3
93254|NCT00818623|324852|P1|Overall Study|Bad prostate specific antigen response|0
93255|NCT00818623|324845|P8|Overall Study|Adverse Event|0
93256|NCT00818623|324846|P7|Overall Study|Adverse Event|0
93257|NCT00818623|324847|P6|Overall Study|Adverse Event|1
93258|NCT00818623|324848|P5|Overall Study|Adverse Event|0
93259|NCT00818623|324849|P4|Overall Study|Adverse Event|0
93260|NCT00818623|324850|P3|Overall Study|Adverse Event|1
93261|NCT00818623|324851|P2|Overall Study|Adverse Event|0
93262|NCT00818623|324852|P1|Overall Study|Adverse Event|1
93263|NCT00818519|324928|P2|Overall Study|participant will leave for long tme|0
93264|NCT00818519|324929|P1|Overall Study|participant will leave for long tme|1
93265|NCT00818519|324928|P2|Overall Study|participant recovered completely|0
93266|NCT00818519|324929|P1|Overall Study|participant recovered completely|1
93267|NCT00818519|324928|P2|Overall Study|Withdrawal by Subject|9
93268|NCT00818519|324929|P1|Overall Study|Withdrawal by Subject|4
93269|NCT00818519|324928|P2|Overall Study|Pregnancy|1
93270|NCT00818519|324929|P1|Overall Study|Pregnancy|0
93271|NCT00818519|324928|P2|Overall Study|Protocol Violation|1
93272|NCT00818519|324929|P1|Overall Study|Protocol Violation|2
93273|NCT00818519|324928|P2|Overall Study|Lost to Follow-up|6
93274|NCT00818519|324929|P1|Overall Study|Lost to Follow-up|4
93275|NCT00818519|324928|P2|Overall Study|Adverse Event|2
93276|NCT00818519|324929|P1|Overall Study|Adverse Event|2
93277|NCT00818454|324959|P4|Treatment Period 3|Adverse Event|1
93278|NCT00818454|324960|P3|Treatment Period 3|Adverse Event|0
93279|NCT00818454|324961|P2|Treatment Period 3|Adverse Event|0
93280|NCT00818454|324962|P1|Treatment Period 3|Adverse Event|0
93281|NCT00818454|324959|P4|Treatment Period 2|not specified|0
93282|NCT00818454|324960|P3|Treatment Period 2|not specified|0
93283|NCT00818454|324961|P2|Treatment Period 2|not specified|1
93284|NCT00818454|324962|P1|Treatment Period 2|not specified|2
93285|NCT00818454|324959|P4|Washout Period of 1 Week|not specified|0
93286|NCT00818454|324960|P3|Washout Period of 1 Week|not specified|0
93287|NCT00818454|324961|P2|Washout Period of 1 Week|not specified|2
93288|NCT00818454|324962|P1|Washout Period of 1 Week|not specified|1
93289|NCT00818454|324959|P4|Washout Period of 1 Week|Protocol Violation|0
93290|NCT00818454|324960|P3|Washout Period of 1 Week|Protocol Violation|0
93291|NCT00818454|324961|P2|Washout Period of 1 Week|Protocol Violation|0
93292|NCT00818454|324962|P1|Washout Period of 1 Week|Protocol Violation|2
93293|NCT00818454|324959|P4|Washout Period of 1 Week|Adverse Event|0
93294|NCT00818454|324960|P3|Washout Period of 1 Week|Adverse Event|0
93295|NCT00818454|324961|P2|Washout Period of 1 Week|Adverse Event|1
93296|NCT00818454|324962|P1|Washout Period of 1 Week|Adverse Event|1
93297|NCT00818454|324959|P4|Treatment Period 1|not specified|0
93298|NCT00818454|324960|P3|Treatment Period 1|not specified|0
93299|NCT00818454|324961|P2|Treatment Period 1|not specified|0
93300|NCT00818454|324962|P1|Treatment Period 1|not specified|3
93301|NCT00818454|324959|P4|Treatment Period 1|Adverse Event|0
93302|NCT00818454|324960|P3|Treatment Period 1|Adverse Event|0
93303|NCT00818454|324961|P2|Treatment Period 1|Adverse Event|1
93304|NCT00818454|324962|P1|Treatment Period 1|Adverse Event|0
93305|NCT00818441|324990|P2|Overall Study|Study terminated by sponsor|2
93306|NCT00818441|324991|P1|Overall Study|Study terminated by sponsor|11
93307|NCT00818441|324990|P2|Overall Study|Adverse Event|1
93308|NCT00818441|324991|P1|Overall Study|Adverse Event|0
93309|NCT00818441|324990|P2|Overall Study|Withdrawal by Subject|0
93310|NCT00818441|324991|P1|Overall Study|Withdrawal by Subject|2
93311|NCT00818441|324990|P2|Overall Study|Lost to Follow-up|1
93312|NCT00818441|324991|P1|Overall Study|Lost to Follow-up|2
93313|NCT00818441|324990|P2|Overall Study|Unspecified|0
93314|NCT00818441|324991|P1|Overall Study|Unspecified|5
93315|NCT00818441|324990|P2|Overall Study|Death|26
93316|NCT00818441|324991|P1|Overall Study|Death|69
93317|NCT00818389|325013|P2|Overall Study|Adverse Event|1
93318|NCT00818389|325014|P1|Overall Study|Adverse Event|0
93319|NCT00818389|325013|P2|Overall Study|Withdrawal by Subject|2
93320|NCT00818389|325014|P1|Overall Study|Withdrawal by Subject|2
93321|NCT00818389|325013|P2|Overall Study|ALS Disease Progression|0
93322|NCT00818389|325014|P1|Overall Study|ALS Disease Progression|1
93323|NCT00818389|325013|P2|Overall Study|Death|3
93324|NCT00818389|325014|P1|Overall Study|Death|1
93325|NCT00818259|325049|P9|Part V|Adverse Event|0
93326|NCT00818259|325050|P8|Part V|Adverse Event|1
93327|NCT00818259|325051|P7|Part V|Adverse Event|0
93328|NCT00818259|325052|P6|Part V|Adverse Event|0
93329|NCT00818259|325053|P5|Part V|Adverse Event|0
93330|NCT00818259|325054|P4|Part V|Adverse Event|0
93331|NCT00818259|325055|P3|Part V|Adverse Event|0
93332|NCT00818259|325056|P2|Part V|Adverse Event|0
93333|NCT00818259|325057|P1|Part V|Adverse Event|0
93334|NCT00818259|325049|P9|Part IV|Physician Decision|0
93335|NCT00818259|325050|P8|Part IV|Physician Decision|0
93336|NCT00818259|325051|P7|Part IV|Physician Decision|0
93337|NCT00818259|325052|P6|Part IV|Physician Decision|1
93338|NCT00818259|325053|P5|Part IV|Physician Decision|0
93339|NCT00818259|325054|P4|Part IV|Physician Decision|0
93340|NCT00818259|325055|P3|Part IV|Physician Decision|0
93341|NCT00818259|325056|P2|Part IV|Physician Decision|0
93342|NCT00818259|325057|P1|Part IV|Physician Decision|0
93343|NCT00818259|325049|P9|Part II|Not Treated|0
93344|NCT00818259|325050|P8|Part II|Not Treated|0
93345|NCT00818259|325051|P7|Part II|Not Treated|0
93346|NCT00818259|325052|P6|Part II|Not Treated|0
93347|NCT00818259|325053|P5|Part II|Not Treated|0
93348|NCT00818259|325054|P4|Part II|Not Treated|1
93349|NCT00818259|325055|P3|Part II|Not Treated|0
93350|NCT00818259|325056|P2|Part II|Not Treated|0
93351|NCT00818259|325057|P1|Part II|Not Treated|0
93352|NCT00818259|325049|P9|Part II|Lack of Efficacy|0
93353|NCT00818259|325050|P8|Part II|Lack of Efficacy|0
93354|NCT00818259|325051|P7|Part II|Lack of Efficacy|0
93355|NCT00818259|325052|P6|Part II|Lack of Efficacy|0
93356|NCT00818259|325053|P5|Part II|Lack of Efficacy|0
93357|NCT00818259|325054|P4|Part II|Lack of Efficacy|1
93358|NCT00818259|325055|P3|Part II|Lack of Efficacy|0
93359|NCT00818259|325056|P2|Part II|Lack of Efficacy|0
93360|NCT00818259|325057|P1|Part II|Lack of Efficacy|0
93361|NCT00818259|325049|P9|Part II|Physician Decision|0
93362|NCT00818259|325050|P8|Part II|Physician Decision|0
93363|NCT00818259|325051|P7|Part II|Physician Decision|0
93364|NCT00818259|325052|P6|Part II|Physician Decision|0
93365|NCT00818259|325053|P5|Part II|Physician Decision|0
93366|NCT00818259|325054|P4|Part II|Physician Decision|0
93367|NCT00818259|325055|P3|Part II|Physician Decision|1
93368|NCT00818259|325056|P2|Part II|Physician Decision|0
93369|NCT00818259|325057|P1|Part II|Physician Decision|0
93370|NCT00818259|325049|P9|Part I|Withdrawal by Subject|0
93371|NCT00818259|325050|P8|Part I|Withdrawal by Subject|0
93372|NCT00818259|325051|P7|Part I|Withdrawal by Subject|0
93373|NCT00818259|325052|P6|Part I|Withdrawal by Subject|0
93374|NCT00818259|325053|P5|Part I|Withdrawal by Subject|0
93375|NCT00818259|325054|P4|Part I|Withdrawal by Subject|0
93376|NCT00818259|325055|P3|Part I|Withdrawal by Subject|0
93377|NCT00818259|325056|P2|Part I|Withdrawal by Subject|0
93378|NCT00818259|325057|P1|Part I|Withdrawal by Subject|1
93379|NCT00818246|325129|P1|Overall Study|Impossible to match pictures|5
93380|NCT00818207|325138|P2|Overall Study|Death|5
93381|NCT00818207|325139|P1|Overall Study|Death|3
93382|NCT00818207|325138|P2|Overall Study|Withdrawal by Subject|104
93383|NCT00818207|325139|P1|Overall Study|Withdrawal by Subject|42
93384|NCT00818207|325138|P2|Overall Study|Multiple reasons|12
93385|NCT00818207|325139|P1|Overall Study|Multiple reasons|11
93386|NCT00818207|325138|P2|Overall Study|Lost to Follow-up|146
93387|NCT00818207|325139|P1|Overall Study|Lost to Follow-up|160
93388|NCT00818207|325138|P2|Overall Study|Adverse Event|0
93389|NCT00818207|325139|P1|Overall Study|Adverse Event|6
93390|NCT00818168|325153|P1|Overall Study|Participant Moved|2
93391|NCT00818168|325153|P1|Overall Study|Reason for Non-completion Not reported|6
93392|NCT00818168|325153|P1|Overall Study|Adverse Event|19
93393|NCT00818168|325153|P1|Overall Study|Lost to Follow-up|7
93394|NCT00818168|325153|P1|Overall Study|Withdrawal by Subject|16
93395|NCT00818168|325153|P1|Overall Study|Pregnancy|2
93396|NCT00818168|325153|P1|Overall Study|Lack of Efficacy|18
93397|NCT00817778|325193|P2|Overall Study|Poor venous access|0
93398|NCT00817778|325194|P1|Overall Study|Poor venous access|1
93399|NCT00817778|325193|P2|Overall Study|Study-specific discontinuation criteria|1
93400|NCT00817778|325194|P1|Overall Study|Study-specific discontinuation criteria|0
93401|NCT00817778|325193|P2|Overall Study|Protocol Violation|1
93402|NCT00817778|325194|P1|Overall Study|Protocol Violation|0
93403|NCT00817778|325193|P2|Overall Study|Withdrawal by Subject|1
93404|NCT00817778|325194|P1|Overall Study|Withdrawal by Subject|1
93405|NCT00817778|325193|P2|Overall Study|Adverse Event|0
93406|NCT00817778|325194|P1|Overall Study|Adverse Event|1
93407|NCT00817531|325223|P1|Overall Study|Lack of Efficacy|1
93408|NCT00817531|325223|P1|Overall Study|Adverse Event|1
93409|NCT00817479|325229|P2|Overall Study|Physician Decision|1
93410|NCT00817479|325230|P1|Overall Study|Physician Decision|1
93411|NCT00817206|325253|P2|Overall Study|Physician Decision|0
93412|NCT00817206|325254|P1|Overall Study|Physician Decision|2
93413|NCT00817206|325253|P2|Overall Study|Withdrawal by Subject|3
93414|NCT00817206|325254|P1|Overall Study|Withdrawal by Subject|7
93415|NCT00817206|325253|P2|Overall Study|Death|0
93416|NCT00817206|325254|P1|Overall Study|Death|2
93417|NCT00817206|325253|P2|Overall Study|Lost to Follow-up|1
93418|NCT00817206|325254|P1|Overall Study|Lost to Follow-up|0
93419|NCT00817206|325253|P2|Overall Study|Protocol Violation|2
93420|NCT00817206|325254|P1|Overall Study|Protocol Violation|0
93421|NCT00817206|325253|P2|Overall Study|Adverse Event|3
93422|NCT00817206|325254|P1|Overall Study|Adverse Event|10
93423|NCT00816595|325321|P2|Overall Study|Withdrawal by Subject|0
93424|NCT00816595|325322|P1|Overall Study|Withdrawal by Subject|2
93425|NCT00816556|325335|P3|Overall Study|Lost to Follow-up|1
93426|NCT00816556|325336|P2|Overall Study|Lost to Follow-up|0
93427|NCT00816556|325337|P1|Overall Study|Lost to Follow-up|0
93428|NCT00816556|325335|P3|Overall Study|Withdrawal by Subject|1
93429|NCT00816556|325336|P2|Overall Study|Withdrawal by Subject|1
93430|NCT00816556|325337|P1|Overall Study|Withdrawal by Subject|1
93431|NCT00816556|325335|P3|Overall Study|Adverse Event|1
93432|NCT00816556|325336|P2|Overall Study|Adverse Event|1
93433|NCT00816556|325337|P1|Overall Study|Adverse Event|1
93434|NCT00816166|325357|P2|Overall Study|Death|2
93435|NCT00816166|325358|P1|Overall Study|Death|4
93436|NCT00816166|325357|P2|Overall Study|Lost to Follow-up|10
93437|NCT00816166|325358|P1|Overall Study|Lost to Follow-up|6
93438|NCT00816036|325385|P2|Overall Study|Withdrawal by Subject|23
93439|NCT00816036|325386|P1|Overall Study|Withdrawal by Subject|54
93440|NCT00816036|325385|P2|Overall Study|Lost to Follow-up|57
93441|NCT00816036|325386|P1|Overall Study|Lost to Follow-up|75
93442|NCT00816036|325385|P2|Overall Study|Death|28
93443|NCT00816036|325386|P1|Overall Study|Death|47
93444|NCT00816023|325400|P4|Overall Study|Randomized Not Treated|11
93445|NCT00816023|325401|P3|Overall Study|Randomized Not Treated|6
93446|NCT00816023|325402|P2|Overall Study|Randomized Not Treated|4
93447|NCT00816023|325403|P1|Overall Study|Randomized Not Treated|6
93448|NCT00816023|325400|P4|Overall Study|assessments complete prior to window|1
93449|NCT00816023|325401|P3|Overall Study|assessments complete prior to window|2
93450|NCT00816023|325402|P2|Overall Study|assessments complete prior to window|1
93451|NCT00816023|325403|P1|Overall Study|assessments complete prior to window|1
93452|NCT00816023|325400|P4|Overall Study|Physician Decision|0
93453|NCT00816023|325401|P3|Overall Study|Physician Decision|1
93454|NCT00816023|325402|P2|Overall Study|Physician Decision|0
93455|NCT00816023|325403|P1|Overall Study|Physician Decision|0
93456|NCT00816023|325400|P4|Overall Study|Withdrawal by Subject|0
93457|NCT00816023|325401|P3|Overall Study|Withdrawal by Subject|0
93458|NCT00816023|325402|P2|Overall Study|Withdrawal by Subject|0
93459|NCT00816023|325403|P1|Overall Study|Withdrawal by Subject|1
93460|NCT00816023|325400|P4|Overall Study|Lost to Follow-up|0
93461|NCT00816023|325401|P3|Overall Study|Lost to Follow-up|0
93462|NCT00816023|325402|P2|Overall Study|Lost to Follow-up|1
93463|NCT00816023|325403|P1|Overall Study|Lost to Follow-up|1
93464|NCT00815919|325417|P1|Overall Study|Lack of Efficacy|2
93465|NCT00815919|325417|P1|Overall Study|AML Relapse|1
93466|NCT00815919|325417|P1|Overall Study|Unrelated Fungal Infection|1
93467|NCT00815659|325460|P1|Overall Study|Protocol Violation|1
93468|NCT00815659|325460|P1|Overall Study|Lost to Follow-up|4
93469|NCT00815659|325460|P1|Overall Study|Withdrawal by Subject|9
93470|NCT00815659|325460|P1|Overall Study|Adverse Event|9
93471|NCT00814892|325503|P1|Overall Study|Study Termination|1
93472|NCT00814892|325503|P1|Overall Study|Disease Progression|1
93473|NCT00814879|325515|P2|By Week 48|Death|1
93474|NCT00814879|325516|P1|By Week 48|Death|0
93475|NCT00814879|325515|P2|By Week 48|Lost to Follow-up|2
93476|NCT00814879|325516|P1|By Week 48|Lost to Follow-up|2
93477|NCT00814879|325515|P2|By Week 24|Incarceration|1
93478|NCT00814879|325516|P1|By Week 24|Incarceration|0
93479|NCT00814879|325515|P2|By Week 24|Cancer Diagnosis|0
93480|NCT00814879|325516|P1|By Week 24|Cancer Diagnosis|1
93481|NCT00814801|325535|P3|Overall Study|Not specified|4
93482|NCT00814801|325536|P2|Overall Study|Not specified|6
93483|NCT00814801|325537|P1|Overall Study|Not specified|2
93484|NCT00814801|325535|P3|Overall Study|Non-compliance|1
93485|NCT00814801|325536|P2|Overall Study|Non-compliance|1
93486|NCT00814801|325537|P1|Overall Study|Non-compliance|0
93487|NCT00814801|325535|P3|Overall Study|Missing or change of caregiver|4
93488|NCT00814801|325536|P2|Overall Study|Missing or change of caregiver|2
93489|NCT00814801|325537|P1|Overall Study|Missing or change of caregiver|6
93490|NCT00814801|325535|P3|Overall Study|Change of patients for CIBIC plus-J|0
93491|NCT00814801|325536|P2|Overall Study|Change of patients for CIBIC plus-J|1
93492|NCT00814801|325537|P1|Overall Study|Change of patients for CIBIC plus-J|1
93493|NCT00814801|325535|P3|Overall Study|Inappropriate as a subject|1
93494|NCT00814801|325536|P2|Overall Study|Inappropriate as a subject|1
93495|NCT00814801|325537|P1|Overall Study|Inappropriate as a subject|1
93496|NCT00814801|325535|P3|Overall Study|Withdrawal by Subject|14
93497|NCT00814801|325536|P2|Overall Study|Withdrawal by Subject|11
93498|NCT00814801|325537|P1|Overall Study|Withdrawal by Subject|9
93499|NCT00814801|325535|P3|Overall Study|Adverse Event|19
93500|NCT00814801|325536|P2|Overall Study|Adverse Event|16
93501|NCT00814801|325537|P1|Overall Study|Adverse Event|15
93502|NCT00814710|325570|P2|Overall Study|Lost to Follow-up|3
93503|NCT00814710|325571|P1|Overall Study|Lost to Follow-up|7
93504|NCT00814710|325570|P2|Overall Study|Adverse Event|0
93505|NCT00814710|325571|P1|Overall Study|Adverse Event|1
93506|NCT00814658|325631|P2|Overall Study|Adverse Event|3
93507|NCT00814658|325632|P1|Overall Study|Adverse Event|3
93508|NCT00814658|325631|P2|Overall Study|Physician Decision|0
93509|NCT00814658|325632|P1|Overall Study|Physician Decision|1
93510|NCT00814658|325631|P2|Overall Study|Lost to Follow-up|1
93511|NCT00814658|325632|P1|Overall Study|Lost to Follow-up|0
93512|NCT00815516|325700|P2|Overall Study|Physician Decision|0
93513|NCT00815516|325701|P1|Overall Study|Physician Decision|1
93514|NCT00815516|325700|P2|Overall Study|Death|1
93515|NCT00815516|325701|P1|Overall Study|Death|3
93516|NCT00815308|325766|P1|Overall Study|Protocol Violation|6
93517|NCT00815308|325766|P1|Overall Study|Withdrawal by Subject|0
93518|NCT00815308|325766|P1|Overall Study|Adverse Event|4
93519|NCT00815295|325775|P3|Overall Study|Cetuximab hypersensitivity reaction|3
93520|NCT00815295|325776|P2|Overall Study|Cetuximab hypersensitivity reaction|1
93521|NCT00815295|325777|P1|Overall Study|Cetuximab hypersensitivity reaction|0
93522|NCT00815191|325789|P2|Overall Study|Protocol Violation|1
93523|NCT00815191|325790|P1|Overall Study|Protocol Violation|1
93524|NCT00814983|325807|P2|Overall Study|Graft failure|0
93525|NCT00814983|325808|P1|Overall Study|Graft failure|1
93526|NCT00814983|325807|P2|Overall Study|Withdrawal by Subject|0
93527|NCT00814983|325808|P1|Overall Study|Withdrawal by Subject|1
93528|NCT00814983|325807|P2|Overall Study|Screen failure|0
93529|NCT00814983|325808|P1|Overall Study|Screen failure|1
93530|NCT00814632|325839|P1|Overall Study|Lack of Efficacy|2
93531|NCT00814580|325845|P2|Overall Study|Did Not Take Drug|2
93532|NCT00814580|325846|P1|Overall Study|Did Not Take Drug|2
93533|NCT00814580|325845|P2|Overall Study|Other|3
93534|NCT00814580|325846|P1|Overall Study|Other|1
93535|NCT00814580|325845|P2|Overall Study|Withdrawal by Subject|2
93536|NCT00814580|325846|P1|Overall Study|Withdrawal by Subject|2
93537|NCT00814580|325845|P2|Overall Study|Protocol Violation|0
93538|NCT00814580|325846|P1|Overall Study|Protocol Violation|2
93539|NCT00814580|325845|P2|Overall Study|Lack of Efficacy|25
93540|NCT00814580|325846|P1|Overall Study|Lack of Efficacy|18
93541|NCT00814580|325845|P2|Overall Study|Adverse Event|15
93542|NCT00814580|325846|P1|Overall Study|Adverse Event|6
93543|NCT00814489|325977|P3|Overall Study|Unspecified|1
93544|NCT00814489|325978|P2|Overall Study|Unspecified|0
93545|NCT00814489|325979|P1|Overall Study|Unspecified|2
93546|NCT00814463|326011|P1|Overall Study|Lost to Follow-up|1
93547|NCT00814346|326017|P2|Open Phase (17 Months)|Not otherwise specified|0
93548|NCT00814346|326018|P1|Open Phase (17 Months)|Not otherwise specified|1
93549|NCT00814346|326017|P2|Open Phase (17 Months)|Lost to Follow-up|0
93550|NCT00814346|326018|P1|Open Phase (17 Months)|Lost to Follow-up|2
93551|NCT00814346|326017|P2|Open Phase (17 Months)|Consent|0
93552|NCT00814346|326018|P1|Open Phase (17 Months)|Consent|2
93553|NCT00814346|326017|P2|Open Phase (17 Months)|Adverse Event|0
93554|NCT00814346|326018|P1|Open Phase (17 Months)|Adverse Event|5
93555|NCT00814346|326017|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
93556|NCT00814346|326018|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
93557|NCT00814346|326017|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
93558|NCT00814346|326018|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
93559|NCT00814333|326084|P2|Enrollment|Lost to Follow-up|0
93560|NCT00814333|326085|P1|Enrollment|Lost to Follow-up|1
93561|NCT00814320|326093|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
93562|NCT00814320|326094|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
93563|NCT00814320|326093|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
93564|NCT00814320|326094|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
93565|NCT00814320|326093|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
93566|NCT00814320|326094|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
93567|NCT00814320|326093|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
93568|NCT00814320|326094|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
93569|NCT00814320|326093|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
93570|NCT00814320|326094|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
93571|NCT00814320|326093|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
93572|NCT00814320|326094|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
93573|NCT00814320|326093|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
93574|NCT00814320|326094|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
93575|NCT00814320|326093|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
93576|NCT00814320|326094|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
93577|NCT00814320|326093|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
93578|NCT00814320|326094|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
93579|NCT00814320|326093|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
93580|NCT00814320|326094|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
93581|NCT00814307|326226|P4|Overall Study|Death|0
93582|NCT00814307|326227|P3|Overall Study|Death|0
93583|NCT00814307|326228|P2|Overall Study|Death|1
93584|NCT00814307|326229|P1|Overall Study|Death|0
93585|NCT00814307|326226|P4|Overall Study|Withdrawal by Subject|2
93586|NCT00814307|326227|P3|Overall Study|Withdrawal by Subject|0
93587|NCT00814307|326228|P2|Overall Study|Withdrawal by Subject|6
93588|NCT00814307|326229|P1|Overall Study|Withdrawal by Subject|4
93589|NCT00814307|326226|P4|Overall Study|Protocol Violation|1
93590|NCT00814307|326227|P3|Overall Study|Protocol Violation|1
93591|NCT00814307|326228|P2|Overall Study|Protocol Violation|8
93592|NCT00814307|326229|P1|Overall Study|Protocol Violation|2
93593|NCT00814307|326226|P4|Overall Study|Unspecified|1
93594|NCT00814307|326227|P3|Overall Study|Unspecified|0
93595|NCT00814307|326228|P2|Overall Study|Unspecified|2
93596|NCT00814307|326229|P1|Overall Study|Unspecified|1
93597|NCT00814307|326226|P4|Overall Study|Lack of Efficacy|4
93598|NCT00814307|326227|P3|Overall Study|Lack of Efficacy|3
93599|NCT00814307|326228|P2|Overall Study|Lack of Efficacy|1
93600|NCT00814307|326229|P1|Overall Study|Lack of Efficacy|1
93601|NCT00814307|326226|P4|Overall Study|Adverse Event|2
93602|NCT00814307|326227|P3|Overall Study|Adverse Event|3
93603|NCT00814307|326228|P2|Overall Study|Adverse Event|9
93604|NCT00814307|326229|P1|Overall Study|Adverse Event|3
93605|NCT00814307|326226|P4|Overall Study|Randomized but not treated|0
93606|NCT00814307|326227|P3|Overall Study|Randomized but not treated|0
93607|NCT00814307|326228|P2|Overall Study|Randomized but not treated|0
93608|NCT00814307|326229|P1|Overall Study|Randomized but not treated|1
93609|NCT00814164|326425|P1|Overall Study|Death|5
93610|NCT00814164|326425|P1|Overall Study|not stated|7
93611|NCT00814164|326425|P1|Overall Study|Progression|7
93612|NCT00813995|326459|P2|Overall Study|Withdrawal by Subject|5
93613|NCT00813995|326460|P1|Overall Study|Withdrawal by Subject|0
93614|NCT00813995|326459|P2|Overall Study|Subject moved|0
93615|NCT00813995|326460|P1|Overall Study|Subject moved|4
93616|NCT00813995|326459|P2|Overall Study|Protocol Violation|2
93617|NCT00813995|326460|P1|Overall Study|Protocol Violation|3
93618|NCT00813995|326459|P2|Overall Study|Other reason|2
93619|NCT00813995|326460|P1|Overall Study|Other reason|2
93620|NCT00813995|326459|P2|Overall Study|Lost to Follow-up|2
93621|NCT00813995|326460|P1|Overall Study|Lost to Follow-up|4
93622|NCT00813995|326459|P2|Overall Study|Lack of Efficacy|0
93623|NCT00813995|326460|P1|Overall Study|Lack of Efficacy|1
93624|NCT00813995|326459|P2|Overall Study|Laboratory adverse event|2
93625|NCT00813995|326460|P1|Overall Study|Laboratory adverse event|0
93626|NCT00813995|326459|P2|Overall Study|Clinical adverse event|3
93627|NCT00813995|326460|P1|Overall Study|Clinical adverse event|9
93628|NCT00813943|326483|P3|Overall Study|Ongoing at cut-off date|3
93629|NCT00813943|326484|P2|Overall Study|Ongoing at cut-off date|5
93630|NCT00813943|326485|P1|Overall Study|Ongoing at cut-off date|5
93631|NCT00813917|326515|P2|Overall Study|Lost to Follow-up|1
93632|NCT00813917|326516|P1|Overall Study|Lost to Follow-up|3
93633|NCT00813917|326515|P2|Overall Study|Withdrawal by Subject|4
93634|NCT00813917|326516|P1|Overall Study|Withdrawal by Subject|3
93635|NCT00813917|326515|P2|Overall Study|Adverse Event|1
93636|NCT00813917|326516|P1|Overall Study|Adverse Event|0
93637|NCT00813904|326522|P1|Overall Study|Death|1
93638|NCT00813813|326530|P2|Overall Study|Other|1
93639|NCT00813813|326531|P1|Overall Study|Other|0
93640|NCT00813813|326530|P2|Overall Study|Lost to Follow-up|7
93641|NCT00813813|326531|P1|Overall Study|Lost to Follow-up|2
93642|NCT00813813|326530|P2|Overall Study|Withdrawal by Subject|1
93643|NCT00813813|326531|P1|Overall Study|Withdrawal by Subject|1
93644|NCT00813800|326547|P1|Overall Study|Physician Decision|1
93645|NCT00813800|326547|P1|Overall Study|Worsening of depression|2
93646|NCT00813800|326547|P1|Overall Study|Adverse Event|1
93647|NCT00813800|326547|P1|Overall Study|Screen Failure after Consent|2
93648|NCT00813761|326555|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
93649|NCT00813761|326556|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
93650|NCT00813761|326557|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
93651|NCT00813761|326558|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
93652|NCT00813761|326555|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
93653|NCT00813761|326556|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
93654|NCT00813761|326557|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
93655|NCT00813761|326558|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
93656|NCT00813761|326555|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
93657|NCT00813761|326556|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
93658|NCT00813761|326557|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
93659|NCT00813761|326558|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
93660|NCT00813761|326555|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
93661|NCT00813761|326556|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
93662|NCT00813761|326557|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
93663|NCT00813761|326558|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
93664|NCT00813761|326555|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
93665|NCT00813761|326556|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
93666|NCT00813761|326557|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
93667|NCT00813761|326558|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
93668|NCT00813761|326555|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
93669|NCT00813761|326556|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
93670|NCT00813761|326557|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
93671|NCT00813761|326558|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
93672|NCT00813761|326555|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
93673|NCT00813761|326556|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
93674|NCT00813761|326557|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
93675|NCT00813761|326558|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
93676|NCT00813761|326555|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
93677|NCT00813761|326556|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
93678|NCT00813761|326557|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
93679|NCT00813761|326558|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
93680|NCT00813761|326555|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
93681|NCT00813761|326556|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
93682|NCT00813761|326557|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
93683|NCT00813761|326558|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
93684|NCT00813761|326555|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
93685|NCT00813761|326556|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
93686|NCT00813761|326557|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
93687|NCT00813761|326558|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
93688|NCT00813761|326555|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
93689|NCT00813761|326556|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
93690|NCT00813761|326557|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
93691|NCT00813761|326558|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
93692|NCT00813761|326555|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
93693|NCT00813761|326556|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
93694|NCT00813761|326557|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
93695|NCT00813761|326558|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
93696|NCT00813748|326608|P2|Skin Test Substudy|Physician Decision|1
93697|NCT00813748|326609|P1|Skin Test Substudy|Physician Decision|0
93698|NCT00813709|326638|P6|Open Label Period|Unspecified|6
93699|NCT00813709|326639|P5|Open Label Period|Unspecified|5
93700|NCT00813709|326640|P4|Open Label Period|Unspecified|11
93701|NCT00813709|326641|P3|Open Label Period|Unspecified|0
93702|NCT00813709|326642|P2|Open Label Period|Unspecified|0
93703|NCT00813709|326643|P1|Open Label Period|Unspecified|0
93704|NCT00813709|326638|P6|Open Label Period|Randomized but not treated|1
93705|NCT00813709|326639|P5|Open Label Period|Randomized but not treated|0
93706|NCT00813709|326640|P4|Open Label Period|Randomized but not treated|1
93707|NCT00813709|326641|P3|Open Label Period|Randomized but not treated|0
93708|NCT00813709|326642|P2|Open Label Period|Randomized but not treated|0
93709|NCT00813709|326643|P1|Open Label Period|Randomized but not treated|0
93710|NCT00813709|326638|P6|Open Label Period|Lack of Efficacy|1
93711|NCT00813709|326639|P5|Open Label Period|Lack of Efficacy|1
93712|NCT00813709|326640|P4|Open Label Period|Lack of Efficacy|3
93713|NCT00813709|326641|P3|Open Label Period|Lack of Efficacy|0
93714|NCT00813709|326642|P2|Open Label Period|Lack of Efficacy|0
93715|NCT00813709|326643|P1|Open Label Period|Lack of Efficacy|0
93716|NCT00813709|326638|P6|Open Label Period|Adverse Event|3
93717|NCT00813709|326639|P5|Open Label Period|Adverse Event|4
93718|NCT00813709|326640|P4|Open Label Period|Adverse Event|5
93719|NCT00813709|326641|P3|Open Label Period|Adverse Event|0
93720|NCT00813709|326642|P2|Open Label Period|Adverse Event|0
93721|NCT00813709|326643|P1|Open Label Period|Adverse Event|0
93722|NCT00813709|326638|P6|Double Blind Period|Unspecified|0
93723|NCT00813709|326639|P5|Double Blind Period|Unspecified|0
93724|NCT00813709|326640|P4|Double Blind Period|Unspecified|0
93725|NCT00813709|326641|P3|Double Blind Period|Unspecified|6
93726|NCT00813709|326642|P2|Double Blind Period|Unspecified|9
93727|NCT00813709|326643|P1|Double Blind Period|Unspecified|14
93728|NCT00813709|326638|P6|Double Blind Period|Randomized but not treated|0
93729|NCT00813709|326639|P5|Double Blind Period|Randomized but not treated|0
93730|NCT00813709|326640|P4|Double Blind Period|Randomized but not treated|0
93731|NCT00813709|326641|P3|Double Blind Period|Randomized but not treated|1
93732|NCT00813709|326642|P2|Double Blind Period|Randomized but not treated|3
93733|NCT00813709|326643|P1|Double Blind Period|Randomized but not treated|1
93734|NCT00813709|326638|P6|Double Blind Period|Switched to open label phase|0
93735|NCT00813709|326639|P5|Double Blind Period|Switched to open label phase|0
93736|NCT00813709|326640|P4|Double Blind Period|Switched to open label phase|0
93737|NCT00813709|326641|P3|Double Blind Period|Switched to open label phase|18
93738|NCT00813709|326642|P2|Double Blind Period|Switched to open label phase|26
93739|NCT00813709|326643|P1|Double Blind Period|Switched to open label phase|9
93740|NCT00813709|326638|P6|Double Blind Period|Lost to Follow-up|0
93741|NCT00813709|326639|P5|Double Blind Period|Lost to Follow-up|0
93742|NCT00813709|326640|P4|Double Blind Period|Lost to Follow-up|0
93743|NCT00813709|326641|P3|Double Blind Period|Lost to Follow-up|2
93744|NCT00813709|326642|P2|Double Blind Period|Lost to Follow-up|2
93745|NCT00813709|326643|P1|Double Blind Period|Lost to Follow-up|3
93746|NCT00813709|326638|P6|Double Blind Period|Adverse Event|0
93747|NCT00813709|326639|P5|Double Blind Period|Adverse Event|0
93748|NCT00813709|326640|P4|Double Blind Period|Adverse Event|0
93749|NCT00813709|326641|P3|Double Blind Period|Adverse Event|4
93750|NCT00813709|326642|P2|Double Blind Period|Adverse Event|1
93751|NCT00813709|326643|P1|Double Blind Period|Adverse Event|4
93752|NCT00813592|326723|P1|Overall Study|Disease assessment was not completed per|2
93753|NCT00813488|326732|P2|Open-label Extension|Not specified|0
93754|NCT00813488|326733|P1|Open-label Extension|Not specified|1
93755|NCT00813488|326732|P2|Open-label Extension|Non-compliance study procedures|1
93756|NCT00813488|326733|P1|Open-label Extension|Non-compliance study procedures|2
93757|NCT00813488|326732|P2|Open-label Extension|Non-compliance study medication|0
93758|NCT00813488|326733|P1|Open-label Extension|Non-compliance study medication|4
93759|NCT00813488|326732|P2|Open-label Extension|Protocol Violation|2
93760|NCT00813488|326733|P1|Open-label Extension|Protocol Violation|1
93761|NCT00813488|326732|P2|Open-label Extension|Withdrawal by Subject|2
93762|NCT00813488|326733|P1|Open-label Extension|Withdrawal by Subject|0
93763|NCT00813488|326732|P2|Open-label Extension|Lack of Efficacy|0
93764|NCT00813488|326733|P1|Open-label Extension|Lack of Efficacy|3
93765|NCT00813488|326732|P2|Open-label Extension|Adverse Event|2
93766|NCT00813488|326733|P1|Open-label Extension|Adverse Event|1
93767|NCT00813488|326732|P2|Double-blind Treatment Period 2|Not Specified|0
93768|NCT00813488|326733|P1|Double-blind Treatment Period 2|Not Specified|1
93769|NCT00813488|326732|P2|Double-blind Treatment Period 2|Protocol Violation|0
93770|NCT00813488|326733|P1|Double-blind Treatment Period 2|Protocol Violation|2
93771|NCT00813488|326732|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
93772|NCT00813488|326733|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
93773|NCT00813488|326732|P2|Double-blind Treatment Period 2|Adverse Event|0
93774|NCT00813488|326733|P1|Double-blind Treatment Period 2|Adverse Event|1
93775|NCT00813488|326732|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
93776|NCT00813488|326733|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
93777|NCT00813488|326732|P2|Double-blind Treatment Period 1|Protocol Violation|2
93778|NCT00813488|326733|P1|Double-blind Treatment Period 1|Protocol Violation|0
93779|NCT00813488|326732|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
93780|NCT00813488|326733|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
93781|NCT00813488|326732|P2|Double-blind Treatment Period 1|Adverse Event|1
93782|NCT00813488|326733|P1|Double-blind Treatment Period 1|Adverse Event|1
93783|NCT00813488|326732|P2|Titration Period 2|Non-compliance with study procedures|1
93784|NCT00813488|326733|P1|Titration Period 2|Non-compliance with study procedures|2
93785|NCT00813488|326732|P2|Titration Period 2|Lost to Follow-up|0
93786|NCT00813488|326733|P1|Titration Period 2|Lost to Follow-up|1
93787|NCT00813488|326732|P2|Titration Period 2|Protocol Violation|2
93788|NCT00813488|326733|P1|Titration Period 2|Protocol Violation|3
93789|NCT00813488|326732|P2|Titration Period 2|Lack of Efficacy|4
93790|NCT00813488|326733|P1|Titration Period 2|Lack of Efficacy|8
93791|NCT00813488|326732|P2|Titration Period 2|Adverse Event|3
93792|NCT00813488|326733|P1|Titration Period 2|Adverse Event|2
93793|NCT00813488|326732|P2|Titration Period 1|Technical Difficulties|1
93794|NCT00813488|326733|P1|Titration Period 1|Technical Difficulties|0
93795|NCT00813488|326732|P2|Titration Period 1|Non-compliance to study procedures|2
93796|NCT00813488|326733|P1|Titration Period 1|Non-compliance to study procedures|2
93797|NCT00813488|326732|P2|Titration Period 1|Non-compliance to study medication|1
93798|NCT00813488|326733|P1|Titration Period 1|Non-compliance to study medication|4
93799|NCT00813488|326732|P2|Titration Period 1|Protocol Violation|3
93800|NCT00813488|326733|P1|Titration Period 1|Protocol Violation|4
93801|NCT00813488|326732|P2|Titration Period 1|Withdrawal by Subject|2
93802|NCT00813488|326733|P1|Titration Period 1|Withdrawal by Subject|2
93803|NCT00813488|326732|P2|Titration Period 1|Lack of Efficacy|7
93804|NCT00813488|326733|P1|Titration Period 1|Lack of Efficacy|9
93805|NCT00813488|326732|P2|Titration Period 1|Adverse Event|1
93806|NCT00813488|326733|P1|Titration Period 1|Adverse Event|6
93807|NCT00813150|326844|P2|Long Term Follow-up|Progression/Relapse|24
93808|NCT00813150|326845|P1|Long Term Follow-up|Progression/Relapse|22
93809|NCT00813150|326844|P2|Long Term Follow-up|Lost to Follow-up|0
93810|NCT00813150|326845|P1|Long Term Follow-up|Lost to Follow-up|2
93811|NCT00813150|326844|P2|Long Term Follow-up|Not specified|3
93812|NCT00813150|326845|P1|Long Term Follow-up|Not specified|0
93813|NCT00813150|326844|P2|Long Term Follow-up|Death|4
93814|NCT00813150|326845|P1|Long Term Follow-up|Death|0
93815|NCT00813150|326844|P2|Treatment Period|Data not available|2
93816|NCT00813150|326845|P1|Treatment Period|Data not available|1
93817|NCT00813150|326844|P2|Treatment Period|Reason not specified|4
93818|NCT00813150|326845|P1|Treatment Period|Reason not specified|3
93819|NCT00813150|326844|P2|Treatment Period|Non compliance|1
93820|NCT00813150|326845|P1|Treatment Period|Non compliance|0
93821|NCT00813150|326844|P2|Treatment Period|Withdrawal by Subject|3
93822|NCT00813150|326845|P1|Treatment Period|Withdrawal by Subject|5
93823|NCT00813150|326844|P2|Treatment Period|Protocol Violation|4
93824|NCT00813150|326845|P1|Treatment Period|Protocol Violation|3
93825|NCT00813150|326844|P2|Treatment Period|Stable disease|2
93826|NCT00813150|326845|P1|Treatment Period|Stable disease|1
93827|NCT00813150|326844|P2|Treatment Period|Complete response|1
93828|NCT00813150|326845|P1|Treatment Period|Complete response|0
93829|NCT00813150|326844|P2|Treatment Period|Progressive disease|0
93830|NCT00813150|326845|P1|Treatment Period|Progressive disease|1
93831|NCT00813150|326844|P2|Treatment Period|Death|0
93832|NCT00813150|326845|P1|Treatment Period|Death|2
93833|NCT00813150|326844|P2|Treatment Period|Adverse Event|15
93834|NCT00813150|326845|P1|Treatment Period|Adverse Event|16
93835|NCT00813098|326869|P3|Overall Study|Withdrew Consent|0
93836|NCT00813098|326870|P2|Overall Study|Withdrew Consent|1
93837|NCT00813098|326871|P1|Overall Study|Withdrew Consent|0
93838|NCT00813098|326869|P3|Overall Study|Principal Investigator decision|0
93839|NCT00813098|326870|P2|Overall Study|Principal Investigator decision|1
93840|NCT00813098|326871|P1|Overall Study|Principal Investigator decision|0
93841|NCT00813098|326869|P3|Overall Study|Protocol Violation|1
93842|NCT00813098|326870|P2|Overall Study|Protocol Violation|0
93843|NCT00813098|326871|P1|Overall Study|Protocol Violation|0
93844|NCT00813098|326869|P3|Overall Study|Lost to Follow-up|0
93845|NCT00813098|326870|P2|Overall Study|Lost to Follow-up|1
93846|NCT00813098|326871|P1|Overall Study|Lost to Follow-up|0
93847|NCT00813098|326869|P3|Overall Study|Inability to complete study procedures|0
93848|NCT00813098|326870|P2|Overall Study|Inability to complete study procedures|0
93849|NCT00813098|326871|P1|Overall Study|Inability to complete study procedures|1
93850|NCT00813098|326869|P3|Overall Study|Withdrawal by Subject|0
93851|NCT00813098|326870|P2|Overall Study|Withdrawal by Subject|1
93852|NCT00813098|326871|P1|Overall Study|Withdrawal by Subject|0
93853|NCT00813098|326869|P3|Overall Study|Adverse Event|1
93854|NCT00813098|326870|P2|Overall Study|Adverse Event|4
93855|NCT00813098|326871|P1|Overall Study|Adverse Event|2
93856|NCT00812968|326894|P1|Overall Study|Study closed due to marketing approval|3
93857|NCT00812968|326894|P1|Overall Study|No further treatment required|1
93858|NCT00812968|326894|P1|Overall Study|Disease progression|1
93859|NCT00812968|326894|P1|Overall Study|Relapse after erythroid response|6
93860|NCT00812955|326929|P4|Overall Study|randomized in error|0
93861|NCT00812955|326930|P3|Overall Study|randomized in error|1
93862|NCT00812955|326931|P2|Overall Study|randomized in error|0
93863|NCT00812955|326932|P1|Overall Study|randomized in error|0
93864|NCT00812955|326929|P4|Overall Study|Withdrawal by Subject|2
93865|NCT00812955|326930|P3|Overall Study|Withdrawal by Subject|1
93866|NCT00812955|326931|P2|Overall Study|Withdrawal by Subject|0
93867|NCT00812955|326932|P1|Overall Study|Withdrawal by Subject|1
93868|NCT00812955|326929|P4|Overall Study|Lost to Follow-up|2
93869|NCT00812955|326930|P3|Overall Study|Lost to Follow-up|1
93870|NCT00812955|326931|P2|Overall Study|Lost to Follow-up|1
93871|NCT00812955|326932|P1|Overall Study|Lost to Follow-up|2
93872|NCT00812955|326929|P4|Overall Study|Adverse Event|4
93873|NCT00812955|326930|P3|Overall Study|Adverse Event|3
93874|NCT00812955|326931|P2|Overall Study|Adverse Event|6
93875|NCT00812955|326932|P1|Overall Study|Adverse Event|7
93876|NCT00812812|326974|P2|Overall Study|Withdrawal by Subject|2
93877|NCT00812812|326975|P1|Overall Study|Withdrawal by Subject|0
93878|NCT00812812|326974|P2|Overall Study|Lost to Follow-up|1
93879|NCT00812812|326975|P1|Overall Study|Lost to Follow-up|0
93880|NCT00812812|326974|P2|Overall Study|Lack of Efficacy|0
93881|NCT00812812|326975|P1|Overall Study|Lack of Efficacy|1
93882|NCT00812812|326974|P2|Overall Study|Adverse Event|1
93883|NCT00812812|326975|P1|Overall Study|Adverse Event|2
93884|NCT00812565|327007|P8|Overall Study|Reason Not Specified|0
93885|NCT00812565|327008|P7|Overall Study|Reason Not Specified|0
93886|NCT00812565|327009|P6|Overall Study|Reason Not Specified|1
93887|NCT00812565|327010|P5|Overall Study|Reason Not Specified|0
93888|NCT00812565|327011|P4|Overall Study|Reason Not Specified|0
93889|NCT00812565|327012|P3|Overall Study|Reason Not Specified|0
93890|NCT00812565|327013|P2|Overall Study|Reason Not Specified|0
93891|NCT00812565|327014|P1|Overall Study|Reason Not Specified|0
93892|NCT00812565|327007|P8|Overall Study|Withdrawal of Consent|0
93893|NCT00812565|327008|P7|Overall Study|Withdrawal of Consent|0
93894|NCT00812565|327009|P6|Overall Study|Withdrawal of Consent|0
93895|NCT00812565|327010|P5|Overall Study|Withdrawal of Consent|1
93896|NCT00812565|327011|P4|Overall Study|Withdrawal of Consent|0
93897|NCT00812565|327012|P3|Overall Study|Withdrawal of Consent|0
93898|NCT00812565|327013|P2|Overall Study|Withdrawal of Consent|0
93899|NCT00812565|327014|P1|Overall Study|Withdrawal of Consent|1
93900|NCT00812565|327007|P8|Overall Study|Did Not Come to Study Visit|0
93901|NCT00812565|327008|P7|Overall Study|Did Not Come to Study Visit|0
93902|NCT00812565|327009|P6|Overall Study|Did Not Come to Study Visit|0
93903|NCT00812565|327010|P5|Overall Study|Did Not Come to Study Visit|0
93904|NCT00812565|327011|P4|Overall Study|Did Not Come to Study Visit|0
93905|NCT00812565|327012|P3|Overall Study|Did Not Come to Study Visit|0
93906|NCT00812565|327013|P2|Overall Study|Did Not Come to Study Visit|0
93907|NCT00812565|327014|P1|Overall Study|Did Not Come to Study Visit|1
93908|NCT00812565|327007|P8|Overall Study|Adverse Event|1
93909|NCT00812565|327008|P7|Overall Study|Adverse Event|0
93910|NCT00812565|327009|P6|Overall Study|Adverse Event|0
93911|NCT00812565|327010|P5|Overall Study|Adverse Event|0
93912|NCT00812565|327011|P4|Overall Study|Adverse Event|2
93913|NCT00812565|327012|P3|Overall Study|Adverse Event|0
93914|NCT00812565|327013|P2|Overall Study|Adverse Event|0
93915|NCT00812565|327014|P1|Overall Study|Adverse Event|0
93916|NCT00812565|327007|P8|Overall Study|Did Not Receive Study Medication|0
93917|NCT00812565|327008|P7|Overall Study|Did Not Receive Study Medication|0
93918|NCT00812565|327009|P6|Overall Study|Did Not Receive Study Medication|0
93919|NCT00812565|327010|P5|Overall Study|Did Not Receive Study Medication|0
93920|NCT00812565|327011|P4|Overall Study|Did Not Receive Study Medication|0
93921|NCT00812565|327012|P3|Overall Study|Did Not Receive Study Medication|0
93922|NCT00812565|327013|P2|Overall Study|Did Not Receive Study Medication|1
93923|NCT00812565|327014|P1|Overall Study|Did Not Receive Study Medication|1
93924|NCT00812487|327138|P2|Overall Study|Protocol Violation|1
93925|NCT00812487|327139|P1|Overall Study|Protocol Violation|0
93926|NCT00812487|327138|P2|Overall Study|Transfer to ICU prior to intervention|0
93927|NCT00812487|327139|P1|Overall Study|Transfer to ICU prior to intervention|1
93928|NCT00812487|327138|P2|Overall Study|Withdrawal by Subject|2
93929|NCT00812487|327139|P1|Overall Study|Withdrawal by Subject|3
93930|NCT00812487|327138|P2|Overall Study|Lost to Follow-up|0
93931|NCT00812487|327139|P1|Overall Study|Lost to Follow-up|2
93932|NCT00812461|327165|P2|All Treated Patients|Other Reason|21
93933|NCT00812461|327166|P1|All Treated Patients|Other Reason|13
93934|NCT00812461|327165|P2|All Treated Patients|Lost to Follow-up|14
93935|NCT00812461|327166|P1|All Treated Patients|Lost to Follow-up|11
93936|NCT00812461|327165|P2|All Treated Patients|Withdrawal by Subject|54
93937|NCT00812461|327166|P1|All Treated Patients|Withdrawal by Subject|45
93938|NCT00812461|327165|P2|All Treated Patients|Protocol Violation|27
93939|NCT00812461|327166|P1|All Treated Patients|Protocol Violation|36
93940|NCT00812461|327165|P2|All Treated Patients|Non-compliance|9
93941|NCT00812461|327166|P1|All Treated Patients|Non-compliance|6
93942|NCT00812461|327165|P2|All Treated Patients|Lack of Efficacy|7
93943|NCT00812461|327166|P1|All Treated Patients|Lack of Efficacy|13
93944|NCT00812461|327165|P2|All Treated Patients|Adverse Event|15
93945|NCT00812461|327166|P1|All Treated Patients|Adverse Event|8
93946|NCT00812461|327165|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
93947|NCT00812461|327166|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
93948|NCT00812331|327189|P5|Overall Study|Adverse Event|0
93949|NCT00812331|327190|P4|Overall Study|Adverse Event|0
93950|NCT00812331|327191|P3|Overall Study|Adverse Event|0
93951|NCT00812331|327192|P2|Overall Study|Adverse Event|0
93952|NCT00812331|327193|P1|Overall Study|Adverse Event|1
93953|NCT00812253|327268|P2|Overall Study|Lost to Follow-up|0
93954|NCT00812253|327269|P1|Overall Study|Lost to Follow-up|2
93955|NCT00812253|327268|P2|Overall Study|Protocol Violation|1
93956|NCT00812253|327269|P1|Overall Study|Protocol Violation|1
93957|NCT00812253|327268|P2|Overall Study|Withdrawal by Subject|2
93958|NCT00812253|327269|P1|Overall Study|Withdrawal by Subject|3
93959|NCT00812097|327288|P4|Overall Study|Unknown reasons and patient/doctor moves|5
93960|NCT00812097|327289|P3|Overall Study|Unknown reasons and patient/doctor moves|15
93961|NCT00812097|327290|P2|Overall Study|Unknown reasons and patient/doctor moves|24
93962|NCT00812097|327291|P1|Overall Study|Unknown reasons and patient/doctor moves|111
93963|NCT00812097|327288|P4|Overall Study|Explantation of study device(s)|20
93964|NCT00812097|327289|P3|Overall Study|Explantation of study device(s)|14
93965|NCT00812097|327290|P2|Overall Study|Explantation of study device(s)|29
93966|NCT00812097|327291|P1|Overall Study|Explantation of study device(s)|27
93967|NCT00812097|327288|P4|Overall Study|Lost to Follow-up|5
93968|NCT00812097|327289|P3|Overall Study|Lost to Follow-up|17
93969|NCT00812097|327290|P2|Overall Study|Lost to Follow-up|14
93970|NCT00812097|327291|P1|Overall Study|Lost to Follow-up|90
93971|NCT00812097|327288|P4|Overall Study|Withdrawal by Subject|2
93972|NCT00812097|327289|P3|Overall Study|Withdrawal by Subject|8
93973|NCT00812097|327290|P2|Overall Study|Withdrawal by Subject|12
93974|NCT00812097|327291|P1|Overall Study|Withdrawal by Subject|14
93975|NCT00812097|327288|P4|Overall Study|Death|3
93976|NCT00812097|327289|P3|Overall Study|Death|3
93977|NCT00812097|327290|P2|Overall Study|Death|10
93978|NCT00812097|327291|P1|Overall Study|Death|3
93979|NCT00812006|327320|P3|Overall Study|Lack of Qualifying Event|2
93980|NCT00812006|327321|P2|Overall Study|Lack of Qualifying Event|2
93981|NCT00812006|327322|P1|Overall Study|Lack of Qualifying Event|4
93982|NCT00812006|327320|P3|Overall Study|Withdrawal by Subject|1
93983|NCT00812006|327321|P2|Overall Study|Withdrawal by Subject|1
93984|NCT00812006|327322|P1|Overall Study|Withdrawal by Subject|2
93985|NCT00812006|327320|P3|Overall Study|Physician Decision|1
93986|NCT00812006|327321|P2|Overall Study|Physician Decision|0
93987|NCT00812006|327322|P1|Overall Study|Physician Decision|0
93988|NCT00812006|327320|P3|Overall Study|Lost to Follow-up|2
93989|NCT00812006|327321|P2|Overall Study|Lost to Follow-up|0
93990|NCT00812006|327322|P1|Overall Study|Lost to Follow-up|0
93991|NCT00811954|327339|P3|Overall Study|Complete Protocol: No follow-up|1
93992|NCT00811954|327340|P2|Overall Study|Complete Protocol: No follow-up|0
93993|NCT00811954|327341|P1|Overall Study|Complete Protocol: No follow-up|0
93994|NCT00811954|327339|P3|Overall Study|Severe Debilitation|1
93995|NCT00811954|327340|P2|Overall Study|Severe Debilitation|0
93996|NCT00811954|327341|P1|Overall Study|Severe Debilitation|2
93997|NCT00811954|327339|P3|Overall Study|Site Closure|1
93998|NCT00811954|327340|P2|Overall Study|Site Closure|0
93999|NCT00811954|327341|P1|Overall Study|Site Closure|4
94000|NCT00811954|327339|P3|Overall Study|Withdraw consent prior study completion|5
94001|NCT00811954|327340|P2|Overall Study|Withdraw consent prior study completion|6
94002|NCT00811954|327341|P1|Overall Study|Withdraw consent prior study completion|4
94003|NCT00811954|327339|P3|Overall Study|Not willing to adhere to requirements|16
94004|NCT00811954|327340|P2|Overall Study|Not willing to adhere to requirements|2
94005|NCT00811954|327341|P1|Overall Study|Not willing to adhere to requirements|12
94006|NCT00811954|327339|P3|Overall Study|Not able to get to clinic|30
94007|NCT00811954|327340|P2|Overall Study|Not able to get to clinic|35
94008|NCT00811954|327341|P1|Overall Study|Not able to get to clinic|28
94009|NCT00811954|327339|P3|Overall Study|Lost to Follow-up|34
94010|NCT00811954|327340|P2|Overall Study|Lost to Follow-up|23
94011|NCT00811954|327341|P1|Overall Study|Lost to Follow-up|29
94012|NCT00811954|327339|P3|Overall Study|Death|13
94013|NCT00811954|327340|P2|Overall Study|Death|6
94014|NCT00811954|327341|P1|Overall Study|Death|10
94015|NCT00811941|327405|P2|All Treated Patients|Other Reason|14
94016|NCT00811941|327406|P1|All Treated Patients|Other Reason|4
94017|NCT00811941|327405|P2|All Treated Patients|Lost to Follow-up|12
94018|NCT00811941|327406|P1|All Treated Patients|Lost to Follow-up|3
94019|NCT00811941|327405|P2|All Treated Patients|Withdrawal by Subject|94
94020|NCT00811941|327406|P1|All Treated Patients|Withdrawal by Subject|35
94021|NCT00811941|327405|P2|All Treated Patients|Protocol Violation|17
94022|NCT00811941|327406|P1|All Treated Patients|Protocol Violation|5
94023|NCT00811941|327405|P2|All Treated Patients|Non-compliance|8
94024|NCT00811941|327406|P1|All Treated Patients|Non-compliance|1
94025|NCT00811941|327405|P2|All Treated Patients|Lack of Efficacy|3
94026|NCT00811941|327406|P1|All Treated Patients|Lack of Efficacy|2
94027|NCT00811941|327405|P2|All Treated Patients|Adverse Event|43
94028|NCT00811941|327406|P1|All Treated Patients|Adverse Event|2
94029|NCT00811941|327405|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
94030|NCT00811941|327406|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
94031|NCT00811928|327444|P2|Overall Study|Poor Compliance|5
94032|NCT00811928|327445|P1|Overall Study|Poor Compliance|2
94033|NCT00811928|327444|P2|Overall Study|Investigator Decision|1
94034|NCT00811928|327445|P1|Overall Study|Investigator Decision|2
94035|NCT00811928|327444|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
94036|NCT00811928|327445|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
94037|NCT00811928|327444|P2|Overall Study|Did Not Take Study Drug|0
94038|NCT00811928|327445|P1|Overall Study|Did Not Take Study Drug|3
94039|NCT00811928|327444|P2|Overall Study|Withdrawal by Subject|12
94040|NCT00811928|327445|P1|Overall Study|Withdrawal by Subject|18
94041|NCT00811928|327444|P2|Overall Study|AEs and SAEs Including Death|11
94042|NCT00811928|327445|P1|Overall Study|AEs and SAEs Including Death|7
94043|NCT00811733|327489|P2|Overall Study|Withdrawal by Subject|2
94044|NCT00811733|327490|P1|Overall Study|Withdrawal by Subject|1
94045|NCT00811733|327489|P2|Overall Study|Investigator Discretion|8
94046|NCT00811733|327490|P1|Overall Study|Investigator Discretion|10
94047|NCT00811720|327538|P2|All Treated Patients|Other Reason|4
94048|NCT00811720|327539|P1|All Treated Patients|Other Reason|7
94049|NCT00811720|327538|P2|All Treated Patients|Lost to Follow-up|16
94050|NCT00811720|327539|P1|All Treated Patients|Lost to Follow-up|10
94051|NCT00811720|327538|P2|All Treated Patients|Withdrawal by Subject|34
94052|NCT00811720|327539|P1|All Treated Patients|Withdrawal by Subject|28
94053|NCT00811720|327538|P2|All Treated Patients|Protocol Violation|16
94054|NCT00811720|327539|P1|All Treated Patients|Protocol Violation|9
94055|NCT00811720|327538|P2|All Treated Patients|Non-compliance|14
94056|NCT00811720|327539|P1|All Treated Patients|Non-compliance|0
94057|NCT00811720|327538|P2|All Treated Patients|Lack of Efficacy|18
94058|NCT00811720|327539|P1|All Treated Patients|Lack of Efficacy|22
94059|NCT00811720|327538|P2|All Treated Patients|Adverse Event|62
94060|NCT00811720|327539|P1|All Treated Patients|Adverse Event|20
94061|NCT00811720|327538|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
94062|NCT00811720|327539|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
94063|NCT00811655|327557|P1|Overall Study|Physician Decision|1
94064|NCT00811642|327569|P1|Overall Study|Cumulative use of antifungal agent|2
94065|NCT00811642|327569|P1|Overall Study|Withdrawal by Subject|7
94066|NCT00811642|327569|P1|Overall Study|Death|2
94067|NCT00811642|327569|P1|Overall Study|Protocol Violation|1
94068|NCT00811642|327569|P1|Overall Study|Adverse Event|3
94069|NCT00811577|327585|P2|Overall Study|Withdrawal by Subject|0
94070|NCT00811577|327586|P1|Overall Study|Withdrawal by Subject|3
94071|NCT00811577|327585|P2|Overall Study|Lost to Follow-up|1
94072|NCT00811577|327586|P1|Overall Study|Lost to Follow-up|7
94073|NCT00811473|327646|P2|Overall Study|Safety Reasons|0
94074|NCT00811473|327647|P1|Overall Study|Safety Reasons|1
94075|NCT00811473|327646|P2|Overall Study|Incorrect Enrollment|0
94076|NCT00811473|327647|P1|Overall Study|Incorrect Enrollment|1
94077|NCT00811473|327646|P2|Overall Study|Other 2|1
94078|NCT00811473|327647|P1|Overall Study|Other 2|4
94079|NCT00811473|327646|P2|Overall Study|Condition under investigation worsened|3
94080|NCT00811473|327647|P1|Overall Study|Condition under investigation worsened|1
94081|NCT00811473|327646|P2|Overall Study|Lack of therapeutic response|1
94082|NCT00811473|327647|P1|Overall Study|Lack of therapeutic response|4
94083|NCT00811473|327646|P2|Overall Study|Severe non-compliance to protocol|4
94084|NCT00811473|327647|P1|Overall Study|Severe non-compliance to protocol|2
94085|NCT00811473|327646|P2|Overall Study|Withdrawal by Subject|4
94086|NCT00811473|327647|P1|Overall Study|Withdrawal by Subject|2
94087|NCT00811473|327646|P2|Overall Study|Lost to Follow-up|1
94088|NCT00811473|327647|P1|Overall Study|Lost to Follow-up|5
94089|NCT00811473|327646|P2|Overall Study|Adverse Event|12
94090|NCT00811473|327647|P1|Overall Study|Adverse Event|3
94091|NCT00811395|327678|P6|Extension Treatment|Other than above|0
94092|NCT00811395|327679|P5|Extension Treatment|Other than above|0
94093|NCT00811395|327680|P4|Extension Treatment|Other than above|0
94094|NCT00811395|327681|P3|Extension Treatment|Other than above|1
94095|NCT00811395|327682|P2|Extension Treatment|Other than above|0
94096|NCT00811395|327683|P1|Extension Treatment|Other than above|0
94097|NCT00811395|327678|P6|Extension Treatment|Participant did not wish to continue|1
94098|NCT00811395|327679|P5|Extension Treatment|Participant did not wish to continue|0
94099|NCT00811395|327680|P4|Extension Treatment|Participant did not wish to continue|1
94100|NCT00811395|327681|P3|Extension Treatment|Participant did not wish to continue|0
94101|NCT00811395|327682|P2|Extension Treatment|Participant did not wish to continue|3
94102|NCT00811395|327683|P1|Extension Treatment|Participant did not wish to continue|0
94103|NCT00811395|327678|P6|Extension Treatment|Progressive disease|0
94104|NCT00811395|327679|P5|Extension Treatment|Progressive disease|0
94105|NCT00811395|327680|P4|Extension Treatment|Progressive disease|0
94106|NCT00811395|327681|P3|Extension Treatment|Progressive disease|0
94107|NCT00811395|327682|P2|Extension Treatment|Progressive disease|1
94108|NCT00811395|327683|P1|Extension Treatment|Progressive disease|1
94109|NCT00811395|327678|P6|Extension Treatment|Adverse Event|1
94110|NCT00811395|327679|P5|Extension Treatment|Adverse Event|0
94111|NCT00811395|327680|P4|Extension Treatment|Adverse Event|2
94112|NCT00811395|327681|P3|Extension Treatment|Adverse Event|2
94113|NCT00811395|327682|P2|Extension Treatment|Adverse Event|2
94114|NCT00811395|327683|P1|Extension Treatment|Adverse Event|1
94115|NCT00811252|327748|P3|Overall Study|Administrative or Other Reasons|2
94116|NCT00811252|327749|P2|Overall Study|Administrative or Other Reasons|3
94117|NCT00811252|327750|P1|Overall Study|Administrative or Other Reasons|0
94118|NCT00811252|327748|P3|Overall Study|Lost to Follow-up|2
94119|NCT00811252|327749|P2|Overall Study|Lost to Follow-up|0
94120|NCT00811252|327750|P1|Overall Study|Lost to Follow-up|0
94121|NCT00811252|327748|P3|Overall Study|Withdrawal of Consent|2
94122|NCT00811252|327749|P2|Overall Study|Withdrawal of Consent|2
94123|NCT00811252|327750|P1|Overall Study|Withdrawal of Consent|1
94124|NCT00811252|327748|P3|Overall Study|Protocol Violation|2
94125|NCT00811252|327749|P2|Overall Study|Protocol Violation|3
94126|NCT00811252|327750|P1|Overall Study|Protocol Violation|3
94127|NCT00811252|327748|P3|Overall Study|Lack of Efficacy|0
94128|NCT00811252|327749|P2|Overall Study|Lack of Efficacy|2
94129|NCT00811252|327750|P1|Overall Study|Lack of Efficacy|7
94130|NCT00811252|327748|P3|Overall Study|Adverse Event|15
94131|NCT00811252|327749|P2|Overall Study|Adverse Event|10
94132|NCT00811252|327750|P1|Overall Study|Adverse Event|6
94133|NCT00811135|327794|P1|Overall Study|Ongoing|59
94134|NCT00811135|327794|P1|Overall Study|Administrative/Other Unspecified|11
94135|NCT00811135|327794|P1|Overall Study|Withdrawal by Subject|3
94136|NCT00811135|327794|P1|Overall Study|Refused Treatment|1
94137|NCT00811135|327794|P1|Overall Study|Violation of Selection Criteria|1
94138|NCT00811135|327794|P1|Overall Study|Protocol Violation|2
94139|NCT00811135|327794|P1|Overall Study|Death|3
94140|NCT00811135|327794|P1|Overall Study|Adverse Event/Intercurrent Illness|8
94141|NCT00811070|327812|P6|Overall Study|Physician Decision|1
94142|NCT00811070|327813|P5|Overall Study|Physician Decision|0
94143|NCT00811070|327814|P4|Overall Study|Physician Decision|0
94144|NCT00811070|327815|P3|Overall Study|Physician Decision|0
94145|NCT00811070|327816|P2|Overall Study|Physician Decision|0
94146|NCT00811070|327817|P1|Overall Study|Physician Decision|0
94147|NCT00811070|327812|P6|Overall Study|Withdrawal by Subject|0
94148|NCT00811070|327813|P5|Overall Study|Withdrawal by Subject|0
94149|NCT00811070|327814|P4|Overall Study|Withdrawal by Subject|0
94150|NCT00811070|327815|P3|Overall Study|Withdrawal by Subject|0
94151|NCT00811070|327816|P2|Overall Study|Withdrawal by Subject|1
94152|NCT00811070|327817|P1|Overall Study|Withdrawal by Subject|0
94153|NCT00811070|327812|P6|Overall Study|Unspecified|0
94154|NCT00811070|327813|P5|Overall Study|Unspecified|0
94155|NCT00811070|327814|P4|Overall Study|Unspecified|0
94156|NCT00811070|327815|P3|Overall Study|Unspecified|0
94157|NCT00811070|327816|P2|Overall Study|Unspecified|0
94158|NCT00811070|327817|P1|Overall Study|Unspecified|1
94159|NCT00811070|327812|P6|Overall Study|Death|0
94160|NCT00811070|327813|P5|Overall Study|Death|5
94161|NCT00811070|327814|P4|Overall Study|Death|2
94162|NCT00811070|327815|P3|Overall Study|Death|0
94163|NCT00811070|327816|P2|Overall Study|Death|0
94164|NCT00811070|327817|P1|Overall Study|Death|0
94165|NCT00811057|327877|P3|Overall Study|Protocol Violation|10
94166|NCT00811057|327878|P2|Overall Study|Protocol Violation|10
94167|NCT00811057|327879|P1|Overall Study|Protocol Violation|5
94168|NCT00811018|327890|P1|Overall Study|Unspecified|26
94169|NCT00811018|327890|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
94170|NCT00811018|327890|P1|Overall Study|Withdrawal by Subject|70
94171|NCT00811018|327890|P1|Overall Study|Sponsor Decision|450
94172|NCT00811018|327890|P1|Overall Study|Pregnancy|6
94173|NCT00811018|327890|P1|Overall Study|Lost to Follow-up|19
94174|NCT00811018|327890|P1|Overall Study|Investigator Decision|57
94175|NCT00811018|327890|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
94176|NCT00811018|327890|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
94177|NCT00811018|327890|P1|Overall Study|Death|147
94178|NCT00811018|327890|P1|Overall Study|Adverse Event|79
94179|NCT00811018|327890|P1|Overall Study|Additional Chronic Treatment|31
94180|NCT00810901|327908|P2|Overall Study|Lost to Follow-up|58
94181|NCT00810901|327909|P1|Overall Study|Lost to Follow-up|88
94182|NCT00810693|327945|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
94183|NCT00810693|327946|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
94184|NCT00810693|327947|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
94185|NCT00810693|327945|P3|Follow-up Period (FUP)|Protocol Violation|0
94186|NCT00810693|327946|P2|Follow-up Period (FUP)|Protocol Violation|1
94187|NCT00810693|327947|P1|Follow-up Period (FUP)|Protocol Violation|0
94188|NCT00810693|327945|P3|Follow-up Period (FUP)|Lost to Follow-up|2
94189|NCT00810693|327946|P2|Follow-up Period (FUP)|Lost to Follow-up|0
94190|NCT00810693|327947|P1|Follow-up Period (FUP)|Lost to Follow-up|1
94191|NCT00810693|327945|P3|Follow-up Period (FUP)|Death|1
94192|NCT00810693|327946|P2|Follow-up Period (FUP)|Death|0
94193|NCT00810693|327947|P1|Follow-up Period (FUP)|Death|2
94194|NCT00810693|327945|P3|Follow-up Period (FUP)|Adverse Event|1
94195|NCT00810693|327946|P2|Follow-up Period (FUP)|Adverse Event|1
94196|NCT00810693|327947|P1|Follow-up Period (FUP)|Adverse Event|3
94197|NCT00810693|327945|P3|Treatment Period|Not treated|1
94198|NCT00810693|327946|P2|Treatment Period|Not treated|1
94199|NCT00810693|327947|P1|Treatment Period|Not treated|0
94200|NCT00810693|327945|P3|Treatment Period|Withdrawal by Subject|3
94201|NCT00810693|327946|P2|Treatment Period|Withdrawal by Subject|2
94202|NCT00810693|327947|P1|Treatment Period|Withdrawal by Subject|6
94203|NCT00810693|327945|P3|Treatment Period|Protocol Violation|2
94204|NCT00810693|327946|P2|Treatment Period|Protocol Violation|2
94205|NCT00810693|327947|P1|Treatment Period|Protocol Violation|1
94206|NCT00810693|327945|P3|Treatment Period|Non-compliance|0
94207|NCT00810693|327946|P2|Treatment Period|Non-compliance|0
94208|NCT00810693|327947|P1|Treatment Period|Non-compliance|1
94209|NCT00810693|327945|P3|Treatment Period|Lost to Follow-up|0
94210|NCT00810693|327946|P2|Treatment Period|Lost to Follow-up|0
94211|NCT00810693|327947|P1|Treatment Period|Lost to Follow-up|1
94212|NCT00810693|327945|P3|Treatment Period|Lack of Efficacy|1
94213|NCT00810693|327946|P2|Treatment Period|Lack of Efficacy|0
94214|NCT00810693|327947|P1|Treatment Period|Lack of Efficacy|0
94215|NCT00810693|327945|P3|Treatment Period|Death|2
94216|NCT00810693|327946|P2|Treatment Period|Death|1
94217|NCT00810693|327947|P1|Treatment Period|Death|0
94218|NCT00810693|327945|P3|Treatment Period|Adverse Event|7
94219|NCT00810693|327946|P2|Treatment Period|Adverse Event|1
94220|NCT00810693|327947|P1|Treatment Period|Adverse Event|8
94221|NCT00810641|327979|P3|Overall Study|Withdrawal by Subject|2
94222|NCT00810641|327980|P2|Overall Study|Withdrawal by Subject|1
94223|NCT00810641|327981|P1|Overall Study|Withdrawal by Subject|0
94224|NCT00810602|327989|P2|Overall Study|Withdrawal by Subject|3
94225|NCT00810602|327990|P1|Overall Study|Withdrawal by Subject|8
94226|NCT00810511|328003|P2|Overall Study|deposits on contact lens|1
94227|NCT00810511|328004|P1|Overall Study|deposits on contact lens|0
94228|NCT00810511|328003|P2|Overall Study|Lost to Follow-up|0
94229|NCT00810511|328004|P1|Overall Study|Lost to Follow-up|1
94230|NCT00810511|328003|P2|Overall Study|death in the family|1
94231|NCT00810511|328004|P1|Overall Study|death in the family|0
94232|NCT00810511|328003|P2|Overall Study|Lack of Efficacy|1
94233|NCT00810511|328004|P1|Overall Study|Lack of Efficacy|9
94234|NCT00810511|328003|P2|Overall Study|Protocol Violation|1
94235|NCT00810511|328004|P1|Overall Study|Protocol Violation|0
94236|NCT00810368|328012|P2|Overall Study|Lack of Efficacy|0
94237|NCT00810368|328013|P1|Overall Study|Lack of Efficacy|2
94238|NCT00810368|328012|P2|Overall Study|Lost to Follow-up|2
94239|NCT00810368|328013|P1|Overall Study|Lost to Follow-up|4
94240|NCT00810355|328034|P3|Overall Study|Withdrawal by Subject|0
94241|NCT00810355|328035|P2|Overall Study|Withdrawal by Subject|0
94242|NCT00810355|328036|P1|Overall Study|Withdrawal by Subject|1
94243|NCT00810355|328034|P3|Overall Study|Lost to Follow-up|11
94244|NCT00810355|328035|P2|Overall Study|Lost to Follow-up|17
94245|NCT00810355|328036|P1|Overall Study|Lost to Follow-up|13
94246|NCT00810342|328052|P2|12-month Followup|Lost to Follow-up|1
94247|NCT00810342|328053|P1|12-month Followup|Lost to Follow-up|3
94248|NCT00810342|328052|P2|12-month Followup|Pregnancy|10
94249|NCT00810342|328053|P1|12-month Followup|Pregnancy|9
94250|NCT00810342|328052|P2|6-month Follow-up|Pregnancy|2
94251|NCT00810342|328053|P1|6-month Follow-up|Pregnancy|6
94252|NCT00810342|328052|P2|6-month Follow-up|Lost to Follow-up|6
94253|NCT00810342|328053|P1|6-month Follow-up|Lost to Follow-up|18
94254|NCT00810342|328052|P2|Month 1 Follow-up|Pregnancy|0
94255|NCT00810342|328053|P1|Month 1 Follow-up|Pregnancy|1
94256|NCT00810342|328052|P2|Month 1 Follow-up|Lost to Follow-up|2
94257|NCT00810342|328053|P1|Month 1 Follow-up|Lost to Follow-up|4
94258|NCT00810277|328086|P1|Overall Study|Adverse Event|1
94259|NCT00810199|328101|P2|Overall Study|Did not receive study drug|1
94260|NCT00810199|328102|P1|Overall Study|Did not receive study drug|2
94261|NCT00810199|328101|P2|Overall Study|Failure to return|4
94262|NCT00810199|328102|P1|Overall Study|Failure to return|1
94263|NCT00810199|328101|P2|Overall Study|Protocol Violation|6
94264|NCT00810199|328102|P1|Overall Study|Protocol Violation|2
94265|NCT00810199|328101|P2|Overall Study|Administrative/Other|6
94266|NCT00810199|328102|P1|Overall Study|Administrative/Other|5
94267|NCT00810199|328101|P2|Overall Study|Refused treatment/Did not cooperate|7
94268|NCT00810199|328102|P1|Overall Study|Refused treatment/Did not cooperate|7
94269|NCT00810199|328101|P2|Overall Study|Insufficient therapeutic response|14
94270|NCT00810199|328102|P1|Overall Study|Insufficient therapeutic response|5
94271|NCT00810199|328101|P2|Overall Study|Withdrew consent|12
94272|NCT00810199|328102|P1|Overall Study|Withdrew consent|9
94273|NCT00810199|328101|P2|Overall Study|Death|6
94274|NCT00810199|328102|P1|Overall Study|Death|4
94275|NCT00810199|328101|P2|Overall Study|Adverse Event|26
94276|NCT00810199|328102|P1|Overall Study|Adverse Event|24
94277|NCT00810108|328180|P2|Overall Study|Withdrawal by Subject|0
94278|NCT00810108|328181|P1|Overall Study|Withdrawal by Subject|1
94279|NCT00810082|328195|P2|Overall Study|Lost to Follow-up|4
94280|NCT00810082|328196|P1|Overall Study|Lost to Follow-up|0
94281|NCT00810069|328204|P3|Double-Blind Period II|Protocol Violation|6
94282|NCT00810069|328205|P2|Double-Blind Period II|Protocol Violation|7
94283|NCT00810069|328206|P1|Double-Blind Period II|Protocol Violation|0
94284|NCT00810069|328204|P3|Double-Blind Period II|Clinical relapse|0
94285|NCT00810069|328205|P2|Double-Blind Period II|Clinical relapse|3
94286|NCT00810069|328206|P1|Double-Blind Period II|Clinical relapse|0
94287|NCT00810069|328204|P3|Double-Blind Period II|Protocol entry criterion not met|1
94288|NCT00810069|328205|P2|Double-Blind Period II|Protocol entry criterion not met|0
94289|NCT00810069|328206|P1|Double-Blind Period II|Protocol entry criterion not met|0
94290|NCT00810069|328204|P3|Double-Blind Period II|Withdrawal by Subject|35
94291|NCT00810069|328205|P2|Double-Blind Period II|Withdrawal by Subject|21
94292|NCT00810069|328206|P1|Double-Blind Period II|Withdrawal by Subject|0
94293|NCT00810069|328204|P3|Double-Blind Period II|Physician Decision|1
94294|NCT00810069|328205|P2|Double-Blind Period II|Physician Decision|0
94295|NCT00810069|328206|P1|Double-Blind Period II|Physician Decision|0
94296|NCT00810069|328204|P3|Double-Blind Period II|Lost to Follow-up|9
94297|NCT00810069|328205|P2|Double-Blind Period II|Lost to Follow-up|9
94298|NCT00810069|328206|P1|Double-Blind Period II|Lost to Follow-up|0
94299|NCT00810069|328204|P3|Double-Blind Period II|Lack of Efficacy|12
94300|NCT00810069|328205|P2|Double-Blind Period II|Lack of Efficacy|7
94301|NCT00810069|328206|P1|Double-Blind Period II|Lack of Efficacy|0
94302|NCT00810069|328204|P3|Double-Blind Period II|Adverse Event|8
94303|NCT00810069|328205|P2|Double-Blind Period II|Adverse Event|9
94304|NCT00810069|328206|P1|Double-Blind Period II|Adverse Event|0
94305|NCT00810069|328204|P3|Lead-in Period I|Randomization criteria not met|0
94306|NCT00810069|328205|P2|Lead-in Period I|Randomization criteria not met|0
94307|NCT00810069|328206|P1|Lead-in Period I|Randomization criteria not met|158
94308|NCT00810069|328204|P3|Lead-in Period I|Protocol entry criterion not met|0
94309|NCT00810069|328205|P2|Lead-in Period I|Protocol entry criterion not met|0
94310|NCT00810069|328206|P1|Lead-in Period I|Protocol entry criterion not met|5
94311|NCT00810069|328204|P3|Lead-in Period I|Withdrawal by Subject|0
94312|NCT00810069|328205|P2|Lead-in Period I|Withdrawal by Subject|0
94313|NCT00810069|328206|P1|Lead-in Period I|Withdrawal by Subject|46
94314|NCT00810069|328204|P3|Lead-in Period I|Protocol Violation|0
94315|NCT00810069|328205|P2|Lead-in Period I|Protocol Violation|0
94316|NCT00810069|328206|P1|Lead-in Period I|Protocol Violation|1
94317|NCT00810069|328204|P3|Lead-in Period I|Physician Decision|0
94318|NCT00810069|328205|P2|Lead-in Period I|Physician Decision|0
94319|NCT00810069|328206|P1|Lead-in Period I|Physician Decision|1
94320|NCT00810069|328204|P3|Lead-in Period I|Lost to Follow-up|0
94321|NCT00810069|328205|P2|Lead-in Period I|Lost to Follow-up|0
94322|NCT00810069|328206|P1|Lead-in Period I|Lost to Follow-up|19
94323|NCT00810069|328204|P3|Lead-in Period I|Lack of Efficacy|0
94324|NCT00810069|328205|P2|Lead-in Period I|Lack of Efficacy|0
94325|NCT00810069|328206|P1|Lead-in Period I|Lack of Efficacy|1
94326|NCT00810069|328204|P3|Lead-in Period I|Adverse Event|0
94327|NCT00810069|328205|P2|Lead-in Period I|Adverse Event|0
94328|NCT00810069|328206|P1|Lead-in Period I|Adverse Event|43
94329|NCT00810043|328251|P3|Overall Study|No longer met enrollment criteria|3
94330|NCT00810043|328252|P2|Overall Study|No longer met enrollment criteria|0
94331|NCT00810043|328253|P1|Overall Study|No longer met enrollment criteria|0
94332|NCT00810043|328251|P3|Overall Study|Non-medical problem|1
94333|NCT00810043|328252|P2|Overall Study|Non-medical problem|0
94334|NCT00810043|328253|P1|Overall Study|Non-medical problem|0
94335|NCT00810043|328251|P3|Overall Study|Unrelated medical problem|0
94336|NCT00810043|328252|P2|Overall Study|Unrelated medical problem|1
94337|NCT00810043|328253|P1|Overall Study|Unrelated medical problem|0
94338|NCT00810043|328251|P3|Overall Study|Death|0
94339|NCT00810043|328252|P2|Overall Study|Death|0
94340|NCT00810043|328253|P1|Overall Study|Death|2
94341|NCT00810043|328251|P3|Overall Study|Physician Decision|2
94342|NCT00810043|328252|P2|Overall Study|Physician Decision|0
94343|NCT00810043|328253|P1|Overall Study|Physician Decision|0
94344|NCT00810043|328251|P3|Overall Study|Lost to Follow-up|0
94345|NCT00810043|328252|P2|Overall Study|Lost to Follow-up|0
94346|NCT00810043|328253|P1|Overall Study|Lost to Follow-up|1
94347|NCT00810043|328251|P3|Overall Study|Withdrawal by Subject|2
94348|NCT00810043|328252|P2|Overall Study|Withdrawal by Subject|0
94349|NCT00810043|328253|P1|Overall Study|Withdrawal by Subject|1
94350|NCT00809965|328275|P3|Overall Study|Other Reason|189
94351|NCT00809965|328276|P2|Overall Study|Other Reason|170
94352|NCT00809965|328277|P1|Overall Study|Other Reason|167
94353|NCT00809965|328275|P3|Overall Study|Withdrawal by Subject|441
94354|NCT00809965|328276|P2|Overall Study|Withdrawal by Subject|448
94355|NCT00809965|328277|P1|Overall Study|Withdrawal by Subject|405
94356|NCT00809965|328275|P3|Overall Study|Lost to Follow-up|18
94357|NCT00809965|328276|P2|Overall Study|Lost to Follow-up|10
94358|NCT00809965|328277|P1|Overall Study|Lost to Follow-up|17
94359|NCT00809965|328275|P3|Overall Study|Death|196
94360|NCT00809965|328276|P2|Overall Study|Death|147
94361|NCT00809965|328277|P1|Overall Study|Death|194
94362|NCT00809926|328299|P2|Overall Study|Protocol deviation|2
94363|NCT00809926|328300|P1|Overall Study|Protocol deviation|0
94364|NCT00809926|328299|P2|Overall Study|Administrative Problems|1
94365|NCT00809926|328300|P1|Overall Study|Administrative Problems|0
94366|NCT00809926|328299|P2|Overall Study|Lost to Follow-up|1
94367|NCT00809926|328300|P1|Overall Study|Lost to Follow-up|2
94368|NCT00809926|328299|P2|Overall Study|Patient withdrew consent|6
94369|NCT00809926|328300|P1|Overall Study|Patient withdrew consent|8
94370|NCT00809926|328299|P2|Overall Study|Unsatisfactory therapeutic effect|3
94371|NCT00809926|328300|P1|Overall Study|Unsatisfactory therapeutic effect|3
94372|NCT00809926|328299|P2|Overall Study|Adverse Event|10
94373|NCT00809926|328300|P1|Overall Study|Adverse Event|18
94374|NCT00809757|328362|P3|Overall Study|Noncompliance with Medication|1
94375|NCT00809757|328363|P2|Overall Study|Noncompliance with Medication|0
94376|NCT00809757|328364|P1|Overall Study|Noncompliance with Medication|0
94377|NCT00809757|328362|P3|Overall Study|Subject Uncooperative|2
94378|NCT00809757|328363|P2|Overall Study|Subject Uncooperative|0
94379|NCT00809757|328364|P1|Overall Study|Subject Uncooperative|1
94380|NCT00809757|328362|P3|Overall Study|Withdrawal by Subject|3
94381|NCT00809757|328363|P2|Overall Study|Withdrawal by Subject|1
94382|NCT00809757|328364|P1|Overall Study|Withdrawal by Subject|2
94383|NCT00809757|328362|P3|Overall Study|Protocol Violation|1
94384|NCT00809757|328363|P2|Overall Study|Protocol Violation|1
94385|NCT00809757|328364|P1|Overall Study|Protocol Violation|1
94386|NCT00809757|328362|P3|Overall Study|Lost to Follow-up|1
94387|NCT00809757|328363|P2|Overall Study|Lost to Follow-up|0
94388|NCT00809757|328364|P1|Overall Study|Lost to Follow-up|0
94389|NCT00809757|328362|P3|Overall Study|Adverse Event|3
94390|NCT00809757|328363|P2|Overall Study|Adverse Event|3
94391|NCT00809757|328364|P1|Overall Study|Adverse Event|2
94392|NCT00809614|328449|P2|Overall Study|Withdrawal by Subject|1
94393|NCT00809614|328450|P1|Overall Study|Withdrawal by Subject|1
94394|NCT00809614|328449|P2|Overall Study|Lack of Efficacy|3
94395|NCT00809614|328450|P1|Overall Study|Lack of Efficacy|2
94396|NCT00809471|328494|P3|Overall Study|Requirement for restricted medication|0
94397|NCT00809471|328495|P2|Overall Study|Requirement for restricted medication|1
94398|NCT00809471|328496|P1|Overall Study|Requirement for restricted medication|1
94399|NCT00809471|328494|P3|Overall Study|Adverse Event|2
94400|NCT00809471|328495|P2|Overall Study|Adverse Event|2
94401|NCT00809471|328496|P1|Overall Study|Adverse Event|0
94402|NCT00809471|328494|P3|Overall Study|Lost to Follow-up|9
94403|NCT00809471|328495|P2|Overall Study|Lost to Follow-up|2
94404|NCT00809471|328496|P1|Overall Study|Lost to Follow-up|4
94405|NCT00809471|328494|P3|Overall Study|Protocol non-compliance|6
94406|NCT00809471|328495|P2|Overall Study|Protocol non-compliance|15
94407|NCT00809471|328496|P1|Overall Study|Protocol non-compliance|15
94408|NCT00809445|328526|P3|6 Month Follow-up|Withdrew consent|1
94409|NCT00809445|328527|P2|6 Month Follow-up|Withdrew consent|0
94410|NCT00809445|328528|P1|6 Month Follow-up|Withdrew consent|0
94411|NCT00809445|328526|P3|6 Month Follow-up|Incarcerated|8
94412|NCT00809445|328527|P2|6 Month Follow-up|Incarcerated|8
94413|NCT00809445|328528|P1|6 Month Follow-up|Incarcerated|6
94414|NCT00809445|328526|P3|6 Month Follow-up|Death|1
94415|NCT00809445|328527|P2|6 Month Follow-up|Death|1
94416|NCT00809445|328528|P1|6 Month Follow-up|Death|2
94417|NCT00809445|328526|P3|6 Month Follow-up|Lost contact|14
94418|NCT00809445|328527|P2|6 Month Follow-up|Lost contact|14
94419|NCT00809445|328528|P1|6 Month Follow-up|Lost contact|16
94420|NCT00809445|328526|P3|1 Month Follow-up|Incarcerated|1
94421|NCT00809445|328527|P2|1 Month Follow-up|Incarcerated|0
94422|NCT00809445|328528|P1|1 Month Follow-up|Incarcerated|0
94423|NCT00809445|328526|P3|1 Month Follow-up|Death|1
94424|NCT00809445|328527|P2|1 Month Follow-up|Death|1
94425|NCT00809445|328528|P1|1 Month Follow-up|Death|0
94426|NCT00809445|328526|P3|1 Month Follow-up|Withdrew consent|1
94427|NCT00809445|328527|P2|1 Month Follow-up|Withdrew consent|1
94428|NCT00809445|328528|P1|1 Month Follow-up|Withdrew consent|1
94429|NCT00809445|328526|P3|1 Month Follow-up|Lost contact|1
94430|NCT00809445|328527|P2|1 Month Follow-up|Lost contact|2
94431|NCT00809445|328528|P1|1 Month Follow-up|Lost contact|1
94432|NCT00809328|328545|P1|Overall Study|Withdrawal by Subject|2
94433|NCT00809328|328545|P1|Overall Study|Protocol Violation|3
94434|NCT00809328|328545|P1|Overall Study|Adverse Event|6
94435|NCT00809328|328545|P1|Overall Study|Lack of Efficacy|18
94436|NCT00809159|328565|P6|Part 1 and 2|Withdrawal by Subject|1
94437|NCT00809159|328566|P5|Part 1 and 2|Withdrawal by Subject|0
94438|NCT00809159|328567|P4|Part 1 and 2|Withdrawal by Subject|0
94439|NCT00809159|328568|P3|Part 1 and 2|Withdrawal by Subject|4
94440|NCT00809159|328569|P2|Part 1 and 2|Withdrawal by Subject|0
94441|NCT00809159|328570|P1|Part 1 and 2|Withdrawal by Subject|0
94442|NCT00809159|328565|P6|Part 1 and 2|Lost to Follow-up|0
94443|NCT00809159|328566|P5|Part 1 and 2|Lost to Follow-up|0
94444|NCT00809159|328567|P4|Part 1 and 2|Lost to Follow-up|1
94445|NCT00809159|328568|P3|Part 1 and 2|Lost to Follow-up|1
94446|NCT00809159|328569|P2|Part 1 and 2|Lost to Follow-up|0
94447|NCT00809159|328570|P1|Part 1 and 2|Lost to Follow-up|0
94448|NCT00809159|328565|P6|Part 1 and 2|Adverse Event|1
94449|NCT00809159|328566|P5|Part 1 and 2|Adverse Event|1
94450|NCT00809159|328567|P4|Part 1 and 2|Adverse Event|0
94451|NCT00809159|328568|P3|Part 1 and 2|Adverse Event|1
94452|NCT00809159|328569|P2|Part 1 and 2|Adverse Event|0
94453|NCT00809159|328570|P1|Part 1 and 2|Adverse Event|0
94454|NCT00809159|328565|P6|Part 1 and 2|Administrative problems|0
94455|NCT00809159|328566|P5|Part 1 and 2|Administrative problems|0
94456|NCT00809159|328567|P4|Part 1 and 2|Administrative problems|1
94457|NCT00809159|328568|P3|Part 1 and 2|Administrative problems|0
94458|NCT00809159|328569|P2|Part 1 and 2|Administrative problems|0
94459|NCT00809159|328570|P1|Part 1 and 2|Administrative problems|0
94460|NCT00809159|328565|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
94461|NCT00809159|328566|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
94462|NCT00809159|328567|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
94463|NCT00809159|328568|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
94464|NCT00809159|328569|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
94465|NCT00809159|328570|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
94466|NCT00809159|328565|P6|Part 1|Unsatisfactory therapeutic effect|0
94467|NCT00809159|328566|P5|Part 1|Unsatisfactory therapeutic effect|0
94468|NCT00809159|328567|P4|Part 1|Unsatisfactory therapeutic effect|0
94469|NCT00809159|328568|P3|Part 1|Unsatisfactory therapeutic effect|0
94470|NCT00809159|328569|P2|Part 1|Unsatisfactory therapeutic effect|1
94471|NCT00809159|328570|P1|Part 1|Unsatisfactory therapeutic effect|3
94472|NCT00809159|328565|P6|Part 1|Withdrawal by Subject|0
94473|NCT00809159|328566|P5|Part 1|Withdrawal by Subject|0
94474|NCT00809159|328567|P4|Part 1|Withdrawal by Subject|0
94475|NCT00809159|328568|P3|Part 1|Withdrawal by Subject|0
94476|NCT00809159|328569|P2|Part 1|Withdrawal by Subject|1
94477|NCT00809159|328570|P1|Part 1|Withdrawal by Subject|3
94478|NCT00809159|328565|P6|Part 1|Lost to Follow-up|0
94479|NCT00809159|328566|P5|Part 1|Lost to Follow-up|0
94480|NCT00809159|328567|P4|Part 1|Lost to Follow-up|0
94481|NCT00809159|328568|P3|Part 1|Lost to Follow-up|0
94482|NCT00809159|328569|P2|Part 1|Lost to Follow-up|0
94483|NCT00809159|328570|P1|Part 1|Lost to Follow-up|1
94484|NCT00809159|328565|P6|Part 1|Adverse Event|0
94485|NCT00809159|328566|P5|Part 1|Adverse Event|0
94486|NCT00809159|328567|P4|Part 1|Adverse Event|0
94487|NCT00809159|328568|P3|Part 1|Adverse Event|0
94488|NCT00809159|328569|P2|Part 1|Adverse Event|1
94489|NCT00809159|328570|P1|Part 1|Adverse Event|1
94490|NCT00809133|328675|P14|Overall Study|Other not mentioned above|0
94491|NCT00809133|328676|P13|Overall Study|Other not mentioned above|0
94492|NCT00809133|328677|P12|Overall Study|Other not mentioned above|0
94493|NCT00809133|328678|P11|Overall Study|Other not mentioned above|0
94494|NCT00809133|328679|P10|Overall Study|Other not mentioned above|0
94495|NCT00809133|328680|P9|Overall Study|Other not mentioned above|0
94496|NCT00809133|328681|P8|Overall Study|Other not mentioned above|0
94497|NCT00809133|328682|P7|Overall Study|Other not mentioned above|0
94498|NCT00809133|328683|P6|Overall Study|Other not mentioned above|1
94499|NCT00809133|328684|P5|Overall Study|Other not mentioned above|0
94500|NCT00809133|328685|P4|Overall Study|Other not mentioned above|0
94501|NCT00809133|328686|P3|Overall Study|Other not mentioned above|0
94502|NCT00809133|328687|P2|Overall Study|Other not mentioned above|1
94503|NCT00809133|328688|P1|Overall Study|Other not mentioned above|0
94504|NCT00809133|328675|P14|Overall Study|Consent withdrawn|0
94505|NCT00809133|328676|P13|Overall Study|Consent withdrawn|0
94506|NCT00809133|328677|P12|Overall Study|Consent withdrawn|0
94507|NCT00809133|328678|P11|Overall Study|Consent withdrawn|0
94508|NCT00809133|328679|P10|Overall Study|Consent withdrawn|0
94509|NCT00809133|328680|P9|Overall Study|Consent withdrawn|0
94510|NCT00809133|328681|P8|Overall Study|Consent withdrawn|0
94511|NCT00809133|328682|P7|Overall Study|Consent withdrawn|0
94512|NCT00809133|328683|P6|Overall Study|Consent withdrawn|0
94513|NCT00809133|328684|P5|Overall Study|Consent withdrawn|1
94514|NCT00809133|328685|P4|Overall Study|Consent withdrawn|0
94515|NCT00809133|328686|P3|Overall Study|Consent withdrawn|0
94516|NCT00809133|328687|P2|Overall Study|Consent withdrawn|0
94517|NCT00809133|328688|P1|Overall Study|Consent withdrawn|0
94518|NCT00809133|328675|P14|Overall Study|Lost to Follow-up|0
94519|NCT00809133|328676|P13|Overall Study|Lost to Follow-up|0
94520|NCT00809133|328677|P12|Overall Study|Lost to Follow-up|0
94521|NCT00809133|328678|P11|Overall Study|Lost to Follow-up|0
94522|NCT00809133|328679|P10|Overall Study|Lost to Follow-up|0
94523|NCT00809133|328680|P9|Overall Study|Lost to Follow-up|0
94524|NCT00809133|328681|P8|Overall Study|Lost to Follow-up|0
94525|NCT00809133|328682|P7|Overall Study|Lost to Follow-up|0
94526|NCT00809133|328683|P6|Overall Study|Lost to Follow-up|1
94527|NCT00809133|328684|P5|Overall Study|Lost to Follow-up|0
94528|NCT00809133|328685|P4|Overall Study|Lost to Follow-up|0
94529|NCT00809133|328686|P3|Overall Study|Lost to Follow-up|0
94530|NCT00809133|328687|P2|Overall Study|Lost to Follow-up|0
94531|NCT00809133|328688|P1|Overall Study|Lost to Follow-up|0
94532|NCT00809133|328675|P14|Overall Study|Other adverse event|1
94533|NCT00809133|328676|P13|Overall Study|Other adverse event|0
94534|NCT00809133|328677|P12|Overall Study|Other adverse event|1
94535|NCT00809133|328678|P11|Overall Study|Other adverse event|1
94536|NCT00809133|328679|P10|Overall Study|Other adverse event|0
94537|NCT00809133|328680|P9|Overall Study|Other adverse event|0
94538|NCT00809133|328681|P8|Overall Study|Other adverse event|4
94539|NCT00809133|328682|P7|Overall Study|Other adverse event|2
94540|NCT00809133|328683|P6|Overall Study|Other adverse event|3
94541|NCT00809133|328684|P5|Overall Study|Other adverse event|0
94542|NCT00809133|328685|P4|Overall Study|Other adverse event|0
94543|NCT00809133|328686|P3|Overall Study|Other adverse event|1
94544|NCT00809133|328687|P2|Overall Study|Other adverse event|1
94545|NCT00809133|328688|P1|Overall Study|Other adverse event|1
94546|NCT00809133|328675|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
94547|NCT00809133|328676|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
94548|NCT00809133|328677|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
94549|NCT00809133|328678|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
94550|NCT00809133|328679|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
94551|NCT00809133|328680|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
94552|NCT00809133|328681|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
94553|NCT00809133|328682|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
94554|NCT00809133|328683|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
94555|NCT00809133|328684|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
94556|NCT00809133|328685|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
94557|NCT00809133|328686|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
94558|NCT00809133|328687|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
94559|NCT00809133|328688|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
94560|NCT00809133|328675|P14|Overall Study|Progressive disease|4
94561|NCT00809133|328676|P13|Overall Study|Progressive disease|5
94562|NCT00809133|328677|P12|Overall Study|Progressive disease|7
94563|NCT00809133|328678|P11|Overall Study|Progressive disease|5
94564|NCT00809133|328679|P10|Overall Study|Progressive disease|9
94565|NCT00809133|328680|P9|Overall Study|Progressive disease|3
94566|NCT00809133|328681|P8|Overall Study|Progressive disease|3
94567|NCT00809133|328682|P7|Overall Study|Progressive disease|3
94568|NCT00809133|328683|P6|Overall Study|Progressive disease|1
94569|NCT00809133|328684|P5|Overall Study|Progressive disease|4
94570|NCT00809133|328685|P4|Overall Study|Progressive disease|3
94571|NCT00809133|328686|P3|Overall Study|Progressive disease|5
94572|NCT00809133|328687|P2|Overall Study|Progressive disease|5
94573|NCT00809133|328688|P1|Overall Study|Progressive disease|2
94574|NCT00809094|328842|P2|Overall Study|Lost to Follow-up|1
94575|NCT00809094|328843|P1|Overall Study|Lost to Follow-up|0
94576|NCT00808899|328888|P1|Overall Study|Physician Decision|3
94577|NCT00808899|328888|P1|Overall Study|Death|1
94578|NCT00808808|328902|P3|Overall Study|Employee was not vaccinated.|2255
94579|NCT00808808|328903|P2|Overall Study|Employee was not vaccinated.|2268
94580|NCT00808808|328904|P1|Overall Study|Employee was not vaccinated.|2686
94581|NCT00808808|328902|P3|Overall Study|Vaccinated; survey not completed|302
94582|NCT00808808|328903|P2|Overall Study|Vaccinated; survey not completed|169
94583|NCT00808808|328904|P1|Overall Study|Vaccinated; survey not completed|131
94584|NCT00808639|328937|P1|Overall Study|Disease progression before surgery.|1
94585|NCT00808509|328945|P2|Randomized Phase|Patient refused rescue therapy|3
94586|NCT00808509|328946|P1|Randomized Phase|Patient refused rescue therapy|0
94587|NCT00808509|328945|P2|Randomized Phase|Reduced methotrexate dose|2
94588|NCT00808509|328946|P1|Randomized Phase|Reduced methotrexate dose|1
94589|NCT00808509|328945|P2|Randomized Phase|Did not meet eligibility criteria|0
94590|NCT00808509|328946|P1|Randomized Phase|Did not meet eligibility criteria|1
94591|NCT00808483|329044|P2|From 5 Months to 12 Months|Lack of Efficacy|0
94592|NCT00808483|329045|P1|From 5 Months to 12 Months|Lack of Efficacy|1
94593|NCT00808483|329044|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
94594|NCT00808483|329045|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
94595|NCT00808483|329044|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
94596|NCT00808483|329045|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
94597|NCT00808444|329067|P2|Overall Study|Lost to Follow-up|1
94598|NCT00808444|329068|P1|Overall Study|Lost to Follow-up|0
94599|NCT00808444|329067|P2|Overall Study|Withdrawal by Subject|0
94600|NCT00808444|329068|P1|Overall Study|Withdrawal by Subject|1
94601|NCT00808249|329143|P4|Overall Study|All other reasons|1
94602|NCT00808249|329144|P3|Overall Study|All other reasons|3
94603|NCT00808249|329145|P2|Overall Study|All other reasons|1
94604|NCT00808249|329146|P1|Overall Study|All other reasons|2
94605|NCT00808249|329143|P4|Overall Study|study specific discontinuation criteria|0
94606|NCT00808249|329144|P3|Overall Study|study specific discontinuation criteria|1
94607|NCT00808249|329145|P2|Overall Study|study specific discontinuation criteria|0
94608|NCT00808249|329146|P1|Overall Study|study specific discontinuation criteria|1
94609|NCT00808249|329143|P4|Overall Study|Lack of Efficacy|0
94610|NCT00808249|329144|P3|Overall Study|Lack of Efficacy|0
94611|NCT00808249|329145|P2|Overall Study|Lack of Efficacy|1
94612|NCT00808249|329146|P1|Overall Study|Lack of Efficacy|1
94613|NCT00808249|329143|P4|Overall Study|Protocol Violation|0
94614|NCT00808249|329144|P3|Overall Study|Protocol Violation|3
94615|NCT00808249|329145|P2|Overall Study|Protocol Violation|3
94616|NCT00808249|329146|P1|Overall Study|Protocol Violation|3
94617|NCT00808249|329143|P4|Overall Study|Withdrawal by Subject|4
94618|NCT00808249|329144|P3|Overall Study|Withdrawal by Subject|2
94619|NCT00808249|329145|P2|Overall Study|Withdrawal by Subject|0
94620|NCT00808249|329146|P1|Overall Study|Withdrawal by Subject|4
94621|NCT00808249|329143|P4|Overall Study|Lost to Follow-up|5
94622|NCT00808249|329144|P3|Overall Study|Lost to Follow-up|3
94623|NCT00808249|329145|P2|Overall Study|Lost to Follow-up|3
94624|NCT00808249|329146|P1|Overall Study|Lost to Follow-up|2
94625|NCT00808249|329143|P4|Overall Study|Adverse Event|6
94626|NCT00808249|329144|P3|Overall Study|Adverse Event|10
94627|NCT00808249|329145|P2|Overall Study|Adverse Event|7
94628|NCT00808249|329146|P1|Overall Study|Adverse Event|4
94629|NCT00808236|329174|P2|Overall Study|Death|30
94630|NCT00808236|329175|P1|Overall Study|Death|18
94631|NCT00808236|329174|P2|Overall Study|Physician Decision|1
94632|NCT00808236|329175|P1|Overall Study|Physician Decision|0
94633|NCT00808236|329174|P2|Overall Study|Lost to Follow-up|1
94634|NCT00808236|329175|P1|Overall Study|Lost to Follow-up|1
94635|NCT00808236|329174|P2|Overall Study|Pre-defined exclusion|3
94636|NCT00808236|329175|P1|Overall Study|Pre-defined exclusion|13
94637|NCT00808236|329174|P2|Overall Study|Was not resuscitated|56
94638|NCT00808236|329175|P1|Overall Study|Was not resuscitated|50
94639|NCT00808132|329208|P5|Overall Study|Unsatisfactory response|12
94640|NCT00808132|329209|P4|Overall Study|Unsatisfactory response|4
94641|NCT00808132|329210|P3|Overall Study|Unsatisfactory response|6
94642|NCT00808132|329211|P2|Overall Study|Unsatisfactory response|6
94643|NCT00808132|329212|P1|Overall Study|Unsatisfactory response|5
94644|NCT00808132|329208|P5|Overall Study|Randomized, but not treated|9
94645|NCT00808132|329209|P4|Overall Study|Randomized, but not treated|8
94646|NCT00808132|329210|P3|Overall Study|Randomized, but not treated|9
94647|NCT00808132|329211|P2|Overall Study|Randomized, but not treated|7
94648|NCT00808132|329212|P1|Overall Study|Randomized, but not treated|10
94649|NCT00808132|329208|P5|Overall Study|Unspecified|15
94650|NCT00808132|329209|P4|Overall Study|Unspecified|2
94651|NCT00808132|329210|P3|Overall Study|Unspecified|6
94652|NCT00808132|329211|P2|Overall Study|Unspecified|4
94653|NCT00808132|329212|P1|Overall Study|Unspecified|6
94654|NCT00808132|329208|P5|Overall Study|Withdrawal by Subject|16
94655|NCT00808132|329209|P4|Overall Study|Withdrawal by Subject|7
94656|NCT00808132|329210|P3|Overall Study|Withdrawal by Subject|2
94657|NCT00808132|329211|P2|Overall Study|Withdrawal by Subject|18
94658|NCT00808132|329212|P1|Overall Study|Withdrawal by Subject|27
94659|NCT00808132|329208|P5|Overall Study|Protocol Violation|5
94660|NCT00808132|329209|P4|Overall Study|Protocol Violation|9
94661|NCT00808132|329210|P3|Overall Study|Protocol Violation|4
94662|NCT00808132|329211|P2|Overall Study|Protocol Violation|9
94663|NCT00808132|329212|P1|Overall Study|Protocol Violation|8
94664|NCT00808132|329208|P5|Overall Study|Lost to Follow-up|9
94665|NCT00808132|329209|P4|Overall Study|Lost to Follow-up|8
94666|NCT00808132|329210|P3|Overall Study|Lost to Follow-up|11
94667|NCT00808132|329211|P2|Overall Study|Lost to Follow-up|10
94668|NCT00808132|329212|P1|Overall Study|Lost to Follow-up|8
94669|NCT00808132|329208|P5|Overall Study|Physician Decision|0
94670|NCT00808132|329209|P4|Overall Study|Physician Decision|0
94671|NCT00808132|329210|P3|Overall Study|Physician Decision|0
94672|NCT00808132|329211|P2|Overall Study|Physician Decision|1
94673|NCT00808132|329212|P1|Overall Study|Physician Decision|0
94674|NCT00808132|329208|P5|Overall Study|Death|1
94675|NCT00808132|329209|P4|Overall Study|Death|0
94676|NCT00808132|329210|P3|Overall Study|Death|0
94677|NCT00808132|329211|P2|Overall Study|Death|0
94678|NCT00808132|329212|P1|Overall Study|Death|0
94679|NCT00808132|329208|P5|Overall Study|Adverse Event|33
94680|NCT00808132|329209|P4|Overall Study|Adverse Event|31
94681|NCT00808132|329210|P3|Overall Study|Adverse Event|16
94682|NCT00808132|329211|P2|Overall Study|Adverse Event|33
94683|NCT00808132|329212|P1|Overall Study|Adverse Event|34
94684|NCT00808080|329284|P1|Overall Study|Patients Became Ineligible for infusion|6
94685|NCT00808067|329290|P2|Overall Study|Excluded from analysis|19
94686|NCT00808067|329291|P1|Overall Study|Excluded from analysis|13
94687|NCT00808067|329290|P2|Overall Study|Other reason not defined above|5
94688|NCT00808067|329291|P1|Overall Study|Other reason not defined above|5
94689|NCT00808067|329290|P2|Overall Study|Site closed for cause|19
94690|NCT00808067|329291|P1|Overall Study|Site closed for cause|19
94691|NCT00808067|329290|P2|Overall Study|Patient elected|9
94692|NCT00808067|329291|P1|Overall Study|Patient elected|7
94693|NCT00808067|329290|P2|Overall Study|Protocol Violation|11
94694|NCT00808067|329291|P1|Overall Study|Protocol Violation|3
94695|NCT00808067|329290|P2|Overall Study|Physician Decision|38
94696|NCT00808067|329291|P1|Overall Study|Physician Decision|47
94697|NCT00808067|329290|P2|Overall Study|Site closed|3
94698|NCT00808067|329291|P1|Overall Study|Site closed|4
94699|NCT00808067|329290|P2|Overall Study|Withdrawal by Subject|25
94700|NCT00808067|329291|P1|Overall Study|Withdrawal by Subject|21
94701|NCT00808067|329290|P2|Overall Study|Procedure|7
94702|NCT00808067|329291|P1|Overall Study|Procedure|6
94703|NCT00808067|329290|P2|Overall Study|Death|1
94704|NCT00808067|329291|P1|Overall Study|Death|1
94705|NCT00808067|329290|P2|Overall Study|Missing|0
94706|NCT00808067|329291|P1|Overall Study|Missing|1
94707|NCT00808067|329290|P2|Overall Study|Patient refused to take study medication|76
94708|NCT00808067|329291|P1|Overall Study|Patient refused to take study medication|65
94709|NCT00808067|329290|P2|Overall Study|Elevated LFT results|3
94710|NCT00808067|329291|P1|Overall Study|Elevated LFT results|7
94711|NCT00808067|329290|P2|Overall Study|Reduced creatinine clearance|55
94712|NCT00808067|329291|P1|Overall Study|Reduced creatinine clearance|53
94713|NCT00808067|329290|P2|Overall Study|Hospitalization due to surgery|40
94714|NCT00808067|329291|P1|Overall Study|Hospitalization due to surgery|37
94715|NCT00808067|329290|P2|Overall Study|Hospitalization (not including surgery)|17
94716|NCT00808067|329291|P1|Overall Study|Hospitalization (not including surgery)|18
94717|NCT00808067|329290|P2|Overall Study|Adverse Event|121
94718|NCT00808067|329291|P1|Overall Study|Adverse Event|111
94719|NCT00808067|329290|P2|Overall Study|Outcome event - other|25
94720|NCT00808067|329291|P1|Overall Study|Outcome event - other|33
94721|NCT00808067|329290|P2|Overall Study|Major/minor bleed|44
94722|NCT00808067|329291|P1|Overall Study|Major/minor bleed|30
94723|NCT00808028|329327|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
94724|NCT00808028|329328|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
94725|NCT00808028|329329|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
94726|NCT00808028|329330|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
94727|NCT00808028|329327|P4|Stage 2 (Followed up to 48 Months )|Death|0
94728|NCT00808028|329328|P3|Stage 2 (Followed up to 48 Months )|Death|1
94729|NCT00808028|329329|P2|Stage 2 (Followed up to 48 Months )|Death|0
94730|NCT00808028|329330|P1|Stage 2 (Followed up to 48 Months )|Death|0
94731|NCT00808028|329327|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
94732|NCT00808028|329328|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
94733|NCT00808028|329329|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
94734|NCT00808028|329330|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
94735|NCT00808028|329327|P4|Stage 2 (Followed up to 48 Months )|Unspecified|1
94736|NCT00808028|329328|P3|Stage 2 (Followed up to 48 Months )|Unspecified|1
94737|NCT00808028|329329|P2|Stage 2 (Followed up to 48 Months )|Unspecified|0
94738|NCT00808028|329330|P1|Stage 2 (Followed up to 48 Months )|Unspecified|0
94739|NCT00808028|329327|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
94740|NCT00808028|329328|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
94741|NCT00808028|329329|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
94742|NCT00808028|329330|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
94743|NCT00808028|329327|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
94744|NCT00808028|329328|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
94745|NCT00808028|329329|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
94746|NCT00808028|329330|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
94747|NCT00808028|329327|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
94748|NCT00808028|329328|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
94749|NCT00808028|329329|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
94750|NCT00808028|329330|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
94751|NCT00808028|329327|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
94752|NCT00808028|329328|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
94753|NCT00808028|329329|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
94754|NCT00808028|329330|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
94755|NCT00808028|329327|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
94756|NCT00808028|329328|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
94757|NCT00808028|329329|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
94758|NCT00808028|329330|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
94759|NCT00808028|329327|P4|Stage 1 (6 Months)|Protocol Violation|1
94760|NCT00808028|329328|P3|Stage 1 (6 Months)|Protocol Violation|0
94761|NCT00808028|329329|P2|Stage 1 (6 Months)|Protocol Violation|0
94762|NCT00808028|329330|P1|Stage 1 (6 Months)|Protocol Violation|0
94763|NCT00808028|329327|P4|Stage 1 (6 Months)|Lost to Follow-up|0
94764|NCT00808028|329328|P3|Stage 1 (6 Months)|Lost to Follow-up|1
94765|NCT00808028|329329|P2|Stage 1 (6 Months)|Lost to Follow-up|0
94766|NCT00808028|329330|P1|Stage 1 (6 Months)|Lost to Follow-up|1
94767|NCT00808028|329327|P4|Stage 1 (6 Months)|Adverse Event|2
94768|NCT00808028|329328|P3|Stage 1 (6 Months)|Adverse Event|1
94769|NCT00808028|329329|P2|Stage 1 (6 Months)|Adverse Event|0
94770|NCT00808028|329330|P1|Stage 1 (6 Months)|Adverse Event|0
94771|NCT00808028|329327|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
94772|NCT00808028|329328|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
94773|NCT00808028|329329|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
94774|NCT00808028|329330|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
94775|NCT00808028|329327|P4|Stage 1 (6 Months)|Unspecified|4
94776|NCT00808028|329328|P3|Stage 1 (6 Months)|Unspecified|2
94777|NCT00808028|329329|P2|Stage 1 (6 Months)|Unspecified|0
94778|NCT00808028|329330|P1|Stage 1 (6 Months)|Unspecified|1
94779|NCT00808028|329327|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
94780|NCT00808028|329328|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
94781|NCT00808028|329329|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
94782|NCT00808028|329330|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
94783|NCT00808015|329366|P1|Overall Study|Enrolled but not treated|4
94784|NCT00808015|329366|P1|Overall Study|Unspecified|25
94785|NCT00808015|329366|P1|Overall Study|Adverse Event|22
94786|NCT00808015|329366|P1|Overall Study|Participants not willing to participate|158
94787|NCT00808015|329366|P1|Overall Study|Lost to Follow-up|76
94788|NCT00808015|329366|P1|Overall Study|Lack of Efficacy|58
94789|NCT00808015|329366|P1|Overall Study|Death|1
94790|NCT00807937|329395|P4|Overall Study|All other reasons (not provided)|1
94791|NCT00807937|329396|P3|Overall Study|All other reasons (not provided)|0
94792|NCT00807937|329397|P2|Overall Study|All other reasons (not provided)|4
94793|NCT00807937|329398|P1|Overall Study|All other reasons (not provided)|2
94794|NCT00807937|329395|P4|Overall Study|Intake of prohibited medicine|0
94795|NCT00807937|329396|P3|Overall Study|Intake of prohibited medicine|2
94796|NCT00807937|329397|P2|Overall Study|Intake of prohibited medicine|0
94797|NCT00807937|329398|P1|Overall Study|Intake of prohibited medicine|0
94798|NCT00807937|329395|P4|Overall Study|Lack of Efficacy|2
94799|NCT00807937|329396|P3|Overall Study|Lack of Efficacy|1
94800|NCT00807937|329397|P2|Overall Study|Lack of Efficacy|0
94801|NCT00807937|329398|P1|Overall Study|Lack of Efficacy|0
94802|NCT00807937|329395|P4|Overall Study|Lost to Follow-up|1
94803|NCT00807937|329396|P3|Overall Study|Lost to Follow-up|2
94804|NCT00807937|329397|P2|Overall Study|Lost to Follow-up|0
94805|NCT00807937|329398|P1|Overall Study|Lost to Follow-up|4
94806|NCT00807937|329395|P4|Overall Study|Withdrawal by Subject|4
94807|NCT00807937|329396|P3|Overall Study|Withdrawal by Subject|1
94808|NCT00807937|329397|P2|Overall Study|Withdrawal by Subject|4
94809|NCT00807937|329398|P1|Overall Study|Withdrawal by Subject|5
94810|NCT00807937|329395|P4|Overall Study|Protocol Violation|3
94811|NCT00807937|329396|P3|Overall Study|Protocol Violation|3
94812|NCT00807937|329397|P2|Overall Study|Protocol Violation|5
94813|NCT00807937|329398|P1|Overall Study|Protocol Violation|4
94814|NCT00807937|329395|P4|Overall Study|Adverse Event|4
94815|NCT00807937|329396|P3|Overall Study|Adverse Event|5
94816|NCT00807937|329397|P2|Overall Study|Adverse Event|12
94817|NCT00807937|329398|P1|Overall Study|Adverse Event|12
94818|NCT00807885|329433|P9|Overall Study|Lost to Follow-up|0
94819|NCT00807885|329434|P8|Overall Study|Lost to Follow-up|0
94820|NCT00807885|329435|P7|Overall Study|Lost to Follow-up|0
94821|NCT00807885|329436|P6|Overall Study|Lost to Follow-up|1
94822|NCT00807885|329437|P5|Overall Study|Lost to Follow-up|0
94823|NCT00807885|329438|P4|Overall Study|Lost to Follow-up|0
94824|NCT00807885|329439|P3|Overall Study|Lost to Follow-up|0
94825|NCT00807885|329440|P2|Overall Study|Lost to Follow-up|0
94826|NCT00807885|329441|P1|Overall Study|Lost to Follow-up|0
94827|NCT00807846|329490|P2|Overall Study|Not Specified|2
94828|NCT00807846|329491|P1|Overall Study|Not Specified|1
94829|NCT00807846|329490|P2|Overall Study|Withdrawal by Subject|1
94830|NCT00807846|329491|P1|Overall Study|Withdrawal by Subject|2
94831|NCT00807846|329490|P2|Overall Study|Protocol Violation|1
94832|NCT00807846|329491|P1|Overall Study|Protocol Violation|2
94833|NCT00807846|329490|P2|Overall Study|Lack of Efficacy|0
94834|NCT00807846|329491|P1|Overall Study|Lack of Efficacy|2
94835|NCT00807846|329490|P2|Overall Study|Adverse Event|0
94836|NCT00807846|329491|P1|Overall Study|Adverse Event|5
94837|NCT00807573|329523|P1|Overall Study|Adverse Event|1
94838|NCT00807573|329523|P1|Overall Study|Withdrawal by Subject|1
94839|NCT00807248|329572|P4|Overall Study|Other Reason|0
94840|NCT00807248|329573|P3|Overall Study|Other Reason|2
94841|NCT00807248|329574|P2|Overall Study|Other Reason|0
94842|NCT00807248|329575|P1|Overall Study|Other Reason|0
94843|NCT00807248|329572|P4|Overall Study|Lost to Follow-up|0
94844|NCT00807248|329573|P3|Overall Study|Lost to Follow-up|0
94845|NCT00807248|329574|P2|Overall Study|Lost to Follow-up|0
94846|NCT00807248|329575|P1|Overall Study|Lost to Follow-up|1
94847|NCT00807248|329572|P4|Overall Study|Withdrawal of Consent|5
94848|NCT00807248|329573|P3|Overall Study|Withdrawal of Consent|5
94849|NCT00807248|329574|P2|Overall Study|Withdrawal of Consent|5
94850|NCT00807248|329575|P1|Overall Study|Withdrawal of Consent|5
94851|NCT00807248|329572|P4|Overall Study|Protocol Violation|0
94852|NCT00807248|329573|P3|Overall Study|Protocol Violation|1
94853|NCT00807248|329574|P2|Overall Study|Protocol Violation|1
94854|NCT00807248|329575|P1|Overall Study|Protocol Violation|0
94855|NCT00807248|329572|P4|Overall Study|Lack of Efficacy|3
94856|NCT00807248|329573|P3|Overall Study|Lack of Efficacy|8
94857|NCT00807248|329574|P2|Overall Study|Lack of Efficacy|4
94858|NCT00807248|329575|P1|Overall Study|Lack of Efficacy|14
94859|NCT00807248|329572|P4|Overall Study|Adverse Event|6
94860|NCT00807248|329573|P3|Overall Study|Adverse Event|2
94861|NCT00807248|329574|P2|Overall Study|Adverse Event|2
94862|NCT00807248|329575|P1|Overall Study|Adverse Event|1
94863|NCT00807235|329619|P2|Overall Study|Adverse Event|0
94864|NCT00807235|329620|P1|Overall Study|Adverse Event|1
94865|NCT00807092|329665|P2|Overall Study|CGMS data collection failed|1
94866|NCT00807092|329666|P1|Overall Study|CGMS data collection failed|0
94867|NCT00807092|329665|P2|Overall Study|Withdrawal by Subject|0
94868|NCT00807092|329666|P1|Overall Study|Withdrawal by Subject|1
94869|NCT00807092|329665|P2|Overall Study|Protocol Violation|2
94870|NCT00807092|329666|P1|Overall Study|Protocol Violation|0
94871|NCT00807092|329665|P2|Overall Study|Adverse Event|1
94872|NCT00807092|329666|P1|Overall Study|Adverse Event|0
94873|NCT00807014|329696|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
94874|NCT00807014|329697|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
94875|NCT00807014|329696|P2|Overall Study|Recovery|0
94876|NCT00807014|329697|P1|Overall Study|Recovery|1
94877|NCT00807014|329696|P2|Overall Study|Lost to Follow-up|7
94878|NCT00807014|329697|P1|Overall Study|Lost to Follow-up|9
94879|NCT00807014|329696|P2|Overall Study|Adverse Event|2
94880|NCT00807014|329697|P1|Overall Study|Adverse Event|0
94881|NCT00807014|329696|P2|Overall Study|Protocol Violation|8
94882|NCT00807014|329697|P1|Overall Study|Protocol Violation|2
94883|NCT00807014|329696|P2|Overall Study|Participant Considered Disease Not Cured|7
94884|NCT00807014|329697|P1|Overall Study|Participant Considered Disease Not Cured|2
94885|NCT00807014|329696|P2|Overall Study|Participant Considered Disease Cured|2
94886|NCT00807014|329697|P1|Overall Study|Participant Considered Disease Cured|13
94887|NCT00807001|329728|P5|Overall Study|Non-compliance|0
94888|NCT00807001|329729|P4|Overall Study|Non-compliance|0
94889|NCT00807001|329730|P3|Overall Study|Non-compliance|0
94890|NCT00807001|329731|P2|Overall Study|Non-compliance|1
94891|NCT00807001|329732|P1|Overall Study|Non-compliance|0
94892|NCT00806819|329751|P2|Overall Study|Reasons other than stated above|41
94893|NCT00806819|329752|P1|Overall Study|Reasons other than stated above|25
94894|NCT00806819|329751|P2|Overall Study|Not treated|3
94895|NCT00806819|329752|P1|Overall Study|Not treated|6
94896|NCT00806819|329751|P2|Overall Study|Withdrawal by Subject|29
94897|NCT00806819|329752|P1|Overall Study|Withdrawal by Subject|32
94898|NCT00806819|329751|P2|Overall Study|Lost to Follow-up|0
94899|NCT00806819|329752|P1|Overall Study|Lost to Follow-up|1
94900|NCT00806819|329751|P2|Overall Study|Protocol Violation|4
94901|NCT00806819|329752|P1|Overall Study|Protocol Violation|9
94902|NCT00806819|329751|P2|Overall Study|Other AE|40
94903|NCT00806819|329752|P1|Overall Study|Other AE|38
94904|NCT00806819|329751|P2|Overall Study|Worsening or AE of underlying disease|25
94905|NCT00806819|329752|P1|Overall Study|Worsening or AE of underlying disease|18
94906|NCT00806819|329751|P2|Overall Study|progressive disease (modified RECIST )|216
94907|NCT00806819|329752|P1|Overall Study|progressive disease (modified RECIST )|217
94908|NCT00806624|329787|P3|Overall Study|discontinued before start of treatment|1
94909|NCT00806624|329788|P2|Overall Study|discontinued before start of treatment|0
94910|NCT00806624|329789|P1|Overall Study|discontinued before start of treatment|0
94911|NCT00806624|329787|P3|Overall Study|Withdrawal by Subject|3
94912|NCT00806624|329788|P2|Overall Study|Withdrawal by Subject|3
94913|NCT00806624|329789|P1|Overall Study|Withdrawal by Subject|6
94914|NCT00806624|329787|P3|Overall Study|Lost to Follow-up|1
94915|NCT00806624|329788|P2|Overall Study|Lost to Follow-up|0
94916|NCT00806624|329789|P1|Overall Study|Lost to Follow-up|1
94917|NCT00806624|329787|P3|Overall Study|Death|1
94918|NCT00806624|329788|P2|Overall Study|Death|1
94919|NCT00806624|329789|P1|Overall Study|Death|0
94920|NCT00806624|329787|P3|Overall Study|Adverse Event|0
94921|NCT00806624|329788|P2|Overall Study|Adverse Event|8
94922|NCT00806624|329789|P1|Overall Study|Adverse Event|2
94923|NCT00806585|329806|P5|Overall Study|Completion status unknown|12
94924|NCT00806585|329807|P4|Overall Study|Completion status unknown|4
94925|NCT00806585|329808|P3|Overall Study|Completion status unknown|12
94926|NCT00806585|329809|P2|Overall Study|Completion status unknown|14
94927|NCT00806585|329810|P1|Overall Study|Completion status unknown|15
94928|NCT00806585|329806|P5|Overall Study|Withdrawal by Subject|11
94929|NCT00806585|329807|P4|Overall Study|Withdrawal by Subject|3
94930|NCT00806585|329808|P3|Overall Study|Withdrawal by Subject|9
94931|NCT00806585|329809|P2|Overall Study|Withdrawal by Subject|8
94932|NCT00806585|329810|P1|Overall Study|Withdrawal by Subject|10
94933|NCT00806585|329806|P5|Overall Study|Adverse Event|2
94934|NCT00806585|329807|P4|Overall Study|Adverse Event|4
94935|NCT00806585|329808|P3|Overall Study|Adverse Event|3
94936|NCT00806585|329809|P2|Overall Study|Adverse Event|5
94937|NCT00806585|329810|P1|Overall Study|Adverse Event|1
94938|NCT00806585|329806|P5|Overall Study|Lack of Efficacy|0
94939|NCT00806585|329807|P4|Overall Study|Lack of Efficacy|0
94940|NCT00806585|329808|P3|Overall Study|Lack of Efficacy|0
94941|NCT00806585|329809|P2|Overall Study|Lack of Efficacy|0
94942|NCT00806585|329810|P1|Overall Study|Lack of Efficacy|1
94943|NCT00806585|329806|P5|Overall Study|Lost to Follow-up|5
94944|NCT00806585|329807|P4|Overall Study|Lost to Follow-up|2
94945|NCT00806585|329808|P3|Overall Study|Lost to Follow-up|2
94946|NCT00806585|329809|P2|Overall Study|Lost to Follow-up|1
94947|NCT00806585|329810|P1|Overall Study|Lost to Follow-up|2
94948|NCT00806585|329806|P5|Overall Study|Physician Decision|1
94949|NCT00806585|329807|P4|Overall Study|Physician Decision|0
94950|NCT00806585|329808|P3|Overall Study|Physician Decision|3
94951|NCT00806585|329809|P2|Overall Study|Physician Decision|2
94952|NCT00806585|329810|P1|Overall Study|Physician Decision|0
94953|NCT00806585|329806|P5|Overall Study|Protocol Violation|0
94954|NCT00806585|329807|P4|Overall Study|Protocol Violation|0
94955|NCT00806585|329808|P3|Overall Study|Protocol Violation|2
94956|NCT00806585|329809|P2|Overall Study|Protocol Violation|1
94957|NCT00806585|329810|P1|Overall Study|Protocol Violation|3
94958|NCT00806585|329806|P5|Overall Study|Study terminated by Sponsor|0
94959|NCT00806585|329807|P4|Overall Study|Study terminated by Sponsor|2
94960|NCT00806585|329808|P3|Overall Study|Study terminated by Sponsor|1
94961|NCT00806585|329809|P2|Overall Study|Study terminated by Sponsor|0
94962|NCT00806585|329810|P1|Overall Study|Study terminated by Sponsor|0
94963|NCT00806546|329842|P1|Overall Study|Various|42
94964|NCT00806546|329842|P1|Overall Study|Protocol Violation|49
94965|NCT00806546|329842|P1|Overall Study|Withdrawal by Subject|75
94966|NCT00806546|329842|P1|Overall Study|Adverse Event|74
94967|NCT00806546|329842|P1|Overall Study|Lost to Follow-up|32
94968|NCT00806546|329842|P1|Overall Study|Enrolled, not treated|35
94969|NCT00806494|329846|P1|Overall Study|Withdrawal by Subject|5
94970|NCT00806494|329846|P1|Overall Study|Unspecified|30
94971|NCT00806494|329846|P1|Overall Study|Lost to Follow-up|10
94972|NCT00806494|329846|P1|Overall Study|Lack of Efficacy|6
94973|NCT00806494|329846|P1|Overall Study|Adverse Event|29
94974|NCT00806416|329872|P4|Period 1 - Part II|Withdrawal by Subject|2
94975|NCT00806416|329873|P3|Period 1 - Part II|Withdrawal by Subject|0
94976|NCT00806416|329874|P2|Period 1 - Part II|Withdrawal by Subject|0
94977|NCT00806416|329875|P1|Period 1 - Part II|Withdrawal by Subject|0
94978|NCT00806416|329872|P4|Period 1 - Part I|Withdrawal by Subject|0
94979|NCT00806416|329873|P3|Period 1 - Part I|Withdrawal by Subject|0
94980|NCT00806416|329874|P2|Period 1 - Part I|Withdrawal by Subject|1
94981|NCT00806416|329875|P1|Period 1 - Part I|Withdrawal by Subject|3
94982|NCT00806416|329872|P4|Period 1 - Part I|Lost to Follow-up|0
94983|NCT00806416|329873|P3|Period 1 - Part I|Lost to Follow-up|0
94984|NCT00806416|329874|P2|Period 1 - Part I|Lost to Follow-up|2
94985|NCT00806416|329875|P1|Period 1 - Part I|Lost to Follow-up|0
94986|NCT00806416|329872|P4|Period 1 - Part I|Adverse Event|0
94987|NCT00806416|329873|P3|Period 1 - Part I|Adverse Event|0
94988|NCT00806416|329874|P2|Period 1 - Part I|Adverse Event|1
94989|NCT00806416|329875|P1|Period 1 - Part I|Adverse Event|0
94990|NCT00806403|329888|P2|Overall Study|Death|3
94991|NCT00806403|329889|P1|Overall Study|Death|4
94992|NCT00806351|329912|P2|Overall Study|Death|4
94993|NCT00806351|329913|P1|Overall Study|Death|5
94994|NCT00806260|329950|P6|Period 3|Pregnancy|0
94995|NCT00806260|329951|P5|Period 3|Pregnancy|0
94996|NCT00806260|329952|P4|Period 3|Pregnancy|0
94997|NCT00806260|329953|P3|Period 3|Pregnancy|0
94998|NCT00806260|329954|P2|Period 3|Pregnancy|0
94999|NCT00806260|329955|P1|Period 3|Pregnancy|1
95000|NCT00806260|329950|P6|Period 3|Protocol Violation|0
95001|NCT00806260|329951|P5|Period 3|Protocol Violation|0
95002|NCT00806260|329952|P4|Period 3|Protocol Violation|0
95003|NCT00806260|329953|P3|Period 3|Protocol Violation|1
95004|NCT00806260|329954|P2|Period 3|Protocol Violation|1
95005|NCT00806260|329955|P1|Period 3|Protocol Violation|0
95006|NCT00806260|329950|P6|Period 2|sponsor request|0
95007|NCT00806260|329951|P5|Period 2|sponsor request|0
95008|NCT00806260|329952|P4|Period 2|sponsor request|1
95009|NCT00806260|329953|P3|Period 2|sponsor request|1
95010|NCT00806260|329954|P2|Period 2|sponsor request|0
95011|NCT00806260|329955|P1|Period 2|sponsor request|0
95012|NCT00806260|329950|P6|Period 2|Need to take concomitant medication|0
95013|NCT00806260|329951|P5|Period 2|Need to take concomitant medication|0
95014|NCT00806260|329952|P4|Period 2|Need to take concomitant medication|0
95015|NCT00806260|329953|P3|Period 2|Need to take concomitant medication|0
95016|NCT00806260|329954|P2|Period 2|Need to take concomitant medication|0
95017|NCT00806260|329955|P1|Period 2|Need to take concomitant medication|1
95018|NCT00806260|329950|P6|Period 2|Protocol Violation|0
95019|NCT00806260|329951|P5|Period 2|Protocol Violation|0
95020|NCT00806260|329952|P4|Period 2|Protocol Violation|0
95021|NCT00806260|329953|P3|Period 2|Protocol Violation|1
95022|NCT00806260|329954|P2|Period 2|Protocol Violation|0
95023|NCT00806260|329955|P1|Period 2|Protocol Violation|1
95024|NCT00806260|329950|P6|Period 2|Adverse Event|0
95025|NCT00806260|329951|P5|Period 2|Adverse Event|0
95026|NCT00806260|329952|P4|Period 2|Adverse Event|1
95027|NCT00806260|329953|P3|Period 2|Adverse Event|0
95028|NCT00806260|329954|P2|Period 2|Adverse Event|0
95029|NCT00806260|329955|P1|Period 2|Adverse Event|0
95030|NCT00806260|329950|P6|Period 1 (1 Day)|Adverse Event|0
95031|NCT00806260|329951|P5|Period 1 (1 Day)|Adverse Event|3
95032|NCT00806260|329952|P4|Period 1 (1 Day)|Adverse Event|0
95033|NCT00806260|329953|P3|Period 1 (1 Day)|Adverse Event|0
95034|NCT00806260|329954|P2|Period 1 (1 Day)|Adverse Event|0
95035|NCT00806260|329955|P1|Period 1 (1 Day)|Adverse Event|0
95036|NCT00806195|329971|P4|Overall Study|Protocol Violation|9
95037|NCT00806195|329972|P3|Overall Study|Protocol Violation|26
95038|NCT00806195|329973|P2|Overall Study|Protocol Violation|24
95039|NCT00806195|329974|P1|Overall Study|Protocol Violation|34
95040|NCT00806195|329971|P4|Overall Study|Administrative Reason|26
95041|NCT00806195|329972|P3|Overall Study|Administrative Reason|66
95042|NCT00806195|329973|P2|Overall Study|Administrative Reason|35
95043|NCT00806195|329974|P1|Overall Study|Administrative Reason|113
95044|NCT00806195|329971|P4|Overall Study|Inappropriate Enrollment|0
95045|NCT00806195|329972|P3|Overall Study|Inappropriate Enrollment|0
95046|NCT00806195|329973|P2|Overall Study|Inappropriate Enrollment|1
95047|NCT00806195|329974|P1|Overall Study|Inappropriate Enrollment|0
95048|NCT00806195|329971|P4|Overall Study|Lost to Follow-up|34
95049|NCT00806195|329972|P3|Overall Study|Lost to Follow-up|90
95050|NCT00806195|329973|P2|Overall Study|Lost to Follow-up|66
95051|NCT00806195|329974|P1|Overall Study|Lost to Follow-up|217
95052|NCT00806195|329971|P4|Overall Study|Withdrawal by Subject|35
95053|NCT00806195|329972|P3|Overall Study|Withdrawal by Subject|76
95054|NCT00806195|329973|P2|Overall Study|Withdrawal by Subject|31
95055|NCT00806195|329974|P1|Overall Study|Withdrawal by Subject|119
95056|NCT00806195|329971|P4|Overall Study|Adverse Event|2
95057|NCT00806195|329972|P3|Overall Study|Adverse Event|11
95058|NCT00806195|329973|P2|Overall Study|Adverse Event|5
95059|NCT00806195|329974|P1|Overall Study|Adverse Event|25
95060|NCT00806195|329971|P4|Overall Study|Death|0
95061|NCT00806195|329972|P3|Overall Study|Death|1
95062|NCT00806195|329973|P2|Overall Study|Death|0
95063|NCT00806195|329974|P1|Overall Study|Death|6
95064|NCT00806026|330005|P6|Overall Study|Adverse Event|9
95065|NCT00806026|330006|P5|Overall Study|Adverse Event|9
95066|NCT00806026|330007|P4|Overall Study|Adverse Event|17
95067|NCT00806026|330008|P3|Overall Study|Adverse Event|44
95068|NCT00806026|330009|P2|Overall Study|Adverse Event|35
95069|NCT00806026|330010|P1|Overall Study|Adverse Event|52
95070|NCT00806026|330005|P6|Overall Study|Protocol Violation|3
95071|NCT00806026|330006|P5|Overall Study|Protocol Violation|2
95072|NCT00806026|330007|P4|Overall Study|Protocol Violation|0
95073|NCT00806026|330008|P3|Overall Study|Protocol Violation|9
95074|NCT00806026|330009|P2|Overall Study|Protocol Violation|9
95075|NCT00806026|330010|P1|Overall Study|Protocol Violation|6
95076|NCT00806026|330005|P6|Overall Study|Unspecified|4
95077|NCT00806026|330006|P5|Overall Study|Unspecified|0
95078|NCT00806026|330007|P4|Overall Study|Unspecified|2
95079|NCT00806026|330008|P3|Overall Study|Unspecified|8
95080|NCT00806026|330009|P2|Overall Study|Unspecified|6
95081|NCT00806026|330010|P1|Overall Study|Unspecified|3
95082|NCT00806026|330005|P6|Overall Study|Withdrawal by Subject|3
95083|NCT00806026|330006|P5|Overall Study|Withdrawal by Subject|5
95084|NCT00806026|330007|P4|Overall Study|Withdrawal by Subject|2
95085|NCT00806026|330008|P3|Overall Study|Withdrawal by Subject|9
95086|NCT00806026|330009|P2|Overall Study|Withdrawal by Subject|17
95087|NCT00806026|330010|P1|Overall Study|Withdrawal by Subject|14
95088|NCT00806026|330005|P6|Overall Study|Lost to Follow-up|6
95089|NCT00806026|330006|P5|Overall Study|Lost to Follow-up|6
95090|NCT00806026|330007|P4|Overall Study|Lost to Follow-up|2
95091|NCT00806026|330008|P3|Overall Study|Lost to Follow-up|8
95092|NCT00806026|330009|P2|Overall Study|Lost to Follow-up|15
95093|NCT00806026|330010|P1|Overall Study|Lost to Follow-up|8
95094|NCT00806026|330005|P6|Overall Study|Lack of Efficacy|7
95095|NCT00806026|330006|P5|Overall Study|Lack of Efficacy|8
95096|NCT00806026|330007|P4|Overall Study|Lack of Efficacy|4
95097|NCT00806026|330008|P3|Overall Study|Lack of Efficacy|13
95098|NCT00806026|330009|P2|Overall Study|Lack of Efficacy|18
95099|NCT00806026|330010|P1|Overall Study|Lack of Efficacy|5
95100|NCT00806026|330005|P6|Overall Study|Did not meet entrance criteria|0
95101|NCT00806026|330006|P5|Overall Study|Did not meet entrance criteria|0
95102|NCT00806026|330007|P4|Overall Study|Did not meet entrance criteria|1
95103|NCT00806026|330008|P3|Overall Study|Did not meet entrance criteria|2
95104|NCT00806026|330009|P2|Overall Study|Did not meet entrance criteria|1
95105|NCT00806026|330010|P1|Overall Study|Did not meet entrance criteria|4
95106|NCT00806026|330005|P6|Overall Study|Death|0
95107|NCT00806026|330006|P5|Overall Study|Death|0
95108|NCT00806026|330007|P4|Overall Study|Death|1
95109|NCT00806026|330008|P3|Overall Study|Death|0
95110|NCT00806026|330009|P2|Overall Study|Death|0
95111|NCT00806026|330010|P1|Overall Study|Death|0
95112|NCT00805961|330105|P1|Maintenance Treatment|Withdrawn Consent|1
95113|NCT00805961|330105|P1|Maintenance Treatment|Symptomatic Deterioration|2
95114|NCT00805961|330105|P1|Maintenance Treatment|Withdrawal by Subject|5
95115|NCT00805961|330105|P1|Maintenance Treatment|Adverse Event|6
95116|NCT00805961|330105|P1|Maintenance Treatment|Intercurrent Illness|7
95117|NCT00805961|330105|P1|Maintenance Treatment|Lack of Efficacy|13
95118|NCT00805961|330105|P1|Treatment-Free Interval|Lack of Efficacy|1
95119|NCT00805961|330105|P1|Treatment-Free Interval|Physician Decision|1
95120|NCT00805961|330105|P1|Treatment-Free Interval|Intercurrent Illness|2
95121|NCT00805961|330105|P1|Treatment-Free Interval|Adverse Event|3
95122|NCT00805961|330105|P1|Modality Therapy|Disease Progression|2
95123|NCT00805961|330105|P1|Modality Therapy|Adverse Event|1
95124|NCT00805961|330105|P1|Modality Therapy|Withdrawal by Subject|1
95125|NCT00805935|330115|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
95126|NCT00805935|330116|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
95127|NCT00805935|330117|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
95128|NCT00805935|330118|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
95129|NCT00805935|330115|P4|Overall Study|Ectopic pregnancy|0
95130|NCT00805935|330116|P3|Overall Study|Ectopic pregnancy|1
95131|NCT00805935|330117|P2|Overall Study|Ectopic pregnancy|0
95132|NCT00805935|330118|P1|Overall Study|Ectopic pregnancy|0
95133|NCT00805935|330115|P4|Overall Study|Chemical pregnancy|2
95134|NCT00805935|330116|P3|Overall Study|Chemical pregnancy|3
95135|NCT00805935|330117|P2|Overall Study|Chemical pregnancy|5
95136|NCT00805935|330118|P1|Overall Study|Chemical pregnancy|0
95137|NCT00805935|330115|P4|Overall Study|Biochemical pregnancy|0
95138|NCT00805935|330116|P3|Overall Study|Biochemical pregnancy|0
95139|NCT00805935|330117|P2|Overall Study|Biochemical pregnancy|1
95140|NCT00805935|330118|P1|Overall Study|Biochemical pregnancy|0
95141|NCT00805935|330115|P4|Overall Study|Pregnancy loss/miscarriage|0
95142|NCT00805935|330116|P3|Overall Study|Pregnancy loss/miscarriage|0
95143|NCT00805935|330117|P2|Overall Study|Pregnancy loss/miscarriage|0
95144|NCT00805935|330118|P1|Overall Study|Pregnancy loss/miscarriage|2
95145|NCT00805935|330115|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
95146|NCT00805935|330116|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
95147|NCT00805935|330117|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
95148|NCT00805935|330118|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
95149|NCT00805935|330115|P4|Overall Study|No positive serum pregnancy|5
95150|NCT00805935|330116|P3|Overall Study|No positive serum pregnancy|6
95151|NCT00805935|330117|P2|Overall Study|No positive serum pregnancy|7
95152|NCT00805935|330118|P1|Overall Study|No positive serum pregnancy|8
95153|NCT00805935|330115|P4|Overall Study|Lost to Follow-up|0
95154|NCT00805935|330116|P3|Overall Study|Lost to Follow-up|0
95155|NCT00805935|330117|P2|Overall Study|Lost to Follow-up|0
95156|NCT00805935|330118|P1|Overall Study|Lost to Follow-up|1
95157|NCT00805935|330115|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
95158|NCT00805935|330116|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
95159|NCT00805935|330117|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
95160|NCT00805935|330118|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
95161|NCT00805935|330115|P4|Overall Study|Cycle cancellation for risk of OHSS|0
95162|NCT00805935|330116|P3|Overall Study|Cycle cancellation for risk of OHSS|1
95163|NCT00805935|330117|P2|Overall Study|Cycle cancellation for risk of OHSS|0
95164|NCT00805935|330118|P1|Overall Study|Cycle cancellation for risk of OHSS|1
95165|NCT00805935|330115|P4|Overall Study|Cycle cancelled|0
95166|NCT00805935|330116|P3|Overall Study|Cycle cancelled|2
95167|NCT00805935|330117|P2|Overall Study|Cycle cancelled|0
95168|NCT00805935|330118|P1|Overall Study|Cycle cancelled|0
95169|NCT00805935|330115|P4|Overall Study|Stimulation Failure|2
95170|NCT00805935|330116|P3|Overall Study|Stimulation Failure|2
95171|NCT00805935|330117|P2|Overall Study|Stimulation Failure|5
95172|NCT00805935|330118|P1|Overall Study|Stimulation Failure|1
95173|NCT00805792|330185|P1|Overall Study|Lost to Follow-up|2
95174|NCT00805792|330185|P1|Overall Study|Death|3
95175|NCT00805766|330193|P1|Increased Dose Period|Withdrawal by Subject|1
95176|NCT00805766|330193|P1|Increased Dose Period|Pregnancy|1
95177|NCT00805766|330193|P1|Increased Dose Period|Lack of Efficacy|7
95178|NCT00805766|330193|P1|Increased Dose Period|Adverse Event|4
95179|NCT00805766|330193|P1|Screening Period|Responder|2
95180|NCT00805766|330193|P1|Screening Period|Pregnancy|1
95181|NCT00805766|330193|P1|Screening Period|Lack of Efficacy|2
95182|NCT00805766|330193|P1|Screening Period|Adverse Event|1
95183|NCT00805740|330202|P2|Overall Study|Randomized, but not treated|0
95184|NCT00805740|330203|P1|Overall Study|Randomized, but not treated|2
95185|NCT00805740|330202|P2|Overall Study|Lost to Follow-up|0
95186|NCT00805740|330203|P1|Overall Study|Lost to Follow-up|1
95187|NCT00805740|330202|P2|Overall Study|Withdrawal by Subject|0
95188|NCT00805740|330203|P1|Overall Study|Withdrawal by Subject|1
95189|NCT00805740|330202|P2|Overall Study|Death|4
95190|NCT00805740|330203|P1|Overall Study|Death|7
95191|NCT00805675|330228|P3|Overall Study|Adverse Event|1
95192|NCT00805675|330229|P2|Overall Study|Adverse Event|0
95193|NCT00805675|330230|P1|Overall Study|Adverse Event|0
95194|NCT00805545|330264|P2|Overall Study|Protocol Violation|1
95195|NCT00805545|330265|P1|Overall Study|Protocol Violation|3
95196|NCT00805545|330264|P2|Overall Study|Protocol Violation|2
95197|NCT00805545|330265|P1|Overall Study|Protocol Violation|3
95198|NCT00805480|330291|P4|Overall Study|Adverse Event|0
95199|NCT00805480|330292|P3|Overall Study|Adverse Event|1
95200|NCT00805480|330293|P2|Overall Study|Adverse Event|0
95201|NCT00805480|330294|P1|Overall Study|Adverse Event|0
95202|NCT00805480|330291|P4|Overall Study|Lost to Follow-up|0
95203|NCT00805480|330292|P3|Overall Study|Lost to Follow-up|0
95204|NCT00805480|330293|P2|Overall Study|Lost to Follow-up|2
95205|NCT00805480|330294|P1|Overall Study|Lost to Follow-up|1
95206|NCT00805480|330291|P4|Overall Study|Withdrawal by Subject|5
95207|NCT00805480|330292|P3|Overall Study|Withdrawal by Subject|11
95208|NCT00805480|330293|P2|Overall Study|Withdrawal by Subject|5
95209|NCT00805480|330294|P1|Overall Study|Withdrawal by Subject|13
95210|NCT00805467|330323|P4|Overall Study|Not reported|7
95211|NCT00805467|330324|P3|Overall Study|Not reported|3
95212|NCT00805467|330325|P2|Overall Study|Not reported|0
95213|NCT00805467|330326|P1|Overall Study|Not reported|0
95214|NCT00805467|330323|P4|Overall Study|Physician Decision|6
95215|NCT00805467|330324|P3|Overall Study|Physician Decision|2
95216|NCT00805467|330325|P2|Overall Study|Physician Decision|1
95217|NCT00805467|330326|P1|Overall Study|Physician Decision|0
95218|NCT00805467|330323|P4|Overall Study|Death|5
95219|NCT00805467|330324|P3|Overall Study|Death|7
95220|NCT00805467|330325|P2|Overall Study|Death|2
95221|NCT00805467|330326|P1|Overall Study|Death|0
95222|NCT00805467|330323|P4|Overall Study|Adverse Event|57
95223|NCT00805467|330324|P3|Overall Study|Adverse Event|26
95224|NCT00805467|330325|P2|Overall Study|Adverse Event|13
95225|NCT00805467|330326|P1|Overall Study|Adverse Event|0
95226|NCT00805467|330323|P4|Overall Study|Protocol Violation|5
95227|NCT00805467|330324|P3|Overall Study|Protocol Violation|0
95228|NCT00805467|330325|P2|Overall Study|Protocol Violation|3
95229|NCT00805467|330326|P1|Overall Study|Protocol Violation|0
95230|NCT00805467|330323|P4|Overall Study|Withdrawal by Subject|50
95231|NCT00805467|330324|P3|Overall Study|Withdrawal by Subject|45
95232|NCT00805467|330325|P2|Overall Study|Withdrawal by Subject|6
95233|NCT00805467|330326|P1|Overall Study|Withdrawal by Subject|0
95234|NCT00805467|330323|P4|Overall Study|Lost to Follow-up|21
95235|NCT00805467|330324|P3|Overall Study|Lost to Follow-up|7
95236|NCT00805467|330325|P2|Overall Study|Lost to Follow-up|1
95237|NCT00805467|330326|P1|Overall Study|Lost to Follow-up|0
95238|NCT00805467|330323|P4|Overall Study|Lack of Efficacy|86
95239|NCT00805467|330324|P3|Overall Study|Lack of Efficacy|13
95240|NCT00805467|330325|P2|Overall Study|Lack of Efficacy|8
95241|NCT00805467|330326|P1|Overall Study|Lack of Efficacy|0
95242|NCT00804193|330347|P3|Overall Study|Withdrawal by Subject|2
95243|NCT00804193|330348|P2|Overall Study|Withdrawal by Subject|1
95244|NCT00804193|330349|P1|Overall Study|Withdrawal by Subject|3
95245|NCT00804193|330347|P3|Overall Study|Lost to Follow-up|4
95246|NCT00804193|330348|P2|Overall Study|Lost to Follow-up|3
95247|NCT00804193|330349|P1|Overall Study|Lost to Follow-up|3
95248|NCT00804193|330347|P3|Overall Study|Protocol Violation|2
95249|NCT00804193|330348|P2|Overall Study|Protocol Violation|8
95250|NCT00804193|330349|P1|Overall Study|Protocol Violation|0
95251|NCT00804193|330347|P3|Overall Study|Lack of Efficacy|3
95252|NCT00804193|330348|P2|Overall Study|Lack of Efficacy|1
95253|NCT00804193|330349|P1|Overall Study|Lack of Efficacy|1
95254|NCT00804193|330347|P3|Overall Study|Adverse Event|2
95255|NCT00804193|330348|P2|Overall Study|Adverse Event|0
95256|NCT00804193|330349|P1|Overall Study|Adverse Event|0
95257|NCT00804193|330347|P3|Overall Study|Lack of baseline fungus|19
95258|NCT00804193|330348|P2|Overall Study|Lack of baseline fungus|31
95259|NCT00804193|330349|P1|Overall Study|Lack of baseline fungus|32
95260|NCT00805389|330368|P5|Overall Study|Withdrawal by Subject|4
95261|NCT00805389|330369|P4|Overall Study|Withdrawal by Subject|5
95262|NCT00805389|330370|P3|Overall Study|Withdrawal by Subject|4
95263|NCT00805389|330371|P2|Overall Study|Withdrawal by Subject|2
95264|NCT00805389|330372|P1|Overall Study|Withdrawal by Subject|3
95265|NCT00805389|330368|P5|Overall Study|Protocol Violation|0
95266|NCT00805389|330369|P4|Overall Study|Protocol Violation|0
95267|NCT00805389|330370|P3|Overall Study|Protocol Violation|1
95268|NCT00805389|330371|P2|Overall Study|Protocol Violation|0
95269|NCT00805389|330372|P1|Overall Study|Protocol Violation|0
95270|NCT00805389|330368|P5|Overall Study|Lost to Follow-up|9
95271|NCT00805389|330369|P4|Overall Study|Lost to Follow-up|10
95272|NCT00805389|330370|P3|Overall Study|Lost to Follow-up|6
95273|NCT00805389|330371|P2|Overall Study|Lost to Follow-up|3
95274|NCT00805389|330372|P1|Overall Study|Lost to Follow-up|4
95275|NCT00805389|330368|P5|Overall Study|Adverse Event|0
95276|NCT00805389|330369|P4|Overall Study|Adverse Event|2
95277|NCT00805389|330370|P3|Overall Study|Adverse Event|1
95278|NCT00805389|330371|P2|Overall Study|Adverse Event|0
95279|NCT00805389|330372|P1|Overall Study|Adverse Event|0
95280|NCT00805285|330614|P1|Overall Study|Lack of Efficacy|1
95281|NCT00805194|330624|P2|Overall Study|Reasons other than stated above|16
95282|NCT00805194|330625|P1|Overall Study|Reasons other than stated above|20
95283|NCT00805194|330624|P2|Overall Study|Not treated|4
95284|NCT00805194|330625|P1|Overall Study|Not treated|3
95285|NCT00805194|330624|P2|Overall Study|Withdrawal by Subject|42
95286|NCT00805194|330625|P1|Overall Study|Withdrawal by Subject|60
95287|NCT00805194|330624|P2|Overall Study|Lost to Follow-up|5
95288|NCT00805194|330625|P1|Overall Study|Lost to Follow-up|5
95289|NCT00805194|330624|P2|Overall Study|Protocol Violation|9
95290|NCT00805194|330625|P1|Overall Study|Protocol Violation|9
95291|NCT00805194|330624|P2|Overall Study|Other AE|73
95292|NCT00805194|330625|P1|Overall Study|Other AE|84
95293|NCT00805194|330624|P2|Overall Study|Worsening or AE of underlying disease|70
95294|NCT00805194|330625|P1|Overall Study|Worsening or AE of underlying disease|64
95295|NCT00805194|330624|P2|Overall Study|Progressive disease (modified RECIST)|435
95296|NCT00805194|330625|P1|Overall Study|Progressive disease (modified RECIST)|404
95297|NCT00805142|330659|P2|Maintenance Period|Unspecified|1
95298|NCT00805142|330660|P1|Maintenance Period|Unspecified|0
95299|NCT00805142|330659|P2|Maintenance Period|Adverse Event|1
95300|NCT00805142|330660|P1|Maintenance Period|Adverse Event|0
95301|NCT00805142|330659|P2|Titration Period|Unspecified|3
95302|NCT00805142|330660|P1|Titration Period|Unspecified|0
95303|NCT00805142|330659|P2|Titration Period|Withdrawal of consent|1
95304|NCT00805142|330660|P1|Titration Period|Withdrawal of consent|0
95305|NCT00805142|330659|P2|Titration Period|Disease Progression|1
95306|NCT00805142|330660|P1|Titration Period|Disease Progression|2
95307|NCT00805142|330659|P2|Titration Period|Lost to Follow-up|1
95308|NCT00805142|330660|P1|Titration Period|Lost to Follow-up|0
95309|NCT00805142|330659|P2|Titration Period|Lack of Efficacy|1
95310|NCT00805142|330660|P1|Titration Period|Lack of Efficacy|1
95311|NCT00805142|330659|P2|Titration Period|Adverse Event|3
95312|NCT00805142|330660|P1|Titration Period|Adverse Event|3
95313|NCT00805025|330693|P1|Overall Study|Physician Decision|1
95314|NCT00805025|330693|P1|Overall Study|Withdrawal by Subject|2
95315|NCT00805025|330693|P1|Overall Study|Adverse Event|4
95316|NCT00805025|330693|P1|Overall Study|Screened but not enrolled/treated|42
95317|NCT00804986|330705|P6|Overall Study|Physician Decision|0
95318|NCT00804986|330706|P5|Overall Study|Physician Decision|0
95319|NCT00804986|330707|P4|Overall Study|Physician Decision|0
95320|NCT00804986|330708|P3|Overall Study|Physician Decision|0
95321|NCT00804986|330709|P2|Overall Study|Physician Decision|0
95322|NCT00804986|330710|P1|Overall Study|Physician Decision|1
95323|NCT00804986|330705|P6|Overall Study|Sponsor Decision|0
95324|NCT00804986|330706|P5|Overall Study|Sponsor Decision|0
95325|NCT00804986|330707|P4|Overall Study|Sponsor Decision|0
95326|NCT00804986|330708|P3|Overall Study|Sponsor Decision|0
95327|NCT00804986|330709|P2|Overall Study|Sponsor Decision|1
95328|NCT00804986|330710|P1|Overall Study|Sponsor Decision|0
95329|NCT00804986|330705|P6|Overall Study|Inclusion/Exclusion criteria not met|1
95330|NCT00804986|330706|P5|Overall Study|Inclusion/Exclusion criteria not met|0
95331|NCT00804986|330707|P4|Overall Study|Inclusion/Exclusion criteria not met|1
95332|NCT00804986|330708|P3|Overall Study|Inclusion/Exclusion criteria not met|0
95333|NCT00804986|330709|P2|Overall Study|Inclusion/Exclusion criteria not met|2
95334|NCT00804986|330710|P1|Overall Study|Inclusion/Exclusion criteria not met|0
95335|NCT00804986|330705|P6|Overall Study|Withdrawal by Subject|3
95336|NCT00804986|330706|P5|Overall Study|Withdrawal by Subject|5
95337|NCT00804986|330707|P4|Overall Study|Withdrawal by Subject|3
95338|NCT00804986|330708|P3|Overall Study|Withdrawal by Subject|0
95339|NCT00804986|330709|P2|Overall Study|Withdrawal by Subject|3
95340|NCT00804986|330710|P1|Overall Study|Withdrawal by Subject|0
95341|NCT00804986|330705|P6|Overall Study|Protocol Violation|0
95342|NCT00804986|330706|P5|Overall Study|Protocol Violation|0
95343|NCT00804986|330707|P4|Overall Study|Protocol Violation|1
95344|NCT00804986|330708|P3|Overall Study|Protocol Violation|0
95345|NCT00804986|330709|P2|Overall Study|Protocol Violation|1
95346|NCT00804986|330710|P1|Overall Study|Protocol Violation|0
95347|NCT00804986|330705|P6|Overall Study|Lost to Follow-up|3
95348|NCT00804986|330706|P5|Overall Study|Lost to Follow-up|1
95349|NCT00804986|330707|P4|Overall Study|Lost to Follow-up|1
95350|NCT00804986|330708|P3|Overall Study|Lost to Follow-up|0
95351|NCT00804986|330709|P2|Overall Study|Lost to Follow-up|0
95352|NCT00804986|330710|P1|Overall Study|Lost to Follow-up|0
95353|NCT00804986|330705|P6|Overall Study|Lack of Efficacy|3
95354|NCT00804986|330706|P5|Overall Study|Lack of Efficacy|0
95355|NCT00804986|330707|P4|Overall Study|Lack of Efficacy|1
95356|NCT00804986|330708|P3|Overall Study|Lack of Efficacy|0
95357|NCT00804986|330709|P2|Overall Study|Lack of Efficacy|0
95358|NCT00804986|330710|P1|Overall Study|Lack of Efficacy|0
95359|NCT00804986|330705|P6|Overall Study|Adverse Event|0
95360|NCT00804986|330706|P5|Overall Study|Adverse Event|3
95361|NCT00804986|330707|P4|Overall Study|Adverse Event|1
95362|NCT00804986|330708|P3|Overall Study|Adverse Event|2
95363|NCT00804986|330709|P2|Overall Study|Adverse Event|1
95364|NCT00804986|330710|P1|Overall Study|Adverse Event|0
95365|NCT00804843|330804|P2|Overall Study|Withdrawal by Subject|2
95366|NCT00804843|330805|P1|Overall Study|Withdrawal by Subject|1
95367|NCT00804843|330804|P2|Overall Study|Adverse Event|5
95368|NCT00804843|330805|P1|Overall Study|Adverse Event|8
95369|NCT00804843|330804|P2|Overall Study|Protocol Violation|0
95370|NCT00804843|330805|P1|Overall Study|Protocol Violation|1
95371|NCT00804687|330823|P6|Period 5: Treatment Period|Positive drug test|0
95372|NCT00804687|330824|P5|Period 5: Treatment Period|Positive drug test|0
95373|NCT00804687|330825|P4|Period 5: Treatment Period|Positive drug test|0
95374|NCT00804687|330826|P3|Period 5: Treatment Period|Positive drug test|0
95375|NCT00804687|330827|P2|Period 5: Treatment Period|Positive drug test|0
95376|NCT00804687|330828|P1|Period 5: Treatment Period|Positive drug test|1
95377|NCT00804687|330823|P6|Period 5: Treatment Period|Positive drugs of abuse|0
95378|NCT00804687|330824|P5|Period 5: Treatment Period|Positive drugs of abuse|0
95379|NCT00804687|330825|P4|Period 5: Treatment Period|Positive drugs of abuse|0
95380|NCT00804687|330826|P3|Period 5: Treatment Period|Positive drugs of abuse|1
95381|NCT00804687|330827|P2|Period 5: Treatment Period|Positive drugs of abuse|0
95382|NCT00804687|330828|P1|Period 5: Treatment Period|Positive drugs of abuse|0
95383|NCT00804687|330823|P6|Period 5: Treatment Period|Withdrawal by Subject|0
95384|NCT00804687|330824|P5|Period 5: Treatment Period|Withdrawal by Subject|1
95385|NCT00804687|330825|P4|Period 5: Treatment Period|Withdrawal by Subject|0
95386|NCT00804687|330826|P3|Period 5: Treatment Period|Withdrawal by Subject|0
95387|NCT00804687|330827|P2|Period 5: Treatment Period|Withdrawal by Subject|0
95388|NCT00804687|330828|P1|Period 5: Treatment Period|Withdrawal by Subject|0
95389|NCT00804687|330823|P6|Period 3: Treatment Period|Positive Drug screen|0
95390|NCT00804687|330824|P5|Period 3: Treatment Period|Positive Drug screen|0
95391|NCT00804687|330825|P4|Period 3: Treatment Period|Positive Drug screen|1
95392|NCT00804687|330826|P3|Period 3: Treatment Period|Positive Drug screen|0
95393|NCT00804687|330827|P2|Period 3: Treatment Period|Positive Drug screen|0
95394|NCT00804687|330828|P1|Period 3: Treatment Period|Positive Drug screen|0
95395|NCT00804570|330907|P2|Overall Study|Withdrawal by Subject|38
95396|NCT00804570|330908|P1|Overall Study|Withdrawal by Subject|21
95397|NCT00804570|330907|P2|Overall Study|Sponsor decision|4
95398|NCT00804570|330908|P1|Overall Study|Sponsor decision|1
95399|NCT00804570|330907|P2|Overall Study|Physician Decision|2
95400|NCT00804570|330908|P1|Overall Study|Physician Decision|1
95401|NCT00804570|330907|P2|Overall Study|Protocol Violation|16
95402|NCT00804570|330908|P1|Overall Study|Protocol Violation|12
95403|NCT00804570|330907|P2|Overall Study|Entry criteria not met|5
95404|NCT00804570|330908|P1|Overall Study|Entry criteria not met|5
95405|NCT00804570|330907|P2|Overall Study|Lost to Follow-up|21
95406|NCT00804570|330908|P1|Overall Study|Lost to Follow-up|18
95407|NCT00804570|330907|P2|Overall Study|Lack of Efficacy|1
95408|NCT00804570|330908|P1|Overall Study|Lack of Efficacy|0
95409|NCT00804570|330907|P2|Overall Study|Adverse Event|7
95410|NCT00804570|330908|P1|Overall Study|Adverse Event|14
95411|NCT00803790|330999|P4|Period 2|Positive Drug Screen or Personal Reasons|0
95412|NCT00803790|331000|P3|Period 2|Positive Drug Screen or Personal Reasons|0
95413|NCT00803790|331001|P2|Period 2|Positive Drug Screen or Personal Reasons|0
95414|NCT00803790|331002|P1|Period 2|Positive Drug Screen or Personal Reasons|1
95415|NCT00803790|330999|P4|Period 2|Withdrawal by Subject|0
95416|NCT00803790|331000|P3|Period 2|Withdrawal by Subject|0
95417|NCT00803790|331001|P2|Period 2|Withdrawal by Subject|0
95418|NCT00803790|331002|P1|Period 2|Withdrawal by Subject|1
95419|NCT00803790|330999|P4|Period 2|Adverse Event|1
95420|NCT00803790|331000|P3|Period 2|Adverse Event|1
95421|NCT00803790|331001|P2|Period 2|Adverse Event|0
95422|NCT00803790|331002|P1|Period 2|Adverse Event|0
95423|NCT00803790|330999|P4|Period 1|Protocol Violation|0
95424|NCT00803790|331000|P3|Period 1|Protocol Violation|1
95425|NCT00803790|331001|P2|Period 1|Protocol Violation|0
95426|NCT00803790|331002|P1|Period 1|Protocol Violation|0
95427|NCT00803790|330999|P4|Period 1|positive drug screen or personal reasons|4
95428|NCT00803790|331000|P3|Period 1|positive drug screen or personal reasons|0
95429|NCT00803790|331001|P2|Period 1|positive drug screen or personal reasons|3
95430|NCT00803790|331002|P1|Period 1|positive drug screen or personal reasons|0
95431|NCT00803790|330999|P4|Period 1|Withdrawal by Subject|0
95432|NCT00803790|331000|P3|Period 1|Withdrawal by Subject|0
95433|NCT00803790|331001|P2|Period 1|Withdrawal by Subject|6
95434|NCT00803790|331002|P1|Period 1|Withdrawal by Subject|8
95435|NCT00803790|330999|P4|Period 1|Lost to Follow-up|0
95436|NCT00803790|331000|P3|Period 1|Lost to Follow-up|0
95437|NCT00803790|331001|P2|Period 1|Lost to Follow-up|2
95438|NCT00803790|331002|P1|Period 1|Lost to Follow-up|1
95439|NCT00803790|330999|P4|Period 1|Adverse Event|0
95440|NCT00803790|331000|P3|Period 1|Adverse Event|0
95441|NCT00803790|331001|P2|Period 1|Adverse Event|1
95442|NCT00803790|331002|P1|Period 1|Adverse Event|0
95443|NCT00803738|331023|P2|Overall Study|Positive Results for STD or abnormal PAP|8
95444|NCT00803738|331024|P1|Overall Study|Positive Results for STD or abnormal PAP|2
95445|NCT00803738|331023|P2|Overall Study|Negative Baseline Culture of Candida|63
95446|NCT00803738|331024|P1|Overall Study|Negative Baseline Culture of Candida|56
95447|NCT00803738|331023|P2|Overall Study|Lack of Efficacy|16
95448|NCT00803738|331024|P1|Overall Study|Lack of Efficacy|10
95449|NCT00803738|331023|P2|Overall Study|Withdrawal by Subject|4
95450|NCT00803738|331024|P1|Overall Study|Withdrawal by Subject|1
95451|NCT00803738|331023|P2|Overall Study|Protocol Violation|10
95452|NCT00803738|331024|P1|Overall Study|Protocol Violation|18
95453|NCT00803738|331023|P2|Overall Study|Lost to Follow-up|4
95454|NCT00803738|331024|P1|Overall Study|Lost to Follow-up|4
95455|NCT00803738|331023|P2|Overall Study|Adverse Event|5
95456|NCT00803738|331024|P1|Overall Study|Adverse Event|3
95457|NCT00803712|331036|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
95458|NCT00803712|331037|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
95459|NCT00803712|331036|P2|Overall Study|Administrative decision|3
95460|NCT00803712|331037|P1|Overall Study|Administrative decision|2
95461|NCT00803712|331036|P2|Overall Study|Protocol criteria (renal transplant)|8
95462|NCT00803712|331037|P1|Overall Study|Protocol criteria (renal transplant)|12
95463|NCT00803712|331036|P2|Overall Study|Protocol criteria (other)|2
95464|NCT00803712|331037|P1|Overall Study|Protocol criteria (other)|0
95465|NCT00803712|331036|P2|Overall Study|"Other in electronic Case Report Form"|1
95466|NCT00803712|331037|P1|Overall Study|"Other in electronic Case Report Form"|0
95467|NCT00803712|331036|P2|Overall Study|Withdrawal by Subject|4
95468|NCT00803712|331037|P1|Overall Study|Withdrawal by Subject|2
95469|NCT00803712|331036|P2|Overall Study|Lost to Follow-up|1
95470|NCT00803712|331037|P1|Overall Study|Lost to Follow-up|3
95471|NCT00803712|331036|P2|Overall Study|Death|7
95472|NCT00803712|331037|P1|Overall Study|Death|8
95473|NCT00803712|331036|P2|Overall Study|Adverse Event|0
95474|NCT00803712|331037|P1|Overall Study|Adverse Event|5
95475|NCT00803712|331036|P2|Overall Study|Noncompliance|0
95476|NCT00803712|331037|P1|Overall Study|Noncompliance|3
95477|NCT00803634|331135|P2|Overall Study|Death|2
95478|NCT00803634|331136|P1|Overall Study|Death|3
95479|NCT00803634|331135|P2|Overall Study|Lost to Follow-up|3
95480|NCT00803634|331136|P1|Overall Study|Lost to Follow-up|2
95481|NCT00803634|331135|P2|Overall Study|Withdrew Consent|0
95482|NCT00803634|331136|P1|Overall Study|Withdrew Consent|1
95483|NCT00803595|331165|P3|Overall Study|Withdrawal by Subject|3
95484|NCT00803595|331166|P2|Overall Study|Withdrawal by Subject|2
95485|NCT00803595|331167|P1|Overall Study|Withdrawal by Subject|5
95486|NCT00803595|331165|P3|Overall Study|Protocol Violation|12
95487|NCT00803595|331166|P2|Overall Study|Protocol Violation|2
95488|NCT00803595|331167|P1|Overall Study|Protocol Violation|7
95489|NCT00803595|331165|P3|Overall Study|Adverse Event|1
95490|NCT00803595|331166|P2|Overall Study|Adverse Event|4
95491|NCT00803595|331167|P1|Overall Study|Adverse Event|3
95492|NCT00803361|331219|P2|Overall Study|Withdrawal by Subject|6
95493|NCT00803361|331220|P1|Overall Study|Withdrawal by Subject|5
95494|NCT00803361|331219|P2|Overall Study|Protocol Violation|4
95495|NCT00803361|331220|P1|Overall Study|Protocol Violation|2
95496|NCT00803361|331219|P2|Overall Study|Physician Decision|0
95497|NCT00803361|331220|P1|Overall Study|Physician Decision|1
95498|NCT00803361|331219|P2|Overall Study|Lost to Follow-up|2
95499|NCT00803361|331220|P1|Overall Study|Lost to Follow-up|1
95500|NCT00803361|331219|P2|Overall Study|Lack of Efficacy|13
95501|NCT00803361|331220|P1|Overall Study|Lack of Efficacy|4
95502|NCT00803361|331219|P2|Overall Study|Adverse Event|3
95503|NCT00803361|331220|P1|Overall Study|Adverse Event|13
95504|NCT00803270|331267|P2|Overall Study|Lost to Follow-up|2
95505|NCT00803270|331268|P1|Overall Study|Lost to Follow-up|1
95506|NCT00803244|331278|P2|Overall Study|Any other reason not above-mentioned|10
95507|NCT00803244|331279|P1|Overall Study|Any other reason not above-mentioned|4
95508|NCT00803244|331278|P2|Overall Study|Withdrawal by Subject|3
95509|NCT00803244|331279|P1|Overall Study|Withdrawal by Subject|2
95510|NCT00803244|331278|P2|Overall Study|Adverse Event|2
95511|NCT00803244|331279|P1|Overall Study|Adverse Event|1
95512|NCT00803179|331287|P1|Overall Study|Lost to Follow-up|3
95513|NCT00803101|331306|P2|Overall Study|Patient did not have surgery|1
95514|NCT00803101|331307|P1|Overall Study|Patient did not have surgery|1
95515|NCT00803101|331306|P2|Overall Study|Patient did not attend scheduled visit|1
95516|NCT00803101|331307|P1|Overall Study|Patient did not attend scheduled visit|2
95517|NCT00803101|331306|P2|Overall Study|Patient died outside SAE report period|0
95518|NCT00803101|331307|P1|Overall Study|Patient died outside SAE report period|1
95519|NCT00803101|331306|P2|Overall Study|Surgery finished outside protocol window|1
95520|NCT00803101|331307|P1|Overall Study|Surgery finished outside protocol window|1
95521|NCT00803101|331306|P2|Overall Study|Protocol Violation|7
95522|NCT00803101|331307|P1|Overall Study|Protocol Violation|1
95523|NCT00803101|331306|P2|Overall Study|Lost to Follow-up|2
95524|NCT00803101|331307|P1|Overall Study|Lost to Follow-up|2
95525|NCT00803101|331306|P2|Overall Study|Withdrawal by Subject|4
95526|NCT00803101|331307|P1|Overall Study|Withdrawal by Subject|6
95527|NCT00803101|331306|P2|Overall Study|Death / Serious Adverse Event|6
95528|NCT00803101|331307|P1|Overall Study|Death / Serious Adverse Event|4
95529|NCT00803049|331354|P4|Overall Study|Other than Specified Above|5
95530|NCT00803049|331355|P3|Overall Study|Other than Specified Above|2
95531|NCT00803049|331356|P2|Overall Study|Other than Specified Above|9
95532|NCT00803049|331357|P1|Overall Study|Other than Specified Above|3
95533|NCT00803049|331354|P4|Overall Study|Randomized and Not Treated|2
95534|NCT00803049|331355|P3|Overall Study|Randomized and Not Treated|0
95535|NCT00803049|331356|P2|Overall Study|Randomized and Not Treated|0
95536|NCT00803049|331357|P1|Overall Study|Randomized and Not Treated|0
95537|NCT00803049|331354|P4|Overall Study|Protocol Violation|0
95538|NCT00803049|331355|P3|Overall Study|Protocol Violation|1
95539|NCT00803049|331356|P2|Overall Study|Protocol Violation|1
95540|NCT00803049|331357|P1|Overall Study|Protocol Violation|0
95541|NCT00803049|331354|P4|Overall Study|Withdrawal by Subject|44
95542|NCT00803049|331355|P3|Overall Study|Withdrawal by Subject|16
95543|NCT00803049|331356|P2|Overall Study|Withdrawal by Subject|43
95544|NCT00803049|331357|P1|Overall Study|Withdrawal by Subject|19
95545|NCT00803049|331354|P4|Overall Study|Progressive Disease|6
95546|NCT00803049|331355|P3|Overall Study|Progressive Disease|6
95547|NCT00803049|331356|P2|Overall Study|Progressive Disease|10
95548|NCT00803049|331357|P1|Overall Study|Progressive Disease|6
95549|NCT00803049|331354|P4|Overall Study|Death|2
95550|NCT00803049|331355|P3|Overall Study|Death|0
95551|NCT00803049|331356|P2|Overall Study|Death|1
95552|NCT00803049|331357|P1|Overall Study|Death|2
95553|NCT00803049|331354|P4|Overall Study|Lost to Follow-up|3
95554|NCT00803049|331355|P3|Overall Study|Lost to Follow-up|0
95555|NCT00803049|331356|P2|Overall Study|Lost to Follow-up|2
95556|NCT00803049|331357|P1|Overall Study|Lost to Follow-up|0
95557|NCT00803049|331354|P4|Overall Study|Lack of Efficacy|13
95558|NCT00803049|331355|P3|Overall Study|Lack of Efficacy|6
95559|NCT00803049|331356|P2|Overall Study|Lack of Efficacy|19
95560|NCT00803049|331357|P1|Overall Study|Lack of Efficacy|10
95561|NCT00803049|331354|P4|Overall Study|Adverse Event|27
95562|NCT00803049|331355|P3|Overall Study|Adverse Event|13
95563|NCT00803049|331356|P2|Overall Study|Adverse Event|33
95564|NCT00803049|331357|P1|Overall Study|Adverse Event|21
95565|NCT00803023|331391|P4|Overall Study|Lack of Efficacy|1
95566|NCT00803023|331392|P3|Overall Study|Lack of Efficacy|1
95567|NCT00803023|331393|P2|Overall Study|Lack of Efficacy|1
95568|NCT00803023|331394|P1|Overall Study|Lack of Efficacy|0
95569|NCT00803023|331391|P4|Overall Study|Lost to Follow-up|1
95570|NCT00803023|331392|P3|Overall Study|Lost to Follow-up|2
95571|NCT00803023|331393|P2|Overall Study|Lost to Follow-up|1
95572|NCT00803023|331394|P1|Overall Study|Lost to Follow-up|0
95573|NCT00803023|331391|P4|Overall Study|Withdrawal by Subject|0
95574|NCT00803023|331392|P3|Overall Study|Withdrawal by Subject|0
95575|NCT00803023|331393|P2|Overall Study|Withdrawal by Subject|2
95576|NCT00803023|331394|P1|Overall Study|Withdrawal by Subject|0
95577|NCT00803023|331391|P4|Overall Study|Adverse Event|6
95578|NCT00803023|331392|P3|Overall Study|Adverse Event|8
95579|NCT00803023|331393|P2|Overall Study|Adverse Event|4
95580|NCT00803023|331394|P1|Overall Study|Adverse Event|5
95581|NCT00802867|331449|P1|Overall Study|Withdrawal by Subject|1
95582|NCT00802867|331449|P1|Overall Study|Protocol Violation|6
95583|NCT00802867|331449|P1|Overall Study|Lost to Follow-up|6
95584|NCT00802841|331459|P2|Overall Study|Treatment duration completed|76
95585|NCT00802841|331460|P1|Overall Study|Treatment duration completed|66
95586|NCT00802841|331459|P2|Overall Study|Protocol deviation|6
95587|NCT00802841|331460|P1|Overall Study|Protocol deviation|2
95588|NCT00802841|331459|P2|Overall Study|Withdrawal by Subject|5
95589|NCT00802841|331460|P1|Overall Study|Withdrawal by Subject|9
95590|NCT00802841|331459|P2|Overall Study|Disease progression|3
95591|NCT00802841|331460|P1|Overall Study|Disease progression|7
95592|NCT00802841|331459|P2|Overall Study|Adverse Event|2
95593|NCT00802841|331460|P1|Overall Study|Adverse Event|8
95594|NCT00802841|331459|P2|Overall Study|Death|2
95595|NCT00802841|331460|P1|Overall Study|Death|1
95596|NCT00802841|331459|P2|Overall Study|Lost to Follow-up|1
95597|NCT00802841|331460|P1|Overall Study|Lost to Follow-up|2
95598|NCT00802841|331459|P2|Overall Study|Administrative problems|0
95599|NCT00802841|331460|P1|Overall Study|Administrative problems|1
95600|NCT00802737|331485|P3|Overall Study|Participant too Unwell|0
95601|NCT00802737|331486|P2|Overall Study|Participant too Unwell|2
95602|NCT00802737|331487|P1|Overall Study|Participant too Unwell|0
95603|NCT00802737|331485|P3|Overall Study|Ongoing CLL-Treatment|0
95604|NCT00802737|331486|P2|Overall Study|Ongoing CLL-Treatment|1
95605|NCT00802737|331487|P1|Overall Study|Ongoing CLL-Treatment|0
95606|NCT00802737|331485|P3|Overall Study|Received Prohibited Therapy|0
95607|NCT00802737|331486|P2|Overall Study|Received Prohibited Therapy|0
95608|NCT00802737|331487|P1|Overall Study|Received Prohibited Therapy|1
95609|NCT00802737|331485|P3|Overall Study|Adverse Event|0
95610|NCT00802737|331486|P2|Overall Study|Adverse Event|0
95611|NCT00802737|331487|P1|Overall Study|Adverse Event|1
95612|NCT00802737|331485|P3|Overall Study|Death|1
95613|NCT00802737|331486|P2|Overall Study|Death|5
95614|NCT00802737|331487|P1|Overall Study|Death|6
95615|NCT00802737|331485|P3|Overall Study|Withdrawn due to Disease Progression|0
95616|NCT00802737|331486|P2|Overall Study|Withdrawn due to Disease Progression|3
95617|NCT00802737|331487|P1|Overall Study|Withdrawn due to Disease Progression|9
95618|NCT00802672|331547|P3|Overall Study|other|2
95619|NCT00802672|331548|P2|Overall Study|other|1
95620|NCT00802672|331549|P1|Overall Study|other|3
95621|NCT00802672|331547|P3|Overall Study|Withdrawal by Subject|2
95622|NCT00802672|331548|P2|Overall Study|Withdrawal by Subject|1
95623|NCT00802672|331549|P1|Overall Study|Withdrawal by Subject|1
95624|NCT00802672|331547|P3|Overall Study|Lost to Follow-up|3
95625|NCT00802672|331548|P2|Overall Study|Lost to Follow-up|5
95626|NCT00802672|331549|P1|Overall Study|Lost to Follow-up|5
95627|NCT00802672|331547|P3|Overall Study|Protocol Violation|1
95628|NCT00802672|331548|P2|Overall Study|Protocol Violation|1
95629|NCT00802672|331549|P1|Overall Study|Protocol Violation|2
95630|NCT00802672|331547|P3|Overall Study|Adverse Event|1
95631|NCT00802672|331548|P2|Overall Study|Adverse Event|1
95632|NCT00802672|331549|P1|Overall Study|Adverse Event|1
95633|NCT00802672|331547|P3|Overall Study|Lack of fungal pathogen at baseline|25
95634|NCT00802672|331548|P2|Overall Study|Lack of fungal pathogen at baseline|43
95635|NCT00802672|331549|P1|Overall Study|Lack of fungal pathogen at baseline|56
95636|NCT00802659|331567|P4|Overall Study|Physician Decision|0
95637|NCT00802659|331568|P3|Overall Study|Physician Decision|0
95638|NCT00802659|331569|P2|Overall Study|Physician Decision|1
95639|NCT00802659|331570|P1|Overall Study|Physician Decision|0
95640|NCT00802529|331609|P2|Overall Study|Lost to Follow-up|1
95641|NCT00802529|331610|P1|Overall Study|Lost to Follow-up|0
95642|NCT00802360|331660|P4|Overall Study|Unspecified|3
95643|NCT00802360|331661|P3|Overall Study|Unspecified|6
95644|NCT00802360|331662|P2|Overall Study|Unspecified|3
95645|NCT00802360|331663|P1|Overall Study|Unspecified|2
95646|NCT00802360|331660|P4|Overall Study|Pregnancy loss/miscarriage|3
95647|NCT00802360|331661|P3|Overall Study|Pregnancy loss/miscarriage|0
95648|NCT00802360|331662|P2|Overall Study|Pregnancy loss/miscarriage|2
95649|NCT00802360|331663|P1|Overall Study|Pregnancy loss/miscarriage|0
95650|NCT00802360|331660|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
95651|NCT00802360|331661|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
95652|NCT00802360|331662|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
95653|NCT00802360|331663|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
95654|NCT00802360|331660|P4|Overall Study|No positive serum pregnancy|10
95655|NCT00802360|331661|P3|Overall Study|No positive serum pregnancy|14
95656|NCT00802360|331662|P2|Overall Study|No positive serum pregnancy|20
95657|NCT00802360|331663|P1|Overall Study|No positive serum pregnancy|17
95658|NCT00802360|331660|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
95659|NCT00802360|331661|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
95660|NCT00802360|331662|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
95661|NCT00802360|331663|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
95662|NCT00802360|331660|P4|Overall Study|Cycle cancelled|1
95663|NCT00802360|331661|P3|Overall Study|Cycle cancelled|1
95664|NCT00802360|331662|P2|Overall Study|Cycle cancelled|1
95665|NCT00802360|331663|P1|Overall Study|Cycle cancelled|0
95666|NCT00802360|331660|P4|Overall Study|Inadequate number of oocytes retrieved|1
95667|NCT00802360|331661|P3|Overall Study|Inadequate number of oocytes retrieved|0
95668|NCT00802360|331662|P2|Overall Study|Inadequate number of oocytes retrieved|0
95669|NCT00802360|331663|P1|Overall Study|Inadequate number of oocytes retrieved|0
95670|NCT00802360|331660|P4|Overall Study|Stimulation failure|3
95671|NCT00802360|331661|P3|Overall Study|Stimulation failure|3
95672|NCT00802360|331662|P2|Overall Study|Stimulation failure|0
95673|NCT00802360|331663|P1|Overall Study|Stimulation failure|4
95674|NCT00802178|331703|P1|Overall Study|Patients wish and other reason|1
95675|NCT00802178|331703|P1|Overall Study|IT and patient wish|8
95676|NCT00802178|331703|P1|Overall Study|Lack of efficacy and patient wish|1
95677|NCT00802178|331703|P1|Overall Study|Other|32
95678|NCT00802178|331703|P1|Overall Study|Withdrawal by Subject|18
95679|NCT00802178|331703|P1|Overall Study|Insufficient tolerability (IT)|17
95680|NCT00802178|331703|P1|Overall Study|Lack of Efficacy|36
95681|NCT00802074|331730|P6|Overall Study|Withdrawal by Subject|0
95682|NCT00802074|331731|P5|Overall Study|Withdrawal by Subject|0
95683|NCT00802074|331732|P4|Overall Study|Withdrawal by Subject|0
95684|NCT00802074|331733|P3|Overall Study|Withdrawal by Subject|0
95685|NCT00802074|331734|P2|Overall Study|Withdrawal by Subject|0
95686|NCT00802074|331735|P1|Overall Study|Withdrawal by Subject|1
95687|NCT00802074|331730|P6|Overall Study|Adverse Event|0
95688|NCT00802074|331731|P5|Overall Study|Adverse Event|0
95689|NCT00802074|331732|P4|Overall Study|Adverse Event|0
95690|NCT00802074|331733|P3|Overall Study|Adverse Event|1
95691|NCT00802074|331734|P2|Overall Study|Adverse Event|1
95692|NCT00802074|331735|P1|Overall Study|Adverse Event|1
95693|NCT00801983|331769|P2|Period 2|Withdrawal by Subject|1
95694|NCT00801983|331770|P1|Period 2|Withdrawal by Subject|2
95695|NCT00801983|331769|P2|Period 1|Withdrawal by Subject|8
95696|NCT00801983|331770|P1|Period 1|Withdrawal by Subject|2
95697|NCT00801983|331769|P2|Period 1|Lost to Follow-up|0
95698|NCT00801983|331770|P1|Period 1|Lost to Follow-up|2
95699|NCT00801632|331811|P1|Overall Study|Re-transplant|1
95700|NCT00801242|331822|P1|Overall Study|Miscellaneous reasons|20
95701|NCT00801242|331822|P1|Overall Study|Lost to Follow-up|1
95702|NCT00801242|331822|P1|Overall Study|Physician Decision|3
95703|NCT00801242|331822|P1|Overall Study|Protocol Violation|5
95704|NCT00801242|331822|P1|Overall Study|Withdrawal by Subject|13
95705|NCT00801242|331822|P1|Overall Study|Adverse Event|10
95706|NCT00801229|331835|P2|Received Study Drug/Placebo|Adverse Event|1
95707|NCT00801229|331836|P1|Received Study Drug/Placebo|Adverse Event|1
95708|NCT00801229|331835|P2|Received Study Drug/Placebo|Lost to Follow-up|1
95709|NCT00801229|331836|P1|Received Study Drug/Placebo|Lost to Follow-up|0
95710|NCT00801229|331835|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
95711|NCT00801229|331836|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
95712|NCT00801229|331835|P2|Received Study Drug/Placebo|Simulator sickness|1
95713|NCT00801229|331836|P1|Received Study Drug/Placebo|Simulator sickness|1
95714|NCT00801229|331835|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
95715|NCT00801229|331836|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
95716|NCT00801229|331835|P2|Received Study Drug/Placebo|Elevated SGOT level|0
95717|NCT00801229|331836|P1|Received Study Drug/Placebo|Elevated SGOT level|1
95718|NCT00801229|331835|P2|Signed Consent|Found Ineligible|1
95719|NCT00801229|331836|P1|Signed Consent|Found Ineligible|1
95720|NCT00801229|331835|P2|Signed Consent|Withdrawal by Subject|2
95721|NCT00801229|331836|P1|Signed Consent|Withdrawal by Subject|2
95722|NCT00801099|331842|P1|Overall Study|Lost to Follow-up|101
95723|NCT00800982|331848|P2|Overall Study|Patient moved out of state|0
95724|NCT00800982|331849|P1|Overall Study|Patient moved out of state|1
95725|NCT00800982|331848|P2|Overall Study|Withdrawal by Subject|1
95726|NCT00800982|331849|P1|Overall Study|Withdrawal by Subject|0
95727|NCT00800982|331848|P2|Overall Study|Lost to Follow-up|2
95728|NCT00800982|331849|P1|Overall Study|Lost to Follow-up|1
95729|NCT00800735|331875|P1|Overall Study|Withdrew Consent|3
95730|NCT00800735|331875|P1|Overall Study|Violation of Selection Criteria at Entry|7
95731|NCT00800735|331875|P1|Overall Study|Insufficient Therapeutic Response|2
95732|NCT00800735|331875|P1|Overall Study|Administrative/Other|2
95733|NCT00800683|331881|P2|Overall Study|Not specified|2
95734|NCT00800683|331882|P1|Overall Study|Not specified|1
95735|NCT00800683|331881|P2|Overall Study|Lack of Efficacy|1
95736|NCT00800683|331882|P1|Overall Study|Lack of Efficacy|1
95737|NCT00800683|331881|P2|Overall Study|Withdrawal by Subject|7
95738|NCT00800683|331882|P1|Overall Study|Withdrawal by Subject|1
95739|NCT00800683|331881|P2|Overall Study|Lost to Follow-up|1
95740|NCT00800683|331882|P1|Overall Study|Lost to Follow-up|3
95741|NCT00800683|331881|P2|Overall Study|Adverse Event|8
95742|NCT00800683|331882|P1|Overall Study|Adverse Event|11
95743|NCT00800540|331928|P2|Period 2: 6 Weeks|Adverse Event|1
95744|NCT00800540|331929|P1|Period 2: 6 Weeks|Adverse Event|0
95745|NCT00800540|331928|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
95746|NCT00800540|331929|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
95747|NCT00800540|331928|P2|Period One: 6 Weeks|Noncompliance|0
95748|NCT00800540|331929|P1|Period One: 6 Weeks|Noncompliance|1
95749|NCT00800436|331964|P7|Overall Study|Withdrawal by Subject|0
95750|NCT00800436|331965|P6|Overall Study|Withdrawal by Subject|0
95751|NCT00800436|331966|P5|Overall Study|Withdrawal by Subject|0
95752|NCT00800436|331967|P4|Overall Study|Withdrawal by Subject|1
95753|NCT00800436|331968|P3|Overall Study|Withdrawal by Subject|1
95754|NCT00800436|331969|P2|Overall Study|Withdrawal by Subject|0
95755|NCT00800436|331970|P1|Overall Study|Withdrawal by Subject|0
95756|NCT00800384|332016|P2|Overall Study|Lost to Follow-up|26
95757|NCT00800384|332017|P1|Overall Study|Lost to Follow-up|17
95758|NCT00800384|332016|P2|Overall Study|Withdrawal by Subject|17
95759|NCT00800384|332017|P1|Overall Study|Withdrawal by Subject|24
95760|NCT00800202|332050|P2|Overall Study|Disease Progression|18
95761|NCT00800202|332051|P1|Overall Study|Disease Progression|54
95762|NCT00800202|332050|P2|Overall Study|Unspecified|0
95763|NCT00800202|332051|P1|Overall Study|Unspecified|5
95764|NCT00800202|332050|P2|Overall Study|Death|0
95765|NCT00800202|332051|P1|Overall Study|Death|1
95766|NCT00800202|332050|P2|Overall Study|Adverse Event|6
95767|NCT00800202|332051|P1|Overall Study|Adverse Event|7
95768|NCT00798967|332071|P2|Overall Study|Randomized in error by site|0
95769|NCT00798967|332072|P1|Overall Study|Randomized in error by site|1
95770|NCT00798967|332071|P2|Overall Study|Physician Decision|0
95771|NCT00798967|332072|P1|Overall Study|Physician Decision|1
95772|NCT00798967|332071|P2|Overall Study|Withdrawal by Subject|1
95773|NCT00798967|332072|P1|Overall Study|Withdrawal by Subject|0
95774|NCT00798967|332071|P2|Overall Study|Adverse Event|3
95775|NCT00798967|332072|P1|Overall Study|Adverse Event|2
95776|NCT00798889|332080|P1|Overall Study|Enrolled, Not treated|3
95777|NCT00798889|332080|P1|Overall Study|Decision of Sponsor|11
95778|NCT00798889|332080|P1|Overall Study|Lack of Efficacy|213
95779|NCT00798889|332080|P1|Overall Study|Lost to Follow-up|1
95780|NCT00798889|332080|P1|Overall Study|Withdrawal by Subject|31
95781|NCT00798889|332080|P1|Overall Study|Protocol Violation|2
95782|NCT00798889|332080|P1|Overall Study|Adverse Event|53
95783|NCT00799825|332084|P1|Overall Study|Pregnancy|3
95784|NCT00799825|332084|P1|Overall Study|Lost to Follow-up|38
95785|NCT00799825|332084|P1|Overall Study|Withdrawal by Subject|6
95786|NCT00799825|332084|P1|Overall Study|Adverse Event|1
95787|NCT00799708|332124|P3|Overall Study|non-compliance|0
95788|NCT00799708|332125|P2|Overall Study|non-compliance|0
95789|NCT00799708|332126|P1|Overall Study|non-compliance|1
95790|NCT00799591|332176|P1|Overall Study|Infectious origin not probable|1
95791|NCT00799591|332176|P1|Overall Study|Antibiotic changed, no apparent reason|1
95792|NCT00799591|332176|P1|Overall Study|Persistance of fever undetermined origin|1
95793|NCT00799591|332176|P1|Overall Study|Resistance germ and technical failure|2
95794|NCT00799591|332176|P1|Overall Study|New infection|4
95795|NCT00799591|332176|P1|Overall Study|Resistant germ|11
95796|NCT00799591|332176|P1|Overall Study|Technical failure|12
95797|NCT00799591|332176|P1|Overall Study|Death|14
95798|NCT00799591|332176|P1|Overall Study|De-escalation of doses|20
95799|NCT00799487|332194|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
95800|NCT00799487|332195|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
95801|NCT00799487|332196|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
95802|NCT00799487|332194|P3|Double-Blind Assessment Period|Subject was out of the state|1
95803|NCT00799487|332195|P2|Double-Blind Assessment Period|Subject was out of the state|0
95804|NCT00799487|332196|P1|Double-Blind Assessment Period|Subject was out of the state|0
95805|NCT00799487|332194|P3|Double-Blind Assessment Period|Lost to Follow-up|1
95806|NCT00799487|332195|P2|Double-Blind Assessment Period|Lost to Follow-up|0
95807|NCT00799487|332196|P1|Double-Blind Assessment Period|Lost to Follow-up|0
95808|NCT00799487|332194|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
95809|NCT00799487|332195|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
95810|NCT00799487|332196|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
95811|NCT00799487|332194|P3|Dose Adjustment Period|Missed laboratory day 1|0
95812|NCT00799487|332195|P2|Dose Adjustment Period|Missed laboratory day 1|0
95813|NCT00799487|332196|P1|Dose Adjustment Period|Missed laboratory day 1|1
95814|NCT00799487|332194|P3|Dose Adjustment Period|Child too young (exclusion)|0
95815|NCT00799487|332195|P2|Dose Adjustment Period|Child too young (exclusion)|0
95816|NCT00799487|332196|P1|Dose Adjustment Period|Child too young (exclusion)|1
95817|NCT00799487|332194|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
95818|NCT00799487|332195|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
95819|NCT00799487|332196|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
95820|NCT00799487|332194|P3|Dose Adjustment Period|Withdrawal by Subject|0
95821|NCT00799487|332195|P2|Dose Adjustment Period|Withdrawal by Subject|0
95822|NCT00799487|332196|P1|Dose Adjustment Period|Withdrawal by Subject|3
95823|NCT00799487|332194|P3|Dose Adjustment Period|Investigator Discretion|0
95824|NCT00799487|332195|P2|Dose Adjustment Period|Investigator Discretion|0
95825|NCT00799487|332196|P1|Dose Adjustment Period|Investigator Discretion|2
95826|NCT00799487|332194|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
95827|NCT00799487|332195|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
95828|NCT00799487|332196|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
95829|NCT00799487|332194|P3|Dose Adjustment Period|Adverse Event|0
95830|NCT00799487|332195|P2|Dose Adjustment Period|Adverse Event|0
95831|NCT00799487|332196|P1|Dose Adjustment Period|Adverse Event|2
95832|NCT00799487|332194|P3|Dose Adjustment Period|Lost to Follow-up|0
95833|NCT00799487|332195|P2|Dose Adjustment Period|Lost to Follow-up|0
95834|NCT00799487|332196|P1|Dose Adjustment Period|Lost to Follow-up|1
95835|NCT00799422|332282|P6|First Week of Wear|Adverse Event|0
95836|NCT00799422|332283|P5|First Week of Wear|Adverse Event|0
95837|NCT00799422|332284|P4|First Week of Wear|Adverse Event|1
95838|NCT00799422|332285|P3|First Week of Wear|Adverse Event|0
95839|NCT00799422|332286|P2|First Week of Wear|Adverse Event|0
95840|NCT00799422|332287|P1|First Week of Wear|Adverse Event|0
95841|NCT00799422|332282|P6|First Week of Wear|Lost to Follow-up|0
95842|NCT00799422|332283|P5|First Week of Wear|Lost to Follow-up|0
95843|NCT00799422|332284|P4|First Week of Wear|Lost to Follow-up|0
95844|NCT00799422|332285|P3|First Week of Wear|Lost to Follow-up|1
95845|NCT00799422|332286|P2|First Week of Wear|Lost to Follow-up|0
95846|NCT00799422|332287|P1|First Week of Wear|Lost to Follow-up|0
95847|NCT00799409|332304|P3|Overall Study|medication compliance|0
95848|NCT00799409|332305|P2|Overall Study|medication compliance|0
95849|NCT00799409|332306|P1|Overall Study|medication compliance|1
95850|NCT00799409|332304|P3|Overall Study|Did not attend lab school day 1|0
95851|NCT00799409|332305|P2|Overall Study|Did not attend lab school day 1|0
95852|NCT00799409|332306|P1|Overall Study|Did not attend lab school day 1|1
95853|NCT00799409|332304|P3|Overall Study|Failure to follow study protocol)|0
95854|NCT00799409|332305|P2|Overall Study|Failure to follow study protocol)|0
95855|NCT00799409|332306|P1|Overall Study|Failure to follow study protocol)|1
95856|NCT00799409|332304|P3|Overall Study|Optimal Dose Not Achieved|0
95857|NCT00799409|332305|P2|Overall Study|Optimal Dose Not Achieved|0
95858|NCT00799409|332306|P1|Overall Study|Optimal Dose Not Achieved|2
95859|NCT00799409|332304|P3|Overall Study|Lost to Follow-up|0
95860|NCT00799409|332305|P2|Overall Study|Lost to Follow-up|0
95861|NCT00799409|332306|P1|Overall Study|Lost to Follow-up|1
95862|NCT00799409|332304|P3|Overall Study|Withdrawal by Subject|0
95863|NCT00799409|332305|P2|Overall Study|Withdrawal by Subject|0
95864|NCT00799409|332306|P1|Overall Study|Withdrawal by Subject|1
95865|NCT00799396|332386|P1|Clopidogrel Plus Aspirin|Physician Decision|4
95866|NCT00799396|332386|P1|Clopidogrel Plus Aspirin|Adverse Event|2
95867|NCT00799396|332386|P1|Clopidogrel Treatment|Withdrawal by Subject|2
95868|NCT00799396|332386|P1|Clopidogrel Treatment|Physician Decision|5
95869|NCT00799396|332386|P1|Clopidogrel Treatment|Adverse Event|6
95870|NCT00798759|332407|P2|Overall Study|Not specified|1
95871|NCT00798759|332408|P1|Overall Study|Not specified|0
95872|NCT00798759|332407|P2|Overall Study|Protocol Violation|8
95873|NCT00798759|332408|P1|Overall Study|Protocol Violation|4
95874|NCT00798759|332407|P2|Overall Study|Lost to Follow-up|1
95875|NCT00798759|332408|P1|Overall Study|Lost to Follow-up|1
95876|NCT00798759|332407|P2|Overall Study|Adverse Event|3
95877|NCT00798759|332408|P1|Overall Study|Adverse Event|3
95878|NCT00798707|332426|P3|Overall Study|Randomized not treated|1
95879|NCT00798707|332427|P2|Overall Study|Randomized not treated|5
95880|NCT00798707|332428|P1|Overall Study|Randomized not treated|4
95881|NCT00798707|332426|P3|Overall Study|Withdrawal by Subject|2
95882|NCT00798707|332427|P2|Overall Study|Withdrawal by Subject|8
95883|NCT00798707|332428|P1|Overall Study|Withdrawal by Subject|3
95884|NCT00798707|332426|P3|Overall Study|Protocol Violation|2
95885|NCT00798707|332427|P2|Overall Study|Protocol Violation|0
95886|NCT00798707|332428|P1|Overall Study|Protocol Violation|4
95887|NCT00798707|332426|P3|Overall Study|Unspecified|0
95888|NCT00798707|332427|P2|Overall Study|Unspecified|1
95889|NCT00798707|332428|P1|Overall Study|Unspecified|0
95890|NCT00798707|332426|P3|Overall Study|Lost to Follow-up|6
95891|NCT00798707|332427|P2|Overall Study|Lost to Follow-up|6
95892|NCT00798707|332428|P1|Overall Study|Lost to Follow-up|5
95893|NCT00798707|332426|P3|Overall Study|Lack of Efficacy|1
95894|NCT00798707|332427|P2|Overall Study|Lack of Efficacy|2
95895|NCT00798707|332428|P1|Overall Study|Lack of Efficacy|2
95896|NCT00798707|332426|P3|Overall Study|Investigator|2
95897|NCT00798707|332427|P2|Overall Study|Investigator|1
95898|NCT00798707|332428|P1|Overall Study|Investigator|0
95899|NCT00798707|332426|P3|Overall Study|Failed to return|0
95900|NCT00798707|332427|P2|Overall Study|Failed to return|2
95901|NCT00798707|332428|P1|Overall Study|Failed to return|2
95902|NCT00798707|332426|P3|Overall Study|Adverse Event|8
95903|NCT00798707|332427|P2|Overall Study|Adverse Event|8
95904|NCT00798707|332428|P1|Overall Study|Adverse Event|6
95905|NCT00798655|332478|P1|Overall Study|Did not receive at least one dose of pan|2
95906|NCT00798603|332483|P1|Overall Study|Lack of insurance coverage|1
95907|NCT00798603|332483|P1|Overall Study|Physician Decision|1
95908|NCT00798603|332483|P1|Overall Study|Adverse Event|22
95909|NCT00798603|332483|P1|Overall Study|Withdrawal by Subject|10
95910|NCT00798603|332483|P1|Overall Study|Still on treatment as of 11/6/2012|1
95911|NCT00798434|332529|P2|Open-Label|Not Treated|1
95912|NCT00798434|332530|P1|Open-Label|Not Treated|0
95913|NCT00798434|332529|P2|Open-Label|Not Specified|2
95914|NCT00798434|332530|P1|Open-Label|Not Specified|1
95915|NCT00798434|332529|P2|Open-Label|Protocol Violation|0
95916|NCT00798434|332530|P1|Open-Label|Protocol Violation|1
95917|NCT00798434|332529|P2|Open-Label|Withdrawal by Subject|7
95918|NCT00798434|332530|P1|Open-Label|Withdrawal by Subject|2
95919|NCT00798434|332529|P2|Open-Label|Lack of Efficacy|11
95920|NCT00798434|332530|P1|Open-Label|Lack of Efficacy|5
95921|NCT00798434|332529|P2|Open-Label|Adverse Event|11
95922|NCT00798434|332530|P1|Open-Label|Adverse Event|33
95923|NCT00798434|332529|P2|Double-Blind|Not Treated|6
95924|NCT00798434|332530|P1|Double-Blind|Not Treated|3
95925|NCT00798434|332529|P2|Double-Blind|Not Specified|0
95926|NCT00798434|332530|P1|Double-Blind|Not Specified|1
95927|NCT00798434|332529|P2|Double-Blind|Did Not Meet Entrance Criteria|1
95928|NCT00798434|332530|P1|Double-Blind|Did Not Meet Entrance Criteria|2
95929|NCT00798434|332529|P2|Double-Blind|Protocol Violation|4
95930|NCT00798434|332530|P1|Double-Blind|Protocol Violation|1
95931|NCT00798434|332529|P2|Double-Blind|Withdrawal by Subject|14
95932|NCT00798434|332530|P1|Double-Blind|Withdrawal by Subject|17
95933|NCT00798434|332529|P2|Double-Blind|Lack of Efficacy|12
95934|NCT00798434|332530|P1|Double-Blind|Lack of Efficacy|8
95935|NCT00798434|332529|P2|Double-Blind|Lost to Follow-up|0
95936|NCT00798434|332530|P1|Double-Blind|Lost to Follow-up|1
95937|NCT00798434|332529|P2|Double-Blind|Death|1
95938|NCT00798434|332530|P1|Double-Blind|Death|0
95939|NCT00798434|332529|P2|Double-Blind|Adverse Event|46
95940|NCT00798434|332530|P1|Double-Blind|Adverse Event|22
95941|NCT00798369|332616|P6|Overall Study|Adminstrative problems|1
95942|NCT00798369|332617|P5|Overall Study|Adminstrative problems|0
95943|NCT00798369|332618|P4|Overall Study|Adminstrative problems|0
95944|NCT00798369|332619|P3|Overall Study|Adminstrative problems|0
95945|NCT00798369|332620|P2|Overall Study|Adminstrative problems|0
95946|NCT00798369|332621|P1|Overall Study|Adminstrative problems|0
95947|NCT00798369|332616|P6|Overall Study|Lost to Follow-up|0
95948|NCT00798369|332617|P5|Overall Study|Lost to Follow-up|1
95949|NCT00798369|332618|P4|Overall Study|Lost to Follow-up|0
95950|NCT00798369|332619|P3|Overall Study|Lost to Follow-up|1
95951|NCT00798369|332620|P2|Overall Study|Lost to Follow-up|1
95952|NCT00798369|332621|P1|Overall Study|Lost to Follow-up|1
95953|NCT00798369|332616|P6|Overall Study|Subject withdrew consent|2
95954|NCT00798369|332617|P5|Overall Study|Subject withdrew consent|0
95955|NCT00798369|332618|P4|Overall Study|Subject withdrew consent|1
95956|NCT00798369|332619|P3|Overall Study|Subject withdrew consent|1
95957|NCT00798369|332620|P2|Overall Study|Subject withdrew consent|0
95958|NCT00798369|332621|P1|Overall Study|Subject withdrew consent|0
95959|NCT00798317|332668|P2|Overall Study|Death|0
95960|NCT00798317|332669|P1|Overall Study|Death|1
95961|NCT00798317|332668|P2|Overall Study|Adverse Event|0
95962|NCT00798317|332669|P1|Overall Study|Adverse Event|2
95963|NCT00798317|332668|P2|Overall Study|Lost to Follow-up|2
95964|NCT00798317|332669|P1|Overall Study|Lost to Follow-up|2
95965|NCT00798317|332668|P2|Overall Study|Withdrawal by Subject|4
95966|NCT00798317|332669|P1|Overall Study|Withdrawal by Subject|5
95967|NCT00798317|332668|P2|Overall Study|Physician Decision|1
95968|NCT00798317|332669|P1|Overall Study|Physician Decision|0
95969|NCT00798304|332680|P3|Overall Study|Discontinuation by Sponsor|9
95970|NCT00798304|332681|P2|Overall Study|Discontinuation by Sponsor|21
95971|NCT00798304|332682|P1|Overall Study|Discontinuation by Sponsor|14
95972|NCT00798304|332680|P3|Overall Study|Adverse Event|1
95973|NCT00798304|332681|P2|Overall Study|Adverse Event|1
95974|NCT00798304|332682|P1|Overall Study|Adverse Event|0
95975|NCT00798161|332715|P7|Overall Study|Other reason (incl. lack of efficacy)|5
95976|NCT00798161|332716|P6|Overall Study|Other reason (incl. lack of efficacy)|4
95977|NCT00798161|332717|P5|Overall Study|Other reason (incl. lack of efficacy)|2
95978|NCT00798161|332718|P4|Overall Study|Other reason (incl. lack of efficacy)|5
95979|NCT00798161|332719|P3|Overall Study|Other reason (incl. lack of efficacy)|3
95980|NCT00798161|332720|P2|Overall Study|Other reason (incl. lack of efficacy)|5
95981|NCT00798161|332721|P1|Overall Study|Other reason (incl. lack of efficacy)|7
95982|NCT00798161|332715|P7|Overall Study|Withdrawal by Subject|1
95983|NCT00798161|332716|P6|Overall Study|Withdrawal by Subject|3
95984|NCT00798161|332717|P5|Overall Study|Withdrawal by Subject|2
95985|NCT00798161|332718|P4|Overall Study|Withdrawal by Subject|4
95986|NCT00798161|332719|P3|Overall Study|Withdrawal by Subject|5
95987|NCT00798161|332720|P2|Overall Study|Withdrawal by Subject|4
95988|NCT00798161|332721|P1|Overall Study|Withdrawal by Subject|5
95989|NCT00798161|332715|P7|Overall Study|Lost to Follow-up|0
95990|NCT00798161|332716|P6|Overall Study|Lost to Follow-up|0
95991|NCT00798161|332717|P5|Overall Study|Lost to Follow-up|4
95992|NCT00798161|332718|P4|Overall Study|Lost to Follow-up|3
95993|NCT00798161|332719|P3|Overall Study|Lost to Follow-up|4
95994|NCT00798161|332720|P2|Overall Study|Lost to Follow-up|3
95995|NCT00798161|332721|P1|Overall Study|Lost to Follow-up|1
95996|NCT00798161|332715|P7|Overall Study|Protocol Violation|0
95997|NCT00798161|332716|P6|Overall Study|Protocol Violation|2
95998|NCT00798161|332717|P5|Overall Study|Protocol Violation|3
95999|NCT00798161|332718|P4|Overall Study|Protocol Violation|3
96000|NCT00798161|332719|P3|Overall Study|Protocol Violation|3
96001|NCT00798161|332720|P2|Overall Study|Protocol Violation|1
96002|NCT00798161|332721|P1|Overall Study|Protocol Violation|2
96003|NCT00798161|332715|P7|Overall Study|Adverse Event|4
96004|NCT00798161|332716|P6|Overall Study|Adverse Event|2
96005|NCT00798161|332717|P5|Overall Study|Adverse Event|5
96006|NCT00798161|332718|P4|Overall Study|Adverse Event|6
96007|NCT00798161|332719|P3|Overall Study|Adverse Event|6
96008|NCT00798161|332720|P2|Overall Study|Adverse Event|4
96009|NCT00798161|332721|P1|Overall Study|Adverse Event|3
96010|NCT00798135|332828|P1|Overall Study|Physician Decision|1
96011|NCT00798135|332828|P1|Overall Study|Disease progression, refractory|1
96012|NCT00798135|332828|P1|Overall Study|Disease progression, relapse|11
96013|NCT00798096|332834|P1|Overall Study|Ongoing|2
96014|NCT00797966|332862|P6|Phase A+|Protocol deviation|4
96015|NCT00797966|332863|P5|Phase A+|Protocol deviation|0
96016|NCT00797966|332864|P4|Phase A+|Protocol deviation|0
96017|NCT00797966|332865|P3|Phase A+|Protocol deviation|0
96018|NCT00797966|332866|P2|Phase A+|Protocol deviation|0
96019|NCT00797966|332867|P1|Phase A+|Protocol deviation|0
96020|NCT00797966|332862|P6|Phase A+|Adverse Event|4
96021|NCT00797966|332863|P5|Phase A+|Adverse Event|0
96022|NCT00797966|332864|P4|Phase A+|Adverse Event|0
96023|NCT00797966|332865|P3|Phase A+|Adverse Event|0
96024|NCT00797966|332866|P2|Phase A+|Adverse Event|0
96025|NCT00797966|332867|P1|Phase A+|Adverse Event|0
96026|NCT00797966|332862|P6|Phase A+|Withdrawal by Subject|6
96027|NCT00797966|332863|P5|Phase A+|Withdrawal by Subject|0
96028|NCT00797966|332864|P4|Phase A+|Withdrawal by Subject|0
96029|NCT00797966|332865|P3|Phase A+|Withdrawal by Subject|0
96030|NCT00797966|332866|P2|Phase A+|Withdrawal by Subject|0
96031|NCT00797966|332867|P1|Phase A+|Withdrawal by Subject|0
96032|NCT00797966|332862|P6|Phase A+|Met withdrawal criteria|5
96033|NCT00797966|332863|P5|Phase A+|Met withdrawal criteria|0
96034|NCT00797966|332864|P4|Phase A+|Met withdrawal criteria|0
96035|NCT00797966|332865|P3|Phase A+|Met withdrawal criteria|0
96036|NCT00797966|332866|P2|Phase A+|Met withdrawal criteria|0
96037|NCT00797966|332867|P1|Phase A+|Met withdrawal criteria|0
96038|NCT00797966|332862|P6|Phase A+|Lost to Follow-up|9
96039|NCT00797966|332863|P5|Phase A+|Lost to Follow-up|0
96040|NCT00797966|332864|P4|Phase A+|Lost to Follow-up|0
96041|NCT00797966|332865|P3|Phase A+|Lost to Follow-up|0
96042|NCT00797966|332866|P2|Phase A+|Lost to Follow-up|0
96043|NCT00797966|332867|P1|Phase A+|Lost to Follow-up|0
96044|NCT00797966|332862|P6|Phase B|Lack of Efficacy|0
96045|NCT00797966|332863|P5|Phase B|Lack of Efficacy|0
96046|NCT00797966|332864|P4|Phase B|Lack of Efficacy|4
96047|NCT00797966|332865|P3|Phase B|Lack of Efficacy|1
96048|NCT00797966|332866|P2|Phase B|Lack of Efficacy|1
96049|NCT00797966|332867|P1|Phase B|Lack of Efficacy|0
96050|NCT00797966|332862|P6|Phase B|Protocol Deviation|0
96051|NCT00797966|332863|P5|Phase B|Protocol Deviation|0
96052|NCT00797966|332864|P4|Phase B|Protocol Deviation|6
96053|NCT00797966|332865|P3|Phase B|Protocol Deviation|2
96054|NCT00797966|332866|P2|Phase B|Protocol Deviation|8
96055|NCT00797966|332867|P1|Phase B|Protocol Deviation|4
96056|NCT00797966|332862|P6|Phase B|Withdrawal by Subject|0
96057|NCT00797966|332863|P5|Phase B|Withdrawal by Subject|0
96058|NCT00797966|332864|P4|Phase B|Withdrawal by Subject|3
96059|NCT00797966|332865|P3|Phase B|Withdrawal by Subject|3
96060|NCT00797966|332866|P2|Phase B|Withdrawal by Subject|4
96061|NCT00797966|332867|P1|Phase B|Withdrawal by Subject|1
96062|NCT00797966|332862|P6|Phase B|Physician Decision|0
96063|NCT00797966|332863|P5|Phase B|Physician Decision|0
96064|NCT00797966|332864|P4|Phase B|Physician Decision|1
96065|NCT00797966|332865|P3|Phase B|Physician Decision|3
96066|NCT00797966|332866|P2|Phase B|Physician Decision|0
96067|NCT00797966|332867|P1|Phase B|Physician Decision|1
96068|NCT00797966|332862|P6|Phase B|Met Withdrawal Criteria|0
96069|NCT00797966|332863|P5|Phase B|Met Withdrawal Criteria|0
96070|NCT00797966|332864|P4|Phase B|Met Withdrawal Criteria|1
96071|NCT00797966|332865|P3|Phase B|Met Withdrawal Criteria|6
96072|NCT00797966|332866|P2|Phase B|Met Withdrawal Criteria|3
96073|NCT00797966|332867|P1|Phase B|Met Withdrawal Criteria|3
96074|NCT00797966|332862|P6|Phase B|Adverse Event|0
96075|NCT00797966|332863|P5|Phase B|Adverse Event|0
96076|NCT00797966|332864|P4|Phase B|Adverse Event|1
96077|NCT00797966|332865|P3|Phase B|Adverse Event|3
96078|NCT00797966|332866|P2|Phase B|Adverse Event|1
96079|NCT00797966|332867|P1|Phase B|Adverse Event|2
96080|NCT00797966|332862|P6|Phase B|Lost to Follow-up|0
96081|NCT00797966|332863|P5|Phase B|Lost to Follow-up|0
96082|NCT00797966|332864|P4|Phase B|Lost to Follow-up|0
96083|NCT00797966|332865|P3|Phase B|Lost to Follow-up|3
96084|NCT00797966|332866|P2|Phase B|Lost to Follow-up|1
96085|NCT00797966|332867|P1|Phase B|Lost to Follow-up|0
96086|NCT00797966|332862|P6|Phase A|Protocol deviation|0
96087|NCT00797966|332863|P5|Phase A|Protocol deviation|56
96088|NCT00797966|332864|P4|Phase A|Protocol deviation|0
96089|NCT00797966|332865|P3|Phase A|Protocol deviation|0
96090|NCT00797966|332866|P2|Phase A|Protocol deviation|0
96091|NCT00797966|332867|P1|Phase A|Protocol deviation|0
96092|NCT00797966|332862|P6|Phase A|Withdrawal by Subject|0
96093|NCT00797966|332863|P5|Phase A|Withdrawal by Subject|33
96094|NCT00797966|332864|P4|Phase A|Withdrawal by Subject|0
96095|NCT00797966|332865|P3|Phase A|Withdrawal by Subject|0
96096|NCT00797966|332866|P2|Phase A|Withdrawal by Subject|0
96097|NCT00797966|332867|P1|Phase A|Withdrawal by Subject|0
96098|NCT00797966|332862|P6|Phase A|Physician Decision|0
96099|NCT00797966|332863|P5|Phase A|Physician Decision|13
96100|NCT00797966|332864|P4|Phase A|Physician Decision|0
96101|NCT00797966|332865|P3|Phase A|Physician Decision|0
96102|NCT00797966|332866|P2|Phase A|Physician Decision|0
96103|NCT00797966|332867|P1|Phase A|Physician Decision|0
96104|NCT00797966|332862|P6|Phase A|Met withdrawal criteria|0
96105|NCT00797966|332863|P5|Phase A|Met withdrawal criteria|4
96106|NCT00797966|332864|P4|Phase A|Met withdrawal criteria|0
96107|NCT00797966|332865|P3|Phase A|Met withdrawal criteria|0
96108|NCT00797966|332866|P2|Phase A|Met withdrawal criteria|0
96109|NCT00797966|332867|P1|Phase A|Met withdrawal criteria|0
96110|NCT00797966|332862|P6|Phase A|Adverse Event|0
96111|NCT00797966|332863|P5|Phase A|Adverse Event|46
96112|NCT00797966|332864|P4|Phase A|Adverse Event|0
96113|NCT00797966|332865|P3|Phase A|Adverse Event|0
96114|NCT00797966|332866|P2|Phase A|Adverse Event|0
96115|NCT00797966|332867|P1|Phase A|Adverse Event|0
96116|NCT00797966|332862|P6|Phase A|Lost to Follow-up|0
96117|NCT00797966|332863|P5|Phase A|Lost to Follow-up|33
96118|NCT00797966|332864|P4|Phase A|Lost to Follow-up|0
96119|NCT00797966|332865|P3|Phase A|Lost to Follow-up|0
96120|NCT00797966|332866|P2|Phase A|Lost to Follow-up|0
96121|NCT00797966|332867|P1|Phase A|Lost to Follow-up|0
96122|NCT00797862|332932|P3|Overall Study|Mis-randomized|1
96123|NCT00797862|332933|P2|Overall Study|Mis-randomized|3
96124|NCT00797862|332934|P1|Overall Study|Mis-randomized|3
96125|NCT00797862|332932|P3|Overall Study|Protocol Violation|8
96126|NCT00797862|332933|P2|Overall Study|Protocol Violation|6
96127|NCT00797862|332934|P1|Overall Study|Protocol Violation|4
96128|NCT00797862|332932|P3|Overall Study|Administrative Problem|0
96129|NCT00797862|332933|P2|Overall Study|Administrative Problem|0
96130|NCT00797862|332934|P1|Overall Study|Administrative Problem|4
96131|NCT00797862|332932|P3|Overall Study|Lost to Follow-up|5
96132|NCT00797862|332933|P2|Overall Study|Lost to Follow-up|0
96133|NCT00797862|332934|P1|Overall Study|Lost to Follow-up|11
96134|NCT00797862|332932|P3|Overall Study|Withdrawal by Subject|7
96135|NCT00797862|332933|P2|Overall Study|Withdrawal by Subject|7
96136|NCT00797862|332934|P1|Overall Study|Withdrawal by Subject|14
96137|NCT00797862|332932|P3|Overall Study|No longer required study medication|0
96138|NCT00797862|332933|P2|Overall Study|No longer required study medication|0
96139|NCT00797862|332934|P1|Overall Study|No longer required study medication|1
96140|NCT00797862|332932|P3|Overall Study|Lack of Efficacy|6
96141|NCT00797862|332933|P2|Overall Study|Lack of Efficacy|7
96142|NCT00797862|332934|P1|Overall Study|Lack of Efficacy|1
96143|NCT00797862|332932|P3|Overall Study|Abnormal Test Procedure Result|1
96144|NCT00797862|332933|P2|Overall Study|Abnormal Test Procedure Result|1
96145|NCT00797862|332934|P1|Overall Study|Abnormal Test Procedure Result|0
96146|NCT00797862|332932|P3|Overall Study|Adverse Event|58
96147|NCT00797862|332933|P2|Overall Study|Adverse Event|44
96148|NCT00797862|332934|P1|Overall Study|Adverse Event|86
96149|NCT00797823|332963|P3|First Period (Initial Randomization)|Physician Decision|0
96150|NCT00797823|332964|P2|First Period (Initial Randomization)|Physician Decision|0
96151|NCT00797823|332965|P1|First Period (Initial Randomization)|Physician Decision|1
96152|NCT00797667|332988|P3|Overall Study|Adverse Event|8
96153|NCT00797667|332989|P2|Overall Study|Adverse Event|8
96154|NCT00797667|332990|P1|Overall Study|Adverse Event|19
96155|NCT00797667|332988|P3|Overall Study|Withdrawal by Subject|2
96156|NCT00797667|332989|P2|Overall Study|Withdrawal by Subject|14
96157|NCT00797667|332990|P1|Overall Study|Withdrawal by Subject|9
96158|NCT00797667|332988|P3|Overall Study|Study Terminated by Sponsor|115
96159|NCT00797667|332989|P2|Overall Study|Study Terminated by Sponsor|216
96160|NCT00797667|332990|P1|Overall Study|Study Terminated by Sponsor|217
96161|NCT00797667|332988|P3|Overall Study|Protocol Violation|0
96162|NCT00797667|332989|P2|Overall Study|Protocol Violation|7
96163|NCT00797667|332990|P1|Overall Study|Protocol Violation|2
96164|NCT00797667|332988|P3|Overall Study|Pregnancy|0
96165|NCT00797667|332989|P2|Overall Study|Pregnancy|0
96166|NCT00797667|332990|P1|Overall Study|Pregnancy|2
96167|NCT00797667|332988|P3|Overall Study|Physician Decision|0
96168|NCT00797667|332989|P2|Overall Study|Physician Decision|1
96169|NCT00797667|332990|P1|Overall Study|Physician Decision|3
96170|NCT00797667|332988|P3|Overall Study|Lost to Follow-up|2
96171|NCT00797667|332989|P2|Overall Study|Lost to Follow-up|12
96172|NCT00797667|332990|P1|Overall Study|Lost to Follow-up|8
96173|NCT00797667|332988|P3|Overall Study|Lack of Efficacy|0
96174|NCT00797667|332989|P2|Overall Study|Lack of Efficacy|1
96175|NCT00797667|332990|P1|Overall Study|Lack of Efficacy|0
96176|NCT00797563|333016|P1|Overall Study|Adverse Event|1
96177|NCT00797511|333022|P1|Overall Study|Withdrawal by Subject|1
96178|NCT00797316|333040|P2|Overall Study|Unsatisfactory therapeutic effect|13
96179|NCT00797316|333041|P1|Overall Study|Unsatisfactory therapeutic effect|0
96180|NCT00797316|333040|P2|Overall Study|Patient withdrew consent|6
96181|NCT00797316|333041|P1|Overall Study|Patient withdrew consent|12
96182|NCT00797316|333040|P2|Overall Study|Protocol Deviation|2
96183|NCT00797316|333041|P1|Overall Study|Protocol Deviation|1
96184|NCT00797316|333040|P2|Overall Study|Lost to Follow-up|8
96185|NCT00797316|333041|P1|Overall Study|Lost to Follow-up|4
96186|NCT00797316|333040|P2|Overall Study|Adverse Event|3
96187|NCT00797316|333041|P1|Overall Study|Adverse Event|5
96188|NCT00797316|333040|P2|Overall Study|Administrative problems|0
96189|NCT00797316|333041|P1|Overall Study|Administrative problems|1
96190|NCT00797108|333075|P3|Overall Study|Randomized but not Treated|0
96191|NCT00797108|333076|P2|Overall Study|Randomized but not Treated|0
96192|NCT00797108|333077|P1|Overall Study|Randomized but not Treated|2
96193|NCT00797108|333075|P3|Overall Study|Unspecified|2
96194|NCT00797108|333076|P2|Overall Study|Unspecified|0
96195|NCT00797108|333077|P1|Overall Study|Unspecified|0
96196|NCT00797108|333075|P3|Overall Study|Lack of Efficacy|1
96197|NCT00797108|333076|P2|Overall Study|Lack of Efficacy|0
96198|NCT00797108|333077|P1|Overall Study|Lack of Efficacy|1
96199|NCT00797108|333075|P3|Overall Study|Global Deterioration of Health Status|0
96200|NCT00797108|333076|P2|Overall Study|Global Deterioration of Health Status|1
96201|NCT00797108|333077|P1|Overall Study|Global Deterioration of Health Status|0
96202|NCT00797108|333075|P3|Overall Study|Did Not Meet Entrance Criteria|0
96203|NCT00797108|333076|P2|Overall Study|Did Not Meet Entrance Criteria|1
96204|NCT00797108|333077|P1|Overall Study|Did Not Meet Entrance Criteria|0
96205|NCT00797108|333075|P3|Overall Study|Adverse Event|3
96206|NCT00797108|333076|P2|Overall Study|Adverse Event|0
96207|NCT00797108|333077|P1|Overall Study|Adverse Event|1
96208|NCT00796991|333112|P3|Overall Study|Withdrawal by Subject|1
96209|NCT00796991|333113|P2|Overall Study|Withdrawal by Subject|0
96210|NCT00796991|333114|P1|Overall Study|Withdrawal by Subject|0
96211|NCT00796991|333112|P3|Overall Study|Study Drug Toxicity|5
96212|NCT00796991|333113|P2|Overall Study|Study Drug Toxicity|3
96213|NCT00796991|333114|P1|Overall Study|Study Drug Toxicity|3
96214|NCT00796991|333112|P3|Overall Study|Disease Progression|7
96215|NCT00796991|333113|P2|Overall Study|Disease Progression|9
96216|NCT00796991|333114|P1|Overall Study|Disease Progression|10
96217|NCT00796991|333112|P3|Overall Study|Death|0
96218|NCT00796991|333113|P2|Overall Study|Death|0
96219|NCT00796991|333114|P1|Overall Study|Death|2
96220|NCT00796991|333112|P3|Overall Study|Adverse Event|1
96221|NCT00796991|333113|P2|Overall Study|Adverse Event|0
96222|NCT00796991|333114|P1|Overall Study|Adverse Event|0
96223|NCT00796822|333223|P2|Overall Study|Adverse Event|0
96224|NCT00796822|333224|P1|Overall Study|Adverse Event|1
96225|NCT00796822|333223|P2|Overall Study|Lost to Follow-up|0
96226|NCT00796822|333224|P1|Overall Study|Lost to Follow-up|2
96227|NCT00796757|333230|P1|Overall Study|Not specified|7
96228|NCT00796757|333230|P1|Overall Study|Investigator's decision|2
96229|NCT00796757|333230|P1|Overall Study|Participant noncompliance|1
96230|NCT00796757|333230|P1|Overall Study|Protocol Violation|1
96231|NCT00796757|333230|P1|Overall Study|Death|61
96232|NCT00796757|333230|P1|Overall Study|Withdrawal by Subject|14
96233|NCT00796718|333264|P1|Overall Study|Withdrawal by Informed Consent|1
96234|NCT00796718|333264|P1|Overall Study|Lost to Follow-up|5
96235|NCT00796718|333264|P1|Overall Study|Exclusion Criteria|1
96236|NCT00796718|333264|P1|Overall Study|Adverse Event|2
96237|NCT00796666|333316|P2|Overall Study|Randomized and not treated|0
96238|NCT00796666|333317|P1|Overall Study|Randomized and not treated|1
96239|NCT00796666|333316|P2|Overall Study|Terminated by sponsor|55
96240|NCT00796666|333317|P1|Overall Study|Terminated by sponsor|53
96241|NCT00796666|333316|P2|Overall Study|Unspecified|0
96242|NCT00796666|333317|P1|Overall Study|Unspecified|1
96243|NCT00796666|333316|P2|Overall Study|Protocol Violation|0
96244|NCT00796666|333317|P1|Overall Study|Protocol Violation|1
96245|NCT00796666|333316|P2|Overall Study|Adverse Event|5
96246|NCT00796666|333317|P1|Overall Study|Adverse Event|7
96247|NCT00796666|333316|P2|Overall Study|Withdrawal by Subject|0
96248|NCT00796666|333317|P1|Overall Study|Withdrawal by Subject|2
96249|NCT00796666|333316|P2|Overall Study|Death|4
96250|NCT00796666|333317|P1|Overall Study|Death|2
96251|NCT00796653|333351|P4|Overall Study|Other reason not described above|4
96252|NCT00796653|333352|P3|Overall Study|Other reason not described above|7
96253|NCT00796653|333353|P2|Overall Study|Other reason not described above|9
96254|NCT00796653|333354|P1|Overall Study|Other reason not described above|4
96255|NCT00796653|333351|P4|Overall Study|Non compliance with protocol|2
96256|NCT00796653|333352|P3|Overall Study|Non compliance with protocol|0
96257|NCT00796653|333353|P2|Overall Study|Non compliance with protocol|2
96258|NCT00796653|333354|P1|Overall Study|Non compliance with protocol|2
96259|NCT00796653|333351|P4|Overall Study|Lack of Efficacy|2
96260|NCT00796653|333352|P3|Overall Study|Lack of Efficacy|3
96261|NCT00796653|333353|P2|Overall Study|Lack of Efficacy|1
96262|NCT00796653|333354|P1|Overall Study|Lack of Efficacy|8
96263|NCT00796653|333351|P4|Overall Study|Withdrawal by Subject|13
96264|NCT00796653|333352|P3|Overall Study|Withdrawal by Subject|8
96265|NCT00796653|333353|P2|Overall Study|Withdrawal by Subject|8
96266|NCT00796653|333354|P1|Overall Study|Withdrawal by Subject|16
96267|NCT00796653|333351|P4|Overall Study|Lost to Follow-up|3
96268|NCT00796653|333352|P3|Overall Study|Lost to Follow-up|2
96269|NCT00796653|333353|P2|Overall Study|Lost to Follow-up|1
96270|NCT00796653|333354|P1|Overall Study|Lost to Follow-up|2
96271|NCT00796653|333351|P4|Overall Study|Adverse Event|16
96272|NCT00796653|333352|P3|Overall Study|Adverse Event|16
96273|NCT00796653|333353|P2|Overall Study|Adverse Event|16
96274|NCT00796653|333354|P1|Overall Study|Adverse Event|19
96275|NCT00796614|333624|P4|Overall Study|Other than stated|0
96276|NCT00796614|333625|P3|Overall Study|Other than stated|0
96277|NCT00796614|333626|P2|Overall Study|Other than stated|0
96278|NCT00796614|333627|P1|Overall Study|Other than stated|1
96279|NCT00796614|333624|P4|Overall Study|Withdrawal by Subject|1
96280|NCT00796614|333625|P3|Overall Study|Withdrawal by Subject|0
96281|NCT00796614|333626|P2|Overall Study|Withdrawal by Subject|0
96282|NCT00796614|333627|P1|Overall Study|Withdrawal by Subject|1
96283|NCT00796614|333624|P4|Overall Study|Lost to Follow-up|0
96284|NCT00796614|333625|P3|Overall Study|Lost to Follow-up|1
96285|NCT00796614|333626|P2|Overall Study|Lost to Follow-up|2
96286|NCT00796614|333627|P1|Overall Study|Lost to Follow-up|2
96287|NCT00796614|333624|P4|Overall Study|Protocol Violation|0
96288|NCT00796614|333625|P3|Overall Study|Protocol Violation|2
96289|NCT00796614|333626|P2|Overall Study|Protocol Violation|0
96290|NCT00796614|333627|P1|Overall Study|Protocol Violation|0
96291|NCT00796614|333624|P4|Overall Study|Adverse Event|0
96292|NCT00796614|333625|P3|Overall Study|Adverse Event|0
96293|NCT00796614|333626|P2|Overall Study|Adverse Event|2
96294|NCT00796614|333627|P1|Overall Study|Adverse Event|1
96295|NCT00796549|333669|P1|Overall Study|Progressive disease|56
96296|NCT00796549|333669|P1|Overall Study|Other|2
96297|NCT00796549|333669|P1|Overall Study|not entered|149
96298|NCT00796549|333669|P1|Overall Study|Adverse Event|11
96299|NCT00796523|333686|P2|Overall Study|Lost to Follow-up|7
96300|NCT00796523|333687|P1|Overall Study|Lost to Follow-up|9
96301|NCT00796510|333697|P2|Overall Study|Study Terminated|0
96302|NCT00796510|333698|P1|Overall Study|Study Terminated|2
96303|NCT00796510|333697|P2|Overall Study|Death|0
96304|NCT00796510|333698|P1|Overall Study|Death|1
96305|NCT00796367|333711|P3|Overall Study|other|3
96306|NCT00796367|333712|P2|Overall Study|other|4
96307|NCT00796367|333713|P1|Overall Study|other|2
96308|NCT00796367|333711|P3|Overall Study|Requirement for restricted medication|2
96309|NCT00796367|333712|P2|Overall Study|Requirement for restricted medication|0
96310|NCT00796367|333713|P1|Overall Study|Requirement for restricted medication|2
96311|NCT00796367|333711|P3|Overall Study|Pregnancy|1
96312|NCT00796367|333712|P2|Overall Study|Pregnancy|0
96313|NCT00796367|333713|P1|Overall Study|Pregnancy|1
96314|NCT00796367|333711|P3|Overall Study|non compliance|1
96315|NCT00796367|333712|P2|Overall Study|non compliance|1
96316|NCT00796367|333713|P1|Overall Study|non compliance|3
96317|NCT00796367|333711|P3|Overall Study|Lack of Efficacy|0
96318|NCT00796367|333712|P2|Overall Study|Lack of Efficacy|1
96319|NCT00796367|333713|P1|Overall Study|Lack of Efficacy|2
96320|NCT00796367|333711|P3|Overall Study|Withdrawal by Subject|12
96321|NCT00796367|333712|P2|Overall Study|Withdrawal by Subject|11
96322|NCT00796367|333713|P1|Overall Study|Withdrawal by Subject|9
96323|NCT00796367|333711|P3|Overall Study|Lost to Follow-up|21
96324|NCT00796367|333712|P2|Overall Study|Lost to Follow-up|4
96325|NCT00796367|333713|P1|Overall Study|Lost to Follow-up|5
96326|NCT00796367|333711|P3|Overall Study|Adverse Event|7
96327|NCT00796367|333712|P2|Overall Study|Adverse Event|4
96328|NCT00796367|333713|P1|Overall Study|Adverse Event|6
96329|NCT00796328|333724|P1|Overall Study|experienced hypotension requiring tx|6
96330|NCT00796315|333728|P3|Overall Study|Protocol Violation|0
96331|NCT00796315|333729|P2|Overall Study|Protocol Violation|1
96332|NCT00796315|333730|P1|Overall Study|Protocol Violation|0
96333|NCT00796224|333758|P2|Overall Study|Protocol Violation|1
96334|NCT00796224|333759|P1|Overall Study|Protocol Violation|0
96335|NCT00796224|333758|P2|Overall Study|Adverse Event|0
96336|NCT00796224|333759|P1|Overall Study|Adverse Event|1
96337|NCT00796120|333779|P2|Overall Study|Randomized but not treated|3
96338|NCT00796120|333780|P1|Overall Study|Randomized but not treated|0
96339|NCT00796120|333779|P2|Overall Study|Physician Decision|17
96340|NCT00796120|333780|P1|Overall Study|Physician Decision|16
96341|NCT00796120|333779|P2|Overall Study|unspecified|17
96342|NCT00796120|333780|P1|Overall Study|unspecified|6
96343|NCT00796120|333779|P2|Overall Study|Participant refusal|4
96344|NCT00796120|333780|P1|Overall Study|Participant refusal|3
96345|NCT00796120|333779|P2|Overall Study|Progressive disease|13
96346|NCT00796120|333780|P1|Overall Study|Progressive disease|22
96347|NCT00796120|333779|P2|Overall Study|Adverse Event|6
96348|NCT00796120|333780|P1|Overall Study|Adverse Event|11
96349|NCT00796120|333779|P2|Overall Study|Death|0
96350|NCT00796120|333780|P1|Overall Study|Death|3
96351|NCT00796003|333796|P2|Overall Study|Participants Not treated|2
96352|NCT00796003|333797|P1|Overall Study|Participants Not treated|0
96353|NCT00796003|333796|P2|Overall Study|Unspecified|1
96354|NCT00796003|333797|P1|Overall Study|Unspecified|0
96355|NCT00796003|333796|P2|Overall Study|Withdrawal by Subject|1
96356|NCT00796003|333797|P1|Overall Study|Withdrawal by Subject|0
96357|NCT00796003|333796|P2|Overall Study|Physician Decision|4
96358|NCT00796003|333797|P1|Overall Study|Physician Decision|0
96359|NCT00796003|333796|P2|Overall Study|Specified organ function not met|1
96360|NCT00796003|333797|P1|Overall Study|Specified organ function not met|0
96361|NCT00796003|333796|P2|Overall Study|Adverse Event|7
96362|NCT00796003|333797|P1|Overall Study|Adverse Event|1
96363|NCT00796003|333796|P2|Overall Study|Disease Progression|13
96364|NCT00796003|333797|P1|Overall Study|Disease Progression|2
96365|NCT00795951|333818|P1|Overall Study|Withdrawal by Subject|1
96366|NCT00795951|333818|P1|Overall Study|Lost to Follow-up|1
96367|NCT00795886|333855|P1|Overall Study|Death|10
96368|NCT00795717|333863|P2|Phase II|too busy|1
96369|NCT00795717|333864|P1|Phase II|too busy|0
96370|NCT00795717|333863|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
96371|NCT00795717|333864|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
96372|NCT00795717|333863|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
96373|NCT00795717|333864|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
96374|NCT00795717|333863|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
96375|NCT00795717|333864|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
96376|NCT00795704|333876|P2|Overall Study|Adverse Event|1
96377|NCT00795704|333877|P1|Overall Study|Adverse Event|1
96378|NCT00795704|333876|P2|Overall Study|Withdrawal by Subject|2
96379|NCT00795704|333877|P1|Overall Study|Withdrawal by Subject|3
96380|NCT00795639|333889|P2|Overall Study|Randomized and not treated|1
96381|NCT00795639|333890|P1|Overall Study|Randomized and not treated|0
96382|NCT00795639|333889|P2|Overall Study|Terminated by sponsor|12
96383|NCT00795639|333890|P1|Overall Study|Terminated by sponsor|13
96384|NCT00795639|333889|P2|Overall Study|Unspecified|2
96385|NCT00795639|333890|P1|Overall Study|Unspecified|0
96386|NCT00795639|333889|P2|Overall Study|Adverse Event|2
96387|NCT00795639|333890|P1|Overall Study|Adverse Event|5
96388|NCT00795639|333889|P2|Overall Study|Pregnancy|0
96389|NCT00795639|333890|P1|Overall Study|Pregnancy|1
96390|NCT00795639|333889|P2|Overall Study|Withdrawal by Subject|3
96391|NCT00795639|333890|P1|Overall Study|Withdrawal by Subject|1
96392|NCT00795639|333889|P2|Overall Study|Death|6
96393|NCT00795639|333890|P1|Overall Study|Death|1
96394|NCT00795600|333902|P2|Overall Study|Unclassified|1
96395|NCT00795600|333903|P1|Overall Study|Unclassified|1
96396|NCT00795600|333902|P2|Overall Study|Withdrawal by Subject|0
96397|NCT00795600|333903|P1|Overall Study|Withdrawal by Subject|1
96398|NCT00795600|333902|P2|Overall Study|Protocol Violation|2
96399|NCT00795600|333903|P1|Overall Study|Protocol Violation|1
96400|NCT00795600|333902|P2|Overall Study|Adverse Event|1
96401|NCT00795600|333903|P1|Overall Study|Adverse Event|1
96402|NCT00795535|334023|P1|Overall Study|incomplete data and technical problems|20
96403|NCT00795509|334030|P1|Overall Study|Protocol Violation|31
96404|NCT00795184|334086|P2|Overall Study|Tissue sampling incomplete/conclusive|13
96405|NCT00795184|334087|P1|Overall Study|Tissue sampling incomplete/conclusive|8
96406|NCT00795132|334148|P1|Overall Study|Relapse|2
96407|NCT00795132|334148|P1|Overall Study|Death|1
96408|NCT00794963|334171|P2|Overall Study|Withdrawal by Subject|4
96409|NCT00794963|334172|P1|Overall Study|Withdrawal by Subject|1
96410|NCT00794924|334180|P2|Overall Study|Adverse Event|2
96411|NCT00794924|334181|P1|Overall Study|Adverse Event|6
96412|NCT00794924|334180|P2|Overall Study|Withdrawal by Subject|60
96413|NCT00794924|334181|P1|Overall Study|Withdrawal by Subject|48
96414|NCT00794924|334180|P2|Overall Study|Lost to Follow-up|8
96415|NCT00794924|334181|P1|Overall Study|Lost to Follow-up|6
96416|NCT00794820|334185|P1|Overall Study|Ineligible/Screen Failure|1
96417|NCT00794820|334185|P1|Overall Study|Resistant Disease|2
96418|NCT00794820|334185|P1|Overall Study|Secondary Malignancies|2
96419|NCT00794820|334185|P1|Overall Study|Adverse Event|11
96420|NCT00794677|334193|P2|First Intervention|Withdrawal by Subject|0
96421|NCT00794677|334194|P1|First Intervention|Withdrawal by Subject|2
96422|NCT00794664|334216|P2|Follow-up Period|Protocol non-compliance|1
96423|NCT00794664|334217|P1|Follow-up Period|Protocol non-compliance|0
96424|NCT00794664|334216|P2|Follow-up Period|Withdrawal by Subject|2
96425|NCT00794664|334217|P1|Follow-up Period|Withdrawal by Subject|0
96426|NCT00794664|334216|P2|Follow-up Period|Not specified|2
96427|NCT00794664|334217|P1|Follow-up Period|Not specified|1
96428|NCT00794664|334216|P2|Treatment Period|Adverse Event|8
96429|NCT00794664|334217|P1|Treatment Period|Adverse Event|1
96430|NCT00794664|334216|P2|Treatment Period|Not specified|1
96431|NCT00794664|334217|P1|Treatment Period|Not specified|0
96432|NCT00794664|334216|P2|Treatment Period|Protocol non-compliance|1
96433|NCT00794664|334217|P1|Treatment Period|Protocol non-compliance|0
96434|NCT00794664|334216|P2|Treatment Period|Withdrawal by Subject|2
96435|NCT00794664|334217|P1|Treatment Period|Withdrawal by Subject|0
96436|NCT00794365|334301|P1|Overall Study|Lack of Efficacy|3
96437|NCT00794365|334301|P1|Overall Study|Adverse Event|10
96438|NCT00794365|334301|P1|Overall Study|Poor Compliance|11
96439|NCT00794365|334301|P1|Overall Study|Unspecified|17
96440|NCT00794365|334301|P1|Overall Study|Lost to Follow-up|38
96441|NCT00794196|334309|P2|Overall Study|Lost to Follow-up|23
96442|NCT00794196|334310|P1|Overall Study|Lost to Follow-up|5
96443|NCT00794157|334330|P3|Overall Study|Protocol deviation|1
96444|NCT00794157|334331|P2|Overall Study|Protocol deviation|1
96445|NCT00794157|334332|P1|Overall Study|Protocol deviation|0
96446|NCT00794157|334330|P3|Overall Study|Abnormal test procedure result(s)|0
96447|NCT00794157|334331|P2|Overall Study|Abnormal test procedure result(s)|1
96448|NCT00794157|334332|P1|Overall Study|Abnormal test procedure result(s)|0
96449|NCT00794157|334330|P3|Overall Study|Administrative problems|4
96450|NCT00794157|334331|P2|Overall Study|Administrative problems|7
96451|NCT00794157|334332|P1|Overall Study|Administrative problems|1
96452|NCT00794157|334330|P3|Overall Study|Unsatisfactory therapeutic effect|2
96453|NCT00794157|334331|P2|Overall Study|Unsatisfactory therapeutic effect|0
96454|NCT00794157|334332|P1|Overall Study|Unsatisfactory therapeutic effect|1
96455|NCT00794157|334330|P3|Overall Study|Lost to Follow-up|1
96456|NCT00794157|334331|P2|Overall Study|Lost to Follow-up|0
96457|NCT00794157|334332|P1|Overall Study|Lost to Follow-up|2
96458|NCT00794157|334330|P3|Overall Study|Subject withdrew consent|3
96459|NCT00794157|334331|P2|Overall Study|Subject withdrew consent|0
96460|NCT00794157|334332|P1|Overall Study|Subject withdrew consent|2
96461|NCT00794157|334330|P3|Overall Study|Adverse Event|8
96462|NCT00794157|334331|P2|Overall Study|Adverse Event|1
96463|NCT00794157|334332|P1|Overall Study|Adverse Event|4
96464|NCT00794118|334361|P1|Overall Study|Changed hospital center|2
96465|NCT00794118|334361|P1|Overall Study|Withdrawal by Subject|9
96466|NCT00794118|334361|P1|Overall Study|Lost to Follow-up|16
96467|NCT00793910|334419|P2|Overall Study|Withdrawal by Subject|1
96468|NCT00793910|334420|P1|Overall Study|Withdrawal by Subject|0
96469|NCT00793910|334419|P2|Overall Study|decided to undergo LASIK instead of PRK|1
96470|NCT00793910|334420|P1|Overall Study|decided to undergo LASIK instead of PRK|2
96471|NCT00793910|334419|P2|Overall Study|ineligible based on entry criteria|3
96472|NCT00793910|334420|P1|Overall Study|ineligible based on entry criteria|2
96473|NCT00793910|334419|P2|Overall Study|did not pick up medications|1
96474|NCT00793910|334420|P1|Overall Study|did not pick up medications|1
96475|NCT00793910|334419|P2|Overall Study|discarded study pills|1
96476|NCT00793910|334420|P1|Overall Study|discarded study pills|0
96477|NCT00793871|334434|P1|Overall Study|Study terminated by the Sponsor|7
96478|NCT00793871|334434|P1|Overall Study|Lost to Follow-up|3
96479|NCT00793871|334434|P1|Overall Study|Death|50
96480|NCT00793819|334448|P2|Overall Study|Lost to Follow-up|1
96481|NCT00793819|334449|P1|Overall Study|Lost to Follow-up|1
96482|NCT00793819|334448|P2|Overall Study|Withdrawal by Subject|3
96483|NCT00793819|334449|P1|Overall Study|Withdrawal by Subject|4
96484|NCT00793819|334448|P2|Overall Study|Lack of Efficacy|1
96485|NCT00793819|334449|P1|Overall Study|Lack of Efficacy|1
96486|NCT00793819|334448|P2|Overall Study|Adverse Event|4
96487|NCT00793819|334449|P1|Overall Study|Adverse Event|8
96488|NCT00793793|334467|P12|Overall Study|reason not specified|4
96489|NCT00793793|334468|P11|Overall Study|reason not specified|2
96490|NCT00793793|334469|P10|Overall Study|reason not specified|6
96491|NCT00793793|334470|P9|Overall Study|reason not specified|7
96492|NCT00793793|334471|P8|Overall Study|reason not specified|0
96493|NCT00793793|334472|P7|Overall Study|reason not specified|2
96494|NCT00793793|334473|P6|Overall Study|reason not specified|1
96495|NCT00793793|334474|P5|Overall Study|reason not specified|1
96496|NCT00793793|334475|P4|Overall Study|reason not specified|1
96497|NCT00793793|334476|P3|Overall Study|reason not specified|0
96498|NCT00793793|334477|P2|Overall Study|reason not specified|1
96499|NCT00793793|334478|P1|Overall Study|reason not specified|0
96500|NCT00793793|334467|P12|Overall Study|Withdrawal by Subject|0
96501|NCT00793793|334468|P11|Overall Study|Withdrawal by Subject|0
96502|NCT00793793|334469|P10|Overall Study|Withdrawal by Subject|0
96503|NCT00793793|334470|P9|Overall Study|Withdrawal by Subject|1
96504|NCT00793793|334471|P8|Overall Study|Withdrawal by Subject|0
96505|NCT00793793|334472|P7|Overall Study|Withdrawal by Subject|0
96506|NCT00793793|334473|P6|Overall Study|Withdrawal by Subject|0
96507|NCT00793793|334474|P5|Overall Study|Withdrawal by Subject|1
96508|NCT00793793|334475|P4|Overall Study|Withdrawal by Subject|0
96509|NCT00793793|334476|P3|Overall Study|Withdrawal by Subject|0
96510|NCT00793793|334477|P2|Overall Study|Withdrawal by Subject|0
96511|NCT00793793|334478|P1|Overall Study|Withdrawal by Subject|0
96512|NCT00793793|334467|P12|Overall Study|Lost to Follow-up|0
96513|NCT00793793|334468|P11|Overall Study|Lost to Follow-up|1
96514|NCT00793793|334469|P10|Overall Study|Lost to Follow-up|3
96515|NCT00793793|334470|P9|Overall Study|Lost to Follow-up|1
96516|NCT00793793|334471|P8|Overall Study|Lost to Follow-up|0
96517|NCT00793793|334472|P7|Overall Study|Lost to Follow-up|0
96518|NCT00793793|334473|P6|Overall Study|Lost to Follow-up|0
96519|NCT00793793|334474|P5|Overall Study|Lost to Follow-up|0
96520|NCT00793793|334475|P4|Overall Study|Lost to Follow-up|0
96521|NCT00793793|334476|P3|Overall Study|Lost to Follow-up|1
96522|NCT00793793|334477|P2|Overall Study|Lost to Follow-up|0
96523|NCT00793793|334478|P1|Overall Study|Lost to Follow-up|0
96524|NCT00793793|334467|P12|Overall Study|Protocol Violation|0
96525|NCT00793793|334468|P11|Overall Study|Protocol Violation|0
96526|NCT00793793|334469|P10|Overall Study|Protocol Violation|0
96527|NCT00793793|334470|P9|Overall Study|Protocol Violation|0
96528|NCT00793793|334471|P8|Overall Study|Protocol Violation|0
96529|NCT00793793|334472|P7|Overall Study|Protocol Violation|0
96530|NCT00793793|334473|P6|Overall Study|Protocol Violation|0
96531|NCT00793793|334474|P5|Overall Study|Protocol Violation|0
96532|NCT00793793|334475|P4|Overall Study|Protocol Violation|1
96533|NCT00793793|334476|P3|Overall Study|Protocol Violation|0
96534|NCT00793793|334477|P2|Overall Study|Protocol Violation|0
96535|NCT00793793|334478|P1|Overall Study|Protocol Violation|0
96536|NCT00793793|334467|P12|Overall Study|Adverse Event|2
96537|NCT00793793|334468|P11|Overall Study|Adverse Event|0
96538|NCT00793793|334469|P10|Overall Study|Adverse Event|0
96539|NCT00793793|334470|P9|Overall Study|Adverse Event|0
96540|NCT00793793|334471|P8|Overall Study|Adverse Event|0
96541|NCT00793793|334472|P7|Overall Study|Adverse Event|2
96542|NCT00793793|334473|P6|Overall Study|Adverse Event|1
96543|NCT00793793|334474|P5|Overall Study|Adverse Event|0
96544|NCT00793793|334475|P4|Overall Study|Adverse Event|1
96545|NCT00793793|334476|P3|Overall Study|Adverse Event|1
96546|NCT00793793|334477|P2|Overall Study|Adverse Event|0
96547|NCT00793793|334478|P1|Overall Study|Adverse Event|0
96548|NCT00793780|334853|P2|Overall Study|Withdrawal by Subject|1
96549|NCT00793780|334854|P1|Overall Study|Withdrawal by Subject|2
96550|NCT00793624|334885|P4|Overall Study|Other reason not described above|3
96551|NCT00793624|334886|P3|Overall Study|Other reason not described above|6
96552|NCT00793624|334887|P2|Overall Study|Other reason not described above|4
96553|NCT00793624|334888|P1|Overall Study|Other reason not described above|6
96554|NCT00793624|334885|P4|Overall Study|Non compliance with protocol|3
96555|NCT00793624|334886|P3|Overall Study|Non compliance with protocol|2
96556|NCT00793624|334887|P2|Overall Study|Non compliance with protocol|3
96557|NCT00793624|334888|P1|Overall Study|Non compliance with protocol|2
96558|NCT00793624|334885|P4|Overall Study|Lack of Efficacy|3
96559|NCT00793624|334886|P3|Overall Study|Lack of Efficacy|1
96560|NCT00793624|334887|P2|Overall Study|Lack of Efficacy|2
96561|NCT00793624|334888|P1|Overall Study|Lack of Efficacy|9
96562|NCT00793624|334885|P4|Overall Study|Withdrawal by Subject|14
96563|NCT00793624|334886|P3|Overall Study|Withdrawal by Subject|11
96564|NCT00793624|334887|P2|Overall Study|Withdrawal by Subject|9
96565|NCT00793624|334888|P1|Overall Study|Withdrawal by Subject|20
96566|NCT00793624|334885|P4|Overall Study|Lost to Follow-up|0
96567|NCT00793624|334886|P3|Overall Study|Lost to Follow-up|4
96568|NCT00793624|334887|P2|Overall Study|Lost to Follow-up|2
96569|NCT00793624|334888|P1|Overall Study|Lost to Follow-up|2
96570|NCT00793624|334885|P4|Overall Study|Adverse Event|20
96571|NCT00793624|334886|P3|Overall Study|Adverse Event|15
96572|NCT00793624|334887|P2|Overall Study|Adverse Event|16
96573|NCT00793624|334888|P1|Overall Study|Adverse Event|18
96574|NCT00793585|335169|P2|Overall Study|Protocol Violation|2
96575|NCT00793585|335170|P1|Overall Study|Protocol Violation|1
96576|NCT00793585|335169|P2|Overall Study|Adverse Event|1
96577|NCT00793585|335170|P1|Overall Study|Adverse Event|1
96578|NCT00793546|335180|P2|Overall Study|Unspecified|0
96579|NCT00793546|335181|P1|Overall Study|Unspecified|1
96580|NCT00793546|335180|P2|Overall Study|Study Terminated by Sponsor|27
96581|NCT00793546|335181|P1|Overall Study|Study Terminated by Sponsor|8
96582|NCT00793546|335180|P2|Overall Study|Withdrawal by Subject|1
96583|NCT00793546|335181|P1|Overall Study|Withdrawal by Subject|1
96584|NCT00793546|335180|P2|Overall Study|Lost to Follow-up|0
96585|NCT00793546|335181|P1|Overall Study|Lost to Follow-up|1
96586|NCT00793546|335180|P2|Overall Study|Death|0
96587|NCT00793546|335181|P1|Overall Study|Death|3
96588|NCT00793403|335231|P1|Overall Study|Unspecified|73
96589|NCT00793325|335278|P1|Overall Study|Lost to Follow-up|1
96590|NCT00793325|335278|P1|Overall Study|Protocol Violation|18
96591|NCT00793104|335306|P1|Overall Study|Lost to Follow-up|1
96592|NCT00792935|335316|P2|Overall Study|Withdrawal by Subject|1
96593|NCT00792935|335317|P1|Overall Study|Withdrawal by Subject|0
96594|NCT00792935|335316|P2|Overall Study|Protocol Violation|0
96595|NCT00792935|335317|P1|Overall Study|Protocol Violation|2
96596|NCT00792935|335316|P2|Overall Study|Lost to Follow-up|1
96597|NCT00792935|335317|P1|Overall Study|Lost to Follow-up|0
96598|NCT00792935|335316|P2|Overall Study|Adverse Event|1
96599|NCT00792935|335317|P1|Overall Study|Adverse Event|2
96600|NCT00792805|335328|P3|Overall Study|Protocol deviation|1
96601|NCT00792805|335329|P2|Overall Study|Protocol deviation|1
96602|NCT00792805|335330|P1|Overall Study|Protocol deviation|0
96603|NCT00792805|335328|P3|Overall Study|Abnormal laboratory value(s)|1
96604|NCT00792805|335329|P2|Overall Study|Abnormal laboratory value(s)|0
96605|NCT00792805|335330|P1|Overall Study|Abnormal laboratory value(s)|0
96606|NCT00792805|335328|P3|Overall Study|Lost to Follow-up|6
96607|NCT00792805|335329|P2|Overall Study|Lost to Follow-up|1
96608|NCT00792805|335330|P1|Overall Study|Lost to Follow-up|1
96609|NCT00792805|335328|P3|Overall Study|Unsatisfactory therapeutic effect|6
96610|NCT00792805|335329|P2|Overall Study|Unsatisfactory therapeutic effect|6
96611|NCT00792805|335330|P1|Overall Study|Unsatisfactory therapeutic effect|1
96612|NCT00792805|335328|P3|Overall Study|Abnormal test procedure result(s)|0
96613|NCT00792805|335329|P2|Overall Study|Abnormal test procedure result(s)|2
96614|NCT00792805|335330|P1|Overall Study|Abnormal test procedure result(s)|1
96615|NCT00792805|335328|P3|Overall Study|Administrative problems|4
96616|NCT00792805|335329|P2|Overall Study|Administrative problems|0
96617|NCT00792805|335330|P1|Overall Study|Administrative problems|2
96618|NCT00792805|335328|P3|Overall Study|Subject withdrew consent|5
96619|NCT00792805|335329|P2|Overall Study|Subject withdrew consent|6
96620|NCT00792805|335330|P1|Overall Study|Subject withdrew consent|5
96621|NCT00792805|335328|P3|Overall Study|Adverse Event|10
96622|NCT00792805|335329|P2|Overall Study|Adverse Event|10
96623|NCT00792805|335330|P1|Overall Study|Adverse Event|12
96624|NCT00792636|335357|P3|Overall Study|Investigator Discretion|2
96625|NCT00792636|335358|P2|Overall Study|Investigator Discretion|0
96626|NCT00792636|335359|P1|Overall Study|Investigator Discretion|2
96627|NCT00792636|335357|P3|Overall Study|Adverse Event|3
96628|NCT00792636|335358|P2|Overall Study|Adverse Event|2
96629|NCT00792636|335359|P1|Overall Study|Adverse Event|4
96630|NCT00792636|335357|P3|Overall Study|Lack of Efficacy|13
96631|NCT00792636|335358|P2|Overall Study|Lack of Efficacy|4
96632|NCT00792636|335359|P1|Overall Study|Lack of Efficacy|3
96633|NCT00792636|335357|P3|Overall Study|Withdrew Consent|9
96634|NCT00792636|335358|P2|Overall Study|Withdrew Consent|13
96635|NCT00792636|335359|P1|Overall Study|Withdrew Consent|10
96636|NCT00792636|335357|P3|Overall Study|Lost to Follow-up|14
96637|NCT00792636|335358|P2|Overall Study|Lost to Follow-up|19
96638|NCT00792636|335359|P1|Overall Study|Lost to Follow-up|13
96639|NCT00792636|335357|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
96640|NCT00792636|335358|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
96641|NCT00792636|335359|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
96642|NCT00792636|335357|P3|Overall Study|Protocol Violation|20
96643|NCT00792636|335358|P2|Overall Study|Protocol Violation|23
96644|NCT00792636|335359|P1|Overall Study|Protocol Violation|17
96645|NCT00792298|335400|P8|Treatment Period 2|Withdrawal by Subject|2
96646|NCT00792298|335401|P7|Treatment Period 2|Withdrawal by Subject|0
96647|NCT00792298|335402|P6|Treatment Period 2|Withdrawal by Subject|0
96648|NCT00792298|335403|P5|Treatment Period 2|Withdrawal by Subject|1
96649|NCT00792298|335404|P4|Treatment Period 2|Withdrawal by Subject|2
96650|NCT00792298|335405|P3|Treatment Period 2|Withdrawal by Subject|0
96651|NCT00792298|335406|P2|Treatment Period 2|Withdrawal by Subject|1
96652|NCT00792298|335407|P1|Treatment Period 2|Withdrawal by Subject|1
96653|NCT00792298|335400|P8|Treatment Period 2|Pregnancy|0
96654|NCT00792298|335401|P7|Treatment Period 2|Pregnancy|0
96655|NCT00792298|335402|P6|Treatment Period 2|Pregnancy|0
96656|NCT00792298|335403|P5|Treatment Period 2|Pregnancy|0
96657|NCT00792298|335404|P4|Treatment Period 2|Pregnancy|0
96658|NCT00792298|335405|P3|Treatment Period 2|Pregnancy|1
96659|NCT00792298|335406|P2|Treatment Period 2|Pregnancy|0
96660|NCT00792298|335407|P1|Treatment Period 2|Pregnancy|0
96661|NCT00792298|335400|P8|Treatment Period 2|Physician Decision|0
96662|NCT00792298|335401|P7|Treatment Period 2|Physician Decision|1
96663|NCT00792298|335402|P6|Treatment Period 2|Physician Decision|0
96664|NCT00792298|335403|P5|Treatment Period 2|Physician Decision|0
96665|NCT00792298|335404|P4|Treatment Period 2|Physician Decision|0
96666|NCT00792298|335405|P3|Treatment Period 2|Physician Decision|0
96667|NCT00792298|335406|P2|Treatment Period 2|Physician Decision|0
96668|NCT00792298|335407|P1|Treatment Period 2|Physician Decision|0
96669|NCT00792298|335400|P8|Treatment Period 2|Lack of Efficacy|0
96670|NCT00792298|335401|P7|Treatment Period 2|Lack of Efficacy|0
96671|NCT00792298|335402|P6|Treatment Period 2|Lack of Efficacy|0
96672|NCT00792298|335403|P5|Treatment Period 2|Lack of Efficacy|1
96673|NCT00792298|335404|P4|Treatment Period 2|Lack of Efficacy|0
96674|NCT00792298|335405|P3|Treatment Period 2|Lack of Efficacy|0
96675|NCT00792298|335406|P2|Treatment Period 2|Lack of Efficacy|0
96676|NCT00792298|335407|P1|Treatment Period 2|Lack of Efficacy|0
96677|NCT00792298|335400|P8|Washout|Withdrawal by Subject|0
96678|NCT00792298|335401|P7|Washout|Withdrawal by Subject|0
96679|NCT00792298|335402|P6|Washout|Withdrawal by Subject|1
96680|NCT00792298|335403|P5|Washout|Withdrawal by Subject|0
96681|NCT00792298|335404|P4|Washout|Withdrawal by Subject|0
96682|NCT00792298|335405|P3|Washout|Withdrawal by Subject|1
96683|NCT00792298|335406|P2|Washout|Withdrawal by Subject|0
96684|NCT00792298|335407|P1|Washout|Withdrawal by Subject|0
96685|NCT00792298|335400|P8|Washout|Adverse Event|0
96686|NCT00792298|335401|P7|Washout|Adverse Event|0
96687|NCT00792298|335402|P6|Washout|Adverse Event|1
96688|NCT00792298|335403|P5|Washout|Adverse Event|0
96689|NCT00792298|335404|P4|Washout|Adverse Event|0
96690|NCT00792298|335405|P3|Washout|Adverse Event|0
96691|NCT00792298|335406|P2|Washout|Adverse Event|0
96692|NCT00792298|335407|P1|Washout|Adverse Event|0
96693|NCT00792298|335400|P8|Treatment Period 1|Protocol Violation|1
96694|NCT00792298|335401|P7|Treatment Period 1|Protocol Violation|0
96695|NCT00792298|335402|P6|Treatment Period 1|Protocol Violation|0
96696|NCT00792298|335403|P5|Treatment Period 1|Protocol Violation|0
96697|NCT00792298|335404|P4|Treatment Period 1|Protocol Violation|0
96698|NCT00792298|335405|P3|Treatment Period 1|Protocol Violation|0
96699|NCT00792298|335406|P2|Treatment Period 1|Protocol Violation|0
96700|NCT00792298|335407|P1|Treatment Period 1|Protocol Violation|0
96701|NCT00792298|335400|P8|Treatment Period 1|Physician Decision|0
96702|NCT00792298|335401|P7|Treatment Period 1|Physician Decision|1
96703|NCT00792298|335402|P6|Treatment Period 1|Physician Decision|0
96704|NCT00792298|335403|P5|Treatment Period 1|Physician Decision|0
96705|NCT00792298|335404|P4|Treatment Period 1|Physician Decision|1
96706|NCT00792298|335405|P3|Treatment Period 1|Physician Decision|0
96707|NCT00792298|335406|P2|Treatment Period 1|Physician Decision|0
96708|NCT00792298|335407|P1|Treatment Period 1|Physician Decision|0
96709|NCT00792298|335400|P8|Treatment Period 1|Lost to Follow-up|0
96710|NCT00792298|335401|P7|Treatment Period 1|Lost to Follow-up|1
96711|NCT00792298|335402|P6|Treatment Period 1|Lost to Follow-up|0
96712|NCT00792298|335403|P5|Treatment Period 1|Lost to Follow-up|0
96713|NCT00792298|335404|P4|Treatment Period 1|Lost to Follow-up|0
96714|NCT00792298|335405|P3|Treatment Period 1|Lost to Follow-up|0
96715|NCT00792298|335406|P2|Treatment Period 1|Lost to Follow-up|0
96716|NCT00792298|335407|P1|Treatment Period 1|Lost to Follow-up|0
96717|NCT00792298|335400|P8|Treatment Period 1|Withdrawal by Subject|0
96718|NCT00792298|335401|P7|Treatment Period 1|Withdrawal by Subject|1
96719|NCT00792298|335402|P6|Treatment Period 1|Withdrawal by Subject|2
96720|NCT00792298|335403|P5|Treatment Period 1|Withdrawal by Subject|0
96721|NCT00792298|335404|P4|Treatment Period 1|Withdrawal by Subject|2
96722|NCT00792298|335405|P3|Treatment Period 1|Withdrawal by Subject|1
96723|NCT00792298|335406|P2|Treatment Period 1|Withdrawal by Subject|0
96724|NCT00792298|335407|P1|Treatment Period 1|Withdrawal by Subject|1
96725|NCT00792298|335400|P8|Treatment Period 1|Lack of Efficacy|0
96726|NCT00792298|335401|P7|Treatment Period 1|Lack of Efficacy|0
96727|NCT00792298|335402|P6|Treatment Period 1|Lack of Efficacy|0
96728|NCT00792298|335403|P5|Treatment Period 1|Lack of Efficacy|0
96729|NCT00792298|335404|P4|Treatment Period 1|Lack of Efficacy|0
96730|NCT00792298|335405|P3|Treatment Period 1|Lack of Efficacy|1
96731|NCT00792298|335406|P2|Treatment Period 1|Lack of Efficacy|0
96732|NCT00792298|335407|P1|Treatment Period 1|Lack of Efficacy|0
96733|NCT00792298|335400|P8|Treatment Period 1|Adverse Event|0
96734|NCT00792298|335401|P7|Treatment Period 1|Adverse Event|1
96735|NCT00792298|335402|P6|Treatment Period 1|Adverse Event|1
96736|NCT00792298|335403|P5|Treatment Period 1|Adverse Event|0
96737|NCT00792298|335404|P4|Treatment Period 1|Adverse Event|1
96738|NCT00792298|335405|P3|Treatment Period 1|Adverse Event|0
96739|NCT00792298|335406|P2|Treatment Period 1|Adverse Event|1
96740|NCT00792298|335407|P1|Treatment Period 1|Adverse Event|0
96741|NCT00792259|335437|P3|Overall Study|Poor Quality Scans|0
96742|NCT00792259|335438|P2|Overall Study|Poor Quality Scans|0
96743|NCT00792259|335439|P1|Overall Study|Poor Quality Scans|1
96744|NCT00792116|335449|P2|Overall Study|Discontnued intervention|0
96745|NCT00792116|335450|P1|Overall Study|Discontnued intervention|1
96746|NCT00792116|335449|P2|Overall Study|Lost to Follow-up|1
96747|NCT00792116|335450|P1|Overall Study|Lost to Follow-up|0
96748|NCT00792103|335460|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
96749|NCT00792103|335460|P1|Overall Study|Protocol Violation|10
96750|NCT00792103|335460|P1|Overall Study|Withdrawal by Subject|52
96751|NCT00792103|335460|P1|Overall Study|Adverse Event|25
96752|NCT00792103|335460|P1|Overall Study|Lost to Follow-up|17
96753|NCT00792103|335460|P1|Overall Study|Enrolled, not treated|15
96754|NCT00791999|335472|P4|Overall Study|Reason other than those above|0
96755|NCT00791999|335473|P3|Overall Study|Reason other than those above|1
96756|NCT00791999|335474|P2|Overall Study|Reason other than those above|0
96757|NCT00791999|335475|P1|Overall Study|Reason other than those above|1
96758|NCT00791999|335472|P4|Overall Study|Lack of Efficacy|2
96759|NCT00791999|335473|P3|Overall Study|Lack of Efficacy|0
96760|NCT00791999|335474|P2|Overall Study|Lack of Efficacy|1
96761|NCT00791999|335475|P1|Overall Study|Lack of Efficacy|0
96762|NCT00791999|335472|P4|Overall Study|Adverse Event|3
96763|NCT00791999|335473|P3|Overall Study|Adverse Event|7
96764|NCT00791999|335474|P2|Overall Study|Adverse Event|3
96765|NCT00791999|335475|P1|Overall Study|Adverse Event|3
96766|NCT00791999|335472|P4|Overall Study|Protocol Violation|0
96767|NCT00791999|335473|P3|Overall Study|Protocol Violation|1
96768|NCT00791999|335474|P2|Overall Study|Protocol Violation|0
96769|NCT00791999|335475|P1|Overall Study|Protocol Violation|3
96770|NCT00791999|335472|P4|Overall Study|Withdrawal by Subject|2
96771|NCT00791999|335473|P3|Overall Study|Withdrawal by Subject|0
96772|NCT00791999|335474|P2|Overall Study|Withdrawal by Subject|1
96773|NCT00791999|335475|P1|Overall Study|Withdrawal by Subject|0
96774|NCT00791999|335472|P4|Overall Study|Protocol planed withdrawal|45
96775|NCT00791999|335473|P3|Overall Study|Protocol planed withdrawal|11
96776|NCT00791999|335474|P2|Overall Study|Protocol planed withdrawal|11
96777|NCT00791999|335475|P1|Overall Study|Protocol planed withdrawal|14
96778|NCT00791934|335500|P1|Overall Study|Did not consent for extended follow-up|13
96779|NCT00791934|335500|P1|Overall Study|Withdrawal by Subject|2
96780|NCT00791921|335510|P2|Overall Study|Reason other than those above|1
96781|NCT00791921|335511|P1|Overall Study|Reason other than those above|0
96782|NCT00791921|335510|P2|Overall Study|Lack of study drug administration|1
96783|NCT00791921|335511|P1|Overall Study|Lack of study drug administration|1
96784|NCT00791921|335510|P2|Overall Study|Lack of Efficacy|2
96785|NCT00791921|335511|P1|Overall Study|Lack of Efficacy|0
96786|NCT00791921|335510|P2|Overall Study|Adverse Event|2
96787|NCT00791921|335511|P1|Overall Study|Adverse Event|8
96788|NCT00791921|335510|P2|Overall Study|Withdrawal by Subject|2
96789|NCT00791921|335511|P1|Overall Study|Withdrawal by Subject|1
96790|NCT00791921|335510|P2|Overall Study|Protocol planed|88
96791|NCT00791921|335511|P1|Overall Study|Protocol planed|24
96792|NCT00791778|335538|P2|Follow-up|Lost to Follow-up|1
96793|NCT00791778|335539|P1|Follow-up|Lost to Follow-up|2
96794|NCT00791778|335538|P2|Follow-up|Withdrawal by Subject|0
96795|NCT00791778|335539|P1|Follow-up|Withdrawal by Subject|3
96796|NCT00791778|335538|P2|Double-blind Treatment|Non-compliant with study medication|0
96797|NCT00791778|335539|P1|Double-blind Treatment|Non-compliant with study medication|2
96798|NCT00791778|335538|P2|Double-blind Treatment|Withdrawal by Subject|9
96799|NCT00791778|335539|P1|Double-blind Treatment|Withdrawal by Subject|20
96800|NCT00791778|335538|P2|Double-blind Treatment|Protocol Violation|4
96801|NCT00791778|335539|P1|Double-blind Treatment|Protocol Violation|0
96802|NCT00791778|335538|P2|Double-blind Treatment|Physician Decision|26
96803|NCT00791778|335539|P1|Double-blind Treatment|Physician Decision|6
96804|NCT00791778|335538|P2|Double-blind Treatment|Adverse Event|9
96805|NCT00791778|335539|P1|Double-blind Treatment|Adverse Event|49
96806|NCT00791765|335593|P2|Weeks 13 to 24|Other|1
96807|NCT00791765|335594|P1|Weeks 13 to 24|Other|0
96808|NCT00791765|335593|P2|Weeks 13 to 24|Lost to Follow-up|2
96809|NCT00791765|335594|P1|Weeks 13 to 24|Lost to Follow-up|1
96810|NCT00791765|335593|P2|Weeks 13 to 24|Disease progression|1
96811|NCT00791765|335594|P1|Weeks 13 to 24|Disease progression|0
96812|NCT00791765|335593|P2|Weeks 13 to 24|Withdrawal by Subject|1
96813|NCT00791765|335594|P1|Weeks 13 to 24|Withdrawal by Subject|2
96814|NCT00791765|335593|P2|Weeks 13 to 24|Adverse Event|3
96815|NCT00791765|335594|P1|Weeks 13 to 24|Adverse Event|0
96816|NCT00791765|335593|P2|Weeks 13 to 24|Protocol deviation|0
96817|NCT00791765|335594|P1|Weeks 13 to 24|Protocol deviation|2
96818|NCT00791765|335593|P2|Weeks 1 to 12|Ineligibility determined|3
96819|NCT00791765|335594|P1|Weeks 1 to 12|Ineligibility determined|0
96820|NCT00791765|335593|P2|Weeks 1 to 12|Disease progression|0
96821|NCT00791765|335594|P1|Weeks 1 to 12|Disease progression|3
96822|NCT00791765|335593|P2|Weeks 1 to 12|Physician Decision|0
96823|NCT00791765|335594|P1|Weeks 1 to 12|Physician Decision|1
96824|NCT00791765|335593|P2|Weeks 1 to 12|Withdrawal by Subject|0
96825|NCT00791765|335594|P1|Weeks 1 to 12|Withdrawal by Subject|3
96826|NCT00791765|335593|P2|Weeks 1 to 12|Lost to Follow-up|0
96827|NCT00791765|335594|P1|Weeks 1 to 12|Lost to Follow-up|1
96828|NCT00791765|335593|P2|Weeks 1 to 12|Adverse Event|1
96829|NCT00791765|335594|P1|Weeks 1 to 12|Adverse Event|0
96830|NCT00791700|335609|P4|Overall Study|Blood sampling not done before Stage 1|1
96831|NCT00791700|335610|P3|Overall Study|Blood sampling not done before Stage 1|0
96832|NCT00791700|335611|P2|Overall Study|Blood sampling not done before Stage 1|0
96833|NCT00791700|335612|P1|Overall Study|Blood sampling not done before Stage 1|0
96834|NCT00791700|335609|P4|Overall Study|Non-compliance with study treatment|2
96835|NCT00791700|335610|P3|Overall Study|Non-compliance with study treatment|0
96836|NCT00791700|335611|P2|Overall Study|Non-compliance with study treatment|0
96837|NCT00791700|335612|P1|Overall Study|Non-compliance with study treatment|1
96838|NCT00791700|335609|P4|Overall Study|No longer willing to participate|1
96839|NCT00791700|335610|P3|Overall Study|No longer willing to participate|0
96840|NCT00791700|335611|P2|Overall Study|No longer willing to participate|1
96841|NCT00791700|335612|P1|Overall Study|No longer willing to participate|0
96842|NCT00791700|335609|P4|Overall Study|Adverse Event|1
96843|NCT00791700|335610|P3|Overall Study|Adverse Event|1
96844|NCT00791700|335611|P2|Overall Study|Adverse Event|0
96845|NCT00791700|335612|P1|Overall Study|Adverse Event|0
96846|NCT00791700|335609|P4|Overall Study|Insufficient clinical response|13
96847|NCT00791700|335610|P3|Overall Study|Insufficient clinical response|3
96848|NCT00791700|335611|P2|Overall Study|Insufficient clinical response|4
96849|NCT00791700|335612|P1|Overall Study|Insufficient clinical response|3
96850|NCT00791661|335700|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
96851|NCT00791661|335701|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
96852|NCT00791661|335702|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
96853|NCT00791661|335700|P3|7 Day Wash-out|Adverse Event|1
96854|NCT00791661|335701|P2|7 Day Wash-out|Adverse Event|0
96855|NCT00791661|335702|P1|7 Day Wash-out|Adverse Event|0
96856|NCT00791557|335793|P1|Overall Study|Adverse Event|1
96857|NCT00791518|335797|P1|Overall Study|Protocol Violation|93
96858|NCT00791492|335825|P2|Overall Study|Liver transplantation|1
96859|NCT00791492|335826|P1|Overall Study|Liver transplantation|5
96860|NCT00791492|335825|P2|Overall Study|Withdrawal by Subject|2
96861|NCT00791492|335826|P1|Overall Study|Withdrawal by Subject|1
96862|NCT00791479|335874|P6|Overall Study|Withdrawal by Subject|1
96863|NCT00791479|335875|P5|Overall Study|Withdrawal by Subject|0
96864|NCT00791479|335876|P4|Overall Study|Withdrawal by Subject|1
96865|NCT00791479|335877|P3|Overall Study|Withdrawal by Subject|0
96866|NCT00791479|335878|P2|Overall Study|Withdrawal by Subject|0
96867|NCT00791479|335879|P1|Overall Study|Withdrawal by Subject|0
96868|NCT00791479|335874|P6|Overall Study|Protocol Violation|0
96869|NCT00791479|335875|P5|Overall Study|Protocol Violation|0
96870|NCT00791479|335876|P4|Overall Study|Protocol Violation|1
96871|NCT00791479|335877|P3|Overall Study|Protocol Violation|0
96872|NCT00791479|335878|P2|Overall Study|Protocol Violation|1
96873|NCT00791479|335879|P1|Overall Study|Protocol Violation|2
96874|NCT00791479|335874|P6|Overall Study|Lost to Follow-up|1
96875|NCT00791479|335875|P5|Overall Study|Lost to Follow-up|0
96876|NCT00791479|335876|P4|Overall Study|Lost to Follow-up|0
96877|NCT00791479|335877|P3|Overall Study|Lost to Follow-up|0
96878|NCT00791479|335878|P2|Overall Study|Lost to Follow-up|1
96879|NCT00791479|335879|P1|Overall Study|Lost to Follow-up|0
96880|NCT00791479|335874|P6|Overall Study|Adverse Event|1
96881|NCT00791479|335875|P5|Overall Study|Adverse Event|0
96882|NCT00791479|335876|P4|Overall Study|Adverse Event|2
96883|NCT00791479|335877|P3|Overall Study|Adverse Event|0
96884|NCT00791479|335878|P2|Overall Study|Adverse Event|1
96885|NCT00791479|335879|P1|Overall Study|Adverse Event|0
96886|NCT00791479|335874|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
96887|NCT00791479|335875|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
96888|NCT00791479|335876|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
96889|NCT00791479|335877|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
96890|NCT00791479|335878|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
96891|NCT00791479|335879|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
96892|NCT00790569|335976|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
96893|NCT00790569|335977|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
96894|NCT00790569|335978|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
96895|NCT00790569|335976|P3|End of Treatment (6 Month Interview)|Incarcerated|3
96896|NCT00790569|335977|P2|End of Treatment (6 Month Interview)|Incarcerated|0
96897|NCT00790569|335978|P1|End of Treatment (6 Month Interview)|Incarcerated|0
96898|NCT00790569|335976|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
96899|NCT00790569|335977|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
96900|NCT00790569|335978|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
96901|NCT00790569|335976|P3|End of Treatment (6 Month Interview)|Hospitalized|0
96902|NCT00790569|335977|P2|End of Treatment (6 Month Interview)|Hospitalized|0
96903|NCT00790569|335978|P1|End of Treatment (6 Month Interview)|Hospitalized|2
96904|NCT00790569|335976|P3|End of Treatment (6 Month Interview)|Death|1
96905|NCT00790569|335977|P2|End of Treatment (6 Month Interview)|Death|2
96906|NCT00790569|335978|P1|End of Treatment (6 Month Interview)|Death|0
96907|NCT00790569|335976|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
96908|NCT00790569|335977|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
96909|NCT00790569|335978|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
96910|NCT00790556|336001|P2|Treatment Period 1|Withdrawal by Subject|0
96911|NCT00790556|336002|P1|Treatment Period 1|Withdrawal by Subject|1
96912|NCT00790556|336001|P2|Treatment Period 1|Physician Decision|0
96913|NCT00790556|336002|P1|Treatment Period 1|Physician Decision|1
96914|NCT00791388|336017|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
96915|NCT00791388|336018|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
96916|NCT00791388|336019|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
96917|NCT00791388|336020|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
96918|NCT00791388|336021|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
96919|NCT00791388|336017|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
96920|NCT00791388|336018|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
96921|NCT00791388|336019|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
96922|NCT00791388|336020|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
96923|NCT00791388|336021|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
96924|NCT00791388|336017|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
96925|NCT00791388|336018|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
96926|NCT00791388|336019|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
96927|NCT00791388|336020|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
96928|NCT00791388|336021|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
96929|NCT00791258|336057|P1|Overall Study|Lack of Efficacy|1
96930|NCT00791258|336057|P1|Overall Study|Subject required restricted medication|1
96931|NCT00791258|336057|P1|Overall Study|Subject incarcerated|1
96932|NCT00791258|336057|P1|Overall Study|non-compliance|3
96933|NCT00791258|336057|P1|Overall Study|subject left area|2
96934|NCT00791258|336057|P1|Overall Study|Did not take medication for >3 days|1
96935|NCT00791258|336057|P1|Overall Study|Withdrawal by Subject|40
96936|NCT00791258|336057|P1|Overall Study|Protocol Violation|109
96937|NCT00791258|336057|P1|Overall Study|Lost to Follow-up|18
96938|NCT00791258|336057|P1|Overall Study|Adverse Event|87
96939|NCT00790907|336144|P3|Overall Study|Did Not Receive Study Drug|0
96940|NCT00790907|336145|P2|Overall Study|Did Not Receive Study Drug|0
96941|NCT00790907|336146|P1|Overall Study|Did Not Receive Study Drug|10
96942|NCT00790907|336144|P3|Overall Study|Verbatim Reason on the Case Report Form|29
96943|NCT00790907|336145|P2|Overall Study|Verbatim Reason on the Case Report Form|20
96944|NCT00790907|336146|P1|Overall Study|Verbatim Reason on the Case Report Form|74
96945|NCT00790907|336144|P3|Overall Study|Qualifying Condition Not Present|16
96946|NCT00790907|336145|P2|Overall Study|Qualifying Condition Not Present|14
96947|NCT00790907|336146|P1|Overall Study|Qualifying Condition Not Present|29
96948|NCT00790907|336144|P3|Overall Study|Required Protocol-prohibited Therapy|7
96949|NCT00790907|336145|P2|Overall Study|Required Protocol-prohibited Therapy|5
96950|NCT00790907|336146|P1|Overall Study|Required Protocol-prohibited Therapy|17
96951|NCT00790907|336144|P3|Overall Study|Bleeding Event|21
96952|NCT00790907|336145|P2|Overall Study|Bleeding Event|16
96953|NCT00790907|336146|P1|Overall Study|Bleeding Event|11
96954|NCT00790907|336144|P3|Overall Study|Withdrawal by Subject|5
96955|NCT00790907|336145|P2|Overall Study|Withdrawal by Subject|7
96956|NCT00790907|336146|P1|Overall Study|Withdrawal by Subject|1
96957|NCT00790907|336144|P3|Overall Study|Physician Decision|255
96958|NCT00790907|336145|P2|Overall Study|Physician Decision|271
96959|NCT00790907|336146|P1|Overall Study|Physician Decision|304
96960|NCT00790907|336144|P3|Overall Study|Adverse Event|6
96961|NCT00790907|336145|P2|Overall Study|Adverse Event|7
96962|NCT00790907|336146|P1|Overall Study|Adverse Event|9
96963|NCT00790790|336183|P3|Study Period 2: Therapy Phase|Physician Decision|0
96964|NCT00790790|336184|P2|Study Period 2: Therapy Phase|Physician Decision|1
96965|NCT00790790|336185|P1|Study Period 2: Therapy Phase|Physician Decision|0
96966|NCT00790790|336183|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
96967|NCT00790790|336184|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
96968|NCT00790790|336185|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
96969|NCT00790790|336183|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
96970|NCT00790790|336184|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
96971|NCT00790790|336185|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
96972|NCT00790790|336183|P3|Study Period 2: Therapy Phase|Protocol Violation|0
96973|NCT00790790|336184|P2|Study Period 2: Therapy Phase|Protocol Violation|1
96974|NCT00790790|336185|P1|Study Period 2: Therapy Phase|Protocol Violation|1
96975|NCT00790790|336183|P3|Study Period 2: Therapy Phase|Adverse Event|16
96976|NCT00790790|336184|P2|Study Period 2: Therapy Phase|Adverse Event|16
96977|NCT00790790|336185|P1|Study Period 2: Therapy Phase|Adverse Event|3
96978|NCT00790751|336262|P4|Overall Study|Physician Decision|1
96979|NCT00790751|336263|P3|Overall Study|Physician Decision|0
96980|NCT00790751|336264|P2|Overall Study|Physician Decision|0
96981|NCT00790751|336265|P1|Overall Study|Physician Decision|0
96982|NCT00790751|336262|P4|Overall Study|Death|0
96983|NCT00790751|336263|P3|Overall Study|Death|1
96984|NCT00790751|336264|P2|Overall Study|Death|0
96985|NCT00790751|336265|P1|Overall Study|Death|0
96986|NCT00790751|336262|P4|Overall Study|Requirement for restricted medication|0
96987|NCT00790751|336263|P3|Overall Study|Requirement for restricted medication|0
96988|NCT00790751|336264|P2|Overall Study|Requirement for restricted medication|2
96989|NCT00790751|336265|P1|Overall Study|Requirement for restricted medication|0
96990|NCT00790751|336262|P4|Overall Study|Adverse Event|4
96991|NCT00790751|336263|P3|Overall Study|Adverse Event|5
96992|NCT00790751|336264|P2|Overall Study|Adverse Event|3
96993|NCT00790751|336265|P1|Overall Study|Adverse Event|5
96994|NCT00790751|336262|P4|Overall Study|Lost to Follow-up|5
96995|NCT00790751|336263|P3|Overall Study|Lost to Follow-up|4
96996|NCT00790751|336264|P2|Overall Study|Lost to Follow-up|9
96997|NCT00790751|336265|P1|Overall Study|Lost to Follow-up|4
96998|NCT00790751|336262|P4|Overall Study|Protocol non-compliance|11
96999|NCT00790751|336263|P3|Overall Study|Protocol non-compliance|10
97000|NCT00790751|336264|P2|Overall Study|Protocol non-compliance|16
97001|NCT00790751|336265|P1|Overall Study|Protocol non-compliance|16
97002|NCT00790647|336313|P1|Overall Study|Adverse Event|1
97003|NCT00790452|336322|P2|Overall Study|Drug supply issue|0
97004|NCT00790452|336323|P1|Overall Study|Drug supply issue|1
97005|NCT00790400|336331|P2|Everolimus Period (Core or Extension)|New treatment|0
97006|NCT00790400|336332|P1|Everolimus Period (Core or Extension)|New treatment|2
97007|NCT00790400|336331|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
97008|NCT00790400|336332|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
97009|NCT00790400|336331|P2|Everolimus Period (Core or Extension)|Disease progression|0
97010|NCT00790400|336332|P1|Everolimus Period (Core or Extension)|Disease progression|5
97011|NCT00790400|336331|P2|Everolimus Period (Core or Extension)|Death|0
97012|NCT00790400|336332|P1|Everolimus Period (Core or Extension)|Death|1
97013|NCT00790400|336331|P2|Everolimus Period (Core or Extension)|Administrative problems|0
97014|NCT00790400|336332|P1|Everolimus Period (Core or Extension)|Administrative problems|2
97015|NCT00790400|336331|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
97016|NCT00790400|336332|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
97017|NCT00790400|336331|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
97018|NCT00790400|336332|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
97019|NCT00790400|336331|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
97020|NCT00790400|336332|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
97021|NCT00790400|336331|P2|Everolimus Period (Core or Extension)|Adverse Event|0
97022|NCT00790400|336332|P1|Everolimus Period (Core or Extension)|Adverse Event|9
97023|NCT00790400|336331|P2|Double-blind Period (Core Phase)|Death|0
97024|NCT00790400|336332|P1|Double-blind Period (Core Phase)|Death|1
97025|NCT00790400|336331|P2|Double-blind Period (Core Phase)|Administrative problems|0
97026|NCT00790400|336332|P1|Double-blind Period (Core Phase)|Administrative problems|1
97027|NCT00790400|336331|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
97028|NCT00790400|336332|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
97029|NCT00790400|336331|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
97030|NCT00790400|336332|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
97031|NCT00790400|336331|P2|Double-blind Period (Core Phase)|Adverse Event|4
97032|NCT00790400|336332|P1|Double-blind Period (Core Phase)|Adverse Event|2
97033|NCT00790400|336331|P2|Double-blind Period (Core Phase)|Progressive disease|9
97034|NCT00790400|336332|P1|Double-blind Period (Core Phase)|Progressive disease|0
97035|NCT00790400|336331|P2|Double-blind Period (Core Phase)|Protocol Violation|0
97036|NCT00790400|336332|P1|Double-blind Period (Core Phase)|Protocol Violation|1
97037|NCT00790296|336361|P2|Overall Study|Adverse Event|1
97038|NCT00790296|336362|P1|Overall Study|Adverse Event|0
97039|NCT00790296|336361|P2|Overall Study|Did not meet study eligibility criteria|1
97040|NCT00790296|336362|P1|Overall Study|Did not meet study eligibility criteria|1
97041|NCT00790218|336384|P3|Overall Study|Death|0
97042|NCT00790218|336385|P2|Overall Study|Death|0
97043|NCT00790218|336386|P1|Overall Study|Death|1
97044|NCT00790205|336396|P2|Overall Study|Withdrawal by Subject|363
97045|NCT00790205|336397|P1|Overall Study|Withdrawal by Subject|299
97046|NCT00790205|336396|P2|Overall Study|Lost to Follow-up|71
97047|NCT00790205|336397|P1|Overall Study|Lost to Follow-up|61
97048|NCT00790023|336495|P3|Overall Study|Not specified|8
97049|NCT00790023|336496|P2|Overall Study|Not specified|5
97050|NCT00790023|336497|P1|Overall Study|Not specified|5
97051|NCT00790023|336495|P3|Overall Study|Lost to Follow-up|1
97052|NCT00790023|336496|P2|Overall Study|Lost to Follow-up|0
97053|NCT00790023|336497|P1|Overall Study|Lost to Follow-up|0
97054|NCT00790023|336495|P3|Overall Study|Withdrawal by Subject|6
97055|NCT00790023|336496|P2|Overall Study|Withdrawal by Subject|0
97056|NCT00790023|336497|P1|Overall Study|Withdrawal by Subject|2
97057|NCT00790023|336495|P3|Overall Study|Protocol Violation|2
97058|NCT00790023|336496|P2|Overall Study|Protocol Violation|4
97059|NCT00790023|336497|P1|Overall Study|Protocol Violation|2
97060|NCT00790023|336495|P3|Overall Study|Adverse Event|4
97061|NCT00790023|336496|P2|Overall Study|Adverse Event|1
97062|NCT00790023|336497|P1|Overall Study|Adverse Event|2
97063|NCT00789958|336596|P1|Overall Study|Not eligible/not analyzable|26
97064|NCT00789958|336596|P1|Overall Study|not protocol specified|1
97065|NCT00789958|336596|P1|Overall Study|Progression|3
97066|NCT00789958|336596|P1|Overall Study|Withdrawal by Subject|4
97067|NCT00789958|336596|P1|Overall Study|Adverse Event|3
97068|NCT00789880|336615|P6|Overall Study|Withdrawal by Subject|0
97069|NCT00789880|336616|P5|Overall Study|Withdrawal by Subject|2
97070|NCT00789880|336617|P4|Overall Study|Withdrawal by Subject|0
97071|NCT00789880|336618|P3|Overall Study|Withdrawal by Subject|0
97072|NCT00789880|336619|P2|Overall Study|Withdrawal by Subject|0
97073|NCT00789880|336620|P1|Overall Study|Withdrawal by Subject|1
97074|NCT00789880|336615|P6|Overall Study|Protocol Violation|0
97075|NCT00789880|336616|P5|Overall Study|Protocol Violation|0
97076|NCT00789880|336617|P4|Overall Study|Protocol Violation|1
97077|NCT00789880|336618|P3|Overall Study|Protocol Violation|0
97078|NCT00789880|336619|P2|Overall Study|Protocol Violation|1
97079|NCT00789880|336620|P1|Overall Study|Protocol Violation|0
97080|NCT00789880|336615|P6|Overall Study|Adverse Event|0
97081|NCT00789880|336616|P5|Overall Study|Adverse Event|1
97082|NCT00789880|336617|P4|Overall Study|Adverse Event|0
97083|NCT00789880|336618|P3|Overall Study|Adverse Event|0
97084|NCT00789880|336619|P2|Overall Study|Adverse Event|0
97085|NCT00789880|336620|P1|Overall Study|Adverse Event|0
97086|NCT00789854|336649|P3|Overall Study|Other|5
97087|NCT00789854|336650|P2|Overall Study|Other|0
97088|NCT00789854|336651|P1|Overall Study|Other|6
97089|NCT00789854|336649|P3|Overall Study|Safety reasons|2
97090|NCT00789854|336650|P2|Overall Study|Safety reasons|0
97091|NCT00789854|336651|P1|Overall Study|Safety reasons|0
97092|NCT00789854|336649|P3|Overall Study|Severe non-compliance to the protocol|0
97093|NCT00789854|336650|P2|Overall Study|Severe non-compliance to the protocol|0
97094|NCT00789854|336651|P1|Overall Study|Severe non-compliance to the protocol|3
97095|NCT00789854|336649|P3|Overall Study|Eligibility criteria not fulfilled|1
97096|NCT00789854|336650|P2|Overall Study|Eligibility criteria not fulfilled|5
97097|NCT00789854|336651|P1|Overall Study|Eligibility criteria not fulfilled|2
97098|NCT00789854|336649|P3|Overall Study|Withdrawal by Subject|17
97099|NCT00789854|336650|P2|Overall Study|Withdrawal by Subject|6
97100|NCT00789854|336651|P1|Overall Study|Withdrawal by Subject|9
97101|NCT00789854|336649|P3|Overall Study|Lost to Follow-up|4
97102|NCT00789854|336650|P2|Overall Study|Lost to Follow-up|1
97103|NCT00789854|336651|P1|Overall Study|Lost to Follow-up|1
97104|NCT00789854|336649|P3|Overall Study|Adverse Event|18
97105|NCT00789854|336650|P2|Overall Study|Adverse Event|23
97106|NCT00789854|336651|P1|Overall Study|Adverse Event|28
97107|NCT00789828|336748|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
97108|NCT00789828|336749|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
97109|NCT00789828|336748|P2|Open-label Extension Period (4 Years)|Disease progression|0
97110|NCT00789828|336749|P1|Open-label Extension Period (4 Years)|Disease progression|1
97111|NCT00789828|336748|P2|Open-label Extension Period (4 Years)|Death|0
97112|NCT00789828|336749|P1|Open-label Extension Period (4 Years)|Death|1
97113|NCT00789828|336748|P2|Open-label Extension Period (4 Years)|Administrative problems|0
97114|NCT00789828|336749|P1|Open-label Extension Period (4 Years)|Administrative problems|7
97115|NCT00789828|336748|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
97116|NCT00789828|336749|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
97117|NCT00789828|336748|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
97118|NCT00789828|336749|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
97119|NCT00789828|336748|P2|Open-label Extension Period (4 Years)|Adverse Event|0
97120|NCT00789828|336749|P1|Open-label Extension Period (4 Years)|Adverse Event|10
97121|NCT00789828|336748|P2|Core Period (48 Weeks)|Lost to Follow-up|1
97122|NCT00789828|336749|P1|Core Period (48 Weeks)|Lost to Follow-up|0
97123|NCT00789828|336748|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
97124|NCT00789828|336749|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
97125|NCT00789828|336748|P2|Core Period (48 Weeks)|Administrative problems|1
97126|NCT00789828|336749|P1|Core Period (48 Weeks)|Administrative problems|0
97127|NCT00789815|336783|P2|Overall Study|Intubation due to massive bleeding|0
97128|NCT00789815|336784|P1|Overall Study|Intubation due to massive bleeding|1
97129|NCT00789815|336783|P2|Overall Study|Protocol Violation|1
97130|NCT00789815|336784|P1|Overall Study|Protocol Violation|6
97131|NCT00789737|336819|P2|Overall Study|not specified|7
97132|NCT00789737|336820|P1|Overall Study|not specified|11
97133|NCT00789737|336819|P2|Overall Study|hyperglycemia that met protocol-specifie|4
97134|NCT00789737|336820|P1|Overall Study|hyperglycemia that met protocol-specifie|0
97135|NCT00789737|336819|P2|Overall Study|Lack of Efficacy|0
97136|NCT00789737|336820|P1|Overall Study|Lack of Efficacy|3
97137|NCT00789737|336819|P2|Overall Study|Protocol Violation|0
97138|NCT00789737|336820|P1|Overall Study|Protocol Violation|3
97139|NCT00789737|336819|P2|Overall Study|Adverse Event|8
97140|NCT00789737|336820|P1|Overall Study|Adverse Event|8
97141|NCT00789737|336819|P2|Overall Study|Lost to Follow-up|14
97142|NCT00789737|336820|P1|Overall Study|Lost to Follow-up|10
97143|NCT00789737|336819|P2|Overall Study|Withdrawal by Subject|22
97144|NCT00789737|336820|P1|Overall Study|Withdrawal by Subject|13
97145|NCT00789698|336863|P4|Overall Study|Administrative|1
97146|NCT00789698|336864|P3|Overall Study|Administrative|3
97147|NCT00789698|336865|P2|Overall Study|Administrative|3
97148|NCT00789698|336866|P1|Overall Study|Administrative|0
97149|NCT00789698|336863|P4|Overall Study|Withdrawal by Subject|19
97150|NCT00789698|336864|P3|Overall Study|Withdrawal by Subject|12
97151|NCT00789698|336865|P2|Overall Study|Withdrawal by Subject|15
97152|NCT00789698|336866|P1|Overall Study|Withdrawal by Subject|14
97153|NCT00789698|336863|P4|Overall Study|Protocol Violation|1
97154|NCT00789698|336864|P3|Overall Study|Protocol Violation|2
97155|NCT00789698|336865|P2|Overall Study|Protocol Violation|1
97156|NCT00789698|336866|P1|Overall Study|Protocol Violation|6
97157|NCT00789698|336863|P4|Overall Study|Lost to Follow-up|9
97158|NCT00789698|336864|P3|Overall Study|Lost to Follow-up|2
97159|NCT00789698|336865|P2|Overall Study|Lost to Follow-up|5
97160|NCT00789698|336866|P1|Overall Study|Lost to Follow-up|5
97161|NCT00789698|336863|P4|Overall Study|Adverse Event|4
97162|NCT00789698|336864|P3|Overall Study|Adverse Event|3
97163|NCT00789698|336865|P2|Overall Study|Adverse Event|5
97164|NCT00789698|336866|P1|Overall Study|Adverse Event|5
97165|NCT00789698|336863|P4|Overall Study|Lack of Efficacy|18
97166|NCT00789698|336864|P3|Overall Study|Lack of Efficacy|5
97167|NCT00789698|336865|P2|Overall Study|Lack of Efficacy|4
97168|NCT00789698|336866|P1|Overall Study|Lack of Efficacy|10
97169|NCT00789555|336922|P3|Overall Study|Protocol Violation|13
97170|NCT00789555|336923|P2|Overall Study|Protocol Violation|9
97171|NCT00789555|336924|P1|Overall Study|Protocol Violation|6
97172|NCT00789555|336922|P3|Overall Study|Treatment failure|12
97173|NCT00789555|336923|P2|Overall Study|Treatment failure|8
97174|NCT00789555|336924|P1|Overall Study|Treatment failure|11
97175|NCT00789555|336922|P3|Overall Study|Patient decision unnrelated to adv event|26
97176|NCT00789555|336923|P2|Overall Study|Patient decision unnrelated to adv event|29
97177|NCT00789555|336924|P1|Overall Study|Patient decision unnrelated to adv event|38
97178|NCT00789555|336922|P3|Overall Study|Lost to Follow-up|18
97179|NCT00789555|336923|P2|Overall Study|Lost to Follow-up|10
97180|NCT00789555|336924|P1|Overall Study|Lost to Follow-up|9
97181|NCT00789555|336922|P3|Overall Study|Adverse Event|10
97182|NCT00789555|336923|P2|Overall Study|Adverse Event|7
97183|NCT00789555|336924|P1|Overall Study|Adverse Event|17
97184|NCT00789555|336922|P3|Overall Study|Protocol Amendment|80
97185|NCT00789555|336923|P2|Overall Study|Protocol Amendment|76
97186|NCT00789555|336924|P1|Overall Study|Protocol Amendment|78
97187|NCT00789529|336949|P2|Overall Study|Other Reason|0
97188|NCT00789529|336950|P1|Overall Study|Other Reason|1
97189|NCT00789529|336949|P2|Overall Study|Withdrawal by Subject|1
97190|NCT00789529|336950|P1|Overall Study|Withdrawal by Subject|0
97191|NCT00789477|336963|P5|Overall Study|Other|0
97192|NCT00789477|336964|P4|Overall Study|Other|3
97193|NCT00789477|336965|P3|Overall Study|Other|1
97194|NCT00789477|336966|P2|Overall Study|Other|0
97195|NCT00789477|336967|P1|Overall Study|Other|2
97196|NCT00789477|336963|P5|Overall Study|Lack of Efficacy|0
97197|NCT00789477|336964|P4|Overall Study|Lack of Efficacy|0
97198|NCT00789477|336965|P3|Overall Study|Lack of Efficacy|0
97199|NCT00789477|336966|P2|Overall Study|Lack of Efficacy|0
97200|NCT00789477|336967|P1|Overall Study|Lack of Efficacy|2
97201|NCT00789477|336963|P5|Overall Study|Lost to Follow-up|4
97202|NCT00789477|336964|P4|Overall Study|Lost to Follow-up|2
97203|NCT00789477|336965|P3|Overall Study|Lost to Follow-up|4
97204|NCT00789477|336966|P2|Overall Study|Lost to Follow-up|1
97205|NCT00789477|336967|P1|Overall Study|Lost to Follow-up|0
97206|NCT00789477|336963|P5|Overall Study|Death|0
97207|NCT00789477|336964|P4|Overall Study|Death|2
97208|NCT00789477|336965|P3|Overall Study|Death|2
97209|NCT00789477|336966|P2|Overall Study|Death|1
97210|NCT00789477|336967|P1|Overall Study|Death|1
97211|NCT00789477|336963|P5|Overall Study|Adverse Event|0
97212|NCT00789477|336964|P4|Overall Study|Adverse Event|0
97213|NCT00789477|336965|P3|Overall Study|Adverse Event|1
97214|NCT00789477|336966|P2|Overall Study|Adverse Event|3
97215|NCT00789477|336967|P1|Overall Study|Adverse Event|3
97216|NCT00789477|336963|P5|Overall Study|Protocol Violation|0
97217|NCT00789477|336964|P4|Overall Study|Protocol Violation|1
97218|NCT00789477|336965|P3|Overall Study|Protocol Violation|0
97219|NCT00789477|336966|P2|Overall Study|Protocol Violation|0
97220|NCT00789477|336967|P1|Overall Study|Protocol Violation|1
97221|NCT00789477|336963|P5|Overall Study|Withdrawal by Subject|3
97222|NCT00789477|336964|P4|Overall Study|Withdrawal by Subject|2
97223|NCT00789477|336965|P3|Overall Study|Withdrawal by Subject|3
97224|NCT00789477|336966|P2|Overall Study|Withdrawal by Subject|1
97225|NCT00789477|336967|P1|Overall Study|Withdrawal by Subject|2
97226|NCT00789373|337012|P3|Maintenance|Participants On-Going at Data Cut-Off|0
97227|NCT00789373|337013|P2|Maintenance|Participants On-Going at Data Cut-Off|4
97228|NCT00789373|337014|P1|Maintenance|Participants On-Going at Data Cut-Off|0
97229|NCT00789373|337012|P3|Maintenance|Sponsor Decision|2
97230|NCT00789373|337013|P2|Maintenance|Sponsor Decision|0
97231|NCT00789373|337014|P1|Maintenance|Sponsor Decision|0
97232|NCT00789373|337012|P3|Maintenance|Withdrawal by Subject|8
97233|NCT00789373|337013|P2|Maintenance|Withdrawal by Subject|21
97234|NCT00789373|337014|P1|Maintenance|Withdrawal by Subject|0
97235|NCT00789373|337012|P3|Maintenance|Progressive Disease|152
97236|NCT00789373|337013|P2|Maintenance|Progressive Disease|253
97237|NCT00789373|337014|P1|Maintenance|Progressive Disease|0
97238|NCT00789373|337012|P3|Maintenance|Lost to Follow-up|0
97239|NCT00789373|337013|P2|Maintenance|Lost to Follow-up|2
97240|NCT00789373|337014|P1|Maintenance|Lost to Follow-up|0
97241|NCT00789373|337012|P3|Maintenance|Protocol entry criteria not met|0
97242|NCT00789373|337013|P2|Maintenance|Protocol entry criteria not met|2
97243|NCT00789373|337014|P1|Maintenance|Protocol entry criteria not met|0
97244|NCT00789373|337012|P3|Maintenance|Investigator Decision|2
97245|NCT00789373|337013|P2|Maintenance|Investigator Decision|4
97246|NCT00789373|337014|P1|Maintenance|Investigator Decision|0
97247|NCT00789373|337012|P3|Maintenance|Death due to toxicity|2
97248|NCT00789373|337013|P2|Maintenance|Death due to toxicity|1
97249|NCT00789373|337014|P1|Maintenance|Death due to toxicity|0
97250|NCT00789373|337012|P3|Maintenance|Death due to adverse event|1
97251|NCT00789373|337013|P2|Maintenance|Death due to adverse event|4
97252|NCT00789373|337014|P1|Maintenance|Death due to adverse event|0
97253|NCT00789373|337012|P3|Maintenance|Death due to study disease|1
97254|NCT00789373|337013|P2|Maintenance|Death due to study disease|3
97255|NCT00789373|337014|P1|Maintenance|Death due to study disease|0
97256|NCT00789373|337012|P3|Maintenance|Adverse Event|12
97257|NCT00789373|337013|P2|Maintenance|Adverse Event|65
97258|NCT00789373|337014|P1|Maintenance|Adverse Event|0
97259|NCT00789373|337012|P3|Induction|Withdrawal by Subject|0
97260|NCT00789373|337013|P2|Induction|Withdrawal by Subject|0
97261|NCT00789373|337014|P1|Induction|Withdrawal by Subject|37
97262|NCT00789373|337012|P3|Induction|Progressive Disease|0
97263|NCT00789373|337013|P2|Induction|Progressive Disease|0
97264|NCT00789373|337014|P1|Induction|Progressive Disease|220
97265|NCT00789373|337012|P3|Induction|Protocol Violation|0
97266|NCT00789373|337013|P2|Induction|Protocol Violation|0
97267|NCT00789373|337014|P1|Induction|Protocol Violation|1
97268|NCT00789373|337012|P3|Induction|Lost to Follow-up|0
97269|NCT00789373|337013|P2|Induction|Lost to Follow-up|0
97270|NCT00789373|337014|P1|Induction|Lost to Follow-up|6
97271|NCT00789373|337012|P3|Induction|Protocol entry criteria not met|0
97272|NCT00789373|337013|P2|Induction|Protocol entry criteria not met|0
97273|NCT00789373|337014|P1|Induction|Protocol entry criteria not met|9
97274|NCT00789373|337012|P3|Induction|Investigator decision|0
97275|NCT00789373|337013|P2|Induction|Investigator decision|0
97276|NCT00789373|337014|P1|Induction|Investigator decision|7
97277|NCT00789373|337012|P3|Induction|Death due to procedure|0
97278|NCT00789373|337013|P2|Induction|Death due to procedure|0
97279|NCT00789373|337014|P1|Induction|Death due to procedure|1
97280|NCT00789373|337012|P3|Induction|Death due to toxicity|0
97281|NCT00789373|337013|P2|Induction|Death due to toxicity|0
97282|NCT00789373|337014|P1|Induction|Death due to toxicity|11
97283|NCT00789373|337012|P3|Induction|Death due to adverse event|0
97284|NCT00789373|337013|P2|Induction|Death due to adverse event|0
97285|NCT00789373|337014|P1|Induction|Death due to adverse event|19
97286|NCT00789373|337012|P3|Induction|Death Due to study disease|0
97287|NCT00789373|337013|P2|Induction|Death Due to study disease|0
97288|NCT00789373|337014|P1|Induction|Death Due to study disease|24
97289|NCT00789373|337012|P3|Induction|Adverse Event|0
97290|NCT00789373|337013|P2|Induction|Adverse Event|0
97291|NCT00789373|337014|P1|Induction|Adverse Event|64
97292|NCT00787839|337048|P1|Overall Study|Failure to have the OGTT was most common|404
97293|NCT00787800|337071|P2|Overall Study|Death|2
97294|NCT00787800|337072|P1|Overall Study|Death|0
97295|NCT00787800|337071|P2|Overall Study|Withdrawal by Subject|5
97296|NCT00787800|337072|P1|Overall Study|Withdrawal by Subject|3
97297|NCT00789321|337101|P2|Overall Study|Adverse Event|1
97298|NCT00789321|337102|P1|Overall Study|Adverse Event|0
97299|NCT00789191|337121|P2|Overall Study|Unclassified|3
97300|NCT00789191|337122|P1|Overall Study|Unclassified|5
97301|NCT00789191|337121|P2|Overall Study|Withdrawal Criteria|4
97302|NCT00789191|337122|P1|Overall Study|Withdrawal Criteria|2
97303|NCT00789191|337121|P2|Overall Study|Protocol Violation|3
97304|NCT00789191|337122|P1|Overall Study|Protocol Violation|5
97305|NCT00789191|337121|P2|Overall Study|Lack of Efficacy|5
97306|NCT00789191|337122|P1|Overall Study|Lack of Efficacy|0
97307|NCT00789191|337121|P2|Overall Study|Adverse Event|4
97308|NCT00789191|337122|P1|Overall Study|Adverse Event|2
97309|NCT00789035|337179|P5|Overall Study|Other reason not defined above|1
97310|NCT00789035|337180|P4|Overall Study|Other reason not defined above|0
97311|NCT00789035|337181|P3|Overall Study|Other reason not defined above|1
97312|NCT00789035|337182|P2|Overall Study|Other reason not defined above|3
97313|NCT00789035|337183|P1|Overall Study|Other reason not defined above|2
97314|NCT00789035|337179|P5|Overall Study|Withdrawal by Subject|0
97315|NCT00789035|337180|P4|Overall Study|Withdrawal by Subject|0
97316|NCT00789035|337181|P3|Overall Study|Withdrawal by Subject|0
97317|NCT00789035|337182|P2|Overall Study|Withdrawal by Subject|2
97318|NCT00789035|337183|P1|Overall Study|Withdrawal by Subject|0
97319|NCT00789035|337179|P5|Overall Study|Protocol Violation|0
97320|NCT00789035|337180|P4|Overall Study|Protocol Violation|0
97321|NCT00789035|337181|P3|Overall Study|Protocol Violation|0
97322|NCT00789035|337182|P2|Overall Study|Protocol Violation|0
97323|NCT00789035|337183|P1|Overall Study|Protocol Violation|1
97324|NCT00789035|337179|P5|Overall Study|Lack of Efficacy|2
97325|NCT00789035|337180|P4|Overall Study|Lack of Efficacy|0
97326|NCT00789035|337181|P3|Overall Study|Lack of Efficacy|0
97327|NCT00789035|337182|P2|Overall Study|Lack of Efficacy|0
97328|NCT00789035|337183|P1|Overall Study|Lack of Efficacy|3
97329|NCT00789035|337179|P5|Overall Study|Adverse Event|3
97330|NCT00789035|337180|P4|Overall Study|Adverse Event|1
97331|NCT00789035|337181|P3|Overall Study|Adverse Event|0
97332|NCT00789035|337182|P2|Overall Study|Adverse Event|2
97333|NCT00789035|337183|P1|Overall Study|Adverse Event|0
97334|NCT00788957|337242|P6|Part 3|On-study at time of data cut-off|0
97335|NCT00788957|337243|P5|Part 3|On-study at time of data cut-off|1
97336|NCT00788957|337244|P4|Part 3|On-study at time of data cut-off|0
97337|NCT00788957|337245|P3|Part 3|On-study at time of data cut-off|0
97338|NCT00788957|337246|P2|Part 3|On-study at time of data cut-off|0
97339|NCT00788957|337247|P1|Part 3|On-study at time of data cut-off|0
97340|NCT00788957|337242|P6|Part 3|Death|9
97341|NCT00788957|337243|P5|Part 3|Death|8
97342|NCT00788957|337244|P4|Part 3|Death|0
97343|NCT00788957|337245|P3|Part 3|Death|0
97344|NCT00788957|337246|P2|Part 3|Death|0
97345|NCT00788957|337247|P1|Part 3|Death|0
97346|NCT00788957|337242|P6|Part 3|Withdrawal by Subject|2
97347|NCT00788957|337243|P5|Part 3|Withdrawal by Subject|0
97348|NCT00788957|337244|P4|Part 3|Withdrawal by Subject|0
97349|NCT00788957|337245|P3|Part 3|Withdrawal by Subject|0
97350|NCT00788957|337246|P2|Part 3|Withdrawal by Subject|0
97351|NCT00788957|337247|P1|Part 3|Withdrawal by Subject|0
97352|NCT00788957|337242|P6|Part 2|On-study at time of data cut-off|0
97353|NCT00788957|337243|P5|Part 2|On-study at time of data cut-off|0
97354|NCT00788957|337244|P4|Part 2|On-study at time of data cut-off|1
97355|NCT00788957|337245|P3|Part 2|On-study at time of data cut-off|1
97356|NCT00788957|337246|P2|Part 2|On-study at time of data cut-off|1
97357|NCT00788957|337247|P1|Part 2|On-study at time of data cut-off|0
97358|NCT00788957|337242|P6|Part 2|Lost to Follow-up|0
97359|NCT00788957|337243|P5|Part 2|Lost to Follow-up|0
97360|NCT00788957|337244|P4|Part 2|Lost to Follow-up|0
97361|NCT00788957|337245|P3|Part 2|Lost to Follow-up|3
97362|NCT00788957|337246|P2|Part 2|Lost to Follow-up|0
97363|NCT00788957|337247|P1|Part 2|Lost to Follow-up|0
97364|NCT00788957|337242|P6|Part 2|Death|0
97365|NCT00788957|337243|P5|Part 2|Death|0
97366|NCT00788957|337244|P4|Part 2|Death|37
97367|NCT00788957|337245|P3|Part 2|Death|35
97368|NCT00788957|337246|P2|Part 2|Death|32
97369|NCT00788957|337247|P1|Part 2|Death|0
97370|NCT00788957|337242|P6|Part 2|Withdrawal by Subject|0
97371|NCT00788957|337243|P5|Part 2|Withdrawal by Subject|0
97372|NCT00788957|337244|P4|Part 2|Withdrawal by Subject|3
97373|NCT00788957|337245|P3|Part 2|Withdrawal by Subject|5
97374|NCT00788957|337246|P2|Part 2|Withdrawal by Subject|9
97375|NCT00788957|337247|P1|Part 2|Withdrawal by Subject|0
97376|NCT00788957|337242|P6|Part 1|Lost to Follow-up|0
97377|NCT00788957|337243|P5|Part 1|Lost to Follow-up|0
97378|NCT00788957|337244|P4|Part 1|Lost to Follow-up|0
97379|NCT00788957|337245|P3|Part 1|Lost to Follow-up|0
97380|NCT00788957|337246|P2|Part 1|Lost to Follow-up|0
97381|NCT00788957|337247|P1|Part 1|Lost to Follow-up|1
97382|NCT00788957|337242|P6|Part 1|Death|0
97383|NCT00788957|337243|P5|Part 1|Death|0
97384|NCT00788957|337244|P4|Part 1|Death|0
97385|NCT00788957|337245|P3|Part 1|Death|0
97386|NCT00788957|337246|P2|Part 1|Death|0
97387|NCT00788957|337247|P1|Part 1|Death|8
97388|NCT00788775|337303|P2|Overall Study|Patient's measurable disease resected.|0
97389|NCT00788775|337304|P1|Overall Study|Patient's measurable disease resected.|1
97390|NCT00788775|337303|P2|Overall Study|Patient Non-Compliance|0
97391|NCT00788775|337304|P1|Overall Study|Patient Non-Compliance|1
97392|NCT00788775|337303|P2|Overall Study|Withdrawal by Subject|2
97393|NCT00788775|337304|P1|Overall Study|Withdrawal by Subject|0
97394|NCT00788775|337303|P2|Overall Study|Progressive Disease|6
97395|NCT00788775|337304|P1|Overall Study|Progressive Disease|8
97396|NCT00788710|337319|P3|Overall Study|Withdrawal by Subject|0
97397|NCT00788710|337320|P2|Overall Study|Withdrawal by Subject|2
97398|NCT00788710|337321|P1|Overall Study|Withdrawal by Subject|2
97399|NCT00788710|337319|P3|Overall Study|Protocol Violation|1
97400|NCT00788710|337320|P2|Overall Study|Protocol Violation|1
97401|NCT00788710|337321|P1|Overall Study|Protocol Violation|0
97402|NCT00788710|337319|P3|Overall Study|Physician Decision|0
97403|NCT00788710|337320|P2|Overall Study|Physician Decision|1
97404|NCT00788710|337321|P1|Overall Study|Physician Decision|2
97405|NCT00788710|337319|P3|Overall Study|Lost to Follow-up|0
97406|NCT00788710|337320|P2|Overall Study|Lost to Follow-up|1
97407|NCT00788710|337321|P1|Overall Study|Lost to Follow-up|0
97408|NCT00788710|337319|P3|Overall Study|Lack of Efficacy|1
97409|NCT00788710|337320|P2|Overall Study|Lack of Efficacy|0
97410|NCT00788710|337321|P1|Overall Study|Lack of Efficacy|0
97411|NCT00788710|337319|P3|Overall Study|Adverse Event|4
97412|NCT00788710|337320|P2|Overall Study|Adverse Event|3
97413|NCT00788710|337321|P1|Overall Study|Adverse Event|1
97414|NCT00788593|337335|P3|Second Intervention Period|Unspecified|1
97415|NCT00788593|337336|P2|Second Intervention Period|Unspecified|0
97416|NCT00788593|337337|P1|Second Intervention Period|Unspecified|0
97417|NCT00788593|337335|P3|Second Intervention Period|Lost to Follow-up|0
97418|NCT00788593|337336|P2|Second Intervention Period|Lost to Follow-up|1
97419|NCT00788593|337337|P1|Second Intervention Period|Lost to Follow-up|0
97420|NCT00788593|337335|P3|First Intervention Period|Adverse Event|0
97421|NCT00788593|337336|P2|First Intervention Period|Adverse Event|1
97422|NCT00788593|337337|P1|First Intervention Period|Adverse Event|0
97423|NCT00788593|337335|P3|Placebo Run-in Phase|Protocol Violation|0
97424|NCT00788593|337336|P2|Placebo Run-in Phase|Protocol Violation|0
97425|NCT00788593|337337|P1|Placebo Run-in Phase|Protocol Violation|2
97426|NCT00788593|337335|P3|Placebo Run-in Phase|Withdrawal by Subject|0
97427|NCT00788593|337336|P2|Placebo Run-in Phase|Withdrawal by Subject|0
97428|NCT00788593|337337|P1|Placebo Run-in Phase|Withdrawal by Subject|2
97429|NCT00788593|337335|P3|Placebo Run-in Phase|Adverse Event|0
97430|NCT00788593|337336|P2|Placebo Run-in Phase|Adverse Event|0
97431|NCT00788593|337337|P1|Placebo Run-in Phase|Adverse Event|2
97432|NCT00787644|337356|P2|Overall Study|Withdrawal by Subject|1
97433|NCT00787644|337357|P1|Overall Study|Withdrawal by Subject|1
97434|NCT00787644|337356|P2|Overall Study|Lost to Follow-up|1
97435|NCT00787644|337357|P1|Overall Study|Lost to Follow-up|1
97436|NCT00787605|337378|P2|Overall Study|Lack of Efficacy|9
97437|NCT00787605|337379|P1|Overall Study|Lack of Efficacy|13
97438|NCT00787605|337378|P2|Overall Study|Withdrawal by Subject|13
97439|NCT00787605|337379|P1|Overall Study|Withdrawal by Subject|6
97440|NCT00787605|337378|P2|Overall Study|Protocol Violation|3
97441|NCT00787605|337379|P1|Overall Study|Protocol Violation|7
97442|NCT00787605|337378|P2|Overall Study|Lost to Follow-up|6
97443|NCT00787605|337379|P1|Overall Study|Lost to Follow-up|3
97444|NCT00787605|337378|P2|Overall Study|Adverse Event|25
97445|NCT00787605|337379|P1|Overall Study|Adverse Event|14
97446|NCT00787605|337378|P2|Overall Study|Administrative Problems|0
97447|NCT00787605|337379|P1|Overall Study|Administrative Problems|3
97448|NCT00788372|337395|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
97449|NCT00788372|337395|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
97450|NCT00788372|337395|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
97451|NCT00788372|337395|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
97452|NCT00788372|337395|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
97453|NCT00788372|337395|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
97454|NCT00788372|337395|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
97455|NCT00788073|337424|P2|Placebo Then STX209|Protocol Violation|1
97456|NCT00788073|337425|P1|Placebo Then STX209|Protocol Violation|0
97457|NCT00788073|337424|P2|Placebo Then STX209|Adverse Event|0
97458|NCT00788073|337425|P1|Placebo Then STX209|Adverse Event|2
97459|NCT00788073|337424|P2|STX209 Then Placebo|unable to return due to travel|1
97460|NCT00788073|337425|P1|STX209 Then Placebo|unable to return due to travel|0
97461|NCT00788073|337424|P2|STX209 Then Placebo|Withdrawal by Subject|1
97462|NCT00788073|337425|P1|STX209 Then Placebo|Withdrawal by Subject|0
97463|NCT00788073|337424|P2|STX209 Then Placebo|Lost to Follow-up|1
97464|NCT00788073|337425|P1|STX209 Then Placebo|Lost to Follow-up|0
97465|NCT00788073|337424|P2|STX209 Then Placebo|Adverse Event|0
97466|NCT00788073|337425|P1|STX209 Then Placebo|Adverse Event|1
97467|NCT00787930|337450|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
97468|NCT00787917|337465|P2|Open Label|Administrative problems|0
97469|NCT00787917|337466|P1|Open Label|Administrative problems|3
97470|NCT00787917|337465|P2|Open Label|Unsatisfactory therapeutic effect|0
97471|NCT00787917|337466|P1|Open Label|Unsatisfactory therapeutic effect|1
97472|NCT00787917|337465|P2|Blinded Treatment|Administrative problems|2
97473|NCT00787917|337466|P1|Blinded Treatment|Administrative problems|3
97474|NCT00787917|337465|P2|Blinded Treatment|Lack of Efficacy|0
97475|NCT00787917|337466|P1|Blinded Treatment|Lack of Efficacy|1
97476|NCT00787917|337465|P2|Blinded Treatment|Adverse Event|0
97477|NCT00787917|337466|P1|Blinded Treatment|Adverse Event|1
97478|NCT00787891|337496|P2|Maintenance Double-blind Phase (Part 2)|Not specified|2
97479|NCT00787891|337497|P1|Maintenance Double-blind Phase (Part 2)|Not specified|5
97480|NCT00787891|337496|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
97481|NCT00787891|337497|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
97482|NCT00787891|337496|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
97483|NCT00787891|337497|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
97484|NCT00787891|337496|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
97485|NCT00787891|337497|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
97486|NCT00787891|337496|P2|Short-term Double-blind Phase (Part 1)|Not specified|2
97487|NCT00787891|337497|P1|Short-term Double-blind Phase (Part 1)|Not specified|0
97488|NCT00787891|337496|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
97489|NCT00787891|337497|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
97490|NCT00787891|337496|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
97491|NCT00787891|337497|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
97492|NCT00787891|337496|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
97493|NCT00787891|337497|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
97494|NCT00787891|337496|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
97495|NCT00787891|337497|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
97496|NCT00787891|337496|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
97497|NCT00787891|337497|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
97498|NCT00787566|337518|P3|Overall Study|AE related to chemotherapy|0
97499|NCT00787566|337519|P2|Overall Study|AE related to chemotherapy|1
97500|NCT00787566|337520|P1|Overall Study|AE related to chemotherapy|0
97501|NCT00787527|337528|P1|Overall Study|Toxicity|3
97502|NCT00787319|337545|P1|Overall Study|Inactive disease|5
97503|NCT00787319|337545|P1|Overall Study|Stabilized disease findings|3
97504|NCT00787319|337545|P1|Overall Study|No health insurance reimbursement|2
97505|NCT00787319|337545|P1|Overall Study|Unresponsiveness to visit invitation|1
97506|NCT00787319|337545|P1|Overall Study|Budget exhausted/exceeded|1
97507|NCT00787319|337545|P1|Overall Study|Lack of Efficacy|1
97508|NCT00787319|337545|P1|Overall Study|Objective progression or relapse|30
97509|NCT00787319|337545|P1|Overall Study|Adverse Event|3
97510|NCT00787319|337545|P1|Overall Study|Withdrawal by Subject|15
97511|NCT00787319|337545|P1|Overall Study|Lost to Follow-up|2
97512|NCT00787267|337557|P1|Overall Study|Withdrawal by Subject|1
97513|NCT00787267|337557|P1|Overall Study|No Reason Provided|1
97514|NCT00787267|337557|P1|Overall Study|Screen failure/Ineligible|10
97515|NCT00787254|337567|P2|Overall Study|Physician Decision|8
97516|NCT00787254|337568|P1|Overall Study|Physician Decision|4
97517|NCT00787254|337567|P2|Overall Study|Institution closed|0
97518|NCT00787254|337568|P1|Overall Study|Institution closed|1
97519|NCT00787254|337567|P2|Overall Study|NSAIDs discontinuation|2
97520|NCT00787254|337568|P1|Overall Study|NSAIDs discontinuation|1
97521|NCT00787254|337567|P2|Overall Study|Lack of Efficacy|15
97522|NCT00787254|337568|P1|Overall Study|Lack of Efficacy|4
97523|NCT00787254|337567|P2|Overall Study|Withdrawal by Subject|11
97524|NCT00787254|337568|P1|Overall Study|Withdrawal by Subject|16
97525|NCT00787254|337567|P2|Overall Study|Protocol Violation|23
97526|NCT00787254|337568|P1|Overall Study|Protocol Violation|26
97527|NCT00787254|337567|P2|Overall Study|Adverse Event|23
97528|NCT00787254|337568|P1|Overall Study|Adverse Event|24
97529|NCT00787202|337692|P5|Overall Study|Randomized, not treated|0
97530|NCT00787202|337693|P4|Overall Study|Randomized, not treated|0
97531|NCT00787202|337694|P3|Overall Study|Randomized, not treated|0
97532|NCT00787202|337695|P2|Overall Study|Randomized, not treated|0
97533|NCT00787202|337696|P1|Overall Study|Randomized, not treated|1
97534|NCT00787202|337692|P5|Overall Study|Protocol Violation|1
97535|NCT00787202|337693|P4|Overall Study|Protocol Violation|0
97536|NCT00787202|337694|P3|Overall Study|Protocol Violation|0
97537|NCT00787202|337695|P2|Overall Study|Protocol Violation|1
97538|NCT00787202|337696|P1|Overall Study|Protocol Violation|2
97539|NCT00787202|337692|P5|Overall Study|Withdrawal by Subject|0
97540|NCT00787202|337693|P4|Overall Study|Withdrawal by Subject|0
97541|NCT00787202|337694|P3|Overall Study|Withdrawal by Subject|2
97542|NCT00787202|337695|P2|Overall Study|Withdrawal by Subject|2
97543|NCT00787202|337696|P1|Overall Study|Withdrawal by Subject|2
97544|NCT00787202|337692|P5|Overall Study|Lost to Follow-up|0
97545|NCT00787202|337693|P4|Overall Study|Lost to Follow-up|0
97546|NCT00787202|337694|P3|Overall Study|Lost to Follow-up|0
97547|NCT00787202|337695|P2|Overall Study|Lost to Follow-up|0
97548|NCT00787202|337696|P1|Overall Study|Lost to Follow-up|1
97549|NCT00787202|337692|P5|Overall Study|Lack of Efficacy|1
97550|NCT00787202|337693|P4|Overall Study|Lack of Efficacy|2
97551|NCT00787202|337694|P3|Overall Study|Lack of Efficacy|5
97552|NCT00787202|337695|P2|Overall Study|Lack of Efficacy|6
97553|NCT00787202|337696|P1|Overall Study|Lack of Efficacy|5
97554|NCT00787202|337692|P5|Overall Study|Adverse Event|2
97555|NCT00787202|337693|P4|Overall Study|Adverse Event|0
97556|NCT00787202|337694|P3|Overall Study|Adverse Event|0
97557|NCT00787202|337695|P2|Overall Study|Adverse Event|2
97558|NCT00787202|337696|P1|Overall Study|Adverse Event|3
97559|NCT00787189|337749|P2|Overall Study|Lost to Follow-up|2
97560|NCT00787189|337750|P1|Overall Study|Lost to Follow-up|2
97561|NCT00787150|337759|P3|Overall Study|Dosing incorrect study durg|0
97562|NCT00787150|337760|P2|Overall Study|Dosing incorrect study durg|0
97563|NCT00787150|337761|P1|Overall Study|Dosing incorrect study durg|2
97564|NCT00787150|337759|P3|Overall Study|Withdrawal by Subject|0
97565|NCT00787150|337760|P2|Overall Study|Withdrawal by Subject|1
97566|NCT00787150|337761|P1|Overall Study|Withdrawal by Subject|2
97567|NCT00787150|337759|P3|Overall Study|Physician Decision|1
97568|NCT00787150|337760|P2|Overall Study|Physician Decision|2
97569|NCT00787150|337761|P1|Overall Study|Physician Decision|1
97570|NCT00787150|337759|P3|Overall Study|Adverse Event|4
97571|NCT00787150|337760|P2|Overall Study|Adverse Event|4
97572|NCT00787150|337761|P1|Overall Study|Adverse Event|4
97573|NCT00787137|337806|P3|Overall Study|Study Termination|1
97574|NCT00787137|337807|P2|Overall Study|Study Termination|0
97575|NCT00787137|337808|P1|Overall Study|Study Termination|0
97576|NCT00786864|337883|P2|Overall Study|Sustained serious back injury|0
97577|NCT00786864|337884|P1|Overall Study|Sustained serious back injury|1
97578|NCT00786864|337883|P2|Overall Study|Lost to Follow-up|1
97579|NCT00786864|337884|P1|Overall Study|Lost to Follow-up|0
97580|NCT00786838|337896|P1|Overall Study|Withdrawal by Subject|4
97581|NCT00786838|337896|P1|Overall Study|Progressive disease|31
97582|NCT00786838|337896|P1|Overall Study|Adverse Event|6
97583|NCT00786838|337896|P1|Overall Study|Death|4
97584|NCT00786838|337896|P1|Overall Study|Physician Decision|4
97585|NCT00786799|337923|P2|Overall Study|Lost to Follow-up|1
97586|NCT00786799|337924|P1|Overall Study|Lost to Follow-up|1
97587|NCT00786565|337954|P1|Post Surgery|Adapt AO implanted posterior side up|1
97588|NCT00786565|337954|P1|Post Surgery|Abnormal macular pucker|1
97589|NCT00786565|337954|P1|Enrollment Prior to Surgery|Protocol Violation|3
97590|NCT00786565|337954|P1|Enrollment Prior to Surgery|Site Closed|3
97591|NCT00786474|338011|P2|Overall Study|Not Specified|4
97592|NCT00786474|338012|P1|Overall Study|Not Specified|4
97593|NCT00786474|338011|P2|Overall Study|Physician Decision|1
97594|NCT00786474|338012|P1|Overall Study|Physician Decision|2
97595|NCT00786474|338011|P2|Overall Study|Lost to Follow-up|3
97596|NCT00786474|338012|P1|Overall Study|Lost to Follow-up|3
97597|NCT00786474|338011|P2|Overall Study|Withdrawal by Subject|31
97598|NCT00786474|338012|P1|Overall Study|Withdrawal by Subject|23
97599|NCT00786474|338011|P2|Overall Study|Death|4
97600|NCT00786474|338012|P1|Overall Study|Death|5
97601|NCT00786422|338024|P1|Follow-up Period|End-of-study done up to 4 days early|2
97602|NCT00786422|338024|P1|Follow-up Period|Death|1
97603|NCT00786422|338024|P1|Rivaroxaban Treatment|Adverse Event|2
97604|NCT00786422|338024|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
97605|NCT00786422|338024|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
97606|NCT00786422|338024|P1|Rivaroxaban Treatment|Physician Decision|1
97607|NCT00786422|338024|P1|Rivaroxaban Treatment|Lack of Efficacy|1
97608|NCT00786422|338024|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
97609|NCT00786422|338024|P1|Rivaroxaban Treatment|Death|2
97610|NCT00786188|338042|P2|Overall Study|Withdrawal by Subject|0
97611|NCT00786188|338043|P1|Overall Study|Withdrawal by Subject|2
97612|NCT00786188|338042|P2|Overall Study|Adverse Event|1
97613|NCT00786188|338043|P1|Overall Study|Adverse Event|3
97614|NCT00786032|338069|P1|Overall Study|Did not complete in the timeframe|6
97615|NCT00786032|338069|P1|Overall Study|Withdrawal by Subject|14
97616|NCT00786032|338069|P1|Overall Study|Death|4
97617|NCT00785980|338079|P1|7 Day Washout Period|Protocol Violation|3
97618|NCT00785785|338097|P2|Optional Extension Phase|Study terminated by sponsor|37
97619|NCT00785785|338098|P1|Optional Extension Phase|Study terminated by sponsor|3
97620|NCT00785785|338097|P2|Optional Extension Phase|Protocol deviation|2
97621|NCT00785785|338098|P1|Optional Extension Phase|Protocol deviation|0
97622|NCT00785785|338097|P2|Optional Extension Phase|Disease progression|70
97623|NCT00785785|338098|P1|Optional Extension Phase|Disease progression|22
97624|NCT00785785|338097|P2|Optional Extension Phase|Death|5
97625|NCT00785785|338098|P1|Optional Extension Phase|Death|1
97626|NCT00785785|338097|P2|Optional Extension Phase|Administrative problems|0
97627|NCT00785785|338098|P1|Optional Extension Phase|Administrative problems|2
97628|NCT00785785|338097|P2|Optional Extension Phase|Lost to Follow-up|0
97629|NCT00785785|338098|P1|Optional Extension Phase|Lost to Follow-up|1
97630|NCT00785785|338097|P2|Optional Extension Phase|Withdrawal by Subject|6
97631|NCT00785785|338098|P1|Optional Extension Phase|Withdrawal by Subject|6
97632|NCT00785785|338097|P2|Optional Extension Phase|Adverse Event|5
97633|NCT00785785|338098|P1|Optional Extension Phase|Adverse Event|4
97634|NCT00785785|338097|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
97635|NCT00785785|338098|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
97636|NCT00785785|338097|P2|Core Phase up to 36 Months|Protocol deviation|6
97637|NCT00785785|338098|P1|Core Phase up to 36 Months|Protocol deviation|5
97638|NCT00785785|338097|P2|Core Phase up to 36 Months|Disease progression|119
97639|NCT00785785|338098|P1|Core Phase up to 36 Months|Disease progression|139
97640|NCT00785785|338097|P2|Core Phase up to 36 Months|Death|8
97641|NCT00785785|338098|P1|Core Phase up to 36 Months|Death|5
97642|NCT00785785|338097|P2|Core Phase up to 36 Months|Administrative problems|3
97643|NCT00785785|338098|P1|Core Phase up to 36 Months|Administrative problems|3
97644|NCT00785785|338097|P2|Core Phase up to 36 Months|Lost to Follow-up|7
97645|NCT00785785|338098|P1|Core Phase up to 36 Months|Lost to Follow-up|3
97646|NCT00785785|338097|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
97647|NCT00785785|338098|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
97648|NCT00785785|338097|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
97649|NCT00785785|338098|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
97650|NCT00785785|338097|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
97651|NCT00785785|338098|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
97652|NCT00785785|338097|P2|Core Phase up to 36 Months|Adverse Event|21
97653|NCT00785785|338098|P1|Core Phase up to 36 Months|Adverse Event|31
97654|NCT00785785|338097|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
97655|NCT00785785|338098|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
97656|NCT00785629|338116|P4|Overall Study|Withdrawal by Subject|2
97657|NCT00785629|338117|P3|Overall Study|Withdrawal by Subject|2
97658|NCT00785629|338118|P2|Overall Study|Withdrawal by Subject|1
97659|NCT00785629|338119|P1|Overall Study|Withdrawal by Subject|0
97660|NCT00785629|338116|P4|Overall Study|administrative decision|4
97661|NCT00785629|338117|P3|Overall Study|administrative decision|3
97662|NCT00785629|338118|P2|Overall Study|administrative decision|1
97663|NCT00785629|338119|P1|Overall Study|administrative decision|5
97664|NCT00785629|338116|P4|Overall Study|Protocol Violation|5
97665|NCT00785629|338117|P3|Overall Study|Protocol Violation|4
97666|NCT00785629|338118|P2|Overall Study|Protocol Violation|2
97667|NCT00785629|338119|P1|Overall Study|Protocol Violation|1
97668|NCT00785629|338116|P4|Overall Study|Adverse Event|5
97669|NCT00785629|338117|P3|Overall Study|Adverse Event|1
97670|NCT00785629|338118|P2|Overall Study|Adverse Event|1
97671|NCT00785629|338119|P1|Overall Study|Adverse Event|2
97672|NCT00785577|338132|P5|Study Period 3: 1-Week Washout Phase|Death|1
97673|NCT00785577|338133|P4|Study Period 3: 1-Week Washout Phase|Death|0
97674|NCT00785577|338134|P3|Study Period 3: 1-Week Washout Phase|Death|0
97675|NCT00785577|338135|P2|Study Period 3: 1-Week Washout Phase|Death|0
97676|NCT00785577|338136|P1|Study Period 3: 1-Week Washout Phase|Death|0
97677|NCT00785577|338132|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
97678|NCT00785577|338133|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
97679|NCT00785577|338134|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
97680|NCT00785577|338135|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
97681|NCT00785577|338136|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
97682|NCT00785577|338132|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
97683|NCT00785577|338133|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
97684|NCT00785577|338134|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
97685|NCT00785577|338135|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
97686|NCT00785577|338136|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
97687|NCT00785577|338132|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
97688|NCT00785577|338133|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
97689|NCT00785577|338134|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
97690|NCT00785577|338135|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
97691|NCT00785577|338136|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
97692|NCT00785577|338132|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
97693|NCT00785577|338133|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
97694|NCT00785577|338134|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
97695|NCT00785577|338135|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
97696|NCT00785577|338136|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
97697|NCT00785577|338132|P5|Study Period 2: Therapy Phase|Protocol Violation|1
97698|NCT00785577|338133|P4|Study Period 2: Therapy Phase|Protocol Violation|0
97699|NCT00785577|338134|P3|Study Period 2: Therapy Phase|Protocol Violation|1
97700|NCT00785577|338135|P2|Study Period 2: Therapy Phase|Protocol Violation|1
97701|NCT00785577|338136|P1|Study Period 2: Therapy Phase|Protocol Violation|1
97702|NCT00785577|338132|P5|Study Period 2: Therapy Phase|Physician Decision|0
97703|NCT00785577|338133|P4|Study Period 2: Therapy Phase|Physician Decision|0
97704|NCT00785577|338134|P3|Study Period 2: Therapy Phase|Physician Decision|0
97705|NCT00785577|338135|P2|Study Period 2: Therapy Phase|Physician Decision|0
97706|NCT00785577|338136|P1|Study Period 2: Therapy Phase|Physician Decision|1
97707|NCT00785577|338132|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
97708|NCT00785577|338133|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
97709|NCT00785577|338134|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
97710|NCT00785577|338135|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
97711|NCT00785577|338136|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
97712|NCT00785577|338132|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
97713|NCT00785577|338133|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
97714|NCT00785577|338134|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
97715|NCT00785577|338135|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
97716|NCT00785577|338136|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
97717|NCT00785577|338132|P5|Study Period 2: Therapy Phase|Adverse Event|17
97718|NCT00785577|338133|P4|Study Period 2: Therapy Phase|Adverse Event|10
97719|NCT00785577|338134|P3|Study Period 2: Therapy Phase|Adverse Event|14
97720|NCT00785577|338135|P2|Study Period 2: Therapy Phase|Adverse Event|7
97721|NCT00785577|338136|P1|Study Period 2: Therapy Phase|Adverse Event|5
97722|NCT00785512|338274|P2|Overall Study|Lack of compliance|1
97723|NCT00785512|338275|P1|Overall Study|Lack of compliance|0
97724|NCT00785512|338274|P2|Overall Study|Physician Decision|0
97725|NCT00785512|338275|P1|Overall Study|Physician Decision|0
97726|NCT00785512|338274|P2|Overall Study|IVRS Programing Error|0
97727|NCT00785512|338275|P1|Overall Study|IVRS Programing Error|0
97728|NCT00785512|338274|P2|Overall Study|Precedure Refused|0
97729|NCT00785512|338275|P1|Overall Study|Precedure Refused|0
97730|NCT00785512|338274|P2|Overall Study|Lost to Follow-up|0
97731|NCT00785512|338275|P1|Overall Study|Lost to Follow-up|3
97732|NCT00785512|338274|P2|Overall Study|Withdrawal by Subject|1
97733|NCT00785512|338275|P1|Overall Study|Withdrawal by Subject|0
97734|NCT00785512|338274|P2|Overall Study|Lack of Efficacy|2
97735|NCT00785512|338275|P1|Overall Study|Lack of Efficacy|0
97736|NCT00785512|338274|P2|Overall Study|Adverse Event|0
97737|NCT00785512|338275|P1|Overall Study|Adverse Event|0
97738|NCT00785512|338274|P2|Overall Study|Inclusion/Exclusion not meet|0
97739|NCT00785512|338275|P1|Overall Study|Inclusion/Exclusion not meet|0
97740|NCT00785486|338284|P1|Midazolam Alone|Withdrawal by Subject|1
97741|NCT00785356|338308|P1|Overall Study|Study prematurely terminated|8
97742|NCT00785291|338319|P3|Overall Study|Other Medical Reasons|15
97743|NCT00785291|338320|P2|Overall Study|Other Medical Reasons|25
97744|NCT00785291|338321|P1|Overall Study|Other Medical Reasons|29
97745|NCT00785291|338319|P3|Overall Study|Complicating illness|4
97746|NCT00785291|338320|P2|Overall Study|Complicating illness|4
97747|NCT00785291|338321|P1|Overall Study|Complicating illness|6
97748|NCT00785291|338319|P3|Overall Study|Alternative Therapy|7
97749|NCT00785291|338320|P2|Overall Study|Alternative Therapy|6
97750|NCT00785291|338321|P1|Overall Study|Alternative Therapy|12
97751|NCT00785291|338319|P3|Overall Study|Withdrawal by Subject|17
97752|NCT00785291|338320|P2|Overall Study|Withdrawal by Subject|36
97753|NCT00785291|338321|P1|Overall Study|Withdrawal by Subject|35
97754|NCT00785291|338319|P3|Overall Study|Death|3
97755|NCT00785291|338320|P2|Overall Study|Death|4
97756|NCT00785291|338321|P1|Overall Study|Death|7
97757|NCT00785291|338319|P3|Overall Study|Adverse Event|56
97758|NCT00785291|338320|P2|Overall Study|Adverse Event|70
97759|NCT00785291|338321|P1|Overall Study|Adverse Event|39
97760|NCT00785291|338319|P3|Overall Study|Never began treatment|4
97761|NCT00785291|338320|P2|Overall Study|Never began treatment|4
97762|NCT00785291|338321|P1|Overall Study|Never began treatment|8
97763|NCT00785213|338341|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
97764|NCT00785213|338341|P1|Quinine Sulfate Alone|Adverse Event|4
97765|NCT00784979|338352|P1|Overall Study|incomplete data|6
97766|NCT00784927|338356|P1|Overall Study|Ineligible|1
97767|NCT00784927|338356|P1|Overall Study|Protocol Violation|1
97768|NCT00784927|338356|P1|Overall Study|Cancel Prior to Initiating Treatment|1
97769|NCT00784875|338368|P4|Period D|Lost to Follow-up|1
97770|NCT00784875|338369|P3|Period D|Lost to Follow-up|1
97771|NCT00784875|338370|P2|Period D|Lost to Follow-up|0
97772|NCT00784875|338371|P1|Period D|Lost to Follow-up|1
97773|NCT00784875|338368|P4|Period D|Sponsor Decision|0
97774|NCT00784875|338369|P3|Period D|Sponsor Decision|1
97775|NCT00784875|338370|P2|Period D|Sponsor Decision|1
97776|NCT00784875|338371|P1|Period D|Sponsor Decision|1
97777|NCT00784875|338368|P4|Period D|Physician Decision|0
97778|NCT00784875|338369|P3|Period D|Physician Decision|0
97779|NCT00784875|338370|P2|Period D|Physician Decision|1
97780|NCT00784875|338371|P1|Period D|Physician Decision|0
97781|NCT00784875|338368|P4|Period D|Withdrawal by Subject|0
97782|NCT00784875|338369|P3|Period D|Withdrawal by Subject|2
97783|NCT00784875|338370|P2|Period D|Withdrawal by Subject|0
97784|NCT00784875|338371|P1|Period D|Withdrawal by Subject|2
97785|NCT00784875|338368|P4|Period D|Protocol Violation|0
97786|NCT00784875|338369|P3|Period D|Protocol Violation|0
97787|NCT00784875|338370|P2|Period D|Protocol Violation|0
97788|NCT00784875|338371|P1|Period D|Protocol Violation|1
97789|NCT00784875|338368|P4|Period D|Adverse Event|0
97790|NCT00784875|338369|P3|Period D|Adverse Event|2
97791|NCT00784875|338370|P2|Period D|Adverse Event|2
97792|NCT00784875|338371|P1|Period D|Adverse Event|0
97793|NCT00784875|338368|P4|Period C|Sponsor Decision|2
97794|NCT00784875|338369|P3|Period C|Sponsor Decision|4
97795|NCT00784875|338370|P2|Period C|Sponsor Decision|5
97796|NCT00784875|338371|P1|Period C|Sponsor Decision|5
97797|NCT00784875|338368|P4|Period C|Physician Decision|1
97798|NCT00784875|338369|P3|Period C|Physician Decision|1
97799|NCT00784875|338370|P2|Period C|Physician Decision|0
97800|NCT00784875|338371|P1|Period C|Physician Decision|0
97801|NCT00784875|338368|P4|Period C|Withdrawal by Subject|0
97802|NCT00784875|338369|P3|Period C|Withdrawal by Subject|2
97803|NCT00784875|338370|P2|Period C|Withdrawal by Subject|1
97804|NCT00784875|338371|P1|Period C|Withdrawal by Subject|1
97805|NCT00784875|338368|P4|Period C|Lack of Efficacy|0
97806|NCT00784875|338369|P3|Period C|Lack of Efficacy|1
97807|NCT00784875|338370|P2|Period C|Lack of Efficacy|0
97808|NCT00784875|338371|P1|Period C|Lack of Efficacy|0
97809|NCT00784875|338368|P4|Period C|Protocol Violation|2
97810|NCT00784875|338369|P3|Period C|Protocol Violation|1
97811|NCT00784875|338370|P2|Period C|Protocol Violation|0
97812|NCT00784875|338371|P1|Period C|Protocol Violation|0
97813|NCT00784875|338368|P4|Period C|Adverse Event|2
97814|NCT00784875|338369|P3|Period C|Adverse Event|4
97815|NCT00784875|338370|P2|Period C|Adverse Event|0
97816|NCT00784875|338371|P1|Period C|Adverse Event|1
97817|NCT00784875|338368|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
97818|NCT00784875|338369|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
97819|NCT00784875|338370|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
97820|NCT00784875|338371|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
97821|NCT00784875|338368|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
97822|NCT00784875|338369|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
97823|NCT00784875|338370|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
97824|NCT00784875|338371|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
97825|NCT00784875|338368|P4|Period B - Efficacy Endpoint|Physician Decision|0
97826|NCT00784875|338369|P3|Period B - Efficacy Endpoint|Physician Decision|1
97827|NCT00784875|338370|P2|Period B - Efficacy Endpoint|Physician Decision|0
97828|NCT00784875|338371|P1|Period B - Efficacy Endpoint|Physician Decision|0
97829|NCT00784875|338368|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
97830|NCT00784875|338369|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
97831|NCT00784875|338370|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
97832|NCT00784875|338371|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
97833|NCT00784875|338368|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
97834|NCT00784875|338369|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
97835|NCT00784875|338370|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
97836|NCT00784875|338371|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
97837|NCT00784875|338368|P4|Period B - Efficacy Endpoint|Protocol Violation|3
97838|NCT00784875|338369|P3|Period B - Efficacy Endpoint|Protocol Violation|2
97839|NCT00784875|338370|P2|Period B - Efficacy Endpoint|Protocol Violation|1
97840|NCT00784875|338371|P1|Period B - Efficacy Endpoint|Protocol Violation|1
97841|NCT00784875|338368|P4|Period B - Efficacy Endpoint|Adverse Event|1
97842|NCT00784875|338369|P3|Period B - Efficacy Endpoint|Adverse Event|2
97843|NCT00784875|338370|P2|Period B - Efficacy Endpoint|Adverse Event|3
97844|NCT00784875|338371|P1|Period B - Efficacy Endpoint|Adverse Event|0
97845|NCT00784875|338368|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
97846|NCT00784875|338369|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
97847|NCT00784875|338370|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
97848|NCT00784875|338371|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
97849|NCT00784875|338368|P4|Period A - Baseline|Lost to Follow-up|2
97850|NCT00784875|338369|P3|Period A - Baseline|Lost to Follow-up|0
97851|NCT00784875|338370|P2|Period A - Baseline|Lost to Follow-up|0
97852|NCT00784875|338371|P1|Period A - Baseline|Lost to Follow-up|0
97853|NCT00784875|338368|P4|Period A - Baseline|Sponsor Decision|113
97854|NCT00784875|338369|P3|Period A - Baseline|Sponsor Decision|0
97855|NCT00784875|338370|P2|Period A - Baseline|Sponsor Decision|0
97856|NCT00784875|338371|P1|Period A - Baseline|Sponsor Decision|0
97857|NCT00784875|338368|P4|Period A - Baseline|Physician Decision|2
97858|NCT00784875|338369|P3|Period A - Baseline|Physician Decision|0
97859|NCT00784875|338370|P2|Period A - Baseline|Physician Decision|0
97860|NCT00784875|338371|P1|Period A - Baseline|Physician Decision|0
97861|NCT00784875|338368|P4|Period A - Baseline|Withdrawal by Subject|27
97862|NCT00784875|338369|P3|Period A - Baseline|Withdrawal by Subject|0
97863|NCT00784875|338370|P2|Period A - Baseline|Withdrawal by Subject|0
97864|NCT00784875|338371|P1|Period A - Baseline|Withdrawal by Subject|0
97865|NCT00784875|338368|P4|Period A - Baseline|Protocol Violation|25
97866|NCT00784875|338369|P3|Period A - Baseline|Protocol Violation|0
97867|NCT00784875|338370|P2|Period A - Baseline|Protocol Violation|0
97868|NCT00784875|338371|P1|Period A - Baseline|Protocol Violation|0
97869|NCT00784875|338368|P4|Period A - Baseline|Adverse Event|8
97870|NCT00784875|338369|P3|Period A - Baseline|Adverse Event|0
97871|NCT00784875|338370|P2|Period A - Baseline|Adverse Event|0
97872|NCT00784875|338371|P1|Period A - Baseline|Adverse Event|0
97873|NCT00784875|338368|P4|Period A - Baseline|Entry Criteria Not Met|5
97874|NCT00784875|338369|P3|Period A - Baseline|Entry Criteria Not Met|0
97875|NCT00784875|338370|P2|Period A - Baseline|Entry Criteria Not Met|0
97876|NCT00784875|338371|P1|Period A - Baseline|Entry Criteria Not Met|0
97877|NCT00784836|338491|P1|Overall Study|Early Study Termination|3
97878|NCT00784810|338498|P2|Overall Study|Lost to Follow-up|1
97879|NCT00784810|338499|P1|Overall Study|Lost to Follow-up|1
97880|NCT00784810|338498|P2|Overall Study|Administrative|8
97881|NCT00784810|338499|P1|Overall Study|Administrative|5
97882|NCT00784810|338498|P2|Overall Study|Withdrawal by Subject|9
97883|NCT00784810|338499|P1|Overall Study|Withdrawal by Subject|11
97884|NCT00784810|338498|P2|Overall Study|Lack of Efficacy|11
97885|NCT00784810|338499|P1|Overall Study|Lack of Efficacy|14
97886|NCT00784810|338498|P2|Overall Study|Adverse Event|20
97887|NCT00784810|338499|P1|Overall Study|Adverse Event|32
97888|NCT00784784|338509|P2|Overall Study|Withdrawal by Subject|2
97889|NCT00784784|338510|P1|Overall Study|Withdrawal by Subject|2
97890|NCT00784719|338525|P7|Overall Study|Withdrawal by Subject|1
97891|NCT00784719|338526|P6|Overall Study|Withdrawal by Subject|0
97892|NCT00784719|338527|P5|Overall Study|Withdrawal by Subject|2
97893|NCT00784719|338528|P4|Overall Study|Withdrawal by Subject|0
97894|NCT00784719|338529|P3|Overall Study|Withdrawal by Subject|0
97895|NCT00784719|338530|P2|Overall Study|Withdrawal by Subject|0
97896|NCT00784719|338531|P1|Overall Study|Withdrawal by Subject|1
97897|NCT00784719|338525|P7|Overall Study|Unspecified|3
97898|NCT00784719|338526|P6|Overall Study|Unspecified|1
97899|NCT00784719|338527|P5|Overall Study|Unspecified|2
97900|NCT00784719|338528|P4|Overall Study|Unspecified|0
97901|NCT00784719|338529|P3|Overall Study|Unspecified|1
97902|NCT00784719|338530|P2|Overall Study|Unspecified|1
97903|NCT00784719|338531|P1|Overall Study|Unspecified|2
97904|NCT00784719|338525|P7|Overall Study|Lost to Follow-up|0
97905|NCT00784719|338526|P6|Overall Study|Lost to Follow-up|1
97906|NCT00784719|338527|P5|Overall Study|Lost to Follow-up|1
97907|NCT00784719|338528|P4|Overall Study|Lost to Follow-up|0
97908|NCT00784719|338529|P3|Overall Study|Lost to Follow-up|0
97909|NCT00784719|338530|P2|Overall Study|Lost to Follow-up|0
97910|NCT00784719|338531|P1|Overall Study|Lost to Follow-up|0
97911|NCT00784719|338525|P7|Overall Study|Adverse Event|1
97912|NCT00784719|338526|P6|Overall Study|Adverse Event|1
97913|NCT00784719|338527|P5|Overall Study|Adverse Event|1
97914|NCT00784719|338528|P4|Overall Study|Adverse Event|0
97915|NCT00784719|338529|P3|Overall Study|Adverse Event|0
97916|NCT00784719|338530|P2|Overall Study|Adverse Event|2
97917|NCT00784719|338531|P1|Overall Study|Adverse Event|0
97918|NCT00784654|338701|P3|Randomized Withdrawal Period|Family reasons|1
97919|NCT00784654|338702|P2|Randomized Withdrawal Period|Family reasons|0
97920|NCT00784654|338703|P1|Randomized Withdrawal Period|Family reasons|0
97921|NCT00784654|338701|P3|Randomized Withdrawal Period|Did not complete a visit|0
97922|NCT00784654|338702|P2|Randomized Withdrawal Period|Did not complete a visit|1
97923|NCT00784654|338703|P1|Randomized Withdrawal Period|Did not complete a visit|0
97924|NCT00784654|338701|P3|Randomized Withdrawal Period|Adverse Event|1
97925|NCT00784654|338702|P2|Randomized Withdrawal Period|Adverse Event|1
97926|NCT00784654|338703|P1|Randomized Withdrawal Period|Adverse Event|0
97927|NCT00784654|338701|P3|Randomized Withdrawal Period|Protocol Violation|1
97928|NCT00784654|338702|P2|Randomized Withdrawal Period|Protocol Violation|2
97929|NCT00784654|338703|P1|Randomized Withdrawal Period|Protocol Violation|0
97930|NCT00784654|338701|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
97931|NCT00784654|338702|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
97932|NCT00784654|338703|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
97933|NCT00784654|338701|P3|Randomized Withdrawal Period|Lack of Efficacy|18
97934|NCT00784654|338702|P2|Randomized Withdrawal Period|Lack of Efficacy|5
97935|NCT00784654|338703|P1|Randomized Withdrawal Period|Lack of Efficacy|0
97936|NCT00784654|338701|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
97937|NCT00784654|338702|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
97938|NCT00784654|338703|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
97939|NCT00784654|338701|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
97940|NCT00784654|338702|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
97941|NCT00784654|338703|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
97942|NCT00784654|338701|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
97943|NCT00784654|338702|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
97944|NCT00784654|338703|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
97945|NCT00784654|338701|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
97946|NCT00784654|338702|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
97947|NCT00784654|338703|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
97948|NCT00784654|338701|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
97949|NCT00784654|338702|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
97950|NCT00784654|338703|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
97951|NCT00784654|338701|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
97952|NCT00784654|338702|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
97953|NCT00784654|338703|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
97954|NCT00784654|338701|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
97955|NCT00784654|338702|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
97956|NCT00784654|338703|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
97957|NCT00784654|338701|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
97958|NCT00784654|338702|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
97959|NCT00784654|338703|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
97960|NCT00784654|338701|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
97961|NCT00784654|338702|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
97962|NCT00784654|338703|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
97963|NCT00784654|338701|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
97964|NCT00784654|338702|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
97965|NCT00784654|338703|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
97966|NCT00784654|338701|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
97967|NCT00784654|338702|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
97968|NCT00784654|338703|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
97969|NCT00784654|338701|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
97970|NCT00784654|338702|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
97971|NCT00784654|338703|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
97972|NCT00784563|338738|P3|Year 3|Adverse Event|1
97973|NCT00784563|338739|P2|Year 3|Adverse Event|0
97974|NCT00784563|338740|P1|Year 3|Adverse Event|0
97975|NCT00784563|338738|P3|Year 3|Withdrawal by Subject|2
97976|NCT00784563|338739|P2|Year 3|Withdrawal by Subject|0
97977|NCT00784563|338740|P1|Year 3|Withdrawal by Subject|0
97978|NCT00784563|338738|P3|Years 1 & 2|Adverse Event|0
97979|NCT00784563|338739|P2|Years 1 & 2|Adverse Event|3
97980|NCT00784563|338740|P1|Years 1 & 2|Adverse Event|0
97981|NCT00784563|338738|P3|Years 1 & 2|Withdrawal by Subject|0
97982|NCT00784563|338739|P2|Years 1 & 2|Withdrawal by Subject|2
97983|NCT00784563|338740|P1|Years 1 & 2|Withdrawal by Subject|3
97984|NCT00784550|338758|P2|Overall Study|Withdrawal by Subject|13
97985|NCT00784550|338759|P1|Overall Study|Withdrawal by Subject|4
97986|NCT00784550|338758|P2|Overall Study|Physician Decision|3
97987|NCT00784550|338759|P1|Overall Study|Physician Decision|2
97988|NCT00784550|338758|P2|Overall Study|Lost to Follow-up|5
97989|NCT00784550|338759|P1|Overall Study|Lost to Follow-up|8
97990|NCT00784550|338758|P2|Overall Study|Protocol Violation|10
97991|NCT00784550|338759|P1|Overall Study|Protocol Violation|10
97992|NCT00784550|338758|P2|Overall Study|Lack of Efficacy|1
97993|NCT00784550|338759|P1|Overall Study|Lack of Efficacy|0
97994|NCT00784550|338758|P2|Overall Study|Adverse Event|10
97995|NCT00784550|338759|P1|Overall Study|Adverse Event|12
97996|NCT00784459|338777|P2|Overall Study|Adverse Event|2
97997|NCT00784459|338778|P1|Overall Study|Adverse Event|0
97998|NCT00784368|338789|P3|Overall Study|Withdrawal of informed consent|0
97999|NCT00784368|338790|P2|Overall Study|Withdrawal of informed consent|1
98000|NCT00784368|338791|P1|Overall Study|Withdrawal of informed consent|0
98001|NCT00784368|338789|P3|Overall Study|Worsening of symptoms|0
98002|NCT00784368|338790|P2|Overall Study|Worsening of symptoms|1
98003|NCT00784368|338791|P1|Overall Study|Worsening of symptoms|0
98004|NCT00784368|338789|P3|Overall Study|Worsening of complications|1
98005|NCT00784368|338790|P2|Overall Study|Worsening of complications|0
98006|NCT00784368|338791|P1|Overall Study|Worsening of complications|0
98007|NCT00784368|338789|P3|Overall Study|Diagnosis of fever|1
98008|NCT00784368|338790|P2|Overall Study|Diagnosis of fever|0
98009|NCT00784368|338791|P1|Overall Study|Diagnosis of fever|0
98010|NCT00784368|338789|P3|Overall Study|Adverse Event|2
98011|NCT00784368|338790|P2|Overall Study|Adverse Event|9
98012|NCT00784368|338791|P1|Overall Study|Adverse Event|6
98013|NCT00784368|338789|P3|Overall Study|Lack of Efficacy|1
98014|NCT00784368|338790|P2|Overall Study|Lack of Efficacy|0
98015|NCT00784368|338791|P1|Overall Study|Lack of Efficacy|2
98016|NCT00784368|338789|P3|Overall Study|Physician Decision|6
98017|NCT00784368|338790|P2|Overall Study|Physician Decision|0
98018|NCT00784368|338791|P1|Overall Study|Physician Decision|0
98019|NCT00784277|338829|P7|ER Treatment|Other|2
98020|NCT00784277|338830|P6|ER Treatment|Other|3
98021|NCT00784277|338831|P5|ER Treatment|Other|1
98022|NCT00784277|338832|P4|ER Treatment|Other|0
98023|NCT00784277|338833|P3|ER Treatment|Other|0
98024|NCT00784277|338834|P2|ER Treatment|Other|0
98025|NCT00784277|338835|P1|ER Treatment|Other|0
98026|NCT00784277|338829|P7|ER Treatment|Study Medication Non-Compliant|3
98027|NCT00784277|338830|P6|ER Treatment|Study Medication Non-Compliant|3
98028|NCT00784277|338831|P5|ER Treatment|Study Medication Non-Compliant|2
98029|NCT00784277|338832|P4|ER Treatment|Study Medication Non-Compliant|0
98030|NCT00784277|338833|P3|ER Treatment|Study Medication Non-Compliant|0
98031|NCT00784277|338834|P2|ER Treatment|Study Medication Non-Compliant|0
98032|NCT00784277|338835|P1|ER Treatment|Study Medication Non-Compliant|0
98033|NCT00784277|338829|P7|ER Treatment|Withdrawal by Subject|3
98034|NCT00784277|338830|P6|ER Treatment|Withdrawal by Subject|5
98035|NCT00784277|338831|P5|ER Treatment|Withdrawal by Subject|2
98036|NCT00784277|338832|P4|ER Treatment|Withdrawal by Subject|0
98037|NCT00784277|338833|P3|ER Treatment|Withdrawal by Subject|0
98038|NCT00784277|338834|P2|ER Treatment|Withdrawal by Subject|0
98039|NCT00784277|338835|P1|ER Treatment|Withdrawal by Subject|0
98040|NCT00784277|338829|P7|ER Treatment|Lost to Follow-up|0
98041|NCT00784277|338830|P6|ER Treatment|Lost to Follow-up|2
98042|NCT00784277|338831|P5|ER Treatment|Lost to Follow-up|0
98043|NCT00784277|338832|P4|ER Treatment|Lost to Follow-up|0
98044|NCT00784277|338833|P3|ER Treatment|Lost to Follow-up|0
98045|NCT00784277|338834|P2|ER Treatment|Lost to Follow-up|0
98046|NCT00784277|338835|P1|ER Treatment|Lost to Follow-up|0
98047|NCT00784277|338829|P7|ER Treatment|Lack of Efficacy|0
98048|NCT00784277|338830|P6|ER Treatment|Lack of Efficacy|4
98049|NCT00784277|338831|P5|ER Treatment|Lack of Efficacy|3
98050|NCT00784277|338832|P4|ER Treatment|Lack of Efficacy|0
98051|NCT00784277|338833|P3|ER Treatment|Lack of Efficacy|0
98052|NCT00784277|338834|P2|ER Treatment|Lack of Efficacy|0
98053|NCT00784277|338835|P1|ER Treatment|Lack of Efficacy|0
98054|NCT00784277|338829|P7|ER Treatment|Adverse Event|7
98055|NCT00784277|338830|P6|ER Treatment|Adverse Event|7
98056|NCT00784277|338831|P5|ER Treatment|Adverse Event|1
98057|NCT00784277|338832|P4|ER Treatment|Adverse Event|0
98058|NCT00784277|338833|P3|ER Treatment|Adverse Event|0
98059|NCT00784277|338834|P2|ER Treatment|Adverse Event|0
98060|NCT00784277|338835|P1|ER Treatment|Adverse Event|0
98061|NCT00784277|338829|P7|IR Treatment|Other|0
98062|NCT00784277|338830|P6|IR Treatment|Other|0
98063|NCT00784277|338831|P5|IR Treatment|Other|0
98064|NCT00784277|338832|P4|IR Treatment|Other|2
98065|NCT00784277|338833|P3|IR Treatment|Other|3
98066|NCT00784277|338834|P2|IR Treatment|Other|3
98067|NCT00784277|338835|P1|IR Treatment|Other|2
98068|NCT00784277|338829|P7|IR Treatment|Resolution Of Pain|0
98069|NCT00784277|338830|P6|IR Treatment|Resolution Of Pain|0
98070|NCT00784277|338831|P5|IR Treatment|Resolution Of Pain|0
98071|NCT00784277|338832|P4|IR Treatment|Resolution Of Pain|0
98072|NCT00784277|338833|P3|IR Treatment|Resolution Of Pain|0
98073|NCT00784277|338834|P2|IR Treatment|Resolution Of Pain|1
98074|NCT00784277|338835|P1|IR Treatment|Resolution Of Pain|0
98075|NCT00784277|338829|P7|IR Treatment|Withdrawal by Subject|0
98076|NCT00784277|338830|P6|IR Treatment|Withdrawal by Subject|0
98077|NCT00784277|338831|P5|IR Treatment|Withdrawal by Subject|0
98078|NCT00784277|338832|P4|IR Treatment|Withdrawal by Subject|6
98079|NCT00784277|338833|P3|IR Treatment|Withdrawal by Subject|4
98080|NCT00784277|338834|P2|IR Treatment|Withdrawal by Subject|1
98081|NCT00784277|338835|P1|IR Treatment|Withdrawal by Subject|5
98082|NCT00784277|338829|P7|IR Treatment|Lost to Follow-up|0
98083|NCT00784277|338830|P6|IR Treatment|Lost to Follow-up|0
98084|NCT00784277|338831|P5|IR Treatment|Lost to Follow-up|0
98085|NCT00784277|338832|P4|IR Treatment|Lost to Follow-up|0
98086|NCT00784277|338833|P3|IR Treatment|Lost to Follow-up|1
98087|NCT00784277|338834|P2|IR Treatment|Lost to Follow-up|0
98088|NCT00784277|338835|P1|IR Treatment|Lost to Follow-up|1
98089|NCT00784277|338829|P7|IR Treatment|Lack of Efficacy|0
98090|NCT00784277|338830|P6|IR Treatment|Lack of Efficacy|0
98091|NCT00784277|338831|P5|IR Treatment|Lack of Efficacy|0
98092|NCT00784277|338832|P4|IR Treatment|Lack of Efficacy|0
98093|NCT00784277|338833|P3|IR Treatment|Lack of Efficacy|1
98094|NCT00784277|338834|P2|IR Treatment|Lack of Efficacy|4
98095|NCT00784277|338835|P1|IR Treatment|Lack of Efficacy|4
98096|NCT00784277|338829|P7|IR Treatment|Adverse Event|0
98097|NCT00784277|338830|P6|IR Treatment|Adverse Event|0
98098|NCT00784277|338831|P5|IR Treatment|Adverse Event|0
98099|NCT00784277|338832|P4|IR Treatment|Adverse Event|35
98100|NCT00784277|338833|P3|IR Treatment|Adverse Event|19
98101|NCT00784277|338834|P2|IR Treatment|Adverse Event|8
98102|NCT00784277|338835|P1|IR Treatment|Adverse Event|4
98103|NCT00784238|338852|P1|Overall Study|Unspecified|14
98104|NCT00784238|338852|P1|Overall Study|Withdrawal by Subject|26
98105|NCT00784238|338852|P1|Overall Study|Pregnancy|1
98106|NCT00784238|338852|P1|Overall Study|Lost to Follow-up|29
98107|NCT00784238|338852|P1|Overall Study|Lack of Efficacy|33
98108|NCT00784238|338852|P1|Overall Study|Death|2
98109|NCT00784238|338852|P1|Overall Study|Adverse Event|14
98110|NCT00784147|338895|P2|Overall Study|Death|0
98111|NCT00784147|338896|P1|Overall Study|Death|2
98112|NCT00784147|338895|P2|Overall Study|Protocol Violation|1
98113|NCT00784147|338896|P1|Overall Study|Protocol Violation|1
98114|NCT00784147|338895|P2|Overall Study|Physician Decision|1
98115|NCT00784147|338896|P1|Overall Study|Physician Decision|2
98116|NCT00784147|338895|P2|Overall Study|Withdrawal by Subject|3
98117|NCT00784147|338896|P1|Overall Study|Withdrawal by Subject|1
98118|NCT00784147|338895|P2|Overall Study|Lost to Follow-up|4
98119|NCT00784147|338896|P1|Overall Study|Lost to Follow-up|2
98120|NCT00783835|338959|P1|Overall Study|Participant not Adherent|3
98121|NCT00783835|338959|P1|Overall Study|Lost to Follow-up|1
98122|NCT00783835|338959|P1|Overall Study|Withdrawal by Subject|2
98123|NCT00783835|338959|P1|Overall Study|Medical Criteria|1
98124|NCT00783835|338959|P1|Overall Study|Adverse Event|3
98125|NCT00783796|338971|P1|Overall Study|Received commercial XIENCE V stent|1
98126|NCT00783796|338971|P1|Overall Study|Received non-XIENCE V stent|1
98127|NCT00783796|338971|P1|Overall Study|Did not receive any stent|4
98128|NCT00783718|339076|P7|Maintenance Phase|Lost to Follow-up|2
98129|NCT00783718|339077|P6|Maintenance Phase|Lost to Follow-up|0
98130|NCT00783718|339078|P5|Maintenance Phase|Lost to Follow-up|2
98131|NCT00783718|339079|P4|Maintenance Phase|Lost to Follow-up|0
98132|NCT00783718|339080|P3|Maintenance Phase|Lost to Follow-up|0
98133|NCT00783718|339081|P2|Maintenance Phase|Lost to Follow-up|0
98134|NCT00783718|339082|P1|Maintenance Phase|Lost to Follow-up|3
98135|NCT00783718|339076|P7|Maintenance Phase|Withdrawal by Subject|20
98136|NCT00783718|339077|P6|Maintenance Phase|Withdrawal by Subject|2
98137|NCT00783718|339078|P5|Maintenance Phase|Withdrawal by Subject|5
98138|NCT00783718|339079|P4|Maintenance Phase|Withdrawal by Subject|2
98139|NCT00783718|339080|P3|Maintenance Phase|Withdrawal by Subject|0
98140|NCT00783718|339081|P2|Maintenance Phase|Withdrawal by Subject|0
98141|NCT00783718|339082|P1|Maintenance Phase|Withdrawal by Subject|6
98142|NCT00783718|339076|P7|Maintenance Phase|Lack of Efficacy|155
98143|NCT00783718|339077|P6|Maintenance Phase|Lack of Efficacy|33
98144|NCT00783718|339078|P5|Maintenance Phase|Lack of Efficacy|31
98145|NCT00783718|339079|P4|Maintenance Phase|Lack of Efficacy|61
98146|NCT00783718|339080|P3|Maintenance Phase|Lack of Efficacy|0
98147|NCT00783718|339081|P2|Maintenance Phase|Lack of Efficacy|0
98148|NCT00783718|339082|P1|Maintenance Phase|Lack of Efficacy|83
98149|NCT00783718|339076|P7|Maintenance Phase|Protocol Violation|2
98150|NCT00783718|339077|P6|Maintenance Phase|Protocol Violation|0
98151|NCT00783718|339078|P5|Maintenance Phase|Protocol Violation|0
98152|NCT00783718|339079|P4|Maintenance Phase|Protocol Violation|0
98153|NCT00783718|339080|P3|Maintenance Phase|Protocol Violation|0
98154|NCT00783718|339081|P2|Maintenance Phase|Protocol Violation|0
98155|NCT00783718|339082|P1|Maintenance Phase|Protocol Violation|1
98156|NCT00783718|339076|P7|Maintenance Phase|Adverse Event|16
98157|NCT00783718|339077|P6|Maintenance Phase|Adverse Event|6
98158|NCT00783718|339078|P5|Maintenance Phase|Adverse Event|7
98159|NCT00783718|339079|P4|Maintenance Phase|Adverse Event|15
98160|NCT00783718|339080|P3|Maintenance Phase|Adverse Event|0
98161|NCT00783718|339081|P2|Maintenance Phase|Adverse Event|0
98162|NCT00783718|339082|P1|Maintenance Phase|Adverse Event|12
98163|NCT00783718|339076|P7|Induction Phase|Lost to Follow-up|0
98164|NCT00783718|339077|P6|Induction Phase|Lost to Follow-up|0
98165|NCT00783718|339078|P5|Induction Phase|Lost to Follow-up|0
98166|NCT00783718|339079|P4|Induction Phase|Lost to Follow-up|0
98167|NCT00783718|339080|P3|Induction Phase|Lost to Follow-up|1
98168|NCT00783718|339081|P2|Induction Phase|Lost to Follow-up|0
98169|NCT00783718|339082|P1|Induction Phase|Lost to Follow-up|1
98170|NCT00783718|339076|P7|Induction Phase|Withdrawal by Subject|0
98171|NCT00783718|339077|P6|Induction Phase|Withdrawal by Subject|0
98172|NCT00783718|339078|P5|Induction Phase|Withdrawal by Subject|0
98173|NCT00783718|339079|P4|Induction Phase|Withdrawal by Subject|0
98174|NCT00783718|339080|P3|Induction Phase|Withdrawal by Subject|8
98175|NCT00783718|339081|P2|Induction Phase|Withdrawal by Subject|4
98176|NCT00783718|339082|P1|Induction Phase|Withdrawal by Subject|3
98177|NCT00783718|339076|P7|Induction Phase|Lack of Efficacy|0
98178|NCT00783718|339077|P6|Induction Phase|Lack of Efficacy|0
98179|NCT00783718|339078|P5|Induction Phase|Lack of Efficacy|0
98180|NCT00783718|339079|P4|Induction Phase|Lack of Efficacy|0
98181|NCT00783718|339080|P3|Induction Phase|Lack of Efficacy|14
98182|NCT00783718|339081|P2|Induction Phase|Lack of Efficacy|2
98183|NCT00783718|339082|P1|Induction Phase|Lack of Efficacy|5
98184|NCT00783718|339076|P7|Induction Phase|Protocol Violation|0
98185|NCT00783718|339077|P6|Induction Phase|Protocol Violation|0
98186|NCT00783718|339078|P5|Induction Phase|Protocol Violation|0
98187|NCT00783718|339079|P4|Induction Phase|Protocol Violation|0
98188|NCT00783718|339080|P3|Induction Phase|Protocol Violation|6
98189|NCT00783718|339081|P2|Induction Phase|Protocol Violation|1
98190|NCT00783718|339082|P1|Induction Phase|Protocol Violation|1
98191|NCT00783718|339076|P7|Induction Phase|Adverse Event|0
98192|NCT00783718|339077|P6|Induction Phase|Adverse Event|0
98193|NCT00783718|339078|P5|Induction Phase|Adverse Event|0
98194|NCT00783718|339079|P4|Induction Phase|Adverse Event|0
98195|NCT00783718|339080|P3|Induction Phase|Adverse Event|7
98196|NCT00783718|339081|P2|Induction Phase|Adverse Event|0
98197|NCT00783718|339082|P1|Induction Phase|Adverse Event|4
98198|NCT00783705|339110|P2|Overall Study|Lost to Follow-up|3
98199|NCT00783705|339111|P1|Overall Study|Lost to Follow-up|1
98200|NCT00783705|339110|P2|Overall Study|Withdrawal by Subject|2
98201|NCT00783705|339111|P1|Overall Study|Withdrawal by Subject|3
98202|NCT00783705|339110|P2|Overall Study|Adverse Event|0
98203|NCT00783705|339111|P1|Overall Study|Adverse Event|2
98204|NCT00783692|339156|P7|Maintenance Phase|Other|1
98205|NCT00783692|339157|P6|Maintenance Phase|Other|1
98206|NCT00783692|339158|P5|Maintenance Phase|Other|0
98207|NCT00783692|339159|P4|Maintenance Phase|Other|1
98208|NCT00783692|339160|P3|Maintenance Phase|Other|0
98209|NCT00783692|339161|P2|Maintenance Phase|Other|0
98210|NCT00783692|339162|P1|Maintenance Phase|Other|0
98211|NCT00783692|339156|P7|Maintenance Phase|Lost to Follow-up|5
98212|NCT00783692|339157|P6|Maintenance Phase|Lost to Follow-up|2
98213|NCT00783692|339158|P5|Maintenance Phase|Lost to Follow-up|3
98214|NCT00783692|339159|P4|Maintenance Phase|Lost to Follow-up|1
98215|NCT00783692|339160|P3|Maintenance Phase|Lost to Follow-up|0
98216|NCT00783692|339161|P2|Maintenance Phase|Lost to Follow-up|0
98217|NCT00783692|339162|P1|Maintenance Phase|Lost to Follow-up|2
98218|NCT00783692|339156|P7|Maintenance Phase|Withdrawal by Subject|24
98219|NCT00783692|339157|P6|Maintenance Phase|Withdrawal by Subject|9
98220|NCT00783692|339158|P5|Maintenance Phase|Withdrawal by Subject|6
98221|NCT00783692|339159|P4|Maintenance Phase|Withdrawal by Subject|7
98222|NCT00783692|339160|P3|Maintenance Phase|Withdrawal by Subject|0
98223|NCT00783692|339161|P2|Maintenance Phase|Withdrawal by Subject|0
98224|NCT00783692|339162|P1|Maintenance Phase|Withdrawal by Subject|7
98225|NCT00783692|339156|P7|Maintenance Phase|Lack of Efficacy|177
98226|NCT00783692|339157|P6|Maintenance Phase|Lack of Efficacy|48
98227|NCT00783692|339158|P5|Maintenance Phase|Lack of Efficacy|58
98228|NCT00783692|339159|P4|Maintenance Phase|Lack of Efficacy|64
98229|NCT00783692|339160|P3|Maintenance Phase|Lack of Efficacy|0
98230|NCT00783692|339161|P2|Maintenance Phase|Lack of Efficacy|0
98231|NCT00783692|339162|P1|Maintenance Phase|Lack of Efficacy|79
98232|NCT00783692|339156|P7|Maintenance Phase|Protocol Violation|4
98233|NCT00783692|339157|P6|Maintenance Phase|Protocol Violation|3
98234|NCT00783692|339158|P5|Maintenance Phase|Protocol Violation|2
98235|NCT00783692|339159|P4|Maintenance Phase|Protocol Violation|1
98236|NCT00783692|339160|P3|Maintenance Phase|Protocol Violation|0
98237|NCT00783692|339161|P2|Maintenance Phase|Protocol Violation|0
98238|NCT00783692|339162|P1|Maintenance Phase|Protocol Violation|0
98239|NCT00783692|339156|P7|Maintenance Phase|Adverse Event|38
98240|NCT00783692|339157|P6|Maintenance Phase|Adverse Event|9
98241|NCT00783692|339158|P5|Maintenance Phase|Adverse Event|12
98242|NCT00783692|339159|P4|Maintenance Phase|Adverse Event|15
98243|NCT00783692|339160|P3|Maintenance Phase|Adverse Event|0
98244|NCT00783692|339161|P2|Maintenance Phase|Adverse Event|0
98245|NCT00783692|339162|P1|Maintenance Phase|Adverse Event|7
98246|NCT00783692|339156|P7|Induction Phase|Other|0
98247|NCT00783692|339157|P6|Induction Phase|Other|0
98248|NCT00783692|339158|P5|Induction Phase|Other|0
98249|NCT00783692|339159|P4|Induction Phase|Other|0
98250|NCT00783692|339160|P3|Induction Phase|Other|2
98251|NCT00783692|339161|P2|Induction Phase|Other|0
98252|NCT00783692|339162|P1|Induction Phase|Other|0
98253|NCT00783692|339156|P7|Induction Phase|Lost to Follow-up|0
98254|NCT00783692|339157|P6|Induction Phase|Lost to Follow-up|0
98255|NCT00783692|339158|P5|Induction Phase|Lost to Follow-up|0
98256|NCT00783692|339159|P4|Induction Phase|Lost to Follow-up|0
98257|NCT00783692|339160|P3|Induction Phase|Lost to Follow-up|3
98258|NCT00783692|339161|P2|Induction Phase|Lost to Follow-up|0
98259|NCT00783692|339162|P1|Induction Phase|Lost to Follow-up|0
98260|NCT00783692|339156|P7|Induction Phase|Withdrawal by Subject|0
98261|NCT00783692|339157|P6|Induction Phase|Withdrawal by Subject|0
98262|NCT00783692|339158|P5|Induction Phase|Withdrawal by Subject|0
98263|NCT00783692|339159|P4|Induction Phase|Withdrawal by Subject|0
98264|NCT00783692|339160|P3|Induction Phase|Withdrawal by Subject|16
98265|NCT00783692|339161|P2|Induction Phase|Withdrawal by Subject|9
98266|NCT00783692|339162|P1|Induction Phase|Withdrawal by Subject|3
98267|NCT00783692|339156|P7|Induction Phase|Lack of Efficacy|0
98268|NCT00783692|339157|P6|Induction Phase|Lack of Efficacy|0
98269|NCT00783692|339158|P5|Induction Phase|Lack of Efficacy|0
98270|NCT00783692|339159|P4|Induction Phase|Lack of Efficacy|0
98271|NCT00783692|339160|P3|Induction Phase|Lack of Efficacy|28
98272|NCT00783692|339161|P2|Induction Phase|Lack of Efficacy|3
98273|NCT00783692|339162|P1|Induction Phase|Lack of Efficacy|1
98274|NCT00783692|339156|P7|Induction Phase|Protocol Violation|0
98275|NCT00783692|339157|P6|Induction Phase|Protocol Violation|0
98276|NCT00783692|339158|P5|Induction Phase|Protocol Violation|0
98277|NCT00783692|339159|P4|Induction Phase|Protocol Violation|0
98278|NCT00783692|339160|P3|Induction Phase|Protocol Violation|1
98279|NCT00783692|339161|P2|Induction Phase|Protocol Violation|0
98280|NCT00783692|339162|P1|Induction Phase|Protocol Violation|0
98281|NCT00783692|339156|P7|Induction Phase|Adverse Event|0
98282|NCT00783692|339157|P6|Induction Phase|Adverse Event|0
98283|NCT00783692|339158|P5|Induction Phase|Adverse Event|0
98284|NCT00783692|339159|P4|Induction Phase|Adverse Event|0
98285|NCT00783692|339160|P3|Induction Phase|Adverse Event|24
98286|NCT00783692|339161|P2|Induction Phase|Adverse Event|9
98287|NCT00783692|339162|P1|Induction Phase|Adverse Event|7
98288|NCT00783432|339204|P2|Overall Study|Protocol Violation|9
98289|NCT00783432|339205|P1|Overall Study|Protocol Violation|6
98290|NCT00783432|339204|P2|Overall Study|subject moved|5
98291|NCT00783432|339205|P1|Overall Study|subject moved|3
98292|NCT00783432|339204|P2|Overall Study|Withdrawal by Subject|20
98293|NCT00783432|339205|P1|Overall Study|Withdrawal by Subject|23
98294|NCT00783432|339204|P2|Overall Study|Lost to Follow-up|6
98295|NCT00783432|339205|P1|Overall Study|Lost to Follow-up|11
98296|NCT00783432|339204|P2|Overall Study|Lack of Efficacy|21
98297|NCT00783432|339205|P1|Overall Study|Lack of Efficacy|20
98298|NCT00783432|339204|P2|Overall Study|Adverse Event|17
98299|NCT00783432|339205|P1|Overall Study|Adverse Event|22
98300|NCT00783302|339215|P1|Overall Study|Withdrawal by Subject|3
98301|NCT00783302|339215|P1|Overall Study|Physician Decision|1
98302|NCT00783302|339215|P1|Overall Study|Protocol Violation|3
98303|NCT00783302|339215|P1|Overall Study|Technical Problems|11
98304|NCT00783302|339215|P1|Overall Study|Lost to Follow-up|17
98305|NCT00783263|339237|P4|Overall Study|Withdrawal by Subject|2
98306|NCT00783263|339238|P3|Overall Study|Withdrawal by Subject|1
98307|NCT00783263|339239|P2|Overall Study|Withdrawal by Subject|1
98308|NCT00783263|339240|P1|Overall Study|Withdrawal by Subject|0
98309|NCT00783263|339237|P4|Overall Study|Lost to Follow-up|0
98310|NCT00783263|339238|P3|Overall Study|Lost to Follow-up|0
98311|NCT00783263|339239|P2|Overall Study|Lost to Follow-up|1
98312|NCT00783263|339240|P1|Overall Study|Lost to Follow-up|1
98313|NCT00783263|339237|P4|Overall Study|Adverse Event|1
98314|NCT00783263|339238|P3|Overall Study|Adverse Event|2
98315|NCT00783263|339239|P2|Overall Study|Adverse Event|0
98316|NCT00783263|339240|P1|Overall Study|Adverse Event|3
98317|NCT00783224|339270|P4|Overall Study|Inappropriate as a study subject|1
98318|NCT00783224|339271|P3|Overall Study|Inappropriate as a study subject|0
98319|NCT00783224|339272|P2|Overall Study|Inappropriate as a study subject|0
98320|NCT00783224|339273|P1|Overall Study|Inappropriate as a study subject|0
98321|NCT00783224|339270|P4|Overall Study|Discarded the Investigational Drug Used|1
98322|NCT00783224|339271|P3|Overall Study|Discarded the Investigational Drug Used|0
98323|NCT00783224|339272|P2|Overall Study|Discarded the Investigational Drug Used|0
98324|NCT00783224|339273|P1|Overall Study|Discarded the Investigational Drug Used|0
98325|NCT00783224|339270|P4|Overall Study|Adverse Event|0
98326|NCT00783224|339271|P3|Overall Study|Adverse Event|1
98327|NCT00783224|339272|P2|Overall Study|Adverse Event|0
98328|NCT00783224|339273|P1|Overall Study|Adverse Event|0
98329|NCT00783198|339285|P3|Overall Study|Administrative|2
98330|NCT00783198|339286|P2|Overall Study|Administrative|1
98331|NCT00783198|339287|P1|Overall Study|Administrative|2
98332|NCT00783198|339285|P3|Overall Study|Did not meet protocol eligibility|0
98333|NCT00783198|339286|P2|Overall Study|Did not meet protocol eligibility|1
98334|NCT00783198|339287|P1|Overall Study|Did not meet protocol eligibility|0
98335|NCT00783198|339285|P3|Overall Study|Noncompliance with protocol|10
98336|NCT00783198|339286|P2|Overall Study|Noncompliance with protocol|7
98337|NCT00783198|339287|P1|Overall Study|Noncompliance with protocol|7
98338|NCT00783198|339285|P3|Overall Study|Withdrawal by Subject|20
98339|NCT00783198|339286|P2|Overall Study|Withdrawal by Subject|14
98340|NCT00783198|339287|P1|Overall Study|Withdrawal by Subject|22
98341|NCT00783198|339285|P3|Overall Study|Lost to Follow-up|7
98342|NCT00783198|339286|P2|Overall Study|Lost to Follow-up|1
98343|NCT00783198|339287|P1|Overall Study|Lost to Follow-up|11
98344|NCT00783198|339285|P3|Overall Study|Adverse Event|3
98345|NCT00783198|339286|P2|Overall Study|Adverse Event|19
98346|NCT00783198|339287|P1|Overall Study|Adverse Event|15
98347|NCT00783094|339310|P3|Open-Label Extension Period|Lack of Efficacy|0
98348|NCT00783094|339311|P2|Open-Label Extension Period|Lack of Efficacy|4
98349|NCT00783094|339312|P1|Open-Label Extension Period|Lack of Efficacy|1
98350|NCT00783094|339310|P3|Open-Label Extension Period|Physician Decision|3
98351|NCT00783094|339311|P2|Open-Label Extension Period|Physician Decision|2
98352|NCT00783094|339312|P1|Open-Label Extension Period|Physician Decision|4
98353|NCT00783094|339310|P3|Open-Label Extension Period|Withdrawal by Subject|3
98354|NCT00783094|339311|P2|Open-Label Extension Period|Withdrawal by Subject|1
98355|NCT00783094|339312|P1|Open-Label Extension Period|Withdrawal by Subject|1
98356|NCT00783094|339310|P3|Open-Label Extension Period|Protocol Violation|7
98357|NCT00783094|339311|P2|Open-Label Extension Period|Protocol Violation|5
98358|NCT00783094|339312|P1|Open-Label Extension Period|Protocol Violation|4
98359|NCT00783094|339310|P3|Open-Label Extension Period|Death|1
98360|NCT00783094|339311|P2|Open-Label Extension Period|Death|0
98361|NCT00783094|339312|P1|Open-Label Extension Period|Death|0
98362|NCT00783094|339310|P3|Open-Label Extension Period|Adverse Event|16
98363|NCT00783094|339311|P2|Open-Label Extension Period|Adverse Event|7
98364|NCT00783094|339312|P1|Open-Label Extension Period|Adverse Event|12
98365|NCT00783094|339310|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
98366|NCT00783094|339311|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
98367|NCT00783094|339312|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
98368|NCT00783094|339310|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
98369|NCT00783094|339311|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
98370|NCT00783094|339312|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
98371|NCT00783094|339310|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
98372|NCT00783094|339311|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
98373|NCT00783094|339312|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
98374|NCT00783094|339310|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
98375|NCT00783094|339311|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
98376|NCT00783094|339312|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
98377|NCT00783094|339310|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
98378|NCT00783094|339311|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
98379|NCT00783094|339312|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
98380|NCT00782834|339388|P1|Treatment Phase|fibrous tumor not GIST|1
98381|NCT00782717|339428|P2|Overall Study|Exited in error|2
98382|NCT00782717|339429|P1|Overall Study|Exited in error|0
98383|NCT00782717|339428|P2|Overall Study|Did not meet entrance criteria|3
98384|NCT00782717|339429|P1|Overall Study|Did not meet entrance criteria|1
98385|NCT00782717|339428|P2|Overall Study|Enrollment close prior to surgery|0
98386|NCT00782717|339429|P1|Overall Study|Enrollment close prior to surgery|1
98387|NCT00782717|339428|P2|Overall Study|Treatment failure|14
98388|NCT00782717|339429|P1|Overall Study|Treatment failure|3
98389|NCT00782717|339428|P2|Overall Study|Noncompliance|1
98390|NCT00782717|339429|P1|Overall Study|Noncompliance|2
98391|NCT00782717|339428|P2|Overall Study|Patient decision unrelated to AE|3
98392|NCT00782717|339429|P1|Overall Study|Patient decision unrelated to AE|6
98393|NCT00782717|339428|P2|Overall Study|Adverse Event|5
98394|NCT00782717|339429|P1|Overall Study|Adverse Event|2
98395|NCT00782626|339456|P1|Overall Study|Other Complicating Disease|1
98396|NCT00782626|339456|P1|Overall Study|Progressive Disease|5
98397|NCT00782626|339456|P1|Overall Study|Adverse Event|1
98398|NCT00782509|339463|P3|Overall Study|Lack of Efficacy|2
98399|NCT00782509|339464|P2|Overall Study|Lack of Efficacy|5
98400|NCT00782509|339465|P1|Overall Study|Lack of Efficacy|10
98401|NCT00782509|339463|P3|Overall Study|Other reasons not stated above|3
98402|NCT00782509|339464|P2|Overall Study|Other reasons not stated above|2
98403|NCT00782509|339465|P1|Overall Study|Other reasons not stated above|5
98404|NCT00782509|339463|P3|Overall Study|Non compliance with protocol|0
98405|NCT00782509|339464|P2|Overall Study|Non compliance with protocol|0
98406|NCT00782509|339465|P1|Overall Study|Non compliance with protocol|2
98407|NCT00782509|339463|P3|Overall Study|Withdrawal by Subject|8
98408|NCT00782509|339464|P2|Overall Study|Withdrawal by Subject|5
98409|NCT00782509|339465|P1|Overall Study|Withdrawal by Subject|3
98410|NCT00782509|339463|P3|Overall Study|Lost to Follow-up|3
98411|NCT00782509|339464|P2|Overall Study|Lost to Follow-up|2
98412|NCT00782509|339465|P1|Overall Study|Lost to Follow-up|1
98413|NCT00782509|339463|P3|Overall Study|Adverse Event|20
98414|NCT00782509|339464|P2|Overall Study|Adverse Event|10
98415|NCT00782509|339465|P1|Overall Study|Adverse Event|20
98416|NCT00782496|339658|P2|Overall Study|Lost to Follow-up|15
98417|NCT00782496|339659|P1|Overall Study|Lost to Follow-up|14
98418|NCT00782483|339666|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
98419|NCT00782418|339670|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
98420|NCT00782418|339671|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
98421|NCT00782418|339672|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
98422|NCT00782418|339673|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
98423|NCT00782418|339674|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
98424|NCT00782418|339675|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
98425|NCT00782418|339676|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
98426|NCT00782418|339670|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
98427|NCT00782418|339671|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
98428|NCT00782418|339672|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
98429|NCT00782418|339673|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
98430|NCT00782418|339674|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
98431|NCT00782418|339675|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
98432|NCT00782418|339676|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
98433|NCT00782340|339713|P3|Open Label Titration|Randomized in error|0
98434|NCT00782340|339714|P2|Open Label Titration|Randomized in error|0
98435|NCT00782340|339715|P1|Open Label Titration|Randomized in error|6
98436|NCT00782340|339713|P3|Open Label Titration|Lost to Follow-up|0
98437|NCT00782340|339714|P2|Open Label Titration|Lost to Follow-up|0
98438|NCT00782340|339715|P1|Open Label Titration|Lost to Follow-up|5
98439|NCT00782340|339713|P3|Open Label Titration|Did not meet responder criteria|0
98440|NCT00782340|339714|P2|Open Label Titration|Did not meet responder criteria|0
98441|NCT00782340|339715|P1|Open Label Titration|Did not meet responder criteria|2
98442|NCT00782340|339713|P3|Open Label Titration|Enrollment capped|0
98443|NCT00782340|339714|P2|Open Label Titration|Enrollment capped|0
98444|NCT00782340|339715|P1|Open Label Titration|Enrollment capped|16
98445|NCT00782340|339713|P3|Open Label Titration|Withdrawal by Subject|0
98446|NCT00782340|339714|P2|Open Label Titration|Withdrawal by Subject|0
98447|NCT00782340|339715|P1|Open Label Titration|Withdrawal by Subject|5
98448|NCT00782340|339713|P3|Open Label Titration|Protocol Violation|0
98449|NCT00782340|339714|P2|Open Label Titration|Protocol Violation|0
98450|NCT00782340|339715|P1|Open Label Titration|Protocol Violation|5
98451|NCT00782340|339713|P3|Open Label Titration|Treatment failure|0
98452|NCT00782340|339714|P2|Open Label Titration|Treatment failure|0
98453|NCT00782340|339715|P1|Open Label Titration|Treatment failure|50
98454|NCT00782340|339713|P3|Open Label Titration|Adverse Event|0
98455|NCT00782340|339714|P2|Open Label Titration|Adverse Event|0
98456|NCT00782340|339715|P1|Open Label Titration|Adverse Event|12
98457|NCT00782210|339788|P3|Overall Study|Other reason not described above|3
98458|NCT00782210|339789|P2|Overall Study|Other reason not described above|2
98459|NCT00782210|339790|P1|Overall Study|Other reason not described above|3
98460|NCT00782210|339788|P3|Overall Study|Lack of Efficacy|1
98461|NCT00782210|339789|P2|Overall Study|Lack of Efficacy|4
98462|NCT00782210|339790|P1|Overall Study|Lack of Efficacy|13
98463|NCT00782210|339788|P3|Overall Study|Non compliance with protocol|2
98464|NCT00782210|339789|P2|Overall Study|Non compliance with protocol|3
98465|NCT00782210|339790|P1|Overall Study|Non compliance with protocol|0
98466|NCT00782210|339788|P3|Overall Study|Withdrawal by Subject|11
98467|NCT00782210|339789|P2|Overall Study|Withdrawal by Subject|8
98468|NCT00782210|339790|P1|Overall Study|Withdrawal by Subject|11
98469|NCT00782210|339788|P3|Overall Study|Lost to Follow-up|2
98470|NCT00782210|339789|P2|Overall Study|Lost to Follow-up|1
98471|NCT00782210|339790|P1|Overall Study|Lost to Follow-up|2
98472|NCT00782210|339788|P3|Overall Study|Adverse Event|16
98473|NCT00782210|339789|P2|Overall Study|Adverse Event|17
98474|NCT00782210|339790|P1|Overall Study|Adverse Event|21
98475|NCT00782184|339983|P2|Overall Study|Withdrawal by Subject|2
98476|NCT00782184|339984|P1|Overall Study|Withdrawal by Subject|3
98477|NCT00782184|339983|P2|Overall Study|Protocol Violation|1
98478|NCT00782184|339984|P1|Overall Study|Protocol Violation|0
98479|NCT00782184|339983|P2|Overall Study|Adverse Event|2
98480|NCT00782184|339984|P1|Overall Study|Adverse Event|1
98481|NCT00781963|340022|P3|Overall Study|Refused follow-up|0
98482|NCT00781963|340023|P2|Overall Study|Refused follow-up|5
98483|NCT00781963|340024|P1|Overall Study|Refused follow-up|4
98484|NCT00781963|340022|P3|Overall Study|Withdrawal by Subject|1
98485|NCT00781963|340023|P2|Overall Study|Withdrawal by Subject|3
98486|NCT00781963|340024|P1|Overall Study|Withdrawal by Subject|0
98487|NCT00781963|340022|P3|Overall Study|Lost to Follow-up|1
98488|NCT00781963|340023|P2|Overall Study|Lost to Follow-up|1
98489|NCT00781963|340024|P1|Overall Study|Lost to Follow-up|1
98490|NCT00781963|340022|P3|Overall Study|Death|0
98491|NCT00781963|340023|P2|Overall Study|Death|0
98492|NCT00781963|340024|P1|Overall Study|Death|3
98493|NCT00781937|340045|P2|Follow up Period (Week 56-68)|Unclassified|4
98494|NCT00781937|340046|P1|Follow up Period (Week 56-68)|Unclassified|5
98495|NCT00781937|340045|P2|Follow up Period (Week 56-68)|Protocol Violation|1
98496|NCT00781937|340046|P1|Follow up Period (Week 56-68)|Protocol Violation|1
98497|NCT00781937|340045|P2|Main Trial Period Through Week 56|Unclassified|15
98498|NCT00781937|340046|P1|Main Trial Period Through Week 56|Unclassified|10
98499|NCT00781937|340045|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
98500|NCT00781937|340046|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
98501|NCT00781937|340045|P2|Main Trial Period Through Week 56|Protocol Violation|5
98502|NCT00781937|340046|P1|Main Trial Period Through Week 56|Protocol Violation|8
98503|NCT00781937|340045|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
98504|NCT00781937|340046|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
98505|NCT00781937|340045|P2|Main Trial Period Through Week 56|Adverse Event|18
98506|NCT00781937|340046|P1|Main Trial Period Through Week 56|Adverse Event|18
98507|NCT00781859|340104|P2|Overall Study|Death|0
98508|NCT00781859|340105|P1|Overall Study|Death|3
98509|NCT00781859|340104|P2|Overall Study|Lost to Follow-up|3
98510|NCT00781859|340105|P1|Overall Study|Lost to Follow-up|6
98511|NCT00781859|340104|P2|Overall Study|Withdrawal by Subject|4
98512|NCT00781859|340105|P1|Overall Study|Withdrawal by Subject|8
98513|NCT00781859|340104|P2|Overall Study|Adverse Event|2
98514|NCT00781859|340105|P1|Overall Study|Adverse Event|2
98515|NCT00781599|340115|P2|Overall Study|Lost to Follow-up|4
98516|NCT00781599|340116|P1|Overall Study|Lost to Follow-up|7
98517|NCT00781456|340141|P2|Overall Study|Other Reason, Unknown|1
98518|NCT00781456|340142|P1|Overall Study|Other Reason, Unknown|0
98519|NCT00781456|340141|P2|Overall Study|Lost to Follow-up|5
98520|NCT00781456|340142|P1|Overall Study|Lost to Follow-up|10
98521|NCT00781456|340141|P2|Overall Study|Noncompliance With Protocol|1
98522|NCT00781456|340142|P1|Overall Study|Noncompliance With Protocol|1
98523|NCT00781456|340141|P2|Overall Study|Protocol Violation|1
98524|NCT00781456|340142|P1|Overall Study|Protocol Violation|4
98525|NCT00781456|340141|P2|Overall Study|Withdrawal by Subject|5
98526|NCT00781456|340142|P1|Overall Study|Withdrawal by Subject|3
98527|NCT00781456|340141|P2|Overall Study|Adverse Event|3
98528|NCT00781456|340142|P1|Overall Study|Adverse Event|3
98529|NCT00781391|340165|P3|Overall Study|Lost to Follow-up|1
98530|NCT00781391|340166|P2|Overall Study|Lost to Follow-up|0
98531|NCT00781391|340167|P1|Overall Study|Lost to Follow-up|0
98532|NCT00781391|340165|P3|Overall Study|Withdrawal by Subject|25
98533|NCT00781391|340166|P2|Overall Study|Withdrawal by Subject|37
98534|NCT00781391|340167|P1|Overall Study|Withdrawal by Subject|47
98535|NCT00781391|340165|P3|Overall Study|Death|706
98536|NCT00781391|340166|P2|Overall Study|Death|730
98537|NCT00781391|340167|P1|Overall Study|Death|789
98538|NCT00781391|340165|P3|Overall Study|Protocol Violation|20
98539|NCT00781391|340166|P2|Overall Study|Protocol Violation|17
98540|NCT00781391|340167|P1|Overall Study|Protocol Violation|19
98541|NCT00781391|340165|P3|Overall Study|never received study drug|32
98542|NCT00781391|340166|P2|Overall Study|never received study drug|23
98543|NCT00781391|340167|P1|Overall Study|never received study drug|24
98544|NCT00781365|340201|P2|Overall Study|Language barrier|0
98545|NCT00781365|340202|P1|Overall Study|Language barrier|1
98546|NCT00781365|340201|P2|Overall Study|Lost to Follow-up|31
98547|NCT00781365|340202|P1|Overall Study|Lost to Follow-up|24
98548|NCT00781365|340201|P2|Overall Study|Withdrawal by Subject|9
98549|NCT00781365|340202|P1|Overall Study|Withdrawal by Subject|15
98550|NCT00781326|340212|P1|Phase I|Physician Decision|2
98551|NCT00781326|340212|P1|Phase I|Withdrawal by Subject|1
98552|NCT00781326|340212|P1|Phase I|Adverse Event|1
98553|NCT00781274|340216|P1|Overall Study|Withdrawal by Subject|2
98554|NCT00780910|340231|P1|Overall Study|Adverse Event|2
98555|NCT00780416|340303|P2|Overall Study|Withdrawal by Subject|6
98556|NCT00780416|340304|P1|Overall Study|Withdrawal by Subject|8
98557|NCT00780416|340303|P2|Overall Study|Protocol Violation|0
98558|NCT00780416|340304|P1|Overall Study|Protocol Violation|1
98559|NCT00780416|340303|P2|Overall Study|Physician Decision|3
98560|NCT00780416|340304|P1|Overall Study|Physician Decision|3
98561|NCT00780273|340349|P1|Overall Study|Lost to Follow-up|1
98562|NCT00780273|340349|P1|Overall Study|Death|1
98563|NCT00779246|340360|P2|Overall Study|Missing sufficient data for analysis|53
98564|NCT00779246|340361|P1|Overall Study|Missing sufficient data for analysis|33
98565|NCT00779857|340367|P1|Overall Study|Missed Visit|2
98566|NCT00779857|340367|P1|Overall Study|Withdrawal by Subject|3
98567|NCT00779857|340367|P1|Overall Study|Death|1
98568|NCT00779779|340372|P1|Overall Study|Lost to Follow-up|5
98569|NCT00779779|340372|P1|Overall Study|Withdrawal by Subject|4
98570|NCT00779779|340372|P1|Overall Study|Protocol Violation|14
98571|NCT00779779|340372|P1|Overall Study|Adverse Event|1
98572|NCT00779766|340381|P2|Overall Study|Withdrawal by Subject|67
98573|NCT00779766|340382|P1|Overall Study|Withdrawal by Subject|84
98574|NCT00779766|340381|P2|Overall Study|Protocol Violation|1
98575|NCT00779766|340382|P1|Overall Study|Protocol Violation|1
98576|NCT00779675|340464|P1|Extended Treatment Period|Lost to Follow-up|6
98577|NCT00779675|340464|P1|Extended Treatment Period|Protocol defined clinical event|1
98578|NCT00779675|340464|P1|Extended Treatment Period|Treatment Failure|11
98579|NCT00779675|340464|P1|Extended Treatment Period|Adverse Event|6
98580|NCT00779675|340464|P1|Extended Treatment Period|Protocol Violation|13
98581|NCT00779675|340464|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
98582|NCT00779675|340464|P1|Treatment Period|Administrative|3
98583|NCT00779675|340464|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
98584|NCT00779675|340464|P1|Treatment Period|Protocol Violation|54
98585|NCT00779675|340464|P1|Treatment Period|Withdrawal by Subject|46
98586|NCT00779675|340464|P1|Treatment Period|Lost to Follow-up|23
98587|NCT00779675|340464|P1|Treatment Period|Transferred to Another Study|38
98588|NCT00779675|340464|P1|Treatment Period|Treatment Failure|80
98589|NCT00779675|340464|P1|Treatment Period|Adverse Event|87
98590|NCT00779506|340500|P1|Overall Study|Lost to Follow-up|1
98591|NCT00779506|340500|P1|Overall Study|Withdrawal by Subject|6
98592|NCT00779506|340500|P1|Overall Study|Protocol Violation|5
98593|NCT00779506|340500|P1|Overall Study|Lack of Efficacy|11
98594|NCT00779506|340500|P1|Overall Study|Adverse Event|4
98595|NCT00779506|340500|P1|Overall Study|Screening Failed|2
98596|NCT00779259|340545|P1|Quinine Alone|Adverse Event|2
98597|NCT00779142|340573|P1|Overall Study|Screen Failures|3
98598|NCT00779038|340585|P1|Overall Study|Study Prematurely Terminated|13
98599|NCT00779025|340594|P1|Overall Study|Withdrawal by Subject|1
98600|NCT00778999|340605|P2|Overall Study|Did not receive recFSH|20
98601|NCT00778999|340606|P1|Overall Study|Did not receive recFSH|14
98602|NCT00778999|340605|P2|Overall Study|Discontinuation: no embryo transfer|14
98603|NCT00778999|340606|P1|Overall Study|Discontinuation: no embryo transfer|14
98604|NCT00778921|340615|P3|Overall Study|Not treated|2
98605|NCT00778921|340616|P2|Overall Study|Not treated|2
98606|NCT00778921|340617|P1|Overall Study|Not treated|0
98607|NCT00778921|340615|P3|Overall Study|Protocol Violation|2
98608|NCT00778921|340616|P2|Overall Study|Protocol Violation|0
98609|NCT00778921|340617|P1|Overall Study|Protocol Violation|3
98610|NCT00778921|340615|P3|Overall Study|Administrative Problems|0
98611|NCT00778921|340616|P2|Overall Study|Administrative Problems|2
98612|NCT00778921|340617|P1|Overall Study|Administrative Problems|1
98613|NCT00778921|340615|P3|Overall Study|Lost to Follow-up|1
98614|NCT00778921|340616|P2|Overall Study|Lost to Follow-up|2
98615|NCT00778921|340617|P1|Overall Study|Lost to Follow-up|0
98616|NCT00778921|340615|P3|Overall Study|Patient withdrew request|6
98617|NCT00778921|340616|P2|Overall Study|Patient withdrew request|1
98618|NCT00778921|340617|P1|Overall Study|Patient withdrew request|3
98619|NCT00778921|340615|P3|Overall Study|Patient No Longer Requires Study Drug|0
98620|NCT00778921|340616|P2|Overall Study|Patient No Longer Requires Study Drug|1
98621|NCT00778921|340617|P1|Overall Study|Patient No Longer Requires Study Drug|0
98622|NCT00778921|340615|P3|Overall Study|Unsatisfactory therapeutic response|1
98623|NCT00778921|340616|P2|Overall Study|Unsatisfactory therapeutic response|1
98624|NCT00778921|340617|P1|Overall Study|Unsatisfactory therapeutic response|1
98625|NCT00778921|340615|P3|Overall Study|Abnormal Test Procedure Result(s)|2
98626|NCT00778921|340616|P2|Overall Study|Abnormal Test Procedure Result(s)|0
98627|NCT00778921|340617|P1|Overall Study|Abnormal Test Procedure Result(s)|0
98628|NCT00778921|340615|P3|Overall Study|Abnormal Laboratory Value(s)|0
98629|NCT00778921|340616|P2|Overall Study|Abnormal Laboratory Value(s)|0
98630|NCT00778921|340617|P1|Overall Study|Abnormal Laboratory Value(s)|1
98631|NCT00778921|340615|P3|Overall Study|Adverse Event|14
98632|NCT00778921|340616|P2|Overall Study|Adverse Event|10
98633|NCT00778921|340617|P1|Overall Study|Adverse Event|9
98634|NCT00778895|340634|P3|ESFU Phase|Unspecified|0
98635|NCT00778895|340635|P2|ESFU Phase|Unspecified|0
98636|NCT00778895|340636|P1|ESFU Phase|Unspecified|2
98637|NCT00778895|340634|P3|ESFU Phase|Lost to Follow-up|2
98638|NCT00778895|340635|P2|ESFU Phase|Lost to Follow-up|7
98639|NCT00778895|340636|P1|ESFU Phase|Lost to Follow-up|6
98640|NCT00778895|340634|P3|ESFU Phase|Withdrawal by Subject|0
98641|NCT00778895|340635|P2|ESFU Phase|Withdrawal by Subject|4
98642|NCT00778895|340636|P1|ESFU Phase|Withdrawal by Subject|1
98643|NCT00778895|340634|P3|ESFU Phase|Adverse Event|0
98644|NCT00778895|340635|P2|ESFU Phase|Adverse Event|1
98645|NCT00778895|340636|P1|ESFU Phase|Adverse Event|2
98646|NCT00778895|340634|P3|Active Phase|Unspecified|0
98647|NCT00778895|340635|P2|Active Phase|Unspecified|0
98648|NCT00778895|340636|P1|Active Phase|Unspecified|2
98649|NCT00778895|340634|P3|Active Phase|Lost to Follow-up|0
98650|NCT00778895|340635|P2|Active Phase|Lost to Follow-up|1
98651|NCT00778895|340636|P1|Active Phase|Lost to Follow-up|1
98652|NCT00778895|340634|P3|Active Phase|Withdrawal by Subject|0
98653|NCT00778895|340635|P2|Active Phase|Withdrawal by Subject|4
98654|NCT00778895|340636|P1|Active Phase|Withdrawal by Subject|1
98655|NCT00778895|340634|P3|Active Phase|Adverse Event|0
98656|NCT00778895|340635|P2|Active Phase|Adverse Event|1
98657|NCT00778895|340636|P1|Active Phase|Adverse Event|3
98658|NCT00778830|340680|P2|Overall Study|Ongoing at data cut-off|1
98659|NCT00778830|340681|P1|Overall Study|Ongoing at data cut-off|0
98660|NCT00778817|340693|P1|Overall Study|Withdrawal by Subject|2
98661|NCT00778817|340693|P1|Overall Study|Adverse Event|2
98662|NCT00778622|340720|P3|Overall Study|unspecified|1
98663|NCT00778622|340721|P2|Overall Study|unspecified|0
98664|NCT00778622|340722|P1|Overall Study|unspecified|1
98665|NCT00778622|340720|P3|Overall Study|immigration|0
98666|NCT00778622|340721|P2|Overall Study|immigration|0
98667|NCT00778622|340722|P1|Overall Study|immigration|1
98668|NCT00778622|340720|P3|Overall Study|Lack of Efficacy|0
98669|NCT00778622|340721|P2|Overall Study|Lack of Efficacy|0
98670|NCT00778622|340722|P1|Overall Study|Lack of Efficacy|2
98671|NCT00778622|340720|P3|Overall Study|Protocol Violation|0
98672|NCT00778622|340721|P2|Overall Study|Protocol Violation|3
98673|NCT00778622|340722|P1|Overall Study|Protocol Violation|0
98674|NCT00778622|340720|P3|Overall Study|Lost to Follow-up|2
98675|NCT00778622|340721|P2|Overall Study|Lost to Follow-up|3
98676|NCT00778622|340722|P1|Overall Study|Lost to Follow-up|3
98677|NCT00778622|340720|P3|Overall Study|Withdrawal by Subject|5
98678|NCT00778622|340721|P2|Overall Study|Withdrawal by Subject|5
98679|NCT00778622|340722|P1|Overall Study|Withdrawal by Subject|4
98680|NCT00778622|340720|P3|Overall Study|Adverse Event|7
98681|NCT00778622|340721|P2|Overall Study|Adverse Event|4
98682|NCT00778622|340722|P1|Overall Study|Adverse Event|5
98683|NCT00778375|340775|P1|Overall Study|Ineligible|3
98684|NCT00778336|340789|P4|3 Month Follow Up|Death|0
98685|NCT00778336|340790|P3|3 Month Follow Up|Death|2
98686|NCT00778336|340791|P2|3 Month Follow Up|Death|3
98687|NCT00778336|340792|P1|3 Month Follow Up|Death|8
98688|NCT00778336|340789|P4|3 Month Follow Up|Lost to Follow-up|0
98689|NCT00778336|340790|P3|3 Month Follow Up|Lost to Follow-up|3
98690|NCT00778336|340791|P2|3 Month Follow Up|Lost to Follow-up|20
98691|NCT00778336|340792|P1|3 Month Follow Up|Lost to Follow-up|15
98692|NCT00778336|340789|P4|Index Procedure-Discharge|Death|0
98693|NCT00778336|340790|P3|Index Procedure-Discharge|Death|2
98694|NCT00778336|340791|P2|Index Procedure-Discharge|Death|3
98695|NCT00778336|340792|P1|Index Procedure-Discharge|Death|6
98696|NCT00778258|340830|P9|Overall Study|Unspecified|0
98697|NCT00778258|340831|P8|Overall Study|Unspecified|0
98698|NCT00778258|340832|P7|Overall Study|Unspecified|1
98699|NCT00778258|340833|P6|Overall Study|Unspecified|0
98700|NCT00778258|340834|P5|Overall Study|Unspecified|0
98701|NCT00778258|340835|P4|Overall Study|Unspecified|0
98702|NCT00778258|340836|P3|Overall Study|Unspecified|0
98703|NCT00778258|340837|P2|Overall Study|Unspecified|0
98704|NCT00778258|340838|P1|Overall Study|Unspecified|0
98705|NCT00778258|340830|P9|Overall Study|Non-compliance|0
98706|NCT00778258|340831|P8|Overall Study|Non-compliance|0
98707|NCT00778258|340832|P7|Overall Study|Non-compliance|0
98708|NCT00778258|340833|P6|Overall Study|Non-compliance|0
98709|NCT00778258|340834|P5|Overall Study|Non-compliance|0
98710|NCT00778258|340835|P4|Overall Study|Non-compliance|1
98711|NCT00778258|340836|P3|Overall Study|Non-compliance|0
98712|NCT00778258|340837|P2|Overall Study|Non-compliance|0
98713|NCT00778258|340838|P1|Overall Study|Non-compliance|0
98714|NCT00778258|340830|P9|Overall Study|New Contraindication|0
98715|NCT00778258|340831|P8|Overall Study|New Contraindication|1
98716|NCT00778258|340832|P7|Overall Study|New Contraindication|0
98717|NCT00778258|340833|P6|Overall Study|New Contraindication|0
98718|NCT00778258|340834|P5|Overall Study|New Contraindication|0
98719|NCT00778258|340835|P4|Overall Study|New Contraindication|0
98720|NCT00778258|340836|P3|Overall Study|New Contraindication|0
98721|NCT00778258|340837|P2|Overall Study|New Contraindication|0
98722|NCT00778258|340838|P1|Overall Study|New Contraindication|0
98723|NCT00778258|340830|P9|Overall Study|Withdrawal by Subject|4
98724|NCT00778258|340831|P8|Overall Study|Withdrawal by Subject|12
98725|NCT00778258|340832|P7|Overall Study|Withdrawal by Subject|12
98726|NCT00778258|340833|P6|Overall Study|Withdrawal by Subject|6
98727|NCT00778258|340834|P5|Overall Study|Withdrawal by Subject|0
98728|NCT00778258|340835|P4|Overall Study|Withdrawal by Subject|2
98729|NCT00778258|340836|P3|Overall Study|Withdrawal by Subject|8
98730|NCT00778258|340837|P2|Overall Study|Withdrawal by Subject|2
98731|NCT00778258|340838|P1|Overall Study|Withdrawal by Subject|6
98732|NCT00778258|340830|P9|Overall Study|Lost to Follow-up|0
98733|NCT00778258|340831|P8|Overall Study|Lost to Follow-up|2
98734|NCT00778258|340832|P7|Overall Study|Lost to Follow-up|2
98735|NCT00778258|340833|P6|Overall Study|Lost to Follow-up|3
98736|NCT00778258|340834|P5|Overall Study|Lost to Follow-up|0
98737|NCT00778258|340835|P4|Overall Study|Lost to Follow-up|0
98738|NCT00778258|340836|P3|Overall Study|Lost to Follow-up|2
98739|NCT00778258|340837|P2|Overall Study|Lost to Follow-up|0
98740|NCT00778258|340838|P1|Overall Study|Lost to Follow-up|0
98741|NCT00778258|340830|P9|Overall Study|Adverse Event|0
98742|NCT00778258|340831|P8|Overall Study|Adverse Event|0
98743|NCT00778258|340832|P7|Overall Study|Adverse Event|0
98744|NCT00778258|340833|P6|Overall Study|Adverse Event|1
98745|NCT00778258|340834|P5|Overall Study|Adverse Event|0
98746|NCT00778258|340835|P4|Overall Study|Adverse Event|0
98747|NCT00778258|340836|P3|Overall Study|Adverse Event|0
98748|NCT00778258|340837|P2|Overall Study|Adverse Event|0
98749|NCT00778258|340838|P1|Overall Study|Adverse Event|1
98750|NCT00778102|340905|P2|Overall Study|Administrative Reason|10
98751|NCT00778102|340906|P1|Overall Study|Administrative Reason|7
98752|NCT00778102|340905|P2|Overall Study|Withdrawal by Subject|1
98753|NCT00778102|340906|P1|Overall Study|Withdrawal by Subject|1
98754|NCT00778102|340905|P2|Overall Study|Refused Treatment|3
98755|NCT00778102|340906|P1|Overall Study|Refused Treatment|2
98756|NCT00778102|340905|P2|Overall Study|Protocol Violation|1
98757|NCT00778102|340906|P1|Overall Study|Protocol Violation|0
98758|NCT00778102|340905|P2|Overall Study|Violation of Selection Criteria|1
98759|NCT00778102|340906|P1|Overall Study|Violation of Selection Criteria|1
98760|NCT00778102|340905|P2|Overall Study|Lost to Follow-up|0
98761|NCT00778102|340906|P1|Overall Study|Lost to Follow-up|1
98762|NCT00778102|340905|P2|Overall Study|Death|1
98763|NCT00778102|340906|P1|Overall Study|Death|1
98764|NCT00778102|340905|P2|Overall Study|Adverse Event|5
98765|NCT00778102|340906|P1|Overall Study|Adverse Event|8
98766|NCT00777946|340941|P3|Overall Study|Randomized in error|0
98767|NCT00777946|340942|P2|Overall Study|Randomized in error|1
98768|NCT00777946|340943|P1|Overall Study|Randomized in error|1
98769|NCT00777946|340941|P3|Overall Study|Protocol deviation|1
98770|NCT00777946|340942|P2|Overall Study|Protocol deviation|1
98771|NCT00777946|340943|P1|Overall Study|Protocol deviation|2
98772|NCT00777946|340941|P3|Overall Study|Lost to Follow-up|0
98773|NCT00777946|340942|P2|Overall Study|Lost to Follow-up|1
98774|NCT00777946|340943|P1|Overall Study|Lost to Follow-up|3
98775|NCT00777946|340941|P3|Overall Study|Patient withdrew consent|3
98776|NCT00777946|340942|P2|Overall Study|Patient withdrew consent|2
98777|NCT00777946|340943|P1|Overall Study|Patient withdrew consent|3
98778|NCT00777946|340941|P3|Overall Study|Condition no longer required study drug|0
98779|NCT00777946|340942|P2|Overall Study|Condition no longer required study drug|0
98780|NCT00777946|340943|P1|Overall Study|Condition no longer required study drug|1
98781|NCT00777946|340941|P3|Overall Study|Lack of Efficacy|9
98782|NCT00777946|340942|P2|Overall Study|Lack of Efficacy|0
98783|NCT00777946|340943|P1|Overall Study|Lack of Efficacy|0
98784|NCT00777946|340941|P3|Overall Study|Adverse Event|3
98785|NCT00777946|340942|P2|Overall Study|Adverse Event|1
98786|NCT00777946|340943|P1|Overall Study|Adverse Event|11
98787|NCT00777803|340978|P2|Overall Study|Non-compliance|2
98788|NCT00777803|340979|P1|Overall Study|Non-compliance|2
98789|NCT00777803|340978|P2|Overall Study|Adverse Event|0
98790|NCT00777803|340979|P1|Overall Study|Adverse Event|1
98791|NCT00777803|340978|P2|Overall Study|Lost to Follow-up|5
98792|NCT00777803|340979|P1|Overall Study|Lost to Follow-up|12
98793|NCT00777608|341058|P2|Overall Study|Investigator Decision|2
98794|NCT00777608|341059|P1|Overall Study|Investigator Decision|1
98795|NCT00777608|341058|P2|Overall Study|Protocol Violation|0
98796|NCT00777608|341059|P1|Overall Study|Protocol Violation|1
98797|NCT00777608|341058|P2|Overall Study|Withdrawal by Subject|3
98798|NCT00777608|341059|P1|Overall Study|Withdrawal by Subject|1
98799|NCT00777608|341058|P2|Overall Study|Lost to Follow-up|1
98800|NCT00777608|341059|P1|Overall Study|Lost to Follow-up|1
98801|NCT00777556|341069|P1|Overall Study|Did not complete all 3 follow-up visits|20
98802|NCT00777556|341069|P1|Overall Study|Dispensed but did not use product|12
98803|NCT00777556|341069|P1|Overall Study|Inappropriate self-selection|34
98804|NCT00777257|341090|P3|Overall Study|Withdrawal by Subject|5
98805|NCT00777257|341091|P2|Overall Study|Withdrawal by Subject|6
98806|NCT00777257|341092|P1|Overall Study|Withdrawal by Subject|3
98807|NCT00777257|341090|P3|Overall Study|Protocol Violation|2
98808|NCT00777257|341091|P2|Overall Study|Protocol Violation|2
98809|NCT00777257|341092|P1|Overall Study|Protocol Violation|2
98810|NCT00777257|341090|P3|Overall Study|Lost to Follow-up|2
98811|NCT00777257|341091|P2|Overall Study|Lost to Follow-up|3
98812|NCT00777257|341092|P1|Overall Study|Lost to Follow-up|3
98813|NCT00777257|341090|P3|Overall Study|Adverse Event|0
98814|NCT00777257|341091|P2|Overall Study|Adverse Event|1
98815|NCT00777257|341092|P1|Overall Study|Adverse Event|3
98816|NCT00777205|341111|P2|Overall Study|Protocol Violation|56
98817|NCT00777205|341112|P1|Overall Study|Protocol Violation|0
98818|NCT00777205|341111|P2|Overall Study|Death|2
98819|NCT00777205|341112|P1|Overall Study|Death|0
98820|NCT00777205|341111|P2|Overall Study|Withdrawal by Subject|4
98821|NCT00777205|341112|P1|Overall Study|Withdrawal by Subject|6
98822|NCT00777205|341111|P2|Overall Study|Lost to Follow-up|9
98823|NCT00777205|341112|P1|Overall Study|Lost to Follow-up|25
98824|NCT00777153|341146|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
98825|NCT00777153|341147|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
98826|NCT00777153|341148|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
98827|NCT00777153|341146|P3|Overall Study|Withdrawal by Subject|3
98828|NCT00777153|341147|P2|Overall Study|Withdrawal by Subject|4
98829|NCT00777153|341148|P1|Overall Study|Withdrawal by Subject|3
98830|NCT00777153|341146|P3|Overall Study|Death|33
98831|NCT00777153|341147|P2|Overall Study|Death|73
98832|NCT00777153|341148|P1|Overall Study|Death|85
98833|NCT00777153|341146|P3|Overall Study|Lost to Follow-up|0
98834|NCT00777153|341147|P2|Overall Study|Lost to Follow-up|1
98835|NCT00777153|341148|P1|Overall Study|Lost to Follow-up|1
98836|NCT00777049|341184|P2|Overall Study|No treatment (elevated liver enzymes)|1
98837|NCT00777049|341185|P1|Overall Study|No treatment (elevated liver enzymes)|0
98838|NCT00777049|341184|P2|Overall Study|Withdrawal by Subject|0
98839|NCT00777049|341185|P1|Overall Study|Withdrawal by Subject|1
98840|NCT00777023|341194|P3|Overall Study|Last dose date unknown|1
98841|NCT00777023|341195|P2|Overall Study|Last dose date unknown|3
98842|NCT00777023|341196|P1|Overall Study|Last dose date unknown|3
98843|NCT00777023|341194|P3|Overall Study|Reasons not specified|2
98844|NCT00777023|341195|P2|Overall Study|Reasons not specified|4
98845|NCT00777023|341196|P1|Overall Study|Reasons not specified|4
98846|NCT00777023|341194|P3|Overall Study|Missing data|0
98847|NCT00777023|341195|P2|Overall Study|Missing data|1
98848|NCT00777023|341196|P1|Overall Study|Missing data|1
98849|NCT00777023|341194|P3|Overall Study|Withdrawal by Subject|8
98850|NCT00777023|341195|P2|Overall Study|Withdrawal by Subject|7
98851|NCT00777023|341196|P1|Overall Study|Withdrawal by Subject|7
98852|NCT00777023|341194|P3|Overall Study|Death|0
98853|NCT00777023|341195|P2|Overall Study|Death|1
98854|NCT00777023|341196|P1|Overall Study|Death|0
98855|NCT00777023|341194|P3|Overall Study|Lost to Follow-up|3
98856|NCT00777023|341195|P2|Overall Study|Lost to Follow-up|3
98857|NCT00777023|341196|P1|Overall Study|Lost to Follow-up|2
98858|NCT00777023|341194|P3|Overall Study|Protocol Violation|1
98859|NCT00777023|341195|P2|Overall Study|Protocol Violation|1
98860|NCT00777023|341196|P1|Overall Study|Protocol Violation|2
98861|NCT00777023|341194|P3|Overall Study|Lack of Efficacy|14
98862|NCT00777023|341195|P2|Overall Study|Lack of Efficacy|0
98863|NCT00777023|341196|P1|Overall Study|Lack of Efficacy|1
98864|NCT00777023|341194|P3|Overall Study|Adverse Event|8
98865|NCT00777023|341195|P2|Overall Study|Adverse Event|21
98866|NCT00777023|341196|P1|Overall Study|Adverse Event|15
98867|NCT00776997|341213|P1|Overall Study|Adverse Event|2
98868|NCT00776984|341222|P2|Overall Study|Other|9
98869|NCT00776984|341223|P1|Overall Study|Other|5
98870|NCT00776984|341222|P2|Overall Study|Lack of Efficacy|1
98871|NCT00776984|341223|P1|Overall Study|Lack of Efficacy|0
98872|NCT00776984|341222|P2|Overall Study|Withdrawal by Subject|7
98873|NCT00776984|341223|P1|Overall Study|Withdrawal by Subject|12
98874|NCT00776984|341222|P2|Overall Study|Lost to Follow-up|0
98875|NCT00776984|341223|P1|Overall Study|Lost to Follow-up|2
98876|NCT00776984|341222|P2|Overall Study|Protocol Violation|2
98877|NCT00776984|341223|P1|Overall Study|Protocol Violation|4
98878|NCT00776984|341222|P2|Overall Study|Adverse Event|2
98879|NCT00776984|341223|P1|Overall Study|Adverse Event|8
98880|NCT00776919|341297|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
98881|NCT00776919|341298|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
98882|NCT00776919|341299|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
98883|NCT00776919|341300|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
98884|NCT00776919|341297|P4|Overall Study|Protocol Violation|1
98885|NCT00776919|341298|P3|Overall Study|Protocol Violation|0
98886|NCT00776919|341299|P2|Overall Study|Protocol Violation|2
98887|NCT00776919|341300|P1|Overall Study|Protocol Violation|1
98888|NCT00776919|341297|P4|Overall Study|Adverse Event|2
98889|NCT00776919|341298|P3|Overall Study|Adverse Event|2
98890|NCT00776919|341299|P2|Overall Study|Adverse Event|0
98891|NCT00776919|341300|P1|Overall Study|Adverse Event|1
98892|NCT00776919|341297|P4|Overall Study|Lost to Follow-up|8
98893|NCT00776919|341298|P3|Overall Study|Lost to Follow-up|11
98894|NCT00776919|341299|P2|Overall Study|Lost to Follow-up|12
98895|NCT00776919|341300|P1|Overall Study|Lost to Follow-up|8
98896|NCT00776919|341297|P4|Overall Study|Withdrawal by Subject|26
98897|NCT00776919|341298|P3|Overall Study|Withdrawal by Subject|15
98898|NCT00776919|341299|P2|Overall Study|Withdrawal by Subject|14
98899|NCT00776919|341300|P1|Overall Study|Withdrawal by Subject|16
98900|NCT00776789|341364|P2|Overall Study|Poor quality video|1
98901|NCT00776789|341365|P1|Overall Study|Poor quality video|1
98902|NCT00776789|341364|P2|Overall Study|Consent refusal|2
98903|NCT00776789|341365|P1|Overall Study|Consent refusal|2
98904|NCT00776659|341377|P1|Overall Study|Study Terminated by Sponsor|1
98905|NCT00776659|341377|P1|Overall Study|Withdrawal by Subject|10
98906|NCT00776659|341377|P1|Overall Study|Lost to Follow-up|15
98907|NCT00776555|341404|P2|Overall Study|Study terminated|0
98908|NCT00776555|341405|P1|Overall Study|Study terminated|3
98909|NCT00776230|341423|P3|Overall Study|Subject missed Visit 4|0
98910|NCT00776230|341424|P2|Overall Study|Subject missed Visit 4|1
98911|NCT00776230|341425|P1|Overall Study|Subject missed Visit 4|0
98912|NCT00776230|341423|P3|Overall Study|Withdrawal by Subject|0
98913|NCT00776230|341424|P2|Overall Study|Withdrawal by Subject|1
98914|NCT00776230|341425|P1|Overall Study|Withdrawal by Subject|0
98915|NCT00776230|341423|P3|Overall Study|Not vaccinated at Day 0|0
98916|NCT00776230|341424|P2|Overall Study|Not vaccinated at Day 0|0
98917|NCT00776230|341425|P1|Overall Study|Not vaccinated at Day 0|1
98918|NCT00776230|341423|P3|Overall Study|Lost to Follow-up|5
98919|NCT00776230|341424|P2|Overall Study|Lost to Follow-up|1
98920|NCT00776230|341425|P1|Overall Study|Lost to Follow-up|2
98921|NCT00776009|341439|P6|Period 3: Third Intervention|Withdrawal by Subject|0
98922|NCT00776009|341440|P5|Period 3: Third Intervention|Withdrawal by Subject|0
98923|NCT00776009|341441|P4|Period 3: Third Intervention|Withdrawal by Subject|0
98924|NCT00776009|341442|P3|Period 3: Third Intervention|Withdrawal by Subject|0
98925|NCT00776009|341443|P2|Period 3: Third Intervention|Withdrawal by Subject|0
98926|NCT00776009|341444|P1|Period 3: Third Intervention|Withdrawal by Subject|1
98927|NCT00776009|341439|P6|Period 2: Second Intervention|Protocol Violation|0
98928|NCT00776009|341440|P5|Period 2: Second Intervention|Protocol Violation|0
98929|NCT00776009|341441|P4|Period 2: Second Intervention|Protocol Violation|0
98930|NCT00776009|341442|P3|Period 2: Second Intervention|Protocol Violation|1
98931|NCT00776009|341443|P2|Period 2: Second Intervention|Protocol Violation|0
98932|NCT00776009|341444|P1|Period 2: Second Intervention|Protocol Violation|1
98933|NCT00776009|341439|P6|Period 2: Second Intervention|Withdrawal by Subject|1
98934|NCT00776009|341440|P5|Period 2: Second Intervention|Withdrawal by Subject|0
98935|NCT00776009|341441|P4|Period 2: Second Intervention|Withdrawal by Subject|0
98936|NCT00776009|341442|P3|Period 2: Second Intervention|Withdrawal by Subject|0
98937|NCT00776009|341443|P2|Period 2: Second Intervention|Withdrawal by Subject|0
98938|NCT00776009|341444|P1|Period 2: Second Intervention|Withdrawal by Subject|0
98939|NCT00776009|341439|P6|Period 1: First Intervention|Protocol Violation|0
98940|NCT00776009|341440|P5|Period 1: First Intervention|Protocol Violation|1
98941|NCT00776009|341441|P4|Period 1: First Intervention|Protocol Violation|0
98942|NCT00776009|341442|P3|Period 1: First Intervention|Protocol Violation|0
98943|NCT00776009|341443|P2|Period 1: First Intervention|Protocol Violation|1
98944|NCT00776009|341444|P1|Period 1: First Intervention|Protocol Violation|0
98945|NCT00776009|341439|P6|Period 1: First Intervention|Withdrawal by Subject|0
98946|NCT00776009|341440|P5|Period 1: First Intervention|Withdrawal by Subject|1
98947|NCT00776009|341441|P4|Period 1: First Intervention|Withdrawal by Subject|0
98948|NCT00776009|341442|P3|Period 1: First Intervention|Withdrawal by Subject|1
98949|NCT00776009|341443|P2|Period 1: First Intervention|Withdrawal by Subject|0
98950|NCT00776009|341444|P1|Period 1: First Intervention|Withdrawal by Subject|0
98951|NCT00775983|341466|P2|Overall Study|Protocol Violation|2
98952|NCT00775983|341467|P1|Overall Study|Protocol Violation|1
98953|NCT00775606|341521|P2|Overall Study|Study sponsor terminated funding|0
98954|NCT00775606|341522|P1|Overall Study|Study sponsor terminated funding|3
98955|NCT00775593|341532|P1|Overall Study|Death|1
98956|NCT00775593|341532|P1|Overall Study|Unmet eligibility criteria|6
98957|NCT00775528|341539|P1|Overall Study|Protocol Violation|1
98958|NCT00775463|341548|P2|Overall Study|Lack of Efficacy|1
98959|NCT00775463|341549|P1|Overall Study|Lack of Efficacy|1
98960|NCT00775463|341548|P2|Overall Study|Lost to Follow-up|0
98961|NCT00775463|341549|P1|Overall Study|Lost to Follow-up|1
98962|NCT00775463|341548|P2|Overall Study|Protocol Violation|2
98963|NCT00775463|341549|P1|Overall Study|Protocol Violation|2
98964|NCT00775463|341548|P2|Overall Study|Adverse Event|9
98965|NCT00775463|341549|P1|Overall Study|Adverse Event|7
98966|NCT00775463|341548|P2|Overall Study|Withdrawal by Subject|1
98967|NCT00775463|341549|P1|Overall Study|Withdrawal by Subject|0
98968|NCT00775450|341586|P5|Overall Study|Withdrawal by Subject|1
98969|NCT00775450|341587|P4|Overall Study|Withdrawal by Subject|0
98970|NCT00775450|341588|P3|Overall Study|Withdrawal by Subject|0
98971|NCT00775450|341589|P2|Overall Study|Withdrawal by Subject|0
98972|NCT00775450|341590|P1|Overall Study|Withdrawal by Subject|1
98973|NCT00775450|341586|P5|Overall Study|Protocol Violation|1
98974|NCT00775450|341587|P4|Overall Study|Protocol Violation|0
98975|NCT00775450|341588|P3|Overall Study|Protocol Violation|0
98976|NCT00775450|341589|P2|Overall Study|Protocol Violation|0
98977|NCT00775450|341590|P1|Overall Study|Protocol Violation|0
98978|NCT00775450|341586|P5|Overall Study|Serious Adverse Event|0
98979|NCT00775450|341587|P4|Overall Study|Serious Adverse Event|0
98980|NCT00775450|341588|P3|Overall Study|Serious Adverse Event|0
98981|NCT00775450|341589|P2|Overall Study|Serious Adverse Event|0
98982|NCT00775450|341590|P1|Overall Study|Serious Adverse Event|2
98983|NCT00775437|341617|P1|Overall Study|Lost to Follow-up|1
98984|NCT00775437|341617|P1|Overall Study|Withdrawal by Subject|3
98985|NCT00775437|341617|P1|Overall Study|Loss of efficacy|2
98986|NCT00775203|341692|P2|Overall Study|Physician Decision|1
98987|NCT00775203|341693|P1|Overall Study|Physician Decision|0
98988|NCT00775203|341692|P2|Overall Study|Entered other study|0
98989|NCT00775203|341693|P1|Overall Study|Entered other study|1
98990|NCT00775203|341692|P2|Overall Study|Protocol Violation|1
98991|NCT00775203|341693|P1|Overall Study|Protocol Violation|0
98992|NCT00775203|341692|P2|Overall Study|Noncompliance|2
98993|NCT00775203|341693|P1|Overall Study|Noncompliance|4
98994|NCT00775203|341692|P2|Overall Study|Administrative reason|0
98995|NCT00775203|341693|P1|Overall Study|Administrative reason|2
98996|NCT00775203|341692|P2|Overall Study|Lost to Follow-up|15
98997|NCT00775203|341693|P1|Overall Study|Lost to Follow-up|11
98998|NCT00775203|341692|P2|Overall Study|Withdrawal by Subject|9
98999|NCT00775203|341693|P1|Overall Study|Withdrawal by Subject|11
99000|NCT00775203|341692|P2|Overall Study|Lack of Efficacy|9
99001|NCT00775203|341693|P1|Overall Study|Lack of Efficacy|8
99002|NCT00775203|341692|P2|Overall Study|Adverse Event|6
99003|NCT00775203|341693|P1|Overall Study|Adverse Event|25
99004|NCT00775021|341725|P2|Second Intervention|Adverse Event|1
99005|NCT00775021|341726|P1|Second Intervention|Adverse Event|0
99006|NCT00775021|341725|P2|First Intervention|Lost to Follow-up|0
99007|NCT00775021|341726|P1|First Intervention|Lost to Follow-up|1
99008|NCT00774995|341744|P4|Overall Study|Protocol Violation|0
99009|NCT00774995|341745|P3|Overall Study|Protocol Violation|1
99010|NCT00774995|341746|P2|Overall Study|Protocol Violation|0
99011|NCT00774995|341747|P1|Overall Study|Protocol Violation|0
99012|NCT00774930|341787|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
99013|NCT00774930|341788|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
99014|NCT00774930|341787|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
99015|NCT00774930|341788|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
99016|NCT00774930|341787|P2|LTOLE Phase|Disease Progression|5
99017|NCT00774930|341788|P1|LTOLE Phase|Disease Progression|2
99018|NCT00774930|341787|P2|LTOLE Phase|Sponsor decision|1
99019|NCT00774930|341788|P1|LTOLE Phase|Sponsor decision|2
99020|NCT00774930|341787|P2|LTOLE Phase|Physician Decision|1
99021|NCT00774930|341788|P1|LTOLE Phase|Physician Decision|4
99022|NCT00774930|341787|P2|LTOLE Phase|Subject decision|5
99023|NCT00774930|341788|P1|LTOLE Phase|Subject decision|0
99024|NCT00774930|341787|P2|LTOLE Phase|Adverse Event|3
99025|NCT00774930|341788|P1|LTOLE Phase|Adverse Event|7
99026|NCT00774930|341787|P2|IOL Phase|Brain radiation|1
99027|NCT00774930|341788|P1|IOL Phase|Brain radiation|0
99028|NCT00774930|341787|P2|IOL Phase|Unspecified|0
99029|NCT00774930|341788|P1|IOL Phase|Unspecified|1
99030|NCT00774930|341787|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
99031|NCT00774930|341788|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
99032|NCT00774930|341787|P2|IOL Phase|Subject Consumed Prohibited Medication|0
99033|NCT00774930|341788|P1|IOL Phase|Subject Consumed Prohibited Medication|1
99034|NCT00774930|341787|P2|IOL Phase|Disease Progression|1
99035|NCT00774930|341788|P1|IOL Phase|Disease Progression|2
99036|NCT00774930|341787|P2|IOL Phase|Sponsor Decision|0
99037|NCT00774930|341788|P1|IOL Phase|Sponsor Decision|1
99038|NCT00774930|341787|P2|IOL Phase|Physician Decision|2
99039|NCT00774930|341788|P1|IOL Phase|Physician Decision|3
99040|NCT00774930|341787|P2|IOL Phase|Subject Decision|3
99041|NCT00774930|341788|P1|IOL Phase|Subject Decision|4
99042|NCT00774930|341787|P2|IOL Phase|Adverse Event|1
99043|NCT00774930|341788|P1|IOL Phase|Adverse Event|1
99044|NCT00774930|341787|P2|DB Phase|Started Nonprotocol Radiation therapy|1
99045|NCT00774930|341788|P1|DB Phase|Started Nonprotocol Radiation therapy|0
99046|NCT00774930|341787|P2|DB Phase|Disease Progression|1
99047|NCT00774930|341788|P1|DB Phase|Disease Progression|1
99048|NCT00774930|341787|P2|DB Phase|Sponsor Decision|1
99049|NCT00774930|341788|P1|DB Phase|Sponsor Decision|0
99050|NCT00774930|341787|P2|DB Phase|Subject Decision|5
99051|NCT00774930|341788|P1|DB Phase|Subject Decision|1
99052|NCT00774930|341787|P2|DB Phase|Adverse Event|2
99053|NCT00774930|341788|P1|DB Phase|Adverse Event|1
99054|NCT00774930|341787|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
99055|NCT00774930|341788|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
99056|NCT00774852|341816|P2|Overall Study|Subject received prohibited medication|0
99057|NCT00774852|341817|P1|Overall Study|Subject received prohibited medication|1
99058|NCT00774852|341816|P2|Overall Study|Protocol Violation|0
99059|NCT00774852|341817|P1|Overall Study|Protocol Violation|1
99060|NCT00774852|341816|P2|Overall Study|Subject non-compliance|1
99061|NCT00774852|341817|P1|Overall Study|Subject non-compliance|0
99062|NCT00774852|341816|P2|Overall Study|Non-responder|11
99063|NCT00774852|341817|P1|Overall Study|Non-responder|15
99064|NCT00774852|341816|P2|Overall Study|Withdrawal by Subject|2
99065|NCT00774852|341817|P1|Overall Study|Withdrawal by Subject|2
99066|NCT00774852|341816|P2|Overall Study|Pregnancy|2
99067|NCT00774852|341817|P1|Overall Study|Pregnancy|1
99068|NCT00774852|341816|P2|Overall Study|Physician Decision|6
99069|NCT00774852|341817|P1|Overall Study|Physician Decision|2
99070|NCT00774852|341816|P2|Overall Study|Lost to Follow-up|5
99071|NCT00774852|341817|P1|Overall Study|Lost to Follow-up|9
99072|NCT00774852|341816|P2|Overall Study|Lack of Efficacy|7
99073|NCT00774852|341817|P1|Overall Study|Lack of Efficacy|3
99074|NCT00774852|341816|P2|Overall Study|Death|1
99075|NCT00774852|341817|P1|Overall Study|Death|2
99076|NCT00774852|341816|P2|Overall Study|Adverse Event|6
99077|NCT00774852|341817|P1|Overall Study|Adverse Event|9
99078|NCT00774800|341865|P1|Intervention 4|Withdrawal by Subject|1
99079|NCT00774787|341887|P1|Overall Study|Lost to Follow-up|1
99080|NCT00774748|341894|P1|Overall Study|Lost to Follow-up|3
99081|NCT00774397|341909|P7|Overall Study|Other than those stated above|1
99082|NCT00774397|341910|P6|Overall Study|Other than those stated above|0
99083|NCT00774397|341911|P5|Overall Study|Other than those stated above|2
99084|NCT00774397|341912|P4|Overall Study|Other than those stated above|2
99085|NCT00774397|341913|P3|Overall Study|Other than those stated above|3
99086|NCT00774397|341914|P2|Overall Study|Other than those stated above|1
99087|NCT00774397|341915|P1|Overall Study|Other than those stated above|1
99088|NCT00774397|341909|P7|Overall Study|Not treated|1
99089|NCT00774397|341910|P6|Overall Study|Not treated|0
99090|NCT00774397|341911|P5|Overall Study|Not treated|1
99091|NCT00774397|341912|P4|Overall Study|Not treated|0
99092|NCT00774397|341913|P3|Overall Study|Not treated|0
99093|NCT00774397|341914|P2|Overall Study|Not treated|0
99094|NCT00774397|341915|P1|Overall Study|Not treated|0
99095|NCT00774397|341909|P7|Overall Study|Refused to continue trial medication|3
99096|NCT00774397|341910|P6|Overall Study|Refused to continue trial medication|2
99097|NCT00774397|341911|P5|Overall Study|Refused to continue trial medication|6
99098|NCT00774397|341912|P4|Overall Study|Refused to continue trial medication|2
99099|NCT00774397|341913|P3|Overall Study|Refused to continue trial medication|2
99100|NCT00774397|341914|P2|Overall Study|Refused to continue trial medication|3
99101|NCT00774397|341915|P1|Overall Study|Refused to continue trial medication|1
99102|NCT00774397|341909|P7|Overall Study|Lost to Follow-up|0
99103|NCT00774397|341910|P6|Overall Study|Lost to Follow-up|1
99104|NCT00774397|341911|P5|Overall Study|Lost to Follow-up|0
99105|NCT00774397|341912|P4|Overall Study|Lost to Follow-up|1
99106|NCT00774397|341913|P3|Overall Study|Lost to Follow-up|1
99107|NCT00774397|341914|P2|Overall Study|Lost to Follow-up|1
99108|NCT00774397|341915|P1|Overall Study|Lost to Follow-up|0
99109|NCT00774397|341909|P7|Overall Study|Protocol Violation|0
99110|NCT00774397|341910|P6|Overall Study|Protocol Violation|1
99111|NCT00774397|341911|P5|Overall Study|Protocol Violation|2
99112|NCT00774397|341912|P4|Overall Study|Protocol Violation|1
99113|NCT00774397|341913|P3|Overall Study|Protocol Violation|3
99114|NCT00774397|341914|P2|Overall Study|Protocol Violation|1
99115|NCT00774397|341915|P1|Overall Study|Protocol Violation|0
99116|NCT00774397|341909|P7|Overall Study|Lack of Efficacy|9
99117|NCT00774397|341910|P6|Overall Study|Lack of Efficacy|15
99118|NCT00774397|341911|P5|Overall Study|Lack of Efficacy|27
99119|NCT00774397|341912|P4|Overall Study|Lack of Efficacy|3
99120|NCT00774397|341913|P3|Overall Study|Lack of Efficacy|5
99121|NCT00774397|341914|P2|Overall Study|Lack of Efficacy|4
99122|NCT00774397|341915|P1|Overall Study|Lack of Efficacy|11
99123|NCT00774397|341909|P7|Overall Study|Adverse Event|16
99124|NCT00774397|341910|P6|Overall Study|Adverse Event|3
99125|NCT00774397|341911|P5|Overall Study|Adverse Event|8
99126|NCT00774397|341912|P4|Overall Study|Adverse Event|8
99127|NCT00774397|341913|P3|Overall Study|Adverse Event|16
99128|NCT00774397|341914|P2|Overall Study|Adverse Event|3
99129|NCT00774397|341915|P1|Overall Study|Adverse Event|1
99130|NCT00774306|342151|P4|Overall Study|Death|0
99131|NCT00774306|342152|P3|Overall Study|Death|0
99132|NCT00774306|342153|P2|Overall Study|Death|1
99133|NCT00774306|342154|P1|Overall Study|Death|1
99134|NCT00774306|342151|P4|Overall Study|Lost to Follow-up|5
99135|NCT00774306|342152|P3|Overall Study|Lost to Follow-up|4
99136|NCT00774306|342153|P2|Overall Study|Lost to Follow-up|0
99137|NCT00774306|342154|P1|Overall Study|Lost to Follow-up|6
99138|NCT00774306|342151|P4|Overall Study|Withdrawal by Subject|0
99139|NCT00774306|342152|P3|Overall Study|Withdrawal by Subject|1
99140|NCT00774306|342153|P2|Overall Study|Withdrawal by Subject|1
99141|NCT00774306|342154|P1|Overall Study|Withdrawal by Subject|6
99142|NCT00774306|342151|P4|Overall Study|Protocol Violation|0
99143|NCT00774306|342152|P3|Overall Study|Protocol Violation|3
99144|NCT00774306|342153|P2|Overall Study|Protocol Violation|0
99145|NCT00774306|342154|P1|Overall Study|Protocol Violation|2
99146|NCT00774306|342151|P4|Overall Study|Adverse Event|0
99147|NCT00774306|342152|P3|Overall Study|Adverse Event|0
99148|NCT00774306|342153|P2|Overall Study|Adverse Event|0
99149|NCT00774306|342154|P1|Overall Study|Adverse Event|3
99150|NCT00774046|342222|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
99151|NCT00774046|342222|P1|Enrollment|Desired other therapy/refused|28
99152|NCT00774046|342222|P1|Screening|Not eligible|56
99153|NCT00773968|342232|P1|Overall Study|Unspecified|8
99154|NCT00773968|342232|P1|Overall Study|Screen Failure|17
99155|NCT00773968|342232|P1|Overall Study|Withdrawal by Subject|11
99156|NCT00773968|342232|P1|Overall Study|Protocol Violation|1
99157|NCT00773968|342232|P1|Overall Study|Lack of Efficacy|3
99158|NCT00773968|342232|P1|Overall Study|Failure to Return|2
99159|NCT00773968|342232|P1|Overall Study|Death|1
99160|NCT00773968|342232|P1|Overall Study|Adverse Event|2
99161|NCT00773734|342263|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
99162|NCT00773734|342264|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
99163|NCT00773734|342265|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
99164|NCT00773734|342266|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
99165|NCT00773734|342267|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
99166|NCT00773734|342268|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
99167|NCT00773734|342263|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
99168|NCT00773734|342264|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
99169|NCT00773734|342265|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
99170|NCT00773734|342266|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
99171|NCT00773734|342267|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
99172|NCT00773734|342268|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
99173|NCT00773734|342263|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
99174|NCT00773734|342264|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
99175|NCT00773734|342265|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
99176|NCT00773734|342266|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
99177|NCT00773734|342267|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
99178|NCT00773734|342268|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
99179|NCT00773734|342263|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
99180|NCT00773734|342264|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
99181|NCT00773734|342265|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
99182|NCT00773734|342266|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
99183|NCT00773734|342267|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
99184|NCT00773734|342268|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
99185|NCT00773734|342263|P6|Extension: Active Treatment Week 24-52|Unspecified|1
99186|NCT00773734|342264|P5|Extension: Active Treatment Week 24-52|Unspecified|0
99187|NCT00773734|342265|P4|Extension: Active Treatment Week 24-52|Unspecified|2
99188|NCT00773734|342266|P3|Extension: Active Treatment Week 24-52|Unspecified|1
99189|NCT00773734|342267|P2|Extension: Active Treatment Week 24-52|Unspecified|0
99190|NCT00773734|342268|P1|Extension: Active Treatment Week 24-52|Unspecified|0
99191|NCT00773734|342263|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
99192|NCT00773734|342264|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
99193|NCT00773734|342265|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
99194|NCT00773734|342266|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
99195|NCT00773734|342267|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
99196|NCT00773734|342268|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
99197|NCT00773734|342263|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
99198|NCT00773734|342264|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
99199|NCT00773734|342265|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
99200|NCT00773734|342266|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
99201|NCT00773734|342267|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
99202|NCT00773734|342268|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
99203|NCT00773734|342263|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
99204|NCT00773734|342264|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
99205|NCT00773734|342265|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
99206|NCT00773734|342266|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
99207|NCT00773734|342267|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
99208|NCT00773734|342268|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
99209|NCT00773734|342263|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
99210|NCT00773734|342264|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
99211|NCT00773734|342265|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
99212|NCT00773734|342266|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
99213|NCT00773734|342267|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
99214|NCT00773734|342268|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
99215|NCT00773734|342263|P6|Core: Active Treatment Phase Week 16-24|Unspecified|0
99216|NCT00773734|342264|P5|Core: Active Treatment Phase Week 16-24|Unspecified|0
99217|NCT00773734|342265|P4|Core: Active Treatment Phase Week 16-24|Unspecified|0
99218|NCT00773734|342266|P3|Core: Active Treatment Phase Week 16-24|Unspecified|0
99219|NCT00773734|342267|P2|Core: Active Treatment Phase Week 16-24|Unspecified|1
99220|NCT00773734|342268|P1|Core: Active Treatment Phase Week 16-24|Unspecified|0
99221|NCT00773734|342263|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
99222|NCT00773734|342264|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
99223|NCT00773734|342265|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
99224|NCT00773734|342266|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
99225|NCT00773734|342267|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
99226|NCT00773734|342268|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
99227|NCT00773734|342263|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
99228|NCT00773734|342264|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
99229|NCT00773734|342265|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
99230|NCT00773734|342266|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
99231|NCT00773734|342267|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
99232|NCT00773734|342268|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
99233|NCT00773734|342263|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
99234|NCT00773734|342264|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
99235|NCT00773734|342265|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
99236|NCT00773734|342266|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
99237|NCT00773734|342267|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
99238|NCT00773734|342268|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
99239|NCT00773734|342263|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
99240|NCT00773734|342264|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
99241|NCT00773734|342265|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
99242|NCT00773734|342266|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
99243|NCT00773734|342267|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
99244|NCT00773734|342268|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
99245|NCT00773734|342263|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
99246|NCT00773734|342264|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
99247|NCT00773734|342265|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
99248|NCT00773734|342266|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
99249|NCT00773734|342267|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
99250|NCT00773734|342268|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
99251|NCT00773734|342263|P6|Core: Placebo Controlled Phase Week 0-16|Unspecified|0
99252|NCT00773734|342264|P5|Core: Placebo Controlled Phase Week 0-16|Unspecified|0
99253|NCT00773734|342265|P4|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
99254|NCT00773734|342266|P3|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
99255|NCT00773734|342267|P2|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
99256|NCT00773734|342268|P1|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
99257|NCT00773734|342263|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
99258|NCT00773734|342264|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
99259|NCT00773734|342265|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
99260|NCT00773734|342266|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
99261|NCT00773734|342267|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
99262|NCT00773734|342268|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
99263|NCT00773734|342263|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
99264|NCT00773734|342264|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
99265|NCT00773734|342265|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
99266|NCT00773734|342266|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
99267|NCT00773734|342267|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
99268|NCT00773734|342268|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
99269|NCT00773734|342263|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
99270|NCT00773734|342264|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
99271|NCT00773734|342265|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
99272|NCT00773734|342266|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
99273|NCT00773734|342267|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
99274|NCT00773734|342268|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
99275|NCT00773734|342263|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
99276|NCT00773734|342264|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
99277|NCT00773734|342265|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
99278|NCT00773734|342266|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
99279|NCT00773734|342267|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
99280|NCT00773734|342268|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
99281|NCT00773734|342263|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
99282|NCT00773734|342264|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
99283|NCT00773734|342265|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
99284|NCT00773734|342266|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
99285|NCT00773734|342267|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
99286|NCT00773734|342268|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
99287|NCT00773734|342263|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
99288|NCT00773734|342264|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
99289|NCT00773734|342265|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
99290|NCT00773734|342266|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
99291|NCT00773734|342267|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
99292|NCT00773734|342268|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
99293|NCT00773461|342839|P2|Overall Study|Withdrawal by Subject|1
99294|NCT00773461|342840|P1|Overall Study|Withdrawal by Subject|4
99295|NCT00773461|342839|P2|Overall Study|Adverse Event|3
99296|NCT00773461|342840|P1|Overall Study|Adverse Event|1
99297|NCT00773383|342878|P1|Overall Study|No study dose received|1
99298|NCT00773383|342878|P1|Overall Study|not specified|2
99299|NCT00773383|342878|P1|Overall Study|Progression of Disease|23
99300|NCT00773383|342878|P1|Overall Study|Death|1
99301|NCT00773383|342878|P1|Overall Study|Adverse Event|4
99302|NCT00773253|342915|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
99303|NCT00773253|342916|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
99304|NCT00773136|342922|P1|Overall Study|Physician Decision|2
99305|NCT00773097|342927|P1|Overall Study|Physician Decision|6
99306|NCT00773097|342927|P1|Overall Study|Withdrawal by Subject|1
99307|NCT00772967|342933|P6|Crossover Treatment 3|Adverse Event|0
99308|NCT00772967|342934|P5|Crossover Treatment 3|Adverse Event|1
99309|NCT00772967|342935|P4|Crossover Treatment 3|Adverse Event|0
99310|NCT00772967|342936|P3|Crossover Treatment 3|Adverse Event|0
99311|NCT00772967|342937|P2|Crossover Treatment 3|Adverse Event|0
99312|NCT00772967|342938|P1|Crossover Treatment 3|Adverse Event|0
99313|NCT00772967|342933|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
99314|NCT00772967|342934|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
99315|NCT00772967|342935|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
99316|NCT00772967|342936|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
99317|NCT00772967|342937|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
99318|NCT00772967|342938|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
99319|NCT00772967|342933|P6|Crossover Treatment 1|Adverse Event (Pain)|0
99320|NCT00772967|342934|P5|Crossover Treatment 1|Adverse Event (Pain)|0
99321|NCT00772967|342935|P4|Crossover Treatment 1|Adverse Event (Pain)|1
99322|NCT00772967|342936|P3|Crossover Treatment 1|Adverse Event (Pain)|0
99323|NCT00772967|342937|P2|Crossover Treatment 1|Adverse Event (Pain)|0
99324|NCT00772967|342938|P1|Crossover Treatment 1|Adverse Event (Pain)|0
99325|NCT00772954|342958|P3|Overall Study|Adverse Event|1
99326|NCT00772954|342959|P2|Overall Study|Adverse Event|0
99327|NCT00772954|342960|P1|Overall Study|Adverse Event|0
99328|NCT00772941|342968|P1|Overall Study|GPSP Violation|90
99329|NCT00772941|342968|P1|Overall Study|Poor Compliance|7
99330|NCT00772941|342968|P1|Overall Study|Missed Visits|374
99331|NCT00772941|342968|P1|Overall Study|Study not completed|16
99332|NCT00772941|342968|P1|Overall Study|CRFs not available|195
99333|NCT00772928|342999|P2|Overall Study|Did not receive vaccine|1
99334|NCT00772928|343000|P1|Overall Study|Did not receive vaccine|0
99335|NCT00772928|342999|P2|Overall Study|Withdrawal by Subject|22
99336|NCT00772928|343000|P1|Overall Study|Withdrawal by Subject|25
99337|NCT00772928|342999|P2|Overall Study|Protocol Violation|12
99338|NCT00772928|343000|P1|Overall Study|Protocol Violation|10
99339|NCT00772928|342999|P2|Overall Study|Lost to Follow-up|6
99340|NCT00772928|343000|P1|Overall Study|Lost to Follow-up|9
99341|NCT00772889|343017|P3|Overall Study|Lost to Follow-up|7
99342|NCT00772889|343018|P2|Overall Study|Lost to Follow-up|6
99343|NCT00772889|343019|P1|Overall Study|Lost to Follow-up|6
99344|NCT00772889|343017|P3|Overall Study|Withdrawal by Subject|9
99345|NCT00772889|343018|P2|Overall Study|Withdrawal by Subject|8
99346|NCT00772889|343019|P1|Overall Study|Withdrawal by Subject|9
99347|NCT00772889|343017|P3|Overall Study|Adverse Event|0
99348|NCT00772889|343018|P2|Overall Study|Adverse Event|4
99349|NCT00772889|343019|P1|Overall Study|Adverse Event|7
99350|NCT00772707|343077|P1|Overall Study|Withdrawn|3
99351|NCT00772668|343082|P1|Overall Study|Physician Decision|3
99352|NCT00772629|343088|P2|Overall Study|Subject was not vaccinated|0
99353|NCT00772629|343089|P1|Overall Study|Subject was not vaccinated|1
99354|NCT00772603|343098|P3|Overall Study|Other|2
99355|NCT00772603|343099|P2|Overall Study|Other|0
99356|NCT00772603|343100|P1|Overall Study|Other|2
99357|NCT00772603|343098|P3|Overall Study|Physician Decision|1
99358|NCT00772603|343099|P2|Overall Study|Physician Decision|0
99359|NCT00772603|343100|P1|Overall Study|Physician Decision|0
99360|NCT00772603|343098|P3|Overall Study|Lost to Follow-up|2
99361|NCT00772603|343099|P2|Overall Study|Lost to Follow-up|5
99362|NCT00772603|343100|P1|Overall Study|Lost to Follow-up|1
99363|NCT00772603|343098|P3|Overall Study|Protocol Violation|1
99364|NCT00772603|343099|P2|Overall Study|Protocol Violation|1
99365|NCT00772603|343100|P1|Overall Study|Protocol Violation|0
99366|NCT00772603|343098|P3|Overall Study|Subject Non-compliance|4
99367|NCT00772603|343099|P2|Overall Study|Subject Non-compliance|6
99368|NCT00772603|343100|P1|Overall Study|Subject Non-compliance|1
99369|NCT00772603|343098|P3|Overall Study|Adverse Event|10
99370|NCT00772603|343099|P2|Overall Study|Adverse Event|18
99371|NCT00772603|343100|P1|Overall Study|Adverse Event|37
99372|NCT00772603|343098|P3|Overall Study|Withdrawal by Subject|6
99373|NCT00772603|343099|P2|Overall Study|Withdrawal by Subject|10
99374|NCT00772603|343100|P1|Overall Study|Withdrawal by Subject|11
99375|NCT00772577|343139|P2|Overall Study|Protocol Deviation|2
99376|NCT00772577|343140|P1|Overall Study|Protocol Deviation|3
99377|NCT00772577|343139|P2|Overall Study|Administrative problems|1
99378|NCT00772577|343140|P1|Overall Study|Administrative problems|2
99379|NCT00772577|343139|P2|Overall Study|Lost to Follow-up|3
99380|NCT00772577|343140|P1|Overall Study|Lost to Follow-up|4
99381|NCT00772577|343139|P2|Overall Study|Patient withdrew consent|5
99382|NCT00772577|343140|P1|Overall Study|Patient withdrew consent|8
99383|NCT00772577|343139|P2|Overall Study|Unsatisfactory therapeutic effect|8
99384|NCT00772577|343140|P1|Overall Study|Unsatisfactory therapeutic effect|0
99385|NCT00772577|343139|P2|Overall Study|Abnormal laboratory values|1
99386|NCT00772577|343140|P1|Overall Study|Abnormal laboratory values|0
99387|NCT00772577|343139|P2|Overall Study|Adverse Event|3
99388|NCT00772577|343140|P1|Overall Study|Adverse Event|6
99389|NCT00772538|343156|P2|Overall Study|Other|7
99390|NCT00772538|343157|P1|Overall Study|Other|7
99391|NCT00772538|343156|P2|Overall Study|Lack of Efficacy|1
99392|NCT00772538|343157|P1|Overall Study|Lack of Efficacy|0
99393|NCT00772538|343156|P2|Overall Study|Withdrawal by Subject|8
99394|NCT00772538|343157|P1|Overall Study|Withdrawal by Subject|3
99395|NCT00772538|343156|P2|Overall Study|Lost to Follow-up|1
99396|NCT00772538|343157|P1|Overall Study|Lost to Follow-up|1
99397|NCT00772538|343156|P2|Overall Study|Protocol Violation|3
99398|NCT00772538|343157|P1|Overall Study|Protocol Violation|3
99399|NCT00772538|343156|P2|Overall Study|Adverse Event|6
99400|NCT00772538|343157|P1|Overall Study|Adverse Event|6
99401|NCT00772447|343229|P2|Overall Study|all others|2
99402|NCT00772447|343230|P1|Overall Study|all others|2
99403|NCT00772447|343229|P2|Overall Study|Protocol Violation|1
99404|NCT00772447|343230|P1|Overall Study|Protocol Violation|0
99405|NCT00772447|343229|P2|Overall Study|incorrect enrolment|4
99406|NCT00772447|343230|P1|Overall Study|incorrect enrolment|3
99407|NCT00772447|343229|P2|Overall Study|Lost to Follow-up|4
99408|NCT00772447|343230|P1|Overall Study|Lost to Follow-up|2
99409|NCT00772447|343229|P2|Overall Study|Physician Decision|8
99410|NCT00772447|343230|P1|Overall Study|Physician Decision|4
99411|NCT00772447|343229|P2|Overall Study|Withdrawal by Subject|5
99412|NCT00772447|343230|P1|Overall Study|Withdrawal by Subject|9
99413|NCT00772382|343258|P1|Overall Study|Other Reasons|10
99414|NCT00772382|343258|P1|Overall Study|Withdrawal by Subject|10
99415|NCT00772382|343258|P1|Overall Study|Protocol Violation|1
99416|NCT00772382|343258|P1|Overall Study|Physician Decision|5
99417|NCT00772382|343258|P1|Overall Study|Lack of Efficacy|4
99418|NCT00772382|343258|P1|Overall Study|Death|6
99419|NCT00772382|343258|P1|Overall Study|Adverse Event|19
99420|NCT00772369|343263|P1|Overall Study|Did not return record release form|1
99421|NCT00772148|343274|P2|Maintenance Phase (Week 52)|Administrative/other|2
99422|NCT00772148|343275|P1|Maintenance Phase (Week 52)|Administrative/other|1
99423|NCT00772148|343274|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
99424|NCT00772148|343275|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
99425|NCT00772148|343274|P2|Maintenance Phase (Week 52)|Adverse Event|0
99426|NCT00772148|343275|P1|Maintenance Phase (Week 52)|Adverse Event|1
99427|NCT00772148|343274|P2|Maintenance Phase (Week 52)|Death|2
99428|NCT00772148|343275|P1|Maintenance Phase (Week 52)|Death|2
99429|NCT00772148|343274|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
99430|NCT00772148|343275|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
99431|NCT00772148|343274|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
99432|NCT00772148|343275|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
99433|NCT00772148|343274|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
99434|NCT00772148|343275|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
99435|NCT00772109|343295|P4|Overall Study|Withdrawal by Subject|16
99436|NCT00772109|343296|P3|Overall Study|Withdrawal by Subject|6
99437|NCT00772109|343297|P2|Overall Study|Withdrawal by Subject|8
99438|NCT00772109|343298|P1|Overall Study|Withdrawal by Subject|8
99439|NCT00772109|343295|P4|Overall Study|Lost to Follow-up|9
99440|NCT00772109|343296|P3|Overall Study|Lost to Follow-up|5
99441|NCT00772109|343297|P2|Overall Study|Lost to Follow-up|3
99442|NCT00772109|343298|P1|Overall Study|Lost to Follow-up|7
99443|NCT00772109|343295|P4|Overall Study|Protocol Violation|6
99444|NCT00772109|343296|P3|Overall Study|Protocol Violation|7
99445|NCT00772109|343297|P2|Overall Study|Protocol Violation|8
99446|NCT00772109|343298|P1|Overall Study|Protocol Violation|5
99447|NCT00772109|343295|P4|Overall Study|Serious adverse event|0
99448|NCT00772109|343296|P3|Overall Study|Serious adverse event|1
99449|NCT00772109|343297|P2|Overall Study|Serious adverse event|0
99450|NCT00772109|343298|P1|Overall Study|Serious adverse event|1
99451|NCT00772070|343322|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
99452|NCT00772070|343323|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
99453|NCT00772070|343322|P2|Overall Study|Withdrawal by Subject|2
99454|NCT00772070|343323|P1|Overall Study|Withdrawal by Subject|0
99455|NCT00772070|343322|P2|Overall Study|Lost to Follow-up|8
99456|NCT00772070|343323|P1|Overall Study|Lost to Follow-up|0
99457|NCT00772031|343335|P2|Overall Study|Lost to Follow-up|33
99458|NCT00772031|343336|P1|Overall Study|Lost to Follow-up|20
99459|NCT00772031|343335|P2|Overall Study|Early termination of trial|10
99460|NCT00772031|343336|P1|Overall Study|Early termination of trial|12
99461|NCT00772005|343362|P4|Overall Study|Non-compliance with drug administration|1
99462|NCT00772005|343363|P3|Overall Study|Non-compliance with drug administration|1
99463|NCT00772005|343364|P2|Overall Study|Non-compliance with drug administration|0
99464|NCT00772005|343365|P1|Overall Study|Non-compliance with drug administration|3
99465|NCT00772005|343362|P4|Overall Study|Non-compliance with study procedures|1
99466|NCT00772005|343363|P3|Overall Study|Non-compliance with study procedures|0
99467|NCT00772005|343364|P2|Overall Study|Non-compliance with study procedures|1
99468|NCT00772005|343365|P1|Overall Study|Non-compliance with study procedures|1
99469|NCT00772005|343362|P4|Overall Study|Lost to Follow-up|3
99470|NCT00772005|343363|P3|Overall Study|Lost to Follow-up|6
99471|NCT00772005|343364|P2|Overall Study|Lost to Follow-up|3
99472|NCT00772005|343365|P1|Overall Study|Lost to Follow-up|7
99473|NCT00772005|343362|P4|Overall Study|Protocol Violation|6
99474|NCT00772005|343363|P3|Overall Study|Protocol Violation|1
99475|NCT00772005|343364|P2|Overall Study|Protocol Violation|4
99476|NCT00772005|343365|P1|Overall Study|Protocol Violation|2
99477|NCT00772005|343362|P4|Overall Study|Withdrawal by Subject|2
99478|NCT00772005|343363|P3|Overall Study|Withdrawal by Subject|10
99479|NCT00772005|343364|P2|Overall Study|Withdrawal by Subject|7
99480|NCT00772005|343365|P1|Overall Study|Withdrawal by Subject|3
99481|NCT00772005|343362|P4|Overall Study|Lack of Efficacy|0
99482|NCT00772005|343363|P3|Overall Study|Lack of Efficacy|0
99483|NCT00772005|343364|P2|Overall Study|Lack of Efficacy|1
99484|NCT00772005|343365|P1|Overall Study|Lack of Efficacy|0
99485|NCT00772005|343362|P4|Overall Study|Adverse Event|13
99486|NCT00772005|343363|P3|Overall Study|Adverse Event|10
99487|NCT00772005|343364|P2|Overall Study|Adverse Event|14
99488|NCT00772005|343365|P1|Overall Study|Adverse Event|9
99489|NCT00771953|344053|P2|Overall Study|Withdrawal by Subject|3
99490|NCT00771953|344054|P1|Overall Study|Withdrawal by Subject|0
99491|NCT00771953|344053|P2|Overall Study|Other complicating disease|0
99492|NCT00771953|344054|P1|Overall Study|Other complicating disease|1
99493|NCT00771953|344053|P2|Overall Study|Sponsor decision|0
99494|NCT00771953|344054|P1|Overall Study|Sponsor decision|1
99495|NCT00771953|344053|P2|Overall Study|Progression before active Tx|2
99496|NCT00771953|344054|P1|Overall Study|Progression before active Tx|1
99497|NCT00771953|344053|P2|Overall Study|Death|2
99498|NCT00771953|344054|P1|Overall Study|Death|2
99499|NCT00771953|344053|P2|Overall Study|Adverse Event|3
99500|NCT00771953|344054|P1|Overall Study|Adverse Event|5
99501|NCT00771927|344064|P2|Overall Study|Other reason|27
99502|NCT00771927|344065|P1|Overall Study|Other reason|23
99503|NCT00771927|344064|P2|Overall Study|Withdrawal by Subject|17
99504|NCT00771927|344065|P1|Overall Study|Withdrawal by Subject|16
99505|NCT00771927|344064|P2|Overall Study|Lost to Follow-up|46
99506|NCT00771927|344065|P1|Overall Study|Lost to Follow-up|46
99507|NCT00771927|344064|P2|Overall Study|Lack of Efficacy|42
99508|NCT00771927|344065|P1|Overall Study|Lack of Efficacy|70
99509|NCT00771927|344064|P2|Overall Study|Adverse Event|105
99510|NCT00771927|344065|P1|Overall Study|Adverse Event|100
99511|NCT00771914|344077|P4|Overall Study|Lost to Follow-up|1
99512|NCT00771914|344078|P3|Overall Study|Lost to Follow-up|0
99513|NCT00771914|344079|P2|Overall Study|Lost to Follow-up|0
99514|NCT00771914|344080|P1|Overall Study|Lost to Follow-up|0
99515|NCT00771914|344077|P4|Overall Study|Physician Decision|1
99516|NCT00771914|344078|P3|Overall Study|Physician Decision|0
99517|NCT00771914|344079|P2|Overall Study|Physician Decision|0
99518|NCT00771914|344080|P1|Overall Study|Physician Decision|0
99519|NCT00771849|344123|P2|Overall Study|Not vaccinated|1
99520|NCT00771849|344124|P1|Overall Study|Not vaccinated|0
99521|NCT00771849|344123|P2|Overall Study|Withdrawal by Subject|1
99522|NCT00771849|344124|P1|Overall Study|Withdrawal by Subject|1
99523|NCT00771849|344123|P2|Overall Study|Lost to Follow-up|2
99524|NCT00771849|344124|P1|Overall Study|Lost to Follow-up|1
99525|NCT00771810|344135|P3|Overall Study|Other|1
99526|NCT00771810|344136|P2|Overall Study|Other|0
99527|NCT00771810|344137|P1|Overall Study|Other|0
99528|NCT00771810|344135|P3|Overall Study|Withdrawal by Subject|0
99529|NCT00771810|344136|P2|Overall Study|Withdrawal by Subject|2
99530|NCT00771810|344137|P1|Overall Study|Withdrawal by Subject|1
99531|NCT00771810|344135|P3|Overall Study|Protocol Violation|1
99532|NCT00771810|344136|P2|Overall Study|Protocol Violation|1
99533|NCT00771810|344137|P1|Overall Study|Protocol Violation|0
99534|NCT00771810|344135|P3|Overall Study|Physician Decision|2
99535|NCT00771810|344136|P2|Overall Study|Physician Decision|2
99536|NCT00771810|344137|P1|Overall Study|Physician Decision|1
99537|NCT00771810|344135|P3|Overall Study|Lost to Follow-up|1
99538|NCT00771810|344136|P2|Overall Study|Lost to Follow-up|0
99539|NCT00771810|344137|P1|Overall Study|Lost to Follow-up|0
99540|NCT00771810|344135|P3|Overall Study|Adverse Event|2
99541|NCT00771810|344136|P2|Overall Study|Adverse Event|0
99542|NCT00771810|344137|P1|Overall Study|Adverse Event|3
99543|NCT00771758|344175|P3|Overall Study|Other|0
99544|NCT00771758|344176|P2|Overall Study|Other|2
99545|NCT00771758|344177|P1|Overall Study|Other|3
99546|NCT00771758|344175|P3|Overall Study|Withdrawal by Subject|0
99547|NCT00771758|344176|P2|Overall Study|Withdrawal by Subject|0
99548|NCT00771758|344177|P1|Overall Study|Withdrawal by Subject|1
99549|NCT00771758|344175|P3|Overall Study|Protocol Violation|0
99550|NCT00771758|344176|P2|Overall Study|Protocol Violation|0
99551|NCT00771758|344177|P1|Overall Study|Protocol Violation|1
99552|NCT00771758|344175|P3|Overall Study|Lost to Follow-up|0
99553|NCT00771758|344176|P2|Overall Study|Lost to Follow-up|0
99554|NCT00771758|344177|P1|Overall Study|Lost to Follow-up|1
99555|NCT00771758|344175|P3|Overall Study|Lack of Efficacy|1
99556|NCT00771758|344176|P2|Overall Study|Lack of Efficacy|2
99557|NCT00771758|344177|P1|Overall Study|Lack of Efficacy|0
99558|NCT00771758|344175|P3|Overall Study|Adverse Event|1
99559|NCT00771758|344176|P2|Overall Study|Adverse Event|8
99560|NCT00771758|344177|P1|Overall Study|Adverse Event|2
99561|NCT00771667|344338|P10|Maintenance Phase|Other|3
99562|NCT00771667|344339|P9|Maintenance Phase|Other|3
99563|NCT00771667|344340|P8|Maintenance Phase|Other|2
99564|NCT00771667|344341|P7|Maintenance Phase|Other|2
99565|NCT00771667|344342|P6|Maintenance Phase|Other|1
99566|NCT00771667|344343|P5|Maintenance Phase|Other|0
99567|NCT00771667|344344|P4|Maintenance Phase|Other|0
99568|NCT00771667|344345|P3|Maintenance Phase|Other|0
99569|NCT00771667|344346|P2|Maintenance Phase|Other|0
99570|NCT00771667|344347|P1|Maintenance Phase|Other|0
99571|NCT00771667|344338|P10|Maintenance Phase|Lack of Efficacy|7
99572|NCT00771667|344339|P9|Maintenance Phase|Lack of Efficacy|11
99573|NCT00771667|344340|P8|Maintenance Phase|Lack of Efficacy|2
99574|NCT00771667|344341|P7|Maintenance Phase|Lack of Efficacy|3
99575|NCT00771667|344342|P6|Maintenance Phase|Lack of Efficacy|3
99576|NCT00771667|344343|P5|Maintenance Phase|Lack of Efficacy|1
99577|NCT00771667|344344|P4|Maintenance Phase|Lack of Efficacy|0
99578|NCT00771667|344345|P3|Maintenance Phase|Lack of Efficacy|0
99579|NCT00771667|344346|P2|Maintenance Phase|Lack of Efficacy|0
99580|NCT00771667|344347|P1|Maintenance Phase|Lack of Efficacy|0
99581|NCT00771667|344338|P10|Maintenance Phase|Adverse Event|7
99582|NCT00771667|344339|P9|Maintenance Phase|Adverse Event|8
99583|NCT00771667|344340|P8|Maintenance Phase|Adverse Event|1
99584|NCT00771667|344341|P7|Maintenance Phase|Adverse Event|5
99585|NCT00771667|344342|P6|Maintenance Phase|Adverse Event|3
99586|NCT00771667|344343|P5|Maintenance Phase|Adverse Event|1
99587|NCT00771667|344344|P4|Maintenance Phase|Adverse Event|0
99588|NCT00771667|344345|P3|Maintenance Phase|Adverse Event|0
99589|NCT00771667|344346|P2|Maintenance Phase|Adverse Event|0
99590|NCT00771667|344347|P1|Maintenance Phase|Adverse Event|0
99591|NCT00771667|344338|P10|Induction Phase|Other|0
99592|NCT00771667|344339|P9|Induction Phase|Other|0
99593|NCT00771667|344340|P8|Induction Phase|Other|0
99594|NCT00771667|344341|P7|Induction Phase|Other|0
99595|NCT00771667|344342|P6|Induction Phase|Other|0
99596|NCT00771667|344343|P5|Induction Phase|Other|0
99597|NCT00771667|344344|P4|Induction Phase|Other|4
99598|NCT00771667|344345|P3|Induction Phase|Other|3
99599|NCT00771667|344346|P2|Induction Phase|Other|6
99600|NCT00771667|344347|P1|Induction Phase|Other|4
99601|NCT00771667|344338|P10|Induction Phase|Lost to Follow-up|0
99602|NCT00771667|344339|P9|Induction Phase|Lost to Follow-up|0
99603|NCT00771667|344340|P8|Induction Phase|Lost to Follow-up|0
99604|NCT00771667|344341|P7|Induction Phase|Lost to Follow-up|0
99605|NCT00771667|344342|P6|Induction Phase|Lost to Follow-up|0
99606|NCT00771667|344343|P5|Induction Phase|Lost to Follow-up|0
99607|NCT00771667|344344|P4|Induction Phase|Lost to Follow-up|0
99608|NCT00771667|344345|P3|Induction Phase|Lost to Follow-up|1
99609|NCT00771667|344346|P2|Induction Phase|Lost to Follow-up|0
99610|NCT00771667|344347|P1|Induction Phase|Lost to Follow-up|1
99611|NCT00771667|344338|P10|Induction Phase|Lack of Efficacy|0
99612|NCT00771667|344339|P9|Induction Phase|Lack of Efficacy|0
99613|NCT00771667|344340|P8|Induction Phase|Lack of Efficacy|0
99614|NCT00771667|344341|P7|Induction Phase|Lack of Efficacy|0
99615|NCT00771667|344342|P6|Induction Phase|Lack of Efficacy|0
99616|NCT00771667|344343|P5|Induction Phase|Lack of Efficacy|0
99617|NCT00771667|344344|P4|Induction Phase|Lack of Efficacy|3
99618|NCT00771667|344345|P3|Induction Phase|Lack of Efficacy|4
99619|NCT00771667|344346|P2|Induction Phase|Lack of Efficacy|2
99620|NCT00771667|344347|P1|Induction Phase|Lack of Efficacy|9
99621|NCT00771667|344338|P10|Induction Phase|Adverse Event|0
99622|NCT00771667|344339|P9|Induction Phase|Adverse Event|0
99623|NCT00771667|344340|P8|Induction Phase|Adverse Event|0
99624|NCT00771667|344341|P7|Induction Phase|Adverse Event|0
99625|NCT00771667|344342|P6|Induction Phase|Adverse Event|0
99626|NCT00771667|344343|P5|Induction Phase|Adverse Event|0
99627|NCT00771667|344344|P4|Induction Phase|Adverse Event|1
99628|NCT00771667|344345|P3|Induction Phase|Adverse Event|4
99629|NCT00771667|344346|P2|Induction Phase|Adverse Event|2
99630|NCT00771667|344347|P1|Induction Phase|Adverse Event|5
99631|NCT00771615|344392|P9|Overall Study|Lost to Follow-up|0
99632|NCT00771615|344393|P8|Overall Study|Lost to Follow-up|0
99633|NCT00771615|344394|P7|Overall Study|Lost to Follow-up|1
99634|NCT00771615|344395|P6|Overall Study|Lost to Follow-up|1
99635|NCT00771615|344396|P5|Overall Study|Lost to Follow-up|0
99636|NCT00771615|344397|P4|Overall Study|Lost to Follow-up|1
99637|NCT00771615|344398|P3|Overall Study|Lost to Follow-up|1
99638|NCT00771615|344399|P2|Overall Study|Lost to Follow-up|1
99639|NCT00771615|344400|P1|Overall Study|Lost to Follow-up|1
99640|NCT00771615|344392|P9|Overall Study|Withdrawal by Subject|0
99641|NCT00771615|344393|P8|Overall Study|Withdrawal by Subject|1
99642|NCT00771615|344394|P7|Overall Study|Withdrawal by Subject|0
99643|NCT00771615|344395|P6|Overall Study|Withdrawal by Subject|0
99644|NCT00771615|344396|P5|Overall Study|Withdrawal by Subject|0
99645|NCT00771615|344397|P4|Overall Study|Withdrawal by Subject|0
99646|NCT00771615|344398|P3|Overall Study|Withdrawal by Subject|0
99647|NCT00771615|344399|P2|Overall Study|Withdrawal by Subject|1
99648|NCT00771615|344400|P1|Overall Study|Withdrawal by Subject|0
99649|NCT00771472|344661|P2|Overall Study|Protocol Violation|0
99650|NCT00771472|344662|P1|Overall Study|Protocol Violation|1
99651|NCT00771472|344661|P2|Overall Study|Progressive Disease|1
99652|NCT00771472|344662|P1|Overall Study|Progressive Disease|3
99653|NCT00771472|344661|P2|Overall Study|Physician Decision|3
99654|NCT00771472|344662|P1|Overall Study|Physician Decision|2
99655|NCT00771316|344682|P2|Overall Study|Discontinued due to early termination|0
99656|NCT00771316|344683|P1|Overall Study|Discontinued due to early termination|1
99657|NCT00771316|344682|P2|Overall Study|Patient withdrew consent|0
99658|NCT00771316|344683|P1|Overall Study|Patient withdrew consent|1
99659|NCT00771316|344682|P2|Overall Study|Adverse Event|1
99660|NCT00771316|344683|P1|Overall Study|Adverse Event|0
99661|NCT00770991|344735|P2|Overall Study|Pregnancy|0
99662|NCT00770991|344736|P1|Overall Study|Pregnancy|1
99663|NCT00770991|344735|P2|Overall Study|Adverse Event|5
99664|NCT00770991|344736|P1|Overall Study|Adverse Event|1
99665|NCT00770991|344735|P2|Overall Study|Withdrawal by Subject|0
99666|NCT00770991|344736|P1|Overall Study|Withdrawal by Subject|1
99667|NCT00770991|344735|P2|Overall Study|Physician Decision|0
99668|NCT00770991|344736|P1|Overall Study|Physician Decision|2
99669|NCT00770965|344752|P4|Excluded Set|Withdrawal by Subject|3
99670|NCT00770965|344753|P3|Excluded Set|Withdrawal by Subject|2
99671|NCT00770965|344754|P2|Excluded Set|Withdrawal by Subject|1
99672|NCT00770965|344755|P1|Excluded Set|Withdrawal by Subject|1
99673|NCT00770965|344752|P4|Excluded Set|Administrative problems|10
99674|NCT00770965|344753|P3|Excluded Set|Administrative problems|12
99675|NCT00770965|344754|P2|Excluded Set|Administrative problems|12
99676|NCT00770965|344755|P1|Excluded Set|Administrative problems|14
99677|NCT00770965|344752|P4|Safety Set|Protocol deviation|0
99678|NCT00770965|344753|P3|Safety Set|Protocol deviation|1
99679|NCT00770965|344754|P2|Safety Set|Protocol deviation|0
99680|NCT00770965|344755|P1|Safety Set|Protocol deviation|0
99681|NCT00770965|344752|P4|Safety Set|Withdrawal by Subject|1
99682|NCT00770965|344753|P3|Safety Set|Withdrawal by Subject|0
99683|NCT00770965|344754|P2|Safety Set|Withdrawal by Subject|0
99684|NCT00770965|344755|P1|Safety Set|Withdrawal by Subject|0
99685|NCT00770913|344776|P3|Overall Study|Incorrect drug was allocated|0
99686|NCT00770913|344777|P2|Overall Study|Incorrect drug was allocated|0
99687|NCT00770913|344778|P1|Overall Study|Incorrect drug was allocated|1
99688|NCT00770913|344776|P3|Overall Study|Protocol Violation|1
99689|NCT00770913|344777|P2|Overall Study|Protocol Violation|0
99690|NCT00770913|344778|P1|Overall Study|Protocol Violation|3
99691|NCT00770913|344776|P3|Overall Study|Physician Decision|1
99692|NCT00770913|344777|P2|Overall Study|Physician Decision|1
99693|NCT00770913|344778|P1|Overall Study|Physician Decision|0
99694|NCT00770913|344776|P3|Overall Study|Refusal to continue participation|5
99695|NCT00770913|344777|P2|Overall Study|Refusal to continue participation|4
99696|NCT00770913|344778|P1|Overall Study|Refusal to continue participation|6
99697|NCT00770913|344776|P3|Overall Study|Adverse Event|6
99698|NCT00770913|344777|P2|Overall Study|Adverse Event|3
99699|NCT00770913|344778|P1|Overall Study|Adverse Event|1
99700|NCT00770809|344800|P3|Overall Study|Other Medical Reasons|3
99701|NCT00770809|344801|P2|Overall Study|Other Medical Reasons|4
99702|NCT00770809|344802|P1|Overall Study|Other Medical Reasons|2
99703|NCT00770809|344800|P3|Overall Study|Complicating illness|1
99704|NCT00770809|344801|P2|Overall Study|Complicating illness|0
99705|NCT00770809|344802|P1|Overall Study|Complicating illness|0
99706|NCT00770809|344800|P3|Overall Study|Progression|0
99707|NCT00770809|344801|P2|Overall Study|Progression|2
99708|NCT00770809|344802|P1|Overall Study|Progression|2
99709|NCT00770809|344800|P3|Overall Study|Withdrawal by Subject|7
99710|NCT00770809|344801|P2|Overall Study|Withdrawal by Subject|3
99711|NCT00770809|344802|P1|Overall Study|Withdrawal by Subject|3
99712|NCT00770809|344800|P3|Overall Study|Death|0
99713|NCT00770809|344801|P2|Overall Study|Death|0
99714|NCT00770809|344802|P1|Overall Study|Death|1
99715|NCT00770809|344800|P3|Overall Study|Adverse Event|12
99716|NCT00770809|344801|P2|Overall Study|Adverse Event|1
99717|NCT00770809|344802|P1|Overall Study|Adverse Event|9
99718|NCT00770770|344812|P2|Overall Study|Study Terminated|0
99719|NCT00770770|344813|P1|Overall Study|Study Terminated|8
99720|NCT00770770|344812|P2|Overall Study|Death|1
99721|NCT00770770|344813|P1|Overall Study|Death|0
99722|NCT00770770|344812|P2|Overall Study|Withdrawal by Subject|0
99723|NCT00770770|344813|P1|Overall Study|Withdrawal by Subject|1
99724|NCT00770770|344812|P2|Overall Study|Lost to Follow-up|0
99725|NCT00770770|344813|P1|Overall Study|Lost to Follow-up|1
99726|NCT00770692|344831|P4|Overall Study|Investigator judgment|1
99727|NCT00770692|344832|P3|Overall Study|Investigator judgment|1
99728|NCT00770692|344833|P2|Overall Study|Investigator judgment|0
99729|NCT00770692|344834|P1|Overall Study|Investigator judgment|2
99730|NCT00770692|344831|P4|Overall Study|Adverse Event|4
99731|NCT00770692|344832|P3|Overall Study|Adverse Event|4
99732|NCT00770692|344833|P2|Overall Study|Adverse Event|0
99733|NCT00770692|344834|P1|Overall Study|Adverse Event|3
99734|NCT00770692|344831|P4|Overall Study|Withdrawal by Subject|6
99735|NCT00770692|344832|P3|Overall Study|Withdrawal by Subject|9
99736|NCT00770692|344833|P2|Overall Study|Withdrawal by Subject|9
99737|NCT00770692|344834|P1|Overall Study|Withdrawal by Subject|7
99738|NCT00770653|344862|P2|Overall Study|Physician Decision|0
99739|NCT00770653|344863|P1|Overall Study|Physician Decision|1
99740|NCT00770653|344862|P2|Overall Study|Lost to Follow-up|2
99741|NCT00770653|344863|P1|Overall Study|Lost to Follow-up|1
99742|NCT00770653|344862|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
99743|NCT00770653|344863|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
99744|NCT00770653|344862|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
99745|NCT00770653|344863|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
99746|NCT00770653|344862|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
99747|NCT00770653|344863|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
99748|NCT00770653|344862|P2|Overall Study|Lack of Compliance|4
99749|NCT00770653|344863|P1|Overall Study|Lack of Compliance|1
99750|NCT00770653|344862|P2|Overall Study|Withdrawal by Subject|7
99751|NCT00770653|344863|P1|Overall Study|Withdrawal by Subject|4
99752|NCT00770653|344862|P2|Overall Study|Protocol Violation|6
99753|NCT00770653|344863|P1|Overall Study|Protocol Violation|8
99754|NCT00770653|344862|P2|Overall Study|Adverse Event|5
99755|NCT00770653|344863|P1|Overall Study|Adverse Event|13
99756|NCT00770588|344933|P2|Overall Study|Withdrawal by Subject|1
99757|NCT00770588|344934|P1|Overall Study|Withdrawal by Subject|1
99758|NCT00770588|344933|P2|Overall Study|Lost to Follow-up|1
99759|NCT00770588|344934|P1|Overall Study|Lost to Follow-up|1
99760|NCT00770588|344933|P2|Overall Study|Death caused by progression of disease|91
99761|NCT00770588|344934|P1|Overall Study|Death caused by progression of disease|70
99762|NCT00770588|344933|P2|Overall Study|Adverse Event|2
99763|NCT00770588|344934|P1|Overall Study|Adverse Event|9
99764|NCT00770562|344950|P2|Overall Study|Did not take treatment|1
99765|NCT00770562|344951|P1|Overall Study|Did not take treatment|1
99766|NCT00770510|344962|P1|Overall Study|Withdrawal by Subject|2
99767|NCT00770510|344962|P1|Overall Study|Pregnancy|1
99768|NCT00770510|344962|P1|Overall Study|Lost to Follow-up|2
99769|NCT00770484|345001|P2|Overall Study|Withdrawal by Subject|0
99770|NCT00770484|345002|P1|Overall Study|Withdrawal by Subject|1
99771|NCT00770432|345010|P2|Overall Study|Non-compliance|1
99772|NCT00770432|345011|P1|Overall Study|Non-compliance|0
99773|NCT00770432|345010|P2|Overall Study|Not specified|6
99774|NCT00770432|345011|P1|Overall Study|Not specified|4
99775|NCT00770367|345019|P2|Second Intervention|Lost to Follow-up|0
99776|NCT00770367|345020|P1|Second Intervention|Lost to Follow-up|2
99777|NCT00770367|345019|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
99778|NCT00770367|345020|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
99779|NCT00770367|345019|P2|First Intervention|Withdrawal by Subject|2
99780|NCT00770367|345020|P1|First Intervention|Withdrawal by Subject|0
99781|NCT00770341|345029|P3|Overall Study|Not treated|0
99782|NCT00770341|345030|P2|Overall Study|Not treated|0
99783|NCT00770341|345031|P1|Overall Study|Not treated|1
99784|NCT00770341|345029|P3|Overall Study|Not specified|0
99785|NCT00770341|345030|P2|Overall Study|Not specified|0
99786|NCT00770341|345031|P1|Overall Study|Not specified|1
99787|NCT00770341|345029|P3|Overall Study|Lack of Efficacy|1
99788|NCT00770341|345030|P2|Overall Study|Lack of Efficacy|0
99789|NCT00770341|345031|P1|Overall Study|Lack of Efficacy|3
99790|NCT00770341|345029|P3|Overall Study|Laboratory adverse event|0
99791|NCT00770341|345030|P2|Overall Study|Laboratory adverse event|3
99792|NCT00770341|345031|P1|Overall Study|Laboratory adverse event|3
99793|NCT00770341|345029|P3|Overall Study|Clinical Adverse Event|2
99794|NCT00770341|345030|P2|Overall Study|Clinical Adverse Event|1
99795|NCT00770341|345031|P1|Overall Study|Clinical Adverse Event|3
99796|NCT00770341|345029|P3|Overall Study|Withdrawal by Subject|0
99797|NCT00770341|345030|P2|Overall Study|Withdrawal by Subject|1
99798|NCT00770341|345031|P1|Overall Study|Withdrawal by Subject|0
99799|NCT00770341|345029|P3|Overall Study|Did not meet eligibility criteria|0
99800|NCT00770341|345030|P2|Overall Study|Did not meet eligibility criteria|0
99801|NCT00770341|345031|P1|Overall Study|Did not meet eligibility criteria|1
99802|NCT00770315|345059|P4|Overall Study|Noncompliance with Protocol|9
99803|NCT00770315|345060|P3|Overall Study|Noncompliance with Protocol|7
99804|NCT00770315|345061|P2|Overall Study|Noncompliance with Protocol|4
99805|NCT00770315|345062|P1|Overall Study|Noncompliance with Protocol|7
99806|NCT00770315|345059|P4|Overall Study|Withdrawal by Subject|20
99807|NCT00770315|345060|P3|Overall Study|Withdrawal by Subject|24
99808|NCT00770315|345061|P2|Overall Study|Withdrawal by Subject|17
99809|NCT00770315|345062|P1|Overall Study|Withdrawal by Subject|13
99810|NCT00770315|345059|P4|Overall Study|Lost to Follow-up|3
99811|NCT00770315|345060|P3|Overall Study|Lost to Follow-up|10
99812|NCT00770315|345061|P2|Overall Study|Lost to Follow-up|5
99813|NCT00770315|345062|P1|Overall Study|Lost to Follow-up|9
99814|NCT00770315|345059|P4|Overall Study|Adverse Event|6
99815|NCT00770315|345060|P3|Overall Study|Adverse Event|16
99816|NCT00770315|345061|P2|Overall Study|Adverse Event|17
99817|NCT00770315|345062|P1|Overall Study|Adverse Event|11
99818|NCT00770289|345088|P1|Overall Study|Unspecified|6
99819|NCT00770211|345099|P2|Overall Study|Withdrawal by Subject|2
99820|NCT00770211|345100|P1|Overall Study|Withdrawal by Subject|0
99821|NCT00770211|345099|P2|Overall Study|Lost to Follow-up|0
99822|NCT00770211|345100|P1|Overall Study|Lost to Follow-up|1
99823|NCT00770146|345116|P2|Follow-up Period|Other|5
99824|NCT00770146|345117|P1|Follow-up Period|Other|4
99825|NCT00770146|345116|P2|Follow-up Period|Adverse Event|2
99826|NCT00770146|345117|P1|Follow-up Period|Adverse Event|0
99827|NCT00770146|345116|P2|Follow-up Period|Withdrawal by Subject|13
99828|NCT00770146|345117|P1|Follow-up Period|Withdrawal by Subject|7
99829|NCT00770146|345116|P2|Treatment Period|Protocol non-compliance|1
99830|NCT00770146|345117|P1|Treatment Period|Protocol non-compliance|0
99831|NCT00770146|345116|P2|Treatment Period|Other|5
99832|NCT00770146|345117|P1|Treatment Period|Other|1
99833|NCT00770146|345116|P2|Treatment Period|Adverse Event|26
99834|NCT00770146|345117|P1|Treatment Period|Adverse Event|2
99835|NCT00770146|345116|P2|Treatment Period|Withdrawal by Subject|13
99836|NCT00770146|345117|P1|Treatment Period|Withdrawal by Subject|6
99837|NCT00770029|345163|P2|Overall Study|Adverse Event|0
99838|NCT00770029|345164|P1|Overall Study|Adverse Event|1
99839|NCT00770029|345163|P2|Overall Study|Withdrawal by Subject|3
99840|NCT00770029|345164|P1|Overall Study|Withdrawal by Subject|3
99841|NCT00770029|345163|P2|Overall Study|Lost to Follow-up|0
99842|NCT00770029|345164|P1|Overall Study|Lost to Follow-up|2
99843|NCT00769860|345180|P2|Overall Study|Withdrawal by Subject|0
99844|NCT00769860|345181|P1|Overall Study|Withdrawal by Subject|2
99845|NCT00769704|345209|P2|Overall Study|Other|2
99846|NCT00769704|345210|P1|Overall Study|Other|1
99847|NCT00769704|345209|P2|Overall Study|Withdrawal by Subject|5
99848|NCT00769704|345210|P1|Overall Study|Withdrawal by Subject|12
99849|NCT00769704|345209|P2|Overall Study|Death|190
99850|NCT00769704|345210|P1|Overall Study|Death|95
99851|NCT00769704|345209|P2|Overall Study|Lost to Follow-up|2
99852|NCT00769704|345210|P1|Overall Study|Lost to Follow-up|3
99853|NCT00769561|345243|P2|Overall Study|Lost to Follow-up|3
99854|NCT00769561|345244|P1|Overall Study|Lost to Follow-up|1
99855|NCT00769561|345243|P2|Overall Study|Withdrawal by Subject|2
99856|NCT00769561|345244|P1|Overall Study|Withdrawal by Subject|2
99857|NCT00769184|345293|P2|No Treatment (6 Weeks)|Adverse Event|1
99858|NCT00769184|345294|P1|No Treatment (6 Weeks)|Adverse Event|1
99859|NCT00769184|345293|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
99860|NCT00769184|345294|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
99861|NCT00769184|345293|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
99862|NCT00769184|345294|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
99863|NCT00769132|345302|P4|Period 4|Withdrawal by Subject|0
99864|NCT00769132|345303|P3|Period 4|Withdrawal by Subject|0
99865|NCT00769132|345304|P2|Period 4|Withdrawal by Subject|1
99866|NCT00769132|345305|P1|Period 4|Withdrawal by Subject|0
99867|NCT00769132|345302|P4|Period 3|Withdrawal by Subject|0
99868|NCT00769132|345303|P3|Period 3|Withdrawal by Subject|0
99869|NCT00769132|345304|P2|Period 3|Withdrawal by Subject|0
99870|NCT00769132|345305|P1|Period 3|Withdrawal by Subject|1
99871|NCT00769132|345302|P4|Period 2|Withdrawal by Subject|1
99872|NCT00769132|345303|P3|Period 2|Withdrawal by Subject|0
99873|NCT00769132|345304|P2|Period 2|Withdrawal by Subject|0
99874|NCT00769132|345305|P1|Period 2|Withdrawal by Subject|0
99875|NCT00769132|345302|P4|Period 1|Adverse Event|1
99876|NCT00769132|345303|P3|Period 1|Adverse Event|0
99877|NCT00769132|345304|P2|Period 1|Adverse Event|0
99878|NCT00769132|345305|P1|Period 1|Adverse Event|1
99879|NCT00769119|345321|P2|Overall Study|Disallowed medication|0
99880|NCT00769119|345322|P1|Overall Study|Disallowed medication|1
99881|NCT00769119|345321|P2|Overall Study|Adverse Event|1
99882|NCT00769119|345322|P1|Overall Study|Adverse Event|1
99883|NCT00769119|345321|P2|Overall Study|Voluntary discontinuation|2
99884|NCT00769119|345322|P1|Overall Study|Voluntary discontinuation|0
99885|NCT00769067|345368|P2|Overall Study|Withdrawal by Subject|1
99886|NCT00769067|345369|P1|Overall Study|Withdrawal by Subject|0
99887|NCT00769067|345368|P2|Overall Study|Unspecified|3
99888|NCT00769067|345369|P1|Overall Study|Unspecified|1
99889|NCT00769067|345368|P2|Overall Study|Study terminated by sponsor|3
99890|NCT00769067|345369|P1|Overall Study|Study terminated by sponsor|1
99891|NCT00769067|345368|P2|Overall Study|Lost to Follow-up|1
99892|NCT00769067|345369|P1|Overall Study|Lost to Follow-up|3
99893|NCT00769067|345368|P2|Overall Study|Death|86
99894|NCT00769067|345369|P1|Overall Study|Death|89
99895|NCT00768989|345417|P2|On or After Week 36|Sponsor Termination|26
99896|NCT00768989|345418|P1|On or After Week 36|Sponsor Termination|45
99897|NCT00768989|345417|P2|On or After Week 36|Did not attend termination visit|0
99898|NCT00768989|345418|P1|On or After Week 36|Did not attend termination visit|2
99899|NCT00768989|345417|P2|On or After Week 36|Protocol Violation|0
99900|NCT00768989|345418|P1|On or After Week 36|Protocol Violation|1
99901|NCT00768989|345417|P2|On or After Week 36|Poor Compliance|0
99902|NCT00768989|345418|P1|On or After Week 36|Poor Compliance|1
99903|NCT00768989|345417|P2|On or After Week 36|Lost to Follow-up|0
99904|NCT00768989|345418|P1|On or After Week 36|Lost to Follow-up|1
99905|NCT00768989|345417|P2|On or After Week 36|Adverse Event|1
99906|NCT00768989|345418|P1|On or After Week 36|Adverse Event|0
99907|NCT00768989|345417|P2|On or After Week 36|Lack of Efficacy|0
99908|NCT00768989|345418|P1|On or After Week 36|Lack of Efficacy|1
99909|NCT00768989|345417|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
99910|NCT00768989|345418|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
99911|NCT00768989|345417|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
99912|NCT00768989|345418|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
99913|NCT00768989|345417|P2|Week 24 to Prior to Week 36|Adverse Event|0
99914|NCT00768989|345418|P1|Week 24 to Prior to Week 36|Adverse Event|1
99915|NCT00768989|345417|P2|Prior to Week 24|Protocol Violation|2
99916|NCT00768989|345418|P1|Prior to Week 24|Protocol Violation|0
99917|NCT00768989|345417|P2|Prior to Week 24|Lost to Follow-up|1
99918|NCT00768989|345418|P1|Prior to Week 24|Lost to Follow-up|0
99919|NCT00768989|345417|P2|Prior to Week 24|Adverse Event|0
99920|NCT00768989|345418|P1|Prior to Week 24|Adverse Event|3
99921|NCT00768989|345417|P2|Prior to Week 24|Withdrawal by Subject|0
99922|NCT00768989|345418|P1|Prior to Week 24|Withdrawal by Subject|1
99923|NCT00768898|345466|P1|Overall Study|Headache|1
99924|NCT00768898|345466|P1|Overall Study|Unrelated injury|1
99925|NCT00768755|345490|P4|Phase 2|Randomized but not treated|2
99926|NCT00768755|345491|P3|Phase 2|Randomized but not treated|0
99927|NCT00768755|345492|P2|Phase 2|Randomized but not treated|0
99928|NCT00768755|345493|P1|Phase 2|Randomized but not treated|0
99929|NCT00768755|345490|P4|Phase 2|Study Terminated by Sponsor|14
99930|NCT00768755|345491|P3|Phase 2|Study Terminated by Sponsor|7
99931|NCT00768755|345492|P2|Phase 2|Study Terminated by Sponsor|13
99932|NCT00768755|345493|P1|Phase 2|Study Terminated by Sponsor|0
99933|NCT00768755|345490|P4|Phase 2|Unspecified|4
99934|NCT00768755|345491|P3|Phase 2|Unspecified|2
99935|NCT00768755|345492|P2|Phase 2|Unspecified|1
99936|NCT00768755|345493|P1|Phase 2|Unspecified|0
99937|NCT00768755|345490|P4|Phase 2|Withdrawal by Subject|1
99938|NCT00768755|345491|P3|Phase 2|Withdrawal by Subject|0
99939|NCT00768755|345492|P2|Phase 2|Withdrawal by Subject|1
99940|NCT00768755|345493|P1|Phase 2|Withdrawal by Subject|0
99941|NCT00768755|345490|P4|Phase 2|Lost to Follow-up|4
99942|NCT00768755|345491|P3|Phase 2|Lost to Follow-up|1
99943|NCT00768755|345492|P2|Phase 2|Lost to Follow-up|1
99944|NCT00768755|345493|P1|Phase 2|Lost to Follow-up|0
99945|NCT00768755|345490|P4|Phase 2|Protocol Violation|1
99946|NCT00768755|345491|P3|Phase 2|Protocol Violation|0
99947|NCT00768755|345492|P2|Phase 2|Protocol Violation|2
99948|NCT00768755|345493|P1|Phase 2|Protocol Violation|0
99949|NCT00768755|345490|P4|Phase 2|Death|31
99950|NCT00768755|345491|P3|Phase 2|Death|48
99951|NCT00768755|345492|P2|Phase 2|Death|37
99952|NCT00768755|345493|P1|Phase 2|Death|0
99953|NCT00768755|345490|P4|Phase 1|Unspecified|0
99954|NCT00768755|345491|P3|Phase 1|Unspecified|0
99955|NCT00768755|345492|P2|Phase 1|Unspecified|0
99956|NCT00768755|345493|P1|Phase 1|Unspecified|4
99957|NCT00768755|345490|P4|Phase 1|Death|0
99958|NCT00768755|345491|P3|Phase 1|Death|0
99959|NCT00768755|345492|P2|Phase 1|Death|0
99960|NCT00768755|345493|P1|Phase 1|Death|6
99961|NCT00768651|345517|P1|Overall Study|Withdrawal by Subject|1
99962|NCT00768560|345556|P6|Intervention Set 1|Adverse Event|0
99963|NCT00768560|345557|P5|Intervention Set 1|Adverse Event|0
99964|NCT00768560|345558|P4|Intervention Set 1|Adverse Event|0
99965|NCT00768560|345559|P3|Intervention Set 1|Adverse Event|0
99966|NCT00768560|345560|P2|Intervention Set 1|Adverse Event|1
99967|NCT00768560|345561|P1|Intervention Set 1|Adverse Event|0
99968|NCT00768430|345598|P2|7 Day Endpoint|Withdrawal by Subject|3
99969|NCT00768430|345599|P1|7 Day Endpoint|Withdrawal by Subject|2
99970|NCT00768300|345607|P2|Overall Study|Missing data|0
99971|NCT00768300|345608|P1|Overall Study|Missing data|1
99972|NCT00768300|345607|P2|Overall Study|Treated but never dosed with Study drug|0
99973|NCT00768300|345608|P1|Overall Study|Treated but never dosed with Study drug|1
99974|NCT00768300|345607|P2|Overall Study|Began prohibited concomitant medication|1
99975|NCT00768300|345608|P1|Overall Study|Began prohibited concomitant medication|0
99976|NCT00768300|345607|P2|Overall Study|Lost to Follow-up|1
99977|NCT00768300|345608|P1|Overall Study|Lost to Follow-up|0
99978|NCT00768300|345607|P2|Overall Study|Received lung transplant|1
99979|NCT00768300|345608|P1|Overall Study|Received lung transplant|1
99980|NCT00768300|345607|P2|Overall Study|Screen failure following randomization|0
99981|NCT00768300|345608|P1|Overall Study|Screen failure following randomization|1
99982|NCT00768300|345607|P2|Overall Study|Subject moved to pursue lung transplant|1
99983|NCT00768300|345608|P1|Overall Study|Subject moved to pursue lung transplant|1
99984|NCT00768300|345607|P2|Overall Study|Death|5
99985|NCT00768300|345608|P1|Overall Study|Death|21
99986|NCT00768300|345607|P2|Overall Study|Study discontinued by Sponsor|140
99987|NCT00768300|345608|P1|Overall Study|Study discontinued by Sponsor|271
99988|NCT00768300|345607|P2|Overall Study|Physician Decision|3
99989|NCT00768300|345608|P1|Overall Study|Physician Decision|2
99990|NCT00768300|345607|P2|Overall Study|Withdrawal by Subject|7
99991|NCT00768300|345608|P1|Overall Study|Withdrawal by Subject|13
99992|NCT00768300|345607|P2|Overall Study|Protocol Violation|1
99993|NCT00768300|345608|P1|Overall Study|Protocol Violation|6
99994|NCT00768300|345607|P2|Overall Study|Adverse Event|2
99995|NCT00768300|345608|P1|Overall Study|Adverse Event|10
99996|NCT00768300|345607|P2|Overall Study|Randomized but not treated|1
99997|NCT00768300|345608|P1|Overall Study|Randomized but not treated|1
99998|NCT00768222|345632|P2|Overall Study|Protocol Violation|2
99999|NCT00768222|345633|P1|Overall Study|Protocol Violation|0
100000|NCT00768222|345632|P2|Overall Study|Withdrawal by Subject|1
100001|NCT00768222|345633|P1|Overall Study|Withdrawal by Subject|3
100002|NCT00768222|345632|P2|Overall Study|Lost to Follow-up|1
100003|NCT00768222|345633|P1|Overall Study|Lost to Follow-up|1
100004|NCT00768144|345655|P1|Overall Study|Pt Withdrew Consent|1
100005|NCT00768144|345655|P1|Overall Study|Patient or MD Decision to End Treatment|1
100006|NCT00768144|345655|P1|Overall Study|Progressive Disease|21
100007|NCT00768144|345655|P1|Overall Study|Adverse Event|13
100008|NCT00768066|345668|P3|Overall Study|Did not receive study product injection.|0
100009|NCT00768066|345669|P2|Overall Study|Did not receive study product injection.|3
100010|NCT00768066|345670|P1|Overall Study|Did not receive study product injection.|3
100011|NCT00768053|345702|P1|Overall Study|Lost to Follow-up|1
100012|NCT00768053|345702|P1|Overall Study|Adverse Event|10
100013|NCT00768040|345733|P2|Overall Study|Abnormal laboratory value|1
100014|NCT00768040|345734|P1|Overall Study|Abnormal laboratory value|1
100015|NCT00768040|345733|P2|Overall Study|Adverse Event|2
100016|NCT00768040|345734|P1|Overall Study|Adverse Event|3
100017|NCT00767806|345742|P2|Overall Study|Sponsor Decision|1
100018|NCT00767806|345743|P1|Overall Study|Sponsor Decision|0
100019|NCT00767806|345742|P2|Overall Study|Entry Criteria Not Met|1
100020|NCT00767806|345743|P1|Overall Study|Entry Criteria Not Met|1
100021|NCT00767806|345742|P2|Overall Study|Lost to Follow-up|4
100022|NCT00767806|345743|P1|Overall Study|Lost to Follow-up|1
100023|NCT00767806|345742|P2|Overall Study|Physician Decision|3
100024|NCT00767806|345743|P1|Overall Study|Physician Decision|4
100025|NCT00767806|345742|P2|Overall Study|Lack of Efficacy|9
100026|NCT00767806|345743|P1|Overall Study|Lack of Efficacy|1
100027|NCT00767806|345742|P2|Overall Study|Protocol Violation|5
100028|NCT00767806|345743|P1|Overall Study|Protocol Violation|6
100029|NCT00767806|345742|P2|Overall Study|Withdrawal by Subject|13
100030|NCT00767806|345743|P1|Overall Study|Withdrawal by Subject|8
100031|NCT00767806|345742|P2|Overall Study|Adverse Event|11
100032|NCT00767806|345743|P1|Overall Study|Adverse Event|30
100033|NCT00767676|345799|P1|Overall Study|Investigator error|54
100034|NCT00767520|345822|P2|Overall Study|Randomized in error and Never treated|2
100035|NCT00767520|345823|P1|Overall Study|Randomized in error and Never treated|0
100036|NCT00767520|345822|P2|Overall Study|Participants still on treatment|15
100037|NCT00767520|345823|P1|Overall Study|Participants still on treatment|11
100038|NCT00767455|345876|P1|Overall Study|Investigator error|19
100039|NCT00767325|345910|P1|Overall Study|Missed visit due to family reasons|1
100040|NCT00767325|345910|P1|Overall Study|No longer met study criteria|2
100041|NCT00767325|345910|P1|Overall Study|Lost to Follow-up|3
100042|NCT00767325|345910|P1|Overall Study|Adverse Event|7
100043|NCT00767325|345910|P1|Overall Study|Lack of Efficacy|2
100044|NCT00767039|345921|P2|Overall Study|Death|2
100045|NCT00767039|345922|P1|Overall Study|Death|5
100046|NCT00767000|345953|P5|Optional 104-week Extension|Study terminated by sponsor|4
100047|NCT00767000|345954|P4|Optional 104-week Extension|Study terminated by sponsor|2
100048|NCT00767000|345955|P3|Optional 104-week Extension|Study terminated by sponsor|7
100049|NCT00767000|345956|P2|Optional 104-week Extension|Study terminated by sponsor|3
100050|NCT00767000|345957|P1|Optional 104-week Extension|Study terminated by sponsor|7
100051|NCT00767000|345953|P5|54-week Study|Reason not reported|0
100052|NCT00767000|345954|P4|54-week Study|Reason not reported|1
100053|NCT00767000|345955|P3|54-week Study|Reason not reported|0
100054|NCT00767000|345956|P2|54-week Study|Reason not reported|0
100055|NCT00767000|345957|P1|54-week Study|Reason not reported|0
100056|NCT00767000|345953|P5|54-week Study|Study terminated by sponsor|194
100057|NCT00767000|345954|P4|54-week Study|Study terminated by sponsor|196
100058|NCT00767000|345955|P3|54-week Study|Study terminated by sponsor|89
100059|NCT00767000|345956|P2|54-week Study|Study terminated by sponsor|102
100060|NCT00767000|345957|P1|54-week Study|Study terminated by sponsor|90
100061|NCT00767000|345953|P5|54-week Study|Withdrawal by Subject|13
100062|NCT00767000|345954|P4|54-week Study|Withdrawal by Subject|11
100063|NCT00767000|345955|P3|54-week Study|Withdrawal by Subject|5
100064|NCT00767000|345956|P2|54-week Study|Withdrawal by Subject|3
100065|NCT00767000|345957|P1|54-week Study|Withdrawal by Subject|2
100066|NCT00767000|345953|P5|54-week Study|Protocol Violation|0
100067|NCT00767000|345954|P4|54-week Study|Protocol Violation|2
100068|NCT00767000|345955|P3|54-week Study|Protocol Violation|1
100069|NCT00767000|345956|P2|54-week Study|Protocol Violation|0
100070|NCT00767000|345957|P1|54-week Study|Protocol Violation|0
100071|NCT00767000|345953|P5|54-week Study|Progressive disease|0
100072|NCT00767000|345954|P4|54-week Study|Progressive disease|0
100073|NCT00767000|345955|P3|54-week Study|Progressive disease|1
100074|NCT00767000|345956|P2|54-week Study|Progressive disease|0
100075|NCT00767000|345957|P1|54-week Study|Progressive disease|0
100076|NCT00767000|345953|P5|54-week Study|Physician Decision|1
100077|NCT00767000|345954|P4|54-week Study|Physician Decision|1
100078|NCT00767000|345955|P3|54-week Study|Physician Decision|1
100079|NCT00767000|345956|P2|54-week Study|Physician Decision|0
100080|NCT00767000|345957|P1|54-week Study|Physician Decision|4
100081|NCT00767000|345953|P5|54-week Study|Lost to Follow-up|2
100082|NCT00767000|345954|P4|54-week Study|Lost to Follow-up|4
100083|NCT00767000|345955|P3|54-week Study|Lost to Follow-up|1
100084|NCT00767000|345956|P2|54-week Study|Lost to Follow-up|0
100085|NCT00767000|345957|P1|54-week Study|Lost to Follow-up|4
100086|NCT00767000|345953|P5|54-week Study|Lack of Efficacy|5
100087|NCT00767000|345954|P4|54-week Study|Lack of Efficacy|0
100088|NCT00767000|345955|P3|54-week Study|Lack of Efficacy|1
100089|NCT00767000|345956|P2|54-week Study|Lack of Efficacy|0
100090|NCT00767000|345957|P1|54-week Study|Lack of Efficacy|2
100091|NCT00767000|345953|P5|54-week Study|Interruption of study medication|0
100092|NCT00767000|345954|P4|54-week Study|Interruption of study medication|0
100093|NCT00767000|345955|P3|54-week Study|Interruption of study medication|1
100094|NCT00767000|345956|P2|54-week Study|Interruption of study medication|0
100095|NCT00767000|345957|P1|54-week Study|Interruption of study medication|0
100096|NCT00767000|345953|P5|54-week Study|Hypoglycemia|0
100097|NCT00767000|345954|P4|54-week Study|Hypoglycemia|0
100098|NCT00767000|345955|P3|54-week Study|Hypoglycemia|0
100099|NCT00767000|345956|P2|54-week Study|Hypoglycemia|1
100100|NCT00767000|345957|P1|54-week Study|Hypoglycemia|0
100101|NCT00767000|345953|P5|54-week Study|Hyperglycemia|1
100102|NCT00767000|345954|P4|54-week Study|Hyperglycemia|0
100103|NCT00767000|345955|P3|54-week Study|Hyperglycemia|1
100104|NCT00767000|345956|P2|54-week Study|Hyperglycemia|0
100105|NCT00767000|345957|P1|54-week Study|Hyperglycemia|0
100106|NCT00767000|345953|P5|54-week Study|Creaninine/creatinine clearance|4
100107|NCT00767000|345954|P4|54-week Study|Creaninine/creatinine clearance|2
100108|NCT00767000|345955|P3|54-week Study|Creaninine/creatinine clearance|2
100109|NCT00767000|345956|P2|54-week Study|Creaninine/creatinine clearance|1
100110|NCT00767000|345957|P1|54-week Study|Creaninine/creatinine clearance|2
100111|NCT00767000|345953|P5|54-week Study|Adverse Event|4
100112|NCT00767000|345954|P4|54-week Study|Adverse Event|8
100113|NCT00767000|345955|P3|54-week Study|Adverse Event|6
100114|NCT00767000|345956|P2|54-week Study|Adverse Event|6
100115|NCT00767000|345957|P1|54-week Study|Adverse Event|4
100116|NCT00766831|345999|P1|Overall Study|Not specified|28
100117|NCT00766831|345999|P1|Overall Study|Non cooperation by participants|14
100118|NCT00766831|345999|P1|Overall Study|Withdrawal of consent|26
100119|NCT00766831|345999|P1|Overall Study|Physician Decision|5
100120|NCT00766831|345999|P1|Overall Study|Protocol Violation|15
100121|NCT00766831|345999|P1|Overall Study|Adverse Event|20
100122|NCT00766831|345999|P1|Overall Study|Lost to Follow-up|3
100123|NCT00766831|345999|P1|Overall Study|Withdrawal by Subject|4
100124|NCT00766675|346015|P1|Overall Study|Insufficient therapy|1
100125|NCT00766675|346015|P1|Overall Study|Receive other anti-neoplastic treatment|1
100126|NCT00766675|346015|P1|Overall Study|Participant took prohibited medication|1
100127|NCT00766675|346015|P1|Overall Study|Protocol Violation|8
100128|NCT00766675|346015|P1|Overall Study|Withdrawal by Subject|11
100129|NCT00766675|346015|P1|Overall Study|Lost to Follow-up|2
100130|NCT00766675|346015|P1|Overall Study|Adverse Event|16
100131|NCT00766636|346042|P2|Overall Study|Disease Progression|0
100132|NCT00766636|346043|P1|Overall Study|Disease Progression|1
100133|NCT00766636|346042|P2|Overall Study|Adverse Event|0
100134|NCT00766636|346043|P1|Overall Study|Adverse Event|1
100135|NCT00766636|346042|P2|Overall Study|Incomplete Treatment|1
100136|NCT00766636|346043|P1|Overall Study|Incomplete Treatment|0
100137|NCT00766636|346042|P2|Overall Study|Withdrawal by Subject|1
100138|NCT00766636|346043|P1|Overall Study|Withdrawal by Subject|1
100139|NCT00766597|346049|P1|Overall Study|Without CCR5-tropic virus|5
100140|NCT00766597|346049|P1|Overall Study|Unexpected closure of study|4
100141|NCT00766532|346061|P1|Overall Study|Protocol Violation|2
100142|NCT00766506|346067|P2|Overall Study|Unspecified|2
100143|NCT00766506|346068|P1|Overall Study|Unspecified|2
100144|NCT00766506|346067|P2|Overall Study|Use rescue medication after 3 hours|0
100145|NCT00766506|346068|P1|Overall Study|Use rescue medication after 3 hours|3
100146|NCT00766493|346092|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
100147|NCT00766493|346092|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
100148|NCT00766493|346092|P1|30 Days Post-Procedure|Discontinued|7
100149|NCT00766467|346102|P2|Overall Study|Physician Decision|0
100150|NCT00766467|346103|P1|Overall Study|Physician Decision|1
100151|NCT00766467|346102|P2|Overall Study|Tumor Progression on Study|1
100152|NCT00766467|346103|P1|Overall Study|Tumor Progression on Study|0
100153|NCT00766467|346102|P2|Overall Study|Protocol Violation|4
100154|NCT00766467|346103|P1|Overall Study|Protocol Violation|2
100155|NCT00766467|346102|P2|Overall Study|Adverse Event|1
100156|NCT00766467|346103|P1|Overall Study|Adverse Event|1
100157|NCT00766467|346102|P2|Overall Study|Withdrawal by Subject|2
100158|NCT00766467|346103|P1|Overall Study|Withdrawal by Subject|7
100159|NCT00766415|346115|P2|Overall Study|Withdrawal by Subject|1
100160|NCT00766415|346116|P1|Overall Study|Withdrawal by Subject|0
100161|NCT00766376|346164|P1|Overall Study|Withdrawal by Subject|27
100162|NCT00766363|346173|P4|Overall Study|Adverse Event Prior to Randomization|0
100319|NCT00765817|346345|P2|Overall Study|Subject decision|11
100163|NCT00766363|346174|P3|Overall Study|Adverse Event Prior to Randomization|0
100164|NCT00766363|346175|P2|Overall Study|Adverse Event Prior to Randomization|1
100165|NCT00766363|346176|P1|Overall Study|Adverse Event Prior to Randomization|0
100166|NCT00766363|346173|P4|Overall Study|Withdrawal by Subject|0
100167|NCT00766363|346174|P3|Overall Study|Withdrawal by Subject|0
100168|NCT00766363|346175|P2|Overall Study|Withdrawal by Subject|0
100169|NCT00766363|346176|P1|Overall Study|Withdrawal by Subject|1
100170|NCT00766090|346215|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
100171|NCT00766090|346216|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
100172|NCT00766090|346217|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
100173|NCT00766090|346218|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
100174|NCT00766090|346219|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
100175|NCT00766090|346220|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
100176|NCT00766090|346221|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
100177|NCT00766090|346222|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
100178|NCT00766090|346223|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
100179|NCT00766090|346224|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
100180|NCT00766090|346225|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
100181|NCT00766090|346226|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
100182|NCT00766090|346215|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
100183|NCT00766090|346216|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
100184|NCT00766090|346217|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
100185|NCT00766090|346218|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
100186|NCT00766090|346219|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
100187|NCT00766090|346220|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
100188|NCT00766090|346221|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
100189|NCT00766090|346222|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
100190|NCT00766090|346223|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
100191|NCT00766090|346224|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
100192|NCT00766090|346225|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
100193|NCT00766090|346226|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
100194|NCT00766090|346215|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
100195|NCT00766090|346216|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
100196|NCT00766090|346217|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
100197|NCT00766090|346218|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
100198|NCT00766090|346219|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
100199|NCT00766090|346220|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
100200|NCT00766090|346221|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
100201|NCT00766090|346222|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
100202|NCT00766090|346223|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
100203|NCT00766090|346224|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
100204|NCT00766090|346225|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
100205|NCT00766090|346226|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
100206|NCT00766090|346215|P12|Washout Period 2 (14 Days)|Physician Decision|0
100207|NCT00766090|346216|P11|Washout Period 2 (14 Days)|Physician Decision|0
100208|NCT00766090|346217|P10|Washout Period 2 (14 Days)|Physician Decision|0
100209|NCT00766090|346218|P9|Washout Period 2 (14 Days)|Physician Decision|0
100210|NCT00766090|346219|P8|Washout Period 2 (14 Days)|Physician Decision|0
100211|NCT00766090|346220|P7|Washout Period 2 (14 Days)|Physician Decision|0
100212|NCT00766090|346221|P6|Washout Period 2 (14 Days)|Physician Decision|0
100213|NCT00766090|346222|P5|Washout Period 2 (14 Days)|Physician Decision|0
100214|NCT00766090|346223|P4|Washout Period 2 (14 Days)|Physician Decision|0
100215|NCT00766090|346224|P3|Washout Period 2 (14 Days)|Physician Decision|1
100216|NCT00766090|346225|P2|Washout Period 2 (14 Days)|Physician Decision|0
100217|NCT00766090|346226|P1|Washout Period 2 (14 Days)|Physician Decision|0
100218|NCT00766090|346215|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
100219|NCT00766090|346216|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
100220|NCT00766090|346217|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
100221|NCT00766090|346218|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
100222|NCT00766090|346219|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
100223|NCT00766090|346220|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
100224|NCT00766090|346221|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
100225|NCT00766090|346222|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
100226|NCT00766090|346223|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
100227|NCT00766090|346224|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
100228|NCT00766090|346225|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
100229|NCT00766090|346226|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
100230|NCT00766090|346215|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
100231|NCT00766090|346216|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
100232|NCT00766090|346217|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
100233|NCT00766090|346218|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
100234|NCT00766090|346219|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
100235|NCT00766090|346220|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
100236|NCT00766090|346221|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
100237|NCT00766090|346222|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
100238|NCT00766090|346223|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
100239|NCT00766090|346224|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
100240|NCT00766090|346225|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
100241|NCT00766090|346226|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
100242|NCT00766090|346215|P12|Washout Period 1 (14 Days)|Protocol Violation|0
100243|NCT00766090|346216|P11|Washout Period 1 (14 Days)|Protocol Violation|0
100244|NCT00766090|346217|P10|Washout Period 1 (14 Days)|Protocol Violation|0
100245|NCT00766090|346218|P9|Washout Period 1 (14 Days)|Protocol Violation|0
100246|NCT00766090|346219|P8|Washout Period 1 (14 Days)|Protocol Violation|0
100247|NCT00766090|346220|P7|Washout Period 1 (14 Days)|Protocol Violation|0
100248|NCT00766090|346221|P6|Washout Period 1 (14 Days)|Protocol Violation|0
100249|NCT00766090|346222|P5|Washout Period 1 (14 Days)|Protocol Violation|0
100250|NCT00766090|346223|P4|Washout Period 1 (14 Days)|Protocol Violation|0
100251|NCT00766090|346224|P3|Washout Period 1 (14 Days)|Protocol Violation|1
100252|NCT00766090|346225|P2|Washout Period 1 (14 Days)|Protocol Violation|0
100253|NCT00766090|346226|P1|Washout Period 1 (14 Days)|Protocol Violation|0
100254|NCT00766090|346215|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
100255|NCT00766090|346216|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
100256|NCT00766090|346217|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
100257|NCT00766090|346218|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
100258|NCT00766090|346219|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
100259|NCT00766090|346220|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
100260|NCT00766090|346221|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
100261|NCT00766090|346222|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
100262|NCT00766090|346223|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
100263|NCT00766090|346224|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
100264|NCT00766090|346225|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
100265|NCT00766090|346226|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
100266|NCT00766090|346215|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
100267|NCT00766090|346216|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
100268|NCT00766090|346217|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
100269|NCT00766090|346218|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
100270|NCT00766090|346219|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
100271|NCT00766090|346220|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
100272|NCT00766090|346221|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
100273|NCT00766090|346222|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
100274|NCT00766090|346223|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
100275|NCT00766090|346224|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
100276|NCT00766090|346225|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
100277|NCT00766090|346226|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
100278|NCT00766090|346215|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
100279|NCT00766090|346216|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
100280|NCT00766090|346217|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
100281|NCT00766090|346218|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
100282|NCT00766090|346219|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
100283|NCT00766090|346220|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
100284|NCT00766090|346221|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
100285|NCT00766090|346222|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
100286|NCT00766090|346223|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
100287|NCT00766090|346224|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
100288|NCT00766090|346225|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
100289|NCT00766090|346226|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
100290|NCT00766051|346267|P2|Overall Study|Withdrawal by Subject|0
100291|NCT00766051|346268|P1|Overall Study|Withdrawal by Subject|2
100292|NCT00765882|346299|P3|Overall Study|Other Reason|2
100293|NCT00765882|346300|P2|Overall Study|Other Reason|1
100294|NCT00765882|346301|P1|Overall Study|Other Reason|3
100295|NCT00765882|346299|P3|Overall Study|Lost to Follow-up|6
100296|NCT00765882|346300|P2|Overall Study|Lost to Follow-up|9
100297|NCT00765882|346301|P1|Overall Study|Lost to Follow-up|1
100298|NCT00765882|346299|P3|Overall Study|Withdrawal by Subject|6
100299|NCT00765882|346300|P2|Overall Study|Withdrawal by Subject|6
100300|NCT00765882|346301|P1|Overall Study|Withdrawal by Subject|2
100301|NCT00765882|346299|P3|Overall Study|Protocol Violation|1
100302|NCT00765882|346300|P2|Overall Study|Protocol Violation|3
100303|NCT00765882|346301|P1|Overall Study|Protocol Violation|4
100304|NCT00765882|346299|P3|Overall Study|Lack of Efficacy|1
100305|NCT00765882|346300|P2|Overall Study|Lack of Efficacy|0
100306|NCT00765882|346301|P1|Overall Study|Lack of Efficacy|4
100307|NCT00765882|346299|P3|Overall Study|Adverse Event|20
100308|NCT00765882|346300|P2|Overall Study|Adverse Event|21
100309|NCT00765882|346301|P1|Overall Study|Adverse Event|10
100310|NCT00765843|346333|P3|Overall Study|Adverse Event|1
100311|NCT00765843|346334|P2|Overall Study|Adverse Event|0
100312|NCT00765843|346335|P1|Overall Study|Adverse Event|0
100313|NCT00765843|346333|P3|Overall Study|did not return to receive intervention|0
100314|NCT00765843|346334|P2|Overall Study|did not return to receive intervention|1
100315|NCT00765843|346335|P1|Overall Study|did not return to receive intervention|0
100316|NCT00765843|346333|P3|Overall Study|Lost to Follow-up|2
100317|NCT00765843|346334|P2|Overall Study|Lost to Follow-up|3
100318|NCT00765843|346335|P1|Overall Study|Lost to Follow-up|1
100320|NCT00765817|346346|P1|Overall Study|Subject decision|7
100321|NCT00765817|346345|P2|Overall Study|Protocol Violation|1
100322|NCT00765817|346346|P1|Overall Study|Protocol Violation|1
100323|NCT00765817|346345|P2|Overall Study|Physician Decision|1
100324|NCT00765817|346346|P1|Overall Study|Physician Decision|2
100325|NCT00765817|346345|P2|Overall Study|Lost to Follow-up|3
100326|NCT00765817|346346|P1|Overall Study|Lost to Follow-up|1
100327|NCT00765817|346345|P2|Overall Study|Loss of glucose control|2
100328|NCT00765817|346346|P1|Overall Study|Loss of glucose control|0
100329|NCT00765817|346345|P2|Overall Study|Entry criteria not met|2
100330|NCT00765817|346346|P1|Overall Study|Entry criteria not met|2
100331|NCT00765817|346345|P2|Overall Study|Death|1
100332|NCT00765817|346346|P1|Overall Study|Death|0
100333|NCT00765817|346345|P2|Overall Study|Adverse Event|1
100334|NCT00765817|346346|P1|Overall Study|Adverse Event|13
100335|NCT00765726|346394|P1|Overall Study|Discontinuation of study by sponsor|8
100336|NCT00765726|346394|P1|Overall Study|Withdrawal by Subject|1
100337|NCT00765674|346402|P4|Overall Study|Randomized in Error - No Study Drug|1
100338|NCT00765674|346403|P3|Overall Study|Randomized in Error - No Study Drug|0
100339|NCT00765674|346404|P2|Overall Study|Randomized in Error - No Study Drug|1
100340|NCT00765674|346405|P1|Overall Study|Randomized in Error - No Study Drug|0
100341|NCT00765674|346402|P4|Overall Study|Lost to Follow-up|1
100342|NCT00765674|346403|P3|Overall Study|Lost to Follow-up|2
100343|NCT00765674|346404|P2|Overall Study|Lost to Follow-up|6
100344|NCT00765674|346405|P1|Overall Study|Lost to Follow-up|4
100345|NCT00765674|346402|P4|Overall Study|Withdrawal by Subject|8
100346|NCT00765674|346403|P3|Overall Study|Withdrawal by Subject|3
100347|NCT00765674|346404|P2|Overall Study|Withdrawal by Subject|7
100348|NCT00765674|346405|P1|Overall Study|Withdrawal by Subject|5
100349|NCT00765674|346402|P4|Overall Study|Protocol Violation|0
100350|NCT00765674|346403|P3|Overall Study|Protocol Violation|1
100351|NCT00765674|346404|P2|Overall Study|Protocol Violation|0
100352|NCT00765674|346405|P1|Overall Study|Protocol Violation|2
100353|NCT00765674|346402|P4|Overall Study|Lack of Efficacy|2
100354|NCT00765674|346403|P3|Overall Study|Lack of Efficacy|1
100355|NCT00765674|346404|P2|Overall Study|Lack of Efficacy|3
100356|NCT00765674|346405|P1|Overall Study|Lack of Efficacy|2
100357|NCT00765674|346402|P4|Overall Study|Abnormal Test Procedure Result(s)|2
100358|NCT00765674|346403|P3|Overall Study|Abnormal Test Procedure Result(s)|1
100359|NCT00765674|346404|P2|Overall Study|Abnormal Test Procedure Result(s)|3
100360|NCT00765674|346405|P1|Overall Study|Abnormal Test Procedure Result(s)|1
100361|NCT00765674|346402|P4|Overall Study|Abnormal Laboratory Value(s)|0
100362|NCT00765674|346403|P3|Overall Study|Abnormal Laboratory Value(s)|1
100363|NCT00765674|346404|P2|Overall Study|Abnormal Laboratory Value(s)|0
100364|NCT00765674|346405|P1|Overall Study|Abnormal Laboratory Value(s)|0
100365|NCT00765674|346402|P4|Overall Study|Adverse Event|11
100366|NCT00765674|346403|P3|Overall Study|Adverse Event|8
100367|NCT00765674|346404|P2|Overall Study|Adverse Event|2
100368|NCT00765674|346405|P1|Overall Study|Adverse Event|7
100369|NCT00765388|346472|P2|Period 1|Hip operation|1
100370|NCT00765388|346473|P1|Period 1|Hip operation|0
100371|NCT00765388|346472|P2|Period 1|Herpes Zoster|1
100372|NCT00765388|346473|P1|Period 1|Herpes Zoster|0
100373|NCT00765388|346472|P2|Period 1|Lost to Follow-up|1
100374|NCT00765388|346473|P1|Period 1|Lost to Follow-up|0
100375|NCT00765388|346472|P2|Period 1|Lack of Efficacy|2
100376|NCT00765388|346473|P1|Period 1|Lack of Efficacy|1
100377|NCT00765362|346507|P1|Overall Study|Lost to Follow-up|95
100378|NCT00765362|346507|P1|Overall Study|Withdrawal by Subject|13
100379|NCT00765362|346507|P1|Overall Study|Protocol Violation|18
100380|NCT00765362|346507|P1|Overall Study|Adverse Event|2
100381|NCT00765362|346507|P1|Overall Study|Death|9
100382|NCT00765336|346515|P2|Overall Study|Adverse Event|1
100383|NCT00765336|346516|P1|Overall Study|Adverse Event|2
100384|NCT00765336|346515|P2|Overall Study|Lost to Follow-up|9
100385|NCT00765336|346516|P1|Overall Study|Lost to Follow-up|7
100386|NCT00765336|346515|P2|Overall Study|Withdrawal by Subject|4
100387|NCT00765336|346516|P1|Overall Study|Withdrawal by Subject|6
100388|NCT00765336|346515|P2|Overall Study|Protocol Violation|2
100389|NCT00765336|346516|P1|Overall Study|Protocol Violation|4
100390|NCT00765245|346524|P2|Overall Study|Death|0
100391|NCT00765245|346525|P1|Overall Study|Death|1
100392|NCT00765245|346524|P2|Overall Study|Physician Decision|0
100393|NCT00765245|346525|P1|Overall Study|Physician Decision|1
100394|NCT00765245|346524|P2|Overall Study|Adverse Event|0
100395|NCT00765245|346525|P1|Overall Study|Adverse Event|5
100396|NCT00765245|346524|P2|Overall Study|Withdrawal by Subject|0
100397|NCT00765245|346525|P1|Overall Study|Withdrawal by Subject|3
100398|NCT00765245|346524|P2|Overall Study|disease progression|2
100399|NCT00765245|346525|P1|Overall Study|disease progression|3
100400|NCT00765102|346571|P1|Overall Study|Protocol Violation|1
100401|NCT00765102|346571|P1|Overall Study|Withdrawal by Subject|2
100402|NCT00765102|346571|P1|Overall Study|Physician Decision|4
100403|NCT00765102|346571|P1|Overall Study|Adverse Event|6
100404|NCT00765102|346571|P1|Overall Study|Progressive disease|18
100405|NCT00765076|346596|P3|Overall Study|Withdrawal by Subject|1
100406|NCT00765076|346597|P2|Overall Study|Withdrawal by Subject|0
100407|NCT00765076|346598|P1|Overall Study|Withdrawal by Subject|0
100408|NCT00765076|346596|P3|Overall Study|Adverse Event|0
100409|NCT00765076|346597|P2|Overall Study|Adverse Event|0
100410|NCT00765076|346598|P1|Overall Study|Adverse Event|1
100411|NCT00765063|346651|P1|Overall Study|Adverse Event|4
100412|NCT00765063|346651|P1|Overall Study|Protocol Violation|6
100413|NCT00765063|346651|P1|Overall Study|Unspecified|16
100414|NCT00765063|346651|P1|Overall Study|Withdrawal by Subject|1
100415|NCT00765063|346651|P1|Overall Study|Lack of Efficacy|5
100416|NCT00765037|346667|P1|Overall Study|Adverse Event|1
100417|NCT00765037|346667|P1|Overall Study|Lost to Follow-up|5
100418|NCT00764946|346674|P3|Overall Study|Never Treated|1
100419|NCT00764946|346675|P2|Overall Study|Never Treated|1
100420|NCT00764946|346676|P1|Overall Study|Never Treated|1
100421|NCT00764946|346674|P3|Overall Study|Withdrawal by Subject|2
100422|NCT00764946|346675|P2|Overall Study|Withdrawal by Subject|6
100423|NCT00764946|346676|P1|Overall Study|Withdrawal by Subject|3
100424|NCT00764946|346674|P3|Overall Study|Adverse Event|1
100425|NCT00764946|346675|P2|Overall Study|Adverse Event|2
100426|NCT00764946|346676|P1|Overall Study|Adverse Event|3
100427|NCT00764946|346674|P3|Overall Study|Physician Decision|0
100428|NCT00764946|346675|P2|Overall Study|Physician Decision|4
100429|NCT00764946|346676|P1|Overall Study|Physician Decision|2
100430|NCT00764946|346674|P3|Overall Study|Lost to Follow-up|0
100431|NCT00764946|346675|P2|Overall Study|Lost to Follow-up|4
100432|NCT00764946|346676|P1|Overall Study|Lost to Follow-up|3
100433|NCT00764946|346674|P3|Overall Study|Lack of Efficacy|0
100434|NCT00764946|346675|P2|Overall Study|Lack of Efficacy|0
100435|NCT00764946|346676|P1|Overall Study|Lack of Efficacy|1
100436|NCT00764881|346704|P2|Overall Study|no treatment or no observation|2
100437|NCT00764881|346705|P1|Overall Study|no treatment or no observation|2
100438|NCT00764881|346704|P2|Overall Study|Possibly noncompliant (study drug)|2
100439|NCT00764881|346705|P1|Overall Study|Possibly noncompliant (study drug)|0
100440|NCT00764881|346704|P2|Overall Study|Carcinoma detected|0
100441|NCT00764881|346705|P1|Overall Study|Carcinoma detected|1
100442|NCT00764881|346704|P2|Overall Study|Wished to become pregnant|0
100443|NCT00764881|346705|P1|Overall Study|Wished to become pregnant|1
100444|NCT00764881|346704|P2|Overall Study|Accidentally discontinued study drug|0
100445|NCT00764881|346705|P1|Overall Study|Accidentally discontinued study drug|1
100446|NCT00764881|346704|P2|Overall Study|Noncompliant|0
100447|NCT00764881|346705|P1|Overall Study|Noncompliant|1
100448|NCT00764881|346704|P2|Overall Study|Lost to Follow-up|0
100449|NCT00764881|346705|P1|Overall Study|Lost to Follow-up|2
100450|NCT00764881|346704|P2|Overall Study|Protocol Violation|2
100451|NCT00764881|346705|P1|Overall Study|Protocol Violation|2
100452|NCT00764881|346704|P2|Overall Study|Withdrawal by Subject|3
100453|NCT00764881|346705|P1|Overall Study|Withdrawal by Subject|1
100454|NCT00764881|346704|P2|Overall Study|Adverse Event|1
100455|NCT00764881|346705|P1|Overall Study|Adverse Event|5
100456|NCT00764868|346929|P1|Overall Study|Sponsor requested withdrawal|1
100457|NCT00764868|346929|P1|Overall Study|Positive drug screen|2
100458|NCT00764868|346929|P1|Overall Study|Met an exclusion criteria|1
100459|NCT00764868|346929|P1|Overall Study|Subject sent to boarding school|1
100460|NCT00764868|346929|P1|Overall Study|Misuse and compliance of study drug|1
100461|NCT00764868|346929|P1|Overall Study|Out of town|1
100462|NCT00764868|346929|P1|Overall Study|Prohibited medication|1
100463|NCT00764868|346929|P1|Overall Study|Pregnancy|3
100464|NCT00764868|346929|P1|Overall Study|Subject moved|7
100465|NCT00764868|346929|P1|Overall Study|Lack of Efficacy|5
100466|NCT00764868|346929|P1|Overall Study|Lost to Follow-up|25
100467|NCT00764868|346929|P1|Overall Study|Non-compliance|16
100468|NCT00764868|346929|P1|Overall Study|Withdrawal by Subject|31
100469|NCT00764868|346929|P1|Overall Study|Adverse Event|18
100470|NCT00764790|346938|P3|Overall Study|Lost to Follow-up|23
100471|NCT00764790|346939|P2|Overall Study|Lost to Follow-up|29
100472|NCT00764790|346940|P1|Overall Study|Lost to Follow-up|28
100473|NCT00764790|346938|P3|Overall Study|Withdrawal by Subject|6
100474|NCT00764790|346939|P2|Overall Study|Withdrawal by Subject|12
100475|NCT00764790|346940|P1|Overall Study|Withdrawal by Subject|10
100476|NCT00764790|346938|P3|Overall Study|Protocol Violation|1
100477|NCT00764790|346939|P2|Overall Study|Protocol Violation|0
100478|NCT00764790|346940|P1|Overall Study|Protocol Violation|0
100479|NCT00764673|346972|P1|Overall Study|Revision of Device|2
100480|NCT00764673|346972|P1|Overall Study|Withdrawal by Subject|6
100481|NCT00764673|346972|P1|Overall Study|Lost to Follow-up|3
100482|NCT00764673|346972|P1|Overall Study|Death|1
100483|NCT00764660|346982|P2|Overall Study|Did Not Meet Protocol Eligibility|0
100484|NCT00764660|346983|P1|Overall Study|Did Not Meet Protocol Eligibility|1
100485|NCT00764660|346982|P2|Overall Study|Noncompliance With Protocol|1
100486|NCT00764660|346983|P1|Overall Study|Noncompliance With Protocol|5
100487|NCT00764660|346982|P2|Overall Study|Withdrawal by Subject|3
100488|NCT00764660|346983|P1|Overall Study|Withdrawal by Subject|7
100489|NCT00764660|346982|P2|Overall Study|Lost to Follow-up|4
100490|NCT00764660|346983|P1|Overall Study|Lost to Follow-up|3
100491|NCT00764660|346982|P2|Overall Study|Adverse Event|3
100492|NCT00764660|346983|P1|Overall Study|Adverse Event|6
100493|NCT00764504|347018|P3|Overall Study|Lost to Follow-up|72
100494|NCT00764504|347019|P2|Overall Study|Lost to Follow-up|34
100495|NCT00764504|347020|P1|Overall Study|Lost to Follow-up|40
100496|NCT00764504|347018|P3|Overall Study|Withdrawal by Subject|4
100497|NCT00764504|347019|P2|Overall Study|Withdrawal by Subject|7
100498|NCT00764504|347020|P1|Overall Study|Withdrawal by Subject|1
100499|NCT00764504|347018|P3|Overall Study|Physician Decision|0
100500|NCT00764504|347019|P2|Overall Study|Physician Decision|0
100501|NCT00764504|347020|P1|Overall Study|Physician Decision|1
100502|NCT00764504|347018|P3|Overall Study|Revision of Device|14
100503|NCT00764504|347019|P2|Overall Study|Revision of Device|23
100504|NCT00764504|347020|P1|Overall Study|Revision of Device|12
100505|NCT00764504|347018|P3|Overall Study|Death|13
100506|NCT00764504|347019|P2|Overall Study|Death|6
100507|NCT00764504|347020|P1|Overall Study|Death|12
100508|NCT00764478|347049|P3|Overall Study|Protocol Violation|1
100509|NCT00764478|347050|P2|Overall Study|Protocol Violation|1
100510|NCT00764478|347051|P1|Overall Study|Protocol Violation|0
100511|NCT00764478|347049|P3|Overall Study|Lost to Follow-up|5
100512|NCT00764478|347050|P2|Overall Study|Lost to Follow-up|8
100513|NCT00764478|347051|P1|Overall Study|Lost to Follow-up|7
100514|NCT00764478|347049|P3|Overall Study|Withdrawal by Subject|1
100515|NCT00764478|347050|P2|Overall Study|Withdrawal by Subject|12
100516|NCT00764478|347051|P1|Overall Study|Withdrawal by Subject|7
100517|NCT00764478|347049|P3|Overall Study|Adverse Event|1
100518|NCT00764478|347050|P2|Overall Study|Adverse Event|1
100519|NCT00764478|347051|P1|Overall Study|Adverse Event|1
100520|NCT00764465|347131|P6|Overall Study|Withdrawal by Subject|0
100521|NCT00764465|347132|P5|Overall Study|Withdrawal by Subject|0
100522|NCT00764465|347133|P4|Overall Study|Withdrawal by Subject|0
100523|NCT00764465|347134|P3|Overall Study|Withdrawal by Subject|1
100524|NCT00764465|347135|P2|Overall Study|Withdrawal by Subject|1
100525|NCT00764465|347136|P1|Overall Study|Withdrawal by Subject|0
100526|NCT00764465|347131|P6|Overall Study|Adverse Event|1
100527|NCT00764465|347132|P5|Overall Study|Adverse Event|1
100528|NCT00764465|347133|P4|Overall Study|Adverse Event|1
100529|NCT00764465|347134|P3|Overall Study|Adverse Event|0
100530|NCT00764465|347135|P2|Overall Study|Adverse Event|0
100531|NCT00764465|347136|P1|Overall Study|Adverse Event|2
100532|NCT00764361|347164|P2|Overall Study|Adverse Event|1
100533|NCT00764361|347165|P1|Overall Study|Adverse Event|0
100534|NCT00764361|347164|P2|Overall Study|Withdrawal by Subject|3
100535|NCT00764361|347165|P1|Overall Study|Withdrawal by Subject|2
100536|NCT00763971|347181|P3|Overall Study|Participation in 489-326 required|0
100537|NCT00763971|347182|P2|Overall Study|Participation in 489-326 required|0
100538|NCT00763971|347183|P1|Overall Study|Participation in 489-326 required|1
100539|NCT00763971|347181|P3|Overall Study|Performed final visit on phone|0
100540|NCT00763971|347182|P2|Overall Study|Performed final visit on phone|1
100541|NCT00763971|347183|P1|Overall Study|Performed final visit on phone|0
100542|NCT00763971|347181|P3|Overall Study|Lack of availability|0
100543|NCT00763971|347182|P2|Overall Study|Lack of availability|1
100544|NCT00763971|347183|P1|Overall Study|Lack of availability|0
100545|NCT00763971|347181|P3|Overall Study|Subject wanted dose reduction|0
100546|NCT00763971|347182|P2|Overall Study|Subject wanted dose reduction|1
100547|NCT00763971|347183|P1|Overall Study|Subject wanted dose reduction|0
100548|NCT00763971|347181|P3|Overall Study|Moved to another country|0
100549|NCT00763971|347182|P2|Overall Study|Moved to another country|1
100550|NCT00763971|347183|P1|Overall Study|Moved to another country|0
100551|NCT00763971|347181|P3|Overall Study|Medical monitor decision|1
100552|NCT00763971|347182|P2|Overall Study|Medical monitor decision|0
100553|NCT00763971|347183|P1|Overall Study|Medical monitor decision|0
100554|NCT00763971|347181|P3|Overall Study|Randomization error|1
100555|NCT00763971|347182|P2|Overall Study|Randomization error|0
100556|NCT00763971|347183|P1|Overall Study|Randomization error|0
100557|NCT00763971|347181|P3|Overall Study|Due to holiday season|1
100558|NCT00763971|347182|P2|Overall Study|Due to holiday season|0
100559|NCT00763971|347183|P1|Overall Study|Due to holiday season|2
100560|NCT00763971|347181|P3|Overall Study|Sponsor decision|0
100561|NCT00763971|347182|P2|Overall Study|Sponsor decision|0
100562|NCT00763971|347183|P1|Overall Study|Sponsor decision|1
100563|NCT00763971|347181|P3|Overall Study|Exclusion criteria met|0
100564|NCT00763971|347182|P2|Overall Study|Exclusion criteria met|0
100565|NCT00763971|347183|P1|Overall Study|Exclusion criteria met|1
100566|NCT00763971|347181|P3|Overall Study|Personal reason|0
100567|NCT00763971|347182|P2|Overall Study|Personal reason|0
100568|NCT00763971|347183|P1|Overall Study|Personal reason|3
100569|NCT00763971|347181|P3|Overall Study|Unable to swallow capsule|1
100570|NCT00763971|347182|P2|Overall Study|Unable to swallow capsule|1
100571|NCT00763971|347183|P1|Overall Study|Unable to swallow capsule|2
100572|NCT00763971|347181|P3|Overall Study|Lack of Efficacy|54
100573|NCT00763971|347182|P2|Overall Study|Lack of Efficacy|22
100574|NCT00763971|347183|P1|Overall Study|Lack of Efficacy|11
100575|NCT00763971|347181|P3|Overall Study|Lost to Follow-up|0
100576|NCT00763971|347182|P2|Overall Study|Lost to Follow-up|1
100577|NCT00763971|347183|P1|Overall Study|Lost to Follow-up|0
100578|NCT00763971|347181|P3|Overall Study|Withdrawal by Subject|5
100579|NCT00763971|347182|P2|Overall Study|Withdrawal by Subject|5
100580|NCT00763971|347183|P1|Overall Study|Withdrawal by Subject|4
100581|NCT00763971|347181|P3|Overall Study|Protocol Violation|2
100582|NCT00763971|347182|P2|Overall Study|Protocol Violation|3
100583|NCT00763971|347183|P1|Overall Study|Protocol Violation|3
100584|NCT00763971|347181|P3|Overall Study|Adverse Event|4
100585|NCT00763971|347182|P2|Overall Study|Adverse Event|2
100586|NCT00763971|347183|P1|Overall Study|Adverse Event|5
100587|NCT00763958|347214|P2|Overall Study|Believed they were receiving placebo|5
100588|NCT00763958|347215|P1|Overall Study|Believed they were receiving placebo|0
100589|NCT00763958|347214|P2|Overall Study|Lost to Follow-up|2
100590|NCT00763958|347215|P1|Overall Study|Lost to Follow-up|10
100591|NCT00763958|347214|P2|Overall Study|did not meet final criteria|4
100592|NCT00763958|347215|P1|Overall Study|did not meet final criteria|4
100593|NCT00763815|347350|P2|Overall Study|Sponsor's Decision|1
100594|NCT00763815|347351|P1|Overall Study|Sponsor's Decision|0
100595|NCT00763815|347350|P2|Overall Study|Protocol Violation|5
100596|NCT00763815|347351|P1|Overall Study|Protocol Violation|2
100597|NCT00763815|347350|P2|Overall Study|Withdrawal by Subject|12
100598|NCT00763815|347351|P1|Overall Study|Withdrawal by Subject|7
100599|NCT00763815|347350|P2|Overall Study|Physician Decision|0
100600|NCT00763815|347351|P1|Overall Study|Physician Decision|1
100601|NCT00763815|347350|P2|Overall Study|Familial and Personal Reasons|16
100602|NCT00763815|347351|P1|Overall Study|Familial and Personal Reasons|9
100603|NCT00763815|347350|P2|Overall Study|Early Termination|0
100604|NCT00763815|347351|P1|Overall Study|Early Termination|1
100605|NCT00763815|347350|P2|Overall Study|Lost to Follow-up|4
100606|NCT00763815|347351|P1|Overall Study|Lost to Follow-up|2
100607|NCT00763815|347350|P2|Overall Study|Poor Compliance to Protocol|6
100608|NCT00763815|347351|P1|Overall Study|Poor Compliance to Protocol|6
100609|NCT00763815|347350|P2|Overall Study|Lack of Efficacy|11
100610|NCT00763815|347351|P1|Overall Study|Lack of Efficacy|10
100611|NCT00763815|347350|P2|Overall Study|Adverse Event|29
100612|NCT00763815|347351|P1|Overall Study|Adverse Event|14
100613|NCT00763698|347379|P1|Overall Study|Withdrawal by Subject|1
100614|NCT00763698|347379|P1|Overall Study|Death|4
100615|NCT00763698|347379|P1|Overall Study|Unsuccessful Implant|5
100616|NCT00763451|347396|P4|Overall Study|Study Site Reason|1
100617|NCT00763451|347397|P3|Overall Study|Study Site Reason|1
100618|NCT00763451|347398|P2|Overall Study|Study Site Reason|1
100619|NCT00763451|347399|P1|Overall Study|Study Site Reason|0
100620|NCT00763451|347396|P4|Overall Study|Randomized but not Treated|0
100621|NCT00763451|347397|P3|Overall Study|Randomized but not Treated|0
100622|NCT00763451|347398|P2|Overall Study|Randomized but not Treated|1
100623|NCT00763451|347399|P1|Overall Study|Randomized but not Treated|1
100624|NCT00763451|347396|P4|Overall Study|Familial and Personal Reasons|4
100625|NCT00763451|347397|P3|Overall Study|Familial and Personal Reasons|5
100626|NCT00763451|347398|P2|Overall Study|Familial and Personal Reasons|3
100627|NCT00763451|347399|P1|Overall Study|Familial and Personal Reasons|5
100628|NCT00763451|347396|P4|Overall Study|Poor Compliance to Protocol|2
100629|NCT00763451|347397|P3|Overall Study|Poor Compliance to Protocol|2
100630|NCT00763451|347398|P2|Overall Study|Poor Compliance to Protocol|1
100631|NCT00763451|347399|P1|Overall Study|Poor Compliance to Protocol|1
100632|NCT00763451|347396|P4|Overall Study|Protocol Violation|0
100633|NCT00763451|347397|P3|Overall Study|Protocol Violation|1
100634|NCT00763451|347398|P2|Overall Study|Protocol Violation|0
100635|NCT00763451|347399|P1|Overall Study|Protocol Violation|0
100636|NCT00763451|347396|P4|Overall Study|Withdrawal by Subject|7
100637|NCT00763451|347397|P3|Overall Study|Withdrawal by Subject|9
100638|NCT00763451|347398|P2|Overall Study|Withdrawal by Subject|6
100639|NCT00763451|347399|P1|Overall Study|Withdrawal by Subject|1
100640|NCT00763451|347396|P4|Overall Study|Lack of Efficacy|2
100641|NCT00763451|347397|P3|Overall Study|Lack of Efficacy|3
100642|NCT00763451|347398|P2|Overall Study|Lack of Efficacy|4
100643|NCT00763451|347399|P1|Overall Study|Lack of Efficacy|1
100644|NCT00763451|347396|P4|Overall Study|Adverse Event|14
100645|NCT00763451|347397|P3|Overall Study|Adverse Event|19
100646|NCT00763451|347398|P2|Overall Study|Adverse Event|6
100647|NCT00763451|347399|P1|Overall Study|Adverse Event|4
100648|NCT00763386|347433|P2|Overall Study|Study Prosthesis Removed|0
100649|NCT00763386|347434|P1|Overall Study|Study Prosthesis Removed|1
100650|NCT00763386|347433|P2|Overall Study|CRF missing|1
100651|NCT00763386|347434|P1|Overall Study|CRF missing|0
100652|NCT00763386|347433|P2|Overall Study|Withdrawal by Subject|1
100653|NCT00763386|347434|P1|Overall Study|Withdrawal by Subject|0
100654|NCT00763386|347433|P2|Overall Study|Lost to Follow-up|3
100655|NCT00763386|347434|P1|Overall Study|Lost to Follow-up|3
100656|NCT00763386|347433|P2|Overall Study|Death|2
100657|NCT00763386|347434|P1|Overall Study|Death|1
100658|NCT00763386|347433|P2|Overall Study|Adverse Event|33
100659|NCT00763386|347434|P1|Overall Study|Adverse Event|43
100660|NCT00763321|347467|P3|Double-blind Period|Not specified|3
100661|NCT00763321|347468|P2|Double-blind Period|Not specified|2
100662|NCT00763321|347469|P1|Double-blind Period|Not specified|0
100663|NCT00763321|347467|P3|Double-blind Period|Withdrawal by Subject|3
100664|NCT00763321|347468|P2|Double-blind Period|Withdrawal by Subject|2
100665|NCT00763321|347469|P1|Double-blind Period|Withdrawal by Subject|0
100666|NCT00763321|347467|P3|Double-blind Period|Lost to Follow-up|2
100667|NCT00763321|347468|P2|Double-blind Period|Lost to Follow-up|4
100668|NCT00763321|347469|P1|Double-blind Period|Lost to Follow-up|0
100669|NCT00763321|347467|P3|Double-blind Period|Adverse Event|4
100670|NCT00763321|347468|P2|Double-blind Period|Adverse Event|4
100671|NCT00763321|347469|P1|Double-blind Period|Adverse Event|0
100672|NCT00763321|347467|P3|Double-blind Period|Lack of Efficacy|17
100673|NCT00763321|347468|P2|Double-blind Period|Lack of Efficacy|9
100674|NCT00763321|347469|P1|Double-blind Period|Lack of Efficacy|0
100675|NCT00763321|347467|P3|Open-label Period|Not specified|0
100676|NCT00763321|347468|P2|Open-label Period|Not specified|0
100677|NCT00763321|347469|P1|Open-label Period|Not specified|4
100678|NCT00763321|347467|P3|Open-label Period|Lack of Efficacy|0
100679|NCT00763321|347468|P2|Open-label Period|Lack of Efficacy|0
100680|NCT00763321|347469|P1|Open-label Period|Lack of Efficacy|2
100681|NCT00763321|347467|P3|Open-label Period|Did not meet DB randomization criteria|0
100682|NCT00763321|347468|P2|Open-label Period|Did not meet DB randomization criteria|0
100683|NCT00763321|347469|P1|Open-label Period|Did not meet DB randomization criteria|5
100684|NCT00763321|347467|P3|Open-label Period|Subject noncompliant|0
100685|NCT00763321|347468|P2|Open-label Period|Subject noncompliant|0
100686|NCT00763321|347469|P1|Open-label Period|Subject noncompliant|7
100687|NCT00763321|347467|P3|Open-label Period|Withdrawal by Subject|0
100688|NCT00763321|347468|P2|Open-label Period|Withdrawal by Subject|0
100689|NCT00763321|347469|P1|Open-label Period|Withdrawal by Subject|7
100690|NCT00763321|347467|P3|Open-label Period|Lost to Follow-up|0
100691|NCT00763321|347468|P2|Open-label Period|Lost to Follow-up|0
100692|NCT00763321|347469|P1|Open-label Period|Lost to Follow-up|14
100693|NCT00763321|347467|P3|Open-label Period|Adverse Event|0
100694|NCT00763321|347468|P2|Open-label Period|Adverse Event|0
100695|NCT00763321|347469|P1|Open-label Period|Adverse Event|24
100696|NCT00763282|347480|P2|Overall Study|Lost to Follow-up|26
100697|NCT00763282|347481|P1|Overall Study|Lost to Follow-up|22
100698|NCT00763282|347480|P2|Overall Study|Death|3
100699|NCT00763282|347481|P1|Overall Study|Death|4
100700|NCT00763282|347480|P2|Overall Study|Withdrawal by Subject|5
100701|NCT00763282|347481|P1|Overall Study|Withdrawal by Subject|6
100702|NCT00763269|347497|P2|Overall Study|Lost to Follow-up|13
100703|NCT00763269|347498|P1|Overall Study|Lost to Follow-up|12
100704|NCT00763256|347512|P2|Overall Study|Didn't return for appointments|10
100705|NCT00763256|347513|P1|Overall Study|Didn't return for appointments|7
100706|NCT00763139|347527|P2|Overall Study|med change not allowed by protocol|0
100707|NCT00763139|347528|P1|Overall Study|med change not allowed by protocol|1
100708|NCT00763139|347527|P2|Overall Study|Withdrawal by Subject|1
100709|NCT00763139|347528|P1|Overall Study|Withdrawal by Subject|0
100710|NCT00763139|347527|P2|Overall Study|Adverse Event|2
100711|NCT00763139|347528|P1|Overall Study|Adverse Event|4
100712|NCT00762996|347590|P4|Period One|Withdrawal by Subject|0
100713|NCT00762996|347591|P3|Period One|Withdrawal by Subject|1
100714|NCT00762996|347592|P2|Period One|Withdrawal by Subject|0
100715|NCT00762996|347593|P1|Period One|Withdrawal by Subject|0
100716|NCT00762996|347590|P4|Period One|Adverse Event|0
100717|NCT00762996|347591|P3|Period One|Adverse Event|1
100718|NCT00762996|347592|P2|Period One|Adverse Event|0
100719|NCT00762996|347593|P1|Period One|Adverse Event|0
100720|NCT00762996|347590|P4|Period One|ineligible|1
100721|NCT00762996|347591|P3|Period One|ineligible|1
100722|NCT00762996|347592|P2|Period One|ineligible|0
100723|NCT00762996|347593|P1|Period One|ineligible|0
100724|NCT00762996|347590|P4|Period One|Protocol Violation|0
100725|NCT00762996|347591|P3|Period One|Protocol Violation|1
100726|NCT00762996|347592|P2|Period One|Protocol Violation|0
100727|NCT00762996|347593|P1|Period One|Protocol Violation|0
100728|NCT00762970|347606|P3|Overall Study|Difficulty of handling lens|0
100729|NCT00762970|347607|P2|Overall Study|Difficulty of handling lens|2
100730|NCT00762970|347608|P1|Overall Study|Difficulty of handling lens|1
100731|NCT00762970|347606|P3|Overall Study|Lost to Follow-up|0
100732|NCT00762970|347607|P2|Overall Study|Lost to Follow-up|2
100733|NCT00762970|347608|P1|Overall Study|Lost to Follow-up|1
100734|NCT00762970|347606|P3|Overall Study|Protocol Violation|1
100735|NCT00762970|347607|P2|Overall Study|Protocol Violation|1
100736|NCT00762970|347608|P1|Overall Study|Protocol Violation|3
100737|NCT00762970|347606|P3|Overall Study|Withdrawal by Subject|0
100738|NCT00762970|347607|P2|Overall Study|Withdrawal by Subject|4
100739|NCT00762970|347608|P1|Overall Study|Withdrawal by Subject|7
100740|NCT00762892|347621|P2|Overall Study|Incarceration|0
100741|NCT00762892|347622|P1|Overall Study|Incarceration|1
100742|NCT00762892|347621|P2|Overall Study|Pregnancy|0
100743|NCT00762892|347622|P1|Overall Study|Pregnancy|1
100744|NCT00762892|347621|P2|Overall Study|Death|0
100745|NCT00762892|347622|P1|Overall Study|Death|1
100746|NCT00762892|347621|P2|Overall Study|Withdrawal by Subject|1
100747|NCT00762892|347622|P1|Overall Study|Withdrawal by Subject|0
100748|NCT00762892|347621|P2|Overall Study|Lost to Follow-up|5
100749|NCT00762892|347622|P1|Overall Study|Lost to Follow-up|2
100750|NCT00762788|347651|P6|Overall Study|Lost to Follow-up|21
100751|NCT00762788|347652|P5|Overall Study|Lost to Follow-up|13
100752|NCT00762788|347653|P4|Overall Study|Lost to Follow-up|26
100753|NCT00762788|347654|P3|Overall Study|Lost to Follow-up|21
100754|NCT00762788|347655|P2|Overall Study|Lost to Follow-up|37
100755|NCT00762788|347656|P1|Overall Study|Lost to Follow-up|26
100756|NCT00762762|347678|P2|Overall Study|Did not report for appointments|10
100757|NCT00762762|347679|P1|Overall Study|Did not report for appointments|8
100758|NCT00762723|347696|P3|Overall Study|Study Terminated slow enrollement|3
100833|NCT00762411|348047|P1|Delayed Start|Caregiver Decision|1
100759|NCT00762723|347697|P2|Overall Study|Study Terminated slow enrollement|5
100760|NCT00762723|347698|P1|Overall Study|Study Terminated slow enrollement|5
100761|NCT00762606|347862|P2|Overall Study|Lost to Follow-up|13
100762|NCT00762606|347863|P1|Overall Study|Lost to Follow-up|18
100763|NCT00762502|347908|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
100764|NCT00762502|347909|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
100765|NCT00762502|347910|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
100766|NCT00762502|347908|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
100767|NCT00762502|347909|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
100768|NCT00762502|347910|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
100769|NCT00762502|347908|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
100770|NCT00762502|347909|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
100771|NCT00762502|347910|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
100772|NCT00762476|347924|P2|Overall Study|Seasonal allergies|0
100773|NCT00762476|347925|P1|Overall Study|Seasonal allergies|1
100774|NCT00762476|347924|P2|Overall Study|non-compliance with study visits|2
100775|NCT00762476|347925|P1|Overall Study|non-compliance with study visits|0
100776|NCT00762476|347924|P2|Overall Study|antibiotic use|1
100777|NCT00762476|347925|P1|Overall Study|antibiotic use|0
100778|NCT00762476|347924|P2|Overall Study|Withdrawal by Subject|12
100779|NCT00762476|347925|P1|Overall Study|Withdrawal by Subject|6
100780|NCT00762476|347924|P2|Overall Study|Physician Decision|14
100781|NCT00762476|347925|P1|Overall Study|Physician Decision|2
100782|NCT00762476|347924|P2|Overall Study|Protocol Violation|6
100783|NCT00762476|347925|P1|Overall Study|Protocol Violation|5
100784|NCT00762476|347924|P2|Overall Study|Lost to Follow-up|0
100785|NCT00762476|347925|P1|Overall Study|Lost to Follow-up|2
100786|NCT00762476|347924|P2|Overall Study|Adverse Event|1
100787|NCT00762476|347925|P1|Overall Study|Adverse Event|7
100788|NCT00762463|347937|P4|Extension Phase (Week 6 to Week 12)|Not specified|1
100789|NCT00762463|347938|P3|Extension Phase (Week 6 to Week 12)|Not specified|0
100790|NCT00762463|347939|P2|Extension Phase (Week 6 to Week 12)|Not specified|0
100791|NCT00762463|347940|P1|Extension Phase (Week 6 to Week 12)|Not specified|0
100792|NCT00762463|347937|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
100793|NCT00762463|347938|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
100794|NCT00762463|347939|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
100795|NCT00762463|347940|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
100796|NCT00762463|347937|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
100797|NCT00762463|347938|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
100798|NCT00762463|347939|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
100799|NCT00762463|347940|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
100800|NCT00762463|347937|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
100801|NCT00762463|347938|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
100802|NCT00762463|347939|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
100803|NCT00762463|347940|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
100804|NCT00762463|347937|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
100805|NCT00762463|347938|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
100806|NCT00762463|347939|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
100807|NCT00762463|347940|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
100808|NCT00762463|347937|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
100809|NCT00762463|347938|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
100810|NCT00762463|347939|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
100811|NCT00762463|347940|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
100812|NCT00762463|347937|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
100813|NCT00762463|347938|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
100814|NCT00762463|347939|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
100815|NCT00762463|347940|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
100816|NCT00762463|347937|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
100817|NCT00762463|347938|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
100818|NCT00762463|347939|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
100819|NCT00762463|347940|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
100820|NCT00762411|348046|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
100821|NCT00762411|348047|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
100822|NCT00762411|348046|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
100823|NCT00762411|348047|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
100824|NCT00762411|348046|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
100825|NCT00762411|348047|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
100826|NCT00762411|348046|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
100827|NCT00762411|348047|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
100828|NCT00762411|348046|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
100829|NCT00762411|348047|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
100830|NCT00762411|348046|P2|Safety Follow Up (SFU)-Optional|Death|8
100831|NCT00762411|348047|P1|Safety Follow Up (SFU)-Optional|Death|1
100832|NCT00762411|348046|P2|Delayed Start|Caregiver Decision|1
100834|NCT00762411|348046|P2|Delayed Start|Sponsor Decision|20
100835|NCT00762411|348047|P1|Delayed Start|Sponsor Decision|16
100836|NCT00762411|348046|P2|Delayed Start|Protocol Violation|1
100837|NCT00762411|348047|P1|Delayed Start|Protocol Violation|0
100838|NCT00762411|348046|P2|Delayed Start|Adverse Event|4
100839|NCT00762411|348047|P1|Delayed Start|Adverse Event|0
100840|NCT00762411|348046|P2|Initial Treatment|Entry Criteria Exclusion|1
100841|NCT00762411|348047|P1|Initial Treatment|Entry Criteria Exclusion|0
100842|NCT00762411|348046|P2|Initial Treatment|Abnormal Lab/ECG Result|4
100843|NCT00762411|348047|P1|Initial Treatment|Abnormal Lab/ECG Result|6
100844|NCT00762411|348046|P2|Initial Treatment|Caregiver Decision|16
100845|NCT00762411|348047|P1|Initial Treatment|Caregiver Decision|21
100846|NCT00762411|348046|P2|Initial Treatment|Lost to Follow-up|0
100847|NCT00762411|348047|P1|Initial Treatment|Lost to Follow-up|5
100848|NCT00762411|348046|P2|Initial Treatment|Sponsor Decision|401
100849|NCT00762411|348047|P1|Initial Treatment|Sponsor Decision|293
100850|NCT00762411|348046|P2|Initial Treatment|Physician Decision|0
100851|NCT00762411|348047|P1|Initial Treatment|Physician Decision|1
100852|NCT00762411|348046|P2|Initial Treatment|Withdrawal by Subject|52
100853|NCT00762411|348047|P1|Initial Treatment|Withdrawal by Subject|65
100854|NCT00762411|348046|P2|Initial Treatment|Protocol Violation|1
100855|NCT00762411|348047|P1|Initial Treatment|Protocol Violation|4
100856|NCT00762411|348046|P2|Initial Treatment|Adverse Event|40
100857|NCT00762411|348047|P1|Initial Treatment|Adverse Event|132
100858|NCT00762411|348046|P2|Initial Treatment|Death|6
100859|NCT00762411|348047|P1|Initial Treatment|Death|7
100860|NCT00762385|348111|P2|Second Intervention|Protocol Violation|3
100861|NCT00762385|348112|P1|Second Intervention|Protocol Violation|3
100862|NCT00762385|348111|P2|First Intervention|Protocol Violation|1
100863|NCT00762385|348112|P1|First Intervention|Protocol Violation|0
100864|NCT00762385|348111|P2|First Intervention|Ineligible|0
100865|NCT00762385|348112|P1|First Intervention|Ineligible|1
100866|NCT00762385|348111|P2|First Intervention|Lost to Follow-up|2
100867|NCT00762385|348112|P1|First Intervention|Lost to Follow-up|0
100868|NCT00762385|348111|P2|First Intervention|Lens Issue|1
100869|NCT00762385|348112|P1|First Intervention|Lens Issue|1
100870|NCT00762359|348124|P2|Overall Study|Withdrew consent|0
100871|NCT00762359|348125|P1|Overall Study|Withdrew consent|1
100872|NCT00762359|348124|P2|Overall Study|Removal|1
100873|NCT00762359|348125|P1|Overall Study|Removal|0
100874|NCT00762359|348124|P2|Overall Study|Physician Decision|3
100875|NCT00762359|348125|P1|Overall Study|Physician Decision|2
100876|NCT00762359|348124|P2|Overall Study|Institution closed|3
100877|NCT00762359|348125|P1|Overall Study|Institution closed|2
100878|NCT00762359|348124|P2|Overall Study|Lack of Efficacy|4
100879|NCT00762359|348125|P1|Overall Study|Lack of Efficacy|0
100880|NCT00762359|348124|P2|Overall Study|Withdrawal by Subject|10
100881|NCT00762359|348125|P1|Overall Study|Withdrawal by Subject|13
100882|NCT00762359|348124|P2|Overall Study|Protocol Violation|13
100883|NCT00762359|348125|P1|Overall Study|Protocol Violation|21
100884|NCT00762359|348124|P2|Overall Study|Adverse Event|23
100885|NCT00762359|348125|P1|Overall Study|Adverse Event|20
100886|NCT00762268|348242|P2|Overall Study|Protocol Violation|2
100887|NCT00762268|348243|P1|Overall Study|Protocol Violation|1
100888|NCT00762229|348251|P2|Overall Study|did not recveive intervention|1
100889|NCT00762229|348252|P1|Overall Study|did not recveive intervention|0
100890|NCT00762229|348251|P2|Overall Study|Lost to Follow-up|1
100891|NCT00762229|348252|P1|Overall Study|Lost to Follow-up|1
100892|NCT00762164|348349|P2|Overall Study|Withdrawal by Subject|1
100893|NCT00762164|348350|P1|Overall Study|Withdrawal by Subject|0
100894|NCT00762164|348349|P2|Overall Study|Discontinued medication|0
100895|NCT00762164|348350|P1|Overall Study|Discontinued medication|2
100896|NCT00762164|348349|P2|Overall Study|Lost to Follow-up|1
100897|NCT00762164|348350|P1|Overall Study|Lost to Follow-up|1
100898|NCT00762086|348360|P2|Overall Study|Ineligible to participate in the study|0
100899|NCT00762086|348361|P1|Overall Study|Ineligible to participate in the study|1
100900|NCT00762086|348360|P2|Overall Study|Withdrawal by Subject|2
100901|NCT00762086|348361|P1|Overall Study|Withdrawal by Subject|2
100902|NCT00762086|348360|P2|Overall Study|Non compliance|0
100903|NCT00762086|348361|P1|Overall Study|Non compliance|1
100904|NCT00762086|348360|P2|Overall Study|Lost to Follow-up|2
100905|NCT00762086|348361|P1|Overall Study|Lost to Follow-up|0
100906|NCT00762086|348360|P2|Overall Study|Adverse Event|0
100907|NCT00762086|348361|P1|Overall Study|Adverse Event|2
100908|NCT00762073|348371|P4|Overall Study|Not on treatment for >/= 77 days|0
100909|NCT00762073|348372|P3|Overall Study|Not on treatment for >/= 77 days|0
100910|NCT00762073|348373|P2|Overall Study|Not on treatment for >/= 77 days|0
100911|NCT00762073|348374|P1|Overall Study|Not on treatment for >/= 77 days|1
100912|NCT00762073|348371|P4|Overall Study|Withdrawal by Subject|1
100913|NCT00762073|348372|P3|Overall Study|Withdrawal by Subject|1
100914|NCT00762073|348373|P2|Overall Study|Withdrawal by Subject|2
100915|NCT00762073|348374|P1|Overall Study|Withdrawal by Subject|1
100916|NCT00762073|348371|P4|Overall Study|Significant Subject Noncompliance|1
100917|NCT00762073|348372|P3|Overall Study|Significant Subject Noncompliance|0
100918|NCT00762073|348373|P2|Overall Study|Significant Subject Noncompliance|1
100919|NCT00762073|348374|P1|Overall Study|Significant Subject Noncompliance|0
100920|NCT00762073|348371|P4|Overall Study|Adverse Event|1
100921|NCT00762073|348372|P3|Overall Study|Adverse Event|1
100922|NCT00762073|348373|P2|Overall Study|Adverse Event|0
100923|NCT00762073|348374|P1|Overall Study|Adverse Event|1
100924|NCT00762073|348371|P4|Overall Study|Lack of Efficacy|0
100925|NCT00762073|348372|P3|Overall Study|Lack of Efficacy|0
100926|NCT00762073|348373|P2|Overall Study|Lack of Efficacy|1
100927|NCT00762073|348374|P1|Overall Study|Lack of Efficacy|1
100928|NCT00762034|348438|P2|Maintenance Period|Other|1
100929|NCT00762034|348439|P1|Maintenance Period|Other|1
100930|NCT00762034|348438|P2|Maintenance Period|Death due to study disease|3
100931|NCT00762034|348439|P1|Maintenance Period|Death due to study disease|3
100932|NCT00762034|348438|P2|Maintenance Period|Death not due to study disease|5
100933|NCT00762034|348439|P1|Maintenance Period|Death not due to study disease|2
100934|NCT00762034|348438|P2|Maintenance Period|Withdrawal by Subject|14
100935|NCT00762034|348439|P1|Maintenance Period|Withdrawal by Subject|34
100936|NCT00762034|348438|P2|Maintenance Period|Physician Decision|20
100937|NCT00762034|348439|P1|Maintenance Period|Physician Decision|25
100938|NCT00762034|348438|P2|Maintenance Period|Progressive Disease|224
100939|NCT00762034|348439|P1|Maintenance Period|Progressive Disease|186
100940|NCT00762034|348438|P2|Maintenance Period|Adverse Event|26
100941|NCT00762034|348439|P1|Maintenance Period|Adverse Event|42
100942|NCT00762034|348438|P2|Maintenance Period|Entry Criterion Not Met|2
100943|NCT00762034|348439|P1|Maintenance Period|Entry Criterion Not Met|0
100944|NCT00762034|348438|P2|Maintenance Period|Protocol Violation|3
100945|NCT00762034|348439|P1|Maintenance Period|Protocol Violation|1
100946|NCT00762034|348438|P2|Induction Period|Deaths Due to Study Disease|9
100947|NCT00762034|348439|P1|Induction Period|Deaths Due to Study Disease|9
100948|NCT00762034|348438|P2|Induction Period|Deaths Not Due to Study Disease|14
100949|NCT00762034|348439|P1|Induction Period|Deaths Not Due to Study Disease|19
100950|NCT00762034|348438|P2|Induction Period|Withdrawal by Subject|19
100951|NCT00762034|348439|P1|Induction Period|Withdrawal by Subject|15
100952|NCT00762034|348438|P2|Induction Period|Physician Decision|20
100953|NCT00762034|348439|P1|Induction Period|Physician Decision|21
100954|NCT00762034|348438|P2|Induction Period|Progressive Disease|55
100955|NCT00762034|348439|P1|Induction Period|Progressive Disease|73
100956|NCT00762034|348438|P2|Induction Period|Lost to Follow-up|1
100957|NCT00762034|348439|P1|Induction Period|Lost to Follow-up|1
100958|NCT00762034|348438|P2|Induction Period|Adverse Event|38
100959|NCT00762034|348439|P1|Induction Period|Adverse Event|27
100960|NCT00762034|348438|P2|Induction Period|Entry Criterion Not Met|11
100961|NCT00762034|348439|P1|Induction Period|Entry Criterion Not Met|12
100962|NCT00762034|348438|P2|Induction Period|Protocol Violation|2
100963|NCT00762034|348439|P1|Induction Period|Protocol Violation|1
100964|NCT00761969|348511|P2|Overall Study|Lost to Follow-up|93
100965|NCT00761969|348512|P1|Overall Study|Lost to Follow-up|88
100966|NCT00761969|348511|P2|Overall Study|Death|47
100967|NCT00761969|348512|P1|Overall Study|Death|112
100968|NCT00761956|348522|P2|Overall Study|Adverse Event|34
100969|NCT00761956|348523|P1|Overall Study|Adverse Event|26
100970|NCT00761956|348522|P2|Overall Study|Death|1
100971|NCT00761956|348523|P1|Overall Study|Death|0
100972|NCT00761956|348522|P2|Overall Study|Withdrawal by Subject|8
100973|NCT00761956|348523|P1|Overall Study|Withdrawal by Subject|3
100974|NCT00761956|348522|P2|Overall Study|Lost to Follow-up|11
100975|NCT00761956|348523|P1|Overall Study|Lost to Follow-up|6
100976|NCT00761865|348552|P2|Overall Study|Lost to Follow-up|7
100977|NCT00761865|348553|P1|Overall Study|Lost to Follow-up|8
100978|NCT00761761|348563|P2|Overall Study|Withdrawal by Subject|0
100979|NCT00761761|348564|P1|Overall Study|Withdrawal by Subject|3
100980|NCT00761761|348563|P2|Overall Study|Lost to Follow-up|1
100981|NCT00761761|348564|P1|Overall Study|Lost to Follow-up|3
100982|NCT00761748|348576|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
100983|NCT00761748|348577|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
100984|NCT00761748|348576|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
100985|NCT00761748|348577|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
100986|NCT00761735|348583|P1|Overall Study|Administrative|1
100987|NCT00761735|348583|P1|Overall Study|Non-compliance with protocol|1
100988|NCT00761735|348583|P1|Overall Study|Withdrawal by Subject|6
100989|NCT00761735|348583|P1|Overall Study|Lost to Follow-up|6
100990|NCT00761631|348599|P6|Overall Study|Unspecified|1
100991|NCT00761631|348600|P5|Overall Study|Unspecified|1
100992|NCT00761631|348601|P4|Overall Study|Unspecified|0
100993|NCT00761631|348602|P3|Overall Study|Unspecified|0
100994|NCT00761631|348603|P2|Overall Study|Unspecified|0
100995|NCT00761631|348604|P1|Overall Study|Unspecified|0
100996|NCT00761631|348599|P6|Overall Study|Physician Decision|0
100997|NCT00761631|348600|P5|Overall Study|Physician Decision|0
100998|NCT00761631|348601|P4|Overall Study|Physician Decision|0
100999|NCT00761631|348602|P3|Overall Study|Physician Decision|0
101000|NCT00761631|348603|P2|Overall Study|Physician Decision|0
101001|NCT00761631|348604|P1|Overall Study|Physician Decision|1
101002|NCT00761631|348599|P6|Overall Study|Failed to return|2
101003|NCT00761631|348600|P5|Overall Study|Failed to return|5
101004|NCT00761631|348601|P4|Overall Study|Failed to return|1
101005|NCT00761631|348602|P3|Overall Study|Failed to return|1
101006|NCT00761631|348603|P2|Overall Study|Failed to return|0
101007|NCT00761631|348604|P1|Overall Study|Failed to return|1
101008|NCT00761631|348599|P6|Overall Study|Randomized, not treated|0
101009|NCT00761631|348600|P5|Overall Study|Randomized, not treated|0
101010|NCT00761631|348601|P4|Overall Study|Randomized, not treated|0
101011|NCT00761631|348602|P3|Overall Study|Randomized, not treated|0
101012|NCT00761631|348603|P2|Overall Study|Randomized, not treated|0
101013|NCT00761631|348604|P1|Overall Study|Randomized, not treated|1
101014|NCT00761631|348599|P6|Overall Study|Protocol Violation|1
101015|NCT00761631|348600|P5|Overall Study|Protocol Violation|5
101016|NCT00761631|348601|P4|Overall Study|Protocol Violation|1
101017|NCT00761631|348602|P3|Overall Study|Protocol Violation|0
101018|NCT00761631|348603|P2|Overall Study|Protocol Violation|0
101019|NCT00761631|348604|P1|Overall Study|Protocol Violation|2
101020|NCT00761631|348599|P6|Overall Study|Lost to Follow-up|1
101021|NCT00761631|348600|P5|Overall Study|Lost to Follow-up|6
101022|NCT00761631|348601|P4|Overall Study|Lost to Follow-up|1
101023|NCT00761631|348602|P3|Overall Study|Lost to Follow-up|7
101024|NCT00761631|348603|P2|Overall Study|Lost to Follow-up|4
101025|NCT00761631|348604|P1|Overall Study|Lost to Follow-up|2
101026|NCT00761631|348599|P6|Overall Study|Parent/legal guardian request|0
101027|NCT00761631|348600|P5|Overall Study|Parent/legal guardian request|5
101028|NCT00761631|348601|P4|Overall Study|Parent/legal guardian request|0
101029|NCT00761631|348602|P3|Overall Study|Parent/legal guardian request|8
101030|NCT00761631|348603|P2|Overall Study|Parent/legal guardian request|3
101031|NCT00761631|348604|P1|Overall Study|Parent/legal guardian request|8
101032|NCT00761605|348639|P1|Overall Study|Unspecified|21
101033|NCT00761605|348639|P1|Overall Study|Withdrawal by Subject|37
101034|NCT00761605|348639|P1|Overall Study|Lost to Follow-up|29
101035|NCT00761605|348639|P1|Overall Study|Lack of Efficacy|26
101036|NCT00761605|348639|P1|Overall Study|Death|2
101037|NCT00761605|348639|P1|Overall Study|Adverse Event|26
101038|NCT00761579|348683|P1|Overall Study|Intake of prohibited concomitant drug|1
101039|NCT00761579|348683|P1|Overall Study|Lost survey form|1
101040|NCT00761579|348683|P1|Overall Study|Aggravation of symptoms by changing drug|1
101041|NCT00761579|348683|P1|Overall Study|Aggravation of depression|1
101042|NCT00761579|348683|P1|Overall Study|Drug overdose|1
101043|NCT00761579|348683|P1|Overall Study|Protocol deviation|1
101044|NCT00761579|348683|P1|Overall Study|Lack of compliance|2
101045|NCT00761579|348683|P1|Overall Study|Withdrawal by Subject|34
101046|NCT00761579|348683|P1|Overall Study|Pregnancy|1
101047|NCT00761579|348683|P1|Overall Study|Lost to Follow-up|16
101048|NCT00761579|348683|P1|Overall Study|Lack of Efficacy|21
101049|NCT00761579|348683|P1|Overall Study|Death|2
101050|NCT00761579|348683|P1|Overall Study|Adverse Event|10
101051|NCT00761527|348716|P1|Overall Study|Unknown reason|2
101052|NCT00761527|348716|P1|Overall Study|Lost to Follow-up|9
101053|NCT00761527|348716|P1|Overall Study|Poor Compliance|8
101054|NCT00761527|348716|P1|Overall Study|Adverse Event|3
101055|NCT00761514|348723|P1|Overall Study|Unable to pay for medications|1
101056|NCT00761514|348723|P1|Overall Study|Problem complying with study visit|1
101057|NCT00761514|348723|P1|Overall Study|Health insurance didn't cover study drug|1
101058|NCT00761514|348723|P1|Overall Study|Lost to Follow-up|1
101059|NCT00761514|348723|P1|Overall Study|Withdrawal by Subject|2
101060|NCT00761514|348723|P1|Overall Study|Adverse Event|1
101061|NCT00761462|348730|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
101062|NCT00761462|348731|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
101063|NCT00761462|348730|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
101064|NCT00761462|348731|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
101065|NCT00761462|348730|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
101066|NCT00761462|348731|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
101067|NCT00761462|348730|P2|Treatment|Subjects never received study medication|12
101068|NCT00761462|348731|P1|Treatment|Subjects never received study medication|23
101069|NCT00761319|348745|P2|Overall Study|Missing|0
101070|NCT00761319|348746|P1|Overall Study|Missing|1
101071|NCT00761319|348745|P2|Overall Study|Nonspecified|2
101072|NCT00761319|348746|P1|Overall Study|Nonspecified|2
101073|NCT00761319|348745|P2|Overall Study|Lost to Follow-up|1
101074|NCT00761319|348746|P1|Overall Study|Lost to Follow-up|1
101075|NCT00761319|348745|P2|Overall Study|Noncompliance|3
101076|NCT00761319|348746|P1|Overall Study|Noncompliance|4
101077|NCT00761319|348745|P2|Overall Study|Withdrawal by Subject|7
101078|NCT00761319|348746|P1|Overall Study|Withdrawal by Subject|8
101079|NCT00761319|348745|P2|Overall Study|Adverse Event|7
101080|NCT00761319|348746|P1|Overall Study|Adverse Event|11
101081|NCT00761319|348745|P2|Overall Study|Protocol Violation|14
101082|NCT00761319|348746|P1|Overall Study|Protocol Violation|21
101083|NCT00761306|348754|P1|Overall Study|Administrative or Other Reasons|5
101084|NCT00761306|348754|P1|Overall Study|Lost to Follow-up|1
101085|NCT00761306|348754|P1|Overall Study|Withdrawal of Consent|3
101086|NCT00761306|348754|P1|Overall Study|Protocol Violation|2
101087|NCT00761306|348754|P1|Overall Study|Lack of Efficacy|4
101088|NCT00761306|348754|P1|Overall Study|Adverse Event|5
101089|NCT00761280|348765|P2|First Dose to End of Study|Lost to Follow-up|1
101090|NCT00761280|348766|P1|First Dose to End of Study|Lost to Follow-up|0
101091|NCT00761280|348765|P2|First Dose to End of Study|Death|0
101092|NCT00761280|348766|P1|First Dose to End of Study|Death|1
101093|NCT00761280|348765|P2|First Dose to End of Study|Sponsor decision|2
101094|NCT00761280|348766|P1|First Dose to End of Study|Sponsor decision|1
101095|NCT00761280|348765|P2|First Dose to End of Study|Progressive disease|3
101096|NCT00761280|348766|P1|First Dose to End of Study|Progressive disease|5
101097|NCT00761280|348765|P2|First Dose to End of Study|End of trial|5
101098|NCT00761280|348766|P1|First Dose to End of Study|End of trial|5
101099|NCT00761280|348765|P2|Randomization to First Dose|Other|0
101100|NCT00761280|348766|P1|Randomization to First Dose|Other|1
101101|NCT00761280|348765|P2|Randomization to First Dose|Sponsor decision|0
101102|NCT00761280|348766|P1|Randomization to First Dose|Sponsor decision|1
101103|NCT00761280|348765|P2|Randomization to First Dose|Withdrawal by Subject|2
101104|NCT00761280|348766|P1|Randomization to First Dose|Withdrawal by Subject|0
101105|NCT00761215|348797|P3|Overall Study|Bacteremia|0
101106|NCT00761215|348798|P2|Overall Study|Bacteremia|0
101107|NCT00761215|348799|P1|Overall Study|Bacteremia|1
101108|NCT00761215|348797|P3|Overall Study|Withdrawal by Subject|0
101109|NCT00761215|348798|P2|Overall Study|Withdrawal by Subject|0
101110|NCT00761215|348799|P1|Overall Study|Withdrawal by Subject|1
101111|NCT00761215|348797|P3|Overall Study|Lost to Follow-up|6
101112|NCT00761215|348798|P2|Overall Study|Lost to Follow-up|3
101113|NCT00761215|348799|P1|Overall Study|Lost to Follow-up|6
101114|NCT00761215|348797|P3|Overall Study|Randomized but didn't receive drug|2
101115|NCT00761215|348798|P2|Overall Study|Randomized but didn't receive drug|1
101116|NCT00761215|348799|P1|Overall Study|Randomized but didn't receive drug|1
101117|NCT00761189|348841|P1|Overall Study|Unspecified|13
101118|NCT00761189|348841|P1|Overall Study|Withdrawal by Subject|49
101119|NCT00761189|348841|P1|Overall Study|Lost to Follow-up|36
101120|NCT00761189|348841|P1|Overall Study|Lack of Efficacy|45
101121|NCT00761189|348841|P1|Overall Study|Adverse Event|42
101122|NCT00761176|348858|P2|Overall Study|Withdrawal by Subject|1
101123|NCT00761176|348859|P1|Overall Study|Withdrawal by Subject|1
101124|NCT00761176|348858|P2|Overall Study|Death|0
101125|NCT00761176|348859|P1|Overall Study|Death|1
101126|NCT00761150|348868|P3|Double-blind Period|Not specified|3
101127|NCT00761150|348869|P2|Double-blind Period|Not specified|3
101128|NCT00761150|348870|P1|Double-blind Period|Not specified|0
101129|NCT00761150|348868|P3|Double-blind Period|Noncompliance|0
101130|NCT00761150|348869|P2|Double-blind Period|Noncompliance|1
101131|NCT00761150|348870|P1|Double-blind Period|Noncompliance|0
101132|NCT00761150|348868|P3|Double-blind Period|Did not meet DB randomization criteria|1
101133|NCT00761150|348869|P2|Double-blind Period|Did not meet DB randomization criteria|0
101134|NCT00761150|348870|P1|Double-blind Period|Did not meet DB randomization criteria|0
101135|NCT00761150|348868|P3|Double-blind Period|Lost to Follow-up|1
101136|NCT00761150|348869|P2|Double-blind Period|Lost to Follow-up|2
101137|NCT00761150|348870|P1|Double-blind Period|Lost to Follow-up|0
101138|NCT00761150|348868|P3|Double-blind Period|Withdrawal by Subject|2
101139|NCT00761150|348869|P2|Double-blind Period|Withdrawal by Subject|3
101140|NCT00761150|348870|P1|Double-blind Period|Withdrawal by Subject|0
101141|NCT00761150|348868|P3|Double-blind Period|Adverse Event|3
101142|NCT00761150|348869|P2|Double-blind Period|Adverse Event|3
101143|NCT00761150|348870|P1|Double-blind Period|Adverse Event|0
101144|NCT00761150|348868|P3|Double-blind Period|Lack of Efficacy|19
101145|NCT00761150|348869|P2|Double-blind Period|Lack of Efficacy|2
101146|NCT00761150|348870|P1|Double-blind Period|Lack of Efficacy|0
101147|NCT00761150|348868|P3|Open-label Period|Not specified|0
101148|NCT00761150|348869|P2|Open-label Period|Not specified|0
101149|NCT00761150|348870|P1|Open-label Period|Not specified|5
101150|NCT00761150|348868|P3|Open-label Period|Noncompliance|0
101151|NCT00761150|348869|P2|Open-label Period|Noncompliance|0
101152|NCT00761150|348870|P1|Open-label Period|Noncompliance|2
101153|NCT00761150|348868|P3|Open-label Period|Withdrawal by Subject|0
101154|NCT00761150|348869|P2|Open-label Period|Withdrawal by Subject|0
101155|NCT00761150|348870|P1|Open-label Period|Withdrawal by Subject|5
101156|NCT00761150|348868|P3|Open-label Period|Lack of Efficacy|0
101157|NCT00761150|348869|P2|Open-label Period|Lack of Efficacy|0
101158|NCT00761150|348870|P1|Open-label Period|Lack of Efficacy|4
101159|NCT00761150|348868|P3|Open-label Period|Lost to Follow-up|0
101160|NCT00761150|348869|P2|Open-label Period|Lost to Follow-up|0
101161|NCT00761150|348870|P1|Open-label Period|Lost to Follow-up|7
101162|NCT00761150|348868|P3|Open-label Period|Did not meet DB randomization criteria|0
101163|NCT00761150|348869|P2|Open-label Period|Did not meet DB randomization criteria|0
101164|NCT00761150|348870|P1|Open-label Period|Did not meet DB randomization criteria|11
101165|NCT00761150|348868|P3|Open-label Period|Adverse Event|0
101166|NCT00761150|348869|P2|Open-label Period|Adverse Event|0
101167|NCT00761150|348870|P1|Open-label Period|Adverse Event|36
101168|NCT00760266|348892|P2|Overall Study|Administrative Problems|1
101169|NCT00760266|348893|P1|Overall Study|Administrative Problems|0
101170|NCT00760266|348892|P2|Overall Study|Lost to Follow-up|1
101171|NCT00760266|348893|P1|Overall Study|Lost to Follow-up|2
101172|NCT00760266|348892|P2|Overall Study|Patient withdrew consent|3
101173|NCT00760266|348893|P1|Overall Study|Patient withdrew consent|3
101174|NCT00760266|348892|P2|Overall Study|Protocol deviation|4
101175|NCT00760266|348893|P1|Overall Study|Protocol deviation|2
101176|NCT00760266|348892|P2|Overall Study|Lack of Efficacy|2
101177|NCT00760266|348893|P1|Overall Study|Lack of Efficacy|2
101178|NCT00760266|348892|P2|Overall Study|Abnormal test procedure result(s)|0
101179|NCT00760266|348893|P1|Overall Study|Abnormal test procedure result(s)|1
101180|NCT00760266|348892|P2|Overall Study|Abnormal laboratory value(s)|0
101181|NCT00760266|348893|P1|Overall Study|Abnormal laboratory value(s)|1
101182|NCT00760266|348892|P2|Overall Study|Adverse Event|7
101183|NCT00760266|348893|P1|Overall Study|Adverse Event|13
101184|NCT00760214|348910|P3|Overall Study|Other|6
101185|NCT00760214|348911|P2|Overall Study|Other|4
101186|NCT00760214|348912|P1|Overall Study|Other|3
101187|NCT00760214|348910|P3|Overall Study|Physician Decision|1
101188|NCT00760214|348911|P2|Overall Study|Physician Decision|1
101189|NCT00760214|348912|P1|Overall Study|Physician Decision|1
101190|NCT00760214|348910|P3|Overall Study|Pregnancy|1
101191|NCT00760214|348911|P2|Overall Study|Pregnancy|0
101192|NCT00760214|348912|P1|Overall Study|Pregnancy|0
101193|NCT00760214|348910|P3|Overall Study|Lack of Efficacy|4
101194|NCT00760214|348911|P2|Overall Study|Lack of Efficacy|2
101195|NCT00760214|348912|P1|Overall Study|Lack of Efficacy|3
101196|NCT00760214|348910|P3|Overall Study|Withdrawal by Subject|13
101197|NCT00760214|348911|P2|Overall Study|Withdrawal by Subject|14
101198|NCT00760214|348912|P1|Overall Study|Withdrawal by Subject|12
101199|NCT00760214|348910|P3|Overall Study|Lost to Follow-up|1
101200|NCT00760214|348911|P2|Overall Study|Lost to Follow-up|0
101201|NCT00760214|348912|P1|Overall Study|Lost to Follow-up|0
101202|NCT00760214|348910|P3|Overall Study|Protocol Violation|3
101203|NCT00760214|348911|P2|Overall Study|Protocol Violation|0
101204|NCT00760214|348912|P1|Overall Study|Protocol Violation|3
101205|NCT00760214|348910|P3|Overall Study|Adverse Event|12
101206|NCT00760214|348911|P2|Overall Study|Adverse Event|9
101207|NCT00760214|348912|P1|Overall Study|Adverse Event|8
101208|NCT00760877|348984|P2|Overall Study|Treatment failure|0
101209|NCT00760877|348985|P1|Overall Study|Treatment failure|1
101210|NCT00760877|348984|P2|Overall Study|Participants transferred to AMN107A2408|1
101211|NCT00760877|348985|P1|Overall Study|Participants transferred to AMN107A2408|11
101212|NCT00760877|348984|P2|Overall Study|Physician Decision|2
101213|NCT00760877|348985|P1|Overall Study|Physician Decision|1
101214|NCT00760877|348984|P2|Overall Study|Participant not eligible to cross-over|1
101215|NCT00760877|348985|P1|Overall Study|Participant not eligible to cross-over|0
101216|NCT00760877|348984|P2|Overall Study|Participant diagnosed with AML|1
101217|NCT00760877|348985|P1|Overall Study|Participant diagnosed with AML|0
101218|NCT00760877|348984|P2|Overall Study|Adverse Event|12
101219|NCT00760877|348985|P1|Overall Study|Adverse Event|19
101220|NCT00760877|348984|P2|Overall Study|Withdrawal by Subject|3
101221|NCT00760877|348985|P1|Overall Study|Withdrawal by Subject|7
101222|NCT00760877|348984|P2|Overall Study|Death|1
101223|NCT00760877|348985|P1|Overall Study|Death|2
101224|NCT00760877|348984|P2|Overall Study|Pregnancy|4
101225|NCT00760877|348985|P1|Overall Study|Pregnancy|1
101226|NCT00760877|348984|P2|Overall Study|Non-compliance with protocol treatment|1
101227|NCT00760877|348985|P1|Overall Study|Non-compliance with protocol treatment|2
101228|NCT00760877|348984|P2|Overall Study|Protocol Violation|0
101229|NCT00760877|348985|P1|Overall Study|Protocol Violation|1
101230|NCT00760838|349003|P2|Overall Study|Withdrawal by Subject|1
101231|NCT00760838|349004|P1|Overall Study|Withdrawal by Subject|1
101232|NCT00760838|349003|P2|Overall Study|Lost to Follow-up|0
101233|NCT00760838|349004|P1|Overall Study|Lost to Follow-up|2
101234|NCT00760838|349003|P2|Overall Study|Lack of Efficacy|0
101235|NCT00760838|349004|P1|Overall Study|Lack of Efficacy|1
101236|NCT00760838|349003|P2|Overall Study|Adverse Event|1
101237|NCT00760838|349004|P1|Overall Study|Adverse Event|1
101238|NCT00760747|349022|P2|Study Period III|Physician Decision|1
101239|NCT00760747|349023|P1|Study Period III|Physician Decision|0
101240|NCT00760747|349022|P2|Study Period III|Protocol Violation|1
101241|NCT00760747|349023|P1|Study Period III|Protocol Violation|1
101242|NCT00760747|349022|P2|Study Period III|Parent/Caregiver Decision|1
101243|NCT00760747|349023|P1|Study Period III|Parent/Caregiver Decision|0
101244|NCT00760747|349022|P2|Study Period III|Lack of Efficacy|0
101245|NCT00760747|349023|P1|Study Period III|Lack of Efficacy|1
101246|NCT00760747|349022|P2|Study Period III|Adverse Event|0
101247|NCT00760747|349023|P1|Study Period III|Adverse Event|1
101248|NCT00760747|349022|P2|Study Period II|No drug administered|1
101249|NCT00760747|349023|P1|Study Period II|No drug administered|0
101250|NCT00760747|349022|P2|Study Period II|Withdrawal by Subject|0
101251|NCT00760747|349023|P1|Study Period II|Withdrawal by Subject|1
101252|NCT00760747|349022|P2|Study Period II|Protocol Violation|3
101253|NCT00760747|349023|P1|Study Period II|Protocol Violation|6
101254|NCT00760747|349022|P2|Study Period II|Parent/Caregiver Decision|0
101255|NCT00760747|349023|P1|Study Period II|Parent/Caregiver Decision|3
101256|NCT00760747|349022|P2|Study Period II|Lack of Efficacy|6
101257|NCT00760747|349023|P1|Study Period II|Lack of Efficacy|0
101258|NCT00760747|349022|P2|Study Period II|Adverse Event|4
101259|NCT00760747|349023|P1|Study Period II|Adverse Event|3
101260|NCT00760669|349051|P1|Overall Study|Took drug before entering in contract|5
101261|NCT00760669|349051|P1|Overall Study|Participants with overlapping cases|1
101262|NCT00760669|349051|P1|Overall Study|Participants missing efficacy assessment|6
101263|NCT00760669|349051|P1|Overall Study|Not assessed for overall improvement|18
101264|NCT00760617|349068|P3|Overall Study|Lost to Follow-up|5
101265|NCT00760617|349069|P2|Overall Study|Lost to Follow-up|0
101266|NCT00760617|349070|P1|Overall Study|Lost to Follow-up|0
101267|NCT00760617|349068|P3|Overall Study|Adverse Event|0
101268|NCT00760617|349069|P2|Overall Study|Adverse Event|2
101269|NCT00760617|349070|P1|Overall Study|Adverse Event|5
101270|NCT00760552|349184|P2|Overall Study|Lost to Follow-up|10
101271|NCT00760552|349185|P1|Overall Study|Lost to Follow-up|11
101272|NCT00760552|349184|P2|Overall Study|Death|0
101273|NCT00760552|349185|P1|Overall Study|Death|2
101274|NCT00760487|349219|P1|Overall Study|Unilateral implantation|3
101275|NCT00760474|349225|P2|Period 2 (P2)|Adverse Event|1
101276|NCT00760474|349226|P1|Period 2 (P2)|Adverse Event|0
101277|NCT00760474|349225|P2|Period 2 (P2)|Lost to Follow-up|0
101278|NCT00760474|349226|P1|Period 2 (P2)|Lost to Follow-up|1
101279|NCT00760474|349225|P2|Placebo Washout Period|Unspecified|1
101280|NCT00760474|349226|P1|Placebo Washout Period|Unspecified|0
101281|NCT00760474|349225|P2|Period 1 (P1)|Discontinued then re-entered|1
101282|NCT00760474|349226|P1|Period 1 (P1)|Discontinued then re-entered|1
101283|NCT00760383|349279|P2|Overall Study|moved away; withdrew; medical reasons|7
101284|NCT00760383|349280|P1|Overall Study|moved away; withdrew; medical reasons|5
101285|NCT00760084|349290|P1|Overall Study|Progressive Disease|3
101286|NCT00760084|349290|P1|Overall Study|Withdrawal by Subject|2
101287|NCT00760084|349290|P1|Overall Study|Physician Decision|5
101288|NCT00759954|349296|P2|Overall Study|Adverse Event|2
101289|NCT00759954|349297|P1|Overall Study|Adverse Event|1
101290|NCT00759954|349296|P2|Overall Study|Personal reason|0
101291|NCT00759954|349297|P1|Overall Study|Personal reason|1
101292|NCT00759941|349311|P2|Overall Study|Exited in error by site|1
101293|NCT00759941|349312|P1|Overall Study|Exited in error by site|1
101294|NCT00759941|349311|P2|Overall Study|Adverse Event|0
101295|NCT00759941|349312|P1|Overall Study|Adverse Event|1
101296|NCT00759941|349311|P2|Overall Study|Use of medication|0
101297|NCT00759941|349312|P1|Overall Study|Use of medication|1
101298|NCT00759915|349326|P2|Overall Study|Adverse Event|1
101299|NCT00759915|349327|P1|Overall Study|Adverse Event|0
101300|NCT00759915|349326|P2|Overall Study|Withdrawal by Subject|0
101301|NCT00759915|349327|P1|Overall Study|Withdrawal by Subject|1
101302|NCT00759902|349341|P2|Overall Study|Adverse Event|1
101303|NCT00759902|349342|P1|Overall Study|Adverse Event|0
101304|NCT00759863|349356|P2|Overall Study|Death, moved, or lost contact|18
101305|NCT00759863|349357|P1|Overall Study|Death, moved, or lost contact|20
101306|NCT00759759|349378|P2|Overall Study|Withdrawal by Subject|1
101307|NCT00759759|349379|P1|Overall Study|Withdrawal by Subject|2
101308|NCT00759759|349378|P2|Overall Study|Didn't receive drug in period 2|0
101309|NCT00759759|349379|P1|Overall Study|Didn't receive drug in period 2|1
101310|NCT00759759|349378|P2|Overall Study|didn't return for period 2|0
101311|NCT00759759|349379|P1|Overall Study|didn't return for period 2|1
101312|NCT00759681|349393|P2|Overall Study|Lost to Follow-up|5
101313|NCT00759681|349394|P1|Overall Study|Lost to Follow-up|8
101314|NCT00759681|349393|P2|Overall Study|Death|5
101315|NCT00759681|349394|P1|Overall Study|Death|2
101316|NCT00759655|349421|P1|Overall Study|Termination of the study by sponsor|1
101317|NCT00759564|349445|P5|Washout Period (at Least 14 Days)|Adverse Event|1
101318|NCT00759564|349446|P4|Washout Period (at Least 14 Days)|Adverse Event|0
101319|NCT00759564|349447|P3|Washout Period (at Least 14 Days)|Adverse Event|0
101320|NCT00759564|349448|P2|Washout Period (at Least 14 Days)|Adverse Event|0
101321|NCT00759564|349449|P1|Washout Period (at Least 14 Days)|Adverse Event|0
101322|NCT00759395|349619|P2|Overall Study|Lack of Efficacy|2
101323|NCT00759395|349620|P1|Overall Study|Lack of Efficacy|0
101324|NCT00759395|349619|P2|Overall Study|Withdrawal by Subject|0
101325|NCT00759395|349620|P1|Overall Study|Withdrawal by Subject|1
101326|NCT00759395|349619|P2|Overall Study|Adverse Event|0
101327|NCT00759395|349620|P1|Overall Study|Adverse Event|1
101328|NCT00759356|349636|P2|Overall Study|Subject was unable to return|0
101329|NCT00759356|349637|P1|Overall Study|Subject was unable to return|1
101330|NCT00759356|349636|P2|Overall Study|Withdrawal by Subject|2
101331|NCT00759356|349637|P1|Overall Study|Withdrawal by Subject|0
101332|NCT00759356|349636|P2|Overall Study|Adverse Event|1
101333|NCT00759356|349637|P1|Overall Study|Adverse Event|0
101334|NCT00759174|349717|P2|Overall Study|Unspecified|2
101335|NCT00759174|349718|P1|Overall Study|Unspecified|0
101336|NCT00759109|349740|P2|Overall Study|Lost during study|0
101337|NCT00759109|349741|P1|Overall Study|Lost during study|1
101338|NCT00759109|349740|P2|Overall Study|Participant had a liver transplant|1
101339|NCT00759109|349741|P1|Overall Study|Participant had a liver transplant|0
101340|NCT00759109|349740|P2|Overall Study|Participant moved to a different city|1
101341|NCT00759109|349741|P1|Overall Study|Participant moved to a different city|0
101342|NCT00759109|349740|P2|Overall Study|HCV RNA negative|0
101343|NCT00759109|349741|P1|Overall Study|HCV RNA negative|1
101344|NCT00759109|349740|P2|Overall Study|Started new therapy|6
101345|NCT00759109|349741|P1|Overall Study|Started new therapy|2
101346|NCT00759109|349740|P2|Overall Study|Lost to Follow-up|6
101347|NCT00759109|349741|P1|Overall Study|Lost to Follow-up|4
101348|NCT00759109|349740|P2|Overall Study|Death|3
101349|NCT00759109|349741|P1|Overall Study|Death|4
101350|NCT00759109|349740|P2|Overall Study|Withdrawal by Subject|5
101351|NCT00759109|349741|P1|Overall Study|Withdrawal by Subject|9
101352|NCT00759109|349740|P2|Overall Study|Inability to comply|1
101353|NCT00759109|349741|P1|Overall Study|Inability to comply|1
101354|NCT00759109|349740|P2|Overall Study|Adverse Event|12
101355|NCT00759109|349741|P1|Overall Study|Adverse Event|17
101356|NCT00759031|349763|P2|First Intervention (1 Day)|Screening failure|0
101357|NCT00759031|349764|P1|First Intervention (1 Day)|Screening failure|1
101358|NCT00759031|349763|P2|First Intervention (1 Day)|Withdrawal by Subject|1
101359|NCT00759031|349764|P1|First Intervention (1 Day)|Withdrawal by Subject|0
101360|NCT00759031|349763|P2|First Intervention (1 Day)|Physician Decision|0
101361|NCT00759031|349764|P1|First Intervention (1 Day)|Physician Decision|1
101362|NCT00758771|349801|P2|Overall Study|Did not meet eligibility criteria|4
101363|NCT00758771|349802|P1|Overall Study|Did not meet eligibility criteria|2
101364|NCT00758771|349801|P2|Overall Study|Withdrawal by Subject|1
101365|NCT00758771|349802|P1|Overall Study|Withdrawal by Subject|1
101366|NCT00758706|349860|P2|Overall Study|Adverse Event|4
101367|NCT00758706|349861|P1|Overall Study|Adverse Event|4
101368|NCT00758680|349897|P10|Overall Study|Withdrawal by Subject|0
101369|NCT00758680|349898|P9|Overall Study|Withdrawal by Subject|1
101370|NCT00758680|349899|P8|Overall Study|Withdrawal by Subject|0
101371|NCT00758680|349900|P7|Overall Study|Withdrawal by Subject|1
101372|NCT00758680|349901|P6|Overall Study|Withdrawal by Subject|0
101373|NCT00758680|349902|P5|Overall Study|Withdrawal by Subject|0
101374|NCT00758680|349903|P4|Overall Study|Withdrawal by Subject|0
101375|NCT00758680|349904|P3|Overall Study|Withdrawal by Subject|0
101376|NCT00758680|349905|P2|Overall Study|Withdrawal by Subject|0
101377|NCT00758680|349906|P1|Overall Study|Withdrawal by Subject|0
101378|NCT00758680|349897|P10|Overall Study|Laboratory Adverse Event|0
101379|NCT00758680|349898|P9|Overall Study|Laboratory Adverse Event|1
101380|NCT00758680|349899|P8|Overall Study|Laboratory Adverse Event|0
101381|NCT00758680|349900|P7|Overall Study|Laboratory Adverse Event|0
101382|NCT00758680|349901|P6|Overall Study|Laboratory Adverse Event|0
101383|NCT00758680|349902|P5|Overall Study|Laboratory Adverse Event|0
101384|NCT00758680|349903|P4|Overall Study|Laboratory Adverse Event|0
101385|NCT00758680|349904|P3|Overall Study|Laboratory Adverse Event|0
101386|NCT00758680|349905|P2|Overall Study|Laboratory Adverse Event|0
101387|NCT00758680|349906|P1|Overall Study|Laboratory Adverse Event|0
101388|NCT00758680|349897|P10|Overall Study|Adverse Event|1
101389|NCT00758680|349898|P9|Overall Study|Adverse Event|0
101390|NCT00758680|349899|P8|Overall Study|Adverse Event|1
101391|NCT00758680|349900|P7|Overall Study|Adverse Event|0
101392|NCT00758680|349901|P6|Overall Study|Adverse Event|0
101393|NCT00758680|349902|P5|Overall Study|Adverse Event|0
101394|NCT00758680|349903|P4|Overall Study|Adverse Event|0
101395|NCT00758680|349904|P3|Overall Study|Adverse Event|0
101396|NCT00758680|349905|P2|Overall Study|Adverse Event|0
101397|NCT00758680|349906|P1|Overall Study|Adverse Event|0
101398|NCT00758602|349959|P2|Overall Study|Reason not specified|3
101399|NCT00758602|349960|P1|Overall Study|Reason not specified|3
101400|NCT00758602|349959|P2|Overall Study|Death|1
101401|NCT00758602|349960|P1|Overall Study|Death|0
101402|NCT00758602|349959|P2|Overall Study|Protocol Violation|2
101403|NCT00758602|349960|P1|Overall Study|Protocol Violation|0
101404|NCT00758602|349959|P2|Overall Study|Withdrawal by Subject|3
101405|NCT00758602|349960|P1|Overall Study|Withdrawal by Subject|1
101406|NCT00758602|349959|P2|Overall Study|Lost to Follow-up|3
101407|NCT00758602|349960|P1|Overall Study|Lost to Follow-up|4
101408|NCT00758602|349959|P2|Overall Study|Adverse Event|10
101409|NCT00758602|349960|P1|Overall Study|Adverse Event|11
101410|NCT00758589|349986|P4|Overall Study|Palm stopped to work|1
101411|NCT00758589|349987|P3|Overall Study|Palm stopped to work|0
101412|NCT00758589|349988|P2|Overall Study|Palm stopped to work|0
101413|NCT00758589|349989|P1|Overall Study|Palm stopped to work|0
101414|NCT00758589|349986|P4|Overall Study|Withdrawal by Subject|1
101415|NCT00758589|349987|P3|Overall Study|Withdrawal by Subject|1
101416|NCT00758589|349988|P2|Overall Study|Withdrawal by Subject|1
101417|NCT00758589|349989|P1|Overall Study|Withdrawal by Subject|0
101418|NCT00758589|349986|P4|Overall Study|Adverse Event|4
101419|NCT00758589|349987|P3|Overall Study|Adverse Event|5
101420|NCT00758589|349988|P2|Overall Study|Adverse Event|2
101421|NCT00758589|349989|P1|Overall Study|Adverse Event|3
101422|NCT00758498|350082|P3|Overall Study|Noncompliance to study procedures|1
101423|NCT00758498|350083|P2|Overall Study|Noncompliance to study procedures|0
101424|NCT00758498|350084|P1|Overall Study|Noncompliance to study procedures|0
101425|NCT00758498|350082|P3|Overall Study|Withdrawal by Subject|1
101426|NCT00758498|350083|P2|Overall Study|Withdrawal by Subject|0
101427|NCT00758498|350084|P1|Overall Study|Withdrawal by Subject|0
101428|NCT00758498|350082|P3|Overall Study|Subject legally detained out of state|0
101429|NCT00758498|350083|P2|Overall Study|Subject legally detained out of state|0
101430|NCT00758498|350084|P1|Overall Study|Subject legally detained out of state|1
101431|NCT00758498|350082|P3|Overall Study|Adverse Event|3
101432|NCT00758498|350083|P2|Overall Study|Adverse Event|2
101433|NCT00758498|350084|P1|Overall Study|Adverse Event|2
101434|NCT00758485|350169|P2|Overall Study|Not Treated|2
101435|NCT00758485|350170|P1|Overall Study|Not Treated|1
101436|NCT00758485|350169|P2|Overall Study|Lost to Follow-up|1
101437|NCT00758485|350170|P1|Overall Study|Lost to Follow-up|0
101438|NCT00758459|350182|P2|Overall Study|Withdrawal by Subject|1
101439|NCT00758459|350183|P1|Overall Study|Withdrawal by Subject|0
101440|NCT00758459|350182|P2|Overall Study|Protocol Violation|1
101441|NCT00758459|350183|P1|Overall Study|Protocol Violation|0
101442|NCT00758459|350182|P2|Overall Study|Adverse Event|2
101443|NCT00758459|350183|P1|Overall Study|Adverse Event|3
101444|NCT00758394|350228|P4|3rd Intervention|Lost to Follow-up|1
101445|NCT00758394|350229|P3|3rd Intervention|Lost to Follow-up|0
101446|NCT00758394|350230|P2|3rd Intervention|Lost to Follow-up|0
101447|NCT00758394|350231|P1|3rd Intervention|Lost to Follow-up|1
101448|NCT00758394|350228|P4|2nd Intervention Order|Lost to Follow-up|0
101449|NCT00758394|350229|P3|2nd Intervention Order|Lost to Follow-up|0
101450|NCT00758394|350230|P2|2nd Intervention Order|Lost to Follow-up|1
101451|NCT00758394|350231|P1|2nd Intervention Order|Lost to Follow-up|0
101452|NCT00758160|350257|P1|Overall Study|Withdrawal by Subject|8
101453|NCT00758160|350257|P1|Overall Study|Protocol Violation|12
101454|NCT00758160|350257|P1|Overall Study|Lost to Follow-up|14
101455|NCT00758160|350257|P1|Overall Study|Lack of Efficacy|10
101456|NCT00758160|350257|P1|Overall Study|Adverse Event|15
101457|NCT00758160|350257|P1|Overall Study|Administration Problems|3
101458|NCT00758160|350257|P1|Overall Study|No Longer Requires Study Medication|4
101459|NCT00758069|350278|P3|Overall Study|Incorrect Study Drug|0
101460|NCT00758069|350279|P2|Overall Study|Incorrect Study Drug|0
101461|NCT00758069|350280|P1|Overall Study|Incorrect Study Drug|1
101462|NCT00758069|350278|P3|Overall Study|Lack of Efficacy|1
101463|NCT00758069|350279|P2|Overall Study|Lack of Efficacy|0
101464|NCT00758069|350280|P1|Overall Study|Lack of Efficacy|0
101465|NCT00758043|350295|P4|Overall Study|Other Reasons|5
101466|NCT00758043|350296|P3|Overall Study|Other Reasons|0
101467|NCT00758043|350297|P2|Overall Study|Other Reasons|1
101468|NCT00758043|350298|P1|Overall Study|Other Reasons|0
101469|NCT00758043|350295|P4|Overall Study|Non-Compliant With study Drug|1
101470|NCT00758043|350296|P3|Overall Study|Non-Compliant With study Drug|0
101471|NCT00758043|350297|P2|Overall Study|Non-Compliant With study Drug|0
101472|NCT00758043|350298|P1|Overall Study|Non-Compliant With study Drug|0
101473|NCT00758043|350295|P4|Overall Study|Required Prohibited Medication|3
101474|NCT00758043|350296|P3|Overall Study|Required Prohibited Medication|1
101475|NCT00758043|350297|P2|Overall Study|Required Prohibited Medication|0
101476|NCT00758043|350298|P1|Overall Study|Required Prohibited Medication|0
101477|NCT00758043|350295|P4|Overall Study|Withdrawal by Subject|4
101478|NCT00758043|350296|P3|Overall Study|Withdrawal by Subject|1
101479|NCT00758043|350297|P2|Overall Study|Withdrawal by Subject|1
101480|NCT00758043|350298|P1|Overall Study|Withdrawal by Subject|0
101481|NCT00758043|350295|P4|Overall Study|Lost to Follow-up|5
101482|NCT00758043|350296|P3|Overall Study|Lost to Follow-up|2
101483|NCT00758043|350297|P2|Overall Study|Lost to Follow-up|2
101484|NCT00758043|350298|P1|Overall Study|Lost to Follow-up|0
101485|NCT00758043|350295|P4|Overall Study|Refused Further Treatment|8
101486|NCT00758043|350296|P3|Overall Study|Refused Further Treatment|5
101487|NCT00758043|350297|P2|Overall Study|Refused Further Treatment|11
101488|NCT00758043|350298|P1|Overall Study|Refused Further Treatment|0
101489|NCT00758043|350295|P4|Overall Study|Lack of Efficacy|12
101490|NCT00758043|350296|P3|Overall Study|Lack of Efficacy|18
101491|NCT00758043|350297|P2|Overall Study|Lack of Efficacy|6
101492|NCT00758043|350298|P1|Overall Study|Lack of Efficacy|0
101493|NCT00758043|350295|P4|Overall Study|Adverse Event|62
101494|NCT00758043|350296|P3|Overall Study|Adverse Event|12
101495|NCT00758043|350297|P2|Overall Study|Adverse Event|20
101496|NCT00758043|350298|P1|Overall Study|Adverse Event|1
101497|NCT00757848|350326|P2|Overall Study|Incorrect enrolment|0
101498|NCT00757848|350327|P1|Overall Study|Incorrect enrolment|1
101499|NCT00757848|350326|P2|Overall Study|Adverse Event|2
101500|NCT00757848|350327|P1|Overall Study|Adverse Event|1
101501|NCT00757848|350326|P2|Overall Study|Voluntary discontinuation|0
101502|NCT00757848|350327|P1|Overall Study|Voluntary discontinuation|1
101503|NCT00757783|350396|P2|Overall Study|Unspecified|2
101504|NCT00757783|350397|P1|Overall Study|Unspecified|1
101505|NCT00757783|350396|P2|Overall Study|Withdrawal by Subject|1
101506|NCT00757783|350397|P1|Overall Study|Withdrawal by Subject|2
101507|NCT00757783|350396|P2|Overall Study|Protocol Violation|0
101508|NCT00757783|350397|P1|Overall Study|Protocol Violation|1
101509|NCT00757783|350396|P2|Overall Study|Lost to Follow-up|1
101510|NCT00757783|350397|P1|Overall Study|Lost to Follow-up|1
101511|NCT00757783|350396|P2|Overall Study|Adverse Event|2
101512|NCT00757783|350397|P1|Overall Study|Adverse Event|0
101513|NCT00757705|350433|P1|Overall Study|Unspecified|18
101514|NCT00757705|350433|P1|Overall Study|Non-compliant|9
101515|NCT00757705|350433|P1|Overall Study|Ineligible to continue|8
101516|NCT00757705|350433|P1|Overall Study|Insufficient Response|26
101517|NCT00757705|350433|P1|Overall Study|Withdrawal by Subject|25
101518|NCT00757705|350433|P1|Overall Study|Lost to Follow-up|16
101519|NCT00757705|350433|P1|Overall Study|Adverse Event|19
101520|NCT00757627|350445|P1|Overall Study|Unspecified|1
101521|NCT00757627|350445|P1|Overall Study|Withdrawal by Subject|27
101522|NCT00757627|350445|P1|Overall Study|Lost to Follow-up|28
101523|NCT00757627|350445|P1|Overall Study|Lack of Efficacy|10
101524|NCT00757627|350445|P1|Overall Study|Adverse Event|15
101525|NCT00757588|350580|P2|Period 2: Long-term (52-week) Phase|Not specified|0
101526|NCT00757588|350581|P1|Period 2: Long-term (52-week) Phase|Not specified|1
101527|NCT00757588|350580|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
101608|NCT00756938|350700|P4|12-week Base Study|Protocol Violation|0
101528|NCT00757588|350581|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
101529|NCT00757588|350580|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
101530|NCT00757588|350581|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
101531|NCT00757588|350580|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
101532|NCT00757588|350581|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
101533|NCT00757588|350580|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
101534|NCT00757588|350581|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
101535|NCT00757588|350580|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
101536|NCT00757588|350581|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
101537|NCT00757588|350580|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
101538|NCT00757588|350581|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
101539|NCT00757588|350580|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
101540|NCT00757588|350581|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
101541|NCT00757588|350580|P2|Period 1: Short-term (24-week) Phase|Not specified|1
101542|NCT00757588|350581|P1|Period 1: Short-term (24-week) Phase|Not specified|0
101543|NCT00757588|350580|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
101544|NCT00757588|350581|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
101545|NCT00757588|350580|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
101546|NCT00757588|350581|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
101547|NCT00757588|350580|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
101548|NCT00757588|350581|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
101549|NCT00757588|350580|P2|Period 1: Short-term (24-week) Phase|Death|0
101550|NCT00757588|350581|P1|Period 1: Short-term (24-week) Phase|Death|1
101551|NCT00757588|350580|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
101552|NCT00757588|350581|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
101553|NCT00757588|350580|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
101554|NCT00757588|350581|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
101555|NCT00757588|350580|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
101556|NCT00757588|350581|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
101557|NCT00757237|350622|P2|Overall Study|Other|2
101558|NCT00757237|350623|P1|Overall Study|Other|0
101559|NCT00757237|350622|P2|Overall Study|Safety or Tolerability|5
101560|NCT00757237|350623|P1|Overall Study|Safety or Tolerability|3
101561|NCT00757237|350622|P2|Overall Study|Withdrawal by Subject|12
101562|NCT00757237|350623|P1|Overall Study|Withdrawal by Subject|8
101563|NCT00757237|350622|P2|Overall Study|Physician Decision|3
101564|NCT00757237|350623|P1|Overall Study|Physician Decision|2
101565|NCT00757237|350622|P2|Overall Study|Protocol Violation|2
101566|NCT00757237|350623|P1|Overall Study|Protocol Violation|0
101567|NCT00757237|350622|P2|Overall Study|Lost to Follow-up|1
101568|NCT00757237|350623|P1|Overall Study|Lost to Follow-up|0
101569|NCT00757172|350651|P1|Overall Study|Progression|4
101570|NCT00757172|350651|P1|Overall Study|Physician Decision|3
101571|NCT00757172|350651|P1|Overall Study|Withdrawal by Subject|4
101572|NCT00756938|350700|P4|Optional Extension|Adverse Event|1
101573|NCT00756938|350701|P3|Optional Extension|Adverse Event|0
101574|NCT00756938|350702|P2|Optional Extension|Adverse Event|0
101575|NCT00756938|350703|P1|Optional Extension|Adverse Event|0
101576|NCT00756938|350700|P4|Optional Extension|Withdrawal by Subject|10
101577|NCT00756938|350701|P3|Optional Extension|Withdrawal by Subject|0
101578|NCT00756938|350702|P2|Optional Extension|Withdrawal by Subject|0
101579|NCT00756938|350703|P1|Optional Extension|Withdrawal by Subject|0
101580|NCT00756938|350700|P4|Optional Extension|Protocol Violation|1
101581|NCT00756938|350701|P3|Optional Extension|Protocol Violation|0
101582|NCT00756938|350702|P2|Optional Extension|Protocol Violation|0
101583|NCT00756938|350703|P1|Optional Extension|Protocol Violation|0
101584|NCT00756938|350700|P4|Optional Extension|Lost to Follow-up|1
101585|NCT00756938|350701|P3|Optional Extension|Lost to Follow-up|0
101586|NCT00756938|350702|P2|Optional Extension|Lost to Follow-up|0
101587|NCT00756938|350703|P1|Optional Extension|Lost to Follow-up|0
101588|NCT00756938|350700|P4|Optional Extension|Physician Decision|3
101589|NCT00756938|350701|P3|Optional Extension|Physician Decision|0
101590|NCT00756938|350702|P2|Optional Extension|Physician Decision|0
101591|NCT00756938|350703|P1|Optional Extension|Physician Decision|0
101592|NCT00756938|350700|P4|Optional Extension|Protocol-specific criteria met|9
101593|NCT00756938|350701|P3|Optional Extension|Protocol-specific criteria met|0
101594|NCT00756938|350702|P2|Optional Extension|Protocol-specific criteria met|0
101595|NCT00756938|350703|P1|Optional Extension|Protocol-specific criteria met|0
101596|NCT00756938|350700|P4|Optional Extension|End of Study|11
101597|NCT00756938|350701|P3|Optional Extension|End of Study|0
101598|NCT00756938|350702|P2|Optional Extension|End of Study|0
101599|NCT00756938|350703|P1|Optional Extension|End of Study|0
101600|NCT00756938|350700|P4|Optional Extension|Lack of Efficacy|1
101601|NCT00756938|350701|P3|Optional Extension|Lack of Efficacy|0
101602|NCT00756938|350702|P2|Optional Extension|Lack of Efficacy|0
101603|NCT00756938|350703|P1|Optional Extension|Lack of Efficacy|0
101604|NCT00756938|350700|P4|12-week Base Study|Lost to Follow-up|0
101605|NCT00756938|350701|P3|12-week Base Study|Lost to Follow-up|0
101606|NCT00756938|350702|P2|12-week Base Study|Lost to Follow-up|0
101607|NCT00756938|350703|P1|12-week Base Study|Lost to Follow-up|1
101609|NCT00756938|350701|P3|12-week Base Study|Protocol Violation|1
101610|NCT00756938|350702|P2|12-week Base Study|Protocol Violation|0
101611|NCT00756938|350703|P1|12-week Base Study|Protocol Violation|0
101612|NCT00756938|350700|P4|12-week Base Study|Protocol-specific Criteria Met|0
101613|NCT00756938|350701|P3|12-week Base Study|Protocol-specific Criteria Met|1
101614|NCT00756938|350702|P2|12-week Base Study|Protocol-specific Criteria Met|0
101615|NCT00756938|350703|P1|12-week Base Study|Protocol-specific Criteria Met|1
101616|NCT00756886|350731|P2|Overall Study|Ineligible|4
101617|NCT00756886|350732|P1|Overall Study|Ineligible|9
101618|NCT00756886|350731|P2|Overall Study|Lack of Efficacy|0
101619|NCT00756886|350732|P1|Overall Study|Lack of Efficacy|1
101620|NCT00756886|350731|P2|Overall Study|Adverse Event|3
101621|NCT00756886|350732|P1|Overall Study|Adverse Event|0
101622|NCT00756886|350731|P2|Overall Study|Lost to Follow-up|0
101623|NCT00756886|350732|P1|Overall Study|Lost to Follow-up|1
101624|NCT00756730|350740|P2|Overall Study|persistent low-level viremmia|1
101625|NCT00756730|350741|P1|Overall Study|persistent low-level viremmia|0
101626|NCT00756730|350740|P2|Overall Study|discontinued due to rash prior to week 4|1
101627|NCT00756730|350741|P1|Overall Study|discontinued due to rash prior to week 4|0
101628|NCT00756574|350774|P2|Overall Study|Lost to Follow-up|4
101629|NCT00756574|350775|P1|Overall Study|Lost to Follow-up|4
101630|NCT00756574|350774|P2|Overall Study|Withdrawal by Subject|7
101631|NCT00756574|350775|P1|Overall Study|Withdrawal by Subject|9
101632|NCT00756470|350819|P1|Overall Study|Adverse Event|4
101633|NCT00756470|350819|P1|Overall Study|Withdrawal by Subject|1
101634|NCT00756457|350826|P2|Overall Study|Lost to Follow-up|2
101635|NCT00756457|350827|P1|Overall Study|Lost to Follow-up|1
101636|NCT00756444|350857|P2|Overall Study|Ineligibility Determined|0
101637|NCT00756444|350858|P1|Overall Study|Ineligibility Determined|1
101638|NCT00756444|350857|P2|Overall Study|Disease Progression|7
101639|NCT00756444|350858|P1|Overall Study|Disease Progression|2
101640|NCT00756444|350857|P2|Overall Study|Death|4
101641|NCT00756444|350858|P1|Overall Study|Death|5
101642|NCT00756444|350857|P2|Overall Study|Lost to Follow-up|1
101643|NCT00756444|350858|P1|Overall Study|Lost to Follow-up|0
101644|NCT00756444|350857|P2|Overall Study|Withdrawal by Subject|8
101645|NCT00756444|350858|P1|Overall Study|Withdrawal by Subject|6
101646|NCT00756444|350857|P2|Overall Study|Adverse Event|1
101647|NCT00756444|350858|P1|Overall Study|Adverse Event|1
101648|NCT00756314|350869|P2|Overall Study|Lost to Follow-up|59
101649|NCT00756314|350870|P1|Overall Study|Lost to Follow-up|2
101650|NCT00756002|350899|P2|Double-Blind Treatment Period|Not Specified|2
101651|NCT00756002|350900|P1|Double-Blind Treatment Period|Not Specified|2
101652|NCT00756002|350899|P2|Double-Blind Treatment Period|Protocol Violation|5
101653|NCT00756002|350900|P1|Double-Blind Treatment Period|Protocol Violation|6
101654|NCT00756002|350899|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
101655|NCT00756002|350900|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
101656|NCT00756002|350899|P2|Double-Blind Treatment Period|Lost to Follow-up|1
101657|NCT00756002|350900|P1|Double-Blind Treatment Period|Lost to Follow-up|0
101658|NCT00756002|350899|P2|Double-Blind Treatment Period|Lack of Efficacy|1
101659|NCT00756002|350900|P1|Double-Blind Treatment Period|Lack of Efficacy|1
101660|NCT00755937|350994|P1|Observational Follow-up|Lost to Follow-up|148
101661|NCT00755937|350994|P1|Recruitment|Unknown if infliximab received|164
101662|NCT00755846|351021|P6|Overall Study|Participant Non-compliance|0
101663|NCT00755846|351022|P5|Overall Study|Participant Non-compliance|1
101664|NCT00755846|351023|P4|Overall Study|Participant Non-compliance|0
101665|NCT00755846|351024|P3|Overall Study|Participant Non-compliance|0
101666|NCT00755846|351025|P2|Overall Study|Participant Non-compliance|0
101667|NCT00755846|351026|P1|Overall Study|Participant Non-compliance|0
101668|NCT00755846|351021|P6|Overall Study|Administrative Error|0
101669|NCT00755846|351022|P5|Overall Study|Administrative Error|0
101670|NCT00755846|351023|P4|Overall Study|Administrative Error|0
101671|NCT00755846|351024|P3|Overall Study|Administrative Error|0
101672|NCT00755846|351025|P2|Overall Study|Administrative Error|1
101673|NCT00755846|351026|P1|Overall Study|Administrative Error|0
101674|NCT00755846|351021|P6|Overall Study|Physician Decision|1
101675|NCT00755846|351022|P5|Overall Study|Physician Decision|0
101676|NCT00755846|351023|P4|Overall Study|Physician Decision|1
101677|NCT00755846|351024|P3|Overall Study|Physician Decision|0
101678|NCT00755846|351025|P2|Overall Study|Physician Decision|3
101679|NCT00755846|351026|P1|Overall Study|Physician Decision|1
101680|NCT00755846|351021|P6|Overall Study|Hyperglycemic Rescue|7
101681|NCT00755846|351022|P5|Overall Study|Hyperglycemic Rescue|8
101682|NCT00755846|351023|P4|Overall Study|Hyperglycemic Rescue|8
101683|NCT00755846|351024|P3|Overall Study|Hyperglycemic Rescue|5
101684|NCT00755846|351025|P2|Overall Study|Hyperglycemic Rescue|7
101685|NCT00755846|351026|P1|Overall Study|Hyperglycemic Rescue|21
101686|NCT00755846|351021|P6|Overall Study|Withdrawal by Subject|1
101687|NCT00755846|351022|P5|Overall Study|Withdrawal by Subject|0
101688|NCT00755846|351023|P4|Overall Study|Withdrawal by Subject|2
101689|NCT00755846|351024|P3|Overall Study|Withdrawal by Subject|5
101690|NCT00755846|351025|P2|Overall Study|Withdrawal by Subject|3
101691|NCT00755846|351026|P1|Overall Study|Withdrawal by Subject|2
101692|NCT00755846|351021|P6|Overall Study|Lost to Follow-up|2
101693|NCT00755846|351022|P5|Overall Study|Lost to Follow-up|4
101694|NCT00755846|351023|P4|Overall Study|Lost to Follow-up|0
101695|NCT00755846|351024|P3|Overall Study|Lost to Follow-up|1
101696|NCT00755846|351025|P2|Overall Study|Lost to Follow-up|2
101697|NCT00755846|351026|P1|Overall Study|Lost to Follow-up|0
101698|NCT00755846|351021|P6|Overall Study|Protocol Violation|1
101699|NCT00755846|351022|P5|Overall Study|Protocol Violation|1
101700|NCT00755846|351023|P4|Overall Study|Protocol Violation|1
101701|NCT00755846|351024|P3|Overall Study|Protocol Violation|1
101702|NCT00755846|351025|P2|Overall Study|Protocol Violation|1
101703|NCT00755846|351026|P1|Overall Study|Protocol Violation|1
101704|NCT00755846|351021|P6|Overall Study|Adverse Event|2
101705|NCT00755846|351022|P5|Overall Study|Adverse Event|3
101706|NCT00755846|351023|P4|Overall Study|Adverse Event|1
101707|NCT00755846|351024|P3|Overall Study|Adverse Event|0
101708|NCT00755846|351025|P2|Overall Study|Adverse Event|0
101709|NCT00755846|351026|P1|Overall Study|Adverse Event|0
101710|NCT00755807|351126|P2|Open-label Extension Phase|Sponsor Decision|1
101711|NCT00755807|351127|P1|Open-label Extension Phase|Sponsor Decision|0
101712|NCT00755807|351126|P2|Open-label Extension Phase|Lost to Follow-up|0
101713|NCT00755807|351127|P1|Open-label Extension Phase|Lost to Follow-up|2
101714|NCT00755807|351126|P2|Open-label Extension Phase|Withdrawal by Subject|3
101715|NCT00755807|351127|P1|Open-label Extension Phase|Withdrawal by Subject|1
101716|NCT00755807|351126|P2|Open-label Extension Phase|Lack of Efficacy|3
101717|NCT00755807|351127|P1|Open-label Extension Phase|Lack of Efficacy|3
101718|NCT00755807|351126|P2|Open-label Extension Phase|Protocol Violation|2
101719|NCT00755807|351127|P1|Open-label Extension Phase|Protocol Violation|5
101720|NCT00755807|351126|P2|Open-label Extension Phase|Adverse Event|7
101721|NCT00755807|351127|P1|Open-label Extension Phase|Adverse Event|7
101722|NCT00755807|351126|P2|Acute Phase|Physician Decision|1
101723|NCT00755807|351127|P1|Acute Phase|Physician Decision|0
101724|NCT00755807|351126|P2|Acute Phase|Lack of Efficacy|1
101725|NCT00755807|351127|P1|Acute Phase|Lack of Efficacy|0
101726|NCT00755807|351126|P2|Acute Phase|Withdrawal by Subject|2
101727|NCT00755807|351127|P1|Acute Phase|Withdrawal by Subject|1
101728|NCT00755807|351126|P2|Acute Phase|Protocol Violation|3
101729|NCT00755807|351127|P1|Acute Phase|Protocol Violation|1
101730|NCT00755807|351126|P2|Acute Phase|Adverse Event|5
101731|NCT00755807|351127|P1|Acute Phase|Adverse Event|16
101732|NCT00755417|351207|P3|Overall Study|Not specified or missing data|12
101733|NCT00755417|351208|P2|Overall Study|Not specified or missing data|18
101734|NCT00755417|351209|P1|Overall Study|Not specified or missing data|9
101735|NCT00755417|351207|P3|Overall Study|Withdrawal by Subject|12
101736|NCT00755417|351208|P2|Overall Study|Withdrawal by Subject|12
101737|NCT00755417|351209|P1|Overall Study|Withdrawal by Subject|12
101738|NCT00755417|351207|P3|Overall Study|Lost to Follow-up|1
101739|NCT00755417|351208|P2|Overall Study|Lost to Follow-up|0
101740|NCT00755417|351209|P1|Overall Study|Lost to Follow-up|3
101741|NCT00755417|351207|P3|Overall Study|Protocol Violation|1
101742|NCT00755417|351208|P2|Overall Study|Protocol Violation|1
101743|NCT00755417|351209|P1|Overall Study|Protocol Violation|2
101744|NCT00755417|351207|P3|Overall Study|Lack of Efficacy|9
101745|NCT00755417|351208|P2|Overall Study|Lack of Efficacy|4
101746|NCT00755417|351209|P1|Overall Study|Lack of Efficacy|8
101747|NCT00755417|351207|P3|Overall Study|Adverse Event|7
101748|NCT00755417|351208|P2|Overall Study|Adverse Event|20
101749|NCT00755417|351209|P1|Overall Study|Adverse Event|28
101750|NCT00755222|351266|P2|Overall Study|Protocol Violation|0
101751|NCT00755222|351267|P1|Overall Study|Protocol Violation|2
101752|NCT00755222|351266|P2|Overall Study|Adverse Event|0
101753|NCT00755222|351267|P1|Overall Study|Adverse Event|2
101754|NCT00755222|351266|P2|Overall Study|Withdrawal by Subject|2
101755|NCT00755222|351267|P1|Overall Study|Withdrawal by Subject|4
101756|NCT00755105|351297|P3|Overall Study|Withdrawal by Subject|4
101757|NCT00755105|351298|P2|Overall Study|Withdrawal by Subject|11
101758|NCT00755105|351299|P1|Overall Study|Withdrawal by Subject|9
101759|NCT00755079|351309|P2|Overall Study|Withdrawal by Subject|2
101760|NCT00755079|351310|P1|Overall Study|Withdrawal by Subject|0
101761|NCT00755079|351309|P2|Overall Study|Adverse Event|1
101762|NCT00755079|351310|P1|Overall Study|Adverse Event|0
101763|NCT00755079|351309|P2|Overall Study|Lost to Follow-up|3
101764|NCT00755079|351310|P1|Overall Study|Lost to Follow-up|1
101765|NCT00754793|351345|P2|Overall Study|voluntary withdrawn from study|1
101766|NCT00754793|351346|P1|Overall Study|voluntary withdrawn from study|0
101767|NCT00754741|351355|P3|Overall Study|Died or disenrolled|54
101768|NCT00754741|351356|P2|Overall Study|Died or disenrolled|69
101769|NCT00754741|351357|P1|Overall Study|Died or disenrolled|57
101770|NCT00754650|351404|P1|Overall Study|Disease Progression|2
101771|NCT00754624|351409|P1|Overall Study|Lost to Follow-up|3
101772|NCT00754624|351409|P1|Overall Study|Various|12
101773|NCT00754624|351409|P1|Overall Study|Withdrawal by Subject|28
101774|NCT00754624|351409|P1|Overall Study|Protocol Violation|1
101775|NCT00754624|351409|P1|Overall Study|Physician Decision|8
101776|NCT00754624|351409|P1|Overall Study|Death|1
101777|NCT00754624|351409|P1|Overall Study|Adverse Event|16
101778|NCT00754572|351419|P1|Overall Study|Lost to Follow-up|1
101779|NCT00754572|351419|P1|Overall Study|Administrative Reason|3
101780|NCT00754572|351419|P1|Overall Study|Death|1
101781|NCT00754572|351419|P1|Overall Study|Lack of Efficacy|2
101782|NCT00754572|351419|P1|Overall Study|Withdrawal by Subject|3
101783|NCT00754572|351419|P1|Overall Study|Protocol Violation|3
101784|NCT00754572|351419|P1|Overall Study|Unspecified|39
101785|NCT00754572|351419|P1|Overall Study|Adverse Event|19
101786|NCT00754559|351446|P1|Overall Study|Withdrawal by Subject|3
101787|NCT00754559|351446|P1|Overall Study|Other|5
101788|NCT00754559|351446|P1|Overall Study|Administrative reason|1
101789|NCT00754559|351446|P1|Overall Study|Lost to Follow-up|2
101790|NCT00754559|351446|P1|Overall Study|Lack of Efficacy|10
101791|NCT00754559|351446|P1|Overall Study|Protocol Violation|11
101792|NCT00754559|351446|P1|Overall Study|Adverse Event|15
101793|NCT00752791|351484|P1|Overall Study|Protocol deviation|1
101794|NCT00752791|351484|P1|Overall Study|Switched to hemodialysis|2
101795|NCT00752791|351484|P1|Overall Study|Renal transplant|3
101796|NCT00752791|351484|P1|Overall Study|Death|1
101797|NCT00752791|351484|P1|Overall Study|Physician Decision|1
101798|NCT00752791|351484|P1|Overall Study|Withdrawal by Subject|1
101799|NCT00752791|351484|P1|Overall Study|Adverse Event|7
101800|NCT00754442|351556|P2|Overall Study|Withdrawal by Subject|3
101801|NCT00754442|351557|P1|Overall Study|Withdrawal by Subject|5
101802|NCT00754390|351564|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
101803|NCT00754390|351564|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
101804|NCT00754390|351564|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
101805|NCT00754390|351564|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
101806|NCT00754338|351586|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
101807|NCT00754338|351587|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
101808|NCT00754338|351588|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
101809|NCT00754338|351589|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
101810|NCT00754338|351586|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
101811|NCT00754338|351587|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
101812|NCT00754338|351588|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
101813|NCT00754338|351589|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
101814|NCT00754325|351621|P2|Initial Treatment|Disease Progression|35
101815|NCT00754325|351622|P1|Initial Treatment|Disease Progression|35
101816|NCT00754325|351621|P2|Initial Treatment|Sponsor Request|1
101817|NCT00754325|351622|P1|Initial Treatment|Sponsor Request|0
101818|NCT00754325|351621|P2|Initial Treatment|Physician Decision|0
101819|NCT00754325|351622|P1|Initial Treatment|Physician Decision|2
101820|NCT00754325|351621|P2|Initial Treatment|Withdrawal by Subject|2
101821|NCT00754325|351622|P1|Initial Treatment|Withdrawal by Subject|2
101822|NCT00754325|351621|P2|Initial Treatment|Adverse Event|6
101823|NCT00754325|351622|P1|Initial Treatment|Adverse Event|7
101824|NCT00754325|351621|P2|Initial Treatment|Continuing Active Treatment|5
101825|NCT00754325|351622|P1|Initial Treatment|Continuing Active Treatment|4
101826|NCT00754234|351641|P1|Overall Study|Withdrawal by Subject|3
101827|NCT00754065|351720|P2|Overall Study|Reason not specified or unknown, etc.|27
101828|NCT00754065|351721|P1|Overall Study|Reason not specified or unknown, etc.|21
101829|NCT00754065|351720|P2|Overall Study|Pregnancy|0
101830|NCT00754065|351721|P1|Overall Study|Pregnancy|6
101831|NCT00754065|351720|P2|Overall Study|Withdrawal by Subject|5
101832|NCT00754065|351721|P1|Overall Study|Withdrawal by Subject|4
101833|NCT00754065|351720|P2|Overall Study|Protocol Violation|10
101834|NCT00754065|351721|P1|Overall Study|Protocol Violation|12
101835|NCT00754065|351720|P2|Overall Study|Lost to Follow-up|11
101836|NCT00754065|351721|P1|Overall Study|Lost to Follow-up|7
101837|NCT00754065|351720|P2|Overall Study|Adverse Event|25
101838|NCT00754065|351721|P1|Overall Study|Adverse Event|19
101839|NCT00754065|351720|P2|Overall Study|Never received treatment|2
101840|NCT00754065|351721|P1|Overall Study|Never received treatment|12
101841|NCT00754013|351961|P2|Overall Study|didn't return after study termed|4
101842|NCT00754013|351962|P1|Overall Study|didn't return after study termed|3
101843|NCT00754013|351961|P2|Overall Study|Lost to Follow-up|1
101844|NCT00754013|351962|P1|Overall Study|Lost to Follow-up|1
101845|NCT00753922|351987|P4|Overall Study|Discontinuation Due to Explantation|4
101846|NCT00753922|351988|P3|Overall Study|Discontinuation Due to Explantation|14
101847|NCT00753922|351989|P2|Overall Study|Discontinuation Due to Explantation|14
101848|NCT00753922|351990|P1|Overall Study|Discontinuation Due to Explantation|14
101849|NCT00753922|351987|P4|Overall Study|Death|1
101850|NCT00753922|351988|P3|Overall Study|Death|2
101851|NCT00753922|351989|P2|Overall Study|Death|23
101852|NCT00753922|351990|P1|Overall Study|Death|2
101853|NCT00753922|351987|P4|Overall Study|Patients Not Completing Visit|0
101854|NCT00753922|351988|P3|Overall Study|Patients Not Completing Visit|1
101855|NCT00753922|351989|P2|Overall Study|Patients Not Completing Visit|0
101856|NCT00753922|351990|P1|Overall Study|Patients Not Completing Visit|11
101857|NCT00753922|351987|P4|Overall Study|Patient Non-compliance|11
101858|NCT00753922|351988|P3|Overall Study|Patient Non-compliance|14
101859|NCT00753922|351989|P2|Overall Study|Patient Non-compliance|22
101860|NCT00753922|351990|P1|Overall Study|Patient Non-compliance|55
101861|NCT00753922|351987|P4|Overall Study|Withdrawal by Subject|2
101862|NCT00753922|351988|P3|Overall Study|Withdrawal by Subject|4
101863|NCT00753922|351989|P2|Overall Study|Withdrawal by Subject|11
101864|NCT00753922|351990|P1|Overall Study|Withdrawal by Subject|9
101865|NCT00753922|351987|P4|Overall Study|Lost to Follow-up|5
101866|NCT00753922|351988|P3|Overall Study|Lost to Follow-up|28
101867|NCT00753922|351989|P2|Overall Study|Lost to Follow-up|24
101868|NCT00753922|351990|P1|Overall Study|Lost to Follow-up|155
101869|NCT00753896|352020|P1|Overall Study|Entry Criteria Not Met|4
101870|NCT00753896|352020|P1|Overall Study|Withdrawal by Subject|4
101871|NCT00753896|352020|P1|Overall Study|Protocol Violation|1
101872|NCT00753896|352020|P1|Overall Study|Lost to Follow-up|2
101873|NCT00753896|352020|P1|Overall Study|Death|1
101874|NCT00753896|352020|P1|Overall Study|Adverse Event|4
101875|NCT00752726|352036|P2|Overall Study|Other Reason|2
101876|NCT00752726|352037|P1|Overall Study|Other Reason|1
101877|NCT00752726|352036|P2|Overall Study|Withdrawal by Subject|10
101878|NCT00752726|352037|P1|Overall Study|Withdrawal by Subject|5
101879|NCT00752726|352036|P2|Overall Study|Adverse Event|0
101880|NCT00752726|352037|P1|Overall Study|Adverse Event|3
101881|NCT00752726|352036|P2|Overall Study|Lost to Follow-up|1
101882|NCT00752726|352037|P1|Overall Study|Lost to Follow-up|2
101883|NCT00753766|352064|P2|Overall Study|Physician Decision|0
101884|NCT00753766|352065|P1|Overall Study|Physician Decision|1
101885|NCT00753714|352075|P2|Overall Study|not specified|5
101886|NCT00753714|352076|P1|Overall Study|not specified|7
101887|NCT00753714|352075|P2|Overall Study|Death|3
101888|NCT00753714|352076|P1|Overall Study|Death|3
101889|NCT00753714|352075|P2|Overall Study|Withdrawal by Subject|1
101890|NCT00753714|352076|P1|Overall Study|Withdrawal by Subject|2
101891|NCT00753714|352075|P2|Overall Study|Lost to Follow-up|1
101892|NCT00753714|352076|P1|Overall Study|Lost to Follow-up|0
101893|NCT00753714|352075|P2|Overall Study|Protocol Violation|0
101894|NCT00753714|352076|P1|Overall Study|Protocol Violation|1
101895|NCT00753714|352075|P2|Overall Study|Adverse Event|18
101896|NCT00753714|352076|P1|Overall Study|Adverse Event|26
101897|NCT00753714|352075|P2|Overall Study|Lack of Efficacy|34
101898|NCT00753714|352076|P1|Overall Study|Lack of Efficacy|21
101899|NCT00753688|352092|P2|Overall Study|Adverse Event|1
101900|NCT00753688|352093|P1|Overall Study|Adverse Event|0
101901|NCT00753688|352092|P2|Overall Study|Ongoing - in Follow-up|31
101902|NCT00753688|352093|P1|Overall Study|Ongoing - in Follow-up|15
101903|NCT00753688|352092|P2|Overall Study|Participant Withdrew Consent|2
101904|NCT00753688|352093|P1|Overall Study|Participant Withdrew Consent|2
101905|NCT00753688|352092|P2|Overall Study|Missing|9
101906|NCT00753688|352093|P1|Overall Study|Missing|4
101907|NCT00753688|352092|P2|Overall Study|Death|203
101908|NCT00753688|352093|P1|Overall Study|Death|102
101909|NCT00753675|352122|P3|Overall Study|Lost to Follow-up|0
101910|NCT00753675|352123|P2|Overall Study|Lost to Follow-up|0
101911|NCT00753675|352124|P1|Overall Study|Lost to Follow-up|1
101912|NCT00753675|352122|P3|Overall Study|Withdrawal by Subject|0
101913|NCT00753675|352123|P2|Overall Study|Withdrawal by Subject|1
101914|NCT00753675|352124|P1|Overall Study|Withdrawal by Subject|0
101915|NCT00753675|352122|P3|Overall Study|Objective progression of disease|35
101916|NCT00753675|352123|P2|Overall Study|Objective progression of disease|35
101917|NCT00753675|352124|P1|Overall Study|Objective progression of disease|35
101918|NCT00753675|352122|P3|Overall Study|Adverse Event|4
101919|NCT00753675|352123|P2|Overall Study|Adverse Event|9
101920|NCT00753675|352124|P1|Overall Study|Adverse Event|11
101921|NCT00753675|352122|P3|Overall Study|Death|4
101922|NCT00753675|352123|P2|Overall Study|Death|2
101923|NCT00753675|352124|P1|Overall Study|Death|1
101924|NCT00753675|352122|P3|Overall Study|other reason|13
101925|NCT00753675|352123|P2|Overall Study|other reason|12
101926|NCT00753675|352124|P1|Overall Study|other reason|11
101927|NCT00753649|352146|P2|Overall Study|Protocol Violation|0
101928|NCT00753649|352147|P1|Overall Study|Protocol Violation|2
101929|NCT00753649|352146|P2|Overall Study|Lost to follow-up-complete vaccination|0
101930|NCT00753649|352147|P1|Overall Study|Lost to follow-up-complete vaccination|1
101931|NCT00753649|352146|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
101932|NCT00753649|352147|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
101933|NCT00753649|352146|P2|Overall Study|Migrated/moved from study area|0
101934|NCT00753649|352147|P1|Overall Study|Migrated/moved from study area|1
101935|NCT00753623|352180|P2|Second Intervention (14 Days)|Physician Decision|1
101936|NCT00753623|352181|P1|Second Intervention (14 Days)|Physician Decision|0
101937|NCT00753623|352180|P2|Washout (7 Days)|Physician Decision|0
101938|NCT00753623|352181|P1|Washout (7 Days)|Physician Decision|1
101939|NCT00753623|352180|P2|First Intervention (14 Days)|Adverse Event|1
101940|NCT00753623|352181|P1|First Intervention (14 Days)|Adverse Event|0
101941|NCT00753623|352180|P2|First Intervention (14 Days)|Physician Decision|2
101942|NCT00753623|352181|P1|First Intervention (14 Days)|Physician Decision|1
101943|NCT00753623|352180|P2|First Intervention (14 Days)|Withdrawal by Subject|1
101944|NCT00753623|352181|P1|First Intervention (14 Days)|Withdrawal by Subject|1
101945|NCT00753545|352188|P2|Overall Study|Consent withrawn prior to treatment|1
101946|NCT00753545|352189|P1|Overall Study|Consent withrawn prior to treatment|0
101947|NCT00753545|352188|P2|Overall Study|Not specified|3
101948|NCT00753545|352189|P1|Overall Study|Not specified|1
101949|NCT00753545|352188|P2|Overall Study|Protocol Violation|1
101950|NCT00753545|352189|P1|Overall Study|Protocol Violation|0
101951|NCT00753545|352188|P2|Overall Study|Lost to Follow-up|0
101952|NCT00753545|352189|P1|Overall Study|Lost to Follow-up|1
101953|NCT00753545|352188|P2|Overall Study|Withdrawal by Subject|8
101954|NCT00753545|352189|P1|Overall Study|Withdrawal by Subject|9
101955|NCT00753545|352188|P2|Overall Study|Lack of Efficacy|93
101956|NCT00753545|352189|P1|Overall Study|Lack of Efficacy|54
101957|NCT00753545|352188|P2|Overall Study|Adverse Event|2
101958|NCT00753545|352189|P1|Overall Study|Adverse Event|3
101959|NCT00753519|352227|P2|Overall Study|Withdrawal by Subject|2
101960|NCT00753519|352228|P1|Overall Study|Withdrawal by Subject|0
101961|NCT00753506|352250|P2|Overall Study|Other reason|1
101962|NCT00753506|352251|P1|Overall Study|Other reason|1
101963|NCT00753506|352250|P2|Overall Study|Lost to Follow-up|0
101964|NCT00753506|352251|P1|Overall Study|Lost to Follow-up|2
101965|NCT00753506|352250|P2|Overall Study|Withdrawal by Subject|1
101966|NCT00753506|352251|P1|Overall Study|Withdrawal by Subject|4
101967|NCT00753454|352257|P1|Overall Study|Investigator Decision|1
101968|NCT00753454|352257|P1|Overall Study|Withdrawal by Subject|5
101969|NCT00753454|352257|P1|Overall Study|Lost to Follow-up|3
101970|NCT00753454|352257|P1|Overall Study|Lack of Efficacy|1
101971|NCT00753454|352257|P1|Overall Study|Adverse Event|4
101972|NCT00753415|352291|P10|Part B|Disease progression|1
101973|NCT00753415|352292|P9|Part B|Disease progression|2
101974|NCT00753415|352293|P8|Part B|Disease progression|0
101975|NCT00753415|352294|P7|Part B|Disease progression|0
101976|NCT00753415|352295|P6|Part B|Disease progression|0
101977|NCT00753415|352296|P5|Part B|Disease progression|0
101978|NCT00753415|352297|P4|Part B|Disease progression|0
101979|NCT00753415|352298|P3|Part B|Disease progression|0
101980|NCT00753415|352299|P2|Part B|Disease progression|0
101981|NCT00753415|352300|P1|Part B|Disease progression|0
101982|NCT00753415|352291|P10|Part B|Lost to Follow-up|0
101983|NCT00753415|352292|P9|Part B|Lost to Follow-up|1
101984|NCT00753415|352293|P8|Part B|Lost to Follow-up|1
101985|NCT00753415|352294|P7|Part B|Lost to Follow-up|0
101986|NCT00753415|352295|P6|Part B|Lost to Follow-up|0
101987|NCT00753415|352296|P5|Part B|Lost to Follow-up|0
101988|NCT00753415|352297|P4|Part B|Lost to Follow-up|0
101989|NCT00753415|352298|P3|Part B|Lost to Follow-up|0
101990|NCT00753415|352299|P2|Part B|Lost to Follow-up|0
101991|NCT00753415|352300|P1|Part B|Lost to Follow-up|0
101992|NCT00753415|352291|P10|Part A|Withdrawal by Subject|0
101993|NCT00753415|352292|P9|Part A|Withdrawal by Subject|0
101994|NCT00753415|352293|P8|Part A|Withdrawal by Subject|0
101995|NCT00753415|352294|P7|Part A|Withdrawal by Subject|0
101996|NCT00753415|352295|P6|Part A|Withdrawal by Subject|0
101997|NCT00753415|352296|P5|Part A|Withdrawal by Subject|0
101998|NCT00753415|352297|P4|Part A|Withdrawal by Subject|0
101999|NCT00753415|352298|P3|Part A|Withdrawal by Subject|1
102000|NCT00753415|352299|P2|Part A|Withdrawal by Subject|0
102001|NCT00753415|352300|P1|Part A|Withdrawal by Subject|0
102002|NCT00753415|352291|P10|Part A|Disease progression|0
102003|NCT00753415|352292|P9|Part A|Disease progression|0
102004|NCT00753415|352293|P8|Part A|Disease progression|0
102005|NCT00753415|352294|P7|Part A|Disease progression|0
102006|NCT00753415|352295|P6|Part A|Disease progression|0
102007|NCT00753415|352296|P5|Part A|Disease progression|0
102008|NCT00753415|352297|P4|Part A|Disease progression|2
102009|NCT00753415|352298|P3|Part A|Disease progression|1
102010|NCT00753415|352299|P2|Part A|Disease progression|0
102011|NCT00753415|352300|P1|Part A|Disease progression|1
102012|NCT00753272|352390|P2|Overall Study|Unspecified|1088
102013|NCT00753272|352391|P1|Overall Study|Unspecified|1104
102014|NCT00753272|352390|P2|Overall Study|Lost to Follow-up|497
102015|NCT00753272|352391|P1|Overall Study|Lost to Follow-up|491
102016|NCT00753272|352390|P2|Overall Study|Withdrawal by Subject|2407
102017|NCT00753272|352391|P1|Overall Study|Withdrawal by Subject|2481
102018|NCT00753272|352390|P2|Overall Study|Protocol Violation|46
102019|NCT00753272|352391|P1|Overall Study|Protocol Violation|28
102020|NCT00753272|352390|P2|Overall Study|Adverse Event|869
102021|NCT00753272|352391|P1|Overall Study|Adverse Event|878
102022|NCT00753012|352476|P2|Overall Study|Confounded endpoint data|0
102023|NCT00753012|352477|P1|Overall Study|Confounded endpoint data|1
102024|NCT00753012|352476|P2|Overall Study|Lost to Follow-up|0
102025|NCT00753012|352477|P1|Overall Study|Lost to Follow-up|4
102026|NCT00753012|352476|P2|Overall Study|Withdrawal by Subject|1
102027|NCT00753012|352477|P1|Overall Study|Withdrawal by Subject|0
102028|NCT00753012|352476|P2|Overall Study|Adverse Event|0
102029|NCT00753012|352477|P1|Overall Study|Adverse Event|2
102030|NCT00753012|352476|P2|Overall Study|Ineligible, abnormal cardiac histo|0
102031|NCT00753012|352477|P1|Overall Study|Ineligible, abnormal cardiac histo|1
102032|NCT00752986|352490|P3|Overall Study|Protocol Violation|0
102033|NCT00752986|352491|P2|Overall Study|Protocol Violation|0
102034|NCT00752986|352492|P1|Overall Study|Protocol Violation|3
102035|NCT00752986|352490|P3|Overall Study|Withdrawal by Subject|2
102036|NCT00752986|352491|P2|Overall Study|Withdrawal by Subject|1
102037|NCT00752986|352492|P1|Overall Study|Withdrawal by Subject|2
102038|NCT00752895|352521|P2|Overall Study|Withdrawal by Subject|3
102039|NCT00752895|352522|P1|Overall Study|Withdrawal by Subject|8
102040|NCT00752622|352530|P1|Interventional Phase|Premature Study Termination|5
102041|NCT00752622|352530|P1|Interventional Phase|Physician Decision|1
102042|NCT00752622|352530|P1|Interventional Phase|Non-responder|2
102043|NCT00752622|352530|P1|Observational Phase|Unspecified|2
102044|NCT00752622|352530|P1|Observational Phase|Adverse Event|1
102045|NCT00752622|352530|P1|Observational Phase|Withdrawal by Subject|2
102046|NCT00752622|352530|P1|Observational Phase|Non-responder|2
102047|NCT00752622|352530|P1|Observational Phase|Premature Study Termination|36
102048|NCT00752622|352530|P1|Induction Phase|Premature study termination|14
102049|NCT00752622|352530|P1|Induction Phase|Withdrawal by Subject|1
102050|NCT00752622|352530|P1|Induction Phase|Non-responder|14
102051|NCT00752622|352530|P1|Induction Phase|Unspecified|3
102052|NCT00752622|352530|P1|Induction Phase|Adverse Event|3
102053|NCT00752609|352543|P2|Overall Study|Received Aranesp in error|0
102054|NCT00752609|352544|P1|Overall Study|Received Aranesp in error|1
102055|NCT00752609|352543|P2|Overall Study|Met exclusion criteria|0
102056|NCT00752609|352544|P1|Overall Study|Met exclusion criteria|1
102057|NCT00752609|352543|P2|Overall Study|Death|0
102058|NCT00752609|352544|P1|Overall Study|Death|1
102059|NCT00752609|352543|P2|Overall Study|Physician Decision|0
102060|NCT00752609|352544|P1|Overall Study|Physician Decision|1
102061|NCT00752609|352543|P2|Overall Study|Withdrawal by Subject|0
102062|NCT00752609|352544|P1|Overall Study|Withdrawal by Subject|3
102063|NCT00752609|352543|P2|Overall Study|Adverse Event|2
102064|NCT00752609|352544|P1|Overall Study|Adverse Event|2
102065|NCT00752232|352570|P7|Overall Study|Caregiver could not attend the subject|0
102066|NCT00752232|352571|P6|Overall Study|Caregiver could not attend the subject|0
102067|NCT00752232|352572|P5|Overall Study|Caregiver could not attend the subject|1
102068|NCT00752232|352573|P4|Overall Study|Caregiver could not attend the subject|0
102069|NCT00752232|352574|P3|Overall Study|Caregiver could not attend the subject|0
102070|NCT00752232|352575|P2|Overall Study|Caregiver could not attend the subject|0
102071|NCT00752232|352576|P1|Overall Study|Caregiver could not attend the subject|0
102072|NCT00752232|352570|P7|Overall Study|Group home admission|0
102073|NCT00752232|352571|P6|Overall Study|Group home admission|0
102074|NCT00752232|352572|P5|Overall Study|Group home admission|0
102075|NCT00752232|352573|P4|Overall Study|Group home admission|1
102076|NCT00752232|352574|P3|Overall Study|Group home admission|0
102077|NCT00752232|352575|P2|Overall Study|Group home admission|0
102078|NCT00752232|352576|P1|Overall Study|Group home admission|0
102079|NCT00752232|352570|P7|Overall Study|Subject request|0
102080|NCT00752232|352571|P6|Overall Study|Subject request|0
102081|NCT00752232|352572|P5|Overall Study|Subject request|0
102082|NCT00752232|352573|P4|Overall Study|Subject request|0
102083|NCT00752232|352574|P3|Overall Study|Subject request|1
102084|NCT00752232|352575|P2|Overall Study|Subject request|0
102085|NCT00752232|352576|P1|Overall Study|Subject request|0
102086|NCT00752232|352570|P7|Overall Study|Investigator request|0
102087|NCT00752232|352571|P6|Overall Study|Investigator request|0
102088|NCT00752232|352572|P5|Overall Study|Investigator request|1
102089|NCT00752232|352573|P4|Overall Study|Investigator request|0
102090|NCT00752232|352574|P3|Overall Study|Investigator request|0
102091|NCT00752232|352575|P2|Overall Study|Investigator request|0
102092|NCT00752232|352576|P1|Overall Study|Investigator request|0
102093|NCT00752232|352570|P7|Overall Study|Caregiver request|0
102094|NCT00752232|352571|P6|Overall Study|Caregiver request|0
102095|NCT00752232|352572|P5|Overall Study|Caregiver request|1
102096|NCT00752232|352573|P4|Overall Study|Caregiver request|0
102097|NCT00752232|352574|P3|Overall Study|Caregiver request|0
102098|NCT00752232|352575|P2|Overall Study|Caregiver request|0
102099|NCT00752232|352576|P1|Overall Study|Caregiver request|2
102100|NCT00752232|352570|P7|Overall Study|Protocol Violation|0
102101|NCT00752232|352571|P6|Overall Study|Protocol Violation|1
102102|NCT00752232|352572|P5|Overall Study|Protocol Violation|0
102103|NCT00752232|352573|P4|Overall Study|Protocol Violation|0
102104|NCT00752232|352574|P3|Overall Study|Protocol Violation|0
102105|NCT00752232|352575|P2|Overall Study|Protocol Violation|0
102106|NCT00752232|352576|P1|Overall Study|Protocol Violation|0
102107|NCT00752128|352648|P1|Overall Study|Withdrawal by Subject|4
102108|NCT00752089|352653|P1|Overall Study|Cannot continue the study|1
102109|NCT00752089|352653|P1|Overall Study|Not capable of wearing partial denture|1
102110|NCT00752089|352653|P1|Overall Study|Could not attend visit 9|1
102111|NCT00752089|352653|P1|Overall Study|Protocol Deviation|2
102112|NCT00752089|352653|P1|Overall Study|Adverse Event|1
102113|NCT00751998|352667|P1|Overall Study|Withdrawal by Subject|2
102114|NCT00751998|352667|P1|Overall Study|Death|11
102115|NCT00751998|352667|P1|Overall Study|Lost to Follow-up|7
102116|NCT00751933|352686|P4|Overall Study|Physician Decision|1
102117|NCT00751933|352687|P3|Overall Study|Physician Decision|1
102118|NCT00751933|352688|P2|Overall Study|Physician Decision|0
102119|NCT00751933|352689|P1|Overall Study|Physician Decision|0
102120|NCT00751933|352686|P4|Overall Study|Withdrawal by Subject|0
102121|NCT00751933|352687|P3|Overall Study|Withdrawal by Subject|0
102122|NCT00751933|352688|P2|Overall Study|Withdrawal by Subject|1
102123|NCT00751933|352689|P1|Overall Study|Withdrawal by Subject|0
102124|NCT00751881|352697|P3|Extension Study Period|Other than specified above|18
102125|NCT00751881|352698|P2|Extension Study Period|Other than specified above|30
102126|NCT00751881|352699|P1|Extension Study Period|Other than specified above|26
102127|NCT00751881|352697|P3|Extension Study Period|Poor Compliance to Protocol|1
102128|NCT00751881|352698|P2|Extension Study Period|Poor Compliance to Protocol|2
102129|NCT00751881|352699|P1|Extension Study Period|Poor Compliance to Protocol|3
102130|NCT00751881|352697|P3|Extension Study Period|Lost to Follow-up|6
102131|NCT00751881|352698|P2|Extension Study Period|Lost to Follow-up|9
102132|NCT00751881|352699|P1|Extension Study Period|Lost to Follow-up|4
102133|NCT00751881|352697|P3|Extension Study Period|Lack of Efficacy|20
102134|NCT00751881|352698|P2|Extension Study Period|Lack of Efficacy|10
102135|NCT00751881|352699|P1|Extension Study Period|Lack of Efficacy|14
102136|NCT00751881|352697|P3|Extension Study Period|Adverse Event|21
102137|NCT00751881|352698|P2|Extension Study Period|Adverse Event|20
102138|NCT00751881|352699|P1|Extension Study Period|Adverse Event|18
102139|NCT00751881|352697|P3|Core Treatment Period|Other:participant's decision/unspecified|16
102140|NCT00751881|352698|P2|Core Treatment Period|Other:participant's decision/unspecified|22
102141|NCT00751881|352699|P1|Core Treatment Period|Other:participant's decision/unspecified|19
102142|NCT00751881|352697|P3|Core Treatment Period|Other: tolerability complaints|0
102143|NCT00751881|352698|P2|Core Treatment Period|Other: tolerability complaints|0
102144|NCT00751881|352699|P1|Core Treatment Period|Other: tolerability complaints|2
102145|NCT00751881|352697|P3|Core Treatment Period|Other: MS treatment change|4
102146|NCT00751881|352698|P2|Core Treatment Period|Other: MS treatment change|4
102147|NCT00751881|352699|P1|Core Treatment Period|Other: MS treatment change|6
102148|NCT00751881|352697|P3|Core Treatment Period|Other: personal/family constraints|10
102149|NCT00751881|352698|P2|Core Treatment Period|Other: personal/family constraints|7
102150|NCT00751881|352699|P1|Core Treatment Period|Other: personal/family constraints|6
102151|NCT00751881|352697|P3|Core Treatment Period|Other: wish to parent|4
102152|NCT00751881|352698|P2|Core Treatment Period|Other: wish to parent|7
102153|NCT00751881|352699|P1|Core Treatment Period|Other: wish to parent|5
102154|NCT00751881|352697|P3|Core Treatment Period|Other: protocol deviation|7
102155|NCT00751881|352698|P2|Core Treatment Period|Other: protocol deviation|3
102156|NCT00751881|352699|P1|Core Treatment Period|Other: protocol deviation|3
102157|NCT00751881|352697|P3|Core Treatment Period|Lost to Follow-up|3
102158|NCT00751881|352698|P2|Core Treatment Period|Lost to Follow-up|4
102159|NCT00751881|352699|P1|Core Treatment Period|Lost to Follow-up|6
102160|NCT00751881|352697|P3|Core Treatment Period|Poor compliance to protocol|4
102161|NCT00751881|352698|P2|Core Treatment Period|Poor compliance to protocol|3
102162|NCT00751881|352699|P1|Core Treatment Period|Poor compliance to protocol|15
102163|NCT00751881|352697|P3|Core Treatment Period|Lack of Efficacy|20
102164|NCT00751881|352698|P2|Core Treatment Period|Lack of Efficacy|30
102165|NCT00751881|352699|P1|Core Treatment Period|Lack of Efficacy|37
102166|NCT00751881|352697|P3|Core Treatment Period|Adverse Event|58
102167|NCT00751881|352698|P2|Core Treatment Period|Adverse Event|54
102168|NCT00751881|352699|P1|Core Treatment Period|Adverse Event|26
102169|NCT00751881|352697|P3|Core Treatment Period|Not treated|2
102170|NCT00751881|352698|P2|Core Treatment Period|Not treated|1
102171|NCT00751881|352699|P1|Core Treatment Period|Not treated|1
102172|NCT00751790|352746|P1|Overall Study|Withdrawal by Subject|1
102173|NCT00751790|352746|P1|Overall Study|Death|3
102174|NCT00751790|352746|P1|Overall Study|Lost to Follow-up|1
102175|NCT00751621|352771|P1|Overall Study|Poor adherence to asthma treatment|1
102176|NCT00751621|352771|P1|Overall Study|Subject moved to another country|1
102177|NCT00751621|352771|P1|Overall Study|Withdrawal by Subject|1
102178|NCT00751621|352771|P1|Overall Study|Adverse Event|1
102179|NCT00751400|352805|P1|Overall Study|Lost to Follow-up|10
102180|NCT00751296|352818|P1|Overall Study|Adverse Event|2
102181|NCT00751140|352846|P1|Overall Study|benign angioma excluded from analysis|1
102182|NCT00751114|352856|P2|Overall Study|Move to another city|0
102183|NCT00751114|352857|P1|Overall Study|Move to another city|1
102184|NCT00751114|352856|P2|Overall Study|Out of country for 2 months|0
102185|NCT00751114|352857|P1|Overall Study|Out of country for 2 months|1
102186|NCT00751114|352856|P2|Overall Study|Not Treated|1
102187|NCT00751114|352857|P1|Overall Study|Not Treated|13
102188|NCT00751114|352856|P2|Overall Study|Lack of Efficacy|7
102189|NCT00751114|352857|P1|Overall Study|Lack of Efficacy|0
102190|NCT00751114|352856|P2|Overall Study|Lost to Follow-up|7
102191|NCT00751114|352857|P1|Overall Study|Lost to Follow-up|4
102192|NCT00751114|352856|P2|Overall Study|Withdrawal by Subject|4
102193|NCT00751114|352857|P1|Overall Study|Withdrawal by Subject|9
102194|NCT00751114|352856|P2|Overall Study|Protocol Violation|9
102195|NCT00751114|352857|P1|Overall Study|Protocol Violation|8
102196|NCT00751114|352856|P2|Overall Study|Adverse Event|4
102197|NCT00751114|352857|P1|Overall Study|Adverse Event|2
102198|NCT00751036|352882|P2|Overall Study|Missing end of Treatment Page|3
102199|NCT00751036|352883|P1|Overall Study|Missing end of Treatment Page|2
102200|NCT00751036|352882|P2|Overall Study|Protocol Violation|0
102201|NCT00751036|352883|P1|Overall Study|Protocol Violation|1
102202|NCT00751036|352882|P2|Overall Study|Lost to Follow-up|1
102203|NCT00751036|352883|P1|Overall Study|Lost to Follow-up|0
102204|NCT00751036|352882|P2|Overall Study|Death|3
102205|NCT00751036|352883|P1|Overall Study|Death|3
102206|NCT00751036|352882|P2|Overall Study|Withdrawal by Subject|2
102207|NCT00751036|352883|P1|Overall Study|Withdrawal by Subject|5
102208|NCT00751036|352882|P2|Overall Study|Administrative Problems|4
102209|NCT00751036|352883|P1|Overall Study|Administrative Problems|3
102210|NCT00751036|352882|P2|Overall Study|Adverse Event|4
102211|NCT00751036|352883|P1|Overall Study|Adverse Event|6
102212|NCT00751036|352882|P2|Overall Study|Disease Progression|29
102213|NCT00751036|352883|P1|Overall Study|Disease Progression|28
102214|NCT00750919|352895|P1|Overall Study|Unspecified|36
102215|NCT00750919|352895|P1|Overall Study|Could not cooperate, unrelated to trial|4
102216|NCT00750919|352895|P1|Overall Study|Lack of Efficacy|8
102217|NCT00750919|352895|P1|Overall Study|Withdrawal by Subject|1
102218|NCT00750919|352895|P1|Overall Study|Adverse Event|9
102219|NCT00750893|352903|P1|Overall Study|Unspecified|17
102220|NCT00750893|352903|P1|Overall Study|Lost to Follow-up|510
102221|NCT00750893|352903|P1|Overall Study|Withdrawal by Subject|10
102222|NCT00750893|352903|P1|Overall Study|Adverse Event|5
102223|NCT00750880|352918|P1|Overall Study|Administrative|11
102224|NCT00750880|352918|P1|Overall Study|Physician Decision|20
102225|NCT00750880|352918|P1|Overall Study|Withdrawal by Subject|33
102226|NCT00750880|352918|P1|Overall Study|Protocol Violation|15
102227|NCT00750880|352918|P1|Overall Study|Lost to Follow-up|10
102228|NCT00750880|352918|P1|Overall Study|Lack of Efficacy|46
102229|NCT00750880|352918|P1|Overall Study|Death|4
102230|NCT00750880|352918|P1|Overall Study|Adverse Event|76
102231|NCT00750867|352941|P1|Overall Study|Adverse Event|2
102232|NCT00750737|352962|P2|Overall Study|Withdrawal by Subject|3
102233|NCT00750737|352963|P1|Overall Study|Withdrawal by Subject|3
102234|NCT00750308|353023|P12|Third Treatment|Withdrawal by Subject|0
102235|NCT00750308|353024|P11|Third Treatment|Withdrawal by Subject|0
102236|NCT00750308|353025|P10|Third Treatment|Withdrawal by Subject|0
102237|NCT00750308|353026|P9|Third Treatment|Withdrawal by Subject|0
102238|NCT00750308|353027|P8|Third Treatment|Withdrawal by Subject|0
102239|NCT00750308|353028|P7|Third Treatment|Withdrawal by Subject|0
102240|NCT00750308|353029|P6|Third Treatment|Withdrawal by Subject|0
102241|NCT00750308|353030|P5|Third Treatment|Withdrawal by Subject|0
102242|NCT00750308|353031|P4|Third Treatment|Withdrawal by Subject|0
102243|NCT00750308|353032|P3|Third Treatment|Withdrawal by Subject|0
102244|NCT00750308|353033|P2|Third Treatment|Withdrawal by Subject|1
102245|NCT00750308|353034|P1|Third Treatment|Withdrawal by Subject|0
102246|NCT00750308|353023|P12|Second Treatment|Withdrawal by Subject|0
102247|NCT00750308|353024|P11|Second Treatment|Withdrawal by Subject|0
102248|NCT00750308|353025|P10|Second Treatment|Withdrawal by Subject|0
102249|NCT00750308|353026|P9|Second Treatment|Withdrawal by Subject|0
102250|NCT00750308|353027|P8|Second Treatment|Withdrawal by Subject|0
102251|NCT00750308|353028|P7|Second Treatment|Withdrawal by Subject|0
102252|NCT00750308|353029|P6|Second Treatment|Withdrawal by Subject|0
102253|NCT00750308|353030|P5|Second Treatment|Withdrawal by Subject|1
102254|NCT00750308|353031|P4|Second Treatment|Withdrawal by Subject|0
102255|NCT00750308|353032|P3|Second Treatment|Withdrawal by Subject|0
102256|NCT00750308|353033|P2|Second Treatment|Withdrawal by Subject|0
102257|NCT00750308|353034|P1|Second Treatment|Withdrawal by Subject|0
102258|NCT00750308|353023|P12|Second Treatment|Adverse Event|0
102259|NCT00750308|353024|P11|Second Treatment|Adverse Event|0
102260|NCT00750308|353025|P10|Second Treatment|Adverse Event|0
102261|NCT00750308|353026|P9|Second Treatment|Adverse Event|1
102262|NCT00750308|353027|P8|Second Treatment|Adverse Event|0
102263|NCT00750308|353028|P7|Second Treatment|Adverse Event|0
102264|NCT00750308|353029|P6|Second Treatment|Adverse Event|1
102265|NCT00750308|353030|P5|Second Treatment|Adverse Event|0
102266|NCT00750308|353031|P4|Second Treatment|Adverse Event|0
102267|NCT00750308|353032|P3|Second Treatment|Adverse Event|0
102268|NCT00750308|353033|P2|Second Treatment|Adverse Event|0
102269|NCT00750308|353034|P1|Second Treatment|Adverse Event|0
102270|NCT00750308|353023|P12|First Treatment|Withdrawal by Subject|0
102271|NCT00750308|353024|P11|First Treatment|Withdrawal by Subject|0
102272|NCT00750308|353025|P10|First Treatment|Withdrawal by Subject|0
102273|NCT00750308|353026|P9|First Treatment|Withdrawal by Subject|0
102274|NCT00750308|353027|P8|First Treatment|Withdrawal by Subject|1
102275|NCT00750308|353028|P7|First Treatment|Withdrawal by Subject|0
102276|NCT00750308|353029|P6|First Treatment|Withdrawal by Subject|0
102277|NCT00750308|353030|P5|First Treatment|Withdrawal by Subject|0
102278|NCT00750308|353031|P4|First Treatment|Withdrawal by Subject|1
102279|NCT00750308|353032|P3|First Treatment|Withdrawal by Subject|0
102280|NCT00750308|353033|P2|First Treatment|Withdrawal by Subject|0
102281|NCT00750308|353034|P1|First Treatment|Withdrawal by Subject|0
102282|NCT00750308|353023|P12|First Treatment|Adverse Event|1
102283|NCT00750308|353024|P11|First Treatment|Adverse Event|1
102284|NCT00750308|353025|P10|First Treatment|Adverse Event|0
102285|NCT00750308|353026|P9|First Treatment|Adverse Event|0
102286|NCT00750308|353027|P8|First Treatment|Adverse Event|0
102287|NCT00750308|353028|P7|First Treatment|Adverse Event|0
102288|NCT00750308|353029|P6|First Treatment|Adverse Event|0
102289|NCT00750308|353030|P5|First Treatment|Adverse Event|0
102290|NCT00750308|353031|P4|First Treatment|Adverse Event|0
102291|NCT00750308|353032|P3|First Treatment|Adverse Event|0
102292|NCT00750308|353033|P2|First Treatment|Adverse Event|1
102293|NCT00750308|353034|P1|First Treatment|Adverse Event|0
102294|NCT00750152|353096|P2|Overall Study|Not specified|8
102295|NCT00750152|353097|P1|Overall Study|Not specified|7
102296|NCT00750152|353096|P2|Overall Study|Termination by sponsor|0
102297|NCT00750152|353097|P1|Overall Study|Termination by sponsor|1
102298|NCT00750152|353096|P2|Overall Study|Non-compliance|1
102299|NCT00750152|353097|P1|Overall Study|Non-compliance|0
102300|NCT00750152|353096|P2|Overall Study|Physician Decision|1
102301|NCT00750152|353097|P1|Overall Study|Physician Decision|1
102302|NCT00750152|353096|P2|Overall Study|Withdrawal by Subject|3
102303|NCT00750152|353097|P1|Overall Study|Withdrawal by Subject|3
102304|NCT00750152|353096|P2|Overall Study|Lost to Follow-up|13
102305|NCT00750152|353097|P1|Overall Study|Lost to Follow-up|8
102306|NCT00750152|353096|P2|Overall Study|Adverse Event|1
102307|NCT00750152|353097|P1|Overall Study|Adverse Event|2
102308|NCT00750139|353109|P4|Overall Study|Non-specific|33
102309|NCT00750139|353110|P3|Overall Study|Non-specific|79
102310|NCT00750139|353111|P2|Overall Study|Non-specific|42
102311|NCT00750139|353112|P1|Overall Study|Non-specific|62
102312|NCT00750139|353109|P4|Overall Study|Termination by sponsor|1
102313|NCT00750139|353110|P3|Overall Study|Termination by sponsor|0
102314|NCT00750139|353111|P2|Overall Study|Termination by sponsor|0
102315|NCT00750139|353112|P1|Overall Study|Termination by sponsor|4
102316|NCT00750139|353109|P4|Overall Study|Non-compliance|3
102317|NCT00750139|353110|P3|Overall Study|Non-compliance|1
102318|NCT00750139|353111|P2|Overall Study|Non-compliance|0
102319|NCT00750139|353112|P1|Overall Study|Non-compliance|1
102320|NCT00750139|353109|P4|Overall Study|Physician Decision|0
102321|NCT00750139|353110|P3|Overall Study|Physician Decision|0
102322|NCT00750139|353111|P2|Overall Study|Physician Decision|1
102323|NCT00750139|353112|P1|Overall Study|Physician Decision|1
102324|NCT00750139|353109|P4|Overall Study|Withdrawal by Subject|2
102325|NCT00750139|353110|P3|Overall Study|Withdrawal by Subject|6
102326|NCT00750139|353111|P2|Overall Study|Withdrawal by Subject|2
102327|NCT00750139|353112|P1|Overall Study|Withdrawal by Subject|3
102328|NCT00750139|353109|P4|Overall Study|Lost to Follow-up|6
102329|NCT00750139|353110|P3|Overall Study|Lost to Follow-up|15
102330|NCT00750139|353111|P2|Overall Study|Lost to Follow-up|12
102331|NCT00750139|353112|P1|Overall Study|Lost to Follow-up|17
102332|NCT00750139|353109|P4|Overall Study|Adverse Event|1
102333|NCT00750139|353110|P3|Overall Study|Adverse Event|0
102334|NCT00750139|353111|P2|Overall Study|Adverse Event|2
102335|NCT00750139|353112|P1|Overall Study|Adverse Event|1
102336|NCT00750061|353128|P2|Overall Study|Physician Decision|1
102337|NCT00750061|353129|P1|Overall Study|Physician Decision|0
102338|NCT00750061|353128|P2|Overall Study|Withdrawal by Subject|1
102339|NCT00750061|353129|P1|Overall Study|Withdrawal by Subject|0
102340|NCT00750061|353128|P2|Overall Study|Adverse Event|0
102341|NCT00750061|353129|P1|Overall Study|Adverse Event|2
102342|NCT00749996|353139|P2|Overall Study|Death|0
102343|NCT00749996|353140|P1|Overall Study|Death|1
102344|NCT00749996|353139|P2|Overall Study|Adverse Event|0
102345|NCT00749996|353140|P1|Overall Study|Adverse Event|1
102346|NCT00749996|353139|P2|Overall Study|Pregnancy|2
102347|NCT00749996|353140|P1|Overall Study|Pregnancy|0
102348|NCT00749996|353139|P2|Overall Study|Physician Decision|0
102349|NCT00749996|353140|P1|Overall Study|Physician Decision|2
102350|NCT00749996|353139|P2|Overall Study|Protocol Violation|3
102351|NCT00749996|353140|P1|Overall Study|Protocol Violation|2
102352|NCT00749996|353139|P2|Overall Study|Withdrawal by Subject|4
102353|NCT00749996|353140|P1|Overall Study|Withdrawal by Subject|5
102354|NCT00749996|353139|P2|Overall Study|Lost to Follow-up|4
102355|NCT00749996|353140|P1|Overall Study|Lost to Follow-up|7
102356|NCT00749944|353163|P2|Overall Study|Withdrawal by Subject|0
102357|NCT00749944|353164|P1|Overall Study|Withdrawal by Subject|2
102358|NCT00749944|353163|P2|Overall Study|Not specified|0
102359|NCT00749944|353164|P1|Overall Study|Not specified|1
102360|NCT00749944|353163|P2|Overall Study|Lost to Follow-up|1
102361|NCT00749944|353164|P1|Overall Study|Lost to Follow-up|2
102362|NCT00749775|353243|P1|Overall Study|No drug administration|3
102363|NCT00749775|353243|P1|Overall Study|No visit after first day of treatment|44
102364|NCT00749775|353243|P1|Overall Study|Lost to Follow-up|36
102365|NCT00749775|353243|P1|Overall Study|Protocol Violation|24
102366|NCT00749684|353259|P1|Overall Study|Missing|9
102367|NCT00749684|353259|P1|Overall Study|AE+discontinuation on participants wish|1
102368|NCT00749684|353259|P1|Overall Study|Therapy according to protocol + AE|2
102369|NCT00749684|353259|P1|Overall Study|Progressive Desease|31
102370|NCT00749684|353259|P1|Overall Study|Not Documented|1
102371|NCT00749684|353259|P1|Overall Study|Participant's Wish|10
102372|NCT00749684|353259|P1|Overall Study|Adverse Event|27
102373|NCT00749684|353259|P1|Overall Study|Death|1
102374|NCT00749580|353277|P2|Overall Study|Adverse Event|1
102375|NCT00749580|353278|P1|Overall Study|Adverse Event|0
102376|NCT00749580|353277|P2|Overall Study|Lost to Follow-up|8
102377|NCT00749580|353278|P1|Overall Study|Lost to Follow-up|4
102378|NCT00749463|353293|P3|Overall Study|Withdrawal by Subject|0
102379|NCT00749463|353294|P2|Overall Study|Withdrawal by Subject|0
102380|NCT00749463|353295|P1|Overall Study|Withdrawal by Subject|1
102381|NCT00749463|353293|P3|Overall Study|Adverse Event|1
102382|NCT00749463|353294|P2|Overall Study|Adverse Event|4
102383|NCT00749463|353295|P1|Overall Study|Adverse Event|0
102384|NCT00749398|353321|P1|Overall Study|Unknown reason|1
102385|NCT00749398|353321|P1|Overall Study|Reason not specified|2
102386|NCT00749398|353321|P1|Overall Study|Lost to Follow-up|11
102387|NCT00749398|353321|P1|Overall Study|Withdrawal by Subject|17
102388|NCT00749398|353321|P1|Overall Study|Serious adverse event|11
102389|NCT00749398|353321|P1|Overall Study|Adverse Event|4
102390|NCT00749398|353321|P1|Overall Study|Lack of Efficacy|7
102391|NCT00749190|353369|P7|Overall Study|Other reason not defined above|0
102392|NCT00749190|353370|P6|Overall Study|Other reason not defined above|0
102393|NCT00749190|353371|P5|Overall Study|Other reason not defined above|0
102394|NCT00749190|353372|P4|Overall Study|Other reason not defined above|1
102395|NCT00749190|353373|P3|Overall Study|Other reason not defined above|0
102396|NCT00749190|353374|P2|Overall Study|Other reason not defined above|0
102397|NCT00749190|353375|P1|Overall Study|Other reason not defined above|0
102398|NCT00749190|353369|P7|Overall Study|Protocol Violation|1
102399|NCT00749190|353370|P6|Overall Study|Protocol Violation|0
102400|NCT00749190|353371|P5|Overall Study|Protocol Violation|0
102401|NCT00749190|353372|P4|Overall Study|Protocol Violation|0
102402|NCT00749190|353373|P3|Overall Study|Protocol Violation|0
102403|NCT00749190|353374|P2|Overall Study|Protocol Violation|1
102404|NCT00749190|353375|P1|Overall Study|Protocol Violation|0
102405|NCT00749190|353369|P7|Overall Study|Withdrawal by Subject|0
102406|NCT00749190|353370|P6|Overall Study|Withdrawal by Subject|1
102407|NCT00749190|353371|P5|Overall Study|Withdrawal by Subject|0
102408|NCT00749190|353372|P4|Overall Study|Withdrawal by Subject|0
102409|NCT00749190|353373|P3|Overall Study|Withdrawal by Subject|0
102410|NCT00749190|353374|P2|Overall Study|Withdrawal by Subject|1
102411|NCT00749190|353375|P1|Overall Study|Withdrawal by Subject|2
102412|NCT00749190|353369|P7|Overall Study|Lack of Efficacy|0
102413|NCT00749190|353370|P6|Overall Study|Lack of Efficacy|1
102414|NCT00749190|353371|P5|Overall Study|Lack of Efficacy|0
102415|NCT00749190|353372|P4|Overall Study|Lack of Efficacy|0
102416|NCT00749190|353373|P3|Overall Study|Lack of Efficacy|1
102417|NCT00749190|353374|P2|Overall Study|Lack of Efficacy|1
102418|NCT00749190|353375|P1|Overall Study|Lack of Efficacy|3
102419|NCT00749190|353369|P7|Overall Study|Adverse Event|0
102420|NCT00749190|353370|P6|Overall Study|Adverse Event|3
102421|NCT00749190|353371|P5|Overall Study|Adverse Event|0
102422|NCT00749190|353372|P4|Overall Study|Adverse Event|4
102423|NCT00749190|353373|P3|Overall Study|Adverse Event|0
102424|NCT00749190|353374|P2|Overall Study|Adverse Event|2
102425|NCT00749190|353375|P1|Overall Study|Adverse Event|0
102426|NCT00748709|353528|P1|Overall Study|Other Reasons|1
102427|NCT00748709|353528|P1|Overall Study|Withdrawal by Subject|1
102428|NCT00748709|353528|P1|Overall Study|Other Adverse Event|1
102429|NCT00748709|353528|P1|Overall Study|Drug reducing Toxity|2
102430|NCT00748709|353528|P1|Overall Study|Progressive disease|15
102431|NCT00748566|353555|P1|Overall Study|Unspecified|9
102432|NCT00748566|353555|P1|Overall Study|Study terminated by sponsor|5
102433|NCT00748566|353555|P1|Overall Study|Withdrawal by Subject|22
102434|NCT00748566|353555|P1|Overall Study|Protocol Violation|13
102435|NCT00748566|353555|P1|Overall Study|Lost to Follow-up|1
102436|NCT00748566|353555|P1|Overall Study|Lack of Efficacy|12
102437|NCT00748566|353555|P1|Overall Study|Death|1
102438|NCT00748566|353555|P1|Overall Study|Adverse Event|49
102439|NCT00748241|353583|P1|Overall Study|Death|2
102440|NCT00748241|353583|P1|Overall Study|Lost to Follow-up|5
102441|NCT00748241|353583|P1|Overall Study|Implant failure|1
102442|NCT00748189|353593|P2|Overall Study|Ongoing|162
102443|NCT00748189|353594|P1|Overall Study|Ongoing|155
102444|NCT00748189|353593|P2|Overall Study|Study terminated by Sponsor|1
102445|NCT00748189|353594|P1|Overall Study|Study terminated by Sponsor|0
102446|NCT00748189|353593|P2|Overall Study|Lost to Follow-up|4
102447|NCT00748189|353594|P1|Overall Study|Lost to Follow-up|2
102448|NCT00748189|353593|P2|Overall Study|Physician Decision|4
102449|NCT00748189|353594|P1|Overall Study|Physician Decision|13
102450|NCT00748189|353593|P2|Overall Study|Withdrawal by Subject|16
102451|NCT00748189|353594|P1|Overall Study|Withdrawal by Subject|15
102452|NCT00748189|353593|P2|Overall Study|Death|34
102453|NCT00748189|353594|P1|Overall Study|Death|40
102454|NCT00748098|353648|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
102455|NCT00748098|353649|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
102456|NCT00748098|353648|P2|Second Treatment Intervention Period|Lost to Follow-up|1
102457|NCT00748098|353649|P1|Second Treatment Intervention Period|Lost to Follow-up|1
102458|NCT00748098|353648|P2|Second Treatment Intervention Period|Adverse Event|1
102459|NCT00748098|353649|P1|Second Treatment Intervention Period|Adverse Event|4
102460|NCT00748098|353648|P2|1-Week Washout Period|Withdrawal by Subject|0
102461|NCT00748098|353649|P1|1-Week Washout Period|Withdrawal by Subject|2
102462|NCT00748098|353648|P2|1-Week Washout Period|Adverse Event|1
102463|NCT00748098|353649|P1|1-Week Washout Period|Adverse Event|0
102464|NCT00748098|353648|P2|First Taper Period|Protocol Stopping Criteria Met|1
102465|NCT00748098|353649|P1|First Taper Period|Protocol Stopping Criteria Met|0
102466|NCT00748098|353648|P2|First Taper Period|Withdrawal by Subject|0
102467|NCT00748098|353649|P1|First Taper Period|Withdrawal by Subject|2
102468|NCT00748098|353648|P2|First Taper Period|Protocol Violation|0
102469|NCT00748098|353649|P1|First Taper Period|Protocol Violation|1
102470|NCT00748098|353648|P2|First Treatment Intervention Period|Withdrawal by Subject|0
102471|NCT00748098|353649|P1|First Treatment Intervention Period|Withdrawal by Subject|2
102472|NCT00748098|353648|P2|First Treatment Intervention Period|Lost to Follow-up|0
102473|NCT00748098|353649|P1|First Treatment Intervention Period|Lost to Follow-up|1
102474|NCT00748098|353648|P2|First Treatment Intervention Period|Protocol Violation|0
102475|NCT00748098|353649|P1|First Treatment Intervention Period|Protocol Violation|1
102476|NCT00748098|353648|P2|First Treatment Intervention Period|Adverse Event|1
102477|NCT00748098|353649|P1|First Treatment Intervention Period|Adverse Event|1
102478|NCT00746356|353734|P2|Overall Study|Patient relocated|0
102479|NCT00746356|353735|P1|Overall Study|Patient relocated|1
102480|NCT00746356|353734|P2|Overall Study|Removal of Device|1
102481|NCT00746356|353735|P1|Overall Study|Removal of Device|0
102482|NCT00746356|353734|P2|Overall Study|Lost to Follow-up|0
102483|NCT00746356|353735|P1|Overall Study|Lost to Follow-up|1
102484|NCT00746356|353734|P2|Overall Study|Death|3
102485|NCT00746356|353735|P1|Overall Study|Death|7
102486|NCT00746356|353734|P2|Overall Study|Withdrawal by Subject|3
102487|NCT00746356|353735|P1|Overall Study|Withdrawal by Subject|2
102488|NCT00746330|353747|P4|Period 1|Abnormal test procedure result|0
102489|NCT00746330|353748|P3|Period 1|Abnormal test procedure result|1
102490|NCT00746330|353749|P2|Period 1|Abnormal test procedure result|0
102491|NCT00746330|353750|P1|Period 1|Abnormal test procedure result|0
102492|NCT00747812|353785|P2|Overall Study|Research Site Staff Relocation|3
102493|NCT00747812|353786|P1|Overall Study|Research Site Staff Relocation|5
102494|NCT00747643|353824|P2|Overall Study|Withdrawal by Subject|27
102495|NCT00747643|353825|P1|Overall Study|Withdrawal by Subject|36
102496|NCT00747617|353839|P2|Overall Study|Lost to Follow-up|1
102497|NCT00747617|353840|P1|Overall Study|Lost to Follow-up|3
102498|NCT00747565|353848|P2|Overall Study|Lost to Follow-up|1
102499|NCT00747565|353849|P1|Overall Study|Lost to Follow-up|4
102500|NCT00747565|353848|P2|Overall Study|Withdrawal by Subject|6
102501|NCT00747565|353849|P1|Overall Study|Withdrawal by Subject|10
102502|NCT00747474|353862|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
102503|NCT00747474|353863|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
102504|NCT00747474|353864|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
102505|NCT00747474|353865|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
102506|NCT00747474|353866|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
102507|NCT00747474|353867|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
102508|NCT00747474|353868|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
102509|NCT00747474|353869|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
102510|NCT00747474|353870|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
102511|NCT00747474|353871|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
102512|NCT00747474|353872|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
102513|NCT00747474|353873|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
102514|NCT00747461|353899|P1|Overall Study|study terminated by sponsor|5
102515|NCT00747344|353906|P4|After Controlled Period|Adverse Event|1
102516|NCT00747344|353907|P3|After Controlled Period|Adverse Event|0
102517|NCT00747344|353908|P2|After Controlled Period|Adverse Event|0
102518|NCT00747344|353909|P1|After Controlled Period|Adverse Event|0
102519|NCT00747344|353906|P4|Controlled Period|Other|0
102520|NCT00747344|353907|P3|Controlled Period|Other|0
102521|NCT00747344|353908|P2|Controlled Period|Other|3
102522|NCT00747344|353909|P1|Controlled Period|Other|0
102523|NCT00747344|353906|P4|Controlled Period|Lack of Efficacy|0
102524|NCT00747344|353907|P3|Controlled Period|Lack of Efficacy|0
102525|NCT00747344|353908|P2|Controlled Period|Lack of Efficacy|1
102526|NCT00747344|353909|P1|Controlled Period|Lack of Efficacy|2
102527|NCT00747344|353906|P4|Controlled Period|Adverse Event|0
102528|NCT00747344|353907|P3|Controlled Period|Adverse Event|0
102529|NCT00747344|353908|P2|Controlled Period|Adverse Event|0
102530|NCT00747344|353909|P1|Controlled Period|Adverse Event|3
102531|NCT00747227|353927|P2|Overall Study|Illness|1
102532|NCT00747227|353928|P1|Overall Study|Illness|1
102533|NCT00747227|353927|P2|Overall Study|Lost to Follow-up|2
102534|NCT00747227|353928|P1|Overall Study|Lost to Follow-up|1
102535|NCT00747227|353927|P2|Overall Study|Withdrawal by Subject|0
102536|NCT00747227|353928|P1|Overall Study|Withdrawal by Subject|1
102537|NCT00747227|353927|P2|Overall Study|Death|1
102538|NCT00747227|353928|P1|Overall Study|Death|3
102539|NCT00747149|353957|P2|Overall Study|Not reported|4
102540|NCT00747149|353958|P1|Overall Study|Not reported|1
102541|NCT00747149|353957|P2|Overall Study|Severe non-compliance to protocol|1
102542|NCT00747149|353958|P1|Overall Study|Severe non-compliance to protocol|0
102543|NCT00747149|353957|P2|Overall Study|Incorrect enrollment|6
102544|NCT00747149|353958|P1|Overall Study|Incorrect enrollment|0
102545|NCT00747149|353957|P2|Overall Study|Did not receive treatment|1
102546|NCT00747149|353958|P1|Overall Study|Did not receive treatment|0
102547|NCT00747149|353957|P2|Overall Study|Withdrawal by Subject|6
102548|NCT00747149|353958|P1|Overall Study|Withdrawal by Subject|0
102549|NCT00747149|353957|P2|Overall Study|Lost to Follow-up|10
102550|NCT00747149|353958|P1|Overall Study|Lost to Follow-up|0
102551|NCT00747149|353957|P2|Overall Study|Adverse Event|15
102552|NCT00747149|353958|P1|Overall Study|Adverse Event|0
102553|NCT00747006|353973|P3|Overall Study|Physician Decision|1
102554|NCT00747006|353974|P2|Overall Study|Physician Decision|0
102555|NCT00747006|353975|P1|Overall Study|Physician Decision|2
102556|NCT00747006|353973|P3|Overall Study|Lost to Follow-up|0
102557|NCT00747006|353974|P2|Overall Study|Lost to Follow-up|1
102558|NCT00747006|353975|P1|Overall Study|Lost to Follow-up|0
102559|NCT00747006|353973|P3|Overall Study|Adverse Event|0
102560|NCT00747006|353974|P2|Overall Study|Adverse Event|0
102561|NCT00747006|353975|P1|Overall Study|Adverse Event|1
102562|NCT00746941|354053|P4|Overall Study|Adverse Event|1
102563|NCT00746941|354054|P3|Overall Study|Adverse Event|0
102564|NCT00746941|354055|P2|Overall Study|Adverse Event|0
102565|NCT00746941|354056|P1|Overall Study|Adverse Event|0
102566|NCT00746941|354053|P4|Overall Study|Other, reason not provided|4
102567|NCT00746941|354054|P3|Overall Study|Other, reason not provided|0
102568|NCT00746941|354055|P2|Overall Study|Other, reason not provided|4
102569|NCT00746941|354056|P1|Overall Study|Other, reason not provided|2
102570|NCT00746941|354053|P4|Overall Study|Withdrawal by Subject|2
102571|NCT00746941|354054|P3|Overall Study|Withdrawal by Subject|0
102572|NCT00746941|354055|P2|Overall Study|Withdrawal by Subject|0
102573|NCT00746941|354056|P1|Overall Study|Withdrawal by Subject|3
102574|NCT00746941|354053|P4|Overall Study|Physician Decision|0
102575|NCT00746941|354054|P3|Overall Study|Physician Decision|2
102576|NCT00746941|354055|P2|Overall Study|Physician Decision|0
102577|NCT00746941|354056|P1|Overall Study|Physician Decision|0
102578|NCT00746941|354053|P4|Overall Study|Death|6
102579|NCT00746941|354054|P3|Overall Study|Death|0
102580|NCT00746941|354055|P2|Overall Study|Death|0
102581|NCT00746941|354056|P1|Overall Study|Death|2
102582|NCT00746798|354114|P4|Overall Study|Participant unable to return for visit|0
102583|NCT00746798|354115|P3|Overall Study|Participant unable to return for visit|0
102584|NCT00746798|354116|P2|Overall Study|Participant unable to return for visit|0
102585|NCT00746798|354117|P1|Overall Study|Participant unable to return for visit|1
102586|NCT00746798|354114|P4|Overall Study|Death|0
102587|NCT00746798|354115|P3|Overall Study|Death|2
102588|NCT00746798|354116|P2|Overall Study|Death|0
102589|NCT00746798|354117|P1|Overall Study|Death|0
102590|NCT00746798|354114|P4|Overall Study|Withdrawal by Subject|0
102591|NCT00746798|354115|P3|Overall Study|Withdrawal by Subject|1
102592|NCT00746798|354116|P2|Overall Study|Withdrawal by Subject|1
102593|NCT00746798|354117|P1|Overall Study|Withdrawal by Subject|0
102594|NCT00746798|354114|P4|Overall Study|Protocol Violation|0
102595|NCT00746798|354115|P3|Overall Study|Protocol Violation|0
102596|NCT00746798|354116|P2|Overall Study|Protocol Violation|1
102597|NCT00746798|354117|P1|Overall Study|Protocol Violation|0
102598|NCT00746785|354142|P3|Overall Study|Lost to Follow-up|27
102599|NCT00746785|354143|P2|Overall Study|Lost to Follow-up|25
102600|NCT00746785|354144|P1|Overall Study|Lost to Follow-up|29
102601|NCT00746733|354152|P2|Third Intervention|Withdrawal by Subject|1
102602|NCT00746733|354153|P1|Third Intervention|Withdrawal by Subject|1
102603|NCT00746733|354152|P2|Second Intervention|Adverse Event|0
102604|NCT00746733|354153|P1|Second Intervention|Adverse Event|1
102605|NCT00746590|354237|P1|Overall Study|Death|1
102606|NCT00746564|354241|P1|Overall Study|Required Pacemaker/ICD Implant|2
102607|NCT00746551|354256|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
102608|NCT00746551|354257|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
102609|NCT00746551|354256|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
102610|NCT00746551|354257|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
102611|NCT00746551|354256|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
102612|NCT00746551|354257|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
102613|NCT00746096|354276|P2|Overall Study|No study drug treatment|1
102614|NCT00746096|354277|P1|Overall Study|No study drug treatment|1
102615|NCT00746096|354276|P2|Overall Study|Protocol Violation|0
102616|NCT00746096|354277|P1|Overall Study|Protocol Violation|1
102617|NCT00746096|354276|P2|Overall Study|Lost to Follow-up|1
102618|NCT00746096|354277|P1|Overall Study|Lost to Follow-up|2
102619|NCT00746096|354276|P2|Overall Study|Withdrawal by Subject|1
102620|NCT00746096|354277|P1|Overall Study|Withdrawal by Subject|5
102621|NCT00746096|354276|P2|Overall Study|Adverse Event|0
102622|NCT00746096|354277|P1|Overall Study|Adverse Event|1
102623|NCT00745901|354304|P2|Overall Study|Patient didn't take any study medication|3
102624|NCT00745901|354305|P1|Overall Study|Patient didn't take any study medication|7
102625|NCT00745901|354304|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
102626|NCT00745901|354305|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
102627|NCT00745901|354304|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
102628|NCT00745901|354305|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
102629|NCT00745901|354304|P2|Overall Study|Patient's next menses did not start with|0
102630|NCT00745901|354305|P1|Overall Study|Patient's next menses did not start with|1
102631|NCT00745901|354304|P2|Overall Study|Lack of compliance|2
102632|NCT00745901|354305|P1|Overall Study|Lack of compliance|2
102633|NCT00745901|354304|P2|Overall Study|Pregnancy|4
102634|NCT00745901|354305|P1|Overall Study|Pregnancy|2
102635|NCT00745901|354304|P2|Overall Study|Lost to Follow-up|4
102636|NCT00745901|354305|P1|Overall Study|Lost to Follow-up|7
102637|NCT00745901|354304|P2|Overall Study|Withdrawal by Subject|0
102638|NCT00745901|354305|P1|Overall Study|Withdrawal by Subject|1
102639|NCT00745901|354304|P2|Overall Study|Protocol Violation|1
102640|NCT00745901|354305|P1|Overall Study|Protocol Violation|0
102641|NCT00745901|354304|P2|Overall Study|Adverse Event|4
102642|NCT00745901|354305|P1|Overall Study|Adverse Event|3
102643|NCT00745875|354351|P2|Overall Study|Continuing study treatment|4
102644|NCT00745875|354352|P1|Overall Study|Continuing study treatment|4
102645|NCT00745823|354362|P2|Overall Study|Study Terminated by Sponsor|349
102646|NCT00745823|354363|P1|Overall Study|Study Terminated by Sponsor|326
102647|NCT00745823|354362|P2|Overall Study|Withdrawal by Subject|8
102648|NCT00745823|354363|P1|Overall Study|Withdrawal by Subject|14
102649|NCT00745823|354362|P2|Overall Study|Pregnancy|4
102650|NCT00745823|354363|P1|Overall Study|Pregnancy|0
102651|NCT00745823|354362|P2|Overall Study|Physician Decision|5
102652|NCT00745823|354363|P1|Overall Study|Physician Decision|10
102653|NCT00745823|354362|P2|Overall Study|Lost to Follow-up|11
102654|NCT00745823|354363|P1|Overall Study|Lost to Follow-up|10
102655|NCT00745823|354362|P2|Overall Study|Lack of Efficacy|6
102656|NCT00745823|354363|P1|Overall Study|Lack of Efficacy|20
102657|NCT00745823|354362|P2|Overall Study|Adverse Event|3
102658|NCT00745823|354363|P1|Overall Study|Adverse Event|5
102659|NCT00745498|354390|P3|Overall Study|Edophthalmitis after preoperative IVB|0
102660|NCT00745498|354391|P2|Overall Study|Edophthalmitis after preoperative IVB|0
102661|NCT00745498|354392|P1|Overall Study|Edophthalmitis after preoperative IVB|1
102662|NCT00745498|354390|P3|Overall Study|Non-PDR related VH|1
102663|NCT00745498|354391|P2|Overall Study|Non-PDR related VH|1
102664|NCT00745498|354392|P1|Overall Study|Non-PDR related VH|0
102665|NCT00745498|354390|P3|Overall Study|Injection of intravitreal silicone oil o|4
102666|NCT00745498|354391|P2|Overall Study|Injection of intravitreal silicone oil o|4
102667|NCT00745498|354392|P1|Overall Study|Injection of intravitreal silicone oil o|3
102668|NCT00745498|354390|P3|Overall Study|Lost to Follow-up|3
102669|NCT00745498|354391|P2|Overall Study|Lost to Follow-up|1
102670|NCT00745498|354392|P1|Overall Study|Lost to Follow-up|1
102671|NCT00744328|354432|P3|Overall Study|Found ineligible after randomization|1
102672|NCT00744328|354433|P2|Overall Study|Found ineligible after randomization|0
102673|NCT00744328|354434|P1|Overall Study|Found ineligible after randomization|0
102674|NCT00744328|354432|P3|Overall Study|Withdrawal by Subject|4
102675|NCT00744328|354433|P2|Overall Study|Withdrawal by Subject|3
102676|NCT00744328|354434|P1|Overall Study|Withdrawal by Subject|5
102677|NCT00744328|354432|P3|Overall Study|Lost to Follow-up|3
102678|NCT00744328|354433|P2|Overall Study|Lost to Follow-up|5
102679|NCT00744328|354434|P1|Overall Study|Lost to Follow-up|2
102680|NCT00744263|354444|P2|Overall Study|Unspecified|2
102681|NCT00744263|354445|P1|Overall Study|Unspecified|2
102682|NCT00744263|354444|P2|Overall Study|Adverse Event|0
102683|NCT00744263|354445|P1|Overall Study|Adverse Event|1
102684|NCT00744263|354444|P2|Overall Study|Protocol Violation|5
102685|NCT00744263|354445|P1|Overall Study|Protocol Violation|3
102686|NCT00744263|354444|P2|Overall Study|Physician Decision|23
102687|NCT00744263|354445|P1|Overall Study|Physician Decision|20
102688|NCT00744263|354444|P2|Overall Study|Withdrawal by Subject|150
102689|NCT00744263|354445|P1|Overall Study|Withdrawal by Subject|166
102690|NCT00744263|354444|P2|Overall Study|Lost to Follow-up|2135
102691|NCT00744263|354445|P1|Overall Study|Lost to Follow-up|2038
102692|NCT00744263|354444|P2|Overall Study|Death|3005
102693|NCT00744263|354445|P1|Overall Study|Death|3006
102694|NCT00744237|354468|P3|Overall Study|Adverse Event|5
102695|NCT00744237|354469|P2|Overall Study|Adverse Event|13
102696|NCT00744237|354470|P1|Overall Study|Adverse Event|9
102697|NCT00744237|354468|P3|Overall Study|Administrative. Site Closed|1
102698|NCT00744237|354469|P2|Overall Study|Administrative. Site Closed|1
102699|NCT00744237|354470|P1|Overall Study|Administrative. Site Closed|1
102700|NCT00744237|354468|P3|Overall Study|Poor Compliance|0
102701|NCT00744237|354469|P2|Overall Study|Poor Compliance|2
102702|NCT00744237|354470|P1|Overall Study|Poor Compliance|0
102703|NCT00744237|354468|P3|Overall Study|Prohibited Concomitant Medication|1
102704|NCT00744237|354469|P2|Overall Study|Prohibited Concomitant Medication|0
102705|NCT00744237|354470|P1|Overall Study|Prohibited Concomitant Medication|0
102706|NCT00744237|354468|P3|Overall Study|Study Drug Error|0
102707|NCT00744237|354469|P2|Overall Study|Study Drug Error|0
102708|NCT00744237|354470|P1|Overall Study|Study Drug Error|1
102709|NCT00744237|354468|P3|Overall Study|Dosing Error|1
102710|NCT00744237|354469|P2|Overall Study|Dosing Error|0
102711|NCT00744237|354470|P1|Overall Study|Dosing Error|1
102712|NCT00744237|354468|P3|Overall Study|Inclusion/Exclusion criteria not met|0
102713|NCT00744237|354469|P2|Overall Study|Inclusion/Exclusion criteria not met|0
102714|NCT00744237|354470|P1|Overall Study|Inclusion/Exclusion criteria not met|1
102715|NCT00744237|354468|P3|Overall Study|Protocol Violation|3
102716|NCT00744237|354469|P2|Overall Study|Protocol Violation|4
102717|NCT00744237|354470|P1|Overall Study|Protocol Violation|3
102718|NCT00744237|354468|P3|Overall Study|Lost to Follow-up|1
102719|NCT00744237|354469|P2|Overall Study|Lost to Follow-up|1
102720|NCT00744237|354470|P1|Overall Study|Lost to Follow-up|1
102721|NCT00744237|354468|P3|Overall Study|Withdrawal by Subject|3
102722|NCT00744237|354469|P2|Overall Study|Withdrawal by Subject|5
102723|NCT00744237|354470|P1|Overall Study|Withdrawal by Subject|9
102724|NCT00744237|354468|P3|Overall Study|Lack of Efficacy|0
102725|NCT00744237|354469|P2|Overall Study|Lack of Efficacy|1
102726|NCT00744237|354470|P1|Overall Study|Lack of Efficacy|1
102727|NCT00745368|354481|P1|Overall Study|Unable to provide sample|3
102728|NCT00745251|354503|P2|Overall Study|Withdrawal by Subject|1
102729|NCT00745251|354504|P1|Overall Study|Withdrawal by Subject|1
102730|NCT00745251|354503|P2|Overall Study|Adverse Event|2
102731|NCT00745251|354504|P1|Overall Study|Adverse Event|1
102732|NCT00745095|354518|P6|Overall Study|Ineligible due to GFR criteria|28
102733|NCT00745095|354519|P5|Overall Study|Ineligible due to GFR criteria|30
102734|NCT00745095|354520|P4|Overall Study|Ineligible due to GFR criteria|3
102735|NCT00745095|354521|P3|Overall Study|Ineligible due to GFR criteria|3
102736|NCT00745095|354522|P2|Overall Study|Ineligible due to GFR criteria|2
102737|NCT00745095|354523|P1|Overall Study|Ineligible due to GFR criteria|0
102738|NCT00745095|354518|P6|Overall Study|Declined to participate|95
102739|NCT00745095|354519|P5|Overall Study|Declined to participate|92
102740|NCT00745095|354520|P4|Overall Study|Declined to participate|0
102741|NCT00745095|354521|P3|Overall Study|Declined to participate|0
102742|NCT00745095|354522|P2|Overall Study|Declined to participate|0
102743|NCT00745095|354523|P1|Overall Study|Declined to participate|1
102744|NCT00744978|354554|P2|Period 2|Adverse Event|1
102745|NCT00744978|354555|P1|Period 2|Adverse Event|0
102746|NCT00744978|354554|P2|Period 1|Randomized but not Treated|1
102747|NCT00744978|354555|P1|Period 1|Randomized but not Treated|1
102748|NCT00744978|354554|P2|Period 1|Adverse Event|0
102749|NCT00744978|354555|P1|Period 1|Adverse Event|4
102750|NCT00744978|354554|P2|Period 1|Unspecified|2
102751|NCT00744978|354555|P1|Period 1|Unspecified|0
102752|NCT00744978|354554|P2|Period 1|Withdrawal by Subject|2
102753|NCT00744978|354555|P1|Period 1|Withdrawal by Subject|0
102754|NCT00744978|354554|P2|Period 1|Lost to Follow-up|0
102755|NCT00744978|354555|P1|Period 1|Lost to Follow-up|1
102756|NCT00744939|354607|P1|Overall Study|incorrect race|1
102757|NCT00744939|354607|P1|Overall Study|coma|1
102758|NCT00744939|354607|P1|Overall Study|Failed inclusion/exclusion criteria|19
102759|NCT00744939|354607|P1|Overall Study|Did not receive Magnevist|7
102760|NCT00744939|354607|P1|Overall Study|Medical history exclusionary|1
102761|NCT00744939|354607|P1|Overall Study|Lost to Follow-up|12
102762|NCT00744939|354607|P1|Overall Study|distance|4
102763|NCT00744939|354607|P1|Overall Study|Death|24
102764|NCT00744939|354607|P1|Overall Study|Protocol Violation|13
102765|NCT00744939|354607|P1|Overall Study|Withdrawal by Subject|9
102766|NCT00744874|354643|P1|Overall Study|Unable to accomodate schedule|1
102767|NCT00744874|354643|P1|Overall Study|Study Device not available at procedure|1
102768|NCT00744874|354643|P1|Overall Study|Withdrawal by Subject|1
102769|NCT00744874|354643|P1|Overall Study|Lost to Follow-up|1
102770|NCT00744757|354668|P1|Overall Study|Adverse Event|2
102771|NCT00744757|354668|P1|Overall Study|Death|6
102772|NCT00744757|354668|P1|Overall Study|Withdrawal by Subject|1
102773|NCT00744757|354668|P1|Overall Study|Physician Decision|5
102774|NCT00744757|354668|P1|Overall Study|Objective disease progression|7
102775|NCT00744653|354693|P1|Overall Study|Physician Decision|3
102776|NCT00744653|354693|P1|Overall Study|Lost to Follow-up|1
102777|NCT00744653|354693|P1|Overall Study|Death|1
102778|NCT00744653|354693|P1|Overall Study|antineoplastic treatment|11
102779|NCT00744627|354701|P2|Overall Study|Other|0
102780|NCT00744627|354702|P1|Overall Study|Other|1
102781|NCT00744627|354701|P2|Overall Study|Lost to Follow-up|1
102782|NCT00744627|354702|P1|Overall Study|Lost to Follow-up|2
102783|NCT00744627|354701|P2|Overall Study|Voluntary Withdrawal|6
102784|NCT00744627|354702|P1|Overall Study|Voluntary Withdrawal|9
102785|NCT00744627|354701|P2|Overall Study|Protocol Deviations|2
102786|NCT00744627|354702|P1|Overall Study|Protocol Deviations|0
102787|NCT00744627|354701|P2|Overall Study|Noncompliance|1
102788|NCT00744627|354702|P1|Overall Study|Noncompliance|0
102789|NCT00744627|354701|P2|Overall Study|Lack of Efficacy|3
102790|NCT00744627|354702|P1|Overall Study|Lack of Efficacy|7
102791|NCT00744627|354701|P2|Overall Study|Adverse Event|9
102792|NCT00744627|354702|P1|Overall Study|Adverse Event|6
102793|NCT00744523|354758|P2|30 Days After the Procedure|Insufficient follow-up|5
102794|NCT00744523|354759|P1|30 Days After the Procedure|Insufficient follow-up|0
102795|NCT00744497|354779|P2|Overall Study|Not defined|13
102796|NCT00744497|354780|P1|Overall Study|Not defined|19
102797|NCT00744497|354779|P2|Overall Study|Maximum clinical benefit|142
102798|NCT00744497|354780|P1|Overall Study|Maximum clinical benefit|141
102799|NCT00744497|354779|P2|Overall Study|Patient requested to stop study drug|80
102800|NCT00744497|354780|P1|Overall Study|Patient requested to stop study drug|65
102801|NCT00744497|354779|P2|Overall Study|Adverse event unrelated to study drug|122
102802|NCT00744497|354780|P1|Overall Study|Adverse event unrelated to study drug|78
102803|NCT00744497|354779|P2|Overall Study|Study drug toxicity|141
102804|NCT00744497|354780|P1|Overall Study|Study drug toxicity|68
102805|NCT00744497|354779|P2|Overall Study|Disease progression|219
102806|NCT00744497|354780|P1|Overall Study|Disease progression|312
102807|NCT00744497|354779|P2|Overall Study|Administrative Reason By Sponsor|8
102808|NCT00744497|354780|P1|Overall Study|Administrative Reason By Sponsor|25
102809|NCT00744497|354779|P2|Overall Study|No longer meets study criteria|3
102810|NCT00744497|354780|P1|Overall Study|No longer meets study criteria|7
102811|NCT00744497|354779|P2|Overall Study|Poor compliance/noncompliance|5
102812|NCT00744497|354780|P1|Overall Study|Poor compliance/noncompliance|9
102813|NCT00744497|354779|P2|Overall Study|Lost to Follow-up|2
102814|NCT00744497|354780|P1|Overall Study|Lost to Follow-up|4
102815|NCT00744497|354779|P2|Overall Study|Death|9
102816|NCT00744497|354780|P1|Overall Study|Death|11
102817|NCT00744497|354779|P2|Overall Study|Withdrawal by Subject|18
102818|NCT00744497|354780|P1|Overall Study|Withdrawal by Subject|21
102819|NCT00744055|354816|P2|Overall Study|Lost to Follow-up|1
102820|NCT00744055|354817|P1|Overall Study|Lost to Follow-up|0
102821|NCT00744055|354816|P2|Overall Study|Protocol Violation|1
102822|NCT00744055|354817|P1|Overall Study|Protocol Violation|1
102823|NCT00744055|354816|P2|Overall Study|Physician Decision|2
102824|NCT00744055|354817|P1|Overall Study|Physician Decision|0
102825|NCT00744055|354816|P2|Overall Study|Lack of Efficacy|1
102826|NCT00744055|354817|P1|Overall Study|Lack of Efficacy|0
102827|NCT00744055|354816|P2|Overall Study|Withdrawal by Subject|9
102828|NCT00744055|354817|P1|Overall Study|Withdrawal by Subject|6
102829|NCT00744042|354825|P1|Overall Study|Withdrawal by Subject|1
102830|NCT00743652|354868|P5|Overall Study|Lost to Follow-up|0
102831|NCT00743652|354869|P4|Overall Study|Lost to Follow-up|0
102832|NCT00743652|354870|P3|Overall Study|Lost to Follow-up|0
102833|NCT00743652|354871|P2|Overall Study|Lost to Follow-up|0
102834|NCT00743652|354872|P1|Overall Study|Lost to Follow-up|1
102835|NCT00743652|354868|P5|Overall Study|Unspecified|0
102836|NCT00743652|354869|P4|Overall Study|Unspecified|0
102837|NCT00743652|354870|P3|Overall Study|Unspecified|0
102838|NCT00743652|354871|P2|Overall Study|Unspecified|1
102839|NCT00743652|354872|P1|Overall Study|Unspecified|1
102840|NCT00743652|354868|P5|Overall Study|Investigator Request|0
102841|NCT00743652|354869|P4|Overall Study|Investigator Request|2
102842|NCT00743652|354870|P3|Overall Study|Investigator Request|0
102843|NCT00743652|354871|P2|Overall Study|Investigator Request|0
102844|NCT00743652|354872|P1|Overall Study|Investigator Request|0
102845|NCT00743652|354868|P5|Overall Study|Death|0
102846|NCT00743652|354869|P4|Overall Study|Death|0
102847|NCT00743652|354870|P3|Overall Study|Death|0
102848|NCT00743652|354871|P2|Overall Study|Death|0
102849|NCT00743652|354872|P1|Overall Study|Death|2
102850|NCT00743652|354868|P5|Overall Study|Adverse Event|0
102851|NCT00743652|354869|P4|Overall Study|Adverse Event|0
102852|NCT00743652|354870|P3|Overall Study|Adverse Event|0
102853|NCT00743652|354871|P2|Overall Study|Adverse Event|0
102854|NCT00743652|354872|P1|Overall Study|Adverse Event|3
102855|NCT00743652|354868|P5|Overall Study|Parent/Legal Guardian Request|0
102856|NCT00743652|354869|P4|Overall Study|Parent/Legal Guardian Request|2
102857|NCT00743652|354870|P3|Overall Study|Parent/Legal Guardian Request|2
102858|NCT00743652|354871|P2|Overall Study|Parent/Legal Guardian Request|2
102859|NCT00743652|354872|P1|Overall Study|Parent/Legal Guardian Request|3
102860|NCT00743509|354956|P1|Overall Study|Withdrawal by Subject|2
102861|NCT00743483|354961|P1|Treatment Period|Adverse Event|1
102862|NCT00743483|354961|P1|Baseline Period|Physician Decision|1
102863|NCT00743444|354965|P2|Washout Period|Adverse Event|1
102864|NCT00743444|354966|P1|Washout Period|Adverse Event|0
102865|NCT00743444|354965|P2|First Intervention|Catheter placement problems|1
102866|NCT00743444|354966|P1|First Intervention|Catheter placement problems|0
102867|NCT00743431|354975|P1|Overall Study|No documentation available|13
102868|NCT00743431|354975|P1|Overall Study|Reason for discontinuation not specified|29
102869|NCT00743431|354975|P1|Overall Study|Death|9
102870|NCT00743431|354975|P1|Overall Study|Withdrawal by Subject|13
102871|NCT00743431|354975|P1|Overall Study|Tumor progression|56
102872|NCT00743431|354975|P1|Overall Study|Toxicity|6
102873|NCT00743288|354979|P7|Overall Study|Worsening of condition (Not PD)|0
102874|NCT00743288|354980|P6|Overall Study|Worsening of condition (Not PD)|0
102875|NCT00743288|354981|P5|Overall Study|Worsening of condition (Not PD)|0
102876|NCT00743288|354982|P4|Overall Study|Worsening of condition (Not PD)|1
102877|NCT00743288|354983|P3|Overall Study|Worsening of condition (Not PD)|1
102878|NCT00743288|354984|P2|Overall Study|Worsening of condition (Not PD)|2
102879|NCT00743288|354985|P1|Overall Study|Worsening of condition (Not PD)|0
102880|NCT00743288|354979|P7|Overall Study|Progressive disease (PD)|6
102881|NCT00743288|354980|P6|Overall Study|Progressive disease (PD)|3
102882|NCT00743288|354981|P5|Overall Study|Progressive disease (PD)|5
102883|NCT00743288|354982|P4|Overall Study|Progressive disease (PD)|4
102884|NCT00743288|354983|P3|Overall Study|Progressive disease (PD)|1
102885|NCT00743288|354984|P2|Overall Study|Progressive disease (PD)|0
102886|NCT00743288|354985|P1|Overall Study|Progressive disease (PD)|2
102887|NCT00743288|354979|P7|Overall Study|Withdrawal by Subject|1
102888|NCT00743288|354980|P6|Overall Study|Withdrawal by Subject|1
102889|NCT00743288|354981|P5|Overall Study|Withdrawal by Subject|0
102890|NCT00743288|354982|P4|Overall Study|Withdrawal by Subject|0
102891|NCT00743288|354983|P3|Overall Study|Withdrawal by Subject|1
102892|NCT00743288|354984|P2|Overall Study|Withdrawal by Subject|0
102893|NCT00743288|354985|P1|Overall Study|Withdrawal by Subject|0
102894|NCT00743288|354979|P7|Overall Study|Adverse Event|2
102895|NCT00743288|354980|P6|Overall Study|Adverse Event|1
102896|NCT00743288|354981|P5|Overall Study|Adverse Event|1
102897|NCT00743288|354982|P4|Overall Study|Adverse Event|2
102898|NCT00743288|354983|P3|Overall Study|Adverse Event|2
102899|NCT00743288|354984|P2|Overall Study|Adverse Event|1
102900|NCT00743288|354985|P1|Overall Study|Adverse Event|1
102901|NCT00743275|354999|P2|Overall Study|Protocol Violation|1
102902|NCT00743275|355000|P1|Overall Study|Protocol Violation|0
102903|NCT00743249|355020|P2|Overall Study|Unsuccessful insertion of stent|1
102904|NCT00743249|355021|P1|Overall Study|Unsuccessful insertion of stent|2
102905|NCT00743249|355020|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
102906|NCT00743249|355021|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
102907|NCT00743249|355020|P2|Overall Study|Adverse Event|4
102908|NCT00743249|355021|P1|Overall Study|Adverse Event|0
103300|NCT00740051|356001|P2|Overall Study|Lack of Efficacy|5
102909|NCT00743197|355031|P2|Overall Study|Study terminated due to departure of PI.|2
102910|NCT00743197|355032|P1|Overall Study|Study terminated due to departure of PI.|1
102911|NCT00742183|355040|P2|Overall Study|Lack of Efficacy|3
102912|NCT00742183|355041|P1|Overall Study|Lack of Efficacy|0
102913|NCT00742183|355040|P2|Overall Study|Withdrawal by Subject|0
102914|NCT00742183|355041|P1|Overall Study|Withdrawal by Subject|1
102915|NCT00742183|355040|P2|Overall Study|Required skin-graft|1
102916|NCT00742183|355041|P1|Overall Study|Required skin-graft|1
102917|NCT00742183|355040|P2|Overall Study|Lost to Follow-up|4
102918|NCT00742183|355041|P1|Overall Study|Lost to Follow-up|4
102919|NCT00742183|355040|P2|Overall Study|Physician Decision|2
102920|NCT00742183|355041|P1|Overall Study|Physician Decision|0
102921|NCT00742183|355040|P2|Overall Study|Death|0
102922|NCT00742183|355041|P1|Overall Study|Death|1
102923|NCT00742183|355040|P2|Overall Study|Adverse Event|2
102924|NCT00742183|355041|P1|Overall Study|Adverse Event|2
102925|NCT00742079|355060|P2|Overall Study|Lost to Follow-up|1
102926|NCT00742079|355061|P1|Overall Study|Lost to Follow-up|0
102927|NCT00741988|355073|P2|Overall Study|Lack of Efficacy|0
102928|NCT00741988|355074|P1|Overall Study|Lack of Efficacy|2
102929|NCT00741988|355073|P2|Overall Study|Adverse Event|4
102930|NCT00741988|355074|P1|Overall Study|Adverse Event|2
102931|NCT00741936|355086|P2|Overall Study|Low compliance|0
102932|NCT00741936|355087|P1|Overall Study|Low compliance|3
102933|NCT00741936|355086|P2|Overall Study|Lack of Efficacy|2
102934|NCT00741936|355087|P1|Overall Study|Lack of Efficacy|0
102935|NCT00741936|355086|P2|Overall Study|Protocol Violation|0
102936|NCT00741936|355087|P1|Overall Study|Protocol Violation|2
102937|NCT00741936|355086|P2|Overall Study|Pregnancy|1
102938|NCT00741936|355087|P1|Overall Study|Pregnancy|0
102939|NCT00741936|355086|P2|Overall Study|Adverse Event|4
102940|NCT00741936|355087|P1|Overall Study|Adverse Event|3
102941|NCT00741936|355086|P2|Overall Study|Lost to Follow-up|1
102942|NCT00741936|355087|P1|Overall Study|Lost to Follow-up|1
102943|NCT00743106|355115|P2|Overall Study|Met intraoperative exclusion criterion|5
102944|NCT00743106|355116|P1|Overall Study|Met intraoperative exclusion criterion|8
102945|NCT00742924|355137|P4|Overall Study|Withdrawal by Subject|0
102946|NCT00742924|355138|P3|Overall Study|Withdrawal by Subject|1
102947|NCT00742924|355139|P2|Overall Study|Withdrawal by Subject|1
102948|NCT00742924|355140|P1|Overall Study|Withdrawal by Subject|0
102949|NCT00742924|355137|P4|Overall Study|Physician Decision|1
102950|NCT00742924|355138|P3|Overall Study|Physician Decision|0
102951|NCT00742924|355139|P2|Overall Study|Physician Decision|0
102952|NCT00742924|355140|P1|Overall Study|Physician Decision|0
102953|NCT00742924|355137|P4|Overall Study|Lack of Efficacy|4
102954|NCT00742924|355138|P3|Overall Study|Lack of Efficacy|2
102955|NCT00742924|355139|P2|Overall Study|Lack of Efficacy|1
102956|NCT00742924|355140|P1|Overall Study|Lack of Efficacy|5
102957|NCT00742924|355137|P4|Overall Study|Adverse Event|1
102958|NCT00742924|355138|P3|Overall Study|Adverse Event|1
102959|NCT00742924|355139|P2|Overall Study|Adverse Event|0
102960|NCT00742924|355140|P1|Overall Study|Adverse Event|0
102961|NCT00742885|355152|P2|Overall Study|Lost to Follow-up|0
102962|NCT00742885|355153|P1|Overall Study|Lost to Follow-up|1
102963|NCT00742781|355208|P1|Overall Study|Withdrawal by Subject|3
102964|NCT00742625|355217|P1|Consolidation|Non protocol therapy|13
102965|NCT00742625|355217|P1|Consolidation|Refused|1
102966|NCT00742625|355217|P1|Consolidation|Death|1
102967|NCT00742625|355217|P1|Consolidation|Adverse Event|1
102968|NCT00742625|355217|P1|Consolidation|Progression|5
102969|NCT00742625|355217|P1|Remission Induction|Other, not specified|5
102970|NCT00742625|355217|P1|Remission Induction|Non protocol treatment|17
102971|NCT00742625|355217|P1|Remission Induction|Refusal|5
102972|NCT00742625|355217|P1|Remission Induction|Death|10
102973|NCT00742625|355217|P1|Remission Induction|Adverse Event|3
102974|NCT00742625|355217|P1|Remission Induction|Failed induction|8
102975|NCT00742625|355217|P1|Remission Induction|Progression|6
102976|NCT00742508|355228|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
102977|NCT00742508|355229|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
102978|NCT00742508|355228|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
102979|NCT00742508|355229|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
102980|NCT00742508|355228|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
102981|NCT00742508|355229|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
102982|NCT00742508|355228|P2|8-Week Primary Evaluation Period|Protocol Violation|0
102983|NCT00742508|355229|P1|8-Week Primary Evaluation Period|Protocol Violation|1
102984|NCT00742508|355228|P2|8-Week Primary Evaluation Period|Adverse Event|4
102985|NCT00742508|355229|P1|8-Week Primary Evaluation Period|Adverse Event|2
102986|NCT00742417|355293|P2|Intensive Period|Adverse Event|0
102987|NCT00742417|355294|P1|Intensive Period|Adverse Event|2
102988|NCT00742417|355293|P2|Intensive Period|Withdrawal by Subject|1
102989|NCT00742417|355294|P1|Intensive Period|Withdrawal by Subject|1
102990|NCT00742417|355293|P2|Randomized|Physician Decision|0
102991|NCT00742417|355294|P1|Randomized|Physician Decision|1
102992|NCT00742417|355293|P2|Randomized|Withdrawal by Subject|0
102993|NCT00742417|355294|P1|Randomized|Withdrawal by Subject|1
102994|NCT00742417|355293|P2|Randomized|Withdrawal by legal representative|1
102995|NCT00742417|355294|P1|Randomized|Withdrawal by legal representative|0
102996|NCT00742391|355318|P2|Overall Study|Protocol Violation|0
102997|NCT00742391|355319|P1|Overall Study|Protocol Violation|1
102998|NCT00742391|355318|P2|Overall Study|Lost to Follow-up|0
102999|NCT00742391|355319|P1|Overall Study|Lost to Follow-up|1
103000|NCT00742391|355318|P2|Overall Study|Adverse Event|1
103001|NCT00742391|355319|P1|Overall Study|Adverse Event|2
103002|NCT00742326|355329|P2|Overall Study|Physician Decision|1
103003|NCT00742326|355330|P1|Overall Study|Physician Decision|0
103004|NCT00742274|355349|P2|Overall Study|Removed for medical reasons|1
103005|NCT00742274|355350|P1|Overall Study|Removed for medical reasons|1
103006|NCT00742274|355349|P2|Overall Study|Withdrawal by Subject|2
103007|NCT00742274|355350|P1|Overall Study|Withdrawal by Subject|1
103008|NCT00742274|355349|P2|Overall Study|Death|0
103009|NCT00742274|355350|P1|Overall Study|Death|1
103010|NCT00742235|355358|P2|Overall Study|Lost to Follow-up|31
103011|NCT00742235|355359|P1|Overall Study|Lost to Follow-up|0
103012|NCT00742209|355372|P5|Overall Study|Investigator Discretion|1
103013|NCT00742209|355373|P4|Overall Study|Investigator Discretion|1
103014|NCT00742209|355374|P3|Overall Study|Investigator Discretion|5
103015|NCT00742209|355375|P2|Overall Study|Investigator Discretion|0
103016|NCT00742209|355376|P1|Overall Study|Investigator Discretion|0
103017|NCT00742209|355372|P5|Overall Study|Lack of Efficacy|1
103018|NCT00742209|355373|P4|Overall Study|Lack of Efficacy|3
103019|NCT00742209|355374|P3|Overall Study|Lack of Efficacy|1
103020|NCT00742209|355375|P2|Overall Study|Lack of Efficacy|1
103021|NCT00742209|355376|P1|Overall Study|Lack of Efficacy|6
103022|NCT00742209|355372|P5|Overall Study|Lost to Follow-up|3
103023|NCT00742209|355373|P4|Overall Study|Lost to Follow-up|5
103024|NCT00742209|355374|P3|Overall Study|Lost to Follow-up|5
103025|NCT00742209|355375|P2|Overall Study|Lost to Follow-up|4
103026|NCT00742209|355376|P1|Overall Study|Lost to Follow-up|3
103027|NCT00742209|355372|P5|Overall Study|Protocol Violation|3
103028|NCT00742209|355373|P4|Overall Study|Protocol Violation|5
103029|NCT00742209|355374|P3|Overall Study|Protocol Violation|4
103030|NCT00742209|355375|P2|Overall Study|Protocol Violation|5
103031|NCT00742209|355376|P1|Overall Study|Protocol Violation|6
103032|NCT00742209|355372|P5|Overall Study|Participant Withdrew Consent|4
103033|NCT00742209|355373|P4|Overall Study|Participant Withdrew Consent|7
103034|NCT00742209|355374|P3|Overall Study|Participant Withdrew Consent|14
103035|NCT00742209|355375|P2|Overall Study|Participant Withdrew Consent|4
103036|NCT00742209|355376|P1|Overall Study|Participant Withdrew Consent|8
103037|NCT00742209|355372|P5|Overall Study|Adverse Event|13
103038|NCT00742209|355373|P4|Overall Study|Adverse Event|16
103039|NCT00742209|355374|P3|Overall Study|Adverse Event|17
103040|NCT00742209|355375|P2|Overall Study|Adverse Event|4
103041|NCT00742209|355376|P1|Overall Study|Adverse Event|11
103042|NCT00741819|355486|P1|Overall Study|Disease progression|1
103043|NCT00741819|355486|P1|Overall Study|Death|1
103044|NCT00741819|355486|P1|Overall Study|Withdrawal by Subject|3
103045|NCT00741819|355486|P1|Overall Study|Adverse Event|3
103046|NCT00741611|355500|P3|Overall Study|Withdrawal by Subject|2
103047|NCT00741611|355501|P2|Overall Study|Withdrawal by Subject|2
103048|NCT00741611|355502|P1|Overall Study|Withdrawal by Subject|0
103049|NCT00741611|355500|P3|Overall Study|Death|1
103050|NCT00741611|355501|P2|Overall Study|Death|0
103051|NCT00741611|355502|P1|Overall Study|Death|0
103052|NCT00741338|355551|P2|Overall Study|Adverse Event|1
103053|NCT00741338|355552|P1|Overall Study|Adverse Event|0
103054|NCT00741286|355562|P2|Overall Study|Primary Outcome|1
103055|NCT00741286|355563|P1|Overall Study|Primary Outcome|1
103056|NCT00741286|355562|P2|Overall Study|Protocol Violation|2
103057|NCT00741286|355563|P1|Overall Study|Protocol Violation|3
103058|NCT00741286|355562|P2|Overall Study|Adverse Event|6
103059|NCT00741286|355563|P1|Overall Study|Adverse Event|1
103060|NCT00741286|355562|P2|Overall Study|Lost to Follow-up|10
103061|NCT00741286|355563|P1|Overall Study|Lost to Follow-up|15
103062|NCT00741091|355612|P1|Overall Study|Missed Visit|22
103063|NCT00741091|355612|P1|Overall Study|Withdrawal by Subject|6
103064|NCT00741091|355612|P1|Overall Study|Lost to Follow-up|16
103065|NCT00741091|355612|P1|Overall Study|Death|13
103066|NCT00741039|355622|P2|Overall Study|Patient non-compliance|0
103067|NCT00741039|355623|P1|Overall Study|Patient non-compliance|2
103068|NCT00741013|355660|P3|Overall Study|Discovered failed screen after enrolled|0
103069|NCT00741013|355661|P2|Overall Study|Discovered failed screen after enrolled|2
103070|NCT00741013|355662|P1|Overall Study|Discovered failed screen after enrolled|0
103071|NCT00741013|355660|P3|Overall Study|Withdrawal by Subject|1
103072|NCT00741013|355661|P2|Overall Study|Withdrawal by Subject|0
103073|NCT00741013|355662|P1|Overall Study|Withdrawal by Subject|0
103074|NCT00741013|355660|P3|Overall Study|Adverse Event|0
103075|NCT00741013|355661|P2|Overall Study|Adverse Event|0
103076|NCT00741013|355662|P1|Overall Study|Adverse Event|1
103077|NCT00739973|355682|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
103078|NCT00739973|355683|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
103079|NCT00739973|355684|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
103080|NCT00739973|355685|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
103301|NCT00740051|356002|P1|Overall Study|Lack of Efficacy|2
103081|NCT00739973|355686|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
103082|NCT00739973|355687|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
103083|NCT00739973|355688|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
103084|NCT00739973|355689|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
103085|NCT00739973|355690|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
103086|NCT00739973|355682|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
103087|NCT00739973|355683|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
103088|NCT00739973|355684|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
103089|NCT00739973|355685|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
103090|NCT00739973|355686|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
103091|NCT00739973|355687|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
103092|NCT00739973|355688|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
103093|NCT00739973|355689|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
103094|NCT00739973|355690|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
103095|NCT00739973|355682|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
103096|NCT00739973|355683|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
103097|NCT00739973|355684|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
103098|NCT00739973|355685|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
103099|NCT00739973|355686|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
103100|NCT00739973|355687|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
103101|NCT00739973|355688|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
103102|NCT00739973|355689|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
103103|NCT00739973|355690|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
103104|NCT00739973|355682|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
103105|NCT00739973|355683|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
103106|NCT00739973|355684|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
103107|NCT00739973|355685|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
103108|NCT00739973|355686|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
103109|NCT00739973|355687|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
103110|NCT00739973|355688|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
103111|NCT00739973|355689|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
103112|NCT00739973|355690|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
103113|NCT00739973|355682|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
103114|NCT00739973|355683|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
103115|NCT00739973|355684|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
103116|NCT00739973|355685|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
103117|NCT00739973|355686|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
103118|NCT00739973|355687|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
103119|NCT00739973|355688|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
103120|NCT00739973|355689|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
103121|NCT00739973|355690|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
103122|NCT00739973|355682|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
103123|NCT00739973|355683|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
103124|NCT00739973|355684|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
103125|NCT00739973|355685|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
103126|NCT00739973|355686|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
103127|NCT00739973|355687|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
103128|NCT00739973|355688|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
103129|NCT00739973|355689|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
103130|NCT00739973|355690|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
103131|NCT00739973|355682|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
103132|NCT00739973|355683|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
103133|NCT00739973|355684|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
103134|NCT00739973|355685|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
103135|NCT00739973|355686|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
103136|NCT00739973|355687|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
103137|NCT00739973|355688|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
103138|NCT00739973|355689|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
103139|NCT00739973|355690|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
103140|NCT00739973|355682|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
103141|NCT00739973|355683|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
103142|NCT00739973|355684|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
103143|NCT00739973|355685|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
103144|NCT00739973|355686|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
103302|NCT00739934|356096|P1|Voriconazole Oral|unspecified|3
103145|NCT00739973|355687|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
103146|NCT00739973|355688|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
103147|NCT00739973|355689|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
103148|NCT00739973|355690|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
103149|NCT00739973|355682|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
103150|NCT00739973|355683|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
103151|NCT00739973|355684|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
103152|NCT00739973|355685|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
103153|NCT00739973|355686|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
103154|NCT00739973|355687|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
103155|NCT00739973|355688|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
103156|NCT00739973|355689|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
103157|NCT00739973|355690|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
103158|NCT00739973|355682|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
103159|NCT00739973|355683|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
103160|NCT00739973|355684|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
103161|NCT00739973|355685|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
103162|NCT00739973|355686|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
103163|NCT00739973|355687|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
103164|NCT00739973|355688|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
103165|NCT00739973|355689|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
103166|NCT00739973|355690|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
103167|NCT00739973|355682|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
103168|NCT00739973|355683|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
103169|NCT00739973|355684|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
103170|NCT00739973|355685|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
103171|NCT00739973|355686|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
103172|NCT00739973|355687|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
103173|NCT00739973|355688|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
103174|NCT00739973|355689|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
103175|NCT00739973|355690|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
103176|NCT00739973|355682|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
103177|NCT00739973|355683|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
103178|NCT00739973|355684|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
103179|NCT00739973|355685|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
103180|NCT00739973|355686|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
103181|NCT00739973|355687|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
103182|NCT00739973|355688|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
103183|NCT00739973|355689|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
103184|NCT00739973|355690|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
103185|NCT00739973|355682|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
103186|NCT00739973|355683|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
103187|NCT00739973|355684|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
103188|NCT00739973|355685|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
103189|NCT00739973|355686|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
103190|NCT00739973|355687|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
103191|NCT00739973|355688|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
103192|NCT00739973|355689|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
103193|NCT00739973|355690|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
103194|NCT00739973|355682|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
103195|NCT00739973|355683|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
103196|NCT00739973|355684|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
103197|NCT00739973|355685|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
103198|NCT00739973|355686|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
103199|NCT00739973|355687|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
103200|NCT00739973|355688|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
103201|NCT00739973|355689|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
103202|NCT00739973|355690|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
103203|NCT00739973|355682|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
103204|NCT00739973|355683|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
103205|NCT00739973|355684|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
103206|NCT00739973|355685|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
103207|NCT00739973|355686|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
103208|NCT00739973|355687|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
103209|NCT00739973|355688|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
103210|NCT00739973|355689|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
103211|NCT00739973|355690|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
103212|NCT00739973|355682|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
103213|NCT00739973|355683|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
103214|NCT00739973|355684|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
103215|NCT00739973|355685|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
103216|NCT00739973|355686|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
103217|NCT00739973|355687|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
103218|NCT00739973|355688|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
103219|NCT00739973|355689|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
103220|NCT00739973|355690|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
103221|NCT00739973|355682|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
103222|NCT00739973|355683|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
103223|NCT00739973|355684|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
103224|NCT00739973|355685|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
103225|NCT00739973|355686|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
103226|NCT00739973|355687|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
103227|NCT00739973|355688|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
103228|NCT00739973|355689|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
103229|NCT00739973|355690|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
103230|NCT00740857|355779|P3|Overall Study|Withdrawal by Subject|0
103231|NCT00740857|355780|P2|Overall Study|Withdrawal by Subject|0
103232|NCT00740857|355781|P1|Overall Study|Withdrawal by Subject|1
103233|NCT00740792|355836|P4|Overall Study|administrative|2
103234|NCT00740792|355837|P3|Overall Study|administrative|8
103235|NCT00740792|355838|P2|Overall Study|administrative|3
103236|NCT00740792|355839|P1|Overall Study|administrative|3
103237|NCT00740792|355836|P4|Overall Study|Withdrawal by Subject|0
103238|NCT00740792|355837|P3|Overall Study|Withdrawal by Subject|0
103239|NCT00740792|355838|P2|Overall Study|Withdrawal by Subject|1
103240|NCT00740792|355839|P1|Overall Study|Withdrawal by Subject|1
103241|NCT00740792|355836|P4|Overall Study|Protocol Violation|2
103242|NCT00740792|355837|P3|Overall Study|Protocol Violation|0
103243|NCT00740792|355838|P2|Overall Study|Protocol Violation|1
103244|NCT00740792|355839|P1|Overall Study|Protocol Violation|0
103245|NCT00740792|355836|P4|Overall Study|Lost to Follow-up|0
103246|NCT00740792|355837|P3|Overall Study|Lost to Follow-up|0
103247|NCT00740792|355838|P2|Overall Study|Lost to Follow-up|1
103248|NCT00740792|355839|P1|Overall Study|Lost to Follow-up|2
103249|NCT00740792|355836|P4|Overall Study|Lack of Efficacy|3
103250|NCT00740792|355837|P3|Overall Study|Lack of Efficacy|0
103251|NCT00740792|355838|P2|Overall Study|Lack of Efficacy|1
103252|NCT00740792|355839|P1|Overall Study|Lack of Efficacy|1
103253|NCT00740792|355836|P4|Overall Study|Adverse Event|3
103254|NCT00740792|355837|P3|Overall Study|Adverse Event|1
103255|NCT00740792|355838|P2|Overall Study|Adverse Event|1
103256|NCT00740792|355839|P1|Overall Study|Adverse Event|3
103257|NCT00740779|355860|P3|Overall Study|Lost to Follow-up|5
103258|NCT00740779|355861|P2|Overall Study|Lost to Follow-up|3
103259|NCT00740779|355862|P1|Overall Study|Lost to Follow-up|2
103260|NCT00740779|355860|P3|Overall Study|Withdrawal by Subject|2
103261|NCT00740779|355861|P2|Overall Study|Withdrawal by Subject|4
103262|NCT00740779|355862|P1|Overall Study|Withdrawal by Subject|2
103263|NCT00740779|355860|P3|Overall Study|Lack of Efficacy|2
103264|NCT00740779|355861|P2|Overall Study|Lack of Efficacy|0
103265|NCT00740779|355862|P1|Overall Study|Lack of Efficacy|0
103266|NCT00740779|355860|P3|Overall Study|Protocol Violation|1
103267|NCT00740779|355861|P2|Overall Study|Protocol Violation|1
103268|NCT00740779|355862|P1|Overall Study|Protocol Violation|1
103269|NCT00740779|355860|P3|Overall Study|Adverse Event|3
103270|NCT00740779|355861|P2|Overall Study|Adverse Event|6
103271|NCT00740779|355862|P1|Overall Study|Adverse Event|4
103272|NCT00740714|355879|P3|Overall Study|Withdrawal by Subject|29
103273|NCT00740714|355880|P2|Overall Study|Withdrawal by Subject|19
103274|NCT00740714|355881|P1|Overall Study|Withdrawal by Subject|17
103275|NCT00740636|355957|P2|Overall Study|Death|0
103276|NCT00740636|355958|P1|Overall Study|Death|1
103277|NCT00740636|355957|P2|Overall Study|Progressive Disease|0
103278|NCT00740636|355958|P1|Overall Study|Progressive Disease|1
103279|NCT00740636|355957|P2|Overall Study|Patient Not Treated|1
103280|NCT00740636|355958|P1|Overall Study|Patient Not Treated|0
103281|NCT00740636|355957|P2|Overall Study|Patient Ineligible|1
103282|NCT00740636|355958|P1|Overall Study|Patient Ineligible|0
103283|NCT00740636|355957|P2|Overall Study|Adverse Event|2
103284|NCT00740636|355958|P1|Overall Study|Adverse Event|0
103285|NCT00740597|355964|P1|Overall Study|insurance would not cover treatment|1
103286|NCT00740584|355968|P1|Overall Study|Withdrawal by Subject|1
103287|NCT00740480|355972|P1|Overall Study|Physician Decision|1
103288|NCT00740480|355972|P1|Overall Study|Adverse Event|1
103289|NCT00740220|355976|P1|Overall Study|screen failures (non-COPD patients)|9
103290|NCT00740051|356001|P2|Overall Study|Other reason (not specified)|1
103291|NCT00740051|356002|P1|Overall Study|Other reason (not specified)|4
103292|NCT00740051|356001|P2|Overall Study|Withdrawal by Subject|8
103293|NCT00740051|356002|P1|Overall Study|Withdrawal by Subject|6
103294|NCT00740051|356001|P2|Overall Study|Lost to Follow-up|8
103295|NCT00740051|356002|P1|Overall Study|Lost to Follow-up|3
103296|NCT00740051|356001|P2|Overall Study|Protocol Violation|6
103297|NCT00740051|356002|P1|Overall Study|Protocol Violation|2
103298|NCT00740051|356001|P2|Overall Study|Adverse Event|4
103299|NCT00740051|356002|P1|Overall Study|Adverse Event|1
103303|NCT00739934|356096|P1|Voriconazole IV|Adverse Event|6
103304|NCT00739908|356118|P2|Overall Study|Relocation|1
103305|NCT00739908|356119|P1|Overall Study|Relocation|0
103306|NCT00739908|356118|P2|Overall Study|Lack of Efficacy|1
103307|NCT00739908|356119|P1|Overall Study|Lack of Efficacy|0
103308|NCT00739908|356118|P2|Overall Study|Non-Compliance With Study Medication|3
103309|NCT00739908|356119|P1|Overall Study|Non-Compliance With Study Medication|0
103310|NCT00739908|356118|P2|Overall Study|Non-Compliance With Study Procedures|3
103311|NCT00739908|356119|P1|Overall Study|Non-Compliance With Study Procedures|2
103312|NCT00739908|356118|P2|Overall Study|Lost to Follow-up|9
103313|NCT00739908|356119|P1|Overall Study|Lost to Follow-up|14
103314|NCT00739908|356118|P2|Overall Study|Withdrawal by Subject|2
103315|NCT00739908|356119|P1|Overall Study|Withdrawal by Subject|4
103316|NCT00739908|356118|P2|Overall Study|Adverse Event|6
103317|NCT00739908|356119|P1|Overall Study|Adverse Event|5
103318|NCT00739882|356139|P2|Open-label Period|Other|5
103319|NCT00739882|356140|P1|Open-label Period|Other|9
103320|NCT00739882|356139|P2|Open-label Period|Adverse Event|0
103321|NCT00739882|356140|P1|Open-label Period|Adverse Event|1
103322|NCT00739882|356139|P2|Double-blind Period|Not specified|8
103323|NCT00739882|356140|P1|Double-blind Period|Not specified|16
103324|NCT00739882|356139|P2|Double-blind Period|Lack of Efficacy|1
103325|NCT00739882|356140|P1|Double-blind Period|Lack of Efficacy|1
103326|NCT00739882|356139|P2|Double-blind Period|Protocol Violation|0
103327|NCT00739882|356140|P1|Double-blind Period|Protocol Violation|1
103328|NCT00739882|356139|P2|Double-blind Period|Adverse Event|2
103329|NCT00739882|356140|P1|Double-blind Period|Adverse Event|1
103330|NCT00739674|356176|P2|Overall Study|Erectile dysfunction|1
103331|NCT00739674|356177|P1|Overall Study|Erectile dysfunction|0
103332|NCT00739674|356176|P2|Overall Study|Home monitoring off meds|0
103333|NCT00739674|356177|P1|Overall Study|Home monitoring off meds|1
103334|NCT00739674|356176|P2|Overall Study|Unable to attend visit|1
103335|NCT00739674|356177|P1|Overall Study|Unable to attend visit|3
103336|NCT00739674|356176|P2|Overall Study|Non compliant|0
103337|NCT00739674|356177|P1|Overall Study|Non compliant|4
103338|NCT00739674|356176|P2|Overall Study|Patient moved|2
103339|NCT00739674|356177|P1|Overall Study|Patient moved|3
103340|NCT00739674|356176|P2|Overall Study|Clinic closed|4
103341|NCT00739674|356177|P1|Overall Study|Clinic closed|6
103342|NCT00739674|356176|P2|Overall Study|Reason missing|0
103343|NCT00739674|356177|P1|Overall Study|Reason missing|2
103344|NCT00739674|356176|P2|Overall Study|Withdrawal by Subject|9
103345|NCT00739674|356177|P1|Overall Study|Withdrawal by Subject|9
103346|NCT00739674|356176|P2|Overall Study|Protocol Violation|5
103347|NCT00739674|356177|P1|Overall Study|Protocol Violation|5
103348|NCT00739674|356176|P2|Overall Study|Lost to Follow-up|30
103349|NCT00739674|356177|P1|Overall Study|Lost to Follow-up|52
103350|NCT00739674|356176|P2|Overall Study|Lack of Efficacy|0
103351|NCT00739674|356177|P1|Overall Study|Lack of Efficacy|1
103352|NCT00739674|356176|P2|Overall Study|Death|0
103353|NCT00739674|356177|P1|Overall Study|Death|1
103354|NCT00739674|356176|P2|Overall Study|Adverse Event|13
103355|NCT00739674|356177|P1|Overall Study|Adverse Event|22
103356|NCT00739674|356176|P2|Overall Study|Dietician consultation >30 days|9
103357|NCT00739674|356177|P1|Overall Study|Dietician consultation >30 days|1
103358|NCT00739674|356176|P2|Overall Study|No follow-up data|18
103359|NCT00739674|356177|P1|Overall Study|No follow-up data|33
103360|NCT00739674|356176|P2|Overall Study|Site 212 removal|13
103361|NCT00739674|356177|P1|Overall Study|Site 212 removal|19
103362|NCT00739674|356176|P2|Overall Study|Screening failures|17
103363|NCT00739674|356177|P1|Overall Study|Screening failures|19
103364|NCT00739661|356205|P2|Overall Study|Reason for discontinuation not available|1
103365|NCT00739661|356206|P1|Overall Study|Reason for discontinuation not available|1
103366|NCT00739661|356205|P2|Overall Study|Disease progression, radiographic|37
103367|NCT00739661|356206|P1|Overall Study|Disease progression, radiographic|33
103368|NCT00739661|356205|P2|Overall Study|Patient decision to withdraw|4
103369|NCT00739661|356206|P1|Overall Study|Patient decision to withdraw|9
103370|NCT00739661|356205|P2|Overall Study|Physician decision to withdraw patient|0
103371|NCT00739661|356206|P1|Overall Study|Physician decision to withdraw patient|1
103372|NCT00739661|356205|P2|Overall Study|Adverse Event|0
103373|NCT00739661|356206|P1|Overall Study|Adverse Event|2
103374|NCT00739648|356218|P2|Overall Study|Do not know|6
103375|NCT00739648|356219|P1|Overall Study|Do not know|4
103376|NCT00739648|356218|P2|Overall Study|Death|0
103377|NCT00739648|356219|P1|Overall Study|Death|2
103378|NCT00739648|356218|P2|Overall Study|Lost to Follow-up|7
103379|NCT00739648|356219|P1|Overall Study|Lost to Follow-up|4
103380|NCT00739648|356218|P2|Overall Study|Withdrawal by Subject|25
103381|NCT00739648|356219|P1|Overall Study|Withdrawal by Subject|13
103382|NCT00739648|356218|P2|Overall Study|Adverse Event|15
103383|NCT00739648|356219|P1|Overall Study|Adverse Event|3
103384|NCT00739596|356233|P2|Overall Study|Protocol Deviation|1
103385|NCT00739596|356234|P1|Overall Study|Protocol Deviation|1
103386|NCT00739596|356233|P2|Overall Study|Lost to Follow-up|2
103387|NCT00739596|356234|P1|Overall Study|Lost to Follow-up|0
103388|NCT00739596|356233|P2|Overall Study|Patient Withdrew Consent|8
103389|NCT00739596|356234|P1|Overall Study|Patient Withdrew Consent|8
103390|NCT00739596|356233|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
103391|NCT00739596|356234|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
103392|NCT00739596|356233|P2|Overall Study|Adverse Event|6
103393|NCT00739596|356234|P1|Overall Study|Adverse Event|12
103394|NCT00739310|356276|P1|Overall Study|Lost to Follow-up|2
103395|NCT00739310|356276|P1|Overall Study|Withdrawal by Subject|1
103396|NCT00739310|356276|P1|Overall Study|Poor adherance to prescribed therapy|4
103397|NCT00739297|356281|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
103398|NCT00739297|356282|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
103399|NCT00739297|356283|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
103400|NCT00739297|356284|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
103401|NCT00739297|356285|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
103402|NCT00739297|356286|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
103403|NCT00739297|356287|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
103404|NCT00739297|356281|P7|First Washout Period of 4-7 Days|Adverse Event|2
103405|NCT00739297|356282|P6|First Washout Period of 4-7 Days|Adverse Event|0
103406|NCT00739297|356283|P5|First Washout Period of 4-7 Days|Adverse Event|0
103407|NCT00739297|356284|P4|First Washout Period of 4-7 Days|Adverse Event|2
103408|NCT00739297|356285|P3|First Washout Period of 4-7 Days|Adverse Event|0
103409|NCT00739297|356286|P2|First Washout Period of 4-7 Days|Adverse Event|0
103410|NCT00739297|356287|P1|First Washout Period of 4-7 Days|Adverse Event|0
103411|NCT00739102|356315|P1|Overall Study|Withdrawal by Subject|10
103412|NCT00739102|356315|P1|Overall Study|Death|5
103413|NCT00739063|356331|P1|Overall Study|Screen failures|8
103414|NCT00738881|356376|P2|Overall Study|Withdrawal by Subject|2
103415|NCT00738881|356377|P1|Overall Study|Withdrawal by Subject|0
103416|NCT00738673|356391|P2|Overall Study|Withdrawal by Subject|1
103417|NCT00738673|356392|P1|Overall Study|Withdrawal by Subject|3
103418|NCT00738673|356391|P2|Overall Study|Protocol Violation|2
103419|NCT00738673|356392|P1|Overall Study|Protocol Violation|1
103420|NCT00738673|356391|P2|Overall Study|Lack of Efficacy|8
103421|NCT00738673|356392|P1|Overall Study|Lack of Efficacy|19
103422|NCT00738673|356391|P2|Overall Study|Adverse Event|0
103423|NCT00738673|356392|P1|Overall Study|Adverse Event|1
103424|NCT00738530|356430|P2|Overall Study|Withdrawal by Subject|8
103425|NCT00738530|356431|P1|Overall Study|Withdrawal by Subject|6
103426|NCT00738530|356430|P2|Overall Study|Lost to Follow-up|6
103427|NCT00738530|356431|P1|Overall Study|Lost to Follow-up|8
103428|NCT00738530|356430|P2|Overall Study|Death|224
103429|NCT00738530|356431|P1|Overall Study|Death|220
103430|NCT00738400|356466|P2|Overall Study|Non-compliant with study medication|1
103431|NCT00738400|356467|P1|Overall Study|Non-compliant with study medication|0
103432|NCT00738400|356466|P2|Overall Study|Protocol Violation|0
103433|NCT00738400|356467|P1|Overall Study|Protocol Violation|1
103434|NCT00738400|356466|P2|Overall Study|Lost to Follow-up|3
103435|NCT00738400|356467|P1|Overall Study|Lost to Follow-up|0
103436|NCT00738400|356466|P2|Overall Study|Lack of Efficacy|1
103437|NCT00738400|356467|P1|Overall Study|Lack of Efficacy|0
103438|NCT00738400|356466|P2|Overall Study|Withdrawal by Subject|1
103439|NCT00738400|356467|P1|Overall Study|Withdrawal by Subject|0
103440|NCT00738400|356466|P2|Overall Study|Adverse Event|1
103441|NCT00738400|356467|P1|Overall Study|Adverse Event|3
103442|NCT00738374|356488|P4|Maintenance Treatment/Observation Phase|Not Specified|0
103443|NCT00738374|356489|P3|Maintenance Treatment/Observation Phase|Not Specified|0
103444|NCT00738374|356490|P2|Maintenance Treatment/Observation Phase|Not Specified|1
103445|NCT00738374|356491|P1|Maintenance Treatment/Observation Phase|Not Specified|0
103446|NCT00738374|356488|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
103447|NCT00738374|356489|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
103448|NCT00738374|356490|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
103449|NCT00738374|356491|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
103450|NCT00738374|356488|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
103451|NCT00738374|356489|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
103452|NCT00738374|356490|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
103453|NCT00738374|356491|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
103454|NCT00738374|356488|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
103455|NCT00738374|356489|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
103456|NCT00738374|356490|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
103457|NCT00738374|356491|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
103458|NCT00738374|356488|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
103459|NCT00738374|356489|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
103460|NCT00738374|356490|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
103461|NCT00738374|356491|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
103462|NCT00738374|356488|P4|Induction Treatment Phase|Withdrawal by Subject|0
103463|NCT00738374|356489|P3|Induction Treatment Phase|Withdrawal by Subject|0
103464|NCT00738374|356490|P2|Induction Treatment Phase|Withdrawal by Subject|0
103465|NCT00738374|356491|P1|Induction Treatment Phase|Withdrawal by Subject|1
103466|NCT00738374|356488|P4|Induction Treatment Phase|Non-compliance|0
103467|NCT00738374|356489|P3|Induction Treatment Phase|Non-compliance|0
103468|NCT00738374|356490|P2|Induction Treatment Phase|Non-compliance|0
103469|NCT00738374|356491|P1|Induction Treatment Phase|Non-compliance|1
103470|NCT00738374|356488|P4|Induction Treatment Phase|Protocol Violation|0
103471|NCT00738374|356489|P3|Induction Treatment Phase|Protocol Violation|0
103472|NCT00738374|356490|P2|Induction Treatment Phase|Protocol Violation|0
103473|NCT00738374|356491|P1|Induction Treatment Phase|Protocol Violation|2
103474|NCT00738374|356488|P4|Induction Treatment Phase|Physician Decision|0
103475|NCT00738374|356489|P3|Induction Treatment Phase|Physician Decision|0
103476|NCT00738374|356490|P2|Induction Treatment Phase|Physician Decision|0
103477|NCT00738374|356491|P1|Induction Treatment Phase|Physician Decision|2
103478|NCT00738374|356488|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
103479|NCT00738374|356489|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
103480|NCT00738374|356490|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
103481|NCT00738374|356491|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
103482|NCT00738374|356488|P4|Induction Treatment Phase|Adverse Event|0
103483|NCT00738374|356489|P3|Induction Treatment Phase|Adverse Event|0
103484|NCT00738374|356490|P2|Induction Treatment Phase|Adverse Event|0
103485|NCT00738374|356491|P1|Induction Treatment Phase|Adverse Event|14
103486|NCT00738283|356529|P1|Overall Study|Discharge home prior to end of study|1
103487|NCT00738283|356529|P1|Overall Study|Transfer to another facility|2
103488|NCT00738283|356529|P1|Overall Study|Death|1
103489|NCT00738062|356536|P3|Open-Label Extension|Study Terminated|0
103490|NCT00738062|356537|P2|Open-Label Extension|Study Terminated|0
103491|NCT00738062|356538|P1|Open-Label Extension|Study Terminated|2
103492|NCT00738062|356536|P3|Open-Label Extension|Protocol Violation|0
103493|NCT00738062|356537|P2|Open-Label Extension|Protocol Violation|0
103494|NCT00738062|356538|P1|Open-Label Extension|Protocol Violation|1
103495|NCT00738062|356536|P3|Open-Label Extension|Withdrawal by Subject|0
103496|NCT00738062|356537|P2|Open-Label Extension|Withdrawal by Subject|0
103497|NCT00738062|356538|P1|Open-Label Extension|Withdrawal by Subject|6
103498|NCT00738062|356536|P3|Open-Label Extension|Lack of Efficacy|0
103499|NCT00738062|356537|P2|Open-Label Extension|Lack of Efficacy|0
103500|NCT00738062|356538|P1|Open-Label Extension|Lack of Efficacy|2
103501|NCT00738062|356536|P3|Open-Label Extension|Physician Decision|0
103502|NCT00738062|356537|P2|Open-Label Extension|Physician Decision|0
103503|NCT00738062|356538|P1|Open-Label Extension|Physician Decision|1
103504|NCT00738062|356536|P3|Open-Label Extension|Adverse Event|0
103505|NCT00738062|356537|P2|Open-Label Extension|Adverse Event|0
103506|NCT00738062|356538|P1|Open-Label Extension|Adverse Event|5
103507|NCT00738062|356536|P3|Open Label Treatment|Investigator Decision|0
103508|NCT00738062|356537|P2|Open Label Treatment|Investigator Decision|0
103509|NCT00738062|356538|P1|Open Label Treatment|Investigator Decision|1
103510|NCT00738062|356536|P3|Open Label Treatment|Withdrawal by Subject|0
103511|NCT00738062|356537|P2|Open Label Treatment|Withdrawal by Subject|0
103512|NCT00738062|356538|P1|Open Label Treatment|Withdrawal by Subject|9
103513|NCT00738062|356536|P3|Open Label Treatment|Protocol Violation|0
103514|NCT00738062|356537|P2|Open Label Treatment|Protocol Violation|0
103515|NCT00738062|356538|P1|Open Label Treatment|Protocol Violation|2
103516|NCT00738062|356536|P3|Open Label Treatment|Adverse Event|0
103517|NCT00738062|356537|P2|Open Label Treatment|Adverse Event|0
103518|NCT00738062|356538|P1|Open Label Treatment|Adverse Event|11
103519|NCT00738062|356536|P3|Open Label Treatment|Lack of Efficacy|0
103520|NCT00738062|356537|P2|Open Label Treatment|Lack of Efficacy|0
103521|NCT00738062|356538|P1|Open Label Treatment|Lack of Efficacy|5
103522|NCT00737711|356600|P1|Overall Study|Other|5
103523|NCT00737711|356600|P1|Overall Study|Blood transfusion|6
103524|NCT00737711|356600|P1|Overall Study|Withdrawal by Subject|5
103525|NCT00737711|356600|P1|Overall Study|Protocol Violation|1
103526|NCT00737711|356600|P1|Overall Study|Failure to return|4
103527|NCT00737711|356600|P1|Overall Study|Death|8
103528|NCT00737711|356600|P1|Overall Study|Adverse Event|2
103529|NCT00737672|356633|P2|Overall Study|Physician Decision|2
103530|NCT00737672|356634|P1|Overall Study|Physician Decision|0
103531|NCT00737672|356633|P2|Overall Study|Miscellaneous|1
103532|NCT00737672|356634|P1|Overall Study|Miscellaneous|7
103533|NCT00737672|356633|P2|Overall Study|Lost to Follow-up|0
103534|NCT00737672|356634|P1|Overall Study|Lost to Follow-up|1
103535|NCT00737672|356633|P2|Overall Study|Withdrawal by Subject|2
103536|NCT00737672|356634|P1|Overall Study|Withdrawal by Subject|1
103537|NCT00737672|356633|P2|Overall Study|Death|22
103538|NCT00737672|356634|P1|Overall Study|Death|23
103539|NCT00737672|356633|P2|Overall Study|Graft Abandonment|56
103540|NCT00737672|356634|P1|Overall Study|Graft Abandonment|48
103541|NCT00737633|356672|P2|Overall Study|protocol non-compliance|1
103542|NCT00737633|356673|P1|Overall Study|protocol non-compliance|0
103543|NCT00737633|356672|P2|Overall Study|Lost to Follow-up|1
103544|NCT00737633|356673|P1|Overall Study|Lost to Follow-up|0
103545|NCT00737633|356672|P2|Overall Study|Study terminated by sponsor|55
103546|NCT00737633|356673|P1|Overall Study|Study terminated by sponsor|44
103547|NCT00737568|356696|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
103548|NCT00737568|356697|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
103549|NCT00737568|356696|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
103550|NCT00737568|356697|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
103551|NCT00737568|356696|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
103552|NCT00737568|356697|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
103553|NCT00737568|356696|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
103554|NCT00737568|356697|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
103555|NCT00737568|356696|P2|Treatment Period Through Week 240|Protocol Violation|3
103556|NCT00737568|356697|P1|Treatment Period Through Week 240|Protocol Violation|2
103557|NCT00737568|356696|P2|Treatment Period Through Week 240|Lost to Follow-up|3
103558|NCT00737568|356697|P1|Treatment Period Through Week 240|Lost to Follow-up|3
103559|NCT00737568|356696|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
103560|NCT00737568|356697|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
103561|NCT00737568|356696|P2|Treatment Period Through Week 240|Withdrew Consent|6
103562|NCT00737568|356697|P1|Treatment Period Through Week 240|Withdrew Consent|5
103563|NCT00737568|356696|P2|Treatment Period Through Week 240|Investigator’s Discretion|5
103564|NCT00737568|356697|P1|Treatment Period Through Week 240|Investigator’s Discretion|6
103565|NCT00737529|356727|P1|Overall Study|Unspecified|2
103566|NCT00737529|356727|P1|Overall Study|Protocol Violation|1
103567|NCT00737529|356727|P1|Overall Study|Death|3
103568|NCT00737529|356727|P1|Overall Study|Withdrawal by Subject|3
103569|NCT00737529|356727|P1|Overall Study|Adverse Event|23
103570|NCT00737529|356727|P1|Overall Study|Disease Progression|80
103571|NCT00737477|356741|P1|Overall Study|Not Specified|4
103572|NCT00737477|356741|P1|Overall Study|Renal Transplantation|10
103573|NCT00737477|356741|P1|Overall Study|Withdrawal by Subject|1
103574|NCT00737477|356741|P1|Overall Study|Treatment Refusal|1
103575|NCT00737477|356741|P1|Overall Study|Death|9
103576|NCT00737477|356741|P1|Overall Study|Adverse Event|9
103577|NCT00737464|356757|P1|Overall Study|Other reasons|4
103578|NCT00737464|356757|P1|Overall Study|Refused Treatment / Withdrew Consent|6
103579|NCT00737464|356757|P1|Overall Study|Other - Failure to Return|1
103580|NCT00737464|356757|P1|Overall Study|Death|6
103581|NCT00737464|356757|P1|Overall Study|Adverse Event|1
103582|NCT00737438|356778|P1|Overall Study|Patient ineligible|1
103583|NCT00737438|356778|P1|Overall Study|Withdrawal by Subject|2
103584|NCT00737282|356791|P1|Overall Study|Study prematurely terminated|175
103585|NCT00737100|356834|P3|Overall Study|Reason discontinued not explained above|1
103586|NCT00737100|356835|P2|Overall Study|Reason discontinued not explained above|1
103587|NCT00737100|356836|P1|Overall Study|Reason discontinued not explained above|1
103588|NCT00737100|356834|P3|Overall Study|Withdrawal by Subject|3
103589|NCT00737100|356835|P2|Overall Study|Withdrawal by Subject|0
103590|NCT00737100|356836|P1|Overall Study|Withdrawal by Subject|0
103591|NCT00737100|356834|P3|Overall Study|Lost to Follow-up|0
103592|NCT00737100|356835|P2|Overall Study|Lost to Follow-up|1
103593|NCT00737100|356836|P1|Overall Study|Lost to Follow-up|0
103594|NCT00737100|356834|P3|Overall Study|Adverse Event|3
103595|NCT00737100|356835|P2|Overall Study|Adverse Event|5
103596|NCT00737100|356836|P1|Overall Study|Adverse Event|6
103597|NCT00737061|356880|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
103598|NCT00737061|356880|P1|1 Year Wearing Period|Discontinued reilance|3
103599|NCT00737061|356880|P1|1 Year Wearing Period|Withdrawal by Subject|2
103600|NCT00737061|356880|P1|1 Year Wearing Period|Lost to Follow-up|11
103601|NCT00737061|356880|P1|Waiting Period|Elected surgical tubal ligation|5
103602|NCT00737061|356880|P1|Waiting Period|Alternative contraception failure|3
103603|NCT00737061|356880|P1|Waiting Period|Deemed patent following HSG|26
103604|NCT00737061|356880|P1|Waiting Period|Bilateral placement failure|34
103605|NCT00737061|356880|P1|Waiting Period|Withdrawal by Subject|1
103606|NCT00737061|356880|P1|Waiting Period|Lost to Follow-up|6
103607|NCT00737048|356897|P3|Overall Study|Worsening of the symptoms|3
103608|NCT00737048|356898|P2|Overall Study|Worsening of the symptoms|5
103609|NCT00737048|356899|P1|Overall Study|Worsening of the symptoms|3
103610|NCT00737048|356897|P3|Overall Study|Adverse Event|0
103611|NCT00737048|356898|P2|Overall Study|Adverse Event|1
103612|NCT00737048|356899|P1|Overall Study|Adverse Event|0
103613|NCT00737048|356897|P3|Overall Study|Physician Decision|1
103614|NCT00737048|356898|P2|Overall Study|Physician Decision|0
103615|NCT00737048|356899|P1|Overall Study|Physician Decision|0
103616|NCT00736996|356943|P3|Overall Study|Lost to Follow-up|2
103617|NCT00736996|356944|P2|Overall Study|Lost to Follow-up|9
103618|NCT00736996|356945|P1|Overall Study|Lost to Follow-up|1
103619|NCT00736957|356959|P1|Overall Study|Physician Decision|5
103620|NCT00736957|356959|P1|Overall Study|not eligible for Treatment Period I|22
103621|NCT00736957|356959|P1|Overall Study|did not attend hospital appointments|1
103622|NCT00736957|356959|P1|Overall Study|violation of eligibility criteria|2
103623|NCT00736957|356959|P1|Overall Study|Withdrawal by Subject|49
103624|NCT00736957|356959|P1|Overall Study|Adverse Event|43
103625|NCT00736944|356969|P1|Definitive Treatment|Physician Decision|1
103626|NCT00736944|356969|P1|Induction|Death|1
103627|NCT00736879|357000|P4|Follow up Period - No Drug Treatment|non-specified|0
103628|NCT00736879|357001|P3|Follow up Period - No Drug Treatment|non-specified|0
103629|NCT00736879|357002|P2|Follow up Period - No Drug Treatment|non-specified|2
103630|NCT00736879|357003|P1|Follow up Period - No Drug Treatment|non-specified|1
103631|NCT00736879|357000|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
103632|NCT00736879|357001|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
103633|NCT00736879|357002|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
103634|NCT00736879|357003|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
103635|NCT00736879|357000|P4|Double Blind Treatment Period|non-specified|0
103636|NCT00736879|357001|P3|Double Blind Treatment Period|non-specified|0
103637|NCT00736879|357002|P2|Double Blind Treatment Period|non-specified|1
103638|NCT00736879|357003|P1|Double Blind Treatment Period|non-specified|0
103639|NCT00736879|357000|P4|Double Blind Treatment Period|No longer met criteria|0
103640|NCT00736879|357001|P3|Double Blind Treatment Period|No longer met criteria|0
103641|NCT00736879|357002|P2|Double Blind Treatment Period|No longer met criteria|1
103642|NCT00736879|357003|P1|Double Blind Treatment Period|No longer met criteria|0
103643|NCT00736879|357000|P4|Double Blind Treatment Period|Poor non-compliance|1
103644|NCT00736879|357001|P3|Double Blind Treatment Period|Poor non-compliance|1
103645|NCT00736879|357002|P2|Double Blind Treatment Period|Poor non-compliance|0
103646|NCT00736879|357003|P1|Double Blind Treatment Period|Poor non-compliance|0
103647|NCT00736879|357000|P4|Double Blind Treatment Period|Lost to Follow-up|1
103648|NCT00736879|357001|P3|Double Blind Treatment Period|Lost to Follow-up|2
103649|NCT00736879|357002|P2|Double Blind Treatment Period|Lost to Follow-up|0
103650|NCT00736879|357003|P1|Double Blind Treatment Period|Lost to Follow-up|0
103651|NCT00736879|357000|P4|Double Blind Treatment Period|Withdrawal by Subject|3
103652|NCT00736879|357001|P3|Double Blind Treatment Period|Withdrawal by Subject|3
103653|NCT00736879|357002|P2|Double Blind Treatment Period|Withdrawal by Subject|1
103654|NCT00736879|357003|P1|Double Blind Treatment Period|Withdrawal by Subject|2
103655|NCT00736879|357000|P4|Double Blind Treatment Period|Adverse Event|0
103656|NCT00736879|357001|P3|Double Blind Treatment Period|Adverse Event|1
103657|NCT00736879|357002|P2|Double Blind Treatment Period|Adverse Event|1
103658|NCT00736879|357003|P1|Double Blind Treatment Period|Adverse Event|0
103659|NCT00736879|357000|P4|Double Blind Treatment Period|Lack of Efficacy|0
103660|NCT00736879|357001|P3|Double Blind Treatment Period|Lack of Efficacy|0
103661|NCT00736879|357002|P2|Double Blind Treatment Period|Lack of Efficacy|0
103662|NCT00736879|357003|P1|Double Blind Treatment Period|Lack of Efficacy|1
103663|NCT00736853|357057|P3|Double-Blind Period|Ineligible to participate the study|0
103664|NCT00736853|357058|P2|Double-Blind Period|Ineligible to participate the study|1
103665|NCT00736853|357059|P1|Double-Blind Period|Ineligible to participate the study|0
103666|NCT00736853|357057|P3|Double-Blind Period|Withdrawal by Subject|4
103667|NCT00736853|357058|P2|Double-Blind Period|Withdrawal by Subject|1
103668|NCT00736853|357059|P1|Double-Blind Period|Withdrawal by Subject|0
103669|NCT00736853|357057|P3|Double-Blind Period|Adverse Event|2
103670|NCT00736853|357058|P2|Double-Blind Period|Adverse Event|3
103671|NCT00736853|357059|P1|Double-Blind Period|Adverse Event|0
103672|NCT00736853|357057|P3|Double-Blind Period|Lack of Efficacy|42
103673|NCT00736853|357058|P2|Double-Blind Period|Lack of Efficacy|19
103674|NCT00736853|357059|P1|Double-Blind Period|Lack of Efficacy|0
103675|NCT00736853|357057|P3|Open-Label Period|Unable to attend hospital appointments|0
103676|NCT00736853|357058|P2|Open-Label Period|Unable to attend hospital appointments|0
103677|NCT00736853|357059|P1|Open-Label Period|Unable to attend hospital appointments|1
103678|NCT00736853|357057|P3|Open-Label Period|Failed to meet the transfer criteria|0
103679|NCT00736853|357058|P2|Open-Label Period|Failed to meet the transfer criteria|0
103680|NCT00736853|357059|P1|Open-Label Period|Failed to meet the transfer criteria|40
103681|NCT00736853|357057|P3|Open-Label Period|Started but not treated|0
103682|NCT00736853|357058|P2|Open-Label Period|Started but not treated|0
103683|NCT00736853|357059|P1|Open-Label Period|Started but not treated|42
103684|NCT00736853|357057|P3|Open-Label Period|Withdrawal by Subject|0
103685|NCT00736853|357058|P2|Open-Label Period|Withdrawal by Subject|0
103686|NCT00736853|357059|P1|Open-Label Period|Withdrawal by Subject|16
103687|NCT00736853|357057|P3|Open-Label Period|Adverse Event|0
103688|NCT00736853|357058|P2|Open-Label Period|Adverse Event|0
103689|NCT00736853|357059|P1|Open-Label Period|Adverse Event|31
103690|NCT00736853|357057|P3|Open-Label Period|Physician Decision|0
103691|NCT00736853|357058|P2|Open-Label Period|Physician Decision|0
103692|NCT00736853|357059|P1|Open-Label Period|Physician Decision|2
103693|NCT00736840|357099|P1|Overall Study|Lost to Follow-up|13
103694|NCT00736723|357106|P2|Overall Study|Withdrawal by Subject|3
103695|NCT00736723|357107|P1|Overall Study|Withdrawal by Subject|4
103696|NCT00736502|357122|P1|Overall Study|Lost to Follow-up|27
103697|NCT00736502|357122|P1|Overall Study|Lack of Efficacy|16
103698|NCT00736502|357122|P1|Overall Study|Adverse Event|22
103699|NCT00736489|357128|P6|Period 1|Withdrawal by Subject|1
103700|NCT00736489|357129|P5|Period 1|Withdrawal by Subject|0
103701|NCT00736489|357130|P4|Period 1|Withdrawal by Subject|0
103702|NCT00736489|357131|P3|Period 1|Withdrawal by Subject|0
103703|NCT00736489|357132|P2|Period 1|Withdrawal by Subject|0
103704|NCT00736489|357133|P1|Period 1|Withdrawal by Subject|0
103705|NCT00736489|357128|P6|Period 1|Lost to Follow-up|0
103706|NCT00736489|357129|P5|Period 1|Lost to Follow-up|0
103707|NCT00736489|357130|P4|Period 1|Lost to Follow-up|0
103708|NCT00736489|357131|P3|Period 1|Lost to Follow-up|0
103709|NCT00736489|357132|P2|Period 1|Lost to Follow-up|0
103710|NCT00736489|357133|P1|Period 1|Lost to Follow-up|1
103711|NCT00736385|357287|P2|Overall Study|Adverse Event|1
103712|NCT00736385|357288|P1|Overall Study|Adverse Event|0
103713|NCT00736385|357287|P2|Overall Study|Withdrawal by Subject|2
103714|NCT00736385|357288|P1|Overall Study|Withdrawal by Subject|2
103715|NCT00736333|357300|P1|Overall Study|Not Specified|4
103716|NCT00736333|357300|P1|Overall Study|Death|7
103717|NCT00736333|357300|P1|Overall Study|Withdrawal by Subject|10
103718|NCT00736333|357300|P1|Overall Study|Toxicity|6
103719|NCT00736333|357300|P1|Overall Study|Tumor Progression|75
103720|NCT00736333|357300|P1|Overall Study|Data Missing|2
103721|NCT00736333|357300|P1|Overall Study|Did Not Receive Drug or Not Documented|7
103722|NCT00736255|357311|P2|Overall Study|Non-compliance|1
103723|NCT00736255|357312|P1|Overall Study|Non-compliance|1
103724|NCT00736255|357311|P2|Overall Study|Physician Decision|0
103725|NCT00736255|357312|P1|Overall Study|Physician Decision|1
103726|NCT00736255|357311|P2|Overall Study|Adverse Event|0
103727|NCT00736255|357312|P1|Overall Study|Adverse Event|1
103728|NCT00736190|357351|P1|Overall Study|Adverse Event|1
103729|NCT00736190|357351|P1|Overall Study|Withdrawal by Subject|1
103730|NCT00736190|357351|P1|Overall Study|Pregnancy|1
103731|NCT00736099|357377|P2|Overall Study|Other reason|10
103732|NCT00736099|357378|P1|Overall Study|Other reason|43
103733|NCT00736099|357377|P2|Overall Study|Lack of Efficacy|8
103734|NCT00736099|357378|P1|Overall Study|Lack of Efficacy|15
103735|NCT00736099|357377|P2|Overall Study|Withdrawal by Subject|13
103736|NCT00736099|357378|P1|Overall Study|Withdrawal by Subject|42
103737|NCT00736099|357377|P2|Overall Study|Lost to Follow-up|5
103738|NCT00736099|357378|P1|Overall Study|Lost to Follow-up|12
103739|NCT00736099|357377|P2|Overall Study|Protocol Violation|4
103740|NCT00736099|357378|P1|Overall Study|Protocol Violation|10
103741|NCT00736099|357377|P2|Overall Study|Adverse Event|18
103742|NCT00736099|357378|P1|Overall Study|Adverse Event|61
103743|NCT00736034|357487|P1|Overall Study|Adverse Event|2
103744|NCT00735943|357495|P1|Overall Study|Adverse Event|1
103745|NCT00735943|357495|P1|Overall Study|Lost to Follow-up|1
103746|NCT00735904|357520|P1|Overall Study|Unspecified|8
103747|NCT00735904|357520|P1|Overall Study|Study Terminated by Sponsor|5
103748|NCT00735904|357520|P1|Overall Study|Withdrawal by Subject|1
103749|NCT00735904|357520|P1|Overall Study|Protocol Violation|1
103750|NCT00735904|357520|P1|Overall Study|Death|20
103751|NCT00735904|357520|P1|Overall Study|Adverse Event|3
103752|NCT00735709|357589|P4|Overall Study|Excluded medication|1
103753|NCT00735709|357590|P3|Overall Study|Excluded medication|0
103754|NCT00735709|357591|P2|Overall Study|Excluded medication|0
103755|NCT00735709|357592|P1|Overall Study|Excluded medication|1
103756|NCT00735709|357589|P4|Overall Study|Lost to Follow-up|1
103757|NCT00735709|357590|P3|Overall Study|Lost to Follow-up|1
103758|NCT00735709|357591|P2|Overall Study|Lost to Follow-up|1
103759|NCT00735709|357592|P1|Overall Study|Lost to Follow-up|0
103760|NCT00735709|357589|P4|Overall Study|Voluntary Withdrawal|7
103761|NCT00735709|357590|P3|Overall Study|Voluntary Withdrawal|5
103762|NCT00735709|357591|P2|Overall Study|Voluntary Withdrawal|3
103763|NCT00735709|357592|P1|Overall Study|Voluntary Withdrawal|1
103764|NCT00735709|357589|P4|Overall Study|Protocol deviations|1
103765|NCT00735709|357590|P3|Overall Study|Protocol deviations|1
103766|NCT00735709|357591|P2|Overall Study|Protocol deviations|2
103767|NCT00735709|357592|P1|Overall Study|Protocol deviations|1
103768|NCT00735709|357589|P4|Overall Study|Noncompliance|0
103769|NCT00735709|357590|P3|Overall Study|Noncompliance|1
103770|NCT00735709|357591|P2|Overall Study|Noncompliance|0
103771|NCT00735709|357592|P1|Overall Study|Noncompliance|0
103772|NCT00735709|357589|P4|Overall Study|Lack of Efficacy|3
103773|NCT00735709|357590|P3|Overall Study|Lack of Efficacy|2
103774|NCT00735709|357591|P2|Overall Study|Lack of Efficacy|4
103775|NCT00735709|357592|P1|Overall Study|Lack of Efficacy|8
103776|NCT00735709|357589|P4|Overall Study|Adverse Event|5
103777|NCT00735709|357590|P3|Overall Study|Adverse Event|1
103778|NCT00735709|357591|P2|Overall Study|Adverse Event|3
103779|NCT00735709|357592|P1|Overall Study|Adverse Event|2
103780|NCT00735696|357702|P1|Overall Study|Enrolled but never Treated|1
103781|NCT00735696|357702|P1|Overall Study|Withdrawal by Subject|1
103782|NCT00735644|357730|P5|Overall Study|Withdrawal by Subject|0
103783|NCT00735644|357731|P4|Overall Study|Withdrawal by Subject|1
103784|NCT00735644|357732|P3|Overall Study|Withdrawal by Subject|1
103785|NCT00735644|357733|P2|Overall Study|Withdrawal by Subject|1
103786|NCT00735644|357734|P1|Overall Study|Withdrawal by Subject|0
103787|NCT00735644|357730|P5|Overall Study|Did not receive study vaccine|0
103788|NCT00735644|357731|P4|Overall Study|Did not receive study vaccine|0
103789|NCT00735644|357732|P3|Overall Study|Did not receive study vaccine|0
103790|NCT00735644|357733|P2|Overall Study|Did not receive study vaccine|1
103791|NCT00735644|357734|P1|Overall Study|Did not receive study vaccine|0
103792|NCT00735553|357778|P1|Overall Study|Study prematurely terminated|77
103793|NCT00735475|357788|P2|Overall Study|Withdrawal by Subject|5
103794|NCT00735475|357789|P1|Overall Study|Withdrawal by Subject|4
103795|NCT00735475|357788|P2|Overall Study|Physician Decision|1
103796|NCT00735475|357789|P1|Overall Study|Physician Decision|0
103797|NCT00735475|357788|P2|Overall Study|Lost to Follow-up|3
103798|NCT00735475|357789|P1|Overall Study|Lost to Follow-up|3
103799|NCT00735475|357788|P2|Overall Study|Death|1
103800|NCT00735475|357789|P1|Overall Study|Death|1
103801|NCT00735475|357788|P2|Overall Study|Adverse Event|1
103802|NCT00735475|357789|P1|Overall Study|Adverse Event|0
103803|NCT00735397|357849|P1|Overall Study|Administrative/Other|502
103804|NCT00735397|357849|P1|Overall Study|Inadequate therapeutic effect|202
103805|NCT00735397|357849|P1|Overall Study|Participant choice|252
103806|NCT00735397|357849|P1|Overall Study|Lost to Follow-up|33
103807|NCT00735397|357849|P1|Overall Study|Adverse Event|194
103808|NCT00735371|357863|P4|Overall Study|Exclusion criteria|0
103809|NCT00735371|357864|P3|Overall Study|Exclusion criteria|0
103810|NCT00735371|357865|P2|Overall Study|Exclusion criteria|0
103811|NCT00735371|357866|P1|Overall Study|Exclusion criteria|1
103812|NCT00735371|357863|P4|Overall Study|Prior Vyvanse Exposure|0
103813|NCT00735371|357864|P3|Overall Study|Prior Vyvanse Exposure|0
103814|NCT00735371|357865|P2|Overall Study|Prior Vyvanse Exposure|1
103815|NCT00735371|357866|P1|Overall Study|Prior Vyvanse Exposure|1
103816|NCT00735371|357863|P4|Overall Study|Protocol Violation|0
103817|NCT00735371|357864|P3|Overall Study|Protocol Violation|2
103818|NCT00735371|357865|P2|Overall Study|Protocol Violation|1
103819|NCT00735371|357866|P1|Overall Study|Protocol Violation|0
103820|NCT00735371|357863|P4|Overall Study|Sponsor Decision|1
103821|NCT00735371|357864|P3|Overall Study|Sponsor Decision|0
103822|NCT00735371|357865|P2|Overall Study|Sponsor Decision|1
103823|NCT00735371|357866|P1|Overall Study|Sponsor Decision|3
103824|NCT00735371|357863|P4|Overall Study|Lack of Efficacy|4
103825|NCT00735371|357864|P3|Overall Study|Lack of Efficacy|0
103826|NCT00735371|357865|P2|Overall Study|Lack of Efficacy|2
103827|NCT00735371|357866|P1|Overall Study|Lack of Efficacy|4
103828|NCT00735371|357863|P4|Overall Study|Lost to Follow-up|1
103829|NCT00735371|357864|P3|Overall Study|Lost to Follow-up|3
103830|NCT00735371|357865|P2|Overall Study|Lost to Follow-up|1
103831|NCT00735371|357866|P1|Overall Study|Lost to Follow-up|1
103832|NCT00735371|357863|P4|Overall Study|Withdrawal by Subject|0
103833|NCT00735371|357864|P3|Overall Study|Withdrawal by Subject|2
103834|NCT00735371|357865|P2|Overall Study|Withdrawal by Subject|2
103835|NCT00735371|357866|P1|Overall Study|Withdrawal by Subject|0
103836|NCT00735371|357863|P4|Overall Study|Protocol Violation|3
103837|NCT00735371|357864|P3|Overall Study|Protocol Violation|0
103838|NCT00735371|357865|P2|Overall Study|Protocol Violation|2
103839|NCT00735371|357866|P1|Overall Study|Protocol Violation|2
103840|NCT00735371|357863|P4|Overall Study|Adverse Event|1
103841|NCT00735371|357864|P3|Overall Study|Adverse Event|4
103842|NCT00735371|357865|P2|Overall Study|Adverse Event|3
103843|NCT00735371|357866|P1|Overall Study|Adverse Event|3
103844|NCT00735072|357892|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
103845|NCT00735072|357893|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
103846|NCT00735072|357892|P2|Overall Study|interrupted study med during ARV change|0
103847|NCT00735072|357893|P1|Overall Study|interrupted study med during ARV change|1
103848|NCT00735007|357899|P1|Overall Study|Protocol Violation|1
103849|NCT00735007|357899|P1|Overall Study|Adverse Event|4
103850|NCT00734994|357924|P1|Overall Study|Withdrawal by Subject|1
103851|NCT00734929|357944|P2|Overall Study|No intervention/ screen fail|3
103852|NCT00734929|357945|P1|Overall Study|No intervention/ screen fail|5
103853|NCT00734929|357944|P2|Overall Study|Lost to Follow-up|2
103854|NCT00734929|357945|P1|Overall Study|Lost to Follow-up|1
103855|NCT00734851|357973|P1|Overall Study|Physician Decision|18
103856|NCT00734851|357973|P1|Overall Study|Lost to Follow-up|1
103857|NCT00734851|357973|P1|Overall Study|Withdrawal by Subject|2
103858|NCT00734747|357994|P1|6 Month Follow-up|Did not meet inclusion criteria|3
103859|NCT00734747|357994|P1|SRS Procedure|No staples placed|3
103860|NCT00734656|358008|P4|Lab Session 4|Withdrawal by Subject|1
103861|NCT00734656|358009|P3|Lab Session 4|Withdrawal by Subject|0
103862|NCT00734656|358010|P2|Lab Session 4|Withdrawal by Subject|0
103863|NCT00734656|358011|P1|Lab Session 4|Withdrawal by Subject|0
103864|NCT00734656|358008|P4|Washout 3|Withdrawal by Subject|1
103865|NCT00734656|358009|P3|Washout 3|Withdrawal by Subject|0
103866|NCT00734656|358010|P2|Washout 3|Withdrawal by Subject|0
103867|NCT00734656|358011|P1|Washout 3|Withdrawal by Subject|1
103868|NCT00734656|358008|P4|Washout 2|Withdrawal by Subject|0
103869|NCT00734656|358009|P3|Washout 2|Withdrawal by Subject|1
103870|NCT00734656|358010|P2|Washout 2|Withdrawal by Subject|1
103871|NCT00734656|358011|P1|Washout 2|Withdrawal by Subject|1
103872|NCT00734656|358008|P4|Lab Session 2|Withdrawal by Subject|1
103873|NCT00734656|358009|P3|Lab Session 2|Withdrawal by Subject|0
103874|NCT00734656|358010|P2|Lab Session 2|Withdrawal by Subject|0
103875|NCT00734656|358011|P1|Lab Session 2|Withdrawal by Subject|1
103876|NCT00734656|358008|P4|Washout 1|Withdrawal by Subject|3
103877|NCT00734656|358009|P3|Washout 1|Withdrawal by Subject|2
103878|NCT00734656|358010|P2|Washout 1|Withdrawal by Subject|5
103879|NCT00734656|358011|P1|Washout 1|Withdrawal by Subject|1
103880|NCT00734656|358008|P4|Lab Session 1|Withdrawal by Subject|0
103881|NCT00734656|358009|P3|Lab Session 1|Withdrawal by Subject|0
103882|NCT00734656|358010|P2|Lab Session 1|Withdrawal by Subject|0
103883|NCT00734656|358011|P1|Lab Session 1|Withdrawal by Subject|2
103884|NCT00734630|358035|P2|Overall Study|Poor Compliance|1
103885|NCT00734630|358036|P1|Overall Study|Poor Compliance|1
103886|NCT00734630|358035|P2|Overall Study|Tested Positive for Illegal Drug Use|1
103887|NCT00734630|358036|P1|Overall Study|Tested Positive for Illegal Drug Use|1
103888|NCT00734630|358035|P2|Overall Study|Randomized in Error|1
103889|NCT00734630|358036|P1|Overall Study|Randomized in Error|0
103890|NCT00734630|358035|P2|Overall Study|Adverse Event|6
103891|NCT00734630|358036|P1|Overall Study|Adverse Event|3
103892|NCT00734630|358035|P2|Overall Study|Inclusion/Exclusion criteria not met|1
103893|NCT00734630|358036|P1|Overall Study|Inclusion/Exclusion criteria not met|0
103894|NCT00734630|358035|P2|Overall Study|Protocol Violation|3
103895|NCT00734630|358036|P1|Overall Study|Protocol Violation|0
103896|NCT00734630|358035|P2|Overall Study|Lost to Follow-up|7
103897|NCT00734630|358036|P1|Overall Study|Lost to Follow-up|13
103898|NCT00734630|358035|P2|Overall Study|Withdrawal by Subject|9
103899|NCT00734630|358036|P1|Overall Study|Withdrawal by Subject|7
103900|NCT00734630|358035|P2|Overall Study|Lack of Efficacy|4
103901|NCT00734630|358036|P1|Overall Study|Lack of Efficacy|4
103902|NCT00734617|358046|P2|Overall Study|Withdrawal by Subject|95
103903|NCT00734617|358047|P1|Overall Study|Withdrawal by Subject|103
103904|NCT00734617|358046|P2|Overall Study|Adverse Event|7
103905|NCT00734617|358047|P1|Overall Study|Adverse Event|4
103906|NCT00734604|358059|P6|Overall Study|Lack of Efficacy|0
103907|NCT00734604|358060|P5|Overall Study|Lack of Efficacy|0
103908|NCT00734604|358061|P4|Overall Study|Lack of Efficacy|0
103909|NCT00734604|358062|P3|Overall Study|Lack of Efficacy|1
103910|NCT00734604|358063|P2|Overall Study|Lack of Efficacy|1
103911|NCT00734604|358064|P1|Overall Study|Lack of Efficacy|0
103912|NCT00734604|358059|P6|Overall Study|Withdrawal by Subject|1
103913|NCT00734604|358060|P5|Overall Study|Withdrawal by Subject|2
103914|NCT00734604|358061|P4|Overall Study|Withdrawal by Subject|1
103915|NCT00734604|358062|P3|Overall Study|Withdrawal by Subject|0
103916|NCT00734604|358063|P2|Overall Study|Withdrawal by Subject|2
103917|NCT00734604|358064|P1|Overall Study|Withdrawal by Subject|0
103918|NCT00734604|358059|P6|Overall Study|Sponsor Decision|0
103919|NCT00734604|358060|P5|Overall Study|Sponsor Decision|2
103920|NCT00734604|358061|P4|Overall Study|Sponsor Decision|0
103921|NCT00734604|358062|P3|Overall Study|Sponsor Decision|1
103922|NCT00734604|358063|P2|Overall Study|Sponsor Decision|2
103923|NCT00734604|358064|P1|Overall Study|Sponsor Decision|1
103924|NCT00734604|358059|P6|Overall Study|Protocol Violation|0
103925|NCT00734604|358060|P5|Overall Study|Protocol Violation|1
103926|NCT00734604|358061|P4|Overall Study|Protocol Violation|0
103927|NCT00734604|358062|P3|Overall Study|Protocol Violation|0
103928|NCT00734604|358063|P2|Overall Study|Protocol Violation|2
103929|NCT00734604|358064|P1|Overall Study|Protocol Violation|0
103930|NCT00734604|358059|P6|Overall Study|Physician Decision|0
103931|NCT00734604|358060|P5|Overall Study|Physician Decision|0
103932|NCT00734604|358061|P4|Overall Study|Physician Decision|0
103933|NCT00734604|358062|P3|Overall Study|Physician Decision|1
103934|NCT00734604|358063|P2|Overall Study|Physician Decision|1
103935|NCT00734604|358064|P1|Overall Study|Physician Decision|0
103936|NCT00734604|358059|P6|Overall Study|Lost to Follow-up|3
103937|NCT00734604|358060|P5|Overall Study|Lost to Follow-up|2
103938|NCT00734604|358061|P4|Overall Study|Lost to Follow-up|4
103939|NCT00734604|358062|P3|Overall Study|Lost to Follow-up|2
103940|NCT00734604|358063|P2|Overall Study|Lost to Follow-up|2
103941|NCT00734604|358064|P1|Overall Study|Lost to Follow-up|1
103942|NCT00734604|358059|P6|Overall Study|Serious Adverse Event|1
103943|NCT00734604|358060|P5|Overall Study|Serious Adverse Event|0
103944|NCT00734604|358061|P4|Overall Study|Serious Adverse Event|2
103945|NCT00734604|358062|P3|Overall Study|Serious Adverse Event|1
103946|NCT00734604|358063|P2|Overall Study|Serious Adverse Event|0
103947|NCT00734604|358064|P1|Overall Study|Serious Adverse Event|1
103948|NCT00734604|358059|P6|Overall Study|Adverse Event|1
103949|NCT00734604|358060|P5|Overall Study|Adverse Event|1
103950|NCT00734604|358061|P4|Overall Study|Adverse Event|2
103951|NCT00734604|358062|P3|Overall Study|Adverse Event|0
103952|NCT00734604|358063|P2|Overall Study|Adverse Event|2
103953|NCT00734604|358064|P1|Overall Study|Adverse Event|0
103954|NCT00734591|358114|P2|Prospective Period|Unspecified|2
103955|NCT00734591|358115|P1|Prospective Period|Unspecified|2
103956|NCT00734591|358114|P2|Prospective Period|Study Terminated|0
103957|NCT00734591|358115|P1|Prospective Period|Study Terminated|1
103958|NCT00734591|358114|P2|Prospective Period|Lost to Follow-up|33
103959|NCT00734591|358115|P1|Prospective Period|Lost to Follow-up|37
103960|NCT00734591|358114|P2|Prospective Period|Withdrawal by Subject|9
103961|NCT00734591|358115|P1|Prospective Period|Withdrawal by Subject|11
103962|NCT00734591|358114|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
103963|NCT00734591|358115|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
103964|NCT00734591|358114|P2|Screening for Prospective Period|Site did not participate|1488
103965|NCT00734591|358115|P1|Screening for Prospective Period|Site did not participate|1604
103966|NCT00734578|358130|P3|Overall Study|Exclusion criteria|0
103967|NCT00734578|358131|P2|Overall Study|Exclusion criteria|0
103968|NCT00734578|358132|P1|Overall Study|Exclusion criteria|1
103969|NCT00734578|358130|P3|Overall Study|Randomized in error|0
103970|NCT00734578|358131|P2|Overall Study|Randomized in error|0
103971|NCT00734578|358132|P1|Overall Study|Randomized in error|1
103972|NCT00734578|358130|P3|Overall Study|Lack of Efficacy|5
103973|NCT00734578|358131|P2|Overall Study|Lack of Efficacy|2
103974|NCT00734578|358132|P1|Overall Study|Lack of Efficacy|3
103975|NCT00734578|358130|P3|Overall Study|Lost to Follow-up|5
103976|NCT00734578|358131|P2|Overall Study|Lost to Follow-up|3
103977|NCT00734578|358132|P1|Overall Study|Lost to Follow-up|9
103978|NCT00734578|358130|P3|Overall Study|Withdrawal by Subject|11
103979|NCT00734578|358131|P2|Overall Study|Withdrawal by Subject|8
103980|NCT00734578|358132|P1|Overall Study|Withdrawal by Subject|7
103981|NCT00734578|358130|P3|Overall Study|Protocol Violation|3
103982|NCT00734578|358131|P2|Overall Study|Protocol Violation|6
103983|NCT00734578|358132|P1|Overall Study|Protocol Violation|8
103984|NCT00734578|358130|P3|Overall Study|Adverse Event|1
103985|NCT00734578|358131|P2|Overall Study|Adverse Event|6
103986|NCT00734578|358132|P1|Overall Study|Adverse Event|4
103987|NCT00734539|358166|P2|Main Study|Enrolled in error; ineligible|0
103988|NCT00734539|358167|P1|Main Study|Enrolled in error; ineligible|1
103989|NCT00734539|358166|P2|Main Study|Withdrawal by Subject|3
103990|NCT00734539|358167|P1|Main Study|Withdrawal by Subject|1
103991|NCT00734539|358166|P2|Main Study|Physician Decision|0
103992|NCT00734539|358167|P1|Main Study|Physician Decision|2
103993|NCT00734539|358166|P2|Main Study|Death|32
103994|NCT00734539|358167|P1|Main Study|Death|33
103995|NCT00734474|358209|P9|Overall Study|Lack of Efficacy|6
103996|NCT00734474|358210|P8|Overall Study|Lack of Efficacy|4
103997|NCT00734474|358211|P7|Overall Study|Lack of Efficacy|0
103998|NCT00734474|358212|P6|Overall Study|Lack of Efficacy|0
103999|NCT00734474|358213|P5|Overall Study|Lack of Efficacy|0
104000|NCT00734474|358214|P4|Overall Study|Lack of Efficacy|0
104001|NCT00734474|358215|P3|Overall Study|Lack of Efficacy|4
104002|NCT00734474|358216|P2|Overall Study|Lack of Efficacy|0
104003|NCT00734474|358217|P1|Overall Study|Lack of Efficacy|0
104004|NCT00734474|358209|P9|Overall Study|Death|1
104005|NCT00734474|358210|P8|Overall Study|Death|2
104006|NCT00734474|358211|P7|Overall Study|Death|0
104007|NCT00734474|358212|P6|Overall Study|Death|0
104008|NCT00734474|358213|P5|Overall Study|Death|0
104009|NCT00734474|358214|P4|Overall Study|Death|0
104010|NCT00734474|358215|P3|Overall Study|Death|1
104011|NCT00734474|358216|P2|Overall Study|Death|0
104012|NCT00734474|358217|P1|Overall Study|Death|0
104013|NCT00734474|358209|P9|Overall Study|Sponsor Decision|0
104014|NCT00734474|358210|P8|Overall Study|Sponsor Decision|0
104015|NCT00734474|358211|P7|Overall Study|Sponsor Decision|0
104016|NCT00734474|358212|P6|Overall Study|Sponsor Decision|0
104017|NCT00734474|358213|P5|Overall Study|Sponsor Decision|2
104018|NCT00734474|358214|P4|Overall Study|Sponsor Decision|0
104019|NCT00734474|358215|P3|Overall Study|Sponsor Decision|0
104020|NCT00734474|358216|P2|Overall Study|Sponsor Decision|0
104021|NCT00734474|358217|P1|Overall Study|Sponsor Decision|0
104022|NCT00734474|358209|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
104023|NCT00734474|358210|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
104024|NCT00734474|358211|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
104025|NCT00734474|358212|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
104026|NCT00734474|358213|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
104027|NCT00734474|358214|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
104028|NCT00734474|358215|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
104029|NCT00734474|358216|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
104030|NCT00734474|358217|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
104031|NCT00734474|358209|P9|Overall Study|Protocol Violation|1
104032|NCT00734474|358210|P8|Overall Study|Protocol Violation|3
104033|NCT00734474|358211|P7|Overall Study|Protocol Violation|0
104034|NCT00734474|358212|P6|Overall Study|Protocol Violation|0
104035|NCT00734474|358213|P5|Overall Study|Protocol Violation|3
104036|NCT00734474|358214|P4|Overall Study|Protocol Violation|0
104037|NCT00734474|358215|P3|Overall Study|Protocol Violation|4
104038|NCT00734474|358216|P2|Overall Study|Protocol Violation|0
104039|NCT00734474|358217|P1|Overall Study|Protocol Violation|0
104040|NCT00734474|358209|P9|Overall Study|Adverse Event|39
104041|NCT00734474|358210|P8|Overall Study|Adverse Event|65
104042|NCT00734474|358211|P7|Overall Study|Adverse Event|1
104043|NCT00734474|358212|P6|Overall Study|Adverse Event|0
104044|NCT00734474|358213|P5|Overall Study|Adverse Event|64
104045|NCT00734474|358214|P4|Overall Study|Adverse Event|1
104046|NCT00734474|358215|P3|Overall Study|Adverse Event|63
104047|NCT00734474|358216|P2|Overall Study|Adverse Event|4
104048|NCT00734474|358217|P1|Overall Study|Adverse Event|4
104049|NCT00734474|358209|P9|Overall Study|Physician Decision|9
104050|NCT00734474|358210|P8|Overall Study|Physician Decision|9
104051|NCT00734474|358211|P7|Overall Study|Physician Decision|0
104052|NCT00734474|358212|P6|Overall Study|Physician Decision|0
104053|NCT00734474|358213|P5|Overall Study|Physician Decision|11
104054|NCT00734474|358214|P4|Overall Study|Physician Decision|1
104055|NCT00734474|358215|P3|Overall Study|Physician Decision|4
104056|NCT00734474|358216|P2|Overall Study|Physician Decision|0
104057|NCT00734474|358217|P1|Overall Study|Physician Decision|0
104058|NCT00734474|358209|P9|Overall Study|Withdrawal by Subject|21
104059|NCT00734474|358210|P8|Overall Study|Withdrawal by Subject|36
104060|NCT00734474|358211|P7|Overall Study|Withdrawal by Subject|0
104061|NCT00734474|358212|P6|Overall Study|Withdrawal by Subject|2
104062|NCT00734474|358213|P5|Overall Study|Withdrawal by Subject|24
104063|NCT00734474|358214|P4|Overall Study|Withdrawal by Subject|0
104064|NCT00734474|358215|P3|Overall Study|Withdrawal by Subject|18
104065|NCT00734474|358216|P2|Overall Study|Withdrawal by Subject|1
104066|NCT00734474|358217|P1|Overall Study|Withdrawal by Subject|2
104067|NCT00734474|358209|P9|Overall Study|Lost to Follow-up|4
104068|NCT00734474|358210|P8|Overall Study|Lost to Follow-up|9
104069|NCT00734474|358211|P7|Overall Study|Lost to Follow-up|0
104070|NCT00734474|358212|P6|Overall Study|Lost to Follow-up|1
104071|NCT00734474|358213|P5|Overall Study|Lost to Follow-up|11
104072|NCT00734474|358214|P4|Overall Study|Lost to Follow-up|0
104073|NCT00734474|358215|P3|Overall Study|Lost to Follow-up|13
104074|NCT00734474|358216|P2|Overall Study|Lost to Follow-up|0
104075|NCT00734474|358217|P1|Overall Study|Lost to Follow-up|1
104076|NCT00734474|358209|P9|Overall Study|Entry Criteria Not Met|1
104077|NCT00734474|358210|P8|Overall Study|Entry Criteria Not Met|1
104078|NCT00734474|358211|P7|Overall Study|Entry Criteria Not Met|0
104079|NCT00734474|358212|P6|Overall Study|Entry Criteria Not Met|1
104080|NCT00734474|358213|P5|Overall Study|Entry Criteria Not Met|3
104081|NCT00734474|358214|P4|Overall Study|Entry Criteria Not Met|0
104082|NCT00734474|358215|P3|Overall Study|Entry Criteria Not Met|5
104083|NCT00734474|358216|P2|Overall Study|Entry Criteria Not Met|0
104084|NCT00734474|358217|P1|Overall Study|Entry Criteria Not Met|0
104085|NCT00734214|358507|P2|Overall Study|MD withdrawal|0
104086|NCT00734214|358508|P1|Overall Study|MD withdrawal|1
104087|NCT00734214|358507|P2|Overall Study|Withdrawal by Subject|4
104088|NCT00734214|358508|P1|Overall Study|Withdrawal by Subject|3
104089|NCT00734162|358518|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
104090|NCT00734162|358519|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
104091|NCT00734162|358520|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
104092|NCT00734162|358521|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
104093|NCT00734162|358518|P4|Open-Label Phase|Lost to Follow-up|1
104094|NCT00734162|358519|P3|Open-Label Phase|Lost to Follow-up|0
104095|NCT00734162|358520|P2|Open-Label Phase|Lost to Follow-up|2
104096|NCT00734162|358521|P1|Open-Label Phase|Lost to Follow-up|1
104097|NCT00734162|358518|P4|Open-Label Phase|Withdrew Consent|1
104098|NCT00734162|358519|P3|Open-Label Phase|Withdrew Consent|1
104099|NCT00734162|358520|P2|Open-Label Phase|Withdrew Consent|0
104100|NCT00734162|358521|P1|Open-Label Phase|Withdrew Consent|1
104101|NCT00734162|358518|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
104102|NCT00734162|358519|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
104103|NCT00734162|358520|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
104104|NCT00734162|358521|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
104105|NCT00734162|358518|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
104106|NCT00734162|358519|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
104107|NCT00734162|358520|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
104108|NCT00734162|358521|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
104109|NCT00734162|358518|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
104110|NCT00734162|358519|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
104111|NCT00734162|358520|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
104112|NCT00734162|358521|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
104113|NCT00734149|358745|P1|Overall Study|Withdrawal by Subject|1
104114|NCT00734097|358752|P1|Open Label|Protocol Violation|4
104115|NCT00734097|358752|P1|Open Label|Withdrawal by Subject|5
104116|NCT00734097|358752|P1|Open Label|Lost to Follow-up|7
104117|NCT00734097|358752|P1|Screening|Unconfirmed pregnancy|1
104118|NCT00734097|358752|P1|Screening|Lost to Follow-up|2
104119|NCT00734097|358752|P1|Screening|Withdrawal by Subject|5
104120|NCT00734097|358752|P1|Screening|Protocol Violation|12
104121|NCT00734071|358769|P2|Overall Study|Other|2
104122|NCT00734071|358770|P1|Overall Study|Other|1
104123|NCT00734071|358769|P2|Overall Study|Lost to Follow-up|8
104124|NCT00734071|358770|P1|Overall Study|Lost to Follow-up|16
104125|NCT00734071|358769|P2|Overall Study|Voluntary Withdrawal|7
104126|NCT00734071|358770|P1|Overall Study|Voluntary Withdrawal|9
104127|NCT00734071|358769|P2|Overall Study|Protocol Deviations|4
104128|NCT00734071|358770|P1|Overall Study|Protocol Deviations|3
104129|NCT00734071|358769|P2|Overall Study|Noncompliance|2
104130|NCT00734071|358770|P1|Overall Study|Noncompliance|2
104131|NCT00734071|358769|P2|Overall Study|Lack of Efficacy|1
104132|NCT00734071|358770|P1|Overall Study|Lack of Efficacy|3
104133|NCT00734071|358769|P2|Overall Study|Adverse Event|3
104134|NCT00734071|358770|P1|Overall Study|Adverse Event|4
104135|NCT00733954|358826|P2|Overall Study|Withdrawal by Subject|0
104136|NCT00733954|358827|P1|Overall Study|Withdrawal by Subject|2
104137|NCT00733954|358826|P2|Overall Study|Protocol Violation|0
104138|NCT00733954|358827|P1|Overall Study|Protocol Violation|1
104139|NCT00733954|358826|P2|Overall Study|Lost to Follow-up|2
104140|NCT00733954|358827|P1|Overall Study|Lost to Follow-up|5
104141|NCT00733824|358874|P5|Phase I|Withdrawal by Subject|0
104142|NCT00733824|358875|P4|Phase I|Withdrawal by Subject|0
104143|NCT00733824|358876|P3|Phase I|Withdrawal by Subject|0
104144|NCT00733824|358877|P2|Phase I|Withdrawal by Subject|0
104145|NCT00733824|358878|P1|Phase I|Withdrawal by Subject|1
104146|NCT00733499|358904|P2|24 Months Follow-up|Death|1
104147|NCT00733499|358905|P1|24 Months Follow-up|Death|0
104148|NCT00733499|358904|P2|12 Months Follow-up|Death|1
104149|NCT00733499|358905|P1|12 Months Follow-up|Death|2
104150|NCT00733499|358904|P2|6 Months Follow-up|Adverse Event|1
104151|NCT00733499|358905|P1|6 Months Follow-up|Adverse Event|0
104152|NCT00733499|358904|P2|6 Months Follow-up|Death|2
104153|NCT00733499|358905|P1|6 Months Follow-up|Death|0
104154|NCT00733499|358904|P2|3 Months Follow-up|Death|2
104155|NCT00733499|358905|P1|3 Months Follow-up|Death|1
104156|NCT00733499|358904|P2|Pre-operative|Protocol Violation|1
104157|NCT00733499|358905|P1|Pre-operative|Protocol Violation|0
104158|NCT00733421|358913|P2|Overall Study|Withdrawal by Subject|1
104159|NCT00733421|358914|P1|Overall Study|Withdrawal by Subject|1
104160|NCT00733369|358938|P2|Overall Study|Protocol Violation|4
104161|NCT00733369|358939|P1|Overall Study|Protocol Violation|4
104162|NCT00733369|358938|P2|Overall Study|Adverse Event|4
104163|NCT00733369|358939|P1|Overall Study|Adverse Event|4
104164|NCT00733369|358938|P2|Overall Study|Lost to Follow-up|1
104165|NCT00733369|358939|P1|Overall Study|Lost to Follow-up|2
104166|NCT00733291|359142|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
104167|NCT00733291|359143|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
104168|NCT00733291|359144|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
104169|NCT00733291|359145|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
104170|NCT00733226|359174|P2|Overall Study|moved to another place|0
104171|NCT00733226|359175|P1|Overall Study|moved to another place|2
104172|NCT00733226|359174|P2|Overall Study|Lost to Follow-up|0
104173|NCT00733226|359175|P1|Overall Study|Lost to Follow-up|2
104174|NCT00733226|359174|P2|Overall Study|Withdrawal by Subject|0
104175|NCT00733226|359175|P1|Overall Study|Withdrawal by Subject|1
104176|NCT00733005|359224|P2|Overall Study|Protocol Violation|0
104177|NCT00733005|359225|P1|Overall Study|Protocol Violation|2
104178|NCT00733005|359224|P2|Overall Study|Withdrawal by Subject|1
104179|NCT00733005|359225|P1|Overall Study|Withdrawal by Subject|0
104180|NCT00733005|359224|P2|Overall Study|Treatment Failure|1
104181|NCT00733005|359225|P1|Overall Study|Treatment Failure|0
104182|NCT00733005|359224|P2|Overall Study|Adverse Event|1
104183|NCT00733005|359225|P1|Overall Study|Adverse Event|0
104184|NCT00732992|359235|P2|Overall Study|Withdrawal by Subject|0
104185|NCT00732992|359236|P1|Overall Study|Withdrawal by Subject|1
104186|NCT00732992|359235|P2|Overall Study|Global Deterioration of Health Status|0
104187|NCT00732992|359236|P1|Overall Study|Global Deterioration of Health Status|1
104188|NCT00732992|359235|P2|Overall Study|Objective Progression or Relapse|5
104189|NCT00732992|359236|P1|Overall Study|Objective Progression or Relapse|3
104190|NCT00732992|359235|P2|Overall Study|Adverse Event|1
104191|NCT00732992|359236|P1|Overall Study|Adverse Event|1
104192|NCT00732940|359255|P2|Overall Study|Lost to Follow-up|0
104193|NCT00732940|359256|P1|Overall Study|Lost to Follow-up|1
104194|NCT00732940|359255|P2|Overall Study|Adverse Event|1
104195|NCT00732940|359256|P1|Overall Study|Adverse Event|0
104196|NCT00732940|359255|P2|Overall Study|Withdrawal by Subject|2
104197|NCT00732940|359256|P1|Overall Study|Withdrawal by Subject|1
104198|NCT00732875|359324|P1|Overall Study|Lack of Efficacy|13
104199|NCT00732875|359324|P1|Overall Study|Withdrawal by Subject|6
104200|NCT00732875|359324|P1|Overall Study|Adverse Event|16
104201|NCT00732758|359332|P2|Overall Study|Lost to Follow-up|16
104202|NCT00732758|359333|P1|Overall Study|Lost to Follow-up|8
104203|NCT00732641|359351|P2|Overall Study|Not Specified|5
104204|NCT00732641|359352|P1|Overall Study|Not Specified|18
104205|NCT00732641|359351|P2|Overall Study|Unable to Complete|1
104206|NCT00732641|359352|P1|Overall Study|Unable to Complete|1
104207|NCT00732641|359351|P2|Overall Study|Withdrawal by Subject|2
104208|NCT00732641|359352|P1|Overall Study|Withdrawal by Subject|4
104209|NCT00732641|359351|P2|Overall Study|Physician Decision|0
104210|NCT00732641|359352|P1|Overall Study|Physician Decision|6
104211|NCT00732641|359351|P2|Overall Study|Serious Adverse Events|3
104212|NCT00732641|359352|P1|Overall Study|Serious Adverse Events|12
104213|NCT00732641|359351|P2|Overall Study|Relapse or Progressive Disease|101
104214|NCT00732641|359352|P1|Overall Study|Relapse or Progressive Disease|65
104215|NCT00732615|359372|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
104216|NCT00732615|359373|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
104217|NCT00732615|359372|P2|Overall Study|Physician Decision|0
104218|NCT00732615|359373|P1|Overall Study|Physician Decision|3
104219|NCT00732615|359372|P2|Overall Study|Adverse Event|2
104220|NCT00732615|359373|P1|Overall Study|Adverse Event|0
104221|NCT00732615|359372|P2|Overall Study|Lost to Follow-up|1
104222|NCT00732615|359373|P1|Overall Study|Lost to Follow-up|0
104223|NCT00732615|359372|P2|Overall Study|Withdrawal by Subject|1
104224|NCT00732615|359373|P1|Overall Study|Withdrawal by Subject|3
104225|NCT00732472|359389|P4|Overall Study|Withdrawal by Subject|1
104226|NCT00732472|359390|P3|Overall Study|Withdrawal by Subject|0
104227|NCT00732472|359391|P2|Overall Study|Withdrawal by Subject|2
104228|NCT00732472|359392|P1|Overall Study|Withdrawal by Subject|0
104229|NCT00732472|359389|P4|Overall Study|Protocol Violation|1
104230|NCT00732472|359390|P3|Overall Study|Protocol Violation|0
104231|NCT00732472|359391|P2|Overall Study|Protocol Violation|0
104232|NCT00732472|359392|P1|Overall Study|Protocol Violation|0
104233|NCT00732472|359389|P4|Overall Study|Adverse Event|1
104234|NCT00732472|359390|P3|Overall Study|Adverse Event|1
104235|NCT00732472|359391|P2|Overall Study|Adverse Event|1
104236|NCT00732472|359392|P1|Overall Study|Adverse Event|0
104237|NCT00732381|359492|P2|Overall Study|Treatment Failure|1
104238|NCT00732381|359493|P1|Overall Study|Treatment Failure|1
104239|NCT00732381|359492|P2|Overall Study|Adverse Event|0
104240|NCT00732381|359493|P1|Overall Study|Adverse Event|1
104241|NCT00732303|359501|P1|Overall Study|Study Terminated|2
104242|NCT00732238|359509|P2|Overall Study|Asymptomatic bacteriuria|0
104243|NCT00732238|359510|P1|Overall Study|Asymptomatic bacteriuria|1
104244|NCT00732238|359509|P2|Overall Study|Bacteremia|1
104245|NCT00732238|359510|P1|Overall Study|Bacteremia|4
104246|NCT00732069|359574|P6|Washout After First Study Drug|Adverse Event|0
104247|NCT00732069|359575|P5|Washout After First Study Drug|Adverse Event|0
104248|NCT00732069|359576|P4|Washout After First Study Drug|Adverse Event|0
104249|NCT00732069|359577|P3|Washout After First Study Drug|Adverse Event|0
104250|NCT00732069|359578|P2|Washout After First Study Drug|Adverse Event|0
104251|NCT00732069|359579|P1|Washout After First Study Drug|Adverse Event|1
104252|NCT00731939|359597|P1|Overall Study|Did not meet enrollment criteria|2
104253|NCT00731939|359597|P1|Overall Study|Withdrawal by Subject|2
104254|NCT00731939|359597|P1|Overall Study|Not implanted with study device|9
104255|NCT00731939|359597|P1|Overall Study|Lost to Follow-up|15
104256|NCT00731939|359597|P1|Overall Study|Adverse Event|6
104257|NCT00731822|359658|P2|Overall Study|Lost to Follow-up|0
104258|NCT00731822|359659|P1|Overall Study|Lost to Follow-up|1
104259|NCT00731822|359658|P2|Overall Study|Protocol Violation|0
104260|NCT00731822|359659|P1|Overall Study|Protocol Violation|1
104261|NCT00731822|359658|P2|Overall Study|Adverse Event|1
104262|NCT00731822|359659|P1|Overall Study|Adverse Event|2
104263|NCT00731783|359673|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
104264|NCT00731783|359674|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
104265|NCT00731783|359673|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
104266|NCT00731783|359674|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
104267|NCT00731783|359673|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
104268|NCT00731783|359674|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
104269|NCT00731783|359673|P2|One Month Follow-Up Visit|Lost to Follow-up|22
104270|NCT00731783|359674|P1|One Month Follow-Up Visit|Lost to Follow-up|14
104271|NCT00731731|359697|P3|Overall Study|Cancel prior to treatment|2
104272|NCT00731731|359698|P2|Overall Study|Cancel prior to treatment|0
104273|NCT00731731|359699|P1|Overall Study|Cancel prior to treatment|0
104274|NCT00731731|359697|P3|Overall Study|Protocol Violation|1
104275|NCT00731731|359698|P2|Overall Study|Protocol Violation|0
104276|NCT00731731|359699|P1|Overall Study|Protocol Violation|0
104277|NCT00731679|359716|P2|Overall Study|Pregnancy|1
104278|NCT00731679|359717|P1|Overall Study|Pregnancy|0
104279|NCT00731679|359716|P2|Overall Study|Noncompliance|1
104280|NCT00731679|359717|P1|Overall Study|Noncompliance|0
104281|NCT00731679|359716|P2|Overall Study|Lost to Follow-up|8
104282|NCT00731679|359717|P1|Overall Study|Lost to Follow-up|7
104283|NCT00731679|359716|P2|Overall Study|Withdrawal by Subject|8
104284|NCT00731679|359717|P1|Overall Study|Withdrawal by Subject|8
104285|NCT00731679|359716|P2|Overall Study|Adverse Event|8
104286|NCT00731679|359717|P1|Overall Study|Adverse Event|7
104287|NCT00731666|359725|P1|Overall Study|Withdrawal by Subject|2
104288|NCT00731666|359725|P1|Overall Study|Lost to Follow-up|8
104289|NCT00731666|359725|P1|Overall Study|Adverse Event|2
104290|NCT00731549|359759|P1|Overall Study|Lack of efficacy without AE|6
104291|NCT00731549|359759|P1|Overall Study|Lack of efficacy with AE|37
104292|NCT00731549|359759|P1|Overall Study|Adverse Event|31
104293|NCT00731549|359759|P1|Overall Study|Protocol deviation|1
104294|NCT00731549|359759|P1|Overall Study|Withdrawal by Subject|89
104295|NCT00731549|359759|P1|Overall Study|Physician Decision|16
104296|NCT00731549|359759|P1|Overall Study|Met withdrawal criteria|24
104297|NCT00731549|359759|P1|Overall Study|Lost to Follow-up|19
104298|NCT00731133|359799|P1|Overall Study|Withdrawal by Subject|10
104299|NCT00731120|359807|P3|Overall Study|Other|1
104300|NCT00731120|359808|P2|Overall Study|Other|0
104301|NCT00731120|359809|P1|Overall Study|Other|4
104302|NCT00731120|359807|P3|Overall Study|Lost to Follow-up|17
104303|NCT00731120|359808|P2|Overall Study|Lost to Follow-up|15
104304|NCT00731120|359809|P1|Overall Study|Lost to Follow-up|10
104305|NCT00731120|359807|P3|Overall Study|Withdrawal of Consent|4
104306|NCT00731120|359808|P2|Overall Study|Withdrawal of Consent|8
104307|NCT00731120|359809|P1|Overall Study|Withdrawal of Consent|13
104308|NCT00731120|359807|P3|Overall Study|Protocol Deviations|1
104309|NCT00731120|359808|P2|Overall Study|Protocol Deviations|6
104310|NCT00731120|359809|P1|Overall Study|Protocol Deviations|1
104311|NCT00731120|359807|P3|Overall Study|Noncompliance with Study Drug|1
104312|NCT00731120|359808|P2|Overall Study|Noncompliance with Study Drug|3
104313|NCT00731120|359809|P1|Overall Study|Noncompliance with Study Drug|3
104314|NCT00731120|359807|P3|Overall Study|Lack of Efficacy|4
104315|NCT00731120|359808|P2|Overall Study|Lack of Efficacy|5
104316|NCT00731120|359809|P1|Overall Study|Lack of Efficacy|4
104317|NCT00731120|359807|P3|Overall Study|Adverse Event|8
104318|NCT00731120|359808|P2|Overall Study|Adverse Event|6
104319|NCT00731120|359809|P1|Overall Study|Adverse Event|7
104320|NCT00731042|359926|P2|Second Intervention|Did not meet inclusion criteria|2
104321|NCT00731042|359927|P1|Second Intervention|Did not meet inclusion criteria|0
104322|NCT00730925|359938|P1|Overall Study|Other|1
104323|NCT00730925|359938|P1|Overall Study|Switch to combination therapy|8
104324|NCT00730925|359938|P1|Overall Study|Withdrawal by Subject|1
104325|NCT00730925|359938|P1|Overall Study|Protocol Violation|1
104326|NCT00730925|359938|P1|Overall Study|Other Averse Event|7
104327|NCT00730925|359938|P1|Overall Study|Dose reducing Event|2
104328|NCT00730925|359938|P1|Overall Study|Progressive Disease|21
104329|NCT00730912|359948|P3|Overall Study|Discontinued|1
104330|NCT00730912|359949|P2|Overall Study|Discontinued|0
104331|NCT00730912|359950|P1|Overall Study|Discontinued|0
104332|NCT00730847|359961|P1|Overall Study|Unspecified|24
104333|NCT00730847|359961|P1|Overall Study|Unknown completion status|21
104334|NCT00730847|359961|P1|Overall Study|Lost to Follow-up|67
104335|NCT00730847|359961|P1|Overall Study|Withdrawal by Subject|16
104336|NCT00730847|359961|P1|Overall Study|Protocol Violation|2
104337|NCT00730847|359961|P1|Overall Study|Adverse Event|1
104338|NCT00730756|359970|P2|Overall Study|Withdrew Consent|1
104339|NCT00730756|359971|P1|Overall Study|Withdrew Consent|0
104340|NCT00730756|359970|P2|Overall Study|Lost to Follow-up|1
104341|NCT00730756|359971|P1|Overall Study|Lost to Follow-up|0
104342|NCT00730756|359970|P2|Overall Study|Protocol Deviation|2
104343|NCT00730756|359971|P1|Overall Study|Protocol Deviation|1
104344|NCT00730756|359970|P2|Overall Study|Lack of Efficacy|1
104345|NCT00730756|359971|P1|Overall Study|Lack of Efficacy|1
104346|NCT00730756|359970|P2|Overall Study|Adverse Event|0
104347|NCT00730756|359971|P1|Overall Study|Adverse Event|2
104348|NCT00730691|360005|P5|Overall Study|Other|2
104349|NCT00730691|360006|P4|Overall Study|Other|2
104350|NCT00730691|360007|P3|Overall Study|Other|1
104351|NCT00730691|360008|P2|Overall Study|Other|1
104352|NCT00730691|360009|P1|Overall Study|Other|1
104353|NCT00730691|360005|P5|Overall Study|Lost to Follow-up|13
104354|NCT00730691|360006|P4|Overall Study|Lost to Follow-up|15
104355|NCT00730691|360007|P3|Overall Study|Lost to Follow-up|13
104356|NCT00730691|360008|P2|Overall Study|Lost to Follow-up|8
104357|NCT00730691|360009|P1|Overall Study|Lost to Follow-up|11
104358|NCT00730691|360005|P5|Overall Study|Withdrawal of Consent|3
104359|NCT00730691|360006|P4|Overall Study|Withdrawal of Consent|6
104360|NCT00730691|360007|P3|Overall Study|Withdrawal of Consent|3
104361|NCT00730691|360008|P2|Overall Study|Withdrawal of Consent|9
104362|NCT00730691|360009|P1|Overall Study|Withdrawal of Consent|7
104363|NCT00730691|360005|P5|Overall Study|Protocol Deviations|5
104364|NCT00730691|360006|P4|Overall Study|Protocol Deviations|7
104365|NCT00730691|360007|P3|Overall Study|Protocol Deviations|3
104366|NCT00730691|360008|P2|Overall Study|Protocol Deviations|5
104367|NCT00730691|360009|P1|Overall Study|Protocol Deviations|3
104368|NCT00730691|360005|P5|Overall Study|Non-compliance with Study Drug|3
104369|NCT00730691|360006|P4|Overall Study|Non-compliance with Study Drug|3
104370|NCT00730691|360007|P3|Overall Study|Non-compliance with Study Drug|6
104371|NCT00730691|360008|P2|Overall Study|Non-compliance with Study Drug|1
104372|NCT00730691|360009|P1|Overall Study|Non-compliance with Study Drug|6
104373|NCT00730691|360005|P5|Overall Study|Lack of Efficacy|1
104374|NCT00730691|360006|P4|Overall Study|Lack of Efficacy|1
104375|NCT00730691|360007|P3|Overall Study|Lack of Efficacy|2
104376|NCT00730691|360008|P2|Overall Study|Lack of Efficacy|4
104377|NCT00730691|360009|P1|Overall Study|Lack of Efficacy|4
104378|NCT00730691|360005|P5|Overall Study|Adverse Event|23
104379|NCT00730691|360006|P4|Overall Study|Adverse Event|11
104380|NCT00730691|360007|P3|Overall Study|Adverse Event|11
104381|NCT00730691|360008|P2|Overall Study|Adverse Event|8
104382|NCT00730691|360009|P1|Overall Study|Adverse Event|4
104383|NCT00730639|360101|P5|Overall Study|Treatment on-going|4
104384|NCT00730639|360102|P4|Overall Study|Treatment on-going|4
104385|NCT00730639|360103|P3|Overall Study|Treatment on-going|5
104386|NCT00730639|360104|P2|Overall Study|Treatment on-going|5
104387|NCT00730639|360105|P1|Overall Study|Treatment on-going|2
104388|NCT00730639|360101|P5|Overall Study|Withdrawal by Subject|4
104389|NCT00730639|360102|P4|Overall Study|Withdrawal by Subject|3
104390|NCT00730639|360103|P3|Overall Study|Withdrawal by Subject|6
104391|NCT00730639|360104|P2|Overall Study|Withdrawal by Subject|0
104392|NCT00730639|360105|P1|Overall Study|Withdrawal by Subject|0
104393|NCT00730639|360101|P5|Overall Study|Protocol Violation|0
104394|NCT00730639|360102|P4|Overall Study|Protocol Violation|0
104395|NCT00730639|360103|P3|Overall Study|Protocol Violation|1
104396|NCT00730639|360104|P2|Overall Study|Protocol Violation|0
104397|NCT00730639|360105|P1|Overall Study|Protocol Violation|0
104398|NCT00730639|360101|P5|Overall Study|non-specified|3
104399|NCT00730639|360102|P4|Overall Study|non-specified|2
104400|NCT00730639|360103|P3|Overall Study|non-specified|4
104401|NCT00730639|360104|P2|Overall Study|non-specified|0
104402|NCT00730639|360105|P1|Overall Study|non-specified|0
104403|NCT00730639|360101|P5|Overall Study|Disease Progression|88
104404|NCT00730639|360102|P4|Overall Study|Disease Progression|32
104405|NCT00730639|360103|P3|Overall Study|Disease Progression|48
104406|NCT00730639|360104|P2|Overall Study|Disease Progression|13
104407|NCT00730639|360105|P1|Overall Study|Disease Progression|12
104408|NCT00730639|360101|P5|Overall Study|Death|2
104409|NCT00730639|360102|P4|Overall Study|Death|0
104410|NCT00730639|360103|P3|Overall Study|Death|0
104411|NCT00730639|360104|P2|Overall Study|Death|0
104412|NCT00730639|360105|P1|Overall Study|Death|0
104413|NCT00730639|360101|P5|Overall Study|Completed Maximum Cycles|6
104414|NCT00730639|360102|P4|Overall Study|Completed Maximum Cycles|3
104415|NCT00730639|360103|P3|Overall Study|Completed Maximum Cycles|11
104416|NCT00730639|360104|P2|Overall Study|Completed Maximum Cycles|0
104417|NCT00730639|360105|P1|Overall Study|Completed Maximum Cycles|0
104418|NCT00730639|360101|P5|Overall Study|Complete Response|1
104419|NCT00730639|360102|P4|Overall Study|Complete Response|2
104420|NCT00730639|360103|P3|Overall Study|Complete Response|2
104421|NCT00730639|360104|P2|Overall Study|Complete Response|0
104422|NCT00730639|360105|P1|Overall Study|Complete Response|0
104423|NCT00730639|360101|P5|Overall Study|Adverse Event|23
104424|NCT00730639|360102|P4|Overall Study|Adverse Event|8
104425|NCT00730639|360103|P3|Overall Study|Adverse Event|9
104426|NCT00730639|360104|P2|Overall Study|Adverse Event|0
104427|NCT00730639|360105|P1|Overall Study|Adverse Event|3
104428|NCT00730327|360171|P2|Overall Study|Subject withdrew (reason not specified)|7
104429|NCT00730327|360172|P1|Overall Study|Subject withdrew (reason not specified)|2
104430|NCT00730327|360171|P2|Overall Study|Withdrawal by Subject|13
104431|NCT00730327|360172|P1|Overall Study|Withdrawal by Subject|3
104432|NCT00730327|360171|P2|Overall Study|Adverse Event|1
104433|NCT00730327|360172|P1|Overall Study|Adverse Event|8
104434|NCT00730327|360171|P2|Overall Study|Lost to Follow-up|16
104435|NCT00730327|360172|P1|Overall Study|Lost to Follow-up|14
104436|NCT00730275|360197|P4|Overall Study|Withdrawal by Subject|1
104437|NCT00730275|360198|P3|Overall Study|Withdrawal by Subject|0
104438|NCT00730275|360199|P2|Overall Study|Withdrawal by Subject|0
104439|NCT00730275|360200|P1|Overall Study|Withdrawal by Subject|0
104440|NCT00730236|360226|P1|Overall Study|Non-compliance|1
104441|NCT00730236|360226|P1|Overall Study|Withdrawal by Subject|1
104442|NCT00730236|360226|P1|Overall Study|Adverse Event|4
104443|NCT00730132|360241|P1|Overall Study|Death|1
104444|NCT00730132|360241|P1|Overall Study|Protocol Violation|154
104445|NCT00730041|360259|P2|Overall Study|Lost to Follow-up|2
104446|NCT00730041|360260|P1|Overall Study|Lost to Follow-up|0
104447|NCT00730028|360283|P5|Overall Study|Randomization Error|2
104448|NCT00730028|360284|P4|Overall Study|Randomization Error|0
104449|NCT00730028|360285|P3|Overall Study|Randomization Error|0
104450|NCT00730028|360286|P2|Overall Study|Randomization Error|0
104451|NCT00730028|360287|P1|Overall Study|Randomization Error|1
104452|NCT00730028|360283|P5|Overall Study|Treatment Failure|1
104453|NCT00730028|360284|P4|Overall Study|Treatment Failure|0
104454|NCT00730028|360285|P3|Overall Study|Treatment Failure|0
104455|NCT00730028|360286|P2|Overall Study|Treatment Failure|5
104456|NCT00730028|360287|P1|Overall Study|Treatment Failure|5
104457|NCT00730028|360283|P5|Overall Study|Physician Decision|2
104458|NCT00730028|360284|P4|Overall Study|Physician Decision|3
104459|NCT00730028|360285|P3|Overall Study|Physician Decision|2
104460|NCT00730028|360286|P2|Overall Study|Physician Decision|3
104461|NCT00730028|360287|P1|Overall Study|Physician Decision|3
104462|NCT00730028|360283|P5|Overall Study|Withdrawal by Subject|9
104463|NCT00730028|360284|P4|Overall Study|Withdrawal by Subject|5
104464|NCT00730028|360285|P3|Overall Study|Withdrawal by Subject|4
104465|NCT00730028|360286|P2|Overall Study|Withdrawal by Subject|5
104466|NCT00730028|360287|P1|Overall Study|Withdrawal by Subject|9
104467|NCT00730028|360283|P5|Overall Study|Protocol Violation|0
104468|NCT00730028|360284|P4|Overall Study|Protocol Violation|2
104469|NCT00730028|360285|P3|Overall Study|Protocol Violation|1
104470|NCT00730028|360286|P2|Overall Study|Protocol Violation|1
104471|NCT00730028|360287|P1|Overall Study|Protocol Violation|6
104472|NCT00730028|360283|P5|Overall Study|Lost to Follow-up|25
104473|NCT00730028|360284|P4|Overall Study|Lost to Follow-up|26
104474|NCT00730028|360285|P3|Overall Study|Lost to Follow-up|22
104475|NCT00730028|360286|P2|Overall Study|Lost to Follow-up|26
104476|NCT00730028|360287|P1|Overall Study|Lost to Follow-up|13
104477|NCT00730028|360283|P5|Overall Study|Adverse Event|43
104478|NCT00730028|360284|P4|Overall Study|Adverse Event|20
104479|NCT00730028|360285|P3|Overall Study|Adverse Event|16
104480|NCT00730028|360286|P2|Overall Study|Adverse Event|26
104481|NCT00730028|360287|P1|Overall Study|Adverse Event|23
104482|NCT00730015|360337|P3|Overall Study|Other Reason|1
104483|NCT00730015|360338|P2|Overall Study|Other Reason|0
104484|NCT00730015|360339|P1|Overall Study|Other Reason|1
104485|NCT00730015|360337|P3|Overall Study|Lack of Efficacy|8
104486|NCT00730015|360338|P2|Overall Study|Lack of Efficacy|2
104487|NCT00730015|360339|P1|Overall Study|Lack of Efficacy|1
104488|NCT00730015|360337|P3|Overall Study|Lost to Follow-up|3
104489|NCT00730015|360338|P2|Overall Study|Lost to Follow-up|10
104490|NCT00730015|360339|P1|Overall Study|Lost to Follow-up|4
104491|NCT00730015|360337|P3|Overall Study|Withdrawal by Subject|8
104492|NCT00730015|360338|P2|Overall Study|Withdrawal by Subject|12
104493|NCT00730015|360339|P1|Overall Study|Withdrawal by Subject|12
104494|NCT00730015|360337|P3|Overall Study|Protocol Violation|4
104495|NCT00730015|360338|P2|Overall Study|Protocol Violation|6
104496|NCT00730015|360339|P1|Overall Study|Protocol Violation|2
104497|NCT00730015|360337|P3|Overall Study|Adverse Event|8
104498|NCT00730015|360338|P2|Overall Study|Adverse Event|10
104499|NCT00730015|360339|P1|Overall Study|Adverse Event|11
104500|NCT00729937|360379|P6|Overall Study|Incarcerated|0
104501|NCT00729937|360380|P5|Overall Study|Incarcerated|0
104502|NCT00729937|360381|P4|Overall Study|Incarcerated|1
104503|NCT00729937|360382|P3|Overall Study|Incarcerated|1
104504|NCT00729937|360383|P2|Overall Study|Incarcerated|2
104505|NCT00729937|360384|P1|Overall Study|Incarcerated|0
104506|NCT00729937|360379|P6|Overall Study|Did not meet eligibility criteria|0
104507|NCT00729937|360380|P5|Overall Study|Did not meet eligibility criteria|0
104508|NCT00729937|360381|P4|Overall Study|Did not meet eligibility criteria|0
104509|NCT00729937|360382|P3|Overall Study|Did not meet eligibility criteria|0
104510|NCT00729937|360383|P2|Overall Study|Did not meet eligibility criteria|1
104511|NCT00729937|360384|P1|Overall Study|Did not meet eligibility criteria|2
104512|NCT00729937|360379|P6|Overall Study|Randomized but not treated|3
104513|NCT00729937|360380|P5|Overall Study|Randomized but not treated|1
104514|NCT00729937|360381|P4|Overall Study|Randomized but not treated|0
104515|NCT00729937|360382|P3|Overall Study|Randomized but not treated|1
104516|NCT00729937|360383|P2|Overall Study|Randomized but not treated|6
104517|NCT00729937|360384|P1|Overall Study|Randomized but not treated|12
104518|NCT00729937|360379|P6|Overall Study|Withdrawal by Subject|2
104519|NCT00729937|360380|P5|Overall Study|Withdrawal by Subject|4
104520|NCT00729937|360381|P4|Overall Study|Withdrawal by Subject|0
104521|NCT00729937|360382|P3|Overall Study|Withdrawal by Subject|6
104522|NCT00729937|360383|P2|Overall Study|Withdrawal by Subject|5
104523|NCT00729937|360384|P1|Overall Study|Withdrawal by Subject|3
104524|NCT00729937|360379|P6|Overall Study|Death|1
104525|NCT00729937|360380|P5|Overall Study|Death|0
104526|NCT00729937|360381|P4|Overall Study|Death|0
104527|NCT00729937|360382|P3|Overall Study|Death|1
104528|NCT00729937|360383|P2|Overall Study|Death|0
104529|NCT00729937|360384|P1|Overall Study|Death|1
104530|NCT00729937|360379|P6|Overall Study|Physician Decision|8
104531|NCT00729937|360380|P5|Overall Study|Physician Decision|5
104532|NCT00729937|360381|P4|Overall Study|Physician Decision|0
104533|NCT00729937|360382|P3|Overall Study|Physician Decision|2
104534|NCT00729937|360383|P2|Overall Study|Physician Decision|16
104535|NCT00729937|360384|P1|Overall Study|Physician Decision|7
104536|NCT00729937|360379|P6|Overall Study|Lost to Follow-up|23
104537|NCT00729937|360380|P5|Overall Study|Lost to Follow-up|18
104538|NCT00729937|360381|P4|Overall Study|Lost to Follow-up|33
104539|NCT00729937|360382|P3|Overall Study|Lost to Follow-up|18
104540|NCT00729937|360383|P2|Overall Study|Lost to Follow-up|58
104541|NCT00729937|360384|P1|Overall Study|Lost to Follow-up|49
104542|NCT00729859|360588|P3|Overall Study|Withdrawal by Subject|0
104543|NCT00729859|360589|P2|Overall Study|Withdrawal by Subject|1
104544|NCT00729859|360590|P1|Overall Study|Withdrawal by Subject|0
104545|NCT00729859|360588|P3|Overall Study|Adverse Event|0
104546|NCT00729859|360589|P2|Overall Study|Adverse Event|1
104547|NCT00729859|360590|P1|Overall Study|Adverse Event|0
104548|NCT00729833|360634|P4|Overall Study|Unspecified Reasons|1
104549|NCT00729833|360635|P3|Overall Study|Unspecified Reasons|5
104550|NCT00729833|360636|P2|Overall Study|Unspecified Reasons|5
104551|NCT00729833|360637|P1|Overall Study|Unspecified Reasons|11
104552|NCT00729833|360634|P4|Overall Study|Withdrawal by Subject|0
104553|NCT00729833|360635|P3|Overall Study|Withdrawal by Subject|3
104554|NCT00729833|360636|P2|Overall Study|Withdrawal by Subject|1
104555|NCT00729833|360637|P1|Overall Study|Withdrawal by Subject|3
104556|NCT00729833|360634|P4|Overall Study|Lost to Follow-up|0
104557|NCT00729833|360635|P3|Overall Study|Lost to Follow-up|0
104558|NCT00729833|360636|P2|Overall Study|Lost to Follow-up|0
104559|NCT00729833|360637|P1|Overall Study|Lost to Follow-up|1
104560|NCT00729833|360634|P4|Overall Study|Study Terminated by Sponsor|0
104561|NCT00729833|360635|P3|Overall Study|Study Terminated by Sponsor|1
104562|NCT00729833|360636|P2|Overall Study|Study Terminated by Sponsor|0
104563|NCT00729833|360637|P1|Overall Study|Study Terminated by Sponsor|0
104564|NCT00729833|360634|P4|Overall Study|Death|5
104565|NCT00729833|360635|P3|Overall Study|Death|3
104566|NCT00729833|360636|P2|Overall Study|Death|1
104567|NCT00729833|360637|P1|Overall Study|Death|5
104568|NCT00729690|360689|P3|Overall Study|IT Catheter Malfunction|2
104569|NCT00729690|360690|P2|Overall Study|IT Catheter Malfunction|2
104570|NCT00729690|360691|P1|Overall Study|IT Catheter Malfunction|0
104571|NCT00729651|360721|P2|Overall Study|Subject’s private reason|0
104572|NCT00729651|360722|P1|Overall Study|Subject’s private reason|2
104573|NCT00729651|360721|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
104574|NCT00729651|360722|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
104575|NCT00729651|360721|P2|Overall Study|Adverse Event|3
104576|NCT00729651|360722|P1|Overall Study|Adverse Event|7
104577|NCT00729651|360721|P2|Overall Study|Protocol Violation|1
104578|NCT00729651|360722|P1|Overall Study|Protocol Violation|0
104579|NCT00729651|360721|P2|Overall Study|Lost to Follow-up|4
104580|NCT00729651|360722|P1|Overall Study|Lost to Follow-up|5
104581|NCT00729651|360721|P2|Overall Study|Withdrawal by Subject|6
104582|NCT00729651|360722|P1|Overall Study|Withdrawal by Subject|5
104583|NCT00729612|360734|P1|Overall Study|Non evaluable for response|10
104584|NCT00729560|360741|P1|Overall Study|Withdrawal by Subject|3
104585|NCT00729469|360767|P2|Overall Study|Other-Not mentioned|4
104586|NCT00729469|360768|P1|Overall Study|Other-Not mentioned|9
104587|NCT00729469|360767|P2|Overall Study|Withdrawal by Subject|8
104588|NCT00729469|360768|P1|Overall Study|Withdrawal by Subject|19
104589|NCT00729469|360767|P2|Overall Study|Protocol Violation|1
104590|NCT00729469|360768|P1|Overall Study|Protocol Violation|2
104591|NCT00729469|360767|P2|Overall Study|Lost to Follow-up|9
104592|NCT00729469|360768|P1|Overall Study|Lost to Follow-up|9
104593|NCT00729469|360767|P2|Overall Study|Adverse Event|25
104594|NCT00729469|360768|P1|Overall Study|Adverse Event|14
104595|NCT00729365|360807|P3|Overall Study|Physician Decision|7
104596|NCT00729365|360808|P2|Overall Study|Physician Decision|6
104597|NCT00729365|360809|P1|Overall Study|Physician Decision|33
104598|NCT00729326|360822|P2|Overall Study|Sponsor Decision|2
104599|NCT00729326|360823|P1|Overall Study|Sponsor Decision|1
104600|NCT00729326|360822|P2|Overall Study|Subject Decision|4
104601|NCT00729326|360823|P1|Overall Study|Subject Decision|4
104602|NCT00729326|360822|P2|Overall Study|Protocol Violation|2
104603|NCT00729326|360823|P1|Overall Study|Protocol Violation|3
104604|NCT00729326|360822|P2|Overall Study|Physician Decision|1
104605|NCT00729326|360823|P1|Overall Study|Physician Decision|0
104606|NCT00729326|360822|P2|Overall Study|Lost to Follow-up|0
104607|NCT00729326|360823|P1|Overall Study|Lost to Follow-up|2
104608|NCT00729248|360865|P1|Overall Study|Physician Decision|2
104609|NCT00728988|360872|P2|Overall Study|Withdrawal by Subject|6
104610|NCT00728988|360873|P1|Overall Study|Withdrawal by Subject|2
104611|NCT00728988|360872|P2|Overall Study|Unspecified|77
104612|NCT00728988|360873|P1|Overall Study|Unspecified|85
104613|NCT00728988|360872|P2|Overall Study|Adverse Event|2
104614|NCT00728988|360873|P1|Overall Study|Adverse Event|3
104615|NCT00728988|360872|P2|Overall Study|Death|1
104616|NCT00728988|360873|P1|Overall Study|Death|1
104617|NCT00728988|360872|P2|Overall Study|Not Treated|2
104618|NCT00728988|360873|P1|Overall Study|Not Treated|2
104619|NCT00728962|360891|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
104620|NCT00728962|360891|P1|Permanent Prosthesis Placement|Adverse Event|3
104621|NCT00728962|360891|P1|Implant Placement Surgery|Protocol Violation|1
104622|NCT00728962|360891|P1|Implant Placement Surgery|Lost to Follow-up|1
104623|NCT00728962|360891|P1|Implant Placement Surgery|Adverse Event|8
104624|NCT00728884|360912|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
104625|NCT00728884|360912|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
104626|NCT00728754|360935|P2|One Year Post Placement Follow-up|Adverse Event|0
104627|NCT00728754|360936|P1|One Year Post Placement Follow-up|Adverse Event|1
104628|NCT00728754|360935|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
104629|NCT00728754|360936|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
104630|NCT00728754|360935|P2|Permanent Prosthesis Placement|Adverse Event|1
104631|NCT00728754|360936|P1|Permanent Prosthesis Placement|Adverse Event|1
104632|NCT00728689|360965|P2|Washout Period (Days 4 - 10)|Death in family|0
104633|NCT00728689|360966|P1|Washout Period (Days 4 - 10)|Death in family|1
104634|NCT00728494|360984|P2|Overall Study|No data available|1
104635|NCT00728494|360985|P1|Overall Study|No data available|0
104636|NCT00728494|360984|P2|Overall Study|Lack of Efficacy|4
104637|NCT00728494|360985|P1|Overall Study|Lack of Efficacy|2
104638|NCT00728494|360984|P2|Overall Study|Withdrawal by Subject|2
104639|NCT00728494|360985|P1|Overall Study|Withdrawal by Subject|0
104640|NCT00728494|360984|P2|Overall Study|Adverse Event|0
104641|NCT00728494|360985|P1|Overall Study|Adverse Event|7
104642|NCT00728481|361003|P2|Overall Study|Incorrectly assigned to opposite arm|0
104643|NCT00728481|361004|P1|Overall Study|Incorrectly assigned to opposite arm|1
104644|NCT00728481|361003|P2|Overall Study|Study medication non-compliance|2
104645|NCT00728481|361004|P1|Overall Study|Study medication non-compliance|0
104646|NCT00728481|361003|P2|Overall Study|Adverse Event|1
104647|NCT00728481|361004|P1|Overall Study|Adverse Event|0
104648|NCT00728481|361003|P2|Overall Study|Withdrawal by Subject|1
104649|NCT00728481|361004|P1|Overall Study|Withdrawal by Subject|0
104650|NCT00728416|361022|P2|Overall Study|Withdrawal by Subject|0
104651|NCT00728416|361023|P1|Overall Study|Withdrawal by Subject|1
104652|NCT00728416|361022|P2|Overall Study|Treatment Failure|1
104653|NCT00728416|361023|P1|Overall Study|Treatment Failure|0
104654|NCT00728416|361022|P2|Overall Study|Adverse Event|1
104655|NCT00728416|361023|P1|Overall Study|Adverse Event|1
104656|NCT00728182|361039|P2|Overall Study|Protocol Noncompliance|1
104657|NCT00728182|361040|P1|Overall Study|Protocol Noncompliance|0
104658|NCT00728182|361039|P2|Overall Study|Death|2
104659|NCT00728182|361040|P1|Overall Study|Death|0
104660|NCT00728182|361039|P2|Overall Study|Lost to Follow-up|0
104661|NCT00728182|361040|P1|Overall Study|Lost to Follow-up|2
104662|NCT00728182|361039|P2|Overall Study|Adverse Event|0
104663|NCT00728182|361040|P1|Overall Study|Adverse Event|1
104664|NCT00728130|361068|P1|Overall Study|Physician Decision|1
104665|NCT00728130|361068|P1|Overall Study|Paperwork not completed in time|1
104666|NCT00728130|361068|P1|Overall Study|Withdrawal by Subject|1
104667|NCT00727961|361073|P1|Overall Study|Progression|30
104668|NCT00727961|361073|P1|Overall Study|Patient's refusal|2
104669|NCT00727961|361073|P1|Overall Study|Adverse Event|4
104670|NCT00727961|361073|P1|Overall Study|Lost to Follow-up|1
104671|NCT00727909|361083|P4|Overall Study|Death|0
104672|NCT00727909|361084|P3|Overall Study|Death|1
104673|NCT00727909|361085|P2|Overall Study|Death|0
104674|NCT00727909|361086|P1|Overall Study|Death|0
104675|NCT00727909|361083|P4|Overall Study|Withdrawal by Subject|5
104676|NCT00727909|361084|P3|Overall Study|Withdrawal by Subject|8
104677|NCT00727909|361085|P2|Overall Study|Withdrawal by Subject|11
104678|NCT00727909|361086|P1|Overall Study|Withdrawal by Subject|5
104679|NCT00727844|361183|P4|Initial Randomization|Physician Decision|0
104680|NCT00727844|361184|P3|Initial Randomization|Physician Decision|0
104681|NCT00727844|361185|P2|Initial Randomization|Physician Decision|0
104682|NCT00727844|361186|P1|Initial Randomization|Physician Decision|2
104683|NCT00727714|361200|P1|Overall Study|Lost to Follow-up|2
104684|NCT00726622|361210|P2|Overall Study|Metastasis|0
104685|NCT00726622|361211|P1|Overall Study|Metastasis|2
104686|NCT00726622|361210|P2|Overall Study|Physician Decision|1
104687|NCT00726622|361211|P1|Overall Study|Physician Decision|0
104688|NCT00726622|361210|P2|Overall Study|Withdrawal by Subject|2
104689|NCT00726622|361211|P1|Overall Study|Withdrawal by Subject|16
104690|NCT00726609|361229|P1|Overall Study|Other|3
104691|NCT00726609|361229|P1|Overall Study|Missing|42
104692|NCT00726609|361229|P1|Overall Study|Not specified|16
104693|NCT00726609|361229|P1|Overall Study|Lack of Efficacy|25
104694|NCT00726609|361229|P1|Overall Study|Withdrawal by Subject|2
104695|NCT00726609|361229|P1|Overall Study|Adverse Event|10
104696|NCT00727649|361235|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
104697|NCT00727649|361236|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
104698|NCT00727649|361235|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
104699|NCT00727649|361236|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
104700|NCT00727649|361235|P2|Second Intervention (4-weeks)|Death|0
104701|NCT00727649|361236|P1|Second Intervention (4-weeks)|Death|1
104702|NCT00727649|361235|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
104703|NCT00727649|361236|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
104704|NCT00727649|361235|P2|Wash-out (2-weeks)|Lost to Follow-up|1
104705|NCT00727649|361236|P1|Wash-out (2-weeks)|Lost to Follow-up|3
104706|NCT00727649|361235|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
104707|NCT00727649|361236|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
104708|NCT00727649|361235|P2|First Intervention (4-weeks)|Lost to Follow-up|2
104709|NCT00727649|361236|P1|First Intervention (4-weeks)|Lost to Follow-up|1
104710|NCT00727571|361278|P4|Overall Study|Other|0
104711|NCT00727571|361279|P3|Overall Study|Other|6
104712|NCT00727571|361280|P2|Overall Study|Other|4
104713|NCT00727571|361281|P1|Overall Study|Other|0
104714|NCT00727571|361278|P4|Overall Study|AE not leading to hospitalization|0
104715|NCT00727571|361279|P3|Overall Study|AE not leading to hospitalization|2
104716|NCT00727571|361280|P2|Overall Study|AE not leading to hospitalization|0
104717|NCT00727571|361281|P1|Overall Study|AE not leading to hospitalization|0
104718|NCT00727571|361278|P4|Overall Study|Hospitalization|1
104719|NCT00727571|361279|P3|Overall Study|Hospitalization|0
104720|NCT00727571|361280|P2|Overall Study|Hospitalization|1
104721|NCT00727571|361281|P1|Overall Study|Hospitalization|0
104722|NCT00727571|361278|P4|Overall Study|Dismissed from nursing home|0
104723|NCT00727571|361279|P3|Overall Study|Dismissed from nursing home|5
104724|NCT00727571|361280|P2|Overall Study|Dismissed from nursing home|9
104725|NCT00727571|361281|P1|Overall Study|Dismissed from nursing home|0
104726|NCT00727571|361278|P4|Overall Study|Subject Non Compliance|4
104727|NCT00727571|361279|P3|Overall Study|Subject Non Compliance|0
104728|NCT00727571|361280|P2|Overall Study|Subject Non Compliance|6
104729|NCT00727571|361281|P1|Overall Study|Subject Non Compliance|0
104730|NCT00727571|361278|P4|Overall Study|Withdrawal by Subject|0
104731|NCT00727571|361279|P3|Overall Study|Withdrawal by Subject|11
104732|NCT00727571|361280|P2|Overall Study|Withdrawal by Subject|10
104733|NCT00727571|361281|P1|Overall Study|Withdrawal by Subject|0
104734|NCT00727571|361278|P4|Overall Study|Physician Decision|0
104735|NCT00727571|361279|P3|Overall Study|Physician Decision|0
104736|NCT00727571|361280|P2|Overall Study|Physician Decision|5
104737|NCT00727571|361281|P1|Overall Study|Physician Decision|0
104738|NCT00727571|361278|P4|Overall Study|Death|1
104739|NCT00727571|361279|P3|Overall Study|Death|5
104740|NCT00727571|361280|P2|Overall Study|Death|19
104741|NCT00727571|361281|P1|Overall Study|Death|0
104742|NCT00727571|361278|P4|Overall Study|Ineligibility determined|0
104743|NCT00727571|361279|P3|Overall Study|Ineligibility determined|1
104744|NCT00727571|361280|P2|Overall Study|Ineligibility determined|1
104745|NCT00727571|361281|P1|Overall Study|Ineligibility determined|1
104746|NCT00727558|361308|P2|Overall Study|Lost to Follow-up|0
104747|NCT00727558|361309|P1|Overall Study|Lost to Follow-up|1
104748|NCT00727558|361308|P2|Overall Study|Subject unable to return for follow-up|1
104749|NCT00727558|361309|P1|Overall Study|Subject unable to return for follow-up|1
104750|NCT00727558|361308|P2|Overall Study|Adverse Event|1
104751|NCT00727558|361309|P1|Overall Study|Adverse Event|0
104752|NCT00727558|361308|P2|Overall Study|Lens issue|1
104753|NCT00727558|361309|P1|Overall Study|Lens issue|0
104754|NCT00727506|361333|P6|Overall Study|Other reason not described above|1
104755|NCT00727506|361334|P5|Overall Study|Other reason not described above|1
104756|NCT00727506|361335|P4|Overall Study|Other reason not described above|4
104757|NCT00727506|361336|P3|Overall Study|Other reason not described above|1
104758|NCT00727506|361337|P2|Overall Study|Other reason not described above|0
104759|NCT00727506|361338|P1|Overall Study|Other reason not described above|0
104760|NCT00727506|361333|P6|Overall Study|Refused to continue medication|2
104761|NCT00727506|361334|P5|Overall Study|Refused to continue medication|1
104762|NCT00727506|361335|P4|Overall Study|Refused to continue medication|2
104763|NCT00727506|361336|P3|Overall Study|Refused to continue medication|2
104764|NCT00727506|361337|P2|Overall Study|Refused to continue medication|1
104765|NCT00727506|361338|P1|Overall Study|Refused to continue medication|0
104766|NCT00727506|361333|P6|Overall Study|Progressive disease|26
104767|NCT00727506|361334|P5|Overall Study|Progressive disease|37
104768|NCT00727506|361335|P4|Overall Study|Progressive disease|28
104769|NCT00727506|361336|P3|Overall Study|Progressive disease|9
104770|NCT00727506|361337|P2|Overall Study|Progressive disease|7
104771|NCT00727506|361338|P1|Overall Study|Progressive disease|4
104772|NCT00727506|361333|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
104773|NCT00727506|361334|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
104774|NCT00727506|361335|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
104775|NCT00727506|361336|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
104776|NCT00727506|361337|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
104777|NCT00727506|361338|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
104778|NCT00727506|361333|P6|Overall Study|Adverse Event|8
104779|NCT00727506|361334|P5|Overall Study|Adverse Event|1
104780|NCT00727506|361335|P4|Overall Study|Adverse Event|4
104781|NCT00727506|361336|P3|Overall Study|Adverse Event|4
104782|NCT00727506|361337|P2|Overall Study|Adverse Event|0
104783|NCT00727506|361338|P1|Overall Study|Adverse Event|0
104784|NCT00727402|361358|P1|Overall Study|Physician Decision|116
104785|NCT00727311|361379|P1|Overall Study|Multiple reasons|39
104786|NCT00727311|361379|P1|Overall Study|not specified|97
104787|NCT00727311|361379|P1|Overall Study|Withdrawal by Subject|77
104788|NCT00727311|361379|P1|Overall Study|Lost to Follow-up|73
104789|NCT00727311|361379|P1|Overall Study|Lack of Efficacy|242
104790|NCT00727311|361379|P1|Overall Study|Adverse Event|58
104791|NCT00727311|361379|P1|Overall Study|Missing end of therapy data|205
104792|NCT00727311|361379|P1|Overall Study|Did not receive drug|316
104793|NCT00727272|361392|P3|Washout Period B|Withdrawal by Subject|1
104794|NCT00727272|361393|P2|Washout Period B|Withdrawal by Subject|0
104795|NCT00727272|361394|P1|Washout Period B|Withdrawal by Subject|0
104796|NCT00727272|361392|P3|Washout Period A|Adverse Event|1
104797|NCT00727272|361393|P2|Washout Period A|Adverse Event|0
104798|NCT00727272|361394|P1|Washout Period A|Adverse Event|0
104799|NCT00727259|361411|P1|Overall Study|Not all questionnaires completed|1055
104800|NCT00727194|361416|P3|Treatment Period 2|Lack of Efficacy|0
104801|NCT00727194|361417|P2|Treatment Period 2|Lack of Efficacy|1
104802|NCT00727194|361418|P1|Treatment Period 2|Lack of Efficacy|0
104803|NCT00727194|361416|P3|Screening Period|History of thymoma|1
104804|NCT00727194|361417|P2|Screening Period|History of thymoma|0
104805|NCT00727194|361418|P1|Screening Period|History of thymoma|0
104806|NCT00727194|361416|P3|Screening Period|Severe infections|2
104807|NCT00727194|361417|P2|Screening Period|Severe infections|0
104808|NCT00727194|361418|P1|Screening Period|Severe infections|0
104809|NCT00727194|361416|P3|Screening Period|Not stable on concomitant MG therapy|2
104810|NCT00727194|361417|P2|Screening Period|Not stable on concomitant MG therapy|0
104811|NCT00727194|361418|P1|Screening Period|Not stable on concomitant MG therapy|0
104812|NCT00727194|361416|P3|Screening Period|Lacked AChR antibodies|5
104813|NCT00727194|361417|P2|Screening Period|Lacked AChR antibodies|0
104814|NCT00727194|361418|P1|Screening Period|Lacked AChR antibodies|0
104815|NCT00727194|361416|P3|Screening Period|Low QMG scores|6
104816|NCT00727194|361417|P2|Screening Period|Low QMG scores|0
104817|NCT00727194|361418|P1|Screening Period|Low QMG scores|0
104818|NCT00727025|361490|P1|Overall Study|Physician Decision|23
104819|NCT00726999|361502|P2|Overall Study|Protocol Violation|0
104820|NCT00726999|361503|P1|Overall Study|Protocol Violation|1
104821|NCT00726999|361502|P2|Overall Study|Withdrawal by Subject|0
104822|NCT00726999|361503|P1|Overall Study|Withdrawal by Subject|2
104823|NCT00726999|361502|P2|Overall Study|Physician Decision|1
104824|NCT00726999|361503|P1|Overall Study|Physician Decision|0
104825|NCT00726986|361513|P1|Maintenance Phase|Lack of Efficacy|2
104826|NCT00726986|361513|P1|Maintenance Phase|Adverse Event|1
104827|NCT00726986|361513|P1|Induction Phase|Secondary Disease|2
104828|NCT00726986|361513|P1|Induction Phase|Lack of Efficacy|5
104829|NCT00726986|361513|P1|Induction Phase|Death|2
104830|NCT00726986|361513|P1|Induction Phase|Withdrawal by Subject|2
104831|NCT00726986|361513|P1|Induction Phase|Adverse Event|4
104832|NCT00726895|361520|P2|Washout Period of 7 Days|Withdrawal by Subject|1
104833|NCT00726895|361521|P1|Washout Period of 7 Days|Withdrawal by Subject|0
104834|NCT00726882|361534|P1|Overall Study|Not Specified|10
104835|NCT00726882|361534|P1|Overall Study|Lost to Follow-up|7
104836|NCT00726882|361534|P1|Overall Study|Withdrawal by Subject|5
104837|NCT00726752|361549|P1|Overall Study|Lack of Efficacy|6
104838|NCT00726661|361611|P2|Overall Study|Not specified|35
104839|NCT00726661|361612|P1|Overall Study|Not specified|47
104840|NCT00726661|361611|P2|Overall Study|Physician Decision|13
104841|NCT00726661|361612|P1|Overall Study|Physician Decision|25
104842|NCT00726661|361611|P2|Overall Study|Death|159
104843|NCT00726661|361612|P1|Overall Study|Death|475
104844|NCT00726661|361611|P2|Overall Study|Trial terminated by sponsor|187
104845|NCT00726661|361612|P1|Overall Study|Trial terminated by sponsor|214
104846|NCT00726661|361611|P2|Overall Study|Withdrawal by Subject|13
104847|NCT00726661|361612|P1|Overall Study|Withdrawal by Subject|17
104848|NCT00726661|361611|P2|Overall Study|Lost to Follow-up|11
104849|NCT00726661|361612|P1|Overall Study|Lost to Follow-up|36
104850|NCT00726557|361627|P1|Overall Study|Inclusion criteria not met|15
104851|NCT00726557|361627|P1|Overall Study|Treatment less than 3 months|17
104852|NCT00726557|361627|P1|Overall Study|No follow-up documentation available|55
104853|NCT00726557|361627|P1|Overall Study|No end of treatment documentation|37
104854|NCT00726557|361627|P1|Overall Study|Screening failure|4
104855|NCT00726453|361634|P2|38 mm Length Group|Death|3
104856|NCT00726453|361635|P1|38 mm Length Group|Death|0
104941|NCT00725985|361743|P6|OLMP|Unspecified|44
104857|NCT00726453|361634|P2|Primary Enrollment Group|Withdrawal by Subject|0
104858|NCT00726453|361635|P1|Primary Enrollment Group|Withdrawal by Subject|13
104859|NCT00726453|361634|P2|Primary Enrollment Group|Death|0
104860|NCT00726453|361635|P1|Primary Enrollment Group|Death|18
104861|NCT00726232|361667|P6|Overall Study|No response|1
104862|NCT00726232|361668|P5|Overall Study|No response|3
104863|NCT00726232|361669|P4|Overall Study|No response|0
104864|NCT00726232|361670|P3|Overall Study|No response|0
104865|NCT00726232|361671|P2|Overall Study|No response|0
104866|NCT00726232|361672|P1|Overall Study|No response|1
104867|NCT00726232|361667|P6|Overall Study|Disease progression|0
104868|NCT00726232|361668|P5|Overall Study|Disease progression|0
104869|NCT00726232|361669|P4|Overall Study|Disease progression|0
104870|NCT00726232|361670|P3|Overall Study|Disease progression|0
104871|NCT00726232|361671|P2|Overall Study|Disease progression|0
104872|NCT00726232|361672|P1|Overall Study|Disease progression|1
104873|NCT00726232|361667|P6|Overall Study|Adverse Event|1
104874|NCT00726232|361668|P5|Overall Study|Adverse Event|2
104875|NCT00726232|361669|P4|Overall Study|Adverse Event|1
104876|NCT00726232|361670|P3|Overall Study|Adverse Event|0
104877|NCT00726232|361671|P2|Overall Study|Adverse Event|1
104878|NCT00726232|361672|P1|Overall Study|Adverse Event|1
104879|NCT00726232|361667|P6|Overall Study|Withdrawal by Subject|2
104880|NCT00726232|361668|P5|Overall Study|Withdrawal by Subject|0
104881|NCT00726232|361669|P4|Overall Study|Withdrawal by Subject|0
104882|NCT00726232|361670|P3|Overall Study|Withdrawal by Subject|0
104883|NCT00726232|361671|P2|Overall Study|Withdrawal by Subject|0
104884|NCT00726232|361672|P1|Overall Study|Withdrawal by Subject|2
104885|NCT00726063|361722|P2|Overall Study|Adverse Event|7
104886|NCT00726063|361723|P1|Overall Study|Adverse Event|9
104887|NCT00725985|361737|P12|LTFU (No Cladribine Treatment)|Unspecified|14
104888|NCT00725985|361738|P11|LTFU (No Cladribine Treatment)|Unspecified|36
104889|NCT00725985|361739|P10|LTFU (No Cladribine Treatment)|Unspecified|34
104890|NCT00725985|361740|P9|LTFU (No Cladribine Treatment)|Unspecified|0
104891|NCT00725985|361741|P8|LTFU (No Cladribine Treatment)|Unspecified|0
104892|NCT00725985|361742|P7|LTFU (No Cladribine Treatment)|Unspecified|0
104893|NCT00725985|361743|P6|LTFU (No Cladribine Treatment)|Unspecified|0
104894|NCT00725985|361744|P5|LTFU (No Cladribine Treatment)|Unspecified|0
104895|NCT00725985|361745|P4|LTFU (No Cladribine Treatment)|Unspecified|0
104896|NCT00725985|361746|P3|LTFU (No Cladribine Treatment)|Unspecified|0
104897|NCT00725985|361747|P2|LTFU (No Cladribine Treatment)|Unspecified|0
104898|NCT00725985|361748|P1|LTFU (No Cladribine Treatment)|Unspecified|0
104899|NCT00725985|361737|P12|LTFU (With Cladribine Treatment)|Unspecified|0
104900|NCT00725985|361738|P11|LTFU (With Cladribine Treatment)|Unspecified|0
104901|NCT00725985|361739|P10|LTFU (With Cladribine Treatment)|Unspecified|0
104902|NCT00725985|361740|P9|LTFU (With Cladribine Treatment)|Unspecified|16
104903|NCT00725985|361741|P8|LTFU (With Cladribine Treatment)|Unspecified|8
104904|NCT00725985|361742|P7|LTFU (With Cladribine Treatment)|Unspecified|9
104905|NCT00725985|361743|P6|LTFU (With Cladribine Treatment)|Unspecified|0
104906|NCT00725985|361744|P5|LTFU (With Cladribine Treatment)|Unspecified|0
104907|NCT00725985|361745|P4|LTFU (With Cladribine Treatment)|Unspecified|0
104908|NCT00725985|361746|P3|LTFU (With Cladribine Treatment)|Unspecified|0
104909|NCT00725985|361747|P2|LTFU (With Cladribine Treatment)|Unspecified|0
104910|NCT00725985|361748|P1|LTFU (With Cladribine Treatment)|Unspecified|0
104911|NCT00725985|361737|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
104912|NCT00725985|361738|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
104913|NCT00725985|361739|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
104914|NCT00725985|361740|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
104915|NCT00725985|361741|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
104916|NCT00725985|361742|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
104917|NCT00725985|361743|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
104918|NCT00725985|361744|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
104919|NCT00725985|361745|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
104920|NCT00725985|361746|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
104921|NCT00725985|361747|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
104922|NCT00725985|361748|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
104923|NCT00725985|361737|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
104924|NCT00725985|361738|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
104925|NCT00725985|361739|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
104926|NCT00725985|361740|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
104927|NCT00725985|361741|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
104928|NCT00725985|361742|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
104929|NCT00725985|361743|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
104930|NCT00725985|361744|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
104931|NCT00725985|361745|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
104932|NCT00725985|361746|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
104933|NCT00725985|361747|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
104934|NCT00725985|361748|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
104935|NCT00725985|361737|P12|OLMP|Unspecified|0
104936|NCT00725985|361738|P11|OLMP|Unspecified|0
104937|NCT00725985|361739|P10|OLMP|Unspecified|0
104938|NCT00725985|361740|P9|OLMP|Unspecified|0
104939|NCT00725985|361741|P8|OLMP|Unspecified|0
104940|NCT00725985|361742|P7|OLMP|Unspecified|0
104942|NCT00725985|361744|P5|OLMP|Unspecified|20
104943|NCT00725985|361745|P4|OLMP|Unspecified|15
104944|NCT00725985|361746|P3|OLMP|Unspecified|0
104945|NCT00725985|361747|P2|OLMP|Unspecified|0
104946|NCT00725985|361748|P1|OLMP|Unspecified|0
104947|NCT00725985|361737|P12|OLMP|Disease progression|0
104948|NCT00725985|361738|P11|OLMP|Disease progression|0
104949|NCT00725985|361739|P10|OLMP|Disease progression|0
104950|NCT00725985|361740|P9|OLMP|Disease progression|0
104951|NCT00725985|361741|P8|OLMP|Disease progression|0
104952|NCT00725985|361742|P7|OLMP|Disease progression|0
104953|NCT00725985|361743|P6|OLMP|Disease progression|4
104954|NCT00725985|361744|P5|OLMP|Disease progression|0
104955|NCT00725985|361745|P4|OLMP|Disease progression|0
104956|NCT00725985|361746|P3|OLMP|Disease progression|0
104957|NCT00725985|361747|P2|OLMP|Disease progression|0
104958|NCT00725985|361748|P1|OLMP|Disease progression|0
104959|NCT00725985|361737|P12|OLMP|Lost to Follow-up|0
104960|NCT00725985|361738|P11|OLMP|Lost to Follow-up|0
104961|NCT00725985|361739|P10|OLMP|Lost to Follow-up|0
104962|NCT00725985|361740|P9|OLMP|Lost to Follow-up|0
104963|NCT00725985|361741|P8|OLMP|Lost to Follow-up|0
104964|NCT00725985|361742|P7|OLMP|Lost to Follow-up|0
104965|NCT00725985|361743|P6|OLMP|Lost to Follow-up|0
104966|NCT00725985|361744|P5|OLMP|Lost to Follow-up|0
104967|NCT00725985|361745|P4|OLMP|Lost to Follow-up|1
104968|NCT00725985|361746|P3|OLMP|Lost to Follow-up|0
104969|NCT00725985|361747|P2|OLMP|Lost to Follow-up|0
104970|NCT00725985|361748|P1|OLMP|Lost to Follow-up|0
104971|NCT00725985|361737|P12|OLMP|Death|0
104972|NCT00725985|361738|P11|OLMP|Death|0
104973|NCT00725985|361739|P10|OLMP|Death|0
104974|NCT00725985|361740|P9|OLMP|Death|0
104975|NCT00725985|361741|P8|OLMP|Death|0
104976|NCT00725985|361742|P7|OLMP|Death|0
104977|NCT00725985|361743|P6|OLMP|Death|0
104978|NCT00725985|361744|P5|OLMP|Death|1
104979|NCT00725985|361745|P4|OLMP|Death|0
104980|NCT00725985|361746|P3|OLMP|Death|0
104981|NCT00725985|361747|P2|OLMP|Death|0
104982|NCT00725985|361748|P1|OLMP|Death|0
104983|NCT00725985|361737|P12|OLMP|Adverse Event|0
104984|NCT00725985|361738|P11|OLMP|Adverse Event|0
104985|NCT00725985|361739|P10|OLMP|Adverse Event|0
104986|NCT00725985|361740|P9|OLMP|Adverse Event|0
104987|NCT00725985|361741|P8|OLMP|Adverse Event|0
104988|NCT00725985|361742|P7|OLMP|Adverse Event|0
104989|NCT00725985|361743|P6|OLMP|Adverse Event|5
104990|NCT00725985|361744|P5|OLMP|Adverse Event|2
104991|NCT00725985|361745|P4|OLMP|Adverse Event|2
104992|NCT00725985|361746|P3|OLMP|Adverse Event|0
104993|NCT00725985|361747|P2|OLMP|Adverse Event|0
104994|NCT00725985|361748|P1|OLMP|Adverse Event|0
104995|NCT00725985|361737|P12|ITP (Up to 96 Weeks)|Unspecified|0
104996|NCT00725985|361738|P11|ITP (Up to 96 Weeks)|Unspecified|0
104997|NCT00725985|361739|P10|ITP (Up to 96 Weeks)|Unspecified|0
104998|NCT00725985|361740|P9|ITP (Up to 96 Weeks)|Unspecified|0
104999|NCT00725985|361741|P8|ITP (Up to 96 Weeks)|Unspecified|0
105000|NCT00725985|361742|P7|ITP (Up to 96 Weeks)|Unspecified|0
105001|NCT00725985|361743|P6|ITP (Up to 96 Weeks)|Unspecified|0
105002|NCT00725985|361744|P5|ITP (Up to 96 Weeks)|Unspecified|0
105003|NCT00725985|361745|P4|ITP (Up to 96 Weeks)|Unspecified|0
105004|NCT00725985|361746|P3|ITP (Up to 96 Weeks)|Unspecified|24
105005|NCT00725985|361747|P2|ITP (Up to 96 Weeks)|Unspecified|38
105006|NCT00725985|361748|P1|ITP (Up to 96 Weeks)|Unspecified|50
105007|NCT00725985|361737|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
105008|NCT00725985|361738|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
105009|NCT00725985|361739|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
105010|NCT00725985|361740|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
105011|NCT00725985|361741|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
105012|NCT00725985|361742|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
105013|NCT00725985|361743|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
105014|NCT00725985|361744|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
105015|NCT00725985|361745|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
105016|NCT00725985|361746|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
105017|NCT00725985|361747|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
105018|NCT00725985|361748|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
105019|NCT00725985|361737|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
105020|NCT00725985|361738|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
105021|NCT00725985|361739|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
105022|NCT00725985|361740|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
105023|NCT00725985|361741|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
105024|NCT00725985|361742|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
105025|NCT00725985|361743|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
105026|NCT00725985|361744|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
105027|NCT00725985|361745|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
105028|NCT00725985|361746|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
105029|NCT00725985|361747|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
105030|NCT00725985|361748|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
105031|NCT00725985|361737|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
105032|NCT00725985|361738|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
105033|NCT00725985|361739|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
105034|NCT00725985|361740|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
105035|NCT00725985|361741|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
105036|NCT00725985|361742|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
105037|NCT00725985|361743|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
105038|NCT00725985|361744|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
105039|NCT00725985|361745|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
105040|NCT00725985|361746|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
105041|NCT00725985|361747|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
105042|NCT00725985|361748|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
105043|NCT00725985|361737|P12|ITP (Up to 96 Weeks)|Adverse Event|0
105044|NCT00725985|361738|P11|ITP (Up to 96 Weeks)|Adverse Event|0
105045|NCT00725985|361739|P10|ITP (Up to 96 Weeks)|Adverse Event|0
105046|NCT00725985|361740|P9|ITP (Up to 96 Weeks)|Adverse Event|0
105047|NCT00725985|361741|P8|ITP (Up to 96 Weeks)|Adverse Event|0
105048|NCT00725985|361742|P7|ITP (Up to 96 Weeks)|Adverse Event|0
105049|NCT00725985|361743|P6|ITP (Up to 96 Weeks)|Adverse Event|0
105050|NCT00725985|361744|P5|ITP (Up to 96 Weeks)|Adverse Event|0
105051|NCT00725985|361745|P4|ITP (Up to 96 Weeks)|Adverse Event|0
105052|NCT00725985|361746|P3|ITP (Up to 96 Weeks)|Adverse Event|5
105053|NCT00725985|361747|P2|ITP (Up to 96 Weeks)|Adverse Event|10
105054|NCT00725985|361748|P1|ITP (Up to 96 Weeks)|Adverse Event|20
105055|NCT00725920|361776|P2|Overall Study|Lack of Efficacy|6
105056|NCT00725920|361777|P1|Overall Study|Lack of Efficacy|3
105057|NCT00725842|361783|P1|Overall Study|No Visit 1 data|1
105058|NCT00725842|361783|P1|Overall Study|Inclusion criterion not met|1
105059|NCT00725842|361783|P1|Overall Study|Consent date prior to study start date|5
105060|NCT00725842|361783|P1|Overall Study|Positive HCV-RNA at Visit 2|13
105061|NCT00725842|361783|P1|Overall Study|Death|1
105062|NCT00725842|361783|P1|Overall Study|Lost to Follow-up|19
105063|NCT00724958|361815|P1|Overall Study|No documentation for end of therapy|13
105064|NCT00724958|361815|P1|Overall Study|Other Reason|76
105065|NCT00724958|361815|P1|Overall Study|Remission|7
105066|NCT00724958|361815|P1|Overall Study|No Response|18
105067|NCT00724958|361815|P1|Overall Study|Loss of Response|40
105068|NCT00724958|361815|P1|Overall Study|Adverse Event|28
105069|NCT00724945|361824|P2|Period 2|lens physiology issue|0
105070|NCT00724945|361825|P1|Period 2|lens physiology issue|1
105071|NCT00724945|361824|P2|Period 2|lens comfort issue|0
105072|NCT00724945|361825|P1|Period 2|lens comfort issue|3
105073|NCT00724945|361824|P2|Period 1|Lost to Follow-up|0
105074|NCT00724945|361825|P1|Period 1|Lost to Follow-up|1
105075|NCT00724945|361824|P2|Period 1|Adverse Event|1
105076|NCT00724945|361825|P1|Period 1|Adverse Event|1
105077|NCT00724945|361824|P2|Period 1|non-compliance|0
105078|NCT00724945|361825|P1|Period 1|non-compliance|1
105079|NCT00724932|361837|P2|Overall Study|Not treated|3
105080|NCT00724932|361838|P1|Overall Study|Not treated|4
105081|NCT00724932|361837|P2|Overall Study|Lost to Follow-up|0
105082|NCT00724932|361838|P1|Overall Study|Lost to Follow-up|1
105083|NCT00725725|361922|P3|Overall Study|Protocol Violation|0
105084|NCT00725725|361923|P2|Overall Study|Protocol Violation|1
105085|NCT00725725|361924|P1|Overall Study|Protocol Violation|0
105086|NCT00725725|361922|P3|Overall Study|Withdrawal by Subject|1
105087|NCT00725725|361923|P2|Overall Study|Withdrawal by Subject|0
105088|NCT00725725|361924|P1|Overall Study|Withdrawal by Subject|1
105089|NCT00725725|361922|P3|Overall Study|Lost to Follow-up|2
105090|NCT00725725|361923|P2|Overall Study|Lost to Follow-up|0
105091|NCT00725725|361924|P1|Overall Study|Lost to Follow-up|2
105092|NCT00725725|361922|P3|Overall Study|Adverse Event|2
105093|NCT00725725|361923|P2|Overall Study|Adverse Event|3
105094|NCT00725725|361924|P1|Overall Study|Adverse Event|1
105095|NCT00725621|361965|P1|Overall Study|Reason not specified|55
105096|NCT00725621|361965|P1|Overall Study|Prepared for elective surgery|1
105097|NCT00725621|361965|P1|Overall Study|Switched to other drug|1
105098|NCT00725621|361965|P1|Overall Study|Switched to other study|1
105099|NCT00725621|361965|P1|Overall Study|Continued treatment by other physician|6
105100|NCT00725621|361965|P1|Overall Study|Non-compliance|8
105101|NCT00725621|361965|P1|Overall Study|Lost to Follow-up|52
105102|NCT00725621|361965|P1|Overall Study|Physician Decision|19
105103|NCT00725621|361965|P1|Overall Study|Withdrawal by Subject|57
105104|NCT00725621|361965|P1|Overall Study|Lack of Efficacy|46
105105|NCT00725621|361965|P1|Overall Study|Adverse Event|25
105106|NCT00725608|361988|P1|Overall Study|Other|7
105107|NCT00725608|361988|P1|Overall Study|Individual reasons|86
105108|NCT00725608|361988|P1|Overall Study|Adverse Event|14
105109|NCT00725608|361988|P1|Overall Study|Lost to Follow-up|60
105110|NCT00725543|361994|P1|Overall Study|Not specified|119
105111|NCT00725543|361994|P1|Overall Study|Non-compliance|2
105112|NCT00725543|361994|P1|Overall Study|Lost to Follow-up|4
105113|NCT00725543|361994|P1|Overall Study|Physician Decision|5
105114|NCT00725543|361994|P1|Overall Study|Withdrawal by Subject|10
105115|NCT00725543|361994|P1|Overall Study|Lack of Efficacy|3
105116|NCT00725543|361994|P1|Overall Study|Adverse Event|10
105117|NCT00725491|362012|P2|Overall Study|No/too few embryos/ bad quality embryos|2
105118|NCT00725491|362013|P1|Overall Study|No/too few embryos/ bad quality embryos|3
105119|NCT00725491|362012|P2|Overall Study|Fertilization failure|1
105120|NCT00725491|362013|P1|Overall Study|Fertilization failure|0
105121|NCT00725491|362012|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
105122|NCT00725491|362013|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
105123|NCT00725491|362012|P2|Overall Study|Risk for hyperstimulation|9
105124|NCT00725491|362013|P1|Overall Study|Risk for hyperstimulation|2
105125|NCT00725491|362012|P2|Overall Study|Pregnancy|3
105126|NCT00725491|362013|P1|Overall Study|Pregnancy|0
105127|NCT00725491|362012|P2|Overall Study|Adverse Event|2
105128|NCT00725491|362013|P1|Overall Study|Adverse Event|3
105129|NCT00725452|362019|P1|Overall Study|Lost to Follow-up|1
105130|NCT00725452|362019|P1|Overall Study|Withdrawal by Subject|3
105131|NCT00725452|362019|P1|Overall Study|Physician Decision|1
105132|NCT00725452|362019|P1|Overall Study|Reason not specified|1
105133|NCT00725452|362019|P1|Overall Study|Lack of Efficacy|2
105134|NCT00725452|362019|P1|Overall Study|Adverse Event|3
105135|NCT00725296|362028|P1|Overall Study|Not Specified|38
105136|NCT00725296|362028|P1|Overall Study|Lost to Follow-up|1
105137|NCT00725296|362028|P1|Overall Study|Non-Compliance|2
105138|NCT00725296|362028|P1|Overall Study|Withdrawal by Subject|3
105139|NCT00725296|362028|P1|Overall Study|Lack of Efficacy|7
105140|NCT00725296|362028|P1|Overall Study|Adverse Event|11
105141|NCT00725205|362037|P1|Overall Study|Treatment Failure|41
105142|NCT00725205|362037|P1|Overall Study|Protocol Defined Clinical Event|1
105143|NCT00725205|362037|P1|Overall Study|Other|8
105144|NCT00725205|362037|P1|Overall Study|Non-compliance With Protocol|14
105145|NCT00725205|362037|P1|Overall Study|Investigator Discontinued|1
105146|NCT00725205|362037|P1|Overall Study|Adverse Event|22
105147|NCT00725101|362050|P1|Overall Study|not specified/no reason given|11
105148|NCT00725101|362050|P1|Overall Study|Withdrawal by Subject|127
105149|NCT00725101|362050|P1|Overall Study|Protocol Violation|1
105150|NCT00725101|362050|P1|Overall Study|Lost to Follow-up|353
105151|NCT00725101|362050|P1|Overall Study|Death|3
105152|NCT00725075|362073|P3|Overall Study|Other|0
105153|NCT00725075|362074|P2|Overall Study|Other|0
105154|NCT00725075|362075|P1|Overall Study|Other|1
105155|NCT00725075|362073|P3|Overall Study|Inclusion/Exclusion Criteria|1
105156|NCT00725075|362074|P2|Overall Study|Inclusion/Exclusion Criteria|0
105157|NCT00725075|362075|P1|Overall Study|Inclusion/Exclusion Criteria|1
105158|NCT00725075|362073|P3|Overall Study|Worsening of Disease|2
105159|NCT00725075|362074|P2|Overall Study|Worsening of Disease|1
105160|NCT00725075|362075|P1|Overall Study|Worsening of Disease|2
105161|NCT00725075|362073|P3|Overall Study|Adverse Event|1
105162|NCT00725075|362074|P2|Overall Study|Adverse Event|1
105163|NCT00725075|362075|P1|Overall Study|Adverse Event|2
105164|NCT00725075|362073|P3|Overall Study|Withdrawal by Subject|4
105165|NCT00725075|362074|P2|Overall Study|Withdrawal by Subject|5
105166|NCT00725075|362075|P1|Overall Study|Withdrawal by Subject|4
105167|NCT00725075|362073|P3|Overall Study|Lost to Follow-up|0
105168|NCT00725075|362074|P2|Overall Study|Lost to Follow-up|0
105169|NCT00725075|362075|P1|Overall Study|Lost to Follow-up|1
105170|NCT00725075|362073|P3|Overall Study|Protocol Violation|1
105171|NCT00725075|362074|P2|Overall Study|Protocol Violation|0
105172|NCT00725075|362075|P1|Overall Study|Protocol Violation|0
105173|NCT00725075|362073|P3|Overall Study|Use of Excluded Medication|0
105174|NCT00725075|362074|P2|Overall Study|Use of Excluded Medication|1
105175|NCT00725075|362075|P1|Overall Study|Use of Excluded Medication|0
105176|NCT00725010|362128|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
105177|NCT00725010|362128|P1|Overall Study|No further documentation|1
105178|NCT00725010|362128|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
105179|NCT00725010|362128|P1|Overall Study|Hepatopathy probably not Temodal-related|1
105180|NCT00725010|362128|P1|Overall Study|Lost to Follow-up|1
105181|NCT00725010|362128|P1|Overall Study|Death|1
105182|NCT00725010|362128|P1|Overall Study|Withdrawal by Subject|2
105183|NCT00725010|362128|P1|Overall Study|Tumor Progression|7
105184|NCT00725010|362128|P1|Overall Study|Toxicity|9
105185|NCT00724893|362138|P2|Overall Study|Unknown, missing data|1
105186|NCT00724893|362139|P1|Overall Study|Unknown, missing data|1
105187|NCT00724893|362138|P2|Overall Study|Lost to Follow-up|52
105188|NCT00724893|362139|P1|Overall Study|Lost to Follow-up|0
105189|NCT00724893|362138|P2|Overall Study|Assigned shorter treatment|2
105190|NCT00724893|362139|P1|Overall Study|Assigned shorter treatment|0
105191|NCT00724893|362138|P2|Overall Study|Financial reasons|2
105192|NCT00724893|362139|P1|Overall Study|Financial reasons|0
105193|NCT00724893|362138|P2|Overall Study|Substance abuse|3
105194|NCT00724893|362139|P1|Overall Study|Substance abuse|0
105195|NCT00724893|362138|P2|Overall Study|Incarceration|9
105196|NCT00724893|362139|P1|Overall Study|Incarceration|0
105197|NCT00724893|362138|P2|Overall Study|Geographic reasons|11
105198|NCT00724893|362139|P1|Overall Study|Geographic reasons|0
105199|NCT00724893|362138|P2|Overall Study|Patient choice|26
105200|NCT00724893|362139|P1|Overall Study|Patient choice|0
105201|NCT00724893|362138|P2|Overall Study|Reason not specified|7
105202|NCT00724893|362139|P1|Overall Study|Reason not specified|193
105203|NCT00724893|362138|P2|Overall Study|Lack of virologic response|202
105204|NCT00724893|362139|P1|Overall Study|Lack of virologic response|94
105205|NCT00724893|362138|P2|Overall Study|Withdrawal by Subject|1
105206|NCT00724893|362139|P1|Overall Study|Withdrawal by Subject|0
105207|NCT00724893|362138|P2|Overall Study|Adverse Event|142
105208|NCT00724893|362139|P1|Overall Study|Adverse Event|76
105209|NCT00724867|362207|P1|Overall Study|Elected to exit due to site closure|2
105210|NCT00724867|362207|P1|Overall Study|Subject moved out of state|1
105211|NCT00724867|362207|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
105212|NCT00724867|362207|P1|Overall Study|Subject incarcerated|1
105213|NCT00724867|362207|P1|Overall Study|Sponsor decision to end study|14
105214|NCT00724867|362207|P1|Overall Study|Withdrawal by Subject|31
105215|NCT00724867|362207|P1|Overall Study|Protocol Violation|1
105216|NCT00724867|362207|P1|Overall Study|Physician Decision|17
105217|NCT00724867|362207|P1|Overall Study|Non-compliance with study drug|6
105218|NCT00724867|362207|P1|Overall Study|Lost to Follow-up|12
105219|NCT00724867|362207|P1|Overall Study|Lack of Efficacy|14
105220|NCT00724867|362207|P1|Overall Study|Adverse Event|25
105221|NCT00724854|362247|P2|Overall Study|Adverse event + lack of efficacy|1
105222|NCT00724854|362248|P1|Overall Study|Adverse event + lack of efficacy|2
105223|NCT00724854|362247|P2|Overall Study|Withdrawal by Subject|0
105224|NCT00724854|362248|P1|Overall Study|Withdrawal by Subject|5
105225|NCT00724854|362247|P2|Overall Study|Change of treatment|0
105226|NCT00724854|362248|P1|Overall Study|Change of treatment|7
105227|NCT00724854|362247|P2|Overall Study|Death|0
105228|NCT00724854|362248|P1|Overall Study|Death|11
105229|NCT00724854|362247|P2|Overall Study|Not specified|3
105230|NCT00724854|362248|P1|Overall Study|Not specified|42
105231|NCT00724854|362247|P2|Overall Study|Adverse Event|4
105232|NCT00724854|362248|P1|Overall Study|Adverse Event|62
105233|NCT00724854|362247|P2|Overall Study|Lost to Follow-up|10
105234|NCT00724854|362248|P1|Overall Study|Lost to Follow-up|87
105235|NCT00724854|362247|P2|Overall Study|Lack of Efficacy|13
105236|NCT00724854|362248|P1|Overall Study|Lack of Efficacy|187
105237|NCT00724815|362265|P2|Overall Study|Other Various|5
105238|NCT00724815|362266|P1|Overall Study|Other Various|3
105239|NCT00724815|362265|P2|Overall Study|Lost to Follow-up|1
105240|NCT00724815|362266|P1|Overall Study|Lost to Follow-up|4
105241|NCT00724815|362265|P2|Overall Study|Adverse Event|3
105242|NCT00724815|362266|P1|Overall Study|Adverse Event|5
105243|NCT00724815|362265|P2|Overall Study|Randomized, not treated|30
105244|NCT00724815|362266|P1|Overall Study|Randomized, not treated|31
105245|NCT00724711|362299|P2|Overall Study|Protocol Violation|0
105246|NCT00724711|362300|P1|Overall Study|Protocol Violation|1
105247|NCT00724711|362299|P2|Overall Study|Lost to Follow-up|5
105248|NCT00724711|362300|P1|Overall Study|Lost to Follow-up|4
105249|NCT00724711|362299|P2|Overall Study|Withdrawal by Subject|4
105250|NCT00724711|362300|P1|Overall Study|Withdrawal by Subject|5
105251|NCT00724711|362299|P2|Overall Study|Physician Decision|3
105252|NCT00724711|362300|P1|Overall Study|Physician Decision|0
105253|NCT00724711|362299|P2|Overall Study|Lack of Efficacy|1
105254|NCT00724711|362300|P1|Overall Study|Lack of Efficacy|0
105255|NCT00724711|362299|P2|Overall Study|Pregnancy|1
105256|NCT00724711|362300|P1|Overall Study|Pregnancy|0
105257|NCT00724711|362299|P2|Overall Study|Adverse Event|3
105258|NCT00724711|362300|P1|Overall Study|Adverse Event|7
105259|NCT00724698|362332|P1|Overall Study|No Info|25
105260|NCT00724698|362332|P1|Overall Study|Lost to Follow-up|36
105261|NCT00724698|362332|P1|Overall Study|Poor Compliance|16
105262|NCT00724698|362332|P1|Overall Study|Failure of Therapy|4
105263|NCT00724698|362332|P1|Overall Study|Adverse Event|9
105264|NCT00724451|362387|P1|Overall Study|Investigator + Participant Decision|13
105265|NCT00724451|362387|P1|Overall Study|Withdrawal by Subject|45
105266|NCT00724451|362387|P1|Overall Study|Physician Decision|116
105267|NCT00724451|362387|P1|Overall Study|Unknown; No Data Sources Available|9
105268|NCT00724451|362387|P1|Overall Study|Never Started Treatment|89
105269|NCT00724451|362387|P1|Overall Study|Participant Refused Treatment|89
105270|NCT00724451|362387|P1|Overall Study|Not Eligible for Treatment|431
105271|NCT00724451|362387|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
105272|NCT00724451|362387|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
105273|NCT00724373|362393|P1|Overall Study|Tolerability|23
105274|NCT00724373|362393|P1|Overall Study|Drug Relapse|1
105275|NCT00724373|362393|P1|Overall Study|Acute HCV infection|1
105276|NCT00724373|362393|P1|Overall Study|Viral Relapse|1
105277|NCT00724373|362393|P1|Overall Study|Only to have 24 week regimen|1
105278|NCT00724373|362393|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
105279|NCT00724373|362393|P1|Overall Study|Participant moved away|1
105280|NCT00724373|362393|P1|Overall Study|HCV RNA negative after 4 weeks|9
105281|NCT00724373|362393|P1|Overall Study|Non-compliance|2
105282|NCT00724373|362393|P1|Overall Study|Lost to Follow-up|7
105283|NCT00724373|362393|P1|Overall Study|Lack of Efficacy|82
105284|NCT00724373|362393|P1|Overall Study|Adverse Event|41
105285|NCT00724282|362410|P1|Overall Study|Physician Decision|1
105286|NCT00724282|362410|P1|Overall Study|Withdrawal by Subject|3
105287|NCT00724243|362414|P1|Overall Study|Adverse Event|5
105288|NCT00724243|362414|P1|Overall Study|Lack of Efficacy|10
105289|NCT00724152|362424|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
105290|NCT00724152|362425|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
105291|NCT00724152|362426|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
105292|NCT00724152|362424|P3|Two-arm Study Period|Withdrawal by Subject|0
105293|NCT00724152|362425|P2|Two-arm Study Period|Withdrawal by Subject|2
105294|NCT00724152|362426|P1|Two-arm Study Period|Withdrawal by Subject|3
105295|NCT00724126|362443|P2|Overall Study|Subject had to leave vicinity of site|1
105296|NCT00724126|362444|P1|Overall Study|Subject had to leave vicinity of site|0
105297|NCT00724126|362443|P2|Overall Study|Subject randomized although ineligible|1
105298|NCT00724126|362444|P1|Overall Study|Subject randomized although ineligible|1
105299|NCT00724126|362443|P2|Overall Study|Noncompliance|1
105300|NCT00724126|362444|P1|Overall Study|Noncompliance|2
105301|NCT00724126|362443|P2|Overall Study|Lost to Follow-up|6
105302|NCT00724126|362444|P1|Overall Study|Lost to Follow-up|6
105303|NCT00724126|362443|P2|Overall Study|Withdrawal by Subject|6
105304|NCT00724126|362444|P1|Overall Study|Withdrawal by Subject|8
105305|NCT00724126|362443|P2|Overall Study|Adverse Event|0
105306|NCT00724126|362444|P1|Overall Study|Adverse Event|2
105307|NCT00724061|362452|P1|Dose Escalation Phase|Disease Progression|3
105308|NCT00724061|362452|P1|Dose Escalation Phase|Adverse Event|2
105309|NCT00723957|362469|P2|Overall Study|Never received treatment|3
105310|NCT00723957|362470|P1|Overall Study|Never received treatment|3
105311|NCT00723957|362469|P2|Overall Study|Reason not analyzed|0
105312|NCT00723957|362470|P1|Overall Study|Reason not analyzed|1
105313|NCT00723957|362469|P2|Overall Study|Withdrawal by Subject|5
105314|NCT00723957|362470|P1|Overall Study|Withdrawal by Subject|7
105315|NCT00723957|362469|P2|Overall Study|Study drug toxicity|6
105316|NCT00723957|362470|P1|Overall Study|Study drug toxicity|4
105317|NCT00723957|362469|P2|Overall Study|Investigator decision|1
105318|NCT00723957|362470|P1|Overall Study|Investigator decision|1
105319|NCT00723957|362469|P2|Overall Study|Maximum clinical benefit|5
105320|NCT00723957|362470|P1|Overall Study|Maximum clinical benefit|4
105321|NCT00723957|362469|P2|Overall Study|Disease progression|25
105322|NCT00723957|362470|P1|Overall Study|Disease progression|27
105323|NCT00723957|362469|P2|Overall Study|Death|4
105324|NCT00723957|362470|P1|Overall Study|Death|3
105325|NCT00723957|362469|P2|Overall Study|Adverse event unrelated to study drug|4
105326|NCT00723957|362470|P1|Overall Study|Adverse event unrelated to study drug|1
105327|NCT00723944|362494|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
105328|NCT00723944|362495|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
105329|NCT00723944|362494|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
105330|NCT00723944|362495|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
105331|NCT00723944|362494|P2|Permanent Prosthesis Placement|Adverse Event|7
105332|NCT00723944|362495|P1|Permanent Prosthesis Placement|Adverse Event|1
105333|NCT00723892|362508|P2|Overall Study|Drug addiction|0
105334|NCT00723892|362509|P1|Overall Study|Drug addiction|1
105335|NCT00723892|362508|P2|Overall Study|Intercurrent infection|0
105336|NCT00723892|362509|P1|Overall Study|Intercurrent infection|2
105337|NCT00723892|362508|P2|Overall Study|Alcohol abuse|1
105338|NCT00723892|362509|P1|Overall Study|Alcohol abuse|0
105339|NCT00723892|362508|P2|Overall Study|Weight loss|3
105340|NCT00723892|362509|P1|Overall Study|Weight loss|1
105341|NCT00723892|362508|P2|Overall Study|Study end|3
105342|NCT00723892|362509|P1|Overall Study|Study end|1
105343|NCT00723892|362508|P2|Overall Study|Not specified|3
105344|NCT00723892|362509|P1|Overall Study|Not specified|6
105345|NCT00723892|362508|P2|Overall Study|Multiple reasons|12
105346|NCT00723892|362509|P1|Overall Study|Multiple reasons|17
105347|NCT00723892|362508|P2|Overall Study|Bad tolerance|5
105348|NCT00723892|362509|P1|Overall Study|Bad tolerance|5
105349|NCT00723892|362508|P2|Overall Study|End planned|7
105350|NCT00723892|362509|P1|Overall Study|End planned|11
105351|NCT00723892|362508|P2|Overall Study|Withdrawal by Subject|9
105352|NCT00723892|362509|P1|Overall Study|Withdrawal by Subject|6
105353|NCT00723892|362508|P2|Overall Study|Virological criterion|9
105354|NCT00723892|362509|P1|Overall Study|Virological criterion|24
105355|NCT00723892|362508|P2|Overall Study|Participant not tracked|35
105356|NCT00723892|362509|P1|Overall Study|Participant not tracked|33
105357|NCT00723840|362516|P1|Overall Study|Unspecified reason|2
105358|NCT00723840|362516|P1|Overall Study|Other Medical Event|2
105359|NCT00723840|362516|P1|Overall Study|Serious Adverse Events|3
105360|NCT00723840|362516|P1|Overall Study|Withdrawal by Subject|55
105361|NCT00723840|362516|P1|Overall Study|Failure to return|18
105362|NCT00723840|362516|P1|Overall Study|Lost to Follow-up|2
105363|NCT00722800|362537|P2|Overall Study|Physician Decision|0
105364|NCT00722800|362538|P1|Overall Study|Physician Decision|1
105365|NCT00722800|362537|P2|Overall Study|Withdrawal by Subject|0
105366|NCT00722800|362538|P1|Overall Study|Withdrawal by Subject|1
105367|NCT00722761|362550|P2|Overall Study|Withdrawal by Subject|2
105368|NCT00722761|362551|P1|Overall Study|Withdrawal by Subject|5
105369|NCT00722761|362550|P2|Overall Study|Lost to Follow-up|4
105370|NCT00722761|362551|P1|Overall Study|Lost to Follow-up|1
105371|NCT00723801|362574|P2|Overall Study|Protocol Violation|1
105372|NCT00723801|362575|P1|Overall Study|Protocol Violation|2
105373|NCT00723801|362574|P2|Overall Study|Lost to Follow-up|2
105374|NCT00723801|362575|P1|Overall Study|Lost to Follow-up|1
105375|NCT00723710|362600|P1|Overall Study|Physician Decision|2
105376|NCT00723710|362600|P1|Overall Study|Withdrawal by Subject|36
105377|NCT00723710|362600|P1|Overall Study|Adverse Event|88
105378|NCT00723710|362600|P1|Overall Study|Disease progression|48
105379|NCT00723697|362604|P1|Overall Study|Other exclusion criteria applied|6
105380|NCT00723697|362604|P1|Overall Study|Missing Informed Consent Form|10
105381|NCT00723697|362604|P1|Overall Study|Physician questionnaires not received|2
105382|NCT00723606|362625|P2|Overall Study|Withdrawal by Subject|2
105383|NCT00723606|362626|P1|Overall Study|Withdrawal by Subject|0
105384|NCT00723606|362625|P2|Overall Study|Unspecified|0
105385|NCT00723606|362626|P1|Overall Study|Unspecified|2
105386|NCT00723606|362625|P2|Overall Study|Adverse Event|5
105387|NCT00723606|362626|P1|Overall Study|Adverse Event|2
105388|NCT00723554|362646|P1|Overall Study|Non-compliance|1
105389|NCT00723554|362646|P1|Overall Study|Lost to Follow-up|1
105390|NCT00723554|362646|P1|Overall Study|Not specified|3
105391|NCT00723554|362646|P1|Overall Study|Withdrawal of consent|3
105392|NCT00723554|362646|P1|Overall Study|Inhaled medication other than iloprost|4
105393|NCT00723554|362646|P1|Overall Study|Investigator's judgement|5
105394|NCT00723554|362646|P1|Overall Study|Adverse Event|12
105395|NCT00723528|362696|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
105396|NCT00723528|362697|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
105397|NCT00723528|362698|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
105398|NCT00723528|362699|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
105399|NCT00723528|362700|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
105400|NCT00723528|362701|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
105401|NCT00723528|362702|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
105402|NCT00723528|362696|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
105403|NCT00723528|362697|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
105404|NCT00723528|362698|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
105405|NCT00723528|362699|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
105406|NCT00723528|362700|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
105407|NCT00723528|362701|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
105408|NCT00723528|362702|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
105409|NCT00723528|362696|P7|Period 2: After Controlled Period|Adverse Event|1
105410|NCT00723528|362697|P6|Period 2: After Controlled Period|Adverse Event|0
105411|NCT00723528|362698|P5|Period 2: After Controlled Period|Adverse Event|1
105412|NCT00723528|362699|P4|Period 2: After Controlled Period|Adverse Event|0
105413|NCT00723528|362700|P3|Period 2: After Controlled Period|Adverse Event|0
105414|NCT00723528|362701|P2|Period 2: After Controlled Period|Adverse Event|0
105415|NCT00723528|362702|P1|Period 2: After Controlled Period|Adverse Event|0
105416|NCT00723528|362696|P7|Period 2: After Controlled Period|Unspecified|0
105417|NCT00723528|362697|P6|Period 2: After Controlled Period|Unspecified|4
105418|NCT00723528|362698|P5|Period 2: After Controlled Period|Unspecified|1
105419|NCT00723528|362699|P4|Period 2: After Controlled Period|Unspecified|0
105420|NCT00723528|362700|P3|Period 2: After Controlled Period|Unspecified|0
105421|NCT00723528|362701|P2|Period 2: After Controlled Period|Unspecified|0
105422|NCT00723528|362702|P1|Period 2: After Controlled Period|Unspecified|0
105423|NCT00723528|362696|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
105424|NCT00723528|362697|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
105425|NCT00723528|362698|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
105426|NCT00723528|362699|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
105427|NCT00723528|362700|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
105428|NCT00723528|362701|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
105429|NCT00723528|362702|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
105430|NCT00723528|362696|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
105431|NCT00723528|362697|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
105432|NCT00723528|362698|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
105433|NCT00723528|362699|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
105434|NCT00723528|362700|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
105435|NCT00723528|362701|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
105436|NCT00723528|362702|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
105437|NCT00723528|362696|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
105438|NCT00723528|362697|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
105439|NCT00723528|362698|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
105440|NCT00723528|362699|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
105441|NCT00723528|362700|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
105442|NCT00723528|362701|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
105443|NCT00723528|362702|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
105444|NCT00723528|362696|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
105445|NCT00723528|362697|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
105446|NCT00723528|362698|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
105447|NCT00723528|362699|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
105448|NCT00723528|362700|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
105449|NCT00723528|362701|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
105450|NCT00723528|362702|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
105451|NCT00723528|362696|P7|Period 1: Controlled Period (CP)|Physician Decision|0
105452|NCT00723528|362697|P6|Period 1: Controlled Period (CP)|Physician Decision|0
105453|NCT00723528|362698|P5|Period 1: Controlled Period (CP)|Physician Decision|0
105454|NCT00723528|362699|P4|Period 1: Controlled Period (CP)|Physician Decision|0
105455|NCT00723528|362700|P3|Period 1: Controlled Period (CP)|Physician Decision|1
105456|NCT00723528|362701|P2|Period 1: Controlled Period (CP)|Physician Decision|0
105457|NCT00723528|362702|P1|Period 1: Controlled Period (CP)|Physician Decision|0
105458|NCT00723528|362696|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
105459|NCT00723528|362697|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
105460|NCT00723528|362698|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
105461|NCT00723528|362699|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
105462|NCT00723528|362700|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
105463|NCT00723528|362701|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
105464|NCT00723528|362702|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
105465|NCT00723528|362696|P7|Period 1: Controlled Period (CP)|Adverse Event|0
105466|NCT00723528|362697|P6|Period 1: Controlled Period (CP)|Adverse Event|0
105467|NCT00723528|362698|P5|Period 1: Controlled Period (CP)|Adverse Event|0
105468|NCT00723528|362699|P4|Period 1: Controlled Period (CP)|Adverse Event|0
105469|NCT00723528|362700|P3|Period 1: Controlled Period (CP)|Adverse Event|1
105470|NCT00723528|362701|P2|Period 1: Controlled Period (CP)|Adverse Event|0
105471|NCT00723528|362702|P1|Period 1: Controlled Period (CP)|Adverse Event|0
105472|NCT00723489|362764|P4|Overall Study|Samples Collected Out of Window|0
105473|NCT00723489|362765|P3|Overall Study|Samples Collected Out of Window|0
105474|NCT00723489|362766|P2|Overall Study|Samples Collected Out of Window|3
105475|NCT00723489|362767|P1|Overall Study|Samples Collected Out of Window|0
105476|NCT00723489|362764|P4|Overall Study|Prohibited Medication|1
105477|NCT00723489|362765|P3|Overall Study|Prohibited Medication|0
105478|NCT00723489|362766|P2|Overall Study|Prohibited Medication|0
105479|NCT00723489|362767|P1|Overall Study|Prohibited Medication|0
105480|NCT00723489|362764|P4|Overall Study|Seropositive at baseline|0
105481|NCT00723489|362765|P3|Overall Study|Seropositive at baseline|0
105482|NCT00723489|362766|P2|Overall Study|Seropositive at baseline|0
105483|NCT00723489|362767|P1|Overall Study|Seropositive at baseline|1
105484|NCT00723489|362764|P4|Overall Study|Withdrawal by Subject|1
105485|NCT00723489|362765|P3|Overall Study|Withdrawal by Subject|0
105486|NCT00723489|362766|P2|Overall Study|Withdrawal by Subject|0
105487|NCT00723489|362767|P1|Overall Study|Withdrawal by Subject|0
105488|NCT00723489|362764|P4|Overall Study|Pregnancy|1
105489|NCT00723489|362765|P3|Overall Study|Pregnancy|0
105490|NCT00723489|362766|P2|Overall Study|Pregnancy|0
105491|NCT00723489|362767|P1|Overall Study|Pregnancy|0
105492|NCT00723489|362764|P4|Overall Study|Physician Decision|0
105493|NCT00723489|362765|P3|Overall Study|Physician Decision|0
105494|NCT00723489|362766|P2|Overall Study|Physician Decision|1
105495|NCT00723489|362767|P1|Overall Study|Physician Decision|0
105496|NCT00723450|362795|P3|Randomized Phase|Withdrawal by Subject|22
105497|NCT00723450|362796|P2|Randomized Phase|Withdrawal by Subject|14
105498|NCT00723450|362797|P1|Randomized Phase|Withdrawal by Subject|0
105499|NCT00723450|362795|P3|Randomized Phase|Physician Decision|1
105500|NCT00723450|362796|P2|Randomized Phase|Physician Decision|3
105501|NCT00723450|362797|P1|Randomized Phase|Physician Decision|0
105502|NCT00723450|362795|P3|Randomized Phase|Lost to Follow-up|3
105503|NCT00723450|362796|P2|Randomized Phase|Lost to Follow-up|2
105504|NCT00723450|362797|P1|Randomized Phase|Lost to Follow-up|0
105505|NCT00723450|362795|P3|Randomized Phase|Protocol Violation|13
105506|NCT00723450|362796|P2|Randomized Phase|Protocol Violation|9
105507|NCT00723450|362797|P1|Randomized Phase|Protocol Violation|0
105508|NCT00723450|362795|P3|Randomized Phase|Lack of Efficacy|11
105509|NCT00723450|362796|P2|Randomized Phase|Lack of Efficacy|11
105510|NCT00723450|362797|P1|Randomized Phase|Lack of Efficacy|0
105511|NCT00723450|362795|P3|Randomized Phase|Adverse Event|17
105512|NCT00723450|362796|P2|Randomized Phase|Adverse Event|26
105513|NCT00723450|362797|P1|Randomized Phase|Adverse Event|0
105514|NCT00723450|362795|P3|Open-Label Phase|Withdrawal by Subject|0
105515|NCT00723450|362796|P2|Open-Label Phase|Withdrawal by Subject|0
105516|NCT00723450|362797|P1|Open-Label Phase|Withdrawal by Subject|37
105517|NCT00723450|362795|P3|Open-Label Phase|Physician Decision|0
105518|NCT00723450|362796|P2|Open-Label Phase|Physician Decision|0
105519|NCT00723450|362797|P1|Open-Label Phase|Physician Decision|2
105520|NCT00723450|362795|P3|Open-Label Phase|Lost to Follow-up|0
105521|NCT00723450|362796|P2|Open-Label Phase|Lost to Follow-up|0
105522|NCT00723450|362797|P1|Open-Label Phase|Lost to Follow-up|7
105523|NCT00723450|362795|P3|Open-Label Phase|Protocol Violation|0
105524|NCT00723450|362796|P2|Open-Label Phase|Protocol Violation|0
105525|NCT00723450|362797|P1|Open-Label Phase|Protocol Violation|35
105526|NCT00723450|362795|P3|Open-Label Phase|Lack of Efficacy|0
105527|NCT00723450|362796|P2|Open-Label Phase|Lack of Efficacy|0
105528|NCT00723450|362797|P1|Open-Label Phase|Lack of Efficacy|18
105529|NCT00723450|362795|P3|Open-Label Phase|Adverse Event|0
105530|NCT00723450|362796|P2|Open-Label Phase|Adverse Event|0
105531|NCT00723450|362797|P1|Open-Label Phase|Adverse Event|26
105532|NCT00723255|362838|P1|Overall Study|Ineligible: Wrong Primary|2
105533|NCT00723255|362838|P1|Overall Study|Ineligible: Second primary|1
105534|NCT00723255|362838|P1|Overall Study|Ineligible: Inadequate pathology|1
105535|NCT00723203|362857|P1|Overall Study|Withdrawal by Subject|3
105536|NCT00723190|362861|P1|Overall Study|Other-Not included in safety population|2
105537|NCT00723190|362861|P1|Overall Study|Other-Premature Discontinuation|9
105538|NCT00723190|362861|P1|Overall Study|Protocol Violation|15
105539|NCT00723190|362861|P1|Overall Study|Lack of Efficacy|16
105540|NCT00723190|362861|P1|Overall Study|Adverse Event|18
105541|NCT00723190|362861|P1|Overall Study|Lost to Follow-up|37
105542|NCT00723190|362861|P1|Overall Study|Withdrawal by Subject|45
105543|NCT00723125|362894|P2|Overall Study|Adverse Event|0
105544|NCT00723125|362895|P1|Overall Study|Adverse Event|2
105545|NCT00723125|362894|P2|Overall Study|Withdrawal by Subject|6
105546|NCT00723125|362895|P1|Overall Study|Withdrawal by Subject|15
105547|NCT00723125|362894|P2|Overall Study|Met Dx|0
105548|NCT00723125|362895|P1|Overall Study|Met Dx|1
105549|NCT00723021|362932|P5|Intervention Period 4|Adverse Event|1
105550|NCT00723021|362933|P4|Intervention Period 4|Adverse Event|0
105551|NCT00723021|362934|P3|Intervention Period 4|Adverse Event|0
105552|NCT00723021|362935|P2|Intervention Period 4|Adverse Event|0
105553|NCT00723021|362936|P1|Intervention Period 4|Adverse Event|0
105554|NCT00723008|362990|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
105555|NCT00723008|362991|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
105556|NCT00723008|362990|P2|4-Week Unblinded Treatment|Adverse Event|0
105557|NCT00723008|362991|P1|4-Week Unblinded Treatment|Adverse Event|1
105558|NCT00723008|362990|P2|4-Week Double Blinded|Lost to Follow-up|3
105559|NCT00723008|362991|P1|4-Week Double Blinded|Lost to Follow-up|4
105560|NCT00723008|362990|P2|4-Week Double Blinded|Withdrawal by Subject|1
105561|NCT00723008|362991|P1|4-Week Double Blinded|Withdrawal by Subject|1
105562|NCT00723008|362990|P2|4-Week Double Blinded|Lack of Efficacy|1
105563|NCT00723008|362991|P1|4-Week Double Blinded|Lack of Efficacy|0
105564|NCT00723008|362990|P2|Enrollment|Lost to Follow-up|0
105565|NCT00723008|362991|P1|Enrollment|Lost to Follow-up|1
105566|NCT00722423|363049|P2|Overall Study|Protocol Violation|1
105567|NCT00722423|363050|P1|Overall Study|Protocol Violation|0
105568|NCT00722371|363065|P7|Overall Study|Withdrawal by Subject|26
105569|NCT00722371|363066|P6|Overall Study|Withdrawal by Subject|18
105570|NCT00722371|363067|P5|Overall Study|Withdrawal by Subject|19
105571|NCT00722371|363068|P4|Overall Study|Withdrawal by Subject|23
105572|NCT00722371|363069|P3|Overall Study|Withdrawal by Subject|19
105573|NCT00722371|363070|P2|Overall Study|Withdrawal by Subject|27
105574|NCT00722371|363071|P1|Overall Study|Withdrawal by Subject|18
105575|NCT00722371|363065|P7|Overall Study|Protocol Violation|1
105576|NCT00722371|363066|P6|Overall Study|Protocol Violation|2
105577|NCT00722371|363067|P5|Overall Study|Protocol Violation|4
105578|NCT00722371|363068|P4|Overall Study|Protocol Violation|1
105579|NCT00722371|363069|P3|Overall Study|Protocol Violation|0
105580|NCT00722371|363070|P2|Overall Study|Protocol Violation|1
105581|NCT00722371|363071|P1|Overall Study|Protocol Violation|6
105582|NCT00722371|363065|P7|Overall Study|Pregnancy|0
105583|NCT00722371|363066|P6|Overall Study|Pregnancy|1
105584|NCT00722371|363067|P5|Overall Study|Pregnancy|0
105585|NCT00722371|363068|P4|Overall Study|Pregnancy|0
105586|NCT00722371|363069|P3|Overall Study|Pregnancy|0
105587|NCT00722371|363070|P2|Overall Study|Pregnancy|1
105588|NCT00722371|363071|P1|Overall Study|Pregnancy|1
105589|NCT00722371|363065|P7|Overall Study|Physician Decision|4
105590|NCT00722371|363066|P6|Overall Study|Physician Decision|3
105591|NCT00722371|363067|P5|Overall Study|Physician Decision|2
105592|NCT00722371|363068|P4|Overall Study|Physician Decision|5
105593|NCT00722371|363069|P3|Overall Study|Physician Decision|2
105594|NCT00722371|363070|P2|Overall Study|Physician Decision|2
105595|NCT00722371|363071|P1|Overall Study|Physician Decision|5
105596|NCT00722371|363065|P7|Overall Study|Lost to Follow-up|13
105597|NCT00722371|363066|P6|Overall Study|Lost to Follow-up|16
105598|NCT00722371|363067|P5|Overall Study|Lost to Follow-up|8
105599|NCT00722371|363068|P4|Overall Study|Lost to Follow-up|13
105600|NCT00722371|363069|P3|Overall Study|Lost to Follow-up|21
105601|NCT00722371|363070|P2|Overall Study|Lost to Follow-up|14
105602|NCT00722371|363071|P1|Overall Study|Lost to Follow-up|11
105603|NCT00722371|363065|P7|Overall Study|Lack of Efficacy|0
105604|NCT00722371|363066|P6|Overall Study|Lack of Efficacy|3
105605|NCT00722371|363067|P5|Overall Study|Lack of Efficacy|2
105606|NCT00722371|363068|P4|Overall Study|Lack of Efficacy|6
105607|NCT00722371|363069|P3|Overall Study|Lack of Efficacy|6
105608|NCT00722371|363070|P2|Overall Study|Lack of Efficacy|6
105609|NCT00722371|363071|P1|Overall Study|Lack of Efficacy|4
105610|NCT00722371|363065|P7|Overall Study|Hypoglycemia|0
105611|NCT00722371|363066|P6|Overall Study|Hypoglycemia|0
105612|NCT00722371|363067|P5|Overall Study|Hypoglycemia|0
105613|NCT00722371|363068|P4|Overall Study|Hypoglycemia|0
105614|NCT00722371|363069|P3|Overall Study|Hypoglycemia|0
105615|NCT00722371|363070|P2|Overall Study|Hypoglycemia|0
105616|NCT00722371|363071|P1|Overall Study|Hypoglycemia|1
105617|NCT00722371|363065|P7|Overall Study|Hyperglycemia|1
105618|NCT00722371|363066|P6|Overall Study|Hyperglycemia|1
105619|NCT00722371|363067|P5|Overall Study|Hyperglycemia|5
105620|NCT00722371|363068|P4|Overall Study|Hyperglycemia|2
105621|NCT00722371|363069|P3|Overall Study|Hyperglycemia|4
105622|NCT00722371|363070|P2|Overall Study|Hyperglycemia|6
105623|NCT00722371|363071|P1|Overall Study|Hyperglycemia|2
105624|NCT00722371|363065|P7|Overall Study|Excluded medication|1
105625|NCT00722371|363066|P6|Overall Study|Excluded medication|0
105626|NCT00722371|363067|P5|Overall Study|Excluded medication|0
105627|NCT00722371|363068|P4|Overall Study|Excluded medication|0
105628|NCT00722371|363069|P3|Overall Study|Excluded medication|1
105629|NCT00722371|363070|P2|Overall Study|Excluded medication|1
105630|NCT00722371|363071|P1|Overall Study|Excluded medication|0
105631|NCT00722371|363065|P7|Overall Study|Creatinine / Creatinine clearance|1
105632|NCT00722371|363066|P6|Overall Study|Creatinine / Creatinine clearance|1
105633|NCT00722371|363067|P5|Overall Study|Creatinine / Creatinine clearance|2
105634|NCT00722371|363068|P4|Overall Study|Creatinine / Creatinine clearance|3
105635|NCT00722371|363069|P3|Overall Study|Creatinine / Creatinine clearance|2
105636|NCT00722371|363070|P2|Overall Study|Creatinine / Creatinine clearance|1
105637|NCT00722371|363071|P1|Overall Study|Creatinine / Creatinine clearance|2
105638|NCT00722371|363065|P7|Overall Study|Contraindication|0
105639|NCT00722371|363066|P6|Overall Study|Contraindication|0
105640|NCT00722371|363067|P5|Overall Study|Contraindication|0
105641|NCT00722371|363068|P4|Overall Study|Contraindication|0
105642|NCT00722371|363069|P3|Overall Study|Contraindication|1
105643|NCT00722371|363070|P2|Overall Study|Contraindication|0
105644|NCT00722371|363071|P1|Overall Study|Contraindication|0
105645|NCT00722371|363065|P7|Overall Study|Adverse Event|4
105646|NCT00722371|363066|P6|Overall Study|Adverse Event|8
105647|NCT00722371|363067|P5|Overall Study|Adverse Event|6
105648|NCT00722371|363068|P4|Overall Study|Adverse Event|10
105649|NCT00722371|363069|P3|Overall Study|Adverse Event|9
105650|NCT00722371|363070|P2|Overall Study|Adverse Event|13
105651|NCT00722371|363071|P1|Overall Study|Adverse Event|6
105652|NCT00722137|363124|P2|Overall Study|Randomized But Not Treated|2
105653|NCT00722137|363125|P1|Overall Study|Randomized But Not Treated|3
105654|NCT00722137|363124|P2|Overall Study|Other Reason Uknown|3
105655|NCT00722137|363125|P1|Overall Study|Other Reason Uknown|4
105656|NCT00722137|363124|P2|Overall Study|Withdrawal by Subject|6
105657|NCT00722137|363125|P1|Overall Study|Withdrawal by Subject|9
105658|NCT00722137|363124|P2|Overall Study|Death|12
105659|NCT00722137|363125|P1|Overall Study|Death|7
105660|NCT00722137|363124|P2|Overall Study|Adverse Event|17
105661|NCT00722137|363125|P1|Overall Study|Adverse Event|21
105662|NCT00722137|363124|P2|Overall Study|Overt Disease Progression|5
105663|NCT00722137|363125|P1|Overall Study|Overt Disease Progression|4
105664|NCT00721968|363179|P2|Overall Study|Lost to Follow-up|0
105665|NCT00721968|363180|P1|Overall Study|Lost to Follow-up|2
105666|NCT00721734|363193|P5|Overall Study|Other|0
105667|NCT00721734|363194|P4|Overall Study|Other|1
105668|NCT00721734|363195|P3|Overall Study|Other|0
105669|NCT00721734|363196|P2|Overall Study|Other|0
105670|NCT00721734|363197|P1|Overall Study|Other|0
105671|NCT00721734|363193|P5|Overall Study|Withdrawal by Subject|1
105672|NCT00721734|363194|P4|Overall Study|Withdrawal by Subject|0
105673|NCT00721734|363195|P3|Overall Study|Withdrawal by Subject|0
105674|NCT00721734|363196|P2|Overall Study|Withdrawal by Subject|1
105675|NCT00721734|363197|P1|Overall Study|Withdrawal by Subject|2
105676|NCT00721734|363193|P5|Overall Study|Adverse Event|3
105677|NCT00721734|363194|P4|Overall Study|Adverse Event|0
105678|NCT00721734|363195|P3|Overall Study|Adverse Event|4
105679|NCT00721734|363196|P2|Overall Study|Adverse Event|1
105680|NCT00721734|363197|P1|Overall Study|Adverse Event|3
105681|NCT00721734|363193|P5|Overall Study|Progressive Disease|2
105682|NCT00721734|363194|P4|Overall Study|Progressive Disease|5
105683|NCT00721734|363195|P3|Overall Study|Progressive Disease|4
105684|NCT00721734|363196|P2|Overall Study|Progressive Disease|10
105685|NCT00721734|363197|P1|Overall Study|Progressive Disease|3
105686|NCT00721578|363333|P2|Overall Study|Withdrawal by Subject|1
105687|NCT00721578|363334|P1|Overall Study|Withdrawal by Subject|1
105688|NCT00721578|363333|P2|Overall Study|Death|1
105689|NCT00721578|363334|P1|Overall Study|Death|1
105690|NCT00721409|363377|P3|Overall Study|Death|0
105691|NCT00721409|363378|P2|Overall Study|Death|1
105692|NCT00721409|363379|P1|Overall Study|Death|0
105693|NCT00721409|363377|P3|Overall Study|Adverse Event|2
105694|NCT00721409|363378|P2|Overall Study|Adverse Event|11
105695|NCT00721409|363379|P1|Overall Study|Adverse Event|0
105696|NCT00721409|363377|P3|Overall Study|Reason not specified|5
105697|NCT00721409|363378|P2|Overall Study|Reason not specified|1
105698|NCT00721409|363379|P1|Overall Study|Reason not specified|0
105699|NCT00721409|363377|P3|Overall Study|Withdrawal by Subject|6
105700|NCT00721409|363378|P2|Overall Study|Withdrawal by Subject|5
105701|NCT00721409|363379|P1|Overall Study|Withdrawal by Subject|1
105702|NCT00721409|363377|P3|Overall Study|Objective progression or relapse|57
105703|NCT00721409|363378|P2|Overall Study|Objective progression or relapse|42
105704|NCT00721409|363379|P1|Overall Study|Objective progression or relapse|7
105705|NCT00721409|363377|P3|Overall Study|Global deterioration of health status|3
105706|NCT00721409|363378|P2|Overall Study|Global deterioration of health status|5
105707|NCT00721409|363379|P1|Overall Study|Global deterioration of health status|2
105708|NCT00721409|363377|P3|Overall Study|Ongoing at date of cutoff|8
105709|NCT00721409|363378|P2|Overall Study|Ongoing at date of cutoff|19
105710|NCT00721409|363379|P1|Overall Study|Ongoing at date of cutoff|2
105711|NCT00721396|363506|P4|Overall Study|Administrative reason|0
105712|NCT00721396|363507|P3|Overall Study|Administrative reason|1
105713|NCT00721396|363508|P2|Overall Study|Administrative reason|0
105714|NCT00721396|363509|P1|Overall Study|Administrative reason|3
105715|NCT00721396|363506|P4|Overall Study|Inappropriate enrollment|0
105716|NCT00721396|363507|P3|Overall Study|Inappropriate enrollment|0
105717|NCT00721396|363508|P2|Overall Study|Inappropriate enrollment|2
105718|NCT00721396|363509|P1|Overall Study|Inappropriate enrollment|0
105719|NCT00721396|363506|P4|Overall Study|Protocol Violation|0
105720|NCT00721396|363507|P3|Overall Study|Protocol Violation|1
105721|NCT00721396|363508|P2|Overall Study|Protocol Violation|3
105722|NCT00721396|363509|P1|Overall Study|Protocol Violation|4
105723|NCT00721396|363506|P4|Overall Study|Lost to Follow-up|3
105724|NCT00721396|363507|P3|Overall Study|Lost to Follow-up|3
105725|NCT00721396|363508|P2|Overall Study|Lost to Follow-up|9
105726|NCT00721396|363509|P1|Overall Study|Lost to Follow-up|7
105727|NCT00721396|363506|P4|Overall Study|Withdrawal by Subject|7
105728|NCT00721396|363507|P3|Overall Study|Withdrawal by Subject|3
105729|NCT00721396|363508|P2|Overall Study|Withdrawal by Subject|15
105730|NCT00721396|363509|P1|Overall Study|Withdrawal by Subject|12
105731|NCT00721396|363506|P4|Overall Study|Adverse Event|0
105732|NCT00721396|363507|P3|Overall Study|Adverse Event|2
105733|NCT00721396|363508|P2|Overall Study|Adverse Event|7
105734|NCT00721396|363509|P1|Overall Study|Adverse Event|4
105735|NCT00721279|363556|P2|Overall Study|Other|16
105736|NCT00721279|363557|P1|Overall Study|Other|12
105737|NCT00721279|363556|P2|Overall Study|Withdrawal by Subject|3
105738|NCT00721279|363557|P1|Overall Study|Withdrawal by Subject|13
105739|NCT00721279|363556|P2|Overall Study|Tolerability insufficient|2
105740|NCT00721279|363557|P1|Overall Study|Tolerability insufficient|5
105741|NCT00721279|363556|P2|Overall Study|Lack of Efficacy|3
105742|NCT00721279|363557|P1|Overall Study|Lack of Efficacy|6
105743|NCT00721227|363585|P2|Overall Study|Noncompliance with scheduled visits.|0
105744|NCT00721227|363586|P1|Overall Study|Noncompliance with scheduled visits.|1
105745|NCT00721227|363585|P2|Overall Study|Lost to Follow-up|0
105746|NCT00721227|363586|P1|Overall Study|Lost to Follow-up|3
105747|NCT00721214|363596|P1|Overall Study|Death|3
105748|NCT00721214|363596|P1|Overall Study|Chose another center for transplant|1
105749|NCT00721149|363646|P1|Overall Study|Physician Decision|1
105750|NCT00721123|363655|P1|Overall Study|Withdrawal by Subject|5
105751|NCT00721123|363655|P1|Overall Study|Failure to Return|9
105752|NCT00721123|363655|P1|Overall Study|Refused Treatment|41
105753|NCT00721123|363655|P1|Overall Study|Protocol Violation|1
105754|NCT00721123|363655|P1|Overall Study|Insufficient Therapeutic Response|21
105755|NCT00721123|363655|P1|Overall Study|Death|10
105756|NCT00721123|363655|P1|Overall Study|Adverse Event|96
105757|NCT00720941|363731|P2|Overall Study|Ongoing|23
105758|NCT00720941|363732|P1|Overall Study|Ongoing|34
105759|NCT00720941|363731|P2|Overall Study|Withdrawal by Subject|35
105760|NCT00720941|363732|P1|Overall Study|Withdrawal by Subject|27
105761|NCT00720941|363731|P2|Overall Study|Physician Decision|5
105762|NCT00720941|363732|P1|Overall Study|Physician Decision|1
105763|NCT00720941|363731|P2|Overall Study|Lost to Follow-up|15
105764|NCT00720941|363732|P1|Overall Study|Lost to Follow-up|17
105765|NCT00720941|363731|P2|Overall Study|Protocol Violation|2
105766|NCT00720941|363732|P1|Overall Study|Protocol Violation|0
105767|NCT00720941|363731|P2|Overall Study|Death|335
105768|NCT00720941|363732|P1|Overall Study|Death|334
105769|NCT00720798|363772|P1|Overall Study|Reason not Specified|83
105770|NCT00720798|363772|P1|Overall Study|Failure to Return|46
105771|NCT00720798|363772|P1|Overall Study|Refused Treatment|151
105772|NCT00720798|363772|P1|Overall Study|Protocol Violation|4
105773|NCT00720798|363772|P1|Overall Study|Insufficient Therapeutic Response|129
105774|NCT00720798|363772|P1|Overall Study|Death|39
105775|NCT00720798|363772|P1|Overall Study|Adverse Event|304
105776|NCT00720759|363795|P4|Overall Study|Lost to Follow-up|0
105777|NCT00720759|363796|P3|Overall Study|Lost to Follow-up|1
105778|NCT00720759|363797|P2|Overall Study|Lost to Follow-up|1
105779|NCT00720759|363798|P1|Overall Study|Lost to Follow-up|0
105780|NCT00720499|363818|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
105781|NCT00720499|363819|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
105782|NCT00720499|363818|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
105783|NCT00720499|363819|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
105784|NCT00720499|363818|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
105785|NCT00720499|363819|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
105786|NCT00720434|363912|P4|Open-Label Period (Week 5-72)|Unspecified|2
105787|NCT00720434|363913|P3|Open-Label Period (Week 5-72)|Unspecified|3
105788|NCT00720434|363914|P2|Open-Label Period (Week 5-72)|Unspecified|3
105789|NCT00720434|363915|P1|Open-Label Period (Week 5-72)|Unspecified|4
105790|NCT00720434|363912|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
105791|NCT00720434|363913|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
105792|NCT00720434|363914|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
105793|NCT00720434|363915|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
105794|NCT00720434|363912|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
105795|NCT00720434|363913|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
105796|NCT00720434|363914|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
105797|NCT00720434|363915|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
105798|NCT00720434|363912|P4|Open-Label Period (Week 5-72)|Adverse Event|2
105799|NCT00720434|363913|P3|Open-Label Period (Week 5-72)|Adverse Event|0
105800|NCT00720434|363914|P2|Open-Label Period (Week 5-72)|Adverse Event|0
105801|NCT00720434|363915|P1|Open-Label Period (Week 5-72)|Adverse Event|0
105802|NCT00720434|363912|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
105803|NCT00720434|363913|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
105804|NCT00720434|363914|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
105805|NCT00720434|363915|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
105806|NCT00720382|363939|P2|Overall Study|administrative|5
105807|NCT00720382|363940|P1|Overall Study|administrative|14
105808|NCT00720382|363939|P2|Overall Study|Lost to Follow-up|14
105809|NCT00720382|363940|P1|Overall Study|Lost to Follow-up|28
105810|NCT00720382|363939|P2|Overall Study|Withdrawal by Subject|11
105811|NCT00720382|363940|P1|Overall Study|Withdrawal by Subject|47
105812|NCT00720382|363939|P2|Overall Study|Non-Compliance|5
105813|NCT00720382|363940|P1|Overall Study|Non-Compliance|15
105814|NCT00720382|363939|P2|Overall Study|Lack of Efficacy|7
105815|NCT00720382|363940|P1|Overall Study|Lack of Efficacy|18
105816|NCT00720382|363939|P2|Overall Study|Adverse Event|17
105817|NCT00720382|363940|P1|Overall Study|Adverse Event|54
105818|NCT00720343|363959|P1|Overall Study|No data|3
105819|NCT00720343|363959|P1|Overall Study|Physician Decision|3
105820|NCT00720278|363968|P3|Overall Study|eligibility criteria violation|1
105821|NCT00720278|363969|P2|Overall Study|eligibility criteria violation|0
105822|NCT00720278|363970|P1|Overall Study|eligibility criteria violation|1
105823|NCT00720278|363968|P3|Overall Study|Non-compliance|0
105824|NCT00720278|363969|P2|Overall Study|Non-compliance|0
105825|NCT00720278|363970|P1|Overall Study|Non-compliance|1
105826|NCT00720278|363968|P3|Overall Study|Lost to Follow-up|1
105827|NCT00720278|363969|P2|Overall Study|Lost to Follow-up|0
105828|NCT00720278|363970|P1|Overall Study|Lost to Follow-up|0
105829|NCT00720278|363968|P3|Overall Study|Withdrawal by Subject|0
105830|NCT00720278|363969|P2|Overall Study|Withdrawal by Subject|1
105831|NCT00720278|363970|P1|Overall Study|Withdrawal by Subject|0
105832|NCT00720278|363968|P3|Overall Study|Adverse Event|4
105833|NCT00720278|363969|P2|Overall Study|Adverse Event|3
105834|NCT00720278|363970|P1|Overall Study|Adverse Event|5
105835|NCT00720122|363990|P1|Overall Study|Withdrawal by Subject|7
105836|NCT00720122|363990|P1|Overall Study|Physician Decision|1
105837|NCT00720122|363990|P1|Overall Study|Lost to Follow-up|1
105838|NCT00720109|363994|P3|Risk Stratification Period|Development of second malignant neoplasm|0
105839|NCT00720109|363995|P2|Risk Stratification Period|Development of second malignant neoplasm|1
105840|NCT00720109|363996|P1|Risk Stratification Period|Development of second malignant neoplasm|0
105841|NCT00720109|363994|P3|Risk Stratification Period|Disease progression or relapse|0
105842|NCT00720109|363995|P2|Risk Stratification Period|Disease progression or relapse|2
105843|NCT00720109|363996|P1|Risk Stratification Period|Disease progression or relapse|0
105844|NCT00720109|363994|P3|Risk Stratification Period|Bone marrow transplant|7
105845|NCT00720109|363995|P2|Risk Stratification Period|Bone marrow transplant|9
105846|NCT00720109|363996|P1|Risk Stratification Period|Bone marrow transplant|0
105847|NCT00720109|363994|P3|Risk Stratification Period|Physician Decision|1
105848|NCT00720109|363995|P2|Risk Stratification Period|Physician Decision|2
105849|NCT00720109|363996|P1|Risk Stratification Period|Physician Decision|0
105850|NCT00720109|363994|P3|Risk Stratification Period|Adverse Event|0
105851|NCT00720109|363995|P2|Risk Stratification Period|Adverse Event|1
105852|NCT00720109|363996|P1|Risk Stratification Period|Adverse Event|0
105853|NCT00720109|363994|P3|Induction Period|Physician Decision|0
105854|NCT00720109|363995|P2|Induction Period|Physician Decision|0
105855|NCT00720109|363996|P1|Induction Period|Physician Decision|1
105856|NCT00720109|363994|P3|Induction Period|Bone Marrow Transplant|0
105857|NCT00720109|363995|P2|Induction Period|Bone Marrow Transplant|0
105858|NCT00720109|363996|P1|Induction Period|Bone Marrow Transplant|2
105859|NCT00720109|363994|P3|Induction Period|Did not meet eligibility criteria|0
105860|NCT00720109|363995|P2|Induction Period|Did not meet eligibility criteria|0
105861|NCT00720109|363996|P1|Induction Period|Did not meet eligibility criteria|3
105862|NCT00720096|364016|P2|Overall Study|Withdrawal by Subject|2
105863|NCT00720096|364017|P1|Overall Study|Withdrawal by Subject|0
105864|NCT00720083|364027|P2|Overall Study|Ineligible|2
105865|NCT00720083|364028|P1|Overall Study|Ineligible|1
105866|NCT00720057|364036|P2|Overall Study|Withdrawal by Subject|1
105867|NCT00720057|364037|P1|Overall Study|Withdrawal by Subject|0
105868|NCT00720057|364036|P2|Overall Study|Protocol Violation|0
105869|NCT00720057|364037|P1|Overall Study|Protocol Violation|1
105870|NCT00720057|364036|P2|Overall Study|Lost to Follow-up|2
105871|NCT00720057|364037|P1|Overall Study|Lost to Follow-up|0
105872|NCT00719953|364053|P1|Overall Study|Adverse Event|4
105873|NCT00719901|364066|P1|Overall Study|Availability of Study Drug|1
105874|NCT00719901|364066|P1|Overall Study|Disease Progression|3
105875|NCT00719901|364066|P1|Overall Study|Alternate Treatment|1
105876|NCT00719901|364066|P1|Overall Study|Withdrawal by Subject|1
105877|NCT00719901|364066|P1|Overall Study|Adverse Event|5
105878|NCT00719862|364078|P2|Overall Study|Other|3
105879|NCT00719862|364079|P1|Overall Study|Other|2
105880|NCT00719862|364078|P2|Overall Study|Lost to Follow-up|1
105881|NCT00719862|364079|P1|Overall Study|Lost to Follow-up|0
105882|NCT00719862|364078|P2|Overall Study|Withdrawal by Subject|0
105883|NCT00719862|364079|P1|Overall Study|Withdrawal by Subject|1
105884|NCT00719862|364078|P2|Overall Study|Non-Compliance|0
105885|NCT00719862|364079|P1|Overall Study|Non-Compliance|1
105886|NCT00719862|364078|P2|Overall Study|Lack of Efficacy|0
105887|NCT00719862|364079|P1|Overall Study|Lack of Efficacy|3
105888|NCT00719862|364078|P2|Overall Study|Adverse Event|2
105889|NCT00719862|364079|P1|Overall Study|Adverse Event|1
105890|NCT00719810|364098|P3|Overall Study|Withdrawal by Subject|2
105891|NCT00719810|364099|P2|Overall Study|Withdrawal by Subject|1
105892|NCT00719810|364100|P1|Overall Study|Withdrawal by Subject|1
105893|NCT00719810|364098|P3|Overall Study|Physician Decision|0
105894|NCT00719810|364099|P2|Overall Study|Physician Decision|1
105895|NCT00719810|364100|P1|Overall Study|Physician Decision|0
105896|NCT00719810|364098|P3|Overall Study|Lost to Follow-up|3
105897|NCT00719810|364099|P2|Overall Study|Lost to Follow-up|0
105898|NCT00719810|364100|P1|Overall Study|Lost to Follow-up|2
105899|NCT00719810|364098|P3|Overall Study|Adverse Event|3
105900|NCT00719810|364099|P2|Overall Study|Adverse Event|2
105901|NCT00719810|364100|P1|Overall Study|Adverse Event|0
105902|NCT00719732|364111|P1|Overall Study|Illness not associated with device|1
105903|NCT00719732|364111|P1|Overall Study|Unilateral (not bilateral) implantation|1
105904|NCT00719732|364111|P1|Overall Study|Lost to Follow-up|20
105905|NCT00719706|364117|P2|Overall Study|Protocol Violation|0
105906|NCT00719706|364118|P1|Overall Study|Protocol Violation|3
105907|NCT00719706|364117|P2|Overall Study|Withdrawal by Subject|2
105908|NCT00719706|364118|P1|Overall Study|Withdrawal by Subject|1
105909|NCT00719706|364117|P2|Overall Study|Adverse Event|4
105910|NCT00719706|364118|P1|Overall Study|Adverse Event|5
105911|NCT00719680|364132|P1|Overall Study|Withdrawal by Subject|3
105912|NCT00719680|364132|P1|Overall Study|Lost to Follow-up|1
105913|NCT00719680|364132|P1|Overall Study|Adverse Event|1
105914|NCT00719563|364167|P2|Overall Study|Lost to Follow-up|3
105915|NCT00719563|364168|P1|Overall Study|Lost to Follow-up|5
105916|NCT00719563|364167|P2|Overall Study|Noncompliant|1
105917|NCT00719563|364168|P1|Overall Study|Noncompliant|1
105918|NCT00719563|364167|P2|Overall Study|Unknown reasons|6
105919|NCT00719563|364168|P1|Overall Study|Unknown reasons|4
105920|NCT00719563|364167|P2|Overall Study|Personal reasons|7
105921|NCT00719563|364168|P1|Overall Study|Personal reasons|6
105922|NCT00719563|364167|P2|Overall Study|Lack of Efficacy|7
105923|NCT00719563|364168|P1|Overall Study|Lack of Efficacy|3
105924|NCT00719563|364167|P2|Overall Study|Medical condition changed|5
105925|NCT00719563|364168|P1|Overall Study|Medical condition changed|3
105926|NCT00719563|364167|P2|Overall Study|Adverse Event|13
105927|NCT00719563|364168|P1|Overall Study|Adverse Event|16
105928|NCT00719472|364198|P1|Received Cycle 2 Treatment|Various Reasons|25
105929|NCT00719472|364198|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
105930|NCT00719472|364198|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
105931|NCT00719472|364198|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
105932|NCT00719472|364198|P1|Received Cycle 2 Treatment|Disease progression|3
105933|NCT00719472|364198|P1|Received Cycle 2 Treatment|Death|6
105934|NCT00719472|364198|P1|Received Cycle 2 Treatment|Adverse Event|12
105935|NCT00719472|364198|P1|Received Cycle 1 Treatment|Various Reasons|13
105936|NCT00719472|364198|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
105937|NCT00719472|364198|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
105938|NCT00719472|364198|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
105939|NCT00719472|364198|P1|Received Cycle 1 Treatment|Death|5
105940|NCT00719472|364198|P1|Received Cycle 1 Treatment|Adverse Event|8
105941|NCT00719472|364198|P1|Enrolled in Study|Various Reasons|17
105942|NCT00719472|364198|P1|Enrolled in Study|Subject decision to withdraw|8
105943|NCT00719472|364198|P1|Enrolled in Study|Physician decision to withdraw patient|1
105944|NCT00719355|364209|P2|Overall Study|Moved|1
105945|NCT00719355|364210|P1|Overall Study|Moved|0
105946|NCT00719355|364209|P2|Overall Study|Compliance|6
105947|NCT00719355|364210|P1|Overall Study|Compliance|4
105948|NCT00719355|364209|P2|Overall Study|Medical|5
105949|NCT00719355|364210|P1|Overall Study|Medical|14
105950|NCT00719355|364209|P2|Overall Study|Death|1
105951|NCT00719355|364210|P1|Overall Study|Death|0
105952|NCT00719264|364239|P2|Overall Study|Disease Progression|107
105953|NCT00719264|364240|P1|Overall Study|Disease Progression|104
105954|NCT00719264|364239|P2|Overall Study|New Cancer Therapy|2
105955|NCT00719264|364240|P1|Overall Study|New Cancer Therapy|4
105956|NCT00719264|364239|P2|Overall Study|Protocol Deviation|3
105957|NCT00719264|364240|P1|Overall Study|Protocol Deviation|1
105958|NCT00719264|364239|P2|Overall Study|Withdrawal by Subject|7
105959|NCT00719264|364240|P1|Overall Study|Withdrawal by Subject|12
105960|NCT00719264|364239|P2|Overall Study|Lost to Follow-up|1
105961|NCT00719264|364240|P1|Overall Study|Lost to Follow-up|1
105962|NCT00719264|364239|P2|Overall Study|Administrative Problems|4
105963|NCT00719264|364240|P1|Overall Study|Administrative Problems|6
105964|NCT00719264|364239|P2|Overall Study|Death|10
105965|NCT00719264|364240|P1|Overall Study|Death|13
105966|NCT00719264|364239|P2|Overall Study|Adverse Event|49
105967|NCT00719264|364240|P1|Overall Study|Adverse Event|41
105968|NCT00719212|364259|P1|Overall Study|Withdrawal by Subject|1
105969|NCT00719212|364259|P1|Overall Study|Lost to Follow-up|2
105970|NCT00719212|364259|P1|Overall Study|Death|41
105971|NCT00719043|364305|P7|Overall Study|Withdrawal by Subject|14
105972|NCT00719043|364306|P6|Overall Study|Withdrawal by Subject|18
105973|NCT00719043|364307|P5|Overall Study|Withdrawal by Subject|16
105974|NCT00719043|364308|P4|Overall Study|Withdrawal by Subject|10
105975|NCT00719043|364309|P3|Overall Study|Withdrawal by Subject|9
105976|NCT00719043|364310|P2|Overall Study|Withdrawal by Subject|14
105977|NCT00719043|364311|P1|Overall Study|Withdrawal by Subject|12
105978|NCT00719043|364305|P7|Overall Study|Unspecified|1
105979|NCT00719043|364306|P6|Overall Study|Unspecified|2
105980|NCT00719043|364307|P5|Overall Study|Unspecified|0
105981|NCT00719043|364308|P4|Overall Study|Unspecified|2
105982|NCT00719043|364309|P3|Overall Study|Unspecified|1
105983|NCT00719043|364310|P2|Overall Study|Unspecified|0
105984|NCT00719043|364311|P1|Overall Study|Unspecified|1
105985|NCT00719043|364305|P7|Overall Study|Protocol Violation|0
105986|NCT00719043|364306|P6|Overall Study|Protocol Violation|1
105987|NCT00719043|364307|P5|Overall Study|Protocol Violation|0
105988|NCT00719043|364308|P4|Overall Study|Protocol Violation|0
105989|NCT00719043|364309|P3|Overall Study|Protocol Violation|0
105990|NCT00719043|364310|P2|Overall Study|Protocol Violation|0
105991|NCT00719043|364311|P1|Overall Study|Protocol Violation|0
105992|NCT00719043|364305|P7|Overall Study|Lost to Follow-up|9
105993|NCT00719043|364306|P6|Overall Study|Lost to Follow-up|9
105994|NCT00719043|364307|P5|Overall Study|Lost to Follow-up|10
105995|NCT00719043|364308|P4|Overall Study|Lost to Follow-up|9
105996|NCT00719043|364309|P3|Overall Study|Lost to Follow-up|8
105997|NCT00719043|364310|P2|Overall Study|Lost to Follow-up|10
105998|NCT00719043|364311|P1|Overall Study|Lost to Follow-up|14
105999|NCT00719043|364305|P7|Overall Study|Adverse Event|4
106000|NCT00719043|364306|P6|Overall Study|Adverse Event|4
106001|NCT00719043|364307|P5|Overall Study|Adverse Event|1
106002|NCT00719043|364308|P4|Overall Study|Adverse Event|2
106003|NCT00719043|364309|P3|Overall Study|Adverse Event|2
106004|NCT00719043|364310|P2|Overall Study|Adverse Event|1
106005|NCT00719043|364311|P1|Overall Study|Adverse Event|5
106006|NCT00718887|364435|P2|Overall Study|Not identified|7
106007|NCT00718887|364436|P1|Overall Study|Not identified|2
106008|NCT00718887|364435|P2|Overall Study|Withdrawal by Subject|2
106009|NCT00718887|364436|P1|Overall Study|Withdrawal by Subject|3
106010|NCT00718861|364460|P2|Overall Study|Death|5
106011|NCT00718861|364461|P1|Overall Study|Death|1
106012|NCT00718861|364460|P2|Overall Study|Administrative Problems|1
106013|NCT00718861|364461|P1|Overall Study|Administrative Problems|1
106014|NCT00718861|364460|P2|Overall Study|Lost to Follow-up|1
106015|NCT00718861|364461|P1|Overall Study|Lost to Follow-up|2
106016|NCT00718861|364460|P2|Overall Study|Adverse Event|1
106017|NCT00718861|364461|P1|Overall Study|Adverse Event|2
106018|NCT00718861|364460|P2|Overall Study|Withdrawal by Subject|10
106019|NCT00718861|364461|P1|Overall Study|Withdrawal by Subject|15
106020|NCT00718809|364489|P2|Overall Study|Noncompliance|0
106021|NCT00718809|364490|P1|Overall Study|Noncompliance|1
106022|NCT00718809|364489|P2|Overall Study|Lost to Follow-up|0
106023|NCT00718809|364490|P1|Overall Study|Lost to Follow-up|1
106024|NCT00718809|364489|P2|Overall Study|Withdrawal by Subject|1
106025|NCT00718809|364490|P1|Overall Study|Withdrawal by Subject|0
106026|NCT00718809|364489|P2|Overall Study|Adverse Event|1
106027|NCT00718809|364490|P1|Overall Study|Adverse Event|1
106028|NCT00718809|364489|P2|Overall Study|Disease progression|7
106029|NCT00718809|364490|P1|Overall Study|Disease progression|9
106030|NCT00718770|364504|P1|Overall Study|Adverse Event|1
106031|NCT00718770|364504|P1|Overall Study|Lack of Efficacy|1
106032|NCT00718770|364504|P1|Overall Study|Adverse Event|1
106033|NCT00718770|364504|P1|Overall Study|Lack of Efficacy|1
106034|NCT00718770|364504|P1|Overall Study|Adverse Event|1
106035|NCT00718770|364504|P1|Overall Study|Lack of Efficacy|1
106036|NCT00718770|364504|P1|Overall Study|Lack of Efficacy|1
106037|NCT00718770|364504|P1|Overall Study|Adverse Event|1
106038|NCT00718640|364508|P1|Overall Study|Unresolved toxicity after 2 weeks|2
106039|NCT00718640|364508|P1|Overall Study|Death|1
106040|NCT00718640|364508|P1|Overall Study|Adverse Event|4
106041|NCT00718523|364522|P2|Overall Study|Death|17
106042|NCT00718523|364523|P1|Overall Study|Death|13
106043|NCT00718523|364522|P2|Overall Study|Withdrawal by Subject|7
106044|NCT00718523|364523|P1|Overall Study|Withdrawal by Subject|5
106045|NCT00718315|364536|P3|Overall Study|Use of ATB and Corticoids|2
106046|NCT00718315|364537|P2|Overall Study|Use of ATB and Corticoids|1
106047|NCT00718315|364538|P1|Overall Study|Use of ATB and Corticoids|0
106048|NCT00718315|364536|P3|Overall Study|Other|1
106049|NCT00718315|364537|P2|Overall Study|Other|0
106050|NCT00718315|364538|P1|Overall Study|Other|0
106051|NCT00718315|364536|P3|Overall Study|Disease progression|1
106052|NCT00718315|364537|P2|Overall Study|Disease progression|1
106053|NCT00718315|364538|P1|Overall Study|Disease progression|0
106054|NCT00718315|364536|P3|Overall Study|Use of Minocyclin|1
106055|NCT00718315|364537|P2|Overall Study|Use of Minocyclin|1
106056|NCT00718315|364538|P1|Overall Study|Use of Minocyclin|1
106057|NCT00718315|364536|P3|Overall Study|Erlotinib dose decreased|1
106058|NCT00718315|364537|P2|Overall Study|Erlotinib dose decreased|3
106059|NCT00718315|364538|P1|Overall Study|Erlotinib dose decreased|4
106060|NCT00718315|364536|P3|Overall Study|Protocol Violation|3
106061|NCT00718315|364537|P2|Overall Study|Protocol Violation|5
106062|NCT00718315|364538|P1|Overall Study|Protocol Violation|5
106063|NCT00718315|364536|P3|Overall Study|Lost to Follow-up|4
106064|NCT00718315|364537|P2|Overall Study|Lost to Follow-up|3
106065|NCT00718315|364538|P1|Overall Study|Lost to Follow-up|2
106066|NCT00718315|364536|P3|Overall Study|Death|5
106067|NCT00718315|364537|P2|Overall Study|Death|6
106068|NCT00718315|364538|P1|Overall Study|Death|6
106069|NCT00718315|364536|P3|Overall Study|Adverse Event|3
106070|NCT00718315|364537|P2|Overall Study|Adverse Event|2
106071|NCT00718315|364538|P1|Overall Study|Adverse Event|1
106072|NCT00718237|364572|P2|Overall Study|Withdrawal by Subject|10
106073|NCT00718237|364573|P1|Overall Study|Withdrawal by Subject|9
106074|NCT00718237|364572|P2|Overall Study|Physician Decision|0
106075|NCT00718237|364573|P1|Overall Study|Physician Decision|1
106076|NCT00718237|364572|P2|Overall Study|Lost to Follow-up|2
106077|NCT00718237|364573|P1|Overall Study|Lost to Follow-up|2
106078|NCT00718237|364572|P2|Overall Study|Adverse Event|3
106079|NCT00718237|364573|P1|Overall Study|Adverse Event|1
106080|NCT00718081|364607|P3|Overall Study|Lack of Efficacy|21
106081|NCT00718081|364608|P2|Overall Study|Lack of Efficacy|3
106082|NCT00718081|364609|P1|Overall Study|Lack of Efficacy|7
106083|NCT00718081|364607|P3|Overall Study|Adverse Event|0
106084|NCT00718081|364608|P2|Overall Study|Adverse Event|1
106085|NCT00718081|364609|P1|Overall Study|Adverse Event|0
106086|NCT00718042|364626|P6|Donor Follow-up|Lost to Follow-up|0
106087|NCT00718042|364627|P5|Donor Follow-up|Lost to Follow-up|19
106088|NCT00718042|364628|P4|Donor Follow-up|Lost to Follow-up|0
106089|NCT00718042|364629|P3|Donor Follow-up|Lost to Follow-up|0
106090|NCT00718042|364630|P2|Donor Follow-up|Lost to Follow-up|0
106091|NCT00718042|364631|P1|Donor Follow-up|Lost to Follow-up|13
106092|NCT00718042|364626|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
106093|NCT00718042|364627|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
106094|NCT00718042|364628|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
106095|NCT00718042|364629|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
106096|NCT00718042|364630|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
106097|NCT00718042|364631|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
106098|NCT00718042|364626|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
106099|NCT00718042|364627|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
106100|NCT00718042|364628|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
106101|NCT00718042|364629|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
106102|NCT00718042|364630|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
106103|NCT00718042|364631|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
106104|NCT00718042|364626|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
106105|NCT00718042|364627|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
106106|NCT00718042|364628|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
106107|NCT00718042|364629|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
106108|NCT00718042|364630|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
106109|NCT00718042|364631|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
106110|NCT00718042|364626|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
106111|NCT00718042|364627|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
106112|NCT00718042|364628|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
106113|NCT00718042|364629|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
106114|NCT00718042|364630|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
106115|NCT00718042|364631|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
106116|NCT00717886|364671|P1|Overall Study|Treatment Failure|1
106117|NCT00717886|364671|P1|Overall Study|Withdrawal by Subject|3
106118|NCT00717860|364686|P2|Overall Study|Withdrew consent|3
106119|NCT00717860|364687|P1|Overall Study|Withdrew consent|7
106120|NCT00717860|364686|P2|Overall Study|Discontinued for other reason|1
106121|NCT00717860|364687|P1|Overall Study|Discontinued for other reason|6
106122|NCT00717860|364686|P2|Overall Study|Lack of Efficacy|13
106123|NCT00717860|364687|P1|Overall Study|Lack of Efficacy|7
106124|NCT00717860|364686|P2|Overall Study|Laboratory adverse experience|2
106125|NCT00717860|364687|P1|Overall Study|Laboratory adverse experience|2
106126|NCT00717860|364686|P2|Overall Study|Clinical adverse experience|9
106127|NCT00717860|364687|P1|Overall Study|Clinical adverse experience|5
106128|NCT00717756|364697|P1|Overall Study|Withdrawal by Subject|1
106129|NCT00717522|364701|P1|Overall Study|Death|1
106130|NCT00717522|364701|P1|Overall Study|Adverse Event|1
106131|NCT00717522|364701|P1|Overall Study|Disease Progression|5
106132|NCT00717314|364737|P2|Overall Study|Withdrawal by Subject|3
106133|NCT00717314|364738|P1|Overall Study|Withdrawal by Subject|1
106134|NCT00717314|364737|P2|Overall Study|Lost to Follow-up|5
106135|NCT00717314|364738|P1|Overall Study|Lost to Follow-up|1
106136|NCT00717314|364737|P2|Overall Study|Protocol Violation|0
106137|NCT00717314|364738|P1|Overall Study|Protocol Violation|1
106138|NCT00717314|364737|P2|Overall Study|Adverse Event|2
106139|NCT00717314|364738|P1|Overall Study|Adverse Event|3
106140|NCT00717275|364775|P1|Overall Study|Premature study termination.|3
106141|NCT00717249|364781|P2|Overall Study|Headaches|0
106142|NCT00717249|364782|P1|Overall Study|Headaches|1
106143|NCT00717249|364781|P2|Overall Study|Subject relocated|0
106144|NCT00717249|364782|P1|Overall Study|Subject relocated|1
106145|NCT00717249|364781|P2|Overall Study|Diagnosed with Multiple Scletosis|0
106146|NCT00717249|364782|P1|Overall Study|Diagnosed with Multiple Scletosis|1
106147|NCT00717249|364781|P2|Overall Study|Diagnosed with Diabetes|0
106148|NCT00717249|364782|P1|Overall Study|Diagnosed with Diabetes|1
106149|NCT00717249|364781|P2|Overall Study|Gastric Surgery|1
106150|NCT00717249|364782|P1|Overall Study|Gastric Surgery|0
106151|NCT00717249|364781|P2|Overall Study|Unsatisfactory Physiological Response|1
106315|NCT00716417|365195|P9|Overall Study|Withdrawal by Subject|0
106152|NCT00717249|364782|P1|Overall Study|Unsatisfactory Physiological Response|0
106153|NCT00717249|364781|P2|Overall Study|Subject became Ineligible|1
106154|NCT00717249|364782|P1|Overall Study|Subject became Ineligible|1
106155|NCT00717249|364781|P2|Overall Study|Protocol Violation|2
106156|NCT00717249|364782|P1|Overall Study|Protocol Violation|0
106157|NCT00717249|364781|P2|Overall Study|Pregnancy|3
106158|NCT00717249|364782|P1|Overall Study|Pregnancy|6
106159|NCT00717249|364781|P2|Overall Study|Withdrawal by Subject|2
106160|NCT00717249|364782|P1|Overall Study|Withdrawal by Subject|1
106161|NCT00717249|364781|P2|Overall Study|Lost to Follow-up|0
106162|NCT00717249|364782|P1|Overall Study|Lost to Follow-up|2
106163|NCT00717249|364781|P2|Overall Study|Adverse Event|2
106164|NCT00717249|364782|P1|Overall Study|Adverse Event|4
106165|NCT00717249|364781|P2|Overall Study|Unsatisfactory visual Response|2
106166|NCT00717249|364782|P1|Overall Study|Unsatisfactory visual Response|0
106167|NCT00717249|364781|P2|Overall Study|Lens Discomfort|1
106168|NCT00717249|364782|P1|Overall Study|Lens Discomfort|4
106169|NCT00717236|364796|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
106170|NCT00717236|364797|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
106171|NCT00717236|364796|P2|Open-Label Period|Other: Completion Accidently Performed|0
106172|NCT00717236|364797|P1|Open-Label Period|Other: Completion Accidently Performed|1
106173|NCT00717236|364796|P2|Open-Label Period|Other: Administration of Golimumab|0
106174|NCT00717236|364797|P1|Open-Label Period|Other: Administration of Golimumab|1
106175|NCT00717236|364796|P2|Open-Label Period|Other: Cataract Surgery|0
106176|NCT00717236|364797|P1|Open-Label Period|Other: Cataract Surgery|1
106177|NCT00717236|364796|P2|Open-Label Period|Other: Sponsor Request|0
106178|NCT00717236|364797|P1|Open-Label Period|Other: Sponsor Request|3
106179|NCT00717236|364796|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
106180|NCT00717236|364797|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
106181|NCT00717236|364796|P2|Open-Label Period|Other: Investigator Decision|0
106182|NCT00717236|364797|P1|Open-Label Period|Other: Investigator Decision|1
106183|NCT00717236|364796|P2|Open-Label Period|Other: Moved|0
106184|NCT00717236|364797|P1|Open-Label Period|Other: Moved|1
106185|NCT00717236|364796|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
106186|NCT00717236|364797|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
106187|NCT00717236|364796|P2|Open-Label Period|Other: Lack of Compliance|1
106188|NCT00717236|364797|P1|Open-Label Period|Other: Lack of Compliance|1
106189|NCT00717236|364796|P2|Open-Label Period|Other: Peripheral Neuropathy|1
106190|NCT00717236|364797|P1|Open-Label Period|Other: Peripheral Neuropathy|0
106191|NCT00717236|364796|P2|Open-Label Period|Loss of Efficacy|1
106192|NCT00717236|364797|P1|Open-Label Period|Loss of Efficacy|6
106193|NCT00717236|364796|P2|Open-Label Period|Withdrawal by Subject|2
106194|NCT00717236|364797|P1|Open-Label Period|Withdrawal by Subject|20
106195|NCT00717236|364796|P2|Open-Label Period|Lost to Follow-up|4
106196|NCT00717236|364797|P1|Open-Label Period|Lost to Follow-up|28
106197|NCT00717236|364796|P2|Open-Label Period|Lack of Efficacy|8
106198|NCT00717236|364797|P1|Open-Label Period|Lack of Efficacy|30
106199|NCT00717236|364796|P2|Open-Label Period|Adverse Event|4
106200|NCT00717236|364797|P1|Open-Label Period|Adverse Event|29
106201|NCT00717236|364796|P2|Double-Blind Period|Other: Investigator Decision|1
106202|NCT00717236|364797|P1|Double-Blind Period|Other: Investigator Decision|0
106203|NCT00717236|364796|P2|Double-Blind Period|Other: Transportation problems|1
106204|NCT00717236|364797|P1|Double-Blind Period|Other: Transportation problems|0
106205|NCT00717236|364796|P2|Double-Blind Period|Other: Prohibited medication taken|2
106206|NCT00717236|364797|P1|Double-Blind Period|Other: Prohibited medication taken|2
106207|NCT00717236|364796|P2|Double-Blind Period|Other: Stopped taking DMARD|0
106208|NCT00717236|364797|P1|Double-Blind Period|Other: Stopped taking DMARD|1
106209|NCT00717236|364796|P2|Double-Blind Period|Other: Subject moved|1
106210|NCT00717236|364797|P1|Double-Blind Period|Other: Subject moved|1
106211|NCT00717236|364796|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
106212|NCT00717236|364797|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
106213|NCT00717236|364796|P2|Double-Blind Period|Other: Inappropriate randomization|0
106214|NCT00717236|364797|P1|Double-Blind Period|Other: Inappropriate randomization|1
106215|NCT00717236|364796|P2|Double-Blind Period|Other: Sponsor request|0
106216|NCT00717236|364797|P1|Double-Blind Period|Other: Sponsor request|1
106217|NCT00717236|364796|P2|Double-Blind Period|Other: History of cancer|0
106218|NCT00717236|364797|P1|Double-Blind Period|Other: History of cancer|1
106219|NCT00717236|364796|P2|Double-Blind Period|Other: History of adenoid grown|0
106220|NCT00717236|364797|P1|Double-Blind Period|Other: History of adenoid grown|1
106221|NCT00717236|364796|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
106222|NCT00717236|364797|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
106223|NCT00717236|364796|P2|Double-Blind Period|Other: subject withdrew consent|1
106224|NCT00717236|364797|P1|Double-Blind Period|Other: subject withdrew consent|1
106225|NCT00717236|364796|P2|Double-Blind Period|Other: Screening failure|0
106226|NCT00717236|364797|P1|Double-Blind Period|Other: Screening failure|1
106227|NCT00717236|364796|P2|Double-Blind Period|Other: Site withdrew|0
106228|NCT00717236|364797|P1|Double-Blind Period|Other: Site withdrew|2
106229|NCT00717236|364796|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
106230|NCT00717236|364797|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
106231|NCT00717236|364796|P2|Double-Blind Period|Other: Protocol Violation|0
106232|NCT00717236|364797|P1|Double-Blind Period|Other: Protocol Violation|2
106233|NCT00717236|364796|P2|Double-Blind Period|Other: Pregnancy|0
106234|NCT00717236|364797|P1|Double-Blind Period|Other: Pregnancy|1
106235|NCT00717236|364796|P2|Double-Blind Period|Other: Death|0
106236|NCT00717236|364797|P1|Double-Blind Period|Other: Death|1
106237|NCT00717236|364796|P2|Double-Blind Period|Loss of efficacy|0
106238|NCT00717236|364797|P1|Double-Blind Period|Loss of efficacy|3
106239|NCT00717236|364796|P2|Double-Blind Period|Withdrawal by Subject|2
106240|NCT00717236|364797|P1|Double-Blind Period|Withdrawal by Subject|10
106241|NCT00717236|364796|P2|Double-Blind Period|Lost to Follow-up|5
106242|NCT00717236|364797|P1|Double-Blind Period|Lost to Follow-up|3
106243|NCT00717236|364796|P2|Double-Blind Period|Lack of Efficacy|6
106244|NCT00717236|364797|P1|Double-Blind Period|Lack of Efficacy|6
106245|NCT00717236|364796|P2|Double-Blind Period|Adverse Event|6
106246|NCT00717236|364797|P1|Double-Blind Period|Adverse Event|33
106247|NCT00717197|364866|P1|Overall Study|Physician Decision|1
106248|NCT00717197|364866|P1|Overall Study|Tumor Progression|1
106249|NCT00717197|364866|P1|Overall Study|Unable to purchase study drug|5
106250|NCT00717093|364872|P2|Overall Study|Randomized but not treated|0
106251|NCT00717093|364873|P1|Overall Study|Randomized but not treated|1
106252|NCT00717093|364872|P2|Overall Study|Unspecified|1
106253|NCT00717093|364873|P1|Overall Study|Unspecified|0
106254|NCT00717093|364872|P2|Overall Study|Withdrawal by Subject|19
106255|NCT00717093|364873|P1|Overall Study|Withdrawal by Subject|12
106256|NCT00717093|364872|P2|Overall Study|Lost to Follow-up|6
106257|NCT00717093|364873|P1|Overall Study|Lost to Follow-up|9
106258|NCT00717093|364872|P2|Overall Study|Lack of Efficacy|13
106259|NCT00717093|364873|P1|Overall Study|Lack of Efficacy|3
106260|NCT00717093|364872|P2|Overall Study|Adverse Event|9
106261|NCT00717093|364873|P1|Overall Study|Adverse Event|19
106262|NCT00717067|364890|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
106263|NCT00717067|364891|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
106264|NCT00717067|364892|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
106265|NCT00717067|364893|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
106266|NCT00717067|364894|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
106267|NCT00716859|365017|P2|Overall Study|Not treated|1
106268|NCT00716859|365018|P1|Overall Study|Not treated|1
106269|NCT00716859|365017|P2|Overall Study|Withdrawal by Subject|3
106270|NCT00716859|365018|P1|Overall Study|Withdrawal by Subject|1
106271|NCT00716859|365017|P2|Overall Study|Lack of Efficacy|0
106272|NCT00716859|365018|P1|Overall Study|Lack of Efficacy|3
106273|NCT00716859|365017|P2|Overall Study|Adverse Event|1
106274|NCT00716859|365018|P1|Overall Study|Adverse Event|4
106275|NCT00716625|365103|P1|Overall Study|Safety was not Assessable|1
106276|NCT00716482|365128|P1|Overall Study|inclusion/exclusion criteria not met|25
106277|NCT00716482|365128|P1|Overall Study|technical/machine error|28
106278|NCT00716482|365128|P1|Overall Study|no pathology obtained|10
106279|NCT00716482|365128|P1|Overall Study|Inadequate acquisition or analysis|50
106280|NCT00716482|365128|P1|Overall Study|Lost to Follow-up|6
106281|NCT00716456|365141|P3|Overall Study|Adverse Event|0
106282|NCT00716456|365142|P2|Overall Study|Adverse Event|2
106283|NCT00716456|365143|P1|Overall Study|Adverse Event|0
106284|NCT00716417|365194|P10|Overall Study|On patient request due to toxicities|0
106285|NCT00716417|365195|P9|Overall Study|On patient request due to toxicities|0
106286|NCT00716417|365196|P8|Overall Study|On patient request due to toxicities|1
106287|NCT00716417|365197|P7|Overall Study|On patient request due to toxicities|0
106288|NCT00716417|365198|P6|Overall Study|On patient request due to toxicities|0
106289|NCT00716417|365199|P5|Overall Study|On patient request due to toxicities|0
106290|NCT00716417|365200|P4|Overall Study|On patient request due to toxicities|0
106291|NCT00716417|365201|P3|Overall Study|On patient request due to toxicities|0
106292|NCT00716417|365202|P2|Overall Study|On patient request due to toxicities|0
106293|NCT00716417|365203|P1|Overall Study|On patient request due to toxicities|0
106294|NCT00716417|365194|P10|Overall Study|Dose limiting toxicity (DLT)|0
106295|NCT00716417|365195|P9|Overall Study|Dose limiting toxicity (DLT)|0
106296|NCT00716417|365196|P8|Overall Study|Dose limiting toxicity (DLT)|0
106297|NCT00716417|365197|P7|Overall Study|Dose limiting toxicity (DLT)|0
106298|NCT00716417|365198|P6|Overall Study|Dose limiting toxicity (DLT)|0
106299|NCT00716417|365199|P5|Overall Study|Dose limiting toxicity (DLT)|1
106300|NCT00716417|365200|P4|Overall Study|Dose limiting toxicity (DLT)|0
106301|NCT00716417|365201|P3|Overall Study|Dose limiting toxicity (DLT)|0
106302|NCT00716417|365202|P2|Overall Study|Dose limiting toxicity (DLT)|0
106303|NCT00716417|365203|P1|Overall Study|Dose limiting toxicity (DLT)|0
106304|NCT00716417|365194|P10|Overall Study|Progressive disease|0
106305|NCT00716417|365195|P9|Overall Study|Progressive disease|5
106306|NCT00716417|365196|P8|Overall Study|Progressive disease|1
106307|NCT00716417|365197|P7|Overall Study|Progressive disease|3
106308|NCT00716417|365198|P6|Overall Study|Progressive disease|3
106309|NCT00716417|365199|P5|Overall Study|Progressive disease|0
106310|NCT00716417|365200|P4|Overall Study|Progressive disease|8
106311|NCT00716417|365201|P3|Overall Study|Progressive disease|3
106312|NCT00716417|365202|P2|Overall Study|Progressive disease|5
106313|NCT00716417|365203|P1|Overall Study|Progressive disease|3
106314|NCT00716417|365194|P10|Overall Study|Withdrawal by Subject|0
106316|NCT00716417|365196|P8|Overall Study|Withdrawal by Subject|0
106317|NCT00716417|365197|P7|Overall Study|Withdrawal by Subject|1
106318|NCT00716417|365198|P6|Overall Study|Withdrawal by Subject|0
106319|NCT00716417|365199|P5|Overall Study|Withdrawal by Subject|0
106320|NCT00716417|365200|P4|Overall Study|Withdrawal by Subject|2
106321|NCT00716417|365201|P3|Overall Study|Withdrawal by Subject|0
106322|NCT00716417|365202|P2|Overall Study|Withdrawal by Subject|1
106323|NCT00716417|365203|P1|Overall Study|Withdrawal by Subject|0
106324|NCT00716417|365194|P10|Overall Study|Adverse Event|3
106325|NCT00716417|365195|P9|Overall Study|Adverse Event|0
106326|NCT00716417|365196|P8|Overall Study|Adverse Event|1
106327|NCT00716417|365197|P7|Overall Study|Adverse Event|3
106328|NCT00716417|365198|P6|Overall Study|Adverse Event|0
106329|NCT00716417|365199|P5|Overall Study|Adverse Event|0
106330|NCT00716417|365200|P4|Overall Study|Adverse Event|1
106331|NCT00716417|365201|P3|Overall Study|Adverse Event|2
106332|NCT00716417|365202|P2|Overall Study|Adverse Event|0
106333|NCT00716417|365203|P1|Overall Study|Adverse Event|0
106334|NCT00716092|365250|P3|Overall Study|Other incl. Lack of Efficacy|0
106335|NCT00716092|365251|P2|Overall Study|Other incl. Lack of Efficacy|1
106336|NCT00716092|365252|P1|Overall Study|Other incl. Lack of Efficacy|2
106337|NCT00715949|365305|P1|Overall Study|could not finish first test|4
106338|NCT00715910|365313|P6|Booster and ESFU Phase|Unspecified|0
106339|NCT00715910|365314|P5|Booster and ESFU Phase|Unspecified|1
106340|NCT00715910|365315|P4|Booster and ESFU Phase|Unspecified|5
106341|NCT00715910|365316|P3|Booster and ESFU Phase|Unspecified|0
106342|NCT00715910|365317|P2|Booster and ESFU Phase|Unspecified|0
106343|NCT00715910|365318|P1|Booster and ESFU Phase|Unspecified|0
106344|NCT00715910|365313|P6|Booster and ESFU Phase|Lost to Follow-up|13
106345|NCT00715910|365314|P5|Booster and ESFU Phase|Lost to Follow-up|1
106346|NCT00715910|365315|P4|Booster and ESFU Phase|Lost to Follow-up|6
106347|NCT00715910|365316|P3|Booster and ESFU Phase|Lost to Follow-up|0
106348|NCT00715910|365317|P2|Booster and ESFU Phase|Lost to Follow-up|0
106349|NCT00715910|365318|P1|Booster and ESFU Phase|Lost to Follow-up|0
106350|NCT00715676|365475|P3|Overall Study|Elevated Blood Glucose|0
106351|NCT00715676|365476|P2|Overall Study|Elevated Blood Glucose|1
106352|NCT00715676|365477|P1|Overall Study|Elevated Blood Glucose|0
106353|NCT00715676|365475|P3|Overall Study|Use of Exclusionary Medication|1
106354|NCT00715676|365476|P2|Overall Study|Use of Exclusionary Medication|0
106355|NCT00715676|365477|P1|Overall Study|Use of Exclusionary Medication|0
106356|NCT00715676|365475|P3|Overall Study|Did Not Meet Entry Criteria|1
106357|NCT00715676|365476|P2|Overall Study|Did Not Meet Entry Criteria|0
106358|NCT00715676|365477|P1|Overall Study|Did Not Meet Entry Criteria|0
106359|NCT00715676|365475|P3|Overall Study|Terminated by Sponsor|0
106360|NCT00715676|365476|P2|Overall Study|Terminated by Sponsor|0
106361|NCT00715676|365477|P1|Overall Study|Terminated by Sponsor|1
106362|NCT00715676|365475|P3|Overall Study|Lost to Follow-up|1
106363|NCT00715676|365476|P2|Overall Study|Lost to Follow-up|2
106364|NCT00715676|365477|P1|Overall Study|Lost to Follow-up|1
106365|NCT00715676|365475|P3|Overall Study|Withdrawal by Subject|8
106366|NCT00715676|365476|P2|Overall Study|Withdrawal by Subject|3
106367|NCT00715676|365477|P1|Overall Study|Withdrawal by Subject|1
106368|NCT00715676|365475|P3|Overall Study|Adverse Event|21
106369|NCT00715676|365476|P2|Overall Study|Adverse Event|5
106370|NCT00715676|365477|P1|Overall Study|Adverse Event|3
106371|NCT00715624|365520|P2|Overall Study|Other|1
106372|NCT00715624|365521|P1|Overall Study|Other|0
106373|NCT00715624|365520|P2|Overall Study|Incorrect randomization (not treated)|1
106374|NCT00715624|365521|P1|Overall Study|Incorrect randomization (not treated)|0
106375|NCT00715624|365520|P2|Overall Study|Sponsor decision|4
106376|NCT00715624|365521|P1|Overall Study|Sponsor decision|0
106377|NCT00715624|365520|P2|Overall Study|Poor compliance|13
106378|NCT00715624|365521|P1|Overall Study|Poor compliance|6
106379|NCT00715624|365520|P2|Overall Study|Familial and personal reasons|22
106380|NCT00715624|365521|P1|Overall Study|Familial and personal reasons|10
106381|NCT00715624|365520|P2|Overall Study|Withdrawal by Subject|25
106382|NCT00715624|365521|P1|Overall Study|Withdrawal by Subject|11
106383|NCT00715624|365520|P2|Overall Study|Protocol Violation|0
106384|NCT00715624|365521|P1|Overall Study|Protocol Violation|1
106385|NCT00715624|365520|P2|Overall Study|Lost to Follow-up|2
106386|NCT00715624|365521|P1|Overall Study|Lost to Follow-up|1
106387|NCT00715624|365520|P2|Overall Study|Lack of Efficacy|11
106388|NCT00715624|365521|P1|Overall Study|Lack of Efficacy|11
106389|NCT00715624|365520|P2|Overall Study|Adverse Event|37
106390|NCT00715624|365521|P1|Overall Study|Adverse Event|12
106391|NCT00715559|365549|P1|Overall Study|medication not tolerated - nausea|1
106392|NCT00715403|365563|P7|Overall Study|Other reason not defined above|0
106393|NCT00715403|365564|P6|Overall Study|Other reason not defined above|1
106394|NCT00715403|365565|P5|Overall Study|Other reason not defined above|1
106395|NCT00715403|365566|P4|Overall Study|Other reason not defined above|0
106396|NCT00715403|365567|P3|Overall Study|Other reason not defined above|1
106397|NCT00715403|365568|P2|Overall Study|Other reason not defined above|0
106398|NCT00715403|365569|P1|Overall Study|Other reason not defined above|0
106399|NCT00715403|365563|P7|Overall Study|Protocol Violation|0
106400|NCT00715403|365564|P6|Overall Study|Protocol Violation|1
106401|NCT00715403|365565|P5|Overall Study|Protocol Violation|0
106402|NCT00715403|365566|P4|Overall Study|Protocol Violation|0
106403|NCT00715403|365567|P3|Overall Study|Protocol Violation|0
106404|NCT00715403|365568|P2|Overall Study|Protocol Violation|0
106405|NCT00715403|365569|P1|Overall Study|Protocol Violation|0
106406|NCT00715403|365563|P7|Overall Study|Other Adverse Event than DLT|0
106407|NCT00715403|365564|P6|Overall Study|Other Adverse Event than DLT|2
106408|NCT00715403|365565|P5|Overall Study|Other Adverse Event than DLT|0
106409|NCT00715403|365566|P4|Overall Study|Other Adverse Event than DLT|0
106410|NCT00715403|365567|P3|Overall Study|Other Adverse Event than DLT|0
106411|NCT00715403|365568|P2|Overall Study|Other Adverse Event than DLT|0
106412|NCT00715403|365569|P1|Overall Study|Other Adverse Event than DLT|1
106413|NCT00715403|365563|P7|Overall Study|Dose limiting Toxicity (DLT)|0
106414|NCT00715403|365564|P6|Overall Study|Dose limiting Toxicity (DLT)|1
106415|NCT00715403|365565|P5|Overall Study|Dose limiting Toxicity (DLT)|0
106416|NCT00715403|365566|P4|Overall Study|Dose limiting Toxicity (DLT)|0
106417|NCT00715403|365567|P3|Overall Study|Dose limiting Toxicity (DLT)|0
106418|NCT00715403|365568|P2|Overall Study|Dose limiting Toxicity (DLT)|0
106419|NCT00715403|365569|P1|Overall Study|Dose limiting Toxicity (DLT)|0
106420|NCT00715403|365563|P7|Overall Study|Progressive disease|1
106421|NCT00715403|365564|P6|Overall Study|Progressive disease|14
106422|NCT00715403|365565|P5|Overall Study|Progressive disease|5
106423|NCT00715403|365566|P4|Overall Study|Progressive disease|9
106424|NCT00715403|365567|P3|Overall Study|Progressive disease|3
106425|NCT00715403|365568|P2|Overall Study|Progressive disease|1
106426|NCT00715403|365569|P1|Overall Study|Progressive disease|0
106427|NCT00715299|365708|P1|Overall Study|failed the pre-screen exercise test|2
106428|NCT00715299|365708|P1|Overall Study|Adverse Event|3
106429|NCT00715299|365708|P1|Overall Study|Withdrawal by Subject|1
106430|NCT00715208|365714|P2|Overall Study|Lack of Efficacy|2
106431|NCT00715208|365715|P1|Overall Study|Lack of Efficacy|0
106432|NCT00715208|365714|P2|Overall Study|Adverse Event|6
106433|NCT00715208|365715|P1|Overall Study|Adverse Event|0
106434|NCT00715208|365714|P2|Overall Study|Withdrawal by Subject|1
106435|NCT00715208|365715|P1|Overall Study|Withdrawal by Subject|1
106436|NCT00715117|365731|P2|Overall Study|Crohn's flare and rescue with steroids|1
106437|NCT00715117|365732|P1|Overall Study|Crohn's flare and rescue with steroids|0
106438|NCT00715078|365800|P3|Overall Study|subject participation is ongoing|31
106439|NCT00715078|365801|P2|Overall Study|subject participation is ongoing|27
106440|NCT00715078|365802|P1|Overall Study|subject participation is ongoing|19
106441|NCT00715026|365810|P1|Overall Study|Surgery done on non-study consented hip|1
106442|NCT00715026|365810|P1|Overall Study|Protocol Violation|1
106443|NCT00715026|365810|P1|Overall Study|Lost to Follow-up|3
106444|NCT00715026|365810|P1|Overall Study|Withdrawal by Subject|5
106445|NCT00714948|365815|P1|Overall Study|Adverse Event|2
106446|NCT00714870|365821|P2|Overall Study|did not attend minimum of 4 sessions|0
106447|NCT00714870|365822|P1|Overall Study|did not attend minimum of 4 sessions|4
106448|NCT00714870|365821|P2|Overall Study|patient unable to come b/c back pain|0
106449|NCT00714870|365822|P1|Overall Study|patient unable to come b/c back pain|1
106450|NCT00714870|365821|P2|Overall Study|Lost to Follow-up|5
106451|NCT00714870|365822|P1|Overall Study|Lost to Follow-up|22
106452|NCT00714714|365828|P1|Overall Study|Adverse Event|1
106453|NCT00714688|365837|P3|Overall Study|Other|5
106454|NCT00714688|365838|P2|Overall Study|Other|6
106455|NCT00714688|365839|P1|Overall Study|Other|1
106456|NCT00714688|365837|P3|Overall Study|Sponsor's Decision|0
106457|NCT00714688|365838|P2|Overall Study|Sponsor's Decision|2
106458|NCT00714688|365839|P1|Overall Study|Sponsor's Decision|0
106459|NCT00714688|365837|P3|Overall Study|Ineligible to Continue the Study|1
106460|NCT00714688|365838|P2|Overall Study|Ineligible to Continue the Study|1
106461|NCT00714688|365839|P1|Overall Study|Ineligible to Continue the Study|0
106462|NCT00714688|365837|P3|Overall Study|Subject Non-compliant|5
106463|NCT00714688|365838|P2|Overall Study|Subject Non-compliant|5
106464|NCT00714688|365839|P1|Overall Study|Subject Non-compliant|3
106465|NCT00714688|365837|P3|Overall Study|Adverse Event|19
106466|NCT00714688|365838|P2|Overall Study|Adverse Event|15
106467|NCT00714688|365839|P1|Overall Study|Adverse Event|2
106468|NCT00714688|365837|P3|Overall Study|Lost to Follow-up|0
106469|NCT00714688|365838|P2|Overall Study|Lost to Follow-up|2
106470|NCT00714688|365839|P1|Overall Study|Lost to Follow-up|5
106471|NCT00714688|365837|P3|Overall Study|Withdrawal by Subject|3
106472|NCT00714688|365838|P2|Overall Study|Withdrawal by Subject|3
106473|NCT00714688|365839|P1|Overall Study|Withdrawal by Subject|4
106474|NCT00714688|365837|P3|Overall Study|Lack of Efficacy|4
106475|NCT00714688|365838|P2|Overall Study|Lack of Efficacy|1
106476|NCT00714688|365839|P1|Overall Study|Lack of Efficacy|14
106477|NCT00714493|365881|P1|Overall Study|OTHER|2
106478|NCT00714493|365881|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
106479|NCT00714493|365881|P1|Overall Study|Protocol Violation|12
106480|NCT00714493|365881|P1|Overall Study|Lost to Follow-up|3
106481|NCT00714493|365881|P1|Overall Study|Lack of Efficacy|10
106482|NCT00714493|365881|P1|Overall Study|Death|3
106483|NCT00714493|365881|P1|Overall Study|Adverse Event|11
106484|NCT00714285|365909|P4|Overall Study|Migrated/moved from study area|0
106485|NCT00714285|365910|P3|Overall Study|Migrated/moved from study area|0
106486|NCT00714285|365911|P2|Overall Study|Migrated/moved from study area|1
106487|NCT00714285|365912|P1|Overall Study|Migrated/moved from study area|0
106488|NCT00714285|365909|P4|Overall Study|Lost to Follow-up|1
106489|NCT00714285|365910|P3|Overall Study|Lost to Follow-up|0
106490|NCT00714285|365911|P2|Overall Study|Lost to Follow-up|2
106491|NCT00714285|365912|P1|Overall Study|Lost to Follow-up|0
106492|NCT00714168|365998|P2|Overall Study|Non-study medical condition|2
106493|NCT00714168|365999|P1|Overall Study|Non-study medical condition|3
106494|NCT00714168|365998|P2|Overall Study|Relocation|3
106495|NCT00714168|365999|P1|Overall Study|Relocation|4
106496|NCT00714168|365998|P2|Overall Study|Lost to Follow-up|50
106497|NCT00714168|365999|P1|Overall Study|Lost to Follow-up|32
106498|NCT00714168|365998|P2|Overall Study|Pregnancy|4
106499|NCT00714168|365999|P1|Overall Study|Pregnancy|5
106500|NCT00714051|366015|P2|Overall Study|Death|1
106501|NCT00714051|366016|P1|Overall Study|Death|0
106502|NCT00714051|366015|P2|Overall Study|Withdrawal by Subject|0
106503|NCT00714051|366016|P1|Overall Study|Withdrawal by Subject|1
106504|NCT00713830|366024|P2|Overall Study|Sponsor Decision|10
106505|NCT00713830|366025|P1|Overall Study|Sponsor Decision|4
106506|NCT00713830|366024|P2|Overall Study|Familial and Personal Reasons|34
106507|NCT00713830|366025|P1|Overall Study|Familial and Personal Reasons|9
106508|NCT00713830|366024|P2|Overall Study|Poor Compliance to Protocol|14
106509|NCT00713830|366025|P1|Overall Study|Poor Compliance to Protocol|7
106510|NCT00713830|366024|P2|Overall Study|Withdrawal by Subject|23
106511|NCT00713830|366025|P1|Overall Study|Withdrawal by Subject|13
106512|NCT00713830|366024|P2|Overall Study|Lost to Follow-up|9
106513|NCT00713830|366025|P1|Overall Study|Lost to Follow-up|2
106514|NCT00713830|366024|P2|Overall Study|Lack of Efficacy|16
106515|NCT00713830|366025|P1|Overall Study|Lack of Efficacy|24
106516|NCT00713830|366024|P2|Overall Study|Adverse Event|71
106517|NCT00713830|366025|P1|Overall Study|Adverse Event|23
106518|NCT00713700|366082|P1|Overall Study|Withdrawal by Subject|1
106519|NCT00713700|366082|P1|Overall Study|Lost to Follow-up|3
106520|NCT00713648|366108|P1|Overall Study|Development of antibodies|3
106521|NCT00713648|366108|P1|Overall Study|According to Protocol|2
106522|NCT00713648|366108|P1|Overall Study|Unclassified|2
106523|NCT00713648|366108|P1|Overall Study|Adverse Event|1
106524|NCT00713596|366118|P3|Overall Study|Study was terminated|2
106525|NCT00713596|366119|P2|Overall Study|Study was terminated|3
106526|NCT00713596|366120|P1|Overall Study|Study was terminated|2
106527|NCT00713544|366137|P6|Overall Study|Hepatotoxicity - not an AE|0
106528|NCT00713544|366138|P5|Overall Study|Hepatotoxicity - not an AE|1
106529|NCT00713544|366139|P4|Overall Study|Hepatotoxicity - not an AE|0
106530|NCT00713544|366140|P3|Overall Study|Hepatotoxicity - not an AE|0
106531|NCT00713544|366141|P2|Overall Study|Hepatotoxicity - not an AE|0
106532|NCT00713544|366142|P1|Overall Study|Hepatotoxicity - not an AE|0
106533|NCT00713544|366137|P6|Overall Study|Incorrect enrollment|0
106534|NCT00713544|366138|P5|Overall Study|Incorrect enrollment|0
106535|NCT00713544|366139|P4|Overall Study|Incorrect enrollment|0
106536|NCT00713544|366140|P3|Overall Study|Incorrect enrollment|0
106537|NCT00713544|366141|P2|Overall Study|Incorrect enrollment|1
106538|NCT00713544|366142|P1|Overall Study|Incorrect enrollment|0
106539|NCT00713544|366137|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
106540|NCT00713544|366138|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
106541|NCT00713544|366139|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
106542|NCT00713544|366140|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
106543|NCT00713544|366141|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
106544|NCT00713544|366142|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
106545|NCT00713544|366137|P6|Overall Study|Lost to Follow-up|0
106546|NCT00713544|366138|P5|Overall Study|Lost to Follow-up|0
106547|NCT00713544|366139|P4|Overall Study|Lost to Follow-up|0
106548|NCT00713544|366140|P3|Overall Study|Lost to Follow-up|1
106549|NCT00713544|366141|P2|Overall Study|Lost to Follow-up|0
106550|NCT00713544|366142|P1|Overall Study|Lost to Follow-up|0
106551|NCT00713544|366137|P6|Overall Study|Lack of Efficacy|0
106552|NCT00713544|366138|P5|Overall Study|Lack of Efficacy|1
106553|NCT00713544|366139|P4|Overall Study|Lack of Efficacy|1
106554|NCT00713544|366140|P3|Overall Study|Lack of Efficacy|0
106555|NCT00713544|366141|P2|Overall Study|Lack of Efficacy|1
106556|NCT00713544|366142|P1|Overall Study|Lack of Efficacy|0
106557|NCT00713544|366137|P6|Overall Study|Physician Decision|2
106558|NCT00713544|366138|P5|Overall Study|Physician Decision|0
106559|NCT00713544|366139|P4|Overall Study|Physician Decision|0
106560|NCT00713544|366140|P3|Overall Study|Physician Decision|0
106561|NCT00713544|366141|P2|Overall Study|Physician Decision|0
106562|NCT00713544|366142|P1|Overall Study|Physician Decision|0
106563|NCT00713544|366137|P6|Overall Study|Protocol Violation|1
106564|NCT00713544|366138|P5|Overall Study|Protocol Violation|0
106565|NCT00713544|366139|P4|Overall Study|Protocol Violation|0
106566|NCT00713544|366140|P3|Overall Study|Protocol Violation|0
106567|NCT00713544|366141|P2|Overall Study|Protocol Violation|0
106568|NCT00713544|366142|P1|Overall Study|Protocol Violation|0
106569|NCT00713544|366137|P6|Overall Study|Withdrawal by Subject|1
106570|NCT00713544|366138|P5|Overall Study|Withdrawal by Subject|3
106571|NCT00713544|366139|P4|Overall Study|Withdrawal by Subject|2
106572|NCT00713544|366140|P3|Overall Study|Withdrawal by Subject|3
106573|NCT00713544|366141|P2|Overall Study|Withdrawal by Subject|0
106574|NCT00713544|366142|P1|Overall Study|Withdrawal by Subject|2
106575|NCT00713544|366137|P6|Overall Study|Adverse Event|5
106576|NCT00713544|366138|P5|Overall Study|Adverse Event|3
106577|NCT00713544|366139|P4|Overall Study|Adverse Event|7
106578|NCT00713544|366140|P3|Overall Study|Adverse Event|7
106579|NCT00713544|366141|P2|Overall Study|Adverse Event|3
106580|NCT00713544|366142|P1|Overall Study|Adverse Event|5
106581|NCT00713349|366193|P1|Overall Study|Protocol Violation|1
106582|NCT00713323|366199|P1|Overall Study|Treatment that may interact with Sativex|1
106583|NCT00713323|366199|P1|Overall Study|Subject travelling to Dominica Republic|1
106584|NCT00713323|366199|P1|Overall Study|Subject travelling to USA|1
106585|NCT00713323|366199|P1|Overall Study|Pain resolved|1
106586|NCT00713323|366199|P1|Overall Study|Non-compliance|1
106587|NCT00713323|366199|P1|Overall Study|Pain free|1
106588|NCT00713323|366199|P1|Overall Study|Surgery cured allodynic pain|1
106589|NCT00713323|366199|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
106590|NCT00713323|366199|P1|Overall Study|Low creatine clearance at screening|1
106591|NCT00713323|366199|P1|Overall Study|Lack of Efficacy|36
106592|NCT00713323|366199|P1|Overall Study|Lost to Follow-up|11
106593|NCT00713323|366199|P1|Overall Study|Withdrawal by Subject|15
106594|NCT00713323|366199|P1|Overall Study|Adverse Event|75
106595|NCT00713310|366212|P2|Overall Study|Withdrawal by Subject|2
106596|NCT00713310|366213|P1|Overall Study|Withdrawal by Subject|0
106597|NCT00713310|366212|P2|Overall Study|Lack of Efficacy|2
106598|NCT00713310|366213|P1|Overall Study|Lack of Efficacy|0
106599|NCT00713310|366212|P2|Overall Study|Adverse Event|2
106600|NCT00713310|366213|P1|Overall Study|Adverse Event|5
106601|NCT00713258|366223|P2|Overall Study|Other|1
106602|NCT00713258|366224|P1|Overall Study|Other|1
106603|NCT00713258|366223|P2|Overall Study|Non-Compliance|1
106604|NCT00713258|366224|P1|Overall Study|Non-Compliance|2
106605|NCT00713258|366223|P2|Overall Study|Adverse Event|4
106606|NCT00713258|366224|P1|Overall Study|Adverse Event|2
106607|NCT00713219|366232|P1|Overall Study|Protocol Violation|1
106608|NCT00713219|366232|P1|Overall Study|Death|1
106609|NCT00713206|366238|P2|Overall Study|Adverse Event|1
106610|NCT00713206|366239|P1|Overall Study|Adverse Event|2
106611|NCT00713206|366238|P2|Overall Study|Lost to Follow-up|2
106612|NCT00713206|366239|P1|Overall Study|Lost to Follow-up|5
106613|NCT00712985|366245|P1|Overall Study|Lack of Efficacy|3
106614|NCT00712985|366245|P1|Overall Study|1 patient moved out of state|1
106615|NCT00712985|366245|P1|Overall Study|1 withdrew prior to start of drug|1
106616|NCT00712959|366251|P2|Overall Study|Withdrawal by Subject|0
106617|NCT00712959|366252|P1|Overall Study|Withdrawal by Subject|3
106618|NCT00712959|366251|P2|Overall Study|Lost to Follow-up|2
106619|NCT00712959|366252|P1|Overall Study|Lost to Follow-up|13
106620|NCT00712959|366251|P2|Overall Study|Protocol Violation|1
106621|NCT00712959|366252|P1|Overall Study|Protocol Violation|3
106622|NCT00712920|366273|P3|Overall Study|Non-compliance|0
106623|NCT00712920|366274|P2|Overall Study|Non-compliance|0
106624|NCT00712920|366275|P1|Overall Study|Non-compliance|3
106625|NCT00712920|366273|P3|Overall Study|Other|3
106626|NCT00712920|366274|P2|Overall Study|Other|7
106627|NCT00712920|366275|P1|Overall Study|Other|5
106628|NCT00712920|366273|P3|Overall Study|Lack of Efficacy|1
106629|NCT00712920|366274|P2|Overall Study|Lack of Efficacy|0
106630|NCT00712920|366275|P1|Overall Study|Lack of Efficacy|1
106631|NCT00712920|366273|P3|Overall Study|Lost to Follow-up|0
106632|NCT00712920|366274|P2|Overall Study|Lost to Follow-up|4
106633|NCT00712920|366275|P1|Overall Study|Lost to Follow-up|1
106634|NCT00712920|366273|P3|Overall Study|Withdrawal by Subject|1
106635|NCT00712920|366274|P2|Overall Study|Withdrawal by Subject|2
106636|NCT00712920|366275|P1|Overall Study|Withdrawal by Subject|4
106637|NCT00712920|366273|P3|Overall Study|Adverse Event|7
106638|NCT00712920|366274|P2|Overall Study|Adverse Event|4
106639|NCT00712920|366275|P1|Overall Study|Adverse Event|3
106640|NCT00712725|366303|P8|Overall Study|Protocol Specified Criteria|1
106641|NCT00712725|366304|P7|Overall Study|Protocol Specified Criteria|2
106642|NCT00712725|366305|P6|Overall Study|Protocol Specified Criteria|0
106643|NCT00712725|366306|P5|Overall Study|Protocol Specified Criteria|1
106644|NCT00712725|366307|P4|Overall Study|Protocol Specified Criteria|2
106645|NCT00712725|366308|P3|Overall Study|Protocol Specified Criteria|1
106646|NCT00712725|366309|P2|Overall Study|Protocol Specified Criteria|0
106647|NCT00712725|366310|P1|Overall Study|Protocol Specified Criteria|3
106648|NCT00712725|366303|P8|Overall Study|Lack of Qualifying Event|6
106649|NCT00712725|366304|P7|Overall Study|Lack of Qualifying Event|11
106650|NCT00712725|366305|P6|Overall Study|Lack of Qualifying Event|13
106651|NCT00712725|366306|P5|Overall Study|Lack of Qualifying Event|11
106652|NCT00712725|366307|P4|Overall Study|Lack of Qualifying Event|8
106653|NCT00712725|366308|P3|Overall Study|Lack of Qualifying Event|6
106654|NCT00712725|366309|P2|Overall Study|Lack of Qualifying Event|2
106655|NCT00712725|366310|P1|Overall Study|Lack of Qualifying Event|16
106656|NCT00712725|366303|P8|Overall Study|Withdrawal by Subject|2
106657|NCT00712725|366304|P7|Overall Study|Withdrawal by Subject|1
106658|NCT00712725|366305|P6|Overall Study|Withdrawal by Subject|1
106659|NCT00712725|366306|P5|Overall Study|Withdrawal by Subject|1
106660|NCT00712725|366307|P4|Overall Study|Withdrawal by Subject|2
106661|NCT00712725|366308|P3|Overall Study|Withdrawal by Subject|1
106662|NCT00712725|366309|P2|Overall Study|Withdrawal by Subject|1
106663|NCT00712725|366310|P1|Overall Study|Withdrawal by Subject|2
106664|NCT00712725|366303|P8|Overall Study|Protocol Violation|1
106665|NCT00712725|366304|P7|Overall Study|Protocol Violation|1
106666|NCT00712725|366305|P6|Overall Study|Protocol Violation|0
106667|NCT00712725|366306|P5|Overall Study|Protocol Violation|2
106668|NCT00712725|366307|P4|Overall Study|Protocol Violation|3
106669|NCT00712725|366308|P3|Overall Study|Protocol Violation|1
106670|NCT00712725|366309|P2|Overall Study|Protocol Violation|0
106671|NCT00712725|366310|P1|Overall Study|Protocol Violation|2
106672|NCT00712725|366303|P8|Overall Study|Pregnancy|0
106673|NCT00712725|366304|P7|Overall Study|Pregnancy|2
106674|NCT00712725|366305|P6|Overall Study|Pregnancy|0
106675|NCT00712725|366306|P5|Overall Study|Pregnancy|1
106676|NCT00712725|366307|P4|Overall Study|Pregnancy|0
106677|NCT00712725|366308|P3|Overall Study|Pregnancy|0
106678|NCT00712725|366309|P2|Overall Study|Pregnancy|1
106679|NCT00712725|366310|P1|Overall Study|Pregnancy|0
106680|NCT00712725|366303|P8|Overall Study|Physician Decision|0
106681|NCT00712725|366304|P7|Overall Study|Physician Decision|2
106682|NCT00712725|366305|P6|Overall Study|Physician Decision|0
106683|NCT00712725|366306|P5|Overall Study|Physician Decision|1
106684|NCT00712725|366307|P4|Overall Study|Physician Decision|0
106685|NCT00712725|366308|P3|Overall Study|Physician Decision|0
106686|NCT00712725|366309|P2|Overall Study|Physician Decision|0
106687|NCT00712725|366310|P1|Overall Study|Physician Decision|2
106688|NCT00712725|366303|P8|Overall Study|Lost to Follow-up|1
106689|NCT00712725|366304|P7|Overall Study|Lost to Follow-up|3
106690|NCT00712725|366305|P6|Overall Study|Lost to Follow-up|2
106691|NCT00712725|366306|P5|Overall Study|Lost to Follow-up|2
106692|NCT00712725|366307|P4|Overall Study|Lost to Follow-up|1
106693|NCT00712725|366308|P3|Overall Study|Lost to Follow-up|1
106694|NCT00712725|366309|P2|Overall Study|Lost to Follow-up|2
106695|NCT00712725|366310|P1|Overall Study|Lost to Follow-up|3
106696|NCT00712725|366303|P8|Overall Study|Adverse Event|0
106697|NCT00712725|366304|P7|Overall Study|Adverse Event|0
106698|NCT00712725|366305|P6|Overall Study|Adverse Event|0
106699|NCT00712725|366306|P5|Overall Study|Adverse Event|0
106700|NCT00712725|366307|P4|Overall Study|Adverse Event|1
106701|NCT00712725|366308|P3|Overall Study|Adverse Event|0
106702|NCT00712725|366309|P2|Overall Study|Adverse Event|0
106703|NCT00712725|366310|P1|Overall Study|Adverse Event|1
106704|NCT00712673|366371|P4|Overall Study|Protocol Violation|0
106705|NCT00712673|366372|P3|Overall Study|Protocol Violation|2
106706|NCT00712673|366373|P2|Overall Study|Protocol Violation|0
106707|NCT00712673|366374|P1|Overall Study|Protocol Violation|0
106708|NCT00712673|366371|P4|Overall Study|Investigator's Decision|0
106709|NCT00712673|366372|P3|Overall Study|Investigator's Decision|0
106710|NCT00712673|366373|P2|Overall Study|Investigator's Decision|0
106711|NCT00712673|366374|P1|Overall Study|Investigator's Decision|1
106712|NCT00712673|366371|P4|Overall Study|Familial and Personal Reasons|2
106713|NCT00712673|366372|P3|Overall Study|Familial and Personal Reasons|5
106714|NCT00712673|366373|P2|Overall Study|Familial and Personal Reasons|0
106715|NCT00712673|366374|P1|Overall Study|Familial and Personal Reasons|5
106716|NCT00712673|366371|P4|Overall Study|Withdrawal by Subject|20
106717|NCT00712673|366372|P3|Overall Study|Withdrawal by Subject|15
106718|NCT00712673|366373|P2|Overall Study|Withdrawal by Subject|7
106719|NCT00712673|366374|P1|Overall Study|Withdrawal by Subject|6
106720|NCT00712673|366371|P4|Overall Study|Lost to Follow-up|0
106721|NCT00712673|366372|P3|Overall Study|Lost to Follow-up|2
106722|NCT00712673|366373|P2|Overall Study|Lost to Follow-up|0
106723|NCT00712673|366374|P1|Overall Study|Lost to Follow-up|1
106724|NCT00712673|366371|P4|Overall Study|Poor Compliance to Protocol|16
106725|NCT00712673|366372|P3|Overall Study|Poor Compliance to Protocol|4
106726|NCT00712673|366373|P2|Overall Study|Poor Compliance to Protocol|3
106727|NCT00712673|366374|P1|Overall Study|Poor Compliance to Protocol|3
106728|NCT00712673|366371|P4|Overall Study|Lack of Efficacy|6
106729|NCT00712673|366372|P3|Overall Study|Lack of Efficacy|8
106730|NCT00712673|366373|P2|Overall Study|Lack of Efficacy|8
106731|NCT00712673|366374|P1|Overall Study|Lack of Efficacy|2
106732|NCT00712673|366371|P4|Overall Study|Adverse Event|26
106733|NCT00712673|366372|P3|Overall Study|Adverse Event|21
106734|NCT00712673|366373|P2|Overall Study|Adverse Event|3
106735|NCT00712673|366374|P1|Overall Study|Adverse Event|3
106736|NCT00712543|366438|P2|Day 8-14|Lost to Follow-up|2
106737|NCT00712543|366439|P1|Day 8-14|Lost to Follow-up|0
106738|NCT00712348|366473|P1|Overall Study|Withdrawal by Subject|1
106739|NCT00712335|366485|P5|Overall Study|Other Reason|0
106740|NCT00712335|366486|P4|Overall Study|Other Reason|0
106741|NCT00712335|366487|P3|Overall Study|Other Reason|1
106742|NCT00712335|366488|P2|Overall Study|Other Reason|3
106743|NCT00712335|366489|P1|Overall Study|Other Reason|0
106744|NCT00712335|366485|P5|Overall Study|Lack of Efficacy|0
106745|NCT00712335|366486|P4|Overall Study|Lack of Efficacy|1
106746|NCT00712335|366487|P3|Overall Study|Lack of Efficacy|1
106747|NCT00712335|366488|P2|Overall Study|Lack of Efficacy|0
106748|NCT00712335|366489|P1|Overall Study|Lack of Efficacy|0
106749|NCT00712335|366485|P5|Overall Study|Protocol Violation|0
106750|NCT00712335|366486|P4|Overall Study|Protocol Violation|0
106751|NCT00712335|366487|P3|Overall Study|Protocol Violation|1
106752|NCT00712335|366488|P2|Overall Study|Protocol Violation|2
106753|NCT00712335|366489|P1|Overall Study|Protocol Violation|1
106754|NCT00712335|366485|P5|Overall Study|Lost to Follow-up|0
106755|NCT00712335|366486|P4|Overall Study|Lost to Follow-up|1
106756|NCT00712335|366487|P3|Overall Study|Lost to Follow-up|0
106757|NCT00712335|366488|P2|Overall Study|Lost to Follow-up|5
106758|NCT00712335|366489|P1|Overall Study|Lost to Follow-up|2
106759|NCT00712335|366485|P5|Overall Study|Withdrawal by Subject|0
106760|NCT00712335|366486|P4|Overall Study|Withdrawal by Subject|3
106761|NCT00712335|366487|P3|Overall Study|Withdrawal by Subject|2
106762|NCT00712335|366488|P2|Overall Study|Withdrawal by Subject|7
106763|NCT00712335|366489|P1|Overall Study|Withdrawal by Subject|0
106764|NCT00712166|366586|P2|Overall Study|Noncompliance|1
106765|NCT00712166|366587|P1|Overall Study|Noncompliance|0
106766|NCT00712010|366630|P1|Washout (7 Days)|Withdrawal by Subject|1
106767|NCT00711880|366668|P2|Overall Study|Lack of Efficacy|5
106768|NCT00711880|366669|P1|Overall Study|Lack of Efficacy|1
106769|NCT00711880|366668|P2|Overall Study|Patient non-compliance|0
106770|NCT00711880|366669|P1|Overall Study|Patient non-compliance|1
106771|NCT00711880|366668|P2|Overall Study|Adverse Event|2
106772|NCT00711880|366669|P1|Overall Study|Adverse Event|11
106773|NCT00711802|366731|P8|Overall Study|Reason not reported|0
106774|NCT00711802|366732|P7|Overall Study|Reason not reported|1
106775|NCT00711802|366733|P6|Overall Study|Reason not reported|0
106776|NCT00711802|366734|P5|Overall Study|Reason not reported|1
106777|NCT00711802|366735|P4|Overall Study|Reason not reported|0
106778|NCT00711802|366736|P3|Overall Study|Reason not reported|1
106779|NCT00711802|366737|P2|Overall Study|Reason not reported|1
106780|NCT00711802|366738|P1|Overall Study|Reason not reported|0
106781|NCT00711802|366731|P8|Overall Study|Lost to Follow-up|2
106782|NCT00711802|366732|P7|Overall Study|Lost to Follow-up|4
106783|NCT00711802|366733|P6|Overall Study|Lost to Follow-up|6
106784|NCT00711802|366734|P5|Overall Study|Lost to Follow-up|10
106785|NCT00711802|366735|P4|Overall Study|Lost to Follow-up|1
106786|NCT00711802|366736|P3|Overall Study|Lost to Follow-up|3
106787|NCT00711802|366737|P2|Overall Study|Lost to Follow-up|0
106788|NCT00711802|366738|P1|Overall Study|Lost to Follow-up|0
106789|NCT00711802|366731|P8|Overall Study|Withdrawal by Subject|0
106790|NCT00711802|366732|P7|Overall Study|Withdrawal by Subject|0
106791|NCT00711802|366733|P6|Overall Study|Withdrawal by Subject|0
106792|NCT00711802|366734|P5|Overall Study|Withdrawal by Subject|0
106793|NCT00711802|366735|P4|Overall Study|Withdrawal by Subject|1
106794|NCT00711802|366736|P3|Overall Study|Withdrawal by Subject|0
106795|NCT00711802|366737|P2|Overall Study|Withdrawal by Subject|1
106796|NCT00711802|366738|P1|Overall Study|Withdrawal by Subject|0
106797|NCT00711802|366731|P8|Overall Study|Physician Decision|0
106798|NCT00711802|366732|P7|Overall Study|Physician Decision|0
106799|NCT00711802|366733|P6|Overall Study|Physician Decision|0
106800|NCT00711802|366734|P5|Overall Study|Physician Decision|0
106801|NCT00711802|366735|P4|Overall Study|Physician Decision|0
106802|NCT00711802|366736|P3|Overall Study|Physician Decision|0
106803|NCT00711802|366737|P2|Overall Study|Physician Decision|2
106804|NCT00711802|366738|P1|Overall Study|Physician Decision|0
106805|NCT00711802|366731|P8|Overall Study|Protocol Violation|0
106806|NCT00711802|366732|P7|Overall Study|Protocol Violation|0
106807|NCT00711802|366733|P6|Overall Study|Protocol Violation|0
106808|NCT00711802|366734|P5|Overall Study|Protocol Violation|0
106809|NCT00711802|366735|P4|Overall Study|Protocol Violation|1
106810|NCT00711802|366736|P3|Overall Study|Protocol Violation|0
106811|NCT00711802|366737|P2|Overall Study|Protocol Violation|0
106812|NCT00711802|366738|P1|Overall Study|Protocol Violation|0
106813|NCT00711802|366731|P8|Overall Study|Microbiological failure|0
106814|NCT00711802|366732|P7|Overall Study|Microbiological failure|0
106815|NCT00711802|366733|P6|Overall Study|Microbiological failure|1
106816|NCT00711802|366734|P5|Overall Study|Microbiological failure|0
106817|NCT00711802|366735|P4|Overall Study|Microbiological failure|0
106818|NCT00711802|366736|P3|Overall Study|Microbiological failure|0
106819|NCT00711802|366737|P2|Overall Study|Microbiological failure|1
106820|NCT00711802|366738|P1|Overall Study|Microbiological failure|0
106821|NCT00711802|366731|P8|Overall Study|Adverse Event|0
106822|NCT00711802|366732|P7|Overall Study|Adverse Event|0
106823|NCT00711802|366733|P6|Overall Study|Adverse Event|1
106824|NCT00711802|366734|P5|Overall Study|Adverse Event|1
106825|NCT00711802|366735|P4|Overall Study|Adverse Event|0
106826|NCT00711802|366736|P3|Overall Study|Adverse Event|0
106827|NCT00711802|366737|P2|Overall Study|Adverse Event|0
106828|NCT00711802|366738|P1|Overall Study|Adverse Event|0
106829|NCT00711802|366731|P8|Overall Study|Not treated (no further detail)|0
106830|NCT00711802|366732|P7|Overall Study|Not treated (no further detail)|0
106831|NCT00711802|366733|P6|Overall Study|Not treated (no further detail)|0
106832|NCT00711802|366734|P5|Overall Study|Not treated (no further detail)|2
106833|NCT00711802|366735|P4|Overall Study|Not treated (no further detail)|0
106834|NCT00711802|366736|P3|Overall Study|Not treated (no further detail)|2
106835|NCT00711802|366737|P2|Overall Study|Not treated (no further detail)|1
106836|NCT00711802|366738|P1|Overall Study|Not treated (no further detail)|2
106837|NCT00711646|366770|P2|Overall Study|patient non-compliance|0
106838|NCT00711646|366771|P1|Overall Study|patient non-compliance|1
106839|NCT00711646|366770|P2|Overall Study|administrative decision|1
106840|NCT00711646|366771|P1|Overall Study|administrative decision|0
106841|NCT00711646|366770|P2|Overall Study|Lost to Follow-up|0
106842|NCT00711646|366771|P1|Overall Study|Lost to Follow-up|1
106843|NCT00711646|366770|P2|Overall Study|Protocol Violation|1
106844|NCT00711646|366771|P1|Overall Study|Protocol Violation|0
106845|NCT00711646|366770|P2|Overall Study|Withdrawal by Subject|0
106846|NCT00711646|366771|P1|Overall Study|Withdrawal by Subject|4
106847|NCT00711646|366770|P2|Overall Study|Adverse Event|1
106848|NCT00711646|366771|P1|Overall Study|Adverse Event|6
106849|NCT00711594|366793|P4|Overall Study|Withdrawal by Subject|2
106850|NCT00711594|366794|P3|Overall Study|Withdrawal by Subject|0
106851|NCT00711594|366795|P2|Overall Study|Withdrawal by Subject|1
106852|NCT00711594|366796|P1|Overall Study|Withdrawal by Subject|0
106853|NCT00711594|366793|P4|Overall Study|Other Adverse Event|16
106854|NCT00711594|366794|P3|Overall Study|Other Adverse Event|0
106855|NCT00711594|366795|P2|Overall Study|Other Adverse Event|0
106856|NCT00711594|366796|P1|Overall Study|Other Adverse Event|1
106857|NCT00711594|366793|P4|Overall Study|Progressive disease|44
106858|NCT00711594|366794|P3|Overall Study|Progressive disease|6
106859|NCT00711594|366795|P2|Overall Study|Progressive disease|2
106860|NCT00711594|366796|P1|Overall Study|Progressive disease|2
106861|NCT00711555|366833|P1|Overall Study|Adverse Event|3
106862|NCT00711529|366842|P2|Overall Study|Withdrawal by Subject|6
106863|NCT00711529|366843|P1|Overall Study|Withdrawal by Subject|2
106864|NCT00711529|366842|P2|Overall Study|Protocol Violation|0
106865|NCT00711529|366843|P1|Overall Study|Protocol Violation|2
106866|NCT00711516|366867|P2|Overall Study|Protocol Violation|1
106867|NCT00711516|366868|P1|Overall Study|Protocol Violation|0
106868|NCT00711516|366867|P2|Overall Study|Withdrawal by Subject|1
106869|NCT00711516|366868|P1|Overall Study|Withdrawal by Subject|0
106870|NCT00711516|366867|P2|Overall Study|Adverse Event|1
106871|NCT00711516|366868|P1|Overall Study|Adverse Event|1
106872|NCT00711477|366975|P2|Overall Study|Noncompliance|1
106873|NCT00711477|366976|P1|Overall Study|Noncompliance|0
106874|NCT00711477|366975|P2|Overall Study|Lost to Follow-up|1
106875|NCT00711477|366976|P1|Overall Study|Lost to Follow-up|0
106876|NCT00711477|366975|P2|Overall Study|Adverse Event|1
106877|NCT00711477|366976|P1|Overall Study|Adverse Event|3
106878|NCT00711425|367004|P1|Overall Study|Lost to Follow-up|1
106879|NCT00711425|367004|P1|Overall Study|Death|2
106880|NCT00711425|367004|P1|Overall Study|Protocol Violation|1
106881|NCT00711191|367032|P3|Overall Study|Withdrawal by Subject|3
106882|NCT00711191|367033|P2|Overall Study|Withdrawal by Subject|1
106883|NCT00711191|367034|P1|Overall Study|Withdrawal by Subject|0
106884|NCT00711191|367032|P3|Overall Study|Objective progression or relapse|7
106885|NCT00711191|367033|P2|Overall Study|Objective progression or relapse|3
106886|NCT00711191|367034|P1|Overall Study|Objective progression or relapse|2
106887|NCT00711191|367032|P3|Overall Study|Adverse Event|2
106888|NCT00711191|367033|P2|Overall Study|Adverse Event|1
106889|NCT00711191|367034|P1|Overall Study|Adverse Event|1
106890|NCT00711113|367071|P1|Overall Study|Implant lost|2
106891|NCT00711113|367071|P1|Overall Study|Lost to Follow-up|9
106892|NCT00711100|367077|P1|Overall Study|Withdrawal by Subject|8
106893|NCT00711100|367077|P1|Overall Study|Lack of Efficacy|5
106894|NCT00711087|367095|P2|Overall Study|Lost to Follow-up|0
106895|NCT00711087|367096|P1|Overall Study|Lost to Follow-up|1
106896|NCT00711009|367108|P2|Overall Study|Dose adjustment|0
106897|NCT00711009|367109|P1|Overall Study|Dose adjustment|1
106898|NCT00711009|367108|P2|Overall Study|Site closing|1
106899|NCT00711009|367109|P1|Overall Study|Site closing|0
106900|NCT00711009|367108|P2|Overall Study|Pregnancy|0
106901|NCT00711009|367109|P1|Overall Study|Pregnancy|1
106902|NCT00711009|367108|P2|Overall Study|Virologic Failure|1
106903|NCT00711009|367109|P1|Overall Study|Virologic Failure|2
106904|NCT00711009|367108|P2|Overall Study|Participant Noncompliant|1
106905|NCT00711009|367109|P1|Overall Study|Participant Noncompliant|0
106906|NCT00711009|367108|P2|Overall Study|Lost to Follow-up|9
106907|NCT00711009|367109|P1|Overall Study|Lost to Follow-up|3
106908|NCT00711009|367108|P2|Overall Study|Withdrawal by Subject|2
106909|NCT00711009|367109|P1|Overall Study|Withdrawal by Subject|4
106910|NCT00711009|367108|P2|Overall Study|Adverse Event/HIV-Related Event|5
106911|NCT00711009|367109|P1|Overall Study|Adverse Event/HIV-Related Event|4
106912|NCT00710970|367290|P1|Overall Study|Never took drug|2
106913|NCT00710970|367290|P1|Overall Study|Lost to Follow-up|8
106914|NCT00710879|367317|P2|Overall Study|Protocol Violation|3
106915|NCT00710879|367318|P1|Overall Study|Protocol Violation|0
106916|NCT00710879|367317|P2|Overall Study|Lost to Follow-up|1
106917|NCT00710879|367318|P1|Overall Study|Lost to Follow-up|2
106918|NCT00710866|367330|P2|Overall Study|Failed to meet eligibility|1
106919|NCT00710866|367331|P1|Overall Study|Failed to meet eligibility|1
106920|NCT00710866|367330|P2|Overall Study|Lost to Follow-up|0
106921|NCT00710866|367331|P1|Overall Study|Lost to Follow-up|1
106922|NCT00710866|367330|P2|Overall Study|Withdrawal by Subject|1
106923|NCT00710866|367331|P1|Overall Study|Withdrawal by Subject|2
106924|NCT00710866|367330|P2|Overall Study|Protocol Violation|4
106925|NCT00710866|367331|P1|Overall Study|Protocol Violation|5
106926|NCT00710762|367377|P2|Overall Study|Reason other than listed above|2
106927|NCT00710762|367378|P1|Overall Study|Reason other than listed above|2
106928|NCT00710762|367377|P2|Overall Study|Lost to Follow-up|0
106929|NCT00710762|367378|P1|Overall Study|Lost to Follow-up|1
106930|NCT00710762|367377|P2|Overall Study|Other Adverse Event|7
106931|NCT00710762|367378|P1|Overall Study|Other Adverse Event|7
106932|NCT00710762|367377|P2|Overall Study|Adverse Event other disease worsening|1
106933|NCT00710762|367378|P1|Overall Study|Adverse Event other disease worsening|2
106934|NCT00710762|367377|P2|Overall Study|Progressive disease|30
106935|NCT00710762|367378|P1|Overall Study|Progressive disease|27
106936|NCT00710749|367394|P2|First Intervention|Withdrawal by Subject|0
106937|NCT00710749|367395|P1|First Intervention|Withdrawal by Subject|1
106938|NCT00710606|367405|P2|Overall Study|Adverse Event|2
106939|NCT00710606|367406|P1|Overall Study|Adverse Event|0
106940|NCT00710554|367418|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
106941|NCT00710554|367419|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
106942|NCT00710554|367418|P2|Overall Study|Lack of Efficacy|12
106943|NCT00710554|367419|P1|Overall Study|Lack of Efficacy|11
106944|NCT00710554|367418|P2|Overall Study|Lost to Follow-up|1
106945|NCT00710554|367419|P1|Overall Study|Lost to Follow-up|7
106946|NCT00710554|367418|P2|Overall Study|Withdrawal by Subject|3
106947|NCT00710554|367419|P1|Overall Study|Withdrawal by Subject|7
106948|NCT00710554|367418|P2|Overall Study|Adverse Event|7
106949|NCT00710554|367419|P1|Overall Study|Adverse Event|24
106950|NCT00710424|367447|P2|Overall Study|Felt good so stopped treatment|1
106951|NCT00710424|367448|P1|Overall Study|Felt good so stopped treatment|0
106952|NCT00710424|367447|P2|Overall Study|Subject preferred paracetamol|1
106953|NCT00710424|367448|P1|Overall Study|Subject preferred paracetamol|0
106954|NCT00710424|367447|P2|Overall Study|Ceased treatment due to travel|0
106955|NCT00710424|367448|P1|Overall Study|Ceased treatment due to travel|1
106956|NCT00710424|367447|P2|Overall Study|Subject thought medication changed|0
106957|NCT00710424|367448|P1|Overall Study|Subject thought medication changed|1
106958|NCT00710424|367447|P2|Overall Study|Did not meet entry criteria at visit 1|0
106959|NCT00710424|367448|P1|Overall Study|Did not meet entry criteria at visit 1|1
106960|NCT00710424|367447|P2|Overall Study|Non-compliance with stable analgesia|0
106961|NCT00710424|367448|P1|Overall Study|Non-compliance with stable analgesia|1
106962|NCT00710424|367447|P2|Overall Study|Refused medication, no side effects|0
106963|NCT00710424|367448|P1|Overall Study|Refused medication, no side effects|1
106964|NCT00710424|367447|P2|Overall Study|Lost to Follow-up|1
106965|NCT00710424|367448|P1|Overall Study|Lost to Follow-up|0
106966|NCT00710424|367447|P2|Overall Study|Withdrawal by Subject|3
106967|NCT00710424|367448|P1|Overall Study|Withdrawal by Subject|5
106968|NCT00710424|367447|P2|Overall Study|Lack of Efficacy|5
106969|NCT00710424|367448|P1|Overall Study|Lack of Efficacy|4
106970|NCT00710424|367447|P2|Overall Study|Adverse Event|12
106971|NCT00710424|367448|P1|Overall Study|Adverse Event|30
106972|NCT00710385|367472|P1|Overall Study|Undisclosed excessive methadone use|1
106973|NCT00710385|367472|P1|Overall Study|Physician Decision|1
106974|NCT00710385|367472|P1|Overall Study|Undisclosed back pain|1
106975|NCT00710385|367472|P1|Overall Study|Withdrawal by Subject|1
106976|NCT00710385|367472|P1|Overall Study|Did not qualify|1
106977|NCT00710021|367518|P3|Overall Study|Physician Decision|0
106978|NCT00710021|367519|P2|Overall Study|Physician Decision|1
106979|NCT00710021|367520|P1|Overall Study|Physician Decision|0
106980|NCT00710021|367518|P3|Overall Study|Subject misrandomized|1
106981|NCT00710021|367519|P2|Overall Study|Subject misrandomized|1
106982|NCT00710021|367520|P1|Overall Study|Subject misrandomized|0
106983|NCT00710021|367518|P3|Overall Study|Subject's Decision|0
106984|NCT00710021|367519|P2|Overall Study|Subject's Decision|1
106985|NCT00710021|367520|P1|Overall Study|Subject's Decision|0
106986|NCT00710021|367518|P3|Overall Study|Lost to Follow-up|0
106987|NCT00710021|367519|P2|Overall Study|Lost to Follow-up|0
106988|NCT00710021|367520|P1|Overall Study|Lost to Follow-up|1
106989|NCT00709956|367635|P2|Overall Study|Inclusion/exclusion criteria violation|3
106990|NCT00709956|367636|P1|Overall Study|Inclusion/exclusion criteria violation|2
106991|NCT00709956|367635|P2|Overall Study|Withdrawal by Subject|1
106992|NCT00709956|367636|P1|Overall Study|Withdrawal by Subject|1
106993|NCT00709852|367666|P2|Period 2|No 72-hour follow-up|0
106994|NCT00709852|367667|P1|Period 2|No 72-hour follow-up|3
106995|NCT00709852|367666|P2|Period 2|Lost to Follow-up|0
106996|NCT00709852|367667|P1|Period 2|Lost to Follow-up|1
106997|NCT00709852|367666|P2|Period 2|Adverse Event|1
106998|NCT00709852|367667|P1|Period 2|Adverse Event|1
106999|NCT00709852|367666|P2|Period 2|Protocol Violation|1
107000|NCT00709852|367667|P1|Period 2|Protocol Violation|4
107001|NCT00709852|367666|P2|Period 1|Lost to Follow-up|0
107002|NCT00709852|367667|P1|Period 1|Lost to Follow-up|1
107003|NCT00709852|367666|P2|Period 1|Defective scanner|1
107004|NCT00709852|367667|P1|Period 1|Defective scanner|0
107005|NCT00709852|367666|P2|Period 1|Protocol Violation|0
107006|NCT00709852|367667|P1|Period 1|Protocol Violation|1
107007|NCT00709852|367666|P2|Period 1|Withdrawal by Subject|2
107008|NCT00709852|367667|P1|Period 1|Withdrawal by Subject|4
107009|NCT00709852|367666|P2|Period 1|Adverse Event|0
107010|NCT00709852|367667|P1|Period 1|Adverse Event|2
107011|NCT00708734|367831|P1|Overall Study|leg fracture|1
107012|NCT00708734|367831|P1|Overall Study|vertigo|1
107013|NCT00708734|367831|P1|Overall Study|knee replacement|1
107014|NCT00708734|367831|P1|Overall Study|leg injury|1
107015|NCT00708734|367831|P1|Overall Study|moved|1
107016|NCT00708734|367831|P1|Overall Study|scheduling conflict|2
107017|NCT00708708|367835|P1|Overall Study|Missing values|392
107018|NCT00708708|367835|P1|Overall Study|Adverse Event|3
107019|NCT00708708|367835|P1|Overall Study|Pregnancy|3
107020|NCT00708708|367835|P1|Overall Study|Lack of compliance|3
107021|NCT00708708|367835|P1|Overall Study|Lack of effectiveness|4
107022|NCT00708708|367835|P1|Overall Study|Administrative reasons|7
107023|NCT00708708|367835|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
107024|NCT00708708|367835|P1|Overall Study|Good effectiveness|9
107025|NCT00708708|367835|P1|Overall Study|Other unspecified|11
107026|NCT00708708|367835|P1|Overall Study|Another therapy along with Enbrel|15
107027|NCT00708708|367835|P1|Overall Study|Intolerance|42
107028|NCT00708708|367835|P1|Overall Study|Withdrawal by Subject|51
107029|NCT00708708|367835|P1|Overall Study|Lost to Follow-up|52
107030|NCT00708708|367835|P1|Overall Study|Another therapy instead of Enbrel|141
107031|NCT00708682|367883|P1|Toddler Dose|Failed to Return|4
107032|NCT00708682|367883|P1|Toddler Dose|Lost to Follow-up|3
107033|NCT00708682|367883|P1|Toddler Dose|Parent/Legal Guardian Request|1
107034|NCT00708682|367883|P1|After Infant Series|Parent/Legal Guardian Request|1
107035|NCT00708682|367883|P1|Infant Series|Not Specified|19
107036|NCT00708682|367883|P1|Infant Series|Failed to return|2
107037|NCT00708682|367883|P1|Infant Series|Parent/legal guardian request|6
107038|NCT00708682|367883|P1|Infant Series|Protocol Violation|1
107039|NCT00708682|367883|P1|Infant Series|Lost to Follow-up|4
107040|NCT00708682|367883|P1|Infant Series|Adverse Event|1
107041|NCT00708643|367904|P2|Overall Study|Adverse Event|1
107042|NCT00708643|367905|P1|Overall Study|Adverse Event|0
107043|NCT00709761|367921|P1|Overall Study|Ongoing|40
107044|NCT00709761|367921|P1|Overall Study|Withdrawal by Subject|7
107045|NCT00709722|367930|P1|Overall Study|Adverse Event|1
107046|NCT00709618|367936|P1|Overall Study|Study Closed/Terminated|25
107047|NCT00709618|367936|P1|Overall Study|Lost to Follow-up|1
107048|NCT00709618|367936|P1|Overall Study|Withdrawal by Subject|4
107049|NCT00709592|367948|P2|Overall Study|Unable to proceed to transplant|1
107050|NCT00709592|367949|P1|Overall Study|Unable to proceed to transplant|0
107051|NCT00709319|367969|P1|Overall Study|Withdrawal by Subject|2
107052|NCT00709319|367969|P1|Overall Study|Death|4
107053|NCT00709228|367977|P1|Overall Study|Non-compliance|5
107054|NCT00709228|367977|P1|Overall Study|Lost to Follow-up|6
107055|NCT00709228|367977|P1|Overall Study|Disease progression|1
107056|NCT00709228|367977|P1|Overall Study|Discontinued follow-up|5
107057|NCT00709228|367977|P1|Overall Study|Did not enter follow-up|4
107058|NCT00709228|367977|P1|Overall Study|Discontinued treatment|14
107059|NCT00709228|367977|P1|Overall Study|Adverse events|2
107060|NCT00709228|367977|P1|Overall Study|Eligibility criteria not met|281
107061|NCT00709228|367977|P1|Overall Study|Not treated|14
107062|NCT00709124|367983|P2|Overall Study|encephalopathy; can't do assessment|0
107063|NCT00709124|367984|P1|Overall Study|encephalopathy; can't do assessment|1
107064|NCT00709124|367983|P2|Overall Study|Death|1
107065|NCT00709124|367984|P1|Overall Study|Death|3
107066|NCT00709111|367990|P1|Overall Study|Unable to attend clinic visits|1
107067|NCT00709111|367990|P1|Overall Study|Withdrawal by Subject|1
107068|NCT00709098|368031|P3|Open-label Period|Lost to Follow-up|1
107069|NCT00709098|368032|P2|Open-label Period|Lost to Follow-up|0
107070|NCT00709098|368033|P1|Open-label Period|Lost to Follow-up|0
107071|NCT00709098|368031|P3|Open-label Period|Death|1
107072|NCT00709098|368032|P2|Open-label Period|Death|0
107073|NCT00709098|368033|P1|Open-label Period|Death|0
107074|NCT00709098|368031|P3|Open-label Period|Administrative reason|5
107075|NCT00709098|368032|P2|Open-label Period|Administrative reason|0
107076|NCT00709098|368033|P1|Open-label Period|Administrative reason|0
107077|NCT00709098|368031|P3|Open-label Period|Withdrawal of consent|7
107078|NCT00709098|368032|P2|Open-label Period|Withdrawal of consent|0
107079|NCT00709098|368033|P1|Open-label Period|Withdrawal of consent|0
107080|NCT00709098|368031|P3|Double-blind Period|Lost to Follow-up|0
107081|NCT00709098|368032|P2|Double-blind Period|Lost to Follow-up|1
107082|NCT00709098|368033|P1|Double-blind Period|Lost to Follow-up|1
107083|NCT00709098|368031|P3|Double-blind Period|Death|0
107084|NCT00709098|368032|P2|Double-blind Period|Death|1
107085|NCT00709098|368033|P1|Double-blind Period|Death|1
107086|NCT00709098|368031|P3|Double-blind Period|Administrative reason|0
107087|NCT00709098|368032|P2|Double-blind Period|Administrative reason|3
107088|NCT00709098|368033|P1|Double-blind Period|Administrative reason|1
107089|NCT00709098|368031|P3|Double-blind Period|Withdrawal of consent|0
107090|NCT00709098|368032|P2|Double-blind Period|Withdrawal of consent|3
107091|NCT00709098|368033|P1|Double-blind Period|Withdrawal of consent|3
107092|NCT00709059|368052|P1|Overall Study|Serious side effects|11
107093|NCT00709059|368052|P1|Overall Study|Side effects|20
107094|NCT00709059|368052|P1|Overall Study|Disease complication|3
107095|NCT00709059|368052|P1|Overall Study|Physician Decision|7
107096|NCT00709059|368052|P1|Overall Study|Withdrawal by Subject|19
107097|NCT00709059|368052|P1|Overall Study|Lost to Follow-up|34
107098|NCT00708500|368113|P3|FOLLOWUP|Non-compliance with protocol|1
107099|NCT00708500|368114|P2|FOLLOWUP|Non-compliance with protocol|0
107100|NCT00708500|368115|P1|FOLLOWUP|Non-compliance with protocol|5
107101|NCT00708500|368113|P3|FOLLOWUP|Subject withdrew consent|5
107102|NCT00708500|368114|P2|FOLLOWUP|Subject withdrew consent|4
107103|NCT00708500|368115|P1|FOLLOWUP|Subject withdrew consent|31
107104|NCT00708500|368113|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
107105|NCT00708500|368114|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
107106|NCT00708500|368115|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
107107|NCT00708500|368113|P3|FOLLOWUP|Lost to Follow-up|4
107108|NCT00708500|368114|P2|FOLLOWUP|Lost to Follow-up|6
107109|NCT00708500|368115|P1|FOLLOWUP|Lost to Follow-up|1
107110|NCT00708500|368113|P3|FOLLOWUP|Adverse Event|0
107111|NCT00708500|368114|P2|FOLLOWUP|Adverse Event|1
107112|NCT00708500|368115|P1|FOLLOWUP|Adverse Event|0
107113|NCT00708500|368113|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
107114|NCT00708500|368114|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
107115|NCT00708500|368115|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
107116|NCT00708500|368113|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
107117|NCT00708500|368114|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
107118|NCT00708500|368115|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
107119|NCT00708500|368113|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
107120|NCT00708500|368114|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
107121|NCT00708500|368115|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
107122|NCT00708500|368113|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
107123|NCT00708500|368114|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
107124|NCT00708500|368115|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
107125|NCT00708500|368113|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
107126|NCT00708500|368114|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
107127|NCT00708500|368115|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
107128|NCT00708500|368113|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
107129|NCT00708500|368114|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
107130|NCT00708500|368115|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
107131|NCT00708500|368113|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
107132|NCT00708500|368114|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
107133|NCT00708500|368115|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
107134|NCT00708500|368113|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
107135|NCT00708500|368114|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
107136|NCT00708500|368115|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
107137|NCT00708500|368113|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
107138|NCT00708500|368114|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
107139|NCT00708500|368115|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
107140|NCT00708500|368113|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
107141|NCT00708500|368114|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
107142|NCT00708500|368115|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
107143|NCT00708500|368113|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
107144|NCT00708500|368114|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
107145|NCT00708500|368115|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
107146|NCT00708500|368113|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
107147|NCT00708500|368114|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
107148|NCT00708500|368115|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
107149|NCT00708500|368113|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
107150|NCT00708500|368114|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
107151|NCT00708500|368115|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
107152|NCT00708461|368134|P2|Overall Study|left workforce|180
107153|NCT00708461|368135|P1|Overall Study|left workforce|115
107154|NCT00708461|368134|P2|Overall Study|Withdrawal by Subject|9
107155|NCT00708461|368135|P1|Overall Study|Withdrawal by Subject|8
107156|NCT00708461|368134|P2|Overall Study|Lost to Follow-up|11
107157|NCT00708461|368135|P1|Overall Study|Lost to Follow-up|18
107158|NCT00708435|368143|P2|Overall Study|Refused hospitalization|0
107159|NCT00708435|368144|P1|Overall Study|Refused hospitalization|1
107160|NCT00708435|368143|P2|Overall Study|Intervention by primary care physician|0
107161|NCT00708435|368144|P1|Overall Study|Intervention by primary care physician|1
107162|NCT00708435|368143|P2|Overall Study|Protocol Violation|1
107163|NCT00708435|368144|P1|Overall Study|Protocol Violation|0
107164|NCT00708435|368143|P2|Overall Study|Adverse Event|0
107165|NCT00708435|368144|P1|Overall Study|Adverse Event|1
107166|NCT00708435|368143|P2|Overall Study|Withdrawal by Subject|7
107167|NCT00708435|368144|P1|Overall Study|Withdrawal by Subject|3
107168|NCT00708435|368143|P2|Overall Study|Lost to Follow-up|4
107169|NCT00708435|368144|P1|Overall Study|Lost to Follow-up|9
107170|NCT00708435|368143|P2|Overall Study|Death / Serious Adverse Event|5
107171|NCT00708435|368144|P1|Overall Study|Death / Serious Adverse Event|10
107172|NCT00708422|368171|P2|Overall Study|Withdrawal by Subject|0
107173|NCT00708422|368172|P1|Overall Study|Withdrawal by Subject|1
107174|NCT00708422|368171|P2|Overall Study|Adverse Event|1
107175|NCT00708422|368172|P1|Overall Study|Adverse Event|3
107176|NCT00708305|368180|P4|Period 3|Other Reason|0
107177|NCT00708305|368181|P3|Period 3|Other Reason|0
107178|NCT00708305|368182|P2|Period 3|Other Reason|0
107179|NCT00708305|368183|P1|Period 3|Other Reason|1
107180|NCT00708305|368180|P4|Period 3|Protocol Violation|0
107181|NCT00708305|368181|P3|Period 3|Protocol Violation|0
107182|NCT00708305|368182|P2|Period 3|Protocol Violation|2
107183|NCT00708305|368183|P1|Period 3|Protocol Violation|0
107184|NCT00708305|368180|P4|Period 2|Other Reason|1
107185|NCT00708305|368181|P3|Period 2|Other Reason|0
107186|NCT00708305|368182|P2|Period 2|Other Reason|0
107187|NCT00708305|368183|P1|Period 2|Other Reason|1
107188|NCT00708305|368180|P4|Period 2|Protocol Violation|0
107189|NCT00708305|368181|P3|Period 2|Protocol Violation|0
107190|NCT00708305|368182|P2|Period 2|Protocol Violation|1
107191|NCT00708305|368183|P1|Period 2|Protocol Violation|0
107192|NCT00708305|368180|P4|Period 2|Lost to Follow-up|0
107193|NCT00708305|368181|P3|Period 2|Lost to Follow-up|0
107194|NCT00708305|368182|P2|Period 2|Lost to Follow-up|1
107195|NCT00708305|368183|P1|Period 2|Lost to Follow-up|0
107196|NCT00708305|368180|P4|Period 1|Other Reason|2
107197|NCT00708305|368181|P3|Period 1|Other Reason|0
107198|NCT00708305|368182|P2|Period 1|Other Reason|0
107199|NCT00708305|368183|P1|Period 1|Other Reason|0
107200|NCT00708305|368180|P4|Period 1|Protocol Violation|0
107201|NCT00708305|368181|P3|Period 1|Protocol Violation|1
107202|NCT00708305|368182|P2|Period 1|Protocol Violation|0
107203|NCT00708305|368183|P1|Period 1|Protocol Violation|1
107204|NCT00708214|368218|P3|Overall Study|Progressive Disease|5
107205|NCT00708214|368219|P2|Overall Study|Progressive Disease|6
107206|NCT00708214|368220|P1|Overall Study|Progressive Disease|4
107207|NCT00708214|368218|P3|Overall Study|Other|1
107208|NCT00708214|368219|P2|Overall Study|Other|1
107209|NCT00708214|368220|P1|Overall Study|Other|0
107210|NCT00708214|368218|P3|Overall Study|Other Adverse Event|2
107211|NCT00708214|368219|P2|Overall Study|Other Adverse Event|6
107212|NCT00708214|368220|P1|Overall Study|Other Adverse Event|3
107213|NCT00708201|368263|P2|Overall Study|Protocol Violation|1
107214|NCT00708201|368264|P1|Overall Study|Protocol Violation|0
107215|NCT00708201|368263|P2|Overall Study|Lost to Follow-up|0
107216|NCT00708201|368264|P1|Overall Study|Lost to Follow-up|2
107217|NCT00708201|368263|P2|Overall Study|Withdrawal by Subject|1
107218|NCT00708201|368264|P1|Overall Study|Withdrawal by Subject|1
107219|NCT00708201|368263|P2|Overall Study|Adverse Event|4
107220|NCT00708201|368264|P1|Overall Study|Adverse Event|4
107221|NCT00708175|368288|P2|Overall Study|BMD loss >7%|3
107222|NCT00708175|368289|P1|Overall Study|BMD loss >7%|2
107223|NCT00708175|368288|P2|Overall Study|Withdrawal by Subject|7
107224|NCT00708175|368289|P1|Overall Study|Withdrawal by Subject|5
107225|NCT00708175|368288|P2|Overall Study|Lost to Follow-up|3
107226|NCT00708175|368289|P1|Overall Study|Lost to Follow-up|5
107227|NCT00708175|368288|P2|Overall Study|Protocol Violation|3
107228|NCT00708175|368289|P1|Overall Study|Protocol Violation|2
107229|NCT00708175|368288|P2|Overall Study|Adverse Event|5
107230|NCT00708175|368289|P1|Overall Study|Adverse Event|4
107231|NCT00708162|368305|P2|Open-Label Phase|Other|0
107232|NCT00708162|368306|P1|Open-Label Phase|Other|1
107233|NCT00708162|368305|P2|Open-Label Phase|Adverse Event|2
107234|NCT00708162|368306|P1|Open-Label Phase|Adverse Event|1
107235|NCT00708162|368305|P2|Open-Label Phase|Death|1
107236|NCT00708162|368306|P1|Open-Label Phase|Death|3
107237|NCT00708162|368305|P2|Open-Label Phase|Investigator's Discretion|2
107238|NCT00708162|368306|P1|Open-Label Phase|Investigator's Discretion|3
107239|NCT00708162|368305|P2|Open-Label Phase|Lack of Efficacy|4
107240|NCT00708162|368306|P1|Open-Label Phase|Lack of Efficacy|7
107241|NCT00708162|368305|P2|Open-Label Phase|Participant Noncompliance|7
107242|NCT00708162|368306|P1|Open-Label Phase|Participant Noncompliance|7
107243|NCT00708162|368305|P2|Open-Label Phase|Withdrew Consent|6
107244|NCT00708162|368306|P1|Open-Label Phase|Withdrew Consent|12
107245|NCT00708162|368305|P2|Open-Label Phase|Lost to Follow-up|8
107246|NCT00708162|368306|P1|Open-Label Phase|Lost to Follow-up|10
107247|NCT00708162|368305|P2|Randomized Phase|Pregnancy|0
107248|NCT00708162|368306|P1|Randomized Phase|Pregnancy|3
107249|NCT00708162|368305|P2|Randomized Phase|Death|9
107250|NCT00708162|368306|P1|Randomized Phase|Death|2
107251|NCT00708162|368305|P2|Randomized Phase|Investigator’s Discretion|10
107252|NCT00708162|368306|P1|Randomized Phase|Investigator’s Discretion|7
107253|NCT00708162|368305|P2|Randomized Phase|Adverse Event|12
107254|NCT00708162|368306|P1|Randomized Phase|Adverse Event|8
107255|NCT00708162|368305|P2|Randomized Phase|Protocol Violation|11
107256|NCT00708162|368306|P1|Randomized Phase|Protocol Violation|10
107257|NCT00708162|368305|P2|Randomized Phase|Lack of Efficacy|19
107258|NCT00708162|368306|P1|Randomized Phase|Lack of Efficacy|14
107259|NCT00708162|368305|P2|Randomized Phase|Withdrew Consent|22
107260|NCT00708162|368306|P1|Randomized Phase|Withdrew Consent|31
107261|NCT00708162|368305|P2|Randomized Phase|Lost to Follow-up|34
107262|NCT00708162|368306|P1|Randomized Phase|Lost to Follow-up|34
107263|NCT00708162|368305|P2|Randomized Phase|Participant Noncompliance|32
107264|NCT00708162|368306|P1|Randomized Phase|Participant Noncompliance|40
107265|NCT00708162|368305|P2|Randomized Phase|Randomized but Not Treated|5
107266|NCT00708162|368306|P1|Randomized Phase|Randomized but Not Treated|7
107267|NCT00708123|368347|P5|Period 4|Protocol Violation|0
107268|NCT00708123|368348|P4|Period 4|Protocol Violation|0
107269|NCT00708123|368349|P3|Period 4|Protocol Violation|0
107270|NCT00708123|368350|P2|Period 4|Protocol Violation|1
107271|NCT00708123|368351|P1|Period 4|Protocol Violation|0
107272|NCT00708123|368347|P5|Period 3|Lost to Follow-up|0
107273|NCT00708123|368348|P4|Period 3|Lost to Follow-up|1
107274|NCT00708123|368349|P3|Period 3|Lost to Follow-up|1
107275|NCT00708123|368350|P2|Period 3|Lost to Follow-up|0
107276|NCT00708123|368351|P1|Period 3|Lost to Follow-up|0
107277|NCT00708123|368347|P5|Period 2|Other Reason|0
107278|NCT00708123|368348|P4|Period 2|Other Reason|0
107279|NCT00708123|368349|P3|Period 2|Other Reason|0
107280|NCT00708123|368350|P2|Period 2|Other Reason|0
107281|NCT00708123|368351|P1|Period 2|Other Reason|1
107282|NCT00708123|368347|P5|Period 2|Protocol Violation|0
107283|NCT00708123|368348|P4|Period 2|Protocol Violation|1
107284|NCT00708123|368349|P3|Period 2|Protocol Violation|0
107285|NCT00708123|368350|P2|Period 2|Protocol Violation|0
107286|NCT00708123|368351|P1|Period 2|Protocol Violation|0
107287|NCT00708123|368347|P5|Period 1|Adverse Event|0
107288|NCT00708123|368348|P4|Period 1|Adverse Event|0
107289|NCT00708123|368349|P3|Period 1|Adverse Event|1
107290|NCT00708123|368350|P2|Period 1|Adverse Event|0
107291|NCT00708123|368351|P1|Period 1|Adverse Event|0
107292|NCT00708123|368347|P5|Period 1|Protocol Violation|0
107293|NCT00708123|368348|P4|Period 1|Protocol Violation|1
107294|NCT00708123|368349|P3|Period 1|Protocol Violation|0
107295|NCT00708123|368350|P2|Period 1|Protocol Violation|1
107296|NCT00708123|368351|P1|Period 1|Protocol Violation|0
107297|NCT00708097|368484|P5|Period 2|Protocol Violation|0
107298|NCT00708097|368485|P4|Period 2|Protocol Violation|1
107299|NCT00708097|368486|P3|Period 2|Protocol Violation|1
107300|NCT00708097|368487|P2|Period 2|Protocol Violation|1
107301|NCT00708097|368488|P1|Period 2|Protocol Violation|0
107302|NCT00708097|368484|P5|Period 1|Other Reason|1
107303|NCT00708097|368485|P4|Period 1|Other Reason|0
107304|NCT00708097|368486|P3|Period 1|Other Reason|0
107305|NCT00708097|368487|P2|Period 1|Other Reason|0
107306|NCT00708097|368488|P1|Period 1|Other Reason|0
107307|NCT00708097|368484|P5|Period 1|Protocol Violation|0
107308|NCT00708097|368485|P4|Period 1|Protocol Violation|2
107309|NCT00708097|368486|P3|Period 1|Protocol Violation|0
107310|NCT00708097|368487|P2|Period 1|Protocol Violation|1
107311|NCT00708097|368488|P1|Period 1|Protocol Violation|0
107312|NCT00708032|368598|P2|Overall Study|Withdrawal by Subject|1
107313|NCT00708032|368599|P1|Overall Study|Withdrawal by Subject|0
107314|NCT00708032|368598|P2|Overall Study|Protocol Violation|1
107315|NCT00708032|368599|P1|Overall Study|Protocol Violation|4
107316|NCT00708032|368598|P2|Overall Study|Did not meet protocol criteria|2
107317|NCT00708032|368599|P1|Overall Study|Did not meet protocol criteria|1
107318|NCT00708032|368598|P2|Overall Study|Visit out of range at month 12|1
107319|NCT00708032|368599|P1|Overall Study|Visit out of range at month 12|4
107320|NCT00708032|368598|P2|Overall Study|Poor vision|6
107321|NCT00708032|368599|P1|Overall Study|Poor vision|0
107322|NCT00708032|368598|P2|Overall Study|Pregnancy|1
107323|NCT00708032|368599|P1|Overall Study|Pregnancy|0
107324|NCT00708032|368598|P2|Overall Study|Lost to Follow-up|2
107325|NCT00708032|368599|P1|Overall Study|Lost to Follow-up|1
107326|NCT00708032|368598|P2|Overall Study|Adverse Event|2
107327|NCT00708032|368599|P1|Overall Study|Adverse Event|0
107328|NCT00707993|368626|P2|Overall Study|Other|0
107329|NCT00707993|368627|P1|Overall Study|Other|2
107330|NCT00707993|368626|P2|Overall Study|Hyperglycemic Rescue|47
107331|NCT00707993|368627|P1|Overall Study|Hyperglycemic Rescue|55
107332|NCT00707993|368626|P2|Overall Study|Withdrawal by Subject|16
107333|NCT00707993|368627|P1|Overall Study|Withdrawal by Subject|12
107334|NCT00707993|368626|P2|Overall Study|Lost to Follow-up|4
107335|NCT00707993|368627|P1|Overall Study|Lost to Follow-up|0
107336|NCT00707993|368626|P2|Overall Study|Protocol Violation|7
107337|NCT00707993|368627|P1|Overall Study|Protocol Violation|4
107338|NCT00707993|368626|P2|Overall Study|Adverse Event|20
107339|NCT00707993|368627|P1|Overall Study|Adverse Event|16
107340|NCT00707980|368669|P1|Overall Study|Other|39
107341|NCT00707980|368669|P1|Overall Study|Lost to Follow-up|59
107342|NCT00707980|368669|P1|Overall Study|Withdrawal of Consent|81
107343|NCT00707980|368669|P1|Overall Study|Protocol Deviations|19
107344|NCT00707980|368669|P1|Overall Study|Non-Compliance with Study Drug|28
107345|NCT00707980|368669|P1|Overall Study|Lack of Efficacy|35
107346|NCT00707980|368669|P1|Overall Study|Adverse Event|49
107347|NCT00707954|368753|P5|Overall Study|Physician Decision|1
107348|NCT00707954|368754|P4|Overall Study|Physician Decision|0
107349|NCT00707954|368755|P3|Overall Study|Physician Decision|0
107350|NCT00707954|368756|P2|Overall Study|Physician Decision|0
107351|NCT00707954|368757|P1|Overall Study|Physician Decision|0
107352|NCT00707746|368798|P2|Treatment Period|Ineligibility|1
107353|NCT00707746|368799|P1|Treatment Period|Ineligibility|0
107354|NCT00707746|368798|P2|Treatment Period|Adverse Event|4
107355|NCT00707746|368799|P1|Treatment Period|Adverse Event|2
107356|NCT00707486|368858|P1|Overall Study|Withdrawal by Subject|1
107357|NCT00707239|368901|P3|Overall Study|Unspecified|5
107358|NCT00707239|368902|P2|Overall Study|Unspecified|3
107359|NCT00707239|368903|P1|Overall Study|Unspecified|8
107360|NCT00707239|368901|P3|Overall Study|Randomized, but not treated|1
107361|NCT00707239|368902|P2|Overall Study|Randomized, but not treated|1
107362|NCT00707239|368903|P1|Overall Study|Randomized, but not treated|1
107363|NCT00707239|368901|P3|Overall Study|Lack of Efficacy|0
107364|NCT00707239|368902|P2|Overall Study|Lack of Efficacy|2
107365|NCT00707239|368903|P1|Overall Study|Lack of Efficacy|1
107366|NCT00707239|368901|P3|Overall Study|Protocol Violation|1
107367|NCT00707239|368902|P2|Overall Study|Protocol Violation|0
107368|NCT00707239|368903|P1|Overall Study|Protocol Violation|0
107369|NCT00707239|368901|P3|Overall Study|Physician Decision|2
107370|NCT00707239|368902|P2|Overall Study|Physician Decision|1
107371|NCT00707239|368903|P1|Overall Study|Physician Decision|1
107372|NCT00707239|368901|P3|Overall Study|Death|3
107373|NCT00707239|368902|P2|Overall Study|Death|1
107374|NCT00707239|368903|P1|Overall Study|Death|3
107375|NCT00707239|368901|P3|Overall Study|Adverse Event|2
107376|NCT00707239|368902|P2|Overall Study|Adverse Event|3
107377|NCT00707239|368903|P1|Overall Study|Adverse Event|5
107378|NCT00707174|368951|P2|Overall Study|Withdrawal by Subject|1
107379|NCT00707174|368952|P1|Overall Study|Withdrawal by Subject|4
107380|NCT00707174|368951|P2|Overall Study|Adverse Event|6
107381|NCT00707174|368952|P1|Overall Study|Adverse Event|1
107382|NCT00707161|368958|P1|Overall Study|Physician Decision|6
107383|NCT00707057|368964|P2|Overall Study|Dosed incorrectly|1
107384|NCT00707057|368965|P1|Overall Study|Dosed incorrectly|0
107385|NCT00707057|368964|P2|Overall Study|Withdrawal by Subject|3
107386|NCT00707057|368965|P1|Overall Study|Withdrawal by Subject|8
107387|NCT00707031|368999|P2|Overall Study|Sponsor Decision|8
107388|NCT00707031|369000|P1|Overall Study|Sponsor Decision|9
107389|NCT00707031|368999|P2|Overall Study|Serious Noncompliance|3
107390|NCT00707031|369000|P1|Overall Study|Serious Noncompliance|2
107391|NCT00707031|368999|P2|Overall Study|Familial or Personal Reasons|15
107392|NCT00707031|369000|P1|Overall Study|Familial or Personal Reasons|12
107393|NCT00707031|368999|P2|Overall Study|Poor Compliance to Protocol|13
107394|NCT00707031|369000|P1|Overall Study|Poor Compliance to Protocol|7
107395|NCT00707031|368999|P2|Overall Study|Withdrawal by Subject|8
107396|NCT00707031|369000|P1|Overall Study|Withdrawal by Subject|7
107397|NCT00707031|368999|P2|Overall Study|Protocol Violation|0
107398|NCT00707031|369000|P1|Overall Study|Protocol Violation|1
107399|NCT00707031|368999|P2|Overall Study|Lost to Follow-up|1
107400|NCT00707031|369000|P1|Overall Study|Lost to Follow-up|2
107401|NCT00707031|368999|P2|Overall Study|Lack of Efficacy|6
107402|NCT00707031|369000|P1|Overall Study|Lack of Efficacy|19
107403|NCT00707031|368999|P2|Overall Study|Adverse Event|45
107404|NCT00707031|369000|P1|Overall Study|Adverse Event|45
107405|NCT00706992|369029|P7|Overall Study|Disease progression before treatment|0
107406|NCT00706992|369030|P6|Overall Study|Disease progression before treatment|0
107407|NCT00706992|369031|P5|Overall Study|Disease progression before treatment|1
107408|NCT00706992|369032|P4|Overall Study|Disease progression before treatment|0
107409|NCT00706992|369033|P3|Overall Study|Disease progression before treatment|0
107410|NCT00706992|369034|P2|Overall Study|Disease progression before treatment|0
107411|NCT00706992|369035|P1|Overall Study|Disease progression before treatment|0
107412|NCT00706992|369029|P7|Overall Study|Study termination|3
107413|NCT00706992|369030|P6|Overall Study|Study termination|2
107414|NCT00706992|369031|P5|Overall Study|Study termination|3
107415|NCT00706992|369032|P4|Overall Study|Study termination|2
107416|NCT00706992|369033|P3|Overall Study|Study termination|6
107417|NCT00706992|369034|P2|Overall Study|Study termination|5
107418|NCT00706992|369035|P1|Overall Study|Study termination|5
107419|NCT00706966|369067|P1|Overall Study|Adverse Event|1
107420|NCT00706901|369103|P3|Overall Study|Death|0
107421|NCT00706901|369104|P2|Overall Study|Death|0
107422|NCT00706901|369105|P1|Overall Study|Death|1
107423|NCT00706901|369103|P3|Overall Study|In Jail|1
107424|NCT00706901|369104|P2|Overall Study|In Jail|0
107425|NCT00706901|369105|P1|Overall Study|In Jail|1
107426|NCT00706901|369103|P3|Overall Study|Withdrawal by Subject|5
107427|NCT00706901|369104|P2|Overall Study|Withdrawal by Subject|2
107428|NCT00706901|369105|P1|Overall Study|Withdrawal by Subject|4
107429|NCT00706901|369103|P3|Overall Study|Lost to Follow-up|2
107430|NCT00706901|369104|P2|Overall Study|Lost to Follow-up|3
107431|NCT00706901|369105|P1|Overall Study|Lost to Follow-up|2
107432|NCT00706849|369130|P2|Follow-up Period|Protocol non-compliance|1
107433|NCT00706849|369131|P1|Follow-up Period|Protocol non-compliance|0
107434|NCT00706849|369130|P2|Follow-up Period|Withdrawal by Subject|2
107435|NCT00706849|369131|P1|Follow-up Period|Withdrawal by Subject|0
107436|NCT00706849|369130|P2|Treatment Period|Other|1
107437|NCT00706849|369131|P1|Treatment Period|Other|0
107438|NCT00706849|369130|P2|Treatment Period|Adverse Event|9
107439|NCT00706849|369131|P1|Treatment Period|Adverse Event|0
107440|NCT00706797|369204|P2|Overall Study|Unspecified|0
107441|NCT00706797|369205|P1|Overall Study|Unspecified|1
107442|NCT00706797|369204|P2|Overall Study|Lost to Follow-up|2
107443|NCT00706797|369205|P1|Overall Study|Lost to Follow-up|1
107444|NCT00706797|369204|P2|Overall Study|Protocol Violation|2
107445|NCT00706797|369205|P1|Overall Study|Protocol Violation|3
107446|NCT00706797|369204|P2|Overall Study|Discontinuation of study by sponsor|63
107447|NCT00706797|369205|P1|Overall Study|Discontinuation of study by sponsor|52
107448|NCT00706797|369204|P2|Overall Study|Death|0
107449|NCT00706797|369205|P1|Overall Study|Death|1
107450|NCT00706797|369204|P2|Overall Study|Withdrawal by Subject|1
107451|NCT00706797|369205|P1|Overall Study|Withdrawal by Subject|8
107452|NCT00706797|369204|P2|Overall Study|Adverse Event|3
107453|NCT00706797|369205|P1|Overall Study|Adverse Event|0
107454|NCT00706797|369204|P2|Overall Study|Lack of Efficacy|0
107455|NCT00706797|369205|P1|Overall Study|Lack of Efficacy|3
107456|NCT00706706|369274|P1|Overall Study|Study endpoint had reached|45
107457|NCT00706706|369274|P1|Overall Study|Lost to Follow-up|7
107458|NCT00706706|369274|P1|Overall Study|Death|53
107459|NCT00706654|369284|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
107460|NCT00706654|369285|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
107461|NCT00706654|369286|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
107462|NCT00706654|369287|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
107463|NCT00706654|369284|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
107464|NCT00706654|369285|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
107465|NCT00706654|369286|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
107466|NCT00706654|369287|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
107467|NCT00706654|369284|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
107468|NCT00706654|369285|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
107469|NCT00706654|369286|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
107470|NCT00706654|369287|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
107471|NCT00706654|369284|P4|Depot Maintenance Phase|Protocol Deviation|1
107472|NCT00706654|369285|P3|Depot Maintenance Phase|Protocol Deviation|3
107473|NCT00706654|369286|P2|Depot Maintenance Phase|Protocol Deviation|2
107474|NCT00706654|369287|P1|Depot Maintenance Phase|Protocol Deviation|0
107475|NCT00706654|369284|P4|Depot Maintenance Phase|Withdrew Consent|14
107476|NCT00706654|369285|P3|Depot Maintenance Phase|Withdrew Consent|29
107477|NCT00706654|369286|P2|Depot Maintenance Phase|Withdrew Consent|21
107478|NCT00706654|369287|P1|Depot Maintenance Phase|Withdrew Consent|0
107479|NCT00706654|369284|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
107480|NCT00706654|369285|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
107481|NCT00706654|369286|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
107482|NCT00706654|369287|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
107483|NCT00706654|369284|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
107484|NCT00706654|369285|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
107485|NCT00706654|369286|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
107486|NCT00706654|369287|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
107487|NCT00706654|369284|P4|Depot Maintenance Phase|Lost to Follow-up|6
107488|NCT00706654|369285|P3|Depot Maintenance Phase|Lost to Follow-up|10
107489|NCT00706654|369286|P2|Depot Maintenance Phase|Lost to Follow-up|4
107490|NCT00706654|369287|P1|Depot Maintenance Phase|Lost to Follow-up|0
107491|NCT00706654|369284|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
107492|NCT00706654|369285|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
107493|NCT00706654|369286|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
107494|NCT00706654|369287|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
107495|NCT00706654|369284|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
107496|NCT00706654|369285|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
107497|NCT00706654|369286|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
107498|NCT00706654|369287|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
107499|NCT00706654|369284|P4|Oral Stabilization Phase|Adverse Event|0
107500|NCT00706654|369285|P3|Oral Stabilization Phase|Adverse Event|0
107501|NCT00706654|369286|P2|Oral Stabilization Phase|Adverse Event|0
107502|NCT00706654|369287|P1|Oral Stabilization Phase|Adverse Event|21
107503|NCT00706654|369284|P4|Oral Stabilization Phase|Protocol Deviation|0
107504|NCT00706654|369285|P3|Oral Stabilization Phase|Protocol Deviation|0
107505|NCT00706654|369286|P2|Oral Stabilization Phase|Protocol Deviation|0
107506|NCT00706654|369287|P1|Oral Stabilization Phase|Protocol Deviation|2
107507|NCT00706654|369284|P4|Oral Stabilization Phase|Withdrew consent|0
107508|NCT00706654|369285|P3|Oral Stabilization Phase|Withdrew consent|0
107509|NCT00706654|369286|P2|Oral Stabilization Phase|Withdrew consent|0
107510|NCT00706654|369287|P1|Oral Stabilization Phase|Withdrew consent|55
107511|NCT00706654|369284|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
107512|NCT00706654|369285|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
107513|NCT00706654|369286|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
107514|NCT00706654|369287|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
107515|NCT00706654|369284|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
107516|NCT00706654|369285|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
107517|NCT00706654|369286|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
107518|NCT00706654|369287|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
107519|NCT00706654|369284|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
107520|NCT00706654|369285|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
107521|NCT00706654|369286|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
107522|NCT00706654|369287|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
107523|NCT00706654|369284|P4|Oral Stabilization Phase|Lost to Follow-up|0
107524|NCT00706654|369285|P3|Oral Stabilization Phase|Lost to Follow-up|0
107525|NCT00706654|369286|P2|Oral Stabilization Phase|Lost to Follow-up|0
107526|NCT00706654|369287|P1|Oral Stabilization Phase|Lost to Follow-up|17
107527|NCT00706654|369284|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
107528|NCT00706654|369285|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
107529|NCT00706654|369286|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
107530|NCT00706654|369287|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
107531|NCT00706654|369284|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
107532|NCT00706654|369285|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
107533|NCT00706654|369286|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
107534|NCT00706654|369287|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
107535|NCT00706654|369284|P4|Conversion Phase|Adverse Event|0
107536|NCT00706654|369285|P3|Conversion Phase|Adverse Event|0
107537|NCT00706654|369286|P2|Conversion Phase|Adverse Event|0
107538|NCT00706654|369287|P1|Conversion Phase|Adverse Event|18
107539|NCT00706654|369284|P4|Conversion Phase|Withdrew Consent|0
107540|NCT00706654|369285|P3|Conversion Phase|Withdrew Consent|0
107541|NCT00706654|369286|P2|Conversion Phase|Withdrew Consent|0
107542|NCT00706654|369287|P1|Conversion Phase|Withdrew Consent|38
107543|NCT00706654|369284|P4|Conversion Phase|Withdrawn by Investigator|0
107544|NCT00706654|369285|P3|Conversion Phase|Withdrawn by Investigator|0
107545|NCT00706654|369286|P2|Conversion Phase|Withdrawn by Investigator|0
107546|NCT00706654|369287|P1|Conversion Phase|Withdrawn by Investigator|14
107547|NCT00706654|369284|P4|Conversion Phase|Met Withdrawal Criteria|0
107548|NCT00706654|369285|P3|Conversion Phase|Met Withdrawal Criteria|0
107549|NCT00706654|369286|P2|Conversion Phase|Met Withdrawal Criteria|0
107550|NCT00706654|369287|P1|Conversion Phase|Met Withdrawal Criteria|2
107551|NCT00706654|369284|P4|Conversion Phase|Sponsor Discontinued Trial|0
107552|NCT00706654|369285|P3|Conversion Phase|Sponsor Discontinued Trial|0
107553|NCT00706654|369286|P2|Conversion Phase|Sponsor Discontinued Trial|0
107554|NCT00706654|369287|P1|Conversion Phase|Sponsor Discontinued Trial|8
107555|NCT00706654|369284|P4|Conversion Phase|Lost to Follow-up|0
107556|NCT00706654|369285|P3|Conversion Phase|Lost to Follow-up|0
107557|NCT00706654|369286|P2|Conversion Phase|Lost to Follow-up|0
107558|NCT00706654|369287|P1|Conversion Phase|Lost to Follow-up|4
107559|NCT00706641|369306|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
107560|NCT00706641|369306|P1|Dasatinib Administration|Ineligible after start of therapy|1
107561|NCT00706641|369306|P1|Dasatinib Administration|Withdrawal by Subject|1
107562|NCT00706628|369320|P4|Overall Study|Not treated|0
107563|NCT00706628|369321|P3|Overall Study|Not treated|0
107564|NCT00706628|369322|P2|Overall Study|Not treated|1
107565|NCT00706628|369323|P1|Overall Study|Not treated|1
107566|NCT00706628|369320|P4|Overall Study|Other than those stated above|0
107567|NCT00706628|369321|P3|Overall Study|Other than those stated above|0
107568|NCT00706628|369322|P2|Overall Study|Other than those stated above|0
107569|NCT00706628|369323|P1|Overall Study|Other than those stated above|4
107570|NCT00706628|369320|P4|Overall Study|Progressive disease|1
107571|NCT00706628|369321|P3|Overall Study|Progressive disease|8
107572|NCT00706628|369322|P2|Overall Study|Progressive disease|13
107573|NCT00706628|369323|P1|Overall Study|Progressive disease|20
107574|NCT00706628|369320|P4|Overall Study|Consent withdrawn|0
107575|NCT00706628|369321|P3|Overall Study|Consent withdrawn|3
107576|NCT00706628|369322|P2|Overall Study|Consent withdrawn|1
107577|NCT00706628|369323|P1|Overall Study|Consent withdrawn|6
107578|NCT00706628|369320|P4|Overall Study|Non compliant with protocol|0
107579|NCT00706628|369321|P3|Overall Study|Non compliant with protocol|0
107580|NCT00706628|369322|P2|Overall Study|Non compliant with protocol|1
107581|NCT00706628|369323|P1|Overall Study|Non compliant with protocol|0
107582|NCT00706628|369320|P4|Overall Study|Other Adverse Event|2
107583|NCT00706628|369321|P3|Overall Study|Other Adverse Event|5
107584|NCT00706628|369322|P2|Overall Study|Other Adverse Event|5
107585|NCT00706628|369323|P1|Overall Study|Other Adverse Event|16
107586|NCT00706433|369434|P4|Overall Study|new job|1
107587|NCT00706433|369435|P3|Overall Study|new job|0
107588|NCT00706433|369436|P2|Overall Study|new job|0
107589|NCT00706433|369437|P1|Overall Study|new job|0
107590|NCT00706433|369434|P4|Overall Study|Protocol Violation|0
107591|NCT00706433|369435|P3|Overall Study|Protocol Violation|0
107592|NCT00706433|369436|P2|Overall Study|Protocol Violation|0
107593|NCT00706433|369437|P1|Overall Study|Protocol Violation|1
107594|NCT00706433|369434|P4|Overall Study|Adverse Event|0
107595|NCT00706433|369435|P3|Overall Study|Adverse Event|1
107596|NCT00706433|369436|P2|Overall Study|Adverse Event|0
107597|NCT00706433|369437|P1|Overall Study|Adverse Event|0
107598|NCT00706433|369434|P4|Overall Study|Withdrawal by Subject|1
107599|NCT00706433|369435|P3|Overall Study|Withdrawal by Subject|3
107600|NCT00706433|369436|P2|Overall Study|Withdrawal by Subject|2
107601|NCT00706433|369437|P1|Overall Study|Withdrawal by Subject|1
107602|NCT00706433|369434|P4|Overall Study|Lost to Follow-up|0
107603|NCT00706433|369435|P3|Overall Study|Lost to Follow-up|6
107604|NCT00706433|369436|P2|Overall Study|Lost to Follow-up|1
107605|NCT00706433|369437|P1|Overall Study|Lost to Follow-up|3
107606|NCT00706355|369755|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
107607|NCT00706355|369756|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
107608|NCT00706355|369757|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
107609|NCT00706355|369758|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
107610|NCT00706355|369755|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
107611|NCT00706355|369756|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
107612|NCT00706355|369757|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
107613|NCT00706355|369758|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
107614|NCT00706355|369755|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
107615|NCT00706355|369756|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
107616|NCT00706355|369757|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
107617|NCT00706355|369758|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
107618|NCT00706355|369755|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
107619|NCT00706355|369756|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
107620|NCT00706355|369757|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
107621|NCT00706355|369758|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
107622|NCT00706355|369755|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
107623|NCT00706355|369756|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
107624|NCT00706355|369757|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
107625|NCT00706355|369758|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
107626|NCT00706355|369755|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
107627|NCT00706355|369756|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
107628|NCT00706355|369757|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
107629|NCT00706355|369758|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
107630|NCT00706355|369755|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
107631|NCT00706355|369756|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
107632|NCT00706355|369757|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
107633|NCT00706355|369758|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
107634|NCT00706355|369755|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
107635|NCT00706355|369756|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
107636|NCT00706355|369757|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
107637|NCT00706355|369758|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
107638|NCT00706355|369755|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
107639|NCT00706355|369756|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
107640|NCT00706355|369757|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
107641|NCT00706355|369758|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
107642|NCT00706342|369810|P1|Overall Study|WIthdrawal of consent|1
107643|NCT00706342|369810|P1|Overall Study|Ongoing|6
107644|NCT00706342|369810|P1|Overall Study|Non-responder Week 12|1
107645|NCT00706342|369810|P1|Overall Study|Investigator discretion|2
107646|NCT00706342|369810|P1|Overall Study|Withdrew from the study on his own.|1
107647|NCT00706342|369810|P1|Overall Study|Death|1
107648|NCT00706342|369810|P1|Overall Study|Withdrawn due to failure to respond|1
107649|NCT00706342|369810|P1|Overall Study|Not responding to treatment|2
107650|NCT00706342|369810|P1|Overall Study|Adverse Event|3
107651|NCT00706134|369827|P4|Overall Study|Did not meet study criteria|0
107652|NCT00706134|369828|P3|Overall Study|Did not meet study criteria|0
107653|NCT00706134|369829|P2|Overall Study|Did not meet study criteria|0
107654|NCT00706134|369830|P1|Overall Study|Did not meet study criteria|2
107655|NCT00706134|369827|P4|Overall Study|Unsatisfactory therapeutic effect|5
107656|NCT00706134|369828|P3|Overall Study|Unsatisfactory therapeutic effect|3
107657|NCT00706134|369829|P2|Overall Study|Unsatisfactory therapeutic effect|3
107658|NCT00706134|369830|P1|Overall Study|Unsatisfactory therapeutic effect|9
107659|NCT00706134|369827|P4|Overall Study|Withdrawal by Subject|0
107660|NCT00706134|369828|P3|Overall Study|Withdrawal by Subject|1
107661|NCT00706134|369829|P2|Overall Study|Withdrawal by Subject|2
107662|NCT00706134|369830|P1|Overall Study|Withdrawal by Subject|1
107663|NCT00706134|369827|P4|Overall Study|Protocol Violation|3
107664|NCT00706134|369828|P3|Overall Study|Protocol Violation|0
107665|NCT00706134|369829|P2|Overall Study|Protocol Violation|6
107666|NCT00706134|369830|P1|Overall Study|Protocol Violation|0
107667|NCT00706134|369827|P4|Overall Study|Lost to Follow-up|0
107668|NCT00706134|369828|P3|Overall Study|Lost to Follow-up|0
107669|NCT00706134|369829|P2|Overall Study|Lost to Follow-up|1
107670|NCT00706134|369830|P1|Overall Study|Lost to Follow-up|0
107671|NCT00706134|369827|P4|Overall Study|Adverse Event|3
107672|NCT00706134|369828|P3|Overall Study|Adverse Event|2
107673|NCT00706134|369829|P2|Overall Study|Adverse Event|7
107674|NCT00706134|369830|P1|Overall Study|Adverse Event|8
107675|NCT00706095|369863|P3|Overall Study|Withdrawal by Subject|0
107676|NCT00706095|369864|P2|Overall Study|Withdrawal by Subject|0
107677|NCT00706095|369865|P1|Overall Study|Withdrawal by Subject|1
107678|NCT00706095|369863|P3|Overall Study|Clinical Progression|2
107679|NCT00706095|369864|P2|Overall Study|Clinical Progression|2
107680|NCT00706095|369865|P1|Overall Study|Clinical Progression|1
107681|NCT00706095|369863|P3|Overall Study|Progressive Disease|3
107682|NCT00706095|369864|P2|Overall Study|Progressive Disease|5
107683|NCT00706095|369865|P1|Overall Study|Progressive Disease|4
107684|NCT00706004|369879|P1|Overall Study|Did not meet eligibility criteria|2
107685|NCT00705939|369907|P3|Overall Study|Physician Decision|0
107686|NCT00705939|369908|P2|Overall Study|Physician Decision|1
107687|NCT00705939|369909|P1|Overall Study|Physician Decision|0
107688|NCT00705939|369907|P3|Overall Study|Withdrawal by Subject|3
107689|NCT00705939|369908|P2|Overall Study|Withdrawal by Subject|1
107690|NCT00705939|369909|P1|Overall Study|Withdrawal by Subject|0
107691|NCT00705939|369907|P3|Overall Study|Protocol Violation|1
107692|NCT00705939|369908|P2|Overall Study|Protocol Violation|0
107693|NCT00705939|369909|P1|Overall Study|Protocol Violation|0
107694|NCT00705783|369963|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
107858|NCT00705614|370079|P2|Initial Intervention|Withdrawal by Subject|71
107695|NCT00705783|369964|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
107696|NCT00705783|369965|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
107697|NCT00705783|369963|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
107698|NCT00705783|369964|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
107699|NCT00705783|369965|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
107700|NCT00705783|369963|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
107701|NCT00705783|369964|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
107702|NCT00705783|369965|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
107703|NCT00705783|369963|P3|Depot Maintenance Phase|Protocol Deviation|0
107704|NCT00705783|369964|P2|Depot Maintenance Phase|Protocol Deviation|2
107705|NCT00705783|369965|P1|Depot Maintenance Phase|Protocol Deviation|0
107706|NCT00705783|369963|P3|Depot Maintenance Phase|Withdrew Consent|4
107707|NCT00705783|369964|P2|Depot Maintenance Phase|Withdrew Consent|14
107708|NCT00705783|369965|P1|Depot Maintenance Phase|Withdrew Consent|0
107709|NCT00705783|369963|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
107710|NCT00705783|369964|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
107711|NCT00705783|369965|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
107712|NCT00705783|369963|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
107713|NCT00705783|369964|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
107714|NCT00705783|369965|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
107715|NCT00705783|369963|P3|Depot Maintenance Phase|Lost to Follow-up|3
107716|NCT00705783|369964|P2|Depot Maintenance Phase|Lost to Follow-up|5
107717|NCT00705783|369965|P1|Depot Maintenance Phase|Lost to Follow-up|0
107718|NCT00705783|369963|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
107719|NCT00705783|369964|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
107720|NCT00705783|369965|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
107721|NCT00705783|369963|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
107722|NCT00705783|369964|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
107723|NCT00705783|369965|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
107724|NCT00705783|369963|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
107725|NCT00705783|369964|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
107726|NCT00705783|369965|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
107727|NCT00705783|369963|P3|Depot Stabilization Phase|Adverse Event|0
107728|NCT00705783|369964|P2|Depot Stabilization Phase|Adverse Event|0
107729|NCT00705783|369965|P1|Depot Stabilization Phase|Adverse Event|17
107730|NCT00705783|369963|P3|Depot Stabilization Phase|Withdrew Consent|0
107731|NCT00705783|369964|P2|Depot Stabilization Phase|Withdrew Consent|0
107732|NCT00705783|369965|P1|Depot Stabilization Phase|Withdrew Consent|29
107733|NCT00705783|369963|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
107734|NCT00705783|369964|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
107735|NCT00705783|369965|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
107736|NCT00705783|369963|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
107737|NCT00705783|369964|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
107738|NCT00705783|369965|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
107739|NCT00705783|369963|P3|Depot Stabilization Phase|Lost to Follow-up|0
107740|NCT00705783|369964|P2|Depot Stabilization Phase|Lost to Follow-up|0
107741|NCT00705783|369965|P1|Depot Stabilization Phase|Lost to Follow-up|11
107742|NCT00705783|369963|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
107743|NCT00705783|369964|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
107744|NCT00705783|369965|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
107745|NCT00705783|369963|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
107746|NCT00705783|369964|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
107747|NCT00705783|369965|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
107748|NCT00705783|369963|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
107749|NCT00705783|369964|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
107750|NCT00705783|369965|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
107751|NCT00705783|369963|P3|Oral Stabilization Phase|Adverse Event|0
107752|NCT00705783|369964|P2|Oral Stabilization Phase|Adverse Event|0
107753|NCT00705783|369965|P1|Oral Stabilization Phase|Adverse Event|14
107754|NCT00705783|369963|P3|Oral Stabilization Phase|Withdrew Consent|0
107755|NCT00705783|369964|P2|Oral Stabilization Phase|Withdrew Consent|0
107756|NCT00705783|369965|P1|Oral Stabilization Phase|Withdrew Consent|29
107757|NCT00705783|369963|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
107758|NCT00705783|369964|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
107759|NCT00705783|369965|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
107760|NCT00705783|369963|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
107761|NCT00705783|369964|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
107762|NCT00705783|369965|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
107763|NCT00705783|369963|P3|Oral Stabilization Phase|Lost to Follow-up|0
107764|NCT00705783|369964|P2|Oral Stabilization Phase|Lost to Follow-up|0
107765|NCT00705783|369965|P1|Oral Stabilization Phase|Lost to Follow-up|7
107766|NCT00705783|369963|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
107767|NCT00705783|369964|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
107768|NCT00705783|369965|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
107769|NCT00705783|369963|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
107770|NCT00705783|369964|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
107771|NCT00705783|369965|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
107772|NCT00705783|369963|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
107773|NCT00705783|369964|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
107774|NCT00705783|369965|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
107775|NCT00705783|369963|P3|Conversion Phase|Adverse Event|0
107776|NCT00705783|369964|P2|Conversion Phase|Adverse Event|0
107777|NCT00705783|369965|P1|Conversion Phase|Adverse Event|11
107778|NCT00705783|369963|P3|Conversion Phase|Protocol Deviation|0
107779|NCT00705783|369964|P2|Conversion Phase|Protocol Deviation|0
107780|NCT00705783|369965|P1|Conversion Phase|Protocol Deviation|2
107781|NCT00705783|369963|P3|Conversion Phase|Withdrew Consent|0
107782|NCT00705783|369964|P2|Conversion Phase|Withdrew Consent|0
107783|NCT00705783|369965|P1|Conversion Phase|Withdrew Consent|24
107784|NCT00705783|369963|P3|Conversion Phase|Withdrawn by Investigator|0
107785|NCT00705783|369964|P2|Conversion Phase|Withdrawn by Investigator|0
107786|NCT00705783|369965|P1|Conversion Phase|Withdrawn by Investigator|4
107787|NCT00705783|369963|P3|Conversion Phase|Met Withdrawal Criteria|0
107788|NCT00705783|369964|P2|Conversion Phase|Met Withdrawal Criteria|0
107789|NCT00705783|369965|P1|Conversion Phase|Met Withdrawal Criteria|4
107790|NCT00705783|369963|P3|Conversion Phase|Lost to Follow-up|0
107791|NCT00705783|369964|P2|Conversion Phase|Lost to Follow-up|0
107792|NCT00705783|369965|P1|Conversion Phase|Lost to Follow-up|13
107793|NCT00705783|369963|P3|Conversion Phase|Sponsor Discontinued Study|0
107794|NCT00705783|369964|P2|Conversion Phase|Sponsor Discontinued Study|0
107795|NCT00705783|369965|P1|Conversion Phase|Sponsor Discontinued Study|54
107796|NCT00705757|369995|P3|Overall Study|Withdrawal by Subject|2
107797|NCT00705757|369996|P2|Overall Study|Withdrawal by Subject|1
107798|NCT00705757|369997|P1|Overall Study|Withdrawal by Subject|1
107799|NCT00705757|369995|P3|Overall Study|Lost to Follow-up|6
107800|NCT00705757|369996|P2|Overall Study|Lost to Follow-up|6
107801|NCT00705757|369997|P1|Overall Study|Lost to Follow-up|7
107802|NCT00705757|369995|P3|Overall Study|Lack of Efficacy|3
107803|NCT00705757|369996|P2|Overall Study|Lack of Efficacy|1
107804|NCT00705757|369997|P1|Overall Study|Lack of Efficacy|5
107805|NCT00705718|370007|P2|Overall Study|Follow up not done|4
107806|NCT00705718|370008|P1|Overall Study|Follow up not done|1
107807|NCT00705718|370007|P2|Overall Study|Not due for Visit|12
107808|NCT00705718|370008|P1|Overall Study|Not due for Visit|0
107809|NCT00705718|370007|P2|Overall Study|Death|6
107810|NCT00705718|370008|P1|Overall Study|Death|6
107811|NCT00705679|370029|P5|Overall Study|Withdrawal by Subject|33
107812|NCT00705679|370030|P4|Overall Study|Withdrawal by Subject|47
107813|NCT00705679|370031|P3|Overall Study|Withdrawal by Subject|68
107814|NCT00705679|370032|P2|Overall Study|Withdrawal by Subject|77
107815|NCT00705679|370033|P1|Overall Study|Withdrawal by Subject|32
107816|NCT00705679|370029|P5|Overall Study|Physician Decision|0
107817|NCT00705679|370030|P4|Overall Study|Physician Decision|1
107818|NCT00705679|370031|P3|Overall Study|Physician Decision|0
107819|NCT00705679|370032|P2|Overall Study|Physician Decision|1
107820|NCT00705679|370033|P1|Overall Study|Physician Decision|0
107821|NCT00705679|370029|P5|Overall Study|Lost to Follow-up|35
107822|NCT00705679|370030|P4|Overall Study|Lost to Follow-up|30
107823|NCT00705679|370031|P3|Overall Study|Lost to Follow-up|44
107824|NCT00705679|370032|P2|Overall Study|Lost to Follow-up|60
107825|NCT00705679|370033|P1|Overall Study|Lost to Follow-up|32
107826|NCT00705679|370029|P5|Overall Study|Death|1
107827|NCT00705679|370030|P4|Overall Study|Death|2
107828|NCT00705679|370031|P3|Overall Study|Death|3
107829|NCT00705679|370032|P2|Overall Study|Death|0
107830|NCT00705679|370033|P1|Overall Study|Death|0
107831|NCT00705679|370029|P5|Overall Study|Adverse Event|0
107832|NCT00705679|370030|P4|Overall Study|Adverse Event|0
107833|NCT00705679|370031|P3|Overall Study|Adverse Event|0
107834|NCT00705679|370032|P2|Overall Study|Adverse Event|1
107835|NCT00705679|370033|P1|Overall Study|Adverse Event|1
107836|NCT00705666|370068|P1|Overall Study|Untreated|5
107837|NCT00705666|370068|P1|Overall Study|Lack of data|3
107838|NCT00705666|370068|P1|Overall Study|Other|2
107839|NCT00705666|370068|P1|Overall Study|Not specified|12
107840|NCT00705666|370068|P1|Overall Study|Adverse Event|4
107841|NCT00705666|370068|P1|Overall Study|Death|1
107842|NCT00705666|370068|P1|Overall Study|Lost to Follow-up|5
107843|NCT00705666|370068|P1|Overall Study|Physician Decision|7
107844|NCT00705666|370068|P1|Overall Study|Withdrawal by Subject|21
107845|NCT00705666|370068|P1|Overall Study|No post-treatment questionnaire|279
107846|NCT00705614|370079|P2|Switch to Remicade|Administrative Reason|9
107847|NCT00705614|370080|P1|Switch to Remicade|Administrative Reason|0
107848|NCT00705614|370079|P2|Switch to Remicade|Withdrawal by Subject|12
107849|NCT00705614|370080|P1|Switch to Remicade|Withdrawal by Subject|0
107850|NCT00705614|370079|P2|Switch to Remicade|Lost to Follow-up|23
107851|NCT00705614|370080|P1|Switch to Remicade|Lost to Follow-up|0
107852|NCT00705614|370079|P2|Switch to Remicade|Adverse Event|5
107853|NCT00705614|370080|P1|Switch to Remicade|Adverse Event|0
107854|NCT00705614|370079|P2|Initial Intervention|Status completion unknown|0
107855|NCT00705614|370080|P1|Initial Intervention|Status completion unknown|3
107856|NCT00705614|370079|P2|Initial Intervention|Administrative Reason|38
107857|NCT00705614|370080|P1|Initial Intervention|Administrative Reason|51
107859|NCT00705614|370080|P1|Initial Intervention|Withdrawal by Subject|114
107860|NCT00705614|370079|P2|Initial Intervention|Lost to Follow-up|191
107861|NCT00705614|370080|P1|Initial Intervention|Lost to Follow-up|310
107862|NCT00705614|370079|P2|Initial Intervention|Adverse Event|21
107863|NCT00705614|370080|P1|Initial Intervention|Adverse Event|40
107864|NCT00705575|370129|P2|Overall Study|Withdrawal by Subject|10
107865|NCT00705575|370130|P1|Overall Study|Withdrawal by Subject|5
107866|NCT00705575|370129|P2|Overall Study|Protocol Violation|2
107867|NCT00705575|370130|P1|Overall Study|Protocol Violation|2
107868|NCT00705575|370129|P2|Overall Study|Lost to Follow-up|4
107869|NCT00705575|370130|P1|Overall Study|Lost to Follow-up|3
107870|NCT00705575|370129|P2|Overall Study|Adverse Event|15
107871|NCT00705575|370130|P1|Overall Study|Adverse Event|11
107872|NCT00705575|370129|P2|Overall Study|Abnormal test procedure result(s)|12
107873|NCT00705575|370130|P1|Overall Study|Abnormal test procedure result(s)|2
107874|NCT00705575|370129|P2|Overall Study|Abnormal laboratory value(s)|3
107875|NCT00705575|370130|P1|Overall Study|Abnormal laboratory value(s)|0
107876|NCT00705536|370144|P4|Start Period 1|Withdrawal by Subject|1
107877|NCT00705536|370145|P3|Start Period 1|Withdrawal by Subject|0
107878|NCT00705536|370146|P2|Start Period 1|Withdrawal by Subject|0
107879|NCT00705536|370147|P1|Start Period 1|Withdrawal by Subject|0
107880|NCT00705523|370208|P2|Overall Study|Lost to Follow-up|3
107881|NCT00705523|370209|P1|Overall Study|Lost to Follow-up|2
107882|NCT00705432|370223|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
107883|NCT00705432|370224|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
107884|NCT00705432|370225|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
107885|NCT00705432|370226|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
107886|NCT00705432|370227|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
107887|NCT00705432|370228|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
107888|NCT00705432|370223|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
107889|NCT00705432|370224|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
107890|NCT00705432|370225|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
107891|NCT00705432|370226|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
107892|NCT00705432|370227|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
107893|NCT00705432|370228|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
107894|NCT00705432|370223|P6|Treatment Period|Non medical reason|7
107895|NCT00705432|370224|P5|Treatment Period|Non medical reason|7
107896|NCT00705432|370225|P4|Treatment Period|Non medical reason|4
107897|NCT00705432|370226|P3|Treatment Period|Non medical reason|37
107898|NCT00705432|370227|P2|Treatment Period|Non medical reason|32
107899|NCT00705432|370228|P1|Treatment Period|Non medical reason|26
107900|NCT00705432|370223|P6|Treatment Period|Treatment failure|14
107901|NCT00705432|370224|P5|Treatment Period|Treatment failure|13
107902|NCT00705432|370225|P4|Treatment Period|Treatment failure|25
107903|NCT00705432|370226|P3|Treatment Period|Treatment failure|33
107904|NCT00705432|370227|P2|Treatment Period|Treatment failure|42
107905|NCT00705432|370228|P1|Treatment Period|Treatment failure|92
107906|NCT00705432|370223|P6|Treatment Period|Adverse Event|9
107907|NCT00705432|370224|P5|Treatment Period|Adverse Event|8
107908|NCT00705432|370225|P4|Treatment Period|Adverse Event|12
107909|NCT00705432|370226|P3|Treatment Period|Adverse Event|51
107910|NCT00705432|370227|P2|Treatment Period|Adverse Event|37
107911|NCT00705432|370228|P1|Treatment Period|Adverse Event|45
107912|NCT00705406|370265|P2|Overall Study|Did not receive study drug|2
107913|NCT00705406|370266|P1|Overall Study|Did not receive study drug|1
107914|NCT00705406|370265|P2|Overall Study|Lost to Follow-up|3
107915|NCT00705406|370266|P1|Overall Study|Lost to Follow-up|3
107916|NCT00705367|370290|P2|Long-term Extension Period|Administrative reason by sponsor|0
107917|NCT00705367|370291|P1|Long-term Extension Period|Administrative reason by sponsor|3
107918|NCT00705367|370290|P2|Long-term Extension Period|No longer met study criteria|0
107919|NCT00705367|370291|P1|Long-term Extension Period|No longer met study criteria|1
107920|NCT00705367|370290|P2|Long-term Extension Period|Lack of Efficacy|0
107921|NCT00705367|370291|P1|Long-term Extension Period|Lack of Efficacy|1
107922|NCT00705367|370290|P2|Long-term Extension Period|Withdrawal by Subject|0
107923|NCT00705367|370291|P1|Long-term Extension Period|Withdrawal by Subject|2
107924|NCT00705367|370290|P2|Long-term Extension Period|Adverse Event|0
107925|NCT00705367|370291|P1|Long-term Extension Period|Adverse Event|2
107926|NCT00705341|370318|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
107927|NCT00705341|370319|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
107928|NCT00705341|370320|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
107929|NCT00705341|370321|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
107930|NCT00705341|370318|P4|Phase 2: Trial|Withdrawal by Subject|4
107931|NCT00705341|370319|P3|Phase 2: Trial|Withdrawal by Subject|6
107932|NCT00705341|370320|P2|Phase 2: Trial|Withdrawal by Subject|0
107933|NCT00705341|370321|P1|Phase 2: Trial|Withdrawal by Subject|0
107934|NCT00705289|370329|P1|Overall Study|Subject or treating physician's choice|131
107935|NCT00705263|370353|P1|Overall Study|Withdrawal by Subject|2
107936|NCT00705250|370357|P1|Overall Study|Patient died in car accident|1
107937|NCT00705250|370357|P1|Overall Study|Withdrawal by Subject|1
107938|NCT00705224|370361|P1|Overall Study|Lost to Follow-up|5
107939|NCT00705224|370361|P1|Overall Study|Withdrawal by Subject|3
107940|NCT00705224|370361|P1|Overall Study|Lack of Efficacy|2
107941|NCT00705224|370361|P1|Overall Study|Adverse Event|1
107942|NCT00705159|370377|P4|Overall Study|Screen Failure|1
107943|NCT00705159|370378|P3|Overall Study|Screen Failure|0
107944|NCT00705159|370379|P2|Overall Study|Screen Failure|0
107945|NCT00705159|370380|P1|Overall Study|Screen Failure|0
107946|NCT00705159|370377|P4|Overall Study|Lost to Follow-up|2
107947|NCT00705159|370378|P3|Overall Study|Lost to Follow-up|3
107948|NCT00705159|370379|P2|Overall Study|Lost to Follow-up|0
107949|NCT00705159|370380|P1|Overall Study|Lost to Follow-up|0
107950|NCT00705159|370377|P4|Overall Study|Adverse Event|0
107951|NCT00705159|370378|P3|Overall Study|Adverse Event|1
107952|NCT00705159|370379|P2|Overall Study|Adverse Event|0
107953|NCT00705159|370380|P1|Overall Study|Adverse Event|0
107954|NCT00705159|370377|P4|Overall Study|Protocol Violation|0
107955|NCT00705159|370378|P3|Overall Study|Protocol Violation|0
107956|NCT00705159|370379|P2|Overall Study|Protocol Violation|1
107957|NCT00705159|370380|P1|Overall Study|Protocol Violation|0
107958|NCT00705159|370377|P4|Overall Study|Withdrawal by Subject|1
107959|NCT00705159|370378|P3|Overall Study|Withdrawal by Subject|1
107960|NCT00705159|370379|P2|Overall Study|Withdrawal by Subject|1
107961|NCT00705159|370380|P1|Overall Study|Withdrawal by Subject|0
107962|NCT00705146|370400|P2|Overall Study|Lost to Follow-up|1
107963|NCT00705146|370401|P1|Overall Study|Lost to Follow-up|1
107964|NCT00705016|370430|P3|Overall Study|Unspecified|6
107965|NCT00705016|370431|P2|Overall Study|Unspecified|6
107966|NCT00705016|370432|P1|Overall Study|Unspecified|9
107967|NCT00705016|370430|P3|Overall Study|Symptomatic Deterioration|1
107968|NCT00705016|370431|P2|Overall Study|Symptomatic Deterioration|1
107969|NCT00705016|370432|P1|Overall Study|Symptomatic Deterioration|3
107970|NCT00705016|370430|P3|Overall Study|Progressive Disease|33
107971|NCT00705016|370431|P2|Overall Study|Progressive Disease|29
107972|NCT00705016|370432|P1|Overall Study|Progressive Disease|33
107973|NCT00705016|370430|P3|Overall Study|Withdrawal by Subject|2
107974|NCT00705016|370431|P2|Overall Study|Withdrawal by Subject|3
107975|NCT00705016|370432|P1|Overall Study|Withdrawal by Subject|4
107976|NCT00705016|370430|P3|Overall Study|Protocol Violation|1
107977|NCT00705016|370431|P2|Overall Study|Protocol Violation|1
107978|NCT00705016|370432|P1|Overall Study|Protocol Violation|0
107979|NCT00705016|370430|P3|Overall Study|Death|5
107980|NCT00705016|370431|P2|Overall Study|Death|7
107981|NCT00705016|370432|P1|Overall Study|Death|5
107982|NCT00705016|370430|P3|Overall Study|Adverse Event|10
107983|NCT00705016|370431|P2|Overall Study|Adverse Event|11
107984|NCT00705016|370432|P1|Overall Study|Adverse Event|6
107985|NCT00704964|370483|P1|Overall Study|Not completed on time|328
107986|NCT00704808|370532|P1|Overall Study|Treatment change|1
107987|NCT00704808|370532|P1|Overall Study|Lost to Follow-up|1
107988|NCT00704808|370532|P1|Overall Study|Adverse Event|1
107989|NCT00704808|370532|P1|Overall Study|Early therapy discontinuation|16
107990|NCT00704808|370532|P1|Overall Study|Patient's decision|11
107991|NCT00704808|370532|P1|Overall Study|Tumor progression|80
107992|NCT00704808|370532|P1|Overall Study|Death|7
107993|NCT00704808|370532|P1|Overall Study|Discontinued prior to starting treatment|14
107994|NCT00704730|370543|P2|Overall Study|Withdrawal by Subject|13
107995|NCT00704730|370544|P1|Overall Study|Withdrawal by Subject|9
107996|NCT00704730|370543|P2|Overall Study|data unavailable|0
107997|NCT00704730|370544|P1|Overall Study|data unavailable|1
107998|NCT00704730|370543|P2|Overall Study|Disease progression per PI|67
107999|NCT00704730|370544|P1|Overall Study|Disease progression per PI|58
108000|NCT00704730|370543|P2|Overall Study|Did not receive drug|2
108001|NCT00704730|370544|P1|Overall Study|Did not receive drug|5
108002|NCT00704730|370543|P2|Overall Study|Physician Decision|0
108003|NCT00704730|370544|P1|Overall Study|Physician Decision|2
108004|NCT00704730|370543|P2|Overall Study|Death|5
108005|NCT00704730|370544|P1|Overall Study|Death|11
108006|NCT00704730|370543|P2|Overall Study|Adverse Event|9
108007|NCT00704730|370544|P1|Overall Study|Adverse Event|35
108008|NCT00704535|370564|P1|Overall Study|Completed status not on Case Report Form|124
108009|NCT00704535|370564|P1|Overall Study|Protocol Violation|10
108010|NCT00704535|370564|P1|Overall Study|Lost to Follow-up|8
108011|NCT00704535|370564|P1|Overall Study|Death|2
108012|NCT00704535|370564|P1|Overall Study|Adverse Event|2
108013|NCT00704522|370577|P2|Overall Study|No information on therapy end|2
108014|NCT00704522|370578|P1|Overall Study|No information on therapy end|27
108015|NCT00704522|370577|P2|Overall Study|Undefined causes|7
108016|NCT00704522|370578|P1|Overall Study|Undefined causes|9
108017|NCT00704522|370577|P2|Overall Study|Adverse Event|1
108018|NCT00704522|370578|P1|Overall Study|Adverse Event|9
108019|NCT00704522|370577|P2|Overall Study|Withdrawal by Subject|8
108020|NCT00704522|370578|P1|Overall Study|Withdrawal by Subject|17
108021|NCT00704522|370577|P2|Overall Study|Failure to appear again at hospital|10
108022|NCT00704522|370578|P1|Overall Study|Failure to appear again at hospital|56
108023|NCT00704522|370577|P2|Overall Study|Lack of Efficacy|17
108024|NCT00704522|370578|P1|Overall Study|Lack of Efficacy|65
108025|NCT00704418|370587|P2|Overall Study|Over-enrolled/surgery postponed|6
108026|NCT00704418|370588|P1|Overall Study|Over-enrolled/surgery postponed|3
108027|NCT00704418|370587|P2|Overall Study|Withdrawal by Subject|0
108028|NCT00704418|370588|P1|Overall Study|Withdrawal by Subject|2
108029|NCT00704405|370601|P5|Overall Study (C Population)|Lost to Follow-up|0
108030|NCT00704405|370602|P4|Overall Study (C Population)|Lost to Follow-up|0
108031|NCT00704405|370603|P3|Overall Study (C Population)|Lost to Follow-up|0
108032|NCT00704405|370604|P2|Overall Study (C Population)|Lost to Follow-up|2
108033|NCT00704405|370605|P1|Overall Study (C Population)|Lost to Follow-up|0
108034|NCT00704405|370601|P5|Overall Study (C Population)|Withdrawal by Subject|0
108035|NCT00704405|370602|P4|Overall Study (C Population)|Withdrawal by Subject|1
108036|NCT00704405|370603|P3|Overall Study (C Population)|Withdrawal by Subject|1
108037|NCT00704405|370604|P2|Overall Study (C Population)|Withdrawal by Subject|1
108038|NCT00704405|370605|P1|Overall Study (C Population)|Withdrawal by Subject|1
108039|NCT00704405|370601|P5|Overall Study (NC Population)|Other|1
108040|NCT00704405|370602|P4|Overall Study (NC Population)|Other|0
108041|NCT00704405|370603|P3|Overall Study (NC Population)|Other|0
108042|NCT00704405|370604|P2|Overall Study (NC Population)|Other|0
108043|NCT00704405|370605|P1|Overall Study (NC Population)|Other|0
108044|NCT00704405|370601|P5|Overall Study (NC Population)|Withdrawal by Subject|2
108045|NCT00704405|370602|P4|Overall Study (NC Population)|Withdrawal by Subject|2
108046|NCT00704405|370603|P3|Overall Study (NC Population)|Withdrawal by Subject|2
108047|NCT00704405|370604|P2|Overall Study (NC Population)|Withdrawal by Subject|3
108048|NCT00704405|370605|P1|Overall Study (NC Population)|Withdrawal by Subject|2
108049|NCT00704405|370601|P5|Overall Study (NC Population)|Lost to Follow-up|2
108050|NCT00704405|370602|P4|Overall Study (NC Population)|Lost to Follow-up|2
108051|NCT00704405|370603|P3|Overall Study (NC Population)|Lost to Follow-up|1
108052|NCT00704405|370604|P2|Overall Study (NC Population)|Lost to Follow-up|1
108053|NCT00704405|370605|P1|Overall Study (NC Population)|Lost to Follow-up|2
108054|NCT00704405|370601|P5|Overall Study (NC Population)|Adverse Event|0
108055|NCT00704405|370602|P4|Overall Study (NC Population)|Adverse Event|0
108056|NCT00704405|370603|P3|Overall Study (NC Population)|Adverse Event|0
108057|NCT00704405|370604|P2|Overall Study (NC Population)|Adverse Event|0
108058|NCT00704405|370605|P1|Overall Study (NC Population)|Adverse Event|1
108059|NCT00704340|370663|P2|Overall Study|Death|1
108060|NCT00704340|370664|P1|Overall Study|Death|0
108061|NCT00704340|370663|P2|Overall Study|Lost to Follow-up|1
108062|NCT00704340|370664|P1|Overall Study|Lost to Follow-up|2
108063|NCT00704184|370679|P5|Open-Label Treatment|Withdrawal by Subject|0
108064|NCT00704184|370680|P4|Open-Label Treatment|Withdrawal by Subject|3
108065|NCT00704184|370681|P3|Open-Label Treatment|Withdrawal by Subject|0
108066|NCT00704184|370682|P2|Open-Label Treatment|Withdrawal by Subject|0
108067|NCT00704184|370683|P1|Open-Label Treatment|Withdrawal by Subject|1
108068|NCT00704184|370679|P5|Open-Label Treatment|Physician Decision|1
108069|NCT00704184|370680|P4|Open-Label Treatment|Physician Decision|0
108070|NCT00704184|370681|P3|Open-Label Treatment|Physician Decision|0
108071|NCT00704184|370682|P2|Open-Label Treatment|Physician Decision|0
108072|NCT00704184|370683|P1|Open-Label Treatment|Physician Decision|0
108073|NCT00704184|370679|P5|Open-Label Treatment|Lack of Efficacy|1
108074|NCT00704184|370680|P4|Open-Label Treatment|Lack of Efficacy|2
108075|NCT00704184|370681|P3|Open-Label Treatment|Lack of Efficacy|2
108076|NCT00704184|370682|P2|Open-Label Treatment|Lack of Efficacy|2
108077|NCT00704184|370683|P1|Open-Label Treatment|Lack of Efficacy|0
108078|NCT00704184|370679|P5|Open-Label Treatment|Adverse Event|1
108079|NCT00704184|370680|P4|Open-Label Treatment|Adverse Event|0
108080|NCT00704184|370681|P3|Open-Label Treatment|Adverse Event|2
108081|NCT00704184|370682|P2|Open-Label Treatment|Adverse Event|0
108082|NCT00704184|370683|P1|Open-Label Treatment|Adverse Event|0
108083|NCT00704184|370679|P5|Double-Blind Treatment|Withdrawal by Subject|0
108084|NCT00704184|370680|P4|Double-Blind Treatment|Withdrawal by Subject|0
108085|NCT00704184|370681|P3|Double-Blind Treatment|Withdrawal by Subject|0
108086|NCT00704184|370682|P2|Double-Blind Treatment|Withdrawal by Subject|0
108087|NCT00704184|370683|P1|Double-Blind Treatment|Withdrawal by Subject|1
108088|NCT00704171|370722|P2|Overall Study|Withdrawal by Subject|0
108089|NCT00704171|370723|P1|Overall Study|Withdrawal by Subject|1
108090|NCT00704132|370741|P2|Overall Study|Withdrawal by Subject|1
108091|NCT00704132|370742|P1|Overall Study|Withdrawal by Subject|0
108092|NCT00704132|370741|P2|Overall Study|Lack of Efficacy|1
108093|NCT00704132|370742|P1|Overall Study|Lack of Efficacy|0
108094|NCT00704132|370741|P2|Overall Study|Clinical Adverse Experience|0
108095|NCT00704132|370742|P1|Overall Study|Clinical Adverse Experience|1
108096|NCT00703963|370759|P2|Overall Study|Physician Decision|1
108097|NCT00703963|370760|P1|Overall Study|Physician Decision|0
108098|NCT00703963|370759|P2|Overall Study|Withdrawal by Subject|13
108099|NCT00703963|370760|P1|Overall Study|Withdrawal by Subject|7
108100|NCT00703924|370781|P2|Overall Study|Withdrawal by Subject|1
108101|NCT00703924|370782|P1|Overall Study|Withdrawal by Subject|1
108102|NCT00703911|370798|P1|Overall Study|Withdrawal by Subject|2
108103|NCT00703911|370798|P1|Overall Study|Lost to Follow-up|1
108104|NCT00703911|370798|P1|Overall Study|Physician Decision|6
108105|NCT00703911|370798|P1|Overall Study|Death|1
108106|NCT00703846|370831|P1|Overall Study|Did Not Receive Study Drug|2
108107|NCT00703846|370831|P1|Overall Study|Other|14
108108|NCT00703846|370831|P1|Overall Study|Death|1
108109|NCT00703846|370831|P1|Overall Study|Withdrawal by Subject|40
108110|NCT00703846|370831|P1|Overall Study|Noncompliance with Study Treatment|2
108111|NCT00703846|370831|P1|Overall Study|Lack of Efficacy|15
108112|NCT00703846|370831|P1|Overall Study|Lost to Follow-up|55
108113|NCT00703846|370831|P1|Overall Study|Adverse Event|8
108114|NCT00703781|370847|P2|Overall Study|Cancelled surgery|0
108115|NCT00703781|370848|P1|Overall Study|Cancelled surgery|1
108116|NCT00703781|370847|P2|Overall Study|Withdrawal by Subject|2
108117|NCT00703781|370848|P1|Overall Study|Withdrawal by Subject|1
108118|NCT00703677|370893|P1|Overall Study|Dropout-withdrawal not related to drug|3
108119|NCT00703534|370908|P2|Overall Study|Severe Non Compliance|5
108120|NCT00703534|370909|P1|Overall Study|Severe Non Compliance|1
108121|NCT00703534|370908|P2|Overall Study|Lost to Follow-up|4
108122|NCT00703534|370909|P1|Overall Study|Lost to Follow-up|1
108123|NCT00703534|370908|P2|Overall Study|Incorrect Enrollment|6
108124|NCT00703534|370909|P1|Overall Study|Incorrect Enrollment|6
108125|NCT00703534|370908|P2|Overall Study|Withdrawal by Subject|7
108126|NCT00703534|370909|P1|Overall Study|Withdrawal by Subject|8
108127|NCT00703534|370908|P2|Overall Study|Adverse Event|3
108128|NCT00703534|370909|P1|Overall Study|Adverse Event|14
108129|NCT00703326|370968|P2|Overall Study|Withdrawal by Subject|20
108130|NCT00703326|370969|P1|Overall Study|Withdrawal by Subject|42
108131|NCT00703326|370968|P2|Overall Study|Lost to Follow-up|8
108132|NCT00703326|370969|P1|Overall Study|Lost to Follow-up|25
108133|NCT00703326|370968|P2|Overall Study|Still on study|197
108134|NCT00703326|370969|P1|Overall Study|Still on study|380
108135|NCT00703118|371002|P3|Overall Study|Not specified|1
108136|NCT00703118|371003|P2|Overall Study|Not specified|0
108137|NCT00703118|371004|P1|Overall Study|Not specified|0
108138|NCT00703118|371002|P3|Overall Study|Withdrawal by Subject|13
108139|NCT00703118|371003|P2|Overall Study|Withdrawal by Subject|7
108140|NCT00703118|371004|P1|Overall Study|Withdrawal by Subject|8
108141|NCT00703118|371002|P3|Overall Study|Lost to Follow-up|4
108142|NCT00703118|371003|P2|Overall Study|Lost to Follow-up|4
108143|NCT00703118|371004|P1|Overall Study|Lost to Follow-up|6
108144|NCT00703118|371002|P3|Overall Study|Subject Ineligible To Continue The Trial|2
108145|NCT00703118|371003|P2|Overall Study|Subject Ineligible To Continue The Trial|3
108146|NCT00703118|371004|P1|Overall Study|Subject Ineligible To Continue The Trial|6
108147|NCT00703118|371002|P3|Overall Study|Adverse Event|2
108148|NCT00703118|371003|P2|Overall Study|Adverse Event|2
108149|NCT00703118|371004|P1|Overall Study|Adverse Event|1
108150|NCT00703092|371035|P1|Overall Study|Withdrawal by Subject|2
108151|NCT00703014|371242|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
108152|NCT00703014|371243|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
108153|NCT00703014|371244|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
108154|NCT00703014|371245|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
108155|NCT00703014|371242|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
108156|NCT00703014|371243|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
108157|NCT00703014|371244|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
108158|NCT00703014|371245|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
108159|NCT00702949|371266|P3|Overall Study|Other Medical Reason/unknown|3
108160|NCT00702949|371267|P2|Overall Study|Other Medical Reason/unknown|1
108161|NCT00702949|371268|P1|Overall Study|Other Medical Reason/unknown|1
108162|NCT00702949|371266|P3|Overall Study|Adverse Event|3
108163|NCT00702949|371267|P2|Overall Study|Adverse Event|6
108164|NCT00702949|371268|P1|Overall Study|Adverse Event|1
108165|NCT00702949|371266|P3|Overall Study|Refusal|2
108166|NCT00702949|371267|P2|Overall Study|Refusal|2
108167|NCT00702949|371268|P1|Overall Study|Refusal|3
108168|NCT00702923|371293|P1|Overall Study|Adverse Event|1
108169|NCT00702845|371304|P2|Overall Study|Not randomized|1
108170|NCT00702845|371305|P1|Overall Study|Not randomized|0
108171|NCT00702845|371304|P2|Overall Study|Patient's decision|1
108172|NCT00702845|371305|P1|Overall Study|Patient's decision|2
108173|NCT00702845|371304|P2|Overall Study|No or abnormal fertilization|2
108174|NCT00702845|371305|P1|Overall Study|No or abnormal fertilization|4
108175|NCT00702845|371304|P2|Overall Study|No/too few/bad quality embryos retrieved|1
108176|NCT00702845|371305|P1|Overall Study|No/too few/bad quality embryos retrieved|7
108177|NCT00702845|371304|P2|Overall Study|Insufficient ovarian response|0
108178|NCT00702845|371305|P1|Overall Study|Insufficient ovarian response|1
108179|NCT00702845|371304|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
108180|NCT00702845|371305|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
108181|NCT00702845|371304|P2|Overall Study|Too high ovarian response|1
108182|NCT00702845|371305|P1|Overall Study|Too high ovarian response|5
108183|NCT00702845|371304|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
108184|NCT00702845|371305|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
108185|NCT00702715|371367|P2|Overall Study|Lost to Follow-up|0
108186|NCT00702715|371368|P1|Overall Study|Lost to Follow-up|1
108187|NCT00702702|371381|P1|Overall Study|Study prematurely terminated|56
108188|NCT00702689|371389|P1|Overall Study|Adverse Event|1
108189|NCT00702689|371389|P1|Overall Study|Recurrent malignancy|1
108190|NCT00702689|371389|P1|Overall Study|Withdrawal by Subject|4
108191|NCT00702650|371394|P1|Overall Study|Adverse Event|3
108192|NCT00702650|371394|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
108193|NCT00702650|371394|P1|Overall Study|Sponsor Request|1
108194|NCT00702650|371394|P1|Overall Study|Non-Compliance with Site Directives|1
108195|NCT00702650|371394|P1|Overall Study|Lost to Follow-up|2
108196|NCT00702650|371394|P1|Overall Study|Non-Compliance of Study Drug|3
108197|NCT00702650|371394|P1|Overall Study|Withdrawal by Subject|9
108198|NCT00702520|371456|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
108199|NCT00702520|371457|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
108200|NCT00702520|371458|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
108201|NCT00702520|371459|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
108202|NCT00702520|371456|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
108203|NCT00702520|371457|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
108204|NCT00702520|371458|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
108205|NCT00702520|371459|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
108206|NCT00702520|371456|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
108207|NCT00702520|371457|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
108208|NCT00702520|371458|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
108209|NCT00702520|371459|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
108210|NCT00702507|371475|P1|Follow-up Phase|Late Enrollment|1
108211|NCT00702507|371475|P1|Follow-up Phase|Lost to Follow-up|23
108212|NCT00702507|371475|P1|Follow-up Phase|Protocol Violation|2
108213|NCT00702507|371475|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
108214|NCT00702507|371475|P1|Initial Treatment Phase|Negative Candida Culture|34
108215|NCT00702507|371475|P1|Initial Treatment Phase|Lost to Follow-up|2
108216|NCT00702507|371475|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
108217|NCT00702507|371475|P1|Initial Treatment Phase|Adverse Event|2
108218|NCT00702325|371558|P2|Overall Study|Incorrectly Discontinued|1
108219|NCT00702325|371559|P1|Overall Study|Incorrectly Discontinued|0
108220|NCT00702325|371558|P2|Overall Study|Withdrew consent|1
108221|NCT00702325|371559|P1|Overall Study|Withdrew consent|0
108222|NCT00702325|371558|P2|Overall Study|Didn't follow study medication dosage|2
108223|NCT00702325|371559|P1|Overall Study|Didn't follow study medication dosage|0
108224|NCT00702325|371558|P2|Overall Study|Termination due to lab results|0
108225|NCT00702325|371559|P1|Overall Study|Termination due to lab results|1
108226|NCT00702325|371558|P2|Overall Study|Severe noncompliance to protocol|3
108227|NCT00702325|371559|P1|Overall Study|Severe noncompliance to protocol|3
108228|NCT00702325|371558|P2|Overall Study|Developed study discontinuation criteria|28
108229|NCT00702325|371559|P1|Overall Study|Developed study discontinuation criteria|18
108230|NCT00702325|371558|P2|Overall Study|Incorrect enrollment|7
108231|NCT00702325|371559|P1|Overall Study|Incorrect enrollment|5
108232|NCT00702325|371558|P2|Overall Study|Lost to Follow-up|4
108233|NCT00702325|371559|P1|Overall Study|Lost to Follow-up|3
108234|NCT00702325|371558|P2|Overall Study|Withdrawal by Subject|7
108235|NCT00702325|371559|P1|Overall Study|Withdrawal by Subject|7
108236|NCT00702325|371558|P2|Overall Study|Adverse Event|0
108237|NCT00702325|371559|P1|Overall Study|Adverse Event|1
108238|NCT00702221|371655|P2|Overall Study|Adverse Event|3
108239|NCT00702221|371656|P1|Overall Study|Adverse Event|4
108240|NCT00702208|371662|P1|Overall Study|Unsatisfactory colposcopy|2
108241|NCT00702208|371662|P1|Overall Study|Did not self-lavage|1
108242|NCT00702208|371662|P1|Overall Study|Lost to Follow-up|28
108243|NCT00702143|371671|P3|Overall Study|Lost to Follow-up|1
108244|NCT00702143|371672|P2|Overall Study|Lost to Follow-up|0
108245|NCT00702143|371673|P1|Overall Study|Lost to Follow-up|0
108246|NCT00701805|371722|P4|Overall Study|Resumption criteria were not met|0
108247|NCT00701805|371723|P3|Overall Study|Resumption criteria were not met|0
108248|NCT00701805|371724|P2|Overall Study|Resumption criteria were not met|1
108249|NCT00701805|371725|P1|Overall Study|Resumption criteria were not met|0
108250|NCT00701805|371722|P4|Overall Study|Difficult to travel to dialysis site|0
108251|NCT00701805|371723|P3|Overall Study|Difficult to travel to dialysis site|1
108252|NCT00701805|371724|P2|Overall Study|Difficult to travel to dialysis site|0
108253|NCT00701805|371725|P1|Overall Study|Difficult to travel to dialysis site|0
108254|NCT00701805|371722|P4|Overall Study|Physician decision, change of therapy|1
108255|NCT00701805|371723|P3|Overall Study|Physician decision, change of therapy|0
108256|NCT00701805|371724|P2|Overall Study|Physician decision, change of therapy|0
108257|NCT00701805|371725|P1|Overall Study|Physician decision, change of therapy|0
108258|NCT00701805|371722|P4|Overall Study|Admitted to hospital for 2 weeks|0
108259|NCT00701805|371723|P3|Overall Study|Admitted to hospital for 2 weeks|1
108260|NCT00701805|371724|P2|Overall Study|Admitted to hospital for 2 weeks|0
108261|NCT00701805|371725|P1|Overall Study|Admitted to hospital for 2 weeks|0
108262|NCT00701805|371722|P4|Overall Study|Missed 7 consecutive doses|0
108263|NCT00701805|371723|P3|Overall Study|Missed 7 consecutive doses|0
108264|NCT00701805|371724|P2|Overall Study|Missed 7 consecutive doses|1
108265|NCT00701805|371725|P1|Overall Study|Missed 7 consecutive doses|0
108266|NCT00701805|371722|P4|Overall Study|Adverse Event|0
108267|NCT00701805|371723|P3|Overall Study|Adverse Event|1
108268|NCT00701805|371724|P2|Overall Study|Adverse Event|1
108269|NCT00701805|371725|P1|Overall Study|Adverse Event|0
108270|NCT00701805|371722|P4|Overall Study|Withdrawal by Subject|3
108271|NCT00701805|371723|P3|Overall Study|Withdrawal by Subject|4
108272|NCT00701805|371724|P2|Overall Study|Withdrawal by Subject|1
108273|NCT00701805|371725|P1|Overall Study|Withdrawal by Subject|3
108274|NCT00701779|371775|P1|Overall Study|Withdrawal by Subject|2
108275|NCT00701779|371775|P1|Overall Study|Lost to Follow-up|1
108276|NCT00701779|371775|P1|Overall Study|Adverse Event|6
108277|NCT00701727|371784|P2|Second Treatment Period|Withdrawal by Subject|0
108278|NCT00701727|371785|P1|Second Treatment Period|Withdrawal by Subject|2
108279|NCT00701727|371784|P2|First Treatment Period|Lost to Follow-up|1
108280|NCT00701727|371785|P1|First Treatment Period|Lost to Follow-up|0
108281|NCT00701727|371784|P2|First Treatment Period|sponsor decision|1
108282|NCT00701727|371785|P1|First Treatment Period|sponsor decision|0
108283|NCT00701727|371784|P2|First Treatment Period|Withdrawal by Subject|0
108284|NCT00701727|371785|P1|First Treatment Period|Withdrawal by Subject|1
108285|NCT00701727|371784|P2|First Treatment Period|Adverse Event|0
108286|NCT00701727|371785|P1|First Treatment Period|Adverse Event|0
108287|NCT00701662|371816|P1|Overall Study|Lack of Efficacy|1
108288|NCT00701558|371841|P1|Overall Study|Lost to Follow-up|8
108289|NCT00701558|371841|P1|Overall Study|Death|7
108290|NCT00701441|371849|P2|Overall Study|failure in cpap compliance|4
108291|NCT00701441|371850|P1|Overall Study|failure in cpap compliance|0
108292|NCT00701415|371862|P2|Overall Study|Social/family issues and needle phobia|0
108293|NCT00701415|371863|P1|Overall Study|Social/family issues and needle phobia|1
108294|NCT00701415|371862|P2|Overall Study|Adverse Event|1
108295|NCT00701415|371863|P1|Overall Study|Adverse Event|0
108296|NCT00701363|371898|P4|Treatment Phase 2|Withdrawal by Subject|0
108297|NCT00701363|371899|P3|Treatment Phase 2|Withdrawal by Subject|1
108298|NCT00701363|371900|P2|Treatment Phase 2|Withdrawal by Subject|0
108299|NCT00701363|371901|P1|Treatment Phase 2|Withdrawal by Subject|0
108300|NCT00701363|371898|P4|Treatment Phase 2|Adverse Event|0
108301|NCT00701363|371899|P3|Treatment Phase 2|Adverse Event|1
108302|NCT00701363|371900|P2|Treatment Phase 2|Adverse Event|0
108303|NCT00701363|371901|P1|Treatment Phase 2|Adverse Event|0
108304|NCT00701363|371898|P4|Treatment Phase 1|Lack of Efficacy|0
108305|NCT00701363|371899|P3|Treatment Phase 1|Lack of Efficacy|0
108306|NCT00701363|371900|P2|Treatment Phase 1|Lack of Efficacy|0
108307|NCT00701363|371901|P1|Treatment Phase 1|Lack of Efficacy|1
108308|NCT00701363|371898|P4|Treatment Phase 1|Withdrawal by Subject|0
108309|NCT00701363|371899|P3|Treatment Phase 1|Withdrawal by Subject|0
108310|NCT00701363|371900|P2|Treatment Phase 1|Withdrawal by Subject|0
108311|NCT00701363|371901|P1|Treatment Phase 1|Withdrawal by Subject|5
108312|NCT00701363|371898|P4|Treatment Phase 1|Protocol Violation|0
108313|NCT00701363|371899|P3|Treatment Phase 1|Protocol Violation|0
108314|NCT00701363|371900|P2|Treatment Phase 1|Protocol Violation|0
108315|NCT00701363|371901|P1|Treatment Phase 1|Protocol Violation|1
108316|NCT00701363|371898|P4|Treatment Phase 1|Adverse Event|0
108317|NCT00701363|371899|P3|Treatment Phase 1|Adverse Event|0
108318|NCT00701363|371900|P2|Treatment Phase 1|Adverse Event|0
108319|NCT00701363|371901|P1|Treatment Phase 1|Adverse Event|7
108320|NCT00701363|371898|P4|Treatment Phase 1|Does not meet entry Criteria|0
108321|NCT00701363|371899|P3|Treatment Phase 1|Does not meet entry Criteria|0
108322|NCT00701363|371900|P2|Treatment Phase 1|Does not meet entry Criteria|0
108323|NCT00701363|371901|P1|Treatment Phase 1|Does not meet entry Criteria|1
108324|NCT00701363|371898|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
108325|NCT00701363|371899|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
108326|NCT00701363|371900|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
108327|NCT00701363|371901|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
108328|NCT00701311|371941|P1|Overall Study|Withdrawal by Subject|2
108329|NCT00701311|371941|P1|Overall Study|Adverse Event|3
108330|NCT00701311|371941|P1|Overall Study|Lack of Efficacy|3
108331|NCT00701129|371945|P1|Overall Study|Death|2
108332|NCT00701090|371958|P2|Overall Study|Other|12
108333|NCT00701090|371959|P1|Overall Study|Other|7
108334|NCT00701090|371958|P2|Overall Study|Withdrawal by Subject|16
108335|NCT00701090|371959|P1|Overall Study|Withdrawal by Subject|11
108336|NCT00701090|371958|P2|Overall Study|Protocol Violation|3
108337|NCT00701090|371959|P1|Overall Study|Protocol Violation|2
108338|NCT00701090|371958|P2|Overall Study|Physician Decision|4
108339|NCT00701090|371959|P1|Overall Study|Physician Decision|3
108340|NCT00701090|371958|P2|Overall Study|Lost to Follow-up|9
108341|NCT00701090|371959|P1|Overall Study|Lost to Follow-up|9
108342|NCT00701090|371958|P2|Overall Study|Lack of Efficacy|4
108343|NCT00701090|371959|P1|Overall Study|Lack of Efficacy|5
108344|NCT00701090|371958|P2|Overall Study|Death|1
108345|NCT00701090|371959|P1|Overall Study|Death|0
108346|NCT00701090|371958|P2|Overall Study|Adverse Event|2
108347|NCT00701090|371959|P1|Overall Study|Adverse Event|11
108348|NCT00701064|371977|P2|Overall Study|initiated other PTSD treatment|2
108349|NCT00701064|371978|P1|Overall Study|initiated other PTSD treatment|2
108350|NCT00701064|371977|P2|Overall Study|Withdrawal by Subject|1
108351|NCT00701064|371978|P1|Overall Study|Withdrawal by Subject|1
108352|NCT00701064|371977|P2|Overall Study|Protocol Violation|1
108353|NCT00701064|371978|P1|Overall Study|Protocol Violation|1
108354|NCT00701051|371986|P3|Exercise Intervention|time conflict; non-study related illness|3
108355|NCT00701051|371987|P2|Exercise Intervention|time conflict; non-study related illness|5
108356|NCT00701051|371988|P1|Exercise Intervention|time conflict; non-study related illness|0
108357|NCT00701051|371986|P3|Screening|Time conflicts|0
108358|NCT00701051|371987|P2|Screening|Time conflicts|0
108359|NCT00701051|371988|P1|Screening|Time conflicts|19
108360|NCT00701051|371986|P3|Screening|Failed Screening|0
108361|NCT00701051|371987|P2|Screening|Failed Screening|0
108362|NCT00701051|371988|P1|Screening|Failed Screening|40
108363|NCT00701038|372006|P2|Overall Study|study amended pilot group of patients|4
108364|NCT00701038|372007|P1|Overall Study|study amended pilot group of patients|4
108365|NCT00700999|372015|P2|Overall Study|Withdrawal by Subject|1
108366|NCT00700999|372016|P1|Overall Study|Withdrawal by Subject|8
108367|NCT00700999|372015|P2|Overall Study|Excluded - did not meet study criteria|1
108368|NCT00700999|372016|P1|Overall Study|Excluded - did not meet study criteria|0
108369|NCT00700999|372015|P2|Overall Study|Lost to Follow-up|7
108370|NCT00700999|372016|P1|Overall Study|Lost to Follow-up|7
108371|NCT00700817|372036|P5|Week 52-78 (Extension Period 2)|Unclassified|1
108372|NCT00700817|372037|P4|Week 52-78 (Extension Period 2)|Unclassified|0
108373|NCT00700817|372038|P3|Week 52-78 (Extension Period 2)|Unclassified|0
108374|NCT00700817|372039|P2|Week 52-78 (Extension Period 2)|Unclassified|4
108375|NCT00700817|372040|P1|Week 52-78 (Extension Period 2)|Unclassified|2
108376|NCT00700817|372036|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
108377|NCT00700817|372037|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
108378|NCT00700817|372038|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
108379|NCT00700817|372039|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
108380|NCT00700817|372040|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
108381|NCT00700817|372036|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
108382|NCT00700817|372037|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
108383|NCT00700817|372038|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
108384|NCT00700817|372039|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
108385|NCT00700817|372040|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
108386|NCT00700817|372036|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
108387|NCT00700817|372037|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
108388|NCT00700817|372038|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
108389|NCT00700817|372039|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
108390|NCT00700817|372040|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
108391|NCT00700817|372036|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
108392|NCT00700817|372037|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
108393|NCT00700817|372038|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
108394|NCT00700817|372039|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
108395|NCT00700817|372040|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
108396|NCT00700817|372036|P5|Week 26-52 (Extension Period 1)|Unclassified|0
108397|NCT00700817|372037|P4|Week 26-52 (Extension Period 1)|Unclassified|0
108398|NCT00700817|372038|P3|Week 26-52 (Extension Period 1)|Unclassified|1
108399|NCT00700817|372039|P2|Week 26-52 (Extension Period 1)|Unclassified|3
108400|NCT00700817|372040|P1|Week 26-52 (Extension Period 1)|Unclassified|4
108401|NCT00700817|372036|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
108402|NCT00700817|372037|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
108403|NCT00700817|372038|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
108404|NCT00700817|372039|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
108405|NCT00700817|372040|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
108406|NCT00700817|372036|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
108407|NCT00700817|372037|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
108408|NCT00700817|372038|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
108409|NCT00700817|372039|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
108410|NCT00700817|372040|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
108411|NCT00700817|372036|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
108412|NCT00700817|372037|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
108413|NCT00700817|372038|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
108414|NCT00700817|372039|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
108415|NCT00700817|372040|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
108416|NCT00700817|372036|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
108417|NCT00700817|372037|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
108418|NCT00700817|372038|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
108419|NCT00700817|372039|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
108420|NCT00700817|372040|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
108421|NCT00700817|372036|P5|Week 0-26 (Main Period)|Unclassified|0
108422|NCT00700817|372037|P4|Week 0-26 (Main Period)|Unclassified|0
108423|NCT00700817|372038|P3|Week 0-26 (Main Period)|Unclassified|8
108424|NCT00700817|372039|P2|Week 0-26 (Main Period)|Unclassified|4
108425|NCT00700817|372040|P1|Week 0-26 (Main Period)|Unclassified|14
108426|NCT00700817|372036|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
108427|NCT00700817|372037|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
108428|NCT00700817|372038|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
108429|NCT00700817|372039|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
108430|NCT00700817|372040|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
108431|NCT00700817|372036|P5|Week 0-26 (Main Period)|Protocol Violation|0
108432|NCT00700817|372037|P4|Week 0-26 (Main Period)|Protocol Violation|0
108433|NCT00700817|372038|P3|Week 0-26 (Main Period)|Protocol Violation|4
108434|NCT00700817|372039|P2|Week 0-26 (Main Period)|Protocol Violation|4
108435|NCT00700817|372040|P1|Week 0-26 (Main Period)|Protocol Violation|14
108436|NCT00700817|372036|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
108437|NCT00700817|372037|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
108438|NCT00700817|372038|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
108439|NCT00700817|372039|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
108440|NCT00700817|372040|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
108441|NCT00700817|372036|P5|Week 0-26 (Main Period)|Adverse Event|0
108442|NCT00700817|372037|P4|Week 0-26 (Main Period)|Adverse Event|0
108443|NCT00700817|372038|P3|Week 0-26 (Main Period)|Adverse Event|4
108444|NCT00700817|372039|P2|Week 0-26 (Main Period)|Adverse Event|15
108445|NCT00700817|372040|P1|Week 0-26 (Main Period)|Adverse Event|14
108446|NCT00700804|372422|P2|Overall Study|Loose Stools|1
108447|NCT00700804|372423|P1|Overall Study|Loose Stools|1
108448|NCT00700804|372422|P2|Overall Study|Protocol Violation|1
108449|NCT00700804|372423|P1|Overall Study|Protocol Violation|1
108450|NCT00700804|372422|P2|Overall Study|Withdrawal by Subject|2
108451|NCT00700804|372423|P1|Overall Study|Withdrawal by Subject|1
108452|NCT00700752|372431|P2|First Intervention|Withdrawal by Subject|2
108453|NCT00700752|372432|P1|First Intervention|Withdrawal by Subject|0
108454|NCT00700739|372440|P2|Overall Study|Lost to Follow-up|4
108455|NCT00700739|372441|P1|Overall Study|Lost to Follow-up|4
108456|NCT00700713|372480|P3|Overall Study|Withdrawal by Subject|1
108457|NCT00700713|372481|P2|Overall Study|Withdrawal by Subject|0
108458|NCT00700713|372482|P1|Overall Study|Withdrawal by Subject|0
108459|NCT00700713|372480|P3|Overall Study|Protocol Violation|1
108460|NCT00700713|372481|P2|Overall Study|Protocol Violation|0
108461|NCT00700713|372482|P1|Overall Study|Protocol Violation|1
108462|NCT00700635|372499|P3|Overall Study|Withdrawal by Subject|1
108463|NCT00700635|372500|P2|Overall Study|Withdrawal by Subject|3
108464|NCT00700635|372501|P1|Overall Study|Withdrawal by Subject|7
108465|NCT00700635|372499|P3|Overall Study|Protocol Violation|0
108466|NCT00700635|372500|P2|Overall Study|Protocol Violation|2
108467|NCT00700635|372501|P1|Overall Study|Protocol Violation|2
108468|NCT00700635|372499|P3|Overall Study|Lost to Follow-up|0
108469|NCT00700635|372500|P2|Overall Study|Lost to Follow-up|3
108470|NCT00700635|372501|P1|Overall Study|Lost to Follow-up|1
108471|NCT00700635|372499|P3|Overall Study|Adverse Event|0
108472|NCT00700635|372500|P2|Overall Study|Adverse Event|0
108473|NCT00700635|372501|P1|Overall Study|Adverse Event|1
108474|NCT00700622|372523|P2|Overall Study|Other|1
108475|NCT00700622|372524|P1|Overall Study|Other|3
108476|NCT00700622|372523|P2|Overall Study|Withdrawal by Subject|1
108477|NCT00700622|372524|P1|Overall Study|Withdrawal by Subject|4
108478|NCT00700622|372523|P2|Overall Study|Protocol Violation|1
108479|NCT00700622|372524|P1|Overall Study|Protocol Violation|0
108480|NCT00700622|372523|P2|Overall Study|Physician Decision|1
108481|NCT00700622|372524|P1|Overall Study|Physician Decision|2
108482|NCT00700622|372523|P2|Overall Study|Lost to Follow-up|1
108483|NCT00700622|372524|P1|Overall Study|Lost to Follow-up|0
108484|NCT00700622|372523|P2|Overall Study|Adverse Event|0
108485|NCT00700622|372524|P1|Overall Study|Adverse Event|4
108486|NCT00700570|372532|P2|Overall Study|Withdrawal by Subject|6
108487|NCT00700570|372533|P1|Overall Study|Withdrawal by Subject|1
108488|NCT00700570|372532|P2|Overall Study|Disease Progression|11
108489|NCT00700570|372533|P1|Overall Study|Disease Progression|8
108490|NCT00700570|372532|P2|Overall Study|Discretion of Investigator or Sponsor|3
108491|NCT00700570|372533|P1|Overall Study|Discretion of Investigator or Sponsor|0
108492|NCT00700570|372532|P2|Overall Study|Adverse Event|6
108493|NCT00700570|372533|P1|Overall Study|Adverse Event|2
108494|NCT00700427|372549|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
108495|NCT00700427|372550|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
108496|NCT00700427|372551|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
108497|NCT00700427|372552|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
108498|NCT00700427|372553|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
108499|NCT00700427|372549|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
108500|NCT00700427|372550|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
108501|NCT00700427|372551|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
108502|NCT00700427|372552|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
108503|NCT00700427|372553|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
108504|NCT00700427|372549|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
108505|NCT00700427|372550|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
108506|NCT00700427|372551|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
108507|NCT00700427|372552|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
108508|NCT00700427|372553|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
108509|NCT00700427|372549|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
108510|NCT00700427|372550|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
108511|NCT00700427|372551|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
108512|NCT00700427|372552|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
108513|NCT00700427|372553|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
108514|NCT00700427|372549|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
108515|NCT00700427|372550|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
108516|NCT00700427|372551|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
108517|NCT00700427|372552|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
108518|NCT00700427|372553|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
108519|NCT00700427|372549|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
108520|NCT00700427|372550|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
108521|NCT00700427|372551|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
108522|NCT00700427|372552|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
108523|NCT00700427|372553|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
108524|NCT00700427|372549|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
108525|NCT00700427|372550|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
108526|NCT00700427|372551|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
108527|NCT00700427|372552|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
108528|NCT00700427|372553|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
108529|NCT00700427|372549|P5|Study Period 4 (Open-Label Extension)|Death|1
108530|NCT00700427|372550|P4|Study Period 4 (Open-Label Extension)|Death|0
108531|NCT00700427|372551|P3|Study Period 4 (Open-Label Extension)|Death|0
108532|NCT00700427|372552|P2|Study Period 4 (Open-Label Extension)|Death|0
108533|NCT00700427|372553|P1|Study Period 4 (Open-Label Extension)|Death|0
108534|NCT00700427|372549|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
108535|NCT00700427|372550|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
108536|NCT00700427|372551|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
108537|NCT00700427|372552|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
108538|NCT00700427|372553|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
108539|NCT00700427|372549|P5|Study Period 3B (Randomized Withdrawal)|Death|0
108540|NCT00700427|372550|P4|Study Period 3B (Randomized Withdrawal)|Death|0
108541|NCT00700427|372551|P3|Study Period 3B (Randomized Withdrawal)|Death|1
108542|NCT00700427|372552|P2|Study Period 3B (Randomized Withdrawal)|Death|0
108543|NCT00700427|372553|P1|Study Period 3B (Randomized Withdrawal)|Death|0
108544|NCT00700427|372549|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
108545|NCT00700427|372550|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
108546|NCT00700427|372551|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
108547|NCT00700427|372552|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
108548|NCT00700427|372553|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
108549|NCT00700427|372549|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
108550|NCT00700427|372550|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
108551|NCT00700427|372551|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
108552|NCT00700427|372552|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
108553|NCT00700427|372553|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
108554|NCT00700427|372549|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
108555|NCT00700427|372550|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
108556|NCT00700427|372551|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
108557|NCT00700427|372552|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
108558|NCT00700427|372553|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
108559|NCT00700427|372549|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
108560|NCT00700427|372550|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
108561|NCT00700427|372551|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
108562|NCT00700427|372552|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
108563|NCT00700427|372553|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
108564|NCT00700427|372549|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
108565|NCT00700427|372550|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
108566|NCT00700427|372551|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
108567|NCT00700427|372552|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
108568|NCT00700427|372553|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
108569|NCT00700427|372549|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
108570|NCT00700427|372550|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
108571|NCT00700427|372551|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
108572|NCT00700427|372552|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
108573|NCT00700427|372553|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
108574|NCT00700427|372549|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
108575|NCT00700427|372550|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
108576|NCT00700427|372551|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
108577|NCT00700427|372552|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
108578|NCT00700427|372553|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
108579|NCT00700427|372549|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
108580|NCT00700427|372550|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
108581|NCT00700427|372551|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
108582|NCT00700427|372552|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
108583|NCT00700427|372553|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
108584|NCT00700427|372549|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
108585|NCT00700427|372550|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
108586|NCT00700427|372551|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
108587|NCT00700427|372552|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
108588|NCT00700427|372553|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
108589|NCT00700427|372549|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
108590|NCT00700427|372550|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
108591|NCT00700427|372551|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
108592|NCT00700427|372552|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
108593|NCT00700427|372553|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
108594|NCT00700427|372549|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
108595|NCT00700427|372550|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
108596|NCT00700427|372551|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
108597|NCT00700427|372552|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
108598|NCT00700427|372553|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
108599|NCT00700427|372549|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
108600|NCT00700427|372550|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
108601|NCT00700427|372551|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
108602|NCT00700427|372552|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
108603|NCT00700427|372553|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
108604|NCT00700427|372549|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
108605|NCT00700427|372550|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
108606|NCT00700427|372551|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
108607|NCT00700427|372552|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
108608|NCT00700427|372553|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
108609|NCT00700427|372549|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
108610|NCT00700427|372550|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
108611|NCT00700427|372551|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
108612|NCT00700427|372552|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
108613|NCT00700427|372553|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
108614|NCT00700427|372549|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
108615|NCT00700427|372550|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
108616|NCT00700427|372551|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
108617|NCT00700427|372552|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
108618|NCT00700427|372553|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
108619|NCT00700427|372549|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
108620|NCT00700427|372550|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
108621|NCT00700427|372551|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
108622|NCT00700427|372552|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
108623|NCT00700427|372553|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
108624|NCT00700427|372549|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
108625|NCT00700427|372550|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
108626|NCT00700427|372551|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
108627|NCT00700427|372552|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
108628|NCT00700427|372553|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
108629|NCT00700427|372549|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
108630|NCT00700427|372550|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
108631|NCT00700427|372551|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
108632|NCT00700427|372552|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
108633|NCT00700427|372553|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
108634|NCT00700427|372549|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
108635|NCT00700427|372550|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
108636|NCT00700427|372551|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
108637|NCT00700427|372552|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
108638|NCT00700427|372553|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
108639|NCT00700427|372549|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
108640|NCT00700427|372550|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
108641|NCT00700427|372551|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
108642|NCT00700427|372552|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
108643|NCT00700427|372553|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
108644|NCT00700427|372549|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
108645|NCT00700427|372550|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
108646|NCT00700427|372551|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
108647|NCT00700427|372552|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
108648|NCT00700427|372553|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
108649|NCT00700427|372549|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
108650|NCT00700427|372550|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
108651|NCT00700427|372551|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
108652|NCT00700427|372552|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
108653|NCT00700427|372553|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
108654|NCT00700427|372549|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
108655|NCT00700427|372550|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
108656|NCT00700427|372551|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
108657|NCT00700427|372552|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
108658|NCT00700427|372553|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
108659|NCT00700427|372549|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
108660|NCT00700427|372550|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
108661|NCT00700427|372551|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
108662|NCT00700427|372552|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
108663|NCT00700427|372553|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
108664|NCT00700427|372549|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
108665|NCT00700427|372550|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
108666|NCT00700427|372551|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
108667|NCT00700427|372552|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
108668|NCT00700427|372553|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
108669|NCT00700427|372549|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
108670|NCT00700427|372550|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
108671|NCT00700427|372551|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
108672|NCT00700427|372552|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
108673|NCT00700427|372553|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
108674|NCT00700427|372549|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
108675|NCT00700427|372550|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
108676|NCT00700427|372551|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
108677|NCT00700427|372552|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
108678|NCT00700427|372553|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
108679|NCT00700427|372549|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
108680|NCT00700427|372550|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
108681|NCT00700427|372551|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
108682|NCT00700427|372552|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
108683|NCT00700427|372553|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
108684|NCT00700401|372575|P1|Overall Study|Withdrawal by Subject|2
108685|NCT00700401|372575|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
108686|NCT00700401|372575|P1|Overall Study|Treatment never started|1
108687|NCT00700401|372575|P1|Overall Study|Lost to Follow-up|1
108688|NCT00700401|372575|P1|Overall Study|Refused Treatment|2
108689|NCT00700401|372575|P1|Overall Study|Adverse Event|5
108690|NCT00700401|372575|P1|Overall Study|Detectable HCV RNA after Week 4|82
108691|NCT00700310|372599|P4|Overall Study|Randomized, Not Treated|2
108692|NCT00700310|372600|P3|Overall Study|Randomized, Not Treated|2
108693|NCT00700310|372601|P2|Overall Study|Randomized, Not Treated|0
108694|NCT00700310|372602|P1|Overall Study|Randomized, Not Treated|2
108695|NCT00700310|372599|P4|Overall Study|Administrative/Other|3
108696|NCT00700310|372600|P3|Overall Study|Administrative/Other|1
108697|NCT00700310|372601|P2|Overall Study|Administrative/Other|3
108698|NCT00700310|372602|P1|Overall Study|Administrative/Other|1
108699|NCT00700310|372599|P4|Overall Study|Lack of Efficacy|1
108700|NCT00700310|372600|P3|Overall Study|Lack of Efficacy|0
108701|NCT00700310|372601|P2|Overall Study|Lack of Efficacy|3
108702|NCT00700310|372602|P1|Overall Study|Lack of Efficacy|0
108703|NCT00700310|372599|P4|Overall Study|Withdrawal by Subject|8
108704|NCT00700310|372600|P3|Overall Study|Withdrawal by Subject|8
108705|NCT00700310|372601|P2|Overall Study|Withdrawal by Subject|9
108706|NCT00700310|372602|P1|Overall Study|Withdrawal by Subject|8
108707|NCT00700310|372599|P4|Overall Study|Lost to Follow-up|1
108708|NCT00700310|372600|P3|Overall Study|Lost to Follow-up|0
108709|NCT00700310|372601|P2|Overall Study|Lost to Follow-up|1
108710|NCT00700310|372602|P1|Overall Study|Lost to Follow-up|4
108711|NCT00700310|372599|P4|Overall Study|Adverse Event|11
108712|NCT00700310|372600|P3|Overall Study|Adverse Event|5
108713|NCT00700310|372601|P2|Overall Study|Adverse Event|10
108714|NCT00700310|372602|P1|Overall Study|Adverse Event|6
108715|NCT00700271|372622|P2|Overall Study|Lost to Follow-up|2
108716|NCT00700271|372623|P1|Overall Study|Lost to Follow-up|2
108717|NCT00700271|372622|P2|Overall Study|Withdrawal by Subject|4
108718|NCT00700271|372623|P1|Overall Study|Withdrawal by Subject|6
108719|NCT00700271|372622|P2|Overall Study|Administrative Reasons|0
108720|NCT00700271|372623|P1|Overall Study|Administrative Reasons|1
108721|NCT00700271|372622|P2|Overall Study|Protocol Violation|0
108722|NCT00700271|372623|P1|Overall Study|Protocol Violation|1
108723|NCT00700271|372622|P2|Overall Study|Adverse Event|6
108724|NCT00700271|372623|P1|Overall Study|Adverse Event|4
108725|NCT00700180|372651|P2|Overall Study|Lost to Follow-up|5
108726|NCT00700180|372652|P1|Overall Study|Lost to Follow-up|4
108727|NCT00700180|372651|P2|Overall Study|Alive in follow-up|27
108728|NCT00700180|372652|P1|Overall Study|Alive in follow-up|46
108729|NCT00700180|372651|P2|Overall Study|Alive on treatment|3
108730|NCT00700180|372652|P1|Overall Study|Alive on treatment|5
108731|NCT00700180|372651|P2|Overall Study|Death|114
108732|NCT00700180|372652|P1|Overall Study|Death|99
108733|NCT00700115|372681|P2|Overall Study|Lost to Follow-up|1
108734|NCT00700115|372682|P1|Overall Study|Lost to Follow-up|0
108735|NCT00700115|372681|P2|Overall Study|Withdrawal by Subject|0
108736|NCT00700115|372682|P1|Overall Study|Withdrawal by Subject|1
108737|NCT00700102|372692|P2|Overall Study|Lost to Follow-up|10
108738|NCT00700102|372693|P1|Overall Study|Lost to Follow-up|8
108739|NCT00700102|372692|P2|Overall Study|Died|385
108740|NCT00700102|372693|P1|Overall Study|Died|394
108741|NCT00700011|372832|P2|Overall Study|Death|1
108742|NCT00700011|372833|P1|Overall Study|Death|0
108743|NCT00699998|372849|P4|Overall Study|Lost to Follow-up|1
108744|NCT00699998|372850|P3|Overall Study|Lost to Follow-up|3
108745|NCT00699998|372851|P2|Overall Study|Lost to Follow-up|1
108746|NCT00699998|372852|P1|Overall Study|Lost to Follow-up|2
108747|NCT00699998|372849|P4|Overall Study|Physician Decision|1
108748|NCT00699998|372850|P3|Overall Study|Physician Decision|1
108749|NCT00699998|372851|P2|Overall Study|Physician Decision|2
108750|NCT00699998|372852|P1|Overall Study|Physician Decision|3
108751|NCT00699998|372849|P4|Overall Study|Withdrawal by Subject|80
108752|NCT00699998|372850|P3|Overall Study|Withdrawal by Subject|202
108753|NCT00699998|372851|P2|Overall Study|Withdrawal by Subject|83
108754|NCT00699998|372852|P1|Overall Study|Withdrawal by Subject|194
108755|NCT00699972|372897|P3|Overall Study|Randomized, Not Treated|1
108756|NCT00699972|372898|P2|Overall Study|Randomized, Not Treated|0
108757|NCT00699972|372899|P1|Overall Study|Randomized, Not Treated|1
108758|NCT00699972|372897|P3|Overall Study|Administrative/Other|4
108759|NCT00699972|372898|P2|Overall Study|Administrative/Other|1
108760|NCT00699972|372899|P1|Overall Study|Administrative/Other|3
108761|NCT00699972|372897|P3|Overall Study|Lack of Efficacy|2
108762|NCT00699972|372898|P2|Overall Study|Lack of Efficacy|0
108763|NCT00699972|372899|P1|Overall Study|Lack of Efficacy|2
108764|NCT00699972|372897|P3|Overall Study|Withdrawal by Subject|4
108765|NCT00699972|372898|P2|Overall Study|Withdrawal by Subject|7
108766|NCT00699972|372899|P1|Overall Study|Withdrawal by Subject|3
108767|NCT00699972|372897|P3|Overall Study|Lost to Follow-up|0
108768|NCT00699972|372898|P2|Overall Study|Lost to Follow-up|2
108769|NCT00699972|372899|P1|Overall Study|Lost to Follow-up|0
108770|NCT00699972|372897|P3|Overall Study|Adverse Event|24
108771|NCT00699972|372898|P2|Overall Study|Adverse Event|9
108772|NCT00699972|372899|P1|Overall Study|Adverse Event|7
108773|NCT00699842|372916|P3|Overall Study|Death|0
108774|NCT00699842|372917|P2|Overall Study|Death|1
108775|NCT00699842|372918|P1|Overall Study|Death|0
108776|NCT00699816|372931|P2|Overall Study|Protocol Violation|3
108777|NCT00699816|372932|P1|Overall Study|Protocol Violation|1
108778|NCT00699751|372950|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
108779|NCT00699751|372951|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
108780|NCT00699751|372950|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
108781|NCT00699751|372951|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
108782|NCT00699751|372950|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
108783|NCT00699751|372951|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
108784|NCT00699751|372950|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
108785|NCT00699751|372951|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
108786|NCT00699751|372950|P2|Period 1: Without/Before Drug Switch|Unspecified|20
108787|NCT00699751|372951|P1|Period 1: Without/Before Drug Switch|Unspecified|30
108788|NCT00699751|372950|P2|Period 1: Without/Before Drug Switch|Subject Request|23
108789|NCT00699751|372951|P1|Period 1: Without/Before Drug Switch|Subject Request|43
108790|NCT00699751|372950|P2|Period 1: Without/Before Drug Switch|Death|29
108791|NCT00699751|372951|P1|Period 1: Without/Before Drug Switch|Death|28
108792|NCT00699751|372950|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
108793|NCT00699751|372951|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
108794|NCT00699699|373036|P1|Overall Study|Individual different reasons|21
108795|NCT00699699|373036|P1|Overall Study|Adverse Event|36
108796|NCT00699660|373045|P2|Overall Study|missing reports and recording failures|6
108797|NCT00699660|373046|P1|Overall Study|missing reports and recording failures|10
108798|NCT00699660|373045|P2|Overall Study|Lost to Follow-up|2
108799|NCT00699660|373046|P1|Overall Study|Lost to Follow-up|4
108800|NCT00699608|373058|P6|Second Intervention|Withdrawal by Subject|0
108801|NCT00699608|373059|P5|Second Intervention|Withdrawal by Subject|0
108802|NCT00699608|373060|P4|Second Intervention|Withdrawal by Subject|1
108803|NCT00699608|373061|P3|Second Intervention|Withdrawal by Subject|0
108804|NCT00699608|373062|P2|Second Intervention|Withdrawal by Subject|0
108805|NCT00699608|373063|P1|Second Intervention|Withdrawal by Subject|0
108806|NCT00699608|373058|P6|Second Intervention|Adverse Event|0
108807|NCT00699608|373059|P5|Second Intervention|Adverse Event|0
108808|NCT00699608|373060|P4|Second Intervention|Adverse Event|0
108809|NCT00699608|373061|P3|Second Intervention|Adverse Event|1
108810|NCT00699608|373062|P2|Second Intervention|Adverse Event|0
108811|NCT00699608|373063|P1|Second Intervention|Adverse Event|0
108812|NCT00699608|373058|P6|First Intervention|Protocol Violation|0
108813|NCT00699608|373059|P5|First Intervention|Protocol Violation|1
108814|NCT00699608|373060|P4|First Intervention|Protocol Violation|0
108815|NCT00699608|373061|P3|First Intervention|Protocol Violation|0
108816|NCT00699608|373062|P2|First Intervention|Protocol Violation|0
108817|NCT00699608|373063|P1|First Intervention|Protocol Violation|0
108818|NCT00699608|373058|P6|First Intervention|Withdrawal by Subject|0
108819|NCT00699608|373059|P5|First Intervention|Withdrawal by Subject|0
108820|NCT00699608|373060|P4|First Intervention|Withdrawal by Subject|0
108821|NCT00699608|373061|P3|First Intervention|Withdrawal by Subject|1
108822|NCT00699608|373062|P2|First Intervention|Withdrawal by Subject|0
108823|NCT00699608|373063|P1|First Intervention|Withdrawal by Subject|0
108824|NCT00699582|373116|P3|Overall Study|Randomized, Not Treated|0
108825|NCT00699582|373117|P2|Overall Study|Randomized, Not Treated|1
108826|NCT00699582|373118|P1|Overall Study|Randomized, Not Treated|2
108827|NCT00699582|373116|P3|Overall Study|Administrative/Other|0
108828|NCT00699582|373117|P2|Overall Study|Administrative/Other|3
108829|NCT00699582|373118|P1|Overall Study|Administrative/Other|4
108830|NCT00699582|373116|P3|Overall Study|Progressive Disease|0
108831|NCT00699582|373117|P2|Overall Study|Progressive Disease|0
108832|NCT00699582|373118|P1|Overall Study|Progressive Disease|1
108833|NCT00699582|373116|P3|Overall Study|Lack of Efficacy|1
108834|NCT00699582|373117|P2|Overall Study|Lack of Efficacy|0
108835|NCT00699582|373118|P1|Overall Study|Lack of Efficacy|1
108836|NCT00699582|373116|P3|Overall Study|Withdrawal by Subject|4
108837|NCT00699582|373117|P2|Overall Study|Withdrawal by Subject|7
108838|NCT00699582|373118|P1|Overall Study|Withdrawal by Subject|6
108839|NCT00699582|373116|P3|Overall Study|Adverse Event|23
108840|NCT00699582|373117|P2|Overall Study|Adverse Event|11
108841|NCT00699582|373118|P1|Overall Study|Adverse Event|4
108842|NCT00699374|373204|P2|Overall Study|Died 28 days after last dose|9
108843|NCT00699374|373205|P1|Overall Study|Died 28 days after last dose|5
108844|NCT00699374|373204|P2|Overall Study|Randomized but not treated|2
108845|NCT00699374|373205|P1|Overall Study|Randomized but not treated|4
108846|NCT00699374|373204|P2|Overall Study|Study terminated by sponsor|28
108847|NCT00699374|373205|P1|Overall Study|Study terminated by sponsor|13
108848|NCT00699374|373204|P2|Overall Study|Protocol Violation|6
108849|NCT00699374|373205|P1|Overall Study|Protocol Violation|2
108850|NCT00699374|373204|P2|Overall Study|Unspecified|15
108851|NCT00699374|373205|P1|Overall Study|Unspecified|18
108852|NCT00699374|373204|P2|Overall Study|Objective progression or relapse|277
108853|NCT00699374|373205|P1|Overall Study|Objective progression or relapse|281
108854|NCT00699374|373204|P2|Overall Study|Withdrawal by Subject|44
108855|NCT00699374|373205|P1|Overall Study|Withdrawal by Subject|34
108856|NCT00699374|373204|P2|Overall Study|Lost to Follow-up|5
108857|NCT00699374|373205|P1|Overall Study|Lost to Follow-up|3
108858|NCT00699374|373204|P2|Overall Study|Global deterioration of health status|8
108859|NCT00699374|373205|P1|Overall Study|Global deterioration of health status|7
108860|NCT00699374|373204|P2|Overall Study|Adverse Event|67
108861|NCT00699374|373205|P1|Overall Study|Adverse Event|70
108862|NCT00699374|373204|P2|Overall Study|Death|83
108863|NCT00699374|373205|P1|Overall Study|Death|93
108864|NCT00699348|373217|P1|Overall Study|Unspecified|5
108865|NCT00699348|373217|P1|Overall Study|Renal transplantation|10
108866|NCT00699348|373217|P1|Overall Study|Blood transfusion|24
108867|NCT00699348|373217|P1|Overall Study|Failure to return|1
108868|NCT00699348|373217|P1|Overall Study|Lack of Efficacy|8
108869|NCT00699348|373217|P1|Overall Study|Protocol Violation|10
108870|NCT00699348|373217|P1|Overall Study|Withdrawal by Subject|11
108871|NCT00699348|373217|P1|Overall Study|Adverse Event|15
108872|NCT00699348|373217|P1|Overall Study|Death|6
108873|NCT00699335|373226|P1|Overall Study|Missing data|52
108874|NCT00699335|373226|P1|Overall Study|Combination of multiple reasons|176
108875|NCT00699283|373259|P2|Overall Study|AE of unknown type|0
108876|NCT00699283|373260|P1|Overall Study|AE of unknown type|1
108877|NCT00699283|373259|P2|Overall Study|AE, non-serious non-fatal|1
108878|NCT00699283|373260|P1|Overall Study|AE, non-serious non-fatal|8
108879|NCT00699283|373259|P2|Overall Study|SAE, non-fatal|1
108880|NCT00699283|373260|P1|Overall Study|SAE, non-fatal|1
108881|NCT00699283|373259|P2|Overall Study|Other Reason|1
108882|NCT00699283|373260|P1|Overall Study|Other Reason|5
108883|NCT00699283|373259|P2|Overall Study|Withdrawal by Subject|0
108884|NCT00699283|373260|P1|Overall Study|Withdrawal by Subject|1
108885|NCT00699283|373259|P2|Overall Study|Lost to Follow-up|0
108886|NCT00699283|373260|P1|Overall Study|Lost to Follow-up|2
108887|NCT00699283|373259|P2|Overall Study|Lack of Efficacy|5
108888|NCT00699283|373260|P1|Overall Study|Lack of Efficacy|15
108889|NCT00699192|373268|P3|Overall Study|Protocol Violation|0
108890|NCT00699192|373269|P2|Overall Study|Protocol Violation|2
108891|NCT00699192|373270|P1|Overall Study|Protocol Violation|2
108892|NCT00699192|373268|P3|Overall Study|Administrative problems|1
108893|NCT00699192|373269|P2|Overall Study|Administrative problems|3
108894|NCT00699192|373270|P1|Overall Study|Administrative problems|1
108895|NCT00699192|373268|P3|Overall Study|Withdrawal by Subject|4
108896|NCT00699192|373269|P2|Overall Study|Withdrawal by Subject|2
108897|NCT00699192|373270|P1|Overall Study|Withdrawal by Subject|3
108898|NCT00699192|373268|P3|Overall Study|Lack of Efficacy|1
108899|NCT00699192|373269|P2|Overall Study|Lack of Efficacy|0
108900|NCT00699192|373270|P1|Overall Study|Lack of Efficacy|0
108901|NCT00699192|373268|P3|Overall Study|Abnormal test procedure result(s)|1
108902|NCT00699192|373269|P2|Overall Study|Abnormal test procedure result(s)|0
108903|NCT00699192|373270|P1|Overall Study|Abnormal test procedure result(s)|0
108904|NCT00699192|373268|P3|Overall Study|Adverse Event|3
108905|NCT00699192|373269|P2|Overall Study|Adverse Event|4
108906|NCT00699192|373270|P1|Overall Study|Adverse Event|9
108907|NCT00699192|373268|P3|Overall Study|Missing|1
108908|NCT00699192|373269|P2|Overall Study|Missing|1
108909|NCT00699192|373270|P1|Overall Study|Missing|1
108910|NCT00699153|373292|P2|Overall Study|Travel Problem|0
108911|NCT00699153|373293|P1|Overall Study|Travel Problem|1
108912|NCT00699153|373292|P2|Overall Study|Protocol Violation|0
108913|NCT00699153|373293|P1|Overall Study|Protocol Violation|1
108914|NCT00699153|373292|P2|Overall Study|Adverse Event|2
108915|NCT00699153|373293|P1|Overall Study|Adverse Event|0
108916|NCT00699153|373292|P2|Overall Study|Lost to Follow-up|0
108917|NCT00699153|373293|P1|Overall Study|Lost to Follow-up|1
108918|NCT00698932|373319|P2|Overall Study|Death|0
108919|NCT00698932|373320|P1|Overall Study|Death|1
108920|NCT00698932|373319|P2|Overall Study|Safety reasons|2
108921|NCT00698932|373320|P1|Overall Study|Safety reasons|0
108922|NCT00698932|373319|P2|Overall Study|Severe non-compliance to protocol|2
108923|NCT00698932|373320|P1|Overall Study|Severe non-compliance to protocol|1
108924|NCT00698932|373319|P2|Overall Study|Lost to Follow-up|1
108925|NCT00698932|373320|P1|Overall Study|Lost to Follow-up|6
108926|NCT00698932|373319|P2|Overall Study|Withdrawal by Subject|23
108927|NCT00698932|373320|P1|Overall Study|Withdrawal by Subject|11
108928|NCT00698932|373319|P2|Overall Study|Study specific discontinuation criteria|4
108929|NCT00698932|373320|P1|Overall Study|Study specific discontinuation criteria|3
108930|NCT00698932|373319|P2|Overall Study|Incorrect enrollment|2
108931|NCT00698932|373320|P1|Overall Study|Incorrect enrollment|0
108932|NCT00698932|373319|P2|Overall Study|Adverse Event|2
108933|NCT00698932|373320|P1|Overall Study|Adverse Event|0
108934|NCT00698841|373336|P1|Overall Study|Other|2
108935|NCT00698841|373336|P1|Overall Study|Study drug toxicity|2
108936|NCT00698841|373336|P1|Overall Study|Failure to meet eligibility criteria|2
108937|NCT00698841|373336|P1|Overall Study|Disease progression|7
108938|NCT00698841|373336|P1|Overall Study|Adverse Event|3
108939|NCT00698841|373336|P1|Overall Study|Withdrawal by Subject|2
108940|NCT00698815|373350|P3|Overall Study|Did not receive protocol treatment|2
108941|NCT00698815|373351|P2|Overall Study|Did not receive protocol treatment|2
108942|NCT00698815|373352|P1|Overall Study|Did not receive protocol treatment|1
108943|NCT00698815|373350|P3|Overall Study|MD discretion|2
108944|NCT00698815|373351|P2|Overall Study|MD discretion|7
108945|NCT00698815|373352|P1|Overall Study|MD discretion|2
108946|NCT00698815|373350|P3|Overall Study|Withdrawal by Subject|2
108947|NCT00698815|373351|P2|Overall Study|Withdrawal by Subject|3
108948|NCT00698815|373352|P1|Overall Study|Withdrawal by Subject|6
108949|NCT00698815|373350|P3|Overall Study|Death|4
108950|NCT00698815|373351|P2|Overall Study|Death|2
108951|NCT00698815|373352|P1|Overall Study|Death|1
108952|NCT00698685|373369|P1|Overall Study|Off study pre transplant by clinic MD|1
108953|NCT00698685|373369|P1|Overall Study|Sister withdrew as donor|1
108954|NCT00698646|373377|P3|Overall Study|Administrative problems|1
108955|NCT00698646|373378|P2|Overall Study|Administrative problems|0
108956|NCT00698646|373379|P1|Overall Study|Administrative problems|1
108957|NCT00698646|373377|P3|Overall Study|Lost to Follow-up|2
108958|NCT00698646|373378|P2|Overall Study|Lost to Follow-up|0
108959|NCT00698646|373379|P1|Overall Study|Lost to Follow-up|0
108960|NCT00698646|373377|P3|Overall Study|Withdrawal by Subject|8
108961|NCT00698646|373378|P2|Overall Study|Withdrawal by Subject|11
108962|NCT00698646|373379|P1|Overall Study|Withdrawal by Subject|10
108963|NCT00698646|373377|P3|Overall Study|Protocol Deviation|3
108964|NCT00698646|373378|P2|Overall Study|Protocol Deviation|2
108965|NCT00698646|373379|P1|Overall Study|Protocol Deviation|6
108966|NCT00698646|373377|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
108967|NCT00698646|373378|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
108968|NCT00698646|373379|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
108969|NCT00698646|373377|P3|Overall Study|Adverse Event|8
108970|NCT00698646|373378|P2|Overall Study|Adverse Event|7
108971|NCT00698646|373379|P1|Overall Study|Adverse Event|8
108972|NCT00698581|373404|P2|Overall Study|AE of unknown type|0
108973|NCT00698581|373405|P1|Overall Study|AE of unknown type|1
108974|NCT00698581|373404|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
108975|NCT00698581|373405|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
108976|NCT00698581|373404|P2|Overall Study|AE, non-serious non-fatal|0
108977|NCT00698581|373405|P1|Overall Study|AE, non-serious non-fatal|4
108978|NCT00698581|373404|P2|Overall Study|SAE, non-fatal|0
108979|NCT00698581|373405|P1|Overall Study|SAE, non-fatal|1
108980|NCT00698581|373404|P2|Overall Study|Other reason|1
108981|NCT00698581|373405|P1|Overall Study|Other reason|9
108982|NCT00698581|373404|P2|Overall Study|Withdrawal by Subject|0
108983|NCT00698581|373405|P1|Overall Study|Withdrawal by Subject|6
108984|NCT00698581|373404|P2|Overall Study|Lack of Efficacy|11
108985|NCT00698581|373405|P1|Overall Study|Lack of Efficacy|23
108986|NCT00698516|373416|P1|Overall Study|Withdrawal by Subject|3
108987|NCT00698516|373416|P1|Overall Study|Study Termination|2
108988|NCT00698451|373434|P1|Overall Study|Disease progression|3
108989|NCT00698451|373434|P1|Overall Study|Withdrawal by Subject|6
108990|NCT00698451|373434|P1|Overall Study|Protocol Violation|6
108991|NCT00698451|373434|P1|Overall Study|Physician Decision|2
108992|NCT00698451|373434|P1|Overall Study|Adverse Event|22
108993|NCT00698204|373441|P2|Overall Study|Withdrawal by Subject|0
108994|NCT00698204|373442|P1|Overall Study|Withdrawal by Subject|1
108995|NCT00698009|373502|P1|Overall Study|Withdrawal by Subject|1
108996|NCT00697827|373508|P2|Overall Study|enrolled but not treated|1
108997|NCT00697827|373509|P1|Overall Study|enrolled but not treated|2
108998|NCT00697619|373549|P2|Overall Study|Adverse Event|6
108999|NCT00697619|373550|P1|Overall Study|Adverse Event|4
109000|NCT00697619|373549|P2|Overall Study|Lack of Efficacy|2
109001|NCT00697619|373550|P1|Overall Study|Lack of Efficacy|2
109002|NCT00697593|373556|P1|Overall Study|Suspension of the study by sponsor|12
109003|NCT00697593|373556|P1|Overall Study|Lack of Efficacy|3
109004|NCT00697593|373556|P1|Overall Study|Protocol Violation|1
109005|NCT00697593|373556|P1|Overall Study|Adverse Event|3
109006|NCT00697515|373600|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
109007|NCT00697515|373601|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
109008|NCT00697515|373600|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
109009|NCT00697515|373601|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
109010|NCT00697515|373600|P2|First Intervention (Crossover Period)|Adverse Event|2
109011|NCT00697515|373601|P1|First Intervention (Crossover Period)|Adverse Event|0
109012|NCT00697515|373600|P2|First Intervention (Crossover Period)|Natural disaster|9
109013|NCT00697515|373601|P1|First Intervention (Crossover Period)|Natural disaster|8
109014|NCT00697515|373600|P2|Dose Optimization Period|elevated QTc|0
109015|NCT00697515|373601|P1|Dose Optimization Period|elevated QTc|1
109016|NCT00697515|373600|P2|Dose Optimization Period|called to active duty|0
109017|NCT00697515|373601|P1|Dose Optimization Period|called to active duty|1
109018|NCT00697515|373600|P2|Dose Optimization Period|sponsor request|0
109019|NCT00697515|373601|P1|Dose Optimization Period|sponsor request|2
109020|NCT00697515|373600|P2|Dose Optimization Period|Lost to Follow-up|0
109021|NCT00697515|373601|P1|Dose Optimization Period|Lost to Follow-up|2
109022|NCT00697515|373600|P2|Dose Optimization Period|Withdrawal by Subject|0
109023|NCT00697515|373601|P1|Dose Optimization Period|Withdrawal by Subject|5
109024|NCT00697515|373600|P2|Dose Optimization Period|Adverse Event|0
109025|NCT00697515|373601|P1|Dose Optimization Period|Adverse Event|4
109026|NCT00697255|373631|P2|Stage 1b|Insufficient ovarian response|1
109027|NCT00697255|373632|P1|Stage 1b|Insufficient ovarian response|0
109028|NCT00697255|373631|P2|Stage 1b|Not growing of dominant follicle|1
109029|NCT00697255|373632|P1|Stage 1b|Not growing of dominant follicle|0
109030|NCT00697255|373631|P2|Stage 1a|Not growing of dominant follicle|0
109031|NCT00697255|373632|P1|Stage 1a|Not growing of dominant follicle|1
109032|NCT00697255|373631|P2|Stage 1a|Multifollicular growth|0
109033|NCT00697255|373632|P1|Stage 1a|Multifollicular growth|1
109034|NCT00697255|373631|P2|Stage 1a|Insufficient ovarian response|0
109035|NCT00697255|373632|P1|Stage 1a|Insufficient ovarian response|1
109036|NCT00697112|373683|P1|Overall Study|Did not meet inclusion criteria|1
109037|NCT00697112|373683|P1|Overall Study|Lost to Follow-up|1
109038|NCT00697112|373683|P1|Overall Study|Adverse Event|8
109039|NCT00697073|373707|P1|Overall Study|non compliance and other|6
109040|NCT00697073|373707|P1|Overall Study|Pregnancy|1
109041|NCT00697073|373707|P1|Overall Study|Withdrawal by Subject|2
109042|NCT00696878|373711|P1|Overall Study|Other reason (not specified)|55
109043|NCT00696878|373711|P1|Overall Study|Trial stopped|32
109044|NCT00696878|373711|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
109045|NCT00696878|373711|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
109046|NCT00696878|373711|P1|Overall Study|Withdrawal by Subject|87
109047|NCT00696878|373711|P1|Overall Study|Adverse Event|8
109048|NCT00696800|373785|P2|Overall Study|Not treated|2
109049|NCT00696800|373786|P1|Overall Study|Not treated|1
109050|NCT00696800|373785|P2|Overall Study|Other Reasons|3
109051|NCT00696800|373786|P1|Overall Study|Other Reasons|5
109052|NCT00696800|373785|P2|Overall Study|No/too few/bad quality embryos|18
109053|NCT00696800|373786|P1|Overall Study|No/too few/bad quality embryos|24
109054|NCT00696800|373785|P2|Overall Study|No/abnormal fertilization|13
109055|NCT00696800|373786|P1|Overall Study|No/abnormal fertilization|11
109056|NCT00696800|373785|P2|Overall Study|No/too few/bad quality oocytes|3
109057|NCT00696800|373786|P1|Overall Study|No/too few/bad quality oocytes|4
109058|NCT00696800|373785|P2|Overall Study|Too high ovarian response|1
109059|NCT00696800|373786|P1|Overall Study|Too high ovarian response|6
109060|NCT00696800|373785|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
109061|NCT00696800|373786|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
109062|NCT00696800|373785|P2|Overall Study|Insufficient ovarian response|1
109063|NCT00696800|373786|P1|Overall Study|Insufficient ovarian response|4
109064|NCT00696800|373785|P2|Overall Study|Insufficient ovarian response on Day 8|1
109065|NCT00696800|373786|P1|Overall Study|Insufficient ovarian response on Day 8|4
109066|NCT00696800|373785|P2|Overall Study|Insufficient compliance with medication|1
109067|NCT00696800|373786|P1|Overall Study|Insufficient compliance with medication|2
109068|NCT00696800|373785|P2|Overall Study|Adverse Event|3
109069|NCT00696800|373786|P1|Overall Study|Adverse Event|16
109070|NCT00696787|373839|P3|Overall Study|Failed to return|1
109071|NCT00696787|373840|P2|Overall Study|Failed to return|3
109072|NCT00696787|373841|P1|Overall Study|Failed to return|1
109073|NCT00696787|373839|P3|Overall Study|Withdrawal by Subject|2
109074|NCT00696787|373840|P2|Overall Study|Withdrawal by Subject|3
109075|NCT00696787|373841|P1|Overall Study|Withdrawal by Subject|0
109076|NCT00696787|373839|P3|Overall Study|Lost to Follow-up|3
109077|NCT00696787|373840|P2|Overall Study|Lost to Follow-up|0
109078|NCT00696787|373841|P1|Overall Study|Lost to Follow-up|4
109079|NCT00696787|373839|P3|Overall Study|Lack of Efficacy|0
109080|NCT00696787|373840|P2|Overall Study|Lack of Efficacy|1
109081|NCT00696787|373841|P1|Overall Study|Lack of Efficacy|0
109082|NCT00696787|373839|P3|Overall Study|Discontinuation by Sponsor|14
109083|NCT00696787|373840|P2|Overall Study|Discontinuation by Sponsor|13
109084|NCT00696787|373841|P1|Overall Study|Discontinuation by Sponsor|9
109085|NCT00696787|373839|P3|Overall Study|Adverse Event|6
109086|NCT00696787|373840|P2|Overall Study|Adverse Event|0
109087|NCT00696787|373841|P1|Overall Study|Adverse Event|1
109088|NCT00696774|373855|P3|Period III|Lack of Efficacy|0
109089|NCT00696774|373856|P2|Period III|Lack of Efficacy|2
109090|NCT00696774|373857|P1|Period III|Lack of Efficacy|0
109091|NCT00696774|373855|P3|Period III|Sponsor Decision|0
109092|NCT00696774|373856|P2|Period III|Sponsor Decision|0
109093|NCT00696774|373857|P1|Period III|Sponsor Decision|2
109094|NCT00696774|373855|P3|Period III|Withdrawal by Subject|0
109095|NCT00696774|373856|P2|Period III|Withdrawal by Subject|2
109096|NCT00696774|373857|P1|Period III|Withdrawal by Subject|1
109097|NCT00696774|373855|P3|Period III|Protocol Violation|0
109098|NCT00696774|373856|P2|Period III|Protocol Violation|1
109099|NCT00696774|373857|P1|Period III|Protocol Violation|1
109100|NCT00696774|373855|P3|Period III|Lost to Follow-up|0
109101|NCT00696774|373856|P2|Period III|Lost to Follow-up|1
109102|NCT00696774|373857|P1|Period III|Lost to Follow-up|2
109103|NCT00696774|373855|P3|Period III|Adverse Event|0
109104|NCT00696774|373856|P2|Period III|Adverse Event|1
109105|NCT00696774|373857|P1|Period III|Adverse Event|1
109106|NCT00696774|373855|P3|Period II|Lack of Efficacy|2
109107|NCT00696774|373856|P2|Period II|Lack of Efficacy|0
109108|NCT00696774|373857|P1|Period II|Lack of Efficacy|0
109109|NCT00696774|373855|P3|Period II|Sponsor Decision|0
109110|NCT00696774|373856|P2|Period II|Sponsor Decision|0
109111|NCT00696774|373857|P1|Period II|Sponsor Decision|0
109112|NCT00696774|373855|P3|Period II|Withdrawal by Subject|4
109113|NCT00696774|373856|P2|Period II|Withdrawal by Subject|0
109114|NCT00696774|373857|P1|Period II|Withdrawal by Subject|0
109115|NCT00696774|373855|P3|Period II|Protocol Violation|11
109116|NCT00696774|373856|P2|Period II|Protocol Violation|0
109117|NCT00696774|373857|P1|Period II|Protocol Violation|0
109118|NCT00696774|373855|P3|Period II|Lost to Follow-up|4
109119|NCT00696774|373856|P2|Period II|Lost to Follow-up|0
109120|NCT00696774|373857|P1|Period II|Lost to Follow-up|0
109121|NCT00696774|373855|P3|Period II|Adverse Event|15
109122|NCT00696774|373856|P2|Period II|Adverse Event|0
109123|NCT00696774|373857|P1|Period II|Adverse Event|0
109124|NCT00696696|373912|P1|Overall Study|Death|3
109125|NCT00696696|373912|P1|Overall Study|Physician Decision|2
109126|NCT00696696|373912|P1|Overall Study|Withdrawal by Subject|8
109127|NCT00696696|373912|P1|Overall Study|Adverse Event|5
109128|NCT00696436|373923|P5|Overall Study|Missing|0
109129|NCT00696436|373924|P4|Overall Study|Missing|0
109130|NCT00696436|373925|P3|Overall Study|Missing|1
109131|NCT00696436|373926|P2|Overall Study|Missing|1
109132|NCT00696436|373927|P1|Overall Study|Missing|0
109133|NCT00696436|373923|P5|Overall Study|Administrative Decision|0
109134|NCT00696436|373924|P4|Overall Study|Administrative Decision|0
109135|NCT00696436|373925|P3|Overall Study|Administrative Decision|0
109136|NCT00696436|373926|P2|Overall Study|Administrative Decision|0
109137|NCT00696436|373927|P1|Overall Study|Administrative Decision|1
109138|NCT00696436|373923|P5|Overall Study|Participant Non-compliance|0
109139|NCT00696436|373924|P4|Overall Study|Participant Non-compliance|2
109140|NCT00696436|373925|P3|Overall Study|Participant Non-compliance|1
109141|NCT00696436|373926|P2|Overall Study|Participant Non-compliance|0
109142|NCT00696436|373927|P1|Overall Study|Participant Non-compliance|0
109143|NCT00696436|373923|P5|Overall Study|Administrative Error|0
109144|NCT00696436|373924|P4|Overall Study|Administrative Error|0
109145|NCT00696436|373925|P3|Overall Study|Administrative Error|2
109146|NCT00696436|373926|P2|Overall Study|Administrative Error|0
109147|NCT00696436|373927|P1|Overall Study|Administrative Error|2
109148|NCT00696436|373923|P5|Overall Study|Participant Unavailability|0
109149|NCT00696436|373924|P4|Overall Study|Participant Unavailability|1
109150|NCT00696436|373925|P3|Overall Study|Participant Unavailability|2
109151|NCT00696436|373926|P2|Overall Study|Participant Unavailability|0
109152|NCT00696436|373927|P1|Overall Study|Participant Unavailability|2
109153|NCT00696436|373923|P5|Overall Study|Lack of Efficacy|4
109154|NCT00696436|373924|P4|Overall Study|Lack of Efficacy|2
109155|NCT00696436|373925|P3|Overall Study|Lack of Efficacy|5
109156|NCT00696436|373926|P2|Overall Study|Lack of Efficacy|1
109157|NCT00696436|373927|P1|Overall Study|Lack of Efficacy|3
109158|NCT00696436|373923|P5|Overall Study|Withdrawal by Subject|1
109159|NCT00696436|373924|P4|Overall Study|Withdrawal by Subject|7
109160|NCT00696436|373925|P3|Overall Study|Withdrawal by Subject|5
109161|NCT00696436|373926|P2|Overall Study|Withdrawal by Subject|11
109162|NCT00696436|373927|P1|Overall Study|Withdrawal by Subject|4
109163|NCT00696436|373923|P5|Overall Study|Lost to Follow-up|3
109164|NCT00696436|373924|P4|Overall Study|Lost to Follow-up|4
109165|NCT00696436|373925|P3|Overall Study|Lost to Follow-up|2
109166|NCT00696436|373926|P2|Overall Study|Lost to Follow-up|6
109167|NCT00696436|373927|P1|Overall Study|Lost to Follow-up|1
109168|NCT00696436|373923|P5|Overall Study|Protocol Violation|1
109169|NCT00696436|373924|P4|Overall Study|Protocol Violation|0
109170|NCT00696436|373925|P3|Overall Study|Protocol Violation|2
109171|NCT00696436|373926|P2|Overall Study|Protocol Violation|2
109172|NCT00696436|373927|P1|Overall Study|Protocol Violation|3
109173|NCT00696436|373923|P5|Overall Study|Adverse Event|4
109174|NCT00696436|373924|P4|Overall Study|Adverse Event|6
109175|NCT00696436|373925|P3|Overall Study|Adverse Event|8
109176|NCT00696436|373926|P2|Overall Study|Adverse Event|9
109177|NCT00696436|373927|P1|Overall Study|Adverse Event|7
109178|NCT00696423|374011|P2|Overall Study|Lost to Follow-up|5
109179|NCT00696423|374012|P1|Overall Study|Lost to Follow-up|0
109180|NCT00696384|374042|P3|Double Blind Phase|Physician Decision|0
109181|NCT00696384|374043|P2|Double Blind Phase|Physician Decision|2
109182|NCT00696384|374044|P1|Double Blind Phase|Physician Decision|0
109183|NCT00696384|374042|P3|Double Blind Phase|Lack of Efficacy|0
109184|NCT00696384|374043|P2|Double Blind Phase|Lack of Efficacy|1
109185|NCT00696384|374044|P1|Double Blind Phase|Lack of Efficacy|0
109186|NCT00696384|374042|P3|Double Blind Phase|Withdrawal by Subject|3
109187|NCT00696384|374043|P2|Double Blind Phase|Withdrawal by Subject|4
109188|NCT00696384|374044|P1|Double Blind Phase|Withdrawal by Subject|0
109189|NCT00696384|374042|P3|Double Blind Phase|Lost to Follow-up|1
109190|NCT00696384|374043|P2|Double Blind Phase|Lost to Follow-up|2
109191|NCT00696384|374044|P1|Double Blind Phase|Lost to Follow-up|0
109192|NCT00696384|374042|P3|Double Blind Phase|Adverse Event|2
109193|NCT00696384|374043|P2|Double Blind Phase|Adverse Event|2
109194|NCT00696384|374044|P1|Double Blind Phase|Adverse Event|0
109195|NCT00696384|374042|P3|Open Label Phase|Physician Decision|0
109196|NCT00696384|374043|P2|Open Label Phase|Physician Decision|0
109197|NCT00696384|374044|P1|Open Label Phase|Physician Decision|4
109198|NCT00696384|374042|P3|Open Label Phase|Lack of Efficacy|0
109199|NCT00696384|374043|P2|Open Label Phase|Lack of Efficacy|0
109200|NCT00696384|374044|P1|Open Label Phase|Lack of Efficacy|3
109201|NCT00696384|374042|P3|Open Label Phase|Other|0
109202|NCT00696384|374043|P2|Open Label Phase|Other|0
109203|NCT00696384|374044|P1|Open Label Phase|Other|6
109204|NCT00696384|374042|P3|Open Label Phase|Withdrawal by Subject|0
109205|NCT00696384|374043|P2|Open Label Phase|Withdrawal by Subject|0
109206|NCT00696384|374044|P1|Open Label Phase|Withdrawal by Subject|37
109207|NCT00696384|374042|P3|Open Label Phase|Lost to Follow-up|0
109208|NCT00696384|374043|P2|Open Label Phase|Lost to Follow-up|0
109209|NCT00696384|374044|P1|Open Label Phase|Lost to Follow-up|24
109210|NCT00696384|374042|P3|Open Label Phase|Protocol Violation|0
109211|NCT00696384|374043|P2|Open Label Phase|Protocol Violation|0
109212|NCT00696384|374044|P1|Open Label Phase|Protocol Violation|18
109213|NCT00696384|374042|P3|Open Label Phase|Adverse Event|0
109214|NCT00696384|374043|P2|Open Label Phase|Adverse Event|0
109215|NCT00696384|374044|P1|Open Label Phase|Adverse Event|27
109216|NCT00696241|374068|P5|Overall Study|Other|1
109217|NCT00696241|374069|P4|Overall Study|Other|2
109218|NCT00696241|374070|P3|Overall Study|Other|5
109219|NCT00696241|374071|P2|Overall Study|Other|1
109220|NCT00696241|374072|P1|Overall Study|Other|6
109221|NCT00696241|374068|P5|Overall Study|Lack of Efficacy|3
109222|NCT00696241|374069|P4|Overall Study|Lack of Efficacy|5
109223|NCT00696241|374070|P3|Overall Study|Lack of Efficacy|4
109224|NCT00696241|374071|P2|Overall Study|Lack of Efficacy|5
109225|NCT00696241|374072|P1|Overall Study|Lack of Efficacy|1
109226|NCT00696241|374068|P5|Overall Study|Withdrawal by Subject|0
109227|NCT00696241|374069|P4|Overall Study|Withdrawal by Subject|1
109228|NCT00696241|374070|P3|Overall Study|Withdrawal by Subject|6
109229|NCT00696241|374071|P2|Overall Study|Withdrawal by Subject|8
109230|NCT00696241|374072|P1|Overall Study|Withdrawal by Subject|4
109231|NCT00696241|374068|P5|Overall Study|Lost to Follow-up|0
109232|NCT00696241|374069|P4|Overall Study|Lost to Follow-up|2
109233|NCT00696241|374070|P3|Overall Study|Lost to Follow-up|1
109234|NCT00696241|374071|P2|Overall Study|Lost to Follow-up|4
109235|NCT00696241|374072|P1|Overall Study|Lost to Follow-up|1
109236|NCT00696241|374068|P5|Overall Study|Protocol Violation|3
109237|NCT00696241|374069|P4|Overall Study|Protocol Violation|0
109238|NCT00696241|374070|P3|Overall Study|Protocol Violation|2
109239|NCT00696241|374071|P2|Overall Study|Protocol Violation|1
109240|NCT00696241|374072|P1|Overall Study|Protocol Violation|1
109241|NCT00696241|374068|P5|Overall Study|Adverse Event|5
109242|NCT00696241|374069|P4|Overall Study|Adverse Event|4
109243|NCT00696241|374070|P3|Overall Study|Adverse Event|6
109244|NCT00696241|374071|P2|Overall Study|Adverse Event|3
109245|NCT00696241|374072|P1|Overall Study|Adverse Event|11
109246|NCT00696072|374156|P2|Overall Study|Non-specified|2
109247|NCT00696072|374157|P1|Overall Study|Non-specified|1
109248|NCT00696072|374156|P2|Overall Study|Disease Progression|30
109249|NCT00696072|374157|P1|Overall Study|Disease Progression|32
109250|NCT00696072|374156|P2|Overall Study|Sponsor Request|1
109251|NCT00696072|374157|P1|Overall Study|Sponsor Request|0
109252|NCT00696072|374156|P2|Overall Study|Investigator Request|4
109253|NCT00696072|374157|P1|Overall Study|Investigator Request|1
109254|NCT00696072|374156|P2|Overall Study|Patient Request|7
109255|NCT00696072|374157|P1|Overall Study|Patient Request|3
109256|NCT00696072|374156|P2|Overall Study|Adverse Event|6
109257|NCT00696072|374157|P1|Overall Study|Adverse Event|10
109258|NCT00696072|374156|P2|Overall Study|continuing active treatment|13
109259|NCT00696072|374157|P1|Overall Study|continuing active treatment|10
109260|NCT00696020|374178|P4|Overall Study|Other not stated above|1
109261|NCT00696020|374179|P3|Overall Study|Other not stated above|1
109262|NCT00696020|374180|P2|Overall Study|Other not stated above|0
109263|NCT00696020|374181|P1|Overall Study|Other not stated above|0
109264|NCT00696020|374178|P4|Overall Study|Withdrawal by Subject|1
109265|NCT00696020|374179|P3|Overall Study|Withdrawal by Subject|0
109266|NCT00696020|374180|P2|Overall Study|Withdrawal by Subject|1
109267|NCT00696020|374181|P1|Overall Study|Withdrawal by Subject|0
109268|NCT00696020|374178|P4|Overall Study|Protocol Violation|1
109269|NCT00696020|374179|P3|Overall Study|Protocol Violation|0
109270|NCT00696020|374180|P2|Overall Study|Protocol Violation|0
109271|NCT00696020|374181|P1|Overall Study|Protocol Violation|0
109272|NCT00696020|374178|P4|Overall Study|Lack of Efficacy|0
109273|NCT00696020|374179|P3|Overall Study|Lack of Efficacy|0
109274|NCT00696020|374180|P2|Overall Study|Lack of Efficacy|0
109275|NCT00696020|374181|P1|Overall Study|Lack of Efficacy|1
109276|NCT00696020|374178|P4|Overall Study|Adverse Event|1
109277|NCT00696020|374179|P3|Overall Study|Adverse Event|2
109278|NCT00696020|374180|P2|Overall Study|Adverse Event|1
109279|NCT00696020|374181|P1|Overall Study|Adverse Event|3
109280|NCT00695955|374289|P1|Cohort 2|Other|5
109281|NCT00695955|374289|P1|Cohort 2|Lack of Efficacy|4
109282|NCT00695955|374289|P1|Cohort 2|Withdrawal by Subject|28
109283|NCT00695955|374289|P1|Cohort 2|Lost to Follow-up|38
109284|NCT00695955|374289|P1|Cohort 2|Protocol Violation|5
109285|NCT00695955|374289|P1|Cohort 2|Adverse Event|24
109286|NCT00695955|374289|P1|Cohort 1|Other|16
109287|NCT00695955|374289|P1|Cohort 1|Lack of Efficacy|3
109288|NCT00695955|374289|P1|Cohort 1|Withdrawal by Subject|25
109289|NCT00695955|374289|P1|Cohort 1|Lost to Follow-up|30
109290|NCT00695955|374289|P1|Cohort 1|Protocol Violation|2
109291|NCT00695955|374289|P1|Cohort 1|Adverse Event|26
109292|NCT00695903|374301|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
109293|NCT00695903|374302|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
109294|NCT00695903|374301|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
109295|NCT00695903|374302|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
109296|NCT00695903|374301|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
109297|NCT00695903|374302|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
109298|NCT00695903|374301|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
109299|NCT00695903|374302|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
109300|NCT00695903|374301|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
109301|NCT00695903|374302|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
109302|NCT00695903|374301|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
109303|NCT00695903|374302|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
109304|NCT00695903|374301|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
109305|NCT00695903|374302|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
109306|NCT00695903|374301|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
109307|NCT00695903|374302|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
109308|NCT00695903|374301|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
109309|NCT00695903|374302|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
109310|NCT00695669|374318|P4|Overall Study|Lost to Follow-up|4
109311|NCT00695669|374319|P3|Overall Study|Lost to Follow-up|1
109312|NCT00695669|374320|P2|Overall Study|Lost to Follow-up|4
109313|NCT00695669|374321|P1|Overall Study|Lost to Follow-up|4
109314|NCT00695669|374318|P4|Overall Study|Adverse Event|0
109315|NCT00695669|374319|P3|Overall Study|Adverse Event|2
109316|NCT00695669|374320|P2|Overall Study|Adverse Event|0
109317|NCT00695669|374321|P1|Overall Study|Adverse Event|0
109318|NCT00695565|374397|P2|Overall Study|Subject did not follow instructions|1
109319|NCT00695565|374398|P1|Overall Study|Subject did not follow instructions|1
109320|NCT00695565|374397|P2|Overall Study|Lack of Efficacy|1
109321|NCT00695565|374398|P1|Overall Study|Lack of Efficacy|1
109322|NCT00695565|374397|P2|Overall Study|Withdrawal by Subject|1
109323|NCT00695565|374398|P1|Overall Study|Withdrawal by Subject|1
109324|NCT00695565|374397|P2|Overall Study|Protocol Violation|1
109325|NCT00695565|374398|P1|Overall Study|Protocol Violation|3
109326|NCT00695565|374397|P2|Overall Study|Adverse Event|1
109327|NCT00695565|374398|P1|Overall Study|Adverse Event|3
109328|NCT00695565|374397|P2|Overall Study|Lost to Follow-up|4
109329|NCT00695565|374398|P1|Overall Study|Lost to Follow-up|4
109330|NCT00695396|374459|P3|Overall Study|Withdrawal by Subject|0
109331|NCT00695396|374460|P2|Overall Study|Withdrawal by Subject|2
109332|NCT00695396|374461|P1|Overall Study|Withdrawal by Subject|2
109333|NCT00695396|374459|P3|Overall Study|Study Closed Prematurely|8
109334|NCT00695396|374460|P2|Overall Study|Study Closed Prematurely|6
109335|NCT00695396|374461|P1|Overall Study|Study Closed Prematurely|5
109336|NCT00695318|374477|P2|Overall Study|Study Terminated|0
109337|NCT00695318|374478|P1|Overall Study|Study Terminated|1
109338|NCT00695318|374477|P2|Overall Study|Death|1
109339|NCT00695318|374478|P1|Overall Study|Death|1
109340|NCT00695318|374477|P2|Overall Study|Withdrawal by Subject|0
109341|NCT00695318|374478|P1|Overall Study|Withdrawal by Subject|2
109342|NCT00695318|374477|P2|Overall Study|Lost to Follow-up|0
109343|NCT00695318|374478|P1|Overall Study|Lost to Follow-up|1
109344|NCT00695136|374503|P1|Overall Study|unrelated adverse event|1
109345|NCT00695136|374503|P1|Overall Study|Withdrawal by Subject|1
109346|NCT00695019|374519|P3|Overall Study|Various|4
109347|NCT00695019|374520|P2|Overall Study|Various|5
109348|NCT00695019|374521|P1|Overall Study|Various|4
109349|NCT00695019|374519|P3|Overall Study|Lack of Efficacy|1
109350|NCT00695019|374520|P2|Overall Study|Lack of Efficacy|0
109351|NCT00695019|374521|P1|Overall Study|Lack of Efficacy|0
109352|NCT00695019|374519|P3|Overall Study|Protocol Violation|1
109353|NCT00695019|374520|P2|Overall Study|Protocol Violation|3
109354|NCT00695019|374521|P1|Overall Study|Protocol Violation|1
109355|NCT00695019|374519|P3|Overall Study|Withdrawal by Subject|4
109356|NCT00695019|374520|P2|Overall Study|Withdrawal by Subject|6
109357|NCT00695019|374521|P1|Overall Study|Withdrawal by Subject|8
109358|NCT00694551|374562|P3|Overall Study|Disease Progression|1
109359|NCT00694551|374563|P2|Overall Study|Disease Progression|0
109360|NCT00694551|374564|P1|Overall Study|Disease Progression|1
109361|NCT00694369|374583|P5|Overall Study|Withdrawal by Subject|2
109362|NCT00694369|374584|P4|Overall Study|Withdrawal by Subject|1
109363|NCT00694369|374585|P3|Overall Study|Withdrawal by Subject|1
109364|NCT00694369|374586|P2|Overall Study|Withdrawal by Subject|1
109365|NCT00694369|374587|P1|Overall Study|Withdrawal by Subject|1
109366|NCT00694369|374583|P5|Overall Study|Protocol Violation|0
109367|NCT00694369|374584|P4|Overall Study|Protocol Violation|0
109368|NCT00694369|374585|P3|Overall Study|Protocol Violation|0
109369|NCT00694369|374586|P2|Overall Study|Protocol Violation|1
109370|NCT00694369|374587|P1|Overall Study|Protocol Violation|0
109371|NCT00694369|374583|P5|Overall Study|Physician Decision|1
109372|NCT00694369|374584|P4|Overall Study|Physician Decision|0
109373|NCT00694369|374585|P3|Overall Study|Physician Decision|0
109374|NCT00694369|374586|P2|Overall Study|Physician Decision|0
109375|NCT00694369|374587|P1|Overall Study|Physician Decision|0
109376|NCT00694369|374583|P5|Overall Study|Lost to Follow-up|0
109377|NCT00694369|374584|P4|Overall Study|Lost to Follow-up|1
109378|NCT00694369|374585|P3|Overall Study|Lost to Follow-up|1
109379|NCT00694369|374586|P2|Overall Study|Lost to Follow-up|0
109380|NCT00694369|374587|P1|Overall Study|Lost to Follow-up|0
109381|NCT00694369|374583|P5|Overall Study|Adverse Event|3
109382|NCT00694369|374584|P4|Overall Study|Adverse Event|1
109383|NCT00694369|374585|P3|Overall Study|Adverse Event|0
109384|NCT00694369|374586|P2|Overall Study|Adverse Event|1
109385|NCT00694369|374587|P1|Overall Study|Adverse Event|0
109386|NCT00694304|374604|P1|Overall Study|Administrative or Other Reasons|32
109387|NCT00694304|374604|P1|Overall Study|Lost to Follow-up|15
109388|NCT00694304|374604|P1|Overall Study|Withdrawal of Consent|61
109389|NCT00694304|374604|P1|Overall Study|Protocol Violation|6
109390|NCT00694304|374604|P1|Overall Study|Non-compliance With Study Product|16
109391|NCT00694304|374604|P1|Overall Study|Lack of Efficacy|35
109392|NCT00694304|374604|P1|Overall Study|Adverse Event|42
109393|NCT00694161|374617|P1|Part 2 (After Week 6 up to Month 12)|Death|1
109394|NCT00694161|374617|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
109395|NCT00694161|374617|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
109396|NCT00694122|374656|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
109397|NCT00694122|374657|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
109398|NCT00694122|374656|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
109399|NCT00694122|374657|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
109400|NCT00694122|374656|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
109401|NCT00694122|374657|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
109402|NCT00694109|374673|P1|Overall Study|Consented but no additional treatment|3
109403|NCT00694109|374673|P1|Overall Study|Unspecified|2
109404|NCT00694109|374673|P1|Overall Study|Enrolled but not treated|1
109405|NCT00694109|374673|P1|Overall Study|Pregnancy|1
109406|NCT00694109|374673|P1|Overall Study|Withdrawal by Subject|13
109407|NCT00694109|374673|P1|Overall Study|Lack of Efficacy|2
109408|NCT00694109|374673|P1|Overall Study|Not consent of more 2 years of treatment|18
109409|NCT00694109|374673|P1|Overall Study|Adverse Event|74
109410|NCT00694109|374673|P1|Overall Study|Physician Decision|3
109411|NCT00694096|374697|P1|Overall Study|Withdrawal by Subject|5
109412|NCT00693784|374733|P1|Overall Study|Withdrawal by Subject|2
109413|NCT00693784|374733|P1|Overall Study|Lost to Follow-up|2
109414|NCT00693706|374746|P2|Overall Study|Protocol Violation|1
109415|NCT00693706|374747|P1|Overall Study|Protocol Violation|0
109416|NCT00693420|374798|P2|Overall Study|Personal Reasons|4
109417|NCT00693420|374799|P1|Overall Study|Personal Reasons|1
109418|NCT00693420|374798|P2|Overall Study|Sponsor Request - Conflict of Interest|2
109419|NCT00693420|374799|P1|Overall Study|Sponsor Request - Conflict of Interest|0
109420|NCT00693420|374798|P2|Overall Study|Protocol Violation|2
109421|NCT00693420|374799|P1|Overall Study|Protocol Violation|0
109422|NCT00693420|374798|P2|Overall Study|Withdrawal by Subject|0
109423|NCT00693420|374799|P1|Overall Study|Withdrawal by Subject|1
109424|NCT00693420|374798|P2|Overall Study|Lost to Follow-up|3
109425|NCT00693420|374799|P1|Overall Study|Lost to Follow-up|0
109426|NCT00693420|374798|P2|Overall Study|Adverse Event|4
109427|NCT00693420|374799|P1|Overall Study|Adverse Event|4
109428|NCT00693225|374838|P2|Overall Study|Adverse Event|3
109429|NCT00693225|374839|P1|Overall Study|Adverse Event|1
109430|NCT00693225|374838|P2|Overall Study|Lost to Follow-up|2
109431|NCT00693225|374839|P1|Overall Study|Lost to Follow-up|1
109432|NCT00693017|374862|P2|Overall Study|Death|1
109433|NCT00693017|374863|P1|Overall Study|Death|0
109434|NCT00693017|374862|P2|Overall Study|Sponsor Decision|1
109435|NCT00693017|374863|P1|Overall Study|Sponsor Decision|2
109436|NCT00692913|374873|P2|Overall Study|Withdrawal by Subject|20
109437|NCT00692913|374874|P1|Overall Study|Withdrawal by Subject|15
109438|NCT00692913|374873|P2|Overall Study|Protocol Violation|1
109439|NCT00692913|374874|P1|Overall Study|Protocol Violation|1
109440|NCT00692913|374873|P2|Overall Study|Physician Decision|0
109441|NCT00692913|374874|P1|Overall Study|Physician Decision|2
109442|NCT00692913|374873|P2|Overall Study|Lost to Follow-up|5
109443|NCT00692913|374874|P1|Overall Study|Lost to Follow-up|3
109444|NCT00692913|374873|P2|Overall Study|Adverse Event|4
109445|NCT00692913|374874|P1|Overall Study|Adverse Event|8
109446|NCT00692770|374896|P2|Overall Study|Randomized but not treated|4
109447|NCT00692770|374897|P1|Overall Study|Randomized but not treated|3
109448|NCT00692770|374896|P2|Overall Study|Study terminated by sponsor|2
109449|NCT00692770|374897|P1|Overall Study|Study terminated by sponsor|2
109450|NCT00692770|374896|P2|Overall Study|Clinical endpoint reached|43
109451|NCT00692770|374897|P1|Overall Study|Clinical endpoint reached|16
109452|NCT00692770|374896|P2|Overall Study|Radiological and clinical progression|8
109453|NCT00692770|374897|P1|Overall Study|Radiological and clinical progression|8
109454|NCT00692770|374896|P2|Overall Study|Completed all planned assessments|101
109455|NCT00692770|374897|P1|Overall Study|Completed all planned assessments|79
109456|NCT00692770|374896|P2|Overall Study|Protocol driven decision point|7
109457|NCT00692770|374897|P1|Overall Study|Protocol driven decision point|3
109458|NCT00692770|374896|P2|Overall Study|Disease progression, recurrence/relapse|279
109459|NCT00692770|374897|P1|Overall Study|Disease progression, recurrence/relapse|170
109460|NCT00692770|374896|P2|Overall Study|Physician decision not protocol driven|14
109461|NCT00692770|374897|P1|Overall Study|Physician decision not protocol driven|10
109462|NCT00692770|374896|P2|Overall Study|Progression by clinical judgment|3
109463|NCT00692770|374897|P1|Overall Study|Progression by clinical judgment|2
109464|NCT00692770|374896|P2|Overall Study|Non-compliant with study medication|5
109465|NCT00692770|374897|P1|Overall Study|Non-compliant with study medication|11
109466|NCT00692770|374896|P2|Overall Study|Lost to Follow-up|3
109467|NCT00692770|374897|P1|Overall Study|Lost to Follow-up|7
109468|NCT00692770|374896|P2|Overall Study|Death|5
109469|NCT00692770|374897|P1|Overall Study|Death|10
109470|NCT00692770|374896|P2|Overall Study|Adverse Event|41
109471|NCT00692770|374897|P1|Overall Study|Adverse Event|136
109472|NCT00692770|374896|P2|Overall Study|Withdrawal by Subject|36
109473|NCT00692770|374897|P1|Overall Study|Withdrawal by Subject|97
109474|NCT00692770|374896|P2|Overall Study|Protocol Violation|7
109475|NCT00692770|374897|P1|Overall Study|Protocol Violation|2
109476|NCT00692406|374935|P1|Overall Study|PI dropped, bad data|57
109477|NCT00692237|374997|P2|Overall Study|Adverse Event|1
109478|NCT00692237|374998|P1|Overall Study|Adverse Event|0
109479|NCT00692237|374997|P2|Overall Study|Withdrawal by Subject|3
109480|NCT00692237|374998|P1|Overall Study|Withdrawal by Subject|1
109481|NCT00692003|375026|P2|Overall Study|Sponsor Decision|1
109482|NCT00692003|375027|P1|Overall Study|Sponsor Decision|5
109483|NCT00691938|375042|P7|Overall Study|QTc prolongation|0
109484|NCT00691938|375043|P6|Overall Study|QTc prolongation|0
109485|NCT00691938|375044|P5|Overall Study|QTc prolongation|0
109486|NCT00691938|375045|P4|Overall Study|QTc prolongation|0
109487|NCT00691938|375046|P3|Overall Study|QTc prolongation|0
109488|NCT00691938|375047|P2|Overall Study|QTc prolongation|0
109489|NCT00691938|375048|P1|Overall Study|QTc prolongation|1
109490|NCT00691704|375115|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
109491|NCT00691704|375115|P1|Two Years of Maintenance Therapy|Physician Decision|4
109492|NCT00691704|375115|P1|Two Years of Maintenance Therapy|Disease Progression|8
109493|NCT00691704|375115|P1|Induction Therapy|Active Hepatitis|1
109494|NCT00691704|375115|P1|Induction Therapy|Disease Progression|1
109495|NCT00691483|375144|P2|Overall Study|Randomized by not treated|1
109496|NCT00691483|375145|P1|Overall Study|Randomized by not treated|7
109497|NCT00691483|375144|P2|Overall Study|Other known cause|1
109498|NCT00691483|375145|P1|Overall Study|Other known cause|6
109499|NCT00691483|375144|P2|Overall Study|Withdrawal by Subject|7
109500|NCT00691483|375145|P1|Overall Study|Withdrawal by Subject|24
109501|NCT00691483|375144|P2|Overall Study|Lost to Follow-up|10
109502|NCT00691483|375145|P1|Overall Study|Lost to Follow-up|17
109503|NCT00691483|375144|P2|Overall Study|Adverse Event|6
109504|NCT00691483|375145|P1|Overall Study|Adverse Event|14
109505|NCT00691210|375180|P8|Overall Study|Lack of Efficacy|0
109506|NCT00691210|375181|P7|Overall Study|Lack of Efficacy|0
109507|NCT00691210|375182|P6|Overall Study|Lack of Efficacy|1
109508|NCT00691210|375183|P5|Overall Study|Lack of Efficacy|0
109509|NCT00691210|375184|P4|Overall Study|Lack of Efficacy|1
109510|NCT00691210|375185|P3|Overall Study|Lack of Efficacy|0
109511|NCT00691210|375186|P2|Overall Study|Lack of Efficacy|0
109512|NCT00691210|375187|P1|Overall Study|Lack of Efficacy|0
109513|NCT00691210|375180|P8|Overall Study|Progression of Disease|0
109514|NCT00691210|375181|P7|Overall Study|Progression of Disease|0
109515|NCT00691210|375182|P6|Overall Study|Progression of Disease|0
109516|NCT00691210|375183|P5|Overall Study|Progression of Disease|0
109517|NCT00691210|375184|P4|Overall Study|Progression of Disease|2
109518|NCT00691210|375185|P3|Overall Study|Progression of Disease|0
109519|NCT00691210|375186|P2|Overall Study|Progression of Disease|0
109520|NCT00691210|375187|P1|Overall Study|Progression of Disease|0
109521|NCT00691093|375220|P1|Overall Study|Ongoing at Date of Cut-Off|4
109522|NCT00691093|375220|P1|Overall Study|Lack of Efficacy|1
109523|NCT00691093|375220|P1|Overall Study|Lost to Follow-up|1
109524|NCT00691093|375220|P1|Overall Study|Adverse Event|1
109525|NCT00691054|375254|P1|Overall Study|Withdrawal by Subject|1
109526|NCT00691028|375265|P4|Double-blind Period|not come to a hospital.|0
109527|NCT00691028|375266|P3|Double-blind Period|not come to a hospital.|0
109528|NCT00691028|375267|P2|Double-blind Period|not come to a hospital.|1
109529|NCT00691028|375268|P1|Double-blind Period|not come to a hospital.|0
109530|NCT00691028|375265|P4|Double-blind Period|Withdrawal by Subject|0
109531|NCT00691028|375266|P3|Double-blind Period|Withdrawal by Subject|1
109532|NCT00691028|375267|P2|Double-blind Period|Withdrawal by Subject|0
109533|NCT00691028|375268|P1|Double-blind Period|Withdrawal by Subject|1
109534|NCT00691028|375265|P4|Double-blind Period|Lack of Efficacy|0
109535|NCT00691028|375266|P3|Double-blind Period|Lack of Efficacy|2
109536|NCT00691028|375267|P2|Double-blind Period|Lack of Efficacy|3
109537|NCT00691028|375268|P1|Double-blind Period|Lack of Efficacy|4
109538|NCT00691028|375265|P4|Double-blind Period|Adverse Event|0
109539|NCT00691028|375266|P3|Double-blind Period|Adverse Event|6
109540|NCT00691028|375267|P2|Double-blind Period|Adverse Event|9
109541|NCT00691028|375268|P1|Double-blind Period|Adverse Event|8
109542|NCT00691028|375265|P4|Open-label Period|not come to a hospital|1
109543|NCT00691028|375266|P3|Open-label Period|not come to a hospital|0
109544|NCT00691028|375267|P2|Open-label Period|not come to a hospital|0
109545|NCT00691028|375268|P1|Open-label Period|not come to a hospital|0
109546|NCT00691028|375265|P4|Open-label Period|Withdrawal by Subject|3
109547|NCT00691028|375266|P3|Open-label Period|Withdrawal by Subject|0
109548|NCT00691028|375267|P2|Open-label Period|Withdrawal by Subject|0
109549|NCT00691028|375268|P1|Open-label Period|Withdrawal by Subject|0
109550|NCT00691028|375265|P4|Open-label Period|Adverse Event|16
109551|NCT00691028|375266|P3|Open-label Period|Adverse Event|0
109552|NCT00691028|375267|P2|Open-label Period|Adverse Event|0
109553|NCT00691028|375268|P1|Open-label Period|Adverse Event|0
109554|NCT00690898|375301|P1|TREATMENT|Other (not otherwise specified)|1
109555|NCT00690898|375301|P1|TREATMENT|Withdrawal by Subject|4
109556|NCT00690898|375301|P1|TREATMENT|Lack of Efficacy|18
109557|NCT00690898|375301|P1|TREATMENT|Adverse Event|3
109558|NCT00690898|375301|P1|SCREENING|Screen failure|18
109559|NCT00690820|375317|P2|Period 1|Withdrawal by Subject|1
109560|NCT00690820|375318|P1|Period 1|Withdrawal by Subject|0
109561|NCT00690794|375340|P2|Overall Study|Other not specified|3
109562|NCT00690794|375341|P1|Overall Study|Other not specified|1
109563|NCT00690794|375340|P2|Overall Study|Noncompliance|2
109564|NCT00690794|375341|P1|Overall Study|Noncompliance|1
109565|NCT00690794|375340|P2|Overall Study|Protocol Violation|7
109566|NCT00690794|375341|P1|Overall Study|Protocol Violation|6
109567|NCT00690794|375340|P2|Overall Study|Withdrawal by Subject|9
109568|NCT00690794|375341|P1|Overall Study|Withdrawal by Subject|0
109569|NCT00690794|375340|P2|Overall Study|Lost to Follow-up|4
109570|NCT00690794|375341|P1|Overall Study|Lost to Follow-up|1
109571|NCT00690794|375340|P2|Overall Study|Adverse Event|10
109572|NCT00690794|375341|P1|Overall Study|Adverse Event|12
109573|NCT00690755|375356|P7|Overall Study|Physician Decision|0
109574|NCT00690755|375357|P6|Overall Study|Physician Decision|4
109575|NCT00690755|375358|P5|Overall Study|Physician Decision|0
109576|NCT00690755|375359|P4|Overall Study|Physician Decision|5
109577|NCT00690755|375360|P3|Overall Study|Physician Decision|46
109578|NCT00690755|375361|P2|Overall Study|Physician Decision|0
109579|NCT00690755|375362|P1|Overall Study|Physician Decision|2
109580|NCT00690612|375378|P1|Overall Study|Withdrawal by Subject|2
109581|NCT00690612|375378|P1|Overall Study|Adverse Event|1
109582|NCT00690573|375383|P1|Overall Study|Withdrawal by Subject|1
109583|NCT00690573|375383|P1|Overall Study|Lack of Efficacy|8
109584|NCT00690482|375402|P2|Overall Study|withdrew consent at rand.day|1
109585|NCT00690482|375403|P1|Overall Study|withdrew consent at rand.day|0
109586|NCT00690482|375402|P2|Overall Study|Intake of prohibited medicine|0
109587|NCT00690482|375403|P1|Overall Study|Intake of prohibited medicine|1
109588|NCT00690482|375402|P2|Overall Study|Study-specific discontinuation criteria|0
109589|NCT00690482|375403|P1|Overall Study|Study-specific discontinuation criteria|1
109590|NCT00690482|375402|P2|Overall Study|Incorrect enrolment|1
109591|NCT00690482|375403|P1|Overall Study|Incorrect enrolment|0
109592|NCT00690482|375402|P2|Overall Study|Adverse Event|1
109593|NCT00690482|375403|P1|Overall Study|Adverse Event|2
109594|NCT00690443|375437|P2|Overall Study|Adverse Event|2
109595|NCT00690443|375438|P1|Overall Study|Adverse Event|1
109596|NCT00690430|375448|P3|Extension Phase|Early Termination|3
109597|NCT00690430|375449|P2|Extension Phase|Early Termination|1
109598|NCT00690430|375450|P1|Extension Phase|Early Termination|10
109599|NCT00690430|375448|P3|Extension Phase|Withdrawal by Subject|2
109600|NCT00690430|375449|P2|Extension Phase|Withdrawal by Subject|0
109601|NCT00690430|375450|P1|Extension Phase|Withdrawal by Subject|0
109602|NCT00690430|375448|P3|Extension Phase|Death|1
109603|NCT00690430|375449|P2|Extension Phase|Death|1
109604|NCT00690430|375450|P1|Extension Phase|Death|1
109605|NCT00690430|375448|P3|Extension Phase|Adverse Event|2
109606|NCT00690430|375449|P2|Extension Phase|Adverse Event|1
109607|NCT00690430|375450|P1|Extension Phase|Adverse Event|2
109608|NCT00690430|375448|P3|Extension Phase|Administrative Problems|1
109609|NCT00690430|375449|P2|Extension Phase|Administrative Problems|1
109610|NCT00690430|375450|P1|Extension Phase|Administrative Problems|0
109611|NCT00690430|375448|P3|Extension Phase|Abnormal test procedure results|0
109612|NCT00690430|375449|P2|Extension Phase|Abnormal test procedure results|0
109613|NCT00690430|375450|P1|Extension Phase|Abnormal test procedure results|1
109614|NCT00690430|375448|P3|Extension Phase|Abnormal Lab Values|0
109615|NCT00690430|375449|P2|Extension Phase|Abnormal Lab Values|0
109616|NCT00690430|375450|P1|Extension Phase|Abnormal Lab Values|1
109617|NCT00690430|375448|P3|Extension Phase|Lack of Efficacy|4
109618|NCT00690430|375449|P2|Extension Phase|Lack of Efficacy|1
109619|NCT00690430|375450|P1|Extension Phase|Lack of Efficacy|3
109620|NCT00690430|375448|P3|Core Phase|Early Termination|0
109621|NCT00690430|375449|P2|Core Phase|Early Termination|5
109622|NCT00690430|375450|P1|Core Phase|Early Termination|0
109623|NCT00690430|375448|P3|Core Phase|Administrative Problems|0
109624|NCT00690430|375449|P2|Core Phase|Administrative Problems|1
109625|NCT00690430|375450|P1|Core Phase|Administrative Problems|0
109626|NCT00690430|375448|P3|Core Phase|Lack of Efficacy|0
109627|NCT00690430|375449|P2|Core Phase|Lack of Efficacy|10
109628|NCT00690430|375450|P1|Core Phase|Lack of Efficacy|8
109629|NCT00690430|375448|P3|Core Phase|Subject no longer requires study drug|0
109630|NCT00690430|375449|P2|Core Phase|Subject no longer requires study drug|0
109631|NCT00690430|375450|P1|Core Phase|Subject no longer requires study drug|1
109632|NCT00690430|375448|P3|Core Phase|Withdrawal by Subject|0
109633|NCT00690430|375449|P2|Core Phase|Withdrawal by Subject|3
109634|NCT00690430|375450|P1|Core Phase|Withdrawal by Subject|3
109635|NCT00690430|375448|P3|Core Phase|Protocol Violation|0
109636|NCT00690430|375449|P2|Core Phase|Protocol Violation|0
109637|NCT00690430|375450|P1|Core Phase|Protocol Violation|1
109638|NCT00690430|375448|P3|Core Phase|Death|0
109639|NCT00690430|375449|P2|Core Phase|Death|2
109640|NCT00690430|375450|P1|Core Phase|Death|0
109641|NCT00690430|375448|P3|Core Phase|Adverse Event|0
109642|NCT00690430|375449|P2|Core Phase|Adverse Event|1
109643|NCT00690430|375450|P1|Core Phase|Adverse Event|5
109644|NCT00690430|375448|P3|Core Phase|Abnormal Laboratory value|0
109645|NCT00690430|375449|P2|Core Phase|Abnormal Laboratory value|1
109646|NCT00690430|375450|P1|Core Phase|Abnormal Laboratory value|0
109647|NCT00689871|375516|P4|Overall Study|Physician Decision|0
109648|NCT00689871|375517|P3|Overall Study|Physician Decision|1
109649|NCT00689871|375518|P2|Overall Study|Physician Decision|1
109650|NCT00689871|375519|P1|Overall Study|Physician Decision|2
109651|NCT00689871|375516|P4|Overall Study|Death|2
109652|NCT00689871|375517|P3|Overall Study|Death|2
109653|NCT00689871|375518|P2|Overall Study|Death|10
109654|NCT00689871|375519|P1|Overall Study|Death|1
109655|NCT00689871|375516|P4|Overall Study|Withdrawal by Subject|1
109656|NCT00689871|375517|P3|Overall Study|Withdrawal by Subject|4
109657|NCT00689871|375518|P2|Overall Study|Withdrawal by Subject|3
109658|NCT00689871|375519|P1|Overall Study|Withdrawal by Subject|13
109659|NCT00689871|375516|P4|Overall Study|Explanted of All Study Devices|3
109660|NCT00689871|375517|P3|Overall Study|Explanted of All Study Devices|29
109661|NCT00689871|375518|P2|Overall Study|Explanted of All Study Devices|25
109662|NCT00689871|375519|P1|Overall Study|Explanted of All Study Devices|36
109663|NCT00689871|375516|P4|Overall Study|Lost to Follow-up|1
109664|NCT00689871|375517|P3|Overall Study|Lost to Follow-up|37
109665|NCT00689871|375518|P2|Overall Study|Lost to Follow-up|13
109666|NCT00689871|375519|P1|Overall Study|Lost to Follow-up|123
109667|NCT00689793|375546|P2|Overall Study|Lost to Follow-up|5
109668|NCT00689793|375547|P1|Overall Study|Lost to Follow-up|4
109669|NCT00689611|375565|P2|Overall Study|Lost to Follow-up|28
109670|NCT00689611|375566|P1|Overall Study|Lost to Follow-up|27
109671|NCT00689611|375565|P2|Overall Study|Withdrawal by Subject|9
109672|NCT00689611|375566|P1|Overall Study|Withdrawal by Subject|8
109673|NCT00689611|375565|P2|Overall Study|Death|9
109674|NCT00689611|375566|P1|Overall Study|Death|6
109675|NCT00689481|375576|P2|Overall Study|Subject early term, left on vacation|1
109676|NCT00689481|375577|P1|Overall Study|Subject early term, left on vacation|0
109677|NCT00689481|375576|P2|Overall Study|Excluded medication started during study|1
109678|NCT00689481|375577|P1|Overall Study|Excluded medication started during study|0
109679|NCT00689481|375576|P2|Overall Study|Withdrawal by Subject|4
109680|NCT00689481|375577|P1|Overall Study|Withdrawal by Subject|8
109681|NCT00689481|375576|P2|Overall Study|Non-compliance with study treatment|1
109682|NCT00689481|375577|P1|Overall Study|Non-compliance with study treatment|1
109683|NCT00689481|375576|P2|Overall Study|Lack of Efficacy|3
109684|NCT00689481|375577|P1|Overall Study|Lack of Efficacy|4
109685|NCT00689481|375576|P2|Overall Study|Lost to Follow-up|3
109686|NCT00689481|375577|P1|Overall Study|Lost to Follow-up|4
109687|NCT00689481|375576|P2|Overall Study|Adverse Event|1
109688|NCT00689481|375577|P1|Overall Study|Adverse Event|7
109689|NCT00689390|375595|P2|Overall Study|Administrative|0
109690|NCT00689390|375596|P1|Overall Study|Administrative|37
109691|NCT00689390|375595|P2|Overall Study|Did Not Meet Protocol Eligibility|0
109692|NCT00689390|375596|P1|Overall Study|Did Not Meet Protocol Eligibility|1
109693|NCT00689390|375595|P2|Overall Study|Non-Compliance With Protocol|0
109694|NCT00689390|375596|P1|Overall Study|Non-Compliance With Protocol|21
109695|NCT00689390|375595|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
109696|NCT00689390|375596|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
109697|NCT00689390|375595|P2|Overall Study|Withdrawal by Subject|3
109698|NCT00689390|375596|P1|Overall Study|Withdrawal by Subject|117
109699|NCT00689390|375595|P2|Overall Study|Lost to Follow-up|7
109700|NCT00689390|375596|P1|Overall Study|Lost to Follow-up|179
109701|NCT00689390|375595|P2|Overall Study|Adverse Event|0
109702|NCT00689390|375596|P1|Overall Study|Adverse Event|19
109703|NCT00689351|375614|P2|After Infant Series|Parent/legal guardian request|0
109704|NCT00689351|375615|P1|After Infant Series|Parent/legal guardian request|1
109705|NCT00689351|375614|P2|Infant Series of Dosing|Lost to Follow-up|1
109706|NCT00689351|375615|P1|Infant Series of Dosing|Lost to Follow-up|0
109707|NCT00689351|375614|P2|Infant Series of Dosing|Adverse Event|0
109708|NCT00689351|375615|P1|Infant Series of Dosing|Adverse Event|1
109709|NCT00689351|375614|P2|Infant Series of Dosing|Parent/legal guardian request|0
109710|NCT00689351|375615|P1|Infant Series of Dosing|Parent/legal guardian request|5
109711|NCT00689338|375647|P1|Overall Study|Protocol Violation|15
109712|NCT00689338|375647|P1|Overall Study|Withdrawal by Subject|3
109713|NCT00689338|375647|P1|Overall Study|Lost to Follow-up|5
109714|NCT00689338|375647|P1|Overall Study|Did not Meet Entrance Criteria|27
109715|NCT00689338|375647|P1|Overall Study|Unspecified|8
109716|NCT00689338|375647|P1|Overall Study|Lack of Efficacy|6
109717|NCT00689338|375647|P1|Overall Study|Insufficient Clinical Response|1
109718|NCT00689338|375647|P1|Overall Study|Adverse Event|13
109719|NCT00689338|375647|P1|Overall Study|Death|65
109720|NCT00689299|375660|P3|Overall Study|Protocol Violation|0
109721|NCT00689299|375661|P2|Overall Study|Protocol Violation|0
109722|NCT00689299|375662|P1|Overall Study|Protocol Violation|1
109723|NCT00689299|375660|P3|Overall Study|Withdrawal by Subject|3
109724|NCT00689299|375661|P2|Overall Study|Withdrawal by Subject|1
109725|NCT00689299|375662|P1|Overall Study|Withdrawal by Subject|4
109726|NCT00689299|375660|P3|Overall Study|Lost to Follow-up|1
109727|NCT00689299|375661|P2|Overall Study|Lost to Follow-up|1
109728|NCT00689299|375662|P1|Overall Study|Lost to Follow-up|0
109729|NCT00689299|375660|P3|Overall Study|Adverse Event|1
109730|NCT00689299|375661|P2|Overall Study|Adverse Event|1
109731|NCT00689299|375662|P1|Overall Study|Adverse Event|2
109732|NCT00689221|375691|P2|Overall Study|Ongoing at cut-off date|36
109733|NCT00689221|375692|P1|Overall Study|Ongoing at cut-off date|39
109734|NCT00689117|375721|P4|Overall Study|Dispensing Error|0
109735|NCT00689117|375722|P3|Overall Study|Dispensing Error|0
109736|NCT00689117|375723|P2|Overall Study|Dispensing Error|1
109737|NCT00689117|375724|P1|Overall Study|Dispensing Error|0
109738|NCT00689117|375721|P4|Overall Study|Personal Reason|0
109739|NCT00689117|375722|P3|Overall Study|Personal Reason|0
109740|NCT00689117|375723|P2|Overall Study|Personal Reason|1
109741|NCT00689117|375724|P1|Overall Study|Personal Reason|0
109742|NCT00689117|375721|P4|Overall Study|Patient Withdrew from Study|1
109743|NCT00689117|375722|P3|Overall Study|Patient Withdrew from Study|0
109744|NCT00689117|375723|P2|Overall Study|Patient Withdrew from Study|0
109745|NCT00689117|375724|P1|Overall Study|Patient Withdrew from Study|0
109746|NCT00689117|375721|P4|Overall Study|Transportation|0
109747|NCT00689117|375722|P3|Overall Study|Transportation|0
109748|NCT00689117|375723|P2|Overall Study|Transportation|0
109749|NCT00689117|375724|P1|Overall Study|Transportation|1
109750|NCT00689117|375721|P4|Overall Study|Fear of Birth Defects|0
109751|NCT00689117|375722|P3|Overall Study|Fear of Birth Defects|1
109752|NCT00689117|375723|P2|Overall Study|Fear of Birth Defects|0
109753|NCT00689117|375724|P1|Overall Study|Fear of Birth Defects|0
109754|NCT00689117|375721|P4|Overall Study|Incarceration|0
109755|NCT00689117|375722|P3|Overall Study|Incarceration|0
109756|NCT00689117|375723|P2|Overall Study|Incarceration|0
109757|NCT00689117|375724|P1|Overall Study|Incarceration|2
109758|NCT00689117|375721|P4|Overall Study|Pregnancy|2
109759|NCT00689117|375722|P3|Overall Study|Pregnancy|0
109760|NCT00689117|375723|P2|Overall Study|Pregnancy|2
109761|NCT00689117|375724|P1|Overall Study|Pregnancy|0
109762|NCT00689117|375721|P4|Overall Study|Use of Prohibitive Medication|0
109763|NCT00689117|375722|P3|Overall Study|Use of Prohibitive Medication|3
109764|NCT00689117|375723|P2|Overall Study|Use of Prohibitive Medication|1
109765|NCT00689117|375724|P1|Overall Study|Use of Prohibitive Medication|2
109766|NCT00689117|375721|P4|Overall Study|Change/Discontinuation of Birth Control|0
109767|NCT00689117|375722|P3|Overall Study|Change/Discontinuation of Birth Control|1
109768|NCT00689117|375723|P2|Overall Study|Change/Discontinuation of Birth Control|1
109769|NCT00689117|375724|P1|Overall Study|Change/Discontinuation of Birth Control|1
109770|NCT00689117|375721|P4|Overall Study|Non-compliance with Treatment Regimen|0
109771|NCT00689117|375722|P3|Overall Study|Non-compliance with Treatment Regimen|0
109772|NCT00689117|375723|P2|Overall Study|Non-compliance with Treatment Regimen|1
109773|NCT00689117|375724|P1|Overall Study|Non-compliance with Treatment Regimen|0
109774|NCT00689117|375721|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
109775|NCT00689117|375722|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
109776|NCT00689117|375723|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
109777|NCT00689117|375724|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
109778|NCT00689117|375721|P4|Overall Study|Unable to Comply with Visit Schedule|1
109779|NCT00689117|375722|P3|Overall Study|Unable to Comply with Visit Schedule|1
109780|NCT00689117|375723|P2|Overall Study|Unable to Comply with Visit Schedule|0
109781|NCT00689117|375724|P1|Overall Study|Unable to Comply with Visit Schedule|0
109782|NCT00689117|375721|P4|Overall Study|Withdrawal by Subject|13
109783|NCT00689117|375722|P3|Overall Study|Withdrawal by Subject|26
109784|NCT00689117|375723|P2|Overall Study|Withdrawal by Subject|18
109785|NCT00689117|375724|P1|Overall Study|Withdrawal by Subject|19
109786|NCT00689117|375721|P4|Overall Study|Non-Compliance with Study Treatment|1
109787|NCT00689117|375722|P3|Overall Study|Non-Compliance with Study Treatment|3
109788|NCT00689117|375723|P2|Overall Study|Non-Compliance with Study Treatment|3
109789|NCT00689117|375724|P1|Overall Study|Non-Compliance with Study Treatment|3
109790|NCT00689117|375721|P4|Overall Study|Lack of Efficacy|2
109791|NCT00689117|375722|P3|Overall Study|Lack of Efficacy|2
109792|NCT00689117|375723|P2|Overall Study|Lack of Efficacy|2
109793|NCT00689117|375724|P1|Overall Study|Lack of Efficacy|1
109794|NCT00689117|375721|P4|Overall Study|Lost to Follow-up|11
109795|NCT00689117|375722|P3|Overall Study|Lost to Follow-up|17
109796|NCT00689117|375723|P2|Overall Study|Lost to Follow-up|19
109797|NCT00689117|375724|P1|Overall Study|Lost to Follow-up|26
109798|NCT00689117|375721|P4|Overall Study|Adverse Event|0
109799|NCT00689117|375722|P3|Overall Study|Adverse Event|5
109800|NCT00689117|375723|P2|Overall Study|Adverse Event|0
109801|NCT00689117|375724|P1|Overall Study|Adverse Event|6
109802|NCT00689104|375754|P4|Overall Study|Non-compliance with study procedures|0
109803|NCT00689104|375755|P3|Overall Study|Non-compliance with study procedures|1
109804|NCT00689104|375756|P2|Overall Study|Non-compliance with study procedures|0
109805|NCT00689104|375757|P1|Overall Study|Non-compliance with study procedures|0
109806|NCT00689104|375754|P4|Overall Study|Physician Decision|0
109807|NCT00689104|375755|P3|Overall Study|Physician Decision|0
109808|NCT00689104|375756|P2|Overall Study|Physician Decision|0
109809|NCT00689104|375757|P1|Overall Study|Physician Decision|1
109810|NCT00689104|375754|P4|Overall Study|Randomized but never received study drug|0
109811|NCT00689104|375755|P3|Overall Study|Randomized but never received study drug|1
109812|NCT00689104|375756|P2|Overall Study|Randomized but never received study drug|1
109813|NCT00689104|375757|P1|Overall Study|Randomized but never received study drug|2
109814|NCT00689104|375754|P4|Overall Study|Protocol Violation|3
109815|NCT00689104|375755|P3|Overall Study|Protocol Violation|5
109816|NCT00689104|375756|P2|Overall Study|Protocol Violation|3
109817|NCT00689104|375757|P1|Overall Study|Protocol Violation|2
109818|NCT00689104|375754|P4|Overall Study|Lost to Follow-up|5
109819|NCT00689104|375755|P3|Overall Study|Lost to Follow-up|2
109820|NCT00689104|375756|P2|Overall Study|Lost to Follow-up|3
109821|NCT00689104|375757|P1|Overall Study|Lost to Follow-up|4
109822|NCT00689104|375754|P4|Overall Study|Withdrawal by Subject|11
109823|NCT00689104|375755|P3|Overall Study|Withdrawal by Subject|18
109824|NCT00689104|375756|P2|Overall Study|Withdrawal by Subject|11
109825|NCT00689104|375757|P1|Overall Study|Withdrawal by Subject|12
109826|NCT00689104|375754|P4|Overall Study|Lack of Efficacy|3
109827|NCT00689104|375755|P3|Overall Study|Lack of Efficacy|2
109828|NCT00689104|375756|P2|Overall Study|Lack of Efficacy|6
109829|NCT00689104|375757|P1|Overall Study|Lack of Efficacy|5
109830|NCT00689104|375754|P4|Overall Study|Adverse Event|24
109831|NCT00689104|375755|P3|Overall Study|Adverse Event|16
109832|NCT00689104|375756|P2|Overall Study|Adverse Event|25
109833|NCT00689104|375757|P1|Overall Study|Adverse Event|13
109834|NCT00689104|375754|P4|Overall Study|Eligibility criterion not met|4
109835|NCT00689104|375755|P3|Overall Study|Eligibility criterion not met|0
109836|NCT00689104|375756|P2|Overall Study|Eligibility criterion not met|8
109837|NCT00689104|375757|P1|Overall Study|Eligibility criterion not met|5
109838|NCT00689052|375898|P2|Overall Study|Early termination of the trial|24
109839|NCT00689052|375899|P1|Overall Study|Early termination of the trial|22
109840|NCT00689052|375898|P2|Overall Study|Withdrawal by Subject|0
109841|NCT00689052|375899|P1|Overall Study|Withdrawal by Subject|2
109842|NCT00689052|375898|P2|Overall Study|Lost to Follow-up|0
109843|NCT00689052|375899|P1|Overall Study|Lost to Follow-up|2
109844|NCT00689052|375898|P2|Overall Study|Protocol Violation|0
109845|NCT00689052|375899|P1|Overall Study|Protocol Violation|1
109846|NCT00689052|375898|P2|Overall Study|Adverse Event|6
109847|NCT00689052|375899|P1|Overall Study|Adverse Event|4
109848|NCT00689026|375931|P2|Overall Study|Withdrawal by Subject|6
109849|NCT00689026|375932|P1|Overall Study|Withdrawal by Subject|13
109850|NCT00688870|375940|P2|Infant Series|Parent or legal guardian request|0
109851|NCT00688870|375941|P1|Infant Series|Parent or legal guardian request|4
109852|NCT00688844|375973|P1|Overall Study|Lost to Follow-up|10
109853|NCT00688753|375983|P1|Overall Study|Lost to Follow-up|3
109854|NCT00688753|375983|P1|Overall Study|Protocol Violation|1
109855|NCT00688753|375983|P1|Overall Study|Adverse Event|20
109856|NCT00688753|375983|P1|Overall Study|Withdrawal by Subject|3
109857|NCT00688753|375983|P1|Overall Study|Death|9
109858|NCT00688753|375983|P1|Overall Study|Missing|1
109859|NCT00688753|375983|P1|Overall Study|Disease progression|55
109860|NCT00688740|375994|P2|Overall Study|Violation of Inclusion Criteria|3
109861|NCT00688740|375995|P1|Overall Study|Violation of Inclusion Criteria|1
109862|NCT00688740|375994|P2|Overall Study|Breast Cancer Relapse|4
109863|NCT00688740|375995|P1|Overall Study|Breast Cancer Relapse|1
109864|NCT00688740|375994|P2|Overall Study|Consent Withdrawn|17
109865|NCT00688740|375995|P1|Overall Study|Consent Withdrawn|17
109866|NCT00688740|375994|P2|Overall Study|Lost to Follow-up|1
109867|NCT00688740|375995|P1|Overall Study|Lost to Follow-up|0
109868|NCT00688740|375994|P2|Overall Study|Death|2
109869|NCT00688740|375995|P1|Overall Study|Death|2
109870|NCT00688740|375994|P2|Overall Study|Adverse Event|8
109871|NCT00688740|375995|P1|Overall Study|Adverse Event|45
109872|NCT00688701|376008|P4|Overall Study|Poor compliance to protocol|0
109873|NCT00688701|376009|P3|Overall Study|Poor compliance to protocol|1
109874|NCT00688701|376010|P2|Overall Study|Poor compliance to protocol|1
109875|NCT00688701|376011|P1|Overall Study|Poor compliance to protocol|0
109876|NCT00688701|376008|P4|Overall Study|Withdrawal by Subject|8
109877|NCT00688701|376009|P3|Overall Study|Withdrawal by Subject|4
109878|NCT00688701|376010|P2|Overall Study|Withdrawal by Subject|3
109879|NCT00688701|376011|P1|Overall Study|Withdrawal by Subject|3
109880|NCT00688701|376008|P4|Overall Study|Lack of Efficacy|0
109881|NCT00688701|376009|P3|Overall Study|Lack of Efficacy|0
109882|NCT00688701|376010|P2|Overall Study|Lack of Efficacy|1
109883|NCT00688701|376011|P1|Overall Study|Lack of Efficacy|0
109884|NCT00688701|376008|P4|Overall Study|Adverse Event|3
109885|NCT00688701|376009|P3|Overall Study|Adverse Event|5
109886|NCT00688701|376010|P2|Overall Study|Adverse Event|0
109887|NCT00688701|376011|P1|Overall Study|Adverse Event|1
109888|NCT00688688|376052|P3|Overall Study|Violation of exclusion criterion|0
109889|NCT00688688|376053|P2|Overall Study|Violation of exclusion criterion|1
109890|NCT00688688|376054|P1|Overall Study|Violation of exclusion criterion|0
109891|NCT00688688|376052|P3|Overall Study|Site closure|0
109892|NCT00688688|376053|P2|Overall Study|Site closure|1
109893|NCT00688688|376054|P1|Overall Study|Site closure|0
109894|NCT00688688|376052|P3|Overall Study|Taking exclusionary medications|0
109895|NCT00688688|376053|P2|Overall Study|Taking exclusionary medications|0
109896|NCT00688688|376054|P1|Overall Study|Taking exclusionary medications|1
109897|NCT00688688|376052|P3|Overall Study|Non-compliance with study procedures|4
109898|NCT00688688|376053|P2|Overall Study|Non-compliance with study procedures|3
109899|NCT00688688|376054|P1|Overall Study|Non-compliance with study procedures|5
109900|NCT00688688|376052|P3|Overall Study|Randomized but never received study drug|0
109901|NCT00688688|376053|P2|Overall Study|Randomized but never received study drug|0
109902|NCT00688688|376054|P1|Overall Study|Randomized but never received study drug|1
109903|NCT00688688|376052|P3|Overall Study|Protocol Violation|11
109904|NCT00688688|376053|P2|Overall Study|Protocol Violation|9
109905|NCT00688688|376054|P1|Overall Study|Protocol Violation|6
109906|NCT00688688|376052|P3|Overall Study|Lost to Follow-up|7
109907|NCT00688688|376053|P2|Overall Study|Lost to Follow-up|7
109908|NCT00688688|376054|P1|Overall Study|Lost to Follow-up|14
109909|NCT00688688|376052|P3|Overall Study|Withdrawal by Subject|65
109910|NCT00688688|376053|P2|Overall Study|Withdrawal by Subject|75
109911|NCT00688688|376054|P1|Overall Study|Withdrawal by Subject|66
109912|NCT00688688|376052|P3|Overall Study|Lack of Efficacy|45
109913|NCT00688688|376053|P2|Overall Study|Lack of Efficacy|25
109914|NCT00688688|376054|P1|Overall Study|Lack of Efficacy|34
109915|NCT00688688|376052|P3|Overall Study|Adverse Event|50
109916|NCT00688688|376053|P2|Overall Study|Adverse Event|51
109917|NCT00688688|376054|P1|Overall Study|Adverse Event|52
109918|NCT00688688|376052|P3|Overall Study|Eligibility criterion not met|10
109919|NCT00688688|376053|P2|Overall Study|Eligibility criterion not met|7
109920|NCT00688688|376054|P1|Overall Study|Eligibility criterion not met|7
109921|NCT00688636|376156|P2|Overall Study|Adverse Event|1
109922|NCT00688636|376157|P1|Overall Study|Adverse Event|2
109923|NCT00688545|376173|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
109924|NCT00688545|376174|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
109925|NCT00688545|376173|P2|Overall Study|Withdrawal by Subject|3
109926|NCT00688545|376174|P1|Overall Study|Withdrawal by Subject|2
109927|NCT00688545|376173|P2|Overall Study|Insurance/cost of drug|1
109928|NCT00688545|376174|P1|Overall Study|Insurance/cost of drug|0
109929|NCT00688545|376173|P2|Overall Study|Lost to Follow-up|4
109930|NCT00688545|376174|P1|Overall Study|Lost to Follow-up|1
109931|NCT00688519|376184|P2|Overall Study|Pregnancy|1
109932|NCT00688519|376185|P1|Overall Study|Pregnancy|0
109933|NCT00688519|376184|P2|Overall Study|Subject moved out of area|0
109934|NCT00688519|376185|P1|Overall Study|Subject moved out of area|1
109935|NCT00688519|376184|P2|Overall Study|Investigator decision|0
109936|NCT00688519|376185|P1|Overall Study|Investigator decision|1
109937|NCT00688519|376184|P2|Overall Study|Subject moved out of state|0
109938|NCT00688519|376185|P1|Overall Study|Subject moved out of state|1
109939|NCT00688519|376184|P2|Overall Study|Non-compliance|1
109940|NCT00688519|376185|P1|Overall Study|Non-compliance|0
109941|NCT00688519|376184|P2|Overall Study|Prohibited medication|0
109942|NCT00688519|376185|P1|Overall Study|Prohibited medication|1
109943|NCT00688519|376184|P2|Overall Study|Withdrawal by Subject|6
109944|NCT00688519|376185|P1|Overall Study|Withdrawal by Subject|7
109945|NCT00688519|376184|P2|Overall Study|Lack of Efficacy|1
109946|NCT00688519|376185|P1|Overall Study|Lack of Efficacy|3
109947|NCT00688519|376184|P2|Overall Study|Lost to Follow-up|3
109948|NCT00688519|376185|P1|Overall Study|Lost to Follow-up|3
109949|NCT00688519|376184|P2|Overall Study|Adverse Event|3
109950|NCT00688519|376185|P1|Overall Study|Adverse Event|2
109951|NCT00688467|376203|P2|Treatment Period 2|Adverse Event|1
109952|NCT00688467|376204|P1|Treatment Period 2|Adverse Event|0
109953|NCT00688467|376203|P2|Treatment Period 2|Protocol Violation|1
109954|NCT00688467|376204|P1|Treatment Period 2|Protocol Violation|0
109955|NCT00688467|376203|P2|Treatment Period 1|Did not meet protocol eligibility|1
109956|NCT00688467|376204|P1|Treatment Period 1|Did not meet protocol eligibility|0
109957|NCT00688467|376203|P2|Treatment Period 1|Adverse Event|1
109958|NCT00688467|376204|P1|Treatment Period 1|Adverse Event|2
109959|NCT00688103|376236|P2|Overall Study|complex reasons|9
109960|NCT00688103|376237|P1|Overall Study|complex reasons|11
109961|NCT00688103|376236|P2|Overall Study|Withdrawal by Subject|2
109962|NCT00688103|376237|P1|Overall Study|Withdrawal by Subject|4
109963|NCT00688103|376236|P2|Overall Study|Lack of Efficacy|1
109964|NCT00688103|376237|P1|Overall Study|Lack of Efficacy|11
109965|NCT00688103|376236|P2|Overall Study|Adverse Event|1
109966|NCT00688103|376237|P1|Overall Study|Adverse Event|4
109967|NCT00688064|376249|P2|Overall Study|Any other reasons|3
109968|NCT00688064|376250|P1|Overall Study|Any other reasons|1
109969|NCT00688064|376249|P2|Overall Study|Pregnancy|0
109970|NCT00688064|376250|P1|Overall Study|Pregnancy|1
109971|NCT00688064|376249|P2|Overall Study|Lack of Efficacy|1
109972|NCT00688064|376250|P1|Overall Study|Lack of Efficacy|0
109973|NCT00688064|376249|P2|Overall Study|Lost to Follow-up|10
109974|NCT00688064|376250|P1|Overall Study|Lost to Follow-up|10
109975|NCT00688064|376249|P2|Overall Study|Withdrawal by Subject|7
109976|NCT00688064|376250|P1|Overall Study|Withdrawal by Subject|7
109977|NCT00688064|376249|P2|Overall Study|Adverse Event|4
109978|NCT00688064|376250|P1|Overall Study|Adverse Event|2
109979|NCT00688064|376249|P2|Overall Study|Protocol Violation|1
109980|NCT00688064|376250|P1|Overall Study|Protocol Violation|0
109981|NCT00687973|376266|P2|Overall Study|Withdrawal by Subject|3
109982|NCT00687973|376267|P1|Overall Study|Withdrawal by Subject|3
109983|NCT00687973|376266|P2|Overall Study|Administrative Reasons|2
109984|NCT00687973|376267|P1|Overall Study|Administrative Reasons|0
109985|NCT00687973|376266|P2|Overall Study|Protocol Violation|2
109986|NCT00687973|376267|P1|Overall Study|Protocol Violation|1
109987|NCT00687973|376266|P2|Overall Study|Lack of Efficacy|3
109988|NCT00687973|376267|P1|Overall Study|Lack of Efficacy|2
109989|NCT00687973|376266|P2|Overall Study|Adverse Event|28
109990|NCT00687973|376267|P1|Overall Study|Adverse Event|18
109991|NCT00687804|376329|P3|Open-Label Extension Study|Death|3
109992|NCT00687804|376330|P2|Open-Label Extension Study|Death|3
109993|NCT00687804|376331|P1|Open-Label Extension Study|Death|2
109994|NCT00687804|376329|P3|Open-Label Extension Study|Administrative problems|0
109995|NCT00687804|376330|P2|Open-Label Extension Study|Administrative problems|1
109996|NCT00687804|376331|P1|Open-Label Extension Study|Administrative problems|1
109997|NCT00687804|376329|P3|Open-Label Extension Study|Lost to Follow-up|2
109998|NCT00687804|376330|P2|Open-Label Extension Study|Lost to Follow-up|1
109999|NCT00687804|376331|P1|Open-Label Extension Study|Lost to Follow-up|2
110000|NCT00687804|376329|P3|Open-Label Extension Study|Subject withdrew consent|4
110001|NCT00687804|376330|P2|Open-Label Extension Study|Subject withdrew consent|4
110002|NCT00687804|376331|P1|Open-Label Extension Study|Subject withdrew consent|3
110003|NCT00687804|376329|P3|Open-Label Extension Study|Adverse Event|2
110004|NCT00687804|376330|P2|Open-Label Extension Study|Adverse Event|2
110005|NCT00687804|376331|P1|Open-Label Extension Study|Adverse Event|2
110006|NCT00687804|376329|P3|Core Study|Protocol Violation|0
110007|NCT00687804|376330|P2|Core Study|Protocol Violation|1
110008|NCT00687804|376331|P1|Core Study|Protocol Violation|1
110009|NCT00687804|376329|P3|Core Study|Death|2
110010|NCT00687804|376330|P2|Core Study|Death|2
110011|NCT00687804|376331|P1|Core Study|Death|2
110012|NCT00687804|376329|P3|Core Study|Lost to Follow-up|0
110013|NCT00687804|376330|P2|Core Study|Lost to Follow-up|1
110014|NCT00687804|376331|P1|Core Study|Lost to Follow-up|0
110015|NCT00687804|376329|P3|Core Study|Withdrawal by Subject|7
110016|NCT00687804|376330|P2|Core Study|Withdrawal by Subject|7
110017|NCT00687804|376331|P1|Core Study|Withdrawal by Subject|4
110018|NCT00687804|376329|P3|Core Study|Lack of Efficacy|1
110019|NCT00687804|376330|P2|Core Study|Lack of Efficacy|1
110020|NCT00687804|376331|P1|Core Study|Lack of Efficacy|1
110021|NCT00687804|376329|P3|Core Study|Abnormal laboratory value(s)|0
110022|NCT00687804|376330|P2|Core Study|Abnormal laboratory value(s)|0
110023|NCT00687804|376331|P1|Core Study|Abnormal laboratory value(s)|1
110024|NCT00687804|376329|P3|Core Study|Adverse Event|3
110025|NCT00687804|376330|P2|Core Study|Adverse Event|3
110026|NCT00687804|376331|P1|Core Study|Adverse Event|5
110027|NCT00687609|376390|P1|Overall Study|Withdrawal by Subject|2
110028|NCT00687609|376390|P1|Overall Study|Physician Decision|1
110029|NCT00687531|376413|P1|Overall Study|Lost to Follow-up|26
110030|NCT00687531|376413|P1|Overall Study|Adverse Event|5
110031|NCT00687531|376413|P1|Overall Study|Did not meet protocol eligibility|104
110032|NCT00687440|376436|P1|Overall Study|Missing|1
110033|NCT00687440|376436|P1|Overall Study|Not specified|1
110034|NCT00687440|376436|P1|Overall Study|Death|2
110035|NCT00687440|376436|P1|Overall Study|Lack of Efficacy|2
110036|NCT00687440|376436|P1|Overall Study|Lost to Follow-up|3
110037|NCT00687440|376436|P1|Overall Study|Adverse Event|3
110038|NCT00687401|376440|P1|Overall Study|For reasons different from those above|4
110039|NCT00687401|376440|P1|Overall Study|Did not return for visit|3
110040|NCT00687401|376440|P1|Overall Study|Withdrawal by Subject|4
110041|NCT00687401|376440|P1|Overall Study|Lack of Efficacy|6
110042|NCT00687401|376440|P1|Overall Study|Adverse Event|6
110043|NCT00687401|376440|P1|Overall Study|Protocol Violation|7
110044|NCT00687362|376445|P1|Overall Study|Withdrawal by Subject|1
110045|NCT00687362|376445|P1|Overall Study|Protocol Violation|2
110046|NCT00687323|376449|P1|Overall Study|Screen failure|148
110047|NCT00687323|376449|P1|Overall Study|Excluded from efficacy evaluations|6
110048|NCT00687323|376449|P1|Overall Study|Withdrawal by Subject|1
110049|NCT00687323|376449|P1|Overall Study|Death|25
110050|NCT00687297|376465|P2|Induction|Other|1
110051|NCT00687297|376466|P1|Induction|Other|0
110052|NCT00687297|376465|P2|Induction|Physician Decision|2
110053|NCT00687297|376466|P1|Induction|Physician Decision|0
110054|NCT00687297|376465|P2|Induction|Patient Noncompliance|0
110055|NCT00687297|376466|P1|Induction|Patient Noncompliance|1
110056|NCT00687297|376465|P2|Induction|Ineligible|1
110057|NCT00687297|376466|P1|Induction|Ineligible|0
110058|NCT00687297|376465|P2|Induction|Lack of Efficacy|21
110059|NCT00687297|376466|P1|Induction|Lack of Efficacy|17
110060|NCT00687297|376465|P2|Induction|Death|11
110061|NCT00687297|376466|P1|Induction|Death|7
110062|NCT00687297|376465|P2|Induction|Adverse Event|15
110063|NCT00687297|376466|P1|Induction|Adverse Event|16
110064|NCT00687297|376465|P2|Induction|Withdrawal by Subject|4
110065|NCT00687297|376466|P1|Induction|Withdrawal by Subject|4
110066|NCT00687297|376465|P2|Randomization|Withdrew before treatment, ineligible|1
110067|NCT00687297|376466|P1|Randomization|Withdrew before treatment, ineligible|1
110068|NCT00687297|376465|P2|Randomization|Withdrawal by Subject|0
110069|NCT00687297|376466|P1|Randomization|Withdrawal by Subject|2
110070|NCT00687219|376476|P1|Overall Study|Lack of Efficacy|1
110071|NCT00687219|376476|P1|Overall Study|Withdrawal by Subject|1
110072|NCT00687219|376476|P1|Overall Study|HCV-RNA positive conversion|34
110073|NCT00687219|376476|P1|Overall Study|Discontinuance criteria met|7
110074|NCT00687219|376476|P1|Overall Study|Adverse Event|8
110075|NCT00687193|376488|P6|Overall Study|Protocol Violation|0
110076|NCT00687193|376489|P5|Overall Study|Protocol Violation|2
110077|NCT00687193|376490|P4|Overall Study|Protocol Violation|1
110078|NCT00687193|376491|P3|Overall Study|Protocol Violation|0
110079|NCT00687193|376492|P2|Overall Study|Protocol Violation|2
110080|NCT00687193|376493|P1|Overall Study|Protocol Violation|1
110081|NCT00687193|376488|P6|Overall Study|Lack of Efficacy|2
110082|NCT00687193|376489|P5|Overall Study|Lack of Efficacy|0
110083|NCT00687193|376490|P4|Overall Study|Lack of Efficacy|0
110084|NCT00687193|376491|P3|Overall Study|Lack of Efficacy|0
110085|NCT00687193|376492|P2|Overall Study|Lack of Efficacy|1
110086|NCT00687193|376493|P1|Overall Study|Lack of Efficacy|1
110087|NCT00687193|376488|P6|Overall Study|Adverse Event|2
110088|NCT00687193|376489|P5|Overall Study|Adverse Event|0
110089|NCT00687193|376490|P4|Overall Study|Adverse Event|3
110090|NCT00687193|376491|P3|Overall Study|Adverse Event|2
110091|NCT00687193|376492|P2|Overall Study|Adverse Event|1
110092|NCT00687193|376493|P1|Overall Study|Adverse Event|0
110093|NCT00686998|376680|P3|Overall Study|Safety Reasons|0
110094|NCT00686998|376681|P2|Overall Study|Safety Reasons|0
110095|NCT00686998|376682|P1|Overall Study|Safety Reasons|1
110096|NCT00686998|376680|P3|Overall Study|Not specified|1
110097|NCT00686998|376681|P2|Overall Study|Not specified|0
110098|NCT00686998|376682|P1|Overall Study|Not specified|0
110099|NCT00686998|376680|P3|Overall Study|Lack of Efficacy|0
110100|NCT00686998|376681|P2|Overall Study|Lack of Efficacy|5
110101|NCT00686998|376682|P1|Overall Study|Lack of Efficacy|7
110102|NCT00686998|376680|P3|Overall Study|Withdrawal by Subject|2
110103|NCT00686998|376681|P2|Overall Study|Withdrawal by Subject|1
110104|NCT00686998|376682|P1|Overall Study|Withdrawal by Subject|2
110105|NCT00686998|376680|P3|Overall Study|Adverse Event|1
110106|NCT00686998|376681|P2|Overall Study|Adverse Event|2
110107|NCT00686998|376682|P1|Overall Study|Adverse Event|3
110108|NCT00686959|376692|P2|Overall Study|Participants censored (no death events)|117
110109|NCT00686959|376693|P1|Overall Study|Participants censored (no death events)|124
110110|NCT00686894|376711|P1|Overall Study|Protocol Violation|4
110111|NCT00686894|376711|P1|Overall Study|Relapse|2
110112|NCT00686881|376717|P2|Overall Study|Never received study drug|6
110113|NCT00686881|376718|P1|Overall Study|Never received study drug|2
110114|NCT00686881|376717|P2|Overall Study|Study discontinuation|32
110115|NCT00686881|376718|P1|Overall Study|Study discontinuation|35
110116|NCT00686881|376717|P2|Overall Study|Irregular visits|0
110117|NCT00686881|376718|P1|Overall Study|Irregular visits|1
110118|NCT00686881|376717|P2|Overall Study|Did not meet protocol eligibility|0
110119|NCT00686881|376718|P1|Overall Study|Did not meet protocol eligibility|1
110120|NCT00686881|376717|P2|Overall Study|Circumstances of site|1
110121|NCT00686881|376718|P1|Overall Study|Circumstances of site|1
110122|NCT00686881|376717|P2|Overall Study|Physician Decision|0
110123|NCT00686881|376718|P1|Overall Study|Physician Decision|1
110124|NCT00686881|376717|P2|Overall Study|Lack of Efficacy|3
110125|NCT00686881|376718|P1|Overall Study|Lack of Efficacy|4
110126|NCT00686881|376717|P2|Overall Study|Onset of malignant tumor|11
110127|NCT00686881|376718|P1|Overall Study|Onset of malignant tumor|11
110128|NCT00686881|376717|P2|Overall Study|Met discontinuation criteria|0
110129|NCT00686881|376718|P1|Overall Study|Met discontinuation criteria|5
110130|NCT00686881|376717|P2|Overall Study|Treatment-related adverse event|9
110131|NCT00686881|376718|P1|Overall Study|Treatment-related adverse event|10
110132|NCT00686881|376717|P2|Overall Study|Lost to Follow-up|1
110133|NCT00686881|376718|P1|Overall Study|Lost to Follow-up|0
110134|NCT00686881|376717|P2|Overall Study|Withdrawal by Subject|18
110135|NCT00686881|376718|P1|Overall Study|Withdrawal by Subject|11
110136|NCT00686855|376730|P2|Overall Study|Progressive GVHD|1
110137|NCT00686855|376731|P1|Overall Study|Progressive GVHD|0
110138|NCT00686855|376730|P2|Overall Study|Lost to Follow-up|0
110139|NCT00686855|376731|P1|Overall Study|Lost to Follow-up|1
110140|NCT00686790|376757|P1|Overall Study|Lost to Follow-up|12
110141|NCT00686790|376757|P1|Overall Study|Death|1
110142|NCT00686790|376757|P1|Overall Study|Withdrawal by Subject|1
110143|NCT00686790|376757|P1|Overall Study|Adverse Event|2
110144|NCT00686777|376765|P1|Overall Study|No Visit|1
110145|NCT00686777|376765|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
110146|NCT00686777|376765|P1|Overall Study|Withdrawal by Subject|2
110147|NCT00686777|376765|P1|Overall Study|Pregnancy|1
110148|NCT00686777|376765|P1|Overall Study|Adverse Event|2
110149|NCT00686725|376773|P2|Overall Study|Not Specified|3
110150|NCT00686725|376774|P1|Overall Study|Not Specified|1
110151|NCT00686725|376773|P2|Overall Study|Protocol Violation|3
110152|NCT00686725|376774|P1|Overall Study|Protocol Violation|1
110153|NCT00686725|376773|P2|Overall Study|Withdrawal by Subject|4
110154|NCT00686725|376774|P1|Overall Study|Withdrawal by Subject|13
110155|NCT00686725|376773|P2|Overall Study|Death|3
110156|NCT00686725|376774|P1|Overall Study|Death|6
110157|NCT00686725|376773|P2|Overall Study|Lost to Follow-up|5
110158|NCT00686725|376774|P1|Overall Study|Lost to Follow-up|7
110159|NCT00686725|376773|P2|Overall Study|Progressive Disease|23
110160|NCT00686725|376774|P1|Overall Study|Progressive Disease|17
110161|NCT00686725|376773|P2|Overall Study|Adverse Event|1
110162|NCT00686725|376774|P1|Overall Study|Adverse Event|1
110163|NCT00686712|376799|P3|Overall Study|Adverse Event|0
110164|NCT00686712|376800|P2|Overall Study|Adverse Event|1
110165|NCT00686712|376801|P1|Overall Study|Adverse Event|1
110166|NCT00686712|376799|P3|Overall Study|Lost to Follow-up|3
110167|NCT00686712|376800|P2|Overall Study|Lost to Follow-up|2
110168|NCT00686712|376801|P1|Overall Study|Lost to Follow-up|1
110169|NCT00686712|376799|P3|Overall Study|Protocol Violation|10
110170|NCT00686712|376800|P2|Overall Study|Protocol Violation|8
110171|NCT00686712|376801|P1|Overall Study|Protocol Violation|8
110172|NCT00686699|376811|P2|Treatment Period 1|Adverse Event|2
110173|NCT00686699|376812|P1|Treatment Period 1|Adverse Event|0
110174|NCT00686686|376836|P1|Overall Study|Lost to Follow-up|3
110175|NCT00686686|376836|P1|Overall Study|Adverse Event|2
110176|NCT00686686|376836|P1|Overall Study|Non-compliance|1
110177|NCT00686647|376844|P1|Overall Study|Death|1
110178|NCT00686647|376844|P1|Overall Study|Lost to Follow-up|1
110179|NCT00686634|376850|P1|Overall Study|Protocol Violation|6
110180|NCT00686595|376857|P1|Overall Study|Poor Compliance|1
110181|NCT00686595|376857|P1|Overall Study|Lack of Efficacy|1
110182|NCT00686595|376857|P1|Overall Study|Lost to Follow-up|1
110183|NCT00686595|376857|P1|Overall Study|Protocol Violation|1
110184|NCT00686595|376857|P1|Overall Study|Adverse Event|3
110185|NCT00686543|376886|P4|Overall Study|Protocol Violation|1
110186|NCT00686543|376887|P3|Overall Study|Protocol Violation|2
110187|NCT00686543|376888|P2|Overall Study|Protocol Violation|0
110188|NCT00686543|376889|P1|Overall Study|Protocol Violation|3
110189|NCT00686543|376886|P4|Overall Study|Withdrawal by Subject|0
110190|NCT00686543|376887|P3|Overall Study|Withdrawal by Subject|0
110191|NCT00686543|376888|P2|Overall Study|Withdrawal by Subject|0
110192|NCT00686543|376889|P1|Overall Study|Withdrawal by Subject|2
110193|NCT00686543|376886|P4|Overall Study|Adverse Event|2
110194|NCT00686543|376887|P3|Overall Study|Adverse Event|3
110195|NCT00686543|376888|P2|Overall Study|Adverse Event|1
110196|NCT00686543|376889|P1|Overall Study|Adverse Event|9
110197|NCT00686517|376910|P3|Treatment|Protocol Violation|0
110198|NCT00686517|376911|P2|Treatment|Protocol Violation|1
110199|NCT00686517|376912|P1|Treatment|Protocol Violation|2
110200|NCT00686517|376910|P3|Treatment|Poor Protocol Compliance|0
110201|NCT00686517|376911|P2|Treatment|Poor Protocol Compliance|0
110202|NCT00686517|376912|P1|Treatment|Poor Protocol Compliance|1
110203|NCT00686517|376910|P3|Treatment|Adverse Event|0
110204|NCT00686517|376911|P2|Treatment|Adverse Event|0
110205|NCT00686517|376912|P1|Treatment|Adverse Event|2
110206|NCT00686517|376910|P3|Treatment|Serious Adverse Event|1
110207|NCT00686517|376911|P2|Treatment|Serious Adverse Event|2
110208|NCT00686517|376912|P1|Treatment|Serious Adverse Event|1
110209|NCT00686335|376935|P1|Run-in Period|violation of inclusion/exclusion criteri|3
110210|NCT00686335|376935|P1|Run-in Period|asthma exacerbation|1
110211|NCT00686335|376935|P1|Run-in Period|Adverse Event|1
110212|NCT00686205|376965|P2|Overall Study|Specimens not confirmed HIV positive|981
110213|NCT00686205|376966|P1|Overall Study|Specimens not confirmed HIV positive|0
110214|NCT00686205|376965|P2|Overall Study|Specimen handling procedure altered|0
110215|NCT00686205|376966|P1|Overall Study|Specimen handling procedure altered|5878
110216|NCT00686205|376965|P2|Overall Study|Withdrawal by Subject|0
110217|NCT00686205|376966|P1|Overall Study|Withdrawal by Subject|2
110218|NCT00686205|376965|P2|Overall Study|Protocol Violation|0
110219|NCT00686205|376966|P1|Overall Study|Protocol Violation|127
110220|NCT00686166|376972|P1|Overall Study|Did not begin protocol therapy|4
110221|NCT00686166|376972|P1|Overall Study|Ineligible|5
110222|NCT00686166|376972|P1|Overall Study|Not Protocol Specified|1
110223|NCT00686166|376972|P1|Overall Study|Death|1
110224|NCT00686166|376972|P1|Overall Study|Progression/Relapse|1
110225|NCT00686166|376972|P1|Overall Study|Withdrawal by Subject|1
110226|NCT00686166|376972|P1|Overall Study|Adverse Event|7
110227|NCT00686127|376984|P2|Overall Study|Withdrawal by Subject|6
110228|NCT00686127|376985|P1|Overall Study|Withdrawal by Subject|14
110229|NCT00686075|377001|P10|Overall Study|unspecified|1
110230|NCT00686075|377002|P9|Overall Study|unspecified|0
110231|NCT00686075|377003|P8|Overall Study|unspecified|0
110232|NCT00686075|377004|P7|Overall Study|unspecified|0
110233|NCT00686075|377005|P6|Overall Study|unspecified|0
110234|NCT00686075|377006|P5|Overall Study|unspecified|0
110235|NCT00686075|377007|P4|Overall Study|unspecified|0
110236|NCT00686075|377008|P3|Overall Study|unspecified|0
110237|NCT00686075|377009|P2|Overall Study|unspecified|1
110238|NCT00686075|377010|P1|Overall Study|unspecified|1
110239|NCT00686075|377001|P10|Overall Study|Lost to Follow-up|3
110240|NCT00686075|377002|P9|Overall Study|Lost to Follow-up|2
110241|NCT00686075|377003|P8|Overall Study|Lost to Follow-up|0
110242|NCT00686075|377004|P7|Overall Study|Lost to Follow-up|0
110243|NCT00686075|377005|P6|Overall Study|Lost to Follow-up|3
110244|NCT00686075|377006|P5|Overall Study|Lost to Follow-up|3
110245|NCT00686075|377007|P4|Overall Study|Lost to Follow-up|2
110246|NCT00686075|377008|P3|Overall Study|Lost to Follow-up|3
110247|NCT00686075|377009|P2|Overall Study|Lost to Follow-up|6
110248|NCT00686075|377010|P1|Overall Study|Lost to Follow-up|3
110249|NCT00686075|377001|P10|Overall Study|Withdrawal by Subject|6
110250|NCT00686075|377002|P9|Overall Study|Withdrawal by Subject|4
110251|NCT00686075|377003|P8|Overall Study|Withdrawal by Subject|2
110252|NCT00686075|377004|P7|Overall Study|Withdrawal by Subject|0
110253|NCT00686075|377005|P6|Overall Study|Withdrawal by Subject|0
110254|NCT00686075|377006|P5|Overall Study|Withdrawal by Subject|1
110255|NCT00686075|377007|P4|Overall Study|Withdrawal by Subject|7
110256|NCT00686075|377008|P3|Overall Study|Withdrawal by Subject|3
110257|NCT00686075|377009|P2|Overall Study|Withdrawal by Subject|3
110258|NCT00686075|377010|P1|Overall Study|Withdrawal by Subject|4
110259|NCT00686036|377204|P2|Overall Study|Other reasons not identified|4
110260|NCT00686036|377205|P1|Overall Study|Other reasons not identified|0
110261|NCT00686036|377204|P2|Overall Study|PSA ≥ 10ng/mL|0
110262|NCT00686036|377205|P1|Overall Study|PSA ≥ 10ng/mL|1
110263|NCT00686036|377204|P2|Overall Study|Study terminated by AstraZeneca|1
110264|NCT00686036|377205|P1|Overall Study|Study terminated by AstraZeneca|2
110265|NCT00686036|377204|P2|Overall Study|Withdrawal by Subject|1
110266|NCT00686036|377205|P1|Overall Study|Withdrawal by Subject|3
110267|NCT00686036|377204|P2|Overall Study|Adverse Event|0
110268|NCT00686036|377205|P1|Overall Study|Adverse Event|3
110269|NCT00685945|377217|P1|L-NMMA + Bradykinin|Physician Decision|1
110270|NCT00685802|377241|P2|Washout Period of 7 Days|Withdrawal by Subject|1
110271|NCT00685802|377242|P1|Washout Period of 7 Days|Withdrawal by Subject|0
110272|NCT00685802|377241|P2|Washout Period of 7 Days|Protocol Violation|0
110273|NCT00685802|377242|P1|Washout Period of 7 Days|Protocol Violation|2
110274|NCT00685763|377252|P1|Overall Study|Protocol Violation|1
110275|NCT00685763|377252|P1|Overall Study|Intercurrent death-incomplete treatment|1
110276|NCT00685698|377256|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
110277|NCT00685698|377256|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
110278|NCT00685698|377256|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
110279|NCT00685698|377256|P1|Overall Study|Adverse Event|3
110280|NCT00685698|377256|P1|Overall Study|Protocol Violation|6
110281|NCT00685698|377256|P1|Overall Study|Withdrawal by Subject|1
110282|NCT00685685|377291|P2|Washout Period of 7 Days|Withdrawal by Subject|1
110283|NCT00685685|377292|P1|Washout Period of 7 Days|Withdrawal by Subject|0
110284|NCT00685685|377291|P2|Washout Period of 7 Days|Adverse Event|0
110285|NCT00685685|377292|P1|Washout Period of 7 Days|Adverse Event|2
110286|NCT00685373|377351|P1|Overall Study|Protocol Violation|1
110287|NCT00685373|377351|P1|Overall Study|Lost to Follow-up|2
110288|NCT00685373|377351|P1|Overall Study|Condition no longer requires study drug|1
110289|NCT00685373|377351|P1|Overall Study|Lack of Efficacy|3
110290|NCT00685373|377351|P1|Overall Study|Withdrawal by Subject|5
110291|NCT00685373|377351|P1|Overall Study|Adverse Event|3
110292|NCT00685334|377360|P2|Overall Study|Chose to enter hospital|1
110293|NCT00685334|377361|P1|Overall Study|Chose to enter hospital|1
110294|NCT00685334|377360|P2|Overall Study|Lost to Follow-up|0
110295|NCT00685334|377361|P1|Overall Study|Lost to Follow-up|4
110296|NCT00685334|377360|P2|Overall Study|Withdrawal by Subject|6
110297|NCT00685334|377361|P1|Overall Study|Withdrawal by Subject|5
110298|NCT00685165|377382|P2|Washout Period of 14 Days|Adverse Event|0
110299|NCT00685165|377383|P1|Washout Period of 14 Days|Adverse Event|1
110300|NCT00685035|377402|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
110301|NCT00685035|377403|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
110302|NCT00684996|377427|P1|Overall Study|Other reasons not protocol specified|1
110303|NCT00684996|377427|P1|Overall Study|Progression/relapse|2
110304|NCT00684996|377427|P1|Overall Study|Refusal unrelated to adverse event|1
110305|NCT00684996|377427|P1|Overall Study|Adverse Event|1
110306|NCT00684814|377449|P2|Second Intervention|Adverse Event|0
110307|NCT00684814|377450|P1|Second Intervention|Adverse Event|1
110308|NCT00684814|377449|P2|Washout Period of 7 Days|Withdrawal by Subject|2
110309|NCT00684814|377450|P1|Washout Period of 7 Days|Withdrawal by Subject|1
110310|NCT00684814|377449|P2|Washout Period of 7 Days|Adverse Event|2
110311|NCT00684814|377450|P1|Washout Period of 7 Days|Adverse Event|1
110312|NCT00684762|377460|P2|Washout Period of 7 Days|Withdrawal by Subject|2
110313|NCT00684762|377461|P1|Washout Period of 7 Days|Withdrawal by Subject|2
110314|NCT00684671|377489|P3|Overall Study|Alcoholic dependance|0
110315|NCT00684671|377490|P2|Overall Study|Alcoholic dependance|0
110316|NCT00684671|377491|P1|Overall Study|Alcoholic dependance|1
110317|NCT00684671|377489|P3|Overall Study|Lost to Follow-up|0
110318|NCT00684671|377490|P2|Overall Study|Lost to Follow-up|0
110319|NCT00684671|377491|P1|Overall Study|Lost to Follow-up|1
110320|NCT00684671|377489|P3|Overall Study|Adverse Event|0
110321|NCT00684671|377490|P2|Overall Study|Adverse Event|0
110322|NCT00684671|377491|P1|Overall Study|Adverse Event|1
110323|NCT00684645|377520|P1|Overall Study|Not specified|15
110324|NCT00684645|377520|P1|Overall Study|Lost to Follow-up|3
110325|NCT00684645|377520|P1|Overall Study|Adverse Event|27
110326|NCT00684645|377520|P1|Overall Study|Progressive disease|67
110327|NCT00684645|377520|P1|Overall Study|Death|2
110328|NCT00684593|377540|P2|Overall Study|Adverse Event|2
110329|NCT00684593|377541|P1|Overall Study|Adverse Event|0
110330|NCT00684567|377553|P1|Monotherapy Period|Progression of primary disease|11
110331|NCT00684567|377553|P1|Monotherapy Period|Death|1
110332|NCT00684567|377553|P1|Monotherapy Period|Adverse Event|2
110333|NCT00684567|377553|P1|Concomitant Radiotherapy Period|Adverse Event|2
110334|NCT00684515|377586|P3|Overall Study|Protocol-Defined Clinical Event|0
110335|NCT00684515|377587|P2|Overall Study|Protocol-Defined Clinical Event|0
110336|NCT00684515|377588|P1|Overall Study|Protocol-Defined Clinical Event|1
110337|NCT00684515|377586|P3|Overall Study|Adverse Event|1
110338|NCT00684515|377587|P2|Overall Study|Adverse Event|3
110339|NCT00684515|377588|P1|Overall Study|Adverse Event|3
110340|NCT00684424|377611|P1|Overall Study|Not Specified|2
110341|NCT00684424|377611|P1|Overall Study|Lost to Follow-up|2
110342|NCT00684424|377611|P1|Overall Study|Adverse Event|1
110343|NCT00684411|377626|P1|Overall Study|Adverse Event|1
110344|NCT00684411|377626|P1|Overall Study|Disease Progression|10
110345|NCT00684411|377626|P1|Overall Study|New Primary Cancer|1
110346|NCT00684307|377648|P5|Overall Study|Criteria from the CSR|3
110347|NCT00684307|377649|P4|Overall Study|Criteria from the CSR|3
110348|NCT00684307|377650|P3|Overall Study|Criteria from the CSR|1
110349|NCT00684307|377651|P2|Overall Study|Criteria from the CSR|0
110350|NCT00684307|377652|P1|Overall Study|Criteria from the CSR|0
110351|NCT00684307|377648|P5|Overall Study|Participant not willing to continue|8
110352|NCT00684307|377649|P4|Overall Study|Participant not willing to continue|5
110353|NCT00684307|377650|P3|Overall Study|Participant not willing to continue|11
110354|NCT00684307|377651|P2|Overall Study|Participant not willing to continue|10
110355|NCT00684307|377652|P1|Overall Study|Participant not willing to continue|7
110356|NCT00684307|377648|P5|Overall Study|Severe non compliance to protocol|2
110357|NCT00684307|377649|P4|Overall Study|Severe non compliance to protocol|1
110358|NCT00684307|377650|P3|Overall Study|Severe non compliance to protocol|0
110359|NCT00684307|377651|P2|Overall Study|Severe non compliance to protocol|0
110360|NCT00684307|377652|P1|Overall Study|Severe non compliance to protocol|1
110361|NCT00684307|377648|P5|Overall Study|Interupted IP for more than 7 days|3
110362|NCT00684307|377649|P4|Overall Study|Interupted IP for more than 7 days|3
110363|NCT00684307|377650|P3|Overall Study|Interupted IP for more than 7 days|1
110364|NCT00684307|377651|P2|Overall Study|Interupted IP for more than 7 days|4
110365|NCT00684307|377652|P1|Overall Study|Interupted IP for more than 7 days|0
110366|NCT00684307|377648|P5|Overall Study|Incorrect enrolment or randomization|0
110367|NCT00684307|377649|P4|Overall Study|Incorrect enrolment or randomization|0
110368|NCT00684307|377650|P3|Overall Study|Incorrect enrolment or randomization|0
110369|NCT00684307|377651|P2|Overall Study|Incorrect enrolment or randomization|0
110370|NCT00684307|377652|P1|Overall Study|Incorrect enrolment or randomization|4
110371|NCT00684307|377648|P5|Overall Study|Fullfillment of exclusion criteria|1
110372|NCT00684307|377649|P4|Overall Study|Fullfillment of exclusion criteria|3
110373|NCT00684307|377650|P3|Overall Study|Fullfillment of exclusion criteria|0
110374|NCT00684307|377651|P2|Overall Study|Fullfillment of exclusion criteria|0
110375|NCT00684307|377652|P1|Overall Study|Fullfillment of exclusion criteria|1
110376|NCT00684307|377648|P5|Overall Study|Development of increasing Liver Function|0
110377|NCT00684307|377649|P4|Overall Study|Development of increasing Liver Function|1
110378|NCT00684307|377650|P3|Overall Study|Development of increasing Liver Function|0
110379|NCT00684307|377651|P2|Overall Study|Development of increasing Liver Function|2
110380|NCT00684307|377652|P1|Overall Study|Development of increasing Liver Function|0
110381|NCT00684307|377648|P5|Overall Study|Adverse Event|8
110382|NCT00684307|377649|P4|Overall Study|Adverse Event|16
110383|NCT00684307|377650|P3|Overall Study|Adverse Event|15
110384|NCT00684307|377651|P2|Overall Study|Adverse Event|6
110385|NCT00684307|377652|P1|Overall Study|Adverse Event|11
110386|NCT00684203|377734|P6|Overall Study|Did not meet protocol eligibility|0
110387|NCT00684203|377735|P5|Overall Study|Did not meet protocol eligibility|0
110388|NCT00684203|377736|P4|Overall Study|Did not meet protocol eligibility|0
110389|NCT00684203|377737|P3|Overall Study|Did not meet protocol eligibility|0
110390|NCT00684203|377738|P2|Overall Study|Did not meet protocol eligibility|1
110391|NCT00684203|377739|P1|Overall Study|Did not meet protocol eligibility|0
110392|NCT00684203|377734|P6|Overall Study|Withdrawal by Subject|0
110393|NCT00684203|377735|P5|Overall Study|Withdrawal by Subject|0
110394|NCT00684203|377736|P4|Overall Study|Withdrawal by Subject|0
110395|NCT00684203|377737|P3|Overall Study|Withdrawal by Subject|1
110396|NCT00684203|377738|P2|Overall Study|Withdrawal by Subject|2
110397|NCT00684203|377739|P1|Overall Study|Withdrawal by Subject|0
110398|NCT00684203|377734|P6|Overall Study|Protocol-defined clinical event|0
110399|NCT00684203|377735|P5|Overall Study|Protocol-defined clinical event|0
110400|NCT00684203|377736|P4|Overall Study|Protocol-defined clinical event|0
110401|NCT00684203|377737|P3|Overall Study|Protocol-defined clinical event|0
110402|NCT00684203|377738|P2|Overall Study|Protocol-defined clinical event|1
110403|NCT00684203|377739|P1|Overall Study|Protocol-defined clinical event|3
110404|NCT00684203|377734|P6|Overall Study|Adverse Event|0
110405|NCT00684203|377735|P5|Overall Study|Adverse Event|0
110406|NCT00684203|377736|P4|Overall Study|Adverse Event|0
110407|NCT00684203|377737|P3|Overall Study|Adverse Event|8
110408|NCT00684203|377738|P2|Overall Study|Adverse Event|4
110409|NCT00684203|377739|P1|Overall Study|Adverse Event|6
110410|NCT00684177|377800|P2|Overall Study|Other|2
110411|NCT00684177|377801|P1|Overall Study|Other|1
110412|NCT00684177|377800|P2|Overall Study|Withdrawal by Subject|2
110413|NCT00684177|377801|P1|Overall Study|Withdrawal by Subject|1
110414|NCT00684177|377800|P2|Overall Study|Physician Decision|0
110415|NCT00684177|377801|P1|Overall Study|Physician Decision|2
110416|NCT00684177|377800|P2|Overall Study|Lost to Follow-up|1
110417|NCT00684177|377801|P1|Overall Study|Lost to Follow-up|2
110418|NCT00684177|377800|P2|Overall Study|Protocol Violation|0
110419|NCT00684177|377801|P1|Overall Study|Protocol Violation|1
110420|NCT00684177|377800|P2|Overall Study|Lack of Efficacy|15
110421|NCT00684177|377801|P1|Overall Study|Lack of Efficacy|10
110422|NCT00684177|377800|P2|Overall Study|Adverse Event|3
110423|NCT00684177|377801|P1|Overall Study|Adverse Event|4
110424|NCT00684073|377836|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
110425|NCT00684073|377836|P1|Selection|request of the sponsor|1
110426|NCT00684073|377836|P1|Selection|Lost to Follow-up|1
110427|NCT00684073|377836|P1|Selection|noncompliance|1
110428|NCT00684073|377836|P1|Selection|Death|1
110429|NCT00684073|377836|P1|Selection|Selection/non-selection criteria|3
110430|NCT00684060|377846|P2|Overall Study|Death|1
110431|NCT00684060|377847|P1|Overall Study|Death|0
110432|NCT00684060|377846|P2|Overall Study|Unable to collect MRI|2
110433|NCT00684060|377847|P1|Overall Study|Unable to collect MRI|1
110434|NCT00684060|377846|P2|Overall Study|New stenosis identified|0
110435|NCT00684060|377847|P1|Overall Study|New stenosis identified|1
110436|NCT00684060|377846|P2|Overall Study|Lost to Follow-up|0
110437|NCT00684060|377847|P1|Overall Study|Lost to Follow-up|1
110438|NCT00684021|377886|P4|Overall Study|Death|0
110439|NCT00684021|377887|P3|Overall Study|Death|0
110440|NCT00684021|377888|P2|Overall Study|Death|0
110441|NCT00684021|377889|P1|Overall Study|Death|1
110442|NCT00684021|377886|P4|Overall Study|MRI not performed|2
110443|NCT00684021|377887|P3|Overall Study|MRI not performed|1
110444|NCT00684021|377888|P2|Overall Study|MRI not performed|1
110445|NCT00684021|377889|P1|Overall Study|MRI not performed|0
110446|NCT00684021|377886|P4|Overall Study|MRI Contraindicated|0
110447|NCT00684021|377887|P3|Overall Study|MRI Contraindicated|1
110448|NCT00684021|377888|P2|Overall Study|MRI Contraindicated|1
110449|NCT00684021|377889|P1|Overall Study|MRI Contraindicated|1
110450|NCT00683917|377950|P1|Overall Study|Study prematurely terminated|10
110451|NCT00683904|377960|P2|Dose Level 2|Adverse Event|2
110452|NCT00683904|377961|P1|Dose Level 2|Adverse Event|0
110453|NCT00683904|377960|P2|Dose Level 1|Adverse Event|0
110454|NCT00683904|377961|P1|Dose Level 1|Adverse Event|1
110455|NCT00683904|377960|P2|Dose Level 1|Disease progression|0
110456|NCT00683904|377961|P1|Dose Level 1|Disease progression|2
110457|NCT00683800|378007|P2|Overall Study|Randomized, not treated|33
110458|NCT00683800|378008|P1|Overall Study|Randomized, not treated|35
110459|NCT00683800|378007|P2|Overall Study|Lack of Efficacy|104
110460|NCT00683800|378008|P1|Overall Study|Lack of Efficacy|61
110461|NCT00683800|378007|P2|Overall Study|Withdrawal by Subject|64
110462|NCT00683800|378008|P1|Overall Study|Withdrawal by Subject|66
110463|NCT00683800|378007|P2|Overall Study|Protocol Violation|16
110464|NCT00683800|378008|P1|Overall Study|Protocol Violation|13
110465|NCT00683800|378007|P2|Overall Study|Unspecified|2
110466|NCT00683800|378008|P1|Overall Study|Unspecified|5
110467|NCT00683800|378007|P2|Overall Study|Lost to Follow-up|44
110468|NCT00683800|378008|P1|Overall Study|Lost to Follow-up|57
110469|NCT00683800|378007|P2|Overall Study|Death|1
110470|NCT00683800|378008|P1|Overall Study|Death|0
110471|NCT00683800|378007|P2|Overall Study|Adverse Event|102
110472|NCT00683800|378008|P1|Overall Study|Adverse Event|195
110473|NCT00683787|378075|P3|Overall Study|Adverse Event|2
110474|NCT00683787|378076|P2|Overall Study|Adverse Event|0
110475|NCT00683787|378077|P1|Overall Study|Adverse Event|0
110476|NCT00683787|378075|P3|Overall Study|Progression|0
110477|NCT00683787|378076|P2|Overall Study|Progression|3
110478|NCT00683787|378077|P1|Overall Study|Progression|3
110479|NCT00683774|378096|P2|Overall Study|Physician Decision|0
110480|NCT00683774|378097|P1|Overall Study|Physician Decision|3
110481|NCT00683774|378096|P2|Overall Study|Withdrawal by Subject|1
110482|NCT00683774|378097|P1|Overall Study|Withdrawal by Subject|0
110483|NCT00683696|378107|P2|Overall Study|Death|30
110484|NCT00683696|378108|P1|Overall Study|Death|46
110485|NCT00683696|378107|P2|Overall Study|Vital status follow-up only|3
110486|NCT00683696|378108|P1|Overall Study|Vital status follow-up only|3
110487|NCT00683696|378107|P2|Overall Study|Lost to Follow-up|6
110488|NCT00683696|378108|P1|Overall Study|Lost to Follow-up|5
110489|NCT00683696|378107|P2|Overall Study|Withdrawn prior to study closure|28
110490|NCT00683696|378108|P1|Overall Study|Withdrawn prior to study closure|13
110491|NCT00683696|378107|P2|Overall Study|Withdrawn due to study closure|338
110492|NCT00683696|378108|P1|Overall Study|Withdrawn due to study closure|337
110493|NCT00683657|378117|P2|Overall Study|Subject Withdrew Consent|0
110494|NCT00683657|378118|P1|Overall Study|Subject Withdrew Consent|1
110495|NCT00683657|378117|P2|Overall Study|Adverse Event|1
110496|NCT00683657|378118|P1|Overall Study|Adverse Event|0
110497|NCT00683618|378135|P3|Extension Treatment Period|Protocol Violation|0
110498|NCT00683618|378136|P2|Extension Treatment Period|Protocol Violation|0
110499|NCT00683618|378137|P1|Extension Treatment Period|Protocol Violation|1
110500|NCT00683618|378135|P3|Extension Treatment Period|Adverse Event|0
110501|NCT00683618|378136|P2|Extension Treatment Period|Adverse Event|0
110502|NCT00683618|378137|P1|Extension Treatment Period|Adverse Event|1
110503|NCT00683618|378135|P3|Extension Treatment Period|Withdrawal by Subject|0
110504|NCT00683618|378136|P2|Extension Treatment Period|Withdrawal by Subject|0
110505|NCT00683618|378137|P1|Extension Treatment Period|Withdrawal by Subject|1
110506|NCT00683618|378135|P3|Randomised Treatment Period|Reason not provided|2
110507|NCT00683618|378136|P2|Randomised Treatment Period|Reason not provided|0
110508|NCT00683618|378137|P1|Randomised Treatment Period|Reason not provided|0
110509|NCT00683618|378135|P3|Randomised Treatment Period|Adverse Event|2
110510|NCT00683618|378136|P2|Randomised Treatment Period|Adverse Event|0
110511|NCT00683618|378137|P1|Randomised Treatment Period|Adverse Event|2
110512|NCT00683618|378135|P3|Randomised Treatment Period|Protocol Violation|0
110513|NCT00683618|378136|P2|Randomised Treatment Period|Protocol Violation|1
110514|NCT00683618|378137|P1|Randomised Treatment Period|Protocol Violation|0
110515|NCT00683618|378135|P3|Randomised Treatment Period|Withdrawal by Subject|2
110516|NCT00683618|378136|P2|Randomised Treatment Period|Withdrawal by Subject|1
110517|NCT00683618|378137|P1|Randomised Treatment Period|Withdrawal by Subject|4
110518|NCT00683592|378187|P2|Overall Study|Other|1
110519|NCT00683592|378188|P1|Overall Study|Other|1
110520|NCT00683592|378187|P2|Overall Study|Non-compliance|5
110521|NCT00683592|378188|P1|Overall Study|Non-compliance|3
110522|NCT00683592|378187|P2|Overall Study|Physician Decision|1
110523|NCT00683592|378188|P1|Overall Study|Physician Decision|0
110524|NCT00683592|378187|P2|Overall Study|Lack of Efficacy|7
110525|NCT00683592|378188|P1|Overall Study|Lack of Efficacy|3
110526|NCT00683592|378187|P2|Overall Study|Lost to Follow-up|17
110527|NCT00683592|378188|P1|Overall Study|Lost to Follow-up|17
110528|NCT00683592|378187|P2|Overall Study|Withdrawal by Subject|11
110529|NCT00683592|378188|P1|Overall Study|Withdrawal by Subject|11
110530|NCT00683592|378187|P2|Overall Study|Adverse Event|4
110531|NCT00683592|378188|P1|Overall Study|Adverse Event|12
110532|NCT00683475|378206|P2|Overall Study|Never Treated: Progressive Disease|0
110533|NCT00683475|378207|P1|Overall Study|Never Treated: Progressive Disease|1
110534|NCT00683475|378206|P2|Overall Study|Never Treated: Adverse Event|3
110535|NCT00683475|378207|P1|Overall Study|Never Treated: Adverse Event|2
110536|NCT00683475|378206|P2|Overall Study|Withdrawal by Subject|0
110537|NCT00683475|378207|P1|Overall Study|Withdrawal by Subject|1
110538|NCT00683449|378242|P5|Overall Study|Lost to Follow-up|0
110539|NCT00683449|378243|P4|Overall Study|Lost to Follow-up|0
110540|NCT00683449|378244|P3|Overall Study|Lost to Follow-up|0
110541|NCT00683449|378245|P2|Overall Study|Lost to Follow-up|1
110542|NCT00683449|378246|P1|Overall Study|Lost to Follow-up|0
110543|NCT00683384|378272|P1|Overall Study|Adverse Event|1
110544|NCT00683384|378272|P1|Overall Study|Death|1
110545|NCT00683293|378282|P2|Overall Study|Withdrawal by Subject|3
110546|NCT00683293|378283|P1|Overall Study|Withdrawal by Subject|2
110547|NCT00682890|378345|P2|Overall Study|heavy menstrual bleeding|0
110548|NCT00682890|378346|P1|Overall Study|heavy menstrual bleeding|1
110549|NCT00682890|378345|P2|Overall Study|subject moved away|1
110550|NCT00682890|378346|P1|Overall Study|subject moved away|0
110551|NCT00682890|378345|P2|Overall Study|Lost to Follow-up|1
110552|NCT00682890|378346|P1|Overall Study|Lost to Follow-up|1
110553|NCT00682786|378388|P2|Overall Study|Did not receive irinotecan|1
110554|NCT00682786|378389|P1|Overall Study|Did not receive irinotecan|0
110555|NCT00682786|378388|P2|Overall Study|Withdrawal by Subject|2
110556|NCT00682786|378389|P1|Overall Study|Withdrawal by Subject|2
110557|NCT00682643|378434|P2|Overall Study|Did Not Receive Study Drug|1
110558|NCT00682643|378435|P1|Overall Study|Did Not Receive Study Drug|1
110559|NCT00682643|378434|P2|Overall Study|Withdrawal by Subject|53
110560|NCT00682643|378435|P1|Overall Study|Withdrawal by Subject|19
110561|NCT00682643|378434|P2|Overall Study|Physician Decision|6
110562|NCT00682643|378435|P1|Overall Study|Physician Decision|2
110563|NCT00682643|378434|P2|Overall Study|Lost to Follow-up|6
110564|NCT00682643|378435|P1|Overall Study|Lost to Follow-up|1
110565|NCT00682643|378434|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
110566|NCT00682643|378435|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
110567|NCT00682643|378434|P2|Overall Study|Protocol Violation|76
110568|NCT00682643|378435|P1|Overall Study|Protocol Violation|38
110569|NCT00682643|378434|P2|Overall Study|Lack of Efficacy|0
110570|NCT00682643|378435|P1|Overall Study|Lack of Efficacy|2
110571|NCT00682643|378434|P2|Overall Study|Adverse Event|23
110572|NCT00682643|378435|P1|Overall Study|Adverse Event|12
110573|NCT00682539|378496|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
110574|NCT00682539|378497|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
110575|NCT00682539|378498|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
110576|NCT00682539|378496|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
110577|NCT00682539|378497|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
110578|NCT00682539|378498|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
110579|NCT00682461|378511|P2|Overall Study|Withdrawal by Subject|19
110580|NCT00682461|378512|P1|Overall Study|Withdrawal by Subject|12
110581|NCT00682461|378511|P2|Overall Study|Lost to Follow-up|5
110582|NCT00682461|378512|P1|Overall Study|Lost to Follow-up|8
110583|NCT00682461|378511|P2|Overall Study|Adverse Event|7
110584|NCT00682461|378512|P1|Overall Study|Adverse Event|5
110585|NCT00681863|378552|P1|Overall Study|not specified|18
110586|NCT00681863|378552|P1|Overall Study|Lack of Efficacy|2
110587|NCT00681863|378552|P1|Overall Study|Lost to Follow-up|2
110588|NCT00681863|378552|P1|Overall Study|Adverse Event|1
110589|NCT00681824|378600|P3|Overall Study|Death|0
110590|NCT00681824|378601|P2|Overall Study|Death|1
110591|NCT00681824|378602|P1|Overall Study|Death|0
110592|NCT00681824|378600|P3|Overall Study|scheduling conflict|0
110593|NCT00681824|378601|P2|Overall Study|scheduling conflict|0
110594|NCT00681824|378602|P1|Overall Study|scheduling conflict|1
110595|NCT00681824|378600|P3|Overall Study|withdrawn by investigator|1
110596|NCT00681824|378601|P2|Overall Study|withdrawn by investigator|0
110597|NCT00681824|378602|P1|Overall Study|withdrawn by investigator|0
110598|NCT00681811|378620|P2|Overall Study|Non-compliance|1
110599|NCT00681811|378621|P1|Overall Study|Non-compliance|0
110600|NCT00681811|378620|P2|Overall Study|Withdrawal by Subject|2
110601|NCT00681811|378621|P1|Overall Study|Withdrawal by Subject|2
110602|NCT00681811|378620|P2|Overall Study|Adverse Event|1
110603|NCT00681811|378621|P1|Overall Study|Adverse Event|1
110604|NCT00681668|378649|P1|Overall Study|Withdrawal by Subject|1
110605|NCT00681668|378649|P1|Overall Study|Protocol Violation|1
110606|NCT00681629|378658|P2|Overall Study|Adverse Event|0
110607|NCT00681629|378659|P1|Overall Study|Adverse Event|1
110608|NCT00681629|378658|P2|Overall Study|Study termination|2
110609|NCT00681629|378659|P1|Overall Study|Study termination|4
110610|NCT00681590|378705|P2|Overall Study|Withdrawal by Subject|12
110611|NCT00681590|378706|P1|Overall Study|Withdrawal by Subject|2
110612|NCT00681564|378716|P2|Overall Study|Death|1
110613|NCT00681564|378717|P1|Overall Study|Death|0
110614|NCT00681564|378716|P2|Overall Study|Withdrawal by Subject|1
110615|NCT00681564|378717|P1|Overall Study|Withdrawal by Subject|0
110616|NCT00681564|378716|P2|Overall Study|Lost to Follow-up|6
110617|NCT00681564|378717|P1|Overall Study|Lost to Follow-up|6
110618|NCT00681187|378809|P2|Overall Study|Adverse Event|1
110619|NCT00681187|378810|P1|Overall Study|Adverse Event|0
110620|NCT00681187|378809|P2|Overall Study|Death|1
110621|NCT00681187|378810|P1|Overall Study|Death|0
110622|NCT00681187|378809|P2|Overall Study|Withdrawal by Subject|0
110623|NCT00681187|378810|P1|Overall Study|Withdrawal by Subject|1
110624|NCT00681109|378845|P3|Overall Study|Lost to Follow-up|0
110625|NCT00681109|378846|P2|Overall Study|Lost to Follow-up|6
110626|NCT00681109|378847|P1|Overall Study|Lost to Follow-up|2
110627|NCT00680914|378876|P2|Overall Study|serious adverse event (SAE)|1
110628|NCT00680914|378877|P1|Overall Study|serious adverse event (SAE)|0
110629|NCT00680914|378876|P2|Overall Study|Lost to Follow-up|0
110630|NCT00680914|378877|P1|Overall Study|Lost to Follow-up|4
110631|NCT00680914|378876|P2|Overall Study|Consent withdrawal|3
110632|NCT00680914|378877|P1|Overall Study|Consent withdrawal|6
110633|NCT00680901|378911|P2|Overall Study|Ongoing: In Follow Up|41
110634|NCT00680901|378912|P1|Overall Study|Ongoing: In Follow Up|45
110635|NCT00680901|378911|P2|Overall Study|Ongoing: On Study Treatment|13
110636|NCT00680901|378912|P1|Overall Study|Ongoing: On Study Treatment|16
110637|NCT00680901|378911|P2|Overall Study|Physician Decision|1
110638|NCT00680901|378912|P1|Overall Study|Physician Decision|0
110639|NCT00680901|378911|P2|Overall Study|Withdrawal by Subject|13
110640|NCT00680901|378912|P1|Overall Study|Withdrawal by Subject|4
110641|NCT00680901|378911|P2|Overall Study|Lost to Follow-up|8
110642|NCT00680901|378912|P1|Overall Study|Lost to Follow-up|8
110643|NCT00680836|378950|P2|Overall Study|Physician Decision|1
110644|NCT00680836|378951|P1|Overall Study|Physician Decision|2
110645|NCT00680836|378950|P2|Overall Study|Lost to Follow-up|1
110646|NCT00680836|378951|P1|Overall Study|Lost to Follow-up|3
110647|NCT00680836|378950|P2|Overall Study|Withdrawal by Subject|0
110648|NCT00680836|378951|P1|Overall Study|Withdrawal by Subject|3
110649|NCT00680771|378986|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
110650|NCT00680771|378987|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
110651|NCT00680771|378986|P2|Overall Study|Sleep Apnea suspected after PSG|0
110652|NCT00680771|378987|P1|Overall Study|Sleep Apnea suspected after PSG|1
110653|NCT00680771|378986|P2|Overall Study|Withdrawal by Subject|0
110654|NCT00680771|378987|P1|Overall Study|Withdrawal by Subject|1
110655|NCT00680745|378997|P4|Overall Study|False Treatment|0
110656|NCT00680745|378998|P3|Overall Study|False Treatment|3
110657|NCT00680745|378999|P2|Overall Study|False Treatment|1
110658|NCT00680745|379000|P1|Overall Study|False Treatment|0
110659|NCT00680745|378997|P4|Overall Study|Subject No Longer Meets Study Criteria|2
110660|NCT00680745|378998|P3|Overall Study|Subject No Longer Meets Study Criteria|0
110661|NCT00680745|378999|P2|Overall Study|Subject No Longer Meets Study Criteria|2
110662|NCT00680745|379000|P1|Overall Study|Subject No Longer Meets Study Criteria|0
110663|NCT00680745|378997|P4|Overall Study|Poor/Non-compliance|0
110664|NCT00680745|378998|P3|Overall Study|Poor/Non-compliance|0
110665|NCT00680745|378999|P2|Overall Study|Poor/Non-compliance|3
110666|NCT00680745|379000|P1|Overall Study|Poor/Non-compliance|0
110667|NCT00680745|378997|P4|Overall Study|Adverse Event|3
110668|NCT00680745|378998|P3|Overall Study|Adverse Event|3
110669|NCT00680745|378999|P2|Overall Study|Adverse Event|3
110670|NCT00680745|379000|P1|Overall Study|Adverse Event|5
110671|NCT00680745|378997|P4|Overall Study|Death|0
110672|NCT00680745|378998|P3|Overall Study|Death|1
110673|NCT00680745|378999|P2|Overall Study|Death|0
110674|NCT00680745|379000|P1|Overall Study|Death|1
110675|NCT00680745|378997|P4|Overall Study|Lost to Follow-up|0
110676|NCT00680745|378998|P3|Overall Study|Lost to Follow-up|1
110677|NCT00680745|378999|P2|Overall Study|Lost to Follow-up|1
110678|NCT00680745|379000|P1|Overall Study|Lost to Follow-up|0
110679|NCT00680745|378997|P4|Overall Study|Withdrawal by Subject|8
110680|NCT00680745|378998|P3|Overall Study|Withdrawal by Subject|2
110681|NCT00680745|378999|P2|Overall Study|Withdrawal by Subject|3
110682|NCT00680745|379000|P1|Overall Study|Withdrawal by Subject|8
110683|NCT00680407|379074|P3|Overall Study|Withdrawal by Subject|2
110684|NCT00680407|379075|P2|Overall Study|Withdrawal by Subject|2
110685|NCT00680407|379076|P1|Overall Study|Withdrawal by Subject|5
110686|NCT00680407|379074|P3|Overall Study|Lost to Follow-up|1
110687|NCT00680407|379075|P2|Overall Study|Lost to Follow-up|3
110688|NCT00680407|379076|P1|Overall Study|Lost to Follow-up|3
110689|NCT00680368|379090|P1|Overall Study|not supervised, not eligible|15
110690|NCT00680186|379113|P2|Overall Study|Other|1
110691|NCT00680186|379114|P1|Overall Study|Other|4
110692|NCT00680186|379113|P2|Overall Study|Withdrawal by Subject|39
110693|NCT00680186|379114|P1|Overall Study|Withdrawal by Subject|32
110694|NCT00680186|379113|P2|Overall Study|Lost to Follow-up|6
110695|NCT00680186|379114|P1|Overall Study|Lost to Follow-up|11
110696|NCT00680186|379113|P2|Overall Study|Protocol Violation|26
110697|NCT00680186|379114|P1|Overall Study|Protocol Violation|31
110698|NCT00680186|379113|P2|Overall Study|Adverse Event|44
110699|NCT00680186|379114|P1|Overall Study|Adverse Event|47
110700|NCT00680121|379140|P2|Overall Study|Lost to Follow-up|23
110701|NCT00680121|379141|P1|Overall Study|Lost to Follow-up|27
110702|NCT00680056|379155|P2|Second Intervention|Protocol Violation|1
110703|NCT00680056|379156|P1|Second Intervention|Protocol Violation|3
110704|NCT00680056|379155|P2|First Intervention|Mainly Exacerbation of COPD|2
110705|NCT00680056|379156|P1|First Intervention|Mainly Exacerbation of COPD|1
110706|NCT00680043|379167|P3|Overall Study|Renal Transplant|4
110707|NCT00680043|379168|P2|Overall Study|Renal Transplant|0
110708|NCT00680043|379169|P1|Overall Study|Renal Transplant|1
110709|NCT00680043|379167|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
110710|NCT00680043|379168|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
110711|NCT00680043|379169|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
110712|NCT00680043|379167|P3|Overall Study|Withdrawal by Subject|0
110713|NCT00680043|379168|P2|Overall Study|Withdrawal by Subject|0
110714|NCT00680043|379169|P1|Overall Study|Withdrawal by Subject|1
110715|NCT00680017|379185|P2|Overall Study|Lost to Follow-up|0
110716|NCT00680017|379186|P1|Overall Study|Lost to Follow-up|2
110717|NCT00680017|379185|P2|Overall Study|Withdrawal by Subject|5
110718|NCT00680017|379186|P1|Overall Study|Withdrawal by Subject|2
110719|NCT00680017|379185|P2|Overall Study|Adverse Event|7
110720|NCT00680017|379186|P1|Overall Study|Adverse Event|13
110721|NCT00679939|379205|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
110722|NCT00679939|379206|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
110723|NCT00679939|379205|P2|24-Week Open-Label (OL) Period|Physician Decision|0
110724|NCT00679939|379206|P1|24-Week Open-Label (OL) Period|Physician Decision|1
110725|NCT00679939|379205|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
110726|NCT00679939|379206|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
110727|NCT00679939|379205|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
110728|NCT00679939|379206|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
110729|NCT00679939|379205|P2|24-Week Open-Label (OL) Period|Adverse Event|1
110730|NCT00679939|379206|P1|24-Week Open-Label (OL) Period|Adverse Event|0
110731|NCT00679939|379205|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
110732|NCT00679939|379206|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
110733|NCT00679939|379205|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
110734|NCT00679939|379206|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
110735|NCT00679939|379205|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
110736|NCT00679939|379206|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
110737|NCT00679939|379205|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
110738|NCT00679939|379206|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
110739|NCT00679939|379205|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
110740|NCT00679939|379206|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
110741|NCT00679913|379357|P2|Overall Study|Protocol Violation|13
110742|NCT00679913|379358|P1|Overall Study|Protocol Violation|18
110743|NCT00679783|379373|P7|Overall Study|Ongoing at data cut-off|0
110744|NCT00679783|379374|P6|Overall Study|Ongoing at data cut-off|0
110745|NCT00679783|379375|P5|Overall Study|Ongoing at data cut-off|1
110746|NCT00679783|379376|P4|Overall Study|Ongoing at data cut-off|9
110747|NCT00679783|379377|P3|Overall Study|Ongoing at data cut-off|0
110748|NCT00679783|379378|P2|Overall Study|Ongoing at data cut-off|2
110749|NCT00679783|379379|P1|Overall Study|Ongoing at data cut-off|2
110750|NCT00679783|379373|P7|Overall Study|Not Captured|0
110751|NCT00679783|379374|P6|Overall Study|Not Captured|0
110752|NCT00679783|379375|P5|Overall Study|Not Captured|0
110753|NCT00679783|379376|P4|Overall Study|Not Captured|5
110754|NCT00679783|379377|P3|Overall Study|Not Captured|0
110755|NCT00679783|379378|P2|Overall Study|Not Captured|0
110756|NCT00679783|379379|P1|Overall Study|Not Captured|0
110757|NCT00679783|379373|P7|Overall Study|Withdrawal by Subject|0
110758|NCT00679783|379374|P6|Overall Study|Withdrawal by Subject|0
110759|NCT00679783|379375|P5|Overall Study|Withdrawal by Subject|0
110760|NCT00679783|379376|P4|Overall Study|Withdrawal by Subject|1
110761|NCT00679783|379377|P3|Overall Study|Withdrawal by Subject|1
110762|NCT00679783|379378|P2|Overall Study|Withdrawal by Subject|0
110763|NCT00679783|379379|P1|Overall Study|Withdrawal by Subject|0
110764|NCT00679783|379373|P7|Overall Study|Lack of Efficacy|0
110765|NCT00679783|379374|P6|Overall Study|Lack of Efficacy|0
110766|NCT00679783|379375|P5|Overall Study|Lack of Efficacy|0
110767|NCT00679783|379376|P4|Overall Study|Lack of Efficacy|2
110768|NCT00679783|379377|P3|Overall Study|Lack of Efficacy|0
110769|NCT00679783|379378|P2|Overall Study|Lack of Efficacy|1
110770|NCT00679783|379379|P1|Overall Study|Lack of Efficacy|0
110771|NCT00679783|379373|P7|Overall Study|Adverse Event|1
110772|NCT00679783|379374|P6|Overall Study|Adverse Event|0
110773|NCT00679783|379375|P5|Overall Study|Adverse Event|0
110774|NCT00679783|379376|P4|Overall Study|Adverse Event|3
110775|NCT00679783|379377|P3|Overall Study|Adverse Event|0
110776|NCT00679783|379378|P2|Overall Study|Adverse Event|0
110777|NCT00679783|379379|P1|Overall Study|Adverse Event|0
110778|NCT00679627|379432|P2|Overall Study|Early Study Closure|405
110779|NCT00679627|379433|P1|Overall Study|Early Study Closure|425
110780|NCT00679627|379432|P2|Overall Study|Lost to Follow-up|26
110781|NCT00679627|379433|P1|Overall Study|Lost to Follow-up|22
110782|NCT00679627|379432|P2|Overall Study|Withdrawal by Subject|172
110783|NCT00679627|379433|P1|Overall Study|Withdrawal by Subject|168
110784|NCT00679627|379432|P2|Overall Study|Adverse Event|53
110785|NCT00679627|379433|P1|Overall Study|Adverse Event|43
110786|NCT00679627|379432|P2|Overall Study|Death|29
110787|NCT00679627|379433|P1|Overall Study|Death|41
110788|NCT00679432|379459|P4|Overall Study|Randomization error, return to prior Rx|0
110789|NCT00679432|379460|P3|Overall Study|Randomization error, return to prior Rx|3
110790|NCT00679432|379461|P2|Overall Study|Randomization error, return to prior Rx|0
110791|NCT00679432|379462|P1|Overall Study|Randomization error, return to prior Rx|0
110792|NCT00679432|379459|P4|Overall Study|Infectious colitis, normal histology|3
110793|NCT00679432|379460|P3|Overall Study|Infectious colitis, normal histology|8
110794|NCT00679432|379461|P2|Overall Study|Infectious colitis, normal histology|4
110795|NCT00679432|379462|P1|Overall Study|Infectious colitis, normal histology|5
110796|NCT00679432|379459|P4|Overall Study|Lack of Efficacy|8
110797|NCT00679432|379460|P3|Overall Study|Lack of Efficacy|14
110798|NCT00679432|379461|P2|Overall Study|Lack of Efficacy|9
110799|NCT00679432|379462|P1|Overall Study|Lack of Efficacy|13
110800|NCT00679432|379459|P4|Overall Study|Sponsor decision|0
110801|NCT00679432|379460|P3|Overall Study|Sponsor decision|0
110802|NCT00679432|379461|P2|Overall Study|Sponsor decision|0
110803|NCT00679432|379462|P1|Overall Study|Sponsor decision|1
110804|NCT00679432|379459|P4|Overall Study|Physician Decision|2
110805|NCT00679432|379460|P3|Overall Study|Physician Decision|2
110806|NCT00679432|379461|P2|Overall Study|Physician Decision|2
110807|NCT00679432|379462|P1|Overall Study|Physician Decision|3
110808|NCT00679432|379459|P4|Overall Study|Lost to Follow-up|2
110809|NCT00679432|379460|P3|Overall Study|Lost to Follow-up|4
110810|NCT00679432|379461|P2|Overall Study|Lost to Follow-up|5
110811|NCT00679432|379462|P1|Overall Study|Lost to Follow-up|1
110812|NCT00679432|379459|P4|Overall Study|Withdrawal by Subject|9
110813|NCT00679432|379460|P3|Overall Study|Withdrawal by Subject|10
110814|NCT00679432|379461|P2|Overall Study|Withdrawal by Subject|11
110815|NCT00679432|379462|P1|Overall Study|Withdrawal by Subject|8
110816|NCT00679432|379459|P4|Overall Study|Protocol Violation|1
110817|NCT00679432|379460|P3|Overall Study|Protocol Violation|2
110818|NCT00679432|379461|P2|Overall Study|Protocol Violation|1
110819|NCT00679432|379462|P1|Overall Study|Protocol Violation|1
110820|NCT00679432|379459|P4|Overall Study|Adverse Event|7
110821|NCT00679432|379460|P3|Overall Study|Adverse Event|10
110822|NCT00679432|379461|P2|Overall Study|Adverse Event|6
110823|NCT00679432|379462|P1|Overall Study|Adverse Event|5
110824|NCT00679354|379505|P1|Overall Study|Ineligible|1
110825|NCT00679354|379505|P1|Overall Study|Physician Decision|4
110826|NCT00679354|379505|P1|Overall Study|Lack of Efficacy|22
110827|NCT00679354|379505|P1|Overall Study|Death|3
110828|NCT00679341|379511|P2|Overall Study|Physician/patient decision to withdraw|6
110829|NCT00679341|379512|P1|Overall Study|Physician/patient decision to withdraw|0
110830|NCT00679341|379511|P2|Overall Study|Not treated|2
110831|NCT00679341|379512|P1|Overall Study|Not treated|0
110832|NCT00679341|379511|P2|Overall Study|Physician Decision|0
110833|NCT00679341|379512|P1|Overall Study|Physician Decision|1
110834|NCT00679341|379511|P2|Overall Study|Not specified|0
110835|NCT00679341|379512|P1|Overall Study|Not specified|1
110836|NCT00679341|379511|P2|Overall Study|Death|1
110837|NCT00679341|379512|P1|Overall Study|Death|1
110838|NCT00679341|379511|P2|Overall Study|Subject/guardian decision to discontinue|0
110839|NCT00679341|379512|P1|Overall Study|Subject/guardian decision to discontinue|3
110840|NCT00679341|379511|P2|Overall Study|Adverse Event|6
110841|NCT00679341|379512|P1|Overall Study|Adverse Event|5
110842|NCT00679341|379511|P2|Overall Study|Disease progression|36
110843|NCT00679341|379512|P1|Overall Study|Disease progression|42
110844|NCT00679302|379532|P2|Overall Study|Lost to Follow-up|4
110845|NCT00679302|379533|P1|Overall Study|Lost to Follow-up|8
110846|NCT00679263|379544|P3|Visit 2/Dose 1|subject not compliance|0
110847|NCT00679263|379545|P2|Visit 2/Dose 1|subject not compliance|1
110848|NCT00679263|379546|P1|Visit 2/Dose 1|subject not compliance|1
110849|NCT00679263|379544|P3|Visit 2/Dose 1|Adverse Event|0
110850|NCT00679263|379545|P2|Visit 2/Dose 1|Adverse Event|0
110851|NCT00679263|379546|P1|Visit 2/Dose 1|Adverse Event|1
110852|NCT00679211|379557|P1|Overall Study|Other|1
110853|NCT00679211|379557|P1|Overall Study|Transferred to extension study TDM4529g|12
110854|NCT00679211|379557|P1|Overall Study|Refused to undergo protocol procedures|1
110855|NCT00679211|379557|P1|Overall Study|Physician Decision|5
110856|NCT00679211|379557|P1|Overall Study|Withdrawal by Subject|2
110857|NCT00679211|379557|P1|Overall Study|Adverse Event|7
110858|NCT00679211|379557|P1|Overall Study|Progressive disease|82
110859|NCT00679081|379569|P1|Overall Study|Lost to Follow-up|1
110860|NCT00679055|379579|P2|Overall Study|Study Terminated|1
110861|NCT00679055|379580|P1|Overall Study|Study Terminated|2
110862|NCT00679055|379579|P2|Overall Study|Other|3
110863|NCT00679055|379580|P1|Overall Study|Other|0
110864|NCT00679055|379579|P2|Overall Study|Adverse Event|1
110865|NCT00679055|379580|P1|Overall Study|Adverse Event|0
110866|NCT00678899|379590|P1|Overall Study|Adverse Event|1
110867|NCT00678795|379622|P2|Overall Study|Lack of Efficacy|1
110868|NCT00678795|379623|P1|Overall Study|Lack of Efficacy|1
110869|NCT00678795|379622|P2|Overall Study|Lost to Follow-up|1
110870|NCT00678795|379623|P1|Overall Study|Lost to Follow-up|0
110871|NCT00678795|379622|P2|Overall Study|Protocol Violation|1
110872|NCT00678795|379623|P1|Overall Study|Protocol Violation|0
110873|NCT00678795|379622|P2|Overall Study|Withdrawal by Subject|0
110874|NCT00678795|379623|P1|Overall Study|Withdrawal by Subject|3
110875|NCT00678795|379622|P2|Overall Study|Adverse Event|3
110876|NCT00678795|379623|P1|Overall Study|Adverse Event|7
110877|NCT00678691|379645|P2|Overall Study|Adverse Event|4
110878|NCT00678691|379646|P1|Overall Study|Adverse Event|6
110879|NCT00678639|379654|P2|Overall Study|Lost to Follow-up at 30 days|0
110880|NCT00678639|379655|P1|Overall Study|Lost to Follow-up at 30 days|2
110881|NCT00678587|379670|P2|Overall Study|Withdrew Consent|3
110882|NCT00678587|379671|P1|Overall Study|Withdrew Consent|8
110883|NCT00678587|379670|P2|Overall Study|Investigator Discretion|6
110884|NCT00678587|379671|P1|Overall Study|Investigator Discretion|2
110885|NCT00678587|379670|P2|Overall Study|Lost to Follow-up|5
110886|NCT00678587|379671|P1|Overall Study|Lost to Follow-up|3
110887|NCT00678587|379670|P2|Overall Study|Study Closed/Terminated|0
110888|NCT00678587|379671|P1|Overall Study|Study Closed/Terminated|1
110889|NCT00678587|379670|P2|Overall Study|Protocol Violation|1
110890|NCT00678587|379671|P1|Overall Study|Protocol Violation|2
110891|NCT00678587|379670|P2|Overall Study|Lack of Efficacy|0
110892|NCT00678587|379671|P1|Overall Study|Lack of Efficacy|1
110893|NCT00678587|379670|P2|Overall Study|Adverse Event|3
110894|NCT00678587|379671|P1|Overall Study|Adverse Event|3
110895|NCT00678392|379745|P2|Overall Study|Ongoing|236
110896|NCT00678392|379746|P1|Overall Study|Ongoing|242
110897|NCT00678392|379745|P2|Overall Study|Randomized but not treated|7
110898|NCT00678392|379746|P1|Overall Study|Randomized but not treated|2
110899|NCT00678392|379745|P2|Overall Study|Unspecified|3
110900|NCT00678392|379746|P1|Overall Study|Unspecified|2
110901|NCT00678392|379745|P2|Overall Study|Global deterioration of health status|0
110902|NCT00678392|379746|P1|Overall Study|Global deterioration of health status|1
110903|NCT00678392|379745|P2|Overall Study|Objective progression or relapse|6
110904|NCT00678392|379746|P1|Overall Study|Objective progression or relapse|3
110905|NCT00678392|379745|P2|Overall Study|Lost to Follow-up|4
110906|NCT00678392|379746|P1|Overall Study|Lost to Follow-up|3
110907|NCT00678392|379745|P2|Overall Study|Protocol Violation|0
110908|NCT00678392|379746|P1|Overall Study|Protocol Violation|2
110909|NCT00678392|379745|P2|Overall Study|Withdrawal by Subject|4
110910|NCT00678392|379746|P1|Overall Study|Withdrawal by Subject|2
110911|NCT00678392|379745|P2|Overall Study|Death|102
110912|NCT00678392|379746|P1|Overall Study|Death|103
110913|NCT00678392|379745|P2|Overall Study|Adverse Event|0
110914|NCT00678392|379746|P1|Overall Study|Adverse Event|1
110915|NCT00678288|379754|P2|Overall Study|Disease progression/recurrence/relapse|1
110916|NCT00678288|379755|P1|Overall Study|Disease progression/recurrence/relapse|6
110917|NCT00678288|379754|P2|Overall Study|Reason not reported|0
110918|NCT00678288|379755|P1|Overall Study|Reason not reported|1
110919|NCT00678288|379754|P2|Overall Study|Switch to commercial drug|1
110920|NCT00678288|379755|P1|Overall Study|Switch to commercial drug|0
110921|NCT00678288|379754|P2|Overall Study|Not compliant with study medication|1
110922|NCT00678288|379755|P1|Overall Study|Not compliant with study medication|0
110923|NCT00678288|379754|P2|Overall Study|Study terminated by the sponsor|0
110924|NCT00678288|379755|P1|Overall Study|Study terminated by the sponsor|2
110925|NCT00678288|379754|P2|Overall Study|Withdrawal by Subject|1
110926|NCT00678288|379755|P1|Overall Study|Withdrawal by Subject|1
110927|NCT00678288|379754|P2|Overall Study|Adverse Event|2
110928|NCT00678288|379755|P1|Overall Study|Adverse Event|0
110929|NCT00678210|379810|P4|Overall Study|Unspecified|0
110930|NCT00678210|379811|P3|Overall Study|Unspecified|1
110931|NCT00678210|379812|P2|Overall Study|Unspecified|0
110932|NCT00678210|379813|P1|Overall Study|Unspecified|1
110933|NCT00678210|379810|P4|Overall Study|Withdrawal by Subject|7
110934|NCT00678210|379811|P3|Overall Study|Withdrawal by Subject|1
110935|NCT00678210|379812|P2|Overall Study|Withdrawal by Subject|4
110936|NCT00678210|379813|P1|Overall Study|Withdrawal by Subject|3
110937|NCT00678210|379810|P4|Overall Study|Lost to Follow-up|1
110938|NCT00678210|379811|P3|Overall Study|Lost to Follow-up|0
110939|NCT00678210|379812|P2|Overall Study|Lost to Follow-up|2
110940|NCT00678210|379813|P1|Overall Study|Lost to Follow-up|4
110941|NCT00678210|379810|P4|Overall Study|Lack of Efficacy|9
110942|NCT00678210|379811|P3|Overall Study|Lack of Efficacy|1
110943|NCT00678210|379812|P2|Overall Study|Lack of Efficacy|3
110944|NCT00678210|379813|P1|Overall Study|Lack of Efficacy|2
110945|NCT00678210|379810|P4|Overall Study|Adverse Event|3
110946|NCT00678210|379811|P3|Overall Study|Adverse Event|3
110947|NCT00678210|379812|P2|Overall Study|Adverse Event|2
110948|NCT00678210|379813|P1|Overall Study|Adverse Event|1
110949|NCT00678041|379849|P2|Overall Study|Physician Decision|5
110950|NCT00678041|379850|P1|Overall Study|Physician Decision|5
110951|NCT00677833|379903|P4|Overall Study|Lost to Follow-up|0
110952|NCT00677833|379904|P3|Overall Study|Lost to Follow-up|1
110953|NCT00677833|379905|P2|Overall Study|Lost to Follow-up|0
110954|NCT00677833|379906|P1|Overall Study|Lost to Follow-up|0
110955|NCT00677833|379903|P4|Overall Study|Withdrawal by Subject|3
110956|NCT00677833|379904|P3|Overall Study|Withdrawal by Subject|1
110957|NCT00677833|379905|P2|Overall Study|Withdrawal by Subject|0
110958|NCT00677833|379906|P1|Overall Study|Withdrawal by Subject|4
110959|NCT00677820|379956|P2|Overall Study|Lost to Follow-up|0
110960|NCT00677820|379957|P1|Overall Study|Lost to Follow-up|1
110961|NCT00677807|379978|P3|Overall Study|Protocol Deviation|0
110962|NCT00677807|379979|P2|Overall Study|Protocol Deviation|3
110963|NCT00677807|379980|P1|Overall Study|Protocol Deviation|1
110964|NCT00677807|379978|P3|Overall Study|Death|1
110965|NCT00677807|379979|P2|Overall Study|Death|1
110966|NCT00677807|379980|P1|Overall Study|Death|0
110967|NCT00677807|379978|P3|Overall Study|Administrative problems|2
110968|NCT00677807|379979|P2|Overall Study|Administrative problems|1
110969|NCT00677807|379980|P1|Overall Study|Administrative problems|1
110970|NCT00677807|379978|P3|Overall Study|Lost to Follow-up|2
110971|NCT00677807|379979|P2|Overall Study|Lost to Follow-up|2
110972|NCT00677807|379980|P1|Overall Study|Lost to Follow-up|2
110973|NCT00677807|379978|P3|Overall Study|Withdrawal by Subject|6
110974|NCT00677807|379979|P2|Overall Study|Withdrawal by Subject|3
110975|NCT00677807|379980|P1|Overall Study|Withdrawal by Subject|10
110976|NCT00677807|379978|P3|Overall Study|Participant no longer needs study drug|1
110977|NCT00677807|379979|P2|Overall Study|Participant no longer needs study drug|0
110978|NCT00677807|379980|P1|Overall Study|Participant no longer needs study drug|0
110979|NCT00677807|379978|P3|Overall Study|Lack of Efficacy|2
110980|NCT00677807|379979|P2|Overall Study|Lack of Efficacy|0
110981|NCT00677807|379980|P1|Overall Study|Lack of Efficacy|0
110982|NCT00677807|379978|P3|Overall Study|Adverse Event|6
110983|NCT00677807|379979|P2|Overall Study|Adverse Event|1
110984|NCT00677807|379980|P1|Overall Study|Adverse Event|4
110985|NCT00677534|380026|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
110986|NCT00677534|380026|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
110987|NCT00677534|380026|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
110988|NCT00677365|380034|P4|Overall Study|Other reason|1
110989|NCT00677365|380035|P3|Overall Study|Other reason|0
110990|NCT00677365|380036|P2|Overall Study|Other reason|0
110991|NCT00677365|380037|P1|Overall Study|Other reason|0
110992|NCT00677365|380034|P4|Overall Study|Withdrawal by Subject|0
110993|NCT00677365|380035|P3|Overall Study|Withdrawal by Subject|1
110994|NCT00677365|380036|P2|Overall Study|Withdrawal by Subject|0
110995|NCT00677365|380037|P1|Overall Study|Withdrawal by Subject|0
110996|NCT00677365|380034|P4|Overall Study|Adverse Event|2
110997|NCT00677365|380035|P3|Overall Study|Adverse Event|1
110998|NCT00677365|380036|P2|Overall Study|Adverse Event|1
110999|NCT00677365|380037|P1|Overall Study|Adverse Event|2
111000|NCT00677352|380069|P2|Tapering Phase|Job transfer|1
111001|NCT00677352|380070|P1|Tapering Phase|Job transfer|0
111002|NCT00677352|380069|P2|Tapering Phase|Pregnancy|1
111003|NCT00677352|380070|P1|Tapering Phase|Pregnancy|0
111004|NCT00677352|380069|P2|Tapering Phase|Withdrawal by Subject|3
111005|NCT00677352|380070|P1|Tapering Phase|Withdrawal by Subject|5
111006|NCT00677352|380069|P2|Tapering Phase|Adverse Event|5
111007|NCT00677352|380070|P1|Tapering Phase|Adverse Event|1
111008|NCT00677352|380069|P2|Treatment Phase|Not treated|2
111009|NCT00677352|380070|P1|Treatment Phase|Not treated|0
111010|NCT00677352|380069|P2|Treatment Phase|Transference or work related matter|5
111011|NCT00677352|380070|P1|Treatment Phase|Transference or work related matter|0
111012|NCT00677352|380069|P2|Treatment Phase|Protocol Violation|1
111013|NCT00677352|380070|P1|Treatment Phase|Protocol Violation|1
111014|NCT00677352|380069|P2|Treatment Phase|Pregnancy|1
111015|NCT00677352|380070|P1|Treatment Phase|Pregnancy|0
111016|NCT00677352|380069|P2|Treatment Phase|Physician Decision|0
111017|NCT00677352|380070|P1|Treatment Phase|Physician Decision|1
111018|NCT00677352|380069|P2|Treatment Phase|Withdrawal by Subject|7
111019|NCT00677352|380070|P1|Treatment Phase|Withdrawal by Subject|7
111020|NCT00677352|380069|P2|Treatment Phase|Lost to Follow-up|1
111021|NCT00677352|380070|P1|Treatment Phase|Lost to Follow-up|0
111022|NCT00677352|380069|P2|Treatment Phase|Lack of Efficacy|3
111023|NCT00677352|380070|P1|Treatment Phase|Lack of Efficacy|2
111024|NCT00677352|380069|P2|Treatment Phase|Adverse Event|22
111025|NCT00677352|380070|P1|Treatment Phase|Adverse Event|14
111026|NCT00677235|380090|P2|Overall Study|Adverse Experience|0
111027|NCT00677235|380091|P1|Overall Study|Adverse Experience|1
111028|NCT00677235|380090|P2|Overall Study|Death|36
111029|NCT00677235|380091|P1|Overall Study|Death|37
111030|NCT00677235|380090|P2|Overall Study|Lost to Follow-up|1
111031|NCT00677235|380091|P1|Overall Study|Lost to Follow-up|2
111032|NCT00677235|380090|P2|Overall Study|Withdrawal by Subject|1
111033|NCT00677235|380091|P1|Overall Study|Withdrawal by Subject|1
111034|NCT00677014|380134|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
111035|NCT00677014|380135|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
111036|NCT00677014|380136|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
111037|NCT00677014|380134|P3|Overall Study|Death|7
111038|NCT00677014|380135|P2|Overall Study|Death|15
111039|NCT00677014|380136|P1|Overall Study|Death|6
111040|NCT00677014|380134|P3|Overall Study|Lost to Follow-up|24
111041|NCT00677014|380135|P2|Overall Study|Lost to Follow-up|12
111042|NCT00677014|380136|P1|Overall Study|Lost to Follow-up|20
111043|NCT00676689|380172|P1|Overall Study|Continuing FU|49
111044|NCT00676689|380172|P1|Overall Study|Withdrawal by Subject|3
111045|NCT00676689|380172|P1|Overall Study|Physician Decision|1
111046|NCT00676689|380172|P1|Overall Study|Lost to Follow-up|4
111047|NCT00676689|380172|P1|Overall Study|Death|2
111048|NCT00676689|380172|P1|Overall Study|Screen Failure|2
111049|NCT00676650|380184|P2|Overall Study|Randomized but not treated|4
111050|NCT00676650|380185|P1|Overall Study|Randomized but not treated|3
111051|NCT00676650|380184|P2|Overall Study|Withdrawal by Subject|24
111052|NCT00676650|380185|P1|Overall Study|Withdrawal by Subject|48
111053|NCT00676650|380184|P2|Overall Study|Study terminated by sponsor|43
111054|NCT00676650|380185|P1|Overall Study|Study terminated by sponsor|57
111055|NCT00676650|380184|P2|Overall Study|Protocol Violation|1
111056|NCT00676650|380185|P1|Overall Study|Protocol Violation|3
111057|NCT00676650|380184|P2|Overall Study|Unspecified|10
111058|NCT00676650|380185|P1|Overall Study|Unspecified|14
111059|NCT00676650|380184|P2|Overall Study|Objective progression or relapse|140
111060|NCT00676650|380185|P1|Overall Study|Objective progression or relapse|189
111061|NCT00676650|380184|P2|Overall Study|Lost to Follow-up|1
111062|NCT00676650|380185|P1|Overall Study|Lost to Follow-up|0
111063|NCT00676650|380184|P2|Overall Study|Global deterioration of health status|31
111064|NCT00676650|380185|P1|Overall Study|Global deterioration of health status|66
111065|NCT00676650|380184|P2|Overall Study|Adverse Event|21
111066|NCT00676650|380185|P1|Overall Study|Adverse Event|159
111067|NCT00676650|380184|P2|Overall Study|Death|14
111068|NCT00676650|380185|P1|Overall Study|Death|45
111069|NCT00676520|380203|P1|Overall Study|Other Reason|18
111070|NCT00676520|380203|P1|Overall Study|Ineligible for Randomization to DAPT|209
111071|NCT00676520|380203|P1|Overall Study|Physician Decision|20
111072|NCT00676520|380203|P1|Overall Study|Death|159
111073|NCT00676520|380203|P1|Overall Study|Lost to Follow-up|162
111074|NCT00676520|380203|P1|Overall Study|Withdrawal by Subject|163
111075|NCT00676494|380260|P1|Overall Study|Withdrawal by Subject|6
111076|NCT00676494|380260|P1|Overall Study|Missed Visit|8
111077|NCT00676403|380277|P6|Overall Study|Withdrawal by Subject|1
111078|NCT00676403|380278|P5|Overall Study|Withdrawal by Subject|0
111079|NCT00676403|380279|P4|Overall Study|Withdrawal by Subject|0
111080|NCT00676403|380280|P3|Overall Study|Withdrawal by Subject|0
111081|NCT00676403|380281|P2|Overall Study|Withdrawal by Subject|0
111082|NCT00676403|380282|P1|Overall Study|Withdrawal by Subject|0
111083|NCT00676403|380277|P6|Overall Study|Reason Unspecified|1
111084|NCT00676403|380278|P5|Overall Study|Reason Unspecified|0
111085|NCT00676403|380279|P4|Overall Study|Reason Unspecified|0
111086|NCT00676403|380280|P3|Overall Study|Reason Unspecified|1
111087|NCT00676403|380281|P2|Overall Study|Reason Unspecified|0
111088|NCT00676403|380282|P1|Overall Study|Reason Unspecified|1
111089|NCT00676403|380277|P6|Overall Study|Lost to Follow-up|1
111090|NCT00676403|380278|P5|Overall Study|Lost to Follow-up|0
111091|NCT00676403|380279|P4|Overall Study|Lost to Follow-up|0
111092|NCT00676403|380280|P3|Overall Study|Lost to Follow-up|0
111093|NCT00676403|380281|P2|Overall Study|Lost to Follow-up|0
111094|NCT00676403|380282|P1|Overall Study|Lost to Follow-up|0
111095|NCT00676403|380277|P6|Overall Study|Adverse Event|2
111096|NCT00676403|380278|P5|Overall Study|Adverse Event|1
111097|NCT00676403|380279|P4|Overall Study|Adverse Event|5
111098|NCT00676403|380280|P3|Overall Study|Adverse Event|0
111099|NCT00676403|380281|P2|Overall Study|Adverse Event|2
111100|NCT00676403|380282|P1|Overall Study|Adverse Event|1
111101|NCT00676338|380425|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
111102|NCT00676338|380426|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
111103|NCT00676338|380427|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
111104|NCT00676338|380428|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
111105|NCT00676338|380425|P4|Overall Study|Entry Criteria Not Met|1
111106|NCT00676338|380426|P3|Overall Study|Entry Criteria Not Met|1
111107|NCT00676338|380427|P2|Overall Study|Entry Criteria Not Met|2
111108|NCT00676338|380428|P1|Overall Study|Entry Criteria Not Met|0
111109|NCT00676338|380425|P4|Overall Study|Withdrawal by Subject|6
111110|NCT00676338|380426|P3|Overall Study|Withdrawal by Subject|12
111111|NCT00676338|380427|P2|Overall Study|Withdrawal by Subject|9
111112|NCT00676338|380428|P1|Overall Study|Withdrawal by Subject|17
111113|NCT00676338|380425|P4|Overall Study|Protocol Violation|5
111114|NCT00676338|380426|P3|Overall Study|Protocol Violation|2
111115|NCT00676338|380427|P2|Overall Study|Protocol Violation|9
111116|NCT00676338|380428|P1|Overall Study|Protocol Violation|5
111117|NCT00676338|380425|P4|Overall Study|Physician Decision|3
111118|NCT00676338|380426|P3|Overall Study|Physician Decision|2
111119|NCT00676338|380427|P2|Overall Study|Physician Decision|3
111120|NCT00676338|380428|P1|Overall Study|Physician Decision|3
111121|NCT00676338|380425|P4|Overall Study|Lost to Follow-up|4
111122|NCT00676338|380426|P3|Overall Study|Lost to Follow-up|3
111123|NCT00676338|380427|P2|Overall Study|Lost to Follow-up|1
111124|NCT00676338|380428|P1|Overall Study|Lost to Follow-up|4
111125|NCT00676338|380425|P4|Overall Study|Adverse Event|1
111126|NCT00676338|380426|P3|Overall Study|Adverse Event|5
111127|NCT00676338|380427|P2|Overall Study|Adverse Event|6
111128|NCT00676338|380428|P1|Overall Study|Adverse Event|6
111129|NCT00676208|380480|P2|Overall Study|Incomplete data|4
111130|NCT00676208|380481|P1|Overall Study|Incomplete data|2
111131|NCT00676208|380480|P2|Overall Study|Lost to Follow-up|2
111132|NCT00676208|380481|P1|Overall Study|Lost to Follow-up|0
111133|NCT00676143|380506|P2|Overall Study|Vasogenic edema recurrence|3
111134|NCT00676143|380507|P1|Overall Study|Vasogenic edema recurrence|1
111135|NCT00676143|380506|P2|Overall Study|Participant participation unknown|4
111136|NCT00676143|380507|P1|Overall Study|Participant participation unknown|1
111137|NCT00676143|380506|P2|Overall Study|Not specified|20
111138|NCT00676143|380507|P1|Overall Study|Not specified|11
111139|NCT00676143|380506|P2|Overall Study|Loss of caregiver|3
111140|NCT00676143|380507|P1|Overall Study|Loss of caregiver|5
111141|NCT00676143|380506|P2|Overall Study|Failed to return|1
111142|NCT00676143|380507|P1|Overall Study|Failed to return|2
111143|NCT00676143|380506|P2|Overall Study|Discontinuation of study by sponsor|88
111144|NCT00676143|380507|P1|Overall Study|Discontinuation of study by sponsor|65
111145|NCT00676143|380506|P2|Overall Study|Withdrawal by Subject|42
111146|NCT00676143|380507|P1|Overall Study|Withdrawal by Subject|24
111147|NCT00676143|380506|P2|Overall Study|Protocol Violation|8
111148|NCT00676143|380507|P1|Overall Study|Protocol Violation|4
111149|NCT00676143|380506|P2|Overall Study|Physician Decision|8
111150|NCT00676143|380507|P1|Overall Study|Physician Decision|5
111151|NCT00676143|380506|P2|Overall Study|Lost to Follow-up|13
111152|NCT00676143|380507|P1|Overall Study|Lost to Follow-up|0
111153|NCT00676143|380506|P2|Overall Study|Lack of Efficacy|6
111154|NCT00676143|380507|P1|Overall Study|Lack of Efficacy|0
111155|NCT00676143|380506|P2|Overall Study|Death|4
111156|NCT00676143|380507|P1|Overall Study|Death|4
111157|NCT00676143|380506|P2|Overall Study|Adverse Event|60
111158|NCT00676143|380507|P1|Overall Study|Adverse Event|34
111159|NCT00676130|380547|P2|Overall Study|Withdrawal by Subject|1
111160|NCT00676130|380548|P1|Overall Study|Withdrawal by Subject|0
111161|NCT00676130|380547|P2|Overall Study|Found ineligible|2
111162|NCT00676130|380548|P1|Overall Study|Found ineligible|3
111163|NCT00676130|380547|P2|Overall Study|Lost to Follow-up|1
111164|NCT00676130|380548|P1|Overall Study|Lost to Follow-up|0
111165|NCT00676091|380558|P2|Toddler Dose|Parent or legal guardian request|0
111166|NCT00676091|380559|P1|Toddler Dose|Parent or legal guardian request|1
111167|NCT00676091|380558|P2|Toddler Dose|Failed to return|0
111168|NCT00676091|380559|P1|Toddler Dose|Failed to return|2
111169|NCT00676091|380558|P2|After Infant Series|Failed to return|1
111170|NCT00676091|380559|P1|After Infant Series|Failed to return|1
111171|NCT00676091|380558|P2|After Infant Series|Protocol Violation|1
111172|NCT00676091|380559|P1|After Infant Series|Protocol Violation|0
111173|NCT00676091|380558|P2|After Infant Series|Adverse Event|1
111174|NCT00676091|380559|P1|After Infant Series|Adverse Event|0
111175|NCT00676091|380558|P2|Infant Series|Died prior to receiving 7vPnC|1
111176|NCT00676091|380559|P1|Infant Series|Died prior to receiving 7vPnC|0
111177|NCT00676091|380558|P2|Infant Series|Lost to Follow-up|0
111178|NCT00676091|380559|P1|Infant Series|Lost to Follow-up|1
111179|NCT00676091|380558|P2|Infant Series|Failed to return|3
111180|NCT00676091|380559|P1|Infant Series|Failed to return|1
111181|NCT00676091|380558|P2|Infant Series|Adverse Event|3
111182|NCT00676091|380559|P1|Infant Series|Adverse Event|2
111183|NCT00676091|380558|P2|Infant Series|Protocol Violation|3
111184|NCT00676091|380559|P1|Infant Series|Protocol Violation|6
111185|NCT00676091|380558|P2|Infant Series|Parent or legal guardian request|8
111186|NCT00676091|380559|P1|Infant Series|Parent or legal guardian request|10
111187|NCT00675948|380623|P2|Overall Study|Patient feels unable to take medication|1
111188|NCT00675948|380624|P1|Overall Study|Patient feels unable to take medication|0
111189|NCT00675948|380623|P2|Overall Study|Patient unable to comply with diaries|0
111190|NCT00675948|380624|P1|Overall Study|Patient unable to comply with diaries|1
111191|NCT00675948|380623|P2|Overall Study|Patient died|0
111192|NCT00675948|380624|P1|Overall Study|Patient died|1
111193|NCT00675948|380623|P2|Overall Study|Sponsor decision|1
111194|NCT00675948|380624|P1|Overall Study|Sponsor decision|0
111195|NCT00675948|380623|P2|Overall Study|Pain under control|0
111196|NCT00675948|380624|P1|Overall Study|Pain under control|1
111197|NCT00675948|380623|P2|Overall Study|Protocol Violation|0
111198|NCT00675948|380624|P1|Overall Study|Protocol Violation|1
111199|NCT00675948|380623|P2|Overall Study|Lost to Follow-up|0
111200|NCT00675948|380624|P1|Overall Study|Lost to Follow-up|2
111201|NCT00675948|380623|P2|Overall Study|Withdrawal by Subject|0
111202|NCT00675948|380624|P1|Overall Study|Withdrawal by Subject|7
111203|NCT00675948|380623|P2|Overall Study|Lack of Efficacy|0
111204|NCT00675948|380624|P1|Overall Study|Lack of Efficacy|3
111205|NCT00675948|380623|P2|Overall Study|Adverse Event|1
111206|NCT00675948|380624|P1|Overall Study|Adverse Event|23
111207|NCT00675766|380675|P4|Overall Study|Lost to Follow-up|26
111208|NCT00675766|380676|P3|Overall Study|Lost to Follow-up|21
111209|NCT00675766|380677|P2|Overall Study|Lost to Follow-up|5
111210|NCT00675766|380678|P1|Overall Study|Lost to Follow-up|6
111211|NCT00675597|380688|P1|Overall Study|Withdrawal by Subject|3
111212|NCT00675506|380722|P2|Overall Study|Schedule conflict|1
111213|NCT00675506|380723|P1|Overall Study|Schedule conflict|0
111214|NCT00675506|380722|P2|Overall Study|Declined participation|0
111215|NCT00675506|380723|P1|Overall Study|Declined participation|1
111216|NCT00675506|380722|P2|Overall Study|Disclosed history of cancer|0
111217|NCT00675506|380723|P1|Overall Study|Disclosed history of cancer|1
111218|NCT00675506|380722|P2|Overall Study|Hypersensitivity Reaction|0
111219|NCT00675506|380723|P1|Overall Study|Hypersensitivity Reaction|1
111220|NCT00675506|380722|P2|Overall Study|Elevated IGF-1|0
111221|NCT00675506|380723|P1|Overall Study|Elevated IGF-1|2
111222|NCT00675506|380722|P2|Overall Study|Elevated IGF-1 prior to treatment|0
111223|NCT00675506|380723|P1|Overall Study|Elevated IGF-1 prior to treatment|1
111224|NCT00675506|380722|P2|Overall Study|Elevated fasting glucose|1
111225|NCT00675506|380723|P1|Overall Study|Elevated fasting glucose|2
111226|NCT00675506|380722|P2|Overall Study|Lost interest|5
111227|NCT00675506|380723|P1|Overall Study|Lost interest|3
111228|NCT00675506|380722|P2|Overall Study|Lost to Follow-up|5
111229|NCT00675506|380723|P1|Overall Study|Lost to Follow-up|1
111230|NCT00675441|380735|P1|Overall Study|Death|1
111231|NCT00675441|380735|P1|Overall Study|Withdrawal by Subject|2
111232|NCT00675428|380741|P2|Overall Study|Physician Decision|0
111233|NCT00675428|380742|P1|Overall Study|Physician Decision|1
111234|NCT00675428|380741|P2|Overall Study|No Disease Response After Cycle 6|1
111235|NCT00675428|380742|P1|Overall Study|No Disease Response After Cycle 6|0
111236|NCT00675428|380741|P2|Overall Study|Disease Progression|2
111237|NCT00675428|380742|P1|Overall Study|Disease Progression|2
111238|NCT00675103|380769|P1|Overall Study|Adverse Event|1
111239|NCT00675103|380769|P1|Overall Study|Lack of Efficacy|2
111240|NCT00674986|380776|P2|Overall Study|Other reasons|8
111241|NCT00674986|380777|P1|Overall Study|Other reasons|4
111242|NCT00674986|380776|P2|Overall Study|Lost to Follow-up|53
111243|NCT00674986|380777|P1|Overall Study|Lost to Follow-up|25
111244|NCT00674986|380776|P2|Overall Study|Subject withdrew consent|19
111245|NCT00674986|380777|P1|Overall Study|Subject withdrew consent|12
111246|NCT00674986|380776|P2|Overall Study|Adverse Event|1
111247|NCT00674986|380777|P1|Overall Study|Adverse Event|2
111248|NCT00674973|380798|P2|Overall Study|Protocol Violation|1
111249|NCT00674973|380799|P1|Overall Study|Protocol Violation|0
111250|NCT00674973|380798|P2|Overall Study|Death|15
111251|NCT00674973|380799|P1|Overall Study|Death|19
111252|NCT00674973|380798|P2|Overall Study|Adverse Event|9
111253|NCT00674973|380799|P1|Overall Study|Adverse Event|2
111254|NCT00674973|380798|P2|Overall Study|Failure to Return|0
111255|NCT00674973|380799|P1|Overall Study|Failure to Return|1
111256|NCT00674973|380798|P2|Overall Study|Refused Treatment|5
111257|NCT00674973|380799|P1|Overall Study|Refused Treatment|1
111258|NCT00674973|380798|P2|Overall Study|Insufficient Therapeutic Response|72
111259|NCT00674973|380799|P1|Overall Study|Insufficient Therapeutic Response|77
111260|NCT00674700|380844|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
111261|NCT00674700|380845|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
111262|NCT00674700|380846|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
111263|NCT00674700|380844|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
111264|NCT00674700|380845|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
111265|NCT00674700|380846|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
111266|NCT00674700|380844|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
111267|NCT00674700|380845|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
111268|NCT00674700|380846|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
111269|NCT00674700|380844|P3|Year 1|Any other reason not above-mentioned|6
111270|NCT00674700|380845|P2|Year 1|Any other reason not above-mentioned|7
111271|NCT00674700|380846|P1|Year 1|Any other reason not above-mentioned|7
111272|NCT00674700|380844|P3|Year 1|Withdrawal by Subject|6
111273|NCT00674700|380845|P2|Year 1|Withdrawal by Subject|7
111274|NCT00674700|380846|P1|Year 1|Withdrawal by Subject|7
111275|NCT00674700|380844|P3|Year 1|Adverse Event|5
111276|NCT00674700|380845|P2|Year 1|Adverse Event|20
111277|NCT00674700|380846|P1|Year 1|Adverse Event|17
111278|NCT00674661|380859|P2|Overall Study|Withdrawal by Subject|5
111279|NCT00674661|380860|P1|Overall Study|Withdrawal by Subject|0
111280|NCT00674661|380859|P2|Overall Study|Lost to Follow-up|3
111281|NCT00674661|380860|P1|Overall Study|Lost to Follow-up|6
111282|NCT00674661|380859|P2|Overall Study|not specified|7
111283|NCT00674661|380860|P1|Overall Study|not specified|5
111284|NCT00674362|380934|P2|Open Label|Other: Subject moved to extension study|0
111285|NCT00674362|380935|P1|Open Label|Other: Subject moved to extension study|1
111286|NCT00674362|380934|P2|Open Label|Adverse Event|0
111287|NCT00674362|380935|P1|Open Label|Adverse Event|1
111288|NCT00674362|380934|P2|Double Blind|Other: Surgery|1
111289|NCT00674362|380935|P1|Double Blind|Other: Surgery|0
111290|NCT00674362|380934|P2|Double Blind|Other: Loss of Patient Compliance|1
111291|NCT00674362|380935|P1|Double Blind|Other: Loss of Patient Compliance|0
111292|NCT00674362|380934|P2|Double Blind|Withdrawal by Subject|3
111293|NCT00674362|380935|P1|Double Blind|Withdrawal by Subject|4
111294|NCT00674362|380934|P2|Double Blind|Loss of efficacy|1
111295|NCT00674362|380935|P1|Double Blind|Loss of efficacy|0
111296|NCT00674362|380934|P2|Double Blind|Lack of Efficacy|6
111297|NCT00674362|380935|P1|Double Blind|Lack of Efficacy|2
111298|NCT00674362|380934|P2|Double Blind|Adverse Event|6
111299|NCT00674362|380935|P1|Double Blind|Adverse Event|6
111300|NCT00674323|381003|P3|Overall Study|Protocol Violation|0
111301|NCT00674323|381004|P2|Overall Study|Protocol Violation|0
111302|NCT00674323|381005|P1|Overall Study|Protocol Violation|1
111303|NCT00674323|381003|P3|Overall Study|Adverse Event|0
111304|NCT00674323|381004|P2|Overall Study|Adverse Event|1
111305|NCT00674323|381005|P1|Overall Study|Adverse Event|0
111306|NCT00674154|381029|P2|Overall Study|Did not want parathyroidectomy|2
111307|NCT00674154|381030|P1|Overall Study|Did not want parathyroidectomy|0
111308|NCT00674154|381029|P2|Overall Study|Withdrawal by Subject|1
111309|NCT00674154|381030|P1|Overall Study|Withdrawal by Subject|3
111310|NCT00674128|381038|P2|Overall Study|Withdrawal by Subject|23
111311|NCT00674128|381039|P1|Overall Study|Withdrawal by Subject|25
111312|NCT00673933|381064|P1|Overall Study|Lost to Follow-up|1
111313|NCT00673933|381064|P1|Overall Study|Withdrawal by Subject|2
111314|NCT00673881|381080|P1|Overall Study|Withdrawal by Subject|1
111315|NCT00673816|381094|P1|Overall Study|Withdrawal by Subject|1
111316|NCT00673816|381094|P1|Overall Study|Adverse Event|1
111317|NCT00673673|381129|P1|Overall Study|Investigators' discretion|2
111318|NCT00673673|381129|P1|Overall Study|Withdrawal by Subject|3
111319|NCT00673673|381129|P1|Overall Study|Adverse Event|4
111320|NCT00673673|381129|P1|Overall Study|Progressive disease|27
111321|NCT00673660|381135|P1|Overall Study|Lost to Follow-up|107
111322|NCT00673465|381157|P12|Part 1/Period 2 (United States)|Protocol Violation|0
111323|NCT00673465|381158|P11|Part 1/Period 2 (United States)|Protocol Violation|0
111324|NCT00673465|381159|P10|Part 1/Period 2 (United States)|Protocol Violation|0
111325|NCT00673465|381160|P9|Part 1/Period 2 (United States)|Protocol Violation|0
111326|NCT00673465|381161|P8|Part 1/Period 2 (United States)|Protocol Violation|0
111327|NCT00673465|381162|P7|Part 1/Period 2 (United States)|Protocol Violation|0
111328|NCT00673465|381163|P6|Part 1/Period 2 (United States)|Protocol Violation|0
111329|NCT00673465|381164|P5|Part 1/Period 2 (United States)|Protocol Violation|1
111330|NCT00673465|381165|P4|Part 1/Period 2 (United States)|Protocol Violation|0
111331|NCT00673465|381166|P3|Part 1/Period 2 (United States)|Protocol Violation|0
111332|NCT00673465|381167|P2|Part 1/Period 2 (United States)|Protocol Violation|0
111333|NCT00673465|381168|P1|Part 1/Period 2 (United States)|Protocol Violation|0
111334|NCT00673465|381157|P12|Part 1/Period 1 (United States)|Protocol Violation|0
111335|NCT00673465|381158|P11|Part 1/Period 1 (United States)|Protocol Violation|0
111336|NCT00673465|381159|P10|Part 1/Period 1 (United States)|Protocol Violation|0
111337|NCT00673465|381160|P9|Part 1/Period 1 (United States)|Protocol Violation|0
111338|NCT00673465|381161|P8|Part 1/Period 1 (United States)|Protocol Violation|0
111339|NCT00673465|381162|P7|Part 1/Period 1 (United States)|Protocol Violation|0
111340|NCT00673465|381163|P6|Part 1/Period 1 (United States)|Protocol Violation|1
111341|NCT00673465|381164|P5|Part 1/Period 1 (United States)|Protocol Violation|1
111342|NCT00673465|381165|P4|Part 1/Period 1 (United States)|Protocol Violation|0
111343|NCT00673465|381166|P3|Part 1/Period 1 (United States)|Protocol Violation|0
111344|NCT00673465|381167|P2|Part 1/Period 1 (United States)|Protocol Violation|0
111345|NCT00673465|381168|P1|Part 1/Period 1 (United States)|Protocol Violation|0
111346|NCT00673452|381217|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
111347|NCT00673452|381218|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
111348|NCT00673452|381217|P2|Continuation Double-Blind Phase|Physician Decision|0
111349|NCT00673452|381218|P1|Continuation Double-Blind Phase|Physician Decision|2
111350|NCT00673452|381217|P2|Continuation Double-Blind Phase|Sponsor Decision|3
111351|NCT00673452|381218|P1|Continuation Double-Blind Phase|Sponsor Decision|0
111352|NCT00673452|381217|P2|Continuation Double-Blind Phase|Protocol Violation|3
111353|NCT00673452|381218|P1|Continuation Double-Blind Phase|Protocol Violation|2
111354|NCT00673452|381217|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
111355|NCT00673452|381218|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
111356|NCT00673452|381217|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
111357|NCT00673452|381218|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
111358|NCT00673452|381217|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
111359|NCT00673452|381218|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
111360|NCT00673452|381217|P2|Continuation Double-Blind Phase|Adverse Event|13
111361|NCT00673452|381218|P1|Continuation Double-Blind Phase|Adverse Event|5
111362|NCT00673452|381217|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
111363|NCT00673452|381218|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
111364|NCT00673452|381217|P2|Acute Double-Blind Phase|Sponsor Decision|1
111365|NCT00673452|381218|P1|Acute Double-Blind Phase|Sponsor Decision|0
111366|NCT00673452|381217|P2|Acute Double-Blind Phase|Protocol Violation|3
111367|NCT00673452|381218|P1|Acute Double-Blind Phase|Protocol Violation|5
111368|NCT00673452|381217|P2|Acute Double-Blind Phase|Physician Decision|6
111369|NCT00673452|381218|P1|Acute Double-Blind Phase|Physician Decision|0
111370|NCT00673452|381217|P2|Acute Double-Blind Phase|Lost to Follow-up|19
111371|NCT00673452|381218|P1|Acute Double-Blind Phase|Lost to Follow-up|16
111372|NCT00673452|381217|P2|Acute Double-Blind Phase|Lack of Efficacy|14
111373|NCT00673452|381218|P1|Acute Double-Blind Phase|Lack of Efficacy|9
111374|NCT00673452|381217|P2|Acute Double-Blind Phase|Adverse Event|24
111375|NCT00673452|381218|P1|Acute Double-Blind Phase|Adverse Event|41
111376|NCT00673387|381281|P8|Overall Study|Lost to Follow-up|5
111377|NCT00673387|381282|P7|Overall Study|Lost to Follow-up|8
111378|NCT00673387|381283|P6|Overall Study|Lost to Follow-up|5
111379|NCT00673387|381284|P5|Overall Study|Lost to Follow-up|6
111380|NCT00673387|381285|P4|Overall Study|Lost to Follow-up|6
111381|NCT00673387|381286|P3|Overall Study|Lost to Follow-up|5
111382|NCT00673387|381287|P2|Overall Study|Lost to Follow-up|6
111383|NCT00673387|381288|P1|Overall Study|Lost to Follow-up|8
111384|NCT00673387|381281|P8|Overall Study|Protocol Violation|3
111385|NCT00673387|381282|P7|Overall Study|Protocol Violation|1
111386|NCT00673387|381283|P6|Overall Study|Protocol Violation|1
111387|NCT00673387|381284|P5|Overall Study|Protocol Violation|0
111388|NCT00673387|381285|P4|Overall Study|Protocol Violation|2
111389|NCT00673387|381286|P3|Overall Study|Protocol Violation|1
111390|NCT00673387|381287|P2|Overall Study|Protocol Violation|0
111391|NCT00673387|381288|P1|Overall Study|Protocol Violation|3
111392|NCT00673387|381281|P8|Overall Study|Physician Decision|1
111393|NCT00673387|381282|P7|Overall Study|Physician Decision|1
111394|NCT00673387|381283|P6|Overall Study|Physician Decision|5
111395|NCT00673387|381284|P5|Overall Study|Physician Decision|0
111396|NCT00673387|381285|P4|Overall Study|Physician Decision|0
111397|NCT00673387|381286|P3|Overall Study|Physician Decision|0
111398|NCT00673387|381287|P2|Overall Study|Physician Decision|0
111399|NCT00673387|381288|P1|Overall Study|Physician Decision|0
111400|NCT00673387|381281|P8|Overall Study|Adverse Event|5
111401|NCT00673387|381282|P7|Overall Study|Adverse Event|5
111402|NCT00673387|381283|P6|Overall Study|Adverse Event|2
111403|NCT00673387|381284|P5|Overall Study|Adverse Event|6
111404|NCT00673387|381285|P4|Overall Study|Adverse Event|2
111405|NCT00673387|381286|P3|Overall Study|Adverse Event|5
111406|NCT00673387|381287|P2|Overall Study|Adverse Event|1
111407|NCT00673387|381288|P1|Overall Study|Adverse Event|3
111408|NCT00673387|381281|P8|Overall Study|Withdrawal by Subject|21
111409|NCT00673387|381282|P7|Overall Study|Withdrawal by Subject|15
111410|NCT00673387|381283|P6|Overall Study|Withdrawal by Subject|21
111411|NCT00673387|381284|P5|Overall Study|Withdrawal by Subject|18
111412|NCT00673387|381285|P4|Overall Study|Withdrawal by Subject|16
111413|NCT00673387|381286|P3|Overall Study|Withdrawal by Subject|20
111414|NCT00673387|381287|P2|Overall Study|Withdrawal by Subject|16
111415|NCT00673387|381288|P1|Overall Study|Withdrawal by Subject|15
111416|NCT00673361|381504|P1|Overall Study|Screen Failure|2
111417|NCT00673257|381508|P1|Overall Study|Unable to obtain specimen|1
111418|NCT00673257|381508|P1|Overall Study|Withdrawal by Subject|4
111419|NCT00673231|381517|P4|Overall Study|Study criteria,compliance,safety, other|4
111420|NCT00673231|381518|P3|Overall Study|Study criteria,compliance,safety, other|7
111421|NCT00673231|381519|P2|Overall Study|Study criteria,compliance,safety, other|5
111422|NCT00673231|381520|P1|Overall Study|Study criteria,compliance,safety, other|8
111423|NCT00673231|381517|P4|Overall Study|Death|0
111424|NCT00673231|381518|P3|Overall Study|Death|1
111425|NCT00673231|381519|P2|Overall Study|Death|0
111426|NCT00673231|381520|P1|Overall Study|Death|0
111427|NCT00673231|381517|P4|Overall Study|Lost to Follow-up|2
111428|NCT00673231|381518|P3|Overall Study|Lost to Follow-up|1
111429|NCT00673231|381519|P2|Overall Study|Lost to Follow-up|2
111430|NCT00673231|381520|P1|Overall Study|Lost to Follow-up|1
111431|NCT00673231|381517|P4|Overall Study|Adverse Event|6
111432|NCT00673231|381518|P3|Overall Study|Adverse Event|9
111433|NCT00673231|381519|P2|Overall Study|Adverse Event|5
111434|NCT00673231|381520|P1|Overall Study|Adverse Event|6
111435|NCT00673231|381517|P4|Overall Study|Withdrawal by Subject|6
111436|NCT00673231|381518|P3|Overall Study|Withdrawal by Subject|8
111437|NCT00673231|381519|P2|Overall Study|Withdrawal by Subject|10
111438|NCT00673231|381520|P1|Overall Study|Withdrawal by Subject|14
111439|NCT00673179|381552|P2|Overall Study|Toxicity/Complications|0
111440|NCT00673179|381553|P1|Overall Study|Toxicity/Complications|3
111441|NCT00673049|381594|P4|After Progression on Erlotinib|study terminated by sponsor|4
111442|NCT00673049|381595|P3|After Progression on Erlotinib|study terminated by sponsor|0
111443|NCT00673049|381596|P2|After Progression on Erlotinib|study terminated by sponsor|0
111444|NCT00673049|381597|P1|After Progression on Erlotinib|study terminated by sponsor|0
111445|NCT00673049|381594|P4|After Progression on Erlotinib|Withdrawal by Subject|5
111446|NCT00673049|381595|P3|After Progression on Erlotinib|Withdrawal by Subject|0
111447|NCT00673049|381596|P2|After Progression on Erlotinib|Withdrawal by Subject|0
111448|NCT00673049|381597|P1|After Progression on Erlotinib|Withdrawal by Subject|0
111449|NCT00673049|381594|P4|After Progression on Erlotinib|Lost to Follow-up|3
111450|NCT00673049|381595|P3|After Progression on Erlotinib|Lost to Follow-up|0
111451|NCT00673049|381596|P2|After Progression on Erlotinib|Lost to Follow-up|0
111452|NCT00673049|381597|P1|After Progression on Erlotinib|Lost to Follow-up|0
111453|NCT00673049|381594|P4|After Progression on Erlotinib|Death|71
111454|NCT00673049|381595|P3|After Progression on Erlotinib|Death|0
111455|NCT00673049|381596|P2|After Progression on Erlotinib|Death|0
111456|NCT00673049|381597|P1|After Progression on Erlotinib|Death|0
111457|NCT00673049|381594|P4|Before Progression on Erlotinib|Switched to figitumumab|0
111458|NCT00673049|381595|P3|Before Progression on Erlotinib|Switched to figitumumab|0
111459|NCT00673049|381596|P2|Before Progression on Erlotinib|Switched to figitumumab|83
111460|NCT00673049|381597|P1|Before Progression on Erlotinib|Switched to figitumumab|0
111461|NCT00673049|381594|P4|Before Progression on Erlotinib|study terminated by sponsor|0
111462|NCT00673049|381595|P3|Before Progression on Erlotinib|study terminated by sponsor|0
111463|NCT00673049|381596|P2|Before Progression on Erlotinib|study terminated by sponsor|14
111464|NCT00673049|381597|P1|Before Progression on Erlotinib|study terminated by sponsor|18
111465|NCT00673049|381594|P4|Before Progression on Erlotinib|Unspecified|0
111466|NCT00673049|381595|P3|Before Progression on Erlotinib|Unspecified|0
111467|NCT00673049|381596|P2|Before Progression on Erlotinib|Unspecified|2
111468|NCT00673049|381597|P1|Before Progression on Erlotinib|Unspecified|1
111469|NCT00673049|381594|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
111470|NCT00673049|381595|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
111471|NCT00673049|381596|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
111472|NCT00673049|381597|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
111473|NCT00673049|381594|P4|Before Progression on Erlotinib|Lost to Follow-up|0
111474|NCT00673049|381595|P3|Before Progression on Erlotinib|Lost to Follow-up|0
111475|NCT00673049|381596|P2|Before Progression on Erlotinib|Lost to Follow-up|5
111476|NCT00673049|381597|P1|Before Progression on Erlotinib|Lost to Follow-up|9
111477|NCT00673049|381594|P4|Before Progression on Erlotinib|Death|0
111478|NCT00673049|381595|P3|Before Progression on Erlotinib|Death|1
111479|NCT00673049|381596|P2|Before Progression on Erlotinib|Death|167
111480|NCT00673049|381597|P1|Before Progression on Erlotinib|Death|235
111481|NCT00673049|381594|P4|Before Progression on Erlotinib|Randomized but not treated|0
111482|NCT00673049|381595|P3|Before Progression on Erlotinib|Randomized but not treated|0
111483|NCT00673049|381596|P2|Before Progression on Erlotinib|Randomized but not treated|1
111484|NCT00673049|381597|P1|Before Progression on Erlotinib|Randomized but not treated|3
111485|NCT00672984|381621|P3|Third Intervention|Adverse Event|1
111486|NCT00672984|381622|P2|Third Intervention|Adverse Event|0
111487|NCT00672984|381623|P1|Third Intervention|Adverse Event|1
111488|NCT00672984|381621|P3|Second Intervention|Protocol Violation|1
111489|NCT00672984|381622|P2|Second Intervention|Protocol Violation|1
111490|NCT00672984|381623|P1|Second Intervention|Protocol Violation|0
111491|NCT00672984|381621|P3|Second Intervention|Withdrawal by Subject|0
111492|NCT00672984|381622|P2|Second Intervention|Withdrawal by Subject|3
111493|NCT00672984|381623|P1|Second Intervention|Withdrawal by Subject|0
111494|NCT00672984|381621|P3|Second Intervention|Non-compliance with facility policies|0
111495|NCT00672984|381622|P2|Second Intervention|Non-compliance with facility policies|2
111496|NCT00672984|381623|P1|Second Intervention|Non-compliance with facility policies|0
111497|NCT00672984|381621|P3|First Intervention|Sponsor decision|0
111498|NCT00672984|381622|P2|First Intervention|Sponsor decision|0
111499|NCT00672984|381623|P1|First Intervention|Sponsor decision|3
111500|NCT00672984|381621|P3|First Intervention|Withdrawal by Subject|2
111501|NCT00672984|381622|P2|First Intervention|Withdrawal by Subject|2
111502|NCT00672984|381623|P1|First Intervention|Withdrawal by Subject|1
111503|NCT00672984|381621|P3|First Intervention|Adverse Event|0
111504|NCT00672984|381622|P2|First Intervention|Adverse Event|0
111505|NCT00672984|381623|P1|First Intervention|Adverse Event|5
111506|NCT00672958|381674|P2|Overall Study|Reason not specified|3
111507|NCT00672958|381675|P1|Overall Study|Reason not specified|0
111508|NCT00672958|381674|P2|Overall Study|Lost to Follow-up|17
111509|NCT00672958|381675|P1|Overall Study|Lost to Follow-up|22
111510|NCT00672958|381674|P2|Overall Study|Voluntary withdrawal|8
111511|NCT00672958|381675|P1|Overall Study|Voluntary withdrawal|12
111512|NCT00672958|381674|P2|Overall Study|Protocol deviations|5
111513|NCT00672958|381675|P1|Overall Study|Protocol deviations|11
111514|NCT00672958|381674|P2|Overall Study|Non-compliance with study drug|3
111515|NCT00672958|381675|P1|Overall Study|Non-compliance with study drug|2
111516|NCT00672958|381674|P2|Overall Study|Lack of Efficacy|11
111517|NCT00672958|381675|P1|Overall Study|Lack of Efficacy|6
111518|NCT00672958|381674|P2|Overall Study|Adverse Event|9
111519|NCT00672958|381675|P1|Overall Study|Adverse Event|11
111520|NCT00672841|381727|P2|Overall Study|Pregnancy|1
111521|NCT00672841|381728|P1|Overall Study|Pregnancy|0
111522|NCT00672841|381727|P2|Overall Study|Adverse Event|3
111523|NCT00672841|381728|P1|Overall Study|Adverse Event|0
111524|NCT00672841|381727|P2|Overall Study|Antifungal therapy, negative glucan|4
111525|NCT00672841|381728|P1|Overall Study|Antifungal therapy, negative glucan|0
111526|NCT00672841|381727|P2|Overall Study|icteric specimens|3
111527|NCT00672841|381728|P1|Overall Study|icteric specimens|0
111528|NCT00672841|381727|P2|Overall Study|Comfort care|4
111529|NCT00672841|381728|P1|Overall Study|Comfort care|1
111530|NCT00672646|381743|P3|Overall Study|Withdrawal by Subject|1
111531|NCT00672646|381744|P2|Overall Study|Withdrawal by Subject|0
111532|NCT00672646|381745|P1|Overall Study|Withdrawal by Subject|0
111533|NCT00672646|381743|P3|Overall Study|Lost to Follow-up|2
111534|NCT00672646|381744|P2|Overall Study|Lost to Follow-up|1
111535|NCT00672646|381745|P1|Overall Study|Lost to Follow-up|0
111536|NCT00672633|381770|P2|Overall Study|Withdrawal by Subject|1
111537|NCT00672633|381771|P1|Overall Study|Withdrawal by Subject|0
111538|NCT00672620|381785|P4|Overall Study|Reason not Specified|1
111539|NCT00672620|381786|P3|Overall Study|Reason not Specified|2
111540|NCT00672620|381787|P2|Overall Study|Reason not Specified|3
111541|NCT00672620|381788|P1|Overall Study|Reason not Specified|3
111542|NCT00672620|381785|P4|Overall Study|Lost to Follow-up|11
111543|NCT00672620|381786|P3|Overall Study|Lost to Follow-up|8
111544|NCT00672620|381787|P2|Overall Study|Lost to Follow-up|19
111545|NCT00672620|381788|P1|Overall Study|Lost to Follow-up|8
111546|NCT00672620|381785|P4|Overall Study|Withdrawal of Consent|6
111547|NCT00672620|381786|P3|Overall Study|Withdrawal of Consent|5
111548|NCT00672620|381787|P2|Overall Study|Withdrawal of Consent|12
111549|NCT00672620|381788|P1|Overall Study|Withdrawal of Consent|6
111550|NCT00672620|381785|P4|Overall Study|Protocol Deviations|5
111551|NCT00672620|381786|P3|Overall Study|Protocol Deviations|2
111552|NCT00672620|381787|P2|Overall Study|Protocol Deviations|7
111553|NCT00672620|381788|P1|Overall Study|Protocol Deviations|5
111554|NCT00672620|381785|P4|Overall Study|Noncompliance with Study Drug|2
111555|NCT00672620|381786|P3|Overall Study|Noncompliance with Study Drug|0
111556|NCT00672620|381787|P2|Overall Study|Noncompliance with Study Drug|4
111557|NCT00672620|381788|P1|Overall Study|Noncompliance with Study Drug|3
111558|NCT00672620|381785|P4|Overall Study|Lack of Efficacy|0
111559|NCT00672620|381786|P3|Overall Study|Lack of Efficacy|2
111560|NCT00672620|381787|P2|Overall Study|Lack of Efficacy|2
111561|NCT00672620|381788|P1|Overall Study|Lack of Efficacy|1
111562|NCT00672620|381785|P4|Overall Study|Adverse Event|17
111563|NCT00672620|381786|P3|Overall Study|Adverse Event|12
111564|NCT00672620|381787|P2|Overall Study|Adverse Event|7
111565|NCT00672620|381788|P1|Overall Study|Adverse Event|7
111566|NCT00672555|381853|P1|Overall Study|Did not want to answer questionnaire|2
111567|NCT00672555|381853|P1|Overall Study|Lost to Follow-up|4
111568|NCT00672490|381864|P2|Overall Study|No reason was provided|2
111569|NCT00672490|381865|P1|Overall Study|No reason was provided|6
111570|NCT00672490|381864|P2|Overall Study|Lost to Follow-up|5
111571|NCT00672490|381865|P1|Overall Study|Lost to Follow-up|1
111572|NCT00672490|381864|P2|Overall Study|Intolerance|2
111573|NCT00672490|381865|P1|Overall Study|Intolerance|0
111574|NCT00672490|381864|P2|Overall Study|Violation of Concomitant Medicine|0
111575|NCT00672490|381865|P1|Overall Study|Violation of Concomitant Medicine|1
111576|NCT00672490|381864|P2|Overall Study|Adverse Event|8
111577|NCT00672490|381865|P1|Overall Study|Adverse Event|5
111578|NCT00672490|381864|P2|Overall Study|Mismatch Include/Exclude Criteria|0
111579|NCT00672490|381865|P1|Overall Study|Mismatch Include/Exclude Criteria|1
111580|NCT00672490|381864|P2|Overall Study|Lack of Compliance|7
111581|NCT00672490|381865|P1|Overall Study|Lack of Compliance|2
111582|NCT00672490|381864|P2|Overall Study|Withdrawal by Subject|8
111583|NCT00672490|381865|P1|Overall Study|Withdrawal by Subject|8
111584|NCT00672256|381921|P1|Overall Study|PI dropped, bad data|44
111585|NCT00671931|381995|P5|Overall Study|Physician Decision|1
111586|NCT00671931|381996|P4|Overall Study|Physician Decision|2
111587|NCT00671931|381997|P3|Overall Study|Physician Decision|0
111588|NCT00671931|381998|P2|Overall Study|Physician Decision|0
111589|NCT00671931|381999|P1|Overall Study|Physician Decision|1
111590|NCT00671879|382019|P3|Overall Study|Withdrawal by Subject|6
111591|NCT00671879|382020|P2|Overall Study|Withdrawal by Subject|4
111592|NCT00671879|382021|P1|Overall Study|Withdrawal by Subject|0
111593|NCT00671853|382034|P2|Overall Study|Non-adherence with study procedures|4
111594|NCT00671853|382035|P1|Overall Study|Non-adherence with study procedures|1
111595|NCT00671853|382034|P2|Overall Study|Physician Decision|2
111596|NCT00671853|382035|P1|Overall Study|Physician Decision|0
111597|NCT00671853|382034|P2|Overall Study|Lost to Follow-up|8
111598|NCT00671853|382035|P1|Overall Study|Lost to Follow-up|8
111599|NCT00671853|382034|P2|Overall Study|Withdrawal by Subject|5
111600|NCT00671853|382035|P1|Overall Study|Withdrawal by Subject|1
111601|NCT00671853|382034|P2|Overall Study|Adverse Event|1
111602|NCT00671853|382035|P1|Overall Study|Adverse Event|7
111603|NCT00671853|382034|P2|Overall Study|Lack of Efficacy|7
111604|NCT00671853|382035|P1|Overall Study|Lack of Efficacy|3
111605|NCT00671788|382051|P1|Overall Study|Other|1
111606|NCT00671788|382051|P1|Overall Study|MD Decision|1
111607|NCT00671788|382051|P1|Overall Study|Ineligible|1
111608|NCT00671788|382051|P1|Overall Study|Refused further treatment|3
111609|NCT00671788|382051|P1|Overall Study|Adverse Event|8
111610|NCT00671749|382058|P1|Overall Study|Lost to Follow-up|1
111611|NCT00671749|382058|P1|Overall Study|Protocol Violation|1
111612|NCT00671749|382058|P1|Overall Study|Withdrawal by Subject|4
111613|NCT00671749|382058|P1|Overall Study|Adverse Event|2
111614|NCT00671554|382101|P1|Overall Study|Disease progression|3
111615|NCT00671437|382140|P1|Overall Study|Ineligible post-hoc|1
111616|NCT00671437|382140|P1|Overall Study|Adverse Event|3
111617|NCT00671437|382140|P1|Overall Study|Cutaneous SCC of head and neck|3
111618|NCT00671437|382140|P1|Overall Study|Progressive disease before C1 week 8|8
111619|NCT00671060|382159|P2|Overall Study|Physician Decision|1
111620|NCT00671060|382160|P1|Overall Study|Physician Decision|0
111621|NCT00671060|382159|P2|Overall Study|Protocol Violation|0
111622|NCT00671060|382160|P1|Overall Study|Protocol Violation|1
111623|NCT00670930|382186|P2|Overall Study|Lost to Follow-up|0
111624|NCT00670930|382187|P1|Overall Study|Lost to Follow-up|1
111625|NCT00670930|382186|P2|Overall Study|Adminstrative Problem|1
111626|NCT00670930|382187|P1|Overall Study|Adminstrative Problem|0
111627|NCT00670800|382203|P2|Overall Study|2 controls were insulin resistant|2
111628|NCT00670800|382204|P1|Overall Study|2 controls were insulin resistant|0
111629|NCT00670748|382224|P4|Overall Study|Not off study|1
111630|NCT00670748|382225|P3|Overall Study|Not off study|1
111631|NCT00670748|382226|P2|Overall Study|Not off study|1
111632|NCT00670748|382227|P1|Overall Study|Not off study|2
111633|NCT00670748|382224|P4|Overall Study|Death during treatment|0
111634|NCT00670748|382225|P3|Overall Study|Death during treatment|1
111635|NCT00670748|382226|P2|Overall Study|Death during treatment|1
111636|NCT00670748|382227|P1|Overall Study|Death during treatment|1
111637|NCT00670540|382256|P1|Overall Study|missing information inclusion criteria|1
111638|NCT00670540|382256|P1|Overall Study|controls randomised for no follow up|2770
111639|NCT00670540|382256|P1|Overall Study|refused to participate|189
111640|NCT00670540|382256|P1|Overall Study|not living in France|348
111641|NCT00670540|382256|P1|Overall Study|ineligible|17
111642|NCT00670449|382301|P4|Overall Study|Abnormal Laboratory Value(s)|0
111643|NCT00670449|382302|P3|Overall Study|Abnormal Laboratory Value(s)|0
111644|NCT00670449|382303|P2|Overall Study|Abnormal Laboratory Value(s)|2
111645|NCT00670449|382304|P1|Overall Study|Abnormal Laboratory Value(s)|0
111646|NCT00670449|382301|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
111647|NCT00670449|382302|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
111648|NCT00670449|382303|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
111649|NCT00670449|382304|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
111650|NCT00670449|382301|P4|Overall Study|Subject Withdrew Consent|1
111651|NCT00670449|382302|P3|Overall Study|Subject Withdrew Consent|0
111652|NCT00670449|382303|P2|Overall Study|Subject Withdrew Consent|2
111653|NCT00670449|382304|P1|Overall Study|Subject Withdrew Consent|0
111654|NCT00670449|382301|P4|Overall Study|Administrative Problems|1
111655|NCT00670449|382302|P3|Overall Study|Administrative Problems|0
111656|NCT00670449|382303|P2|Overall Study|Administrative Problems|2
111657|NCT00670449|382304|P1|Overall Study|Administrative Problems|0
111658|NCT00670449|382301|P4|Overall Study|Protocol Deviation|1
111659|NCT00670449|382302|P3|Overall Study|Protocol Deviation|0
111660|NCT00670449|382303|P2|Overall Study|Protocol Deviation|2
111661|NCT00670449|382304|P1|Overall Study|Protocol Deviation|1
111662|NCT00670449|382301|P4|Overall Study|Adverse Event|5
111663|NCT00670449|382302|P3|Overall Study|Adverse Event|8
111664|NCT00670449|382303|P2|Overall Study|Adverse Event|2
111665|NCT00670449|382304|P1|Overall Study|Adverse Event|6
111666|NCT00670306|382328|P1|Overall Study|incl/excl criterias did not meet|19
111667|NCT00670306|382328|P1|Overall Study|Lost to Follow-up|8
111668|NCT00670306|382328|P1|Overall Study|Physician Decision|1
111669|NCT00670306|382328|P1|Overall Study|Withdrawal by Subject|9
111670|NCT00670306|382328|P1|Overall Study|Lack of Efficacy|10
111671|NCT00670306|382328|P1|Overall Study|Adverse Event|8
111672|NCT00670228|382367|P2|Overall Study|Not meeting the selection criteria|0
111673|NCT00670228|382368|P1|Overall Study|Not meeting the selection criteria|2
111674|NCT00670228|382367|P2|Overall Study|Not treated|2
111675|NCT00670228|382368|P1|Overall Study|Not treated|2
111676|NCT00670228|382367|P2|Overall Study|Death or MACE|1
111677|NCT00670228|382368|P1|Overall Study|Death or MACE|0
111678|NCT00670228|382367|P2|Overall Study|Adverse Event|0
111679|NCT00670228|382368|P1|Overall Study|Adverse Event|1
111680|NCT00670007|382380|P1|Overall Study|Withdrawal by Subject|4
111681|NCT00670007|382380|P1|Overall Study|Adverse Event|1
111682|NCT00670007|382380|P1|Overall Study|Adverse event, serious fatal|1
111683|NCT00670007|382380|P1|Overall Study|Travel/Vacation|1
111684|NCT00670007|382380|P1|Overall Study|Lung transplant|1
111685|NCT00670007|382380|P1|Overall Study|Drug abuse|1
111686|NCT00669955|382407|P2|Overall Study|not compliant with study drug/visit|3
111687|NCT00669955|382408|P1|Overall Study|not compliant with study drug/visit|2
111688|NCT00669955|382407|P2|Overall Study|Investigator Sponsor Jugement|1
111689|NCT00669955|382408|P1|Overall Study|Investigator Sponsor Jugement|0
111690|NCT00669955|382407|P2|Overall Study|Protocol Violation|7
111691|NCT00669955|382408|P1|Overall Study|Protocol Violation|2
111692|NCT00669955|382407|P2|Overall Study|Lost to Follow-up|7
111693|NCT00669955|382408|P1|Overall Study|Lost to Follow-up|5
111694|NCT00669955|382407|P2|Overall Study|Withdrawal by Subject|3
111695|NCT00669955|382408|P1|Overall Study|Withdrawal by Subject|2
111696|NCT00669955|382407|P2|Overall Study|Death|1
111697|NCT00669955|382408|P1|Overall Study|Death|0
111698|NCT00669955|382407|P2|Overall Study|Adverse Event|5
111699|NCT00669955|382408|P1|Overall Study|Adverse Event|3
111700|NCT00669942|382438|P12|Parts 2 and 3|Protocol Violation|0
111701|NCT00669942|382439|P11|Parts 2 and 3|Protocol Violation|0
111702|NCT00669942|382440|P10|Parts 2 and 3|Protocol Violation|0
111703|NCT00669942|382441|P9|Parts 2 and 3|Protocol Violation|0
111704|NCT00669942|382442|P8|Parts 2 and 3|Protocol Violation|0
111705|NCT00669942|382443|P7|Parts 2 and 3|Protocol Violation|0
111706|NCT00669942|382444|P6|Parts 2 and 3|Protocol Violation|1
111707|NCT00669942|382445|P5|Parts 2 and 3|Protocol Violation|0
111708|NCT00669942|382446|P4|Parts 2 and 3|Protocol Violation|0
111709|NCT00669942|382447|P3|Parts 2 and 3|Protocol Violation|0
111710|NCT00669942|382448|P2|Parts 2 and 3|Protocol Violation|0
111711|NCT00669942|382449|P1|Parts 2 and 3|Protocol Violation|0
111712|NCT00669942|382438|P12|Parts 2 and 3|Withdrawal by Subject|0
111713|NCT00669942|382439|P11|Parts 2 and 3|Withdrawal by Subject|0
111714|NCT00669942|382440|P10|Parts 2 and 3|Withdrawal by Subject|0
111715|NCT00669942|382441|P9|Parts 2 and 3|Withdrawal by Subject|2
111716|NCT00669942|382442|P8|Parts 2 and 3|Withdrawal by Subject|0
111717|NCT00669942|382443|P7|Parts 2 and 3|Withdrawal by Subject|0
111718|NCT00669942|382444|P6|Parts 2 and 3|Withdrawal by Subject|1
111719|NCT00669942|382445|P5|Parts 2 and 3|Withdrawal by Subject|0
111720|NCT00669942|382446|P4|Parts 2 and 3|Withdrawal by Subject|0
111721|NCT00669942|382447|P3|Parts 2 and 3|Withdrawal by Subject|0
111722|NCT00669942|382448|P2|Parts 2 and 3|Withdrawal by Subject|0
111723|NCT00669942|382449|P1|Parts 2 and 3|Withdrawal by Subject|0
111724|NCT00669942|382438|P12|Parts 2 and 3|Adverse Event|0
111725|NCT00669942|382439|P11|Parts 2 and 3|Adverse Event|0
111726|NCT00669942|382440|P10|Parts 2 and 3|Adverse Event|0
111727|NCT00669942|382441|P9|Parts 2 and 3|Adverse Event|1
111728|NCT00669942|382442|P8|Parts 2 and 3|Adverse Event|2
111729|NCT00669942|382443|P7|Parts 2 and 3|Adverse Event|0
111730|NCT00669942|382444|P6|Parts 2 and 3|Adverse Event|0
111731|NCT00669942|382445|P5|Parts 2 and 3|Adverse Event|0
111732|NCT00669942|382446|P4|Parts 2 and 3|Adverse Event|0
111733|NCT00669942|382447|P3|Parts 2 and 3|Adverse Event|0
111734|NCT00669942|382448|P2|Parts 2 and 3|Adverse Event|0
111735|NCT00669942|382449|P1|Parts 2 and 3|Adverse Event|0
111736|NCT00669903|382532|P4|Overall Study|Protocol Violation|0
111737|NCT00669903|382533|P3|Overall Study|Protocol Violation|0
111738|NCT00669903|382534|P2|Overall Study|Protocol Violation|1
111739|NCT00669903|382535|P1|Overall Study|Protocol Violation|0
111740|NCT00669903|382532|P4|Overall Study|Lost to Follow-up|1
111741|NCT00669903|382533|P3|Overall Study|Lost to Follow-up|0
111742|NCT00669903|382534|P2|Overall Study|Lost to Follow-up|1
111743|NCT00669903|382535|P1|Overall Study|Lost to Follow-up|1
111744|NCT00669903|382532|P4|Overall Study|Withdrawal by Subject|2
111745|NCT00669903|382533|P3|Overall Study|Withdrawal by Subject|2
111746|NCT00669903|382534|P2|Overall Study|Withdrawal by Subject|2
111747|NCT00669903|382535|P1|Overall Study|Withdrawal by Subject|0
111748|NCT00669903|382532|P4|Overall Study|Adverse Event|1
111749|NCT00669903|382533|P3|Overall Study|Adverse Event|3
111750|NCT00669903|382534|P2|Overall Study|Adverse Event|1
111751|NCT00669903|382535|P1|Overall Study|Adverse Event|0
111752|NCT00669864|382565|P1|Overall Study|Other|2
111753|NCT00669864|382565|P1|Overall Study|Withdrawal by Subject|3
111754|NCT00669864|382565|P1|Overall Study|Protocol Violation|2
111755|NCT00669864|382565|P1|Overall Study|Lost to Follow-up|2
111756|NCT00669617|382579|P5|Period 3|Lost to Follow-up|0
111757|NCT00669617|382580|P4|Period 3|Lost to Follow-up|0
111758|NCT00669617|382581|P3|Period 3|Lost to Follow-up|0
111759|NCT00669617|382582|P2|Period 3|Lost to Follow-up|0
111760|NCT00669617|382583|P1|Period 3|Lost to Follow-up|1
111761|NCT00669617|382579|P5|Period 1|Protocol Deviation|1
111762|NCT00669617|382580|P4|Period 1|Protocol Deviation|0
111763|NCT00669617|382581|P3|Period 1|Protocol Deviation|0
111764|NCT00669617|382582|P2|Period 1|Protocol Deviation|0
111765|NCT00669617|382583|P1|Period 1|Protocol Deviation|0
111766|NCT00669617|382579|P5|Period 1|Withdrawal by Subject|0
111767|NCT00669617|382580|P4|Period 1|Withdrawal by Subject|0
111768|NCT00669617|382581|P3|Period 1|Withdrawal by Subject|1
111769|NCT00669617|382582|P2|Period 1|Withdrawal by Subject|0
111770|NCT00669617|382583|P1|Period 1|Withdrawal by Subject|0
111771|NCT00669396|382631|P2|Overall Study|Lost to Follow-up|12
111772|NCT00669396|382632|P1|Overall Study|Lost to Follow-up|10
111773|NCT00669331|382646|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
111774|NCT00669331|382647|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
111775|NCT00669331|382646|P2|Blinded Treatment Period|Physician Decision|3
111776|NCT00669331|382647|P1|Blinded Treatment Period|Physician Decision|3
111777|NCT00669331|382646|P2|Blinded Treatment Period|Death|2
111778|NCT00669331|382647|P1|Blinded Treatment Period|Death|0
111779|NCT00669331|382646|P2|Blinded Treatment Period|Lost to Follow-up|2
111780|NCT00669331|382647|P1|Blinded Treatment Period|Lost to Follow-up|3
111781|NCT00669331|382646|P2|Blinded Treatment Period|Withdrawal by Subject|19
111782|NCT00669331|382647|P1|Blinded Treatment Period|Withdrawal by Subject|17
111783|NCT00669331|382646|P2|Blinded Treatment Period|Protocol Violation|1
111784|NCT00669331|382647|P1|Blinded Treatment Period|Protocol Violation|1
111785|NCT00669331|382646|P2|Blinded Treatment Period|Adverse Event|10
111786|NCT00669331|382647|P1|Blinded Treatment Period|Adverse Event|16
111787|NCT00669331|382646|P2|Randomisation to First Dose|Randomised in error|10
111788|NCT00669331|382647|P1|Randomisation to First Dose|Randomised in error|3
111789|NCT00669331|382646|P2|Randomisation to First Dose|Sponsor decision|1
111790|NCT00669331|382647|P1|Randomisation to First Dose|Sponsor decision|0
111791|NCT00669331|382646|P2|Randomisation to First Dose|Death|0
111792|NCT00669331|382647|P1|Randomisation to First Dose|Death|1
111793|NCT00669331|382646|P2|Randomisation to First Dose|Lost to Follow-up|0
111794|NCT00669331|382647|P1|Randomisation to First Dose|Lost to Follow-up|2
111795|NCT00669331|382646|P2|Randomisation to First Dose|Withdrawal by Subject|2
111796|NCT00669331|382647|P1|Randomisation to First Dose|Withdrawal by Subject|3
111797|NCT00669331|382646|P2|Randomisation to First Dose|Protocol Violation|0
111798|NCT00669331|382647|P1|Randomisation to First Dose|Protocol Violation|1
111799|NCT00669331|382646|P2|Randomisation to First Dose|Adverse Event|0
111800|NCT00669331|382647|P1|Randomisation to First Dose|Adverse Event|1
111801|NCT00669318|382689|P1|Overall Study|Withdrawal by Subject|2
111802|NCT00669240|382706|P1|Overall Study|Enrolled but no dosing record|1
111803|NCT00669240|382706|P1|Overall Study|Enrolled but not treated|15
111804|NCT00669240|382706|P1|Overall Study|Unspecified|19
111805|NCT00669240|382706|P1|Overall Study|Adverse Event|21
111806|NCT00669240|382706|P1|Overall Study|Lost to Follow-up|34
111807|NCT00669240|382706|P1|Overall Study|Withdrawal by Subject|42
111808|NCT00669240|382706|P1|Overall Study|Lack of Efficacy|33
111809|NCT00669110|382757|P2|Overall Study|Withdrawal by Subject|2
111810|NCT00669110|382758|P1|Overall Study|Withdrawal by Subject|0
111811|NCT00669110|382757|P2|Overall Study|Protocol Violation|5
111812|NCT00669110|382758|P1|Overall Study|Protocol Violation|0
111813|NCT00669110|382757|P2|Overall Study|Lost to Follow-up|0
111814|NCT00669110|382758|P1|Overall Study|Lost to Follow-up|1
111815|NCT00669110|382757|P2|Overall Study|Physician Decision|1
111816|NCT00669110|382758|P1|Overall Study|Physician Decision|0
111817|NCT00669110|382757|P2|Overall Study|Caregiver request|2
111818|NCT00669110|382758|P1|Overall Study|Caregiver request|3
111819|NCT00669110|382757|P2|Overall Study|Adverse Event|3
111820|NCT00669110|382758|P1|Overall Study|Adverse Event|4
111821|NCT00669071|382794|P1|Overall Study|Final visit 40 days out of window|1
111822|NCT00669071|382794|P1|Overall Study|Lost to Follow-up|3
111823|NCT00669032|382815|P2|Overall Study|No fulfilment of the selection criteria|5
111824|NCT00669032|382816|P1|Overall Study|No fulfilment of the selection criteria|5
111825|NCT00669032|382815|P2|Overall Study|Physician Decision|1
111826|NCT00669032|382816|P1|Overall Study|Physician Decision|1
111827|NCT00669032|382815|P2|Overall Study|Adverse Event|16
111828|NCT00669032|382816|P1|Overall Study|Adverse Event|12
111829|NCT00669032|382815|P2|Overall Study|Withdrawal by Subject|13
111830|NCT00669032|382816|P1|Overall Study|Withdrawal by Subject|12
111831|NCT00669032|382815|P2|Overall Study|Lack of Efficacy|19
111832|NCT00669032|382816|P1|Overall Study|Lack of Efficacy|8
111833|NCT00669032|382815|P2|Overall Study|Lost to Follow-up|5
111834|NCT00669032|382816|P1|Overall Study|Lost to Follow-up|6
111835|NCT00668863|382862|P1|Overall Study|Physician Decision|1
111836|NCT00668863|382862|P1|Overall Study|Subject’s work scheduling problem|1
111837|NCT00668863|382862|P1|Overall Study|Surgery|1
111838|NCT00668863|382862|P1|Overall Study|Withdrawal by Subject|1
111839|NCT00668863|382862|P1|Overall Study|Global Deterioration of Health Status|4
111840|NCT00668863|382862|P1|Overall Study|Study Terminated by Sponsor|8
111841|NCT00668863|382862|P1|Overall Study|Adverse Event|13
111842|NCT00668863|382862|P1|Overall Study|Objective Progression or Relapse|42
111843|NCT00668746|382887|P2|Overall Study|Lost to Follow-up|1
111844|NCT00668746|382888|P1|Overall Study|Lost to Follow-up|2
111845|NCT00668733|382908|P2|Overall Study|Withdrawal by Subject|4
111846|NCT00668733|382909|P1|Overall Study|Withdrawal by Subject|0
111847|NCT00668733|382908|P2|Overall Study|Lost to Follow-up|3
111848|NCT00668733|382909|P1|Overall Study|Lost to Follow-up|2
111849|NCT00668395|382954|P3|Overall Study|Physician Decision|0
111850|NCT00668395|382955|P2|Overall Study|Physician Decision|1
111851|NCT00668395|382956|P1|Overall Study|Physician Decision|1
111852|NCT00668395|382954|P3|Overall Study|Adverse Event|0
111853|NCT00668395|382955|P2|Overall Study|Adverse Event|1
111854|NCT00668395|382956|P1|Overall Study|Adverse Event|1
111855|NCT00668395|382954|P3|Overall Study|Withdrawal by Subject|1
111856|NCT00668395|382955|P2|Overall Study|Withdrawal by Subject|4
111857|NCT00668395|382956|P1|Overall Study|Withdrawal by Subject|4
111858|NCT00668317|382968|P1|Overall Study|Adverse Event|2
111859|NCT00668200|382983|P1|Overall Study|Lost to Follow-up|1
111860|NCT00668200|382983|P1|Overall Study|Withdrawal by Subject|2
111861|NCT00667992|382991|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
111862|NCT00667992|382992|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
111863|NCT00667992|382991|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
111864|NCT00667992|382992|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
111865|NCT00667992|382991|P2|Wash-out|Withdrawal by Subject|0
111866|NCT00667992|382992|P1|Wash-out|Withdrawal by Subject|1
111867|NCT00667992|382991|P2|Wash-out|Failure to wash-out|2
111868|NCT00667992|382992|P1|Wash-out|Failure to wash-out|2
111869|NCT00667992|382991|P2|Wash-out|Not within one doubling dilution|3
111870|NCT00667992|382992|P1|Wash-out|Not within one doubling dilution|4
111871|NCT00667992|382991|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
111872|NCT00667992|382992|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
111873|NCT00667992|382991|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
111874|NCT00667992|382992|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
111875|NCT00667992|382991|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
111876|NCT00667992|382992|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
111877|NCT00667992|382991|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
111878|NCT00667992|382992|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
111879|NCT00667992|382991|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
111880|NCT00667992|382992|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
111881|NCT00667992|382991|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
111882|NCT00667992|382992|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
111883|NCT00667992|382991|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
111884|NCT00667992|382992|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
111885|NCT00667992|382991|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
111886|NCT00667992|382992|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
111887|NCT00667875|383049|P3|Overall Study|Withdrawal by Subject|7
111888|NCT00667875|383050|P2|Overall Study|Withdrawal by Subject|9
111889|NCT00667875|383051|P1|Overall Study|Withdrawal by Subject|10
111890|NCT00667875|383049|P3|Overall Study|Adverse Event|6
111891|NCT00667875|383050|P2|Overall Study|Adverse Event|2
111892|NCT00667875|383051|P1|Overall Study|Adverse Event|0
111893|NCT00667810|383076|P4|Overall Study|Not specified|0
111894|NCT00667810|383077|P3|Overall Study|Not specified|5
111895|NCT00667810|383078|P2|Overall Study|Not specified|6
111896|NCT00667810|383079|P1|Overall Study|Not specified|6
111897|NCT00667810|383076|P4|Overall Study|Vasogenic Edema Recurrence|0
111898|NCT00667810|383077|P3|Overall Study|Vasogenic Edema Recurrence|0
111899|NCT00667810|383078|P2|Overall Study|Vasogenic Edema Recurrence|3
111900|NCT00667810|383079|P1|Overall Study|Vasogenic Edema Recurrence|0
111901|NCT00667810|383076|P4|Overall Study|Loss of Caregiver|0
111902|NCT00667810|383077|P3|Overall Study|Loss of Caregiver|3
111903|NCT00667810|383078|P2|Overall Study|Loss of Caregiver|1
111904|NCT00667810|383079|P1|Overall Study|Loss of Caregiver|0
111905|NCT00667810|383076|P4|Overall Study|Failed to Return|0
111906|NCT00667810|383077|P3|Overall Study|Failed to Return|2
111907|NCT00667810|383078|P2|Overall Study|Failed to Return|0
111908|NCT00667810|383079|P1|Overall Study|Failed to Return|0
111909|NCT00667810|383076|P4|Overall Study|Discontinuation of Study by Sponsor|0
111910|NCT00667810|383077|P3|Overall Study|Discontinuation of Study by Sponsor|155
111911|NCT00667810|383078|P2|Overall Study|Discontinuation of Study by Sponsor|118
111912|NCT00667810|383079|P1|Overall Study|Discontinuation of Study by Sponsor|130
111913|NCT00667810|383076|P4|Overall Study|Withdrawal by Subject|1
111914|NCT00667810|383077|P3|Overall Study|Withdrawal by Subject|29
111915|NCT00667810|383078|P2|Overall Study|Withdrawal by Subject|20
111916|NCT00667810|383079|P1|Overall Study|Withdrawal by Subject|14
111917|NCT00667810|383076|P4|Overall Study|Protocol Violation|0
111918|NCT00667810|383077|P3|Overall Study|Protocol Violation|0
111919|NCT00667810|383078|P2|Overall Study|Protocol Violation|2
111920|NCT00667810|383079|P1|Overall Study|Protocol Violation|0
111921|NCT00667810|383076|P4|Overall Study|Physician Decision|0
111922|NCT00667810|383077|P3|Overall Study|Physician Decision|2
111923|NCT00667810|383078|P2|Overall Study|Physician Decision|1
111924|NCT00667810|383079|P1|Overall Study|Physician Decision|1
111925|NCT00667810|383076|P4|Overall Study|Lost to Follow-up|0
111926|NCT00667810|383077|P3|Overall Study|Lost to Follow-up|2
111927|NCT00667810|383078|P2|Overall Study|Lost to Follow-up|4
111928|NCT00667810|383079|P1|Overall Study|Lost to Follow-up|1
111929|NCT00667810|383076|P4|Overall Study|Lack of Efficacy|0
111930|NCT00667810|383077|P3|Overall Study|Lack of Efficacy|2
111931|NCT00667810|383078|P2|Overall Study|Lack of Efficacy|0
111932|NCT00667810|383079|P1|Overall Study|Lack of Efficacy|1
111933|NCT00667810|383076|P4|Overall Study|Death|0
111934|NCT00667810|383077|P3|Overall Study|Death|3
111935|NCT00667810|383078|P2|Overall Study|Death|1
111936|NCT00667810|383079|P1|Overall Study|Death|1
111937|NCT00667810|383076|P4|Overall Study|Adverse Event|1
111938|NCT00667810|383077|P3|Overall Study|Adverse Event|19
111939|NCT00667810|383078|P2|Overall Study|Adverse Event|14
111940|NCT00667810|383079|P1|Overall Study|Adverse Event|13
111941|NCT00667732|383149|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
111942|NCT00667732|383150|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
111943|NCT00667732|383151|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
111944|NCT00667732|383149|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
111945|NCT00667732|383150|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
111946|NCT00667732|383151|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
111947|NCT00667732|383149|P3|Run -In (8 Weeks)|Adverse Event|0
111948|NCT00667732|383150|P2|Run -In (8 Weeks)|Adverse Event|0
111949|NCT00667732|383151|P1|Run -In (8 Weeks)|Adverse Event|4
111950|NCT00667602|383174|P3|Overall Study|Protocol Violation|0
111951|NCT00667602|383175|P2|Overall Study|Protocol Violation|1
111952|NCT00667602|383176|P1|Overall Study|Protocol Violation|0
111953|NCT00667602|383174|P3|Overall Study|Administrative reason|2
111954|NCT00667602|383175|P2|Overall Study|Administrative reason|0
111955|NCT00667602|383176|P1|Overall Study|Administrative reason|0
111956|NCT00667602|383174|P3|Overall Study|Lost to Follow-up|6
111957|NCT00667602|383175|P2|Overall Study|Lost to Follow-up|5
111958|NCT00667602|383176|P1|Overall Study|Lost to Follow-up|4
111959|NCT00667602|383174|P3|Overall Study|Withdrawal by Subject|10
111960|NCT00667602|383175|P2|Overall Study|Withdrawal by Subject|9
111961|NCT00667602|383176|P1|Overall Study|Withdrawal by Subject|4
111962|NCT00667576|383244|P5|Overall Study|Missed Visit|0
111963|NCT00667576|383245|P4|Overall Study|Missed Visit|1
111964|NCT00667576|383246|P3|Overall Study|Missed Visit|0
111965|NCT00667576|383247|P2|Overall Study|Missed Visit|0
111966|NCT00667576|383248|P1|Overall Study|Missed Visit|0
111967|NCT00667576|383244|P5|Overall Study|Physician Decision|0
111968|NCT00667576|383245|P4|Overall Study|Physician Decision|1
111969|NCT00667576|383246|P3|Overall Study|Physician Decision|0
111970|NCT00667576|383247|P2|Overall Study|Physician Decision|0
111971|NCT00667576|383248|P1|Overall Study|Physician Decision|0
111972|NCT00667576|383244|P5|Overall Study|Protocol Violation|0
111973|NCT00667576|383245|P4|Overall Study|Protocol Violation|1
111974|NCT00667576|383246|P3|Overall Study|Protocol Violation|0
111975|NCT00667576|383247|P2|Overall Study|Protocol Violation|0
111976|NCT00667576|383248|P1|Overall Study|Protocol Violation|0
111977|NCT00667576|383244|P5|Overall Study|Lost to Follow-up|0
111978|NCT00667576|383245|P4|Overall Study|Lost to Follow-up|0
111979|NCT00667576|383246|P3|Overall Study|Lost to Follow-up|1
111980|NCT00667576|383247|P2|Overall Study|Lost to Follow-up|0
111981|NCT00667576|383248|P1|Overall Study|Lost to Follow-up|0
111982|NCT00667576|383244|P5|Overall Study|Adverse Event|0
111983|NCT00667576|383245|P4|Overall Study|Adverse Event|0
111984|NCT00667576|383246|P3|Overall Study|Adverse Event|0
111985|NCT00667576|383247|P2|Overall Study|Adverse Event|1
111986|NCT00667576|383248|P1|Overall Study|Adverse Event|1
111987|NCT00667576|383244|P5|Overall Study|Withdrawal by Subject|1
111988|NCT00667576|383245|P4|Overall Study|Withdrawal by Subject|1
111989|NCT00667576|383246|P3|Overall Study|Withdrawal by Subject|1
111990|NCT00667576|383247|P2|Overall Study|Withdrawal by Subject|0
111991|NCT00667576|383248|P1|Overall Study|Withdrawal by Subject|1
111992|NCT00667563|383295|P1|Overall Study|Protocol Violation|24
111993|NCT00667459|383315|P2|Overall Study|Lost to Follow-up|43
111994|NCT00667459|383316|P1|Overall Study|Lost to Follow-up|8
111995|NCT00667459|383315|P2|Overall Study|Death|2
111996|NCT00667459|383316|P1|Overall Study|Death|0
111997|NCT00667446|383358|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
111998|NCT00667446|383359|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
111999|NCT00667446|383358|P2|Treatment Period (36 Months)|Therapeutic Failure|1
112000|NCT00667446|383359|P1|Treatment Period (36 Months)|Therapeutic Failure|1
112001|NCT00667446|383358|P2|Treatment Period (36 Months)|Protocol Violation|1
112002|NCT00667446|383359|P1|Treatment Period (36 Months)|Protocol Violation|1
112003|NCT00667446|383358|P2|Treatment Period (36 Months)|Lost to Follow-up|0
112004|NCT00667446|383359|P1|Treatment Period (36 Months)|Lost to Follow-up|1
112005|NCT00667446|383358|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
112006|NCT00667446|383359|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
112007|NCT00667446|383358|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
112008|NCT00667446|383359|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
112009|NCT00667446|383358|P2|Treatment Period (36 Months)|Personal reasons|2
112010|NCT00667446|383359|P1|Treatment Period (36 Months)|Personal reasons|2
112011|NCT00667446|383358|P2|Treatment Period (36 Months)|Other|2
112012|NCT00667446|383359|P1|Treatment Period (36 Months)|Other|2
112013|NCT00667446|383358|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
112014|NCT00667446|383359|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
112015|NCT00667420|383381|P1|Overall Study|Withdrawal by Subject|2
112016|NCT00667420|383381|P1|Overall Study|Physician Decision|1
112017|NCT00667420|383381|P1|Overall Study|Lack of Efficacy|5
112018|NCT00667420|383381|P1|Overall Study|Adverse Event|2
112019|NCT00667394|383391|P2|Overall Study|Progressive disease|0
112020|NCT00667394|383392|P1|Overall Study|Progressive disease|1
112021|NCT00667394|383391|P2|Overall Study|Adverse Event|0
112022|NCT00667394|383392|P1|Overall Study|Adverse Event|3
112023|NCT00667368|383419|P2|Overall Study|Discontinued early|17
112024|NCT00667368|383420|P1|Overall Study|Discontinued early|24
112025|NCT00667368|383419|P2|Overall Study|Lost to Follow-up|155
112026|NCT00667368|383420|P1|Overall Study|Lost to Follow-up|176
112027|NCT00667355|383428|P1|Overall Study|Other reason was not specified|5
112028|NCT00667355|383428|P1|Overall Study|Lost to Follow-up|1
112029|NCT00667355|383428|P1|Overall Study|Adverse Event|5
112030|NCT00667342|383453|P3|Overall Study|Ineligible|1
112031|NCT00667342|383454|P2|Overall Study|Ineligible|0
112032|NCT00667342|383455|P1|Overall Study|Ineligible|0
112033|NCT00667342|383453|P3|Overall Study|Adverse Event|1
112034|NCT00667342|383454|P2|Overall Study|Adverse Event|0
112035|NCT00667342|383455|P1|Overall Study|Adverse Event|0
112036|NCT00667342|383453|P3|Overall Study|Relapse or tumor progression|7
112037|NCT00667342|383454|P2|Overall Study|Relapse or tumor progression|0
112038|NCT00667342|383455|P1|Overall Study|Relapse or tumor progression|9
112039|NCT00667342|383453|P3|Overall Study|Physician Decision|0
112040|NCT00667342|383454|P2|Overall Study|Physician Decision|0
112041|NCT00667342|383455|P1|Overall Study|Physician Decision|3
112042|NCT00667342|383453|P3|Overall Study|Withdrawal by Subject|0
112043|NCT00667342|383454|P2|Overall Study|Withdrawal by Subject|0
112044|NCT00667342|383455|P1|Overall Study|Withdrawal by Subject|1
112045|NCT00667342|383453|P3|Overall Study|Protocol Violation|0
112046|NCT00667342|383454|P2|Overall Study|Protocol Violation|0
112047|NCT00667342|383455|P1|Overall Study|Protocol Violation|1
112048|NCT00667277|383482|P1|Overall Study|Withdrawal by Subject|2
112049|NCT00667251|383489|P2|Overall Study|Symptomatic progression|2
112050|NCT00667251|383490|P1|Overall Study|Symptomatic progression|1
112051|NCT00667251|383489|P2|Overall Study|Intercurrent Illness|3
112052|NCT00667251|383490|P1|Overall Study|Intercurrent Illness|4
112053|NCT00667251|383489|P2|Overall Study|Other/missing|84
112054|NCT00667251|383490|P1|Overall Study|Other/missing|46
112055|NCT00667251|383489|P2|Overall Study|Withdrawal by Subject|2
112056|NCT00667251|383490|P1|Overall Study|Withdrawal by Subject|6
112057|NCT00667251|383489|P2|Overall Study|Adverse Event|4
112058|NCT00667251|383490|P1|Overall Study|Adverse Event|13
112059|NCT00667225|383516|P2|Overall Study|Lost to Follow-up|1
112060|NCT00667225|383517|P1|Overall Study|Lost to Follow-up|0
112061|NCT00667225|383516|P2|Overall Study|Subject had no more lesions to treat.|0
112062|NCT00667225|383517|P1|Overall Study|Subject had no more lesions to treat.|1
112063|NCT00667095|383538|P2|Overall Study|Withdrawal by Subject|1
112064|NCT00667095|383539|P1|Overall Study|Withdrawal by Subject|0
112065|NCT00666965|383559|P4|Overall Study|Withdrawal by Subject|2
112066|NCT00666965|383560|P3|Overall Study|Withdrawal by Subject|0
112067|NCT00666965|383561|P2|Overall Study|Withdrawal by Subject|0
112068|NCT00666965|383562|P1|Overall Study|Withdrawal by Subject|0
112069|NCT00666965|383559|P4|Overall Study|Discontinuation criteria|2
112070|NCT00666965|383560|P3|Overall Study|Discontinuation criteria|1
112071|NCT00666965|383561|P2|Overall Study|Discontinuation criteria|1
112072|NCT00666965|383562|P1|Overall Study|Discontinuation criteria|2
112073|NCT00666965|383559|P4|Overall Study|Protocol Violation|2
112074|NCT00666965|383560|P3|Overall Study|Protocol Violation|0
112075|NCT00666965|383561|P2|Overall Study|Protocol Violation|0
112076|NCT00666965|383562|P1|Overall Study|Protocol Violation|0
112077|NCT00666965|383559|P4|Overall Study|Lack of Efficacy|0
112078|NCT00666965|383560|P3|Overall Study|Lack of Efficacy|0
112079|NCT00666965|383561|P2|Overall Study|Lack of Efficacy|1
112080|NCT00666965|383562|P1|Overall Study|Lack of Efficacy|1
112081|NCT00666965|383559|P4|Overall Study|Adverse Event|9
112082|NCT00666965|383560|P3|Overall Study|Adverse Event|1
112083|NCT00666965|383561|P2|Overall Study|Adverse Event|2
112084|NCT00666965|383562|P1|Overall Study|Adverse Event|0
112085|NCT00666926|383592|P16|Overall Study|Death|0
112086|NCT00666926|383593|P15|Overall Study|Death|0
112087|NCT00666926|383594|P14|Overall Study|Death|0
112088|NCT00666926|383595|P13|Overall Study|Death|0
112089|NCT00666926|383596|P12|Overall Study|Death|1
112090|NCT00666926|383597|P11|Overall Study|Death|0
112091|NCT00666926|383598|P10|Overall Study|Death|0
112092|NCT00666926|383599|P9|Overall Study|Death|0
112093|NCT00666926|383600|P8|Overall Study|Death|0
112094|NCT00666926|383601|P7|Overall Study|Death|0
112095|NCT00666926|383602|P6|Overall Study|Death|0
112096|NCT00666926|383603|P5|Overall Study|Death|0
112097|NCT00666926|383604|P4|Overall Study|Death|0
112098|NCT00666926|383605|P3|Overall Study|Death|0
112099|NCT00666926|383606|P2|Overall Study|Death|0
112100|NCT00666926|383607|P1|Overall Study|Death|0
112101|NCT00666926|383592|P16|Overall Study|Withdrawal by Subject|3
112102|NCT00666926|383593|P15|Overall Study|Withdrawal by Subject|3
112103|NCT00666926|383594|P14|Overall Study|Withdrawal by Subject|1
112104|NCT00666926|383595|P13|Overall Study|Withdrawal by Subject|0
112105|NCT00666926|383596|P12|Overall Study|Withdrawal by Subject|3
112106|NCT00666926|383597|P11|Overall Study|Withdrawal by Subject|0
112107|NCT00666926|383598|P10|Overall Study|Withdrawal by Subject|3
112108|NCT00666926|383599|P9|Overall Study|Withdrawal by Subject|0
112109|NCT00666926|383600|P8|Overall Study|Withdrawal by Subject|1
112110|NCT00666926|383601|P7|Overall Study|Withdrawal by Subject|0
112111|NCT00666926|383602|P6|Overall Study|Withdrawal by Subject|0
112112|NCT00666926|383603|P5|Overall Study|Withdrawal by Subject|0
112113|NCT00666926|383604|P4|Overall Study|Withdrawal by Subject|0
112114|NCT00666926|383605|P3|Overall Study|Withdrawal by Subject|0
112115|NCT00666926|383606|P2|Overall Study|Withdrawal by Subject|0
112116|NCT00666926|383607|P1|Overall Study|Withdrawal by Subject|0
112117|NCT00666926|383592|P16|Overall Study|Unspecified|4
112118|NCT00666926|383593|P15|Overall Study|Unspecified|4
112119|NCT00666926|383594|P14|Overall Study|Unspecified|2
112120|NCT00666926|383595|P13|Overall Study|Unspecified|3
112121|NCT00666926|383596|P12|Overall Study|Unspecified|26
112122|NCT00666926|383597|P11|Overall Study|Unspecified|3
112123|NCT00666926|383598|P10|Overall Study|Unspecified|5
112124|NCT00666926|383599|P9|Overall Study|Unspecified|3
112125|NCT00666926|383600|P8|Overall Study|Unspecified|0
112126|NCT00666926|383601|P7|Overall Study|Unspecified|4
112127|NCT00666926|383602|P6|Overall Study|Unspecified|3
112128|NCT00666926|383603|P5|Overall Study|Unspecified|3
112129|NCT00666926|383604|P4|Overall Study|Unspecified|3
112130|NCT00666926|383605|P3|Overall Study|Unspecified|3
112131|NCT00666926|383606|P2|Overall Study|Unspecified|4
112132|NCT00666926|383607|P1|Overall Study|Unspecified|2
112133|NCT00666926|383592|P16|Overall Study|Lost to Follow-up|0
112134|NCT00666926|383593|P15|Overall Study|Lost to Follow-up|0
112135|NCT00666926|383594|P14|Overall Study|Lost to Follow-up|0
112136|NCT00666926|383595|P13|Overall Study|Lost to Follow-up|0
112137|NCT00666926|383596|P12|Overall Study|Lost to Follow-up|0
112138|NCT00666926|383597|P11|Overall Study|Lost to Follow-up|0
112139|NCT00666926|383598|P10|Overall Study|Lost to Follow-up|0
112140|NCT00666926|383599|P9|Overall Study|Lost to Follow-up|0
112141|NCT00666926|383600|P8|Overall Study|Lost to Follow-up|0
112142|NCT00666926|383601|P7|Overall Study|Lost to Follow-up|0
112143|NCT00666926|383602|P6|Overall Study|Lost to Follow-up|0
112144|NCT00666926|383603|P5|Overall Study|Lost to Follow-up|0
112145|NCT00666926|383604|P4|Overall Study|Lost to Follow-up|1
112146|NCT00666926|383605|P3|Overall Study|Lost to Follow-up|0
112147|NCT00666926|383606|P2|Overall Study|Lost to Follow-up|0
112148|NCT00666926|383607|P1|Overall Study|Lost to Follow-up|0
112149|NCT00666926|383592|P16|Overall Study|Lack of Efficacy|0
112150|NCT00666926|383593|P15|Overall Study|Lack of Efficacy|0
112151|NCT00666926|383594|P14|Overall Study|Lack of Efficacy|0
112152|NCT00666926|383595|P13|Overall Study|Lack of Efficacy|0
112153|NCT00666926|383596|P12|Overall Study|Lack of Efficacy|1
112154|NCT00666926|383597|P11|Overall Study|Lack of Efficacy|0
112155|NCT00666926|383598|P10|Overall Study|Lack of Efficacy|0
112156|NCT00666926|383599|P9|Overall Study|Lack of Efficacy|0
112157|NCT00666926|383600|P8|Overall Study|Lack of Efficacy|0
112158|NCT00666926|383601|P7|Overall Study|Lack of Efficacy|0
112159|NCT00666926|383602|P6|Overall Study|Lack of Efficacy|1
112160|NCT00666926|383603|P5|Overall Study|Lack of Efficacy|0
112161|NCT00666926|383604|P4|Overall Study|Lack of Efficacy|0
112162|NCT00666926|383605|P3|Overall Study|Lack of Efficacy|0
112163|NCT00666926|383606|P2|Overall Study|Lack of Efficacy|0
112164|NCT00666926|383607|P1|Overall Study|Lack of Efficacy|0
112165|NCT00666926|383592|P16|Overall Study|Laboratory abnormality|1
112166|NCT00666926|383593|P15|Overall Study|Laboratory abnormality|0
112167|NCT00666926|383594|P14|Overall Study|Laboratory abnormality|0
112168|NCT00666926|383595|P13|Overall Study|Laboratory abnormality|0
112169|NCT00666926|383596|P12|Overall Study|Laboratory abnormality|0
112170|NCT00666926|383597|P11|Overall Study|Laboratory abnormality|1
112171|NCT00666926|383598|P10|Overall Study|Laboratory abnormality|0
112172|NCT00666926|383599|P9|Overall Study|Laboratory abnormality|0
112173|NCT00666926|383600|P8|Overall Study|Laboratory abnormality|0
112174|NCT00666926|383601|P7|Overall Study|Laboratory abnormality|0
112175|NCT00666926|383602|P6|Overall Study|Laboratory abnormality|0
112176|NCT00666926|383603|P5|Overall Study|Laboratory abnormality|0
112177|NCT00666926|383604|P4|Overall Study|Laboratory abnormality|0
112178|NCT00666926|383605|P3|Overall Study|Laboratory abnormality|0
112179|NCT00666926|383606|P2|Overall Study|Laboratory abnormality|0
112180|NCT00666926|383607|P1|Overall Study|Laboratory abnormality|0
112181|NCT00666926|383592|P16|Overall Study|Adverse Event|0
112182|NCT00666926|383593|P15|Overall Study|Adverse Event|0
112183|NCT00666926|383594|P14|Overall Study|Adverse Event|1
112184|NCT00666926|383595|P13|Overall Study|Adverse Event|0
112185|NCT00666926|383596|P12|Overall Study|Adverse Event|2
112186|NCT00666926|383597|P11|Overall Study|Adverse Event|2
112187|NCT00666926|383598|P10|Overall Study|Adverse Event|2
112188|NCT00666926|383599|P9|Overall Study|Adverse Event|0
112189|NCT00666926|383600|P8|Overall Study|Adverse Event|0
112190|NCT00666926|383601|P7|Overall Study|Adverse Event|0
112191|NCT00666926|383602|P6|Overall Study|Adverse Event|0
112192|NCT00666926|383603|P5|Overall Study|Adverse Event|0
112193|NCT00666926|383604|P4|Overall Study|Adverse Event|0
112194|NCT00666926|383605|P3|Overall Study|Adverse Event|0
112195|NCT00666926|383606|P2|Overall Study|Adverse Event|0
112196|NCT00666926|383607|P1|Overall Study|Adverse Event|0
112197|NCT00666757|383916|P2|Overall Study|Sponsor decision|1
112198|NCT00666757|383917|P1|Overall Study|Sponsor decision|0
112199|NCT00666757|383916|P2|Overall Study|Physician Decision|2
112200|NCT00666757|383917|P1|Overall Study|Physician Decision|0
112201|NCT00666757|383916|P2|Overall Study|Lack of Efficacy|6
112202|NCT00666757|383917|P1|Overall Study|Lack of Efficacy|3
112203|NCT00666757|383916|P2|Overall Study|Withdrawal by Subject|17
112204|NCT00666757|383917|P1|Overall Study|Withdrawal by Subject|13
112205|NCT00666757|383916|P2|Overall Study|Adverse Event|12
112206|NCT00666757|383917|P1|Overall Study|Adverse Event|22
112207|NCT00666757|383916|P2|Overall Study|Protocol Violation|24
112208|NCT00666757|383917|P1|Overall Study|Protocol Violation|23
112209|NCT00666757|383916|P2|Overall Study|Lost to Follow-up|35
112210|NCT00666757|383917|P1|Overall Study|Lost to Follow-up|39
112211|NCT00666718|383976|P2|Overall Study|Physician Decision|2
112212|NCT00666718|383977|P1|Overall Study|Physician Decision|0
112213|NCT00666718|383976|P2|Overall Study|Withdrawal by Subject|12
112214|NCT00666718|383977|P1|Overall Study|Withdrawal by Subject|7
112215|NCT00666718|383976|P2|Overall Study|Protocol Violation|3
112216|NCT00666718|383977|P1|Overall Study|Protocol Violation|1
112217|NCT00666718|383976|P2|Overall Study|Entry Criteria Not Met|0
112218|NCT00666718|383977|P1|Overall Study|Entry Criteria Not Met|2
112219|NCT00666718|383976|P2|Overall Study|Lost to Follow-up|0
112220|NCT00666718|383977|P1|Overall Study|Lost to Follow-up|1
112221|NCT00666718|383976|P2|Overall Study|Death|0
112222|NCT00666718|383977|P1|Overall Study|Death|1
112223|NCT00666718|383976|P2|Overall Study|Adverse Event|1
112224|NCT00666718|383977|P1|Overall Study|Adverse Event|0
112225|NCT00666705|384003|P1|Overall Study|Withdrawal by Subject|1
112226|NCT00666679|384022|P2|Second Intervention|Death|1
112227|NCT00666679|384023|P1|Second Intervention|Death|0
112228|NCT00666679|384022|P2|Second Intervention|Adverse Event|0
112229|NCT00666679|384023|P1|Second Intervention|Adverse Event|1
112230|NCT00666679|384022|P2|Washout Period of 1 Week|Protocol Violation|1
112231|NCT00666679|384023|P1|Washout Period of 1 Week|Protocol Violation|0
112232|NCT00666679|384022|P2|Washout Period of 1 Week|Lost to Follow-up|1
112233|NCT00666679|384023|P1|Washout Period of 1 Week|Lost to Follow-up|0
112234|NCT00666679|384022|P2|First Intervention|Randomized did not start treatment|1
112235|NCT00666679|384023|P1|First Intervention|Randomized did not start treatment|1
112236|NCT00666679|384022|P2|First Intervention|Withdrawal by Subject|0
112237|NCT00666679|384023|P1|First Intervention|Withdrawal by Subject|1
112238|NCT00666679|384022|P2|First Intervention|Protocol Violation|0
112239|NCT00666679|384023|P1|First Intervention|Protocol Violation|1
112240|NCT00666679|384022|P2|First Intervention|Lost to Follow-up|0
112241|NCT00666679|384023|P1|First Intervention|Lost to Follow-up|1
112242|NCT00666588|384053|P4|Overall Study|inevaluable|0
112243|NCT00666588|384054|P3|Overall Study|inevaluable|0
112244|NCT00666588|384055|P2|Overall Study|inevaluable|0
112245|NCT00666588|384056|P1|Overall Study|inevaluable|2
112246|NCT00666588|384053|P4|Overall Study|ineligible|2
112247|NCT00666588|384054|P3|Overall Study|ineligible|0
112248|NCT00666588|384055|P2|Overall Study|ineligible|0
112249|NCT00666588|384056|P1|Overall Study|ineligible|2
112250|NCT00666562|384073|P3|Overall Study|Concomitant Medication|0
112251|NCT00666562|384074|P2|Overall Study|Concomitant Medication|1
112252|NCT00666562|384075|P1|Overall Study|Concomitant Medication|0
112253|NCT00666562|384073|P3|Overall Study|Withdrawal by Subject|0
112254|NCT00666562|384074|P2|Overall Study|Withdrawal by Subject|1
112255|NCT00666562|384075|P1|Overall Study|Withdrawal by Subject|0
112256|NCT00666536|384122|P2|Overall Study|Lost to Follow-up|3
112257|NCT00666536|384123|P1|Overall Study|Lost to Follow-up|4
112258|NCT00666536|384122|P2|Overall Study|Withdrawal by Subject|9
112259|NCT00666536|384123|P1|Overall Study|Withdrawal by Subject|10
112260|NCT00666536|384122|P2|Overall Study|Protocol deviation(s)|6
112261|NCT00666536|384123|P1|Overall Study|Protocol deviation(s)|8
112262|NCT00666536|384122|P2|Overall Study|Unsatisfactory therapeutic effect|0
112263|NCT00666536|384123|P1|Overall Study|Unsatisfactory therapeutic effect|2
112264|NCT00666536|384122|P2|Overall Study|Adverse Event|19
112265|NCT00666536|384123|P1|Overall Study|Adverse Event|9
112266|NCT00666458|384141|P2|Overall Study|Medical history of anemia|0
112267|NCT00666458|384142|P1|Overall Study|Medical history of anemia|1
112268|NCT00666458|384141|P2|Overall Study|Safety reasons|0
112269|NCT00666458|384142|P1|Overall Study|Safety reasons|1
112270|NCT00666458|384141|P2|Overall Study|Severe non-compliance to the protocol|1
112271|NCT00666458|384142|P1|Overall Study|Severe non-compliance to the protocol|1
112272|NCT00666458|384141|P2|Overall Study|Study specific discontinuation criteria|7
112273|NCT00666458|384142|P1|Overall Study|Study specific discontinuation criteria|14
112274|NCT00666458|384141|P2|Overall Study|Incorrect enrollment|1
112275|NCT00666458|384142|P1|Overall Study|Incorrect enrollment|7
112276|NCT00666458|384141|P2|Overall Study|Administrative reason by sponsor|1
112277|NCT00666458|384142|P1|Overall Study|Administrative reason by sponsor|1
112278|NCT00666458|384141|P2|Overall Study|Lost to Follow-up|3
112279|NCT00666458|384142|P1|Overall Study|Lost to Follow-up|0
112280|NCT00666458|384141|P2|Overall Study|Withdrawal by Subject|4
112281|NCT00666458|384142|P1|Overall Study|Withdrawal by Subject|5
112282|NCT00666458|384141|P2|Overall Study|Adverse Event|7
112283|NCT00666458|384142|P1|Overall Study|Adverse Event|8
112284|NCT00666328|384230|P1|Overall Study|No longer met eligibility criteria|1
112285|NCT00666328|384230|P1|Overall Study|Lost to Follow-up|2
112286|NCT00666328|384230|P1|Overall Study|Death|2
112287|NCT00666276|384243|P1|Overall Study|Protocol Violation|34
112288|NCT00666263|384267|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
112289|NCT00666263|384268|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
112290|NCT00666263|384267|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
112291|NCT00666263|384268|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
112292|NCT00666263|384267|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
112293|NCT00666263|384268|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
112294|NCT00666224|384412|P2|Open-Label|Undefined/Unknown|1
112295|NCT00666224|384413|P1|Open-Label|Undefined/Unknown|1
112296|NCT00666224|384412|P2|Open-Label|Noncompliance|1
112297|NCT00666224|384413|P1|Open-Label|Noncompliance|2
112298|NCT00666224|384412|P2|Open-Label|Pregnancy|5
112299|NCT00666224|384413|P1|Open-Label|Pregnancy|1
112300|NCT00666224|384412|P2|Open-Label|Physician Decision|5
112301|NCT00666224|384413|P1|Open-Label|Physician Decision|7
112302|NCT00666224|384412|P2|Open-Label|Withdrawal by Subject|25
112303|NCT00666224|384413|P1|Open-Label|Withdrawal by Subject|12
112304|NCT00666224|384412|P2|Open-Label|Lost to Follow-up|5
112305|NCT00666224|384413|P1|Open-Label|Lost to Follow-up|4
112306|NCT00666224|384412|P2|Open-Label|Adverse Event|43
112307|NCT00666224|384413|P1|Open-Label|Adverse Event|8
112308|NCT00666224|384412|P2|Double-Blind|Undefined/Unknown|1
112309|NCT00666224|384413|P1|Double-Blind|Undefined/Unknown|4
112310|NCT00666224|384412|P2|Double-Blind|Death|0
112311|NCT00666224|384413|P1|Double-Blind|Death|1
112312|NCT00666224|384412|P2|Double-Blind|Noncompliance|0
112313|NCT00666224|384413|P1|Double-Blind|Noncompliance|1
112314|NCT00666224|384412|P2|Double-Blind|Pregnancy|2
112315|NCT00666224|384413|P1|Double-Blind|Pregnancy|3
112316|NCT00666224|384412|P2|Double-Blind|Sponsor decision|0
112317|NCT00666224|384413|P1|Double-Blind|Sponsor decision|1
112318|NCT00666224|384412|P2|Double-Blind|Physician Decision|3
112319|NCT00666224|384413|P1|Double-Blind|Physician Decision|0
112320|NCT00666224|384412|P2|Double-Blind|Withdrawal by Subject|14
112321|NCT00666224|384413|P1|Double-Blind|Withdrawal by Subject|18
112322|NCT00666224|384412|P2|Double-Blind|Lost to Follow-up|2
112323|NCT00666224|384413|P1|Double-Blind|Lost to Follow-up|2
112324|NCT00666224|384412|P2|Double-Blind|Adverse Event|5
112325|NCT00666224|384413|P1|Double-Blind|Adverse Event|15
112326|NCT00666211|384432|P2|Overall Study|Physician Decision|1
112327|NCT00666211|384433|P1|Overall Study|Physician Decision|0
112328|NCT00666211|384432|P2|Overall Study|off tx for other complicating disease|1
112329|NCT00666211|384433|P1|Overall Study|off tx for other complicating disease|0
112330|NCT00666211|384432|P2|Overall Study|Death|2
112331|NCT00666211|384433|P1|Overall Study|Death|0
112332|NCT00666211|384432|P2|Overall Study|hospital admission|5
112333|NCT00666211|384433|P1|Overall Study|hospital admission|0
112334|NCT00666211|384432|P2|Overall Study|toxicity|2
112335|NCT00666211|384433|P1|Overall Study|toxicity|0
112336|NCT00666211|384432|P2|Overall Study|Lost to Follow-up|0
112337|NCT00666211|384433|P1|Overall Study|Lost to Follow-up|2
112338|NCT00666211|384432|P2|Overall Study|disease progression|8
112339|NCT00666211|384433|P1|Overall Study|disease progression|1
112340|NCT00666211|384432|P2|Overall Study|patient non-compliant|6
112341|NCT00666211|384433|P1|Overall Study|patient non-compliant|6
112342|NCT00666211|384432|P2|Overall Study|went off medication, no more pain|0
112343|NCT00666211|384433|P1|Overall Study|went off medication, no more pain|1
112344|NCT00666211|384432|P2|Overall Study|Withdrawal by Subject|13
112345|NCT00666211|384433|P1|Overall Study|Withdrawal by Subject|10
112346|NCT00665925|384466|P4|Overall Study|Due to exclusion criteria|0
112347|NCT00665925|384467|P3|Overall Study|Due to exclusion criteria|0
112348|NCT00665925|384468|P2|Overall Study|Due to exclusion criteria|0
112349|NCT00665925|384469|P1|Overall Study|Due to exclusion criteria|1
112350|NCT00665925|384466|P4|Overall Study|Enrolled by mistake|1
112351|NCT00665925|384467|P3|Overall Study|Enrolled by mistake|0
112352|NCT00665925|384468|P2|Overall Study|Enrolled by mistake|0
112353|NCT00665925|384469|P1|Overall Study|Enrolled by mistake|0
112354|NCT00665925|384466|P4|Overall Study|Adverse Event|5
112355|NCT00665925|384467|P3|Overall Study|Adverse Event|10
112356|NCT00665925|384468|P2|Overall Study|Adverse Event|5
112357|NCT00665925|384469|P1|Overall Study|Adverse Event|1
112358|NCT00665925|384466|P4|Overall Study|Severe Non-Compliance to Protocol|1
112359|NCT00665925|384467|P3|Overall Study|Severe Non-Compliance to Protocol|1
112360|NCT00665925|384468|P2|Overall Study|Severe Non-Compliance to Protocol|0
112361|NCT00665925|384469|P1|Overall Study|Severe Non-Compliance to Protocol|0
112362|NCT00665925|384466|P4|Overall Study|Physician Decision|2
112363|NCT00665925|384467|P3|Overall Study|Physician Decision|1
112364|NCT00665925|384468|P2|Overall Study|Physician Decision|0
112365|NCT00665925|384469|P1|Overall Study|Physician Decision|0
112366|NCT00665925|384466|P4|Overall Study|Withdrawal by Subject|2
112367|NCT00665925|384467|P3|Overall Study|Withdrawal by Subject|3
112368|NCT00665925|384468|P2|Overall Study|Withdrawal by Subject|2
112369|NCT00665925|384469|P1|Overall Study|Withdrawal by Subject|2
112370|NCT00665925|384466|P4|Overall Study|Lost to Follow-up|2
112371|NCT00665925|384467|P3|Overall Study|Lost to Follow-up|2
112372|NCT00665925|384468|P2|Overall Study|Lost to Follow-up|2
112373|NCT00665925|384469|P1|Overall Study|Lost to Follow-up|1
112374|NCT00665925|384466|P4|Overall Study|Lack of Efficacy|8
112375|NCT00665925|384467|P3|Overall Study|Lack of Efficacy|9
112376|NCT00665925|384468|P2|Overall Study|Lack of Efficacy|8
112377|NCT00665925|384469|P1|Overall Study|Lack of Efficacy|10
112378|NCT00665847|384880|P1|Overall Study|Switch to Commercial Medication|1
112379|NCT00665847|384880|P1|Overall Study|Subject ineligible to continue the trial|1
112380|NCT00665847|384880|P1|Overall Study|Resistance to TMC125|1
112381|NCT00665847|384880|P1|Overall Study|Subject reached a virologic endpoint|4
112382|NCT00665847|384880|P1|Overall Study|Subject non-compliant|8
112383|NCT00665847|384880|P1|Overall Study|Withdrawal by Subject|2
112384|NCT00665847|384880|P1|Overall Study|Adverse Event|8
112385|NCT00665626|384899|P2|Overall Study|Death|0
112386|NCT00665626|384900|P1|Overall Study|Death|1
112387|NCT00665626|384899|P2|Overall Study|Unably to comply with dosing regimen|1
112388|NCT00665626|384900|P1|Overall Study|Unably to comply with dosing regimen|0
112389|NCT00665626|384899|P2|Overall Study|Did not fulfil inclusion criteria|1
112390|NCT00665626|384900|P1|Overall Study|Did not fulfil inclusion criteria|0
112391|NCT00665626|384899|P2|Overall Study|Due to exclusion criteria|1
112392|NCT00665626|384900|P1|Overall Study|Due to exclusion criteria|0
112393|NCT00665626|384899|P2|Overall Study|Adverse Event|9
112394|NCT00665626|384900|P1|Overall Study|Adverse Event|1
112395|NCT00665626|384899|P2|Overall Study|Protocol Violation|2
112396|NCT00665626|384900|P1|Overall Study|Protocol Violation|0
112397|NCT00665626|384899|P2|Overall Study|Withdrawal by Subject|1
112398|NCT00665626|384900|P1|Overall Study|Withdrawal by Subject|0
112399|NCT00665626|384899|P2|Overall Study|Lost to Follow-up|2
112400|NCT00665626|384900|P1|Overall Study|Lost to Follow-up|0
112401|NCT00665626|384899|P2|Overall Study|Lack of Efficacy|5
112402|NCT00665626|384900|P1|Overall Study|Lack of Efficacy|8
112403|NCT00665444|384977|P1|Overall Study|Study Terminated by Study Sponsor|1
112404|NCT00665444|384977|P1|Overall Study|Physician Decision|1
112405|NCT00665431|384985|P3|Overall Study|Other|2
112406|NCT00665431|384986|P2|Overall Study|Other|7
112407|NCT00665431|384987|P1|Overall Study|Other|4
112408|NCT00665431|384985|P3|Overall Study|Lost to Follow-up|1
112409|NCT00665431|384986|P2|Overall Study|Lost to Follow-up|3
112410|NCT00665431|384987|P1|Overall Study|Lost to Follow-up|3
112411|NCT00665431|384985|P3|Overall Study|Withdrawal by Subject|15
112412|NCT00665431|384986|P2|Overall Study|Withdrawal by Subject|25
112413|NCT00665431|384987|P1|Overall Study|Withdrawal by Subject|17
112414|NCT00665431|384985|P3|Overall Study|Adverse Event|6
112415|NCT00665431|384986|P2|Overall Study|Adverse Event|22
112416|NCT00665431|384987|P1|Overall Study|Adverse Event|16
112417|NCT00665366|385030|P2|Overall Study|Other reasons|1
112418|NCT00665366|385031|P1|Overall Study|Other reasons|4
112419|NCT00665366|385030|P2|Overall Study|No longer meets study criteria|1
112420|NCT00665366|385031|P1|Overall Study|No longer meets study criteria|0
112421|NCT00665366|385030|P2|Overall Study|Pregnancy|0
112422|NCT00665366|385031|P1|Overall Study|Pregnancy|1
112423|NCT00665366|385030|P2|Overall Study|Poor compliance/noncompliance|5
112424|NCT00665366|385031|P1|Overall Study|Poor compliance/noncompliance|3
112425|NCT00665366|385030|P2|Overall Study|Lost to Follow-up|5
112426|NCT00665366|385031|P1|Overall Study|Lost to Follow-up|3
112427|NCT00665366|385030|P2|Overall Study|Withdrawal by Subject|14
112428|NCT00665366|385031|P1|Overall Study|Withdrawal by Subject|11
112429|NCT00665366|385030|P2|Overall Study|Adverse Event|23
112430|NCT00665366|385031|P1|Overall Study|Adverse Event|25
112431|NCT00665366|385030|P2|Overall Study|Lack of Efficacy|10
112432|NCT00665366|385031|P1|Overall Study|Lack of Efficacy|11
112433|NCT00665353|385059|P1|Study Step 2|Lack of Efficacy|12
112434|NCT00665353|385059|P1|Study Step 2|Lost to Follow-up|2
112435|NCT00665353|385059|P1|Study Step 1|Withdrawal by Subject|2
112436|NCT00665353|385059|P1|Study Step 1|Adverse Event|1
112437|NCT00665002|385076|P1|Overall Study|Cytogenetic resistance|1
112438|NCT00665002|385076|P1|Overall Study|Progression/relapse during treatment|11
112439|NCT00664742|385081|P1|Overall Study|Lost to Follow-up|92
112440|NCT00664742|385081|P1|Overall Study|Withdrawal by Subject|31
112441|NCT00664742|385081|P1|Overall Study|Withdrawn due to adverse events|3
112442|NCT00664560|385089|P3|Overall Study|Other|5
112443|NCT00664560|385090|P2|Overall Study|Other|4
112444|NCT00664560|385091|P1|Overall Study|Other|11
112445|NCT00664560|385089|P3|Overall Study|Lost to Follow-up|0
112446|NCT00664560|385090|P2|Overall Study|Lost to Follow-up|2
112447|NCT00664560|385091|P1|Overall Study|Lost to Follow-up|0
112448|NCT00664560|385089|P3|Overall Study|Withdrawal by Subject|7
112449|NCT00664560|385090|P2|Overall Study|Withdrawal by Subject|13
112450|NCT00664560|385091|P1|Overall Study|Withdrawal by Subject|9
112451|NCT00664560|385089|P3|Overall Study|Adverse Event|7
112452|NCT00664560|385090|P2|Overall Study|Adverse Event|16
112453|NCT00664560|385091|P1|Overall Study|Adverse Event|19
112454|NCT00664534|385134|P2|Overall Study|Sponsor decision|6
112455|NCT00664534|385135|P1|Overall Study|Sponsor decision|8
112456|NCT00664534|385134|P2|Overall Study|Physician Decision|0
112457|NCT00664534|385135|P1|Overall Study|Physician Decision|8
112458|NCT00664534|385134|P2|Overall Study|Withdrawal by Subject|6
112459|NCT00664534|385135|P1|Overall Study|Withdrawal by Subject|7
112460|NCT00664534|385134|P2|Overall Study|Protocol Violation|8
112461|NCT00664534|385135|P1|Overall Study|Protocol Violation|10
112462|NCT00664534|385134|P2|Overall Study|Lost to Follow-up|10
112463|NCT00664534|385135|P1|Overall Study|Lost to Follow-up|6
112464|NCT00664534|385134|P2|Overall Study|Adverse Event|3
112465|NCT00664534|385135|P1|Overall Study|Adverse Event|2
112466|NCT00664521|385163|P2|Overall Study|Unspecified|0
112467|NCT00664521|385164|P1|Overall Study|Unspecified|1
112468|NCT00664521|385163|P2|Overall Study|Lost to Follow-up|0
112469|NCT00664521|385164|P1|Overall Study|Lost to Follow-up|1
112470|NCT00664521|385163|P2|Overall Study|Adverse Event|1
112471|NCT00664521|385164|P1|Overall Study|Adverse Event|4
112472|NCT00664326|385190|P1|Overall Study|ongoing with treatment|6
112473|NCT00664326|385190|P1|Overall Study|Physician Decision|1
112474|NCT00664326|385190|P1|Overall Study|Withdrawal by Subject|1
112475|NCT00664326|385190|P1|Overall Study|Noncompliance with study medication|3
112476|NCT00664326|385190|P1|Overall Study|Adverse Event|13
112477|NCT00664105|385209|P1|Overall Study|Disease progression|7
112478|NCT00664105|385209|P1|Overall Study|Adverse Event|9
112479|NCT00664105|385209|P1|Overall Study|Withdrawal by Subject|5
112480|NCT00664105|385209|P1|Overall Study|Death|3
112481|NCT00664066|385216|P1|Overall Study|Study terminated|3
112482|NCT00663962|385222|P2|Overall Study|somnolence|0
112483|NCT00663962|385223|P1|Overall Study|somnolence|1
112484|NCT00663923|385229|P1|Overall Study|Lost to Follow-up|2
112485|NCT00663858|385246|P3|Overall Study|Other|4
112486|NCT00663858|385247|P2|Overall Study|Other|2
112487|NCT00663858|385248|P1|Overall Study|Other|8
112488|NCT00663858|385246|P3|Overall Study|Protocol Violation|4
112489|NCT00663858|385247|P2|Overall Study|Protocol Violation|3
112490|NCT00663858|385248|P1|Overall Study|Protocol Violation|5
112491|NCT00663858|385246|P3|Overall Study|Withdrawal by Subject|3
112492|NCT00663858|385247|P2|Overall Study|Withdrawal by Subject|3
112493|NCT00663858|385248|P1|Overall Study|Withdrawal by Subject|7
112494|NCT00663858|385246|P3|Overall Study|Lack of Efficacy|3
112495|NCT00663858|385247|P2|Overall Study|Lack of Efficacy|1
112496|NCT00663858|385248|P1|Overall Study|Lack of Efficacy|5
112497|NCT00663858|385246|P3|Overall Study|Adverse Event|6
112498|NCT00663858|385247|P2|Overall Study|Adverse Event|1
112499|NCT00663858|385248|P1|Overall Study|Adverse Event|9
112500|NCT00663702|385280|P2|Overall Study|Lack of Efficacy|3
112501|NCT00663702|385281|P1|Overall Study|Lack of Efficacy|3
112502|NCT00663702|385280|P2|Overall Study|Death|1
112503|NCT00663702|385281|P1|Overall Study|Death|1
112504|NCT00663702|385280|P2|Overall Study|Lost to Follow-up|0
112505|NCT00663702|385281|P1|Overall Study|Lost to Follow-up|3
112506|NCT00663702|385280|P2|Overall Study|Pregnancy|1
112507|NCT00663702|385281|P1|Overall Study|Pregnancy|0
112508|NCT00663702|385280|P2|Overall Study|Withdrawal by Subject|1
112509|NCT00663702|385281|P1|Overall Study|Withdrawal by Subject|3
112510|NCT00663702|385280|P2|Overall Study|Adverse Event|4
112511|NCT00663702|385281|P1|Overall Study|Adverse Event|8
112512|NCT00663260|385317|P3|Overall Study|non-compliance, not met criteria, etc.|3
112513|NCT00663260|385318|P2|Overall Study|non-compliance, not met criteria, etc.|2
112514|NCT00663260|385319|P1|Overall Study|non-compliance, not met criteria, etc.|3
112515|NCT00663260|385317|P3|Overall Study|Lost to Follow-up|0
112516|NCT00663260|385318|P2|Overall Study|Lost to Follow-up|1
112517|NCT00663260|385319|P1|Overall Study|Lost to Follow-up|0
112518|NCT00663260|385317|P3|Overall Study|Death|1
112519|NCT00663260|385318|P2|Overall Study|Death|0
112520|NCT00663260|385319|P1|Overall Study|Death|1
112521|NCT00663260|385317|P3|Overall Study|Withdrawal by Subject|6
112522|NCT00663260|385318|P2|Overall Study|Withdrawal by Subject|1
112523|NCT00663260|385319|P1|Overall Study|Withdrawal by Subject|3
112524|NCT00663260|385317|P3|Overall Study|Adverse Event|6
112525|NCT00663260|385318|P2|Overall Study|Adverse Event|7
112526|NCT00663260|385319|P1|Overall Study|Adverse Event|12
112527|NCT00663260|385317|P3|Overall Study|Lack of Efficacy|0
112528|NCT00663260|385318|P2|Overall Study|Lack of Efficacy|0
112529|NCT00663260|385319|P1|Overall Study|Lack of Efficacy|2
112530|NCT00663234|385333|P1|Overall Study|Not willing to adhere to requirements|1
112531|NCT00663208|385366|P7|Follow-up Period|Other reason|1
112532|NCT00663208|385367|P6|Follow-up Period|Other reason|0
112533|NCT00663208|385368|P5|Follow-up Period|Other reason|0
112534|NCT00663208|385369|P4|Follow-up Period|Other reason|0
112535|NCT00663208|385370|P3|Follow-up Period|Other reason|0
112536|NCT00663208|385371|P2|Follow-up Period|Other reason|0
112537|NCT00663208|385372|P1|Follow-up Period|Other reason|1
112538|NCT00663208|385366|P7|Follow-up Period|Lost to Follow-up|0
112539|NCT00663208|385367|P6|Follow-up Period|Lost to Follow-up|0
112540|NCT00663208|385368|P5|Follow-up Period|Lost to Follow-up|0
112541|NCT00663208|385369|P4|Follow-up Period|Lost to Follow-up|2
112542|NCT00663208|385370|P3|Follow-up Period|Lost to Follow-up|3
112543|NCT00663208|385371|P2|Follow-up Period|Lost to Follow-up|0
112544|NCT00663208|385372|P1|Follow-up Period|Lost to Follow-up|2
112545|NCT00663208|385366|P7|Treatment Period|Lost to Follow-up|0
112546|NCT00663208|385367|P6|Treatment Period|Lost to Follow-up|0
112547|NCT00663208|385368|P5|Treatment Period|Lost to Follow-up|0
112548|NCT00663208|385369|P4|Treatment Period|Lost to Follow-up|0
112549|NCT00663208|385370|P3|Treatment Period|Lost to Follow-up|0
112550|NCT00663208|385371|P2|Treatment Period|Lost to Follow-up|1
112551|NCT00663208|385372|P1|Treatment Period|Lost to Follow-up|0
112552|NCT00663117|385550|P2|Overall Study|Lack of Efficacy|0
112553|NCT00663117|385551|P1|Overall Study|Lack of Efficacy|1
112554|NCT00663052|385565|P2|Overall Study|Unspecified|1
112555|NCT00663052|385566|P1|Overall Study|Unspecified|0
112556|NCT00663052|385565|P2|Overall Study|Unsatisfactory Response - Efficacy|1
112557|NCT00663052|385566|P1|Overall Study|Unsatisfactory Response - Efficacy|1
112558|NCT00663052|385565|P2|Overall Study|Withdrawal by Subject|5
112559|NCT00663052|385566|P1|Overall Study|Withdrawal by Subject|2
112560|NCT00663052|385565|P2|Overall Study|Protocol Violation|0
112561|NCT00663052|385566|P1|Overall Study|Protocol Violation|1
112562|NCT00663052|385565|P2|Overall Study|Discontinuation of Study by Sponsor|0
112563|NCT00663052|385566|P1|Overall Study|Discontinuation of Study by Sponsor|2
112564|NCT00663052|385565|P2|Overall Study|Adverse Event|3
112565|NCT00663052|385566|P1|Overall Study|Adverse Event|6
112566|NCT00663026|385649|P3|Overall Study|Withdrawal by Subject|1
112567|NCT00663026|385650|P2|Overall Study|Withdrawal by Subject|0
112568|NCT00663026|385651|P1|Overall Study|Withdrawal by Subject|0
112569|NCT00663026|385649|P3|Overall Study|Caregiver Request|0
112570|NCT00663026|385650|P2|Overall Study|Caregiver Request|2
112571|NCT00663026|385651|P1|Overall Study|Caregiver Request|0
112572|NCT00663026|385649|P3|Overall Study|Adverse Event|3
112573|NCT00663026|385650|P2|Overall Study|Adverse Event|2
112574|NCT00663026|385651|P1|Overall Study|Adverse Event|0
112575|NCT00663026|385649|P3|Overall Study|Unspecified|0
112576|NCT00663026|385650|P2|Overall Study|Unspecified|2
112577|NCT00663026|385651|P1|Overall Study|Unspecified|1
112578|NCT00663026|385649|P3|Overall Study|Lost to Follow-up|0
112579|NCT00663026|385650|P2|Overall Study|Lost to Follow-up|0
112580|NCT00663026|385651|P1|Overall Study|Lost to Follow-up|1
112581|NCT00662909|385674|P3|Overall Study|Eligibility criterion not met|1
112582|NCT00662909|385675|P2|Overall Study|Eligibility criterion not met|1
112583|NCT00662909|385676|P1|Overall Study|Eligibility criterion not met|0
112584|NCT00662909|385674|P3|Overall Study|Physician Decision|2
112585|NCT00662909|385675|P2|Overall Study|Physician Decision|1
112586|NCT00662909|385676|P1|Overall Study|Physician Decision|1
112587|NCT00662909|385674|P3|Overall Study|Non-compliance with study procedures|2
112588|NCT00662909|385675|P2|Overall Study|Non-compliance with study procedures|3
112589|NCT00662909|385676|P1|Overall Study|Non-compliance with study procedures|3
112590|NCT00662909|385674|P3|Overall Study|Randomized- never received study drug|0
112591|NCT00662909|385675|P2|Overall Study|Randomized- never received study drug|0
112592|NCT00662909|385676|P1|Overall Study|Randomized- never received study drug|1
112593|NCT00662909|385674|P3|Overall Study|Protocol Violation|5
112594|NCT00662909|385675|P2|Overall Study|Protocol Violation|4
112595|NCT00662909|385676|P1|Overall Study|Protocol Violation|7
112596|NCT00662909|385674|P3|Overall Study|Lost to Follow-up|3
112597|NCT00662909|385675|P2|Overall Study|Lost to Follow-up|9
112598|NCT00662909|385676|P1|Overall Study|Lost to Follow-up|2
112599|NCT00662909|385674|P3|Overall Study|Withdrawal by Subject|16
112600|NCT00662909|385675|P2|Overall Study|Withdrawal by Subject|22
112601|NCT00662909|385676|P1|Overall Study|Withdrawal by Subject|29
112602|NCT00662909|385674|P3|Overall Study|Lack of Efficacy|5
112603|NCT00662909|385675|P2|Overall Study|Lack of Efficacy|1
112604|NCT00662909|385676|P1|Overall Study|Lack of Efficacy|9
112605|NCT00662909|385674|P3|Overall Study|Adverse Event|19
112606|NCT00662909|385675|P2|Overall Study|Adverse Event|18
112607|NCT00662909|385676|P1|Overall Study|Adverse Event|17
112608|NCT00662857|385774|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
112609|NCT00662857|385775|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
112610|NCT00662857|385774|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
112611|NCT00662857|385775|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
112612|NCT00662857|385774|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
112613|NCT00662857|385775|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
112614|NCT00662831|385790|P2|Overall Study|Adverse Event|16
112615|NCT00662831|385791|P1|Overall Study|Adverse Event|23
112616|NCT00662831|385790|P2|Overall Study|Protocol Violation|4
112617|NCT00662831|385791|P1|Overall Study|Protocol Violation|8
112618|NCT00662831|385790|P2|Overall Study|Unspecified|31
112619|NCT00662831|385791|P1|Overall Study|Unspecified|62
112620|NCT00662831|385790|P2|Overall Study|Withdrawal by Subject|1
112621|NCT00662831|385791|P1|Overall Study|Withdrawal by Subject|2
112622|NCT00662831|385790|P2|Overall Study|Lost to Follow-up|0
112623|NCT00662831|385791|P1|Overall Study|Lost to Follow-up|1
112624|NCT00662831|385790|P2|Overall Study|Lack of Efficacy|6
112625|NCT00662831|385791|P1|Overall Study|Lack of Efficacy|6
112626|NCT00662831|385790|P2|Overall Study|Death|1
112627|NCT00662831|385791|P1|Overall Study|Death|4
112628|NCT00662649|385871|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
112629|NCT00662649|385872|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
112630|NCT00662649|385873|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
112631|NCT00662649|385874|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
112632|NCT00662649|385875|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
112633|NCT00662649|385871|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
112634|NCT00662649|385872|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
112635|NCT00662649|385873|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
112636|NCT00662649|385874|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
112637|NCT00662649|385875|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
112638|NCT00662649|385871|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
112639|NCT00662649|385872|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
112640|NCT00662649|385873|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
112641|NCT00662649|385874|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
112642|NCT00662649|385875|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
112643|NCT00662649|385871|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
112644|NCT00662649|385872|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
112645|NCT00662649|385873|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
112646|NCT00662649|385874|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
112647|NCT00662649|385875|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
112648|NCT00662649|385871|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
112649|NCT00662649|385872|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
112650|NCT00662649|385873|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
112651|NCT00662649|385874|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
112652|NCT00662649|385875|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
112653|NCT00662649|385871|P5|Extension Study (Month 24 to 60)|Adverse Event|10
112654|NCT00662649|385872|P4|Extension Study (Month 24 to 60)|Adverse Event|6
112655|NCT00662649|385873|P3|Extension Study (Month 24 to 60)|Adverse Event|0
112656|NCT00662649|385874|P2|Extension Study (Month 24 to 60)|Adverse Event|9
112657|NCT00662649|385875|P1|Extension Study (Month 24 to 60)|Adverse Event|6
112658|NCT00662649|385871|P5|Extension Study (Month 24 to 60)|Administrative problems|0
112659|NCT00662649|385872|P4|Extension Study (Month 24 to 60)|Administrative problems|1
112660|NCT00662649|385873|P3|Extension Study (Month 24 to 60)|Administrative problems|0
112661|NCT00662649|385874|P2|Extension Study (Month 24 to 60)|Administrative problems|0
112662|NCT00662649|385875|P1|Extension Study (Month 24 to 60)|Administrative problems|0
112663|NCT00662649|385871|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
112664|NCT00662649|385872|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
112665|NCT00662649|385873|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
112666|NCT00662649|385874|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
112667|NCT00662649|385875|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
112668|NCT00662649|385871|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
112669|NCT00662649|385872|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
112670|NCT00662649|385873|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
112671|NCT00662649|385874|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
112672|NCT00662649|385875|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
112673|NCT00662649|385871|P5|Core Study (24 Months)|Death|0
112674|NCT00662649|385872|P4|Core Study (24 Months)|Death|0
112675|NCT00662649|385873|P3|Core Study (24 Months)|Death|2
112676|NCT00662649|385874|P2|Core Study (24 Months)|Death|0
112677|NCT00662649|385875|P1|Core Study (24 Months)|Death|1
112678|NCT00662649|385871|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
112679|NCT00662649|385872|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
112680|NCT00662649|385873|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
112681|NCT00662649|385874|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
112682|NCT00662649|385875|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
112683|NCT00662649|385871|P5|Core Study (24 Months)|Protocol Violation|0
112684|NCT00662649|385872|P4|Core Study (24 Months)|Protocol Violation|0
112685|NCT00662649|385873|P3|Core Study (24 Months)|Protocol Violation|4
112686|NCT00662649|385874|P2|Core Study (24 Months)|Protocol Violation|5
112687|NCT00662649|385875|P1|Core Study (24 Months)|Protocol Violation|5
112688|NCT00662649|385871|P5|Core Study (24 Months)|Lost to Follow-up|0
112689|NCT00662649|385872|P4|Core Study (24 Months)|Lost to Follow-up|0
112690|NCT00662649|385873|P3|Core Study (24 Months)|Lost to Follow-up|7
112691|NCT00662649|385874|P2|Core Study (24 Months)|Lost to Follow-up|5
112692|NCT00662649|385875|P1|Core Study (24 Months)|Lost to Follow-up|3
112693|NCT00662649|385871|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
112694|NCT00662649|385872|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
112695|NCT00662649|385873|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
112696|NCT00662649|385874|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
112697|NCT00662649|385875|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
112698|NCT00662649|385871|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
112699|NCT00662649|385872|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
112700|NCT00662649|385873|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
112701|NCT00662649|385874|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
112702|NCT00662649|385875|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
112703|NCT00662649|385871|P5|Core Study (24 Months)|Adverse Event|0
112704|NCT00662649|385872|P4|Core Study (24 Months)|Adverse Event|0
112705|NCT00662649|385873|P3|Core Study (24 Months)|Adverse Event|18
112706|NCT00662649|385874|P2|Core Study (24 Months)|Adverse Event|13
112707|NCT00662649|385875|P1|Core Study (24 Months)|Adverse Event|22
112708|NCT00662649|385871|P5|Core Study (24 Months)|Withdrawal by Subject|0
112709|NCT00662649|385872|P4|Core Study (24 Months)|Withdrawal by Subject|0
112710|NCT00662649|385873|P3|Core Study (24 Months)|Withdrawal by Subject|28
112711|NCT00662649|385874|P2|Core Study (24 Months)|Withdrawal by Subject|17
112712|NCT00662649|385875|P1|Core Study (24 Months)|Withdrawal by Subject|31
112713|NCT00662558|385915|P2|Overall Study|Randomized But Did Not Receive Treatment|8
112714|NCT00662558|385916|P1|Overall Study|Randomized But Did Not Receive Treatment|2
112715|NCT00662558|385915|P2|Overall Study|Withdrawal by Subject|12
112716|NCT00662558|385916|P1|Overall Study|Withdrawal by Subject|7
112717|NCT00662558|385915|P2|Overall Study|Other|14
112718|NCT00662558|385916|P1|Overall Study|Other|9
112719|NCT00662558|385915|P2|Overall Study|Lost to Follow-up|10
112720|NCT00662558|385916|P1|Overall Study|Lost to Follow-up|13
112721|NCT00662558|385915|P2|Overall Study|Lack of Efficacy|7
112722|NCT00662558|385916|P1|Overall Study|Lack of Efficacy|4
112723|NCT00662558|385915|P2|Overall Study|Adverse Event|59
112724|NCT00662558|385916|P1|Overall Study|Adverse Event|21
112725|NCT00662532|385967|P2|Overall Study|Lost to Follow-up|1
112726|NCT00662532|385968|P1|Overall Study|Lost to Follow-up|0
112727|NCT00662532|385967|P2|Overall Study|Adverse Event|1
112728|NCT00662532|385968|P1|Overall Study|Adverse Event|0
112729|NCT00662363|385983|P2|Overall Study|Protocol Violation|1
112730|NCT00662363|385984|P1|Overall Study|Protocol Violation|1
112731|NCT00662363|385983|P2|Overall Study|Discharged early from rehab|1
112732|NCT00662363|385984|P1|Overall Study|Discharged early from rehab|4
112733|NCT00662363|385983|P2|Overall Study|Adverse Event|3
112734|NCT00662363|385984|P1|Overall Study|Adverse Event|0
112735|NCT00662363|385983|P2|Overall Study|Withdrawal by Subject|5
112736|NCT00662363|385984|P1|Overall Study|Withdrawal by Subject|6
112737|NCT00662025|385999|P1|Overall Study|Domestic circumstances|1
112738|NCT00662025|385999|P1|Overall Study|Target lesion cannot be evaluated|1
112739|NCT00662025|385999|P1|Overall Study|Results of other clinical study|2
112740|NCT00662025|385999|P1|Overall Study|Withdrawal by Subject|1
112741|NCT00662025|385999|P1|Overall Study|Adverse Event|7
112742|NCT00662025|385999|P1|Overall Study|Objective progression or relapse|51
112743|NCT00661999|386022|P3|Overall Study|Other Medical Problems|9
112744|NCT00661999|386023|P2|Overall Study|Other Medical Problems|4
112745|NCT00661999|386024|P1|Overall Study|Other Medical Problems|4
112746|NCT00661999|386022|P3|Overall Study|Alternative Treatment|0
112747|NCT00661999|386023|P2|Overall Study|Alternative Treatment|0
112748|NCT00661999|386024|P1|Overall Study|Alternative Treatment|1
112749|NCT00661999|386022|P3|Overall Study|Withdrawal by Subject|14
112750|NCT00661999|386023|P2|Overall Study|Withdrawal by Subject|23
112751|NCT00661999|386024|P1|Overall Study|Withdrawal by Subject|30
112752|NCT00661999|386022|P3|Overall Study|Other Reasons|23
112753|NCT00661999|386023|P2|Overall Study|Other Reasons|12
112754|NCT00661999|386024|P1|Overall Study|Other Reasons|5
112755|NCT00661999|386022|P3|Overall Study|Death|3
112756|NCT00661999|386023|P2|Overall Study|Death|6
112757|NCT00661999|386024|P1|Overall Study|Death|8
112758|NCT00661999|386022|P3|Overall Study|Adverse Event|8
112759|NCT00661999|386023|P2|Overall Study|Adverse Event|5
112760|NCT00661999|386024|P1|Overall Study|Adverse Event|11
112761|NCT00661830|386101|P2|Overall Study|Other reason|5
112762|NCT00661830|386102|P1|Overall Study|Other reason|1
112763|NCT00661830|386101|P2|Overall Study|Withdrawal by Subject|1
112764|NCT00661830|386102|P1|Overall Study|Withdrawal by Subject|1
112765|NCT00661830|386101|P2|Overall Study|Lost to Follow-up|3
112766|NCT00661830|386102|P1|Overall Study|Lost to Follow-up|1
112767|NCT00661830|386101|P2|Overall Study|Death|33
112768|NCT00661830|386102|P1|Overall Study|Death|37
112769|NCT00661778|386114|P1|Overall Study|Withdrawal of Consent|1
112770|NCT00661778|386114|P1|Overall Study|Protocol Violation|2
112771|NCT00661778|386114|P1|Overall Study|Reason not Specified|6
112772|NCT00661778|386114|P1|Overall Study|Adverse Event|18
112773|NCT00661778|386114|P1|Overall Study|Disease Progression|23
112774|NCT00661726|386121|P1|Overall Study|Adverse Event|1
112775|NCT00661713|386144|P8|Overall Study|Inappropriate Enrollment|0
112776|NCT00661713|386145|P7|Overall Study|Inappropriate Enrollment|1
112777|NCT00661713|386146|P6|Overall Study|Inappropriate Enrollment|0
112778|NCT00661713|386147|P5|Overall Study|Inappropriate Enrollment|0
112779|NCT00661713|386148|P4|Overall Study|Inappropriate Enrollment|0
112780|NCT00661713|386149|P3|Overall Study|Inappropriate Enrollment|0
112781|NCT00661713|386150|P2|Overall Study|Inappropriate Enrollment|0
112782|NCT00661713|386151|P1|Overall Study|Inappropriate Enrollment|0
112783|NCT00661713|386144|P8|Overall Study|Adverse Event|0
112784|NCT00661713|386145|P7|Overall Study|Adverse Event|1
112785|NCT00661713|386146|P6|Overall Study|Adverse Event|0
112786|NCT00661713|386147|P5|Overall Study|Adverse Event|0
112787|NCT00661713|386148|P4|Overall Study|Adverse Event|0
112788|NCT00661713|386149|P3|Overall Study|Adverse Event|0
112789|NCT00661713|386150|P2|Overall Study|Adverse Event|0
112790|NCT00661713|386151|P1|Overall Study|Adverse Event|0
112791|NCT00661713|386144|P8|Overall Study|Administrative Reason|0
112792|NCT00661713|386145|P7|Overall Study|Administrative Reason|1
112793|NCT00661713|386146|P6|Overall Study|Administrative Reason|2
112794|NCT00661713|386147|P5|Overall Study|Administrative Reason|2
112795|NCT00661713|386148|P4|Overall Study|Administrative Reason|2
112796|NCT00661713|386149|P3|Overall Study|Administrative Reason|0
112797|NCT00661713|386150|P2|Overall Study|Administrative Reason|1
112798|NCT00661713|386151|P1|Overall Study|Administrative Reason|0
112799|NCT00661713|386144|P8|Overall Study|Lost to Follow-up|1
112800|NCT00661713|386145|P7|Overall Study|Lost to Follow-up|14
112801|NCT00661713|386146|P6|Overall Study|Lost to Follow-up|7
112802|NCT00661713|386147|P5|Overall Study|Lost to Follow-up|5
112803|NCT00661713|386148|P4|Overall Study|Lost to Follow-up|2
112804|NCT00661713|386149|P3|Overall Study|Lost to Follow-up|2
112805|NCT00661713|386150|P2|Overall Study|Lost to Follow-up|7
112806|NCT00661713|386151|P1|Overall Study|Lost to Follow-up|2
112807|NCT00661713|386144|P8|Overall Study|Withdrawal by Subject|9
112808|NCT00661713|386145|P7|Overall Study|Withdrawal by Subject|45
112809|NCT00661713|386146|P6|Overall Study|Withdrawal by Subject|26
112810|NCT00661713|386147|P5|Overall Study|Withdrawal by Subject|12
112811|NCT00661713|386148|P4|Overall Study|Withdrawal by Subject|21
112812|NCT00661713|386149|P3|Overall Study|Withdrawal by Subject|12
112813|NCT00661713|386150|P2|Overall Study|Withdrawal by Subject|25
112814|NCT00661713|386151|P1|Overall Study|Withdrawal by Subject|11
112815|NCT00661713|386144|P8|Overall Study|Protocol Violation|1
112816|NCT00661713|386145|P7|Overall Study|Protocol Violation|2
112817|NCT00661713|386146|P6|Overall Study|Protocol Violation|2
112818|NCT00661713|386147|P5|Overall Study|Protocol Violation|0
112819|NCT00661713|386148|P4|Overall Study|Protocol Violation|3
112820|NCT00661713|386149|P3|Overall Study|Protocol Violation|3
112821|NCT00661713|386150|P2|Overall Study|Protocol Violation|6
112822|NCT00661713|386151|P1|Overall Study|Protocol Violation|1
112823|NCT00661713|386144|P8|Overall Study|Unable to Classify|0
112824|NCT00661713|386145|P7|Overall Study|Unable to Classify|0
112825|NCT00661713|386146|P6|Overall Study|Unable to Classify|0
112826|NCT00661713|386147|P5|Overall Study|Unable to Classify|0
112827|NCT00661713|386148|P4|Overall Study|Unable to Classify|0
112828|NCT00661713|386149|P3|Overall Study|Unable to Classify|0
112829|NCT00661713|386150|P2|Overall Study|Unable to Classify|0
112830|NCT00661713|386151|P1|Overall Study|Unable to Classify|1
112831|NCT00661713|386144|P8|Overall Study|Death|0
112832|NCT00661713|386145|P7|Overall Study|Death|0
112833|NCT00661713|386146|P6|Overall Study|Death|0
112834|NCT00661713|386147|P5|Overall Study|Death|1
112835|NCT00661713|386148|P4|Overall Study|Death|0
112836|NCT00661713|386149|P3|Overall Study|Death|0
112837|NCT00661713|386150|P2|Overall Study|Death|0
112838|NCT00661713|386151|P1|Overall Study|Death|1
112839|NCT00661687|386241|P1|Overall Study|Adverse Event|2
112840|NCT00661687|386241|P1|Overall Study|Physician Decision|1
112841|NCT00661687|386241|P1|Overall Study|Inability to maintain wearing schedule|3
112842|NCT00661687|386241|P1|Overall Study|Positive slit lamp findings|4
112843|NCT00661687|386241|P1|Overall Study|Study related symptoms and complaints|5
112844|NCT00661661|386253|P2|Overall Study|Not assigned treatment|0
112845|NCT00661661|386254|P1|Overall Study|Not assigned treatment|1
112846|NCT00661661|386253|P2|Overall Study|Unspecified|7
112847|NCT00661661|386254|P1|Overall Study|Unspecified|22
112848|NCT00661661|386253|P2|Overall Study|Withdrawal by Subject|5
112849|NCT00661661|386254|P1|Overall Study|Withdrawal by Subject|15
112850|NCT00661661|386253|P2|Overall Study|Lost to Follow-up|1
112851|NCT00661661|386254|P1|Overall Study|Lost to Follow-up|0
112852|NCT00661661|386253|P2|Overall Study|Lack of Efficacy|2
112853|NCT00661661|386254|P1|Overall Study|Lack of Efficacy|3
112854|NCT00661661|386253|P2|Overall Study|Adverse Event|24
112855|NCT00661661|386254|P1|Overall Study|Adverse Event|99
112856|NCT00661622|386330|P2|Overall Study|Protocol Violation|0
112857|NCT00661622|386331|P1|Overall Study|Protocol Violation|1
112858|NCT00661609|386345|P1|Overall Study|Disease progression|3
112859|NCT00661609|386345|P1|Overall Study|Survival follow up stage discontinued|11
112860|NCT00661609|386345|P1|Overall Study|PI Decision|1
112861|NCT00661609|386345|P1|Overall Study|Withdrawal by Subject|2
112862|NCT00661609|386345|P1|Overall Study|Death|20
112863|NCT00661609|386345|P1|Overall Study|Adverse Event|4
112864|NCT00661505|386385|P1|Overall Study|Not Specified|2
112865|NCT00661505|386385|P1|Overall Study|Lost to Follow-up|3
112866|NCT00661505|386385|P1|Overall Study|Withdrawal by Subject|8
112867|NCT00661505|386385|P1|Overall Study|Protocol Violation|14
112868|NCT00661505|386385|P1|Overall Study|Adverse Event|3
112869|NCT00661492|386413|P2|Overall Study|Other|0
112870|NCT00661492|386414|P1|Overall Study|Other|1
112871|NCT00661492|386413|P2|Overall Study|Lost to Follow-up|1
112872|NCT00661492|386414|P1|Overall Study|Lost to Follow-up|0
112873|NCT00661492|386413|P2|Overall Study|Investigator Request|0
112874|NCT00661492|386414|P1|Overall Study|Investigator Request|1
112875|NCT00661492|386413|P2|Overall Study|Patient Request|1
112876|NCT00661492|386414|P1|Overall Study|Patient Request|6
112877|NCT00661492|386413|P2|Overall Study|Disease Progression|14
112878|NCT00661492|386414|P1|Overall Study|Disease Progression|44
112879|NCT00661492|386413|P2|Overall Study|Adverse Event|13
112880|NCT00661492|386414|P1|Overall Study|Adverse Event|16
112881|NCT00661427|386460|P2|Overall Study|Patient not treated|2
112882|NCT00661427|386461|P1|Overall Study|Patient not treated|0
112883|NCT00661427|386460|P2|Overall Study|Adverse Event|5
112884|NCT00661427|386461|P1|Overall Study|Adverse Event|5
112885|NCT00661388|386467|P1|Overall Study|Administrative reasons|1
112886|NCT00661388|386467|P1|Overall Study|Dialysis initiation|1
112887|NCT00661388|386467|P1|Overall Study|Renal transplantation|1
112888|NCT00661388|386467|P1|Overall Study|Protocol Violation|7
112889|NCT00661388|386467|P1|Overall Study|Adverse Event|14
112890|NCT00661362|386490|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
112891|NCT00661362|386491|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
112892|NCT00661362|386490|P2|Overall Study|Safety reasons|0
112893|NCT00661362|386491|P1|Overall Study|Safety reasons|1
112894|NCT00661362|386490|P2|Overall Study|Severe non-compliance to protocol|1
112895|NCT00661362|386491|P1|Overall Study|Severe non-compliance to protocol|0
112896|NCT00661362|386490|P2|Overall Study|Lost to Follow-up|1
112897|NCT00661362|386491|P1|Overall Study|Lost to Follow-up|3
112898|NCT00661362|386490|P2|Overall Study|Withdrawal by Subject|23
112899|NCT00661362|386491|P1|Overall Study|Withdrawal by Subject|13
112900|NCT00661362|386490|P2|Overall Study|Study specific discontinuation criteria|11
112901|NCT00661362|386491|P1|Overall Study|Study specific discontinuation criteria|4
112902|NCT00661362|386490|P2|Overall Study|Incorrect enrollment|0
112903|NCT00661362|386491|P1|Overall Study|Incorrect enrollment|2
112904|NCT00661362|386490|P2|Overall Study|Adverse Event|4
112905|NCT00661362|386491|P1|Overall Study|Adverse Event|5
112906|NCT00661193|386509|P2|Overall Study|Not protocol specified|0
112907|NCT00661193|386510|P1|Overall Study|Not protocol specified|1
112908|NCT00661193|386509|P2|Overall Study|Progression|24
112909|NCT00661193|386510|P1|Overall Study|Progression|27
112910|NCT00661193|386509|P2|Overall Study|Withdrawal by Subject|1
112911|NCT00661193|386510|P1|Overall Study|Withdrawal by Subject|3
112912|NCT00661193|386509|P2|Overall Study|Adverse Event|1
112913|NCT00661193|386510|P1|Overall Study|Adverse Event|2
112914|NCT00661089|386520|P2|Overall Study|death at 8 weeks due to new stroke|1
112915|NCT00661089|386521|P1|Overall Study|death at 8 weeks due to new stroke|0
112916|NCT00661089|386520|P2|Overall Study|1 subject withdrawal|1
112917|NCT00661089|386521|P1|Overall Study|1 subject withdrawal|0
112918|NCT00660907|386556|P2|Overall Study|Various|8
112919|NCT00660907|386557|P1|Overall Study|Various|11
112920|NCT00660907|386556|P2|Overall Study|Death|3
112921|NCT00660907|386557|P1|Overall Study|Death|1
112922|NCT00660907|386556|P2|Overall Study|Safety|0
112923|NCT00660907|386557|P1|Overall Study|Safety|1
112924|NCT00660907|386556|P2|Overall Study|Poor/Non-Compliance|1
112925|NCT00660907|386557|P1|Overall Study|Poor/Non-Compliance|5
112926|NCT00660907|386556|P2|Overall Study|Lost to Follow-up|3
112927|NCT00660907|386557|P1|Overall Study|Lost to Follow-up|3
112928|NCT00660907|386556|P2|Overall Study|Withdrawal by Subject|32
112929|NCT00660907|386557|P1|Overall Study|Withdrawal by Subject|23
112930|NCT00660907|386556|P2|Overall Study|Subject No Longer Meets Study Criteria|27
112931|NCT00660907|386557|P1|Overall Study|Subject No Longer Meets Study Criteria|6
112932|NCT00660907|386556|P2|Overall Study|Adverse Event|19
112933|NCT00660907|386557|P1|Overall Study|Adverse Event|33
112934|NCT00660907|386556|P2|Overall Study|Incorrect Enrollment|1
112935|NCT00660907|386557|P1|Overall Study|Incorrect Enrollment|1
112936|NCT00660829|386571|P2|Overall Study|Other|4
112937|NCT00660829|386572|P1|Overall Study|Other|9
112938|NCT00660829|386571|P2|Overall Study|Lost to Follow-up|2
112939|NCT00660829|386572|P1|Overall Study|Lost to Follow-up|3
112940|NCT00660829|386571|P2|Overall Study|Withdrawal by Subject|2
112941|NCT00660829|386572|P1|Overall Study|Withdrawal by Subject|1
112942|NCT00660829|386571|P2|Overall Study|Non-Compliance|4
112943|NCT00660829|386572|P1|Overall Study|Non-Compliance|0
112944|NCT00660829|386571|P2|Overall Study|Lack of Efficacy|3
112945|NCT00660829|386572|P1|Overall Study|Lack of Efficacy|2
112946|NCT00660829|386571|P2|Overall Study|Adverse Event|4
112947|NCT00660829|386572|P1|Overall Study|Adverse Event|3
112948|NCT00660816|386590|P2|Overall Study|Complicating Disease|1
112949|NCT00660816|386591|P1|Overall Study|Complicating Disease|0
112950|NCT00660816|386590|P2|Overall Study|Disease Progression|12
112951|NCT00660816|386591|P1|Overall Study|Disease Progression|16
112952|NCT00660816|386590|P2|Overall Study|Protocol Violation|0
112953|NCT00660816|386591|P1|Overall Study|Protocol Violation|1
112954|NCT00660816|386590|P2|Overall Study|Physician Decision|2
112955|NCT00660816|386591|P1|Overall Study|Physician Decision|0
112956|NCT00660816|386590|P2|Overall Study|Lack of Efficacy|0
112957|NCT00660816|386591|P1|Overall Study|Lack of Efficacy|1
112958|NCT00660816|386590|P2|Overall Study|Death|2
112959|NCT00660816|386591|P1|Overall Study|Death|0
112960|NCT00660816|386590|P2|Overall Study|Withdrawal by Subject|0
112961|NCT00660816|386591|P1|Overall Study|Withdrawal by Subject|1
112962|NCT00660816|386590|P2|Overall Study|Adverse Event|2
112963|NCT00660816|386591|P1|Overall Study|Adverse Event|1
112964|NCT00660699|386603|P1|Overall Study|Withdrawal by Subject|2
112965|NCT00660660|386619|P2|Overall Study|New medication after randomization|0
112966|NCT00660660|386620|P1|Overall Study|New medication after randomization|1
112967|NCT00660660|386619|P2|Overall Study|Incorrect enrollment and other|1
112968|NCT00660660|386620|P1|Overall Study|Incorrect enrollment and other|0
112969|NCT00660660|386619|P2|Overall Study|Withdrawal by Subject|0
112970|NCT00660660|386620|P1|Overall Study|Withdrawal by Subject|3
112971|NCT00660660|386619|P2|Overall Study|Lack of Efficacy|2
112972|NCT00660660|386620|P1|Overall Study|Lack of Efficacy|0
112973|NCT00660660|386619|P2|Overall Study|Lost to Follow-up|6
112974|NCT00660660|386620|P1|Overall Study|Lost to Follow-up|0
112975|NCT00660660|386619|P2|Overall Study|Adverse Event|0
112976|NCT00660660|386620|P1|Overall Study|Adverse Event|1
112977|NCT00660595|386720|P2|Overall Study|Non Specified reasons|0
112978|NCT00660595|386721|P1|Overall Study|Non Specified reasons|5
112979|NCT00660595|386720|P2|Overall Study|Participant left hospital|0
112980|NCT00660595|386721|P1|Overall Study|Participant left hospital|1
112981|NCT00660595|386720|P2|Overall Study|Did not consent to participate in study|8
112982|NCT00660595|386721|P1|Overall Study|Did not consent to participate in study|12
112983|NCT00660595|386720|P2|Overall Study|Lost to Follow-up|1
112984|NCT00660595|386721|P1|Overall Study|Lost to Follow-up|0
112985|NCT00659490|386736|P3|Overall Study|Lost to Follow-up|1
112986|NCT00659490|386737|P2|Overall Study|Lost to Follow-up|0
112987|NCT00659490|386738|P1|Overall Study|Lost to Follow-up|2
112988|NCT00659438|386811|P2|Overall Study|Lost to Follow-up|0
112989|NCT00659438|386812|P1|Overall Study|Lost to Follow-up|1
112990|NCT00659438|386811|P2|Overall Study|Death|6
112991|NCT00659438|386812|P1|Overall Study|Death|11
112992|NCT00659438|386811|P2|Overall Study|Withdrawal by Subject|2
112993|NCT00659438|386812|P1|Overall Study|Withdrawal by Subject|2
112994|NCT00659373|386836|P2|Overall Study|Assessment Missed|2
112995|NCT00659373|386837|P1|Overall Study|Assessment Missed|2
112996|NCT00659373|386836|P2|Overall Study|Withdrawal by Subject|5
112997|NCT00659373|386837|P1|Overall Study|Withdrawal by Subject|3
112998|NCT00659334|386858|P7|Overall Study|Screen Failure|1
112999|NCT00659334|386859|P6|Overall Study|Screen Failure|0
113000|NCT00659334|386860|P5|Overall Study|Screen Failure|0
113001|NCT00659334|386861|P4|Overall Study|Screen Failure|0
113002|NCT00659334|386862|P3|Overall Study|Screen Failure|0
113003|NCT00659334|386863|P2|Overall Study|Screen Failure|5
113004|NCT00659334|386864|P1|Overall Study|Screen Failure|8
113005|NCT00660400|386929|P1|Overall Study|Withdrawal by Subject|1
113006|NCT00660400|386929|P1|Overall Study|Intracranial hemorrhage|1
113007|NCT00660400|386929|P1|Overall Study|Suboptimal organ function|1
113008|NCT00660400|386929|P1|Overall Study|Lack of insurance approval|1
113009|NCT00660387|386938|P2|Overall Study|Protocol Violation|0
113010|NCT00660387|386939|P1|Overall Study|Protocol Violation|1
113011|NCT00660387|386938|P2|Overall Study|Lack of Efficacy|1
113012|NCT00660387|386939|P1|Overall Study|Lack of Efficacy|0
113013|NCT00660387|386938|P2|Overall Study|Adverse Event|2
113014|NCT00660387|386939|P1|Overall Study|Adverse Event|1
113015|NCT00660348|386993|P2|Overall Study|Withdrawal by Subject|0
113016|NCT00660348|386994|P1|Overall Study|Withdrawal by Subject|1
113017|NCT00660309|387002|P2|Overall Study|Withdrawal by Subject|3
113018|NCT00660309|387003|P1|Overall Study|Withdrawal by Subject|0
113019|NCT00660309|387002|P2|Overall Study|Adverse Event|0
113020|NCT00660309|387003|P1|Overall Study|Adverse Event|2
113021|NCT00660192|387044|P2|Overall Study|Lost to Follow-up|3
113022|NCT00660192|387045|P1|Overall Study|Lost to Follow-up|2
113023|NCT00660179|387056|P3|Overall Study|Incorrect randomization|0
113024|NCT00660179|387057|P2|Overall Study|Incorrect randomization|0
113025|NCT00660179|387058|P1|Overall Study|Incorrect randomization|1
113026|NCT00660179|387056|P3|Overall Study|Administrative reason|1
113027|NCT00660179|387057|P2|Overall Study|Administrative reason|0
113028|NCT00660179|387058|P1|Overall Study|Administrative reason|0
113029|NCT00660179|387056|P3|Overall Study|Lost to Follow-up|2
113030|NCT00660179|387057|P2|Overall Study|Lost to Follow-up|5
113031|NCT00660179|387058|P1|Overall Study|Lost to Follow-up|7
113032|NCT00660179|387056|P3|Overall Study|Withdrawal of consent|4
113033|NCT00660179|387057|P2|Overall Study|Withdrawal of consent|6
113034|NCT00660179|387058|P1|Overall Study|Withdrawal of consent|4
113035|NCT00660179|387056|P3|Overall Study|Death|34
113036|NCT00660179|387057|P2|Overall Study|Death|47
113037|NCT00660179|387058|P1|Overall Study|Death|44
113038|NCT00660023|387103|P1|Overall Study|Other Screening Failure|9
113039|NCT00660023|387103|P1|Overall Study|Missed Pregnancy Test|1
113040|NCT00660023|387103|P1|Overall Study|Withdrawal by Subject|1
113041|NCT00660023|387103|P1|Overall Study|Renal Transplantation|3
113042|NCT00660023|387103|P1|Overall Study|Blood Transfusion|5
113043|NCT00660023|387103|P1|Overall Study|Death|8
113044|NCT00660023|387103|P1|Overall Study|Adverse Event|2
113045|NCT00660010|387114|P1|Overall Study|Noncompliance with visit schedule|3
113046|NCT00660010|387114|P1|Overall Study|Adverse Event|1
113047|NCT00660010|387114|P1|Overall Study|Lost to Follow-up|3
113048|NCT00660010|387114|P1|Overall Study|Withdrawal by Subject|2
113049|NCT00659815|387139|P2|Overall Study|Withdrawal by Subject|1
113050|NCT00659815|387140|P1|Overall Study|Withdrawal by Subject|1
113051|NCT00659815|387139|P2|Overall Study|Inability to maintain wearing schedule|2
113052|NCT00659815|387140|P1|Overall Study|Inability to maintain wearing schedule|1
113053|NCT00659815|387139|P2|Overall Study|Study related symptoms and complaints|1
113054|NCT00659815|387140|P1|Overall Study|Study related symptoms and complaints|2
113055|NCT00659607|387196|P1|Overall Study|Inconsistent BP measuring date|2
113056|NCT00659607|387196|P1|Overall Study|No recorded efficacy data|15
113057|NCT00659607|387196|P1|Overall Study|‘Unable to evaluate’ for the final asses|67
113058|NCT00659607|387196|P1|Overall Study|Unknown measuring date of blood pressure|85
113059|NCT00659607|387196|P1|Overall Study|No blood pressure recorded|147
113060|NCT00659581|387214|P1|Overall Study|Other|6393
113061|NCT00659581|387214|P1|Overall Study|Lack of Efficacy|1183
113062|NCT00659581|387214|P1|Overall Study|Adverse Event|1006
113063|NCT00659529|387226|P1|Overall Study|Screen failure|9
113064|NCT00659529|387226|P1|Overall Study|Protocol Violation|3
113065|NCT00659529|387226|P1|Overall Study|Withdrawal by Subject|4
113066|NCT00659269|387241|P2|Overall Study|Physician Decision|1
113067|NCT00659269|387242|P1|Overall Study|Physician Decision|1
113068|NCT00659061|387281|P2|Overall Study|Migration due to political unrest|15
113069|NCT00659061|387282|P1|Overall Study|Migration due to political unrest|21
113070|NCT00658996|387300|P2|Second Intervention|Positive slit lamp finding|1
113071|NCT00658996|387301|P1|Second Intervention|Positive slit lamp finding|0
113072|NCT00658996|387300|P2|Second Intervention|Developed a stye on upper lid|0
113073|NCT00658996|387301|P1|Second Intervention|Developed a stye on upper lid|1
113074|NCT00658996|387300|P2|Crossover Period|Ineligible|1
113075|NCT00658996|387301|P1|Crossover Period|Ineligible|1
113076|NCT00658996|387300|P2|Crossover Period|Physician Decision|0
113077|NCT00658996|387301|P1|Crossover Period|Physician Decision|1
113078|NCT00658996|387300|P2|First Intervention|Lack of lenses|1
113079|NCT00658996|387301|P1|First Intervention|Lack of lenses|0
113080|NCT00658996|387300|P2|First Intervention|Positive slit lamp finding|0
113081|NCT00658996|387301|P1|First Intervention|Positive slit lamp finding|1
113082|NCT00658814|387313|P2|Maintenance Therapy|Not eligible|0
113083|NCT00658814|387314|P1|Maintenance Therapy|Not eligible|1
113084|NCT00658814|387313|P2|Maintenance Therapy|Not protocol specified|0
113085|NCT00658814|387314|P1|Maintenance Therapy|Not protocol specified|1
113086|NCT00658814|387313|P2|Maintenance Therapy|Adverse Event|1
113087|NCT00658814|387314|P1|Maintenance Therapy|Adverse Event|1
113088|NCT00658814|387313|P2|Consolidation Therapy|Not eligible|2
113089|NCT00658814|387314|P1|Consolidation Therapy|Not eligible|2
113090|NCT00658814|387313|P2|Consolidation Therapy|Not protocol specified|1
113091|NCT00658814|387314|P1|Consolidation Therapy|Not protocol specified|0
113092|NCT00658814|387313|P2|Remission Induction Chemotherapy|Not eligible|2
113093|NCT00658814|387314|P1|Remission Induction Chemotherapy|Not eligible|1
113094|NCT00658814|387313|P2|Remission Induction Chemotherapy|Not protocol specified|4
113095|NCT00658814|387314|P1|Remission Induction Chemotherapy|Not protocol specified|2
113096|NCT00658814|387313|P2|Remission Induction Chemotherapy|Death|4
113097|NCT00658814|387314|P1|Remission Induction Chemotherapy|Death|1
113098|NCT00658814|387313|P2|Remission Induction Chemotherapy|Progression/Relapse|1
113099|NCT00658814|387314|P1|Remission Induction Chemotherapy|Progression/Relapse|0
113100|NCT00658814|387313|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
113101|NCT00658814|387314|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
113102|NCT00658814|387313|P2|Remission Induction Chemotherapy|Adverse Event|3
113103|NCT00658814|387314|P1|Remission Induction Chemotherapy|Adverse Event|1
113104|NCT00658788|387328|P1|Overall Study|Treatment Discontinuation|32
113105|NCT00658788|387328|P1|Overall Study|Lost to Follow-up|18
113106|NCT00658788|387328|P1|Overall Study|Withdrawal by Subject|13
113107|NCT00658788|387328|P1|Overall Study|Adverse Event|11
113108|NCT00658775|387383|P2|Overall Study|Not specified|8
113109|NCT00658775|387384|P1|Overall Study|Not specified|7
113110|NCT00658775|387383|P2|Overall Study|Withdrawal of consent|7
113111|NCT00658775|387384|P1|Overall Study|Withdrawal of consent|8
113112|NCT00658775|387383|P2|Overall Study|Withdrawal by Subject|4
113113|NCT00658775|387384|P1|Overall Study|Withdrawal by Subject|6
113114|NCT00658775|387383|P2|Overall Study|Lost to Follow-up|18
113115|NCT00658775|387384|P1|Overall Study|Lost to Follow-up|17
113116|NCT00658775|387383|P2|Overall Study|Adverse Event|6
113117|NCT00658775|387384|P1|Overall Study|Adverse Event|4
113118|NCT00658723|387396|P3|Overall Study|Withdrawal by Subject|1
113119|NCT00658723|387397|P2|Overall Study|Withdrawal by Subject|0
113120|NCT00658723|387398|P1|Overall Study|Withdrawal by Subject|1
113121|NCT00658723|387396|P3|Overall Study|Scheduling Issue|0
113122|NCT00658723|387397|P2|Overall Study|Scheduling Issue|1
113123|NCT00658723|387398|P1|Overall Study|Scheduling Issue|1
113124|NCT00658723|387396|P3|Overall Study|Death|4
113125|NCT00658723|387397|P2|Overall Study|Death|1
113126|NCT00658723|387398|P1|Overall Study|Death|2
113127|NCT00658723|387396|P3|Overall Study|Lost to Follow-up|2
113128|NCT00658723|387397|P2|Overall Study|Lost to Follow-up|2
113129|NCT00658723|387398|P1|Overall Study|Lost to Follow-up|0
113130|NCT00658684|387436|P4|Overall Study|Pregnancy|0
113131|NCT00658684|387437|P3|Overall Study|Pregnancy|0
113132|NCT00658684|387438|P2|Overall Study|Pregnancy|1
113133|NCT00658684|387439|P1|Overall Study|Pregnancy|1
113134|NCT00658684|387436|P4|Overall Study|Protocol Violation|0
113135|NCT00658684|387437|P3|Overall Study|Protocol Violation|0
113136|NCT00658684|387438|P2|Overall Study|Protocol Violation|1
113137|NCT00658684|387439|P1|Overall Study|Protocol Violation|1
113138|NCT00658684|387436|P4|Overall Study|Lack of Efficacy|0
113139|NCT00658684|387437|P3|Overall Study|Lack of Efficacy|0
113140|NCT00658684|387438|P2|Overall Study|Lack of Efficacy|1
113141|NCT00658684|387439|P1|Overall Study|Lack of Efficacy|1
113142|NCT00658684|387436|P4|Overall Study|Withdrawal by Subject|1
113143|NCT00658684|387437|P3|Overall Study|Withdrawal by Subject|1
113144|NCT00658684|387438|P2|Overall Study|Withdrawal by Subject|4
113145|NCT00658684|387439|P1|Overall Study|Withdrawal by Subject|6
113146|NCT00658684|387436|P4|Overall Study|Adverse Event|0
113147|NCT00658684|387437|P3|Overall Study|Adverse Event|2
113148|NCT00658684|387438|P2|Overall Study|Adverse Event|8
113149|NCT00658684|387439|P1|Overall Study|Adverse Event|10
113150|NCT00658658|387494|P5|Overall Study|Other|1
113151|NCT00658658|387495|P4|Overall Study|Other|0
113152|NCT00658658|387496|P3|Overall Study|Other|0
113153|NCT00658658|387497|P2|Overall Study|Other|0
113154|NCT00658658|387498|P1|Overall Study|Other|0
113155|NCT00658658|387494|P5|Overall Study|Protocol-specified Criteria|0
113156|NCT00658658|387495|P4|Overall Study|Protocol-specified Criteria|0
113157|NCT00658658|387496|P3|Overall Study|Protocol-specified Criteria|0
113158|NCT00658658|387497|P2|Overall Study|Protocol-specified Criteria|0
113159|NCT00658658|387498|P1|Overall Study|Protocol-specified Criteria|1
113160|NCT00658658|387494|P5|Overall Study|Disease Progression|3
113161|NCT00658658|387495|P4|Overall Study|Disease Progression|1
113162|NCT00658658|387496|P3|Overall Study|Disease Progression|0
113163|NCT00658658|387497|P2|Overall Study|Disease Progression|1
113164|NCT00658658|387498|P1|Overall Study|Disease Progression|0
113165|NCT00658658|387494|P5|Overall Study|Death|1
113166|NCT00658658|387495|P4|Overall Study|Death|1
113167|NCT00658658|387496|P3|Overall Study|Death|0
113168|NCT00658658|387497|P2|Overall Study|Death|0
113169|NCT00658658|387498|P1|Overall Study|Death|4
113170|NCT00658658|387494|P5|Overall Study|Withdrawal by Subject|0
113171|NCT00658658|387495|P4|Overall Study|Withdrawal by Subject|0
113172|NCT00658658|387496|P3|Overall Study|Withdrawal by Subject|0
113173|NCT00658658|387497|P2|Overall Study|Withdrawal by Subject|1
113174|NCT00658658|387498|P1|Overall Study|Withdrawal by Subject|0
113175|NCT00658632|387557|P2|Overall Study|Not specified|8
113176|NCT00658632|387558|P1|Overall Study|Not specified|7
113177|NCT00658632|387557|P2|Overall Study|Pregnancy|1
113178|NCT00658632|387558|P1|Overall Study|Pregnancy|1
113179|NCT00658632|387557|P2|Overall Study|Withdrawal of consent|14
113180|NCT00658632|387558|P1|Overall Study|Withdrawal of consent|8
113181|NCT00658632|387557|P2|Overall Study|Lack of Efficacy|1
113182|NCT00658632|387558|P1|Overall Study|Lack of Efficacy|0
113183|NCT00658632|387557|P2|Overall Study|Withdrawal by Subject|7
113184|NCT00658632|387558|P1|Overall Study|Withdrawal by Subject|10
113185|NCT00658632|387557|P2|Overall Study|Lost to Follow-up|23
113186|NCT00658632|387558|P1|Overall Study|Lost to Follow-up|25
113187|NCT00658632|387557|P2|Overall Study|Adverse Event|11
113188|NCT00658632|387558|P1|Overall Study|Adverse Event|13
113189|NCT00658606|387599|P2|Overall Study|Lack of Compliance|3
113190|NCT00658606|387600|P1|Overall Study|Lack of Compliance|0
113191|NCT00658606|387599|P2|Overall Study|Withdrawal by Subject|16
113192|NCT00658606|387600|P1|Overall Study|Withdrawal by Subject|7
113193|NCT00658606|387599|P2|Overall Study|Lost to Follow-up|0
113194|NCT00658606|387600|P1|Overall Study|Lost to Follow-up|1
113195|NCT00658606|387599|P2|Overall Study|Lack of Efficacy|3
113196|NCT00658606|387600|P1|Overall Study|Lack of Efficacy|6
113197|NCT00658606|387599|P2|Overall Study|Adverse Event|1
113198|NCT00658606|387600|P1|Overall Study|Adverse Event|2
113199|NCT00658567|387629|P3|Overall Study|At Discretion of Sponsor|1
113200|NCT00658567|387630|P2|Overall Study|At Discretion of Sponsor|1
113201|NCT00658567|387631|P1|Overall Study|At Discretion of Sponsor|1
113202|NCT00658567|387629|P3|Overall Study|Physician Decision|0
113203|NCT00658567|387630|P2|Overall Study|Physician Decision|1
113204|NCT00658567|387631|P1|Overall Study|Physician Decision|0
113205|NCT00658567|387629|P3|Overall Study|Voluntary Withdrawal of Consent|2
113206|NCT00658567|387630|P2|Overall Study|Voluntary Withdrawal of Consent|0
113207|NCT00658567|387631|P1|Overall Study|Voluntary Withdrawal of Consent|2
113208|NCT00658567|387629|P3|Overall Study|Adverse Event|3
113209|NCT00658567|387630|P2|Overall Study|Adverse Event|2
113210|NCT00658567|387631|P1|Overall Study|Adverse Event|5
113211|NCT00658541|387642|P2|Washout Period of 7 Days|Withdrawal by Subject|1
113212|NCT00658541|387643|P1|Washout Period of 7 Days|Withdrawal by Subject|0
113213|NCT00658541|387642|P2|Washout Period of 7 Days|Withdrawal by Subject|1
113214|NCT00658541|387643|P1|Washout Period of 7 Days|Withdrawal by Subject|1
113215|NCT00658528|387655|P2|Overall Study|Not specified|4
113216|NCT00658528|387656|P1|Overall Study|Not specified|8
113217|NCT00658528|387655|P2|Overall Study|Withdrawal of consent|6
113218|NCT00658528|387656|P1|Overall Study|Withdrawal of consent|5
113219|NCT00658528|387655|P2|Overall Study|Withdrawal by Subject|6
113220|NCT00658528|387656|P1|Overall Study|Withdrawal by Subject|8
113221|NCT00658528|387655|P2|Overall Study|Lost to Follow-up|22
113222|NCT00658528|387656|P1|Overall Study|Lost to Follow-up|14
113223|NCT00658528|387655|P2|Overall Study|Adverse Event|7
113224|NCT00658528|387656|P1|Overall Study|Adverse Event|5
113225|NCT00658333|387680|P2|Overall Study|Adverse Event|1
113226|NCT00658333|387681|P1|Overall Study|Adverse Event|2
113227|NCT00658320|387691|P2|Extension Study: After Month 24|Subject withdrew consent|0
113228|NCT00658320|387692|P1|Extension Study: After Month 24|Subject withdrew consent|2
113229|NCT00658320|387691|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
113230|NCT00658320|387692|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
113231|NCT00658320|387691|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
113232|NCT00658320|387692|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
113233|NCT00658320|387691|P2|Core Study: 12 Months|Subject withdrew consent|3
113234|NCT00658320|387692|P1|Core Study: 12 Months|Subject withdrew consent|5
113235|NCT00657709|387725|P5|Overall Study|Protocol Violation|2
113236|NCT00657709|387726|P4|Overall Study|Protocol Violation|1
113237|NCT00657709|387727|P3|Overall Study|Protocol Violation|0
113238|NCT00657709|387728|P2|Overall Study|Protocol Violation|2
113239|NCT00657709|387729|P1|Overall Study|Protocol Violation|0
113240|NCT00657709|387725|P5|Overall Study|Lost to Follow-up|21
113241|NCT00657709|387726|P4|Overall Study|Lost to Follow-up|1
113242|NCT00657709|387727|P3|Overall Study|Lost to Follow-up|7
113243|NCT00657709|387728|P2|Overall Study|Lost to Follow-up|9
113244|NCT00657709|387729|P1|Overall Study|Lost to Follow-up|9
113245|NCT00657709|387725|P5|Overall Study|Withdrawal by Subject|9
113246|NCT00657709|387726|P4|Overall Study|Withdrawal by Subject|5
113247|NCT00657709|387727|P3|Overall Study|Withdrawal by Subject|15
113248|NCT00657709|387728|P2|Overall Study|Withdrawal by Subject|15
113249|NCT00657709|387729|P1|Overall Study|Withdrawal by Subject|7
113250|NCT00657709|387725|P5|Overall Study|AE or Death|1
113251|NCT00657709|387726|P4|Overall Study|AE or Death|7
113252|NCT00657709|387727|P3|Overall Study|AE or Death|6
113253|NCT00657709|387728|P2|Overall Study|AE or Death|7
113254|NCT00657709|387729|P1|Overall Study|AE or Death|7
113255|NCT00657553|387780|P2|Overall Study|low accrual, no analysis run|5
113256|NCT00657553|387781|P1|Overall Study|low accrual, no analysis run|5
113257|NCT00657371|387787|P1|Overall Study|Pre-existing medical condition|4
113258|NCT00657371|387787|P1|Overall Study|Device- related reasons|13
113259|NCT00657371|387787|P1|Overall Study|Protocol Violation|2
113260|NCT00657371|387787|P1|Overall Study|Unable to intubate the cecum|5
113261|NCT00657371|387787|P1|Overall Study|Poor bowel preparation|15
113262|NCT00657358|387792|P1|Overall Study|Lack of Efficacy|6
113263|NCT00657267|387804|P1|Overall Study|Adverse Event|9
113264|NCT00657267|387804|P1|Overall Study|Progressive disease|45
113265|NCT00657150|387814|P2|Treatment|Not Specified|15
113266|NCT00657150|387815|P1|Treatment|Not Specified|13
113267|NCT00657150|387814|P2|Treatment|Withdrawal by Subject|20
113268|NCT00657150|387815|P1|Treatment|Withdrawal by Subject|23
113269|NCT00657150|387814|P2|Treatment|Lost to Follow-up|0
113270|NCT00657150|387815|P1|Treatment|Lost to Follow-up|1
113271|NCT00657150|387814|P2|Treatment|Non-compliant with protocol|9
113272|NCT00657150|387815|P1|Treatment|Non-compliant with protocol|10
113273|NCT00657150|387814|P2|Treatment|Adverse Event|53
113274|NCT00657150|387815|P1|Treatment|Adverse Event|60
113275|NCT00657150|387814|P2|Overall Study|Not Specified|38
113276|NCT00657150|387815|P1|Overall Study|Not Specified|38
113277|NCT00657150|387814|P2|Overall Study|Withdrawal by Subject|36
113278|NCT00657150|387815|P1|Overall Study|Withdrawal by Subject|51
113279|NCT00657150|387814|P2|Overall Study|Lost to Follow-up|0
113280|NCT00657150|387815|P1|Overall Study|Lost to Follow-up|2
113281|NCT00657150|387814|P2|Overall Study|Non-compliant with protocol|9
113282|NCT00657150|387815|P1|Overall Study|Non-compliant with protocol|5
113283|NCT00657150|387814|P2|Overall Study|Adverse Event|10
113284|NCT00657150|387815|P1|Overall Study|Adverse Event|19
113285|NCT00657046|387846|P3|Overall Study|Surgery|1
113286|NCT00657046|387847|P2|Overall Study|Surgery|0
113287|NCT00657046|387848|P1|Overall Study|Surgery|0
113288|NCT00657046|387846|P3|Overall Study|Death|1
113289|NCT00657046|387847|P2|Overall Study|Death|0
113290|NCT00657046|387848|P1|Overall Study|Death|0
113291|NCT00657046|387846|P3|Overall Study|Withdrawal by Subject|0
113292|NCT00657046|387847|P2|Overall Study|Withdrawal by Subject|0
113293|NCT00657046|387848|P1|Overall Study|Withdrawal by Subject|1
113294|NCT00657046|387846|P3|Overall Study|Protocol Violation|0
113295|NCT00657046|387847|P2|Overall Study|Protocol Violation|2
113296|NCT00657046|387848|P1|Overall Study|Protocol Violation|2
113297|NCT00657046|387846|P3|Overall Study|Adverse Event|0
113298|NCT00657046|387847|P2|Overall Study|Adverse Event|1
113299|NCT00657046|387848|P1|Overall Study|Adverse Event|1
113300|NCT00657020|387880|P2|PERIOD 1|Adverse Event|1
113301|NCT00657020|387881|P1|PERIOD 1|Adverse Event|0
113302|NCT00656851|387931|P2|Overall Study|Withdrawal by Subject|4
113303|NCT00656851|387932|P1|Overall Study|Withdrawal by Subject|0
113304|NCT00656799|387954|P1|Overall Study|Death|2
113305|NCT00656669|387976|P1|AC (Cycles 6-9)|Did not start segment 3|1
113306|NCT00656669|387976|P1|AC (Cycles 6-9)|Adverse Event|1
113307|NCT00656669|387976|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
113308|NCT00656669|387976|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
113309|NCT00656617|387990|P1|Overall Study|Move to different clinical trial|2
113310|NCT00656617|387990|P1|Overall Study|Insurance Issues|2
113311|NCT00656617|387990|P1|Overall Study|Death|2
113312|NCT00656617|387990|P1|Overall Study|Adverse Event|1
113313|NCT00656474|387996|P1|Overall Study|Other Reason|1
113314|NCT00656370|388014|P1|Overall Study|Alternates|3
113315|NCT00656370|388014|P1|Overall Study|Screen Failures|7
113316|NCT00656175|388031|P2|Overall Study|Transportation issues|1
113317|NCT00656175|388032|P1|Overall Study|Transportation issues|0
113318|NCT00656175|388031|P2|Overall Study|Adverse Event|0
113319|NCT00656175|388032|P1|Overall Study|Adverse Event|1
113320|NCT00656136|388040|P2|Overall Study|Unknown and others|4
113321|NCT00656136|388041|P1|Overall Study|Unknown and others|4
113322|NCT00656136|388040|P2|Overall Study|Patient refused to take study medication|10
113323|NCT00656136|388041|P1|Overall Study|Patient refused to take study medication|7
113324|NCT00656136|388040|P2|Overall Study|Protocol Violation|3
113325|NCT00656136|388041|P1|Overall Study|Protocol Violation|2
113326|NCT00656136|388040|P2|Overall Study|Other Adverse Event|51
113327|NCT00656136|388041|P1|Overall Study|Other Adverse Event|5
113328|NCT00656136|388040|P2|Overall Study|Progressive disease|322
113329|NCT00656136|388041|P1|Overall Study|Progressive disease|177
113330|NCT00656084|388051|P1|Overall Study|Investigator Request|1
113331|NCT00656084|388051|P1|Overall Study|Patient Request|1
113332|NCT00656084|388051|P1|Overall Study|Withdrawal by Subject|1
113333|NCT00656084|388051|P1|Overall Study|Adverse Event|4
113334|NCT00656058|388058|P1|Overall Study|Withdrawal by Subject|4
113335|NCT00656058|388058|P1|Overall Study|Withdrawal by Subject|2
113336|NCT00655889|388067|P1|Overall Study|Protocol Violation|1
113337|NCT00655889|388067|P1|Overall Study|Inadequate cell growth|1
113338|NCT00655863|388075|P3|Overall Study|Lost to Follow-up|1
113339|NCT00655863|388076|P2|Overall Study|Lost to Follow-up|0
113340|NCT00655863|388077|P1|Overall Study|Lost to Follow-up|0
113341|NCT00655824|388136|P1|Follow-up (FU) Period|Did Not Show for Scheduled FU Visit|1
113342|NCT00655824|388136|P1|Follow-up (FU) Period|Physician Decision; Low B-cells|1
113343|NCT00655824|388136|P1|Follow-up (FU) Period|Started Adalimumab Therapy|1
113344|NCT00655824|388136|P1|Follow-up (FU) Period|Withdrawal by Subject|4
113345|NCT00655824|388136|P1|Follow-up (FU) Period|Protocol Violation|59
113346|NCT00655824|388136|P1|Treatment Period|Deterioration of Trial Disease|2
113347|NCT00655824|388136|P1|Treatment Period|Withdrawal by Subject|4
113348|NCT00655824|388136|P1|Treatment Period|Protocol Violation|1
113349|NCT00655824|388136|P1|Treatment Period|Early Termination of Study by Sponsor|74
113350|NCT00655824|388136|P1|Treatment Period|Adverse Event|3
113351|NCT00655746|388180|P1|Overall Study|Withdrawal by Subject|1
113352|NCT00655733|388199|P2|Overall Study|Physician Decision|1
113353|NCT00655733|388200|P1|Overall Study|Physician Decision|0
113354|NCT00655733|388199|P2|Overall Study|Withdrawal by Subject|3
113355|NCT00655733|388200|P1|Overall Study|Withdrawal by Subject|3
113356|NCT00655733|388199|P2|Overall Study|Adverse Event|2
113357|NCT00655733|388200|P1|Overall Study|Adverse Event|2
113358|NCT00655733|388199|P2|Overall Study|Lost to Follow-up|2
113359|NCT00655733|388200|P1|Overall Study|Lost to Follow-up|2
113360|NCT00655668|388206|P1|Overall Study|Withdrawal by Subject|2
113361|NCT00655668|388206|P1|Overall Study|New Lymphoma Treatment Started|4
113362|NCT00655668|388206|P1|Overall Study|Unspecified|1
113363|NCT00655668|388206|P1|Overall Study|Study Terminated|9
113364|NCT00655668|388206|P1|Overall Study|Disease Progression|27
113365|NCT00655668|388206|P1|Overall Study|Death|5
113366|NCT00655668|388206|P1|Overall Study|Adverse Event|6
113367|NCT00655629|388233|P2|Overall Study|consent withdrawn|4
113368|NCT00655629|388234|P1|Overall Study|consent withdrawn|6
113369|NCT00655629|388233|P2|Overall Study|Protocol Violation|3
113370|NCT00655629|388234|P1|Overall Study|Protocol Violation|5
113371|NCT00655629|388233|P2|Overall Study|Lost to Follow-up|3
113372|NCT00655629|388234|P1|Overall Study|Lost to Follow-up|4
113373|NCT00655629|388233|P2|Overall Study|Lack of Efficacy|12
113374|NCT00655629|388234|P1|Overall Study|Lack of Efficacy|2
113375|NCT00655629|388233|P2|Overall Study|Adverse Event|1
113376|NCT00655629|388234|P1|Overall Study|Adverse Event|4
113377|NCT00655564|388270|P1|Overall Study|Desired Alternate Therapy|1
113378|NCT00655564|388270|P1|Overall Study|Lost to Follow-up|1
113379|NCT00655564|388270|P1|Overall Study|Adverse Event|1
113380|NCT00655551|388278|P3|Period 4 (up to 7 Days)|Adverse Event|0
113381|NCT00655551|388279|P2|Period 4 (up to 7 Days)|Adverse Event|2
113382|NCT00655551|388280|P1|Period 4 (up to 7 Days)|Adverse Event|0
113383|NCT00655551|388278|P3|Period 3 (up to 7 Days)|Adverse Event|4
113384|NCT00655551|388279|P2|Period 3 (up to 7 Days)|Adverse Event|0
113385|NCT00655551|388280|P1|Period 3 (up to 7 Days)|Adverse Event|0
113386|NCT00655551|388278|P3|Period 2 (up to 7 Days)|Adverse Event|0
113387|NCT00655551|388279|P2|Period 2 (up to 7 Days)|Adverse Event|1
113388|NCT00655551|388280|P1|Period 2 (up to 7 Days)|Adverse Event|0
113389|NCT00655551|388278|P3|All Periods Combined|Adverse Event|4
113390|NCT00655551|388279|P2|All Periods Combined|Adverse Event|3
113391|NCT00655551|388280|P1|All Periods Combined|Adverse Event|0
113392|NCT00655486|388294|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
113393|NCT00655486|388294|P1|Overall Study|Other: Could not tolerate BID dosing|1
113394|NCT00655486|388294|P1|Overall Study|Other: Pregnancy|1
113395|NCT00655486|388294|P1|Overall Study|Unsatisfactory compliance|2
113396|NCT00655486|388294|P1|Overall Study|Protocol Violation|1
113397|NCT00655486|388294|P1|Overall Study|Withdrawal by Subject|4
113398|NCT00655486|388294|P1|Overall Study|Lack of Efficacy|8
113399|NCT00655486|388294|P1|Overall Study|Adverse Event|10
113400|NCT00655356|388301|P2|Overall Study|Other Reason|0
113401|NCT00655356|388302|P1|Overall Study|Other Reason|1
113402|NCT00655356|388301|P2|Overall Study|Protocol Violation|1
113403|NCT00655356|388302|P1|Overall Study|Protocol Violation|2
113404|NCT00655356|388301|P2|Overall Study|Adverse Event|1
113405|NCT00655356|388302|P1|Overall Study|Adverse Event|1
113406|NCT00655356|388301|P2|Overall Study|Sponsor Request|4
113407|NCT00655356|388302|P1|Overall Study|Sponsor Request|10
113408|NCT00655356|388301|P2|Overall Study|Withdrawal by Subject|4
113409|NCT00655356|388302|P1|Overall Study|Withdrawal by Subject|3
113410|NCT00654940|388353|P2|Period 1|Intolerable Pain Level|0
113411|NCT00654940|388354|P1|Period 1|Intolerable Pain Level|1
113412|NCT00654940|388353|P2|Period 1|Adverse Event|1
113413|NCT00654940|388354|P1|Period 1|Adverse Event|0
113414|NCT00654901|388378|P4|Overall Study|Withdrawal by Subject|0
113415|NCT00654901|388379|P3|Overall Study|Withdrawal by Subject|1
113416|NCT00654901|388380|P2|Overall Study|Withdrawal by Subject|0
113417|NCT00654901|388381|P1|Overall Study|Withdrawal by Subject|3
113418|NCT00654901|388378|P4|Overall Study|Lost to Follow-up|0
113419|NCT00654901|388379|P3|Overall Study|Lost to Follow-up|1
113420|NCT00654901|388380|P2|Overall Study|Lost to Follow-up|0
113421|NCT00654901|388381|P1|Overall Study|Lost to Follow-up|1
113422|NCT00654875|388401|P2|Overall Study|Administrative Problems|0
113423|NCT00654875|388402|P1|Overall Study|Administrative Problems|1
113424|NCT00654875|388401|P2|Overall Study|Abnormal Test Procedure Result(s)|0
113425|NCT00654875|388402|P1|Overall Study|Abnormal Test Procedure Result(s)|1
113426|NCT00654875|388401|P2|Overall Study|Lost to Follow-up|3
113427|NCT00654875|388402|P1|Overall Study|Lost to Follow-up|1
113428|NCT00654875|388401|P2|Overall Study|Lack of Efficacy|2
113429|NCT00654875|388402|P1|Overall Study|Lack of Efficacy|2
113430|NCT00654875|388401|P2|Overall Study|Protocol Violation|3
113431|NCT00654875|388402|P1|Overall Study|Protocol Violation|3
113432|NCT00654875|388401|P2|Overall Study|Withdrawal by Subject|4
113433|NCT00654875|388402|P1|Overall Study|Withdrawal by Subject|4
113434|NCT00654875|388401|P2|Overall Study|Adverse Event|5
113435|NCT00654875|388402|P1|Overall Study|Adverse Event|5
113436|NCT00654745|388429|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
113437|NCT00654745|388429|P1|Overall Study|Withdrawal by Subject|10
113438|NCT00654745|388429|P1|Overall Study|Protocol Violation|11
113439|NCT00654745|388429|P1|Overall Study|Lost to Follow-up|7
113440|NCT00654745|388429|P1|Overall Study|Adverse Event|12
113441|NCT00654641|388474|P2|Overall Study|Lost to Follow-up|3
113442|NCT00654641|388475|P1|Overall Study|Lost to Follow-up|2
113443|NCT00654628|388481|P1|6 –Week Extension Period (Single Site)|Lost to Follow-up|1
113444|NCT00654628|388481|P1|6 –Week Extension Period (Single Site)|Adverse Event|4
113445|NCT00654628|388481|P1|6-week Active Treatment Period|Out of window period|1
113446|NCT00654628|388481|P1|6-week Active Treatment Period|Transferred to branch hospital|1
113447|NCT00654628|388481|P1|6-week Active Treatment Period|Lost to Follow-up|10
113448|NCT00654628|388481|P1|6-week Active Treatment Period|Adverse Event|9
113449|NCT00654498|388519|P2|Overall Study|Other reason not defined above|5
113450|NCT00654498|388520|P1|Overall Study|Other reason not defined above|4
113451|NCT00654498|388519|P2|Overall Study|Withdrawal by Subject|0
113452|NCT00654498|388520|P1|Overall Study|Withdrawal by Subject|1
113453|NCT00654498|388519|P2|Overall Study|Lost to Follow-up|5
113454|NCT00654498|388520|P1|Overall Study|Lost to Follow-up|1
113455|NCT00654498|388519|P2|Overall Study|Protocol Violation|1
113456|NCT00654498|388520|P1|Overall Study|Protocol Violation|1
113457|NCT00654498|388519|P2|Overall Study|Adverse Event|1
113458|NCT00654498|388520|P1|Overall Study|Adverse Event|6
113459|NCT00654498|388519|P2|Overall Study|Not Treated|0
113460|NCT00654498|388520|P1|Overall Study|Not Treated|1
113461|NCT00654420|388552|P4|Phase II|Missing Disposition Record|0
113462|NCT00654420|388553|P3|Phase II|Missing Disposition Record|1
113463|NCT00654420|388554|P2|Phase II|Missing Disposition Record|0
113464|NCT00654420|388555|P1|Phase II|Missing Disposition Record|0
113465|NCT00654420|388552|P4|Phase II|Withdrawal by Subject|1
113466|NCT00654420|388553|P3|Phase II|Withdrawal by Subject|4
113467|NCT00654420|388554|P2|Phase II|Withdrawal by Subject|0
113468|NCT00654420|388555|P1|Phase II|Withdrawal by Subject|0
113469|NCT00654420|388552|P4|Phase II|Progressive Disease|29
113470|NCT00654420|388553|P3|Phase II|Progressive Disease|29
113471|NCT00654420|388554|P2|Phase II|Progressive Disease|0
113472|NCT00654420|388555|P1|Phase II|Progressive Disease|0
113473|NCT00654420|388552|P4|Phase II|Physician Decision|4
113474|NCT00654420|388553|P3|Phase II|Physician Decision|0
113475|NCT00654420|388554|P2|Phase II|Physician Decision|0
113476|NCT00654420|388555|P1|Phase II|Physician Decision|0
113477|NCT00654420|388552|P4|Phase II|Lost to Follow-up|1
113478|NCT00654420|388553|P3|Phase II|Lost to Follow-up|0
113479|NCT00654420|388554|P2|Phase II|Lost to Follow-up|0
113480|NCT00654420|388555|P1|Phase II|Lost to Follow-up|0
113481|NCT00654420|388552|P4|Phase II|Adverse Event|3
113482|NCT00654420|388553|P3|Phase II|Adverse Event|3
113483|NCT00654420|388554|P2|Phase II|Adverse Event|0
113484|NCT00654420|388555|P1|Phase II|Adverse Event|0
113485|NCT00654420|388552|P4|Phase I (Dose Escalation)|Progressive Disease|0
113486|NCT00654420|388553|P3|Phase I (Dose Escalation)|Progressive Disease|0
113487|NCT00654420|388554|P2|Phase I (Dose Escalation)|Progressive Disease|15
113488|NCT00654420|388555|P1|Phase I (Dose Escalation)|Progressive Disease|4
113489|NCT00654420|388552|P4|Phase I (Dose Escalation)|Adverse Event|0
113490|NCT00654420|388553|P3|Phase I (Dose Escalation)|Adverse Event|0
113491|NCT00654420|388554|P2|Phase I (Dose Escalation)|Adverse Event|1
113492|NCT00654420|388555|P1|Phase I (Dose Escalation)|Adverse Event|0
113493|NCT00654381|388581|P6|Extension Stage|Closure of the trial site|1
113494|NCT00654381|388582|P5|Extension Stage|Closure of the trial site|1
113495|NCT00654381|388583|P4|Extension Stage|Closure of the trial site|0
113496|NCT00654381|388584|P3|Extension Stage|Closure of the trial site|0
113497|NCT00654381|388585|P2|Extension Stage|Closure of the trial site|0
113498|NCT00654381|388586|P1|Extension Stage|Closure of the trial site|0
113499|NCT00654381|388581|P6|Extension Stage|Withdrawal by Subject|1
113500|NCT00654381|388582|P5|Extension Stage|Withdrawal by Subject|1
113501|NCT00654381|388583|P4|Extension Stage|Withdrawal by Subject|1
113502|NCT00654381|388584|P3|Extension Stage|Withdrawal by Subject|1
113503|NCT00654381|388585|P2|Extension Stage|Withdrawal by Subject|0
113504|NCT00654381|388586|P1|Extension Stage|Withdrawal by Subject|0
113505|NCT00654381|388581|P6|Extension Stage|Lack of Efficacy|0
113506|NCT00654381|388582|P5|Extension Stage|Lack of Efficacy|0
113507|NCT00654381|388583|P4|Extension Stage|Lack of Efficacy|0
113508|NCT00654381|388584|P3|Extension Stage|Lack of Efficacy|1
113509|NCT00654381|388585|P2|Extension Stage|Lack of Efficacy|0
113510|NCT00654381|388586|P1|Extension Stage|Lack of Efficacy|0
113511|NCT00654381|388581|P6|Extension Stage|Protocol Violation|0
113512|NCT00654381|388582|P5|Extension Stage|Protocol Violation|0
113513|NCT00654381|388583|P4|Extension Stage|Protocol Violation|1
113514|NCT00654381|388584|P3|Extension Stage|Protocol Violation|0
113515|NCT00654381|388585|P2|Extension Stage|Protocol Violation|0
113516|NCT00654381|388586|P1|Extension Stage|Protocol Violation|0
113517|NCT00654381|388581|P6|Extension Stage|Adverse Event|1
113518|NCT00654381|388582|P5|Extension Stage|Adverse Event|1
113519|NCT00654381|388583|P4|Extension Stage|Adverse Event|7
113520|NCT00654381|388584|P3|Extension Stage|Adverse Event|9
113521|NCT00654381|388585|P2|Extension Stage|Adverse Event|2
113522|NCT00654381|388586|P1|Extension Stage|Adverse Event|1
113523|NCT00654381|388581|P6|2nd Stage|Investigator's decision|0
113524|NCT00654381|388582|P5|2nd Stage|Investigator's decision|0
113525|NCT00654381|388583|P4|2nd Stage|Investigator's decision|1
113526|NCT00654381|388584|P3|2nd Stage|Investigator's decision|1
113527|NCT00654381|388585|P2|2nd Stage|Investigator's decision|0
113528|NCT00654381|388586|P1|2nd Stage|Investigator's decision|0
113529|NCT00654381|388581|P6|2nd Stage|Withdrawal by Subject|1
113530|NCT00654381|388582|P5|2nd Stage|Withdrawal by Subject|1
113531|NCT00654381|388583|P4|2nd Stage|Withdrawal by Subject|0
113532|NCT00654381|388584|P3|2nd Stage|Withdrawal by Subject|0
113533|NCT00654381|388585|P2|2nd Stage|Withdrawal by Subject|0
113534|NCT00654381|388586|P1|2nd Stage|Withdrawal by Subject|0
113535|NCT00654381|388581|P6|2nd Stage|Adverse Event|2
113536|NCT00654381|388582|P5|2nd Stage|Adverse Event|7
113537|NCT00654381|388583|P4|2nd Stage|Adverse Event|3
113538|NCT00654381|388584|P3|2nd Stage|Adverse Event|2
113539|NCT00654381|388585|P2|2nd Stage|Adverse Event|0
113540|NCT00654381|388586|P1|2nd Stage|Adverse Event|2
113541|NCT00654381|388581|P6|1st Stage|Investigator's decision|0
113542|NCT00654381|388582|P5|1st Stage|Investigator's decision|0
113543|NCT00654381|388583|P4|1st Stage|Investigator's decision|1
113544|NCT00654381|388584|P3|1st Stage|Investigator's decision|0
113545|NCT00654381|388585|P2|1st Stage|Investigator's decision|0
113546|NCT00654381|388586|P1|1st Stage|Investigator's decision|0
113547|NCT00654381|388581|P6|1st Stage|Withdrawal by Subject|1
113548|NCT00654381|388582|P5|1st Stage|Withdrawal by Subject|0
113549|NCT00654381|388583|P4|1st Stage|Withdrawal by Subject|1
113550|NCT00654381|388584|P3|1st Stage|Withdrawal by Subject|0
113551|NCT00654381|388585|P2|1st Stage|Withdrawal by Subject|0
113552|NCT00654381|388586|P1|1st Stage|Withdrawal by Subject|0
113553|NCT00654381|388581|P6|1st Stage|Adverse Event|1
113554|NCT00654381|388582|P5|1st Stage|Adverse Event|2
113555|NCT00654381|388583|P4|1st Stage|Adverse Event|3
113556|NCT00654381|388584|P3|1st Stage|Adverse Event|3
113557|NCT00654381|388585|P2|1st Stage|Adverse Event|3
113558|NCT00654381|388586|P1|1st Stage|Adverse Event|3
113559|NCT00654368|388623|P3|Overall Study|Adverse Event|6
113560|NCT00654368|388624|P2|Overall Study|Adverse Event|9
113561|NCT00654368|388625|P1|Overall Study|Adverse Event|14
113562|NCT00654368|388623|P3|Overall Study|Other|3
113563|NCT00654368|388624|P2|Overall Study|Other|2
113564|NCT00654368|388625|P1|Overall Study|Other|0
113565|NCT00654368|388623|P3|Overall Study|Pregnancy|2
113566|NCT00654368|388624|P2|Overall Study|Pregnancy|0
113567|NCT00654368|388625|P1|Overall Study|Pregnancy|0
113568|NCT00654368|388623|P3|Overall Study|Death|0
113569|NCT00654368|388624|P2|Overall Study|Death|0
113570|NCT00654368|388625|P1|Overall Study|Death|1
113571|NCT00654368|388623|P3|Overall Study|Physician Decision|2
113572|NCT00654368|388624|P2|Overall Study|Physician Decision|0
113573|NCT00654368|388625|P1|Overall Study|Physician Decision|0
113574|NCT00654368|388623|P3|Overall Study|Requirement for alternative therapy|1
113575|NCT00654368|388624|P2|Overall Study|Requirement for alternative therapy|1
113576|NCT00654368|388625|P1|Overall Study|Requirement for alternative therapy|1
113577|NCT00654368|388623|P3|Overall Study|Disease progression|13
113578|NCT00654368|388624|P2|Overall Study|Disease progression|31
113579|NCT00654368|388625|P1|Overall Study|Disease progression|21
113580|NCT00654368|388623|P3|Overall Study|Withdrawal by Subject|2
113581|NCT00654368|388624|P2|Overall Study|Withdrawal by Subject|2
113582|NCT00654368|388625|P1|Overall Study|Withdrawal by Subject|5
113583|NCT00654368|388623|P3|Overall Study|Non-compliance|2
113584|NCT00654368|388624|P2|Overall Study|Non-compliance|1
113585|NCT00654368|388625|P1|Overall Study|Non-compliance|2
113586|NCT00654368|388623|P3|Overall Study|Protocol deviation|1
113587|NCT00654368|388624|P2|Overall Study|Protocol deviation|2
113588|NCT00654368|388625|P1|Overall Study|Protocol deviation|3
113589|NCT00654368|388623|P3|Overall Study|Ineligibility determined|0
113590|NCT00654368|388624|P2|Overall Study|Ineligibility determined|0
113591|NCT00654368|388625|P1|Overall Study|Ineligibility determined|6
113592|NCT00654186|388677|P1|Overall Study|Withdrawal by Subject|5
113593|NCT00654095|388702|P1|Overall Study|Did not meet inclusion criteria|1
113594|NCT00654095|388702|P1|Overall Study|Adverse reaction did not improve (5)|4
113595|NCT00654095|388702|P1|Overall Study|Elevated alanine aminotransferase (4)|7
113596|NCT00654095|388702|P1|Overall Study|Withdrawal by Subject|5
113597|NCT00654095|388702|P1|Overall Study|Adverse Event|11
113598|NCT00654095|388702|P1|Overall Study|Elevated alanine aminotransferase (3)|1
113599|NCT00654095|388702|P1|Overall Study|Elevated triglyceride level (2)|1
113600|NCT00654095|388702|P1|Overall Study|Drop in low density lipoprotein (1)|2
113601|NCT00654004|388712|P2|Overall Study|Lost to Follow-up|0
113602|NCT00654004|388713|P1|Overall Study|Lost to Follow-up|1
113603|NCT00653939|388729|P2|Overall Study|Not Specified|6
113604|NCT00653939|388730|P1|Overall Study|Not Specified|2
113605|NCT00653939|388729|P2|Overall Study|Disease Progression|3
113606|NCT00653939|388730|P1|Overall Study|Disease Progression|2
113607|NCT00653939|388729|P2|Overall Study|Physician Decision|0
113608|NCT00653939|388730|P1|Overall Study|Physician Decision|4
113609|NCT00653939|388729|P2|Overall Study|Withdrawal by Subject|3
113610|NCT00653939|388730|P1|Overall Study|Withdrawal by Subject|3
113611|NCT00653939|388729|P2|Overall Study|Adverse Event|3
113612|NCT00653939|388730|P1|Overall Study|Adverse Event|1
113613|NCT00653523|388755|P1|Overall Study|Adverse reaction did not improve (4)|1
113614|NCT00653523|388755|P1|Overall Study|Elevated alanine aminotransferase (3)|2
113615|NCT00653523|388755|P1|Overall Study|Withdrawal by Subject|6
113616|NCT00653523|388755|P1|Overall Study|Adverse Event|7
113617|NCT00653523|388755|P1|Overall Study|Elevated creatine phosphokinase (2)|1
113618|NCT00653523|388755|P1|Overall Study|Drop in low density lipoprotein (1)|2
113619|NCT00653328|388759|P1|Overall Study|Drug manufacturer no longing making drug|2
113620|NCT00653328|388759|P1|Overall Study|Disease progression|10
113621|NCT00653328|388759|P1|Overall Study|Adverse Event|2
113622|NCT00653328|388759|P1|Overall Study|Withdrawal by Subject|1
113623|NCT00653263|388766|P1|Overall Study|Physician Decision|1
113624|NCT00653263|388766|P1|Overall Study|Withdrawal by Subject|1
113625|NCT00653224|388774|P2|Overall Study|Other|4
113626|NCT00653224|388775|P1|Overall Study|Other|2
113627|NCT00653224|388774|P2|Overall Study|Lost to Follow-up|0
113628|NCT00653224|388775|P1|Overall Study|Lost to Follow-up|1
113629|NCT00653224|388774|P2|Overall Study|Loss of efficacy|0
113630|NCT00653224|388775|P1|Overall Study|Loss of efficacy|1
113631|NCT00653224|388774|P2|Overall Study|Lack of Efficacy|2
113632|NCT00653224|388775|P1|Overall Study|Lack of Efficacy|1
113633|NCT00653224|388774|P2|Overall Study|Adverse Event|1
113634|NCT00653224|388775|P1|Overall Study|Adverse Event|2
113635|NCT00653159|388974|P2|Overall Study|Lost to Follow-up|2
113636|NCT00653159|388975|P1|Overall Study|Lost to Follow-up|1
113637|NCT00653159|388974|P2|Overall Study|Adverse Event|1
113638|NCT00653159|388975|P1|Overall Study|Adverse Event|4
113639|NCT00653068|389002|P1|Overall Study|Ineligible|2
113640|NCT00653068|389002|P1|Overall Study|Withdrawal by Subject|1
113641|NCT00653068|389002|P1|Overall Study|Physician Decision|4
113642|NCT00653068|389002|P1|Overall Study|Lack of Efficacy|34
113643|NCT00653068|389002|P1|Overall Study|Death|9
113644|NCT00652938|389016|P3|Overall Study|fear of blood sampling|0
113645|NCT00652938|389017|P2|Overall Study|fear of blood sampling|1
113646|NCT00652938|389018|P1|Overall Study|fear of blood sampling|0
113647|NCT00652938|389016|P3|Overall Study|Lost to Follow-up|2
113648|NCT00652938|389017|P2|Overall Study|Lost to Follow-up|0
113649|NCT00652938|389018|P1|Overall Study|Lost to Follow-up|0
113650|NCT00652938|389016|P3|Overall Study|Withdrawal by Subject|1
113651|NCT00652938|389017|P2|Overall Study|Withdrawal by Subject|6
113652|NCT00652938|389018|P1|Overall Study|Withdrawal by Subject|0
113653|NCT00652938|389016|P3|Overall Study|Adverse Event|2
113654|NCT00652938|389017|P2|Overall Study|Adverse Event|0
113655|NCT00652938|389018|P1|Overall Study|Adverse Event|1
113656|NCT00652899|389083|P1|Overall Study|Treating physician decision|1
113657|NCT00652899|389083|P1|Overall Study|Death|1
113658|NCT00652834|389093|P1|Overall Study|Lost to Follow-up|2
113659|NCT00652834|389093|P1|Overall Study|Withdrawal by Subject|3
113660|NCT00652626|389104|P7|Extension Phase|Death|1
113661|NCT00652626|389105|P6|Extension Phase|Death|1
113662|NCT00652626|389106|P5|Extension Phase|Death|0
113663|NCT00652626|389107|P4|Extension Phase|Death|0
113664|NCT00652626|389108|P3|Extension Phase|Death|0
113665|NCT00652626|389109|P2|Extension Phase|Death|0
113666|NCT00652626|389110|P1|Extension Phase|Death|0
113667|NCT00652626|389104|P7|Extension Phase|Physician Decision|1
113668|NCT00652626|389105|P6|Extension Phase|Physician Decision|1
113669|NCT00652626|389106|P5|Extension Phase|Physician Decision|0
113670|NCT00652626|389107|P4|Extension Phase|Physician Decision|0
113671|NCT00652626|389108|P3|Extension Phase|Physician Decision|0
113672|NCT00652626|389109|P2|Extension Phase|Physician Decision|0
113673|NCT00652626|389110|P1|Extension Phase|Physician Decision|0
113674|NCT00652626|389104|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
113675|NCT00652626|389105|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
113676|NCT00652626|389106|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
113677|NCT00652626|389107|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
113678|NCT00652626|389108|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
113679|NCT00652626|389109|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
113680|NCT00652626|389110|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
113681|NCT00652626|389104|P7|Extension Phase|Adverse Event|1
113682|NCT00652626|389105|P6|Extension Phase|Adverse Event|2
113683|NCT00652626|389106|P5|Extension Phase|Adverse Event|0
113684|NCT00652626|389107|P4|Extension Phase|Adverse Event|0
113685|NCT00652626|389108|P3|Extension Phase|Adverse Event|0
113686|NCT00652626|389109|P2|Extension Phase|Adverse Event|0
113687|NCT00652626|389110|P1|Extension Phase|Adverse Event|0
113688|NCT00652626|389104|P7|Extension Phase|Withdrawal by Subject|0
113689|NCT00652626|389105|P6|Extension Phase|Withdrawal by Subject|2
113690|NCT00652626|389106|P5|Extension Phase|Withdrawal by Subject|0
113691|NCT00652626|389107|P4|Extension Phase|Withdrawal by Subject|0
113692|NCT00652626|389108|P3|Extension Phase|Withdrawal by Subject|0
113693|NCT00652626|389109|P2|Extension Phase|Withdrawal by Subject|0
113694|NCT00652626|389110|P1|Extension Phase|Withdrawal by Subject|0
113695|NCT00652626|389104|P7|Initial Treatment Phase|Lost to Follow-up|0
113696|NCT00652626|389105|P6|Initial Treatment Phase|Lost to Follow-up|0
113697|NCT00652626|389106|P5|Initial Treatment Phase|Lost to Follow-up|1
113698|NCT00652626|389107|P4|Initial Treatment Phase|Lost to Follow-up|0
113699|NCT00652626|389108|P3|Initial Treatment Phase|Lost to Follow-up|0
113700|NCT00652626|389109|P2|Initial Treatment Phase|Lost to Follow-up|0
113701|NCT00652626|389110|P1|Initial Treatment Phase|Lost to Follow-up|0
113702|NCT00652626|389104|P7|Initial Treatment Phase|Sponsor Request|0
113703|NCT00652626|389105|P6|Initial Treatment Phase|Sponsor Request|0
113704|NCT00652626|389106|P5|Initial Treatment Phase|Sponsor Request|0
113705|NCT00652626|389107|P4|Initial Treatment Phase|Sponsor Request|0
113706|NCT00652626|389108|P3|Initial Treatment Phase|Sponsor Request|1
113707|NCT00652626|389109|P2|Initial Treatment Phase|Sponsor Request|0
113708|NCT00652626|389110|P1|Initial Treatment Phase|Sponsor Request|0
113709|NCT00652626|389104|P7|Initial Treatment Phase|Physician Decision|0
113710|NCT00652626|389105|P6|Initial Treatment Phase|Physician Decision|0
113711|NCT00652626|389106|P5|Initial Treatment Phase|Physician Decision|1
113712|NCT00652626|389107|P4|Initial Treatment Phase|Physician Decision|0
113713|NCT00652626|389108|P3|Initial Treatment Phase|Physician Decision|0
113714|NCT00652626|389109|P2|Initial Treatment Phase|Physician Decision|0
113715|NCT00652626|389110|P1|Initial Treatment Phase|Physician Decision|0
113716|NCT00652626|389104|P7|Initial Treatment Phase|Protocol Violation|0
113717|NCT00652626|389105|P6|Initial Treatment Phase|Protocol Violation|0
113718|NCT00652626|389106|P5|Initial Treatment Phase|Protocol Violation|0
113719|NCT00652626|389107|P4|Initial Treatment Phase|Protocol Violation|1
113720|NCT00652626|389108|P3|Initial Treatment Phase|Protocol Violation|0
113721|NCT00652626|389109|P2|Initial Treatment Phase|Protocol Violation|0
113722|NCT00652626|389110|P1|Initial Treatment Phase|Protocol Violation|0
113723|NCT00652626|389104|P7|Initial Treatment Phase|Adverse Event|0
113724|NCT00652626|389105|P6|Initial Treatment Phase|Adverse Event|0
113725|NCT00652626|389106|P5|Initial Treatment Phase|Adverse Event|1
113726|NCT00652626|389107|P4|Initial Treatment Phase|Adverse Event|0
113727|NCT00652626|389108|P3|Initial Treatment Phase|Adverse Event|0
113728|NCT00652626|389109|P2|Initial Treatment Phase|Adverse Event|0
113729|NCT00652626|389110|P1|Initial Treatment Phase|Adverse Event|0
113730|NCT00652366|389179|P5|Overall Study|Not specified|0
113731|NCT00652366|389180|P4|Overall Study|Not specified|4
113732|NCT00652366|389181|P3|Overall Study|Not specified|3
113733|NCT00652366|389182|P2|Overall Study|Not specified|2
113734|NCT00652366|389183|P1|Overall Study|Not specified|5
113735|NCT00652366|389179|P5|Overall Study|Refused treatment|5
113736|NCT00652366|389180|P4|Overall Study|Refused treatment|17
113737|NCT00652366|389181|P3|Overall Study|Refused treatment|6
113738|NCT00652366|389182|P2|Overall Study|Refused treatment|7
113739|NCT00652366|389183|P1|Overall Study|Refused treatment|3
113740|NCT00652366|389179|P5|Overall Study|Protocol Violation|0
113741|NCT00652366|389180|P4|Overall Study|Protocol Violation|0
113742|NCT00652366|389181|P3|Overall Study|Protocol Violation|0
113743|NCT00652366|389182|P2|Overall Study|Protocol Violation|0
113744|NCT00652366|389183|P1|Overall Study|Protocol Violation|1
113745|NCT00652366|389179|P5|Overall Study|Violation of Selection Criteria|0
113746|NCT00652366|389180|P4|Overall Study|Violation of Selection Criteria|0
113747|NCT00652366|389181|P3|Overall Study|Violation of Selection Criteria|1
113748|NCT00652366|389182|P2|Overall Study|Violation of Selection Criteria|0
113749|NCT00652366|389183|P1|Overall Study|Violation of Selection Criteria|0
113750|NCT00652366|389179|P5|Overall Study|Lack of Efficacy|13
113751|NCT00652366|389180|P4|Overall Study|Lack of Efficacy|133
113752|NCT00652366|389181|P3|Overall Study|Lack of Efficacy|53
113753|NCT00652366|389182|P2|Overall Study|Lack of Efficacy|58
113754|NCT00652366|389183|P1|Overall Study|Lack of Efficacy|84
113755|NCT00652366|389179|P5|Overall Study|Death|5
113756|NCT00652366|389180|P4|Overall Study|Death|8
113757|NCT00652366|389181|P3|Overall Study|Death|1
113758|NCT00652366|389182|P2|Overall Study|Death|4
113759|NCT00652366|389183|P1|Overall Study|Death|5
113760|NCT00652366|389179|P5|Overall Study|Adverse Event|13
113761|NCT00652366|389180|P4|Overall Study|Adverse Event|17
113762|NCT00652366|389181|P3|Overall Study|Adverse Event|7
113763|NCT00652366|389182|P2|Overall Study|Adverse Event|4
113764|NCT00652366|389183|P1|Overall Study|Adverse Event|8
113765|NCT00652340|389218|P2|Overall Study|Had not progressed.|3
113766|NCT00652340|389219|P1|Overall Study|Had not progressed.|4
113767|NCT00652327|389229|P2|Overall Study|Lost to Follow-up|3
113768|NCT00652327|389230|P1|Overall Study|Lost to Follow-up|0
113769|NCT00652327|389229|P2|Overall Study|Adverse Event|2
113770|NCT00652327|389230|P1|Overall Study|Adverse Event|0
113771|NCT00652093|389259|P6|Overall Study|Physician Decision|0
113772|NCT00652093|389260|P5|Overall Study|Physician Decision|1
113773|NCT00652093|389261|P4|Overall Study|Physician Decision|0
113774|NCT00652093|389262|P3|Overall Study|Physician Decision|0
113775|NCT00652093|389263|P2|Overall Study|Physician Decision|0
113776|NCT00652093|389264|P1|Overall Study|Physician Decision|0
113777|NCT00652093|389259|P6|Overall Study|Withdrawal by Subject|0
113778|NCT00652093|389260|P5|Overall Study|Withdrawal by Subject|1
113779|NCT00652093|389261|P4|Overall Study|Withdrawal by Subject|0
113780|NCT00652093|389262|P3|Overall Study|Withdrawal by Subject|1
113781|NCT00652093|389263|P2|Overall Study|Withdrawal by Subject|0
113782|NCT00652093|389264|P1|Overall Study|Withdrawal by Subject|0
113783|NCT00652028|389348|P4|Overall Study|Physician Decision|0
113784|NCT00652028|389349|P3|Overall Study|Physician Decision|1
113785|NCT00652028|389350|P2|Overall Study|Physician Decision|0
113786|NCT00652028|389351|P1|Overall Study|Physician Decision|0
113787|NCT00652028|389348|P4|Overall Study|No Longer Meets Entry Criteria|0
113788|NCT00652028|389349|P3|Overall Study|No Longer Meets Entry Criteria|0
113789|NCT00652028|389350|P2|Overall Study|No Longer Meets Entry Criteria|1
113790|NCT00652028|389351|P1|Overall Study|No Longer Meets Entry Criteria|0
113791|NCT00652028|389348|P4|Overall Study|Adverse Event|0
113792|NCT00652028|389349|P3|Overall Study|Adverse Event|0
113793|NCT00652028|389350|P2|Overall Study|Adverse Event|0
113794|NCT00652028|389351|P1|Overall Study|Adverse Event|1
113795|NCT00651924|389395|P2|Overall Study|Withdrawal by Subject|5
113796|NCT00651924|389396|P1|Overall Study|Withdrawal by Subject|0
113797|NCT00651924|389395|P2|Overall Study|Withdrawal by PI|2
113798|NCT00651924|389396|P1|Overall Study|Withdrawal by PI|0
113799|NCT00651820|389402|P1|Overall Study|Lost to Follow-up|2
113800|NCT00651755|389409|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
113801|NCT00651755|389410|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
113802|NCT00651755|389409|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
113803|NCT00651755|389410|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
113804|NCT00651313|389455|P2|Overall Study|Adminstrative Discontinuation|3
113805|NCT00651313|389456|P1|Overall Study|Adminstrative Discontinuation|2
113806|NCT00651313|389455|P2|Overall Study|Lost to Follow-up|1
113807|NCT00651313|389456|P1|Overall Study|Lost to Follow-up|1
113808|NCT00651313|389455|P2|Overall Study|Withdrawal by Subject|1
113809|NCT00651313|389456|P1|Overall Study|Withdrawal by Subject|3
113810|NCT00651313|389455|P2|Overall Study|Adverse Event|1
113811|NCT00651313|389456|P1|Overall Study|Adverse Event|0
113812|NCT00651261|389464|P2|Overall Study|Never treated|3
113813|NCT00651261|389465|P1|Overall Study|Never treated|5
113814|NCT00651261|389464|P2|Overall Study|Other disease or participant decisions|23
113815|NCT00651261|389465|P1|Overall Study|Other disease or participant decisions|23
113816|NCT00651261|389464|P2|Overall Study|Alternative therapy|107
113817|NCT00651261|389465|P1|Overall Study|Alternative therapy|109
113818|NCT00651261|389464|P2|Overall Study|Disease progression|58
113819|NCT00651261|389465|P1|Overall Study|Disease progression|58
113820|NCT00651261|389464|P2|Overall Study|Induction failure|35
113821|NCT00651261|389465|P1|Overall Study|Induction failure|24
113822|NCT00651261|389464|P2|Overall Study|Withdrawal by Subject|40
113823|NCT00651261|389465|P1|Overall Study|Withdrawal by Subject|22
113824|NCT00651261|389464|P2|Overall Study|Death|18
113825|NCT00651261|389465|P1|Overall Study|Death|18
113826|NCT00651261|389464|P2|Overall Study|Adverse Event|22
113827|NCT00651261|389465|P1|Overall Study|Adverse Event|32
113828|NCT00651183|389481|P2|Overall Study|missing|0
113829|NCT00651183|389482|P1|Overall Study|missing|1
113830|NCT00651183|389481|P2|Overall Study|Other reasons|2
113831|NCT00651183|389482|P1|Overall Study|Other reasons|4
113832|NCT00651183|389481|P2|Overall Study|Lost to Follow-up|1
113833|NCT00651183|389482|P1|Overall Study|Lost to Follow-up|3
113834|NCT00651183|389481|P2|Overall Study|Withdrawal by Subject|3
113835|NCT00651183|389482|P1|Overall Study|Withdrawal by Subject|6
113836|NCT00651183|389481|P2|Overall Study|Tolerability insufficient +Patients wish|1
113837|NCT00651183|389482|P1|Overall Study|Tolerability insufficient +Patients wish|0
113838|NCT00651183|389481|P2|Overall Study|Tolerability insufficient|2
113839|NCT00651183|389482|P1|Overall Study|Tolerability insufficient|5
113840|NCT00651183|389481|P2|Overall Study|Efficacy insufficient + patients wish|1
113841|NCT00651183|389482|P1|Overall Study|Efficacy insufficient + patients wish|0
113842|NCT00651183|389481|P2|Overall Study|Lack of Efficacy|0
113843|NCT00651183|389482|P1|Overall Study|Lack of Efficacy|1
113844|NCT00651157|389494|P1|Overall Study|Protocol Violation|1
113845|NCT00651157|389494|P1|Overall Study|Death|1
113846|NCT00651118|389504|P4|Overall Study|Withdrawal by Subject|1
113847|NCT00651118|389505|P3|Overall Study|Withdrawal by Subject|1
113848|NCT00651118|389506|P2|Overall Study|Withdrawal by Subject|1
113849|NCT00651118|389507|P1|Overall Study|Withdrawal by Subject|0
113850|NCT00651118|389504|P4|Overall Study|administrative|1
113851|NCT00651118|389505|P3|Overall Study|administrative|2
113852|NCT00651118|389506|P2|Overall Study|administrative|4
113853|NCT00651118|389507|P1|Overall Study|administrative|1
113854|NCT00651118|389504|P4|Overall Study|Lost to Follow-up|2
113855|NCT00651118|389505|P3|Overall Study|Lost to Follow-up|1
113856|NCT00651118|389506|P2|Overall Study|Lost to Follow-up|0
113857|NCT00651118|389507|P1|Overall Study|Lost to Follow-up|2
113858|NCT00651118|389504|P4|Overall Study|Protocol Violation|2
113859|NCT00651118|389505|P3|Overall Study|Protocol Violation|6
113860|NCT00651118|389506|P2|Overall Study|Protocol Violation|2
113861|NCT00651118|389507|P1|Overall Study|Protocol Violation|2
113862|NCT00651118|389504|P4|Overall Study|Adverse Event|1
113863|NCT00651118|389505|P3|Overall Study|Adverse Event|1
113864|NCT00651118|389506|P2|Overall Study|Adverse Event|0
113865|NCT00651118|389507|P1|Overall Study|Adverse Event|4
113866|NCT00650845|389555|P2|Overall Study|Protocol Violation|13
113867|NCT00650845|389556|P1|Overall Study|Protocol Violation|0
113868|NCT00650845|389555|P2|Overall Study|Withdrawal by Subject|0
113869|NCT00650845|389556|P1|Overall Study|Withdrawal by Subject|5
113870|NCT00650806|389576|P4|Overall Study|Not specified|0
113871|NCT00650806|389577|P3|Overall Study|Not specified|2
113872|NCT00650806|389578|P2|Overall Study|Not specified|1
113873|NCT00650806|389579|P1|Overall Study|Not specified|1
113874|NCT00650806|389576|P4|Overall Study|Study terminated by sponsor|4
113875|NCT00650806|389577|P3|Overall Study|Study terminated by sponsor|5
113876|NCT00650806|389578|P2|Overall Study|Study terminated by sponsor|3
113877|NCT00650806|389579|P1|Overall Study|Study terminated by sponsor|2
113878|NCT00650806|389576|P4|Overall Study|Noncompliance with study drug regimen|0
113879|NCT00650806|389577|P3|Overall Study|Noncompliance with study drug regimen|0
113880|NCT00650806|389578|P2|Overall Study|Noncompliance with study drug regimen|1
113881|NCT00650806|389579|P1|Overall Study|Noncompliance with study drug regimen|1
113882|NCT00650806|389576|P4|Overall Study|Withdrawal by Subject|6
113883|NCT00650806|389577|P3|Overall Study|Withdrawal by Subject|8
113884|NCT00650806|389578|P2|Overall Study|Withdrawal by Subject|5
113885|NCT00650806|389579|P1|Overall Study|Withdrawal by Subject|7
113886|NCT00650806|389576|P4|Overall Study|Pregnancy|1
113887|NCT00650806|389577|P3|Overall Study|Pregnancy|0
113888|NCT00650806|389578|P2|Overall Study|Pregnancy|0
113889|NCT00650806|389579|P1|Overall Study|Pregnancy|0
113890|NCT00650806|389576|P4|Overall Study|Protocol Violation|1
113891|NCT00650806|389577|P3|Overall Study|Protocol Violation|0
113892|NCT00650806|389578|P2|Overall Study|Protocol Violation|0
113893|NCT00650806|389579|P1|Overall Study|Protocol Violation|0
113894|NCT00650806|389576|P4|Overall Study|Lost to Follow-up|10
113895|NCT00650806|389577|P3|Overall Study|Lost to Follow-up|11
113896|NCT00650806|389578|P2|Overall Study|Lost to Follow-up|6
113897|NCT00650806|389579|P1|Overall Study|Lost to Follow-up|7
113898|NCT00650806|389576|P4|Overall Study|Adverse Event|4
113899|NCT00650806|389577|P3|Overall Study|Adverse Event|3
113900|NCT00650806|389578|P2|Overall Study|Adverse Event|5
113901|NCT00650806|389579|P1|Overall Study|Adverse Event|0
113902|NCT00650767|389621|P4|Overall Study|Other|0
113903|NCT00650767|389622|P3|Overall Study|Other|0
113904|NCT00650767|389623|P2|Overall Study|Other|1
113905|NCT00650767|389624|P1|Overall Study|Other|1
113906|NCT00650767|389621|P4|Overall Study|Lost to Follow-up|0
113907|NCT00650767|389622|P3|Overall Study|Lost to Follow-up|1
113908|NCT00650767|389623|P2|Overall Study|Lost to Follow-up|1
113909|NCT00650767|389624|P1|Overall Study|Lost to Follow-up|1
113910|NCT00650767|389621|P4|Overall Study|Withdrawal by Subject|3
113911|NCT00650767|389622|P3|Overall Study|Withdrawal by Subject|3
113912|NCT00650767|389623|P2|Overall Study|Withdrawal by Subject|4
113913|NCT00650767|389624|P1|Overall Study|Withdrawal by Subject|2
113914|NCT00650767|389621|P4|Overall Study|Death|0
113915|NCT00650767|389622|P3|Overall Study|Death|0
113916|NCT00650767|389623|P2|Overall Study|Death|0
113917|NCT00650767|389624|P1|Overall Study|Death|1
113918|NCT00650767|389621|P4|Overall Study|Adverse Event|8
113919|NCT00650767|389622|P3|Overall Study|Adverse Event|10
113920|NCT00650767|389623|P2|Overall Study|Adverse Event|3
113921|NCT00650767|389624|P1|Overall Study|Adverse Event|0
113922|NCT00650585|390128|P2|Overall Study|Excluded/ruled ineligible|129
113923|NCT00650585|390129|P1|Overall Study|Excluded/ruled ineligible|357
113924|NCT00650585|390128|P2|Overall Study|No parental consent|866
113925|NCT00650585|390129|P1|Overall Study|No parental consent|935
113926|NCT00650585|390128|P2|Overall Study|Lost to Follow-up|482
113927|NCT00650585|390129|P1|Overall Study|Lost to Follow-up|505
113928|NCT00650104|390173|P1|Overall Study|Sponsor Terminated Dosing|1
113929|NCT00650104|390173|P1|Overall Study|Non-compliance|2
113930|NCT00650104|390173|P1|Overall Study|Lost to Follow-up|1
113931|NCT00650104|390173|P1|Overall Study|Physician Decision|7
113932|NCT00650104|390173|P1|Overall Study|Withdrawal by Subject|11
113933|NCT00650104|390173|P1|Overall Study|Death|2
113934|NCT00650104|390173|P1|Overall Study|Adverse Event|17
113935|NCT00650091|390188|P3|Amended Study Design|Not specified|0
113936|NCT00650091|390189|P2|Amended Study Design|Not specified|3
113937|NCT00650091|390190|P1|Amended Study Design|Not specified|1
113938|NCT00650091|390188|P3|Amended Study Design|Lung transplantation|0
113939|NCT00650091|390189|P2|Amended Study Design|Lung transplantation|2
113940|NCT00650091|390190|P1|Amended Study Design|Lung transplantation|4
113941|NCT00650091|390188|P3|Amended Study Design|Adverse Event|0
113942|NCT00650091|390189|P2|Amended Study Design|Adverse Event|4
113943|NCT00650091|390190|P1|Amended Study Design|Adverse Event|1
113944|NCT00650091|390188|P3|Amended Study Design|Physician Decision|0
113945|NCT00650091|390189|P2|Amended Study Design|Physician Decision|0
113946|NCT00650091|390190|P1|Amended Study Design|Physician Decision|5
113947|NCT00650091|390188|P3|Amended Study Design|Withdrawal by Subject|0
113948|NCT00650091|390189|P2|Amended Study Design|Withdrawal by Subject|11
113949|NCT00650091|390190|P1|Amended Study Design|Withdrawal by Subject|12
113950|NCT00649428|390233|P2|Overall Study|Physician Decision|1
113951|NCT00649428|390234|P1|Overall Study|Physician Decision|0
113952|NCT00649428|390233|P2|Overall Study|Protocol Violation|2
113953|NCT00649428|390234|P1|Overall Study|Protocol Violation|6
113954|NCT00649428|390233|P2|Overall Study|Insufficient manufacturing yield|1
113955|NCT00649428|390234|P1|Overall Study|Insufficient manufacturing yield|5
113956|NCT00649428|390233|P2|Overall Study|Lost to Follow-up|3
113957|NCT00649428|390234|P1|Overall Study|Lost to Follow-up|1
113958|NCT00649428|390233|P2|Overall Study|Withdrawal by Subject|6
113959|NCT00649428|390234|P1|Overall Study|Withdrawal by Subject|6
113960|NCT00649428|390233|P2|Overall Study|Adverse Event|2
113961|NCT00649428|390234|P1|Overall Study|Adverse Event|2
113962|NCT00649389|390250|P4|Overall Study|Other|6
113963|NCT00649389|390251|P3|Overall Study|Other|1
113964|NCT00649389|390252|P2|Overall Study|Other|9
113965|NCT00649389|390253|P1|Overall Study|Other|3
113966|NCT00649389|390250|P4|Overall Study|Withdrawal by Subject|23
113967|NCT00649389|390251|P3|Overall Study|Withdrawal by Subject|19
113968|NCT00649389|390252|P2|Overall Study|Withdrawal by Subject|21
113969|NCT00649389|390253|P1|Overall Study|Withdrawal by Subject|20
113970|NCT00649389|390250|P4|Overall Study|Protocol Violation|8
113971|NCT00649389|390251|P3|Overall Study|Protocol Violation|9
113972|NCT00649389|390252|P2|Overall Study|Protocol Violation|13
113973|NCT00649389|390253|P1|Overall Study|Protocol Violation|11
113974|NCT00649389|390250|P4|Overall Study|Lost to Follow-up|26
113975|NCT00649389|390251|P3|Overall Study|Lost to Follow-up|21
113976|NCT00649389|390252|P2|Overall Study|Lost to Follow-up|17
113977|NCT00649389|390253|P1|Overall Study|Lost to Follow-up|15
113978|NCT00649389|390250|P4|Overall Study|Adverse Event|48
113979|NCT00649389|390251|P3|Overall Study|Adverse Event|38
113980|NCT00649389|390252|P2|Overall Study|Adverse Event|46
113981|NCT00649389|390253|P1|Overall Study|Adverse Event|22
113982|NCT00649220|390275|P1|Overall Study|Withdrawal by Subject|1
113983|NCT00649220|390275|P1|Overall Study|Adverse Event|2
113984|NCT00648895|390296|P2|Overall Study|Lack of Efficacy|1
113985|NCT00648895|390297|P1|Overall Study|Lack of Efficacy|0
113986|NCT00648037|390324|P1|Overall Study|Other|1
113987|NCT00648037|390324|P1|Overall Study|Relapse|2
113988|NCT00648037|390324|P1|Overall Study|Adverse Event|11
113989|NCT00648037|390324|P1|Overall Study|Withdrawal by Subject|1
113990|NCT00648037|390324|P1|Overall Study|Not Treated|1
113991|NCT00647699|390339|P2|Overall Study|Withdrawal by Subject|8
113992|NCT00647699|390340|P1|Overall Study|Withdrawal by Subject|3
113993|NCT00647699|390339|P2|Overall Study|Lost to Follow-up|4
113994|NCT00647699|390340|P1|Overall Study|Lost to Follow-up|5
113995|NCT00647556|390348|P2|Overall Study|Surgery for pre-existing neck pain|0
113996|NCT00647556|390349|P1|Overall Study|Surgery for pre-existing neck pain|1
113997|NCT00647556|390348|P2|Overall Study|Withdrawal by Subject|0
113998|NCT00647556|390349|P1|Overall Study|Withdrawal by Subject|1
113999|NCT00647556|390348|P2|Overall Study|Protocol Violation|1
114000|NCT00647556|390349|P1|Overall Study|Protocol Violation|0
114001|NCT00647556|390348|P2|Overall Study|Lost to Follow-up|0
114002|NCT00647556|390349|P1|Overall Study|Lost to Follow-up|1
114003|NCT00647556|390348|P2|Overall Study|Adverse Event|1
114004|NCT00647556|390349|P1|Overall Study|Adverse Event|0
114005|NCT00647270|390379|P3|Period 2, Placebo Switched to Adalimumab|Other|0
114006|NCT00647270|390380|P2|Period 2, Placebo Switched to Adalimumab|Other|6
114007|NCT00647270|390381|P1|Period 2, Placebo Switched to Adalimumab|Other|2
114008|NCT00647270|390379|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
114009|NCT00647270|390380|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
114010|NCT00647270|390381|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
114011|NCT00647270|390379|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
114012|NCT00647270|390380|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
114013|NCT00647270|390381|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
114014|NCT00647270|390379|P3|Period 1, Placebo-control (12 Weeks)|Other|8
114015|NCT00647270|390380|P2|Period 1, Placebo-control (12 Weeks)|Other|4
114016|NCT00647270|390381|P1|Period 1, Placebo-control (12 Weeks)|Other|4
114017|NCT00647270|390379|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
114018|NCT00647270|390380|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
114019|NCT00647270|390381|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
114020|NCT00647270|390379|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
114021|NCT00647270|390380|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
114022|NCT00647270|390381|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
114023|NCT00647270|390379|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
114024|NCT00647270|390380|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
114025|NCT00647270|390381|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
114026|NCT00646958|390407|P3|Overall Study|Did not receive study drug|2
114027|NCT00646958|390408|P2|Overall Study|Did not receive study drug|0
114028|NCT00646958|390409|P1|Overall Study|Did not receive study drug|2
114029|NCT00646958|390407|P3|Overall Study|Withdrawal by Subject|0
114030|NCT00646958|390408|P2|Overall Study|Withdrawal by Subject|2
114031|NCT00646958|390409|P1|Overall Study|Withdrawal by Subject|1
114032|NCT00646958|390407|P3|Overall Study|Abnormal screening lab tests|0
114033|NCT00646958|390408|P2|Overall Study|Abnormal screening lab tests|1
114034|NCT00646958|390409|P1|Overall Study|Abnormal screening lab tests|1
114035|NCT00646958|390407|P3|Overall Study|Protocol Violation|0
114036|NCT00646958|390408|P2|Overall Study|Protocol Violation|1
114037|NCT00646958|390409|P1|Overall Study|Protocol Violation|1
114038|NCT00646958|390407|P3|Overall Study|Lost to Follow-up|7
114039|NCT00646958|390408|P2|Overall Study|Lost to Follow-up|5
114040|NCT00646958|390409|P1|Overall Study|Lost to Follow-up|1
114041|NCT00646958|390407|P3|Overall Study|Adverse Event|0
114042|NCT00646958|390408|P2|Overall Study|Adverse Event|0
114043|NCT00646958|390409|P1|Overall Study|Adverse Event|4
114044|NCT00646958|390407|P3|Overall Study|Lack of Efficacy|0
114045|NCT00646958|390408|P2|Overall Study|Lack of Efficacy|0
114046|NCT00646958|390409|P1|Overall Study|Lack of Efficacy|1
114047|NCT00646776|390422|P2|Overall Study|Investigator discretion|4
114048|NCT00646776|390423|P1|Overall Study|Investigator discretion|0
114049|NCT00646776|390422|P2|Overall Study|Adverse Event|9
114050|NCT00646776|390423|P1|Overall Study|Adverse Event|1
114051|NCT00646399|390521|P2|Overall Study|Other Reason|11
114052|NCT00646399|390522|P1|Overall Study|Other Reason|11
114053|NCT00646399|390521|P2|Overall Study|Withdrawal by Subject|10
114054|NCT00646399|390522|P1|Overall Study|Withdrawal by Subject|9
114055|NCT00646399|390521|P2|Overall Study|Death|53
114056|NCT00646399|390522|P1|Overall Study|Death|63
114057|NCT00646282|390530|P2|Overall Study|Protocol terminated|4
114058|NCT00646282|390531|P1|Overall Study|Protocol terminated|4
114059|NCT00645944|390554|P2|Received Medication|Protocol Violation|1
114060|NCT00645944|390555|P1|Received Medication|Protocol Violation|2
114061|NCT00645944|390554|P2|Received Medication|Lost to Follow-up|0
114062|NCT00645944|390555|P1|Received Medication|Lost to Follow-up|1
114063|NCT00645944|390554|P2|Received Medication|Withdrawal by Subject|1
114064|NCT00645944|390555|P1|Received Medication|Withdrawal by Subject|1
114065|NCT00645944|390554|P2|Received Medication|Adverse Event|1
114066|NCT00645944|390555|P1|Received Medication|Adverse Event|2
114067|NCT00645944|390554|P2|Randomized|Withdrawal by Subject|2
114068|NCT00645944|390555|P1|Randomized|Withdrawal by Subject|1
114069|NCT00645853|390563|P2|Overall Study|recall of ICF, planned operation, death|4
114070|NCT00645853|390564|P1|Overall Study|recall of ICF, planned operation, death|7
114071|NCT00645853|390563|P2|Overall Study|Discontinuation criteria|2
114072|NCT00645853|390564|P1|Overall Study|Discontinuation criteria|2
114073|NCT00645853|390563|P2|Overall Study|Protocol Violation|2
114074|NCT00645853|390564|P1|Overall Study|Protocol Violation|0
114075|NCT00645853|390563|P2|Overall Study|Withdrawal by Subject|2
114076|NCT00645853|390564|P1|Overall Study|Withdrawal by Subject|5
114077|NCT00645853|390563|P2|Overall Study|AZ study closure in Hungary|40
114078|NCT00645853|390564|P1|Overall Study|AZ study closure in Hungary|60
114079|NCT00645853|390563|P2|Overall Study|Adverse Event|7
114080|NCT00645853|390564|P1|Overall Study|Adverse Event|18
114081|NCT00645788|390595|P4|Overall Study|Pulmonary exacerbation|9
114082|NCT00645788|390596|P3|Overall Study|Pulmonary exacerbation|11
114083|NCT00645788|390597|P2|Overall Study|Pulmonary exacerbation|16
114084|NCT00645788|390598|P1|Overall Study|Pulmonary exacerbation|13
114085|NCT00645788|390595|P4|Overall Study|Withdrawal by Subject|2
114086|NCT00645788|390596|P3|Overall Study|Withdrawal by Subject|0
114087|NCT00645788|390597|P2|Overall Study|Withdrawal by Subject|1
114088|NCT00645788|390598|P1|Overall Study|Withdrawal by Subject|0
114089|NCT00645788|390595|P4|Overall Study|Protocol Violation|0
114090|NCT00645788|390596|P3|Overall Study|Protocol Violation|2
114091|NCT00645788|390597|P2|Overall Study|Protocol Violation|0
114092|NCT00645788|390598|P1|Overall Study|Protocol Violation|1
114093|NCT00645788|390595|P4|Overall Study|Lost to Follow-up|0
114094|NCT00645788|390596|P3|Overall Study|Lost to Follow-up|0
114095|NCT00645788|390597|P2|Overall Study|Lost to Follow-up|0
114096|NCT00645788|390598|P1|Overall Study|Lost to Follow-up|1
114097|NCT00645788|390595|P4|Overall Study|Adverse Event|3
114098|NCT00645788|390596|P3|Overall Study|Adverse Event|5
114099|NCT00645788|390597|P2|Overall Study|Adverse Event|9
114100|NCT00645788|390598|P1|Overall Study|Adverse Event|4
114101|NCT00645788|390595|P4|Overall Study|Did not receive study drug|0
114102|NCT00645788|390596|P3|Overall Study|Did not receive study drug|0
114103|NCT00645788|390597|P2|Overall Study|Did not receive study drug|1
114104|NCT00645788|390598|P1|Overall Study|Did not receive study drug|1
114105|NCT00645671|390656|P2|Overall Study|Physician Decision|1
114106|NCT00645671|390657|P1|Overall Study|Physician Decision|0
114107|NCT00645671|390656|P2|Overall Study|Adverse Event|1
114108|NCT00645671|390657|P1|Overall Study|Adverse Event|0
114109|NCT00645671|390656|P2|Overall Study|Withdrawal by Subject|4
114110|NCT00645671|390657|P1|Overall Study|Withdrawal by Subject|0
114111|NCT00645671|390656|P2|Overall Study|Protocol Violation|0
114112|NCT00645671|390657|P1|Overall Study|Protocol Violation|1
114113|NCT00645593|390671|P2|Overall Study|Later found to be ineligible|0
114114|NCT00645593|390672|P1|Overall Study|Later found to be ineligible|1
114115|NCT00645528|390684|P1|Overall Study|Did not show up for Visit 2|7
114116|NCT00645411|390697|P4|Overall Study|Unable to classify|4
114117|NCT00645411|390698|P3|Overall Study|Unable to classify|3
114118|NCT00645411|390699|P2|Overall Study|Unable to classify|0
114119|NCT00645411|390700|P1|Overall Study|Unable to classify|0
114120|NCT00645411|390697|P4|Overall Study|Inappropriate enrollment|1
114121|NCT00645411|390698|P3|Overall Study|Inappropriate enrollment|4
114122|NCT00645411|390699|P2|Overall Study|Inappropriate enrollment|0
114123|NCT00645411|390700|P1|Overall Study|Inappropriate enrollment|0
114124|NCT00645411|390697|P4|Overall Study|Protocol Violation|0
114125|NCT00645411|390698|P3|Overall Study|Protocol Violation|1
114126|NCT00645411|390699|P2|Overall Study|Protocol Violation|0
114127|NCT00645411|390700|P1|Overall Study|Protocol Violation|1
114128|NCT00645411|390697|P4|Overall Study|Lost to Follow-up|75
114129|NCT00645411|390698|P3|Overall Study|Lost to Follow-up|124
114130|NCT00645411|390699|P2|Overall Study|Lost to Follow-up|5
114131|NCT00645411|390700|P1|Overall Study|Lost to Follow-up|10
114132|NCT00645411|390697|P4|Overall Study|Withdrawal by Subject|21
114133|NCT00645411|390698|P3|Overall Study|Withdrawal by Subject|19
114134|NCT00645411|390699|P2|Overall Study|Withdrawal by Subject|1
114135|NCT00645411|390700|P1|Overall Study|Withdrawal by Subject|2
114136|NCT00645411|390697|P4|Overall Study|Adverse Event|2
114137|NCT00645411|390698|P3|Overall Study|Adverse Event|0
114138|NCT00645411|390699|P2|Overall Study|Adverse Event|0
114139|NCT00645411|390700|P1|Overall Study|Adverse Event|0
114140|NCT00645164|390741|P1|Overall Study|Protocol Violation|1
114141|NCT00645164|390741|P1|Overall Study|Withdrawal by Subject|4
114142|NCT00645164|390741|P1|Overall Study|Lost to Follow-up|2
114143|NCT00645099|390747|P2|Overall Study|Other|5
114144|NCT00645099|390748|P1|Overall Study|Other|9
114145|NCT00645099|390747|P2|Overall Study|Adverse Event|5
114146|NCT00645099|390748|P1|Overall Study|Adverse Event|11
114147|NCT00645099|390747|P2|Overall Study|Lost to Follow-up|4
114148|NCT00645099|390748|P1|Overall Study|Lost to Follow-up|6
114149|NCT00645099|390747|P2|Overall Study|Withdrawal by Subject|22
114150|NCT00645099|390748|P1|Overall Study|Withdrawal by Subject|30
114151|NCT00645099|390747|P2|Overall Study|Lack of Efficacy|6
114152|NCT00645099|390748|P1|Overall Study|Lack of Efficacy|15
114153|NCT00644995|390792|P2|Overall Study|Refused|0
114154|NCT00644995|390793|P1|Overall Study|Refused|1
114155|NCT00644995|390792|P2|Overall Study|Lost to Follow-up|4
114156|NCT00644995|390793|P1|Overall Study|Lost to Follow-up|1
114157|NCT00644969|390813|P2|Post Treatment Phase|Unspecified|0
114158|NCT00644969|390814|P1|Post Treatment Phase|Unspecified|1
114159|NCT00644969|390813|P2|Post Treatment Phase|Lost to Follow-up|1
114160|NCT00644969|390814|P1|Post Treatment Phase|Lost to Follow-up|4
114161|NCT00644969|390813|P2|Post Treatment Phase|Withdrawal by Subject|2
114162|NCT00644969|390814|P1|Post Treatment Phase|Withdrawal by Subject|4
114163|NCT00644969|390813|P2|Post Treatment Phase|Death|0
114164|NCT00644969|390814|P1|Post Treatment Phase|Death|1
114165|NCT00644969|390813|P2|Treatment Phase|Unspecified|1
114166|NCT00644969|390814|P1|Treatment Phase|Unspecified|4
114167|NCT00644969|390813|P2|Treatment Phase|Lost to Follow-up|2
114168|NCT00644969|390814|P1|Treatment Phase|Lost to Follow-up|2
114169|NCT00644969|390813|P2|Treatment Phase|Withdrawal by Subject|0
114170|NCT00644969|390814|P1|Treatment Phase|Withdrawal by Subject|4
114171|NCT00644969|390813|P2|Treatment Phase|Adverse Event|0
114172|NCT00644969|390814|P1|Treatment Phase|Adverse Event|3
114173|NCT00644969|390813|P2|Treatment Phase|Randomized, not treated|0
114174|NCT00644969|390814|P1|Treatment Phase|Randomized, not treated|1
114175|NCT00644917|390860|P1|Overall Study|Withdrawal by Subject|2
114176|NCT00644787|390868|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
114177|NCT00644787|390869|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
114178|NCT00644787|390870|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
114179|NCT00644787|390868|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
114180|NCT00644787|390869|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
114181|NCT00644787|390870|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
114182|NCT00644787|390868|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
114183|NCT00644787|390869|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
114184|NCT00644787|390870|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
114185|NCT00644787|390868|P3|Period 2: Double Blind Phase|Adverse Event|4
114186|NCT00644787|390869|P2|Period 2: Double Blind Phase|Adverse Event|2
114187|NCT00644787|390870|P1|Period 2: Double Blind Phase|Adverse Event|0
114188|NCT00644787|390868|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
114189|NCT00644787|390869|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
114190|NCT00644787|390870|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
114191|NCT00644787|390868|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
114192|NCT00644787|390869|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
114193|NCT00644787|390870|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
114194|NCT00644787|390868|P3|Period 1: Titration Phase|Worsening of symptoms|0
114195|NCT00644787|390869|P2|Period 1: Titration Phase|Worsening of symptoms|0
114196|NCT00644787|390870|P1|Period 1: Titration Phase|Worsening of symptoms|1
114197|NCT00644787|390868|P3|Period 1: Titration Phase|Worsening of complications|0
114198|NCT00644787|390869|P2|Period 1: Titration Phase|Worsening of complications|0
114199|NCT00644787|390870|P1|Period 1: Titration Phase|Worsening of complications|1
114200|NCT00644787|390868|P3|Period 1: Titration Phase|Worsening of underlying disease|0
114201|NCT00644787|390869|P2|Period 1: Titration Phase|Worsening of underlying disease|0
114202|NCT00644787|390870|P1|Period 1: Titration Phase|Worsening of underlying disease|5
114203|NCT00644787|390868|P3|Period 1: Titration Phase|Physician Decision|0
114204|NCT00644787|390869|P2|Period 1: Titration Phase|Physician Decision|0
114205|NCT00644787|390870|P1|Period 1: Titration Phase|Physician Decision|1
114206|NCT00644787|390868|P3|Period 1: Titration Phase|Withdrawal by Subject|0
114207|NCT00644787|390869|P2|Period 1: Titration Phase|Withdrawal by Subject|0
114208|NCT00644787|390870|P1|Period 1: Titration Phase|Withdrawal by Subject|2
114209|NCT00644787|390868|P3|Period 1: Titration Phase|Adverse Event|0
114210|NCT00644787|390869|P2|Period 1: Titration Phase|Adverse Event|0
114211|NCT00644787|390870|P1|Period 1: Titration Phase|Adverse Event|11
114212|NCT00644332|390912|P1|Overall Study|Could Not Attend Scheduled Visits|1
114213|NCT00644332|390912|P1|Overall Study|Did Not Meet Eligibility Requirements|1
114214|NCT00644332|390912|P1|Overall Study|Completion Status Unknown|2
114215|NCT00644332|390912|P1|Overall Study|Withdrawal by Subject|6
114216|NCT00644332|390912|P1|Overall Study|Adverse Event|11
114217|NCT00644059|390939|P3|Overall Study|Unable to classify|3
114218|NCT00644059|390940|P2|Overall Study|Unable to classify|2
114219|NCT00644059|390941|P1|Overall Study|Unable to classify|6
114220|NCT00644059|390939|P3|Overall Study|Protocol Deviation/violation|15
114221|NCT00644059|390940|P2|Overall Study|Protocol Deviation/violation|19
114222|NCT00644059|390941|P1|Overall Study|Protocol Deviation/violation|20
114223|NCT00644059|390939|P3|Overall Study|Inappropriate Enrollment|0
114224|NCT00644059|390940|P2|Overall Study|Inappropriate Enrollment|3
114225|NCT00644059|390941|P1|Overall Study|Inappropriate Enrollment|1
114226|NCT00644059|390939|P3|Overall Study|Adverse Event|1
114227|NCT00644059|390940|P2|Overall Study|Adverse Event|5
114228|NCT00644059|390941|P1|Overall Study|Adverse Event|8
114229|NCT00644059|390939|P3|Overall Study|Withdrawal by Subject|30
114230|NCT00644059|390940|P2|Overall Study|Withdrawal by Subject|60
114231|NCT00644059|390941|P1|Overall Study|Withdrawal by Subject|52
114232|NCT00644059|390939|P3|Overall Study|Lost to Follow-up|16
114233|NCT00644059|390940|P2|Overall Study|Lost to Follow-up|34
114234|NCT00644059|390941|P1|Overall Study|Lost to Follow-up|37
114235|NCT00643201|391027|P2|Completed Study Follow Up|non-specified|0
114236|NCT00643201|391028|P1|Completed Study Follow Up|non-specified|1
114237|NCT00643201|391027|P2|Completed Study Follow Up|Lost to Follow-up|16
114238|NCT00643201|391028|P1|Completed Study Follow Up|Lost to Follow-up|18
114239|NCT00643201|391027|P2|Completed Study Follow Up|Withdrawal by Subject|29
114240|NCT00643201|391028|P1|Completed Study Follow Up|Withdrawal by Subject|23
114241|NCT00643201|391027|P2|Completed Study Follow Up|Death|34
114242|NCT00643201|391028|P1|Completed Study Follow Up|Death|28
114243|NCT00643201|391027|P2|Randomized, Completed 6 Months of Study|not specified|107
114244|NCT00643201|391028|P1|Randomized, Completed 6 Months of Study|not specified|107
114245|NCT00643201|391027|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
114246|NCT00643201|391028|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
114247|NCT00643201|391027|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
114248|NCT00643201|391028|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
114249|NCT00643201|391027|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
114250|NCT00643201|391028|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
114251|NCT00643201|391027|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
114252|NCT00643201|391028|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
114253|NCT00643201|391027|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
114254|NCT00643201|391028|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
114255|NCT00643201|391027|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
114256|NCT00643201|391028|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
114257|NCT00643201|391027|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
114258|NCT00643201|391028|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
114259|NCT00643201|391027|P2|Randomized, Completed 6 Months of Study|Death|26
114260|NCT00643201|391028|P1|Randomized, Completed 6 Months of Study|Death|20
114261|NCT00643916|391102|P6|Overall Study|Not Vaccinated|0
114262|NCT00643916|391103|P5|Overall Study|Not Vaccinated|2
114263|NCT00643916|391104|P4|Overall Study|Not Vaccinated|0
114264|NCT00643916|391105|P3|Overall Study|Not Vaccinated|3
114265|NCT00643916|391106|P2|Overall Study|Not Vaccinated|2
114266|NCT00643916|391107|P1|Overall Study|Not Vaccinated|2
114267|NCT00643916|391102|P6|Overall Study|Withdrawal by Subject|1
114268|NCT00643916|391103|P5|Overall Study|Withdrawal by Subject|0
114269|NCT00643916|391104|P4|Overall Study|Withdrawal by Subject|1
114270|NCT00643916|391105|P3|Overall Study|Withdrawal by Subject|2
114271|NCT00643916|391106|P2|Overall Study|Withdrawal by Subject|2
114272|NCT00643916|391107|P1|Overall Study|Withdrawal by Subject|2
114273|NCT00643916|391102|P6|Overall Study|Lost to Follow-up|0
114274|NCT00643916|391103|P5|Overall Study|Lost to Follow-up|0
114275|NCT00643916|391104|P4|Overall Study|Lost to Follow-up|0
114276|NCT00643916|391105|P3|Overall Study|Lost to Follow-up|0
114277|NCT00643916|391106|P2|Overall Study|Lost to Follow-up|1
114278|NCT00643916|391107|P1|Overall Study|Lost to Follow-up|0
114279|NCT00643916|391102|P6|Overall Study|Protocol Violation|0
114280|NCT00643916|391103|P5|Overall Study|Protocol Violation|0
114281|NCT00643916|391104|P4|Overall Study|Protocol Violation|1
114282|NCT00643916|391105|P3|Overall Study|Protocol Violation|1
114283|NCT00643916|391106|P2|Overall Study|Protocol Violation|1
114284|NCT00643916|391107|P1|Overall Study|Protocol Violation|0
114285|NCT00643760|391132|P5|Overall Study|Withdrawal by Subject|1
114286|NCT00643760|391133|P4|Overall Study|Withdrawal by Subject|4
114287|NCT00643760|391134|P3|Overall Study|Withdrawal by Subject|2
114288|NCT00643760|391135|P2|Overall Study|Withdrawal by Subject|1
114289|NCT00643760|391136|P1|Overall Study|Withdrawal by Subject|3
114290|NCT00643760|391132|P5|Overall Study|Investigator Discretion|0
114291|NCT00643760|391133|P4|Overall Study|Investigator Discretion|2
114292|NCT00643760|391134|P3|Overall Study|Investigator Discretion|0
114293|NCT00643760|391135|P2|Overall Study|Investigator Discretion|0
114294|NCT00643760|391136|P1|Overall Study|Investigator Discretion|0
114295|NCT00643760|391132|P5|Overall Study|Lost to Follow-up|3
114296|NCT00643760|391133|P4|Overall Study|Lost to Follow-up|3
114297|NCT00643760|391134|P3|Overall Study|Lost to Follow-up|1
114298|NCT00643760|391135|P2|Overall Study|Lost to Follow-up|2
114299|NCT00643760|391136|P1|Overall Study|Lost to Follow-up|6
114300|NCT00643760|391132|P5|Overall Study|Protocol Violation|6
114301|NCT00643760|391133|P4|Overall Study|Protocol Violation|4
114302|NCT00643760|391134|P3|Overall Study|Protocol Violation|4
114303|NCT00643760|391135|P2|Overall Study|Protocol Violation|6
114304|NCT00643760|391136|P1|Overall Study|Protocol Violation|7
114305|NCT00643760|391132|P5|Overall Study|Lack of Efficacy|3
114306|NCT00643760|391133|P4|Overall Study|Lack of Efficacy|4
114307|NCT00643760|391134|P3|Overall Study|Lack of Efficacy|0
114308|NCT00643760|391135|P2|Overall Study|Lack of Efficacy|1
114309|NCT00643760|391136|P1|Overall Study|Lack of Efficacy|3
114310|NCT00643760|391132|P5|Overall Study|Adverse Event|6
114311|NCT00643760|391133|P4|Overall Study|Adverse Event|21
114312|NCT00643760|391134|P3|Overall Study|Adverse Event|12
114313|NCT00643760|391135|P2|Overall Study|Adverse Event|5
114314|NCT00643760|391136|P1|Overall Study|Adverse Event|11
114315|NCT00643682|391240|P2|Overall Study|did not keep appointment|509
114316|NCT00643682|391241|P1|Overall Study|did not keep appointment|522
114317|NCT00643604|391253|P1|Overall Study|Death|1
114318|NCT00643565|391281|P2|Overall Study|Lost to Follow-up|0
114319|NCT00643565|391282|P1|Overall Study|Lost to Follow-up|2
114320|NCT00643565|391281|P2|Overall Study|Withdrawal by Subject|1
114321|NCT00643565|391282|P1|Overall Study|Withdrawal by Subject|2
114322|NCT00643565|391281|P2|Overall Study|Ongoing in Follow-up|39
114323|NCT00643565|391282|P1|Overall Study|Ongoing in Follow-up|39
114324|NCT00643565|391281|P2|Overall Study|Death|34
114325|NCT00643565|391282|P1|Overall Study|Death|37
114326|NCT00643487|391304|P1|Overall Study|Technical difficulty|3
114327|NCT00643448|391311|P3|Overall Study|QTcF>550 ms|0
114328|NCT00643448|391312|P2|Overall Study|QTcF>550 ms|3
114329|NCT00643448|391313|P1|Overall Study|QTcF>550 ms|0
114330|NCT00643448|391311|P3|Overall Study|Adverse Event|2
114331|NCT00643448|391312|P2|Overall Study|Adverse Event|2
114332|NCT00643448|391313|P1|Overall Study|Adverse Event|2
114333|NCT00643448|391311|P3|Overall Study|Lack of Efficacy|4
114334|NCT00643448|391312|P2|Overall Study|Lack of Efficacy|0
114335|NCT00643448|391313|P1|Overall Study|Lack of Efficacy|2
114336|NCT00643006|391330|P2|Overall Study|Lost to Follow-up|4
114337|NCT00643006|391331|P1|Overall Study|Lost to Follow-up|5
114338|NCT00642993|391341|P2|Overall Study|Administrative|0
114339|NCT00642993|391342|P1|Overall Study|Administrative|1
114340|NCT00642993|391341|P2|Overall Study|Did not meet protocol eligibility|1
114341|NCT00642993|391342|P1|Overall Study|Did not meet protocol eligibility|0
114342|NCT00642993|391341|P2|Overall Study|Protocol Violation|4
114343|NCT00642993|391342|P1|Overall Study|Protocol Violation|1
114344|NCT00642993|391341|P2|Overall Study|Withdrew - reason unrelated to treatment|3
114345|NCT00642993|391342|P1|Overall Study|Withdrew - reason unrelated to treatment|11
114346|NCT00642993|391341|P2|Overall Study|Lost to Follow-up|4
114347|NCT00642993|391342|P1|Overall Study|Lost to Follow-up|8
114348|NCT00642993|391341|P2|Overall Study|Adverse Event|4
114349|NCT00642993|391342|P1|Overall Study|Adverse Event|85
114350|NCT00642902|391360|P4|Overall Study|Unspecified|4
114351|NCT00642902|391361|P3|Overall Study|Unspecified|1
114352|NCT00642902|391362|P2|Overall Study|Unspecified|5
114353|NCT00642902|391363|P1|Overall Study|Unspecified|1
114354|NCT00642902|391360|P4|Overall Study|Randomized, but not treated|0
114355|NCT00642902|391361|P3|Overall Study|Randomized, but not treated|1
114356|NCT00642902|391362|P2|Overall Study|Randomized, but not treated|0
114357|NCT00642902|391363|P1|Overall Study|Randomized, but not treated|0
114358|NCT00642902|391360|P4|Overall Study|Premature termination of clinical trial|35
114359|NCT00642902|391361|P3|Overall Study|Premature termination of clinical trial|35
114360|NCT00642902|391362|P2|Overall Study|Premature termination of clinical trial|32
114361|NCT00642902|391363|P1|Overall Study|Premature termination of clinical trial|37
114362|NCT00642902|391360|P4|Overall Study|Death|0
114363|NCT00642902|391361|P3|Overall Study|Death|0
114364|NCT00642902|391362|P2|Overall Study|Death|0
114365|NCT00642902|391363|P1|Overall Study|Death|1
114366|NCT00642902|391360|P4|Overall Study|Lack of Efficacy|0
114367|NCT00642902|391361|P3|Overall Study|Lack of Efficacy|3
114368|NCT00642902|391362|P2|Overall Study|Lack of Efficacy|3
114369|NCT00642902|391363|P1|Overall Study|Lack of Efficacy|0
114370|NCT00642902|391360|P4|Overall Study|Lost to Follow-up|0
114371|NCT00642902|391361|P3|Overall Study|Lost to Follow-up|0
114372|NCT00642902|391362|P2|Overall Study|Lost to Follow-up|1
114373|NCT00642902|391363|P1|Overall Study|Lost to Follow-up|1
114374|NCT00642902|391360|P4|Overall Study|Adverse Event|1
114375|NCT00642902|391361|P3|Overall Study|Adverse Event|3
114376|NCT00642902|391362|P2|Overall Study|Adverse Event|1
114377|NCT00642902|391363|P1|Overall Study|Adverse Event|0
114378|NCT00642850|391385|P1|Overall Study|Other reasons|7
114379|NCT00642850|391385|P1|Overall Study|Blood transfusion|6
114380|NCT00642850|391385|P1|Overall Study|Kidney transplantation|8
114381|NCT00642850|391385|P1|Overall Study|Protocol Violation|2
114382|NCT00642850|391385|P1|Overall Study|Lack of Efficacy|1
114383|NCT00642850|391385|P1|Overall Study|Adverse Event|2
114384|NCT00642850|391385|P1|Overall Study|Death|7
114385|NCT00642811|391401|P6|Overall Study|Other|0
114386|NCT00642811|391402|P5|Overall Study|Other|0
114387|NCT00642811|391403|P4|Overall Study|Other|1
114388|NCT00642811|391404|P3|Overall Study|Other|0
114389|NCT00642811|391405|P2|Overall Study|Other|1
114390|NCT00642811|391406|P1|Overall Study|Other|0
114391|NCT00642811|391401|P6|Overall Study|Severe Non-compliance to protocol|0
114392|NCT00642811|391402|P5|Overall Study|Severe Non-compliance to protocol|0
114393|NCT00642811|391403|P4|Overall Study|Severe Non-compliance to protocol|0
114394|NCT00642811|391404|P3|Overall Study|Severe Non-compliance to protocol|0
114395|NCT00642811|391405|P2|Overall Study|Severe Non-compliance to protocol|0
114396|NCT00642811|391406|P1|Overall Study|Severe Non-compliance to protocol|1
114397|NCT00642811|391401|P6|Overall Study|Developement of discontinuation criteria|0
114398|NCT00642811|391402|P5|Overall Study|Developement of discontinuation criteria|1
114399|NCT00642811|391403|P4|Overall Study|Developement of discontinuation criteria|0
114400|NCT00642811|391404|P3|Overall Study|Developement of discontinuation criteria|0
114401|NCT00642811|391405|P2|Overall Study|Developement of discontinuation criteria|0
114402|NCT00642811|391406|P1|Overall Study|Developement of discontinuation criteria|0
114403|NCT00642811|391401|P6|Overall Study|Adverse Event|1
114404|NCT00642811|391402|P5|Overall Study|Adverse Event|0
114405|NCT00642811|391403|P4|Overall Study|Adverse Event|0
114406|NCT00642811|391404|P3|Overall Study|Adverse Event|0
114407|NCT00642811|391405|P2|Overall Study|Adverse Event|3
114408|NCT00642811|391406|P1|Overall Study|Adverse Event|2
114409|NCT00642772|391428|P1|Overall Study|Withdrawal by Subject|7
114410|NCT00642772|391428|P1|Overall Study|Lost to Follow-up|3
114411|NCT00642746|391438|P2|Overall Study|Patient unevaluable|0
114412|NCT00642746|391439|P1|Overall Study|Patient unevaluable|1
114413|NCT00642707|391453|P4|Overall Study|Withdrawal by Subject|0
114414|NCT00642707|391454|P3|Overall Study|Withdrawal by Subject|0
114415|NCT00642707|391455|P2|Overall Study|Withdrawal by Subject|0
114416|NCT00642707|391456|P1|Overall Study|Withdrawal by Subject|1
114417|NCT00642707|391453|P4|Overall Study|Adverse Event|2
114418|NCT00642707|391454|P3|Overall Study|Adverse Event|0
114419|NCT00642707|391455|P2|Overall Study|Adverse Event|0
114420|NCT00642707|391456|P1|Overall Study|Adverse Event|0
114421|NCT00642668|391477|P1|Overall Study|Blood Transfusion|2
114422|NCT00642668|391477|P1|Overall Study|Dialysis Initiation|5
114423|NCT00642668|391477|P1|Overall Study|Failure to Return|1
114424|NCT00642668|391477|P1|Overall Study|Insufficient Therapeutic Response|1
114425|NCT00642668|391477|P1|Overall Study|Death|2
114426|NCT00642668|391477|P1|Overall Study|Adverse Event|2
114427|NCT00642668|391477|P1|Overall Study|Lost to Follow-up|1
114428|NCT00642642|391485|P1|Treatment & Follow Up|Lost to Follow-up|10
114429|NCT00642642|391485|P1|Treatment & Follow Up|Withdrawal by Subject|5
114430|NCT00642642|391485|P1|Treatment & Follow Up|Adverse Event|2
114431|NCT00642616|391502|P4|Overall Study|Physician Decision|1
114432|NCT00642616|391503|P3|Overall Study|Physician Decision|1
114433|NCT00642616|391504|P2|Overall Study|Physician Decision|0
114434|NCT00642616|391505|P1|Overall Study|Physician Decision|0
114435|NCT00642616|391502|P4|Overall Study|Protocol Violation|0
114436|NCT00642616|391503|P3|Overall Study|Protocol Violation|2
114437|NCT00642616|391504|P2|Overall Study|Protocol Violation|0
114438|NCT00642616|391505|P1|Overall Study|Protocol Violation|0
114439|NCT00642616|391502|P4|Overall Study|Withdrawal by Subject|1
114440|NCT00642616|391503|P3|Overall Study|Withdrawal by Subject|1
114441|NCT00642616|391504|P2|Overall Study|Withdrawal by Subject|1
114442|NCT00642616|391505|P1|Overall Study|Withdrawal by Subject|0
114443|NCT00642616|391502|P4|Overall Study|Study Terminated by Sponsor|5
114444|NCT00642616|391503|P3|Overall Study|Study Terminated by Sponsor|4
114445|NCT00642616|391504|P2|Overall Study|Study Terminated by Sponsor|6
114446|NCT00642616|391505|P1|Overall Study|Study Terminated by Sponsor|7
114447|NCT00642616|391502|P4|Overall Study|Adverse Event|0
114448|NCT00642616|391503|P3|Overall Study|Adverse Event|1
114449|NCT00642616|391504|P2|Overall Study|Adverse Event|0
114450|NCT00642616|391505|P1|Overall Study|Adverse Event|2
114451|NCT00642473|391538|P2|Overall Study|Unspecified|2
114452|NCT00642473|391539|P1|Overall Study|Unspecified|2
114453|NCT00642473|391538|P2|Overall Study|Progression or death|4
114454|NCT00642473|391539|P1|Overall Study|Progression or death|2
114455|NCT00642473|391538|P2|Overall Study|Withdrawal by Subject|5
114456|NCT00642473|391539|P1|Overall Study|Withdrawal by Subject|0
114457|NCT00642460|391553|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
114458|NCT00642460|391554|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
114459|NCT00642460|391555|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
114460|NCT00642460|391556|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
114461|NCT00642460|391557|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
114462|NCT00642460|391558|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
114463|NCT00642460|391553|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
114464|NCT00642460|391554|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
114465|NCT00642460|391555|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
114466|NCT00642460|391556|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
114467|NCT00642460|391557|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
114468|NCT00642460|391558|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
114469|NCT00642460|391553|P6|Part III: Open-Label Up to Week 260|Death|3
114470|NCT00642460|391554|P5|Part III: Open-Label Up to Week 260|Death|0
114471|NCT00642460|391555|P4|Part III: Open-Label Up to Week 260|Death|0
114472|NCT00642460|391556|P3|Part III: Open-Label Up to Week 260|Death|0
114473|NCT00642460|391557|P2|Part III: Open-Label Up to Week 260|Death|0
114474|NCT00642460|391558|P1|Part III: Open-Label Up to Week 260|Death|0
114475|NCT00642460|391553|P6|Part III: Open-Label Up to Week 260|Unspecified|2
114476|NCT00642460|391554|P5|Part III: Open-Label Up to Week 260|Unspecified|2
114477|NCT00642460|391555|P4|Part III: Open-Label Up to Week 260|Unspecified|0
114478|NCT00642460|391556|P3|Part III: Open-Label Up to Week 260|Unspecified|0
114479|NCT00642460|391557|P2|Part III: Open-Label Up to Week 260|Unspecified|0
114480|NCT00642460|391558|P1|Part III: Open-Label Up to Week 260|Unspecified|0
114481|NCT00642460|391553|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
114482|NCT00642460|391554|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
114483|NCT00642460|391555|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
114484|NCT00642460|391556|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
114485|NCT00642460|391557|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
114486|NCT00642460|391558|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
114487|NCT00642460|391553|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
114488|NCT00642460|391554|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
114489|NCT00642460|391555|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
114490|NCT00642460|391556|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
114491|NCT00642460|391557|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
114492|NCT00642460|391558|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
114493|NCT00642460|391553|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
114494|NCT00642460|391554|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
114495|NCT00642460|391555|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
114496|NCT00642460|391556|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
114497|NCT00642460|391557|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
114498|NCT00642460|391558|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
114499|NCT00642460|391553|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
114500|NCT00642460|391554|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
114501|NCT00642460|391555|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
114502|NCT00642460|391556|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
114503|NCT00642460|391557|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
114504|NCT00642460|391558|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
114505|NCT00642460|391553|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
114506|NCT00642460|391554|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
114507|NCT00642460|391555|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
114508|NCT00642460|391556|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
114509|NCT00642460|391557|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
114510|NCT00642460|391558|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
114511|NCT00642460|391553|P6|Part II: Open-Label Up to Week 92|Failure to return|0
114512|NCT00642460|391554|P5|Part II: Open-Label Up to Week 92|Failure to return|0
114513|NCT00642460|391555|P4|Part II: Open-Label Up to Week 92|Failure to return|0
114514|NCT00642460|391556|P3|Part II: Open-Label Up to Week 92|Failure to return|0
114515|NCT00642460|391557|P2|Part II: Open-Label Up to Week 92|Failure to return|1
114516|NCT00642460|391558|P1|Part II: Open-Label Up to Week 92|Failure to return|0
114517|NCT00642460|391553|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
114518|NCT00642460|391554|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
114519|NCT00642460|391555|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
114520|NCT00642460|391556|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
114521|NCT00642460|391557|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
114522|NCT00642460|391558|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
114523|NCT00642460|391553|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
114524|NCT00642460|391554|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
114525|NCT00642460|391555|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
114526|NCT00642460|391556|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
114527|NCT00642460|391557|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
114528|NCT00642460|391558|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
114529|NCT00642460|391553|P6|Part II: Open-Label Up to Week 92|Death|0
114530|NCT00642460|391554|P5|Part II: Open-Label Up to Week 92|Death|0
114531|NCT00642460|391555|P4|Part II: Open-Label Up to Week 92|Death|2
114532|NCT00642460|391556|P3|Part II: Open-Label Up to Week 92|Death|0
114533|NCT00642460|391557|P2|Part II: Open-Label Up to Week 92|Death|1
114534|NCT00642460|391558|P1|Part II: Open-Label Up to Week 92|Death|0
114535|NCT00642460|391553|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
114536|NCT00642460|391554|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
114537|NCT00642460|391555|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
114538|NCT00642460|391556|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
114539|NCT00642460|391557|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
114540|NCT00642460|391558|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
114541|NCT00642460|391553|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
114542|NCT00642460|391554|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
114543|NCT00642460|391555|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
114544|NCT00642460|391556|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
114545|NCT00642460|391557|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
114546|NCT00642460|391558|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
114547|NCT00642460|391553|P6|Part I: 12 Week Double-Blind|Adverse Event|0
114548|NCT00642460|391554|P5|Part I: 12 Week Double-Blind|Adverse Event|0
114549|NCT00642460|391555|P4|Part I: 12 Week Double-Blind|Adverse Event|0
114550|NCT00642460|391556|P3|Part I: 12 Week Double-Blind|Adverse Event|1
114551|NCT00642460|391557|P2|Part I: 12 Week Double-Blind|Adverse Event|1
114552|NCT00642460|391558|P1|Part I: 12 Week Double-Blind|Adverse Event|0
114553|NCT00642369|391624|P2|Overall Study|Lack of Efficacy|2
114554|NCT00642369|391625|P1|Overall Study|Lack of Efficacy|2
114555|NCT00642369|391624|P2|Overall Study|misdiagnosis|1
114556|NCT00642369|391625|P1|Overall Study|misdiagnosis|0
114557|NCT00642369|391624|P2|Overall Study|Withdrawal by Subject|0
114558|NCT00642369|391625|P1|Overall Study|Withdrawal by Subject|1
114559|NCT00642369|391624|P2|Overall Study|Adverse Event|3
114560|NCT00642369|391625|P1|Overall Study|Adverse Event|2
114561|NCT00642356|391635|P2|Overall Study|Lack of Efficacy|0
114562|NCT00642356|391636|P1|Overall Study|Lack of Efficacy|1
114563|NCT00642356|391635|P2|Overall Study|Protocol Violation|3
114564|NCT00642356|391636|P1|Overall Study|Protocol Violation|0
114565|NCT00642356|391635|P2|Overall Study|Adverse Event|0
114566|NCT00642356|391636|P1|Overall Study|Adverse Event|1
114567|NCT00642304|391644|P1|Overall Study|Transplantation|1
114568|NCT00642304|391644|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
114569|NCT00642304|391644|P1|Overall Study|Blood transfusion|2
114570|NCT00642304|391644|P1|Overall Study|Death|1
114571|NCT00642304|391644|P1|Overall Study|Adverse Event|1
114572|NCT00642278|391660|P7|Overall Study|Not specified|0
114573|NCT00642278|391661|P6|Overall Study|Not specified|1
114574|NCT00642278|391662|P5|Overall Study|Not specified|0
114575|NCT00642278|391663|P4|Overall Study|Not specified|1
114576|NCT00642278|391664|P3|Overall Study|Not specified|0
114577|NCT00642278|391665|P2|Overall Study|Not specified|1
114578|NCT00642278|391666|P1|Overall Study|Not specified|2
114579|NCT00642278|391660|P7|Overall Study|Noncompliance with study drug regimen|0
114580|NCT00642278|391661|P6|Overall Study|Noncompliance with study drug regimen|0
114581|NCT00642278|391662|P5|Overall Study|Noncompliance with study drug regimen|0
114582|NCT00642278|391663|P4|Overall Study|Noncompliance with study drug regimen|1
114583|NCT00642278|391664|P3|Overall Study|Noncompliance with study drug regimen|0
114584|NCT00642278|391665|P2|Overall Study|Noncompliance with study drug regimen|0
114585|NCT00642278|391666|P1|Overall Study|Noncompliance with study drug regimen|0
114586|NCT00642278|391660|P7|Overall Study|Withdrawal by Subject|2
114587|NCT00642278|391661|P6|Overall Study|Withdrawal by Subject|2
114588|NCT00642278|391662|P5|Overall Study|Withdrawal by Subject|6
114589|NCT00642278|391663|P4|Overall Study|Withdrawal by Subject|3
114590|NCT00642278|391664|P3|Overall Study|Withdrawal by Subject|1
114591|NCT00642278|391665|P2|Overall Study|Withdrawal by Subject|1
114592|NCT00642278|391666|P1|Overall Study|Withdrawal by Subject|1
114593|NCT00642278|391660|P7|Overall Study|Protocol Violation|2
114594|NCT00642278|391661|P6|Overall Study|Protocol Violation|1
114595|NCT00642278|391662|P5|Overall Study|Protocol Violation|0
114596|NCT00642278|391663|P4|Overall Study|Protocol Violation|1
114597|NCT00642278|391664|P3|Overall Study|Protocol Violation|1
114598|NCT00642278|391665|P2|Overall Study|Protocol Violation|0
114599|NCT00642278|391666|P1|Overall Study|Protocol Violation|0
114600|NCT00642278|391660|P7|Overall Study|Physician Decision|0
114601|NCT00642278|391661|P6|Overall Study|Physician Decision|0
114602|NCT00642278|391662|P5|Overall Study|Physician Decision|0
114603|NCT00642278|391663|P4|Overall Study|Physician Decision|1
114604|NCT00642278|391664|P3|Overall Study|Physician Decision|0
114605|NCT00642278|391665|P2|Overall Study|Physician Decision|0
114606|NCT00642278|391666|P1|Overall Study|Physician Decision|0
114607|NCT00642278|391660|P7|Overall Study|Lost to Follow-up|1
114608|NCT00642278|391661|P6|Overall Study|Lost to Follow-up|1
114609|NCT00642278|391662|P5|Overall Study|Lost to Follow-up|0
114610|NCT00642278|391663|P4|Overall Study|Lost to Follow-up|1
114611|NCT00642278|391664|P3|Overall Study|Lost to Follow-up|0
114612|NCT00642278|391665|P2|Overall Study|Lost to Follow-up|1
114613|NCT00642278|391666|P1|Overall Study|Lost to Follow-up|5
114614|NCT00642278|391660|P7|Overall Study|Lack of Efficacy|0
114615|NCT00642278|391661|P6|Overall Study|Lack of Efficacy|0
114616|NCT00642278|391662|P5|Overall Study|Lack of Efficacy|0
114617|NCT00642278|391663|P4|Overall Study|Lack of Efficacy|0
114618|NCT00642278|391664|P3|Overall Study|Lack of Efficacy|0
114619|NCT00642278|391665|P2|Overall Study|Lack of Efficacy|1
114620|NCT00642278|391666|P1|Overall Study|Lack of Efficacy|0
114621|NCT00642278|391660|P7|Overall Study|Adverse Event|0
114622|NCT00642278|391661|P6|Overall Study|Adverse Event|2
114623|NCT00642278|391662|P5|Overall Study|Adverse Event|2
114624|NCT00642278|391663|P4|Overall Study|Adverse Event|1
114625|NCT00642278|391664|P3|Overall Study|Adverse Event|3
114626|NCT00642278|391665|P2|Overall Study|Adverse Event|1
114627|NCT00642278|391666|P1|Overall Study|Adverse Event|2
114628|NCT00642174|391719|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
114629|NCT00642174|391720|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
114630|NCT00640835|391745|P2|Overall Study|Other Reason|4
114631|NCT00640835|391746|P1|Overall Study|Other Reason|19
114632|NCT00640835|391745|P2|Overall Study|Lost to Follow-up|13
114633|NCT00640835|391746|P1|Overall Study|Lost to Follow-up|17
114634|NCT00640835|391745|P2|Overall Study|Protocol Violation|2
114635|NCT00640835|391746|P1|Overall Study|Protocol Violation|2
114636|NCT00640835|391745|P2|Overall Study|Sponsor's Decision|7
114637|NCT00640835|391746|P1|Overall Study|Sponsor's Decision|11
114638|NCT00640835|391745|P2|Overall Study|Physician Decision|14
114639|NCT00640835|391746|P1|Overall Study|Physician Decision|10
114640|NCT00640835|391745|P2|Overall Study|Withdrawal by Subject|14
114641|NCT00640835|391746|P1|Overall Study|Withdrawal by Subject|12
114642|NCT00640835|391745|P2|Overall Study|Adverse Event|3
114643|NCT00640835|391746|P1|Overall Study|Adverse Event|5
114644|NCT00641719|391765|P2|Overall Study|Reason Not Specified|2
114645|NCT00641719|391766|P1|Overall Study|Reason Not Specified|1
114646|NCT00641719|391765|P2|Overall Study|Withdrawal by Subject|4
114647|NCT00641719|391766|P1|Overall Study|Withdrawal by Subject|4
114648|NCT00641719|391765|P2|Overall Study|Adverse Event|29
114649|NCT00641719|391766|P1|Overall Study|Adverse Event|24
114650|NCT00641719|391765|P2|Overall Study|Lack of Efficacy|2
114651|NCT00641719|391766|P1|Overall Study|Lack of Efficacy|1
114652|NCT00641706|391790|P2|Overall Study|Lead Investigator Decision|1
114653|NCT00641706|391791|P1|Overall Study|Lead Investigator Decision|0
114654|NCT00641706|391790|P2|Overall Study|Clinical Decline|0
114655|NCT00641706|391791|P1|Overall Study|Clinical Decline|1
114656|NCT00641706|391790|P2|Overall Study|Withdrawal by Subject|1
114657|NCT00641706|391791|P1|Overall Study|Withdrawal by Subject|6
114658|NCT00641706|391790|P2|Overall Study|Adverse Event|1
114659|NCT00641706|391791|P1|Overall Study|Adverse Event|2
114660|NCT00641667|391803|P1|Overall Study|Worsening of underlying disease|3
114661|NCT00641667|391803|P1|Overall Study|Physician Decision|1
114662|NCT00641667|391803|P1|Overall Study|Adverse Event|1
114663|NCT00641667|391803|P1|Overall Study|Withdrawal by Subject|1
114664|NCT00641537|391831|P8|24-Week Supplemental Follow-up Period|Unspecified|1
114665|NCT00641537|391832|P7|24-Week Supplemental Follow-up Period|Unspecified|1
114666|NCT00641537|391833|P6|24-Week Supplemental Follow-up Period|Unspecified|0
114667|NCT00641537|391834|P5|24-Week Supplemental Follow-up Period|Unspecified|3
114668|NCT00641537|391835|P4|24-Week Supplemental Follow-up Period|Unspecified|1
114669|NCT00641537|391836|P3|24-Week Supplemental Follow-up Period|Unspecified|2
114670|NCT00641537|391837|P2|24-Week Supplemental Follow-up Period|Unspecified|2
114671|NCT00641537|391838|P1|24-Week Supplemental Follow-up Period|Unspecified|0
114672|NCT00641537|391831|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
114673|NCT00641537|391832|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
114674|NCT00641537|391833|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
114675|NCT00641537|391834|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
114676|NCT00641537|391835|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
114677|NCT00641537|391836|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
114678|NCT00641537|391837|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
114679|NCT00641537|391838|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
114680|NCT00641537|391831|P8|96-week Period|Unspecified|6
114681|NCT00641537|391832|P7|96-week Period|Unspecified|4
114682|NCT00641537|391833|P6|96-week Period|Unspecified|6
114683|NCT00641537|391834|P5|96-week Period|Unspecified|12
114684|NCT00641537|391835|P4|96-week Period|Unspecified|9
114685|NCT00641537|391836|P3|96-week Period|Unspecified|14
114686|NCT00641537|391837|P2|96-week Period|Unspecified|7
114687|NCT00641537|391838|P1|96-week Period|Unspecified|4
114688|NCT00641537|391831|P8|96-week Period|Death|0
114689|NCT00641537|391832|P7|96-week Period|Death|0
114690|NCT00641537|391833|P6|96-week Period|Death|0
114691|NCT00641537|391834|P5|96-week Period|Death|0
114692|NCT00641537|391835|P4|96-week Period|Death|0
114693|NCT00641537|391836|P3|96-week Period|Death|1
114694|NCT00641537|391837|P2|96-week Period|Death|0
114695|NCT00641537|391838|P1|96-week Period|Death|2
114696|NCT00641537|391831|P8|96-week Period|Protocol Violation|0
114697|NCT00641537|391832|P7|96-week Period|Protocol Violation|0
114698|NCT00641537|391833|P6|96-week Period|Protocol Violation|1
114699|NCT00641537|391834|P5|96-week Period|Protocol Violation|0
114700|NCT00641537|391835|P4|96-week Period|Protocol Violation|1
114701|NCT00641537|391836|P3|96-week Period|Protocol Violation|0
114702|NCT00641537|391837|P2|96-week Period|Protocol Violation|1
114703|NCT00641537|391838|P1|96-week Period|Protocol Violation|0
114704|NCT00641537|391831|P8|96-week Period|Lost to Follow-up|0
114705|NCT00641537|391832|P7|96-week Period|Lost to Follow-up|1
114706|NCT00641537|391833|P6|96-week Period|Lost to Follow-up|0
114707|NCT00641537|391834|P5|96-week Period|Lost to Follow-up|4
114708|NCT00641537|391835|P4|96-week Period|Lost to Follow-up|2
114709|NCT00641537|391836|P3|96-week Period|Lost to Follow-up|2
114710|NCT00641537|391837|P2|96-week Period|Lost to Follow-up|1
114711|NCT00641537|391838|P1|96-week Period|Lost to Follow-up|3
114712|NCT00641537|391831|P8|96-week Period|Adverse Event|0
114713|NCT00641537|391832|P7|96-week Period|Adverse Event|0
114714|NCT00641537|391833|P6|96-week Period|Adverse Event|0
114715|NCT00641537|391834|P5|96-week Period|Adverse Event|2
114716|NCT00641537|391835|P4|96-week Period|Adverse Event|0
114717|NCT00641537|391836|P3|96-week Period|Adverse Event|3
114718|NCT00641537|391837|P2|96-week Period|Adverse Event|1
114719|NCT00641537|391838|P1|96-week Period|Adverse Event|0
114720|NCT00641056|391893|P2|Overall Study|Sponsor Decision|2
114721|NCT00641056|391894|P1|Overall Study|Sponsor Decision|1
114722|NCT00641056|391893|P2|Overall Study|Subject Decision|19
114723|NCT00641056|391894|P1|Overall Study|Subject Decision|6
114724|NCT00641056|391893|P2|Overall Study|Entry Criteria Not Met|0
114725|NCT00641056|391894|P1|Overall Study|Entry Criteria Not Met|3
114726|NCT00641056|391893|P2|Overall Study|Protocol Violation|0
114727|NCT00641056|391894|P1|Overall Study|Protocol Violation|2
114728|NCT00641056|391893|P2|Overall Study|Physician Decision|1
114729|NCT00641056|391894|P1|Overall Study|Physician Decision|3
114730|NCT00641056|391893|P2|Overall Study|Lost to Follow-up|1
114731|NCT00641056|391894|P1|Overall Study|Lost to Follow-up|2
114732|NCT00641056|391893|P2|Overall Study|Adverse Event|2
114733|NCT00641056|391894|P1|Overall Study|Adverse Event|12
114734|NCT00641043|391922|P2|Overall Study|Other incl. lack of efficacy|2
114735|NCT00641043|391923|P1|Overall Study|Other incl. lack of efficacy|4
114736|NCT00641043|391922|P2|Overall Study|Withdrawal by Subject|4
114737|NCT00641043|391923|P1|Overall Study|Withdrawal by Subject|4
114738|NCT00641043|391922|P2|Overall Study|Lost to Follow-up|2
114739|NCT00641043|391923|P1|Overall Study|Lost to Follow-up|3
114740|NCT00641043|391922|P2|Overall Study|Protocol Violation|3
114741|NCT00641043|391923|P1|Overall Study|Protocol Violation|2
114742|NCT00641043|391922|P2|Overall Study|Adverse Event|4
114743|NCT00641043|391923|P1|Overall Study|Adverse Event|6
114744|NCT00640926|391960|P3|Overall Study|Withdrawal by Subject|1
114745|NCT00640926|391961|P2|Overall Study|Withdrawal by Subject|0
114746|NCT00640926|391962|P1|Overall Study|Withdrawal by Subject|1
114747|NCT00640926|391960|P3|Overall Study|Lost to Follow-up|2
114748|NCT00640926|391961|P2|Overall Study|Lost to Follow-up|1
114749|NCT00640926|391962|P1|Overall Study|Lost to Follow-up|3
114750|NCT00640926|391960|P3|Overall Study|Protocol Violation|2
114751|NCT00640926|391961|P2|Overall Study|Protocol Violation|0
114752|NCT00640926|391962|P1|Overall Study|Protocol Violation|2
114753|NCT00640926|391960|P3|Overall Study|Lack of Efficacy|1
114754|NCT00640926|391961|P2|Overall Study|Lack of Efficacy|2
114755|NCT00640926|391962|P1|Overall Study|Lack of Efficacy|0
114756|NCT00640926|391960|P3|Overall Study|Adverse Event|2
114757|NCT00640926|391961|P2|Overall Study|Adverse Event|3
114758|NCT00640926|391962|P1|Overall Study|Adverse Event|2
114759|NCT00640614|391988|P2|Overall Study|Lost to Follow-up|0
114760|NCT00640614|391989|P1|Overall Study|Lost to Follow-up|1
114761|NCT00640601|392031|P1|Overall Study|treatment naive, combination therapy|10
114762|NCT00640601|392031|P1|Overall Study|Physician Decision|8
114763|NCT00640601|392031|P1|Overall Study|Lost to Follow-up|9
114764|NCT00640601|392031|P1|Overall Study|Lack of Efficacy|16
114765|NCT00640601|392031|P1|Overall Study|Protocol Violation|6
114766|NCT00640601|392031|P1|Overall Study|Withdrawal by Subject|20
114767|NCT00640601|392031|P1|Overall Study|Adverse Event|43
114768|NCT00640562|392047|P2|Overall Study|Glycosylated Hemoglobin >8|0
114769|NCT00640562|392048|P1|Overall Study|Glycosylated Hemoglobin >8|1
114770|NCT00640562|392047|P2|Overall Study|Low study drug dose|1
114771|NCT00640562|392048|P1|Overall Study|Low study drug dose|0
114772|NCT00640562|392047|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
114773|NCT00640562|392048|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
114774|NCT00640562|392047|P2|Overall Study|Known risperidone intolerance|1
114775|NCT00640562|392048|P1|Overall Study|Known risperidone intolerance|0
114776|NCT00640562|392047|P2|Overall Study|Withdrawal by Subject|10
114777|NCT00640562|392048|P1|Overall Study|Withdrawal by Subject|6
114778|NCT00640562|392047|P2|Overall Study|Protocol Violation|4
114779|NCT00640562|392048|P1|Overall Study|Protocol Violation|2
114780|NCT00640562|392047|P2|Overall Study|Lack of Efficacy|4
114781|NCT00640562|392048|P1|Overall Study|Lack of Efficacy|1
114782|NCT00640562|392047|P2|Overall Study|Adverse Event|5
114783|NCT00640562|392048|P1|Overall Study|Adverse Event|8
114784|NCT00640510|392076|P2|Overall Study|Physician Decision|1
114785|NCT00640510|392077|P1|Overall Study|Physician Decision|0
114786|NCT00640510|392076|P2|Overall Study|Protocol Violation|0
114787|NCT00640510|392077|P1|Overall Study|Protocol Violation|1
114788|NCT00640510|392076|P2|Overall Study|Lack of Efficacy|1
114789|NCT00640510|392077|P1|Overall Study|Lack of Efficacy|0
114790|NCT00640393|392089|P3|Part 2|Adverse Event|0
114791|NCT00640393|392090|P2|Part 2|Adverse Event|1
114792|NCT00640393|392091|P1|Part 2|Adverse Event|0
114793|NCT00640393|392089|P3|Part 2|Non-adherence|0
114794|NCT00640393|392090|P2|Part 2|Non-adherence|1
114795|NCT00640393|392091|P1|Part 2|Non-adherence|0
114796|NCT00640393|392089|P3|Part 2|Withdrawal by Subject|1
114797|NCT00640393|392090|P2|Part 2|Withdrawal by Subject|6
114798|NCT00640393|392091|P1|Part 2|Withdrawal by Subject|0
114799|NCT00640393|392089|P3|Part 2|Lost to Follow-up|2
114800|NCT00640393|392090|P2|Part 2|Lost to Follow-up|2
114801|NCT00640393|392091|P1|Part 2|Lost to Follow-up|0
114802|NCT00640393|392089|P3|Randomization|Never randomized by site|0
114803|NCT00640393|392090|P2|Randomization|Never randomized by site|0
114804|NCT00640393|392091|P1|Randomization|Never randomized by site|2
114805|NCT00640393|392089|P3|Randomization|Withdrawn per protocol|0
114806|NCT00640393|392090|P2|Randomization|Withdrawn per protocol|0
114807|NCT00640393|392091|P1|Randomization|Withdrawn per protocol|17
114808|NCT00640393|392089|P3|Part 1|Withdrawal by Subject|0
114809|NCT00640393|392090|P2|Part 1|Withdrawal by Subject|0
114810|NCT00640393|392091|P1|Part 1|Withdrawal by Subject|3
114811|NCT00640393|392089|P3|Part 1|Lost to Follow-up|0
114812|NCT00640393|392090|P2|Part 1|Lost to Follow-up|0
114813|NCT00640393|392091|P1|Part 1|Lost to Follow-up|2
114814|NCT00640341|392156|P3|Overall Study|Adverse event and positive slit lamp|0
114815|NCT00640341|392157|P2|Overall Study|Adverse event and positive slit lamp|0
114816|NCT00640341|392158|P1|Overall Study|Adverse event and positive slit lamp|1
114817|NCT00640341|392156|P3|Overall Study|Ineligable at Baseline|2
114818|NCT00640341|392157|P2|Overall Study|Ineligable at Baseline|3
114819|NCT00640341|392158|P1|Overall Study|Ineligable at Baseline|5
114820|NCT00640341|392156|P3|Overall Study|Poor fit/Uncomfortable|0
114821|NCT00640341|392157|P2|Overall Study|Poor fit/Uncomfortable|0
114822|NCT00640341|392158|P1|Overall Study|Poor fit/Uncomfortable|4
114823|NCT00640341|392156|P3|Overall Study|Unacceptable Lens Movement|0
114824|NCT00640341|392157|P2|Overall Study|Unacceptable Lens Movement|0
114825|NCT00640341|392158|P1|Overall Study|Unacceptable Lens Movement|1
114826|NCT00640341|392156|P3|Overall Study|Withdrawal by Subject|1
114827|NCT00640341|392157|P2|Overall Study|Withdrawal by Subject|0
114828|NCT00640341|392158|P1|Overall Study|Withdrawal by Subject|4
114829|NCT00640341|392156|P3|Overall Study|Lost to Follow-up|0
114830|NCT00640341|392157|P2|Overall Study|Lost to Follow-up|0
114831|NCT00640341|392158|P1|Overall Study|Lost to Follow-up|2
114832|NCT00640341|392156|P3|Overall Study|Failure to Follow Subject Instructions|0
114833|NCT00640341|392157|P2|Overall Study|Failure to Follow Subject Instructions|0
114834|NCT00640341|392158|P1|Overall Study|Failure to Follow Subject Instructions|1
114835|NCT00640341|392156|P3|Overall Study|Inability to Maintain Wearing Schedule|0
114836|NCT00640341|392157|P2|Overall Study|Inability to Maintain Wearing Schedule|1
114837|NCT00640341|392158|P1|Overall Study|Inability to Maintain Wearing Schedule|1
114838|NCT00640341|392156|P3|Overall Study|Study Related Symptoms/Complaints|2
114839|NCT00640341|392157|P2|Overall Study|Study Related Symptoms/Complaints|1
114840|NCT00640341|392158|P1|Overall Study|Study Related Symptoms/Complaints|2
114841|NCT00640341|392156|P3|Overall Study|Positive Slit Lamp Findings|1
114842|NCT00640341|392157|P2|Overall Study|Positive Slit Lamp Findings|0
114843|NCT00640341|392158|P1|Overall Study|Positive Slit Lamp Findings|0
114844|NCT00640341|392156|P3|Overall Study|Adverse Event|1
114845|NCT00640341|392157|P2|Overall Study|Adverse Event|0
114846|NCT00640341|392158|P1|Overall Study|Adverse Event|0
114847|NCT00640328|392178|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
114848|NCT00640328|392179|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
114849|NCT00640328|392180|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
114850|NCT00640328|392181|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
114851|NCT00640328|392182|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
114852|NCT00640328|392183|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
114853|NCT00640328|392178|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
114854|NCT00640328|392179|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
114855|NCT00640328|392180|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
114856|NCT00640328|392181|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
114857|NCT00640328|392182|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
114858|NCT00640328|392183|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
114859|NCT00640328|392178|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
114860|NCT00640328|392179|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
114861|NCT00640328|392180|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
114862|NCT00640328|392181|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
114863|NCT00640328|392182|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
114864|NCT00640328|392183|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
114865|NCT00640328|392178|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
114866|NCT00640328|392179|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
114867|NCT00640328|392180|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
114868|NCT00640328|392181|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
114869|NCT00640328|392182|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
114870|NCT00640328|392183|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
114871|NCT00640315|392349|P2|Overall Study|Withdrawal by Subject|1
114872|NCT00640315|392350|P1|Overall Study|Withdrawal by Subject|0
114873|NCT00640042|392476|P1|Enrollment|Did not receive study drug|83
114874|NCT00640016|392492|P4|Overall Study|Adverse Event|1
114875|NCT00640016|392493|P3|Overall Study|Adverse Event|0
114876|NCT00640016|392494|P2|Overall Study|Adverse Event|0
114877|NCT00640016|392495|P1|Overall Study|Adverse Event|0
114878|NCT00640016|392492|P4|Overall Study|Study termination|2
114879|NCT00640016|392493|P3|Overall Study|Study termination|3
114880|NCT00640016|392494|P2|Overall Study|Study termination|1
114881|NCT00640016|392495|P1|Overall Study|Study termination|2
114882|NCT00640016|392492|P4|Overall Study|Withdrawal by Subject|0
114883|NCT00640016|392493|P3|Overall Study|Withdrawal by Subject|0
114884|NCT00640016|392494|P2|Overall Study|Withdrawal by Subject|1
114885|NCT00640016|392495|P1|Overall Study|Withdrawal by Subject|0
114886|NCT00639769|392547|P1|Overall Study|Withdrawal by Subject|4
114887|NCT00639769|392547|P1|Overall Study|Disease progression|26
114888|NCT00639769|392547|P1|Overall Study|Lack of Efficacy|1
114889|NCT00639769|392547|P1|Overall Study|Adverse Event|7
114890|NCT00639769|392547|P1|Overall Study|Death|2
114891|NCT00639678|392564|P4|Overall Study|Lack of Compliance|0
114892|NCT00639678|392565|P3|Overall Study|Lack of Compliance|1
114893|NCT00639678|392566|P2|Overall Study|Lack of Compliance|0
114894|NCT00639678|392567|P1|Overall Study|Lack of Compliance|0
114895|NCT00639678|392564|P4|Overall Study|Adverse Event|0
114896|NCT00639678|392565|P3|Overall Study|Adverse Event|0
114897|NCT00639678|392566|P2|Overall Study|Adverse Event|1
114898|NCT00639678|392567|P1|Overall Study|Adverse Event|0
114899|NCT00639678|392564|P4|Overall Study|Lost to Follow-up|0
114900|NCT00639678|392565|P3|Overall Study|Lost to Follow-up|6
114901|NCT00639678|392566|P2|Overall Study|Lost to Follow-up|0
114902|NCT00639678|392567|P1|Overall Study|Lost to Follow-up|1
114903|NCT00639678|392564|P4|Overall Study|Withdrawal by Subject|0
114904|NCT00639678|392565|P3|Overall Study|Withdrawal by Subject|4
114905|NCT00639678|392566|P2|Overall Study|Withdrawal by Subject|0
114906|NCT00639678|392567|P1|Overall Study|Withdrawal by Subject|3
114907|NCT00639509|392627|P1|Overall Study|Death|1
114908|NCT00639457|392635|P2|Overall Study|Withdrawal by Subject|3
114909|NCT00639457|392636|P1|Overall Study|Withdrawal by Subject|2
114910|NCT00639379|392695|P2|Period 1 - 2 Weeks|lens issue|0
114911|NCT00639379|392696|P1|Period 1 - 2 Weeks|lens issue|3
114912|NCT00639379|392695|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
114913|NCT00639379|392696|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
114914|NCT00639223|392712|P2|Overall Study|Lost to Follow-up|2
114915|NCT00639223|392713|P1|Overall Study|Lost to Follow-up|0
114916|NCT00639002|392753|P1|Overall Study|Lack of Efficacy|1
114917|NCT00639002|392753|P1|Overall Study|Physician Decision|6
114918|NCT00639002|392753|P1|Overall Study|Disease progression|3
114919|NCT00639002|392753|P1|Overall Study|Protocol Violation|1
114920|NCT00639002|392753|P1|Overall Study|Adverse Event|1
114921|NCT00639002|392753|P1|Overall Study|Death|1
114922|NCT00638963|392761|P2|Overall Study|Withdrawal by Subject|0
114923|NCT00638963|392762|P1|Overall Study|Withdrawal by Subject|1
114924|NCT00638846|392802|P2|Overall Study|lens issue|3
114925|NCT00638846|392803|P1|Overall Study|lens issue|1
114926|NCT00638846|392802|P2|Overall Study|Lost to Follow-up|2
114927|NCT00638846|392803|P1|Overall Study|Lost to Follow-up|3
114928|NCT00638846|392802|P2|Overall Study|Adverse Event|1
114929|NCT00638846|392803|P1|Overall Study|Adverse Event|0
114930|NCT00638690|392828|P2|Overall Study|Lost to Follow-up|2
114931|NCT00638690|392829|P1|Overall Study|Lost to Follow-up|4
114932|NCT00638690|392828|P2|Overall Study|Withdrawal by Subject|5
114933|NCT00638690|392829|P1|Overall Study|Withdrawal by Subject|22
114934|NCT00638690|392828|P2|Overall Study|Death|335
114935|NCT00638690|392829|P1|Overall Study|Death|655
114936|NCT00638443|392851|P2|First Intervention|Adverse Event|1
114937|NCT00638443|392852|P1|First Intervention|Adverse Event|2
114938|NCT00638378|392880|P1|Overall Study|Physician Decision|4
114939|NCT00638378|392880|P1|Overall Study|Disease progression|15
114940|NCT00638378|392880|P1|Overall Study|Adverse Event|1
114941|NCT00638378|392880|P1|Overall Study|Death|2
114942|NCT00638235|392909|P9|Overall Study|Lost to Follow-up|18
114943|NCT00638235|392910|P8|Overall Study|Lost to Follow-up|1
114944|NCT00638235|392911|P7|Overall Study|Lost to Follow-up|0
114945|NCT00638235|392912|P6|Overall Study|Lost to Follow-up|26
114946|NCT00638235|392913|P5|Overall Study|Lost to Follow-up|13
114947|NCT00638235|392914|P4|Overall Study|Lost to Follow-up|10
114948|NCT00638235|392915|P3|Overall Study|Lost to Follow-up|18
114949|NCT00638235|392916|P2|Overall Study|Lost to Follow-up|3
114950|NCT00638235|392917|P1|Overall Study|Lost to Follow-up|31
114951|NCT00638183|393327|P1|Overall Study|Other reason not defined above|27
114952|NCT00638183|393327|P1|Overall Study|Lost to Follow-up|46
114953|NCT00638183|393327|P1|Overall Study|Physician Decision|9
114954|NCT00638183|393327|P1|Overall Study|Lack of Efficacy|14
114955|NCT00638183|393327|P1|Overall Study|Adverse Event|23
114956|NCT00638157|393336|P2|Overall Study|Randomized, not treated|0
114957|NCT00638157|393337|P1|Overall Study|Randomized, not treated|2
114958|NCT00638157|393336|P2|Overall Study|Not Specified|2
114959|NCT00638157|393337|P1|Overall Study|Not Specified|1
114960|NCT00638157|393336|P2|Overall Study|Physician Decision|0
114961|NCT00638157|393337|P1|Overall Study|Physician Decision|1
114962|NCT00638157|393336|P2|Overall Study|Lost to Follow-up|0
114963|NCT00638157|393337|P1|Overall Study|Lost to Follow-up|1
114964|NCT00638157|393336|P2|Overall Study|Microbiological failure|0
114965|NCT00638157|393337|P1|Overall Study|Microbiological failure|1
114966|NCT00638157|393336|P2|Overall Study|Clinical (symptomatic) failure|1
114967|NCT00638157|393337|P1|Overall Study|Clinical (symptomatic) failure|1
114968|NCT00638157|393336|P2|Overall Study|Adverse Event|1
114969|NCT00638157|393337|P1|Overall Study|Adverse Event|0
114970|NCT00638027|393347|P2|Overall Study|Adverse Event|2
114971|NCT00638027|393348|P1|Overall Study|Adverse Event|0
114972|NCT00637806|393395|P4|Extension Phase|Study Discontinued|1
114973|NCT00637806|393396|P3|Extension Phase|Study Discontinued|0
114974|NCT00637806|393397|P2|Extension Phase|Study Discontinued|0
114975|NCT00637806|393398|P1|Extension Phase|Study Discontinued|0
114976|NCT00637806|393395|P4|Double-blind Phase|Study Discontinued|0
114977|NCT00637806|393396|P3|Double-blind Phase|Study Discontinued|1
114978|NCT00637806|393397|P2|Double-blind Phase|Study Discontinued|0
114979|NCT00637806|393398|P1|Double-blind Phase|Study Discontinued|2
114980|NCT00637728|393418|P3|Double-blind Phase|Study Discontinued|0
114981|NCT00637728|393419|P2|Double-blind Phase|Study Discontinued|1
114982|NCT00637728|393420|P1|Double-blind Phase|Study Discontinued|1
114983|NCT00637728|393418|P3|Double-blind Phase|Non-compliance|0
114984|NCT00637728|393419|P2|Double-blind Phase|Non-compliance|0
114985|NCT00637728|393420|P1|Double-blind Phase|Non-compliance|2
114986|NCT00637728|393418|P3|Double-blind Phase|Adverse Event|0
114987|NCT00637728|393419|P2|Double-blind Phase|Adverse Event|0
114988|NCT00637728|393420|P1|Double-blind Phase|Adverse Event|1
114989|NCT00637572|393435|P2|Overall Study|Illicit Drug Use|0
114990|NCT00637572|393436|P1|Overall Study|Illicit Drug Use|1
114991|NCT00637572|393435|P2|Overall Study|Withdrawal by Subject|2
114992|NCT00637572|393436|P1|Overall Study|Withdrawal by Subject|0
114993|NCT00637572|393435|P2|Overall Study|Physician Decision|1
114994|NCT00637572|393436|P1|Overall Study|Physician Decision|1
114995|NCT00637572|393435|P2|Overall Study|Lost to Follow-up|1
114996|NCT00637572|393436|P1|Overall Study|Lost to Follow-up|0
114997|NCT00637572|393435|P2|Overall Study|Death|1
114998|NCT00637572|393436|P1|Overall Study|Death|0
114999|NCT00637572|393435|P2|Overall Study|Adverse Event|2
115000|NCT00637572|393436|P1|Overall Study|Adverse Event|1
115001|NCT00637416|393473|P2|Overall Study|Unable to take study drug|1
115002|NCT00637416|393474|P1|Overall Study|Unable to take study drug|0
115003|NCT00637416|393473|P2|Overall Study|Lost to Follow-up|1
115004|NCT00637416|393474|P1|Overall Study|Lost to Follow-up|1
115005|NCT00637377|393484|P4|Overall Study|Other (no further information available)|5
115006|NCT00637377|393485|P3|Overall Study|Other (no further information available)|10
115007|NCT00637377|393486|P2|Overall Study|Other (no further information available)|6
115008|NCT00637377|393487|P1|Overall Study|Other (no further information available)|7
115009|NCT00637377|393484|P4|Overall Study|Withdrawal by Subject|11
115010|NCT00637377|393485|P3|Overall Study|Withdrawal by Subject|13
115011|NCT00637377|393486|P2|Overall Study|Withdrawal by Subject|15
115012|NCT00637377|393487|P1|Overall Study|Withdrawal by Subject|11
115013|NCT00637377|393484|P4|Overall Study|Protocol Violation|0
115014|NCT00637377|393485|P3|Overall Study|Protocol Violation|1
115015|NCT00637377|393486|P2|Overall Study|Protocol Violation|1
115016|NCT00637377|393487|P1|Overall Study|Protocol Violation|2
115017|NCT00637377|393484|P4|Overall Study|Lost to Follow-up|2
115018|NCT00637377|393485|P3|Overall Study|Lost to Follow-up|2
115019|NCT00637377|393486|P2|Overall Study|Lost to Follow-up|1
115020|NCT00637377|393487|P1|Overall Study|Lost to Follow-up|4
115021|NCT00637377|393484|P4|Overall Study|Lack of Efficacy|1
115022|NCT00637377|393485|P3|Overall Study|Lack of Efficacy|1
115023|NCT00637377|393486|P2|Overall Study|Lack of Efficacy|0
115024|NCT00637377|393487|P1|Overall Study|Lack of Efficacy|0
115025|NCT00637377|393484|P4|Overall Study|Death|1
115026|NCT00637377|393485|P3|Overall Study|Death|2
115027|NCT00637377|393486|P2|Overall Study|Death|3
115028|NCT00637377|393487|P1|Overall Study|Death|1
115029|NCT00637377|393484|P4|Overall Study|Adverse Event|9
115030|NCT00637377|393485|P3|Overall Study|Adverse Event|8
115031|NCT00637377|393486|P2|Overall Study|Adverse Event|6
115032|NCT00637377|393487|P1|Overall Study|Adverse Event|2
115033|NCT00637273|393536|P3|Overall Study|Loss of Glucose Control|1
115034|NCT00637273|393537|P2|Overall Study|Loss of Glucose Control|1
115035|NCT00637273|393538|P1|Overall Study|Loss of Glucose Control|1
115036|NCT00637273|393536|P3|Overall Study|Administrative|0
115037|NCT00637273|393537|P2|Overall Study|Administrative|0
115038|NCT00637273|393538|P1|Overall Study|Administrative|2
115039|NCT00637273|393536|P3|Overall Study|Investigator Decision|1
115040|NCT00637273|393537|P2|Overall Study|Investigator Decision|3
115041|NCT00637273|393538|P1|Overall Study|Investigator Decision|1
115042|NCT00637273|393536|P3|Overall Study|Withdrawal of Consent|18
115043|NCT00637273|393537|P2|Overall Study|Withdrawal of Consent|6
115044|NCT00637273|393538|P1|Overall Study|Withdrawal of Consent|18
115045|NCT00637273|393536|P3|Overall Study|Protocol Violation|1
115046|NCT00637273|393537|P2|Overall Study|Protocol Violation|4
115047|NCT00637273|393538|P1|Overall Study|Protocol Violation|2
115048|NCT00637273|393536|P3|Overall Study|Lost to Follow-up|13
115049|NCT00637273|393537|P2|Overall Study|Lost to Follow-up|9
115050|NCT00637273|393538|P1|Overall Study|Lost to Follow-up|8
115051|NCT00637273|393536|P3|Overall Study|Adverse Event|7
115052|NCT00637273|393537|P2|Overall Study|Adverse Event|5
115053|NCT00637273|393538|P1|Overall Study|Adverse Event|11
115054|NCT00637195|393594|P2|Overall Study|Withdrawal by Subject|1
115055|NCT00637195|393595|P1|Overall Study|Withdrawal by Subject|0
115056|NCT00637195|393594|P2|Overall Study|Other|0
115057|NCT00637195|393595|P1|Overall Study|Other|2
115058|NCT00637195|393594|P2|Overall Study|Lost to Follow-up|0
115059|NCT00637195|393595|P1|Overall Study|Lost to Follow-up|1
115060|NCT00637156|393631|P2|Overall Study|Lost to Follow-up|16
115061|NCT00637156|393632|P1|Overall Study|Lost to Follow-up|10
115062|NCT00637156|393631|P2|Overall Study|Death|1
115063|NCT00637156|393632|P1|Overall Study|Death|0
115064|NCT00637156|393631|P2|Overall Study|Withdrawal by Subject|7
115065|NCT00637156|393632|P1|Overall Study|Withdrawal by Subject|0
115066|NCT00637000|393674|P2|Overall Study|Withdrawal by Subject|3
115067|NCT00637000|393675|P1|Overall Study|Withdrawal by Subject|4
115068|NCT00636961|393717|P2|Period 2|Adverse Event|0
115069|NCT00636961|393718|P1|Period 2|Adverse Event|1
115070|NCT00636961|393717|P2|Period 1|Administrative problems|1
115071|NCT00636961|393718|P1|Period 1|Administrative problems|1
115072|NCT00636818|393732|P1|Overall Study|Withdrawal by Subject|4
115073|NCT00636818|393732|P1|Overall Study|Protocol Violation|1
115074|NCT00636818|393732|P1|Overall Study|Entry Criteria Exclusion|3
115075|NCT00636818|393732|P1|Overall Study|Lost to Follow-up|2
115076|NCT00636818|393732|P1|Overall Study|Adverse Event|1
115077|NCT00636792|393757|P1|Overall Study|Other|3
115078|NCT00636792|393757|P1|Overall Study|Withdrawal by Subject|3
115079|NCT00636792|393757|P1|Overall Study|Progressive Disease|4
115080|NCT00636792|393757|P1|Overall Study|Physician Decision|7
115081|NCT00636792|393757|P1|Overall Study|Adverse Event|16
115082|NCT00636636|393804|P2|Overall Study|Withdrawal by Subject|9
115083|NCT00636636|393805|P1|Overall Study|Withdrawal by Subject|4
115084|NCT00636636|393804|P2|Overall Study|Death|1
115085|NCT00636636|393805|P1|Overall Study|Death|0
115086|NCT00636636|393804|P2|Overall Study|Lost to Follow-up|1
115087|NCT00636636|393805|P1|Overall Study|Lost to Follow-up|0
115088|NCT00636636|393804|P2|Overall Study|Protocol Violation|2
115089|NCT00636636|393805|P1|Overall Study|Protocol Violation|2
115090|NCT00636636|393804|P2|Overall Study|Lack of Efficacy|12
115091|NCT00636636|393805|P1|Overall Study|Lack of Efficacy|7
115092|NCT00636636|393804|P2|Overall Study|Adverse Event|8
115093|NCT00636636|393805|P1|Overall Study|Adverse Event|19
115094|NCT00636636|393804|P2|Overall Study|Other reason|6
115095|NCT00636636|393805|P1|Overall Study|Other reason|4
115096|NCT00636610|393821|P2|Overall Study|Reason for discontinuation not available|2
115097|NCT00636610|393822|P1|Overall Study|Reason for discontinuation not available|3
115098|NCT00636610|393821|P2|Overall Study|Disease progression - clinical|3
115099|NCT00636610|393822|P1|Overall Study|Disease progression - clinical|8
115100|NCT00636610|393821|P2|Overall Study|Disease progression - radiographic|51
115101|NCT00636610|393822|P1|Overall Study|Disease progression - radiographic|41
115102|NCT00636610|393821|P2|Overall Study|Subject decision to withdraw|11
115103|NCT00636610|393822|P1|Overall Study|Subject decision to withdraw|15
115104|NCT00636610|393821|P2|Overall Study|Physician decision to withdraw patient|9
115105|NCT00636610|393822|P1|Overall Study|Physician decision to withdraw patient|15
115106|NCT00636610|393821|P2|Overall Study|Death|3
115107|NCT00636610|393822|P1|Overall Study|Death|6
115108|NCT00636610|393821|P2|Overall Study|Adverse Event|4
115109|NCT00636610|393822|P1|Overall Study|Adverse Event|4
115110|NCT00636441|393839|P7|Overall Study|Screen Failure|17
115111|NCT00636441|393840|P6|Overall Study|Screen Failure|0
115112|NCT00636441|393841|P5|Overall Study|Screen Failure|0
115113|NCT00636441|393842|P4|Overall Study|Screen Failure|0
115114|NCT00636441|393843|P3|Overall Study|Screen Failure|0
115115|NCT00636441|393844|P2|Overall Study|Screen Failure|0
115116|NCT00636441|393845|P1|Overall Study|Screen Failure|0
115117|NCT00636441|393839|P7|Overall Study|Late, ineligible|1
115118|NCT00636441|393840|P6|Overall Study|Late, ineligible|0
115119|NCT00636441|393841|P5|Overall Study|Late, ineligible|0
115120|NCT00636441|393842|P4|Overall Study|Late, ineligible|0
115121|NCT00636441|393843|P3|Overall Study|Late, ineligible|0
115122|NCT00636441|393844|P2|Overall Study|Late, ineligible|0
115123|NCT00636441|393845|P1|Overall Study|Late, ineligible|0
115124|NCT00636441|393839|P7|Overall Study|Adverse Event|0
115125|NCT00636441|393840|P6|Overall Study|Adverse Event|1
115126|NCT00636441|393841|P5|Overall Study|Adverse Event|0
115127|NCT00636441|393842|P4|Overall Study|Adverse Event|0
115128|NCT00636441|393843|P3|Overall Study|Adverse Event|1
115129|NCT00636441|393844|P2|Overall Study|Adverse Event|1
115130|NCT00636441|393845|P1|Overall Study|Adverse Event|0
115131|NCT00636363|393888|P3|Overall Study|Withdrawal by Subject|2
115132|NCT00636363|393889|P2|Overall Study|Withdrawal by Subject|3
115133|NCT00636363|393890|P1|Overall Study|Withdrawal by Subject|1
115134|NCT00636363|393888|P3|Overall Study|Lost to Follow-up|2
115135|NCT00636363|393889|P2|Overall Study|Lost to Follow-up|4
115136|NCT00636363|393890|P1|Overall Study|Lost to Follow-up|3
115137|NCT00636363|393888|P3|Overall Study|Protocol Violation|0
115138|NCT00636363|393889|P2|Overall Study|Protocol Violation|3
115139|NCT00636363|393890|P1|Overall Study|Protocol Violation|0
115140|NCT00636363|393888|P3|Overall Study|Lack of motivation|1
115141|NCT00636363|393889|P2|Overall Study|Lack of motivation|0
115142|NCT00636363|393890|P1|Overall Study|Lack of motivation|1
115143|NCT00636363|393888|P3|Overall Study|Missed > 1 visit|3
115144|NCT00636363|393889|P2|Overall Study|Missed > 1 visit|1
115145|NCT00636363|393890|P1|Overall Study|Missed > 1 visit|0
115146|NCT00636363|393888|P3|Overall Study|Met ineligibility criteria|3
115147|NCT00636363|393889|P2|Overall Study|Met ineligibility criteria|0
115148|NCT00636363|393890|P1|Overall Study|Met ineligibility criteria|0
115149|NCT00636363|393888|P3|Overall Study|Study related symptoms/complaints|4
115150|NCT00636363|393889|P2|Overall Study|Study related symptoms/complaints|7
115151|NCT00636363|393890|P1|Overall Study|Study related symptoms/complaints|8
115152|NCT00636363|393888|P3|Overall Study|Positive slit lamp finding|1
115153|NCT00636363|393889|P2|Overall Study|Positive slit lamp finding|2
115154|NCT00636363|393890|P1|Overall Study|Positive slit lamp finding|0
115155|NCT00636363|393888|P3|Overall Study|Adverse Event|1
115156|NCT00636363|393889|P2|Overall Study|Adverse Event|0
115157|NCT00636363|393890|P1|Overall Study|Adverse Event|0
115158|NCT00636363|393888|P3|Overall Study|Conjunctivitis|1
115159|NCT00636363|393889|P2|Overall Study|Conjunctivitis|0
115160|NCT00636363|393890|P1|Overall Study|Conjunctivitis|0
115161|NCT00635219|393940|P5|Overall Study|Administrative or Other Reasons|1
115162|NCT00635219|393941|P4|Overall Study|Administrative or Other Reasons|0
115163|NCT00635219|393942|P3|Overall Study|Administrative or Other Reasons|1
115164|NCT00635219|393943|P2|Overall Study|Administrative or Other Reasons|1
115165|NCT00635219|393944|P1|Overall Study|Administrative or Other Reasons|0
115166|NCT00635219|393940|P5|Overall Study|Lost to Follow-up|3
115167|NCT00635219|393941|P4|Overall Study|Lost to Follow-up|0
115168|NCT00635219|393942|P3|Overall Study|Lost to Follow-up|2
115169|NCT00635219|393943|P2|Overall Study|Lost to Follow-up|0
115170|NCT00635219|393944|P1|Overall Study|Lost to Follow-up|0
115171|NCT00635219|393940|P5|Overall Study|Withdrawal of Consent|8
115172|NCT00635219|393941|P4|Overall Study|Withdrawal of Consent|11
115173|NCT00635219|393942|P3|Overall Study|Withdrawal of Consent|8
115174|NCT00635219|393943|P2|Overall Study|Withdrawal of Consent|6
115175|NCT00635219|393944|P1|Overall Study|Withdrawal of Consent|8
115176|NCT00635219|393940|P5|Overall Study|Protocol Violation|4
115177|NCT00635219|393941|P4|Overall Study|Protocol Violation|2
115178|NCT00635219|393942|P3|Overall Study|Protocol Violation|3
115179|NCT00635219|393943|P2|Overall Study|Protocol Violation|2
115180|NCT00635219|393944|P1|Overall Study|Protocol Violation|0
115181|NCT00635219|393940|P5|Overall Study|Non-compliance With Study Product|1
115182|NCT00635219|393941|P4|Overall Study|Non-compliance With Study Product|2
115183|NCT00635219|393942|P3|Overall Study|Non-compliance With Study Product|0
115184|NCT00635219|393943|P2|Overall Study|Non-compliance With Study Product|0
115185|NCT00635219|393944|P1|Overall Study|Non-compliance With Study Product|0
115186|NCT00635219|393940|P5|Overall Study|Lack of Efficacy|6
115187|NCT00635219|393941|P4|Overall Study|Lack of Efficacy|4
115188|NCT00635219|393942|P3|Overall Study|Lack of Efficacy|3
115189|NCT00635219|393943|P2|Overall Study|Lack of Efficacy|6
115190|NCT00635219|393944|P1|Overall Study|Lack of Efficacy|5
115191|NCT00635219|393940|P5|Overall Study|Adverse Event|19
115192|NCT00635219|393941|P4|Overall Study|Adverse Event|15
115193|NCT00635219|393942|P3|Overall Study|Adverse Event|18
115194|NCT00635219|393943|P2|Overall Study|Adverse Event|10
115195|NCT00635219|393944|P1|Overall Study|Adverse Event|12
115196|NCT00633477|394003|P2|Overall Study|Randomized but not treated|0
115197|NCT00633477|394004|P1|Overall Study|Randomized but not treated|1
115198|NCT00633477|394003|P2|Overall Study|Death|0
115199|NCT00633477|394004|P1|Overall Study|Death|1
115200|NCT00633464|394020|P2|Overall Study|Never Treated (Randomized in error)|1
115201|NCT00633464|394021|P1|Overall Study|Never Treated (Randomized in error)|0
115202|NCT00633464|394020|P2|Overall Study|Never Treated (Not met study criteria)|1
115203|NCT00633464|394021|P1|Overall Study|Never Treated (Not met study criteria)|0
115204|NCT00636207|394061|P7|Overall Study|Withdrawal by Subject|0
115205|NCT00636207|394062|P6|Overall Study|Withdrawal by Subject|0
115206|NCT00636207|394063|P5|Overall Study|Withdrawal by Subject|1
115207|NCT00636207|394064|P4|Overall Study|Withdrawal by Subject|0
115208|NCT00636207|394065|P3|Overall Study|Withdrawal by Subject|0
115209|NCT00636207|394066|P2|Overall Study|Withdrawal by Subject|1
115210|NCT00636207|394067|P1|Overall Study|Withdrawal by Subject|0
115211|NCT00636207|394061|P7|Overall Study|Adverse Event|0
115212|NCT00636207|394062|P6|Overall Study|Adverse Event|0
115213|NCT00636207|394063|P5|Overall Study|Adverse Event|0
115214|NCT00636207|394064|P4|Overall Study|Adverse Event|0
115215|NCT00636207|394065|P3|Overall Study|Adverse Event|0
115216|NCT00636207|394066|P2|Overall Study|Adverse Event|0
115217|NCT00636207|394067|P1|Overall Study|Adverse Event|1
115218|NCT00636194|394131|P2|Overall Study|Protocol Violation|0
115219|NCT00636194|394132|P1|Overall Study|Protocol Violation|2
115220|NCT00636194|394131|P2|Overall Study|Study related symptoms and complaints|0
115221|NCT00636194|394132|P1|Overall Study|Study related symptoms and complaints|1
115222|NCT00636168|394144|P2|Treated With Study Drug|Still remains on treatment|94
115223|NCT00636168|394145|P1|Treated With Study Drug|Still remains on treatment|48
115224|NCT00636168|394144|P2|Treated With Study Drug|non-specified|1
115225|NCT00636168|394145|P1|Treated With Study Drug|non-specified|1
115226|NCT00636168|394144|P2|Treated With Study Drug|No longer meets criteria|0
115227|NCT00636168|394145|P1|Treated With Study Drug|No longer meets criteria|1
115228|NCT00636168|394144|P2|Treated With Study Drug|Pregnancy|0
115229|NCT00636168|394145|P1|Treated With Study Drug|Pregnancy|1
115230|NCT00636168|394144|P2|Treated With Study Drug|Death|0
115231|NCT00636168|394145|P1|Treated With Study Drug|Death|3
115232|NCT00636168|394144|P2|Treated With Study Drug|Poor or non-compliance|3
115233|NCT00636168|394145|P1|Treated With Study Drug|Poor or non-compliance|1
115234|NCT00636168|394144|P2|Treated With Study Drug|Withdrawal by Subject|20
115235|NCT00636168|394145|P1|Treated With Study Drug|Withdrawal by Subject|16
115236|NCT00636168|394144|P2|Treated With Study Drug|Adverse Event|20
115237|NCT00636168|394145|P1|Treated With Study Drug|Adverse Event|244
115238|NCT00636168|394144|P2|Treated With Study Drug|Recurrence of disease|273
115239|NCT00636168|394145|P1|Treated With Study Drug|Recurrence of disease|132
115240|NCT00636168|394144|P2|Randomized to Study Drug|No longer met study criteria|0
115241|NCT00636168|394145|P1|Randomized to Study Drug|No longer met study criteria|1
115242|NCT00636168|394144|P2|Randomized to Study Drug|Adverse Event|0
115243|NCT00636168|394145|P1|Randomized to Study Drug|Adverse Event|1
115244|NCT00636168|394144|P2|Randomized to Study Drug|Withdrawal by Subject|2
115245|NCT00636168|394145|P1|Randomized to Study Drug|Withdrawal by Subject|2
115246|NCT00636155|394161|P1|Overall Study|Physician Decision|5
115247|NCT00636155|394161|P1|Overall Study|Stem cell transplant|1
115248|NCT00636155|394161|P1|Overall Study|Withdrawal by Subject|3
115249|NCT00636155|394161|P1|Overall Study|Lack of Efficacy|1
115250|NCT00636155|394161|P1|Overall Study|Adverse Event|8
115251|NCT00635882|394206|P6|Overall Study|Protocol Violation|0
115252|NCT00635882|394207|P5|Overall Study|Protocol Violation|0
115253|NCT00635882|394208|P4|Overall Study|Protocol Violation|0
115254|NCT00635882|394209|P3|Overall Study|Protocol Violation|0
115255|NCT00635882|394210|P2|Overall Study|Protocol Violation|0
115256|NCT00635882|394211|P1|Overall Study|Protocol Violation|1
115257|NCT00635804|394341|P8|Overall Study|Withdrawal by Subject|0
115258|NCT00635804|394342|P7|Overall Study|Withdrawal by Subject|0
115259|NCT00635804|394343|P6|Overall Study|Withdrawal by Subject|0
115260|NCT00635804|394344|P5|Overall Study|Withdrawal by Subject|0
115261|NCT00635804|394345|P4|Overall Study|Withdrawal by Subject|0
115262|NCT00635804|394346|P3|Overall Study|Withdrawal by Subject|0
115263|NCT00635804|394347|P2|Overall Study|Withdrawal by Subject|0
115264|NCT00635804|394348|P1|Overall Study|Withdrawal by Subject|1
115265|NCT00635804|394341|P8|Overall Study|Adverse Event|0
115266|NCT00635804|394342|P7|Overall Study|Adverse Event|0
115267|NCT00635804|394343|P6|Overall Study|Adverse Event|1
115268|NCT00635804|394344|P5|Overall Study|Adverse Event|0
115269|NCT00635804|394345|P4|Overall Study|Adverse Event|0
115270|NCT00635804|394346|P3|Overall Study|Adverse Event|0
115271|NCT00635804|394347|P2|Overall Study|Adverse Event|0
115272|NCT00635804|394348|P1|Overall Study|Adverse Event|0
115273|NCT00635661|394454|P1|Overall Study|Withdrawal by Subject|4
115274|NCT00635648|394458|P1|Overall Study|Other reason|2
115275|NCT00635648|394458|P1|Overall Study|Noncompliance with protocol|1
115276|NCT00635648|394458|P1|Overall Study|No improvement after 7-10 days treatment|4
115277|NCT00635648|394458|P1|Overall Study|Use of other antifungal agent needed|1
115278|NCT00635648|394458|P1|Overall Study|Rapid progression of baseline disease|4
115279|NCT00635648|394458|P1|Overall Study|Physician Decision|4
115280|NCT00635648|394458|P1|Overall Study|Withdrawal by Subject|9
115281|NCT00635648|394458|P1|Overall Study|Adverse Event|12
115282|NCT00635570|394480|P2|Overall Study|Early termination(No sexual activity)|1
115283|NCT00635570|394481|P1|Overall Study|Early termination(No sexual activity)|1
115284|NCT00635570|394480|P2|Overall Study|Did not complete survey|1
115285|NCT00635570|394481|P1|Overall Study|Did not complete survey|2
115286|NCT00635570|394480|P2|Overall Study|Physician Decision|0
115287|NCT00635570|394481|P1|Overall Study|Physician Decision|1
115288|NCT00635570|394480|P2|Overall Study|Adverse Event|0
115289|NCT00635570|394481|P1|Overall Study|Adverse Event|2
115290|NCT00635570|394480|P2|Overall Study|Withdrawal by Subject|1
115291|NCT00635570|394481|P1|Overall Study|Withdrawal by Subject|1
115292|NCT00635570|394480|P2|Overall Study|Lost to Follow-up|8
115293|NCT00635570|394481|P1|Overall Study|Lost to Follow-up|8
115294|NCT00635492|394495|P2|Overall Study|Withdrawal by Subject|45
115295|NCT00635492|394496|P1|Overall Study|Withdrawal by Subject|82
115296|NCT00635492|394495|P2|Overall Study|Sponsor decision|3
115297|NCT00635492|394496|P1|Overall Study|Sponsor decision|2
115298|NCT00635492|394495|P2|Overall Study|Physician Decision|22
115299|NCT00635492|394496|P1|Overall Study|Physician Decision|32
115300|NCT00635492|394495|P2|Overall Study|Lost to Follow-up|172
115301|NCT00635492|394496|P1|Overall Study|Lost to Follow-up|151
115302|NCT00635492|394495|P2|Overall Study|Death|40
115303|NCT00635492|394496|P1|Overall Study|Death|12
115304|NCT00635427|394554|P5|Overall Study|Withdrawal Of Consent|2
115305|NCT00635427|394555|P4|Overall Study|Withdrawal Of Consent|2
115306|NCT00635427|394556|P3|Overall Study|Withdrawal Of Consent|0
115307|NCT00635427|394557|P2|Overall Study|Withdrawal Of Consent|0
115308|NCT00635427|394558|P1|Overall Study|Withdrawal Of Consent|0
115309|NCT00635427|394554|P5|Overall Study|Termination Of Study By Sponsor|6
115310|NCT00635427|394555|P4|Overall Study|Termination Of Study By Sponsor|6
115311|NCT00635427|394556|P3|Overall Study|Termination Of Study By Sponsor|10
115312|NCT00635427|394557|P2|Overall Study|Termination Of Study By Sponsor|6
115313|NCT00635427|394558|P1|Overall Study|Termination Of Study By Sponsor|12
115314|NCT00635427|394554|P5|Overall Study|Death|0
115315|NCT00635427|394555|P4|Overall Study|Death|1
115316|NCT00635427|394556|P3|Overall Study|Death|0
115317|NCT00635427|394557|P2|Overall Study|Death|0
115318|NCT00635427|394558|P1|Overall Study|Death|0
115319|NCT00635427|394554|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
115320|NCT00635427|394555|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
115321|NCT00635427|394556|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
115322|NCT00635427|394557|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
115323|NCT00635427|394558|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
115324|NCT00635349|394597|P2|Overall Study|Adverse Event|9
115325|NCT00635349|394598|P1|Overall Study|Adverse Event|11
115326|NCT00635349|394597|P2|Overall Study|Lost to Follow-up|3
115327|NCT00635349|394598|P1|Overall Study|Lost to Follow-up|4
115328|NCT00635349|394597|P2|Overall Study|Withdrawal by Subject|8
115329|NCT00635349|394598|P1|Overall Study|Withdrawal by Subject|3
115330|NCT00635349|394597|P2|Overall Study|Protocol Violation|22
115331|NCT00635349|394598|P1|Overall Study|Protocol Violation|18
115332|NCT00635349|394597|P2|Overall Study|Unspecified|6
115333|NCT00635349|394598|P1|Overall Study|Unspecified|8
115334|NCT00635154|394616|P1|Overall Study|Still on treatment|21
115335|NCT00635154|394616|P1|Overall Study|Other|4
115336|NCT00635154|394616|P1|Overall Study|Alternative Treatment|8
115337|NCT00635102|394628|P2|Overall Study|Withdrawal by Subject|8
115338|NCT00635102|394629|P1|Overall Study|Withdrawal by Subject|7
115339|NCT00635050|394723|P1|Overall Study|Withdrawal by Subject|1
115340|NCT00635024|394730|P1|Overall Study|Adverse Event|1
115341|NCT00634933|394741|P5|Part B: Week 24 to Week 52|Unspecified|1
115342|NCT00634933|394742|P4|Part B: Week 24 to Week 52|Unspecified|0
115343|NCT00634933|394743|P3|Part B: Week 24 to Week 52|Unspecified|5
115344|NCT00634933|394744|P2|Part B: Week 24 to Week 52|Unspecified|0
115345|NCT00634933|394745|P1|Part B: Week 24 to Week 52|Unspecified|0
115346|NCT00634933|394741|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
115347|NCT00634933|394742|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
115348|NCT00634933|394743|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
115349|NCT00634933|394744|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
115350|NCT00634933|394745|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
115351|NCT00634933|394741|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
115352|NCT00634933|394742|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
115353|NCT00634933|394743|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
115354|NCT00634933|394744|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
115355|NCT00634933|394745|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
115356|NCT00634933|394741|P5|Part B: Week 24 to Week 52|Protocol Violation|1
115357|NCT00634933|394742|P4|Part B: Week 24 to Week 52|Protocol Violation|0
115358|NCT00634933|394743|P3|Part B: Week 24 to Week 52|Protocol Violation|0
115359|NCT00634933|394744|P2|Part B: Week 24 to Week 52|Protocol Violation|0
115360|NCT00634933|394745|P1|Part B: Week 24 to Week 52|Protocol Violation|0
115361|NCT00634933|394741|P5|Part B: Week 24 to Week 52|Physician Decision|0
115362|NCT00634933|394742|P4|Part B: Week 24 to Week 52|Physician Decision|0
115363|NCT00634933|394743|P3|Part B: Week 24 to Week 52|Physician Decision|1
115364|NCT00634933|394744|P2|Part B: Week 24 to Week 52|Physician Decision|1
115365|NCT00634933|394745|P1|Part B: Week 24 to Week 52|Physician Decision|0
115366|NCT00634933|394741|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
115367|NCT00634933|394742|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
115368|NCT00634933|394743|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
115369|NCT00634933|394744|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
115370|NCT00634933|394745|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
115371|NCT00634933|394741|P5|Part B: Week 24 to Week 52|Adverse Event|0
115372|NCT00634933|394742|P4|Part B: Week 24 to Week 52|Adverse Event|1
115373|NCT00634933|394743|P3|Part B: Week 24 to Week 52|Adverse Event|1
115374|NCT00634933|394744|P2|Part B: Week 24 to Week 52|Adverse Event|1
115375|NCT00634933|394745|P1|Part B: Week 24 to Week 52|Adverse Event|0
115376|NCT00634933|394741|P5|Between Part A and Part B|Physician Decision|0
115377|NCT00634933|394742|P4|Between Part A and Part B|Physician Decision|0
115378|NCT00634933|394743|P3|Between Part A and Part B|Physician Decision|0
115379|NCT00634933|394744|P2|Between Part A and Part B|Physician Decision|1
115380|NCT00634933|394745|P1|Between Part A and Part B|Physician Decision|0
115381|NCT00634933|394741|P5|Part A: Baseline to Week 24|Unspecified|0
115382|NCT00634933|394742|P4|Part A: Baseline to Week 24|Unspecified|0
115383|NCT00634933|394743|P3|Part A: Baseline to Week 24|Unspecified|5
115384|NCT00634933|394744|P2|Part A: Baseline to Week 24|Unspecified|8
115385|NCT00634933|394745|P1|Part A: Baseline to Week 24|Unspecified|1
115386|NCT00634933|394741|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
115387|NCT00634933|394742|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
115388|NCT00634933|394743|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
115389|NCT00634933|394744|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
115390|NCT00634933|394745|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
115391|NCT00634933|394741|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
115392|NCT00634933|394742|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
115393|NCT00634933|394743|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
115394|NCT00634933|394744|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
115395|NCT00634933|394745|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
115396|NCT00634933|394741|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
115397|NCT00634933|394742|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
115398|NCT00634933|394743|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
115399|NCT00634933|394744|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
115400|NCT00634933|394745|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
115401|NCT00634933|394741|P5|Part A: Baseline to Week 24|Investigator Request|0
115402|NCT00634933|394742|P4|Part A: Baseline to Week 24|Investigator Request|0
115403|NCT00634933|394743|P3|Part A: Baseline to Week 24|Investigator Request|1
115404|NCT00634933|394744|P2|Part A: Baseline to Week 24|Investigator Request|1
115405|NCT00634933|394745|P1|Part A: Baseline to Week 24|Investigator Request|1
115406|NCT00634933|394741|P5|Part A: Baseline to Week 24|Failed to Return|0
115407|NCT00634933|394742|P4|Part A: Baseline to Week 24|Failed to Return|0
115408|NCT00634933|394743|P3|Part A: Baseline to Week 24|Failed to Return|0
115409|NCT00634933|394744|P2|Part A: Baseline to Week 24|Failed to Return|0
115410|NCT00634933|394745|P1|Part A: Baseline to Week 24|Failed to Return|1
115411|NCT00634933|394741|P5|Part A: Baseline to Week 24|Death|0
115412|NCT00634933|394742|P4|Part A: Baseline to Week 24|Death|0
115413|NCT00634933|394743|P3|Part A: Baseline to Week 24|Death|0
115414|NCT00634933|394744|P2|Part A: Baseline to Week 24|Death|0
115415|NCT00634933|394745|P1|Part A: Baseline to Week 24|Death|1
115416|NCT00634933|394741|P5|Part A: Baseline to Week 24|Adverse Event|0
115417|NCT00634933|394742|P4|Part A: Baseline to Week 24|Adverse Event|0
115418|NCT00634933|394743|P3|Part A: Baseline to Week 24|Adverse Event|8
115419|NCT00634933|394744|P2|Part A: Baseline to Week 24|Adverse Event|4
115420|NCT00634933|394745|P1|Part A: Baseline to Week 24|Adverse Event|4
115421|NCT00634920|394814|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
115422|NCT00634920|394815|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
115423|NCT00634920|394816|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
115424|NCT00634920|394814|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
115425|NCT00634920|394815|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
115426|NCT00634920|394816|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
115427|NCT00634920|394814|P3|Period 2 - Post-Randomization|Death|0
115428|NCT00634920|394815|P2|Period 2 - Post-Randomization|Death|5
115429|NCT00634920|394816|P1|Period 2 - Post-Randomization|Death|2
115430|NCT00634920|394814|P3|Period 2 - Post-Randomization|Rejection|0
115431|NCT00634920|394815|P2|Period 2 - Post-Randomization|Rejection|5
115432|NCT00634920|394816|P1|Period 2 - Post-Randomization|Rejection|11
115433|NCT00634920|394814|P3|Period 2 - Post-Randomization|Adverse Event|0
115434|NCT00634920|394815|P2|Period 2 - Post-Randomization|Adverse Event|9
115435|NCT00634920|394816|P1|Period 2 - Post-Randomization|Adverse Event|37
115436|NCT00634920|394814|P3|Period 1 - Pre-Randomization|Other issues|6
115437|NCT00634920|394815|P2|Period 1 - Pre-Randomization|Other issues|0
115438|NCT00634920|394816|P1|Period 1 - Pre-Randomization|Other issues|0
115439|NCT00634920|394814|P3|Period 1 - Pre-Randomization|Non-Compliance|3
115440|NCT00634920|394815|P2|Period 1 - Pre-Randomization|Non-Compliance|0
115441|NCT00634920|394816|P1|Period 1 - Pre-Randomization|Non-Compliance|0
115442|NCT00634920|394814|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
115443|NCT00634920|394815|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
115444|NCT00634920|394816|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
115445|NCT00634920|394814|P3|Period 1 - Pre-Randomization|Rejections|55
115446|NCT00634920|394815|P2|Period 1 - Pre-Randomization|Rejections|0
115447|NCT00634920|394816|P1|Period 1 - Pre-Randomization|Rejections|0
115448|NCT00634920|394814|P3|Period 1 - Pre-Randomization|Wound healing problems|16
115449|NCT00634920|394815|P2|Period 1 - Pre-Randomization|Wound healing problems|0
115450|NCT00634920|394816|P1|Period 1 - Pre-Randomization|Wound healing problems|0
115451|NCT00634920|394814|P3|Period 1 - Pre-Randomization|Adverse Event|36
115452|NCT00634920|394815|P2|Period 1 - Pre-Randomization|Adverse Event|0
115453|NCT00634920|394816|P1|Period 1 - Pre-Randomization|Adverse Event|0
115454|NCT00634842|394860|P2|Overall Study|Subject off study drug for too long|1
115455|NCT00634842|394861|P1|Overall Study|Subject off study drug for too long|0
115456|NCT00634842|394860|P2|Overall Study|No wish to keep taking Avandia|1
115457|NCT00634842|394861|P1|Overall Study|No wish to keep taking Avandia|0
115458|NCT00634842|394860|P2|Overall Study|No need of study drug to treat diabetes|1
115459|NCT00634842|394861|P1|Overall Study|No need of study drug to treat diabetes|0
115460|NCT00634842|394860|P2|Overall Study|Discontinued due to injection|2
115461|NCT00634842|394861|P1|Overall Study|Discontinued due to injection|0
115462|NCT00634842|394860|P2|Overall Study|Lack of time and intolerance to drug|1
115463|NCT00634842|394861|P1|Overall Study|Lack of time and intolerance to drug|0
115464|NCT00634842|394860|P2|Overall Study|Withdrawal by Subject|3
115465|NCT00634842|394861|P1|Overall Study|Withdrawal by Subject|1
115466|NCT00634842|394860|P2|Overall Study|Physician Decision|0
115467|NCT00634842|394861|P1|Overall Study|Physician Decision|1
115468|NCT00634842|394860|P2|Overall Study|Lost to Follow-up|2
115469|NCT00634842|394861|P1|Overall Study|Lost to Follow-up|1
115470|NCT00634842|394860|P2|Overall Study|Inclusion criteria were not met|0
115471|NCT00634842|394861|P1|Overall Study|Inclusion criteria were not met|1
115472|NCT00634842|394860|P2|Overall Study|Move to another state|0
115473|NCT00634842|394861|P1|Overall Study|Move to another state|1
115474|NCT00634842|394860|P2|Overall Study|Protocol Violation|4
115475|NCT00634842|394861|P1|Overall Study|Protocol Violation|8
115476|NCT00634842|394860|P2|Overall Study|Adverse Event|3
115477|NCT00634842|394861|P1|Overall Study|Adverse Event|2
115478|NCT00634647|394873|P1|Overall Study|declined to participate before treatment|1
115479|NCT00634647|394873|P1|Overall Study|refused further treatment|3
115480|NCT00634647|394873|P1|Overall Study|death on study|5
115481|NCT00634569|394892|P2|Overall Study|Physician Decision|1
115482|NCT00634569|394893|P1|Overall Study|Physician Decision|0
115483|NCT00634569|394892|P2|Overall Study|Withdrawal by Subject|4
115484|NCT00634569|394893|P1|Overall Study|Withdrawal by Subject|0
115485|NCT00634543|394907|P2|Overall Study|Lost to Follow-up|1
115486|NCT00634543|394908|P1|Overall Study|Lost to Follow-up|0
115487|NCT00634543|394907|P2|Overall Study|Withdrawal by Subject|4
115488|NCT00634543|394908|P1|Overall Study|Withdrawal by Subject|4
115489|NCT00634543|394907|P2|Overall Study|Adverse Event|11
115490|NCT00634543|394908|P1|Overall Study|Adverse Event|11
115491|NCT00634543|394907|P2|Overall Study|Protocol Violation|3
115492|NCT00634543|394908|P1|Overall Study|Protocol Violation|3
115493|NCT00634543|394907|P2|Overall Study|Unspecified|2
115494|NCT00634543|394908|P1|Overall Study|Unspecified|1
115495|NCT00634504|394926|P2|Overall Study|Protocol Violation|0
115496|NCT00634504|394927|P1|Overall Study|Protocol Violation|1
115497|NCT00633594|394936|P3|Overall Study|Disease Progression|1
115498|NCT00633594|394937|P2|Overall Study|Disease Progression|0
115499|NCT00633594|394938|P1|Overall Study|Disease Progression|0
115500|NCT00633594|394936|P3|Overall Study|Death|2
115501|NCT00633594|394937|P2|Overall Study|Death|1
115502|NCT00633594|394938|P1|Overall Study|Death|0
115503|NCT00633594|394936|P3|Overall Study|Adverse Event|7
115504|NCT00633594|394937|P2|Overall Study|Adverse Event|4
115505|NCT00633594|394938|P1|Overall Study|Adverse Event|0
115506|NCT00634244|395008|P3|Overall Study|Other complicating disease|0
115507|NCT00634244|395009|P2|Overall Study|Other complicating disease|1
115508|NCT00634244|395010|P1|Overall Study|Other complicating disease|0
115509|NCT00634244|395008|P3|Overall Study|Disease progression/relapse|0
115510|NCT00634244|395009|P2|Overall Study|Disease progression/relapse|1
115511|NCT00634244|395010|P1|Overall Study|Disease progression/relapse|0
115512|NCT00634244|395008|P3|Overall Study|Physician Decision|0
115513|NCT00634244|395009|P2|Overall Study|Physician Decision|1
115514|NCT00634244|395010|P1|Overall Study|Physician Decision|0
115515|NCT00634244|395008|P3|Overall Study|Withdrawal by Subject|0
115516|NCT00634244|395009|P2|Overall Study|Withdrawal by Subject|1
115517|NCT00634244|395010|P1|Overall Study|Withdrawal by Subject|0
115518|NCT00634244|395008|P3|Overall Study|Adverse Event|0
115519|NCT00634244|395009|P2|Overall Study|Adverse Event|2
115520|NCT00634244|395010|P1|Overall Study|Adverse Event|0
115521|NCT00634244|395008|P3|Overall Study|Death|0
115522|NCT00634244|395009|P2|Overall Study|Death|6
115523|NCT00634244|395010|P1|Overall Study|Death|1
115524|NCT00634244|395008|P3|Overall Study|Never started treatment|0
115525|NCT00634244|395009|P2|Overall Study|Never started treatment|1
115526|NCT00634244|395010|P1|Overall Study|Never started treatment|0
115527|NCT00634179|395021|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
115528|NCT00634114|395040|P3|Overall Study|Other reason|1
115529|NCT00634114|395041|P2|Overall Study|Other reason|1
115530|NCT00634114|395042|P1|Overall Study|Other reason|1
115531|NCT00634114|395040|P3|Overall Study|Difficult to continue|1
115532|NCT00634114|395041|P2|Overall Study|Difficult to continue|1
115533|NCT00634114|395042|P1|Overall Study|Difficult to continue|3
115534|NCT00634114|395040|P3|Overall Study|Recurrence of reflux esophagitis|21
115535|NCT00634114|395041|P2|Overall Study|Recurrence of reflux esophagitis|15
115536|NCT00634114|395042|P1|Overall Study|Recurrence of reflux esophagitis|5
115537|NCT00634114|395040|P3|Overall Study|Incorrect enrolment|0
115538|NCT00634114|395041|P2|Overall Study|Incorrect enrolment|1
115539|NCT00634114|395042|P1|Overall Study|Incorrect enrolment|0
115540|NCT00634114|395040|P3|Overall Study|Pregnancy|0
115541|NCT00634114|395041|P2|Overall Study|Pregnancy|0
115542|NCT00634114|395042|P1|Overall Study|Pregnancy|1
115543|NCT00634114|395040|P3|Overall Study|Protocol Violation|1
115544|NCT00634114|395041|P2|Overall Study|Protocol Violation|3
115545|NCT00634114|395042|P1|Overall Study|Protocol Violation|3
115546|NCT00634114|395040|P3|Overall Study|Lost to Follow-up|1
115547|NCT00634114|395041|P2|Overall Study|Lost to Follow-up|0
115548|NCT00634114|395042|P1|Overall Study|Lost to Follow-up|0
115549|NCT00634114|395040|P3|Overall Study|Withdrawal by Subject|11
115550|NCT00634114|395041|P2|Overall Study|Withdrawal by Subject|6
115551|NCT00634114|395042|P1|Overall Study|Withdrawal by Subject|9
115552|NCT00634114|395040|P3|Overall Study|Adverse Event|3
115553|NCT00634114|395041|P2|Overall Study|Adverse Event|8
115554|NCT00634114|395042|P1|Overall Study|Adverse Event|6
115555|NCT00634088|395060|P4|Time Period 3: Dose Level 3|Progressive disease|0
115556|NCT00634088|395061|P3|Time Period 3: Dose Level 3|Progressive disease|1
115557|NCT00634088|395062|P2|Time Period 3: Dose Level 3|Progressive disease|0
115558|NCT00634088|395063|P1|Time Period 3: Dose Level 3|Progressive disease|0
115559|NCT00634088|395060|P4|Time Period 2: Dose Level 2|Progressive disease|0
115560|NCT00634088|395061|P3|Time Period 2: Dose Level 2|Progressive disease|0
115561|NCT00634088|395062|P2|Time Period 2: Dose Level 2|Progressive disease|1
115562|NCT00634088|395063|P1|Time Period 2: Dose Level 2|Progressive disease|0
115563|NCT00634088|395060|P4|Time Period 2: Dose Level 2|Adverse Event|0
115564|NCT00634088|395061|P3|Time Period 2: Dose Level 2|Adverse Event|0
115565|NCT00634088|395062|P2|Time Period 2: Dose Level 2|Adverse Event|2
115566|NCT00634088|395063|P1|Time Period 2: Dose Level 2|Adverse Event|0
115567|NCT00634088|395060|P4|Time Period 1: Dose Level 1|Adverse Event|0
115568|NCT00634088|395061|P3|Time Period 1: Dose Level 1|Adverse Event|0
115569|NCT00634088|395062|P2|Time Period 1: Dose Level 1|Adverse Event|0
115570|NCT00634088|395063|P1|Time Period 1: Dose Level 1|Adverse Event|3
115571|NCT00634088|395060|P4|Time Period 1: Dose Level 1|Physician Decision|0
115572|NCT00634088|395061|P3|Time Period 1: Dose Level 1|Physician Decision|0
115573|NCT00634088|395062|P2|Time Period 1: Dose Level 1|Physician Decision|0
115574|NCT00634088|395063|P1|Time Period 1: Dose Level 1|Physician Decision|1
115575|NCT00634088|395060|P4|Time Period 1: Dose Level 1|Disease progression|0
115576|NCT00634088|395061|P3|Time Period 1: Dose Level 1|Disease progression|0
115577|NCT00634088|395062|P2|Time Period 1: Dose Level 1|Disease progression|0
115578|NCT00634088|395063|P1|Time Period 1: Dose Level 1|Disease progression|2
115579|NCT00634049|395114|P1|Overall Study|Screening failure|1
115580|NCT00634049|395114|P1|Overall Study|Died prior to receiving study drug|1
115581|NCT00634049|395114|P1|Overall Study|Never received study drug|1
115582|NCT00634010|395193|P2|Overall Study|Non-Compliant|1
115583|NCT00634010|395194|P1|Overall Study|Non-Compliant|1
115584|NCT00634010|395193|P2|Overall Study|Disease Progression|1
115585|NCT00634010|395194|P1|Overall Study|Disease Progression|1
115586|NCT00634010|395193|P2|Overall Study|Physician Decision|1
115587|NCT00634010|395194|P1|Overall Study|Physician Decision|1
115588|NCT00634010|395193|P2|Overall Study|Withdrawal by Subject|6
115589|NCT00634010|395194|P1|Overall Study|Withdrawal by Subject|5
115590|NCT00634010|395193|P2|Overall Study|Adverse Event|5
115591|NCT00634010|395194|P1|Overall Study|Adverse Event|2
115592|NCT00633984|395202|P2|Overall Study|Hospitalized|0
115593|NCT00633984|395203|P1|Overall Study|Hospitalized|1
115594|NCT00633984|395202|P2|Overall Study|Withdrawal by Subject|7
115595|NCT00633984|395203|P1|Overall Study|Withdrawal by Subject|8
115596|NCT00633984|395202|P2|Overall Study|Lost to Follow-up|6
115597|NCT00633984|395203|P1|Overall Study|Lost to Follow-up|0
115598|NCT00633932|395214|P3|Overall Study|Moved Away|0
115599|NCT00633932|395215|P2|Overall Study|Moved Away|0
115600|NCT00633932|395216|P1|Overall Study|Moved Away|1
115601|NCT00633932|395214|P3|Overall Study|Doctor's judgement|0
115602|NCT00633932|395215|P2|Overall Study|Doctor's judgement|0
115603|NCT00633932|395216|P1|Overall Study|Doctor's judgement|1
115604|NCT00633932|395214|P3|Overall Study|Physician Decision|1
115605|NCT00633932|395215|P2|Overall Study|Physician Decision|0
115606|NCT00633932|395216|P1|Overall Study|Physician Decision|0
115607|NCT00633932|395214|P3|Overall Study|Protocol Violation|3
115608|NCT00633932|395215|P2|Overall Study|Protocol Violation|2
115609|NCT00633932|395216|P1|Overall Study|Protocol Violation|5
115610|NCT00633932|395214|P3|Overall Study|Lost to Follow-up|2
115611|NCT00633932|395215|P2|Overall Study|Lost to Follow-up|0
115612|NCT00633932|395216|P1|Overall Study|Lost to Follow-up|1
115613|NCT00633932|395214|P3|Overall Study|Withdrawal by Subject|1
115614|NCT00633932|395215|P2|Overall Study|Withdrawal by Subject|9
115615|NCT00633932|395216|P1|Overall Study|Withdrawal by Subject|3
115616|NCT00633932|395214|P3|Overall Study|Adverse Event|4
115617|NCT00633932|395215|P2|Overall Study|Adverse Event|3
115618|NCT00633932|395216|P1|Overall Study|Adverse Event|1
115619|NCT00633893|395247|P3|Overall Study|not specified|31
115620|NCT00633893|395248|P2|Overall Study|not specified|33
115621|NCT00633893|395249|P1|Overall Study|not specified|28
115622|NCT00633893|395247|P3|Overall Study|Not meet/no longer meets criteria|4
115623|NCT00633893|395248|P2|Overall Study|Not meet/no longer meets criteria|6
115624|NCT00633893|395249|P1|Overall Study|Not meet/no longer meets criteria|4
115625|NCT00633893|395247|P3|Overall Study|Pregnancy|1
115626|NCT00633893|395248|P2|Overall Study|Pregnancy|1
115627|NCT00633893|395249|P1|Overall Study|Pregnancy|2
115628|NCT00633893|395247|P3|Overall Study|Poor/non-compliance|3
115629|NCT00633893|395248|P2|Overall Study|Poor/non-compliance|12
115630|NCT00633893|395249|P1|Overall Study|Poor/non-compliance|5
115631|NCT00633893|395247|P3|Overall Study|Lost to Follow-up|8
115632|NCT00633893|395248|P2|Overall Study|Lost to Follow-up|4
115633|NCT00633893|395249|P1|Overall Study|Lost to Follow-up|2
115634|NCT00633893|395247|P3|Overall Study|Withdrawal by Subject|6
115635|NCT00633893|395248|P2|Overall Study|Withdrawal by Subject|12
115636|NCT00633893|395249|P1|Overall Study|Withdrawal by Subject|7
115637|NCT00633893|395247|P3|Overall Study|Adverse Event|126
115638|NCT00633893|395248|P2|Overall Study|Adverse Event|58
115639|NCT00633893|395249|P1|Overall Study|Adverse Event|65
115640|NCT00633893|395247|P3|Overall Study|Death|9
115641|NCT00633893|395248|P2|Overall Study|Death|3
115642|NCT00633893|395249|P1|Overall Study|Death|1
115643|NCT00633880|395323|P3|Open Label Titration|Withdrawal by Subject|0
115644|NCT00633880|395324|P2|Open Label Titration|Withdrawal by Subject|0
115645|NCT00633880|395325|P1|Open Label Titration|Withdrawal by Subject|4
115646|NCT00633880|395323|P3|Open Label Titration|Physician Decision|0
115647|NCT00633880|395324|P2|Open Label Titration|Physician Decision|0
115648|NCT00633880|395325|P1|Open Label Titration|Physician Decision|1
115649|NCT00633880|395323|P3|Open Label Titration|Protocol Violation|0
115650|NCT00633880|395324|P2|Open Label Titration|Protocol Violation|0
115651|NCT00633880|395325|P1|Open Label Titration|Protocol Violation|6
115652|NCT00633880|395323|P3|Open Label Titration|Treatment Failure|0
115653|NCT00633880|395324|P2|Open Label Titration|Treatment Failure|0
115654|NCT00633880|395325|P1|Open Label Titration|Treatment Failure|55
115655|NCT00633880|395323|P3|Open Label Titration|Adverse Event|0
115656|NCT00633880|395324|P2|Open Label Titration|Adverse Event|0
115657|NCT00633880|395325|P1|Open Label Titration|Adverse Event|13
115658|NCT00633880|395323|P3|Open Label Titration|Lack of Efficacy|0
115659|NCT00633880|395324|P2|Open Label Titration|Lack of Efficacy|0
115660|NCT00633880|395325|P1|Open Label Titration|Lack of Efficacy|1
115661|NCT00633750|395361|P1|Overall Study|Withdrawal by Subject|3
115662|NCT00633750|395361|P1|Overall Study|Adverse Event|2
115663|NCT00633243|395382|P2|Overall Study|Couldn't tolerate side-effects|1
115664|NCT00633243|395383|P1|Overall Study|Couldn't tolerate side-effects|1
115665|NCT00633243|395382|P2|Overall Study|Mental Health--Depression|1
115666|NCT00633243|395383|P1|Overall Study|Mental Health--Depression|0
115667|NCT00633243|395382|P2|Overall Study|Not comfortable with self-injecting|1
115668|NCT00633243|395383|P1|Overall Study|Not comfortable with self-injecting|0
115669|NCT00633243|395382|P2|Overall Study|Homeless--no refrigeration for meds|1
115670|NCT00633243|395383|P1|Overall Study|Homeless--no refrigeration for meds|0
115671|NCT00633243|395382|P2|Overall Study|incarceration|2
115672|NCT00633243|395383|P1|Overall Study|incarceration|0
115673|NCT00633243|395382|P2|Overall Study|Withdrawal by Subject|1
115674|NCT00633243|395383|P1|Overall Study|Withdrawal by Subject|0
115675|NCT00633217|395391|P2|Overall Study|Withdrew Consent|3
115676|NCT00633217|395392|P1|Overall Study|Withdrew Consent|3
115677|NCT00633217|395391|P2|Overall Study|Investigator Discretion|0
115678|NCT00633217|395392|P1|Overall Study|Investigator Discretion|2
115679|NCT00633217|395391|P2|Overall Study|Lost to Follow-up|2
115680|NCT00633217|395392|P1|Overall Study|Lost to Follow-up|2
115681|NCT00633217|395391|P2|Overall Study|Protocol Violation|7
115682|NCT00633217|395392|P1|Overall Study|Protocol Violation|3
115683|NCT00633217|395391|P2|Overall Study|Lack of Efficacy|2
115684|NCT00633217|395392|P1|Overall Study|Lack of Efficacy|0
115685|NCT00633217|395391|P2|Overall Study|Adverse Event|9
115686|NCT00633217|395392|P1|Overall Study|Adverse Event|5
115687|NCT00633152|395404|P2|Overall Study|Miscellaneous Other|2
115688|NCT00633152|395405|P1|Overall Study|Miscellaneous Other|3
115689|NCT00633152|395404|P2|Overall Study|Lost to Follow-up|1
115690|NCT00633152|395405|P1|Overall Study|Lost to Follow-up|4
115691|NCT00633152|395404|P2|Overall Study|Withdrawal by Subject|1
115692|NCT00633152|395405|P1|Overall Study|Withdrawal by Subject|1
115693|NCT00633152|395404|P2|Overall Study|Randomized, did not receive study drug|2
115694|NCT00633152|395405|P1|Overall Study|Randomized, did not receive study drug|5
115695|NCT00633152|395404|P2|Overall Study|Adverse Event|0
115696|NCT00633152|395405|P1|Overall Study|Adverse Event|1
115697|NCT00633139|395416|P3|Overall Study|Withdrawal by Subject|0
115698|NCT00633139|395417|P2|Overall Study|Withdrawal by Subject|1
115699|NCT00633139|395418|P1|Overall Study|Withdrawal by Subject|0
115700|NCT00633139|395416|P3|Overall Study|Non compliance|1
115701|NCT00633139|395417|P2|Overall Study|Non compliance|0
115702|NCT00633139|395418|P1|Overall Study|Non compliance|0
115703|NCT00633126|395432|P1|Overall Study|Did not receive full dose|1
115704|NCT00633074|395446|P2|Overall Study|Adverse Event|0
115705|NCT00633074|395447|P1|Overall Study|Adverse Event|1
115706|NCT00632931|395491|P3|Part 2|Withdrawal by Subject|3
115707|NCT00632931|395492|P2|Part 2|Withdrawal by Subject|0
115708|NCT00632931|395493|P1|Part 2|Withdrawal by Subject|0
115709|NCT00632931|395491|P3|Part 2|Lack of Efficacy|17
115710|NCT00632931|395492|P2|Part 2|Lack of Efficacy|0
115711|NCT00632931|395493|P1|Part 2|Lack of Efficacy|0
115712|NCT00632931|395491|P3|Part 2|Death|1
115713|NCT00632931|395492|P2|Part 2|Death|0
115714|NCT00632931|395493|P1|Part 2|Death|0
115715|NCT00632931|395491|P3|Part 2|Adverse Event|3
115716|NCT00632931|395492|P2|Part 2|Adverse Event|0
115717|NCT00632931|395493|P1|Part 2|Adverse Event|0
115718|NCT00632931|395491|P3|Part 1, Period 1|Withdrawal by Subject|0
115719|NCT00632931|395492|P2|Part 1, Period 1|Withdrawal by Subject|0
115720|NCT00632931|395493|P1|Part 1, Period 1|Withdrawal by Subject|1
115721|NCT00632931|395491|P3|Part 1, Period 1|Protocol Violation|0
115722|NCT00632931|395492|P2|Part 1, Period 1|Protocol Violation|0
115723|NCT00632931|395493|P1|Part 1, Period 1|Protocol Violation|1
115724|NCT00632749|395563|P14|Overall Study|Reason other than those specified above|2
115725|NCT00632749|395564|P13|Overall Study|Reason other than those specified above|0
115726|NCT00632749|395565|P12|Overall Study|Reason other than those specified above|1
115727|NCT00632749|395566|P11|Overall Study|Reason other than those specified above|2
115728|NCT00632749|395567|P10|Overall Study|Reason other than those specified above|0
115729|NCT00632749|395568|P9|Overall Study|Reason other than those specified above|0
115730|NCT00632749|395569|P8|Overall Study|Reason other than those specified above|0
115731|NCT00632749|395570|P7|Overall Study|Reason other than those specified above|1
115732|NCT00632749|395571|P6|Overall Study|Reason other than those specified above|0
115733|NCT00632749|395572|P5|Overall Study|Reason other than those specified above|1
115734|NCT00632749|395573|P4|Overall Study|Reason other than those specified above|0
115735|NCT00632749|395574|P3|Overall Study|Reason other than those specified above|0
115736|NCT00632749|395575|P2|Overall Study|Reason other than those specified above|2
115737|NCT00632749|395576|P1|Overall Study|Reason other than those specified above|0
115738|NCT00632749|395563|P14|Overall Study|Refuse to continue medication|0
115739|NCT00632749|395564|P13|Overall Study|Refuse to continue medication|0
115740|NCT00632749|395565|P12|Overall Study|Refuse to continue medication|0
115741|NCT00632749|395566|P11|Overall Study|Refuse to continue medication|0
115742|NCT00632749|395567|P10|Overall Study|Refuse to continue medication|1
115743|NCT00632749|395568|P9|Overall Study|Refuse to continue medication|0
115744|NCT00632749|395569|P8|Overall Study|Refuse to continue medication|0
115745|NCT00632749|395570|P7|Overall Study|Refuse to continue medication|0
115746|NCT00632749|395571|P6|Overall Study|Refuse to continue medication|0
115747|NCT00632749|395572|P5|Overall Study|Refuse to continue medication|0
115748|NCT00632749|395573|P4|Overall Study|Refuse to continue medication|1
115749|NCT00632749|395574|P3|Overall Study|Refuse to continue medication|0
115750|NCT00632749|395575|P2|Overall Study|Refuse to continue medication|0
115751|NCT00632749|395576|P1|Overall Study|Refuse to continue medication|0
115752|NCT00632749|395563|P14|Overall Study|Other Adverse event|0
115753|NCT00632749|395564|P13|Overall Study|Other Adverse event|1
115754|NCT00632749|395565|P12|Overall Study|Other Adverse event|0
115755|NCT00632749|395566|P11|Overall Study|Other Adverse event|1
115756|NCT00632749|395567|P10|Overall Study|Other Adverse event|0
115757|NCT00632749|395568|P9|Overall Study|Other Adverse event|2
115758|NCT00632749|395569|P8|Overall Study|Other Adverse event|2
115759|NCT00632749|395570|P7|Overall Study|Other Adverse event|1
115760|NCT00632749|395571|P6|Overall Study|Other Adverse event|4
115761|NCT00632749|395572|P5|Overall Study|Other Adverse event|2
115762|NCT00632749|395573|P4|Overall Study|Other Adverse event|1
115763|NCT00632749|395574|P3|Overall Study|Other Adverse event|1
115764|NCT00632749|395575|P2|Overall Study|Other Adverse event|1
115765|NCT00632749|395576|P1|Overall Study|Other Adverse event|1
115766|NCT00632749|395563|P14|Overall Study|Progressive disease|4
115767|NCT00632749|395564|P13|Overall Study|Progressive disease|2
115768|NCT00632749|395565|P12|Overall Study|Progressive disease|3
115769|NCT00632749|395566|P11|Overall Study|Progressive disease|4
115770|NCT00632749|395567|P10|Overall Study|Progressive disease|2
115771|NCT00632749|395568|P9|Overall Study|Progressive disease|3
115772|NCT00632749|395569|P8|Overall Study|Progressive disease|2
115773|NCT00632749|395570|P7|Overall Study|Progressive disease|3
115774|NCT00632749|395571|P6|Overall Study|Progressive disease|4
115775|NCT00632749|395572|P5|Overall Study|Progressive disease|4
115776|NCT00632749|395573|P4|Overall Study|Progressive disease|2
115777|NCT00632749|395574|P3|Overall Study|Progressive disease|2
115778|NCT00632749|395575|P2|Overall Study|Progressive disease|2
115779|NCT00632749|395576|P1|Overall Study|Progressive disease|3
115780|NCT00632736|395870|P1|Overall Study|Other|16
115781|NCT00632736|395870|P1|Overall Study|Non-compliance|10
115782|NCT00632736|395870|P1|Overall Study|Sponsor terminated study|5
115783|NCT00632736|395870|P1|Overall Study|Lack of Efficacy|5
115784|NCT00632736|395870|P1|Overall Study|Withdrawal by Subject|99
115785|NCT00632736|395870|P1|Overall Study|Protocol Violation|14
115786|NCT00632736|395870|P1|Overall Study|Lost to Follow-up|15
115787|NCT00632736|395870|P1|Overall Study|Adverse Event|104
115788|NCT00632541|395905|P1|Overall Study|Adverse Event|7
115789|NCT00632502|395911|P2|Overall Study|Randomized not treated|0
115790|NCT00632502|395912|P1|Overall Study|Randomized not treated|3
115791|NCT00632502|395911|P2|Overall Study|Adverse Event|1
115792|NCT00632502|395912|P1|Overall Study|Adverse Event|0
115793|NCT00632463|395956|P3|Overall Study|Adverse Event|0
115794|NCT00632463|395957|P2|Overall Study|Adverse Event|1
115795|NCT00632463|395958|P1|Overall Study|Adverse Event|0
115796|NCT00632424|395975|P1|Overall Study|Study Drug Toxicity|1
115797|NCT00632424|395975|P1|Overall Study|Disease Progression|17
115798|NCT00632229|396004|P2|Overall Study|Undisclosed reasons within the first wee|1
115799|NCT00632229|396005|P1|Overall Study|Undisclosed reasons within the first wee|0
115800|NCT00632229|396004|P2|Overall Study|Lack of Efficacy|2
115801|NCT00632229|396005|P1|Overall Study|Lack of Efficacy|0
115802|NCT00632229|396004|P2|Overall Study|Lost to Follow-up|3
115803|NCT00632229|396005|P1|Overall Study|Lost to Follow-up|0
115804|NCT00632229|396004|P2|Overall Study|Adverse Event|0
115805|NCT00632229|396005|P1|Overall Study|Adverse Event|6
115806|NCT00632203|396015|P2|Overall Study|Did not start study treatment|0
115807|NCT00632203|396016|P1|Overall Study|Did not start study treatment|1
115808|NCT00632099|396036|P2|Overall Study|Lost to Follow-up|3
115809|NCT00632099|396037|P1|Overall Study|Lost to Follow-up|3
115810|NCT00631969|396045|P2|Overall Study|No Drug Exposure|2
115811|NCT00631969|396046|P1|Overall Study|No Drug Exposure|2
115812|NCT00631969|396045|P2|Overall Study|Noncompliant With Study Medication|1
115813|NCT00631969|396046|P1|Overall Study|Noncompliant With Study Medication|0
115814|NCT00631969|396045|P2|Overall Study|Consent Withdrawn|7
115815|NCT00631969|396046|P1|Overall Study|Consent Withdrawn|5
115816|NCT00631969|396045|P2|Overall Study|Protocol Violation|1
115817|NCT00631969|396046|P1|Overall Study|Protocol Violation|1
115818|NCT00631969|396045|P2|Overall Study|Lost to Follow-up|1
115819|NCT00631969|396046|P1|Overall Study|Lost to Follow-up|2
115820|NCT00631969|396045|P2|Overall Study|Lack of Efficacy|8
115821|NCT00631969|396046|P1|Overall Study|Lack of Efficacy|2
115822|NCT00631969|396045|P2|Overall Study|Adverse Event|1
115823|NCT00631969|396046|P1|Overall Study|Adverse Event|3
115824|NCT00631917|396092|P2|Overall Study|Death|0
115825|NCT00631917|396093|P1|Overall Study|Death|1
115826|NCT00631917|396092|P2|Overall Study|Administrative problems|0
115827|NCT00631917|396093|P1|Overall Study|Administrative problems|2
115828|NCT00631917|396092|P2|Overall Study|Lost to Follow-up|7
115829|NCT00631917|396093|P1|Overall Study|Lost to Follow-up|7
115830|NCT00631917|396092|P2|Overall Study|Subject withdrew consent|33
115831|NCT00631917|396093|P1|Overall Study|Subject withdrew consent|25
115832|NCT00631917|396092|P2|Overall Study|Protocol deviation|5
115833|NCT00631917|396093|P1|Overall Study|Protocol deviation|6
115834|NCT00631917|396092|P2|Overall Study|No longer required study drug|1
115835|NCT00631917|396093|P1|Overall Study|No longer required study drug|0
115836|NCT00631917|396092|P2|Overall Study|Unsatisfactory therapeutic effect|14
115837|NCT00631917|396093|P1|Overall Study|Unsatisfactory therapeutic effect|8
115838|NCT00631917|396092|P2|Overall Study|Abnormal test procedure result(s)|2
115839|NCT00631917|396093|P1|Overall Study|Abnormal test procedure result(s)|3
115840|NCT00631917|396092|P2|Overall Study|Abnormal laboratory value(s)|1
115841|NCT00631917|396093|P1|Overall Study|Abnormal laboratory value(s)|2
115842|NCT00631917|396092|P2|Overall Study|Adverse Event|45
115843|NCT00631917|396093|P1|Overall Study|Adverse Event|34
115844|NCT00631696|396120|P2|Overall Study|Adverse Event|0
115845|NCT00631696|396121|P1|Overall Study|Adverse Event|5
115846|NCT00631696|396120|P2|Overall Study|Study terminated by sponsor|3
115847|NCT00631696|396121|P1|Overall Study|Study terminated by sponsor|3
115848|NCT00631696|396120|P2|Overall Study|Protocol Violation|9
115849|NCT00631696|396121|P1|Overall Study|Protocol Violation|9
115850|NCT00631696|396120|P2|Overall Study|Unspecified|8
115851|NCT00631696|396121|P1|Overall Study|Unspecified|8
115852|NCT00631696|396120|P2|Overall Study|Withdrawal by Subject|9
115853|NCT00631696|396121|P1|Overall Study|Withdrawal by Subject|2
115854|NCT00631696|396120|P2|Overall Study|Lost to Follow-up|10
115855|NCT00631696|396121|P1|Overall Study|Lost to Follow-up|7
115856|NCT00631696|396120|P2|Overall Study|Follow up after database release date|0
115857|NCT00631696|396121|P1|Overall Study|Follow up after database release date|1
115858|NCT00631696|396120|P2|Overall Study|Discontinued after database release date|0
115859|NCT00631696|396121|P1|Overall Study|Discontinued after database release date|1
115860|NCT00631696|396120|P2|Overall Study|Entered, not randomized to treatment|1
115861|NCT00631696|396121|P1|Overall Study|Entered, not randomized to treatment|1
115862|NCT00631657|396164|P3|7-Day Discontinuation Period|Unspecified|0
115863|NCT00631657|396165|P2|7-Day Discontinuation Period|Unspecified|0
115864|NCT00631657|396166|P1|7-Day Discontinuation Period|Unspecified|1
115865|NCT00631657|396164|P3|7-Day Discontinuation Period|Not Treated|1
115866|NCT00631657|396165|P2|7-Day Discontinuation Period|Not Treated|1
115867|NCT00631657|396166|P1|7-Day Discontinuation Period|Not Treated|1
115868|NCT00631657|396164|P3|6-Month Treatment Period|Not Treated|1
115869|NCT00631657|396165|P2|6-Month Treatment Period|Not Treated|0
115870|NCT00631657|396166|P1|6-Month Treatment Period|Not Treated|2
115871|NCT00631657|396164|P3|6-Month Treatment Period|Unspecified|4
115872|NCT00631657|396165|P2|6-Month Treatment Period|Unspecified|0
115873|NCT00631657|396166|P1|6-Month Treatment Period|Unspecified|16
115874|NCT00631657|396164|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
115875|NCT00631657|396165|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
115876|NCT00631657|396166|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
115877|NCT00631657|396164|P3|6-Month Treatment Period|Lost to Follow-up|2
115878|NCT00631657|396165|P2|6-Month Treatment Period|Lost to Follow-up|0
115879|NCT00631657|396166|P1|6-Month Treatment Period|Lost to Follow-up|7
115880|NCT00631657|396164|P3|6-Month Treatment Period|Lack of Efficacy|25
115881|NCT00631657|396165|P2|6-Month Treatment Period|Lack of Efficacy|0
115882|NCT00631657|396166|P1|6-Month Treatment Period|Lack of Efficacy|34
115883|NCT00631657|396164|P3|6-Month Treatment Period|Withdrawal by Subject|5
115884|NCT00631657|396165|P2|6-Month Treatment Period|Withdrawal by Subject|0
115885|NCT00631657|396166|P1|6-Month Treatment Period|Withdrawal by Subject|14
115886|NCT00631657|396164|P3|6-Month Treatment Period|Adverse Event|7
115887|NCT00631657|396165|P2|6-Month Treatment Period|Adverse Event|0
115888|NCT00631657|396166|P1|6-Month Treatment Period|Adverse Event|47
115889|NCT00631540|396193|P1|Overall Study|Core Lab Data Unavailable|3
115890|NCT00631540|396193|P1|Overall Study|Lost to Follow-up|2
115891|NCT00631540|396193|P1|Overall Study|Death|4
115892|NCT00631540|396193|P1|Overall Study|Withdrawal by Subject|5
115893|NCT00631488|396205|P3|Overall Study|Protocol Violation|1
115894|NCT00631488|396206|P2|Overall Study|Protocol Violation|0
115895|NCT00631488|396207|P1|Overall Study|Protocol Violation|0
115896|NCT00631488|396205|P3|Overall Study|Physician Decision|1
115897|NCT00631488|396206|P2|Overall Study|Physician Decision|0
115898|NCT00631488|396207|P1|Overall Study|Physician Decision|1
115899|NCT00631488|396205|P3|Overall Study|Lost to Follow-up|0
115900|NCT00631488|396206|P2|Overall Study|Lost to Follow-up|2
115901|NCT00631488|396207|P1|Overall Study|Lost to Follow-up|2
115902|NCT00631488|396205|P3|Overall Study|Adverse Event|0
115903|NCT00631488|396206|P2|Overall Study|Adverse Event|0
115904|NCT00631488|396207|P1|Overall Study|Adverse Event|1
115905|NCT00631475|396227|P1|Overall Study|Preparation for lung transplant|8
115906|NCT00631475|396227|P1|Overall Study|Withdrew consent|5
115907|NCT00631475|396227|P1|Overall Study|Adverse Event|14
115908|NCT00631475|396227|P1|Overall Study|Death|18
115909|NCT00631410|396246|P2|Overall Study|Surgery|0
115910|NCT00631410|396247|P1|Overall Study|Surgery|1
115911|NCT00631410|396246|P2|Overall Study|Objective Progression or Relapse|3
115912|NCT00631410|396247|P1|Overall Study|Objective Progression or Relapse|4
115913|NCT00631410|396246|P2|Overall Study|Adverse Event|3
115914|NCT00631410|396247|P1|Overall Study|Adverse Event|1
115915|NCT00631371|396266|P2|Overall Study|Death|239
115916|NCT00631371|396267|P1|Overall Study|Death|263
115917|NCT00631371|396266|P2|Overall Study|Discontinuation of study by Sponsor|76
115918|NCT00631371|396267|P1|Overall Study|Discontinuation of study by Sponsor|70
115919|NCT00631371|396266|P2|Overall Study|subject request|45
115920|NCT00631371|396267|P1|Overall Study|subject request|38
115921|NCT00631371|396266|P2|Overall Study|Other reason|12
115922|NCT00631371|396267|P1|Overall Study|Other reason|5
115923|NCT00631371|396266|P2|Overall Study|Lost to Follow-up|19
115924|NCT00631371|396267|P1|Overall Study|Lost to Follow-up|24
115925|NCT00631189|396300|P4|Treatment Phase|patient did not take pravastatin|0
115926|NCT00631189|396301|P3|Treatment Phase|patient did not take pravastatin|1
115927|NCT00631189|396302|P2|Treatment Phase|patient did not take pravastatin|0
115928|NCT00631189|396303|P1|Treatment Phase|patient did not take pravastatin|0
115929|NCT00631189|396300|P4|Treatment Phase|Pregnancy|0
115930|NCT00631189|396301|P3|Treatment Phase|Pregnancy|1
115931|NCT00631189|396302|P2|Treatment Phase|Pregnancy|0
115932|NCT00631189|396303|P1|Treatment Phase|Pregnancy|0
115933|NCT00631189|396300|P4|Treatment Phase|Lost to Follow-up|0
115934|NCT00631189|396301|P3|Treatment Phase|Lost to Follow-up|0
115935|NCT00631189|396302|P2|Treatment Phase|Lost to Follow-up|1
115936|NCT00631189|396303|P1|Treatment Phase|Lost to Follow-up|0
115937|NCT00631189|396300|P4|Treatment Phase|Adverse Event|4
115938|NCT00631189|396301|P3|Treatment Phase|Adverse Event|2
115939|NCT00631189|396302|P2|Treatment Phase|Adverse Event|3
115940|NCT00631189|396303|P1|Treatment Phase|Adverse Event|0
115941|NCT00631189|396300|P4|Treatment Phase|Protocol Violation|2
115942|NCT00631189|396301|P3|Treatment Phase|Protocol Violation|6
115943|NCT00631189|396302|P2|Treatment Phase|Protocol Violation|1
115944|NCT00631189|396303|P1|Treatment Phase|Protocol Violation|0
115945|NCT00631189|396300|P4|Treatment Phase|Withdrawal by Subject|1
115946|NCT00631189|396301|P3|Treatment Phase|Withdrawal by Subject|1
115947|NCT00631189|396302|P2|Treatment Phase|Withdrawal by Subject|2
115948|NCT00631189|396303|P1|Treatment Phase|Withdrawal by Subject|0
115949|NCT00631189|396300|P4|Initial Phase|Withdrawal by Subject|0
115950|NCT00631189|396301|P3|Initial Phase|Withdrawal by Subject|0
115951|NCT00631189|396302|P2|Initial Phase|Withdrawal by Subject|0
115952|NCT00631189|396303|P1|Initial Phase|Withdrawal by Subject|4
115953|NCT00631189|396300|P4|Initial Phase|Protocol Violation|0
115954|NCT00631189|396301|P3|Initial Phase|Protocol Violation|0
115955|NCT00631189|396302|P2|Initial Phase|Protocol Violation|0
115956|NCT00631189|396303|P1|Initial Phase|Protocol Violation|347
115957|NCT00631020|396345|P1|Overall Study|Incarcerated|1
115958|NCT00631020|396345|P1|Overall Study|Lost to Follow-up|7
115959|NCT00631007|396360|P6|Overall Study|Other|0
115960|NCT00631007|396361|P5|Overall Study|Other|1
115961|NCT00631007|396362|P4|Overall Study|Other|0
115962|NCT00631007|396363|P3|Overall Study|Other|0
115963|NCT00631007|396364|P2|Overall Study|Other|1
115964|NCT00631007|396365|P1|Overall Study|Other|2
115965|NCT00631007|396360|P6|Overall Study|Withdrawal by Subject|3
115966|NCT00631007|396361|P5|Overall Study|Withdrawal by Subject|1
115967|NCT00631007|396362|P4|Overall Study|Withdrawal by Subject|2
115968|NCT00631007|396363|P3|Overall Study|Withdrawal by Subject|2
115969|NCT00631007|396364|P2|Overall Study|Withdrawal by Subject|5
115970|NCT00631007|396365|P1|Overall Study|Withdrawal by Subject|4
115971|NCT00631007|396360|P6|Overall Study|Persistent Hyperglycemia|5
115972|NCT00631007|396361|P5|Overall Study|Persistent Hyperglycemia|2
115973|NCT00631007|396362|P4|Overall Study|Persistent Hyperglycemia|1
115974|NCT00631007|396363|P3|Overall Study|Persistent Hyperglycemia|5
115975|NCT00631007|396364|P2|Overall Study|Persistent Hyperglycemia|2
115976|NCT00631007|396365|P1|Overall Study|Persistent Hyperglycemia|2
115977|NCT00631007|396360|P6|Overall Study|Physician Decision|2
115978|NCT00631007|396361|P5|Overall Study|Physician Decision|0
115979|NCT00631007|396362|P4|Overall Study|Physician Decision|0
115980|NCT00631007|396363|P3|Overall Study|Physician Decision|1
115981|NCT00631007|396364|P2|Overall Study|Physician Decision|0
115982|NCT00631007|396365|P1|Overall Study|Physician Decision|1
115983|NCT00631007|396360|P6|Overall Study|Lost to Follow-up|3
115984|NCT00631007|396361|P5|Overall Study|Lost to Follow-up|5
115985|NCT00631007|396362|P4|Overall Study|Lost to Follow-up|4
115986|NCT00631007|396363|P3|Overall Study|Lost to Follow-up|2
115987|NCT00631007|396364|P2|Overall Study|Lost to Follow-up|1
115988|NCT00631007|396365|P1|Overall Study|Lost to Follow-up|2
115989|NCT00631007|396360|P6|Overall Study|Adverse Event|2
115990|NCT00631007|396361|P5|Overall Study|Adverse Event|3
115991|NCT00631007|396362|P4|Overall Study|Adverse Event|2
115992|NCT00631007|396363|P3|Overall Study|Adverse Event|0
115993|NCT00631007|396364|P2|Overall Study|Adverse Event|2
115994|NCT00631007|396365|P1|Overall Study|Adverse Event|0
115995|NCT00630994|396385|P1|Overall Study|Other|1
115996|NCT00630994|396385|P1|Overall Study|Lack of Efficacy|1
115997|NCT00630994|396385|P1|Overall Study|Disease Progression|1
115998|NCT00630994|396385|P1|Overall Study|Adverse Event|1
115999|NCT00630916|396409|P1|Overall Study|Lack of Efficacy|3
116000|NCT00630916|396409|P1|Overall Study|Physician Decision|47
116001|NCT00630916|396409|P1|Overall Study|Protocol Violation|7
116002|NCT00630916|396409|P1|Overall Study|Withdrawal by Subject|30
116003|NCT00630916|396409|P1|Overall Study|Lost to Follow-up|5
116004|NCT00630916|396409|P1|Overall Study|Explant|8
116005|NCT00630916|396409|P1|Overall Study|Death|110
116006|NCT00630877|396419|P3|Overall Study|Personal reasons|1
116007|NCT00630877|396420|P2|Overall Study|Personal reasons|0
116008|NCT00630877|396421|P1|Overall Study|Personal reasons|0
116009|NCT00630877|396419|P3|Overall Study|Protocol violation|1
116010|NCT00630877|396420|P2|Overall Study|Protocol violation|0
116011|NCT00630877|396421|P1|Overall Study|Protocol violation|1
116012|NCT00630877|396419|P3|Overall Study|Noncompliance|1
116013|NCT00630877|396420|P2|Overall Study|Noncompliance|3
116014|NCT00630877|396421|P1|Overall Study|Noncompliance|2
116015|NCT00630877|396419|P3|Overall Study|Lost to Follow-up|0
116016|NCT00630877|396420|P2|Overall Study|Lost to Follow-up|0
116017|NCT00630877|396421|P1|Overall Study|Lost to Follow-up|2
116018|NCT00630877|396419|P3|Overall Study|Withdrawal by Subject|0
116019|NCT00630877|396420|P2|Overall Study|Withdrawal by Subject|4
116020|NCT00630877|396421|P1|Overall Study|Withdrawal by Subject|3
116021|NCT00630877|396419|P3|Overall Study|Adverse Event|7
116022|NCT00630877|396420|P2|Overall Study|Adverse Event|8
116023|NCT00630877|396421|P1|Overall Study|Adverse Event|11
116024|NCT00630864|396439|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
116025|NCT00630864|396439|P1|Part 1 (up to Week 6)|Adverse Event|1
116026|NCT00630838|396478|P2|Overall Study|Lost to Follow-up|1
116027|NCT00630838|396479|P1|Overall Study|Lost to Follow-up|0
116028|NCT00630838|396478|P2|Overall Study|Death|1
116029|NCT00630838|396479|P1|Overall Study|Death|0
116030|NCT00630825|396491|P4|Overall Study|Withdrawal by Subject|3
116031|NCT00630825|396492|P3|Overall Study|Withdrawal by Subject|2
116032|NCT00630825|396493|P2|Overall Study|Withdrawal by Subject|2
116033|NCT00630825|396494|P1|Overall Study|Withdrawal by Subject|2
116034|NCT00630825|396491|P4|Overall Study|Physician Decision|0
116035|NCT00630825|396492|P3|Overall Study|Physician Decision|0
116036|NCT00630825|396493|P2|Overall Study|Physician Decision|0
116037|NCT00630825|396494|P1|Overall Study|Physician Decision|1
116038|NCT00630825|396491|P4|Overall Study|Lost to Follow-up|1
116039|NCT00630825|396492|P3|Overall Study|Lost to Follow-up|1
116040|NCT00630825|396493|P2|Overall Study|Lost to Follow-up|1
116041|NCT00630825|396494|P1|Overall Study|Lost to Follow-up|1
116042|NCT00630825|396491|P4|Overall Study|Entry Criteria Not Met|1
116043|NCT00630825|396492|P3|Overall Study|Entry Criteria Not Met|2
116044|NCT00630825|396493|P2|Overall Study|Entry Criteria Not Met|0
116045|NCT00630825|396494|P1|Overall Study|Entry Criteria Not Met|1
116046|NCT00630825|396491|P4|Overall Study|Adverse Event|1
116047|NCT00630825|396492|P3|Overall Study|Adverse Event|3
116048|NCT00630825|396493|P2|Overall Study|Adverse Event|4
116049|NCT00630825|396494|P1|Overall Study|Adverse Event|4
116050|NCT00630786|396566|P3|Overall Study|Not specified|0
116051|NCT00630786|396567|P2|Overall Study|Not specified|0
116052|NCT00630786|396568|P1|Overall Study|Not specified|1
116053|NCT00630786|396566|P3|Overall Study|Lost to Follow-up|0
116054|NCT00630786|396567|P2|Overall Study|Lost to Follow-up|1
116055|NCT00630786|396568|P1|Overall Study|Lost to Follow-up|0
116056|NCT00630786|396566|P3|Overall Study|Withdrawal by Subject|1
116057|NCT00630786|396567|P2|Overall Study|Withdrawal by Subject|1
116058|NCT00630786|396568|P1|Overall Study|Withdrawal by Subject|0
116059|NCT00630786|396566|P3|Overall Study|Physician Decision|1
116060|NCT00630786|396567|P2|Overall Study|Physician Decision|0
116061|NCT00630786|396568|P1|Overall Study|Physician Decision|0
116062|NCT00630747|396587|P1|Overall Study|Returned to country of origin|1
116063|NCT00630747|396587|P1|Overall Study|Transferred to Study TKT031NPU|7
116064|NCT00630747|396587|P1|Overall Study|Death|1
116065|NCT00630539|396640|P4|Overall Study|Withdrawal by Subject|1
116066|NCT00630539|396641|P3|Overall Study|Withdrawal by Subject|0
116067|NCT00630539|396642|P2|Overall Study|Withdrawal by Subject|1
116068|NCT00630539|396643|P1|Overall Study|Withdrawal by Subject|0
116069|NCT00630539|396640|P4|Overall Study|Adverse Event|2
116070|NCT00630539|396641|P3|Overall Study|Adverse Event|1
116071|NCT00630539|396642|P2|Overall Study|Adverse Event|3
116072|NCT00630539|396643|P1|Overall Study|Adverse Event|1
116073|NCT00630396|396734|P1|Overall Study|Lost to Follow-up|3
116074|NCT00630396|396734|P1|Overall Study|Death|4
116075|NCT00630331|396747|P3|Overall Study|Protocol Violation|6
116076|NCT00630331|396748|P2|Overall Study|Protocol Violation|5
116077|NCT00630331|396749|P1|Overall Study|Protocol Violation|4
116078|NCT00630331|396747|P3|Overall Study|Unable to classify|3
116079|NCT00630331|396748|P2|Overall Study|Unable to classify|4
116080|NCT00630331|396749|P1|Overall Study|Unable to classify|9
116081|NCT00630331|396747|P3|Overall Study|Inappropriate enrollment|3
116082|NCT00630331|396748|P2|Overall Study|Inappropriate enrollment|6
116083|NCT00630331|396749|P1|Overall Study|Inappropriate enrollment|3
116084|NCT00630331|396747|P3|Overall Study|Lost to Follow-up|170
116085|NCT00630331|396748|P2|Overall Study|Lost to Follow-up|143
116086|NCT00630331|396749|P1|Overall Study|Lost to Follow-up|175
116087|NCT00630331|396747|P3|Overall Study|Withdrawal by Subject|5
116088|NCT00630331|396748|P2|Overall Study|Withdrawal by Subject|7
116089|NCT00630331|396749|P1|Overall Study|Withdrawal by Subject|12
116090|NCT00630331|396747|P3|Overall Study|Adverse Event|0
116091|NCT00630331|396748|P2|Overall Study|Adverse Event|0
116092|NCT00630331|396749|P1|Overall Study|Adverse Event|1
116093|NCT00630331|396747|P3|Overall Study|Death|1
116094|NCT00630331|396748|P2|Overall Study|Death|1
116095|NCT00630331|396749|P1|Overall Study|Death|2
116096|NCT00630292|396790|P1|Overall Study|Withdrawal by Subject|1
116097|NCT00630058|396796|P2|Overall Study|stopping criteria|2
116098|NCT00630058|396797|P1|Overall Study|stopping criteria|3
116099|NCT00630058|396796|P2|Overall Study|Withdrawal by Subject|1
116100|NCT00630058|396797|P1|Overall Study|Withdrawal by Subject|0
116101|NCT00630058|396796|P2|Overall Study|Adverse Event|1
116102|NCT00630058|396797|P1|Overall Study|Adverse Event|1
116103|NCT00629772|396828|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
116104|NCT00629772|396829|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
116105|NCT00629772|396828|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
116106|NCT00629772|396829|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
116107|NCT00629707|396849|P2|Overall Study|Physician Decision|1
116108|NCT00629707|396850|P1|Overall Study|Physician Decision|0
116109|NCT00629707|396849|P2|Overall Study|Withdrawal by Subject|1
116110|NCT00629707|396850|P1|Overall Study|Withdrawal by Subject|0
116111|NCT00629265|396870|P2|Overall Study|Unknown Reason|2
116112|NCT00629265|396871|P1|Overall Study|Unknown Reason|2
116113|NCT00629265|396870|P2|Overall Study|Unrelated Medical Complications|1
116114|NCT00629265|396871|P1|Overall Study|Unrelated Medical Complications|3
116115|NCT00629265|396870|P2|Overall Study|Needed Esophageal Dilation|1
116116|NCT00629265|396871|P1|Overall Study|Needed Esophageal Dilation|4
116117|NCT00629265|396870|P2|Overall Study|Other CA Requiring Treatment|3
116118|NCT00629265|396871|P1|Overall Study|Other CA Requiring Treatment|1
116119|NCT00629265|396870|P2|Overall Study|HNC Recurrence|0
116120|NCT00629265|396871|P1|Overall Study|HNC Recurrence|4
116121|NCT00629265|396870|P2|Overall Study|Adverse Event|0
116122|NCT00629265|396871|P1|Overall Study|Adverse Event|2
116123|NCT00629265|396870|P2|Overall Study|Death|0
116124|NCT00629265|396871|P1|Overall Study|Death|1
116125|NCT00629265|396870|P2|Overall Study|Withdrawal by Subject|8
116126|NCT00629265|396871|P1|Overall Study|Withdrawal by Subject|11
116127|NCT00629265|396870|P2|Overall Study|Lost to Follow-up|5
116128|NCT00629265|396871|P1|Overall Study|Lost to Follow-up|4
116129|NCT00629239|396881|P2|Overall Study|Physician Decision|0
116130|NCT00629239|396882|P1|Overall Study|Physician Decision|1
116131|NCT00629239|396881|P2|Overall Study|Adverse Event|4
116132|NCT00629239|396882|P1|Overall Study|Adverse Event|7
116133|NCT00628927|396927|P2|Overall Study|Equipment failure|0
116134|NCT00628927|396928|P1|Overall Study|Equipment failure|1
116135|NCT00628927|396927|P2|Overall Study|Lost to Follow-up|0
116136|NCT00628927|396928|P1|Overall Study|Lost to Follow-up|1
116137|NCT00628927|396927|P2|Overall Study|Problems performing blood draw|0
116138|NCT00628927|396928|P1|Overall Study|Problems performing blood draw|6
116139|NCT00628862|396973|P3|Overall Study|COPD Exacerbation|0
116140|NCT00628862|396974|P2|Overall Study|COPD Exacerbation|1
116141|NCT00628862|396975|P1|Overall Study|COPD Exacerbation|0
116142|NCT00628862|396973|P3|Overall Study|Protocol Violation|0
116143|NCT00628862|396974|P2|Overall Study|Protocol Violation|0
116144|NCT00628862|396975|P1|Overall Study|Protocol Violation|1
116145|NCT00628862|396973|P3|Overall Study|Lost to Follow-up|1
116146|NCT00628862|396974|P2|Overall Study|Lost to Follow-up|2
116147|NCT00628862|396975|P1|Overall Study|Lost to Follow-up|0
116148|NCT00628862|396973|P3|Overall Study|Withdrawal by Subject|11
116149|NCT00628862|396974|P2|Overall Study|Withdrawal by Subject|6
116150|NCT00628862|396975|P1|Overall Study|Withdrawal by Subject|4
116151|NCT00628862|396973|P3|Overall Study|Adverse Event|10
116152|NCT00628862|396974|P2|Overall Study|Adverse Event|8
116153|NCT00628862|396975|P1|Overall Study|Adverse Event|6
116154|NCT00628758|397021|P2|Overall Study|Treatment Failure|2
116155|NCT00628758|397022|P1|Overall Study|Treatment Failure|0
116156|NCT00628758|397021|P2|Overall Study|Investigator Moved|0
116157|NCT00628758|397022|P1|Overall Study|Investigator Moved|3
116158|NCT00628758|397021|P2|Overall Study|Pregnancy|2
116159|NCT00628758|397022|P1|Overall Study|Pregnancy|2
116160|NCT00628758|397021|P2|Overall Study|Lost to Follow-up|31
116161|NCT00628758|397022|P1|Overall Study|Lost to Follow-up|25
116162|NCT00628758|397021|P2|Overall Study|Protocol Violation|1
116163|NCT00628758|397022|P1|Overall Study|Protocol Violation|5
116164|NCT00628758|397021|P2|Overall Study|Death|0
116165|NCT00628758|397022|P1|Overall Study|Death|1
116166|NCT00628758|397021|P2|Overall Study|Withdrawal by Subject|3
116167|NCT00628758|397022|P1|Overall Study|Withdrawal by Subject|6
116168|NCT00628758|397021|P2|Overall Study|Adverse Event|3
116169|NCT00628758|397022|P1|Overall Study|Adverse Event|2
116170|NCT00628446|397043|P1|Overall Study|Protocol Violation|3
116171|NCT00628446|397043|P1|Overall Study|Withdrawal by Subject|1
116172|NCT00628446|397043|P1|Overall Study|Lost to Follow-up|3
116173|NCT00628355|397054|P2|Overall Study|Withdrawal by Subject|1
116174|NCT00628355|397055|P1|Overall Study|Withdrawal by Subject|1
116175|NCT00628251|397066|P3|Cross-over/ Continuation of Olaparib|Other|0
116176|NCT00628251|397067|P2|Cross-over/ Continuation of Olaparib|Other|1
116177|NCT00628251|397068|P1|Cross-over/ Continuation of Olaparib|Other|1
116178|NCT00628251|397066|P3|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|4
116179|NCT00628251|397067|P2|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|2
116180|NCT00628251|397068|P1|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|1
116181|NCT00628251|397066|P3|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|13
116182|NCT00628251|397067|P2|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|21
116183|NCT00628251|397068|P1|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|24
116184|NCT00628251|397066|P3|Cross-over/ Continuation of Olaparib|Adverse Event|0
116185|NCT00628251|397067|P2|Cross-over/ Continuation of Olaparib|Adverse Event|2
116186|NCT00628251|397068|P1|Cross-over/ Continuation of Olaparib|Adverse Event|1
116187|NCT00628251|397066|P3|Randomised Part|Did not receive cross over treatment|8
116188|NCT00628251|397067|P2|Randomised Part|Did not receive cross over treatment|0
116189|NCT00628251|397068|P1|Randomised Part|Did not receive cross over treatment|0
116190|NCT00628212|397111|P4|Overall Study|Physician Decision|3
116191|NCT00628212|397112|P3|Overall Study|Physician Decision|2
116192|NCT00628212|397113|P2|Overall Study|Physician Decision|1
116193|NCT00628212|397114|P1|Overall Study|Physician Decision|1
116194|NCT00628212|397111|P4|Overall Study|Adverse Event|2
116195|NCT00628212|397112|P3|Overall Study|Adverse Event|1
116196|NCT00628212|397113|P2|Overall Study|Adverse Event|0
116197|NCT00628212|397114|P1|Overall Study|Adverse Event|2
116198|NCT00628108|397147|P2|Overall Study|Withdrawal by Subject|0
116199|NCT00628108|397148|P1|Overall Study|Withdrawal by Subject|1
116200|NCT00628108|397147|P2|Overall Study|Adverse Event|3
116201|NCT00628108|397148|P1|Overall Study|Adverse Event|0
116202|NCT00628030|397180|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
116203|NCT00628030|397181|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
116204|NCT00628030|397180|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
116205|NCT00628030|397181|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
116206|NCT00628030|397180|P2|Baseline to Post-Assessment|Lost to Follow-up|29
116207|NCT00628030|397181|P1|Baseline to Post-Assessment|Lost to Follow-up|28
116208|NCT00627926|397198|P3|Overall Study|Noncompliance/unspecified|17
116209|NCT00627926|397199|P2|Overall Study|Noncompliance/unspecified|23
116210|NCT00627926|397200|P1|Overall Study|Noncompliance/unspecified|8
116211|NCT00627926|397198|P3|Overall Study|Lack of Efficacy|38
116212|NCT00627926|397199|P2|Overall Study|Lack of Efficacy|40
116213|NCT00627926|397200|P1|Overall Study|Lack of Efficacy|118
116214|NCT00627926|397198|P3|Overall Study|Withdrawal by Subject|0
116215|NCT00627926|397199|P2|Overall Study|Withdrawal by Subject|1
116216|NCT00627926|397200|P1|Overall Study|Withdrawal by Subject|2
116217|NCT00627926|397198|P3|Overall Study|Lost to Follow-up|4
116218|NCT00627926|397199|P2|Overall Study|Lost to Follow-up|3
116219|NCT00627926|397200|P1|Overall Study|Lost to Follow-up|4
116220|NCT00627926|397198|P3|Overall Study|Death|0
116221|NCT00627926|397199|P2|Overall Study|Death|0
116222|NCT00627926|397200|P1|Overall Study|Death|1
116223|NCT00627926|397198|P3|Overall Study|Adverse Event|36
116224|NCT00627926|397199|P2|Overall Study|Adverse Event|37
116225|NCT00627926|397200|P1|Overall Study|Adverse Event|26
116226|NCT00627523|397281|P2|Overall Study|Not specified|0
116227|NCT00627523|397282|P1|Overall Study|Not specified|1
116228|NCT00627523|397281|P2|Overall Study|Withdrawal by Subject|2
116229|NCT00627523|397282|P1|Overall Study|Withdrawal by Subject|0
116230|NCT00627523|397281|P2|Overall Study|Lack of Efficacy|0
116231|NCT00627523|397282|P1|Overall Study|Lack of Efficacy|1
116232|NCT00627497|397310|P4|Overall Study|Lost to Follow-up|0
116233|NCT00627497|397311|P3|Overall Study|Lost to Follow-up|0
116234|NCT00627497|397312|P2|Overall Study|Lost to Follow-up|1
116235|NCT00627497|397313|P1|Overall Study|Lost to Follow-up|1
116236|NCT00627445|397373|P2|Overall Study|Other|8
116237|NCT00627445|397374|P1|Overall Study|Other|6
116238|NCT00627445|397373|P2|Overall Study|Lack of Efficacy|1
116239|NCT00627445|397374|P1|Overall Study|Lack of Efficacy|0
116240|NCT00627445|397373|P2|Overall Study|Adverse Event|3
116241|NCT00627445|397374|P1|Overall Study|Adverse Event|3
116242|NCT00627393|397417|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
116243|NCT00627393|397418|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
116244|NCT00627393|397417|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
116245|NCT00627393|397418|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
116246|NCT00627393|397417|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
116247|NCT00627393|397418|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
116248|NCT00627393|397417|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
116249|NCT00627393|397418|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
116250|NCT00627094|397439|P2|Overall Study|Other reason|0
116251|NCT00627094|397440|P1|Overall Study|Other reason|1
116252|NCT00627094|397439|P2|Overall Study|ulcer healed|7
116253|NCT00627094|397440|P1|Overall Study|ulcer healed|1
116254|NCT00627094|397439|P2|Overall Study|Withdrawal by Subject|1
116255|NCT00627094|397440|P1|Overall Study|Withdrawal by Subject|1
116256|NCT00627094|397439|P2|Overall Study|Lost to Follow-up|0
116257|NCT00627094|397440|P1|Overall Study|Lost to Follow-up|1
116258|NCT00627094|397439|P2|Overall Study|Adverse Event|7
116259|NCT00627094|397440|P1|Overall Study|Adverse Event|8
116260|NCT00627042|397452|P1|Overall Study|Withdrawal by Subject|2
116261|NCT00627016|397464|P2|Overall Study|Pregnancy|0
116262|NCT00627016|397465|P1|Overall Study|Pregnancy|1
116263|NCT00627016|397464|P2|Overall Study|Placed on Excluded Drugs|0
116264|NCT00627016|397465|P1|Overall Study|Placed on Excluded Drugs|1
116265|NCT00627016|397464|P2|Overall Study|Lack of Efficacy|0
116266|NCT00627016|397465|P1|Overall Study|Lack of Efficacy|1
116267|NCT00627016|397464|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
116268|NCT00627016|397465|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
116269|NCT00627016|397464|P2|Overall Study|Withdrawal by Subject|1
116270|NCT00627016|397465|P1|Overall Study|Withdrawal by Subject|2
116271|NCT00627016|397464|P2|Overall Study|Lost to Follow-up|1
116272|NCT00627016|397465|P1|Overall Study|Lost to Follow-up|0
116273|NCT00627016|397464|P2|Overall Study|Protocol Violation|2
116274|NCT00627016|397465|P1|Overall Study|Protocol Violation|0
116275|NCT00627016|397464|P2|Overall Study|Adverse Event|1
116276|NCT00627016|397465|P1|Overall Study|Adverse Event|1
116277|NCT00626925|397477|P2|Overall Study|Time constraints|1
116278|NCT00626925|397478|P1|Overall Study|Time constraints|3
116279|NCT00626925|397477|P2|Overall Study|Lack of Efficacy|4
116280|NCT00626925|397478|P1|Overall Study|Lack of Efficacy|1
116281|NCT00626925|397477|P2|Overall Study|Adverse effect|2
116282|NCT00626925|397478|P1|Overall Study|Adverse effect|6
116283|NCT00626925|397477|P2|Overall Study|relapse|0
116284|NCT00626925|397478|P1|Overall Study|relapse|1
116285|NCT00626925|397477|P2|Overall Study|Lost to Follow-up|2
116286|NCT00626925|397478|P1|Overall Study|Lost to Follow-up|1
116287|NCT00626821|397504|P1|Overall Study|other/unknown reason|104
116288|NCT00626821|397504|P1|Overall Study|Product dysfunction|21
116289|NCT00626821|397504|P1|Overall Study|Physician Decision|9
116290|NCT00626821|397504|P1|Overall Study|Withdrawal by Subject|10
116291|NCT00626821|397504|P1|Overall Study|Protocol Violation|33
116292|NCT00626821|397504|P1|Overall Study|Adverse Event|44
116293|NCT00626639|397603|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
116294|NCT00626639|397604|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
116295|NCT00626561|397629|P1|Overall Study|Disease Progression|2
116296|NCT00626561|397629|P1|Overall Study|Withdrawal by Subject|2
116297|NCT00626548|397635|P2|Overall Study|Other termination reason|613
116298|NCT00626548|397636|P1|Overall Study|Other termination reason|493
116299|NCT00626548|397635|P2|Overall Study|Lost to Follow-up|2
116300|NCT00626548|397636|P1|Overall Study|Lost to Follow-up|2
116301|NCT00626548|397635|P2|Overall Study|Protocol Violation|11
116302|NCT00626548|397636|P1|Overall Study|Protocol Violation|4
116303|NCT00626548|397635|P2|Overall Study|Withdrawal by Subject|46
116304|NCT00626548|397636|P1|Overall Study|Withdrawal by Subject|42
116305|NCT00626548|397635|P2|Overall Study|Adverse Event|44
116306|NCT00626548|397636|P1|Overall Study|Adverse Event|164
116307|NCT00626522|397650|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
116308|NCT00626522|397651|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
116309|NCT00626522|397652|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
116310|NCT00626522|397653|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
116311|NCT00626522|397654|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
116312|NCT00626522|397655|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
116313|NCT00626522|397650|P6|Overall Study|Inconsistent reason reported|0
116314|NCT00626522|397651|P5|Overall Study|Inconsistent reason reported|0
116315|NCT00626522|397652|P4|Overall Study|Inconsistent reason reported|0
116316|NCT00626522|397653|P3|Overall Study|Inconsistent reason reported|0
116317|NCT00626522|397654|P2|Overall Study|Inconsistent reason reported|0
116318|NCT00626522|397655|P1|Overall Study|Inconsistent reason reported|1
116319|NCT00626522|397650|P6|Overall Study|Lost to Follow-up|0
116320|NCT00626522|397651|P5|Overall Study|Lost to Follow-up|0
116321|NCT00626522|397652|P4|Overall Study|Lost to Follow-up|0
116322|NCT00626522|397653|P3|Overall Study|Lost to Follow-up|0
116323|NCT00626522|397654|P2|Overall Study|Lost to Follow-up|1
116324|NCT00626522|397655|P1|Overall Study|Lost to Follow-up|0
116325|NCT00626522|397650|P6|Overall Study|COPD exacerbation|0
116326|NCT00626522|397651|P5|Overall Study|COPD exacerbation|1
116327|NCT00626522|397652|P4|Overall Study|COPD exacerbation|1
116328|NCT00626522|397653|P3|Overall Study|COPD exacerbation|0
116329|NCT00626522|397654|P2|Overall Study|COPD exacerbation|0
116330|NCT00626522|397655|P1|Overall Study|COPD exacerbation|0
116331|NCT00626522|397650|P6|Overall Study|Withdrawal by Subject|1
116332|NCT00626522|397651|P5|Overall Study|Withdrawal by Subject|4
116333|NCT00626522|397652|P4|Overall Study|Withdrawal by Subject|0
116334|NCT00626522|397653|P3|Overall Study|Withdrawal by Subject|5
116335|NCT00626522|397654|P2|Overall Study|Withdrawal by Subject|5
116336|NCT00626522|397655|P1|Overall Study|Withdrawal by Subject|2
116337|NCT00626522|397650|P6|Overall Study|Adverse Event|1
116338|NCT00626522|397651|P5|Overall Study|Adverse Event|1
116339|NCT00626522|397652|P4|Overall Study|Adverse Event|0
116340|NCT00626522|397653|P3|Overall Study|Adverse Event|2
116341|NCT00626522|397654|P2|Overall Study|Adverse Event|1
116342|NCT00626522|397655|P1|Overall Study|Adverse Event|2
116343|NCT00626522|397650|P6|Overall Study|Protocol Violation|0
116344|NCT00626522|397651|P5|Overall Study|Protocol Violation|1
116345|NCT00626522|397652|P4|Overall Study|Protocol Violation|0
116346|NCT00626522|397653|P3|Overall Study|Protocol Violation|0
116347|NCT00626522|397654|P2|Overall Study|Protocol Violation|0
116348|NCT00626522|397655|P1|Overall Study|Protocol Violation|0
116349|NCT00626392|397722|P6|Coadministration Period|Other|1
116350|NCT00626392|397723|P5|Coadministration Period|Other|1
116351|NCT00626392|397724|P4|Coadministration Period|Other|1
116352|NCT00626392|397725|P3|Coadministration Period|Other|3
116353|NCT00626392|397726|P2|Coadministration Period|Other|2
116354|NCT00626392|397727|P1|Coadministration Period|Other|0
116355|NCT00626392|397722|P6|Coadministration Period|Protocol Violation|0
116356|NCT00626392|397723|P5|Coadministration Period|Protocol Violation|1
116357|NCT00626392|397724|P4|Coadministration Period|Protocol Violation|1
116358|NCT00626392|397725|P3|Coadministration Period|Protocol Violation|0
116359|NCT00626392|397726|P2|Coadministration Period|Protocol Violation|1
116360|NCT00626392|397727|P1|Coadministration Period|Protocol Violation|0
116361|NCT00626392|397722|P6|Coadministration Period|Withdrawal by Subject|1
116362|NCT00626392|397723|P5|Coadministration Period|Withdrawal by Subject|0
116363|NCT00626392|397724|P4|Coadministration Period|Withdrawal by Subject|1
116364|NCT00626392|397725|P3|Coadministration Period|Withdrawal by Subject|0
116365|NCT00626392|397726|P2|Coadministration Period|Withdrawal by Subject|1
116366|NCT00626392|397727|P1|Coadministration Period|Withdrawal by Subject|1
116367|NCT00626392|397722|P6|Coadministration Period|Adverse Event|4
116368|NCT00626392|397723|P5|Coadministration Period|Adverse Event|3
116369|NCT00626392|397724|P4|Coadministration Period|Adverse Event|4
116370|NCT00626392|397725|P3|Coadministration Period|Adverse Event|7
116371|NCT00626392|397726|P2|Coadministration Period|Adverse Event|1
116372|NCT00626392|397727|P1|Coadministration Period|Adverse Event|3
116373|NCT00626392|397722|P6|Run-in Period|Noncompliance|0
116374|NCT00626392|397723|P5|Run-in Period|Noncompliance|0
116375|NCT00626392|397724|P4|Run-in Period|Noncompliance|0
116376|NCT00626392|397725|P3|Run-in Period|Noncompliance|1
116377|NCT00626392|397726|P2|Run-in Period|Noncompliance|0
116378|NCT00626392|397727|P1|Run-in Period|Noncompliance|1
116379|NCT00626392|397722|P6|Run-in Period|Withdrawal by Subject|1
116380|NCT00626392|397723|P5|Run-in Period|Withdrawal by Subject|3
116381|NCT00626392|397724|P4|Run-in Period|Withdrawal by Subject|1
116382|NCT00626392|397725|P3|Run-in Period|Withdrawal by Subject|1
116383|NCT00626392|397726|P2|Run-in Period|Withdrawal by Subject|1
116384|NCT00626392|397727|P1|Run-in Period|Withdrawal by Subject|0
116385|NCT00626392|397722|P6|Run-in Period|Adverse Event|0
116386|NCT00626392|397723|P5|Run-in Period|Adverse Event|1
116387|NCT00626392|397724|P4|Run-in Period|Adverse Event|0
116388|NCT00626392|397725|P3|Run-in Period|Adverse Event|1
116389|NCT00626392|397726|P2|Run-in Period|Adverse Event|0
116390|NCT00626392|397727|P1|Run-in Period|Adverse Event|0
116391|NCT00626327|397742|P3|Overall Study|Protocol Violation|26
116392|NCT00626327|397743|P2|Overall Study|Protocol Violation|4
116393|NCT00626327|397744|P1|Overall Study|Protocol Violation|26
116394|NCT00626327|397742|P3|Overall Study|Administrative Reason|6
116395|NCT00626327|397743|P2|Overall Study|Administrative Reason|0
116396|NCT00626327|397744|P1|Overall Study|Administrative Reason|2
116397|NCT00626327|397742|P3|Overall Study|Inappropriate enrollment|3
116398|NCT00626327|397743|P2|Overall Study|Inappropriate enrollment|5
116399|NCT00626327|397744|P1|Overall Study|Inappropriate enrollment|4
116400|NCT00626327|397742|P3|Overall Study|Lost to Follow-up|23
116401|NCT00626327|397743|P2|Overall Study|Lost to Follow-up|21
116402|NCT00626327|397744|P1|Overall Study|Lost to Follow-up|24
116403|NCT00626327|397742|P3|Overall Study|Adverse Event|0
116404|NCT00626327|397743|P2|Overall Study|Adverse Event|0
116405|NCT00626327|397744|P1|Overall Study|Adverse Event|1
116406|NCT00626327|397742|P3|Overall Study|Withdrawal by Subject|30
116407|NCT00626327|397743|P2|Overall Study|Withdrawal by Subject|29
116408|NCT00626327|397744|P1|Overall Study|Withdrawal by Subject|21
116409|NCT00626275|397770|P8|Part B|Withdrawal by Subject|1
116410|NCT00626275|397771|P7|Part B|Withdrawal by Subject|0
116411|NCT00626275|397772|P6|Part B|Withdrawal by Subject|0
116412|NCT00626275|397773|P5|Part B|Withdrawal by Subject|0
116413|NCT00626275|397774|P4|Part B|Withdrawal by Subject|0
116414|NCT00626275|397775|P3|Part B|Withdrawal by Subject|0
116415|NCT00626275|397776|P2|Part B|Withdrawal by Subject|0
116416|NCT00626275|397777|P1|Part B|Withdrawal by Subject|0
116417|NCT00626275|397770|P8|Part B|Lost to Follow-up|0
116418|NCT00626275|397771|P7|Part B|Lost to Follow-up|1
116419|NCT00626275|397772|P6|Part B|Lost to Follow-up|0
116420|NCT00626275|397773|P5|Part B|Lost to Follow-up|0
116421|NCT00626275|397774|P4|Part B|Lost to Follow-up|0
116422|NCT00626275|397775|P3|Part B|Lost to Follow-up|0
116423|NCT00626275|397776|P2|Part B|Lost to Follow-up|0
116424|NCT00626275|397777|P1|Part B|Lost to Follow-up|0
116425|NCT00626275|397770|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
116426|NCT00626275|397771|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
116427|NCT00626275|397772|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
116428|NCT00626275|397773|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
116429|NCT00626275|397774|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
116430|NCT00626275|397775|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
116431|NCT00626275|397776|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
116432|NCT00626275|397777|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
116433|NCT00626275|397770|P8|Part A - Treatment Period 1|Adverse Event|0
116434|NCT00626275|397771|P7|Part A - Treatment Period 1|Adverse Event|0
116435|NCT00626275|397772|P6|Part A - Treatment Period 1|Adverse Event|0
116436|NCT00626275|397773|P5|Part A - Treatment Period 1|Adverse Event|0
116437|NCT00626275|397774|P4|Part A - Treatment Period 1|Adverse Event|0
116438|NCT00626275|397775|P3|Part A - Treatment Period 1|Adverse Event|0
116439|NCT00626275|397776|P2|Part A - Treatment Period 1|Adverse Event|0
116440|NCT00626275|397777|P1|Part A - Treatment Period 1|Adverse Event|1
116441|NCT00626093|397821|P1|Overall Study|One of the required devices not implante|6
116442|NCT00626093|397821|P1|Overall Study|Protocol Violation|1
116443|NCT00626093|397821|P1|Overall Study|Withdrawal by Subject|6
116444|NCT00626093|397821|P1|Overall Study|Physician Decision|4
116445|NCT00626093|397821|P1|Overall Study|Death|1
116446|NCT00626093|397821|P1|Overall Study|Lost to Follow-up|5
116447|NCT00626028|397828|P2|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|6
116448|NCT00626028|397829|P1|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|3
116449|NCT00626028|397828|P2|Treatment 1 NO First, O2 Last|Physician Decision|1
116450|NCT00626028|397829|P1|Treatment 1 NO First, O2 Last|Physician Decision|2
116451|NCT00626028|397828|P2|Treatment 1 NO First, O2 Last|Device Failure|1
116452|NCT00626028|397829|P1|Treatment 1 NO First, O2 Last|Device Failure|0
116453|NCT00626028|397828|P2|Treatment 1 NO First, O2 Last|Adverse Event|1
116454|NCT00626028|397829|P1|Treatment 1 NO First, O2 Last|Adverse Event|1
116455|NCT00625872|397849|P2|Overall Study|Randomized but not treated|1
116456|NCT00625872|397850|P1|Overall Study|Randomized but not treated|0
116457|NCT00625872|397849|P2|Overall Study|Terminated by sponsor|5
116458|NCT00625872|397850|P1|Overall Study|Terminated by sponsor|2
116459|NCT00625872|397849|P2|Overall Study|Does not meet inclusion criteria|0
116460|NCT00625872|397850|P1|Overall Study|Does not meet inclusion criteria|1
116461|NCT00625872|397849|P2|Overall Study|Withdrawal by Subject|0
116462|NCT00625872|397850|P1|Overall Study|Withdrawal by Subject|1
116463|NCT00625820|397960|P1|Overall Study|Withdrawal by Subject|1
116464|NCT00625742|397966|P1|Overall Study|Ineligible|1
116465|NCT00625742|397966|P1|Overall Study|Lost to Follow-up|4
116466|NCT00625742|397966|P1|Overall Study|Adverse Event|4
116467|NCT00625742|397966|P1|Overall Study|Withdrawal by Subject|1
116468|NCT00625742|397966|P1|Overall Study|Disease Progression|2
116469|NCT00625586|397980|P1|Overall Study|Adverse Event|1
116470|NCT00625365|398040|P1|Overall Study|VSD|1
116471|NCT00625365|398040|P1|Overall Study|No IV access|5
116472|NCT00625365|398040|P1|Overall Study|Withdrawal by Subject|1
116473|NCT00625183|398046|P1|Overall Study|Disease Progression|1
116474|NCT00625131|398055|P3|Overall Study|Withdrawal by Subject|5
116475|NCT00625131|398056|P2|Overall Study|Withdrawal by Subject|0
116476|NCT00625131|398057|P1|Overall Study|Withdrawal by Subject|1
116477|NCT00625131|398055|P3|Overall Study|Lost to Follow-up|0
116478|NCT00625131|398056|P2|Overall Study|Lost to Follow-up|2
116479|NCT00625131|398057|P1|Overall Study|Lost to Follow-up|3
116480|NCT00624832|398071|P4|Overall Study|Abnormal Laboratory Value|0
116481|NCT00624832|398072|P3|Overall Study|Abnormal Laboratory Value|0
116482|NCT00624832|398073|P2|Overall Study|Abnormal Laboratory Value|0
116483|NCT00624832|398074|P1|Overall Study|Abnormal Laboratory Value|2
116484|NCT00624832|398071|P4|Overall Study|Adverse Event|1
116485|NCT00624832|398072|P3|Overall Study|Adverse Event|0
116486|NCT00624832|398073|P2|Overall Study|Adverse Event|1
116487|NCT00624832|398074|P1|Overall Study|Adverse Event|0
116488|NCT00624780|398105|P6|Follow-up (Week 26)|Unspecified|0
116489|NCT00624780|398106|P5|Follow-up (Week 26)|Unspecified|0
116490|NCT00624780|398107|P4|Follow-up (Week 26)|Unspecified|0
116491|NCT00624780|398108|P3|Follow-up (Week 26)|Unspecified|0
116492|NCT00624780|398109|P2|Follow-up (Week 26)|Unspecified|1
116493|NCT00624780|398110|P1|Follow-up (Week 26)|Unspecified|1
116494|NCT00624780|398105|P6|Follow-up (Week 26)|Withdrawal by Subject|0
116495|NCT00624780|398106|P5|Follow-up (Week 26)|Withdrawal by Subject|0
116496|NCT00624780|398107|P4|Follow-up (Week 26)|Withdrawal by Subject|0
116497|NCT00624780|398108|P3|Follow-up (Week 26)|Withdrawal by Subject|0
116498|NCT00624780|398109|P2|Follow-up (Week 26)|Withdrawal by Subject|0
116499|NCT00624780|398110|P1|Follow-up (Week 26)|Withdrawal by Subject|1
116500|NCT00624780|398105|P6|Follow-up (Week 26)|Lost to Follow-up|0
116501|NCT00624780|398106|P5|Follow-up (Week 26)|Lost to Follow-up|1
116502|NCT00624780|398107|P4|Follow-up (Week 26)|Lost to Follow-up|0
116503|NCT00624780|398108|P3|Follow-up (Week 26)|Lost to Follow-up|1
116504|NCT00624780|398109|P2|Follow-up (Week 26)|Lost to Follow-up|0
116505|NCT00624780|398110|P1|Follow-up (Week 26)|Lost to Follow-up|0
116506|NCT00624780|398105|P6|Follow-up (Week 26)|Adverse Event|0
116507|NCT00624780|398106|P5|Follow-up (Week 26)|Adverse Event|1
116508|NCT00624780|398107|P4|Follow-up (Week 26)|Adverse Event|0
116509|NCT00624780|398108|P3|Follow-up (Week 26)|Adverse Event|0
116510|NCT00624780|398109|P2|Follow-up (Week 26)|Adverse Event|0
116511|NCT00624780|398110|P1|Follow-up (Week 26)|Adverse Event|0
116512|NCT00624780|398105|P6|Follow-up (Week 26)|Death|0
116513|NCT00624780|398106|P5|Follow-up (Week 26)|Death|0
116514|NCT00624780|398107|P4|Follow-up (Week 26)|Death|0
116515|NCT00624780|398108|P3|Follow-up (Week 26)|Death|1
116516|NCT00624780|398109|P2|Follow-up (Week 26)|Death|0
116517|NCT00624780|398110|P1|Follow-up (Week 26)|Death|0
116518|NCT00624780|398105|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
116519|NCT00624780|398106|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
116520|NCT00624780|398107|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
116521|NCT00624780|398108|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
116522|NCT00624780|398109|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
116523|NCT00624780|398110|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
116524|NCT00624780|398105|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
116525|NCT00624780|398106|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
116526|NCT00624780|398107|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
116527|NCT00624780|398108|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
116528|NCT00624780|398109|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
116529|NCT00624780|398110|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
116530|NCT00624780|398105|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
116531|NCT00624780|398106|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
116532|NCT00624780|398107|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
116533|NCT00624780|398108|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
116534|NCT00624780|398109|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
116535|NCT00624780|398110|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
116536|NCT00624780|398105|P6|Fixed Dosing (Week 13 to Week 24)|Unspecified|3
116537|NCT00624780|398106|P5|Fixed Dosing (Week 13 to Week 24)|Unspecified|4
116538|NCT00624780|398107|P4|Fixed Dosing (Week 13 to Week 24)|Unspecified|1
116539|NCT00624780|398108|P3|Fixed Dosing (Week 13 to Week 24)|Unspecified|4
116540|NCT00624780|398109|P2|Fixed Dosing (Week 13 to Week 24)|Unspecified|3
116541|NCT00624780|398110|P1|Fixed Dosing (Week 13 to Week 24)|Unspecified|5
116542|NCT00624780|398105|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
116543|NCT00624780|398106|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
116544|NCT00624780|398107|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
116545|NCT00624780|398108|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
116546|NCT00624780|398109|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
116547|NCT00624780|398110|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
116548|NCT00624780|398105|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
116549|NCT00624780|398106|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
116550|NCT00624780|398107|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
116551|NCT00624780|398108|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
116552|NCT00624780|398109|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
116553|NCT00624780|398110|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
116554|NCT00624780|398105|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
116555|NCT00624780|398106|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
116556|NCT00624780|398107|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
116557|NCT00624780|398108|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
116558|NCT00624780|398109|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
116559|NCT00624780|398110|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
116560|NCT00624780|398105|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
116561|NCT00624780|398106|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
116562|NCT00624780|398107|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
116563|NCT00624780|398108|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
116564|NCT00624780|398109|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
116565|NCT00624780|398110|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
116566|NCT00624780|398105|P6|Treatment Optimization (Up to Week 12)|Unspecified|0
116567|NCT00624780|398106|P5|Treatment Optimization (Up to Week 12)|Unspecified|9
116568|NCT00624780|398107|P4|Treatment Optimization (Up to Week 12)|Unspecified|2
116569|NCT00624780|398108|P3|Treatment Optimization (Up to Week 12)|Unspecified|8
116570|NCT00624780|398109|P2|Treatment Optimization (Up to Week 12)|Unspecified|4
116571|NCT00624780|398110|P1|Treatment Optimization (Up to Week 12)|Unspecified|10
116572|NCT00624780|398105|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
116573|NCT00624780|398106|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
116574|NCT00624780|398107|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
116575|NCT00624780|398108|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
116576|NCT00624780|398109|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
116577|NCT00624780|398110|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
116578|NCT00624780|398105|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
116579|NCT00624780|398106|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
116580|NCT00624780|398107|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
116581|NCT00624780|398108|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
116582|NCT00624780|398109|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
116583|NCT00624780|398110|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
116584|NCT00624780|398105|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
116585|NCT00624780|398106|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
116586|NCT00624780|398107|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
116587|NCT00624780|398108|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
116588|NCT00624780|398109|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
116589|NCT00624780|398110|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
116590|NCT00624780|398105|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
116591|NCT00624780|398106|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
116592|NCT00624780|398107|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
116593|NCT00624780|398108|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
116594|NCT00624780|398109|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
116595|NCT00624780|398110|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
116596|NCT00624585|398292|P1|Overall Study|Adverse Event|3
116597|NCT00624585|398292|P1|Overall Study|Disease Progression|6
116598|NCT00624585|398292|P1|Overall Study|Death|3
116599|NCT00624520|398322|P2|Overall Study|Death|1
116600|NCT00624520|398323|P1|Overall Study|Death|0
116601|NCT00624520|398322|P2|Overall Study|Withdrawal by Subject|7
116602|NCT00624520|398323|P1|Overall Study|Withdrawal by Subject|12
116603|NCT00624468|398350|P4|Safety Follow-up (SFU) Period|Unspecified|1
116604|NCT00624468|398351|P3|Safety Follow-up (SFU) Period|Unspecified|1
116605|NCT00624468|398352|P2|Safety Follow-up (SFU) Period|Unspecified|0
116606|NCT00624468|398353|P1|Safety Follow-up (SFU) Period|Unspecified|0
116607|NCT00624468|398350|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
116608|NCT00624468|398351|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
116609|NCT00624468|398352|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
116610|NCT00624468|398353|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
116611|NCT00624468|398350|P4|Double-blind Period|Withdrew Prematurely|0
116612|NCT00624468|398351|P3|Double-blind Period|Withdrew Prematurely|0
116613|NCT00624468|398352|P2|Double-blind Period|Withdrew Prematurely|1
116614|NCT00624468|398353|P1|Double-blind Period|Withdrew Prematurely|1
116615|NCT00624468|398350|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
116616|NCT00624468|398351|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
116617|NCT00624468|398352|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
116618|NCT00624468|398353|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
116619|NCT00624377|398420|P1|Overall Study|Non-evaluable population|84
116620|NCT00624377|398420|P1|Overall Study|Other|91
116621|NCT00624377|398420|P1|Overall Study|Adverse Event|14
116622|NCT00624377|398420|P1|Overall Study|Withdrawal by Subject|100
116623|NCT00624377|398420|P1|Overall Study|Lost to Follow-up|355
116624|NCT00624338|398434|P3|Overall Study|Randomized but not treated|3
116625|NCT00624338|398435|P2|Overall Study|Randomized but not treated|1
116626|NCT00624338|398436|P1|Overall Study|Randomized but not treated|2
116627|NCT00624338|398434|P3|Overall Study|Unspecified|9
116628|NCT00624338|398435|P2|Overall Study|Unspecified|5
116629|NCT00624338|398436|P1|Overall Study|Unspecified|15
116630|NCT00624338|398434|P3|Overall Study|Termination of 150 mg group by Sponsor|0
116631|NCT00624338|398435|P2|Overall Study|Termination of 150 mg group by Sponsor|55
116632|NCT00624338|398436|P1|Overall Study|Termination of 150 mg group by Sponsor|0
116633|NCT00624338|398434|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
116634|NCT00624338|398435|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
116635|NCT00624338|398436|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
116636|NCT00624338|398434|P3|Overall Study|Death|0
116637|NCT00624338|398435|P2|Overall Study|Death|2
116638|NCT00624338|398436|P1|Overall Study|Death|0
116639|NCT00624338|398434|P3|Overall Study|Protocol Violation|2
116640|NCT00624338|398435|P2|Overall Study|Protocol Violation|3
116641|NCT00624338|398436|P1|Overall Study|Protocol Violation|3
116642|NCT00624338|398434|P3|Overall Study|Lack of Efficacy|14
116643|NCT00624338|398435|P2|Overall Study|Lack of Efficacy|3
116644|NCT00624338|398436|P1|Overall Study|Lack of Efficacy|11
116645|NCT00624338|398434|P3|Overall Study|Lost to Follow-up|0
116646|NCT00624338|398435|P2|Overall Study|Lost to Follow-up|0
116647|NCT00624338|398436|P1|Overall Study|Lost to Follow-up|1
116648|NCT00624338|398434|P3|Overall Study|Adverse Event|18
116649|NCT00624338|398435|P2|Overall Study|Adverse Event|14
116650|NCT00624338|398436|P1|Overall Study|Adverse Event|14
116651|NCT00624286|398458|P2|Overall Study|Death|1
116652|NCT00624286|398459|P1|Overall Study|Death|0
116653|NCT00624286|398458|P2|Overall Study|Abnormal test procedure result(s)|1
116654|NCT00624286|398459|P1|Overall Study|Abnormal test procedure result(s)|0
116655|NCT00624286|398458|P2|Overall Study|Not stated|1
116656|NCT00624286|398459|P1|Overall Study|Not stated|0
116657|NCT00624286|398458|P2|Overall Study|Lack of Efficacy|6
116658|NCT00624286|398459|P1|Overall Study|Lack of Efficacy|1
116659|NCT00624286|398458|P2|Overall Study|Administrative problems|0
116660|NCT00624286|398459|P1|Overall Study|Administrative problems|3
116661|NCT00624286|398458|P2|Overall Study|Lost to Follow-up|2
116662|NCT00624286|398459|P1|Overall Study|Lost to Follow-up|3
116663|NCT00624286|398458|P2|Overall Study|Withdrawal by Subject|4
116664|NCT00624286|398459|P1|Overall Study|Withdrawal by Subject|5
116665|NCT00624286|398458|P2|Overall Study|Adverse Event|3
116666|NCT00624286|398459|P1|Overall Study|Adverse Event|6
116667|NCT00624286|398458|P2|Overall Study|Protocol Deviation|9
116668|NCT00624286|398459|P1|Overall Study|Protocol Deviation|7
116669|NCT00624065|398487|P2|Overall Study|Met protocol-defined stopping criteria|9
116670|NCT00624065|398488|P1|Overall Study|Met protocol-defined stopping criteria|4
116671|NCT00624065|398487|P2|Overall Study|Lack of Efficacy|3
116672|NCT00624065|398488|P1|Overall Study|Lack of Efficacy|0
116673|NCT00624065|398487|P2|Overall Study|Consent withdrawn|5
116674|NCT00624065|398488|P1|Overall Study|Consent withdrawn|6
116675|NCT00624065|398487|P2|Overall Study|Lost to Follow-up|1
116676|NCT00624065|398488|P1|Overall Study|Lost to Follow-up|4
116677|NCT00624065|398487|P2|Overall Study|Adverse Event|6
116678|NCT00624065|398488|P1|Overall Study|Adverse Event|5
116679|NCT00624052|398500|P4|Overall Study|Changed job/ran out if meds|0
116680|NCT00624052|398501|P3|Overall Study|Changed job/ran out if meds|0
116681|NCT00624052|398502|P2|Overall Study|Changed job/ran out if meds|2
116682|NCT00624052|398503|P1|Overall Study|Changed job/ran out if meds|0
116683|NCT00624052|398500|P4|Overall Study|Consent withdrawn|0
116684|NCT00624052|398501|P3|Overall Study|Consent withdrawn|1
116685|NCT00624052|398502|P2|Overall Study|Consent withdrawn|1
116686|NCT00624052|398503|P1|Overall Study|Consent withdrawn|3
116687|NCT00624052|398500|P4|Overall Study|Non compliant with the protocol|1
116688|NCT00624052|398501|P3|Overall Study|Non compliant with the protocol|1
116689|NCT00624052|398502|P2|Overall Study|Non compliant with the protocol|1
116690|NCT00624052|398503|P1|Overall Study|Non compliant with the protocol|2
116691|NCT00624052|398500|P4|Overall Study|Lost to Follow-up|0
116692|NCT00624052|398501|P3|Overall Study|Lost to Follow-up|1
116693|NCT00624052|398502|P2|Overall Study|Lost to Follow-up|3
116694|NCT00624052|398503|P1|Overall Study|Lost to Follow-up|2
116695|NCT00624052|398500|P4|Overall Study|Lack of Efficacy|0
116696|NCT00624052|398501|P3|Overall Study|Lack of Efficacy|0
116697|NCT00624052|398502|P2|Overall Study|Lack of Efficacy|1
116698|NCT00624052|398503|P1|Overall Study|Lack of Efficacy|1
116699|NCT00624052|398500|P4|Overall Study|Adverse Event|3
116700|NCT00624052|398501|P3|Overall Study|Adverse Event|0
116701|NCT00624052|398502|P2|Overall Study|Adverse Event|6
116702|NCT00624052|398503|P1|Overall Study|Adverse Event|7
116703|NCT00623935|398569|P1|Overall Study|Patient Declined Transplant|1
116704|NCT00623935|398569|P1|Overall Study|Death|1
116705|NCT00623831|398576|P2|Overall Study|Progressive Disease|1
116706|NCT00623831|398577|P1|Overall Study|Progressive Disease|0
116707|NCT00623831|398576|P2|Overall Study|Withdrawal by Subject|0
116708|NCT00623831|398577|P1|Overall Study|Withdrawal by Subject|1
116709|NCT00623805|398589|P2|Overall Study|Reason not Specified|6
116710|NCT00623805|398590|P1|Overall Study|Reason not Specified|3
116711|NCT00623805|398589|P2|Overall Study|Protocol Violation|1
116712|NCT00623805|398590|P1|Overall Study|Protocol Violation|1
116713|NCT00623805|398589|P2|Overall Study|Lost to Follow-up|2
116714|NCT00623805|398590|P1|Overall Study|Lost to Follow-up|2
116715|NCT00623805|398589|P2|Overall Study|Lack of Efficacy|7
116716|NCT00623805|398590|P1|Overall Study|Lack of Efficacy|3
116717|NCT00623805|398589|P2|Overall Study|Death|0
116718|NCT00623805|398590|P1|Overall Study|Death|2
116719|NCT00623805|398589|P2|Overall Study|Adverse Event|6
116720|NCT00623805|398590|P1|Overall Study|Adverse Event|9
116721|NCT00623779|398607|P3|Overall Study|Criteria from CSR|1
116722|NCT00623779|398608|P2|Overall Study|Criteria from CSR|0
116723|NCT00623779|398609|P1|Overall Study|Criteria from CSR|2
116724|NCT00623779|398607|P3|Overall Study|Adverse Event|0
116725|NCT00623779|398608|P2|Overall Study|Adverse Event|3
116726|NCT00623779|398609|P1|Overall Study|Adverse Event|1
116727|NCT00623766|398658|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
116728|NCT00623766|398659|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
116729|NCT00623766|398658|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
116730|NCT00623766|398659|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
116731|NCT00623766|398658|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
116732|NCT00623766|398659|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
116733|NCT00623766|398658|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
116734|NCT00623766|398659|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
116735|NCT00623766|398658|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
116736|NCT00623766|398659|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
116737|NCT00623727|398683|P2|Open Label Follow-up|Participant convenience|1
116738|NCT00623727|398684|P1|Open Label Follow-up|Participant convenience|0
116739|NCT00623727|398683|P2|Open Label Follow-up|Study termination|6
116740|NCT00623727|398684|P1|Open Label Follow-up|Study termination|0
116741|NCT00623727|398683|P2|Open Label Follow-up|Withdrawal by Subject|1
116742|NCT00623727|398684|P1|Open Label Follow-up|Withdrawal by Subject|0
116743|NCT00623727|398683|P2|Double Blind (DB)|Protocol Violation|2
116744|NCT00623727|398684|P1|Double Blind (DB)|Protocol Violation|2
116745|NCT00623727|398683|P2|Double Blind (DB)|Lost to Follow-up|1
116746|NCT00623727|398684|P1|Double Blind (DB)|Lost to Follow-up|1
116747|NCT00623727|398683|P2|Double Blind (DB)|Termination of the double-blind period|21
116748|NCT00623727|398684|P1|Double Blind (DB)|Termination of the double-blind period|22
116749|NCT00623727|398683|P2|Double Blind (DB)|Lack of Efficacy|2
116750|NCT00623727|398684|P1|Double Blind (DB)|Lack of Efficacy|2
116751|NCT00623727|398683|P2|Double Blind (DB)|Withdrawal by Subject|2
116752|NCT00623727|398684|P1|Double Blind (DB)|Withdrawal by Subject|8
116753|NCT00623727|398683|P2|Double Blind (DB)|Physician Decision|1
116754|NCT00623727|398684|P1|Double Blind (DB)|Physician Decision|0
116755|NCT00623727|398683|P2|Double Blind (DB)|Adverse Event|3
116756|NCT00623727|398684|P1|Double Blind (DB)|Adverse Event|1
116757|NCT00623597|398739|P2|Overall Study|Failed to return|0
116758|NCT00623597|398740|P1|Overall Study|Failed to return|1
116759|NCT00623545|398803|P1|Overall Study|Withdrawal by Subject|4
116760|NCT00623545|398803|P1|Overall Study|Adverse Event|6
116761|NCT00623480|398823|P2|Overall Study|Site closed by sponsor|1
116762|NCT00623480|398824|P1|Overall Study|Site closed by sponsor|0
116763|NCT00623480|398823|P2|Overall Study|Protocol Violation|1
116764|NCT00623480|398824|P1|Overall Study|Protocol Violation|0
116765|NCT00623480|398823|P2|Overall Study|Non-compliant with study medication|0
116766|NCT00623480|398824|P1|Overall Study|Non-compliant with study medication|4
116767|NCT00623480|398823|P2|Overall Study|Lack of Efficacy|0
116768|NCT00623480|398824|P1|Overall Study|Lack of Efficacy|1
116769|NCT00623480|398823|P2|Overall Study|Withdrawal by Subject|4
116770|NCT00623480|398824|P1|Overall Study|Withdrawal by Subject|2
116771|NCT00623480|398823|P2|Overall Study|Lost to Follow-up|1
116772|NCT00623480|398824|P1|Overall Study|Lost to Follow-up|0
116773|NCT00623467|398836|P1|Overall Study|Withdrawal by Subject|2
116774|NCT00623467|398836|P1|Overall Study|Protocol Violation|4
116775|NCT00623467|398836|P1|Overall Study|Lost to Follow-up|1
116776|NCT00623428|398906|P2|Follow-up Period|Death|1
116777|NCT00623428|398907|P1|Follow-up Period|Death|0
116778|NCT00623428|398906|P2|Follow-up Period|Reason not specified|1
116779|NCT00623428|398907|P1|Follow-up Period|Reason not specified|1
116780|NCT00623428|398906|P2|Follow-up Period|Did not cooperate|3
116781|NCT00623428|398907|P1|Follow-up Period|Did not cooperate|0
116782|NCT00623428|398906|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
116783|NCT00623428|398907|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
116784|NCT00623428|398906|P2|Follow-up Period|Patient withdrew consent|4
116785|NCT00623428|398907|P1|Follow-up Period|Patient withdrew consent|5
116786|NCT00623428|398906|P2|Follow-up Period|Failure to return|2
116787|NCT00623428|398907|P1|Follow-up Period|Failure to return|10
116788|NCT00623428|398906|P2|Follow-up Period|Relapse post-treatment|3
116789|NCT00623428|398907|P1|Follow-up Period|Relapse post-treatment|11
116790|NCT00623428|398906|P2|Treatment Period|Withdrawal by Subject|1
116791|NCT00623428|398907|P1|Treatment Period|Withdrawal by Subject|0
116792|NCT00623428|398906|P2|Treatment Period|Other|1
116793|NCT00623428|398907|P1|Treatment Period|Other|0
116794|NCT00623428|398906|P2|Treatment Period|Insufficient therapeutic response|2
116795|NCT00623428|398907|P1|Treatment Period|Insufficient therapeutic response|0
116796|NCT00623428|398906|P2|Treatment Period|Did not cooperate / refused treatment|13
116797|NCT00623428|398907|P1|Treatment Period|Did not cooperate / refused treatment|0
116798|NCT00623428|398906|P2|Treatment Period|Death|1
116799|NCT00623428|398907|P1|Treatment Period|Death|0
116800|NCT00623428|398906|P2|Treatment Period|Adverse event/intercurrent illness|9
116801|NCT00623428|398907|P1|Treatment Period|Adverse event/intercurrent illness|0
116802|NCT00623233|398925|P1|Overall Study|Withdrawal by Subject|3
116803|NCT00623233|398925|P1|Overall Study|Lost to Follow-up|1
116804|NCT00623233|398925|P1|Overall Study|Physician Decision|10
116805|NCT00623233|398925|P1|Overall Study|Adverse Event|10
116806|NCT00623194|398932|P1|Overall Study|Unclassified|1
116807|NCT00623194|398932|P1|Overall Study|Protocol Violation|3
116808|NCT00623194|398932|P1|Overall Study|Lack of Efficacy|1
116809|NCT00623103|398969|P2|Overall Study|Protocol deviation|1
116810|NCT00623103|398970|P1|Overall Study|Protocol deviation|2
116811|NCT00623103|398969|P2|Overall Study|Death|11
116812|NCT00623103|398970|P1|Overall Study|Death|11
116813|NCT00623103|398969|P2|Overall Study|Administrative problems|4
116814|NCT00623103|398970|P1|Overall Study|Administrative problems|2
116815|NCT00623103|398969|P2|Overall Study|Lost to Follow-up|1
116816|NCT00623103|398970|P1|Overall Study|Lost to Follow-up|4
116817|NCT00623103|398969|P2|Overall Study|Withdrawal by Subject|24
116818|NCT00623103|398970|P1|Overall Study|Withdrawal by Subject|18
116819|NCT00623103|398969|P2|Overall Study|Unsatisfactory therapeutic effect|12
116820|NCT00623103|398970|P1|Overall Study|Unsatisfactory therapeutic effect|4
116821|NCT00623103|398969|P2|Overall Study|Adverse Event|60
116822|NCT00623103|398970|P1|Overall Study|Adverse Event|70
116823|NCT00622908|398998|P2|Overall Study|Termination by study sponser|1
116824|NCT00622908|398999|P1|Overall Study|Termination by study sponser|0
116825|NCT00622908|398998|P2|Overall Study|Refusal|1
116826|NCT00622908|398999|P1|Overall Study|Refusal|0
116827|NCT00622908|398998|P2|Overall Study|Lost to Follow-up|0
116828|NCT00622908|398999|P1|Overall Study|Lost to Follow-up|1
116829|NCT00622908|398998|P2|Overall Study|Lack of Efficacy|7
116830|NCT00622908|398999|P1|Overall Study|Lack of Efficacy|1
116831|NCT00622908|398998|P2|Overall Study|Adverse Event|1
116832|NCT00622908|398999|P1|Overall Study|Adverse Event|0
116833|NCT00622908|398998|P2|Overall Study|Protocol Violation|0
116834|NCT00622908|398999|P1|Overall Study|Protocol Violation|1
116835|NCT00622869|399014|P3|Overall Study|Missing|1
116836|NCT00622869|399015|P2|Overall Study|Missing|1
116837|NCT00622869|399016|P1|Overall Study|Missing|0
116838|NCT00622869|399014|P3|Overall Study|Graft Loss|2
116839|NCT00622869|399015|P2|Overall Study|Graft Loss|3
116840|NCT00622869|399016|P1|Overall Study|Graft Loss|5
116841|NCT00622869|399014|P3|Overall Study|Lost to Follow-up|2
116842|NCT00622869|399015|P2|Overall Study|Lost to Follow-up|4
116843|NCT00622869|399016|P1|Overall Study|Lost to Follow-up|2
116844|NCT00622869|399014|P3|Overall Study|Death|10
116845|NCT00622869|399015|P2|Overall Study|Death|15
116846|NCT00622869|399016|P1|Overall Study|Death|12
116847|NCT00622869|399014|P3|Overall Study|Administrative Problems|13
116848|NCT00622869|399015|P2|Overall Study|Administrative Problems|17
116849|NCT00622869|399016|P1|Overall Study|Administrative Problems|11
116850|NCT00622869|399014|P3|Overall Study|Subject Withdrew Consent|11
116851|NCT00622869|399015|P2|Overall Study|Subject Withdrew Consent|17
116852|NCT00622869|399016|P1|Overall Study|Subject Withdrew Consent|13
116853|NCT00622739|399035|P2|Overall Study|Lost to Follow-up|1
116854|NCT00622739|399036|P1|Overall Study|Lost to Follow-up|0
116855|NCT00622739|399035|P2|Overall Study|Withdrawal by Subject|1
116856|NCT00622739|399036|P1|Overall Study|Withdrawal by Subject|0
116857|NCT00622739|399035|P2|Overall Study|Lack of Efficacy|2
116858|NCT00622739|399036|P1|Overall Study|Lack of Efficacy|0
116859|NCT00622739|399035|P2|Overall Study|Adverse Event|2
116860|NCT00622739|399036|P1|Overall Study|Adverse Event|1
116861|NCT00622739|399035|P2|Overall Study|Physician Decision|0
116862|NCT00622739|399036|P1|Overall Study|Physician Decision|1
116863|NCT00622726|399044|P2|August, 2010 to April, 2013|Death|5
116864|NCT00622726|399045|P1|August, 2010 to April, 2013|Death|1
116865|NCT00622726|399044|P2|March, 2008 to August, 2010|Death|2
116866|NCT00622726|399045|P1|March, 2008 to August, 2010|Death|5
116867|NCT00622713|399055|P1|Overall Study|Did not meet eligibility criteria|1
116868|NCT00622713|399055|P1|Overall Study|Subject no longer required study drug|1
116869|NCT00622713|399055|P1|Overall Study|Death|2
116870|NCT00622713|399055|P1|Overall Study|Lost to Follow-up|5
116871|NCT00622713|399055|P1|Overall Study|Withdrawal by Subject|11
116872|NCT00622713|399055|P1|Overall Study|Administrative problems|4
116873|NCT00622713|399055|P1|Overall Study|Adverse Event|35
116874|NCT00622700|399066|P3|Overall Study|Other Than Above|5
116875|NCT00622700|399067|P2|Overall Study|Other Than Above|2
116876|NCT00622700|399068|P1|Overall Study|Other Than Above|2
116877|NCT00622700|399066|P3|Overall Study|Withdrawal by Subject|15
116878|NCT00622700|399067|P2|Overall Study|Withdrawal by Subject|18
116879|NCT00622700|399068|P1|Overall Study|Withdrawal by Subject|12
116880|NCT00622700|399066|P3|Overall Study|Progressive Disease|0
116881|NCT00622700|399067|P2|Overall Study|Progressive Disease|1
116882|NCT00622700|399068|P1|Overall Study|Progressive Disease|3
116883|NCT00622700|399066|P3|Overall Study|Death|0
116884|NCT00622700|399067|P2|Overall Study|Death|0
116885|NCT00622700|399068|P1|Overall Study|Death|1
116886|NCT00622700|399066|P3|Overall Study|Lost to Follow-up|1
116887|NCT00622700|399067|P2|Overall Study|Lost to Follow-up|1
116888|NCT00622700|399068|P1|Overall Study|Lost to Follow-up|1
116889|NCT00622700|399066|P3|Overall Study|Lack of Efficacy|12
116890|NCT00622700|399067|P2|Overall Study|Lack of Efficacy|6
116891|NCT00622700|399068|P1|Overall Study|Lack of Efficacy|19
116892|NCT00622700|399066|P3|Overall Study|Adverse Event|18
116893|NCT00622700|399067|P2|Overall Study|Adverse Event|25
116894|NCT00622700|399068|P1|Overall Study|Adverse Event|18
116895|NCT00622700|399066|P3|Overall Study|Randomized but Not Treated|2
116896|NCT00622700|399067|P2|Overall Study|Randomized but Not Treated|2
116897|NCT00622700|399068|P1|Overall Study|Randomized but Not Treated|0
116898|NCT00622635|399115|P6|Treatment Period 3|Withdrawal by Subject|0
116899|NCT00622635|399116|P5|Treatment Period 3|Withdrawal by Subject|0
116900|NCT00622635|399117|P4|Treatment Period 3|Withdrawal by Subject|1
116901|NCT00622635|399118|P3|Treatment Period 3|Withdrawal by Subject|0
116902|NCT00622635|399119|P2|Treatment Period 3|Withdrawal by Subject|0
116903|NCT00622635|399120|P1|Treatment Period 3|Withdrawal by Subject|0
116904|NCT00622635|399115|P6|Treatment Period 3|Adverse Event|0
116905|NCT00622635|399116|P5|Treatment Period 3|Adverse Event|0
116906|NCT00622635|399117|P4|Treatment Period 3|Adverse Event|2
116907|NCT00622635|399118|P3|Treatment Period 3|Adverse Event|0
116908|NCT00622635|399119|P2|Treatment Period 3|Adverse Event|0
116909|NCT00622635|399120|P1|Treatment Period 3|Adverse Event|0
116910|NCT00622635|399115|P6|Treatment Period 2|Adverse Event|0
116911|NCT00622635|399116|P5|Treatment Period 2|Adverse Event|0
116912|NCT00622635|399117|P4|Treatment Period 2|Adverse Event|0
116913|NCT00622635|399118|P3|Treatment Period 2|Adverse Event|0
116914|NCT00622635|399119|P2|Treatment Period 2|Adverse Event|0
116915|NCT00622635|399120|P1|Treatment Period 2|Adverse Event|1
116916|NCT00622635|399115|P6|Treatment Period 1|Abnormal test procedure result(s)|0
116917|NCT00622635|399116|P5|Treatment Period 1|Abnormal test procedure result(s)|1
116918|NCT00622635|399117|P4|Treatment Period 1|Abnormal test procedure result(s)|0
116919|NCT00622635|399118|P3|Treatment Period 1|Abnormal test procedure result(s)|0
116920|NCT00622635|399119|P2|Treatment Period 1|Abnormal test procedure result(s)|0
116921|NCT00622635|399120|P1|Treatment Period 1|Abnormal test procedure result(s)|0
116922|NCT00622635|399115|P6|Treatment Period 1|Withdrawal by Subject|0
116923|NCT00622635|399116|P5|Treatment Period 1|Withdrawal by Subject|0
116924|NCT00622635|399117|P4|Treatment Period 1|Withdrawal by Subject|0
116925|NCT00622635|399118|P3|Treatment Period 1|Withdrawal by Subject|0
116926|NCT00622635|399119|P2|Treatment Period 1|Withdrawal by Subject|1
116927|NCT00622635|399120|P1|Treatment Period 1|Withdrawal by Subject|0
116928|NCT00622635|399115|P6|Treatment Period 1|Adverse Event|0
116929|NCT00622635|399116|P5|Treatment Period 1|Adverse Event|0
116930|NCT00622635|399117|P4|Treatment Period 1|Adverse Event|0
116931|NCT00622635|399118|P3|Treatment Period 1|Adverse Event|1
116932|NCT00622635|399119|P2|Treatment Period 1|Adverse Event|0
116933|NCT00622635|399120|P1|Treatment Period 1|Adverse Event|0
116934|NCT00622440|399198|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
116935|NCT00622440|399199|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
116936|NCT00622440|399198|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
116937|NCT00622440|399199|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
116938|NCT00622440|399198|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
116939|NCT00622440|399199|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
116940|NCT00622440|399198|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
116941|NCT00622440|399199|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
116942|NCT00622401|399225|P3|Overall Study|Disease progression prior to treatment|0
116943|NCT00622401|399226|P2|Overall Study|Disease progression prior to treatment|2
116944|NCT00622401|399227|P1|Overall Study|Disease progression prior to treatment|3
116945|NCT00622388|399231|P1|Overall Study|Insurance Expired|1
116946|NCT00622388|399231|P1|Overall Study|Withdrew Consent|1
116947|NCT00622388|399231|P1|Overall Study|Took Prohibited Medication|2
116948|NCT00622388|399231|P1|Overall Study|Received Alternate Anticancer Therapy|8
116949|NCT00622388|399231|P1|Overall Study|Death|3
116950|NCT00622388|399231|P1|Overall Study|Participant Refusal|1
116951|NCT00622388|399231|P1|Overall Study|Protocol Violation|3
116952|NCT00622388|399231|P1|Overall Study|Adverse Event|6
116953|NCT00622388|399231|P1|Overall Study|Disease Progression|47
116954|NCT00622336|399249|P1|Extension Phase|Unspecified|9
116955|NCT00622336|399249|P1|Extension Phase|Lost to Follow-up|1
116956|NCT00622336|399249|P1|Extension Phase|Withdrawal by Subject|1
116957|NCT00622336|399249|P1|Extension Phase|Lack of therapeutic effect|2
116958|NCT00622336|399249|P1|Extension Phase|Progressive Disease|6
116959|NCT00622336|399249|P1|Extension Phase|Adverse Event|2
116960|NCT00622336|399249|P1|Treatment Phase|Lost to Follow-up|2
116961|NCT00622336|399249|P1|Treatment Phase|Withdrawal by Subject|13
116962|NCT00622336|399249|P1|Treatment Phase|Lack of therapeutic effect|13
116963|NCT00622336|399249|P1|Treatment Phase|Death|14
116964|NCT00622336|399249|P1|Treatment Phase|Unspecified|40
116965|NCT00622336|399249|P1|Treatment Phase|Adverse Event|46
116966|NCT00622336|399249|P1|Treatment Phase|Progression of Disease|181
116967|NCT00622284|399260|P2|Overall Study|Other reason (not specified)|24
116968|NCT00622284|399261|P1|Overall Study|Other reason (not specified)|33
116969|NCT00622284|399260|P2|Overall Study|Withdrawal by Subject|24
116970|NCT00622284|399261|P1|Overall Study|Withdrawal by Subject|27
116971|NCT00622284|399260|P2|Overall Study|Lost to Follow-up|13
116972|NCT00622284|399261|P1|Overall Study|Lost to Follow-up|11
116973|NCT00622284|399260|P2|Overall Study|Protocol Violation|5
116974|NCT00622284|399261|P1|Overall Study|Protocol Violation|12
116975|NCT00622284|399260|P2|Overall Study|Adverse Event|90
116976|NCT00622284|399261|P1|Overall Study|Adverse Event|61
116977|NCT00622284|399260|P2|Overall Study|Lack of Efficacy|15
116978|NCT00622284|399261|P1|Overall Study|Lack of Efficacy|45
116979|NCT00622167|399323|P1|Overall Study|Did not meet angiographic criteria|20
116980|NCT00621985|399327|P1|Dexamethasone Admission|Adverse Event|1
116981|NCT00621959|399335|P2|Overall Study|Other|3
116982|NCT00621959|399336|P1|Overall Study|Other|1
116983|NCT00621959|399335|P2|Overall Study|Withdrawal by Subject|1
116984|NCT00621959|399336|P1|Overall Study|Withdrawal by Subject|1
116985|NCT00621959|399335|P2|Overall Study|Lost to Follow-up|2
116986|NCT00621959|399336|P1|Overall Study|Lost to Follow-up|0
116987|NCT00621959|399335|P2|Overall Study|Lack of Efficacy|1
116988|NCT00621959|399336|P1|Overall Study|Lack of Efficacy|1
116989|NCT00621959|399335|P2|Overall Study|Adverse Event|2
116990|NCT00621959|399336|P1|Overall Study|Adverse Event|4
116991|NCT00621855|399375|P5|Overall Study|Patients did not receive study drug|2
116992|NCT00621855|399376|P4|Overall Study|Patients did not receive study drug|4
116993|NCT00621855|399377|P3|Overall Study|Patients did not receive study drug|5
116994|NCT00621855|399378|P2|Overall Study|Patients did not receive study drug|3
116995|NCT00621855|399379|P1|Overall Study|Patients did not receive study drug|3
116996|NCT00621855|399375|P5|Overall Study|Other|4
116997|NCT00621855|399376|P4|Overall Study|Other|5
116998|NCT00621855|399377|P3|Overall Study|Other|6
116999|NCT00621855|399378|P2|Overall Study|Other|7
117000|NCT00621855|399379|P1|Overall Study|Other|9
117001|NCT00621855|399375|P5|Overall Study|Withdrawal by Subject|9
117002|NCT00621855|399376|P4|Overall Study|Withdrawal by Subject|13
117003|NCT00621855|399377|P3|Overall Study|Withdrawal by Subject|13
117004|NCT00621855|399378|P2|Overall Study|Withdrawal by Subject|11
117005|NCT00621855|399379|P1|Overall Study|Withdrawal by Subject|16
117006|NCT00621855|399375|P5|Overall Study|Protocol Violation|8
117007|NCT00621855|399376|P4|Overall Study|Protocol Violation|7
117008|NCT00621855|399377|P3|Overall Study|Protocol Violation|6
117009|NCT00621855|399378|P2|Overall Study|Protocol Violation|8
117010|NCT00621855|399379|P1|Overall Study|Protocol Violation|16
117011|NCT00621855|399375|P5|Overall Study|Lost to Follow-up|1
117012|NCT00621855|399376|P4|Overall Study|Lost to Follow-up|4
117013|NCT00621855|399377|P3|Overall Study|Lost to Follow-up|3
117014|NCT00621855|399378|P2|Overall Study|Lost to Follow-up|1
117015|NCT00621855|399379|P1|Overall Study|Lost to Follow-up|0
117016|NCT00621855|399375|P5|Overall Study|Adverse Event|31
117017|NCT00621855|399376|P4|Overall Study|Adverse Event|34
117018|NCT00621855|399377|P3|Overall Study|Adverse Event|48
117019|NCT00621855|399378|P2|Overall Study|Adverse Event|31
117020|NCT00621855|399379|P1|Overall Study|Adverse Event|32
117021|NCT00621842|399421|P1|Overall Study|Lack of Efficacy|2
117022|NCT00621842|399421|P1|Overall Study|Protocol Violation|4
117023|NCT00621842|399421|P1|Overall Study|Withdrawal by Subject|7
117024|NCT00621842|399421|P1|Overall Study|Adverse Event|6
117025|NCT00621777|399438|P2|Randomized Phase|Death|1
117026|NCT00621777|399439|P1|Randomized Phase|Death|0
117027|NCT00621777|399438|P2|Randomized Phase|administrative|3
117028|NCT00621777|399439|P1|Randomized Phase|administrative|0
117029|NCT00621777|399438|P2|Randomized Phase|Withdrawal by Subject|9
117030|NCT00621777|399439|P1|Randomized Phase|Withdrawal by Subject|1
117031|NCT00621777|399438|P2|Randomized Phase|Lost to Follow-up|3
117032|NCT00621777|399439|P1|Randomized Phase|Lost to Follow-up|3
117033|NCT00621777|399438|P2|Randomized Phase|Adverse Event|3
117034|NCT00621777|399439|P1|Randomized Phase|Adverse Event|3
117035|NCT00621777|399438|P2|Open Phase|Lost to Follow-up|0
117036|NCT00621777|399439|P1|Open Phase|Lost to Follow-up|10
117037|NCT00621777|399438|P2|Open Phase|administrative|0
117038|NCT00621777|399439|P1|Open Phase|administrative|13
117039|NCT00621777|399438|P2|Open Phase|Withdrawal by Subject|0
117040|NCT00621777|399439|P1|Open Phase|Withdrawal by Subject|17
117041|NCT00621777|399438|P2|Open Phase|Did not abstain during open phase|0
117042|NCT00621777|399439|P1|Open Phase|Did not abstain during open phase|56
117043|NCT00621777|399438|P2|Open Phase|Adverse Event|0
117044|NCT00621777|399439|P1|Open Phase|Adverse Event|20
117045|NCT00621764|399450|P4|Overall Study|Protocol Violation|1
117046|NCT00621764|399451|P3|Overall Study|Protocol Violation|0
117047|NCT00621764|399452|P2|Overall Study|Protocol Violation|0
117048|NCT00621764|399453|P1|Overall Study|Protocol Violation|0
117049|NCT00621621|399499|P2|Overall Study|Subjects were exited at EP study|0
117050|NCT00621621|399500|P1|Overall Study|Subjects were exited at EP study|30
117051|NCT00621582|399508|P1|Overall Study|issues not identified by investigators|18
117052|NCT00621582|399508|P1|Overall Study|Lost to Follow-up|24
117053|NCT00621582|399508|P1|Overall Study|Protocol Violation|57
117054|NCT00621582|399508|P1|Overall Study|Adverse Event|7
117055|NCT00621543|399515|P1|Overall Study|Lost to Follow-up|23
117056|NCT00621517|399522|P2|Overall Study|Adverse Event|0
117057|NCT00621517|399523|P1|Overall Study|Adverse Event|1
117058|NCT00621517|399522|P2|Overall Study|Withdrawal by Subject|4
117059|NCT00621517|399523|P1|Overall Study|Withdrawal by Subject|3
117060|NCT00621517|399522|P2|Overall Study|Lost to Follow-up|3
117061|NCT00621517|399523|P1|Overall Study|Lost to Follow-up|3
117062|NCT00621504|399531|P2|Overall Study|Death|6
117063|NCT00621504|399532|P1|Overall Study|Death|6
117064|NCT00621504|399531|P2|Overall Study|Other|0
117065|NCT00621504|399532|P1|Overall Study|Other|1
117066|NCT00621504|399531|P2|Overall Study|Lost to Follow-up|10
117067|NCT00621504|399532|P1|Overall Study|Lost to Follow-up|8
117068|NCT00621504|399531|P2|Overall Study|Withdrew consent|6
117069|NCT00621504|399532|P1|Overall Study|Withdrew consent|9
117070|NCT00621504|399531|P2|Overall Study|At the request of sponsor/investigator|0
117071|NCT00621504|399532|P1|Overall Study|At the request of sponsor/investigator|1
117072|NCT00621504|399531|P2|Overall Study|Adverse Event|3
117073|NCT00621504|399532|P1|Overall Study|Adverse Event|1
117074|NCT00621322|399566|P6|Overall Study|Migrated/moved from study area|2
117075|NCT00621322|399567|P5|Overall Study|Migrated/moved from study area|0
117076|NCT00621322|399568|P4|Overall Study|Migrated/moved from study area|1
117077|NCT00621322|399569|P3|Overall Study|Migrated/moved from study area|1
117078|NCT00621322|399570|P2|Overall Study|Migrated/moved from study area|0
117079|NCT00621322|399571|P1|Overall Study|Migrated/moved from study area|1
117080|NCT00621322|399566|P6|Overall Study|Withdrawal by Subject|2
117081|NCT00621322|399567|P5|Overall Study|Withdrawal by Subject|0
117082|NCT00621322|399568|P4|Overall Study|Withdrawal by Subject|1
117083|NCT00621322|399569|P3|Overall Study|Withdrawal by Subject|0
117084|NCT00621322|399570|P2|Overall Study|Withdrawal by Subject|0
117085|NCT00621322|399571|P1|Overall Study|Withdrawal by Subject|0
117086|NCT00621322|399566|P6|Overall Study|Physician Decision|0
117087|NCT00621322|399567|P5|Overall Study|Physician Decision|0
117088|NCT00621322|399568|P4|Overall Study|Physician Decision|1
117089|NCT00621322|399569|P3|Overall Study|Physician Decision|1
117090|NCT00621322|399570|P2|Overall Study|Physician Decision|0
117091|NCT00621322|399571|P1|Overall Study|Physician Decision|0
117092|NCT00621322|399566|P6|Overall Study|Lost to Follow-up|0
117093|NCT00621322|399567|P5|Overall Study|Lost to Follow-up|1
117094|NCT00621322|399568|P4|Overall Study|Lost to Follow-up|0
117095|NCT00621322|399569|P3|Overall Study|Lost to Follow-up|0
117096|NCT00621322|399570|P2|Overall Study|Lost to Follow-up|0
117097|NCT00621322|399571|P1|Overall Study|Lost to Follow-up|0
117098|NCT00621296|399651|P1|Overall Study|Stopping Criteria|3
117099|NCT00621296|399651|P1|Overall Study|Unmatch Criteria|1
117100|NCT00621296|399651|P1|Overall Study|Physician Decision|7
117101|NCT00621296|399651|P1|Overall Study|Lack of Efficacy|1
117102|NCT00621296|399651|P1|Overall Study|Adverse Event|2
117103|NCT00621257|399660|P5|Overall Study|Withdrawal by Subject|1
117104|NCT00621257|399661|P4|Overall Study|Withdrawal by Subject|1
117105|NCT00621257|399662|P3|Overall Study|Withdrawal by Subject|0
117106|NCT00621257|399663|P2|Overall Study|Withdrawal by Subject|0
117107|NCT00621257|399664|P1|Overall Study|Withdrawal by Subject|0
117108|NCT00621257|399660|P5|Overall Study|Physician Decision|1
117109|NCT00621257|399661|P4|Overall Study|Physician Decision|1
117110|NCT00621257|399662|P3|Overall Study|Physician Decision|0
117111|NCT00621257|399663|P2|Overall Study|Physician Decision|2
117112|NCT00621257|399664|P1|Overall Study|Physician Decision|0
117113|NCT00621257|399660|P5|Overall Study|Adverse Event|0
117114|NCT00621257|399661|P4|Overall Study|Adverse Event|0
117115|NCT00621257|399662|P3|Overall Study|Adverse Event|1
117116|NCT00621257|399663|P2|Overall Study|Adverse Event|1
117117|NCT00621257|399664|P1|Overall Study|Adverse Event|0
117118|NCT00621257|399660|P5|Overall Study|Lost to Follow-up|7
117119|NCT00621257|399661|P4|Overall Study|Lost to Follow-up|4
117120|NCT00621257|399662|P3|Overall Study|Lost to Follow-up|2
117121|NCT00621257|399663|P2|Overall Study|Lost to Follow-up|0
117122|NCT00621257|399664|P1|Overall Study|Lost to Follow-up|4
117123|NCT00621192|399680|P4|Overall Study|Final Assessments not Completed|1
117212|NCT00620659|399908|P3|Treatment Period 3|Adverse Event|0
117124|NCT00621192|399681|P3|Overall Study|Final Assessments not Completed|3
117125|NCT00621192|399682|P2|Overall Study|Final Assessments not Completed|0
117126|NCT00621192|399683|P1|Overall Study|Final Assessments not Completed|0
117127|NCT00621192|399680|P4|Overall Study|Death|0
117128|NCT00621192|399681|P3|Overall Study|Death|0
117129|NCT00621192|399682|P2|Overall Study|Death|5
117130|NCT00621192|399683|P1|Overall Study|Death|2
117131|NCT00621192|399680|P4|Overall Study|Adverse Event|1
117132|NCT00621192|399681|P3|Overall Study|Adverse Event|0
117133|NCT00621192|399682|P2|Overall Study|Adverse Event|1
117134|NCT00621192|399683|P1|Overall Study|Adverse Event|0
117135|NCT00621192|399680|P4|Overall Study|Protocol Violation|1
117136|NCT00621192|399681|P3|Overall Study|Protocol Violation|0
117137|NCT00621192|399682|P2|Overall Study|Protocol Violation|0
117138|NCT00621192|399683|P1|Overall Study|Protocol Violation|1
117139|NCT00621192|399680|P4|Overall Study|Physician Decision|0
117140|NCT00621192|399681|P3|Overall Study|Physician Decision|0
117141|NCT00621192|399682|P2|Overall Study|Physician Decision|3
117142|NCT00621192|399683|P1|Overall Study|Physician Decision|1
117143|NCT00621192|399680|P4|Overall Study|Withdrawal by Subject|0
117144|NCT00621192|399681|P3|Overall Study|Withdrawal by Subject|2
117145|NCT00621192|399682|P2|Overall Study|Withdrawal by Subject|0
117146|NCT00621192|399683|P1|Overall Study|Withdrawal by Subject|0
117147|NCT00621153|399707|P2|Overall Study|Withdrawal by Subject|5
117148|NCT00621153|399708|P1|Overall Study|Withdrawal by Subject|4
117149|NCT00621153|399707|P2|Overall Study|Lost to Follow-up|1
117150|NCT00621153|399708|P1|Overall Study|Lost to Follow-up|5
117151|NCT00621153|399707|P2|Overall Study|Adverse Event|2
117152|NCT00621153|399708|P1|Overall Study|Adverse Event|3
117153|NCT00621153|399707|P2|Overall Study|Safety Reason|7
117154|NCT00621153|399708|P1|Overall Study|Safety Reason|8
117155|NCT00621140|399716|P2|Overall Study|Other incl. lack of efficacy|5
117156|NCT00621140|399717|P1|Overall Study|Other incl. lack of efficacy|6
117157|NCT00621140|399716|P2|Overall Study|Withdrawal by Subject|6
117158|NCT00621140|399717|P1|Overall Study|Withdrawal by Subject|4
117159|NCT00621140|399716|P2|Overall Study|Lost to Follow-up|2
117160|NCT00621140|399717|P1|Overall Study|Lost to Follow-up|1
117161|NCT00621140|399716|P2|Overall Study|Adverse Event|5
117162|NCT00621140|399717|P1|Overall Study|Adverse Event|4
117163|NCT00621023|399764|P1|Overall Study|Follow up discontinued|1
117164|NCT00621023|399764|P1|Overall Study|Death|5
117165|NCT00620854|399776|P6|Washout 1|Withdrawal by Subject|0
117166|NCT00620854|399777|P5|Washout 1|Withdrawal by Subject|0
117167|NCT00620854|399778|P4|Washout 1|Withdrawal by Subject|1
117168|NCT00620854|399779|P3|Washout 1|Withdrawal by Subject|1
117169|NCT00620854|399780|P2|Washout 1|Withdrawal by Subject|0
117170|NCT00620854|399781|P1|Washout 1|Withdrawal by Subject|0
117171|NCT00620815|399812|P3|Overall Study|Protocol Violation|1
117172|NCT00620815|399813|P2|Overall Study|Protocol Violation|2
117173|NCT00620815|399814|P1|Overall Study|Protocol Violation|1
117174|NCT00620815|399812|P3|Overall Study|Inappropriate enrolment|1
117175|NCT00620815|399813|P2|Overall Study|Inappropriate enrolment|0
117176|NCT00620815|399814|P1|Overall Study|Inappropriate enrolment|0
117177|NCT00620815|399812|P3|Overall Study|Lost to Follow-up|3
117178|NCT00620815|399813|P2|Overall Study|Lost to Follow-up|6
117179|NCT00620815|399814|P1|Overall Study|Lost to Follow-up|1
117180|NCT00620815|399812|P3|Overall Study|Withdrawal by Subject|0
117181|NCT00620815|399813|P2|Overall Study|Withdrawal by Subject|2
117182|NCT00620815|399814|P1|Overall Study|Withdrawal by Subject|1
117183|NCT00620815|399812|P3|Overall Study|Adverse Event|2
117184|NCT00620815|399813|P2|Overall Study|Adverse Event|1
117185|NCT00620815|399814|P1|Overall Study|Adverse Event|1
117186|NCT00620776|399854|P2|Overall Study|Withdrawal by Subject|2
117187|NCT00620776|399855|P1|Overall Study|Withdrawal by Subject|3
117188|NCT00620776|399854|P2|Overall Study|Lost to Follow-up|5
117189|NCT00620776|399855|P1|Overall Study|Lost to Follow-up|2
117190|NCT00620776|399854|P2|Overall Study|Lack of Efficacy|1
117191|NCT00620776|399855|P1|Overall Study|Lack of Efficacy|2
117192|NCT00620776|399854|P2|Overall Study|Adverse Event|3
117193|NCT00620776|399855|P1|Overall Study|Adverse Event|2
117194|NCT00620776|399854|P2|Overall Study|Did not receive treatment|5
117195|NCT00620776|399855|P1|Overall Study|Did not receive treatment|3
117196|NCT00620763|399883|P2|Period: Second Intervention|Withdrawal by Subject|0
117197|NCT00620763|399884|P1|Period: Second Intervention|Withdrawal by Subject|1
117198|NCT00620763|399883|P2|Period: First Intervention|Protocol Violation|3
117199|NCT00620763|399884|P1|Period: First Intervention|Protocol Violation|0
117200|NCT00620763|399883|P2|Period: First Intervention|Withdrawal by Subject|2
117201|NCT00620763|399884|P1|Period: First Intervention|Withdrawal by Subject|0
117202|NCT00620750|399890|P1|Overall Study|Lost to Follow-up|25
117203|NCT00620659|399905|P6|Treatment Period 3|Withdrawal by Subject|0
117204|NCT00620659|399906|P5|Treatment Period 3|Withdrawal by Subject|0
117205|NCT00620659|399907|P4|Treatment Period 3|Withdrawal by Subject|1
117206|NCT00620659|399908|P3|Treatment Period 3|Withdrawal by Subject|0
117207|NCT00620659|399909|P2|Treatment Period 3|Withdrawal by Subject|0
117208|NCT00620659|399910|P1|Treatment Period 3|Withdrawal by Subject|0
117209|NCT00620659|399905|P6|Treatment Period 3|Adverse Event|0
117210|NCT00620659|399906|P5|Treatment Period 3|Adverse Event|0
117211|NCT00620659|399907|P4|Treatment Period 3|Adverse Event|0
117213|NCT00620659|399909|P2|Treatment Period 3|Adverse Event|2
117214|NCT00620659|399910|P1|Treatment Period 3|Adverse Event|0
117215|NCT00620659|399905|P6|Placebo Washout Period 2|Adverse Event|0
117216|NCT00620659|399906|P5|Placebo Washout Period 2|Adverse Event|0
117217|NCT00620659|399907|P4|Placebo Washout Period 2|Adverse Event|0
117218|NCT00620659|399908|P3|Placebo Washout Period 2|Adverse Event|0
117219|NCT00620659|399909|P2|Placebo Washout Period 2|Adverse Event|0
117220|NCT00620659|399910|P1|Placebo Washout Period 2|Adverse Event|2
117221|NCT00620659|399905|P6|Treatment Period 2|Withdrawal by Subject|0
117222|NCT00620659|399906|P5|Treatment Period 2|Withdrawal by Subject|3
117223|NCT00620659|399907|P4|Treatment Period 2|Withdrawal by Subject|0
117224|NCT00620659|399908|P3|Treatment Period 2|Withdrawal by Subject|1
117225|NCT00620659|399909|P2|Treatment Period 2|Withdrawal by Subject|0
117226|NCT00620659|399910|P1|Treatment Period 2|Withdrawal by Subject|0
117227|NCT00620659|399905|P6|Treatment Period 2|Adverse Event|0
117228|NCT00620659|399906|P5|Treatment Period 2|Adverse Event|2
117229|NCT00620659|399907|P4|Treatment Period 2|Adverse Event|0
117230|NCT00620659|399908|P3|Treatment Period 2|Adverse Event|0
117231|NCT00620659|399909|P2|Treatment Period 2|Adverse Event|3
117232|NCT00620659|399910|P1|Treatment Period 2|Adverse Event|0
117233|NCT00620659|399905|P6|Placebo Washout Period 1|Withdrawal by Subject|0
117234|NCT00620659|399906|P5|Placebo Washout Period 1|Withdrawal by Subject|0
117235|NCT00620659|399907|P4|Placebo Washout Period 1|Withdrawal by Subject|1
117236|NCT00620659|399908|P3|Placebo Washout Period 1|Withdrawal by Subject|0
117237|NCT00620659|399909|P2|Placebo Washout Period 1|Withdrawal by Subject|0
117238|NCT00620659|399910|P1|Placebo Washout Period 1|Withdrawal by Subject|0
117239|NCT00620659|399905|P6|Treatment Period 1|Withdrawal by Subject|0
117240|NCT00620659|399906|P5|Treatment Period 1|Withdrawal by Subject|1
117241|NCT00620659|399907|P4|Treatment Period 1|Withdrawal by Subject|0
117242|NCT00620659|399908|P3|Treatment Period 1|Withdrawal by Subject|1
117243|NCT00620659|399909|P2|Treatment Period 1|Withdrawal by Subject|0
117244|NCT00620659|399910|P1|Treatment Period 1|Withdrawal by Subject|1
117245|NCT00620659|399905|P6|Treatment Period 1|Protocol Violation|0
117246|NCT00620659|399906|P5|Treatment Period 1|Protocol Violation|0
117247|NCT00620659|399907|P4|Treatment Period 1|Protocol Violation|0
117248|NCT00620659|399908|P3|Treatment Period 1|Protocol Violation|0
117249|NCT00620659|399909|P2|Treatment Period 1|Protocol Violation|0
117250|NCT00620659|399910|P1|Treatment Period 1|Protocol Violation|1
117251|NCT00620659|399905|P6|Treatment Period 1|Adverse Event|0
117252|NCT00620659|399906|P5|Treatment Period 1|Adverse Event|0
117253|NCT00620659|399907|P4|Treatment Period 1|Adverse Event|3
117254|NCT00620659|399908|P3|Treatment Period 1|Adverse Event|0
117255|NCT00620659|399909|P2|Treatment Period 1|Adverse Event|0
117256|NCT00620659|399910|P1|Treatment Period 1|Adverse Event|1
117257|NCT00620555|399928|P1|Overall Study|Visit failure against planned|1
117258|NCT00620555|399928|P1|Overall Study|Choice of other treatment|1
117259|NCT00620555|399928|P1|Overall Study|Withdrawal by Subject|1
117260|NCT00620555|399928|P1|Overall Study|Lack of Efficacy|12
117261|NCT00620555|399928|P1|Overall Study|Protocol Violation|2
117262|NCT00620555|399928|P1|Overall Study|Adverse Event|4
117263|NCT00620542|399937|P4|Part B (2 Year Core Study)|IVUS not available|2
117264|NCT00620542|399938|P3|Part B (2 Year Core Study)|IVUS not available|3
117265|NCT00620542|399939|P2|Part B (2 Year Core Study)|IVUS not available|0
117266|NCT00620542|399940|P1|Part B (2 Year Core Study)|IVUS not available|0
117267|NCT00620542|399937|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
117268|NCT00620542|399938|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
117269|NCT00620542|399939|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
117270|NCT00620542|399940|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
117271|NCT00620542|399937|P4|Part B (2 Year Core Study)|Safety reasons|3
117272|NCT00620542|399938|P3|Part B (2 Year Core Study)|Safety reasons|2
117273|NCT00620542|399939|P2|Part B (2 Year Core Study)|Safety reasons|0
117274|NCT00620542|399940|P1|Part B (2 Year Core Study)|Safety reasons|0
117275|NCT00620542|399937|P4|Part B (2 Year Core Study)|Protocol Violation|16
117276|NCT00620542|399938|P3|Part B (2 Year Core Study)|Protocol Violation|13
117277|NCT00620542|399939|P2|Part B (2 Year Core Study)|Protocol Violation|0
117278|NCT00620542|399940|P1|Part B (2 Year Core Study)|Protocol Violation|0
117279|NCT00620542|399937|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
117280|NCT00620542|399938|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
117281|NCT00620542|399939|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
117282|NCT00620542|399940|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
117283|NCT00620542|399937|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
117284|NCT00620542|399938|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
117285|NCT00620542|399939|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
117286|NCT00620542|399940|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
117287|NCT00620542|399937|P4|Part B (2 Year Core Study)|Protocol Violation|5
117288|NCT00620542|399938|P3|Part B (2 Year Core Study)|Protocol Violation|3
117289|NCT00620542|399939|P2|Part B (2 Year Core Study)|Protocol Violation|0
117290|NCT00620542|399940|P1|Part B (2 Year Core Study)|Protocol Violation|0
117291|NCT00620542|399937|P4|Part B (2 Year Core Study)|Adverse Event|49
117292|NCT00620542|399938|P3|Part B (2 Year Core Study)|Adverse Event|46
117293|NCT00620542|399939|P2|Part B (2 Year Core Study)|Adverse Event|0
117294|NCT00620542|399940|P1|Part B (2 Year Core Study)|Adverse Event|0
117295|NCT00620542|399937|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
117296|NCT00620542|399938|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
117297|NCT00620542|399939|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
117298|NCT00620542|399940|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
117299|NCT00620542|399937|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
117300|NCT00620542|399938|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
117301|NCT00620542|399939|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
117302|NCT00620542|399940|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
117303|NCT00620542|399937|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
117304|NCT00620542|399938|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
117305|NCT00620542|399939|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
117306|NCT00620542|399940|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
117307|NCT00620542|399937|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
117308|NCT00620542|399938|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
117309|NCT00620542|399939|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
117310|NCT00620542|399940|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
117311|NCT00620542|399937|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
117312|NCT00620542|399938|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
117313|NCT00620542|399939|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
117314|NCT00620542|399940|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
117315|NCT00620542|399937|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
117316|NCT00620542|399938|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
117317|NCT00620542|399939|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
117318|NCT00620542|399940|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
117319|NCT00620542|399937|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
117320|NCT00620542|399938|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
117321|NCT00620542|399939|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
117322|NCT00620542|399940|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
117323|NCT00620464|399980|P2|Overall Study|Used prohibited medication|0
117324|NCT00620464|399981|P1|Overall Study|Used prohibited medication|1
117325|NCT00620464|399980|P2|Overall Study|Personal|2
117326|NCT00620464|399981|P1|Overall Study|Personal|2
117327|NCT00620464|399980|P2|Overall Study|Planning Pregnancy|4
117328|NCT00620464|399981|P1|Overall Study|Planning Pregnancy|1
117329|NCT00620464|399980|P2|Overall Study|Lost to Follow-up|1
117330|NCT00620464|399981|P1|Overall Study|Lost to Follow-up|1
117331|NCT00620464|399980|P2|Overall Study|Adverse Event|17
117332|NCT00620464|399981|P1|Overall Study|Adverse Event|15
117333|NCT00620373|400000|P1|Overall Study|Unverified cancer status|33
117334|NCT00620282|400019|P3|Overall Study|Withdrawal by Subject|0
117335|NCT00620282|400020|P2|Overall Study|Withdrawal by Subject|1
117336|NCT00620282|400021|P1|Overall Study|Withdrawal by Subject|0
117337|NCT00620282|400019|P3|Overall Study|Arterial line unable to be placed|1
117338|NCT00620282|400020|P2|Overall Study|Arterial line unable to be placed|0
117339|NCT00620282|400021|P1|Overall Study|Arterial line unable to be placed|0
117340|NCT00620282|400019|P3|Overall Study|Adverse Event|0
117341|NCT00620282|400020|P2|Overall Study|Adverse Event|1
117342|NCT00620282|400021|P1|Overall Study|Adverse Event|0
117343|NCT00620074|400081|P1|Overall Study|Adverse Event|1
117344|NCT00620035|400089|P1|Overall Study|Other Reason|38
117345|NCT00620035|400089|P1|Overall Study|Withdrawal of Informed Consent|1
117346|NCT00620035|400089|P1|Overall Study|Adverse Event|106
117347|NCT00620022|400099|P2|Treatment Period 2|Adverse Event|2
117348|NCT00620022|400100|P1|Treatment Period 2|Adverse Event|2
117349|NCT00620022|400099|P2|Treatment Period 1|Subject withdrew consent|0
117350|NCT00620022|400100|P1|Treatment Period 1|Subject withdrew consent|1
117351|NCT00620022|400099|P2|Treatment Period 1|Adverse Event|6
117352|NCT00620022|400100|P1|Treatment Period 1|Adverse Event|4
117353|NCT00619957|400125|P2|Month 48 Open-Label|Withdrawal by Subject|9
117354|NCT00619957|400126|P1|Month 48 Open-Label|Withdrawal by Subject|6
117355|NCT00619957|400125|P2|Month 48 Open-Label|Lost to Follow-up|4
117356|NCT00619957|400126|P1|Month 48 Open-Label|Lost to Follow-up|2
117357|NCT00619957|400125|P2|Month 48 Open-Label|Adverse Event|4
117358|NCT00619957|400126|P1|Month 48 Open-Label|Adverse Event|4
117359|NCT00619957|400125|P2|Month 24 Double-Blind|Did not take any study medication|1
117360|NCT00619957|400126|P1|Month 24 Double-Blind|Did not take any study medication|0
117361|NCT00619957|400125|P2|Month 24 Double-Blind|Lost to Follow-up|0
117362|NCT00619957|400126|P1|Month 24 Double-Blind|Lost to Follow-up|1
117363|NCT00619957|400125|P2|Month 24 Double-Blind|Withdrawal by Subject|9
117364|NCT00619957|400126|P1|Month 24 Double-Blind|Withdrawal by Subject|7
117365|NCT00619957|400125|P2|Month 24 Double-Blind|Protocol Violation|0
117366|NCT00619957|400126|P1|Month 24 Double-Blind|Protocol Violation|1
117367|NCT00619957|400125|P2|Month 24 Double-Blind|Adverse Event|7
117368|NCT00619957|400126|P1|Month 24 Double-Blind|Adverse Event|9
117369|NCT00619918|400208|P2|Overall Study|Left before receiving first dose|8
117370|NCT00619918|400209|P1|Overall Study|Left before receiving first dose|5
117371|NCT00619918|400208|P2|Overall Study|Transfer to outside facility|3
117372|NCT00619918|400209|P1|Overall Study|Transfer to outside facility|3
117373|NCT00619918|400208|P2|Overall Study|Physician Decision|8
117374|NCT00619918|400209|P1|Overall Study|Physician Decision|8
117375|NCT00619918|400208|P2|Overall Study|Withdrawal by Subject|3
117376|NCT00619918|400209|P1|Overall Study|Withdrawal by Subject|4
117377|NCT00619892|400219|P2|Overall Study|Intercurrent illness|1
117378|NCT00619892|400220|P1|Overall Study|Intercurrent illness|0
117379|NCT00619892|400219|P2|Overall Study|Lost to Follow-up|1
117380|NCT00619892|400220|P1|Overall Study|Lost to Follow-up|0
117381|NCT00619892|400219|P2|Overall Study|Adverse Event|0
117382|NCT00619892|400220|P1|Overall Study|Adverse Event|3
117383|NCT00619827|400230|P2|Overall Study|Withdrawal by Subject|2
117384|NCT00619827|400231|P1|Overall Study|Withdrawal by Subject|2
117385|NCT00619827|400230|P2|Overall Study|Adverse Event|2
117386|NCT00619827|400231|P1|Overall Study|Adverse Event|1
117387|NCT00619801|400239|P2|Overall Study|Loss of efficacy|1
117388|NCT00619801|400240|P1|Overall Study|Loss of efficacy|0
117389|NCT00619801|400239|P2|Overall Study|Withdrawal by Subject|1
117390|NCT00619801|400240|P1|Overall Study|Withdrawal by Subject|1
117391|NCT00619801|400239|P2|Overall Study|Lack of Efficacy|1
117392|NCT00619801|400240|P1|Overall Study|Lack of Efficacy|0
117393|NCT00619619|400283|P8|Overall Study|Adverse Event|2
117394|NCT00619619|400284|P7|Overall Study|Adverse Event|0
117395|NCT00619619|400285|P6|Overall Study|Adverse Event|0
117396|NCT00619619|400286|P5|Overall Study|Adverse Event|2
117397|NCT00619619|400287|P4|Overall Study|Adverse Event|0
117398|NCT00619619|400288|P3|Overall Study|Adverse Event|0
117399|NCT00619619|400289|P2|Overall Study|Adverse Event|0
117400|NCT00619619|400290|P1|Overall Study|Adverse Event|0
117401|NCT00619619|400283|P8|Overall Study|Protocol Violation|1
117402|NCT00619619|400284|P7|Overall Study|Protocol Violation|1
117403|NCT00619619|400285|P6|Overall Study|Protocol Violation|0
117404|NCT00619619|400286|P5|Overall Study|Protocol Violation|0
117405|NCT00619619|400287|P4|Overall Study|Protocol Violation|1
117406|NCT00619619|400288|P3|Overall Study|Protocol Violation|0
117407|NCT00619619|400289|P2|Overall Study|Protocol Violation|0
117408|NCT00619619|400290|P1|Overall Study|Protocol Violation|0
117409|NCT00619619|400283|P8|Overall Study|Physician Decision|0
117410|NCT00619619|400284|P7|Overall Study|Physician Decision|0
117411|NCT00619619|400285|P6|Overall Study|Physician Decision|0
117412|NCT00619619|400286|P5|Overall Study|Physician Decision|0
117413|NCT00619619|400287|P4|Overall Study|Physician Decision|0
117414|NCT00619619|400288|P3|Overall Study|Physician Decision|1
117415|NCT00619619|400289|P2|Overall Study|Physician Decision|0
117416|NCT00619619|400290|P1|Overall Study|Physician Decision|0
117417|NCT00619502|400377|P2|Overall Study|Lost to Follow-up|10
117418|NCT00619502|400378|P1|Overall Study|Lost to Follow-up|8
117419|NCT00619489|400390|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
117420|NCT00619489|400391|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
117421|NCT00619489|400390|P2|Overall Study|Lack of Efficacy|11
117422|NCT00619489|400391|P1|Overall Study|Lack of Efficacy|0
117423|NCT00619489|400390|P2|Overall Study|Withdrawal by Subject|1
117424|NCT00619489|400391|P1|Overall Study|Withdrawal by Subject|1
117425|NCT00619489|400390|P2|Overall Study|Adverse Event|7
117426|NCT00619489|400391|P1|Overall Study|Adverse Event|0
117427|NCT00619476|400413|P4|Overall Study|Withdrawal by Subject|4
117428|NCT00619476|400414|P3|Overall Study|Withdrawal by Subject|5
117429|NCT00619476|400415|P2|Overall Study|Withdrawal by Subject|7
117430|NCT00619476|400416|P1|Overall Study|Withdrawal by Subject|5
117431|NCT00619476|400413|P4|Overall Study|Investigator Discretion|0
117432|NCT00619476|400414|P3|Overall Study|Investigator Discretion|2
117433|NCT00619476|400415|P2|Overall Study|Investigator Discretion|2
117434|NCT00619476|400416|P1|Overall Study|Investigator Discretion|2
117435|NCT00619476|400413|P4|Overall Study|Lost to Follow-up|1
117436|NCT00619476|400414|P3|Overall Study|Lost to Follow-up|0
117437|NCT00619476|400415|P2|Overall Study|Lost to Follow-up|2
117438|NCT00619476|400416|P1|Overall Study|Lost to Follow-up|1
117439|NCT00619476|400413|P4|Overall Study|Protocol Violation|9
117440|NCT00619476|400414|P3|Overall Study|Protocol Violation|4
117441|NCT00619476|400415|P2|Overall Study|Protocol Violation|4
117442|NCT00619476|400416|P1|Overall Study|Protocol Violation|5
117443|NCT00619476|400413|P4|Overall Study|Lack of Efficacy|4
117444|NCT00619476|400414|P3|Overall Study|Lack of Efficacy|1
117445|NCT00619476|400415|P2|Overall Study|Lack of Efficacy|1
117446|NCT00619476|400416|P1|Overall Study|Lack of Efficacy|6
117447|NCT00619476|400413|P4|Overall Study|Adverse Event|16
117448|NCT00619476|400414|P3|Overall Study|Adverse Event|12
117449|NCT00619476|400415|P2|Overall Study|Adverse Event|6
117450|NCT00619476|400416|P1|Overall Study|Adverse Event|12
117451|NCT00619385|400501|P3|Overall Study|Other|1
117452|NCT00619385|400502|P2|Overall Study|Other|2
117453|NCT00619385|400503|P1|Overall Study|Other|1
117454|NCT00619385|400501|P3|Overall Study|Adverse Event|3
117455|NCT00619385|400502|P2|Overall Study|Adverse Event|0
117456|NCT00619385|400503|P1|Overall Study|Adverse Event|0
117457|NCT00619359|400518|P2|Overall Study|Progressive Disease|1
117458|NCT00619359|400519|P1|Overall Study|Progressive Disease|3
117459|NCT00619359|400518|P2|Overall Study|Withdrawal by Subject|20
117460|NCT00619359|400519|P1|Overall Study|Withdrawal by Subject|19
117461|NCT00619359|400518|P2|Overall Study|Protocol Violation|1
117462|NCT00619359|400519|P1|Overall Study|Protocol Violation|1
117463|NCT00619359|400518|P2|Overall Study|Physician Decision|7
117464|NCT00619359|400519|P1|Overall Study|Physician Decision|0
117465|NCT00619359|400518|P2|Overall Study|Lost to Follow-up|16
117466|NCT00619359|400519|P1|Overall Study|Lost to Follow-up|12
117467|NCT00619359|400518|P2|Overall Study|Adverse Event|36
117468|NCT00619359|400519|P1|Overall Study|Adverse Event|32
117469|NCT00619307|400531|P2|Overall Study|MS attack plus steroids|1
117470|NCT00619307|400532|P1|Overall Study|MS attack plus steroids|0
117471|NCT00619307|400531|P2|Overall Study|Severe migraine|1
117472|NCT00619307|400532|P1|Overall Study|Severe migraine|0
117473|NCT00619307|400531|P2|Overall Study|Withdrew consent|0
117474|NCT00619307|400532|P1|Overall Study|Withdrew consent|1
117475|NCT00619307|400531|P2|Overall Study|Protocol Violation|0
117476|NCT00619307|400532|P1|Overall Study|Protocol Violation|3
117477|NCT00619307|400531|P2|Overall Study|Lost to Follow-up|1
117478|NCT00619307|400532|P1|Overall Study|Lost to Follow-up|0
117479|NCT00619307|400531|P2|Overall Study|Adverse Event|1
117480|NCT00619307|400532|P1|Overall Study|Adverse Event|0
117481|NCT00619229|400552|P2|Overall Study|Investigator planned Cataract Operation|0
117482|NCT00619229|400553|P1|Overall Study|Investigator planned Cataract Operation|1
117483|NCT00619229|400552|P2|Overall Study|Termination of the Study by the Sponsor|1
117484|NCT00619229|400553|P1|Overall Study|Termination of the Study by the Sponsor|1
117485|NCT00619229|400552|P2|Overall Study|Lost to Follow-up|0
117486|NCT00619229|400553|P1|Overall Study|Lost to Follow-up|1
117487|NCT00619229|400552|P2|Overall Study|Withdrawal by Subject|1
117488|NCT00619229|400553|P1|Overall Study|Withdrawal by Subject|1
117489|NCT00619177|400592|P1|Overall Study|Not specified reasons|6
117490|NCT00619177|400592|P1|Overall Study|Missing termination information|481
117491|NCT00619177|400592|P1|Overall Study|Lack of Efficacy|1
117492|NCT00619177|400592|P1|Overall Study|Lost to Follow-up|2
117493|NCT00619177|400592|P1|Overall Study|Adverse Event|18
117494|NCT00619151|400602|P2|Overall Study|Study terminated prior to followup|0
117495|NCT00619151|400603|P1|Overall Study|Study terminated prior to followup|1
117496|NCT00619099|400617|P2|Overall Study|Physician Decision|6
117497|NCT00619099|400618|P1|Overall Study|Physician Decision|9
117498|NCT00619099|400617|P2|Overall Study|Withdrawal by Subject|2
117499|NCT00619099|400618|P1|Overall Study|Withdrawal by Subject|10
117500|NCT00619099|400617|P2|Overall Study|Emergence of Clinically Significant Lab|2
117501|NCT00619099|400618|P1|Overall Study|Emergence of Clinically Significant Lab|1
117502|NCT00619099|400617|P2|Overall Study|Adverse Event|3
117503|NCT00619099|400618|P1|Overall Study|Adverse Event|4
117504|NCT00619099|400617|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
117505|NCT00619099|400618|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
117506|NCT00619099|400617|P2|Overall Study|Progressive Disease|5
117507|NCT00619099|400618|P1|Overall Study|Progressive Disease|7
117508|NCT00618995|400640|P4|Period 4|Adverse Event|0
117509|NCT00618995|400641|P3|Period 4|Adverse Event|0
117510|NCT00618995|400642|P2|Period 4|Adverse Event|0
117511|NCT00618995|400643|P1|Period 4|Adverse Event|1
117512|NCT00618995|400640|P4|Period 2|Protocol Violation|0
117513|NCT00618995|400641|P3|Period 2|Protocol Violation|1
117514|NCT00618995|400642|P2|Period 2|Protocol Violation|0
117515|NCT00618995|400643|P1|Period 2|Protocol Violation|0
117516|NCT00618995|400640|P4|Period 1|Protocol Violation|0
117517|NCT00618995|400641|P3|Period 1|Protocol Violation|1
117518|NCT00618995|400642|P2|Period 1|Protocol Violation|1
117519|NCT00618995|400643|P1|Period 1|Protocol Violation|0
117520|NCT00618995|400640|P4|Period 1|Adverse Event|0
117521|NCT00618995|400641|P3|Period 1|Adverse Event|1
117522|NCT00618995|400642|P2|Period 1|Adverse Event|0
117523|NCT00618995|400643|P1|Period 1|Adverse Event|0
117524|NCT00618982|400657|P1|Overall Study|ongoing, still treated with study med.|25
117525|NCT00618982|400657|P1|Overall Study|Protocol Violation|1
117526|NCT00618982|400657|P1|Overall Study|Withdrawal by Subject|1
117527|NCT00618982|400657|P1|Overall Study|Adverse Event|23
117528|NCT00618956|400680|P2|Overall Study|did not meet criteria, non-compliance|1
117529|NCT00618956|400681|P1|Overall Study|did not meet criteria, non-compliance|2
117530|NCT00618956|400680|P2|Overall Study|Protocol Violation|2
117531|NCT00618956|400681|P1|Overall Study|Protocol Violation|2
117532|NCT00618956|400680|P2|Overall Study|Lost to Follow-up|5
117533|NCT00618956|400681|P1|Overall Study|Lost to Follow-up|4
117534|NCT00618956|400680|P2|Overall Study|Withdrawal by Subject|7
117535|NCT00618956|400681|P1|Overall Study|Withdrawal by Subject|5
117536|NCT00618956|400680|P2|Overall Study|Lack of Efficacy|1
117537|NCT00618956|400681|P1|Overall Study|Lack of Efficacy|2
117538|NCT00618956|400680|P2|Overall Study|Adverse Event|34
117539|NCT00618956|400681|P1|Overall Study|Adverse Event|10
117540|NCT00618813|400706|P1|Overall Study|Withdrawal by Subject|1
117541|NCT00618813|400706|P1|Overall Study|Physician Decision|2
117542|NCT00618813|400706|P1|Overall Study|Lack of Efficacy|1
117543|NCT00618787|400716|P2|Overall Study|Lost to Follow-up|0
117544|NCT00618787|400717|P1|Overall Study|Lost to Follow-up|1
117545|NCT00618787|400716|P2|Overall Study|Withdrawal by Subject|1
117546|NCT00618787|400717|P1|Overall Study|Withdrawal by Subject|2
117547|NCT00618787|400716|P2|Overall Study|Adverse Event|1
117548|NCT00618787|400717|P1|Overall Study|Adverse Event|0
117549|NCT00618774|400725|P2|Overall Study|Withdrawal by Subject|0
117550|NCT00618774|400726|P1|Overall Study|Withdrawal by Subject|1
117551|NCT00618774|400725|P2|Overall Study|Adverse Event|3
117552|NCT00618774|400726|P1|Overall Study|Adverse Event|5
117553|NCT00618748|400759|P3|Overall Study|Withdrawal by Subject|5
117554|NCT00618748|400760|P2|Overall Study|Withdrawal by Subject|1
117555|NCT00618748|400761|P1|Overall Study|Withdrawal by Subject|4
117556|NCT00618748|400759|P3|Overall Study|Physician Decision|1
117557|NCT00618748|400760|P2|Overall Study|Physician Decision|1
117558|NCT00618748|400761|P1|Overall Study|Physician Decision|3
117559|NCT00618748|400759|P3|Overall Study|Adverse Event|8
117560|NCT00618748|400760|P2|Overall Study|Adverse Event|3
117561|NCT00618748|400761|P1|Overall Study|Adverse Event|4
117562|NCT00618722|400806|P4|Overall Study|Miscellaneous Reasons|1
117563|NCT00618722|400807|P3|Overall Study|Miscellaneous Reasons|1
117564|NCT00618722|400808|P2|Overall Study|Miscellaneous Reasons|0
117565|NCT00618722|400809|P1|Overall Study|Miscellaneous Reasons|0
117566|NCT00618722|400806|P4|Overall Study|Lost to Follow-up|2
117567|NCT00618722|400807|P3|Overall Study|Lost to Follow-up|0
117568|NCT00618722|400808|P2|Overall Study|Lost to Follow-up|0
117569|NCT00618722|400809|P1|Overall Study|Lost to Follow-up|2
117570|NCT00618722|400806|P4|Overall Study|Inability to Complete Study Procedure|0
117571|NCT00618722|400807|P3|Overall Study|Inability to Complete Study Procedure|0
117572|NCT00618722|400808|P2|Overall Study|Inability to Complete Study Procedure|1
117573|NCT00618722|400809|P1|Overall Study|Inability to Complete Study Procedure|0
117574|NCT00618722|400806|P4|Overall Study|Patient Request|1
117575|NCT00618722|400807|P3|Overall Study|Patient Request|1
117576|NCT00618722|400808|P2|Overall Study|Patient Request|1
117577|NCT00618722|400809|P1|Overall Study|Patient Request|1
117578|NCT00618722|400806|P4|Overall Study|Refusal of Treatment|0
117579|NCT00618722|400807|P3|Overall Study|Refusal of Treatment|1
117580|NCT00618722|400808|P2|Overall Study|Refusal of Treatment|0
117581|NCT00618722|400809|P1|Overall Study|Refusal of Treatment|0
117582|NCT00618618|400847|P4|Overall Study|Death|0
117583|NCT00618618|400848|P3|Overall Study|Death|0
117584|NCT00618618|400849|P2|Overall Study|Death|1
117585|NCT00618618|400850|P1|Overall Study|Death|0
117586|NCT00618618|400847|P4|Overall Study|Did Not Meet Entry Criteria|0
117587|NCT00618618|400848|P3|Overall Study|Did Not Meet Entry Criteria|1
117588|NCT00618618|400849|P2|Overall Study|Did Not Meet Entry Criteria|0
117589|NCT00618618|400850|P1|Overall Study|Did Not Meet Entry Criteria|0
117590|NCT00618618|400847|P4|Overall Study|Non-compliance|0
117591|NCT00618618|400848|P3|Overall Study|Non-compliance|0
117592|NCT00618618|400849|P2|Overall Study|Non-compliance|1
117593|NCT00618618|400850|P1|Overall Study|Non-compliance|1
117594|NCT00618618|400847|P4|Overall Study|Lost to Follow-up|1
117595|NCT00618618|400848|P3|Overall Study|Lost to Follow-up|0
117596|NCT00618618|400849|P2|Overall Study|Lost to Follow-up|0
117597|NCT00618618|400850|P1|Overall Study|Lost to Follow-up|3
117598|NCT00618618|400847|P4|Overall Study|Inability to Complete Study Procedures|0
117599|NCT00618618|400848|P3|Overall Study|Inability to Complete Study Procedures|0
117600|NCT00618618|400849|P2|Overall Study|Inability to Complete Study Procedures|1
117601|NCT00618618|400850|P1|Overall Study|Inability to Complete Study Procedures|0
117602|NCT00618618|400847|P4|Overall Study|Patient Request|0
117603|NCT00618618|400848|P3|Overall Study|Patient Request|2
117604|NCT00618618|400849|P2|Overall Study|Patient Request|0
117605|NCT00618618|400850|P1|Overall Study|Patient Request|0
117606|NCT00618514|400909|P3|Overall Study|Lost to Follow-up|4
117607|NCT00618514|400910|P2|Overall Study|Lost to Follow-up|12
117608|NCT00618514|400911|P1|Overall Study|Lost to Follow-up|11
117609|NCT00618449|400931|P2|Overall Study|Lost to Follow-up|110
117610|NCT00618449|400932|P1|Overall Study|Lost to Follow-up|98
117611|NCT00618410|400951|P2|Washout Period (2 Weeks)|Physician Decision|1
117612|NCT00618410|400952|P1|Washout Period (2 Weeks)|Physician Decision|0
117613|NCT00618371|400968|P1|Overall Study|Withdrawal by Subject|2
117614|NCT00618072|401001|P3|Overall Study|Physician Decision|1
117615|NCT00618072|401002|P2|Overall Study|Physician Decision|1
117616|NCT00618072|401003|P1|Overall Study|Physician Decision|0
117617|NCT00618072|401001|P3|Overall Study|Lost to Follow-up|3
117618|NCT00618072|401002|P2|Overall Study|Lost to Follow-up|0
117619|NCT00618072|401003|P1|Overall Study|Lost to Follow-up|2
117620|NCT00617929|401035|P1|Overall Study|Physician Decision|1
117621|NCT00617903|401047|P2|Overall Study|noncompliance|1
117622|NCT00617903|401048|P1|Overall Study|noncompliance|0
117623|NCT00617903|401047|P2|Overall Study|Adverse Event|1
117624|NCT00617903|401048|P1|Overall Study|Adverse Event|0
117625|NCT00617903|401047|P2|Overall Study|Lack of Efficacy|1
117626|NCT00617903|401048|P1|Overall Study|Lack of Efficacy|0
117627|NCT00617903|401047|P2|Overall Study|Lost to Follow-up|1
117628|NCT00617903|401048|P1|Overall Study|Lost to Follow-up|1
117629|NCT00617903|401047|P2|Overall Study|Withdrawal by Subject|3
117630|NCT00617903|401048|P1|Overall Study|Withdrawal by Subject|2
117631|NCT00617890|401094|P4|Overall Study|Not treated|1
117632|NCT00617890|401095|P3|Overall Study|Not treated|1
117633|NCT00617890|401096|P2|Overall Study|Not treated|0
117634|NCT00617890|401097|P1|Overall Study|Not treated|1
117635|NCT00617890|401094|P4|Overall Study|Adverse Event|8
117636|NCT00617890|401095|P3|Overall Study|Adverse Event|3
117637|NCT00617890|401096|P2|Overall Study|Adverse Event|0
117638|NCT00617890|401097|P1|Overall Study|Adverse Event|1
117639|NCT00617890|401094|P4|Overall Study|Protocol Violation|0
117640|NCT00617890|401095|P3|Overall Study|Protocol Violation|0
117641|NCT00617890|401096|P2|Overall Study|Protocol Violation|1
117642|NCT00617890|401097|P1|Overall Study|Protocol Violation|2
117643|NCT00617890|401094|P4|Overall Study|Withdrawal by Subject|2
117644|NCT00617890|401095|P3|Overall Study|Withdrawal by Subject|0
117645|NCT00617890|401096|P2|Overall Study|Withdrawal by Subject|1
117646|NCT00617890|401097|P1|Overall Study|Withdrawal by Subject|4
117647|NCT00617890|401094|P4|Overall Study|Lost to Follow-up|2
117648|NCT00617890|401095|P3|Overall Study|Lost to Follow-up|1
117649|NCT00617890|401096|P2|Overall Study|Lost to Follow-up|0
117650|NCT00617890|401097|P1|Overall Study|Lost to Follow-up|0
117651|NCT00617890|401094|P4|Overall Study|Lack of Efficacy|97
117652|NCT00617890|401095|P3|Overall Study|Lack of Efficacy|30
117653|NCT00617890|401096|P2|Overall Study|Lack of Efficacy|26
117654|NCT00617890|401097|P1|Overall Study|Lack of Efficacy|23
117655|NCT00617890|401094|P4|Overall Study|Treatment ongoing at data cut-off|5
117656|NCT00617890|401095|P3|Overall Study|Treatment ongoing at data cut-off|0
117657|NCT00617890|401096|P2|Overall Study|Treatment ongoing at data cut-off|0
117658|NCT00617890|401097|P1|Overall Study|Treatment ongoing at data cut-off|0
117659|NCT00617851|401133|P4|Overall Study|Unable to classify|0
117660|NCT00617851|401134|P3|Overall Study|Unable to classify|1
117661|NCT00617851|401135|P2|Overall Study|Unable to classify|0
117662|NCT00617851|401136|P1|Overall Study|Unable to classify|1
117663|NCT00617851|401133|P4|Overall Study|Inappropriate Enrollment|1
117664|NCT00617851|401134|P3|Overall Study|Inappropriate Enrollment|1
117665|NCT00617851|401135|P2|Overall Study|Inappropriate Enrollment|4
117666|NCT00617851|401136|P1|Overall Study|Inappropriate Enrollment|5
117667|NCT00617851|401133|P4|Overall Study|Lost to Follow-up|19
117668|NCT00617851|401134|P3|Overall Study|Lost to Follow-up|31
117669|NCT00617851|401135|P2|Overall Study|Lost to Follow-up|29
117670|NCT00617851|401136|P1|Overall Study|Lost to Follow-up|27
117671|NCT00617851|401133|P4|Overall Study|Withdrawal by Subject|4
117672|NCT00617851|401134|P3|Overall Study|Withdrawal by Subject|12
117673|NCT00617851|401135|P2|Overall Study|Withdrawal by Subject|7
117674|NCT00617851|401136|P1|Overall Study|Withdrawal by Subject|14
117675|NCT00617851|401133|P4|Overall Study|Death|1
117676|NCT00617851|401134|P3|Overall Study|Death|0
117677|NCT00617851|401135|P2|Overall Study|Death|0
117678|NCT00617851|401136|P1|Overall Study|Death|0
117679|NCT00617773|401174|P1|Overall Study|Protocol Violation|1
117680|NCT00617773|401174|P1|Overall Study|Progressive disease|19
117681|NCT00617773|401174|P1|Overall Study|Death|1
117682|NCT00617773|401174|P1|Overall Study|Withdrawal by Subject|1
117683|NCT00617773|401174|P1|Overall Study|Lack of compliance with the protocol|1
117684|NCT00617773|401174|P1|Overall Study|Physician Decision|1
117685|NCT00617708|401192|P3|Overall Study|Not eligible|5
117686|NCT00617708|401193|P2|Overall Study|Not eligible|3
117687|NCT00617708|401194|P1|Overall Study|Not eligible|1
117688|NCT00617708|401192|P3|Overall Study|Not protocol specified|2
117689|NCT00617708|401193|P2|Overall Study|Not protocol specified|4
117690|NCT00617708|401194|P1|Overall Study|Not protocol specified|1
117691|NCT00617708|401192|P3|Overall Study|Progression/Relapse|36
117692|NCT00617708|401193|P2|Overall Study|Progression/Relapse|40
117693|NCT00617708|401194|P1|Overall Study|Progression/Relapse|7
117694|NCT00617708|401192|P3|Overall Study|Death|5
117695|NCT00617708|401193|P2|Overall Study|Death|6
117696|NCT00617708|401194|P1|Overall Study|Death|0
117697|NCT00617708|401192|P3|Overall Study|Withdrawal by Subject|7
117698|NCT00617708|401193|P2|Overall Study|Withdrawal by Subject|1
117699|NCT00617708|401194|P1|Overall Study|Withdrawal by Subject|1
117700|NCT00617708|401192|P3|Overall Study|Adverse Event|9
117701|NCT00617708|401193|P2|Overall Study|Adverse Event|6
117702|NCT00617708|401194|P1|Overall Study|Adverse Event|0
117703|NCT00617669|401211|P2|Overall Study|Patients randomized but not treated|3
117704|NCT00617669|401212|P1|Overall Study|Patients randomized but not treated|2
117705|NCT00617669|401211|P2|Overall Study|Reason not otherwise captured, eg; death|290
117706|NCT00617669|401212|P1|Overall Study|Reason not otherwise captured, eg; death|265
117707|NCT00617669|401211|P2|Overall Study|Protocol Violation|3
117708|NCT00617669|401212|P1|Overall Study|Protocol Violation|2
117709|NCT00617669|401211|P2|Overall Study|Adverse Event|76
117710|NCT00617669|401212|P1|Overall Study|Adverse Event|87
117711|NCT00617669|401211|P2|Overall Study|Lost to Follow-up|2
117712|NCT00617669|401212|P1|Overall Study|Lost to Follow-up|3
117713|NCT00617669|401211|P2|Overall Study|Withdrawal by Subject|77
117714|NCT00617669|401212|P1|Overall Study|Withdrawal by Subject|71
117715|NCT00617604|401234|P2|Overall Study|Randomized but Never Received Study Drug|3
117716|NCT00617604|401235|P1|Overall Study|Randomized but Never Received Study Drug|3
117717|NCT00617604|401234|P2|Overall Study|Withdrawal by Subject|6
117718|NCT00617604|401235|P1|Overall Study|Withdrawal by Subject|4
117719|NCT00617604|401234|P2|Overall Study|Miscellaneous Reasons|10
117720|NCT00617604|401235|P1|Overall Study|Miscellaneous Reasons|8
117721|NCT00617604|401234|P2|Overall Study|Lost to Follow-up|0
117722|NCT00617604|401235|P1|Overall Study|Lost to Follow-up|1
117723|NCT00617604|401234|P2|Overall Study|Death|1
117724|NCT00617604|401235|P1|Overall Study|Death|2
117725|NCT00617591|401279|P1|Overall Study|Withdrew consent during Maintenance|6
117726|NCT00617591|401279|P1|Overall Study|Withdrew consent during Induction|4
117727|NCT00617461|401287|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
117728|NCT00617461|401288|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
117729|NCT00617461|401287|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
117730|NCT00617461|401288|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
117731|NCT00617461|401287|P2|Second Treatment Intervention Period|Lack of Efficacy|3
117732|NCT00617461|401288|P1|Second Treatment Intervention Period|Lack of Efficacy|0
117733|NCT00617461|401287|P2|Second Treatment Intervention Period|Adverse Event|1
117734|NCT00617461|401288|P1|Second Treatment Intervention Period|Adverse Event|0
117735|NCT00617461|401287|P2|4-Day Crossover Period|Withdrawal by Subject|0
117736|NCT00617461|401288|P1|4-Day Crossover Period|Withdrawal by Subject|1
117737|NCT00617461|401287|P2|First Treatment Intervention Period|Withdrawal by Subject|0
117738|NCT00617461|401288|P1|First Treatment Intervention Period|Withdrawal by Subject|4
117739|NCT00617461|401287|P2|First Treatment Intervention Period|Investigator Discretion|1
117740|NCT00617461|401288|P1|First Treatment Intervention Period|Investigator Discretion|1
117741|NCT00617461|401287|P2|First Treatment Intervention Period|Lost to Follow-up|1
117742|NCT00617461|401288|P1|First Treatment Intervention Period|Lost to Follow-up|0
117743|NCT00617461|401287|P2|First Treatment Intervention Period|Protocol Violation|1
117744|NCT00617461|401288|P1|First Treatment Intervention Period|Protocol Violation|2
117745|NCT00617461|401287|P2|First Treatment Intervention Period|Lack of Efficacy|0
117746|NCT00617461|401288|P1|First Treatment Intervention Period|Lack of Efficacy|1
117747|NCT00617461|401287|P2|First Treatment Intervention Period|Adverse Event|0
117748|NCT00617461|401288|P1|First Treatment Intervention Period|Adverse Event|2
117749|NCT00617409|401344|P3|Overall Study|Alternative Therapy|0
117750|NCT00617409|401345|P2|Overall Study|Alternative Therapy|2
117751|NCT00617409|401346|P1|Overall Study|Alternative Therapy|1
117752|NCT00617409|401344|P3|Overall Study|Death|4
117753|NCT00617409|401345|P2|Overall Study|Death|5
117754|NCT00617409|401346|P1|Overall Study|Death|3
117755|NCT00617409|401344|P3|Overall Study|Disease Progression|18
117756|NCT00617409|401345|P2|Overall Study|Disease Progression|8
117757|NCT00617409|401346|P1|Overall Study|Disease Progression|8
117758|NCT00617409|401344|P3|Overall Study|Adverse Event|3
117759|NCT00617409|401345|P2|Overall Study|Adverse Event|2
117760|NCT00617409|401346|P1|Overall Study|Adverse Event|0
117761|NCT00617409|401344|P3|Overall Study|Withdrawal by Subject|2
117762|NCT00617409|401345|P2|Overall Study|Withdrawal by Subject|1
117763|NCT00617409|401346|P1|Overall Study|Withdrawal by Subject|4
117764|NCT00617357|401361|P1|Overall Study|Physician Decision|1
117765|NCT00617357|401361|P1|Overall Study|Withdrawal by Subject|1
117766|NCT00617357|401361|P1|Overall Study|insurance concerns|2
117767|NCT00617357|401361|P1|Overall Study|Death|5
117768|NCT00617357|401361|P1|Overall Study|Lost to Follow-up|7
117769|NCT00617305|401374|P3|Overall Study|Withdrawal by Subject|0
117770|NCT00617305|401375|P2|Overall Study|Withdrawal by Subject|0
117771|NCT00617305|401376|P1|Overall Study|Withdrawal by Subject|1
117772|NCT00617305|401374|P3|Overall Study|Protocol Violation|1
117773|NCT00617305|401375|P2|Overall Study|Protocol Violation|0
117774|NCT00617305|401376|P1|Overall Study|Protocol Violation|1
117775|NCT00617305|401374|P3|Overall Study|Physician Decision|0
117776|NCT00617305|401375|P2|Overall Study|Physician Decision|0
117777|NCT00617305|401376|P1|Overall Study|Physician Decision|1
117778|NCT00617305|401374|P3|Overall Study|Death|0
117779|NCT00617305|401375|P2|Overall Study|Death|0
117780|NCT00617305|401376|P1|Overall Study|Death|1
117781|NCT00617305|401374|P3|Overall Study|Adverse Event|0
117782|NCT00617305|401375|P2|Overall Study|Adverse Event|0
117783|NCT00617305|401376|P1|Overall Study|Adverse Event|4
117784|NCT00617279|401432|P2|Overall Study|Death|2
117785|NCT00617279|401433|P1|Overall Study|Death|1
117786|NCT00617279|401432|P2|Overall Study|Lost to Follow-up|0
117787|NCT00617279|401433|P1|Overall Study|Lost to Follow-up|1
117788|NCT00617279|401432|P2|Overall Study|Graft abandonment|0
117789|NCT00617279|401433|P1|Overall Study|Graft abandonment|2
117790|NCT00617279|401432|P2|Overall Study|Study terminated by Sponsor|15
117791|NCT00617279|401433|P1|Overall Study|Study terminated by Sponsor|10
117792|NCT00617240|401489|P2|Overall Study|Lack of Efficacy|0
117793|NCT00617240|401490|P1|Overall Study|Lack of Efficacy|1
117794|NCT00617201|401510|P2|Overall Study|Lost to Follow-up|13
117795|NCT00617201|401511|P1|Overall Study|Lost to Follow-up|9
117796|NCT00617123|401539|P2|Study Treatment Period|Noncompliance with Protocol|1
117797|NCT00617123|401540|P1|Study Treatment Period|Noncompliance with Protocol|0
117798|NCT00617123|401539|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
117799|NCT00617123|401540|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
117800|NCT00617123|401539|P2|Study Treatment Period|Adverse Event|3
117801|NCT00617123|401540|P1|Study Treatment Period|Adverse Event|7
117802|NCT00617123|401539|P2|Study Treatment Period|Withdrawal by Subject|12
117803|NCT00617123|401540|P1|Study Treatment Period|Withdrawal by Subject|8
117804|NCT00617123|401539|P2|Referral Screening Period|Adverse Event|1
117805|NCT00617123|401540|P1|Referral Screening Period|Adverse Event|0
117806|NCT00617123|401539|P2|Referral Screening Period|Did Not Wish To Continue|1
117807|NCT00617123|401540|P1|Referral Screening Period|Did Not Wish To Continue|3
117808|NCT00617123|401539|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
117809|NCT00617123|401540|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
117810|NCT00617084|401571|P2|Overall Study|Missed 12 Months visit|19
117811|NCT00617084|401572|P1|Overall Study|Missed 12 Months visit|16
117812|NCT00617084|401571|P2|Overall Study|Withdrawal by Subject|7
117813|NCT00617084|401572|P1|Overall Study|Withdrawal by Subject|5
117814|NCT00616967|401625|P3|Overall Study|Withdrawal by Subject|1
117815|NCT00616967|401626|P2|Overall Study|Withdrawal by Subject|0
117816|NCT00616967|401627|P1|Overall Study|Withdrawal by Subject|0
117817|NCT00616928|401640|P4|Overall Study|Lost to Follow-up|0
117818|NCT00616928|401641|P3|Overall Study|Lost to Follow-up|0
117819|NCT00616928|401642|P2|Overall Study|Lost to Follow-up|7
117820|NCT00616928|401643|P1|Overall Study|Lost to Follow-up|5
117821|NCT00616928|401640|P4|Overall Study|Unspecified|5
117822|NCT00616928|401641|P3|Overall Study|Unspecified|15
117823|NCT00616928|401642|P2|Overall Study|Unspecified|8
117824|NCT00616928|401643|P1|Overall Study|Unspecified|51
117825|NCT00616928|401640|P4|Overall Study|Adverse Event|2
117826|NCT00616928|401641|P3|Overall Study|Adverse Event|2
117827|NCT00616928|401642|P2|Overall Study|Adverse Event|3
117828|NCT00616928|401643|P1|Overall Study|Adverse Event|6
117829|NCT00616902|401707|P2|Overall Study|Termination of study|6
117830|NCT00616902|401708|P1|Overall Study|Termination of study|6
117831|NCT00616759|401751|P2|Overall Study|Withdrawal by Subject|2
117832|NCT00616759|401752|P1|Overall Study|Withdrawal by Subject|1
117833|NCT00616759|401751|P2|Overall Study|Physician Decision|0
117834|NCT00616759|401752|P1|Overall Study|Physician Decision|2
117835|NCT00616655|401761|P3|Overall Study|unspecified|5
117836|NCT00616655|401762|P2|Overall Study|unspecified|6
117837|NCT00616655|401763|P1|Overall Study|unspecified|6
117838|NCT00616655|401761|P3|Overall Study|Does not meet in/ex criteria|2
117839|NCT00616655|401762|P2|Overall Study|Does not meet in/ex criteria|0
117840|NCT00616655|401763|P1|Overall Study|Does not meet in/ex criteria|0
117841|NCT00616655|401761|P3|Overall Study|Withdrawal by Subject|11
117842|NCT00616655|401762|P2|Overall Study|Withdrawal by Subject|7
117843|NCT00616655|401763|P1|Overall Study|Withdrawal by Subject|9
117844|NCT00616655|401761|P3|Overall Study|Protocol Violation|3
117845|NCT00616655|401762|P2|Overall Study|Protocol Violation|4
117846|NCT00616655|401763|P1|Overall Study|Protocol Violation|2
117847|NCT00616655|401761|P3|Overall Study|Lost to Follow-up|10
117848|NCT00616655|401762|P2|Overall Study|Lost to Follow-up|12
117849|NCT00616655|401763|P1|Overall Study|Lost to Follow-up|3
117850|NCT00616655|401761|P3|Overall Study|Lack of Efficacy|5
117851|NCT00616655|401762|P2|Overall Study|Lack of Efficacy|5
117852|NCT00616655|401763|P1|Overall Study|Lack of Efficacy|5
117853|NCT00616655|401761|P3|Overall Study|Adverse Event|12
117854|NCT00616655|401762|P2|Overall Study|Adverse Event|7
117855|NCT00616655|401763|P1|Overall Study|Adverse Event|10
117856|NCT00616642|401803|P2|Overall Study|Withdrawal by Subject|1
117857|NCT00616642|401804|P1|Overall Study|Withdrawal by Subject|0
117858|NCT00616629|401815|P5|Overall Study|AV-block|0
117859|NCT00616629|401816|P4|Overall Study|AV-block|0
117860|NCT00616629|401817|P3|Overall Study|AV-block|0
117861|NCT00616629|401818|P2|Overall Study|AV-block|0
117862|NCT00616629|401819|P1|Overall Study|AV-block|1
117863|NCT00616629|401815|P5|Overall Study|Protocol Violation|0
117864|NCT00616629|401816|P4|Overall Study|Protocol Violation|0
117865|NCT00616629|401817|P3|Overall Study|Protocol Violation|1
117866|NCT00616629|401818|P2|Overall Study|Protocol Violation|2
117867|NCT00616629|401819|P1|Overall Study|Protocol Violation|1
117868|NCT00616603|401864|P3|Overall Study|Physician Decision|2
117869|NCT00616603|401865|P2|Overall Study|Physician Decision|0
117870|NCT00616603|401866|P1|Overall Study|Physician Decision|2
117871|NCT00616434|401889|P2|Overall Study|Protocol deviation|1
117872|NCT00616434|401890|P1|Overall Study|Protocol deviation|0
117873|NCT00616434|401889|P2|Overall Study|Withdrawal by Subject|1
117874|NCT00616434|401890|P1|Overall Study|Withdrawal by Subject|1
117875|NCT00616434|401889|P2|Overall Study|Physician Decision|4
117876|NCT00616434|401890|P1|Overall Study|Physician Decision|0
117877|NCT00616434|401889|P2|Overall Study|Adverse Event|2
117878|NCT00616434|401890|P1|Overall Study|Adverse Event|5
117879|NCT00616421|401903|P3|Overall Study|Unable to classify|0
117880|NCT00616421|401904|P2|Overall Study|Unable to classify|0
117881|NCT00616421|401905|P1|Overall Study|Unable to classify|1
117882|NCT00616421|401903|P3|Overall Study|Protocol Violation|2
117883|NCT00616421|401904|P2|Overall Study|Protocol Violation|1
117884|NCT00616421|401905|P1|Overall Study|Protocol Violation|0
117885|NCT00616421|401903|P3|Overall Study|Administrative reason|0
117886|NCT00616421|401904|P2|Overall Study|Administrative reason|0
117887|NCT00616421|401905|P1|Overall Study|Administrative reason|1
117888|NCT00616421|401903|P3|Overall Study|Inappropriate enrollment|1
117889|NCT00616421|401904|P2|Overall Study|Inappropriate enrollment|0
117890|NCT00616421|401905|P1|Overall Study|Inappropriate enrollment|3
117891|NCT00616421|401903|P3|Overall Study|Lost to Follow-up|30
117892|NCT00616421|401904|P2|Overall Study|Lost to Follow-up|26
117893|NCT00616421|401905|P1|Overall Study|Lost to Follow-up|12
117894|NCT00616421|401903|P3|Overall Study|Withdrawal by Subject|8
117895|NCT00616421|401904|P2|Overall Study|Withdrawal by Subject|11
117896|NCT00616421|401905|P1|Overall Study|Withdrawal by Subject|9
117897|NCT00616239|401946|P1|Overall Study|Withdrawal by Subject|2
117898|NCT00616018|401979|P1|Overall Study|Protocol Violation|3
117899|NCT00615992|401984|P1|Overall Study|Protocol Violation|67
117900|NCT00615914|402010|P1|Overall Study|Irregularly enrolled patients|10
117901|NCT00615914|402010|P1|Overall Study|No treatment|2
117902|NCT00615914|402010|P1|Overall Study|No data was collected.|65
117903|NCT00615914|402010|P1|Overall Study|Physician Decision|4
117904|NCT00615914|402010|P1|Overall Study|Withdrawal by Subject|16
117905|NCT00615914|402010|P1|Overall Study|Lost to Follow-up|187
117906|NCT00615914|402010|P1|Overall Study|Lack of Efficacy|59
117907|NCT00615914|402010|P1|Overall Study|Death|20
117908|NCT00615914|402010|P1|Overall Study|Adverse Event|274
117909|NCT00615836|402021|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
117910|NCT00615836|402022|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
117911|NCT00615836|402023|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
117912|NCT00615836|402024|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
117913|NCT00615836|402025|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
117914|NCT00615836|402021|P5|Extension Study (FE992026 CS31)|Not reported|0
117915|NCT00615836|402022|P4|Extension Study (FE992026 CS31)|Not reported|4
117916|NCT00615836|402023|P3|Extension Study (FE992026 CS31)|Not reported|1
117917|NCT00615836|402024|P2|Extension Study (FE992026 CS31)|Not reported|4
117918|NCT00615836|402025|P1|Extension Study (FE992026 CS31)|Not reported|6
117919|NCT00615836|402021|P5|Extension Study (FE992026 CS31)|Not specified|0
117920|NCT00615836|402022|P4|Extension Study (FE992026 CS31)|Not specified|8
117921|NCT00615836|402023|P3|Extension Study (FE992026 CS31)|Not specified|8
117922|NCT00615836|402024|P2|Extension Study (FE992026 CS31)|Not specified|7
117923|NCT00615836|402025|P1|Extension Study (FE992026 CS31)|Not specified|10
117924|NCT00615836|402021|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
117925|NCT00615836|402022|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
117926|NCT00615836|402023|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
117927|NCT00615836|402024|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
117928|NCT00615836|402025|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
117929|NCT00615836|402021|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
117930|NCT00615836|402022|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
117931|NCT00615836|402023|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
117932|NCT00615836|402024|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
117933|NCT00615836|402025|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
117934|NCT00615836|402021|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
117935|NCT00615836|402022|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
117936|NCT00615836|402023|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
117937|NCT00615836|402024|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
117938|NCT00615836|402025|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
117939|NCT00615836|402021|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
117940|NCT00615836|402022|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
117941|NCT00615836|402023|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
117942|NCT00615836|402024|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
117943|NCT00615836|402025|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
117944|NCT00615836|402021|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
117945|NCT00615836|402022|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
117946|NCT00615836|402023|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
117947|NCT00615836|402024|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
117948|NCT00615836|402025|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
117949|NCT00615836|402021|P5|Extension Study (FE992026 CS31)|Adverse Event|0
117950|NCT00615836|402022|P4|Extension Study (FE992026 CS31)|Adverse Event|13
117951|NCT00615836|402023|P3|Extension Study (FE992026 CS31)|Adverse Event|15
117952|NCT00615836|402024|P2|Extension Study (FE992026 CS31)|Adverse Event|12
117953|NCT00615836|402025|P1|Extension Study (FE992026 CS31)|Adverse Event|7
117954|NCT00615719|402085|P1|Overall Study|Physician Decision|5
117955|NCT00615550|402099|P2|Overall Study|Lost to Follow-up|1
117956|NCT00615550|402100|P1|Overall Study|Lost to Follow-up|6
117957|NCT00615459|402123|P4|Period III|Unsatisfactory therapeutic effect|0
117958|NCT00615459|402124|P3|Period III|Unsatisfactory therapeutic effect|0
117959|NCT00615459|402125|P2|Period III|Unsatisfactory therapeutic effect|1
117960|NCT00615459|402126|P1|Period III|Unsatisfactory therapeutic effect|0
117961|NCT00615459|402123|P4|Period III|Administrative problems|0
117962|NCT00615459|402124|P3|Period III|Administrative problems|1
117963|NCT00615459|402125|P2|Period III|Administrative problems|1
117964|NCT00615459|402126|P1|Period III|Administrative problems|0
117965|NCT00615459|402123|P4|Period III|Adverse Event|0
117966|NCT00615459|402124|P3|Period III|Adverse Event|0
117967|NCT00615459|402125|P2|Period III|Adverse Event|1
117968|NCT00615459|402126|P1|Period III|Adverse Event|0
117969|NCT00615459|402123|P4|Period II|Lost to Follow-up|1
117970|NCT00615459|402124|P3|Period II|Lost to Follow-up|0
117971|NCT00615459|402125|P2|Period II|Lost to Follow-up|0
117972|NCT00615459|402126|P1|Period II|Lost to Follow-up|0
117973|NCT00615459|402123|P4|Period II|Adverse Event|0
117974|NCT00615459|402124|P3|Period II|Adverse Event|0
117975|NCT00615459|402125|P2|Period II|Adverse Event|0
117976|NCT00615459|402126|P1|Period II|Adverse Event|1
117977|NCT00615459|402123|P4|Period I|Abnormal test procedure results|0
117978|NCT00615459|402124|P3|Period I|Abnormal test procedure results|1
117979|NCT00615459|402125|P2|Period I|Abnormal test procedure results|1
117980|NCT00615459|402126|P1|Period I|Abnormal test procedure results|1
117981|NCT00615459|402123|P4|Period I|Subject withdrew consent|1
117982|NCT00615459|402124|P3|Period I|Subject withdrew consent|0
117983|NCT00615459|402125|P2|Period I|Subject withdrew consent|0
117984|NCT00615459|402126|P1|Period I|Subject withdrew consent|1
117985|NCT00615459|402123|P4|Period I|Adverse Event|0
117986|NCT00615459|402124|P3|Period I|Adverse Event|1
117987|NCT00615459|402125|P2|Period I|Adverse Event|0
117988|NCT00615459|402126|P1|Period I|Adverse Event|2
117989|NCT00614120|402165|P4|Overall Study|Lost to Follow-up|4
117990|NCT00614120|402166|P3|Overall Study|Lost to Follow-up|3
117991|NCT00614120|402167|P2|Overall Study|Lost to Follow-up|2
117992|NCT00614120|402168|P1|Overall Study|Lost to Follow-up|1
117993|NCT00614120|402165|P4|Overall Study|Taken inhibition medication eg Prandin|1
117994|NCT00614120|402166|P3|Overall Study|Taken inhibition medication eg Prandin|1
117995|NCT00614120|402167|P2|Overall Study|Taken inhibition medication eg Prandin|0
117996|NCT00614120|402168|P1|Overall Study|Taken inhibition medication eg Prandin|0
117997|NCT00614120|402165|P4|Overall Study|Late syphilis, latent|0
117998|NCT00614120|402166|P3|Overall Study|Late syphilis, latent|0
117999|NCT00614120|402167|P2|Overall Study|Late syphilis, latent|0
118000|NCT00614120|402168|P1|Overall Study|Late syphilis, latent|1
118001|NCT00614120|402165|P4|Overall Study|Lack of trial product|0
118002|NCT00614120|402166|P3|Overall Study|Lack of trial product|2
118003|NCT00614120|402167|P2|Overall Study|Lack of trial product|3
118004|NCT00614120|402168|P1|Overall Study|Lack of trial product|3
118005|NCT00614120|402165|P4|Overall Study|Hypoglycaemia|1
118006|NCT00614120|402166|P3|Overall Study|Hypoglycaemia|0
118007|NCT00614120|402167|P2|Overall Study|Hypoglycaemia|0
118008|NCT00614120|402168|P1|Overall Study|Hypoglycaemia|0
118009|NCT00614120|402165|P4|Overall Study|hCG positive (not pregnant)|0
118010|NCT00614120|402166|P3|Overall Study|hCG positive (not pregnant)|1
118011|NCT00614120|402167|P2|Overall Study|hCG positive (not pregnant)|0
118012|NCT00614120|402168|P1|Overall Study|hCG positive (not pregnant)|0
118013|NCT00614120|402165|P4|Overall Study|Did not meet trial criteria|1
118014|NCT00614120|402166|P3|Overall Study|Did not meet trial criteria|1
118015|NCT00614120|402167|P2|Overall Study|Did not meet trial criteria|1
118016|NCT00614120|402168|P1|Overall Study|Did not meet trial criteria|0
118017|NCT00614120|402165|P4|Overall Study|Withdrawal by Subject|3
118018|NCT00614120|402166|P3|Overall Study|Withdrawal by Subject|16
118019|NCT00614120|402167|P2|Overall Study|Withdrawal by Subject|10
118020|NCT00614120|402168|P1|Overall Study|Withdrawal by Subject|9
118021|NCT00614120|402165|P4|Overall Study|Withdrawal criteria|0
118022|NCT00614120|402166|P3|Overall Study|Withdrawal criteria|0
118023|NCT00614120|402167|P2|Overall Study|Withdrawal criteria|0
118024|NCT00614120|402168|P1|Overall Study|Withdrawal criteria|1
118025|NCT00614120|402165|P4|Overall Study|Protocol Violation|1
118026|NCT00614120|402166|P3|Overall Study|Protocol Violation|3
118027|NCT00614120|402167|P2|Overall Study|Protocol Violation|5
118028|NCT00614120|402168|P1|Overall Study|Protocol Violation|2
118029|NCT00614120|402165|P4|Overall Study|Lack of Efficacy|2
118030|NCT00614120|402166|P3|Overall Study|Lack of Efficacy|2
118031|NCT00614120|402167|P2|Overall Study|Lack of Efficacy|3
118032|NCT00614120|402168|P1|Overall Study|Lack of Efficacy|3
118033|NCT00614120|402165|P4|Overall Study|Adverse Event|3
118034|NCT00614120|402166|P3|Overall Study|Adverse Event|30
118035|NCT00614120|402167|P2|Overall Study|Adverse Event|22
118036|NCT00614120|402168|P1|Overall Study|Adverse Event|9
118037|NCT00614055|402209|P3|Overall Study|Unclassified|2
118038|NCT00614055|402210|P2|Overall Study|Unclassified|4
118039|NCT00614055|402211|P1|Overall Study|Unclassified|1
118040|NCT00614055|402209|P3|Overall Study|Lack of Efficacy|2
118041|NCT00614055|402210|P2|Overall Study|Lack of Efficacy|0
118042|NCT00614055|402211|P1|Overall Study|Lack of Efficacy|0
118043|NCT00614055|402209|P3|Overall Study|Protocol Violation|1
118044|NCT00614055|402210|P2|Overall Study|Protocol Violation|2
118045|NCT00614055|402211|P1|Overall Study|Protocol Violation|2
118046|NCT00614055|402209|P3|Overall Study|Adverse Event|0
118047|NCT00614055|402210|P2|Overall Study|Adverse Event|0
118048|NCT00614055|402211|P1|Overall Study|Adverse Event|1
118049|NCT00613951|402258|P3|Overall Study|Unclassified|2
118050|NCT00613951|402259|P2|Overall Study|Unclassified|3
118051|NCT00613951|402260|P1|Overall Study|Unclassified|5
118052|NCT00613951|402258|P3|Overall Study|Protocol Violation|1
118053|NCT00613951|402259|P2|Overall Study|Protocol Violation|1
118054|NCT00613951|402260|P1|Overall Study|Protocol Violation|1
118055|NCT00613951|402258|P3|Overall Study|Lack of Efficacy|1
118056|NCT00613951|402259|P2|Overall Study|Lack of Efficacy|1
118057|NCT00613951|402260|P1|Overall Study|Lack of Efficacy|0
118058|NCT00613951|402258|P3|Overall Study|Adverse Event|1
118059|NCT00613951|402259|P2|Overall Study|Adverse Event|0
118060|NCT00613951|402260|P1|Overall Study|Adverse Event|1
118061|NCT00615290|402301|P1|Overall Study|Other|2
118062|NCT00615290|402301|P1|Overall Study|Withdrawal by Subject|1
118063|NCT00615290|402301|P1|Overall Study|Lost to Follow-up|3
118064|NCT00615290|402301|P1|Overall Study|Adverse Event|2
118065|NCT00615264|402315|P2|Overall Study|Dermal Hypersensitivity|3
118066|NCT00615264|402316|P1|Overall Study|Dermal Hypersensitivity|0
118067|NCT00615264|402315|P2|Overall Study|Not defined|4
118068|NCT00615264|402316|P1|Overall Study|Not defined|7
118069|NCT00615264|402315|P2|Overall Study|Protocol Violation|7
118070|NCT00615264|402316|P1|Overall Study|Protocol Violation|11
118071|NCT00615264|402315|P2|Overall Study|Death|1
118072|NCT00615264|402316|P1|Overall Study|Death|1
118073|NCT00615264|402315|P2|Overall Study|Adverse Event|5
118074|NCT00615264|402316|P1|Overall Study|Adverse Event|8
118075|NCT00615264|402315|P2|Overall Study|Lost to Follow-up|13
118076|NCT00615264|402316|P1|Overall Study|Lost to Follow-up|6
118077|NCT00615264|402315|P2|Overall Study|Withdrawal by Subject|19
118078|NCT00615264|402316|P1|Overall Study|Withdrawal by Subject|17
118079|NCT00615199|402328|P4|Overall Study|Withdrawal by Subject|0
118080|NCT00615199|402329|P3|Overall Study|Withdrawal by Subject|0
118081|NCT00615199|402330|P2|Overall Study|Withdrawal by Subject|1
118082|NCT00615199|402331|P1|Overall Study|Withdrawal by Subject|2
118083|NCT00615199|402328|P4|Overall Study|Unspecified|1
118084|NCT00615199|402329|P3|Overall Study|Unspecified|0
118085|NCT00615199|402330|P2|Overall Study|Unspecified|0
118086|NCT00615199|402331|P1|Overall Study|Unspecified|0
118087|NCT00615199|402328|P4|Overall Study|Lost to Follow-up|0
118088|NCT00615199|402329|P3|Overall Study|Lost to Follow-up|0
118089|NCT00615199|402330|P2|Overall Study|Lost to Follow-up|0
118090|NCT00615199|402331|P1|Overall Study|Lost to Follow-up|1
118091|NCT00615199|402328|P4|Overall Study|Lack of Efficacy|1
118092|NCT00615199|402329|P3|Overall Study|Lack of Efficacy|0
118093|NCT00615199|402330|P2|Overall Study|Lack of Efficacy|0
118094|NCT00615199|402331|P1|Overall Study|Lack of Efficacy|2
118095|NCT00615199|402328|P4|Overall Study|Adverse Event|0
118096|NCT00615199|402329|P3|Overall Study|Adverse Event|1
118097|NCT00615199|402330|P2|Overall Study|Adverse Event|1
118098|NCT00615199|402331|P1|Overall Study|Adverse Event|3
118099|NCT00615108|402365|P1|Overall Study|Lost to Follow-up|15
118100|NCT00615108|402365|P1|Overall Study|Other|370
118101|NCT00615108|402365|P1|Overall Study|Adverse Event|122
118102|NCT00615069|402380|P1|Overall Study|Withdrawal by Subject|4
118103|NCT00615069|402380|P1|Overall Study|Physician Decision|2
118104|NCT00615069|402380|P1|Overall Study|Death|10
118105|NCT00615056|402389|P4|Overall Study|Randomized but not treated|0
118106|NCT00615056|402390|P3|Overall Study|Randomized but not treated|0
118107|NCT00615056|402391|P2|Overall Study|Randomized but not treated|0
118108|NCT00615056|402392|P1|Overall Study|Randomized but not treated|3
118109|NCT00615056|402389|P4|Overall Study|Discontinued by Sponsor|0
118110|NCT00615056|402390|P3|Overall Study|Discontinued by Sponsor|0
118111|NCT00615056|402391|P2|Overall Study|Discontinued by Sponsor|0
118112|NCT00615056|402392|P1|Overall Study|Discontinued by Sponsor|1
118113|NCT00615056|402389|P4|Overall Study|Withdrawal by Subject|0
118114|NCT00615056|402390|P3|Overall Study|Withdrawal by Subject|1
118115|NCT00615056|402391|P2|Overall Study|Withdrawal by Subject|1
118116|NCT00615056|402392|P1|Overall Study|Withdrawal by Subject|0
118117|NCT00615056|402389|P4|Overall Study|Objective progression or relapse|0
118118|NCT00615056|402390|P3|Overall Study|Objective progression or relapse|0
118119|NCT00615056|402391|P2|Overall Study|Objective progression or relapse|2
118120|NCT00615056|402392|P1|Overall Study|Objective progression or relapse|0
118121|NCT00615056|402389|P4|Overall Study|Unspecified|7
118122|NCT00615056|402390|P3|Overall Study|Unspecified|10
118123|NCT00615056|402391|P2|Overall Study|Unspecified|15
118124|NCT00615056|402392|P1|Overall Study|Unspecified|13
118125|NCT00615056|402389|P4|Overall Study|Lost to Follow-up|5
118126|NCT00615056|402390|P3|Overall Study|Lost to Follow-up|4
118127|NCT00615056|402391|P2|Overall Study|Lost to Follow-up|2
118128|NCT00615056|402392|P1|Overall Study|Lost to Follow-up|1
118129|NCT00615056|402389|P4|Overall Study|Death|23
118130|NCT00615056|402390|P3|Overall Study|Death|21
118131|NCT00615056|402391|P2|Overall Study|Death|31
118132|NCT00615056|402392|P1|Overall Study|Death|31
118133|NCT00615030|402422|P12|Period III|Administrative problems|0
118134|NCT00615030|402423|P11|Period III|Administrative problems|0
118135|NCT00615030|402424|P10|Period III|Administrative problems|0
118136|NCT00615030|402425|P9|Period III|Administrative problems|0
118137|NCT00615030|402426|P8|Period III|Administrative problems|0
118138|NCT00615030|402427|P7|Period III|Administrative problems|0
118139|NCT00615030|402428|P6|Period III|Administrative problems|0
118140|NCT00615030|402429|P5|Period III|Administrative problems|0
118141|NCT00615030|402430|P4|Period III|Administrative problems|1
118142|NCT00615030|402431|P3|Period III|Administrative problems|0
118143|NCT00615030|402432|P2|Period III|Administrative problems|0
118144|NCT00615030|402433|P1|Period III|Administrative problems|1
118145|NCT00615030|402422|P12|Period II|Subject withdrew consent|0
118146|NCT00615030|402423|P11|Period II|Subject withdrew consent|0
118147|NCT00615030|402424|P10|Period II|Subject withdrew consent|0
118148|NCT00615030|402425|P9|Period II|Subject withdrew consent|0
118149|NCT00615030|402426|P8|Period II|Subject withdrew consent|0
118150|NCT00615030|402427|P7|Period II|Subject withdrew consent|1
118151|NCT00615030|402428|P6|Period II|Subject withdrew consent|0
118152|NCT00615030|402429|P5|Period II|Subject withdrew consent|0
118153|NCT00615030|402430|P4|Period II|Subject withdrew consent|1
118154|NCT00615030|402431|P3|Period II|Subject withdrew consent|0
118155|NCT00615030|402432|P2|Period II|Subject withdrew consent|0
118156|NCT00615030|402433|P1|Period II|Subject withdrew consent|0
118157|NCT00615030|402422|P12|Period II|Adverse Event|0
118158|NCT00615030|402423|P11|Period II|Adverse Event|0
118159|NCT00615030|402424|P10|Period II|Adverse Event|0
118160|NCT00615030|402425|P9|Period II|Adverse Event|1
118161|NCT00615030|402426|P8|Period II|Adverse Event|0
118162|NCT00615030|402427|P7|Period II|Adverse Event|0
118163|NCT00615030|402428|P6|Period II|Adverse Event|0
118164|NCT00615030|402429|P5|Period II|Adverse Event|0
118165|NCT00615030|402430|P4|Period II|Adverse Event|0
118166|NCT00615030|402431|P3|Period II|Adverse Event|1
118167|NCT00615030|402432|P2|Period II|Adverse Event|0
118168|NCT00615030|402433|P1|Period II|Adverse Event|0
118169|NCT00615030|402422|P12|Period I|Abnormal laboratory value(s)|0
118170|NCT00615030|402423|P11|Period I|Abnormal laboratory value(s)|0
118171|NCT00615030|402424|P10|Period I|Abnormal laboratory value(s)|0
118172|NCT00615030|402425|P9|Period I|Abnormal laboratory value(s)|0
118173|NCT00615030|402426|P8|Period I|Abnormal laboratory value(s)|0
118174|NCT00615030|402427|P7|Period I|Abnormal laboratory value(s)|0
118175|NCT00615030|402428|P6|Period I|Abnormal laboratory value(s)|1
118176|NCT00615030|402429|P5|Period I|Abnormal laboratory value(s)|0
118177|NCT00615030|402430|P4|Period I|Abnormal laboratory value(s)|0
118178|NCT00615030|402431|P3|Period I|Abnormal laboratory value(s)|0
118179|NCT00615030|402432|P2|Period I|Abnormal laboratory value(s)|0
118180|NCT00615030|402433|P1|Period I|Abnormal laboratory value(s)|0
118181|NCT00615030|402422|P12|Period I|Subject withdrew consent|1
118182|NCT00615030|402423|P11|Period I|Subject withdrew consent|1
118183|NCT00615030|402424|P10|Period I|Subject withdrew consent|0
118184|NCT00615030|402425|P9|Period I|Subject withdrew consent|1
118185|NCT00615030|402426|P8|Period I|Subject withdrew consent|0
118186|NCT00615030|402427|P7|Period I|Subject withdrew consent|0
118187|NCT00615030|402428|P6|Period I|Subject withdrew consent|0
118188|NCT00615030|402429|P5|Period I|Subject withdrew consent|0
118189|NCT00615030|402430|P4|Period I|Subject withdrew consent|0
118190|NCT00615030|402431|P3|Period I|Subject withdrew consent|0
118191|NCT00615030|402432|P2|Period I|Subject withdrew consent|0
118192|NCT00615030|402433|P1|Period I|Subject withdrew consent|0
118193|NCT00615030|402422|P12|Period I|Protocol deviation|0
118194|NCT00615030|402423|P11|Period I|Protocol deviation|0
118195|NCT00615030|402424|P10|Period I|Protocol deviation|0
118196|NCT00615030|402425|P9|Period I|Protocol deviation|0
118197|NCT00615030|402426|P8|Period I|Protocol deviation|0
118198|NCT00615030|402427|P7|Period I|Protocol deviation|0
118199|NCT00615030|402428|P6|Period I|Protocol deviation|0
118200|NCT00615030|402429|P5|Period I|Protocol deviation|0
118201|NCT00615030|402430|P4|Period I|Protocol deviation|0
118202|NCT00615030|402431|P3|Period I|Protocol deviation|0
118203|NCT00615030|402432|P2|Period I|Protocol deviation|0
118204|NCT00615030|402433|P1|Period I|Protocol deviation|1
118205|NCT00615030|402422|P12|Period I|Administrative problem|0
118206|NCT00615030|402423|P11|Period I|Administrative problem|0
118207|NCT00615030|402424|P10|Period I|Administrative problem|0
118208|NCT00615030|402425|P9|Period I|Administrative problem|0
118209|NCT00615030|402426|P8|Period I|Administrative problem|0
118210|NCT00615030|402427|P7|Period I|Administrative problem|0
118211|NCT00615030|402428|P6|Period I|Administrative problem|0
118212|NCT00615030|402429|P5|Period I|Administrative problem|1
118213|NCT00615030|402430|P4|Period I|Administrative problem|0
118214|NCT00615030|402431|P3|Period I|Administrative problem|0
118215|NCT00615030|402432|P2|Period I|Administrative problem|0
118216|NCT00615030|402433|P1|Period I|Administrative problem|0
118217|NCT00615017|402453|P6|Overall Study|Physician discontinued drug|1
118218|NCT00615017|402454|P5|Overall Study|Physician discontinued drug|0
118219|NCT00615017|402455|P4|Overall Study|Physician discontinued drug|0
118220|NCT00615017|402456|P3|Overall Study|Physician discontinued drug|0
118221|NCT00615017|402457|P2|Overall Study|Physician discontinued drug|0
118222|NCT00615017|402458|P1|Overall Study|Physician discontinued drug|0
118223|NCT00615017|402453|P6|Overall Study|Transferred out of Intensive Care Unit|0
118224|NCT00615017|402454|P5|Overall Study|Transferred out of Intensive Care Unit|0
118225|NCT00615017|402455|P4|Overall Study|Transferred out of Intensive Care Unit|1
118226|NCT00615017|402456|P3|Overall Study|Transferred out of Intensive Care Unit|0
118227|NCT00615017|402457|P2|Overall Study|Transferred out of Intensive Care Unit|0
118228|NCT00615017|402458|P1|Overall Study|Transferred out of Intensive Care Unit|0
118229|NCT00615017|402453|P6|Overall Study|Sepsis resolved|0
118230|NCT00615017|402454|P5|Overall Study|Sepsis resolved|0
118231|NCT00615017|402455|P4|Overall Study|Sepsis resolved|0
118232|NCT00615017|402456|P3|Overall Study|Sepsis resolved|1
118233|NCT00615017|402457|P2|Overall Study|Sepsis resolved|0
118234|NCT00615017|402458|P1|Overall Study|Sepsis resolved|0
118235|NCT00615017|402453|P6|Overall Study|Death|1
118236|NCT00615017|402454|P5|Overall Study|Death|1
118237|NCT00615017|402455|P4|Overall Study|Death|0
118238|NCT00615017|402456|P3|Overall Study|Death|2
118239|NCT00615017|402457|P2|Overall Study|Death|0
118240|NCT00615017|402458|P1|Overall Study|Death|0
118241|NCT00615017|402453|P6|Overall Study|Adverse Event|1
118242|NCT00615017|402454|P5|Overall Study|Adverse Event|0
118243|NCT00615017|402455|P4|Overall Study|Adverse Event|0
118244|NCT00615017|402456|P3|Overall Study|Adverse Event|2
118245|NCT00615017|402457|P2|Overall Study|Adverse Event|1
118246|NCT00615017|402458|P1|Overall Study|Adverse Event|0
118247|NCT00614991|402616|P6|Overall Study|Adverse Event|0
118248|NCT00614991|402617|P5|Overall Study|Adverse Event|1
118249|NCT00614991|402618|P4|Overall Study|Adverse Event|0
118250|NCT00614991|402619|P3|Overall Study|Adverse Event|0
118251|NCT00614991|402620|P2|Overall Study|Adverse Event|3
118252|NCT00614991|402621|P1|Overall Study|Adverse Event|3
118253|NCT00614939|402655|P2|Overall Study|Hospitalized due to kidney transplant|0
118254|NCT00614939|402656|P1|Overall Study|Hospitalized due to kidney transplant|1
118255|NCT00614939|402655|P2|Overall Study|Poor/non-compliance|0
118256|NCT00614939|402656|P1|Overall Study|Poor/non-compliance|4
118257|NCT00614939|402655|P2|Overall Study|Death|3
118258|NCT00614939|402656|P1|Overall Study|Death|4
118259|NCT00614939|402655|P2|Overall Study|Incorrect enrollment|2
118260|NCT00614939|402656|P1|Overall Study|Incorrect enrollment|1
118261|NCT00614939|402655|P2|Overall Study|Adverse Event|5
118262|NCT00614939|402656|P1|Overall Study|Adverse Event|2
118263|NCT00614939|402655|P2|Overall Study|Study specific discontinuation criteris|16
118264|NCT00614939|402656|P1|Overall Study|Study specific discontinuation criteris|13
118265|NCT00614939|402655|P2|Overall Study|Withdrawal by Subject|17
118266|NCT00614939|402656|P1|Overall Study|Withdrawal by Subject|10
118267|NCT00614926|402690|P2|Overall Study|Adverse Event|0
118268|NCT00614926|402691|P1|Overall Study|Adverse Event|3
118269|NCT00614926|402690|P2|Overall Study|Burden of travel|0
118270|NCT00614926|402691|P1|Overall Study|Burden of travel|1
118271|NCT00614874|402704|P1|Overall Study|Withdrawal by Subject|1
118272|NCT00614874|402704|P1|Overall Study|Protocol Violation|1
118273|NCT00614614|402713|P5|Booster Vaccination Phase|Unspecified|1
118274|NCT00614614|402714|P4|Booster Vaccination Phase|Unspecified|2
118275|NCT00614614|402715|P3|Booster Vaccination Phase|Unspecified|3
118276|NCT00614614|402716|P2|Booster Vaccination Phase|Unspecified|1
118277|NCT00614614|402717|P1|Booster Vaccination Phase|Unspecified|0
118278|NCT00614614|402713|P5|Booster Vaccination Phase|Protocol Violation|0
118279|NCT00614614|402714|P4|Booster Vaccination Phase|Protocol Violation|3
118280|NCT00614614|402715|P3|Booster Vaccination Phase|Protocol Violation|2
118281|NCT00614614|402716|P2|Booster Vaccination Phase|Protocol Violation|0
118282|NCT00614614|402717|P1|Booster Vaccination Phase|Protocol Violation|0
118283|NCT00614614|402713|P5|Booster Vaccination Phase|Lost to Follow-up|8
118284|NCT00614614|402714|P4|Booster Vaccination Phase|Lost to Follow-up|10
118285|NCT00614614|402715|P3|Booster Vaccination Phase|Lost to Follow-up|17
118286|NCT00614614|402716|P2|Booster Vaccination Phase|Lost to Follow-up|5
118287|NCT00614614|402717|P1|Booster Vaccination Phase|Lost to Follow-up|0
118288|NCT00614614|402713|P5|Booster Vaccination Phase|Withdrawal by Subject|4
118289|NCT00614614|402714|P4|Booster Vaccination Phase|Withdrawal by Subject|3
118290|NCT00614614|402715|P3|Booster Vaccination Phase|Withdrawal by Subject|4
118291|NCT00614614|402716|P2|Booster Vaccination Phase|Withdrawal by Subject|0
118292|NCT00614614|402717|P1|Booster Vaccination Phase|Withdrawal by Subject|0
118293|NCT00614614|402713|P5|Booster Vaccination Phase|Adverse Event|0
118294|NCT00614614|402714|P4|Booster Vaccination Phase|Adverse Event|1
118295|NCT00614614|402715|P3|Booster Vaccination Phase|Adverse Event|1
118296|NCT00614614|402716|P2|Booster Vaccination Phase|Adverse Event|0
118297|NCT00614614|402717|P1|Booster Vaccination Phase|Adverse Event|0
118298|NCT00614614|402713|P5|Primary Vaccination Phase|Unspecified|0
118299|NCT00614614|402714|P4|Primary Vaccination Phase|Unspecified|0
118300|NCT00614614|402715|P3|Primary Vaccination Phase|Unspecified|0
118301|NCT00614614|402716|P2|Primary Vaccination Phase|Unspecified|0
118302|NCT00614614|402717|P1|Primary Vaccination Phase|Unspecified|4
118303|NCT00614614|402713|P5|Primary Vaccination Phase|Protocol Violation|0
118304|NCT00614614|402714|P4|Primary Vaccination Phase|Protocol Violation|0
118305|NCT00614614|402715|P3|Primary Vaccination Phase|Protocol Violation|0
118306|NCT00614614|402716|P2|Primary Vaccination Phase|Protocol Violation|3
118307|NCT00614614|402717|P1|Primary Vaccination Phase|Protocol Violation|9
118308|NCT00614614|402713|P5|Primary Vaccination Phase|Lost to Follow-up|0
118309|NCT00614614|402714|P4|Primary Vaccination Phase|Lost to Follow-up|0
118310|NCT00614614|402715|P3|Primary Vaccination Phase|Lost to Follow-up|0
118311|NCT00614614|402716|P2|Primary Vaccination Phase|Lost to Follow-up|8
118312|NCT00614614|402717|P1|Primary Vaccination Phase|Lost to Follow-up|26
118313|NCT00614614|402713|P5|Primary Vaccination Phase|Withdrawal by Subject|0
118314|NCT00614614|402714|P4|Primary Vaccination Phase|Withdrawal by Subject|0
118315|NCT00614614|402715|P3|Primary Vaccination Phase|Withdrawal by Subject|0
118316|NCT00614614|402716|P2|Primary Vaccination Phase|Withdrawal by Subject|6
118317|NCT00614614|402717|P1|Primary Vaccination Phase|Withdrawal by Subject|45
118318|NCT00614614|402713|P5|Primary Vaccination Phase|Adverse Event|0
118319|NCT00614614|402714|P4|Primary Vaccination Phase|Adverse Event|0
118320|NCT00614614|402715|P3|Primary Vaccination Phase|Adverse Event|0
118321|NCT00614614|402716|P2|Primary Vaccination Phase|Adverse Event|0
118322|NCT00614614|402717|P1|Primary Vaccination Phase|Adverse Event|6
118323|NCT00614575|402840|P1|Overall Study|No treatment|1
118324|NCT00614575|402840|P1|Overall Study|Irregularly enrolled patients|23
118325|NCT00614575|402840|P1|Overall Study|No data were collected.|18
118326|NCT00614575|402840|P1|Overall Study|Physician Decision|2
118327|NCT00614575|402840|P1|Overall Study|Death|3
118328|NCT00614575|402840|P1|Overall Study|Withdrawal by Subject|6
118329|NCT00614575|402840|P1|Overall Study|Lack of Efficacy|14
118330|NCT00614575|402840|P1|Overall Study|Lost to Follow-up|55
118331|NCT00614575|402840|P1|Overall Study|Adverse Event|106
118332|NCT00614523|402851|P2|Overall Study|Administrative Decision|46
118333|NCT00614523|402852|P1|Overall Study|Administrative Decision|23
118334|NCT00614523|402851|P2|Overall Study|Disease Progression|8
118335|NCT00614523|402852|P1|Overall Study|Disease Progression|0
118336|NCT00614523|402851|P2|Overall Study|Ineligibility Determined|2
118337|NCT00614523|402852|P1|Overall Study|Ineligibility Determined|1
118338|NCT00614523|402851|P2|Overall Study|Other|11
118339|NCT00614523|402852|P1|Overall Study|Other|6
118340|NCT00614523|402851|P2|Overall Study|Withdrawal by Subject|22
118341|NCT00614523|402852|P1|Overall Study|Withdrawal by Subject|12
118342|NCT00614523|402851|P2|Overall Study|Protocol Violation|2
118343|NCT00614523|402852|P1|Overall Study|Protocol Violation|3
118344|NCT00614523|402851|P2|Overall Study|Lost to Follow-up|1
118345|NCT00614523|402852|P1|Overall Study|Lost to Follow-up|0
118346|NCT00614523|402851|P2|Overall Study|Lack of Efficacy|11
118347|NCT00614523|402852|P1|Overall Study|Lack of Efficacy|9
118348|NCT00614523|402851|P2|Overall Study|Death|8
118349|NCT00614523|402852|P1|Overall Study|Death|5
118350|NCT00614523|402851|P2|Overall Study|Adverse Event|20
118351|NCT00614523|402852|P1|Overall Study|Adverse Event|4
118352|NCT00614393|402908|P5|Overall Study|Not Treated|2
118353|NCT00614393|402909|P4|Overall Study|Not Treated|0
118354|NCT00614393|402910|P3|Overall Study|Not Treated|0
118355|NCT00614393|402911|P2|Overall Study|Not Treated|0
118356|NCT00614393|402912|P1|Overall Study|Not Treated|0
118357|NCT00614393|402908|P5|Overall Study|Other|2
118358|NCT00614393|402909|P4|Overall Study|Other|4
118359|NCT00614393|402910|P3|Overall Study|Other|0
118360|NCT00614393|402911|P2|Overall Study|Other|0
118361|NCT00614393|402912|P1|Overall Study|Other|4
118362|NCT00614393|402908|P5|Overall Study|Withdrawal by Subject|13
118363|NCT00614393|402909|P4|Overall Study|Withdrawal by Subject|16
118364|NCT00614393|402910|P3|Overall Study|Withdrawal by Subject|1
118365|NCT00614393|402911|P2|Overall Study|Withdrawal by Subject|1
118366|NCT00614393|402912|P1|Overall Study|Withdrawal by Subject|20
118367|NCT00614393|402908|P5|Overall Study|Terminated by Sponsor|1
118368|NCT00614393|402909|P4|Overall Study|Terminated by Sponsor|0
118369|NCT00614393|402910|P3|Overall Study|Terminated by Sponsor|0
118370|NCT00614393|402911|P2|Overall Study|Terminated by Sponsor|0
118371|NCT00614393|402912|P1|Overall Study|Terminated by Sponsor|0
118372|NCT00614393|402908|P5|Overall Study|Protocol Violation|0
118373|NCT00614393|402909|P4|Overall Study|Protocol Violation|0
118374|NCT00614393|402910|P3|Overall Study|Protocol Violation|0
118375|NCT00614393|402911|P2|Overall Study|Protocol Violation|0
118376|NCT00614393|402912|P1|Overall Study|Protocol Violation|1
118377|NCT00614393|402908|P5|Overall Study|Progressive Disease|130
118378|NCT00614393|402909|P4|Overall Study|Progressive Disease|138
118379|NCT00614393|402910|P3|Overall Study|Progressive Disease|5
118380|NCT00614393|402911|P2|Overall Study|Progressive Disease|5
118381|NCT00614393|402912|P1|Overall Study|Progressive Disease|118
118382|NCT00614393|402908|P5|Overall Study|Physician Decision|9
118383|NCT00614393|402909|P4|Overall Study|Physician Decision|8
118384|NCT00614393|402910|P3|Overall Study|Physician Decision|1
118385|NCT00614393|402911|P2|Overall Study|Physician Decision|0
118386|NCT00614393|402912|P1|Overall Study|Physician Decision|17
118387|NCT00614393|402908|P5|Overall Study|Lost to Follow-up|2
118388|NCT00614393|402909|P4|Overall Study|Lost to Follow-up|1
118389|NCT00614393|402910|P3|Overall Study|Lost to Follow-up|0
118390|NCT00614393|402911|P2|Overall Study|Lost to Follow-up|0
118391|NCT00614393|402912|P1|Overall Study|Lost to Follow-up|0
118392|NCT00614393|402908|P5|Overall Study|Adverse Event|21
118393|NCT00614393|402909|P4|Overall Study|Adverse Event|13
118394|NCT00614393|402910|P3|Overall Study|Adverse Event|3
118395|NCT00614393|402911|P2|Overall Study|Adverse Event|2
118396|NCT00614393|402912|P1|Overall Study|Adverse Event|20
118397|NCT00614380|402958|P4|Overall Study|Consent withdrawn|0
118398|NCT00614380|402959|P3|Overall Study|Consent withdrawn|0
118399|NCT00614380|402960|P2|Overall Study|Consent withdrawn|1
118400|NCT00614380|402961|P1|Overall Study|Consent withdrawn|3
118401|NCT00614380|402958|P4|Overall Study|Non compliant with the protocol|2
118402|NCT00614380|402959|P3|Overall Study|Non compliant with the protocol|1
118403|NCT00614380|402960|P2|Overall Study|Non compliant with the protocol|2
118404|NCT00614380|402961|P1|Overall Study|Non compliant with the protocol|12
118405|NCT00614380|402958|P4|Overall Study|Lost to Follow-up|0
118406|NCT00614380|402959|P3|Overall Study|Lost to Follow-up|0
118407|NCT00614380|402960|P2|Overall Study|Lost to Follow-up|1
118408|NCT00614380|402961|P1|Overall Study|Lost to Follow-up|6
118409|NCT00614380|402958|P4|Overall Study|Adverse Event|0
118410|NCT00614380|402959|P3|Overall Study|Adverse Event|0
118411|NCT00614380|402960|P2|Overall Study|Adverse Event|4
118412|NCT00614380|402961|P1|Overall Study|Adverse Event|14
118413|NCT00613938|403019|P4|Overall Study|Other|3
118414|NCT00613938|403020|P3|Overall Study|Other|1
118415|NCT00613938|403021|P2|Overall Study|Other|2
118416|NCT00613938|403022|P1|Overall Study|Other|1
118417|NCT00613938|403019|P4|Overall Study|Lack of Efficacy|9
118418|NCT00613938|403020|P3|Overall Study|Lack of Efficacy|5
118419|NCT00613938|403021|P2|Overall Study|Lack of Efficacy|18
118420|NCT00613938|403022|P1|Overall Study|Lack of Efficacy|16
118421|NCT00613938|403019|P4|Overall Study|Adverse Event|5
118422|NCT00613938|403020|P3|Overall Study|Adverse Event|8
118423|NCT00613938|403021|P2|Overall Study|Adverse Event|4
118424|NCT00613938|403022|P1|Overall Study|Adverse Event|1
118425|NCT00613938|403019|P4|Overall Study|Withdrawal by Subject|9
118426|NCT00613938|403020|P3|Overall Study|Withdrawal by Subject|9
118427|NCT00613938|403021|P2|Overall Study|Withdrawal by Subject|4
118428|NCT00613938|403022|P1|Overall Study|Withdrawal by Subject|2
118429|NCT00613925|403054|P2|Overall Study|1 did not tolerate outpatient biopsy|1
118430|NCT00613925|403055|P1|Overall Study|1 did not tolerate outpatient biopsy|0
118431|NCT00613730|403063|P1|Overall Study|Administrative decision|1
118432|NCT00613730|403063|P1|Overall Study|Disease progression|2
118433|NCT00613626|403072|P3|Overall Study|Ineligible|0
118434|NCT00613626|403073|P2|Overall Study|Ineligible|1
118435|NCT00613626|403074|P1|Overall Study|Ineligible|0
118436|NCT00613574|403090|P1|Overall Study|Other|1
118437|NCT00613574|403090|P1|Overall Study|Lost to Follow-up|2
118438|NCT00613574|403090|P1|Overall Study|Adverse Event|3
118439|NCT00613509|403102|P2|Cycle 1|Other administrative reason|1
118440|NCT00613509|403103|P1|Cycle 1|Other administrative reason|0
118441|NCT00613509|403102|P2|Cycle 1|Unacceptable Toxicity|0
118442|NCT00613509|403103|P1|Cycle 1|Unacceptable Toxicity|1
118443|NCT00613509|403102|P2|Cycle 1|Disease Progression|6
118444|NCT00613509|403103|P1|Cycle 1|Disease Progression|2
118445|NCT00613509|403102|P2|Cycle 1|Adverse Event|1
118446|NCT00613509|403103|P1|Cycle 1|Adverse Event|2
118447|NCT00613366|403149|P2|Overall Study|Withdrawal by Subject|2
118448|NCT00613366|403150|P1|Overall Study|Withdrawal by Subject|3
118449|NCT00613327|403158|P1|Overall Study|Unspecified|47
118450|NCT00613327|403158|P1|Overall Study|Protocol Violation|2
118451|NCT00613327|403158|P1|Overall Study|Withdrawal by Subject|6
118452|NCT00613327|403158|P1|Overall Study|Lost to Follow-up|8
118453|NCT00613327|403158|P1|Overall Study|Adverse Event|38
118454|NCT00613314|403177|P1|Overall Study|Other reason not defined above|90
118455|NCT00613314|403177|P1|Overall Study|Lost to Follow-up|46
118456|NCT00613314|403177|P1|Overall Study|Protocol Violation|14
118457|NCT00613314|403177|P1|Overall Study|Adverse Event|5
118458|NCT00613301|403185|P1|Overall Study|Irregularly enrolled patients|12
118459|NCT00613301|403185|P1|Overall Study|No data was collected|53
118460|NCT00613301|403185|P1|Overall Study|Physician Decision|2
118461|NCT00613301|403185|P1|Overall Study|Lack of Efficacy|13
118462|NCT00613301|403185|P1|Overall Study|Death|6
118463|NCT00613301|403185|P1|Overall Study|Withdrawal by Subject|5
118464|NCT00613301|403185|P1|Overall Study|Lost to Follow-up|88
118465|NCT00613301|403185|P1|Overall Study|Adverse Event|49
118466|NCT00613106|403194|P2|Overall Study|misc|3
118467|NCT00613106|403195|P1|Overall Study|misc|4
118468|NCT00613106|403194|P2|Overall Study|Lost to Follow-up|2
118469|NCT00613106|403195|P1|Overall Study|Lost to Follow-up|7
118470|NCT00613106|403194|P2|Overall Study|Withdrawal by Subject|3
118471|NCT00613106|403195|P1|Overall Study|Withdrawal by Subject|6
118472|NCT00613106|403194|P2|Overall Study|Adverse Event|1
118473|NCT00613106|403195|P1|Overall Study|Adverse Event|3
118474|NCT00613080|403201|P1|Overall Study|Ineligible / no protocol treatment|11
118475|NCT00613015|403228|P6|Overall Study|Lost to Follow-up|3
118476|NCT00613015|403229|P5|Overall Study|Lost to Follow-up|2
118477|NCT00613015|403230|P4|Overall Study|Lost to Follow-up|3
118478|NCT00613015|403231|P3|Overall Study|Lost to Follow-up|3
118479|NCT00613015|403232|P2|Overall Study|Lost to Follow-up|1
118480|NCT00613015|403233|P1|Overall Study|Lost to Follow-up|0
118481|NCT00612807|403269|P2|Overall Study|Withdrawal by Subject|0
118482|NCT00612807|403270|P1|Overall Study|Withdrawal by Subject|2
118483|NCT00612690|403280|P2|Overall Study|Withdrawal by Site|0
118484|NCT00612690|403281|P1|Overall Study|Withdrawal by Site|11
118485|NCT00612690|403280|P2|Overall Study|Withdrawal by Subject|20
118486|NCT00612690|403281|P1|Overall Study|Withdrawal by Subject|32
118487|NCT00612690|403280|P2|Overall Study|Lost to Follow-up|98
118488|NCT00612690|403281|P1|Overall Study|Lost to Follow-up|72
118489|NCT00612677|403289|P1|Overall Study|study closed before treatment started|1
118490|NCT00612534|403328|P4|Overall Study|Other Reason|0
118491|NCT00612534|403329|P3|Overall Study|Other Reason|0
118492|NCT00612534|403330|P2|Overall Study|Other Reason|1
118493|NCT00612534|403331|P1|Overall Study|Other Reason|0
118494|NCT00612534|403328|P4|Overall Study|Lack of Efficacy|16
118495|NCT00612534|403329|P3|Overall Study|Lack of Efficacy|5
118496|NCT00612534|403330|P2|Overall Study|Lack of Efficacy|12
118497|NCT00612534|403331|P1|Overall Study|Lack of Efficacy|13
118498|NCT00612534|403328|P4|Overall Study|Adverse Event|1
118499|NCT00612534|403329|P3|Overall Study|Adverse Event|2
118500|NCT00612534|403330|P2|Overall Study|Adverse Event|4
118501|NCT00612534|403331|P1|Overall Study|Adverse Event|0
118502|NCT00612508|403343|P2|Overall Study|Withdrawal by Subject|4
118503|NCT00612508|403344|P1|Overall Study|Withdrawal by Subject|3
118504|NCT00612313|403375|P2|Overall Study|Lost to Follow-up|4
118505|NCT00612313|403376|P1|Overall Study|Lost to Follow-up|11
118506|NCT00612313|403375|P2|Overall Study|Withdrawal by Subject|9
118507|NCT00612313|403376|P1|Overall Study|Withdrawal by Subject|6
118508|NCT00612105|403400|P2|Period Title 3: 3-Week Taper Phase|Other|0
118509|NCT00612105|403401|P1|Period Title 3: 3-Week Taper Phase|Other|1
118510|NCT00612105|403400|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
118511|NCT00612105|403401|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
118512|NCT00612105|403400|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
118513|NCT00612105|403401|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
118514|NCT00612105|403400|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
118515|NCT00612105|403401|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
118516|NCT00612105|403400|P2|Period Title 1: 6-Week Titration Phase|Other|1
118517|NCT00612105|403401|P1|Period Title 1: 6-Week Titration Phase|Other|0
118518|NCT00612105|403400|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
118519|NCT00612105|403401|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
118520|NCT00612105|403400|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
118521|NCT00612105|403401|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
118522|NCT00612105|403400|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
118523|NCT00612105|403401|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
118524|NCT00612105|403400|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
118525|NCT00612105|403401|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
118526|NCT00612105|403400|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
118527|NCT00612105|403401|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
118528|NCT00612105|403400|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
118529|NCT00612105|403401|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
118530|NCT00612105|403400|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
118531|NCT00612105|403401|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
118532|NCT00612066|403451|P1|Overall Study|Adverse Event|1
118533|NCT00612040|403458|P3|Overall Study|Unclassified|5
118534|NCT00612040|403459|P2|Overall Study|Unclassified|2
118535|NCT00612040|403460|P1|Overall Study|Unclassified|2
118536|NCT00612040|403458|P3|Overall Study|Lack of Efficacy|0
118537|NCT00612040|403459|P2|Overall Study|Lack of Efficacy|1
118538|NCT00612040|403460|P1|Overall Study|Lack of Efficacy|2
118539|NCT00612040|403458|P3|Overall Study|Protocol Violation|1
118540|NCT00612040|403459|P2|Overall Study|Protocol Violation|2
118541|NCT00612040|403460|P1|Overall Study|Protocol Violation|1
118542|NCT00612040|403458|P3|Overall Study|Adverse Event|1
118543|NCT00612040|403459|P2|Overall Study|Adverse Event|2
118544|NCT00612040|403460|P1|Overall Study|Adverse Event|0
118545|NCT00611884|403533|P4|Overall Study|Unclassified|3
118546|NCT00611884|403534|P3|Overall Study|Unclassified|2
118547|NCT00611884|403535|P2|Overall Study|Unclassified|4
118548|NCT00611884|403536|P1|Overall Study|Unclassified|7
118549|NCT00611884|403533|P4|Overall Study|Lack of Efficacy|0
118550|NCT00611884|403534|P3|Overall Study|Lack of Efficacy|0
118551|NCT00611884|403535|P2|Overall Study|Lack of Efficacy|1
118552|NCT00611884|403536|P1|Overall Study|Lack of Efficacy|0
118553|NCT00611884|403533|P4|Overall Study|Non-Compliance|2
118554|NCT00611884|403534|P3|Overall Study|Non-Compliance|2
118555|NCT00611884|403535|P2|Overall Study|Non-Compliance|4
118556|NCT00611884|403536|P1|Overall Study|Non-Compliance|1
118557|NCT00611884|403533|P4|Overall Study|Adverse Event|1
118558|NCT00611884|403534|P3|Overall Study|Adverse Event|0
118559|NCT00611884|403535|P2|Overall Study|Adverse Event|0
118560|NCT00611884|403536|P1|Overall Study|Adverse Event|1
118561|NCT00611806|403592|P2|Overall Study|Lost to Follow-up|0
118562|NCT00611806|403593|P1|Overall Study|Lost to Follow-up|6
118563|NCT00611806|403592|P2|Overall Study|Adverse Event|1
118564|NCT00611806|403593|P1|Overall Study|Adverse Event|2
118565|NCT00611806|403592|P2|Overall Study|Withdrawal by Subject|2
118566|NCT00611806|403593|P1|Overall Study|Withdrawal by Subject|8
118567|NCT00611715|403607|P2|Overall Study|two patients are still on treatment|0
118568|NCT00611715|403608|P1|Overall Study|two patients are still on treatment|2
118569|NCT00611715|403607|P2|Overall Study|Death|0
118570|NCT00611715|403608|P1|Overall Study|Death|1
118571|NCT00611715|403607|P2|Overall Study|Adverse Event|1
118572|NCT00611715|403608|P1|Overall Study|Adverse Event|9
118573|NCT00611715|403607|P2|Overall Study|Withdrawal by Subject|1
118574|NCT00611715|403608|P1|Overall Study|Withdrawal by Subject|5
118575|NCT00611715|403607|P2|Overall Study|Disease Progression|4
118576|NCT00611715|403608|P1|Overall Study|Disease Progression|24
118577|NCT00611559|403623|P3|Overall Study|Protocol Violation|1
118578|NCT00611559|403624|P2|Overall Study|Protocol Violation|0
118579|NCT00611559|403625|P1|Overall Study|Protocol Violation|1
118580|NCT00611559|403623|P3|Overall Study|Lost to Follow-up|0
118581|NCT00611559|403624|P2|Overall Study|Lost to Follow-up|1
118582|NCT00611559|403625|P1|Overall Study|Lost to Follow-up|0
118583|NCT00611455|403699|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
118584|NCT00611455|403700|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
118585|NCT00611455|403701|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
118586|NCT00611455|403699|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
118587|NCT00611455|403700|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
118588|NCT00611455|403701|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
118589|NCT00611455|403699|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
118590|NCT00611455|403700|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
118591|NCT00611455|403701|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
118592|NCT00611455|403699|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
118593|NCT00611455|403700|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
118594|NCT00611455|403701|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
118595|NCT00611455|403699|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
118596|NCT00611455|403700|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
118597|NCT00611455|403701|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
118598|NCT00611455|403699|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
118599|NCT00611455|403700|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
118600|NCT00611455|403701|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
118601|NCT00611455|403699|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
118602|NCT00611455|403700|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
118603|NCT00611455|403701|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
118604|NCT00611455|403699|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
118605|NCT00611455|403700|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
118606|NCT00611455|403701|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
118607|NCT00611455|403699|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
118608|NCT00611455|403700|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
118609|NCT00611455|403701|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
118610|NCT00611455|403699|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
118611|NCT00611455|403700|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
118612|NCT00611455|403701|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
118613|NCT00611455|403699|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
118614|NCT00611455|403700|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
118615|NCT00611455|403701|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
118616|NCT00611455|403699|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
118617|NCT00611455|403700|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
118618|NCT00611455|403701|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
118619|NCT00611455|403699|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
118620|NCT00611455|403700|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
118621|NCT00611455|403701|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
118622|NCT00611455|403699|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
118623|NCT00611455|403700|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
118624|NCT00611455|403701|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
118625|NCT00611455|403699|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
118626|NCT00611455|403700|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
118627|NCT00611455|403701|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
118628|NCT00611455|403699|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
118629|NCT00611455|403700|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
118630|NCT00611455|403701|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
118631|NCT00611455|403699|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
118632|NCT00611455|403700|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
118633|NCT00611455|403701|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
118634|NCT00611455|403699|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
118635|NCT00611455|403700|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
118636|NCT00611455|403701|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
118637|NCT00611455|403699|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
118638|NCT00611455|403700|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
118639|NCT00611455|403701|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
118640|NCT00611455|403699|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
118641|NCT00611455|403700|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
118642|NCT00611455|403701|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
118643|NCT00611455|403699|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
118644|NCT00611455|403700|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
118645|NCT00611455|403701|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
118646|NCT00611247|403874|P2|Overall Study|Lack of Efficacy|16
118647|NCT00611247|403875|P1|Overall Study|Lack of Efficacy|1
118648|NCT00611247|403874|P2|Overall Study|Death|5
118649|NCT00611247|403875|P1|Overall Study|Death|1
118650|NCT00611130|403887|P2|Overall Study|Death|0
118651|NCT00611130|403888|P1|Overall Study|Death|1
118652|NCT00611130|403887|P2|Overall Study|Adverse Event|0
118653|NCT00611130|403888|P1|Overall Study|Adverse Event|1
118654|NCT00611130|403887|P2|Overall Study|Administrative|1
118655|NCT00611130|403888|P1|Overall Study|Administrative|1
118656|NCT00611130|403887|P2|Overall Study|Incarceration|2
118657|NCT00611130|403888|P1|Overall Study|Incarceration|3
118658|NCT00611130|403887|P2|Overall Study|Unspecified|4
118659|NCT00611130|403888|P1|Overall Study|Unspecified|5
118660|NCT00611130|403887|P2|Overall Study|Withdrawal by Subject|5
118661|NCT00611130|403888|P1|Overall Study|Withdrawal by Subject|6
118662|NCT00611130|403887|P2|Overall Study|Protocol noncompliance|6
118663|NCT00611130|403888|P1|Overall Study|Protocol noncompliance|7
118664|NCT00611130|403887|P2|Overall Study|Lost to Follow-up|29
118665|NCT00611130|403888|P1|Overall Study|Lost to Follow-up|25
118666|NCT00611026|403898|P3|Double-blind Treatment Period|Unspecified|18
118667|NCT00611026|403899|P2|Double-blind Treatment Period|Unspecified|20
118668|NCT00611026|403900|P1|Double-blind Treatment Period|Unspecified|13
118669|NCT00611026|403898|P3|Double-blind Treatment Period|Withdrawal by Subject|16
118670|NCT00611026|403899|P2|Double-blind Treatment Period|Withdrawal by Subject|19
118671|NCT00611026|403900|P1|Double-blind Treatment Period|Withdrawal by Subject|7
118672|NCT00611026|403898|P3|Double-blind Treatment Period|Lost to Follow-up|14
118673|NCT00611026|403899|P2|Double-blind Treatment Period|Lost to Follow-up|11
118674|NCT00611026|403900|P1|Double-blind Treatment Period|Lost to Follow-up|6
118675|NCT00611026|403898|P3|Double-blind Treatment Period|Lack of Efficacy|4
118676|NCT00611026|403899|P2|Double-blind Treatment Period|Lack of Efficacy|10
118677|NCT00611026|403900|P1|Double-blind Treatment Period|Lack of Efficacy|11
118678|NCT00611026|403898|P3|Double-blind Treatment Period|Adverse Event|46
118679|NCT00611026|403899|P2|Double-blind Treatment Period|Adverse Event|28
118680|NCT00611026|403900|P1|Double-blind Treatment Period|Adverse Event|9
118681|NCT00611026|403898|P3|Double-blind Treatment Period|Death|0
118682|NCT00611026|403899|P2|Double-blind Treatment Period|Death|0
118683|NCT00611026|403900|P1|Double-blind Treatment Period|Death|1
118684|NCT00611026|403898|P3|Randomized to Double-blind Treatment|Not treated|3
118685|NCT00611026|403899|P2|Randomized to Double-blind Treatment|Not treated|1
118686|NCT00611026|403900|P1|Randomized to Double-blind Treatment|Not treated|2
118687|NCT00610857|403977|P1|Overall Study|Not evaluable for response|2
118688|NCT00610714|403992|P2|Overall Study|Study completion at 120 PFS events|2
118689|NCT00610714|403993|P1|Overall Study|Study completion at 120 PFS events|2
118690|NCT00610714|403992|P2|Overall Study|Withdrawal by Subject|3
118691|NCT00610714|403993|P1|Overall Study|Withdrawal by Subject|9
118692|NCT00610714|403992|P2|Overall Study|Death|18
118693|NCT00610714|403993|P1|Overall Study|Death|12
118694|NCT00610714|403992|P2|Overall Study|Adverse Event|1
118695|NCT00610714|403993|P1|Overall Study|Adverse Event|3
118696|NCT00610675|404031|P1|Overall Study|Other reason (not specified)|25
118697|NCT00610675|404031|P1|Overall Study|Lost to Follow-up|31
118698|NCT00610675|404031|P1|Overall Study|Lack of Compliance|7
118699|NCT00610675|404031|P1|Overall Study|Reasons unrelated to trial|27
118700|NCT00610675|404031|P1|Overall Study|Withdrawal by Subject|28
118701|NCT00610675|404031|P1|Overall Study|Insufficient Effect|31
118702|NCT00610675|404031|P1|Overall Study|Adverse Event|67
118703|NCT00610675|404031|P1|Overall Study|Untreated|4
118704|NCT00610649|404053|P11|Overall Study|Withdrawal by Subject|0
118705|NCT00610649|404054|P10|Overall Study|Withdrawal by Subject|1
118706|NCT00610649|404055|P9|Overall Study|Withdrawal by Subject|0
118707|NCT00610649|404056|P8|Overall Study|Withdrawal by Subject|0
118708|NCT00610649|404057|P7|Overall Study|Withdrawal by Subject|0
118709|NCT00610649|404058|P6|Overall Study|Withdrawal by Subject|0
118710|NCT00610649|404059|P5|Overall Study|Withdrawal by Subject|0
118711|NCT00610649|404060|P4|Overall Study|Withdrawal by Subject|0
118712|NCT00610649|404061|P3|Overall Study|Withdrawal by Subject|0
118713|NCT00610649|404062|P2|Overall Study|Withdrawal by Subject|0
118714|NCT00610649|404063|P1|Overall Study|Withdrawal by Subject|0
118715|NCT00610649|404053|P11|Overall Study|Family Emergency|0
118716|NCT00610649|404054|P10|Overall Study|Family Emergency|0
118717|NCT00610649|404055|P9|Overall Study|Family Emergency|0
118718|NCT00610649|404056|P8|Overall Study|Family Emergency|0
118719|NCT00610649|404057|P7|Overall Study|Family Emergency|0
118720|NCT00610649|404058|P6|Overall Study|Family Emergency|0
118721|NCT00610649|404059|P5|Overall Study|Family Emergency|0
118722|NCT00610649|404060|P4|Overall Study|Family Emergency|0
118723|NCT00610649|404061|P3|Overall Study|Family Emergency|0
118724|NCT00610649|404062|P2|Overall Study|Family Emergency|1
118725|NCT00610649|404063|P1|Overall Study|Family Emergency|0
118726|NCT00610649|404053|P11|Overall Study|Adverse Event|1
118727|NCT00610649|404054|P10|Overall Study|Adverse Event|0
118728|NCT00610649|404055|P9|Overall Study|Adverse Event|0
118729|NCT00610649|404056|P8|Overall Study|Adverse Event|0
118730|NCT00610649|404057|P7|Overall Study|Adverse Event|0
118731|NCT00610649|404058|P6|Overall Study|Adverse Event|0
118732|NCT00610649|404059|P5|Overall Study|Adverse Event|0
118733|NCT00610649|404060|P4|Overall Study|Adverse Event|0
118734|NCT00610649|404061|P3|Overall Study|Adverse Event|0
118735|NCT00610649|404062|P2|Overall Study|Adverse Event|0
118736|NCT00610649|404063|P1|Overall Study|Adverse Event|1
118737|NCT00610441|404127|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
118738|NCT00610441|404128|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
118739|NCT00610441|404129|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
118740|NCT00610441|404130|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
118741|NCT00610441|404127|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
118742|NCT00610441|404128|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
118743|NCT00610441|404129|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
118744|NCT00610441|404130|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
118745|NCT00610441|404127|P4|Treatment Period 2 - 3 Weeks|Unspecified|1
118746|NCT00610441|404128|P3|Treatment Period 2 - 3 Weeks|Unspecified|0
118747|NCT00610441|404129|P2|Treatment Period 2 - 3 Weeks|Unspecified|1
118748|NCT00610441|404130|P1|Treatment Period 2 - 3 Weeks|Unspecified|1
118749|NCT00610441|404127|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
118750|NCT00610441|404128|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
118751|NCT00610441|404129|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
118752|NCT00610441|404130|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
118753|NCT00610441|404127|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
118754|NCT00610441|404128|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
118755|NCT00610441|404129|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
118756|NCT00610441|404130|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
118757|NCT00610441|404127|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
118758|NCT00610441|404128|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
118759|NCT00610441|404129|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
118760|NCT00610441|404130|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
118761|NCT00610441|404127|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
118762|NCT00610441|404128|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
118763|NCT00610441|404129|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
118764|NCT00610441|404130|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
118765|NCT00610441|404127|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
118766|NCT00610441|404128|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
118767|NCT00610441|404129|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
118768|NCT00610441|404130|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
118769|NCT00610441|404127|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
118770|NCT00610441|404128|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
118771|NCT00610441|404129|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
118772|NCT00610441|404130|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
118773|NCT00610207|404228|P1|Overall Study|Lost to Follow-up|3
118774|NCT00610155|404233|P6|Period 3|Adverse Event|0
118775|NCT00610155|404234|P5|Period 3|Adverse Event|0
118776|NCT00610155|404235|P4|Period 3|Adverse Event|0
118777|NCT00610155|404236|P3|Period 3|Adverse Event|0
118778|NCT00610155|404237|P2|Period 3|Adverse Event|0
118779|NCT00610155|404238|P1|Period 3|Adverse Event|1
118780|NCT00610155|404233|P6|Period 1|Withdrawal by Subject|0
118781|NCT00610155|404234|P5|Period 1|Withdrawal by Subject|0
118782|NCT00610155|404235|P4|Period 1|Withdrawal by Subject|0
118783|NCT00610155|404236|P3|Period 1|Withdrawal by Subject|1
118784|NCT00610155|404237|P2|Period 1|Withdrawal by Subject|0
118785|NCT00610155|404238|P1|Period 1|Withdrawal by Subject|0
118786|NCT00610129|404285|P1|Overall Study|Not treated since patients ineligible|3
118787|NCT00609986|404291|P2|Overall Study|Did not receive transplant or treatment|3
118788|NCT00609986|404292|P1|Overall Study|Did not receive transplant or treatment|8
118789|NCT00609973|404306|P2|Overall Study|Withdrawal by Subject|1
118790|NCT00609973|404307|P1|Overall Study|Withdrawal by Subject|0
118791|NCT00609973|404306|P2|Overall Study|Lost to Follow-up|1
118792|NCT00609973|404307|P1|Overall Study|Lost to Follow-up|2
118793|NCT00609973|404306|P2|Overall Study|Protocol Violation|3
118794|NCT00609973|404307|P1|Overall Study|Protocol Violation|4
118795|NCT00609973|404306|P2|Overall Study|Adverse Event|1
118796|NCT00609973|404307|P1|Overall Study|Adverse Event|2
118797|NCT00609947|404315|P1|Overall Study|Death|1
118798|NCT00609869|404320|P1|Overall Study|Mantle cell: not evaluable|4
118799|NCT00609869|404320|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
118800|NCT00609869|404320|P1|Overall Study|Hepatitis B infection|1
118801|NCT00609869|404320|P1|Overall Study|Severe tumor flare reaction|1
118802|NCT00609869|404320|P1|Overall Study|Seizures|1
118803|NCT00609869|404320|P1|Overall Study|Withdrawal by Subject|1
118804|NCT00609869|404320|P1|Overall Study|Severe hematologic toxicity|1
118805|NCT00609869|404320|P1|Overall Study|Withdrawn, ischemic stroke|1
118806|NCT00609765|404339|P1|Overall Study|Study ended prior to 12 months|1
118807|NCT00609674|404353|P2|Overall Study|Withdrew consent|1
118808|NCT00609674|404354|P1|Overall Study|Withdrew consent|2
118809|NCT00609674|404353|P2|Overall Study|Lost to Follow-up|0
118810|NCT00609674|404354|P1|Overall Study|Lost to Follow-up|1
118811|NCT00609674|404353|P2|Overall Study|Protocol Violation|5
118812|NCT00609674|404354|P1|Overall Study|Protocol Violation|3
118813|NCT00609674|404353|P2|Overall Study|Adverse Event|1
118814|NCT00609674|404354|P1|Overall Study|Adverse Event|1
118815|NCT00609622|404390|P2|Overall Study|Global deterioration of health status|2
118816|NCT00609622|404391|P1|Overall Study|Global deterioration of health status|6
118817|NCT00609622|404390|P2|Overall Study|Unspecified|14
118818|NCT00609622|404391|P1|Overall Study|Unspecified|7
118819|NCT00609622|404390|P2|Overall Study|Study terminated by sponsor|3
118820|NCT00609622|404391|P1|Overall Study|Study terminated by sponsor|16
118821|NCT00609622|404390|P2|Overall Study|Objective progression or relapse|41
118822|NCT00609622|404391|P1|Overall Study|Objective progression or relapse|47
118823|NCT00609622|404390|P2|Overall Study|Protocol Violation|1
118824|NCT00609622|404391|P1|Overall Study|Protocol Violation|1
118825|NCT00609622|404390|P2|Overall Study|Death|4
118826|NCT00609622|404391|P1|Overall Study|Death|1
118827|NCT00609622|404390|P2|Overall Study|Withdrawal by Subject|20
118828|NCT00609622|404391|P1|Overall Study|Withdrawal by Subject|4
118829|NCT00609622|404390|P2|Overall Study|Adverse Event|10
118830|NCT00609622|404391|P1|Overall Study|Adverse Event|14
118831|NCT00609518|404413|P2|Overall Study|Death from Adverse Event|2
118832|NCT00609518|404414|P1|Overall Study|Death from Adverse Event|2
118833|NCT00609518|404413|P2|Overall Study|Physician Decision|3
118834|NCT00609518|404414|P1|Overall Study|Physician Decision|1
118835|NCT00609518|404413|P2|Overall Study|Lost to Follow-up|0
118836|NCT00609518|404414|P1|Overall Study|Lost to Follow-up|3
118837|NCT00609518|404413|P2|Overall Study|Withdrawal by Subject|3
118838|NCT00609518|404414|P1|Overall Study|Withdrawal by Subject|5
118839|NCT00609518|404413|P2|Overall Study|Death from Study Disease|32
118840|NCT00609518|404414|P1|Overall Study|Death from Study Disease|32
118841|NCT00609466|404429|P3|Overall Study|Lack of Efficacy|2
118842|NCT00609466|404430|P2|Overall Study|Lack of Efficacy|2
118843|NCT00609466|404431|P1|Overall Study|Lack of Efficacy|0
118844|NCT00609466|404429|P3|Overall Study|Adverse Event|1
118845|NCT00609466|404430|P2|Overall Study|Adverse Event|3
118846|NCT00609466|404431|P1|Overall Study|Adverse Event|2
118847|NCT00609466|404429|P3|Overall Study|Withdrawal by Subject|1
118848|NCT00609466|404430|P2|Overall Study|Withdrawal by Subject|1
118849|NCT00609466|404431|P1|Overall Study|Withdrawal by Subject|0
118850|NCT00609362|404459|P2|Overall Study|Adverse Event|0
118851|NCT00609362|404460|P1|Overall Study|Adverse Event|1
118852|NCT00609362|404459|P2|Overall Study|Withdrawal by Subject|1
118853|NCT00609362|404460|P1|Overall Study|Withdrawal by Subject|2
118854|NCT00609167|404472|P2|Overall Study|Stem Cell Transplant|6
118855|NCT00609167|404473|P1|Overall Study|Stem Cell Transplant|0
118856|NCT00609167|404472|P2|Overall Study|Disease Progression|0
118857|NCT00609167|404473|P1|Overall Study|Disease Progression|1
118858|NCT00609167|404472|P2|Overall Study|Adverse Event|1
118859|NCT00609167|404473|P1|Overall Study|Adverse Event|5
118860|NCT00609167|404472|P2|Overall Study|Lack of Efficacy|0
118861|NCT00609167|404473|P1|Overall Study|Lack of Efficacy|1
118862|NCT00609167|404472|P2|Overall Study|Withdrawal by Subject|0
118863|NCT00609167|404473|P1|Overall Study|Withdrawal by Subject|1
118864|NCT00608985|404499|P4|Overall Study|Lost to Follow-up|0
118865|NCT00608985|404500|P3|Overall Study|Lost to Follow-up|0
118866|NCT00608985|404501|P2|Overall Study|Lost to Follow-up|1
118867|NCT00608985|404502|P1|Overall Study|Lost to Follow-up|2
118868|NCT00608985|404499|P4|Overall Study|Withdrawal of Consent|1
118869|NCT00608985|404500|P3|Overall Study|Withdrawal of Consent|1
118870|NCT00608985|404501|P2|Overall Study|Withdrawal of Consent|1
118871|NCT00608985|404502|P1|Overall Study|Withdrawal of Consent|5
118872|NCT00608985|404499|P4|Overall Study|Administrative/Other|2
118873|NCT00608985|404500|P3|Overall Study|Administrative/Other|1
118874|NCT00608985|404501|P2|Overall Study|Administrative/Other|4
118875|NCT00608985|404502|P1|Overall Study|Administrative/Other|7
118876|NCT00608985|404499|P4|Overall Study|Adverse Event|6
118877|NCT00608985|404500|P3|Overall Study|Adverse Event|4
118878|NCT00608985|404501|P2|Overall Study|Adverse Event|7
118879|NCT00608985|404502|P1|Overall Study|Adverse Event|2
118880|NCT00608959|404534|P1|Part 1|Did not meet eligibility criteria|1
118881|NCT00608907|404547|P3|Overall Study|Progressive Disease|0
118882|NCT00608907|404548|P2|Overall Study|Progressive Disease|0
118883|NCT00608907|404549|P1|Overall Study|Progressive Disease|1
118884|NCT00608907|404547|P3|Overall Study|Withdrawal by Subject|0
118885|NCT00608907|404548|P2|Overall Study|Withdrawal by Subject|0
118886|NCT00608907|404549|P1|Overall Study|Withdrawal by Subject|4
118887|NCT00608907|404547|P3|Overall Study|Death|0
118888|NCT00608907|404548|P2|Overall Study|Death|0
118889|NCT00608907|404549|P1|Overall Study|Death|1
118890|NCT00608907|404547|P3|Overall Study|Adverse Event|1
118891|NCT00608907|404548|P2|Overall Study|Adverse Event|0
118892|NCT00608907|404549|P1|Overall Study|Adverse Event|6
118893|NCT00608881|404559|P2|Overall Study|Institutionalized|2
118894|NCT00608881|404560|P1|Overall Study|Institutionalized|1
118895|NCT00608881|404559|P2|Overall Study|Physician Decision|5
118896|NCT00608881|404560|P1|Overall Study|Physician Decision|5
118897|NCT00608881|404559|P2|Overall Study|Withdrawal by Subject|29
118898|NCT00608881|404560|P1|Overall Study|Withdrawal by Subject|18
118899|NCT00608881|404559|P2|Overall Study|Lost to Follow-up|14
118900|NCT00608881|404560|P1|Overall Study|Lost to Follow-up|28
118901|NCT00608881|404559|P2|Overall Study|Adverse Event|3
118902|NCT00608881|404560|P1|Overall Study|Adverse Event|5
118903|NCT00608881|404559|P2|Overall Study|Death|13
118904|NCT00608881|404560|P1|Overall Study|Death|22
118905|NCT00608868|404594|P1|Overall Study|Physician Decision|2
118906|NCT00608868|404594|P1|Overall Study|Adverse Event|1
118907|NCT00608868|404594|P1|Overall Study|Lost to Follow-up|2
118908|NCT00608868|404594|P1|Overall Study|Protocol Violation|3
118909|NCT00608868|404594|P1|Overall Study|Withdrawal by Subject|7
118910|NCT00608842|404605|P4|Overall Study|Lost to Follow-up|0
118911|NCT00608842|404606|P3|Overall Study|Lost to Follow-up|0
118912|NCT00608842|404607|P2|Overall Study|Lost to Follow-up|0
118913|NCT00608842|404608|P1|Overall Study|Lost to Follow-up|1
118914|NCT00608842|404605|P4|Overall Study|Participant's Request|1
118915|NCT00608842|404606|P3|Overall Study|Participant's Request|2
118916|NCT00608842|404607|P2|Overall Study|Participant's Request|1
118917|NCT00608842|404608|P1|Overall Study|Participant's Request|0
118918|NCT00608829|404642|P1|Overall Study|Subject refuses to follow up or return.|5
118919|NCT00608829|404642|P1|Overall Study|Withdrawal by Subject|4
118920|NCT00608829|404642|P1|Overall Study|Death|6
118921|NCT00608582|404668|P2|Overall Study|Early stage Design Change|3
118922|NCT00608582|404669|P1|Overall Study|Early stage Design Change|0
118923|NCT00608582|404668|P2|Overall Study|Illicit Drug Use|0
118924|NCT00608582|404669|P1|Overall Study|Illicit Drug Use|1
118925|NCT00608582|404668|P2|Overall Study|No Best Response in Phase 1 located|1
118926|NCT00608582|404669|P1|Overall Study|No Best Response in Phase 1 located|1
118927|NCT00608582|404668|P2|Overall Study|Lost to Follow-up|0
118928|NCT00608582|404669|P1|Overall Study|Lost to Follow-up|2
118929|NCT00608569|404679|P2|Overall Study|Unable to adhere with study requirements|1
119019|NCT00607724|405188|P5|Stage 2: Expanded Cohort|Physician Decision|1
118930|NCT00608569|404680|P1|Overall Study|Unable to adhere with study requirements|0
118931|NCT00608569|404679|P2|Overall Study|Adverse Event|0
118932|NCT00608569|404680|P1|Overall Study|Adverse Event|1
118933|NCT00608569|404679|P2|Overall Study|Withdrawal by Subject|0
118934|NCT00608569|404680|P1|Overall Study|Withdrawal by Subject|1
118935|NCT00608569|404679|P2|Overall Study|Lost to Follow-up|5
118936|NCT00608569|404680|P1|Overall Study|Lost to Follow-up|4
118937|NCT00608569|404679|P2|Overall Study|Death|3
118938|NCT00608569|404680|P1|Overall Study|Death|4
118939|NCT00608543|404700|P1|Overall Study|Adverse Event|4
118940|NCT00608530|404711|P2|Overall Study|Withdrawal by Subject|5
118941|NCT00608530|404712|P1|Overall Study|Withdrawal by Subject|11
118942|NCT00608517|404725|P3|Overall Study|Death|0
118943|NCT00608517|404726|P2|Overall Study|Death|0
118944|NCT00608517|404727|P1|Overall Study|Death|1
118945|NCT00608426|404902|P2|Overall Study|refused, health issues, wrong address|348
118946|NCT00608426|404903|P1|Overall Study|refused, health issues, wrong address|319
118947|NCT00608426|404902|P2|Overall Study|Lost to Follow-up|521
118948|NCT00608426|404903|P1|Overall Study|Lost to Follow-up|485
118949|NCT00608426|404902|P2|Overall Study|Death|36
118950|NCT00608426|404903|P1|Overall Study|Death|32
118951|NCT00608322|404915|P2|Overall Study|Death|1
118952|NCT00608322|404916|P1|Overall Study|Death|2
118953|NCT00608244|404922|P1|Overall Study|Low trough levels|1
118954|NCT00608244|404922|P1|Overall Study|Adverse Event|1
118955|NCT00608205|404933|P2|Overall Study|Patient non-compliant|1
118956|NCT00608205|404934|P1|Overall Study|Patient non-compliant|0
118957|NCT00608205|404933|P2|Overall Study|Adverse Event|2
118958|NCT00608205|404934|P1|Overall Study|Adverse Event|3
118959|NCT00608023|405036|P3|Overall Study|Unknown reason|0
118960|NCT00608023|405037|P2|Overall Study|Unknown reason|3
118961|NCT00608023|405038|P1|Overall Study|Unknown reason|0
118962|NCT00608023|405036|P3|Overall Study|Protocol Violation|1
118963|NCT00608023|405037|P2|Overall Study|Protocol Violation|3
118964|NCT00608023|405038|P1|Overall Study|Protocol Violation|1
118965|NCT00608023|405036|P3|Overall Study|Lost to Follow-up|1
118966|NCT00608023|405037|P2|Overall Study|Lost to Follow-up|2
118967|NCT00608023|405038|P1|Overall Study|Lost to Follow-up|2
118968|NCT00608023|405036|P3|Overall Study|Adverse Event|5
118969|NCT00608023|405037|P2|Overall Study|Adverse Event|4
118970|NCT00608023|405038|P1|Overall Study|Adverse Event|1
118971|NCT00608023|405036|P3|Overall Study|Withdrawal by Subject|7
118972|NCT00608023|405037|P2|Overall Study|Withdrawal by Subject|10
118973|NCT00608023|405038|P1|Overall Study|Withdrawal by Subject|8
118974|NCT00607919|405060|P2|Open-Label Phase|Parent/Caregiver Decision|2
118975|NCT00607919|405061|P1|Open-Label Phase|Parent/Caregiver Decision|1
118976|NCT00607919|405060|P2|Open-Label Phase|Withdrawal by Subject|2
118977|NCT00607919|405061|P1|Open-Label Phase|Withdrawal by Subject|2
118978|NCT00607919|405060|P2|Open-Label Phase|Protocol Violation|2
118979|NCT00607919|405061|P1|Open-Label Phase|Protocol Violation|2
118980|NCT00607919|405060|P2|Open-Label Phase|Lost to Follow-up|1
118981|NCT00607919|405061|P1|Open-Label Phase|Lost to Follow-up|4
118982|NCT00607919|405060|P2|Open-Label Phase|Adverse Event|5
118983|NCT00607919|405061|P1|Open-Label Phase|Adverse Event|1
118984|NCT00607919|405060|P2|Acute Phase|Withdrawal by Subject|3
118985|NCT00607919|405061|P1|Acute Phase|Withdrawal by Subject|3
118986|NCT00607919|405060|P2|Acute Phase|Protocol Violation|1
118987|NCT00607919|405061|P1|Acute Phase|Protocol Violation|5
118988|NCT00607919|405060|P2|Acute Phase|Parent/Caregiver Decision|4
118989|NCT00607919|405061|P1|Acute Phase|Parent/Caregiver Decision|6
118990|NCT00607919|405060|P2|Acute Phase|Lost to Follow-up|3
118991|NCT00607919|405061|P1|Acute Phase|Lost to Follow-up|9
118992|NCT00607919|405060|P2|Acute Phase|Lack of Efficacy|2
118993|NCT00607919|405061|P1|Acute Phase|Lack of Efficacy|1
118994|NCT00607919|405060|P2|Acute Phase|Entry Criteria Not Met|1
118995|NCT00607919|405061|P1|Acute Phase|Entry Criteria Not Met|1
118996|NCT00607919|405060|P2|Acute Phase|Adverse Event|2
118997|NCT00607919|405061|P1|Acute Phase|Adverse Event|9
118998|NCT00607880|405119|P2|Overall Study|Unable to place port due to occlusion|0
118999|NCT00607880|405120|P1|Overall Study|Unable to place port due to occlusion|1
119000|NCT00607789|405170|P2|Overall Study|Withdrawal by Subject|0
119001|NCT00607789|405171|P1|Overall Study|Withdrawal by Subject|1
119002|NCT00607789|405170|P2|Overall Study|Lost to Follow-up|5
119003|NCT00607789|405171|P1|Overall Study|Lost to Follow-up|0
119004|NCT00607789|405170|P2|Overall Study|Inadequate adherence|0
119005|NCT00607789|405171|P1|Overall Study|Inadequate adherence|3
119006|NCT00607789|405170|P2|Overall Study|Lack of Efficacy|1
119007|NCT00607789|405171|P1|Overall Study|Lack of Efficacy|0
119008|NCT00607789|405170|P2|Overall Study|Adverse Event|0
119009|NCT00607789|405171|P1|Overall Study|Adverse Event|3
119010|NCT00607724|405186|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
119011|NCT00607724|405187|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
119012|NCT00607724|405188|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
119013|NCT00607724|405189|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
119014|NCT00607724|405190|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
119015|NCT00607724|405191|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
119016|NCT00607724|405192|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
119017|NCT00607724|405186|P7|Stage 2: Expanded Cohort|Physician Decision|0
119018|NCT00607724|405187|P6|Stage 2: Expanded Cohort|Physician Decision|1
119020|NCT00607724|405189|P4|Stage 2: Expanded Cohort|Physician Decision|0
119021|NCT00607724|405190|P3|Stage 2: Expanded Cohort|Physician Decision|0
119022|NCT00607724|405191|P2|Stage 2: Expanded Cohort|Physician Decision|0
119023|NCT00607724|405192|P1|Stage 2: Expanded Cohort|Physician Decision|0
119024|NCT00607724|405186|P7|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|10
119025|NCT00607724|405187|P6|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|11
119026|NCT00607724|405188|P5|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|8
119027|NCT00607724|405189|P4|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|4
119028|NCT00607724|405190|P3|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
119029|NCT00607724|405191|P2|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
119030|NCT00607724|405192|P1|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
119031|NCT00607724|405186|P7|Stage 2: Expanded Cohort|Adverse Event|1
119032|NCT00607724|405187|P6|Stage 2: Expanded Cohort|Adverse Event|0
119033|NCT00607724|405188|P5|Stage 2: Expanded Cohort|Adverse Event|0
119034|NCT00607724|405189|P4|Stage 2: Expanded Cohort|Adverse Event|0
119035|NCT00607724|405190|P3|Stage 2: Expanded Cohort|Adverse Event|0
119036|NCT00607724|405191|P2|Stage 2: Expanded Cohort|Adverse Event|0
119037|NCT00607724|405192|P1|Stage 2: Expanded Cohort|Adverse Event|0
119038|NCT00607724|405186|P7|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
119039|NCT00607724|405187|P6|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
119040|NCT00607724|405188|P5|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
119041|NCT00607724|405189|P4|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
119042|NCT00607724|405190|P3|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|4
119043|NCT00607724|405191|P2|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|8
119044|NCT00607724|405192|P1|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|7
119045|NCT00607386|405333|P1|Overall Study|Physician Decision|1
119046|NCT00607373|405348|P2|Follow-up Period|Withdrawal by Subject|3
119047|NCT00607373|405349|P1|Follow-up Period|Withdrawal by Subject|1
119048|NCT00607373|405348|P2|Follow-up Period|Protocol Violation|1
119049|NCT00607373|405349|P1|Follow-up Period|Protocol Violation|0
119050|NCT00607373|405348|P2|Follow-up Period|Not specified|1
119051|NCT00607373|405349|P1|Follow-up Period|Not specified|0
119052|NCT00607373|405348|P2|Treatment Period|Withdrawal by Subject|1
119053|NCT00607373|405349|P1|Treatment Period|Withdrawal by Subject|0
119054|NCT00607373|405348|P2|Treatment Period|Physician Decision|1
119055|NCT00607373|405349|P1|Treatment Period|Physician Decision|0
119056|NCT00607373|405348|P2|Treatment Period|Adverse Event|4
119057|NCT00607373|405349|P1|Treatment Period|Adverse Event|0
119058|NCT00607087|405451|P3|Period 3|Adverse Event|0
119059|NCT00607087|405452|P2|Period 3|Adverse Event|1
119060|NCT00607087|405453|P1|Period 3|Adverse Event|0
119061|NCT00607087|405451|P3|Period 3|Withdrawal by Subject|0
119062|NCT00607087|405452|P2|Period 3|Withdrawal by Subject|1
119063|NCT00607087|405453|P1|Period 3|Withdrawal by Subject|2
119064|NCT00607087|405451|P3|Period 2|Poor compliance to protocol|1
119065|NCT00607087|405452|P2|Period 2|Poor compliance to protocol|0
119066|NCT00607087|405453|P1|Period 2|Poor compliance to protocol|0
119067|NCT00607087|405451|P3|Period 2|Adverse Event|3
119068|NCT00607087|405452|P2|Period 2|Adverse Event|1
119069|NCT00607087|405453|P1|Period 2|Adverse Event|0
119070|NCT00607087|405451|P3|Period 2|Other reason|0
119071|NCT00607087|405452|P2|Period 2|Other reason|1
119072|NCT00607087|405453|P1|Period 2|Other reason|1
119073|NCT00607087|405451|P3|Period 2|Withdrawal by Subject|1
119074|NCT00607087|405452|P2|Period 2|Withdrawal by Subject|1
119075|NCT00607087|405453|P1|Period 2|Withdrawal by Subject|0
119076|NCT00607087|405451|P3|Period 1|Other reason|2
119077|NCT00607087|405452|P2|Period 1|Other reason|4
119078|NCT00607087|405453|P1|Period 1|Other reason|0
119079|NCT00607087|405451|P3|Period 1|Lost to Follow-up|0
119080|NCT00607087|405452|P2|Period 1|Lost to Follow-up|0
119081|NCT00607087|405453|P1|Period 1|Lost to Follow-up|1
119082|NCT00607087|405451|P3|Period 1|Poor compliance to protocol|0
119083|NCT00607087|405452|P2|Period 1|Poor compliance to protocol|0
119084|NCT00607087|405453|P1|Period 1|Poor compliance to protocol|1
119085|NCT00607087|405451|P3|Period 1|Adverse Event|0
119086|NCT00607087|405452|P2|Period 1|Adverse Event|0
119087|NCT00607087|405453|P1|Period 1|Adverse Event|3
119088|NCT00607087|405451|P3|Period 1|Withdrawal by Subject|3
119089|NCT00607087|405452|P2|Period 1|Withdrawal by Subject|2
119090|NCT00607087|405453|P1|Period 1|Withdrawal by Subject|7
119091|NCT00607087|405451|P3|Overall Study|Lost to Follow-up|0
119092|NCT00607087|405452|P2|Overall Study|Lost to Follow-up|0
119093|NCT00607087|405453|P1|Overall Study|Lost to Follow-up|1
119094|NCT00607087|405451|P3|Overall Study|Poor compliance to protocol|1
119095|NCT00607087|405452|P2|Overall Study|Poor compliance to protocol|0
119096|NCT00607087|405453|P1|Overall Study|Poor compliance to protocol|1
119097|NCT00607087|405451|P3|Overall Study|Other reason|2
119098|NCT00607087|405452|P2|Overall Study|Other reason|5
119099|NCT00607087|405453|P1|Overall Study|Other reason|1
119100|NCT00607087|405451|P3|Overall Study|Adverse Event|3
119101|NCT00607087|405452|P2|Overall Study|Adverse Event|2
119102|NCT00607087|405453|P1|Overall Study|Adverse Event|3
119103|NCT00607087|405451|P3|Overall Study|Withdrawal by Subject|4
119104|NCT00607087|405452|P2|Overall Study|Withdrawal by Subject|4
119105|NCT00607087|405453|P1|Overall Study|Withdrawal by Subject|9
119106|NCT00607048|405511|P6|Overall Study|Unspecified|1
119107|NCT00607048|405512|P5|Overall Study|Unspecified|0
119108|NCT00607048|405513|P4|Overall Study|Unspecified|0
119109|NCT00607048|405514|P3|Overall Study|Unspecified|0
119110|NCT00607048|405515|P2|Overall Study|Unspecified|1
119111|NCT00607048|405516|P1|Overall Study|Unspecified|1
119112|NCT00607048|405511|P6|Overall Study|Withdrawal by Subject|2
119113|NCT00607048|405512|P5|Overall Study|Withdrawal by Subject|0
119114|NCT00607048|405513|P4|Overall Study|Withdrawal by Subject|1
119115|NCT00607048|405514|P3|Overall Study|Withdrawal by Subject|0
119116|NCT00607048|405515|P2|Overall Study|Withdrawal by Subject|0
119117|NCT00607048|405516|P1|Overall Study|Withdrawal by Subject|0
119118|NCT00607048|405511|P6|Overall Study|Objective disease progression - relapse|2
119119|NCT00607048|405512|P5|Overall Study|Objective disease progression - relapse|2
119120|NCT00607048|405513|P4|Overall Study|Objective disease progression - relapse|2
119121|NCT00607048|405514|P3|Overall Study|Objective disease progression - relapse|4
119122|NCT00607048|405515|P2|Overall Study|Objective disease progression - relapse|2
119123|NCT00607048|405516|P1|Overall Study|Objective disease progression - relapse|1
119124|NCT00607048|405511|P6|Overall Study|Global deterioration of health|0
119125|NCT00607048|405512|P5|Overall Study|Global deterioration of health|0
119126|NCT00607048|405513|P4|Overall Study|Global deterioration of health|0
119127|NCT00607048|405514|P3|Overall Study|Global deterioration of health|0
119128|NCT00607048|405515|P2|Overall Study|Global deterioration of health|0
119129|NCT00607048|405516|P1|Overall Study|Global deterioration of health|1
119130|NCT00607048|405511|P6|Overall Study|Adverse Event|0
119131|NCT00607048|405512|P5|Overall Study|Adverse Event|4
119132|NCT00607048|405513|P4|Overall Study|Adverse Event|0
119133|NCT00607048|405514|P3|Overall Study|Adverse Event|0
119134|NCT00607048|405515|P2|Overall Study|Adverse Event|1
119135|NCT00607048|405516|P1|Overall Study|Adverse Event|0
119136|NCT00606931|405607|P1|Overall Study|Withdrawal by Subject|3
119137|NCT00606905|405615|P2|Overall Study|Withdrew|5
119138|NCT00606905|405616|P1|Overall Study|Withdrew|5
119139|NCT00606905|405615|P2|Overall Study|Non-Index Pregnancy|4
119140|NCT00606905|405616|P1|Overall Study|Non-Index Pregnancy|1
119141|NCT00606905|405615|P2|Overall Study|No Pregnancy|6
119142|NCT00606905|405616|P1|Overall Study|No Pregnancy|9
119143|NCT00606892|405622|P2|First Intervention|Protocol Violation|4
119144|NCT00606892|405623|P1|First Intervention|Protocol Violation|1
119145|NCT00606801|405657|P2|Intervention|Protocol Violation|3
119146|NCT00606801|405658|P1|Intervention|Protocol Violation|3
119147|NCT00606684|405686|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
119148|NCT00606684|405687|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
119149|NCT00606684|405688|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
119150|NCT00606684|405689|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
119151|NCT00606684|405690|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
119152|NCT00606684|405691|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
119153|NCT00606684|405692|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
119154|NCT00606684|405686|P7|Double-Blind Treatment Period|Physician Decision|2
119155|NCT00606684|405687|P6|Double-Blind Treatment Period|Physician Decision|1
119156|NCT00606684|405688|P5|Double-Blind Treatment Period|Physician Decision|3
119157|NCT00606684|405689|P4|Double-Blind Treatment Period|Physician Decision|0
119158|NCT00606684|405690|P3|Double-Blind Treatment Period|Physician Decision|1
119159|NCT00606684|405691|P2|Double-Blind Treatment Period|Physician Decision|5
119160|NCT00606684|405692|P1|Double-Blind Treatment Period|Physician Decision|0
119161|NCT00606684|405686|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
119162|NCT00606684|405687|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
119163|NCT00606684|405688|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
119164|NCT00606684|405689|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
119165|NCT00606684|405690|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
119166|NCT00606684|405691|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
119167|NCT00606684|405692|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
119168|NCT00606684|405686|P7|Double-Blind Treatment Period|Protocol Violation|4
119169|NCT00606684|405687|P6|Double-Blind Treatment Period|Protocol Violation|3
119170|NCT00606684|405688|P5|Double-Blind Treatment Period|Protocol Violation|0
119171|NCT00606684|405689|P4|Double-Blind Treatment Period|Protocol Violation|3
119172|NCT00606684|405690|P3|Double-Blind Treatment Period|Protocol Violation|5
119173|NCT00606684|405691|P2|Double-Blind Treatment Period|Protocol Violation|5
119174|NCT00606684|405692|P1|Double-Blind Treatment Period|Protocol Violation|0
119175|NCT00606684|405686|P7|Double-Blind Treatment Period|Lack of Efficacy|0
119176|NCT00606684|405687|P6|Double-Blind Treatment Period|Lack of Efficacy|0
119177|NCT00606684|405688|P5|Double-Blind Treatment Period|Lack of Efficacy|1
119178|NCT00606684|405689|P4|Double-Blind Treatment Period|Lack of Efficacy|0
119179|NCT00606684|405690|P3|Double-Blind Treatment Period|Lack of Efficacy|0
119180|NCT00606684|405691|P2|Double-Blind Treatment Period|Lack of Efficacy|1
119181|NCT00606684|405692|P1|Double-Blind Treatment Period|Lack of Efficacy|0
119182|NCT00606684|405686|P7|Double-Blind Treatment Period|Adverse Event|1
119183|NCT00606684|405687|P6|Double-Blind Treatment Period|Adverse Event|0
119184|NCT00606684|405688|P5|Double-Blind Treatment Period|Adverse Event|2
119185|NCT00606684|405689|P4|Double-Blind Treatment Period|Adverse Event|4
119186|NCT00606684|405690|P3|Double-Blind Treatment Period|Adverse Event|2
119187|NCT00606684|405691|P2|Double-Blind Treatment Period|Adverse Event|3
119188|NCT00606684|405692|P1|Double-Blind Treatment Period|Adverse Event|0
119189|NCT00606684|405686|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
119190|NCT00606684|405687|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
119191|NCT00606684|405688|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
119192|NCT00606684|405689|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
119193|NCT00606684|405690|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
119194|NCT00606684|405691|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
119195|NCT00606684|405692|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
119196|NCT00606684|405686|P7|2-week Single-Blind Run-in Period|Adverse Event|0
119197|NCT00606684|405687|P6|2-week Single-Blind Run-in Period|Adverse Event|0
119198|NCT00606684|405688|P5|2-week Single-Blind Run-in Period|Adverse Event|0
119199|NCT00606684|405689|P4|2-week Single-Blind Run-in Period|Adverse Event|0
119200|NCT00606684|405690|P3|2-week Single-Blind Run-in Period|Adverse Event|0
119201|NCT00606684|405691|P2|2-week Single-Blind Run-in Period|Adverse Event|0
119202|NCT00606684|405692|P1|2-week Single-Blind Run-in Period|Adverse Event|2
119203|NCT00606684|405686|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
119204|NCT00606684|405687|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
119205|NCT00606684|405688|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
119206|NCT00606684|405689|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
119207|NCT00606684|405690|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
119208|NCT00606684|405691|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
119209|NCT00606684|405692|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
119210|NCT00606684|405686|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
119211|NCT00606684|405687|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
119212|NCT00606684|405688|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
119213|NCT00606684|405689|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
119214|NCT00606684|405690|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
119215|NCT00606684|405691|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
119216|NCT00606684|405692|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
119217|NCT00606684|405686|P7|2-week Single-Blind Run-in Period|Physician Decision|0
119218|NCT00606684|405687|P6|2-week Single-Blind Run-in Period|Physician Decision|0
119219|NCT00606684|405688|P5|2-week Single-Blind Run-in Period|Physician Decision|0
119220|NCT00606684|405689|P4|2-week Single-Blind Run-in Period|Physician Decision|0
119221|NCT00606684|405690|P3|2-week Single-Blind Run-in Period|Physician Decision|0
119222|NCT00606684|405691|P2|2-week Single-Blind Run-in Period|Physician Decision|0
119223|NCT00606684|405692|P1|2-week Single-Blind Run-in Period|Physician Decision|18
119224|NCT00606684|405686|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
119225|NCT00606684|405687|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
119226|NCT00606684|405688|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
119227|NCT00606684|405689|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
119228|NCT00606684|405690|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
119229|NCT00606684|405691|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
119230|NCT00606684|405692|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
119231|NCT00606684|405686|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
119232|NCT00606684|405687|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
119233|NCT00606684|405688|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
119234|NCT00606684|405689|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
119235|NCT00606684|405690|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
119236|NCT00606684|405691|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
119237|NCT00606684|405692|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
119238|NCT00606632|405724|P1|Overall Study|Miscellaneous reasons|9
119239|NCT00606632|405724|P1|Overall Study|Withdrawal by Subject|13
119240|NCT00606593|405731|P10|Overall Study|Administrative/Other|0
119241|NCT00606593|405732|P9|Overall Study|Administrative/Other|0
119242|NCT00606593|405733|P8|Overall Study|Administrative/Other|0
119243|NCT00606593|405734|P7|Overall Study|Administrative/Other|0
119244|NCT00606593|405735|P6|Overall Study|Administrative/Other|0
119245|NCT00606593|405736|P5|Overall Study|Administrative/Other|0
119246|NCT00606593|405737|P4|Overall Study|Administrative/Other|0
119247|NCT00606593|405738|P3|Overall Study|Administrative/Other|1
119248|NCT00606593|405739|P2|Overall Study|Administrative/Other|0
119249|NCT00606593|405740|P1|Overall Study|Administrative/Other|0
119250|NCT00606593|405731|P10|Overall Study|Withdrawal of consent|0
119251|NCT00606593|405732|P9|Overall Study|Withdrawal of consent|0
119252|NCT00606593|405733|P8|Overall Study|Withdrawal of consent|0
119253|NCT00606593|405734|P7|Overall Study|Withdrawal of consent|0
119254|NCT00606593|405735|P6|Overall Study|Withdrawal of consent|0
119255|NCT00606593|405736|P5|Overall Study|Withdrawal of consent|0
119256|NCT00606593|405737|P4|Overall Study|Withdrawal of consent|0
119257|NCT00606593|405738|P3|Overall Study|Withdrawal of consent|1
119258|NCT00606593|405739|P2|Overall Study|Withdrawal of consent|0
119259|NCT00606593|405740|P1|Overall Study|Withdrawal of consent|1
119260|NCT00606593|405731|P10|Overall Study|Adverse Event|0
119261|NCT00606593|405732|P9|Overall Study|Adverse Event|1
119262|NCT00606593|405733|P8|Overall Study|Adverse Event|2
119263|NCT00606593|405734|P7|Overall Study|Adverse Event|1
119264|NCT00606593|405735|P6|Overall Study|Adverse Event|0
119265|NCT00606593|405736|P5|Overall Study|Adverse Event|1
119266|NCT00606593|405737|P4|Overall Study|Adverse Event|1
119267|NCT00606593|405738|P3|Overall Study|Adverse Event|0
119268|NCT00606593|405739|P2|Overall Study|Adverse Event|0
119269|NCT00606593|405740|P1|Overall Study|Adverse Event|0
119270|NCT00606580|405761|P3|Overall Study|Withdrawal by Subject|0
119271|NCT00606580|405762|P2|Overall Study|Withdrawal by Subject|1
119272|NCT00606580|405763|P1|Overall Study|Withdrawal by Subject|0
119273|NCT00606580|405761|P3|Overall Study|Withdrawal by investigator|6
119274|NCT00606580|405762|P2|Overall Study|Withdrawal by investigator|1
119275|NCT00606580|405763|P1|Overall Study|Withdrawal by investigator|0
119276|NCT00606580|405761|P3|Overall Study|Clinical failures|12
119277|NCT00606580|405762|P2|Overall Study|Clinical failures|0
119278|NCT00606580|405763|P1|Overall Study|Clinical failures|1
119279|NCT00606580|405761|P3|Overall Study|Lost to Follow-up|4
119280|NCT00606580|405762|P2|Overall Study|Lost to Follow-up|1
119281|NCT00606580|405763|P1|Overall Study|Lost to Follow-up|1
119282|NCT00606502|405819|P2|Treatment|Treatment ongoing at time of data cutoff|3
119283|NCT00606502|405820|P1|Treatment|Treatment ongoing at time of data cutoff|0
119284|NCT00606502|405819|P2|Randomization|Randomized but not treated|0
119285|NCT00606502|405820|P1|Randomization|Randomized but not treated|3
119286|NCT00605345|405874|P2|Overall Study|Protocol Violation|2
119287|NCT00605345|405875|P1|Overall Study|Protocol Violation|0
119288|NCT00605345|405874|P2|Overall Study|Adverse Event|1
119289|NCT00605345|405875|P1|Overall Study|Adverse Event|0
119290|NCT00605345|405874|P2|Overall Study|Withdrawal by Subject|0
119291|NCT00605345|405875|P1|Overall Study|Withdrawal by Subject|1
119292|NCT00605306|405893|P2|Overall Study|Adverse Event|1
119293|NCT00605306|405894|P1|Overall Study|Adverse Event|0
119294|NCT00605293|405908|P2|Overall Study|Principal Investigator Decision|1
119295|NCT00605293|405909|P1|Overall Study|Principal Investigator Decision|0
119296|NCT00605293|405908|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
119297|NCT00605293|405909|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
119298|NCT00605293|405908|P2|Overall Study|Incorrect Epoetin Beta Administration|0
119299|NCT00605293|405909|P1|Overall Study|Incorrect Epoetin Beta Administration|1
119300|NCT00605293|405908|P2|Overall Study|Renal Transplantation|1
119301|NCT00605293|405909|P1|Overall Study|Renal Transplantation|3
119302|NCT00605293|405908|P2|Overall Study|Blood Transfusion|1
119303|NCT00605293|405909|P1|Overall Study|Blood Transfusion|7
119304|NCT00605293|405908|P2|Overall Study|Holidays Dialysis Out|0
119305|NCT00605293|405909|P1|Overall Study|Holidays Dialysis Out|1
119306|NCT00605293|405908|P2|Overall Study|Adverse Event|0
119307|NCT00605293|405909|P1|Overall Study|Adverse Event|1
119308|NCT00605293|405908|P2|Overall Study|Insufficient Therapeutic Response|0
119309|NCT00605293|405909|P1|Overall Study|Insufficient Therapeutic Response|2
119310|NCT00605293|405908|P2|Overall Study|Death|1
119311|NCT00605293|405909|P1|Overall Study|Death|2
119312|NCT00605280|405929|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
119313|NCT00605280|405930|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
119314|NCT00605280|405931|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
119315|NCT00605280|405932|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
119316|NCT00605280|405929|P4|Year 3 Extension|Unspecified|0
119317|NCT00605280|405930|P3|Year 3 Extension|Unspecified|0
119318|NCT00605280|405931|P2|Year 3 Extension|Unspecified|0
119319|NCT00605280|405932|P1|Year 3 Extension|Unspecified|2
119320|NCT00605280|405929|P4|Year 3 Extension|Withdrawal by Subject|5
119321|NCT00605280|405930|P3|Year 3 Extension|Withdrawal by Subject|0
119322|NCT00605280|405931|P2|Year 3 Extension|Withdrawal by Subject|0
119323|NCT00605280|405932|P1|Year 3 Extension|Withdrawal by Subject|2
119324|NCT00605280|405929|P4|Year 3 Extension|Physician Decision|2
119325|NCT00605280|405930|P3|Year 3 Extension|Physician Decision|0
119326|NCT00605280|405931|P2|Year 3 Extension|Physician Decision|0
119327|NCT00605280|405932|P1|Year 3 Extension|Physician Decision|0
119328|NCT00605280|405929|P4|Year 3 Extension|Adverse Event|2
119329|NCT00605280|405930|P3|Year 3 Extension|Adverse Event|0
119330|NCT00605280|405931|P2|Year 3 Extension|Adverse Event|0
119331|NCT00605280|405932|P1|Year 3 Extension|Adverse Event|2
119332|NCT00605280|405929|P4|Year 2|Lost to Follow-up or Patient non-comply|2
119333|NCT00605280|405930|P3|Year 2|Lost to Follow-up or Patient non-comply|0
119334|NCT00605280|405931|P2|Year 2|Lost to Follow-up or Patient non-comply|0
119335|NCT00605280|405932|P1|Year 2|Lost to Follow-up or Patient non-comply|4
119336|NCT00605280|405929|P4|Year 2|Unspecified|1
119337|NCT00605280|405930|P3|Year 2|Unspecified|0
119338|NCT00605280|405931|P2|Year 2|Unspecified|0
119339|NCT00605280|405932|P1|Year 2|Unspecified|1
119340|NCT00605280|405929|P4|Year 2|Withdrawal by Subject|4
119341|NCT00605280|405930|P3|Year 2|Withdrawal by Subject|0
119342|NCT00605280|405931|P2|Year 2|Withdrawal by Subject|0
119343|NCT00605280|405932|P1|Year 2|Withdrawal by Subject|4
119344|NCT00605280|405929|P4|Year 2|Physician Decision|11
119345|NCT00605280|405930|P3|Year 2|Physician Decision|4
119346|NCT00605280|405931|P2|Year 2|Physician Decision|6
119347|NCT00605280|405932|P1|Year 2|Physician Decision|11
119348|NCT00605280|405929|P4|Year 2|Adverse Event|4
119349|NCT00605280|405930|P3|Year 2|Adverse Event|2
119350|NCT00605280|405931|P2|Year 2|Adverse Event|0
119351|NCT00605280|405932|P1|Year 2|Adverse Event|4
119352|NCT00605280|405929|P4|Year 1|Lost to Follow-up or Patient non-comply|2
119353|NCT00605280|405930|P3|Year 1|Lost to Follow-up or Patient non-comply|0
119354|NCT00605280|405931|P2|Year 1|Lost to Follow-up or Patient non-comply|1
119355|NCT00605280|405932|P1|Year 1|Lost to Follow-up or Patient non-comply|5
119356|NCT00605280|405929|P4|Year 1|Unspecified|1
119357|NCT00605280|405930|P3|Year 1|Unspecified|0
119358|NCT00605280|405931|P2|Year 1|Unspecified|1
119359|NCT00605280|405932|P1|Year 1|Unspecified|2
119360|NCT00605280|405929|P4|Year 1|Withdrawal by Subject|4
119361|NCT00605280|405930|P3|Year 1|Withdrawal by Subject|0
119362|NCT00605280|405931|P2|Year 1|Withdrawal by Subject|4
119363|NCT00605280|405932|P1|Year 1|Withdrawal by Subject|2
119364|NCT00605280|405929|P4|Year 1|Physician Decision|6
119365|NCT00605280|405930|P3|Year 1|Physician Decision|0
119366|NCT00605280|405931|P2|Year 1|Physician Decision|4
119367|NCT00605280|405932|P1|Year 1|Physician Decision|7
119368|NCT00605280|405929|P4|Year 1|Adverse Event|5
119369|NCT00605280|405930|P3|Year 1|Adverse Event|1
119370|NCT00605280|405931|P2|Year 1|Adverse Event|1
119371|NCT00605280|405932|P1|Year 1|Adverse Event|3
119372|NCT00605280|405929|P4|Year 1|Protocol Violation|1
119373|NCT00605280|405930|P3|Year 1|Protocol Violation|0
119374|NCT00605280|405931|P2|Year 1|Protocol Violation|0
119375|NCT00605280|405932|P1|Year 1|Protocol Violation|0
119376|NCT00605267|405966|P2|Overall Study|Withdrawal by Subject|3
119377|NCT00605267|405967|P1|Overall Study|Withdrawal by Subject|2
119378|NCT00605267|405966|P2|Overall Study|Lack of Efficacy|5
119379|NCT00605267|405967|P1|Overall Study|Lack of Efficacy|1
119380|NCT00605267|405966|P2|Overall Study|Adverse Event|1
119381|NCT00605267|405967|P1|Overall Study|Adverse Event|0
119382|NCT00606320|406005|P1|Overall Study|Progression to depressive phase|4
119383|NCT00606320|406005|P1|Overall Study|Withdrawal by Subject|10
119384|NCT00606320|406005|P1|Overall Study|Protocol Violation|8
119385|NCT00606320|406005|P1|Overall Study|Physician Decision|7
119386|NCT00606320|406005|P1|Overall Study|Lack of Efficacy|5
119387|NCT00606320|406005|P1|Overall Study|Adverse Event|3
119388|NCT00606281|406012|P2|Overall Study|Change of residence or other commitments|1
119389|NCT00606281|406013|P1|Overall Study|Change of residence or other commitments|1
119390|NCT00606281|406012|P2|Overall Study|Progression to depressive phase|1
119391|NCT00606281|406013|P1|Overall Study|Progression to depressive phase|1
119392|NCT00606281|406012|P2|Overall Study|Withdrawal by Subject|13
119393|NCT00606281|406013|P1|Overall Study|Withdrawal by Subject|11
119394|NCT00606281|406012|P2|Overall Study|Protocol Violation|3
119395|NCT00606281|406013|P1|Overall Study|Protocol Violation|3
119396|NCT00606281|406012|P2|Overall Study|Physician Decision|1
119397|NCT00606281|406013|P1|Overall Study|Physician Decision|0
119398|NCT00606281|406012|P2|Overall Study|Lack of Efficacy|35
119399|NCT00606281|406013|P1|Overall Study|Lack of Efficacy|28
119400|NCT00606281|406012|P2|Overall Study|Death|0
119401|NCT00606281|406013|P1|Overall Study|Death|1
119402|NCT00606281|406012|P2|Overall Study|Adverse Event|12
119403|NCT00606281|406013|P1|Overall Study|Adverse Event|11
119404|NCT00606229|406021|P1|Overall Study|change of residence or other commitments|2
119405|NCT00606229|406021|P1|Overall Study|does not meet inclusion criterion 1-3|4
119406|NCT00606229|406021|P1|Overall Study|Withdrawal by Subject|4
119407|NCT00606229|406021|P1|Overall Study|Lack of Efficacy|1
119408|NCT00606229|406021|P1|Overall Study|Adverse Event|11
119409|NCT00606177|406028|P2|Overall Study|Change of residence or other commitments|1
119410|NCT00606177|406029|P1|Overall Study|Change of residence or other commitments|1
119411|NCT00606177|406028|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
119412|NCT00606177|406029|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
119413|NCT00606177|406028|P2|Overall Study|Progression to depressive phase|1
119414|NCT00606177|406029|P1|Overall Study|Progression to depressive phase|6
119415|NCT00606177|406028|P2|Overall Study|Withdrawal by Subject|6
119416|NCT00606177|406029|P1|Overall Study|Withdrawal by Subject|5
119417|NCT00606177|406028|P2|Overall Study|Protocol Violation|4
119418|NCT00606177|406029|P1|Overall Study|Protocol Violation|1
119419|NCT00606177|406028|P2|Overall Study|Physician Decision|0
119420|NCT00606177|406029|P1|Overall Study|Physician Decision|1
119421|NCT00606177|406028|P2|Overall Study|Lack of Efficacy|7
119422|NCT00606177|406029|P1|Overall Study|Lack of Efficacy|3
119423|NCT00606177|406028|P2|Overall Study|Adverse Event|5
119424|NCT00606177|406029|P1|Overall Study|Adverse Event|9
119425|NCT00606086|406056|P2|Overall Study|Randomized, not treated|2
119426|NCT00606086|406057|P1|Overall Study|Randomized, not treated|1
119427|NCT00606086|406056|P2|Overall Study|Non-compliance|1
119428|NCT00606086|406057|P1|Overall Study|Non-compliance|0
119429|NCT00606086|406056|P2|Overall Study|Withdrawal by Subject|3
119430|NCT00606086|406057|P1|Overall Study|Withdrawal by Subject|5
119431|NCT00606086|406056|P2|Overall Study|Protocol Violation|0
119432|NCT00606086|406057|P1|Overall Study|Protocol Violation|1
119433|NCT00606086|406056|P2|Overall Study|Lost to Follow-up|8
119434|NCT00606086|406057|P1|Overall Study|Lost to Follow-up|4
119435|NCT00606086|406056|P2|Overall Study|Adverse Event|1
119436|NCT00606086|406057|P1|Overall Study|Adverse Event|1
119437|NCT00606034|406063|P1|Overall Study|incarceration|1
119438|NCT00606021|406071|P3|Maintenance Phase|Lost to Follow-up|2
119439|NCT00606021|406072|P2|Maintenance Phase|Lost to Follow-up|5
119440|NCT00606021|406073|P1|Maintenance Phase|Lost to Follow-up|0
119441|NCT00606021|406071|P3|Maintenance Phase|Physician Decision|0
119442|NCT00606021|406072|P2|Maintenance Phase|Physician Decision|1
119443|NCT00606021|406073|P1|Maintenance Phase|Physician Decision|0
119444|NCT00606021|406071|P3|Maintenance Phase|Death|15
119445|NCT00606021|406072|P2|Maintenance Phase|Death|17
119446|NCT00606021|406073|P1|Maintenance Phase|Death|0
119447|NCT00606021|406071|P3|Induction Phase|Lost to Follow-up|0
119448|NCT00606021|406072|P2|Induction Phase|Lost to Follow-up|0
119449|NCT00606021|406073|P1|Induction Phase|Lost to Follow-up|10
119450|NCT00606021|406071|P3|Induction Phase|Withdrawal by Subject|0
119451|NCT00606021|406072|P2|Induction Phase|Withdrawal by Subject|0
119452|NCT00606021|406073|P1|Induction Phase|Withdrawal by Subject|2
119453|NCT00606021|406071|P3|Induction Phase|Physician Decision|0
119454|NCT00606021|406072|P2|Induction Phase|Physician Decision|0
119455|NCT00606021|406073|P1|Induction Phase|Physician Decision|2
119456|NCT00606021|406071|P3|Induction Phase|Death|0
119457|NCT00606021|406072|P2|Induction Phase|Death|0
119458|NCT00606021|406073|P1|Induction Phase|Death|73
119459|NCT00606008|406091|P1|Overall Study|Withdrawal by Subject|4
119460|NCT00606008|406091|P1|Overall Study|Adverse Event|1
119461|NCT00605917|406105|P1|Overall Study|Protocol Violation|79
119462|NCT00605865|406157|P1|Overall Study|Protocol Violation|115
119463|NCT00605839|406199|P3|Overall Study|Protocol Violation|0
119464|NCT00605839|406200|P2|Overall Study|Protocol Violation|0
119465|NCT00605839|406201|P1|Overall Study|Protocol Violation|1
119466|NCT00605813|406209|P1|Overall Study|Protocol Violation|25
119467|NCT00605722|406222|P1|Overall Study|Failure to return|1
119468|NCT00605722|406222|P1|Overall Study|Insufficient therapeutic response|44
119469|NCT00605722|406222|P1|Overall Study|Adverse Event|6
119470|NCT00605657|406232|P1|Overall Study|Protocol Violation|1
119471|NCT00605657|406232|P1|Overall Study|Adverse Event|1
119472|NCT00605540|406237|P1|Overall Study|Lost to Follow-up|23
119473|NCT00605540|406237|P1|Overall Study|Death|15
119474|NCT00605475|406255|P10|Overall Study|Withdrawal by Subject|1
119475|NCT00605475|406256|P9|Overall Study|Withdrawal by Subject|0
119476|NCT00605475|406257|P8|Overall Study|Withdrawal by Subject|0
119477|NCT00605475|406258|P7|Overall Study|Withdrawal by Subject|0
119478|NCT00605475|406259|P6|Overall Study|Withdrawal by Subject|2
119479|NCT00605475|406260|P5|Overall Study|Withdrawal by Subject|0
119480|NCT00605475|406261|P4|Overall Study|Withdrawal by Subject|0
119481|NCT00605475|406262|P3|Overall Study|Withdrawal by Subject|0
119482|NCT00605475|406263|P2|Overall Study|Withdrawal by Subject|0
119483|NCT00605475|406264|P1|Overall Study|Withdrawal by Subject|0
119484|NCT00605475|406255|P10|Overall Study|Protocol Violation|0
119485|NCT00605475|406256|P9|Overall Study|Protocol Violation|0
119486|NCT00605475|406257|P8|Overall Study|Protocol Violation|0
119487|NCT00605475|406258|P7|Overall Study|Protocol Violation|0
119488|NCT00605475|406259|P6|Overall Study|Protocol Violation|0
119489|NCT00605475|406260|P5|Overall Study|Protocol Violation|1
119490|NCT00605475|406261|P4|Overall Study|Protocol Violation|0
119491|NCT00605475|406262|P3|Overall Study|Protocol Violation|0
119492|NCT00605475|406263|P2|Overall Study|Protocol Violation|0
119493|NCT00605475|406264|P1|Overall Study|Protocol Violation|0
119494|NCT00605475|406255|P10|Overall Study|Lost to Follow-up|1
119495|NCT00605475|406256|P9|Overall Study|Lost to Follow-up|1
119496|NCT00605475|406257|P8|Overall Study|Lost to Follow-up|0
119497|NCT00605475|406258|P7|Overall Study|Lost to Follow-up|0
119498|NCT00605475|406259|P6|Overall Study|Lost to Follow-up|0
119499|NCT00605475|406260|P5|Overall Study|Lost to Follow-up|0
119500|NCT00605475|406261|P4|Overall Study|Lost to Follow-up|0
119501|NCT00605475|406262|P3|Overall Study|Lost to Follow-up|0
119502|NCT00605475|406263|P2|Overall Study|Lost to Follow-up|0
119503|NCT00605475|406264|P1|Overall Study|Lost to Follow-up|0
119504|NCT00605475|406255|P10|Overall Study|Administrative problems|0
119505|NCT00605475|406256|P9|Overall Study|Administrative problems|0
119506|NCT00605475|406257|P8|Overall Study|Administrative problems|0
119507|NCT00605475|406258|P7|Overall Study|Administrative problems|1
119508|NCT00605475|406259|P6|Overall Study|Administrative problems|0
119509|NCT00605475|406260|P5|Overall Study|Administrative problems|0
119510|NCT00605475|406261|P4|Overall Study|Administrative problems|0
119511|NCT00605475|406262|P3|Overall Study|Administrative problems|0
119512|NCT00605475|406263|P2|Overall Study|Administrative problems|0
119513|NCT00605475|406264|P1|Overall Study|Administrative problems|0
119514|NCT00605475|406255|P10|Overall Study|Abnormal Laboratory Values|0
119515|NCT00605475|406256|P9|Overall Study|Abnormal Laboratory Values|1
119516|NCT00605475|406257|P8|Overall Study|Abnormal Laboratory Values|0
119517|NCT00605475|406258|P7|Overall Study|Abnormal Laboratory Values|0
119518|NCT00605475|406259|P6|Overall Study|Abnormal Laboratory Values|0
119519|NCT00605475|406260|P5|Overall Study|Abnormal Laboratory Values|0
119520|NCT00605475|406261|P4|Overall Study|Abnormal Laboratory Values|0
119521|NCT00605475|406262|P3|Overall Study|Abnormal Laboratory Values|0
119522|NCT00605475|406263|P2|Overall Study|Abnormal Laboratory Values|0
119523|NCT00605475|406264|P1|Overall Study|Abnormal Laboratory Values|0
119524|NCT00605176|406409|P3|Overall Study|Other (not due to AE)|0
119525|NCT00605176|406410|P2|Overall Study|Other (not due to AE)|1
119526|NCT00605176|406411|P1|Overall Study|Other (not due to AE)|1
119527|NCT00605176|406409|P3|Overall Study|Use of concomitant therapy|1
119528|NCT00605176|406410|P2|Overall Study|Use of concomitant therapy|0
119529|NCT00605176|406411|P1|Overall Study|Use of concomitant therapy|1
119530|NCT00605176|406409|P3|Overall Study|Non-complicance with study procedures|0
119531|NCT00605176|406410|P2|Overall Study|Non-complicance with study procedures|0
119532|NCT00605176|406411|P1|Overall Study|Non-complicance with study procedures|1
119533|NCT00605176|406409|P3|Overall Study|Lost to Follow-up|1
119534|NCT00605176|406410|P2|Overall Study|Lost to Follow-up|2
119535|NCT00605176|406411|P1|Overall Study|Lost to Follow-up|2
119536|NCT00605176|406409|P3|Overall Study|Withdrawal by Subject|4
119537|NCT00605176|406410|P2|Overall Study|Withdrawal by Subject|2
119538|NCT00605176|406411|P1|Overall Study|Withdrawal by Subject|4
119539|NCT00605176|406409|P3|Overall Study|Adverse Event|3
119540|NCT00605176|406410|P2|Overall Study|Adverse Event|1
119541|NCT00605176|406411|P1|Overall Study|Adverse Event|2
119542|NCT00605085|406434|P2|Overall Study|administrative reasons|8
119543|NCT00605085|406435|P1|Overall Study|administrative reasons|18
119544|NCT00605085|406434|P2|Overall Study|Lost to Follow-up|5
119545|NCT00605085|406435|P1|Overall Study|Lost to Follow-up|10
119546|NCT00605085|406434|P2|Overall Study|Protocol Violation|2
119547|NCT00605085|406435|P1|Overall Study|Protocol Violation|3
119548|NCT00605085|406434|P2|Overall Study|Pregnancy|0
119549|NCT00605085|406435|P1|Overall Study|Pregnancy|2
119550|NCT00605085|406434|P2|Overall Study|Adverse Event|5
119551|NCT00605085|406435|P1|Overall Study|Adverse Event|9
119552|NCT00605085|406434|P2|Overall Study|Withdrawal by Subject|5
119553|NCT00605085|406435|P1|Overall Study|Withdrawal by Subject|8
119554|NCT00605033|406468|P2|Overall Study|Protocol Violation|1
119555|NCT00605033|406469|P1|Overall Study|Protocol Violation|1
119556|NCT00605033|406468|P2|Overall Study|Withdrawal by Subject|4
119557|NCT00605033|406469|P1|Overall Study|Withdrawal by Subject|3
119558|NCT00605033|406468|P2|Overall Study|Lost to Follow-up|1
119559|NCT00605033|406469|P1|Overall Study|Lost to Follow-up|1
119560|NCT00605033|406468|P2|Overall Study|Adverse Event|2
119561|NCT00605033|406469|P1|Overall Study|Adverse Event|2
119562|NCT00604721|406525|P1|Overall Study|Withdrawal by Subject|1
119563|NCT00604721|406525|P1|Overall Study|Physician Decision|1
119564|NCT00604708|406533|P2|Overall Study|Adverse Event|6
119565|NCT00604708|406534|P1|Overall Study|Adverse Event|6
119566|NCT00604708|406533|P2|Overall Study|administrative reasons|11
119567|NCT00604708|406534|P1|Overall Study|administrative reasons|9
119568|NCT00604708|406533|P2|Overall Study|Lost to Follow-up|5
119569|NCT00604708|406534|P1|Overall Study|Lost to Follow-up|5
119570|NCT00604708|406533|P2|Overall Study|Protocol Violation|8
119571|NCT00604708|406534|P1|Overall Study|Protocol Violation|2
119572|NCT00604708|406533|P2|Overall Study|Withdrawal by Subject|10
119573|NCT00604708|406534|P1|Overall Study|Withdrawal by Subject|9
119574|NCT00604695|406544|P2|Overall Study|Did not receive first bolus.|4
119575|NCT00604695|406545|P1|Overall Study|Did not receive first bolus.|0
119576|NCT00604669|406567|P1|Overall Study|lack of information in chart|7
119577|NCT00604565|406573|P2|Overall Study|Study terminated|3
119578|NCT00604565|406574|P1|Overall Study|Study terminated|0
119579|NCT00604500|406591|P1|Overall Study|Did not meet protocol eligibility|1
119580|NCT00604500|406591|P1|Overall Study|Administrative|1
119581|NCT00604500|406591|P1|Overall Study|Withdrawal by Subject|4
119582|NCT00604500|406591|P1|Overall Study|Treatment Failure|1
119583|NCT00604500|406591|P1|Overall Study|Protocol Violation|2
119584|NCT00604500|406591|P1|Overall Study|Adverse Event|2
119585|NCT00604383|406605|P2|Overall Study|Physician Decision|3
119586|NCT00604383|406606|P1|Overall Study|Physician Decision|0
119587|NCT00604383|406605|P2|Overall Study|Adverse Event|9
119588|NCT00604383|406606|P1|Overall Study|Adverse Event|16
119589|NCT00604383|406605|P2|Overall Study|Death|22
119590|NCT00604383|406606|P1|Overall Study|Death|14
119591|NCT00604383|406605|P2|Overall Study|Lost to Follow-up|19
119592|NCT00604383|406606|P1|Overall Study|Lost to Follow-up|24
119593|NCT00604383|406605|P2|Overall Study|Withdrawal by Subject|31
119594|NCT00604383|406606|P1|Overall Study|Withdrawal by Subject|33
119595|NCT00604279|406622|P2|Overall Study|unspecified|4
119596|NCT00604279|406623|P1|Overall Study|unspecified|8
119597|NCT00604279|406622|P2|Overall Study|Adverse Event|5
119598|NCT00604279|406623|P1|Overall Study|Adverse Event|4
119599|NCT00604279|406622|P2|Overall Study|Withdrawal by Subject|5
119600|NCT00604279|406623|P1|Overall Study|Withdrawal by Subject|16
119601|NCT00604279|406622|P2|Overall Study|Protocol Violation|1
119602|NCT00604279|406623|P1|Overall Study|Protocol Violation|3
119603|NCT00604279|406622|P2|Overall Study|Pregnancy|0
119604|NCT00604279|406623|P1|Overall Study|Pregnancy|2
119605|NCT00604279|406622|P2|Overall Study|Lost to Follow-up|14
119606|NCT00604279|406623|P1|Overall Study|Lost to Follow-up|9
119607|NCT00604279|406622|P2|Overall Study|Lack of Efficacy|9
119608|NCT00604279|406623|P1|Overall Study|Lack of Efficacy|22
119609|NCT00604214|406639|P2|Day 91 to Day 180|Withdrawal by Subject|1
119610|NCT00604214|406640|P1|Day 91 to Day 180|Withdrawal by Subject|1
119611|NCT00604214|406639|P2|Day 91 to Day 180|Lost to Follow-up|8
119612|NCT00604214|406640|P1|Day 91 to Day 180|Lost to Follow-up|6
119613|NCT00604214|406639|P2|Day 91 to Day 180|Death|23
119614|NCT00604214|406640|P1|Day 91 to Day 180|Death|19
119615|NCT00604214|406639|P2|Day 29 to Day 90|Withdrawal by Subject|6
119616|NCT00604214|406640|P1|Day 29 to Day 90|Withdrawal by Subject|0
119617|NCT00604214|406639|P2|Day 29 to Day 90|Lost to Follow-up|6
119618|NCT00604214|406640|P1|Day 29 to Day 90|Lost to Follow-up|4
119619|NCT00604214|406639|P2|Day 29 to Day 90|Death|67
119620|NCT00604214|406640|P1|Day 29 to Day 90|Death|64
119621|NCT00604214|406639|P2|Baseline to Day 28|Withdrawal by Subject|7
119622|NCT00604214|406640|P1|Baseline to Day 28|Withdrawal by Subject|3
119623|NCT00604214|406639|P2|Baseline to Day 28|Lost to Follow-up|4
119624|NCT00604214|406640|P1|Baseline to Day 28|Lost to Follow-up|2
119625|NCT00604214|406639|P2|Baseline to Day 28|Death|202
119626|NCT00604214|406640|P1|Baseline to Day 28|Death|223
119627|NCT00604188|406672|P2|Overall Study|Did not receive study drug|1
119628|NCT00604188|406673|P1|Overall Study|Did not receive study drug|0
119629|NCT00604188|406672|P2|Overall Study|Non-compliance with protocol|4
119630|NCT00604188|406673|P1|Overall Study|Non-compliance with protocol|4
119631|NCT00604188|406672|P2|Overall Study|Withdrawal by Subject|1
119632|NCT00604188|406673|P1|Overall Study|Withdrawal by Subject|5
119633|NCT00604188|406672|P2|Overall Study|Lost to Follow-up|15
119634|NCT00604188|406673|P1|Overall Study|Lost to Follow-up|17
119635|NCT00604188|406672|P2|Overall Study|Adverse Event|4
119636|NCT00604188|406673|P1|Overall Study|Adverse Event|1
119637|NCT00604175|406696|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
119638|NCT00604175|406697|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
119639|NCT00604175|406698|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
119640|NCT00604175|406696|P3|Week 29 Through Week 72|Site closure|0
119641|NCT00604175|406697|P2|Week 29 Through Week 72|Site closure|1
119642|NCT00604175|406698|P1|Week 29 Through Week 72|Site closure|0
119643|NCT00604175|406696|P3|Week 29 Through Week 72|Lost to Follow-up|2
119644|NCT00604175|406697|P2|Week 29 Through Week 72|Lost to Follow-up|6
119645|NCT00604175|406698|P1|Week 29 Through Week 72|Lost to Follow-up|12
119646|NCT00604175|406696|P3|Week 29 Through Week 72|Death|1
119647|NCT00604175|406697|P2|Week 29 Through Week 72|Death|0
119648|NCT00604175|406698|P1|Week 29 Through Week 72|Death|0
119649|NCT00604175|406696|P3|Entry Through Week 28|Did not start intervention|1
119650|NCT00604175|406697|P2|Entry Through Week 28|Did not start intervention|0
119651|NCT00604175|406698|P1|Entry Through Week 28|Did not start intervention|2
119652|NCT00604175|406696|P3|Entry Through Week 28|Ineligible|0
119653|NCT00604175|406697|P2|Entry Through Week 28|Ineligible|0
119654|NCT00604175|406698|P1|Entry Through Week 28|Ineligible|1
119655|NCT00604175|406696|P3|Entry Through Week 28|Lost to Follow-up|0
119656|NCT00604175|406697|P2|Entry Through Week 28|Lost to Follow-up|3
119657|NCT00604175|406698|P1|Entry Through Week 28|Lost to Follow-up|4
119658|NCT00604175|406696|P3|Entry Through Week 28|Withdrawal by Subject|0
119659|NCT00604175|406697|P2|Entry Through Week 28|Withdrawal by Subject|0
119660|NCT00604175|406698|P1|Entry Through Week 28|Withdrawal by Subject|1
119661|NCT00604175|406696|P3|Entry Through Week 28|Death|0
119662|NCT00604175|406697|P2|Entry Through Week 28|Death|0
119663|NCT00604175|406698|P1|Entry Through Week 28|Death|2
119664|NCT00604162|406751|P1|Overall Study|Withdrawal by Subject|1
119665|NCT00604162|406751|P1|Overall Study|Physician Decision|3
119666|NCT00603915|406793|P1|Overall Study|Physician Decision|1
119667|NCT00603837|406823|P2|Overall Study|Physician Decision|0
119668|NCT00603837|406824|P1|Overall Study|Physician Decision|3
119669|NCT00603798|406833|P3|Overall Study|Not due to AE|4
119670|NCT00603798|406834|P2|Overall Study|Not due to AE|1
119671|NCT00603798|406835|P1|Overall Study|Not due to AE|1
119672|NCT00603798|406833|P3|Overall Study|Non-compliance with study procedures|0
119673|NCT00603798|406834|P2|Overall Study|Non-compliance with study procedures|1
119674|NCT00603798|406835|P1|Overall Study|Non-compliance with study procedures|0
119675|NCT00603798|406833|P3|Overall Study|Lost to Follow-up|1
119676|NCT00603798|406834|P2|Overall Study|Lost to Follow-up|0
119677|NCT00603798|406835|P1|Overall Study|Lost to Follow-up|1
119678|NCT00603798|406833|P3|Overall Study|Withdrawal by Subject|4
119679|NCT00603798|406834|P2|Overall Study|Withdrawal by Subject|3
119680|NCT00603798|406835|P1|Overall Study|Withdrawal by Subject|4
119681|NCT00603798|406833|P3|Overall Study|Adverse Event|1
119682|NCT00603798|406834|P2|Overall Study|Adverse Event|2
119683|NCT00603798|406835|P1|Overall Study|Adverse Event|4
119684|NCT00603746|406858|P6|Overall Study|Withdrawal by Subject|1
119685|NCT00603746|406859|P5|Overall Study|Withdrawal by Subject|3
119686|NCT00603746|406860|P4|Overall Study|Withdrawal by Subject|1
119687|NCT00603746|406861|P3|Overall Study|Withdrawal by Subject|0
119688|NCT00603746|406862|P2|Overall Study|Withdrawal by Subject|0
119689|NCT00603746|406863|P1|Overall Study|Withdrawal by Subject|1
119690|NCT00603746|406858|P6|Overall Study|Physician Decision|0
119691|NCT00603746|406859|P5|Overall Study|Physician Decision|1
119692|NCT00603746|406860|P4|Overall Study|Physician Decision|0
119693|NCT00603746|406861|P3|Overall Study|Physician Decision|0
119694|NCT00603746|406862|P2|Overall Study|Physician Decision|0
119695|NCT00603746|406863|P1|Overall Study|Physician Decision|1
119696|NCT00603746|406858|P6|Overall Study|Lost to Follow-up|0
119697|NCT00603746|406859|P5|Overall Study|Lost to Follow-up|0
119698|NCT00603746|406860|P4|Overall Study|Lost to Follow-up|0
119699|NCT00603746|406861|P3|Overall Study|Lost to Follow-up|1
119700|NCT00603746|406862|P2|Overall Study|Lost to Follow-up|1
119701|NCT00603746|406863|P1|Overall Study|Lost to Follow-up|0
119702|NCT00603746|406858|P6|Overall Study|Protocol Violation|0
119703|NCT00603746|406859|P5|Overall Study|Protocol Violation|1
119704|NCT00603746|406860|P4|Overall Study|Protocol Violation|0
119705|NCT00603746|406861|P3|Overall Study|Protocol Violation|1
119706|NCT00603746|406862|P2|Overall Study|Protocol Violation|3
119707|NCT00603746|406863|P1|Overall Study|Protocol Violation|0
119708|NCT00603746|406858|P6|Overall Study|Lack of Efficacy|8
119709|NCT00603746|406859|P5|Overall Study|Lack of Efficacy|12
119710|NCT00603746|406860|P4|Overall Study|Lack of Efficacy|11
119711|NCT00603746|406861|P3|Overall Study|Lack of Efficacy|6
119712|NCT00603746|406862|P2|Overall Study|Lack of Efficacy|11
119713|NCT00603746|406863|P1|Overall Study|Lack of Efficacy|34
119714|NCT00603746|406858|P6|Overall Study|Adverse Event|4
119715|NCT00603746|406859|P5|Overall Study|Adverse Event|0
119716|NCT00603746|406860|P4|Overall Study|Adverse Event|1
119717|NCT00603746|406861|P3|Overall Study|Adverse Event|0
119718|NCT00603746|406862|P2|Overall Study|Adverse Event|3
119719|NCT00603746|406863|P1|Overall Study|Adverse Event|2
119720|NCT00603733|407011|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
119721|NCT00603733|407012|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
119722|NCT00603733|407011|P2|Maintenance Phase ITT|Physician Decision|1
119723|NCT00603733|407012|P1|Maintenance Phase ITT|Physician Decision|0
119724|NCT00603733|407011|P2|Maintenance Phase ITT|Lack of Efficacy|2
119725|NCT00603733|407012|P1|Maintenance Phase ITT|Lack of Efficacy|2
119726|NCT00603733|407011|P2|Maintenance Phase ITT|Lost to Follow-up|1
119727|NCT00603733|407012|P1|Maintenance Phase ITT|Lost to Follow-up|0
119728|NCT00603733|407011|P2|Maintenance Phase ITT|Protocol Violation|1
119729|NCT00603733|407012|P1|Maintenance Phase ITT|Protocol Violation|1
119730|NCT00603733|407011|P2|Maintenance Phase ITT|Withdrawal by Subject|0
119731|NCT00603733|407012|P1|Maintenance Phase ITT|Withdrawal by Subject|1
119732|NCT00603733|407011|P2|Maintenance Phase ITT|Adverse Event|6
119733|NCT00603733|407012|P1|Maintenance Phase ITT|Adverse Event|3
119734|NCT00603733|407011|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
119735|NCT00603733|407012|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
119736|NCT00603733|407011|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
119737|NCT00603733|407012|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
119738|NCT00603733|407011|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
119739|NCT00603733|407012|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
119740|NCT00603733|407011|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
119741|NCT00603733|407012|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
119742|NCT00603733|407011|P2|Run-In Phase - 4 Weeks|Adverse Event|1
119743|NCT00603733|407012|P1|Run-In Phase - 4 Weeks|Adverse Event|2
119744|NCT00603733|407011|P2|Active Phase ITT|Subject moved, site closed|1
119745|NCT00603733|407012|P1|Active Phase ITT|Subject moved, site closed|1
119746|NCT00603733|407011|P2|Active Phase ITT|Lack of Efficacy|2
119747|NCT00603733|407012|P1|Active Phase ITT|Lack of Efficacy|1
119748|NCT00603733|407011|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
119749|NCT00603733|407012|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
119750|NCT00603733|407011|P2|Active Phase ITT|Lost to Follow-up|1
119751|NCT00603733|407012|P1|Active Phase ITT|Lost to Follow-up|0
119752|NCT00603733|407011|P2|Active Phase ITT|Withdrawal by Subject|3
119753|NCT00603733|407012|P1|Active Phase ITT|Withdrawal by Subject|0
119754|NCT00603733|407011|P2|Active Phase ITT|Adverse Event|7
119755|NCT00603733|407012|P1|Active Phase ITT|Adverse Event|8
119756|NCT00603590|407041|P2|Overall Study|Cardiovascular event|1
119757|NCT00603590|407042|P1|Overall Study|Cardiovascular event|0
119758|NCT00603590|407041|P2|Overall Study|Lost to Follow-up|4
119759|NCT00603590|407042|P1|Overall Study|Lost to Follow-up|8
119760|NCT00603590|407041|P2|Overall Study|Adverse Event|0
119761|NCT00603590|407042|P1|Overall Study|Adverse Event|2
119762|NCT00603590|407041|P2|Overall Study|Patient discontinued study drug|15
119763|NCT00603590|407042|P1|Overall Study|Patient discontinued study drug|22
119764|NCT00603590|407041|P2|Overall Study|Refused blood test|1
119765|NCT00603590|407042|P1|Overall Study|Refused blood test|5
119766|NCT00603590|407041|P2|Overall Study|Did not attend study clinic|30
119767|NCT00603590|407042|P1|Overall Study|Did not attend study clinic|39
119768|NCT00603538|407066|P3|Overall Study|Objective progression or relapse|0
119769|NCT00603538|407067|P2|Overall Study|Objective progression or relapse|0
119770|NCT00603538|407068|P1|Overall Study|Objective progression or relapse|3
119771|NCT00603538|407066|P3|Overall Study|Adverse Event|2
119772|NCT00603538|407067|P2|Overall Study|Adverse Event|4
119773|NCT00603538|407068|P1|Overall Study|Adverse Event|0
119774|NCT00603525|407108|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
119775|NCT00603525|407109|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
119776|NCT00603525|407110|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
119777|NCT00603525|407108|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
119778|NCT00603525|407109|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
119779|NCT00603525|407110|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
119780|NCT00603525|407108|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
119781|NCT00603525|407109|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
119782|NCT00603525|407110|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
119783|NCT00603525|407108|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
119784|NCT00603525|407109|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
119785|NCT00603525|407110|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
119786|NCT00603525|407108|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
119787|NCT00603525|407109|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
119788|NCT00603525|407110|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
119789|NCT00603525|407108|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
119790|NCT00603525|407109|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
119791|NCT00603525|407110|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
119792|NCT00603525|407108|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
119793|NCT00603525|407109|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
119794|NCT00603525|407110|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
119795|NCT00603525|407108|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
119796|NCT00603525|407109|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
119797|NCT00603525|407110|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
119798|NCT00603525|407108|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
119799|NCT00603525|407109|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
119800|NCT00603525|407110|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
119801|NCT00603525|407108|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
119802|NCT00603525|407109|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
119803|NCT00603525|407110|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
119804|NCT00603525|407108|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
119805|NCT00603525|407109|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
119806|NCT00603525|407110|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
119807|NCT00603525|407108|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
119808|NCT00603525|407109|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
119809|NCT00603525|407110|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
119810|NCT00603525|407108|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
119811|NCT00603525|407109|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
119812|NCT00603525|407110|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
119813|NCT00603525|407108|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
119814|NCT00603525|407109|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
119815|NCT00603525|407110|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
119816|NCT00603525|407108|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
119817|NCT00603525|407109|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
119818|NCT00603525|407110|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
119819|NCT00603512|407242|P5|Overall Study|Randomized but not treated|0
119820|NCT00603512|407243|P4|Overall Study|Randomized but not treated|2
119821|NCT00603512|407244|P3|Overall Study|Randomized but not treated|1
119822|NCT00603512|407245|P2|Overall Study|Randomized but not treated|1
119823|NCT00603512|407246|P1|Overall Study|Randomized but not treated|0
119824|NCT00603512|407242|P5|Overall Study|Withdrawal by Subject|1
119825|NCT00603512|407243|P4|Overall Study|Withdrawal by Subject|0
119826|NCT00603512|407244|P3|Overall Study|Withdrawal by Subject|0
119827|NCT00603512|407245|P2|Overall Study|Withdrawal by Subject|0
119828|NCT00603512|407246|P1|Overall Study|Withdrawal by Subject|0
119829|NCT00603512|407242|P5|Overall Study|Unspecified|1
119830|NCT00603512|407243|P4|Overall Study|Unspecified|1
119831|NCT00603512|407244|P3|Overall Study|Unspecified|0
119832|NCT00603512|407245|P2|Overall Study|Unspecified|1
119833|NCT00603512|407246|P1|Overall Study|Unspecified|2
119834|NCT00603512|407242|P5|Overall Study|Lack of Efficacy|1
119835|NCT00603512|407243|P4|Overall Study|Lack of Efficacy|0
119836|NCT00603512|407244|P3|Overall Study|Lack of Efficacy|0
119837|NCT00603512|407245|P2|Overall Study|Lack of Efficacy|1
119838|NCT00603512|407246|P1|Overall Study|Lack of Efficacy|0
119839|NCT00603512|407242|P5|Overall Study|Adverse Event|2
119840|NCT00603512|407243|P4|Overall Study|Adverse Event|4
119841|NCT00603512|407244|P3|Overall Study|Adverse Event|4
119842|NCT00603512|407245|P2|Overall Study|Adverse Event|2
119843|NCT00603512|407246|P1|Overall Study|Adverse Event|0
119844|NCT00603473|407388|P1|Overall Study|Protocol Violation|1
119845|NCT00603473|407388|P1|Overall Study|Lack of Efficacy|4
119846|NCT00603473|407388|P1|Overall Study|Adverse Event|4
119847|NCT00603447|407401|P7|Overall Study|Withdrew Consent|1
119848|NCT00603447|407402|P6|Overall Study|Withdrew Consent|0
119849|NCT00603447|407403|P5|Overall Study|Withdrew Consent|1
119850|NCT00603447|407404|P4|Overall Study|Withdrew Consent|0
119851|NCT00603447|407405|P3|Overall Study|Withdrew Consent|0
119852|NCT00603447|407406|P2|Overall Study|Withdrew Consent|2
119853|NCT00603447|407407|P1|Overall Study|Withdrew Consent|0
119854|NCT00603447|407401|P7|Overall Study|Other|13
119855|NCT00603447|407402|P6|Overall Study|Other|0
119856|NCT00603447|407403|P5|Overall Study|Other|3
119857|NCT00603447|407404|P4|Overall Study|Other|0
119858|NCT00603447|407405|P3|Overall Study|Other|1
119859|NCT00603447|407406|P2|Overall Study|Other|0
119860|NCT00603447|407407|P1|Overall Study|Other|0
119861|NCT00603447|407401|P7|Overall Study|Adverse Event|10
119862|NCT00603447|407402|P6|Overall Study|Adverse Event|2
119863|NCT00603447|407403|P5|Overall Study|Adverse Event|1
119864|NCT00603447|407404|P4|Overall Study|Adverse Event|2
119865|NCT00603447|407405|P3|Overall Study|Adverse Event|1
119866|NCT00603447|407406|P2|Overall Study|Adverse Event|1
119867|NCT00603447|407407|P1|Overall Study|Adverse Event|0
119868|NCT00603382|407446|P6|Overall Study|Withdrawal by Subject|1
119869|NCT00603382|407447|P5|Overall Study|Withdrawal by Subject|0
119870|NCT00603382|407448|P4|Overall Study|Withdrawal by Subject|1
119871|NCT00603382|407449|P3|Overall Study|Withdrawal by Subject|1
119872|NCT00603382|407450|P2|Overall Study|Withdrawal by Subject|3
119873|NCT00603382|407451|P1|Overall Study|Withdrawal by Subject|3
119874|NCT00603382|407446|P6|Overall Study|Physician Decision|3
119875|NCT00603382|407447|P5|Overall Study|Physician Decision|1
119876|NCT00603382|407448|P4|Overall Study|Physician Decision|0
119877|NCT00603382|407449|P3|Overall Study|Physician Decision|2
119878|NCT00603382|407450|P2|Overall Study|Physician Decision|0
119879|NCT00603382|407451|P1|Overall Study|Physician Decision|0
119880|NCT00603382|407446|P6|Overall Study|Lost to Follow-up|1
119881|NCT00603382|407447|P5|Overall Study|Lost to Follow-up|0
119882|NCT00603382|407448|P4|Overall Study|Lost to Follow-up|1
119883|NCT00603382|407449|P3|Overall Study|Lost to Follow-up|1
119884|NCT00603382|407450|P2|Overall Study|Lost to Follow-up|1
119885|NCT00603382|407451|P1|Overall Study|Lost to Follow-up|0
119886|NCT00603382|407446|P6|Overall Study|Protocol Violation|0
119887|NCT00603382|407447|P5|Overall Study|Protocol Violation|1
119888|NCT00603382|407448|P4|Overall Study|Protocol Violation|2
119889|NCT00603382|407449|P3|Overall Study|Protocol Violation|1
119890|NCT00603382|407450|P2|Overall Study|Protocol Violation|0
119891|NCT00603382|407451|P1|Overall Study|Protocol Violation|1
119892|NCT00603382|407446|P6|Overall Study|Lack of Efficacy|11
119893|NCT00603382|407447|P5|Overall Study|Lack of Efficacy|6
119894|NCT00603382|407448|P4|Overall Study|Lack of Efficacy|6
119895|NCT00603382|407449|P3|Overall Study|Lack of Efficacy|3
119896|NCT00603382|407450|P2|Overall Study|Lack of Efficacy|9
119897|NCT00603382|407451|P1|Overall Study|Lack of Efficacy|14
119898|NCT00603382|407446|P6|Overall Study|Adverse Event|2
119899|NCT00603382|407447|P5|Overall Study|Adverse Event|1
119900|NCT00603382|407448|P4|Overall Study|Adverse Event|2
119901|NCT00603382|407449|P3|Overall Study|Adverse Event|1
119902|NCT00603382|407450|P2|Overall Study|Adverse Event|1
119903|NCT00603382|407451|P1|Overall Study|Adverse Event|0
119904|NCT00603304|407599|P2|Overall Study|Patient Decision|0
119905|NCT00603304|407600|P1|Overall Study|Patient Decision|2
119906|NCT00603304|407599|P2|Overall Study|Not Specified|0
119907|NCT00603304|407600|P1|Overall Study|Not Specified|2
119908|NCT00603304|407599|P2|Overall Study|Moved Away|2
119909|NCT00603304|407600|P1|Overall Study|Moved Away|0
119910|NCT00603304|407599|P2|Overall Study|Non-Compliant|1
119911|NCT00603304|407600|P1|Overall Study|Non-Compliant|0
119912|NCT00603304|407599|P2|Overall Study|Exclusionary Medication|3
119913|NCT00603304|407600|P1|Overall Study|Exclusionary Medication|2
119914|NCT00603304|407599|P2|Overall Study|Crossed Over to Open Label Therapy|3
119915|NCT00603304|407600|P1|Overall Study|Crossed Over to Open Label Therapy|3
119916|NCT00603304|407599|P2|Overall Study|Unacceptable Treatment Toxicity|8
119917|NCT00603304|407600|P1|Overall Study|Unacceptable Treatment Toxicity|5
119918|NCT00603304|407599|P2|Overall Study|Adverse Event|2
119919|NCT00603304|407600|P1|Overall Study|Adverse Event|4
119920|NCT00603304|407599|P2|Overall Study|Protocol Violation|0
119921|NCT00603304|407600|P1|Overall Study|Protocol Violation|1
119922|NCT00603304|407599|P2|Overall Study|Withdrawal by Subject|5
119923|NCT00603304|407600|P1|Overall Study|Withdrawal by Subject|8
119924|NCT00603304|407599|P2|Overall Study|Lost to Follow-up|7
119925|NCT00603304|407600|P1|Overall Study|Lost to Follow-up|5
119926|NCT00603278|407656|P6|Overall Study|Lost to Follow-up|0
119927|NCT00603278|407657|P5|Overall Study|Lost to Follow-up|1
119928|NCT00603278|407658|P4|Overall Study|Lost to Follow-up|0
119929|NCT00603278|407659|P3|Overall Study|Lost to Follow-up|0
119930|NCT00603278|407660|P2|Overall Study|Lost to Follow-up|0
119931|NCT00603278|407661|P1|Overall Study|Lost to Follow-up|1
119932|NCT00603278|407656|P6|Overall Study|Physician Decision|1
119933|NCT00603278|407657|P5|Overall Study|Physician Decision|2
119934|NCT00603278|407658|P4|Overall Study|Physician Decision|0
119935|NCT00603278|407659|P3|Overall Study|Physician Decision|0
119936|NCT00603278|407660|P2|Overall Study|Physician Decision|1
119937|NCT00603278|407661|P1|Overall Study|Physician Decision|0
119938|NCT00603278|407656|P6|Overall Study|Protocol Violation|1
119939|NCT00603278|407657|P5|Overall Study|Protocol Violation|0
119940|NCT00603278|407658|P4|Overall Study|Protocol Violation|1
119941|NCT00603278|407659|P3|Overall Study|Protocol Violation|1
119942|NCT00603278|407660|P2|Overall Study|Protocol Violation|0
119943|NCT00603278|407661|P1|Overall Study|Protocol Violation|3
119944|NCT00603278|407656|P6|Overall Study|Withdrawal by Subject|2
119945|NCT00603278|407657|P5|Overall Study|Withdrawal by Subject|1
119946|NCT00603278|407658|P4|Overall Study|Withdrawal by Subject|2
119947|NCT00603278|407659|P3|Overall Study|Withdrawal by Subject|1
119948|NCT00603278|407660|P2|Overall Study|Withdrawal by Subject|3
119949|NCT00603278|407661|P1|Overall Study|Withdrawal by Subject|2
119950|NCT00603278|407656|P6|Overall Study|Adverse Event|1
119951|NCT00603278|407657|P5|Overall Study|Adverse Event|2
119952|NCT00603278|407658|P4|Overall Study|Adverse Event|0
119953|NCT00603278|407659|P3|Overall Study|Adverse Event|1
119954|NCT00603278|407660|P2|Overall Study|Adverse Event|3
119955|NCT00603278|407661|P1|Overall Study|Adverse Event|0
119956|NCT00603278|407656|P6|Overall Study|Lack of Efficacy|14
119957|NCT00603278|407657|P5|Overall Study|Lack of Efficacy|7
119958|NCT00603278|407658|P4|Overall Study|Lack of Efficacy|8
119959|NCT00603278|407659|P3|Overall Study|Lack of Efficacy|11
119960|NCT00603278|407660|P2|Overall Study|Lack of Efficacy|10
119961|NCT00603278|407661|P1|Overall Study|Lack of Efficacy|35
119962|NCT00603265|407810|P3|Overall Study|Protocol Violation|0
119963|NCT00603265|407811|P2|Overall Study|Protocol Violation|0
119964|NCT00603265|407812|P1|Overall Study|Protocol Violation|1
119965|NCT00603265|407810|P3|Overall Study|Participant Left Country, No Responses|0
119966|NCT00603265|407811|P2|Overall Study|Participant Left Country, No Responses|1
119967|NCT00603265|407812|P1|Overall Study|Participant Left Country, No Responses|0
119968|NCT00603265|407810|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
119969|NCT00603265|407811|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
119970|NCT00603265|407812|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
119971|NCT00603265|407810|P3|Overall Study|Lost to Follow-up|0
119972|NCT00603265|407811|P2|Overall Study|Lost to Follow-up|1
119973|NCT00603265|407812|P1|Overall Study|Lost to Follow-up|0
119974|NCT00603265|407810|P3|Overall Study|Lack of Efficacy|3
119975|NCT00603265|407811|P2|Overall Study|Lack of Efficacy|0
119976|NCT00603265|407812|P1|Overall Study|Lack of Efficacy|3
119977|NCT00603265|407810|P3|Overall Study|Withdrawal by Subject|1
119978|NCT00603265|407811|P2|Overall Study|Withdrawal by Subject|2
119979|NCT00603265|407812|P1|Overall Study|Withdrawal by Subject|1
119980|NCT00603265|407810|P3|Overall Study|Adverse Event|1
119981|NCT00603265|407811|P2|Overall Study|Adverse Event|11
119982|NCT00603265|407812|P1|Overall Study|Adverse Event|2
119983|NCT00603239|407840|P2|Overall Study|Subject decision|1
119984|NCT00603239|407841|P1|Overall Study|Subject decision|2
119985|NCT00603239|407840|P2|Overall Study|Protocol Violation|0
119986|NCT00603239|407841|P1|Overall Study|Protocol Violation|2
119987|NCT00603239|407840|P2|Overall Study|Physician Decision|0
119988|NCT00603239|407841|P1|Overall Study|Physician Decision|2
119989|NCT00603239|407840|P2|Overall Study|Lost to Follow-up|1
119990|NCT00603239|407841|P1|Overall Study|Lost to Follow-up|2
119991|NCT00603239|407840|P2|Overall Study|Loss of glucose control|0
119992|NCT00603239|407841|P1|Overall Study|Loss of glucose control|3
119993|NCT00603239|407840|P2|Overall Study|Entry criteria not met|1
119994|NCT00603239|407841|P1|Overall Study|Entry criteria not met|0
119995|NCT00603239|407840|P2|Overall Study|Adverse Event|1
119996|NCT00603239|407841|P1|Overall Study|Adverse Event|4
119997|NCT00602927|407899|P2|Period 3: 13 Days|MRI data quality|2
119998|NCT00602927|407900|P1|Period 3: 13 Days|MRI data quality|2
119999|NCT00602927|407899|P2|Period 3: 13 Days|Protocol Violation|1
120000|NCT00602927|407900|P1|Period 3: 13 Days|Protocol Violation|0
120001|NCT00602927|407899|P2|Period 2: 14 Days|Protocol Violation|2
120002|NCT00602927|407900|P1|Period 2: 14 Days|Protocol Violation|0
120003|NCT00602927|407899|P2|Period 1: 13 Days|Claustrophobia|1
120004|NCT00602927|407900|P1|Period 1: 13 Days|Claustrophobia|0
120005|NCT00602927|407899|P2|Period 1: 13 Days|Time|0
120006|NCT00602927|407900|P1|Period 1: 13 Days|Time|1
120007|NCT00602927|407899|P2|Period 1: 13 Days|MRI scanner technical issue|0
120008|NCT00602927|407900|P1|Period 1: 13 Days|MRI scanner technical issue|1
120009|NCT00602927|407899|P2|Period 1: 13 Days|Protocol Violation|4
120010|NCT00602927|407900|P1|Period 1: 13 Days|Protocol Violation|2
120011|NCT00602641|407923|P2|Overall Study|Other|1
120012|NCT00602641|407924|P1|Overall Study|Other|3
120013|NCT00602641|407923|P2|Overall Study|Administrative Closure|1
120014|NCT00602641|407924|P1|Overall Study|Administrative Closure|1
120015|NCT00602641|407923|P2|Overall Study|Physician Decision|4
120016|NCT00602641|407924|P1|Overall Study|Physician Decision|5
120017|NCT00602641|407923|P2|Overall Study|Other Complicating Disease|2
120018|NCT00602641|407924|P1|Overall Study|Other Complicating Disease|5
120019|NCT00602641|407923|P2|Overall Study|Alternative therapy|2
120020|NCT00602641|407924|P1|Overall Study|Alternative therapy|5
120021|NCT00602641|407923|P2|Overall Study|Withdrawal by Subject|12
120022|NCT00602641|407924|P1|Overall Study|Withdrawal by Subject|15
120023|NCT00602641|407923|P2|Overall Study|Death|5
120024|NCT00602641|407924|P1|Overall Study|Death|6
120025|NCT00602641|407923|P2|Overall Study|Disease progression|55
120026|NCT00602641|407924|P1|Overall Study|Disease progression|38
120027|NCT00602641|407923|P2|Overall Study|Adverse Event|53
120028|NCT00602641|407924|P1|Overall Study|Adverse Event|62
120029|NCT00602641|407923|P2|Overall Study|Still on treatment at time of analysis|15
120030|NCT00602641|407924|P1|Overall Study|Still on treatment at time of analysis|8
120031|NCT00602641|407923|P2|Overall Study|Never started protocol therapy|2
120032|NCT00602641|407924|P1|Overall Study|Never started protocol therapy|6
120033|NCT00602472|407938|P2|Overall Study|Other incl. lack of efficacy|2
120034|NCT00602472|407939|P1|Overall Study|Other incl. lack of efficacy|4
120035|NCT00602472|407938|P2|Overall Study|Withdrawal by Subject|14
120036|NCT00602472|407939|P1|Overall Study|Withdrawal by Subject|8
120037|NCT00602472|407938|P2|Overall Study|Protocol Violation|19
120038|NCT00602472|407939|P1|Overall Study|Protocol Violation|4
120039|NCT00602472|407938|P2|Overall Study|Adverse Event|23
120040|NCT00602472|407939|P1|Overall Study|Adverse Event|5
120041|NCT00602420|407976|P2|Overall Study|Adverse Event|0
120042|NCT00602420|407977|P1|Overall Study|Adverse Event|1
120043|NCT00602420|407976|P2|Overall Study|Withdrawal by Subject|17
120044|NCT00602420|407977|P1|Overall Study|Withdrawal by Subject|18
120045|NCT00602420|407976|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
120046|NCT00602420|407977|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
120047|NCT00602420|407976|P2|Overall Study|Death|4
120048|NCT00602420|407977|P1|Overall Study|Death|1
120049|NCT00601900|408064|P2|Overall Study|Withdrawal by Subject|3
120050|NCT00601900|408065|P1|Overall Study|Withdrawal by Subject|0
120051|NCT00601835|408081|P2|Overall Study|Relocate|2
120052|NCT00601835|408082|P1|Overall Study|Relocate|12
120053|NCT00601835|408081|P2|Overall Study|Adverse Event|1
120054|NCT00601835|408082|P1|Overall Study|Adverse Event|1
120055|NCT00601835|408081|P2|Overall Study|Lost to Follow-up|5
120056|NCT00601835|408082|P1|Overall Study|Lost to Follow-up|37
120057|NCT00601835|408081|P2|Overall Study|Physician Decision|0
120058|NCT00601835|408082|P1|Overall Study|Physician Decision|1
120059|NCT00601835|408081|P2|Overall Study|Withdrawal by Subject|6
120060|NCT00601835|408082|P1|Overall Study|Withdrawal by Subject|9
120061|NCT00601523|408166|P2|Overall Study|not specified|1
120062|NCT00601523|408167|P1|Overall Study|not specified|9
120063|NCT00601523|408166|P2|Overall Study|Withdrawal by Subject|9
120064|NCT00601523|408167|P1|Overall Study|Withdrawal by Subject|18
120065|NCT00601523|408166|P2|Overall Study|Lost to Follow-up|1
120066|NCT00601523|408167|P1|Overall Study|Lost to Follow-up|0
120067|NCT00601523|408166|P2|Overall Study|Protocol Violation|1
120068|NCT00601523|408167|P1|Overall Study|Protocol Violation|5
120069|NCT00601523|408166|P2|Overall Study|Lack of Efficacy|0
120070|NCT00601523|408167|P1|Overall Study|Lack of Efficacy|3
120071|NCT00601523|408166|P2|Overall Study|Adverse Event|14
120072|NCT00601523|408167|P1|Overall Study|Adverse Event|42
120073|NCT00601458|408202|P3|Overall Study|Early Termination|1
120074|NCT00601458|408203|P2|Overall Study|Early Termination|1
120075|NCT00601458|408204|P1|Overall Study|Early Termination|0
120076|NCT00601458|408202|P3|Overall Study|Protocol Violation|1
120077|NCT00601458|408203|P2|Overall Study|Protocol Violation|2
120078|NCT00601458|408204|P1|Overall Study|Protocol Violation|3
120079|NCT00601458|408202|P3|Overall Study|Incomplete Data|0
120080|NCT00601458|408203|P2|Overall Study|Incomplete Data|2
120081|NCT00601458|408204|P1|Overall Study|Incomplete Data|0
120082|NCT00601458|408202|P3|Overall Study|Dosing Error|0
120083|NCT00601458|408203|P2|Overall Study|Dosing Error|0
120084|NCT00601458|408204|P1|Overall Study|Dosing Error|1
120085|NCT00601419|408215|P1|Overall Study|Missed Visits|1
120086|NCT00601419|408215|P1|Overall Study|Lost to Follow-up|3
120087|NCT00601354|408245|P2|Overall Study|Lost to Follow-up|5
120088|NCT00601354|408246|P1|Overall Study|Lost to Follow-up|4
120089|NCT00601250|408258|P2|Overall Study|Other incl. lack of efficacy|9
120090|NCT00601250|408259|P1|Overall Study|Other incl. lack of efficacy|2
120091|NCT00601250|408258|P2|Overall Study|Withdrawal by Subject|13
120092|NCT00601250|408259|P1|Overall Study|Withdrawal by Subject|4
120093|NCT00601250|408258|P2|Overall Study|Lost to Follow-up|6
120094|NCT00601250|408259|P1|Overall Study|Lost to Follow-up|2
120095|NCT00601250|408258|P2|Overall Study|Protocol Violation|2
120096|NCT00601250|408259|P1|Overall Study|Protocol Violation|3
120097|NCT00601250|408258|P2|Overall Study|Adverse Event|9
120098|NCT00601250|408259|P1|Overall Study|Adverse Event|3
120099|NCT00601107|408301|P4|Overall Study|Undefined|0
120100|NCT00601107|408302|P3|Overall Study|Undefined|1
120101|NCT00601107|408303|P2|Overall Study|Undefined|0
120102|NCT00601107|408304|P1|Overall Study|Undefined|1
120103|NCT00601107|408301|P4|Overall Study|Worsening of Psoriasis|4
120104|NCT00601107|408302|P3|Overall Study|Worsening of Psoriasis|1
120105|NCT00601107|408303|P2|Overall Study|Worsening of Psoriasis|1
120106|NCT00601107|408304|P1|Overall Study|Worsening of Psoriasis|4
120107|NCT00601107|408301|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
120108|NCT00601107|408302|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
120109|NCT00601107|408303|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
120110|NCT00601107|408304|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
120111|NCT00601107|408301|P4|Overall Study|Lost to Follow-up|3
120112|NCT00601107|408302|P3|Overall Study|Lost to Follow-up|0
120113|NCT00601107|408303|P2|Overall Study|Lost to Follow-up|3
120114|NCT00601107|408304|P1|Overall Study|Lost to Follow-up|3
120115|NCT00601107|408301|P4|Overall Study|Withdrawal by Subject|4
120116|NCT00601107|408302|P3|Overall Study|Withdrawal by Subject|7
120117|NCT00601107|408303|P2|Overall Study|Withdrawal by Subject|4
120118|NCT00601107|408304|P1|Overall Study|Withdrawal by Subject|5
120119|NCT00601107|408301|P4|Overall Study|Adverse Event|0
120120|NCT00601107|408302|P3|Overall Study|Adverse Event|3
120121|NCT00601107|408303|P2|Overall Study|Adverse Event|1
120122|NCT00601107|408304|P1|Overall Study|Adverse Event|0
120123|NCT00600938|408324|P4|Extension Study|Death|0
120124|NCT00600938|408325|P3|Extension Study|Death|0
120125|NCT00600938|408326|P2|Extension Study|Death|0
120126|NCT00600938|408327|P1|Extension Study|Death|1
120127|NCT00600938|408324|P4|Extension Study|Lost to Follow-up|0
120128|NCT00600938|408325|P3|Extension Study|Lost to Follow-up|2
120129|NCT00600938|408326|P2|Extension Study|Lost to Follow-up|1
120130|NCT00600938|408327|P1|Extension Study|Lost to Follow-up|1
120131|NCT00600938|408324|P4|Extension Study|Withdrawal by Subject|0
120132|NCT00600938|408325|P3|Extension Study|Withdrawal by Subject|3
120133|NCT00600938|408326|P2|Extension Study|Withdrawal by Subject|2
120134|NCT00600938|408327|P1|Extension Study|Withdrawal by Subject|2
120135|NCT00600938|408324|P4|Extension Study|Unsatisfactory therapeutic effect|0
120136|NCT00600938|408325|P3|Extension Study|Unsatisfactory therapeutic effect|1
120137|NCT00600938|408326|P2|Extension Study|Unsatisfactory therapeutic effect|1
120138|NCT00600938|408327|P1|Extension Study|Unsatisfactory therapeutic effect|4
120139|NCT00600938|408324|P4|Extension Study|Abnormal test procedure results|1
120140|NCT00600938|408325|P3|Extension Study|Abnormal test procedure results|1
120141|NCT00600938|408326|P2|Extension Study|Abnormal test procedure results|1
120142|NCT00600938|408327|P1|Extension Study|Abnormal test procedure results|0
120143|NCT00600938|408324|P4|Extension Study|Adverse Event|0
120144|NCT00600938|408325|P3|Extension Study|Adverse Event|2
120145|NCT00600938|408326|P2|Extension Study|Adverse Event|0
120146|NCT00600938|408327|P1|Extension Study|Adverse Event|1
120147|NCT00600938|408324|P4|Core Study|Protocol Violation|0
120148|NCT00600938|408325|P3|Core Study|Protocol Violation|0
120149|NCT00600938|408326|P2|Core Study|Protocol Violation|2
120150|NCT00600938|408327|P1|Core Study|Protocol Violation|1
120151|NCT00600938|408324|P4|Core Study|Death|0
120152|NCT00600938|408325|P3|Core Study|Death|0
120153|NCT00600938|408326|P2|Core Study|Death|1
120154|NCT00600938|408327|P1|Core Study|Death|1
120155|NCT00600938|408324|P4|Core Study|Lost to Follow-up|0
120156|NCT00600938|408325|P3|Core Study|Lost to Follow-up|0
120157|NCT00600938|408326|P2|Core Study|Lost to Follow-up|2
120158|NCT00600938|408327|P1|Core Study|Lost to Follow-up|3
120159|NCT00600938|408324|P4|Core Study|Patient withdrew consent|0
120160|NCT00600938|408325|P3|Core Study|Patient withdrew consent|0
120161|NCT00600938|408326|P2|Core Study|Patient withdrew consent|12
120162|NCT00600938|408327|P1|Core Study|Patient withdrew consent|7
120163|NCT00600938|408324|P4|Core Study|Unsatisfactory therapeutic effect|0
120164|NCT00600938|408325|P3|Core Study|Unsatisfactory therapeutic effect|0
120165|NCT00600938|408326|P2|Core Study|Unsatisfactory therapeutic effect|2
120166|NCT00600938|408327|P1|Core Study|Unsatisfactory therapeutic effect|1
120167|NCT00600938|408324|P4|Core Study|Abnormal test procedure result(s)|0
120168|NCT00600938|408325|P3|Core Study|Abnormal test procedure result(s)|0
120169|NCT00600938|408326|P2|Core Study|Abnormal test procedure result(s)|2
120170|NCT00600938|408327|P1|Core Study|Abnormal test procedure result(s)|3
120171|NCT00600886|408391|P2|Extension-start of Crossover to Month 26|Abnormal Lab Value (s)|0
120172|NCT00600886|408392|P1|Extension-start of Crossover to Month 26|Abnormal Lab Value (s)|1
120173|NCT00600886|408391|P2|Extension-start of Crossover to Month 26|Subject no longer requires study drug|0
120174|NCT00600886|408392|P1|Extension-start of Crossover to Month 26|Subject no longer requires study drug|2
120175|NCT00600886|408391|P2|Extension-start of Crossover to Month 26|Administrative Problems|4
120176|NCT00600886|408392|P1|Extension-start of Crossover to Month 26|Administrative Problems|1
120177|NCT00600886|408391|P2|Extension-start of Crossover to Month 26|Lack of Efficacy|4
120178|NCT00600886|408392|P1|Extension-start of Crossover to Month 26|Lack of Efficacy|7
120179|NCT00600886|408391|P2|Extension-start of Crossover to Month 26|Withdrawal by Subject|4
120180|NCT00600886|408392|P1|Extension-start of Crossover to Month 26|Withdrawal by Subject|8
120181|NCT00600886|408391|P2|Extension-start of Crossover to Month 26|Adverse Event|1
120182|NCT00600886|408392|P1|Extension-start of Crossover to Month 26|Adverse Event|12
120183|NCT00600886|408391|P2|Ext Month 12 - 26 Same Treatment|Death|1
120184|NCT00600886|408392|P1|Ext Month 12 - 26 Same Treatment|Death|1
120185|NCT00600886|408391|P2|Ext Month 12 - 26 Same Treatment|Abnormal Lab Value (s)|0
120186|NCT00600886|408392|P1|Ext Month 12 - 26 Same Treatment|Abnormal Lab Value (s)|2
120187|NCT00600886|408391|P2|Ext Month 12 - 26 Same Treatment|Adverse Event|1
120188|NCT00600886|408392|P1|Ext Month 12 - 26 Same Treatment|Adverse Event|2
120189|NCT00600886|408391|P2|Ext Month 12 - 26 Same Treatment|Lost to Follow-up|1
120190|NCT00600886|408392|P1|Ext Month 12 - 26 Same Treatment|Lost to Follow-up|3
120191|NCT00600886|408391|P2|Ext Month 12 - 26 Same Treatment|Administrative Problems|2
120192|NCT00600886|408392|P1|Ext Month 12 - 26 Same Treatment|Administrative Problems|3
120193|NCT00600886|408391|P2|Ext Month 12 - 26 Same Treatment|Lack of Efficacy|3
120194|NCT00600886|408392|P1|Ext Month 12 - 26 Same Treatment|Lack of Efficacy|3
120195|NCT00600886|408391|P2|Ext Month 12 - 26 Same Treatment|Withdrawal by Subject|2
120196|NCT00600886|408392|P1|Ext Month 12 - 26 Same Treatment|Withdrawal by Subject|9
120197|NCT00600886|408391|P2|Core Phase - Full Analysis Set|Death|1
120198|NCT00600886|408392|P1|Core Phase - Full Analysis Set|Death|0
120199|NCT00600886|408391|P2|Core Phase - Full Analysis Set|Lost to Follow-up|0
120200|NCT00600886|408392|P1|Core Phase - Full Analysis Set|Lost to Follow-up|1
120201|NCT00600886|408391|P2|Core Phase - Full Analysis Set|Abnormal laboratory value(s)|0
120202|NCT00600886|408392|P1|Core Phase - Full Analysis Set|Abnormal laboratory value(s)|1
120203|NCT00600886|408391|P2|Core Phase - Full Analysis Set|Administrative Problems|0
120204|NCT00600886|408392|P1|Core Phase - Full Analysis Set|Administrative Problems|2
120205|NCT00600886|408391|P2|Core Phase - Full Analysis Set|Withdrawal by Subject|3
120206|NCT00600886|408392|P1|Core Phase - Full Analysis Set|Withdrawal by Subject|5
120207|NCT00600886|408391|P2|Core Phase - Full Analysis Set|Lack of Efficacy|8
120208|NCT00600886|408392|P1|Core Phase - Full Analysis Set|Lack of Efficacy|5
120209|NCT00600886|408391|P2|Core Phase - Full Analysis Set|Protocol Violation|8
120210|NCT00600886|408392|P1|Core Phase - Full Analysis Set|Protocol Violation|7
120211|NCT00600886|408391|P2|Core Phase - Full Analysis Set|Adverse Event|6
120212|NCT00600886|408392|P1|Core Phase - Full Analysis Set|Adverse Event|14
120213|NCT00600821|408402|P2|Overall Study|Unspecified|3
120214|NCT00600821|408403|P1|Overall Study|Unspecified|2
120215|NCT00600821|408402|P2|Overall Study|Randomized but not treated|1
120216|NCT00600821|408403|P1|Overall Study|Randomized but not treated|0
120217|NCT00600821|408402|P2|Overall Study|Objective progression or relapse|1
120218|NCT00600821|408403|P1|Overall Study|Objective progression or relapse|0
120219|NCT00600821|408402|P2|Overall Study|Terminated by sponsor|6
120220|NCT00600821|408403|P1|Overall Study|Terminated by sponsor|8
120221|NCT00600821|408402|P2|Overall Study|Withdrawal by Subject|1
120222|NCT00600821|408403|P1|Overall Study|Withdrawal by Subject|1
120223|NCT00600821|408402|P2|Overall Study|Lost to Follow-up|2
120224|NCT00600821|408403|P1|Overall Study|Lost to Follow-up|2
120225|NCT00600821|408402|P2|Overall Study|Death|46
120226|NCT00600821|408403|P1|Overall Study|Death|45
120227|NCT00600756|408431|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
120228|NCT00600756|408432|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
120229|NCT00600756|408431|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
120230|NCT00600756|408432|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
120231|NCT00600756|408431|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
120232|NCT00600756|408432|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
120233|NCT00600756|408431|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
120234|NCT00600756|408432|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
120235|NCT00600756|408431|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
120236|NCT00600756|408432|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
120237|NCT00600756|408431|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
120238|NCT00600756|408432|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
120239|NCT00600756|408431|P2|Overall Study Analysis After 12 Months|Adverse Event|44
120240|NCT00600756|408432|P1|Overall Study Analysis After 12 Months|Adverse Event|53
120241|NCT00600756|408431|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
120242|NCT00600756|408432|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
120243|NCT00600756|408431|P2|Analysis After 6 Months|Lost to Follow-up|8
120244|NCT00600756|408432|P1|Analysis After 6 Months|Lost to Follow-up|10
120245|NCT00600756|408431|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
120246|NCT00600756|408432|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
120247|NCT00600756|408431|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
120248|NCT00600756|408432|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
120249|NCT00600756|408431|P2|Analysis After 6 Months|Incorrect Enrollment|21
120250|NCT00600756|408432|P1|Analysis After 6 Months|Incorrect Enrollment|12
120251|NCT00600756|408431|P2|Analysis After 6 Months|Withdrawal by Subject|30
120252|NCT00600756|408432|P1|Analysis After 6 Months|Withdrawal by Subject|38
120253|NCT00600756|408431|P2|Analysis After 6 Months|Adverse Event|33
120254|NCT00600756|408432|P1|Analysis After 6 Months|Adverse Event|43
120255|NCT00600613|408507|P1|Overall Study|Protocol Deviation|1
120256|NCT00600171|408517|P6|Overall Study|Lost to Follow-up|0
120257|NCT00600171|408518|P5|Overall Study|Lost to Follow-up|0
120258|NCT00600171|408519|P4|Overall Study|Lost to Follow-up|1
120259|NCT00600171|408520|P3|Overall Study|Lost to Follow-up|0
120260|NCT00600171|408521|P2|Overall Study|Lost to Follow-up|0
120261|NCT00600171|408522|P1|Overall Study|Lost to Follow-up|0
120262|NCT00600171|408517|P6|Overall Study|Physician Decision|2
120263|NCT00600171|408518|P5|Overall Study|Physician Decision|0
120264|NCT00600171|408519|P4|Overall Study|Physician Decision|1
120265|NCT00600171|408520|P3|Overall Study|Physician Decision|0
120266|NCT00600171|408521|P2|Overall Study|Physician Decision|1
120267|NCT00600171|408522|P1|Overall Study|Physician Decision|0
120268|NCT00600171|408517|P6|Overall Study|Withdrawal by Subject|1
120269|NCT00600171|408518|P5|Overall Study|Withdrawal by Subject|1
120270|NCT00600171|408519|P4|Overall Study|Withdrawal by Subject|1
120271|NCT00600171|408520|P3|Overall Study|Withdrawal by Subject|0
120272|NCT00600171|408521|P2|Overall Study|Withdrawal by Subject|0
120273|NCT00600171|408522|P1|Overall Study|Withdrawal by Subject|3
120274|NCT00600171|408517|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
120275|NCT00600171|408518|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
120276|NCT00600171|408519|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
120277|NCT00600171|408520|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
120278|NCT00600171|408521|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
120279|NCT00600171|408522|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
120280|NCT00600171|408517|P6|Overall Study|Protocol Violation|0
120281|NCT00600171|408518|P5|Overall Study|Protocol Violation|0
120282|NCT00600171|408519|P4|Overall Study|Protocol Violation|1
120283|NCT00600171|408520|P3|Overall Study|Protocol Violation|0
120284|NCT00600171|408521|P2|Overall Study|Protocol Violation|2
120285|NCT00600171|408522|P1|Overall Study|Protocol Violation|1
120286|NCT00600171|408517|P6|Overall Study|Lack of Efficacy|0
120287|NCT00600171|408518|P5|Overall Study|Lack of Efficacy|4
120288|NCT00600171|408519|P4|Overall Study|Lack of Efficacy|5
120289|NCT00600171|408520|P3|Overall Study|Lack of Efficacy|3
120290|NCT00600171|408521|P2|Overall Study|Lack of Efficacy|12
120291|NCT00600171|408522|P1|Overall Study|Lack of Efficacy|9
120292|NCT00600171|408517|P6|Overall Study|Adverse Event|0
120293|NCT00600171|408518|P5|Overall Study|Adverse Event|1
120294|NCT00600171|408519|P4|Overall Study|Adverse Event|0
120295|NCT00600171|408520|P3|Overall Study|Adverse Event|0
120296|NCT00600171|408521|P2|Overall Study|Adverse Event|1
120297|NCT00600171|408522|P1|Overall Study|Adverse Event|0
120298|NCT00600119|408596|P6|Follow-up Period|Other|0
120299|NCT00600119|408597|P5|Follow-up Period|Other|0
120300|NCT00600119|408598|P4|Follow-up Period|Other|0
120301|NCT00600119|408599|P3|Follow-up Period|Other|0
120302|NCT00600119|408600|P2|Follow-up Period|Other|0
120303|NCT00600119|408601|P1|Follow-up Period|Other|1
120304|NCT00600119|408596|P6|Follow-up Period|Adverse Event|1
120305|NCT00600119|408597|P5|Follow-up Period|Adverse Event|0
120306|NCT00600119|408598|P4|Follow-up Period|Adverse Event|0
120307|NCT00600119|408599|P3|Follow-up Period|Adverse Event|0
120308|NCT00600119|408600|P2|Follow-up Period|Adverse Event|0
120309|NCT00600119|408601|P1|Follow-up Period|Adverse Event|0
120310|NCT00600119|408596|P6|Double-blind Treatment Period|Adverse Event|10
120311|NCT00600119|408597|P5|Double-blind Treatment Period|Adverse Event|2
120312|NCT00600119|408598|P4|Double-blind Treatment Period|Adverse Event|1
120313|NCT00600119|408599|P3|Double-blind Treatment Period|Adverse Event|0
120314|NCT00600119|408600|P2|Double-blind Treatment Period|Adverse Event|1
120315|NCT00600119|408601|P1|Double-blind Treatment Period|Adverse Event|1
120316|NCT00600119|408596|P6|Double-blind Treatment Period|Lost to Follow-up|0
120317|NCT00600119|408597|P5|Double-blind Treatment Period|Lost to Follow-up|0
120318|NCT00600119|408598|P4|Double-blind Treatment Period|Lost to Follow-up|0
120319|NCT00600119|408599|P3|Double-blind Treatment Period|Lost to Follow-up|0
120320|NCT00600119|408600|P2|Double-blind Treatment Period|Lost to Follow-up|1
120321|NCT00600119|408601|P1|Double-blind Treatment Period|Lost to Follow-up|0
120322|NCT00600119|408596|P6|Double-blind Treatment Period|Physician Decision|0
120323|NCT00600119|408597|P5|Double-blind Treatment Period|Physician Decision|0
120324|NCT00600119|408598|P4|Double-blind Treatment Period|Physician Decision|0
120325|NCT00600119|408599|P3|Double-blind Treatment Period|Physician Decision|0
120326|NCT00600119|408600|P2|Double-blind Treatment Period|Physician Decision|0
120327|NCT00600119|408601|P1|Double-blind Treatment Period|Physician Decision|2
120328|NCT00600119|408596|P6|Double-blind Treatment Period|Sponsor Decision|0
120329|NCT00600119|408597|P5|Double-blind Treatment Period|Sponsor Decision|1
120330|NCT00600119|408598|P4|Double-blind Treatment Period|Sponsor Decision|0
120331|NCT00600119|408599|P3|Double-blind Treatment Period|Sponsor Decision|0
120332|NCT00600119|408600|P2|Double-blind Treatment Period|Sponsor Decision|1
120333|NCT00600119|408601|P1|Double-blind Treatment Period|Sponsor Decision|0
120334|NCT00600119|408596|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
120335|NCT00600119|408597|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
120336|NCT00600119|408598|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
120337|NCT00600119|408599|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
120338|NCT00600119|408600|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
120339|NCT00600119|408601|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
120340|NCT00600119|408596|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
120341|NCT00600119|408597|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
120342|NCT00600119|408598|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
120343|NCT00600119|408599|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
120344|NCT00600119|408600|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
120345|NCT00600119|408601|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
120346|NCT00600119|408596|P6|Double-blind Treatment Period|Other|1
120347|NCT00600119|408597|P5|Double-blind Treatment Period|Other|2
120348|NCT00600119|408598|P4|Double-blind Treatment Period|Other|0
120349|NCT00600119|408599|P3|Double-blind Treatment Period|Other|0
120350|NCT00600119|408600|P2|Double-blind Treatment Period|Other|0
120351|NCT00600119|408601|P1|Double-blind Treatment Period|Other|0
120352|NCT00600119|408596|P6|Double-blind Treatment Period|Withdrawal by Subject|3
120353|NCT00600119|408597|P5|Double-blind Treatment Period|Withdrawal by Subject|0
120354|NCT00600119|408598|P4|Double-blind Treatment Period|Withdrawal by Subject|1
120355|NCT00600119|408599|P3|Double-blind Treatment Period|Withdrawal by Subject|0
120356|NCT00600119|408600|P2|Double-blind Treatment Period|Withdrawal by Subject|0
120357|NCT00600119|408601|P1|Double-blind Treatment Period|Withdrawal by Subject|2
120358|NCT00600119|408596|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
120359|NCT00600119|408597|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
120360|NCT00600119|408598|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
120361|NCT00600119|408599|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
120362|NCT00600119|408600|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
120363|NCT00600119|408601|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
120364|NCT00600119|408596|P6|Single-blind Placebo run-in Period|Adverse Event|1
120365|NCT00600119|408597|P5|Single-blind Placebo run-in Period|Adverse Event|0
120366|NCT00600119|408598|P4|Single-blind Placebo run-in Period|Adverse Event|1
120367|NCT00600119|408599|P3|Single-blind Placebo run-in Period|Adverse Event|0
120368|NCT00600119|408600|P2|Single-blind Placebo run-in Period|Adverse Event|0
120369|NCT00600119|408601|P1|Single-blind Placebo run-in Period|Adverse Event|0
120370|NCT00600119|408596|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
120371|NCT00600119|408597|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
120372|NCT00600119|408598|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
120373|NCT00600119|408599|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
120374|NCT00600119|408600|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
120375|NCT00600119|408601|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
120376|NCT00600119|408596|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
120377|NCT00600119|408597|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
120378|NCT00600119|408598|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
120379|NCT00600119|408599|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
120380|NCT00600119|408600|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
120381|NCT00600119|408601|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
120382|NCT00600119|408596|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
120383|NCT00600119|408597|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
120384|NCT00600119|408598|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
120385|NCT00600119|408599|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
120386|NCT00600119|408600|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
120387|NCT00600119|408601|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
120388|NCT00600119|408596|P6|Single-blind Placebo run-in Period|Other - Not specified|1
120389|NCT00600119|408597|P5|Single-blind Placebo run-in Period|Other - Not specified|1
120390|NCT00600119|408598|P4|Single-blind Placebo run-in Period|Other - Not specified|0
120391|NCT00600119|408599|P3|Single-blind Placebo run-in Period|Other - Not specified|0
120392|NCT00600119|408600|P2|Single-blind Placebo run-in Period|Other - Not specified|0
120393|NCT00600119|408601|P1|Single-blind Placebo run-in Period|Other - Not specified|1
120394|NCT00600067|408648|P2|Overall Study|Lack of Efficacy|0
120395|NCT00600067|408649|P1|Overall Study|Lack of Efficacy|1
120396|NCT00600067|408648|P2|Overall Study|protocol non-compliance|3
120397|NCT00600067|408649|P1|Overall Study|protocol non-compliance|0
120398|NCT00600067|408648|P2|Overall Study|Lost to Follow-up|3
120399|NCT00600067|408649|P1|Overall Study|Lost to Follow-up|2
120400|NCT00600067|408648|P2|Overall Study|Adverse Event|1
120401|NCT00600067|408649|P1|Overall Study|Adverse Event|0
120402|NCT00599924|408675|P7|Overall Study|Other|2
120403|NCT00599924|408676|P6|Overall Study|Other|0
120404|NCT00599924|408677|P5|Overall Study|Other|2
120405|NCT00599924|408678|P4|Overall Study|Other|1
120406|NCT00599924|408679|P3|Overall Study|Other|0
120407|NCT00599924|408680|P2|Overall Study|Other|0
120408|NCT00599924|408681|P1|Overall Study|Other|0
120409|NCT00599924|408675|P7|Overall Study|Withdrawal by Subject|0
120410|NCT00599924|408676|P6|Overall Study|Withdrawal by Subject|0
120411|NCT00599924|408677|P5|Overall Study|Withdrawal by Subject|1
120412|NCT00599924|408678|P4|Overall Study|Withdrawal by Subject|0
120413|NCT00599924|408679|P3|Overall Study|Withdrawal by Subject|1
120414|NCT00599924|408680|P2|Overall Study|Withdrawal by Subject|0
120415|NCT00599924|408681|P1|Overall Study|Withdrawal by Subject|0
120416|NCT00599924|408675|P7|Overall Study|Protocol Violation|0
120417|NCT00599924|408676|P6|Overall Study|Protocol Violation|0
120418|NCT00599924|408677|P5|Overall Study|Protocol Violation|0
120419|NCT00599924|408678|P4|Overall Study|Protocol Violation|1
120420|NCT00599924|408679|P3|Overall Study|Protocol Violation|0
120421|NCT00599924|408680|P2|Overall Study|Protocol Violation|0
120422|NCT00599924|408681|P1|Overall Study|Protocol Violation|0
120423|NCT00599924|408675|P7|Overall Study|Death|1
120424|NCT00599924|408676|P6|Overall Study|Death|2
120425|NCT00599924|408677|P5|Overall Study|Death|0
120426|NCT00599924|408678|P4|Overall Study|Death|2
120427|NCT00599924|408679|P3|Overall Study|Death|0
120428|NCT00599924|408680|P2|Overall Study|Death|0
120429|NCT00599924|408681|P1|Overall Study|Death|0
120430|NCT00599924|408675|P7|Overall Study|Adverse Event|2
120431|NCT00599924|408676|P6|Overall Study|Adverse Event|0
120432|NCT00599924|408677|P5|Overall Study|Adverse Event|0
120433|NCT00599924|408678|P4|Overall Study|Adverse Event|2
120434|NCT00599924|408679|P3|Overall Study|Adverse Event|0
120435|NCT00599924|408680|P2|Overall Study|Adverse Event|0
120436|NCT00599924|408681|P1|Overall Study|Adverse Event|0
120437|NCT00599924|408675|P7|Overall Study|Lack of Efficacy|0
120438|NCT00599924|408676|P6|Overall Study|Lack of Efficacy|2
120439|NCT00599924|408677|P5|Overall Study|Lack of Efficacy|3
120440|NCT00599924|408678|P4|Overall Study|Lack of Efficacy|2
120441|NCT00599924|408679|P3|Overall Study|Lack of Efficacy|1
120442|NCT00599924|408680|P2|Overall Study|Lack of Efficacy|5
120443|NCT00599924|408681|P1|Overall Study|Lack of Efficacy|3
120444|NCT00599755|408785|P1|Overall Study|No data available|1
120445|NCT00599755|408785|P1|Overall Study|Other Reason|2
120446|NCT00599755|408785|P1|Overall Study|Progression of Disease|3
120447|NCT00599755|408785|P1|Overall Study|Withdrawal by Subject|2
120448|NCT00599755|408785|P1|Overall Study|Adverse Event|11
120449|NCT00599521|408796|P2|Overall Study|Pregnancy|2
120450|NCT00599521|408797|P1|Overall Study|Pregnancy|0
120451|NCT00599521|408796|P2|Overall Study|Lost to Follow-up|23
120452|NCT00599521|408797|P1|Overall Study|Lost to Follow-up|23
120453|NCT00599521|408796|P2|Overall Study|Protocol Violation|1
120454|NCT00599521|408797|P1|Overall Study|Protocol Violation|1
120455|NCT00599521|408796|P2|Overall Study|Withdrawal by Subject|34
120456|NCT00599521|408797|P1|Overall Study|Withdrawal by Subject|28
120457|NCT00599521|408796|P2|Overall Study|Adverse Event|1
120458|NCT00599521|408797|P1|Overall Study|Adverse Event|4
120459|NCT00599521|408796|P2|Overall Study|Lack of Efficacy|8
120460|NCT00599521|408797|P1|Overall Study|Lack of Efficacy|4
120461|NCT00599339|408811|P1|Overall Study|Study Termination Status Unknown|12
120462|NCT00599339|408811|P1|Overall Study|No valid data consent|36
120463|NCT00599339|408811|P1|Overall Study|Lost to Follow-up|221
120464|NCT00599339|408811|P1|Overall Study|Other Reason|179
120465|NCT00599339|408811|P1|Overall Study|Withdrawal by Subject|137
120466|NCT00599339|408811|P1|Overall Study|Adverse Event|79
120467|NCT00599326|408913|P1|Overall Study|Noncompliant|1
120468|NCT00599326|408913|P1|Overall Study|Lost to Follow-up|1
120469|NCT00599313|408918|P1|Overall Study|Ineligible|1
120470|NCT00599313|408918|P1|Overall Study|Patient Request|4
120471|NCT00599313|408918|P1|Overall Study|Disease Progression|12
120472|NCT00599313|408918|P1|Overall Study|Adverse Event|19
120473|NCT00599196|408938|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
120474|NCT00599196|408938|P1|Overall Study|Other: Patient Stopped Due To Moving|1
120475|NCT00599196|408938|P1|Overall Study|Other: Pt Moved To Australia|1
120476|NCT00599196|408938|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
120477|NCT00599196|408938|P1|Overall Study|Other: Spouse Withdrew Consent|1
120478|NCT00599196|408938|P1|Overall Study|Other: Patient Leaving For Israel|1
120479|NCT00599196|408938|P1|Overall Study|Lost to Follow-up|17
120480|NCT00599196|408938|P1|Overall Study|Study ended per sponsor|197
120481|NCT00599196|408938|P1|Overall Study|Subject withdrew consent|43
120482|NCT00599196|408938|P1|Overall Study|Unsatisfactory compliance of subject|3
120483|NCT00599196|408938|P1|Overall Study|Adverse Event|93
120484|NCT00599196|408938|P1|Overall Study|Lack of Efficacy|22
120485|NCT00599027|408969|P2|Overall Study|Treatment Failure|1
120486|NCT00599027|408970|P1|Overall Study|Treatment Failure|0
120487|NCT00599027|408969|P2|Overall Study|Adverse Event|1
120488|NCT00599027|408970|P1|Overall Study|Adverse Event|0
120489|NCT00599027|408969|P2|Overall Study|Withdrawal by Subject|1
120490|NCT00599027|408970|P1|Overall Study|Withdrawal by Subject|1
120491|NCT00598871|408983|P2|Overall Study|Adverse Event|1
120492|NCT00598871|408984|P1|Overall Study|Adverse Event|0
120493|NCT00598832|408994|P2|Overall Study|Non compliance|0
120494|NCT00598832|408995|P1|Overall Study|Non compliance|1
120495|NCT00598832|408994|P2|Overall Study|Physician Decision|4
120496|NCT00598832|408995|P1|Overall Study|Physician Decision|1
120497|NCT00598832|408994|P2|Overall Study|Pregnancy|2
120498|NCT00598832|408995|P1|Overall Study|Pregnancy|2
120499|NCT00598832|408994|P2|Overall Study|Lost to Follow-up|29
120500|NCT00598832|408995|P1|Overall Study|Lost to Follow-up|24
120501|NCT00598832|408994|P2|Overall Study|Protocol Violation|2
120502|NCT00598832|408995|P1|Overall Study|Protocol Violation|0
120503|NCT00598832|408994|P2|Overall Study|Withdrawal by Subject|36
120504|NCT00598832|408995|P1|Overall Study|Withdrawal by Subject|25
120505|NCT00598832|408994|P2|Overall Study|Adverse Event|2
120506|NCT00598832|408995|P1|Overall Study|Adverse Event|6
120507|NCT00598832|408994|P2|Overall Study|Lack of Efficacy|7
120508|NCT00598832|408995|P1|Overall Study|Lack of Efficacy|3
120509|NCT00598702|409025|P8|Overall Study|Dose limiting toxicity|0
120510|NCT00598702|409026|P7|Overall Study|Dose limiting toxicity|0
120511|NCT00598702|409027|P6|Overall Study|Dose limiting toxicity|1
120512|NCT00598702|409028|P5|Overall Study|Dose limiting toxicity|1
120513|NCT00598702|409029|P4|Overall Study|Dose limiting toxicity|1
120514|NCT00598702|409030|P3|Overall Study|Dose limiting toxicity|0
120515|NCT00598702|409031|P2|Overall Study|Dose limiting toxicity|0
120516|NCT00598702|409032|P1|Overall Study|Dose limiting toxicity|0
120517|NCT00598702|409025|P8|Overall Study|Physician Decision|0
120518|NCT00598702|409026|P7|Overall Study|Physician Decision|0
120519|NCT00598702|409027|P6|Overall Study|Physician Decision|0
120520|NCT00598702|409028|P5|Overall Study|Physician Decision|1
120521|NCT00598702|409029|P4|Overall Study|Physician Decision|0
120522|NCT00598702|409030|P3|Overall Study|Physician Decision|0
120523|NCT00598702|409031|P2|Overall Study|Physician Decision|0
120524|NCT00598702|409032|P1|Overall Study|Physician Decision|0
120525|NCT00598702|409025|P8|Overall Study|Withdrawal by Subject|0
120526|NCT00598702|409026|P7|Overall Study|Withdrawal by Subject|0
120527|NCT00598702|409027|P6|Overall Study|Withdrawal by Subject|0
120528|NCT00598702|409028|P5|Overall Study|Withdrawal by Subject|1
120529|NCT00598702|409029|P4|Overall Study|Withdrawal by Subject|1
120530|NCT00598702|409030|P3|Overall Study|Withdrawal by Subject|0
120531|NCT00598702|409031|P2|Overall Study|Withdrawal by Subject|0
120532|NCT00598702|409032|P1|Overall Study|Withdrawal by Subject|0
120533|NCT00598702|409025|P8|Overall Study|Adverse Event|0
120534|NCT00598702|409026|P7|Overall Study|Adverse Event|0
120535|NCT00598702|409027|P6|Overall Study|Adverse Event|0
120536|NCT00598702|409028|P5|Overall Study|Adverse Event|0
120537|NCT00598702|409029|P4|Overall Study|Adverse Event|1
120538|NCT00598702|409030|P3|Overall Study|Adverse Event|0
120539|NCT00598702|409031|P2|Overall Study|Adverse Event|0
120540|NCT00598702|409032|P1|Overall Study|Adverse Event|0
120541|NCT00598702|409025|P8|Overall Study|Early discharge from hospital|0
120542|NCT00598702|409026|P7|Overall Study|Early discharge from hospital|1
120543|NCT00598702|409027|P6|Overall Study|Early discharge from hospital|10
120544|NCT00598702|409028|P5|Overall Study|Early discharge from hospital|0
120545|NCT00598702|409029|P4|Overall Study|Early discharge from hospital|5
120546|NCT00598702|409030|P3|Overall Study|Early discharge from hospital|2
120547|NCT00598702|409031|P2|Overall Study|Early discharge from hospital|0
120548|NCT00598702|409032|P1|Overall Study|Early discharge from hospital|0
120549|NCT00598702|409025|P8|Overall Study|Not specified|0
120550|NCT00598702|409026|P7|Overall Study|Not specified|0
120551|NCT00598702|409027|P6|Overall Study|Not specified|1
120552|NCT00598702|409028|P5|Overall Study|Not specified|0
120553|NCT00598702|409029|P4|Overall Study|Not specified|0
120554|NCT00598702|409030|P3|Overall Study|Not specified|0
120555|NCT00598702|409031|P2|Overall Study|Not specified|2
120556|NCT00598702|409032|P1|Overall Study|Not specified|0
120557|NCT00598650|409087|P1|Overall Study|Physician Decision|2
120558|NCT00598650|409087|P1|Overall Study|Prohibited Concomitant Medication|2
120559|NCT00598650|409087|P1|Overall Study|Not eligible|1
120560|NCT00598650|409087|P1|Overall Study|No treatment for 3 weeks|1
120561|NCT00598650|409087|P1|Overall Study|Adverse Event|18
120562|NCT00598650|409087|P1|Overall Study|Withdrawal by Subject|3
120563|NCT00598559|409097|P3|Overall Study|Subject unable/unwilling to attend visit|0
120564|NCT00598559|409098|P2|Overall Study|Subject unable/unwilling to attend visit|7
120565|NCT00598559|409099|P1|Overall Study|Subject unable/unwilling to attend visit|4
120566|NCT00598559|409097|P3|Overall Study|Early discharge from hospital|3
120567|NCT00598559|409098|P2|Overall Study|Early discharge from hospital|12
120568|NCT00598559|409099|P1|Overall Study|Early discharge from hospital|9
120569|NCT00598559|409097|P3|Overall Study|Protocol Non-compliance|0
120570|NCT00598559|409098|P2|Overall Study|Protocol Non-compliance|0
120571|NCT00598559|409099|P1|Overall Study|Protocol Non-compliance|1
120572|NCT00598559|409097|P3|Overall Study|Withdrawal by Subject|0
120573|NCT00598559|409098|P2|Overall Study|Withdrawal by Subject|2
120574|NCT00598559|409099|P1|Overall Study|Withdrawal by Subject|2
120575|NCT00598559|409097|P3|Overall Study|Adverse Event|0
120576|NCT00598559|409098|P2|Overall Study|Adverse Event|7
120577|NCT00598559|409099|P1|Overall Study|Adverse Event|11
120578|NCT00598442|409126|P3|Overall Study|Started dialysis|0
120579|NCT00598442|409127|P2|Overall Study|Started dialysis|0
120580|NCT00598442|409128|P1|Overall Study|Started dialysis|1
120581|NCT00598442|409126|P3|Overall Study|Site closed by sponsor|1
120582|NCT00598442|409127|P2|Overall Study|Site closed by sponsor|2
120583|NCT00598442|409128|P1|Overall Study|Site closed by sponsor|5
120584|NCT00598442|409126|P3|Overall Study|Renal transplant|1
120585|NCT00598442|409127|P2|Overall Study|Renal transplant|0
120586|NCT00598442|409128|P1|Overall Study|Renal transplant|0
120587|NCT00598442|409126|P3|Overall Study|Relocation|0
120588|NCT00598442|409127|P2|Overall Study|Relocation|4
120589|NCT00598442|409128|P1|Overall Study|Relocation|1
120590|NCT00598442|409126|P3|Overall Study|Noncompliance|1
120591|NCT00598442|409127|P2|Overall Study|Noncompliance|2
120592|NCT00598442|409128|P1|Overall Study|Noncompliance|0
120593|NCT00598442|409126|P3|Overall Study|Withdrawal by Subject|6
120594|NCT00598442|409127|P2|Overall Study|Withdrawal by Subject|16
120595|NCT00598442|409128|P1|Overall Study|Withdrawal by Subject|8
120596|NCT00598442|409126|P3|Overall Study|Physician Decision|1
120597|NCT00598442|409127|P2|Overall Study|Physician Decision|1
120598|NCT00598442|409128|P1|Overall Study|Physician Decision|2
120599|NCT00598442|409126|P3|Overall Study|Lost to Follow-up|3
120600|NCT00598442|409127|P2|Overall Study|Lost to Follow-up|3
120601|NCT00598442|409128|P1|Overall Study|Lost to Follow-up|4
120602|NCT00598442|409126|P3|Overall Study|Death|11
120603|NCT00598442|409127|P2|Overall Study|Death|11
120604|NCT00598442|409128|P1|Overall Study|Death|19
120605|NCT00598442|409126|P3|Overall Study|Adverse Event|0
120606|NCT00598442|409127|P2|Overall Study|Adverse Event|0
120607|NCT00598442|409128|P1|Overall Study|Adverse Event|3
120608|NCT00598273|409145|P3|Overall Study|Started dialysis|5
120609|NCT00598273|409146|P2|Overall Study|Started dialysis|4
120610|NCT00598273|409147|P1|Overall Study|Started dialysis|6
120611|NCT00598273|409145|P3|Overall Study|Site elected to close|0
120612|NCT00598273|409146|P2|Overall Study|Site elected to close|0
120613|NCT00598273|409147|P1|Overall Study|Site elected to close|1
120614|NCT00598273|409145|P3|Overall Study|Renal transplant|1
120615|NCT00598273|409146|P2|Overall Study|Renal transplant|0
120616|NCT00598273|409147|P1|Overall Study|Renal transplant|1
120617|NCT00598273|409145|P3|Overall Study|Relocation|4
120618|NCT00598273|409146|P2|Overall Study|Relocation|2
120619|NCT00598273|409147|P1|Overall Study|Relocation|0
120620|NCT00598273|409145|P3|Overall Study|Noncompliance|3
120621|NCT00598273|409146|P2|Overall Study|Noncompliance|2
120622|NCT00598273|409147|P1|Overall Study|Noncompliance|3
120623|NCT00598273|409145|P3|Overall Study|Withdrawal by Subject|10
120624|NCT00598273|409146|P2|Overall Study|Withdrawal by Subject|10
120625|NCT00598273|409147|P1|Overall Study|Withdrawal by Subject|12
120626|NCT00598273|409145|P3|Overall Study|Physician Decision|1
120627|NCT00598273|409146|P2|Overall Study|Physician Decision|0
120628|NCT00598273|409147|P1|Overall Study|Physician Decision|0
120629|NCT00598273|409145|P3|Overall Study|Lost to Follow-up|5
120630|NCT00598273|409146|P2|Overall Study|Lost to Follow-up|3
120631|NCT00598273|409147|P1|Overall Study|Lost to Follow-up|8
120632|NCT00598273|409145|P3|Overall Study|Death|8
120633|NCT00598273|409146|P2|Overall Study|Death|12
120634|NCT00598273|409147|P1|Overall Study|Death|6
120635|NCT00598273|409145|P3|Overall Study|Adverse Event|2
120636|NCT00598273|409146|P2|Overall Study|Adverse Event|5
120637|NCT00598273|409147|P1|Overall Study|Adverse Event|4
120638|NCT00598078|409161|P2|Period 2 (Day 2)|Adverse Event|0
120639|NCT00598078|409162|P1|Period 2 (Day 2)|Adverse Event|1
120640|NCT00597753|409214|P2|Overall Study|Site elected to close|4
120641|NCT00597753|409215|P1|Overall Study|Site elected to close|2
120642|NCT00597753|409214|P2|Overall Study|Site closed by sponsor|7
120643|NCT00597753|409215|P1|Overall Study|Site closed by sponsor|19
120644|NCT00597753|409214|P2|Overall Study|Renal transplant|3
120645|NCT00597753|409215|P1|Overall Study|Renal transplant|10
120646|NCT00597753|409214|P2|Overall Study|Relocation|6
120647|NCT00597753|409215|P1|Overall Study|Relocation|17
120648|NCT00597753|409214|P2|Overall Study|Noncompliance|1
120649|NCT00597753|409215|P1|Overall Study|Noncompliance|2
120650|NCT00597753|409214|P2|Overall Study|Never dosed|0
120651|NCT00597753|409215|P1|Overall Study|Never dosed|2
120652|NCT00597753|409214|P2|Overall Study|Discontinued Dialysis|1
120653|NCT00597753|409215|P1|Overall Study|Discontinued Dialysis|0
120654|NCT00597753|409214|P2|Overall Study|Withdrawal by Subject|12
120655|NCT00597753|409215|P1|Overall Study|Withdrawal by Subject|35
120656|NCT00597753|409214|P2|Overall Study|Pregnancy|0
120657|NCT00597753|409215|P1|Overall Study|Pregnancy|1
120658|NCT00597753|409214|P2|Overall Study|Physician Decision|1
120659|NCT00597753|409215|P1|Overall Study|Physician Decision|5
120660|NCT00597753|409214|P2|Overall Study|Lost to Follow-up|3
120661|NCT00597753|409215|P1|Overall Study|Lost to Follow-up|10
120662|NCT00597753|409214|P2|Overall Study|Lack of Efficacy|0
120663|NCT00597753|409215|P1|Overall Study|Lack of Efficacy|2
120664|NCT00597753|409214|P2|Overall Study|Death|29
120665|NCT00597753|409215|P1|Overall Study|Death|55
120666|NCT00597753|409214|P2|Overall Study|Adverse Event|2
120667|NCT00597753|409215|P1|Overall Study|Adverse Event|6
120668|NCT00597714|409227|P3|Overall Study|Recipient death|10
120669|NCT00597714|409228|P2|Overall Study|Recipient death|0
120670|NCT00597714|409229|P1|Overall Study|Recipient death|0
120671|NCT00597714|409227|P3|Overall Study|Death|0
120672|NCT00597714|409228|P2|Overall Study|Death|46
120673|NCT00597714|409229|P1|Overall Study|Death|56
120674|NCT00597701|409241|P2|Overall Study|Did not start intervention (pharmacy er)|2
120675|NCT00597701|409242|P1|Overall Study|Did not start intervention (pharmacy er)|0
120676|NCT00597701|409241|P2|Overall Study|Physician Decision|0
120677|NCT00597701|409242|P1|Overall Study|Physician Decision|2
120678|NCT00597701|409241|P2|Overall Study|Death|1
120679|NCT00597701|409242|P1|Overall Study|Death|0
120680|NCT00597701|409241|P2|Overall Study|Withdrawal by Subject|5
120681|NCT00597701|409242|P1|Overall Study|Withdrawal by Subject|5
120682|NCT00597584|409250|P2|Overall Study|Renal transplant|7
120683|NCT00597584|409251|P1|Overall Study|Renal transplant|9
120684|NCT00597584|409250|P2|Overall Study|Relocation|6
120685|NCT00597584|409251|P1|Overall Study|Relocation|8
120686|NCT00597584|409250|P2|Overall Study|Never dosed|0
120687|NCT00597584|409251|P1|Overall Study|Never dosed|1
120688|NCT00597584|409250|P2|Overall Study|Lost ability to consent|1
120689|NCT00597584|409251|P1|Overall Study|Lost ability to consent|1
120690|NCT00597584|409250|P2|Overall Study|Discontinued Dialysis|1
120691|NCT00597584|409251|P1|Overall Study|Discontinued Dialysis|0
120692|NCT00597584|409250|P2|Overall Study|Withdrawal by Subject|12
120693|NCT00597584|409251|P1|Overall Study|Withdrawal by Subject|44
120694|NCT00597584|409250|P2|Overall Study|Pregnancy|0
120695|NCT00597584|409251|P1|Overall Study|Pregnancy|2
120696|NCT00597584|409250|P2|Overall Study|Physician Decision|0
120697|NCT00597584|409251|P1|Overall Study|Physician Decision|3
120698|NCT00597584|409250|P2|Overall Study|Lost to Follow-up|4
120699|NCT00597584|409251|P1|Overall Study|Lost to Follow-up|2
120700|NCT00597584|409250|P2|Overall Study|Lack of Efficacy|0
120701|NCT00597584|409251|P1|Overall Study|Lack of Efficacy|1
120702|NCT00597584|409250|P2|Overall Study|Death|30
120703|NCT00597584|409251|P1|Overall Study|Death|53
120704|NCT00597584|409250|P2|Overall Study|Adverse Event|2
120705|NCT00597584|409251|P1|Overall Study|Adverse Event|4
120706|NCT00596466|409261|P1|Overall Study|Enrolled, not treated|2
120707|NCT00596466|409261|P1|Overall Study|Unpecified|2
120708|NCT00596466|409261|P1|Overall Study|Protocol Violation|2
120709|NCT00596466|409261|P1|Overall Study|Withdrawal by Subject|2
120710|NCT00596466|409261|P1|Overall Study|Adverse Event|4
120711|NCT00596466|409261|P1|Overall Study|Lack of Efficacy|5
120712|NCT00596427|409291|P2|Overall Study|Protocol Violation|0
120713|NCT00596427|409292|P1|Overall Study|Protocol Violation|1
120714|NCT00596427|409291|P2|Overall Study|Increased Fasting Triacylglycerol level|0
120715|NCT00596427|409292|P1|Overall Study|Increased Fasting Triacylglycerol level|1
120716|NCT00596427|409291|P2|Overall Study|Withdrawal by Subject|2
120717|NCT00596427|409292|P1|Overall Study|Withdrawal by Subject|2
120718|NCT00597519|409333|P1|Overall Study|Death|1
120719|NCT00597506|409337|P1|Overall Study|Subject is being followed for survival|1
120720|NCT00597376|409387|P2|Overall Study|Adverse Event|1
120721|NCT00597376|409388|P1|Overall Study|Adverse Event|4
120722|NCT00597376|409387|P2|Overall Study|Withdrawal by Subject|3
120723|NCT00597376|409388|P1|Overall Study|Withdrawal by Subject|4
120724|NCT00597207|409429|P2|Overall Study|Lost to Follow-up|7
120725|NCT00597207|409430|P1|Overall Study|Lost to Follow-up|5
120726|NCT00597116|409438|P2|Overall Study|Progressive disease|6
120727|NCT00597116|409439|P1|Overall Study|Progressive disease|11
120728|NCT00597116|409438|P2|Overall Study|Lost to Follow-up|0
120729|NCT00597116|409439|P1|Overall Study|Lost to Follow-up|1
120730|NCT00597116|409438|P2|Overall Study|Death|1
120731|NCT00597116|409439|P1|Overall Study|Death|0
120732|NCT00597116|409438|P2|Overall Study|Physician Decision|1
120733|NCT00597116|409439|P1|Overall Study|Physician Decision|0
120734|NCT00597116|409438|P2|Overall Study|Withdrawal by Subject|2
120735|NCT00597116|409439|P1|Overall Study|Withdrawal by Subject|0
120736|NCT00597116|409438|P2|Overall Study|Adverse Event|1
120737|NCT00597116|409439|P1|Overall Study|Adverse Event|2
120738|NCT00597012|409465|P2|Overall Study|Lost to Follow-up|2
120739|NCT00597012|409466|P1|Overall Study|Lost to Follow-up|0
120740|NCT00597012|409465|P2|Overall Study|Ineligible|0
120741|NCT00597012|409466|P1|Overall Study|Ineligible|2
120742|NCT00597012|409465|P2|Overall Study|Withdrawal by Subject|4
120743|NCT00597012|409466|P1|Overall Study|Withdrawal by Subject|7
120744|NCT00597012|409465|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
120745|NCT00597012|409466|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
120746|NCT00597012|409465|P2|Overall Study|Death|1
120747|NCT00597012|409466|P1|Overall Study|Death|1
120748|NCT00596960|409478|P2|Overall Study|No alcohol use data|1
120749|NCT00596960|409479|P1|Overall Study|No alcohol use data|0
120750|NCT00596960|409478|P2|Overall Study|Protocol Violation|1
120751|NCT00596960|409479|P1|Overall Study|Protocol Violation|0
120752|NCT00596960|409478|P2|Overall Study|Physician Decision|0
120753|NCT00596960|409479|P1|Overall Study|Physician Decision|1
120754|NCT00596960|409478|P2|Overall Study|Incarcerated|0
120755|NCT00596960|409479|P1|Overall Study|Incarcerated|2
120756|NCT00596960|409478|P2|Overall Study|Withdrawal by Subject|0
120757|NCT00596960|409479|P1|Overall Study|Withdrawal by Subject|1
120758|NCT00596960|409478|P2|Overall Study|Lost to Follow-up|5
120759|NCT00596960|409479|P1|Overall Study|Lost to Follow-up|6
120760|NCT00596960|409478|P2|Overall Study|Death|2
120761|NCT00596960|409479|P1|Overall Study|Death|1
120762|NCT00596947|409491|P2|Overall Study|Lost to Follow-up|0
120763|NCT00596947|409492|P1|Overall Study|Lost to Follow-up|1
120764|NCT00596947|409491|P2|Overall Study|study halted due to low enrollment|4
120765|NCT00596947|409492|P1|Overall Study|study halted due to low enrollment|4
120766|NCT00596934|409532|P1|Overall Study|Withdrawal by Subject|1
120767|NCT00596934|409532|P1|Overall Study|Protocol Violation|1
120768|NCT00596830|409545|P2|Overall Study|Randomized but not treated|7
120769|NCT00596830|409546|P1|Overall Study|Randomized but not treated|3
120770|NCT00596830|409545|P2|Overall Study|Follow-up was discontinued|0
120771|NCT00596830|409546|P1|Overall Study|Follow-up was discontinued|1
120772|NCT00596830|409545|P2|Overall Study|Study terminated by sponsor|62
120773|NCT00596830|409546|P1|Overall Study|Study terminated by sponsor|51
120774|NCT00596830|409545|P2|Overall Study|Withdrawal by Subject|12
120775|NCT00596830|409546|P1|Overall Study|Withdrawal by Subject|22
120776|NCT00596830|409545|P2|Overall Study|Lost to Follow-up|11
120777|NCT00596830|409546|P1|Overall Study|Lost to Follow-up|7
120778|NCT00596830|409545|P2|Overall Study|Death|247
120779|NCT00596830|409546|P1|Overall Study|Death|258
120780|NCT00596817|409572|P2|Double-blind Period|Other Reasons|18
120781|NCT00596817|409573|P1|Double-blind Period|Other Reasons|10
120782|NCT00596817|409572|P2|Double-blind Period|Lost to Follow-up|2
120783|NCT00596817|409573|P1|Double-blind Period|Lost to Follow-up|0
120784|NCT00596817|409572|P2|Double-blind Period|Withdrawal of Consent|3
120785|NCT00596817|409573|P1|Double-blind Period|Withdrawal of Consent|7
120786|NCT00596817|409572|P2|Double-blind Period|Protocol Violation|8
120787|NCT00596817|409573|P1|Double-blind Period|Protocol Violation|11
120788|NCT00596817|409572|P2|Double-blind Period|Non-compliance With Study Product|4
120789|NCT00596817|409573|P1|Double-blind Period|Non-compliance With Study Product|3
120790|NCT00596817|409572|P2|Double-blind Period|Lack of Efficacy|28
120791|NCT00596817|409573|P1|Double-blind Period|Lack of Efficacy|52
120792|NCT00596817|409572|P2|Double-blind Period|Adverse Event|16
120793|NCT00596817|409573|P1|Double-blind Period|Adverse Event|5
120794|NCT00596817|409572|P2|Open-label Period to Double-blind Period|Other Reasons|14
120795|NCT00596817|409573|P1|Open-label Period to Double-blind Period|Other Reasons|0
120796|NCT00596817|409572|P2|Open-label Period to Double-blind Period|Not Eligible|49
120797|NCT00596817|409573|P1|Open-label Period to Double-blind Period|Not Eligible|0
120798|NCT00596817|409572|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
120799|NCT00596817|409573|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
120800|NCT00596817|409572|P2|Open-label Period to Double-blind Period|Adverse Event|5
120801|NCT00596817|409573|P1|Open-label Period to Double-blind Period|Adverse Event|0
120802|NCT00596817|409572|P2|Open-label Period|Other Reasons|65
120803|NCT00596817|409573|P1|Open-label Period|Other Reasons|0
120804|NCT00596817|409572|P2|Open-label Period|Lack of Efficacy|33
120805|NCT00596817|409573|P1|Open-label Period|Lack of Efficacy|0
120806|NCT00596817|409572|P2|Open-label Period|Adverse Event|49
120807|NCT00596817|409573|P1|Open-label Period|Adverse Event|0
120808|NCT00596752|409598|P2|Overall Study|Protocol Violation|0
120809|NCT00596752|409599|P1|Overall Study|Protocol Violation|1
120810|NCT00596752|409598|P2|Overall Study|Lack of Efficacy|7
120811|NCT00596752|409599|P1|Overall Study|Lack of Efficacy|4
120812|NCT00596752|409598|P2|Overall Study|Unsatisfactory Compliance|6
120813|NCT00596752|409599|P1|Overall Study|Unsatisfactory Compliance|9
120814|NCT00596752|409598|P2|Overall Study|Withdrawal by Subject|9
120815|NCT00596752|409599|P1|Overall Study|Withdrawal by Subject|12
120816|NCT00596752|409598|P2|Overall Study|Lost to Follow-up|38
120817|NCT00596752|409599|P1|Overall Study|Lost to Follow-up|22
120818|NCT00596752|409598|P2|Overall Study|Adverse Event|34
120819|NCT00596752|409599|P1|Overall Study|Adverse Event|34
120820|NCT00596752|409598|P2|Overall Study|Other Reason|49
120821|NCT00596752|409599|P1|Overall Study|Other Reason|44
120822|NCT00596687|409629|P2|Overall Study|cancelled surgery|1
120823|NCT00596687|409630|P1|Overall Study|cancelled surgery|1
120824|NCT00596687|409629|P2|Overall Study|Withdrawal by Subject|1
120825|NCT00596687|409630|P1|Overall Study|Withdrawal by Subject|3
120826|NCT00596687|409629|P2|Overall Study|continuous insulin infusion during TPN|1
120827|NCT00596687|409630|P1|Overall Study|continuous insulin infusion during TPN|2
120828|NCT00596687|409629|P2|Overall Study|< 24 hours of insulin treatment|6
120829|NCT00596687|409630|P1|Overall Study|< 24 hours of insulin treatment|8
120830|NCT00596635|409641|P3|Overall Study|Could not provide urine specimen|2
120831|NCT00596635|409642|P2|Overall Study|Could not provide urine specimen|2
120832|NCT00596635|409643|P1|Overall Study|Could not provide urine specimen|1
120833|NCT00596635|409641|P3|Overall Study|Hip fracture|3
120834|NCT00596635|409642|P2|Overall Study|Hip fracture|3
120835|NCT00596635|409643|P1|Overall Study|Hip fracture|2
120836|NCT00596635|409641|P3|Overall Study|Treatment for symptomatic UTI|3
120837|NCT00596635|409642|P2|Overall Study|Treatment for symptomatic UTI|6
120838|NCT00596635|409643|P1|Overall Study|Treatment for symptomatic UTI|4
120839|NCT00596635|409641|P3|Overall Study|Lost to Follow-up|0
120840|NCT00596635|409642|P2|Overall Study|Lost to Follow-up|2
120841|NCT00596635|409643|P1|Overall Study|Lost to Follow-up|0
120842|NCT00596362|409669|P1|Overall Study|Progressive Disease|1
120843|NCT00596011|409705|P2|Overall Study|Adverse Event|7
120844|NCT00596011|409706|P1|Overall Study|Adverse Event|11
120845|NCT00596011|409705|P2|Overall Study|Withdrawal by Subject|3
120846|NCT00596011|409706|P1|Overall Study|Withdrawal by Subject|2
120847|NCT00595959|409722|P1|Overall Study|Lost to Follow-up|1
120848|NCT00595959|409722|P1|Overall Study|Withdrawal by Subject|1
120849|NCT00595920|409756|P1|Overall Study|The OLTERMS study was discontinued by th|116
120850|NCT00595868|409767|P2|Overall Study|Lost to Follow-up|50
120851|NCT00595868|409768|P1|Overall Study|Lost to Follow-up|45
120852|NCT00595764|409791|P2|Overall Study|Withdrawal by Subject|0
120853|NCT00595764|409792|P1|Overall Study|Withdrawal by Subject|4
120854|NCT00595764|409791|P2|Overall Study|Missed 3 PM visits|7
120855|NCT00595764|409792|P1|Overall Study|Missed 3 PM visits|1
120856|NCT00595764|409791|P2|Overall Study|Missed Medication >1 week|17
120857|NCT00595764|409792|P1|Overall Study|Missed Medication >1 week|10
120858|NCT00595764|409791|P2|Overall Study|Protocol Violation|19
120859|NCT00595764|409792|P1|Overall Study|Protocol Violation|24
120860|NCT00595582|409806|P1|Overall Study|Physician Decision|5
120861|NCT00595582|409806|P1|Overall Study|Adverse Event|2
120862|NCT00595582|409806|P1|Overall Study|Lost to Follow-up|1
120863|NCT00595582|409806|P1|Overall Study|Pilot study that PI terminated|2
120864|NCT00595517|409831|P1|Overall Study|No intention to attend regularly|1
120865|NCT00595517|409831|P1|Overall Study|usage of prohibited treatment|1
120866|NCT00595517|409831|P1|Overall Study|Recurrence of ulcer|5
120867|NCT00595517|409831|P1|Overall Study|Protocol Violation|2
120868|NCT00595517|409831|P1|Overall Study|Withdrawal by Subject|4
120869|NCT00595517|409831|P1|Overall Study|Adverse Event|6
120870|NCT00595504|409840|P2|Overall Study|Physician Decision|0
120871|NCT00595504|409841|P1|Overall Study|Physician Decision|1
120872|NCT00595504|409840|P2|Overall Study|Withdrawal by Subject|3
120873|NCT00595504|409841|P1|Overall Study|Withdrawal by Subject|1
120874|NCT00595465|409854|P3|Overall Study|administrative reason|1
120875|NCT00595465|409855|P2|Overall Study|administrative reason|0
120876|NCT00595465|409856|P1|Overall Study|administrative reason|0
120877|NCT00595465|409854|P3|Overall Study|Lost to Follow-up|2
120878|NCT00595465|409855|P2|Overall Study|Lost to Follow-up|0
120879|NCT00595465|409856|P1|Overall Study|Lost to Follow-up|0
120880|NCT00595465|409854|P3|Overall Study|Protocol Violation|0
120881|NCT00595465|409855|P2|Overall Study|Protocol Violation|1
120882|NCT00595465|409856|P1|Overall Study|Protocol Violation|2
120883|NCT00595465|409854|P3|Overall Study|Pregnancy|1
120884|NCT00595465|409855|P2|Overall Study|Pregnancy|0
120885|NCT00595465|409856|P1|Overall Study|Pregnancy|0
120886|NCT00595465|409854|P3|Overall Study|Adverse Event|3
120887|NCT00595465|409855|P2|Overall Study|Adverse Event|3
120888|NCT00595465|409856|P1|Overall Study|Adverse Event|4
120889|NCT00595413|409868|P4|Overall Study|Unspecified|0
120890|NCT00595413|409869|P3|Overall Study|Unspecified|5
120891|NCT00595413|409870|P2|Overall Study|Unspecified|1
120892|NCT00595413|409871|P1|Overall Study|Unspecified|5
120893|NCT00595413|409868|P4|Overall Study|Death|0
120894|NCT00595413|409869|P3|Overall Study|Death|1
120895|NCT00595413|409870|P2|Overall Study|Death|0
120896|NCT00595413|409871|P1|Overall Study|Death|0
120897|NCT00595413|409868|P4|Overall Study|Lost to Follow-up|3
120898|NCT00595413|409869|P3|Overall Study|Lost to Follow-up|1
120899|NCT00595413|409870|P2|Overall Study|Lost to Follow-up|2
120900|NCT00595413|409871|P1|Overall Study|Lost to Follow-up|2
120901|NCT00595413|409868|P4|Overall Study|Adverse Event|1
120902|NCT00595413|409869|P3|Overall Study|Adverse Event|1
120903|NCT00595413|409870|P2|Overall Study|Adverse Event|2
120904|NCT00595413|409871|P1|Overall Study|Adverse Event|0
120905|NCT00595335|409908|P2|Six Months to Twelve Months|Disease Progression|0
120906|NCT00595335|409909|P1|Six Months to Twelve Months|Disease Progression|1
120907|NCT00595335|409908|P2|Six Months to Twelve Months|Withdrawal by Subject|1
120908|NCT00595335|409909|P1|Six Months to Twelve Months|Withdrawal by Subject|0
120909|NCT00595335|409908|P2|Baseline to Six Months|Adverse Event|0
120910|NCT00595335|409909|P1|Baseline to Six Months|Adverse Event|1
120911|NCT00595335|409908|P2|Baseline to Six Months|Disease Progression|1
120912|NCT00595335|409909|P1|Baseline to Six Months|Disease Progression|1
120913|NCT00595335|409908|P2|Baseline to Six Months|Withdrawal by Subject|1
120914|NCT00595335|409909|P1|Baseline to Six Months|Withdrawal by Subject|0
120915|NCT00595309|409929|P1|Overall Study|personal reason|1
120916|NCT00595309|409929|P1|Overall Study|acute infection after V0|1
120917|NCT00595309|409929|P1|Overall Study|planned vaccination against yellow fever|1
120918|NCT00595309|409929|P1|Overall Study|Lost to Follow-up|1
120919|NCT00595127|409959|P1|Overall Study|joined another trial|1
120920|NCT00595127|409959|P1|Overall Study|Relapsed|3
120921|NCT00595127|409959|P1|Overall Study|Death|6
120922|NCT00595075|409981|P2|Overall Study|Withdrawal by Subject|0
120923|NCT00595075|409982|P1|Overall Study|Withdrawal by Subject|1
120924|NCT00594958|410003|P3|Overall Study|administrative|2
120925|NCT00594958|410004|P2|Overall Study|administrative|0
120926|NCT00594958|410005|P1|Overall Study|administrative|3
120927|NCT00594958|410003|P3|Overall Study|Lost to Follow-up|3
120928|NCT00594958|410004|P2|Overall Study|Lost to Follow-up|0
120929|NCT00594958|410005|P1|Overall Study|Lost to Follow-up|5
120930|NCT00594958|410003|P3|Overall Study|Protocol Violation|2
120931|NCT00594958|410004|P2|Overall Study|Protocol Violation|0
120932|NCT00594958|410005|P1|Overall Study|Protocol Violation|1
120933|NCT00594958|410003|P3|Overall Study|Pregnancy|0
120934|NCT00594958|410004|P2|Overall Study|Pregnancy|2
120935|NCT00594958|410005|P1|Overall Study|Pregnancy|0
120936|NCT00594958|410003|P3|Overall Study|Adverse Event|2
120937|NCT00594958|410004|P2|Overall Study|Adverse Event|1
120938|NCT00594958|410005|P1|Overall Study|Adverse Event|4
120939|NCT00594958|410003|P3|Overall Study|Withdrawal by Subject|1
120940|NCT00594958|410004|P2|Overall Study|Withdrawal by Subject|0
120941|NCT00594958|410005|P1|Overall Study|Withdrawal by Subject|1
120942|NCT00594906|410026|P2|Overall Study|Death|1
120943|NCT00594906|410027|P1|Overall Study|Death|0
120944|NCT00594906|410026|P2|Overall Study|Physician Decision|1
120945|NCT00594906|410027|P1|Overall Study|Physician Decision|0
120946|NCT00594906|410026|P2|Overall Study|Physician Decision|0
120947|NCT00594906|410027|P1|Overall Study|Physician Decision|1
120948|NCT00594880|410035|P2|Overall Study|Lost to Follow-up|0
120949|NCT00594880|410036|P1|Overall Study|Lost to Follow-up|1
120950|NCT00594880|410035|P2|Overall Study|Withdrawal by Subject|1
120951|NCT00594880|410036|P1|Overall Study|Withdrawal by Subject|1
120952|NCT00594854|410048|P2|Overall Study|Study terminated|10
120953|NCT00594854|410049|P1|Overall Study|Study terminated|7
120954|NCT00594659|410079|P3|Overall Study|Lost to Follow-up|7
120955|NCT00594659|410080|P2|Overall Study|Lost to Follow-up|9
120956|NCT00594659|410081|P1|Overall Study|Lost to Follow-up|13
120957|NCT00594646|410092|P1|Overall Study|Lost to Follow-up|15
120958|NCT00594646|410092|P1|Overall Study|Withdrawal by Subject|1
120959|NCT00594568|410100|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
120960|NCT00594568|410101|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
120961|NCT00594568|410102|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
120962|NCT00594568|410100|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
120963|NCT00594568|410101|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
120964|NCT00594568|410102|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
120965|NCT00594568|410100|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
120966|NCT00594568|410101|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
120967|NCT00594568|410102|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
120968|NCT00594568|410100|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
120969|NCT00594568|410101|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
120970|NCT00594568|410102|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
120971|NCT00594568|410100|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
120972|NCT00594568|410101|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
120973|NCT00594568|410102|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
120974|NCT00594568|410100|P3|Safety Follow Up (SFU)-Optional|Death|0
120975|NCT00594568|410101|P2|Safety Follow Up (SFU)-Optional|Death|1
120976|NCT00594568|410102|P1|Safety Follow Up (SFU)-Optional|Death|0
120977|NCT00594568|410100|P3|Delayed Start|Sponsor Decision|59
120978|NCT00594568|410101|P2|Delayed Start|Sponsor Decision|66
120979|NCT00594568|410102|P1|Delayed Start|Sponsor Decision|77
120980|NCT00594568|410100|P3|Delayed Start|Caregiver Decision|2
120981|NCT00594568|410101|P2|Delayed Start|Caregiver Decision|6
120982|NCT00594568|410102|P1|Delayed Start|Caregiver Decision|5
120983|NCT00594568|410100|P3|Delayed Start|Lost to Follow-up|1
120984|NCT00594568|410101|P2|Delayed Start|Lost to Follow-up|0
120985|NCT00594568|410102|P1|Delayed Start|Lost to Follow-up|0
120986|NCT00594568|410100|P3|Delayed Start|Physician Decision|1
120987|NCT00594568|410101|P2|Delayed Start|Physician Decision|0
120988|NCT00594568|410102|P1|Delayed Start|Physician Decision|0
120989|NCT00594568|410100|P3|Delayed Start|Withdrawal by Subject|0
120990|NCT00594568|410101|P2|Delayed Start|Withdrawal by Subject|3
120991|NCT00594568|410102|P1|Delayed Start|Withdrawal by Subject|4
120992|NCT00594568|410100|P3|Delayed Start|Adverse Event|2
120993|NCT00594568|410101|P2|Delayed Start|Adverse Event|2
120994|NCT00594568|410102|P1|Delayed Start|Adverse Event|12
120995|NCT00594568|410100|P3|Delayed Start|Death|1
120996|NCT00594568|410101|P2|Delayed Start|Death|0
120997|NCT00594568|410102|P1|Delayed Start|Death|0
120998|NCT00594568|410100|P3|Initial Treatment|Entry criteria exclusion|1
120999|NCT00594568|410101|P2|Initial Treatment|Entry criteria exclusion|1
121000|NCT00594568|410102|P1|Initial Treatment|Entry criteria exclusion|0
121001|NCT00594568|410100|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
121002|NCT00594568|410101|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
121003|NCT00594568|410102|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
121004|NCT00594568|410100|P3|Initial Treatment|Caregiver decision|36
121005|NCT00594568|410101|P2|Initial Treatment|Caregiver decision|36
121006|NCT00594568|410102|P1|Initial Treatment|Caregiver decision|21
121007|NCT00594568|410100|P3|Initial Treatment|Sponsor decision|147
121008|NCT00594568|410101|P2|Initial Treatment|Sponsor decision|142
121009|NCT00594568|410102|P1|Initial Treatment|Sponsor decision|193
121010|NCT00594568|410100|P3|Initial Treatment|Withdrawal by Subject|46
121011|NCT00594568|410101|P2|Initial Treatment|Withdrawal by Subject|31
121012|NCT00594568|410102|P1|Initial Treatment|Withdrawal by Subject|25
121013|NCT00594568|410100|P3|Initial Treatment|Protocol Violation|5
121014|NCT00594568|410101|P2|Initial Treatment|Protocol Violation|2
121015|NCT00594568|410102|P1|Initial Treatment|Protocol Violation|2
121016|NCT00594568|410100|P3|Initial Treatment|Physician Decision|4
121017|NCT00594568|410101|P2|Initial Treatment|Physician Decision|2
121018|NCT00594568|410102|P1|Initial Treatment|Physician Decision|3
121019|NCT00594568|410100|P3|Initial Treatment|Lost to Follow-up|4
121020|NCT00594568|410101|P2|Initial Treatment|Lost to Follow-up|1
121021|NCT00594568|410102|P1|Initial Treatment|Lost to Follow-up|4
121022|NCT00594568|410100|P3|Initial Treatment|Death|15
121023|NCT00594568|410101|P2|Initial Treatment|Death|11
121024|NCT00594568|410102|P1|Initial Treatment|Death|6
121025|NCT00594568|410100|P3|Initial Treatment|Adverse Event|144
121026|NCT00594568|410101|P2|Initial Treatment|Adverse Event|121
121027|NCT00594568|410102|P1|Initial Treatment|Adverse Event|51
121028|NCT00594516|410190|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
121029|NCT00594516|410191|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
121030|NCT00594516|410192|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
121031|NCT00594516|410190|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
121032|NCT00594516|410191|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
121033|NCT00594516|410192|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
121034|NCT00594516|410190|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
121035|NCT00594516|410191|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
121036|NCT00594516|410192|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
121037|NCT00594516|410190|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
121038|NCT00594516|410191|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
121039|NCT00594516|410192|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
121040|NCT00594516|410190|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
121041|NCT00594516|410191|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
121042|NCT00594516|410192|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
121043|NCT00594516|410190|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
121044|NCT00594516|410191|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
121045|NCT00594516|410192|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
121046|NCT00594516|410190|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
121047|NCT00594516|410191|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
121048|NCT00594516|410192|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
121049|NCT00594516|410190|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
121050|NCT00594516|410191|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
121051|NCT00594516|410192|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
121052|NCT00594516|410190|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
121053|NCT00594516|410191|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
121054|NCT00594516|410192|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
121055|NCT00594464|410200|P1|Overall Study|Delay in operation|2
121056|NCT00594464|410200|P1|Overall Study|Withdrawal by Subject|1
121057|NCT00594399|410329|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
121058|NCT00594399|410330|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
121059|NCT00594399|410331|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
121060|NCT00594399|410329|P3|Rerandomization Arm 1 Only|Death|0
121061|NCT00594399|410330|P2|Rerandomization Arm 1 Only|Death|1
121062|NCT00594399|410331|P1|Rerandomization Arm 1 Only|Death|2
121063|NCT00594399|410329|P3|Initial 3 Month Counseling|Family illness|0
121064|NCT00594399|410330|P2|Initial 3 Month Counseling|Family illness|0
121065|NCT00594399|410331|P1|Initial 3 Month Counseling|Family illness|1
121066|NCT00594399|410329|P3|Initial 3 Month Counseling|Moved|0
121067|NCT00594399|410330|P2|Initial 3 Month Counseling|Moved|0
121068|NCT00594399|410331|P1|Initial 3 Month Counseling|Moved|1
121069|NCT00594399|410329|P3|Initial 3 Month Counseling|Pain|0
121070|NCT00594399|410330|P2|Initial 3 Month Counseling|Pain|0
121071|NCT00594399|410331|P1|Initial 3 Month Counseling|Pain|2
121072|NCT00594399|410329|P3|Initial 3 Month Counseling|Too busy|0
121073|NCT00594399|410330|P2|Initial 3 Month Counseling|Too busy|1
121074|NCT00594399|410331|P1|Initial 3 Month Counseling|Too busy|7
121075|NCT00594399|410329|P3|Initial 3 Month Counseling|Personal issues|0
121076|NCT00594399|410330|P2|Initial 3 Month Counseling|Personal issues|0
121077|NCT00594399|410331|P1|Initial 3 Month Counseling|Personal issues|2
121078|NCT00594399|410329|P3|Initial 3 Month Counseling|Lack of Interest|0
121079|NCT00594399|410330|P2|Initial 3 Month Counseling|Lack of Interest|3
121080|NCT00594399|410331|P1|Initial 3 Month Counseling|Lack of Interest|3
121081|NCT00594399|410329|P3|Initial 3 Month Counseling|Not ready to exercise|0
121082|NCT00594399|410330|P2|Initial 3 Month Counseling|Not ready to exercise|0
121083|NCT00594399|410331|P1|Initial 3 Month Counseling|Not ready to exercise|1
121084|NCT00594386|410353|P1|Overall Study|Other: Loss of drivers license|1
121085|NCT00594386|410353|P1|Overall Study|Other: Patient wants prescription Neupro|1
121086|NCT00594386|410353|P1|Overall Study|Other: Site terminated participation|1
121087|NCT00594386|410353|P1|Overall Study|Other: Sponsor closure of study|1
121088|NCT00594386|410353|P1|Overall Study|Other: Study terminated per investigator|2
121089|NCT00594386|410353|P1|Overall Study|Other: Subject admitted to nursing home|1
121090|NCT00594386|410353|P1|Overall Study|Other: Subject moved to Seattle|1
121091|NCT00594386|410353|P1|Overall Study|Other: Patient went off patch (hospital)|1
121092|NCT00594386|410353|P1|Overall Study|Lost to Follow-up|6
121093|NCT00594386|410353|P1|Overall Study|Study ended per sponsor|115
121094|NCT00594386|410353|P1|Overall Study|Subject withdrew consent|35
121095|NCT00594386|410353|P1|Overall Study|Unsatisfactory compliance of subject|11
121096|NCT00594386|410353|P1|Overall Study|Adverse Event|68
121097|NCT00594386|410353|P1|Overall Study|Lack of Efficacy|12
121098|NCT00594386|410353|P1|Overall Study|Major protocol violation|2
121099|NCT00594204|410386|P2|Overall Study|Randomized but not treated|1
121100|NCT00594204|410387|P1|Overall Study|Randomized but not treated|4
121101|NCT00594204|410386|P2|Overall Study|Lack of Efficacy|4
121102|NCT00594204|410387|P1|Overall Study|Lack of Efficacy|3
121103|NCT00594204|410386|P2|Overall Study|Unspecified|3
121104|NCT00594204|410387|P1|Overall Study|Unspecified|4
121105|NCT00594204|410386|P2|Overall Study|Withdrawal by Subject|29
121106|NCT00594204|410387|P1|Overall Study|Withdrawal by Subject|23
121107|NCT00594204|410386|P2|Overall Study|Lost to Follow-up|5
121108|NCT00594204|410387|P1|Overall Study|Lost to Follow-up|9
121109|NCT00594204|410386|P2|Overall Study|Adverse Event|3
121110|NCT00594204|410387|P1|Overall Study|Adverse Event|15
121111|NCT00594178|410397|P1|Overall Study|Physician Decision|5
121112|NCT00594165|410402|P1|Overall Study|Other: Site terminated participation|2
121113|NCT00594165|410402|P1|Overall Study|Other: Subject enrolled in other trial|1
121114|NCT00594165|410402|P1|Overall Study|Other: House bound; can't get to clinic|1
121115|NCT00594165|410402|P1|Overall Study|Other: Brain surgery controlled symptoms|1
121116|NCT00594165|410402|P1|Overall Study|Other: Subject moving|3
121117|NCT00594165|410402|P1|Overall Study|Other: PI discretion|5
121118|NCT00594165|410402|P1|Overall Study|Lost to Follow-up|4
121119|NCT00594165|410402|P1|Overall Study|Study ended per sponsor|102
121120|NCT00594165|410402|P1|Overall Study|Subject withdrew consent|27
121121|NCT00594165|410402|P1|Overall Study|Unsatisfactory compliance of subject|6
121122|NCT00594165|410402|P1|Overall Study|Adverse Event|52
121123|NCT00594165|410402|P1|Overall Study|Lack of Efficacy|12
121124|NCT00594165|410402|P1|Overall Study|Major protocol violation|1
121125|NCT00594100|410408|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
121126|NCT00594100|410408|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
121127|NCT00594100|410408|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
121128|NCT00594100|410408|P1|Procedure|Technical Failure|9
121129|NCT00594035|410419|P2|Overall Study|Subject couldn't return due to job|1
121130|NCT00594035|410420|P1|Overall Study|Subject couldn't return due to job|0
121131|NCT00594035|410419|P2|Overall Study|Subject transferred to nursing home|1
121132|NCT00594035|410420|P1|Overall Study|Subject transferred to nursing home|0
121133|NCT00594035|410419|P2|Overall Study|Withdrawal by Subject|0
121134|NCT00594035|410420|P1|Overall Study|Withdrawal by Subject|1
121135|NCT00594035|410419|P2|Overall Study|Lost to Follow-up|1
121136|NCT00594035|410420|P1|Overall Study|Lost to Follow-up|1
121137|NCT00593957|410446|P3|Overall Study|Physician Decision|2
121138|NCT00593957|410447|P2|Overall Study|Physician Decision|1
121139|NCT00593957|410448|P1|Overall Study|Physician Decision|0
121140|NCT00593918|410472|P2|Overall Study|Withdrawal by Subject|24
121141|NCT00593918|410473|P1|Overall Study|Withdrawal by Subject|5
121142|NCT00593827|410488|P2|Overall Study|On Active Treatment/Pending|2
121143|NCT00593827|410489|P1|Overall Study|On Active Treatment/Pending|0
121144|NCT00593814|410513|P2|Overall Study|Physician Decision|0
121145|NCT00593814|410514|P1|Overall Study|Physician Decision|3
121146|NCT00593814|410513|P2|Overall Study|Lost to Follow-up|0
121147|NCT00593814|410514|P1|Overall Study|Lost to Follow-up|7
121148|NCT00593814|410513|P2|Overall Study|Withdrawal by Subject|0
121149|NCT00593814|410514|P1|Overall Study|Withdrawal by Subject|7
121150|NCT00593814|410513|P2|Overall Study|Death|0
121151|NCT00593814|410514|P1|Overall Study|Death|7
121152|NCT00593736|410524|P4|Treatment Period and Placebo Run-out|Various|0
121153|NCT00593736|410525|P3|Treatment Period and Placebo Run-out|Various|1
121154|NCT00593736|410526|P2|Treatment Period and Placebo Run-out|Various|1
121155|NCT00593736|410527|P1|Treatment Period and Placebo Run-out|Various|1
121156|NCT00593736|410524|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
121157|NCT00593736|410525|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
121158|NCT00593736|410526|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
121159|NCT00593736|410527|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
121160|NCT00593736|410524|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
121161|NCT00593736|410525|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
121162|NCT00593736|410526|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
121163|NCT00593736|410527|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
121164|NCT00593736|410524|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
121165|NCT00593736|410525|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
121166|NCT00593736|410526|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
121167|NCT00593736|410527|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
121168|NCT00593736|410524|P4|Screening Period and Placebo Run-in|Various|25
121169|NCT00593736|410525|P3|Screening Period and Placebo Run-in|Various|0
121170|NCT00593736|410526|P2|Screening Period and Placebo Run-in|Various|0
121171|NCT00593736|410527|P1|Screening Period and Placebo Run-in|Various|0
121172|NCT00593736|410524|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
121173|NCT00593736|410525|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
121174|NCT00593736|410526|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
121175|NCT00593736|410527|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
121176|NCT00593736|410524|P4|Screening Period and Placebo Run-in|Study Termination|15
121177|NCT00593736|410525|P3|Screening Period and Placebo Run-in|Study Termination|0
121178|NCT00593736|410526|P2|Screening Period and Placebo Run-in|Study Termination|0
121179|NCT00593736|410527|P1|Screening Period and Placebo Run-in|Study Termination|0
121180|NCT00593736|410524|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
121181|NCT00593736|410525|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
121182|NCT00593736|410526|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
121183|NCT00593736|410527|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
121184|NCT00593736|410524|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
121185|NCT00593736|410525|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
121186|NCT00593736|410526|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
121187|NCT00593736|410527|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
121188|NCT00593736|410524|P4|Screening Period and Placebo Run-in|Adverse Event|3
121189|NCT00593736|410525|P3|Screening Period and Placebo Run-in|Adverse Event|0
121190|NCT00593736|410526|P2|Screening Period and Placebo Run-in|Adverse Event|0
121191|NCT00593736|410527|P1|Screening Period and Placebo Run-in|Adverse Event|0
121192|NCT00593684|410775|P2|Overall Study|Death|1
121193|NCT00593684|410776|P1|Overall Study|Death|2
121194|NCT00593606|410802|P1|Overall Study|Screen Failure|3
121195|NCT00593606|410802|P1|Overall Study|Run-In Failure|5
121196|NCT00593606|410802|P1|Overall Study|Lost to Follow-up|2
121197|NCT00593606|410802|P1|Overall Study|Protocol Violation|3
121198|NCT00593606|410802|P1|Overall Study|Withdrawal by Subject|1
121199|NCT00593606|410802|P1|Overall Study|Adverse Event|13
121200|NCT00593112|411025|P2|Overall Study|Withdrawal by Subject|0
121201|NCT00593112|411026|P1|Overall Study|Withdrawal by Subject|5
121202|NCT00593112|411025|P2|Overall Study|Unreadable Scan|0
121203|NCT00593112|411026|P1|Overall Study|Unreadable Scan|1
121204|NCT00593112|411025|P2|Overall Study|Abnormal Scan|0
121205|NCT00593112|411026|P1|Overall Study|Abnormal Scan|1
121206|NCT00593112|411025|P2|Overall Study|Scan Anxiety|0
121207|NCT00593112|411026|P1|Overall Study|Scan Anxiety|3
121208|NCT00592904|411053|P4|Overall Study|Not specified|0
121209|NCT00592904|411054|P3|Overall Study|Not specified|0
121210|NCT00592904|411055|P2|Overall Study|Not specified|3
121211|NCT00592904|411056|P1|Overall Study|Not specified|3
121212|NCT00592904|411053|P4|Overall Study|Physician Decision|0
121213|NCT00592904|411054|P3|Overall Study|Physician Decision|1
121214|NCT00592904|411055|P2|Overall Study|Physician Decision|3
121215|NCT00592904|411056|P1|Overall Study|Physician Decision|0
121216|NCT00592904|411053|P4|Overall Study|Lack of Efficacy|3
121217|NCT00592904|411054|P3|Overall Study|Lack of Efficacy|2
121218|NCT00592904|411055|P2|Overall Study|Lack of Efficacy|7
121219|NCT00592904|411056|P1|Overall Study|Lack of Efficacy|2
121220|NCT00592904|411053|P4|Overall Study|Withdrawal by Subject|2
121221|NCT00592904|411054|P3|Overall Study|Withdrawal by Subject|1
121222|NCT00592904|411055|P2|Overall Study|Withdrawal by Subject|16
121223|NCT00592904|411056|P1|Overall Study|Withdrawal by Subject|4
121224|NCT00592904|411053|P4|Overall Study|Protocol Violation|1
121225|NCT00592904|411054|P3|Overall Study|Protocol Violation|0
121226|NCT00592904|411055|P2|Overall Study|Protocol Violation|1
121227|NCT00592904|411056|P1|Overall Study|Protocol Violation|1
121228|NCT00592904|411053|P4|Overall Study|Adverse Event|5
121229|NCT00592904|411054|P3|Overall Study|Adverse Event|13
121230|NCT00592904|411055|P2|Overall Study|Adverse Event|25
121231|NCT00592904|411056|P1|Overall Study|Adverse Event|15
121232|NCT00592852|411082|P1|Overall Study|Withdrawal by Subject|1
121233|NCT00592852|411082|P1|Overall Study|Found ineligible|1
121234|NCT00592852|411082|P1|Overall Study|Adverse Event|3
121235|NCT00592852|411082|P1|Overall Study|Non-compliance|1
121236|NCT00592839|411090|P3|Overall Study|Lost to Follow-up|1
121237|NCT00592839|411091|P2|Overall Study|Lost to Follow-up|1
121238|NCT00592839|411092|P1|Overall Study|Lost to Follow-up|0
121239|NCT00592839|411090|P3|Overall Study|Adverse Event|0
121240|NCT00592839|411091|P2|Overall Study|Adverse Event|1
121241|NCT00592839|411092|P1|Overall Study|Adverse Event|0
121242|NCT00592839|411090|P3|Overall Study|Protocol Violation|2
121243|NCT00592839|411091|P2|Overall Study|Protocol Violation|1
121244|NCT00592839|411092|P1|Overall Study|Protocol Violation|1
121245|NCT00592839|411090|P3|Overall Study|Withdrawal by Subject|3
121246|NCT00592839|411091|P2|Overall Study|Withdrawal by Subject|1
121247|NCT00592839|411092|P1|Overall Study|Withdrawal by Subject|1
121248|NCT00592774|411120|P5|Overall Study|Not specified|2
121249|NCT00592774|411121|P4|Overall Study|Not specified|0
121250|NCT00592774|411122|P3|Overall Study|Not specified|1
121251|NCT00592774|411123|P2|Overall Study|Not specified|1
121252|NCT00592774|411124|P1|Overall Study|Not specified|0
121253|NCT00592774|411120|P5|Overall Study|Physician Decision|1
121254|NCT00592774|411121|P4|Overall Study|Physician Decision|0
121255|NCT00592774|411122|P3|Overall Study|Physician Decision|1
121256|NCT00592774|411123|P2|Overall Study|Physician Decision|1
121257|NCT00592774|411124|P1|Overall Study|Physician Decision|0
121258|NCT00592774|411120|P5|Overall Study|Lack of Efficacy|2
121259|NCT00592774|411121|P4|Overall Study|Lack of Efficacy|0
121260|NCT00592774|411122|P3|Overall Study|Lack of Efficacy|0
121261|NCT00592774|411123|P2|Overall Study|Lack of Efficacy|3
121262|NCT00592774|411124|P1|Overall Study|Lack of Efficacy|3
121263|NCT00592774|411120|P5|Overall Study|Withdrawal by Subject|0
121264|NCT00592774|411121|P4|Overall Study|Withdrawal by Subject|0
121265|NCT00592774|411122|P3|Overall Study|Withdrawal by Subject|0
121266|NCT00592774|411123|P2|Overall Study|Withdrawal by Subject|7
121267|NCT00592774|411124|P1|Overall Study|Withdrawal by Subject|3
121268|NCT00592774|411120|P5|Overall Study|Protocol Violation|1
121269|NCT00592774|411121|P4|Overall Study|Protocol Violation|0
121270|NCT00592774|411122|P3|Overall Study|Protocol Violation|0
121271|NCT00592774|411123|P2|Overall Study|Protocol Violation|1
121272|NCT00592774|411124|P1|Overall Study|Protocol Violation|0
121273|NCT00592774|411120|P5|Overall Study|Adverse Event|8
121274|NCT00592774|411121|P4|Overall Study|Adverse Event|14
121275|NCT00592774|411122|P3|Overall Study|Adverse Event|2
121276|NCT00592774|411123|P2|Overall Study|Adverse Event|19
121277|NCT00592774|411124|P1|Overall Study|Adverse Event|5
121278|NCT00592683|411196|P2|Overall Study|Lost to Follow-up|1
121279|NCT00592683|411197|P1|Overall Study|Lost to Follow-up|0
121280|NCT00592683|411196|P2|Overall Study|Other|0
121281|NCT00592683|411197|P1|Overall Study|Other|1
121282|NCT00592683|411196|P2|Overall Study|Study drug expired|0
121283|NCT00592683|411197|P1|Overall Study|Study drug expired|1
121284|NCT00592683|411196|P2|Overall Study|Protocol Violation|0
121285|NCT00592683|411197|P1|Overall Study|Protocol Violation|1
121286|NCT00592683|411196|P2|Overall Study|Adverse Event|2
121287|NCT00592683|411197|P1|Overall Study|Adverse Event|0
121288|NCT00592683|411196|P2|Overall Study|Withdrawal by Subject|0
121289|NCT00592683|411197|P1|Overall Study|Withdrawal by Subject|1
121290|NCT00592683|411196|P2|Overall Study|Found ineligible|1
121291|NCT00592683|411197|P1|Overall Study|Found ineligible|0
121292|NCT00592631|411207|P2|Overall Study|Lost to Follow-up|2
121293|NCT00592631|411208|P1|Overall Study|Lost to Follow-up|0
121294|NCT00592384|411253|P2|Overall Study|Withdrawal by Subject|6
121295|NCT00592384|411254|P1|Overall Study|Withdrawal by Subject|5
121296|NCT00592358|411262|P1|Overall Study|Inability to swallow pills|1
121297|NCT00592358|411262|P1|Overall Study|Lack of Efficacy|2
121298|NCT00592358|411262|P1|Overall Study|Adverse Event|1
121299|NCT00592358|411262|P1|Overall Study|Withdrawal by Subject|2
121300|NCT00592319|411269|P2|Overall Study|Lost to Follow-up|3
121301|NCT00592319|411270|P1|Overall Study|Lost to Follow-up|0
121302|NCT00592072|411283|P2|Wash Out Period|Lost to Follow-up|1
121303|NCT00592072|411284|P1|Wash Out Period|Lost to Follow-up|1
121304|NCT00591864|411306|P1|Overall Study|Incomplete Imaging|5
121305|NCT00591851|411312|P1|Overall Study|Progressive Disease|1
121306|NCT00591851|411312|P1|Overall Study|Adverse Event|2
121307|NCT00591851|411312|P1|Overall Study|Withdrawal by Subject|3
121308|NCT00591773|411319|P3|Overall Study|Other|4
121309|NCT00591773|411320|P2|Overall Study|Other|1
121310|NCT00591773|411321|P1|Overall Study|Other|1
121311|NCT00591773|411319|P3|Overall Study|Lack of Efficacy|2
121312|NCT00591773|411320|P2|Overall Study|Lack of Efficacy|2
121313|NCT00591773|411321|P1|Overall Study|Lack of Efficacy|1
121314|NCT00591773|411319|P3|Overall Study|Withdrawal by Subject|3
121315|NCT00591773|411320|P2|Overall Study|Withdrawal by Subject|5
121316|NCT00591773|411321|P1|Overall Study|Withdrawal by Subject|2
121317|NCT00591773|411319|P3|Overall Study|Lost to Follow-up|1
121318|NCT00591773|411320|P2|Overall Study|Lost to Follow-up|4
121319|NCT00591773|411321|P1|Overall Study|Lost to Follow-up|1
121320|NCT00591773|411319|P3|Overall Study|Protocol Violation|0
121321|NCT00591773|411320|P2|Overall Study|Protocol Violation|3
121322|NCT00591773|411321|P1|Overall Study|Protocol Violation|2
121323|NCT00591773|411319|P3|Overall Study|Adverse Event|6
121324|NCT00591773|411320|P2|Overall Study|Adverse Event|9
121325|NCT00591773|411321|P1|Overall Study|Adverse Event|9
121326|NCT00591734|411380|P1|Overall Study|Intercurrent Illness|8
121327|NCT00591734|411380|P1|Overall Study|Physician Decision|5
121328|NCT00591734|411380|P1|Overall Study|Adverse Event|5
121329|NCT00591734|411380|P1|Overall Study|Lack of Efficacy|35
121330|NCT00591721|411386|P2|Overall Study|Intervention not received|8
121331|NCT00591721|411387|P1|Overall Study|Intervention not received|10
121332|NCT00591721|411386|P2|Overall Study|Lost to Follow-up|4
121333|NCT00591721|411387|P1|Overall Study|Lost to Follow-up|1
121334|NCT00591721|411386|P2|Overall Study|Withdrawal by Subject|10
121335|NCT00591721|411387|P1|Overall Study|Withdrawal by Subject|10
121336|NCT00591591|411395|P2|Overall Study|Lack of Efficacy|2
121337|NCT00591591|411396|P1|Overall Study|Lack of Efficacy|10
121338|NCT00591591|411395|P2|Overall Study|Withdrawal by Subject|37
121339|NCT00591591|411396|P1|Overall Study|Withdrawal by Subject|1
121340|NCT00591578|411413|P3|Open-Label Extension Phase|Other|0
121341|NCT00591578|411414|P2|Open-Label Extension Phase|Other|0
121342|NCT00591578|411415|P1|Open-Label Extension Phase|Other|1
121343|NCT00591578|411413|P3|Open-Label Extension Phase|Withdrawal by Subject|0
121344|NCT00591578|411414|P2|Open-Label Extension Phase|Withdrawal by Subject|1
121345|NCT00591578|411415|P1|Open-Label Extension Phase|Withdrawal by Subject|1
121346|NCT00591578|411413|P3|Open-Label Extension Phase|Lost to Follow-up|0
121347|NCT00591578|411414|P2|Open-Label Extension Phase|Lost to Follow-up|4
121348|NCT00591578|411415|P1|Open-Label Extension Phase|Lost to Follow-up|1
121349|NCT00591578|411413|P3|Open-Label Extension Phase|Adverse Event|0
121350|NCT00591578|411414|P2|Open-Label Extension Phase|Adverse Event|5
121351|NCT00591578|411415|P1|Open-Label Extension Phase|Adverse Event|3
121352|NCT00591578|411413|P3|Double-Blind Treatment Phase|Other|4
121353|NCT00591578|411414|P2|Double-Blind Treatment Phase|Other|9
121354|NCT00591578|411415|P1|Double-Blind Treatment Phase|Other|4
121355|NCT00591578|411413|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
121356|NCT00591578|411414|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
121357|NCT00591578|411415|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
121358|NCT00591578|411413|P3|Double-Blind Treatment Phase|Pregnancy|0
121359|NCT00591578|411414|P2|Double-Blind Treatment Phase|Pregnancy|0
121360|NCT00591578|411415|P1|Double-Blind Treatment Phase|Pregnancy|1
121361|NCT00591578|411413|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
121362|NCT00591578|411414|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
121363|NCT00591578|411415|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
121364|NCT00591578|411413|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
121365|NCT00591578|411414|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
121366|NCT00591578|411415|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
121367|NCT00591578|411413|P3|Double-Blind Treatment Phase|Protocol Violation|3
121368|NCT00591578|411414|P2|Double-Blind Treatment Phase|Protocol Violation|2
121369|NCT00591578|411415|P1|Double-Blind Treatment Phase|Protocol Violation|3
121370|NCT00591578|411413|P3|Double-Blind Treatment Phase|Adverse Event|19
121371|NCT00591578|411414|P2|Double-Blind Treatment Phase|Adverse Event|26
121372|NCT00591578|411415|P1|Double-Blind Treatment Phase|Adverse Event|20
121373|NCT00591565|411466|P1|Overall Study|lost follow up, withdrawn|5
121374|NCT00591370|411470|P1|Overall Study|Not Treated|2
121375|NCT00591344|411478|P2|Overall Study|Did not want to come off medication|1
121376|NCT00591344|411479|P1|Overall Study|Did not want to come off medication|0
121377|NCT00591344|411478|P2|Overall Study|Lost to Follow-up|1
121378|NCT00591344|411479|P1|Overall Study|Lost to Follow-up|0
121379|NCT00591344|411478|P2|Overall Study|Death|1
121380|NCT00591344|411479|P1|Overall Study|Death|0
121381|NCT00591344|411478|P2|Overall Study|Underwent DBS|2
121382|NCT00591344|411479|P1|Overall Study|Underwent DBS|2
121383|NCT00591344|411478|P2|Overall Study|Medical complications|3
121384|NCT00591344|411479|P1|Overall Study|Medical complications|1
121385|NCT00591344|411478|P2|Overall Study|Moved out of state|0
121386|NCT00591344|411479|P1|Overall Study|Moved out of state|1
121387|NCT00591344|411478|P2|Overall Study|Transportation issues|0
121388|NCT00591344|411479|P1|Overall Study|Transportation issues|1
121389|NCT00591266|411492|P3|Overall Study|Other|5
121390|NCT00591266|411493|P2|Overall Study|Other|4
121391|NCT00591266|411494|P1|Overall Study|Other|1
121392|NCT00591266|411492|P3|Overall Study|Lack of Efficacy|0
121393|NCT00591266|411493|P2|Overall Study|Lack of Efficacy|2
121394|NCT00591266|411494|P1|Overall Study|Lack of Efficacy|0
121395|NCT00591266|411492|P3|Overall Study|Withdrawal by Subject|5
121396|NCT00591266|411493|P2|Overall Study|Withdrawal by Subject|2
121397|NCT00591266|411494|P1|Overall Study|Withdrawal by Subject|6
121398|NCT00591266|411492|P3|Overall Study|Protocol Violation|1
121399|NCT00591266|411493|P2|Overall Study|Protocol Violation|0
121400|NCT00591266|411494|P1|Overall Study|Protocol Violation|0
121401|NCT00591266|411492|P3|Overall Study|Lost to Follow-up|0
121402|NCT00591266|411493|P2|Overall Study|Lost to Follow-up|1
121403|NCT00591266|411494|P1|Overall Study|Lost to Follow-up|0
121404|NCT00591266|411492|P3|Overall Study|Adverse Event|3
121405|NCT00591266|411493|P2|Overall Study|Adverse Event|2
121406|NCT00591266|411494|P1|Overall Study|Adverse Event|2
121407|NCT00591253|411547|P3|Overall Study|Other|3
121408|NCT00591253|411548|P2|Overall Study|Other|5
121409|NCT00591253|411549|P1|Overall Study|Other|5
121410|NCT00591253|411547|P3|Overall Study|Lack of Efficacy|3
121411|NCT00591253|411548|P2|Overall Study|Lack of Efficacy|0
121412|NCT00591253|411549|P1|Overall Study|Lack of Efficacy|1
121413|NCT00591253|411547|P3|Overall Study|Withdrawal by Subject|6
121414|NCT00591253|411548|P2|Overall Study|Withdrawal by Subject|7
121415|NCT00591253|411549|P1|Overall Study|Withdrawal by Subject|1
121416|NCT00591253|411547|P3|Overall Study|Lost to Follow-up|0
121417|NCT00591253|411548|P2|Overall Study|Lost to Follow-up|4
121418|NCT00591253|411549|P1|Overall Study|Lost to Follow-up|2
121419|NCT00591253|411547|P3|Overall Study|Protocol Violation|2
121420|NCT00591253|411548|P2|Overall Study|Protocol Violation|2
121421|NCT00591253|411549|P1|Overall Study|Protocol Violation|2
121422|NCT00591253|411547|P3|Overall Study|Adverse Event|1
121423|NCT00591253|411548|P2|Overall Study|Adverse Event|3
121424|NCT00591253|411549|P1|Overall Study|Adverse Event|3
121425|NCT00591214|411617|P1|Overall Study|Withdrawal by Subject|1
121426|NCT00591214|411617|P1|Overall Study|Physician Decision|7
121427|NCT00591006|411638|P24|Overall Study|Adverse Event|0
121428|NCT00591006|411639|P23|Overall Study|Adverse Event|1
121429|NCT00591006|411640|P22|Overall Study|Adverse Event|0
121430|NCT00591006|411641|P21|Overall Study|Adverse Event|0
121431|NCT00591006|411642|P20|Overall Study|Adverse Event|0
121432|NCT00591006|411643|P19|Overall Study|Adverse Event|0
121433|NCT00591006|411644|P18|Overall Study|Adverse Event|0
121434|NCT00591006|411645|P17|Overall Study|Adverse Event|0
121435|NCT00591006|411646|P16|Overall Study|Adverse Event|0
121436|NCT00591006|411647|P15|Overall Study|Adverse Event|0
121437|NCT00591006|411648|P14|Overall Study|Adverse Event|0
121438|NCT00591006|411649|P13|Overall Study|Adverse Event|0
121439|NCT00591006|411650|P12|Overall Study|Adverse Event|0
121440|NCT00591006|411651|P11|Overall Study|Adverse Event|0
121441|NCT00591006|411652|P10|Overall Study|Adverse Event|0
121442|NCT00591006|411653|P9|Overall Study|Adverse Event|0
121443|NCT00591006|411654|P8|Overall Study|Adverse Event|0
121444|NCT00591006|411655|P7|Overall Study|Adverse Event|0
121445|NCT00591006|411656|P6|Overall Study|Adverse Event|0
121446|NCT00591006|411657|P5|Overall Study|Adverse Event|0
121447|NCT00591006|411658|P4|Overall Study|Adverse Event|0
121448|NCT00591006|411659|P3|Overall Study|Adverse Event|0
121449|NCT00591006|411660|P2|Overall Study|Adverse Event|0
121450|NCT00591006|411661|P1|Overall Study|Adverse Event|0
121451|NCT00591006|411638|P24|Overall Study|Withdrawal by Subject|1
121452|NCT00591006|411639|P23|Overall Study|Withdrawal by Subject|0
121453|NCT00591006|411640|P22|Overall Study|Withdrawal by Subject|0
121454|NCT00591006|411641|P21|Overall Study|Withdrawal by Subject|0
121455|NCT00591006|411642|P20|Overall Study|Withdrawal by Subject|0
121456|NCT00591006|411643|P19|Overall Study|Withdrawal by Subject|0
121457|NCT00591006|411644|P18|Overall Study|Withdrawal by Subject|0
121458|NCT00591006|411645|P17|Overall Study|Withdrawal by Subject|0
121459|NCT00591006|411646|P16|Overall Study|Withdrawal by Subject|1
121460|NCT00591006|411647|P15|Overall Study|Withdrawal by Subject|0
121461|NCT00591006|411648|P14|Overall Study|Withdrawal by Subject|0
121462|NCT00591006|411649|P13|Overall Study|Withdrawal by Subject|0
121463|NCT00591006|411650|P12|Overall Study|Withdrawal by Subject|0
121464|NCT00591006|411651|P11|Overall Study|Withdrawal by Subject|0
121465|NCT00591006|411652|P10|Overall Study|Withdrawal by Subject|0
121466|NCT00591006|411653|P9|Overall Study|Withdrawal by Subject|0
121467|NCT00591006|411654|P8|Overall Study|Withdrawal by Subject|0
121468|NCT00591006|411655|P7|Overall Study|Withdrawal by Subject|0
121469|NCT00591006|411656|P6|Overall Study|Withdrawal by Subject|0
121470|NCT00591006|411657|P5|Overall Study|Withdrawal by Subject|0
121471|NCT00591006|411658|P4|Overall Study|Withdrawal by Subject|0
121472|NCT00591006|411659|P3|Overall Study|Withdrawal by Subject|0
121473|NCT00591006|411660|P2|Overall Study|Withdrawal by Subject|0
121474|NCT00591006|411661|P1|Overall Study|Withdrawal by Subject|0
121475|NCT00590967|411681|P2|Overall Study|Did not receive chemo per protocol|0
121476|NCT00590967|411682|P1|Overall Study|Did not receive chemo per protocol|1
121477|NCT00590967|411681|P2|Overall Study|Did not sign consent form|1
121478|NCT00590967|411682|P1|Overall Study|Did not sign consent form|0
121479|NCT00590967|411681|P2|Overall Study|Non-compliant|2
121480|NCT00590967|411682|P1|Overall Study|Non-compliant|0
121481|NCT00590967|411681|P2|Overall Study|Poor performance status|1
121482|NCT00590967|411682|P1|Overall Study|Poor performance status|0
121483|NCT00590967|411681|P2|Overall Study|Ineligible|0
121484|NCT00590967|411682|P1|Overall Study|Ineligible|1
121485|NCT00590967|411681|P2|Overall Study|Withdrawal by Subject|1
121486|NCT00590967|411682|P1|Overall Study|Withdrawal by Subject|1
121487|NCT00590902|411694|P1|Overall Study|Death|1
121488|NCT00590759|411729|P1|Overall Study|Lost to Follow-up|28
121489|NCT00590759|411729|P1|Overall Study|Death|52
121490|NCT00590720|411736|P2|Overall Study|Withdrawal by Subject|1
121491|NCT00590720|411737|P1|Overall Study|Withdrawal by Subject|0
121492|NCT00590720|411736|P2|Overall Study|Lost to Follow-up|0
121493|NCT00590720|411737|P1|Overall Study|Lost to Follow-up|1
121494|NCT00590590|411782|P3|Overall Study|Did not complete study|0
121495|NCT00590590|411783|P2|Overall Study|Did not complete study|1
121496|NCT00590590|411784|P1|Overall Study|Did not complete study|0
121497|NCT00590590|411782|P3|Overall Study|Did not complete due to study closure|1
121498|NCT00590590|411783|P2|Overall Study|Did not complete due to study closure|1
121499|NCT00590590|411784|P1|Overall Study|Did not complete due to study closure|1
121500|NCT00590590|411782|P3|Overall Study|Withdrawal by Subject|1
121501|NCT00590590|411783|P2|Overall Study|Withdrawal by Subject|1
121502|NCT00590590|411784|P1|Overall Study|Withdrawal by Subject|0
121503|NCT00590590|411782|P3|Overall Study|Lost to Follow-up|2
121504|NCT00590590|411783|P2|Overall Study|Lost to Follow-up|1
121505|NCT00590590|411784|P1|Overall Study|Lost to Follow-up|4
121506|NCT00590590|411782|P3|Overall Study|Protocol Violation|2
121507|NCT00590590|411783|P2|Overall Study|Protocol Violation|0
121508|NCT00590590|411784|P1|Overall Study|Protocol Violation|0
121509|NCT00590590|411782|P3|Overall Study|Adverse Event|0
121510|NCT00590590|411783|P2|Overall Study|Adverse Event|0
121511|NCT00590590|411784|P1|Overall Study|Adverse Event|1
121512|NCT00590590|411782|P3|Overall Study|Lack of Efficacy|0
121513|NCT00590590|411783|P2|Overall Study|Lack of Efficacy|2
121514|NCT00590590|411784|P1|Overall Study|Lack of Efficacy|1
121515|NCT00590577|411811|P4|Overall Study|Various reasons|2
121516|NCT00590577|411812|P3|Overall Study|Various reasons|1
121517|NCT00590577|411813|P2|Overall Study|Various reasons|3
121518|NCT00590577|411814|P1|Overall Study|Various reasons|1
121519|NCT00590577|411811|P4|Overall Study|Pregnancy|0
121520|NCT00590577|411812|P3|Overall Study|Pregnancy|0
121521|NCT00590577|411813|P2|Overall Study|Pregnancy|1
121522|NCT00590577|411814|P1|Overall Study|Pregnancy|0
121523|NCT00590577|411811|P4|Overall Study|Lost to Follow-up|9
121524|NCT00590577|411812|P3|Overall Study|Lost to Follow-up|6
121525|NCT00590577|411813|P2|Overall Study|Lost to Follow-up|6
121526|NCT00590577|411814|P1|Overall Study|Lost to Follow-up|12
121527|NCT00590577|411811|P4|Overall Study|Adverse Event|11
121528|NCT00590577|411812|P3|Overall Study|Adverse Event|13
121529|NCT00590577|411813|P2|Overall Study|Adverse Event|10
121530|NCT00590577|411814|P1|Overall Study|Adverse Event|10
121531|NCT00590577|411811|P4|Overall Study|Withdrawal by Subject|26
121532|NCT00590577|411812|P3|Overall Study|Withdrawal by Subject|30
121533|NCT00590577|411813|P2|Overall Study|Withdrawal by Subject|28
121534|NCT00590577|411814|P1|Overall Study|Withdrawal by Subject|23
121535|NCT00590577|411811|P4|Overall Study|Lack of Efficacy|45
121536|NCT00590577|411812|P3|Overall Study|Lack of Efficacy|23
121537|NCT00590577|411813|P2|Overall Study|Lack of Efficacy|28
121538|NCT00590577|411814|P1|Overall Study|Lack of Efficacy|31
121539|NCT00590564|411832|P1|Overall Study|Patient Non-compliance|6
121540|NCT00590564|411832|P1|Overall Study|Patient Found to be Ineligible|1
121541|NCT00590564|411832|P1|Overall Study|Protocol Violation|1
121542|NCT00590564|411832|P1|Overall Study|Lost to Follow-up|6
121543|NCT00590564|411832|P1|Overall Study|Withdrawal by Subject|4
121544|NCT00590538|411836|P1|Overall Study|Study terminated before completed|2
121545|NCT00590317|411877|P2|Overall Study|Lack of Efficacy|5
121546|NCT00590317|411878|P1|Overall Study|Lack of Efficacy|1
121547|NCT00590044|411910|P2|Overall Study|Protocol Violation|0
121548|NCT00590044|411911|P1|Overall Study|Protocol Violation|1
121549|NCT00590044|411910|P2|Overall Study|wrong insulin arm assigned|0
121550|NCT00590044|411911|P1|Overall Study|wrong insulin arm assigned|1
121551|NCT00590044|411910|P2|Overall Study|Withdrawal by Subject|2
121552|NCT00590044|411911|P1|Overall Study|Withdrawal by Subject|2
121553|NCT00590031|411917|P1|Overall Study|Admin Hold|1
121554|NCT00590031|411917|P1|Overall Study|Metastatic Disease|1
121555|NCT00590031|411917|P1|Overall Study|Withdrawal by Subject|1
121556|NCT00590031|411917|P1|Overall Study|Adverse Event|3
121557|NCT00589979|411944|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
121558|NCT00589979|411945|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
121559|NCT00589979|411946|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
121560|NCT00589979|411944|P3|Double-Blind Treatment Period 3|Protocol Violation|0
121561|NCT00589979|411945|P2|Double-Blind Treatment Period 3|Protocol Violation|1
121562|NCT00589979|411946|P1|Double-Blind Treatment Period 3|Protocol Violation|0
121563|NCT00589979|411944|P3|Double-Blind Treatment Period 2|Other|1
121564|NCT00589979|411945|P2|Double-Blind Treatment Period 2|Other|0
121565|NCT00589979|411946|P1|Double-Blind Treatment Period 2|Other|0
121566|NCT00589979|411944|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
121567|NCT00589979|411945|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
121568|NCT00589979|411946|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
121569|NCT00589979|411944|P3|Double-Blind Treatment Period 2|Adverse Event|0
121570|NCT00589979|411945|P2|Double-Blind Treatment Period 2|Adverse Event|1
121571|NCT00589979|411946|P1|Double-Blind Treatment Period 2|Adverse Event|0
121572|NCT00589979|411944|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
121573|NCT00589979|411945|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
121574|NCT00589979|411946|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
121575|NCT00589979|411944|P3|Double-Blind Treatment Period 1|Protocol Violation|1
121576|NCT00589979|411945|P2|Double-Blind Treatment Period 1|Protocol Violation|1
121577|NCT00589979|411946|P1|Double-Blind Treatment Period 1|Protocol Violation|0
121578|NCT00589979|411944|P3|Double-Blind Treatment Period 1|Adverse Event|0
121579|NCT00589979|411945|P2|Double-Blind Treatment Period 1|Adverse Event|1
121580|NCT00589979|411946|P1|Double-Blind Treatment Period 1|Adverse Event|0
121581|NCT00589979|411944|P3|Run-In Period|Informed Consent Withdrawn|0
121582|NCT00589979|411945|P2|Run-In Period|Informed Consent Withdrawn|0
121583|NCT00589979|411946|P1|Run-In Period|Informed Consent Withdrawn|4
121584|NCT00589979|411944|P3|Run-In Period|Withdrawal by Subject|0
121585|NCT00589979|411945|P2|Run-In Period|Withdrawal by Subject|0
121586|NCT00589979|411946|P1|Run-In Period|Withdrawal by Subject|10
121587|NCT00589979|411944|P3|Run-In Period|Did not qualify for randomization|0
121588|NCT00589979|411945|P2|Run-In Period|Did not qualify for randomization|0
121589|NCT00589979|411946|P1|Run-In Period|Did not qualify for randomization|54
121590|NCT00589979|411944|P3|Run-In Period|Protocol Violation|0
121591|NCT00589979|411945|P2|Run-In Period|Protocol Violation|0
121592|NCT00589979|411946|P1|Run-In Period|Protocol Violation|3
121593|NCT00589979|411944|P3|Run-In Period|Adverse Event|0
121594|NCT00589979|411945|P2|Run-In Period|Adverse Event|0
121595|NCT00589979|411946|P1|Run-In Period|Adverse Event|5
121596|NCT00589914|411985|P2|Overall Study|Other|17
121597|NCT00589914|411986|P1|Overall Study|Other|22
121598|NCT00589914|411985|P2|Overall Study|Withdrawal by Subject|49
121599|NCT00589914|411986|P1|Overall Study|Withdrawal by Subject|55
121600|NCT00589914|411985|P2|Overall Study|Pregnancy|0
121601|NCT00589914|411986|P1|Overall Study|Pregnancy|1
121602|NCT00589914|411985|P2|Overall Study|Lost to Follow-up|18
121603|NCT00589914|411986|P1|Overall Study|Lost to Follow-up|11
121604|NCT00589914|411985|P2|Overall Study|Lack of Efficacy|43
121605|NCT00589914|411986|P1|Overall Study|Lack of Efficacy|40
121606|NCT00589914|411985|P2|Overall Study|Death|0
121607|NCT00589914|411986|P1|Overall Study|Death|2
121608|NCT00589914|411985|P2|Overall Study|Adverse Event|10
121609|NCT00589914|411986|P1|Overall Study|Adverse Event|19
121610|NCT00589784|412018|P2|Overall Study|Adverse Event|4
121611|NCT00589784|412019|P1|Overall Study|Adverse Event|0
121612|NCT00589784|412018|P2|Overall Study|Patient inevaluable|0
121613|NCT00589784|412019|P1|Overall Study|Patient inevaluable|1
121614|NCT00589784|412018|P2|Overall Study|Withdrawal by Subject|6
121615|NCT00589784|412019|P1|Overall Study|Withdrawal by Subject|0
121616|NCT00589693|412026|P2|Overall Study|Protocol Violation|1
121617|NCT00589693|412027|P1|Overall Study|Protocol Violation|1
121618|NCT00589693|412026|P2|Overall Study|Physician Decision|1
121619|NCT00589693|412027|P1|Overall Study|Physician Decision|0
121620|NCT00589693|412026|P2|Overall Study|Lost to Follow-up|0
121621|NCT00589693|412027|P1|Overall Study|Lost to Follow-up|1
121622|NCT00589693|412026|P2|Overall Study|Lack of Efficacy|1
121623|NCT00589693|412027|P1|Overall Study|Lack of Efficacy|0
121624|NCT00589693|412026|P2|Overall Study|Death|16
121625|NCT00589693|412027|P1|Overall Study|Death|26
121626|NCT00589693|412026|P2|Overall Study|Adverse Event|4
121627|NCT00589693|412027|P1|Overall Study|Adverse Event|4
121628|NCT00589693|412026|P2|Overall Study|randomized in error|6
121629|NCT00589693|412027|P1|Overall Study|randomized in error|12
121630|NCT00589667|412041|P1|Overall Study|Withdrawal by Subject|1
121631|NCT00589667|412041|P1|Overall Study|Adverse Event|2
121632|NCT00589628|412048|P2|Overall Study|Lost to Follow-up|1
121633|NCT00589628|412049|P1|Overall Study|Lost to Follow-up|0
121634|NCT00589303|412084|P2|Overall Study|Withdrawal by Subject|1
121635|NCT00589303|412085|P1|Overall Study|Withdrawal by Subject|2
121636|NCT00589290|412091|P1|Overall Study|Withdrawal by Subject|1
121637|NCT00589108|412115|P3|Overall Study|Death|4
121638|NCT00589108|412116|P2|Overall Study|Death|3
121639|NCT00589108|412117|P1|Overall Study|Death|3
121640|NCT00589108|412115|P3|Overall Study|Lost to Follow-up|1
121641|NCT00589108|412116|P2|Overall Study|Lost to Follow-up|1
121642|NCT00589108|412117|P1|Overall Study|Lost to Follow-up|1
121643|NCT00588861|412147|P2|10 Years|Incomplete due to study termination|114
121644|NCT00588861|412148|P1|10 Years|Incomplete due to study termination|107
121645|NCT00588861|412147|P2|8 Years|Patients did not return for follow-up|114
121646|NCT00588861|412148|P1|8 Years|Patients did not return for follow-up|105
121647|NCT00588861|412147|P2|6 Years|Patients did not return for follow-up|109
121648|NCT00588861|412148|P1|6 Years|Patients did not return for follow-up|104
121649|NCT00588861|412147|P2|4 Years|Patients did not return for follow-up|103
121650|NCT00588861|412148|P1|4 Years|Patients did not return for follow-up|91
121651|NCT00588861|412147|P2|2 Years|Patients did not return for follow-up|87
121652|NCT00588861|412148|P1|2 Years|Patients did not return for follow-up|92
121653|NCT00588861|412147|P2|1 Year|Patients did not return for follow-up|82
121654|NCT00588861|412148|P1|1 Year|Patients did not return for follow-up|89
121655|NCT00588861|412147|P2|6 Months|Patients did not return for follow-up|73
121656|NCT00588861|412148|P1|6 Months|Patients did not return for follow-up|98
121657|NCT00588861|412147|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
121658|NCT00588861|412148|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
121659|NCT00588822|412167|P1|Overall Study|progression of disease|8
121660|NCT00588692|412187|P2|Overall Study|Death|0
121661|NCT00588692|412188|P1|Overall Study|Death|1
121662|NCT00588692|412187|P2|Overall Study|Cancer|0
121663|NCT00588692|412188|P1|Overall Study|Cancer|1
121664|NCT00588692|412187|P2|Overall Study|Severe Peptic Ulcer Disease|0
121665|NCT00588692|412188|P1|Overall Study|Severe Peptic Ulcer Disease|1
121666|NCT00588692|412187|P2|Overall Study|Hip Surgery|1
121667|NCT00588692|412188|P1|Overall Study|Hip Surgery|0
121668|NCT00588692|412187|P2|Overall Study|Withdrawal by Subject|2
121669|NCT00588692|412188|P1|Overall Study|Withdrawal by Subject|4
121670|NCT00588666|412224|P1|Overall Study|Adverse Event|4
121671|NCT00588640|412229|P1|Overall Study|Ineligible Patient|1
121672|NCT00588640|412229|P1|Overall Study|Physician Decision|1
121673|NCT00588445|412248|P1|Overall Study|Not Treated|10
121674|NCT00588445|412248|P1|Overall Study|Disease Progression|1
121675|NCT00588445|412248|P1|Overall Study|Withdrawal by Subject|3
121676|NCT00588445|412248|P1|Overall Study|Protocol Violation|1
121677|NCT00588354|412272|P2|Baseline to 4 Weeks|Lost to Follow-up|1
121678|NCT00588354|412273|P1|Baseline to 4 Weeks|Lost to Follow-up|0
121679|NCT00588354|412272|P2|Baseline to 2 Weeks|Lack of Efficacy|0
121680|NCT00588354|412273|P1|Baseline to 2 Weeks|Lack of Efficacy|1
121681|NCT00588354|412272|P2|Baseline to 2 Weeks|Adverse Event|0
121682|NCT00588354|412273|P1|Baseline to 2 Weeks|Adverse Event|1
121683|NCT00588341|412293|P1|Overall Study|Patient ineligible|1
121684|NCT00588341|412293|P1|Overall Study|Not treated due to metastatic disease|1
121685|NCT00588341|412293|P1|Overall Study|Withdrawal by Subject|3
121686|NCT00588237|412297|P1|Overall Study|Patien not treated|1
121687|NCT00588237|412297|P1|Overall Study|Evaluable for toxicity only|3
121688|NCT00588146|412320|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
121689|NCT00588146|412321|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
121690|NCT00588094|412327|P1|Overall Study|Progression of Disease|2
121691|NCT00588094|412327|P1|Overall Study|Adverse Event|3
121692|NCT00587964|412344|P1|Overall Study|Progression of Disease|4
121693|NCT00587964|412344|P1|Overall Study|Patient did not receive intervention|5
121694|NCT00587964|412344|P1|Overall Study|Patient found to be ineligible|1
121695|NCT00587964|412344|P1|Overall Study|Lost to Follow-up|1
121696|NCT00587964|412344|P1|Overall Study|Withdrawal by Subject|1
121697|NCT00587860|412350|P2|Overall Study|Withdrawal by Subject|3
121698|NCT00587860|412351|P1|Overall Study|Withdrawal by Subject|3
121699|NCT00587860|412350|P2|Overall Study|Lost to Follow-up|2
121700|NCT00587860|412351|P1|Overall Study|Lost to Follow-up|2
121701|NCT00587847|412371|P1|Overall Study|Adverse Event|2
121702|NCT00587847|412371|P1|Overall Study|Lack of Efficacy|5
121703|NCT00587639|412440|P1|Overall Study|Withdrawal by Subject|1
121704|NCT00587587|412470|P2|Overall Study|Lost to Follow-up|1
121705|NCT00587587|412471|P1|Overall Study|Lost to Follow-up|6
121706|NCT00587431|412524|P2|Overall Study|Withdrawal by Subject|1
121707|NCT00587431|412525|P1|Overall Study|Withdrawal by Subject|0
121708|NCT00587431|412524|P2|Overall Study|Adverse Event|0
121709|NCT00587431|412525|P1|Overall Study|Adverse Event|1
121710|NCT00587288|412536|P2|Overall Study|Protocol Violation|0
121711|NCT00587288|412537|P1|Overall Study|Protocol Violation|1
121712|NCT00587288|412536|P2|Overall Study|Lack of Efficacy|8
121713|NCT00587288|412537|P1|Overall Study|Lack of Efficacy|2
121714|NCT00587288|412536|P2|Overall Study|Adverse Event|1
121715|NCT00587288|412537|P1|Overall Study|Adverse Event|0
121716|NCT00587223|412555|P1|Overall Study|Adverse Event|1
121717|NCT00587171|412572|P2|Overall Study|Lost to Follow-up|1
121718|NCT00587171|412573|P1|Overall Study|Lost to Follow-up|1
121719|NCT00587158|412603|P2|Overall Study|Subject did not want to take study med|1
121720|NCT00587158|412604|P1|Overall Study|Subject did not want to take study med|0
121721|NCT00587158|412603|P2|Overall Study|Death|1
121722|NCT00587158|412604|P1|Overall Study|Death|0
121723|NCT00587158|412603|P2|Overall Study|Lost to Follow-up|2
121724|NCT00587158|412604|P1|Overall Study|Lost to Follow-up|1
121725|NCT00587158|412603|P2|Overall Study|Physician Decision|1
121726|NCT00587158|412604|P1|Overall Study|Physician Decision|0
121727|NCT00587158|412603|P2|Overall Study|Did not want to do 24 hr urine collect.|3
121728|NCT00587158|412604|P1|Overall Study|Did not want to do 24 hr urine collect.|4
121729|NCT00586898|412667|P1|Overall Study|Evaluable for Toxicity Only|5
121730|NCT00586898|412667|P1|Overall Study|Patiemt Non-compliance|1
121731|NCT00586898|412667|P1|Overall Study|Adverse Event|1
121732|NCT00586846|412671|P1|Overall Study|Evaluable for Toxicity Only|4
121733|NCT00586846|412671|P1|Overall Study|Death|1
121734|NCT00586846|412671|P1|Overall Study|Physician Decision|1
121735|NCT00586820|412677|P2|Overall Study|Unsuccessful PCI|0
121736|NCT00586820|412678|P1|Overall Study|Unsuccessful PCI|1
121737|NCT00586703|412686|P1|Overall Study|Death|12
121738|NCT00586690|412693|P2|Overall Study|Lab can't accommodate|0
121739|NCT00586690|412694|P1|Overall Study|Lab can't accommodate|1
121740|NCT00586690|412693|P2|Overall Study|Lack of Efficacy|0
121741|NCT00586690|412694|P1|Overall Study|Lack of Efficacy|2
121742|NCT00586690|412693|P2|Overall Study|Adverse Event|0
121743|NCT00586690|412694|P1|Overall Study|Adverse Event|1
121744|NCT00586690|412693|P2|Overall Study|Disease Progression|0
121745|NCT00586690|412694|P1|Overall Study|Disease Progression|10
121746|NCT00586690|412693|P2|Overall Study|Death|0
121747|NCT00586690|412694|P1|Overall Study|Death|2
121748|NCT00586664|412704|P3|Overall Study|Exclusion criteria met|0
121749|NCT00586664|412705|P2|Overall Study|Exclusion criteria met|0
121750|NCT00586664|412706|P1|Overall Study|Exclusion criteria met|2
121751|NCT00586664|412704|P3|Overall Study|Withdrawal by Subject|1
121752|NCT00586664|412705|P2|Overall Study|Withdrawal by Subject|7
121753|NCT00586664|412706|P1|Overall Study|Withdrawal by Subject|3
121754|NCT00586625|412752|P2|Overall Study|Subject unable to return for visit|0
121755|NCT00586625|412753|P1|Overall Study|Subject unable to return for visit|2
121756|NCT00586625|412752|P2|Overall Study|Subject non-compliance|1
121757|NCT00586625|412753|P1|Overall Study|Subject non-compliance|0
121758|NCT00586625|412752|P2|Overall Study|Withdrawal by Subject|10
121759|NCT00586625|412753|P1|Overall Study|Withdrawal by Subject|32
121760|NCT00586625|412752|P2|Overall Study|Protocol Violation|0
121761|NCT00586625|412753|P1|Overall Study|Protocol Violation|3
121762|NCT00586625|412752|P2|Overall Study|Adverse Event|6
121763|NCT00586625|412753|P1|Overall Study|Adverse Event|6
121764|NCT00586612|412761|P2|Booster Phase|Lost to Follow-up|1
121765|NCT00586612|412762|P1|Booster Phase|Lost to Follow-up|3
121766|NCT00586612|412761|P2|Primary Phase|Withdrawal by Subject|2
121767|NCT00586612|412762|P1|Primary Phase|Withdrawal by Subject|0
121768|NCT00586612|412761|P2|Primary Phase|Lost to Follow-up|1
121769|NCT00586612|412762|P1|Primary Phase|Lost to Follow-up|0
121770|NCT00586612|412761|P2|Primary Phase|Protocol Violation|0
121771|NCT00586612|412762|P1|Primary Phase|Protocol Violation|1
121772|NCT00586521|412832|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
121773|NCT00586495|412839|P1|Follow-up|Switch to commercial drug|10
121774|NCT00586495|412839|P1|Follow-up|Protocol driven decision point|37
121775|NCT00586495|412839|P1|Follow-up|Withdrawal by Subject|4
121776|NCT00586495|412839|P1|Follow-up|Lost to Follow-up|1
121777|NCT00586495|412839|P1|Follow-up|Death|40
121778|NCT00586495|412839|P1|Treatment Period|Switch to commercial drug|10
121779|NCT00586495|412839|P1|Treatment Period|Disease progression, recurrence/relapse|71
121780|NCT00586495|412839|P1|Treatment Period|Withdrawal by Subject|1
121781|NCT00586495|412839|P1|Treatment Period|Protocol Violation|1
121782|NCT00586495|412839|P1|Treatment Period|Death|1
121783|NCT00586495|412839|P1|Treatment Period|Adverse Event|11
121784|NCT00586469|412868|P2|Overall Study|Adverse Event|1
121785|NCT00586469|412869|P1|Overall Study|Adverse Event|0
121786|NCT00586339|412896|P3|Overall Study|Withdrawal by Subject|1
121787|NCT00586339|412897|P2|Overall Study|Withdrawal by Subject|3
121788|NCT00586339|412898|P1|Overall Study|Withdrawal by Subject|1
121789|NCT00586339|412896|P3|Overall Study|Lost to Follow-up|5
121790|NCT00586339|412897|P2|Overall Study|Lost to Follow-up|4
121791|NCT00586339|412898|P1|Overall Study|Lost to Follow-up|6
121792|NCT00586326|412990|P1|Treated Through 5-yr Follow Up-Treated|Other|2
121793|NCT00586326|412990|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
121794|NCT00586326|412990|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
121795|NCT00586326|412990|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
121796|NCT00586326|412990|P1|Treated Through 5-yr Follow Up-Treated|Death|2
121797|NCT00586326|412990|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
121798|NCT00586326|412990|P1|Device Placed toTreatment-ITT|Physician Decision|1
121799|NCT00586326|412990|P1|Device Placed toTreatment-ITT|Positive Margins|3
121800|NCT00586326|412990|P1|Device Placed toTreatment-ITT|Microinvasion|1
121801|NCT00586326|412990|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
121802|NCT00586326|412990|P1|Device Placed toTreatment-ITT|Skin Distance|7
121803|NCT00586326|412990|P1|Enrollment to Device Placement-Enrolled|Other|1
121804|NCT00586326|412990|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
121805|NCT00586326|412990|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
121806|NCT00586326|412990|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
121807|NCT00586326|412990|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
121808|NCT00586326|412990|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
121809|NCT00586313|413001|P1|Overall Study|Lack of Efficacy|2
121810|NCT00586157|413037|P2|Second Intervention|Adverse Event|1
121811|NCT00586157|413038|P1|Second Intervention|Adverse Event|0
121812|NCT00586157|413037|P2|Second Intervention|Worsening behavior|0
121813|NCT00586157|413038|P1|Second Intervention|Worsening behavior|1
121814|NCT00586157|413037|P2|Second Intervention|Withdrawal by Subject|0
121815|NCT00586157|413038|P1|Second Intervention|Withdrawal by Subject|1
121816|NCT00586157|413037|P2|First Intervention|Worsening behavior|0
121817|NCT00586157|413038|P1|First Intervention|Worsening behavior|1
121818|NCT00586105|413048|P1|Overall Study|Reason not reported|1
121819|NCT00586105|413048|P1|Overall Study|Switched to commercial drug|9
121820|NCT00586105|413048|P1|Overall Study|Disease progression|19
121821|NCT00586105|413048|P1|Overall Study|Withdrawal by Subject|3
121822|NCT00586105|413048|P1|Overall Study|Protocol Violation|1
121823|NCT00586105|413048|P1|Overall Study|Death|2
121824|NCT00586105|413048|P1|Overall Study|Adverse Event|4
121825|NCT00585975|413063|P2|Overall Study|Enrollment met/over-enrolled|9
121826|NCT00585975|413064|P1|Overall Study|Enrollment met/over-enrolled|10
121827|NCT00585975|413063|P2|Overall Study|Lost to Follow-up|1
121828|NCT00585975|413064|P1|Overall Study|Lost to Follow-up|2
121829|NCT00585975|413063|P2|Overall Study|Withdrawal by Subject|3
121830|NCT00585975|413064|P1|Overall Study|Withdrawal by Subject|3
121831|NCT00585923|413074|P2|Overall Study|Physician decided not to continue|33
121832|NCT00585923|413075|P1|Overall Study|Physician decided not to continue|31
121833|NCT00585689|413106|P1|Overall Study|Death|1
121834|NCT00585689|413106|P1|Overall Study|Patient had unresectable disease|1
121835|NCT00585689|413106|P1|Overall Study|Patient Declined Surgery|1
121836|NCT00585689|413106|P1|Overall Study|Adverse Event|1
121837|NCT00585689|413106|P1|Overall Study|Received different ABI-007 schedule|3
121838|NCT00585533|413152|P1|Overall Study|objective or symptomatic progression|9
121839|NCT00585468|413161|P2|First Intervention|Withdrawal by Subject|1
121840|NCT00585468|413162|P1|First Intervention|Withdrawal by Subject|1
121841|NCT00585351|413194|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
121842|NCT00585351|413195|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
121843|NCT00585351|413196|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
121844|NCT00585351|413197|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
121845|NCT00585351|413198|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
121846|NCT00585351|413199|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
121847|NCT00585351|413200|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
121848|NCT00585351|413201|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
121849|NCT00585351|413194|P8|Enrollment Period (Intervention)|Death|0
121850|NCT00585351|413195|P7|Enrollment Period (Intervention)|Death|1
121851|NCT00585351|413196|P6|Enrollment Period (Intervention)|Death|0
121852|NCT00585351|413197|P5|Enrollment Period (Intervention)|Death|1
121853|NCT00585351|413198|P4|Enrollment Period (Intervention)|Death|0
121854|NCT00585351|413199|P3|Enrollment Period (Intervention)|Death|0
121855|NCT00585351|413200|P2|Enrollment Period (Intervention)|Death|0
121856|NCT00585351|413201|P1|Enrollment Period (Intervention)|Death|0
121857|NCT00585351|413194|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
121858|NCT00585351|413195|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
121859|NCT00585351|413196|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
121860|NCT00585351|413197|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
121861|NCT00585351|413198|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
121862|NCT00585351|413199|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
121863|NCT00585351|413200|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
121864|NCT00585351|413201|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
121865|NCT00585351|413194|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
121866|NCT00585351|413195|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
121867|NCT00585351|413196|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
121868|NCT00585351|413197|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
121869|NCT00585351|413198|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
121870|NCT00585351|413199|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
121871|NCT00585351|413200|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
121872|NCT00585351|413201|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
121873|NCT00585351|413194|P8|Notification Period (Informed Consent)|No study medication on flight|0
121874|NCT00585351|413195|P7|Notification Period (Informed Consent)|No study medication on flight|0
121875|NCT00585351|413196|P6|Notification Period (Informed Consent)|No study medication on flight|0
121876|NCT00585351|413197|P5|Notification Period (Informed Consent)|No study medication on flight|0
121877|NCT00585351|413198|P4|Notification Period (Informed Consent)|No study medication on flight|0
121878|NCT00585351|413199|P3|Notification Period (Informed Consent)|No study medication on flight|0
121879|NCT00585351|413200|P2|Notification Period (Informed Consent)|No study medication on flight|1
121880|NCT00585351|413201|P1|Notification Period (Informed Consent)|No study medication on flight|0
121881|NCT00585351|413194|P8|Notification Period (Informed Consent)|Flight aborted|0
121882|NCT00585351|413195|P7|Notification Period (Informed Consent)|Flight aborted|0
121883|NCT00585351|413196|P6|Notification Period (Informed Consent)|Flight aborted|0
121884|NCT00585351|413197|P5|Notification Period (Informed Consent)|Flight aborted|0
121885|NCT00585351|413198|P4|Notification Period (Informed Consent)|Flight aborted|0
121886|NCT00585351|413199|P3|Notification Period (Informed Consent)|Flight aborted|0
121887|NCT00585351|413200|P2|Notification Period (Informed Consent)|Flight aborted|1
121888|NCT00585351|413201|P1|Notification Period (Informed Consent)|Flight aborted|2
121889|NCT00585351|413194|P8|Notification Period (Informed Consent)|Physician Decision|0
121890|NCT00585351|413195|P7|Notification Period (Informed Consent)|Physician Decision|0
121891|NCT00585351|413196|P6|Notification Period (Informed Consent)|Physician Decision|0
121892|NCT00585351|413197|P5|Notification Period (Informed Consent)|Physician Decision|0
121893|NCT00585351|413198|P4|Notification Period (Informed Consent)|Physician Decision|0
121894|NCT00585351|413199|P3|Notification Period (Informed Consent)|Physician Decision|0
121895|NCT00585351|413200|P2|Notification Period (Informed Consent)|Physician Decision|2
121896|NCT00585351|413201|P1|Notification Period (Informed Consent)|Physician Decision|0
121897|NCT00585312|413217|P2|Overall Study|Study terminated by the sponsor|31
121898|NCT00585312|413218|P1|Overall Study|Study terminated by the sponsor|34
121899|NCT00585312|413217|P2|Overall Study|Withdrawal by Subject|1
121900|NCT00585312|413218|P1|Overall Study|Withdrawal by Subject|5
121901|NCT00585312|413217|P2|Overall Study|Reason not specified|0
121902|NCT00585312|413218|P1|Overall Study|Reason not specified|2
121903|NCT00585312|413217|P2|Overall Study|Lost to Follow-up|1
121904|NCT00585312|413218|P1|Overall Study|Lost to Follow-up|1
121905|NCT00585312|413217|P2|Overall Study|Lack of Efficacy|11
121906|NCT00585312|413218|P1|Overall Study|Lack of Efficacy|6
121907|NCT00585312|413217|P2|Overall Study|Adverse Event|0
121908|NCT00585312|413218|P1|Overall Study|Adverse Event|3
121909|NCT00585286|413230|P1|Overall Study|Lost to Follow-up|1
121910|NCT00585221|413237|P1|Overall Study|Protocol Violation|8
121911|NCT00585169|413247|P1|Overall Study|Withdrawal by Subject|1
121912|NCT00585039|413259|P2|Overall Study|medication spilled|0
121913|NCT00585039|413260|P1|Overall Study|medication spilled|2
121914|NCT00584987|413289|P4|Overall Study|Adverse Event|1
121915|NCT00584987|413290|P3|Overall Study|Adverse Event|0
121916|NCT00584987|413291|P2|Overall Study|Adverse Event|0
121917|NCT00584987|413292|P1|Overall Study|Adverse Event|0
121918|NCT00584987|413289|P4|Overall Study|Protocol Violation|0
121919|NCT00584987|413290|P3|Overall Study|Protocol Violation|1
121920|NCT00584987|413291|P2|Overall Study|Protocol Violation|1
121921|NCT00584987|413292|P1|Overall Study|Protocol Violation|1
121922|NCT00584909|413326|P1|Overall Study|Adverse Event|4
121923|NCT00584740|413378|P2|Overall Study|Lost to Follow-up|1
121924|NCT00584740|413379|P1|Overall Study|Lost to Follow-up|0
121925|NCT00584740|413378|P2|Overall Study|Withdrawal by Subject|2
121926|NCT00584740|413379|P1|Overall Study|Withdrawal by Subject|3
121927|NCT00584740|413378|P2|Overall Study|Lack of Efficacy|2
121928|NCT00584740|413379|P1|Overall Study|Lack of Efficacy|8
121929|NCT00584740|413378|P2|Overall Study|Adverse Event|1
121930|NCT00584740|413379|P1|Overall Study|Adverse Event|1
121931|NCT00584727|413397|P6|Third Intervention|Protocol Violation|2
121932|NCT00584727|413398|P5|Third Intervention|Protocol Violation|4
121933|NCT00584727|413399|P4|Third Intervention|Protocol Violation|0
121934|NCT00584727|413400|P3|Third Intervention|Protocol Violation|1
121935|NCT00584727|413401|P2|Third Intervention|Protocol Violation|0
121936|NCT00584727|413402|P1|Third Intervention|Protocol Violation|0
121937|NCT00584727|413397|P6|First Intervention|Discontinuation|0
121938|NCT00584727|413398|P5|First Intervention|Discontinuation|0
121939|NCT00584727|413399|P4|First Intervention|Discontinuation|0
121940|NCT00584727|413400|P3|First Intervention|Discontinuation|1
121941|NCT00584727|413401|P2|First Intervention|Discontinuation|0
121942|NCT00584727|413402|P1|First Intervention|Discontinuation|0
121943|NCT00584415|413435|P1|Overall Study|Adverse Event|7
121944|NCT00583947|413455|P2|Cross-over Period|not specified|1
121945|NCT00583947|413456|P1|Cross-over Period|not specified|1
121946|NCT00583947|413455|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
121947|NCT00583947|413456|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
121948|NCT00583947|413455|P2|Cross-over Period|Withdrawal by Subject|0
121949|NCT00583947|413456|P1|Cross-over Period|Withdrawal by Subject|2
121950|NCT00583947|413455|P2|Cross-over Period|Adverse Event|0
121951|NCT00583947|413456|P1|Cross-over Period|Adverse Event|2
121952|NCT00583596|413622|P1|Overall Study|Outside f-up window|26
121953|NCT00583596|413622|P1|Overall Study|Not consented|15
121954|NCT00583596|413622|P1|Overall Study|Data not complete|1
121955|NCT00583596|413622|P1|Overall Study|Lost to Follow-up|94
121956|NCT00583596|413622|P1|Overall Study|Withdrawal by Subject|6
121957|NCT00583596|413622|P1|Overall Study|Death|2
121958|NCT00583596|413622|P1|Overall Study|Excluded due to Hurricane Katrina|30
121959|NCT00583596|413622|P1|Overall Study|Lost to Follow-up|110
121960|NCT00583557|413627|P1|Overall Study|Did not receive belimumab in LBRA99|2
121961|NCT00583557|413627|P1|Overall Study|Other|5
121962|NCT00583557|413627|P1|Overall Study|Lack of Compliance|5
121963|NCT00583557|413627|P1|Overall Study|Lack of Efficacy|31
121964|NCT00583557|413627|P1|Overall Study|Adverse Event|9
121965|NCT00583557|413627|P1|Overall Study|Withdrawal by Subject|18
121966|NCT00583219|413650|P1|Phase 2|Withdrawal by Subject|1
121967|NCT00583115|413667|P1|Overall Study|Death|1
121968|NCT00582972|413672|P1|Overall Study|Protocol Violation|2
121969|NCT00582933|413681|P1|Overall Study|Physician Decision|3
121970|NCT00582907|413685|P4|2nd Course|Lack of Efficacy|0
121971|NCT00582907|413686|P3|2nd Course|Lack of Efficacy|0
121972|NCT00582907|413687|P2|2nd Course|Lack of Efficacy|0
121973|NCT00582907|413688|P1|2nd Course|Lack of Efficacy|1
121974|NCT00582907|413685|P4|1st Course|Lost to Follow-up|1
121975|NCT00582907|413686|P3|1st Course|Lost to Follow-up|0
121976|NCT00582907|413687|P2|1st Course|Lost to Follow-up|0
121977|NCT00582907|413688|P1|1st Course|Lost to Follow-up|0
121978|NCT00582907|413685|P4|1st Course|Withdrawal by Subject|0
121979|NCT00582907|413686|P3|1st Course|Withdrawal by Subject|0
121980|NCT00582907|413687|P2|1st Course|Withdrawal by Subject|0
121981|NCT00582907|413688|P1|1st Course|Withdrawal by Subject|1
121982|NCT00582790|413727|P1|Overall Study|Rapid progression of disease|1
121983|NCT00582738|413736|P2|Overall Study|Withdrawal by Subject|3
121984|NCT00582738|413737|P1|Overall Study|Withdrawal by Subject|0
121985|NCT00582738|413736|P2|Overall Study|Protocol Violation|1
121986|NCT00582738|413737|P1|Overall Study|Protocol Violation|1
121987|NCT00582738|413736|P2|Overall Study|Other|0
121988|NCT00582738|413737|P1|Overall Study|Other|1
121989|NCT00582738|413736|P2|Overall Study|Graft Lost|1
121990|NCT00582738|413737|P1|Overall Study|Graft Lost|0
121991|NCT00582738|413736|P2|Overall Study|Adverse Event|5
121992|NCT00582738|413737|P1|Overall Study|Adverse Event|0
121993|NCT00582738|413736|P2|Overall Study|Administrative Problems|8
121994|NCT00582738|413737|P1|Overall Study|Administrative Problems|7
121995|NCT00582712|413761|P1|Overall Study|Complicating disease requiring treatment|1
121996|NCT00582712|413761|P1|Overall Study|Withdrawal by Subject|1
121997|NCT00582712|413761|P1|Overall Study|Lack of Efficacy|1
121998|NCT00582712|413761|P1|Overall Study|Adverse Event|1
121999|NCT00582556|413779|P3|Overall Study|Physician Decision|1
122000|NCT00582556|413780|P2|Overall Study|Physician Decision|0
122001|NCT00582556|413781|P1|Overall Study|Physician Decision|0
122002|NCT00582556|413779|P3|Overall Study|Withdrawal by Subject|1
122003|NCT00582556|413780|P2|Overall Study|Withdrawal by Subject|1
122004|NCT00582556|413781|P1|Overall Study|Withdrawal by Subject|0
122005|NCT00582491|413809|P2|Overall Study|Withdrawal by Subject|0
122006|NCT00582491|413810|P1|Overall Study|Withdrawal by Subject|1
122007|NCT00582426|413834|P2|Overall Study|Use of illicit drugs|0
122008|NCT00582426|413835|P1|Overall Study|Use of illicit drugs|1
122009|NCT00582426|413834|P2|Overall Study|Disease Progression|2
122010|NCT00582426|413835|P1|Overall Study|Disease Progression|2
122011|NCT00582426|413834|P2|Overall Study|Withdrawal by Subject|2
122012|NCT00582426|413835|P1|Overall Study|Withdrawal by Subject|3
122013|NCT00582426|413834|P2|Overall Study|Death|3
122014|NCT00582426|413835|P1|Overall Study|Death|4
122015|NCT00582426|413834|P2|Overall Study|Protocol Violation|2
122016|NCT00582426|413835|P1|Overall Study|Protocol Violation|6
122017|NCT00582426|413834|P2|Overall Study|Adverse Event|2
122018|NCT00582426|413835|P1|Overall Study|Adverse Event|4
122019|NCT00582426|413834|P2|Overall Study|Lost to Follow-up|2
122020|NCT00582426|413835|P1|Overall Study|Lost to Follow-up|0
122021|NCT00582309|413882|P3|Overall Study|Protocol Violation|2
122022|NCT00582309|413883|P2|Overall Study|Protocol Violation|0
122023|NCT00582309|413884|P1|Overall Study|Protocol Violation|0
122024|NCT00582114|413894|P2|Overall Study|Stopped by data safety monitoring board|20
122025|NCT00582114|413895|P1|Overall Study|Stopped by data safety monitoring board|19
122026|NCT00582114|413894|P2|Overall Study|Physician Decision|6
122027|NCT00582114|413895|P1|Overall Study|Physician Decision|0
122028|NCT00582114|413894|P2|Overall Study|Adverse Event|1
122029|NCT00582114|413895|P1|Overall Study|Adverse Event|1
122030|NCT00582114|413894|P2|Overall Study|Withdrawal by Subject|16
122031|NCT00582114|413895|P1|Overall Study|Withdrawal by Subject|8
122032|NCT00582114|413894|P2|Overall Study|Lost to Follow-up|6
122033|NCT00582114|413895|P1|Overall Study|Lost to Follow-up|7
122034|NCT00582114|413894|P2|Overall Study|Kidney Transplant|1
122035|NCT00582114|413895|P1|Overall Study|Kidney Transplant|3
122036|NCT00582114|413894|P2|Overall Study|Death|4
122037|NCT00582114|413895|P1|Overall Study|Death|4
122038|NCT00582036|413910|P2|Overall Study|Withdrawal by Subject|1
122039|NCT00582036|413911|P1|Overall Study|Withdrawal by Subject|0
122040|NCT00582010|413919|P2|Overall Study|Death|1
122041|NCT00582010|413920|P1|Overall Study|Death|0
122042|NCT00581945|413949|P2|Overall Study|Death|0
122043|NCT00581945|413950|P1|Overall Study|Death|1
122044|NCT00581945|413949|P2|Overall Study|Withdrawal by Subject|6
122045|NCT00581945|413950|P1|Overall Study|Withdrawal by Subject|2
122046|NCT00581945|413949|P2|Overall Study|Unsatisfactory therapeutic effect|0
122047|NCT00581945|413950|P1|Overall Study|Unsatisfactory therapeutic effect|2
122048|NCT00581945|413949|P2|Overall Study|Adverse Event|4
122049|NCT00581945|413950|P1|Overall Study|Adverse Event|4
122050|NCT00581919|413966|P1|Overall Study|Withdrawal by Subject|1
122051|NCT00581919|413966|P1|Overall Study|Started Non-Protocol Therapy|2
122052|NCT00581919|413966|P1|Overall Study|Other Complicating Disease|1
122053|NCT00581919|413966|P1|Overall Study|Physician Decision|1
122054|NCT00581919|413966|P1|Overall Study|Disease Progression|10
122055|NCT00581919|413966|P1|Overall Study|Death|1
122056|NCT00581919|413966|P1|Overall Study|Adverse Event|8
122057|NCT00581828|413985|P1|Overall Study|Protocol Violation|1
122058|NCT00581776|413989|P1|Overall Study|Disease progression or no response|3
122059|NCT00581555|414007|P2|Overall Study|Other reasons|4
122060|NCT00581555|414008|P1|Overall Study|Other reasons|16
122061|NCT00581555|414007|P2|Overall Study|Lost to Follow-up|2
122062|NCT00581555|414008|P1|Overall Study|Lost to Follow-up|2
122063|NCT00581555|414007|P2|Overall Study|Withdrawal by Subject|9
122064|NCT00581555|414008|P1|Overall Study|Withdrawal by Subject|18
122065|NCT00581555|414007|P2|Overall Study|Physician Decision|2
122066|NCT00581555|414008|P1|Overall Study|Physician Decision|3
122067|NCT00581555|414007|P2|Overall Study|Adverse Event|3
122068|NCT00581555|414008|P1|Overall Study|Adverse Event|4
122069|NCT00581542|414032|P2|Overall Study|Lost to Follow-up|21
122070|NCT00581542|414033|P1|Overall Study|Lost to Follow-up|9
122071|NCT00581542|414032|P2|Overall Study|they met an exclusion criteria|2
122072|NCT00581542|414033|P1|Overall Study|they met an exclusion criteria|2
122073|NCT00581360|414085|P1|Overall Study|Withdrawal by Subject|1
122074|NCT00581308|414104|P1|Month 12|Other|3
122075|NCT00581308|414104|P1|Month 12|Device Removed|1
122076|NCT00581308|414104|P1|Month 12|Withdrawal by Subject|2
122077|NCT00581308|414104|P1|Month 12|Lost to Follow-up|14
122078|NCT00581308|414104|P1|Month 12|Death|1
122079|NCT00581308|414104|P1|Month 6|Withdrawal by Subject|4
122080|NCT00581308|414104|P1|Month 6|Lost to Follow-up|1
122081|NCT00581308|414104|P1|Month 1|Device Removed|2
122082|NCT00581308|414104|P1|Month 1|Withdrawal by Subject|3
122083|NCT00581308|414104|P1|Month 1|Lost to Follow-up|4
122084|NCT00581308|414104|P1|Pre Discharge|Device Removed|1
122085|NCT00581308|414104|P1|Pre Discharge|Lost to Follow-up|2
122086|NCT00581113|414136|P2|Overall Study|Withdrawal by Subject|1
122087|NCT00581113|414137|P1|Overall Study|Withdrawal by Subject|0
122088|NCT00581100|414147|P2|Overall Study|Unspecified|0
122089|NCT00581100|414148|P1|Overall Study|Unspecified|3
122090|NCT00581100|414147|P2|Overall Study|Withdrawal by Subject|4
122091|NCT00581100|414148|P1|Overall Study|Withdrawal by Subject|1
122092|NCT00581100|414147|P2|Overall Study|Adverse Event|1
122093|NCT00581100|414148|P1|Overall Study|Adverse Event|2
122094|NCT00581100|414147|P2|Overall Study|Death|0
122095|NCT00581100|414148|P1|Overall Study|Death|1
122096|NCT00580983|414190|P1|Overall Study|Did not complete 12 mon post RT studies|7
122097|NCT00580970|414197|P1|Treatment (Lovastatin)|Death|1
122098|NCT00580970|414197|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
122099|NCT00580970|414197|P1|Treatment (Lovastatin)|Physician Decision|4
122100|NCT00580970|414197|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
122101|NCT00580970|414197|P1|Treatment (Lovastatin)|Non-compliance|6
122102|NCT00580970|414197|P1|Pre-treatment|Non-compliance|1
122103|NCT00580866|414212|P2|Overall Study|Lost to Follow-up|2
122104|NCT00580866|414213|P1|Overall Study|Lost to Follow-up|2
122105|NCT00580840|414221|P4|Double-Blind|Other: Forbidden Medication|0
122106|NCT00580840|414222|P3|Double-Blind|Other: Forbidden Medication|1
122107|NCT00580840|414223|P2|Double-Blind|Other: Forbidden Medication|0
122108|NCT00580840|414224|P1|Double-Blind|Other: Forbidden Medication|0
122109|NCT00580840|414221|P4|Double-Blind|Other: Discontinued Methotrexate|0
122110|NCT00580840|414222|P3|Double-Blind|Other: Discontinued Methotrexate|0
122111|NCT00580840|414223|P2|Double-Blind|Other: Discontinued Methotrexate|1
122112|NCT00580840|414224|P1|Double-Blind|Other: Discontinued Methotrexate|0
122113|NCT00580840|414221|P4|Double-Blind|Withdrawal by Subject|2
122114|NCT00580840|414222|P3|Double-Blind|Withdrawal by Subject|2
122115|NCT00580840|414223|P2|Double-Blind|Withdrawal by Subject|1
122116|NCT00580840|414224|P1|Double-Blind|Withdrawal by Subject|0
122117|NCT00580840|414221|P4|Double-Blind|Lost to Follow-up|2
122118|NCT00580840|414222|P3|Double-Blind|Lost to Follow-up|0
122119|NCT00580840|414223|P2|Double-Blind|Lost to Follow-up|1
122120|NCT00580840|414224|P1|Double-Blind|Lost to Follow-up|0
122121|NCT00580840|414221|P4|Double-Blind|Loss of Efficacy|10
122122|NCT00580840|414222|P3|Double-Blind|Loss of Efficacy|2
122123|NCT00580840|414223|P2|Double-Blind|Loss of Efficacy|1
122124|NCT00580840|414224|P1|Double-Blind|Loss of Efficacy|0
122125|NCT00580840|414221|P4|Double-Blind|Adverse Event|1
122126|NCT00580840|414222|P3|Double-Blind|Adverse Event|4
122127|NCT00580840|414223|P2|Double-Blind|Adverse Event|3
122128|NCT00580840|414224|P1|Double-Blind|Adverse Event|0
122129|NCT00580840|414221|P4|Run-in|Other: Exclusionary Lab Value|0
122130|NCT00580840|414222|P3|Run-in|Other: Exclusionary Lab Value|0
122131|NCT00580840|414223|P2|Run-in|Other: Exclusionary Lab Value|0
122132|NCT00580840|414224|P1|Run-in|Other: Exclusionary Lab Value|1
122133|NCT00580840|414221|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
122134|NCT00580840|414222|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
122135|NCT00580840|414223|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
122136|NCT00580840|414224|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
122137|NCT00580840|414221|P4|Run-in|Other: Per Sponsor Request|0
122138|NCT00580840|414222|P3|Run-in|Other: Per Sponsor Request|0
122139|NCT00580840|414223|P2|Run-in|Other: Per Sponsor Request|0
122140|NCT00580840|414224|P1|Run-in|Other: Per Sponsor Request|2
122141|NCT00580840|414221|P4|Run-in|Withdrawal by Subject|0
122142|NCT00580840|414222|P3|Run-in|Withdrawal by Subject|0
122143|NCT00580840|414223|P2|Run-in|Withdrawal by Subject|0
122144|NCT00580840|414224|P1|Run-in|Withdrawal by Subject|5
122145|NCT00580840|414221|P4|Run-in|Lost to Follow-up|0
122146|NCT00580840|414222|P3|Run-in|Lost to Follow-up|0
122147|NCT00580840|414223|P2|Run-in|Lost to Follow-up|0
122148|NCT00580840|414224|P1|Run-in|Lost to Follow-up|4
122149|NCT00580840|414221|P4|Run-in|Loss of Efficacy|0
122150|NCT00580840|414222|P3|Run-in|Loss of Efficacy|0
122151|NCT00580840|414223|P2|Run-in|Loss of Efficacy|0
122152|NCT00580840|414224|P1|Run-in|Loss of Efficacy|1
122153|NCT00580840|414221|P4|Run-in|Lack of Efficacy|0
122154|NCT00580840|414222|P3|Run-in|Lack of Efficacy|0
122155|NCT00580840|414223|P2|Run-in|Lack of Efficacy|0
122156|NCT00580840|414224|P1|Run-in|Lack of Efficacy|93
122157|NCT00580840|414221|P4|Run-in|Adverse Event|0
122158|NCT00580840|414222|P3|Run-in|Adverse Event|0
122159|NCT00580840|414223|P2|Run-in|Adverse Event|0
122160|NCT00580840|414224|P1|Run-in|Adverse Event|17
122161|NCT00580801|414332|P3|Overall Study|Travel|0
122162|NCT00580801|414333|P2|Overall Study|Travel|0
122163|NCT00580801|414334|P1|Overall Study|Travel|1
122164|NCT00580801|414332|P3|Overall Study|Participant non-compliant|1
122165|NCT00580801|414333|P2|Overall Study|Participant non-compliant|0
122166|NCT00580801|414334|P1|Overall Study|Participant non-compliant|0
122167|NCT00580801|414332|P3|Overall Study|Reached a virologic endpoint|2
122168|NCT00580801|414333|P2|Overall Study|Reached a virologic endpoint|1
122169|NCT00580801|414334|P1|Overall Study|Reached a virologic endpoint|0
122170|NCT00580801|414332|P3|Overall Study|Lost to Follow-up|0
122171|NCT00580801|414333|P2|Overall Study|Lost to Follow-up|0
122172|NCT00580801|414334|P1|Overall Study|Lost to Follow-up|2
122173|NCT00580801|414332|P3|Overall Study|Adverse Event|0
122174|NCT00580801|414333|P2|Overall Study|Adverse Event|0
122175|NCT00580801|414334|P1|Overall Study|Adverse Event|2
122176|NCT00580801|414332|P3|Overall Study|Physician Decision|0
122177|NCT00580801|414333|P2|Overall Study|Physician Decision|0
122178|NCT00580801|414334|P1|Overall Study|Physician Decision|1
122179|NCT00580788|414373|P4|Overall Study|Adverse Event|1
122180|NCT00580788|414374|P3|Overall Study|Adverse Event|0
122181|NCT00580788|414375|P2|Overall Study|Adverse Event|0
122182|NCT00580788|414376|P1|Overall Study|Adverse Event|0
122183|NCT00580723|414434|P1|Overall Study|Lost to Follow-up|5
122184|NCT00580723|414434|P1|Overall Study|Did not want to participate in extension|3
122185|NCT00580606|414461|P2|Open Label (OL)|Needed Prohibited Medication|1
122186|NCT00580606|414462|P1|Open Label (OL)|Needed Prohibited Medication|0
122187|NCT00580606|414461|P2|Open Label (OL)|Physician Decision|1
122188|NCT00580606|414462|P1|Open Label (OL)|Physician Decision|1
122189|NCT00580606|414461|P2|Open Label (OL)|Non-compliance|0
122190|NCT00580606|414462|P1|Open Label (OL)|Non-compliance|2
122191|NCT00580606|414461|P2|Open Label (OL)|Pregnancy|1
122192|NCT00580606|414462|P1|Open Label (OL)|Pregnancy|0
122193|NCT00580606|414461|P2|Open Label (OL)|Lost to Follow-up|1
122194|NCT00580606|414462|P1|Open Label (OL)|Lost to Follow-up|0
122195|NCT00580606|414461|P2|Open Label (OL)|Dosing Symptoms|1
122196|NCT00580606|414462|P1|Open Label (OL)|Dosing Symptoms|0
122197|NCT00580606|414461|P2|Open Label (OL)|Withdrawal by Subject|6
122198|NCT00580606|414462|P1|Open Label (OL)|Withdrawal by Subject|4
122199|NCT00580606|414461|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
122200|NCT00580606|414462|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
122201|NCT00580034|414525|P2|Overall Study|Toxicity|0
122202|NCT00580034|414526|P1|Overall Study|Toxicity|10
122203|NCT00579982|414532|P1|Overall Study|Protocol Violation|4
122204|NCT00579982|414532|P1|Overall Study|Adverse Event|4
122205|NCT00579670|414565|P5|Overall Study|Withdrawal by Subject|0
122206|NCT00579670|414566|P4|Overall Study|Withdrawal by Subject|0
122207|NCT00579670|414567|P3|Overall Study|Withdrawal by Subject|1
122208|NCT00579670|414568|P2|Overall Study|Withdrawal by Subject|0
122209|NCT00579670|414569|P1|Overall Study|Withdrawal by Subject|0
122210|NCT00579670|414565|P5|Overall Study|Other|0
122211|NCT00579670|414566|P4|Overall Study|Other|2
122212|NCT00579670|414567|P3|Overall Study|Other|1
122213|NCT00579670|414568|P2|Overall Study|Other|0
122214|NCT00579670|414569|P1|Overall Study|Other|0
122215|NCT00579670|414565|P5|Overall Study|Lost to Follow-up|0
122216|NCT00579670|414566|P4|Overall Study|Lost to Follow-up|4
122217|NCT00579670|414567|P3|Overall Study|Lost to Follow-up|0
122218|NCT00579670|414568|P2|Overall Study|Lost to Follow-up|1
122219|NCT00579670|414569|P1|Overall Study|Lost to Follow-up|0
122220|NCT00579670|414565|P5|Overall Study|Lack of Efficacy|0
122221|NCT00579670|414566|P4|Overall Study|Lack of Efficacy|14
122222|NCT00579670|414567|P3|Overall Study|Lack of Efficacy|1
122223|NCT00579670|414568|P2|Overall Study|Lack of Efficacy|0
122224|NCT00579670|414569|P1|Overall Study|Lack of Efficacy|0
122225|NCT00579670|414565|P5|Overall Study|Adverse Event|0
122226|NCT00579670|414566|P4|Overall Study|Adverse Event|2
122227|NCT00579670|414567|P3|Overall Study|Adverse Event|1
122228|NCT00579670|414568|P2|Overall Study|Adverse Event|0
122229|NCT00579670|414569|P1|Overall Study|Adverse Event|1
122230|NCT00579670|414565|P5|Overall Study|Death|0
122231|NCT00579670|414566|P4|Overall Study|Death|0
122232|NCT00579670|414567|P3|Overall Study|Death|0
122233|NCT00579670|414568|P2|Overall Study|Death|0
122234|NCT00579670|414569|P1|Overall Study|Death|1
122235|NCT00579501|414781|P1|Overall Study|Radiation therapy before surgery|1
122236|NCT00579501|414781|P1|Overall Study|Secondary lesion|1
122237|NCT00579501|414781|P1|Overall Study|toxicity|1
122238|NCT00579501|414781|P1|Overall Study|End of neoadjuvant therapy|25
122239|NCT00579501|414781|P1|Overall Study|Death|1
122240|NCT00579345|414794|P8|Overall Study|Death|0
122241|NCT00579345|414795|P7|Overall Study|Death|0
122242|NCT00579345|414796|P6|Overall Study|Death|0
122243|NCT00579345|414797|P5|Overall Study|Death|0
122244|NCT00579345|414798|P4|Overall Study|Death|1
122245|NCT00579345|414799|P3|Overall Study|Death|1
122246|NCT00579345|414800|P2|Overall Study|Death|1
122247|NCT00579345|414801|P1|Overall Study|Death|1
122248|NCT00579345|414794|P8|Overall Study|Protocol Violation|1
122249|NCT00579345|414795|P7|Overall Study|Protocol Violation|0
122250|NCT00579345|414796|P6|Overall Study|Protocol Violation|0
122251|NCT00579345|414797|P5|Overall Study|Protocol Violation|0
122252|NCT00579345|414798|P4|Overall Study|Protocol Violation|0
122253|NCT00579345|414799|P3|Overall Study|Protocol Violation|0
122254|NCT00579345|414800|P2|Overall Study|Protocol Violation|0
122255|NCT00579345|414801|P1|Overall Study|Protocol Violation|1
122256|NCT00579345|414794|P8|Overall Study|Adverse Event|0
122257|NCT00579345|414795|P7|Overall Study|Adverse Event|0
122258|NCT00579345|414796|P6|Overall Study|Adverse Event|0
122259|NCT00579345|414797|P5|Overall Study|Adverse Event|0
122260|NCT00579345|414798|P4|Overall Study|Adverse Event|0
122261|NCT00579345|414799|P3|Overall Study|Adverse Event|1
122262|NCT00579345|414800|P2|Overall Study|Adverse Event|0
122263|NCT00579345|414801|P1|Overall Study|Adverse Event|0
122264|NCT00579345|414794|P8|Overall Study|Lost to Follow-up|0
122265|NCT00579345|414795|P7|Overall Study|Lost to Follow-up|0
122266|NCT00579345|414796|P6|Overall Study|Lost to Follow-up|0
122267|NCT00579345|414797|P5|Overall Study|Lost to Follow-up|0
122268|NCT00579345|414798|P4|Overall Study|Lost to Follow-up|0
122269|NCT00579345|414799|P3|Overall Study|Lost to Follow-up|0
122270|NCT00579345|414800|P2|Overall Study|Lost to Follow-up|0
122271|NCT00579345|414801|P1|Overall Study|Lost to Follow-up|1
122272|NCT00579345|414794|P8|Overall Study|Withdrawal by Subject|1
122273|NCT00579345|414795|P7|Overall Study|Withdrawal by Subject|0
122274|NCT00579345|414796|P6|Overall Study|Withdrawal by Subject|0
122275|NCT00579345|414797|P5|Overall Study|Withdrawal by Subject|0
122276|NCT00579345|414798|P4|Overall Study|Withdrawal by Subject|0
122277|NCT00579345|414799|P3|Overall Study|Withdrawal by Subject|0
122278|NCT00579345|414800|P2|Overall Study|Withdrawal by Subject|0
122279|NCT00579345|414801|P1|Overall Study|Withdrawal by Subject|2
122280|NCT00579254|414833|P1|Overall Study|Discontinued when study terminated|73
122281|NCT00579254|414833|P1|Overall Study|Lost to Follow-up|39
122282|NCT00579098|414857|P2|Overall Study|AF returned after ablation|2
122283|NCT00579098|414858|P1|Overall Study|AF returned after ablation|3
122284|NCT00579098|414857|P2|Overall Study|Withdrawal by Subject|3
122285|NCT00579098|414858|P1|Overall Study|Withdrawal by Subject|2
122286|NCT00579098|414857|P2|Overall Study|Adverse Event|3
122287|NCT00579098|414858|P1|Overall Study|Adverse Event|2
122288|NCT00579098|414857|P2|Overall Study|Lost to Follow-up|0
122289|NCT00579098|414858|P1|Overall Study|Lost to Follow-up|2
122290|NCT00579059|414874|P2|Overall Study|Study Canceled at 1 Year|10
122291|NCT00579059|414875|P1|Overall Study|Study Canceled at 1 Year|21
122292|NCT00578942|414949|P1|Overall Study|Lost to Follow-up|1
122293|NCT00578864|414988|P2|Overall Study|Death|0
122294|NCT00578864|414989|P1|Overall Study|Death|1
122295|NCT00578812|415005|P2|Overall Study|Not treated|7
122296|NCT00578812|415006|P1|Overall Study|Not treated|6
122297|NCT00578786|415045|P3|Overall Study|Qualified but Not Enrolled in Extension|0
122298|NCT00578786|415046|P2|Overall Study|Qualified but Not Enrolled in Extension|3
122299|NCT00578786|415047|P1|Overall Study|Qualified but Not Enrolled in Extension|0
122300|NCT00578786|415045|P3|Overall Study|Not Otherwise Specified|1
122301|NCT00578786|415046|P2|Overall Study|Not Otherwise Specified|4
122302|NCT00578786|415047|P1|Overall Study|Not Otherwise Specified|0
122303|NCT00578786|415045|P3|Overall Study|Pregnancy|0
122304|NCT00578786|415046|P2|Overall Study|Pregnancy|1
122305|NCT00578786|415047|P1|Overall Study|Pregnancy|0
122306|NCT00578786|415045|P3|Overall Study|Lost to Follow-up|0
122307|NCT00578786|415046|P2|Overall Study|Lost to Follow-up|4
122308|NCT00578786|415047|P1|Overall Study|Lost to Follow-up|0
122309|NCT00578786|415045|P3|Overall Study|Sponsor Decision|1
122310|NCT00578786|415046|P2|Overall Study|Sponsor Decision|0
122311|NCT00578786|415047|P1|Overall Study|Sponsor Decision|0
122312|NCT00578786|415045|P3|Overall Study|Physician Decision|1
122313|NCT00578786|415046|P2|Overall Study|Physician Decision|0
122314|NCT00578786|415047|P1|Overall Study|Physician Decision|1
122315|NCT00578786|415045|P3|Overall Study|Protocol Violation|1
122316|NCT00578786|415046|P2|Overall Study|Protocol Violation|3
122317|NCT00578786|415047|P1|Overall Study|Protocol Violation|0
122318|NCT00578786|415045|P3|Overall Study|Withdrawal by Subject|5
122319|NCT00578786|415046|P2|Overall Study|Withdrawal by Subject|8
122320|NCT00578786|415047|P1|Overall Study|Withdrawal by Subject|7
122321|NCT00578786|415045|P3|Overall Study|Early Escape from Prior Study|2
122322|NCT00578786|415046|P2|Overall Study|Early Escape from Prior Study|1
122323|NCT00578786|415047|P1|Overall Study|Early Escape from Prior Study|2
122324|NCT00578786|415045|P3|Overall Study|Lack of Efficacy|2
122325|NCT00578786|415046|P2|Overall Study|Lack of Efficacy|5
122326|NCT00578786|415047|P1|Overall Study|Lack of Efficacy|2
122327|NCT00578786|415045|P3|Overall Study|Adverse Event|17
122328|NCT00578786|415046|P2|Overall Study|Adverse Event|37
122329|NCT00578786|415047|P1|Overall Study|Adverse Event|27
122330|NCT00578565|415146|P1|Overall Study|Adverse Event|3
122331|NCT00578448|415176|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
122332|NCT00578448|415176|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
122333|NCT00578448|415176|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
122334|NCT00578448|415176|P1|Day 1 up to 3 Years of Planned Study|Death|1
122335|NCT00578318|415240|P2|Overall Study|Physician Decision|0
122336|NCT00578318|415241|P1|Overall Study|Physician Decision|1
122337|NCT00578318|415240|P2|Overall Study|Lost to Follow-up|0
122338|NCT00578318|415241|P1|Overall Study|Lost to Follow-up|2
122339|NCT00578227|415323|P3|Overall Study|Withdrawal by Subject|3
122340|NCT00578227|415324|P2|Overall Study|Withdrawal by Subject|1
122341|NCT00578227|415325|P1|Overall Study|Withdrawal by Subject|5
122342|NCT00578227|415323|P3|Overall Study|Lost to Follow-up|1
122343|NCT00578227|415324|P2|Overall Study|Lost to Follow-up|1
122344|NCT00578227|415325|P1|Overall Study|Lost to Follow-up|0
122345|NCT00578136|415531|P2|Overall Study|Not given intervention|1
122346|NCT00578136|415532|P1|Overall Study|Not given intervention|1
122347|NCT00577889|415550|P3|Overall Study|Withdrawal by Subject|0
122348|NCT00577889|415551|P2|Overall Study|Withdrawal by Subject|0
122349|NCT00577889|415552|P1|Overall Study|Withdrawal by Subject|1
122350|NCT00577863|415571|P2|Overall Study|Did Not Receive at Least One Injection|1
122351|NCT00577863|415572|P1|Overall Study|Did Not Receive at Least One Injection|0
122352|NCT00577863|415571|P2|Overall Study|Sponsor Decision|7
122353|NCT00577863|415572|P1|Overall Study|Sponsor Decision|2
122354|NCT00577863|415571|P2|Overall Study|Withdrawal by Subject|2
122355|NCT00577863|415572|P1|Overall Study|Withdrawal by Subject|0
122356|NCT00577863|415571|P2|Overall Study|Entry Criteria Exclusion|0
122357|NCT00577863|415572|P1|Overall Study|Entry Criteria Exclusion|1
122358|NCT00577863|415571|P2|Overall Study|Lost to Follow-up|2
122359|NCT00577863|415572|P1|Overall Study|Lost to Follow-up|2
122360|NCT00577863|415571|P2|Overall Study|Death|0
122361|NCT00577863|415572|P1|Overall Study|Death|1
122362|NCT00577863|415571|P2|Overall Study|Adverse Event|2
122363|NCT00577863|415572|P1|Overall Study|Adverse Event|4
122364|NCT00577824|415614|P3|Overall Study|Protocol Violation|0
122365|NCT00577824|415615|P2|Overall Study|Protocol Violation|1
122366|NCT00577824|415616|P1|Overall Study|Protocol Violation|1
122367|NCT00577824|415614|P3|Overall Study|Patient decision|1
122368|NCT00577824|415615|P2|Overall Study|Patient decision|1
122369|NCT00577824|415616|P1|Overall Study|Patient decision|0
122370|NCT00577824|415614|P3|Overall Study|Adverse Event|1
122371|NCT00577824|415615|P2|Overall Study|Adverse Event|18
122372|NCT00577824|415616|P1|Overall Study|Adverse Event|6
122373|NCT00577772|415674|P2|Overall Study|Lost to Follow-up|1
122374|NCT00577772|415675|P1|Overall Study|Lost to Follow-up|0
122375|NCT00577720|415685|P4|Overall Study|Withdrawal by Subject|2
122376|NCT00577720|415686|P3|Overall Study|Withdrawal by Subject|0
122377|NCT00577720|415687|P2|Overall Study|Withdrawal by Subject|0
122378|NCT00577720|415688|P1|Overall Study|Withdrawal by Subject|2
122379|NCT00577720|415685|P4|Overall Study|Protocol Violation|1
122380|NCT00577720|415686|P3|Overall Study|Protocol Violation|0
122381|NCT00577720|415687|P2|Overall Study|Protocol Violation|0
122382|NCT00577720|415688|P1|Overall Study|Protocol Violation|0
122383|NCT00577720|415685|P4|Overall Study|Lost to Follow-up|0
122384|NCT00577720|415686|P3|Overall Study|Lost to Follow-up|1
122385|NCT00577720|415687|P2|Overall Study|Lost to Follow-up|0
122386|NCT00577720|415688|P1|Overall Study|Lost to Follow-up|0
122387|NCT00577720|415685|P4|Overall Study|Adverse Event|4
122388|NCT00577720|415686|P3|Overall Study|Adverse Event|0
122389|NCT00577720|415687|P2|Overall Study|Adverse Event|1
122390|NCT00577720|415688|P1|Overall Study|Adverse Event|2
122391|NCT00577707|415706|P1|Overall Study|Withdrawal by Subject|3
122392|NCT00577655|415712|P2|Overall Study|Lost to Follow-up|1
122393|NCT00577655|415713|P1|Overall Study|Lost to Follow-up|1
122394|NCT00577655|415712|P2|Overall Study|Protocol Violation|1
122395|NCT00577655|415713|P1|Overall Study|Protocol Violation|0
122396|NCT00577655|415712|P2|Overall Study|Patient Request|2
122397|NCT00577655|415713|P1|Overall Study|Patient Request|0
122398|NCT00577629|415751|P1|Overall Study|Withdrawal by Subject|1
122399|NCT00577473|415762|P2|Overall Study|Lack of Efficacy|7
122400|NCT00577473|415763|P1|Overall Study|Lack of Efficacy|8
122401|NCT00577473|415762|P2|Overall Study|Physician Decision|2
122402|NCT00577473|415763|P1|Overall Study|Physician Decision|2
122403|NCT00577473|415762|P2|Overall Study|Withdrawal by Subject|6
122404|NCT00577473|415763|P1|Overall Study|Withdrawal by Subject|2
122405|NCT00577473|415762|P2|Overall Study|Adverse Event|5
122406|NCT00577473|415763|P1|Overall Study|Adverse Event|8
122407|NCT00577473|415762|P2|Overall Study|Protocol Violation|4
122408|NCT00577473|415763|P1|Overall Study|Protocol Violation|1
122409|NCT00577460|415794|P3|Overall Study|not specified|2
122410|NCT00577460|415795|P2|Overall Study|not specified|3
122411|NCT00577460|415796|P1|Overall Study|not specified|0
122412|NCT00577460|415794|P3|Overall Study|Withdrawal by Subject|6
122413|NCT00577460|415795|P2|Overall Study|Withdrawal by Subject|5
122414|NCT00577460|415796|P1|Overall Study|Withdrawal by Subject|5
122415|NCT00577460|415794|P3|Overall Study|Lost to Follow-up|4
122416|NCT00577460|415795|P2|Overall Study|Lost to Follow-up|3
122417|NCT00577460|415796|P1|Overall Study|Lost to Follow-up|0
122418|NCT00577460|415794|P3|Overall Study|Protocol Violation|1
122419|NCT00577460|415795|P2|Overall Study|Protocol Violation|1
122420|NCT00577460|415796|P1|Overall Study|Protocol Violation|0
122421|NCT00577460|415794|P3|Overall Study|Adverse Event|14
122422|NCT00577460|415795|P2|Overall Study|Adverse Event|7
122423|NCT00577460|415796|P1|Overall Study|Adverse Event|11
122424|NCT00577395|415905|P2|Overall Study|Study was terminated early by Sponsor|6
122425|NCT00577395|415906|P1|Overall Study|Study was terminated early by Sponsor|7
122426|NCT00577382|415916|P2|Overall Study|Lost to Follow-up|2
122427|NCT00577382|415917|P1|Overall Study|Lost to Follow-up|2
122428|NCT00577382|415916|P2|Overall Study|Death|1
122429|NCT00577382|415917|P1|Overall Study|Death|1
122430|NCT00577382|415916|P2|Overall Study|Intercurrent Illness|2
122431|NCT00577382|415917|P1|Overall Study|Intercurrent Illness|1
122432|NCT00577382|415916|P2|Overall Study|Progressive Disease|19
122433|NCT00577382|415917|P1|Overall Study|Progressive Disease|17
122434|NCT00577382|415916|P2|Overall Study|Withdrawal by Subject|1
122435|NCT00577382|415917|P1|Overall Study|Withdrawal by Subject|0
122436|NCT00577382|415916|P2|Overall Study|Adverse Event|6
122437|NCT00577382|415917|P1|Overall Study|Adverse Event|0
122438|NCT00577122|416060|P2|Overall Study|Alternative Therapy|1
122439|NCT00577122|416061|P1|Overall Study|Alternative Therapy|0
122440|NCT00577122|416060|P2|Overall Study|Prog, refract disease during active trt|5
122441|NCT00577122|416061|P1|Overall Study|Prog, refract disease during active trt|8
122442|NCT00577122|416060|P2|Overall Study|Progression, relapse during active trt|8
122443|NCT00577122|416061|P1|Overall Study|Progression, relapse during active trt|6
122444|NCT00577122|416060|P2|Overall Study|Adverse Event|2
122445|NCT00577122|416061|P1|Overall Study|Adverse Event|0
122446|NCT00577096|416075|P2|Short Term Participation|Death|1
122447|NCT00577096|416076|P1|Short Term Participation|Death|1
122448|NCT00577096|416075|P2|Short Term Participation|Withdrawal by Subject|5
122449|NCT00577096|416076|P1|Short Term Participation|Withdrawal by Subject|3
122450|NCT00577096|416075|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
122451|NCT00577096|416076|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
122452|NCT00577031|416109|P1|Overall Study|Death|6
122453|NCT00577031|416109|P1|Overall Study|Medical decision|14
122454|NCT00577031|416109|P1|Overall Study|Need for surgery|17
122455|NCT00577031|416109|P1|Overall Study|Participant non-compliance|5
122456|NCT00577031|416109|P1|Overall Study|Participant withdrew consent|13
122457|NCT00577031|416109|P1|Overall Study|Protocol Violation|5
122458|NCT00577031|416109|P1|Overall Study|Progression of disease|93
122459|NCT00577031|416109|P1|Overall Study|Adverse Event|52
122460|NCT00576927|416130|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
122461|NCT00576927|416130|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
122462|NCT00576927|416130|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
122463|NCT00576927|416130|P1|Sleep Hygiene Behavioral Intervention|Death|1
122464|NCT00576927|416130|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
122465|NCT00576927|416130|P1|Baseline|Withdrawal by Subject|3
122466|NCT00576927|416130|P1|Baseline|Medication Change by PCP of subject|1
122467|NCT00576927|416130|P1|Baseline|Physician Decision|9
122468|NCT00576927|416130|P1|Clinical Assessment|Physician Decision|1
122469|NCT00576927|416130|P1|Clinical Assessment|Withdrawal by Subject|10
122470|NCT00576927|416130|P1|Clinical Assessment|Death|1
122471|NCT00576927|416130|P1|Clinical Assessment|Lack of Efficacy|24
122472|NCT00576901|416142|P1|Overall Study|Protocol Violation|1
122473|NCT00576901|416142|P1|Overall Study|Disease course|1
122474|NCT00576901|416142|P1|Overall Study|Withdrawal by Subject|1
122475|NCT00576823|416153|P3|40-week Safety Extension Phase|Lack of Efficacy|0
122476|NCT00576823|416154|P2|40-week Safety Extension Phase|Lack of Efficacy|0
122477|NCT00576823|416155|P1|40-week Safety Extension Phase|Lack of Efficacy|1
122478|NCT00576823|416153|P3|12-week Efficacy Phase|Parentʼs schedule issue|0
122479|NCT00576823|416154|P2|12-week Efficacy Phase|Parentʼs schedule issue|0
122480|NCT00576823|416155|P1|12-week Efficacy Phase|Parentʼs schedule issue|1
122481|NCT00576758|416171|P2|Follow-up Period|Withdrew consent|1
122482|NCT00576758|416172|P1|Follow-up Period|Withdrew consent|2
122483|NCT00576758|416171|P2|Follow-up Period|Insufficient therapeutic response|5
122484|NCT00576758|416172|P1|Follow-up Period|Insufficient therapeutic response|16
122485|NCT00576758|416171|P2|Follow-up Period|Death|3
122486|NCT00576758|416172|P1|Follow-up Period|Death|3
122487|NCT00576758|416171|P2|Follow-up Period|Administrative/Other|8
122488|NCT00576758|416172|P1|Follow-up Period|Administrative/Other|6
122489|NCT00576758|416171|P2|Extension Treatment Period|Administrative/Other|1
122490|NCT00576758|416172|P1|Extension Treatment Period|Administrative/Other|3
122491|NCT00576758|416171|P2|Extension Treatment Period|Insufficient therapeutic response|33
122492|NCT00576758|416172|P1|Extension Treatment Period|Insufficient therapeutic response|30
122493|NCT00576758|416171|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
122494|NCT00576758|416172|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
122495|NCT00576758|416171|P2|Extension Treatment Period|Death|1
122496|NCT00576758|416172|P1|Extension Treatment Period|Death|1
122497|NCT00576758|416171|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
122498|NCT00576758|416172|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
122499|NCT00576758|416171|P2|Induction Treatment Period|Withdrew consent|0
122500|NCT00576758|416172|P1|Induction Treatment Period|Withdrew consent|1
122501|NCT00576758|416171|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
122502|NCT00576758|416172|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
122503|NCT00576758|416171|P2|Induction Treatment Period|Death|0
122504|NCT00576758|416172|P1|Induction Treatment Period|Death|1
122505|NCT00576758|416171|P2|Induction Treatment Period|Violation of selection criteria at entry|1
122506|NCT00576758|416172|P1|Induction Treatment Period|Violation of selection criteria at entry|1
122507|NCT00576758|416171|P2|Induction Treatment Period|Insufficient therapeutic response|0
122508|NCT00576758|416172|P1|Induction Treatment Period|Insufficient therapeutic response|2
122509|NCT00576758|416171|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
122510|NCT00576758|416172|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
122511|NCT00576732|416218|P6|OPEN LABEL|Protocol Violation|0
122512|NCT00576732|416219|P5|OPEN LABEL|Protocol Violation|1
122513|NCT00576732|416220|P4|OPEN LABEL|Protocol Violation|2
122514|NCT00576732|416221|P3|OPEN LABEL|Protocol Violation|0
122515|NCT00576732|416222|P2|OPEN LABEL|Protocol Violation|0
122516|NCT00576732|416223|P1|OPEN LABEL|Protocol Violation|0
122517|NCT00576732|416218|P6|OPEN LABEL|Lack of Efficacy|3
122518|NCT00576732|416219|P5|OPEN LABEL|Lack of Efficacy|2
122519|NCT00576732|416220|P4|OPEN LABEL|Lack of Efficacy|2
122520|NCT00576732|416221|P3|OPEN LABEL|Lack of Efficacy|0
122521|NCT00576732|416222|P2|OPEN LABEL|Lack of Efficacy|0
122522|NCT00576732|416223|P1|OPEN LABEL|Lack of Efficacy|0
122523|NCT00576732|416218|P6|OPEN LABEL|OTHER|2
122524|NCT00576732|416219|P5|OPEN LABEL|OTHER|0
122525|NCT00576732|416220|P4|OPEN LABEL|OTHER|0
122526|NCT00576732|416221|P3|OPEN LABEL|OTHER|0
122527|NCT00576732|416222|P2|OPEN LABEL|OTHER|0
122528|NCT00576732|416223|P1|OPEN LABEL|OTHER|0
122529|NCT00576732|416218|P6|OPEN LABEL|Withdrawal by Subject|1
122530|NCT00576732|416219|P5|OPEN LABEL|Withdrawal by Subject|0
122531|NCT00576732|416220|P4|OPEN LABEL|Withdrawal by Subject|1
122532|NCT00576732|416221|P3|OPEN LABEL|Withdrawal by Subject|0
122533|NCT00576732|416222|P2|OPEN LABEL|Withdrawal by Subject|0
122534|NCT00576732|416223|P1|OPEN LABEL|Withdrawal by Subject|0
122535|NCT00576732|416218|P6|OPEN LABEL|Lost to Follow-up|1
122536|NCT00576732|416219|P5|OPEN LABEL|Lost to Follow-up|1
122537|NCT00576732|416220|P4|OPEN LABEL|Lost to Follow-up|2
122538|NCT00576732|416221|P3|OPEN LABEL|Lost to Follow-up|0
122539|NCT00576732|416222|P2|OPEN LABEL|Lost to Follow-up|0
122540|NCT00576732|416223|P1|OPEN LABEL|Lost to Follow-up|0
122541|NCT00576732|416218|P6|OPEN LABEL|Adverse Event|1
122542|NCT00576732|416219|P5|OPEN LABEL|Adverse Event|0
122543|NCT00576732|416220|P4|OPEN LABEL|Adverse Event|4
122544|NCT00576732|416221|P3|OPEN LABEL|Adverse Event|0
122545|NCT00576732|416222|P2|OPEN LABEL|Adverse Event|0
122546|NCT00576732|416223|P1|OPEN LABEL|Adverse Event|0
122547|NCT00576732|416218|P6|DOUBLE BLIND|Protocol Violation|0
122548|NCT00576732|416219|P5|DOUBLE BLIND|Protocol Violation|0
122549|NCT00576732|416220|P4|DOUBLE BLIND|Protocol Violation|0
122550|NCT00576732|416221|P3|DOUBLE BLIND|Protocol Violation|0
122551|NCT00576732|416222|P2|DOUBLE BLIND|Protocol Violation|0
122552|NCT00576732|416223|P1|DOUBLE BLIND|Protocol Violation|1
122553|NCT00576732|416218|P6|DOUBLE BLIND|Lack of Efficacy|0
122554|NCT00576732|416219|P5|DOUBLE BLIND|Lack of Efficacy|0
122555|NCT00576732|416220|P4|DOUBLE BLIND|Lack of Efficacy|0
122556|NCT00576732|416221|P3|DOUBLE BLIND|Lack of Efficacy|0
122557|NCT00576732|416222|P2|DOUBLE BLIND|Lack of Efficacy|1
122558|NCT00576732|416223|P1|DOUBLE BLIND|Lack of Efficacy|6
122559|NCT00576732|416218|P6|DOUBLE BLIND|OTHER|0
122560|NCT00576732|416219|P5|DOUBLE BLIND|OTHER|0
122561|NCT00576732|416220|P4|DOUBLE BLIND|OTHER|0
122562|NCT00576732|416221|P3|DOUBLE BLIND|OTHER|1
122563|NCT00576732|416222|P2|DOUBLE BLIND|OTHER|2
122564|NCT00576732|416223|P1|DOUBLE BLIND|OTHER|0
122565|NCT00576732|416218|P6|DOUBLE BLIND|Withdrawal by Subject|0
122566|NCT00576732|416219|P5|DOUBLE BLIND|Withdrawal by Subject|0
122567|NCT00576732|416220|P4|DOUBLE BLIND|Withdrawal by Subject|0
122568|NCT00576732|416221|P3|DOUBLE BLIND|Withdrawal by Subject|3
122569|NCT00576732|416222|P2|DOUBLE BLIND|Withdrawal by Subject|1
122570|NCT00576732|416223|P1|DOUBLE BLIND|Withdrawal by Subject|1
122571|NCT00576732|416218|P6|DOUBLE BLIND|Lost to Follow-up|0
122572|NCT00576732|416219|P5|DOUBLE BLIND|Lost to Follow-up|0
122573|NCT00576732|416220|P4|DOUBLE BLIND|Lost to Follow-up|0
122574|NCT00576732|416221|P3|DOUBLE BLIND|Lost to Follow-up|1
122575|NCT00576732|416222|P2|DOUBLE BLIND|Lost to Follow-up|1
122576|NCT00576732|416223|P1|DOUBLE BLIND|Lost to Follow-up|0
122577|NCT00576732|416218|P6|DOUBLE BLIND|Adverse Event|0
122578|NCT00576732|416219|P5|DOUBLE BLIND|Adverse Event|0
122579|NCT00576732|416220|P4|DOUBLE BLIND|Adverse Event|0
122580|NCT00576732|416221|P3|DOUBLE BLIND|Adverse Event|1
122581|NCT00576732|416222|P2|DOUBLE BLIND|Adverse Event|0
122582|NCT00576732|416223|P1|DOUBLE BLIND|Adverse Event|0
122583|NCT00576693|416255|P2|Overall Study|Withdrawal by Subject|13
122584|NCT00576693|416256|P1|Overall Study|Withdrawal by Subject|3
122585|NCT00576693|416255|P2|Overall Study|Lost to Follow-up|11
122586|NCT00576693|416256|P1|Overall Study|Lost to Follow-up|7
122587|NCT00576628|416262|P1|Overall Study|Dialysis|15
122588|NCT00576628|416262|P1|Overall Study|Transplantation|1
122589|NCT00576628|416262|P1|Overall Study|The patient move into other town|1
122590|NCT00576628|416262|P1|Overall Study|Progression of Renal Failure|1
122591|NCT00576628|416262|P1|Overall Study|Progression of Kidney Disease|1
122592|NCT00576628|416262|P1|Overall Study|RBC transfusion|1
122593|NCT00576628|416262|P1|Overall Study|Pregnancy|1
122594|NCT00576628|416262|P1|Overall Study|Refused Treatment|8
122595|NCT00576628|416262|P1|Overall Study|Failure to return|1
122596|NCT00576628|416262|P1|Overall Study|Death|2
122597|NCT00576628|416262|P1|Overall Study|Adverse Event|11
122598|NCT00576576|416282|P1|Overall Study|Protocol Violation|1
122599|NCT00576576|416282|P1|Overall Study|Lost to Follow-up|6
122600|NCT00576472|416316|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
122601|NCT00576472|416317|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
122602|NCT00576472|416318|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
122603|NCT00576472|416319|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
122604|NCT00576472|416320|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
122605|NCT00576472|416321|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
122606|NCT00576472|416322|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
122607|NCT00576472|416323|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
122608|NCT00576472|416324|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
122609|NCT00576472|416325|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
122610|NCT00576472|416326|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
122611|NCT00576472|416327|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
122612|NCT00576472|416328|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
122613|NCT00576472|416329|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
122614|NCT00576472|416330|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
122615|NCT00576472|416316|P15|MPH Home Maintenance Phase|Medical reasons|6
122616|NCT00576472|416317|P14|MPH Home Maintenance Phase|Medical reasons|0
122617|NCT00576472|416318|P13|MPH Home Maintenance Phase|Medical reasons|0
122618|NCT00576472|416319|P12|MPH Home Maintenance Phase|Medical reasons|0
122619|NCT00576472|416320|P11|MPH Home Maintenance Phase|Medical reasons|0
122620|NCT00576472|416321|P10|MPH Home Maintenance Phase|Medical reasons|0
122621|NCT00576472|416322|P9|MPH Home Maintenance Phase|Medical reasons|0
122622|NCT00576472|416323|P8|MPH Home Maintenance Phase|Medical reasons|0
122623|NCT00576472|416324|P7|MPH Home Maintenance Phase|Medical reasons|0
122624|NCT00576472|416325|P6|MPH Home Maintenance Phase|Medical reasons|0
122625|NCT00576472|416326|P5|MPH Home Maintenance Phase|Medical reasons|0
122626|NCT00576472|416327|P4|MPH Home Maintenance Phase|Medical reasons|0
122627|NCT00576472|416328|P3|MPH Home Maintenance Phase|Medical reasons|0
122628|NCT00576472|416329|P2|MPH Home Maintenance Phase|Medical reasons|0
122629|NCT00576472|416330|P1|MPH Home Maintenance Phase|Medical reasons|0
122630|NCT00576472|416316|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
122631|NCT00576472|416317|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
122632|NCT00576472|416318|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
122633|NCT00576472|416319|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
122634|NCT00576472|416320|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
122635|NCT00576472|416321|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
122636|NCT00576472|416322|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
122637|NCT00576472|416323|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
122638|NCT00576472|416324|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
122639|NCT00576472|416325|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
122640|NCT00576472|416326|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
122641|NCT00576472|416327|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
122642|NCT00576472|416328|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
122643|NCT00576472|416329|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
122644|NCT00576472|416330|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
122645|NCT00576472|416316|P15|MPH Home Maintenance Phase|Side effects|8
122646|NCT00576472|416317|P14|MPH Home Maintenance Phase|Side effects|0
122647|NCT00576472|416318|P13|MPH Home Maintenance Phase|Side effects|0
122648|NCT00576472|416319|P12|MPH Home Maintenance Phase|Side effects|0
122649|NCT00576472|416320|P11|MPH Home Maintenance Phase|Side effects|0
122650|NCT00576472|416321|P10|MPH Home Maintenance Phase|Side effects|0
122651|NCT00576472|416322|P9|MPH Home Maintenance Phase|Side effects|0
122652|NCT00576472|416323|P8|MPH Home Maintenance Phase|Side effects|0
122653|NCT00576472|416324|P7|MPH Home Maintenance Phase|Side effects|0
122654|NCT00576472|416325|P6|MPH Home Maintenance Phase|Side effects|0
122655|NCT00576472|416326|P5|MPH Home Maintenance Phase|Side effects|0
122656|NCT00576472|416327|P4|MPH Home Maintenance Phase|Side effects|0
122657|NCT00576472|416328|P3|MPH Home Maintenance Phase|Side effects|0
122658|NCT00576472|416329|P2|MPH Home Maintenance Phase|Side effects|0
122659|NCT00576472|416330|P1|MPH Home Maintenance Phase|Side effects|0
122660|NCT00576472|416316|P15|MPH Home Maintenance Phase|Insufficient data|0
122661|NCT00576472|416317|P14|MPH Home Maintenance Phase|Insufficient data|4
122662|NCT00576472|416318|P13|MPH Home Maintenance Phase|Insufficient data|0
122663|NCT00576472|416319|P12|MPH Home Maintenance Phase|Insufficient data|0
122664|NCT00576472|416320|P11|MPH Home Maintenance Phase|Insufficient data|0
122665|NCT00576472|416321|P10|MPH Home Maintenance Phase|Insufficient data|0
122666|NCT00576472|416322|P9|MPH Home Maintenance Phase|Insufficient data|0
122667|NCT00576472|416323|P8|MPH Home Maintenance Phase|Insufficient data|0
122668|NCT00576472|416324|P7|MPH Home Maintenance Phase|Insufficient data|0
122669|NCT00576472|416325|P6|MPH Home Maintenance Phase|Insufficient data|0
122670|NCT00576472|416326|P5|MPH Home Maintenance Phase|Insufficient data|0
122671|NCT00576472|416327|P4|MPH Home Maintenance Phase|Insufficient data|0
122672|NCT00576472|416328|P3|MPH Home Maintenance Phase|Insufficient data|0
122673|NCT00576472|416329|P2|MPH Home Maintenance Phase|Insufficient data|0
122674|NCT00576472|416330|P1|MPH Home Maintenance Phase|Insufficient data|0
122675|NCT00576472|416316|P15|MPH Home Maintenance Phase|Declined to participate|0
122676|NCT00576472|416317|P14|MPH Home Maintenance Phase|Declined to participate|7
122677|NCT00576472|416318|P13|MPH Home Maintenance Phase|Declined to participate|0
122678|NCT00576472|416319|P12|MPH Home Maintenance Phase|Declined to participate|0
122679|NCT00576472|416320|P11|MPH Home Maintenance Phase|Declined to participate|0
122680|NCT00576472|416321|P10|MPH Home Maintenance Phase|Declined to participate|0
122681|NCT00576472|416322|P9|MPH Home Maintenance Phase|Declined to participate|0
122682|NCT00576472|416323|P8|MPH Home Maintenance Phase|Declined to participate|0
122683|NCT00576472|416324|P7|MPH Home Maintenance Phase|Declined to participate|0
122684|NCT00576472|416325|P6|MPH Home Maintenance Phase|Declined to participate|0
122685|NCT00576472|416326|P5|MPH Home Maintenance Phase|Declined to participate|0
122686|NCT00576472|416327|P4|MPH Home Maintenance Phase|Declined to participate|0
122687|NCT00576472|416328|P3|MPH Home Maintenance Phase|Declined to participate|0
122688|NCT00576472|416329|P2|MPH Home Maintenance Phase|Declined to participate|0
122689|NCT00576472|416330|P1|MPH Home Maintenance Phase|Declined to participate|0
122690|NCT00576472|416316|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
122691|NCT00576472|416317|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
122692|NCT00576472|416318|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
122693|NCT00576472|416319|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
122694|NCT00576472|416320|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
122695|NCT00576472|416321|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
122696|NCT00576472|416322|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
122697|NCT00576472|416323|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
122698|NCT00576472|416324|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
122699|NCT00576472|416325|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
122700|NCT00576472|416326|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
122701|NCT00576472|416327|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
122702|NCT00576472|416328|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
122703|NCT00576472|416329|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
122704|NCT00576472|416330|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
122705|NCT00576472|416316|P15|MPH Cross Over Phase|Did not complete cross over phase|0
122706|NCT00576472|416317|P14|MPH Cross Over Phase|Did not complete cross over phase|0
122707|NCT00576472|416318|P13|MPH Cross Over Phase|Did not complete cross over phase|0
122708|NCT00576472|416319|P12|MPH Cross Over Phase|Did not complete cross over phase|1
122709|NCT00576472|416320|P11|MPH Cross Over Phase|Did not complete cross over phase|1
122710|NCT00576472|416321|P10|MPH Cross Over Phase|Did not complete cross over phase|0
122711|NCT00576472|416322|P9|MPH Cross Over Phase|Did not complete cross over phase|2
122712|NCT00576472|416323|P8|MPH Cross Over Phase|Did not complete cross over phase|0
122713|NCT00576472|416324|P7|MPH Cross Over Phase|Did not complete cross over phase|0
122714|NCT00576472|416325|P6|MPH Cross Over Phase|Did not complete cross over phase|0
122715|NCT00576472|416326|P5|MPH Cross Over Phase|Did not complete cross over phase|0
122716|NCT00576472|416327|P4|MPH Cross Over Phase|Did not complete cross over phase|0
122717|NCT00576472|416328|P3|MPH Cross Over Phase|Did not complete cross over phase|0
122718|NCT00576472|416329|P2|MPH Cross Over Phase|Did not complete cross over phase|0
122719|NCT00576472|416330|P1|MPH Cross Over Phase|Did not complete cross over phase|0
122720|NCT00576472|416316|P15|MPH Cross Over Phase|Physician Decision|0
122721|NCT00576472|416317|P14|MPH Cross Over Phase|Physician Decision|0
122722|NCT00576472|416318|P13|MPH Cross Over Phase|Physician Decision|0
122723|NCT00576472|416319|P12|MPH Cross Over Phase|Physician Decision|0
122724|NCT00576472|416320|P11|MPH Cross Over Phase|Physician Decision|0
122725|NCT00576472|416321|P10|MPH Cross Over Phase|Physician Decision|0
122726|NCT00576472|416322|P9|MPH Cross Over Phase|Physician Decision|0
122727|NCT00576472|416323|P8|MPH Cross Over Phase|Physician Decision|0
122728|NCT00576472|416324|P7|MPH Cross Over Phase|Physician Decision|4
122729|NCT00576472|416325|P6|MPH Cross Over Phase|Physician Decision|0
122730|NCT00576472|416326|P5|MPH Cross Over Phase|Physician Decision|0
122731|NCT00576472|416327|P4|MPH Cross Over Phase|Physician Decision|0
122732|NCT00576472|416328|P3|MPH Cross Over Phase|Physician Decision|0
122733|NCT00576472|416329|P2|MPH Cross Over Phase|Physician Decision|0
122734|NCT00576472|416330|P1|MPH Cross Over Phase|Physician Decision|0
122735|NCT00576472|416316|P15|MPH Cross Over Phase|Ineligible due to disease|0
122736|NCT00576472|416317|P14|MPH Cross Over Phase|Ineligible due to disease|0
122737|NCT00576472|416318|P13|MPH Cross Over Phase|Ineligible due to disease|0
122738|NCT00576472|416319|P12|MPH Cross Over Phase|Ineligible due to disease|0
122739|NCT00576472|416320|P11|MPH Cross Over Phase|Ineligible due to disease|0
122740|NCT00576472|416321|P10|MPH Cross Over Phase|Ineligible due to disease|0
122741|NCT00576472|416322|P9|MPH Cross Over Phase|Ineligible due to disease|0
122742|NCT00576472|416323|P8|MPH Cross Over Phase|Ineligible due to disease|0
122743|NCT00576472|416324|P7|MPH Cross Over Phase|Ineligible due to disease|2
122744|NCT00576472|416325|P6|MPH Cross Over Phase|Ineligible due to disease|0
122745|NCT00576472|416326|P5|MPH Cross Over Phase|Ineligible due to disease|0
122746|NCT00576472|416327|P4|MPH Cross Over Phase|Ineligible due to disease|0
122747|NCT00576472|416328|P3|MPH Cross Over Phase|Ineligible due to disease|0
122748|NCT00576472|416329|P2|MPH Cross Over Phase|Ineligible due to disease|0
122749|NCT00576472|416330|P1|MPH Cross Over Phase|Ineligible due to disease|0
122750|NCT00576472|416316|P15|MPH Cross Over Phase|Withdrawal by Subject|0
122751|NCT00576472|416317|P14|MPH Cross Over Phase|Withdrawal by Subject|0
122752|NCT00576472|416318|P13|MPH Cross Over Phase|Withdrawal by Subject|0
122753|NCT00576472|416319|P12|MPH Cross Over Phase|Withdrawal by Subject|0
122754|NCT00576472|416320|P11|MPH Cross Over Phase|Withdrawal by Subject|0
122755|NCT00576472|416321|P10|MPH Cross Over Phase|Withdrawal by Subject|0
122756|NCT00576472|416322|P9|MPH Cross Over Phase|Withdrawal by Subject|0
122757|NCT00576472|416323|P8|MPH Cross Over Phase|Withdrawal by Subject|0
122758|NCT00576472|416324|P7|MPH Cross Over Phase|Withdrawal by Subject|6
122759|NCT00576472|416325|P6|MPH Cross Over Phase|Withdrawal by Subject|0
122760|NCT00576472|416326|P5|MPH Cross Over Phase|Withdrawal by Subject|0
122761|NCT00576472|416327|P4|MPH Cross Over Phase|Withdrawal by Subject|0
122762|NCT00576472|416328|P3|MPH Cross Over Phase|Withdrawal by Subject|0
122763|NCT00576472|416329|P2|MPH Cross Over Phase|Withdrawal by Subject|0
122764|NCT00576472|416330|P1|MPH Cross Over Phase|Withdrawal by Subject|0
122765|NCT00576472|416316|P15|MPH In-Lab Phase|Psychiatric exclusion|0
122766|NCT00576472|416317|P14|MPH In-Lab Phase|Psychiatric exclusion|0
122767|NCT00576472|416318|P13|MPH In-Lab Phase|Psychiatric exclusion|0
122768|NCT00576472|416319|P12|MPH In-Lab Phase|Psychiatric exclusion|0
122769|NCT00576472|416320|P11|MPH In-Lab Phase|Psychiatric exclusion|0
122770|NCT00576472|416321|P10|MPH In-Lab Phase|Psychiatric exclusion|0
122771|NCT00576472|416322|P9|MPH In-Lab Phase|Psychiatric exclusion|0
122772|NCT00576472|416323|P8|MPH In-Lab Phase|Psychiatric exclusion|0
122773|NCT00576472|416324|P7|MPH In-Lab Phase|Psychiatric exclusion|0
122774|NCT00576472|416325|P6|MPH In-Lab Phase|Psychiatric exclusion|0
122775|NCT00576472|416326|P5|MPH In-Lab Phase|Psychiatric exclusion|0
122776|NCT00576472|416327|P4|MPH In-Lab Phase|Psychiatric exclusion|10
122777|NCT00576472|416328|P3|MPH In-Lab Phase|Psychiatric exclusion|0
122778|NCT00576472|416329|P2|MPH In-Lab Phase|Psychiatric exclusion|0
122779|NCT00576472|416330|P1|MPH In-Lab Phase|Psychiatric exclusion|0
122780|NCT00576472|416316|P15|MPH In-Lab Phase|No attention/academic problems|0
122781|NCT00576472|416317|P14|MPH In-Lab Phase|No attention/academic problems|0
122782|NCT00576472|416318|P13|MPH In-Lab Phase|No attention/academic problems|0
122783|NCT00576472|416319|P12|MPH In-Lab Phase|No attention/academic problems|0
122784|NCT00576472|416320|P11|MPH In-Lab Phase|No attention/academic problems|0
122785|NCT00576472|416321|P10|MPH In-Lab Phase|No attention/academic problems|0
122786|NCT00576472|416322|P9|MPH In-Lab Phase|No attention/academic problems|0
122787|NCT00576472|416323|P8|MPH In-Lab Phase|No attention/academic problems|0
122788|NCT00576472|416324|P7|MPH In-Lab Phase|No attention/academic problems|0
122789|NCT00576472|416325|P6|MPH In-Lab Phase|No attention/academic problems|0
122790|NCT00576472|416326|P5|MPH In-Lab Phase|No attention/academic problems|0
122791|NCT00576472|416327|P4|MPH In-Lab Phase|No attention/academic problems|245
122792|NCT00576472|416328|P3|MPH In-Lab Phase|No attention/academic problems|0
122793|NCT00576472|416329|P2|MPH In-Lab Phase|No attention/academic problems|0
122794|NCT00576472|416330|P1|MPH In-Lab Phase|No attention/academic problems|0
122795|NCT00576472|416316|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122796|NCT00576472|416317|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122797|NCT00576472|416318|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122798|NCT00576472|416319|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122799|NCT00576472|416320|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122800|NCT00576472|416321|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122801|NCT00576472|416322|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122802|NCT00576472|416323|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122803|NCT00576472|416324|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122804|NCT00576472|416325|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122805|NCT00576472|416326|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122806|NCT00576472|416327|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
122807|NCT00576472|416328|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122808|NCT00576472|416329|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122809|NCT00576472|416330|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
122810|NCT00576472|416316|P15|MPH In-Lab Phase|Lost to Follow-up|0
122811|NCT00576472|416317|P14|MPH In-Lab Phase|Lost to Follow-up|0
122812|NCT00576472|416318|P13|MPH In-Lab Phase|Lost to Follow-up|0
122813|NCT00576472|416319|P12|MPH In-Lab Phase|Lost to Follow-up|0
122814|NCT00576472|416320|P11|MPH In-Lab Phase|Lost to Follow-up|0
122815|NCT00576472|416321|P10|MPH In-Lab Phase|Lost to Follow-up|0
122816|NCT00576472|416322|P9|MPH In-Lab Phase|Lost to Follow-up|0
122817|NCT00576472|416323|P8|MPH In-Lab Phase|Lost to Follow-up|0
122818|NCT00576472|416324|P7|MPH In-Lab Phase|Lost to Follow-up|0
122819|NCT00576472|416325|P6|MPH In-Lab Phase|Lost to Follow-up|0
122820|NCT00576472|416326|P5|MPH In-Lab Phase|Lost to Follow-up|0
122821|NCT00576472|416327|P4|MPH In-Lab Phase|Lost to Follow-up|1
122822|NCT00576472|416328|P3|MPH In-Lab Phase|Lost to Follow-up|0
122823|NCT00576472|416329|P2|MPH In-Lab Phase|Lost to Follow-up|0
122824|NCT00576472|416330|P1|MPH In-Lab Phase|Lost to Follow-up|0
122825|NCT00576472|416316|P15|MPH In-Lab Phase|Declined participation in medication pha|0
122826|NCT00576472|416317|P14|MPH In-Lab Phase|Declined participation in medication pha|0
122827|NCT00576472|416318|P13|MPH In-Lab Phase|Declined participation in medication pha|0
122828|NCT00576472|416319|P12|MPH In-Lab Phase|Declined participation in medication pha|0
122829|NCT00576472|416320|P11|MPH In-Lab Phase|Declined participation in medication pha|0
122830|NCT00576472|416321|P10|MPH In-Lab Phase|Declined participation in medication pha|0
122831|NCT00576472|416322|P9|MPH In-Lab Phase|Declined participation in medication pha|0
122832|NCT00576472|416323|P8|MPH In-Lab Phase|Declined participation in medication pha|0
122833|NCT00576472|416324|P7|MPH In-Lab Phase|Declined participation in medication pha|0
122834|NCT00576472|416325|P6|MPH In-Lab Phase|Declined participation in medication pha|0
122835|NCT00576472|416326|P5|MPH In-Lab Phase|Declined participation in medication pha|0
122836|NCT00576472|416327|P4|MPH In-Lab Phase|Declined participation in medication pha|75
122837|NCT00576472|416328|P3|MPH In-Lab Phase|Declined participation in medication pha|0
122838|NCT00576472|416329|P2|MPH In-Lab Phase|Declined participation in medication pha|0
122839|NCT00576472|416330|P1|MPH In-Lab Phase|Declined participation in medication pha|0
122840|NCT00576420|416423|P3|Overall Study|Death|1
122841|NCT00576420|416424|P2|Overall Study|Death|0
122842|NCT00576420|416425|P1|Overall Study|Death|0
122843|NCT00576381|416590|P1|Overall Study|Adverse Event|4
122844|NCT00576381|416590|P1|Overall Study|Reoperation|3
122845|NCT00576316|416594|P1|Overall Study|Protocol Violation|9
122846|NCT00576316|416594|P1|Overall Study|Withdrawal by Subject|2
122847|NCT00576316|416594|P1|Overall Study|Adverse Event|9
122848|NCT00576303|416599|P1|Long Term Safety Period|Early withdrawal|16
122849|NCT00576303|416599|P1|Efficacy Evaluation Period|Early withdrawal|5
122850|NCT00576303|416599|P1|Dose Titration Period|Early withdrawal|17
122851|NCT00576199|416617|P1|Overall Study|Reason Unspecified|2
122852|NCT00576199|416617|P1|Overall Study|Refused Treatment|2
122853|NCT00576199|416617|P1|Overall Study|Insufficient Therapeutic Response|14
122854|NCT00576199|416617|P1|Overall Study|Adverse Event|12
122855|NCT00576056|416630|P1|Overall Study|Physician Decision|1
122856|NCT00576056|416630|P1|Overall Study|did not meet eligibility criteria|8
122857|NCT00576056|416630|P1|Overall Study|Withdrawal by Subject|2
122858|NCT00576056|416630|P1|Overall Study|Lack of Efficacy|1
122859|NCT00576056|416630|P1|Overall Study|Death|1
122860|NCT00576056|416630|P1|Overall Study|Adverse Event|1
122861|NCT00575666|416646|P2|Overall Study|Physician Decision|1
122862|NCT00575666|416647|P1|Overall Study|Physician Decision|1
122863|NCT00575666|416646|P2|Overall Study|Withdrawal by Subject|2
122864|NCT00575666|416647|P1|Overall Study|Withdrawal by Subject|3
122865|NCT00575588|416687|P2|Overall Study|Impossible to determine HbA1c|1
122866|NCT00575588|416688|P1|Overall Study|Impossible to determine HbA1c|0
122867|NCT00575588|416687|P2|Overall Study|Patient moved|3
122868|NCT00575588|416688|P1|Overall Study|Patient moved|1
122869|NCT00575588|416687|P2|Overall Study|Elevated triglyceride|0
122870|NCT00575588|416688|P1|Overall Study|Elevated triglyceride|1
122871|NCT00575588|416687|P2|Overall Study|Safety reasons|1
122872|NCT00575588|416688|P1|Overall Study|Safety reasons|2
122873|NCT00575588|416687|P2|Overall Study|Severe non-compliance to protocol|7
122874|NCT00575588|416688|P1|Overall Study|Severe non-compliance to protocol|5
122875|NCT00575588|416687|P2|Overall Study|Study specific discontinuation criteria|218
122876|NCT00575588|416688|P1|Overall Study|Study specific discontinuation criteria|203
122877|NCT00575588|416687|P2|Overall Study|Incorrect enrollment|4
122878|NCT00575588|416688|P1|Overall Study|Incorrect enrollment|8
122879|NCT00575588|416687|P2|Overall Study|Death|2
122880|NCT00575588|416688|P1|Overall Study|Death|4
122881|NCT00575588|416687|P2|Overall Study|Lost to Follow-up|3
122882|NCT00575588|416688|P1|Overall Study|Lost to Follow-up|1
122883|NCT00575588|416687|P2|Overall Study|Withdrawal by Subject|31
122884|NCT00575588|416688|P1|Overall Study|Withdrawal by Subject|27
122885|NCT00575588|416687|P2|Overall Study|Adverse Event|13
122886|NCT00575588|416688|P1|Overall Study|Adverse Event|11
122887|NCT00575510|416711|P3|Overall Study|Pregnancy|1
122888|NCT00575510|416712|P2|Overall Study|Pregnancy|0
122889|NCT00575510|416713|P1|Overall Study|Pregnancy|0
122890|NCT00575510|416711|P3|Overall Study|Clinic Called Patient|7
122891|NCT00575510|416712|P2|Overall Study|Clinic Called Patient|7
122892|NCT00575510|416713|P1|Overall Study|Clinic Called Patient|7
122893|NCT00575510|416711|P3|Overall Study|Withdrawal by Subject|0
122894|NCT00575510|416712|P2|Overall Study|Withdrawal by Subject|0
122895|NCT00575510|416713|P1|Overall Study|Withdrawal by Subject|1
122896|NCT00575510|416711|P3|Overall Study|Lost to Follow-up|9
122897|NCT00575510|416712|P2|Overall Study|Lost to Follow-up|6
122898|NCT00575510|416713|P1|Overall Study|Lost to Follow-up|4
122899|NCT00575380|416726|P2|Overall Study|Various|2
122900|NCT00575380|416727|P1|Overall Study|Various|0
122901|NCT00575380|416726|P2|Overall Study|Adverse Event|1
122902|NCT00575380|416727|P1|Overall Study|Adverse Event|0
122903|NCT00575380|416726|P2|Overall Study|Withdrawal by Subject|0
122904|NCT00575380|416727|P1|Overall Study|Withdrawal by Subject|1
122905|NCT00575094|416761|P1|Overall Study|Withdrawal by Subject|1
122906|NCT00575094|416761|P1|Overall Study|Adverse Event|2
122907|NCT00575042|416765|P1|Overall Study|Lost to Follow-up|1
122908|NCT00575042|416765|P1|Overall Study|Adverse Event|2
122909|NCT00574912|416816|P1|Overall Study|Physician Decision|2
122910|NCT00574912|416816|P1|Overall Study|scheduling conflicts|3
122911|NCT00574912|416816|P1|Overall Study|Could not place IV lines.|3
122912|NCT00574873|416830|P2|Overall Study|Extension Study|0
122913|NCT00574873|416831|P1|Overall Study|Extension Study|126
122914|NCT00574873|416830|P2|Overall Study|Blank, site closed per local regulations|2
122915|NCT00574873|416831|P1|Overall Study|Blank, site closed per local regulations|2
122916|NCT00574873|416830|P2|Overall Study|Discontinuation of study by sponsor|199
122917|NCT00574873|416831|P1|Overall Study|Discontinuation of study by sponsor|5
122918|NCT00574873|416830|P2|Overall Study|Unspecified|4
122919|NCT00574873|416831|P1|Overall Study|Unspecified|40
122920|NCT00574873|416830|P2|Overall Study|Lost to Follow-up|5
122921|NCT00574873|416831|P1|Overall Study|Lost to Follow-up|14
122922|NCT00574873|416830|P2|Overall Study|Death|14
122923|NCT00574873|416831|P1|Overall Study|Death|15
122924|NCT00574873|416830|P2|Overall Study|Investigator request|8
122925|NCT00574873|416831|P1|Overall Study|Investigator request|18
122926|NCT00574873|416830|P2|Overall Study|Withdrawal by Subject|19
122927|NCT00574873|416831|P1|Overall Study|Withdrawal by Subject|18
122928|NCT00574847|416849|P2|Overall Study|Did not receive medication (declined)|5
122929|NCT00574847|416850|P1|Overall Study|Did not receive medication (declined)|2
122930|NCT00574847|416849|P2|Overall Study|Physician Decision|0
122931|NCT00574847|416850|P1|Overall Study|Physician Decision|1
122932|NCT00574847|416849|P2|Overall Study|Withdrawal by Subject|2
122933|NCT00574847|416850|P1|Overall Study|Withdrawal by Subject|2
122934|NCT00574847|416849|P2|Overall Study|Death|0
122935|NCT00574847|416850|P1|Overall Study|Death|1
122936|NCT00574847|416849|P2|Overall Study|Adverse Event|0
122937|NCT00574847|416850|P1|Overall Study|Adverse Event|2
122938|NCT00574795|416895|P1|Toddler Dose|Withdrawal by Subject|1
122939|NCT00574795|416895|P1|After Infant Series|Adverse Event|2
122940|NCT00574795|416895|P1|After Infant Series|Withdrawal by Subject|1
122941|NCT00574795|416895|P1|Infant Series|Adverse Event|1
122942|NCT00574795|416895|P1|Infant Series|Protocol Violation|2
122943|NCT00574795|416895|P1|Infant Series|Withdrawal by Subject|2
122944|NCT00574405|416978|P2|Overall Study|Withdrawal by Subject|2
122945|NCT00574405|416979|P1|Overall Study|Withdrawal by Subject|3
122946|NCT00574275|416991|P2|Overall Study|Operation for curative intent|1
122947|NCT00574275|416992|P1|Overall Study|Operation for curative intent|0
122948|NCT00574275|416991|P2|Overall Study|Insurance change|1
122949|NCT00574275|416992|P1|Overall Study|Insurance change|0
122950|NCT00574275|416991|P2|Overall Study|Patient and Investigator decision|1
122951|NCT00574275|416992|P1|Overall Study|Patient and Investigator decision|0
122952|NCT00574275|416991|P2|Overall Study|Protocol Violation|1
122953|NCT00574275|416992|P1|Overall Study|Protocol Violation|0
122954|NCT00574275|416991|P2|Overall Study|Physician Decision|1
122955|NCT00574275|416992|P1|Overall Study|Physician Decision|1
122956|NCT00574275|416991|P2|Overall Study|Error calculating tumor measurement|0
122957|NCT00574275|416992|P1|Overall Study|Error calculating tumor measurement|1
122958|NCT00574275|416991|P2|Overall Study|Withdrawal by Subject|17
122959|NCT00574275|416992|P1|Overall Study|Withdrawal by Subject|15
122960|NCT00574275|416991|P2|Overall Study|Study stopped based on DMC decision|23
122961|NCT00574275|416992|P1|Overall Study|Study stopped based on DMC decision|62
122962|NCT00574275|416991|P2|Overall Study|Lost to Follow-up|1
122963|NCT00574275|416992|P1|Overall Study|Lost to Follow-up|2
122964|NCT00574275|416991|P2|Overall Study|Disease progression|146
122965|NCT00574275|416992|P1|Overall Study|Disease progression|160
122966|NCT00574275|416991|P2|Overall Study|Adverse Event|76
122967|NCT00574275|416992|P1|Overall Study|Adverse Event|32
122968|NCT00574275|416991|P2|Overall Study|Randomized but not treated|3
122969|NCT00574275|416992|P1|Overall Study|Randomized but not treated|2
122970|NCT00574249|417010|P2|Overall Study|PPD test taken twice|1
122971|NCT00574249|417011|P1|Overall Study|PPD test taken twice|0
122972|NCT00574249|417010|P2|Overall Study|Excluded by company|1
122973|NCT00574249|417011|P1|Overall Study|Excluded by company|0
122974|NCT00574249|417010|P2|Overall Study|Pregnancy|0
122975|NCT00574249|417011|P1|Overall Study|Pregnancy|1
122976|NCT00574249|417010|P2|Overall Study|Physician Decision|0
122977|NCT00574249|417011|P1|Overall Study|Physician Decision|1
122978|NCT00574249|417010|P2|Overall Study|Withdrawal by Subject|0
122979|NCT00574249|417011|P1|Overall Study|Withdrawal by Subject|3
122980|NCT00574249|417010|P2|Overall Study|History of carcinoma|0
122981|NCT00574249|417011|P1|Overall Study|History of carcinoma|1
122982|NCT00574249|417010|P2|Overall Study|Protocol Violation|2
122983|NCT00574249|417011|P1|Overall Study|Protocol Violation|5
122984|NCT00574249|417010|P2|Overall Study|Lost to Follow-up|3
122985|NCT00574249|417011|P1|Overall Study|Lost to Follow-up|4
122986|NCT00574249|417010|P2|Overall Study|Lack of Efficacy|3
122987|NCT00574249|417011|P1|Overall Study|Lack of Efficacy|5
122988|NCT00574249|417010|P2|Overall Study|Adverse Event|18
122989|NCT00574249|417011|P1|Overall Study|Adverse Event|6
122990|NCT00574145|417057|P2|Overall Study|Withdrawal by Subject|1
122991|NCT00574145|417058|P1|Overall Study|Withdrawal by Subject|2
122992|NCT00574080|417070|P2|Overall Study|Death|10
122993|NCT00574080|417071|P1|Overall Study|Death|10
122994|NCT00573937|417119|P2|Overall Study|Study Terminated|1
122995|NCT00573937|417120|P1|Overall Study|Study Terminated|0
122996|NCT00573859|417128|P1|Smoking Versus Abstinence|Scheduling conflicts|12
122997|NCT00573859|417128|P1|Medication Versus Placebo|Scheduling conflicts|12
122998|NCT00573768|417137|P3|Overall Study|Lost to Follow-up|1
122999|NCT00573768|417138|P2|Overall Study|Lost to Follow-up|0
123000|NCT00573768|417139|P1|Overall Study|Lost to Follow-up|0
123001|NCT00573768|417137|P3|Overall Study|Withdrawal by Subject|0
123002|NCT00573768|417138|P2|Overall Study|Withdrawal by Subject|1
123003|NCT00573768|417139|P1|Overall Study|Withdrawal by Subject|0
123004|NCT00573768|417137|P3|Overall Study|Protocol Violation|1
123005|NCT00573768|417138|P2|Overall Study|Protocol Violation|0
123006|NCT00573768|417139|P1|Overall Study|Protocol Violation|1
123007|NCT00573768|417137|P3|Overall Study|Adverse Event|2
123008|NCT00573768|417138|P2|Overall Study|Adverse Event|1
123009|NCT00573768|417139|P1|Overall Study|Adverse Event|1
123010|NCT00573755|417149|P2|Overall Study|Still receiving treatment|0
123011|NCT00573755|417150|P1|Overall Study|Still receiving treatment|1
123012|NCT00573534|417166|P1|Overall Study|oppositional behavior|3
123013|NCT00573469|417207|P3|Overall Study|Not Specified|3
123014|NCT00573469|417208|P2|Overall Study|Not Specified|1
123015|NCT00573469|417209|P1|Overall Study|Not Specified|5
123016|NCT00573469|417207|P3|Overall Study|Withdrawal by Subject|0
123017|NCT00573469|417208|P2|Overall Study|Withdrawal by Subject|2
123018|NCT00573469|417209|P1|Overall Study|Withdrawal by Subject|0
123019|NCT00573469|417207|P3|Overall Study|Adverse Event|1
123020|NCT00573469|417208|P2|Overall Study|Adverse Event|1
123021|NCT00573469|417209|P1|Overall Study|Adverse Event|1
123022|NCT00573443|417232|P3|Open-Label Extension Phase|Not Specified|0
123023|NCT00573443|417233|P2|Open-Label Extension Phase|Not Specified|0
123024|NCT00573443|417234|P1|Open-Label Extension Phase|Not Specified|2
123025|NCT00573443|417232|P3|Open-Label Extension Phase|Protocol Violation|0
123026|NCT00573443|417233|P2|Open-Label Extension Phase|Protocol Violation|0
123027|NCT00573443|417234|P1|Open-Label Extension Phase|Protocol Violation|2
123028|NCT00573443|417232|P3|Open-Label Extension Phase|Withdrawal by Subject|0
123029|NCT00573443|417233|P2|Open-Label Extension Phase|Withdrawal by Subject|0
123030|NCT00573443|417234|P1|Open-Label Extension Phase|Withdrawal by Subject|3
123031|NCT00573443|417232|P3|Open-Label Extension Phase|Serious Adverse Event|0
123032|NCT00573443|417233|P2|Open-Label Extension Phase|Serious Adverse Event|0
123033|NCT00573443|417234|P1|Open-Label Extension Phase|Serious Adverse Event|5
123034|NCT00573443|417232|P3|Open-Label Extension Phase|Adverse Event|0
123035|NCT00573443|417233|P2|Open-Label Extension Phase|Adverse Event|0
123036|NCT00573443|417234|P1|Open-Label Extension Phase|Adverse Event|3
123037|NCT00573443|417232|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
123038|NCT00573443|417233|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
123039|NCT00573443|417234|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
123040|NCT00573443|417232|P3|Open-Label Extension Phase|Lost to Follow-up|0
123041|NCT00573443|417233|P2|Open-Label Extension Phase|Lost to Follow-up|0
123042|NCT00573443|417234|P1|Open-Label Extension Phase|Lost to Follow-up|1
123043|NCT00573443|417232|P3|Double-Blind Phase|Not specified|3
123044|NCT00573443|417233|P2|Double-Blind Phase|Not specified|2
123045|NCT00573443|417234|P1|Double-Blind Phase|Not specified|0
123046|NCT00573443|417232|P3|Double-Blind Phase|Protocol Violation|1
123047|NCT00573443|417233|P2|Double-Blind Phase|Protocol Violation|2
123048|NCT00573443|417234|P1|Double-Blind Phase|Protocol Violation|0
123049|NCT00573443|417232|P3|Double-Blind Phase|Withdrawal by Subject|7
123050|NCT00573443|417233|P2|Double-Blind Phase|Withdrawal by Subject|2
123051|NCT00573443|417234|P1|Double-Blind Phase|Withdrawal by Subject|2
123052|NCT00573443|417232|P3|Double-Blind Phase|Medication refusal due to AE|0
123053|NCT00573443|417233|P2|Double-Blind Phase|Medication refusal due to AE|2
123054|NCT00573443|417234|P1|Double-Blind Phase|Medication refusal due to AE|2
123055|NCT00573443|417232|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
123056|NCT00573443|417233|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
123057|NCT00573443|417234|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
123058|NCT00573443|417232|P3|Double-Blind Phase|Adverse Event|0
123059|NCT00573443|417233|P2|Double-Blind Phase|Adverse Event|5
123060|NCT00573443|417234|P1|Double-Blind Phase|Adverse Event|1
123061|NCT00573443|417232|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
123062|NCT00573443|417233|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
123063|NCT00573443|417234|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
123064|NCT00573443|417232|P3|Double-Blind Phase|Lost to Follow-up|2
123065|NCT00573443|417233|P2|Double-Blind Phase|Lost to Follow-up|3
123066|NCT00573443|417234|P1|Double-Blind Phase|Lost to Follow-up|1
123067|NCT00573430|417264|P3|Overall Study|Eligibility criteria not fulfilled|3
123068|NCT00573430|417265|P2|Overall Study|Eligibility criteria not fulfilled|0
123069|NCT00573430|417266|P1|Overall Study|Eligibility criteria not fulfilled|0
123070|NCT00573430|417264|P3|Overall Study|Protocol Violation|1
123071|NCT00573430|417265|P2|Overall Study|Protocol Violation|1
123072|NCT00573430|417266|P1|Overall Study|Protocol Violation|0
123073|NCT00573430|417264|P3|Overall Study|Withdrawal by Subject|1
123074|NCT00573430|417265|P2|Overall Study|Withdrawal by Subject|0
123075|NCT00573430|417266|P1|Overall Study|Withdrawal by Subject|1
123076|NCT00573430|417264|P3|Overall Study|Adverse Event|2
123077|NCT00573430|417265|P2|Overall Study|Adverse Event|0
123078|NCT00573430|417266|P1|Overall Study|Adverse Event|0
123079|NCT00573430|417264|P3|Overall Study|Incorrect enrollment of randomization|3
123080|NCT00573430|417265|P2|Overall Study|Incorrect enrollment of randomization|4
123081|NCT00573430|417266|P1|Overall Study|Incorrect enrollment of randomization|0
123082|NCT00573391|417288|P2|Overall Study|Death|0
123083|NCT00573391|417289|P1|Overall Study|Death|1
123084|NCT00573391|417288|P2|Overall Study|study stopped|2
123085|NCT00573391|417289|P1|Overall Study|study stopped|2
123086|NCT00573313|417299|P4|Overall Study|Protocol Violation|0
123087|NCT00573313|417300|P3|Overall Study|Protocol Violation|6
123088|NCT00573313|417301|P2|Overall Study|Protocol Violation|0
123089|NCT00573313|417302|P1|Overall Study|Protocol Violation|5
123090|NCT00573248|417350|P2|Overall Study|scheduling conflicts|11
123091|NCT00573248|417351|P1|Overall Study|scheduling conflicts|15
123092|NCT00573183|417365|P2|Overall Study|Unspecified|2
123093|NCT00573183|417366|P1|Overall Study|Unspecified|5
123094|NCT00573183|417365|P2|Overall Study|Incarceration|8
123095|NCT00573183|417366|P1|Overall Study|Incarceration|5
123096|NCT00573183|417365|P2|Overall Study|Adverse Event|0
123097|NCT00573183|417366|P1|Overall Study|Adverse Event|2
123098|NCT00573183|417365|P2|Overall Study|Death|1
123099|NCT00573183|417366|P1|Overall Study|Death|0
123100|NCT00573183|417365|P2|Overall Study|Withdrawal by Subject|2
123101|NCT00573183|417366|P1|Overall Study|Withdrawal by Subject|8
123102|NCT00573183|417365|P2|Overall Study|Lost to Follow-up|50
123103|NCT00573183|417366|P1|Overall Study|Lost to Follow-up|52
123104|NCT00573170|417374|P6|Third Treatment Period|Lost to Follow-up|2
123105|NCT00573170|417375|P5|Third Treatment Period|Lost to Follow-up|0
123106|NCT00573170|417376|P4|Third Treatment Period|Lost to Follow-up|0
123107|NCT00573170|417377|P3|Third Treatment Period|Lost to Follow-up|0
123108|NCT00573170|417378|P2|Third Treatment Period|Lost to Follow-up|0
123109|NCT00573170|417379|P1|Third Treatment Period|Lost to Follow-up|0
123110|NCT00573170|417374|P6|Third Treatment Period|Withdrawal by Subject|0
123111|NCT00573170|417375|P5|Third Treatment Period|Withdrawal by Subject|0
123112|NCT00573170|417376|P4|Third Treatment Period|Withdrawal by Subject|0
123113|NCT00573170|417377|P3|Third Treatment Period|Withdrawal by Subject|0
123114|NCT00573170|417378|P2|Third Treatment Period|Withdrawal by Subject|0
123115|NCT00573170|417379|P1|Third Treatment Period|Withdrawal by Subject|1
123116|NCT00573170|417374|P6|Second Washout Period|Other|2
123117|NCT00573170|417375|P5|Second Washout Period|Other|6
123118|NCT00573170|417376|P4|Second Washout Period|Other|4
123119|NCT00573170|417377|P3|Second Washout Period|Other|1
123120|NCT00573170|417378|P2|Second Washout Period|Other|2
123121|NCT00573170|417379|P1|Second Washout Period|Other|1
123122|NCT00573170|417374|P6|Second Washout Period|Lost to Follow-up|0
123123|NCT00573170|417375|P5|Second Washout Period|Lost to Follow-up|0
123124|NCT00573170|417376|P4|Second Washout Period|Lost to Follow-up|1
123125|NCT00573170|417377|P3|Second Washout Period|Lost to Follow-up|0
123126|NCT00573170|417378|P2|Second Washout Period|Lost to Follow-up|0
123127|NCT00573170|417379|P1|Second Washout Period|Lost to Follow-up|0
123128|NCT00573170|417374|P6|Second Washout Period|Withdrawal by Subject|0
123129|NCT00573170|417375|P5|Second Washout Period|Withdrawal by Subject|1
123130|NCT00573170|417376|P4|Second Washout Period|Withdrawal by Subject|0
123131|NCT00573170|417377|P3|Second Washout Period|Withdrawal by Subject|2
123132|NCT00573170|417378|P2|Second Washout Period|Withdrawal by Subject|1
123133|NCT00573170|417379|P1|Second Washout Period|Withdrawal by Subject|1
123134|NCT00573170|417374|P6|Second Washout Period|Protocol Violation|0
123135|NCT00573170|417375|P5|Second Washout Period|Protocol Violation|0
123136|NCT00573170|417376|P4|Second Washout Period|Protocol Violation|0
123137|NCT00573170|417377|P3|Second Washout Period|Protocol Violation|1
123138|NCT00573170|417378|P2|Second Washout Period|Protocol Violation|1
123139|NCT00573170|417379|P1|Second Washout Period|Protocol Violation|2
123140|NCT00573170|417374|P6|Second Washout Period|Adverse Event|0
123141|NCT00573170|417375|P5|Second Washout Period|Adverse Event|1
123142|NCT00573170|417376|P4|Second Washout Period|Adverse Event|0
123143|NCT00573170|417377|P3|Second Washout Period|Adverse Event|0
123144|NCT00573170|417378|P2|Second Washout Period|Adverse Event|0
123145|NCT00573170|417379|P1|Second Washout Period|Adverse Event|1
123146|NCT00573170|417374|P6|First Washout Period|Other|0
123147|NCT00573170|417375|P5|First Washout Period|Other|0
123148|NCT00573170|417376|P4|First Washout Period|Other|1
123149|NCT00573170|417377|P3|First Washout Period|Other|1
123150|NCT00573170|417378|P2|First Washout Period|Other|0
123151|NCT00573170|417379|P1|First Washout Period|Other|4
123152|NCT00573170|417374|P6|First Washout Period|Withdrawal by Subject|3
123153|NCT00573170|417375|P5|First Washout Period|Withdrawal by Subject|3
123154|NCT00573170|417376|P4|First Washout Period|Withdrawal by Subject|2
123155|NCT00573170|417377|P3|First Washout Period|Withdrawal by Subject|0
123156|NCT00573170|417378|P2|First Washout Period|Withdrawal by Subject|0
123157|NCT00573170|417379|P1|First Washout Period|Withdrawal by Subject|2
123158|NCT00573170|417374|P6|First Washout Period|Lost to Follow-up|2
123159|NCT00573170|417375|P5|First Washout Period|Lost to Follow-up|0
123160|NCT00573170|417376|P4|First Washout Period|Lost to Follow-up|2
123161|NCT00573170|417377|P3|First Washout Period|Lost to Follow-up|0
123162|NCT00573170|417378|P2|First Washout Period|Lost to Follow-up|1
123163|NCT00573170|417379|P1|First Washout Period|Lost to Follow-up|1
123164|NCT00573170|417374|P6|First Washout Period|Lack of Efficacy|1
123165|NCT00573170|417375|P5|First Washout Period|Lack of Efficacy|0
123166|NCT00573170|417376|P4|First Washout Period|Lack of Efficacy|0
123167|NCT00573170|417377|P3|First Washout Period|Lack of Efficacy|0
123168|NCT00573170|417378|P2|First Washout Period|Lack of Efficacy|0
123169|NCT00573170|417379|P1|First Washout Period|Lack of Efficacy|0
123170|NCT00573170|417374|P6|First Washout Period|Adverse Event|1
123171|NCT00573170|417375|P5|First Washout Period|Adverse Event|0
123172|NCT00573170|417376|P4|First Washout Period|Adverse Event|0
123173|NCT00573170|417377|P3|First Washout Period|Adverse Event|0
123174|NCT00573170|417378|P2|First Washout Period|Adverse Event|1
123175|NCT00573170|417379|P1|First Washout Period|Adverse Event|1
123176|NCT00573170|417374|P6|First Treatment Period|Did Not Treat Attack 1|0
123177|NCT00573170|417375|P5|First Treatment Period|Did Not Treat Attack 1|1
123178|NCT00573170|417376|P4|First Treatment Period|Did Not Treat Attack 1|0
123179|NCT00573170|417377|P3|First Treatment Period|Did Not Treat Attack 1|0
123180|NCT00573170|417378|P2|First Treatment Period|Did Not Treat Attack 1|0
123181|NCT00573170|417379|P1|First Treatment Period|Did Not Treat Attack 1|0
123182|NCT00573157|417455|P2|Overall Study|Unspecified|1
123183|NCT00573157|417456|P1|Overall Study|Unspecified|1
123184|NCT00573157|417455|P2|Overall Study|Adverse Event|1
123185|NCT00573157|417456|P1|Overall Study|Adverse Event|3
123186|NCT00573144|417468|P2|Overall Study|Withdrawal by Subject|3
123187|NCT00573144|417469|P1|Overall Study|Withdrawal by Subject|2
123188|NCT00573131|417481|P2|Overall Study|Withdrawal by Subject|8
123189|NCT00573131|417482|P1|Overall Study|Withdrawal by Subject|10
123190|NCT00573066|417488|P1|Overall Study|Postoperative bleeding|1
123191|NCT00573066|417488|P1|Overall Study|IV malfunction|1
123192|NCT00573066|417488|P1|Overall Study|Exclusion criteria|18
123193|NCT00572910|417498|P11|Overall Study|Withdrawal by Subject|1
123194|NCT00572910|417499|P10|Overall Study|Withdrawal by Subject|2
123195|NCT00572910|417500|P9|Overall Study|Withdrawal by Subject|2
123196|NCT00572910|417501|P8|Overall Study|Withdrawal by Subject|2
123197|NCT00572910|417502|P7|Overall Study|Withdrawal by Subject|0
123198|NCT00572910|417503|P6|Overall Study|Withdrawal by Subject|3
123199|NCT00572910|417504|P5|Overall Study|Withdrawal by Subject|1
123200|NCT00572910|417505|P4|Overall Study|Withdrawal by Subject|0
123201|NCT00572910|417506|P3|Overall Study|Withdrawal by Subject|1
123202|NCT00572910|417507|P2|Overall Study|Withdrawal by Subject|0
123203|NCT00572910|417508|P1|Overall Study|Withdrawal by Subject|3
123204|NCT00572910|417498|P11|Overall Study|Lost to Follow-up|0
123205|NCT00572910|417499|P10|Overall Study|Lost to Follow-up|1
123206|NCT00572910|417500|P9|Overall Study|Lost to Follow-up|0
123207|NCT00572910|417501|P8|Overall Study|Lost to Follow-up|0
123208|NCT00572910|417502|P7|Overall Study|Lost to Follow-up|0
123209|NCT00572910|417503|P6|Overall Study|Lost to Follow-up|0
123210|NCT00572910|417504|P5|Overall Study|Lost to Follow-up|1
123211|NCT00572910|417505|P4|Overall Study|Lost to Follow-up|2
123212|NCT00572910|417506|P3|Overall Study|Lost to Follow-up|1
123213|NCT00572910|417507|P2|Overall Study|Lost to Follow-up|1
123214|NCT00572910|417508|P1|Overall Study|Lost to Follow-up|0
123215|NCT00572910|417498|P11|Overall Study|Adverse Event|2
123216|NCT00572910|417499|P10|Overall Study|Adverse Event|3
123217|NCT00572910|417500|P9|Overall Study|Adverse Event|1
123218|NCT00572910|417501|P8|Overall Study|Adverse Event|2
123219|NCT00572910|417502|P7|Overall Study|Adverse Event|4
123220|NCT00572910|417503|P6|Overall Study|Adverse Event|0
123221|NCT00572910|417504|P5|Overall Study|Adverse Event|0
123222|NCT00572910|417505|P4|Overall Study|Adverse Event|2
123223|NCT00572910|417506|P3|Overall Study|Adverse Event|0
123224|NCT00572910|417507|P2|Overall Study|Adverse Event|2
123225|NCT00572910|417508|P1|Overall Study|Adverse Event|1
123226|NCT00572832|417575|P2|Overall Study|Pregnancy|1
123227|NCT00572832|417576|P1|Overall Study|Pregnancy|0
123228|NCT00572832|417575|P2|Overall Study|Lost to Follow-up|11
123229|NCT00572832|417576|P1|Overall Study|Lost to Follow-up|0
123230|NCT00572728|417582|P1|Overall Study|Pathology missing|1
123231|NCT00572728|417582|P1|Overall Study|FLT2 after second chemotherapy initiated|7
123232|NCT00572728|417582|P1|Overall Study|Second chemotherapy not initiated|1
123233|NCT00572728|417582|P1|Overall Study|FLT2 not completed|5
123234|NCT00572728|417582|P1|Overall Study|First Chemotherapy not initiated|2
123235|NCT00572728|417582|P1|Overall Study|FLT1 not completed|4
123236|NCT00572728|417582|P1|Overall Study|Offstudy due to complicating disease|1
123237|NCT00572728|417582|P1|Overall Study|Enrolled under Amendment 4|5
123238|NCT00572728|417582|P1|Overall Study|Ineligible|3
123239|NCT00572728|417582|P1|Overall Study|Withdrawal by Subject|10
123240|NCT00572572|417596|P2|Overall Study|Withdrawal by Subject|6
123241|NCT00572572|417597|P1|Overall Study|Withdrawal by Subject|3
123242|NCT00572533|417615|P2|Overall Study|Transfer out of Facility|1
123243|NCT00572533|417616|P1|Overall Study|Transfer out of Facility|0
123244|NCT00572533|417615|P2|Overall Study|Social Issues|0
123245|NCT00572533|417616|P1|Overall Study|Social Issues|1
123246|NCT00572533|417615|P2|Overall Study|Received Kidney Transplant|1
123247|NCT00572533|417616|P1|Overall Study|Received Kidney Transplant|2
123248|NCT00572533|417615|P2|Overall Study|Death|1
123249|NCT00572533|417616|P1|Overall Study|Death|4
123250|NCT00572156|417644|P4|Overall Study|Sponsor Decision|19
123251|NCT00572156|417645|P3|Overall Study|Sponsor Decision|17
123252|NCT00572156|417646|P2|Overall Study|Sponsor Decision|16
123253|NCT00572156|417647|P1|Overall Study|Sponsor Decision|20
123254|NCT00572156|417644|P4|Overall Study|Patient/Parent Decision|3
123255|NCT00572156|417645|P3|Overall Study|Patient/Parent Decision|4
123256|NCT00572156|417646|P2|Overall Study|Patient/Parent Decision|6
123257|NCT00572156|417647|P1|Overall Study|Patient/Parent Decision|1
123258|NCT00572156|417644|P4|Overall Study|Protocol Violation|2
123259|NCT00572156|417645|P3|Overall Study|Protocol Violation|0
123260|NCT00572156|417646|P2|Overall Study|Protocol Violation|2
123261|NCT00572156|417647|P1|Overall Study|Protocol Violation|1
123262|NCT00572156|417644|P4|Overall Study|Lost to Follow-up|0
123263|NCT00572156|417645|P3|Overall Study|Lost to Follow-up|1
123264|NCT00572156|417646|P2|Overall Study|Lost to Follow-up|1
123265|NCT00572156|417647|P1|Overall Study|Lost to Follow-up|1
123266|NCT00572156|417644|P4|Overall Study|Adverse Event|1
123267|NCT00572156|417645|P3|Overall Study|Adverse Event|5
123268|NCT00572156|417646|P2|Overall Study|Adverse Event|1
123269|NCT00572156|417647|P1|Overall Study|Adverse Event|3
123270|NCT00572039|417718|P2|Overall Study|Ill|1
123271|NCT00572039|417719|P1|Overall Study|Ill|5
123272|NCT00572039|417718|P2|Overall Study|Death|3
123273|NCT00572039|417719|P1|Overall Study|Death|2
123274|NCT00572039|417718|P2|Overall Study|Withdrawal by Subject|6
123275|NCT00572039|417719|P1|Overall Study|Withdrawal by Subject|9
123276|NCT00571948|417751|P2|Overall Study|Parent were afraid of blood colection|5
123277|NCT00571948|417752|P1|Overall Study|Parent were afraid of blood colection|2
123278|NCT00571948|417751|P2|Overall Study|infant refused study meal|4
123279|NCT00571948|417752|P1|Overall Study|infant refused study meal|3
123280|NCT00571948|417751|P2|Overall Study|Protocol Violation|3
123281|NCT00571948|417752|P1|Overall Study|Protocol Violation|3
123282|NCT00571948|417751|P2|Overall Study|Withdrawal by Subject|2
123283|NCT00571948|417752|P1|Overall Study|Withdrawal by Subject|1
123284|NCT00571948|417751|P2|Overall Study|Lost to Follow-up|0
123285|NCT00571948|417752|P1|Overall Study|Lost to Follow-up|2
123286|NCT00571922|417760|P2|Overall Study|Completion unknown|36
123287|NCT00571922|417761|P1|Overall Study|Completion unknown|36
123288|NCT00571662|417769|P1|Overall Study|Adverse Event|5
123289|NCT00571662|417769|P1|Overall Study|psychiatric instability|1
123290|NCT00571662|417769|P1|Overall Study|Withdrawal by Subject|2
123291|NCT00571649|417777|P2|Follow-up Period|Protocol Violation|12
123292|NCT00571649|417778|P1|Follow-up Period|Protocol Violation|5
123293|NCT00571649|417777|P2|Follow-up Period|Patient convenience|121
123294|NCT00571649|417778|P1|Follow-up Period|Patient convenience|136
123295|NCT00571649|417777|P2|Follow-up Period|Lost to Follow-up|92
123296|NCT00571649|417778|P1|Follow-up Period|Lost to Follow-up|95
123297|NCT00571649|417777|P2|Follow-up Period|Physician Decision|13
123298|NCT00571649|417778|P1|Follow-up Period|Physician Decision|7
123299|NCT00571649|417777|P2|Follow-up Period|Death|133
123300|NCT00571649|417778|P1|Follow-up Period|Death|132
123301|NCT00571649|417777|P2|Follow-up Period|Withdrawal by Subject|115
123302|NCT00571649|417778|P1|Follow-up Period|Withdrawal by Subject|119
123303|NCT00571649|417777|P2|Follow-up Period|Clinical endpoint reached|2
123304|NCT00571649|417778|P1|Follow-up Period|Clinical endpoint reached|5
123305|NCT00571649|417777|P2|Follow-up Period|Adverse Event|40
123306|NCT00571649|417778|P1|Follow-up Period|Adverse Event|46
123307|NCT00571649|417777|P2|Treatment Period|Technical problems|5
123308|NCT00571649|417778|P1|Treatment Period|Technical problems|3
123309|NCT00571649|417777|P2|Treatment Period|Protocol Violation|92
123310|NCT00571649|417778|P1|Treatment Period|Protocol Violation|90
123311|NCT00571649|417777|P2|Treatment Period|Patient convenience|13
123312|NCT00571649|417778|P1|Treatment Period|Patient convenience|11
123313|NCT00571649|417777|P2|Treatment Period|Non-compliant with study medication|89
123314|NCT00571649|417778|P1|Treatment Period|Non-compliant with study medication|88
123315|NCT00571649|417777|P2|Treatment Period|Lost to Follow-up|41
123316|NCT00571649|417778|P1|Treatment Period|Lost to Follow-up|43
123317|NCT00571649|417777|P2|Treatment Period|Physician Decision|9
123318|NCT00571649|417778|P1|Treatment Period|Physician Decision|8
123319|NCT00571649|417777|P2|Treatment Period|Death|59
123320|NCT00571649|417778|P1|Treatment Period|Death|76
123321|NCT00571649|417777|P2|Treatment Period|Withdrawal by Subject|255
123322|NCT00571649|417778|P1|Treatment Period|Withdrawal by Subject|285
123323|NCT00571649|417777|P2|Treatment Period|Clinical endpoint reached|56
123324|NCT00571649|417778|P1|Treatment Period|Clinical endpoint reached|50
123325|NCT00571649|417777|P2|Treatment Period|Adverse Event|385
123326|NCT00571649|417778|P1|Treatment Period|Adverse Event|438
123327|NCT00571038|417860|P2|Overall Study|Moved out of state|2
123328|NCT00571038|417861|P1|Overall Study|Moved out of state|2
123329|NCT00571038|417860|P2|Overall Study|Withdrawal by Subject|3
123330|NCT00571038|417861|P1|Overall Study|Withdrawal by Subject|1
123331|NCT00571038|417860|P2|Overall Study|Death|5
123332|NCT00571038|417861|P1|Overall Study|Death|7
123333|NCT00571038|417860|P2|Overall Study|Lost to Follow-up|4
123334|NCT00571038|417861|P1|Overall Study|Lost to Follow-up|1
123335|NCT00570921|417916|P1|Overall Study|Physician Decision|1
123336|NCT00570921|417916|P1|Overall Study|Protocol Violation|1
123337|NCT00570908|417922|P1|Overall Study|Withdrawal by Subject|2
123338|NCT00570908|417922|P1|Overall Study|Adverse Event|5
123339|NCT00570778|417926|P4|Overall Study|Subject no longer requires study drug|0
123340|NCT00570778|417927|P3|Overall Study|Subject no longer requires study drug|0
123341|NCT00570778|417928|P2|Overall Study|Subject no longer requires study drug|1
123342|NCT00570778|417929|P1|Overall Study|Subject no longer requires study drug|0
123343|NCT00570778|417926|P4|Overall Study|Lost to Follow-up|0
123344|NCT00570778|417927|P3|Overall Study|Lost to Follow-up|1
123345|NCT00570778|417928|P2|Overall Study|Lost to Follow-up|0
123346|NCT00570778|417929|P1|Overall Study|Lost to Follow-up|0
123347|NCT00570778|417926|P4|Overall Study|Unsatisfactory therapeutic effect|0
123348|NCT00570778|417927|P3|Overall Study|Unsatisfactory therapeutic effect|0
123349|NCT00570778|417928|P2|Overall Study|Unsatisfactory therapeutic effect|0
123350|NCT00570778|417929|P1|Overall Study|Unsatisfactory therapeutic effect|1
123351|NCT00570778|417926|P4|Overall Study|Abnormal test procedure|0
123352|NCT00570778|417927|P3|Overall Study|Abnormal test procedure|0
123353|NCT00570778|417928|P2|Overall Study|Abnormal test procedure|0
123354|NCT00570778|417929|P1|Overall Study|Abnormal test procedure|1
123355|NCT00570778|417926|P4|Overall Study|Subject withdrew consent|1
123356|NCT00570778|417927|P3|Overall Study|Subject withdrew consent|0
123357|NCT00570778|417928|P2|Overall Study|Subject withdrew consent|1
123358|NCT00570778|417929|P1|Overall Study|Subject withdrew consent|0
123359|NCT00570778|417926|P4|Overall Study|Adverse Event|1
123360|NCT00570778|417927|P3|Overall Study|Adverse Event|4
123361|NCT00570778|417928|P2|Overall Study|Adverse Event|1
123362|NCT00570778|417929|P1|Overall Study|Adverse Event|0
123363|NCT00570778|417926|P4|Overall Study|Protocol deviation|2
123364|NCT00570778|417927|P3|Overall Study|Protocol deviation|2
123365|NCT00570778|417928|P2|Overall Study|Protocol deviation|1
123366|NCT00570778|417929|P1|Overall Study|Protocol deviation|2
123367|NCT00570739|417970|P4|Overall Study|Not specified|3
123368|NCT00570739|417971|P3|Overall Study|Not specified|5
123369|NCT00570739|417972|P2|Overall Study|Not specified|2
123370|NCT00570739|417973|P1|Overall Study|Not specified|0
123371|NCT00570739|417970|P4|Overall Study|Met discontinuation criteria|1
123372|NCT00570739|417971|P3|Overall Study|Met discontinuation criteria|1
123373|NCT00570739|417972|P2|Overall Study|Met discontinuation criteria|0
123374|NCT00570739|417973|P1|Overall Study|Met discontinuation criteria|1
123375|NCT00570739|417970|P4|Overall Study|Required restricted medication|0
123376|NCT00570739|417971|P3|Overall Study|Required restricted medication|1
123377|NCT00570739|417972|P2|Overall Study|Required restricted medication|0
123378|NCT00570739|417973|P1|Overall Study|Required restricted medication|0
123379|NCT00570739|417970|P4|Overall Study|Withdrawal by Subject|5
123380|NCT00570739|417971|P3|Overall Study|Withdrawal by Subject|3
123381|NCT00570739|417972|P2|Overall Study|Withdrawal by Subject|7
123382|NCT00570739|417973|P1|Overall Study|Withdrawal by Subject|7
123383|NCT00570739|417970|P4|Overall Study|Physician Decision|0
123384|NCT00570739|417971|P3|Overall Study|Physician Decision|0
123385|NCT00570739|417972|P2|Overall Study|Physician Decision|1
123386|NCT00570739|417973|P1|Overall Study|Physician Decision|1
123387|NCT00570739|417970|P4|Overall Study|Lost to Follow-up|1
123388|NCT00570739|417971|P3|Overall Study|Lost to Follow-up|4
123389|NCT00570739|417972|P2|Overall Study|Lost to Follow-up|5
123390|NCT00570739|417973|P1|Overall Study|Lost to Follow-up|4
123391|NCT00570739|417970|P4|Overall Study|Adverse Event|2
123392|NCT00570739|417971|P3|Overall Study|Adverse Event|2
123393|NCT00570739|417972|P2|Overall Study|Adverse Event|6
123394|NCT00570739|417973|P1|Overall Study|Adverse Event|8
123395|NCT00570713|418125|P2|Overall Study|Discontinuation of Study by the Sponsor|7
123396|NCT00570713|418126|P1|Overall Study|Discontinuation of Study by the Sponsor|10
123397|NCT00570713|418125|P2|Overall Study|Withdrawal by Subject|3
123398|NCT00570713|418126|P1|Overall Study|Withdrawal by Subject|3
123399|NCT00570713|418125|P2|Overall Study|Physician Decision|2
123400|NCT00570713|418126|P1|Overall Study|Physician Decision|2
123401|NCT00570713|418125|P2|Overall Study|Lack of Efficacy|49
123402|NCT00570713|418126|P1|Overall Study|Lack of Efficacy|40
123403|NCT00570713|418125|P2|Overall Study|Death|7
123404|NCT00570713|418126|P1|Overall Study|Death|7
123405|NCT00570713|418125|P2|Overall Study|Adverse Event|9
123406|NCT00570713|418126|P1|Overall Study|Adverse Event|16
123407|NCT00570687|418138|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123408|NCT00570687|418139|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123409|NCT00570687|418140|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123410|NCT00570687|418141|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
123411|NCT00570687|418142|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123412|NCT00570687|418143|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123413|NCT00570687|418144|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123414|NCT00570687|418145|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123415|NCT00570687|418146|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123416|NCT00570687|418147|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123417|NCT00570687|418138|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123418|NCT00570687|418139|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
123419|NCT00570687|418140|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123420|NCT00570687|418141|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123421|NCT00570687|418142|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123422|NCT00570687|418143|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123423|NCT00570687|418144|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123424|NCT00570687|418145|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123425|NCT00570687|418146|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123426|NCT00570687|418147|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123427|NCT00570687|418138|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
123428|NCT00570687|418139|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
123429|NCT00570687|418140|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
123430|NCT00570687|418141|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
123431|NCT00570687|418142|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
123432|NCT00570687|418143|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
123433|NCT00570687|418144|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123434|NCT00570687|418145|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123435|NCT00570687|418146|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123436|NCT00570687|418147|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
123437|NCT00570674|418173|P7|Overall Study|Withdrawal by Subject|0
123438|NCT00570674|418174|P6|Overall Study|Withdrawal by Subject|0
123439|NCT00570674|418175|P5|Overall Study|Withdrawal by Subject|0
123440|NCT00570674|418176|P4|Overall Study|Withdrawal by Subject|0
123441|NCT00570674|418177|P3|Overall Study|Withdrawal by Subject|1
123442|NCT00570674|418178|P2|Overall Study|Withdrawal by Subject|0
123443|NCT00570674|418179|P1|Overall Study|Withdrawal by Subject|0
123444|NCT00570505|418197|P1|Overall Study|Other loss to follow-up|4
123445|NCT00570505|418197|P1|Overall Study|Lost to Follow-up|23
123446|NCT00570505|418197|P1|Overall Study|Withdrawal by Subject|7
123447|NCT00570505|418197|P1|Overall Study|Adverse Event|7
123448|NCT00570492|418210|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
123523|NCT00569803|418358|P8|Overall Study|Lost to Follow-up|0
123449|NCT00570492|418211|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
123450|NCT00570492|418212|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
123451|NCT00570492|418210|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
123452|NCT00570492|418211|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
123453|NCT00570492|418212|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
123454|NCT00570492|418210|P3|52-week Double-blind Treatment Period|Physician Decision|4
123455|NCT00570492|418211|P2|52-week Double-blind Treatment Period|Physician Decision|2
123456|NCT00570492|418212|P1|52-week Double-blind Treatment Period|Physician Decision|0
123457|NCT00570492|418210|P3|52-week Double-blind Treatment Period|Adverse Event|5
123458|NCT00570492|418211|P2|52-week Double-blind Treatment Period|Adverse Event|5
123459|NCT00570492|418212|P1|52-week Double-blind Treatment Period|Adverse Event|0
123460|NCT00570492|418210|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
123461|NCT00570492|418211|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
123462|NCT00570492|418212|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
123463|NCT00570492|418210|P3|52-week Double-blind Treatment Period|Protocol Violation|15
123464|NCT00570492|418211|P2|52-week Double-blind Treatment Period|Protocol Violation|12
123465|NCT00570492|418212|P1|52-week Double-blind Treatment Period|Protocol Violation|0
123466|NCT00570492|418210|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
123467|NCT00570492|418211|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
123468|NCT00570492|418212|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
123469|NCT00570492|418210|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
123470|NCT00570492|418211|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
123471|NCT00570492|418212|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
123472|NCT00570492|418210|P3|16-week Single-blind Baseline Period|Adverse Event|0
123473|NCT00570492|418211|P2|16-week Single-blind Baseline Period|Adverse Event|0
123474|NCT00570492|418212|P1|16-week Single-blind Baseline Period|Adverse Event|1
123475|NCT00570492|418210|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
123476|NCT00570492|418211|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
123477|NCT00570492|418212|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
123478|NCT00570492|418210|P3|16-week Single-blind Baseline Period|Protocol Violation|0
123479|NCT00570492|418211|P2|16-week Single-blind Baseline Period|Protocol Violation|0
123480|NCT00570492|418212|P1|16-week Single-blind Baseline Period|Protocol Violation|15
123481|NCT00570492|418210|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
123482|NCT00570492|418211|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
123483|NCT00570492|418212|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
123484|NCT00570492|418210|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
123485|NCT00570492|418211|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
123486|NCT00570492|418212|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
123487|NCT00570492|418210|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
123488|NCT00570492|418211|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
123489|NCT00570492|418212|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
123490|NCT00570401|418250|P1|Overall Study|Adverse Event|2
123491|NCT00570310|418284|P2|Overall Study|Lack of Efficacy|4
123492|NCT00570310|418285|P1|Overall Study|Lack of Efficacy|1
123493|NCT00570310|418284|P2|Overall Study|Adverse Event|2
123494|NCT00570310|418285|P1|Overall Study|Adverse Event|1
123495|NCT00570232|418293|P1|Overall Study|discontinued due to noncompliance|2
123496|NCT00570232|418293|P1|Overall Study|discontinued due to recurrence|8
123497|NCT00570232|418293|P1|Overall Study|discontinued due to medical condition|3
123498|NCT00570232|418293|P1|Overall Study|Adverse Event|10
123499|NCT00570141|418299|P1|Overall Study|Lost to Follow-up|1
123500|NCT00570141|418299|P1|Overall Study|Missed visits|1
123501|NCT00570141|418299|P1|Overall Study|Adverse Event|1
123502|NCT00570037|418315|P2|Overall Study|Could not reach for 6-8 week contact|69
123503|NCT00570037|418316|P1|Overall Study|Could not reach for 6-8 week contact|44
123504|NCT00569946|418326|P1|Overall Study|Global Deterioration of Health Status|1
123505|NCT00569946|418326|P1|Overall Study|Objective Progression or Relapse|42
123506|NCT00569946|418326|P1|Overall Study|Adverse Event|16
123507|NCT00569803|418358|P8|Overall Study|Withdrawal by Subject|1
123508|NCT00569803|418359|P7|Overall Study|Withdrawal by Subject|0
123509|NCT00569803|418360|P6|Overall Study|Withdrawal by Subject|0
123510|NCT00569803|418361|P5|Overall Study|Withdrawal by Subject|0
123511|NCT00569803|418362|P4|Overall Study|Withdrawal by Subject|0
123512|NCT00569803|418363|P3|Overall Study|Withdrawal by Subject|0
123513|NCT00569803|418364|P2|Overall Study|Withdrawal by Subject|0
123514|NCT00569803|418365|P1|Overall Study|Withdrawal by Subject|0
123515|NCT00569803|418358|P8|Overall Study|injection syringe leaked during dosing|0
123516|NCT00569803|418359|P7|Overall Study|injection syringe leaked during dosing|0
123517|NCT00569803|418360|P6|Overall Study|injection syringe leaked during dosing|0
123518|NCT00569803|418361|P5|Overall Study|injection syringe leaked during dosing|0
123519|NCT00569803|418362|P4|Overall Study|injection syringe leaked during dosing|1
123520|NCT00569803|418363|P3|Overall Study|injection syringe leaked during dosing|0
123521|NCT00569803|418364|P2|Overall Study|injection syringe leaked during dosing|0
123522|NCT00569803|418365|P1|Overall Study|injection syringe leaked during dosing|0
123524|NCT00569803|418359|P7|Overall Study|Lost to Follow-up|0
123525|NCT00569803|418360|P6|Overall Study|Lost to Follow-up|0
123526|NCT00569803|418361|P5|Overall Study|Lost to Follow-up|0
123527|NCT00569803|418362|P4|Overall Study|Lost to Follow-up|0
123528|NCT00569803|418363|P3|Overall Study|Lost to Follow-up|0
123529|NCT00569803|418364|P2|Overall Study|Lost to Follow-up|0
123530|NCT00569803|418365|P1|Overall Study|Lost to Follow-up|1
123531|NCT00569777|418492|P2|Overall Study|pregnant|0
123532|NCT00569777|418493|P1|Overall Study|pregnant|1
123533|NCT00569777|418492|P2|Overall Study|did not meet exclusion criteria|2
123534|NCT00569777|418493|P1|Overall Study|did not meet exclusion criteria|1
123535|NCT00569777|418492|P2|Overall Study|scheduled eye surgery|1
123536|NCT00569777|418493|P1|Overall Study|scheduled eye surgery|0
123537|NCT00569777|418492|P2|Overall Study|Lost to Follow-up|0
123538|NCT00569777|418493|P1|Overall Study|Lost to Follow-up|1
123539|NCT00569777|418492|P2|Overall Study|Adverse Event|0
123540|NCT00569777|418493|P1|Overall Study|Adverse Event|3
123541|NCT00569777|418492|P2|Overall Study|Withdrawal by Subject|0
123542|NCT00569777|418493|P1|Overall Study|Withdrawal by Subject|4
123543|NCT00569582|418543|P1|Overall Study|Subject was non-compliant.|1
123544|NCT00569582|418543|P1|Overall Study|Subject was too ill to travel.|1
123545|NCT00569582|418543|P1|Overall Study|Adverse Event|7
123546|NCT00569582|418543|P1|Overall Study|Death|2
123547|NCT00569582|418543|P1|Overall Study|Withdrawal by Subject|5
123548|NCT00569374|418559|P1|Overall Study|Withdrawal by Subject|4
123549|NCT00569270|418569|P2|Period: First Intervention|Protocol Violation|1
123550|NCT00569270|418570|P1|Period: First Intervention|Protocol Violation|0
123551|NCT00569231|418605|P1|Overall Study|Non-compliance|2
123552|NCT00569231|418605|P1|Overall Study|Car accident injury|1
123553|NCT00569231|418605|P1|Overall Study|Withdrawal by Subject|1
123554|NCT00569231|418605|P1|Overall Study|Airfare expense|2
123555|NCT00569231|418605|P1|Overall Study|Study unrelated surgery|1
123556|NCT00569166|418643|P3|Overall Study|Lost to Follow-up|1
123557|NCT00569166|418644|P2|Overall Study|Lost to Follow-up|1
123558|NCT00569166|418645|P1|Overall Study|Lost to Follow-up|2
123559|NCT00569166|418643|P3|Overall Study|Withdrawal by Subject|3
123560|NCT00569166|418644|P2|Overall Study|Withdrawal by Subject|5
123561|NCT00569166|418645|P1|Overall Study|Withdrawal by Subject|7
123562|NCT00569127|418655|P2|Overall Study|Still on Treatment|3
123563|NCT00569127|418656|P1|Overall Study|Still on Treatment|7
123564|NCT00569127|418655|P2|Overall Study|Not Eligible|11
123565|NCT00569127|418656|P1|Overall Study|Not Eligible|14
123566|NCT00569127|418655|P2|Overall Study|Lost to Follow-up|3
123567|NCT00569127|418656|P1|Overall Study|Lost to Follow-up|0
123568|NCT00569127|418655|P2|Overall Study|Not Specified|19
123569|NCT00569127|418656|P1|Overall Study|Not Specified|20
123570|NCT00569127|418655|P2|Overall Study|Death|3
123571|NCT00569127|418656|P1|Overall Study|Death|4
123572|NCT00569127|418655|P2|Overall Study|Progression|100
123573|NCT00569127|418656|P1|Overall Study|Progression|99
123574|NCT00569127|418655|P2|Overall Study|Withdrawal by Subject|27
123575|NCT00569127|418656|P1|Overall Study|Withdrawal by Subject|13
123576|NCT00569127|418655|P2|Overall Study|Adverse Event|47
123577|NCT00569127|418656|P1|Overall Study|Adverse Event|57
123578|NCT00568958|418691|P2|Follow-Up|Family Emergency|0
123579|NCT00568958|418692|P1|Follow-Up|Family Emergency|1
123580|NCT00568958|418691|P2|Follow-Up|Physician Decision|1
123581|NCT00568958|418692|P1|Follow-Up|Physician Decision|1
123582|NCT00568958|418691|P2|Follow-Up|Withdrawal by Subject|3
123583|NCT00568958|418692|P1|Follow-Up|Withdrawal by Subject|6
123584|NCT00568958|418691|P2|Allocation|Physician Decision|0
123585|NCT00568958|418692|P1|Allocation|Physician Decision|2
123586|NCT00568958|418691|P2|Allocation|Withdrawal by Subject|3
123587|NCT00568958|418692|P1|Allocation|Withdrawal by Subject|7
123588|NCT00568776|418725|P4|Overall Study|Miscellaeneous|4
123589|NCT00568776|418726|P3|Overall Study|Miscellaeneous|1
123590|NCT00568776|418727|P2|Overall Study|Miscellaeneous|3
123591|NCT00568776|418728|P1|Overall Study|Miscellaeneous|3
123592|NCT00568776|418725|P4|Overall Study|Sponsor Decision|42
123593|NCT00568776|418726|P3|Overall Study|Sponsor Decision|41
123594|NCT00568776|418727|P2|Overall Study|Sponsor Decision|2
123595|NCT00568776|418728|P1|Overall Study|Sponsor Decision|2
123596|NCT00568776|418725|P4|Overall Study|Loss of Caregiver|2
123597|NCT00568776|418726|P3|Overall Study|Loss of Caregiver|1
123598|NCT00568776|418727|P2|Overall Study|Loss of Caregiver|2
123599|NCT00568776|418728|P1|Overall Study|Loss of Caregiver|0
123600|NCT00568776|418725|P4|Overall Study|Withdrawal by Subject|7
123601|NCT00568776|418726|P3|Overall Study|Withdrawal by Subject|13
123602|NCT00568776|418727|P2|Overall Study|Withdrawal by Subject|15
123603|NCT00568776|418728|P1|Overall Study|Withdrawal by Subject|13
123604|NCT00568776|418725|P4|Overall Study|Protocol Violation|1
123605|NCT00568776|418726|P3|Overall Study|Protocol Violation|1
123606|NCT00568776|418727|P2|Overall Study|Protocol Violation|0
123607|NCT00568776|418728|P1|Overall Study|Protocol Violation|1
123608|NCT00568776|418725|P4|Overall Study|Lost to Follow-up|1
123609|NCT00568776|418726|P3|Overall Study|Lost to Follow-up|1
123610|NCT00568776|418727|P2|Overall Study|Lost to Follow-up|1
123611|NCT00568776|418728|P1|Overall Study|Lost to Follow-up|1
123612|NCT00568776|418725|P4|Overall Study|Lack of Efficacy|4
123613|NCT00568776|418726|P3|Overall Study|Lack of Efficacy|2
123614|NCT00568776|418727|P2|Overall Study|Lack of Efficacy|2
123615|NCT00568776|418728|P1|Overall Study|Lack of Efficacy|2
123616|NCT00568776|418725|P4|Overall Study|Physician Decision|0
123617|NCT00568776|418726|P3|Overall Study|Physician Decision|0
123618|NCT00568776|418727|P2|Overall Study|Physician Decision|2
123619|NCT00568776|418728|P1|Overall Study|Physician Decision|0
123620|NCT00568776|418725|P4|Overall Study|Death|3
123621|NCT00568776|418726|P3|Overall Study|Death|4
123622|NCT00568776|418727|P2|Overall Study|Death|1
123623|NCT00568776|418728|P1|Overall Study|Death|0
123624|NCT00568776|418725|P4|Overall Study|Adverse Event|8
123625|NCT00568776|418726|P3|Overall Study|Adverse Event|10
123626|NCT00568776|418727|P2|Overall Study|Adverse Event|8
123627|NCT00568776|418728|P1|Overall Study|Adverse Event|8
123628|NCT00568685|418765|P3|Overall Study|Protocol Violation|0
123629|NCT00568685|418766|P2|Overall Study|Protocol Violation|0
123630|NCT00568685|418767|P1|Overall Study|Protocol Violation|1
123631|NCT00568685|418765|P3|Overall Study|Withdrawal by Subject|2
123632|NCT00568685|418766|P2|Overall Study|Withdrawal by Subject|2
123633|NCT00568685|418767|P1|Overall Study|Withdrawal by Subject|7
123634|NCT00568685|418765|P3|Overall Study|Adverse Event|3
123635|NCT00568685|418766|P2|Overall Study|Adverse Event|3
123636|NCT00568685|418767|P1|Overall Study|Adverse Event|2
123637|NCT00568555|418801|P2|Overall Study|Withdrawal by Subject|1
123638|NCT00568555|418802|P1|Overall Study|Withdrawal by Subject|1
123639|NCT00568451|418820|P4|Overall Study|Disease Progression|7
123640|NCT00568451|418821|P3|Overall Study|Disease Progression|2
123641|NCT00568451|418822|P2|Overall Study|Disease Progression|0
123642|NCT00568451|418823|P1|Overall Study|Disease Progression|0
123643|NCT00568399|418839|P1|Overall Study|Withdrawal by Subject|8
123644|NCT00568399|418839|P1|Overall Study|Adverse Event|5
123645|NCT00568399|418839|P1|Overall Study|Death|2
123646|NCT00568178|418854|P6|Open Label Extension|Withdrawal by Subject|4
123647|NCT00568178|418855|P5|Open Label Extension|Withdrawal by Subject|4
123648|NCT00568178|418856|P4|Open Label Extension|Withdrawal by Subject|0
123649|NCT00568178|418857|P3|Open Label Extension|Withdrawal by Subject|0
123650|NCT00568178|418858|P2|Open Label Extension|Withdrawal by Subject|0
123651|NCT00568178|418859|P1|Open Label Extension|Withdrawal by Subject|0
123652|NCT00568178|418854|P6|Open Label Extension|Termination of Trial|47
123653|NCT00568178|418855|P5|Open Label Extension|Termination of Trial|45
123654|NCT00568178|418856|P4|Open Label Extension|Termination of Trial|0
123655|NCT00568178|418857|P3|Open Label Extension|Termination of Trial|0
123656|NCT00568178|418858|P2|Open Label Extension|Termination of Trial|0
123657|NCT00568178|418859|P1|Open Label Extension|Termination of Trial|0
123658|NCT00568178|418854|P6|Open Label Extension|Progressive Disease|1
123659|NCT00568178|418855|P5|Open Label Extension|Progressive Disease|3
123660|NCT00568178|418856|P4|Open Label Extension|Progressive Disease|0
123661|NCT00568178|418857|P3|Open Label Extension|Progressive Disease|0
123662|NCT00568178|418858|P2|Open Label Extension|Progressive Disease|0
123663|NCT00568178|418859|P1|Open Label Extension|Progressive Disease|0
123664|NCT00568178|418854|P6|Open Label Extension|Pregnancy|1
123665|NCT00568178|418855|P5|Open Label Extension|Pregnancy|0
123666|NCT00568178|418856|P4|Open Label Extension|Pregnancy|0
123667|NCT00568178|418857|P3|Open Label Extension|Pregnancy|0
123668|NCT00568178|418858|P2|Open Label Extension|Pregnancy|0
123669|NCT00568178|418859|P1|Open Label Extension|Pregnancy|0
123670|NCT00568178|418854|P6|Open Label Extension|Physician Decision|8
123671|NCT00568178|418855|P5|Open Label Extension|Physician Decision|9
123672|NCT00568178|418856|P4|Open Label Extension|Physician Decision|0
123673|NCT00568178|418857|P3|Open Label Extension|Physician Decision|0
123674|NCT00568178|418858|P2|Open Label Extension|Physician Decision|0
123675|NCT00568178|418859|P1|Open Label Extension|Physician Decision|0
123676|NCT00568178|418854|P6|Open Label Extension|Lost to Follow-up|11
123677|NCT00568178|418855|P5|Open Label Extension|Lost to Follow-up|6
123678|NCT00568178|418856|P4|Open Label Extension|Lost to Follow-up|0
123679|NCT00568178|418857|P3|Open Label Extension|Lost to Follow-up|0
123680|NCT00568178|418858|P2|Open Label Extension|Lost to Follow-up|0
123681|NCT00568178|418859|P1|Open Label Extension|Lost to Follow-up|0
123682|NCT00568178|418854|P6|Open Label Extension|Protocol Violation|0
123683|NCT00568178|418855|P5|Open Label Extension|Protocol Violation|1
123684|NCT00568178|418856|P4|Open Label Extension|Protocol Violation|0
123685|NCT00568178|418857|P3|Open Label Extension|Protocol Violation|0
123686|NCT00568178|418858|P2|Open Label Extension|Protocol Violation|0
123687|NCT00568178|418859|P1|Open Label Extension|Protocol Violation|0
123688|NCT00568178|418854|P6|Open Label Extension|Adverse Event|8
123689|NCT00568178|418855|P5|Open Label Extension|Adverse Event|11
123690|NCT00568178|418856|P4|Open Label Extension|Adverse Event|0
123691|NCT00568178|418857|P3|Open Label Extension|Adverse Event|0
123692|NCT00568178|418858|P2|Open Label Extension|Adverse Event|0
123693|NCT00568178|418859|P1|Open Label Extension|Adverse Event|0
123694|NCT00568178|418854|P6|Double Blind Base Study|Progressive Disease|0
123695|NCT00568178|418855|P5|Double Blind Base Study|Progressive Disease|0
123696|NCT00568178|418856|P4|Double Blind Base Study|Progressive Disease|1
123697|NCT00568178|418857|P3|Double Blind Base Study|Progressive Disease|0
123698|NCT00568178|418858|P2|Double Blind Base Study|Progressive Disease|0
123699|NCT00568178|418859|P1|Double Blind Base Study|Progressive Disease|0
123700|NCT00568178|418854|P6|Double Blind Base Study|Withdrawal by Subject|0
123701|NCT00568178|418855|P5|Double Blind Base Study|Withdrawal by Subject|0
123702|NCT00568178|418856|P4|Double Blind Base Study|Withdrawal by Subject|0
123703|NCT00568178|418857|P3|Double Blind Base Study|Withdrawal by Subject|0
123704|NCT00568178|418858|P2|Double Blind Base Study|Withdrawal by Subject|1
123705|NCT00568178|418859|P1|Double Blind Base Study|Withdrawal by Subject|1
123706|NCT00568178|418854|P6|Double Blind Base Study|Protocol Violation|0
123707|NCT00568178|418855|P5|Double Blind Base Study|Protocol Violation|0
123708|NCT00568178|418856|P4|Double Blind Base Study|Protocol Violation|0
123709|NCT00568178|418857|P3|Double Blind Base Study|Protocol Violation|0
123710|NCT00568178|418858|P2|Double Blind Base Study|Protocol Violation|2
123711|NCT00568178|418859|P1|Double Blind Base Study|Protocol Violation|3
123712|NCT00568178|418854|P6|Double Blind Base Study|Physician Decision|0
123713|NCT00568178|418855|P5|Double Blind Base Study|Physician Decision|0
123714|NCT00568178|418856|P4|Double Blind Base Study|Physician Decision|1
123715|NCT00568178|418857|P3|Double Blind Base Study|Physician Decision|0
123716|NCT00568178|418858|P2|Double Blind Base Study|Physician Decision|1
123717|NCT00568178|418859|P1|Double Blind Base Study|Physician Decision|1
123718|NCT00568178|418854|P6|Double Blind Base Study|Lost to Follow-up|0
123719|NCT00568178|418855|P5|Double Blind Base Study|Lost to Follow-up|0
123720|NCT00568178|418856|P4|Double Blind Base Study|Lost to Follow-up|1
123721|NCT00568178|418857|P3|Double Blind Base Study|Lost to Follow-up|0
123722|NCT00568178|418858|P2|Double Blind Base Study|Lost to Follow-up|0
123723|NCT00568178|418859|P1|Double Blind Base Study|Lost to Follow-up|1
123724|NCT00568178|418854|P6|Double Blind Base Study|Adverse Event|0
123725|NCT00568178|418855|P5|Double Blind Base Study|Adverse Event|0
123726|NCT00568178|418856|P4|Double Blind Base Study|Adverse Event|2
123727|NCT00568178|418857|P3|Double Blind Base Study|Adverse Event|1
123728|NCT00568178|418858|P2|Double Blind Base Study|Adverse Event|2
123729|NCT00568178|418859|P1|Double Blind Base Study|Adverse Event|0
123730|NCT00568061|418890|P2|Overall Study|Adverse Event|1
123731|NCT00568061|418891|P1|Overall Study|Adverse Event|0
123732|NCT00568061|418890|P2|Overall Study|Inclusion / exclusion criteria|1
123733|NCT00568061|418891|P1|Overall Study|Inclusion / exclusion criteria|5
123734|NCT00567996|418935|P3|Overall Study|Patient's inability to use the device|0
123735|NCT00567996|418936|P2|Overall Study|Patient's inability to use the device|1
123736|NCT00567996|418937|P1|Overall Study|Patient's inability to use the device|0
123737|NCT00567996|418935|P3|Overall Study|Death|2
123738|NCT00567996|418936|P2|Overall Study|Death|0
123739|NCT00567996|418937|P1|Overall Study|Death|1
123740|NCT00567996|418935|P3|Overall Study|Administrative problems|0
123741|NCT00567996|418936|P2|Overall Study|Administrative problems|1
123742|NCT00567996|418937|P1|Overall Study|Administrative problems|1
123743|NCT00567996|418935|P3|Overall Study|Unsatisfactory therapeutic effect|15
123744|NCT00567996|418936|P2|Overall Study|Unsatisfactory therapeutic effect|2
123745|NCT00567996|418937|P1|Overall Study|Unsatisfactory therapeutic effect|1
123746|NCT00567996|418935|P3|Overall Study|Lost to Follow-up|2
123747|NCT00567996|418936|P2|Overall Study|Lost to Follow-up|5
123748|NCT00567996|418937|P1|Overall Study|Lost to Follow-up|2
123749|NCT00567996|418935|P3|Overall Study|Abnormal test procedure result(s)|1
123750|NCT00567996|418936|P2|Overall Study|Abnormal test procedure result(s)|1
123751|NCT00567996|418937|P1|Overall Study|Abnormal test procedure result(s)|2
123752|NCT00567996|418935|P3|Overall Study|Abnormal Lab value(s)|2
123753|NCT00567996|418936|P2|Overall Study|Abnormal Lab value(s)|1
123754|NCT00567996|418937|P1|Overall Study|Abnormal Lab value(s)|2
123755|NCT00567996|418935|P3|Overall Study|Withdrawal by Subject|22
123756|NCT00567996|418936|P2|Overall Study|Withdrawal by Subject|12
123757|NCT00567996|418937|P1|Overall Study|Withdrawal by Subject|8
123758|NCT00567996|418935|P3|Overall Study|Protocol Deviation|13
123759|NCT00567996|418936|P2|Overall Study|Protocol Deviation|11
123760|NCT00567996|418937|P1|Overall Study|Protocol Deviation|9
123761|NCT00567996|418935|P3|Overall Study|Adverse Event|13
123762|NCT00567996|418936|P2|Overall Study|Adverse Event|16
123763|NCT00567996|418937|P1|Overall Study|Adverse Event|18
123764|NCT00567892|418953|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
123765|NCT00567892|418954|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
123766|NCT00567892|418955|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
123767|NCT00567892|418956|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
123768|NCT00567892|418953|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
123769|NCT00567892|418954|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
123770|NCT00567892|418955|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
123771|NCT00567892|418956|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
123772|NCT00567879|418974|P6|Overall Study|Disease progression|3
123773|NCT00567879|418975|P5|Overall Study|Disease progression|11
123774|NCT00567879|418976|P4|Overall Study|Disease progression|5
123775|NCT00567879|418977|P3|Overall Study|Disease progression|15
123776|NCT00567879|418978|P2|Overall Study|Disease progression|7
123777|NCT00567879|418979|P1|Overall Study|Disease progression|5
123778|NCT00567879|418974|P6|Overall Study|New cancer therapy|0
123779|NCT00567879|418975|P5|Overall Study|New cancer therapy|0
123780|NCT00567879|418976|P4|Overall Study|New cancer therapy|0
123781|NCT00567879|418977|P3|Overall Study|New cancer therapy|1
123782|NCT00567879|418978|P2|Overall Study|New cancer therapy|0
123783|NCT00567879|418979|P1|Overall Study|New cancer therapy|0
123784|NCT00567879|418974|P6|Overall Study|Withdrawal by Subject|0
123785|NCT00567879|418975|P5|Overall Study|Withdrawal by Subject|0
123786|NCT00567879|418976|P4|Overall Study|Withdrawal by Subject|1
123787|NCT00567879|418977|P3|Overall Study|Withdrawal by Subject|3
123788|NCT00567879|418978|P2|Overall Study|Withdrawal by Subject|0
123789|NCT00567879|418979|P1|Overall Study|Withdrawal by Subject|0
123790|NCT00567879|418974|P6|Overall Study|Abnormal test procedure(s)|0
123791|NCT00567879|418975|P5|Overall Study|Abnormal test procedure(s)|0
123792|NCT00567879|418976|P4|Overall Study|Abnormal test procedure(s)|0
123793|NCT00567879|418977|P3|Overall Study|Abnormal test procedure(s)|1
123794|NCT00567879|418978|P2|Overall Study|Abnormal test procedure(s)|0
123795|NCT00567879|418979|P1|Overall Study|Abnormal test procedure(s)|0
123796|NCT00567879|418974|P6|Overall Study|Adverse Event|0
123797|NCT00567879|418975|P5|Overall Study|Adverse Event|1
123798|NCT00567879|418976|P4|Overall Study|Adverse Event|0
123799|NCT00567879|418977|P3|Overall Study|Adverse Event|1
123800|NCT00567879|418978|P2|Overall Study|Adverse Event|0
123801|NCT00567879|418979|P1|Overall Study|Adverse Event|2
123802|NCT00567593|419000|P1|Overall Study|Physician Decision|1
123803|NCT00567593|419000|P1|Overall Study|Adverse Event|1
123804|NCT00567541|419006|P2|Overall Study|Adverse Event|1
123805|NCT00567541|419007|P1|Overall Study|Adverse Event|0
123806|NCT00567502|419017|P4|Overall Study|Never Initiated Treatment|72
123807|NCT00567502|419018|P3|Overall Study|Never Initiated Treatment|0
123808|NCT00567502|419019|P2|Overall Study|Never Initiated Treatment|0
123809|NCT00567502|419020|P1|Overall Study|Never Initiated Treatment|0
123810|NCT00567502|419017|P4|Overall Study|Sponsor request|1
123811|NCT00567502|419018|P3|Overall Study|Sponsor request|30
123812|NCT00567502|419019|P2|Overall Study|Sponsor request|0
123813|NCT00567502|419020|P1|Overall Study|Sponsor request|9
123814|NCT00567502|419017|P4|Overall Study|Participant request|1
123815|NCT00567502|419018|P3|Overall Study|Participant request|33
123816|NCT00567502|419019|P2|Overall Study|Participant request|1
123817|NCT00567502|419020|P1|Overall Study|Participant request|12
123818|NCT00567502|419017|P4|Overall Study|Unspecified|6
123819|NCT00567502|419018|P3|Overall Study|Unspecified|134
123820|NCT00567502|419019|P2|Overall Study|Unspecified|2
123821|NCT00567502|419020|P1|Overall Study|Unspecified|64
123822|NCT00567502|419017|P4|Overall Study|Death|5
123823|NCT00567502|419018|P3|Overall Study|Death|360
123824|NCT00567502|419019|P2|Overall Study|Death|16
123825|NCT00567502|419020|P1|Overall Study|Death|65
123826|NCT00567502|419017|P4|Overall Study|Lost to Follow-up|2
123827|NCT00567502|419018|P3|Overall Study|Lost to Follow-up|351
123828|NCT00567502|419019|P2|Overall Study|Lost to Follow-up|14
123829|NCT00567502|419020|P1|Overall Study|Lost to Follow-up|91
123830|NCT00567476|419057|P2|Overall Study|Non-adherence to protocol|1
123831|NCT00567476|419058|P1|Overall Study|Non-adherence to protocol|0
123832|NCT00567476|419057|P2|Overall Study|Medical Decision|1
123833|NCT00567476|419058|P1|Overall Study|Medical Decision|0
123834|NCT00567476|419057|P2|Overall Study|Administrative issues|0
123835|NCT00567476|419058|P1|Overall Study|Administrative issues|1
123836|NCT00567476|419057|P2|Overall Study|Lost to Follow-up|1
123837|NCT00567476|419058|P1|Overall Study|Lost to Follow-up|0
123838|NCT00567476|419057|P2|Overall Study|Protocol Violation|1
123839|NCT00567476|419058|P1|Overall Study|Protocol Violation|4
123840|NCT00567476|419057|P2|Overall Study|Pregnancy|0
123841|NCT00567476|419058|P1|Overall Study|Pregnancy|1
123842|NCT00567476|419057|P2|Overall Study|Adverse Event|0
123843|NCT00567476|419058|P1|Overall Study|Adverse Event|2
123844|NCT00567268|419100|P1|Overall Study|"Safety Evaluation Not Assessable"|1
123845|NCT00567268|419100|P1|Overall Study|No Drug Administration|4
123846|NCT00567268|419100|P1|Overall Study|No Visit After First Day of Treatment|2
123847|NCT00567268|419100|P1|Overall Study|Lost to Follow-up|36
123848|NCT00567268|419100|P1|Overall Study|Protocol Violation|7
123849|NCT00567255|419151|P2|Overall Study|Drug noncompliance,moved,other|15
123850|NCT00567255|419152|P1|Overall Study|Drug noncompliance,moved,other|25
123851|NCT00567255|419151|P2|Overall Study|Pregnancy|0
123852|NCT00567255|419152|P1|Overall Study|Pregnancy|6
123853|NCT00567255|419151|P2|Overall Study|Protocol Violation|8
123854|NCT00567255|419152|P1|Overall Study|Protocol Violation|20
123855|NCT00567255|419151|P2|Overall Study|Lack of Efficacy|33
123856|NCT00567255|419152|P1|Overall Study|Lack of Efficacy|19
123857|NCT00567255|419151|P2|Overall Study|Withdrawal by Subject|56
123858|NCT00567255|419152|P1|Overall Study|Withdrawal by Subject|75
123859|NCT00567255|419151|P2|Overall Study|Lost to Follow-up|48
123860|NCT00567255|419152|P1|Overall Study|Lost to Follow-up|77
123861|NCT00567255|419151|P2|Overall Study|Adverse Event|68
123862|NCT00567255|419152|P1|Overall Study|Adverse Event|241
123863|NCT00567190|419215|P2|Overall Study|Withdrew Consent or Lost to Follow-up|43
123864|NCT00567190|419216|P1|Overall Study|Withdrew Consent or Lost to Follow-up|42
123865|NCT00567190|419215|P2|Overall Study|Death|221
123866|NCT00567190|419216|P1|Overall Study|Death|168
123867|NCT00567164|419236|P3|Overall Study|Missing|0
123868|NCT00567164|419237|P2|Overall Study|Missing|0
123869|NCT00567164|419238|P1|Overall Study|Missing|1
123870|NCT00567164|419236|P3|Overall Study|Primary Reason coded as 'Other'|16
123871|NCT00567164|419237|P2|Overall Study|Primary Reason coded as 'Other'|8
123872|NCT00567164|419238|P1|Overall Study|Primary Reason coded as 'Other'|37
123873|NCT00567164|419236|P3|Overall Study|Pregnancy|6
123874|NCT00567164|419237|P2|Overall Study|Pregnancy|4
123875|NCT00567164|419238|P1|Overall Study|Pregnancy|20
123876|NCT00567164|419236|P3|Overall Study|Lost to Follow-up|21
123877|NCT00567164|419237|P2|Overall Study|Lost to Follow-up|23
123878|NCT00567164|419238|P1|Overall Study|Lost to Follow-up|202
123879|NCT00567164|419236|P3|Overall Study|Death|1
123880|NCT00567164|419237|P2|Overall Study|Death|0
123881|NCT00567164|419238|P1|Overall Study|Death|0
123882|NCT00567164|419236|P3|Overall Study|Adverse Event|9
123883|NCT00567164|419237|P2|Overall Study|Adverse Event|13
123884|NCT00567164|419238|P1|Overall Study|Adverse Event|92
123885|NCT00567164|419236|P3|Overall Study|Protocol Violation|2
123886|NCT00567164|419237|P2|Overall Study|Protocol Violation|4
123887|NCT00567164|419238|P1|Overall Study|Protocol Violation|23
123888|NCT00567164|419236|P3|Overall Study|Withdrawal by Subject|17
123889|NCT00567164|419237|P2|Overall Study|Withdrawal by Subject|21
123890|NCT00567164|419238|P1|Overall Study|Withdrawal by Subject|171
123891|NCT00567112|419310|P3|Washout Period 3 (3 Days)|Protocol Violation|0
123892|NCT00567112|419311|P2|Washout Period 3 (3 Days)|Protocol Violation|0
123893|NCT00567112|419312|P1|Washout Period 3 (3 Days)|Protocol Violation|1
123894|NCT00567112|419310|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
123895|NCT00567112|419311|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
123896|NCT00567112|419312|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
123897|NCT00567112|419310|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
123898|NCT00567112|419311|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
123899|NCT00567112|419312|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
123900|NCT00566995|419343|P1|Overall Study|Withdrew consent|4
123901|NCT00566995|419343|P1|Overall Study|Physician Decision|1
123902|NCT00566995|419343|P1|Overall Study|Toxicity|3
123903|NCT00566982|419350|P2|Overall Study|Other-family problems & doctor's request|2
123904|NCT00566982|419351|P1|Overall Study|Other-family problems & doctor's request|0
123905|NCT00566982|419350|P2|Overall Study|Lost to Follow-up|1
123906|NCT00566982|419351|P1|Overall Study|Lost to Follow-up|0
123907|NCT00566982|419350|P2|Overall Study|Protocol Violation|4
123908|NCT00566982|419351|P1|Overall Study|Protocol Violation|1
123909|NCT00566982|419350|P2|Overall Study|Withdrawal by Subject|14
123910|NCT00566982|419351|P1|Overall Study|Withdrawal by Subject|1
123911|NCT00566982|419350|P2|Overall Study|Adverse Event|48
123912|NCT00566982|419351|P1|Overall Study|Adverse Event|6
123913|NCT00566735|419416|P2|Overall Study|Switched into a manic episode|1
123914|NCT00566735|419417|P1|Overall Study|Switched into a manic episode|0
123915|NCT00566735|419416|P2|Overall Study|Refused neuropsychological testing|5
123916|NCT00566735|419417|P1|Overall Study|Refused neuropsychological testing|2
123917|NCT00566735|419416|P2|Overall Study|Withdrawal by Subject|1
123918|NCT00566735|419417|P1|Overall Study|Withdrawal by Subject|0
123919|NCT00566722|419430|P3|Overall Study|Noncompliant with drug administration|1
123920|NCT00566722|419431|P2|Overall Study|Noncompliant with drug administration|0
123921|NCT00566722|419432|P1|Overall Study|Noncompliant with drug administration|0
123922|NCT00566722|419430|P3|Overall Study|Serious adverse event|0
123923|NCT00566722|419431|P2|Overall Study|Serious adverse event|1
123924|NCT00566722|419432|P1|Overall Study|Serious adverse event|0
123925|NCT00566722|419430|P3|Overall Study|Did not meet exclusion criteria|2
123926|NCT00566722|419431|P2|Overall Study|Did not meet exclusion criteria|0
123927|NCT00566722|419432|P1|Overall Study|Did not meet exclusion criteria|0
123928|NCT00566722|419430|P3|Overall Study|Lack of Efficacy|4
123929|NCT00566722|419431|P2|Overall Study|Lack of Efficacy|2
123930|NCT00566722|419432|P1|Overall Study|Lack of Efficacy|1
123931|NCT00566722|419430|P3|Overall Study|Lost to Follow-up|1
123932|NCT00566722|419431|P2|Overall Study|Lost to Follow-up|1
123933|NCT00566722|419432|P1|Overall Study|Lost to Follow-up|1
123934|NCT00566722|419430|P3|Overall Study|Withdrawal by Subject|1
123935|NCT00566722|419431|P2|Overall Study|Withdrawal by Subject|0
123936|NCT00566722|419432|P1|Overall Study|Withdrawal by Subject|0
123937|NCT00566722|419430|P3|Overall Study|Adverse Event|0
123938|NCT00566722|419431|P2|Overall Study|Adverse Event|1
123939|NCT00566722|419432|P1|Overall Study|Adverse Event|0
123940|NCT00566709|419478|P2|Overall Study|Protocol Violation|0
123941|NCT00566709|419479|P1|Overall Study|Protocol Violation|5
123942|NCT00566696|419495|P1|Overall Study|Non-Patient Donors|37
123943|NCT00566696|419495|P1|Overall Study|Physician Decision|1
123944|NCT00566696|419495|P1|Overall Study|Health Status Change|1
123945|NCT00566696|419495|P1|Overall Study|Muromonab not available|1
123946|NCT00566696|419495|P1|Overall Study|Met Exclusion Criteria|2
123947|NCT00566631|419503|P1|Part 2: Extension Phase|Unspecified|5
123948|NCT00566631|419503|P1|Part 2: Extension Phase|Death|1
123949|NCT00566631|419503|P1|Part 2: Extension Phase|Lost to Follow-up|6
123950|NCT00566631|419503|P1|Part 2: Extension Phase|Adverse Event|11
123951|NCT00566631|419503|P1|Part 2: Extension Phase|Withdrawal by Subject|34
123952|NCT00566631|419503|P1|Part 2: Extension Phase|Lack of Efficacy|25
123953|NCT00566631|419503|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
123954|NCT00566631|419503|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
123955|NCT00566631|419503|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
123956|NCT00566631|419503|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
123957|NCT00566631|419503|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
123958|NCT00566631|419503|P1|Part 1: Core Treatment Phase|Adverse Event|9
123959|NCT00566631|419503|P1|Part 1: Core Treatment Phase|Physician Decision|1
123960|NCT00566631|419503|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
123961|NCT00566254|419543|P2|Overall Study|Not Specified|2
123962|NCT00566254|419544|P1|Overall Study|Not Specified|0
123963|NCT00566254|419543|P2|Overall Study|Lack of Efficacy|6
123964|NCT00566254|419544|P1|Overall Study|Lack of Efficacy|5
123965|NCT00566254|419543|P2|Overall Study|Withdrawal by Subject|2
123966|NCT00566254|419544|P1|Overall Study|Withdrawal by Subject|1
123967|NCT00566254|419543|P2|Overall Study|Protocol Violation|3
123968|NCT00566254|419544|P1|Overall Study|Protocol Violation|1
123969|NCT00566254|419543|P2|Overall Study|Adverse Event|1
123970|NCT00566254|419544|P1|Overall Study|Adverse Event|3
123971|NCT00566111|419573|P2|Overall Study|Adverse Event|2
123972|NCT00566111|419574|P1|Overall Study|Adverse Event|0
123973|NCT00566020|419588|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
123974|NCT00566020|419589|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
123975|NCT00566020|419588|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
123976|NCT00566020|419589|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
123977|NCT00566020|419588|P2|46-week Long-term Administration Phase|Physician Decision|7
123978|NCT00566020|419589|P1|46-week Long-term Administration Phase|Physician Decision|0
123979|NCT00566020|419588|P2|46-week Long-term Administration Phase|Adverse Event|7
123980|NCT00566020|419589|P1|46-week Long-term Administration Phase|Adverse Event|0
123981|NCT00566020|419588|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
123982|NCT00566020|419589|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
123983|NCT00566020|419588|P2|6-week Dosage Adjustment Phase|Adverse Event|0
123984|NCT00566020|419589|P1|6-week Dosage Adjustment Phase|Adverse Event|5
123985|NCT00565812|419617|P3|Overall Study|Physician Decision|0
123986|NCT00565812|419618|P2|Overall Study|Physician Decision|0
123987|NCT00565812|419619|P1|Overall Study|Physician Decision|2
123988|NCT00565812|419617|P3|Overall Study|Follow-up Visit Not Completed|1
123989|NCT00565812|419618|P2|Overall Study|Follow-up Visit Not Completed|0
123990|NCT00565812|419619|P1|Overall Study|Follow-up Visit Not Completed|2
123991|NCT00565812|419617|P3|Overall Study|Low Compliance|1
123992|NCT00565812|419618|P2|Overall Study|Low Compliance|0
123993|NCT00565812|419619|P1|Overall Study|Low Compliance|1
123994|NCT00565812|419617|P3|Overall Study|Surgical Intervention|2
123995|NCT00565812|419618|P2|Overall Study|Surgical Intervention|1
123996|NCT00565812|419619|P1|Overall Study|Surgical Intervention|0
123997|NCT00565812|419617|P3|Overall Study|Research Site Closure|8
123998|NCT00565812|419618|P2|Overall Study|Research Site Closure|1
123999|NCT00565812|419619|P1|Overall Study|Research Site Closure|6
124000|NCT00565812|419617|P3|Overall Study|Domestic Reasons|3
124001|NCT00565812|419618|P2|Overall Study|Domestic Reasons|1
124002|NCT00565812|419619|P1|Overall Study|Domestic Reasons|7
124003|NCT00565812|419617|P3|Overall Study|Sponsor Decision|1
124004|NCT00565812|419618|P2|Overall Study|Sponsor Decision|5
124005|NCT00565812|419619|P1|Overall Study|Sponsor Decision|1
124006|NCT00565812|419617|P3|Overall Study|Relocated Out of Area|9
124007|NCT00565812|419618|P2|Overall Study|Relocated Out of Area|8
124008|NCT00565812|419619|P1|Overall Study|Relocated Out of Area|5
124009|NCT00565812|419617|P3|Overall Study|Jury Duty|0
124010|NCT00565812|419618|P2|Overall Study|Jury Duty|0
124011|NCT00565812|419619|P1|Overall Study|Jury Duty|1
124012|NCT00565812|419617|P3|Overall Study|Adverse Event|40
124013|NCT00565812|419618|P2|Overall Study|Adverse Event|54
124014|NCT00565812|419619|P1|Overall Study|Adverse Event|41
124015|NCT00565812|419617|P3|Overall Study|Protocol Violation|4
124016|NCT00565812|419618|P2|Overall Study|Protocol Violation|6
124017|NCT00565812|419619|P1|Overall Study|Protocol Violation|2
124018|NCT00565812|419617|P3|Overall Study|Work Schedule|1
124019|NCT00565812|419618|P2|Overall Study|Work Schedule|3
124020|NCT00565812|419619|P1|Overall Study|Work Schedule|5
124021|NCT00565812|419617|P3|Overall Study|Withdrawal by Subject|48
124022|NCT00565812|419618|P2|Overall Study|Withdrawal by Subject|47
124023|NCT00565812|419619|P1|Overall Study|Withdrawal by Subject|58
124024|NCT00565812|419617|P3|Overall Study|Lost to Follow-up|8
124025|NCT00565812|419618|P2|Overall Study|Lost to Follow-up|8
124026|NCT00565812|419619|P1|Overall Study|Lost to Follow-up|10
124027|NCT00565812|419617|P3|Overall Study|Did not Meet Entrance Criteria|1
124028|NCT00565812|419618|P2|Overall Study|Did not Meet Entrance Criteria|0
124029|NCT00565812|419619|P1|Overall Study|Did not Meet Entrance Criteria|1
124030|NCT00565812|419617|P3|Overall Study|Death|3
124031|NCT00565812|419618|P2|Overall Study|Death|1
124032|NCT00565812|419619|P1|Overall Study|Death|2
124033|NCT00565747|419758|P2|Overall Study|No embryo transfer|73
124034|NCT00565747|419759|P1|Overall Study|No embryo transfer|67
124035|NCT00565721|419769|P1|Overall Study|Other reasons|6
124036|NCT00565721|419769|P1|Overall Study|Physician Decision|2
124037|NCT00565721|419769|P1|Overall Study|Technical Problems|1
124038|NCT00565721|419769|P1|Overall Study|Lost to Follow-up|6
124039|NCT00565721|419769|P1|Overall Study|Screen Failure|2
124040|NCT00565604|419809|P1|Overall Study|Lost to Follow-up|2
124041|NCT00565604|419809|P1|Overall Study|Failure to treat|2
124042|NCT00565448|419837|P2|Overall Study|Withdrawal by Subject|0
124043|NCT00565448|419838|P1|Overall Study|Withdrawal by Subject|1
124044|NCT00565448|419837|P2|Overall Study|Disease progression|0
124045|NCT00565448|419838|P1|Overall Study|Disease progression|1
124046|NCT00565448|419837|P2|Overall Study|Adverse Event|2
124047|NCT00565448|419838|P1|Overall Study|Adverse Event|1
124048|NCT00565409|419849|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
124049|NCT00565409|419850|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
124050|NCT00565409|419851|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
124051|NCT00565409|419852|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
124052|NCT00565409|419849|P4|Period 2 Double-Blind|unspecified|9
124053|NCT00565409|419850|P3|Period 2 Double-Blind|unspecified|5
124054|NCT00565409|419851|P2|Period 2 Double-Blind|unspecified|4
124055|NCT00565409|419852|P1|Period 2 Double-Blind|unspecified|0
124056|NCT00565409|419849|P4|Period 2 Double-Blind|Lost to Follow-up|0
124057|NCT00565409|419850|P3|Period 2 Double-Blind|Lost to Follow-up|1
124058|NCT00565409|419851|P2|Period 2 Double-Blind|Lost to Follow-up|0
124059|NCT00565409|419852|P1|Period 2 Double-Blind|Lost to Follow-up|0
124060|NCT00565409|419849|P4|Period 2 Double-Blind|Protocol Violation|2
124061|NCT00565409|419850|P3|Period 2 Double-Blind|Protocol Violation|6
124062|NCT00565409|419851|P2|Period 2 Double-Blind|Protocol Violation|4
124063|NCT00565409|419852|P1|Period 2 Double-Blind|Protocol Violation|0
124064|NCT00565409|419849|P4|Period 2 Double-Blind|Death|0
124065|NCT00565409|419850|P3|Period 2 Double-Blind|Death|0
124066|NCT00565409|419851|P2|Period 2 Double-Blind|Death|2
124067|NCT00565409|419852|P1|Period 2 Double-Blind|Death|0
124068|NCT00565409|419849|P4|Period 2 Double-Blind|Adverse Event|5
124069|NCT00565409|419850|P3|Period 2 Double-Blind|Adverse Event|4
124070|NCT00565409|419851|P2|Period 2 Double-Blind|Adverse Event|7
124071|NCT00565409|419852|P1|Period 2 Double-Blind|Adverse Event|0
124072|NCT00565409|419849|P4|After Period 1, Prior to Period 2|did not meet criteria|0
124073|NCT00565409|419850|P3|After Period 1, Prior to Period 2|did not meet criteria|0
124074|NCT00565409|419851|P2|After Period 1, Prior to Period 2|did not meet criteria|0
124075|NCT00565409|419852|P1|After Period 1, Prior to Period 2|did not meet criteria|152
124076|NCT00565409|419849|P4|Period 1 Open Label|no conclusion of participation record|0
124077|NCT00565409|419850|P3|Period 1 Open Label|no conclusion of participation record|0
124078|NCT00565409|419851|P2|Period 1 Open Label|no conclusion of participation record|0
124079|NCT00565409|419852|P1|Period 1 Open Label|no conclusion of participation record|1
124080|NCT00565409|419849|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
124081|NCT00565409|419850|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
124082|NCT00565409|419851|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
124083|NCT00565409|419852|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
124084|NCT00565409|419849|P4|Period 1 Open Label|Protocol Violation|0
124085|NCT00565409|419850|P3|Period 1 Open Label|Protocol Violation|0
124086|NCT00565409|419851|P2|Period 1 Open Label|Protocol Violation|0
124087|NCT00565409|419852|P1|Period 1 Open Label|Protocol Violation|14
124088|NCT00565409|419849|P4|Period 1 Open Label|unspecified|0
124089|NCT00565409|419850|P3|Period 1 Open Label|unspecified|0
124090|NCT00565409|419851|P2|Period 1 Open Label|unspecified|0
124091|NCT00565409|419852|P1|Period 1 Open Label|unspecified|21
124092|NCT00565409|419849|P4|Period 1 Open Label|Lost to Follow-up|0
124093|NCT00565409|419850|P3|Period 1 Open Label|Lost to Follow-up|0
124094|NCT00565409|419851|P2|Period 1 Open Label|Lost to Follow-up|0
124095|NCT00565409|419852|P1|Period 1 Open Label|Lost to Follow-up|1
124096|NCT00565409|419849|P4|Period 1 Open Label|Death|0
124097|NCT00565409|419850|P3|Period 1 Open Label|Death|0
124098|NCT00565409|419851|P2|Period 1 Open Label|Death|0
124099|NCT00565409|419852|P1|Period 1 Open Label|Death|2
124100|NCT00565409|419849|P4|Period 1 Open Label|Adverse Event|0
124101|NCT00565409|419850|P3|Period 1 Open Label|Adverse Event|0
124102|NCT00565409|419851|P2|Period 1 Open Label|Adverse Event|0
124103|NCT00565409|419852|P1|Period 1 Open Label|Adverse Event|17
124104|NCT00565136|419970|P1|Overall Study|Protocol Violation|1
124105|NCT00565136|419970|P1|Overall Study|Withdrawal by Subject|1
124106|NCT00565136|419970|P1|Overall Study|Lost to Follow-up|1
124107|NCT00565058|420000|P2|Overall Study|Adverse Event|0
124108|NCT00565058|420001|P1|Overall Study|Adverse Event|1
124109|NCT00564902|420048|P3|Overall Study|Death|0
124110|NCT00564902|420049|P2|Overall Study|Death|1
124111|NCT00564902|420050|P1|Overall Study|Death|1
124112|NCT00564902|420048|P3|Overall Study|Withdrawal by Subject|4
124113|NCT00564902|420049|P2|Overall Study|Withdrawal by Subject|3
124114|NCT00564902|420050|P1|Overall Study|Withdrawal by Subject|0
124115|NCT00564889|420082|P1|Overall Study|Other, not specified|4
124116|NCT00564889|420082|P1|Overall Study|Disease progression|3
124117|NCT00564889|420082|P1|Overall Study|Alternative treatment|3
124118|NCT00564889|420082|P1|Overall Study|Adverse Event|12
124119|NCT00564889|420082|P1|Overall Study|Death|7
124120|NCT00564850|420097|P1|Overall Study|Protocol Violation|2
124121|NCT00564733|420115|P1|Overall Study|Ineligible|5
124122|NCT00564733|420115|P1|Overall Study|Withdrawal by Subject|4
124123|NCT00564629|420149|P2|Overall Study|Vomited within 2 hours of receiving drug|9
124124|NCT00564629|420150|P1|Overall Study|Vomited within 2 hours of receiving drug|15
124125|NCT00564486|420175|P4|Overall Study|Lost to Follow-up|2
124126|NCT00564486|420176|P3|Overall Study|Lost to Follow-up|2
124127|NCT00564486|420177|P2|Overall Study|Lost to Follow-up|0
124128|NCT00564486|420178|P1|Overall Study|Lost to Follow-up|3
124129|NCT00564486|420175|P4|Overall Study|Subject refused to have blood drawn|0
124130|NCT00564486|420176|P3|Overall Study|Subject refused to have blood drawn|1
124131|NCT00564486|420177|P2|Overall Study|Subject refused to have blood drawn|0
124132|NCT00564486|420178|P1|Overall Study|Subject refused to have blood drawn|0
124133|NCT00564486|420175|P4|Overall Study|Withdrawal by Subject|5
124134|NCT00564486|420176|P3|Overall Study|Withdrawal by Subject|0
124135|NCT00564486|420177|P2|Overall Study|Withdrawal by Subject|0
124136|NCT00564486|420178|P1|Overall Study|Withdrawal by Subject|4
124137|NCT00564486|420175|P4|Overall Study|Adverse Event|0
124138|NCT00564486|420176|P3|Overall Study|Adverse Event|0
124139|NCT00564486|420177|P2|Overall Study|Adverse Event|1
124140|NCT00564486|420178|P1|Overall Study|Adverse Event|0
124141|NCT00564278|420229|P2|Overall Study|Withdrawal by Subject|7
124142|NCT00564278|420230|P1|Overall Study|Withdrawal by Subject|11
124143|NCT00564278|420229|P2|Overall Study|Physician Decision|2
124144|NCT00564278|420230|P1|Overall Study|Physician Decision|1
124145|NCT00564278|420229|P2|Overall Study|Lost to Follow-up|33
124146|NCT00564278|420230|P1|Overall Study|Lost to Follow-up|35
124147|NCT00563797|420252|P2|Overall Study|Lost to Follow-up|2
124148|NCT00563797|420253|P1|Overall Study|Lost to Follow-up|7
124149|NCT00563706|420274|P9|DB Treatment Period (Day 1 up to Day 28)|Unspecified|2
124150|NCT00563706|420275|P8|DB Treatment Period (Day 1 up to Day 28)|Unspecified|1
124151|NCT00563706|420276|P7|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
124152|NCT00563706|420277|P6|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
124153|NCT00563706|420278|P5|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
124154|NCT00563706|420279|P4|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
124155|NCT00563706|420280|P3|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
124156|NCT00563706|420281|P2|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
124157|NCT00563706|420282|P1|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
124158|NCT00563706|420274|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
124159|NCT00563706|420275|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
124160|NCT00563706|420276|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
124161|NCT00563706|420277|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
124162|NCT00563706|420278|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
124163|NCT00563706|420279|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
124164|NCT00563706|420280|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
124165|NCT00563706|420281|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
124166|NCT00563706|420282|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
124167|NCT00563706|420274|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
124168|NCT00563706|420275|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
124169|NCT00563706|420276|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
124170|NCT00563706|420277|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
124171|NCT00563706|420278|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
124172|NCT00563706|420279|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
124173|NCT00563706|420280|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
124174|NCT00563706|420281|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
124175|NCT00563706|420282|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
124176|NCT00563706|420274|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
124177|NCT00563706|420275|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
124178|NCT00563706|420276|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
124179|NCT00563706|420277|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
124180|NCT00563706|420278|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
124181|NCT00563706|420279|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
124182|NCT00563706|420280|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
124183|NCT00563706|420281|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
124184|NCT00563706|420282|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
124185|NCT00563706|420274|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
124186|NCT00563706|420275|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
124187|NCT00563706|420276|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
124188|NCT00563706|420277|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
124189|NCT00563706|420278|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
124190|NCT00563706|420279|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
124191|NCT00563706|420280|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
124192|NCT00563706|420281|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
124193|NCT00563706|420282|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
124194|NCT00563381|420398|P2|Overall Study|Individual different reasons|34
124195|NCT00563381|420399|P1|Overall Study|Individual different reasons|24
124196|NCT00563381|420398|P2|Overall Study|Lack of Efficacy|24
124197|NCT00563381|420399|P1|Overall Study|Lack of Efficacy|32
124198|NCT00563381|420398|P2|Overall Study|Withdrawal by Subject|209
124199|NCT00563381|420399|P1|Overall Study|Withdrawal by Subject|192
124200|NCT00563381|420398|P2|Overall Study|Lost to Follow-up|15
124201|NCT00563381|420399|P1|Overall Study|Lost to Follow-up|7
124202|NCT00563381|420398|P2|Overall Study|Protocol Violation|74
124203|NCT00563381|420399|P1|Overall Study|Protocol Violation|66
124204|NCT00563381|420398|P2|Overall Study|Adverse Event|292
124205|NCT00563381|420399|P1|Overall Study|Adverse Event|264
124206|NCT00563368|420472|P7|Overall Study|not specified|0
124207|NCT00563368|420473|P6|Overall Study|not specified|4
124208|NCT00563368|420474|P5|Overall Study|not specified|4
124209|NCT00563368|420475|P4|Overall Study|not specified|4
124210|NCT00563368|420476|P3|Overall Study|not specified|3
124211|NCT00563368|420477|P2|Overall Study|not specified|5
124212|NCT00563368|420478|P1|Overall Study|not specified|5
124213|NCT00563368|420472|P7|Overall Study|requirement for restricted medication|0
124214|NCT00563368|420473|P6|Overall Study|requirement for restricted medication|0
124215|NCT00563368|420474|P5|Overall Study|requirement for restricted medication|0
124216|NCT00563368|420475|P4|Overall Study|requirement for restricted medication|0
124217|NCT00563368|420476|P3|Overall Study|requirement for restricted medication|2
124218|NCT00563368|420477|P2|Overall Study|requirement for restricted medication|0
124219|NCT00563368|420478|P1|Overall Study|requirement for restricted medication|0
124220|NCT00563368|420472|P7|Overall Study|Pregnancy|0
124221|NCT00563368|420473|P6|Overall Study|Pregnancy|2
124222|NCT00563368|420474|P5|Overall Study|Pregnancy|1
124223|NCT00563368|420475|P4|Overall Study|Pregnancy|2
124224|NCT00563368|420476|P3|Overall Study|Pregnancy|1
124225|NCT00563368|420477|P2|Overall Study|Pregnancy|0
124226|NCT00563368|420478|P1|Overall Study|Pregnancy|1
124227|NCT00563368|420472|P7|Overall Study|protocol non-compliance|3
124228|NCT00563368|420473|P6|Overall Study|protocol non-compliance|1
124229|NCT00563368|420474|P5|Overall Study|protocol non-compliance|0
124230|NCT00563368|420475|P4|Overall Study|protocol non-compliance|1
124231|NCT00563368|420476|P3|Overall Study|protocol non-compliance|2
124232|NCT00563368|420477|P2|Overall Study|protocol non-compliance|1
124233|NCT00563368|420478|P1|Overall Study|protocol non-compliance|1
124234|NCT00563368|420472|P7|Overall Study|Withdrawal by Subject|4
124235|NCT00563368|420473|P6|Overall Study|Withdrawal by Subject|5
124236|NCT00563368|420474|P5|Overall Study|Withdrawal by Subject|8
124237|NCT00563368|420475|P4|Overall Study|Withdrawal by Subject|7
124238|NCT00563368|420476|P3|Overall Study|Withdrawal by Subject|5
124239|NCT00563368|420477|P2|Overall Study|Withdrawal by Subject|6
124240|NCT00563368|420478|P1|Overall Study|Withdrawal by Subject|11
124241|NCT00563368|420472|P7|Overall Study|Adverse Event|17
124242|NCT00563368|420473|P6|Overall Study|Adverse Event|10
124243|NCT00563368|420474|P5|Overall Study|Adverse Event|6
124244|NCT00563368|420475|P4|Overall Study|Adverse Event|9
124245|NCT00563368|420476|P3|Overall Study|Adverse Event|5
124246|NCT00563368|420477|P2|Overall Study|Adverse Event|4
124247|NCT00563368|420478|P1|Overall Study|Adverse Event|3
124248|NCT00563368|420472|P7|Overall Study|Lost to Follow-up|9
124249|NCT00563368|420473|P6|Overall Study|Lost to Follow-up|8
124250|NCT00563368|420474|P5|Overall Study|Lost to Follow-up|9
124251|NCT00563368|420475|P4|Overall Study|Lost to Follow-up|6
124252|NCT00563368|420476|P3|Overall Study|Lost to Follow-up|12
124253|NCT00563368|420477|P2|Overall Study|Lost to Follow-up|14
124254|NCT00563368|420478|P1|Overall Study|Lost to Follow-up|14
124255|NCT00563316|420501|P1|Overall Study|Other|1
124256|NCT00563316|420501|P1|Overall Study|On-going in study as of 16 July 2009.|5
124257|NCT00563316|420501|P1|Overall Study|Death|1
124258|NCT00563316|420501|P1|Overall Study|Lost to Follow-up|2
124259|NCT00563316|420501|P1|Overall Study|Physician Decision|1
124260|NCT00563316|420501|P1|Overall Study|Adverse Event|2
124261|NCT00562861|420526|P2|Overall Study|Lost to Follow-up|3
124262|NCT00562861|420527|P1|Overall Study|Lost to Follow-up|7
124263|NCT00562861|420526|P2|Overall Study|noncompliance, moved|2
124264|NCT00562861|420527|P1|Overall Study|noncompliance, moved|7
124265|NCT00562861|420526|P2|Overall Study|Lack of Efficacy|5
124266|NCT00562861|420527|P1|Overall Study|Lack of Efficacy|5
124267|NCT00562861|420526|P2|Overall Study|Adverse Event|1
124268|NCT00562861|420527|P1|Overall Study|Adverse Event|1
124269|NCT00562627|420536|P3|Overall Study|Protocol Violation|1
124270|NCT00562627|420537|P2|Overall Study|Protocol Violation|1
124271|NCT00562627|420538|P1|Overall Study|Protocol Violation|1
124272|NCT00562588|420554|P2|Overall Study|Other|2
124273|NCT00562588|420555|P1|Overall Study|Other|0
124274|NCT00562588|420554|P2|Overall Study|Withdrawal by Subject|9
124275|NCT00562588|420555|P1|Overall Study|Withdrawal by Subject|10
124276|NCT00562588|420554|P2|Overall Study|Lost to Follow-up|4
124277|NCT00562588|420555|P1|Overall Study|Lost to Follow-up|12
124278|NCT00562588|420554|P2|Overall Study|Protocol Violation|26
124279|NCT00562588|420555|P1|Overall Study|Protocol Violation|30
124280|NCT00562588|420554|P2|Overall Study|Adverse Event|58
124281|NCT00562588|420555|P1|Overall Study|Adverse Event|40
124282|NCT00562484|420585|P2|Overall Study|Reason not provided or not specified|12
124283|NCT00562484|420586|P1|Overall Study|Reason not provided or not specified|25
124284|NCT00562484|420585|P2|Overall Study|Lost to Follow-up|71
124285|NCT00562484|420586|P1|Overall Study|Lost to Follow-up|132
124286|NCT00562484|420585|P2|Overall Study|Moved away from the study area|9
124287|NCT00562484|420586|P1|Overall Study|Moved away from the study area|20
124288|NCT00562484|420585|P2|Overall Study|Withdrawal by Subject|9
124289|NCT00562484|420586|P1|Overall Study|Withdrawal by Subject|12
124290|NCT00562484|420585|P2|Overall Study|Protocol Violation|2
124291|NCT00562484|420586|P1|Overall Study|Protocol Violation|11
124292|NCT00562484|420585|P2|Overall Study|Adverse Event|1
124293|NCT00562484|420586|P1|Overall Study|Adverse Event|6
124294|NCT00562354|420618|P2|Overall Study|Lost to Follow-up|1
124295|NCT00562354|420619|P1|Overall Study|Lost to Follow-up|0
124296|NCT00562354|420618|P2|Overall Study|Physician Decision|1
124297|NCT00562354|420619|P1|Overall Study|Physician Decision|0
124298|NCT00562302|420681|P2|Overall Study|Not stated|4
124299|NCT00562302|420682|P1|Overall Study|Not stated|1
124300|NCT00562302|420681|P2|Overall Study|Lung resection prior to study completion|7
124301|NCT00562302|420682|P1|Overall Study|Lung resection prior to study completion|7
124302|NCT00562302|420681|P2|Overall Study|Death|2
124303|NCT00562302|420682|P1|Overall Study|Death|1
124304|NCT00562302|420681|P2|Overall Study|Withdrawal by Subject|8
124305|NCT00562302|420682|P1|Overall Study|Withdrawal by Subject|7
124306|NCT00562302|420681|P2|Overall Study|Non-compliance|2
124307|NCT00562302|420682|P1|Overall Study|Non-compliance|1
124308|NCT00562302|420681|P2|Overall Study|Adverse Event|6
124309|NCT00562302|420682|P1|Overall Study|Adverse Event|0
124310|NCT00562302|420681|P2|Overall Study|Lost to Follow-up|3
124311|NCT00562302|420682|P1|Overall Study|Lost to Follow-up|3
124312|NCT00562159|420704|P2|Overall Study|Did not meet protocol eligibility|1
124313|NCT00562159|420705|P1|Overall Study|Did not meet protocol eligibility|1
124314|NCT00562159|420704|P2|Overall Study|Protocol Violation|12
124315|NCT00562159|420705|P1|Overall Study|Protocol Violation|12
124316|NCT00562159|420704|P2|Overall Study|Withdrawal by Subject|8
124317|NCT00562159|420705|P1|Overall Study|Withdrawal by Subject|9
124318|NCT00562159|420704|P2|Overall Study|Lost to Follow-up|4
124319|NCT00562159|420705|P1|Overall Study|Lost to Follow-up|5
124320|NCT00562159|420704|P2|Overall Study|Adverse Event|8
124321|NCT00562159|420705|P1|Overall Study|Adverse Event|11
124322|NCT00562120|420717|P4|First Intervention Period|Randomized but not Treated|0
124323|NCT00562120|420718|P3|First Intervention Period|Randomized but not Treated|0
124324|NCT00562120|420719|P2|First Intervention Period|Randomized but not Treated|0
124325|NCT00562120|420720|P1|First Intervention Period|Randomized but not Treated|1
124326|NCT00562120|420717|P4|First Intervention Period|Adverse Event|0
124327|NCT00562120|420718|P3|First Intervention Period|Adverse Event|0
124328|NCT00562120|420719|P2|First Intervention Period|Adverse Event|0
124329|NCT00562120|420720|P1|First Intervention Period|Adverse Event|1
124330|NCT00562094|420752|P1|Overall Study|Lost to Follow-up|62
124331|NCT00561977|420767|P3|Overall Study|Pregnancy|1
124332|NCT00561977|420768|P2|Overall Study|Pregnancy|1
124333|NCT00561977|420769|P1|Overall Study|Pregnancy|0
124334|NCT00561977|420767|P3|Overall Study|Withdrawal by Subject|1
124335|NCT00561977|420768|P2|Overall Study|Withdrawal by Subject|2
124336|NCT00561977|420769|P1|Overall Study|Withdrawal by Subject|0
124337|NCT00561951|420795|P3|Overall Study|Adverse Event Occured Before Treatment|1
124338|NCT00561951|420796|P2|Overall Study|Adverse Event Occured Before Treatment|2
124339|NCT00561951|420797|P1|Overall Study|Adverse Event Occured Before Treatment|1
124340|NCT00561951|420795|P3|Overall Study|Meet Withdrawal Criterion|1
124341|NCT00561951|420796|P2|Overall Study|Meet Withdrawal Criterion|1
124342|NCT00561951|420797|P1|Overall Study|Meet Withdrawal Criterion|0
124343|NCT00561951|420795|P3|Overall Study|Pregnancy|0
124344|NCT00561951|420796|P2|Overall Study|Pregnancy|1
124345|NCT00561951|420797|P1|Overall Study|Pregnancy|0
124346|NCT00561951|420795|P3|Overall Study|Physician Decision|0
124347|NCT00561951|420796|P2|Overall Study|Physician Decision|0
124348|NCT00561951|420797|P1|Overall Study|Physician Decision|1
124349|NCT00561951|420795|P3|Overall Study|Protocol Violation|4
124350|NCT00561951|420796|P2|Overall Study|Protocol Violation|3
124351|NCT00561951|420797|P1|Overall Study|Protocol Violation|4
124352|NCT00561951|420795|P3|Overall Study|Withdrawal by Subject|10
124353|NCT00561951|420796|P2|Overall Study|Withdrawal by Subject|9
124354|NCT00561951|420797|P1|Overall Study|Withdrawal by Subject|10
124355|NCT00561951|420795|P3|Overall Study|Lost to Follow-up|0
124356|NCT00561951|420796|P2|Overall Study|Lost to Follow-up|1
124357|NCT00561951|420797|P1|Overall Study|Lost to Follow-up|1
124358|NCT00561951|420795|P3|Overall Study|Lack of Efficacy|2
124359|NCT00561951|420796|P2|Overall Study|Lack of Efficacy|3
124360|NCT00561951|420797|P1|Overall Study|Lack of Efficacy|5
124361|NCT00561951|420795|P3|Overall Study|Adverse Event|14
124362|NCT00561951|420796|P2|Overall Study|Adverse Event|14
124363|NCT00561951|420797|P1|Overall Study|Adverse Event|11
124364|NCT00561925|420853|P5|Open-Label Extension Period|Declined entry into extension period|50
124365|NCT00561925|420854|P4|Open-Label Extension Period|Declined entry into extension period|43
124366|NCT00561925|420855|P3|Open-Label Extension Period|Declined entry into extension period|0
124367|NCT00561925|420856|P2|Open-Label Extension Period|Declined entry into extension period|0
124368|NCT00561925|420857|P1|Open-Label Extension Period|Declined entry into extension period|0
124369|NCT00561925|420853|P5|144-week Double-blind, Double-dummy|Other|0
124370|NCT00561925|420854|P4|144-week Double-blind, Double-dummy|Other|0
124371|NCT00561925|420855|P3|144-week Double-blind, Double-dummy|Other|11
124372|NCT00561925|420856|P2|144-week Double-blind, Double-dummy|Other|8
124373|NCT00561925|420857|P1|144-week Double-blind, Double-dummy|Other|0
124374|NCT00561925|420853|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
124375|NCT00561925|420854|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
124376|NCT00561925|420855|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
124377|NCT00561925|420856|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
124378|NCT00561925|420857|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
124379|NCT00561925|420853|P5|144-week Double-blind, Double-dummy|Death|0
124380|NCT00561925|420854|P4|144-week Double-blind, Double-dummy|Death|0
124381|NCT00561925|420855|P3|144-week Double-blind, Double-dummy|Death|3
124382|NCT00561925|420856|P2|144-week Double-blind, Double-dummy|Death|6
124383|NCT00561925|420857|P1|144-week Double-blind, Double-dummy|Death|0
124384|NCT00561925|420853|P5|144-week Double-blind, Double-dummy|Pregnancy|0
124385|NCT00561925|420854|P4|144-week Double-blind, Double-dummy|Pregnancy|0
124386|NCT00561925|420855|P3|144-week Double-blind, Double-dummy|Pregnancy|9
124387|NCT00561925|420856|P2|144-week Double-blind, Double-dummy|Pregnancy|1
124388|NCT00561925|420857|P1|144-week Double-blind, Double-dummy|Pregnancy|0
124389|NCT00561925|420853|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
124390|NCT00561925|420854|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
124391|NCT00561925|420855|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
124392|NCT00561925|420856|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
124393|NCT00561925|420857|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
124394|NCT00561925|420853|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
124395|NCT00561925|420854|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
124396|NCT00561925|420855|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
124397|NCT00561925|420856|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
124398|NCT00561925|420857|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
124399|NCT00561925|420853|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
124400|NCT00561925|420854|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
124401|NCT00561925|420855|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
124402|NCT00561925|420856|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
124403|NCT00561925|420857|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
124404|NCT00561925|420853|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
124405|NCT00561925|420854|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
124406|NCT00561925|420855|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
124407|NCT00561925|420856|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
124408|NCT00561925|420857|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
124409|NCT00561925|420853|P5|144-week Double-blind, Double-dummy|Adverse Event|0
124410|NCT00561925|420854|P4|144-week Double-blind, Double-dummy|Adverse Event|0
124411|NCT00561925|420855|P3|144-week Double-blind, Double-dummy|Adverse Event|43
124412|NCT00561925|420856|P2|144-week Double-blind, Double-dummy|Adverse Event|48
124413|NCT00561925|420857|P1|144-week Double-blind, Double-dummy|Adverse Event|0
124414|NCT00561925|420853|P5|14 Day Lead-In Period|Other|0
124415|NCT00561925|420854|P4|14 Day Lead-In Period|Other|0
124416|NCT00561925|420855|P3|14 Day Lead-In Period|Other|0
124417|NCT00561925|420856|P2|14 Day Lead-In Period|Other|0
124418|NCT00561925|420857|P1|14 Day Lead-In Period|Other|5
124419|NCT00561925|420853|P5|14 Day Lead-In Period|Withdrawal by Subject|0
124420|NCT00561925|420854|P4|14 Day Lead-In Period|Withdrawal by Subject|0
124421|NCT00561925|420855|P3|14 Day Lead-In Period|Withdrawal by Subject|0
124422|NCT00561925|420856|P2|14 Day Lead-In Period|Withdrawal by Subject|0
124423|NCT00561925|420857|P1|14 Day Lead-In Period|Withdrawal by Subject|4
124424|NCT00561925|420853|P5|14 Day Lead-In Period|Lost to Follow-up|0
124425|NCT00561925|420854|P4|14 Day Lead-In Period|Lost to Follow-up|0
124426|NCT00561925|420855|P3|14 Day Lead-In Period|Lost to Follow-up|0
124427|NCT00561925|420856|P2|14 Day Lead-In Period|Lost to Follow-up|0
124428|NCT00561925|420857|P1|14 Day Lead-In Period|Lost to Follow-up|4
124429|NCT00561925|420853|P5|14 Day Lead-In Period|In/Exclusion criteria|0
124430|NCT00561925|420854|P4|14 Day Lead-In Period|In/Exclusion criteria|0
124431|NCT00561925|420855|P3|14 Day Lead-In Period|In/Exclusion criteria|0
124432|NCT00561925|420856|P2|14 Day Lead-In Period|In/Exclusion criteria|0
124433|NCT00561925|420857|P1|14 Day Lead-In Period|In/Exclusion criteria|4
124434|NCT00561925|420853|P5|14 Day Lead-In Period|Adverse Event|0
124435|NCT00561925|420854|P4|14 Day Lead-In Period|Adverse Event|0
124436|NCT00561925|420855|P3|14 Day Lead-In Period|Adverse Event|0
124437|NCT00561925|420856|P2|14 Day Lead-In Period|Adverse Event|0
124438|NCT00561925|420857|P1|14 Day Lead-In Period|Adverse Event|38
124439|NCT00561912|420906|P1|Overall Study|ineligible|1
124440|NCT00561821|420918|P4|Overall Study|Adverse Event|1
124441|NCT00561821|420919|P3|Overall Study|Adverse Event|1
124442|NCT00561821|420920|P2|Overall Study|Adverse Event|3
124443|NCT00561821|420921|P1|Overall Study|Adverse Event|2
124444|NCT00561821|420918|P4|Overall Study|Other (reason not specified)|0
124445|NCT00561821|420919|P3|Overall Study|Other (reason not specified)|0
124446|NCT00561821|420920|P2|Overall Study|Other (reason not specified)|1
124447|NCT00561821|420921|P1|Overall Study|Other (reason not specified)|1
124448|NCT00561821|420918|P4|Overall Study|Reasons not related to trial|0
124449|NCT00561821|420919|P3|Overall Study|Reasons not related to trial|0
124450|NCT00561821|420920|P2|Overall Study|Reasons not related to trial|1
124451|NCT00561821|420921|P1|Overall Study|Reasons not related to trial|2
124452|NCT00561821|420918|P4|Overall Study|Withdrawal by Subject|2
124453|NCT00561821|420919|P3|Overall Study|Withdrawal by Subject|0
124454|NCT00561821|420920|P2|Overall Study|Withdrawal by Subject|1
124455|NCT00561821|420921|P1|Overall Study|Withdrawal by Subject|0
124456|NCT00561821|420918|P4|Overall Study|Not treated|0
124457|NCT00561821|420919|P3|Overall Study|Not treated|1
124458|NCT00561821|420920|P2|Overall Study|Not treated|0
124459|NCT00561821|420921|P1|Overall Study|Not treated|0
124460|NCT00561795|420997|P4|Overall Study|Physician Decision|0
124461|NCT00561795|420998|P3|Overall Study|Physician Decision|0
124462|NCT00561795|420999|P2|Overall Study|Physician Decision|0
124463|NCT00561795|421000|P1|Overall Study|Physician Decision|1
124464|NCT00561795|420997|P4|Overall Study|Study Closed/Terminated|0
124465|NCT00561795|420998|P3|Overall Study|Study Closed/Terminated|0
124466|NCT00561795|420999|P2|Overall Study|Study Closed/Terminated|3
124467|NCT00561795|421000|P1|Overall Study|Study Closed/Terminated|0
124468|NCT00561795|420997|P4|Overall Study|Adverse Event|0
124469|NCT00561795|420998|P3|Overall Study|Adverse Event|0
124470|NCT00561795|420999|P2|Overall Study|Adverse Event|3
124471|NCT00561795|421000|P1|Overall Study|Adverse Event|3
124472|NCT00561730|421020|P1|Overall Study|Not specified reasons|1
124473|NCT00561730|421020|P1|Overall Study|Lost to Follow-up|5
124474|NCT00561730|421020|P1|Overall Study|Handling of the drug|1
124475|NCT00561730|421020|P1|Overall Study|Adverse Event|2
124476|NCT00561652|421036|P2|Overall Study|Withdrawal by Subject|1
124477|NCT00561652|421037|P1|Overall Study|Withdrawal by Subject|0
124478|NCT00561574|421120|P2|Overall Study|Unspecified|7
124479|NCT00561574|421121|P1|Overall Study|Unspecified|5
124480|NCT00561574|421120|P2|Overall Study|Lost to Follow-up|0
124481|NCT00561574|421121|P1|Overall Study|Lost to Follow-up|1
124482|NCT00561574|421120|P2|Overall Study|Reason Unrelated to Trial|2
124483|NCT00561574|421121|P1|Overall Study|Reason Unrelated to Trial|6
124484|NCT00561574|421120|P2|Overall Study|Withdrawal by Subject|4
124485|NCT00561574|421121|P1|Overall Study|Withdrawal by Subject|4
124486|NCT00561574|421120|P2|Overall Study|Lack of Efficacy|21
124487|NCT00561574|421121|P1|Overall Study|Lack of Efficacy|11
124488|NCT00561574|421120|P2|Overall Study|Adverse Event|24
124489|NCT00561574|421121|P1|Overall Study|Adverse Event|21
124490|NCT00561470|421147|P2|Overall Study|Ongoing Treatment|14
124491|NCT00561470|421148|P1|Overall Study|Ongoing Treatment|11
124492|NCT00561470|421147|P2|Overall Study|Planning surgery|1
124493|NCT00561470|421148|P1|Overall Study|Planning surgery|1
124494|NCT00561470|421147|P2|Overall Study|Missed visit window|4
124495|NCT00561470|421148|P1|Overall Study|Missed visit window|1
124496|NCT00561470|421147|P2|Overall Study|Randomized but not treated|5
124497|NCT00561470|421148|P1|Overall Study|Randomized but not treated|5
124498|NCT00561470|421147|P2|Overall Study|Unauthorized procedure|1
124499|NCT00561470|421148|P1|Overall Study|Unauthorized procedure|3
124500|NCT00561470|421147|P2|Overall Study|Metastatic surgery|12
124501|NCT00561470|421148|P1|Overall Study|Metastatic surgery|10
124502|NCT00561470|421147|P2|Overall Study|Subject request|77
124503|NCT00561470|421148|P1|Overall Study|Subject request|43
124504|NCT00561470|421147|P2|Overall Study|Consent Withdrawn|6
124505|NCT00561470|421148|P1|Overall Study|Consent Withdrawn|2
124506|NCT00561470|421147|P2|Overall Study|Physician Decision|20
124507|NCT00561470|421148|P1|Overall Study|Physician Decision|21
124508|NCT00561470|421147|P2|Overall Study|Lost to Follow-up|0
124509|NCT00561470|421148|P1|Overall Study|Lost to Follow-up|2
124510|NCT00561470|421147|P2|Overall Study|poor compliance to protocol|4
124511|NCT00561470|421148|P1|Overall Study|poor compliance to protocol|4
124512|NCT00561470|421147|P2|Overall Study|Disease progression|305
124513|NCT00561470|421148|P1|Overall Study|Disease progression|437
124514|NCT00561470|421147|P2|Overall Study|Adverse Event|163
124515|NCT00561470|421148|P1|Overall Study|Adverse Event|74
124516|NCT00561392|421184|P1|Overall Study|Administrative problems|4
124517|NCT00561392|421184|P1|Overall Study|Withdrawal by Subject|8
124518|NCT00561392|421184|P1|Overall Study|Protocol Violation|1
124519|NCT00561392|421184|P1|Overall Study|Lack of Efficacy|2
124520|NCT00561392|421184|P1|Overall Study|Adverse Event|38
124521|NCT00561353|421206|P10|Overall Study|Withdrawal by Subject|0
124522|NCT00561353|421207|P9|Overall Study|Withdrawal by Subject|0
124523|NCT00561353|421208|P8|Overall Study|Withdrawal by Subject|0
124524|NCT00561353|421209|P7|Overall Study|Withdrawal by Subject|0
124525|NCT00561353|421210|P6|Overall Study|Withdrawal by Subject|0
124526|NCT00561353|421211|P5|Overall Study|Withdrawal by Subject|0
124527|NCT00561353|421212|P4|Overall Study|Withdrawal by Subject|0
124528|NCT00561353|421213|P3|Overall Study|Withdrawal by Subject|0
124529|NCT00561353|421214|P2|Overall Study|Withdrawal by Subject|2
124530|NCT00561353|421215|P1|Overall Study|Withdrawal by Subject|0
124531|NCT00561353|421206|P10|Overall Study|Lost to Follow-up|0
124532|NCT00561353|421207|P9|Overall Study|Lost to Follow-up|0
124533|NCT00561353|421208|P8|Overall Study|Lost to Follow-up|0
124534|NCT00561353|421209|P7|Overall Study|Lost to Follow-up|0
124535|NCT00561353|421210|P6|Overall Study|Lost to Follow-up|0
124536|NCT00561353|421211|P5|Overall Study|Lost to Follow-up|0
124537|NCT00561353|421212|P4|Overall Study|Lost to Follow-up|0
124538|NCT00561353|421213|P3|Overall Study|Lost to Follow-up|1
124539|NCT00561353|421214|P2|Overall Study|Lost to Follow-up|0
124540|NCT00561353|421215|P1|Overall Study|Lost to Follow-up|2
124541|NCT00561353|421206|P10|Overall Study|Adverse Event|1
124542|NCT00561353|421207|P9|Overall Study|Adverse Event|0
124543|NCT00561353|421208|P8|Overall Study|Adverse Event|0
124544|NCT00561353|421209|P7|Overall Study|Adverse Event|1
124545|NCT00561353|421210|P6|Overall Study|Adverse Event|0
124546|NCT00561353|421211|P5|Overall Study|Adverse Event|0
124547|NCT00561353|421212|P4|Overall Study|Adverse Event|2
124548|NCT00561353|421213|P3|Overall Study|Adverse Event|0
124549|NCT00561353|421214|P2|Overall Study|Adverse Event|0
124550|NCT00561353|421215|P1|Overall Study|Adverse Event|0
124551|NCT00561353|421206|P10|Overall Study|Not specified|0
124552|NCT00561353|421207|P9|Overall Study|Not specified|0
124553|NCT00561353|421208|P8|Overall Study|Not specified|0
124554|NCT00561353|421209|P7|Overall Study|Not specified|0
124555|NCT00561353|421210|P6|Overall Study|Not specified|2
124556|NCT00561353|421211|P5|Overall Study|Not specified|0
124557|NCT00561353|421212|P4|Overall Study|Not specified|0
124558|NCT00561353|421213|P3|Overall Study|Not specified|1
124559|NCT00561353|421214|P2|Overall Study|Not specified|0
124560|NCT00561353|421215|P1|Overall Study|Not specified|1
124561|NCT00561353|421206|P10|Overall Study|Subject ineligible to continue the trial|1
124562|NCT00561353|421207|P9|Overall Study|Subject ineligible to continue the trial|2
124563|NCT00561353|421208|P8|Overall Study|Subject ineligible to continue the trial|0
124564|NCT00561353|421209|P7|Overall Study|Subject ineligible to continue the trial|1
124565|NCT00561353|421210|P6|Overall Study|Subject ineligible to continue the trial|1
124566|NCT00561353|421211|P5|Overall Study|Subject ineligible to continue the trial|0
124567|NCT00561353|421212|P4|Overall Study|Subject ineligible to continue the trial|0
124568|NCT00561353|421213|P3|Overall Study|Subject ineligible to continue the trial|0
124569|NCT00561353|421214|P2|Overall Study|Subject ineligible to continue the trial|0
124570|NCT00561353|421215|P1|Overall Study|Subject ineligible to continue the trial|0
124571|NCT00561353|421206|P10|Overall Study|Subject reached a virologic endpoint|0
124572|NCT00561353|421207|P9|Overall Study|Subject reached a virologic endpoint|5
124573|NCT00561353|421208|P8|Overall Study|Subject reached a virologic endpoint|4
124574|NCT00561353|421209|P7|Overall Study|Subject reached a virologic endpoint|4
124575|NCT00561353|421210|P6|Overall Study|Subject reached a virologic endpoint|3
124576|NCT00561353|421211|P5|Overall Study|Subject reached a virologic endpoint|1
124577|NCT00561353|421212|P4|Overall Study|Subject reached a virologic endpoint|4
124578|NCT00561353|421213|P3|Overall Study|Subject reached a virologic endpoint|1
124579|NCT00561353|421214|P2|Overall Study|Subject reached a virologic endpoint|1
124580|NCT00561353|421215|P1|Overall Study|Subject reached a virologic endpoint|2
124581|NCT00561340|421370|P2|Overall Study|refused to drink pediasure|0
124582|NCT00561340|421371|P1|Overall Study|refused to drink pediasure|6
124583|NCT00561015|421394|P6|Overall Study|Participant non-compliance|0
124584|NCT00561015|421395|P5|Overall Study|Participant non-compliance|0
124585|NCT00561015|421396|P4|Overall Study|Participant non-compliance|0
124586|NCT00561015|421397|P3|Overall Study|Participant non-compliance|0
124587|NCT00561015|421398|P2|Overall Study|Participant non-compliance|0
124588|NCT00561015|421399|P1|Overall Study|Participant non-compliance|2
124589|NCT00561015|421394|P6|Overall Study|Lost to Follow-up|3
124590|NCT00561015|421395|P5|Overall Study|Lost to Follow-up|0
124591|NCT00561015|421396|P4|Overall Study|Lost to Follow-up|1
124592|NCT00561015|421397|P3|Overall Study|Lost to Follow-up|0
124593|NCT00561015|421398|P2|Overall Study|Lost to Follow-up|0
124594|NCT00561015|421399|P1|Overall Study|Lost to Follow-up|2
124595|NCT00561015|421394|P6|Overall Study|Adverse Event|0
124596|NCT00561015|421395|P5|Overall Study|Adverse Event|1
124597|NCT00561015|421396|P4|Overall Study|Adverse Event|0
124598|NCT00561015|421397|P3|Overall Study|Adverse Event|0
124599|NCT00561015|421398|P2|Overall Study|Adverse Event|0
124600|NCT00561015|421399|P1|Overall Study|Adverse Event|0
124601|NCT00560950|421490|P2|Overall Study|Lost to Follow-up|0
124602|NCT00560950|421491|P1|Overall Study|Lost to Follow-up|1
124603|NCT00560937|421529|P2|Overall Study|Physician Decision|1
124604|NCT00560937|421530|P1|Overall Study|Physician Decision|1
124605|NCT00560937|421529|P2|Overall Study|Withdrawal by Subject|1
124606|NCT00560937|421530|P1|Overall Study|Withdrawal by Subject|0
124607|NCT00560885|421546|P1|Overall Study|Withdrawal by Subject|1
124608|NCT00560885|421546|P1|Overall Study|Death|7
124609|NCT00560833|421571|P5|Overall Study|Never received drug|1
124610|NCT00560833|421572|P4|Overall Study|Never received drug|0
124611|NCT00560833|421573|P3|Overall Study|Never received drug|0
124612|NCT00560833|421574|P2|Overall Study|Never received drug|1
124613|NCT00560833|421575|P1|Overall Study|Never received drug|0
124614|NCT00560833|421571|P5|Overall Study|Unspecified|0
124615|NCT00560833|421572|P4|Overall Study|Unspecified|0
124616|NCT00560833|421573|P3|Overall Study|Unspecified|3
124617|NCT00560833|421574|P2|Overall Study|Unspecified|1
124618|NCT00560833|421575|P1|Overall Study|Unspecified|1
124619|NCT00560833|421571|P5|Overall Study|Participant uncooperative|2
124620|NCT00560833|421572|P4|Overall Study|Participant uncooperative|4
124621|NCT00560833|421573|P3|Overall Study|Participant uncooperative|4
124622|NCT00560833|421574|P2|Overall Study|Participant uncooperative|5
124623|NCT00560833|421575|P1|Overall Study|Participant uncooperative|5
124624|NCT00560833|421571|P5|Overall Study|Lack of Efficacy|4
124625|NCT00560833|421572|P4|Overall Study|Lack of Efficacy|4
124626|NCT00560833|421573|P3|Overall Study|Lack of Efficacy|6
124627|NCT00560833|421574|P2|Overall Study|Lack of Efficacy|9
124628|NCT00560833|421575|P1|Overall Study|Lack of Efficacy|22
124629|NCT00560833|421571|P5|Overall Study|Lost to Follow-up|0
124630|NCT00560833|421572|P4|Overall Study|Lost to Follow-up|0
124631|NCT00560833|421573|P3|Overall Study|Lost to Follow-up|1
124632|NCT00560833|421574|P2|Overall Study|Lost to Follow-up|0
124633|NCT00560833|421575|P1|Overall Study|Lost to Follow-up|0
124634|NCT00560833|421571|P5|Overall Study|Adverse Event|35
124635|NCT00560833|421572|P4|Overall Study|Adverse Event|23
124636|NCT00560833|421573|P3|Overall Study|Adverse Event|25
124637|NCT00560833|421574|P2|Overall Study|Adverse Event|10
124638|NCT00560833|421575|P1|Overall Study|Adverse Event|16
124639|NCT00560794|421607|P1|Overall Study|Received Bone Marrow Transplant|6
124640|NCT00560794|421607|P1|Overall Study|Hematological Relapse|1
124641|NCT00560794|421607|P1|Overall Study|Minimal Residual Disease Relapse|1
124642|NCT00560794|421607|P1|Overall Study|Patient was not Compliant|1
124643|NCT00560794|421607|P1|Overall Study|Adverse Event|2
124644|NCT00560703|421626|P2|Overall Study|non-compliance|1
124645|NCT00560703|421627|P1|Overall Study|non-compliance|0
124646|NCT00560703|421626|P2|Overall Study|Withdrawal by Subject|1
124647|NCT00560703|421627|P1|Overall Study|Withdrawal by Subject|0
124648|NCT00560703|421626|P2|Overall Study|Protocol Violation|2
124649|NCT00560703|421627|P1|Overall Study|Protocol Violation|0
124650|NCT00560703|421626|P2|Overall Study|Adverse Event|2
124651|NCT00560703|421627|P1|Overall Study|Adverse Event|0
124652|NCT00560573|421644|P6|Overall Study|Enrolled, not treated|0
124653|NCT00560573|421645|P5|Overall Study|Enrolled, not treated|1
124654|NCT00560573|421646|P4|Overall Study|Enrolled, not treated|0
124655|NCT00560573|421647|P3|Overall Study|Enrolled, not treated|0
124656|NCT00560573|421648|P2|Overall Study|Enrolled, not treated|0
124657|NCT00560573|421649|P1|Overall Study|Enrolled, not treated|0
124658|NCT00560573|421644|P6|Overall Study|Unspecified|3
124659|NCT00560573|421645|P5|Overall Study|Unspecified|3
124660|NCT00560573|421646|P4|Overall Study|Unspecified|3
124661|NCT00560573|421647|P3|Overall Study|Unspecified|2
124662|NCT00560573|421648|P2|Overall Study|Unspecified|2
124663|NCT00560573|421649|P1|Overall Study|Unspecified|2
124664|NCT00560573|421644|P6|Overall Study|Withdrawal by Subject|0
124665|NCT00560573|421645|P5|Overall Study|Withdrawal by Subject|1
124666|NCT00560573|421646|P4|Overall Study|Withdrawal by Subject|1
124667|NCT00560573|421647|P3|Overall Study|Withdrawal by Subject|0
124668|NCT00560573|421648|P2|Overall Study|Withdrawal by Subject|0
124669|NCT00560573|421649|P1|Overall Study|Withdrawal by Subject|0
124670|NCT00560573|421644|P6|Overall Study|Lost to Follow-up|0
124671|NCT00560573|421645|P5|Overall Study|Lost to Follow-up|1
124672|NCT00560573|421646|P4|Overall Study|Lost to Follow-up|1
124673|NCT00560573|421647|P3|Overall Study|Lost to Follow-up|0
124674|NCT00560573|421648|P2|Overall Study|Lost to Follow-up|0
124675|NCT00560573|421649|P1|Overall Study|Lost to Follow-up|0
124676|NCT00560573|421644|P6|Overall Study|Death|10
124677|NCT00560573|421645|P5|Overall Study|Death|1
124678|NCT00560573|421646|P4|Overall Study|Death|5
124679|NCT00560573|421647|P3|Overall Study|Death|4
124680|NCT00560573|421648|P2|Overall Study|Death|1
124681|NCT00560573|421649|P1|Overall Study|Death|4
124682|NCT00560508|421726|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
124683|NCT00560508|421727|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
124684|NCT00560508|421726|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
124685|NCT00560508|421727|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
124686|NCT00560508|421726|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
124687|NCT00560508|421727|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
124688|NCT00560508|421726|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
124689|NCT00560508|421727|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
124690|NCT00560508|421726|P2|12 Week Double-blind Period|Withdrawal by Subject|1
124691|NCT00560508|421727|P1|12 Week Double-blind Period|Withdrawal by Subject|1
124692|NCT00560508|421726|P2|12 Week Double-blind Period|Protocol Violation|0
124693|NCT00560508|421727|P1|12 Week Double-blind Period|Protocol Violation|1
124694|NCT00560508|421726|P2|12 Week Double-blind Period|Adverse Event|2
124695|NCT00560508|421727|P1|12 Week Double-blind Period|Adverse Event|3
124696|NCT00560417|421786|P2|Overall Study|Withdrawal by Subject|3
124697|NCT00560417|421787|P1|Overall Study|Withdrawal by Subject|3
124698|NCT00560417|421786|P2|Overall Study|Sponsor Decision|0
124699|NCT00560417|421787|P1|Overall Study|Sponsor Decision|2
124700|NCT00560417|421786|P2|Overall Study|Protocol Violation|5
124701|NCT00560417|421787|P1|Overall Study|Protocol Violation|6
124702|NCT00560417|421786|P2|Overall Study|Physician Decision|6
124703|NCT00560417|421787|P1|Overall Study|Physician Decision|2
124704|NCT00560417|421786|P2|Overall Study|Lost to Follow-up|1
124705|NCT00560417|421787|P1|Overall Study|Lost to Follow-up|0
124706|NCT00560417|421786|P2|Overall Study|Entry Criteria Not Met|0
124707|NCT00560417|421787|P1|Overall Study|Entry Criteria Not Met|1
124708|NCT00560417|421786|P2|Overall Study|Adverse Event|2
124709|NCT00560417|421787|P1|Overall Study|Adverse Event|3
124710|NCT00560404|421815|P2|Overall Study|Other withdrawal reason|5
124711|NCT00560404|421816|P1|Overall Study|Other withdrawal reason|13
124712|NCT00560404|421815|P2|Overall Study|Failure to return|2
124713|NCT00560404|421816|P1|Overall Study|Failure to return|1
124714|NCT00560404|421815|P2|Overall Study|Withdrew Consent|0
124715|NCT00560404|421816|P1|Overall Study|Withdrew Consent|4
124716|NCT00560404|421815|P2|Overall Study|Administrative Reasons|1
124717|NCT00560404|421816|P1|Overall Study|Administrative Reasons|1
124718|NCT00560404|421815|P2|Overall Study|Protocol Violation|7
124719|NCT00560404|421816|P1|Overall Study|Protocol Violation|12
124720|NCT00560404|421815|P2|Overall Study|Death|3
124721|NCT00560404|421816|P1|Overall Study|Death|3
124722|NCT00560404|421815|P2|Overall Study|Adverse Event|3
124723|NCT00560404|421816|P1|Overall Study|Adverse Event|2
124724|NCT00560391|421863|P5|Overall Study|Still on treatment|2
124725|NCT00560391|421864|P4|Overall Study|Still on treatment|1
124726|NCT00560391|421865|P3|Overall Study|Still on treatment|0
124727|NCT00560391|421866|P2|Overall Study|Still on treatment|0
124728|NCT00560391|421867|P1|Overall Study|Still on treatment|0
124729|NCT00560352|421923|P3|Overall Study|Maximum clinical benefit|0
124730|NCT00560352|421924|P2|Overall Study|Maximum clinical benefit|0
124731|NCT00560352|421925|P1|Overall Study|Maximum clinical benefit|1
124732|NCT00560352|421923|P3|Overall Study|Withdrawal by Subject|1
124733|NCT00560352|421924|P2|Overall Study|Withdrawal by Subject|1
124734|NCT00560352|421925|P1|Overall Study|Withdrawal by Subject|1
124735|NCT00560352|421923|P3|Overall Study|Disease progression|1
124736|NCT00560352|421924|P2|Overall Study|Disease progression|1
124737|NCT00560352|421925|P1|Overall Study|Disease progression|0
124738|NCT00560352|421923|P3|Overall Study|Study drug toxicity|1
124739|NCT00560352|421924|P2|Overall Study|Study drug toxicity|0
124740|NCT00560352|421925|P1|Overall Study|Study drug toxicity|3
124741|NCT00560352|421923|P3|Overall Study|Adverse event unrelated to study drug|1
124742|NCT00560352|421924|P2|Overall Study|Adverse event unrelated to study drug|1
124743|NCT00560352|421925|P1|Overall Study|Adverse event unrelated to study drug|2
124744|NCT00560313|421942|P1|Overall Study|Protocol Violation|1
124745|NCT00560313|421942|P1|Overall Study|Lost to Follow-up|1
124746|NCT00560313|421942|P1|Overall Study|Withdrawal by Subject|2
124747|NCT00560313|421942|P1|Overall Study|Adverse Events or Death|2
124748|NCT00560235|421969|P3|Phase 2|Ongoing at Date of Cut-Off|1
124749|NCT00560235|421970|P2|Phase 2|Ongoing at Date of Cut-Off|0
124750|NCT00560235|421971|P1|Phase 2|Ongoing at Date of Cut-Off|0
124751|NCT00560235|421969|P3|Phase 2|Discontinued|96
124752|NCT00560235|421970|P2|Phase 2|Discontinued|0
124753|NCT00560235|421971|P1|Phase 2|Discontinued|0
124754|NCT00560235|421969|P3|Phase 1B|Discontinued|0
124755|NCT00560235|421970|P2|Phase 1B|Discontinued|19
124756|NCT00560235|421971|P1|Phase 1B|Discontinued|0
124757|NCT00560235|421969|P3|Phase 1|Discontinued|0
124758|NCT00560235|421970|P2|Phase 1|Discontinued|0
124759|NCT00560235|421971|P1|Phase 1|Discontinued|8
124760|NCT00560105|422002|P2|Overall Study|musculoskeletal chest discomfort with us|2
124761|NCT00560105|422003|P1|Overall Study|musculoskeletal chest discomfort with us|1
124762|NCT00560066|422017|P2|Overall Study|Missing primary reason|2
124763|NCT00560066|422018|P1|Overall Study|Missing primary reason|0
124764|NCT00560066|422017|P2|Overall Study|Administrative reason|5
124765|NCT00560066|422018|P1|Overall Study|Administrative reason|0
124766|NCT00560066|422017|P2|Overall Study|Protocol Violation|1
124767|NCT00560066|422018|P1|Overall Study|Protocol Violation|0
124768|NCT00560066|422017|P2|Overall Study|Lost to Follow-up|10
124769|NCT00560066|422018|P1|Overall Study|Lost to Follow-up|4
124770|NCT00560066|422017|P2|Overall Study|Withdrawal by Subject|3
124771|NCT00560066|422018|P1|Overall Study|Withdrawal by Subject|0
124772|NCT00560066|422017|P2|Overall Study|Death|1
124773|NCT00560066|422018|P1|Overall Study|Death|2
124774|NCT00559988|422050|P2|Overall Study|ICD device explanted|17
124775|NCT00559988|422051|P1|Overall Study|ICD device explanted|10
124776|NCT00559988|422050|P2|Overall Study|Lost to Follow-up|56
124777|NCT00559988|422051|P1|Overall Study|Lost to Follow-up|42
124778|NCT00559988|422050|P2|Overall Study|Withdrawal by Subject|139
124779|NCT00559988|422051|P1|Overall Study|Withdrawal by Subject|152
124780|NCT00559988|422050|P2|Overall Study|Death|140
124781|NCT00559988|422051|P1|Overall Study|Death|147
124782|NCT00559962|422065|P8|Overall Study|Inclusion/exclusion criteria not met|0
124783|NCT00559962|422066|P7|Overall Study|Inclusion/exclusion criteria not met|1
124784|NCT00559962|422067|P6|Overall Study|Inclusion/exclusion criteria not met|0
124785|NCT00559962|422068|P5|Overall Study|Inclusion/exclusion criteria not met|0
124786|NCT00559962|422069|P4|Overall Study|Inclusion/exclusion criteria not met|0
124787|NCT00559962|422070|P3|Overall Study|Inclusion/exclusion criteria not met|0
124788|NCT00559962|422071|P2|Overall Study|Inclusion/exclusion criteria not met|0
124789|NCT00559962|422072|P1|Overall Study|Inclusion/exclusion criteria not met|0
124790|NCT00559962|422065|P8|Overall Study|Withdrawal by Subject|2
124791|NCT00559962|422066|P7|Overall Study|Withdrawal by Subject|0
124792|NCT00559962|422067|P6|Overall Study|Withdrawal by Subject|1
124793|NCT00559962|422068|P5|Overall Study|Withdrawal by Subject|3
124794|NCT00559962|422069|P4|Overall Study|Withdrawal by Subject|0
124795|NCT00559962|422070|P3|Overall Study|Withdrawal by Subject|2
124796|NCT00559962|422071|P2|Overall Study|Withdrawal by Subject|1
124797|NCT00559962|422072|P1|Overall Study|Withdrawal by Subject|1
124798|NCT00559962|422065|P8|Overall Study|Lost to Follow-up|0
124799|NCT00559962|422066|P7|Overall Study|Lost to Follow-up|0
124800|NCT00559962|422067|P6|Overall Study|Lost to Follow-up|0
124801|NCT00559962|422068|P5|Overall Study|Lost to Follow-up|0
124802|NCT00559962|422069|P4|Overall Study|Lost to Follow-up|0
124803|NCT00559962|422070|P3|Overall Study|Lost to Follow-up|0
124804|NCT00559962|422071|P2|Overall Study|Lost to Follow-up|1
124805|NCT00559962|422072|P1|Overall Study|Lost to Follow-up|0
124806|NCT00559962|422065|P8|Overall Study|Adverse Event|2
124807|NCT00559962|422066|P7|Overall Study|Adverse Event|4
124808|NCT00559962|422067|P6|Overall Study|Adverse Event|4
124809|NCT00559962|422068|P5|Overall Study|Adverse Event|11
124810|NCT00559962|422069|P4|Overall Study|Adverse Event|5
124811|NCT00559962|422070|P3|Overall Study|Adverse Event|8
124812|NCT00559962|422071|P2|Overall Study|Adverse Event|7
124813|NCT00559962|422072|P1|Overall Study|Adverse Event|1
124814|NCT00559949|422092|P1|Overall Study|No disease evaluation per protocol|1
124815|NCT00559949|422092|P1|Overall Study|Withdrawal by Subject|4
124816|NCT00559949|422092|P1|Overall Study|Adverse Event|1
124817|NCT00559949|422092|P1|Overall Study|Progressive Disease during cycle 1|1
124818|NCT00559754|422108|P1|Overall Study|Withdrawal by Subject|2
124819|NCT00559754|422108|P1|Overall Study|Investigator criteria|2
124820|NCT00559754|422108|P1|Overall Study|Protocol Violation|1
124821|NCT00559754|422108|P1|Overall Study|Adverse Event|5
124822|NCT00559754|422108|P1|Overall Study|Disease progression|1
124823|NCT00559637|422132|P1|Overall Study|Inclusion or exclusion criteria violated|2
124824|NCT00559637|422132|P1|Overall Study|Change of home|1
124825|NCT00559637|422132|P1|Overall Study|Change of center|1
124826|NCT00559637|422132|P1|Overall Study|Delayed administration of C.E.R.A|1
124827|NCT00559637|422132|P1|Overall Study|Participation in another study|1
124828|NCT00559637|422132|P1|Overall Study|Suspected lung cancer|1
124829|NCT00559637|422132|P1|Overall Study|Started requiring dialysis after month 7|2
124830|NCT00559637|422132|P1|Overall Study|Insufficient response|3
124831|NCT00559637|422132|P1|Overall Study|Failure to return|6
124832|NCT00559637|422132|P1|Overall Study|Withdrawal criteria fulfilled|4
124833|NCT00559637|422132|P1|Overall Study|Protocol Violation|6
124834|NCT00559637|422132|P1|Overall Study|Withdrawal by Subject|4
124835|NCT00559637|422132|P1|Overall Study|Adverse Event|22
124836|NCT00559585|422145|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
124837|NCT00559585|422146|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
124838|NCT00559585|422145|P2|Open Label LT Period Main + Sub-Study|non-specified|0
124839|NCT00559585|422146|P1|Open Label LT Period Main + Sub-Study|non-specified|71
124840|NCT00559585|422145|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
124841|NCT00559585|422146|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
124842|NCT00559585|422145|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
124843|NCT00559585|422146|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
124844|NCT00559585|422145|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
124845|NCT00559585|422146|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
124846|NCT00559585|422145|P2|Open Label LT Period Main + Sub-Study|Death|0
124847|NCT00559585|422146|P1|Open Label LT Period Main + Sub-Study|Death|20
124848|NCT00559585|422145|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
124849|NCT00559585|422146|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
124850|NCT00559585|422145|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
124851|NCT00559585|422146|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
124852|NCT00559585|422145|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
124853|NCT00559585|422146|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
124854|NCT00559585|422145|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
124855|NCT00559585|422146|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
124856|NCT00559585|422145|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
124857|NCT00559585|422146|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
124858|NCT00559585|422145|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
124859|NCT00559585|422146|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
124860|NCT00559585|422145|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
124861|NCT00559585|422146|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
124862|NCT00559585|422145|P2|Double Blind ST Period Main Study|Investigator Decision|1
124863|NCT00559585|422146|P1|Double Blind ST Period Main Study|Investigator Decision|0
124864|NCT00559585|422145|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
124865|NCT00559585|422146|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
124866|NCT00559585|422145|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
124867|NCT00559585|422146|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
124868|NCT00559585|422145|P2|Double Blind ST Period Main Study|Early Discontinuation|1
124869|NCT00559585|422146|P1|Double Blind ST Period Main Study|Early Discontinuation|0
124870|NCT00559585|422145|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
124871|NCT00559585|422146|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
124872|NCT00559585|422145|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
124873|NCT00559585|422146|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
124874|NCT00559585|422145|P2|Double Blind ST Period Main Study|Missed Doses|1
124875|NCT00559585|422146|P1|Double Blind ST Period Main Study|Missed Doses|0
124876|NCT00559585|422145|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
124877|NCT00559585|422146|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
124878|NCT00559585|422145|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
124879|NCT00559585|422146|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
124880|NCT00559585|422145|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
124881|NCT00559585|422146|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
124882|NCT00559585|422145|P2|Double Blind ST Period Main Study|Death|1
124883|NCT00559585|422146|P1|Double Blind ST Period Main Study|Death|1
124884|NCT00559585|422145|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
124885|NCT00559585|422146|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
124886|NCT00559585|422145|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
124887|NCT00559585|422146|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
124888|NCT00559585|422145|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
124889|NCT00559585|422146|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
124890|NCT00559585|422145|P2|Double Blind ST Period Main Study|Adverse Event|25
124891|NCT00559585|422146|P1|Double Blind ST Period Main Study|Adverse Event|17
124892|NCT00559507|422206|P1|Overall Study|Not treated, patient ineligible|3
124893|NCT00559377|422212|P1|Overall Study|Withdrawal by Subject|9
124894|NCT00559364|422222|P2|Overall Study|Inclusion/exclusion criteria failure|0
124895|NCT00559364|422223|P1|Overall Study|Inclusion/exclusion criteria failure|1
124896|NCT00559273|422235|P2|Evaluation Period (8 Weeks)|Physician Decision|1
124897|NCT00559273|422236|P1|Evaluation Period (8 Weeks)|Physician Decision|0
124898|NCT00559273|422235|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
124899|NCT00559273|422236|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
124900|NCT00559273|422235|P2|Evaluation Period (8 Weeks)|Adverse Event|1
124901|NCT00559273|422236|P1|Evaluation Period (8 Weeks)|Adverse Event|0
124902|NCT00559273|422235|P2|Evaluation Period (8 Weeks)|Death|3
124903|NCT00559273|422236|P1|Evaluation Period (8 Weeks)|Death|1
124904|NCT00559273|422235|P2|Correction Period (20 Weeks)|Did not received study treatment|0
124905|NCT00559273|422236|P1|Correction Period (20 Weeks)|Did not received study treatment|2
124906|NCT00559273|422235|P2|Correction Period (20 Weeks)|Participant treated by another center|1
124907|NCT00559273|422236|P1|Correction Period (20 Weeks)|Participant treated by another center|0
124908|NCT00559273|422235|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
124909|NCT00559273|422236|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
124910|NCT00559273|422235|P2|Correction Period (20 Weeks)|Adverse Event|1
124911|NCT00559273|422236|P1|Correction Period (20 Weeks)|Adverse Event|2
124912|NCT00559273|422235|P2|Correction Period (20 Weeks)|Death|4
124913|NCT00559273|422236|P1|Correction Period (20 Weeks)|Death|3
124914|NCT00559104|422258|P2|Overall Study|Lack of Efficacy|0
124915|NCT00559104|422259|P1|Overall Study|Lack of Efficacy|9
124916|NCT00558896|422280|P7|Overall Study|Continues on treatment|6
124917|NCT00558896|422281|P6|Overall Study|Continues on treatment|25
124918|NCT00558896|422282|P5|Overall Study|Continues on treatment|9
124919|NCT00558896|422283|P4|Overall Study|Continues on treatment|1
124920|NCT00558896|422284|P3|Overall Study|Continues on treatment|0
124921|NCT00558896|422285|P2|Overall Study|Continues on treatment|1
124922|NCT00558896|422286|P1|Overall Study|Continues on treatment|10
124923|NCT00558896|422280|P7|Overall Study|Physician discretion|3
124924|NCT00558896|422281|P6|Overall Study|Physician discretion|3
124925|NCT00558896|422282|P5|Overall Study|Physician discretion|1
124926|NCT00558896|422283|P4|Overall Study|Physician discretion|2
124927|NCT00558896|422284|P3|Overall Study|Physician discretion|1
124928|NCT00558896|422285|P2|Overall Study|Physician discretion|2
124929|NCT00558896|422286|P1|Overall Study|Physician discretion|3
124930|NCT00558896|422280|P7|Overall Study|Alternative Treatment|1
124931|NCT00558896|422281|P6|Overall Study|Alternative Treatment|7
124932|NCT00558896|422282|P5|Overall Study|Alternative Treatment|6
124933|NCT00558896|422283|P4|Overall Study|Alternative Treatment|2
124934|NCT00558896|422284|P3|Overall Study|Alternative Treatment|0
124935|NCT00558896|422285|P2|Overall Study|Alternative Treatment|2
124936|NCT00558896|422286|P1|Overall Study|Alternative Treatment|2
124937|NCT00558896|422280|P7|Overall Study|Withdrawal by Subject|5
124938|NCT00558896|422281|P6|Overall Study|Withdrawal by Subject|5
124939|NCT00558896|422282|P5|Overall Study|Withdrawal by Subject|1
124940|NCT00558896|422283|P4|Overall Study|Withdrawal by Subject|1
124941|NCT00558896|422284|P3|Overall Study|Withdrawal by Subject|1
124942|NCT00558896|422285|P2|Overall Study|Withdrawal by Subject|1
124943|NCT00558896|422286|P1|Overall Study|Withdrawal by Subject|2
124944|NCT00558896|422280|P7|Overall Study|Death|6
124945|NCT00558896|422281|P6|Overall Study|Death|2
124946|NCT00558896|422282|P5|Overall Study|Death|2
124947|NCT00558896|422283|P4|Overall Study|Death|3
124948|NCT00558896|422284|P3|Overall Study|Death|2
124949|NCT00558896|422285|P2|Overall Study|Death|0
124950|NCT00558896|422286|P1|Overall Study|Death|3
124951|NCT00558896|422280|P7|Overall Study|Adverse Event|3
124952|NCT00558896|422281|P6|Overall Study|Adverse Event|10
124953|NCT00558896|422282|P5|Overall Study|Adverse Event|4
124954|NCT00558896|422283|P4|Overall Study|Adverse Event|3
124955|NCT00558896|422284|P3|Overall Study|Adverse Event|1
124956|NCT00558896|422285|P2|Overall Study|Adverse Event|1
124957|NCT00558896|422286|P1|Overall Study|Adverse Event|1
124958|NCT00558831|422327|P1|Overall Study|Lost to Follow-up|1
124959|NCT00558753|422384|P2|Overall Study|Lost to Follow-up|7
124960|NCT00558753|422385|P1|Overall Study|Lost to Follow-up|5
124961|NCT00558701|422397|P2|Overall Study|Protocol Deviations|4
124962|NCT00558701|422398|P1|Overall Study|Protocol Deviations|1
124963|NCT00558636|422406|P2|Follow-up|Premature termination of the study|7
124964|NCT00558636|422407|P1|Follow-up|Premature termination of the study|12
124965|NCT00558636|422406|P2|Treatment|Disease progression|5
124966|NCT00558636|422407|P1|Treatment|Disease progression|1
124967|NCT00558636|422406|P2|Treatment|Premature termination of the study|37
124968|NCT00558636|422407|P1|Treatment|Premature termination of the study|35
124969|NCT00558636|422406|P2|Treatment|Withdrawal by Subject|0
124970|NCT00558636|422407|P1|Treatment|Withdrawal by Subject|2
124971|NCT00558636|422406|P2|Treatment|Adverse Event|2
124972|NCT00558636|422407|P1|Treatment|Adverse Event|9
124973|NCT00558558|422507|P1|Overall Study|Lack of Efficacy|4
124974|NCT00558558|422507|P1|Overall Study|Withdrawal by Subject|1
124975|NCT00558558|422507|P1|Overall Study|Unable to swallow|1
124976|NCT00558467|422513|P2|Overall Study|Patient moving out of state|1
124977|NCT00558467|422514|P1|Overall Study|Patient moving out of state|0
124978|NCT00558467|422513|P2|Overall Study|Lack of Efficacy|1
124979|NCT00558467|422514|P1|Overall Study|Lack of Efficacy|0
124980|NCT00558467|422513|P2|Overall Study|Adverse Event|2
124981|NCT00558467|422514|P1|Overall Study|Adverse Event|1
124982|NCT00558428|422574|P4|Overall Study|Other|1
124983|NCT00558428|422575|P3|Overall Study|Other|0
124984|NCT00558428|422576|P2|Overall Study|Other|0
124985|NCT00558428|422577|P1|Overall Study|Other|3
124986|NCT00558428|422574|P4|Overall Study|Consent withdrawn|1
124987|NCT00558428|422575|P3|Overall Study|Consent withdrawn|0
124988|NCT00558428|422576|P2|Overall Study|Consent withdrawn|1
124989|NCT00558428|422577|P1|Overall Study|Consent withdrawn|2
124990|NCT00558428|422574|P4|Overall Study|Non compliant with protocol|3
124991|NCT00558428|422575|P3|Overall Study|Non compliant with protocol|0
124992|NCT00558428|422576|P2|Overall Study|Non compliant with protocol|0
124993|NCT00558428|422577|P1|Overall Study|Non compliant with protocol|1
124994|NCT00558428|422574|P4|Overall Study|Lack of Efficacy|2
124995|NCT00558428|422575|P3|Overall Study|Lack of Efficacy|1
124996|NCT00558428|422576|P2|Overall Study|Lack of Efficacy|0
124997|NCT00558428|422577|P1|Overall Study|Lack of Efficacy|0
124998|NCT00558428|422574|P4|Overall Study|Lost to Follow-up|0
124999|NCT00558428|422575|P3|Overall Study|Lost to Follow-up|0
125000|NCT00558428|422576|P2|Overall Study|Lost to Follow-up|1
125001|NCT00558428|422577|P1|Overall Study|Lost to Follow-up|0
125002|NCT00558428|422574|P4|Overall Study|Adverse Event|4
125003|NCT00558428|422575|P3|Overall Study|Adverse Event|3
125004|NCT00558428|422576|P2|Overall Study|Adverse Event|22
125005|NCT00558428|422577|P1|Overall Study|Adverse Event|6
125006|NCT00558363|422617|P2|Overall Study|Hospitalized; Unable to Continue|1
125007|NCT00558363|422618|P1|Overall Study|Hospitalized; Unable to Continue|0
125008|NCT00558363|422617|P2|Overall Study|Randomized in Error|2
125009|NCT00558363|422618|P1|Overall Study|Randomized in Error|1
125010|NCT00558363|422617|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
125011|NCT00558363|422618|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
125012|NCT00558363|422617|P2|Overall Study|Lost to Follow-up|1
125013|NCT00558363|422618|P1|Overall Study|Lost to Follow-up|0
125014|NCT00558363|422617|P2|Overall Study|Protocol Violation|1
125015|NCT00558363|422618|P1|Overall Study|Protocol Violation|2
125016|NCT00558363|422617|P2|Overall Study|Lack of Efficacy|2
125017|NCT00558363|422618|P1|Overall Study|Lack of Efficacy|2
125018|NCT00558363|422617|P2|Overall Study|Adverse Event|5
125019|NCT00558363|422618|P1|Overall Study|Adverse Event|5
125020|NCT00558363|422617|P2|Overall Study|Withdrawal by Subject|4
125021|NCT00558363|422618|P1|Overall Study|Withdrawal by Subject|11
125022|NCT00558363|422617|P2|Overall Study|Physician Decision|4
125023|NCT00558363|422618|P1|Overall Study|Physician Decision|18
125024|NCT00558285|422673|P5|Overall Study|Protocol deviation|0
125025|NCT00558285|422674|P4|Overall Study|Protocol deviation|1
125026|NCT00558285|422675|P3|Overall Study|Protocol deviation|0
125027|NCT00558285|422676|P2|Overall Study|Protocol deviation|1
125028|NCT00558285|422677|P1|Overall Study|Protocol deviation|1
125029|NCT00558285|422673|P5|Overall Study|Administrative problems|1
125030|NCT00558285|422674|P4|Overall Study|Administrative problems|1
125031|NCT00558285|422675|P3|Overall Study|Administrative problems|0
125032|NCT00558285|422676|P2|Overall Study|Administrative problems|0
125033|NCT00558285|422677|P1|Overall Study|Administrative problems|0
125034|NCT00558285|422673|P5|Overall Study|Lost to Follow-up|0
125035|NCT00558285|422674|P4|Overall Study|Lost to Follow-up|0
125036|NCT00558285|422675|P3|Overall Study|Lost to Follow-up|0
125037|NCT00558285|422676|P2|Overall Study|Lost to Follow-up|1
125038|NCT00558285|422677|P1|Overall Study|Lost to Follow-up|1
125039|NCT00558285|422673|P5|Overall Study|Subject withdrew consent|1
125040|NCT00558285|422674|P4|Overall Study|Subject withdrew consent|1
125041|NCT00558285|422675|P3|Overall Study|Subject withdrew consent|1
125042|NCT00558285|422676|P2|Overall Study|Subject withdrew consent|0
125043|NCT00558285|422677|P1|Overall Study|Subject withdrew consent|2
125044|NCT00558285|422673|P5|Overall Study|Abnormal test procedure result(s)|0
125045|NCT00558285|422674|P4|Overall Study|Abnormal test procedure result(s)|0
125046|NCT00558285|422675|P3|Overall Study|Abnormal test procedure result(s)|0
125047|NCT00558285|422676|P2|Overall Study|Abnormal test procedure result(s)|0
125048|NCT00558285|422677|P1|Overall Study|Abnormal test procedure result(s)|1
125049|NCT00558285|422673|P5|Overall Study|Adverse Event|2
125050|NCT00558285|422674|P4|Overall Study|Adverse Event|1
125051|NCT00558285|422675|P3|Overall Study|Adverse Event|4
125052|NCT00558285|422676|P2|Overall Study|Adverse Event|1
125053|NCT00558285|422677|P1|Overall Study|Adverse Event|1
125054|NCT00558272|422721|P2|Overall Study|Withdrawal by Subject|1
125055|NCT00558272|422722|P1|Overall Study|Withdrawal by Subject|0
125056|NCT00558272|422721|P2|Overall Study|Incorrectly enrolled|0
125057|NCT00558272|422722|P1|Overall Study|Incorrectly enrolled|1
125058|NCT00558272|422721|P2|Overall Study|AZ study team decision|1
125059|NCT00558272|422722|P1|Overall Study|AZ study team decision|0
125060|NCT00558272|422721|P2|Overall Study|Dev. of study specific discon. criteria|0
125061|NCT00558272|422722|P1|Overall Study|Dev. of study specific discon. criteria|1
125062|NCT00558272|422721|P2|Overall Study|Death|0
125063|NCT00558272|422722|P1|Overall Study|Death|1
125064|NCT00558272|422721|P2|Overall Study|Adverse Event|0
125065|NCT00558272|422722|P1|Overall Study|Adverse Event|10
125066|NCT00558259|422762|P2|Overall Study|Withdrawal by Subject|13
125067|NCT00558259|422763|P1|Overall Study|Withdrawal by Subject|12
125068|NCT00558259|422762|P2|Overall Study|Protocol Violation|5
125069|NCT00558259|422763|P1|Overall Study|Protocol Violation|9
125070|NCT00558259|422762|P2|Overall Study|Adverse Event|81
125071|NCT00558259|422763|P1|Overall Study|Adverse Event|50
125072|NCT00558103|422803|P6|Monotherapy Extension Phase|Disease Progression|8
125073|NCT00558103|422804|P5|Monotherapy Extension Phase|Disease Progression|0
125074|NCT00558103|422805|P4|Monotherapy Extension Phase|Disease Progression|0
125075|NCT00558103|422806|P3|Monotherapy Extension Phase|Disease Progression|0
125076|NCT00558103|422807|P2|Monotherapy Extension Phase|Disease Progression|0
125077|NCT00558103|422808|P1|Monotherapy Extension Phase|Disease Progression|0
125078|NCT00558103|422803|P6|Monotherapy Extension Phase|Protocol Violation|1
125079|NCT00558103|422804|P5|Monotherapy Extension Phase|Protocol Violation|0
125080|NCT00558103|422805|P4|Monotherapy Extension Phase|Protocol Violation|0
125081|NCT00558103|422806|P3|Monotherapy Extension Phase|Protocol Violation|0
125082|NCT00558103|422807|P2|Monotherapy Extension Phase|Protocol Violation|0
125083|NCT00558103|422808|P1|Monotherapy Extension Phase|Protocol Violation|0
125084|NCT00558103|422803|P6|Randomized Treatment Phase|Adverse Event|0
125085|NCT00558103|422804|P5|Randomized Treatment Phase|Adverse Event|1
125086|NCT00558103|422805|P4|Randomized Treatment Phase|Adverse Event|1
125087|NCT00558103|422806|P3|Randomized Treatment Phase|Adverse Event|0
125088|NCT00558103|422807|P2|Randomized Treatment Phase|Adverse Event|0
125089|NCT00558103|422808|P1|Randomized Treatment Phase|Adverse Event|0
125090|NCT00558103|422803|P6|Randomized Treatment Phase|Disease Progression|0
125091|NCT00558103|422804|P5|Randomized Treatment Phase|Disease Progression|0
125092|NCT00558103|422805|P4|Randomized Treatment Phase|Disease Progression|0
125093|NCT00558103|422806|P3|Randomized Treatment Phase|Disease Progression|1
125094|NCT00558103|422807|P2|Randomized Treatment Phase|Disease Progression|0
125095|NCT00558103|422808|P1|Randomized Treatment Phase|Disease Progression|1
125096|NCT00558103|422803|P6|Randomized Treatment Phase|Withdrawal by Subject|0
125097|NCT00558103|422804|P5|Randomized Treatment Phase|Withdrawal by Subject|1
125098|NCT00558103|422805|P4|Randomized Treatment Phase|Withdrawal by Subject|0
125099|NCT00558103|422806|P3|Randomized Treatment Phase|Withdrawal by Subject|0
125100|NCT00558103|422807|P2|Randomized Treatment Phase|Withdrawal by Subject|2
125101|NCT00558103|422808|P1|Randomized Treatment Phase|Withdrawal by Subject|2
125102|NCT00558103|422803|P6|Randomized Treatment Phase|Lost to Follow-up|0
125103|NCT00558103|422804|P5|Randomized Treatment Phase|Lost to Follow-up|3
125104|NCT00558103|422805|P4|Randomized Treatment Phase|Lost to Follow-up|1
125105|NCT00558103|422806|P3|Randomized Treatment Phase|Lost to Follow-up|2
125106|NCT00558103|422807|P2|Randomized Treatment Phase|Lost to Follow-up|2
125107|NCT00558103|422808|P1|Randomized Treatment Phase|Lost to Follow-up|2
125108|NCT00558064|422838|P2|Overall Study|No visit within allowance period|0
125109|NCT00558064|422839|P1|Overall Study|No visit within allowance period|1
125110|NCT00558064|422838|P2|Overall Study|Withdrawal by Subject|1
125111|NCT00558064|422839|P1|Overall Study|Withdrawal by Subject|0
125112|NCT00558064|422838|P2|Overall Study|Lost to Follow-up|1
125113|NCT00558064|422839|P1|Overall Study|Lost to Follow-up|0
125114|NCT00558064|422838|P2|Overall Study|Protocol Violation|0
125115|NCT00558064|422839|P1|Overall Study|Protocol Violation|1
125116|NCT00558064|422838|P2|Overall Study|Lack of Efficacy|1
125117|NCT00558064|422839|P1|Overall Study|Lack of Efficacy|0
125118|NCT00558064|422838|P2|Overall Study|Adverse Event|2
125119|NCT00558064|422839|P1|Overall Study|Adverse Event|3
125120|NCT00558025|422861|P2|Overall Study|Protocol Violation|0
125121|NCT00558025|422862|P1|Overall Study|Protocol Violation|1
125122|NCT00558025|422861|P2|Overall Study|Withdrawal by Subject|2
125123|NCT00558025|422862|P1|Overall Study|Withdrawal by Subject|2
125124|NCT00558025|422861|P2|Overall Study|Adverse Event|1
125125|NCT00558025|422862|P1|Overall Study|Adverse Event|1
125126|NCT00557856|422909|P9|Part 2: Exploratory Phase|global deterioration of health status|1
125127|NCT00557856|422910|P8|Part 2: Exploratory Phase|global deterioration of health status|0
125128|NCT00557856|422911|P7|Part 2: Exploratory Phase|global deterioration of health status|0
125129|NCT00557856|422912|P6|Part 2: Exploratory Phase|global deterioration of health status|0
125130|NCT00557856|422913|P5|Part 2: Exploratory Phase|global deterioration of health status|0
125131|NCT00557856|422914|P4|Part 2: Exploratory Phase|global deterioration of health status|0
125132|NCT00557856|422915|P3|Part 2: Exploratory Phase|global deterioration of health status|0
125133|NCT00557856|422916|P2|Part 2: Exploratory Phase|global deterioration of health status|0
125134|NCT00557856|422917|P1|Part 2: Exploratory Phase|global deterioration of health status|0
125135|NCT00557856|422909|P9|Part 2: Exploratory Phase|Death|2
125136|NCT00557856|422910|P8|Part 2: Exploratory Phase|Death|0
125137|NCT00557856|422911|P7|Part 2: Exploratory Phase|Death|0
125138|NCT00557856|422912|P6|Part 2: Exploratory Phase|Death|0
125139|NCT00557856|422913|P5|Part 2: Exploratory Phase|Death|0
125140|NCT00557856|422914|P4|Part 2: Exploratory Phase|Death|0
125141|NCT00557856|422915|P3|Part 2: Exploratory Phase|Death|0
125142|NCT00557856|422916|P2|Part 2: Exploratory Phase|Death|0
125143|NCT00557856|422917|P1|Part 2: Exploratory Phase|Death|0
125144|NCT00557856|422909|P9|Part 2: Exploratory Phase|unspecified|1
125145|NCT00557856|422910|P8|Part 2: Exploratory Phase|unspecified|0
125146|NCT00557856|422911|P7|Part 2: Exploratory Phase|unspecified|0
125147|NCT00557856|422912|P6|Part 2: Exploratory Phase|unspecified|0
125148|NCT00557856|422913|P5|Part 2: Exploratory Phase|unspecified|0
125149|NCT00557856|422914|P4|Part 2: Exploratory Phase|unspecified|0
125150|NCT00557856|422915|P3|Part 2: Exploratory Phase|unspecified|0
125151|NCT00557856|422916|P2|Part 2: Exploratory Phase|unspecified|0
125152|NCT00557856|422917|P1|Part 2: Exploratory Phase|unspecified|0
125153|NCT00557856|422909|P9|Part 2: Exploratory Phase|Adverse Event|4
125154|NCT00557856|422910|P8|Part 2: Exploratory Phase|Adverse Event|0
125155|NCT00557856|422911|P7|Part 2: Exploratory Phase|Adverse Event|0
125156|NCT00557856|422912|P6|Part 2: Exploratory Phase|Adverse Event|0
125157|NCT00557856|422913|P5|Part 2: Exploratory Phase|Adverse Event|0
125158|NCT00557856|422914|P4|Part 2: Exploratory Phase|Adverse Event|0
125159|NCT00557856|422915|P3|Part 2: Exploratory Phase|Adverse Event|0
125160|NCT00557856|422916|P2|Part 2: Exploratory Phase|Adverse Event|0
125161|NCT00557856|422917|P1|Part 2: Exploratory Phase|Adverse Event|0
125162|NCT00557856|422909|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
125163|NCT00557856|422910|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
125164|NCT00557856|422911|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
125165|NCT00557856|422912|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
125166|NCT00557856|422913|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
125167|NCT00557856|422914|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
125168|NCT00557856|422915|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
125169|NCT00557856|422916|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
125170|NCT00557856|422917|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
125171|NCT00557856|422909|P9|Part 2: Exploratory Phase|objective progression or relapse|15
125172|NCT00557856|422910|P8|Part 2: Exploratory Phase|objective progression or relapse|0
125173|NCT00557856|422911|P7|Part 2: Exploratory Phase|objective progression or relapse|0
125174|NCT00557856|422912|P6|Part 2: Exploratory Phase|objective progression or relapse|0
125175|NCT00557856|422913|P5|Part 2: Exploratory Phase|objective progression or relapse|0
125176|NCT00557856|422914|P4|Part 2: Exploratory Phase|objective progression or relapse|0
125177|NCT00557856|422915|P3|Part 2: Exploratory Phase|objective progression or relapse|0
125178|NCT00557856|422916|P2|Part 2: Exploratory Phase|objective progression or relapse|0
125179|NCT00557856|422917|P1|Part 2: Exploratory Phase|objective progression or relapse|0
125180|NCT00557856|422909|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
125181|NCT00557856|422910|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
125182|NCT00557856|422911|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
125183|NCT00557856|422912|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
125184|NCT00557856|422913|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
125185|NCT00557856|422914|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
125186|NCT00557856|422915|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
125187|NCT00557856|422916|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
125188|NCT00557856|422917|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
125189|NCT00557856|422909|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
125190|NCT00557856|422910|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
125191|NCT00557856|422911|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
125192|NCT00557856|422912|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
125193|NCT00557856|422913|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
125194|NCT00557856|422914|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
125195|NCT00557856|422915|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
125196|NCT00557856|422916|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
125197|NCT00557856|422917|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
125198|NCT00557856|422909|P9|Part 1: Dose Escalation Phase|Death|0
125199|NCT00557856|422910|P8|Part 1: Dose Escalation Phase|Death|0
125200|NCT00557856|422911|P7|Part 1: Dose Escalation Phase|Death|0
125201|NCT00557856|422912|P6|Part 1: Dose Escalation Phase|Death|1
125202|NCT00557856|422913|P5|Part 1: Dose Escalation Phase|Death|0
125203|NCT00557856|422914|P4|Part 1: Dose Escalation Phase|Death|0
125204|NCT00557856|422915|P3|Part 1: Dose Escalation Phase|Death|0
125205|NCT00557856|422916|P2|Part 1: Dose Escalation Phase|Death|0
125206|NCT00557856|422917|P1|Part 1: Dose Escalation Phase|Death|0
125207|NCT00557856|422909|P9|Part 1: Dose Escalation Phase|unspecified|0
125208|NCT00557856|422910|P8|Part 1: Dose Escalation Phase|unspecified|1
125209|NCT00557856|422911|P7|Part 1: Dose Escalation Phase|unspecified|0
125210|NCT00557856|422912|P6|Part 1: Dose Escalation Phase|unspecified|0
125211|NCT00557856|422913|P5|Part 1: Dose Escalation Phase|unspecified|0
125212|NCT00557856|422914|P4|Part 1: Dose Escalation Phase|unspecified|1
125213|NCT00557856|422915|P3|Part 1: Dose Escalation Phase|unspecified|1
125214|NCT00557856|422916|P2|Part 1: Dose Escalation Phase|unspecified|0
125215|NCT00557856|422917|P1|Part 1: Dose Escalation Phase|unspecified|0
125216|NCT00557856|422909|P9|Part 1: Dose Escalation Phase|Adverse Event|0
125217|NCT00557856|422910|P8|Part 1: Dose Escalation Phase|Adverse Event|2
125218|NCT00557856|422911|P7|Part 1: Dose Escalation Phase|Adverse Event|1
125219|NCT00557856|422912|P6|Part 1: Dose Escalation Phase|Adverse Event|3
125220|NCT00557856|422913|P5|Part 1: Dose Escalation Phase|Adverse Event|1
125221|NCT00557856|422914|P4|Part 1: Dose Escalation Phase|Adverse Event|1
125222|NCT00557856|422915|P3|Part 1: Dose Escalation Phase|Adverse Event|1
125223|NCT00557856|422916|P2|Part 1: Dose Escalation Phase|Adverse Event|0
125224|NCT00557856|422917|P1|Part 1: Dose Escalation Phase|Adverse Event|1
125225|NCT00557856|422909|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
125226|NCT00557856|422910|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
125227|NCT00557856|422911|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
125228|NCT00557856|422912|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
125229|NCT00557856|422913|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
125230|NCT00557856|422914|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
125231|NCT00557856|422915|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
125232|NCT00557856|422916|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
125233|NCT00557856|422917|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
125234|NCT00557856|422909|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
125235|NCT00557856|422910|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
125236|NCT00557856|422911|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
125237|NCT00557856|422912|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
125238|NCT00557856|422913|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
125239|NCT00557856|422914|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
125240|NCT00557856|422915|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
125241|NCT00557856|422916|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
125242|NCT00557856|422917|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
125243|NCT00557830|423116|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
125244|NCT00557830|423117|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
125245|NCT00557830|423118|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
125246|NCT00557830|423116|P3|Screening Treatment Phase|Adverse Event|0
125247|NCT00557830|423117|P2|Screening Treatment Phase|Adverse Event|0
125248|NCT00557830|423118|P1|Screening Treatment Phase|Adverse Event|2
125249|NCT00557830|423116|P3|Screening Treatment Phase|Withdrawal by Subject|0
125250|NCT00557830|423117|P2|Screening Treatment Phase|Withdrawal by Subject|0
125251|NCT00557830|423118|P1|Screening Treatment Phase|Withdrawal by Subject|1
125252|NCT00557622|423140|P2|12-Week Treatment Phase|Lost to Follow-up|1
125253|NCT00557622|423141|P1|12-Week Treatment Phase|Lost to Follow-up|0
125254|NCT00557622|423140|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
125255|NCT00557622|423141|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
125256|NCT00557622|423140|P2|4-Week Run-in Phase|Withdrawal by Subject|0
125257|NCT00557622|423141|P1|4-Week Run-in Phase|Withdrawal by Subject|1
125258|NCT00557505|423170|P9|Overall Study|Withdrawal by Subject|1
125259|NCT00557505|423171|P8|Overall Study|Withdrawal by Subject|0
125260|NCT00557505|423172|P7|Overall Study|Withdrawal by Subject|0
125261|NCT00557505|423173|P6|Overall Study|Withdrawal by Subject|0
125262|NCT00557505|423174|P5|Overall Study|Withdrawal by Subject|0
125263|NCT00557505|423175|P4|Overall Study|Withdrawal by Subject|1
125264|NCT00557505|423176|P3|Overall Study|Withdrawal by Subject|0
125265|NCT00557505|423177|P2|Overall Study|Withdrawal by Subject|0
125266|NCT00557505|423178|P1|Overall Study|Withdrawal by Subject|0
125267|NCT00557505|423170|P9|Overall Study|Objective progression or relapse|15
125268|NCT00557505|423171|P8|Overall Study|Objective progression or relapse|5
125269|NCT00557505|423172|P7|Overall Study|Objective progression or relapse|2
125270|NCT00557505|423173|P6|Overall Study|Objective progression or relapse|3
125271|NCT00557505|423174|P5|Overall Study|Objective progression or relapse|2
125272|NCT00557505|423175|P4|Overall Study|Objective progression or relapse|2
125273|NCT00557505|423176|P3|Overall Study|Objective progression or relapse|3
125274|NCT00557505|423177|P2|Overall Study|Objective progression or relapse|3
125275|NCT00557505|423178|P1|Overall Study|Objective progression or relapse|2
125276|NCT00557505|423170|P9|Overall Study|Global deterioration of health|0
125277|NCT00557505|423171|P8|Overall Study|Global deterioration of health|0
125278|NCT00557505|423172|P7|Overall Study|Global deterioration of health|0
125279|NCT00557505|423173|P6|Overall Study|Global deterioration of health|0
125280|NCT00557505|423174|P5|Overall Study|Global deterioration of health|0
125281|NCT00557505|423175|P4|Overall Study|Global deterioration of health|0
125282|NCT00557505|423176|P3|Overall Study|Global deterioration of health|0
125283|NCT00557505|423177|P2|Overall Study|Global deterioration of health|0
125284|NCT00557505|423178|P1|Overall Study|Global deterioration of health|1
125285|NCT00557505|423170|P9|Overall Study|Adverse Event|0
125286|NCT00557505|423171|P8|Overall Study|Adverse Event|0
125287|NCT00557505|423172|P7|Overall Study|Adverse Event|1
125288|NCT00557505|423173|P6|Overall Study|Adverse Event|0
125289|NCT00557505|423174|P5|Overall Study|Adverse Event|0
125290|NCT00557505|423175|P4|Overall Study|Adverse Event|0
125291|NCT00557505|423176|P3|Overall Study|Adverse Event|1
125292|NCT00557505|423177|P2|Overall Study|Adverse Event|0
125293|NCT00557505|423178|P1|Overall Study|Adverse Event|0
125294|NCT00557505|423170|P9|Overall Study|Death|1
125295|NCT00557505|423171|P8|Overall Study|Death|0
125296|NCT00557505|423172|P7|Overall Study|Death|0
125297|NCT00557505|423173|P6|Overall Study|Death|0
125298|NCT00557505|423174|P5|Overall Study|Death|0
125299|NCT00557505|423175|P4|Overall Study|Death|0
125300|NCT00557505|423176|P3|Overall Study|Death|0
125301|NCT00557505|423177|P2|Overall Study|Death|0
125302|NCT00557505|423178|P1|Overall Study|Death|0
125303|NCT00557492|423342|P1|Overall Study|Change in health insurance|1
125304|NCT00557466|423360|P6|Overall Study|Lost to Follow-up|0
125305|NCT00557466|423361|P5|Overall Study|Lost to Follow-up|0
125306|NCT00557466|423362|P4|Overall Study|Lost to Follow-up|1
125307|NCT00557466|423363|P3|Overall Study|Lost to Follow-up|0
125308|NCT00557466|423364|P2|Overall Study|Lost to Follow-up|0
125309|NCT00557466|423365|P1|Overall Study|Lost to Follow-up|0
125310|NCT00557466|423360|P6|Overall Study|Abnormal test procedure results|0
125311|NCT00557466|423361|P5|Overall Study|Abnormal test procedure results|0
125312|NCT00557466|423362|P4|Overall Study|Abnormal test procedure results|0
125313|NCT00557466|423363|P3|Overall Study|Abnormal test procedure results|1
125314|NCT00557466|423364|P2|Overall Study|Abnormal test procedure results|0
125315|NCT00557466|423365|P1|Overall Study|Abnormal test procedure results|0
125316|NCT00557466|423360|P6|Overall Study|Administrative problems|0
125317|NCT00557466|423361|P5|Overall Study|Administrative problems|0
125318|NCT00557466|423362|P4|Overall Study|Administrative problems|0
125319|NCT00557466|423363|P3|Overall Study|Administrative problems|1
125320|NCT00557466|423364|P2|Overall Study|Administrative problems|1
125321|NCT00557466|423365|P1|Overall Study|Administrative problems|0
125322|NCT00557466|423360|P6|Overall Study|Subject withdrew consent|2
125323|NCT00557466|423361|P5|Overall Study|Subject withdrew consent|1
125324|NCT00557466|423362|P4|Overall Study|Subject withdrew consent|0
125325|NCT00557466|423363|P3|Overall Study|Subject withdrew consent|0
125326|NCT00557466|423364|P2|Overall Study|Subject withdrew consent|0
125327|NCT00557466|423365|P1|Overall Study|Subject withdrew consent|0
125328|NCT00557466|423360|P6|Overall Study|Protocol deviation|0
125329|NCT00557466|423361|P5|Overall Study|Protocol deviation|0
125330|NCT00557466|423362|P4|Overall Study|Protocol deviation|2
125331|NCT00557466|423363|P3|Overall Study|Protocol deviation|0
125332|NCT00557466|423364|P2|Overall Study|Protocol deviation|1
125333|NCT00557466|423365|P1|Overall Study|Protocol deviation|0
125334|NCT00557466|423360|P6|Overall Study|Abnormal laboratory value(s)|0
125335|NCT00557466|423361|P5|Overall Study|Abnormal laboratory value(s)|0
125336|NCT00557466|423362|P4|Overall Study|Abnormal laboratory value(s)|0
125337|NCT00557466|423363|P3|Overall Study|Abnormal laboratory value(s)|0
125338|NCT00557466|423364|P2|Overall Study|Abnormal laboratory value(s)|2
125339|NCT00557466|423365|P1|Overall Study|Abnormal laboratory value(s)|1
125340|NCT00557466|423360|P6|Overall Study|Adverse Event|4
125341|NCT00557466|423361|P5|Overall Study|Adverse Event|2
125342|NCT00557466|423362|P4|Overall Study|Adverse Event|1
125343|NCT00557466|423363|P3|Overall Study|Adverse Event|4
125344|NCT00557466|423364|P2|Overall Study|Adverse Event|1
125345|NCT00557466|423365|P1|Overall Study|Adverse Event|3
125346|NCT00557440|423418|P3|Treatment Period 1|Adverse Event|1
125347|NCT00557440|423419|P2|Treatment Period 1|Adverse Event|0
125348|NCT00557440|423420|P1|Treatment Period 1|Adverse Event|0
125349|NCT00557323|423474|P1|Overall Study|Administrative change|2
125350|NCT00557323|423474|P1|Overall Study|Withdrawal by Subject|2
125351|NCT00557323|423474|P1|Overall Study|Death|3
125352|NCT00557310|423479|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
125353|NCT00557310|423479|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
125354|NCT00557310|423479|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
125355|NCT00557310|423479|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
125356|NCT00557310|423479|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
125357|NCT00557310|423479|P1|Main Study (0 - 18 Months)|Adverse Event|4
125358|NCT00557245|423525|P3|Overall Study|Ineligible|2
125359|NCT00557245|423526|P2|Overall Study|Ineligible|4
125360|NCT00557245|423527|P1|Overall Study|Ineligible|5
125361|NCT00557245|423525|P3|Overall Study|Lost to Follow-up|10
125362|NCT00557245|423526|P2|Overall Study|Lost to Follow-up|8
125363|NCT00557245|423527|P1|Overall Study|Lost to Follow-up|7
125364|NCT00557076|423567|P2|Overall Study|Unblinding|1
125365|NCT00557076|423568|P1|Overall Study|Unblinding|0
125366|NCT00556998|423576|P1|Voriconazole Oral|Intolerant of oral treatment|1
125367|NCT00556998|423576|P1|Voriconazole Oral|Adverse Event|1
125368|NCT00556998|423576|P1|Voriconazole Intravenous (IV)|unspecified|4
125369|NCT00556998|423576|P1|Voriconazole Intravenous (IV)|Adverse Event|1
125370|NCT00556933|423611|P4|CNI Withdrawal vs. Minimization|Death|1
125371|NCT00556933|423612|P3|CNI Withdrawal vs. Minimization|Death|0
125372|NCT00556933|423613|P2|CNI Withdrawal vs. Minimization|Death|0
125373|NCT00556933|423614|P1|CNI Withdrawal vs. Minimization|Death|0
125374|NCT00556933|423611|P4|CNI Withdrawal vs. Minimization|Graft loss|0
125375|NCT00556933|423612|P3|CNI Withdrawal vs. Minimization|Graft loss|2
125376|NCT00556933|423613|P2|CNI Withdrawal vs. Minimization|Graft loss|1
125377|NCT00556933|423614|P1|CNI Withdrawal vs. Minimization|Graft loss|0
125378|NCT00556933|423611|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
125379|NCT00556933|423612|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
125380|NCT00556933|423613|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
125381|NCT00556933|423614|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
125382|NCT00556933|423611|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
125383|NCT00556933|423612|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
125384|NCT00556933|423613|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
125385|NCT00556933|423614|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
125386|NCT00556933|423611|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
125387|NCT00556933|423612|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
125388|NCT00556933|423613|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
125389|NCT00556933|423614|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
125390|NCT00556933|423611|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
125391|NCT00556933|423612|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
125392|NCT00556933|423613|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
125393|NCT00556933|423614|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
125394|NCT00556933|423611|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
125395|NCT00556933|423612|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
125396|NCT00556933|423613|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
125397|NCT00556933|423614|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
125398|NCT00556933|423611|P4|Single vs. Divided-dose rATG Induction|Death|0
125399|NCT00556933|423612|P3|Single vs. Divided-dose rATG Induction|Death|0
125400|NCT00556933|423613|P2|Single vs. Divided-dose rATG Induction|Death|1
125401|NCT00556933|423614|P1|Single vs. Divided-dose rATG Induction|Death|0
125402|NCT00556933|423611|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
125403|NCT00556933|423612|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
125404|NCT00556933|423613|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
125405|NCT00556933|423614|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
125406|NCT00556933|423611|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
125407|NCT00556933|423612|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
125408|NCT00556933|423613|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
125409|NCT00556933|423614|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
125410|NCT00556933|423611|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
125411|NCT00556933|423612|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
125412|NCT00556933|423613|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
125413|NCT00556933|423614|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
125414|NCT00556894|423671|P3|Overall Study|Withdrawal by Subject|1
125415|NCT00556894|423672|P2|Overall Study|Withdrawal by Subject|1
125416|NCT00556894|423673|P1|Overall Study|Withdrawal by Subject|1
125417|NCT00556894|423671|P3|Overall Study|Change in therapy|2
125418|NCT00556894|423672|P2|Overall Study|Change in therapy|1
125419|NCT00556894|423673|P1|Overall Study|Change in therapy|2
125420|NCT00556894|423671|P3|Overall Study|regulatory decision in Bulgaria|13
125421|NCT00556894|423672|P2|Overall Study|regulatory decision in Bulgaria|14
125422|NCT00556894|423673|P1|Overall Study|regulatory decision in Bulgaria|10
125423|NCT00556894|423671|P3|Overall Study|Death|0
125424|NCT00556894|423672|P2|Overall Study|Death|0
125425|NCT00556894|423673|P1|Overall Study|Death|1
125426|NCT00556894|423671|P3|Overall Study|Adverse Event|3
125427|NCT00556894|423672|P2|Overall Study|Adverse Event|3
125428|NCT00556894|423673|P1|Overall Study|Adverse Event|2
125429|NCT00556712|423683|P2|Overall Study|Ongoing at Data Cutoff|66
125430|NCT00556712|423684|P1|Overall Study|Ongoing at Data Cutoff|32
125431|NCT00556712|423683|P2|Overall Study|Not Specified|2
125432|NCT00556712|423684|P1|Overall Study|Not Specified|2
125433|NCT00556712|423683|P2|Overall Study|Failure to Return|3
125434|NCT00556712|423684|P1|Overall Study|Failure to Return|2
125435|NCT00556712|423683|P2|Overall Study|Refused Treatment|16
125436|NCT00556712|423684|P1|Overall Study|Refused Treatment|17
125437|NCT00556712|423683|P2|Overall Study|Protocol Violation|2
125438|NCT00556712|423684|P1|Overall Study|Protocol Violation|3
125439|NCT00556712|423683|P2|Overall Study|Progressive Disease|320
125440|NCT00556712|423684|P1|Overall Study|Progressive Disease|383
125441|NCT00556712|423683|P2|Overall Study|Death|10
125442|NCT00556712|423684|P1|Overall Study|Death|5
125443|NCT00556712|423683|P2|Overall Study|Adverse Event|19
125444|NCT00556712|423684|P1|Overall Study|Adverse Event|7
125445|NCT00556673|423762|P2|Overall Study|Protocol deviation|2
125446|NCT00556673|423763|P1|Overall Study|Protocol deviation|3
125447|NCT00556426|423884|P1|Overall Study|Death|6
125448|NCT00556426|423884|P1|Overall Study|Withdrawal by Subject|3
125449|NCT00556374|423906|P2|Overall Study|Lost to Follow-up|5
125450|NCT00556374|423907|P1|Overall Study|Lost to Follow-up|7
125451|NCT00556374|423906|P2|Overall Study|Death|43
125452|NCT00556374|423907|P1|Overall Study|Death|50
125453|NCT00556374|423906|P2|Overall Study|Withdrawal by Subject|172
125454|NCT00556374|423907|P1|Overall Study|Withdrawal by Subject|190
125455|NCT00556322|423925|P2|Overall Study|Death|14
125456|NCT00556322|423926|P1|Overall Study|Death|20
125457|NCT00556322|423925|P2|Overall Study|Ongoing at data cutoff|5
125458|NCT00556322|423926|P1|Overall Study|Ongoing at data cutoff|3
125459|NCT00556322|423925|P2|Overall Study|Protocol Violation|1
125460|NCT00556322|423926|P1|Overall Study|Protocol Violation|5
125461|NCT00556322|423925|P2|Overall Study|Withdrawal by Subject|7
125462|NCT00556322|423926|P1|Overall Study|Withdrawal by Subject|19
125463|NCT00556322|423925|P2|Overall Study|Lost to Follow-up|3
125464|NCT00556322|423926|P1|Overall Study|Lost to Follow-up|5
125465|NCT00556322|423925|P2|Overall Study|Unspecified|1
125466|NCT00556322|423926|P1|Overall Study|Unspecified|4
125467|NCT00556322|423925|P2|Overall Study|Adverse Event|4
125468|NCT00556322|423926|P1|Overall Study|Adverse Event|7
125469|NCT00556322|423925|P2|Overall Study|Insufficient therapeutic response|168
125470|NCT00556322|423926|P1|Overall Study|Insufficient therapeutic response|158
125471|NCT00556166|423974|P1|Overall Study|Withdrawal by Subject|1
125472|NCT00556075|423987|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
125473|NCT00556075|423988|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
125474|NCT00556075|423989|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
125475|NCT00556075|423987|P3|Overall Study|Personal issues|0
125476|NCT00556075|423988|P2|Overall Study|Personal issues|1
125477|NCT00556075|423989|P1|Overall Study|Personal issues|4
125478|NCT00556075|423987|P3|Overall Study|Adverse Event|0
125479|NCT00556075|423988|P2|Overall Study|Adverse Event|2
125480|NCT00556075|423989|P1|Overall Study|Adverse Event|1
125481|NCT00556075|423987|P3|Overall Study|Not eligible|2
125482|NCT00556075|423988|P2|Overall Study|Not eligible|1
125483|NCT00556075|423989|P1|Overall Study|Not eligible|1
125484|NCT00556075|423987|P3|Overall Study|Protocol Violation|3
125485|NCT00556075|423988|P2|Overall Study|Protocol Violation|1
125486|NCT00556075|423989|P1|Overall Study|Protocol Violation|1
125487|NCT00556075|423987|P3|Overall Study|Withdrawal by Subject|0
125488|NCT00556075|423988|P2|Overall Study|Withdrawal by Subject|3
125489|NCT00556075|423989|P1|Overall Study|Withdrawal by Subject|3
125490|NCT00556075|423987|P3|Overall Study|Lost to Follow-up|3
125491|NCT00556075|423988|P2|Overall Study|Lost to Follow-up|0
125492|NCT00556075|423989|P1|Overall Study|Lost to Follow-up|3
125493|NCT00555906|424041|P5|Phase 2|Randomized but not Treated|2
125494|NCT00555906|424042|P4|Phase 2|Randomized but not Treated|0
125495|NCT00555906|424043|P3|Phase 2|Randomized but not Treated|0
125496|NCT00555906|424044|P2|Phase 2|Randomized but not Treated|0
125497|NCT00555906|424045|P1|Phase 2|Randomized but not Treated|0
125498|NCT00555906|424041|P5|Phase 2|Unspecified|6
125499|NCT00555906|424042|P4|Phase 2|Unspecified|0
125500|NCT00555906|424043|P3|Phase 2|Unspecified|0
125501|NCT00555906|424044|P2|Phase 2|Unspecified|0
125502|NCT00555906|424045|P1|Phase 2|Unspecified|0
125503|NCT00555906|424041|P5|Phase 2|Withdrawal by Subject|2
125504|NCT00555906|424042|P4|Phase 2|Withdrawal by Subject|0
125505|NCT00555906|424043|P3|Phase 2|Withdrawal by Subject|0
125506|NCT00555906|424044|P2|Phase 2|Withdrawal by Subject|0
125507|NCT00555906|424045|P1|Phase 2|Withdrawal by Subject|0
125508|NCT00555906|424041|P5|Phase 2|Objective Progression or Relapse|16
125509|NCT00555906|424042|P4|Phase 2|Objective Progression or Relapse|0
125510|NCT00555906|424043|P3|Phase 2|Objective Progression or Relapse|0
125511|NCT00555906|424044|P2|Phase 2|Objective Progression or Relapse|0
125512|NCT00555906|424045|P1|Phase 2|Objective Progression or Relapse|0
125513|NCT00555906|424041|P5|Phase 2|Global Deterioration of Health Status|2
125514|NCT00555906|424042|P4|Phase 2|Global Deterioration of Health Status|0
125515|NCT00555906|424043|P3|Phase 2|Global Deterioration of Health Status|0
125516|NCT00555906|424044|P2|Phase 2|Global Deterioration of Health Status|0
125517|NCT00555906|424045|P1|Phase 2|Global Deterioration of Health Status|0
125518|NCT00555906|424041|P5|Phase 2|Adverse Event|4
125519|NCT00555906|424042|P4|Phase 2|Adverse Event|0
125520|NCT00555906|424043|P3|Phase 2|Adverse Event|0
125521|NCT00555906|424044|P2|Phase 2|Adverse Event|0
125522|NCT00555906|424045|P1|Phase 2|Adverse Event|0
125523|NCT00555906|424041|P5|Phase 1|Withdrawal by Subject|0
125524|NCT00555906|424042|P4|Phase 1|Withdrawal by Subject|1
125525|NCT00555906|424043|P3|Phase 1|Withdrawal by Subject|0
125526|NCT00555906|424044|P2|Phase 1|Withdrawal by Subject|0
125527|NCT00555906|424045|P1|Phase 1|Withdrawal by Subject|0
125528|NCT00555906|424041|P5|Phase 1|Adverse Event|0
125529|NCT00555906|424042|P4|Phase 1|Adverse Event|2
125530|NCT00555906|424043|P3|Phase 1|Adverse Event|3
125531|NCT00555906|424044|P2|Phase 1|Adverse Event|0
125532|NCT00555906|424045|P1|Phase 1|Adverse Event|0
125533|NCT00555906|424041|P5|Phase 1|Global Deterioration of Health Status|0
125534|NCT00555906|424042|P4|Phase 1|Global Deterioration of Health Status|1
125535|NCT00555906|424043|P3|Phase 1|Global Deterioration of Health Status|1
125536|NCT00555906|424044|P2|Phase 1|Global Deterioration of Health Status|1
125537|NCT00555906|424045|P1|Phase 1|Global Deterioration of Health Status|0
125538|NCT00555906|424041|P5|Phase 1|Objective Progression or Relapse|0
125539|NCT00555906|424042|P4|Phase 1|Objective Progression or Relapse|1
125540|NCT00555906|424043|P3|Phase 1|Objective Progression or Relapse|3
125541|NCT00555906|424044|P2|Phase 1|Objective Progression or Relapse|5
125542|NCT00555906|424045|P1|Phase 1|Objective Progression or Relapse|3
125543|NCT00555672|424161|P2|Overall Study|Participant refused|0
125544|NCT00555672|424162|P1|Overall Study|Participant refused|2
125545|NCT00555672|424161|P2|Overall Study|Unspecified|1
125546|NCT00555672|424162|P1|Overall Study|Unspecified|3
125547|NCT00555672|424161|P2|Overall Study|Objective progression or relapse|5
125548|NCT00555672|424162|P1|Overall Study|Objective progression or relapse|11
125549|NCT00555672|424161|P2|Overall Study|Adverse Event|2
125550|NCT00555672|424162|P1|Overall Study|Adverse Event|8
125551|NCT00555672|424161|P2|Overall Study|Death|2
125552|NCT00555672|424162|P1|Overall Study|Death|0
125553|NCT00555620|424187|P6|Overall Study|Not specified|3
125554|NCT00555620|424188|P5|Overall Study|Not specified|0
125555|NCT00555620|424189|P4|Overall Study|Not specified|1
125556|NCT00555620|424190|P3|Overall Study|Not specified|0
125557|NCT00555620|424191|P2|Overall Study|Not specified|0
125558|NCT00555620|424192|P1|Overall Study|Not specified|0
125559|NCT00555620|424187|P6|Overall Study|Participant refused treatment|1
125560|NCT00555620|424188|P5|Overall Study|Participant refused treatment|0
125561|NCT00555620|424189|P4|Overall Study|Participant refused treatment|0
125562|NCT00555620|424190|P3|Overall Study|Participant refused treatment|1
125563|NCT00555620|424191|P2|Overall Study|Participant refused treatment|1
125564|NCT00555620|424192|P1|Overall Study|Participant refused treatment|0
125565|NCT00555620|424187|P6|Overall Study|Objective progression or relapse|16
125566|NCT00555620|424188|P5|Overall Study|Objective progression or relapse|3
125567|NCT00555620|424189|P4|Overall Study|Objective progression or relapse|17
125568|NCT00555620|424190|P3|Overall Study|Objective progression or relapse|12
125569|NCT00555620|424191|P2|Overall Study|Objective progression or relapse|5
125570|NCT00555620|424192|P1|Overall Study|Objective progression or relapse|6
125571|NCT00555620|424187|P6|Overall Study|Adverse Event|1
125572|NCT00555620|424188|P5|Overall Study|Adverse Event|0
125573|NCT00555620|424189|P4|Overall Study|Adverse Event|5
125574|NCT00555620|424190|P3|Overall Study|Adverse Event|1
125575|NCT00555620|424191|P2|Overall Study|Adverse Event|0
125576|NCT00555620|424192|P1|Overall Study|Adverse Event|0
125577|NCT00555620|424187|P6|Overall Study|Study terminated by sponsor|0
125578|NCT00555620|424188|P5|Overall Study|Study terminated by sponsor|0
125579|NCT00555620|424189|P4|Overall Study|Study terminated by sponsor|0
125580|NCT00555620|424190|P3|Overall Study|Study terminated by sponsor|1
125581|NCT00555620|424191|P2|Overall Study|Study terminated by sponsor|0
125582|NCT00555620|424192|P1|Overall Study|Study terminated by sponsor|0
125583|NCT00555620|424187|P6|Overall Study|Death|1
125584|NCT00555620|424188|P5|Overall Study|Death|0
125585|NCT00555620|424189|P4|Overall Study|Death|0
125586|NCT00555620|424190|P3|Overall Study|Death|0
125587|NCT00555620|424191|P2|Overall Study|Death|1
125588|NCT00555620|424192|P1|Overall Study|Death|0
125589|NCT00555568|424307|P3|Overall Study|Lost to Follow-up|16
125590|NCT00555568|424308|P2|Overall Study|Lost to Follow-up|16
125591|NCT00555568|424309|P1|Overall Study|Lost to Follow-up|26
125592|NCT00555477|424331|P2|Overall Study|Physician Decision|2
125593|NCT00555477|424332|P1|Overall Study|Physician Decision|1
125594|NCT00555477|424331|P2|Overall Study|Withdrawal by Subject|2
125595|NCT00555477|424332|P1|Overall Study|Withdrawal by Subject|1
125596|NCT00555477|424331|P2|Overall Study|Adverse Event|9
125597|NCT00555477|424332|P1|Overall Study|Adverse Event|0
125598|NCT00555438|424348|P1|Between 10 Days and 30 Days Postoperativ|Death|5
125599|NCT00555438|424348|P1|10 Days Post-operative|Death|4
125600|NCT00555425|424358|P2|Overall Study|Became pregnant and transferred care|1
125601|NCT00555425|424359|P1|Overall Study|Became pregnant and transferred care|0
125602|NCT00555425|424358|P2|Overall Study|Met criteria for protective transfer|3
125603|NCT00555425|424359|P1|Overall Study|Met criteria for protective transfer|16
125604|NCT00555425|424358|P2|Overall Study|Missed 3 physician management visits|0
125605|NCT00555425|424359|P1|Overall Study|Missed 3 physician management visits|1
125606|NCT00555425|424358|P2|Overall Study|Missed Medication > 1 wk|15
125607|NCT00555425|424359|P1|Overall Study|Missed Medication > 1 wk|34
125608|NCT00555321|424395|P5|Long-term Extension Phase|Other Reason|0
125609|NCT00555321|424396|P4|Long-term Extension Phase|Other Reason|0
125610|NCT00555321|424397|P3|Long-term Extension Phase|Other Reason|2
125611|NCT00555321|424398|P2|Long-term Extension Phase|Other Reason|0
125612|NCT00555321|424399|P1|Long-term Extension Phase|Other Reason|1
125613|NCT00555321|424395|P5|Long-term Extension Phase|Participant did not meet study criteria|1
125614|NCT00555321|424396|P4|Long-term Extension Phase|Participant did not meet study criteria|0
125615|NCT00555321|424397|P3|Long-term Extension Phase|Participant did not meet study criteria|0
125616|NCT00555321|424398|P2|Long-term Extension Phase|Participant did not meet study criteria|0
125617|NCT00555321|424399|P1|Long-term Extension Phase|Participant did not meet study criteria|0
125618|NCT00555321|424395|P5|Long-term Extension Phase|Death|0
125619|NCT00555321|424396|P4|Long-term Extension Phase|Death|3
125620|NCT00555321|424397|P3|Long-term Extension Phase|Death|0
125621|NCT00555321|424398|P2|Long-term Extension Phase|Death|0
125622|NCT00555321|424399|P1|Long-term Extension Phase|Death|2
125623|NCT00555321|424395|P5|Long-term Extension Phase|Administrative reason by sponsor|23
125624|NCT00555321|424396|P4|Long-term Extension Phase|Administrative reason by sponsor|31
125705|NCT00554216|424920|P3|Overall Study|not specified|10
125625|NCT00555321|424397|P3|Long-term Extension Phase|Administrative reason by sponsor|18
125626|NCT00555321|424398|P2|Long-term Extension Phase|Administrative reason by sponsor|21
125627|NCT00555321|424399|P1|Long-term Extension Phase|Administrative reason by sponsor|23
125628|NCT00555321|424395|P5|Long-term Extension Phase|Withdrawal by Subject|2
125629|NCT00555321|424396|P4|Long-term Extension Phase|Withdrawal by Subject|3
125630|NCT00555321|424397|P3|Long-term Extension Phase|Withdrawal by Subject|2
125631|NCT00555321|424398|P2|Long-term Extension Phase|Withdrawal by Subject|1
125632|NCT00555321|424399|P1|Long-term Extension Phase|Withdrawal by Subject|2
125633|NCT00555321|424395|P5|Long-term Extension Phase|Adverse Event|0
125634|NCT00555321|424396|P4|Long-term Extension Phase|Adverse Event|1
125635|NCT00555321|424397|P3|Long-term Extension Phase|Adverse Event|2
125636|NCT00555321|424398|P2|Long-term Extension Phase|Adverse Event|5
125637|NCT00555321|424399|P1|Long-term Extension Phase|Adverse Event|2
125638|NCT00555321|424395|P5|Treatment Phase up to 12-months|Never treated|4
125639|NCT00555321|424396|P4|Treatment Phase up to 12-months|Never treated|0
125640|NCT00555321|424397|P3|Treatment Phase up to 12-months|Never treated|1
125641|NCT00555321|424398|P2|Treatment Phase up to 12-months|Never treated|3
125642|NCT00555321|424399|P1|Treatment Phase up to 12-months|Never treated|2
125643|NCT00555321|424395|P5|Treatment Phase up to 12-months|Other Reason|0
125644|NCT00555321|424396|P4|Treatment Phase up to 12-months|Other Reason|0
125645|NCT00555321|424397|P3|Treatment Phase up to 12-months|Other Reason|2
125646|NCT00555321|424398|P2|Treatment Phase up to 12-months|Other Reason|3
125647|NCT00555321|424399|P1|Treatment Phase up to 12-months|Other Reason|1
125648|NCT00555321|424395|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
125649|NCT00555321|424396|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
125650|NCT00555321|424397|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
125651|NCT00555321|424398|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
125652|NCT00555321|424399|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
125653|NCT00555321|424395|P5|Treatment Phase up to 12-months|Death|0
125654|NCT00555321|424396|P4|Treatment Phase up to 12-months|Death|0
125655|NCT00555321|424397|P3|Treatment Phase up to 12-months|Death|4
125656|NCT00555321|424398|P2|Treatment Phase up to 12-months|Death|1
125657|NCT00555321|424399|P1|Treatment Phase up to 12-months|Death|2
125658|NCT00555321|424395|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
125659|NCT00555321|424396|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
125660|NCT00555321|424397|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
125661|NCT00555321|424398|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
125662|NCT00555321|424399|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
125663|NCT00555321|424395|P5|Treatment Phase up to 12-months|Adverse Event|18
125664|NCT00555321|424396|P4|Treatment Phase up to 12-months|Adverse Event|7
125665|NCT00555321|424397|P3|Treatment Phase up to 12-months|Adverse Event|11
125666|NCT00555321|424398|P2|Treatment Phase up to 12-months|Adverse Event|7
125667|NCT00555321|424399|P1|Treatment Phase up to 12-months|Adverse Event|6
125668|NCT00555217|424703|P2|Overall Study|close out sites|17
125669|NCT00555217|424704|P1|Overall Study|close out sites|21
125670|NCT00555217|424703|P2|Overall Study|Lost to Follow-up|20
125671|NCT00555217|424704|P1|Overall Study|Lost to Follow-up|19
125672|NCT00555217|424703|P2|Overall Study|Withdrawal by Subject|31
125673|NCT00555217|424704|P1|Overall Study|Withdrawal by Subject|35
125674|NCT00555061|424741|P1|Overall Study|Participant enrolled, but never treated|1
125675|NCT00555061|424741|P1|Overall Study|Withdrawal by Subject|2
125676|NCT00555061|424741|P1|Overall Study|Lost to Follow-up|2
125677|NCT00555061|424741|P1|Overall Study|Protocol Violation|1
125678|NCT00555061|424741|P1|Overall Study|Adverse Event|3
125679|NCT00555009|424750|P2|Overall Study|Terminated by Sponsor|5
125680|NCT00555009|424751|P1|Overall Study|Terminated by Sponsor|2
125681|NCT00555009|424750|P2|Overall Study|Withdrawal by Subject|1
125682|NCT00555009|424751|P1|Overall Study|Withdrawal by Subject|0
125683|NCT00554801|424831|P2|Overall Study|Withdrawal by Subject|0
125684|NCT00554801|424832|P1|Overall Study|Withdrawal by Subject|14
125685|NCT00554801|424831|P2|Overall Study|left area before completion|0
125686|NCT00554801|424832|P1|Overall Study|left area before completion|5
125687|NCT00554619|424854|P1|Overall Study|Liver Function Test Abnormality|1
125688|NCT00554619|424854|P1|Overall Study|Physician Decision|1
125689|NCT00554619|424854|P1|Overall Study|Adverse Event|1
125690|NCT00554229|424894|P2|Overall Study|Randomised but no treatment received|0
125691|NCT00554229|424895|P1|Overall Study|Randomised but no treatment received|1
125692|NCT00554229|424894|P2|Overall Study|Reason not otherwise captured, eg; death|140
125693|NCT00554229|424895|P1|Overall Study|Reason not otherwise captured, eg; death|119
125694|NCT00554229|424894|P2|Overall Study|Protocol Violation|3
125695|NCT00554229|424895|P1|Overall Study|Protocol Violation|3
125696|NCT00554229|424894|P2|Overall Study|Adverse Event|39
125697|NCT00554229|424895|P1|Overall Study|Adverse Event|71
125698|NCT00554229|424894|P2|Overall Study|Withdrawal by Subject|37
125699|NCT00554229|424895|P1|Overall Study|Withdrawal by Subject|29
125700|NCT00554229|424894|P2|Overall Study|Lost to Follow-up|6
125701|NCT00554229|424895|P1|Overall Study|Lost to Follow-up|3
125702|NCT00554216|424920|P3|Overall Study|Lack of Efficacy|0
125703|NCT00554216|424921|P2|Overall Study|Lack of Efficacy|3
125704|NCT00554216|424922|P1|Overall Study|Lack of Efficacy|15
125706|NCT00554216|424921|P2|Overall Study|not specified|7
125707|NCT00554216|424922|P1|Overall Study|not specified|12
125708|NCT00554216|424920|P3|Overall Study|Restricted med|1
125709|NCT00554216|424921|P2|Overall Study|Restricted med|1
125710|NCT00554216|424922|P1|Overall Study|Restricted med|3
125711|NCT00554216|424920|P3|Overall Study|Pregnancy|14
125712|NCT00554216|424921|P2|Overall Study|Pregnancy|1
125713|NCT00554216|424922|P1|Overall Study|Pregnancy|2
125714|NCT00554216|424920|P3|Overall Study|Non compliance|5
125715|NCT00554216|424921|P2|Overall Study|Non compliance|4
125716|NCT00554216|424922|P1|Overall Study|Non compliance|10
125717|NCT00554216|424920|P3|Overall Study|Withdrawal by Subject|43
125718|NCT00554216|424921|P2|Overall Study|Withdrawal by Subject|31
125719|NCT00554216|424922|P1|Overall Study|Withdrawal by Subject|92
125720|NCT00554216|424920|P3|Overall Study|Adverse Event|36
125721|NCT00554216|424921|P2|Overall Study|Adverse Event|16
125722|NCT00554216|424922|P1|Overall Study|Adverse Event|16
125723|NCT00554216|424920|P3|Overall Study|Lost to Follow-up|63
125724|NCT00554216|424921|P2|Overall Study|Lost to Follow-up|31
125725|NCT00554216|424922|P1|Overall Study|Lost to Follow-up|92
125726|NCT00554190|424933|P1|Overall Study|Termination forms not completed|10
125727|NCT00554099|424942|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
125728|NCT00554099|424943|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
125729|NCT00554099|424944|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
125730|NCT00554099|424942|P3|Non-Treatment Phase (9 Months)|Relapse|1
125731|NCT00554099|424943|P2|Non-Treatment Phase (9 Months)|Relapse|1
125732|NCT00554099|424944|P1|Non-Treatment Phase (9 Months)|Relapse|2
125733|NCT00554099|424942|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
125734|NCT00554099|424943|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
125735|NCT00554099|424944|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
125736|NCT00554099|424942|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
125737|NCT00554099|424943|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
125738|NCT00554099|424944|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
125739|NCT00554099|424942|P3|Treatment Period (12 Weeks)|Protocol Violation|2
125740|NCT00554099|424943|P2|Treatment Period (12 Weeks)|Protocol Violation|0
125741|NCT00554099|424944|P1|Treatment Period (12 Weeks)|Protocol Violation|0
125742|NCT00554099|424942|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
125743|NCT00554099|424943|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
125744|NCT00554099|424944|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
125745|NCT00554099|424942|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
125746|NCT00554099|424943|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
125747|NCT00554099|424944|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
125748|NCT00554099|424942|P3|Treatment Period (12 Weeks)|Physician Decision|0
125749|NCT00554099|424943|P2|Treatment Period (12 Weeks)|Physician Decision|0
125750|NCT00554099|424944|P1|Treatment Period (12 Weeks)|Physician Decision|3
125751|NCT00554099|424942|P3|Treatment Period (12 Weeks)|Adverse Event|1
125752|NCT00554099|424943|P2|Treatment Period (12 Weeks)|Adverse Event|5
125753|NCT00554099|424944|P1|Treatment Period (12 Weeks)|Adverse Event|3
125754|NCT00553787|424999|P3|Overall Study|not specified|13
125755|NCT00553787|425000|P2|Overall Study|not specified|10
125756|NCT00553787|425001|P1|Overall Study|not specified|18
125757|NCT00553787|424999|P3|Overall Study|Requirement for restricted medication|5
125758|NCT00553787|425000|P2|Overall Study|Requirement for restricted medication|7
125759|NCT00553787|425001|P1|Overall Study|Requirement for restricted medication|8
125760|NCT00553787|424999|P3|Overall Study|non compliance|11
125761|NCT00553787|425000|P2|Overall Study|non compliance|0
125762|NCT00553787|425001|P1|Overall Study|non compliance|4
125763|NCT00553787|424999|P3|Overall Study|Pregnancy|2
125764|NCT00553787|425000|P2|Overall Study|Pregnancy|1
125765|NCT00553787|425001|P1|Overall Study|Pregnancy|0
125766|NCT00553787|424999|P3|Overall Study|Lack of Efficacy|3
125767|NCT00553787|425000|P2|Overall Study|Lack of Efficacy|1
125768|NCT00553787|425001|P1|Overall Study|Lack of Efficacy|31
125769|NCT00553787|424999|P3|Overall Study|Withdrawal by Subject|83
125770|NCT00553787|425000|P2|Overall Study|Withdrawal by Subject|40
125771|NCT00553787|425001|P1|Overall Study|Withdrawal by Subject|151
125772|NCT00553787|424999|P3|Overall Study|Lost to Follow-up|78
125773|NCT00553787|425000|P2|Overall Study|Lost to Follow-up|44
125774|NCT00553787|425001|P1|Overall Study|Lost to Follow-up|132
125775|NCT00553787|424999|P3|Overall Study|Adverse Event|67
125776|NCT00553787|425000|P2|Overall Study|Adverse Event|21
125777|NCT00553787|425001|P1|Overall Study|Adverse Event|34
125778|NCT00553696|425016|P4|Overall Study|Withdrawal by Subject|0
125779|NCT00553696|425017|P3|Overall Study|Withdrawal by Subject|0
125780|NCT00553696|425018|P2|Overall Study|Withdrawal by Subject|1
125781|NCT00553696|425019|P1|Overall Study|Withdrawal by Subject|0
125782|NCT00553696|425016|P4|Overall Study|Objective progression or relapse|0
125783|NCT00553696|425017|P3|Overall Study|Objective progression or relapse|6
125784|NCT00553696|425018|P2|Overall Study|Objective progression or relapse|9
125785|NCT00553696|425019|P1|Overall Study|Objective progression or relapse|2
125786|NCT00553696|425016|P4|Overall Study|Global deterioration of health status|0
125787|NCT00553696|425017|P3|Overall Study|Global deterioration of health status|0
125788|NCT00553696|425018|P2|Overall Study|Global deterioration of health status|2
125789|NCT00553696|425019|P1|Overall Study|Global deterioration of health status|0
125790|NCT00553696|425016|P4|Overall Study|Adverse Event|1
125791|NCT00553696|425017|P3|Overall Study|Adverse Event|0
125792|NCT00553696|425018|P2|Overall Study|Adverse Event|4
125793|NCT00553696|425019|P1|Overall Study|Adverse Event|2
125794|NCT00553644|425057|P1|Overall Study|Alternative therapy|6
125795|NCT00553644|425057|P1|Overall Study|Physician Decision|1
125796|NCT00553644|425057|P1|Overall Study|Withdrawal by Subject|4
125797|NCT00553644|425057|P1|Overall Study|Adverse Event|17
125798|NCT00553631|425063|P2|Overall Study|Lost to Follow-up|0
125799|NCT00553631|425064|P1|Overall Study|Lost to Follow-up|1
125800|NCT00553631|425063|P2|Overall Study|Withdrawal by Subject|1
125801|NCT00553631|425064|P1|Overall Study|Withdrawal by Subject|0
125802|NCT00553605|425086|P2|Overall Study|Randomized but not treated|0
125803|NCT00553605|425087|P1|Overall Study|Randomized but not treated|2
125804|NCT00553605|425086|P2|Overall Study|Did not receive full dose|0
125805|NCT00553605|425087|P1|Overall Study|Did not receive full dose|1
125806|NCT00553605|425086|P2|Overall Study|Did not meet entrance criteria|3
125807|NCT00553605|425087|P1|Overall Study|Did not meet entrance criteria|1
125808|NCT00553514|425116|P5|Overall Study|Unspecified|1
125809|NCT00553514|425117|P4|Overall Study|Unspecified|0
125810|NCT00553514|425118|P3|Overall Study|Unspecified|0
125811|NCT00553514|425119|P2|Overall Study|Unspecified|1
125812|NCT00553514|425120|P1|Overall Study|Unspecified|1
125813|NCT00553514|425116|P5|Overall Study|Risk of multiple pregnancy|0
125814|NCT00553514|425117|P4|Overall Study|Risk of multiple pregnancy|1
125815|NCT00553514|425118|P3|Overall Study|Risk of multiple pregnancy|0
125816|NCT00553514|425119|P2|Overall Study|Risk of multiple pregnancy|2
125817|NCT00553514|425120|P1|Overall Study|Risk of multiple pregnancy|0
125818|NCT00553514|425116|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
125819|NCT00553514|425117|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
125820|NCT00553514|425118|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
125821|NCT00553514|425119|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
125822|NCT00553514|425120|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
125823|NCT00553514|425116|P5|Overall Study|Lack of ovarian response|6
125824|NCT00553514|425117|P4|Overall Study|Lack of ovarian response|5
125825|NCT00553514|425118|P3|Overall Study|Lack of ovarian response|5
125826|NCT00553514|425119|P2|Overall Study|Lack of ovarian response|5
125827|NCT00553514|425120|P1|Overall Study|Lack of ovarian response|4
125828|NCT00553514|425116|P5|Overall Study|Protocol deviation|0
125829|NCT00553514|425117|P4|Overall Study|Protocol deviation|1
125830|NCT00553514|425118|P3|Overall Study|Protocol deviation|0
125831|NCT00553514|425119|P2|Overall Study|Protocol deviation|0
125832|NCT00553514|425120|P1|Overall Study|Protocol deviation|0
125833|NCT00553501|425157|P1|Overall Study|Progression|1
125834|NCT00553501|425157|P1|Overall Study|Death|1
125835|NCT00553501|425157|P1|Overall Study|Adverse Event|2
125836|NCT00553475|425166|P3|Overall Study|Due to moving|0
125837|NCT00553475|425167|P2|Overall Study|Due to moving|1
125838|NCT00553475|425168|P1|Overall Study|Due to moving|0
125839|NCT00553475|425166|P3|Overall Study|Physician Decision|0
125840|NCT00553475|425167|P2|Overall Study|Physician Decision|0
125841|NCT00553475|425168|P1|Overall Study|Physician Decision|1
125842|NCT00553475|425166|P3|Overall Study|Withdrawal by Subject|0
125843|NCT00553475|425167|P2|Overall Study|Withdrawal by Subject|1
125844|NCT00553475|425168|P1|Overall Study|Withdrawal by Subject|1
125845|NCT00553475|425166|P3|Overall Study|Lack of Efficacy|0
125846|NCT00553475|425167|P2|Overall Study|Lack of Efficacy|1
125847|NCT00553475|425168|P1|Overall Study|Lack of Efficacy|7
125848|NCT00553475|425166|P3|Overall Study|Adverse Event|13
125849|NCT00553475|425167|P2|Overall Study|Adverse Event|17
125850|NCT00553475|425168|P1|Overall Study|Adverse Event|7
125851|NCT00553462|425290|P1|Overall Study|Physician Decision|1
125852|NCT00553462|425290|P1|Overall Study|Withdrawal by Subject|5
125853|NCT00553462|425290|P1|Overall Study|Progression|4
125854|NCT00553462|425290|P1|Overall Study|Adverse Event|4
125855|NCT00553436|425296|P1|Overall Study|Conversion to another procedure|1
125856|NCT00553358|425305|P3|Overall Study|Other: Reason Not Specified|20
125857|NCT00553358|425306|P2|Overall Study|Other: Reason Not Specified|4
125858|NCT00553358|425307|P1|Overall Study|Other: Reason Not Specified|15
125859|NCT00553358|425305|P3|Overall Study|Missing|1
125860|NCT00553358|425306|P2|Overall Study|Missing|1
125861|NCT00553358|425307|P1|Overall Study|Missing|1
125862|NCT00553358|425305|P3|Overall Study|Participant Withdrawal from Drug|3
125863|NCT00553358|425306|P2|Overall Study|Participant Withdrawal from Drug|0
125864|NCT00553358|425307|P1|Overall Study|Participant Withdrawal from Drug|0
125865|NCT00553358|425305|P3|Overall Study|Recurrence of Disease|1
125866|NCT00553358|425306|P2|Overall Study|Recurrence of Disease|4
125867|NCT00553358|425307|P1|Overall Study|Recurrence of Disease|3
125868|NCT00553358|425305|P3|Overall Study|Withdrawal by Subject|1
125869|NCT00553358|425306|P2|Overall Study|Withdrawal by Subject|0
125870|NCT00553358|425307|P1|Overall Study|Withdrawal by Subject|5
125871|NCT00553358|425305|P3|Overall Study|Protocol Violation|1
125872|NCT00553358|425306|P2|Overall Study|Protocol Violation|1
125873|NCT00553358|425307|P1|Overall Study|Protocol Violation|0
125874|NCT00553358|425305|P3|Overall Study|Lost to Follow-up|1
125875|NCT00553358|425306|P2|Overall Study|Lost to Follow-up|0
125876|NCT00553358|425307|P1|Overall Study|Lost to Follow-up|0
125877|NCT00553358|425305|P3|Overall Study|Adverse Event|32
125878|NCT00553358|425306|P2|Overall Study|Adverse Event|2
125879|NCT00553358|425307|P1|Overall Study|Adverse Event|29
125880|NCT00553332|425333|P1|Overall Study|ineligible, incorrect diagnosis|1
125881|NCT00553319|425345|P3|Overall Study|moved|1
125882|NCT00553319|425346|P2|Overall Study|moved|0
125883|NCT00553319|425347|P1|Overall Study|moved|1
125884|NCT00553319|425345|P3|Overall Study|incarceration|0
125885|NCT00553319|425346|P2|Overall Study|incarceration|0
125886|NCT00553319|425347|P1|Overall Study|incarceration|1
125887|NCT00553319|425345|P3|Overall Study|non-compliance|2
125888|NCT00553319|425346|P2|Overall Study|non-compliance|0
125889|NCT00553319|425347|P1|Overall Study|non-compliance|0
125890|NCT00553319|425345|P3|Overall Study|wanted treatment elsewhere|1
125891|NCT00553319|425346|P2|Overall Study|wanted treatment elsewhere|1
125892|NCT00553319|425347|P1|Overall Study|wanted treatment elsewhere|2
125893|NCT00553319|425345|P3|Overall Study|Lost to Follow-up|5
125894|NCT00553319|425346|P2|Overall Study|Lost to Follow-up|9
125895|NCT00553319|425347|P1|Overall Study|Lost to Follow-up|10
125896|NCT00553280|425358|P1|Overall Study|Physician Decision|1
125897|NCT00553280|425358|P1|Overall Study|Withdrawal by Subject|3
125898|NCT00553280|425358|P1|Overall Study|Lack of Efficacy|3
125899|NCT00553280|425358|P1|Overall Study|Adverse Event|19
125900|NCT00553267|425370|P3|Overall Study|Specified category|1
125901|NCT00553267|425371|P2|Overall Study|Specified category|2
125902|NCT00553267|425372|P1|Overall Study|Specified category|1
125903|NCT00553267|425370|P3|Overall Study|Consent withdrawn|1
125904|NCT00553267|425371|P2|Overall Study|Consent withdrawn|3
125905|NCT00553267|425372|P1|Overall Study|Consent withdrawn|2
125906|NCT00553267|425370|P3|Overall Study|Lost to Follow-up|1
125907|NCT00553267|425371|P2|Overall Study|Lost to Follow-up|0
125908|NCT00553267|425372|P1|Overall Study|Lost to Follow-up|0
125909|NCT00553267|425370|P3|Overall Study|Non compliant with protocol|2
125910|NCT00553267|425371|P2|Overall Study|Non compliant with protocol|3
125911|NCT00553267|425372|P1|Overall Study|Non compliant with protocol|3
125912|NCT00553267|425370|P3|Overall Study|Adverse Event|5
125913|NCT00553267|425371|P2|Overall Study|Adverse Event|10
125914|NCT00553267|425372|P1|Overall Study|Adverse Event|8
125915|NCT00553150|425409|P2|Overall Study|Ineligible|1
125916|NCT00553150|425410|P1|Overall Study|Ineligible|0
125917|NCT00553150|425409|P2|Overall Study|Protocol Violation|1
125918|NCT00553150|425410|P1|Overall Study|Protocol Violation|0
125919|NCT00553150|425409|P2|Overall Study|Withdrawal by Subject|2
125920|NCT00553150|425410|P1|Overall Study|Withdrawal by Subject|0
125921|NCT00552760|425441|P2|Overall Study|Medication Change|0
125922|NCT00552760|425442|P1|Overall Study|Medication Change|1
125923|NCT00552760|425441|P2|Overall Study|Withdrawal by Subject|0
125924|NCT00552760|425442|P1|Overall Study|Withdrawal by Subject|3
125925|NCT00552760|425441|P2|Overall Study|Medical Condition|1
125926|NCT00552760|425442|P1|Overall Study|Medical Condition|1
125927|NCT00552760|425441|P2|Overall Study|Non-compliance|1
125928|NCT00552760|425442|P1|Overall Study|Non-compliance|1
125929|NCT00552760|425441|P2|Overall Study|Lost to Follow-up|1
125930|NCT00552760|425442|P1|Overall Study|Lost to Follow-up|1
125931|NCT00552760|425441|P2|Overall Study|Protocol Violation|1
125932|NCT00552760|425442|P1|Overall Study|Protocol Violation|0
125933|NCT00552760|425441|P2|Overall Study|Relapsed- Mixed Event|5
125934|NCT00552760|425442|P1|Overall Study|Relapsed- Mixed Event|3
125935|NCT00552760|425441|P2|Overall Study|Relapse- Manic Event|3
125936|NCT00552760|425442|P1|Overall Study|Relapse- Manic Event|3
125937|NCT00552760|425441|P2|Overall Study|Relapsed- Depressed Event|16
125938|NCT00552760|425442|P1|Overall Study|Relapsed- Depressed Event|10
125939|NCT00552760|425441|P2|Overall Study|Adverse Event|5
125940|NCT00552760|425442|P1|Overall Study|Adverse Event|3
125941|NCT00552669|425469|P2|Overall Study|Death|7
125942|NCT00552669|425470|P1|Overall Study|Death|3
125943|NCT00552578|425482|P2|Overall Study|Lost to Follow-up|1
125944|NCT00552578|425483|P1|Overall Study|Lost to Follow-up|1
125945|NCT00552513|425495|P2|Overall Study|Lost to Follow-up|1
125946|NCT00552513|425496|P1|Overall Study|Lost to Follow-up|5
125947|NCT00552396|425541|P7|Overall Study|protocol withdrawal criteria|9
125948|NCT00552396|425542|P6|Overall Study|protocol withdrawal criteria|3
125949|NCT00552396|425543|P5|Overall Study|protocol withdrawal criteria|3
125950|NCT00552396|425544|P4|Overall Study|protocol withdrawal criteria|6
125951|NCT00552396|425545|P3|Overall Study|protocol withdrawal criteria|3
125952|NCT00552396|425546|P2|Overall Study|protocol withdrawal criteria|3
125953|NCT00552396|425547|P1|Overall Study|protocol withdrawal criteria|3
125954|NCT00552344|425584|P1|Overall Study|Other Reason|22
125955|NCT00552344|425584|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
125956|NCT00552344|425584|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
125957|NCT00552344|425584|P1|Overall Study|AE, non-serious non-fatal|38
125958|NCT00552344|425584|P1|Overall Study|SAE, non-fatal|6
125959|NCT00552344|425584|P1|Overall Study|Withdrawal by Subject|48
125960|NCT00552344|425584|P1|Overall Study|Lost to Follow-up|8
125961|NCT00552344|425584|P1|Overall Study|Loss of efficacy|75
125962|NCT00552344|425584|P1|Overall Study|Lack of Efficacy|55
125963|NCT00552305|425593|P1|Overall Study|Other: Subject went to rehab|1
125964|NCT00552305|425593|P1|Overall Study|Other: Subject incarcerated|1
125965|NCT00552305|425593|P1|Overall Study|Other: Subject moved from area|2
125966|NCT00552305|425593|P1|Overall Study|Other: Health problems, not drug related|1
125967|NCT00552305|425593|P1|Overall Study|Other: Subject became pregnant|1
125968|NCT00552305|425593|P1|Overall Study|Other: Subject underwent surgery|4
125969|NCT00552305|425593|P1|Overall Study|Other: Unable to attend visits|1
125970|NCT00552305|425593|P1|Overall Study|Other: Personal problems|1
125971|NCT00552305|425593|P1|Overall Study|Other: Site closed|4
125972|NCT00552305|425593|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
125973|NCT00552305|425593|P1|Overall Study|AE/Other: prohibited drug required|1
125974|NCT00552305|425593|P1|Overall Study|Poor compliance/lost to follow-up|1
125975|NCT00552305|425593|P1|Overall Study|Unsatisfactory compliance|11
125976|NCT00552305|425593|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
125977|NCT00552305|425593|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
125978|NCT00552305|425593|P1|Overall Study|Lack of efficacy/withdrew consent|1
125979|NCT00552305|425593|P1|Overall Study|Withdrawal by Subject|44
125980|NCT00552305|425593|P1|Overall Study|Protocol Violation|3
125981|NCT00552305|425593|P1|Overall Study|Lost to Follow-up|4
125982|NCT00552305|425593|P1|Overall Study|Lack of Efficacy|120
125983|NCT00552305|425593|P1|Overall Study|Adverse Event|43
125984|NCT00552279|425603|P2|Overall Study|Other|1
125985|NCT00552279|425604|P1|Overall Study|Other|1
125986|NCT00552279|425603|P2|Overall Study|Lost to Follow-up|0
125987|NCT00552279|425604|P1|Overall Study|Lost to Follow-up|1
125988|NCT00552279|425603|P2|Overall Study|Withdrawal by Subject|1
125989|NCT00552279|425604|P1|Overall Study|Withdrawal by Subject|12
125990|NCT00552279|425603|P2|Overall Study|Adverse Event|1
125991|NCT00552279|425604|P1|Overall Study|Adverse Event|0
125992|NCT00552240|425630|P2|Overall Study|not specified|0
125993|NCT00552240|425631|P1|Overall Study|not specified|1
125994|NCT00552240|425630|P2|Overall Study|Lack of Efficacy|0
125995|NCT00552240|425631|P1|Overall Study|Lack of Efficacy|6
125996|NCT00552240|425630|P2|Overall Study|Withdrawal by Subject|2
125997|NCT00552240|425631|P1|Overall Study|Withdrawal by Subject|2
125998|NCT00552240|425630|P2|Overall Study|Lost to Follow-up|6
125999|NCT00552240|425631|P1|Overall Study|Lost to Follow-up|5
126000|NCT00552240|425630|P2|Overall Study|Protocol Violation|1
126001|NCT00552240|425631|P1|Overall Study|Protocol Violation|1
126002|NCT00552240|425630|P2|Overall Study|Adverse Event|9
126003|NCT00552240|425631|P1|Overall Study|Adverse Event|9
126004|NCT00552188|425733|P2|Overall Study|Subject returned to home country|1
126005|NCT00552188|425734|P1|Overall Study|Subject returned to home country|0
126006|NCT00552188|425733|P2|Overall Study|Withdrawal of consent|1
126007|NCT00552188|425734|P1|Overall Study|Withdrawal of consent|0
126008|NCT00552188|425733|P2|Overall Study|Lost to Follow-up|1
126009|NCT00552188|425734|P1|Overall Study|Lost to Follow-up|2
126010|NCT00552188|425733|P2|Overall Study|Adverse Event|2
126011|NCT00552188|425734|P1|Overall Study|Adverse Event|0
126012|NCT00552175|425745|P3|Overall Study|Reason Not Specified|1
126013|NCT00552175|425746|P2|Overall Study|Reason Not Specified|1
126014|NCT00552175|425747|P1|Overall Study|Reason Not Specified|3
126015|NCT00552175|425745|P3|Overall Study|Entry Criteria Not Met|0
126016|NCT00552175|425746|P2|Overall Study|Entry Criteria Not Met|1
126017|NCT00552175|425747|P1|Overall Study|Entry Criteria Not Met|1
126018|NCT00552175|425745|P3|Overall Study|Lost to Follow-up|1
126019|NCT00552175|425746|P2|Overall Study|Lost to Follow-up|0
126020|NCT00552175|425747|P1|Overall Study|Lost to Follow-up|0
126021|NCT00552175|425745|P3|Overall Study|Withdrawal by Subject|1
126022|NCT00552175|425746|P2|Overall Study|Withdrawal by Subject|2
126023|NCT00552175|425747|P1|Overall Study|Withdrawal by Subject|2
126024|NCT00552175|425745|P3|Overall Study|Adverse Event|10
126025|NCT00552175|425746|P2|Overall Study|Adverse Event|9
126026|NCT00552175|425747|P1|Overall Study|Adverse Event|9
126027|NCT00552175|425745|P3|Overall Study|Lack of Efficacy|1
126028|NCT00552175|425746|P2|Overall Study|Lack of Efficacy|0
126029|NCT00552175|425747|P1|Overall Study|Lack of Efficacy|2
126030|NCT00552110|425787|P5|Overall Study|Nonserious Adverse Event (AE)|0
126031|NCT00552110|425788|P4|Overall Study|Nonserious Adverse Event (AE)|1
126032|NCT00552110|425789|P3|Overall Study|Nonserious Adverse Event (AE)|0
126033|NCT00552110|425790|P2|Overall Study|Nonserious Adverse Event (AE)|0
126034|NCT00552110|425791|P1|Overall Study|Nonserious Adverse Event (AE)|1
126035|NCT00552110|425787|P5|Overall Study|Increased Blood Pressure at Visit 2|0
126036|NCT00552110|425788|P4|Overall Study|Increased Blood Pressure at Visit 2|1
126037|NCT00552110|425789|P3|Overall Study|Increased Blood Pressure at Visit 2|0
126038|NCT00552110|425790|P2|Overall Study|Increased Blood Pressure at Visit 2|0
126039|NCT00552110|425791|P1|Overall Study|Increased Blood Pressure at Visit 2|0
126040|NCT00552110|425787|P5|Overall Study|Delay of Study due to Relabeling|0
126041|NCT00552110|425788|P4|Overall Study|Delay of Study due to Relabeling|1
126042|NCT00552110|425789|P3|Overall Study|Delay of Study due to Relabeling|0
126043|NCT00552110|425790|P2|Overall Study|Delay of Study due to Relabeling|0
126044|NCT00552110|425791|P1|Overall Study|Delay of Study due to Relabeling|0
126045|NCT00552110|425787|P5|Overall Study|Use of Prohibited Medication|0
126046|NCT00552110|425788|P4|Overall Study|Use of Prohibited Medication|0
126047|NCT00552110|425789|P3|Overall Study|Use of Prohibited Medication|0
126048|NCT00552110|425790|P2|Overall Study|Use of Prohibited Medication|1
126049|NCT00552110|425791|P1|Overall Study|Use of Prohibited Medication|1
126050|NCT00552110|425787|P5|Overall Study|Withdrawn per Sponsor|1
126051|NCT00552110|425788|P4|Overall Study|Withdrawn per Sponsor|0
126052|NCT00552110|425789|P3|Overall Study|Withdrawn per Sponsor|0
126053|NCT00552110|425790|P2|Overall Study|Withdrawn per Sponsor|1
126054|NCT00552110|425791|P1|Overall Study|Withdrawn per Sponsor|0
126055|NCT00552110|425787|P5|Overall Study|Failed to Comply With Study Requirements|1
126056|NCT00552110|425788|P4|Overall Study|Failed to Comply With Study Requirements|0
126057|NCT00552110|425789|P3|Overall Study|Failed to Comply With Study Requirements|1
126058|NCT00552110|425790|P2|Overall Study|Failed to Comply With Study Requirements|1
126059|NCT00552110|425791|P1|Overall Study|Failed to Comply With Study Requirements|1
126060|NCT00552110|425787|P5|Overall Study|Lost to Follow-up|1
126061|NCT00552110|425788|P4|Overall Study|Lost to Follow-up|1
126062|NCT00552110|425789|P3|Overall Study|Lost to Follow-up|0
126063|NCT00552110|425790|P2|Overall Study|Lost to Follow-up|0
126064|NCT00552110|425791|P1|Overall Study|Lost to Follow-up|0
126065|NCT00552110|425787|P5|Overall Study|Withdrawal by Subject|2
126066|NCT00552110|425788|P4|Overall Study|Withdrawal by Subject|3
126067|NCT00552110|425789|P3|Overall Study|Withdrawal by Subject|0
126068|NCT00552110|425790|P2|Overall Study|Withdrawal by Subject|2
126069|NCT00552110|425791|P1|Overall Study|Withdrawal by Subject|0
126070|NCT00552110|425787|P5|Overall Study|Lack of Efficacy|4
126071|NCT00552110|425788|P4|Overall Study|Lack of Efficacy|1
126072|NCT00552110|425789|P3|Overall Study|Lack of Efficacy|0
126073|NCT00552110|425790|P2|Overall Study|Lack of Efficacy|0
126074|NCT00552110|425791|P1|Overall Study|Lack of Efficacy|1
126075|NCT00552110|425787|P5|Overall Study|Serious or Life-Threatening AE|0
126076|NCT00552110|425788|P4|Overall Study|Serious or Life-Threatening AE|0
126077|NCT00552110|425789|P3|Overall Study|Serious or Life-Threatening AE|1
126078|NCT00552110|425790|P2|Overall Study|Serious or Life-Threatening AE|0
126079|NCT00552110|425791|P1|Overall Study|Serious or Life-Threatening AE|0
126080|NCT00552084|425810|P2|Overall Study|change in anti-arrythmic drug|1
126081|NCT00552084|425811|P1|Overall Study|change in anti-arrythmic drug|1
126082|NCT00552084|425810|P2|Overall Study|Protocol Violation|0
126083|NCT00552084|425811|P1|Overall Study|Protocol Violation|1
126084|NCT00552084|425810|P2|Overall Study|Withdrawal by Subject|5
126085|NCT00552084|425811|P1|Overall Study|Withdrawal by Subject|4
126086|NCT00552084|425810|P2|Overall Study|Adverse Event|3
126087|NCT00552084|425811|P1|Overall Study|Adverse Event|2
126088|NCT00552058|425819|P2|Overall Study|Other: Early Roll Over|0
126089|NCT00552058|425820|P1|Overall Study|Other: Early Roll Over|1
126090|NCT00552058|425819|P2|Overall Study|Other: Sponsors Decision|1
126091|NCT00552058|425820|P1|Overall Study|Other: Sponsors Decision|0
126092|NCT00552058|425819|P2|Overall Study|Other: Randomized in error|1
126093|NCT00552058|425820|P1|Overall Study|Other: Randomized in error|0
126094|NCT00552058|425819|P2|Overall Study|Other: Positive Stool Result|1
126095|NCT00552058|425820|P1|Overall Study|Other: Positive Stool Result|0
126096|NCT00552058|425819|P2|Overall Study|Other: Low CDAI score, entry violation|1
126097|NCT00552058|425820|P1|Overall Study|Other: Low CDAI score, entry violation|0
126098|NCT00552058|425819|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
126099|NCT00552058|425820|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
126100|NCT00552058|425819|P2|Overall Study|Other: Non Compliance|2
126101|NCT00552058|425820|P1|Overall Study|Other: Non Compliance|1
126102|NCT00552058|425819|P2|Overall Study|Other: Protocol Violation|1
126103|NCT00552058|425820|P1|Overall Study|Other: Protocol Violation|0
126104|NCT00552058|425819|P2|Overall Study|Withdrawal by Subject|4
126105|NCT00552058|425820|P1|Overall Study|Withdrawal by Subject|4
126106|NCT00552058|425819|P2|Overall Study|Lost to Follow-up|0
126107|NCT00552058|425820|P1|Overall Study|Lost to Follow-up|1
126108|NCT00552058|425819|P2|Overall Study|Lack of Efficacy|5
126109|NCT00552058|425820|P1|Overall Study|Lack of Efficacy|1
126110|NCT00552058|425819|P2|Overall Study|Adverse Event|7
126111|NCT00552058|425820|P1|Overall Study|Adverse Event|8
126112|NCT00552032|425860|P2|Overall Study|Lost to Follow-up|5
126113|NCT00552032|425861|P1|Overall Study|Lost to Follow-up|8
126114|NCT00552032|425860|P2|Overall Study|Protocol Violation|12
126115|NCT00552032|425861|P1|Overall Study|Protocol Violation|7
126116|NCT00552032|425860|P2|Overall Study|Withdrawal by Subject|2
126117|NCT00552032|425861|P1|Overall Study|Withdrawal by Subject|2
126118|NCT00551759|425905|P1|Overall Study|Ineligible|1
126119|NCT00551759|425905|P1|Overall Study|Death|5
126120|NCT00551759|425905|P1|Overall Study|Adverse Event|7
126121|NCT00551642|425946|P2|Overall Study|Inclusion/Exclusion criteria|4
126122|NCT00551642|425947|P1|Overall Study|Inclusion/Exclusion criteria|4
126123|NCT00551642|425946|P2|Overall Study|Delivery device failure|3
126124|NCT00551642|425947|P1|Overall Study|Delivery device failure|1
126125|NCT00551642|425946|P2|Overall Study|Physician Decision|1
126126|NCT00551642|425947|P1|Overall Study|Physician Decision|0
126127|NCT00551642|425946|P2|Overall Study|Protocol Violation|11
126128|NCT00551642|425947|P1|Overall Study|Protocol Violation|6
126129|NCT00551642|425946|P2|Overall Study|Death|31
126130|NCT00551642|425947|P1|Overall Study|Death|33
126131|NCT00551642|425946|P2|Overall Study|Adverse Event|12
126132|NCT00551642|425947|P1|Overall Study|Adverse Event|15
126133|NCT00551642|425946|P2|Overall Study|Withdrawal by Subject|1
126134|NCT00551642|425947|P1|Overall Study|Withdrawal by Subject|2
126135|NCT00551421|425953|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
126136|NCT00551369|425960|P1|Overall Study|Not treated per protocol and re|1
126137|NCT00551369|425960|P1|Overall Study|Withdrawal by Subject|1
126138|NCT00551369|425960|P1|Overall Study|Protocol Violation|5
126139|NCT00551291|425967|P1|Overall Study|Physician Decision|1
126140|NCT00551213|425975|P2|Overall Study|Not Treated|2
126141|NCT00551213|425976|P1|Overall Study|Not Treated|1
126142|NCT00551213|425975|P2|Overall Study|Withdrawal by Subject|0
126143|NCT00551213|425976|P1|Overall Study|Withdrawal by Subject|2
126144|NCT00551213|425975|P2|Overall Study|Progressive Disease|12
126145|NCT00551213|425976|P1|Overall Study|Progressive Disease|41
126146|NCT00551213|425975|P2|Overall Study|Adverse Event|3
126147|NCT00551213|425976|P1|Overall Study|Adverse Event|6
126148|NCT00551161|426020|P1|Overall Study|Withdrawal by Subject|1
126149|NCT00551135|426028|P4|Overall Study|Withdrawal by Subject|1
126150|NCT00551135|426029|P3|Overall Study|Withdrawal by Subject|3
126151|NCT00551135|426030|P2|Overall Study|Withdrawal by Subject|0
126152|NCT00551135|426031|P1|Overall Study|Withdrawal by Subject|1
126153|NCT00551135|426028|P4|Overall Study|Unspecified|2
126154|NCT00551135|426029|P3|Overall Study|Unspecified|1
126155|NCT00551135|426030|P2|Overall Study|Unspecified|2
126156|NCT00551135|426031|P1|Overall Study|Unspecified|3
126157|NCT00551135|426028|P4|Overall Study|Lost to Follow-up|1
126158|NCT00551135|426029|P3|Overall Study|Lost to Follow-up|0
126159|NCT00551135|426030|P2|Overall Study|Lost to Follow-up|0
126160|NCT00551135|426031|P1|Overall Study|Lost to Follow-up|0
126161|NCT00551135|426028|P4|Overall Study|Adverse Event|1
126162|NCT00551135|426029|P3|Overall Study|Adverse Event|1
126163|NCT00551135|426030|P2|Overall Study|Adverse Event|0
126164|NCT00551135|426031|P1|Overall Study|Adverse Event|1
126165|NCT00551031|426160|P5|Overall Study|Did not receive vaccine|0
126166|NCT00551031|426161|P4|Overall Study|Did not receive vaccine|0
126167|NCT00551031|426162|P3|Overall Study|Did not receive vaccine|0
126168|NCT00551031|426163|P2|Overall Study|Did not receive vaccine|2
126169|NCT00551031|426164|P1|Overall Study|Did not receive vaccine|1
126170|NCT00551031|426160|P5|Overall Study|Serious Adverse Event|0
126171|NCT00551031|426161|P4|Overall Study|Serious Adverse Event|0
126172|NCT00551031|426162|P3|Overall Study|Serious Adverse Event|1
126173|NCT00551031|426163|P2|Overall Study|Serious Adverse Event|2
126174|NCT00551031|426164|P1|Overall Study|Serious Adverse Event|0
126175|NCT00551031|426160|P5|Overall Study|Withdrawal by Subject|0
126176|NCT00551031|426161|P4|Overall Study|Withdrawal by Subject|2
126177|NCT00551031|426162|P3|Overall Study|Withdrawal by Subject|1
126178|NCT00551031|426163|P2|Overall Study|Withdrawal by Subject|4
126179|NCT00551031|426164|P1|Overall Study|Withdrawal by Subject|0
126180|NCT00551031|426160|P5|Overall Study|Lost to Follow-up|1
126181|NCT00551031|426161|P4|Overall Study|Lost to Follow-up|1
126182|NCT00551031|426162|P3|Overall Study|Lost to Follow-up|0
126183|NCT00551031|426163|P2|Overall Study|Lost to Follow-up|1
126184|NCT00551031|426164|P1|Overall Study|Lost to Follow-up|0
126185|NCT00551031|426160|P5|Overall Study|Protocol Violation|0
126186|NCT00551031|426161|P4|Overall Study|Protocol Violation|0
126187|NCT00551031|426162|P3|Overall Study|Protocol Violation|0
126188|NCT00551031|426163|P2|Overall Study|Protocol Violation|1
126189|NCT00551031|426164|P1|Overall Study|Protocol Violation|1
126190|NCT00551031|426160|P5|Overall Study|Adverse Event|0
126191|NCT00551031|426161|P4|Overall Study|Adverse Event|0
126192|NCT00551031|426162|P3|Overall Study|Adverse Event|0
126193|NCT00551031|426163|P2|Overall Study|Adverse Event|1
126194|NCT00551031|426164|P1|Overall Study|Adverse Event|0
126195|NCT00550953|426193|P2|Overall Study|Not able to visit the site|3
126196|NCT00550953|426194|P1|Overall Study|Not able to visit the site|2
126197|NCT00550953|426193|P2|Overall Study|Adverse Event|3
126198|NCT00550953|426194|P1|Overall Study|Adverse Event|4
126199|NCT00550771|426241|P2|Overall Study|Protocol Violation|5
126200|NCT00550771|426242|P1|Overall Study|Protocol Violation|4
126201|NCT00550771|426241|P2|Overall Study|Withdrawal by Subject|1
126202|NCT00550771|426242|P1|Overall Study|Withdrawal by Subject|0
126203|NCT00550771|426241|P2|Overall Study|Physician Decision|0
126204|NCT00550771|426242|P1|Overall Study|Physician Decision|2
126205|NCT00550771|426241|P2|Overall Study|Discontinued for study-related reasons|1
126206|NCT00550771|426242|P1|Overall Study|Discontinued for study-related reasons|0
126207|NCT00550771|426241|P2|Overall Study|Adverse Event|3
126208|NCT00550771|426242|P1|Overall Study|Adverse Event|11
126209|NCT00550745|426256|P2|Overall Study|Screen failure|0
126210|NCT00550745|426257|P1|Overall Study|Screen failure|1
126211|NCT00550745|426256|P2|Overall Study|Withdrawal by Subject|10
126212|NCT00550745|426257|P1|Overall Study|Withdrawal by Subject|17
126213|NCT00550745|426256|P2|Overall Study|Protocol Violation|2
126214|NCT00550745|426257|P1|Overall Study|Protocol Violation|4
126215|NCT00550745|426256|P2|Overall Study|Physician Decision|2
126216|NCT00550745|426257|P1|Overall Study|Physician Decision|0
126217|NCT00550745|426256|P2|Overall Study|Lost to Follow-up|30
126218|NCT00550745|426257|P1|Overall Study|Lost to Follow-up|45
126219|NCT00550745|426256|P2|Overall Study|Death|16
126220|NCT00550745|426257|P1|Overall Study|Death|20
126221|NCT00550732|426265|P1|Overall Study|Adverse Event|1
126222|NCT00550732|426265|P1|Overall Study|Palliative care|1
126223|NCT00550732|426265|P1|Overall Study|Lost to Follow-up|1
126224|NCT00550732|426265|P1|Overall Study|Physician Decision|2
126225|NCT00550732|426265|P1|Overall Study|Withdrawal by Subject|2
126226|NCT00550732|426265|P1|Overall Study|Death|4
126227|NCT00550680|426276|P1|Overall Study|Screen Failure|6
126228|NCT00550680|426276|P1|Overall Study|Refused Treatment|19
126229|NCT00550680|426276|P1|Overall Study|Protocol Violation|7
126230|NCT00550680|426276|P1|Overall Study|Not Specified|10
126231|NCT00550680|426276|P1|Overall Study|Lack of Efficacy|1
126232|NCT00550680|426276|P1|Overall Study|Lost to Follow-up|3
126233|NCT00550680|426276|P1|Overall Study|Early Improvement|1
126234|NCT00550680|426276|P1|Overall Study|Death|3
126235|NCT00550680|426276|P1|Overall Study|Adverse Event|5
126236|NCT00550680|426276|P1|Overall Study|Administrative Reasons|1
126237|NCT00550550|426308|P2|Overall Study|Randomized But Not Treated|0
126238|NCT00550550|426309|P1|Overall Study|Randomized But Not Treated|1
126239|NCT00550550|426308|P2|Overall Study|Did Not Meet Protocol Eligibility|1
126240|NCT00550550|426309|P1|Overall Study|Did Not Meet Protocol Eligibility|1
126241|NCT00550550|426308|P2|Overall Study|Protocol Violation|14
126242|NCT00550550|426309|P1|Overall Study|Protocol Violation|5
126243|NCT00550550|426308|P2|Overall Study|Withdrawal by Subject|8
126244|NCT00550550|426309|P1|Overall Study|Withdrawal by Subject|10
126245|NCT00550550|426308|P2|Overall Study|Lost to Follow-up|0
126246|NCT00550550|426309|P1|Overall Study|Lost to Follow-up|4
126247|NCT00550550|426308|P2|Overall Study|Treatment Failure|1
126248|NCT00550550|426309|P1|Overall Study|Treatment Failure|0
126249|NCT00550550|426308|P2|Overall Study|Adverse Event|5
126250|NCT00550550|426309|P1|Overall Study|Adverse Event|13
126251|NCT00550459|426323|P2|Overall Study|Withdrawal by Subject|1
126252|NCT00550459|426324|P1|Overall Study|Withdrawal by Subject|1
126253|NCT00550459|426323|P2|Overall Study|Adverse Event|2
126254|NCT00550459|426324|P1|Overall Study|Adverse Event|0
126255|NCT00550446|426393|P11|Post Week 12|Unspecified|0
126256|NCT00550446|426394|P10|Post Week 12|Unspecified|1
126257|NCT00550446|426395|P9|Post Week 12|Unspecified|1
126258|NCT00550446|426396|P8|Post Week 12|Unspecified|0
126259|NCT00550446|426397|P7|Post Week 12|Unspecified|1
126260|NCT00550446|426398|P6|Post Week 12|Unspecified|0
126261|NCT00550446|426399|P5|Post Week 12|Unspecified|0
126262|NCT00550446|426400|P4|Post Week 12|Unspecified|1
126263|NCT00550446|426401|P3|Post Week 12|Unspecified|0
126264|NCT00550446|426402|P2|Post Week 12|Unspecified|1
126265|NCT00550446|426403|P1|Post Week 12|Unspecified|1
126266|NCT00550446|426393|P11|Post Week 12|Withdrawal by Subject|0
126267|NCT00550446|426394|P10|Post Week 12|Withdrawal by Subject|0
126268|NCT00550446|426395|P9|Post Week 12|Withdrawal by Subject|0
126269|NCT00550446|426396|P8|Post Week 12|Withdrawal by Subject|0
126270|NCT00550446|426397|P7|Post Week 12|Withdrawal by Subject|0
126271|NCT00550446|426398|P6|Post Week 12|Withdrawal by Subject|0
126272|NCT00550446|426399|P5|Post Week 12|Withdrawal by Subject|1
126273|NCT00550446|426400|P4|Post Week 12|Withdrawal by Subject|0
126274|NCT00550446|426401|P3|Post Week 12|Withdrawal by Subject|0
126275|NCT00550446|426402|P2|Post Week 12|Withdrawal by Subject|0
126276|NCT00550446|426403|P1|Post Week 12|Withdrawal by Subject|0
126277|NCT00550446|426393|P11|Post Week 12|Lost to Follow-up|0
126278|NCT00550446|426394|P10|Post Week 12|Lost to Follow-up|0
126279|NCT00550446|426395|P9|Post Week 12|Lost to Follow-up|0
126280|NCT00550446|426396|P8|Post Week 12|Lost to Follow-up|0
126281|NCT00550446|426397|P7|Post Week 12|Lost to Follow-up|1
126282|NCT00550446|426398|P6|Post Week 12|Lost to Follow-up|0
126283|NCT00550446|426399|P5|Post Week 12|Lost to Follow-up|0
126284|NCT00550446|426400|P4|Post Week 12|Lost to Follow-up|1
126285|NCT00550446|426401|P3|Post Week 12|Lost to Follow-up|1
126286|NCT00550446|426402|P2|Post Week 12|Lost to Follow-up|0
126287|NCT00550446|426403|P1|Post Week 12|Lost to Follow-up|0
126288|NCT00550446|426393|P11|Post Week 12|Lack of Efficacy|1
126289|NCT00550446|426394|P10|Post Week 12|Lack of Efficacy|2
126290|NCT00550446|426395|P9|Post Week 12|Lack of Efficacy|1
126291|NCT00550446|426396|P8|Post Week 12|Lack of Efficacy|1
126292|NCT00550446|426397|P7|Post Week 12|Lack of Efficacy|0
126293|NCT00550446|426398|P6|Post Week 12|Lack of Efficacy|0
126294|NCT00550446|426399|P5|Post Week 12|Lack of Efficacy|0
126295|NCT00550446|426400|P4|Post Week 12|Lack of Efficacy|0
126296|NCT00550446|426401|P3|Post Week 12|Lack of Efficacy|1
126297|NCT00550446|426402|P2|Post Week 12|Lack of Efficacy|0
126298|NCT00550446|426403|P1|Post Week 12|Lack of Efficacy|0
126299|NCT00550446|426393|P11|Post Week 12|Adverse Event|0
126300|NCT00550446|426394|P10|Post Week 12|Adverse Event|4
126301|NCT00550446|426395|P9|Post Week 12|Adverse Event|0
126302|NCT00550446|426396|P8|Post Week 12|Adverse Event|0
126303|NCT00550446|426397|P7|Post Week 12|Adverse Event|0
126304|NCT00550446|426398|P6|Post Week 12|Adverse Event|1
126305|NCT00550446|426399|P5|Post Week 12|Adverse Event|1
126306|NCT00550446|426400|P4|Post Week 12|Adverse Event|1
126307|NCT00550446|426401|P3|Post Week 12|Adverse Event|1
126308|NCT00550446|426402|P2|Post Week 12|Adverse Event|1
126309|NCT00550446|426403|P1|Post Week 12|Adverse Event|2
126310|NCT00550446|426393|P11|Up To Week 12|Randomized not treated|0
126311|NCT00550446|426394|P10|Up To Week 12|Randomized not treated|0
126312|NCT00550446|426395|P9|Up To Week 12|Randomized not treated|0
126313|NCT00550446|426396|P8|Up To Week 12|Randomized not treated|0
126314|NCT00550446|426397|P7|Up To Week 12|Randomized not treated|0
126315|NCT00550446|426398|P6|Up To Week 12|Randomized not treated|0
126316|NCT00550446|426399|P5|Up To Week 12|Randomized not treated|0
126317|NCT00550446|426400|P4|Up To Week 12|Randomized not treated|0
126318|NCT00550446|426401|P3|Up To Week 12|Randomized not treated|1
126319|NCT00550446|426402|P2|Up To Week 12|Randomized not treated|1
126320|NCT00550446|426403|P1|Up To Week 12|Randomized not treated|0
126321|NCT00550446|426393|P11|Up To Week 12|Unspecified|0
126322|NCT00550446|426394|P10|Up To Week 12|Unspecified|0
126323|NCT00550446|426395|P9|Up To Week 12|Unspecified|0
126324|NCT00550446|426396|P8|Up To Week 12|Unspecified|0
126325|NCT00550446|426397|P7|Up To Week 12|Unspecified|4
126326|NCT00550446|426398|P6|Up To Week 12|Unspecified|1
126327|NCT00550446|426399|P5|Up To Week 12|Unspecified|0
126328|NCT00550446|426400|P4|Up To Week 12|Unspecified|0
126329|NCT00550446|426401|P3|Up To Week 12|Unspecified|0
126330|NCT00550446|426402|P2|Up To Week 12|Unspecified|0
126331|NCT00550446|426403|P1|Up To Week 12|Unspecified|3
126332|NCT00550446|426393|P11|Up To Week 12|Withdrawal by Subject|0
126333|NCT00550446|426394|P10|Up To Week 12|Withdrawal by Subject|0
126334|NCT00550446|426395|P9|Up To Week 12|Withdrawal by Subject|0
126335|NCT00550446|426396|P8|Up To Week 12|Withdrawal by Subject|0
126336|NCT00550446|426397|P7|Up To Week 12|Withdrawal by Subject|3
126337|NCT00550446|426398|P6|Up To Week 12|Withdrawal by Subject|1
126338|NCT00550446|426399|P5|Up To Week 12|Withdrawal by Subject|0
126339|NCT00550446|426400|P4|Up To Week 12|Withdrawal by Subject|2
126340|NCT00550446|426401|P3|Up To Week 12|Withdrawal by Subject|3
126341|NCT00550446|426402|P2|Up To Week 12|Withdrawal by Subject|0
126342|NCT00550446|426403|P1|Up To Week 12|Withdrawal by Subject|2
126343|NCT00550446|426393|P11|Up To Week 12|Lost to Follow-up|0
126344|NCT00550446|426394|P10|Up To Week 12|Lost to Follow-up|0
126345|NCT00550446|426395|P9|Up To Week 12|Lost to Follow-up|0
126346|NCT00550446|426396|P8|Up To Week 12|Lost to Follow-up|0
126347|NCT00550446|426397|P7|Up To Week 12|Lost to Follow-up|2
126348|NCT00550446|426398|P6|Up To Week 12|Lost to Follow-up|1
126349|NCT00550446|426399|P5|Up To Week 12|Lost to Follow-up|1
126350|NCT00550446|426400|P4|Up To Week 12|Lost to Follow-up|0
126351|NCT00550446|426401|P3|Up To Week 12|Lost to Follow-up|0
126352|NCT00550446|426402|P2|Up To Week 12|Lost to Follow-up|1
126353|NCT00550446|426403|P1|Up To Week 12|Lost to Follow-up|0
126354|NCT00550446|426393|P11|Up To Week 12|Lack of Efficacy|0
126355|NCT00550446|426394|P10|Up To Week 12|Lack of Efficacy|0
126356|NCT00550446|426395|P9|Up To Week 12|Lack of Efficacy|0
126357|NCT00550446|426396|P8|Up To Week 12|Lack of Efficacy|0
126358|NCT00550446|426397|P7|Up To Week 12|Lack of Efficacy|3
126359|NCT00550446|426398|P6|Up To Week 12|Lack of Efficacy|3
126360|NCT00550446|426399|P5|Up To Week 12|Lack of Efficacy|0
126361|NCT00550446|426400|P4|Up To Week 12|Lack of Efficacy|1
126362|NCT00550446|426401|P3|Up To Week 12|Lack of Efficacy|0
126363|NCT00550446|426402|P2|Up To Week 12|Lack of Efficacy|1
126364|NCT00550446|426403|P1|Up To Week 12|Lack of Efficacy|3
126365|NCT00550446|426393|P11|Up To Week 12|Adverse Event|0
126366|NCT00550446|426394|P10|Up To Week 12|Adverse Event|0
126367|NCT00550446|426395|P9|Up To Week 12|Adverse Event|0
126368|NCT00550446|426396|P8|Up To Week 12|Adverse Event|0
126369|NCT00550446|426397|P7|Up To Week 12|Adverse Event|1
126370|NCT00550446|426398|P6|Up To Week 12|Adverse Event|2
126371|NCT00550446|426399|P5|Up To Week 12|Adverse Event|2
126372|NCT00550446|426400|P4|Up To Week 12|Adverse Event|0
126373|NCT00550446|426401|P3|Up To Week 12|Adverse Event|0
126374|NCT00550446|426402|P2|Up To Week 12|Adverse Event|2
126375|NCT00550446|426403|P1|Up To Week 12|Adverse Event|2
126376|NCT00550407|426837|P3|26-Week Randomized Phase|Withdrawal by Subject|3
126377|NCT00550407|426838|P2|26-Week Randomized Phase|Withdrawal by Subject|1
126378|NCT00550407|426839|P1|26-Week Randomized Phase|Withdrawal by Subject|0
126379|NCT00550407|426837|P3|26-Week Randomized Phase|Investigator Discretion|0
126380|NCT00550407|426838|P2|26-Week Randomized Phase|Investigator Discretion|1
126381|NCT00550407|426839|P1|26-Week Randomized Phase|Investigator Discretion|0
126382|NCT00550407|426837|P3|26-Week Randomized Phase|Lack of Efficacy|19
126383|NCT00550407|426838|P2|26-Week Randomized Phase|Lack of Efficacy|36
126384|NCT00550407|426839|P1|26-Week Randomized Phase|Lack of Efficacy|0
126385|NCT00550407|426837|P3|26-Week Randomized Phase|Adverse Event|2
126386|NCT00550407|426838|P2|26-Week Randomized Phase|Adverse Event|5
126387|NCT00550407|426839|P1|26-Week Randomized Phase|Adverse Event|0
126388|NCT00550407|426837|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
126389|NCT00550407|426838|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
126390|NCT00550407|426839|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
126391|NCT00550407|426837|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
126392|NCT00550407|426838|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
126393|NCT00550407|426839|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
126394|NCT00550407|426837|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
126395|NCT00550407|426838|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
126396|NCT00550407|426839|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
126397|NCT00550407|426837|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
126398|NCT00550407|426838|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
126399|NCT00550407|426839|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
126480|NCT00549770|427114|P4|Overall Study|Abnormal laboratory values|0
126400|NCT00550407|426837|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
126401|NCT00550407|426838|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
126402|NCT00550407|426839|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
126403|NCT00550407|426837|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
126404|NCT00550407|426838|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
126405|NCT00550407|426839|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
126406|NCT00550407|426837|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
126407|NCT00550407|426838|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
126408|NCT00550407|426839|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
126409|NCT00550407|426837|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
126410|NCT00550407|426838|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
126411|NCT00550407|426839|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
126412|NCT00547703|426889|P2|Overall Study|Lost to Follow-up|0
126413|NCT00547703|426890|P1|Overall Study|Lost to Follow-up|1
126414|NCT00550173|426918|P3|Overall Study|Lost to Follow-up|3
126415|NCT00550173|426919|P2|Overall Study|Lost to Follow-up|4
126416|NCT00550173|426920|P1|Overall Study|Lost to Follow-up|4
126417|NCT00550173|426918|P3|Overall Study|Sponsor Decision|1
126418|NCT00550173|426919|P2|Overall Study|Sponsor Decision|7
126419|NCT00550173|426920|P1|Overall Study|Sponsor Decision|13
126420|NCT00550173|426918|P3|Overall Study|Withdrawal by Subject|17
126421|NCT00550173|426919|P2|Overall Study|Withdrawal by Subject|12
126422|NCT00550173|426920|P1|Overall Study|Withdrawal by Subject|9
126423|NCT00550173|426918|P3|Overall Study|Physician Decision|2
126424|NCT00550173|426919|P2|Overall Study|Physician Decision|2
126425|NCT00550173|426920|P1|Overall Study|Physician Decision|1
126426|NCT00550173|426918|P3|Overall Study|Death|50
126427|NCT00550173|426919|P2|Overall Study|Death|38
126428|NCT00550173|426920|P1|Overall Study|Death|45
126429|NCT00550147|426949|P1|Quetiapine Addition Treatment Period|Moved out of state|1
126430|NCT00550147|426949|P1|Quetiapine Addition Treatment Period|Noncompliance|2
126431|NCT00550147|426949|P1|Quetiapine Addition Treatment Period|Adverse Event|3
126432|NCT00550147|426949|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
126433|NCT00550147|426949|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
126434|NCT00550043|426972|P5|Overall Study|Other Reasons- Unspecified|0
126435|NCT00550043|426973|P4|Overall Study|Other Reasons- Unspecified|1
126436|NCT00550043|426974|P3|Overall Study|Other Reasons- Unspecified|0
126437|NCT00550043|426975|P2|Overall Study|Other Reasons- Unspecified|1
126438|NCT00550043|426976|P1|Overall Study|Other Reasons- Unspecified|0
126439|NCT00550043|426972|P5|Overall Study|Subject Withdrew Consent|0
126440|NCT00550043|426973|P4|Overall Study|Subject Withdrew Consent|0
126441|NCT00550043|426974|P3|Overall Study|Subject Withdrew Consent|1
126442|NCT00550043|426975|P2|Overall Study|Subject Withdrew Consent|2
126443|NCT00550043|426976|P1|Overall Study|Subject Withdrew Consent|0
126444|NCT00550043|426972|P5|Overall Study|Adverse Event|1
126445|NCT00550043|426973|P4|Overall Study|Adverse Event|1
126446|NCT00550043|426974|P3|Overall Study|Adverse Event|0
126447|NCT00550043|426975|P2|Overall Study|Adverse Event|0
126448|NCT00550043|426976|P1|Overall Study|Adverse Event|0
126449|NCT00549939|427031|P3|40-week Open Label Treatment Period|Other|4
126450|NCT00549939|427032|P2|40-week Open Label Treatment Period|Other|1
126451|NCT00549939|427033|P1|40-week Open Label Treatment Period|Other|0
126452|NCT00549939|427031|P3|40-week Open Label Treatment Period|Protocol Violation|0
126453|NCT00549939|427032|P2|40-week Open Label Treatment Period|Protocol Violation|1
126454|NCT00549939|427033|P1|40-week Open Label Treatment Period|Protocol Violation|0
126455|NCT00549939|427031|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
126456|NCT00549939|427032|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
126457|NCT00549939|427033|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
126458|NCT00549939|427031|P3|40-week Open Label Treatment Period|Adverse Event|1
126459|NCT00549939|427032|P2|40-week Open Label Treatment Period|Adverse Event|2
126460|NCT00549939|427033|P1|40-week Open Label Treatment Period|Adverse Event|0
126461|NCT00549939|427031|P3|12-week Double Blind Treatment Period|Too many blood draws|0
126462|NCT00549939|427032|P2|12-week Double Blind Treatment Period|Too many blood draws|1
126463|NCT00549939|427033|P1|12-week Double Blind Treatment Period|Too many blood draws|0
126464|NCT00549939|427031|P3|12-week Double Blind Treatment Period|Adverse Event|2
126465|NCT00549939|427032|P2|12-week Double Blind Treatment Period|Adverse Event|1
126466|NCT00549939|427033|P1|12-week Double Blind Treatment Period|Adverse Event|1
126467|NCT00549900|427060|P1|Overall Study|Adverse Event|1
126468|NCT00549770|427110|P8|Overall Study|Adverse Event|4
126469|NCT00549770|427111|P7|Overall Study|Adverse Event|5
126470|NCT00549770|427112|P6|Overall Study|Adverse Event|0
126471|NCT00549770|427113|P5|Overall Study|Adverse Event|1
126472|NCT00549770|427114|P4|Overall Study|Adverse Event|2
126473|NCT00549770|427115|P3|Overall Study|Adverse Event|1
126474|NCT00549770|427116|P2|Overall Study|Adverse Event|3
126475|NCT00549770|427117|P1|Overall Study|Adverse Event|1
126476|NCT00549770|427110|P8|Overall Study|Abnormal laboratory values|0
126477|NCT00549770|427111|P7|Overall Study|Abnormal laboratory values|0
126478|NCT00549770|427112|P6|Overall Study|Abnormal laboratory values|1
126479|NCT00549770|427113|P5|Overall Study|Abnormal laboratory values|0
126481|NCT00549770|427115|P3|Overall Study|Abnormal laboratory values|0
126482|NCT00549770|427116|P2|Overall Study|Abnormal laboratory values|0
126483|NCT00549770|427117|P1|Overall Study|Abnormal laboratory values|0
126484|NCT00549770|427110|P8|Overall Study|Abnormal test procedure results|1
126485|NCT00549770|427111|P7|Overall Study|Abnormal test procedure results|1
126486|NCT00549770|427112|P6|Overall Study|Abnormal test procedure results|1
126487|NCT00549770|427113|P5|Overall Study|Abnormal test procedure results|0
126488|NCT00549770|427114|P4|Overall Study|Abnormal test procedure results|2
126489|NCT00549770|427115|P3|Overall Study|Abnormal test procedure results|0
126490|NCT00549770|427116|P2|Overall Study|Abnormal test procedure results|0
126491|NCT00549770|427117|P1|Overall Study|Abnormal test procedure results|0
126492|NCT00549770|427110|P8|Overall Study|Lack of Efficacy|8
126493|NCT00549770|427111|P7|Overall Study|Lack of Efficacy|3
126494|NCT00549770|427112|P6|Overall Study|Lack of Efficacy|1
126495|NCT00549770|427113|P5|Overall Study|Lack of Efficacy|5
126496|NCT00549770|427114|P4|Overall Study|Lack of Efficacy|3
126497|NCT00549770|427115|P3|Overall Study|Lack of Efficacy|2
126498|NCT00549770|427116|P2|Overall Study|Lack of Efficacy|0
126499|NCT00549770|427117|P1|Overall Study|Lack of Efficacy|1
126500|NCT00549770|427110|P8|Overall Study|Withdrawal by Subject|9
126501|NCT00549770|427111|P7|Overall Study|Withdrawal by Subject|4
126502|NCT00549770|427112|P6|Overall Study|Withdrawal by Subject|6
126503|NCT00549770|427113|P5|Overall Study|Withdrawal by Subject|6
126504|NCT00549770|427114|P4|Overall Study|Withdrawal by Subject|5
126505|NCT00549770|427115|P3|Overall Study|Withdrawal by Subject|4
126506|NCT00549770|427116|P2|Overall Study|Withdrawal by Subject|6
126507|NCT00549770|427117|P1|Overall Study|Withdrawal by Subject|4
126508|NCT00549770|427110|P8|Overall Study|Lost to Follow-up|0
126509|NCT00549770|427111|P7|Overall Study|Lost to Follow-up|0
126510|NCT00549770|427112|P6|Overall Study|Lost to Follow-up|2
126511|NCT00549770|427113|P5|Overall Study|Lost to Follow-up|3
126512|NCT00549770|427114|P4|Overall Study|Lost to Follow-up|2
126513|NCT00549770|427115|P3|Overall Study|Lost to Follow-up|2
126514|NCT00549770|427116|P2|Overall Study|Lost to Follow-up|0
126515|NCT00549770|427117|P1|Overall Study|Lost to Follow-up|0
126516|NCT00549770|427110|P8|Overall Study|Administrative problems|1
126517|NCT00549770|427111|P7|Overall Study|Administrative problems|0
126518|NCT00549770|427112|P6|Overall Study|Administrative problems|0
126519|NCT00549770|427113|P5|Overall Study|Administrative problems|0
126520|NCT00549770|427114|P4|Overall Study|Administrative problems|0
126521|NCT00549770|427115|P3|Overall Study|Administrative problems|0
126522|NCT00549770|427116|P2|Overall Study|Administrative problems|1
126523|NCT00549770|427117|P1|Overall Study|Administrative problems|0
126524|NCT00549770|427110|P8|Overall Study|Protocol deviation|2
126525|NCT00549770|427111|P7|Overall Study|Protocol deviation|1
126526|NCT00549770|427112|P6|Overall Study|Protocol deviation|2
126527|NCT00549770|427113|P5|Overall Study|Protocol deviation|2
126528|NCT00549770|427114|P4|Overall Study|Protocol deviation|2
126529|NCT00549770|427115|P3|Overall Study|Protocol deviation|1
126530|NCT00549770|427116|P2|Overall Study|Protocol deviation|1
126531|NCT00549770|427117|P1|Overall Study|Protocol deviation|1
126532|NCT00549757|427201|P2|Extension Period (in Average 9 Months)|Patient's request|436
126533|NCT00549757|427202|P1|Extension Period (in Average 9 Months)|Patient's request|421
126534|NCT00549757|427201|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
126535|NCT00549757|427202|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
126536|NCT00549757|427201|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
126537|NCT00549757|427202|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
126538|NCT00549757|427201|P2|Extension Period (in Average 9 Months)|Death|136
126539|NCT00549757|427202|P1|Extension Period (in Average 9 Months)|Death|143
126540|NCT00549757|427201|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
126541|NCT00549757|427202|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
126542|NCT00549757|427201|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
126543|NCT00549757|427202|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
126544|NCT00549757|427201|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
126545|NCT00549757|427202|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
126546|NCT00549757|427201|P2|Active Treatment Phase: Max. 50 Months|Death|200
126547|NCT00549757|427202|P1|Active Treatment Phase: Max. 50 Months|Death|188
126548|NCT00549757|427201|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
126549|NCT00549757|427202|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
126550|NCT00549757|427201|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
126551|NCT00549757|427202|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
126552|NCT00549757|427201|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
126553|NCT00549757|427202|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
126554|NCT00549757|427201|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
126555|NCT00549757|427202|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
126556|NCT00549757|427201|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
126557|NCT00549757|427202|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
126558|NCT00549757|427201|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
126647|NCT00549302|427419|P2|Open-Label|Lost to Follow-up|0
126559|NCT00549757|427202|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
126560|NCT00549757|427201|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
126561|NCT00549757|427202|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
126562|NCT00549718|427264|P4|Overall Study|Administrative|1
126563|NCT00549718|427265|P3|Overall Study|Administrative|2
126564|NCT00549718|427266|P2|Overall Study|Administrative|2
126565|NCT00549718|427267|P1|Overall Study|Administrative|2
126566|NCT00549718|427264|P4|Overall Study|Withdrawal by Subject|13
126567|NCT00549718|427265|P3|Overall Study|Withdrawal by Subject|12
126568|NCT00549718|427266|P2|Overall Study|Withdrawal by Subject|18
126569|NCT00549718|427267|P1|Overall Study|Withdrawal by Subject|9
126570|NCT00549718|427264|P4|Overall Study|Lost to Follow-up|6
126571|NCT00549718|427265|P3|Overall Study|Lost to Follow-up|0
126572|NCT00549718|427266|P2|Overall Study|Lost to Follow-up|2
126573|NCT00549718|427267|P1|Overall Study|Lost to Follow-up|4
126574|NCT00549718|427264|P4|Overall Study|Adverse Event|3
126575|NCT00549718|427265|P3|Overall Study|Adverse Event|7
126576|NCT00549718|427266|P2|Overall Study|Adverse Event|8
126577|NCT00549718|427267|P1|Overall Study|Adverse Event|6
126578|NCT00549718|427264|P4|Overall Study|Insufficient clinical response|32
126579|NCT00549718|427265|P3|Overall Study|Insufficient clinical response|18
126580|NCT00549718|427266|P2|Overall Study|Insufficient clinical response|7
126581|NCT00549718|427267|P1|Overall Study|Insufficient clinical response|20
126582|NCT00549640|427283|P2|Overall Study|Lost to Follow-up|4
126583|NCT00549640|427284|P1|Overall Study|Lost to Follow-up|7
126584|NCT00549640|427283|P2|Overall Study|Adverse Event|0
126585|NCT00549640|427284|P1|Overall Study|Adverse Event|5
126586|NCT00549640|427283|P2|Overall Study|Withdrawal by Subject|12
126587|NCT00549640|427284|P1|Overall Study|Withdrawal by Subject|6
126588|NCT00549601|427297|P3|Received Study Drug|Withdrawal by Subject|1
126589|NCT00549601|427298|P2|Received Study Drug|Withdrawal by Subject|0
126590|NCT00549601|427299|P1|Received Study Drug|Withdrawal by Subject|2
126591|NCT00549601|427297|P3|Received Study Drug|Protocol Violation|1
126592|NCT00549601|427298|P2|Received Study Drug|Protocol Violation|4
126593|NCT00549601|427299|P1|Received Study Drug|Protocol Violation|3
126594|NCT00549601|427297|P3|Received Study Drug|Lost to Follow-up|1
126595|NCT00549601|427298|P2|Received Study Drug|Lost to Follow-up|1
126596|NCT00549601|427299|P1|Received Study Drug|Lost to Follow-up|0
126597|NCT00549601|427297|P3|Received Study Drug|Death|0
126598|NCT00549601|427298|P2|Received Study Drug|Death|1
126599|NCT00549601|427299|P1|Received Study Drug|Death|0
126600|NCT00549601|427297|P3|Received Study Drug|Adverse Event|1
126601|NCT00549601|427298|P2|Received Study Drug|Adverse Event|5
126602|NCT00549601|427299|P1|Received Study Drug|Adverse Event|2
126603|NCT00549601|427297|P3|Randomized|Withdrawal by Subject|1
126604|NCT00549601|427298|P2|Randomized|Withdrawal by Subject|1
126605|NCT00549601|427299|P1|Randomized|Withdrawal by Subject|0
126606|NCT00549601|427297|P3|Randomized|Protocol Violation|1
126607|NCT00549601|427298|P2|Randomized|Protocol Violation|0
126608|NCT00549601|427299|P1|Randomized|Protocol Violation|0
126609|NCT00549549|427325|P4|Overall Study|Randomized but not treated|1
126610|NCT00549549|427326|P3|Overall Study|Randomized but not treated|1
126611|NCT00549549|427327|P2|Overall Study|Randomized but not treated|0
126612|NCT00549549|427328|P1|Overall Study|Randomized but not treated|0
126613|NCT00549549|427325|P4|Overall Study|Unspecified|11
126614|NCT00549549|427326|P3|Overall Study|Unspecified|9
126615|NCT00549549|427327|P2|Overall Study|Unspecified|9
126616|NCT00549549|427328|P1|Overall Study|Unspecified|9
126617|NCT00549549|427325|P4|Overall Study|Withdrawal by Subject|0
126618|NCT00549549|427326|P3|Overall Study|Withdrawal by Subject|1
126619|NCT00549549|427327|P2|Overall Study|Withdrawal by Subject|4
126620|NCT00549549|427328|P1|Overall Study|Withdrawal by Subject|0
126621|NCT00549549|427325|P4|Overall Study|Lost to Follow-up|2
126622|NCT00549549|427326|P3|Overall Study|Lost to Follow-up|1
126623|NCT00549549|427327|P2|Overall Study|Lost to Follow-up|0
126624|NCT00549549|427328|P1|Overall Study|Lost to Follow-up|1
126625|NCT00549549|427325|P4|Overall Study|Lack of Efficacy|2
126626|NCT00549549|427326|P3|Overall Study|Lack of Efficacy|4
126627|NCT00549549|427327|P2|Overall Study|Lack of Efficacy|6
126628|NCT00549549|427328|P1|Overall Study|Lack of Efficacy|9
126629|NCT00549549|427325|P4|Overall Study|Adverse Event|9
126630|NCT00549549|427326|P3|Overall Study|Adverse Event|1
126631|NCT00549549|427327|P2|Overall Study|Adverse Event|3
126632|NCT00549549|427328|P1|Overall Study|Adverse Event|5
126633|NCT00549328|427407|P1|Overall Study|Use of Prohibited Medication|1
126634|NCT00549328|427407|P1|Overall Study|Death|1
126635|NCT00549328|427407|P1|Overall Study|Disease Progression|10
126636|NCT00549328|427407|P1|Overall Study|Adverse Event|2
126637|NCT00549302|427418|P3|Open-Label|Withdrawal by Subject|6
126638|NCT00549302|427419|P2|Open-Label|Withdrawal by Subject|0
126639|NCT00549302|427420|P1|Open-Label|Withdrawal by Subject|0
126640|NCT00549302|427418|P3|Open-Label|New drug pulmonary atrial hypertension|2
126641|NCT00549302|427419|P2|Open-Label|New drug pulmonary atrial hypertension|0
126642|NCT00549302|427420|P1|Open-Label|New drug pulmonary atrial hypertension|0
126643|NCT00549302|427418|P3|Open-Label|Unspecified|3
126644|NCT00549302|427419|P2|Open-Label|Unspecified|0
126645|NCT00549302|427420|P1|Open-Label|Unspecified|0
126646|NCT00549302|427418|P3|Open-Label|Lost to Follow-up|2
126648|NCT00549302|427420|P1|Open-Label|Lost to Follow-up|0
126649|NCT00549302|427418|P3|Open-Label|Investigator Decision|5
126650|NCT00549302|427419|P2|Open-Label|Investigator Decision|0
126651|NCT00549302|427420|P1|Open-Label|Investigator Decision|0
126652|NCT00549302|427418|P3|Open-Label|Death|40
126653|NCT00549302|427419|P2|Open-Label|Death|0
126654|NCT00549302|427420|P1|Open-Label|Death|0
126655|NCT00549302|427418|P3|Open-Label|Adverse Event|11
126656|NCT00549302|427419|P2|Open-Label|Adverse Event|0
126657|NCT00549302|427420|P1|Open-Label|Adverse Event|0
126658|NCT00549302|427418|P3|Double-Blind|New condition or starts new therapy|0
126659|NCT00549302|427419|P2|Double-Blind|New condition or starts new therapy|2
126660|NCT00549302|427420|P1|Double-Blind|New condition or starts new therapy|0
126661|NCT00549302|427418|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
126662|NCT00549302|427419|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
126663|NCT00549302|427420|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
126664|NCT00549302|427418|P3|Double-Blind|Lost to Follow-up|0
126665|NCT00549302|427419|P2|Double-Blind|Lost to Follow-up|2
126666|NCT00549302|427420|P1|Double-Blind|Lost to Follow-up|1
126667|NCT00549302|427418|P3|Double-Blind|Sponsor Decision|0
126668|NCT00549302|427419|P2|Double-Blind|Sponsor Decision|1
126669|NCT00549302|427420|P1|Double-Blind|Sponsor Decision|0
126670|NCT00549302|427418|P3|Double-Blind|Investigator Decision|0
126671|NCT00549302|427419|P2|Double-Blind|Investigator Decision|5
126672|NCT00549302|427420|P1|Double-Blind|Investigator Decision|1
126673|NCT00549302|427418|P3|Double-Blind|Withdrawal by Subject|0
126674|NCT00549302|427419|P2|Double-Blind|Withdrawal by Subject|8
126675|NCT00549302|427420|P1|Double-Blind|Withdrawal by Subject|3
126676|NCT00549302|427418|P3|Double-Blind|Adverse Event|0
126677|NCT00549302|427419|P2|Double-Blind|Adverse Event|16
126678|NCT00549302|427420|P1|Double-Blind|Adverse Event|3
126679|NCT00549302|427418|P3|Double-Blind|Death|0
126680|NCT00549302|427419|P2|Double-Blind|Death|9
126681|NCT00549302|427420|P1|Double-Blind|Death|2
126682|NCT00547534|427430|P1|Overall Study|Disease Progression|4
126683|NCT00547534|427430|P1|Overall Study|Adverse Event|7
126684|NCT00547521|427438|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
126685|NCT00547521|427439|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
126686|NCT00547521|427438|P2|Long Term Extension (LTE) Study|Not Specified|2
126687|NCT00547521|427439|P1|Long Term Extension (LTE) Study|Not Specified|0
126688|NCT00547521|427438|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
126689|NCT00547521|427439|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
126690|NCT00547521|427438|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
126691|NCT00547521|427439|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
126692|NCT00547521|427438|P2|Long Term Extension (LTE) Study|Adverse Event|9
126693|NCT00547521|427439|P1|Long Term Extension (LTE) Study|Adverse Event|0
126694|NCT00547521|427438|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
126695|NCT00547521|427439|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
126696|NCT00547521|427438|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
126697|NCT00547521|427439|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
126698|NCT00547521|427438|P2|Short Term Study (4 Months)|Withdrawal of consent|1
126699|NCT00547521|427439|P1|Short Term Study (4 Months)|Withdrawal of consent|0
126700|NCT00547521|427438|P2|Short Term Study (4 Months)|Lack of Efficacy|2
126701|NCT00547521|427439|P1|Short Term Study (4 Months)|Lack of Efficacy|0
126702|NCT00547521|427438|P2|Short Term Study (4 Months)|Adverse Event|0
126703|NCT00547521|427439|P1|Short Term Study (4 Months)|Adverse Event|1
126704|NCT00549198|427511|P2|Overall Study|Not Exposed to Study Drug|4
126705|NCT00549198|427512|P1|Overall Study|Not Exposed to Study Drug|3
126706|NCT00549198|427511|P2|Overall Study|Pregnancy|3
126707|NCT00549198|427512|P1|Overall Study|Pregnancy|0
126708|NCT00549198|427511|P2|Overall Study|No scan facilities|2
126709|NCT00549198|427512|P1|Overall Study|No scan facilities|0
126710|NCT00549198|427511|P2|Overall Study|Participant overweight, no scan possible|0
126711|NCT00549198|427512|P1|Overall Study|Participant overweight, no scan possible|1
126712|NCT00549198|427511|P2|Overall Study|Participant planning pregnancy|0
126713|NCT00549198|427512|P1|Overall Study|Participant planning pregnancy|1
126714|NCT00549198|427511|P2|Overall Study|Prohibited Medication|2
126715|NCT00549198|427512|P1|Overall Study|Prohibited Medication|1
126716|NCT00549198|427511|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
126717|NCT00549198|427512|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
126718|NCT00549198|427511|P2|Overall Study|Participant not able to perform Week 96|0
126719|NCT00549198|427512|P1|Overall Study|Participant not able to perform Week 96|1
126720|NCT00549198|427511|P2|Overall Study|Participant Moved|0
126721|NCT00549198|427512|P1|Overall Study|Participant Moved|2
126722|NCT00549198|427511|P2|Overall Study|Disease Progression|0
126723|NCT00549198|427512|P1|Overall Study|Disease Progression|1
126724|NCT00549198|427511|P2|Overall Study|Withdrawal by Subject|7
126725|NCT00549198|427512|P1|Overall Study|Withdrawal by Subject|7
126726|NCT00549198|427511|P2|Overall Study|Investigator Decision|3
126727|NCT00549198|427512|P1|Overall Study|Investigator Decision|4
126728|NCT00549198|427511|P2|Overall Study|Protocol Violation|2
126729|NCT00549198|427512|P1|Overall Study|Protocol Violation|7
126730|NCT00549198|427511|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
126731|NCT00549198|427512|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
126732|NCT00549198|427511|P2|Overall Study|Lost to Follow-up|8
126733|NCT00549198|427512|P1|Overall Study|Lost to Follow-up|7
126734|NCT00549198|427511|P2|Overall Study|Non-compliance|4
126735|NCT00549198|427512|P1|Overall Study|Non-compliance|2
126736|NCT00549198|427511|P2|Overall Study|Protocol-defined Virological Failure|0
126737|NCT00549198|427512|P1|Overall Study|Protocol-defined Virological Failure|7
126738|NCT00549198|427511|P2|Overall Study|Insufficient Viral Load Response|2
126739|NCT00549198|427512|P1|Overall Study|Insufficient Viral Load Response|4
126740|NCT00549198|427511|P2|Overall Study|Adverse Event|26
126741|NCT00549198|427512|P1|Overall Study|Adverse Event|28
126742|NCT00549055|427649|P1|Overall Study|Very low visual acuity (VA)|1
126743|NCT00549055|427649|P1|Overall Study|Choroidal neovascularization|1
126744|NCT00549055|427649|P1|Overall Study|Growth choroidal neovascularisation|1
126745|NCT00549055|427649|P1|Overall Study|Vitreous hemorrhage|1
126746|NCT00549055|427649|P1|Overall Study|Active choroidal neovascula increased|1
126747|NCT00549055|427649|P1|Overall Study|Decrease of size|1
126748|NCT00549055|427649|P1|Overall Study|Progression to fibrosis|2
126749|NCT00549055|427649|P1|Overall Study|Stabilization|5
126750|NCT00549055|427649|P1|Overall Study|Lack of efficacy|18
126751|NCT00549055|427649|P1|Overall Study|Adverse Event|4
126752|NCT00548847|427672|P1|Overall Study|Disease progression|7
126753|NCT00548808|427679|P2|Overall Study|Sponsor Decision|1
126754|NCT00548808|427680|P1|Overall Study|Sponsor Decision|1
126755|NCT00548808|427679|P2|Overall Study|Lack of Efficacy|0
126756|NCT00548808|427680|P1|Overall Study|Lack of Efficacy|2
126757|NCT00548808|427679|P2|Overall Study|Entry Criteria Not Met|2
126758|NCT00548808|427680|P1|Overall Study|Entry Criteria Not Met|2
126759|NCT00548808|427679|P2|Overall Study|Death|0
126760|NCT00548808|427680|P1|Overall Study|Death|2
126761|NCT00548808|427679|P2|Overall Study|Adverse Event|5
126762|NCT00548808|427680|P1|Overall Study|Adverse Event|4
126763|NCT00548808|427679|P2|Overall Study|Physician Decision|3
126764|NCT00548808|427680|P1|Overall Study|Physician Decision|6
126765|NCT00548808|427679|P2|Overall Study|Withdrawal by Subject|4
126766|NCT00548808|427680|P1|Overall Study|Withdrawal by Subject|8
126767|NCT00548808|427679|P2|Overall Study|Protocol Violation|8
126768|NCT00548808|427680|P1|Overall Study|Protocol Violation|8
126769|NCT00548808|427679|P2|Overall Study|Lost to Follow-up|3
126770|NCT00548808|427680|P1|Overall Study|Lost to Follow-up|9
126771|NCT00548717|427704|P2|Overall Study|Alternative treatment for GVHD|0
126772|NCT00548717|427705|P1|Overall Study|Alternative treatment for GVHD|1
126773|NCT00548717|427704|P2|Overall Study|Relapse|0
126774|NCT00548717|427705|P1|Overall Study|Relapse|3
126775|NCT00548717|427704|P2|Overall Study|Death|2
126776|NCT00548717|427705|P1|Overall Study|Death|5
126777|NCT00548548|427733|P2|Overall Study|Lost to Follow-up|18
126778|NCT00548548|427734|P1|Overall Study|Lost to Follow-up|17
126779|NCT00548548|427733|P2|Overall Study|Death|348
126780|NCT00548548|427734|P1|Overall Study|Death|345
126781|NCT00547365|427758|P1|Overall Study|death (not related to study)|4
126782|NCT00547365|427758|P1|Overall Study|Protocol Violation|2
126783|NCT00547365|427758|P1|Overall Study|Lost to Follow-up|1
126784|NCT00547365|427758|P1|Overall Study|Physician Decision|1
126785|NCT00548405|427778|P3|Overall Study|Randomized but not treated|0
126786|NCT00548405|427779|P2|Overall Study|Randomized but not treated|0
126787|NCT00548405|427780|P1|Overall Study|Randomized but not treated|1
126788|NCT00548405|427778|P3|Overall Study|Sponsor decision|0
126789|NCT00548405|427779|P2|Overall Study|Sponsor decision|0
126790|NCT00548405|427780|P1|Overall Study|Sponsor decision|1
126791|NCT00548405|427778|P3|Overall Study|Death|1
126792|NCT00548405|427779|P2|Overall Study|Death|1
126793|NCT00548405|427780|P1|Overall Study|Death|0
126794|NCT00548405|427778|P3|Overall Study|Lost to Follow-up|2
126795|NCT00548405|427779|P2|Overall Study|Lost to Follow-up|1
126796|NCT00548405|427780|P1|Overall Study|Lost to Follow-up|1
126797|NCT00548405|427778|P3|Overall Study|Withdrawal by Subject|5
126798|NCT00548405|427779|P2|Overall Study|Withdrawal by Subject|12
126799|NCT00548405|427780|P1|Overall Study|Withdrawal by Subject|36
126800|NCT00548405|427778|P3|Overall Study|Protocol Violation|0
126801|NCT00548405|427779|P2|Overall Study|Protocol Violation|0
126802|NCT00548405|427780|P1|Overall Study|Protocol Violation|1
126803|NCT00548405|427778|P3|Overall Study|Pregnancy|0
126804|NCT00548405|427779|P2|Overall Study|Pregnancy|0
126805|NCT00548405|427780|P1|Overall Study|Pregnancy|1
126806|NCT00548405|427778|P3|Overall Study|Physician Decision|1
126807|NCT00548405|427779|P2|Overall Study|Physician Decision|4
126808|NCT00548405|427780|P1|Overall Study|Physician Decision|3
126809|NCT00548405|427778|P3|Overall Study|Lack of Efficacy|0
126810|NCT00548405|427779|P2|Overall Study|Lack of Efficacy|0
126811|NCT00548405|427780|P1|Overall Study|Lack of Efficacy|6
126812|NCT00548405|427778|P3|Overall Study|Adverse Event|0
126813|NCT00548405|427779|P2|Overall Study|Adverse Event|2
126814|NCT00548405|427780|P1|Overall Study|Adverse Event|6
126815|NCT00548340|427801|P3|Overall Study|Other|1
126816|NCT00548340|427802|P2|Overall Study|Other|1
126817|NCT00548340|427803|P1|Overall Study|Other|1
126818|NCT00548340|427801|P3|Overall Study|Withdrawal by Subject|3
126819|NCT00548340|427802|P2|Overall Study|Withdrawal by Subject|4
126820|NCT00548340|427803|P1|Overall Study|Withdrawal by Subject|2
126821|NCT00548340|427801|P3|Overall Study|Lost to Follow-up|0
126822|NCT00548340|427802|P2|Overall Study|Lost to Follow-up|1
126823|NCT00548340|427803|P1|Overall Study|Lost to Follow-up|1
126824|NCT00548340|427801|P3|Overall Study|Adverse Event|2
126825|NCT00548340|427802|P2|Overall Study|Adverse Event|2
126826|NCT00548340|427803|P1|Overall Study|Adverse Event|2
126827|NCT00548340|427801|P3|Overall Study|Protocol Violation|3
126828|NCT00548340|427802|P2|Overall Study|Protocol Violation|3
126829|NCT00548340|427803|P1|Overall Study|Protocol Violation|2
126830|NCT00548327|427822|P2|Overall Study|Adverse Event|1
126831|NCT00548327|427823|P1|Overall Study|Adverse Event|0
126832|NCT00548262|427841|P1|Overall Study|Withdrawal by Subject|1
126833|NCT00548262|427841|P1|Overall Study|Unspecified|3
126834|NCT00548262|427841|P1|Overall Study|Lost to Follow-up|1
126835|NCT00548262|427841|P1|Overall Study|Lack of Efficacy|4
126836|NCT00548262|427841|P1|Overall Study|Adverse Event|2
126837|NCT00548262|427841|P1|Overall Study|Death|21
126838|NCT00548249|427871|P5|Overall Study|Sponsor's request|0
126839|NCT00548249|427872|P4|Overall Study|Sponsor's request|1
126840|NCT00548249|427873|P3|Overall Study|Sponsor's request|0
126841|NCT00548249|427874|P2|Overall Study|Sponsor's request|0
126842|NCT00548249|427875|P1|Overall Study|Sponsor's request|0
126843|NCT00548249|427871|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
126844|NCT00548249|427872|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
126845|NCT00548249|427873|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
126846|NCT00548249|427874|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
126847|NCT00548249|427875|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
126848|NCT00548249|427871|P5|Overall Study|Withdrawal by Subject|0
126849|NCT00548249|427872|P4|Overall Study|Withdrawal by Subject|0
126850|NCT00548249|427873|P3|Overall Study|Withdrawal by Subject|0
126851|NCT00548249|427874|P2|Overall Study|Withdrawal by Subject|0
126852|NCT00548249|427875|P1|Overall Study|Withdrawal by Subject|2
126853|NCT00548249|427871|P5|Overall Study|Prolonged hospitalization|0
126854|NCT00548249|427872|P4|Overall Study|Prolonged hospitalization|1
126855|NCT00548249|427873|P3|Overall Study|Prolonged hospitalization|2
126856|NCT00548249|427874|P2|Overall Study|Prolonged hospitalization|0
126857|NCT00548249|427875|P1|Overall Study|Prolonged hospitalization|0
126858|NCT00548249|427871|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
126859|NCT00548249|427872|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
126860|NCT00548249|427873|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
126861|NCT00548249|427874|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
126862|NCT00548249|427875|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
126863|NCT00548249|427871|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
126864|NCT00548249|427872|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
126865|NCT00548249|427873|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
126866|NCT00548249|427874|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
126867|NCT00548249|427875|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
126868|NCT00548249|427871|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
126869|NCT00548249|427872|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
126870|NCT00548249|427873|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
126871|NCT00548249|427874|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
126872|NCT00548249|427875|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
126873|NCT00548249|427871|P5|Overall Study|Adverse Event|1
126874|NCT00548249|427872|P4|Overall Study|Adverse Event|1
126875|NCT00548249|427873|P3|Overall Study|Adverse Event|0
126876|NCT00548249|427874|P2|Overall Study|Adverse Event|2
126877|NCT00548249|427875|P1|Overall Study|Adverse Event|2
126878|NCT00548249|427871|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
126879|NCT00548249|427872|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
126880|NCT00548249|427873|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
126881|NCT00548249|427874|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
126882|NCT00548249|427875|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
126883|NCT00548249|427871|P5|Overall Study|Miscellaneous|2
126884|NCT00548249|427872|P4|Overall Study|Miscellaneous|0
126885|NCT00548249|427873|P3|Overall Study|Miscellaneous|2
126886|NCT00548249|427874|P2|Overall Study|Miscellaneous|3
126887|NCT00548249|427875|P1|Overall Study|Miscellaneous|2
126888|NCT00548249|427871|P5|Overall Study|Protocol Violation|3
126889|NCT00548249|427872|P4|Overall Study|Protocol Violation|0
126890|NCT00548249|427873|P3|Overall Study|Protocol Violation|4
126891|NCT00548249|427874|P2|Overall Study|Protocol Violation|1
126892|NCT00548249|427875|P1|Overall Study|Protocol Violation|1
126893|NCT00548249|427871|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
126894|NCT00548249|427872|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
126895|NCT00548249|427873|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
126896|NCT00548249|427874|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
126897|NCT00548249|427875|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
126898|NCT00548249|427871|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
126899|NCT00548249|427872|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
126900|NCT00548249|427873|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
126901|NCT00548249|427874|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
126902|NCT00548249|427875|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
126903|NCT00548184|427912|P1|Overall Study|Found Her2 negative|1
126904|NCT00548184|427912|P1|Overall Study|took other drug|1
126905|NCT00548184|427912|P1|Overall Study|Adverse Event|3
126906|NCT00548145|427918|P2|Overall Study|Physician Decision|1
126907|NCT00548145|427919|P1|Overall Study|Physician Decision|1
126908|NCT00548145|427918|P2|Overall Study|Withdrawal by Subject|2
126909|NCT00548145|427919|P1|Overall Study|Withdrawal by Subject|0
126910|NCT00548145|427918|P2|Overall Study|Death|1
126911|NCT00548145|427919|P1|Overall Study|Death|0
126912|NCT00547911|427944|P6|Overall Study|Adverse Event|0
126913|NCT00547911|427945|P5|Overall Study|Adverse Event|0
126914|NCT00547911|427946|P4|Overall Study|Adverse Event|1
126915|NCT00547911|427947|P3|Overall Study|Adverse Event|0
126916|NCT00547911|427948|P2|Overall Study|Adverse Event|0
126917|NCT00547911|427949|P1|Overall Study|Adverse Event|0
126918|NCT00547157|427980|P2|Overall Study|Lost to Follow-up|2
126919|NCT00547157|427981|P1|Overall Study|Lost to Follow-up|4
126920|NCT00547157|427980|P2|Overall Study|Administrative decision|2
126921|NCT00547157|427981|P1|Overall Study|Administrative decision|3
126922|NCT00547157|427980|P2|Overall Study|Withdrawal by Subject|1
126923|NCT00547157|427981|P1|Overall Study|Withdrawal by Subject|3
126924|NCT00547157|427980|P2|Overall Study|Death|18
126925|NCT00547157|427981|P1|Overall Study|Death|38
126926|NCT00547157|427980|P2|Overall Study|Other|0
126927|NCT00547157|427981|P1|Overall Study|Other|1
126928|NCT00547118|427999|P2|Overall Study|Did not qualify prior to starting drug|2
126929|NCT00547118|428000|P1|Overall Study|Did not qualify prior to starting drug|0
126930|NCT00547118|427999|P2|Overall Study|Withdrawal by Subject|0
126931|NCT00547118|428000|P1|Overall Study|Withdrawal by Subject|1
126932|NCT00546910|428008|P2|Overall Study|Withdrawal by Subject|0
126933|NCT00546910|428009|P1|Overall Study|Withdrawal by Subject|2
126934|NCT00546910|428008|P2|Overall Study|Physician Decision|1
126935|NCT00546910|428009|P1|Overall Study|Physician Decision|0
126936|NCT00546910|428008|P2|Overall Study|Lack of Efficacy|7
126937|NCT00546910|428009|P1|Overall Study|Lack of Efficacy|5
126938|NCT00546910|428008|P2|Overall Study|Adverse Event|3
126939|NCT00546910|428009|P1|Overall Study|Adverse Event|2
126940|NCT00546871|428066|P2|Study Extension Period|Withdrawal by Subject|1
126941|NCT00546871|428067|P1|Study Extension Period|Withdrawal by Subject|0
126942|NCT00546871|428066|P2|Study Extension Period|Protocol Violation|0
126943|NCT00546871|428067|P1|Study Extension Period|Protocol Violation|1
126944|NCT00546871|428066|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
126945|NCT00546871|428067|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
126946|NCT00546871|428066|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
126947|NCT00546871|428067|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
126948|NCT00546871|428066|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
126949|NCT00546871|428067|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
126950|NCT00546819|428172|P2|Overall Study|Withdrawal by Subject|2
126951|NCT00546819|428173|P1|Overall Study|Withdrawal by Subject|4
126952|NCT00546819|428172|P2|Overall Study|Lost to Follow-up|1
126953|NCT00546819|428173|P1|Overall Study|Lost to Follow-up|2
126954|NCT00546819|428172|P2|Overall Study|Adverse Event|3
126955|NCT00546819|428173|P1|Overall Study|Adverse Event|2
126956|NCT00546754|428185|P2|Overall Study|Missing|7
126957|NCT00546754|428186|P1|Overall Study|Missing|14
126958|NCT00546754|428185|P2|Overall Study|Patient's Decision|1
126959|NCT00546754|428186|P1|Overall Study|Patient's Decision|0
126960|NCT00546754|428185|P2|Overall Study|Elevated Creatinine and Potassium levels|1
126961|NCT00546754|428186|P1|Overall Study|Elevated Creatinine and Potassium levels|0
126962|NCT00546754|428185|P2|Overall Study|Missing Cooperation|0
126963|NCT00546754|428186|P1|Overall Study|Missing Cooperation|1
126964|NCT00546754|428185|P2|Overall Study|Suicide|0
126965|NCT00546754|428186|P1|Overall Study|Suicide|1
126966|NCT00546754|428185|P2|Overall Study|Hip Replacement|0
126967|NCT00546754|428186|P1|Overall Study|Hip Replacement|1
126968|NCT00546754|428185|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
126969|NCT00546754|428186|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
126970|NCT00546754|428185|P2|Overall Study|Dyspnea|0
126971|NCT00546754|428186|P1|Overall Study|Dyspnea|1
126972|NCT00546754|428185|P2|Overall Study|Withdrawal by Subject|7
126973|NCT00546754|428186|P1|Overall Study|Withdrawal by Subject|6
126974|NCT00546754|428185|P2|Overall Study|Protocol Violation|0
126975|NCT00546754|428186|P1|Overall Study|Protocol Violation|3
126976|NCT00546754|428185|P2|Overall Study|Lost to Follow-up|15
126977|NCT00546754|428186|P1|Overall Study|Lost to Follow-up|9
126978|NCT00546754|428185|P2|Overall Study|Lack of Efficacy|1
126979|NCT00546754|428186|P1|Overall Study|Lack of Efficacy|1
126980|NCT00546754|428185|P2|Overall Study|Adverse Event|16
126981|NCT00546754|428186|P1|Overall Study|Adverse Event|11
126982|NCT00546754|428185|P2|Overall Study|Serious Adverse Event|1
126983|NCT00546754|428186|P1|Overall Study|Serious Adverse Event|1
126984|NCT00546715|428229|P4|Overall Study|Withdrawal by Subject|0
126985|NCT00546715|428230|P3|Overall Study|Withdrawal by Subject|0
126986|NCT00546715|428231|P2|Overall Study|Withdrawal by Subject|1
126987|NCT00546715|428232|P1|Overall Study|Withdrawal by Subject|0
126988|NCT00546637|428287|P2|Overall Study|Randomized, but not treated|1
126989|NCT00546637|428288|P1|Overall Study|Randomized, but not treated|3
126990|NCT00546637|428287|P2|Overall Study|Withdrawal by Subject|9
126991|NCT00546637|428288|P1|Overall Study|Withdrawal by Subject|7
126992|NCT00546637|428287|P2|Overall Study|Unspecified|12
126993|NCT00546637|428288|P1|Overall Study|Unspecified|10
126994|NCT00546637|428287|P2|Overall Study|Lost to Follow-up|2
126995|NCT00546637|428288|P1|Overall Study|Lost to Follow-up|2
126996|NCT00546637|428287|P2|Overall Study|Lack of Efficacy|5
126997|NCT00546637|428288|P1|Overall Study|Lack of Efficacy|5
126998|NCT00546637|428287|P2|Overall Study|Adverse Event|20
126999|NCT00546637|428288|P1|Overall Study|Adverse Event|46
127000|NCT00546572|428362|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
127001|NCT00546572|428363|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
127002|NCT00546572|428362|P2|Vax 2 / Year 1|Adverse Event|0
127003|NCT00546572|428363|P1|Vax 2 / Year 1|Adverse Event|1
127004|NCT00546572|428362|P2|Vax 2 / Year 1|Unspecified|1
127005|NCT00546572|428363|P1|Vax 2 / Year 1|Unspecified|1
127006|NCT00546572|428362|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
127007|NCT00546572|428363|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
127008|NCT00546572|428362|P2|Vax 1 / Year 0|Lost to Follow-up|1
127009|NCT00546572|428363|P1|Vax 1 / Year 0|Lost to Follow-up|0
127010|NCT00546572|428362|P2|Vax 1 / Year 0|Adverse Event|1
127011|NCT00546572|428363|P1|Vax 1 / Year 0|Adverse Event|0
127012|NCT00546572|428362|P2|Vax 1 / Year 0|Death|2
127013|NCT00546572|428363|P1|Vax 1 / Year 0|Death|2
127014|NCT00546572|428362|P2|Vax 1 / Year 0|Protocol Violation|4
127015|NCT00546572|428363|P1|Vax 1 / Year 0|Protocol Violation|3
127016|NCT00546572|428362|P2|Vax 1 / Year 0|Withdrawal by Subject|2
127017|NCT00546572|428363|P1|Vax 1 / Year 0|Withdrawal by Subject|3
127018|NCT00546572|428362|P2|Vax 1 / Year 0|Randomized, not treated|1
127019|NCT00546572|428363|P1|Vax 1 / Year 0|Randomized, not treated|1
127020|NCT00546481|428407|P3|Maintenance Phase (CERA)|Other Reason|1
127021|NCT00546481|428408|P2|Maintenance Phase (CERA)|Other Reason|0
127022|NCT00546481|428409|P1|Maintenance Phase (CERA)|Other Reason|0
127023|NCT00546481|428407|P3|Maintenance Phase (CERA)|Kidney transplantation|1
127024|NCT00546481|428408|P2|Maintenance Phase (CERA)|Kidney transplantation|0
127025|NCT00546481|428409|P1|Maintenance Phase (CERA)|Kidney transplantation|0
127026|NCT00546481|428407|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
127027|NCT00546481|428408|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
127028|NCT00546481|428409|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
127029|NCT00546481|428407|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
127030|NCT00546481|428408|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
127031|NCT00546481|428409|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
127032|NCT00546481|428407|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
127033|NCT00546481|428408|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
127034|NCT00546481|428409|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
127035|NCT00546481|428407|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
127036|NCT00546481|428408|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
127037|NCT00546481|428409|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
127038|NCT00546481|428407|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
127039|NCT00546481|428408|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
127040|NCT00546481|428409|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
127041|NCT00546481|428407|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
127042|NCT00546481|428408|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
127043|NCT00546481|428409|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
127044|NCT00546481|428407|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
127045|NCT00546481|428408|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
127046|NCT00546481|428409|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
127047|NCT00546377|428436|P1|Overall Study|Adverse Event|6
127048|NCT00546377|428436|P1|Overall Study|Deemed ineligible|1
127049|NCT00546364|428444|P3|Overall Study|Sponsor decision|1
127050|NCT00546364|428445|P2|Overall Study|Sponsor decision|0
127051|NCT00546364|428446|P1|Overall Study|Sponsor decision|0
127052|NCT00546364|428444|P3|Overall Study|Physician Decision|1
127053|NCT00546364|428445|P2|Overall Study|Physician Decision|0
127054|NCT00546364|428446|P1|Overall Study|Physician Decision|0
127055|NCT00546364|428444|P3|Overall Study|Target lesions resected|0
127056|NCT00546364|428445|P2|Overall Study|Target lesions resected|0
127057|NCT00546364|428446|P1|Overall Study|Target lesions resected|1
127058|NCT00546364|428444|P3|Overall Study|Palliative treatment|1
127059|NCT00546364|428445|P2|Overall Study|Palliative treatment|0
127060|NCT00546364|428446|P1|Overall Study|Palliative treatment|1
127061|NCT00546364|428444|P3|Overall Study|Mixed response|0
127062|NCT00546364|428445|P2|Overall Study|Mixed response|0
127063|NCT00546364|428446|P1|Overall Study|Mixed response|1
127064|NCT00546364|428444|P3|Overall Study|Prior taxotere|0
127065|NCT00546364|428445|P2|Overall Study|Prior taxotere|0
127066|NCT00546364|428446|P1|Overall Study|Prior taxotere|1
127067|NCT00546364|428444|P3|Overall Study|Withdrawal by Subject|3
127068|NCT00546364|428445|P2|Overall Study|Withdrawal by Subject|6
127069|NCT00546364|428446|P1|Overall Study|Withdrawal by Subject|5
127070|NCT00546364|428444|P3|Overall Study|No longer meets study criteria|0
127071|NCT00546364|428445|P2|Overall Study|No longer meets study criteria|1
127072|NCT00546364|428446|P1|Overall Study|No longer meets study criteria|1
127073|NCT00546364|428444|P3|Overall Study|Poor compliance/noncompliance|1
127074|NCT00546364|428445|P2|Overall Study|Poor compliance/noncompliance|0
127075|NCT00546364|428446|P1|Overall Study|Poor compliance/noncompliance|0
127076|NCT00546364|428444|P3|Overall Study|Administrative reason by sponsor|0
127077|NCT00546364|428445|P2|Overall Study|Administrative reason by sponsor|0
127078|NCT00546364|428446|P1|Overall Study|Administrative reason by sponsor|1
127079|NCT00546364|428444|P3|Overall Study|Completed and off treatment|2
127080|NCT00546364|428445|P2|Overall Study|Completed and off treatment|0
127081|NCT00546364|428446|P1|Overall Study|Completed and off treatment|1
127082|NCT00546364|428444|P3|Overall Study|Disease progression|8
127083|NCT00546364|428445|P2|Overall Study|Disease progression|11
127084|NCT00546364|428446|P1|Overall Study|Disease progression|5
127085|NCT00546351|428481|P1|Overall Study|Other reasons for premature termination|17
127086|NCT00546351|428481|P1|Overall Study|Unsatisfactory compliance|9
127087|NCT00546351|428481|P1|Overall Study|Protocol Deviation|1
127088|NCT00546351|428481|P1|Overall Study|Lost to Follow-up|9
127089|NCT00546351|428481|P1|Overall Study|Withdrawal by Subject|109
127090|NCT00546351|428481|P1|Overall Study|Lack of Efficacy|15
127091|NCT00546351|428481|P1|Overall Study|Adverse Event|76
127092|NCT00546260|428527|P2|Overall Study|Drug not given pre diagnostic angiogr|2
127093|NCT00546260|428528|P1|Overall Study|Drug not given pre diagnostic angiogr|8
127094|NCT00546117|428550|P2|Overall Study|Inability to schedule follow-up visit|0
127095|NCT00546117|428551|P1|Overall Study|Inability to schedule follow-up visit|1
127096|NCT00546117|428550|P2|Overall Study|Withdrawal by Subject|0
127097|NCT00546117|428551|P1|Overall Study|Withdrawal by Subject|3
127098|NCT00546078|428570|P2|Overall Study|Other reason|1
127099|NCT00546078|428571|P1|Overall Study|Other reason|1
127100|NCT00546078|428570|P2|Overall Study|Withdrawal by Subject|3
127101|NCT00546078|428571|P1|Overall Study|Withdrawal by Subject|2
127102|NCT00546078|428570|P2|Overall Study|Lost to Follow-up|3
127103|NCT00546078|428571|P1|Overall Study|Lost to Follow-up|1
127104|NCT00546052|428609|P1|Overall Study|Non Compliance|7
127105|NCT00546052|428609|P1|Overall Study|Withdrawal by Subject|20
127106|NCT00546052|428609|P1|Overall Study|Protocol Violation|9
127107|NCT00546052|428609|P1|Overall Study|Lost to Follow-up|144
127108|NCT00546052|428609|P1|Overall Study|Adverse Event|47
127109|NCT00546000|428627|P1|Overall Study|Baseline HPA Axis Supression|2
127110|NCT00546000|428627|P1|Overall Study|Lost to Follow-up|1
127111|NCT00546000|428627|P1|Overall Study|Adverse Event|1
127112|NCT00545948|428646|P3|Overall Study|Not Treated|7
127113|NCT00545948|428647|P2|Overall Study|Not Treated|1
127114|NCT00545948|428648|P1|Overall Study|Not Treated|1
127115|NCT00545844|428658|P1|Overall Study|Withdrawal by Subject|2
127116|NCT00545844|428658|P1|Overall Study|Protocol Violation|1
127117|NCT00545844|428658|P1|Overall Study|Lost to Follow-up|9
127118|NCT00545792|428672|P1|Overall Study|Withdrawal by Subject|1
127119|NCT00545779|428677|P1|Overall Study|Failure to return|3
127120|NCT00545779|428677|P1|Overall Study|Adverse Event/intercurrent illness|5
127121|NCT00545779|428677|P1|Overall Study|Withdrawal by Subject|20
127122|NCT00545779|428677|P1|Overall Study|Did not cooperate|7
127123|NCT00545779|428677|P1|Overall Study|Other protocol violation|1
127124|NCT00545779|428677|P1|Overall Study|Violation of selection criteria at entry|8
127125|NCT00545753|428697|P3|Overall Study|Protocol Violation|4
127126|NCT00545753|428698|P2|Overall Study|Protocol Violation|1
127127|NCT00545753|428699|P1|Overall Study|Protocol Violation|3
127128|NCT00545753|428697|P3|Overall Study|Lost to Follow-up|12
127129|NCT00545753|428698|P2|Overall Study|Lost to Follow-up|3
127130|NCT00545753|428699|P1|Overall Study|Lost to Follow-up|13
127131|NCT00545753|428697|P3|Overall Study|Withdrawal by Subject|10
127132|NCT00545753|428698|P2|Overall Study|Withdrawal by Subject|1
127133|NCT00545753|428699|P1|Overall Study|Withdrawal by Subject|0
127134|NCT00545740|428712|P4|Overall Study|Husband against study|0
127135|NCT00545740|428713|P3|Overall Study|Husband against study|1
127136|NCT00545740|428714|P2|Overall Study|Husband against study|0
127137|NCT00545740|428715|P1|Overall Study|Husband against study|0
127138|NCT00545740|428712|P4|Overall Study|Patient difficulties|0
127139|NCT00545740|428713|P3|Overall Study|Patient difficulties|0
127140|NCT00545740|428714|P2|Overall Study|Patient difficulties|1
127141|NCT00545740|428715|P1|Overall Study|Patient difficulties|0
127142|NCT00545740|428712|P4|Overall Study|Non-adherence to visits|0
127143|NCT00545740|428713|P3|Overall Study|Non-adherence to visits|0
127144|NCT00545740|428714|P2|Overall Study|Non-adherence to visits|1
127145|NCT00545740|428715|P1|Overall Study|Non-adherence to visits|0
127146|NCT00545740|428712|P4|Overall Study|Lack of time|0
127147|NCT00545740|428713|P3|Overall Study|Lack of time|0
127148|NCT00545740|428714|P2|Overall Study|Lack of time|1
127149|NCT00545740|428715|P1|Overall Study|Lack of time|0
127150|NCT00545740|428712|P4|Overall Study|Sponsor decision|0
127151|NCT00545740|428713|P3|Overall Study|Sponsor decision|0
127152|NCT00545740|428714|P2|Overall Study|Sponsor decision|1
127153|NCT00545740|428715|P1|Overall Study|Sponsor decision|0
127154|NCT00545740|428712|P4|Overall Study|Accepted only monthly telephone calls|0
127155|NCT00545740|428713|P3|Overall Study|Accepted only monthly telephone calls|0
127156|NCT00545740|428714|P2|Overall Study|Accepted only monthly telephone calls|0
127157|NCT00545740|428715|P1|Overall Study|Accepted only monthly telephone calls|1
127158|NCT00545740|428712|P4|Overall Study|Physician Decision|0
127159|NCT00545740|428713|P3|Overall Study|Physician Decision|3
127160|NCT00545740|428714|P2|Overall Study|Physician Decision|0
127161|NCT00545740|428715|P1|Overall Study|Physician Decision|0
127162|NCT00545740|428712|P4|Overall Study|Missed visit|0
127163|NCT00545740|428713|P3|Overall Study|Missed visit|0
127164|NCT00545740|428714|P2|Overall Study|Missed visit|0
127165|NCT00545740|428715|P1|Overall Study|Missed visit|1
127166|NCT00545740|428712|P4|Overall Study|Site closure|0
127167|NCT00545740|428713|P3|Overall Study|Site closure|0
127168|NCT00545740|428714|P2|Overall Study|Site closure|0
127169|NCT00545740|428715|P1|Overall Study|Site closure|1
127170|NCT00545740|428712|P4|Overall Study|Suspected Diverticulitis Recurrence|1
127171|NCT00545740|428713|P3|Overall Study|Suspected Diverticulitis Recurrence|1
127172|NCT00545740|428714|P2|Overall Study|Suspected Diverticulitis Recurrence|1
127173|NCT00545740|428715|P1|Overall Study|Suspected Diverticulitis Recurrence|1
127174|NCT00545740|428712|P4|Overall Study|Diverticulitis attack|1
127175|NCT00545740|428713|P3|Overall Study|Diverticulitis attack|1
127176|NCT00545740|428714|P2|Overall Study|Diverticulitis attack|0
127177|NCT00545740|428715|P1|Overall Study|Diverticulitis attack|0
127178|NCT00545740|428712|P4|Overall Study|Moved|0
127179|NCT00545740|428713|P3|Overall Study|Moved|1
127180|NCT00545740|428714|P2|Overall Study|Moved|0
127181|NCT00545740|428715|P1|Overall Study|Moved|2
127182|NCT00545740|428712|P4|Overall Study|Non-compliance|0
127183|NCT00545740|428713|P3|Overall Study|Non-compliance|1
127184|NCT00545740|428714|P2|Overall Study|Non-compliance|2
127185|NCT00545740|428715|P1|Overall Study|Non-compliance|0
127186|NCT00545740|428712|P4|Overall Study|Protocol Violation|0
127187|NCT00545740|428713|P3|Overall Study|Protocol Violation|1
127188|NCT00545740|428714|P2|Overall Study|Protocol Violation|3
127189|NCT00545740|428715|P1|Overall Study|Protocol Violation|1
127190|NCT00545740|428712|P4|Overall Study|Lost to Follow-up|6
127191|NCT00545740|428713|P3|Overall Study|Lost to Follow-up|5
127192|NCT00545740|428714|P2|Overall Study|Lost to Follow-up|5
127193|NCT00545740|428715|P1|Overall Study|Lost to Follow-up|7
127194|NCT00545740|428712|P4|Overall Study|Adverse Event|9
127195|NCT00545740|428713|P3|Overall Study|Adverse Event|19
127196|NCT00545740|428714|P2|Overall Study|Adverse Event|18
127197|NCT00545740|428715|P1|Overall Study|Adverse Event|10
127198|NCT00545740|428712|P4|Overall Study|Withdrawal by Subject|18
127199|NCT00545740|428713|P3|Overall Study|Withdrawal by Subject|16
127200|NCT00545740|428714|P2|Overall Study|Withdrawal by Subject|15
127201|NCT00545740|428715|P1|Overall Study|Withdrawal by Subject|17
127202|NCT00545740|428712|P4|Overall Study|Lack of Efficacy|36
127203|NCT00545740|428713|P3|Overall Study|Lack of Efficacy|47
127204|NCT00545740|428714|P2|Overall Study|Lack of Efficacy|35
127205|NCT00545740|428715|P1|Overall Study|Lack of Efficacy|34
127206|NCT00545688|428753|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
127207|NCT00545688|428754|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
127208|NCT00545688|428755|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
127209|NCT00545688|428756|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
127210|NCT00545688|428753|P4|Follow-Up Period|Unspecified Reason|8
127211|NCT00545688|428754|P3|Follow-Up Period|Unspecified Reason|6
127212|NCT00545688|428755|P2|Follow-Up Period|Unspecified Reason|5
127213|NCT00545688|428756|P1|Follow-Up Period|Unspecified Reason|2
127214|NCT00545688|428753|P4|Follow-Up Period|Lost to Follow-up|1
127215|NCT00545688|428754|P3|Follow-Up Period|Lost to Follow-up|3
127216|NCT00545688|428755|P2|Follow-Up Period|Lost to Follow-up|3
127217|NCT00545688|428756|P1|Follow-Up Period|Lost to Follow-up|3
127218|NCT00545688|428753|P4|Follow-Up Period|Refused Treatment|2
127219|NCT00545688|428754|P3|Follow-Up Period|Refused Treatment|0
127220|NCT00545688|428755|P2|Follow-Up Period|Refused Treatment|2
127221|NCT00545688|428756|P1|Follow-Up Period|Refused Treatment|6
127222|NCT00545688|428753|P4|Follow-Up Period|Disease Progression|9
127223|NCT00545688|428754|P3|Follow-Up Period|Disease Progression|9
127224|NCT00545688|428755|P2|Follow-Up Period|Disease Progression|5
127225|NCT00545688|428756|P1|Follow-Up Period|Disease Progression|6
127226|NCT00545688|428753|P4|Follow-Up Period|Death|6
127227|NCT00545688|428754|P3|Follow-Up Period|Death|2
127228|NCT00545688|428755|P2|Follow-Up Period|Death|2
127229|NCT00545688|428756|P1|Follow-Up Period|Death|4
127230|NCT00545688|428753|P4|Adjuvant Treatment Period|Unknown Reason|0
127231|NCT00545688|428754|P3|Adjuvant Treatment Period|Unknown Reason|0
127232|NCT00545688|428755|P2|Adjuvant Treatment Period|Unknown Reason|1
127233|NCT00545688|428756|P1|Adjuvant Treatment Period|Unknown Reason|0
127234|NCT00545688|428753|P4|Adjuvant Treatment Period|Adverse Event|2
127235|NCT00545688|428754|P3|Adjuvant Treatment Period|Adverse Event|2
127236|NCT00545688|428755|P2|Adjuvant Treatment Period|Adverse Event|3
127237|NCT00545688|428756|P1|Adjuvant Treatment Period|Adverse Event|0
127238|NCT00545688|428753|P4|Adjuvant Treatment Period|Lost to Follow-up|0
127239|NCT00545688|428754|P3|Adjuvant Treatment Period|Lost to Follow-up|1
127240|NCT00545688|428755|P2|Adjuvant Treatment Period|Lost to Follow-up|0
127241|NCT00545688|428756|P1|Adjuvant Treatment Period|Lost to Follow-up|1
127242|NCT00545688|428753|P4|Adjuvant Treatment Period|Refused Treatment|5
127243|NCT00545688|428754|P3|Adjuvant Treatment Period|Refused Treatment|1
127244|NCT00545688|428755|P2|Adjuvant Treatment Period|Refused Treatment|1
127245|NCT00545688|428756|P1|Adjuvant Treatment Period|Refused Treatment|1
127246|NCT00545688|428753|P4|Adjuvant Treatment Period|Disease Progression|7
127247|NCT00545688|428754|P3|Adjuvant Treatment Period|Disease Progression|0
127248|NCT00545688|428755|P2|Adjuvant Treatment Period|Disease Progression|3
127249|NCT00545688|428756|P1|Adjuvant Treatment Period|Disease Progression|3
127250|NCT00545688|428753|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
127251|NCT00545688|428754|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
127252|NCT00545688|428755|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
127253|NCT00545688|428756|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
127254|NCT00545688|428753|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
127255|NCT00545688|428754|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
127256|NCT00545688|428755|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
127257|NCT00545688|428756|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
127258|NCT00545688|428753|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
127259|NCT00545688|428754|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
127260|NCT00545688|428755|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
127261|NCT00545688|428756|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
127262|NCT00545688|428753|P4|Neo-Adjuvant Treatment Period|Death|0
127263|NCT00545688|428754|P3|Neo-Adjuvant Treatment Period|Death|0
127264|NCT00545688|428755|P2|Neo-Adjuvant Treatment Period|Death|1
127265|NCT00545688|428756|P1|Neo-Adjuvant Treatment Period|Death|0
127266|NCT00545688|428753|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
127267|NCT00545688|428754|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
127268|NCT00545688|428755|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
127269|NCT00545688|428756|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
127270|NCT00545688|428753|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
127271|NCT00545688|428754|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
127272|NCT00545688|428755|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
127273|NCT00545688|428756|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
127274|NCT00545688|428753|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
127275|NCT00545688|428754|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
127276|NCT00545688|428755|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
127277|NCT00545688|428756|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
127278|NCT00545584|428855|P3|Overall Study|Two or more reasons for discontinuation|8
127279|NCT00545584|428856|P2|Overall Study|Two or more reasons for discontinuation|19
127280|NCT00545584|428857|P1|Overall Study|Two or more reasons for discontinuation|17
127281|NCT00545584|428855|P3|Overall Study|Only one reason for discontinuation|48
127282|NCT00545584|428856|P2|Overall Study|Only one reason for discontinuation|61
127283|NCT00545584|428857|P1|Overall Study|Only one reason for discontinuation|62
127284|NCT00545571|428868|P1|Overall Study|Kidney Transplantation|3
127285|NCT00545571|428868|P1|Overall Study|Early Termination of Study|24
127286|NCT00545571|428868|P1|Overall Study|Transfusion|12
127287|NCT00545571|428868|P1|Overall Study|Screen Failure|16
127288|NCT00545571|428868|P1|Overall Study|Refused Treatment|1
127289|NCT00545571|428868|P1|Overall Study|Protocol Violation|2
127290|NCT00545571|428868|P1|Overall Study|Lack of Efficacy|1
127291|NCT00545571|428868|P1|Overall Study|Death|5
127292|NCT00545571|428868|P1|Overall Study|Adverse Event|2
127293|NCT00545571|428868|P1|Overall Study|Administrative Reasons|1
127294|NCT00545441|428892|P2|Overall Study|Patients were not treated|3
127295|NCT00545441|428893|P1|Overall Study|Patients were not treated|1
127296|NCT00545441|428892|P2|Overall Study|Persistence or recurrence of fistula|2
127297|NCT00545441|428893|P1|Overall Study|Persistence or recurrence of fistula|5
127298|NCT00545441|428892|P2|Overall Study|Withdrawal by Subject|1
127299|NCT00545441|428893|P1|Overall Study|Withdrawal by Subject|1
127300|NCT00545441|428892|P2|Overall Study|Technical failure|1
127301|NCT00545441|428893|P1|Overall Study|Technical failure|0
127302|NCT00545441|428892|P2|Overall Study|Lost to Follow-up|5
127303|NCT00545441|428893|P1|Overall Study|Lost to Follow-up|9
127304|NCT00545441|428892|P2|Overall Study|Fistula draining at 6 months|4
127305|NCT00545441|428893|P1|Overall Study|Fistula draining at 6 months|2
127306|NCT00545402|428901|P2|Overall Study|Reason not specified|1
127307|NCT00545402|428902|P1|Overall Study|Reason not specified|1
127308|NCT00545402|428901|P2|Overall Study|Protocol Violation|0
127309|NCT00545402|428902|P1|Overall Study|Protocol Violation|1
127310|NCT00545402|428901|P2|Overall Study|Withdrawal by Subject|1
127311|NCT00545402|428902|P1|Overall Study|Withdrawal by Subject|0
127312|NCT00545402|428901|P2|Overall Study|Graft loss|4
127313|NCT00545402|428902|P1|Overall Study|Graft loss|2
127314|NCT00545402|428901|P2|Overall Study|Death|7
127315|NCT00545402|428902|P1|Overall Study|Death|5
127316|NCT00545402|428901|P2|Overall Study|Use of unauthorized immunosuppressant|7
127317|NCT00545402|428902|P1|Overall Study|Use of unauthorized immunosuppressant|8
127318|NCT00545402|428901|P2|Overall Study|Discontinuation of treatment|9
127319|NCT00545402|428902|P1|Overall Study|Discontinuation of treatment|17
127320|NCT00545363|428920|P2|Overall Study|Unspecified|1
127321|NCT00545363|428921|P1|Overall Study|Unspecified|1
127322|NCT00545363|428920|P2|Overall Study|Lost to Follow-up|0
127323|NCT00545363|428921|P1|Overall Study|Lost to Follow-up|2
127324|NCT00545363|428920|P2|Overall Study|Did not meet entry criteria|1
127325|NCT00545363|428921|P1|Overall Study|Did not meet entry criteria|1
127326|NCT00545363|428920|P2|Overall Study|Non-compliance|1
127327|NCT00545363|428921|P1|Overall Study|Non-compliance|3
127328|NCT00545363|428920|P2|Overall Study|Withdrawal by Subject|5
127329|NCT00545363|428921|P1|Overall Study|Withdrawal by Subject|6
127330|NCT00545363|428920|P2|Overall Study|Adverse Event|7
127331|NCT00545363|428921|P1|Overall Study|Adverse Event|6
127332|NCT00545298|428936|P3|Overall Study|Issues with Standard of Care|1
127333|NCT00545298|428937|P2|Overall Study|Issues with Standard of Care|0
127334|NCT00545298|428938|P1|Overall Study|Issues with Standard of Care|2
127335|NCT00545272|428955|P6|Overall Study|Lost to Follow-up|0
127336|NCT00545272|428956|P5|Overall Study|Lost to Follow-up|1
127337|NCT00545272|428957|P4|Overall Study|Lost to Follow-up|0
127338|NCT00545272|428958|P3|Overall Study|Lost to Follow-up|0
127339|NCT00545272|428959|P2|Overall Study|Lost to Follow-up|0
127340|NCT00545272|428960|P1|Overall Study|Lost to Follow-up|0
127341|NCT00545272|428955|P6|Overall Study|Abnormal test procedure result(s)|0
127342|NCT00545272|428956|P5|Overall Study|Abnormal test procedure result(s)|1
127343|NCT00545272|428957|P4|Overall Study|Abnormal test procedure result(s)|0
127344|NCT00545272|428958|P3|Overall Study|Abnormal test procedure result(s)|0
127345|NCT00545272|428959|P2|Overall Study|Abnormal test procedure result(s)|0
127346|NCT00545272|428960|P1|Overall Study|Abnormal test procedure result(s)|0
127347|NCT00545272|428955|P6|Overall Study|Abnormal laboratory value(s)|1
127348|NCT00545272|428956|P5|Overall Study|Abnormal laboratory value(s)|0
127349|NCT00545272|428957|P4|Overall Study|Abnormal laboratory value(s)|0
127350|NCT00545272|428958|P3|Overall Study|Abnormal laboratory value(s)|0
127351|NCT00545272|428959|P2|Overall Study|Abnormal laboratory value(s)|0
127352|NCT00545272|428960|P1|Overall Study|Abnormal laboratory value(s)|0
127353|NCT00545272|428955|P6|Overall Study|Adverse Event|1
127354|NCT00545272|428956|P5|Overall Study|Adverse Event|0
127355|NCT00545272|428957|P4|Overall Study|Adverse Event|0
127356|NCT00545272|428958|P3|Overall Study|Adverse Event|1
127357|NCT00545272|428959|P2|Overall Study|Adverse Event|0
127358|NCT00545272|428960|P1|Overall Study|Adverse Event|0
127359|NCT00545272|428955|P6|Overall Study|Protocol deviation|1
127360|NCT00545272|428956|P5|Overall Study|Protocol deviation|0
127361|NCT00545272|428957|P4|Overall Study|Protocol deviation|1
127362|NCT00545272|428958|P3|Overall Study|Protocol deviation|0
127363|NCT00545272|428959|P2|Overall Study|Protocol deviation|1
127364|NCT00545272|428960|P1|Overall Study|Protocol deviation|0
127365|NCT00545233|429012|P2|Overall Study|Physician Decision|1
127366|NCT00545233|429013|P1|Overall Study|Physician Decision|2
127367|NCT00545233|429012|P2|Overall Study|Insufficient response|15
127368|NCT00545233|429013|P1|Overall Study|Insufficient response|14
127369|NCT00545233|429012|P2|Overall Study|Failure to Return|6
127370|NCT00545233|429013|P1|Overall Study|Failure to Return|4
127371|NCT00545233|429012|P2|Overall Study|Refused Treatment|7
127372|NCT00545233|429013|P1|Overall Study|Refused Treatment|9
127373|NCT00545233|429012|P2|Overall Study|Protocol Violation|0
127374|NCT00545233|429013|P1|Overall Study|Protocol Violation|2
127375|NCT00545233|429012|P2|Overall Study|Violation of Selection Criteria at Entry|1
127376|NCT00545233|429013|P1|Overall Study|Violation of Selection Criteria at Entry|5
127377|NCT00545233|429012|P2|Overall Study|Adverse Event|5
127378|NCT00545233|429013|P1|Overall Study|Adverse Event|10
127379|NCT00545168|429072|P3|Overall Study|Visit for Day 21 was not done in error|2
127380|NCT00545168|429073|P2|Overall Study|Visit for Day 21 was not done in error|0
127381|NCT00545168|429074|P1|Overall Study|Visit for Day 21 was not done in error|1
127382|NCT00545168|429072|P3|Overall Study|Protocol Violation|1
127383|NCT00545168|429073|P2|Overall Study|Protocol Violation|0
127384|NCT00545168|429074|P1|Overall Study|Protocol Violation|1
127385|NCT00545168|429072|P3|Overall Study|Withdrawal by Subject|13
127386|NCT00545168|429073|P2|Overall Study|Withdrawal by Subject|0
127387|NCT00545168|429074|P1|Overall Study|Withdrawal by Subject|9
127388|NCT00545168|429072|P3|Overall Study|Lost to Follow-up|5
127389|NCT00545168|429073|P2|Overall Study|Lost to Follow-up|5
127390|NCT00545168|429074|P1|Overall Study|Lost to Follow-up|5
127391|NCT00545103|429100|P4|Overall Study|Death|0
127392|NCT00545103|429101|P3|Overall Study|Death|0
127393|NCT00545103|429102|P2|Overall Study|Death|1
127394|NCT00545103|429103|P1|Overall Study|Death|0
127395|NCT00545103|429100|P4|Overall Study|Subject met endpoint under protocol v. 1|0
127396|NCT00545103|429101|P3|Overall Study|Subject met endpoint under protocol v. 1|1
127397|NCT00545103|429102|P2|Overall Study|Subject met endpoint under protocol v. 1|0
127398|NCT00545103|429103|P1|Overall Study|Subject met endpoint under protocol v. 1|0
127399|NCT00545103|429100|P4|Overall Study|Does not want to take study drug anymore|0
127400|NCT00545103|429101|P3|Overall Study|Does not want to take study drug anymore|1
127401|NCT00545103|429102|P2|Overall Study|Does not want to take study drug anymore|0
127402|NCT00545103|429103|P1|Overall Study|Does not want to take study drug anymore|1
127403|NCT00545103|429100|P4|Overall Study|Use of prohibited medication|0
127404|NCT00545103|429101|P3|Overall Study|Use of prohibited medication|1
127405|NCT00545103|429102|P2|Overall Study|Use of prohibited medication|0
127406|NCT00545103|429103|P1|Overall Study|Use of prohibited medication|0
127407|NCT00545103|429100|P4|Overall Study|Subject moved|0
127408|NCT00545103|429101|P3|Overall Study|Subject moved|0
127409|NCT00545103|429102|P2|Overall Study|Subject moved|1
127410|NCT00545103|429103|P1|Overall Study|Subject moved|0
127411|NCT00545103|429100|P4|Overall Study|Investigator decision|0
127412|NCT00545103|429101|P3|Overall Study|Investigator decision|1
127413|NCT00545103|429102|P2|Overall Study|Investigator decision|0
127414|NCT00545103|429103|P1|Overall Study|Investigator decision|0
127415|NCT00545103|429100|P4|Overall Study|Noncompliance|0
127416|NCT00545103|429101|P3|Overall Study|Noncompliance|0
127417|NCT00545103|429102|P2|Overall Study|Noncompliance|1
127418|NCT00545103|429103|P1|Overall Study|Noncompliance|0
127419|NCT00545103|429100|P4|Overall Study|Subject's decision|0
127420|NCT00545103|429101|P3|Overall Study|Subject's decision|0
127421|NCT00545103|429102|P2|Overall Study|Subject's decision|0
127422|NCT00545103|429103|P1|Overall Study|Subject's decision|1
127423|NCT00545103|429100|P4|Overall Study|Personal reasons|0
127424|NCT00545103|429101|P3|Overall Study|Personal reasons|0
127425|NCT00545103|429102|P2|Overall Study|Personal reasons|0
127426|NCT00545103|429103|P1|Overall Study|Personal reasons|1
127427|NCT00545103|429100|P4|Overall Study|Diverticulitis crisis|1
127428|NCT00545103|429101|P3|Overall Study|Diverticulitis crisis|0
127429|NCT00545103|429102|P2|Overall Study|Diverticulitis crisis|0
127430|NCT00545103|429103|P1|Overall Study|Diverticulitis crisis|0
127431|NCT00545103|429100|P4|Overall Study|Wish to start a family|1
127432|NCT00545103|429101|P3|Overall Study|Wish to start a family|0
127433|NCT00545103|429102|P2|Overall Study|Wish to start a family|0
127434|NCT00545103|429103|P1|Overall Study|Wish to start a family|0
127435|NCT00545103|429100|P4|Overall Study|Investigational product not taken|1
127436|NCT00545103|429101|P3|Overall Study|Investigational product not taken|0
127437|NCT00545103|429102|P2|Overall Study|Investigational product not taken|0
127438|NCT00545103|429103|P1|Overall Study|Investigational product not taken|1
127439|NCT00545103|429100|P4|Overall Study|Difficult to open package|1
127440|NCT00545103|429101|P3|Overall Study|Difficult to open package|0
127441|NCT00545103|429102|P2|Overall Study|Difficult to open package|0
127442|NCT00545103|429103|P1|Overall Study|Difficult to open package|0
127443|NCT00545103|429100|P4|Overall Study|Suspected recurrence of diverticulitis|3
127444|NCT00545103|429101|P3|Overall Study|Suspected recurrence of diverticulitis|0
127445|NCT00545103|429102|P2|Overall Study|Suspected recurrence of diverticulitis|0
127446|NCT00545103|429103|P1|Overall Study|Suspected recurrence of diverticulitis|1
127447|NCT00545103|429100|P4|Overall Study|Protocol Violation|0
127448|NCT00545103|429101|P3|Overall Study|Protocol Violation|3
127449|NCT00545103|429102|P2|Overall Study|Protocol Violation|2
127450|NCT00545103|429103|P1|Overall Study|Protocol Violation|1
127451|NCT00545103|429100|P4|Overall Study|Lost to Follow-up|4
127452|NCT00545103|429101|P3|Overall Study|Lost to Follow-up|3
127453|NCT00545103|429102|P2|Overall Study|Lost to Follow-up|6
127454|NCT00545103|429103|P1|Overall Study|Lost to Follow-up|4
127455|NCT00545103|429100|P4|Overall Study|Adverse Event|10
127456|NCT00545103|429101|P3|Overall Study|Adverse Event|17
127457|NCT00545103|429102|P2|Overall Study|Adverse Event|12
127458|NCT00545103|429103|P1|Overall Study|Adverse Event|11
127459|NCT00545103|429100|P4|Overall Study|Withdrawal by Subject|22
127460|NCT00545103|429101|P3|Overall Study|Withdrawal by Subject|18
127461|NCT00545103|429102|P2|Overall Study|Withdrawal by Subject|10
127462|NCT00545103|429103|P1|Overall Study|Withdrawal by Subject|6
127463|NCT00545103|429100|P4|Overall Study|Lack of Efficacy|27
127464|NCT00545103|429101|P3|Overall Study|Lack of Efficacy|31
127465|NCT00545103|429102|P2|Overall Study|Lack of Efficacy|45
127466|NCT00545103|429103|P1|Overall Study|Lack of Efficacy|48
127467|NCT00545064|429137|P1|Overall Study|inclement weather|1
127468|NCT00545064|429137|P1|Overall Study|cancel all appointments, no rebooking|1
127469|NCT00545064|429137|P1|Overall Study|did not complete course of treatment|1
127470|NCT00545064|429137|P1|Overall Study|Withdrawal by Subject|2
127471|NCT00545064|429137|P1|Overall Study|Lost to Follow-up|3
127472|NCT00545051|429148|P2|Overall Study|Administrative reasons|1
127473|NCT00545051|429149|P1|Overall Study|Administrative reasons|0
127474|NCT00545051|429148|P2|Overall Study|Withdrawal by Subject|1
127475|NCT00545051|429149|P1|Overall Study|Withdrawal by Subject|0
127476|NCT00545051|429148|P2|Overall Study|Protocol Violation|0
127477|NCT00545051|429149|P1|Overall Study|Protocol Violation|1
127478|NCT00545051|429148|P2|Overall Study|Violation of inclusion/exclusion|2
127479|NCT00545051|429149|P1|Overall Study|Violation of inclusion/exclusion|0
127480|NCT00545051|429148|P2|Overall Study|Death|0
127481|NCT00545051|429149|P1|Overall Study|Death|1
127482|NCT00545051|429148|P2|Overall Study|Adverse Event|3
127483|NCT00545051|429149|P1|Overall Study|Adverse Event|7
127484|NCT00544882|429193|P3|Cycle 3: Follow-up|Pregnancy|0
127485|NCT00544882|429194|P2|Cycle 3: Follow-up|Pregnancy|1
127486|NCT00544882|429195|P1|Cycle 3: Follow-up|Pregnancy|0
127487|NCT00544882|429193|P3|Cycle 3: Follow-up|Noncompliance|0
127488|NCT00544882|429194|P2|Cycle 3: Follow-up|Noncompliance|1
127489|NCT00544882|429195|P1|Cycle 3: Follow-up|Noncompliance|0
127490|NCT00544882|429193|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
127491|NCT00544882|429194|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
127492|NCT00544882|429195|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
127493|NCT00544882|429193|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
127494|NCT00544882|429194|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
127495|NCT00544882|429195|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
127496|NCT00544882|429193|P3|Cycle 1: Run-in Cycle|Adverse Event|0
127497|NCT00544882|429194|P2|Cycle 1: Run-in Cycle|Adverse Event|0
127498|NCT00544882|429195|P1|Cycle 1: Run-in Cycle|Adverse Event|1
127499|NCT00544882|429193|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
127500|NCT00544882|429194|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
127501|NCT00544882|429195|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
127502|NCT00544869|429220|P3|Overall Study|Physician Decision|0
127503|NCT00544869|429221|P2|Overall Study|Physician Decision|0
127504|NCT00544869|429222|P1|Overall Study|Physician Decision|2
127505|NCT00544869|429220|P3|Overall Study|Lack of Efficacy|0
127506|NCT00544869|429221|P2|Overall Study|Lack of Efficacy|1
127507|NCT00544869|429222|P1|Overall Study|Lack of Efficacy|1
127508|NCT00544869|429220|P3|Overall Study|Adverse Event|0
127509|NCT00544869|429221|P2|Overall Study|Adverse Event|1
127510|NCT00544869|429222|P1|Overall Study|Adverse Event|6
127511|NCT00544869|429220|P3|Overall Study|Rsolution of congenitive symptoms|0
127512|NCT00544869|429221|P2|Overall Study|Rsolution of congenitive symptoms|0
127513|NCT00544869|429222|P1|Overall Study|Rsolution of congenitive symptoms|3
127514|NCT00544817|429230|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
127515|NCT00544817|429230|P1|Follow-up Systemic Therapy|Physician Decision|3
127516|NCT00544817|429230|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
127517|NCT00544817|429230|P1|No Treatment Interval|Adverse Event|1
127518|NCT00544817|429230|P1|No Treatment Interval|Physician Decision|3
127519|NCT00544817|429230|P1|No Treatment Interval|Lack of Efficacy|8
127520|NCT00544817|429230|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
127521|NCT00544817|429230|P1|Combined Modality|Adverse Event|2
127522|NCT00544817|429230|P1|Combined Modality|Worsening Neurologic Symptoms|2
127523|NCT00544817|429230|P1|Combined Modality|Lack of Efficacy|2
127524|NCT00544648|429279|P2|Overall Study|progression of disease|0
127525|NCT00544648|429280|P1|Overall Study|progression of disease|1
127526|NCT00544648|429279|P2|Overall Study|Adverse Event|1
127527|NCT00544648|429280|P1|Overall Study|Adverse Event|1
127528|NCT00544648|429279|P2|Overall Study|Withdrawal by Subject|0
127529|NCT00544648|429280|P1|Overall Study|Withdrawal by Subject|1
127530|NCT00544557|429294|P1|Overall Study|Unspecified|98
127531|NCT00544557|429294|P1|Overall Study|Lack of Efficacy|196
127532|NCT00544557|429294|P1|Overall Study|Adverse Event|140
127533|NCT00544544|429325|P1|Overall Study|Lost to Follow-up|1
127534|NCT00544544|429325|P1|Overall Study|Adverse Event|1
127535|NCT00544544|429325|P1|Overall Study|Withdrawal by Subject|1
127536|NCT00544440|429329|P1|Overall Study|Unspecified|5
127537|NCT00544440|429329|P1|Overall Study|Progressive Disease|47
127538|NCT00544440|429329|P1|Overall Study|Subject Non-compliance|1
127539|NCT00544440|429329|P1|Overall Study|Withdrawal by Subject|2
127540|NCT00544440|429329|P1|Overall Study|Adverse Event|1
127541|NCT00544440|429329|P1|Overall Study|Other|1
127542|NCT00544167|429336|P1|Overall Study|Physician Decision|8
127543|NCT00544167|429336|P1|Overall Study|Adverse Event|21
127544|NCT00543985|429340|P1|Overall Study|Withdrawal by Subject|4
127545|NCT00543855|429349|P4|Overall Study|Protocol Violation|0
127546|NCT00543855|429350|P3|Overall Study|Protocol Violation|0
127547|NCT00543855|429351|P2|Overall Study|Protocol Violation|0
127548|NCT00543855|429352|P1|Overall Study|Protocol Violation|1
127549|NCT00543855|429349|P4|Overall Study|Withdrawal by Subject|0
127550|NCT00543855|429350|P3|Overall Study|Withdrawal by Subject|2
127551|NCT00543855|429351|P2|Overall Study|Withdrawal by Subject|1
127552|NCT00543855|429352|P1|Overall Study|Withdrawal by Subject|0
127553|NCT00543855|429349|P4|Overall Study|Lost to Follow-up|0
127554|NCT00543855|429350|P3|Overall Study|Lost to Follow-up|1
127555|NCT00543855|429351|P2|Overall Study|Lost to Follow-up|0
127556|NCT00543855|429352|P1|Overall Study|Lost to Follow-up|0
127557|NCT00543855|429349|P4|Overall Study|Adverse Event|4
127558|NCT00543855|429350|P3|Overall Study|Adverse Event|3
127559|NCT00543855|429351|P2|Overall Study|Adverse Event|1
127560|NCT00543855|429352|P1|Overall Study|Adverse Event|3
127561|NCT00543803|429374|P1|Overall Study|not specified|86
127562|NCT00543803|429374|P1|Overall Study|Lost to Follow-up|20
127563|NCT00543803|429374|P1|Overall Study|Lack of Efficacy|22
127564|NCT00543803|429374|P1|Overall Study|Adverse Event|14
127565|NCT00543725|429402|P2|Overall Study|Not specified|3
127566|NCT00543725|429403|P1|Overall Study|Not specified|3
127567|NCT00543725|429402|P2|Overall Study|Lost to Follow-up|11
127568|NCT00543725|429403|P1|Overall Study|Lost to Follow-up|15
127569|NCT00543725|429402|P2|Overall Study|Withdrawal by Subject|13
127570|NCT00543725|429403|P1|Overall Study|Withdrawal by Subject|4
127571|NCT00543725|429402|P2|Overall Study|Protocol Violation|1
127572|NCT00543725|429403|P1|Overall Study|Protocol Violation|0
127573|NCT00543725|429402|P2|Overall Study|Subject Reached A Virologic Endpoint|14
127574|NCT00543725|429403|P1|Overall Study|Subject Reached A Virologic Endpoint|22
127575|NCT00543725|429402|P2|Overall Study|Subject Ineligible To Continue The Trial|0
127576|NCT00543725|429403|P1|Overall Study|Subject Ineligible To Continue The Trial|2
127577|NCT00543725|429402|P2|Overall Study|Subject Non-Compliant|4
127578|NCT00543725|429403|P1|Overall Study|Subject Non-Compliant|4
127579|NCT00543725|429402|P2|Overall Study|Sponsor's Decision|1
127580|NCT00543725|429403|P1|Overall Study|Sponsor's Decision|0
127581|NCT00543725|429402|P2|Overall Study|Adverse Event|27
127582|NCT00543725|429403|P1|Overall Study|Adverse Event|18
127583|NCT00543569|429429|P4|Overall Study|Randomized but never received study drug|3
127584|NCT00543569|429430|P3|Overall Study|Randomized but never received study drug|5
127585|NCT00543569|429431|P2|Overall Study|Randomized but never received study drug|3
127586|NCT00543569|429432|P1|Overall Study|Randomized but never received study drug|3
127587|NCT00543569|429429|P4|Overall Study|Miscellaneous Reasons|4
127588|NCT00543569|429430|P3|Overall Study|Miscellaneous Reasons|11
127589|NCT00543569|429431|P2|Overall Study|Miscellaneous Reasons|3
127590|NCT00543569|429432|P1|Overall Study|Miscellaneous Reasons|7
127591|NCT00543569|429429|P4|Overall Study|Lost to Follow-up|1
127592|NCT00543569|429430|P3|Overall Study|Lost to Follow-up|1
127593|NCT00543569|429431|P2|Overall Study|Lost to Follow-up|0
127594|NCT00543569|429432|P1|Overall Study|Lost to Follow-up|0
127595|NCT00543569|429429|P4|Overall Study|Death|1
127596|NCT00543569|429430|P3|Overall Study|Death|3
127597|NCT00543569|429431|P2|Overall Study|Death|2
127598|NCT00543569|429432|P1|Overall Study|Death|2
127599|NCT00543543|429538|P4|Overall Study|Withdrawal by Subject|503
127600|NCT00543543|429539|P3|Overall Study|Withdrawal by Subject|5
127601|NCT00543543|429540|P2|Overall Study|Withdrawal by Subject|482
127602|NCT00543543|429541|P1|Overall Study|Withdrawal by Subject|7
127603|NCT00543543|429538|P4|Overall Study|Protocol Violation|6
127604|NCT00543543|429539|P3|Overall Study|Protocol Violation|0
127605|NCT00543543|429540|P2|Overall Study|Protocol Violation|6
127606|NCT00543543|429541|P1|Overall Study|Protocol Violation|0
127607|NCT00543543|429538|P4|Overall Study|Physician Decision|7
127608|NCT00543543|429539|P3|Overall Study|Physician Decision|0
127609|NCT00543543|429540|P2|Overall Study|Physician Decision|4
127610|NCT00543543|429541|P1|Overall Study|Physician Decision|0
127611|NCT00543543|429538|P4|Overall Study|Lost to Follow-up|701
127612|NCT00543543|429539|P3|Overall Study|Lost to Follow-up|9
127613|NCT00543543|429540|P2|Overall Study|Lost to Follow-up|749
127614|NCT00543543|429541|P1|Overall Study|Lost to Follow-up|12
127615|NCT00543543|429538|P4|Overall Study|Adverse Event|5
127616|NCT00543543|429539|P3|Overall Study|Adverse Event|0
127617|NCT00543543|429540|P2|Overall Study|Adverse Event|11
127618|NCT00543543|429541|P1|Overall Study|Adverse Event|1
127619|NCT00543296|429577|P1|Overall Study|Physician Decision|7
127620|NCT00543140|429584|P1|Overall Study|Conversion to different procedure|1
127621|NCT00543140|429584|P1|Overall Study|Subject moved|1
127622|NCT00543140|429584|P1|Overall Study|Death|1
127623|NCT00543140|429584|P1|Overall Study|SAE leading to explant of SAGB|3
127624|NCT00543140|429584|P1|Overall Study|Insufficient weight loss|10
127625|NCT00543140|429584|P1|Overall Study|Protocol Violation|10
127626|NCT00543140|429584|P1|Overall Study|Withdrawal by Subject|13
127627|NCT00543140|429584|P1|Overall Study|Lost to Follow-up|33
127628|NCT00542997|429607|P1|Efficacy Period|Adverse Event|3
127629|NCT00542997|429607|P1|Wash in / Wash Out Period|Adverse Event|3
127630|NCT00542997|429607|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
127631|NCT00542880|429629|P2|Period 3|Adverse Event|2
127632|NCT00542880|429630|P1|Period 3|Adverse Event|0
127633|NCT00542880|429629|P2|Period 2|Not specified|1
127634|NCT00542880|429630|P1|Period 2|Not specified|0
127635|NCT00542880|429629|P2|Period 2|Severe non-compliance|1
127636|NCT00542880|429630|P1|Period 2|Severe non-compliance|0
127637|NCT00542880|429629|P2|Period 2|Discontinuation criteria|0
127638|NCT00542880|429630|P1|Period 2|Discontinuation criteria|2
127639|NCT00542880|429629|P2|Period 2|Eligibility not fulfilled|1
127640|NCT00542880|429630|P1|Period 2|Eligibility not fulfilled|0
127641|NCT00542880|429629|P2|Period 2|Adverse Event|7
127642|NCT00542880|429630|P1|Period 2|Adverse Event|5
127643|NCT00542880|429629|P2|Period 1|Protocol Violation|1
127644|NCT00542880|429630|P1|Period 1|Protocol Violation|0
127645|NCT00542880|429629|P2|Period 1|Withdrawal by Subject|1
127646|NCT00542880|429630|P1|Period 1|Withdrawal by Subject|1
127647|NCT00542880|429629|P2|Period 1|Development of study-specific criteria|2
127648|NCT00542880|429630|P1|Period 1|Development of study-specific criteria|1
127649|NCT00542880|429629|P2|Period 1|Adverse Event|2
127650|NCT00542880|429630|P1|Period 1|Adverse Event|2
127651|NCT00542880|429629|P2|Period 1|Eligibility criteria not fulfilled|6
127652|NCT00542880|429630|P1|Period 1|Eligibility criteria not fulfilled|2
127653|NCT00542828|429666|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
127654|NCT00542828|429666|P1|Overall Study|Study Prematurely Discontinued|7
127655|NCT00542828|429666|P1|Overall Study|Need for Prohibited Treatment|3
127656|NCT00542828|429666|P1|Overall Study|Physician Decision|1
127657|NCT00542815|429684|P3|Overall Study|Other reasons|10
127658|NCT00542815|429685|P2|Overall Study|Other reasons|10
127659|NCT00542815|429686|P1|Overall Study|Other reasons|24
127660|NCT00542815|429684|P3|Overall Study|Withdrawal by Subject|8
127661|NCT00542815|429685|P2|Overall Study|Withdrawal by Subject|5
127662|NCT00542815|429686|P1|Overall Study|Withdrawal by Subject|41
127663|NCT00542815|429684|P3|Overall Study|Protocol Violation|2
127664|NCT00542815|429685|P2|Overall Study|Protocol Violation|1
127665|NCT00542815|429686|P1|Overall Study|Protocol Violation|1
127666|NCT00542815|429684|P3|Overall Study|Physician Decision|0
127667|NCT00542815|429685|P2|Overall Study|Physician Decision|1
127668|NCT00542815|429686|P1|Overall Study|Physician Decision|2
127669|NCT00542815|429684|P3|Overall Study|Lack of Efficacy|0
127670|NCT00542815|429685|P2|Overall Study|Lack of Efficacy|2
127671|NCT00542815|429686|P1|Overall Study|Lack of Efficacy|9
127672|NCT00542815|429684|P3|Overall Study|Death|3
127673|NCT00542815|429685|P2|Overall Study|Death|7
127674|NCT00542815|429686|P1|Overall Study|Death|10
127675|NCT00542815|429684|P3|Overall Study|Adverse Event|9
127676|NCT00542815|429685|P2|Overall Study|Adverse Event|6
127677|NCT00542815|429686|P1|Overall Study|Adverse Event|19
127678|NCT00542789|429699|P2|Overall Study|Recurrence of Gastric Ulcer|57
127679|NCT00542789|429700|P1|Overall Study|Recurrence of Gastric Ulcer|8
127680|NCT00542789|429699|P2|Overall Study|Protocol Violation|1
127681|NCT00542789|429700|P1|Overall Study|Protocol Violation|8
127682|NCT00542789|429699|P2|Overall Study|Withdrawal by Subject|3
127683|NCT00542789|429700|P1|Overall Study|Withdrawal by Subject|7
127684|NCT00542789|429699|P2|Overall Study|Adverse Event|17
127685|NCT00542789|429700|P1|Overall Study|Adverse Event|18
127686|NCT00542425|429791|P5|Extended 24 Weeks of Treatment|Other|1
127687|NCT00542425|429792|P4|Extended 24 Weeks of Treatment|Other|0
127688|NCT00542425|429793|P3|Extended 24 Weeks of Treatment|Other|0
127689|NCT00542425|429794|P2|Extended 24 Weeks of Treatment|Other|1
127690|NCT00542425|429795|P1|Extended 24 Weeks of Treatment|Other|1
127691|NCT00542425|429791|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
127692|NCT00542425|429792|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
127693|NCT00542425|429793|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
127694|NCT00542425|429794|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
127695|NCT00542425|429795|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
127696|NCT00542425|429791|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
127697|NCT00542425|429792|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
127698|NCT00542425|429793|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
127699|NCT00542425|429794|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
127700|NCT00542425|429795|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
127701|NCT00542425|429791|P5|Extended 24 Weeks of Treatment|Adverse Event|0
127702|NCT00542425|429792|P4|Extended 24 Weeks of Treatment|Adverse Event|1
127703|NCT00542425|429793|P3|Extended 24 Weeks of Treatment|Adverse Event|1
127704|NCT00542425|429794|P2|Extended 24 Weeks of Treatment|Adverse Event|0
127705|NCT00542425|429795|P1|Extended 24 Weeks of Treatment|Adverse Event|0
127706|NCT00542425|429791|P5|Initial 24 Weeks|Other|0
127707|NCT00542425|429792|P4|Initial 24 Weeks|Other|0
127708|NCT00542425|429793|P3|Initial 24 Weeks|Other|1
127709|NCT00542425|429794|P2|Initial 24 Weeks|Other|2
127710|NCT00542425|429795|P1|Initial 24 Weeks|Other|0
127711|NCT00542425|429791|P5|Initial 24 Weeks|Refusal of treatment|1
127712|NCT00542425|429792|P4|Initial 24 Weeks|Refusal of treatment|4
127713|NCT00542425|429793|P3|Initial 24 Weeks|Refusal of treatment|1
127714|NCT00542425|429794|P2|Initial 24 Weeks|Refusal of treatment|2
127715|NCT00542425|429795|P1|Initial 24 Weeks|Refusal of treatment|2
127716|NCT00542425|429791|P5|Initial 24 Weeks|Protocol Violation|0
127717|NCT00542425|429792|P4|Initial 24 Weeks|Protocol Violation|1
127718|NCT00542425|429793|P3|Initial 24 Weeks|Protocol Violation|0
127719|NCT00542425|429794|P2|Initial 24 Weeks|Protocol Violation|0
127720|NCT00542425|429795|P1|Initial 24 Weeks|Protocol Violation|0
127721|NCT00542425|429791|P5|Initial 24 Weeks|Non-compliance|1
127722|NCT00542425|429792|P4|Initial 24 Weeks|Non-compliance|1
127723|NCT00542425|429793|P3|Initial 24 Weeks|Non-compliance|0
127724|NCT00542425|429794|P2|Initial 24 Weeks|Non-compliance|0
127725|NCT00542425|429795|P1|Initial 24 Weeks|Non-compliance|0
127726|NCT00542425|429791|P5|Initial 24 Weeks|Lost to Follow-up|0
127727|NCT00542425|429792|P4|Initial 24 Weeks|Lost to Follow-up|0
127728|NCT00542425|429793|P3|Initial 24 Weeks|Lost to Follow-up|1
127729|NCT00542425|429794|P2|Initial 24 Weeks|Lost to Follow-up|2
127730|NCT00542425|429795|P1|Initial 24 Weeks|Lost to Follow-up|2
127731|NCT00542425|429791|P5|Initial 24 Weeks|Inability to complete procedures|2
127732|NCT00542425|429792|P4|Initial 24 Weeks|Inability to complete procedures|1
127733|NCT00542425|429793|P3|Initial 24 Weeks|Inability to complete procedures|2
127734|NCT00542425|429794|P2|Initial 24 Weeks|Inability to complete procedures|3
127735|NCT00542425|429795|P1|Initial 24 Weeks|Inability to complete procedures|0
127736|NCT00542425|429791|P5|Initial 24 Weeks|Adverse Event|2
127737|NCT00542425|429792|P4|Initial 24 Weeks|Adverse Event|3
127738|NCT00542425|429793|P3|Initial 24 Weeks|Adverse Event|1
127739|NCT00542425|429794|P2|Initial 24 Weeks|Adverse Event|1
127740|NCT00542425|429795|P1|Initial 24 Weeks|Adverse Event|0
127741|NCT00542425|429791|P5|Initial 24 Weeks|Administrative reasons|0
127742|NCT00542425|429792|P4|Initial 24 Weeks|Administrative reasons|1
127743|NCT00542425|429793|P3|Initial 24 Weeks|Administrative reasons|1
127744|NCT00542425|429794|P2|Initial 24 Weeks|Administrative reasons|0
127745|NCT00542425|429795|P1|Initial 24 Weeks|Administrative reasons|0
127746|NCT00542386|429833|P6|Overall Study|Other Reasons|2
127747|NCT00542386|429834|P5|Overall Study|Other Reasons|4
127748|NCT00542386|429835|P4|Overall Study|Other Reasons|3
127749|NCT00542386|429836|P3|Overall Study|Other Reasons|4
127750|NCT00542386|429837|P2|Overall Study|Other Reasons|1
127751|NCT00542386|429838|P1|Overall Study|Other Reasons|4
127752|NCT00542386|429833|P6|Overall Study|Withdrawal by Subject|7
127753|NCT00542386|429834|P5|Overall Study|Withdrawal by Subject|15
127754|NCT00542386|429835|P4|Overall Study|Withdrawal by Subject|11
127755|NCT00542386|429836|P3|Overall Study|Withdrawal by Subject|10
127756|NCT00542386|429837|P2|Overall Study|Withdrawal by Subject|8
127757|NCT00542386|429838|P1|Overall Study|Withdrawal by Subject|5
127758|NCT00542386|429833|P6|Overall Study|Protocol Violation|4
127759|NCT00542386|429834|P5|Overall Study|Protocol Violation|0
127760|NCT00542386|429835|P4|Overall Study|Protocol Violation|0
127761|NCT00542386|429836|P3|Overall Study|Protocol Violation|1
127762|NCT00542386|429837|P2|Overall Study|Protocol Violation|0
127763|NCT00542386|429838|P1|Overall Study|Protocol Violation|0
127764|NCT00542386|429833|P6|Overall Study|Physician Decision|0
127765|NCT00542386|429834|P5|Overall Study|Physician Decision|0
127766|NCT00542386|429835|P4|Overall Study|Physician Decision|1
127767|NCT00542386|429836|P3|Overall Study|Physician Decision|0
127768|NCT00542386|429837|P2|Overall Study|Physician Decision|0
127769|NCT00542386|429838|P1|Overall Study|Physician Decision|1
127770|NCT00542386|429833|P6|Overall Study|Lack of Efficacy|31
127771|NCT00542386|429834|P5|Overall Study|Lack of Efficacy|7
127772|NCT00542386|429835|P4|Overall Study|Lack of Efficacy|13
127773|NCT00542386|429836|P3|Overall Study|Lack of Efficacy|10
127774|NCT00542386|429837|P2|Overall Study|Lack of Efficacy|12
127775|NCT00542386|429838|P1|Overall Study|Lack of Efficacy|32
127776|NCT00542386|429833|P6|Overall Study|Death|2
127777|NCT00542386|429834|P5|Overall Study|Death|1
127778|NCT00542386|429835|P4|Overall Study|Death|2
127779|NCT00542386|429836|P3|Overall Study|Death|1
127780|NCT00542386|429837|P2|Overall Study|Death|0
127781|NCT00542386|429838|P1|Overall Study|Death|0
127782|NCT00542386|429833|P6|Overall Study|Adverse Event|4
127783|NCT00542386|429834|P5|Overall Study|Adverse Event|13
127784|NCT00542386|429835|P4|Overall Study|Adverse Event|8
127785|NCT00542386|429836|P3|Overall Study|Adverse Event|7
127786|NCT00542386|429837|P2|Overall Study|Adverse Event|7
127787|NCT00542386|429838|P1|Overall Study|Adverse Event|1
127788|NCT00542321|429860|P2|Overall Study|Death|1
127789|NCT00542321|429861|P1|Overall Study|Death|0
127790|NCT00542269|429883|P3|Overall Study|Administrative problems|1
127791|NCT00542269|429884|P2|Overall Study|Administrative problems|1
127792|NCT00542269|429885|P1|Overall Study|Administrative problems|1
127793|NCT00542269|429883|P3|Overall Study|Withdrawal by Subject|0
127794|NCT00542269|429884|P2|Overall Study|Withdrawal by Subject|0
127795|NCT00542269|429885|P1|Overall Study|Withdrawal by Subject|1
127796|NCT00542269|429883|P3|Overall Study|Protocol Violation|0
127797|NCT00542269|429884|P2|Overall Study|Protocol Violation|1
127798|NCT00542269|429885|P1|Overall Study|Protocol Violation|1
127799|NCT00542269|429883|P3|Overall Study|Adverse Event|5
127800|NCT00542269|429884|P2|Overall Study|Adverse Event|4
127801|NCT00542269|429885|P1|Overall Study|Adverse Event|10
127802|NCT00542178|429920|P8|Overall Study|did not complete year 4 follow-up|85
127803|NCT00542178|429921|P7|Overall Study|did not complete year 4 follow-up|87
127804|NCT00542178|429922|P6|Overall Study|did not complete year 4 follow-up|89
127805|NCT00542178|429923|P5|Overall Study|did not complete year 4 follow-up|64
127806|NCT00542178|429924|P4|Overall Study|did not complete year 4 follow-up|62
127807|NCT00542178|429925|P3|Overall Study|did not complete year 4 follow-up|74
127808|NCT00542178|429926|P2|Overall Study|did not complete year 4 follow-up|80
127809|NCT00542178|429927|P1|Overall Study|did not complete year 4 follow-up|75
127810|NCT00541970|429945|P4|Month 60|Protocol Violation|72
127811|NCT00541970|429946|P3|Month 60|Protocol Violation|82
127812|NCT00541970|429947|P2|Month 60|Protocol Violation|77
127813|NCT00541970|429948|P1|Month 60|Protocol Violation|78
127814|NCT00541970|429945|P4|Month 48|Lost to Follow-up|73
127815|NCT00541970|429946|P3|Month 48|Lost to Follow-up|68
127816|NCT00541970|429947|P2|Month 48|Lost to Follow-up|68
127817|NCT00541970|429948|P1|Month 48|Lost to Follow-up|66
127818|NCT00541970|429945|P4|Month 48|Unspecified|0
127819|NCT00541970|429946|P3|Month 48|Unspecified|1
127820|NCT00541970|429947|P2|Month 48|Unspecified|1
127821|NCT00541970|429948|P1|Month 48|Unspecified|3
127822|NCT00541970|429945|P4|Month 48|Withdrawal by Subject|2
127823|NCT00541970|429946|P3|Month 48|Withdrawal by Subject|4
127824|NCT00541970|429947|P2|Month 48|Withdrawal by Subject|4
127825|NCT00541970|429948|P1|Month 48|Withdrawal by Subject|2
127826|NCT00541970|429945|P4|Month 36|Protocol Violation|60
127827|NCT00541970|429946|P3|Month 36|Protocol Violation|66
127828|NCT00541970|429947|P2|Month 36|Protocol Violation|66
127829|NCT00541970|429948|P1|Month 36|Protocol Violation|61
127830|NCT00541970|429945|P4|Month 24|Protocol Violation|21
127831|NCT00541970|429946|P3|Month 24|Protocol Violation|31
127832|NCT00541970|429947|P2|Month 24|Protocol Violation|31
127833|NCT00541970|429948|P1|Month 24|Protocol Violation|29
127834|NCT00541970|429945|P4|Month 24|Adverse Event|1
127835|NCT00541970|429946|P3|Month 24|Adverse Event|1
127836|NCT00541970|429947|P2|Month 24|Adverse Event|1
127837|NCT00541970|429948|P1|Month 24|Adverse Event|0
127838|NCT00541970|429945|P4|Month 18|Protocol Violation|16
127839|NCT00541970|429946|P3|Month 18|Protocol Violation|24
127840|NCT00541970|429947|P2|Month 18|Protocol Violation|23
127841|NCT00541970|429948|P1|Month 18|Protocol Violation|14
127842|NCT00541970|429945|P4|Month 18|Adverse Event|1
127843|NCT00541970|429946|P3|Month 18|Adverse Event|1
127844|NCT00541970|429947|P2|Month 18|Adverse Event|1
127845|NCT00541970|429948|P1|Month 18|Adverse Event|0
127846|NCT00541970|429945|P4|Month 12|Protocol Violation|15
127847|NCT00541970|429946|P3|Month 12|Protocol Violation|20
127848|NCT00541970|429947|P2|Month 12|Protocol Violation|21
127849|NCT00541970|429948|P1|Month 12|Protocol Violation|12
127850|NCT00541970|429945|P4|Month 12|Adverse Event|1
127851|NCT00541970|429946|P3|Month 12|Adverse Event|1
127852|NCT00541970|429947|P2|Month 12|Adverse Event|1
127853|NCT00541970|429948|P1|Month 12|Adverse Event|0
127854|NCT00541970|429945|P4|Month 7|Protocol Violation|5
127855|NCT00541970|429946|P3|Month 7|Protocol Violation|11
127856|NCT00541970|429947|P2|Month 7|Protocol Violation|13
127857|NCT00541970|429948|P1|Month 7|Protocol Violation|9
127858|NCT00541775|430100|P3|Overall Study|Withdrawal by Subject and Other|2
127859|NCT00541775|430101|P2|Overall Study|Withdrawal by Subject and Other|0
127860|NCT00541775|430102|P1|Overall Study|Withdrawal by Subject and Other|5
127861|NCT00541775|430100|P3|Overall Study|Protocol Violation|0
127862|NCT00541775|430101|P2|Overall Study|Protocol Violation|0
127863|NCT00541775|430102|P1|Overall Study|Protocol Violation|1
127864|NCT00541775|430100|P3|Overall Study|Lost to Follow-up|2
127865|NCT00541775|430101|P2|Overall Study|Lost to Follow-up|0
127866|NCT00541775|430102|P1|Overall Study|Lost to Follow-up|0
127867|NCT00541775|430100|P3|Overall Study|Lack of Efficacy|3
127868|NCT00541775|430101|P2|Overall Study|Lack of Efficacy|0
127869|NCT00541775|430102|P1|Overall Study|Lack of Efficacy|0
127870|NCT00541775|430100|P3|Overall Study|Adverse Event|1
127871|NCT00541775|430101|P2|Overall Study|Adverse Event|2
127872|NCT00541775|430102|P1|Overall Study|Adverse Event|3
127873|NCT00541658|430128|P3|Overall Study|Took No Study Drug|0
127874|NCT00541658|430129|P2|Overall Study|Took No Study Drug|0
127875|NCT00541658|430130|P1|Overall Study|Took No Study Drug|1
127876|NCT00541658|430128|P3|Overall Study|Withdrawal by Subject|32
127877|NCT00541658|430129|P2|Overall Study|Withdrawal by Subject|32
127878|NCT00541658|430130|P1|Overall Study|Withdrawal by Subject|28
127879|NCT00541658|430128|P3|Overall Study|Protocol Violation|1
127880|NCT00541658|430129|P2|Overall Study|Protocol Violation|1
127881|NCT00541658|430130|P1|Overall Study|Protocol Violation|0
127882|NCT00541658|430128|P3|Overall Study|Lost to Follow-up|6
127883|NCT00541658|430129|P2|Overall Study|Lost to Follow-up|3
127884|NCT00541658|430130|P1|Overall Study|Lost to Follow-up|3
127885|NCT00541658|430128|P3|Overall Study|Physician Decision|4
127886|NCT00541658|430129|P2|Overall Study|Physician Decision|0
127887|NCT00541658|430130|P1|Overall Study|Physician Decision|0
127888|NCT00541658|430128|P3|Overall Study|Adverse Event|25
127889|NCT00541658|430129|P2|Overall Study|Adverse Event|37
127890|NCT00541658|430130|P1|Overall Study|Adverse Event|28
127891|NCT00541450|430293|P2|Phase B|Withdrawal by Subject|6
127892|NCT00541450|430294|P1|Phase B|Withdrawal by Subject|8
127893|NCT00541450|430293|P2|Phase B|Protocol Violation|3
127894|NCT00541450|430294|P1|Phase B|Protocol Violation|3
127895|NCT00541450|430293|P2|Phase B|Pregnancy|1
127896|NCT00541450|430294|P1|Phase B|Pregnancy|0
127897|NCT00541450|430293|P2|Phase B|Physician Decision|2
127898|NCT00541450|430294|P1|Phase B|Physician Decision|4
127899|NCT00541450|430293|P2|Phase B|Lost to Follow-up|4
127900|NCT00541450|430294|P1|Phase B|Lost to Follow-up|6
127901|NCT00541450|430293|P2|Phase B|Hyperglycemia|9
127902|NCT00541450|430294|P1|Phase B|Hyperglycemia|10
127903|NCT00541450|430293|P2|Phase B|Adverse Event|6
127904|NCT00541450|430294|P1|Phase B|Adverse Event|6
127905|NCT00541450|430293|P2|Phase A|Withdrawal by Subject|7
127906|NCT00541450|430294|P1|Phase A|Withdrawal by Subject|7
127907|NCT00541450|430293|P2|Phase A|Protocol Violation|3
127908|NCT00541450|430294|P1|Phase A|Protocol Violation|2
127909|NCT00541450|430293|P2|Phase A|Physician Decision|0
127910|NCT00541450|430294|P1|Phase A|Physician Decision|2
127911|NCT00541450|430293|P2|Phase A|Lost to Follow-up|4
127912|NCT00541450|430294|P1|Phase A|Lost to Follow-up|6
127913|NCT00541450|430293|P2|Phase A|Hyperglycemia|1
127914|NCT00541450|430294|P1|Phase A|Hyperglycemia|0
127915|NCT00541450|430293|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
127916|NCT00541450|430294|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
127917|NCT00541450|430293|P2|Phase A|Adverse Event|0
127918|NCT00541450|430294|P1|Phase A|Adverse Event|3
127919|NCT00541346|430312|P1|Follow-up|Adverse Event|1
127920|NCT00541307|430326|P1|Overall Study|Surgical Bypass|5
127921|NCT00541307|430326|P1|Overall Study|Subject returned early (outside window)|1
127922|NCT00541307|430326|P1|Overall Study|Lost to Follow-up|4
127923|NCT00541307|430326|P1|Overall Study|Withdrawal by Subject|6
127924|NCT00541307|430326|P1|Overall Study|Physician Decision|3
127925|NCT00541307|430326|P1|Overall Study|Death|5
127926|NCT00541229|430351|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
127927|NCT00541229|430352|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
127928|NCT00541229|430353|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
127929|NCT00541229|430354|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
127930|NCT00541229|430355|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
127931|NCT00541229|430356|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
127932|NCT00541229|430351|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
127933|NCT00541229|430352|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
127934|NCT00541229|430353|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
127935|NCT00541229|430354|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
127936|NCT00541229|430355|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
127937|NCT00541229|430356|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
127938|NCT00541229|430351|P6|Treatment Period III (Week 11)|Adverse Event|0
127939|NCT00541229|430352|P5|Treatment Period III (Week 11)|Adverse Event|1
127940|NCT00541229|430353|P4|Treatment Period III (Week 11)|Adverse Event|0
127941|NCT00541229|430354|P3|Treatment Period III (Week 11)|Adverse Event|0
127942|NCT00541229|430355|P2|Treatment Period III (Week 11)|Adverse Event|0
127943|NCT00541229|430356|P1|Treatment Period III (Week 11)|Adverse Event|0
127944|NCT00541229|430351|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
127945|NCT00541229|430352|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
127946|NCT00541229|430353|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
127947|NCT00541229|430354|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
127948|NCT00541229|430355|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
127949|NCT00541229|430356|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
127950|NCT00541229|430351|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
127951|NCT00541229|430352|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
127952|NCT00541229|430353|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
127953|NCT00541229|430354|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
127954|NCT00541229|430355|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
127955|NCT00541229|430356|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
127956|NCT00541229|430351|P6|Washout Period II (Week 7-10)|Protocol Violation|0
127957|NCT00541229|430352|P5|Washout Period II (Week 7-10)|Protocol Violation|0
127958|NCT00541229|430353|P4|Washout Period II (Week 7-10)|Protocol Violation|0
127959|NCT00541229|430354|P3|Washout Period II (Week 7-10)|Protocol Violation|0
127960|NCT00541229|430355|P2|Washout Period II (Week 7-10)|Protocol Violation|0
127961|NCT00541229|430356|P1|Washout Period II (Week 7-10)|Protocol Violation|1
127962|NCT00541229|430351|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
127963|NCT00541229|430352|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
127964|NCT00541229|430353|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
127965|NCT00541229|430354|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
127966|NCT00541229|430355|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
127967|NCT00541229|430356|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
127968|NCT00541229|430351|P6|Treatment Period II (Week 6)|Protocol Violation|1
127969|NCT00541229|430352|P5|Treatment Period II (Week 6)|Protocol Violation|1
127970|NCT00541229|430353|P4|Treatment Period II (Week 6)|Protocol Violation|0
127971|NCT00541229|430354|P3|Treatment Period II (Week 6)|Protocol Violation|0
127972|NCT00541229|430355|P2|Treatment Period II (Week 6)|Protocol Violation|0
127973|NCT00541229|430356|P1|Treatment Period II (Week 6)|Protocol Violation|0
127974|NCT00541229|430351|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
127975|NCT00541229|430352|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
127976|NCT00541229|430353|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
127977|NCT00541229|430354|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
127978|NCT00541229|430355|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
127979|NCT00541229|430356|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
127980|NCT00541229|430351|P6|Washout Period I (Week 2-5)|Protocol Violation|1
127981|NCT00541229|430352|P5|Washout Period I (Week 2-5)|Protocol Violation|0
127982|NCT00541229|430353|P4|Washout Period I (Week 2-5)|Protocol Violation|0
127983|NCT00541229|430354|P3|Washout Period I (Week 2-5)|Protocol Violation|0
127984|NCT00541229|430355|P2|Washout Period I (Week 2-5)|Protocol Violation|0
127985|NCT00541229|430356|P1|Washout Period I (Week 2-5)|Protocol Violation|0
127986|NCT00541229|430351|P6|Washout Period I (Week 2-5)|Physician Decision|0
127987|NCT00541229|430352|P5|Washout Period I (Week 2-5)|Physician Decision|0
127988|NCT00541229|430353|P4|Washout Period I (Week 2-5)|Physician Decision|1
127989|NCT00541229|430354|P3|Washout Period I (Week 2-5)|Physician Decision|0
127990|NCT00541229|430355|P2|Washout Period I (Week 2-5)|Physician Decision|0
127991|NCT00541229|430356|P1|Washout Period I (Week 2-5)|Physician Decision|0
127992|NCT00541229|430351|P6|Washout Period I (Week 2-5)|Adverse Event|0
127993|NCT00541229|430352|P5|Washout Period I (Week 2-5)|Adverse Event|0
127994|NCT00541229|430353|P4|Washout Period I (Week 2-5)|Adverse Event|0
127995|NCT00541229|430354|P3|Washout Period I (Week 2-5)|Adverse Event|1
127996|NCT00541229|430355|P2|Washout Period I (Week 2-5)|Adverse Event|0
127997|NCT00541229|430356|P1|Washout Period I (Week 2-5)|Adverse Event|1
127998|NCT00541229|430351|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
127999|NCT00541229|430352|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
128000|NCT00541229|430353|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
128001|NCT00541229|430354|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
128002|NCT00541229|430355|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
128003|NCT00541229|430356|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
128004|NCT00541229|430351|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
128005|NCT00541229|430352|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
128006|NCT00541229|430353|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
128007|NCT00541229|430354|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
128008|NCT00541229|430355|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
128009|NCT00541229|430356|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
128010|NCT00541229|430351|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
128011|NCT00541229|430352|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
128012|NCT00541229|430353|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
128013|NCT00541229|430354|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
128014|NCT00541229|430355|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
128015|NCT00541229|430356|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
128103|NCT00540423|430736|P1|Open-Label Treatment Period|Lack of Efficacy|0
128016|NCT00541229|430351|P6|Treatment Period I (Week 1)|Physician Decision|0
128017|NCT00541229|430352|P5|Treatment Period I (Week 1)|Physician Decision|0
128018|NCT00541229|430353|P4|Treatment Period I (Week 1)|Physician Decision|0
128019|NCT00541229|430354|P3|Treatment Period I (Week 1)|Physician Decision|1
128020|NCT00541229|430355|P2|Treatment Period I (Week 1)|Physician Decision|0
128021|NCT00541229|430356|P1|Treatment Period I (Week 1)|Physician Decision|0
128022|NCT00541099|430375|P1|Overall Study|Ineligible|3
128023|NCT00540644|430394|P2|Overall Study|Noncomplilance|0
128024|NCT00540644|430395|P1|Overall Study|Noncomplilance|1
128025|NCT00540644|430394|P2|Overall Study|Withdrawal by Subject|2
128026|NCT00540644|430395|P1|Overall Study|Withdrawal by Subject|2
128027|NCT00540644|430394|P2|Overall Study|Physician Decision|5
128028|NCT00540644|430395|P1|Overall Study|Physician Decision|0
128029|NCT00540644|430394|P2|Overall Study|Disease Progression|1
128030|NCT00540644|430395|P1|Overall Study|Disease Progression|3
128031|NCT00540644|430394|P2|Overall Study|Adverse Event|1
128032|NCT00540644|430395|P1|Overall Study|Adverse Event|3
128033|NCT00540592|430415|P10|Overall Study|Withdrawal by Subject|0
128034|NCT00540592|430416|P9|Overall Study|Withdrawal by Subject|0
128035|NCT00540592|430417|P8|Overall Study|Withdrawal by Subject|0
128036|NCT00540592|430418|P7|Overall Study|Withdrawal by Subject|0
128037|NCT00540592|430419|P6|Overall Study|Withdrawal by Subject|0
128038|NCT00540592|430420|P5|Overall Study|Withdrawal by Subject|0
128039|NCT00540592|430421|P4|Overall Study|Withdrawal by Subject|1
128040|NCT00540592|430422|P3|Overall Study|Withdrawal by Subject|1
128041|NCT00540592|430423|P2|Overall Study|Withdrawal by Subject|0
128042|NCT00540592|430424|P1|Overall Study|Withdrawal by Subject|0
128043|NCT00540592|430415|P10|Overall Study|Lost to Follow-up|0
128044|NCT00540592|430416|P9|Overall Study|Lost to Follow-up|0
128045|NCT00540592|430417|P8|Overall Study|Lost to Follow-up|0
128046|NCT00540592|430418|P7|Overall Study|Lost to Follow-up|0
128047|NCT00540592|430419|P6|Overall Study|Lost to Follow-up|0
128048|NCT00540592|430420|P5|Overall Study|Lost to Follow-up|0
128049|NCT00540592|430421|P4|Overall Study|Lost to Follow-up|0
128050|NCT00540592|430422|P3|Overall Study|Lost to Follow-up|0
128051|NCT00540592|430423|P2|Overall Study|Lost to Follow-up|0
128052|NCT00540592|430424|P1|Overall Study|Lost to Follow-up|2
128053|NCT00540592|430415|P10|Overall Study|Adverse Event|2
128054|NCT00540592|430416|P9|Overall Study|Adverse Event|1
128055|NCT00540592|430417|P8|Overall Study|Adverse Event|1
128056|NCT00540592|430418|P7|Overall Study|Adverse Event|0
128057|NCT00540592|430419|P6|Overall Study|Adverse Event|0
128058|NCT00540592|430420|P5|Overall Study|Adverse Event|1
128059|NCT00540592|430421|P4|Overall Study|Adverse Event|0
128060|NCT00540592|430422|P3|Overall Study|Adverse Event|0
128061|NCT00540592|430423|P2|Overall Study|Adverse Event|1
128062|NCT00540592|430424|P1|Overall Study|Adverse Event|0
128063|NCT00540514|430663|P2|Overall Study|Paclitaxel not available|2
128064|NCT00540514|430664|P1|Overall Study|Paclitaxel not available|0
128065|NCT00540514|430663|P2|Overall Study|Excluded prior to treatment|7
128066|NCT00540514|430664|P1|Overall Study|Excluded prior to treatment|7
128067|NCT00540514|430663|P2|Overall Study|Withdrawal by Subject|67
128068|NCT00540514|430664|P1|Overall Study|Withdrawal by Subject|65
128069|NCT00540514|430663|P2|Overall Study|Lost to Follow-up|1
128070|NCT00540514|430664|P1|Overall Study|Lost to Follow-up|1
128071|NCT00540514|430663|P2|Overall Study|Protocol Deviation|4
128072|NCT00540514|430664|P1|Overall Study|Protocol Deviation|3
128073|NCT00540514|430663|P2|Overall Study|Physician Decision|99
128074|NCT00540514|430664|P1|Overall Study|Physician Decision|86
128075|NCT00540514|430663|P2|Overall Study|Adverse Event|24
128076|NCT00540514|430664|P1|Overall Study|Adverse Event|20
128077|NCT00540514|430663|P2|Overall Study|Unacceptable Toxicity|62
128078|NCT00540514|430664|P1|Overall Study|Unacceptable Toxicity|61
128079|NCT00540514|430663|P2|Overall Study|Still on treatment|0
128080|NCT00540514|430664|P1|Overall Study|Still on treatment|3
128081|NCT00540449|430696|P2|Overall Study|Not specified|4
128082|NCT00540449|430697|P1|Overall Study|Not specified|1
128083|NCT00540449|430696|P2|Overall Study|Withdrawal by Subject|10
128084|NCT00540449|430697|P1|Overall Study|Withdrawal by Subject|10
128085|NCT00540449|430696|P2|Overall Study|Subject Reached A Virologic Endpoint|8
128086|NCT00540449|430697|P1|Overall Study|Subject Reached A Virologic Endpoint|32
128087|NCT00540449|430696|P2|Overall Study|Subject Non-Compliant|5
128088|NCT00540449|430697|P1|Overall Study|Subject Non-Compliant|7
128089|NCT00540449|430696|P2|Overall Study|Lost to Follow-up|17
128090|NCT00540449|430697|P1|Overall Study|Lost to Follow-up|19
128091|NCT00540449|430696|P2|Overall Study|Subject Ineligible To Continue The Trial|1
128092|NCT00540449|430697|P1|Overall Study|Subject Ineligible To Continue The Trial|2
128093|NCT00540449|430696|P2|Overall Study|Sponsor's Decision|1
128094|NCT00540449|430697|P1|Overall Study|Sponsor's Decision|1
128095|NCT00540449|430696|P2|Overall Study|Adverse Event|32
128096|NCT00540449|430697|P1|Overall Study|Adverse Event|12
128097|NCT00540436|430719|P1|Second 12-Week Treatment Period|Adverse Event|1
128098|NCT00540436|430719|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
128099|NCT00540436|430719|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
128100|NCT00540436|430719|P1|First 12-Week Treatment Period|Adverse Event|1
128101|NCT00540423|430734|P3|Open-Label Treatment Period|Lack of Efficacy|2
128102|NCT00540423|430735|P2|Open-Label Treatment Period|Lack of Efficacy|0
128104|NCT00540423|430734|P3|Double-Blind Treatment Period|Adverse Event|0
128105|NCT00540423|430735|P2|Double-Blind Treatment Period|Adverse Event|1
128106|NCT00540423|430736|P1|Double-Blind Treatment Period|Adverse Event|0
128107|NCT00538629|430829|P1|Overall Study|Subject's untimely distrust of medicine|1
128108|NCT00538629|430829|P1|Overall Study|Lost to Follow-up|6
128109|NCT00538629|430829|P1|Overall Study|Lack of Efficacy|12
128110|NCT00538629|430829|P1|Overall Study|Adverse Event|2
128111|NCT00538629|430829|P1|Overall Study|At subject's request|1
128112|NCT00538590|430885|P2|Overall Study|Death|0
128113|NCT00538590|430886|P1|Overall Study|Death|1
128114|NCT00540293|430900|P1|Overall Study|Protocol violation, & subject schedule|12
128115|NCT00540293|430900|P1|Overall Study|Withdrawal by Subject|6
128116|NCT00540293|430900|P1|Overall Study|Adverse event not related to study drug|7
128117|NCT00540293|430900|P1|Overall Study|Adverse event related to study drug|10
128118|NCT00540228|430948|P5|Overall Study|Lost to Follow-up|0
128119|NCT00540228|430949|P4|Overall Study|Lost to Follow-up|0
128120|NCT00540228|430950|P3|Overall Study|Lost to Follow-up|0
128121|NCT00540228|430951|P2|Overall Study|Lost to Follow-up|1
128122|NCT00540228|430952|P1|Overall Study|Lost to Follow-up|1
128123|NCT00540228|430948|P5|Overall Study|Adverse Event|0
128124|NCT00540228|430949|P4|Overall Study|Adverse Event|0
128125|NCT00540228|430950|P3|Overall Study|Adverse Event|0
128126|NCT00540228|430951|P2|Overall Study|Adverse Event|0
128127|NCT00540228|430952|P1|Overall Study|Adverse Event|2
128128|NCT00540124|431022|P3|Overall Study|Withdrawal by Subject|0
128129|NCT00540124|431023|P2|Overall Study|Withdrawal by Subject|1
128130|NCT00540124|431024|P1|Overall Study|Withdrawal by Subject|1
128131|NCT00540124|431022|P3|Overall Study|Lack of Efficacy|0
128132|NCT00540124|431023|P2|Overall Study|Lack of Efficacy|0
128133|NCT00540124|431024|P1|Overall Study|Lack of Efficacy|1
128134|NCT00540124|431022|P3|Overall Study|Entry Criteria Not Met|0
128135|NCT00540124|431023|P2|Overall Study|Entry Criteria Not Met|0
128136|NCT00540124|431024|P1|Overall Study|Entry Criteria Not Met|2
128137|NCT00540124|431022|P3|Overall Study|Adverse Event|1
128138|NCT00540124|431023|P2|Overall Study|Adverse Event|2
128139|NCT00540124|431024|P1|Overall Study|Adverse Event|0
128140|NCT00540046|431070|P2|Overall Study|Lost to Follow-up|23
128141|NCT00540046|431071|P1|Overall Study|Lost to Follow-up|33
128142|NCT00539994|431082|P3|Overall Study|Physician Decision|1
128143|NCT00539994|431083|P2|Overall Study|Physician Decision|0
128144|NCT00539994|431084|P1|Overall Study|Physician Decision|0
128145|NCT00539994|431082|P3|Overall Study|Withdrawal by Subject|1
128146|NCT00539994|431083|P2|Overall Study|Withdrawal by Subject|0
128147|NCT00539994|431084|P1|Overall Study|Withdrawal by Subject|1
128148|NCT00539994|431082|P3|Overall Study|Lost to Follow-up|0
128149|NCT00539994|431083|P2|Overall Study|Lost to Follow-up|1
128150|NCT00539994|431084|P1|Overall Study|Lost to Follow-up|2
128151|NCT00539864|431134|P2|Overall Study|Withdrawal by Subject|1
128152|NCT00539864|431135|P1|Overall Study|Withdrawal by Subject|1
128153|NCT00539864|431134|P2|Overall Study|Lost to Follow-up|1
128154|NCT00539864|431135|P1|Overall Study|Lost to Follow-up|0
128155|NCT00536874|431172|P1|Overall Study|Withdrawal by Subject|1
128156|NCT00536874|431172|P1|Overall Study|Death|2
128157|NCT00536874|431172|P1|Overall Study|Adverse Event|1
128158|NCT00539734|431182|P1|Overall Study|Protocol Violation|1
128159|NCT00539591|431199|P3|Overall Study|Disease progression|3
128160|NCT00539591|431200|P2|Overall Study|Disease progression|2
128161|NCT00539591|431201|P1|Overall Study|Disease progression|2
128162|NCT00539591|431199|P3|Overall Study|Toxicity|0
128163|NCT00539591|431200|P2|Overall Study|Toxicity|0
128164|NCT00539591|431201|P1|Overall Study|Toxicity|3
128165|NCT00539513|431353|P2|Overall Study|Lost to Follow-up|1
128166|NCT00539513|431354|P1|Overall Study|Lost to Follow-up|0
128167|NCT00539513|431353|P2|Overall Study|Withdrawal by Subject|1
128168|NCT00539513|431354|P1|Overall Study|Withdrawal by Subject|2
128169|NCT00539305|431368|P2|Overall Study|Withdrawal by Subject|1
128170|NCT00539305|431369|P1|Overall Study|Withdrawal by Subject|0
128171|NCT00539305|431368|P2|Overall Study|Substance Use|1
128172|NCT00539305|431369|P1|Overall Study|Substance Use|0
128173|NCT00539305|431368|P2|Overall Study|Adverse Event|0
128174|NCT00539305|431369|P1|Overall Study|Adverse Event|1
128175|NCT00539279|431383|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
128176|NCT00539279|431384|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
128177|NCT00539279|431383|P2|Post-Treatment Assessment|Lost to Follow-up|9
128178|NCT00539279|431384|P1|Post-Treatment Assessment|Lost to Follow-up|12
128179|NCT00539279|431383|P2|Treatment|Death|0
128180|NCT00539279|431384|P1|Treatment|Death|1
128181|NCT00539279|431383|P2|Treatment|Withdrawal by Subject|8
128182|NCT00539279|431384|P1|Treatment|Withdrawal by Subject|10
128183|NCT00539240|431405|P3|Overall Study|Adverse Event|10
128184|NCT00539240|431406|P2|Overall Study|Adverse Event|1
128185|NCT00539240|431407|P1|Overall Study|Adverse Event|3
128186|NCT00539240|431405|P3|Overall Study|Lost to Follow-up|1
128187|NCT00539240|431406|P2|Overall Study|Lost to Follow-up|3
128188|NCT00539240|431407|P1|Overall Study|Lost to Follow-up|2
128189|NCT00539240|431405|P3|Overall Study|Protocol Violation|4
128190|NCT00539240|431406|P2|Overall Study|Protocol Violation|1
128191|NCT00539240|431407|P1|Overall Study|Protocol Violation|1
128192|NCT00539240|431405|P3|Overall Study|Withdrawal by Subject|0
128193|NCT00539240|431406|P2|Overall Study|Withdrawal by Subject|2
128194|NCT00539240|431407|P1|Overall Study|Withdrawal by Subject|0
128195|NCT00539188|431426|P2|Overall Study|Lost to Follow-up|1
128196|NCT00539188|431427|P1|Overall Study|Lost to Follow-up|2
128197|NCT00539188|431426|P2|Overall Study|Withdrawal by Subject|0
128198|NCT00539188|431427|P1|Overall Study|Withdrawal by Subject|1
128199|NCT00539032|431450|P2|Overall Study|Withdrawal by Subject|1
128200|NCT00539032|431451|P1|Overall Study|Withdrawal by Subject|2
128201|NCT00539006|431465|P4|Treatment Period 2|Other|0
128202|NCT00539006|431466|P3|Treatment Period 2|Other|0
128203|NCT00539006|431467|P2|Treatment Period 2|Other|1
128204|NCT00539006|431468|P1|Treatment Period 2|Other|0
128205|NCT00539006|431465|P4|Treatment Period 2|Protocol Violation|0
128206|NCT00539006|431466|P3|Treatment Period 2|Protocol Violation|0
128207|NCT00539006|431467|P2|Treatment Period 2|Protocol Violation|0
128208|NCT00539006|431468|P1|Treatment Period 2|Protocol Violation|1
128209|NCT00539006|431465|P4|Washout|Other|3
128210|NCT00539006|431466|P3|Washout|Other|2
128211|NCT00539006|431467|P2|Washout|Other|1
128212|NCT00539006|431468|P1|Washout|Other|1
128213|NCT00539006|431465|P4|Washout|Failed to meet continuation criteria|6
128214|NCT00539006|431466|P3|Washout|Failed to meet continuation criteria|14
128215|NCT00539006|431467|P2|Washout|Failed to meet continuation criteria|5
128216|NCT00539006|431468|P1|Washout|Failed to meet continuation criteria|16
128217|NCT00539006|431465|P4|Washout|Withdrawal by Subject|0
128218|NCT00539006|431466|P3|Washout|Withdrawal by Subject|0
128219|NCT00539006|431467|P2|Washout|Withdrawal by Subject|2
128220|NCT00539006|431468|P1|Washout|Withdrawal by Subject|0
128221|NCT00539006|431465|P4|Washout|Protocol Violation|0
128222|NCT00539006|431466|P3|Washout|Protocol Violation|0
128223|NCT00539006|431467|P2|Washout|Protocol Violation|1
128224|NCT00539006|431468|P1|Washout|Protocol Violation|1
128225|NCT00539006|431465|P4|Washout|Adverse Event|0
128226|NCT00539006|431466|P3|Washout|Adverse Event|0
128227|NCT00539006|431467|P2|Washout|Adverse Event|1
128228|NCT00539006|431468|P1|Washout|Adverse Event|2
128229|NCT00539006|431465|P4|Treatment Period 1|Lack of Efficacy|1
128230|NCT00539006|431466|P3|Treatment Period 1|Lack of Efficacy|0
128231|NCT00539006|431467|P2|Treatment Period 1|Lack of Efficacy|0
128232|NCT00539006|431468|P1|Treatment Period 1|Lack of Efficacy|0
128233|NCT00539006|431465|P4|Treatment Period 1|Protocol Violation|0
128234|NCT00539006|431466|P3|Treatment Period 1|Protocol Violation|1
128235|NCT00539006|431467|P2|Treatment Period 1|Protocol Violation|0
128236|NCT00539006|431468|P1|Treatment Period 1|Protocol Violation|0
128237|NCT00539006|431465|P4|Treatment Period 1|Lost to Follow-up|0
128238|NCT00539006|431466|P3|Treatment Period 1|Lost to Follow-up|1
128239|NCT00539006|431467|P2|Treatment Period 1|Lost to Follow-up|0
128240|NCT00539006|431468|P1|Treatment Period 1|Lost to Follow-up|0
128241|NCT00539006|431465|P4|Pre-treatment|Other|0
128242|NCT00539006|431466|P3|Pre-treatment|Other|0
128243|NCT00539006|431467|P2|Pre-treatment|Other|1
128244|NCT00539006|431468|P1|Pre-treatment|Other|0
128245|NCT00538902|431505|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
128246|NCT00538902|431506|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
128247|NCT00538902|431507|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
128248|NCT00538902|431505|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
128249|NCT00538902|431506|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
128250|NCT00538902|431507|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
128251|NCT00538902|431505|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
128252|NCT00538902|431506|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
128253|NCT00538902|431507|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
128254|NCT00538902|431505|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
128255|NCT00538902|431506|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
128256|NCT00538902|431507|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
128257|NCT00538902|431505|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
128258|NCT00538902|431506|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
128259|NCT00538902|431507|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
128260|NCT00538902|431505|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
128261|NCT00538902|431506|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
128262|NCT00538902|431507|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
128263|NCT00538902|431505|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
128264|NCT00538902|431506|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
128265|NCT00538902|431507|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
128266|NCT00538902|431505|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
128267|NCT00538902|431506|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
128268|NCT00538902|431507|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
128269|NCT00538785|431564|P2|Overall Study|Lost to Follow-up|0
128270|NCT00538785|431565|P1|Overall Study|Lost to Follow-up|1
128271|NCT00538785|431564|P2|Overall Study|Withdrawal of consent|7
128272|NCT00538785|431565|P1|Overall Study|Withdrawal of consent|9
128273|NCT00538785|431564|P2|Overall Study|Death|10
128274|NCT00538785|431565|P1|Overall Study|Death|9
128275|NCT00538473|431601|P2|Overall Study|Adverse Event|0
128276|NCT00538473|431602|P1|Overall Study|Adverse Event|1
128277|NCT00536809|431663|P1|Phase II|Referred for surgical resection|1
128278|NCT00536809|431663|P1|Phase II|Adverse Event|1
128279|NCT00536744|431686|P2|Overall Study|PI tried alternative treatment|3
128280|NCT00536744|431687|P1|Overall Study|PI tried alternative treatment|1
128281|NCT00536744|431686|P2|Overall Study|Withdrawal by Subject|8
128282|NCT00536744|431687|P1|Overall Study|Withdrawal by Subject|7
128283|NCT00536744|431686|P2|Overall Study|Lost to Follow-up|5
128284|NCT00536744|431687|P1|Overall Study|Lost to Follow-up|3
128285|NCT00536744|431686|P2|Overall Study|Physician Decision|1
128286|NCT00536744|431687|P1|Overall Study|Physician Decision|3
128287|NCT00536744|431686|P2|Overall Study|Death|1
128288|NCT00536744|431687|P1|Overall Study|Death|2
128289|NCT00536744|431686|P2|Overall Study|Adverse Event|10
128290|NCT00536744|431687|P1|Overall Study|Adverse Event|13
128291|NCT00536731|431696|P3|Overall Study|Other|0
128292|NCT00536731|431697|P2|Overall Study|Other|1
128293|NCT00536731|431698|P1|Overall Study|Other|1
128294|NCT00536731|431696|P3|Overall Study|Safety reasons|1
128295|NCT00536731|431697|P2|Overall Study|Safety reasons|0
128296|NCT00536731|431698|P1|Overall Study|Safety reasons|0
128297|NCT00536731|431696|P3|Overall Study|Intake of prohibited conc. medication|1
128298|NCT00536731|431697|P2|Overall Study|Intake of prohibited conc. medication|0
128299|NCT00536731|431698|P1|Overall Study|Intake of prohibited conc. medication|0
128300|NCT00536731|431696|P3|Overall Study|Withdrawal by Subject|0
128301|NCT00536731|431697|P2|Overall Study|Withdrawal by Subject|2
128302|NCT00536731|431698|P1|Overall Study|Withdrawal by Subject|0
128303|NCT00536731|431696|P3|Overall Study|Adverse Event|3
128304|NCT00536731|431697|P2|Overall Study|Adverse Event|2
128305|NCT00536731|431698|P1|Overall Study|Adverse Event|3
128306|NCT00538291|431761|P1|Overall Study|Withdrawal by Subject|1
128307|NCT00538291|431761|P1|Overall Study|Adverse Event|2
128308|NCT00537979|431819|P2|Overall Study|Heart failure|1
128309|NCT00537979|431820|P1|Overall Study|Heart failure|0
128310|NCT00537979|431819|P2|Overall Study|Kidney transplant|3
128311|NCT00537979|431820|P1|Overall Study|Kidney transplant|0
128312|NCT00537979|431819|P2|Overall Study|Death|3
128313|NCT00537979|431820|P1|Overall Study|Death|0
128314|NCT00537979|431819|P2|Overall Study|Non-compliance with treatment/procedure|2
128315|NCT00537979|431820|P1|Overall Study|Non-compliance with treatment/procedure|2
128316|NCT00537979|431819|P2|Overall Study|Lack of Efficacy|1
128317|NCT00537979|431820|P1|Overall Study|Lack of Efficacy|0
128318|NCT00537979|431819|P2|Overall Study|Lost to Follow-up|4
128319|NCT00537979|431820|P1|Overall Study|Lost to Follow-up|1
128320|NCT00537979|431819|P2|Overall Study|Withdrawal by Subject|4
128321|NCT00537979|431820|P1|Overall Study|Withdrawal by Subject|1
128322|NCT00537979|431819|P2|Overall Study|Adverse Event|2
128323|NCT00537979|431820|P1|Overall Study|Adverse Event|2
128324|NCT00537940|431836|P2|Overall Study|Unspecified|12
128325|NCT00537940|431837|P1|Overall Study|Unspecified|10
128326|NCT00537940|431836|P2|Overall Study|Study terminated by sponsor|3
128327|NCT00537940|431837|P1|Overall Study|Study terminated by sponsor|2
128328|NCT00537940|431836|P2|Overall Study|Pregnancy|1
128329|NCT00537940|431837|P1|Overall Study|Pregnancy|1
128330|NCT00537940|431836|P2|Overall Study|Protocol Violation|4
128331|NCT00537940|431837|P1|Overall Study|Protocol Violation|6
128332|NCT00537940|431836|P2|Overall Study|Withdrawal by Subject|95
128333|NCT00537940|431837|P1|Overall Study|Withdrawal by Subject|113
128334|NCT00537940|431836|P2|Overall Study|Lost to Follow-up|29
128335|NCT00537940|431837|P1|Overall Study|Lost to Follow-up|23
128336|NCT00537940|431836|P2|Overall Study|Lack of Efficacy|16
128337|NCT00537940|431837|P1|Overall Study|Lack of Efficacy|8
128338|NCT00537940|431836|P2|Overall Study|Adverse Event|19
128339|NCT00537940|431837|P1|Overall Study|Adverse Event|20
128340|NCT00536575|431859|P1|Overall Study|Death|1
128341|NCT00536575|431859|P1|Overall Study|Withdrawal by Subject|1
128342|NCT00536510|431865|P2|Overall Study|Patient Discontinued for Other Reasons|2
128343|NCT00536510|431866|P1|Overall Study|Patient Discontinued for Other Reasons|2
128344|NCT00536510|431865|P2|Overall Study|Laboratory Adverse Event|1
128345|NCT00536510|431866|P1|Overall Study|Laboratory Adverse Event|2
128346|NCT00536510|431865|P2|Overall Study|Flushing with Product|0
128347|NCT00536510|431866|P1|Overall Study|Flushing with Product|20
128348|NCT00536510|431865|P2|Overall Study|Withdrawal by Subject|9
128349|NCT00536510|431866|P1|Overall Study|Withdrawal by Subject|16
128350|NCT00536510|431865|P2|Overall Study|Protocol Violation|5
128351|NCT00536510|431866|P1|Overall Study|Protocol Violation|4
128352|NCT00536510|431865|P2|Overall Study|Lost to Follow-up|8
128353|NCT00536510|431866|P1|Overall Study|Lost to Follow-up|11
128354|NCT00536510|431865|P2|Overall Study|Adverse Event|4
128355|NCT00536510|431866|P1|Overall Study|Adverse Event|27
128356|NCT00536484|431876|P2|Overall Study|Other|0
128357|NCT00536484|431877|P1|Overall Study|Other|4
128358|NCT00536484|431876|P2|Overall Study|Lack of Efficacy|5
128359|NCT00536484|431877|P1|Overall Study|Lack of Efficacy|16
128360|NCT00536484|431876|P2|Overall Study|Lost to Follow-up|6
128361|NCT00536484|431877|P1|Overall Study|Lost to Follow-up|8
128362|NCT00536484|431876|P2|Overall Study|Withdrawal by Subject|11
128363|NCT00536484|431877|P1|Overall Study|Withdrawal by Subject|11
128364|NCT00536484|431876|P2|Overall Study|Adverse Event|34
128365|NCT00536484|431877|P1|Overall Study|Adverse Event|21
128366|NCT00536471|431911|P4|Overall Study|Sponsor Decision|2
128367|NCT00536471|431912|P3|Overall Study|Sponsor Decision|3
128368|NCT00536471|431913|P2|Overall Study|Sponsor Decision|1
128369|NCT00536471|431914|P1|Overall Study|Sponsor Decision|0
128370|NCT00536471|431911|P4|Overall Study|Death|2
128371|NCT00536471|431912|P3|Overall Study|Death|1
128372|NCT00536471|431913|P2|Overall Study|Death|0
128373|NCT00536471|431914|P1|Overall Study|Death|0
128374|NCT00536471|431911|P4|Overall Study|Physician Decision|2
128375|NCT00536471|431912|P3|Overall Study|Physician Decision|3
128376|NCT00536471|431913|P2|Overall Study|Physician Decision|1
128377|NCT00536471|431914|P1|Overall Study|Physician Decision|11
128378|NCT00536471|431911|P4|Overall Study|Protocol Violation|3
128379|NCT00536471|431912|P3|Overall Study|Protocol Violation|2
128380|NCT00536471|431913|P2|Overall Study|Protocol Violation|1
128381|NCT00536471|431914|P1|Overall Study|Protocol Violation|8
128382|NCT00536471|431911|P4|Overall Study|Lack of Efficacy|9
128383|NCT00536471|431912|P3|Overall Study|Lack of Efficacy|11
128384|NCT00536471|431913|P2|Overall Study|Lack of Efficacy|18
128385|NCT00536471|431914|P1|Overall Study|Lack of Efficacy|17
128386|NCT00536471|431911|P4|Overall Study|Withdrawal by Subject|21
128387|NCT00536471|431912|P3|Overall Study|Withdrawal by Subject|43
128388|NCT00536471|431913|P2|Overall Study|Withdrawal by Subject|24
128389|NCT00536471|431914|P1|Overall Study|Withdrawal by Subject|40
128390|NCT00536471|431911|P4|Overall Study|Adverse Event|13
128391|NCT00536471|431912|P3|Overall Study|Adverse Event|28
128392|NCT00536471|431913|P2|Overall Study|Adverse Event|16
128393|NCT00536471|431914|P1|Overall Study|Adverse Event|32
128394|NCT00536471|431911|P4|Overall Study|Lost to Follow-up|22
128395|NCT00536471|431912|P3|Overall Study|Lost to Follow-up|48
128396|NCT00536471|431913|P2|Overall Study|Lost to Follow-up|23
128397|NCT00536471|431914|P1|Overall Study|Lost to Follow-up|48
128398|NCT00536380|432159|P3|Overall Study|Administrative|1
128399|NCT00536380|432160|P2|Overall Study|Administrative|0
128400|NCT00536380|432161|P1|Overall Study|Administrative|0
128401|NCT00536380|432159|P3|Overall Study|Did not meet protocol eligibility|1
128402|NCT00536380|432160|P2|Overall Study|Did not meet protocol eligibility|0
128403|NCT00536380|432161|P1|Overall Study|Did not meet protocol eligibility|0
128404|NCT00536380|432159|P3|Overall Study|Noncompliance with protocol|2
128405|NCT00536380|432160|P2|Overall Study|Noncompliance with protocol|2
128406|NCT00536380|432161|P1|Overall Study|Noncompliance with protocol|3
128407|NCT00536380|432159|P3|Overall Study|Withdrawal related to study drug|2
128408|NCT00536380|432160|P2|Overall Study|Withdrawal related to study drug|5
128409|NCT00536380|432161|P1|Overall Study|Withdrawal related to study drug|7
128410|NCT00536380|432159|P3|Overall Study|Withdrawal unrelated to study drug|1
128411|NCT00536380|432160|P2|Overall Study|Withdrawal unrelated to study drug|0
128412|NCT00536380|432161|P1|Overall Study|Withdrawal unrelated to study drug|2
128413|NCT00536380|432159|P3|Overall Study|Lost to Follow-up|1
128414|NCT00536380|432160|P2|Overall Study|Lost to Follow-up|0
128415|NCT00536380|432161|P1|Overall Study|Lost to Follow-up|0
128416|NCT00536380|432159|P3|Overall Study|Adverse Event|2
128417|NCT00536380|432160|P2|Overall Study|Adverse Event|2
128418|NCT00536380|432161|P1|Overall Study|Adverse Event|0
128419|NCT00537823|432171|P2|Overall Study|Adverse Event|0
128420|NCT00537823|432172|P1|Overall Study|Adverse Event|2
128421|NCT00537810|432198|P4|Overall Study|Medically withdrawn|1
128422|NCT00537810|432199|P3|Overall Study|Medically withdrawn|0
128423|NCT00537810|432200|P2|Overall Study|Medically withdrawn|2
128424|NCT00537810|432201|P1|Overall Study|Medically withdrawn|2
128425|NCT00537810|432198|P4|Overall Study|Withdrawal by Subject|3
128426|NCT00537810|432199|P3|Overall Study|Withdrawal by Subject|4
128427|NCT00537810|432200|P2|Overall Study|Withdrawal by Subject|11
128428|NCT00537810|432201|P1|Overall Study|Withdrawal by Subject|4
128429|NCT00537771|432217|P2|Overall Study|Severe Non-Compliance to Protocol|2
128430|NCT00537771|432218|P1|Overall Study|Severe Non-Compliance to Protocol|4
128431|NCT00537771|432217|P2|Overall Study|Protocol Violation|6
128432|NCT00537771|432218|P1|Overall Study|Protocol Violation|2
128433|NCT00537771|432217|P2|Overall Study|Lost to Follow-up|15
128434|NCT00537771|432218|P1|Overall Study|Lost to Follow-up|9
128435|NCT00537771|432217|P2|Overall Study|Adverse Event|15
128436|NCT00537771|432218|P1|Overall Study|Adverse Event|8
128437|NCT00537771|432217|P2|Overall Study|Withdrawal by Subject|23
128438|NCT00537771|432218|P1|Overall Study|Withdrawal by Subject|6
128439|NCT00537745|432228|P1|Overall Study|Subject unable to provide Interlock info|1
128440|NCT00537745|432228|P1|Overall Study|Withdrawal by Subject|2
128441|NCT00537745|432228|P1|Overall Study|Did not meet eligibility criteria|2
128442|NCT00537485|432273|P2|Overall Study|Physician Decision|0
128443|NCT00537485|432274|P1|Overall Study|Physician Decision|1
128444|NCT00537485|432273|P2|Overall Study|Withdrawal by Subject|3
128445|NCT00537485|432274|P1|Overall Study|Withdrawal by Subject|1
128446|NCT00537485|432273|P2|Overall Study|Withdrawal by Subject|2
128447|NCT00537485|432274|P1|Overall Study|Withdrawal by Subject|3
128448|NCT00537485|432273|P2|Overall Study|Adverse Event|5
128449|NCT00537485|432274|P1|Overall Study|Adverse Event|10
128450|NCT00537394|432347|P3|2nd Year of Follow-up|Clinic site closure|0
128451|NCT00537394|432348|P2|2nd Year of Follow-up|Clinic site closure|0
128452|NCT00537394|432349|P1|2nd Year of Follow-up|Clinic site closure|1
128453|NCT00537394|432347|P3|2nd Year of Follow-up|Lost to Follow-up|2
128454|NCT00537394|432348|P2|2nd Year of Follow-up|Lost to Follow-up|7
128455|NCT00537394|432349|P1|2nd Year of Follow-up|Lost to Follow-up|6
128456|NCT00537394|432347|P3|2nd Year of Follow-up|Withdrawal by Subject|2
128457|NCT00537394|432348|P2|2nd Year of Follow-up|Withdrawal by Subject|1
128458|NCT00537394|432349|P1|2nd Year of Follow-up|Withdrawal by Subject|0
128459|NCT00537394|432347|P3|2nd Year of Follow-up|Death|2
128460|NCT00537394|432348|P2|2nd Year of Follow-up|Death|1
128461|NCT00537394|432349|P1|2nd Year of Follow-up|Death|4
128462|NCT00537394|432347|P3|First Year of Follow-up|Lost to Follow-up|1
128463|NCT00537394|432348|P2|First Year of Follow-up|Lost to Follow-up|5
128464|NCT00537394|432349|P1|First Year of Follow-up|Lost to Follow-up|1
128465|NCT00537394|432347|P3|First Year of Follow-up|Withdrawal by Subject|1
128466|NCT00537394|432348|P2|First Year of Follow-up|Withdrawal by Subject|6
128467|NCT00537394|432349|P1|First Year of Follow-up|Withdrawal by Subject|3
128468|NCT00537394|432347|P3|First Year of Follow-up|Severe debilitation|1
128469|NCT00537394|432348|P2|First Year of Follow-up|Severe debilitation|0
128470|NCT00537394|432349|P1|First Year of Follow-up|Severe debilitation|1
128471|NCT00537394|432347|P3|First Year of Follow-up|Death|0
128472|NCT00537394|432348|P2|First Year of Follow-up|Death|0
128473|NCT00537394|432349|P1|First Year of Follow-up|Death|7
128474|NCT00537381|432385|P2|Overall Study|Unspecified|3
128475|NCT00537381|432386|P1|Overall Study|Unspecified|5
128476|NCT00537381|432385|P2|Overall Study|Sponsor decision|9
128477|NCT00537381|432386|P1|Overall Study|Sponsor decision|14
128478|NCT00537381|432385|P2|Overall Study|Disease Progression|18
128479|NCT00537381|432386|P1|Overall Study|Disease Progression|9
128480|NCT00537381|432385|P2|Overall Study|Physician Decision|6
128481|NCT00537381|432386|P1|Overall Study|Physician Decision|7
128482|NCT00537381|432385|P2|Overall Study|Withdrawal by Subject|14
128483|NCT00537381|432386|P1|Overall Study|Withdrawal by Subject|5
128484|NCT00537381|432385|P2|Overall Study|Death|3
128485|NCT00537381|432386|P1|Overall Study|Death|3
128486|NCT00537381|432385|P2|Overall Study|Adverse Event|9
128487|NCT00537381|432386|P1|Overall Study|Adverse Event|13
128488|NCT00537329|432406|P1|Overall Study|Unspecified|1
128489|NCT00537329|432406|P1|Overall Study|Withdrawal by Subject|4
128490|NCT00537329|432406|P1|Overall Study|Lost to Follow-up|6
128491|NCT00537329|432406|P1|Overall Study|Lack of Efficacy|2
128492|NCT00537329|432406|P1|Overall Study|Adverse Event|3
128493|NCT00537329|432406|P1|Overall Study|Death|10
128494|NCT00537316|432426|P7|Part 2|Administrative|1
128495|NCT00537316|432427|P6|Part 2|Administrative|4
128496|NCT00537316|432428|P5|Part 2|Administrative|1
128497|NCT00537316|432429|P4|Part 2|Administrative|3
128498|NCT00537316|432430|P3|Part 2|Administrative|24
128499|NCT00537316|432431|P2|Part 2|Administrative|8
128500|NCT00537316|432432|P1|Part 2|Administrative|16
128501|NCT00537316|432426|P7|Part 2|Withdrawal by Subject|0
128502|NCT00537316|432427|P6|Part 2|Withdrawal by Subject|0
128503|NCT00537316|432428|P5|Part 2|Withdrawal by Subject|0
128504|NCT00537316|432429|P4|Part 2|Withdrawal by Subject|0
128505|NCT00537316|432430|P3|Part 2|Withdrawal by Subject|4
128506|NCT00537316|432431|P2|Part 2|Withdrawal by Subject|1
128507|NCT00537316|432432|P1|Part 2|Withdrawal by Subject|5
128508|NCT00537316|432426|P7|Part 2|Lost to Follow-up|0
128509|NCT00537316|432427|P6|Part 2|Lost to Follow-up|0
128510|NCT00537316|432428|P5|Part 2|Lost to Follow-up|0
128511|NCT00537316|432429|P4|Part 2|Lost to Follow-up|0
128512|NCT00537316|432430|P3|Part 2|Lost to Follow-up|2
128513|NCT00537316|432431|P2|Part 2|Lost to Follow-up|0
128514|NCT00537316|432432|P1|Part 2|Lost to Follow-up|1
128515|NCT00537316|432426|P7|Part 2|Adverse Event|0
128516|NCT00537316|432427|P6|Part 2|Adverse Event|0
128517|NCT00537316|432428|P5|Part 2|Adverse Event|0
128518|NCT00537316|432429|P4|Part 2|Adverse Event|0
128519|NCT00537316|432430|P3|Part 2|Adverse Event|2
128520|NCT00537316|432431|P2|Part 2|Adverse Event|0
128521|NCT00537316|432432|P1|Part 2|Adverse Event|4
128522|NCT00537316|432426|P7|Part 2|Never entered follow-up|1
128523|NCT00537316|432427|P6|Part 2|Never entered follow-up|0
128524|NCT00537316|432428|P5|Part 2|Never entered follow-up|0
128525|NCT00537316|432429|P4|Part 2|Never entered follow-up|0
128526|NCT00537316|432430|P3|Part 2|Never entered follow-up|0
128527|NCT00537316|432431|P2|Part 2|Never entered follow-up|0
128528|NCT00537316|432432|P1|Part 2|Never entered follow-up|0
128529|NCT00537316|432426|P7|Part 1|Administrative|0
128530|NCT00537316|432427|P6|Part 1|Administrative|0
128531|NCT00537316|432428|P5|Part 1|Administrative|0
128532|NCT00537316|432429|P4|Part 1|Administrative|0
128533|NCT00537316|432430|P3|Part 1|Administrative|2
128534|NCT00537316|432431|P2|Part 1|Administrative|0
128535|NCT00537316|432432|P1|Part 1|Administrative|0
128536|NCT00537316|432426|P7|Part 1|Did not meet protocol eligibility|0
128537|NCT00537316|432427|P6|Part 1|Did not meet protocol eligibility|0
128538|NCT00537316|432428|P5|Part 1|Did not meet protocol eligibility|0
128539|NCT00537316|432429|P4|Part 1|Did not meet protocol eligibility|0
128540|NCT00537316|432430|P3|Part 1|Did not meet protocol eligibility|2
128541|NCT00537316|432431|P2|Part 1|Did not meet protocol eligibility|3
128542|NCT00537316|432432|P1|Part 1|Did not meet protocol eligibility|1
128543|NCT00537316|432426|P7|Part 1|Protocol Violation|0
128544|NCT00537316|432427|P6|Part 1|Protocol Violation|0
128545|NCT00537316|432428|P5|Part 1|Protocol Violation|0
128546|NCT00537316|432429|P4|Part 1|Protocol Violation|0
128547|NCT00537316|432430|P3|Part 1|Protocol Violation|1
128548|NCT00537316|432431|P2|Part 1|Protocol Violation|5
128549|NCT00537316|432432|P1|Part 1|Protocol Violation|1
128550|NCT00537316|432426|P7|Part 1|Withdrawal by Subject|0
128551|NCT00537316|432427|P6|Part 1|Withdrawal by Subject|0
128552|NCT00537316|432428|P5|Part 1|Withdrawal by Subject|0
128553|NCT00537316|432429|P4|Part 1|Withdrawal by Subject|0
128554|NCT00537316|432430|P3|Part 1|Withdrawal by Subject|4
128555|NCT00537316|432431|P2|Part 1|Withdrawal by Subject|8
128556|NCT00537316|432432|P1|Part 1|Withdrawal by Subject|3
128557|NCT00537316|432426|P7|Part 1|Lost to Follow-up|0
128558|NCT00537316|432427|P6|Part 1|Lost to Follow-up|0
128559|NCT00537316|432428|P5|Part 1|Lost to Follow-up|0
128560|NCT00537316|432429|P4|Part 1|Lost to Follow-up|0
128561|NCT00537316|432430|P3|Part 1|Lost to Follow-up|0
128562|NCT00537316|432431|P2|Part 1|Lost to Follow-up|0
128563|NCT00537316|432432|P1|Part 1|Lost to Follow-up|1
128564|NCT00537316|432426|P7|Part 1|Protocol defined clinical event|0
128565|NCT00537316|432427|P6|Part 1|Protocol defined clinical event|0
128566|NCT00537316|432428|P5|Part 1|Protocol defined clinical event|0
128567|NCT00537316|432429|P4|Part 1|Protocol defined clinical event|0
128568|NCT00537316|432430|P3|Part 1|Protocol defined clinical event|0
128569|NCT00537316|432431|P2|Part 1|Protocol defined clinical event|0
128570|NCT00537316|432432|P1|Part 1|Protocol defined clinical event|1
128571|NCT00537316|432426|P7|Part 1|Adverse Event|0
128572|NCT00537316|432427|P6|Part 1|Adverse Event|0
128573|NCT00537316|432428|P5|Part 1|Adverse Event|0
128574|NCT00537316|432429|P4|Part 1|Adverse Event|0
128575|NCT00537316|432430|P3|Part 1|Adverse Event|8
128576|NCT00537316|432431|P2|Part 1|Adverse Event|11
128577|NCT00537316|432432|P1|Part 1|Adverse Event|7
128578|NCT00537303|432459|P2|Overall Study|Unclassified|7
128579|NCT00537303|432460|P1|Overall Study|Unclassified|8
128580|NCT00537303|432459|P2|Overall Study|Withdrawal criteria|3
128581|NCT00537303|432460|P1|Overall Study|Withdrawal criteria|3
128582|NCT00537303|432459|P2|Overall Study|Protocol Violation|4
128583|NCT00537303|432460|P1|Overall Study|Protocol Violation|8
128584|NCT00537303|432459|P2|Overall Study|Lack of Efficacy|7
128585|NCT00537303|432460|P1|Overall Study|Lack of Efficacy|6
128586|NCT00537303|432459|P2|Overall Study|Adverse Event|4
128587|NCT00537303|432460|P1|Overall Study|Adverse Event|1
128588|NCT00537277|432476|P1|Overall Study|Non-compliance with trial procedures|15
128589|NCT00537277|432476|P1|Overall Study|Inability to tolerate trial medication|4
128590|NCT00537277|432476|P1|Overall Study|Unclassified|4
128591|NCT00537277|432476|P1|Overall Study|Protocol Violation|11
128592|NCT00537277|432476|P1|Overall Study|Lost to Follow-up|12
128593|NCT00537277|432476|P1|Overall Study|Lack of Efficacy|2
128594|NCT00537277|432476|P1|Overall Study|Adverse Event|1
128595|NCT00537238|432487|P2|Overall Study|Unspecified|52
128596|NCT00537238|432488|P1|Overall Study|Unspecified|44
128597|NCT00537238|432487|P2|Overall Study|Does not meet entrance criteria|2
128598|NCT00537238|432488|P1|Overall Study|Does not meet entrance criteria|0
128599|NCT00537238|432487|P2|Overall Study|Protocol Violation|19
128600|NCT00537238|432488|P1|Overall Study|Protocol Violation|15
128601|NCT00537238|432487|P2|Overall Study|Withdrawal by Subject|47
128602|NCT00537238|432488|P1|Overall Study|Withdrawal by Subject|51
128603|NCT00537238|432487|P2|Overall Study|Lost to Follow-up|8
128604|NCT00537238|432488|P1|Overall Study|Lost to Follow-up|12
128605|NCT00537238|432487|P2|Overall Study|Lack of Efficacy|21
128606|NCT00537238|432488|P1|Overall Study|Lack of Efficacy|20
128607|NCT00537238|432487|P2|Overall Study|Adverse Event|22
128608|NCT00537238|432488|P1|Overall Study|Adverse Event|31
128609|NCT00537238|432487|P2|Overall Study|Death|2
128610|NCT00537238|432488|P1|Overall Study|Death|1
128611|NCT00537199|432508|P1|Overall Study|Study Terminated|1
128612|NCT00537095|432514|P2|Overall Study|Incorrect enrolment|1
128613|NCT00537095|432515|P1|Overall Study|Incorrect enrolment|0
128614|NCT00537095|432514|P2|Overall Study|subjective disease progression|1
128615|NCT00537095|432515|P1|Overall Study|subjective disease progression|0
128616|NCT00537095|432514|P2|Overall Study|Withdrawal by Subject|2
128617|NCT00537095|432515|P1|Overall Study|Withdrawal by Subject|2
128618|NCT00537095|432514|P2|Overall Study|Death|1
128619|NCT00537095|432515|P1|Overall Study|Death|3
128620|NCT00537095|432514|P2|Overall Study|disease progression|48
128621|NCT00537095|432515|P1|Overall Study|disease progression|21
128622|NCT00537095|432514|P2|Overall Study|Adverse Event|4
128623|NCT00537095|432515|P1|Overall Study|Adverse Event|24
128624|NCT00537095|432514|P2|Overall Study|surgery|0
128625|NCT00537095|432515|P1|Overall Study|surgery|1
128626|NCT00537082|432530|P3|Overall Study|Discontinued before initiating treatment|0
128627|NCT00537082|432531|P2|Overall Study|Discontinued before initiating treatment|0
128628|NCT00537082|432532|P1|Overall Study|Discontinued before initiating treatment|3
128629|NCT00537082|432530|P3|Overall Study|Withdrawal by Subject|0
128630|NCT00537082|432531|P2|Overall Study|Withdrawal by Subject|1
128631|NCT00537082|432532|P1|Overall Study|Withdrawal by Subject|0
128632|NCT00537082|432530|P3|Overall Study|Lack of Efficacy|2
128633|NCT00537082|432531|P2|Overall Study|Lack of Efficacy|0
128634|NCT00537082|432532|P1|Overall Study|Lack of Efficacy|0
128635|NCT00537082|432530|P3|Overall Study|Protocol Violation|1
128636|NCT00537082|432531|P2|Overall Study|Protocol Violation|2
128637|NCT00537082|432532|P1|Overall Study|Protocol Violation|0
128638|NCT00537082|432530|P3|Overall Study|Adverse Event|3
128639|NCT00537082|432531|P2|Overall Study|Adverse Event|6
128640|NCT00537082|432532|P1|Overall Study|Adverse Event|6
128641|NCT00537030|432549|P1|Overall Study|Inevaluable|3
128642|NCT00537030|432549|P1|Overall Study|Confirm patient ineligibility|1
128643|NCT00537030|432549|P1|Overall Study|Disease progression or relapse during ac|1
128644|NCT00537030|432549|P1|Overall Study|Greater then or equal to a Grade 2 aller|7
128645|NCT00537030|432549|P1|Overall Study|Withdrawal by Subject|2
128646|NCT00537030|432549|P1|Overall Study|Physician Decision|2
128647|NCT00537017|432553|P1|Follow-up Phase|Withdrawal by Subject|9
128648|NCT00537017|432553|P1|Treatment Phase|Protocol Violation|2
128649|NCT00537017|432553|P1|Treatment Phase|Withdrawal by Subject|13
128650|NCT00537017|432553|P1|Treatment Phase|Adverse Event|19
128651|NCT00536978|432564|P1|Overall Study|Not eligible for Adback Infusion|22
128652|NCT00536263|432584|P3|Overall Study|Did not meet protocol eligibility|2
128653|NCT00536263|432585|P2|Overall Study|Did not meet protocol eligibility|2
128654|NCT00536263|432586|P1|Overall Study|Did not meet protocol eligibility|1
128655|NCT00536263|432584|P3|Overall Study|Noncompliance with protocol|1
128656|NCT00536263|432585|P2|Overall Study|Noncompliance with protocol|0
128657|NCT00536263|432586|P1|Overall Study|Noncompliance with protocol|0
128658|NCT00536263|432584|P3|Overall Study|Subject withdrew - treatment related|2
128659|NCT00536263|432585|P2|Overall Study|Subject withdrew - treatment related|3
128660|NCT00536263|432586|P1|Overall Study|Subject withdrew - treatment related|0
128661|NCT00536263|432584|P3|Overall Study|Subject withdrew - not treatment related|5
128662|NCT00536263|432585|P2|Overall Study|Subject withdrew - not treatment related|0
128663|NCT00536263|432586|P1|Overall Study|Subject withdrew - not treatment related|2
128664|NCT00536263|432584|P3|Overall Study|Lost to Follow-up|4
128665|NCT00536263|432585|P2|Overall Study|Lost to Follow-up|4
128666|NCT00536263|432586|P1|Overall Study|Lost to Follow-up|3
128667|NCT00536263|432584|P3|Overall Study|Adverse Event|7
128668|NCT00536263|432585|P2|Overall Study|Adverse Event|5
128669|NCT00536263|432586|P1|Overall Study|Adverse Event|5
128670|NCT00536198|432626|P2|Overall Study|Protocol Violation|1
128671|NCT00536198|432627|P1|Overall Study|Protocol Violation|0
128672|NCT00536198|432626|P2|Overall Study|Pregnancy|1
128673|NCT00536198|432627|P1|Overall Study|Pregnancy|1
128674|NCT00536198|432626|P2|Overall Study|Rescue|9
128675|NCT00536198|432627|P1|Overall Study|Rescue|3
128676|NCT00536198|432626|P2|Overall Study|Adverse Event|2
128677|NCT00536198|432627|P1|Overall Study|Adverse Event|2
128678|NCT00536198|432626|P2|Overall Study|Withdrawal by Subject|12
128679|NCT00536198|432627|P1|Overall Study|Withdrawal by Subject|16
128680|NCT00536198|432626|P2|Overall Study|Lost to Follow-up|14
128681|NCT00536198|432627|P1|Overall Study|Lost to Follow-up|15
128682|NCT00536120|432666|P2|Overall Study|Missed Study Visit|1
128683|NCT00536120|432667|P1|Overall Study|Missed Study Visit|0
128684|NCT00536120|432666|P2|Overall Study|Steroid Use|2
128685|NCT00536120|432667|P1|Overall Study|Steroid Use|0
128686|NCT00536120|432666|P2|Overall Study|Sponsor Decision Due to Lab Values|0
128687|NCT00536120|432667|P1|Overall Study|Sponsor Decision Due to Lab Values|1
128688|NCT00536120|432666|P2|Overall Study|Non-compliance|0
128689|NCT00536120|432667|P1|Overall Study|Non-compliance|1
128690|NCT00536120|432666|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
128691|NCT00536120|432667|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
128692|NCT00536120|432666|P2|Overall Study|Lost to Follow-up|0
128693|NCT00536120|432667|P1|Overall Study|Lost to Follow-up|1
128694|NCT00536107|432681|P2|Overall Study|Study Termination|4
128695|NCT00536107|432682|P1|Overall Study|Study Termination|2
128696|NCT00536107|432681|P2|Overall Study|Withdrawal by Subject|1
128697|NCT00536107|432682|P1|Overall Study|Withdrawal by Subject|0
128698|NCT00536107|432681|P2|Overall Study|Incorrect enrolment|0
128699|NCT00536107|432682|P1|Overall Study|Incorrect enrolment|1
128700|NCT00536107|432681|P2|Overall Study|Death|1
128701|NCT00536107|432682|P1|Overall Study|Death|5
128702|NCT00535847|432736|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
128703|NCT00535847|432737|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
128704|NCT00535847|432738|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
128705|NCT00535847|432736|P3|Overall Study|Non compliance|0
128706|NCT00535847|432737|P2|Overall Study|Non compliance|1
128707|NCT00535847|432738|P1|Overall Study|Non compliance|1
128708|NCT00535847|432736|P3|Overall Study|Adverse Event|2
128709|NCT00535847|432737|P2|Overall Study|Adverse Event|3
128710|NCT00535847|432738|P1|Overall Study|Adverse Event|5
128711|NCT00535730|432804|P2|Overall Study|Withdrawal by Subject|4
128712|NCT00535730|432805|P1|Overall Study|Withdrawal by Subject|0
128713|NCT00535730|432804|P2|Overall Study|Protocol Violation|0
128714|NCT00535730|432805|P1|Overall Study|Protocol Violation|1
128715|NCT00535730|432804|P2|Overall Study|Physician Decision|1
128716|NCT00535730|432805|P1|Overall Study|Physician Decision|0
128717|NCT00535730|432804|P2|Overall Study|Lost to Follow-up|1
128718|NCT00535730|432805|P1|Overall Study|Lost to Follow-up|0
128719|NCT00535730|432804|P2|Overall Study|Adverse Event|1
128720|NCT00535730|432805|P1|Overall Study|Adverse Event|1
128721|NCT00535496|432843|P4|Overall Study|Not treated with sugammadex|0
128722|NCT00535496|432844|P3|Overall Study|Not treated with sugammadex|0
128723|NCT00535496|432845|P2|Overall Study|Not treated with sugammadex|1
128724|NCT00535496|432846|P1|Overall Study|Not treated with sugammadex|0
128725|NCT00535496|432843|P4|Overall Study|Lost to Follow-up|0
128726|NCT00535496|432844|P3|Overall Study|Lost to Follow-up|0
128727|NCT00535496|432845|P2|Overall Study|Lost to Follow-up|1
128728|NCT00535496|432846|P1|Overall Study|Lost to Follow-up|0
128729|NCT00535405|432866|P5|Overall Study|Withdrawal by Subject|8
128730|NCT00535405|432867|P4|Overall Study|Withdrawal by Subject|10
128731|NCT00535405|432868|P3|Overall Study|Withdrawal by Subject|10
128732|NCT00535405|432869|P2|Overall Study|Withdrawal by Subject|11
128733|NCT00535405|432870|P1|Overall Study|Withdrawal by Subject|5
128734|NCT00535405|432866|P5|Overall Study|Protocol Violation|0
128735|NCT00535405|432867|P4|Overall Study|Protocol Violation|1
128736|NCT00535405|432868|P3|Overall Study|Protocol Violation|2
128737|NCT00535405|432869|P2|Overall Study|Protocol Violation|2
128738|NCT00535405|432870|P1|Overall Study|Protocol Violation|2
128739|NCT00535405|432866|P5|Overall Study|Physician Decision|1
128740|NCT00535405|432867|P4|Overall Study|Physician Decision|1
128741|NCT00535405|432868|P3|Overall Study|Physician Decision|0
128742|NCT00535405|432869|P2|Overall Study|Physician Decision|2
128743|NCT00535405|432870|P1|Overall Study|Physician Decision|3
128744|NCT00535405|432866|P5|Overall Study|Lost to Follow-up|1
128745|NCT00535405|432867|P4|Overall Study|Lost to Follow-up|2
128746|NCT00535405|432868|P3|Overall Study|Lost to Follow-up|3
128747|NCT00535405|432869|P2|Overall Study|Lost to Follow-up|3
128748|NCT00535405|432870|P1|Overall Study|Lost to Follow-up|1
128749|NCT00535405|432866|P5|Overall Study|Adverse Event|6
128750|NCT00535405|432867|P4|Overall Study|Adverse Event|8
128751|NCT00535405|432868|P3|Overall Study|Adverse Event|3
128752|NCT00535405|432869|P2|Overall Study|Adverse Event|8
128753|NCT00535405|432870|P1|Overall Study|Adverse Event|6
128754|NCT00535288|432931|P5|Overall Study|Not specified|1
128755|NCT00535288|432932|P4|Overall Study|Not specified|2
128756|NCT00535288|432933|P3|Overall Study|Not specified|1
128757|NCT00535288|432934|P2|Overall Study|Not specified|1
128758|NCT00535288|432935|P1|Overall Study|Not specified|2
128759|NCT00535288|432931|P5|Overall Study|Unwilling to cooperate|4
128760|NCT00535288|432932|P4|Overall Study|Unwilling to cooperate|3
128761|NCT00535288|432933|P3|Overall Study|Unwilling to cooperate|3
128762|NCT00535288|432934|P2|Overall Study|Unwilling to cooperate|6
128763|NCT00535288|432935|P1|Overall Study|Unwilling to cooperate|6
128764|NCT00535288|432931|P5|Overall Study|Lack of Efficacy|7
128765|NCT00535288|432932|P4|Overall Study|Lack of Efficacy|4
128766|NCT00535288|432933|P3|Overall Study|Lack of Efficacy|4
128767|NCT00535288|432934|P2|Overall Study|Lack of Efficacy|3
128768|NCT00535288|432935|P1|Overall Study|Lack of Efficacy|26
128769|NCT00535288|432931|P5|Overall Study|Lost to Follow-up|0
128770|NCT00535288|432932|P4|Overall Study|Lost to Follow-up|0
128771|NCT00535288|432933|P3|Overall Study|Lost to Follow-up|0
128772|NCT00535288|432934|P2|Overall Study|Lost to Follow-up|3
128773|NCT00535288|432935|P1|Overall Study|Lost to Follow-up|0
128774|NCT00535288|432931|P5|Overall Study|Adverse Event|30
128775|NCT00535288|432932|P4|Overall Study|Adverse Event|20
128776|NCT00535288|432933|P3|Overall Study|Adverse Event|25
128777|NCT00535288|432934|P2|Overall Study|Adverse Event|19
128778|NCT00535288|432935|P1|Overall Study|Adverse Event|20
128779|NCT00535262|433012|P1|Overall Study|No funding|3
128780|NCT00535223|433018|P2|Overall Study|Withdrawal by Subject|1
128781|NCT00535223|433019|P1|Overall Study|Withdrawal by Subject|4
128782|NCT00535145|433027|P1|Phase II|Subject non-compliance|2
128783|NCT00535145|433027|P1|Phase II|Withdrawal by Subject|5
128784|NCT00535145|433027|P1|Phase II|Lost to Follow-up|5
128785|NCT00535145|433027|P1|Phase II|Lack of Efficacy|1
128786|NCT00535145|433027|P1|Phase II|Adverse Event|2
128787|NCT00535145|433027|P1|Phase I|(diagnosis)|3
128788|NCT00535145|433027|P1|Phase I|(PI decision)|1
128789|NCT00535145|433027|P1|Phase I|(protocol violation)|1
128790|NCT00535145|433027|P1|Phase I|(eligibility)|8
128791|NCT00535145|433027|P1|Phase I|Withdrawal by Subject|6
128792|NCT00535145|433027|P1|Phase I|Lost to Follow-up|7
128793|NCT00535145|433027|P1|Phase I|Adverse Event|3
128794|NCT00535132|433039|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
128795|NCT00535132|433040|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
128796|NCT00535132|433039|P2|Safety Analysis Set|Did Not Receive Study Medication|2
128797|NCT00535132|433040|P1|Safety Analysis Set|Did Not Receive Study Medication|2
128798|NCT00534976|433092|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
128799|NCT00534976|433093|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
128800|NCT00534976|433092|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
128801|NCT00534976|433093|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
128802|NCT00534976|433092|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
128803|NCT00534976|433093|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
128804|NCT00533702|433154|P2|Overall Study|Found ineligible after randomization|1
128805|NCT00533702|433155|P1|Overall Study|Found ineligible after randomization|2
128806|NCT00533702|433154|P2|Overall Study|Withdrawal by Subject|1
128807|NCT00533702|433155|P1|Overall Study|Withdrawal by Subject|3
128808|NCT00534638|433181|P2|Overall Study|Refused participation to study|883
128809|NCT00534638|433182|P1|Overall Study|Refused participation to study|1665
128810|NCT00534638|433181|P2|Overall Study|Rejected origin of signature|2
128811|NCT00534638|433182|P1|Overall Study|Rejected origin of signature|0
128812|NCT00534638|433181|P2|Overall Study|Received without ICF|1
128813|NCT00534638|433182|P1|Overall Study|Received without ICF|0
128814|NCT00534638|433181|P2|Overall Study|Subject unable to read|1
128815|NCT00534638|433182|P1|Overall Study|Subject unable to read|0
128816|NCT00534638|433181|P2|Overall Study|ICF not returned|1
128817|NCT00534638|433182|P1|Overall Study|ICF not returned|0
128818|NCT00534638|433181|P2|Overall Study|Mentally disabled|0
128819|NCT00534638|433182|P1|Overall Study|Mentally disabled|1
128820|NCT00534638|433181|P2|Overall Study|Death|5
128821|NCT00534638|433182|P1|Overall Study|Death|5
128822|NCT00534638|433181|P2|Overall Study|Pregnancy|4
128823|NCT00534638|433182|P1|Overall Study|Pregnancy|6
128824|NCT00534638|433181|P2|Overall Study|Blinded treatment broken|0
128825|NCT00534638|433182|P1|Overall Study|Blinded treatment broken|2
128826|NCT00534638|433181|P2|Overall Study|Urticaria|0
128827|NCT00534638|433182|P1|Overall Study|Urticaria|1
128828|NCT00534638|433181|P2|Overall Study|Already received HPV vaccine|1
128829|NCT00534638|433182|P1|Overall Study|Already received HPV vaccine|0
128830|NCT00534638|433181|P2|Overall Study|Lost to Follow-up|10875
128831|NCT00534638|433182|P1|Overall Study|Lost to Follow-up|4793
128832|NCT00534638|433181|P2|Overall Study|Migrated/moved from study area|13
128833|NCT00534638|433182|P1|Overall Study|Migrated/moved from study area|14
128834|NCT00534638|433181|P2|Overall Study|Withdrawal by Subject|5
128835|NCT00534638|433182|P1|Overall Study|Withdrawal by Subject|4
128836|NCT00534599|433217|P2|Overall Study|Unspecified|0
128837|NCT00534599|433218|P1|Overall Study|Unspecified|7
128838|NCT00534599|433217|P2|Overall Study|Withdrawal by Subject|6
128839|NCT00534599|433218|P1|Overall Study|Withdrawal by Subject|4
128840|NCT00534599|433217|P2|Overall Study|Lost to Follow-up|14
128841|NCT00534599|433218|P1|Overall Study|Lost to Follow-up|11
128842|NCT00534599|433217|P2|Overall Study|Protocol Violation|3
128843|NCT00534599|433218|P1|Overall Study|Protocol Violation|1
128844|NCT00534599|433217|P2|Overall Study|Generalized anxiety disorder worsened|1
128845|NCT00534599|433218|P1|Overall Study|Generalized anxiety disorder worsened|0
128846|NCT00534599|433217|P2|Overall Study|Lack of Efficacy|1
128847|NCT00534599|433218|P1|Overall Study|Lack of Efficacy|0
128848|NCT00534599|433217|P2|Overall Study|Developed study-specific d/c criteria|0
128849|NCT00534599|433218|P1|Overall Study|Developed study-specific d/c criteria|5
128850|NCT00534599|433217|P2|Overall Study|Mis-randomization|2
128851|NCT00534599|433218|P1|Overall Study|Mis-randomization|2
128852|NCT00534599|433217|P2|Overall Study|Incorrect enrollment|1
128853|NCT00534599|433218|P1|Overall Study|Incorrect enrollment|2
128854|NCT00534599|433217|P2|Overall Study|Adverse Event|4
128855|NCT00534599|433218|P1|Overall Study|Adverse Event|25
128856|NCT00534495|433254|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
128857|NCT00534495|433255|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
128858|NCT00534495|433256|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
128859|NCT00534495|433254|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
128860|NCT00534495|433255|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
128861|NCT00534495|433256|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
128862|NCT00534495|433254|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
128863|NCT00534495|433255|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
128864|NCT00534495|433256|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
128865|NCT00534495|433254|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
128866|NCT00534495|433255|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
128867|NCT00534495|433256|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
128868|NCT00534495|433254|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
128869|NCT00534495|433255|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
128870|NCT00534495|433256|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
128871|NCT00534495|433254|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
128872|NCT00534495|433255|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
128873|NCT00534495|433256|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
128874|NCT00534495|433254|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
128875|NCT00534495|433255|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
128876|NCT00534495|433256|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
128877|NCT00534495|433254|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
128878|NCT00534495|433255|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
128879|NCT00534495|433256|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
128880|NCT00534495|433254|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
128881|NCT00534495|433255|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
128882|NCT00534495|433256|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
128883|NCT00534404|433294|P3|Overall Study|Lost to Follow-up|201
128884|NCT00534404|433295|P2|Overall Study|Lost to Follow-up|138
128885|NCT00534404|433296|P1|Overall Study|Lost to Follow-up|170
128886|NCT00534404|433294|P3|Overall Study|Removed by study staff|1
128887|NCT00534404|433295|P2|Overall Study|Removed by study staff|3
128888|NCT00534404|433296|P1|Overall Study|Removed by study staff|2
128889|NCT00534404|433294|P3|Overall Study|Withdrawal by Subject|38
128890|NCT00534404|433295|P2|Overall Study|Withdrawal by Subject|2
128891|NCT00534404|433296|P1|Overall Study|Withdrawal by Subject|8
128892|NCT00534404|433294|P3|Overall Study|Death|2
128893|NCT00534404|433295|P2|Overall Study|Death|0
128894|NCT00534404|433296|P1|Overall Study|Death|0
128895|NCT00534352|433310|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
128896|NCT00534352|433310|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
128897|NCT00534352|433310|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
128898|NCT00534352|433310|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
128899|NCT00534352|433310|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
128900|NCT00534352|433310|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
128901|NCT00534313|433354|P4|Long-term Period|Not specified|2
128902|NCT00534313|433355|P3|Long-term Period|Not specified|2
128903|NCT00534313|433356|P2|Long-term Period|Not specified|2
128904|NCT00534313|433357|P1|Long-term Period|Not specified|1
128905|NCT00534313|433354|P4|Long-term Period|Administrative reason by sponsor|18
128906|NCT00534313|433355|P3|Long-term Period|Administrative reason by sponsor|26
128907|NCT00534313|433356|P2|Long-term Period|Administrative reason by sponsor|15
128908|NCT00534313|433357|P1|Long-term Period|Administrative reason by sponsor|17
128909|NCT00534313|433354|P4|Long-term Period|Poor compliance/noncompliance|0
128910|NCT00534313|433355|P3|Long-term Period|Poor compliance/noncompliance|1
128911|NCT00534313|433356|P2|Long-term Period|Poor compliance/noncompliance|1
128912|NCT00534313|433357|P1|Long-term Period|Poor compliance/noncompliance|0
128913|NCT00534313|433354|P4|Long-term Period|No longer meets study criteria|0
128914|NCT00534313|433355|P3|Long-term Period|No longer meets study criteria|0
128915|NCT00534313|433356|P2|Long-term Period|No longer meets study criteria|1
128916|NCT00534313|433357|P1|Long-term Period|No longer meets study criteria|0
128917|NCT00534313|433354|P4|Long-term Period|Withdrawal by Subject|0
128918|NCT00534313|433355|P3|Long-term Period|Withdrawal by Subject|0
128919|NCT00534313|433356|P2|Long-term Period|Withdrawal by Subject|2
128920|NCT00534313|433357|P1|Long-term Period|Withdrawal by Subject|2
128921|NCT00534313|433354|P4|Long-term Period|Lost to Follow-up|0
128922|NCT00534313|433355|P3|Long-term Period|Lost to Follow-up|0
128923|NCT00534313|433356|P2|Long-term Period|Lost to Follow-up|2
128924|NCT00534313|433357|P1|Long-term Period|Lost to Follow-up|1
128925|NCT00534313|433354|P4|Long-term Period|Lack of Efficacy|12
128926|NCT00534313|433355|P3|Long-term Period|Lack of Efficacy|14
128927|NCT00534313|433356|P2|Long-term Period|Lack of Efficacy|10
128928|NCT00534313|433357|P1|Long-term Period|Lack of Efficacy|14
128929|NCT00534313|433354|P4|Long-term Period|Adverse Event|1
128930|NCT00534313|433355|P3|Long-term Period|Adverse Event|0
128931|NCT00534313|433356|P2|Long-term Period|Adverse Event|1
128932|NCT00534313|433357|P1|Long-term Period|Adverse Event|2
128933|NCT00534313|433354|P4|Short-term Period|Pregnancy|0
128934|NCT00534313|433355|P3|Short-term Period|Pregnancy|1
128935|NCT00534313|433356|P2|Short-term Period|Pregnancy|0
128936|NCT00534313|433357|P1|Short-term Period|Pregnancy|0
128937|NCT00534313|433354|P4|Short-term Period|Participant withdrew consent|2
128938|NCT00534313|433355|P3|Short-term Period|Participant withdrew consent|0
128939|NCT00534313|433356|P2|Short-term Period|Participant withdrew consent|0
128940|NCT00534313|433357|P1|Short-term Period|Participant withdrew consent|2
128941|NCT00534313|433354|P4|Short-term Period|Participant not meeting study criteria|1
128942|NCT00534313|433355|P3|Short-term Period|Participant not meeting study criteria|0
128943|NCT00534313|433356|P2|Short-term Period|Participant not meeting study criteria|0
128944|NCT00534313|433357|P1|Short-term Period|Participant not meeting study criteria|0
128945|NCT00534313|433354|P4|Short-term Period|Lack of Efficacy|3
128946|NCT00534313|433355|P3|Short-term Period|Lack of Efficacy|0
128947|NCT00534313|433356|P2|Short-term Period|Lack of Efficacy|4
128948|NCT00534313|433357|P1|Short-term Period|Lack of Efficacy|3
128949|NCT00534313|433354|P4|Short-term Period|Adverse Event|3
128950|NCT00534313|433355|P3|Short-term Period|Adverse Event|1
128951|NCT00534313|433356|P2|Short-term Period|Adverse Event|2
128952|NCT00534313|433357|P1|Short-term Period|Adverse Event|1
128953|NCT00534248|433452|P2|Overall Study|Withdrawal by Subject|255
128954|NCT00534248|433453|P1|Overall Study|Withdrawal by Subject|263
128955|NCT00534248|433452|P2|Overall Study|Protocol Violation|4
128956|NCT00534248|433453|P1|Overall Study|Protocol Violation|3
128957|NCT00534248|433452|P2|Overall Study|Physician Decision|7
128958|NCT00534248|433453|P1|Overall Study|Physician Decision|10
128959|NCT00534248|433452|P2|Overall Study|Other protocol specified criteria|3
128960|NCT00534248|433453|P1|Overall Study|Other protocol specified criteria|13
128961|NCT00534248|433452|P2|Overall Study|Lost to Follow-up|375
128962|NCT00534248|433453|P1|Overall Study|Lost to Follow-up|353
128963|NCT00534248|433452|P2|Overall Study|Adverse Event|29
128964|NCT00534248|433453|P1|Overall Study|Adverse Event|19
128965|NCT00534105|433469|P2|Overall Study|Lost to Follow-up|39
128966|NCT00534105|433470|P1|Overall Study|Lost to Follow-up|23
128967|NCT00534092|433484|P2|Overall Study|personal reasons/family concerns|0
128968|NCT00534092|433485|P1|Overall Study|personal reasons/family concerns|1
128969|NCT00534092|433484|P2|Overall Study|Lost to Follow-up|0
128970|NCT00534092|433485|P1|Overall Study|Lost to Follow-up|1
128971|NCT00533897|433511|P8|Long Term Extension (LTE)|not specified|6
128972|NCT00533897|433512|P7|Long Term Extension (LTE)|not specified|1
128973|NCT00533897|433513|P6|Long Term Extension (LTE)|not specified|0
128974|NCT00533897|433514|P5|Long Term Extension (LTE)|not specified|0
128975|NCT00533897|433515|P4|Long Term Extension (LTE)|not specified|0
128976|NCT00533897|433516|P3|Long Term Extension (LTE)|not specified|0
128977|NCT00533897|433517|P2|Long Term Extension (LTE)|not specified|0
128978|NCT00533897|433518|P1|Long Term Extension (LTE)|not specified|0
128979|NCT00533897|433511|P8|Long Term Extension (LTE)|Lost to Follow-up|1
128980|NCT00533897|433512|P7|Long Term Extension (LTE)|Lost to Follow-up|1
128981|NCT00533897|433513|P6|Long Term Extension (LTE)|Lost to Follow-up|0
128982|NCT00533897|433514|P5|Long Term Extension (LTE)|Lost to Follow-up|0
128983|NCT00533897|433515|P4|Long Term Extension (LTE)|Lost to Follow-up|0
128984|NCT00533897|433516|P3|Long Term Extension (LTE)|Lost to Follow-up|0
128985|NCT00533897|433517|P2|Long Term Extension (LTE)|Lost to Follow-up|0
128986|NCT00533897|433518|P1|Long Term Extension (LTE)|Lost to Follow-up|0
128987|NCT00533897|433511|P8|Long Term Extension (LTE)|Pregnancy|2
128988|NCT00533897|433512|P7|Long Term Extension (LTE)|Pregnancy|0
128989|NCT00533897|433513|P6|Long Term Extension (LTE)|Pregnancy|0
128990|NCT00533897|433514|P5|Long Term Extension (LTE)|Pregnancy|0
128991|NCT00533897|433515|P4|Long Term Extension (LTE)|Pregnancy|0
128992|NCT00533897|433516|P3|Long Term Extension (LTE)|Pregnancy|0
128993|NCT00533897|433517|P2|Long Term Extension (LTE)|Pregnancy|0
128994|NCT00533897|433518|P1|Long Term Extension (LTE)|Pregnancy|0
128995|NCT00533897|433511|P8|Long Term Extension (LTE)|Adverse Event|5
128996|NCT00533897|433512|P7|Long Term Extension (LTE)|Adverse Event|2
128997|NCT00533897|433513|P6|Long Term Extension (LTE)|Adverse Event|0
128998|NCT00533897|433514|P5|Long Term Extension (LTE)|Adverse Event|0
128999|NCT00533897|433515|P4|Long Term Extension (LTE)|Adverse Event|0
129000|NCT00533897|433516|P3|Long Term Extension (LTE)|Adverse Event|0
129001|NCT00533897|433517|P2|Long Term Extension (LTE)|Adverse Event|0
129002|NCT00533897|433518|P1|Long Term Extension (LTE)|Adverse Event|0
129003|NCT00533897|433511|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
129004|NCT00533897|433512|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
129005|NCT00533897|433513|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
129006|NCT00533897|433514|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
129007|NCT00533897|433515|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
129008|NCT00533897|433516|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
129009|NCT00533897|433517|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
129010|NCT00533897|433518|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
129011|NCT00533897|433511|P8|Long Term Extension (LTE)|Lack of Efficacy|3
129012|NCT00533897|433512|P7|Long Term Extension (LTE)|Lack of Efficacy|5
129013|NCT00533897|433513|P6|Long Term Extension (LTE)|Lack of Efficacy|0
129014|NCT00533897|433514|P5|Long Term Extension (LTE)|Lack of Efficacy|0
129015|NCT00533897|433515|P4|Long Term Extension (LTE)|Lack of Efficacy|0
129016|NCT00533897|433516|P3|Long Term Extension (LTE)|Lack of Efficacy|0
129017|NCT00533897|433517|P2|Long Term Extension (LTE)|Lack of Efficacy|0
129018|NCT00533897|433518|P1|Long Term Extension (LTE)|Lack of Efficacy|0
129019|NCT00533897|433511|P8|Long Term Extension (LTE)|Death|3
129020|NCT00533897|433512|P7|Long Term Extension (LTE)|Death|1
129021|NCT00533897|433513|P6|Long Term Extension (LTE)|Death|0
129022|NCT00533897|433514|P5|Long Term Extension (LTE)|Death|0
129023|NCT00533897|433515|P4|Long Term Extension (LTE)|Death|0
129024|NCT00533897|433516|P3|Long Term Extension (LTE)|Death|0
129025|NCT00533897|433517|P2|Long Term Extension (LTE)|Death|0
129026|NCT00533897|433518|P1|Long Term Extension (LTE)|Death|0
129027|NCT00533897|433511|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
129028|NCT00533897|433512|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
129029|NCT00533897|433513|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
129030|NCT00533897|433514|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
129031|NCT00533897|433515|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
129032|NCT00533897|433516|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
129033|NCT00533897|433517|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
129034|NCT00533897|433518|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
129035|NCT00533897|433511|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
129036|NCT00533897|433512|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
129037|NCT00533897|433513|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
129038|NCT00533897|433514|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
129039|NCT00533897|433515|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
129040|NCT00533897|433516|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
129041|NCT00533897|433517|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
129042|NCT00533897|433518|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
129043|NCT00533897|433511|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
129044|NCT00533897|433512|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
129045|NCT00533897|433513|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
129046|NCT00533897|433514|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
129047|NCT00533897|433515|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
129048|NCT00533897|433516|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
129049|NCT00533897|433517|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
129050|NCT00533897|433518|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
129051|NCT00533897|433511|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
129052|NCT00533897|433512|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
129053|NCT00533897|433513|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
129054|NCT00533897|433514|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
129055|NCT00533897|433515|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
129056|NCT00533897|433516|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
129057|NCT00533897|433517|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
129058|NCT00533897|433518|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
129059|NCT00533897|433511|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
129060|NCT00533897|433512|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
129061|NCT00533897|433513|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
129062|NCT00533897|433514|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
129063|NCT00533897|433515|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
129064|NCT00533897|433516|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
129065|NCT00533897|433517|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
129066|NCT00533897|433518|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
129067|NCT00533897|433511|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
129068|NCT00533897|433512|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
129069|NCT00533897|433513|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
129070|NCT00533897|433514|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
129071|NCT00533897|433515|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
129072|NCT00533897|433516|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
129073|NCT00533897|433517|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
129074|NCT00533897|433518|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
129075|NCT00533897|433511|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
129076|NCT00533897|433512|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
129077|NCT00533897|433513|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
129078|NCT00533897|433514|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
129079|NCT00533897|433515|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
129080|NCT00533897|433516|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
129081|NCT00533897|433517|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
129082|NCT00533897|433518|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
129083|NCT00533897|433511|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
129084|NCT00533897|433512|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
129085|NCT00533897|433513|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
129086|NCT00533897|433514|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
129087|NCT00533897|433515|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
129088|NCT00533897|433516|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
129089|NCT00533897|433517|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
129090|NCT00533897|433518|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
129091|NCT00533897|433511|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
129092|NCT00533897|433512|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
129093|NCT00533897|433513|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
129094|NCT00533897|433514|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
129095|NCT00533897|433515|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
129096|NCT00533897|433516|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
129097|NCT00533897|433517|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
129098|NCT00533897|433518|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
129099|NCT00533897|433511|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
129100|NCT00533897|433512|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
129101|NCT00533897|433513|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
129102|NCT00533897|433514|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
129103|NCT00533897|433515|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
129104|NCT00533897|433516|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
129105|NCT00533897|433517|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
129106|NCT00533897|433518|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
129107|NCT00533897|433511|P8|Lead-in (LI) Period 1|Adverse Event|0
129108|NCT00533897|433512|P7|Lead-in (LI) Period 1|Adverse Event|0
129109|NCT00533897|433513|P6|Lead-in (LI) Period 1|Adverse Event|0
129110|NCT00533897|433514|P5|Lead-in (LI) Period 1|Adverse Event|0
129111|NCT00533897|433515|P4|Lead-in (LI) Period 1|Adverse Event|0
129112|NCT00533897|433516|P3|Lead-in (LI) Period 1|Adverse Event|0
129113|NCT00533897|433517|P2|Lead-in (LI) Period 1|Adverse Event|0
129114|NCT00533897|433518|P1|Lead-in (LI) Period 1|Adverse Event|1
129115|NCT00533507|433663|P1|Overall Study|Withdrawal by Subject|1
129116|NCT00533273|433695|P2|Open-label|Withdrawal by Subject|0
129117|NCT00533273|433696|P1|Open-label|Withdrawal by Subject|6
129118|NCT00533273|433695|P2|Double-blind|Withdrew consent|2
129119|NCT00533273|433696|P1|Double-blind|Withdrew consent|0
129120|NCT00532948|433705|P3|Overall Study|Failure to return|0
129121|NCT00532948|433706|P2|Overall Study|Failure to return|1
129122|NCT00532948|433707|P1|Overall Study|Failure to return|0
129123|NCT00532948|433705|P3|Overall Study|Violation of selection criteria at entry|0
129124|NCT00532948|433706|P2|Overall Study|Violation of selection criteria at entry|1
129125|NCT00532948|433707|P1|Overall Study|Violation of selection criteria at entry|0
129126|NCT00532948|433705|P3|Overall Study|Death|4
129127|NCT00532948|433706|P2|Overall Study|Death|3
129128|NCT00532948|433707|P1|Overall Study|Death|3
129129|NCT00532948|433705|P3|Overall Study|Protocol Violation|0
129130|NCT00532948|433706|P2|Overall Study|Protocol Violation|0
129131|NCT00532948|433707|P1|Overall Study|Protocol Violation|1
129132|NCT00532935|433739|P2|Overall Study|Protocol Specific Criteria|15
129133|NCT00532935|433740|P1|Overall Study|Protocol Specific Criteria|11
129134|NCT00532935|433739|P2|Overall Study|Withdrawal by Subject|9
129135|NCT00532935|433740|P1|Overall Study|Withdrawal by Subject|10
129136|NCT00532935|433739|P2|Overall Study|Protocol Violation|2
129137|NCT00532935|433740|P1|Overall Study|Protocol Violation|4
129138|NCT00532935|433739|P2|Overall Study|Pregnancy|0
129139|NCT00532935|433740|P1|Overall Study|Pregnancy|1
129140|NCT00532935|433739|P2|Overall Study|Physician Decision|5
129141|NCT00532935|433740|P1|Overall Study|Physician Decision|4
129142|NCT00532935|433739|P2|Overall Study|Lost to Follow-up|6
129143|NCT00532935|433740|P1|Overall Study|Lost to Follow-up|10
129144|NCT00532935|433739|P2|Overall Study|Lack of Efficacy|3
129145|NCT00532935|433740|P1|Overall Study|Lack of Efficacy|0
129146|NCT00532935|433739|P2|Overall Study|Adverse Event|12
129147|NCT00532935|433740|P1|Overall Study|Adverse Event|11
129148|NCT00532883|433758|P4|Overall Study|Early Study Termination|4
129149|NCT00532883|433759|P3|Overall Study|Early Study Termination|1
129150|NCT00532883|433760|P2|Overall Study|Early Study Termination|4
129151|NCT00532883|433761|P1|Overall Study|Early Study Termination|4
129152|NCT00532883|433758|P4|Overall Study|Subject was Nonadherent|0
129153|NCT00532883|433759|P3|Overall Study|Subject was Nonadherent|1
129154|NCT00532883|433760|P2|Overall Study|Subject was Nonadherent|1
129155|NCT00532883|433761|P1|Overall Study|Subject was Nonadherent|0
129156|NCT00532883|433758|P4|Overall Study|Withdrawal by Subject|0
129157|NCT00532883|433759|P3|Overall Study|Withdrawal by Subject|1
129158|NCT00532883|433760|P2|Overall Study|Withdrawal by Subject|1
129159|NCT00532883|433761|P1|Overall Study|Withdrawal by Subject|0
129160|NCT00532883|433758|P4|Overall Study|Lost to Follow-up|0
129161|NCT00532883|433759|P3|Overall Study|Lost to Follow-up|1
129162|NCT00532883|433760|P2|Overall Study|Lost to Follow-up|1
129163|NCT00532883|433761|P1|Overall Study|Lost to Follow-up|1
129164|NCT00532883|433758|P4|Overall Study|Adverse Event|1
129165|NCT00532883|433759|P3|Overall Study|Adverse Event|0
129166|NCT00532883|433760|P2|Overall Study|Adverse Event|0
129167|NCT00532883|433761|P1|Overall Study|Adverse Event|1
129168|NCT00532779|433774|P3|Overall Study|Drug noncompliance, moved, other|29
129169|NCT00532779|433775|P2|Overall Study|Drug noncompliance, moved, other|23
129170|NCT00532779|433776|P1|Overall Study|Drug noncompliance, moved, other|14
129171|NCT00532779|433774|P3|Overall Study|Death|0
129172|NCT00532779|433775|P2|Overall Study|Death|1
129173|NCT00532779|433776|P1|Overall Study|Death|0
129174|NCT00532779|433774|P3|Overall Study|Pregnancy|3
129175|NCT00532779|433775|P2|Overall Study|Pregnancy|5
129176|NCT00532779|433776|P1|Overall Study|Pregnancy|2
129177|NCT00532779|433774|P3|Overall Study|Protocol Violation|7
129178|NCT00532779|433775|P2|Overall Study|Protocol Violation|9
129179|NCT00532779|433776|P1|Overall Study|Protocol Violation|5
129180|NCT00532779|433774|P3|Overall Study|Lack of Efficacy|40
129181|NCT00532779|433775|P2|Overall Study|Lack of Efficacy|12
129182|NCT00532779|433776|P1|Overall Study|Lack of Efficacy|12
129183|NCT00532779|433774|P3|Overall Study|Withdrawal by Subject|90
129184|NCT00532779|433775|P2|Overall Study|Withdrawal by Subject|60
129185|NCT00532779|433776|P1|Overall Study|Withdrawal by Subject|63
129186|NCT00532779|433774|P3|Overall Study|Lost to Follow-up|66
129187|NCT00532779|433775|P2|Overall Study|Lost to Follow-up|65
129188|NCT00532779|433776|P1|Overall Study|Lost to Follow-up|76
129189|NCT00532779|433774|P3|Overall Study|Adverse Event|56
129190|NCT00532779|433775|P2|Overall Study|Adverse Event|112
129191|NCT00532779|433776|P1|Overall Study|Adverse Event|122
129192|NCT00532493|433837|P2|Overall Study|Contraindicative Medication|0
129193|NCT00532493|433838|P1|Overall Study|Contraindicative Medication|1
129194|NCT00532493|433837|P2|Overall Study|Subject Moved Away|1
129195|NCT00532493|433838|P1|Overall Study|Subject Moved Away|3
129196|NCT00532493|433837|P2|Overall Study|Protocol Deviation|0
129197|NCT00532493|433838|P1|Overall Study|Protocol Deviation|1
129198|NCT00532493|433837|P2|Overall Study|Adverse Event|5
129199|NCT00532493|433838|P1|Overall Study|Adverse Event|6
129200|NCT00532493|433837|P2|Overall Study|Physician Decision|6
129201|NCT00532493|433838|P1|Overall Study|Physician Decision|1
129202|NCT00532493|433837|P2|Overall Study|Withdrawal by Subject|9
129203|NCT00532493|433838|P1|Overall Study|Withdrawal by Subject|7
129204|NCT00532493|433837|P2|Overall Study|Lost to Follow-up|7
129205|NCT00532493|433838|P1|Overall Study|Lost to Follow-up|10
129206|NCT00532493|433837|P2|Overall Study|Death|1
129207|NCT00532493|433838|P1|Overall Study|Death|1
129208|NCT00532441|433872|P2|Overall Study|Death|0
129209|NCT00532441|433873|P1|Overall Study|Death|1
129210|NCT00532298|433888|P6|Overall Study|Lost to Follow-up|1
129211|NCT00532298|433889|P5|Overall Study|Lost to Follow-up|0
129212|NCT00532298|433890|P4|Overall Study|Lost to Follow-up|0
129213|NCT00532298|433891|P3|Overall Study|Lost to Follow-up|1
129214|NCT00532298|433892|P2|Overall Study|Lost to Follow-up|1
129215|NCT00532298|433893|P1|Overall Study|Lost to Follow-up|1
129216|NCT00532298|433888|P6|Overall Study|Adverse Event|1
129217|NCT00532298|433889|P5|Overall Study|Adverse Event|1
129218|NCT00532298|433890|P4|Overall Study|Adverse Event|0
129219|NCT00532298|433891|P3|Overall Study|Adverse Event|0
129220|NCT00532298|433892|P2|Overall Study|Adverse Event|0
129221|NCT00532298|433893|P1|Overall Study|Adverse Event|1
129222|NCT00532259|433973|P1|Overall Study|Protocol Violation|1
129223|NCT00532259|433973|P1|Overall Study|Physician Decision|3
129224|NCT00532259|433973|P1|Overall Study|Lost to Follow-up|3
129225|NCT00532259|433973|P1|Overall Study|Lack of Efficacy|21
129226|NCT00532259|433973|P1|Overall Study|Death|1
129227|NCT00532259|433973|P1|Overall Study|Adverse Event|1
129228|NCT00532259|433973|P1|Overall Study|Withdrawal by Subject|2
129229|NCT00532155|433980|P2|Overall Study|Did not receive study medication|6
129230|NCT00532155|433981|P1|Overall Study|Did not receive study medication|2
129231|NCT00532155|433980|P2|Overall Study|Study termination stop further treatment|0
129232|NCT00532155|433981|P1|Overall Study|Study termination stop further treatment|4
129233|NCT00532155|433980|P2|Overall Study|Study terminated by sponsor|0
129234|NCT00532155|433981|P1|Overall Study|Study terminated by sponsor|1
129235|NCT00532155|433980|P2|Overall Study|Study stopped|0
129236|NCT00532155|433981|P1|Overall Study|Study stopped|1
129237|NCT00532155|433980|P2|Overall Study|Had brain metastasis, was mis-randomized|0
129238|NCT00532155|433981|P1|Overall Study|Had brain metastasis, was mis-randomized|1
129239|NCT00532155|433980|P2|Overall Study|Progressive disease (by incorrect scan)|1
129240|NCT00532155|433981|P1|Overall Study|Progressive disease (by incorrect scan)|0
129241|NCT00532155|433980|P2|Overall Study|Promotor ended study|0
129242|NCT00532155|433981|P1|Overall Study|Promotor ended study|1
129243|NCT00532155|433980|P2|Overall Study|Occurence of a secondary cancer|1
129244|NCT00532155|433981|P1|Overall Study|Occurence of a secondary cancer|0
129245|NCT00532155|433980|P2|Overall Study|Occurence of a second cancer|1
129246|NCT00532155|433981|P1|Overall Study|Occurence of a second cancer|0
129247|NCT00532155|433980|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
129248|NCT00532155|433981|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
129249|NCT00532155|433980|P2|Overall Study|Moved|0
129250|NCT00532155|433981|P1|Overall Study|Moved|1
129251|NCT00532155|433980|P2|Overall Study|Consent withdrawn|7
129252|NCT00532155|433981|P1|Overall Study|Consent withdrawn|5
129253|NCT00532155|433980|P2|Overall Study|Withdrawal by Subject|44
129254|NCT00532155|433981|P1|Overall Study|Withdrawal by Subject|23
129255|NCT00532155|433980|P2|Overall Study|Physician Decision|15
129256|NCT00532155|433981|P1|Overall Study|Physician Decision|16
129257|NCT00532155|433980|P2|Overall Study|Lost to Follow-up|0
129258|NCT00532155|433981|P1|Overall Study|Lost to Follow-up|2
129259|NCT00532155|433980|P2|Overall Study|Protocol Violation|3
129260|NCT00532155|433981|P1|Overall Study|Protocol Violation|1
129261|NCT00532155|433980|P2|Overall Study|Lack of Efficacy|255
129262|NCT00532155|433981|P1|Overall Study|Lack of Efficacy|332
129263|NCT00532155|433980|P2|Overall Study|Adverse Event|123
129264|NCT00532155|433981|P1|Overall Study|Adverse Event|66
129265|NCT00532129|433995|P1|Follow-up Period|Unspecified|6
129266|NCT00532129|433995|P1|Follow-up Period|Lost to Follow-up|1
129267|NCT00532129|433995|P1|Follow-up Period|Disease progression|57
129268|NCT00532129|433995|P1|Follow-up Period|Adverse event/Serious adverse event|1
129269|NCT00532129|433995|P1|Treatment Period|Unspecified|5
129270|NCT00532129|433995|P1|Treatment Period|Protocol Violation|1
129271|NCT00532129|433995|P1|Treatment Period|Disease progression|3
129272|NCT00532129|433995|P1|Treatment Period|Physician Decision|15
129273|NCT00532129|433995|P1|Treatment Period|Adverse event/Serious adverse event|25
129274|NCT00531960|434015|P2|Overall Study|Not Specified|10
129275|NCT00531960|434016|P1|Overall Study|Not Specified|4
129276|NCT00531960|434015|P2|Overall Study|Refused Treatment|6
129277|NCT00531960|434016|P1|Overall Study|Refused Treatment|5
129278|NCT00531960|434015|P2|Overall Study|Violation of Selection Criteria|0
129279|NCT00531960|434016|P1|Overall Study|Violation of Selection Criteria|2
129280|NCT00531960|434015|P2|Overall Study|Lack of Efficacy|41
129281|NCT00531960|434016|P1|Overall Study|Lack of Efficacy|42
129282|NCT00531960|434015|P2|Overall Study|Death|2
129283|NCT00531960|434016|P1|Overall Study|Death|3
129284|NCT00531960|434015|P2|Overall Study|Adverse Event|4
129285|NCT00531960|434016|P1|Overall Study|Adverse Event|5
129286|NCT00531947|434034|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
129287|NCT00531947|434035|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
129288|NCT00531947|434034|P2|Overall Study|Non-Compliance|7
129289|NCT00531947|434035|P1|Overall Study|Non-Compliance|4
129290|NCT00531947|434034|P2|Overall Study|Protocol Violation|1
129291|NCT00531947|434035|P1|Overall Study|Protocol Violation|2
129292|NCT00531947|434034|P2|Overall Study|Withdrawal by Subject|19
129293|NCT00531947|434035|P1|Overall Study|Withdrawal by Subject|14
129294|NCT00531947|434034|P2|Overall Study|Lost to Follow-up|9
129295|NCT00531947|434035|P1|Overall Study|Lost to Follow-up|12
129296|NCT00531947|434034|P2|Overall Study|Adverse Event|10
129297|NCT00531947|434035|P1|Overall Study|Adverse Event|5
129298|NCT00531934|434079|P2|Overall Study|Not specified|2
129299|NCT00531934|434080|P1|Overall Study|Not specified|2
129300|NCT00531934|434079|P2|Overall Study|Withdrawal by Subject|1
129301|NCT00531934|434080|P1|Overall Study|Withdrawal by Subject|1
129302|NCT00531934|434079|P2|Overall Study|Death|10
129303|NCT00531934|434080|P1|Overall Study|Death|7
129304|NCT00531934|434079|P2|Overall Study|Progression|42
129305|NCT00531934|434080|P1|Overall Study|Progression|52
129306|NCT00531934|434079|P2|Overall Study|Adverse Event|8
129307|NCT00531934|434080|P1|Overall Study|Adverse Event|4
129308|NCT00531752|434195|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
129309|NCT00531752|434196|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
129310|NCT00531752|434197|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
129311|NCT00531752|434198|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
129312|NCT00531752|434195|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
129313|NCT00531752|434196|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
129314|NCT00531752|434197|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
129315|NCT00531752|434198|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
129316|NCT00531752|434195|P4|Second Double-blind Intervention Period|unspecified|0
129317|NCT00531752|434196|P3|Second Double-blind Intervention Period|unspecified|0
129318|NCT00531752|434197|P2|Second Double-blind Intervention Period|unspecified|1
129319|NCT00531752|434198|P1|Second Double-blind Intervention Period|unspecified|1
129320|NCT00531752|434195|P4|Second Double-blind Intervention Period|Adverse Event|0
129321|NCT00531752|434196|P3|Second Double-blind Intervention Period|Adverse Event|0
129322|NCT00531752|434197|P2|Second Double-blind Intervention Period|Adverse Event|1
129323|NCT00531752|434198|P1|Second Double-blind Intervention Period|Adverse Event|1
129324|NCT00531752|434195|P4|First Double-blind Intervention Period|Randomized but not treated|0
129325|NCT00531752|434196|P3|First Double-blind Intervention Period|Randomized but not treated|0
129326|NCT00531752|434197|P2|First Double-blind Intervention Period|Randomized but not treated|0
129327|NCT00531752|434198|P1|First Double-blind Intervention Period|Randomized but not treated|1
129328|NCT00531752|434195|P4|First Double-blind Intervention Period|Lost to Follow-up|1
129329|NCT00531752|434196|P3|First Double-blind Intervention Period|Lost to Follow-up|1
129330|NCT00531752|434197|P2|First Double-blind Intervention Period|Lost to Follow-up|0
129331|NCT00531752|434198|P1|First Double-blind Intervention Period|Lost to Follow-up|0
129332|NCT00531752|434195|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
129333|NCT00531752|434196|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
129334|NCT00531752|434197|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
129335|NCT00531752|434198|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
129336|NCT00531752|434195|P4|First Double-blind Intervention Period|unspecified|0
129337|NCT00531752|434196|P3|First Double-blind Intervention Period|unspecified|4
129338|NCT00531752|434197|P2|First Double-blind Intervention Period|unspecified|4
129339|NCT00531752|434198|P1|First Double-blind Intervention Period|unspecified|1
129340|NCT00531752|434195|P4|First Double-blind Intervention Period|Adverse Event|1
129341|NCT00531752|434196|P3|First Double-blind Intervention Period|Adverse Event|1
129342|NCT00531752|434197|P2|First Double-blind Intervention Period|Adverse Event|0
129343|NCT00531752|434198|P1|First Double-blind Intervention Period|Adverse Event|2
129344|NCT00531479|434309|P2|Overall Study|Did not receive treatment|3
129345|NCT00531479|434310|P1|Overall Study|Did not receive treatment|2
129346|NCT00531479|434309|P2|Overall Study|Withdrawal by Subject|6
129347|NCT00531479|434310|P1|Overall Study|Withdrawal by Subject|6
129348|NCT00531479|434309|P2|Overall Study|Unspecified|1
129349|NCT00531479|434310|P1|Overall Study|Unspecified|0
129350|NCT00531479|434309|P2|Overall Study|Lost to Follow-up|2
129351|NCT00531479|434310|P1|Overall Study|Lost to Follow-up|0
129352|NCT00531479|434309|P2|Overall Study|Death|71
129353|NCT00531479|434310|P1|Overall Study|Death|68
129354|NCT00531427|434341|P2|Overall Study|Administrative|9
129355|NCT00531427|434342|P1|Overall Study|Administrative|4
129356|NCT00531427|434341|P2|Overall Study|Lack of Efficacy|39
129357|NCT00531427|434342|P1|Overall Study|Lack of Efficacy|14
129358|NCT00531427|434341|P2|Overall Study|Lost to Follow-up|3
129359|NCT00531427|434342|P1|Overall Study|Lost to Follow-up|4
129360|NCT00531427|434341|P2|Overall Study|Adverse Event|30
129361|NCT00531427|434342|P1|Overall Study|Adverse Event|44
129362|NCT00531427|434341|P2|Overall Study|Withdrawal by Subject|13
129363|NCT00531427|434342|P1|Overall Study|Withdrawal by Subject|7
129364|NCT00531284|434370|P17|Overall Study|Other|0
129365|NCT00531284|434371|P16|Overall Study|Other|0
129366|NCT00531284|434372|P15|Overall Study|Other|1
129367|NCT00531284|434373|P14|Overall Study|Other|0
129368|NCT00531284|434374|P13|Overall Study|Other|0
129369|NCT00531284|434375|P12|Overall Study|Other|2
129370|NCT00531284|434376|P11|Overall Study|Other|0
129371|NCT00531284|434377|P10|Overall Study|Other|1
129372|NCT00531284|434378|P9|Overall Study|Other|2
129373|NCT00531284|434379|P8|Overall Study|Other|0
129374|NCT00531284|434380|P7|Overall Study|Other|0
129375|NCT00531284|434381|P6|Overall Study|Other|1
129376|NCT00531284|434382|P5|Overall Study|Other|2
129377|NCT00531284|434383|P4|Overall Study|Other|10
129378|NCT00531284|434384|P3|Overall Study|Other|0
129379|NCT00531284|434385|P2|Overall Study|Other|0
129380|NCT00531284|434386|P1|Overall Study|Other|1
129381|NCT00531284|434370|P17|Overall Study|Withdrawal by Subject|1
129382|NCT00531284|434371|P16|Overall Study|Withdrawal by Subject|1
129383|NCT00531284|434372|P15|Overall Study|Withdrawal by Subject|0
129384|NCT00531284|434373|P14|Overall Study|Withdrawal by Subject|1
129385|NCT00531284|434374|P13|Overall Study|Withdrawal by Subject|0
129386|NCT00531284|434375|P12|Overall Study|Withdrawal by Subject|3
129387|NCT00531284|434376|P11|Overall Study|Withdrawal by Subject|0
129388|NCT00531284|434377|P10|Overall Study|Withdrawal by Subject|0
129389|NCT00531284|434378|P9|Overall Study|Withdrawal by Subject|0
129390|NCT00531284|434379|P8|Overall Study|Withdrawal by Subject|0
129391|NCT00531284|434380|P7|Overall Study|Withdrawal by Subject|0
129392|NCT00531284|434381|P6|Overall Study|Withdrawal by Subject|0
129393|NCT00531284|434382|P5|Overall Study|Withdrawal by Subject|0
129394|NCT00531284|434383|P4|Overall Study|Withdrawal by Subject|4
129395|NCT00531284|434384|P3|Overall Study|Withdrawal by Subject|0
129396|NCT00531284|434385|P2|Overall Study|Withdrawal by Subject|0
129397|NCT00531284|434386|P1|Overall Study|Withdrawal by Subject|1
129398|NCT00531284|434370|P17|Overall Study|Adverse Event|2
129399|NCT00531284|434371|P16|Overall Study|Adverse Event|0
129400|NCT00531284|434372|P15|Overall Study|Adverse Event|1
129401|NCT00531284|434373|P14|Overall Study|Adverse Event|1
129402|NCT00531284|434374|P13|Overall Study|Adverse Event|0
129403|NCT00531284|434375|P12|Overall Study|Adverse Event|5
129404|NCT00531284|434376|P11|Overall Study|Adverse Event|0
129405|NCT00531284|434377|P10|Overall Study|Adverse Event|0
129406|NCT00531284|434378|P9|Overall Study|Adverse Event|3
129407|NCT00531284|434379|P8|Overall Study|Adverse Event|2
129408|NCT00531284|434380|P7|Overall Study|Adverse Event|3
129409|NCT00531284|434381|P6|Overall Study|Adverse Event|2
129410|NCT00531284|434382|P5|Overall Study|Adverse Event|0
129411|NCT00531284|434383|P4|Overall Study|Adverse Event|7
129412|NCT00531284|434384|P3|Overall Study|Adverse Event|1
129413|NCT00531284|434385|P2|Overall Study|Adverse Event|1
129414|NCT00531284|434386|P1|Overall Study|Adverse Event|0
129415|NCT00531284|434370|P17|Overall Study|Progressive Disease|5
129416|NCT00531284|434371|P16|Overall Study|Progressive Disease|11
129417|NCT00531284|434372|P15|Overall Study|Progressive Disease|2
129418|NCT00531284|434373|P14|Overall Study|Progressive Disease|1
129419|NCT00531284|434374|P13|Overall Study|Progressive Disease|2
129420|NCT00531284|434375|P12|Overall Study|Progressive Disease|14
129421|NCT00531284|434376|P11|Overall Study|Progressive Disease|3
129422|NCT00531284|434377|P10|Overall Study|Progressive Disease|3
129423|NCT00531284|434378|P9|Overall Study|Progressive Disease|6
129424|NCT00531284|434379|P8|Overall Study|Progressive Disease|8
129425|NCT00531284|434380|P7|Overall Study|Progressive Disease|3
129426|NCT00531284|434381|P6|Overall Study|Progressive Disease|4
129427|NCT00531284|434382|P5|Overall Study|Progressive Disease|4
129428|NCT00531284|434383|P4|Overall Study|Progressive Disease|42
129429|NCT00531284|434384|P3|Overall Study|Progressive Disease|5
129430|NCT00531284|434385|P2|Overall Study|Progressive Disease|3
129431|NCT00531284|434386|P1|Overall Study|Progressive Disease|1
129432|NCT00531206|434536|P1|Overall Study|including non-related adverse events|8
129433|NCT00531206|434536|P1|Overall Study|Lost to Follow-up|5
129434|NCT00531206|434536|P1|Overall Study|Lack of Efficacy|2
129435|NCT00531206|434536|P1|Overall Study|Adverse Event related|5
129436|NCT00531050|434566|P6|Part 2: Period 3|Abnormal test procedure|1
129437|NCT00531050|434567|P5|Part 2: Period 3|Abnormal test procedure|0
129438|NCT00531050|434568|P4|Part 2: Period 3|Abnormal test procedure|0
129439|NCT00531050|434569|P3|Part 2: Period 3|Abnormal test procedure|0
129440|NCT00531050|434570|P2|Part 2: Period 3|Abnormal test procedure|0
129441|NCT00531050|434571|P1|Part 2: Period 3|Abnormal test procedure|1
129442|NCT00531050|434566|P6|Part 2: Period 1|Adverse Event|1
129443|NCT00531050|434567|P5|Part 2: Period 1|Adverse Event|0
129444|NCT00531050|434568|P4|Part 2: Period 1|Adverse Event|0
129445|NCT00531050|434569|P3|Part 2: Period 1|Adverse Event|0
129446|NCT00531050|434570|P2|Part 2: Period 1|Adverse Event|0
129447|NCT00531050|434571|P1|Part 2: Period 1|Adverse Event|0
129448|NCT00531050|434566|P6|Part 1: Period 3|Adverse Event|0
129449|NCT00531050|434567|P5|Part 1: Period 3|Adverse Event|0
129450|NCT00531050|434568|P4|Part 1: Period 3|Adverse Event|0
129451|NCT00531050|434569|P3|Part 1: Period 3|Adverse Event|0
129452|NCT00531050|434570|P2|Part 1: Period 3|Adverse Event|0
129453|NCT00531050|434571|P1|Part 1: Period 3|Adverse Event|1
129454|NCT00531050|434566|P6|Part 1: Period 1|Protocol Deviation|0
129455|NCT00531050|434567|P5|Part 1: Period 1|Protocol Deviation|0
129456|NCT00531050|434568|P4|Part 1: Period 1|Protocol Deviation|1
129457|NCT00531050|434569|P3|Part 1: Period 1|Protocol Deviation|0
129458|NCT00531050|434570|P2|Part 1: Period 1|Protocol Deviation|0
129459|NCT00531050|434571|P1|Part 1: Period 1|Protocol Deviation|0
129460|NCT00531050|434566|P6|Part 1: Period 1|Adverse Event|0
129461|NCT00531050|434567|P5|Part 1: Period 1|Adverse Event|0
129462|NCT00531050|434568|P4|Part 1: Period 1|Adverse Event|0
129463|NCT00531050|434569|P3|Part 1: Period 1|Adverse Event|0
129464|NCT00531050|434570|P2|Part 1: Period 1|Adverse Event|1
129465|NCT00531050|434571|P1|Part 1: Period 1|Adverse Event|0
129466|NCT00531011|434600|P2|Overall Study|Physician Decision|3
129467|NCT00531011|434601|P1|Overall Study|Physician Decision|0
129468|NCT00531011|434600|P2|Overall Study|Lost to Follow-up|0
129469|NCT00531011|434601|P1|Overall Study|Lost to Follow-up|1
129470|NCT00531011|434600|P2|Overall Study|Death|0
129471|NCT00531011|434601|P1|Overall Study|Death|1
129472|NCT00531011|434600|P2|Overall Study|Withdrawal by Subject|4
129473|NCT00531011|434601|P1|Overall Study|Withdrawal by Subject|2
129474|NCT00530946|434647|P4|Overall Study|Noncompliance|0
129475|NCT00530946|434648|P3|Overall Study|Noncompliance|0
129476|NCT00530946|434649|P2|Overall Study|Noncompliance|0
129477|NCT00530946|434650|P1|Overall Study|Noncompliance|1
129478|NCT00530946|434647|P4|Overall Study|Protocol Violation|1
129479|NCT00530946|434648|P3|Overall Study|Protocol Violation|0
129480|NCT00530946|434649|P2|Overall Study|Protocol Violation|0
129481|NCT00530946|434650|P1|Overall Study|Protocol Violation|0
129482|NCT00530946|434647|P4|Overall Study|Adverse Event|1
129483|NCT00530946|434648|P3|Overall Study|Adverse Event|1
129484|NCT00530946|434649|P2|Overall Study|Adverse Event|2
129485|NCT00530946|434650|P1|Overall Study|Adverse Event|1
129486|NCT00530920|434703|P3|Overall Study|Withdrawal by Subject|1
129487|NCT00530920|434704|P2|Overall Study|Withdrawal by Subject|0
129488|NCT00530920|434705|P1|Overall Study|Withdrawal by Subject|0
129489|NCT00530920|434703|P3|Overall Study|Adverse Event|3
129490|NCT00530920|434704|P2|Overall Study|Adverse Event|0
129491|NCT00530920|434705|P1|Overall Study|Adverse Event|0
129492|NCT00530920|434703|P3|Overall Study|Randomized but not treated|0
129493|NCT00530920|434704|P2|Overall Study|Randomized but not treated|2
129494|NCT00530920|434705|P1|Overall Study|Randomized but not treated|0
129495|NCT00530855|434761|P1|Overall Study|Other reason for premature termination|17
129496|NCT00530855|434761|P1|Overall Study|Lost to Follow-up|9
129497|NCT00530855|434761|P1|Overall Study|Unsatisfactory compliance of subject|11
129498|NCT00530855|434761|P1|Overall Study|Protocol Violation|3
129499|NCT00530855|434761|P1|Overall Study|Non Fatal Non Serious AE|12
129500|NCT00530855|434761|P1|Overall Study|Non Fatal Serious AE|7
129501|NCT00530855|434761|P1|Overall Study|Fatal Serious AE|3
129502|NCT00530855|434761|P1|Overall Study|Withdrawal by Subject|30
129503|NCT00530855|434761|P1|Overall Study|Lack of Efficacy|20
129504|NCT00530842|434770|P2|Period 2|Individual different reasons|0
129505|NCT00530842|434771|P1|Period 2|Individual different reasons|2
129506|NCT00530842|434770|P2|Period 2|Withdrawal by Subject|2
129507|NCT00530842|434771|P1|Period 2|Withdrawal by Subject|1
129508|NCT00530842|434770|P2|Period 2|Protocol Violation|0
129509|NCT00530842|434771|P1|Period 2|Protocol Violation|1
129510|NCT00530842|434770|P2|Period 2|Lost to Follow-up|4
129511|NCT00530842|434771|P1|Period 2|Lost to Follow-up|0
129512|NCT00530842|434770|P2|Period 2|Lack of Efficacy|0
129513|NCT00530842|434771|P1|Period 2|Lack of Efficacy|1
129514|NCT00530842|434770|P2|Period 2|Adverse Event|3
129515|NCT00530842|434771|P1|Period 2|Adverse Event|3
129516|NCT00530842|434770|P2|Period 1|Individual different reasons|3
129517|NCT00530842|434771|P1|Period 1|Individual different reasons|2
129518|NCT00530842|434770|P2|Period 1|Withdrawal by Subject|3
129519|NCT00530842|434771|P1|Period 1|Withdrawal by Subject|2
129520|NCT00530842|434770|P2|Period 1|Protocol Violation|1
129521|NCT00530842|434771|P1|Period 1|Protocol Violation|2
129522|NCT00530842|434770|P2|Period 1|Lack of Efficacy|1
129523|NCT00530842|434771|P1|Period 1|Lack of Efficacy|1
129524|NCT00530842|434770|P2|Period 1|Adverse Event|3
129525|NCT00530842|434771|P1|Period 1|Adverse Event|7
129526|NCT00530842|434770|P2|Overall Study|Individual different reasons|3
129527|NCT00530842|434771|P1|Overall Study|Individual different reasons|4
129528|NCT00530842|434770|P2|Overall Study|Withdrawal by Subject|5
129529|NCT00530842|434771|P1|Overall Study|Withdrawal by Subject|4
129530|NCT00530842|434770|P2|Overall Study|Protocol Violation|2
129531|NCT00530842|434771|P1|Overall Study|Protocol Violation|3
129532|NCT00530842|434770|P2|Overall Study|Lost to Follow-up|4
129533|NCT00530842|434771|P1|Overall Study|Lost to Follow-up|0
129534|NCT00530842|434770|P2|Overall Study|Lack of Efficacy|1
129535|NCT00530842|434771|P1|Overall Study|Lack of Efficacy|2
129536|NCT00530842|434770|P2|Overall Study|Adverse Event|6
129537|NCT00530842|434771|P1|Overall Study|Adverse Event|10
129538|NCT00530816|434898|P3|Overall Study|Withdrawal by Subject|6
129539|NCT00530816|434899|P2|Overall Study|Withdrawal by Subject|2
129540|NCT00530816|434900|P1|Overall Study|Withdrawal by Subject|1
129541|NCT00530816|434898|P3|Overall Study|Other|4
129542|NCT00530816|434899|P2|Overall Study|Other|3
129543|NCT00530816|434900|P1|Overall Study|Other|3
129544|NCT00530816|434898|P3|Overall Study|Adverse Event|7
129545|NCT00530816|434899|P2|Overall Study|Adverse Event|13
129546|NCT00530816|434900|P1|Overall Study|Adverse Event|6
129547|NCT00530816|434898|P3|Overall Study|Progressive Disease|24
129548|NCT00530816|434899|P2|Overall Study|Progressive Disease|24
129549|NCT00530816|434900|P1|Overall Study|Progressive Disease|16
129550|NCT00530790|434926|P1|Overall Study|Physician Decision|1
129551|NCT00530790|434926|P1|Overall Study|Withdrawal by Subject|2
129552|NCT00530790|434926|P1|Overall Study|Adverse Event|2
129553|NCT00530777|434948|P2|Overall Study|Unable to adhere to visit schedule|1
129554|NCT00530777|434949|P1|Overall Study|Unable to adhere to visit schedule|5
129555|NCT00530777|434948|P2|Overall Study|Withdrawal by Subject|1
129556|NCT00530777|434949|P1|Overall Study|Withdrawal by Subject|0
129557|NCT00530777|434948|P2|Overall Study|Physician Decision|0
129558|NCT00530777|434949|P1|Overall Study|Physician Decision|1
129559|NCT00530777|434948|P2|Overall Study|Death|2
129560|NCT00530777|434949|P1|Overall Study|Death|1
129561|NCT00530777|434948|P2|Overall Study|Lost to Follow-up|1
129562|NCT00530777|434949|P1|Overall Study|Lost to Follow-up|0
129563|NCT00530712|435006|P1|12 Month Follow-up Visit|Death|9
129564|NCT00530712|435006|P1|12 Month Follow-up Visit|Lost to Follow-up|7
129565|NCT00530712|435006|P1|12 Month Follow-up Visit|Missed Visit|3
129566|NCT00530712|435006|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
129567|NCT00530712|435006|P1|6 Month Follow-up Visit|Death|2
129568|NCT00530712|435006|P1|6 Month Follow-up Visit|Lost to Follow-up|3
129569|NCT00530712|435006|P1|6 Month Follow-up Visit|Missed Visit|3
129570|NCT00530712|435006|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
129571|NCT00530712|435006|P1|30 Day Follow-up Visit|Missed Visit|5
129572|NCT00530712|435006|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
129573|NCT00530504|435025|P1|Overall Study|Exited study due to other reasons|33
129574|NCT00530504|435025|P1|Overall Study|Withdrawal by Subject|39
129575|NCT00530504|435025|P1|Overall Study|Lost to Follow-up|26
129576|NCT00530504|435025|P1|Overall Study|Death|54
129577|NCT00530439|435031|P2|Overall Study|Severe malformation/abortion|3
129578|NCT00530439|435032|P1|Overall Study|Severe malformation/abortion|0
129579|NCT00530439|435031|P2|Overall Study|Twin pregnancy|2
129580|NCT00530439|435032|P1|Overall Study|Twin pregnancy|0
129581|NCT00530439|435031|P2|Overall Study|Misclassification|0
129582|NCT00530439|435032|P1|Overall Study|Misclassification|2
129583|NCT00530439|435031|P2|Overall Study|Missed abortion|4
129584|NCT00530439|435032|P1|Overall Study|Missed abortion|1
129585|NCT00530439|435031|P2|Overall Study|Withdraw|14
129586|NCT00530439|435032|P1|Overall Study|Withdraw|18
129587|NCT00530439|435031|P2|Overall Study|GDM|3
129588|NCT00530439|435032|P1|Overall Study|GDM|9
129589|NCT00530348|435040|P2|Overall Study|Noncompliance with inclusion criterion 3|1
129590|NCT00530348|435041|P1|Overall Study|Noncompliance with inclusion criterion 3|0
129591|NCT00530348|435040|P2|Overall Study|Randomised in error|0
129592|NCT00530348|435041|P1|Overall Study|Randomised in error|1
129593|NCT00530348|435040|P2|Overall Study|Withdrawal by Subject|12
129594|NCT00530348|435041|P1|Overall Study|Withdrawal by Subject|12
129595|NCT00530348|435040|P2|Overall Study|Pregnancy|0
129596|NCT00530348|435041|P1|Overall Study|Pregnancy|1
129597|NCT00530348|435040|P2|Overall Study|Physician Decision|2
129598|NCT00530348|435041|P1|Overall Study|Physician Decision|1
129599|NCT00530348|435040|P2|Overall Study|Lost to Follow-up|2
129600|NCT00530348|435041|P1|Overall Study|Lost to Follow-up|0
129601|NCT00530348|435040|P2|Overall Study|Lack of Efficacy|0
129602|NCT00530348|435041|P1|Overall Study|Lack of Efficacy|2
129603|NCT00530348|435040|P2|Overall Study|Death|1
129604|NCT00530348|435041|P1|Overall Study|Death|0
129605|NCT00530348|435040|P2|Overall Study|Adverse Event|1
129606|NCT00530348|435041|P1|Overall Study|Adverse Event|5
129607|NCT00530335|435057|P1|Overall Study|Physician Decision|1
129608|NCT00530335|435057|P1|Overall Study|Withdrawal by Subject|1
129609|NCT00530335|435057|P1|Overall Study|Protocol Violation|1
129610|NCT00530335|435057|P1|Overall Study|Adverse Event|3
129611|NCT00530270|435074|P2|Overall Study|Protocol Violation|0
129612|NCT00530270|435075|P1|Overall Study|Protocol Violation|1
129613|NCT00530257|435089|P1|Overall Study|Lost to Follow-up|1
129614|NCT00530088|435117|P1|Overall Study|Other Not Specified|2
129615|NCT00530088|435117|P1|Overall Study|Physician Decision|4
129616|NCT00530088|435117|P1|Overall Study|Disease Progression|4
129617|NCT00530023|435124|P2|Overall Study|Withdrawal by Subject|1
129618|NCT00530023|435125|P1|Overall Study|Withdrawal by Subject|0
129619|NCT00529789|435139|P1|Study Period IV|Lost to Follow-up|3
129620|NCT00529789|435139|P1|Study Period IV|Lack of Efficacy|1
129621|NCT00529789|435139|P1|Study Period IV|Adverse Event|1
129622|NCT00529789|435139|P1|Study Period IV|Parent/Caregiver Decision|1
129623|NCT00529789|435139|P1|Study Period II/III|Lost to Follow-up|3
129624|NCT00529789|435139|P1|Study Period II/III|Physician Decision|3
129625|NCT00529789|435139|P1|Study Period II/III|Protocol Violation|3
129626|NCT00529789|435139|P1|Study Period II/III|Withdrawal by Subject|1
129627|NCT00529789|435139|P1|Study Period II/III|Lack of Efficacy|2
129628|NCT00529789|435139|P1|Study Period II/III|Adverse Event|3
129629|NCT00529789|435139|P1|Study Period II/III|Parent/Caregiver Decision|9
129630|NCT00529763|435164|P3|Overall Study|Patient Withdrew Consent|2
129631|NCT00529763|435165|P2|Overall Study|Patient Withdrew Consent|3
129632|NCT00529763|435166|P1|Overall Study|Patient Withdrew Consent|2
129633|NCT00529763|435164|P3|Overall Study|Study Drug Toxicity|1
129634|NCT00529763|435165|P2|Overall Study|Study Drug Toxicity|6
129635|NCT00529763|435166|P1|Overall Study|Study Drug Toxicity|1
129636|NCT00529763|435164|P3|Overall Study|Stem Cell Transplant|0
129637|NCT00529763|435165|P2|Overall Study|Stem Cell Transplant|3
129638|NCT00529763|435166|P1|Overall Study|Stem Cell Transplant|0
129639|NCT00529763|435164|P3|Overall Study|Lost to Follow-up|1
129640|NCT00529763|435165|P2|Overall Study|Lost to Follow-up|1
129641|NCT00529763|435166|P1|Overall Study|Lost to Follow-up|0
129642|NCT00529763|435164|P3|Overall Study|Disease Progression|1
129643|NCT00529763|435165|P2|Overall Study|Disease Progression|16
129644|NCT00529763|435166|P1|Overall Study|Disease Progression|6
129645|NCT00529763|435164|P3|Overall Study|Death|1
129646|NCT00529763|435165|P2|Overall Study|Death|1
129647|NCT00529763|435166|P1|Overall Study|Death|0
129648|NCT00529763|435164|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
129649|NCT00529763|435165|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
129650|NCT00529763|435166|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
129651|NCT00529659|435204|P2|Overall Study|Withdrawal by Subject|6
129652|NCT00529659|435205|P1|Overall Study|Withdrawal by Subject|1
129653|NCT00529659|435204|P2|Overall Study|Protocol Violation|6
129654|NCT00529659|435205|P1|Overall Study|Protocol Violation|2
129655|NCT00529659|435204|P2|Overall Study|Physician Decision|2
129656|NCT00529659|435205|P1|Overall Study|Physician Decision|0
129657|NCT00529659|435204|P2|Overall Study|Lost to Follow-up|2
129658|NCT00529659|435205|P1|Overall Study|Lost to Follow-up|0
129659|NCT00529659|435204|P2|Overall Study|Adverse Event|7
129660|NCT00529659|435205|P1|Overall Study|Adverse Event|8
129661|NCT00529633|435223|P2|Overall Study|Withdrawal by Subject|1
129662|NCT00529633|435224|P1|Overall Study|Withdrawal by Subject|1
129663|NCT00529568|435236|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
129664|NCT00529568|435237|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
129665|NCT00529568|435238|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
129666|NCT00529568|435236|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
129667|NCT00529568|435237|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
129668|NCT00529568|435238|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
129669|NCT00529568|435236|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
129670|NCT00529568|435237|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
129671|NCT00529568|435238|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
129672|NCT00529568|435236|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
129673|NCT00529568|435237|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
129674|NCT00529568|435238|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
129675|NCT00529568|435236|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
129676|NCT00529568|435237|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
129677|NCT00529568|435238|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
129678|NCT00529568|435236|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
129679|NCT00529568|435237|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
129680|NCT00529568|435238|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
129681|NCT00529568|435236|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
129682|NCT00529568|435237|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
129683|NCT00529568|435238|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
129684|NCT00529568|435236|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
129685|NCT00529568|435237|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
129686|NCT00529568|435238|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
129687|NCT00529568|435236|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
129688|NCT00529568|435237|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
129689|NCT00529568|435238|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
129690|NCT00529568|435236|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
129691|NCT00529568|435237|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
129692|NCT00529568|435238|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
129693|NCT00529568|435236|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
129694|NCT00529568|435237|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
129695|NCT00529568|435238|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
129696|NCT00529542|435301|P2|Overall Study|Lost to Follow-up|1
129697|NCT00529542|435302|P1|Overall Study|Lost to Follow-up|0
129698|NCT00529542|435301|P2|Overall Study|Withdrawal by Subject|0
129699|NCT00529542|435302|P1|Overall Study|Withdrawal by Subject|1
129700|NCT00529529|435345|P3|Overall Study|Administrative problems|3
129701|NCT00529529|435346|P2|Overall Study|Administrative problems|0
129702|NCT00529529|435347|P1|Overall Study|Administrative problems|1
129703|NCT00529529|435345|P3|Overall Study|Abnormal test procedure result(s)|0
129704|NCT00529529|435346|P2|Overall Study|Abnormal test procedure result(s)|0
129705|NCT00529529|435347|P1|Overall Study|Abnormal test procedure result(s)|1
129706|NCT00529529|435345|P3|Overall Study|Death|0
129707|NCT00529529|435346|P2|Overall Study|Death|0
129708|NCT00529529|435347|P1|Overall Study|Death|2
129709|NCT00529529|435345|P3|Overall Study|Unsatisfactory therapeutic effect|2
129710|NCT00529529|435346|P2|Overall Study|Unsatisfactory therapeutic effect|2
129711|NCT00529529|435347|P1|Overall Study|Unsatisfactory therapeutic effect|2
129712|NCT00529529|435345|P3|Overall Study|Lost to Follow-up|1
129713|NCT00529529|435346|P2|Overall Study|Lost to Follow-up|3
129714|NCT00529529|435347|P1|Overall Study|Lost to Follow-up|5
129715|NCT00529529|435345|P3|Overall Study|Protocol deviation|5
129716|NCT00529529|435346|P2|Overall Study|Protocol deviation|12
129717|NCT00529529|435347|P1|Overall Study|Protocol deviation|8
129718|NCT00529529|435345|P3|Overall Study|Subject withdrew consent|12
129719|NCT00529529|435346|P2|Overall Study|Subject withdrew consent|9
129720|NCT00529529|435347|P1|Overall Study|Subject withdrew consent|12
129721|NCT00529529|435345|P3|Overall Study|Adverse Event|8
129722|NCT00529529|435346|P2|Overall Study|Adverse Event|17
129723|NCT00529529|435347|P1|Overall Study|Adverse Event|12
129724|NCT00529516|435406|P3|Overall Study|Lost to Follow-up|1
129725|NCT00529516|435407|P2|Overall Study|Lost to Follow-up|0
129726|NCT00529516|435408|P1|Overall Study|Lost to Follow-up|0
129727|NCT00529516|435406|P3|Overall Study|Withdrawal by Subject|0
129728|NCT00529516|435407|P2|Overall Study|Withdrawal by Subject|1
129729|NCT00529516|435408|P1|Overall Study|Withdrawal by Subject|1
129730|NCT00529516|435406|P3|Overall Study|Adverse Event|0
129731|NCT00529516|435407|P2|Overall Study|Adverse Event|1
129732|NCT00529516|435408|P1|Overall Study|Adverse Event|2
129733|NCT00529451|435493|P4|Overall Study|Administrative problems|2
129734|NCT00529451|435494|P3|Overall Study|Administrative problems|0
129735|NCT00529451|435495|P2|Overall Study|Administrative problems|1
129736|NCT00529451|435496|P1|Overall Study|Administrative problems|1
129737|NCT00529451|435493|P4|Overall Study|Protocol deviation|1
129738|NCT00529451|435494|P3|Overall Study|Protocol deviation|4
129739|NCT00529451|435495|P2|Overall Study|Protocol deviation|1
129740|NCT00529451|435496|P1|Overall Study|Protocol deviation|1
129741|NCT00529451|435493|P4|Overall Study|Lost to Follow-up|4
129742|NCT00529451|435494|P3|Overall Study|Lost to Follow-up|4
129743|NCT00529451|435495|P2|Overall Study|Lost to Follow-up|7
129744|NCT00529451|435496|P1|Overall Study|Lost to Follow-up|4
129745|NCT00529451|435493|P4|Overall Study|Unsatisfactory therapeutic response|4
129746|NCT00529451|435494|P3|Overall Study|Unsatisfactory therapeutic response|5
129747|NCT00529451|435495|P2|Overall Study|Unsatisfactory therapeutic response|2
129748|NCT00529451|435496|P1|Overall Study|Unsatisfactory therapeutic response|6
129749|NCT00529451|435493|P4|Overall Study|Adverse Event|8
129750|NCT00529451|435494|P3|Overall Study|Adverse Event|14
129751|NCT00529451|435495|P2|Overall Study|Adverse Event|16
129752|NCT00529451|435496|P1|Overall Study|Adverse Event|9
129753|NCT00529451|435493|P4|Overall Study|Subject withdrew consent|12
129754|NCT00529451|435494|P3|Overall Study|Subject withdrew consent|13
129755|NCT00529451|435495|P2|Overall Study|Subject withdrew consent|21
129756|NCT00529451|435496|P1|Overall Study|Subject withdrew consent|16
129757|NCT00529399|435523|P3|Overall Study|Non-compliant|0
129758|NCT00529399|435524|P2|Overall Study|Non-compliant|1
129759|NCT00529399|435525|P1|Overall Study|Non-compliant|0
129760|NCT00529399|435523|P3|Overall Study|Withdrawal by Subject|1
129761|NCT00529399|435524|P2|Overall Study|Withdrawal by Subject|0
129762|NCT00529399|435525|P1|Overall Study|Withdrawal by Subject|1
129763|NCT00529399|435523|P3|Overall Study|Lost to Follow-up|1
129764|NCT00529399|435524|P2|Overall Study|Lost to Follow-up|0
129765|NCT00529399|435525|P1|Overall Study|Lost to Follow-up|1
129766|NCT00529308|435535|P2|Overall Study|Withdrawal by Subject|1
129767|NCT00529308|435536|P1|Overall Study|Withdrawal by Subject|1
129768|NCT00529243|435565|P1|Overall Study|Relocated|1
129769|NCT00529243|435565|P1|Overall Study|Death|1
129770|NCT00529243|435565|P1|Overall Study|Adverse Event|1
129771|NCT00529217|435570|P1|Overall Study|Unable to adhere to study schedule|2
129772|NCT00529217|435570|P1|Overall Study|Lack of Efficacy|2
129773|NCT00529152|435590|P1|Overall Study|Lost to Follow-up|1
129774|NCT00529152|435590|P1|Overall Study|Withdrawal by Subject|2
129775|NCT00529152|435590|P1|Overall Study|Adverse Event|2
129776|NCT00529100|435614|P2|Overall Study|Participant Ineligibility|1
129777|NCT00529100|435615|P1|Overall Study|Participant Ineligibility|0
129778|NCT00529100|435614|P2|Overall Study|Withdrawal by Subject|1
129779|NCT00529100|435615|P1|Overall Study|Withdrawal by Subject|0
129780|NCT00529100|435614|P2|Overall Study|Progressive Disease|1
129781|NCT00529100|435615|P1|Overall Study|Progressive Disease|0
129782|NCT00529100|435614|P2|Overall Study|Protocol Violation|1
129783|NCT00529100|435615|P1|Overall Study|Protocol Violation|0
129784|NCT00529100|435614|P2|Overall Study|Adverse Event|5
129785|NCT00529100|435615|P1|Overall Study|Adverse Event|0
129786|NCT00529087|435632|P3|Overall Study|Protocol deviation|2
129787|NCT00529087|435633|P2|Overall Study|Protocol deviation|1
129788|NCT00529087|435634|P1|Overall Study|Protocol deviation|1
129789|NCT00529087|435632|P3|Overall Study|Withdrawal by Subject|3
129790|NCT00529087|435633|P2|Overall Study|Withdrawal by Subject|3
129791|NCT00529087|435634|P1|Overall Study|Withdrawal by Subject|3
129792|NCT00529087|435632|P3|Overall Study|Protocol Violation|6
129793|NCT00529087|435633|P2|Overall Study|Protocol Violation|7
129794|NCT00529087|435634|P1|Overall Study|Protocol Violation|8
129795|NCT00529087|435632|P3|Overall Study|Lost to Follow-up|1
129796|NCT00529087|435633|P2|Overall Study|Lost to Follow-up|4
129797|NCT00529087|435634|P1|Overall Study|Lost to Follow-up|6
129798|NCT00529087|435632|P3|Overall Study|Adverse Event|4
129799|NCT00529087|435633|P2|Overall Study|Adverse Event|13
129800|NCT00529087|435634|P1|Overall Study|Adverse Event|10
129801|NCT00529035|435698|P1|Overall Study|Withdrawal by Subject|1
129802|NCT00528957|435720|P2|Second Extension (Week 144 to Week 240)|Poor adherence|0
129803|NCT00528957|435721|P1|Second Extension (Week 144 to Week 240)|Poor adherence|1
129804|NCT00528957|435720|P2|Second Extension (Week 144 to Week 240)|Lack of Efficacy|0
129805|NCT00528957|435721|P1|Second Extension (Week 144 to Week 240)|Lack of Efficacy|1
129806|NCT00528957|435720|P2|Second Extension (Week 144 to Week 240)|Adverse Event|2
129807|NCT00528957|435721|P1|Second Extension (Week 144 to Week 240)|Adverse Event|2
129808|NCT00528957|435720|P2|Second Extension (Week 144 to Week 240)|Physician Decision|0
129809|NCT00528957|435721|P1|Second Extension (Week 144 to Week 240)|Physician Decision|2
129810|NCT00528957|435720|P2|Second Extension (Week 144 to Week 240)|Study Ongoing|38
129811|NCT00528957|435721|P1|Second Extension (Week 144 to Week 240)|Study Ongoing|28
129812|NCT00528957|435720|P2|First Extension (Week 48 to Week 144)|Adverse Event|0
129813|NCT00528957|435721|P1|First Extension (Week 48 to Week 144)|Adverse Event|1
129814|NCT00528957|435720|P2|First Extension (Week 48 to Week 144)|Withdrawal by Subject|1
129815|NCT00528957|435721|P1|First Extension (Week 48 to Week 144)|Withdrawal by Subject|0
129816|NCT00528957|435720|P2|First Extension (Week 48 to Week 144)|Physician Decision|0
129817|NCT00528957|435721|P1|First Extension (Week 48 to Week 144)|Physician Decision|2
129818|NCT00528957|435720|P2|Randomized Phase (Baseline to Week 48)|Intolerability to oral powder|0
129819|NCT00528957|435721|P1|Randomized Phase (Baseline to Week 48)|Intolerability to oral powder|1
129820|NCT00528957|435720|P2|Randomized Phase (Baseline to Week 48)|Lack of Efficacy|0
129821|NCT00528957|435721|P1|Randomized Phase (Baseline to Week 48)|Lack of Efficacy|1
129822|NCT00528957|435720|P2|Randomized Phase (Baseline to Week 48)|Withdrawal by Subject|1
129823|NCT00528957|435721|P1|Randomized Phase (Baseline to Week 48)|Withdrawal by Subject|2
129824|NCT00528931|435764|P1|Overall Study|Lost to Follow-up|1
129825|NCT00528879|435776|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
129826|NCT00528879|435777|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
129827|NCT00528879|435778|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
129828|NCT00528879|435779|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
129829|NCT00528879|435776|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
129830|NCT00528879|435777|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
129831|NCT00528879|435778|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
129832|NCT00528879|435779|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
129833|NCT00528879|435776|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
129834|NCT00528879|435777|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
129835|NCT00528879|435778|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
129836|NCT00528879|435779|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
129837|NCT00528879|435776|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
129838|NCT00528879|435777|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
129839|NCT00528879|435778|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
129840|NCT00528879|435779|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
129841|NCT00528879|435776|P4|Long-term Period (Weeks 24 to 102)|Death|0
129842|NCT00528879|435777|P3|Long-term Period (Weeks 24 to 102)|Death|0
129843|NCT00528879|435778|P2|Long-term Period (Weeks 24 to 102)|Death|1
129844|NCT00528879|435779|P1|Long-term Period (Weeks 24 to 102)|Death|0
129845|NCT00528879|435776|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
129846|NCT00528879|435777|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
129847|NCT00528879|435778|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
129848|NCT00528879|435779|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
129849|NCT00528879|435776|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
129850|NCT00528879|435777|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
129851|NCT00528879|435778|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
129852|NCT00528879|435779|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
129853|NCT00528879|435776|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
129854|NCT00528879|435777|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
129855|NCT00528879|435778|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
129856|NCT00528879|435779|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
129857|NCT00528879|435776|P4|Short-term Period (Day 1 to Week 24)|Not specified|1
129858|NCT00528879|435777|P3|Short-term Period (Day 1 to Week 24)|Not specified|1
129859|NCT00528879|435778|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
129860|NCT00528879|435779|P1|Short-term Period (Day 1 to Week 24)|Not specified|0
129861|NCT00528879|435776|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
129862|NCT00528879|435777|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
129863|NCT00528879|435778|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
129864|NCT00528879|435779|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
129865|NCT00528879|435776|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
129866|NCT00528879|435777|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
129867|NCT00528879|435778|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
129868|NCT00528879|435779|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
129869|NCT00528879|435776|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
129870|NCT00528879|435777|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
129871|NCT00528879|435778|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
129872|NCT00528879|435779|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
129873|NCT00528879|435776|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
129874|NCT00528879|435777|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
129875|NCT00528879|435778|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
129876|NCT00528879|435779|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
129877|NCT00528879|435776|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
129878|NCT00528879|435777|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
129879|NCT00528879|435778|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
129880|NCT00528879|435779|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
129881|NCT00528879|435776|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
129882|NCT00528879|435777|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
129883|NCT00528879|435778|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
129884|NCT00528879|435779|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
129885|NCT00528879|435776|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
129886|NCT00528879|435777|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
129887|NCT00528879|435778|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
129888|NCT00528879|435779|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
129889|NCT00528840|435845|P1|Overall Study|Not Specified|2
129890|NCT00528840|435845|P1|Overall Study|Administrative Reasons|1
129891|NCT00528840|435845|P1|Overall Study|Death|2
129892|NCT00528840|435845|P1|Overall Study|Withdrawal by Subject|17
129893|NCT00528840|435845|P1|Overall Study|Adverse Event|1
129894|NCT00528840|435845|P1|Overall Study|Lost to Follow-up|10
129895|NCT00528801|435851|P2|Overall Study|Administrative Reasons|1
129896|NCT00528801|435852|P1|Overall Study|Administrative Reasons|0
129897|NCT00528801|435851|P2|Overall Study|Lost to Follow-up|4
129898|NCT00528801|435852|P1|Overall Study|Lost to Follow-up|15
129899|NCT00528801|435851|P2|Overall Study|Protocol Violation|5
129900|NCT00528801|435852|P1|Overall Study|Protocol Violation|11
129901|NCT00528801|435851|P2|Overall Study|Withdrawal by Subject|1
129902|NCT00528801|435852|P1|Overall Study|Withdrawal by Subject|1
129903|NCT00528775|435866|P1|Overall Study|Other not specified|1
129904|NCT00528645|435874|P1|Overall Study|Adverse Event|3
129905|NCT00528606|435880|P2|Overall Study|Not specified|0
129906|NCT00528606|435881|P1|Overall Study|Not specified|2
129907|NCT00528606|435880|P2|Overall Study|Adverse Event|0
129908|NCT00528606|435881|P1|Overall Study|Adverse Event|3
129909|NCT00528606|435880|P2|Overall Study|Lost to Follow-up|1
129910|NCT00528606|435881|P1|Overall Study|Lost to Follow-up|4
129911|NCT00528606|435880|P2|Overall Study|Withdrew consent|3
129912|NCT00528606|435881|P1|Overall Study|Withdrew consent|4
129913|NCT00528567|435889|P2|Overall Study|Administrative/Other|75
129914|NCT00528567|435890|P1|Overall Study|Administrative/Other|22
129915|NCT00528567|435889|P2|Overall Study|Other Protocol Violation|21
129916|NCT00528567|435890|P1|Overall Study|Other Protocol Violation|5
129917|NCT00528567|435889|P2|Overall Study|Failure to Return|4
129918|NCT00528567|435890|P1|Overall Study|Failure to Return|1
129919|NCT00528567|435889|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
129920|NCT00528567|435890|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
129921|NCT00528567|435889|P2|Overall Study|Withdrew Consent|55
129922|NCT00528567|435890|P1|Overall Study|Withdrew Consent|59
129923|NCT00528567|435889|P2|Overall Study|Violation Criteria at Entry|17
129924|NCT00528567|435890|P1|Overall Study|Violation Criteria at Entry|3
129925|NCT00528567|435889|P2|Overall Study|Adverse Event/Intermittent Illness|29
129926|NCT00528567|435890|P1|Overall Study|Adverse Event/Intermittent Illness|255
129927|NCT00528567|435889|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
129928|NCT00528567|435890|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
129929|NCT00528567|435889|P2|Overall Study|Death|5
129930|NCT00528567|435890|P1|Overall Study|Death|4
129931|NCT00528528|435957|P4|Overall Study|Ongoing participant|0
129932|NCT00528528|435958|P3|Overall Study|Ongoing participant|1
129933|NCT00528528|435959|P2|Overall Study|Ongoing participant|0
129934|NCT00528528|435960|P1|Overall Study|Ongoing participant|0
129935|NCT00528528|435957|P4|Overall Study|Withdrawal by Subject|1
129936|NCT00528528|435958|P3|Overall Study|Withdrawal by Subject|1
129937|NCT00528528|435959|P2|Overall Study|Withdrawal by Subject|2
129938|NCT00528528|435960|P1|Overall Study|Withdrawal by Subject|3
129939|NCT00528528|435957|P4|Overall Study|Unspecified|0
129940|NCT00528528|435958|P3|Overall Study|Unspecified|0
129941|NCT00528528|435959|P2|Overall Study|Unspecified|1
129942|NCT00528528|435960|P1|Overall Study|Unspecified|0
129943|NCT00528528|435957|P4|Overall Study|Ineligible to continue the trial|1
129944|NCT00528528|435958|P3|Overall Study|Ineligible to continue the trial|0
129945|NCT00528528|435959|P2|Overall Study|Ineligible to continue the trial|0
129946|NCT00528528|435960|P1|Overall Study|Ineligible to continue the trial|0
129947|NCT00528528|435957|P4|Overall Study|Lost to Follow-up|1
129948|NCT00528528|435958|P3|Overall Study|Lost to Follow-up|1
129949|NCT00528528|435959|P2|Overall Study|Lost to Follow-up|0
129950|NCT00528528|435960|P1|Overall Study|Lost to Follow-up|0
129951|NCT00528424|435998|P1|Overall Study|Not specified|12
129952|NCT00528424|435998|P1|Overall Study|Administrative reason|2
129953|NCT00528424|435998|P1|Overall Study|Withdrew consent|2
129954|NCT00528424|435998|P1|Overall Study|Lost to Follow-up|13
129955|NCT00528411|436005|P3|Overall Study|Prior commitment medication|0
129956|NCT00528411|436006|P2|Overall Study|Prior commitment medication|1
129957|NCT00528411|436007|P1|Overall Study|Prior commitment medication|0
129958|NCT00528411|436005|P3|Overall Study|Severe non-compliance to protocol|0
129959|NCT00528411|436006|P2|Overall Study|Severe non-compliance to protocol|1
129960|NCT00528411|436007|P1|Overall Study|Severe non-compliance to protocol|0
129961|NCT00528411|436005|P3|Overall Study|Incorrect Enrolment|0
129962|NCT00528411|436006|P2|Overall Study|Incorrect Enrolment|1
129963|NCT00528411|436007|P1|Overall Study|Incorrect Enrolment|1
129964|NCT00528411|436005|P3|Overall Study|Adverse Event|1
129965|NCT00528411|436006|P2|Overall Study|Adverse Event|0
129966|NCT00528411|436007|P1|Overall Study|Adverse Event|4
129967|NCT00528372|436144|P9|Long-term (LT) Period (Weeks 24-102)|Not specified|0
129968|NCT00528372|436145|P8|Long-term (LT) Period (Weeks 24-102)|Not specified|1
129969|NCT00528372|436146|P7|Long-term (LT) Period (Weeks 24-102)|Not specified|3
129970|NCT00528372|436147|P6|Long-term (LT) Period (Weeks 24-102)|Not specified|0
129971|NCT00528372|436148|P5|Long-term (LT) Period (Weeks 24-102)|Not specified|3
129972|NCT00528372|436149|P4|Long-term (LT) Period (Weeks 24-102)|Not specified|2
129973|NCT00528372|436150|P3|Long-term (LT) Period (Weeks 24-102)|Not specified|1
129974|NCT00528372|436151|P2|Long-term (LT) Period (Weeks 24-102)|Not specified|2
129975|NCT00528372|436152|P1|Long-term (LT) Period (Weeks 24-102)|Not specified|2
129976|NCT00528372|436144|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
129977|NCT00528372|436145|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
129978|NCT00528372|436146|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
129979|NCT00528372|436147|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
129980|NCT00528372|436148|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
129981|NCT00528372|436149|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
129982|NCT00528372|436150|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
129983|NCT00528372|436151|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
129984|NCT00528372|436152|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
129985|NCT00528372|436144|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
129986|NCT00528372|436145|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
129987|NCT00528372|436146|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
129988|NCT00528372|436147|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
129989|NCT00528372|436148|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
129990|NCT00528372|436149|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
129991|NCT00528372|436150|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
129992|NCT00528372|436151|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
129993|NCT00528372|436152|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
129994|NCT00528372|436144|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
129995|NCT00528372|436145|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
129996|NCT00528372|436146|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
129997|NCT00528372|436147|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
129998|NCT00528372|436148|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
129999|NCT00528372|436149|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
130000|NCT00528372|436150|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
130001|NCT00528372|436151|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
130002|NCT00528372|436152|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
130003|NCT00528372|436144|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
130004|NCT00528372|436145|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
130005|NCT00528372|436146|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
130006|NCT00528372|436147|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
130007|NCT00528372|436148|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
130008|NCT00528372|436149|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
130009|NCT00528372|436150|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
130010|NCT00528372|436151|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
130011|NCT00528372|436152|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
130012|NCT00528372|436144|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
130013|NCT00528372|436145|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
130014|NCT00528372|436146|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
130015|NCT00528372|436147|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
130016|NCT00528372|436148|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
130017|NCT00528372|436149|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
130018|NCT00528372|436150|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
130019|NCT00528372|436151|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
130020|NCT00528372|436152|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
130021|NCT00528372|436144|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
130022|NCT00528372|436145|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
130023|NCT00528372|436146|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
130024|NCT00528372|436147|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
130025|NCT00528372|436148|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
130026|NCT00528372|436149|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
130027|NCT00528372|436150|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
130028|NCT00528372|436151|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
130029|NCT00528372|436152|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
130030|NCT00528372|436144|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
130031|NCT00528372|436145|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
130032|NCT00528372|436146|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
130033|NCT00528372|436147|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
130034|NCT00528372|436148|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
130035|NCT00528372|436149|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
130036|NCT00528372|436150|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
130037|NCT00528372|436151|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
130038|NCT00528372|436152|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
130039|NCT00528372|436144|P9|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
130040|NCT00528372|436145|P8|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
130041|NCT00528372|436146|P7|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
130042|NCT00528372|436147|P6|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
130043|NCT00528372|436148|P5|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
130044|NCT00528372|436149|P4|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
130045|NCT00528372|436150|P3|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
130046|NCT00528372|436151|P2|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
130047|NCT00528372|436152|P1|Short-term (ST) Period (Day 1-Week 24)|Not specified|3
130048|NCT00528372|436144|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
130049|NCT00528372|436145|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
130050|NCT00528372|436146|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
130051|NCT00528372|436147|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
130052|NCT00528372|436148|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
130053|NCT00528372|436149|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
130054|NCT00528372|436150|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
130055|NCT00528372|436151|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
130056|NCT00528372|436152|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
130057|NCT00528372|436144|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130058|NCT00528372|436145|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130059|NCT00528372|436146|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130060|NCT00528372|436147|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
130061|NCT00528372|436148|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130062|NCT00528372|436149|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
130063|NCT00528372|436150|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130064|NCT00528372|436151|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130065|NCT00528372|436152|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130066|NCT00528372|436144|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
130067|NCT00528372|436145|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
130068|NCT00528372|436146|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
130069|NCT00528372|436147|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
130070|NCT00528372|436148|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
130071|NCT00528372|436149|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
130072|NCT00528372|436150|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
130073|NCT00528372|436151|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
130074|NCT00528372|436152|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
130075|NCT00528372|436144|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
130076|NCT00528372|436145|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
130077|NCT00528372|436146|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
130078|NCT00528372|436147|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
130079|NCT00528372|436148|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
130080|NCT00528372|436149|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
130081|NCT00528372|436150|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
130082|NCT00528372|436151|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
130083|NCT00528372|436152|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
130084|NCT00528372|436144|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
130085|NCT00528372|436145|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
130086|NCT00528372|436146|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
130087|NCT00528372|436147|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
130088|NCT00528372|436148|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
130089|NCT00528372|436149|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
130090|NCT00528372|436150|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
130091|NCT00528372|436151|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
130092|NCT00528372|436152|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
130093|NCT00528372|436144|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130094|NCT00528372|436145|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130095|NCT00528372|436146|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130096|NCT00528372|436147|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130097|NCT00528372|436148|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130098|NCT00528372|436149|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130099|NCT00528372|436150|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130100|NCT00528372|436151|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130101|NCT00528372|436152|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
130102|NCT00527111|436275|P2|Overall Study|Other|2
130103|NCT00527111|436276|P1|Overall Study|Other|2
130104|NCT00527111|436275|P2|Overall Study|Patient Request|5
130105|NCT00527111|436276|P1|Overall Study|Patient Request|2
130106|NCT00527111|436275|P2|Overall Study|Investigator Request|1
130107|NCT00527111|436276|P1|Overall Study|Investigator Request|2
130108|NCT00527111|436275|P2|Overall Study|Death|1
130109|NCT00527111|436276|P1|Overall Study|Death|0
130110|NCT00527111|436275|P2|Overall Study|Adverse Event|13
130111|NCT00527111|436276|P1|Overall Study|Adverse Event|14
130112|NCT00527072|436298|P1|Overall Study|Withdrawal by Subject|7
130113|NCT00527072|436298|P1|Overall Study|Protocol Violation|2
130114|NCT00527072|436298|P1|Overall Study|Lost to Follow-up|3
130115|NCT00527072|436298|P1|Overall Study|Lack of Efficacy|11
130116|NCT00527072|436298|P1|Overall Study|Adverse Event|13
130117|NCT00526994|436307|P3|Overall Study|incarcerated, impaired, incomplete|3
130118|NCT00526994|436308|P2|Overall Study|incarcerated, impaired, incomplete|3
130119|NCT00526994|436309|P1|Overall Study|incarcerated, impaired, incomplete|4
130120|NCT00526994|436307|P3|Overall Study|Withdrawal by Subject|5
130121|NCT00526994|436308|P2|Overall Study|Withdrawal by Subject|7
130122|NCT00526994|436309|P1|Overall Study|Withdrawal by Subject|2
130123|NCT00526994|436307|P3|Overall Study|Death|3
130124|NCT00526994|436308|P2|Overall Study|Death|3
130125|NCT00526994|436309|P1|Overall Study|Death|4
130126|NCT00526994|436307|P3|Overall Study|Lost to Follow-up|96
130127|NCT00526994|436308|P2|Overall Study|Lost to Follow-up|108
130128|NCT00526994|436309|P1|Overall Study|Lost to Follow-up|98
130129|NCT00525915|436328|P2|Overall Study|Unrelated illness|0
130130|NCT00525915|436329|P1|Overall Study|Unrelated illness|1
130131|NCT00525915|436328|P2|Overall Study|Refused Surgery|2
130132|NCT00525915|436329|P1|Overall Study|Refused Surgery|1
130133|NCT00525915|436328|P2|Overall Study|Withdrawal by Subject|0
130134|NCT00525915|436329|P1|Overall Study|Withdrawal by Subject|1
130135|NCT00525915|436328|P2|Overall Study|Disease Progression|6
130136|NCT00525915|436329|P1|Overall Study|Disease Progression|5
130137|NCT00525915|436328|P2|Overall Study|Non-Compliance|1
130138|NCT00525915|436329|P1|Overall Study|Non-Compliance|0
130139|NCT00525902|436335|P1|Overall Study|Lack of Efficacy|1
130140|NCT00528112|436342|P2|Extension Phase|Protocol Violation|2
130141|NCT00528112|436343|P1|Extension Phase|Protocol Violation|0
130142|NCT00528112|436342|P2|Extension Phase|Adverse Event|36
130143|NCT00528112|436343|P1|Extension Phase|Adverse Event|0
130144|NCT00528112|436342|P2|Extension Phase|Death|1
130145|NCT00528112|436343|P1|Extension Phase|Death|0
130146|NCT00528112|436342|P2|Extension Phase|Lost to Follow-up|12
130147|NCT00528112|436343|P1|Extension Phase|Lost to Follow-up|0
130148|NCT00528112|436342|P2|Extension Phase|Pregnancy|3
130149|NCT00528112|436343|P1|Extension Phase|Pregnancy|0
130150|NCT00528112|436342|P2|Extension Phase|Other reasons|100
130151|NCT00528112|436343|P1|Extension Phase|Other reasons|0
130152|NCT00528112|436342|P2|Extension Phase|Withdrawal by Subject|3
130153|NCT00528112|436343|P1|Extension Phase|Withdrawal by Subject|0
130154|NCT00528112|436342|P2|Treatment up to 3 Years|Other reasons|186
130155|NCT00528112|436343|P1|Treatment up to 3 Years|Other reasons|186
130156|NCT00528112|436342|P2|Treatment up to 3 Years|Pregnancy|10
130157|NCT00528112|436343|P1|Treatment up to 3 Years|Pregnancy|9
130158|NCT00528112|436342|P2|Treatment up to 3 Years|Lost to Follow-up|61
130159|NCT00528112|436343|P1|Treatment up to 3 Years|Lost to Follow-up|63
130160|NCT00528112|436342|P2|Treatment up to 3 Years|Death|1
130161|NCT00528112|436343|P1|Treatment up to 3 Years|Death|0
130162|NCT00528112|436342|P2|Treatment up to 3 Years|Protocol Violation|16
130163|NCT00528112|436343|P1|Treatment up to 3 Years|Protocol Violation|16
130164|NCT00528112|436342|P2|Treatment up to 3 Years|Withdrawal by Subject|31
130165|NCT00528112|436343|P1|Treatment up to 3 Years|Withdrawal by Subject|26
130166|NCT00528112|436342|P2|Treatment up to 3 Years|Adverse Event|278
130167|NCT00528112|436343|P1|Treatment up to 3 Years|Adverse Event|313
130168|NCT00528021|436401|P4|Overall Study|Lack of Efficacy|9
130169|NCT00528021|436402|P3|Overall Study|Lack of Efficacy|7
130170|NCT00528021|436403|P2|Overall Study|Lack of Efficacy|13
130171|NCT00528021|436404|P1|Overall Study|Lack of Efficacy|17
130172|NCT00527982|436416|P2|Overall Study|Physician Decision|0
130173|NCT00527982|436417|P1|Overall Study|Physician Decision|1
130174|NCT00527904|436458|P1|Overall Study|misc|22
130175|NCT00527904|436458|P1|Overall Study|Lost to Follow-up|8
130176|NCT00527904|436458|P1|Overall Study|Withdrawal by Subject|21
130177|NCT00527904|436458|P1|Overall Study|Adverse Event|45
130178|NCT00527826|436477|P2|Overall Study|Participant moved away|1
130179|NCT00527826|436478|P1|Overall Study|Participant moved away|0
130180|NCT00527826|436477|P2|Overall Study|Additional Intake of Viani forte|1
130181|NCT00527826|436478|P1|Overall Study|Additional Intake of Viani forte|0
130182|NCT00527826|436477|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
130183|NCT00527826|436478|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
130184|NCT00527826|436477|P2|Overall Study|Inclusion Criteria Not Met|3
130185|NCT00527826|436478|P1|Overall Study|Inclusion Criteria Not Met|3
130186|NCT00527826|436477|P2|Overall Study|Withdrawal by Subject|8
130187|NCT00527826|436478|P1|Overall Study|Withdrawal by Subject|5
130188|NCT00527826|436477|P2|Overall Study|Lost to Follow-up|2
130189|NCT00527826|436478|P1|Overall Study|Lost to Follow-up|3
130190|NCT00527826|436477|P2|Overall Study|Adverse Event|10
130191|NCT00527826|436478|P1|Overall Study|Adverse Event|10
130192|NCT00527787|436527|P2|Overall Study|misc|2
130193|NCT00527787|436528|P1|Overall Study|misc|5
130194|NCT00527787|436527|P2|Overall Study|Duodenal Ulcer|10
130195|NCT00527787|436528|P1|Overall Study|Duodenal Ulcer|1
130196|NCT00527787|436527|P2|Overall Study|Lost to Follow-up|2
130197|NCT00527787|436528|P1|Overall Study|Lost to Follow-up|5
130198|NCT00527787|436527|P2|Overall Study|Withdrawal by Subject|25
130199|NCT00527787|436528|P1|Overall Study|Withdrawal by Subject|13
130200|NCT00527787|436527|P2|Overall Study|Adverse Event|24
130201|NCT00527787|436528|P1|Overall Study|Adverse Event|14
130202|NCT00527735|436553|P3|Overall Study|Completed treatment during maintenance|1
130203|NCT00527735|436554|P2|Overall Study|Completed treatment during maintenance|2
130204|NCT00527735|436555|P1|Overall Study|Completed treatment during maintenance|2
130205|NCT00527735|436553|P3|Overall Study|Poor compliance or noncompliance|1
130206|NCT00527735|436554|P2|Overall Study|Poor compliance or noncompliance|1
130207|NCT00527735|436555|P1|Overall Study|Poor compliance or noncompliance|0
130208|NCT00527735|436553|P3|Overall Study|Lost to Follow-up|3
130209|NCT00527735|436554|P2|Overall Study|Lost to Follow-up|0
130210|NCT00527735|436555|P1|Overall Study|Lost to Follow-up|0
130211|NCT00527735|436553|P3|Overall Study|No longer met study criteria|1
130212|NCT00527735|436554|P2|Overall Study|No longer met study criteria|2
130213|NCT00527735|436555|P1|Overall Study|No longer met study criteria|2
130214|NCT00527735|436553|P3|Overall Study|Withdrawal by Subject|3
130215|NCT00527735|436554|P2|Overall Study|Withdrawal by Subject|4
130216|NCT00527735|436555|P1|Overall Study|Withdrawal by Subject|5
130217|NCT00527735|436553|P3|Overall Study|Not identified|5
130218|NCT00527735|436554|P2|Overall Study|Not identified|5
130219|NCT00527735|436555|P1|Overall Study|Not identified|5
130220|NCT00527735|436553|P3|Overall Study|Adverse Event|7
130221|NCT00527735|436554|P2|Overall Study|Adverse Event|6
130222|NCT00527735|436555|P1|Overall Study|Adverse Event|10
130223|NCT00527735|436553|P3|Overall Study|Completed treatment in treatment phase|18
130224|NCT00527735|436554|P2|Overall Study|Completed treatment in treatment phase|13
130225|NCT00527735|436555|P1|Overall Study|Completed treatment in treatment phase|14
130226|NCT00527735|436553|P3|Overall Study|Death|15
130227|NCT00527735|436554|P2|Overall Study|Death|13
130228|NCT00527735|436555|P1|Overall Study|Death|23
130229|NCT00527735|436553|P3|Overall Study|Disease progression|53
130230|NCT00527735|436554|P2|Overall Study|Disease progression|61
130231|NCT00527735|436555|P1|Overall Study|Disease progression|47
130232|NCT00527618|436636|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
130233|NCT00527618|436637|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
130234|NCT00527618|436636|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
130235|NCT00527618|436637|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
130236|NCT00527618|436636|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
130237|NCT00527618|436637|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
130238|NCT00527618|436636|P2|Week 13-14 (Washout)|Lost to Follow-up|0
130239|NCT00527618|436637|P1|Week 13-14 (Washout)|Lost to Follow-up|1
130240|NCT00527618|436636|P2|Week 1-12 (First Intervention)|Adverse Event|1
130241|NCT00527618|436637|P1|Week 1-12 (First Intervention)|Adverse Event|0
130242|NCT00527618|436636|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
130243|NCT00527618|436637|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
130244|NCT00527605|436652|P2|Overall Study|Protocol Violation|2
130245|NCT00527605|436653|P1|Overall Study|Protocol Violation|1
130246|NCT00527605|436652|P2|Overall Study|Lost to Follow-up|2
130247|NCT00527605|436653|P1|Overall Study|Lost to Follow-up|6
130248|NCT00527605|436652|P2|Overall Study|Withdrawal by Subject|7
130249|NCT00527605|436653|P1|Overall Study|Withdrawal by Subject|3
130250|NCT00527605|436652|P2|Overall Study|Adverse Event|0
130251|NCT00527605|436653|P1|Overall Study|Adverse Event|3
130252|NCT00527514|436695|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
130253|NCT00527514|436695|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
130254|NCT00527514|436695|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
130255|NCT00527514|436695|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
130256|NCT00527514|436695|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
130257|NCT00527514|436695|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
130258|NCT00527514|436695|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
130259|NCT00527488|436711|P4|Overall Study|Withdrawn prior to dosing|0
130260|NCT00527488|436712|P3|Overall Study|Withdrawn prior to dosing|1
130261|NCT00527488|436713|P2|Overall Study|Withdrawn prior to dosing|1
130262|NCT00527488|436714|P1|Overall Study|Withdrawn prior to dosing|0
130263|NCT00527423|436797|P1|Overall Study|Death|9
130264|NCT00527423|436797|P1|Overall Study|OTHER|4
130265|NCT00527423|436797|P1|Overall Study|Lost to Follow-up|4
130266|NCT00527423|436797|P1|Overall Study|Withdrawal by Subject|10
130267|NCT00527423|436797|P1|Overall Study|Physician Decision|4
130268|NCT00527423|436797|P1|Overall Study|Adverse Event|5
130269|NCT00527423|436797|P1|Overall Study|Protocol Violation|1
130270|NCT00527397|436803|P1|Overall Study|Study terminated by sponsor|13
130271|NCT00527397|436803|P1|Overall Study|Withdrawal by Subject|6
130272|NCT00527397|436803|P1|Overall Study|Protocol Violation|1
130273|NCT00527397|436803|P1|Overall Study|Lack of Efficacy|1
130274|NCT00527397|436803|P1|Overall Study|Adverse Event|3
130275|NCT00527332|436829|P2|Overall Study|Withdrew consent|1
130276|NCT00527332|436830|P1|Overall Study|Withdrew consent|5
130277|NCT00527332|436829|P2|Overall Study|Protocol Violation|8
130278|NCT00527332|436830|P1|Overall Study|Protocol Violation|4
130279|NCT00527319|436839|P3|Overall Study|Adverse Event|1
130280|NCT00527319|436840|P2|Overall Study|Adverse Event|0
130281|NCT00527319|436841|P1|Overall Study|Adverse Event|0
130282|NCT00527319|436839|P3|Overall Study|Intercurrent Medical Illness|3
130283|NCT00527319|436840|P2|Overall Study|Intercurrent Medical Illness|1
130284|NCT00527319|436841|P1|Overall Study|Intercurrent Medical Illness|0
130285|NCT00527319|436839|P3|Overall Study|Death|1
130286|NCT00527319|436840|P2|Overall Study|Death|3
130287|NCT00527319|436841|P1|Overall Study|Death|0
130288|NCT00527319|436839|P3|Overall Study|Lost to Follow-up|0
130289|NCT00527319|436840|P2|Overall Study|Lost to Follow-up|0
130290|NCT00527319|436841|P1|Overall Study|Lost to Follow-up|1
130291|NCT00527319|436839|P3|Overall Study|Withdrawal by Subject|1
130292|NCT00527319|436840|P2|Overall Study|Withdrawal by Subject|0
130293|NCT00527319|436841|P1|Overall Study|Withdrawal by Subject|5
130294|NCT00526890|436852|P1|Overall Study|Adverse Event|2
130295|NCT00526890|436852|P1|Overall Study|Not treated (became ineligible)|5
130296|NCT00526799|436863|P2|Overall Study|Intercurrent Complicating Disease|1
130297|NCT00526799|436864|P1|Overall Study|Intercurrent Complicating Disease|0
130298|NCT00526799|436863|P2|Overall Study|Withdrawal by Subject|0
130299|NCT00526799|436864|P1|Overall Study|Withdrawal by Subject|1
130300|NCT00526669|436872|P2|Combined Treatment Phase|Death|2
130301|NCT00526669|436873|P1|Combined Treatment Phase|Death|0
130302|NCT00526669|436872|P2|Combined Treatment Phase|Sponsor Terminated Study|2
130303|NCT00526669|436873|P1|Combined Treatment Phase|Sponsor Terminated Study|0
130304|NCT00526669|436872|P2|Combined Treatment Phase|Withdrawal by Subject|2
130305|NCT00526669|436873|P1|Combined Treatment Phase|Withdrawal by Subject|0
130306|NCT00526669|436872|P2|Combined Treatment Phase|Lost to Follow-up|2
130307|NCT00526669|436873|P1|Combined Treatment Phase|Lost to Follow-up|0
130308|NCT00526630|436902|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
130309|NCT00526630|436903|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
130310|NCT00526630|436902|P2|First Intervention Period - 12 Weeks|Withdrawn|3
130311|NCT00526630|436903|P1|First Intervention Period - 12 Weeks|Withdrawn|0
130312|NCT00526331|437002|P1|Overall Study|Sponsor Termination|55
130313|NCT00526227|437010|P1|Overall Study|Death|1
130314|NCT00526227|437010|P1|Overall Study|Device not implanted|1
130315|NCT00526162|437021|P1|Overall Study|Device not implanted|3
130316|NCT00526110|437051|P2|Overall Study|Poor Tolerance|5
130317|NCT00526110|437052|P1|Overall Study|Poor Tolerance|0
130318|NCT00526110|437051|P2|Overall Study|Withdrawal by Subject|2
130319|NCT00526110|437052|P1|Overall Study|Withdrawal by Subject|0
130320|NCT00526110|437051|P2|Overall Study|Maximal Response|6
130321|NCT00526110|437052|P1|Overall Study|Maximal Response|0
130322|NCT00526110|437051|P2|Overall Study|Disease Progression|19
130323|NCT00526110|437052|P1|Overall Study|Disease Progression|0
130324|NCT00526110|437051|P2|Overall Study|Adverse Event|9
130325|NCT00526110|437052|P1|Overall Study|Adverse Event|2
130326|NCT00526097|437061|P2|Overall Study|Other|1
130327|NCT00526097|437062|P1|Overall Study|Other|2
130328|NCT00526097|437061|P2|Overall Study|Withdrawal by Subject|1
130329|NCT00526097|437062|P1|Overall Study|Withdrawal by Subject|3
130330|NCT00526097|437061|P2|Overall Study|Protocol Violation|10
130331|NCT00526097|437062|P1|Overall Study|Protocol Violation|4
130332|NCT00526097|437061|P2|Overall Study|Adverse Event|44
130333|NCT00526097|437062|P1|Overall Study|Adverse Event|6
130334|NCT00525824|437264|P4|Overall Study|Other|1
130335|NCT00525824|437265|P3|Overall Study|Other|3
130336|NCT00525824|437266|P2|Overall Study|Other|3
130337|NCT00525824|437267|P1|Overall Study|Other|1
130338|NCT00525824|437264|P4|Overall Study|Safety reasons|0
130339|NCT00525824|437265|P3|Overall Study|Safety reasons|1
130340|NCT00525824|437266|P2|Overall Study|Safety reasons|0
130341|NCT00525824|437267|P1|Overall Study|Safety reasons|1
130342|NCT00525824|437264|P4|Overall Study|Severe non-compliance|1
130343|NCT00525824|437265|P3|Overall Study|Severe non-compliance|1
130344|NCT00525824|437266|P2|Overall Study|Severe non-compliance|1
130345|NCT00525824|437267|P1|Overall Study|Severe non-compliance|0
130346|NCT00525824|437264|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
130347|NCT00525824|437265|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
130348|NCT00525824|437266|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
130349|NCT00525824|437267|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
130350|NCT00525824|437264|P4|Overall Study|Lost to Follow-up|0
130351|NCT00525824|437265|P3|Overall Study|Lost to Follow-up|4
130352|NCT00525824|437266|P2|Overall Study|Lost to Follow-up|2
130353|NCT00525824|437267|P1|Overall Study|Lost to Follow-up|4
130354|NCT00525824|437264|P4|Overall Study|Withdrawal by Subject|4
130355|NCT00525824|437265|P3|Overall Study|Withdrawal by Subject|3
130356|NCT00525824|437266|P2|Overall Study|Withdrawal by Subject|9
130357|NCT00525824|437267|P1|Overall Study|Withdrawal by Subject|5
130358|NCT00525824|437264|P4|Overall Study|Adverse Event|7
130359|NCT00525824|437265|P3|Overall Study|Adverse Event|6
130360|NCT00525824|437266|P2|Overall Study|Adverse Event|11
130361|NCT00525824|437267|P1|Overall Study|Adverse Event|7
130362|NCT00525512|437365|P4|Open-Label Phase|Other reason (not specified)|5
130363|NCT00525512|437366|P3|Open-Label Phase|Other reason (not specified)|4
130364|NCT00525512|437367|P2|Open-Label Phase|Other reason (not specified)|0
130365|NCT00525512|437368|P1|Open-Label Phase|Other reason (not specified)|0
130366|NCT00525512|437365|P4|Open-Label Phase|Lost to Follow-up|0
130367|NCT00525512|437366|P3|Open-Label Phase|Lost to Follow-up|1
130368|NCT00525512|437367|P2|Open-Label Phase|Lost to Follow-up|0
130369|NCT00525512|437368|P1|Open-Label Phase|Lost to Follow-up|0
130370|NCT00525512|437365|P4|Open-Label Phase|Adverse Event|0
130371|NCT00525512|437366|P3|Open-Label Phase|Adverse Event|1
130372|NCT00525512|437367|P2|Open-Label Phase|Adverse Event|0
130373|NCT00525512|437368|P1|Open-Label Phase|Adverse Event|0
130374|NCT00525512|437365|P4|Double-Blind Phase|Other reason (not specified)|0
130375|NCT00525512|437366|P3|Double-Blind Phase|Other reason (not specified)|0
130376|NCT00525512|437367|P2|Double-Blind Phase|Other reason (not specified)|13
130377|NCT00525512|437368|P1|Double-Blind Phase|Other reason (not specified)|12
130378|NCT00525512|437365|P4|Double-Blind Phase|Lack of Efficacy|0
130379|NCT00525512|437366|P3|Double-Blind Phase|Lack of Efficacy|0
130380|NCT00525512|437367|P2|Double-Blind Phase|Lack of Efficacy|5
130381|NCT00525512|437368|P1|Double-Blind Phase|Lack of Efficacy|13
130382|NCT00525512|437365|P4|Double-Blind Phase|Withdrawal by Subject|0
130383|NCT00525512|437366|P3|Double-Blind Phase|Withdrawal by Subject|0
130384|NCT00525512|437367|P2|Double-Blind Phase|Withdrawal by Subject|12
130385|NCT00525512|437368|P1|Double-Blind Phase|Withdrawal by Subject|17
130386|NCT00525512|437365|P4|Double-Blind Phase|Lost to Follow-up|0
130387|NCT00525512|437366|P3|Double-Blind Phase|Lost to Follow-up|0
130388|NCT00525512|437367|P2|Double-Blind Phase|Lost to Follow-up|7
130389|NCT00525512|437368|P1|Double-Blind Phase|Lost to Follow-up|3
130390|NCT00525512|437365|P4|Double-Blind Phase|Protocol Violation|0
130391|NCT00525512|437366|P3|Double-Blind Phase|Protocol Violation|0
130392|NCT00525512|437367|P2|Double-Blind Phase|Protocol Violation|1
130393|NCT00525512|437368|P1|Double-Blind Phase|Protocol Violation|3
130394|NCT00525512|437365|P4|Double-Blind Phase|Adverse Event|0
130395|NCT00525512|437366|P3|Double-Blind Phase|Adverse Event|0
130396|NCT00525512|437367|P2|Double-Blind Phase|Adverse Event|28
130397|NCT00525512|437368|P1|Double-Blind Phase|Adverse Event|48
130398|NCT00525499|437510|P4|Overall Study|Protocol Violation|0
130399|NCT00525499|437511|P3|Overall Study|Protocol Violation|1
130400|NCT00525499|437512|P2|Overall Study|Protocol Violation|1
130401|NCT00525499|437513|P1|Overall Study|Protocol Violation|0
130402|NCT00525499|437510|P4|Overall Study|Withdrawal by Subject|2
130403|NCT00525499|437511|P3|Overall Study|Withdrawal by Subject|5
130404|NCT00525499|437512|P2|Overall Study|Withdrawal by Subject|1
130405|NCT00525499|437513|P1|Overall Study|Withdrawal by Subject|5
130406|NCT00525499|437510|P4|Overall Study|Adverse Event|1
130407|NCT00525499|437511|P3|Overall Study|Adverse Event|0
130408|NCT00525499|437512|P2|Overall Study|Adverse Event|1
130409|NCT00525499|437513|P1|Overall Study|Adverse Event|0
130410|NCT00525499|437510|P4|Overall Study|Lost to Follow-up|4
130411|NCT00525499|437511|P3|Overall Study|Lost to Follow-up|1
130412|NCT00525499|437512|P2|Overall Study|Lost to Follow-up|4
130413|NCT00525499|437513|P1|Overall Study|Lost to Follow-up|2
130414|NCT00525265|437540|P2|Overall Study|Protocol Violation|0
130415|NCT00525265|437541|P1|Overall Study|Protocol Violation|1
130416|NCT00525161|437598|P1|Overall Study|Adverse Event|1
130417|NCT00525148|437608|P4|Overall Study|Other than stated|3
130418|NCT00525148|437609|P3|Overall Study|Other than stated|0
130419|NCT00525148|437610|P2|Overall Study|Other than stated|1
130420|NCT00525148|437611|P1|Overall Study|Other than stated|2
130421|NCT00525148|437608|P4|Overall Study|Refused continuation of study medication|1
130422|NCT00525148|437609|P3|Overall Study|Refused continuation of study medication|0
130423|NCT00525148|437610|P2|Overall Study|Refused continuation of study medication|2
130424|NCT00525148|437611|P1|Overall Study|Refused continuation of study medication|0
130425|NCT00525148|437608|P4|Overall Study|Progressive disease|49
130426|NCT00525148|437609|P3|Overall Study|Progressive disease|6
130427|NCT00525148|437610|P2|Overall Study|Progressive disease|30
130428|NCT00525148|437611|P1|Overall Study|Progressive disease|18
130429|NCT00525148|437608|P4|Overall Study|Other Adverse Event|8
130430|NCT00525148|437609|P3|Overall Study|Other Adverse Event|1
130431|NCT00525148|437610|P2|Overall Study|Other Adverse Event|5
130432|NCT00525148|437611|P1|Overall Study|Other Adverse Event|3
130433|NCT00524771|437644|P2|Overall Study|Protocol Violation|585
130434|NCT00524771|437645|P1|Overall Study|Protocol Violation|220
130435|NCT00524745|437659|P4|Overall Study|subject withdrawal or lost to follow up|22
130436|NCT00524745|437660|P3|Overall Study|subject withdrawal or lost to follow up|29
130437|NCT00524745|437661|P2|Overall Study|subject withdrawal or lost to follow up|13
130438|NCT00524745|437662|P1|Overall Study|subject withdrawal or lost to follow up|34
130439|NCT00524680|437688|P4|Overall Study|Withdrawal by Subject|1
130440|NCT00524680|437689|P3|Overall Study|Withdrawal by Subject|1
130441|NCT00524680|437690|P2|Overall Study|Withdrawal by Subject|0
130442|NCT00524680|437691|P1|Overall Study|Withdrawal by Subject|1
130443|NCT00524680|437688|P4|Overall Study|not specified|3
130444|NCT00524680|437689|P3|Overall Study|not specified|2
130445|NCT00524680|437690|P2|Overall Study|not specified|1
130446|NCT00524680|437691|P1|Overall Study|not specified|0
130447|NCT00524680|437688|P4|Overall Study|Adverse Event|1
130448|NCT00524680|437689|P3|Overall Study|Adverse Event|0
130449|NCT00524680|437690|P2|Overall Study|Adverse Event|0
130450|NCT00524680|437691|P1|Overall Study|Adverse Event|2
130451|NCT00524680|437688|P4|Overall Study|progression|1
130452|NCT00524680|437689|P3|Overall Study|progression|0
130453|NCT00524680|437690|P2|Overall Study|progression|0
130454|NCT00524680|437691|P1|Overall Study|progression|0
130455|NCT00524589|437713|P1|Overall Study|Disease Progression|16
130456|NCT00524589|437713|P1|Overall Study|Withdrawal by Subject|2
130457|NCT00524459|437763|P1|Overall Study|Other|1
130458|NCT00524459|437763|P1|Overall Study|Withdrawal by Subject|1
130459|NCT00524420|437773|P2|Overall Study|Lack of Efficacy|0
130460|NCT00524420|437774|P1|Overall Study|Lack of Efficacy|1
130461|NCT00524368|437792|P2|Overall Study|Unspecified|2
130462|NCT00524368|437793|P1|Overall Study|Unspecified|3
130463|NCT00524368|437792|P2|Overall Study|Ineligible to Continue the study|5
130464|NCT00524368|437793|P1|Overall Study|Ineligible to Continue the study|2
130465|NCT00524368|437792|P2|Overall Study|Sponsor's Decision|0
130466|NCT00524368|437793|P1|Overall Study|Sponsor's Decision|2
130467|NCT00524368|437792|P2|Overall Study|Reached a Virologic Endpoint|2
130468|NCT00524368|437793|P1|Overall Study|Reached a Virologic Endpoint|3
130469|NCT00524368|437792|P2|Overall Study|Non-compliant|9
130470|NCT00524368|437793|P1|Overall Study|Non-compliant|8
130471|NCT00524368|437792|P2|Overall Study|Withdrawal by Subject|5
130472|NCT00524368|437793|P1|Overall Study|Withdrawal by Subject|4
130473|NCT00524368|437792|P2|Overall Study|Lost to Follow-up|13
130474|NCT00524368|437793|P1|Overall Study|Lost to Follow-up|9
130475|NCT00524368|437792|P2|Overall Study|Adverse Event|12
130476|NCT00524368|437793|P1|Overall Study|Adverse Event|10
130477|NCT00524316|437826|P1|Overall Study|Disease Progression|7
130478|NCT00524316|437826|P1|Overall Study|Adverse Event|7
130479|NCT00524316|437826|P1|Overall Study|Withdrawal by Subject|2
130480|NCT00524303|437838|P3|Overall Study|Completed 5 years|1
130481|NCT00524303|437839|P2|Overall Study|Completed 5 years|0
130482|NCT00524303|437840|P1|Overall Study|Completed 5 years|0
130483|NCT00524303|437838|P3|Overall Study|Physician Decision|1
130484|NCT00524303|437839|P2|Overall Study|Physician Decision|0
130485|NCT00524303|437840|P1|Overall Study|Physician Decision|0
130486|NCT00524303|437838|P3|Overall Study|Sponsor Request|1
130487|NCT00524303|437839|P2|Overall Study|Sponsor Request|0
130488|NCT00524303|437840|P1|Overall Study|Sponsor Request|0
130489|NCT00524303|437838|P3|Overall Study|Disease Recurrence|0
130490|NCT00524303|437839|P2|Overall Study|Disease Recurrence|1
130491|NCT00524303|437840|P1|Overall Study|Disease Recurrence|0
130492|NCT00524303|437838|P3|Overall Study|Disease Progression|1
130493|NCT00524303|437839|P2|Overall Study|Disease Progression|4
130494|NCT00524303|437840|P1|Overall Study|Disease Progression|0
130495|NCT00524303|437838|P3|Overall Study|Worsening Peripheral Neuropathy|0
130496|NCT00524303|437839|P2|Overall Study|Worsening Peripheral Neuropathy|0
130497|NCT00524303|437840|P1|Overall Study|Worsening Peripheral Neuropathy|1
130498|NCT00524303|437838|P3|Overall Study|Did not Complete Study Dosing|0
130499|NCT00524303|437839|P2|Overall Study|Did not Complete Study Dosing|0
130500|NCT00524303|437840|P1|Overall Study|Did not Complete Study Dosing|1
130501|NCT00524303|437838|P3|Overall Study|Adverse Event|3
130502|NCT00524303|437839|P2|Overall Study|Adverse Event|2
130503|NCT00524303|437840|P1|Overall Study|Adverse Event|1
130504|NCT00524303|437838|P3|Overall Study|Death|3
130505|NCT00524303|437839|P2|Overall Study|Death|2
130506|NCT00524303|437840|P1|Overall Study|Death|0
130507|NCT00524303|437838|P3|Overall Study|Withdrawal by Subject|4
130508|NCT00524303|437839|P2|Overall Study|Withdrawal by Subject|0
130509|NCT00524303|437840|P1|Overall Study|Withdrawal by Subject|3
130510|NCT00524303|437838|P3|Overall Study|Protocol Violation|1
130511|NCT00524303|437839|P2|Overall Study|Protocol Violation|1
130512|NCT00524303|437840|P1|Overall Study|Protocol Violation|0
130513|NCT00524303|437838|P3|Overall Study|Lost to Follow-up|3
130514|NCT00524303|437839|P2|Overall Study|Lost to Follow-up|0
130515|NCT00524303|437840|P1|Overall Study|Lost to Follow-up|6
130516|NCT00524134|437888|P1|Overall Study|Physician Decision|1
130517|NCT00524134|437888|P1|Overall Study|Withdrawal by Subject|1
130518|NCT00524121|437895|P1|Overall Study|Not treated (changed mind)|1
130519|NCT00524121|437895|P1|Overall Study|Not treated (became ineligible)|4
130520|NCT00524121|437895|P1|Overall Study|Death|1
130521|NCT00524121|437895|P1|Overall Study|unspecified|1
130522|NCT00524121|437895|P1|Overall Study|Patient refused|2
130523|NCT00524121|437895|P1|Overall Study|Adverse Event|4
130524|NCT00524121|437895|P1|Overall Study|Disease progression|6
130525|NCT00524043|437915|P3|Overall Study|Various (eg, incarceration)|0
130526|NCT00524043|437916|P2|Overall Study|Various (eg, incarceration)|1
130527|NCT00524043|437917|P1|Overall Study|Various (eg, incarceration)|2
130528|NCT00524043|437915|P3|Overall Study|Lost to Follow-up|3
130529|NCT00524043|437916|P2|Overall Study|Lost to Follow-up|5
130530|NCT00524043|437917|P1|Overall Study|Lost to Follow-up|3
130531|NCT00524043|437915|P3|Overall Study|Adverse Event|7
130532|NCT00524043|437916|P2|Overall Study|Adverse Event|2
130533|NCT00524043|437917|P1|Overall Study|Adverse Event|5
130534|NCT00524043|437915|P3|Overall Study|Withdrawal by Subject|7
130535|NCT00524043|437916|P2|Overall Study|Withdrawal by Subject|7
130536|NCT00524043|437917|P1|Overall Study|Withdrawal by Subject|5
130537|NCT00524043|437915|P3|Overall Study|Lack of Efficacy|14
130538|NCT00524043|437916|P2|Overall Study|Lack of Efficacy|13
130539|NCT00524043|437917|P1|Overall Study|Lack of Efficacy|15
130540|NCT00524030|437939|P2|Overall Study|Death|1
130541|NCT00524030|437940|P1|Overall Study|Death|0
130542|NCT00524030|437939|P2|Overall Study|Adverse Event|21
130543|NCT00524030|437940|P1|Overall Study|Adverse Event|3
130544|NCT00524030|437939|P2|Overall Study|Pregnancy|0
130545|NCT00524030|437940|P1|Overall Study|Pregnancy|1
130546|NCT00524030|437939|P2|Overall Study|Protocol Violation|1
130547|NCT00524030|437940|P1|Overall Study|Protocol Violation|0
130548|NCT00524030|437939|P2|Overall Study|Noncompliance/Investigator discretion|2
130549|NCT00524030|437940|P1|Overall Study|Noncompliance/Investigator discretion|0
130550|NCT00524030|437939|P2|Overall Study|Withdrawal by Subject|8
130551|NCT00524030|437940|P1|Overall Study|Withdrawal by Subject|3
130552|NCT00524030|437939|P2|Overall Study|Lost to Follow-up|2
130553|NCT00524030|437940|P1|Overall Study|Lost to Follow-up|0
130554|NCT00524030|437939|P2|Overall Study|Lack of Efficacy|24
130555|NCT00524030|437940|P1|Overall Study|Lack of Efficacy|10
130556|NCT00523991|437958|P2|Overall Study|Other reason (not specified)|0
130557|NCT00523991|437959|P1|Overall Study|Other reason (not specified)|3
130558|NCT00523991|437958|P2|Overall Study|Withdrawal by Subject|17
130559|NCT00523991|437959|P1|Overall Study|Withdrawal by Subject|7
130560|NCT00523991|437958|P2|Overall Study|Lost to Follow-up|1
130561|NCT00523991|437959|P1|Overall Study|Lost to Follow-up|4
130562|NCT00523991|437958|P2|Overall Study|Protocol Violation|4
130563|NCT00523991|437959|P1|Overall Study|Protocol Violation|1
130564|NCT00523991|437958|P2|Overall Study|Adverse Event|5
130565|NCT00523991|437959|P1|Overall Study|Adverse Event|6
130566|NCT00523978|438239|P2|Overall Study|Death|0
130567|NCT00523978|438240|P1|Overall Study|Death|1
130568|NCT00523978|438239|P2|Overall Study|Screen Failures|1
130569|NCT00523978|438240|P1|Overall Study|Screen Failures|5
130570|NCT00523978|438239|P2|Overall Study|Withdrawal by Subject|7
130571|NCT00523978|438240|P1|Overall Study|Withdrawal by Subject|3
130572|NCT00523848|438262|P1|Overall Study|Other, unspecified|4
130573|NCT00523848|438262|P1|Overall Study|Disease Progression|5
130574|NCT00523848|438262|P1|Overall Study|NOT TREATED (Became ineligible)|2
130575|NCT00523848|438262|P1|Overall Study|Withdrawal by Subject|2
130576|NCT00523848|438262|P1|Overall Study|Adverse Event|11
130577|NCT00523744|438272|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
130578|NCT00523744|438272|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
130579|NCT00523744|438272|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
130580|NCT00523744|438272|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
130581|NCT00523744|438272|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
130582|NCT00523744|438272|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
130583|NCT00523718|438291|P2|Overall Study|Protocol Violation|0
130584|NCT00523718|438292|P1|Overall Study|Protocol Violation|2
130585|NCT00523718|438291|P2|Overall Study|Withdrawal by Subject|0
130586|NCT00523718|438292|P1|Overall Study|Withdrawal by Subject|1
130587|NCT00523705|438306|P2|Overall Study|No time for study.|1
130588|NCT00523705|438307|P1|Overall Study|No time for study.|0
130589|NCT00523640|438319|P1|Overall Study|Death|1
130590|NCT00523549|438336|P2|Overall Study|Lost to Follow-up|5
130591|NCT00523549|438337|P1|Overall Study|Lost to Follow-up|3
130592|NCT00523549|438336|P2|Overall Study|Patient withdrew consent|6
130593|NCT00523549|438337|P1|Overall Study|Patient withdrew consent|7
130594|NCT00523549|438336|P2|Overall Study|Protocol Deviation|1
130595|NCT00523549|438337|P1|Overall Study|Protocol Deviation|3
130596|NCT00523549|438336|P2|Overall Study|Unsatisfactory therapeutic effect|1
130597|NCT00523549|438337|P1|Overall Study|Unsatisfactory therapeutic effect|0
130598|NCT00523549|438336|P2|Overall Study|Adverse Event|3
130599|NCT00523549|438337|P1|Overall Study|Adverse Event|6
130600|NCT00523419|438355|P1|Overall Study|Death due to Adverse Event|2
130601|NCT00523419|438355|P1|Overall Study|Death due to Study Disease|4
130602|NCT00523419|438355|P1|Overall Study|Progressive Disease|22
130603|NCT00523419|438355|P1|Overall Study|Physician Decision|2
130604|NCT00523419|438355|P1|Overall Study|Withdrawal by Subject|1
130605|NCT00523419|438355|P1|Overall Study|Adverse Event|1
130606|NCT00523367|438365|P1|Overall Study|4 Withdrawn by PI|4
130607|NCT00523367|438365|P1|Overall Study|19 screen failures|19
130608|NCT00523341|438371|P2|Overall Study|Disease Progression|0
130609|NCT00523341|438372|P1|Overall Study|Disease Progression|1
130610|NCT00523341|438371|P2|Overall Study|Ineligibility Determined|4
130611|NCT00523341|438372|P1|Overall Study|Ineligibility Determined|3
130612|NCT00523341|438371|P2|Overall Study|Protocol Deviation|5
130613|NCT00523341|438372|P1|Overall Study|Protocol Deviation|6
130614|NCT00523341|438371|P2|Overall Study|Requirement for Alternative Therapy|14
130615|NCT00523341|438372|P1|Overall Study|Requirement for Alternative Therapy|4
130616|NCT00523341|438371|P2|Overall Study|Physician Decision|13
130617|NCT00523341|438372|P1|Overall Study|Physician Decision|14
130618|NCT00523341|438371|P2|Overall Study|Non-compliance|13
130619|NCT00523341|438372|P1|Overall Study|Non-compliance|20
130620|NCT00523341|438371|P2|Overall Study|Lost to Follow-up|61
130621|NCT00523341|438372|P1|Overall Study|Lost to Follow-up|73
130622|NCT00523341|438371|P2|Overall Study|Death|110
130623|NCT00523341|438372|P1|Overall Study|Death|101
130624|NCT00523341|438371|P2|Overall Study|Adverse Event|155
130625|NCT00523341|438372|P1|Overall Study|Adverse Event|122
130626|NCT00523341|438371|P2|Overall Study|Other|198
130627|NCT00523341|438372|P1|Overall Study|Other|181
130628|NCT00523341|438371|P2|Overall Study|Withdrawal by Subject|427
130629|NCT00523341|438372|P1|Overall Study|Withdrawal by Subject|399
130630|NCT00522951|438420|P2|Period 2|residual contrast medium|1
130631|NCT00522951|438421|P1|Period 2|residual contrast medium|1
130632|NCT00522951|438420|P2|Period 2|Withdrawal by Subject|0
130633|NCT00522951|438421|P1|Period 2|Withdrawal by Subject|1
130634|NCT00522951|438420|P2|Washout Period|Death|1
130635|NCT00522951|438421|P1|Washout Period|Death|0
130636|NCT00522951|438420|P2|Washout Period|Adverse Event|1
130637|NCT00522951|438421|P1|Washout Period|Adverse Event|0
130638|NCT00522951|438420|P2|Period 1|body motion|1
130639|NCT00522951|438421|P1|Period 1|body motion|0
130640|NCT00522873|438476|P2|Overall Study|Never Received Medication|0
130641|NCT00522873|438477|P1|Overall Study|Never Received Medication|1
130642|NCT00522873|438476|P2|Overall Study|Medication Errors|1
130643|NCT00522873|438477|P1|Overall Study|Medication Errors|1
130644|NCT00522873|438476|P2|Overall Study|Personal Reasons|1
130645|NCT00522873|438477|P1|Overall Study|Personal Reasons|8
130646|NCT00522873|438476|P2|Overall Study|Lost to Follow-up|3
130647|NCT00522873|438477|P1|Overall Study|Lost to Follow-up|11
130648|NCT00522873|438476|P2|Overall Study|Protocol Violation|4
130649|NCT00522873|438477|P1|Overall Study|Protocol Violation|14
130650|NCT00522873|438476|P2|Overall Study|Withdrawal by Subject|9
130651|NCT00522873|438477|P1|Overall Study|Withdrawal by Subject|20
130652|NCT00522873|438476|P2|Overall Study|Adverse Event|26
130653|NCT00522873|438477|P1|Overall Study|Adverse Event|41
130654|NCT00522626|438490|P1|Overall Study|Lost to Follow-up|7
130655|NCT00522457|438494|P1|Overall Study|Adverse Event|2
130656|NCT00522457|438494|P1|Overall Study|Due to disease progression|16
130657|NCT00522418|438506|P2|Overall Study|Lack of Efficacy|1
130658|NCT00522418|438507|P1|Overall Study|Lack of Efficacy|0
130659|NCT00522418|438506|P2|Overall Study|Consent Withdraw|2
130660|NCT00522418|438507|P1|Overall Study|Consent Withdraw|1
130661|NCT00522418|438506|P2|Overall Study|Reason Not Specified|1
130662|NCT00522418|438507|P1|Overall Study|Reason Not Specified|3
130663|NCT00522418|438506|P2|Overall Study|Noncompliance|2
130664|NCT00522418|438507|P1|Overall Study|Noncompliance|2
130665|NCT00522418|438506|P2|Overall Study|Early Study Termination|47
130666|NCT00522418|438507|P1|Overall Study|Early Study Termination|46
130667|NCT00522418|438506|P2|Overall Study|Local IRB Consent Violation|5
130668|NCT00522418|438507|P1|Overall Study|Local IRB Consent Violation|5
130669|NCT00522392|438555|P2|Overall Study|Non-compliance|1
130670|NCT00522392|438556|P1|Overall Study|Non-compliance|0
130671|NCT00522392|438555|P2|Overall Study|Physician Decision|1
130672|NCT00522392|438556|P1|Overall Study|Physician Decision|0
130673|NCT00522392|438555|P2|Overall Study|Withdrawal by Subject|1
130674|NCT00522392|438556|P1|Overall Study|Withdrawal by Subject|1
130675|NCT00522392|438555|P2|Overall Study|Adverse Event|7
130676|NCT00522392|438556|P1|Overall Study|Adverse Event|7
130677|NCT00522392|438555|P2|Overall Study|Disease progression|3
130678|NCT00522392|438556|P1|Overall Study|Disease progression|0
130679|NCT00522379|438573|P5|Overall Study|Subject Withdrawal|0
130680|NCT00522379|438574|P4|Overall Study|Subject Withdrawal|1
130681|NCT00522379|438575|P3|Overall Study|Subject Withdrawal|0
130682|NCT00522379|438576|P2|Overall Study|Subject Withdrawal|0
130683|NCT00522379|438577|P1|Overall Study|Subject Withdrawal|0
130684|NCT00522379|438573|P5|Overall Study|Site Closed|0
130685|NCT00522379|438574|P4|Overall Study|Site Closed|1
130686|NCT00522379|438575|P3|Overall Study|Site Closed|0
130687|NCT00522379|438576|P2|Overall Study|Site Closed|0
130688|NCT00522379|438577|P1|Overall Study|Site Closed|0
130689|NCT00522379|438573|P5|Overall Study|Family Problem|0
130690|NCT00522379|438574|P4|Overall Study|Family Problem|0
130691|NCT00522379|438575|P3|Overall Study|Family Problem|1
130692|NCT00522379|438576|P2|Overall Study|Family Problem|0
130693|NCT00522379|438577|P1|Overall Study|Family Problem|0
130694|NCT00522379|438573|P5|Overall Study|Sponsor Request|0
130695|NCT00522379|438574|P4|Overall Study|Sponsor Request|0
130696|NCT00522379|438575|P3|Overall Study|Sponsor Request|0
130697|NCT00522379|438576|P2|Overall Study|Sponsor Request|1
130698|NCT00522379|438577|P1|Overall Study|Sponsor Request|0
130699|NCT00522379|438573|P5|Overall Study|Subject Moved|0
130700|NCT00522379|438574|P4|Overall Study|Subject Moved|0
130701|NCT00522379|438575|P3|Overall Study|Subject Moved|0
130702|NCT00522379|438576|P2|Overall Study|Subject Moved|1
130703|NCT00522379|438577|P1|Overall Study|Subject Moved|1
130704|NCT00522379|438573|P5|Overall Study|Dispensing error|0
130705|NCT00522379|438574|P4|Overall Study|Dispensing error|1
130706|NCT00522379|438575|P3|Overall Study|Dispensing error|0
130707|NCT00522379|438576|P2|Overall Study|Dispensing error|0
130708|NCT00522379|438577|P1|Overall Study|Dispensing error|1
130709|NCT00522379|438573|P5|Overall Study|Randomization error|1
130710|NCT00522379|438574|P4|Overall Study|Randomization error|0
130711|NCT00522379|438575|P3|Overall Study|Randomization error|0
130712|NCT00522379|438576|P2|Overall Study|Randomization error|0
130713|NCT00522379|438577|P1|Overall Study|Randomization error|0
130714|NCT00522379|438573|P5|Overall Study|Lost to Follow-up|2
130715|NCT00522379|438574|P4|Overall Study|Lost to Follow-up|2
130716|NCT00522379|438575|P3|Overall Study|Lost to Follow-up|4
130717|NCT00522379|438576|P2|Overall Study|Lost to Follow-up|0
130718|NCT00522379|438577|P1|Overall Study|Lost to Follow-up|1
130719|NCT00522379|438573|P5|Overall Study|Unsatisfactory Subject Compliance|0
130720|NCT00522379|438574|P4|Overall Study|Unsatisfactory Subject Compliance|0
130721|NCT00522379|438575|P3|Overall Study|Unsatisfactory Subject Compliance|0
130722|NCT00522379|438576|P2|Overall Study|Unsatisfactory Subject Compliance|2
130723|NCT00522379|438577|P1|Overall Study|Unsatisfactory Subject Compliance|1
130724|NCT00522379|438573|P5|Overall Study|Protocol Violation|0
130725|NCT00522379|438574|P4|Overall Study|Protocol Violation|0
130726|NCT00522379|438575|P3|Overall Study|Protocol Violation|2
130727|NCT00522379|438576|P2|Overall Study|Protocol Violation|1
130728|NCT00522379|438577|P1|Overall Study|Protocol Violation|1
130729|NCT00522379|438573|P5|Overall Study|Withdrawal by Subject|0
130730|NCT00522379|438574|P4|Overall Study|Withdrawal by Subject|2
130731|NCT00522379|438575|P3|Overall Study|Withdrawal by Subject|1
130732|NCT00522379|438576|P2|Overall Study|Withdrawal by Subject|3
130733|NCT00522379|438577|P1|Overall Study|Withdrawal by Subject|2
130734|NCT00522379|438573|P5|Overall Study|Lack of Efficacy|7
130735|NCT00522379|438574|P4|Overall Study|Lack of Efficacy|2
130736|NCT00522379|438575|P3|Overall Study|Lack of Efficacy|2
130737|NCT00522379|438576|P2|Overall Study|Lack of Efficacy|0
130738|NCT00522379|438577|P1|Overall Study|Lack of Efficacy|3
130739|NCT00522379|438573|P5|Overall Study|Adverse Event|17
130740|NCT00522379|438574|P4|Overall Study|Adverse Event|5
130741|NCT00522379|438575|P3|Overall Study|Adverse Event|12
130742|NCT00522379|438576|P2|Overall Study|Adverse Event|15
130743|NCT00522379|438577|P1|Overall Study|Adverse Event|12
130744|NCT00522301|438679|P1|Overall Study|Adverse Event|5
130745|NCT00522301|438679|P1|Overall Study|Withdrawal by Subject|1
130746|NCT00522275|438683|P1|Overall Study|Other: Subject had surgery for epilepsy|2
130747|NCT00522275|438683|P1|Overall Study|Other: Subject ran out of medication|1
130748|NCT00522275|438683|P1|Overall Study|Other: Sponsor request|2
130749|NCT00522275|438683|P1|Overall Study|Other: Travel to / from site difficulty|3
130750|NCT00522275|438683|P1|Overall Study|Other: Site / clinic closed|4
130751|NCT00522275|438683|P1|Overall Study|Other: Subject arrested|1
130752|NCT00522275|438683|P1|Overall Study|Other: Subject relocated|2
130753|NCT00522275|438683|P1|Overall Study|Other: Subject is pregnant|2
130754|NCT00522275|438683|P1|Overall Study|Other: Subject wants to become pregnant|2
130755|NCT00522275|438683|P1|Overall Study|Lost to Follow-up|8
130756|NCT00522275|438683|P1|Overall Study|Unsatisfactory compliance|11
130757|NCT00522275|438683|P1|Overall Study|Protocol deviation|1
130758|NCT00522275|438683|P1|Overall Study|Subject withdrew consent|16
130759|NCT00522275|438683|P1|Overall Study|Lack of Efficacy|80
130760|NCT00522275|438683|P1|Overall Study|Adverse Event|35
130761|NCT00522041|438704|P2|Overall Study|Did not receive treatment|1
130762|NCT00522041|438705|P1|Overall Study|Did not receive treatment|0
130763|NCT00522041|438704|P2|Overall Study|Voluntary withdrawal|4
130764|NCT00522041|438705|P1|Overall Study|Voluntary withdrawal|5
130765|NCT00522041|438704|P2|Overall Study|Lost to Follow-up|4
130766|NCT00522041|438705|P1|Overall Study|Lost to Follow-up|1
130767|NCT00522041|438704|P2|Overall Study|Protocol Violation|0
130768|NCT00522041|438705|P1|Overall Study|Protocol Violation|2
130769|NCT00522041|438704|P2|Overall Study|Adverse Event|3
130770|NCT00522041|438705|P1|Overall Study|Adverse Event|9
130771|NCT00521599|438753|P3|Overall Study|Did not meet protocol eligibility|1
130772|NCT00521599|438754|P2|Overall Study|Did not meet protocol eligibility|2
130773|NCT00521599|438755|P1|Overall Study|Did not meet protocol eligibility|2
130774|NCT00521599|438753|P3|Overall Study|Protocol Violation|2
130775|NCT00521599|438754|P2|Overall Study|Protocol Violation|4
130776|NCT00521599|438755|P1|Overall Study|Protocol Violation|2
130777|NCT00521599|438753|P3|Overall Study|Withdrawal by subject treatment related|2
130778|NCT00521599|438754|P2|Overall Study|Withdrawal by subject treatment related|1
130779|NCT00521599|438755|P1|Overall Study|Withdrawal by subject treatment related|3
130780|NCT00521599|438753|P3|Overall Study|Withdrawal by Subject|1
130781|NCT00521599|438754|P2|Overall Study|Withdrawal by Subject|5
130782|NCT00521599|438755|P1|Overall Study|Withdrawal by Subject|3
130783|NCT00521599|438753|P3|Overall Study|Lost to Follow-up|2
130784|NCT00521599|438754|P2|Overall Study|Lost to Follow-up|1
130785|NCT00521599|438755|P1|Overall Study|Lost to Follow-up|2
130786|NCT00521599|438753|P3|Overall Study|Treatment Failure|22
130787|NCT00521599|438754|P2|Overall Study|Treatment Failure|9
130788|NCT00521599|438755|P1|Overall Study|Treatment Failure|8
130789|NCT00521599|438753|P3|Overall Study|Adverse Event|6
130790|NCT00521599|438754|P2|Overall Study|Adverse Event|7
130791|NCT00521599|438755|P1|Overall Study|Adverse Event|5
130792|NCT00521586|438766|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
130793|NCT00521586|438767|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
130794|NCT00521586|438766|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
130795|NCT00521586|438767|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
130796|NCT00521586|438766|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
130797|NCT00521586|438767|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
130798|NCT00521586|438766|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
130799|NCT00521586|438767|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
130800|NCT00521586|438766|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
130801|NCT00521586|438767|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
130802|NCT00521586|438766|P2|Follow-up (From 6-month[Year 0]-Year 5)|unspecified|26
130803|NCT00521586|438767|P1|Follow-up (From 6-month[Year 0]-Year 5)|unspecified|22
130804|NCT00521586|438766|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
130805|NCT00521586|438767|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
130806|NCT00521586|438766|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
130807|NCT00521586|438767|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
130808|NCT00521586|438766|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
130809|NCT00521586|438767|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
130810|NCT00521586|438766|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
130811|NCT00521586|438767|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
130812|NCT00521586|438766|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
130813|NCT00521586|438767|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
130814|NCT00521586|438766|P2|Initial Vaccination (Year 0)|Failed to return|1
130815|NCT00521586|438767|P1|Initial Vaccination (Year 0)|Failed to return|0
130816|NCT00521586|438766|P2|Initial Vaccination (Year 0)|Death|0
130817|NCT00521586|438767|P1|Initial Vaccination (Year 0)|Death|1
130818|NCT00521586|438766|P2|Initial Vaccination (Year 0)|Adverse Event|1
130819|NCT00521586|438767|P1|Initial Vaccination (Year 0)|Adverse Event|0
130820|NCT00521586|438766|P2|Initial Vaccination (Year 0)|Investigator request|0
130821|NCT00521586|438767|P1|Initial Vaccination (Year 0)|Investigator request|2
130822|NCT00521586|438766|P2|Initial Vaccination (Year 0)|Other, unspecified|1
130823|NCT00521586|438767|P1|Initial Vaccination (Year 0)|Other, unspecified|3
130824|NCT00521586|438766|P2|Initial Vaccination (Year 0)|Protocol Violation|5
130825|NCT00521586|438767|P1|Initial Vaccination (Year 0)|Protocol Violation|2
130826|NCT00521586|438766|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
130827|NCT00521586|438767|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
130828|NCT00521586|438766|P2|Initial Vaccination (Year 0)|Subject request|11
130829|NCT00521586|438767|P1|Initial Vaccination (Year 0)|Subject request|8
130830|NCT00521365|438840|P1|Overall Study|Usage of not allowed drugs|6
130831|NCT00521365|438840|P1|Overall Study|Drug compliance|3
130832|NCT00521365|438840|P1|Overall Study|Protocol deviation|2
130833|NCT00521365|438840|P1|Overall Study|Lost to Follow-up|6
130834|NCT00521365|438840|P1|Overall Study|Adverse Event|3
130835|NCT00521339|438870|P3|Treatment Extension Phase|Death|1
130836|NCT00521339|438871|P2|Treatment Extension Phase|Death|0
130837|NCT00521339|438872|P1|Treatment Extension Phase|Death|0
130838|NCT00521339|438870|P3|Treatment Extension Phase|Withdrawal by Subject|2
130839|NCT00521339|438871|P2|Treatment Extension Phase|Withdrawal by Subject|0
130840|NCT00521339|438872|P1|Treatment Extension Phase|Withdrawal by Subject|0
130841|NCT00521339|438870|P3|Treatment Phase|Protocol Violation|0
130842|NCT00521339|438871|P2|Treatment Phase|Protocol Violation|0
130843|NCT00521339|438872|P1|Treatment Phase|Protocol Violation|1
130844|NCT00521339|438870|P3|Treatment Phase|Lost to Follow-up|0
130845|NCT00521339|438871|P2|Treatment Phase|Lost to Follow-up|0
130846|NCT00521339|438872|P1|Treatment Phase|Lost to Follow-up|1
130847|NCT00521339|438870|P3|Treatment Phase|Withdrawal by Subject|0
130848|NCT00521339|438871|P2|Treatment Phase|Withdrawal by Subject|0
130849|NCT00521339|438872|P1|Treatment Phase|Withdrawal by Subject|3
130850|NCT00521339|438870|P3|Treatment Phase|Lack of Efficacy|0
130851|NCT00521339|438871|P2|Treatment Phase|Lack of Efficacy|0
130852|NCT00521339|438872|P1|Treatment Phase|Lack of Efficacy|3
130853|NCT00521339|438870|P3|Treatment Phase|Intolerability to study drug|0
130854|NCT00521339|438871|P2|Treatment Phase|Intolerability to study drug|0
130855|NCT00521339|438872|P1|Treatment Phase|Intolerability to study drug|2
130856|NCT00521339|438870|P3|Treatment Phase|Adverse Event|0
130857|NCT00521339|438871|P2|Treatment Phase|Adverse Event|0
130858|NCT00521339|438872|P1|Treatment Phase|Adverse Event|2
130859|NCT00521144|438940|P5|Overall Study|Progressive Disease|6
130860|NCT00521144|438941|P4|Overall Study|Progressive Disease|0
130861|NCT00521144|438942|P3|Overall Study|Progressive Disease|2
130862|NCT00521144|438943|P2|Overall Study|Progressive Disease|2
130863|NCT00521144|438944|P1|Overall Study|Progressive Disease|4
130864|NCT00521144|438940|P5|Overall Study|Adverse Event|1
130865|NCT00521144|438941|P4|Overall Study|Adverse Event|0
130866|NCT00521144|438942|P3|Overall Study|Adverse Event|0
130867|NCT00521144|438943|P2|Overall Study|Adverse Event|1
130868|NCT00521144|438944|P1|Overall Study|Adverse Event|0
130869|NCT00521144|438940|P5|Overall Study|Not Treated|0
130870|NCT00521144|438941|P4|Overall Study|Not Treated|1
130871|NCT00521144|438942|P3|Overall Study|Not Treated|0
130872|NCT00521144|438943|P2|Overall Study|Not Treated|0
130873|NCT00521144|438944|P1|Overall Study|Not Treated|0
130874|NCT00521053|438956|P1|Observation Phase|Physician Decision|1
130875|NCT00521053|438956|P1|Observation Phase|Other non-study melanoma treatment|1
130876|NCT00521053|438956|P1|Observation Phase|Adverse Event|1
130877|NCT00521053|438956|P1|Observation Phase|Death|2
130878|NCT00521053|438956|P1|Observation Phase|Additional PV-10 via alternate protocol|8
130879|NCT00521053|438956|P1|Observation Phase|Disease Progression|55
130880|NCT00521014|438966|P1|Overall Study|Inevaluable, not treated|1
130881|NCT00520975|438972|P2|Overall Study|Not start protocol therapy|2
130882|NCT00520975|438973|P1|Overall Study|Not start protocol therapy|1
130883|NCT00520975|438972|P2|Overall Study|Other reasons|2
130884|NCT00520975|438973|P1|Overall Study|Other reasons|4
130885|NCT00520975|438972|P2|Overall Study|Other therapy|4
130886|NCT00520975|438973|P1|Overall Study|Other therapy|2
130887|NCT00520975|438972|P2|Overall Study|Withdrawal by Subject|5
130888|NCT00520975|438973|P1|Overall Study|Withdrawal by Subject|3
130889|NCT00520975|438972|P2|Overall Study|Death|2
130890|NCT00520975|438973|P1|Overall Study|Death|0
130891|NCT00520975|438972|P2|Overall Study|Adverse Event|10
130892|NCT00520975|438973|P1|Overall Study|Adverse Event|7
130893|NCT00520975|438972|P2|Overall Study|Disease progression|23
130894|NCT00520975|438973|P1|Overall Study|Disease progression|31
130895|NCT00520936|439005|P8|Overall Study|Protocol Violation|0
130896|NCT00520936|439006|P7|Overall Study|Protocol Violation|1
130897|NCT00520936|439007|P6|Overall Study|Protocol Violation|0
130898|NCT00520936|439008|P5|Overall Study|Protocol Violation|1
130899|NCT00520936|439009|P4|Overall Study|Protocol Violation|0
130900|NCT00520936|439010|P3|Overall Study|Protocol Violation|1
130901|NCT00520936|439011|P2|Overall Study|Protocol Violation|1
130902|NCT00520936|439012|P1|Overall Study|Protocol Violation|0
130903|NCT00520936|439005|P8|Overall Study|Death|0
130904|NCT00520936|439006|P7|Overall Study|Death|1
130905|NCT00520936|439007|P6|Overall Study|Death|0
130906|NCT00520936|439008|P5|Overall Study|Death|0
130907|NCT00520936|439009|P4|Overall Study|Death|0
130908|NCT00520936|439010|P3|Overall Study|Death|0
130909|NCT00520936|439011|P2|Overall Study|Death|0
130910|NCT00520936|439012|P1|Overall Study|Death|0
130911|NCT00520936|439005|P8|Overall Study|Toxicity Requiring Removal from Study|0
130912|NCT00520936|439006|P7|Overall Study|Toxicity Requiring Removal from Study|2
130913|NCT00520936|439007|P6|Overall Study|Toxicity Requiring Removal from Study|0
130914|NCT00520936|439008|P5|Overall Study|Toxicity Requiring Removal from Study|0
130915|NCT00520936|439009|P4|Overall Study|Toxicity Requiring Removal from Study|0
130916|NCT00520936|439010|P3|Overall Study|Toxicity Requiring Removal from Study|0
130917|NCT00520936|439011|P2|Overall Study|Toxicity Requiring Removal from Study|1
130918|NCT00520936|439012|P1|Overall Study|Toxicity Requiring Removal from Study|0
130919|NCT00520936|439005|P8|Overall Study|Withdrawal by Subject|1
130920|NCT00520936|439006|P7|Overall Study|Withdrawal by Subject|0
130921|NCT00520936|439007|P6|Overall Study|Withdrawal by Subject|0
130922|NCT00520936|439008|P5|Overall Study|Withdrawal by Subject|0
130923|NCT00520936|439009|P4|Overall Study|Withdrawal by Subject|0
130924|NCT00520936|439010|P3|Overall Study|Withdrawal by Subject|0
130925|NCT00520936|439011|P2|Overall Study|Withdrawal by Subject|0
130926|NCT00520936|439012|P1|Overall Study|Withdrawal by Subject|0
130927|NCT00520936|439005|P8|Overall Study|Physician Decision|0
130928|NCT00520936|439006|P7|Overall Study|Physician Decision|0
130929|NCT00520936|439007|P6|Overall Study|Physician Decision|0
130930|NCT00520936|439008|P5|Overall Study|Physician Decision|0
130931|NCT00520936|439009|P4|Overall Study|Physician Decision|0
130932|NCT00520936|439010|P3|Overall Study|Physician Decision|1
130933|NCT00520936|439011|P2|Overall Study|Physician Decision|2
130934|NCT00520936|439012|P1|Overall Study|Physician Decision|0
130935|NCT00520845|439039|P1|Overall Study|Alternative Therapy|1
130936|NCT00520845|439039|P1|Overall Study|Withdrawal by Subject|1
130937|NCT00520845|439039|P1|Overall Study|Disease Progression, relapse|13
130938|NCT00520845|439039|P1|Overall Study|Adverse Event|4
130939|NCT00520845|439039|P1|Overall Study|Death|3
130940|NCT00520767|439047|P1|Overall Study|Death|2
130941|NCT00520741|439053|P2|Overall Study|Other reasons for premature termination|6
130942|NCT00520741|439054|P1|Overall Study|Other reasons for premature termination|0
130943|NCT00520741|439053|P2|Overall Study|Lost to Follow-up|4
130944|NCT00520741|439054|P1|Overall Study|Lost to Follow-up|4
130945|NCT00520741|439053|P2|Overall Study|Unsatisfactory compliance of subject|3
130946|NCT00520741|439054|P1|Overall Study|Unsatisfactory compliance of subject|4
130947|NCT00520741|439053|P2|Overall Study|Protocol Violation|15
130948|NCT00520741|439054|P1|Overall Study|Protocol Violation|2
130949|NCT00520741|439053|P2|Overall Study|Withdrawal by Subject|11
130950|NCT00520741|439054|P1|Overall Study|Withdrawal by Subject|0
130951|NCT00520741|439053|P2|Overall Study|Lack of Efficacy|30
130952|NCT00520741|439054|P1|Overall Study|Lack of Efficacy|11
130953|NCT00520741|439053|P2|Overall Study|Adverse Event|56
130954|NCT00520741|439054|P1|Overall Study|Adverse Event|16
130955|NCT00520676|439072|P2|Overall Study|Withdrawal by Subject|11
130956|NCT00520676|439073|P1|Overall Study|Withdrawal by Subject|7
130957|NCT00520676|439072|P2|Overall Study|Physician Decision|1
130958|NCT00520676|439073|P1|Overall Study|Physician Decision|4
130959|NCT00520676|439072|P2|Overall Study|Lost to Follow-up|10
130960|NCT00520676|439073|P1|Overall Study|Lost to Follow-up|6
130961|NCT00520676|439072|P2|Overall Study|Death|81
130962|NCT00520676|439073|P1|Overall Study|Death|84
130963|NCT00520572|439099|P6|Overall Study|Did not receive Treatment|0
130964|NCT00520572|439100|P5|Overall Study|Did not receive Treatment|0
130965|NCT00520572|439101|P4|Overall Study|Did not receive Treatment|0
130966|NCT00520572|439102|P3|Overall Study|Did not receive Treatment|1
130967|NCT00520572|439103|P2|Overall Study|Did not receive Treatment|0
130968|NCT00520572|439104|P1|Overall Study|Did not receive Treatment|1
130969|NCT00520572|439099|P6|Overall Study|Long break in taking Medication|0
130970|NCT00520572|439100|P5|Overall Study|Long break in taking Medication|0
130971|NCT00520572|439101|P4|Overall Study|Long break in taking Medication|1
130972|NCT00520572|439102|P3|Overall Study|Long break in taking Medication|0
130973|NCT00520572|439103|P2|Overall Study|Long break in taking Medication|0
130974|NCT00520572|439104|P1|Overall Study|Long break in taking Medication|0
130975|NCT00520572|439099|P6|Overall Study|Oral corticotherapy for acute urticaria|0
130976|NCT00520572|439100|P5|Overall Study|Oral corticotherapy for acute urticaria|0
130977|NCT00520572|439101|P4|Overall Study|Oral corticotherapy for acute urticaria|0
130978|NCT00520572|439102|P3|Overall Study|Oral corticotherapy for acute urticaria|0
130979|NCT00520572|439103|P2|Overall Study|Oral corticotherapy for acute urticaria|1
130980|NCT00520572|439104|P1|Overall Study|Oral corticotherapy for acute urticaria|0
130981|NCT00520572|439099|P6|Overall Study|Incorrect enrollment|0
130982|NCT00520572|439100|P5|Overall Study|Incorrect enrollment|1
130983|NCT00520572|439101|P4|Overall Study|Incorrect enrollment|0
130984|NCT00520572|439102|P3|Overall Study|Incorrect enrollment|1
130985|NCT00520572|439103|P2|Overall Study|Incorrect enrollment|0
130986|NCT00520572|439104|P1|Overall Study|Incorrect enrollment|1
130987|NCT00520572|439099|P6|Overall Study|Lost to Follow-up|0
130988|NCT00520572|439100|P5|Overall Study|Lost to Follow-up|1
130989|NCT00520572|439101|P4|Overall Study|Lost to Follow-up|0
130990|NCT00520572|439102|P3|Overall Study|Lost to Follow-up|0
130991|NCT00520572|439103|P2|Overall Study|Lost to Follow-up|0
130992|NCT00520572|439104|P1|Overall Study|Lost to Follow-up|0
130993|NCT00520572|439099|P6|Overall Study|Lack of Efficacy|0
130994|NCT00520572|439100|P5|Overall Study|Lack of Efficacy|1
130995|NCT00520572|439101|P4|Overall Study|Lack of Efficacy|2
130996|NCT00520572|439102|P3|Overall Study|Lack of Efficacy|1
130997|NCT00520572|439103|P2|Overall Study|Lack of Efficacy|1
130998|NCT00520572|439104|P1|Overall Study|Lack of Efficacy|1
130999|NCT00520572|439099|P6|Overall Study|Protocol Violation|0
131000|NCT00520572|439100|P5|Overall Study|Protocol Violation|0
131001|NCT00520572|439101|P4|Overall Study|Protocol Violation|0
131002|NCT00520572|439102|P3|Overall Study|Protocol Violation|1
131003|NCT00520572|439103|P2|Overall Study|Protocol Violation|0
131004|NCT00520572|439104|P1|Overall Study|Protocol Violation|0
131005|NCT00520572|439099|P6|Overall Study|Withdrawal by Subject|0
131006|NCT00520572|439100|P5|Overall Study|Withdrawal by Subject|2
131007|NCT00520572|439101|P4|Overall Study|Withdrawal by Subject|2
131008|NCT00520572|439102|P3|Overall Study|Withdrawal by Subject|5
131009|NCT00520572|439103|P2|Overall Study|Withdrawal by Subject|9
131010|NCT00520572|439104|P1|Overall Study|Withdrawal by Subject|0
131011|NCT00520572|439099|P6|Overall Study|Adverse Event|2
131012|NCT00520572|439100|P5|Overall Study|Adverse Event|7
131013|NCT00520572|439101|P4|Overall Study|Adverse Event|9
131014|NCT00520572|439102|P3|Overall Study|Adverse Event|6
131015|NCT00520572|439103|P2|Overall Study|Adverse Event|3
131016|NCT00520572|439104|P1|Overall Study|Adverse Event|9
131017|NCT00520546|439142|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
131018|NCT00520546|439142|P1|Overall Study|Withdrawal by Subject|1
131019|NCT00519779|439167|P2|Overall Study|Withdrawal by Subject|1
131020|NCT00519779|439168|P1|Overall Study|Withdrawal by Subject|0
131021|NCT00519649|439184|P1|Overall Study|Withdrawal by Subject|1
131022|NCT00520494|439193|P1|Overall Study|Withdrawal by Subject|1
131023|NCT00520403|439220|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
131024|NCT00520403|439220|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
131025|NCT00520403|439220|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
131026|NCT00520403|439220|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
131027|NCT00520403|439220|P1|Bevacizumab + IFN/Vinblastine|Death|2
131028|NCT00520403|439220|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
131029|NCT00520403|439220|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
131030|NCT00520403|439220|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
131031|NCT00520351|439229|P2|First Intervention|Withdrawal by Subject|1
131032|NCT00520351|439230|P1|First Intervention|Withdrawal by Subject|1
131033|NCT00520013|439258|P3|Overall Study|Physician Decision|3
131034|NCT00520013|439259|P2|Overall Study|Physician Decision|0
131035|NCT00520013|439260|P1|Overall Study|Physician Decision|0
131036|NCT00520013|439258|P3|Overall Study|Death|0
131037|NCT00520013|439259|P2|Overall Study|Death|1
131038|NCT00520013|439260|P1|Overall Study|Death|0
131039|NCT00520013|439258|P3|Overall Study|Clinical Progression|0
131040|NCT00520013|439259|P2|Overall Study|Clinical Progression|1
131041|NCT00520013|439260|P1|Overall Study|Clinical Progression|3
131042|NCT00520013|439258|P3|Overall Study|Progressive Disease|0
131043|NCT00520013|439259|P2|Overall Study|Progressive Disease|3
131044|NCT00520013|439260|P1|Overall Study|Progressive Disease|7
131045|NCT00520013|439258|P3|Overall Study|Adverse Event|7
131046|NCT00520013|439259|P2|Overall Study|Adverse Event|10
131047|NCT00520013|439260|P1|Overall Study|Adverse Event|2
131048|NCT00520013|439258|P3|Overall Study|Withdrawal by Subject|1
131049|NCT00520013|439259|P2|Overall Study|Withdrawal by Subject|0
131050|NCT00520013|439260|P1|Overall Study|Withdrawal by Subject|0
131051|NCT00519636|439274|P4|Post Study Period|Subject randomized in error|1
131052|NCT00519636|439275|P3|Post Study Period|Subject randomized in error|0
131053|NCT00519636|439276|P2|Post Study Period|Subject randomized in error|0
131054|NCT00519636|439277|P1|Post Study Period|Subject randomized in error|0
131055|NCT00519636|439274|P4|Treatment Period 2|Subject misrandomized|1
131056|NCT00519636|439275|P3|Treatment Period 2|Subject misrandomized|0
131057|NCT00519636|439276|P2|Treatment Period 2|Subject misrandomized|0
131058|NCT00519636|439277|P1|Treatment Period 2|Subject misrandomized|0
131059|NCT00519636|439274|P4|Treatment Period 2|Per doctors request|0
131060|NCT00519636|439275|P3|Treatment Period 2|Per doctors request|1
131061|NCT00519636|439276|P2|Treatment Period 2|Per doctors request|0
131062|NCT00519636|439277|P1|Treatment Period 2|Per doctors request|0
131063|NCT00519636|439274|P4|Treatment Period 2|Subject randomized in error|0
131064|NCT00519636|439275|P3|Treatment Period 2|Subject randomized in error|0
131065|NCT00519636|439276|P2|Treatment Period 2|Subject randomized in error|1
131066|NCT00519636|439277|P1|Treatment Period 2|Subject randomized in error|0
131067|NCT00519636|439274|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
131068|NCT00519636|439275|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
131232|NCT00518882|439634|P2|Double-Blind, Week 0-26|Subject decision|1
131069|NCT00519636|439276|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
131070|NCT00519636|439277|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
131071|NCT00519636|439274|P4|Washout Period|Prohibited medications|0
131072|NCT00519636|439275|P3|Washout Period|Prohibited medications|1
131073|NCT00519636|439276|P2|Washout Period|Prohibited medications|0
131074|NCT00519636|439277|P1|Washout Period|Prohibited medications|0
131075|NCT00519636|439274|P4|Washout Period|Subject randomized in error|0
131076|NCT00519636|439275|P3|Washout Period|Subject randomized in error|1
131077|NCT00519636|439276|P2|Washout Period|Subject randomized in error|0
131078|NCT00519636|439277|P1|Washout Period|Subject randomized in error|0
131079|NCT00519636|439274|P4|Washout Period|Per doctors request|0
131080|NCT00519636|439275|P3|Washout Period|Per doctors request|0
131081|NCT00519636|439276|P2|Washout Period|Per doctors request|1
131082|NCT00519636|439277|P1|Washout Period|Per doctors request|0
131083|NCT00519636|439274|P4|Washout Period|Non-compliant|0
131084|NCT00519636|439275|P3|Washout Period|Non-compliant|0
131085|NCT00519636|439276|P2|Washout Period|Non-compliant|1
131086|NCT00519636|439277|P1|Washout Period|Non-compliant|0
131087|NCT00519636|439274|P4|Washout Period|Participating in study at another site|0
131088|NCT00519636|439275|P3|Washout Period|Participating in study at another site|0
131089|NCT00519636|439276|P2|Washout Period|Participating in study at another site|0
131090|NCT00519636|439277|P1|Washout Period|Participating in study at another site|1
131091|NCT00519636|439274|P4|Washout Period|Out of pollen area > 48 hours|0
131092|NCT00519636|439275|P3|Washout Period|Out of pollen area > 48 hours|0
131093|NCT00519636|439276|P2|Washout Period|Out of pollen area > 48 hours|0
131094|NCT00519636|439277|P1|Washout Period|Out of pollen area > 48 hours|1
131095|NCT00519636|439274|P4|Washout Period|Failed to meet continuation criteria|3
131096|NCT00519636|439275|P3|Washout Period|Failed to meet continuation criteria|9
131097|NCT00519636|439276|P2|Washout Period|Failed to meet continuation criteria|11
131098|NCT00519636|439277|P1|Washout Period|Failed to meet continuation criteria|14
131099|NCT00519636|439274|P4|Washout Period|Withdrawal by Subject|0
131100|NCT00519636|439275|P3|Washout Period|Withdrawal by Subject|1
131101|NCT00519636|439276|P2|Washout Period|Withdrawal by Subject|0
131102|NCT00519636|439277|P1|Washout Period|Withdrawal by Subject|1
131103|NCT00519636|439274|P4|Washout Period|Protocol Violation|2
131104|NCT00519636|439275|P3|Washout Period|Protocol Violation|1
131105|NCT00519636|439276|P2|Washout Period|Protocol Violation|0
131106|NCT00519636|439277|P1|Washout Period|Protocol Violation|0
131107|NCT00519636|439274|P4|Washout Period|Lost to Follow-up|0
131108|NCT00519636|439275|P3|Washout Period|Lost to Follow-up|0
131109|NCT00519636|439276|P2|Washout Period|Lost to Follow-up|0
131110|NCT00519636|439277|P1|Washout Period|Lost to Follow-up|1
131111|NCT00519636|439274|P4|Washout Period|Adverse Event|0
131112|NCT00519636|439275|P3|Washout Period|Adverse Event|1
131113|NCT00519636|439276|P2|Washout Period|Adverse Event|1
131114|NCT00519636|439277|P1|Washout Period|Adverse Event|2
131115|NCT00519636|439274|P4|Treatment Period 1|Sponsor request due to missed visit|0
131116|NCT00519636|439275|P3|Treatment Period 1|Sponsor request due to missed visit|0
131117|NCT00519636|439276|P2|Treatment Period 1|Sponsor request due to missed visit|0
131118|NCT00519636|439277|P1|Treatment Period 1|Sponsor request due to missed visit|1
131119|NCT00519636|439274|P4|Treatment Period 1|Adverse Event|0
131120|NCT00519636|439275|P3|Treatment Period 1|Adverse Event|1
131121|NCT00519636|439276|P2|Treatment Period 1|Adverse Event|0
131122|NCT00519636|439277|P1|Treatment Period 1|Adverse Event|1
131123|NCT00519623|439307|P1|Overall Study|Adverse Event|1
131124|NCT00519532|439312|P1|Overall Study|Lost to Follow-up|2
131125|NCT00519532|439312|P1|Overall Study|Withdrawal by Subject|5
131126|NCT00519532|439312|P1|Overall Study|Adverse Event|11
131127|NCT00519376|439319|P16|Treatment Period 4|Lost to Follow-up|0
131128|NCT00519376|439320|P15|Treatment Period 4|Lost to Follow-up|0
131129|NCT00519376|439321|P14|Treatment Period 4|Lost to Follow-up|0
131130|NCT00519376|439322|P13|Treatment Period 4|Lost to Follow-up|0
131131|NCT00519376|439323|P12|Treatment Period 4|Lost to Follow-up|0
131132|NCT00519376|439324|P11|Treatment Period 4|Lost to Follow-up|0
131133|NCT00519376|439325|P10|Treatment Period 4|Lost to Follow-up|0
131134|NCT00519376|439326|P9|Treatment Period 4|Lost to Follow-up|0
131135|NCT00519376|439327|P8|Treatment Period 4|Lost to Follow-up|0
131136|NCT00519376|439328|P7|Treatment Period 4|Lost to Follow-up|0
131137|NCT00519376|439329|P6|Treatment Period 4|Lost to Follow-up|0
131138|NCT00519376|439330|P5|Treatment Period 4|Lost to Follow-up|0
131139|NCT00519376|439331|P4|Treatment Period 4|Lost to Follow-up|0
131140|NCT00519376|439332|P3|Treatment Period 4|Lost to Follow-up|1
131141|NCT00519376|439333|P2|Treatment Period 4|Lost to Follow-up|0
131142|NCT00519376|439334|P1|Treatment Period 4|Lost to Follow-up|0
131143|NCT00519376|439319|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131144|NCT00519376|439320|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131145|NCT00519376|439321|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131146|NCT00519376|439322|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
131147|NCT00519376|439323|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131148|NCT00519376|439324|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131149|NCT00519376|439325|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131150|NCT00519376|439326|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131151|NCT00519376|439327|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131152|NCT00519376|439328|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131153|NCT00519376|439329|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131154|NCT00519376|439330|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131155|NCT00519376|439331|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131156|NCT00519376|439332|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131157|NCT00519376|439333|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131158|NCT00519376|439334|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
131159|NCT00519285|439458|P2|Overall Study|Treatment ongoing|2
131160|NCT00519285|439459|P1|Overall Study|Treatment ongoing|1
131161|NCT00519285|439458|P2|Overall Study|Not treated|7
131162|NCT00519285|439459|P1|Overall Study|Not treated|8
131163|NCT00519285|439458|P2|Overall Study|Reason unspecified|8
131164|NCT00519285|439459|P1|Overall Study|Reason unspecified|5
131165|NCT00519285|439458|P2|Overall Study|Poor compliance to protocol|7
131166|NCT00519285|439459|P1|Overall Study|Poor compliance to protocol|5
131167|NCT00519285|439458|P2|Overall Study|Consent withdrawn|5
131168|NCT00519285|439459|P1|Overall Study|Consent withdrawn|4
131169|NCT00519285|439458|P2|Overall Study|Participant's request|84
131170|NCT00519285|439459|P1|Overall Study|Participant's request|53
131171|NCT00519285|439458|P2|Overall Study|Physician Decision|47
131172|NCT00519285|439459|P1|Overall Study|Physician Decision|75
131173|NCT00519285|439458|P2|Overall Study|Disease progression|186
131174|NCT00519285|439459|P1|Overall Study|Disease progression|334
131175|NCT00519285|439458|P2|Overall Study|Adverse Event|266
131176|NCT00519285|439459|P1|Overall Study|Adverse Event|127
131177|NCT00519194|439485|P1|Overall Study|Lost to Follow-up|3
131178|NCT00519194|439485|P1|Overall Study|Death|9
131179|NCT00519194|439485|P1|Overall Study|Withdrawal by Subject|9
131180|NCT00519077|439500|P1|Overall Study|Other|2
131181|NCT00519077|439500|P1|Overall Study|Death|6
131182|NCT00518986|439507|P2|Overall Study|Non-Specific|1
131183|NCT00518986|439508|P1|Overall Study|Non-Specific|2
131184|NCT00518986|439507|P2|Overall Study|Withdrawal by Subject|4
131185|NCT00518986|439508|P1|Overall Study|Withdrawal by Subject|4
131186|NCT00518986|439507|P2|Overall Study|Protocol Violation|7
131187|NCT00518986|439508|P1|Overall Study|Protocol Violation|5
131188|NCT00518986|439507|P2|Overall Study|Physician Decision|3
131189|NCT00518986|439508|P1|Overall Study|Physician Decision|0
131190|NCT00518986|439507|P2|Overall Study|Lost to Follow-up|2
131191|NCT00518986|439508|P1|Overall Study|Lost to Follow-up|3
131192|NCT00518986|439507|P2|Overall Study|Lack of Efficacy|2
131193|NCT00518986|439508|P1|Overall Study|Lack of Efficacy|0
131194|NCT00518986|439507|P2|Overall Study|Adverse Event|7
131195|NCT00518986|439508|P1|Overall Study|Adverse Event|12
131196|NCT00518882|439634|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
131197|NCT00518882|439635|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
131198|NCT00518882|439634|P2|Open-Label Extension, Week 26-78|Subject decision|0
131199|NCT00518882|439635|P1|Open-Label Extension, Week 26-78|Subject decision|2
131200|NCT00518882|439634|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
131201|NCT00518882|439635|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
131202|NCT00518882|439634|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
131203|NCT00518882|439635|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
131204|NCT00518882|439634|P2|Open-Label Extension, Week 26-78|Creatine increased|0
131205|NCT00518882|439635|P1|Open-Label Extension, Week 26-78|Creatine increased|1
131206|NCT00518882|439634|P2|Open-Label Extension, Week 26-78|Change in treatment|1
131207|NCT00518882|439635|P1|Open-Label Extension, Week 26-78|Change in treatment|1
131208|NCT00518882|439634|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
131209|NCT00518882|439635|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
131210|NCT00518882|439634|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
131211|NCT00518882|439635|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
131212|NCT00518882|439634|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
131213|NCT00518882|439635|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
131214|NCT00518882|439634|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
131215|NCT00518882|439635|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
131216|NCT00518882|439634|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
131217|NCT00518882|439635|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
131218|NCT00518882|439634|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
131219|NCT00518882|439635|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
131220|NCT00518882|439634|P2|Open-Label Extension, Week 26-78|Adverse Event|9
131221|NCT00518882|439635|P1|Open-Label Extension, Week 26-78|Adverse Event|3
131222|NCT00518882|439634|P2|Double-Blind, Week 0-26|Mutual consent|1
131223|NCT00518882|439635|P1|Double-Blind, Week 0-26|Mutual consent|0
131224|NCT00518882|439634|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
131225|NCT00518882|439635|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
131226|NCT00518882|439634|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
131227|NCT00518882|439635|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
131228|NCT00518882|439634|P2|Double-Blind, Week 0-26|Loss of trust|1
131229|NCT00518882|439635|P1|Double-Blind, Week 0-26|Loss of trust|0
131230|NCT00518882|439634|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
131231|NCT00518882|439635|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
131233|NCT00518882|439635|P1|Double-Blind, Week 0-26|Subject decision|1
131234|NCT00518882|439634|P2|Double-Blind, Week 0-26|Lost to follow up|1
131235|NCT00518882|439635|P1|Double-Blind, Week 0-26|Lost to follow up|2
131236|NCT00518882|439634|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
131237|NCT00518882|439635|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
131238|NCT00518882|439634|P2|Double-Blind, Week 0-26|Protocol Violation|3
131239|NCT00518882|439635|P1|Double-Blind, Week 0-26|Protocol Violation|4
131240|NCT00518882|439634|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
131241|NCT00518882|439635|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
131242|NCT00518882|439634|P2|Double-Blind, Week 0-26|Adverse Event|31
131243|NCT00518882|439635|P1|Double-Blind, Week 0-26|Adverse Event|23
131244|NCT00518687|439816|P2|Overall Study|Withdrawal by Subject|110
131245|NCT00518687|439817|P1|Overall Study|Withdrawal by Subject|110
131246|NCT00518687|439816|P2|Overall Study|Study terminated by sponsor|918
131247|NCT00518687|439817|P1|Overall Study|Study terminated by sponsor|930
131248|NCT00518687|439816|P2|Overall Study|Protocol Violation|10
131249|NCT00518687|439817|P1|Overall Study|Protocol Violation|8
131250|NCT00518687|439816|P2|Overall Study|Progressive disease|2
131251|NCT00518687|439817|P1|Overall Study|Progressive disease|2
131252|NCT00518687|439816|P2|Overall Study|Physician Decision|48
131253|NCT00518687|439817|P1|Overall Study|Physician Decision|42
131254|NCT00518687|439816|P2|Overall Study|Lost to Follow-up|155
131255|NCT00518687|439817|P1|Overall Study|Lost to Follow-up|144
131256|NCT00518687|439816|P2|Overall Study|Adverse Event|177
131257|NCT00518687|439817|P1|Overall Study|Adverse Event|201
131258|NCT00518622|439837|P8|Overall Study|Study medication taken incorrectly|0
131259|NCT00518622|439838|P7|Overall Study|Study medication taken incorrectly|0
131260|NCT00518622|439839|P6|Overall Study|Study medication taken incorrectly|0
131261|NCT00518622|439840|P5|Overall Study|Study medication taken incorrectly|0
131262|NCT00518622|439841|P4|Overall Study|Study medication taken incorrectly|0
131263|NCT00518622|439842|P3|Overall Study|Study medication taken incorrectly|0
131264|NCT00518622|439843|P2|Overall Study|Study medication taken incorrectly|1
131265|NCT00518622|439844|P1|Overall Study|Study medication taken incorrectly|0
131266|NCT00518622|439837|P8|Overall Study|Lost to Follow-up|0
131267|NCT00518622|439838|P7|Overall Study|Lost to Follow-up|0
131268|NCT00518622|439839|P6|Overall Study|Lost to Follow-up|0
131269|NCT00518622|439840|P5|Overall Study|Lost to Follow-up|0
131270|NCT00518622|439841|P4|Overall Study|Lost to Follow-up|0
131271|NCT00518622|439842|P3|Overall Study|Lost to Follow-up|1
131272|NCT00518622|439843|P2|Overall Study|Lost to Follow-up|0
131273|NCT00518622|439844|P1|Overall Study|Lost to Follow-up|0
131274|NCT00518531|439872|P2|Treatment Period 2|Non-compliance|2
131275|NCT00518531|439873|P1|Treatment Period 2|Non-compliance|1
131276|NCT00518531|439872|P2|Treatment Period 2|Protocol-specified criteria|1
131277|NCT00518531|439873|P1|Treatment Period 2|Protocol-specified criteria|0
131278|NCT00518531|439872|P2|Treatment Period 2|Adverse Event|7
131279|NCT00518531|439873|P1|Treatment Period 2|Adverse Event|1
131280|NCT00518531|439872|P2|Treatment Period 2|Complete out of scheduled visit window|2
131281|NCT00518531|439873|P1|Treatment Period 2|Complete out of scheduled visit window|1
131282|NCT00518531|439872|P2|Treatment Period 2|Withdrawal by Subject|8
131283|NCT00518531|439873|P1|Treatment Period 2|Withdrawal by Subject|0
131284|NCT00518531|439872|P2|Treatment Period 1|Early crossover|3
131285|NCT00518531|439873|P1|Treatment Period 1|Early crossover|1
131286|NCT00518531|439872|P2|Treatment Period 1|Withdrawal by Subject|6
131287|NCT00518531|439873|P1|Treatment Period 1|Withdrawal by Subject|4
131288|NCT00518531|439872|P2|Treatment Period 1|Protocol Violation|0
131289|NCT00518531|439873|P1|Treatment Period 1|Protocol Violation|2
131290|NCT00518531|439872|P2|Treatment Period 1|Physician Decision|0
131291|NCT00518531|439873|P1|Treatment Period 1|Physician Decision|1
131292|NCT00518531|439872|P2|Treatment Period 1|Lost to Follow-up|3
131293|NCT00518531|439873|P1|Treatment Period 1|Lost to Follow-up|5
131294|NCT00518531|439872|P2|Treatment Period 1|Adverse Event|0
131295|NCT00518531|439873|P1|Treatment Period 1|Adverse Event|5
131296|NCT00518336|439909|P2|Year 9|Personal reasons|0
131297|NCT00518336|439910|P1|Year 9|Personal reasons|1
131298|NCT00518336|439909|P2|Year 9|Lost to Follow-up|0
131299|NCT00518336|439910|P1|Year 9|Lost to Follow-up|3
131300|NCT00518336|439909|P2|Year 9|Migrated/moved from study area|1
131301|NCT00518336|439910|P1|Year 9|Migrated/moved from study area|1
131302|NCT00518336|439909|P2|Year 8|Could not attend in time|1
131303|NCT00518336|439910|P1|Year 8|Could not attend in time|0
131304|NCT00518336|439909|P2|Year 8|Lost to Follow-up|1
131305|NCT00518336|439910|P1|Year 8|Lost to Follow-up|1
131306|NCT00518336|439909|P2|Year 7|Could not attend in time|3
131307|NCT00518336|439910|P1|Year 7|Could not attend in time|0
131308|NCT00518336|439909|P2|Year 7|Lost to Follow-up|0
131309|NCT00518336|439910|P1|Year 7|Lost to Follow-up|2
131310|NCT00518323|440076|P4|Overall Study|Prohibited medication and others|0
131311|NCT00518323|440077|P3|Overall Study|Prohibited medication and others|1
131312|NCT00518323|440078|P2|Overall Study|Prohibited medication and others|1
131313|NCT00518323|440079|P1|Overall Study|Prohibited medication and others|3
131314|NCT00518323|440076|P4|Overall Study|Adverse Event|0
131315|NCT00518323|440077|P3|Overall Study|Adverse Event|1
131316|NCT00518323|440078|P2|Overall Study|Adverse Event|1
131317|NCT00518323|440079|P1|Overall Study|Adverse Event|1
131318|NCT00518323|440076|P4|Overall Study|Lost to Follow-up|3
131319|NCT00518323|440077|P3|Overall Study|Lost to Follow-up|1
131320|NCT00518323|440078|P2|Overall Study|Lost to Follow-up|2
131321|NCT00518323|440079|P1|Overall Study|Lost to Follow-up|0
131322|NCT00518323|440076|P4|Overall Study|Withdrawal by Subject|2
131323|NCT00518323|440077|P3|Overall Study|Withdrawal by Subject|4
131324|NCT00518323|440078|P2|Overall Study|Withdrawal by Subject|2
131325|NCT00518323|440079|P1|Overall Study|Withdrawal by Subject|1
131326|NCT00518323|440076|P4|Overall Study|Lack of Efficacy|20
131327|NCT00518323|440077|P3|Overall Study|Lack of Efficacy|4
131328|NCT00518323|440078|P2|Overall Study|Lack of Efficacy|2
131329|NCT00518323|440079|P1|Overall Study|Lack of Efficacy|14
131330|NCT00518284|440109|P4|Overall Study|Study Termination|2
131331|NCT00518284|440110|P3|Overall Study|Study Termination|1
131332|NCT00518284|440111|P2|Overall Study|Study Termination|2
131333|NCT00518284|440112|P1|Overall Study|Study Termination|0
131334|NCT00518284|440109|P4|Overall Study|Adverse Event|0
131335|NCT00518284|440110|P3|Overall Study|Adverse Event|0
131336|NCT00518284|440111|P2|Overall Study|Adverse Event|1
131337|NCT00518284|440112|P1|Overall Study|Adverse Event|0
131338|NCT00518180|440169|P3|Overall Study|Adverse Event|0
131339|NCT00518180|440170|P2|Overall Study|Adverse Event|0
131340|NCT00518180|440171|P1|Overall Study|Adverse Event|1
131341|NCT00518180|440169|P3|Overall Study|Unable to classify|0
131342|NCT00518180|440170|P2|Overall Study|Unable to classify|2
131343|NCT00518180|440171|P1|Overall Study|Unable to classify|0
131344|NCT00518180|440169|P3|Overall Study|Protocol Violation|4
131345|NCT00518180|440170|P2|Overall Study|Protocol Violation|7
131346|NCT00518180|440171|P1|Overall Study|Protocol Violation|5
131347|NCT00518180|440169|P3|Overall Study|Administrative reason|2
131348|NCT00518180|440170|P2|Overall Study|Administrative reason|2
131349|NCT00518180|440171|P1|Overall Study|Administrative reason|0
131350|NCT00518180|440169|P3|Overall Study|Lost to Follow-up|34
131351|NCT00518180|440170|P2|Overall Study|Lost to Follow-up|28
131352|NCT00518180|440171|P1|Overall Study|Lost to Follow-up|30
131353|NCT00518180|440169|P3|Overall Study|Withdrawal by Subject|42
131354|NCT00518180|440170|P2|Overall Study|Withdrawal by Subject|30
131355|NCT00518180|440171|P1|Overall Study|Withdrawal by Subject|29
131356|NCT00518115|440223|P10|Overall Study|Moved Out of State|1
131357|NCT00518115|440224|P9|Overall Study|Moved Out of State|0
131358|NCT00518115|440225|P8|Overall Study|Moved Out of State|0
131359|NCT00518115|440226|P7|Overall Study|Moved Out of State|0
131360|NCT00518115|440227|P6|Overall Study|Moved Out of State|0
131361|NCT00518115|440228|P5|Overall Study|Moved Out of State|0
131362|NCT00518115|440229|P4|Overall Study|Moved Out of State|0
131363|NCT00518115|440230|P3|Overall Study|Moved Out of State|0
131364|NCT00518115|440231|P2|Overall Study|Moved Out of State|0
131365|NCT00518115|440232|P1|Overall Study|Moved Out of State|0
131366|NCT00518115|440223|P10|Overall Study|Withdrew Consent|0
131367|NCT00518115|440224|P9|Overall Study|Withdrew Consent|0
131368|NCT00518115|440225|P8|Overall Study|Withdrew Consent|0
131369|NCT00518115|440226|P7|Overall Study|Withdrew Consent|0
131370|NCT00518115|440227|P6|Overall Study|Withdrew Consent|1
131371|NCT00518115|440228|P5|Overall Study|Withdrew Consent|0
131372|NCT00518115|440229|P4|Overall Study|Withdrew Consent|0
131373|NCT00518115|440230|P3|Overall Study|Withdrew Consent|0
131374|NCT00518115|440231|P2|Overall Study|Withdrew Consent|0
131375|NCT00518115|440232|P1|Overall Study|Withdrew Consent|0
131376|NCT00518115|440223|P10|Overall Study|Family Emergency; Had to Go to England|0
131377|NCT00518115|440224|P9|Overall Study|Family Emergency; Had to Go to England|0
131378|NCT00518115|440225|P8|Overall Study|Family Emergency; Had to Go to England|0
131379|NCT00518115|440226|P7|Overall Study|Family Emergency; Had to Go to England|0
131380|NCT00518115|440227|P6|Overall Study|Family Emergency; Had to Go to England|0
131381|NCT00518115|440228|P5|Overall Study|Family Emergency; Had to Go to England|1
131382|NCT00518115|440229|P4|Overall Study|Family Emergency; Had to Go to England|0
131383|NCT00518115|440230|P3|Overall Study|Family Emergency; Had to Go to England|0
131384|NCT00518115|440231|P2|Overall Study|Family Emergency; Had to Go to England|0
131385|NCT00518115|440232|P1|Overall Study|Family Emergency; Had to Go to England|0
131386|NCT00518115|440223|P10|Overall Study|Violation of Exclusion Criteria|0
131387|NCT00518115|440224|P9|Overall Study|Violation of Exclusion Criteria|0
131388|NCT00518115|440225|P8|Overall Study|Violation of Exclusion Criteria|0
131389|NCT00518115|440226|P7|Overall Study|Violation of Exclusion Criteria|1
131390|NCT00518115|440227|P6|Overall Study|Violation of Exclusion Criteria|0
131391|NCT00518115|440228|P5|Overall Study|Violation of Exclusion Criteria|0
131392|NCT00518115|440229|P4|Overall Study|Violation of Exclusion Criteria|1
131393|NCT00518115|440230|P3|Overall Study|Violation of Exclusion Criteria|0
131394|NCT00518115|440231|P2|Overall Study|Violation of Exclusion Criteria|0
131395|NCT00518115|440232|P1|Overall Study|Violation of Exclusion Criteria|0
131396|NCT00518115|440223|P10|Overall Study|Wrong Monotherapy Administered|0
131397|NCT00518115|440224|P9|Overall Study|Wrong Monotherapy Administered|0
131398|NCT00518115|440225|P8|Overall Study|Wrong Monotherapy Administered|0
131399|NCT00518115|440226|P7|Overall Study|Wrong Monotherapy Administered|1
131400|NCT00518115|440227|P6|Overall Study|Wrong Monotherapy Administered|0
131401|NCT00518115|440228|P5|Overall Study|Wrong Monotherapy Administered|0
131402|NCT00518115|440229|P4|Overall Study|Wrong Monotherapy Administered|0
131403|NCT00518115|440230|P3|Overall Study|Wrong Monotherapy Administered|1
131404|NCT00518115|440231|P2|Overall Study|Wrong Monotherapy Administered|0
131405|NCT00518115|440232|P1|Overall Study|Wrong Monotherapy Administered|0
131406|NCT00518115|440223|P10|Overall Study|Different Monotherapy Diabetic Drug|0
131407|NCT00518115|440224|P9|Overall Study|Different Monotherapy Diabetic Drug|1
131408|NCT00518115|440225|P8|Overall Study|Different Monotherapy Diabetic Drug|0
131409|NCT00518115|440226|P7|Overall Study|Different Monotherapy Diabetic Drug|0
131410|NCT00518115|440227|P6|Overall Study|Different Monotherapy Diabetic Drug|0
131411|NCT00518115|440228|P5|Overall Study|Different Monotherapy Diabetic Drug|0
131412|NCT00518115|440229|P4|Overall Study|Different Monotherapy Diabetic Drug|0
131413|NCT00518115|440230|P3|Overall Study|Different Monotherapy Diabetic Drug|1
131414|NCT00518115|440231|P2|Overall Study|Different Monotherapy Diabetic Drug|0
131415|NCT00518115|440232|P1|Overall Study|Different Monotherapy Diabetic Drug|0
131416|NCT00518115|440223|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
131417|NCT00518115|440224|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
131418|NCT00518115|440225|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
131419|NCT00518115|440226|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
131420|NCT00518115|440227|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
131421|NCT00518115|440228|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
131422|NCT00518115|440229|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
131423|NCT00518115|440230|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
131424|NCT00518115|440231|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
131425|NCT00518115|440232|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
131426|NCT00518115|440223|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
131427|NCT00518115|440224|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
131428|NCT00518115|440225|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
131429|NCT00518115|440226|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
131430|NCT00518115|440227|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
131431|NCT00518115|440228|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
131432|NCT00518115|440229|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
131433|NCT00518115|440230|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
131434|NCT00518115|440231|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
131435|NCT00518115|440232|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
131436|NCT00518115|440223|P10|Overall Study|Non-Compliance|1
131437|NCT00518115|440224|P9|Overall Study|Non-Compliance|0
131438|NCT00518115|440225|P8|Overall Study|Non-Compliance|1
131439|NCT00518115|440226|P7|Overall Study|Non-Compliance|1
131440|NCT00518115|440227|P6|Overall Study|Non-Compliance|1
131441|NCT00518115|440228|P5|Overall Study|Non-Compliance|1
131442|NCT00518115|440229|P4|Overall Study|Non-Compliance|0
131443|NCT00518115|440230|P3|Overall Study|Non-Compliance|1
131444|NCT00518115|440231|P2|Overall Study|Non-Compliance|0
131445|NCT00518115|440232|P1|Overall Study|Non-Compliance|1
131446|NCT00518115|440223|P10|Overall Study|Lack of Efficacy|0
131447|NCT00518115|440224|P9|Overall Study|Lack of Efficacy|0
131448|NCT00518115|440225|P8|Overall Study|Lack of Efficacy|1
131449|NCT00518115|440226|P7|Overall Study|Lack of Efficacy|0
131450|NCT00518115|440227|P6|Overall Study|Lack of Efficacy|0
131451|NCT00518115|440228|P5|Overall Study|Lack of Efficacy|0
131452|NCT00518115|440229|P4|Overall Study|Lack of Efficacy|1
131453|NCT00518115|440230|P3|Overall Study|Lack of Efficacy|1
131454|NCT00518115|440231|P2|Overall Study|Lack of Efficacy|0
131455|NCT00518115|440232|P1|Overall Study|Lack of Efficacy|1
131456|NCT00518115|440223|P10|Overall Study|Withdrawal by Subject|3
131457|NCT00518115|440224|P9|Overall Study|Withdrawal by Subject|1
131458|NCT00518115|440225|P8|Overall Study|Withdrawal by Subject|2
131459|NCT00518115|440226|P7|Overall Study|Withdrawal by Subject|0
131460|NCT00518115|440227|P6|Overall Study|Withdrawal by Subject|1
131461|NCT00518115|440228|P5|Overall Study|Withdrawal by Subject|2
131462|NCT00518115|440229|P4|Overall Study|Withdrawal by Subject|0
131463|NCT00518115|440230|P3|Overall Study|Withdrawal by Subject|5
131464|NCT00518115|440231|P2|Overall Study|Withdrawal by Subject|1
131465|NCT00518115|440232|P1|Overall Study|Withdrawal by Subject|1
131466|NCT00518115|440223|P10|Overall Study|Protocol Violation|0
131467|NCT00518115|440224|P9|Overall Study|Protocol Violation|0
131468|NCT00518115|440225|P8|Overall Study|Protocol Violation|0
131469|NCT00518115|440226|P7|Overall Study|Protocol Violation|0
131470|NCT00518115|440227|P6|Overall Study|Protocol Violation|0
131471|NCT00518115|440228|P5|Overall Study|Protocol Violation|0
131472|NCT00518115|440229|P4|Overall Study|Protocol Violation|0
131473|NCT00518115|440230|P3|Overall Study|Protocol Violation|1
131474|NCT00518115|440231|P2|Overall Study|Protocol Violation|3
131475|NCT00518115|440232|P1|Overall Study|Protocol Violation|1
131476|NCT00518115|440223|P10|Overall Study|Lost to Follow-up|1
131477|NCT00518115|440224|P9|Overall Study|Lost to Follow-up|1
131478|NCT00518115|440225|P8|Overall Study|Lost to Follow-up|1
131479|NCT00518115|440226|P7|Overall Study|Lost to Follow-up|0
131480|NCT00518115|440227|P6|Overall Study|Lost to Follow-up|3
131481|NCT00518115|440228|P5|Overall Study|Lost to Follow-up|1
131482|NCT00518115|440229|P4|Overall Study|Lost to Follow-up|3
131483|NCT00518115|440230|P3|Overall Study|Lost to Follow-up|2
131484|NCT00518115|440231|P2|Overall Study|Lost to Follow-up|0
131485|NCT00518115|440232|P1|Overall Study|Lost to Follow-up|0
131486|NCT00518115|440223|P10|Overall Study|Adverse Event|9
131487|NCT00518115|440224|P9|Overall Study|Adverse Event|2
131488|NCT00518115|440225|P8|Overall Study|Adverse Event|10
131489|NCT00518115|440226|P7|Overall Study|Adverse Event|5
131490|NCT00518115|440227|P6|Overall Study|Adverse Event|5
131491|NCT00518115|440228|P5|Overall Study|Adverse Event|5
131492|NCT00518115|440229|P4|Overall Study|Adverse Event|6
131493|NCT00518115|440230|P3|Overall Study|Adverse Event|5
131494|NCT00518115|440231|P2|Overall Study|Adverse Event|1
131495|NCT00518115|440232|P1|Overall Study|Adverse Event|6
131496|NCT00518011|440407|P2|Overall Study|Withdrawal by Subject|0
131497|NCT00518011|440408|P1|Overall Study|Withdrawal by Subject|1
131498|NCT00518011|440407|P2|Overall Study|Other Reasons|2
131499|NCT00518011|440408|P1|Overall Study|Other Reasons|3
131500|NCT00518011|440407|P2|Overall Study|Disease Progression|2
131501|NCT00518011|440408|P1|Overall Study|Disease Progression|2
131502|NCT00518011|440407|P2|Overall Study|Adverse Event|3
131503|NCT00518011|440408|P1|Overall Study|Adverse Event|2
131504|NCT00518011|440407|P2|Overall Study|Death|1
131505|NCT00518011|440408|P1|Overall Study|Death|1
131506|NCT00517933|440430|P2|Period 2|Underwent lung transplant|2
131507|NCT00517933|440431|P1|Period 2|Underwent lung transplant|0
131508|NCT00517933|440430|P2|Period 2|Withdrawal by Subject|3
131509|NCT00517933|440431|P1|Period 2|Withdrawal by Subject|1
131510|NCT00517933|440430|P2|Period 2|Physician Decision|0
131511|NCT00517933|440431|P1|Period 2|Physician Decision|1
131512|NCT00517933|440430|P2|Period 2|Adverse Event|4
131513|NCT00517933|440431|P1|Period 2|Adverse Event|2
131514|NCT00517933|440430|P2|Period 2|Death|4
131515|NCT00517933|440431|P1|Period 2|Death|2
131516|NCT00517933|440430|P2|Period 1|Underwent lung transplant|1
131517|NCT00517933|440431|P1|Period 1|Underwent lung transplant|0
131518|NCT00517933|440430|P2|Period 1|Lost to Follow-up|0
131519|NCT00517933|440431|P1|Period 1|Lost to Follow-up|2
131520|NCT00517933|440430|P2|Period 1|Adverse Event|4
131521|NCT00517933|440431|P1|Period 1|Adverse Event|4
131522|NCT00517933|440430|P2|Period 1|Death|1
131523|NCT00517933|440431|P1|Period 1|Death|2
131524|NCT00517881|440495|P1|Overall Study|Renal transplantation|2
131525|NCT00517881|440495|P1|Overall Study|Adverse Event|1
131526|NCT00517881|440495|P1|Overall Study|Protocol Violation|2
131527|NCT00517829|440507|P2|Overall Study|Other|1
131528|NCT00517829|440508|P1|Overall Study|Other|3
131529|NCT00517829|440507|P2|Overall Study|Investigator Request|3
131530|NCT00517829|440508|P1|Overall Study|Investigator Request|5
131531|NCT00517829|440507|P2|Overall Study|Patient Request|5
131532|NCT00517829|440508|P1|Overall Study|Patient Request|6
131533|NCT00517829|440507|P2|Overall Study|Disease Progression|32
131534|NCT00517829|440508|P1|Overall Study|Disease Progression|39
131535|NCT00517829|440507|P2|Overall Study|Adverse Event|34
131536|NCT00517829|440508|P1|Overall Study|Adverse Event|22
131537|NCT00517751|440522|P1|Overall Study|Missing|3
131538|NCT00517751|440522|P1|Overall Study|Patient not due for visit|76
131539|NCT00517751|440522|P1|Overall Study|patient not over due|6
131540|NCT00517751|440522|P1|Overall Study|Lost to Follow-up|4
131541|NCT00517751|440522|P1|Overall Study|Withdrawal by Subject|37
131542|NCT00517751|440522|P1|Overall Study|Death|3
131543|NCT00517699|440545|P1|Overall Study|Study terminated by Sponsor|2
131544|NCT00517699|440545|P1|Overall Study|Administrative error|1
131545|NCT00517699|440545|P1|Overall Study|Lack of Efficacy|1
131546|NCT00517699|440545|P1|Overall Study|Withdrawal by Subject|1
131547|NCT00517634|440553|P6|Second Treatment Period|Withdrawal by Subject|0
131548|NCT00517634|440554|P5|Second Treatment Period|Withdrawal by Subject|1
131549|NCT00517634|440555|P4|Second Treatment Period|Withdrawal by Subject|0
131550|NCT00517634|440556|P3|Second Treatment Period|Withdrawal by Subject|0
131551|NCT00517634|440557|P2|Second Treatment Period|Withdrawal by Subject|0
131552|NCT00517634|440558|P1|Second Treatment Period|Withdrawal by Subject|0
131553|NCT00516386|440569|P1|Overall Study|Lost to Follow-up|2
131554|NCT00516386|440569|P1|Overall Study|not interested in the study|4
131555|NCT00517413|440656|P1|Overall Study|Other-Reasons|23
131556|NCT00517413|440656|P1|Overall Study|Failure to return|1
131557|NCT00517413|440656|P1|Overall Study|Withdrawal by Subject|2
131558|NCT00517413|440656|P1|Overall Study|Protocol Violation|15
131559|NCT00517413|440656|P1|Overall Study|Death|13
131560|NCT00517413|440656|P1|Overall Study|Adverse Event|7
131561|NCT00517361|440677|P1|Overall Study|The study was terminated|5
131562|NCT00517361|440677|P1|Overall Study|Death|6
131563|NCT00517192|440686|P2|Overall Study|Early termination of the trial|18
131564|NCT00517192|440687|P1|Overall Study|Early termination of the trial|16
131565|NCT00517192|440686|P2|Overall Study|Withdrawal by Subject|0
131566|NCT00517192|440687|P1|Overall Study|Withdrawal by Subject|1
131567|NCT00517192|440686|P2|Overall Study|Lost to Follow-up|1
131568|NCT00517192|440687|P1|Overall Study|Lost to Follow-up|1
131569|NCT00517192|440686|P2|Overall Study|Adverse Event|1
131570|NCT00517192|440687|P1|Overall Study|Adverse Event|1
131571|NCT00516906|440794|P2|Overall Study|Final Dressing Removal Data not captured|2
131572|NCT00516906|440795|P1|Overall Study|Final Dressing Removal Data not captured|6
131573|NCT00516893|440805|P1|Overall Study|Received Medication From Another Study|1
131574|NCT00516893|440805|P1|Overall Study|Pregnancy|1
131575|NCT00516893|440805|P1|Overall Study|Relocated|1
131576|NCT00516893|440805|P1|Overall Study|Persistent Antibodies per Protocol|6
131577|NCT00516893|440805|P1|Overall Study|Death|1
131578|NCT00516893|440805|P1|Overall Study|Noncompliance|2
131579|NCT00516893|440805|P1|Overall Study|Withdrawal by Subject|2
131580|NCT00516893|440805|P1|Overall Study|Adverse Event|3
131581|NCT00516893|440805|P1|Overall Study|Lost to Follow-up|4
131582|NCT00516737|440814|P2|Overall Study|Lack of Qualifying Event|6
131583|NCT00516737|440815|P1|Overall Study|Lack of Qualifying Event|9
131584|NCT00516737|440814|P2|Overall Study|Withdrawal by Subject|1
131585|NCT00516737|440815|P1|Overall Study|Withdrawal by Subject|0
131586|NCT00516737|440814|P2|Overall Study|Physician Decision|1
131587|NCT00516737|440815|P1|Overall Study|Physician Decision|0
131588|NCT00516737|440814|P2|Overall Study|Lost to Follow-up|0
131589|NCT00516737|440815|P1|Overall Study|Lost to Follow-up|2
131590|NCT00516321|440835|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
131591|NCT00516321|440836|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
131592|NCT00516321|440837|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
131593|NCT00516321|440835|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
131594|NCT00516321|440836|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
131595|NCT00516321|440837|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
131596|NCT00516321|440835|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
131597|NCT00516321|440836|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
131598|NCT00516321|440837|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
131599|NCT00516321|440835|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
131600|NCT00516321|440836|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
131601|NCT00516321|440837|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
131602|NCT00516321|440835|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
131603|NCT00516321|440836|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
131604|NCT00516321|440837|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
131605|NCT00516321|440835|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
131606|NCT00516321|440836|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
131607|NCT00516321|440837|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
131608|NCT00516321|440835|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
131609|NCT00516321|440836|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
131610|NCT00516321|440837|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
131611|NCT00516321|440835|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
131612|NCT00516321|440836|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
131613|NCT00516321|440837|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
131614|NCT00516321|440835|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
131615|NCT00516321|440836|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
131616|NCT00516321|440837|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
131617|NCT00516321|440835|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
131618|NCT00516321|440836|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
131619|NCT00516321|440837|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
131620|NCT00516321|440835|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
131621|NCT00516321|440836|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
131622|NCT00516321|440837|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
131623|NCT00516295|440888|P3|Overall Study|Ineligible|0
131624|NCT00516295|440889|P2|Overall Study|Ineligible|0
131625|NCT00516295|440890|P1|Overall Study|Ineligible|1
131626|NCT00516295|440888|P3|Overall Study|Lack of Efficacy|0
131627|NCT00516295|440889|P2|Overall Study|Lack of Efficacy|0
131628|NCT00516295|440890|P1|Overall Study|Lack of Efficacy|2
131629|NCT00516269|440903|P2|Overall Study|Protocol Violation|1
131630|NCT00516269|440904|P1|Overall Study|Protocol Violation|0
131631|NCT00516269|440903|P2|Overall Study|Lost to Follow-up|1
131632|NCT00516269|440904|P1|Overall Study|Lost to Follow-up|0
131633|NCT00516269|440903|P2|Overall Study|Adverse Event|1
131634|NCT00516269|440904|P1|Overall Study|Adverse Event|2
131635|NCT00516139|440925|P1|Overall Study|Lack of Efficacy|1
131636|NCT00516139|440925|P1|Overall Study|Withdrawal by Subject|8
131637|NCT00516139|440925|P1|Overall Study|Protocol Violation|1
131638|NCT00516139|440925|P1|Overall Study|Lost to Follow-up|1
131639|NCT00516139|440925|P1|Overall Study|Adverse Event|27
131640|NCT00516074|440956|P2|Overall Study|Loss of Glucose Control|0
131641|NCT00516074|440957|P1|Overall Study|Loss of Glucose Control|2
131642|NCT00516074|440956|P2|Overall Study|Subject Decision|2
131643|NCT00516074|440957|P1|Overall Study|Subject Decision|4
131644|NCT00516074|440956|P2|Overall Study|Adverse Event|1
131645|NCT00516074|440957|P1|Overall Study|Adverse Event|0
131646|NCT00516048|440975|P3|Overall Study|Subject Decision|0
131647|NCT00516048|440976|P2|Overall Study|Subject Decision|2
131648|NCT00516048|440977|P1|Overall Study|Subject Decision|0
131649|NCT00516048|440975|P3|Overall Study|Death|1
131650|NCT00516048|440976|P2|Overall Study|Death|0
131651|NCT00516048|440977|P1|Overall Study|Death|0
131652|NCT00515827|441004|P2|Second Intervention (12 Weeks)|Consent withdraw|0
131653|NCT00515827|441005|P1|Second Intervention (12 Weeks)|Consent withdraw|1
131654|NCT00515827|441004|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
131655|NCT00515827|441005|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
131656|NCT00515671|441040|P2|Overall Study|incarcerated|2
131657|NCT00515671|441041|P1|Overall Study|incarcerated|1
131658|NCT00515671|441040|P2|Overall Study|Withdrawal by Subject|5
131659|NCT00515671|441041|P1|Overall Study|Withdrawal by Subject|3
131660|NCT00515671|441040|P2|Overall Study|Lost to Follow-up|10
131661|NCT00515671|441041|P1|Overall Study|Lost to Follow-up|13
131662|NCT00515619|441049|P1|Overall Study|Other: Subject interested in other AED|1
131663|NCT00515619|441049|P1|Overall Study|Other: Drug available on license|1
131664|NCT00515619|441049|P1|Overall Study|Other: Request from sponsor|1
131665|NCT00515619|441049|P1|Overall Study|Other: Subject became pregnant|1
131666|NCT00515619|441049|P1|Overall Study|Other: Investigator decision|1
131667|NCT00515619|441049|P1|Overall Study|Other: Subject moved to another country|1
131668|NCT00515619|441049|P1|Overall Study|Other: Subject required surgery|1
131669|NCT00515619|441049|P1|Overall Study|Other: Subject cannot attend visits|2
131670|NCT00515619|441049|P1|Overall Study|Other: Site discontinuing trials|2
131671|NCT00515619|441049|P1|Overall Study|Unsatisfactory compliance|6
131672|NCT00515619|441049|P1|Overall Study|Lost to Follow-up|4
131673|NCT00515619|441049|P1|Overall Study|Protocol Violation|3
131674|NCT00515619|441049|P1|Overall Study|Withdrawal by Subject|66
131675|NCT00515619|441049|P1|Overall Study|Lack of Efficacy|92
131676|NCT00515619|441049|P1|Overall Study|Adverse Event|34
131677|NCT00515541|441061|P4|Overall Study|Withdrawal by Subject|2
131678|NCT00515541|441062|P3|Overall Study|Withdrawal by Subject|0
131679|NCT00515541|441063|P2|Overall Study|Withdrawal by Subject|2
131680|NCT00515541|441064|P1|Overall Study|Withdrawal by Subject|0
131681|NCT00515541|441061|P4|Overall Study|No show for appointments|2
131682|NCT00515541|441062|P3|Overall Study|No show for appointments|0
131683|NCT00515541|441063|P2|Overall Study|No show for appointments|1
131684|NCT00515541|441064|P1|Overall Study|No show for appointments|0
131685|NCT00515541|441061|P4|Overall Study|Physician Decision|1
131686|NCT00515541|441062|P3|Overall Study|Physician Decision|0
131687|NCT00515541|441063|P2|Overall Study|Physician Decision|2
131688|NCT00515541|441064|P1|Overall Study|Physician Decision|0
131689|NCT00515502|441086|P12|Treatment Period 2|Adverse Event|0
131690|NCT00515502|441087|P11|Treatment Period 2|Adverse Event|0
131691|NCT00515502|441088|P10|Treatment Period 2|Adverse Event|0
131692|NCT00515502|441089|P9|Treatment Period 2|Adverse Event|0
131693|NCT00515502|441090|P8|Treatment Period 2|Adverse Event|0
131694|NCT00515502|441091|P7|Treatment Period 2|Adverse Event|0
131695|NCT00515502|441092|P6|Treatment Period 2|Adverse Event|0
131696|NCT00515502|441093|P5|Treatment Period 2|Adverse Event|0
131697|NCT00515502|441094|P4|Treatment Period 2|Adverse Event|0
131698|NCT00515502|441095|P3|Treatment Period 2|Adverse Event|0
131699|NCT00515502|441096|P2|Treatment Period 2|Adverse Event|1
131700|NCT00515502|441097|P1|Treatment Period 2|Adverse Event|0
131701|NCT00515502|441086|P12|Treatment Period 1|Adverse Event|1
131702|NCT00515502|441087|P11|Treatment Period 1|Adverse Event|0
131703|NCT00515502|441088|P10|Treatment Period 1|Adverse Event|0
131704|NCT00515502|441089|P9|Treatment Period 1|Adverse Event|1
131705|NCT00515502|441090|P8|Treatment Period 1|Adverse Event|0
131706|NCT00515502|441091|P7|Treatment Period 1|Adverse Event|1
131707|NCT00515502|441092|P6|Treatment Period 1|Adverse Event|0
131708|NCT00515502|441093|P5|Treatment Period 1|Adverse Event|0
131709|NCT00515502|441094|P4|Treatment Period 1|Adverse Event|0
131710|NCT00515502|441095|P3|Treatment Period 1|Adverse Event|0
131711|NCT00515502|441096|P2|Treatment Period 1|Adverse Event|0
131712|NCT00515502|441097|P1|Treatment Period 1|Adverse Event|0
131713|NCT00515463|441257|P2|Overall Study|Other|1
131714|NCT00515463|441258|P1|Overall Study|Other|0
131715|NCT00515463|441257|P2|Overall Study|Lost to Follow-up|5
131716|NCT00515463|441258|P1|Overall Study|Lost to Follow-up|6
131717|NCT00515463|441257|P2|Overall Study|Withdrawal by Subject|4
131718|NCT00515463|441258|P1|Overall Study|Withdrawal by Subject|3
131719|NCT00515463|441257|P2|Overall Study|Adverse Event|2
131720|NCT00515463|441258|P1|Overall Study|Adverse Event|1
131721|NCT00515463|441257|P2|Overall Study|Physician Decision|2
131722|NCT00515463|441258|P1|Overall Study|Physician Decision|4
131723|NCT00515216|441437|P1|Overall Study|Withdrawal by Subject|1
131724|NCT00515112|441499|P2|Overall Study|The study was terminated|2
131725|NCT00515112|441500|P1|Overall Study|The study was terminated|3
131726|NCT00515112|441499|P2|Overall Study|Death|1
131727|NCT00515112|441500|P1|Overall Study|Death|0
131728|NCT00515099|441510|P2|Overall Study|IRB Recommendation|0
131729|NCT00515099|441511|P1|Overall Study|IRB Recommendation|1
131730|NCT00515099|441510|P2|Overall Study|Withdrawal by Subject|0
131731|NCT00515099|441511|P1|Overall Study|Withdrawal by Subject|2
131732|NCT00515099|441510|P2|Overall Study|Lost to Follow-up|4
131733|NCT00515099|441511|P1|Overall Study|Lost to Follow-up|0
131734|NCT00515086|441533|P4|Overall Study|Death|0
131735|NCT00515086|441534|P3|Overall Study|Death|0
131736|NCT00515086|441535|P2|Overall Study|Death|0
131737|NCT00515086|441536|P1|Overall Study|Death|2
131738|NCT00515086|441533|P4|Overall Study|Study drug no longer required|0
131739|NCT00515086|441534|P3|Overall Study|Study drug no longer required|0
131740|NCT00515086|441535|P2|Overall Study|Study drug no longer required|1
131741|NCT00515086|441536|P1|Overall Study|Study drug no longer required|0
131742|NCT00515086|441533|P4|Overall Study|Lost to Follow-up|0
131743|NCT00515086|441534|P3|Overall Study|Lost to Follow-up|0
131744|NCT00515086|441535|P2|Overall Study|Lost to Follow-up|0
131745|NCT00515086|441536|P1|Overall Study|Lost to Follow-up|1
131746|NCT00515086|441533|P4|Overall Study|Unsatisfactory therapeutic effect|2
131747|NCT00515086|441534|P3|Overall Study|Unsatisfactory therapeutic effect|3
131748|NCT00515086|441535|P2|Overall Study|Unsatisfactory therapeutic effect|3
131749|NCT00515086|441536|P1|Overall Study|Unsatisfactory therapeutic effect|18
131750|NCT00515086|441533|P4|Overall Study|Withdrawal by Subject|1
131751|NCT00515086|441534|P3|Overall Study|Withdrawal by Subject|0
131752|NCT00515086|441535|P2|Overall Study|Withdrawal by Subject|0
131753|NCT00515086|441536|P1|Overall Study|Withdrawal by Subject|1
131754|NCT00515086|441533|P4|Overall Study|Administrative|0
131755|NCT00515086|441534|P3|Overall Study|Administrative|0
131756|NCT00515086|441535|P2|Overall Study|Administrative|1
131757|NCT00515086|441536|P1|Overall Study|Administrative|1
131758|NCT00515086|441533|P4|Overall Study|Adverse Event|3
131759|NCT00515086|441534|P3|Overall Study|Adverse Event|2
131760|NCT00515086|441535|P2|Overall Study|Adverse Event|1
131761|NCT00515086|441536|P1|Overall Study|Adverse Event|1
131762|NCT00515073|441563|P1|Overall Study|Physician Decision|1
131763|NCT00515073|441563|P1|Overall Study|Withdrawal by Subject|1
131764|NCT00515034|441571|P4|Overall Study|Other|1
131765|NCT00515034|441572|P3|Overall Study|Other|2
131766|NCT00515034|441573|P2|Overall Study|Other|0
131767|NCT00515034|441574|P1|Overall Study|Other|1
131768|NCT00515034|441571|P4|Overall Study|Physician Decision|1
131769|NCT00515034|441572|P3|Overall Study|Physician Decision|1
131770|NCT00515034|441573|P2|Overall Study|Physician Decision|0
131771|NCT00515034|441574|P1|Overall Study|Physician Decision|0
131772|NCT00515034|441571|P4|Overall Study|Withdrawal by Subject|0
131773|NCT00515034|441572|P3|Overall Study|Withdrawal by Subject|3
131774|NCT00515034|441573|P2|Overall Study|Withdrawal by Subject|0
131775|NCT00515034|441574|P1|Overall Study|Withdrawal by Subject|1
131776|NCT00515034|441571|P4|Overall Study|Death|3
131777|NCT00515034|441572|P3|Overall Study|Death|1
131778|NCT00515034|441573|P2|Overall Study|Death|2
131779|NCT00515034|441574|P1|Overall Study|Death|4
131780|NCT00515034|441571|P4|Overall Study|Adverse Event|0
131781|NCT00515034|441572|P3|Overall Study|Adverse Event|1
131782|NCT00515034|441573|P2|Overall Study|Adverse Event|0
131783|NCT00515034|441574|P1|Overall Study|Adverse Event|2
131784|NCT00515008|441594|P2|Overall Study|Scheduling conflict|0
131785|NCT00515008|441595|P1|Overall Study|Scheduling conflict|1
131786|NCT00515008|441594|P2|Overall Study|Left the Boston Area|1
131787|NCT00515008|441595|P1|Overall Study|Left the Boston Area|1
131788|NCT00515008|441594|P2|Overall Study|Declined|3
131789|NCT00515008|441595|P1|Overall Study|Declined|0
131790|NCT00515008|441594|P2|Overall Study|Lost to Follow-up|0
131791|NCT00515008|441595|P1|Overall Study|Lost to Follow-up|1
131792|NCT00514943|441619|P2|Stage 2|Other than stated above|2
131793|NCT00514943|441620|P1|Stage 2|Other than stated above|0
131794|NCT00514943|441619|P2|Stage 2|Patient refused to continue study meds|0
131795|NCT00514943|441620|P1|Stage 2|Patient refused to continue study meds|2
131796|NCT00514943|441619|P2|Stage 2|Other Adverse Event|10
131797|NCT00514943|441620|P1|Stage 2|Other Adverse Event|3
131798|NCT00514943|441619|P2|Stage 2|Progressive disease|24
131799|NCT00514943|441620|P1|Stage 2|Progressive disease|27
131800|NCT00514943|441619|P2|Stage 1|Other than stated above|7
131801|NCT00514943|441620|P1|Stage 1|Other than stated above|1
131802|NCT00514943|441619|P2|Stage 1|Patient refused to continue study meds|3
131803|NCT00514943|441620|P1|Stage 1|Patient refused to continue study meds|8
131804|NCT00514943|441619|P2|Stage 1|Not treated|2
131805|NCT00514943|441620|P1|Stage 1|Not treated|1
131806|NCT00514943|441619|P2|Stage 1|Other Adverse Event|6
131807|NCT00514943|441620|P1|Stage 1|Other Adverse Event|16
131808|NCT00514943|441619|P2|Stage 1|Progressive disease|8
131809|NCT00514943|441620|P1|Stage 1|Progressive disease|4
131810|NCT00514917|441678|P2|Overall Study|Undefined|5
131811|NCT00514917|441679|P1|Overall Study|Undefined|11
131812|NCT00514917|441678|P2|Overall Study|Discontinued due to study closure|81
131813|NCT00514917|441679|P1|Overall Study|Discontinued due to study closure|88
131814|NCT00514917|441678|P2|Overall Study|Withdrawal by Subject|16
131815|NCT00514917|441679|P1|Overall Study|Withdrawal by Subject|18
131816|NCT00514917|441678|P2|Overall Study|Lost to Follow-up|3
131817|NCT00514917|441679|P1|Overall Study|Lost to Follow-up|4
131818|NCT00514917|441678|P2|Overall Study|Protocol Violation|0
131819|NCT00514917|441679|P1|Overall Study|Protocol Violation|1
131820|NCT00514917|441678|P2|Overall Study|Death|10
131821|NCT00514917|441679|P1|Overall Study|Death|4
131822|NCT00514813|441736|P4|Overall Study|Death|2
131823|NCT00514813|441737|P3|Overall Study|Death|3
131824|NCT00514813|441738|P2|Overall Study|Death|2
131825|NCT00514813|441739|P1|Overall Study|Death|0
131826|NCT00514813|441736|P4|Overall Study|Kidney transplant|0
131827|NCT00514813|441737|P3|Overall Study|Kidney transplant|2
131828|NCT00514813|441738|P2|Overall Study|Kidney transplant|6
131829|NCT00514813|441739|P1|Overall Study|Kidney transplant|0
131830|NCT00514813|441736|P4|Overall Study|Lack of Efficacy|0
131831|NCT00514813|441737|P3|Overall Study|Lack of Efficacy|0
131832|NCT00514813|441738|P2|Overall Study|Lack of Efficacy|1
131833|NCT00514813|441739|P1|Overall Study|Lack of Efficacy|0
131834|NCT00514813|441736|P4|Overall Study|Withdrawal by Subject|0
131835|NCT00514813|441737|P3|Overall Study|Withdrawal by Subject|0
131836|NCT00514813|441738|P2|Overall Study|Withdrawal by Subject|1
131837|NCT00514813|441739|P1|Overall Study|Withdrawal by Subject|0
131838|NCT00514813|441736|P4|Overall Study|Protocol Violation|0
131839|NCT00514813|441737|P3|Overall Study|Protocol Violation|0
131840|NCT00514813|441738|P2|Overall Study|Protocol Violation|0
131841|NCT00514813|441739|P1|Overall Study|Protocol Violation|1
131842|NCT00514813|441736|P4|Overall Study|Adverse Event|0
131843|NCT00514813|441737|P3|Overall Study|Adverse Event|2
131844|NCT00514813|441738|P2|Overall Study|Adverse Event|2
131845|NCT00514813|441739|P1|Overall Study|Adverse Event|0
131846|NCT00514813|441736|P4|Overall Study|Study terminated|2
131847|NCT00514813|441737|P3|Overall Study|Study terminated|40
131848|NCT00514813|441738|P2|Overall Study|Study terminated|74
131849|NCT00514813|441739|P1|Overall Study|Study terminated|14
131850|NCT00514735|441759|P2|Overall Study|Lost to Follow-up|1
131851|NCT00514735|441760|P1|Overall Study|Lost to Follow-up|0
131852|NCT00514735|441759|P2|Overall Study|Death|0
131853|NCT00514735|441760|P1|Overall Study|Death|1
131854|NCT00514735|441759|P2|Overall Study|Withdrawal by Subject|5
131855|NCT00514735|441760|P1|Overall Study|Withdrawal by Subject|13
131856|NCT00514683|441796|P5|Overall Study|Reason other than listed above|1
131857|NCT00514683|441797|P4|Overall Study|Reason other than listed above|0
131858|NCT00514683|441798|P3|Overall Study|Reason other than listed above|2
131859|NCT00514683|441799|P2|Overall Study|Reason other than listed above|1
131860|NCT00514683|441800|P1|Overall Study|Reason other than listed above|0
131861|NCT00514683|441796|P5|Overall Study|Withdrawal by Subject|4
131862|NCT00514683|441797|P4|Overall Study|Withdrawal by Subject|0
131863|NCT00514683|441798|P3|Overall Study|Withdrawal by Subject|1
131864|NCT00514683|441799|P2|Overall Study|Withdrawal by Subject|2
131865|NCT00514683|441800|P1|Overall Study|Withdrawal by Subject|2
131866|NCT00514683|441796|P5|Overall Study|Protocol Violation|0
131867|NCT00514683|441797|P4|Overall Study|Protocol Violation|1
131868|NCT00514683|441798|P3|Overall Study|Protocol Violation|0
131869|NCT00514683|441799|P2|Overall Study|Protocol Violation|1
131870|NCT00514683|441800|P1|Overall Study|Protocol Violation|1
131871|NCT00514683|441796|P5|Overall Study|Adverse Event|27
131872|NCT00514683|441797|P4|Overall Study|Adverse Event|13
131873|NCT00514683|441798|P3|Overall Study|Adverse Event|15
131874|NCT00514683|441799|P2|Overall Study|Adverse Event|20
131875|NCT00514683|441800|P1|Overall Study|Adverse Event|21
131876|NCT00514683|441796|P5|Overall Study|Not treated|1
131877|NCT00514683|441797|P4|Overall Study|Not treated|0
131878|NCT00514683|441798|P3|Overall Study|Not treated|0
131879|NCT00514683|441799|P2|Overall Study|Not treated|1
131880|NCT00514683|441800|P1|Overall Study|Not treated|2
131881|NCT00514514|441999|P3|Extension - 4 Years|Adverse Event|3
131882|NCT00514514|442000|P2|Extension - 4 Years|Adverse Event|6
131883|NCT00514514|442001|P1|Extension - 4 Years|Adverse Event|9
131884|NCT00514514|441999|P3|Extension - 4 Years|Death|6
131885|NCT00514514|442000|P2|Extension - 4 Years|Death|3
131886|NCT00514514|442001|P1|Extension - 4 Years|Death|8
131887|NCT00514514|441999|P3|Extension - 4 Years|Administrative problems|1
131888|NCT00514514|442000|P2|Extension - 4 Years|Administrative problems|1
131889|NCT00514514|442001|P1|Extension - 4 Years|Administrative problems|3
131890|NCT00514514|441999|P3|Extension - 4 Years|Lost to Follow-up|9
131891|NCT00514514|442000|P2|Extension - 4 Years|Lost to Follow-up|10
131892|NCT00514514|442001|P1|Extension - 4 Years|Lost to Follow-up|12
131893|NCT00514514|441999|P3|Extension - 4 Years|Withdrawal by Subject|2
131894|NCT00514514|442000|P2|Extension - 4 Years|Withdrawal by Subject|2
131895|NCT00514514|442001|P1|Extension - 4 Years|Withdrawal by Subject|5
131896|NCT00514514|441999|P3|Randomized - 9 Month|Adverse Event|27
131897|NCT00514514|442000|P2|Randomized - 9 Month|Adverse Event|44
131898|NCT00514514|442001|P1|Randomized - 9 Month|Adverse Event|25
131899|NCT00514514|441999|P3|Randomized - 9 Month|Abnormal laboratory values|1
131900|NCT00514514|442000|P2|Randomized - 9 Month|Abnormal laboratory values|3
131901|NCT00514514|442001|P1|Randomized - 9 Month|Abnormal laboratory values|0
131902|NCT00514514|441999|P3|Randomized - 9 Month|Lack of Efficacy|1
131903|NCT00514514|442000|P2|Randomized - 9 Month|Lack of Efficacy|3
131904|NCT00514514|442001|P1|Randomized - 9 Month|Lack of Efficacy|2
131905|NCT00514514|441999|P3|Randomized - 9 Month|Protocol Violation|0
131906|NCT00514514|442000|P2|Randomized - 9 Month|Protocol Violation|1
131907|NCT00514514|442001|P1|Randomized - 9 Month|Protocol Violation|1
131908|NCT00514514|441999|P3|Randomized - 9 Month|Withdrawal by Subject|5
131909|NCT00514514|442000|P2|Randomized - 9 Month|Withdrawal by Subject|7
131910|NCT00514514|442001|P1|Randomized - 9 Month|Withdrawal by Subject|7
131911|NCT00514514|441999|P3|Randomized - 9 Month|Administrative problems|2
131912|NCT00514514|442000|P2|Randomized - 9 Month|Administrative problems|1
131913|NCT00514514|442001|P1|Randomized - 9 Month|Administrative problems|1
131914|NCT00514514|441999|P3|Randomized - 9 Month|Death|2
131915|NCT00514514|442000|P2|Randomized - 9 Month|Death|2
131916|NCT00514514|442001|P1|Randomized - 9 Month|Death|3
131917|NCT00514514|441999|P3|Pre-phase|Withdrawal by Subject|0
131918|NCT00514514|442000|P2|Pre-phase|Withdrawal by Subject|0
131919|NCT00514514|442001|P1|Pre-phase|Withdrawal by Subject|66
131920|NCT00514514|441999|P3|Pre-phase|Adverse Event|0
131921|NCT00514514|442000|P2|Pre-phase|Adverse Event|0
131922|NCT00514514|442001|P1|Pre-phase|Adverse Event|137
131923|NCT00514514|441999|P3|Pre-phase|Lack of Efficacy|0
131924|NCT00514514|442000|P2|Pre-phase|Lack of Efficacy|0
131925|NCT00514514|442001|P1|Pre-phase|Lack of Efficacy|35
131926|NCT00514514|441999|P3|Pre-phase|abnormal lab values|0
131927|NCT00514514|442000|P2|Pre-phase|abnormal lab values|0
131928|NCT00514514|442001|P1|Pre-phase|abnormal lab values|23
131929|NCT00514514|441999|P3|Pre-phase|Lost to Follow-up|0
131930|NCT00514514|442000|P2|Pre-phase|Lost to Follow-up|0
131931|NCT00514514|442001|P1|Pre-phase|Lost to Follow-up|2
131932|NCT00514514|441999|P3|Pre-phase|abnormal test procedure results|0
131933|NCT00514514|442000|P2|Pre-phase|abnormal test procedure results|0
131934|NCT00514514|442001|P1|Pre-phase|abnormal test procedure results|15
131935|NCT00514514|441999|P3|Pre-phase|condition no longer requires study drug|0
131936|NCT00514514|442000|P2|Pre-phase|condition no longer requires study drug|0
131937|NCT00514514|442001|P1|Pre-phase|condition no longer requires study drug|7
131938|NCT00514514|441999|P3|Pre-phase|Protocol Violation|0
131939|NCT00514514|442000|P2|Pre-phase|Protocol Violation|0
131940|NCT00514514|442001|P1|Pre-phase|Protocol Violation|6
131941|NCT00514514|441999|P3|Pre-phase|administrative problems|0
131942|NCT00514514|442000|P2|Pre-phase|administrative problems|0
131943|NCT00514514|442001|P1|Pre-phase|administrative problems|2
131944|NCT00514514|441999|P3|Pre-phase|Death|0
131945|NCT00514514|442000|P2|Pre-phase|Death|0
131946|NCT00514514|442001|P1|Pre-phase|Death|10
131947|NCT00514020|442062|P1|Overall Study|"patients moved to the no tx group"|6
131948|NCT00514020|442062|P1|Overall Study|patient went to radiation treatment|1
131949|NCT00514020|442062|P1|Overall Study|other complicating disease|2
131950|NCT00514020|442062|P1|Overall Study|disease progression|9
131951|NCT00514020|442062|P1|Overall Study|Physician Decision|1
131952|NCT00514020|442062|P1|Overall Study|Withdrawal by Subject|3
131953|NCT00514020|442062|P1|Overall Study|Adverse Event|6
131954|NCT00513708|442094|P3|Overall Study|Lost to Follow-up|4
131955|NCT00513708|442095|P2|Overall Study|Lost to Follow-up|4
131956|NCT00513708|442096|P1|Overall Study|Lost to Follow-up|4
131957|NCT00513682|442110|P1|Washout Phase|Adverse Event|2
131958|NCT00513604|442140|P5|Overall Study|Death during treatment|0
131959|NCT00513604|442141|P4|Overall Study|Death during treatment|0
131960|NCT00513604|442142|P3|Overall Study|Death during treatment|2
131961|NCT00513604|442143|P2|Overall Study|Death during treatment|3
131962|NCT00513604|442144|P1|Overall Study|Death during treatment|0
131963|NCT00513604|442140|P5|Overall Study|Not treated|0
131964|NCT00513604|442141|P4|Overall Study|Not treated|0
131965|NCT00513604|442142|P3|Overall Study|Not treated|1
131966|NCT00513604|442143|P2|Overall Study|Not treated|0
131967|NCT00513604|442144|P1|Overall Study|Not treated|2
131968|NCT00513500|442178|P2|Overall Study|Hospitalized|14
131969|NCT00513500|442179|P1|Overall Study|Hospitalized|4
131970|NCT00513500|442178|P2|Overall Study|Death|1
131971|NCT00513500|442179|P1|Overall Study|Death|2
131972|NCT00513500|442178|P2|Overall Study|Lost to Follow-up|39
131973|NCT00513500|442179|P1|Overall Study|Lost to Follow-up|35
131974|NCT00513409|442196|P2|Overall Study|Visit 3 not done|2
131975|NCT00513409|442197|P1|Overall Study|Visit 3 not done|1
131976|NCT00513409|442196|P2|Overall Study|Physician Decision|0
131977|NCT00513409|442197|P1|Overall Study|Physician Decision|1
131978|NCT00513409|442196|P2|Overall Study|Lost to Follow-up|1
131979|NCT00513409|442197|P1|Overall Study|Lost to Follow-up|0
131980|NCT00513409|442196|P2|Overall Study|Withdrawal by Subject|2
131981|NCT00513409|442197|P1|Overall Study|Withdrawal by Subject|0
131982|NCT00513409|442196|P2|Overall Study|Adverse Event|1
131983|NCT00513409|442197|P1|Overall Study|Adverse Event|0
131984|NCT00513357|442253|P2|Overall Study|Disease Progression|1
131985|NCT00513357|442254|P1|Overall Study|Disease Progression|2
131986|NCT00513357|442253|P2|Overall Study|Withdrawal by Subject|4
131987|NCT00513357|442254|P1|Overall Study|Withdrawal by Subject|5
131988|NCT00513357|442253|P2|Overall Study|Death|0
131989|NCT00513357|442254|P1|Overall Study|Death|2
131990|NCT00513357|442253|P2|Overall Study|Adverse Event|2
131991|NCT00513357|442254|P1|Overall Study|Adverse Event|4
131992|NCT00513357|442253|P2|Overall Study|did not receive allocated placebo|3
131993|NCT00513357|442254|P1|Overall Study|did not receive allocated placebo|2
131994|NCT00513305|442273|P2|Overall Study|Sponsor Decision|2
131995|NCT00513305|442274|P1|Overall Study|Sponsor Decision|0
131996|NCT00513305|442273|P2|Overall Study|Persistent hypocellularity|1
131997|NCT00513305|442274|P1|Overall Study|Persistent hypocellularity|0
131998|NCT00513305|442273|P2|Overall Study|Physician Decision|0
131999|NCT00513305|442274|P1|Overall Study|Physician Decision|1
132000|NCT00513305|442273|P2|Overall Study|Hematologic counts did not recover|0
132001|NCT00513305|442274|P1|Overall Study|Hematologic counts did not recover|1
132002|NCT00513305|442273|P2|Overall Study|Eligible for stem cell transplant|0
132003|NCT00513305|442274|P1|Overall Study|Eligible for stem cell transplant|1
132004|NCT00513305|442273|P2|Overall Study|Disease progression|5
132005|NCT00513305|442274|P1|Overall Study|Disease progression|8
132006|NCT00513305|442273|P2|Overall Study|Withdrawal by Subject|2
132007|NCT00513305|442274|P1|Overall Study|Withdrawal by Subject|1
132008|NCT00513305|442273|P2|Overall Study|Lack of Efficacy|13
132009|NCT00513305|442274|P1|Overall Study|Lack of Efficacy|8
132010|NCT00513305|442273|P2|Overall Study|Death (through Consolidation Treatment)|2
132011|NCT00513305|442274|P1|Overall Study|Death (through Consolidation Treatment)|2
132012|NCT00513305|442273|P2|Overall Study|Adverse Event|2
132013|NCT00513305|442274|P1|Overall Study|Adverse Event|6
132014|NCT00513240|442311|P2|Overall Study|Withdrawal by Subject|4
132015|NCT00513240|442312|P1|Overall Study|Withdrawal by Subject|7
132016|NCT00513240|442311|P2|Overall Study|Death|3
132017|NCT00513240|442312|P1|Overall Study|Death|3
132018|NCT00513240|442311|P2|Overall Study|Did not have intended surgery|0
132019|NCT00513240|442312|P1|Overall Study|Did not have intended surgery|3
132020|NCT00513071|442319|P1|Overall Study|Physician Decision|3
132021|NCT00513071|442319|P1|Overall Study|Withdrawal by Subject|1
132022|NCT00513071|442319|P1|Overall Study|Adverse Event|1
132023|NCT00513019|442326|P2|Overall Study|Withdrawal by Subject|5
132024|NCT00513019|442327|P1|Overall Study|Withdrawal by Subject|4
132025|NCT00513019|442326|P2|Overall Study|Adverse Event|0
132026|NCT00513019|442327|P1|Overall Study|Adverse Event|1
132027|NCT00512902|442333|P1|Overall Study|Lost to Follow-up|1
132028|NCT00512902|442333|P1|Overall Study|Adverse Event|7
132029|NCT00512798|442348|P2|Overall Study|Withdrawal by Subject|0
132030|NCT00512798|442349|P1|Overall Study|Withdrawal by Subject|3
132031|NCT00512798|442348|P2|Overall Study|Progression of disease|20
132032|NCT00512798|442349|P1|Overall Study|Progression of disease|14
132033|NCT00512798|442348|P2|Overall Study|Adverse Event|4
132034|NCT00512798|442349|P1|Overall Study|Adverse Event|2
132035|NCT00512798|442348|P2|Overall Study|Death|3
132036|NCT00512798|442349|P1|Overall Study|Death|0
132037|NCT00512252|442361|P3|Overall Study|Death|1
132038|NCT00512252|442362|P2|Overall Study|Death|0
132039|NCT00512252|442363|P1|Overall Study|Death|0
132040|NCT00512252|442361|P3|Overall Study|Protocol Violation|1
132041|NCT00512252|442362|P2|Overall Study|Protocol Violation|0
132042|NCT00512252|442363|P1|Overall Study|Protocol Violation|0
132043|NCT00512252|442361|P3|Overall Study|Lost to Follow-up|1
132044|NCT00512252|442362|P2|Overall Study|Lost to Follow-up|0
132045|NCT00512252|442363|P1|Overall Study|Lost to Follow-up|0
132046|NCT00512148|442391|P1|Primay Study Period|Withdrawal by Subject|1
132047|NCT00512096|442396|P1|Overall Study|Lack of Efficacy|3
132048|NCT00512096|442396|P1|Overall Study|Withdrawal by Subject|2
132049|NCT00512096|442396|P1|Overall Study|Adverse Event|2
132050|NCT00511901|442419|P2|Overall Study|Withdrawal by Subject|3
132051|NCT00511901|442420|P1|Overall Study|Withdrawal by Subject|1
132052|NCT00511836|442458|P2|Double-blind Period|Lost to Follow-up|0
132053|NCT00511836|442459|P1|Double-blind Period|Lost to Follow-up|1
132054|NCT00511810|442476|P2|Overall Study|Refused second scn|1
132055|NCT00511810|442477|P1|Overall Study|Refused second scn|0
132056|NCT00511810|442476|P2|Overall Study|Lack of Efficacy|2
132057|NCT00511810|442477|P1|Overall Study|Lack of Efficacy|0
132058|NCT00511810|442476|P2|Overall Study|Lost to Follow-up|2
132059|NCT00511810|442477|P1|Overall Study|Lost to Follow-up|1
132060|NCT00511797|442487|P4|Overall Study|Other (moving etc)|2
132061|NCT00511797|442488|P3|Overall Study|Other (moving etc)|1
132062|NCT00511797|442489|P2|Overall Study|Other (moving etc)|0
132063|NCT00511797|442490|P1|Overall Study|Other (moving etc)|1
132064|NCT00511797|442487|P4|Overall Study|Partially missing diary|0
132065|NCT00511797|442488|P3|Overall Study|Partially missing diary|1
132066|NCT00511797|442489|P2|Overall Study|Partially missing diary|0
132067|NCT00511797|442490|P1|Overall Study|Partially missing diary|0
132068|NCT00511797|442487|P4|Overall Study|Study drug not taken|1
132069|NCT00511797|442488|P3|Overall Study|Study drug not taken|0
132070|NCT00511797|442489|P2|Overall Study|Study drug not taken|1
132071|NCT00511797|442490|P1|Overall Study|Study drug not taken|0
132072|NCT00511797|442487|P4|Overall Study|Never dispensed|3
132073|NCT00511797|442488|P3|Overall Study|Never dispensed|1
132074|NCT00511797|442489|P2|Overall Study|Never dispensed|0
132075|NCT00511797|442490|P1|Overall Study|Never dispensed|1
132076|NCT00511797|442487|P4|Overall Study|Withdrawal by Subject|2
132077|NCT00511797|442488|P3|Overall Study|Withdrawal by Subject|4
132078|NCT00511797|442489|P2|Overall Study|Withdrawal by Subject|3
132079|NCT00511797|442490|P1|Overall Study|Withdrawal by Subject|3
132080|NCT00511797|442487|P4|Overall Study|Protocol Violation|3
132081|NCT00511797|442488|P3|Overall Study|Protocol Violation|2
132082|NCT00511797|442489|P2|Overall Study|Protocol Violation|2
132083|NCT00511797|442490|P1|Overall Study|Protocol Violation|0
132084|NCT00511797|442487|P4|Overall Study|Pregnancy|1
132085|NCT00511797|442488|P3|Overall Study|Pregnancy|0
132086|NCT00511797|442489|P2|Overall Study|Pregnancy|0
132087|NCT00511797|442490|P1|Overall Study|Pregnancy|0
132088|NCT00511797|442487|P4|Overall Study|Lost to Follow-up|1
132089|NCT00511797|442488|P3|Overall Study|Lost to Follow-up|0
132090|NCT00511797|442489|P2|Overall Study|Lost to Follow-up|0
132091|NCT00511797|442490|P1|Overall Study|Lost to Follow-up|1
132092|NCT00511797|442487|P4|Overall Study|Adverse Event|2
132093|NCT00511797|442488|P3|Overall Study|Adverse Event|2
132094|NCT00511797|442489|P2|Overall Study|Adverse Event|2
132095|NCT00511797|442490|P1|Overall Study|Adverse Event|1
132096|NCT00511667|442609|P2|Overall Study|Other|1
132097|NCT00511667|442610|P1|Overall Study|Other|2
132098|NCT00511667|442609|P2|Overall Study|Site terminated|1
132099|NCT00511667|442610|P1|Overall Study|Site terminated|6
132100|NCT00511667|442609|P2|Overall Study|Withdrawal by Subject|0
132101|NCT00511667|442610|P1|Overall Study|Withdrawal by Subject|2
132102|NCT00511667|442609|P2|Overall Study|Protocol Violation|1
132103|NCT00511667|442610|P1|Overall Study|Protocol Violation|1
132104|NCT00511667|442609|P2|Overall Study|Adverse Event|0
132105|NCT00511667|442610|P1|Overall Study|Adverse Event|1
132106|NCT00511472|442645|P2|Overall Study|Not reported|2
132107|NCT00511472|442646|P1|Overall Study|Not reported|2
132108|NCT00511472|442645|P2|Overall Study|Laboratory Adverse Event|2
132109|NCT00511472|442646|P1|Overall Study|Laboratory Adverse Event|0
132110|NCT00511472|442645|P2|Overall Study|Clinical Adverse Event|2
132111|NCT00511472|442646|P1|Overall Study|Clinical Adverse Event|1
132112|NCT00511433|442665|P2|Overall Study|Other Reason|1
132113|NCT00511433|442666|P1|Overall Study|Other Reason|1
132114|NCT00511433|442665|P2|Overall Study|Adverse Event|0
132115|NCT00511433|442666|P1|Overall Study|Adverse Event|5
132116|NCT00511355|442706|P2|Overall Study|Other reason pre-treatment|1
132117|NCT00511355|442707|P1|Overall Study|Other reason pre-treatment|0
132118|NCT00511355|442706|P2|Overall Study|Withdrawal of informed consent|1
132119|NCT00511355|442707|P1|Overall Study|Withdrawal of informed consent|0
132120|NCT00511355|442706|P2|Overall Study|Pre-treatment (serious) adverse event|1
132121|NCT00511355|442707|P1|Overall Study|Pre-treatment (serious) adverse event|0
132122|NCT00511355|442706|P2|Overall Study|Other Reason|1
132123|NCT00511355|442707|P1|Overall Study|Other Reason|0
132124|NCT00511355|442706|P2|Overall Study|Lost to Follow-up|1
132125|NCT00511355|442707|P1|Overall Study|Lost to Follow-up|2
132126|NCT00511355|442706|P2|Overall Study|Pregnancy Wish|0
132127|NCT00511355|442707|P1|Overall Study|Pregnancy Wish|1
132128|NCT00511355|442706|P2|Overall Study|Adverse Event|4
132129|NCT00511355|442707|P1|Overall Study|Adverse Event|4
132130|NCT00511342|442807|P2|Overall Study|Other Reason|2
132131|NCT00511342|442808|P1|Overall Study|Other Reason|2
132132|NCT00511342|442807|P2|Overall Study|Lost to Follow-up|5
132133|NCT00511342|442808|P1|Overall Study|Lost to Follow-up|1
132134|NCT00511342|442807|P2|Overall Study|Pregnancy wish|1
132135|NCT00511342|442808|P1|Overall Study|Pregnancy wish|0
132136|NCT00511342|442807|P2|Overall Study|Pregnancy|1
132137|NCT00511342|442808|P1|Overall Study|Pregnancy|0
132138|NCT00511342|442807|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
132139|NCT00511342|442808|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
132140|NCT00511342|442807|P2|Overall Study|Unacceptable vaginal bleeding|1
132141|NCT00511342|442808|P1|Overall Study|Unacceptable vaginal bleeding|2
132142|NCT00511238|442834|P2|Overall Study|various reasons|14
132143|NCT00511238|442835|P1|Overall Study|various reasons|4
132144|NCT00511238|442834|P2|Overall Study|Progressive Disease|157
132145|NCT00511238|442835|P1|Overall Study|Progressive Disease|23
132146|NCT00511238|442834|P2|Overall Study|Withdrawal by Subject|22
132147|NCT00511238|442835|P1|Overall Study|Withdrawal by Subject|2
132148|NCT00511238|442834|P2|Overall Study|Adverse Event|33
132149|NCT00511238|442835|P1|Overall Study|Adverse Event|13
132150|NCT00511199|442854|P2|Overall Study|Other Reason|37
132151|NCT00511199|442855|P1|Overall Study|Other Reason|78
132152|NCT00511199|442854|P2|Overall Study|Lost to Follow-up|17
132153|NCT00511199|442855|P1|Overall Study|Lost to Follow-up|40
132154|NCT00511199|442854|P2|Overall Study|Pregnancy Wish|8
132155|NCT00511199|442855|P1|Overall Study|Pregnancy Wish|16
132156|NCT00511199|442854|P2|Overall Study|Pregnancy|3
132157|NCT00511199|442855|P1|Overall Study|Pregnancy|6
132158|NCT00511199|442854|P2|Overall Study|Withdrawal of Informed Consent|4
132159|NCT00511199|442855|P1|Overall Study|Withdrawal of Informed Consent|19
132160|NCT00511199|442854|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
132161|NCT00511199|442855|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
132162|NCT00511199|442854|P2|Overall Study|Unacceptable Vaginal Bleeding|4
132163|NCT00511199|442855|P1|Overall Study|Unacceptable Vaginal Bleeding|63
132164|NCT00511134|442886|P2|Overall Study|Withdrawal by Subject|2
132165|NCT00511134|442887|P1|Overall Study|Withdrawal by Subject|0
132166|NCT00511108|442899|P4|Overall Study|Withdrawal by Subject|2
132167|NCT00511108|442900|P3|Overall Study|Withdrawal by Subject|3
132168|NCT00511108|442901|P2|Overall Study|Withdrawal by Subject|0
132169|NCT00511108|442902|P1|Overall Study|Withdrawal by Subject|4
132170|NCT00511108|442899|P4|Overall Study|Physician Decision|1
132171|NCT00511108|442900|P3|Overall Study|Physician Decision|0
132172|NCT00511108|442901|P2|Overall Study|Physician Decision|0
132173|NCT00511108|442902|P1|Overall Study|Physician Decision|0
132174|NCT00511108|442899|P4|Overall Study|Lost to Follow-up|0
132175|NCT00511108|442900|P3|Overall Study|Lost to Follow-up|1
132176|NCT00511108|442901|P2|Overall Study|Lost to Follow-up|2
132177|NCT00511108|442902|P1|Overall Study|Lost to Follow-up|0
132178|NCT00511108|442899|P4|Overall Study|Adverse Event|2
132179|NCT00511108|442900|P3|Overall Study|Adverse Event|1
132180|NCT00511108|442901|P2|Overall Study|Adverse Event|0
132181|NCT00511108|442902|P1|Overall Study|Adverse Event|2
132182|NCT00511004|442923|P3|Overall Study|Lost to Follow-up|4
132183|NCT00511004|442924|P2|Overall Study|Lost to Follow-up|0
132184|NCT00511004|442925|P1|Overall Study|Lost to Follow-up|0
132185|NCT00510952|442944|P2|Overall Study|Did Not Receive Study Drug|0
132186|NCT00510952|442945|P1|Overall Study|Did Not Receive Study Drug|2
132187|NCT00510952|442944|P2|Overall Study|Withdrawal by Subject|7
132188|NCT00510952|442945|P1|Overall Study|Withdrawal by Subject|6
132189|NCT00510952|442944|P2|Overall Study|Sponsor Decision|0
132190|NCT00510952|442945|P1|Overall Study|Sponsor Decision|1
132191|NCT00510952|442944|P2|Overall Study|Protocol Violation|4
132192|NCT00510952|442945|P1|Overall Study|Protocol Violation|7
132193|NCT00510952|442944|P2|Overall Study|Physician Decision|1
132194|NCT00510952|442945|P1|Overall Study|Physician Decision|1
132195|NCT00510952|442944|P2|Overall Study|Lost to Follow-up|3
132196|NCT00510952|442945|P1|Overall Study|Lost to Follow-up|5
132197|NCT00510952|442944|P2|Overall Study|Entry Criteria Not Met|1
132198|NCT00510952|442945|P1|Overall Study|Entry Criteria Not Met|3
132199|NCT00510952|442944|P2|Overall Study|Adverse Event|0
132200|NCT00510952|442945|P1|Overall Study|Adverse Event|1
132201|NCT00510887|442971|P1|Overall Study|Lost to Follow-up|1
132202|NCT00510874|442987|P7|Overall Study|Lost to Follow-up|1
132203|NCT00510874|442988|P6|Overall Study|Lost to Follow-up|0
132204|NCT00510874|442989|P5|Overall Study|Lost to Follow-up|4
132205|NCT00510874|442990|P4|Overall Study|Lost to Follow-up|3
132206|NCT00510874|442991|P3|Overall Study|Lost to Follow-up|1
132207|NCT00510874|442992|P2|Overall Study|Lost to Follow-up|3
132208|NCT00510874|442993|P1|Overall Study|Lost to Follow-up|2
132209|NCT00510874|442987|P7|Overall Study|Withdrawal by Subject|0
132210|NCT00510874|442988|P6|Overall Study|Withdrawal by Subject|0
132211|NCT00510874|442989|P5|Overall Study|Withdrawal by Subject|3
132212|NCT00510874|442990|P4|Overall Study|Withdrawal by Subject|0
132213|NCT00510874|442991|P3|Overall Study|Withdrawal by Subject|0
132214|NCT00510874|442992|P2|Overall Study|Withdrawal by Subject|1
132215|NCT00510874|442993|P1|Overall Study|Withdrawal by Subject|1
132216|NCT00510835|443096|P3|Overall Study|Withdrawal by Subject|2
132217|NCT00510835|443097|P2|Overall Study|Withdrawal by Subject|2
132218|NCT00510835|443098|P1|Overall Study|Withdrawal by Subject|6
132219|NCT00510783|443124|P2|Overall Study|Protocol Violation|1
132220|NCT00510783|443125|P1|Overall Study|Protocol Violation|0
132221|NCT00510783|443124|P2|Overall Study|Withdrawal by Subject|3
132222|NCT00510783|443125|P1|Overall Study|Withdrawal by Subject|2
132223|NCT00510783|443124|P2|Overall Study|Lost to Follow-up|25
132224|NCT00510783|443125|P1|Overall Study|Lost to Follow-up|29
132225|NCT00510692|443137|P2|Overall Study|Withdrawal by Subject|0
132226|NCT00510692|443138|P1|Overall Study|Withdrawal by Subject|1
132227|NCT00510692|443137|P2|Overall Study|Adverse Event|3
132228|NCT00510692|443138|P1|Overall Study|Adverse Event|1
132229|NCT00510653|443152|P1|Overall Study|Monetary|3
132230|NCT00510653|443152|P1|Overall Study|Withdrawal by Subject|8
132231|NCT00510510|443159|P3|Overall Study|Protocol Violation|4
132232|NCT00510510|443160|P2|Overall Study|Protocol Violation|3
132233|NCT00510510|443161|P1|Overall Study|Protocol Violation|0
132234|NCT00510510|443159|P3|Overall Study|Lost to Follow-up|1
132235|NCT00510510|443160|P2|Overall Study|Lost to Follow-up|0
132236|NCT00510510|443161|P1|Overall Study|Lost to Follow-up|0
132237|NCT00510510|443159|P3|Overall Study|Withdrawal by Subject|3
132238|NCT00510510|443160|P2|Overall Study|Withdrawal by Subject|2
132239|NCT00510510|443161|P1|Overall Study|Withdrawal by Subject|1
132240|NCT00510510|443159|P3|Overall Study|Subjects no longer requires study drug|2
132241|NCT00510510|443160|P2|Overall Study|Subjects no longer requires study drug|0
132242|NCT00510510|443161|P1|Overall Study|Subjects no longer requires study drug|0
132243|NCT00510510|443159|P3|Overall Study|Lack of Efficacy|1
132244|NCT00510510|443160|P2|Overall Study|Lack of Efficacy|1
132245|NCT00510510|443161|P1|Overall Study|Lack of Efficacy|0
132246|NCT00510510|443159|P3|Overall Study|Adverse Event|6
132247|NCT00510510|443160|P2|Overall Study|Adverse Event|3
132248|NCT00510510|443161|P1|Overall Study|Adverse Event|4
132249|NCT00510484|443179|P2|Wash-out Period|Adverse Event|1
132250|NCT00510484|443180|P1|Wash-out Period|Adverse Event|0
132251|NCT00510289|443200|P1|Overall Study|Progressed prior to starting drug|2
132252|NCT00510289|443200|P1|Overall Study|Lost to Follow-up|1
132253|NCT00510289|443200|P1|Overall Study|Refused bone marrow biopsy|2
132254|NCT00510289|443200|P1|Overall Study|Withdrawal by Subject|7
132255|NCT00510276|443210|P2|Extension Open-Label Phase|Subject Decision|9
132256|NCT00510276|443211|P1|Extension Open-Label Phase|Subject Decision|7
132257|NCT00510276|443210|P2|Extension Open-Label Phase|Sponsor Decision|0
132258|NCT00510276|443211|P1|Extension Open-Label Phase|Sponsor Decision|1
132259|NCT00510276|443210|P2|Extension Open-Label Phase|Protocol Violation|1
132260|NCT00510276|443211|P1|Extension Open-Label Phase|Protocol Violation|0
132261|NCT00510276|443210|P2|Extension Open-Label Phase|Physician Decision|3
132262|NCT00510276|443211|P1|Extension Open-Label Phase|Physician Decision|2
132263|NCT00510276|443210|P2|Extension Open-Label Phase|Lost to Follow-up|10
132264|NCT00510276|443211|P1|Extension Open-Label Phase|Lost to Follow-up|12
132265|NCT00510276|443210|P2|Extension Open-Label Phase|Lack of Efficacy|7
132266|NCT00510276|443211|P1|Extension Open-Label Phase|Lack of Efficacy|2
132267|NCT00510276|443210|P2|Extension Open-Label Phase|Adverse Event|18
132268|NCT00510276|443211|P1|Extension Open-Label Phase|Adverse Event|9
132269|NCT00510276|443210|P2|Acute Double-Blind Phase|Subject Decision|28
132270|NCT00510276|443211|P1|Acute Double-Blind Phase|Subject Decision|26
132271|NCT00510276|443210|P2|Acute Double-Blind Phase|Sponsor Decision|1
132272|NCT00510276|443211|P1|Acute Double-Blind Phase|Sponsor Decision|2
132273|NCT00510276|443210|P2|Acute Double-Blind Phase|Protocol Violation|3
132274|NCT00510276|443211|P1|Acute Double-Blind Phase|Protocol Violation|4
132275|NCT00510276|443210|P2|Acute Double-Blind Phase|Physician Decision|3
132276|NCT00510276|443211|P1|Acute Double-Blind Phase|Physician Decision|0
132277|NCT00510276|443210|P2|Acute Double-Blind Phase|Lost to Follow-up|49
132278|NCT00510276|443211|P1|Acute Double-Blind Phase|Lost to Follow-up|48
132279|NCT00510276|443210|P2|Acute Double-Blind Phase|Lack of Efficacy|4
132280|NCT00510276|443211|P1|Acute Double-Blind Phase|Lack of Efficacy|3
132281|NCT00510276|443210|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
132282|NCT00510276|443211|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
132283|NCT00510276|443210|P2|Acute Double-Blind Phase|Adverse Event|6
132284|NCT00510276|443211|P1|Acute Double-Blind Phase|Adverse Event|21
132285|NCT00510146|443305|P2|Open-Label Treatment|Sponsor Decision|0
132286|NCT00510146|443306|P1|Open-Label Treatment|Sponsor Decision|2
132287|NCT00510146|443305|P2|Open-Label Treatment|Clinical Relapse|1
132288|NCT00510146|443306|P1|Open-Label Treatment|Clinical Relapse|1
132289|NCT00510146|443305|P2|Open-Label Treatment|Withdrawal by Subject|12
132290|NCT00510146|443306|P1|Open-Label Treatment|Withdrawal by Subject|24
132291|NCT00510146|443305|P2|Open-Label Treatment|Protocol Violation|2
132292|NCT00510146|443306|P1|Open-Label Treatment|Protocol Violation|4
132293|NCT00510146|443305|P2|Open-Label Treatment|Physician Decision|1
132294|NCT00510146|443306|P1|Open-Label Treatment|Physician Decision|3
132295|NCT00510146|443305|P2|Open-Label Treatment|Lost to Follow-up|1
132296|NCT00510146|443306|P1|Open-Label Treatment|Lost to Follow-up|10
132297|NCT00510146|443305|P2|Open-Label Treatment|Lack of Efficacy|0
132298|NCT00510146|443306|P1|Open-Label Treatment|Lack of Efficacy|4
132299|NCT00510146|443305|P2|Open-Label Treatment|Death|1
132300|NCT00510146|443306|P1|Open-Label Treatment|Death|1
132301|NCT00510146|443305|P2|Open-Label Treatment|Adverse Event|8
132302|NCT00510146|443306|P1|Open-Label Treatment|Adverse Event|22
132303|NCT00510146|443305|P2|Double-Blind Treatment|Entry Criteria Not Met|0
132304|NCT00510146|443306|P1|Double-Blind Treatment|Entry Criteria Not Met|3
132305|NCT00510146|443305|P2|Double-Blind Treatment|Clinical Relapse|1
132306|NCT00510146|443306|P1|Double-Blind Treatment|Clinical Relapse|0
132307|NCT00510146|443305|P2|Double-Blind Treatment|Withdrawal by Subject|13
132308|NCT00510146|443306|P1|Double-Blind Treatment|Withdrawal by Subject|27
132309|NCT00510146|443305|P2|Double-Blind Treatment|Protocol Violation|2
132310|NCT00510146|443306|P1|Double-Blind Treatment|Protocol Violation|1
132311|NCT00510146|443305|P2|Double-Blind Treatment|Physician Decision|0
132312|NCT00510146|443306|P1|Double-Blind Treatment|Physician Decision|6
132313|NCT00510146|443305|P2|Double-Blind Treatment|Lost to Follow-up|7
132314|NCT00510146|443306|P1|Double-Blind Treatment|Lost to Follow-up|3
132315|NCT00510146|443305|P2|Double-Blind Treatment|Lack of Efficacy|13
132316|NCT00510146|443306|P1|Double-Blind Treatment|Lack of Efficacy|6
132317|NCT00510146|443305|P2|Double-Blind Treatment|Adverse Event|13
132318|NCT00510146|443306|P1|Double-Blind Treatment|Adverse Event|30
132319|NCT00510068|443395|P2|Open-label Period|Abnormal laboratory value (s)|0
132320|NCT00510068|443396|P1|Open-label Period|Abnormal laboratory value (s)|1
132321|NCT00510068|443395|P2|Open-label Period|Protocol Violation|0
132322|NCT00510068|443396|P1|Open-label Period|Protocol Violation|2
132323|NCT00510068|443395|P2|Open-label Period|New cancer therapy|0
132324|NCT00510068|443396|P1|Open-label Period|New cancer therapy|7
132325|NCT00510068|443395|P2|Open-label Period|Death|0
132326|NCT00510068|443396|P1|Open-label Period|Death|7
132327|NCT00510068|443395|P2|Open-label Period|Administrative problems|0
132328|NCT00510068|443396|P1|Open-label Period|Administrative problems|17
132329|NCT00510068|443395|P2|Open-label Period|Withdrawal by Subject|0
132330|NCT00510068|443396|P1|Open-label Period|Withdrawal by Subject|21
132331|NCT00510068|443395|P2|Open-label Period|Adverse Event|0
132332|NCT00510068|443396|P1|Open-label Period|Adverse Event|46
132333|NCT00510068|443395|P2|Open-label Period|Disease Progression|0
132334|NCT00510068|443396|P1|Open-label Period|Disease Progression|124
132335|NCT00510068|443395|P2|Double-blind Period|Protocol Violation|0
132336|NCT00510068|443396|P1|Double-blind Period|Protocol Violation|6
132337|NCT00510068|443395|P2|Double-blind Period|Lost to Follow-up|0
132338|NCT00510068|443396|P1|Double-blind Period|Lost to Follow-up|1
132339|NCT00510068|443395|P2|Double-blind Period|Abnormal test result (s)|0
132340|NCT00510068|443396|P1|Double-blind Period|Abnormal test result (s)|1
132341|NCT00510068|443395|P2|Double-blind Period|Death|3
132342|NCT00510068|443396|P1|Double-blind Period|Death|4
132343|NCT00510068|443395|P2|Double-blind Period|Withdrawal by Subject|6
132344|NCT00510068|443396|P1|Double-blind Period|Withdrawal by Subject|8
132345|NCT00510068|443395|P2|Double-blind Period|Adverse Event|7
132346|NCT00510068|443396|P1|Double-blind Period|Adverse Event|37
132347|NCT00510068|443395|P2|Double-blind Period|Final primary analysis|18
132348|NCT00510068|443396|P1|Double-blind Period|Final primary analysis|52
132349|NCT00510068|443395|P2|Double-blind Period|Disease progression|169
132350|NCT00510068|443396|P1|Double-blind Period|Disease progression|98
132351|NCT00509925|443437|P2|Overall Study|Personal reasons|1
132352|NCT00509925|443438|P1|Overall Study|Personal reasons|0
132353|NCT00509899|443486|P8|Overall Study|Lack of Efficacy|0
132354|NCT00509899|443487|P7|Overall Study|Lack of Efficacy|0
132355|NCT00509899|443488|P6|Overall Study|Lack of Efficacy|1
132356|NCT00509899|443489|P5|Overall Study|Lack of Efficacy|0
132357|NCT00509899|443490|P4|Overall Study|Lack of Efficacy|0
132358|NCT00509899|443491|P3|Overall Study|Lack of Efficacy|2
132359|NCT00509899|443492|P2|Overall Study|Lack of Efficacy|0
132360|NCT00509899|443493|P1|Overall Study|Lack of Efficacy|1
132361|NCT00509899|443486|P8|Overall Study|Death|1
132362|NCT00509899|443487|P7|Overall Study|Death|1
132363|NCT00509899|443488|P6|Overall Study|Death|1
132364|NCT00509899|443489|P5|Overall Study|Death|1
132365|NCT00509899|443490|P4|Overall Study|Death|0
132366|NCT00509899|443491|P3|Overall Study|Death|3
132367|NCT00509899|443492|P2|Overall Study|Death|2
132368|NCT00509899|443493|P1|Overall Study|Death|2
132369|NCT00509899|443486|P8|Overall Study|Intercurrent Illness|0
132370|NCT00509899|443487|P7|Overall Study|Intercurrent Illness|0
132371|NCT00509899|443488|P6|Overall Study|Intercurrent Illness|1
132372|NCT00509899|443489|P5|Overall Study|Intercurrent Illness|0
132373|NCT00509899|443490|P4|Overall Study|Intercurrent Illness|1
132374|NCT00509899|443491|P3|Overall Study|Intercurrent Illness|0
132375|NCT00509899|443492|P2|Overall Study|Intercurrent Illness|0
132376|NCT00509899|443493|P1|Overall Study|Intercurrent Illness|1
132377|NCT00509899|443486|P8|Overall Study|Physician Decision|0
132378|NCT00509899|443487|P7|Overall Study|Physician Decision|0
132379|NCT00509899|443488|P6|Overall Study|Physician Decision|4
132380|NCT00509899|443489|P5|Overall Study|Physician Decision|1
132381|NCT00509899|443490|P4|Overall Study|Physician Decision|0
132382|NCT00509899|443491|P3|Overall Study|Physician Decision|7
132383|NCT00509899|443492|P2|Overall Study|Physician Decision|2
132384|NCT00509899|443493|P1|Overall Study|Physician Decision|4
132385|NCT00509899|443486|P8|Overall Study|Withdrawal by Subject|0
132386|NCT00509899|443487|P7|Overall Study|Withdrawal by Subject|0
132387|NCT00509899|443488|P6|Overall Study|Withdrawal by Subject|2
132388|NCT00509899|443489|P5|Overall Study|Withdrawal by Subject|3
132389|NCT00509899|443490|P4|Overall Study|Withdrawal by Subject|0
132390|NCT00509899|443491|P3|Overall Study|Withdrawal by Subject|3
132391|NCT00509899|443492|P2|Overall Study|Withdrawal by Subject|2
132392|NCT00509899|443493|P1|Overall Study|Withdrawal by Subject|6
132393|NCT00509899|443486|P8|Overall Study|Unacceptable Toxicity|0
132394|NCT00509899|443487|P7|Overall Study|Unacceptable Toxicity|0
132395|NCT00509899|443488|P6|Overall Study|Unacceptable Toxicity|0
132396|NCT00509899|443489|P5|Overall Study|Unacceptable Toxicity|0
132397|NCT00509899|443490|P4|Overall Study|Unacceptable Toxicity|2
132398|NCT00509899|443491|P3|Overall Study|Unacceptable Toxicity|0
132399|NCT00509899|443492|P2|Overall Study|Unacceptable Toxicity|0
132400|NCT00509899|443493|P1|Overall Study|Unacceptable Toxicity|1
132401|NCT00509899|443486|P8|Overall Study|Progressive disease|0
132402|NCT00509899|443487|P7|Overall Study|Progressive disease|0
132403|NCT00509899|443488|P6|Overall Study|Progressive disease|1
132404|NCT00509899|443489|P5|Overall Study|Progressive disease|0
132405|NCT00509899|443490|P4|Overall Study|Progressive disease|1
132406|NCT00509899|443491|P3|Overall Study|Progressive disease|5
132407|NCT00509899|443492|P2|Overall Study|Progressive disease|3
132408|NCT00509899|443493|P1|Overall Study|Progressive disease|1
132409|NCT00509795|443552|P4|Overall Study|Withdrawal by Subject|8
132410|NCT00509795|443553|P3|Overall Study|Withdrawal by Subject|7
132411|NCT00509795|443554|P2|Overall Study|Withdrawal by Subject|5
132412|NCT00509795|443555|P1|Overall Study|Withdrawal by Subject|10
132413|NCT00509795|443552|P4|Overall Study|Protocol Violation|1
132414|NCT00509795|443553|P3|Overall Study|Protocol Violation|3
132415|NCT00509795|443554|P2|Overall Study|Protocol Violation|0
132416|NCT00509795|443555|P1|Overall Study|Protocol Violation|3
132417|NCT00509795|443552|P4|Overall Study|OTHER|1
132418|NCT00509795|443553|P3|Overall Study|OTHER|4
132419|NCT00509795|443554|P2|Overall Study|OTHER|0
132420|NCT00509795|443555|P1|Overall Study|OTHER|1
132421|NCT00509795|443552|P4|Overall Study|Lost to Follow-up|4
132422|NCT00509795|443553|P3|Overall Study|Lost to Follow-up|4
132423|NCT00509795|443554|P2|Overall Study|Lost to Follow-up|2
132424|NCT00509795|443555|P1|Overall Study|Lost to Follow-up|1
132425|NCT00509795|443552|P4|Overall Study|Lack of Efficacy|2
132426|NCT00509795|443553|P3|Overall Study|Lack of Efficacy|2
132427|NCT00509795|443554|P2|Overall Study|Lack of Efficacy|0
132428|NCT00509795|443555|P1|Overall Study|Lack of Efficacy|0
132429|NCT00509795|443552|P4|Overall Study|Death|7
132430|NCT00509795|443553|P3|Overall Study|Death|2
132431|NCT00509795|443554|P2|Overall Study|Death|1
132432|NCT00509795|443555|P1|Overall Study|Death|3
132433|NCT00509795|443552|P4|Overall Study|Adverse Event|4
132434|NCT00509795|443553|P3|Overall Study|Adverse Event|5
132435|NCT00509795|443554|P2|Overall Study|Adverse Event|3
132436|NCT00509795|443555|P1|Overall Study|Adverse Event|4
132437|NCT00509769|443586|P1|Overall Study|Use of prohibited therapies during study|1
132438|NCT00509769|443586|P1|Overall Study|Physician Decision|8
132439|NCT00509769|443586|P1|Overall Study|Patient’s decision|1
132440|NCT00509769|443586|P1|Overall Study|Adverse Event|4
132441|NCT00509769|443586|P1|Overall Study|Progressive disease|77
132442|NCT00509600|443595|P1|Overall Study|Adverse Event|1
132443|NCT00509366|443623|P5|Overall Study|Not Treated (Screen Failure)|0
132444|NCT00509366|443624|P4|Overall Study|Not Treated (Screen Failure)|0
132445|NCT00509366|443625|P3|Overall Study|Not Treated (Screen Failure)|1
132446|NCT00509366|443626|P2|Overall Study|Not Treated (Screen Failure)|1
132447|NCT00509366|443627|P1|Overall Study|Not Treated (Screen Failure)|1
132448|NCT00509262|443651|P2|Overall Study|Withdrawal by Subject|11
132449|NCT00509262|443652|P1|Overall Study|Withdrawal by Subject|24
132450|NCT00509262|443651|P2|Overall Study|Protocol Violation|2
132451|NCT00509262|443652|P1|Overall Study|Protocol Violation|2
132452|NCT00509262|443651|P2|Overall Study|Physician Decision|3
132453|NCT00509262|443652|P1|Overall Study|Physician Decision|1
132454|NCT00509262|443651|P2|Overall Study|Lost to Follow-up|6
132455|NCT00509262|443652|P1|Overall Study|Lost to Follow-up|1
132456|NCT00509262|443651|P2|Overall Study|Lack of Efficacy|0
132457|NCT00509262|443652|P1|Overall Study|Lack of Efficacy|1
132458|NCT00509262|443651|P2|Overall Study|Not specified|2
132459|NCT00509262|443652|P1|Overall Study|Not specified|2
132460|NCT00509262|443651|P2|Overall Study|Adverse Event|18
132461|NCT00509262|443652|P1|Overall Study|Adverse Event|16
132462|NCT00509236|443670|P2|Overall Study|Scheduled Kidney Transplant|0
132463|NCT00509236|443671|P1|Overall Study|Scheduled Kidney Transplant|1
132464|NCT00509236|443670|P2|Overall Study|Excluded Medication|1
132465|NCT00509236|443671|P1|Overall Study|Excluded Medication|1
132466|NCT00509236|443670|P2|Overall Study|Protocol Violation|0
132467|NCT00509236|443671|P1|Overall Study|Protocol Violation|3
132468|NCT00509236|443670|P2|Overall Study|Withdrawal by Subject|10
132469|NCT00509236|443671|P1|Overall Study|Withdrawal by Subject|5
132470|NCT00509236|443670|P2|Overall Study|Adverse Event|9
132471|NCT00509236|443671|P1|Overall Study|Adverse Event|7
132472|NCT00509223|443686|P2|Overall Study|Did not meet revised inclusion criteria|62
132473|NCT00509223|443687|P1|Overall Study|Did not meet revised inclusion criteria|56
132474|NCT00509223|443686|P2|Overall Study|Including: subject change of address|2
132475|NCT00509223|443687|P1|Overall Study|Including: subject change of address|5
132476|NCT00509223|443686|P2|Overall Study|Withdrawal by Subject|6
132477|NCT00509223|443687|P1|Overall Study|Withdrawal by Subject|25
132478|NCT00509223|443686|P2|Overall Study|Adverse Event|1
132479|NCT00509223|443687|P1|Overall Study|Adverse Event|1
132480|NCT00509223|443686|P2|Overall Study|Lost to Follow-up|1
132481|NCT00509223|443687|P1|Overall Study|Lost to Follow-up|1
132482|NCT00509106|443710|P2|Overall Study|Death|6
132483|NCT00509106|443711|P1|Overall Study|Death|6
132484|NCT00509106|443710|P2|Overall Study|Other|0
132485|NCT00509106|443711|P1|Overall Study|Other|1
132486|NCT00509106|443710|P2|Overall Study|Lost to Follow-up|10
132487|NCT00509106|443711|P1|Overall Study|Lost to Follow-up|16
132488|NCT00509106|443710|P2|Overall Study|Withdrew consent|8
132489|NCT00509106|443711|P1|Overall Study|Withdrew consent|4
132490|NCT00509106|443710|P2|Overall Study|At the request of sponsor/investigator|2
132491|NCT00509106|443711|P1|Overall Study|At the request of sponsor/investigator|1
132492|NCT00509106|443710|P2|Overall Study|Noncompliance|1
132493|NCT00509106|443711|P1|Overall Study|Noncompliance|0
132494|NCT00509106|443710|P2|Overall Study|Adverse Event|2
132495|NCT00509106|443711|P1|Overall Study|Adverse Event|3
132496|NCT00509067|443719|P2|Overall Study|Protocol Violation|3
132497|NCT00509067|443720|P1|Overall Study|Protocol Violation|0
132498|NCT00509067|443719|P2|Overall Study|Adverse Event|1
132499|NCT00509067|443720|P1|Overall Study|Adverse Event|3
132500|NCT00509067|443719|P2|Overall Study|Lost to Follow-up|1
132501|NCT00509067|443720|P1|Overall Study|Lost to Follow-up|1
132502|NCT00509028|443735|P2|Overall Study|Non-compliance|1
132503|NCT00509028|443736|P1|Overall Study|Non-compliance|2
132504|NCT00509028|443735|P2|Overall Study|Protocol Violation|2
132505|NCT00509028|443736|P1|Overall Study|Protocol Violation|4
132506|NCT00509028|443735|P2|Overall Study|Lost to Follow-up|1
132507|NCT00509028|443736|P1|Overall Study|Lost to Follow-up|0
132508|NCT00509028|443735|P2|Overall Study|Withdrawal by Subject|3
132509|NCT00509028|443736|P1|Overall Study|Withdrawal by Subject|4
132510|NCT00509028|443735|P2|Overall Study|Adverse Event|0
132511|NCT00509028|443736|P1|Overall Study|Adverse Event|2
132512|NCT00508924|443772|P4|Overall Study|Protocol Violation|1
132513|NCT00508924|443773|P3|Overall Study|Protocol Violation|1
132514|NCT00508924|443774|P2|Overall Study|Protocol Violation|0
132515|NCT00508924|443775|P1|Overall Study|Protocol Violation|0
132516|NCT00508872|443789|P1|Overall Study|Physician Decision|1
132517|NCT00508872|443789|P1|Overall Study|Lost to Follow-up|1
132518|NCT00508820|443795|P2|Overall Study|Protocol-specified Criteria|12
132519|NCT00508820|443796|P1|Overall Study|Protocol-specified Criteria|3
132520|NCT00508820|443795|P2|Overall Study|Requirement for alternative therapy|15
132521|NCT00508820|443796|P1|Overall Study|Requirement for alternative therapy|7
132522|NCT00508820|443795|P2|Overall Study|Noncompliance|0
132523|NCT00508820|443796|P1|Overall Study|Noncompliance|1
132524|NCT00508820|443795|P2|Overall Study|Other|2
132525|NCT00508820|443796|P1|Overall Study|Other|11
132526|NCT00508820|443795|P2|Overall Study|Withdrawal by Subject|12
132527|NCT00508820|443796|P1|Overall Study|Withdrawal by Subject|10
132528|NCT00508820|443795|P2|Overall Study|Protocol Violation|0
132529|NCT00508820|443796|P1|Overall Study|Protocol Violation|2
132530|NCT00508820|443795|P2|Overall Study|Pregnancy|2
132531|NCT00508820|443796|P1|Overall Study|Pregnancy|0
132532|NCT00508820|443795|P2|Overall Study|Physician Decision|2
132533|NCT00508820|443796|P1|Overall Study|Physician Decision|8
132534|NCT00508820|443795|P2|Overall Study|Lost to Follow-up|1
132535|NCT00508820|443796|P1|Overall Study|Lost to Follow-up|1
132536|NCT00508820|443795|P2|Overall Study|Death|8
132537|NCT00508820|443796|P1|Overall Study|Death|6
132538|NCT00508820|443795|P2|Overall Study|Adverse Event|10
132539|NCT00508820|443796|P1|Overall Study|Adverse Event|6
132540|NCT00508755|443806|P1|Overall Study|Withdrawal by Subject|1
132541|NCT00508742|443814|P2|Period 3: Toddler Dose|Unspecified|4
132542|NCT00508742|443815|P1|Period 3: Toddler Dose|Unspecified|5
132543|NCT00508742|443814|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
132544|NCT00508742|443815|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
132545|NCT00508742|443814|P2|Period 3: Toddler Dose|Lost to Follow-up|3
132546|NCT00508742|443815|P1|Period 3: Toddler Dose|Lost to Follow-up|2
132547|NCT00508742|443814|P2|Period 3: Toddler Dose|Adverse Event|0
132548|NCT00508742|443815|P1|Period 3: Toddler Dose|Adverse Event|1
132549|NCT00508742|443814|P2|Period 2: After Infant Series|Unspecified|1
132550|NCT00508742|443815|P1|Period 2: After Infant Series|Unspecified|2
132551|NCT00508742|443814|P2|Period 2: After Infant Series|Failed to Return|0
132552|NCT00508742|443815|P1|Period 2: After Infant Series|Failed to Return|1
132553|NCT00508742|443814|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
132554|NCT00508742|443815|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
132555|NCT00508742|443814|P2|Period 2: After Infant Series|Protocol Violation|0
132556|NCT00508742|443815|P1|Period 2: After Infant Series|Protocol Violation|1
132557|NCT00508742|443814|P2|Period 2: After Infant Series|Lost to Follow-up|1
132558|NCT00508742|443815|P1|Period 2: After Infant Series|Lost to Follow-up|1
132559|NCT00508742|443814|P2|Period 2: After Infant Series|Adverse Event|6
132560|NCT00508742|443815|P1|Period 2: After Infant Series|Adverse Event|2
132561|NCT00508742|443814|P2|Period 1: Infant Series|Unspecified|1
132562|NCT00508742|443815|P1|Period 1: Infant Series|Unspecified|4
132563|NCT00508742|443814|P2|Period 1: Infant Series|Physician Decision|0
132564|NCT00508742|443815|P1|Period 1: Infant Series|Physician Decision|1
132565|NCT00508742|443814|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
132566|NCT00508742|443815|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
132567|NCT00508742|443814|P2|Period 1: Infant Series|Protocol Violation|0
132568|NCT00508742|443815|P1|Period 1: Infant Series|Protocol Violation|1
132569|NCT00508742|443814|P2|Period 1: Infant Series|Adverse Event|4
132570|NCT00508742|443815|P1|Period 1: Infant Series|Adverse Event|5
132571|NCT00508651|443840|P2|Overall Study|Withdrawal by Subject|1
132572|NCT00508651|443841|P1|Overall Study|Withdrawal by Subject|1
132573|NCT00508651|443840|P2|Overall Study|Lost to Follow-up|1
132574|NCT00508651|443841|P1|Overall Study|Lost to Follow-up|3
132575|NCT00508482|443922|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
132576|NCT00508482|443923|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
132577|NCT00508482|443924|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
132578|NCT00508482|443922|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
132579|NCT00508482|443923|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
132580|NCT00508482|443924|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
132581|NCT00508482|443922|P3|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|4
132582|NCT00508482|443923|P2|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|7
132583|NCT00508482|443924|P1|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|9
132584|NCT00508404|443968|P1|Overall Study|Other - Not Specified|3
132585|NCT00508404|443968|P1|Overall Study|Lost to Follow-up|2
132586|NCT00508404|443968|P1|Overall Study|Protocol-specified Criteria|2
132587|NCT00508404|443968|P1|Overall Study|Withdrawal by Subject|3
132588|NCT00508404|443968|P1|Overall Study|Physician Decision|2
132589|NCT00508404|443968|P1|Overall Study|Death|16
132590|NCT00508404|443968|P1|Overall Study|Adverse Event|2
132591|NCT00508404|443968|P1|Overall Study|Ongoing at Data Cut-off|12
132592|NCT00508391|443995|P2|Second Treatment|Withdrawal by Subject|0
132593|NCT00508391|443996|P1|Second Treatment|Withdrawal by Subject|2
132594|NCT00508391|443995|P2|First Treatment|Withdrawal by Subject|3
132595|NCT00508391|443996|P1|First Treatment|Withdrawal by Subject|6
132596|NCT00508274|444007|P1|Overall Study|Withdrawal by Subject|1
132597|NCT00508274|444007|P1|Overall Study|Adverse Event|1
132598|NCT00508157|444018|P2|Overall Study|Other known cause|1
132599|NCT00508157|444019|P1|Overall Study|Other known cause|0
132600|NCT00508157|444018|P2|Overall Study|Subject no longer met study criteria|1
132601|NCT00508157|444019|P1|Overall Study|Subject no longer met study criteria|0
132602|NCT00508157|444018|P2|Overall Study|Lost to Follow-up|0
132603|NCT00508157|444019|P1|Overall Study|Lost to Follow-up|1
132604|NCT00508157|444018|P2|Overall Study|Subject Withdrew Consent|0
132605|NCT00508157|444019|P1|Overall Study|Subject Withdrew Consent|1
132606|NCT00508157|444018|P2|Overall Study|Adverse Event|1
132607|NCT00508157|444019|P1|Overall Study|Adverse Event|0
132608|NCT00508144|444041|P1|Overall Study|Death|5
132609|NCT00508144|444041|P1|Overall Study|Not eligible|6
132610|NCT00508027|444067|P1|Dose Level 2|Withdrawal by Subject|2
132611|NCT00508027|444067|P1|Dose Level 2|Lost to Follow-up|2
132612|NCT00508027|444067|P1|Dose Level 1|Physician Decision|2
132613|NCT00508027|444067|P1|Dose Level 1|Withdrawal by Subject|2
132614|NCT00508027|444067|P1|Dose Level 1|Lost to Follow-up|4
132615|NCT00508001|444108|P3|Overall Study|Withdrawal by Subject|1
132616|NCT00508001|444109|P2|Overall Study|Withdrawal by Subject|4
132617|NCT00508001|444110|P1|Overall Study|Withdrawal by Subject|4
132618|NCT00508001|444108|P3|Overall Study|Death|1
132619|NCT00508001|444109|P2|Overall Study|Death|1
132620|NCT00508001|444110|P1|Overall Study|Death|0
132621|NCT00508001|444108|P3|Overall Study|condition under investigation worsened|1
132622|NCT00508001|444109|P2|Overall Study|condition under investigation worsened|7
132623|NCT00508001|444110|P1|Overall Study|condition under investigation worsened|13
132624|NCT00508001|444108|P3|Overall Study|Adverse Event|4
132625|NCT00508001|444109|P2|Overall Study|Adverse Event|0
132626|NCT00508001|444110|P1|Overall Study|Adverse Event|2
132627|NCT00507819|444127|P2|Washout (6 Weeks)|Withdrawal by Subject|0
132628|NCT00507819|444128|P1|Washout (6 Weeks)|Withdrawal by Subject|1
132629|NCT00507689|444147|P2|Randomized Period|Withdrawal by Subject|1
132630|NCT00507689|444148|P1|Randomized Period|Withdrawal by Subject|0
132631|NCT00507689|444147|P2|Randomized Period|Adverse Event|1
132632|NCT00507689|444148|P1|Randomized Period|Adverse Event|1
132633|NCT00507689|444147|P2|Pre-Randomization Period|Withdrawal by Subject|0
132634|NCT00507689|444148|P1|Pre-Randomization Period|Withdrawal by Subject|1
132635|NCT00507689|444147|P2|Pre-Randomization Period|Physician Decision|0
132636|NCT00507689|444148|P1|Pre-Randomization Period|Physician Decision|1
132637|NCT00507689|444147|P2|Pre-Randomization Period|Adverse Event|0
132638|NCT00507689|444148|P1|Pre-Randomization Period|Adverse Event|1
132639|NCT00507546|444180|P2|Overall Study|Physician Decision|1
132640|NCT00507546|444181|P1|Overall Study|Physician Decision|0
132641|NCT00507546|444180|P2|Overall Study|Protocol Violation|0
132642|NCT00507546|444181|P1|Overall Study|Protocol Violation|1
132643|NCT00507546|444180|P2|Overall Study|Withdrawal by Subject|0
132644|NCT00507546|444181|P1|Overall Study|Withdrawal by Subject|1
132645|NCT00507507|444191|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
132646|NCT00507507|444192|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
132647|NCT00507507|444191|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
132648|NCT00507507|444192|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
132649|NCT00507507|444191|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
132650|NCT00507507|444192|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
132651|NCT00507507|444191|P2|Treatment Period|Withdrawal by Subject|47
132652|NCT00507507|444192|P1|Treatment Period|Withdrawal by Subject|46
132653|NCT00507507|444191|P2|Treatment Period|Adverse Event|1
132654|NCT00507507|444192|P1|Treatment Period|Adverse Event|1
132655|NCT00507507|444191|P2|Treatment Period|Protocol Violation|2
132656|NCT00507507|444192|P1|Treatment Period|Protocol Violation|1
132657|NCT00507507|444191|P2|Treatment Period|Physician Decision|1
132658|NCT00507507|444192|P1|Treatment Period|Physician Decision|4
132659|NCT00507507|444191|P2|Treatment Period|Lost to Follow-up|2
132660|NCT00507507|444192|P1|Treatment Period|Lost to Follow-up|0
132661|NCT00507455|444227|P3|Overall Study|Other - miscellaneous reason|1
132662|NCT00507455|444228|P2|Overall Study|Other - miscellaneous reason|0
132663|NCT00507455|444229|P1|Overall Study|Other - miscellaneous reason|1
132664|NCT00507455|444227|P3|Overall Study|Lack of Efficacy|0
132665|NCT00507455|444228|P2|Overall Study|Lack of Efficacy|1
132666|NCT00507455|444229|P1|Overall Study|Lack of Efficacy|0
132667|NCT00507455|444227|P3|Overall Study|Lost to Follow-up|2
132668|NCT00507455|444228|P2|Overall Study|Lost to Follow-up|0
132669|NCT00507455|444229|P1|Overall Study|Lost to Follow-up|2
132670|NCT00507455|444227|P3|Overall Study|Protocol Violation|1
132671|NCT00507455|444228|P2|Overall Study|Protocol Violation|1
132672|NCT00507455|444229|P1|Overall Study|Protocol Violation|4
132673|NCT00507455|444227|P3|Overall Study|Withdrawal by Subject|2
132674|NCT00507455|444228|P2|Overall Study|Withdrawal by Subject|1
132675|NCT00507455|444229|P1|Overall Study|Withdrawal by Subject|2
132676|NCT00507455|444227|P3|Overall Study|Adverse Event|6
132677|NCT00507455|444228|P2|Overall Study|Adverse Event|3
132678|NCT00507455|444229|P1|Overall Study|Adverse Event|3
132679|NCT00507442|444292|P4|Overall Study|Not Specified|2
132680|NCT00507442|444293|P3|Overall Study|Not Specified|2
132681|NCT00507442|444294|P2|Overall Study|Not Specified|5
132682|NCT00507442|444295|P1|Overall Study|Not Specified|2
132683|NCT00507442|444292|P4|Overall Study|Withdrawal by Subject|1
132684|NCT00507442|444293|P3|Overall Study|Withdrawal by Subject|2
132685|NCT00507442|444294|P2|Overall Study|Withdrawal by Subject|4
132686|NCT00507442|444295|P1|Overall Study|Withdrawal by Subject|4
132687|NCT00507442|444292|P4|Overall Study|Progressive Disease|0
132688|NCT00507442|444293|P3|Overall Study|Progressive Disease|2
132689|NCT00507442|444294|P2|Overall Study|Progressive Disease|4
132690|NCT00507442|444295|P1|Overall Study|Progressive Disease|2
132691|NCT00507442|444292|P4|Overall Study|Physician Decision|1
132692|NCT00507442|444293|P3|Overall Study|Physician Decision|4
132693|NCT00507442|444294|P2|Overall Study|Physician Decision|2
132694|NCT00507442|444295|P1|Overall Study|Physician Decision|0
132695|NCT00507442|444292|P4|Overall Study|Lost to Follow-up|0
132696|NCT00507442|444293|P3|Overall Study|Lost to Follow-up|1
132697|NCT00507442|444294|P2|Overall Study|Lost to Follow-up|0
132698|NCT00507442|444295|P1|Overall Study|Lost to Follow-up|0
132699|NCT00507442|444292|P4|Overall Study|Protocol Violation|0
132700|NCT00507442|444293|P3|Overall Study|Protocol Violation|0
132701|NCT00507442|444294|P2|Overall Study|Protocol Violation|1
132702|NCT00507442|444295|P1|Overall Study|Protocol Violation|0
132703|NCT00507442|444292|P4|Overall Study|Adverse Event|1
132704|NCT00507442|444293|P3|Overall Study|Adverse Event|4
132705|NCT00507442|444294|P2|Overall Study|Adverse Event|11
132706|NCT00507442|444295|P1|Overall Study|Adverse Event|8
132707|NCT00507429|444347|P2|Maintenance Phase|Progressive Disease|0
132708|NCT00507429|444348|P1|Maintenance Phase|Progressive Disease|14
132709|NCT00507429|444347|P2|Treatment Phase|Other|3
132710|NCT00507429|444348|P1|Treatment Phase|Other|6
132711|NCT00507429|444347|P2|Treatment Phase|Physician Decision|2
132712|NCT00507429|444348|P1|Treatment Phase|Physician Decision|4
132713|NCT00507429|444347|P2|Treatment Phase|Withdrawal by Subject|3
132714|NCT00507429|444348|P1|Treatment Phase|Withdrawal by Subject|3
132715|NCT00507429|444347|P2|Treatment Phase|Adverse Event|5
132716|NCT00507429|444348|P1|Treatment Phase|Adverse Event|12
132717|NCT00507429|444347|P2|Treatment Phase|Disease Progression|5
132718|NCT00507429|444348|P1|Treatment Phase|Disease Progression|12
132719|NCT00507416|444359|P3|Overall Study|Did not Receive Study Treatment|4
132720|NCT00507416|444360|P2|Overall Study|Did not Receive Study Treatment|9
132721|NCT00507416|444361|P1|Overall Study|Did not Receive Study Treatment|3
132722|NCT00507416|444359|P3|Overall Study|Other|13
132723|NCT00507416|444360|P2|Overall Study|Other|16
132724|NCT00507416|444361|P1|Overall Study|Other|11
132725|NCT00507416|444359|P3|Overall Study|Patient declined further treatment|11
132726|NCT00507416|444360|P2|Overall Study|Patient declined further treatment|14
132727|NCT00507416|444361|P1|Overall Study|Patient declined further treatment|18
132728|NCT00507416|444359|P3|Overall Study|Progressive Disease|13
132729|NCT00507416|444360|P2|Overall Study|Progressive Disease|10
132730|NCT00507416|444361|P1|Overall Study|Progressive Disease|20
132731|NCT00507416|444359|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
132732|NCT00507416|444360|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
132733|NCT00507416|444361|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
132734|NCT00507416|444359|P3|Overall Study|Protocol Violation|0
132735|NCT00507416|444360|P2|Overall Study|Protocol Violation|2
132736|NCT00507416|444361|P1|Overall Study|Protocol Violation|1
132737|NCT00507416|444359|P3|Overall Study|Adverse Event|65
132738|NCT00507416|444360|P2|Overall Study|Adverse Event|67
132739|NCT00507416|444361|P1|Overall Study|Adverse Event|58
132740|NCT00503997|444399|P1|Overall Study|Withdrawal by Subject|1
132741|NCT00503997|444399|P1|Overall Study|Death|1
132742|NCT00503997|444399|P1|Overall Study|Adverse Event|5
132743|NCT00503997|444399|P1|Overall Study|disease progression|1
132744|NCT00503984|444405|P6|Overall Study|Death|0
132745|NCT00503984|444406|P5|Overall Study|Death|1
132746|NCT00503984|444407|P4|Overall Study|Death|0
132747|NCT00503984|444408|P3|Overall Study|Death|0
132748|NCT00503984|444409|P2|Overall Study|Death|0
132749|NCT00503984|444410|P1|Overall Study|Death|0
132750|NCT00503984|444405|P6|Overall Study|Adverse Event|0
132751|NCT00503984|444406|P5|Overall Study|Adverse Event|0
132752|NCT00503984|444407|P4|Overall Study|Adverse Event|0
132753|NCT00503984|444408|P3|Overall Study|Adverse Event|0
132754|NCT00503984|444409|P2|Overall Study|Adverse Event|1
132755|NCT00503984|444410|P1|Overall Study|Adverse Event|0
132756|NCT00503984|444405|P6|Overall Study|Protocol Violation|0
132757|NCT00503984|444406|P5|Overall Study|Protocol Violation|0
132758|NCT00503984|444407|P4|Overall Study|Protocol Violation|0
132759|NCT00503984|444408|P3|Overall Study|Protocol Violation|0
132760|NCT00503984|444409|P2|Overall Study|Protocol Violation|1
132761|NCT00503984|444410|P1|Overall Study|Protocol Violation|0
132762|NCT00503906|444436|P1|Overall Study|Withdrawal by Subject|1
132763|NCT00507130|444448|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
132764|NCT00507130|444449|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
132765|NCT00507130|444450|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
132766|NCT00507130|444451|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
132767|NCT00507130|444448|P4|Overall Study|Lost to Follow-up|1
132768|NCT00507130|444449|P3|Overall Study|Lost to Follow-up|1
132769|NCT00507130|444450|P2|Overall Study|Lost to Follow-up|0
132770|NCT00507130|444451|P1|Overall Study|Lost to Follow-up|0
132771|NCT00506948|444493|P1|Overall Study|Physician Decision|1
132772|NCT00506948|444493|P1|Overall Study|Adverse Event|5
132773|NCT00506948|444493|P1|Overall Study|Death|4
132774|NCT00506922|444502|P5|Overall Study|Withdrawal by Subject|1
132775|NCT00506922|444503|P4|Overall Study|Withdrawal by Subject|0
132776|NCT00506922|444504|P3|Overall Study|Withdrawal by Subject|0
132777|NCT00506922|444505|P2|Overall Study|Withdrawal by Subject|0
132778|NCT00506922|444506|P1|Overall Study|Withdrawal by Subject|0
132779|NCT00506922|444502|P5|Overall Study|Physician Decision|0
132780|NCT00506922|444503|P4|Overall Study|Physician Decision|2
132781|NCT00506922|444504|P3|Overall Study|Physician Decision|0
132782|NCT00506922|444505|P2|Overall Study|Physician Decision|0
132783|NCT00506922|444506|P1|Overall Study|Physician Decision|0
132784|NCT00506883|444517|P3|Overall Study|Other|1
132785|NCT00506883|444518|P2|Overall Study|Other|1
132786|NCT00506883|444519|P1|Overall Study|Other|5
132787|NCT00506883|444517|P3|Overall Study|Lack of Efficacy|1
132788|NCT00506883|444518|P2|Overall Study|Lack of Efficacy|1
132789|NCT00506883|444519|P1|Overall Study|Lack of Efficacy|0
132790|NCT00506883|444517|P3|Overall Study|Withdrawal by Subject|1
132791|NCT00506883|444518|P2|Overall Study|Withdrawal by Subject|0
132792|NCT00506883|444519|P1|Overall Study|Withdrawal by Subject|1
132793|NCT00506883|444517|P3|Overall Study|Lost to Follow-up|1
132794|NCT00506883|444518|P2|Overall Study|Lost to Follow-up|1
132795|NCT00506883|444519|P1|Overall Study|Lost to Follow-up|1
132796|NCT00506831|444532|P1|Overall Study|Withdrawal by Subject|1
132797|NCT00506831|444532|P1|Overall Study|Death|1
132798|NCT00506662|444564|P2|Overall Study|Not recorded|6
132799|NCT00506662|444565|P1|Overall Study|Not recorded|4
132800|NCT00506662|444564|P2|Overall Study|Trial terminated|16
132801|NCT00506662|444565|P1|Overall Study|Trial terminated|10
132802|NCT00506662|444564|P2|Overall Study|Protocol Violation|4
132803|NCT00506662|444565|P1|Overall Study|Protocol Violation|2
132804|NCT00506662|444564|P2|Overall Study|Lack of Efficacy|0
132805|NCT00506662|444565|P1|Overall Study|Lack of Efficacy|1
132806|NCT00506662|444564|P2|Overall Study|Adverse Event|2
132807|NCT00506662|444565|P1|Overall Study|Adverse Event|0
132808|NCT00506493|444599|P1|Overall Study|Withdrawal by Subject|5
132809|NCT00506493|444599|P1|Overall Study|Death|6
132810|NCT00506454|444608|P2|Overall Study|Withdrawal by Subject|1
132811|NCT00506454|444609|P1|Overall Study|Withdrawal by Subject|1
132812|NCT00506441|444615|P2|Period 2; Double-blind Period|Other Reason|1
132813|NCT00506441|444616|P1|Period 2; Double-blind Period|Other Reason|1
132814|NCT00506441|444615|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
132815|NCT00506441|444616|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
132816|NCT00506441|444615|P2|Period 2; Double-blind Period|Physician Decision|1
132817|NCT00506441|444616|P1|Period 2; Double-blind Period|Physician Decision|1
132818|NCT00506441|444615|P2|Period 2; Double-blind Period|Lack of Efficacy|2
132819|NCT00506441|444616|P1|Period 2; Double-blind Period|Lack of Efficacy|0
132820|NCT00506441|444615|P2|Period 2; Double-blind Period|Adverse Event|1
132821|NCT00506441|444616|P1|Period 2; Double-blind Period|Adverse Event|0
132822|NCT00506441|444615|P2|Period 1; Open-label Period|Other Reasons|0
132823|NCT00506441|444616|P1|Period 1; Open-label Period|Other Reasons|13
132824|NCT00506441|444615|P2|Period 1; Open-label Period|Withdrawal by Subject|0
132825|NCT00506441|444616|P1|Period 1; Open-label Period|Withdrawal by Subject|13
132826|NCT00506441|444615|P2|Period 1; Open-label Period|Protocol Violation|0
132827|NCT00506441|444616|P1|Period 1; Open-label Period|Protocol Violation|9
132828|NCT00506441|444615|P2|Period 1; Open-label Period|Physician Decision|0
132829|NCT00506441|444616|P1|Period 1; Open-label Period|Physician Decision|5
132830|NCT00506441|444615|P2|Period 1; Open-label Period|Lost to Follow-up|0
132831|NCT00506441|444616|P1|Period 1; Open-label Period|Lost to Follow-up|2
132832|NCT00506441|444615|P2|Period 1; Open-label Period|Lack of Efficacy|0
132833|NCT00506441|444616|P1|Period 1; Open-label Period|Lack of Efficacy|13
132834|NCT00506441|444615|P2|Period 1; Open-label Period|Adverse Event|0
132835|NCT00506441|444616|P1|Period 1; Open-label Period|Adverse Event|21
132836|NCT00506415|444624|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
132837|NCT00506415|444625|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
132838|NCT00506415|444626|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
132839|NCT00506415|444627|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
132840|NCT00506415|444624|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
132841|NCT00506415|444625|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
132842|NCT00506415|444626|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
132843|NCT00506415|444627|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
132844|NCT00506415|444624|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
132845|NCT00506415|444625|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
132846|NCT00506415|444626|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
132847|NCT00506415|444627|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
132848|NCT00506415|444624|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
132849|NCT00506415|444625|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
132850|NCT00506415|444626|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
132851|NCT00506415|444627|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
132852|NCT00506415|444624|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
132853|NCT00506415|444625|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
132854|NCT00506415|444626|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
132855|NCT00506415|444627|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
132856|NCT00506415|444624|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
132857|NCT00506415|444625|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
132858|NCT00506415|444626|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
132859|NCT00506415|444627|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
132860|NCT00506415|444624|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
132861|NCT00506415|444625|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
132862|NCT00506415|444626|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
132863|NCT00506415|444627|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
132864|NCT00506415|444624|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
132865|NCT00506415|444625|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
132866|NCT00506415|444626|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
132867|NCT00506415|444627|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
132868|NCT00506415|444624|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
132869|NCT00506415|444625|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
132870|NCT00506415|444626|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
132871|NCT00506415|444627|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
132872|NCT00506415|444624|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
132873|NCT00506415|444625|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
132874|NCT00506415|444626|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
132875|NCT00506415|444627|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
132876|NCT00506415|444624|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
132877|NCT00506415|444625|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
132878|NCT00506415|444626|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
132879|NCT00506415|444627|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
132880|NCT00506415|444624|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
132881|NCT00506415|444625|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
132882|NCT00506415|444626|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
132883|NCT00506415|444627|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
132884|NCT00506415|444624|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
132885|NCT00506415|444625|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
132886|NCT00506415|444626|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
132887|NCT00506415|444627|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
132888|NCT00506415|444624|P4|Double Blind (Maximum 48 Weeks )|Death|0
132889|NCT00506415|444625|P3|Double Blind (Maximum 48 Weeks )|Death|3
132890|NCT00506415|444626|P2|Double Blind (Maximum 48 Weeks )|Death|5
132891|NCT00506415|444627|P1|Double Blind (Maximum 48 Weeks )|Death|0
132892|NCT00506415|444624|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
132893|NCT00506415|444625|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
132894|NCT00506415|444626|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
132895|NCT00506415|444627|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
132896|NCT00506415|444624|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
132897|NCT00506415|444625|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
132898|NCT00506415|444626|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
132899|NCT00506415|444627|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
132900|NCT00506415|444624|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
132901|NCT00506415|444625|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
132902|NCT00506415|444626|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
132903|NCT00506415|444627|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
132904|NCT00506415|444624|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
132905|NCT00506415|444625|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
132906|NCT00506415|444626|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
132907|NCT00506415|444627|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
132908|NCT00506415|444624|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
132909|NCT00506415|444625|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
132910|NCT00506415|444626|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
132911|NCT00506415|444627|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
132912|NCT00506415|444624|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
132913|NCT00506415|444625|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
132914|NCT00506415|444626|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
132915|NCT00506415|444627|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
132916|NCT00506415|444624|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
132917|NCT00506415|444625|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
132918|NCT00506415|444626|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
132919|NCT00506415|444627|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
132920|NCT00506415|444624|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
132921|NCT00506415|444625|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
132922|NCT00506415|444626|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
132923|NCT00506415|444627|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
132924|NCT00506415|444624|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
132925|NCT00506415|444625|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
132926|NCT00506415|444626|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
132927|NCT00506415|444627|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
132928|NCT00506415|444624|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
132929|NCT00506415|444625|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
132930|NCT00506415|444626|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
132931|NCT00506415|444627|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
132932|NCT00506389|444652|P3|In-treatment Period|Randomized but not treated|1
132933|NCT00506389|444653|P2|In-treatment Period|Randomized but not treated|1
132934|NCT00506389|444654|P1|In-treatment Period|Randomized but not treated|4
132935|NCT00506389|444652|P3|In-treatment Period|Adverse Event|2
132936|NCT00506389|444653|P2|In-treatment Period|Adverse Event|5
132937|NCT00506389|444654|P1|In-treatment Period|Adverse Event|11
132938|NCT00506389|444652|P3|In-treatment Period|Lack of Efficacy|0
132939|NCT00506389|444653|P2|In-treatment Period|Lack of Efficacy|2
132940|NCT00506389|444654|P1|In-treatment Period|Lack of Efficacy|0
132941|NCT00506389|444652|P3|In-treatment Period|Withdrawal by Subject|4
132942|NCT00506389|444653|P2|In-treatment Period|Withdrawal by Subject|3
132943|NCT00506389|444654|P1|In-treatment Period|Withdrawal by Subject|3
132944|NCT00506389|444652|P3|In-treatment Period|Reasons not related to trial|0
132945|NCT00506389|444653|P2|In-treatment Period|Reasons not related to trial|1
132946|NCT00506389|444654|P1|In-treatment Period|Reasons not related to trial|4
132947|NCT00506389|444652|P3|In-treatment Period|Lack of compliance|0
132948|NCT00506389|444653|P2|In-treatment Period|Lack of compliance|0
132949|NCT00506389|444654|P1|In-treatment Period|Lack of compliance|1
132950|NCT00506389|444652|P3|In-treatment Period|Lost to Follow-up|1
132951|NCT00506389|444653|P2|In-treatment Period|Lost to Follow-up|0
132952|NCT00506389|444654|P1|In-treatment Period|Lost to Follow-up|0
132953|NCT00506389|444652|P3|In-treatment Period|Not specified|4
132954|NCT00506389|444653|P2|In-treatment Period|Not specified|3
132955|NCT00506389|444654|P1|In-treatment Period|Not specified|3
132956|NCT00506285|444673|P2|6-month Open Label Phase|Withdrawal by Subject|5
132957|NCT00506285|444674|P1|6-month Open Label Phase|Withdrawal by Subject|9
132958|NCT00506285|444673|P2|6-month Open Label Phase|Lost to Follow-up|7
132959|NCT00506285|444674|P1|6-month Open Label Phase|Lost to Follow-up|1
132960|NCT00506285|444673|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
132961|NCT00506285|444674|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
132962|NCT00506285|444673|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
132963|NCT00506285|444674|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
132964|NCT00506285|444673|P2|3 Week Screening Phase|Withdrawal by Subject|10
132965|NCT00506285|444674|P1|3 Week Screening Phase|Withdrawal by Subject|17
132966|NCT00506077|444689|P2|Treatment Period 2|Withdrawal by Subject|0
132967|NCT00506077|444690|P1|Treatment Period 2|Withdrawal by Subject|1
132968|NCT00506077|444689|P2|Treatment Period 2|Adverse Event|1
132969|NCT00506077|444690|P1|Treatment Period 2|Adverse Event|0
132970|NCT00506077|444689|P2|Treatment Period 1|Withdrawal by Subject|0
132971|NCT00506077|444690|P1|Treatment Period 1|Withdrawal by Subject|2
132972|NCT00506077|444689|P2|Treatment Period 1|Lost to Follow-up|2
132973|NCT00506077|444690|P1|Treatment Period 1|Lost to Follow-up|0
132974|NCT00506077|444689|P2|Treatment Period 1|Adverse Event|1
132975|NCT00506077|444690|P1|Treatment Period 1|Adverse Event|2
132976|NCT00505934|444732|P1|Overall Study|Other: IV dose needed to be changed|1
132977|NCT00505934|444732|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
132978|NCT00505934|444732|P1|Overall Study|Adverse Event|1
132979|NCT00505921|444738|P1|Overall Study|Failed to Mobilize|8
132980|NCT00505921|444738|P1|Overall Study|Ineligible|1
132981|NCT00505778|444755|P2|Overall Study|Took No Study Drug|2
132982|NCT00505778|444756|P1|Overall Study|Took No Study Drug|2
132983|NCT00505778|444755|P2|Overall Study|Relapse|65
132984|NCT00505778|444756|P1|Overall Study|Relapse|65
132985|NCT00505778|444755|P2|Overall Study|Withdrawal by Subject|14
132986|NCT00505778|444756|P1|Overall Study|Withdrawal by Subject|29
132987|NCT00505778|444755|P2|Overall Study|Protocol Violation|9
132988|NCT00505778|444756|P1|Overall Study|Protocol Violation|7
132989|NCT00505778|444755|P2|Overall Study|Unable to Meet Protocol Criteria|1
132990|NCT00505778|444756|P1|Overall Study|Unable to Meet Protocol Criteria|4
132991|NCT00505778|444755|P2|Overall Study|Lost to Follow-up|23
132992|NCT00505778|444756|P1|Overall Study|Lost to Follow-up|17
132993|NCT00505778|444755|P2|Overall Study|Physician Decision|14
132994|NCT00505778|444756|P1|Overall Study|Physician Decision|8
132995|NCT00505778|444755|P2|Overall Study|Adverse Event|7
132996|NCT00505778|444756|P1|Overall Study|Adverse Event|2
132997|NCT00505765|444775|P3|Overall Study|Noncompliance|3
132998|NCT00505765|444776|P2|Overall Study|Noncompliance|1
132999|NCT00505765|444777|P1|Overall Study|Noncompliance|0
133000|NCT00505765|444775|P3|Overall Study|Adverse Event|0
133001|NCT00505765|444776|P2|Overall Study|Adverse Event|2
133002|NCT00505765|444777|P1|Overall Study|Adverse Event|1
133003|NCT00505765|444775|P3|Overall Study|Withdrawal by Subject|0
133004|NCT00505765|444776|P2|Overall Study|Withdrawal by Subject|0
133005|NCT00505765|444777|P1|Overall Study|Withdrawal by Subject|1
133006|NCT00505752|444804|P4|Overall Study|Unspecified|2
133007|NCT00505752|444805|P3|Overall Study|Unspecified|1
133008|NCT00505752|444806|P2|Overall Study|Unspecified|2
133009|NCT00505752|444807|P1|Overall Study|Unspecified|1
133010|NCT00505752|444804|P4|Overall Study|All embryos/blastocysts discarded|1
133011|NCT00505752|444805|P3|Overall Study|All embryos/blastocysts discarded|1
133012|NCT00505752|444806|P2|Overall Study|All embryos/blastocysts discarded|0
133013|NCT00505752|444807|P1|Overall Study|All embryos/blastocysts discarded|0
133014|NCT00505752|444804|P4|Overall Study|No Fertilization|1
133015|NCT00505752|444805|P3|Overall Study|No Fertilization|2
133016|NCT00505752|444806|P2|Overall Study|No Fertilization|1
133017|NCT00505752|444807|P1|Overall Study|No Fertilization|1
133018|NCT00505752|444804|P4|Overall Study|No oocytes retrieved|1
133019|NCT00505752|444805|P3|Overall Study|No oocytes retrieved|0
133020|NCT00505752|444806|P2|Overall Study|No oocytes retrieved|2
133021|NCT00505752|444807|P1|Overall Study|No oocytes retrieved|0
133022|NCT00505752|444804|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
133023|NCT00505752|444805|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
133024|NCT00505752|444806|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
133025|NCT00505752|444807|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
133026|NCT00505752|444804|P4|Overall Study|Lack of ovarian response|0
133027|NCT00505752|444805|P3|Overall Study|Lack of ovarian response|0
133028|NCT00505752|444806|P2|Overall Study|Lack of ovarian response|3
133029|NCT00505752|444807|P1|Overall Study|Lack of ovarian response|1
133030|NCT00505752|444804|P4|Overall Study|Lost to Follow-up|0
133031|NCT00505752|444805|P3|Overall Study|Lost to Follow-up|0
133032|NCT00505752|444806|P2|Overall Study|Lost to Follow-up|0
133033|NCT00505752|444807|P1|Overall Study|Lost to Follow-up|1
133034|NCT00505752|444804|P4|Overall Study|Adverse Event|0
133035|NCT00505752|444805|P3|Overall Study|Adverse Event|1
133036|NCT00505752|444806|P2|Overall Study|Adverse Event|0
133037|NCT00505752|444807|P1|Overall Study|Adverse Event|1
133038|NCT00505687|444821|P1|Overall Study|Other: As Per Sponsor|8
133039|NCT00505687|444821|P1|Overall Study|Other: Disease Progression|1
133040|NCT00505687|444821|P1|Overall Study|Other: Neupro Given In Hospital|1
133041|NCT00505687|444821|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
133042|NCT00505687|444821|P1|Overall Study|Other: Prolonged Hospitalization|1
133043|NCT00505687|444821|P1|Overall Study|Other: Scheduled DBS Surgery|1
133044|NCT00505687|444821|P1|Overall Study|Other: Underwent Implantation Of DBS|1
133045|NCT00505687|444821|P1|Overall Study|Lost to Follow-up|1
133046|NCT00505687|444821|P1|Overall Study|Subject withdrew consent|15
133047|NCT00505687|444821|P1|Overall Study|Adverse Event|48
133048|NCT00505687|444821|P1|Overall Study|Lack of Efficacy|15
133049|NCT00505687|444821|P1|Overall Study|Important protocol violation|2
133050|NCT00505661|444827|P1|Overall Study|Not Eligible|4
133051|NCT00505622|444838|P3|Overall Study|Study termination by sponsor|90
133052|NCT00505622|444839|P2|Overall Study|Study termination by sponsor|98
133053|NCT00505622|444840|P1|Overall Study|Study termination by sponsor|115
133054|NCT00505622|444838|P3|Overall Study|Withdrawal by Subject|2
133055|NCT00505622|444839|P2|Overall Study|Withdrawal by Subject|3
133056|NCT00505622|444840|P1|Overall Study|Withdrawal by Subject|0
133057|NCT00505622|444838|P3|Overall Study|Protocol Violation|0
133058|NCT00505622|444839|P2|Overall Study|Protocol Violation|1
133059|NCT00505622|444840|P1|Overall Study|Protocol Violation|1
133060|NCT00505622|444838|P3|Overall Study|Adverse Event|4
133061|NCT00505622|444839|P2|Overall Study|Adverse Event|6
133062|NCT00505622|444840|P1|Overall Study|Adverse Event|5
133063|NCT00505414|444865|P5|Maintenance Phase|underlying disease and therapy required|0
133064|NCT00505414|444866|P4|Maintenance Phase|underlying disease and therapy required|0
133065|NCT00505414|444867|P3|Maintenance Phase|underlying disease and therapy required|2
133066|NCT00505414|444868|P2|Maintenance Phase|underlying disease and therapy required|2
133067|NCT00505414|444869|P1|Maintenance Phase|underlying disease and therapy required|0
133068|NCT00505414|444865|P5|Maintenance Phase|Withdrawal by Subject|0
133069|NCT00505414|444866|P4|Maintenance Phase|Withdrawal by Subject|0
133070|NCT00505414|444867|P3|Maintenance Phase|Withdrawal by Subject|1
133071|NCT00505414|444868|P2|Maintenance Phase|Withdrawal by Subject|0
133072|NCT00505414|444869|P1|Maintenance Phase|Withdrawal by Subject|0
133073|NCT00505414|444865|P5|Maintenance Phase|Lack of Efficacy|0
133074|NCT00505414|444866|P4|Maintenance Phase|Lack of Efficacy|0
133075|NCT00505414|444867|P3|Maintenance Phase|Lack of Efficacy|1
133076|NCT00505414|444868|P2|Maintenance Phase|Lack of Efficacy|1
133077|NCT00505414|444869|P1|Maintenance Phase|Lack of Efficacy|2
133078|NCT00505414|444865|P5|Maintenance Phase|Death|0
133079|NCT00505414|444866|P4|Maintenance Phase|Death|0
133080|NCT00505414|444867|P3|Maintenance Phase|Death|1
133081|NCT00505414|444868|P2|Maintenance Phase|Death|0
133082|NCT00505414|444869|P1|Maintenance Phase|Death|2
133083|NCT00505414|444865|P5|Maintenance Phase|Adverse Event|0
133084|NCT00505414|444866|P4|Maintenance Phase|Adverse Event|0
133085|NCT00505414|444867|P3|Maintenance Phase|Adverse Event|3
133086|NCT00505414|444868|P2|Maintenance Phase|Adverse Event|2
133087|NCT00505414|444869|P1|Maintenance Phase|Adverse Event|2
133088|NCT00505414|444865|P5|Titration Phase|Underlying disease and therapy required|3
133089|NCT00505414|444866|P4|Titration Phase|Underlying disease and therapy required|7
133090|NCT00505414|444867|P3|Titration Phase|Underlying disease and therapy required|0
133091|NCT00505414|444868|P2|Titration Phase|Underlying disease and therapy required|0
133092|NCT00505414|444869|P1|Titration Phase|Underlying disease and therapy required|0
133093|NCT00505414|444865|P5|Titration Phase|Withdrawal by Subject|4
133094|NCT00505414|444866|P4|Titration Phase|Withdrawal by Subject|3
133095|NCT00505414|444867|P3|Titration Phase|Withdrawal by Subject|0
133096|NCT00505414|444868|P2|Titration Phase|Withdrawal by Subject|0
133097|NCT00505414|444869|P1|Titration Phase|Withdrawal by Subject|0
133098|NCT00505414|444865|P5|Titration Phase|Protocol Violation|1
133099|NCT00505414|444866|P4|Titration Phase|Protocol Violation|0
133100|NCT00505414|444867|P3|Titration Phase|Protocol Violation|0
133101|NCT00505414|444868|P2|Titration Phase|Protocol Violation|0
133102|NCT00505414|444869|P1|Titration Phase|Protocol Violation|0
133103|NCT00505414|444865|P5|Titration Phase|Lack of Efficacy|1
133104|NCT00505414|444866|P4|Titration Phase|Lack of Efficacy|10
133105|NCT00505414|444867|P3|Titration Phase|Lack of Efficacy|0
133106|NCT00505414|444868|P2|Titration Phase|Lack of Efficacy|0
133107|NCT00505414|444869|P1|Titration Phase|Lack of Efficacy|0
133108|NCT00505414|444865|P5|Titration Phase|Death|0
133109|NCT00505414|444866|P4|Titration Phase|Death|2
133110|NCT00505414|444867|P3|Titration Phase|Death|0
133111|NCT00505414|444868|P2|Titration Phase|Death|0
133112|NCT00505414|444869|P1|Titration Phase|Death|0
133113|NCT00505414|444865|P5|Titration Phase|Adverse Event|3
133114|NCT00505414|444866|P4|Titration Phase|Adverse Event|8
133115|NCT00505414|444867|P3|Titration Phase|Adverse Event|0
133116|NCT00505414|444868|P2|Titration Phase|Adverse Event|0
133117|NCT00505414|444869|P1|Titration Phase|Adverse Event|0
133118|NCT00505375|444886|P2|Overall Study|Travel issues|1
133119|NCT00505375|444887|P1|Overall Study|Travel issues|0
133120|NCT00505375|444886|P2|Overall Study|Pregnancy|0
133121|NCT00505375|444887|P1|Overall Study|Pregnancy|1
133122|NCT00505375|444886|P2|Overall Study|Lost to Follow-up|2
133123|NCT00505375|444887|P1|Overall Study|Lost to Follow-up|0
133124|NCT00505375|444886|P2|Overall Study|Withdrawal by Subject|2
133125|NCT00505375|444887|P1|Overall Study|Withdrawal by Subject|2
133126|NCT00505375|444886|P2|Overall Study|Death|0
133127|NCT00505375|444887|P1|Overall Study|Death|1
133128|NCT00505284|444898|P5|Overall Study|Not specified|4
133129|NCT00505284|444899|P4|Overall Study|Not specified|4
133130|NCT00505284|444900|P3|Overall Study|Not specified|0
133131|NCT00505284|444901|P2|Overall Study|Not specified|0
133132|NCT00505284|444902|P1|Overall Study|Not specified|5
133133|NCT00505284|444898|P5|Overall Study|Physician Decision|0
133134|NCT00505284|444899|P4|Overall Study|Physician Decision|0
133135|NCT00505284|444900|P3|Overall Study|Physician Decision|0
133136|NCT00505284|444901|P2|Overall Study|Physician Decision|1
133137|NCT00505284|444902|P1|Overall Study|Physician Decision|0
133138|NCT00505284|444898|P5|Overall Study|Lack of Efficacy|1
133139|NCT00505284|444899|P4|Overall Study|Lack of Efficacy|1
133140|NCT00505284|444900|P3|Overall Study|Lack of Efficacy|1
133141|NCT00505284|444901|P2|Overall Study|Lack of Efficacy|1
133142|NCT00505284|444902|P1|Overall Study|Lack of Efficacy|0
133143|NCT00505284|444898|P5|Overall Study|Withdrawal by Subject|6
133144|NCT00505284|444899|P4|Overall Study|Withdrawal by Subject|0
133145|NCT00505284|444900|P3|Overall Study|Withdrawal by Subject|1
133146|NCT00505284|444901|P2|Overall Study|Withdrawal by Subject|6
133147|NCT00505284|444902|P1|Overall Study|Withdrawal by Subject|2
133148|NCT00505284|444898|P5|Overall Study|Protocol Violation|0
133149|NCT00505284|444899|P4|Overall Study|Protocol Violation|0
133150|NCT00505284|444900|P3|Overall Study|Protocol Violation|1
133151|NCT00505284|444901|P2|Overall Study|Protocol Violation|1
133152|NCT00505284|444902|P1|Overall Study|Protocol Violation|0
133153|NCT00505284|444898|P5|Overall Study|Adverse Event|22
133154|NCT00505284|444899|P4|Overall Study|Adverse Event|14
133155|NCT00505284|444900|P3|Overall Study|Adverse Event|9
133156|NCT00505284|444901|P2|Overall Study|Adverse Event|7
133157|NCT00505284|444902|P1|Overall Study|Adverse Event|3
133158|NCT00505076|444972|P3|Overall Study|Withdrawal by Subject|2
133159|NCT00505076|444973|P2|Overall Study|Withdrawal by Subject|1
133160|NCT00505076|444974|P1|Overall Study|Withdrawal by Subject|0
133161|NCT00505076|444972|P3|Overall Study|Protocol Violation|2
133162|NCT00505076|444973|P2|Overall Study|Protocol Violation|1
133163|NCT00505076|444974|P1|Overall Study|Protocol Violation|2
133164|NCT00505076|444972|P3|Overall Study|Adverse Event|1
133165|NCT00505076|444973|P2|Overall Study|Adverse Event|0
133166|NCT00505076|444974|P1|Overall Study|Adverse Event|1
133167|NCT00504777|444992|P1|Overall Study|Adverse Event|1
133168|NCT00504725|445001|P2|Overall Study|Protocol Violation|0
133169|NCT00504725|445002|P1|Overall Study|Protocol Violation|1
133170|NCT00504595|445025|P4|Overall Study|Not specified|0
133171|NCT00504595|445026|P3|Overall Study|Not specified|2
133172|NCT00504595|445027|P2|Overall Study|Not specified|0
133173|NCT00504595|445028|P1|Overall Study|Not specified|0
133174|NCT00504595|445025|P4|Overall Study|Lack of Efficacy|0
133175|NCT00504595|445026|P3|Overall Study|Lack of Efficacy|0
133176|NCT00504595|445027|P2|Overall Study|Lack of Efficacy|0
133177|NCT00504595|445028|P1|Overall Study|Lack of Efficacy|1
133178|NCT00504556|445045|P5|Overall Study|not in safety analysis set|1
133179|NCT00504556|445046|P4|Overall Study|not in safety analysis set|0
133180|NCT00504556|445047|P3|Overall Study|not in safety analysis set|1
133181|NCT00504556|445048|P2|Overall Study|not in safety analysis set|1
133182|NCT00504556|445049|P1|Overall Study|not in safety analysis set|0
133183|NCT00504556|445045|P5|Overall Study|not specified|0
133184|NCT00504556|445046|P4|Overall Study|not specified|3
133185|NCT00504556|445047|P3|Overall Study|not specified|2
133186|NCT00504556|445048|P2|Overall Study|not specified|2
133187|NCT00504556|445049|P1|Overall Study|not specified|2
133188|NCT00504556|445045|P5|Overall Study|data monitor committee decision|0
133189|NCT00504556|445046|P4|Overall Study|data monitor committee decision|100
133190|NCT00504556|445047|P3|Overall Study|data monitor committee decision|0
133191|NCT00504556|445048|P2|Overall Study|data monitor committee decision|0
133192|NCT00504556|445049|P1|Overall Study|data monitor committee decision|0
133193|NCT00504556|445045|P5|Overall Study|did not meet entry criteria|0
133194|NCT00504556|445046|P4|Overall Study|did not meet entry criteria|1
133195|NCT00504556|445047|P3|Overall Study|did not meet entry criteria|1
133196|NCT00504556|445048|P2|Overall Study|did not meet entry criteria|0
133197|NCT00504556|445049|P1|Overall Study|did not meet entry criteria|2
133198|NCT00504556|445045|P5|Overall Study|administrative reasons|2
133199|NCT00504556|445046|P4|Overall Study|administrative reasons|1
133200|NCT00504556|445047|P3|Overall Study|administrative reasons|2
133201|NCT00504556|445048|P2|Overall Study|administrative reasons|2
133202|NCT00504556|445049|P1|Overall Study|administrative reasons|0
133203|NCT00504556|445045|P5|Overall Study|Withdrawal by Subject|12
133204|NCT00504556|445046|P4|Overall Study|Withdrawal by Subject|8
133205|NCT00504556|445047|P3|Overall Study|Withdrawal by Subject|7
133206|NCT00504556|445048|P2|Overall Study|Withdrawal by Subject|16
133207|NCT00504556|445049|P1|Overall Study|Withdrawal by Subject|16
133208|NCT00504556|445045|P5|Overall Study|Lost to Follow-up|1
133209|NCT00504556|445046|P4|Overall Study|Lost to Follow-up|1
133210|NCT00504556|445047|P3|Overall Study|Lost to Follow-up|1
133211|NCT00504556|445048|P2|Overall Study|Lost to Follow-up|0
133212|NCT00504556|445049|P1|Overall Study|Lost to Follow-up|0
133213|NCT00504556|445045|P5|Overall Study|Protocol Violation|2
133214|NCT00504556|445046|P4|Overall Study|Protocol Violation|1
133215|NCT00504556|445047|P3|Overall Study|Protocol Violation|2
133216|NCT00504556|445048|P2|Overall Study|Protocol Violation|3
133217|NCT00504556|445049|P1|Overall Study|Protocol Violation|1
133218|NCT00504556|445045|P5|Overall Study|Death|2
133219|NCT00504556|445046|P4|Overall Study|Death|0
133220|NCT00504556|445047|P3|Overall Study|Death|1
133221|NCT00504556|445048|P2|Overall Study|Death|3
133222|NCT00504556|445049|P1|Overall Study|Death|3
133223|NCT00504556|445045|P5|Overall Study|Adverse Event|5
133224|NCT00504556|445046|P4|Overall Study|Adverse Event|13
133225|NCT00504556|445047|P3|Overall Study|Adverse Event|14
133226|NCT00504556|445048|P2|Overall Study|Adverse Event|11
133227|NCT00504556|445049|P1|Overall Study|Adverse Event|11
133228|NCT00504426|445117|P4|Overall Study|Withdrawal by Subject|0
133229|NCT00504426|445118|P3|Overall Study|Withdrawal by Subject|0
133230|NCT00504426|445119|P2|Overall Study|Withdrawal by Subject|0
133231|NCT00504426|445120|P1|Overall Study|Withdrawal by Subject|2
133232|NCT00504426|445117|P4|Overall Study|Protocol Violation|0
133233|NCT00504426|445118|P3|Overall Study|Protocol Violation|2
133234|NCT00504426|445119|P2|Overall Study|Protocol Violation|1
133235|NCT00504426|445120|P1|Overall Study|Protocol Violation|1
133236|NCT00504426|445117|P4|Overall Study|Adverse Event|0
133237|NCT00504426|445118|P3|Overall Study|Adverse Event|2
133238|NCT00504426|445119|P2|Overall Study|Adverse Event|0
133239|NCT00504426|445120|P1|Overall Study|Adverse Event|0
133240|NCT00504257|445134|P1|Overall Study|ineligible histology|2
133241|NCT00504257|445134|P1|Overall Study|Withdrawal by Subject|2
133242|NCT00504231|445146|P4|Overall Study|Discrepant chart documentation re route|0
133243|NCT00504231|445147|P3|Overall Study|Discrepant chart documentation re route|1
133244|NCT00504231|445148|P2|Overall Study|Discrepant chart documentation re route|0
133245|NCT00504231|445149|P1|Overall Study|Discrepant chart documentation re route|0
133246|NCT00504166|445169|P2|Overall Study|Lost to Follow-up|3
133247|NCT00504166|445170|P1|Overall Study|Lost to Follow-up|1
133248|NCT00504166|445169|P2|Overall Study|Physician Decision|1
133249|NCT00504166|445170|P1|Overall Study|Physician Decision|1
133250|NCT00504166|445169|P2|Overall Study|Withdrawal by Subject|6
133251|NCT00504166|445170|P1|Overall Study|Withdrawal by Subject|3
133252|NCT00504166|445169|P2|Overall Study|Adverse Event|4
133253|NCT00504166|445170|P1|Overall Study|Adverse Event|1
133254|NCT00504153|445176|P1|Overall Study|Death|1
133255|NCT00504153|445176|P1|Overall Study|Adverse Event|4
133256|NCT00504153|445176|P1|Overall Study|Withdrawal by Subject|1
133257|NCT00504075|445184|P1|Overall Study|Required other therapeutic intervention|1
133258|NCT00504075|445184|P1|Overall Study|Withdrawal by Subject|1
133259|NCT00504075|445184|P1|Overall Study|Lost to Follow-up|5
133260|NCT00504075|445184|P1|Overall Study|Adverse Event|1
133261|NCT00503841|445190|P1|Overall Study|All screen failures|44
133262|NCT00503776|445198|P4|Overall Study|Physician Decision|1
133263|NCT00503776|445199|P3|Overall Study|Physician Decision|1
133264|NCT00503776|445200|P2|Overall Study|Physician Decision|0
133265|NCT00503776|445201|P1|Overall Study|Physician Decision|0
133266|NCT00503776|445198|P4|Overall Study|Withdrawal by Subject|1
133267|NCT00503776|445199|P3|Overall Study|Withdrawal by Subject|1
133268|NCT00503776|445200|P2|Overall Study|Withdrawal by Subject|0
133269|NCT00503776|445201|P1|Overall Study|Withdrawal by Subject|1
133270|NCT00503698|445226|P2|Overall Study|Not exposed to trial drug|6
133271|NCT00503698|445227|P1|Overall Study|Not exposed to trial drug|11
133272|NCT00503698|445226|P2|Overall Study|Unclassified|32
133273|NCT00503698|445227|P1|Overall Study|Unclassified|48
133274|NCT00503698|445226|P2|Overall Study|Critically ill|0
133275|NCT00503698|445227|P1|Overall Study|Critically ill|2
133276|NCT00503698|445226|P2|Overall Study|Move to nonparticipating dialysis center|1
133277|NCT00503698|445227|P1|Overall Study|Move to nonparticipating dialysis center|2
133278|NCT00503698|445226|P2|Overall Study|Switch to peritoneal or home dialysis|2
133279|NCT00503698|445227|P1|Overall Study|Switch to peritoneal or home dialysis|2
133280|NCT00503698|445226|P2|Overall Study|Any condition in exclusion criteria|6
133281|NCT00503698|445227|P1|Overall Study|Any condition in exclusion criteria|4
133282|NCT00503698|445226|P2|Overall Study|Pregnancy/intention to become pregnant|0
133283|NCT00503698|445227|P1|Overall Study|Pregnancy/intention to become pregnant|1
133284|NCT00503698|445226|P2|Overall Study|End hemodialysis due to renal transplant|4
133285|NCT00503698|445227|P1|Overall Study|End hemodialysis due to renal transplant|10
133286|NCT00503698|445226|P2|Overall Study|Trial terminated|253
133287|NCT00503698|445227|P1|Overall Study|Trial terminated|216
133288|NCT00503698|445226|P2|Overall Study|Lack of Efficacy|4
133289|NCT00503698|445227|P1|Overall Study|Lack of Efficacy|3
133290|NCT00503698|445226|P2|Overall Study|Death|0
133291|NCT00503698|445227|P1|Overall Study|Death|1
133292|NCT00503698|445226|P2|Overall Study|Adverse Event|41
133293|NCT00503698|445227|P1|Overall Study|Adverse Event|52
133294|NCT00503698|445226|P2|Overall Study|Protocol Violation|6
133295|NCT00503698|445227|P1|Overall Study|Protocol Violation|5
133296|NCT00503425|445241|P1|Overall Study|Missing Data/Unknown|4
133297|NCT00503425|445241|P1|Overall Study|Death|3
133298|NCT00503425|445241|P1|Overall Study|Lost to Follow-up|3
133299|NCT00503425|445241|P1|Overall Study|Withdrawal by Subject|8
133300|NCT00503425|445241|P1|Overall Study|Lack of Efficacy|25
133301|NCT00503425|445241|P1|Overall Study|Adverse Event|5
133302|NCT00503425|445241|P1|Overall Study|Participant files lost|6
133303|NCT00503399|445251|P2|Overall Study|Lost to Follow-up|2
133304|NCT00503399|445252|P1|Overall Study|Lost to Follow-up|0
133305|NCT00503399|445251|P2|Overall Study|Adverse Event|3
133306|NCT00503399|445252|P1|Overall Study|Adverse Event|0
133307|NCT00503399|445251|P2|Overall Study|Withdrawal by Subject|2
133308|NCT00503399|445252|P1|Overall Study|Withdrawal by Subject|4
133309|NCT00503399|445251|P2|Overall Study|Protocol Violation|0
133310|NCT00503399|445252|P1|Overall Study|Protocol Violation|1
133311|NCT00503399|445251|P2|Overall Study|Death|1
133312|NCT00503399|445252|P1|Overall Study|Death|2
133313|NCT00503308|445276|P2|Overall Study|Protocol Violation|1
133314|NCT00503308|445277|P1|Overall Study|Protocol Violation|2
133315|NCT00503009|445320|P3|Overall Study|Physician Decision|1
133316|NCT00503009|445321|P2|Overall Study|Physician Decision|1
133317|NCT00503009|445322|P1|Overall Study|Physician Decision|0
133318|NCT00503009|445320|P3|Overall Study|Withdrawal by Subject|1
133319|NCT00503009|445321|P2|Overall Study|Withdrawal by Subject|1
133320|NCT00503009|445322|P1|Overall Study|Withdrawal by Subject|0
133321|NCT00503009|445320|P3|Overall Study|Protocol Violation|1
133322|NCT00503009|445321|P2|Overall Study|Protocol Violation|0
133323|NCT00503009|445322|P1|Overall Study|Protocol Violation|1
133324|NCT00502996|445339|P1|Overall Study|Adverse Event|2
133325|NCT00502996|445339|P1|Overall Study|Withdrawal Informed Consent|6
133326|NCT00502996|445339|P1|Overall Study|Treatment failure|25
133327|NCT00502996|445339|P1|Overall Study|Protocol Violation|2
133328|NCT00502996|445339|P1|Overall Study|Lost to Follow-up|9
133329|NCT00502840|445407|P1|Overall Study|Not specified|20
133330|NCT00502840|445407|P1|Overall Study|Administrative problems|1
133331|NCT00502840|445407|P1|Overall Study|Lost to Follow-up|6
133332|NCT00502840|445407|P1|Overall Study|Withdrawal by Subject|5
133333|NCT00502840|445407|P1|Overall Study|Protocol Violation|4
133334|NCT00502840|445407|P1|Overall Study|Lack of Efficacy|11
133335|NCT00502840|445407|P1|Overall Study|Additional or changed therapy|48
133336|NCT00502840|445407|P1|Overall Study|Adverse Event|5
133337|NCT00502801|445435|P1|End of Therapy to Test of Cure|OTHER|2
133338|NCT00502801|445435|P1|End of Therapy to Test of Cure|Death|3
133339|NCT00502801|445435|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
133340|NCT00502801|445435|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
133341|NCT00502801|445435|P1|Treatment Period|OTHER|30
133342|NCT00502801|445435|P1|Treatment Period|Death|14
133343|NCT00502801|445435|P1|Treatment Period|Adverse Event|7
133344|NCT00502801|445435|P1|Treatment Period|Withdrawal by Subject|3
133345|NCT00502775|445443|P3|Overall Study|Subject took disallowed drug|1
133346|NCT00502775|445444|P2|Overall Study|Subject took disallowed drug|0
133347|NCT00502775|445445|P1|Overall Study|Subject took disallowed drug|0
133348|NCT00502775|445443|P3|Overall Study|Subject in jail|0
133349|NCT00502775|445444|P2|Overall Study|Subject in jail|1
133350|NCT00502775|445445|P1|Overall Study|Subject in jail|0
133351|NCT00502775|445443|P3|Overall Study|Declining pollen counts|1
133352|NCT00502775|445444|P2|Overall Study|Declining pollen counts|1
133353|NCT00502775|445445|P1|Overall Study|Declining pollen counts|0
133354|NCT00502775|445443|P3|Overall Study|Outside pollen area more than 48 hours|0
133355|NCT00502775|445444|P2|Overall Study|Outside pollen area more than 48 hours|1
133356|NCT00502775|445445|P1|Overall Study|Outside pollen area more than 48 hours|0
133357|NCT00502775|445443|P3|Overall Study|Non-compliance|2
133358|NCT00502775|445444|P2|Overall Study|Non-compliance|2
133359|NCT00502775|445445|P1|Overall Study|Non-compliance|0
133360|NCT00502775|445443|P3|Overall Study|Randomized in error|1
133361|NCT00502775|445444|P2|Overall Study|Randomized in error|1
133362|NCT00502775|445445|P1|Overall Study|Randomized in error|0
133363|NCT00502775|445443|P3|Overall Study|Logpad compliance <80%|0
133364|NCT00502775|445444|P2|Overall Study|Logpad compliance <80%|0
133365|NCT00502775|445445|P1|Overall Study|Logpad compliance <80%|1
133366|NCT00502775|445443|P3|Overall Study|Subject unable to swallow capsule|1
133367|NCT00502775|445444|P2|Overall Study|Subject unable to swallow capsule|0
133368|NCT00502775|445445|P1|Overall Study|Subject unable to swallow capsule|1
133369|NCT00502775|445443|P3|Overall Study|Non-compliance with eDiary|1
133370|NCT00502775|445444|P2|Overall Study|Non-compliance with eDiary|1
133371|NCT00502775|445445|P1|Overall Study|Non-compliance with eDiary|4
133372|NCT00502775|445443|P3|Overall Study|Sponsor Terminated Study|1
133373|NCT00502775|445444|P2|Overall Study|Sponsor Terminated Study|0
133374|NCT00502775|445445|P1|Overall Study|Sponsor Terminated Study|1
133375|NCT00502775|445443|P3|Overall Study|Withdrawal by Subject|2
133376|NCT00502775|445444|P2|Overall Study|Withdrawal by Subject|1
133377|NCT00502775|445445|P1|Overall Study|Withdrawal by Subject|1
133378|NCT00502775|445443|P3|Overall Study|Protocol Violation|2
133379|NCT00502775|445444|P2|Overall Study|Protocol Violation|5
133380|NCT00502775|445445|P1|Overall Study|Protocol Violation|1
133381|NCT00502775|445443|P3|Overall Study|Adverse Event|1
133382|NCT00502775|445444|P2|Overall Study|Adverse Event|2
133383|NCT00502775|445445|P1|Overall Study|Adverse Event|1
133384|NCT00502697|445488|P2|Overall Study|did not meet assignment criteria|2
133385|NCT00502697|445489|P1|Overall Study|did not meet assignment criteria|4
133386|NCT00502697|445488|P2|Overall Study|found not to meet eligibility criteria|4
133387|NCT00502697|445489|P1|Overall Study|found not to meet eligibility criteria|3
133388|NCT00502697|445488|P2|Overall Study|disenrolled due to pregnancy loss|5
133389|NCT00502697|445489|P1|Overall Study|disenrolled due to pregnancy loss|3
133390|NCT00502697|445488|P2|Overall Study|Withdrawal by Subject|1
133391|NCT00502697|445489|P1|Overall Study|Withdrawal by Subject|3
133392|NCT00502671|445497|P1|Overall Study|Adverse Event|19
133393|NCT00502671|445497|P1|Overall Study|Protocol Violation|16
133394|NCT00502671|445497|P1|Overall Study|Lost to Follow-up|7
133395|NCT00502671|445497|P1|Overall Study|Personal Reasons|22
133396|NCT00502671|445497|P1|Overall Study|Disease Progression|13
133397|NCT00502593|445514|P12|Overall Study|Lost to Follow-up|0
133398|NCT00502593|445515|P11|Overall Study|Lost to Follow-up|1
133399|NCT00502593|445516|P10|Overall Study|Lost to Follow-up|0
133400|NCT00502593|445517|P9|Overall Study|Lost to Follow-up|3
133401|NCT00502593|445518|P8|Overall Study|Lost to Follow-up|0
133402|NCT00502593|445519|P7|Overall Study|Lost to Follow-up|0
133403|NCT00502593|445520|P6|Overall Study|Lost to Follow-up|0
133404|NCT00502593|445521|P5|Overall Study|Lost to Follow-up|0
133405|NCT00502593|445522|P4|Overall Study|Lost to Follow-up|1
133406|NCT00502593|445523|P3|Overall Study|Lost to Follow-up|1
133407|NCT00502593|445524|P2|Overall Study|Lost to Follow-up|1
133408|NCT00502593|445525|P1|Overall Study|Lost to Follow-up|2
133409|NCT00502593|445514|P12|Overall Study|Withdrawal by Subject|0
133410|NCT00502593|445515|P11|Overall Study|Withdrawal by Subject|1
133411|NCT00502593|445516|P10|Overall Study|Withdrawal by Subject|0
133412|NCT00502593|445517|P9|Overall Study|Withdrawal by Subject|3
133413|NCT00502593|445518|P8|Overall Study|Withdrawal by Subject|0
133414|NCT00502593|445519|P7|Overall Study|Withdrawal by Subject|3
133415|NCT00502593|445520|P6|Overall Study|Withdrawal by Subject|0
133416|NCT00502593|445521|P5|Overall Study|Withdrawal by Subject|2
133417|NCT00502593|445522|P4|Overall Study|Withdrawal by Subject|2
133418|NCT00502593|445523|P3|Overall Study|Withdrawal by Subject|6
133419|NCT00502593|445524|P2|Overall Study|Withdrawal by Subject|0
133420|NCT00502593|445525|P1|Overall Study|Withdrawal by Subject|0
133421|NCT00502593|445514|P12|Overall Study|Withdrawn unspecified reason|0
133422|NCT00502593|445515|P11|Overall Study|Withdrawn unspecified reason|0
133423|NCT00502593|445516|P10|Overall Study|Withdrawn unspecified reason|0
133424|NCT00502593|445517|P9|Overall Study|Withdrawn unspecified reason|0
133425|NCT00502593|445518|P8|Overall Study|Withdrawn unspecified reason|0
133426|NCT00502593|445519|P7|Overall Study|Withdrawn unspecified reason|2
133427|NCT00502593|445520|P6|Overall Study|Withdrawn unspecified reason|0
133428|NCT00502593|445521|P5|Overall Study|Withdrawn unspecified reason|2
133429|NCT00502593|445522|P4|Overall Study|Withdrawn unspecified reason|1
133430|NCT00502593|445523|P3|Overall Study|Withdrawn unspecified reason|3
133431|NCT00502593|445524|P2|Overall Study|Withdrawn unspecified reason|1
133432|NCT00502593|445525|P1|Overall Study|Withdrawn unspecified reason|1
133433|NCT00502320|446041|P2|Overall Study|Adverse Event|5
133434|NCT00502320|446042|P1|Overall Study|Adverse Event|3
133435|NCT00502320|446041|P2|Overall Study|Screen Failure|1
133436|NCT00502320|446042|P1|Overall Study|Screen Failure|0
133437|NCT00502320|446041|P2|Overall Study|No longer met criteria|0
133438|NCT00502320|446042|P1|Overall Study|No longer met criteria|1
133439|NCT00502320|446041|P2|Overall Study|Withdrew Consent|0
133440|NCT00502320|446042|P1|Overall Study|Withdrew Consent|1
133441|NCT00502320|446041|P2|Overall Study|Lost to Follow-up|1
133442|NCT00502320|446042|P1|Overall Study|Lost to Follow-up|1
133443|NCT00502242|446054|P2|Overall Study|Withdrawal by Subject|7
133444|NCT00502242|446055|P1|Overall Study|Withdrawal by Subject|6
133445|NCT00502242|446054|P2|Overall Study|Protocol Violation|1
133446|NCT00502242|446055|P1|Overall Study|Protocol Violation|3
133447|NCT00502242|446054|P2|Overall Study|Other - Unspecified|14
133448|NCT00502242|446055|P1|Overall Study|Other - Unspecified|8
133449|NCT00502242|446054|P2|Overall Study|Physician Decision|3
133450|NCT00502242|446055|P1|Overall Study|Physician Decision|2
133451|NCT00502242|446054|P2|Overall Study|Adverse Event|20
133452|NCT00502242|446055|P1|Overall Study|Adverse Event|31
133453|NCT00502242|446054|P2|Overall Study|Lack of Efficacy|11
133454|NCT00502242|446055|P1|Overall Study|Lack of Efficacy|1
133455|NCT00502203|446115|P1|Overall Study|Inevaluable|1
133456|NCT00501293|446125|P2|Maintenance Period|Application site reaction|0
133457|NCT00501293|446126|P1|Maintenance Period|Application site reaction|1
133458|NCT00501293|446125|P2|Maintenance Period|Would not wear patch|0
133459|NCT00501293|446126|P1|Maintenance Period|Would not wear patch|1
133460|NCT00501293|446125|P2|Maintenance Period|Went into rehabilitation|0
133461|NCT00501293|446126|P1|Maintenance Period|Went into rehabilitation|1
133462|NCT00501293|446125|P2|Maintenance Period|Noncompliant with study medication|0
133463|NCT00501293|446126|P1|Maintenance Period|Noncompliant with study medication|5
133464|NCT00501293|446125|P2|Maintenance Period|Lack of Efficacy|1
133465|NCT00501293|446126|P1|Maintenance Period|Lack of Efficacy|4
133466|NCT00501293|446125|P2|Maintenance Period|Protocol Violation|1
133467|NCT00501293|446126|P1|Maintenance Period|Protocol Violation|2
133468|NCT00501293|446125|P2|Maintenance Period|Adverse Event|6
133469|NCT00501293|446126|P1|Maintenance Period|Adverse Event|6
133470|NCT00501293|446125|P2|Maintenance Period|Lost to Follow-up|7
133471|NCT00501293|446126|P1|Maintenance Period|Lost to Follow-up|12
133472|NCT00501293|446125|P2|Maintenance Period|Withdrawal by Subject|13
133473|NCT00501293|446126|P1|Maintenance Period|Withdrawal by Subject|14
133474|NCT00501293|446125|P2|Optimization Period|Enrolled in error|0
133475|NCT00501293|446126|P1|Optimization Period|Enrolled in error|1
133476|NCT00501228|446153|P1|Overall Study|Withdrawal by Subject|1
133477|NCT00501969|446161|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
133478|NCT00501969|446161|P1|Overall Study|Other: Admin Request from the Sponsor|3
133479|NCT00501969|446161|P1|Overall Study|Other: As Required by Local EC|2
133480|NCT00501969|446161|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
133481|NCT00501969|446161|P1|Overall Study|Other: Pat Pending Surgery for PD|1
133482|NCT00501969|446161|P1|Overall Study|Other: Patient is Going to Have DBS|1
133483|NCT00501969|446161|P1|Overall Study|Other: Patients + Investigator Agreement|1
133484|NCT00501969|446161|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
133485|NCT00501969|446161|P1|Overall Study|Other: Sponsor Stopped Study|12
133486|NCT00501969|446161|P1|Overall Study|Other: Sponsor Termination at Site|1
133487|NCT00501969|446161|P1|Overall Study|Other: Sponsors Request|10
133488|NCT00501969|446161|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
133489|NCT00501969|446161|P1|Overall Study|Lost to Follow-up|4
133490|NCT00501969|446161|P1|Overall Study|Subject withdrew consent|51
133491|NCT00501969|446161|P1|Overall Study|Unsatisfactory compliance of subject|7
133492|NCT00501969|446161|P1|Overall Study|Adverse Event|76
133493|NCT00501969|446161|P1|Overall Study|Lack of Efficacy|29
133494|NCT00501969|446161|P1|Overall Study|Major Protocol Violation|4
133495|NCT00501852|446193|P1|Overall Study|Withdrawal by Subject|2
133496|NCT00501852|446193|P1|Overall Study|Adverse Event|3
133497|NCT00501644|446213|P1|Overall Study|Withdrawal by Subject|1
133498|NCT00501644|446213|P1|Overall Study|Adverse Event|4
133499|NCT00501085|446242|P1|Overall Study|Other loss to follow-up|32
133500|NCT00501085|446242|P1|Overall Study|Study closed by sponsor|109
133501|NCT00501085|446242|P1|Overall Study|Non-Compliance|24
133502|NCT00501085|446242|P1|Overall Study|Adverse Event|4
133503|NCT00501085|446242|P1|Overall Study|Explantation Surgery|26
133504|NCT00501085|446242|P1|Overall Study|Revision Surgery|7
133505|NCT00501085|446242|P1|Overall Study|Subject Decision|1
133506|NCT00501085|446242|P1|Overall Study|Withdrawal by Subject|34
133507|NCT00501085|446242|P1|Overall Study|Lost to Follow-up|195
133508|NCT00501046|446252|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
133509|NCT00501046|446253|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
133510|NCT00501046|446252|P2|Overall Study|Withdrawal by Subject|83
133511|NCT00501046|446253|P1|Overall Study|Withdrawal by Subject|84
133512|NCT00501046|446252|P2|Overall Study|Protocol Violation|1
133513|NCT00501046|446253|P1|Overall Study|Protocol Violation|2
133514|NCT00501046|446252|P2|Overall Study|Pregnancy|3
133515|NCT00501046|446253|P1|Overall Study|Pregnancy|0
133516|NCT00501046|446252|P2|Overall Study|Physician Decision|2
133517|NCT00501046|446253|P1|Overall Study|Physician Decision|7
133518|NCT00501046|446252|P2|Overall Study|Lost to Follow-up|13
133519|NCT00501046|446253|P1|Overall Study|Lost to Follow-up|14
133520|NCT00501046|446252|P2|Overall Study|Death|30
133521|NCT00501046|446253|P1|Overall Study|Death|23
133522|NCT00501046|446252|P2|Overall Study|Adverse Event|25
133523|NCT00501046|446253|P1|Overall Study|Adverse Event|21
133524|NCT00501007|446259|P2|Overall Study|Inclusion criteria not met.|25
133525|NCT00501007|446260|P1|Overall Study|Inclusion criteria not met.|29
133526|NCT00500760|446268|P2|Overall Study|Other|2
133527|NCT00500760|446269|P1|Overall Study|Other|1
133528|NCT00500760|446268|P2|Overall Study|Lost to Follow-up|0
133529|NCT00500760|446269|P1|Overall Study|Lost to Follow-up|3
133530|NCT00500760|446268|P2|Overall Study|Administrative decision|0
133531|NCT00500760|446269|P1|Overall Study|Administrative decision|2
133532|NCT00500760|446268|P2|Overall Study|Withdrawal by Subject|7
133533|NCT00500760|446269|P1|Overall Study|Withdrawal by Subject|5
133534|NCT00500760|446268|P2|Overall Study|Death|15
133535|NCT00500760|446269|P1|Overall Study|Death|32
133536|NCT00500682|446289|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
133537|NCT00500682|446290|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
133538|NCT00500682|446289|P2|Overall Study|Withdrawal by Subject|74
133539|NCT00500682|446290|P1|Overall Study|Withdrawal by Subject|80
133540|NCT00500682|446289|P2|Overall Study|Protocol Violation|3
133541|NCT00500682|446290|P1|Overall Study|Protocol Violation|1
133542|NCT00500682|446289|P2|Overall Study|Pregnancy|0
133543|NCT00500682|446290|P1|Overall Study|Pregnancy|2
133544|NCT00500682|446289|P2|Overall Study|Physician Decision|10
133545|NCT00500682|446290|P1|Overall Study|Physician Decision|6
133546|NCT00500682|446289|P2|Overall Study|Lost to Follow-up|11
133547|NCT00500682|446290|P1|Overall Study|Lost to Follow-up|11
133548|NCT00500682|446289|P2|Overall Study|Death|16
133549|NCT00500682|446290|P1|Overall Study|Death|25
133550|NCT00500682|446289|P2|Overall Study|Adverse Event|29
133551|NCT00500682|446290|P1|Overall Study|Adverse Event|37
133552|NCT00500539|446324|P1|Follow-up Period (16 Weeks)|Missing|3
133553|NCT00500539|446324|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
133554|NCT00500539|446324|P1|Follow-up Period (16 Weeks)|Death|1
133555|NCT00500539|446324|P1|Follow-up Period (16 Weeks)|Administrative problems|1
133556|NCT00500539|446324|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
133557|NCT00500539|446324|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
133558|NCT00500539|446324|P1|Follow-up Period (16 Weeks)|Adverse Event|1
133559|NCT00500539|446324|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
133560|NCT00500539|446324|P1|Treatment Period (24 Weeks)|Administrative problems|2
133561|NCT00500539|446324|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
133562|NCT00500539|446324|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
133563|NCT00500539|446324|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
133564|NCT00500539|446324|P1|Treatment Period (24 Weeks)|Adverse Event|4
133565|NCT00500370|446350|P2|Overall Study|Subject Decision|17
133566|NCT00500370|446351|P1|Overall Study|Subject Decision|10
133567|NCT00500370|446350|P2|Overall Study|Sponsor Decision|0
133568|NCT00500370|446351|P1|Overall Study|Sponsor Decision|2
133569|NCT00500370|446350|P2|Overall Study|Protocol Violation|4
133570|NCT00500370|446351|P1|Overall Study|Protocol Violation|2
133571|NCT00500370|446350|P2|Overall Study|Lost to Follow-up|10
133572|NCT00500370|446351|P1|Overall Study|Lost to Follow-up|10
133573|NCT00500370|446350|P2|Overall Study|Adverse Event|3
133574|NCT00500370|446351|P1|Overall Study|Adverse Event|9
133575|NCT00500357|446387|P1|Overall Study|Death|1
133576|NCT00500318|446408|P2|Overall Study|Other Reason|1
133577|NCT00500318|446409|P1|Overall Study|Other Reason|0
133578|NCT00500318|446408|P2|Overall Study|Lack of Efficacy|3
133579|NCT00500318|446409|P1|Overall Study|Lack of Efficacy|0
133580|NCT00500318|446408|P2|Overall Study|Withdrawal by Subject|2
133581|NCT00500318|446409|P1|Overall Study|Withdrawal by Subject|1
133582|NCT00500318|446408|P2|Overall Study|Protocol Violation|3
133583|NCT00500318|446409|P1|Overall Study|Protocol Violation|1
133584|NCT00500318|446408|P2|Overall Study|Adverse Event|8
133585|NCT00500318|446409|P1|Overall Study|Adverse Event|3
133586|NCT00500292|446426|P3|Overall Study|Other|4
133587|NCT00500292|446427|P2|Overall Study|Other|1
133588|NCT00500292|446428|P1|Overall Study|Other|1
133589|NCT00500292|446426|P3|Overall Study|Withdrawal by Subject|0
133590|NCT00500292|446427|P2|Overall Study|Withdrawal by Subject|1
133591|NCT00500292|446428|P1|Overall Study|Withdrawal by Subject|0
133592|NCT00500292|446426|P3|Overall Study|Condition under investigation worsened|19
133593|NCT00500292|446427|P2|Overall Study|Condition under investigation worsened|23
133594|NCT00500292|446428|P1|Overall Study|Condition under investigation worsened|21
133595|NCT00500292|446426|P3|Overall Study|Adverse Event|4
133596|NCT00500292|446427|P2|Overall Study|Adverse Event|6
133597|NCT00500292|446428|P1|Overall Study|Adverse Event|3
133598|NCT00500266|446436|P1|Overall Study|Assigned, not treated|4
133599|NCT00500266|446436|P1|Overall Study|Withdrawal by Subject|3
133600|NCT00500266|446436|P1|Overall Study|Lost to Follow-up|3
133601|NCT00500266|446436|P1|Overall Study|Death|3
133602|NCT00500149|446456|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
133603|NCT00500149|446457|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
133604|NCT00500149|446456|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
133605|NCT00500149|446457|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
133606|NCT00500149|446456|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
133607|NCT00500149|446457|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
133608|NCT00500149|446456|P2|First Intervention (Cross-over Phase)|Adverse Event|1
133609|NCT00500149|446457|P1|First Intervention (Cross-over Phase)|Adverse Event|0
133610|NCT00500149|446456|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
133611|NCT00500149|446457|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
133612|NCT00500149|446456|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
133613|NCT00500149|446457|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
133614|NCT00500149|446456|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
133615|NCT00500149|446457|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
133616|NCT00500110|446465|P1|Overall Study|Withdrawal by Subject|3
133617|NCT00500071|446469|P1|30-day Safety Follow-up|Lost to Follow-up|17
133618|NCT00500071|446469|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
133619|NCT00500071|446469|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
133620|NCT00500071|446469|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
133621|NCT00500071|446469|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
133622|NCT00500071|446469|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
133623|NCT00500071|446469|P1|Screening and Washout Phase|Protocol Violation|1
133624|NCT00499889|446487|P1|Overall Study|Infection prior to treatment|1
133625|NCT00499863|446495|P2|Overall Study|Lost to Follow-up|1
133626|NCT00499863|446496|P1|Overall Study|Lost to Follow-up|1
133627|NCT00499863|446495|P2|Overall Study|Sponsor decision|2
133628|NCT00499863|446496|P1|Overall Study|Sponsor decision|2
133629|NCT00499863|446495|P2|Overall Study|Adverse Event|2
133630|NCT00499863|446496|P1|Overall Study|Adverse Event|8
133631|NCT00499863|446495|P2|Overall Study|Withdrawal by Subject|4
133632|NCT00499863|446496|P1|Overall Study|Withdrawal by Subject|6
133633|NCT00499863|446495|P2|Overall Study|Protocol Violation|7
133634|NCT00499863|446496|P1|Overall Study|Protocol Violation|12
133635|NCT00499863|446495|P2|Overall Study|Lack of Efficacy|27
133636|NCT00499863|446496|P1|Overall Study|Lack of Efficacy|21
133637|NCT00499694|446524|P1|Overall Study|Patient never received treatment.|1
133638|NCT00499681|446530|P2|Overall Study|disease progression|1
133639|NCT00499681|446531|P1|Overall Study|disease progression|0
133640|NCT00499681|446530|P2|Overall Study|toxicity|1
133641|NCT00499681|446531|P1|Overall Study|toxicity|0
133642|NCT00499603|446539|P2|Overall Study|Adverse Event|1
133643|NCT00499603|446540|P1|Overall Study|Adverse Event|0
133644|NCT00499590|446553|P3|Overall Study|Not treated|1
133645|NCT00499590|446554|P2|Overall Study|Not treated|0
133646|NCT00499590|446555|P1|Overall Study|Not treated|1
133647|NCT00499590|446553|P3|Overall Study|Study Terminated|112
133648|NCT00499590|446554|P2|Overall Study|Study Terminated|112
133649|NCT00499590|446555|P1|Overall Study|Study Terminated|112
133650|NCT00499486|446566|P1|Overall Study|Withdrawal by Subject|16
133651|NCT00499369|446604|P5|Overall Study|Ineligible|0
133652|NCT00499369|446605|P4|Overall Study|Ineligible|1
133653|NCT00499369|446606|P3|Overall Study|Ineligible|1
133654|NCT00499369|446607|P2|Overall Study|Ineligible|2
133655|NCT00499369|446608|P1|Overall Study|Ineligible|2
133656|NCT00499369|446604|P5|Overall Study|Not protocol specified|0
133657|NCT00499369|446605|P4|Overall Study|Not protocol specified|1
133658|NCT00499369|446606|P3|Overall Study|Not protocol specified|3
133659|NCT00499369|446607|P2|Overall Study|Not protocol specified|0
133660|NCT00499369|446608|P1|Overall Study|Not protocol specified|2
133661|NCT00499369|446604|P5|Overall Study|Death|0
133662|NCT00499369|446605|P4|Overall Study|Death|0
133663|NCT00499369|446606|P3|Overall Study|Death|0
133664|NCT00499369|446607|P2|Overall Study|Death|1
133665|NCT00499369|446608|P1|Overall Study|Death|0
133666|NCT00499369|446604|P5|Overall Study|Progression|10
133667|NCT00499369|446605|P4|Overall Study|Progression|6
133668|NCT00499369|446606|P3|Overall Study|Progression|9
133669|NCT00499369|446607|P2|Overall Study|Progression|12
133670|NCT00499369|446608|P1|Overall Study|Progression|10
133671|NCT00499369|446604|P5|Overall Study|Withdrawal by Subject|0
133672|NCT00499369|446605|P4|Overall Study|Withdrawal by Subject|0
133673|NCT00499369|446606|P3|Overall Study|Withdrawal by Subject|1
133674|NCT00499369|446607|P2|Overall Study|Withdrawal by Subject|1
133675|NCT00499369|446608|P1|Overall Study|Withdrawal by Subject|0
133676|NCT00499369|446604|P5|Overall Study|Adverse Event|2
133677|NCT00499369|446605|P4|Overall Study|Adverse Event|1
133678|NCT00499369|446606|P3|Overall Study|Adverse Event|3
133679|NCT00499369|446607|P2|Overall Study|Adverse Event|2
133680|NCT00499369|446608|P1|Overall Study|Adverse Event|2
133681|NCT00499252|446644|P1|Overall Study|<no further label>|3
133682|NCT00499252|446644|P1|Overall Study|Ineligible|4
133683|NCT00499252|446644|P1|Overall Study|Refused further treatment|2
133684|NCT00499252|446644|P1|Overall Study|Adverse Event|3
133685|NCT00499031|446691|P1|Overall Study|Never treated|1
133686|NCT00499031|446691|P1|Overall Study|Required test not done|1
133687|NCT00499031|446691|P1|Overall Study|Improper pre-protocol treatment|1
133688|NCT00498797|446712|P2|Overall Study|Other|1
133689|NCT00498797|446713|P1|Overall Study|Other|3
133690|NCT00498797|446712|P2|Overall Study|Condition under investigation worsened|21
133691|NCT00498797|446713|P1|Overall Study|Condition under investigation worsened|19
133692|NCT00498797|446712|P2|Overall Study|Adverse Event|5
133693|NCT00498797|446713|P1|Overall Study|Adverse Event|12
133694|NCT00498797|446712|P2|Overall Study|Withdrawal by Subject|2
133695|NCT00498797|446713|P1|Overall Study|Withdrawal by Subject|4
133696|NCT00498602|446771|P7|Overall Study|Not specified|0
133697|NCT00498602|446772|P6|Overall Study|Not specified|3
133698|NCT00498602|446773|P5|Overall Study|Not specified|0
133699|NCT00498602|446774|P4|Overall Study|Not specified|0
133700|NCT00498602|446775|P3|Overall Study|Not specified|1
133701|NCT00498602|446776|P2|Overall Study|Not specified|3
133702|NCT00498602|446777|P1|Overall Study|Not specified|2
133703|NCT00498602|446771|P7|Overall Study|Subject Request|1
133704|NCT00498602|446772|P6|Overall Study|Subject Request|4
133705|NCT00498602|446773|P5|Overall Study|Subject Request|1
133706|NCT00498602|446774|P4|Overall Study|Subject Request|1
133707|NCT00498602|446775|P3|Overall Study|Subject Request|1
133708|NCT00498602|446776|P2|Overall Study|Subject Request|0
133709|NCT00498602|446777|P1|Overall Study|Subject Request|3
133710|NCT00498602|446771|P7|Overall Study|Investigator Request|0
133711|NCT00498602|446772|P6|Overall Study|Investigator Request|0
133712|NCT00498602|446773|P5|Overall Study|Investigator Request|0
133713|NCT00498602|446774|P4|Overall Study|Investigator Request|0
133714|NCT00498602|446775|P3|Overall Study|Investigator Request|1
133715|NCT00498602|446776|P2|Overall Study|Investigator Request|0
133716|NCT00498602|446777|P1|Overall Study|Investigator Request|0
133717|NCT00498602|446771|P7|Overall Study|Caregiver Request|0
133718|NCT00498602|446772|P6|Overall Study|Caregiver Request|2
133719|NCT00498602|446773|P5|Overall Study|Caregiver Request|1
133720|NCT00498602|446774|P4|Overall Study|Caregiver Request|0
133721|NCT00498602|446775|P3|Overall Study|Caregiver Request|2
133722|NCT00498602|446776|P2|Overall Study|Caregiver Request|2
133723|NCT00498602|446777|P1|Overall Study|Caregiver Request|2
133724|NCT00498602|446771|P7|Overall Study|AE not related to Study Drug|1
133725|NCT00498602|446772|P6|Overall Study|AE not related to Study Drug|2
133726|NCT00498602|446773|P5|Overall Study|AE not related to Study Drug|2
133727|NCT00498602|446774|P4|Overall Study|AE not related to Study Drug|0
133728|NCT00498602|446775|P3|Overall Study|AE not related to Study Drug|0
133729|NCT00498602|446776|P2|Overall Study|AE not related to Study Drug|3
133730|NCT00498602|446777|P1|Overall Study|AE not related to Study Drug|1
133731|NCT00498602|446771|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
133732|NCT00498602|446772|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
133733|NCT00498602|446773|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
133734|NCT00498602|446774|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
133735|NCT00498602|446775|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
133736|NCT00498602|446776|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
133737|NCT00498602|446777|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
133738|NCT00498602|446771|P7|Overall Study|Lost to Follow-up|0
133739|NCT00498602|446772|P6|Overall Study|Lost to Follow-up|0
133740|NCT00498602|446773|P5|Overall Study|Lost to Follow-up|0
133741|NCT00498602|446774|P4|Overall Study|Lost to Follow-up|2
133742|NCT00498602|446775|P3|Overall Study|Lost to Follow-up|0
133743|NCT00498602|446776|P2|Overall Study|Lost to Follow-up|2
133744|NCT00498602|446777|P1|Overall Study|Lost to Follow-up|0
133745|NCT00498602|446771|P7|Overall Study|Lack of Efficacy|0
133746|NCT00498602|446772|P6|Overall Study|Lack of Efficacy|0
133747|NCT00498602|446773|P5|Overall Study|Lack of Efficacy|0
133748|NCT00498602|446774|P4|Overall Study|Lack of Efficacy|0
133749|NCT00498602|446775|P3|Overall Study|Lack of Efficacy|0
133750|NCT00498602|446776|P2|Overall Study|Lack of Efficacy|0
133751|NCT00498602|446777|P1|Overall Study|Lack of Efficacy|1
133752|NCT00498602|446771|P7|Overall Study|Death|0
133753|NCT00498602|446772|P6|Overall Study|Death|1
133754|NCT00498602|446773|P5|Overall Study|Death|0
133755|NCT00498602|446774|P4|Overall Study|Death|0
133756|NCT00498602|446775|P3|Overall Study|Death|0
133757|NCT00498602|446776|P2|Overall Study|Death|0
133758|NCT00498602|446777|P1|Overall Study|Death|0
133759|NCT00498485|446825|P2|Overall Study|Adverse Event|5
133760|NCT00498485|446826|P1|Overall Study|Adverse Event|1
133761|NCT00498433|446837|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
133762|NCT00498433|446838|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
133763|NCT00498433|446839|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
133764|NCT00498433|446837|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
133765|NCT00498433|446838|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
133766|NCT00498433|446839|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
133767|NCT00498433|446837|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
133768|NCT00498433|446838|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
133769|NCT00498433|446839|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
133770|NCT00498433|446837|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
133771|NCT00498433|446838|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
133772|NCT00498433|446839|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
133773|NCT00498368|446884|P2|Overall Study|Withdrawal by Subject|2
133774|NCT00498368|446885|P1|Overall Study|Withdrawal by Subject|3
133775|NCT00498355|446897|P1|Overall Study|Lost to Follow-up|1
133776|NCT00498186|446901|P1|Overall Study|Other|10
133777|NCT00498186|446901|P1|Overall Study|Lost to Follow-up|3
133778|NCT00498186|446901|P1|Overall Study|Withdrawal by Subject|18
133779|NCT00498186|446901|P1|Overall Study|Unsatisfactory compliance of subject|12
133780|NCT00498186|446901|P1|Overall Study|Adverse Event|89
133781|NCT00498186|446901|P1|Overall Study|Lack of Efficacy|31
133782|NCT00498186|446901|P1|Overall Study|Protocol Violation|10
133783|NCT00497874|446908|P2|Overall Study|Unable to schedule|24
133784|NCT00497874|446909|P1|Overall Study|Unable to schedule|37
133785|NCT00497874|446908|P2|Overall Study|Unable to contact|67
133786|NCT00497874|446909|P1|Overall Study|Unable to contact|52
133787|NCT00497874|446908|P2|Overall Study|Death|4
133788|NCT00497874|446909|P1|Overall Study|Death|2
133789|NCT00497874|446908|P2|Overall Study|Illness|4
133790|NCT00497874|446909|P1|Overall Study|Illness|8
133791|NCT00497874|446908|P2|Overall Study|Withdrawal by Subject|17
133792|NCT00497874|446909|P1|Overall Study|Withdrawal by Subject|48
133793|NCT00497796|446927|P2|Overall Study|Not applicable (randomized not treated)|4
133794|NCT00497796|446928|P1|Overall Study|Not applicable (randomized not treated)|0
133795|NCT00497796|446927|P2|Overall Study|Lost to Follow-up|1
133796|NCT00497796|446928|P1|Overall Study|Lost to Follow-up|0
133797|NCT00497796|446927|P2|Overall Study|Investigator/sponsor discretion|34
133798|NCT00497796|446928|P1|Overall Study|Investigator/sponsor discretion|31
133799|NCT00497796|446927|P2|Overall Study|Consent withdrawn|3
133800|NCT00497796|446928|P1|Overall Study|Consent withdrawn|10
133801|NCT00497796|446927|P2|Overall Study|CMV infection or disease treatment|4
133802|NCT00497796|446928|P1|Overall Study|CMV infection or disease treatment|30
133803|NCT00497796|446927|P2|Overall Study|Adverse event (related)|4
133804|NCT00497796|446928|P1|Overall Study|Adverse event (related)|5
133805|NCT00497796|446927|P2|Overall Study|Adverse event (not related)|9
133806|NCT00497796|446928|P1|Overall Study|Adverse event (not related)|9
133807|NCT00497198|447015|P2|Overall Study|Withdrawal by Subject|1
133808|NCT00497198|447016|P1|Overall Study|Withdrawal by Subject|0
133809|NCT00497198|447015|P2|Overall Study|Physician Decision|2
133810|NCT00497198|447016|P1|Overall Study|Physician Decision|1
133811|NCT00497198|447015|P2|Overall Study|Adverse Event|2
133812|NCT00497198|447016|P1|Overall Study|Adverse Event|4
133813|NCT00497146|447032|P2|Long-term Follow-up Period|Other|1
133814|NCT00497146|447033|P1|Long-term Follow-up Period|Other|0
133815|NCT00497146|447032|P2|Long-term Follow-up Period|Lost to Follow-up|1
133816|NCT00497146|447033|P1|Long-term Follow-up Period|Lost to Follow-up|5
133817|NCT00497146|447032|P2|Long-term Follow-up Period|Withdrawal by Subject|2
133818|NCT00497146|447033|P1|Long-term Follow-up Period|Withdrawal by Subject|8
133819|NCT00497146|447032|P2|Long-term Follow-up Period|Adverse Event|2
133820|NCT00497146|447033|P1|Long-term Follow-up Period|Adverse Event|2
133821|NCT00497146|447032|P2|Treatment Period|Other Reason|3
133822|NCT00497146|447033|P1|Treatment Period|Other Reason|2
133823|NCT00497146|447032|P2|Treatment Period|Unable to dose reduce per protocol|1
133824|NCT00497146|447033|P1|Treatment Period|Unable to dose reduce per protocol|4
133825|NCT00497146|447032|P2|Treatment Period|Change in RAAS inhibitor therapy|2
133826|NCT00497146|447033|P1|Treatment Period|Change in RAAS inhibitor therapy|5
133827|NCT00497146|447032|P2|Treatment Period|Required dialysis|1
133828|NCT00497146|447033|P1|Treatment Period|Required dialysis|4
133829|NCT00497146|447032|P2|Treatment Period|Lost to Follow-up|3
133830|NCT00497146|447033|P1|Treatment Period|Lost to Follow-up|1
133831|NCT00497146|447032|P2|Treatment Period|Withdrawal by Subject|9
133832|NCT00497146|447033|P1|Treatment Period|Withdrawal by Subject|5
133833|NCT00497146|447032|P2|Treatment Period|Adverse Event|2
133834|NCT00497146|447033|P1|Treatment Period|Adverse Event|6
133835|NCT00496964|447101|P2|Overall Study|Withdrawal by Subject|1
133836|NCT00496964|447102|P1|Overall Study|Withdrawal by Subject|0
133837|NCT00496873|447110|P1|Overall Study|Withdrawal by Subject|3
133838|NCT00496873|447110|P1|Overall Study|Death|2
133839|NCT00496873|447110|P1|Overall Study|Ineligible|2
133840|NCT00496834|447143|P2|Overall Study|Blood Pressure control failure|1
133841|NCT00496834|447144|P1|Overall Study|Blood Pressure control failure|2
133842|NCT00496834|447143|P2|Overall Study|Lost to Follow-up|0
133843|NCT00496834|447144|P1|Overall Study|Lost to Follow-up|2
133844|NCT00496834|447143|P2|Overall Study|IP administration violation|0
133845|NCT00496834|447144|P1|Overall Study|IP administration violation|2
133846|NCT00496834|447143|P2|Overall Study|Adverse Event|3
133847|NCT00496834|447144|P1|Overall Study|Adverse Event|5
133848|NCT00496834|447143|P2|Overall Study|Inclusion/exclusion criteria not met|2
133849|NCT00496834|447144|P1|Overall Study|Inclusion/exclusion criteria not met|3
133850|NCT00496834|447143|P2|Overall Study|Contraindicated medication administered|1
133851|NCT00496834|447144|P1|Overall Study|Contraindicated medication administered|0
133852|NCT00496834|447143|P2|Overall Study|Withdrawal by Subject|6
133853|NCT00496834|447144|P1|Overall Study|Withdrawal by Subject|4
133854|NCT00496782|447163|P2|Overall Study|Protocol Violation|2
133855|NCT00496782|447164|P1|Overall Study|Protocol Violation|1
133856|NCT00496769|447198|P2|Overall Study|>=1 reason assigned per patient|649
133857|NCT00496769|447199|P1|Overall Study|>=1 reason assigned per patient|558
133858|NCT00496730|447223|P2|Overall Study|Withdrawal by Subject|2
133859|NCT00496730|447224|P1|Overall Study|Withdrawal by Subject|2
133860|NCT00496730|447223|P2|Overall Study|Lost to Follow-up|3
133861|NCT00496730|447224|P1|Overall Study|Lost to Follow-up|4
133862|NCT00496626|447236|P2|Overall Study|Relocated|1
133863|NCT00496626|447237|P1|Overall Study|Relocated|0
133864|NCT00496626|447236|P2|Overall Study|Withdrawal by Subject|4
133865|NCT00496626|447237|P1|Overall Study|Withdrawal by Subject|5
133866|NCT00496626|447236|P2|Overall Study|Protocol Violation|0
133867|NCT00496626|447237|P1|Overall Study|Protocol Violation|1
133868|NCT00496626|447236|P2|Overall Study|Lost to Follow-up|1
133869|NCT00496626|447237|P1|Overall Study|Lost to Follow-up|0
133870|NCT00496483|447249|P1|Overall Study|Lack of Efficacy|1
133871|NCT00496483|447249|P1|Overall Study|Adverse Event|2
133872|NCT00496483|447249|P1|Overall Study|Not dosed|9
133873|NCT00496470|447266|P2|Overall Study|Other reason|2
133874|NCT00496470|447267|P1|Overall Study|Other reason|0
133875|NCT00496470|447266|P2|Overall Study|Incorrectly enrolled|5
133876|NCT00496470|447267|P1|Overall Study|Incorrectly enrolled|13
133877|NCT00496470|447266|P2|Overall Study|Withdrawal by Subject|12
133878|NCT00496470|447267|P1|Overall Study|Withdrawal by Subject|5
133879|NCT00496470|447266|P2|Overall Study|Adverse Event|10
133880|NCT00496470|447267|P1|Overall Study|Adverse Event|8
133881|NCT00496197|447379|P1|Overall Study|Protocol Violation|8
133882|NCT00496197|447379|P1|Overall Study|Unspecified|14
133883|NCT00496197|447379|P1|Overall Study|Pathogen not isolated baseline specimen|4
133884|NCT00496197|447379|P1|Overall Study|Withdrawal by Subject|11
133885|NCT00496197|447379|P1|Overall Study|Lost to Follow-up|11
133886|NCT00496197|447379|P1|Overall Study|Insufficient bacteriological response|10
133887|NCT00496197|447379|P1|Overall Study|Insufficient clinical response|3
133888|NCT00496197|447379|P1|Overall Study|Does not meet entrance criteria|5
133889|NCT00496197|447379|P1|Overall Study|Adverse Event|13
133890|NCT00496197|447379|P1|Overall Study|Discontinued study due to death|43
133891|NCT00496080|447406|P1|Overall Study|Physician Decision|6
133892|NCT00496080|447406|P1|Overall Study|Withdrawal by Subject|5
133893|NCT00496080|447406|P1|Overall Study|Surgical re-intervention|7
133894|NCT00496080|447406|P1|Overall Study|Lost to Follow-up|9
133895|NCT00496054|447416|P1|Overall Study|Lost to Follow-up|7
133896|NCT00496054|447416|P1|Overall Study|Adverse Event|1
133897|NCT00495820|447445|P2|Overall Study|Adverse Event|1
133898|NCT00495820|447446|P1|Overall Study|Adverse Event|1
133899|NCT00495794|447458|P2|Overall Study|Pharmacist did not activate patient|0
133900|NCT00495794|447459|P1|Overall Study|Pharmacist did not activate patient|522
133901|NCT00495755|447469|P1|Overall Study|Adverse Event|3
133902|NCT00495677|447481|P7|Stage 1 (25 Days)|Adverse Event|0
133903|NCT00495677|447482|P6|Stage 1 (25 Days)|Adverse Event|0
133904|NCT00495677|447483|P5|Stage 1 (25 Days)|Adverse Event|0
133905|NCT00495677|447484|P4|Stage 1 (25 Days)|Adverse Event|0
133906|NCT00495677|447485|P3|Stage 1 (25 Days)|Adverse Event|1
133907|NCT00495677|447486|P2|Stage 1 (25 Days)|Adverse Event|0
133908|NCT00495677|447487|P1|Stage 1 (25 Days)|Adverse Event|0
133909|NCT00495625|447542|P1|Overall Study|Did not complete at least 1 42 day cycle|10
133910|NCT00495612|447553|P2|Overall Study|Subject's Decision to Withdraw|0
133911|NCT00495612|447554|P1|Overall Study|Subject's Decision to Withdraw|3
133912|NCT00495612|447553|P2|Overall Study|Lost to Follow-up|0
133913|NCT00495612|447554|P1|Overall Study|Lost to Follow-up|1
133914|NCT00495586|447572|P2|Overall Study|Withdrawal by Subject|4
133915|NCT00495586|447573|P1|Overall Study|Withdrawal by Subject|4
133916|NCT00495495|447581|P1|Overall Study|Protocol Violation|99
133917|NCT00495391|447596|P2|Overall Study|Withdrawal by Subject|3
133918|NCT00495391|447597|P1|Overall Study|Withdrawal by Subject|2
133919|NCT00495391|447596|P2|Overall Study|Lack of Efficacy|18
133920|NCT00495391|447597|P1|Overall Study|Lack of Efficacy|34
133921|NCT00495131|447635|P2|Overall Study|Withdrawal by Subject|0
133922|NCT00495131|447636|P1|Overall Study|Withdrawal by Subject|1
133923|NCT00495131|447635|P2|Overall Study|Lost to Follow-up|2
133924|NCT00495131|447636|P1|Overall Study|Lost to Follow-up|0
133925|NCT00495131|447635|P2|Overall Study|Lack of Efficacy|2
133926|NCT00495131|447636|P1|Overall Study|Lack of Efficacy|0
133927|NCT00495131|447635|P2|Overall Study|Adverse Event|2
133928|NCT00495131|447636|P1|Overall Study|Adverse Event|6
133929|NCT00494871|447664|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
133930|NCT00494871|447665|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
133931|NCT00494871|447664|P2|Follow-up (FU) Period|Withdrawal by Subject|5
133932|NCT00494871|447665|P1|Follow-up (FU) Period|Withdrawal by Subject|5
133933|NCT00494871|447664|P2|Follow-up (FU) Period|Protocol Violation|0
133934|NCT00494871|447665|P1|Follow-up (FU) Period|Protocol Violation|1
133935|NCT00494871|447664|P2|Follow-up (FU) Period|Physician Decision|1
133936|NCT00494871|447665|P1|Follow-up (FU) Period|Physician Decision|0
133937|NCT00494871|447664|P2|Follow-up (FU) Period|Lost to Follow-up|2
133938|NCT00494871|447665|P1|Follow-up (FU) Period|Lost to Follow-up|6
133939|NCT00494871|447664|P2|Follow-up (FU) Period|Death|12
133940|NCT00494871|447665|P1|Follow-up (FU) Period|Death|13
133941|NCT00494871|447664|P2|Follow-up (FU) Period|Adverse Event|1
133942|NCT00494871|447665|P1|Follow-up (FU) Period|Adverse Event|1
133943|NCT00494871|447664|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
133944|NCT00494871|447665|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
133945|NCT00494871|447664|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
133946|NCT00494871|447665|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
133947|NCT00494871|447664|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
133948|NCT00494871|447665|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
133949|NCT00494871|447664|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
133950|NCT00494871|447665|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
133951|NCT00494871|447664|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
133952|NCT00494871|447665|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
133953|NCT00494871|447664|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
133954|NCT00494871|447665|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
133955|NCT00494871|447664|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
133956|NCT00494871|447665|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
133957|NCT00494871|447664|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
133958|NCT00494871|447665|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
133959|NCT00494871|447664|P2|Double-blind (DB) Treatment Period|Physician Decision|13
133960|NCT00494871|447665|P1|Double-blind (DB) Treatment Period|Physician Decision|4
133961|NCT00494871|447664|P2|Double-blind (DB) Treatment Period|Death|3
133962|NCT00494871|447665|P1|Double-blind (DB) Treatment Period|Death|8
133963|NCT00494871|447664|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
133964|NCT00494871|447665|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
133965|NCT00494871|447664|P2|Double-blind (DB) Treatment Period|Adverse Event|70
133966|NCT00494871|447665|P1|Double-blind (DB) Treatment Period|Adverse Event|73
133967|NCT00494780|447706|P2|Overall Study|Insurance Issues|1
133968|NCT00494780|447707|P1|Overall Study|Insurance Issues|0
133969|NCT00494780|447706|P2|Overall Study|Residual Tumour Mass|1
133970|NCT00494780|447707|P1|Overall Study|Residual Tumour Mass|0
133971|NCT00494780|447706|P2|Overall Study|Non-compliance|0
133972|NCT00494780|447707|P1|Overall Study|Non-compliance|1
133973|NCT00494780|447706|P2|Overall Study|New Treatment|2
133974|NCT00494780|447707|P1|Overall Study|New Treatment|2
133975|NCT00494780|447706|P2|Overall Study|Progression of Study Disease|8
133976|NCT00494780|447707|P1|Overall Study|Progression of Study Disease|7
133977|NCT00494780|447706|P2|Overall Study|Withdrew before Dosed|1
133978|NCT00494780|447707|P1|Overall Study|Withdrew before Dosed|0
133979|NCT00494780|447706|P2|Overall Study|Adverse Event|0
133980|NCT00494780|447707|P1|Overall Study|Adverse Event|1
133981|NCT00494676|447745|P2|Second Intervention|Withdrawal by Subject|1
133982|NCT00494676|447746|P1|Second Intervention|Withdrawal by Subject|1
133983|NCT00494676|447745|P2|First Intervention|Withdrawal by Subject|3
133984|NCT00494676|447746|P1|First Intervention|Withdrawal by Subject|1
133985|NCT00494676|447745|P2|Allocation|Withdrawal by Subject|4
133986|NCT00494676|447746|P1|Allocation|Withdrawal by Subject|2
133987|NCT00494507|447761|P4|Open-Label Phase|Worsening Disease|2
133988|NCT00494507|447762|P3|Open-Label Phase|Worsening Disease|0
133989|NCT00494507|447763|P2|Open-Label Phase|Worsening Disease|0
133990|NCT00494507|447764|P1|Open-Label Phase|Worsening Disease|0
133991|NCT00494507|447761|P4|Open-Label Phase|Adverse Event|3
133992|NCT00494507|447762|P3|Open-Label Phase|Adverse Event|5
133993|NCT00494507|447763|P2|Open-Label Phase|Adverse Event|1
133994|NCT00494507|447764|P1|Open-Label Phase|Adverse Event|0
133995|NCT00494507|447761|P4|Double-Blind Phase|Negative DNA test|1
133996|NCT00494507|447762|P3|Double-Blind Phase|Negative DNA test|0
133997|NCT00494507|447763|P2|Double-Blind Phase|Negative DNA test|0
133998|NCT00494507|447764|P1|Double-Blind Phase|Negative DNA test|0
133999|NCT00494507|447761|P4|Double-Blind Phase|Subject Non-compliance|0
134000|NCT00494507|447762|P3|Double-Blind Phase|Subject Non-compliance|1
134001|NCT00494507|447763|P2|Double-Blind Phase|Subject Non-compliance|0
134002|NCT00494507|447764|P1|Double-Blind Phase|Subject Non-compliance|0
134003|NCT00494507|447761|P4|Double-Blind Phase|Withdrawal by Subject|0
134004|NCT00494507|447762|P3|Double-Blind Phase|Withdrawal by Subject|0
134005|NCT00494507|447763|P2|Double-Blind Phase|Withdrawal by Subject|0
134006|NCT00494507|447764|P1|Double-Blind Phase|Withdrawal by Subject|1
134007|NCT00494507|447761|P4|Double-Blind Phase|Adverse Event|0
134008|NCT00494507|447762|P3|Double-Blind Phase|Adverse Event|1
134009|NCT00494507|447763|P2|Double-Blind Phase|Adverse Event|0
134010|NCT00494507|447764|P1|Double-Blind Phase|Adverse Event|2
134011|NCT00494481|447807|P2|Overall Study|Never received IP|0
134012|NCT00494481|447808|P1|Overall Study|Never received IP|2
134013|NCT00494481|447807|P2|Overall Study|Other|0
134014|NCT00494481|447808|P1|Overall Study|Other|1
134015|NCT00494481|447807|P2|Overall Study|Adverse Event|11
134016|NCT00494481|447808|P1|Overall Study|Adverse Event|15
134017|NCT00494481|447807|P2|Overall Study|Condition under investigation worsened|13
134018|NCT00494481|447808|P1|Overall Study|Condition under investigation worsened|11
134019|NCT00494442|447816|P2|Overall Study|Intercurrent illness|1
134020|NCT00494442|447817|P1|Overall Study|Intercurrent illness|0
134021|NCT00494442|447816|P2|Overall Study|Non-compliance|1
134022|NCT00494442|447817|P1|Overall Study|Non-compliance|0
134023|NCT00494442|447816|P2|Overall Study|Physician Decision|1
134024|NCT00494442|447817|P1|Overall Study|Physician Decision|0
134025|NCT00494442|447816|P2|Overall Study|Adverse Event|2
134026|NCT00494442|447817|P1|Overall Study|Adverse Event|0
134027|NCT00494442|447816|P2|Overall Study|Lack of Efficacy|10
134028|NCT00494442|447817|P1|Overall Study|Lack of Efficacy|16
134029|NCT00494442|447816|P2|Overall Study|Death|1
134030|NCT00494442|447817|P1|Overall Study|Death|1
134031|NCT00494299|447833|P2|Overall Study|Protocol Driven Decision Point|22
134032|NCT00494299|447834|P1|Overall Study|Protocol Driven Decision Point|11
134033|NCT00494299|447833|P2|Overall Study|Site Closed by Sponsor|0
134034|NCT00494299|447834|P1|Overall Study|Site Closed by Sponsor|6
134035|NCT00494299|447833|P2|Overall Study|Participant Did Not Take Study Drug|2
134036|NCT00494299|447834|P1|Overall Study|Participant Did Not Take Study Drug|0
134037|NCT00494299|447833|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
134038|NCT00494299|447834|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
134039|NCT00494299|447833|P2|Overall Study|Withdrawal by Subject|3
134040|NCT00494299|447834|P1|Overall Study|Withdrawal by Subject|8
134041|NCT00494299|447833|P2|Overall Study|Protocol Violation|2
134042|NCT00494299|447834|P1|Overall Study|Protocol Violation|1
134043|NCT00494299|447833|P2|Overall Study|Physician Decision|2
134044|NCT00494299|447834|P1|Overall Study|Physician Decision|0
134045|NCT00494299|447833|P2|Overall Study|Lost to Follow-up|0
134046|NCT00494299|447834|P1|Overall Study|Lost to Follow-up|1
134047|NCT00494299|447833|P2|Overall Study|Adverse Event|13
134048|NCT00494299|447834|P1|Overall Study|Adverse Event|93
134049|NCT00494234|447846|P2|Overall Study|Death|1
134050|NCT00494234|447847|P1|Overall Study|Death|2
134051|NCT00494234|447846|P2|Overall Study|Withdrawal by Subject|0
134052|NCT00494234|447847|P1|Overall Study|Withdrawal by Subject|1
134053|NCT00494234|447846|P2|Overall Study|Lack of Efficacy|9
134054|NCT00494234|447847|P1|Overall Study|Lack of Efficacy|12
134055|NCT00494221|447866|P3|Overall Study|Withdrawal by Subject|0
134056|NCT00494221|447867|P2|Overall Study|Withdrawal by Subject|2
134057|NCT00494221|447868|P1|Overall Study|Withdrawal by Subject|1
134058|NCT00494221|447866|P3|Overall Study|Death|14
134059|NCT00494221|447867|P2|Overall Study|Death|9
134060|NCT00494221|447868|P1|Overall Study|Death|15
134061|NCT00494091|447909|P2|Overall Study|Withdrawal by Subject|7
134062|NCT00494091|447910|P1|Overall Study|Withdrawal by Subject|0
134063|NCT00494091|447909|P2|Overall Study|Not Specified|11
134064|NCT00494091|447910|P1|Overall Study|Not Specified|1
134065|NCT00494091|447909|P2|Overall Study|Lost to Follow-up|4
134066|NCT00494091|447910|P1|Overall Study|Lost to Follow-up|0
134067|NCT00494091|447909|P2|Overall Study|Death|54
134068|NCT00494091|447910|P1|Overall Study|Death|5
134069|NCT00494026|447932|P1|Overall Study|Sponsor Decision|4
134070|NCT00494013|447942|P2|Overall Study|Sponsor Decision|1
134071|NCT00494013|447943|P1|Overall Study|Sponsor Decision|0
134072|NCT00494013|447942|P2|Overall Study|Withdrawal by Subject|14
134073|NCT00494013|447943|P1|Overall Study|Withdrawal by Subject|13
134074|NCT00494013|447942|P2|Overall Study|Protocol Violation|5
134075|NCT00494013|447943|P1|Overall Study|Protocol Violation|8
134076|NCT00494013|447942|P2|Overall Study|Physician Decision|5
134077|NCT00494013|447943|P1|Overall Study|Physician Decision|3
134078|NCT00494013|447942|P2|Overall Study|Lost to Follow-up|6
134079|NCT00494013|447943|P1|Overall Study|Lost to Follow-up|5
134080|NCT00494013|447942|P2|Overall Study|Entry Criteria Not Met|4
134081|NCT00494013|447943|P1|Overall Study|Entry Criteria Not Met|1
134082|NCT00494013|447942|P2|Overall Study|Adverse Event|1
134083|NCT00494013|447943|P1|Overall Study|Adverse Event|0
134084|NCT00493974|447973|P2|Overall Study|Lost to Follow-up|6
134085|NCT00493974|447974|P1|Overall Study|Lost to Follow-up|4
134086|NCT00493974|447973|P2|Overall Study|Withdrawal by Subject|6
134087|NCT00493974|447974|P1|Overall Study|Withdrawal by Subject|8
134088|NCT00493974|447973|P2|Overall Study|Death|2
134089|NCT00493974|447974|P1|Overall Study|Death|1
134090|NCT00493779|448001|P1|Overall Study|Logistical issue at site|1
134091|NCT00493649|448008|P1|Overall Study|Other|13
134092|NCT00493649|448008|P1|Overall Study|Lost to Follow-up|1
134093|NCT00493649|448008|P1|Overall Study|Disease Progression|1
134094|NCT00493649|448008|P1|Overall Study|Investigator Request|2
134095|NCT00493649|448008|P1|Overall Study|Patient Request|21
134096|NCT00493649|448008|P1|Overall Study|Adverse Event|44
134097|NCT00493636|448021|P2|Overall Study|Mis-randomization|1
134098|NCT00493636|448022|P1|Overall Study|Mis-randomization|1
134099|NCT00493636|448021|P2|Overall Study|Disease progression/recurrence/relapse|1
134100|NCT00493636|448022|P1|Overall Study|Disease progression/recurrence/relapse|0
134101|NCT00493636|448021|P2|Overall Study|Withdrawal by Subject|0
134102|NCT00493636|448022|P1|Overall Study|Withdrawal by Subject|1
134103|NCT00493454|448036|P1|Overall Study|Withdrawal by Subject|1
134104|NCT00493311|448042|P2|Overall Study|Need for rescue medication|2
134105|NCT00493311|448043|P1|Overall Study|Need for rescue medication|2
134106|NCT00493285|448063|P6|Overall Study|Lost to Follow-up|0
134107|NCT00493285|448064|P5|Overall Study|Lost to Follow-up|1
134108|NCT00493285|448065|P4|Overall Study|Lost to Follow-up|0
134109|NCT00493285|448066|P3|Overall Study|Lost to Follow-up|0
134110|NCT00493285|448067|P2|Overall Study|Lost to Follow-up|0
134111|NCT00493285|448068|P1|Overall Study|Lost to Follow-up|0
134112|NCT00493246|448300|P8|Overall Study|Lost to Follow-up|0
134113|NCT00493246|448301|P7|Overall Study|Lost to Follow-up|1
134114|NCT00493246|448302|P6|Overall Study|Lost to Follow-up|0
134115|NCT00493246|448303|P5|Overall Study|Lost to Follow-up|0
134116|NCT00493246|448304|P4|Overall Study|Lost to Follow-up|0
134117|NCT00493246|448305|P3|Overall Study|Lost to Follow-up|0
134118|NCT00493246|448306|P2|Overall Study|Lost to Follow-up|0
134119|NCT00493246|448307|P1|Overall Study|Lost to Follow-up|0
134120|NCT00493246|448300|P8|Overall Study|No access to draw blood|0
134121|NCT00493246|448301|P7|Overall Study|No access to draw blood|0
134122|NCT00493246|448302|P6|Overall Study|No access to draw blood|1
134123|NCT00493246|448303|P5|Overall Study|No access to draw blood|0
134124|NCT00493246|448304|P4|Overall Study|No access to draw blood|0
134125|NCT00493246|448305|P3|Overall Study|No access to draw blood|0
134126|NCT00493246|448306|P2|Overall Study|No access to draw blood|0
134127|NCT00493246|448307|P1|Overall Study|No access to draw blood|0
134128|NCT00493246|448300|P8|Overall Study|Withdrawal by Subject|0
134129|NCT00493246|448301|P7|Overall Study|Withdrawal by Subject|0
134130|NCT00493246|448302|P6|Overall Study|Withdrawal by Subject|0
134131|NCT00493246|448303|P5|Overall Study|Withdrawal by Subject|1
134132|NCT00493246|448304|P4|Overall Study|Withdrawal by Subject|0
134133|NCT00493246|448305|P3|Overall Study|Withdrawal by Subject|0
134134|NCT00493246|448306|P2|Overall Study|Withdrawal by Subject|0
134135|NCT00493246|448307|P1|Overall Study|Withdrawal by Subject|0
134136|NCT00493220|448371|P6|Third Intervention|Withdrawal by Subject|0
134137|NCT00493220|448372|P5|Third Intervention|Withdrawal by Subject|0
134138|NCT00493220|448373|P4|Third Intervention|Withdrawal by Subject|0
134139|NCT00493220|448374|P3|Third Intervention|Withdrawal by Subject|0
134140|NCT00493220|448375|P2|Third Intervention|Withdrawal by Subject|0
134141|NCT00493220|448376|P1|Third Intervention|Withdrawal by Subject|1
134142|NCT00493038|448399|P2|Follow-up|Lost to Follow-up|0
134143|NCT00493038|448400|P1|Follow-up|Lost to Follow-up|1
134144|NCT00493038|448399|P2|Treatment|Other|1
134145|NCT00493038|448400|P1|Treatment|Other|0
134146|NCT00493038|448399|P2|Treatment|Withdrawal by Subject|12
134147|NCT00493038|448400|P1|Treatment|Withdrawal by Subject|11
134148|NCT00493038|448399|P2|Treatment|Lost to Follow-up|3
134149|NCT00493038|448400|P1|Treatment|Lost to Follow-up|5
134150|NCT00493038|448399|P2|Treatment|Adverse Event|4
134151|NCT00493038|448400|P1|Treatment|Adverse Event|8
134152|NCT00493012|448416|P2|Overall Study|Lost to Follow-up|17
134153|NCT00493012|448417|P1|Overall Study|Lost to Follow-up|18
134154|NCT00492856|448460|P4|Post-consolidation|Observation Arm|0
134155|NCT00492856|448461|P3|Post-consolidation|Observation Arm|27
134156|NCT00492856|448462|P2|Post-consolidation|Observation Arm|0
134157|NCT00492856|448463|P1|Post-consolidation|Observation Arm|0
134158|NCT00492856|448460|P4|Post-consolidation|Lost to Follow-up|0
134159|NCT00492856|448461|P3|Post-consolidation|Lost to Follow-up|0
134160|NCT00492856|448462|P2|Post-consolidation|Lost to Follow-up|2
134161|NCT00492856|448463|P1|Post-consolidation|Lost to Follow-up|0
134162|NCT00492856|448460|P4|Post-consolidation|Not protocol specified|0
134163|NCT00492856|448461|P3|Post-consolidation|Not protocol specified|0
134164|NCT00492856|448462|P2|Post-consolidation|Not protocol specified|1
134165|NCT00492856|448463|P1|Post-consolidation|Not protocol specified|0
134166|NCT00492856|448460|P4|Post-consolidation|Death|0
134167|NCT00492856|448461|P3|Post-consolidation|Death|0
134168|NCT00492856|448462|P2|Post-consolidation|Death|1
134169|NCT00492856|448463|P1|Post-consolidation|Death|0
134170|NCT00492856|448460|P4|Post-consolidation|Withdrawal by Subject|0
134171|NCT00492856|448461|P3|Post-consolidation|Withdrawal by Subject|0
134172|NCT00492856|448462|P2|Post-consolidation|Withdrawal by Subject|4
134173|NCT00492856|448463|P1|Post-consolidation|Withdrawal by Subject|0
134174|NCT00492856|448460|P4|Post-consolidation|Adverse Event|1
134175|NCT00492856|448461|P3|Post-consolidation|Adverse Event|0
134176|NCT00492856|448462|P2|Post-consolidation|Adverse Event|4
134177|NCT00492856|448463|P1|Post-consolidation|Adverse Event|0
134178|NCT00492856|448460|P4|Consolidation|Lost to Follow-up|0
134179|NCT00492856|448461|P3|Consolidation|Lost to Follow-up|0
134180|NCT00492856|448462|P2|Consolidation|Lost to Follow-up|0
134181|NCT00492856|448463|P1|Consolidation|Lost to Follow-up|1
134182|NCT00492856|448460|P4|Consolidation|Not protocol specified|0
134183|NCT00492856|448461|P3|Consolidation|Not protocol specified|0
134184|NCT00492856|448462|P2|Consolidation|Not protocol specified|0
134185|NCT00492856|448463|P1|Consolidation|Not protocol specified|2
134186|NCT00492856|448460|P4|Consolidation|Adverse Event|0
134187|NCT00492856|448461|P3|Consolidation|Adverse Event|0
134188|NCT00492856|448462|P2|Consolidation|Adverse Event|0
134189|NCT00492856|448463|P1|Consolidation|Adverse Event|6
134190|NCT00492856|448460|P4|Induction|Death|0
134191|NCT00492856|448461|P3|Induction|Death|0
134192|NCT00492856|448462|P2|Induction|Death|0
134193|NCT00492856|448463|P1|Induction|Death|3
134194|NCT00492856|448460|P4|Induction|Withdrawal by Subject|0
134195|NCT00492856|448461|P3|Induction|Withdrawal by Subject|0
134196|NCT00492856|448462|P2|Induction|Withdrawal by Subject|0
134197|NCT00492856|448463|P1|Induction|Withdrawal by Subject|1
134198|NCT00492856|448460|P4|Induction|Adverse Event|0
134199|NCT00492856|448461|P3|Induction|Adverse Event|0
134200|NCT00492856|448462|P2|Induction|Adverse Event|0
134201|NCT00492856|448463|P1|Induction|Adverse Event|2
134202|NCT00492752|448477|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
134203|NCT00492752|448478|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
134204|NCT00492752|448479|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
134205|NCT00492752|448480|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
134206|NCT00492752|448477|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
134207|NCT00492752|448478|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
134208|NCT00492752|448479|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
134209|NCT00492752|448480|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
134210|NCT00492752|448477|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
134211|NCT00492752|448478|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
134212|NCT00492752|448479|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
134213|NCT00492752|448480|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
134214|NCT00492752|448477|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
134215|NCT00492752|448478|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
134216|NCT00492752|448479|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
134217|NCT00492752|448480|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
134218|NCT00492752|448477|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
134219|NCT00492752|448478|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
134220|NCT00492752|448479|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
134221|NCT00492752|448480|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
134222|NCT00492752|448477|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
134223|NCT00492752|448478|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
134224|NCT00492752|448479|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
134225|NCT00492752|448480|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
134226|NCT00492752|448477|P4|Follow-up and/or Open Label Sorafenib|Death|1
134227|NCT00492752|448478|P3|Follow-up and/or Open Label Sorafenib|Death|45
134228|NCT00492752|448479|P2|Follow-up and/or Open Label Sorafenib|Death|5
134229|NCT00492752|448480|P1|Follow-up and/or Open Label Sorafenib|Death|75
134230|NCT00492752|448477|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
134231|NCT00492752|448478|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
134232|NCT00492752|448479|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
134233|NCT00492752|448480|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
134234|NCT00492752|448477|P4|Double Blind Treatment|Protocol Violation|0
134235|NCT00492752|448478|P3|Double Blind Treatment|Protocol Violation|1
134236|NCT00492752|448479|P2|Double Blind Treatment|Protocol Violation|0
134237|NCT00492752|448480|P1|Double Blind Treatment|Protocol Violation|0
134238|NCT00492752|448477|P4|Double Blind Treatment|Adverse Event|0
134239|NCT00492752|448478|P3|Double Blind Treatment|Adverse Event|0
134240|NCT00492752|448479|P2|Double Blind Treatment|Adverse Event|0
134241|NCT00492752|448480|P1|Double Blind Treatment|Adverse Event|1
134242|NCT00492752|448477|P4|Double Blind Treatment|Death|0
134243|NCT00492752|448478|P3|Double Blind Treatment|Death|2
134244|NCT00492752|448479|P2|Double Blind Treatment|Death|0
134245|NCT00492752|448480|P1|Double Blind Treatment|Death|13
134246|NCT00492726|448515|P2|Overall Study|Non compliant with study medication|3
134247|NCT00492726|448516|P1|Overall Study|Non compliant with study medication|0
134248|NCT00492726|448515|P2|Overall Study|Withdrawal by Subject|3
134249|NCT00492726|448516|P1|Overall Study|Withdrawal by Subject|6
134250|NCT00492726|448515|P2|Overall Study|Physician Decision|1
134251|NCT00492726|448516|P1|Overall Study|Physician Decision|0
134252|NCT00492726|448515|P2|Overall Study|Lost to Follow-up|19
134253|NCT00492726|448516|P1|Overall Study|Lost to Follow-up|27
134254|NCT00492726|448515|P2|Overall Study|Lack of Efficacy|2
134255|NCT00492726|448516|P1|Overall Study|Lack of Efficacy|0
134256|NCT00492726|448515|P2|Overall Study|Death|2
134257|NCT00492726|448516|P1|Overall Study|Death|7
134258|NCT00492726|448515|P2|Overall Study|Adverse Event|6
134259|NCT00492726|448516|P1|Overall Study|Adverse Event|10
134260|NCT00492557|448551|P2|Overall Study|Lost to Follow-up|1
134261|NCT00492557|448552|P1|Overall Study|Lost to Follow-up|0
134262|NCT00492557|448551|P2|Overall Study|Failed to return|0
134263|NCT00492557|448552|P1|Overall Study|Failed to return|1
134264|NCT00492557|448551|P2|Overall Study|Adverse Event|0
134265|NCT00492557|448552|P1|Overall Study|Adverse Event|1
134266|NCT00492557|448551|P2|Overall Study|Death|1
134267|NCT00492557|448552|P1|Overall Study|Death|1
134268|NCT00492557|448551|P2|Overall Study|Unspecified|2
134269|NCT00492557|448552|P1|Overall Study|Unspecified|2
134270|NCT00492557|448551|P2|Overall Study|Protocol Violation|8
134271|NCT00492557|448552|P1|Overall Study|Protocol Violation|7
134272|NCT00492557|448551|P2|Overall Study|Subject request|11
134273|NCT00492557|448552|P1|Overall Study|Subject request|12
134274|NCT00492531|448582|P2|Overall Study|Withdrawn(More than one reason selected)|23
134275|NCT00492531|448583|P1|Overall Study|Withdrawn(More than one reason selected)|22
134276|NCT00492297|448613|P1|Survival Only Follow-up|Study terminated by sponsor|12
134277|NCT00492297|448613|P1|Survival Only Follow-up|Lack of Efficacy|1
134278|NCT00492297|448613|P1|Survival Only Follow-up|Death|46
134279|NCT00492297|448613|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
134280|NCT00492297|448613|P1|Active Follow-up 30(+4) Days Duration|Death|17
134281|NCT00492297|448613|P1|Treatment|Study terminated by sponsor|3
134282|NCT00492297|448613|P1|Treatment|Death|2
134283|NCT00492284|448631|P4|Overall Study|Withdrawal by Subject|2
134284|NCT00492284|448632|P3|Overall Study|Withdrawal by Subject|0
134285|NCT00492284|448633|P2|Overall Study|Withdrawal by Subject|0
134286|NCT00492284|448634|P1|Overall Study|Withdrawal by Subject|1
134287|NCT00492284|448631|P4|Overall Study|Death|5
134288|NCT00492284|448632|P3|Overall Study|Death|2
134289|NCT00492284|448633|P2|Overall Study|Death|3
134290|NCT00492284|448634|P1|Overall Study|Death|0
134291|NCT00492284|448631|P4|Overall Study|Lost to Follow-up|1
134292|NCT00492284|448632|P3|Overall Study|Lost to Follow-up|3
134293|NCT00492284|448633|P2|Overall Study|Lost to Follow-up|0
134294|NCT00492284|448634|P1|Overall Study|Lost to Follow-up|0
134295|NCT00492284|448631|P4|Overall Study|Adverse Event|2
134296|NCT00492284|448632|P3|Overall Study|Adverse Event|1
134297|NCT00492284|448633|P2|Overall Study|Adverse Event|1
134298|NCT00492284|448634|P1|Overall Study|Adverse Event|0
134299|NCT00492232|448678|P2|Open-Label Treatment|Withdrawal by Subject|0
134300|NCT00492232|448679|P1|Open-Label Treatment|Withdrawal by Subject|1
134301|NCT00492232|448678|P2|Double-Blind Treatment|Randomized not treated|0
134302|NCT00492232|448679|P1|Double-Blind Treatment|Randomized not treated|1
134303|NCT00492232|448678|P2|Double-Blind Treatment|Other|5
134304|NCT00492232|448679|P1|Double-Blind Treatment|Other|6
134305|NCT00492232|448678|P2|Double-Blind Treatment|Lack of Efficacy|0
134306|NCT00492232|448679|P1|Double-Blind Treatment|Lack of Efficacy|1
134307|NCT00492232|448678|P2|Double-Blind Treatment|Withdrawal by Subject|8
134308|NCT00492232|448679|P1|Double-Blind Treatment|Withdrawal by Subject|4
134309|NCT00492232|448678|P2|Double-Blind Treatment|Lost to Follow-up|3
134310|NCT00492232|448679|P1|Double-Blind Treatment|Lost to Follow-up|2
134311|NCT00492232|448678|P2|Double-Blind Treatment|Protocol Violation|7
134312|NCT00492232|448679|P1|Double-Blind Treatment|Protocol Violation|3
134313|NCT00492232|448678|P2|Double-Blind Treatment|Adverse Event|2
134314|NCT00492232|448679|P1|Double-Blind Treatment|Adverse Event|1
134315|NCT00492232|448678|P2|Placebo Run-in|Missing|2
134316|NCT00492232|448679|P1|Placebo Run-in|Missing|0
134317|NCT00492232|448678|P2|Placebo Run-in|Other|6
134318|NCT00492232|448679|P1|Placebo Run-in|Other|0
134319|NCT00492232|448678|P2|Placebo Run-in|Entrance criteria not met|45
134320|NCT00492232|448679|P1|Placebo Run-in|Entrance criteria not met|0
134321|NCT00492232|448678|P2|Placebo Run-in|Pregnancy|1
134322|NCT00492232|448679|P1|Placebo Run-in|Pregnancy|0
134323|NCT00492232|448678|P2|Placebo Run-in|Withdrawal by Subject|8
134324|NCT00492232|448679|P1|Placebo Run-in|Withdrawal by Subject|0
134325|NCT00492232|448678|P2|Placebo Run-in|Lost to Follow-up|3
134326|NCT00492232|448679|P1|Placebo Run-in|Lost to Follow-up|0
134327|NCT00492232|448678|P2|Placebo Run-in|Protocol Violation|3
134328|NCT00492232|448679|P1|Placebo Run-in|Protocol Violation|0
134329|NCT00492232|448678|P2|Placebo Run-in|Adverse Event|2
134330|NCT00492232|448679|P1|Placebo Run-in|Adverse Event|0
134331|NCT00492063|448731|P4|Overall Study|Protocol Violation|1
134332|NCT00492063|448732|P3|Overall Study|Protocol Violation|0
134333|NCT00492063|448733|P2|Overall Study|Protocol Violation|0
134334|NCT00492063|448734|P1|Overall Study|Protocol Violation|0
134335|NCT00492063|448731|P4|Overall Study|Lost to Follow-up|3
134336|NCT00492063|448732|P3|Overall Study|Lost to Follow-up|5
134337|NCT00492063|448733|P2|Overall Study|Lost to Follow-up|11
134338|NCT00492063|448734|P1|Overall Study|Lost to Follow-up|6
134339|NCT00492063|448731|P4|Overall Study|Withdrawal by Subject|4
134340|NCT00492063|448732|P3|Overall Study|Withdrawal by Subject|5
134341|NCT00492063|448733|P2|Overall Study|Withdrawal by Subject|3
134342|NCT00492063|448734|P1|Overall Study|Withdrawal by Subject|4
134343|NCT00492063|448731|P4|Overall Study|Death|2
134344|NCT00492063|448732|P3|Overall Study|Death|1
134345|NCT00492063|448733|P2|Overall Study|Death|0
134346|NCT00492063|448734|P1|Overall Study|Death|0
134347|NCT00492024|448758|P2|Follow up|Lost to Follow-up|1
134348|NCT00492024|448759|P1|Follow up|Lost to Follow-up|1
134349|NCT00492024|448758|P2|Follow up|Lack of Efficacy|1
134350|NCT00492024|448759|P1|Follow up|Lack of Efficacy|0
134351|NCT00492024|448758|P2|Treatment|Withdrawal by Subject|0
134352|NCT00492024|448759|P1|Treatment|Withdrawal by Subject|2
134353|NCT00492024|448758|P2|Treatment|Lost to Follow-up|1
134354|NCT00492024|448759|P1|Treatment|Lost to Follow-up|3
134355|NCT00492024|448758|P2|Treatment|Lack of Efficacy|20
134356|NCT00492024|448759|P1|Treatment|Lack of Efficacy|21
134357|NCT00492024|448758|P2|Treatment|Adverse Event|1
134358|NCT00492024|448759|P1|Treatment|Adverse Event|3
134359|NCT00491894|448775|P1|Overall Study|Other-Intake of prohibited medication|1
134360|NCT00491894|448775|P1|Overall Study|Protocol Violation|2
134361|NCT00491894|448775|P1|Overall Study|Physician Decision|2
134362|NCT00491894|448775|P1|Overall Study|Other-Failed to meet any criteria|2
134363|NCT00491894|448775|P1|Overall Study|Lack of Efficacy|2
134364|NCT00491894|448775|P1|Overall Study|Lost to Follow-up|3
134365|NCT00491894|448775|P1|Overall Study|Death|3
134366|NCT00491894|448775|P1|Overall Study|Withdrawal by Subject|5
134367|NCT00491894|448775|P1|Overall Study|Adverse Event|14
134368|NCT00491764|448802|P6|Overall Study|Administrative|0
134369|NCT00491764|448803|P5|Overall Study|Administrative|0
134370|NCT00491764|448804|P4|Overall Study|Administrative|1
134371|NCT00491764|448805|P3|Overall Study|Administrative|2
134372|NCT00491764|448806|P2|Overall Study|Administrative|0
134373|NCT00491764|448807|P1|Overall Study|Administrative|1
134374|NCT00491764|448802|P6|Overall Study|Did not Meet Protocol Eligibility|1
134375|NCT00491764|448803|P5|Overall Study|Did not Meet Protocol Eligibility|1
134376|NCT00491764|448804|P4|Overall Study|Did not Meet Protocol Eligibility|0
134377|NCT00491764|448805|P3|Overall Study|Did not Meet Protocol Eligibility|1
134378|NCT00491764|448806|P2|Overall Study|Did not Meet Protocol Eligibility|1
134379|NCT00491764|448807|P1|Overall Study|Did not Meet Protocol Eligibility|0
134380|NCT00491764|448802|P6|Overall Study|Non Compliance with the Protocol|0
134381|NCT00491764|448803|P5|Overall Study|Non Compliance with the Protocol|0
134382|NCT00491764|448804|P4|Overall Study|Non Compliance with the Protocol|0
134383|NCT00491764|448805|P3|Overall Study|Non Compliance with the Protocol|0
134384|NCT00491764|448806|P2|Overall Study|Non Compliance with the Protocol|0
134385|NCT00491764|448807|P1|Overall Study|Non Compliance with the Protocol|1
134386|NCT00491764|448802|P6|Overall Study|Withdrawal by Subject|4
134387|NCT00491764|448803|P5|Overall Study|Withdrawal by Subject|2
134388|NCT00491764|448804|P4|Overall Study|Withdrawal by Subject|2
134389|NCT00491764|448805|P3|Overall Study|Withdrawal by Subject|1
134390|NCT00491764|448806|P2|Overall Study|Withdrawal by Subject|3
134391|NCT00491764|448807|P1|Overall Study|Withdrawal by Subject|2
134392|NCT00491764|448802|P6|Overall Study|Lost to Follow-up|3
134393|NCT00491764|448803|P5|Overall Study|Lost to Follow-up|0
134394|NCT00491764|448804|P4|Overall Study|Lost to Follow-up|1
134395|NCT00491764|448805|P3|Overall Study|Lost to Follow-up|0
134396|NCT00491764|448806|P2|Overall Study|Lost to Follow-up|1
134397|NCT00491764|448807|P1|Overall Study|Lost to Follow-up|0
134398|NCT00491764|448802|P6|Overall Study|Adverse Event|1
134399|NCT00491764|448803|P5|Overall Study|Adverse Event|0
134400|NCT00491764|448804|P4|Overall Study|Adverse Event|4
134401|NCT00491764|448805|P3|Overall Study|Adverse Event|4
134402|NCT00491764|448806|P2|Overall Study|Adverse Event|2
134403|NCT00491764|448807|P1|Overall Study|Adverse Event|1
134404|NCT00491608|448840|P1|Overall Study|Withdrawal by Subject|1
134405|NCT00491608|448840|P1|Overall Study|Death|2
134406|NCT00491556|448851|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
134407|NCT00491556|448852|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
134408|NCT00491556|448851|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
134409|NCT00491556|448852|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
134410|NCT00491556|448851|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|0
134411|NCT00491556|448852|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|2
134412|NCT00491556|448851|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
134413|NCT00491556|448852|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
134414|NCT00491556|448851|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
134415|NCT00491556|448852|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
134416|NCT00491556|448851|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
134417|NCT00491556|448852|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
134418|NCT00491556|448851|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
134419|NCT00491556|448852|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
134420|NCT00491556|448851|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
134421|NCT00491556|448852|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
134422|NCT00491556|448851|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
134423|NCT00491556|448852|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
134424|NCT00491556|448851|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
134425|NCT00491556|448852|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
134426|NCT00491556|448851|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
134427|NCT00491556|448852|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
134428|NCT00491556|448851|P2|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|0
134429|NCT00491556|448852|P1|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|3
134430|NCT00491556|448851|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
134431|NCT00491556|448852|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
134432|NCT00491556|448851|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
134433|NCT00491556|448852|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
134434|NCT00491556|448851|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
134435|NCT00491556|448852|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
134436|NCT00491556|448851|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
134437|NCT00491556|448852|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
134438|NCT00491556|448851|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
134439|NCT00491556|448852|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
134440|NCT00491556|448851|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
134441|NCT00491556|448852|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
134442|NCT00491556|448851|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
134443|NCT00491556|448852|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
134444|NCT00491556|448851|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
134445|NCT00491556|448852|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
134446|NCT00491530|448911|P3|Overall Study|Use of Prohibited Medication|1
134447|NCT00491530|448912|P2|Overall Study|Use of Prohibited Medication|0
134448|NCT00491530|448913|P1|Overall Study|Use of Prohibited Medication|0
134449|NCT00491530|448911|P3|Overall Study|Patient Request|0
134450|NCT00491530|448912|P2|Overall Study|Patient Request|1
134451|NCT00491530|448913|P1|Overall Study|Patient Request|0
134452|NCT00491530|448911|P3|Overall Study|Investigator Discretion|0
134453|NCT00491530|448912|P2|Overall Study|Investigator Discretion|1
134454|NCT00491530|448913|P1|Overall Study|Investigator Discretion|0
134455|NCT00491530|448911|P3|Overall Study|Lack of Efficacy|0
134456|NCT00491530|448912|P2|Overall Study|Lack of Efficacy|1
134457|NCT00491530|448913|P1|Overall Study|Lack of Efficacy|0
134458|NCT00491530|448911|P3|Overall Study|Lost to Follow-up|2
134459|NCT00491530|448912|P2|Overall Study|Lost to Follow-up|2
134460|NCT00491530|448913|P1|Overall Study|Lost to Follow-up|3
134461|NCT00491530|448911|P3|Overall Study|Withdrawal by Subject|0
134462|NCT00491530|448912|P2|Overall Study|Withdrawal by Subject|0
134463|NCT00491530|448913|P1|Overall Study|Withdrawal by Subject|3
134464|NCT00491530|448911|P3|Overall Study|Adverse Event|2
134465|NCT00491530|448912|P2|Overall Study|Adverse Event|1
134466|NCT00491530|448913|P1|Overall Study|Adverse Event|6
134467|NCT00491504|448943|P4|Overall Study|Protocol Violation|2
134468|NCT00491504|448944|P3|Overall Study|Protocol Violation|3
134469|NCT00491504|448945|P2|Overall Study|Protocol Violation|0
134470|NCT00491504|448946|P1|Overall Study|Protocol Violation|0
134471|NCT00491504|448943|P4|Overall Study|Withdrawal by Subject|2
134472|NCT00491504|448944|P3|Overall Study|Withdrawal by Subject|1
134473|NCT00491504|448945|P2|Overall Study|Withdrawal by Subject|0
134474|NCT00491504|448946|P1|Overall Study|Withdrawal by Subject|0
134475|NCT00491504|448943|P4|Overall Study|Adverse Event|0
134476|NCT00491504|448944|P3|Overall Study|Adverse Event|0
134477|NCT00491504|448945|P2|Overall Study|Adverse Event|1
134478|NCT00491504|448946|P1|Overall Study|Adverse Event|0
134479|NCT00491400|448956|P2|Overall Study|Withdrawal by Subject|4
134480|NCT00491400|448957|P1|Overall Study|Withdrawal by Subject|5
134481|NCT00491179|448991|P2|Overall Study|Withdrawal by Subject|1
134482|NCT00491179|448992|P1|Overall Study|Withdrawal by Subject|2
134483|NCT00491179|448991|P2|Overall Study|Adverse Event|1
134484|NCT00491179|448992|P1|Overall Study|Adverse Event|5
134485|NCT00491075|449000|P1|Overall Study|Physician Decision|1
134486|NCT00491075|449000|P1|Overall Study|Withdrawal by Subject|1
134487|NCT00490971|449006|P5|Maintenance|Not specified|3
134488|NCT00490971|449007|P4|Maintenance|Not specified|9
134489|NCT00490971|449008|P3|Maintenance|Not specified|11
134490|NCT00490971|449009|P2|Maintenance|Not specified|0
134491|NCT00490971|449010|P1|Maintenance|Not specified|0
134492|NCT00490971|449006|P5|Maintenance|Withdrawal by Subject|18
134493|NCT00490971|449007|P4|Maintenance|Withdrawal by Subject|28
134494|NCT00490971|449008|P3|Maintenance|Withdrawal by Subject|26
134495|NCT00490971|449009|P2|Maintenance|Withdrawal by Subject|0
134496|NCT00490971|449010|P1|Maintenance|Withdrawal by Subject|0
134497|NCT00490971|449006|P5|Maintenance|Protocol Violation|1
134498|NCT00490971|449007|P4|Maintenance|Protocol Violation|1
134499|NCT00490971|449008|P3|Maintenance|Protocol Violation|4
134500|NCT00490971|449009|P2|Maintenance|Protocol Violation|0
134501|NCT00490971|449010|P1|Maintenance|Protocol Violation|0
134502|NCT00490971|449006|P5|Maintenance|Pregnancy|0
134503|NCT00490971|449007|P4|Maintenance|Pregnancy|0
134504|NCT00490971|449008|P3|Maintenance|Pregnancy|1
134505|NCT00490971|449009|P2|Maintenance|Pregnancy|0
134506|NCT00490971|449010|P1|Maintenance|Pregnancy|0
134507|NCT00490971|449006|P5|Maintenance|Lost to Follow-up|10
134508|NCT00490971|449007|P4|Maintenance|Lost to Follow-up|8
134509|NCT00490971|449008|P3|Maintenance|Lost to Follow-up|5
134510|NCT00490971|449009|P2|Maintenance|Lost to Follow-up|0
134511|NCT00490971|449010|P1|Maintenance|Lost to Follow-up|0
134512|NCT00490971|449006|P5|Maintenance|Death|0
134513|NCT00490971|449007|P4|Maintenance|Death|2
134514|NCT00490971|449008|P3|Maintenance|Death|0
134515|NCT00490971|449009|P2|Maintenance|Death|0
134516|NCT00490971|449010|P1|Maintenance|Death|0
134517|NCT00490971|449006|P5|Maintenance|Adverse Event|7
134518|NCT00490971|449007|P4|Maintenance|Adverse Event|5
134519|NCT00490971|449008|P3|Maintenance|Adverse Event|4
134520|NCT00490971|449009|P2|Maintenance|Adverse Event|0
134521|NCT00490971|449010|P1|Maintenance|Adverse Event|0
134522|NCT00490971|449006|P5|Acute/Continuation|Not specified|0
134523|NCT00490971|449007|P4|Acute/Continuation|Not specified|0
134524|NCT00490971|449008|P3|Acute/Continuation|Not specified|0
134525|NCT00490971|449009|P2|Acute/Continuation|Not specified|4
134526|NCT00490971|449010|P1|Acute/Continuation|Not specified|11
134527|NCT00490971|449006|P5|Acute/Continuation|Withdrawal by Subject|0
134528|NCT00490971|449007|P4|Acute/Continuation|Withdrawal by Subject|0
134529|NCT00490971|449008|P3|Acute/Continuation|Withdrawal by Subject|0
134530|NCT00490971|449009|P2|Acute/Continuation|Withdrawal by Subject|24
134531|NCT00490971|449010|P1|Acute/Continuation|Withdrawal by Subject|92
134532|NCT00490971|449006|P5|Acute/Continuation|Protocol Violation|0
134533|NCT00490971|449007|P4|Acute/Continuation|Protocol Violation|0
134534|NCT00490971|449008|P3|Acute/Continuation|Protocol Violation|0
134535|NCT00490971|449009|P2|Acute/Continuation|Protocol Violation|2
134536|NCT00490971|449010|P1|Acute/Continuation|Protocol Violation|10
134537|NCT00490971|449006|P5|Acute/Continuation|Lost to Follow-up|0
134538|NCT00490971|449007|P4|Acute/Continuation|Lost to Follow-up|0
134539|NCT00490971|449008|P3|Acute/Continuation|Lost to Follow-up|0
134540|NCT00490971|449009|P2|Acute/Continuation|Lost to Follow-up|7
134541|NCT00490971|449010|P1|Acute/Continuation|Lost to Follow-up|23
134542|NCT00490971|449006|P5|Acute/Continuation|Lack of Efficacy|0
134543|NCT00490971|449007|P4|Acute/Continuation|Lack of Efficacy|0
134544|NCT00490971|449008|P3|Acute/Continuation|Lack of Efficacy|0
134545|NCT00490971|449009|P2|Acute/Continuation|Lack of Efficacy|12
134546|NCT00490971|449010|P1|Acute/Continuation|Lack of Efficacy|106
134547|NCT00490971|449006|P5|Acute/Continuation|Death|0
134548|NCT00490971|449007|P4|Acute/Continuation|Death|0
134549|NCT00490971|449008|P3|Acute/Continuation|Death|0
134550|NCT00490971|449009|P2|Acute/Continuation|Death|0
134551|NCT00490971|449010|P1|Acute/Continuation|Death|2
134552|NCT00490971|449006|P5|Acute/Continuation|Adverse Event|0
134553|NCT00490971|449007|P4|Acute/Continuation|Adverse Event|0
134554|NCT00490971|449008|P3|Acute/Continuation|Adverse Event|0
134555|NCT00490971|449009|P2|Acute/Continuation|Adverse Event|13
134556|NCT00490971|449010|P1|Acute/Continuation|Adverse Event|62
134557|NCT00490945|449057|P5|Overall Study|Adverse Event|0
134558|NCT00490945|449058|P4|Overall Study|Adverse Event|0
134559|NCT00490945|449059|P3|Overall Study|Adverse Event|0
134560|NCT00490945|449060|P2|Overall Study|Adverse Event|1
134561|NCT00490945|449061|P1|Overall Study|Adverse Event|0
134562|NCT00490919|449097|P3|Double-blind Phase|Administrative|6
134563|NCT00490919|449098|P2|Double-blind Phase|Administrative|6
134564|NCT00490919|449099|P1|Double-blind Phase|Administrative|0
134565|NCT00490919|449097|P3|Double-blind Phase|Lack of Efficacy|36
134566|NCT00490919|449098|P2|Double-blind Phase|Lack of Efficacy|22
134567|NCT00490919|449099|P1|Double-blind Phase|Lack of Efficacy|0
134568|NCT00490919|449097|P3|Double-blind Phase|Lost to Follow-up|11
134569|NCT00490919|449098|P2|Double-blind Phase|Lost to Follow-up|8
134570|NCT00490919|449099|P1|Double-blind Phase|Lost to Follow-up|0
134571|NCT00490919|449097|P3|Double-blind Phase|Withdrawal by Subject|11
134572|NCT00490919|449098|P2|Double-blind Phase|Withdrawal by Subject|10
134573|NCT00490919|449099|P1|Double-blind Phase|Withdrawal by Subject|0
134574|NCT00490919|449097|P3|Double-blind Phase|Adverse Event|20
134575|NCT00490919|449098|P2|Double-blind Phase|Adverse Event|40
134576|NCT00490919|449099|P1|Double-blind Phase|Adverse Event|0
134577|NCT00490919|449097|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
134578|NCT00490919|449098|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
134579|NCT00490919|449099|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
134580|NCT00490919|449097|P3|Open-label Run-in Period|Administrative|0
134581|NCT00490919|449098|P2|Open-label Run-in Period|Administrative|0
134582|NCT00490919|449099|P1|Open-label Run-in Period|Administrative|40
134583|NCT00490919|449097|P3|Open-label Run-in Period|Lack of Efficacy|0
134584|NCT00490919|449098|P2|Open-label Run-in Period|Lack of Efficacy|0
134585|NCT00490919|449099|P1|Open-label Run-in Period|Lack of Efficacy|143
134586|NCT00490919|449097|P3|Open-label Run-in Period|Lost to Follow-up|0
134587|NCT00490919|449098|P2|Open-label Run-in Period|Lost to Follow-up|0
134588|NCT00490919|449099|P1|Open-label Run-in Period|Lost to Follow-up|21
134589|NCT00490919|449097|P3|Open-label Run-in Period|Withdrawal by Subject|0
134590|NCT00490919|449098|P2|Open-label Run-in Period|Withdrawal by Subject|0
134591|NCT00490919|449099|P1|Open-label Run-in Period|Withdrawal by Subject|37
134592|NCT00490919|449097|P3|Open-label Run-in Period|Adverse Event|0
134593|NCT00490919|449098|P2|Open-label Run-in Period|Adverse Event|0
134594|NCT00490919|449099|P1|Open-label Run-in Period|Adverse Event|239
134595|NCT00490841|449110|P1|Overall Study|30 day f/u, only non-study stent used|3
134596|NCT00490841|449110|P1|Overall Study|Lost to Follow-up|1
134597|NCT00490841|449110|P1|Overall Study|Withdrawal by Subject|4
134598|NCT00490841|449110|P1|Overall Study|Death|5
134599|NCT00490815|449132|P2|Overall Study|Death|3
134600|NCT00490815|449133|P1|Overall Study|Death|1
134601|NCT00490815|449132|P2|Overall Study|Lost to Follow-up|3
134602|NCT00490815|449133|P1|Overall Study|Lost to Follow-up|1
134603|NCT00490815|449132|P2|Overall Study|Withdrawal by Subject|0
134604|NCT00490815|449133|P1|Overall Study|Withdrawal by Subject|4
134605|NCT00490815|449132|P2|Overall Study|Adverse Event|3
134606|NCT00490815|449133|P1|Overall Study|Adverse Event|2
134607|NCT00490724|449161|P3|Period II|Treatment Discontinuation|3
134608|NCT00490724|449162|P2|Period II|Treatment Discontinuation|1
134609|NCT00490724|449163|P1|Period II|Treatment Discontinuation|3
134610|NCT00490724|449161|P3|Period I|Physician Decision|1
134611|NCT00490724|449162|P2|Period I|Physician Decision|0
134612|NCT00490724|449163|P1|Period I|Physician Decision|0
134613|NCT00490698|449228|P1|Overall Study|Physician Decision|2
134614|NCT00490698|449228|P1|Overall Study|Disease Progression|7
134615|NCT00490698|449228|P1|Overall Study|Withdrawal by Subject|1
134616|NCT00490646|449234|P2|Overall Study|Never Treated (withdrew consent)|1
134617|NCT00490646|449235|P1|Overall Study|Never Treated (withdrew consent)|0
134618|NCT00490646|449234|P2|Overall Study|Never Treated (had an adverse event)|0
134619|NCT00490646|449235|P1|Overall Study|Never Treated (had an adverse event)|1
134620|NCT00490646|449234|P2|Overall Study|Still on trastuzumab monotherapy|1
134621|NCT00490646|449235|P1|Overall Study|Still on trastuzumab monotherapy|1
134622|NCT00490555|449259|P4|Overall Study|noncompliant with drug administration|0
134623|NCT00490555|449260|P3|Overall Study|noncompliant with drug administration|2
134624|NCT00490555|449261|P2|Overall Study|noncompliant with drug administration|0
134625|NCT00490555|449262|P1|Overall Study|noncompliant with drug administration|0
134626|NCT00490542|449290|P2|Overall Study|Lack of Efficacy|1
134627|NCT00490542|449291|P1|Overall Study|Lack of Efficacy|1
134628|NCT00490542|449290|P2|Overall Study|Adverse Event|3
134629|NCT00490542|449291|P1|Overall Study|Adverse Event|3
134630|NCT00490542|449290|P2|Overall Study|Lost to Follow-up|0
134631|NCT00490542|449291|P1|Overall Study|Lost to Follow-up|3
134632|NCT00490139|449328|P4|Overall Study|Participant Withdrew Consent|116
134633|NCT00490139|449329|P3|Overall Study|Participant Withdrew Consent|208
134634|NCT00490139|449330|P2|Overall Study|Participant Withdrew Consent|110
134635|NCT00490139|449331|P1|Overall Study|Participant Withdrew Consent|146
134636|NCT00490139|449328|P4|Overall Study|Lost to Follow-up|56
134637|NCT00490139|449329|P3|Overall Study|Lost to Follow-up|58
134638|NCT00490139|449330|P2|Overall Study|Lost to Follow-up|46
134639|NCT00490139|449331|P1|Overall Study|Lost to Follow-up|56
134640|NCT00490139|449328|P4|Overall Study|Death|135
134641|NCT00490139|449329|P3|Overall Study|Death|168
134642|NCT00490139|449330|P2|Overall Study|Death|119
134643|NCT00490139|449331|P1|Overall Study|Death|106
134644|NCT00490035|449370|P4|Overall Study|AE of unknown type|0
134645|NCT00490035|449371|P3|Overall Study|AE of unknown type|2
134646|NCT00490035|449372|P2|Overall Study|AE of unknown type|0
134647|NCT00490035|449373|P1|Overall Study|AE of unknown type|0
134648|NCT00490035|449370|P4|Overall Study|SAE, non-fatal|0
134649|NCT00490035|449371|P3|Overall Study|SAE, non-fatal|1
134650|NCT00490035|449372|P2|Overall Study|SAE, non-fatal|0
134651|NCT00490035|449373|P1|Overall Study|SAE, non-fatal|0
134652|NCT00490035|449370|P4|Overall Study|AE, serious fatal|0
134653|NCT00490035|449371|P3|Overall Study|AE, serious fatal|0
134654|NCT00490035|449372|P2|Overall Study|AE, serious fatal|0
134655|NCT00490035|449373|P1|Overall Study|AE, serious fatal|1
134656|NCT00490035|449370|P4|Overall Study|Other reason|1
134657|NCT00490035|449371|P3|Overall Study|Other reason|3
134658|NCT00490035|449372|P2|Overall Study|Other reason|1
134659|NCT00490035|449373|P1|Overall Study|Other reason|0
134660|NCT00490035|449370|P4|Overall Study|Withdrawal by Subject|0
134661|NCT00490035|449371|P3|Overall Study|Withdrawal by Subject|1
134662|NCT00490035|449372|P2|Overall Study|Withdrawal by Subject|1
134663|NCT00490035|449373|P1|Overall Study|Withdrawal by Subject|2
134664|NCT00490035|449370|P4|Overall Study|Lost to Follow-up|0
134665|NCT00490035|449371|P3|Overall Study|Lost to Follow-up|1
134666|NCT00490035|449372|P2|Overall Study|Lost to Follow-up|0
134667|NCT00490035|449373|P1|Overall Study|Lost to Follow-up|2
134668|NCT00490035|449370|P4|Overall Study|AE, non-serious non-fatal|5
134669|NCT00490035|449371|P3|Overall Study|AE, non-serious non-fatal|4
134670|NCT00490035|449372|P2|Overall Study|AE, non-serious non-fatal|4
134671|NCT00490035|449373|P1|Overall Study|AE, non-serious non-fatal|3
134672|NCT00490022|449469|P2|Overall Study|Subject failed to disclose concommitant|1
134673|NCT00490022|449470|P1|Overall Study|Subject failed to disclose concommitant|0
134674|NCT00490022|449469|P2|Overall Study|Withdrawal by Subject|0
134675|NCT00490022|449470|P1|Overall Study|Withdrawal by Subject|1
134676|NCT00490022|449469|P2|Overall Study|Adverse Event|2
134677|NCT00490022|449470|P1|Overall Study|Adverse Event|0
134678|NCT00489853|449522|P3|Treatment Period 3|Study specific discontinuation criteria|0
134679|NCT00489853|449523|P2|Treatment Period 3|Study specific discontinuation criteria|1
134680|NCT00489853|449524|P1|Treatment Period 3|Study specific discontinuation criteria|0
134681|NCT00489853|449522|P3|Wash-out Period 2|Study specific discontinuation criteria|2
134682|NCT00489853|449523|P2|Wash-out Period 2|Study specific discontinuation criteria|2
134683|NCT00489853|449524|P1|Wash-out Period 2|Study specific discontinuation criteria|3
134684|NCT00489853|449522|P3|Wash-out Period 2|Adverse Event|0
134685|NCT00489853|449523|P2|Wash-out Period 2|Adverse Event|1
134686|NCT00489853|449524|P1|Wash-out Period 2|Adverse Event|1
134687|NCT00489853|449522|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
134688|NCT00489853|449523|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
134689|NCT00489853|449524|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
134690|NCT00489853|449522|P3|Wash-out Period 1|Protocol Violation|1
134691|NCT00489853|449523|P2|Wash-out Period 1|Protocol Violation|1
134692|NCT00489853|449524|P1|Wash-out Period 1|Protocol Violation|0
134693|NCT00489853|449522|P3|Wash-out Period 1|Adverse Event|1
134694|NCT00489853|449523|P2|Wash-out Period 1|Adverse Event|1
134695|NCT00489853|449524|P1|Wash-out Period 1|Adverse Event|0
134696|NCT00489853|449522|P3|Wash-out Period 1|Withdrawal by Subject|0
134697|NCT00489853|449523|P2|Wash-out Period 1|Withdrawal by Subject|0
134698|NCT00489853|449524|P1|Wash-out Period 1|Withdrawal by Subject|1
134699|NCT00489736|449621|P2|Overall Study|Not coded/ Not pre-specified|8
134700|NCT00489736|449622|P1|Overall Study|Not coded/ Not pre-specified|5
134701|NCT00489736|449621|P2|Overall Study|Poor compliance|2
134702|NCT00489736|449622|P1|Overall Study|Poor compliance|6
134703|NCT00489736|449621|P2|Overall Study|Adverse Event|45
134704|NCT00489736|449622|P1|Overall Study|Adverse Event|32
134705|NCT00489736|449621|P2|Overall Study|Lack of Efficacy|14
134706|NCT00489736|449622|P1|Overall Study|Lack of Efficacy|53
134707|NCT00489554|449632|P1|Overall Study|Lost to Follow-up|1
134708|NCT00489554|449632|P1|Overall Study|Withdrawal by Subject|1
134709|NCT00489554|449632|P1|Overall Study|Adverse Event|2
134710|NCT00489541|449652|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
134711|NCT00489541|449653|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
134712|NCT00489541|449652|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
134713|NCT00489541|449653|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
134714|NCT00489541|449652|P2|12-Month Clinical Follow-up|Death|2
134715|NCT00489541|449653|P1|12-Month Clinical Follow-up|Death|3
134716|NCT00489541|449652|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
134717|NCT00489541|449653|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
134718|NCT00489541|449652|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
134719|NCT00489541|449653|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
134720|NCT00489541|449652|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
134721|NCT00489541|449653|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
134722|NCT00489489|449664|P3|Overall Study|Other than above|0
134723|NCT00489489|449665|P2|Overall Study|Other than above|1
134724|NCT00489489|449666|P1|Overall Study|Other than above|0
134725|NCT00489489|449664|P3|Overall Study|Participant did not wish to continue|0
134726|NCT00489489|449665|P2|Overall Study|Participant did not wish to continue|1
134727|NCT00489489|449666|P1|Overall Study|Participant did not wish to continue|1
134728|NCT00489489|449664|P3|Overall Study|Progressive disease|0
134729|NCT00489489|449665|P2|Overall Study|Progressive disease|1
134730|NCT00489489|449666|P1|Overall Study|Progressive disease|0
134731|NCT00489489|449664|P3|Overall Study|Protocol Violation|1
134732|NCT00489489|449665|P2|Overall Study|Protocol Violation|0
134733|NCT00489489|449666|P1|Overall Study|Protocol Violation|1
134734|NCT00489489|449664|P3|Overall Study|Adverse Event|1
134735|NCT00489489|449665|P2|Overall Study|Adverse Event|1
134736|NCT00489489|449666|P1|Overall Study|Adverse Event|1
134737|NCT00489489|449664|P3|Overall Study|Not treated due to protocol violation|1
134738|NCT00489489|449665|P2|Overall Study|Not treated due to protocol violation|1
134739|NCT00489489|449666|P1|Overall Study|Not treated due to protocol violation|0
134740|NCT00489424|449697|P3|Overall Study|Administrative problems|1
134741|NCT00489424|449698|P2|Overall Study|Administrative problems|2
134742|NCT00489424|449699|P1|Overall Study|Administrative problems|0
134743|NCT00489424|449697|P3|Overall Study|Lack of Efficacy|0
134744|NCT00489424|449698|P2|Overall Study|Lack of Efficacy|0
134745|NCT00489424|449699|P1|Overall Study|Lack of Efficacy|1
134746|NCT00489424|449697|P3|Overall Study|Adverse Event|4
134747|NCT00489424|449698|P2|Overall Study|Adverse Event|3
134748|NCT00489424|449699|P1|Overall Study|Adverse Event|3
134749|NCT00489359|449730|P2|Overall Study|Adverse Event|16
134750|NCT00489359|449731|P1|Overall Study|Adverse Event|0
134751|NCT00489359|449730|P2|Overall Study|Withdrawal by Subject|5
134752|NCT00489359|449731|P1|Overall Study|Withdrawal by Subject|1
134753|NCT00489359|449730|P2|Overall Study|Lost to Follow-up|0
134754|NCT00489359|449731|P1|Overall Study|Lost to Follow-up|1
134755|NCT00489359|449730|P2|Overall Study|Progressive Disease|6
134756|NCT00489359|449731|P1|Overall Study|Progressive Disease|5
134757|NCT00489359|449730|P2|Overall Study|Death|2
134758|NCT00489359|449731|P1|Overall Study|Death|0
134759|NCT00489255|449792|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
134760|NCT00489255|449793|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
134761|NCT00489255|449792|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
134762|NCT00489255|449793|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
134763|NCT00489255|449792|P2|Period 3: Days 57 to 84|Adverse Event|3
134764|NCT00489255|449793|P1|Period 3: Days 57 to 84|Adverse Event|3
134765|NCT00489255|449792|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
134766|NCT00489255|449793|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
134767|NCT00489255|449792|P2|Period 2: Days 29 to 56|Adverse Event|1
134768|NCT00489255|449793|P1|Period 2: Days 29 to 56|Adverse Event|3
134769|NCT00489255|449792|P2|Period 1: Days 1 to 28|Noncompliance|0
134770|NCT00489255|449793|P1|Period 1: Days 1 to 28|Noncompliance|2
134771|NCT00489255|449792|P2|Period 1: Days 1 to 28|Physician Decision|4
134772|NCT00489255|449793|P1|Period 1: Days 1 to 28|Physician Decision|1
134773|NCT00489255|449792|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
134774|NCT00489255|449793|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
134775|NCT00489255|449792|P2|Period 1: Days 1 to 28|Adverse Event|8
134776|NCT00489255|449793|P1|Period 1: Days 1 to 28|Adverse Event|21
134777|NCT00489255|449792|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
134778|NCT00489255|449793|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
134779|NCT00488826|449854|P3|Overall Study|Protocol Deviations|1
134780|NCT00488826|449855|P2|Overall Study|Protocol Deviations|1
134781|NCT00488826|449856|P1|Overall Study|Protocol Deviations|2
134782|NCT00488826|449854|P3|Overall Study|Lost to Follow-up|0
134783|NCT00488826|449855|P2|Overall Study|Lost to Follow-up|1
134784|NCT00488826|449856|P1|Overall Study|Lost to Follow-up|5
134785|NCT00488826|449854|P3|Overall Study|Adverse Event|4
134786|NCT00488826|449855|P2|Overall Study|Adverse Event|15
134787|NCT00488826|449856|P1|Overall Study|Adverse Event|9
134788|NCT00488826|449854|P3|Overall Study|Protocol Violation|2
134789|NCT00488826|449855|P2|Overall Study|Protocol Violation|0
134790|NCT00488826|449856|P1|Overall Study|Protocol Violation|0
134791|NCT00488826|449854|P3|Overall Study|Withdrawal by Subject|19
134792|NCT00488826|449855|P2|Overall Study|Withdrawal by Subject|35
134793|NCT00488826|449856|P1|Overall Study|Withdrawal by Subject|40
134794|NCT00488774|449871|P4|Overall Study|Lost to Follow-up|1
134795|NCT00488774|449872|P3|Overall Study|Lost to Follow-up|1
134796|NCT00488774|449873|P2|Overall Study|Lost to Follow-up|0
134797|NCT00488774|449874|P1|Overall Study|Lost to Follow-up|0
134798|NCT00488774|449871|P4|Overall Study|unspecified|2
134799|NCT00488774|449872|P3|Overall Study|unspecified|2
134800|NCT00488774|449873|P2|Overall Study|unspecified|3
134801|NCT00488774|449874|P1|Overall Study|unspecified|6
134802|NCT00488774|449871|P4|Overall Study|Withdrawal of consent|0
134803|NCT00488774|449872|P3|Overall Study|Withdrawal of consent|2
134804|NCT00488774|449873|P2|Overall Study|Withdrawal of consent|2
134805|NCT00488774|449874|P1|Overall Study|Withdrawal of consent|2
134806|NCT00488683|449891|P3|Overall Study|Unable to Classify|0
134807|NCT00488683|449892|P2|Overall Study|Unable to Classify|0
134808|NCT00488683|449893|P1|Overall Study|Unable to Classify|1
134809|NCT00488683|449891|P3|Overall Study|Protocol Violation|0
134810|NCT00488683|449892|P2|Overall Study|Protocol Violation|1
134811|NCT00488683|449893|P1|Overall Study|Protocol Violation|5
134812|NCT00488683|449891|P3|Overall Study|Lost to Follow-up|0
134813|NCT00488683|449892|P2|Overall Study|Lost to Follow-up|3
134814|NCT00488683|449893|P1|Overall Study|Lost to Follow-up|5
134815|NCT00488683|449891|P3|Overall Study|Withdrawal by Subject|2
134816|NCT00488683|449892|P2|Overall Study|Withdrawal by Subject|2
134817|NCT00488683|449893|P1|Overall Study|Withdrawal by Subject|1
134818|NCT00488644|449952|P1|Overall Study|Not Evaluable|1
134819|NCT00488644|449952|P1|Overall Study|Not Eligible|1
134820|NCT00488631|449962|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
134821|NCT00488631|449963|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
134822|NCT00488631|449964|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
134823|NCT00488631|449965|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
134824|NCT00488631|449966|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
134825|NCT00488631|449967|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
134826|NCT00488631|449968|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
134827|NCT00488631|449969|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
134828|NCT00488631|449970|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
134829|NCT00488631|449971|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
134830|NCT00488631|449962|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
134831|NCT00488631|449963|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
134832|NCT00488631|449964|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
134833|NCT00488631|449965|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
134834|NCT00488631|449966|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
134835|NCT00488631|449967|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
134836|NCT00488631|449968|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
134837|NCT00488631|449969|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
134838|NCT00488631|449970|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
134839|NCT00488631|449971|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
134840|NCT00488631|449962|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
134841|NCT00488631|449963|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
134842|NCT00488631|449964|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
134843|NCT00488631|449965|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
134844|NCT00488631|449966|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
134845|NCT00488631|449967|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
134846|NCT00488631|449968|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
134847|NCT00488631|449969|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
134848|NCT00488631|449970|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
134849|NCT00488631|449971|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
134850|NCT00488631|449962|P10|Open Label Study Extension (Week 54-228)|Death|0
134851|NCT00488631|449963|P9|Open Label Study Extension (Week 54-228)|Death|1
134852|NCT00488631|449964|P8|Open Label Study Extension (Week 54-228)|Death|0
134853|NCT00488631|449965|P7|Open Label Study Extension (Week 54-228)|Death|0
134854|NCT00488631|449966|P6|Open Label Study Extension (Week 54-228)|Death|0
134855|NCT00488631|449967|P5|Open Label Study Extension (Week 54-228)|Death|0
134856|NCT00488631|449968|P4|Open Label Study Extension (Week 54-228)|Death|0
134857|NCT00488631|449969|P3|Open Label Study Extension (Week 54-228)|Death|0
134858|NCT00488631|449970|P2|Open Label Study Extension (Week 54-228)|Death|0
134859|NCT00488631|449971|P1|Open Label Study Extension (Week 54-228)|Death|0
134860|NCT00488631|449962|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
134861|NCT00488631|449963|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
134862|NCT00488631|449964|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
134863|NCT00488631|449965|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
134864|NCT00488631|449966|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
134865|NCT00488631|449967|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
134866|NCT00488631|449968|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
134867|NCT00488631|449969|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
134868|NCT00488631|449970|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
134869|NCT00488631|449971|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
134870|NCT00488631|449962|P10|Double Blind Period (Week 0-54)|Unspecified|0
134871|NCT00488631|449963|P9|Double Blind Period (Week 0-54)|Unspecified|0
134872|NCT00488631|449964|P8|Double Blind Period (Week 0-54)|Unspecified|0
134873|NCT00488631|449965|P7|Double Blind Period (Week 0-54)|Unspecified|0
134874|NCT00488631|449966|P6|Double Blind Period (Week 0-54)|Unspecified|34
134875|NCT00488631|449967|P5|Double Blind Period (Week 0-54)|Unspecified|14
134876|NCT00488631|449968|P4|Double Blind Period (Week 0-54)|Unspecified|11
134877|NCT00488631|449969|P3|Double Blind Period (Week 0-54)|Unspecified|10
134878|NCT00488631|449970|P2|Double Blind Period (Week 0-54)|Unspecified|12
134879|NCT00488631|449971|P1|Double Blind Period (Week 0-54)|Unspecified|6
134880|NCT00488631|449962|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
134881|NCT00488631|449963|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
134882|NCT00488631|449964|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
134883|NCT00488631|449965|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
134884|NCT00488631|449966|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
134885|NCT00488631|449967|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
134886|NCT00488631|449968|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
134887|NCT00488631|449969|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
134888|NCT00488631|449970|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
134889|NCT00488631|449971|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
134890|NCT00488631|449962|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
134891|NCT00488631|449963|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
134892|NCT00488631|449964|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
134893|NCT00488631|449965|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
134894|NCT00488631|449966|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
134895|NCT00488631|449967|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
134896|NCT00488631|449968|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
134897|NCT00488631|449969|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
134898|NCT00488631|449970|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
134899|NCT00488631|449971|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
134900|NCT00488631|449962|P10|Double Blind Period (Week 0-54)|Death|0
134901|NCT00488631|449963|P9|Double Blind Period (Week 0-54)|Death|0
134902|NCT00488631|449964|P8|Double Blind Period (Week 0-54)|Death|0
134903|NCT00488631|449965|P7|Double Blind Period (Week 0-54)|Death|0
134904|NCT00488631|449966|P6|Double Blind Period (Week 0-54)|Death|1
134905|NCT00488631|449967|P5|Double Blind Period (Week 0-54)|Death|0
134906|NCT00488631|449968|P4|Double Blind Period (Week 0-54)|Death|0
134907|NCT00488631|449969|P3|Double Blind Period (Week 0-54)|Death|0
134908|NCT00488631|449970|P2|Double Blind Period (Week 0-54)|Death|0
134909|NCT00488631|449971|P1|Double Blind Period (Week 0-54)|Death|0
134910|NCT00488631|449962|P10|Double Blind Period (Week 0-54)|Adverse Event|0
134911|NCT00488631|449963|P9|Double Blind Period (Week 0-54)|Adverse Event|0
134912|NCT00488631|449964|P8|Double Blind Period (Week 0-54)|Adverse Event|0
134913|NCT00488631|449965|P7|Double Blind Period (Week 0-54)|Adverse Event|0
134914|NCT00488631|449966|P6|Double Blind Period (Week 0-54)|Adverse Event|50
134915|NCT00488631|449967|P5|Double Blind Period (Week 0-54)|Adverse Event|30
134916|NCT00488631|449968|P4|Double Blind Period (Week 0-54)|Adverse Event|12
134917|NCT00488631|449969|P3|Double Blind Period (Week 0-54)|Adverse Event|12
134918|NCT00488631|449970|P2|Double Blind Period (Week 0-54)|Adverse Event|12
134919|NCT00488631|449971|P1|Double Blind Period (Week 0-54)|Adverse Event|17
134920|NCT00488592|450006|P1|Overall Study|Enrolled but not treated|1
134921|NCT00488592|450006|P1|Overall Study|Disease progression|1
134922|NCT00488592|450006|P1|Overall Study|Withdrawal by Subject|1
134923|NCT00488514|450010|P1|Overall Study|Increased use of concomitant medication|1
134924|NCT00488514|450010|P1|Overall Study|Increase in number of migraines|2
134925|NCT00488514|450010|P1|Overall Study|Participant had too few migraines|5
134926|NCT00488514|450010|P1|Overall Study|Investigator decision|1
134927|NCT00488514|450010|P1|Overall Study|Withdrawn per medical monitor decision|2
134928|NCT00488514|450010|P1|Overall Study|Postive drug screen|1
134929|NCT00488514|450010|P1|Overall Study|Did not meet criteria for treatment|30
134930|NCT00488514|450010|P1|Overall Study|Lack of Efficacy|28
134931|NCT00488514|450010|P1|Overall Study|Withdrawal by Subject|106
134932|NCT00488514|450010|P1|Overall Study|Protocol Violation|32
134933|NCT00488514|450010|P1|Overall Study|Lost to Follow-up|44
134934|NCT00488514|450010|P1|Overall Study|Adverse Event|41
134935|NCT00488475|450098|P1|Overall Study|Unspecified|1754
134936|NCT00488345|450127|P3|Overall Study|Parent/legal guardian request|1
134937|NCT00488345|450128|P2|Overall Study|Parent/legal guardian request|1
134938|NCT00488345|450129|P1|Overall Study|Parent/legal guardian request|0
134939|NCT00488345|450127|P3|Overall Study|Surgical team recommendation|0
134940|NCT00488345|450128|P2|Overall Study|Surgical team recommendation|1
134941|NCT00488345|450129|P1|Overall Study|Surgical team recommendation|0
134942|NCT00488345|450127|P3|Overall Study|Institutional Review Board review|1
134943|NCT00488345|450128|P2|Overall Study|Institutional Review Board review|0
134944|NCT00488345|450129|P1|Overall Study|Institutional Review Board review|0
134945|NCT00488345|450127|P3|Overall Study|Unable to administer antibiotics at home|0
134946|NCT00488345|450128|P2|Overall Study|Unable to administer antibiotics at home|1
134947|NCT00488345|450129|P1|Overall Study|Unable to administer antibiotics at home|0
134948|NCT00488345|450127|P3|Overall Study|Adverse Event|1
134949|NCT00488345|450128|P2|Overall Study|Adverse Event|1
134950|NCT00488345|450129|P1|Overall Study|Adverse Event|0
134951|NCT00488319|450155|P3|Overall Study|Other reasons for withdrawal|12
134952|NCT00488319|450156|P2|Overall Study|Other reasons for withdrawal|4
134953|NCT00488319|450157|P1|Overall Study|Other reasons for withdrawal|0
134954|NCT00488319|450155|P3|Overall Study|Withdrawal by Subject|44
134955|NCT00488319|450156|P2|Overall Study|Withdrawal by Subject|20
134956|NCT00488319|450157|P1|Overall Study|Withdrawal by Subject|5
134957|NCT00488319|450155|P3|Overall Study|Lost to Follow-up|16
134958|NCT00488319|450156|P2|Overall Study|Lost to Follow-up|5
134959|NCT00488319|450157|P1|Overall Study|Lost to Follow-up|3
134960|NCT00488319|450155|P3|Overall Study|Lack of Efficacy|27
134961|NCT00488319|450156|P2|Overall Study|Lack of Efficacy|12
134962|NCT00488319|450157|P1|Overall Study|Lack of Efficacy|6
134963|NCT00488319|450155|P3|Overall Study|Adverse Event|23
134964|NCT00488319|450156|P2|Overall Study|Adverse Event|2
134965|NCT00488319|450157|P1|Overall Study|Adverse Event|1
134966|NCT00488293|450244|P2|Overall Study|Misrandomization/Other Unspecified|1
134967|NCT00488293|450245|P1|Overall Study|Misrandomization/Other Unspecified|1
134968|NCT00488293|450244|P2|Overall Study|Death|1
134969|NCT00488293|450245|P1|Overall Study|Death|2
134970|NCT00488293|450244|P2|Overall Study|Withdrawal by Subject|3
134971|NCT00488293|450245|P1|Overall Study|Withdrawal by Subject|5
134972|NCT00488293|450244|P2|Overall Study|Lost to Follow-up|25
134973|NCT00488293|450245|P1|Overall Study|Lost to Follow-up|28
134974|NCT00487981|450288|P1|Overall Study|Hypothyroidism diagnosis|1
134975|NCT00487942|450296|P4|Overall Study|Withdrawal by Subject|0
134976|NCT00487942|450297|P3|Overall Study|Withdrawal by Subject|2
134977|NCT00487942|450298|P2|Overall Study|Withdrawal by Subject|1
134978|NCT00487942|450299|P1|Overall Study|Withdrawal by Subject|0
134979|NCT00487942|450296|P4|Overall Study|Protocol Violation|0
134980|NCT00487942|450297|P3|Overall Study|Protocol Violation|0
134981|NCT00487942|450298|P2|Overall Study|Protocol Violation|1
134982|NCT00487942|450299|P1|Overall Study|Protocol Violation|1
134983|NCT00487942|450296|P4|Overall Study|Lost to Follow-up|1
134984|NCT00487942|450297|P3|Overall Study|Lost to Follow-up|0
134985|NCT00487942|450298|P2|Overall Study|Lost to Follow-up|0
134986|NCT00487942|450299|P1|Overall Study|Lost to Follow-up|1
134987|NCT00487942|450296|P4|Overall Study|Adverse Event|1
134988|NCT00487942|450297|P3|Overall Study|Adverse Event|1
134989|NCT00487942|450298|P2|Overall Study|Adverse Event|1
134990|NCT00487942|450299|P1|Overall Study|Adverse Event|1
134991|NCT00487825|450683|P2|Overall Study|not specified|2
134992|NCT00487825|450684|P1|Overall Study|not specified|3
134993|NCT00487825|450683|P2|Overall Study|Lack of Efficacy|1
134994|NCT00487825|450684|P1|Overall Study|Lack of Efficacy|1
134995|NCT00487825|450683|P2|Overall Study|Adverse Event|2
134996|NCT00487825|450684|P1|Overall Study|Adverse Event|2
134997|NCT00487695|450704|P2|Second Procedure|Withdrawal by Subject|2
134998|NCT00487695|450705|P1|Second Procedure|Withdrawal by Subject|1
134999|NCT00487695|450704|P2|Second Procedure|active wheezing|1
135000|NCT00487695|450705|P1|Second Procedure|active wheezing|0
135001|NCT00487695|450704|P2|First Procedure|esophageal stricture found (excl crit)|0
135002|NCT00487695|450705|P1|First Procedure|esophageal stricture found (excl crit)|1
135003|NCT00487695|450704|P2|First Procedure|active wheezing (did not have procedure)|0
135004|NCT00487695|450705|P1|First Procedure|active wheezing (did not have procedure)|1
135005|NCT00487695|450704|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
135006|NCT00487695|450705|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
135007|NCT00487578|450733|P2|Overall Study|Lost to Follow-up|1
135008|NCT00487578|450734|P1|Overall Study|Lost to Follow-up|0
135009|NCT00487578|450733|P2|Overall Study|Lack of Efficacy|1
135010|NCT00487578|450734|P1|Overall Study|Lack of Efficacy|0
135011|NCT00487578|450733|P2|Overall Study|Adverse Event|2
135012|NCT00487578|450734|P1|Overall Study|Adverse Event|1
135013|NCT00487552|450754|P1|Overall Study|Stent not placed|1
135014|NCT00487552|450754|P1|Overall Study|Death due to progressive malignancy|2
135015|NCT00487552|450754|P1|Overall Study|Unsuccessful magnet placements|3
135016|NCT00487539|450763|P4|Overall Study|Unspecified|2
135017|NCT00487539|450764|P3|Overall Study|Unspecified|2
135018|NCT00487539|450765|P2|Overall Study|Unspecified|1
135019|NCT00487539|450766|P1|Overall Study|Unspecified|3
135020|NCT00487539|450763|P4|Overall Study|Unsatisfactory therapeutic effect|1
135021|NCT00487539|450764|P3|Overall Study|Unsatisfactory therapeutic effect|0
135022|NCT00487539|450765|P2|Overall Study|Unsatisfactory therapeutic effect|0
135023|NCT00487539|450766|P1|Overall Study|Unsatisfactory therapeutic effect|1
135024|NCT00487539|450763|P4|Overall Study|Adverse Event|1
135025|NCT00487539|450764|P3|Overall Study|Adverse Event|1
135026|NCT00487539|450765|P2|Overall Study|Adverse Event|2
135027|NCT00487539|450766|P1|Overall Study|Adverse Event|3
135028|NCT00487435|450800|P1|Overall Study|Other|83
135029|NCT00487435|450800|P1|Overall Study|Study Medication Non-Compliant|32
135030|NCT00487435|450800|P1|Overall Study|Resolution Of Pain|1
135031|NCT00487435|450800|P1|Overall Study|Withdrawal by Subject|132
135032|NCT00487435|450800|P1|Overall Study|Pregnancy|2
135033|NCT00487435|450800|P1|Overall Study|Lost to Follow-up|54
135034|NCT00487435|450800|P1|Overall Study|Lack of Efficacy|33
135035|NCT00487435|450800|P1|Overall Study|Death|2
135036|NCT00487435|450800|P1|Overall Study|Adverse Event|146
135037|NCT00487279|450813|P2|Overall Study|Withdrawal by Subject|2
135038|NCT00487279|450814|P1|Overall Study|Withdrawal by Subject|0
135039|NCT00487279|450813|P2|Overall Study|Death|0
135040|NCT00487279|450814|P1|Overall Study|Death|1
135041|NCT00487240|450824|P2|Overall Study|Physician Decision|0
135042|NCT00487240|450825|P1|Overall Study|Physician Decision|2
135043|NCT00487240|450824|P2|Overall Study|Sponsor Decision|1
135044|NCT00487240|450825|P1|Overall Study|Sponsor Decision|2
135045|NCT00487240|450824|P2|Overall Study|Entry Criteria Not Met|4
135046|NCT00487240|450825|P1|Overall Study|Entry Criteria Not Met|3
135047|NCT00487240|450824|P2|Overall Study|Protocol Violation|5
135048|NCT00487240|450825|P1|Overall Study|Protocol Violation|5
135049|NCT00487240|450824|P2|Overall Study|Adverse Event|4
135050|NCT00487240|450825|P1|Overall Study|Adverse Event|0
135051|NCT00487240|450824|P2|Overall Study|Lost to Follow-up|6
135052|NCT00487240|450825|P1|Overall Study|Lost to Follow-up|7
135053|NCT00487240|450824|P2|Overall Study|Withdrawal by Subject|6
135054|NCT00487240|450825|P1|Overall Study|Withdrawal by Subject|12
135055|NCT00487188|450853|P3|Maintenance Phase|Administrative|1
135056|NCT00487188|450854|P2|Maintenance Phase|Administrative|0
135057|NCT00487188|450855|P1|Maintenance Phase|Administrative|0
135058|NCT00487188|450853|P3|Maintenance Phase|Lost to Follow-up|0
135059|NCT00487188|450854|P2|Maintenance Phase|Lost to Follow-up|0
135060|NCT00487188|450855|P1|Maintenance Phase|Lost to Follow-up|1
135061|NCT00487188|450853|P3|Maintenance Phase|Death|0
135062|NCT00487188|450854|P2|Maintenance Phase|Death|0
135063|NCT00487188|450855|P1|Maintenance Phase|Death|1
135064|NCT00487188|450853|P3|Maintenance Phase|Adverse Event|0
135065|NCT00487188|450854|P2|Maintenance Phase|Adverse Event|0
135066|NCT00487188|450855|P1|Maintenance Phase|Adverse Event|1
135067|NCT00487188|450853|P3|Induction Phase|Administrative|0
135068|NCT00487188|450854|P2|Induction Phase|Administrative|1
135069|NCT00487188|450855|P1|Induction Phase|Administrative|0
135070|NCT00487188|450853|P3|Induction Phase|Lost to Follow-up|0
135071|NCT00487188|450854|P2|Induction Phase|Lost to Follow-up|2
135072|NCT00487188|450855|P1|Induction Phase|Lost to Follow-up|2
135073|NCT00487188|450853|P3|Induction Phase|Refused Treatment|0
135074|NCT00487188|450854|P2|Induction Phase|Refused Treatment|2
135075|NCT00487188|450855|P1|Induction Phase|Refused Treatment|1
135076|NCT00487188|450853|P3|Induction Phase|Protocol Violation|0
135077|NCT00487188|450854|P2|Induction Phase|Protocol Violation|0
135078|NCT00487188|450855|P1|Induction Phase|Protocol Violation|1
135079|NCT00487188|450853|P3|Induction Phase|Lack of Efficacy|0
135080|NCT00487188|450854|P2|Induction Phase|Lack of Efficacy|1
135081|NCT00487188|450855|P1|Induction Phase|Lack of Efficacy|0
135082|NCT00487188|450853|P3|Induction Phase|Adverse Event|0
135083|NCT00487188|450854|P2|Induction Phase|Adverse Event|0
135084|NCT00487188|450855|P1|Induction Phase|Adverse Event|5
135085|NCT00487188|450853|P3|Induction Phase|Abnormality of Laboratory Test|0
135086|NCT00487188|450854|P2|Induction Phase|Abnormality of Laboratory Test|1
135087|NCT00487188|450855|P1|Induction Phase|Abnormality of Laboratory Test|0
135088|NCT00487162|450894|P2|Overall Study|Withdrawal by Subject|3
135089|NCT00487162|450895|P1|Overall Study|Withdrawal by Subject|2
135090|NCT00487162|450894|P2|Overall Study|Physician Decision|1
135091|NCT00487162|450895|P1|Overall Study|Physician Decision|0
135092|NCT00487162|450894|P2|Overall Study|Adverse Event|1
135093|NCT00487162|450895|P1|Overall Study|Adverse Event|0
135094|NCT00487084|450906|P3|Overall Study|Did not receive intervention|5
135095|NCT00487084|450907|P2|Overall Study|Did not receive intervention|3
135096|NCT00487084|450908|P1|Overall Study|Did not receive intervention|4
135097|NCT00486954|450929|P5|Randomized Part|Sponsor Terminated Study|13
135098|NCT00486954|450930|P4|Randomized Part|Sponsor Terminated Study|19
135099|NCT00486954|450931|P3|Randomized Part|Sponsor Terminated Study|0
135100|NCT00486954|450932|P2|Randomized Part|Sponsor Terminated Study|0
135101|NCT00486954|450933|P1|Randomized Part|Sponsor Terminated Study|0
135102|NCT00486954|450929|P5|Randomized Part|Withdrawal by Subject|0
135103|NCT00486954|450930|P4|Randomized Part|Withdrawal by Subject|1
135104|NCT00486954|450931|P3|Randomized Part|Withdrawal by Subject|0
135105|NCT00486954|450932|P2|Randomized Part|Withdrawal by Subject|0
135106|NCT00486954|450933|P1|Randomized Part|Withdrawal by Subject|0
135107|NCT00486954|450929|P5|Randomized Part|Lost to Follow-up|1
135108|NCT00486954|450930|P4|Randomized Part|Lost to Follow-up|0
135109|NCT00486954|450931|P3|Randomized Part|Lost to Follow-up|0
135110|NCT00486954|450932|P2|Randomized Part|Lost to Follow-up|0
135111|NCT00486954|450933|P1|Randomized Part|Lost to Follow-up|0
135112|NCT00486954|450929|P5|Pilot Part|Disease Progression|0
135113|NCT00486954|450930|P4|Pilot Part|Disease Progression|0
135114|NCT00486954|450931|P3|Pilot Part|Disease Progression|1
135115|NCT00486954|450932|P2|Pilot Part|Disease Progression|0
135116|NCT00486954|450933|P1|Pilot Part|Disease Progression|2
135117|NCT00486954|450929|P5|Pilot Part|Adverse Event|0
135118|NCT00486954|450930|P4|Pilot Part|Adverse Event|0
135119|NCT00486954|450931|P3|Pilot Part|Adverse Event|5
135120|NCT00486954|450932|P2|Pilot Part|Adverse Event|0
135121|NCT00486954|450933|P1|Pilot Part|Adverse Event|4
135122|NCT00486902|451031|P2|Overall Study|No toradol due to hemmorhage or allergy|1
135123|NCT00486902|451032|P1|Overall Study|No toradol due to hemmorhage or allergy|3
135124|NCT00486902|451031|P2|Overall Study|Did not meet inclusion criteria|0
135125|NCT00486902|451032|P1|Overall Study|Did not meet inclusion criteria|1
135126|NCT00486902|451031|P2|Overall Study|spinal anesthetic protocal violation|1
135127|NCT00486902|451032|P1|Overall Study|spinal anesthetic protocal violation|1
135128|NCT00486902|451031|P2|Overall Study|decision for postpartum tubal ligation|1
135129|NCT00486902|451032|P1|Overall Study|decision for postpartum tubal ligation|3
135130|NCT00486902|451031|P2|Overall Study|Withdrawal by Subject|2
135131|NCT00486902|451032|P1|Overall Study|Withdrawal by Subject|1
135132|NCT00486837|451099|P2|Overall Study|No sputum, devise issues, exacerbation|4
135133|NCT00486837|451100|P1|Overall Study|No sputum, devise issues, exacerbation|3
135134|NCT00486837|451099|P2|Overall Study|Protocol Violation|2
135135|NCT00486837|451100|P1|Overall Study|Protocol Violation|4
135136|NCT00486837|451099|P2|Overall Study|Adverse Event|1
135137|NCT00486837|451100|P1|Overall Study|Adverse Event|1
135138|NCT00486837|451099|P2|Overall Study|Withdrawal by Subject|0
135139|NCT00486837|451100|P1|Overall Study|Withdrawal by Subject|1
135140|NCT00486811|451119|P3|Overall Study|All other|7
135141|NCT00486811|451120|P2|Overall Study|All other|11
135142|NCT00486811|451121|P1|Overall Study|All other|18
135143|NCT00486811|451119|P3|Overall Study|Study drug non-compliant|3
135144|NCT00486811|451120|P2|Overall Study|Study drug non-compliant|6
135145|NCT00486811|451121|P1|Overall Study|Study drug non-compliant|5
135146|NCT00486811|451119|P3|Overall Study|Withdrawal by Subject|58
135147|NCT00486811|451120|P2|Overall Study|Withdrawal by Subject|44
135148|NCT00486811|451121|P1|Overall Study|Withdrawal by Subject|33
135149|NCT00486811|451119|P3|Overall Study|Lost to Follow-up|4
135150|NCT00486811|451120|P2|Overall Study|Lost to Follow-up|6
135151|NCT00486811|451121|P1|Overall Study|Lost to Follow-up|4
135152|NCT00486811|451119|P3|Overall Study|Lack of Efficacy|7
135153|NCT00486811|451120|P2|Overall Study|Lack of Efficacy|14
135154|NCT00486811|451121|P1|Overall Study|Lack of Efficacy|34
135155|NCT00486811|451119|P3|Overall Study|Adverse Event|135
135156|NCT00486811|451120|P2|Overall Study|Adverse Event|60
135157|NCT00486811|451121|P1|Overall Study|Adverse Event|28
135158|NCT00486759|451164|P2|Safety Follow-up|Adverse event/intercurrent illness|0
135159|NCT00486759|451165|P1|Safety Follow-up|Adverse event/intercurrent illness|4
135160|NCT00486759|451164|P2|Safety Follow-up|Refused treatment/did not cooperate|4
135161|NCT00486759|451165|P1|Safety Follow-up|Refused treatment/did not cooperate|6
135162|NCT00486759|451164|P2|Safety Follow-up|Administrative/not specified|6
135163|NCT00486759|451165|P1|Safety Follow-up|Administrative/not specified|8
135164|NCT00486759|451164|P2|Safety Follow-up|Failure to return|6
135165|NCT00486759|451165|P1|Safety Follow-up|Failure to return|9
135166|NCT00486759|451164|P2|Safety Follow-up|Withdrew consent|23
135167|NCT00486759|451165|P1|Safety Follow-up|Withdrew consent|32
135168|NCT00486759|451164|P2|Safety Follow-up|Death|29
135169|NCT00486759|451165|P1|Safety Follow-up|Death|40
135170|NCT00486759|451164|P2|Safety Follow-up|Insufficient therapeutic response|50
135171|NCT00486759|451165|P1|Safety Follow-up|Insufficient therapeutic response|40
135172|NCT00486759|451164|P2|Treatment|Failure to return|1
135173|NCT00486759|451165|P1|Treatment|Failure to return|1
135174|NCT00486759|451164|P2|Treatment|Other protocol violation|5
135175|NCT00486759|451165|P1|Treatment|Other protocol violation|1
135176|NCT00486759|451164|P2|Treatment|Violation of selection criteria at entry|3
135177|NCT00486759|451165|P1|Treatment|Violation of selection criteria at entry|3
135178|NCT00486759|451164|P2|Treatment|Refused treatment|7
135179|NCT00486759|451165|P1|Treatment|Refused treatment|10
135180|NCT00486759|451164|P2|Treatment|Administrative/reason not specified|21
135181|NCT00486759|451165|P1|Treatment|Administrative/reason not specified|17
135182|NCT00486759|451164|P2|Treatment|Withdrew consent|12
135183|NCT00486759|451165|P1|Treatment|Withdrew consent|15
135184|NCT00486759|451164|P2|Treatment|Death|10
135185|NCT00486759|451165|P1|Treatment|Death|17
135186|NCT00486759|451164|P2|Treatment|Insufficient therapeutic response|39
135187|NCT00486759|451165|P1|Treatment|Insufficient therapeutic response|37
135188|NCT00486759|451164|P2|Treatment|Adverse event/intercurrent illness|39
135189|NCT00486759|451165|P1|Treatment|Adverse event/intercurrent illness|86
135190|NCT00486720|451177|P2|Overall Study|Progressive Disease|1
135191|NCT00486720|451178|P1|Overall Study|Progressive Disease|0
135192|NCT00486720|451177|P2|Overall Study|Withdrawal by Subject|1
135193|NCT00486720|451178|P1|Overall Study|Withdrawal by Subject|3
135194|NCT00486720|451177|P2|Overall Study|Protocol Violation|0
135195|NCT00486720|451178|P1|Overall Study|Protocol Violation|1
135196|NCT00486720|451177|P2|Overall Study|Physician Decision|2
135197|NCT00486720|451178|P1|Overall Study|Physician Decision|1
135198|NCT00486720|451177|P2|Overall Study|Lack of Efficacy|6
135199|NCT00486720|451178|P1|Overall Study|Lack of Efficacy|4
135200|NCT00486720|451177|P2|Overall Study|Adverse Event|2
135201|NCT00486720|451178|P1|Overall Study|Adverse Event|1
135202|NCT00486434|451207|P2|Overall Study|Personal reasons|6
135203|NCT00486434|451208|P1|Overall Study|Personal reasons|5
135204|NCT00486434|451207|P2|Overall Study|Death|2
135205|NCT00486434|451208|P1|Overall Study|Death|1
135206|NCT00486434|451207|P2|Overall Study|Lost to Follow-up|3
135207|NCT00486434|451208|P1|Overall Study|Lost to Follow-up|2
135208|NCT00486434|451207|P2|Overall Study|Lack of Efficacy|19
135209|NCT00486434|451208|P1|Overall Study|Lack of Efficacy|12
135210|NCT00486434|451207|P2|Overall Study|Protocol Violation|21
135211|NCT00486434|451208|P1|Overall Study|Protocol Violation|22
135212|NCT00486434|451207|P2|Overall Study|Adverse Event|44
135213|NCT00486434|451208|P1|Overall Study|Adverse Event|118
135214|NCT00486434|451207|P2|Overall Study|Withdrawal by Subject|39
135215|NCT00486434|451208|P1|Overall Study|Withdrawal by Subject|34
135216|NCT00486330|451218|P1|Overall Study|Adverse Event|2
135217|NCT00486291|451224|P2|Overall Study|requirement for restricted medication|3
135218|NCT00486291|451225|P1|Overall Study|requirement for restricted medication|0
135219|NCT00486291|451224|P2|Overall Study|protocol non-compliance|15
135220|NCT00486291|451225|P1|Overall Study|protocol non-compliance|10
135221|NCT00486291|451224|P2|Overall Study|Lost to Follow-up|7
135222|NCT00486291|451225|P1|Overall Study|Lost to Follow-up|3
135223|NCT00486291|451224|P2|Overall Study|Adverse Event|4
135224|NCT00486291|451225|P1|Overall Study|Adverse Event|3
135225|NCT00486278|451233|P1|Overall Study|Physician Decision|2
135226|NCT00486278|451233|P1|Overall Study|Withdrawal by Subject|2
135227|NCT00486278|451233|P1|Overall Study|Adverse Event|5
135228|NCT00486265|451367|P1|Overall Study|Lack of Efficacy|8
135229|NCT00486265|451367|P1|Overall Study|Adverse Event|1
135230|NCT00486252|451371|P1|Overall Study|Other|18
135231|NCT00486252|451371|P1|Overall Study|Lost to Follow-up|24
135232|NCT00486252|451371|P1|Overall Study|Lack of Efficacy|9
135233|NCT00486252|451371|P1|Overall Study|Adverse Event|7
135234|NCT00486226|451386|P1|Overall Study|Lost to Follow-up|8
135235|NCT00486226|451386|P1|Overall Study|Withdrawal by Subject|1
135236|NCT00486226|451386|P1|Overall Study|Adverse Event|1
135237|NCT00486226|451386|P1|Overall Study|Death|3
135238|NCT00486044|451396|P2|Overall Study|Lost to Follow-up|1
135239|NCT00486044|451397|P1|Overall Study|Lost to Follow-up|0
135240|NCT00486044|451396|P2|Overall Study|Adverse Event|1
135241|NCT00486044|451397|P1|Overall Study|Adverse Event|0
135242|NCT00486044|451396|P2|Overall Study|Withdrawal by Subject|1
135243|NCT00486044|451397|P1|Overall Study|Withdrawal by Subject|2
135244|NCT00485758|451482|P2|Overall Study|Study Terminated by Sponsor|0
135245|NCT00485758|451483|P1|Overall Study|Study Terminated by Sponsor|3
135246|NCT00485758|451482|P2|Overall Study|Withdrawal by Subject|27
135247|NCT00485758|451483|P1|Overall Study|Withdrawal by Subject|32
135248|NCT00485758|451482|P2|Overall Study|Protocol Violation|2
135249|NCT00485758|451483|P1|Overall Study|Protocol Violation|11
135250|NCT00485758|451482|P2|Overall Study|Physician Decision|3
135251|NCT00485758|451483|P1|Overall Study|Physician Decision|3
135252|NCT00485758|451482|P2|Overall Study|Lost to Follow-up|1
135253|NCT00485758|451483|P1|Overall Study|Lost to Follow-up|5
135254|NCT00485758|451482|P2|Overall Study|Death|1
135255|NCT00485758|451483|P1|Overall Study|Death|0
135256|NCT00485758|451482|P2|Overall Study|Adverse Event|31
135257|NCT00485758|451483|P1|Overall Study|Adverse Event|102
135258|NCT00485732|451495|P2|Overall Study|Lost to Follow-up|2
135259|NCT00485732|451496|P1|Overall Study|Lost to Follow-up|2
135260|NCT00485732|451495|P2|Overall Study|Withdrawal by Subject|4
135261|NCT00485732|451496|P1|Overall Study|Withdrawal by Subject|5
135262|NCT00485732|451495|P2|Overall Study|Protocol Violation|3
135263|NCT00485732|451496|P1|Overall Study|Protocol Violation|1
135264|NCT00485472|451534|P2|Overall Study|Lost to Follow-up|1
135265|NCT00485472|451535|P1|Overall Study|Lost to Follow-up|0
135266|NCT00485472|451534|P2|Overall Study|Unspecified|1
135267|NCT00485472|451535|P1|Overall Study|Unspecified|2
135268|NCT00485472|451534|P2|Overall Study|Protocol Violation|1
135269|NCT00485472|451535|P1|Overall Study|Protocol Violation|0
135270|NCT00485472|451534|P2|Overall Study|Withdrawal by Subject|0
135271|NCT00485472|451535|P1|Overall Study|Withdrawal by Subject|1
135272|NCT00485472|451534|P2|Overall Study|Lack of Efficacy|4
135273|NCT00485472|451535|P1|Overall Study|Lack of Efficacy|5
135274|NCT00485472|451534|P2|Overall Study|Adverse Event|5
135275|NCT00485472|451535|P1|Overall Study|Adverse Event|8
135276|NCT00485303|451572|P1|Overall Study|Treatment ongoing at cutoff date|2
135277|NCT00485303|451572|P1|Overall Study|Initiation of new anti-cancer treatment|2
135278|NCT00485303|451572|P1|Overall Study|Unspecified|3
135279|NCT00485303|451572|P1|Overall Study|Progressive Disease|44
135280|NCT00485303|451572|P1|Overall Study|Adverse Event|5
135281|NCT00485264|451590|P6|Overall Study|Data frozen before reaching week 48|0
135282|NCT00485264|451591|P5|Overall Study|Data frozen before reaching week 48|0
135283|NCT00485264|451592|P4|Overall Study|Data frozen before reaching week 48|9
135284|NCT00485264|451593|P3|Overall Study|Data frozen before reaching week 48|0
135285|NCT00485264|451594|P2|Overall Study|Data frozen before reaching week 48|0
135286|NCT00485264|451595|P1|Overall Study|Data frozen before reaching week 48|0
135287|NCT00485264|451590|P6|Overall Study|Lack of Efficacy|0
135288|NCT00485264|451591|P5|Overall Study|Lack of Efficacy|0
135289|NCT00485264|451592|P4|Overall Study|Lack of Efficacy|1
135290|NCT00485264|451593|P3|Overall Study|Lack of Efficacy|0
135291|NCT00485264|451594|P2|Overall Study|Lack of Efficacy|0
135292|NCT00485264|451595|P1|Overall Study|Lack of Efficacy|0
135293|NCT00485264|451590|P6|Overall Study|Physician Decision|0
135294|NCT00485264|451591|P5|Overall Study|Physician Decision|0
135295|NCT00485264|451592|P4|Overall Study|Physician Decision|0
135296|NCT00485264|451593|P3|Overall Study|Physician Decision|0
135297|NCT00485264|451594|P2|Overall Study|Physician Decision|1
135298|NCT00485264|451595|P1|Overall Study|Physician Decision|0
135299|NCT00485264|451590|P6|Overall Study|Non-compliant|0
135300|NCT00485264|451591|P5|Overall Study|Non-compliant|0
135301|NCT00485264|451592|P4|Overall Study|Non-compliant|0
135302|NCT00485264|451593|P3|Overall Study|Non-compliant|0
135303|NCT00485264|451594|P2|Overall Study|Non-compliant|0
135304|NCT00485264|451595|P1|Overall Study|Non-compliant|6
135305|NCT00485173|451681|P2|Overall Study|Lost to Follow-up|61
135306|NCT00485173|451682|P1|Overall Study|Lost to Follow-up|32
135307|NCT00485173|451681|P2|Overall Study|Death|3
135308|NCT00485173|451682|P1|Overall Study|Death|4
135309|NCT00485069|451724|P2|Overall Study|Withdrawal by Subject|6
135310|NCT00485069|451725|P1|Overall Study|Withdrawal by Subject|6
135311|NCT00485069|451724|P2|Overall Study|Protocol Violation|1
135312|NCT00485069|451725|P1|Overall Study|Protocol Violation|0
135313|NCT00485069|451724|P2|Overall Study|Lack of Efficacy|1
135314|NCT00485069|451725|P1|Overall Study|Lack of Efficacy|2
135315|NCT00485069|451724|P2|Overall Study|Adverse Event|4
135316|NCT00485069|451725|P1|Overall Study|Adverse Event|10
135317|NCT00484939|451770|P2|Overall Study|Reason Not Specified|6
135318|NCT00484939|451771|P1|Overall Study|Reason Not Specified|11
135319|NCT00484939|451770|P2|Overall Study|Screen Failure|2
135320|NCT00484939|451771|P1|Overall Study|Screen Failure|2
135321|NCT00484939|451770|P2|Overall Study|Disease progression|88
135322|NCT00484939|451771|P1|Overall Study|Disease progression|67
135323|NCT00484939|451770|P2|Overall Study|Discretion of Investigator or Sponsor|3
135324|NCT00484939|451771|P1|Overall Study|Discretion of Investigator or Sponsor|7
135325|NCT00484939|451770|P2|Overall Study|Lost to Follow-up|3
135326|NCT00484939|451771|P1|Overall Study|Lost to Follow-up|0
135327|NCT00484939|451770|P2|Overall Study|Protocol Violation|3
135328|NCT00484939|451771|P1|Overall Study|Protocol Violation|3
135329|NCT00484939|451770|P2|Overall Study|Patient Withdrew Consent|10
135330|NCT00484939|451771|P1|Overall Study|Patient Withdrew Consent|19
135331|NCT00484939|451770|P2|Overall Study|Adverse Event|12
135332|NCT00484939|451771|P1|Overall Study|Adverse Event|22
135333|NCT00484939|451770|P2|Overall Study|Death|13
135334|NCT00484939|451771|P1|Overall Study|Death|9
135335|NCT00484679|451791|P1|Overall Study|Withdrawal by Subject|3
135336|NCT00484419|451798|P3|Overall Study|sponsor decision, randomized in error|2
135337|NCT00484419|451799|P2|Overall Study|sponsor decision, randomized in error|0
135338|NCT00484419|451800|P1|Overall Study|sponsor decision, randomized in error|0
135339|NCT00484419|451798|P3|Overall Study|subject relocated|0
135340|NCT00484419|451799|P2|Overall Study|subject relocated|1
135341|NCT00484419|451800|P1|Overall Study|subject relocated|0
135342|NCT00484419|451798|P3|Overall Study|subject unable to receive medication|0
135343|NCT00484419|451799|P2|Overall Study|subject unable to receive medication|0
135344|NCT00484419|451800|P1|Overall Study|subject unable to receive medication|1
135345|NCT00484419|451798|P3|Overall Study|Physician Decision|1
135346|NCT00484419|451799|P2|Overall Study|Physician Decision|1
135347|NCT00484419|451800|P1|Overall Study|Physician Decision|1
135348|NCT00484419|451798|P3|Overall Study|required restricted medication|1
135349|NCT00484419|451799|P2|Overall Study|required restricted medication|0
135350|NCT00484419|451800|P1|Overall Study|required restricted medication|1
135351|NCT00484419|451798|P3|Overall Study|subject met discontinuation criteria|4
135352|NCT00484419|451799|P2|Overall Study|subject met discontinuation criteria|2
135353|NCT00484419|451800|P1|Overall Study|subject met discontinuation criteria|2
135354|NCT00484419|451798|P3|Overall Study|Withdrawal by Subject|1
135355|NCT00484419|451799|P2|Overall Study|Withdrawal by Subject|1
135356|NCT00484419|451800|P1|Overall Study|Withdrawal by Subject|3
135357|NCT00484419|451798|P3|Overall Study|Lost to Follow-up|2
135358|NCT00484419|451799|P2|Overall Study|Lost to Follow-up|0
135359|NCT00484419|451800|P1|Overall Study|Lost to Follow-up|1
135360|NCT00484419|451798|P3|Overall Study|Adverse Event|0
135361|NCT00484419|451799|P2|Overall Study|Adverse Event|0
135362|NCT00484419|451800|P1|Overall Study|Adverse Event|3
135363|NCT00484315|451867|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
135364|NCT00484315|451868|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
135365|NCT00484315|451867|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
135366|NCT00484315|451868|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
135367|NCT00484315|451867|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
135368|NCT00484315|451868|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
135369|NCT00484315|451867|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
135370|NCT00484315|451868|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
135371|NCT00484315|451867|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
135372|NCT00484315|451868|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
135373|NCT00484315|451867|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
135374|NCT00484315|451868|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
135375|NCT00484315|451867|P2|12-Month Clinical Follow-up|Death|2
135376|NCT00484315|451868|P1|12-Month Clinical Follow-up|Death|6
135377|NCT00484289|451879|P3|Post Marketing Phase|Adverse Event|0
135378|NCT00484289|451880|P2|Post Marketing Phase|Adverse Event|1
135379|NCT00484289|451881|P1|Post Marketing Phase|Adverse Event|0
135380|NCT00484289|451879|P3|Long Term Phase|Other Reason|1
135381|NCT00484289|451880|P2|Long Term Phase|Other Reason|5
135382|NCT00484289|451881|P1|Long Term Phase|Other Reason|0
135383|NCT00484289|451879|P3|Long Term Phase|Inadequate response|4
135384|NCT00484289|451880|P2|Long Term Phase|Inadequate response|7
135385|NCT00484289|451881|P1|Long Term Phase|Inadequate response|2
135386|NCT00484289|451879|P3|Long Term Phase|Withdrawal by Subject|6
135387|NCT00484289|451880|P2|Long Term Phase|Withdrawal by Subject|7
135388|NCT00484289|451881|P1|Long Term Phase|Withdrawal by Subject|0
135389|NCT00484289|451879|P3|Long Term Phase|Adverse Event|5
135390|NCT00484289|451880|P2|Long Term Phase|Adverse Event|17
135391|NCT00484289|451881|P1|Long Term Phase|Adverse Event|1
135392|NCT00484185|451953|P1|Overall Study|Death|2
135393|NCT00484185|451953|P1|Overall Study|Randomized but not treated|5
135394|NCT00484185|451953|P1|Overall Study|Unspecified|20
135395|NCT00484185|451953|P1|Overall Study|Lost to Follow-up|44
135396|NCT00484159|451975|P3|Overall Study|Lost to Follow-up|0
135397|NCT00484159|451976|P2|Overall Study|Lost to Follow-up|1
135398|NCT00484159|451977|P1|Overall Study|Lost to Follow-up|1
135399|NCT00484094|451988|P1|Overall Study|Other|3
135400|NCT00484094|451988|P1|Overall Study|Discontinued|39
135401|NCT00483938|452004|P7|Overall Study|Unspecified|32
135402|NCT00483938|452005|P6|Overall Study|Unspecified|4
135403|NCT00483938|452006|P5|Overall Study|Unspecified|0
135404|NCT00483938|452007|P4|Overall Study|Unspecified|4
135405|NCT00483938|452008|P3|Overall Study|Unspecified|0
135406|NCT00483938|452009|P2|Overall Study|Unspecified|9
135407|NCT00483938|452010|P1|Overall Study|Unspecified|3
135408|NCT00483938|452004|P7|Overall Study|Death|0
135409|NCT00483938|452005|P6|Overall Study|Death|0
135410|NCT00483938|452006|P5|Overall Study|Death|0
135411|NCT00483938|452007|P4|Overall Study|Death|0
135412|NCT00483938|452008|P3|Overall Study|Death|0
135413|NCT00483938|452009|P2|Overall Study|Death|2
135414|NCT00483938|452010|P1|Overall Study|Death|0
135415|NCT00483938|452004|P7|Overall Study|Lost to Follow-up|3
135416|NCT00483938|452005|P6|Overall Study|Lost to Follow-up|1
135417|NCT00483938|452006|P5|Overall Study|Lost to Follow-up|1
135418|NCT00483938|452007|P4|Overall Study|Lost to Follow-up|2
135419|NCT00483938|452008|P3|Overall Study|Lost to Follow-up|0
135420|NCT00483938|452009|P2|Overall Study|Lost to Follow-up|2
135421|NCT00483938|452010|P1|Overall Study|Lost to Follow-up|1
135422|NCT00483938|452004|P7|Overall Study|Withdrawal by Subject|2
135423|NCT00483938|452005|P6|Overall Study|Withdrawal by Subject|3
135424|NCT00483938|452006|P5|Overall Study|Withdrawal by Subject|1
135425|NCT00483938|452007|P4|Overall Study|Withdrawal by Subject|0
135426|NCT00483938|452008|P3|Overall Study|Withdrawal by Subject|0
135427|NCT00483938|452009|P2|Overall Study|Withdrawal by Subject|6
135428|NCT00483938|452010|P1|Overall Study|Withdrawal by Subject|1
135429|NCT00483938|452004|P7|Overall Study|Protocol Violation|3
135430|NCT00483938|452005|P6|Overall Study|Protocol Violation|0
135431|NCT00483938|452006|P5|Overall Study|Protocol Violation|0
135432|NCT00483938|452007|P4|Overall Study|Protocol Violation|0
135433|NCT00483938|452008|P3|Overall Study|Protocol Violation|0
135434|NCT00483938|452009|P2|Overall Study|Protocol Violation|0
135435|NCT00483938|452010|P1|Overall Study|Protocol Violation|0
135436|NCT00482729|452033|P2|Overall Study|Withdrawal by Subject|69
135437|NCT00482729|452034|P1|Overall Study|Withdrawal by Subject|67
135438|NCT00482729|452033|P2|Overall Study|Protocol Violation|18
135439|NCT00482729|452034|P1|Overall Study|Protocol Violation|10
135440|NCT00482729|452033|P2|Overall Study|Pregnancy|2
135441|NCT00482729|452034|P1|Overall Study|Pregnancy|4
135442|NCT00482729|452033|P2|Overall Study|Physician Decision|7
135443|NCT00482729|452034|P1|Overall Study|Physician Decision|10
135444|NCT00482729|452033|P2|Overall Study|Lost to Follow-up|66
135445|NCT00482729|452034|P1|Overall Study|Lost to Follow-up|86
135446|NCT00482729|452033|P2|Overall Study|Lack of Efficacy|16
135447|NCT00482729|452034|P1|Overall Study|Lack of Efficacy|4
135448|NCT00482729|452033|P2|Overall Study|Hyperglycemia Criteria|5
135449|NCT00482729|452034|P1|Overall Study|Hyperglycemia Criteria|7
135450|NCT00482729|452033|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
135451|NCT00482729|452034|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
135452|NCT00482729|452033|P2|Overall Study|Adverse Event|33
135453|NCT00482729|452034|P1|Overall Study|Adverse Event|29
135454|NCT00482703|452050|P2|Overall Study|Poor compliance|0
135455|NCT00482703|452051|P1|Overall Study|Poor compliance|1
135456|NCT00483756|452099|P3|Overall Study|Randomized, Not Treated|4
135457|NCT00483756|452100|P2|Overall Study|Randomized, Not Treated|4
135458|NCT00483756|452101|P1|Overall Study|Randomized, Not Treated|1
135459|NCT00483756|452099|P3|Overall Study|Unspecified|3
135460|NCT00483756|452100|P2|Overall Study|Unspecified|4
135461|NCT00483756|452101|P1|Overall Study|Unspecified|2
135462|NCT00483756|452099|P3|Overall Study|Withdrawal by Subject|4
135463|NCT00483756|452100|P2|Overall Study|Withdrawal by Subject|3
135464|NCT00483756|452101|P1|Overall Study|Withdrawal by Subject|5
135465|NCT00483756|452099|P3|Overall Study|Lost to Follow-up|0
135466|NCT00483756|452100|P2|Overall Study|Lost to Follow-up|1
135467|NCT00483756|452101|P1|Overall Study|Lost to Follow-up|3
135468|NCT00483756|452099|P3|Overall Study|Lack of Efficacy|0
135469|NCT00483756|452100|P2|Overall Study|Lack of Efficacy|0
135470|NCT00483756|452101|P1|Overall Study|Lack of Efficacy|1
135471|NCT00483756|452099|P3|Overall Study|Adverse Event|40
135472|NCT00483756|452100|P2|Overall Study|Adverse Event|38
135473|NCT00483756|452101|P1|Overall Study|Adverse Event|19
135474|NCT00483756|452099|P3|Overall Study|Death|1
135475|NCT00483756|452100|P2|Overall Study|Death|0
135476|NCT00483756|452101|P1|Overall Study|Death|2
135477|NCT00483717|452165|P2|Overall Study|Withdrawal by Subject|0
135478|NCT00483717|452166|P1|Overall Study|Withdrawal by Subject|1
135479|NCT00483717|452165|P2|Overall Study|Lost to Follow-up|0
135480|NCT00483717|452166|P1|Overall Study|Lost to Follow-up|1
135481|NCT00483717|452165|P2|Overall Study|No treatment for migraine|13
135482|NCT00483717|452166|P1|Overall Study|No treatment for migraine|16
135483|NCT00483717|452165|P2|Overall Study|Time of dosing missing|1
135484|NCT00483717|452166|P1|Overall Study|Time of dosing missing|1
135485|NCT00483717|452165|P2|Overall Study|Protocol Violation|7
135486|NCT00483717|452166|P1|Overall Study|Protocol Violation|5
135487|NCT00483704|452189|P3|Treatment|Physician Decision|4
135488|NCT00483704|452190|P2|Treatment|Physician Decision|1
135489|NCT00483704|452191|P1|Treatment|Physician Decision|0
135490|NCT00483704|452189|P3|Treatment|Pregnancy|0
135491|NCT00483704|452190|P2|Treatment|Pregnancy|1
135492|NCT00483704|452191|P1|Treatment|Pregnancy|0
135493|NCT00483704|452189|P3|Treatment|Lack of Efficacy|1
135494|NCT00483704|452190|P2|Treatment|Lack of Efficacy|1
135495|NCT00483704|452191|P1|Treatment|Lack of Efficacy|1
135496|NCT00483704|452189|P3|Treatment|Lost to Follow-up|5
135497|NCT00483704|452190|P2|Treatment|Lost to Follow-up|7
135498|NCT00483704|452191|P1|Treatment|Lost to Follow-up|2
135499|NCT00483704|452189|P3|Treatment|Protocol Violation|5
135500|NCT00483704|452190|P2|Treatment|Protocol Violation|3
135501|NCT00483704|452191|P1|Treatment|Protocol Violation|6
135502|NCT00483704|452189|P3|Treatment|Withdrawal by Subject|21
135503|NCT00483704|452190|P2|Treatment|Withdrawal by Subject|12
135504|NCT00483704|452191|P1|Treatment|Withdrawal by Subject|16
135505|NCT00483704|452189|P3|Treatment|Adverse Event|4
135506|NCT00483704|452190|P2|Treatment|Adverse Event|5
135507|NCT00483704|452191|P1|Treatment|Adverse Event|3
135508|NCT00483704|452189|P3|Treatment|Lack of qualifying migraines|116
135509|NCT00483704|452190|P2|Treatment|Lack of qualifying migraines|99
135510|NCT00483704|452191|P1|Treatment|Lack of qualifying migraines|101
135511|NCT00483704|452189|P3|Randomization|Lack of qualifying migraines|31
135512|NCT00483704|452190|P2|Randomization|Lack of qualifying migraines|25
135513|NCT00483704|452191|P1|Randomization|Lack of qualifying migraines|21
135514|NCT00483704|452189|P3|Randomization|Progressive disease|1
135515|NCT00483704|452190|P2|Randomization|Progressive disease|0
135516|NCT00483704|452191|P1|Randomization|Progressive disease|0
135517|NCT00483704|452189|P3|Randomization|Physician Decision|0
135518|NCT00483704|452190|P2|Randomization|Physician Decision|4
135519|NCT00483704|452191|P1|Randomization|Physician Decision|2
135520|NCT00483704|452189|P3|Randomization|Pregnancy|0
135521|NCT00483704|452190|P2|Randomization|Pregnancy|0
135522|NCT00483704|452191|P1|Randomization|Pregnancy|1
135523|NCT00483704|452189|P3|Randomization|Lost to Follow-up|19
135524|NCT00483704|452190|P2|Randomization|Lost to Follow-up|14
135525|NCT00483704|452191|P1|Randomization|Lost to Follow-up|14
135526|NCT00483704|452189|P3|Randomization|Protocol Violation|22
135527|NCT00483704|452190|P2|Randomization|Protocol Violation|25
135528|NCT00483704|452191|P1|Randomization|Protocol Violation|14
135529|NCT00483704|452189|P3|Randomization|Withdrawal by Subject|18
135530|NCT00483704|452190|P2|Randomization|Withdrawal by Subject|28
135531|NCT00483704|452191|P1|Randomization|Withdrawal by Subject|19
135532|NCT00483652|452237|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
135533|NCT00483652|452238|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
135534|NCT00483652|452237|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
135535|NCT00483652|452238|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
135536|NCT00483652|452237|P2|Double-blind Treatment Period|Adverse Event|4
135537|NCT00483652|452238|P1|Double-blind Treatment Period|Adverse Event|3
135538|NCT00483652|452237|P2|Double-blind Treatment Period|Protocol Violation|1
135539|NCT00483652|452238|P1|Double-blind Treatment Period|Protocol Violation|2
135540|NCT00483574|452248|P2|Overall Study|Withdrawal by Subject|0
135541|NCT00483574|452249|P1|Overall Study|Withdrawal by Subject|52
135542|NCT00483574|452248|P2|Overall Study|Lost to Follow-up|4
135543|NCT00483574|452249|P1|Overall Study|Lost to Follow-up|16
135544|NCT00483574|452248|P2|Overall Study|Protocol Violation|9
135545|NCT00483574|452249|P1|Overall Study|Protocol Violation|28
135546|NCT00483574|452248|P2|Overall Study|Adverse Event|0
135547|NCT00483574|452249|P1|Overall Study|Adverse Event|6
135548|NCT00483548|452259|P2|Overall Study|Withdrawal by Subject|2
135549|NCT00483548|452260|P1|Overall Study|Withdrawal by Subject|5
135550|NCT00483548|452259|P2|Overall Study|Lost to Follow-up|4
135551|NCT00483548|452260|P1|Overall Study|Lost to Follow-up|3
135552|NCT00483548|452259|P2|Overall Study|Non-compliance with medication|0
135553|NCT00483548|452260|P1|Overall Study|Non-compliance with medication|2
135554|NCT00483548|452259|P2|Overall Study|Unable to comply with protocol schedule|0
135555|NCT00483548|452260|P1|Overall Study|Unable to comply with protocol schedule|1
135556|NCT00483548|452259|P2|Overall Study|Protocol required discontinuation|6
135557|NCT00483548|452260|P1|Overall Study|Protocol required discontinuation|6
135558|NCT00483548|452259|P2|Overall Study|Pregnancy|0
135559|NCT00483548|452260|P1|Overall Study|Pregnancy|1
135560|NCT00483548|452259|P2|Overall Study|Protocol Violation|7
135561|NCT00483548|452260|P1|Overall Study|Protocol Violation|11
135562|NCT00483548|452259|P2|Overall Study|Lack of Efficacy|8
135563|NCT00483548|452260|P1|Overall Study|Lack of Efficacy|4
135564|NCT00483548|452259|P2|Overall Study|Laboratory abnormality|2
135565|NCT00483548|452260|P1|Overall Study|Laboratory abnormality|1
135566|NCT00483548|452259|P2|Overall Study|Adverse Event|14
135567|NCT00483548|452260|P1|Overall Study|Adverse Event|25
135568|NCT00483548|452259|P2|Overall Study|Randomized; not treated with study drug|3
135569|NCT00483548|452260|P1|Overall Study|Randomized; not treated with study drug|1
135570|NCT00483379|452311|P2|Treatment Period|Withdrawal by Subject|0
135571|NCT00483379|452312|P1|Treatment Period|Withdrawal by Subject|1
135572|NCT00483379|452311|P2|Treatment Period|Adverse Event|0
135573|NCT00483379|452312|P1|Treatment Period|Adverse Event|1
135574|NCT00483327|452348|P1|Overall Study|Patient Non Compliance|2
135575|NCT00483327|452348|P1|Overall Study|Lost to Follow-up|4
135576|NCT00483327|452348|P1|Overall Study|Withdrawal by Subject|3
135577|NCT00483327|452348|P1|Overall Study|Adverse Event|1
135578|NCT00483184|452371|P3|Overall Study|Protocol Violation|1
135579|NCT00483184|452372|P2|Overall Study|Protocol Violation|0
135580|NCT00483184|452373|P1|Overall Study|Protocol Violation|1
135581|NCT00483184|452371|P3|Overall Study|Adverse Event|2
135582|NCT00483184|452372|P2|Overall Study|Adverse Event|2
135583|NCT00483184|452373|P1|Overall Study|Adverse Event|1
135584|NCT00483184|452371|P3|Overall Study|Lost to Follow-up|0
135585|NCT00483184|452372|P2|Overall Study|Lost to Follow-up|0
135586|NCT00483184|452373|P1|Overall Study|Lost to Follow-up|1
135587|NCT00483184|452371|P3|Overall Study|Withdrawal by Subject|0
135588|NCT00483184|452372|P2|Overall Study|Withdrawal by Subject|2
135589|NCT00483184|452373|P1|Overall Study|Withdrawal by Subject|2
135590|NCT00483119|452383|P2|Overall Study|Physician Decision|0
135591|NCT00483119|452384|P1|Overall Study|Physician Decision|1
135592|NCT00483119|452383|P2|Overall Study|Adverse Event|1
135593|NCT00483119|452384|P1|Overall Study|Adverse Event|0
135594|NCT00483041|452398|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
135595|NCT00483041|452399|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
135596|NCT00483002|452429|P1|Overall Study|Unspecified|967
135597|NCT00483002|452429|P1|Overall Study|Other|2
135598|NCT00483002|452429|P1|Overall Study|Lost to Follow-up|962
135599|NCT00483002|452429|P1|Overall Study|Lack of Efficacy|555
135600|NCT00483002|452429|P1|Overall Study|Adverse Event|68
135601|NCT00482612|452459|P4|Follow-up Period|Reasons not related to trial|3
135602|NCT00482612|452460|P3|Follow-up Period|Reasons not related to trial|1
135603|NCT00482612|452461|P2|Follow-up Period|Reasons not related to trial|0
135604|NCT00482612|452462|P1|Follow-up Period|Reasons not related to trial|1
135605|NCT00482612|452459|P4|Follow-up Period|Withdrawal by Subject|2
135606|NCT00482612|452460|P3|Follow-up Period|Withdrawal by Subject|7
135607|NCT00482612|452461|P2|Follow-up Period|Withdrawal by Subject|5
135608|NCT00482612|452462|P1|Follow-up Period|Withdrawal by Subject|3
135609|NCT00482612|452459|P4|Follow-up Period|Lack of Efficacy|0
135610|NCT00482612|452460|P3|Follow-up Period|Lack of Efficacy|1
135611|NCT00482612|452461|P2|Follow-up Period|Lack of Efficacy|0
135612|NCT00482612|452462|P1|Follow-up Period|Lack of Efficacy|2
135613|NCT00482612|452459|P4|Follow-up Period|Adverse Event|0
135614|NCT00482612|452460|P3|Follow-up Period|Adverse Event|9
135615|NCT00482612|452461|P2|Follow-up Period|Adverse Event|7
135616|NCT00482612|452462|P1|Follow-up Period|Adverse Event|4
135617|NCT00482612|452459|P4|Follow-up Period|Lost to Follow-up|1
135618|NCT00482612|452460|P3|Follow-up Period|Lost to Follow-up|2
135619|NCT00482612|452461|P2|Follow-up Period|Lost to Follow-up|4
135620|NCT00482612|452462|P1|Follow-up Period|Lost to Follow-up|0
135621|NCT00482612|452459|P4|Follow-up Period|Lack of compliance|0
135622|NCT00482612|452460|P3|Follow-up Period|Lack of compliance|1
135623|NCT00482612|452461|P2|Follow-up Period|Lack of compliance|0
135624|NCT00482612|452462|P1|Follow-up Period|Lack of compliance|0
135625|NCT00482612|452459|P4|Follow-up Period|Unspecified|2
135626|NCT00482612|452460|P3|Follow-up Period|Unspecified|1
135627|NCT00482612|452461|P2|Follow-up Period|Unspecified|2
135628|NCT00482612|452462|P1|Follow-up Period|Unspecified|4
135629|NCT00482612|452459|P4|In-treatment Period|No study medication administered|0
135630|NCT00482612|452460|P3|In-treatment Period|No study medication administered|1
135631|NCT00482612|452461|P2|In-treatment Period|No study medication administered|0
135632|NCT00482612|452462|P1|In-treatment Period|No study medication administered|0
135633|NCT00482274|452511|P1|Overall Study|Adverse Event|1
135634|NCT00482170|452521|P2|Overall Study|Unspecified reason|2
135635|NCT00482170|452522|P1|Overall Study|Unspecified reason|0
135636|NCT00482170|452521|P2|Overall Study|Lost to Follow-up|0
135637|NCT00482170|452522|P1|Overall Study|Lost to Follow-up|2
135638|NCT00482170|452521|P2|Overall Study|Protocol Violation|3
135639|NCT00482170|452522|P1|Overall Study|Protocol Violation|2
135640|NCT00482170|452521|P2|Overall Study|Withdrawal by Subject|1
135641|NCT00482170|452522|P1|Overall Study|Withdrawal by Subject|6
135642|NCT00482170|452521|P2|Overall Study|Adverse Event|14
135643|NCT00482170|452522|P1|Overall Study|Adverse Event|5
135644|NCT00482014|452644|P4|Overall Study|Sponsor Decision|1
135645|NCT00482014|452645|P3|Overall Study|Sponsor Decision|1
135646|NCT00482014|452646|P2|Overall Study|Sponsor Decision|2
135647|NCT00482014|452647|P1|Overall Study|Sponsor Decision|1
135648|NCT00482014|452644|P4|Overall Study|Lack of Efficacy|6
135649|NCT00482014|452645|P3|Overall Study|Lack of Efficacy|4
135650|NCT00482014|452646|P2|Overall Study|Lack of Efficacy|0
135651|NCT00482014|452647|P1|Overall Study|Lack of Efficacy|1
135652|NCT00482014|452644|P4|Overall Study|Death|4
135653|NCT00482014|452645|P3|Overall Study|Death|1
135654|NCT00482014|452646|P2|Overall Study|Death|2
135655|NCT00482014|452647|P1|Overall Study|Death|1
135656|NCT00482014|452644|P4|Overall Study|Adverse Event|8
135657|NCT00482014|452645|P3|Overall Study|Adverse Event|2
135658|NCT00482014|452646|P2|Overall Study|Adverse Event|0
135659|NCT00482014|452647|P1|Overall Study|Adverse Event|3
135660|NCT00482014|452644|P4|Overall Study|Withdrawal by Subject|4
135661|NCT00482014|452645|P3|Overall Study|Withdrawal by Subject|3
135662|NCT00482014|452646|P2|Overall Study|Withdrawal by Subject|2
135663|NCT00482014|452647|P1|Overall Study|Withdrawal by Subject|1
135664|NCT00481988|452671|P2|Overall Study|Withdrawal by Subject|1
135665|NCT00481988|452672|P1|Overall Study|Withdrawal by Subject|1
135666|NCT00481871|452685|P5|Overall Study|Progressive Disease - pt withdrew|0
135667|NCT00481871|452686|P4|Overall Study|Progressive Disease - pt withdrew|0
135668|NCT00481871|452687|P3|Overall Study|Progressive Disease - pt withdrew|1
135669|NCT00481871|452688|P2|Overall Study|Progressive Disease - pt withdrew|0
135670|NCT00481871|452689|P1|Overall Study|Progressive Disease - pt withdrew|0
135671|NCT00481767|452716|P2|Overall Study|Lost to Follow-up|10
135672|NCT00481767|452717|P1|Overall Study|Lost to Follow-up|16
135673|NCT00481767|452716|P2|Overall Study|Withdrawal by Subject|11
135674|NCT00481767|452717|P1|Overall Study|Withdrawal by Subject|16
135675|NCT00481676|452749|P2|Overall Study|Administrative problem|0
135676|NCT00481676|452750|P1|Overall Study|Administrative problem|1
135677|NCT00481676|452749|P2|Overall Study|Unsatisfactory therapeutic effect|4
135678|NCT00481676|452750|P1|Overall Study|Unsatisfactory therapeutic effect|1
135679|NCT00481676|452749|P2|Overall Study|Adverse Event|1
135680|NCT00481676|452750|P1|Overall Study|Adverse Event|0
135681|NCT00480636|452772|P1|Overall Study|Lost to follow-up; subsequently died|1
135682|NCT00480636|452772|P1|Overall Study|Unspecified|2
135683|NCT00480636|452772|P1|Overall Study|Lost to Follow-up|4
135684|NCT00480636|452772|P1|Overall Study|Death|12
135685|NCT00481247|452808|P2|Overall Study|Did not receive treatment|2
135686|NCT00481247|452809|P1|Overall Study|Did not receive treatment|1
135687|NCT00481247|452808|P2|Overall Study|Varied|15
135688|NCT00481247|452809|P1|Overall Study|Varied|6
135689|NCT00481247|452808|P2|Overall Study|Administrative reason by sponsor|162
135690|NCT00481247|452809|P1|Overall Study|Administrative reason by sponsor|157
135691|NCT00481247|452808|P2|Overall Study|Poor compliance/noncompliance|7
135692|NCT00481247|452809|P1|Overall Study|Poor compliance/noncompliance|1
135693|NCT00481247|452808|P2|Overall Study|Lost to Follow-up|2
135694|NCT00481247|452809|P1|Overall Study|Lost to Follow-up|1
135695|NCT00481247|452808|P2|Overall Study|Pregnancy|1
135696|NCT00481247|452809|P1|Overall Study|Pregnancy|2
135697|NCT00481247|452808|P2|Overall Study|Withdrawal by Subject|13
135698|NCT00481247|452809|P1|Overall Study|Withdrawal by Subject|8
135699|NCT00481247|452808|P2|Overall Study|AE unrelated to study drug|4
135700|NCT00481247|452809|P1|Overall Study|AE unrelated to study drug|13
135701|NCT00481247|452808|P2|Overall Study|Treatment failure|14
135702|NCT00481247|452809|P1|Overall Study|Treatment failure|10
135703|NCT00481247|452808|P2|Overall Study|Intolerance|17
135704|NCT00481247|452809|P1|Overall Study|Intolerance|42
135705|NCT00481247|452808|P2|Overall Study|Disease progression|22
135706|NCT00481247|452809|P1|Overall Study|Disease progression|18
135707|NCT00481247|452808|P2|Overall Study|Death|1
135708|NCT00481247|452809|P1|Overall Study|Death|0
135709|NCT00481195|452833|P2|Overall Study|Miscellaneous|2
135710|NCT00481195|452834|P1|Overall Study|Miscellaneous|2
135711|NCT00481195|452833|P2|Overall Study|Withdrawal by Subject|9
135712|NCT00481195|452834|P1|Overall Study|Withdrawal by Subject|3
135713|NCT00481195|452833|P2|Overall Study|Protocol Violation|7
135714|NCT00481195|452834|P1|Overall Study|Protocol Violation|10
135715|NCT00481195|452833|P2|Overall Study|Physician Decision|1
135716|NCT00481195|452834|P1|Overall Study|Physician Decision|3
135717|NCT00481195|452833|P2|Overall Study|Lost to Follow-up|6
135718|NCT00481195|452834|P1|Overall Study|Lost to Follow-up|4
135719|NCT00481195|452833|P2|Overall Study|Lack of Efficacy|3
135720|NCT00481195|452834|P1|Overall Study|Lack of Efficacy|1
135721|NCT00481195|452833|P2|Overall Study|Adverse Event|11
135722|NCT00481195|452834|P1|Overall Study|Adverse Event|16
135723|NCT00481078|452920|P2|Overall Study|Brain metastasis|1
135724|NCT00481078|452921|P1|Overall Study|Brain metastasis|0
135725|NCT00481078|452920|P2|Overall Study|Received other treatment|1
135726|NCT00481078|452921|P1|Overall Study|Received other treatment|2
135727|NCT00481078|452920|P2|Overall Study|Information not available|0
135728|NCT00481078|452921|P1|Overall Study|Information not available|1
135729|NCT00481078|452920|P2|Overall Study|Withdrawal by Subject|1
135730|NCT00481078|452921|P1|Overall Study|Withdrawal by Subject|7
135731|NCT00481078|452920|P2|Overall Study|Intercurrent illness|0
135732|NCT00481078|452921|P1|Overall Study|Intercurrent illness|1
135733|NCT00481078|452920|P2|Overall Study|Death|3
135734|NCT00481078|452921|P1|Overall Study|Death|5
135735|NCT00481078|452920|P2|Overall Study|Adverse Event|3
135736|NCT00481078|452921|P1|Overall Study|Adverse Event|15
135737|NCT00481078|452920|P2|Overall Study|Progression of disease|11
135738|NCT00481078|452921|P1|Overall Study|Progression of disease|11
135739|NCT00481065|452939|P8|Overall Study|Unable to classify|0
135740|NCT00481065|452940|P7|Overall Study|Unable to classify|0
135741|NCT00481065|452941|P6|Overall Study|Unable to classify|0
135742|NCT00481065|452942|P5|Overall Study|Unable to classify|1
135743|NCT00481065|452943|P4|Overall Study|Unable to classify|0
135744|NCT00481065|452944|P3|Overall Study|Unable to classify|2
135745|NCT00481065|452945|P2|Overall Study|Unable to classify|1
135746|NCT00481065|452946|P1|Overall Study|Unable to classify|0
135747|NCT00481065|452939|P8|Overall Study|Protocol Violation|2
135748|NCT00481065|452940|P7|Overall Study|Protocol Violation|3
135749|NCT00481065|452941|P6|Overall Study|Protocol Violation|6
135750|NCT00481065|452942|P5|Overall Study|Protocol Violation|2
135751|NCT00481065|452943|P4|Overall Study|Protocol Violation|1
135752|NCT00481065|452944|P3|Overall Study|Protocol Violation|1
135753|NCT00481065|452945|P2|Overall Study|Protocol Violation|1
135754|NCT00481065|452946|P1|Overall Study|Protocol Violation|2
135755|NCT00481065|452939|P8|Overall Study|Administrative reason|0
135756|NCT00481065|452940|P7|Overall Study|Administrative reason|1
135757|NCT00481065|452941|P6|Overall Study|Administrative reason|2
135758|NCT00481065|452942|P5|Overall Study|Administrative reason|0
135759|NCT00481065|452943|P4|Overall Study|Administrative reason|0
135760|NCT00481065|452944|P3|Overall Study|Administrative reason|0
135761|NCT00481065|452945|P2|Overall Study|Administrative reason|0
135762|NCT00481065|452946|P1|Overall Study|Administrative reason|0
135763|NCT00481065|452939|P8|Overall Study|Inappropriate enrollment|1
135764|NCT00481065|452940|P7|Overall Study|Inappropriate enrollment|0
135765|NCT00481065|452941|P6|Overall Study|Inappropriate enrollment|1
135766|NCT00481065|452942|P5|Overall Study|Inappropriate enrollment|2
135767|NCT00481065|452943|P4|Overall Study|Inappropriate enrollment|0
135768|NCT00481065|452944|P3|Overall Study|Inappropriate enrollment|2
135769|NCT00481065|452945|P2|Overall Study|Inappropriate enrollment|0
135770|NCT00481065|452946|P1|Overall Study|Inappropriate enrollment|4
135771|NCT00481065|452939|P8|Overall Study|Lost to Follow-up|5
135772|NCT00481065|452940|P7|Overall Study|Lost to Follow-up|2
135773|NCT00481065|452941|P6|Overall Study|Lost to Follow-up|3
135774|NCT00481065|452942|P5|Overall Study|Lost to Follow-up|3
135775|NCT00481065|452943|P4|Overall Study|Lost to Follow-up|3
135776|NCT00481065|452944|P3|Overall Study|Lost to Follow-up|4
135777|NCT00481065|452945|P2|Overall Study|Lost to Follow-up|2
135778|NCT00481065|452946|P1|Overall Study|Lost to Follow-up|4
135779|NCT00481065|452939|P8|Overall Study|Withdrawal by Subject|10
135780|NCT00481065|452940|P7|Overall Study|Withdrawal by Subject|9
135781|NCT00481065|452941|P6|Overall Study|Withdrawal by Subject|12
135782|NCT00481065|452942|P5|Overall Study|Withdrawal by Subject|13
135783|NCT00481065|452943|P4|Overall Study|Withdrawal by Subject|11
135784|NCT00481065|452944|P3|Overall Study|Withdrawal by Subject|7
135785|NCT00481065|452945|P2|Overall Study|Withdrawal by Subject|12
135786|NCT00481065|452946|P1|Overall Study|Withdrawal by Subject|11
135787|NCT00481065|452939|P8|Overall Study|Adverse event or death|1
135788|NCT00481065|452940|P7|Overall Study|Adverse event or death|1
135789|NCT00481065|452941|P6|Overall Study|Adverse event or death|0
135790|NCT00481065|452942|P5|Overall Study|Adverse event or death|2
135791|NCT00481065|452943|P4|Overall Study|Adverse event or death|0
135792|NCT00481065|452944|P3|Overall Study|Adverse event or death|3
135793|NCT00481065|452945|P2|Overall Study|Adverse event or death|1
135794|NCT00481065|452946|P1|Overall Study|Adverse event or death|1
135795|NCT00480857|453036|P1|Overall Study|Lack of Efficacy|2
135796|NCT00480779|453043|P2|Overall Study|Job and Health-related|3
135797|NCT00480779|453044|P1|Overall Study|Job and Health-related|0
135798|NCT00480779|453043|P2|Overall Study|Other|0
135799|NCT00480779|453044|P1|Overall Study|Other|2
135800|NCT00480532|453085|P4|Overall Study|Protocol Violation|0
135801|NCT00480532|453086|P3|Overall Study|Protocol Violation|1
135802|NCT00480532|453087|P2|Overall Study|Protocol Violation|0
135803|NCT00480532|453088|P1|Overall Study|Protocol Violation|0
135804|NCT00480532|453085|P4|Overall Study|Withdrawal by Subject|1
135805|NCT00480532|453086|P3|Overall Study|Withdrawal by Subject|3
135806|NCT00480532|453087|P2|Overall Study|Withdrawal by Subject|4
135807|NCT00480532|453088|P1|Overall Study|Withdrawal by Subject|2
135808|NCT00480493|453108|P2|Overall Study|moved|7
135809|NCT00480493|453109|P1|Overall Study|moved|2
135810|NCT00480324|453121|P2|Overall Study|Subject’s mother pregnant|1
135811|NCT00480324|453122|P1|Overall Study|Subject’s mother pregnant|0
135812|NCT00480324|453121|P2|Overall Study|Lost to Follow-up|8
135813|NCT00480324|453122|P1|Overall Study|Lost to Follow-up|17
135814|NCT00480324|453121|P2|Overall Study|Withdrawal by Subject|5
135815|NCT00480324|453122|P1|Overall Study|Withdrawal by Subject|14
135816|NCT00480324|453121|P2|Overall Study|Protocol Violation|1
135817|NCT00480324|453122|P1|Overall Study|Protocol Violation|0
135818|NCT00480324|453121|P2|Overall Study|Adverse Event|1
135819|NCT00480324|453122|P1|Overall Study|Adverse Event|1
135820|NCT00479882|453152|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
135821|NCT00479882|453153|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
135822|NCT00479882|453154|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
135823|NCT00479882|453155|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
135824|NCT00479882|453152|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
135825|NCT00479882|453153|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
135826|NCT00479882|453154|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
135827|NCT00479882|453155|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
135828|NCT00479882|453152|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
135829|NCT00479882|453153|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
135830|NCT00479882|453154|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
135831|NCT00479882|453155|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
135832|NCT00479882|453152|P4|Crossover: Period III (Weeks 13-20)|Other|2
135833|NCT00479882|453153|P3|Crossover: Period III (Weeks 13-20)|Other|2
135834|NCT00479882|453154|P2|Crossover: Period III (Weeks 13-20)|Other|0
135835|NCT00479882|453155|P1|Crossover: Period III (Weeks 13-20)|Other|5
135836|NCT00479882|453152|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
135837|NCT00479882|453153|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
135838|NCT00479882|453154|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
135839|NCT00479882|453155|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
135840|NCT00479882|453152|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
135841|NCT00479882|453153|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
135842|NCT00479882|453154|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
135843|NCT00479882|453155|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
135844|NCT00479882|453152|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
135845|NCT00479882|453153|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
135846|NCT00479882|453154|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
135847|NCT00479882|453155|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
135848|NCT00479882|453152|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
135849|NCT00479882|453153|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
135850|NCT00479882|453154|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
135851|NCT00479882|453155|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
135852|NCT00479882|453152|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
135853|NCT00479882|453153|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
135854|NCT00479882|453154|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
135855|NCT00479882|453155|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
135856|NCT00479882|453152|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
135857|NCT00479882|453153|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
135858|NCT00479882|453154|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
135859|NCT00479882|453155|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
135860|NCT00479882|453152|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
135861|NCT00479882|453153|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
135862|NCT00479882|453154|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
135863|NCT00479882|453155|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
135864|NCT00479882|453152|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
135865|NCT00479882|453153|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
135866|NCT00479882|453154|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
135867|NCT00479882|453155|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
135868|NCT00479882|453152|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
135869|NCT00479882|453153|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
135870|NCT00479882|453154|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
135871|NCT00479882|453155|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
135872|NCT00479882|453152|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
135873|NCT00479882|453153|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
135874|NCT00479882|453154|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
135875|NCT00479882|453155|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
135876|NCT00479856|453285|P1|Overall Study|Physician Decision|1
135877|NCT00479856|453285|P1|Overall Study|Withdrawal by Subject|1
135878|NCT00479856|453285|P1|Overall Study|Adverse Event|1
135879|NCT00479765|453294|P1|Overall Study|study terminated|4
135880|NCT00479713|453300|P2|Overall Study|Withdrawal by Subject|1
135881|NCT00479713|453301|P1|Overall Study|Withdrawal by Subject|4
135882|NCT00479713|453300|P2|Overall Study|Protocol Violation|1
135883|NCT00479713|453301|P1|Overall Study|Protocol Violation|0
135884|NCT00479713|453300|P2|Overall Study|Lost to Follow-up|1
135885|NCT00479713|453301|P1|Overall Study|Lost to Follow-up|0
135886|NCT00479713|453300|P2|Overall Study|Death|0
135887|NCT00479713|453301|P1|Overall Study|Death|1
135888|NCT00479713|453300|P2|Overall Study|Adverse Event|6
135889|NCT00479713|453301|P1|Overall Study|Adverse Event|8
135890|NCT00479674|453325|P1|Overall Study|none provided|3
135891|NCT00479674|453325|P1|Overall Study|Physician Decision|14
135892|NCT00479674|453325|P1|Overall Study|Withdrawal by Subject|6
135893|NCT00479674|453325|P1|Overall Study|Adverse Event|18
135894|NCT00479557|453340|P7|Overall Study|Not specified|0
135895|NCT00479557|453341|P6|Overall Study|Not specified|3
135896|NCT00479557|453342|P5|Overall Study|Not specified|0
135897|NCT00479557|453343|P4|Overall Study|Not specified|0
135898|NCT00479557|453344|P3|Overall Study|Not specified|1
135899|NCT00479557|453345|P2|Overall Study|Not specified|3
135900|NCT00479557|453346|P1|Overall Study|Not specified|2
135901|NCT00479557|453340|P7|Overall Study|Subject Request|1
135902|NCT00479557|453341|P6|Overall Study|Subject Request|4
135903|NCT00479557|453342|P5|Overall Study|Subject Request|1
135904|NCT00479557|453343|P4|Overall Study|Subject Request|1
135905|NCT00479557|453344|P3|Overall Study|Subject Request|1
135906|NCT00479557|453345|P2|Overall Study|Subject Request|0
135907|NCT00479557|453346|P1|Overall Study|Subject Request|3
135908|NCT00479557|453340|P7|Overall Study|Investigator Request|0
135909|NCT00479557|453341|P6|Overall Study|Investigator Request|0
135910|NCT00479557|453342|P5|Overall Study|Investigator Request|0
135911|NCT00479557|453343|P4|Overall Study|Investigator Request|0
135912|NCT00479557|453344|P3|Overall Study|Investigator Request|1
135913|NCT00479557|453345|P2|Overall Study|Investigator Request|0
135914|NCT00479557|453346|P1|Overall Study|Investigator Request|0
135915|NCT00479557|453340|P7|Overall Study|Caregiver Request|0
135916|NCT00479557|453341|P6|Overall Study|Caregiver Request|2
135917|NCT00479557|453342|P5|Overall Study|Caregiver Request|1
135918|NCT00479557|453343|P4|Overall Study|Caregiver Request|0
135919|NCT00479557|453344|P3|Overall Study|Caregiver Request|2
135920|NCT00479557|453345|P2|Overall Study|Caregiver Request|2
135921|NCT00479557|453346|P1|Overall Study|Caregiver Request|2
135922|NCT00479557|453340|P7|Overall Study|AE not related to Study Drug|1
135923|NCT00479557|453341|P6|Overall Study|AE not related to Study Drug|2
135924|NCT00479557|453342|P5|Overall Study|AE not related to Study Drug|2
135925|NCT00479557|453343|P4|Overall Study|AE not related to Study Drug|0
135926|NCT00479557|453344|P3|Overall Study|AE not related to Study Drug|0
135927|NCT00479557|453345|P2|Overall Study|AE not related to Study Drug|3
135928|NCT00479557|453346|P1|Overall Study|AE not related to Study Drug|1
135929|NCT00479557|453340|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
135930|NCT00479557|453341|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
135931|NCT00479557|453342|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
135932|NCT00479557|453343|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
135933|NCT00479557|453344|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
135934|NCT00479557|453345|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
135935|NCT00479557|453346|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
135936|NCT00479557|453340|P7|Overall Study|Lost to Follow-up|0
135937|NCT00479557|453341|P6|Overall Study|Lost to Follow-up|0
135938|NCT00479557|453342|P5|Overall Study|Lost to Follow-up|0
135939|NCT00479557|453343|P4|Overall Study|Lost to Follow-up|2
135940|NCT00479557|453344|P3|Overall Study|Lost to Follow-up|0
135941|NCT00479557|453345|P2|Overall Study|Lost to Follow-up|2
135942|NCT00479557|453346|P1|Overall Study|Lost to Follow-up|0
135943|NCT00479557|453340|P7|Overall Study|Lack of Efficacy|0
135944|NCT00479557|453341|P6|Overall Study|Lack of Efficacy|0
135945|NCT00479557|453342|P5|Overall Study|Lack of Efficacy|0
135946|NCT00479557|453343|P4|Overall Study|Lack of Efficacy|0
135947|NCT00479557|453344|P3|Overall Study|Lack of Efficacy|0
135948|NCT00479557|453345|P2|Overall Study|Lack of Efficacy|0
135949|NCT00479557|453346|P1|Overall Study|Lack of Efficacy|1
135950|NCT00479557|453340|P7|Overall Study|Death|0
135951|NCT00479557|453341|P6|Overall Study|Death|1
135952|NCT00479557|453342|P5|Overall Study|Death|0
135953|NCT00479557|453343|P4|Overall Study|Death|0
135954|NCT00479557|453344|P3|Overall Study|Death|0
135955|NCT00479557|453345|P2|Overall Study|Death|0
135956|NCT00479557|453346|P1|Overall Study|Death|0
135957|NCT00479466|453389|P6|Overall Study|Withdrawal by Subject|1
135958|NCT00479466|453390|P5|Overall Study|Withdrawal by Subject|3
135959|NCT00479466|453391|P4|Overall Study|Withdrawal by Subject|2
135960|NCT00479466|453392|P3|Overall Study|Withdrawal by Subject|0
135961|NCT00479466|453393|P2|Overall Study|Withdrawal by Subject|5
135962|NCT00479466|453394|P1|Overall Study|Withdrawal by Subject|3
135963|NCT00479466|453389|P6|Overall Study|Protocol Violation|0
135964|NCT00479466|453390|P5|Overall Study|Protocol Violation|0
135965|NCT00479466|453391|P4|Overall Study|Protocol Violation|0
135966|NCT00479466|453392|P3|Overall Study|Protocol Violation|0
135967|NCT00479466|453393|P2|Overall Study|Protocol Violation|0
135968|NCT00479466|453394|P1|Overall Study|Protocol Violation|1
135969|NCT00479466|453389|P6|Overall Study|Pregnancy|0
135970|NCT00479466|453390|P5|Overall Study|Pregnancy|1
135971|NCT00479466|453391|P4|Overall Study|Pregnancy|0
135972|NCT00479466|453392|P3|Overall Study|Pregnancy|0
135973|NCT00479466|453393|P2|Overall Study|Pregnancy|0
135974|NCT00479466|453394|P1|Overall Study|Pregnancy|0
135975|NCT00479466|453389|P6|Overall Study|Physician Decision|0
135976|NCT00479466|453390|P5|Overall Study|Physician Decision|0
135977|NCT00479466|453391|P4|Overall Study|Physician Decision|0
135978|NCT00479466|453392|P3|Overall Study|Physician Decision|1
135979|NCT00479466|453393|P2|Overall Study|Physician Decision|1
135980|NCT00479466|453394|P1|Overall Study|Physician Decision|2
135981|NCT00479466|453389|P6|Overall Study|Lost to Follow-up|2
135982|NCT00479466|453390|P5|Overall Study|Lost to Follow-up|2
135983|NCT00479466|453391|P4|Overall Study|Lost to Follow-up|0
135984|NCT00479466|453392|P3|Overall Study|Lost to Follow-up|1
135985|NCT00479466|453393|P2|Overall Study|Lost to Follow-up|1
135986|NCT00479466|453394|P1|Overall Study|Lost to Follow-up|0
135987|NCT00479466|453389|P6|Overall Study|Lack of Efficacy|0
135988|NCT00479466|453390|P5|Overall Study|Lack of Efficacy|0
135989|NCT00479466|453391|P4|Overall Study|Lack of Efficacy|0
135990|NCT00479466|453392|P3|Overall Study|Lack of Efficacy|1
135991|NCT00479466|453393|P2|Overall Study|Lack of Efficacy|0
135992|NCT00479466|453394|P1|Overall Study|Lack of Efficacy|2
135993|NCT00479466|453389|P6|Overall Study|Hyperglycemia|1
135994|NCT00479466|453390|P5|Overall Study|Hyperglycemia|0
135995|NCT00479466|453391|P4|Overall Study|Hyperglycemia|0
135996|NCT00479466|453392|P3|Overall Study|Hyperglycemia|0
135997|NCT00479466|453393|P2|Overall Study|Hyperglycemia|0
135998|NCT00479466|453394|P1|Overall Study|Hyperglycemia|0
135999|NCT00479466|453389|P6|Overall Study|Adverse Event|0
136000|NCT00479466|453390|P5|Overall Study|Adverse Event|2
136001|NCT00479466|453391|P4|Overall Study|Adverse Event|1
136002|NCT00479466|453392|P3|Overall Study|Adverse Event|0
136003|NCT00479466|453393|P2|Overall Study|Adverse Event|1
136004|NCT00479466|453394|P1|Overall Study|Adverse Event|5
136005|NCT00479401|453423|P3|Overall Study|Exclusion criteria, relocation|0
136006|NCT00479401|453424|P2|Overall Study|Exclusion criteria, relocation|3
136007|NCT00479401|453425|P1|Overall Study|Exclusion criteria, relocation|4
136008|NCT00479401|453423|P3|Overall Study|Withdrawal by Subject|2
136009|NCT00479401|453424|P2|Overall Study|Withdrawal by Subject|10
136010|NCT00479401|453425|P1|Overall Study|Withdrawal by Subject|16
136011|NCT00479401|453423|P3|Overall Study|Lost to Follow-up|1
136012|NCT00479401|453424|P2|Overall Study|Lost to Follow-up|1
136013|NCT00479401|453425|P1|Overall Study|Lost to Follow-up|1
136014|NCT00479401|453423|P3|Overall Study|Protocol Violation|1
136015|NCT00479401|453424|P2|Overall Study|Protocol Violation|1
136016|NCT00479401|453425|P1|Overall Study|Protocol Violation|2
136017|NCT00479401|453423|P3|Overall Study|Lack of Efficacy|4
136018|NCT00479401|453424|P2|Overall Study|Lack of Efficacy|2
136019|NCT00479401|453425|P1|Overall Study|Lack of Efficacy|2
136020|NCT00479401|453423|P3|Overall Study|Adverse Event|4
136021|NCT00479401|453424|P2|Overall Study|Adverse Event|20
136022|NCT00479401|453425|P1|Overall Study|Adverse Event|24
136023|NCT00479388|453480|P2|Overall Study|Withdrawal by Subject|17
136024|NCT00479388|453481|P1|Overall Study|Withdrawal by Subject|32
136025|NCT00479388|453480|P2|Overall Study|Protocol Violation|9
136026|NCT00479388|453481|P1|Overall Study|Protocol Violation|10
136027|NCT00479388|453480|P2|Overall Study|Lost to Follow-up|2
136028|NCT00479388|453481|P1|Overall Study|Lost to Follow-up|0
136029|NCT00479388|453480|P2|Overall Study|Adverse Event|45
136030|NCT00479388|453481|P1|Overall Study|Adverse Event|90
136031|NCT00479336|453495|P4|Overall Study|Resolution of all hepatic edema findings|0
136032|NCT00479336|453496|P3|Overall Study|Resolution of all hepatic edema findings|0
136121|NCT00478673|453613|P1|30-Days Post-Procedure|Withdrawal by Subject|1
136033|NCT00479336|453497|P2|Overall Study|Resolution of all hepatic edema findings|1
136034|NCT00479336|453498|P1|Overall Study|Resolution of all hepatic edema findings|1
136035|NCT00479336|453495|P4|Overall Study|Physician Decision|2
136036|NCT00479336|453496|P3|Overall Study|Physician Decision|0
136037|NCT00479336|453497|P2|Overall Study|Physician Decision|1
136038|NCT00479336|453498|P1|Overall Study|Physician Decision|0
136039|NCT00479336|453495|P4|Overall Study|Withdrawal by Subject|0
136040|NCT00479336|453496|P3|Overall Study|Withdrawal by Subject|0
136041|NCT00479336|453497|P2|Overall Study|Withdrawal by Subject|2
136042|NCT00479336|453498|P1|Overall Study|Withdrawal by Subject|1
136043|NCT00479336|453495|P4|Overall Study|Protocol Violation|0
136044|NCT00479336|453496|P3|Overall Study|Protocol Violation|0
136045|NCT00479336|453497|P2|Overall Study|Protocol Violation|1
136046|NCT00479336|453498|P1|Overall Study|Protocol Violation|0
136047|NCT00479336|453495|P4|Overall Study|Lack of Efficacy|0
136048|NCT00479336|453496|P3|Overall Study|Lack of Efficacy|0
136049|NCT00479336|453497|P2|Overall Study|Lack of Efficacy|0
136050|NCT00479336|453498|P1|Overall Study|Lack of Efficacy|1
136051|NCT00479336|453495|P4|Overall Study|Adverse Event|3
136052|NCT00479336|453496|P3|Overall Study|Adverse Event|1
136053|NCT00479336|453497|P2|Overall Study|Adverse Event|1
136054|NCT00479336|453498|P1|Overall Study|Adverse Event|1
136055|NCT00479232|453521|P6|Overall Study|Withdrew Consent|3
136056|NCT00479232|453522|P5|Overall Study|Withdrew Consent|1
136057|NCT00479232|453523|P4|Overall Study|Withdrew Consent|0
136058|NCT00479232|453524|P3|Overall Study|Withdrew Consent|6
136059|NCT00479232|453525|P2|Overall Study|Withdrew Consent|2
136060|NCT00479232|453526|P1|Overall Study|Withdrew Consent|0
136061|NCT00479232|453521|P6|Overall Study|Progressive Disease|12
136062|NCT00479232|453522|P5|Overall Study|Progressive Disease|3
136063|NCT00479232|453523|P4|Overall Study|Progressive Disease|3
136064|NCT00479232|453524|P3|Overall Study|Progressive Disease|12
136065|NCT00479232|453525|P2|Overall Study|Progressive Disease|1
136066|NCT00479232|453526|P1|Overall Study|Progressive Disease|3
136067|NCT00479232|453521|P6|Overall Study|Physician Decision|1
136068|NCT00479232|453522|P5|Overall Study|Physician Decision|0
136069|NCT00479232|453523|P4|Overall Study|Physician Decision|0
136070|NCT00479232|453524|P3|Overall Study|Physician Decision|2
136071|NCT00479232|453525|P2|Overall Study|Physician Decision|0
136072|NCT00479232|453526|P1|Overall Study|Physician Decision|0
136073|NCT00479232|453521|P6|Overall Study|Lack of Efficacy|4
136074|NCT00479232|453522|P5|Overall Study|Lack of Efficacy|0
136075|NCT00479232|453523|P4|Overall Study|Lack of Efficacy|0
136076|NCT00479232|453524|P3|Overall Study|Lack of Efficacy|2
136077|NCT00479232|453525|P2|Overall Study|Lack of Efficacy|0
136078|NCT00479232|453526|P1|Overall Study|Lack of Efficacy|0
136079|NCT00479232|453521|P6|Overall Study|Deviation from Protocol|0
136080|NCT00479232|453522|P5|Overall Study|Deviation from Protocol|0
136081|NCT00479232|453523|P4|Overall Study|Deviation from Protocol|0
136082|NCT00479232|453524|P3|Overall Study|Deviation from Protocol|1
136083|NCT00479232|453525|P2|Overall Study|Deviation from Protocol|0
136084|NCT00479232|453526|P1|Overall Study|Deviation from Protocol|0
136085|NCT00479232|453521|P6|Overall Study|Adverse Event|10
136086|NCT00479232|453522|P5|Overall Study|Adverse Event|0
136087|NCT00479232|453523|P4|Overall Study|Adverse Event|0
136088|NCT00479232|453524|P3|Overall Study|Adverse Event|5
136089|NCT00479232|453525|P2|Overall Study|Adverse Event|0
136090|NCT00479232|453526|P1|Overall Study|Adverse Event|0
136091|NCT00478881|453581|P2|Overall Study|Non-Compliance with Study Medication|2
136092|NCT00478881|453582|P1|Overall Study|Non-Compliance with Study Medication|0
136093|NCT00478881|453581|P2|Overall Study|Withdrawal by Subject|2
136094|NCT00478881|453582|P1|Overall Study|Withdrawal by Subject|6
136095|NCT00478881|453581|P2|Overall Study|Protocol Violation|2
136096|NCT00478881|453582|P1|Overall Study|Protocol Violation|2
136097|NCT00478881|453581|P2|Overall Study|Lost to Follow-up|1
136098|NCT00478881|453582|P1|Overall Study|Lost to Follow-up|0
136099|NCT00478881|453581|P2|Overall Study|Lack of Efficacy|3
136100|NCT00478881|453582|P1|Overall Study|Lack of Efficacy|0
136101|NCT00478881|453581|P2|Overall Study|Adverse Event|12
136102|NCT00478881|453582|P1|Overall Study|Adverse Event|31
136103|NCT00478777|453606|P1|Overall Study|Not treated with lenalidomide|6
136104|NCT00478777|453606|P1|Overall Study|End of therapy|2
136105|NCT00478777|453606|P1|Overall Study|Lymphocytes infusion|1
136106|NCT00478777|453606|P1|Overall Study|Lack of compliance|1
136107|NCT00478777|453606|P1|Overall Study|Intolerance of therapy|1
136108|NCT00478777|453606|P1|Overall Study|Physician Decision|1
136109|NCT00478777|453606|P1|Overall Study|Lost to Follow-up|3
136110|NCT00478777|453606|P1|Overall Study|Protocol Violation|3
136111|NCT00478777|453606|P1|Overall Study|Death|3
136112|NCT00478777|453606|P1|Overall Study|Withdrawal by Subject|4
136113|NCT00478777|453606|P1|Overall Study|Lack of Efficacy|23
136114|NCT00478777|453606|P1|Overall Study|Adverse Event|29
136115|NCT00478673|453613|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
136116|NCT00478673|453613|P1|12-Months Post-Procedure|Missed Visit|25
136117|NCT00478673|453613|P1|12-Months Post-Procedure|Withdrawal by Subject|6
136118|NCT00478673|453613|P1|12-Months Post-Procedure|Lost to Follow-up|4
136119|NCT00478673|453613|P1|12-Months Post-Procedure|Death|23
136120|NCT00478673|453613|P1|30-Days Post-Procedure|Missed Visit|7
136122|NCT00478673|453613|P1|30-Days Post-Procedure|Death|2
136123|NCT00478647|453618|P1|Overall Study|Withdrawal by Subject|1
136124|NCT00478647|453618|P1|Overall Study|Adverse Event|1
136125|NCT00478608|453626|P1|Overall Study|Protocol Violation|3
136126|NCT00478608|453626|P1|Overall Study|Withdrawal by Subject|2
136127|NCT00478608|453626|P1|Overall Study|Serious Adverse Event|14
136128|NCT00478608|453626|P1|Overall Study|Adverse Event|1
136129|NCT00478257|453661|P2|Overall Study|Withdrawal by Subject|3
136130|NCT00478257|453662|P1|Overall Study|Withdrawal by Subject|8
136131|NCT00478244|453668|P1|Overall Study|Did not receive transplant|1
136132|NCT00478231|453681|P1|Overall Study|Randomized, not treated|3
136133|NCT00478231|453681|P1|Overall Study|Adverse Event|5
136134|NCT00478231|453681|P1|Overall Study|Unspecified|9
136135|NCT00478231|453681|P1|Overall Study|Withdrawal by Subject|6
136136|NCT00478231|453681|P1|Overall Study|Lost to Follow-up|7
136137|NCT00478231|453681|P1|Overall Study|Lack of Efficacy|47
136138|NCT00478231|453681|P1|Overall Study|Death|7
136139|NCT00478205|453717|P2|Overall Study|Not specified|12
136140|NCT00478205|453718|P1|Overall Study|Not specified|24
136141|NCT00478205|453717|P2|Overall Study|Lack of Efficacy|0
136142|NCT00478205|453718|P1|Overall Study|Lack of Efficacy|1
136143|NCT00478205|453717|P2|Overall Study|Withdrawal by Subject|22
136144|NCT00478205|453718|P1|Overall Study|Withdrawal by Subject|61
136145|NCT00478205|453717|P2|Overall Study|Request of Investigator or Sponsor|5
136146|NCT00478205|453718|P1|Overall Study|Request of Investigator or Sponsor|4
136147|NCT00478205|453717|P2|Overall Study|Protocol Violation|5
136148|NCT00478205|453718|P1|Overall Study|Protocol Violation|15
136149|NCT00478205|453717|P2|Overall Study|Medication Non-compliance|4
136150|NCT00478205|453718|P1|Overall Study|Medication Non-compliance|9
136151|NCT00478205|453717|P2|Overall Study|Adverse Event|39
136152|NCT00478205|453718|P1|Overall Study|Adverse Event|182
136153|NCT00478140|453762|P1|Overall Study|Disease Progression|3
136154|NCT00477334|453768|P2|Overall Study|Protocol Violation|1
136155|NCT00477334|453769|P1|Overall Study|Protocol Violation|7
136156|NCT00477334|453768|P2|Overall Study|Administrative Problems|15
136157|NCT00477334|453769|P1|Overall Study|Administrative Problems|39
136158|NCT00477334|453768|P2|Overall Study|Lost to Follow-up|4
136159|NCT00477334|453769|P1|Overall Study|Lost to Follow-up|15
136160|NCT00477334|453768|P2|Overall Study|Withdrawal by Subject|1
136161|NCT00477334|453769|P1|Overall Study|Withdrawal by Subject|2
136162|NCT00477334|453768|P2|Overall Study|Adverse Event|2
136163|NCT00477334|453769|P1|Overall Study|Adverse Event|1
136164|NCT00477334|453768|P2|Overall Study|Discontinued prior to taking study drug|53
136165|NCT00477334|453769|P1|Overall Study|Discontinued prior to taking study drug|106
136166|NCT00477295|453795|P2|Overall Study|Not specified|3
136167|NCT00477295|453796|P1|Overall Study|Not specified|4
136168|NCT00477295|453795|P2|Overall Study|Lost to Follow-up|11
136169|NCT00477295|453796|P1|Overall Study|Lost to Follow-up|21
136170|NCT00477295|453795|P2|Overall Study|Physician Decision|5
136171|NCT00477295|453796|P1|Overall Study|Physician Decision|4
136172|NCT00477295|453795|P2|Overall Study|Protocol Violation|8
136173|NCT00477295|453796|P1|Overall Study|Protocol Violation|3
136174|NCT00477295|453795|P2|Overall Study|Lack of Efficacy|23
136175|NCT00477295|453796|P1|Overall Study|Lack of Efficacy|23
136176|NCT00477295|453795|P2|Overall Study|Withdrawal by Subject|24
136177|NCT00477295|453796|P1|Overall Study|Withdrawal by Subject|35
136178|NCT00477295|453795|P2|Overall Study|Adverse Event|35
136179|NCT00477295|453796|P1|Overall Study|Adverse Event|31
136180|NCT00477269|453824|P3|Open Label Extension|Death|4
136181|NCT00477269|453825|P2|Open Label Extension|Death|0
136182|NCT00477269|453826|P1|Open Label Extension|Death|0
136183|NCT00477269|453824|P3|Open Label Extension|Adminiatrative problems|2
136184|NCT00477269|453825|P2|Open Label Extension|Adminiatrative problems|0
136185|NCT00477269|453826|P1|Open Label Extension|Adminiatrative problems|0
136186|NCT00477269|453824|P3|Open Label Extension|unsatisfactory therapeutic effects|2
136187|NCT00477269|453825|P2|Open Label Extension|unsatisfactory therapeutic effects|0
136188|NCT00477269|453826|P1|Open Label Extension|unsatisfactory therapeutic effects|0
136189|NCT00477269|453824|P3|Open Label Extension|Abnormal laboratory values|1
136190|NCT00477269|453825|P2|Open Label Extension|Abnormal laboratory values|0
136191|NCT00477269|453826|P1|Open Label Extension|Abnormal laboratory values|0
136192|NCT00477269|453824|P3|Open Label Extension|Adverse Event|4
136193|NCT00477269|453825|P2|Open Label Extension|Adverse Event|0
136194|NCT00477269|453826|P1|Open Label Extension|Adverse Event|0
136195|NCT00477269|453824|P3|Core Study|Withdrawn Consent|0
136196|NCT00477269|453825|P2|Core Study|Withdrawn Consent|1
136197|NCT00477269|453826|P1|Core Study|Withdrawn Consent|0
136198|NCT00477269|453824|P3|Core Study|Death|0
136199|NCT00477269|453825|P2|Core Study|Death|3
136200|NCT00477269|453826|P1|Core Study|Death|3
136201|NCT00477269|453824|P3|Core Study|Adverse Event|0
136202|NCT00477269|453825|P2|Core Study|Adverse Event|4
136203|NCT00477269|453826|P1|Core Study|Adverse Event|6
136204|NCT00478023|453905|P5|Overall Study|Lack of pain, Technical difficulties|3
136205|NCT00478023|453906|P4|Overall Study|Lack of pain, Technical difficulties|6
136206|NCT00478023|453907|P3|Overall Study|Lack of pain, Technical difficulties|5
136207|NCT00478023|453908|P2|Overall Study|Lack of pain, Technical difficulties|3
136208|NCT00478023|453909|P1|Overall Study|Lack of pain, Technical difficulties|7
136209|NCT00478023|453905|P5|Overall Study|Withdrawal by Subject|5
136210|NCT00478023|453906|P4|Overall Study|Withdrawal by Subject|4
136211|NCT00478023|453907|P3|Overall Study|Withdrawal by Subject|2
136212|NCT00478023|453908|P2|Overall Study|Withdrawal by Subject|3
136213|NCT00478023|453909|P1|Overall Study|Withdrawal by Subject|2
136214|NCT00478023|453905|P5|Overall Study|Lost to Follow-up|0
136215|NCT00478023|453906|P4|Overall Study|Lost to Follow-up|1
136216|NCT00478023|453907|P3|Overall Study|Lost to Follow-up|1
136217|NCT00478023|453908|P2|Overall Study|Lost to Follow-up|1
136218|NCT00478023|453909|P1|Overall Study|Lost to Follow-up|3
136219|NCT00478023|453905|P5|Overall Study|Lack of Efficacy|41
136220|NCT00478023|453906|P4|Overall Study|Lack of Efficacy|5
136221|NCT00478023|453907|P3|Overall Study|Lack of Efficacy|4
136222|NCT00478023|453908|P2|Overall Study|Lack of Efficacy|10
136223|NCT00478023|453909|P1|Overall Study|Lack of Efficacy|11
136224|NCT00478023|453905|P5|Overall Study|Death|0
136225|NCT00478023|453906|P4|Overall Study|Death|0
136226|NCT00478023|453907|P3|Overall Study|Death|0
136227|NCT00478023|453908|P2|Overall Study|Death|0
136228|NCT00478023|453909|P1|Overall Study|Death|1
136229|NCT00478023|453905|P5|Overall Study|Adverse Event|6
136230|NCT00478023|453906|P4|Overall Study|Adverse Event|14
136231|NCT00478023|453907|P3|Overall Study|Adverse Event|8
136232|NCT00478023|453908|P2|Overall Study|Adverse Event|7
136233|NCT00478023|453909|P1|Overall Study|Adverse Event|11
136234|NCT00477971|453928|P2|Overall Study|Alternative treatment|1
136235|NCT00477971|453929|P1|Overall Study|Alternative treatment|3
136236|NCT00477971|453928|P2|Overall Study|Death|4
136237|NCT00477971|453929|P1|Overall Study|Death|2
136238|NCT00477971|453928|P2|Overall Study|Adverse Event|0
136239|NCT00477971|453929|P1|Overall Study|Adverse Event|3
136240|NCT00477971|453928|P2|Overall Study|Withdrawal by Subject|1
136241|NCT00477971|453929|P1|Overall Study|Withdrawal by Subject|3
136242|NCT00477971|453928|P2|Overall Study|Disease progression|0
136243|NCT00477971|453929|P1|Overall Study|Disease progression|6
136244|NCT00477750|453941|P1|Overall Study|Currently Receiving Treatment|11
136245|NCT00477672|453953|P3|Overall Study|Discretion of Sponsor|0
136246|NCT00477672|453954|P2|Overall Study|Discretion of Sponsor|2
136247|NCT00477672|453955|P1|Overall Study|Discretion of Sponsor|1
136248|NCT00477672|453953|P3|Overall Study|Consent withdrawn|10
136249|NCT00477672|453954|P2|Overall Study|Consent withdrawn|5
136250|NCT00477672|453955|P1|Overall Study|Consent withdrawn|2
136251|NCT00477672|453953|P3|Overall Study|Protocol noncompliance|0
136252|NCT00477672|453954|P2|Overall Study|Protocol noncompliance|2
136253|NCT00477672|453955|P1|Overall Study|Protocol noncompliance|0
136254|NCT00477672|453953|P3|Overall Study|Physician Decision|0
136255|NCT00477672|453954|P2|Overall Study|Physician Decision|0
136256|NCT00477672|453955|P1|Overall Study|Physician Decision|1
136257|NCT00477672|453953|P3|Overall Study|Disease progression|0
136258|NCT00477672|453954|P2|Overall Study|Disease progression|1
136259|NCT00477672|453955|P1|Overall Study|Disease progression|0
136260|NCT00477672|453953|P3|Overall Study|Death|0
136261|NCT00477672|453954|P2|Overall Study|Death|1
136262|NCT00477672|453955|P1|Overall Study|Death|0
136263|NCT00477672|453953|P3|Overall Study|Adverse Event|6
136264|NCT00477672|453954|P2|Overall Study|Adverse Event|5
136265|NCT00477672|453955|P1|Overall Study|Adverse Event|3
136266|NCT00477633|453966|P1|Overall Study|Various (Moving, Enrollment closed)|75
136267|NCT00477633|453966|P1|Overall Study|Protocol Violation|25
136268|NCT00477633|453966|P1|Overall Study|Withdrawal by Subject|149
136269|NCT00477633|453966|P1|Overall Study|Lost to Follow-up|271
136270|NCT00477633|453966|P1|Overall Study|Pregnancy|23
136271|NCT00477633|453966|P1|Overall Study|Adverse Event|143
136272|NCT00477633|453966|P1|Overall Study|Did not receive treatment|23
136273|NCT00477607|453974|P2|Overall Study|Lost to Follow-up|7
136274|NCT00477607|453975|P1|Overall Study|Lost to Follow-up|7
136275|NCT00477594|453987|P2|Follow-up Period|Other|0
136276|NCT00477594|453988|P1|Follow-up Period|Other|1
136277|NCT00477594|453987|P2|Follow-up Period|Withdrawal by Subject|1
136278|NCT00477594|453988|P1|Follow-up Period|Withdrawal by Subject|2
136279|NCT00477594|453987|P2|Year 3|Withdrawal by Subject|0
136280|NCT00477594|453988|P1|Year 3|Withdrawal by Subject|1
136281|NCT00477594|453987|P2|Year 3|Adverse Event|0
136282|NCT00477594|453988|P1|Year 3|Adverse Event|1
136283|NCT00477594|453987|P2|Year 1 and Year 2|Other|0
136284|NCT00477594|453988|P1|Year 1 and Year 2|Other|1
136285|NCT00477594|453987|P2|Year 1 and Year 2|Withdrawal by Subject|1
136286|NCT00477594|453988|P1|Year 1 and Year 2|Withdrawal by Subject|2
136287|NCT00477594|453987|P2|Year 1 and Year 2|Physician Decision|1
136288|NCT00477594|453988|P1|Year 1 and Year 2|Physician Decision|2
136289|NCT00477594|453987|P2|Year 1 and Year 2|Adverse Event|2
136290|NCT00477594|453988|P1|Year 1 and Year 2|Adverse Event|4
136291|NCT00477490|454049|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
136292|NCT00477490|454050|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
136293|NCT00477490|454051|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
136294|NCT00477490|454052|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
136295|NCT00477490|454053|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
136296|NCT00477490|454054|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
136297|NCT00477490|454055|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
136298|NCT00477490|454056|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
136299|NCT00477490|454057|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
136300|NCT00477490|454049|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
136301|NCT00477490|454050|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
136302|NCT00477490|454051|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
136303|NCT00477490|454052|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
136304|NCT00477490|454053|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
136305|NCT00477490|454054|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
136306|NCT00477490|454055|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
136307|NCT00477490|454056|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
136308|NCT00477490|454057|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
136309|NCT00477490|454049|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
136310|NCT00477490|454050|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
136311|NCT00477490|454051|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
136312|NCT00477490|454052|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
136313|NCT00477490|454053|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
136314|NCT00477490|454054|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
136315|NCT00477490|454055|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
136316|NCT00477490|454056|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
136317|NCT00477490|454057|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
136318|NCT00477490|454049|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
136319|NCT00477490|454050|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
136320|NCT00477490|454051|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
136321|NCT00477490|454052|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
136322|NCT00477490|454053|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
136323|NCT00477490|454054|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
136324|NCT00477490|454055|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
136325|NCT00477490|454056|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
136326|NCT00477490|454057|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
136327|NCT00477490|454049|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
136328|NCT00477490|454050|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
136329|NCT00477490|454051|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
136330|NCT00477490|454052|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
136331|NCT00477490|454053|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
136332|NCT00477490|454054|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
136333|NCT00477490|454055|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
136334|NCT00477490|454056|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
136335|NCT00477490|454057|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
136336|NCT00477490|454049|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
136337|NCT00477490|454050|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
136338|NCT00477490|454051|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
136339|NCT00477490|454052|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
136340|NCT00477490|454053|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
136341|NCT00477490|454054|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
136342|NCT00477490|454055|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
136343|NCT00477490|454056|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
136344|NCT00477490|454057|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
136345|NCT00477490|454049|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
136346|NCT00477490|454050|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
136347|NCT00477490|454051|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
136348|NCT00477490|454052|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
136349|NCT00477490|454053|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
136350|NCT00477490|454054|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
136351|NCT00477490|454055|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
136352|NCT00477490|454056|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
136353|NCT00477490|454057|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
136354|NCT00477490|454049|P9|Part I: 4 Week Efficacy|Not Reported|0
136355|NCT00477490|454050|P8|Part I: 4 Week Efficacy|Not Reported|0
136356|NCT00477490|454051|P7|Part I: 4 Week Efficacy|Not Reported|0
136357|NCT00477490|454052|P6|Part I: 4 Week Efficacy|Not Reported|0
136358|NCT00477490|454053|P5|Part I: 4 Week Efficacy|Not Reported|1
136359|NCT00477490|454054|P4|Part I: 4 Week Efficacy|Not Reported|0
136360|NCT00477490|454055|P3|Part I: 4 Week Efficacy|Not Reported|3
136361|NCT00477490|454056|P2|Part I: 4 Week Efficacy|Not Reported|2
136362|NCT00477490|454057|P1|Part I: 4 Week Efficacy|Not Reported|1
136363|NCT00477490|454049|P9|Part I: 4 Week Efficacy|Other, not specified|0
136364|NCT00477490|454050|P8|Part I: 4 Week Efficacy|Other, not specified|0
136365|NCT00477490|454051|P7|Part I: 4 Week Efficacy|Other, not specified|0
136366|NCT00477490|454052|P6|Part I: 4 Week Efficacy|Other, not specified|0
136367|NCT00477490|454053|P5|Part I: 4 Week Efficacy|Other, not specified|1
136368|NCT00477490|454054|P4|Part I: 4 Week Efficacy|Other, not specified|1
136369|NCT00477490|454055|P3|Part I: 4 Week Efficacy|Other, not specified|0
136370|NCT00477490|454056|P2|Part I: 4 Week Efficacy|Other, not specified|4
136371|NCT00477490|454057|P1|Part I: 4 Week Efficacy|Other, not specified|2
136372|NCT00477490|454049|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
136373|NCT00477490|454050|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
136374|NCT00477490|454051|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
136375|NCT00477490|454052|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
136376|NCT00477490|454053|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
136377|NCT00477490|454054|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
136378|NCT00477490|454055|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
136379|NCT00477490|454056|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
136380|NCT00477490|454057|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
136381|NCT00477490|454049|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
136382|NCT00477490|454050|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
136383|NCT00477490|454051|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
136384|NCT00477490|454052|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
136385|NCT00477490|454053|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
136386|NCT00477490|454054|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
136387|NCT00477490|454055|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
136388|NCT00477490|454056|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
136389|NCT00477490|454057|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
136390|NCT00477490|454049|P9|Part I: 4 Week Efficacy|Protocol Violation|0
136391|NCT00477490|454050|P8|Part I: 4 Week Efficacy|Protocol Violation|0
136392|NCT00477490|454051|P7|Part I: 4 Week Efficacy|Protocol Violation|0
136393|NCT00477490|454052|P6|Part I: 4 Week Efficacy|Protocol Violation|0
136394|NCT00477490|454053|P5|Part I: 4 Week Efficacy|Protocol Violation|1
136395|NCT00477490|454054|P4|Part I: 4 Week Efficacy|Protocol Violation|0
136396|NCT00477490|454055|P3|Part I: 4 Week Efficacy|Protocol Violation|0
136397|NCT00477490|454056|P2|Part I: 4 Week Efficacy|Protocol Violation|0
136398|NCT00477490|454057|P1|Part I: 4 Week Efficacy|Protocol Violation|2
136399|NCT00477490|454049|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
136400|NCT00477490|454050|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
136401|NCT00477490|454051|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
136402|NCT00477490|454052|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
136403|NCT00477490|454053|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
136404|NCT00477490|454054|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
136405|NCT00477490|454055|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
136406|NCT00477490|454056|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
136407|NCT00477490|454057|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
136408|NCT00477490|454049|P9|Part I: 4 Week Efficacy|Adverse Event|0
136409|NCT00477490|454050|P8|Part I: 4 Week Efficacy|Adverse Event|0
136410|NCT00477490|454051|P7|Part I: 4 Week Efficacy|Adverse Event|0
136411|NCT00477490|454052|P6|Part I: 4 Week Efficacy|Adverse Event|0
136412|NCT00477490|454053|P5|Part I: 4 Week Efficacy|Adverse Event|6
136413|NCT00477490|454054|P4|Part I: 4 Week Efficacy|Adverse Event|5
136414|NCT00477490|454055|P3|Part I: 4 Week Efficacy|Adverse Event|0
136415|NCT00477490|454056|P2|Part I: 4 Week Efficacy|Adverse Event|4
136416|NCT00477490|454057|P1|Part I: 4 Week Efficacy|Adverse Event|1
136417|NCT00477464|454141|P1|Overall Study|Completion of protocol-defined follow-up|14
136418|NCT00477464|454141|P1|Overall Study|Death|36
136419|NCT00477464|454141|P1|Overall Study|Lost to Follow-up|1
136420|NCT00477386|454166|P2|Overall Study|Withdrawal by Subject|0
136421|NCT00477386|454167|P1|Overall Study|Withdrawal by Subject|1
136422|NCT00477386|454166|P2|Overall Study|Physician Decision|0
136423|NCT00477386|454167|P1|Overall Study|Physician Decision|1
136424|NCT00477386|454166|P2|Overall Study|Other|2
136425|NCT00477386|454167|P1|Overall Study|Other|1
136426|NCT00477386|454166|P2|Overall Study|Disease progression, refractory|3
136427|NCT00477386|454167|P1|Overall Study|Disease progression, refractory|1
136428|NCT00477386|454166|P2|Overall Study|Disease progression, relapse|4
136429|NCT00477386|454167|P1|Overall Study|Disease progression, relapse|3
136430|NCT00477386|454166|P2|Overall Study|Adverse Event|8
136431|NCT00477386|454167|P1|Overall Study|Adverse Event|4
136432|NCT00477152|454191|P1|Overall Study|Adverse Event|1
136433|NCT00477152|454191|P1|Overall Study|Parent withdrew consent|2
136434|NCT00476957|454200|P2|Overall Study|Lost to Follow-up|193
136435|NCT00476957|454201|P1|Overall Study|Lost to Follow-up|176
136436|NCT00476593|454265|P4|Overall Study|Lost to Follow-up|22
136437|NCT00476593|454266|P3|Overall Study|Lost to Follow-up|8
136438|NCT00476593|454267|P2|Overall Study|Lost to Follow-up|2
136439|NCT00476593|454268|P1|Overall Study|Lost to Follow-up|10
136440|NCT00476476|454280|P2|Overall Study|Progressive Disease|17
136441|NCT00476476|454281|P1|Overall Study|Progressive Disease|0
136442|NCT00476476|454280|P2|Overall Study|Adverse Event|7
136443|NCT00476476|454281|P1|Overall Study|Adverse Event|2
136444|NCT00476229|454297|P1|Overall Study|Progressive shortness of breath|1
136445|NCT00476151|454303|P2|Overall Study|Physician Decision|2
136446|NCT00476151|454304|P1|Overall Study|Physician Decision|0
136447|NCT00476151|454303|P2|Overall Study|Withdrawal by Subject|0
136448|NCT00476151|454304|P1|Overall Study|Withdrawal by Subject|2
136449|NCT00476151|454303|P2|Overall Study|Protocol Violation|3
136450|NCT00476151|454304|P1|Overall Study|Protocol Violation|1
136451|NCT00476151|454303|P2|Overall Study|Adverse Event|2
136452|NCT00476151|454304|P1|Overall Study|Adverse Event|0
136453|NCT00476086|454310|P1|Overall Study|Progressive Disease|4
136454|NCT00476086|454310|P1|Overall Study|Alternative therapy|1
136455|NCT00476008|454335|P2|Overall Study|Death|0
136456|NCT00476008|454336|P1|Overall Study|Death|1
136457|NCT00476008|454335|P2|Overall Study|Withdrawal by Subject|1
136458|NCT00476008|454336|P1|Overall Study|Withdrawal by Subject|0
136459|NCT00476008|454335|P2|Overall Study|Physician Decision: Medication Noncompli|1
136460|NCT00476008|454336|P1|Overall Study|Physician Decision: Medication Noncompli|2
136461|NCT00476008|454335|P2|Overall Study|Placebo concerns|2
136462|NCT00476008|454336|P1|Overall Study|Placebo concerns|2
136463|NCT00476008|454335|P2|Overall Study|Adverse Event|4
136464|NCT00476008|454336|P1|Overall Study|Adverse Event|4
136465|NCT00475865|454390|P3|Overall Study|Other than above|0
136466|NCT00475865|454391|P2|Overall Study|Other than above|1
136467|NCT00475865|454392|P1|Overall Study|Other than above|0
136468|NCT00475865|454390|P3|Overall Study|Participant did not wish to continue|0
136469|NCT00475865|454391|P2|Overall Study|Participant did not wish to continue|0
136470|NCT00475865|454392|P1|Overall Study|Participant did not wish to continue|1
136471|NCT00475865|454390|P3|Overall Study|Progressive disease|2
136472|NCT00475865|454391|P2|Overall Study|Progressive disease|1
136473|NCT00475865|454392|P1|Overall Study|Progressive disease|0
136474|NCT00475865|454390|P3|Overall Study|Lack of Efficacy|0
136475|NCT00475865|454391|P2|Overall Study|Lack of Efficacy|0
136476|NCT00475865|454392|P1|Overall Study|Lack of Efficacy|1
136477|NCT00475865|454390|P3|Overall Study|Adverse Event|4
136478|NCT00475865|454391|P2|Overall Study|Adverse Event|3
136479|NCT00475865|454392|P1|Overall Study|Adverse Event|0
136480|NCT00475852|454422|P2|Overall Study|Lost to Follow-up|68
136481|NCT00475852|454423|P1|Overall Study|Lost to Follow-up|54
136482|NCT00475852|454422|P2|Overall Study|Withdrawal by Subject|24
136483|NCT00475852|454423|P1|Overall Study|Withdrawal by Subject|19
136484|NCT00475852|454422|P2|Overall Study|Death|456
136485|NCT00475852|454423|P1|Overall Study|Death|444
136486|NCT00475735|454474|P6|Treatment Period 2|Withdrawal by Subject|0
136487|NCT00475735|454475|P5|Treatment Period 2|Withdrawal by Subject|1
136488|NCT00475735|454476|P4|Treatment Period 2|Withdrawal by Subject|0
136489|NCT00475735|454477|P3|Treatment Period 2|Withdrawal by Subject|0
136490|NCT00475735|454478|P2|Treatment Period 2|Withdrawal by Subject|0
136491|NCT00475735|454479|P1|Treatment Period 2|Withdrawal by Subject|0
136492|NCT00475735|454474|P6|Treatment Period 2|Lack of Efficacy|1
136493|NCT00475735|454475|P5|Treatment Period 2|Lack of Efficacy|0
136494|NCT00475735|454476|P4|Treatment Period 2|Lack of Efficacy|0
136495|NCT00475735|454477|P3|Treatment Period 2|Lack of Efficacy|0
136496|NCT00475735|454478|P2|Treatment Period 2|Lack of Efficacy|0
136497|NCT00475735|454479|P1|Treatment Period 2|Lack of Efficacy|0
136498|NCT00475735|454474|P6|Treatment Period 2|Adverse Event|0
136499|NCT00475735|454475|P5|Treatment Period 2|Adverse Event|0
136500|NCT00475735|454476|P4|Treatment Period 2|Adverse Event|2
136501|NCT00475735|454477|P3|Treatment Period 2|Adverse Event|0
136502|NCT00475735|454478|P2|Treatment Period 2|Adverse Event|1
136503|NCT00475735|454479|P1|Treatment Period 2|Adverse Event|0
136504|NCT00475735|454474|P6|Treatment Washout|Protocol Violation|0
136505|NCT00475735|454475|P5|Treatment Washout|Protocol Violation|0
136506|NCT00475735|454476|P4|Treatment Washout|Protocol Violation|0
136507|NCT00475735|454477|P3|Treatment Washout|Protocol Violation|0
136508|NCT00475735|454478|P2|Treatment Washout|Protocol Violation|1
136509|NCT00475735|454479|P1|Treatment Washout|Protocol Violation|0
136510|NCT00475735|454474|P6|Treatment Washout|Lost to Follow-up|0
136511|NCT00475735|454475|P5|Treatment Washout|Lost to Follow-up|0
136512|NCT00475735|454476|P4|Treatment Washout|Lost to Follow-up|0
136513|NCT00475735|454477|P3|Treatment Washout|Lost to Follow-up|0
136514|NCT00475735|454478|P2|Treatment Washout|Lost to Follow-up|1
136515|NCT00475735|454479|P1|Treatment Washout|Lost to Follow-up|0
136516|NCT00475735|454474|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
136517|NCT00475735|454475|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
136518|NCT00475735|454476|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
136519|NCT00475735|454477|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
136520|NCT00475735|454478|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
136521|NCT00475735|454479|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
136522|NCT00475735|454474|P6|Treatment Period 1|DC due to AE but continuing|2
136523|NCT00475735|454475|P5|Treatment Period 1|DC due to AE but continuing|2
136524|NCT00475735|454476|P4|Treatment Period 1|DC due to AE but continuing|1
136525|NCT00475735|454477|P3|Treatment Period 1|DC due to AE but continuing|0
136526|NCT00475735|454478|P2|Treatment Period 1|DC due to AE but continuing|0
136527|NCT00475735|454479|P1|Treatment Period 1|DC due to AE but continuing|0
136528|NCT00475735|454474|P6|Treatment Period 1|Withdrawal by Subject|0
136529|NCT00475735|454475|P5|Treatment Period 1|Withdrawal by Subject|0
136530|NCT00475735|454476|P4|Treatment Period 1|Withdrawal by Subject|0
136531|NCT00475735|454477|P3|Treatment Period 1|Withdrawal by Subject|0
136532|NCT00475735|454478|P2|Treatment Period 1|Withdrawal by Subject|1
136533|NCT00475735|454479|P1|Treatment Period 1|Withdrawal by Subject|1
136534|NCT00475735|454474|P6|Treatment Period 1|Protocol Violation|0
136535|NCT00475735|454475|P5|Treatment Period 1|Protocol Violation|0
136536|NCT00475735|454476|P4|Treatment Period 1|Protocol Violation|1
136537|NCT00475735|454477|P3|Treatment Period 1|Protocol Violation|0
136538|NCT00475735|454478|P2|Treatment Period 1|Protocol Violation|0
136539|NCT00475735|454479|P1|Treatment Period 1|Protocol Violation|0
136540|NCT00475735|454474|P6|Treatment Period 1|Lost to Follow-up|1
136541|NCT00475735|454475|P5|Treatment Period 1|Lost to Follow-up|0
136542|NCT00475735|454476|P4|Treatment Period 1|Lost to Follow-up|0
136543|NCT00475735|454477|P3|Treatment Period 1|Lost to Follow-up|0
136544|NCT00475735|454478|P2|Treatment Period 1|Lost to Follow-up|0
136545|NCT00475735|454479|P1|Treatment Period 1|Lost to Follow-up|0
136546|NCT00475735|454474|P6|Treatment Period 1|Lack of Efficacy|0
136547|NCT00475735|454475|P5|Treatment Period 1|Lack of Efficacy|0
136548|NCT00475735|454476|P4|Treatment Period 1|Lack of Efficacy|0
136549|NCT00475735|454477|P3|Treatment Period 1|Lack of Efficacy|0
136550|NCT00475735|454478|P2|Treatment Period 1|Lack of Efficacy|0
136551|NCT00475735|454479|P1|Treatment Period 1|Lack of Efficacy|1
136552|NCT00475735|454474|P6|Treatment Period 1|Adverse Event|0
136553|NCT00475735|454475|P5|Treatment Period 1|Adverse Event|0
136554|NCT00475735|454476|P4|Treatment Period 1|Adverse Event|0
136555|NCT00475735|454477|P3|Treatment Period 1|Adverse Event|0
136556|NCT00475735|454478|P2|Treatment Period 1|Adverse Event|0
136557|NCT00475735|454479|P1|Treatment Period 1|Adverse Event|2
136558|NCT00475722|454492|P2|Overall Study|Protocol Violation|0
136559|NCT00475722|454493|P1|Overall Study|Protocol Violation|3
136560|NCT00475722|454492|P2|Overall Study|Withdrawal by Subject|12
136561|NCT00475722|454493|P1|Overall Study|Withdrawal by Subject|12
136562|NCT00475709|454499|P1|Overall Study|Lost to Follow-up|21
136563|NCT00475709|454499|P1|Overall Study|Device Explant|6
136564|NCT00475709|454499|P1|Overall Study|Death|41
136565|NCT00475709|454499|P1|Overall Study|Did not meet eligibility criteria|8
136566|NCT00475670|454507|P2|Overall Study|Not Specified|3
136567|NCT00475670|454508|P1|Overall Study|Not Specified|0
136568|NCT00475670|454507|P2|Overall Study|Failure to Return|1
136569|NCT00475670|454508|P1|Overall Study|Failure to Return|0
136570|NCT00475670|454507|P2|Overall Study|Refused treatment|2
136571|NCT00475670|454508|P1|Overall Study|Refused treatment|0
136572|NCT00475670|454507|P2|Overall Study|Lack of Efficacy|34
136573|NCT00475670|454508|P1|Overall Study|Lack of Efficacy|3
136574|NCT00475670|454507|P2|Overall Study|Death|1
136575|NCT00475670|454508|P1|Overall Study|Death|0
136576|NCT00475657|454532|P1|Overall Study|Sponsor's Decision|3
136577|NCT00475657|454532|P1|Overall Study|Death|1
136578|NCT00475423|454597|P1|Overall Study|Lost to Follow-up|7
136579|NCT00475423|454597|P1|Overall Study|Reason not specified|1
136580|NCT00475423|454597|P1|Overall Study|Death|1
136581|NCT00475423|454597|P1|Overall Study|Lack of Efficacy|8
136582|NCT00475423|454597|P1|Overall Study|Withdrawal by Subject|6
136583|NCT00475423|454597|P1|Overall Study|Adverse Event|4
136584|NCT00475423|454597|P1|Overall Study|Protocol Violation|5
136585|NCT00475306|454643|P4|Overall Study|Protocol Violation|1
136586|NCT00475306|454644|P3|Overall Study|Protocol Violation|0
136587|NCT00475306|454645|P2|Overall Study|Protocol Violation|1
136588|NCT00475306|454646|P1|Overall Study|Protocol Violation|1
136589|NCT00475176|454669|P1|Overall Study|Protocol Violation|1
136590|NCT00475176|454669|P1|Overall Study|Withdrawal by Subject|1
136591|NCT00475176|454669|P1|Overall Study|Adverse Event|2
136592|NCT00475033|454709|P2|Toddler Dose|Lost to Follow-up|0
136593|NCT00475033|454710|P1|Toddler Dose|Lost to Follow-up|1
136594|NCT00475033|454709|P2|Toddler Dose|Failed to return|0
136595|NCT00475033|454710|P1|Toddler Dose|Failed to return|1
136596|NCT00475033|454709|P2|Toddler Dose|Parent or legal guardian request|0
136597|NCT00475033|454710|P1|Toddler Dose|Parent or legal guardian request|2
136598|NCT00475033|454709|P2|After the Infant Series|Unspecified|1
136599|NCT00475033|454710|P1|After the Infant Series|Unspecified|0
136600|NCT00475033|454709|P2|After the Infant Series|Lost to Follow-up|0
136601|NCT00475033|454710|P1|After the Infant Series|Lost to Follow-up|1
136602|NCT00475033|454709|P2|After the Infant Series|Protocol Violation|0
136603|NCT00475033|454710|P1|After the Infant Series|Protocol Violation|1
136604|NCT00475033|454709|P2|After the Infant Series|Failed to return|1
136605|NCT00475033|454710|P1|After the Infant Series|Failed to return|2
136606|NCT00475033|454709|P2|After the Infant Series|Parent or legal guardian request|2
136607|NCT00475033|454710|P1|After the Infant Series|Parent or legal guardian request|2
136608|NCT00475033|454709|P2|After the Infant Series|Adverse Event|4
136609|NCT00475033|454710|P1|After the Infant Series|Adverse Event|0
136610|NCT00475033|454709|P2|Infant Series|Adverse Event|2
136611|NCT00475033|454710|P1|Infant Series|Adverse Event|0
136612|NCT00475033|454709|P2|Infant Series|Lost to Follow-up|0
136613|NCT00475033|454710|P1|Infant Series|Lost to Follow-up|2
136614|NCT00475033|454709|P2|Infant Series|Protocol Violation|2
136615|NCT00475033|454710|P1|Infant Series|Protocol Violation|1
136616|NCT00475033|454709|P2|Infant Series|Parent or legal guardian request|5
136617|NCT00475033|454710|P1|Infant Series|Parent or legal guardian request|1
136618|NCT00475033|454709|P2|Infant Series|Failed to return|4
136619|NCT00475033|454710|P1|Infant Series|Failed to return|3
136620|NCT00474994|454758|P1|Overall Study|Patient found to be ineligible|1
136621|NCT00474994|454758|P1|Overall Study|Patient evaluable for toxicity only|3
136622|NCT00474994|454758|P1|Overall Study|Patient Not treated|1
136623|NCT00474968|454764|P2|Overall Study|Sample not collected|1
136624|NCT00474968|454765|P1|Overall Study|Sample not collected|1
136625|NCT00474968|454764|P2|Overall Study|Protocol Violation|8
136626|NCT00474968|454765|P1|Overall Study|Protocol Violation|9
136627|NCT00474968|454764|P2|Overall Study|Withdrawal by Subject|7
136628|NCT00474968|454765|P1|Overall Study|Withdrawal by Subject|8
136629|NCT00474955|454775|P1|Overall Study|Personal reasons|5
136630|NCT00474955|454775|P1|Overall Study|Drug unavailability|1
136631|NCT00474955|454775|P1|Overall Study|Adverse Event|2
136632|NCT00474929|454791|P5|Overall Study|Physician Decision|0
136633|NCT00474929|454792|P4|Overall Study|Physician Decision|2
136634|NCT00474929|454793|P3|Overall Study|Physician Decision|1
136635|NCT00474929|454794|P2|Overall Study|Physician Decision|0
136636|NCT00474929|454795|P1|Overall Study|Physician Decision|0
136637|NCT00474929|454791|P5|Overall Study|Unrelated medical condition|0
136638|NCT00474929|454792|P4|Overall Study|Unrelated medical condition|0
136639|NCT00474929|454793|P3|Overall Study|Unrelated medical condition|1
136640|NCT00474929|454794|P2|Overall Study|Unrelated medical condition|0
136641|NCT00474929|454795|P1|Overall Study|Unrelated medical condition|0
136642|NCT00474929|454791|P5|Overall Study|Withdrawal by Subject|0
136643|NCT00474929|454792|P4|Overall Study|Withdrawal by Subject|0
136644|NCT00474929|454793|P3|Overall Study|Withdrawal by Subject|0
136645|NCT00474929|454794|P2|Overall Study|Withdrawal by Subject|1
136646|NCT00474929|454795|P1|Overall Study|Withdrawal by Subject|0
136647|NCT00474903|454812|P3|Overall Study|Protocol Violation|2
136648|NCT00474903|454813|P2|Overall Study|Protocol Violation|5
136649|NCT00474903|454814|P1|Overall Study|Protocol Violation|1
136650|NCT00474812|454836|P1|Overall Study|No Initiation of treatment|2
136651|NCT00474812|454836|P1|Overall Study|Withdrawal by Subject|5
136652|NCT00474786|454846|P2|Overall Study|Not specified|0
136653|NCT00474786|454847|P1|Overall Study|Not specified|5
136654|NCT00474786|454846|P2|Overall Study|Withdrawal by Subject|15
136655|NCT00474786|454847|P1|Overall Study|Withdrawal by Subject|15
136656|NCT00474786|454846|P2|Overall Study|Protocol Violation|0
136657|NCT00474786|454847|P1|Overall Study|Protocol Violation|2
136658|NCT00474786|454846|P2|Overall Study|Lost to Follow-up|7
136659|NCT00474786|454847|P1|Overall Study|Lost to Follow-up|4
136660|NCT00474786|454846|P2|Overall Study|Discontinuation of Study by Sponsor|59
136661|NCT00474786|454847|P1|Overall Study|Discontinuation of Study by Sponsor|42
136662|NCT00474786|454846|P2|Overall Study|Death|170
136663|NCT00474786|454847|P1|Overall Study|Death|189
136664|NCT00474786|454846|P2|Overall Study|Investigator Request|1
136665|NCT00474786|454847|P1|Overall Study|Investigator Request|2
136666|NCT00474786|454846|P2|Overall Study|Not Meeting Study Criteria|1
136667|NCT00474786|454847|P1|Overall Study|Not Meeting Study Criteria|0
136668|NCT00474760|454872|P7|Overall Study|Terminated by sponsor|2
136669|NCT00474760|454873|P6|Overall Study|Terminated by sponsor|0
136670|NCT00474760|454874|P5|Overall Study|Terminated by sponsor|0
136671|NCT00474760|454875|P4|Overall Study|Terminated by sponsor|0
136672|NCT00474760|454876|P3|Overall Study|Terminated by sponsor|0
136673|NCT00474760|454877|P2|Overall Study|Terminated by sponsor|0
136674|NCT00474760|454878|P1|Overall Study|Terminated by sponsor|0
136675|NCT00474760|454872|P7|Overall Study|Progressive disease|7
136676|NCT00474760|454873|P6|Overall Study|Progressive disease|20
136677|NCT00474760|454874|P5|Overall Study|Progressive disease|8
136678|NCT00474760|454875|P4|Overall Study|Progressive disease|2
136679|NCT00474760|454876|P3|Overall Study|Progressive disease|3
136680|NCT00474760|454877|P2|Overall Study|Progressive disease|2
136681|NCT00474760|454878|P1|Overall Study|Progressive disease|3
136682|NCT00474760|454872|P7|Overall Study|Unspecified|0
136683|NCT00474760|454873|P6|Overall Study|Unspecified|0
136684|NCT00474760|454874|P5|Overall Study|Unspecified|1
136685|NCT00474760|454875|P4|Overall Study|Unspecified|0
136686|NCT00474760|454876|P3|Overall Study|Unspecified|0
136687|NCT00474760|454877|P2|Overall Study|Unspecified|1
136688|NCT00474760|454878|P1|Overall Study|Unspecified|0
136689|NCT00474760|454872|P7|Overall Study|Withdrawal by Subject|1
136690|NCT00474760|454873|P6|Overall Study|Withdrawal by Subject|1
136691|NCT00474760|454874|P5|Overall Study|Withdrawal by Subject|0
136692|NCT00474760|454875|P4|Overall Study|Withdrawal by Subject|1
136693|NCT00474760|454876|P3|Overall Study|Withdrawal by Subject|0
136694|NCT00474760|454877|P2|Overall Study|Withdrawal by Subject|0
136695|NCT00474760|454878|P1|Overall Study|Withdrawal by Subject|0
136696|NCT00474760|454872|P7|Overall Study|Laboratory abnormality|0
136697|NCT00474760|454873|P6|Overall Study|Laboratory abnormality|1
136698|NCT00474760|454874|P5|Overall Study|Laboratory abnormality|0
136699|NCT00474760|454875|P4|Overall Study|Laboratory abnormality|0
136700|NCT00474760|454876|P3|Overall Study|Laboratory abnormality|0
136701|NCT00474760|454877|P2|Overall Study|Laboratory abnormality|0
136702|NCT00474760|454878|P1|Overall Study|Laboratory abnormality|0
136703|NCT00474760|454872|P7|Overall Study|Adverse Event|0
136704|NCT00474760|454873|P6|Overall Study|Adverse Event|7
136705|NCT00474760|454874|P5|Overall Study|Adverse Event|1
136706|NCT00474760|454875|P4|Overall Study|Adverse Event|0
136707|NCT00474760|454876|P3|Overall Study|Adverse Event|0
136708|NCT00474760|454877|P2|Overall Study|Adverse Event|0
136709|NCT00474760|454878|P1|Overall Study|Adverse Event|0
136710|NCT00474760|454872|P7|Overall Study|Death|0
136711|NCT00474760|454873|P6|Overall Study|Death|0
136712|NCT00474760|454874|P5|Overall Study|Death|2
136713|NCT00474760|454875|P4|Overall Study|Death|0
136714|NCT00474760|454876|P3|Overall Study|Death|0
136715|NCT00474760|454877|P2|Overall Study|Death|0
136716|NCT00474760|454878|P1|Overall Study|Death|0
136717|NCT00474708|454985|P2|Overall Study|Physician Decision|6
136718|NCT00474708|454986|P1|Overall Study|Physician Decision|9
136719|NCT00474708|454985|P2|Overall Study|Lost to Follow-up|9
136720|NCT00474708|454986|P1|Overall Study|Lost to Follow-up|18
136721|NCT00474708|454985|P2|Overall Study|Lack of compliance|4
136722|NCT00474708|454986|P1|Overall Study|Lack of compliance|12
136723|NCT00474708|454985|P2|Overall Study|Withdrawal by Subject|0
136724|NCT00474708|454986|P1|Overall Study|Withdrawal by Subject|7
136725|NCT00474708|454985|P2|Overall Study|Suicide ideation/behavior|1
136726|NCT00474708|454986|P1|Overall Study|Suicide ideation/behavior|0
136727|NCT00474708|454985|P2|Overall Study|Lack of Efficacy|5
136728|NCT00474708|454986|P1|Overall Study|Lack of Efficacy|11
136729|NCT00474630|454996|P2|Overall Study|Drug noncompliance, other|4
136730|NCT00474630|454997|P1|Overall Study|Drug noncompliance, other|11
136731|NCT00474630|454996|P2|Overall Study|Lack of Efficacy|6
136732|NCT00474630|454997|P1|Overall Study|Lack of Efficacy|5
136733|NCT00474630|454996|P2|Overall Study|Protocol Violation|4
136734|NCT00474630|454997|P1|Overall Study|Protocol Violation|3
136735|NCT00474630|454996|P2|Overall Study|Withdrawal by Subject|15
136736|NCT00474630|454997|P1|Overall Study|Withdrawal by Subject|21
136737|NCT00474630|454996|P2|Overall Study|Lost to Follow-up|15
136738|NCT00474630|454997|P1|Overall Study|Lost to Follow-up|22
136739|NCT00474630|454996|P2|Overall Study|Adverse Event|26
136740|NCT00474630|454997|P1|Overall Study|Adverse Event|98
136741|NCT00474539|455053|P2|Toddler Dose|Protocol Violation|0
136742|NCT00474539|455054|P1|Toddler Dose|Protocol Violation|1
136743|NCT00474539|455053|P2|After Infant Series|Withdrawal by Subject|0
136744|NCT00474539|455054|P1|After Infant Series|Withdrawal by Subject|1
136745|NCT00474539|455053|P2|After Infant Series|Lost to Follow-up|0
136746|NCT00474539|455054|P1|After Infant Series|Lost to Follow-up|3
136747|NCT00474539|455053|P2|Infant Series|Protocol Violation|1
136748|NCT00474539|455054|P1|Infant Series|Protocol Violation|0
136749|NCT00474539|455053|P2|Infant Series|Lost to Follow-up|1
136750|NCT00474539|455054|P1|Infant Series|Lost to Follow-up|2
136751|NCT00474539|455053|P2|Infant Series|Randomization error|0
136752|NCT00474539|455054|P1|Infant Series|Randomization error|5
136753|NCT00474539|455053|P2|Infant Series|Withdrawal by Subject|4
136754|NCT00474539|455054|P1|Infant Series|Withdrawal by Subject|3
136755|NCT00474526|455119|P17|Overall Study|Withdrawal by Subject|1
136756|NCT00474526|455120|P16|Overall Study|Withdrawal by Subject|1
136757|NCT00474526|455121|P15|Overall Study|Withdrawal by Subject|22
136758|NCT00474526|455122|P14|Overall Study|Withdrawal by Subject|37
136759|NCT00474526|455123|P13|Overall Study|Withdrawal by Subject|4
136760|NCT00474526|455124|P12|Overall Study|Withdrawal by Subject|4
136761|NCT00474526|455125|P11|Overall Study|Withdrawal by Subject|5
136762|NCT00474526|455126|P10|Overall Study|Withdrawal by Subject|13
136763|NCT00474526|455127|P9|Overall Study|Withdrawal by Subject|4
136764|NCT00474526|455128|P8|Overall Study|Withdrawal by Subject|4
136765|NCT00474526|455129|P7|Overall Study|Withdrawal by Subject|12
136766|NCT00474526|455130|P6|Overall Study|Withdrawal by Subject|6
136767|NCT00474526|455131|P5|Overall Study|Withdrawal by Subject|38
136768|NCT00474526|455132|P4|Overall Study|Withdrawal by Subject|52
136769|NCT00474526|455133|P3|Overall Study|Withdrawal by Subject|21
136770|NCT00474526|455134|P2|Overall Study|Withdrawal by Subject|24
136771|NCT00474526|455135|P1|Overall Study|Withdrawal by Subject|9
136772|NCT00474526|455119|P17|Overall Study|UNABLE TO CLASSIFY|1
136773|NCT00474526|455120|P16|Overall Study|UNABLE TO CLASSIFY|6
136774|NCT00474526|455121|P15|Overall Study|UNABLE TO CLASSIFY|12
136775|NCT00474526|455122|P14|Overall Study|UNABLE TO CLASSIFY|20
136776|NCT00474526|455123|P13|Overall Study|UNABLE TO CLASSIFY|0
136777|NCT00474526|455124|P12|Overall Study|UNABLE TO CLASSIFY|0
136778|NCT00474526|455125|P11|Overall Study|UNABLE TO CLASSIFY|0
136779|NCT00474526|455126|P10|Overall Study|UNABLE TO CLASSIFY|3
136780|NCT00474526|455127|P9|Overall Study|UNABLE TO CLASSIFY|0
136781|NCT00474526|455128|P8|Overall Study|UNABLE TO CLASSIFY|1
136782|NCT00474526|455129|P7|Overall Study|UNABLE TO CLASSIFY|0
136783|NCT00474526|455130|P6|Overall Study|UNABLE TO CLASSIFY|2
136784|NCT00474526|455131|P5|Overall Study|UNABLE TO CLASSIFY|3
136785|NCT00474526|455132|P4|Overall Study|UNABLE TO CLASSIFY|1
136786|NCT00474526|455133|P3|Overall Study|UNABLE TO CLASSIFY|0
136787|NCT00474526|455134|P2|Overall Study|UNABLE TO CLASSIFY|0
136788|NCT00474526|455135|P1|Overall Study|UNABLE TO CLASSIFY|1
136789|NCT00474526|455119|P17|Overall Study|Protocol Violation|2
136790|NCT00474526|455120|P16|Overall Study|Protocol Violation|6
136791|NCT00474526|455121|P15|Overall Study|Protocol Violation|9
136792|NCT00474526|455122|P14|Overall Study|Protocol Violation|19
136793|NCT00474526|455123|P13|Overall Study|Protocol Violation|4
136794|NCT00474526|455124|P12|Overall Study|Protocol Violation|2
136795|NCT00474526|455125|P11|Overall Study|Protocol Violation|2
136796|NCT00474526|455126|P10|Overall Study|Protocol Violation|4
136797|NCT00474526|455127|P9|Overall Study|Protocol Violation|0
136798|NCT00474526|455128|P8|Overall Study|Protocol Violation|0
136799|NCT00474526|455129|P7|Overall Study|Protocol Violation|3
136800|NCT00474526|455130|P6|Overall Study|Protocol Violation|1
136801|NCT00474526|455131|P5|Overall Study|Protocol Violation|3
136802|NCT00474526|455132|P4|Overall Study|Protocol Violation|12
136803|NCT00474526|455133|P3|Overall Study|Protocol Violation|4
136804|NCT00474526|455134|P2|Overall Study|Protocol Violation|6
136805|NCT00474526|455135|P1|Overall Study|Protocol Violation|2
136806|NCT00474526|455119|P17|Overall Study|Lost to Follow-up|5
136807|NCT00474526|455120|P16|Overall Study|Lost to Follow-up|4
136808|NCT00474526|455121|P15|Overall Study|Lost to Follow-up|29
136809|NCT00474526|455122|P14|Overall Study|Lost to Follow-up|74
136810|NCT00474526|455123|P13|Overall Study|Lost to Follow-up|6
136811|NCT00474526|455124|P12|Overall Study|Lost to Follow-up|4
136812|NCT00474526|455125|P11|Overall Study|Lost to Follow-up|2
136813|NCT00474526|455126|P10|Overall Study|Lost to Follow-up|6
136814|NCT00474526|455127|P9|Overall Study|Lost to Follow-up|0
136815|NCT00474526|455128|P8|Overall Study|Lost to Follow-up|1
136816|NCT00474526|455129|P7|Overall Study|Lost to Follow-up|8
136817|NCT00474526|455130|P6|Overall Study|Lost to Follow-up|5
136818|NCT00474526|455131|P5|Overall Study|Lost to Follow-up|11
136819|NCT00474526|455132|P4|Overall Study|Lost to Follow-up|29
136820|NCT00474526|455133|P3|Overall Study|Lost to Follow-up|13
136821|NCT00474526|455134|P2|Overall Study|Lost to Follow-up|6
136822|NCT00474526|455135|P1|Overall Study|Lost to Follow-up|8
136823|NCT00474526|455119|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
136824|NCT00474526|455120|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
136825|NCT00474526|455121|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
136826|NCT00474526|455122|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
136827|NCT00474526|455123|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
136828|NCT00474526|455124|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
136829|NCT00474526|455125|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
136830|NCT00474526|455126|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
136831|NCT00474526|455127|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
136832|NCT00474526|455128|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
136833|NCT00474526|455129|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
136834|NCT00474526|455130|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
136835|NCT00474526|455131|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
136836|NCT00474526|455132|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
136837|NCT00474526|455133|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
136838|NCT00474526|455134|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
136839|NCT00474526|455135|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
136840|NCT00474526|455119|P17|Overall Study|Death|0
136841|NCT00474526|455120|P16|Overall Study|Death|0
136842|NCT00474526|455121|P15|Overall Study|Death|0
136843|NCT00474526|455122|P14|Overall Study|Death|3
136844|NCT00474526|455123|P13|Overall Study|Death|0
136845|NCT00474526|455124|P12|Overall Study|Death|0
136846|NCT00474526|455125|P11|Overall Study|Death|0
136847|NCT00474526|455126|P10|Overall Study|Death|0
136848|NCT00474526|455127|P9|Overall Study|Death|0
136849|NCT00474526|455128|P8|Overall Study|Death|0
136850|NCT00474526|455129|P7|Overall Study|Death|0
136851|NCT00474526|455130|P6|Overall Study|Death|0
136852|NCT00474526|455131|P5|Overall Study|Death|0
136853|NCT00474526|455132|P4|Overall Study|Death|0
136854|NCT00474526|455133|P3|Overall Study|Death|0
136855|NCT00474526|455134|P2|Overall Study|Death|0
136856|NCT00474526|455135|P1|Overall Study|Death|0
136857|NCT00474526|455119|P17|Overall Study|Adverse Event|0
136858|NCT00474526|455120|P16|Overall Study|Adverse Event|1
136859|NCT00474526|455121|P15|Overall Study|Adverse Event|1
136860|NCT00474526|455122|P14|Overall Study|Adverse Event|0
136861|NCT00474526|455123|P13|Overall Study|Adverse Event|0
136862|NCT00474526|455124|P12|Overall Study|Adverse Event|0
136863|NCT00474526|455125|P11|Overall Study|Adverse Event|0
136864|NCT00474526|455126|P10|Overall Study|Adverse Event|0
136865|NCT00474526|455127|P9|Overall Study|Adverse Event|0
136866|NCT00474526|455128|P8|Overall Study|Adverse Event|0
136867|NCT00474526|455129|P7|Overall Study|Adverse Event|1
136868|NCT00474526|455130|P6|Overall Study|Adverse Event|1
136869|NCT00474526|455131|P5|Overall Study|Adverse Event|2
136870|NCT00474526|455132|P4|Overall Study|Adverse Event|4
136871|NCT00474526|455133|P3|Overall Study|Adverse Event|2
136872|NCT00474526|455134|P2|Overall Study|Adverse Event|0
136873|NCT00474526|455135|P1|Overall Study|Adverse Event|2
136874|NCT00474526|455119|P17|Overall Study|ADMINISTRATIVE REASON|0
136875|NCT00474526|455120|P16|Overall Study|ADMINISTRATIVE REASON|0
136876|NCT00474526|455121|P15|Overall Study|ADMINISTRATIVE REASON|2
136877|NCT00474526|455122|P14|Overall Study|ADMINISTRATIVE REASON|1
136878|NCT00474526|455123|P13|Overall Study|ADMINISTRATIVE REASON|1
136879|NCT00474526|455124|P12|Overall Study|ADMINISTRATIVE REASON|1
136880|NCT00474526|455125|P11|Overall Study|ADMINISTRATIVE REASON|1
136881|NCT00474526|455126|P10|Overall Study|ADMINISTRATIVE REASON|1
136882|NCT00474526|455127|P9|Overall Study|ADMINISTRATIVE REASON|2
136883|NCT00474526|455128|P8|Overall Study|ADMINISTRATIVE REASON|0
136884|NCT00474526|455129|P7|Overall Study|ADMINISTRATIVE REASON|1
136885|NCT00474526|455130|P6|Overall Study|ADMINISTRATIVE REASON|1
136886|NCT00474526|455131|P5|Overall Study|ADMINISTRATIVE REASON|9
136887|NCT00474526|455132|P4|Overall Study|ADMINISTRATIVE REASON|20
136888|NCT00474526|455133|P3|Overall Study|ADMINISTRATIVE REASON|9
136889|NCT00474526|455134|P2|Overall Study|ADMINISTRATIVE REASON|9
136890|NCT00474526|455135|P1|Overall Study|ADMINISTRATIVE REASON|11
136891|NCT00474487|455300|P4|Overall Study|Death|0
136892|NCT00474487|455301|P3|Overall Study|Death|0
136893|NCT00474487|455302|P2|Overall Study|Death|1
136894|NCT00474487|455303|P1|Overall Study|Death|0
136895|NCT00474487|455300|P4|Overall Study|Inappropriate enrollment|0
136896|NCT00474487|455301|P3|Overall Study|Inappropriate enrollment|7
136897|NCT00474487|455302|P2|Overall Study|Inappropriate enrollment|0
136898|NCT00474487|455303|P1|Overall Study|Inappropriate enrollment|4
136899|NCT00474487|455300|P4|Overall Study|Lost to Follow-up|0
136900|NCT00474487|455301|P3|Overall Study|Lost to Follow-up|7
136901|NCT00474487|455302|P2|Overall Study|Lost to Follow-up|1
136902|NCT00474487|455303|P1|Overall Study|Lost to Follow-up|20
136903|NCT00474487|455300|P4|Overall Study|Withdrawal by Subject|0
136904|NCT00474487|455301|P3|Overall Study|Withdrawal by Subject|0
136905|NCT00474487|455302|P2|Overall Study|Withdrawal by Subject|0
136906|NCT00474487|455303|P1|Overall Study|Withdrawal by Subject|6
136907|NCT00474383|455323|P2|Extension|Progressive Disease|5
136908|NCT00474383|455324|P1|Extension|Progressive Disease|0
136909|NCT00474383|455323|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
136910|NCT00474383|455324|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
136911|NCT00474383|455323|P2|Main Study|Other|0
136912|NCT00474383|455324|P1|Main Study|Other|1
136913|NCT00474383|455323|P2|Main Study|Progressive Disease|0
136914|NCT00474383|455324|P1|Main Study|Progressive Disease|23
136915|NCT00474383|455323|P2|Main Study|Symptomatic Deterioration|0
136916|NCT00474383|455324|P1|Main Study|Symptomatic Deterioration|1
136917|NCT00474383|455323|P2|Main Study|Adverse Event|0
136918|NCT00474383|455324|P1|Main Study|Adverse Event|11
136919|NCT00474240|455341|P6|Overall Study|Removed due to lab value|1
136920|NCT00474240|455342|P5|Overall Study|Removed due to lab value|0
136921|NCT00474240|455343|P4|Overall Study|Removed due to lab value|0
136922|NCT00474240|455344|P3|Overall Study|Removed due to lab value|0
136923|NCT00474240|455345|P2|Overall Study|Removed due to lab value|0
136924|NCT00474240|455346|P1|Overall Study|Removed due to lab value|0
136925|NCT00474240|455341|P6|Overall Study|Adverse Event|16
136926|NCT00474240|455342|P5|Overall Study|Adverse Event|5
136927|NCT00474240|455343|P4|Overall Study|Adverse Event|14
136928|NCT00474240|455344|P3|Overall Study|Adverse Event|9
136929|NCT00474240|455345|P2|Overall Study|Adverse Event|0
136930|NCT00474240|455346|P1|Overall Study|Adverse Event|0
136931|NCT00474240|455341|P6|Overall Study|Withdrawal by Subject|1
136932|NCT00474240|455342|P5|Overall Study|Withdrawal by Subject|3
136933|NCT00474240|455343|P4|Overall Study|Withdrawal by Subject|2
136934|NCT00474240|455344|P3|Overall Study|Withdrawal by Subject|0
136935|NCT00474240|455345|P2|Overall Study|Withdrawal by Subject|1
136936|NCT00474240|455346|P1|Overall Study|Withdrawal by Subject|1
136937|NCT00474188|455371|P1|Overall Study|Study discontinued by sponsor|5
136938|NCT00474188|455371|P1|Overall Study|Withdrawal by Subject|1
136939|NCT00474175|455381|P3|Overall Study|Administrative|0
136940|NCT00474175|455382|P2|Overall Study|Administrative|1
136941|NCT00474175|455383|P1|Overall Study|Administrative|0
136942|NCT00474175|455381|P3|Overall Study|Protocol Violation|1
136943|NCT00474175|455382|P2|Overall Study|Protocol Violation|2
136944|NCT00474175|455383|P1|Overall Study|Protocol Violation|0
136945|NCT00474175|455381|P3|Overall Study|Ineligible|1
136946|NCT00474175|455382|P2|Overall Study|Ineligible|3
136947|NCT00474175|455383|P1|Overall Study|Ineligible|1
136948|NCT00474175|455381|P3|Overall Study|Withdrawal by Subject|1
136949|NCT00474175|455382|P2|Overall Study|Withdrawal by Subject|1
136950|NCT00474175|455383|P1|Overall Study|Withdrawal by Subject|0
136951|NCT00474175|455381|P3|Overall Study|Lack of Efficacy|1
136952|NCT00474175|455382|P2|Overall Study|Lack of Efficacy|0
136953|NCT00474175|455383|P1|Overall Study|Lack of Efficacy|0
136954|NCT00474058|455447|P2|Overall Study|Other|0
136955|NCT00474058|455448|P1|Overall Study|Other|2
136956|NCT00474058|455447|P2|Overall Study|Withdrawal by Subject|7
136957|NCT00474058|455448|P1|Overall Study|Withdrawal by Subject|11
136958|NCT00474058|455447|P2|Overall Study|Lack of Efficacy|4
136959|NCT00474058|455448|P1|Overall Study|Lack of Efficacy|0
136960|NCT00474058|455447|P2|Overall Study|Adverse Event|6
136961|NCT00474058|455448|P1|Overall Study|Adverse Event|11
136962|NCT00474045|455462|P2|Overall Study|Withdrawal criteria|50
136963|NCT00474045|455463|P1|Overall Study|Withdrawal criteria|60
136964|NCT00474045|455462|P2|Overall Study|Withdrawal by Subject|18
136965|NCT00474045|455463|P1|Overall Study|Withdrawal by Subject|16
136966|NCT00474045|455462|P2|Overall Study|Protocol Violation|12
136967|NCT00474045|455463|P1|Overall Study|Protocol Violation|10
136968|NCT00474045|455462|P2|Overall Study|Lost to Follow-up|1
136969|NCT00474045|455463|P1|Overall Study|Lost to Follow-up|1
136970|NCT00474045|455462|P2|Overall Study|Lack of Efficacy|9
136971|NCT00474045|455463|P1|Overall Study|Lack of Efficacy|0
136972|NCT00474045|455462|P2|Overall Study|Unclassified|3
136973|NCT00474045|455463|P1|Overall Study|Unclassified|1
136974|NCT00474045|455462|P2|Overall Study|Adverse Event|8
136975|NCT00474045|455463|P1|Overall Study|Adverse Event|18
136976|NCT00473889|455563|P2|Overall Study|Withdrawal by Subject|0
136977|NCT00473889|455564|P1|Overall Study|Withdrawal by Subject|5
136978|NCT00473889|455563|P2|Overall Study|Trial Terminated|6
136979|NCT00473889|455564|P1|Overall Study|Trial Terminated|3
136980|NCT00473889|455563|P2|Overall Study|Physician Decision|5
136981|NCT00473889|455564|P1|Overall Study|Physician Decision|10
136982|NCT00473889|455563|P2|Overall Study|Lost to Follow-up|1
136983|NCT00473889|455564|P1|Overall Study|Lost to Follow-up|2
136984|NCT00473889|455563|P2|Overall Study|Lack of Efficacy|29
136985|NCT00473889|455564|P1|Overall Study|Lack of Efficacy|28
136986|NCT00473889|455563|P2|Overall Study|Protocol Violation|2
136987|NCT00473889|455564|P1|Overall Study|Protocol Violation|4
136988|NCT00473889|455563|P2|Overall Study|Adverse Event|17
136989|NCT00473889|455564|P1|Overall Study|Adverse Event|30
136990|NCT00473889|455563|P2|Overall Study|Did not receive study medication|4
136991|NCT00473889|455564|P1|Overall Study|Did not receive study medication|1
136992|NCT00473876|455576|P2|Overall Study|Lost to Follow-up|1
136993|NCT00473876|455577|P1|Overall Study|Lost to Follow-up|3
136994|NCT00473824|455596|P2|Overall Study|Withdrawal by physician|0
136995|NCT00473824|455597|P1|Overall Study|Withdrawal by physician|1
136996|NCT00473824|455596|P2|Overall Study|Lost to Follow-up|0
136997|NCT00473824|455597|P1|Overall Study|Lost to Follow-up|1
136998|NCT00473824|455596|P2|Overall Study|Death|0
136999|NCT00473824|455597|P1|Overall Study|Death|1
137000|NCT00473824|455596|P2|Overall Study|Adverse Event|0
137001|NCT00473824|455597|P1|Overall Study|Adverse Event|1
137002|NCT00473824|455596|P2|Overall Study|Virologic Breakthrough|0
137003|NCT00473824|455597|P1|Overall Study|Virologic Breakthrough|1
137004|NCT00473746|455608|P5|Period 2 (Phase 2)|Reason not specified|3
137005|NCT00473746|455609|P4|Period 2 (Phase 2)|Reason not specified|0
137006|NCT00473746|455610|P3|Period 2 (Phase 2)|Reason not specified|0
137007|NCT00473746|455611|P2|Period 2 (Phase 2)|Reason not specified|0
137008|NCT00473746|455612|P1|Period 2 (Phase 2)|Reason not specified|0
137009|NCT00473746|455608|P5|Period 2 (Phase 2)|Progressive Disease|20
137010|NCT00473746|455609|P4|Period 2 (Phase 2)|Progressive Disease|0
137011|NCT00473746|455610|P3|Period 2 (Phase 2)|Progressive Disease|0
137012|NCT00473746|455611|P2|Period 2 (Phase 2)|Progressive Disease|0
137013|NCT00473746|455612|P1|Period 2 (Phase 2)|Progressive Disease|0
137014|NCT00473746|455608|P5|Period 2 (Phase 2)|Death|1
137015|NCT00473746|455609|P4|Period 2 (Phase 2)|Death|0
137016|NCT00473746|455610|P3|Period 2 (Phase 2)|Death|0
137017|NCT00473746|455611|P2|Period 2 (Phase 2)|Death|0
137018|NCT00473746|455612|P1|Period 2 (Phase 2)|Death|0
137019|NCT00473746|455608|P5|Period 2 (Phase 2)|Adverse Event|3
137020|NCT00473746|455609|P4|Period 2 (Phase 2)|Adverse Event|0
137021|NCT00473746|455610|P3|Period 2 (Phase 2)|Adverse Event|0
137022|NCT00473746|455611|P2|Period 2 (Phase 2)|Adverse Event|0
137023|NCT00473746|455612|P1|Period 2 (Phase 2)|Adverse Event|0
137024|NCT00473746|455608|P5|Period 1 (Phase 1)|Reason not specified|0
137025|NCT00473746|455609|P4|Period 1 (Phase 1)|Reason not specified|0
137026|NCT00473746|455610|P3|Period 1 (Phase 1)|Reason not specified|0
137027|NCT00473746|455611|P2|Period 1 (Phase 1)|Reason not specified|1
137028|NCT00473746|455612|P1|Period 1 (Phase 1)|Reason not specified|0
137029|NCT00473746|455608|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
137030|NCT00473746|455609|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
137031|NCT00473746|455610|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
137032|NCT00473746|455611|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
137033|NCT00473746|455612|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
137034|NCT00473746|455608|P5|Period 1 (Phase 1)|Progressive Disease|0
137035|NCT00473746|455609|P4|Period 1 (Phase 1)|Progressive Disease|10
137036|NCT00473746|455610|P3|Period 1 (Phase 1)|Progressive Disease|6
137037|NCT00473746|455611|P2|Period 1 (Phase 1)|Progressive Disease|6
137038|NCT00473746|455612|P1|Period 1 (Phase 1)|Progressive Disease|5
137039|NCT00473746|455608|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
137040|NCT00473746|455609|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
137041|NCT00473746|455610|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
137042|NCT00473746|455611|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
137043|NCT00473746|455612|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
137044|NCT00473746|455608|P5|Period 1 (Phase 1)|Adverse Event|0
137045|NCT00473746|455609|P4|Period 1 (Phase 1)|Adverse Event|0
137046|NCT00473746|455610|P3|Period 1 (Phase 1)|Adverse Event|0
137047|NCT00473746|455611|P2|Period 1 (Phase 1)|Adverse Event|0
137048|NCT00473746|455612|P1|Period 1 (Phase 1)|Adverse Event|1
137049|NCT00473655|455660|P3|Overall Study|Lost to Follow-up|8
137050|NCT00473655|455661|P2|Overall Study|Lost to Follow-up|5
137051|NCT00473655|455662|P1|Overall Study|Lost to Follow-up|9
137052|NCT00473590|455709|P2|Overall Study|Other|1
137053|NCT00473590|455710|P1|Overall Study|Other|0
137054|NCT00473590|455709|P2|Overall Study|Withdrawal by Subject|3
137055|NCT00473590|455710|P1|Overall Study|Withdrawal by Subject|5
137056|NCT00473590|455709|P2|Overall Study|Physician Decision|4
137057|NCT00473590|455710|P1|Overall Study|Physician Decision|2
137058|NCT00473590|455709|P2|Overall Study|Non–protocol-specified therapy|5
137059|NCT00473590|455710|P1|Overall Study|Non–protocol-specified therapy|7
137060|NCT00473590|455709|P2|Overall Study|Progression not resulting in death|20
137061|NCT00473590|455710|P1|Overall Study|Progression not resulting in death|24
137062|NCT00473590|455709|P2|Overall Study|Death|2
137063|NCT00473590|455710|P1|Overall Study|Death|4
137064|NCT00473590|455709|P2|Overall Study|Adverse Event|3
137065|NCT00473590|455710|P1|Overall Study|Adverse Event|3
137066|NCT00473564|455726|P1|Overall Study|robot surgery aborted in OR|23
137067|NCT00473512|455736|P5|Period 2 (Phase 2)|Unspecified|0
137068|NCT00473512|455737|P4|Period 2 (Phase 2)|Unspecified|3
137069|NCT00473512|455738|P3|Period 2 (Phase 2)|Unspecified|0
137070|NCT00473512|455739|P2|Period 2 (Phase 2)|Unspecified|0
137071|NCT00473512|455740|P1|Period 2 (Phase 2)|Unspecified|1
137072|NCT00473512|455736|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
137073|NCT00473512|455737|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
137074|NCT00473512|455738|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
137075|NCT00473512|455739|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
137076|NCT00473512|455740|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
137077|NCT00473512|455736|P5|Period 2 (Phase 2)|Disease Progression|1
137078|NCT00473512|455737|P4|Period 2 (Phase 2)|Disease Progression|17
137079|NCT00473512|455738|P3|Period 2 (Phase 2)|Disease Progression|2
137080|NCT00473512|455739|P2|Period 2 (Phase 2)|Disease Progression|2
137081|NCT00473512|455740|P1|Period 2 (Phase 2)|Disease Progression|0
137082|NCT00473512|455736|P5|Period 2 (Phase 2)|Death|1
137083|NCT00473512|455737|P4|Period 2 (Phase 2)|Death|1
137084|NCT00473512|455738|P3|Period 2 (Phase 2)|Death|0
137085|NCT00473512|455739|P2|Period 2 (Phase 2)|Death|0
137086|NCT00473512|455740|P1|Period 2 (Phase 2)|Death|0
137087|NCT00473512|455736|P5|Period 2 (Phase 2)|Adverse Event|0
137088|NCT00473512|455737|P4|Period 2 (Phase 2)|Adverse Event|1
137089|NCT00473512|455738|P3|Period 2 (Phase 2)|Adverse Event|0
137090|NCT00473512|455739|P2|Period 2 (Phase 2)|Adverse Event|0
137091|NCT00473512|455740|P1|Period 2 (Phase 2)|Adverse Event|0
137092|NCT00473512|455736|P5|Period 1 (Phase 1)|Unspecified|0
137093|NCT00473512|455737|P4|Period 1 (Phase 1)|Unspecified|1
137094|NCT00473512|455738|P3|Period 1 (Phase 1)|Unspecified|0
137095|NCT00473512|455739|P2|Period 1 (Phase 1)|Unspecified|0
137096|NCT00473512|455740|P1|Period 1 (Phase 1)|Unspecified|0
137097|NCT00473512|455736|P5|Period 1 (Phase 1)|Disease Progression|1
137098|NCT00473512|455737|P4|Period 1 (Phase 1)|Disease Progression|10
137099|NCT00473512|455738|P3|Period 1 (Phase 1)|Disease Progression|0
137100|NCT00473512|455739|P2|Period 1 (Phase 1)|Disease Progression|1
137101|NCT00473512|455740|P1|Period 1 (Phase 1)|Disease Progression|1
137102|NCT00473512|455736|P5|Period 1 (Phase 1)|Death|0
137103|NCT00473512|455737|P4|Period 1 (Phase 1)|Death|1
137104|NCT00473512|455738|P3|Period 1 (Phase 1)|Death|0
137105|NCT00473512|455739|P2|Period 1 (Phase 1)|Death|0
137106|NCT00473512|455740|P1|Period 1 (Phase 1)|Death|0
137107|NCT00473512|455736|P5|Period 1 (Phase 1)|Adverse Event|0
137108|NCT00473512|455737|P4|Period 1 (Phase 1)|Adverse Event|5
137109|NCT00473512|455738|P3|Period 1 (Phase 1)|Adverse Event|0
137110|NCT00473512|455739|P2|Period 1 (Phase 1)|Adverse Event|0
137111|NCT00473512|455740|P1|Period 1 (Phase 1)|Adverse Event|0
137112|NCT00473434|455798|P1|Overall Study|No longer required|1
137113|NCT00473434|455798|P1|Overall Study|Switching to trial medication|1
137114|NCT00473434|455798|P1|Overall Study|Ceased in favor of Paliperidone|1
137115|NCT00473434|455798|P1|Overall Study|Reason not specified|6
137116|NCT00473434|455798|P1|Overall Study|Safety evaluation|1
137117|NCT00473434|455798|P1|Overall Study|Patient was selling medication to others|1
137118|NCT00473434|455798|P1|Overall Study|Adverse Event|3
137119|NCT00473434|455798|P1|Overall Study|Lack of Efficacy|3
137120|NCT00473434|455798|P1|Overall Study|Compliance|3
137121|NCT00473434|455798|P1|Overall Study|Withdrawal by Subject|9
137122|NCT00473434|455798|P1|Overall Study|Physician Decision|3
137123|NCT00473382|455863|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
137124|NCT00473382|455864|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
137125|NCT00473382|455865|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
137126|NCT00473382|455863|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|69
137127|NCT00473382|455864|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|70
137128|NCT00473382|455865|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|75
137129|NCT00473382|455863|P3|Open-label Extension Through Month 60|Subject's Decision|6
137130|NCT00473382|455864|P2|Open-label Extension Through Month 60|Subject's Decision|1
137131|NCT00473382|455865|P1|Open-label Extension Through Month 60|Subject's Decision|7
137132|NCT00473382|455863|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
137133|NCT00473382|455864|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
137134|NCT00473382|455865|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
137135|NCT00473382|455863|P3|Open-label Extension Through Month 60|Death|4
137136|NCT00473382|455864|P2|Open-label Extension Through Month 60|Death|7
137137|NCT00473382|455865|P1|Open-label Extension Through Month 60|Death|1
137138|NCT00473382|455863|P3|Open-label Extension Through Month 60|Adverse Event|2
137139|NCT00473382|455864|P2|Open-label Extension Through Month 60|Adverse Event|0
137140|NCT00473382|455865|P1|Open-label Extension Through Month 60|Adverse Event|0
137141|NCT00473382|455863|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
137142|NCT00473382|455864|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
137143|NCT00473382|455865|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
137144|NCT00473382|455863|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|36
137145|NCT00473382|455864|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|34
137146|NCT00473382|455865|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|41
137147|NCT00473382|455863|P3|Open-label Extension Through Month 48|Subject's Decision|6
137148|NCT00473382|455864|P2|Open-label Extension Through Month 48|Subject's Decision|1
137149|NCT00473382|455865|P1|Open-label Extension Through Month 48|Subject's Decision|5
137150|NCT00473382|455863|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
137151|NCT00473382|455864|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
137152|NCT00473382|455865|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
137153|NCT00473382|455863|P3|Open-label Extension Through Month 48|Death|3
137154|NCT00473382|455864|P2|Open-label Extension Through Month 48|Death|3
137155|NCT00473382|455865|P1|Open-label Extension Through Month 48|Death|1
137156|NCT00473382|455863|P3|Open-label Extension Through Month 48|Adverse Event|1
137157|NCT00473382|455864|P2|Open-label Extension Through Month 48|Adverse Event|0
137158|NCT00473382|455865|P1|Open-label Extension Through Month 48|Adverse Event|0
137159|NCT00473382|455863|P3|Core Study|Subject's decision|10
137160|NCT00473382|455864|P2|Core Study|Subject's decision|11
137161|NCT00473382|455865|P1|Core Study|Subject's decision|12
137162|NCT00473382|455863|P3|Core Study|Subject needed other treatment|2
137163|NCT00473382|455864|P2|Core Study|Subject needed other treatment|3
137164|NCT00473382|455865|P1|Core Study|Subject needed other treatment|1
137165|NCT00473382|455863|P3|Core Study|Subject non-compliance|1
137166|NCT00473382|455864|P2|Core Study|Subject non-compliance|2
137167|NCT00473382|455865|P1|Core Study|Subject non-compliance|5
137168|NCT00473382|455863|P3|Core Study|Physician Decision|2
137169|NCT00473382|455864|P2|Core Study|Physician Decision|2
137170|NCT00473382|455865|P1|Core Study|Physician Decision|1
137171|NCT00473382|455863|P3|Core Study|Lost to Follow-up|3
137172|NCT00473382|455864|P2|Core Study|Lost to Follow-up|3
137173|NCT00473382|455865|P1|Core Study|Lost to Follow-up|3
137174|NCT00473382|455863|P3|Core Study|Death|10
137175|NCT00473382|455864|P2|Core Study|Death|5
137176|NCT00473382|455865|P1|Core Study|Death|3
137177|NCT00473382|455863|P3|Core Study|Adverse Event|1
137178|NCT00473382|455864|P2|Core Study|Adverse Event|1
137179|NCT00473382|455865|P1|Core Study|Adverse Event|3
137180|NCT00473330|455923|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
137181|NCT00473330|455924|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
137182|NCT00473330|455925|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
137183|NCT00473330|455923|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
137184|NCT00473330|455924|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
137185|NCT00473330|455925|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
137186|NCT00473330|455923|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|62
137187|NCT00473330|455924|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|71
137188|NCT00473330|455925|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|77
137189|NCT00473330|455923|P3|Open-label Extension Through Month 60|Subject's Decision|4
137190|NCT00473330|455924|P2|Open-label Extension Through Month 60|Subject's Decision|3
137191|NCT00473330|455925|P1|Open-label Extension Through Month 60|Subject's Decision|1
137192|NCT00473330|455923|P3|Open-label Extension Through Month 60|Physician's Decision|3
137193|NCT00473330|455924|P2|Open-label Extension Through Month 60|Physician's Decision|1
137194|NCT00473330|455925|P1|Open-label Extension Through Month 60|Physician's Decision|2
137195|NCT00473330|455923|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
137196|NCT00473330|455924|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
137197|NCT00473330|455925|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
137198|NCT00473330|455923|P3|Open-label Extension Through Month 60|Death|1
137199|NCT00473330|455924|P2|Open-label Extension Through Month 60|Death|2
137200|NCT00473330|455925|P1|Open-label Extension Through Month 60|Death|2
137201|NCT00473330|455923|P3|Open-label Extension Through Month 60|Adverse Event|2
137202|NCT00473330|455924|P2|Open-label Extension Through Month 60|Adverse Event|0
137203|NCT00473330|455925|P1|Open-label Extension Through Month 60|Adverse Event|0
137204|NCT00473330|455923|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
137205|NCT00473330|455924|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
137206|NCT00473330|455925|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
137207|NCT00473330|455923|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
137208|NCT00473330|455924|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
137209|NCT00473330|455925|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
137210|NCT00473330|455923|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|16
137211|NCT00473330|455924|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|15
137212|NCT00473330|455925|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|18
137213|NCT00473330|455923|P3|Open-label Extension Through Month 48|Subject's Decision|3
137214|NCT00473330|455924|P2|Open-label Extension Through Month 48|Subject's Decision|3
137215|NCT00473330|455925|P1|Open-label Extension Through Month 48|Subject's Decision|1
137216|NCT00473330|455923|P3|Open-label Extension Through Month 48|Physician's Decision|3
137217|NCT00473330|455924|P2|Open-label Extension Through Month 48|Physician's Decision|1
137218|NCT00473330|455925|P1|Open-label Extension Through Month 48|Physician's Decision|2
137219|NCT00473330|455923|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
137220|NCT00473330|455924|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
137221|NCT00473330|455925|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
137222|NCT00473330|455923|P3|Open-label Extension Through Month 48|Death|0
137223|NCT00473330|455924|P2|Open-label Extension Through Month 48|Death|0
137224|NCT00473330|455925|P1|Open-label Extension Through Month 48|Death|2
137225|NCT00473330|455923|P3|Open-label Extension Through Month 48|Adverse Event|2
137226|NCT00473330|455924|P2|Open-label Extension Through Month 48|Adverse Event|0
137227|NCT00473330|455925|P1|Open-label Extension Through Month 48|Adverse Event|0
137228|NCT00473330|455923|P3|Core Study|Subject's Decision|19
137229|NCT00473330|455924|P2|Core Study|Subject's Decision|8
137230|NCT00473330|455925|P1|Core Study|Subject's Decision|9
137231|NCT00473330|455923|P3|Core Study|Subject Required Other Therapy|3
137232|NCT00473330|455924|P2|Core Study|Subject Required Other Therapy|1
137233|NCT00473330|455925|P1|Core Study|Subject Required Other Therapy|0
137234|NCT00473330|455923|P3|Core Study|Subject Non-compliance|1
137235|NCT00473330|455924|P2|Core Study|Subject Non-compliance|2
137236|NCT00473330|455925|P1|Core Study|Subject Non-compliance|1
137237|NCT00473330|455923|P3|Core Study|Physician Decision|3
137238|NCT00473330|455924|P2|Core Study|Physician Decision|1
137239|NCT00473330|455925|P1|Core Study|Physician Decision|2
137240|NCT00473330|455923|P3|Core Study|Lost to Follow-up|10
137241|NCT00473330|455924|P2|Core Study|Lost to Follow-up|5
137242|NCT00473330|455925|P1|Core Study|Lost to Follow-up|5
137243|NCT00473330|455923|P3|Core Study|Death|4
137244|NCT00473330|455924|P2|Core Study|Death|4
137245|NCT00473330|455925|P1|Core Study|Death|6
137246|NCT00473330|455923|P3|Core Study|Adverse Event|1
137247|NCT00473330|455924|P2|Core Study|Adverse Event|4
137248|NCT00473330|455925|P1|Core Study|Adverse Event|4
137249|NCT00473265|455980|P1|Overall Study|Off treatment early|15
137250|NCT00473265|455980|P1|Overall Study|Unrelated adverse event|5
137251|NCT00472446|456053|P4|Overall Study|Questionnaires not returned|4
137252|NCT00472446|456054|P3|Overall Study|Questionnaires not returned|6
137253|NCT00472446|456055|P2|Overall Study|Questionnaires not returned|6
137254|NCT00472446|456056|P1|Overall Study|Questionnaires not returned|5
137255|NCT00472446|456053|P4|Overall Study|Reintervention|1
137256|NCT00472446|456054|P3|Overall Study|Reintervention|1
137257|NCT00472446|456055|P2|Overall Study|Reintervention|0
137258|NCT00472446|456056|P1|Overall Study|Reintervention|0
137259|NCT00472446|456053|P4|Overall Study|Protocol Violation|1
137260|NCT00472446|456054|P3|Overall Study|Protocol Violation|0
137261|NCT00472446|456055|P2|Overall Study|Protocol Violation|0
137262|NCT00472446|456056|P1|Overall Study|Protocol Violation|0
137263|NCT00472420|456086|P1|Follow-up Period|Protocol Violation|1
137264|NCT00472420|456086|P1|Follow-up Period|Lost to Follow-up|2
137265|NCT00472420|456086|P1|Follow-up Period|Physician Decision|9
137266|NCT00472420|456086|P1|Follow-up Period|Death|5
137267|NCT00472420|456086|P1|Induction Treatment Period|Death|3
137268|NCT00472420|456086|P1|Induction Treatment Period|Non-compliance|1
137269|NCT00472420|456086|P1|Induction Treatment Period|Adverse Event|3
137270|NCT00472420|456086|P1|Induction Treatment Period|Physician Decision|9
137271|NCT00470418|456094|P2|Overall Study|Withdrawal by Subject|0
137272|NCT00470418|456095|P1|Overall Study|Withdrawal by Subject|1
137273|NCT00470275|456120|P1|Overall Study|Withdrawal by Subject|2
137274|NCT00470275|456120|P1|Overall Study|Lack of Efficacy|7
137275|NCT00470275|456120|P1|Overall Study|Death|1
137276|NCT00470262|456126|P2|Overall Study|Withdrawal by Subject|0
137277|NCT00470262|456127|P1|Overall Study|Withdrawal by Subject|2
137278|NCT00470184|456135|P1|Overall Study|recurrence|1
137279|NCT00470184|456135|P1|Overall Study|other|5
137280|NCT00470184|456135|P1|Overall Study|Withdrawal by Subject|4
137281|NCT00470184|456135|P1|Overall Study|Adverse Event|3
137282|NCT00470184|456135|P1|Overall Study|disease Progression|4
137283|NCT00470184|456135|P1|Overall Study|Not treated (other)|1
137284|NCT00470184|456135|P1|Overall Study|Not Treated(became ineligible)|4
137285|NCT00472303|456144|P3|Maintenance Phase|not specified|0
137286|NCT00472303|456145|P2|Maintenance Phase|not specified|1
137287|NCT00472303|456146|P1|Maintenance Phase|not specified|1
137288|NCT00472303|456144|P3|Maintenance Phase|Resolution of pain|1
137289|NCT00472303|456145|P2|Maintenance Phase|Resolution of pain|0
137290|NCT00472303|456146|P1|Maintenance Phase|Resolution of pain|0
137291|NCT00472303|456144|P3|Maintenance Phase|Trial medication non-compliant|1
137292|NCT00472303|456145|P2|Maintenance Phase|Trial medication non-compliant|0
137293|NCT00472303|456146|P1|Maintenance Phase|Trial medication non-compliant|0
137294|NCT00472303|456144|P3|Maintenance Phase|Withdrawal by Subject|3
137295|NCT00472303|456145|P2|Maintenance Phase|Withdrawal by Subject|7
137296|NCT00472303|456146|P1|Maintenance Phase|Withdrawal by Subject|6
137297|NCT00472303|456144|P3|Maintenance Phase|Lack of Efficacy|4
137298|NCT00472303|456145|P2|Maintenance Phase|Lack of Efficacy|2
137299|NCT00472303|456146|P1|Maintenance Phase|Lack of Efficacy|2
137300|NCT00472303|456144|P3|Maintenance Phase|Death|2
137301|NCT00472303|456145|P2|Maintenance Phase|Death|0
137302|NCT00472303|456146|P1|Maintenance Phase|Death|3
137303|NCT00472303|456144|P3|Maintenance Phase|Adverse Event|6
137304|NCT00472303|456145|P2|Maintenance Phase|Adverse Event|6
137305|NCT00472303|456146|P1|Maintenance Phase|Adverse Event|5
137306|NCT00472303|456144|P3|Discontinuations After Titration Phase|not specified|0
137307|NCT00472303|456145|P2|Discontinuations After Titration Phase|not specified|0
137308|NCT00472303|456146|P1|Discontinuations After Titration Phase|not specified|5
137309|NCT00472303|456144|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
137310|NCT00472303|456145|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
137311|NCT00472303|456146|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
137312|NCT00472303|456144|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
137313|NCT00472303|456145|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
137314|NCT00472303|456146|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
137315|NCT00472303|456144|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
137316|NCT00472303|456145|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
137317|NCT00472303|456146|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
137318|NCT00472303|456144|P3|Discontinuations After Titration Phase|Adverse Event|0
137319|NCT00472303|456145|P2|Discontinuations After Titration Phase|Adverse Event|0
137320|NCT00472303|456146|P1|Discontinuations After Titration Phase|Adverse Event|6
137321|NCT00472303|456144|P3|Titration Phase|not specified|0
137322|NCT00472303|456145|P2|Titration Phase|not specified|1
137323|NCT00472303|456146|P1|Titration Phase|not specified|3
137324|NCT00472303|456144|P3|Titration Phase|Trial Medication non-compliant|0
137325|NCT00472303|456145|P2|Titration Phase|Trial Medication non-compliant|1
137326|NCT00472303|456146|P1|Titration Phase|Trial Medication non-compliant|4
137327|NCT00472303|456144|P3|Titration Phase|Withdrawal by Subject|0
137328|NCT00472303|456145|P2|Titration Phase|Withdrawal by Subject|13
137329|NCT00472303|456146|P1|Titration Phase|Withdrawal by Subject|16
137330|NCT00472303|456144|P3|Titration Phase|Lack of Efficacy|0
137331|NCT00472303|456145|P2|Titration Phase|Lack of Efficacy|0
137332|NCT00472303|456146|P1|Titration Phase|Lack of Efficacy|10
137333|NCT00472303|456144|P3|Titration Phase|Death|0
137334|NCT00472303|456145|P2|Titration Phase|Death|2
137335|NCT00472303|456146|P1|Titration Phase|Death|4
137336|NCT00472303|456144|P3|Titration Phase|Adverse Event|0
137337|NCT00472303|456145|P2|Titration Phase|Adverse Event|12
137338|NCT00472303|456146|P1|Titration Phase|Adverse Event|22
137339|NCT00472290|456209|P1|Overall Study|Requirement for alternative therapy|7
137340|NCT00472290|456209|P1|Overall Study|Adverse Event|6
137341|NCT00472290|456209|P1|Overall Study|Withdrawal by Subject|5
137342|NCT00472290|456209|P1|Overall Study|Disease Progression|4
137343|NCT00472290|456209|P1|Overall Study|Lack of Efficacy|1
137344|NCT00472290|456209|P1|Overall Study|Lost to Follow-up|1
137345|NCT00472290|456209|P1|Overall Study|Death|3
137346|NCT00472290|456209|P1|Overall Study|Administrative Decision|37
137347|NCT00472290|456209|P1|Overall Study|Protocol Specified Criteria|7
137348|NCT00472290|456209|P1|Overall Study|Progression of Therapy-Related MDS|1
137349|NCT00472199|456221|P2|Overall Study|patient was asymptomatic|0
137350|NCT00472199|456222|P1|Overall Study|patient was asymptomatic|1
137351|NCT00472199|456221|P2|Overall Study|personal reason|1
137352|NCT00472199|456222|P1|Overall Study|personal reason|0
137353|NCT00472199|456221|P2|Overall Study|Withdrawal by Subject|5
137354|NCT00472199|456222|P1|Overall Study|Withdrawal by Subject|6
137355|NCT00472199|456221|P2|Overall Study|Protocol Violation|2
137356|NCT00472199|456222|P1|Overall Study|Protocol Violation|3
137357|NCT00472199|456221|P2|Overall Study|Lost to Follow-up|4
137358|NCT00472199|456222|P1|Overall Study|Lost to Follow-up|2
137359|NCT00472199|456221|P2|Overall Study|Lack of Efficacy|25
137360|NCT00472199|456222|P1|Overall Study|Lack of Efficacy|4
137361|NCT00472199|456221|P2|Overall Study|Adverse Event|23
137362|NCT00472199|456222|P1|Overall Study|Adverse Event|19
137363|NCT00472082|456288|P1|Overall Study|Study prematurely terminated|5
137364|NCT00472030|456310|P2|Overall Study|Physician Decision|0
137365|NCT00472030|456311|P1|Overall Study|Physician Decision|1
137366|NCT00471822|456327|P1|Overall Study|Protocol Violation|2
137367|NCT00471718|456335|P1|Overall Study|Withdrawal by Subject|1
137368|NCT00471718|456335|P1|Overall Study|disease progression|22
137369|NCT00471718|456335|P1|Overall Study|other complicating disease|1
137370|NCT00471718|456335|P1|Overall Study|Adverse Event|3
137371|NCT00471536|456363|P1|Overall Study|Withdrawal by Subject|1
137372|NCT00471497|456375|P3|Overall Study|Sub optimal response or treat. failure|0
137373|NCT00471497|456376|P2|Overall Study|Sub optimal response or treat. failure|3
137374|NCT00471497|456377|P1|Overall Study|Sub optimal response or treat. failure|8
137375|NCT00471497|456375|P3|Overall Study|Protocol Violation|5
137376|NCT00471497|456376|P2|Overall Study|Protocol Violation|3
137377|NCT00471497|456377|P1|Overall Study|Protocol Violation|3
137378|NCT00471497|456375|P3|Overall Study|Disease Progression|2
137379|NCT00471497|456376|P2|Overall Study|Disease Progression|2
137380|NCT00471497|456377|P1|Overall Study|Disease Progression|8
137381|NCT00471497|456375|P3|Overall Study|Death|0
137382|NCT00471497|456376|P2|Overall Study|Death|2
137383|NCT00471497|456377|P1|Overall Study|Death|0
137384|NCT00471497|456375|P3|Overall Study|Lost to Follow-up|1
137385|NCT00471497|456376|P2|Overall Study|Lost to Follow-up|2
137386|NCT00471497|456377|P1|Overall Study|Lost to Follow-up|1
137387|NCT00471497|456375|P3|Overall Study|Withdrawal by Subject|5
137388|NCT00471497|456376|P2|Overall Study|Withdrawal by Subject|5
137389|NCT00471497|456377|P1|Overall Study|Withdrawal by Subject|3
137390|NCT00471497|456375|P3|Overall Study|Condition no longer requires study drug|0
137391|NCT00471497|456376|P2|Overall Study|Condition no longer requires study drug|1
137392|NCT00471497|456377|P1|Overall Study|Condition no longer requires study drug|0
137393|NCT00471497|456375|P3|Overall Study|Abnormal Test Procedure|1
137394|NCT00471497|456376|P2|Overall Study|Abnormal Test Procedure|0
137395|NCT00471497|456377|P1|Overall Study|Abnormal Test Procedure|1
137396|NCT00471497|456375|P3|Overall Study|Abnormal Laboratory Value|4
137397|NCT00471497|456376|P2|Overall Study|Abnormal Laboratory Value|6
137398|NCT00471497|456377|P1|Overall Study|Abnormal Laboratory Value|3
137399|NCT00471497|456375|P3|Overall Study|Adverse Event|22
137400|NCT00471497|456376|P2|Overall Study|Adverse Event|11
137401|NCT00471497|456377|P1|Overall Study|Adverse Event|19
137402|NCT00471445|456387|P2|Overall Study|Protocol Violation|1
137403|NCT00471445|456388|P1|Overall Study|Protocol Violation|0
137404|NCT00471445|456387|P2|Overall Study|Ineligible|0
137405|NCT00471445|456388|P1|Overall Study|Ineligible|1
137406|NCT00471445|456387|P2|Overall Study|Withdrawal by Subject|1
137407|NCT00471445|456388|P1|Overall Study|Withdrawal by Subject|1
137408|NCT00471354|456401|P1|Overall Study|Patient/Caregiver Decision|12
137409|NCT00471354|456401|P1|Overall Study|Lack of Efficacy|5
137410|NCT00471354|456401|P1|Overall Study|Lost to Follow-up|3
137411|NCT00471354|456401|P1|Overall Study|Sponsor Decision|1
137412|NCT00471354|456401|P1|Overall Study|Physician Decision|4
137413|NCT00471354|456401|P1|Overall Study|Withdrawal by Subject|1
137414|NCT00471354|456401|P1|Overall Study|Protocol Violation|12
137415|NCT00471354|456401|P1|Overall Study|Adverse Event|13
137416|NCT00471354|456401|P1|Overall Study|Protocol Entry Criteria Not Met|1
137417|NCT00471328|456413|P2|Extension Phase|Administrative Problem|0
137418|NCT00471328|456414|P1|Extension Phase|Administrative Problem|1
137419|NCT00471328|456413|P2|Extension Phase|New cancer Therapy|0
137420|NCT00471328|456414|P1|Extension Phase|New cancer Therapy|1
137421|NCT00471328|456413|P2|Extension Phase|Disease Progression|44
137422|NCT00471328|456414|P1|Extension Phase|Disease Progression|32
137423|NCT00471328|456413|P2|Extension Phase|Treatment duration as per protocol|1
137424|NCT00471328|456414|P1|Extension Phase|Treatment duration as per protocol|0
137425|NCT00471328|456413|P2|Extension Phase|Protocol Deviation|1
137426|NCT00471328|456414|P1|Extension Phase|Protocol Deviation|3
137427|NCT00471328|456413|P2|Extension Phase|Death|7
137428|NCT00471328|456414|P1|Extension Phase|Death|1
137429|NCT00471328|456413|P2|Extension Phase|Withdrawal by Subject|2
137430|NCT00471328|456414|P1|Extension Phase|Withdrawal by Subject|0
137431|NCT00471328|456413|P2|Extension Phase|Adverse Event|12
137432|NCT00471328|456414|P1|Extension Phase|Adverse Event|3
137433|NCT00471328|456413|P2|Core Phase|Protocol Deviation|1
137434|NCT00471328|456414|P1|Core Phase|Protocol Deviation|0
137435|NCT00471328|456413|P2|Core Phase|Administrative Problem|1
137436|NCT00471328|456414|P1|Core Phase|Administrative Problem|0
137437|NCT00471328|456413|P2|Core Phase|Disease Progression|53
137438|NCT00471328|456414|P1|Core Phase|Disease Progression|78
137439|NCT00471328|456413|P2|Core Phase|Abnormal laboratory value|0
137440|NCT00471328|456414|P1|Core Phase|Abnormal laboratory value|1
137441|NCT00471328|456413|P2|Core Phase|Withdrawal by Subject|2
137442|NCT00471328|456414|P1|Core Phase|Withdrawal by Subject|2
137443|NCT00471328|456413|P2|Core Phase|Death|4
137444|NCT00471328|456414|P1|Core Phase|Death|8
137445|NCT00471328|456413|P2|Core Phase|Adverse Event|6
137446|NCT00471328|456414|P1|Core Phase|Adverse Event|18
137447|NCT00471315|456433|P1|Overall Study|Withdrawal by Subject|1
137448|NCT00471315|456433|P1|Overall Study|Adverse Event|7
137449|NCT00471276|456438|P1|Overall Study|Refused treatment|6
137450|NCT00471276|456438|P1|Overall Study|Unspecified|3
137451|NCT00471276|456438|P1|Overall Study|Global deterioration of health status|1
137452|NCT00471276|456438|P1|Overall Study|Objective progression or relapse|54
137453|NCT00471276|456438|P1|Overall Study|Protocol Violation|1
137454|NCT00471276|456438|P1|Overall Study|Adverse Event|16
137455|NCT00471276|456438|P1|Overall Study|Death|2
137456|NCT00471146|456463|P2|Overall Study|Unspecified|5
137457|NCT00471146|456464|P1|Overall Study|Unspecified|4
137458|NCT00471146|456463|P2|Overall Study|Randomized but not treated|8
137459|NCT00471146|456464|P1|Overall Study|Randomized but not treated|9
137460|NCT00471146|456463|P2|Overall Study|Global deterioration of health status|14
137461|NCT00471146|456464|P1|Overall Study|Global deterioration of health status|12
137462|NCT00471146|456463|P2|Overall Study|Objective progression or relapse|87
137463|NCT00471146|456464|P1|Overall Study|Objective progression or relapse|84
137464|NCT00471146|456463|P2|Overall Study|Protocol Violation|2
137465|NCT00471146|456464|P1|Overall Study|Protocol Violation|2
137466|NCT00471146|456463|P2|Overall Study|Lost to Follow-up|2
137467|NCT00471146|456464|P1|Overall Study|Lost to Follow-up|4
137468|NCT00471146|456463|P2|Overall Study|Death|12
137469|NCT00471146|456464|P1|Overall Study|Death|11
137470|NCT00471146|456463|P2|Overall Study|Withdrawal by Subject|11
137471|NCT00471146|456464|P1|Overall Study|Withdrawal by Subject|14
137472|NCT00471146|456463|P2|Overall Study|Adverse Event|33
137473|NCT00471146|456464|P1|Overall Study|Adverse Event|32
137474|NCT00471107|456489|P3|Overall Study|Technical problems/data loss|3
137475|NCT00471107|456490|P2|Overall Study|Technical problems/data loss|1
137476|NCT00471107|456491|P1|Overall Study|Technical problems/data loss|3
137477|NCT00470847|456508|P1|Overall Study|Pt still receiving treatment|1
137478|NCT00470834|456521|P2|Extension Period (24 Months)|Disease Progression|1
137479|NCT00470834|456522|P1|Extension Period (24 Months)|Disease Progression|0
137480|NCT00470834|456521|P2|Extension Period (24 Months)|Non-compliance|1
137481|NCT00470834|456522|P1|Extension Period (24 Months)|Non-compliance|0
137482|NCT00470834|456521|P2|Extension Period (24 Months)|Lost to Follow-up|1
137483|NCT00470834|456522|P1|Extension Period (24 Months)|Lost to Follow-up|0
137484|NCT00470834|456521|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
137485|NCT00470834|456522|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
137486|NCT00470834|456521|P2|Extension Period (24 Months)|Physician Decision|3
137487|NCT00470834|456522|P1|Extension Period (24 Months)|Physician Decision|4
137488|NCT00470834|456521|P2|Extension Period (24 Months)|Withdrawal by Subject|5
137489|NCT00470834|456522|P1|Extension Period (24 Months)|Withdrawal by Subject|2
137490|NCT00470834|456521|P2|Extension Period (24 Months)|Adverse Event|4
137491|NCT00470834|456522|P1|Extension Period (24 Months)|Adverse Event|3
137492|NCT00470834|456521|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
137493|NCT00470834|456522|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
137494|NCT00470834|456521|P2|Treatment Period (18 Months)|Lack of Efficacy|0
137495|NCT00470834|456522|P1|Treatment Period (18 Months)|Lack of Efficacy|1
137496|NCT00470834|456521|P2|Treatment Period (18 Months)|Non-compliance|0
137497|NCT00470834|456522|P1|Treatment Period (18 Months)|Non-compliance|1
137498|NCT00470834|456521|P2|Treatment Period (18 Months)|Lost to Follow-up|0
137499|NCT00470834|456522|P1|Treatment Period (18 Months)|Lost to Follow-up|1
137500|NCT00470834|456521|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
137501|NCT00470834|456522|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
137502|NCT00470834|456521|P2|Treatment Period (18 Months)|Protocol Violation|1
137503|NCT00470834|456522|P1|Treatment Period (18 Months)|Protocol Violation|3
137504|NCT00470834|456521|P2|Treatment Period (18 Months)|Physician Decision|4
137505|NCT00470834|456522|P1|Treatment Period (18 Months)|Physician Decision|4
137506|NCT00470834|456521|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
137507|NCT00470834|456522|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
137508|NCT00470834|456521|P2|Treatment Period (18 Months)|Adverse Event|6
137509|NCT00470834|456522|P1|Treatment Period (18 Months)|Adverse Event|7
137510|NCT00470834|456521|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
137511|NCT00470834|456522|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
137512|NCT00470626|456536|P1|Overall Study|Withdrawal by Subject|7
137513|NCT00470626|456536|P1|Overall Study|Lost to Follow-up|10
137514|NCT00470535|456555|P1|Overall Study|other|2
137515|NCT00470535|456555|P1|Overall Study|Death|1
137516|NCT00470535|456555|P1|Overall Study|Adverse Event|1
137517|NCT00470535|456555|P1|Overall Study|Withdrawal by Subject|1
137518|NCT00470535|456555|P1|Overall Study|Disease Progression|13
137519|NCT00470470|456564|P1|Overall Study|Not treated|1
137520|NCT00470470|456564|P1|Overall Study|Death|2
137521|NCT00470470|456564|P1|Overall Study|Adverse Event|2
137522|NCT00470158|456574|P5|Overall Study|Protocol Violation|0
137523|NCT00470158|456575|P4|Overall Study|Protocol Violation|0
137524|NCT00470158|456576|P3|Overall Study|Protocol Violation|0
137525|NCT00470158|456577|P2|Overall Study|Protocol Violation|0
137526|NCT00470158|456578|P1|Overall Study|Protocol Violation|1
137527|NCT00470158|456574|P5|Overall Study|Lost to Follow-up|4
137528|NCT00470158|456575|P4|Overall Study|Lost to Follow-up|5
137529|NCT00470158|456576|P3|Overall Study|Lost to Follow-up|8
137530|NCT00470158|456577|P2|Overall Study|Lost to Follow-up|8
137531|NCT00470158|456578|P1|Overall Study|Lost to Follow-up|7
137532|NCT00470158|456574|P5|Overall Study|Death|2
137533|NCT00470158|456575|P4|Overall Study|Death|0
137534|NCT00470158|456576|P3|Overall Study|Death|0
137535|NCT00470158|456577|P2|Overall Study|Death|0
137536|NCT00470158|456578|P1|Overall Study|Death|0
137537|NCT00470067|456611|P1|Overall Study|Disease Progression|6
137538|NCT00470067|456611|P1|Overall Study|Death|1
137539|NCT00470054|456615|P1|Overall Study|Ineligible|1
137540|NCT00469898|456623|P1|Overall Study|Decreased performance status|1
137541|NCT00469898|456623|P1|Overall Study|Disease progression|9
137542|NCT00469898|456623|P1|Overall Study|Death|4
137543|NCT00469898|456623|P1|Overall Study|Withdrawal by Subject|4
137544|NCT00469898|456623|P1|Overall Study|Adverse Event|7
137545|NCT00469859|456632|P2|Overall Study|Inevaluable|2
137546|NCT00469859|456633|P1|Overall Study|Inevaluable|0
137547|NCT00469833|456641|P1|Overall Study|No IV access|2
137548|NCT00469456|456668|P2|Overall Study|Withdrawal by Subject|1
137549|NCT00469456|456669|P1|Overall Study|Withdrawal by Subject|4
137550|NCT00469456|456668|P2|Overall Study|Protocol Violation|0
137551|NCT00469456|456669|P1|Overall Study|Protocol Violation|1
137552|NCT00469456|456668|P2|Overall Study|Adverse Event|3
137553|NCT00469456|456669|P1|Overall Study|Adverse Event|4
137554|NCT00468312|456688|P2|Overall Study|Did not meet protocol eligibility|1
137555|NCT00468312|456689|P1|Overall Study|Did not meet protocol eligibility|0
137556|NCT00468312|456688|P2|Overall Study|Protocol Violation|1
137557|NCT00468312|456689|P1|Overall Study|Protocol Violation|2
137558|NCT00468312|456688|P2|Overall Study|Withdrawal by Subject|1
137559|NCT00468312|456689|P1|Overall Study|Withdrawal by Subject|0
137560|NCT00468312|456688|P2|Overall Study|Lack of Efficacy|1
137561|NCT00468312|456689|P1|Overall Study|Lack of Efficacy|0
137562|NCT00468312|456688|P2|Overall Study|Adverse Event|1
137563|NCT00468312|456689|P1|Overall Study|Adverse Event|2
137564|NCT00468299|456705|P2|Overall Study|Withdrawal by Subject|1
137565|NCT00468299|456706|P1|Overall Study|Withdrawal by Subject|0
137566|NCT00468286|456716|P2|Overall Study|Physician Decision|1
137567|NCT00468286|456717|P1|Overall Study|Physician Decision|0
137568|NCT00468286|456716|P2|Overall Study|Withdrawal by Subject|3
137569|NCT00468286|456717|P1|Overall Study|Withdrawal by Subject|4
137570|NCT00468286|456716|P2|Overall Study|Protocol Violation|2
137571|NCT00468286|456717|P1|Overall Study|Protocol Violation|2
137572|NCT00468286|456716|P2|Overall Study|Adverse Event|6
137573|NCT00468286|456717|P1|Overall Study|Adverse Event|1
137574|NCT00469209|456759|P3|Overall Study|Adverse Event|1
137575|NCT00469209|456760|P2|Overall Study|Adverse Event|0
137576|NCT00469209|456761|P1|Overall Study|Adverse Event|1
137577|NCT00469092|456771|P2|Overall Study|Use of Corticosteroid|0
137578|NCT00469092|456772|P1|Overall Study|Use of Corticosteroid|1
137579|NCT00469092|456771|P2|Overall Study|Abnormal lab value|0
137580|NCT00469092|456772|P1|Overall Study|Abnormal lab value|1
137581|NCT00469092|456771|P2|Overall Study|Hypoglycaemic Episodes|1
137582|NCT00469092|456772|P1|Overall Study|Hypoglycaemic Episodes|1
137583|NCT00469092|456771|P2|Overall Study|Use of lipid lowering drug|0
137584|NCT00469092|456772|P1|Overall Study|Use of lipid lowering drug|1
137585|NCT00469092|456771|P2|Overall Study|Contraindication metformin/glimepiride|0
137586|NCT00469092|456772|P1|Overall Study|Contraindication metformin/glimepiride|1
137587|NCT00469092|456771|P2|Overall Study|Incorrectly Randomised|3
137588|NCT00469092|456772|P1|Overall Study|Incorrectly Randomised|4
137589|NCT00469092|456771|P2|Overall Study|Withdrawal Criteria|4
137590|NCT00469092|456772|P1|Overall Study|Withdrawal Criteria|3
137591|NCT00469092|456771|P2|Overall Study|Withdrawal by Subject|4
137592|NCT00469092|456772|P1|Overall Study|Withdrawal by Subject|4
137593|NCT00469092|456771|P2|Overall Study|Protocol Violation|3
137594|NCT00469092|456772|P1|Overall Study|Protocol Violation|3
137595|NCT00469092|456771|P2|Overall Study|Lost to Follow-up|2
137596|NCT00469092|456772|P1|Overall Study|Lost to Follow-up|1
137597|NCT00469092|456771|P2|Overall Study|Lack of Efficacy|0
137598|NCT00469092|456772|P1|Overall Study|Lack of Efficacy|1
137599|NCT00469092|456771|P2|Overall Study|Adverse Event|4
137600|NCT00469092|456772|P1|Overall Study|Adverse Event|5
137601|NCT00469079|456791|P3|Overall Study|Ineligible|0
137602|NCT00469079|456792|P2|Overall Study|Ineligible|1
137603|NCT00469079|456793|P1|Overall Study|Ineligible|0
137604|NCT00469079|456791|P3|Overall Study|Withdrawal by Subject|2
137605|NCT00469079|456792|P2|Overall Study|Withdrawal by Subject|2
137606|NCT00469079|456793|P1|Overall Study|Withdrawal by Subject|1
137607|NCT00469079|456791|P3|Overall Study|Lost to Follow-up|10
137608|NCT00469079|456792|P2|Overall Study|Lost to Follow-up|8
137609|NCT00469079|456793|P1|Overall Study|Lost to Follow-up|4
137610|NCT00469079|456791|P3|Overall Study|Adverse Event|2
137611|NCT00469079|456792|P2|Overall Study|Adverse Event|3
137612|NCT00469079|456793|P1|Overall Study|Adverse Event|1
137613|NCT00469079|456791|P3|Overall Study|Lack of Efficacy|5
137614|NCT00469079|456792|P2|Overall Study|Lack of Efficacy|8
137615|NCT00469079|456793|P1|Overall Study|Lack of Efficacy|3
137616|NCT00468845|456813|P3|Overall Study|Randomized, not treated|2
137617|NCT00468845|456814|P2|Overall Study|Randomized, not treated|4
137618|NCT00468845|456815|P1|Overall Study|Randomized, not treated|1
137619|NCT00468845|456813|P3|Overall Study|No longer willing to participate|10
137620|NCT00468845|456814|P2|Overall Study|No longer willing to participate|6
137621|NCT00468845|456815|P1|Overall Study|No longer willing to participate|5
137622|NCT00468845|456813|P3|Overall Study|Unspecified|5
137623|NCT00468845|456814|P2|Overall Study|Unspecified|9
137624|NCT00468845|456815|P1|Overall Study|Unspecified|4
137625|NCT00468845|456813|P3|Overall Study|Lost to Follow-up|2
137626|NCT00468845|456814|P2|Overall Study|Lost to Follow-up|1
137627|NCT00468845|456815|P1|Overall Study|Lost to Follow-up|2
137628|NCT00468845|456813|P3|Overall Study|Adverse Event|11
137629|NCT00468845|456814|P2|Overall Study|Adverse Event|14
137630|NCT00468845|456815|P1|Overall Study|Adverse Event|9
137631|NCT00468819|456952|P3|Overall Study|Drop-outs (Treatment never received)|0
137632|NCT00468819|456953|P2|Overall Study|Drop-outs (Treatment never received)|0
137633|NCT00468819|456954|P1|Overall Study|Drop-outs (Treatment never received)|2
137634|NCT00468819|456952|P3|Overall Study|Lost to Follow-up|1
137635|NCT00468819|456953|P2|Overall Study|Lost to Follow-up|0
137636|NCT00468819|456954|P1|Overall Study|Lost to Follow-up|0
137637|NCT00468819|456952|P3|Overall Study|Withdrawal by Subject|1
137638|NCT00468819|456953|P2|Overall Study|Withdrawal by Subject|0
137639|NCT00468819|456954|P1|Overall Study|Withdrawal by Subject|4
137640|NCT00468728|457034|P2|Follow-up|mITT failure|31
137641|NCT00468728|457035|P1|Follow-up|mITT failure|34
137642|NCT00468728|457034|P2|Treatment|criteria for mITT population|11
137643|NCT00468728|457035|P1|Treatment|criteria for mITT population|4
137644|NCT00468676|457047|P2|Overall Study|Death|1
137645|NCT00468676|457048|P1|Overall Study|Death|2
137646|NCT00468676|457047|P2|Overall Study|Lost to Follow-up|11
137647|NCT00468676|457048|P1|Overall Study|Lost to Follow-up|14
137648|NCT00468650|457065|P1|Overall Study|Protocol Violation|1
137649|NCT00468650|457065|P1|Overall Study|Withdrawal by Subject|2
137650|NCT00468650|457065|P1|Overall Study|Lost to Follow-up|4
137651|NCT00468585|457113|P4|Overall Study|Withdrawal by Subject|1
137652|NCT00468585|457114|P3|Overall Study|Withdrawal by Subject|2
137653|NCT00468585|457115|P2|Overall Study|Withdrawal by Subject|0
137654|NCT00468585|457116|P1|Overall Study|Withdrawal by Subject|0
137655|NCT00468585|457113|P4|Overall Study|Adverse Event|0
137656|NCT00468585|457114|P3|Overall Study|Adverse Event|1
137657|NCT00468585|457115|P2|Overall Study|Adverse Event|0
137658|NCT00468585|457116|P1|Overall Study|Adverse Event|0
137659|NCT00468585|457113|P4|Overall Study|Patient found to be ineligible|0
137660|NCT00468585|457114|P3|Overall Study|Patient found to be ineligible|1
137661|NCT00468585|457115|P2|Overall Study|Patient found to be ineligible|0
137662|NCT00468585|457116|P1|Overall Study|Patient found to be ineligible|0
137663|NCT00468585|457113|P4|Overall Study|Patient not treated|0
137664|NCT00468585|457114|P3|Overall Study|Patient not treated|1
137665|NCT00468585|457115|P2|Overall Study|Patient not treated|0
137666|NCT00468585|457116|P1|Overall Study|Patient not treated|1
137667|NCT00468559|457128|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
137668|NCT00468559|457129|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
137669|NCT00468559|457130|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
137670|NCT00468559|457128|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
137671|NCT00468559|457129|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
137672|NCT00468559|457130|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
137673|NCT00468559|457128|P3|Open-label Treatment Phase|Withdrawal by Subject|0
137674|NCT00468559|457129|P2|Open-label Treatment Phase|Withdrawal by Subject|0
137675|NCT00468559|457130|P1|Open-label Treatment Phase|Withdrawal by Subject|4
137676|NCT00468559|457128|P3|Open-label Treatment Phase|Lack of Efficacy|0
137677|NCT00468559|457129|P2|Open-label Treatment Phase|Lack of Efficacy|0
137678|NCT00468559|457130|P1|Open-label Treatment Phase|Lack of Efficacy|9
137679|NCT00468559|457128|P3|Open-label Treatment Phase|Adverse Event|0
137680|NCT00468559|457129|P2|Open-label Treatment Phase|Adverse Event|0
137681|NCT00468559|457130|P1|Open-label Treatment Phase|Adverse Event|5
137682|NCT00468546|457158|P2|Week 24 to Week 104 Analysis|Other|14
137683|NCT00468546|457159|P1|Week 24 to Week 104 Analysis|Other|17
137684|NCT00468546|457158|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
137685|NCT00468546|457159|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
137686|NCT00468546|457158|P2|Week 24 to Week 104 Analysis|Failure to return|2
137687|NCT00468546|457159|P1|Week 24 to Week 104 Analysis|Failure to return|1
137688|NCT00468546|457158|P2|Week 24 to Week 104 Analysis|Refused treatment|7
137689|NCT00468546|457159|P1|Week 24 to Week 104 Analysis|Refused treatment|4
137690|NCT00468546|457158|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
137691|NCT00468546|457159|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
137692|NCT00468546|457158|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
137693|NCT00468546|457159|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
137694|NCT00468546|457158|P2|Week 24 to Week 104 Analysis|Death|0
137695|NCT00468546|457159|P1|Week 24 to Week 104 Analysis|Death|1
137696|NCT00468546|457158|P2|Week 24 to Week 104 Analysis|Adverse Event|5
137697|NCT00468546|457159|P1|Week 24 to Week 104 Analysis|Adverse Event|2
137698|NCT00468546|457158|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
137699|NCT00468546|457159|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
137700|NCT00468546|457158|P2|Week 24 Analysis|Went onto rescue therapy|0
137701|NCT00468546|457159|P1|Week 24 Analysis|Went onto rescue therapy|1
137702|NCT00468546|457158|P2|Week 24 Analysis|Due to clinical hold|0
137703|NCT00468546|457159|P1|Week 24 Analysis|Due to clinical hold|1
137704|NCT00468546|457158|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
137705|NCT00468546|457159|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
137706|NCT00468546|457158|P2|Week 24 Analysis|Rescue therapy|0
137707|NCT00468546|457159|P1|Week 24 Analysis|Rescue therapy|2
137708|NCT00468546|457158|P2|Week 24 Analysis|Failure to return|4
137709|NCT00468546|457159|P1|Week 24 Analysis|Failure to return|3
137710|NCT00468546|457158|P2|Week 24 Analysis|Adverse Event|8
137711|NCT00468546|457159|P1|Week 24 Analysis|Adverse Event|1
137712|NCT00468546|457158|P2|Week 24 Analysis|Refused treatment|5
137713|NCT00468546|457159|P1|Week 24 Analysis|Refused treatment|5
137714|NCT00468546|457158|P2|Week 24 Analysis|Lack of Efficacy|37
137715|NCT00468546|457159|P1|Week 24 Analysis|Lack of Efficacy|83
137716|NCT00468481|457189|P2|Overall Study|Other|0
137717|NCT00468481|457190|P1|Overall Study|Other|6
137718|NCT00468481|457189|P2|Overall Study|Non-Compliance|0
137719|NCT00468481|457190|P1|Overall Study|Non-Compliance|5
137720|NCT00468481|457189|P2|Overall Study|Moved out of area|1
137721|NCT00468481|457190|P1|Overall Study|Moved out of area|4
137722|NCT00468481|457189|P2|Overall Study|Egg Donor|0
137723|NCT00468481|457190|P1|Overall Study|Egg Donor|1
137724|NCT00468481|457189|P2|Overall Study|Prohibited Medication|1
137725|NCT00468481|457190|P1|Overall Study|Prohibited Medication|1
137726|NCT00468481|457189|P2|Overall Study|susp/diag malignant/premalignant disease|0
137727|NCT00468481|457190|P1|Overall Study|susp/diag malignant/premalignant disease|1
137728|NCT00468481|457189|P2|Overall Study|Withdrawal by Subject|3
137729|NCT00468481|457190|P1|Overall Study|Withdrawal by Subject|12
137730|NCT00468481|457189|P2|Overall Study|Protocol Violation|8
137731|NCT00468481|457190|P1|Overall Study|Protocol Violation|18
137732|NCT00468481|457189|P2|Overall Study|Pregnancy|0
137733|NCT00468481|457190|P1|Overall Study|Pregnancy|2
137734|NCT00468481|457189|P2|Overall Study|Lost to Follow-up|8
137735|NCT00468481|457190|P1|Overall Study|Lost to Follow-up|25
137736|NCT00468481|457189|P2|Overall Study|Adverse Event|3
137737|NCT00468481|457190|P1|Overall Study|Adverse Event|13
137825|NCT00467779|457437|P12|Stage 3|Death|0
137738|NCT00468143|457288|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
137739|NCT00468143|457289|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
137740|NCT00468143|457288|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
137741|NCT00468143|457289|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
137742|NCT00468104|457303|P2|Second Intervention|discarded for malposition of chest tube|2
137743|NCT00468104|457304|P1|Second Intervention|discarded for malposition of chest tube|0
137744|NCT00468104|457303|P2|Second Intervention|Withdrawal by Subject|2
137745|NCT00468104|457304|P1|Second Intervention|Withdrawal by Subject|5
137746|NCT00468104|457303|P2|First Intervention|trapped lung|0
137747|NCT00468104|457304|P1|First Intervention|trapped lung|1
137748|NCT00468104|457303|P2|First Intervention|associated prolonged pneumothorax|0
137749|NCT00468104|457304|P1|First Intervention|associated prolonged pneumothorax|1
137750|NCT00468104|457303|P2|First Intervention|large lung mass with minimal effusion|0
137751|NCT00468104|457304|P1|First Intervention|large lung mass with minimal effusion|1
137752|NCT00468104|457303|P2|First Intervention|malposition/blocked chest tube tube|0
137753|NCT00468104|457304|P1|First Intervention|malposition/blocked chest tube tube|2
137754|NCT00468104|457303|P2|First Intervention|died within 3 weeks|0
137755|NCT00468104|457304|P1|First Intervention|died within 3 weeks|1
137756|NCT00468104|457303|P2|First Intervention|bleeding at chest tube site--first dose|0
137757|NCT00468104|457304|P1|First Intervention|bleeding at chest tube site--first dose|1
137758|NCT00468104|457303|P2|First Intervention|Protocol Violation|1
137759|NCT00468104|457304|P1|First Intervention|Protocol Violation|2
137760|NCT00468052|457321|P2|Overall Study|Protocol Violation|8
137761|NCT00468052|457322|P1|Overall Study|Protocol Violation|7
137762|NCT00467961|457340|P1|Overall Study|Disease Progression|2
137763|NCT00467961|457340|P1|Overall Study|Technical Failures|5
137764|NCT00467896|457344|P1|Overall Study|Patient had no improvement|1
137765|NCT00467896|457344|P1|Overall Study|Started inhaled Remodulin|1
137766|NCT00467896|457344|P1|Overall Study|Started intravenous prostacyclin|1
137767|NCT00467896|457344|P1|Overall Study|Mainly used Prodose not I-neb® device|1
137768|NCT00467896|457344|P1|Overall Study|Patient weaned off iloprost|1
137769|NCT00467896|457344|P1|Overall Study|Patient had atrial septostomy|1
137770|NCT00467896|457344|P1|Overall Study|Patient received transplant|2
137771|NCT00467896|457344|P1|Overall Study|Changed therapy|2
137772|NCT00467896|457344|P1|Overall Study|Non-compliance|3
137773|NCT00467896|457344|P1|Overall Study|Serious Adverse Event|13
137774|NCT00467896|457344|P1|Overall Study|Adverse Event|7
137775|NCT00467896|457344|P1|Overall Study|Consent Withdrawal|18
137776|NCT00467857|457366|P2|Overall Study|Discontinuation reason missing|3
137777|NCT00467857|457367|P1|Overall Study|Discontinuation reason missing|0
137778|NCT00467857|457366|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
137779|NCT00467857|457367|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
137780|NCT00467857|457366|P2|Overall Study|Emergency care required|1
137781|NCT00467857|457367|P1|Overall Study|Emergency care required|0
137782|NCT00467857|457366|P2|Overall Study|Discharged from court service|1
137783|NCT00467857|457367|P1|Overall Study|Discharged from court service|0
137784|NCT00467857|457366|P2|Overall Study|Death|1
137785|NCT00467857|457367|P1|Overall Study|Death|0
137786|NCT00467857|457366|P2|Overall Study|Withdrew consent|0
137787|NCT00467857|457367|P1|Overall Study|Withdrew consent|2
137788|NCT00467857|457366|P2|Overall Study|Adverse Event|0
137789|NCT00467857|457367|P1|Overall Study|Adverse Event|1
137790|NCT00467831|457415|P1|Overall Study|Withdrawal by Subject|1
137791|NCT00467831|457415|P1|Overall Study|Death|2
137792|NCT00467779|457434|P15|Stage 3|Unspecified Reason|5
137793|NCT00467779|457435|P14|Stage 3|Unspecified Reason|0
137794|NCT00467779|457436|P13|Stage 3|Unspecified Reason|0
137795|NCT00467779|457437|P12|Stage 3|Unspecified Reason|0
137796|NCT00467779|457438|P11|Stage 3|Unspecified Reason|0
137797|NCT00467779|457439|P10|Stage 3|Unspecified Reason|0
137798|NCT00467779|457440|P9|Stage 3|Unspecified Reason|0
137799|NCT00467779|457441|P8|Stage 3|Unspecified Reason|0
137800|NCT00467779|457442|P7|Stage 3|Unspecified Reason|0
137801|NCT00467779|457443|P6|Stage 3|Unspecified Reason|0
137802|NCT00467779|457444|P5|Stage 3|Unspecified Reason|0
137803|NCT00467779|457445|P4|Stage 3|Unspecified Reason|0
137804|NCT00467779|457446|P3|Stage 3|Unspecified Reason|0
137805|NCT00467779|457447|P2|Stage 3|Unspecified Reason|0
137806|NCT00467779|457448|P1|Stage 3|Unspecified Reason|0
137807|NCT00467779|457434|P15|Stage 3|Disease Progression|9
137808|NCT00467779|457435|P14|Stage 3|Disease Progression|0
137809|NCT00467779|457436|P13|Stage 3|Disease Progression|0
137810|NCT00467779|457437|P12|Stage 3|Disease Progression|0
137811|NCT00467779|457438|P11|Stage 3|Disease Progression|0
137812|NCT00467779|457439|P10|Stage 3|Disease Progression|0
137813|NCT00467779|457440|P9|Stage 3|Disease Progression|0
137814|NCT00467779|457441|P8|Stage 3|Disease Progression|0
137815|NCT00467779|457442|P7|Stage 3|Disease Progression|0
137816|NCT00467779|457443|P6|Stage 3|Disease Progression|0
137817|NCT00467779|457444|P5|Stage 3|Disease Progression|0
137818|NCT00467779|457445|P4|Stage 3|Disease Progression|0
137819|NCT00467779|457446|P3|Stage 3|Disease Progression|0
137820|NCT00467779|457447|P2|Stage 3|Disease Progression|0
137821|NCT00467779|457448|P1|Stage 3|Disease Progression|0
137822|NCT00467779|457434|P15|Stage 3|Death|1
137823|NCT00467779|457435|P14|Stage 3|Death|0
137824|NCT00467779|457436|P13|Stage 3|Death|0
137826|NCT00467779|457438|P11|Stage 3|Death|0
137827|NCT00467779|457439|P10|Stage 3|Death|0
137828|NCT00467779|457440|P9|Stage 3|Death|0
137829|NCT00467779|457441|P8|Stage 3|Death|0
137830|NCT00467779|457442|P7|Stage 3|Death|0
137831|NCT00467779|457443|P6|Stage 3|Death|0
137832|NCT00467779|457444|P5|Stage 3|Death|0
137833|NCT00467779|457445|P4|Stage 3|Death|0
137834|NCT00467779|457446|P3|Stage 3|Death|0
137835|NCT00467779|457447|P2|Stage 3|Death|0
137836|NCT00467779|457448|P1|Stage 3|Death|0
137837|NCT00467779|457434|P15|Stage 3|Adverse Event|2
137838|NCT00467779|457435|P14|Stage 3|Adverse Event|0
137839|NCT00467779|457436|P13|Stage 3|Adverse Event|0
137840|NCT00467779|457437|P12|Stage 3|Adverse Event|0
137841|NCT00467779|457438|P11|Stage 3|Adverse Event|0
137842|NCT00467779|457439|P10|Stage 3|Adverse Event|0
137843|NCT00467779|457440|P9|Stage 3|Adverse Event|0
137844|NCT00467779|457441|P8|Stage 3|Adverse Event|0
137845|NCT00467779|457442|P7|Stage 3|Adverse Event|0
137846|NCT00467779|457443|P6|Stage 3|Adverse Event|0
137847|NCT00467779|457444|P5|Stage 3|Adverse Event|0
137848|NCT00467779|457445|P4|Stage 3|Adverse Event|0
137849|NCT00467779|457446|P3|Stage 3|Adverse Event|0
137850|NCT00467779|457447|P2|Stage 3|Adverse Event|0
137851|NCT00467779|457448|P1|Stage 3|Adverse Event|0
137852|NCT00467779|457434|P15|Stage 2A|Withdrawal by Subject|0
137853|NCT00467779|457435|P14|Stage 2A|Withdrawal by Subject|1
137854|NCT00467779|457436|P13|Stage 2A|Withdrawal by Subject|0
137855|NCT00467779|457437|P12|Stage 2A|Withdrawal by Subject|0
137856|NCT00467779|457438|P11|Stage 2A|Withdrawal by Subject|0
137857|NCT00467779|457439|P10|Stage 2A|Withdrawal by Subject|0
137858|NCT00467779|457440|P9|Stage 2A|Withdrawal by Subject|0
137859|NCT00467779|457441|P8|Stage 2A|Withdrawal by Subject|0
137860|NCT00467779|457442|P7|Stage 2A|Withdrawal by Subject|0
137861|NCT00467779|457443|P6|Stage 2A|Withdrawal by Subject|0
137862|NCT00467779|457444|P5|Stage 2A|Withdrawal by Subject|0
137863|NCT00467779|457445|P4|Stage 2A|Withdrawal by Subject|0
137864|NCT00467779|457446|P3|Stage 2A|Withdrawal by Subject|0
137865|NCT00467779|457447|P2|Stage 2A|Withdrawal by Subject|0
137866|NCT00467779|457448|P1|Stage 2A|Withdrawal by Subject|0
137867|NCT00467779|457434|P15|Stage 2A|Unspecified Reason|0
137868|NCT00467779|457435|P14|Stage 2A|Unspecified Reason|7
137869|NCT00467779|457436|P13|Stage 2A|Unspecified Reason|0
137870|NCT00467779|457437|P12|Stage 2A|Unspecified Reason|0
137871|NCT00467779|457438|P11|Stage 2A|Unspecified Reason|0
137872|NCT00467779|457439|P10|Stage 2A|Unspecified Reason|0
137873|NCT00467779|457440|P9|Stage 2A|Unspecified Reason|0
137874|NCT00467779|457441|P8|Stage 2A|Unspecified Reason|0
137875|NCT00467779|457442|P7|Stage 2A|Unspecified Reason|0
137876|NCT00467779|457443|P6|Stage 2A|Unspecified Reason|0
137877|NCT00467779|457444|P5|Stage 2A|Unspecified Reason|0
137878|NCT00467779|457445|P4|Stage 2A|Unspecified Reason|0
137879|NCT00467779|457446|P3|Stage 2A|Unspecified Reason|0
137880|NCT00467779|457447|P2|Stage 2A|Unspecified Reason|0
137881|NCT00467779|457448|P1|Stage 2A|Unspecified Reason|0
137882|NCT00467779|457434|P15|Stage 2A|Disease Progression|0
137883|NCT00467779|457435|P14|Stage 2A|Disease Progression|10
137884|NCT00467779|457436|P13|Stage 2A|Disease Progression|0
137885|NCT00467779|457437|P12|Stage 2A|Disease Progression|0
137886|NCT00467779|457438|P11|Stage 2A|Disease Progression|0
137887|NCT00467779|457439|P10|Stage 2A|Disease Progression|0
137888|NCT00467779|457440|P9|Stage 2A|Disease Progression|0
137889|NCT00467779|457441|P8|Stage 2A|Disease Progression|0
137890|NCT00467779|457442|P7|Stage 2A|Disease Progression|0
137891|NCT00467779|457443|P6|Stage 2A|Disease Progression|0
137892|NCT00467779|457444|P5|Stage 2A|Disease Progression|0
137893|NCT00467779|457445|P4|Stage 2A|Disease Progression|0
137894|NCT00467779|457446|P3|Stage 2A|Disease Progression|0
137895|NCT00467779|457447|P2|Stage 2A|Disease Progression|0
137896|NCT00467779|457448|P1|Stage 2A|Disease Progression|0
137897|NCT00467779|457434|P15|Stage 2A|Death|0
137898|NCT00467779|457435|P14|Stage 2A|Death|1
137899|NCT00467779|457436|P13|Stage 2A|Death|0
137900|NCT00467779|457437|P12|Stage 2A|Death|0
137901|NCT00467779|457438|P11|Stage 2A|Death|0
137902|NCT00467779|457439|P10|Stage 2A|Death|0
137903|NCT00467779|457440|P9|Stage 2A|Death|0
137904|NCT00467779|457441|P8|Stage 2A|Death|0
137905|NCT00467779|457442|P7|Stage 2A|Death|0
137906|NCT00467779|457443|P6|Stage 2A|Death|0
137907|NCT00467779|457444|P5|Stage 2A|Death|0
137908|NCT00467779|457445|P4|Stage 2A|Death|0
137909|NCT00467779|457446|P3|Stage 2A|Death|0
137910|NCT00467779|457447|P2|Stage 2A|Death|0
137911|NCT00467779|457448|P1|Stage 2A|Death|0
137912|NCT00467779|457434|P15|Stage 2A|Adverse Event|0
137913|NCT00467779|457435|P14|Stage 2A|Adverse Event|2
137914|NCT00467779|457436|P13|Stage 2A|Adverse Event|0
137915|NCT00467779|457437|P12|Stage 2A|Adverse Event|0
137916|NCT00467779|457438|P11|Stage 2A|Adverse Event|0
137917|NCT00467779|457439|P10|Stage 2A|Adverse Event|0
137918|NCT00467779|457440|P9|Stage 2A|Adverse Event|0
137919|NCT00467779|457441|P8|Stage 2A|Adverse Event|0
137920|NCT00467779|457442|P7|Stage 2A|Adverse Event|0
137921|NCT00467779|457443|P6|Stage 2A|Adverse Event|0
137922|NCT00467779|457444|P5|Stage 2A|Adverse Event|0
137923|NCT00467779|457445|P4|Stage 2A|Adverse Event|0
137924|NCT00467779|457446|P3|Stage 2A|Adverse Event|0
137925|NCT00467779|457447|P2|Stage 2A|Adverse Event|0
137926|NCT00467779|457448|P1|Stage 2A|Adverse Event|0
137927|NCT00467779|457434|P15|Stage 2|Unspecified Reason|0
137928|NCT00467779|457435|P14|Stage 2|Unspecified Reason|0
137929|NCT00467779|457436|P13|Stage 2|Unspecified Reason|0
137930|NCT00467779|457437|P12|Stage 2|Unspecified Reason|0
137931|NCT00467779|457438|P11|Stage 2|Unspecified Reason|0
137932|NCT00467779|457439|P10|Stage 2|Unspecified Reason|0
137933|NCT00467779|457440|P9|Stage 2|Unspecified Reason|3
137934|NCT00467779|457441|P8|Stage 2|Unspecified Reason|0
137935|NCT00467779|457442|P7|Stage 2|Unspecified Reason|0
137936|NCT00467779|457443|P6|Stage 2|Unspecified Reason|0
137937|NCT00467779|457444|P5|Stage 2|Unspecified Reason|0
137938|NCT00467779|457445|P4|Stage 2|Unspecified Reason|0
137939|NCT00467779|457446|P3|Stage 2|Unspecified Reason|0
137940|NCT00467779|457447|P2|Stage 2|Unspecified Reason|0
137941|NCT00467779|457448|P1|Stage 2|Unspecified Reason|0
137942|NCT00467779|457434|P15|Stage 2|Disease Progression|0
137943|NCT00467779|457435|P14|Stage 2|Disease Progression|0
137944|NCT00467779|457436|P13|Stage 2|Disease Progression|0
137945|NCT00467779|457437|P12|Stage 2|Disease Progression|0
137946|NCT00467779|457438|P11|Stage 2|Disease Progression|0
137947|NCT00467779|457439|P10|Stage 2|Disease Progression|0
137948|NCT00467779|457440|P9|Stage 2|Disease Progression|16
137949|NCT00467779|457441|P8|Stage 2|Disease Progression|0
137950|NCT00467779|457442|P7|Stage 2|Disease Progression|0
137951|NCT00467779|457443|P6|Stage 2|Disease Progression|0
137952|NCT00467779|457444|P5|Stage 2|Disease Progression|0
137953|NCT00467779|457445|P4|Stage 2|Disease Progression|0
137954|NCT00467779|457446|P3|Stage 2|Disease Progression|0
137955|NCT00467779|457447|P2|Stage 2|Disease Progression|0
137956|NCT00467779|457448|P1|Stage 2|Disease Progression|0
137957|NCT00467779|457434|P15|Stage 2|Death|0
137958|NCT00467779|457435|P14|Stage 2|Death|0
137959|NCT00467779|457436|P13|Stage 2|Death|0
137960|NCT00467779|457437|P12|Stage 2|Death|0
137961|NCT00467779|457438|P11|Stage 2|Death|0
137962|NCT00467779|457439|P10|Stage 2|Death|0
137963|NCT00467779|457440|P9|Stage 2|Death|1
137964|NCT00467779|457441|P8|Stage 2|Death|0
137965|NCT00467779|457442|P7|Stage 2|Death|0
137966|NCT00467779|457443|P6|Stage 2|Death|0
137967|NCT00467779|457444|P5|Stage 2|Death|0
137968|NCT00467779|457445|P4|Stage 2|Death|0
137969|NCT00467779|457446|P3|Stage 2|Death|0
137970|NCT00467779|457447|P2|Stage 2|Death|0
137971|NCT00467779|457448|P1|Stage 2|Death|0
137972|NCT00467779|457434|P15|Stage 2|Adverse Event|0
137973|NCT00467779|457435|P14|Stage 2|Adverse Event|0
137974|NCT00467779|457436|P13|Stage 2|Adverse Event|0
137975|NCT00467779|457437|P12|Stage 2|Adverse Event|0
137976|NCT00467779|457438|P11|Stage 2|Adverse Event|0
137977|NCT00467779|457439|P10|Stage 2|Adverse Event|0
137978|NCT00467779|457440|P9|Stage 2|Adverse Event|1
137979|NCT00467779|457441|P8|Stage 2|Adverse Event|0
137980|NCT00467779|457442|P7|Stage 2|Adverse Event|0
137981|NCT00467779|457443|P6|Stage 2|Adverse Event|0
137982|NCT00467779|457444|P5|Stage 2|Adverse Event|0
137983|NCT00467779|457445|P4|Stage 2|Adverse Event|0
137984|NCT00467779|457446|P3|Stage 2|Adverse Event|0
137985|NCT00467779|457447|P2|Stage 2|Adverse Event|0
137986|NCT00467779|457448|P1|Stage 2|Adverse Event|0
137987|NCT00467779|457434|P15|Stage 1A|Unspecified Reason|0
137988|NCT00467779|457435|P14|Stage 1A|Unspecified Reason|0
137989|NCT00467779|457436|P13|Stage 1A|Unspecified Reason|1
137990|NCT00467779|457437|P12|Stage 1A|Unspecified Reason|1
137991|NCT00467779|457438|P11|Stage 1A|Unspecified Reason|0
137992|NCT00467779|457439|P10|Stage 1A|Unspecified Reason|0
137993|NCT00467779|457440|P9|Stage 1A|Unspecified Reason|0
137994|NCT00467779|457441|P8|Stage 1A|Unspecified Reason|0
137995|NCT00467779|457442|P7|Stage 1A|Unspecified Reason|0
137996|NCT00467779|457443|P6|Stage 1A|Unspecified Reason|0
137997|NCT00467779|457444|P5|Stage 1A|Unspecified Reason|0
137998|NCT00467779|457445|P4|Stage 1A|Unspecified Reason|0
137999|NCT00467779|457446|P3|Stage 1A|Unspecified Reason|0
138000|NCT00467779|457447|P2|Stage 1A|Unspecified Reason|0
138001|NCT00467779|457448|P1|Stage 1A|Unspecified Reason|0
138002|NCT00467779|457434|P15|Stage 1A|Withdrawal by Subject|0
138003|NCT00467779|457435|P14|Stage 1A|Withdrawal by Subject|0
138004|NCT00467779|457436|P13|Stage 1A|Withdrawal by Subject|1
138005|NCT00467779|457437|P12|Stage 1A|Withdrawal by Subject|1
138006|NCT00467779|457438|P11|Stage 1A|Withdrawal by Subject|1
138007|NCT00467779|457439|P10|Stage 1A|Withdrawal by Subject|0
138008|NCT00467779|457440|P9|Stage 1A|Withdrawal by Subject|0
138009|NCT00467779|457441|P8|Stage 1A|Withdrawal by Subject|0
138010|NCT00467779|457442|P7|Stage 1A|Withdrawal by Subject|0
138011|NCT00467779|457443|P6|Stage 1A|Withdrawal by Subject|0
138012|NCT00467779|457444|P5|Stage 1A|Withdrawal by Subject|0
138013|NCT00467779|457445|P4|Stage 1A|Withdrawal by Subject|0
138014|NCT00467779|457446|P3|Stage 1A|Withdrawal by Subject|0
138015|NCT00467779|457447|P2|Stage 1A|Withdrawal by Subject|0
138016|NCT00467779|457448|P1|Stage 1A|Withdrawal by Subject|0
138017|NCT00467779|457434|P15|Stage 1A|Physician Decision|0
138018|NCT00467779|457435|P14|Stage 1A|Physician Decision|0
138019|NCT00467779|457436|P13|Stage 1A|Physician Decision|0
138020|NCT00467779|457437|P12|Stage 1A|Physician Decision|0
138021|NCT00467779|457438|P11|Stage 1A|Physician Decision|0
138022|NCT00467779|457439|P10|Stage 1A|Physician Decision|1
138023|NCT00467779|457440|P9|Stage 1A|Physician Decision|0
138024|NCT00467779|457441|P8|Stage 1A|Physician Decision|0
138025|NCT00467779|457442|P7|Stage 1A|Physician Decision|0
138026|NCT00467779|457443|P6|Stage 1A|Physician Decision|0
138027|NCT00467779|457444|P5|Stage 1A|Physician Decision|0
138028|NCT00467779|457445|P4|Stage 1A|Physician Decision|0
138029|NCT00467779|457446|P3|Stage 1A|Physician Decision|0
138030|NCT00467779|457447|P2|Stage 1A|Physician Decision|0
138031|NCT00467779|457448|P1|Stage 1A|Physician Decision|0
138032|NCT00467779|457434|P15|Stage 1A|Disease Progression|0
138033|NCT00467779|457435|P14|Stage 1A|Disease Progression|0
138034|NCT00467779|457436|P13|Stage 1A|Disease Progression|2
138035|NCT00467779|457437|P12|Stage 1A|Disease Progression|5
138036|NCT00467779|457438|P11|Stage 1A|Disease Progression|2
138037|NCT00467779|457439|P10|Stage 1A|Disease Progression|2
138038|NCT00467779|457440|P9|Stage 1A|Disease Progression|0
138039|NCT00467779|457441|P8|Stage 1A|Disease Progression|0
138040|NCT00467779|457442|P7|Stage 1A|Disease Progression|0
138041|NCT00467779|457443|P6|Stage 1A|Disease Progression|0
138042|NCT00467779|457444|P5|Stage 1A|Disease Progression|0
138043|NCT00467779|457445|P4|Stage 1A|Disease Progression|0
138044|NCT00467779|457446|P3|Stage 1A|Disease Progression|0
138045|NCT00467779|457447|P2|Stage 1A|Disease Progression|0
138046|NCT00467779|457448|P1|Stage 1A|Disease Progression|0
138047|NCT00467779|457434|P15|Stage 1A|Death|0
138048|NCT00467779|457435|P14|Stage 1A|Death|0
138049|NCT00467779|457436|P13|Stage 1A|Death|1
138050|NCT00467779|457437|P12|Stage 1A|Death|1
138051|NCT00467779|457438|P11|Stage 1A|Death|0
138052|NCT00467779|457439|P10|Stage 1A|Death|0
138053|NCT00467779|457440|P9|Stage 1A|Death|0
138054|NCT00467779|457441|P8|Stage 1A|Death|0
138055|NCT00467779|457442|P7|Stage 1A|Death|0
138056|NCT00467779|457443|P6|Stage 1A|Death|0
138057|NCT00467779|457444|P5|Stage 1A|Death|0
138058|NCT00467779|457445|P4|Stage 1A|Death|0
138059|NCT00467779|457446|P3|Stage 1A|Death|0
138060|NCT00467779|457447|P2|Stage 1A|Death|0
138061|NCT00467779|457448|P1|Stage 1A|Death|0
138062|NCT00467779|457434|P15|Stage 1A|Adverse Event|0
138063|NCT00467779|457435|P14|Stage 1A|Adverse Event|0
138064|NCT00467779|457436|P13|Stage 1A|Adverse Event|1
138065|NCT00467779|457437|P12|Stage 1A|Adverse Event|0
138066|NCT00467779|457438|P11|Stage 1A|Adverse Event|0
138067|NCT00467779|457439|P10|Stage 1A|Adverse Event|0
138068|NCT00467779|457440|P9|Stage 1A|Adverse Event|0
138069|NCT00467779|457441|P8|Stage 1A|Adverse Event|0
138070|NCT00467779|457442|P7|Stage 1A|Adverse Event|0
138071|NCT00467779|457443|P6|Stage 1A|Adverse Event|0
138072|NCT00467779|457444|P5|Stage 1A|Adverse Event|0
138073|NCT00467779|457445|P4|Stage 1A|Adverse Event|0
138074|NCT00467779|457446|P3|Stage 1A|Adverse Event|0
138075|NCT00467779|457447|P2|Stage 1A|Adverse Event|0
138076|NCT00467779|457448|P1|Stage 1A|Adverse Event|0
138077|NCT00467779|457434|P15|Stage 1|Withdrawal by Subject|0
138078|NCT00467779|457435|P14|Stage 1|Withdrawal by Subject|0
138079|NCT00467779|457436|P13|Stage 1|Withdrawal by Subject|0
138080|NCT00467779|457437|P12|Stage 1|Withdrawal by Subject|0
138081|NCT00467779|457438|P11|Stage 1|Withdrawal by Subject|0
138082|NCT00467779|457439|P10|Stage 1|Withdrawal by Subject|0
138083|NCT00467779|457440|P9|Stage 1|Withdrawal by Subject|0
138084|NCT00467779|457441|P8|Stage 1|Withdrawal by Subject|1
138085|NCT00467779|457442|P7|Stage 1|Withdrawal by Subject|1
138086|NCT00467779|457443|P6|Stage 1|Withdrawal by Subject|0
138087|NCT00467779|457444|P5|Stage 1|Withdrawal by Subject|0
138088|NCT00467779|457445|P4|Stage 1|Withdrawal by Subject|0
138089|NCT00467779|457446|P3|Stage 1|Withdrawal by Subject|0
138090|NCT00467779|457447|P2|Stage 1|Withdrawal by Subject|0
138091|NCT00467779|457448|P1|Stage 1|Withdrawal by Subject|0
138092|NCT00467779|457434|P15|Stage 1|Physician Decision|0
138093|NCT00467779|457435|P14|Stage 1|Physician Decision|0
138094|NCT00467779|457436|P13|Stage 1|Physician Decision|0
138095|NCT00467779|457437|P12|Stage 1|Physician Decision|0
138096|NCT00467779|457438|P11|Stage 1|Physician Decision|0
138097|NCT00467779|457439|P10|Stage 1|Physician Decision|0
138098|NCT00467779|457440|P9|Stage 1|Physician Decision|0
138099|NCT00467779|457441|P8|Stage 1|Physician Decision|0
138100|NCT00467779|457442|P7|Stage 1|Physician Decision|0
138101|NCT00467779|457443|P6|Stage 1|Physician Decision|0
138102|NCT00467779|457444|P5|Stage 1|Physician Decision|0
138103|NCT00467779|457445|P4|Stage 1|Physician Decision|0
138104|NCT00467779|457446|P3|Stage 1|Physician Decision|0
138105|NCT00467779|457447|P2|Stage 1|Physician Decision|1
138106|NCT00467779|457448|P1|Stage 1|Physician Decision|0
138107|NCT00467779|457434|P15|Stage 1|Unspecified Reason|0
138108|NCT00467779|457435|P14|Stage 1|Unspecified Reason|0
138109|NCT00467779|457436|P13|Stage 1|Unspecified Reason|0
138110|NCT00467779|457437|P12|Stage 1|Unspecified Reason|0
138111|NCT00467779|457438|P11|Stage 1|Unspecified Reason|0
138112|NCT00467779|457439|P10|Stage 1|Unspecified Reason|0
138113|NCT00467779|457440|P9|Stage 1|Unspecified Reason|0
138114|NCT00467779|457441|P8|Stage 1|Unspecified Reason|0
138115|NCT00467779|457442|P7|Stage 1|Unspecified Reason|0
138116|NCT00467779|457443|P6|Stage 1|Unspecified Reason|2
138117|NCT00467779|457444|P5|Stage 1|Unspecified Reason|1
138118|NCT00467779|457445|P4|Stage 1|Unspecified Reason|0
138119|NCT00467779|457446|P3|Stage 1|Unspecified Reason|1
138120|NCT00467779|457447|P2|Stage 1|Unspecified Reason|0
138121|NCT00467779|457448|P1|Stage 1|Unspecified Reason|1
138122|NCT00467779|457434|P15|Stage 1|Disease Progression|0
138123|NCT00467779|457435|P14|Stage 1|Disease Progression|0
138124|NCT00467779|457436|P13|Stage 1|Disease Progression|0
138125|NCT00467779|457437|P12|Stage 1|Disease Progression|0
138126|NCT00467779|457438|P11|Stage 1|Disease Progression|0
138127|NCT00467779|457439|P10|Stage 1|Disease Progression|0
138128|NCT00467779|457440|P9|Stage 1|Disease Progression|0
138129|NCT00467779|457441|P8|Stage 1|Disease Progression|5
138130|NCT00467779|457442|P7|Stage 1|Disease Progression|4
138131|NCT00467779|457443|P6|Stage 1|Disease Progression|2
138132|NCT00467779|457444|P5|Stage 1|Disease Progression|2
138133|NCT00467779|457445|P4|Stage 1|Disease Progression|3
138134|NCT00467779|457446|P3|Stage 1|Disease Progression|2
138135|NCT00467779|457447|P2|Stage 1|Disease Progression|2
138136|NCT00467779|457448|P1|Stage 1|Disease Progression|2
138137|NCT00467779|457434|P15|Stage 1|Adverse Event|0
138138|NCT00467779|457435|P14|Stage 1|Adverse Event|0
138139|NCT00467779|457436|P13|Stage 1|Adverse Event|0
138140|NCT00467779|457437|P12|Stage 1|Adverse Event|0
138141|NCT00467779|457438|P11|Stage 1|Adverse Event|0
138142|NCT00467779|457439|P10|Stage 1|Adverse Event|0
138143|NCT00467779|457440|P9|Stage 1|Adverse Event|0
138144|NCT00467779|457441|P8|Stage 1|Adverse Event|1
138145|NCT00467779|457442|P7|Stage 1|Adverse Event|2
138146|NCT00467779|457443|P6|Stage 1|Adverse Event|1
138147|NCT00467779|457444|P5|Stage 1|Adverse Event|0
138148|NCT00467779|457445|P4|Stage 1|Adverse Event|0
138149|NCT00467779|457446|P3|Stage 1|Adverse Event|0
138150|NCT00467779|457447|P2|Stage 1|Adverse Event|0
138151|NCT00467779|457448|P1|Stage 1|Adverse Event|1
138152|NCT00467753|457622|P2|Overall Study|Adverse Event|0
138153|NCT00467753|457623|P1|Overall Study|Adverse Event|2
138154|NCT00467753|457622|P2|Overall Study|Lost to Follow-up|2
138155|NCT00467753|457623|P1|Overall Study|Lost to Follow-up|1
138156|NCT00467740|457634|P5|Overall Study|Lack of Efficacy|0
138157|NCT00467740|457635|P4|Overall Study|Lack of Efficacy|0
138158|NCT00467740|457636|P3|Overall Study|Lack of Efficacy|0
138159|NCT00467740|457637|P2|Overall Study|Lack of Efficacy|1
138160|NCT00467740|457638|P1|Overall Study|Lack of Efficacy|0
138161|NCT00467740|457634|P5|Overall Study|Withdrawal by Subject|0
138162|NCT00467740|457635|P4|Overall Study|Withdrawal by Subject|1
138163|NCT00467740|457636|P3|Overall Study|Withdrawal by Subject|0
138164|NCT00467740|457637|P2|Overall Study|Withdrawal by Subject|1
138165|NCT00467740|457638|P1|Overall Study|Withdrawal by Subject|1
138166|NCT00467740|457634|P5|Overall Study|Lost to Follow-up|0
138167|NCT00467740|457635|P4|Overall Study|Lost to Follow-up|0
138168|NCT00467740|457636|P3|Overall Study|Lost to Follow-up|0
138169|NCT00467740|457637|P2|Overall Study|Lost to Follow-up|1
138170|NCT00467740|457638|P1|Overall Study|Lost to Follow-up|0
138171|NCT00467740|457634|P5|Overall Study|Protocol Violation|0
138172|NCT00467740|457635|P4|Overall Study|Protocol Violation|0
138173|NCT00467740|457636|P3|Overall Study|Protocol Violation|1
138174|NCT00467740|457637|P2|Overall Study|Protocol Violation|0
138175|NCT00467740|457638|P1|Overall Study|Protocol Violation|0
138176|NCT00467740|457634|P5|Overall Study|Adverse Event|0
138177|NCT00467740|457635|P4|Overall Study|Adverse Event|0
138178|NCT00467740|457636|P3|Overall Study|Adverse Event|1
138179|NCT00467740|457637|P2|Overall Study|Adverse Event|0
138180|NCT00467740|457638|P1|Overall Study|Adverse Event|0
138181|NCT00467649|457827|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
138182|NCT00467649|457828|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
138183|NCT00467649|457829|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
138184|NCT00467649|457830|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
138185|NCT00467649|457831|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
138186|NCT00467649|457832|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
138187|NCT00467649|457827|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
138188|NCT00467649|457828|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
138189|NCT00467649|457829|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
138190|NCT00467649|457830|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
138191|NCT00467649|457831|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
138192|NCT00467649|457832|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
138193|NCT00467649|457827|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
138194|NCT00467649|457828|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
138195|NCT00467649|457829|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
138196|NCT00467649|457830|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
138197|NCT00467649|457831|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
138198|NCT00467649|457832|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
138199|NCT00467649|457827|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
138200|NCT00467649|457828|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
138201|NCT00467649|457829|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
138202|NCT00467649|457830|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
138203|NCT00467649|457831|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
138204|NCT00467649|457832|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
138205|NCT00467649|457827|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
138206|NCT00467649|457828|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
138207|NCT00467649|457829|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
138208|NCT00467649|457830|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
138209|NCT00467649|457831|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
138210|NCT00467649|457832|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
138211|NCT00467649|457827|P6|Phase 1 (Randomized Population)|Investigator Decision|0
138212|NCT00467649|457828|P5|Phase 1 (Randomized Population)|Investigator Decision|0
138213|NCT00467649|457829|P4|Phase 1 (Randomized Population)|Investigator Decision|0
138214|NCT00467649|457830|P3|Phase 1 (Randomized Population)|Investigator Decision|0
138215|NCT00467649|457831|P2|Phase 1 (Randomized Population)|Investigator Decision|0
138216|NCT00467649|457832|P1|Phase 1 (Randomized Population)|Investigator Decision|1
138217|NCT00467649|457827|P6|Phase 1 (Randomized Population)|Adverse Event|0
138218|NCT00467649|457828|P5|Phase 1 (Randomized Population)|Adverse Event|0
138219|NCT00467649|457829|P4|Phase 1 (Randomized Population)|Adverse Event|0
138220|NCT00467649|457830|P3|Phase 1 (Randomized Population)|Adverse Event|0
138221|NCT00467649|457831|P2|Phase 1 (Randomized Population)|Adverse Event|0
138222|NCT00467649|457832|P1|Phase 1 (Randomized Population)|Adverse Event|2
138223|NCT00467610|457872|P1|Overall Study|Withdrawal by Subject|1
138224|NCT00467597|457883|P2|Overall Study|Withdrawal by Subject|0
138225|NCT00467597|457884|P1|Overall Study|Withdrawal by Subject|2
138226|NCT00467584|457897|P3|Overall Study|Withdrawal by Subject|1
138227|NCT00467584|457898|P2|Overall Study|Withdrawal by Subject|5
138228|NCT00467584|457899|P1|Overall Study|Withdrawal by Subject|4
138229|NCT00467558|457909|P2|Overall Study|Lost to Follow-up|0
138230|NCT00467558|457910|P1|Overall Study|Lost to Follow-up|2
138231|NCT00467519|457920|P2|Overall Study|Withdrawal by Subject|10
138232|NCT00467519|457921|P1|Overall Study|Withdrawal by Subject|4
138233|NCT00467519|457920|P2|Overall Study|Lost to Follow-up|9
138234|NCT00467519|457921|P1|Overall Study|Lost to Follow-up|2
138235|NCT00467519|457920|P2|Overall Study|Protocol Violation|4
138236|NCT00467519|457921|P1|Overall Study|Protocol Violation|8
138237|NCT00467363|457950|P2|Overall Study|Lost to Follow-up|70
138238|NCT00467363|457951|P1|Overall Study|Lost to Follow-up|80
138239|NCT00467285|457987|P2|Overall Study|Lost to Follow-up|4
138240|NCT00467285|457988|P1|Overall Study|Lost to Follow-up|4
138241|NCT00467259|458008|P2|Overall Study|Site Closed|1
138242|NCT00467259|458009|P1|Overall Study|Site Closed|2
138243|NCT00467259|458008|P2|Overall Study|Lost to Follow-up|34
138244|NCT00467259|458009|P1|Overall Study|Lost to Follow-up|14
138245|NCT00467259|458008|P2|Overall Study|Physician Decision|2
138246|NCT00467259|458009|P1|Overall Study|Physician Decision|0
138247|NCT00467259|458008|P2|Overall Study|Withdrawal by Subject|108
138248|NCT00467259|458009|P1|Overall Study|Withdrawal by Subject|34
138249|NCT00467259|458008|P2|Overall Study|Protocol Violation|7
138250|NCT00467259|458009|P1|Overall Study|Protocol Violation|1
138251|NCT00467259|458008|P2|Overall Study|Adverse Event|90
138252|NCT00467259|458009|P1|Overall Study|Adverse Event|24
138253|NCT00467051|458019|P1|Overall Study|Adverse Event|2
138254|NCT00466947|458036|P2|Study End Analysis Period|Other – Unconformity in team’s treatment|1
138255|NCT00466947|458037|P1|Study End Analysis Period|Other – Unconformity in team’s treatment|0
138256|NCT00466947|458036|P2|Study End Analysis Period|Other – Subject without a legal guardian|0
138257|NCT00466947|458037|P1|Study End Analysis Period|Other – Subject without a legal guardian|1
138258|NCT00466947|458036|P2|Study End Analysis Period|Other – Forbidden vaccination|10
138259|NCT00466947|458037|P1|Study End Analysis Period|Other – Forbidden vaccination|21
138260|NCT00466947|458036|P2|Study End Analysis Period|Withdrawal by Subject|1267
138261|NCT00466947|458037|P1|Study End Analysis Period|Withdrawal by Subject|1264
138262|NCT00466947|458036|P2|Study End Analysis Period|Protocol Violation|17
138263|NCT00466947|458037|P1|Study End Analysis Period|Protocol Violation|9
138264|NCT00466947|458036|P2|Study End Analysis Period|Physician Decision|29
138265|NCT00466947|458037|P1|Study End Analysis Period|Physician Decision|29
138266|NCT00466947|458036|P2|Study End Analysis Period|Lost to Follow-up|1167
138267|NCT00466947|458037|P1|Study End Analysis Period|Lost to Follow-up|1137
138268|NCT00466947|458036|P2|Study End Analysis Period|Adverse Event|43
138269|NCT00466947|458037|P1|Study End Analysis Period|Adverse Event|35
138270|NCT00466947|458036|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
138271|NCT00466947|458037|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
138272|NCT00466687|458219|P1|Overall Study|Disease progression|29
138273|NCT00466687|458219|P1|Overall Study|Withdrawal by Subject|1
138274|NCT00466687|458219|P1|Overall Study|Other complicating illness|3
138275|NCT00466687|458219|P1|Overall Study|Adverse Event|1
138276|NCT00466505|458226|P1|Overall Study|Adverse Event|4
138277|NCT00466505|458226|P1|Overall Study|disease progression|13
138278|NCT00466193|458276|P2|Overall Study|Patient refused Visit 4 procedures|0
138279|NCT00466193|458277|P1|Overall Study|Patient refused Visit 4 procedures|1
138280|NCT00466193|458276|P2|Overall Study|Withdrawal by Subject|2
138281|NCT00466193|458277|P1|Overall Study|Withdrawal by Subject|7
138282|NCT00466193|458276|P2|Overall Study|Protocol Violation|1
138283|NCT00466193|458277|P1|Overall Study|Protocol Violation|1
138284|NCT00466193|458276|P2|Overall Study|Physician Decision|0
138285|NCT00466193|458277|P1|Overall Study|Physician Decision|1
138286|NCT00466193|458276|P2|Overall Study|Lost to Follow-up|4
138287|NCT00466193|458277|P1|Overall Study|Lost to Follow-up|2
138288|NCT00466193|458276|P2|Overall Study|Adverse Event|1
138289|NCT00466193|458277|P1|Overall Study|Adverse Event|0
138290|NCT00466167|458304|P3|Overall Study|Not treated|0
138291|NCT00466167|458305|P2|Overall Study|Not treated|0
138292|NCT00466167|458306|P1|Overall Study|Not treated|1
138293|NCT00466167|458304|P3|Overall Study|patient did not meet inclusion criteria|1
138294|NCT00466167|458305|P2|Overall Study|patient did not meet inclusion criteria|0
138295|NCT00466167|458306|P1|Overall Study|patient did not meet inclusion criteria|1
138296|NCT00466167|458304|P3|Overall Study|Withdrawal by Subject|6
138297|NCT00466167|458305|P2|Overall Study|Withdrawal by Subject|1
138298|NCT00466167|458306|P1|Overall Study|Withdrawal by Subject|4
138299|NCT00466167|458304|P3|Overall Study|Lost to Follow-up|2
138300|NCT00466167|458305|P2|Overall Study|Lost to Follow-up|2
138301|NCT00466167|458306|P1|Overall Study|Lost to Follow-up|3
138302|NCT00466167|458304|P3|Overall Study|Protocol Violation|2
138303|NCT00466167|458305|P2|Overall Study|Protocol Violation|1
138304|NCT00466167|458306|P1|Overall Study|Protocol Violation|1
138305|NCT00466167|458304|P3|Overall Study|Lack of Efficacy|3
138306|NCT00466167|458305|P2|Overall Study|Lack of Efficacy|0
138307|NCT00466167|458306|P1|Overall Study|Lack of Efficacy|2
138308|NCT00466167|458304|P3|Overall Study|Adverse Event|7
138309|NCT00466167|458305|P2|Overall Study|Adverse Event|8
138310|NCT00466167|458306|P1|Overall Study|Adverse Event|8
138311|NCT00465985|458367|P2|Part III - Open-label Treatment Period|Adverse Event|0
138312|NCT00465985|458368|P1|Part III - Open-label Treatment Period|Adverse Event|1
138313|NCT00465985|458367|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
138314|NCT00465985|458368|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
138315|NCT00465985|458367|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
138316|NCT00465985|458368|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
138317|NCT00465985|458367|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
138318|NCT00465985|458368|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
138319|NCT00465972|458391|P2|Overall Study|Withdrawal by Subject|1
138320|NCT00465972|458392|P1|Overall Study|Withdrawal by Subject|2
138321|NCT00465816|458412|P3|Overall Study|Lost to Follow-up|2
138322|NCT00465816|458413|P2|Overall Study|Lost to Follow-up|0
138323|NCT00465816|458414|P1|Overall Study|Lost to Follow-up|0
138324|NCT00465738|458496|P2|Overall Study|Other|5
138325|NCT00465738|458497|P1|Overall Study|Other|2
138326|NCT00465738|458496|P2|Overall Study|Withdrawal by Subject|0
138327|NCT00465738|458497|P1|Overall Study|Withdrawal by Subject|2
138328|NCT00465738|458496|P2|Overall Study|Adverse Event|1
138329|NCT00465738|458497|P1|Overall Study|Adverse Event|0
138330|NCT00465738|458496|P2|Overall Study|Lost to Follow-up|0
138331|NCT00465738|458497|P1|Overall Study|Lost to Follow-up|2
138332|NCT00465647|458591|P4|Overall Study|"The other reasons included loss of IV"|2
138333|NCT00465647|458592|P3|Overall Study|"The other reasons included loss of IV"|3
138334|NCT00465647|458593|P2|Overall Study|"The other reasons included loss of IV"|4
138335|NCT00465647|458594|P1|Overall Study|"The other reasons included loss of IV"|8
138336|NCT00465647|458591|P4|Overall Study|Withdrawal by Subject|7
138337|NCT00465647|458592|P3|Overall Study|Withdrawal by Subject|2
138338|NCT00465647|458593|P2|Overall Study|Withdrawal by Subject|2
138339|NCT00465647|458594|P1|Overall Study|Withdrawal by Subject|1
138340|NCT00465647|458591|P4|Overall Study|Adverse Event|2
138341|NCT00465647|458592|P3|Overall Study|Adverse Event|3
138342|NCT00465647|458593|P2|Overall Study|Adverse Event|0
138343|NCT00465647|458594|P1|Overall Study|Adverse Event|2
138344|NCT00465647|458591|P4|Overall Study|Administrative|2
138345|NCT00465647|458592|P3|Overall Study|Administrative|3
138346|NCT00465647|458593|P2|Overall Study|Administrative|2
138347|NCT00465647|458594|P1|Overall Study|Administrative|2
138348|NCT00465361|458630|P1|Baseline Assessment|Personal Issues/Scheduling|4
138349|NCT00465179|458634|P1|Overall Study|Progression of Disease|47
138350|NCT00465179|458634|P1|Overall Study|Withdrawal by Subject|2
138351|NCT00465179|458634|P1|Overall Study|Adverse Event|4
138352|NCT00465101|458640|P1|Overall Study|Withdrew consent prior to procedure|3
138353|NCT00465101|458640|P1|Overall Study|Physician Decision|1
138354|NCT00465101|458640|P1|Overall Study|Withdrawal by Subject|25
138355|NCT00465101|458640|P1|Overall Study|Death|3
138356|NCT00465101|458640|P1|Overall Study|Unable to obtain IRB approval|1
138357|NCT00465101|458640|P1|Overall Study|Site closed due to IRB expiration|1
138358|NCT00465101|458640|P1|Overall Study|Patient postponed procedure|1
138359|NCT00465101|458640|P1|Overall Study|Pt. Insurance not accepted at center|2
138360|NCT00465101|458640|P1|Overall Study|Other|6
138361|NCT00465101|458640|P1|Overall Study|Lost to Follow-up|5
138362|NCT00465101|458640|P1|Overall Study|Did not meet study criteria|4
138363|NCT00465101|458640|P1|Overall Study|Change in health precluded follow up|4
138364|NCT00465101|458640|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
138365|NCT00464945|458710|P2|Toddler Dose|Lost to Follow-up|1
138366|NCT00464945|458711|P1|Toddler Dose|Lost to Follow-up|0
138367|NCT00464945|458710|P2|After Infant Series|Withdrawal by Subject|2
138368|NCT00464945|458711|P1|After Infant Series|Withdrawal by Subject|0
138369|NCT00464945|458710|P2|Infant Series|Lost to Follow-up|0
138370|NCT00464945|458711|P1|Infant Series|Lost to Follow-up|1
138371|NCT00464945|458710|P2|Infant Series|Protocol Violation|0
138372|NCT00464945|458711|P1|Infant Series|Protocol Violation|1
138373|NCT00464945|458710|P2|Infant Series|Withdrawal by parent/guardian request|1
138374|NCT00464945|458711|P1|Infant Series|Withdrawal by parent/guardian request|2
138375|NCT00464737|458742|P3|Overall Study|Other: Subject's disability per sponsor|1
138376|NCT00464737|458743|P2|Overall Study|Other: Subject's disability per sponsor|0
138377|NCT00464737|458744|P1|Overall Study|Other: Subject's disability per sponsor|0
138378|NCT00464737|458742|P3|Overall Study|Other: Personal family reasons|1
138379|NCT00464737|458743|P2|Overall Study|Other: Personal family reasons|0
138380|NCT00464737|458744|P1|Overall Study|Other: Personal family reasons|0
138381|NCT00464737|458742|P3|Overall Study|Other: Study demands too great|0
138382|NCT00464737|458743|P2|Overall Study|Other: Study demands too great|1
138383|NCT00464737|458744|P1|Overall Study|Other: Study demands too great|0
138384|NCT00464737|458742|P3|Overall Study|Other: Subject left town; family illness|0
138385|NCT00464737|458743|P2|Overall Study|Other: Subject left town; family illness|0
138386|NCT00464737|458744|P1|Overall Study|Other: Subject left town; family illness|1
138387|NCT00464737|458742|P3|Overall Study|Other: Subject's schedule doesn't permit|0
138388|NCT00464737|458743|P2|Overall Study|Other: Subject's schedule doesn't permit|0
138389|NCT00464737|458744|P1|Overall Study|Other: Subject's schedule doesn't permit|1
138390|NCT00464737|458742|P3|Overall Study|Lost to Follow-up|5
138391|NCT00464737|458743|P2|Overall Study|Lost to Follow-up|2
138392|NCT00464737|458744|P1|Overall Study|Lost to Follow-up|5
138393|NCT00464737|458742|P3|Overall Study|Non-compliance|1
138394|NCT00464737|458743|P2|Overall Study|Non-compliance|1
138395|NCT00464737|458744|P1|Overall Study|Non-compliance|0
138396|NCT00464737|458742|P3|Overall Study|Protocol Violation|5
138397|NCT00464737|458743|P2|Overall Study|Protocol Violation|1
138398|NCT00464737|458744|P1|Overall Study|Protocol Violation|1
138399|NCT00464737|458742|P3|Overall Study|Withdrawal by Subject|5
138400|NCT00464737|458743|P2|Overall Study|Withdrawal by Subject|3
138401|NCT00464737|458744|P1|Overall Study|Withdrawal by Subject|5
138402|NCT00464737|458742|P3|Overall Study|Lack of Efficacy|4
138403|NCT00464737|458743|P2|Overall Study|Lack of Efficacy|7
138404|NCT00464737|458744|P1|Overall Study|Lack of Efficacy|7
138405|NCT00464737|458742|P3|Overall Study|Adverse Event|33
138406|NCT00464737|458743|P2|Overall Study|Adverse Event|17
138407|NCT00464737|458744|P1|Overall Study|Adverse Event|12
138408|NCT00464672|458814|P6|Overall Study|Lost to Follow-up|0
138409|NCT00464672|458815|P5|Overall Study|Lost to Follow-up|1
138410|NCT00464672|458816|P4|Overall Study|Lost to Follow-up|0
138411|NCT00464672|458817|P3|Overall Study|Lost to Follow-up|0
138412|NCT00464672|458818|P2|Overall Study|Lost to Follow-up|10
138413|NCT00464672|458819|P1|Overall Study|Lost to Follow-up|25
138414|NCT00464672|458814|P6|Overall Study|withdrawal of consent|4
138415|NCT00464672|458815|P5|Overall Study|withdrawal of consent|9
138416|NCT00464672|458816|P4|Overall Study|withdrawal of consent|1
138417|NCT00464672|458817|P3|Overall Study|withdrawal of consent|0
138418|NCT00464672|458818|P2|Overall Study|withdrawal of consent|0
138419|NCT00464672|458819|P1|Overall Study|withdrawal of consent|0
138420|NCT00464542|458898|P1|Pre-treatment|Withdrawal by Subject|2
138421|NCT00464490|458905|P2|Overall Study|Physician Decision|11
138422|NCT00464490|458906|P1|Overall Study|Physician Decision|11
138423|NCT00464334|458953|P11|Overall Study|Withdrawal by Subject|0
138424|NCT00464334|458954|P10|Overall Study|Withdrawal by Subject|0
138425|NCT00464334|458955|P9|Overall Study|Withdrawal by Subject|3
138426|NCT00464334|458956|P8|Overall Study|Withdrawal by Subject|1
138427|NCT00464334|458957|P7|Overall Study|Withdrawal by Subject|2
138428|NCT00464334|458958|P6|Overall Study|Withdrawal by Subject|2
138429|NCT00464334|458959|P5|Overall Study|Withdrawal by Subject|2
138430|NCT00464334|458960|P4|Overall Study|Withdrawal by Subject|2
138431|NCT00464334|458961|P3|Overall Study|Withdrawal by Subject|4
138432|NCT00464334|458962|P2|Overall Study|Withdrawal by Subject|7
138433|NCT00464334|458963|P1|Overall Study|Withdrawal by Subject|1
138434|NCT00464334|458953|P11|Overall Study|Study Terminated by Sponsor|0
138435|NCT00464334|458954|P10|Overall Study|Study Terminated by Sponsor|0
138436|NCT00464334|458955|P9|Overall Study|Study Terminated by Sponsor|0
138437|NCT00464334|458956|P8|Overall Study|Study Terminated by Sponsor|0
138438|NCT00464334|458957|P7|Overall Study|Study Terminated by Sponsor|0
138439|NCT00464334|458958|P6|Overall Study|Study Terminated by Sponsor|0
138440|NCT00464334|458959|P5|Overall Study|Study Terminated by Sponsor|0
138441|NCT00464334|458960|P4|Overall Study|Study Terminated by Sponsor|1
138442|NCT00464334|458961|P3|Overall Study|Study Terminated by Sponsor|0
138443|NCT00464334|458962|P2|Overall Study|Study Terminated by Sponsor|0
138444|NCT00464334|458963|P1|Overall Study|Study Terminated by Sponsor|0
138445|NCT00464334|458953|P11|Overall Study|Progressive Disease|0
138446|NCT00464334|458954|P10|Overall Study|Progressive Disease|0
138447|NCT00464334|458955|P9|Overall Study|Progressive Disease|1
138448|NCT00464334|458956|P8|Overall Study|Progressive Disease|0
138449|NCT00464334|458957|P7|Overall Study|Progressive Disease|0
138450|NCT00464334|458958|P6|Overall Study|Progressive Disease|1
138451|NCT00464334|458959|P5|Overall Study|Progressive Disease|0
138452|NCT00464334|458960|P4|Overall Study|Progressive Disease|0
138453|NCT00464334|458961|P3|Overall Study|Progressive Disease|0
138454|NCT00464334|458962|P2|Overall Study|Progressive Disease|0
138455|NCT00464334|458963|P1|Overall Study|Progressive Disease|0
138456|NCT00464334|458953|P11|Overall Study|Lost to Follow-up|2
138457|NCT00464334|458954|P10|Overall Study|Lost to Follow-up|0
138458|NCT00464334|458955|P9|Overall Study|Lost to Follow-up|0
138459|NCT00464334|458956|P8|Overall Study|Lost to Follow-up|0
138460|NCT00464334|458957|P7|Overall Study|Lost to Follow-up|1
138461|NCT00464334|458958|P6|Overall Study|Lost to Follow-up|0
138462|NCT00464334|458959|P5|Overall Study|Lost to Follow-up|1
138463|NCT00464334|458960|P4|Overall Study|Lost to Follow-up|0
138464|NCT00464334|458961|P3|Overall Study|Lost to Follow-up|1
138465|NCT00464334|458962|P2|Overall Study|Lost to Follow-up|0
138466|NCT00464334|458963|P1|Overall Study|Lost to Follow-up|0
138467|NCT00464334|458953|P11|Overall Study|Lack of Efficacy|0
138468|NCT00464334|458954|P10|Overall Study|Lack of Efficacy|0
138469|NCT00464334|458955|P9|Overall Study|Lack of Efficacy|0
138470|NCT00464334|458956|P8|Overall Study|Lack of Efficacy|0
138471|NCT00464334|458957|P7|Overall Study|Lack of Efficacy|0
138472|NCT00464334|458958|P6|Overall Study|Lack of Efficacy|0
138473|NCT00464334|458959|P5|Overall Study|Lack of Efficacy|0
138474|NCT00464334|458960|P4|Overall Study|Lack of Efficacy|0
138475|NCT00464334|458961|P3|Overall Study|Lack of Efficacy|0
138476|NCT00464334|458962|P2|Overall Study|Lack of Efficacy|1
138477|NCT00464334|458963|P1|Overall Study|Lack of Efficacy|0
138478|NCT00464334|458953|P11|Overall Study|Adverse Event|2
138479|NCT00464334|458954|P10|Overall Study|Adverse Event|1
138480|NCT00464334|458955|P9|Overall Study|Adverse Event|2
138481|NCT00464334|458956|P8|Overall Study|Adverse Event|0
138482|NCT00464334|458957|P7|Overall Study|Adverse Event|0
138483|NCT00464334|458958|P6|Overall Study|Adverse Event|1
138484|NCT00464334|458959|P5|Overall Study|Adverse Event|1
138485|NCT00464334|458960|P4|Overall Study|Adverse Event|1
138486|NCT00464334|458961|P3|Overall Study|Adverse Event|0
138487|NCT00464334|458962|P2|Overall Study|Adverse Event|0
138488|NCT00464334|458963|P1|Overall Study|Adverse Event|0
138489|NCT00464308|459023|P3|Overall Study|Physician Decision|0
138490|NCT00464308|459024|P2|Overall Study|Physician Decision|0
138491|NCT00464308|459025|P1|Overall Study|Physician Decision|1
138492|NCT00464308|459023|P3|Overall Study|Patient discontinued and other reasons|23
138493|NCT00464308|459024|P2|Overall Study|Patient discontinued and other reasons|17
138494|NCT00464308|459025|P1|Overall Study|Patient discontinued and other reasons|17
138495|NCT00464308|459023|P3|Overall Study|Lost to Follow-up|20
138496|NCT00464308|459024|P2|Overall Study|Lost to Follow-up|19
138497|NCT00464308|459025|P1|Overall Study|Lost to Follow-up|29
138498|NCT00464308|459023|P3|Overall Study|Adverse Event|16
138499|NCT00464308|459024|P2|Overall Study|Adverse Event|27
138500|NCT00464308|459025|P1|Overall Study|Adverse Event|22
138501|NCT00464269|459055|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
138502|NCT00464269|459056|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
138503|NCT00464269|459057|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
138504|NCT00464269|459058|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
138505|NCT00464269|459055|P4|Overall Study|AE, non-serious non-fatal|4
138506|NCT00464269|459056|P3|Overall Study|AE, non-serious non-fatal|3
138507|NCT00464269|459057|P2|Overall Study|AE, non-serious non-fatal|8
138508|NCT00464269|459058|P1|Overall Study|AE, non-serious non-fatal|2
138509|NCT00464269|459055|P4|Overall Study|SAE, non-fatal|1
138510|NCT00464269|459056|P3|Overall Study|SAE, non-fatal|0
138511|NCT00464269|459057|P2|Overall Study|SAE, non-fatal|0
138512|NCT00464269|459058|P1|Overall Study|SAE, non-fatal|0
138513|NCT00464269|459055|P4|Overall Study|AE, serious fatal|1
138514|NCT00464269|459056|P3|Overall Study|AE, serious fatal|1
138515|NCT00464269|459057|P2|Overall Study|AE, serious fatal|0
138516|NCT00464269|459058|P1|Overall Study|AE, serious fatal|0
138517|NCT00464269|459055|P4|Overall Study|Other reason|1
138518|NCT00464269|459056|P3|Overall Study|Other reason|1
138519|NCT00464269|459057|P2|Overall Study|Other reason|3
138520|NCT00464269|459058|P1|Overall Study|Other reason|3
138521|NCT00464269|459055|P4|Overall Study|Withdrawal by Subject|1
138522|NCT00464269|459056|P3|Overall Study|Withdrawal by Subject|1
138523|NCT00464269|459057|P2|Overall Study|Withdrawal by Subject|2
138524|NCT00464269|459058|P1|Overall Study|Withdrawal by Subject|0
138525|NCT00464269|459055|P4|Overall Study|Lost to Follow-up|1
138526|NCT00464269|459056|P3|Overall Study|Lost to Follow-up|0
138527|NCT00464269|459057|P2|Overall Study|Lost to Follow-up|4
138528|NCT00464269|459058|P1|Overall Study|Lost to Follow-up|0
138529|NCT00464269|459055|P4|Overall Study|Lack of Efficacy|0
138530|NCT00464269|459056|P3|Overall Study|Lack of Efficacy|0
138531|NCT00464269|459057|P2|Overall Study|Lack of Efficacy|0
138532|NCT00464269|459058|P1|Overall Study|Lack of Efficacy|1
138533|NCT00464087|459192|P3|Overall Study|No PCI per inclusion criteria|29
138534|NCT00464087|459193|P2|Overall Study|No PCI per inclusion criteria|0
138535|NCT00464087|459194|P1|Overall Study|No PCI per inclusion criteria|0
138536|NCT00463866|459212|P2|Overall Study|Unspecified|22
138537|NCT00463866|459213|P1|Overall Study|Unspecified|22
138538|NCT00463866|459212|P2|Overall Study|Mis-Randomization of subject|1
138539|NCT00463866|459213|P1|Overall Study|Mis-Randomization of subject|0
138540|NCT00463866|459212|P2|Overall Study|Safety Reason|3
138541|NCT00463866|459213|P1|Overall Study|Safety Reason|1
138542|NCT00463866|459212|P2|Overall Study|Severe Non-Compliance to Protocol|21
138543|NCT00463866|459213|P1|Overall Study|Severe Non-Compliance to Protocol|25
138544|NCT00463866|459212|P2|Overall Study|Incorrect Enrolment|66
138545|NCT00463866|459213|P1|Overall Study|Incorrect Enrolment|64
138546|NCT00463866|459212|P2|Overall Study|Lost to Follow-up|55
138547|NCT00463866|459213|P1|Overall Study|Lost to Follow-up|46
138548|NCT00463866|459212|P2|Overall Study|Withdrawal by Subject|79
138549|NCT00463866|459213|P1|Overall Study|Withdrawal by Subject|81
138550|NCT00463866|459212|P2|Overall Study|Adverse Event|93
138551|NCT00463866|459213|P1|Overall Study|Adverse Event|70
138552|NCT00463840|459233|P1|Overall Study|Adverse Event|3
138553|NCT00463840|459233|P1|Overall Study|Withdrawal by Subject|2
138554|NCT00463840|459233|P1|Overall Study|Disease progression|7
138555|NCT00463801|459237|P1|Overall Study|No longer require therapy|1
138556|NCT00463801|459237|P1|Overall Study|Lost to Follow-up|5
138557|NCT00463801|459237|P1|Overall Study|Adverse Event|4
138558|NCT00463801|459237|P1|Overall Study|Lack of Efficacy|2
138559|NCT00463801|459237|P1|Overall Study|Protocol Violation|1
138560|NCT00463788|459243|P2|Overall Study|Randomized but not treated|1
138561|NCT00463788|459244|P1|Overall Study|Randomized but not treated|1
138562|NCT00463788|459243|P2|Overall Study|Unspecified|0
138563|NCT00463788|459244|P1|Overall Study|Unspecified|3
138564|NCT00463788|459243|P2|Overall Study|Protocol Violation|1
138565|NCT00463788|459244|P1|Overall Study|Protocol Violation|0
138566|NCT00463788|459243|P2|Overall Study|Lost to Follow-up|0
138567|NCT00463788|459244|P1|Overall Study|Lost to Follow-up|1
138568|NCT00463788|459243|P2|Overall Study|Symptomatic Deterioration|3
138569|NCT00463788|459244|P1|Overall Study|Symptomatic Deterioration|2
138570|NCT00463788|459243|P2|Overall Study|Death|3
138571|NCT00463788|459244|P1|Overall Study|Death|4
138572|NCT00463788|459243|P2|Overall Study|Withdrawal by Subject|2
138573|NCT00463788|459244|P1|Overall Study|Withdrawal by Subject|6
138574|NCT00463788|459243|P2|Overall Study|Adverse Event|2
138575|NCT00463788|459244|P1|Overall Study|Adverse Event|6
138576|NCT00463788|459243|P2|Overall Study|Progressive Disease|42
138577|NCT00463788|459244|P1|Overall Study|Progressive Disease|86
138578|NCT00463606|459262|P3|Overall Study|Protocol Violation|1
138579|NCT00463606|459263|P2|Overall Study|Protocol Violation|0
138580|NCT00463606|459264|P1|Overall Study|Protocol Violation|0
138581|NCT00463606|459262|P3|Overall Study|Participation in another ABT-335 trial|0
138582|NCT00463606|459263|P2|Overall Study|Participation in another ABT-335 trial|0
138583|NCT00463606|459264|P1|Overall Study|Participation in another ABT-335 trial|1
138584|NCT00463606|459262|P3|Overall Study|Patient randomized in error|0
138585|NCT00463606|459263|P2|Overall Study|Patient randomized in error|0
138586|NCT00463606|459264|P1|Overall Study|Patient randomized in error|1
138587|NCT00463606|459262|P3|Overall Study|Coordinator error|0
138588|NCT00463606|459263|P2|Overall Study|Coordinator error|0
138589|NCT00463606|459264|P1|Overall Study|Coordinator error|1
138590|NCT00463606|459262|P3|Overall Study|Exclusion criteria violation|0
138591|NCT00463606|459263|P2|Overall Study|Exclusion criteria violation|0
138592|NCT00463606|459264|P1|Overall Study|Exclusion criteria violation|2
138593|NCT00463606|459262|P3|Overall Study|Sponsor request|0
138594|NCT00463606|459263|P2|Overall Study|Sponsor request|1
138595|NCT00463606|459264|P1|Overall Study|Sponsor request|0
138596|NCT00463606|459262|P3|Overall Study|Physician Decision|0
138597|NCT00463606|459263|P2|Overall Study|Physician Decision|1
138598|NCT00463606|459264|P1|Overall Study|Physician Decision|0
138599|NCT00463606|459262|P3|Overall Study|Subject moved out of town|0
138600|NCT00463606|459263|P2|Overall Study|Subject moved out of town|0
138601|NCT00463606|459264|P1|Overall Study|Subject moved out of town|1
138602|NCT00463606|459262|P3|Overall Study|Subject noncompliance|0
138603|NCT00463606|459263|P2|Overall Study|Subject noncompliance|1
138604|NCT00463606|459264|P1|Overall Study|Subject noncompliance|1
138605|NCT00463606|459262|P3|Overall Study|Lost to Follow-up|3
138606|NCT00463606|459263|P2|Overall Study|Lost to Follow-up|2
138607|NCT00463606|459264|P1|Overall Study|Lost to Follow-up|2
138608|NCT00463606|459262|P3|Overall Study|Withdrawal by Subject|5
138609|NCT00463606|459263|P2|Overall Study|Withdrawal by Subject|11
138610|NCT00463606|459264|P1|Overall Study|Withdrawal by Subject|11
138611|NCT00463606|459262|P3|Overall Study|Adverse Event|11
138612|NCT00463606|459263|P2|Overall Study|Adverse Event|18
138613|NCT00463606|459264|P1|Overall Study|Adverse Event|21
138614|NCT00463580|459289|P2|Overall Study|Medical/psychiatric complications|2
138615|NCT00463580|459290|P1|Overall Study|Medical/psychiatric complications|0
138616|NCT00463580|459289|P2|Overall Study|schedule conflict|0
138617|NCT00463580|459290|P1|Overall Study|schedule conflict|2
138618|NCT00463580|459289|P2|Overall Study|Lost to Follow-up|0
138619|NCT00463580|459290|P1|Overall Study|Lost to Follow-up|1
138620|NCT00463567|459305|P7|Overall Study|Death|0
138621|NCT00463567|459306|P6|Overall Study|Death|0
138622|NCT00463567|459307|P5|Overall Study|Death|0
138623|NCT00463567|459308|P4|Overall Study|Death|0
138624|NCT00463567|459309|P3|Overall Study|Death|2
138625|NCT00463567|459310|P2|Overall Study|Death|0
138626|NCT00463567|459311|P1|Overall Study|Death|1
138627|NCT00463567|459305|P7|Overall Study|Abnormal test procedure result(s)|0
138628|NCT00463567|459306|P6|Overall Study|Abnormal test procedure result(s)|2
138629|NCT00463567|459307|P5|Overall Study|Abnormal test procedure result(s)|0
138630|NCT00463567|459308|P4|Overall Study|Abnormal test procedure result(s)|2
138631|NCT00463567|459309|P3|Overall Study|Abnormal test procedure result(s)|6
138632|NCT00463567|459310|P2|Overall Study|Abnormal test procedure result(s)|1
138633|NCT00463567|459311|P1|Overall Study|Abnormal test procedure result(s)|1
138634|NCT00463567|459305|P7|Overall Study|Abnormal lab value(s)|0
138635|NCT00463567|459306|P6|Overall Study|Abnormal lab value(s)|0
138636|NCT00463567|459307|P5|Overall Study|Abnormal lab value(s)|1
138637|NCT00463567|459308|P4|Overall Study|Abnormal lab value(s)|1
138638|NCT00463567|459309|P3|Overall Study|Abnormal lab value(s)|2
138639|NCT00463567|459310|P2|Overall Study|Abnormal lab value(s)|1
138640|NCT00463567|459311|P1|Overall Study|Abnormal lab value(s)|1
138641|NCT00463567|459305|P7|Overall Study|Lack of Efficacy|1
138642|NCT00463567|459306|P6|Overall Study|Lack of Efficacy|0
138643|NCT00463567|459307|P5|Overall Study|Lack of Efficacy|1
138644|NCT00463567|459308|P4|Overall Study|Lack of Efficacy|17
138645|NCT00463567|459309|P3|Overall Study|Lack of Efficacy|9
138646|NCT00463567|459310|P2|Overall Study|Lack of Efficacy|9
138647|NCT00463567|459311|P1|Overall Study|Lack of Efficacy|4
138648|NCT00463567|459305|P7|Overall Study|Administrative problems|2
138649|NCT00463567|459306|P6|Overall Study|Administrative problems|2
138650|NCT00463567|459307|P5|Overall Study|Administrative problems|3
138651|NCT00463567|459308|P4|Overall Study|Administrative problems|9
138652|NCT00463567|459309|P3|Overall Study|Administrative problems|6
138653|NCT00463567|459310|P2|Overall Study|Administrative problems|3
138654|NCT00463567|459311|P1|Overall Study|Administrative problems|5
138655|NCT00463567|459305|P7|Overall Study|Lost to Follow-up|1
138656|NCT00463567|459306|P6|Overall Study|Lost to Follow-up|1
138657|NCT00463567|459307|P5|Overall Study|Lost to Follow-up|1
138658|NCT00463567|459308|P4|Overall Study|Lost to Follow-up|8
138659|NCT00463567|459309|P3|Overall Study|Lost to Follow-up|13
138660|NCT00463567|459310|P2|Overall Study|Lost to Follow-up|6
138661|NCT00463567|459311|P1|Overall Study|Lost to Follow-up|12
138662|NCT00463567|459305|P7|Overall Study|Protocol Deviation|2
138663|NCT00463567|459306|P6|Overall Study|Protocol Deviation|1
138664|NCT00463567|459307|P5|Overall Study|Protocol Deviation|1
138665|NCT00463567|459308|P4|Overall Study|Protocol Deviation|11
138666|NCT00463567|459309|P3|Overall Study|Protocol Deviation|14
138667|NCT00463567|459310|P2|Overall Study|Protocol Deviation|9
138668|NCT00463567|459311|P1|Overall Study|Protocol Deviation|13
138669|NCT00463567|459305|P7|Overall Study|Withdrawal by Subject|1
138670|NCT00463567|459306|P6|Overall Study|Withdrawal by Subject|5
138671|NCT00463567|459307|P5|Overall Study|Withdrawal by Subject|6
138672|NCT00463567|459308|P4|Overall Study|Withdrawal by Subject|37
138673|NCT00463567|459309|P3|Overall Study|Withdrawal by Subject|20
138674|NCT00463567|459310|P2|Overall Study|Withdrawal by Subject|22
138675|NCT00463567|459311|P1|Overall Study|Withdrawal by Subject|29
138676|NCT00463567|459305|P7|Overall Study|Adverse Event|4
138677|NCT00463567|459306|P6|Overall Study|Adverse Event|10
138678|NCT00463567|459307|P5|Overall Study|Adverse Event|10
138679|NCT00463567|459308|P4|Overall Study|Adverse Event|46
138680|NCT00463567|459309|P3|Overall Study|Adverse Event|17
138681|NCT00463567|459310|P2|Overall Study|Adverse Event|26
138682|NCT00463567|459311|P1|Overall Study|Adverse Event|29
138683|NCT00463437|459346|P4|Overall Study|Other|7
138684|NCT00463437|459347|P3|Overall Study|Other|6
138685|NCT00463437|459348|P2|Overall Study|Other|11
138686|NCT00463437|459349|P1|Overall Study|Other|4
138687|NCT00463385|459415|P4|Overall Study|1 participant received commercial drug|0
138688|NCT00463385|459416|P3|Overall Study|1 participant received commercial drug|0
138689|NCT00463385|459417|P2|Overall Study|1 participant received commercial drug|1
138690|NCT00463385|459418|P1|Overall Study|1 participant received commercial drug|0
138691|NCT00463385|459415|P4|Overall Study|Missing|2
138692|NCT00463385|459416|P3|Overall Study|Missing|0
138693|NCT00463385|459417|P2|Overall Study|Missing|0
138694|NCT00463385|459418|P1|Overall Study|Missing|2
138695|NCT00463385|459415|P4|Overall Study|Death|0
138696|NCT00463385|459416|P3|Overall Study|Death|2
138697|NCT00463385|459417|P2|Overall Study|Death|1
138698|NCT00463385|459418|P1|Overall Study|Death|2
138699|NCT00463385|459415|P4|Overall Study|Lost to Follow-up|1
138700|NCT00463385|459416|P3|Overall Study|Lost to Follow-up|0
138701|NCT00463385|459417|P2|Overall Study|Lost to Follow-up|0
138702|NCT00463385|459418|P1|Overall Study|Lost to Follow-up|0
138703|NCT00463385|459415|P4|Overall Study|Withdrawal by Subject|4
138704|NCT00463385|459416|P3|Overall Study|Withdrawal by Subject|3
138705|NCT00463385|459417|P2|Overall Study|Withdrawal by Subject|3
138706|NCT00463385|459418|P1|Overall Study|Withdrawal by Subject|3
138707|NCT00463385|459415|P4|Overall Study|Lack of Efficacy|9
138708|NCT00463385|459416|P3|Overall Study|Lack of Efficacy|7
138709|NCT00463385|459417|P2|Overall Study|Lack of Efficacy|6
138710|NCT00463385|459418|P1|Overall Study|Lack of Efficacy|6
138711|NCT00463385|459415|P4|Overall Study|Adverse Event|2
138712|NCT00463385|459416|P3|Overall Study|Adverse Event|4
138713|NCT00463385|459417|P2|Overall Study|Adverse Event|8
138714|NCT00463385|459418|P1|Overall Study|Adverse Event|5
138715|NCT00463385|459415|P4|Overall Study|Unspecified|4
138716|NCT00463385|459416|P3|Overall Study|Unspecified|6
138717|NCT00463385|459417|P2|Overall Study|Unspecified|3
138718|NCT00463385|459418|P1|Overall Study|Unspecified|4
138719|NCT00463346|459470|P2|Overall Study|Withdrawal by Subject|3
138720|NCT00463346|459471|P1|Overall Study|Withdrawal by Subject|3
138721|NCT00463229|459481|P2|Overall Study|Death|3
138722|NCT00463229|459482|P1|Overall Study|Death|4
138723|NCT00463229|459481|P2|Overall Study|Lost to Follow-up|7
138724|NCT00463229|459482|P1|Overall Study|Lost to Follow-up|5
138725|NCT00463047|459488|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
138726|NCT00463047|459489|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
138727|NCT00463047|459488|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
138728|NCT00463047|459489|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
138729|NCT00463047|459488|P2|Double-Blind Treatment Period 2|Adverse Event|1
138730|NCT00463047|459489|P1|Double-Blind Treatment Period 2|Adverse Event|0
138731|NCT00463047|459488|P2|Double-Blind Treatment Period 1|Not specified|0
138732|NCT00463047|459489|P1|Double-Blind Treatment Period 1|Not specified|1
138733|NCT00463047|459488|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
138734|NCT00463047|459489|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
138735|NCT00463047|459488|P2|Double-Blind Treatment Period 1|Protocol Violation|2
138736|NCT00463047|459489|P1|Double-Blind Treatment Period 1|Protocol Violation|1
138737|NCT00463047|459488|P2|Double-Blind Treatment Period 1|Adverse Event|2
138738|NCT00463047|459489|P1|Double-Blind Treatment Period 1|Adverse Event|0
138739|NCT00463047|459488|P2|Titration Period 2|Not specified|2
138740|NCT00463047|459489|P1|Titration Period 2|Not specified|3
138741|NCT00463047|459488|P2|Titration Period 2|Non-compliance procedures|1
138742|NCT00463047|459489|P1|Titration Period 2|Non-compliance procedures|4
138743|NCT00463047|459488|P2|Titration Period 2|Non-compliance study medication|2
138744|NCT00463047|459489|P1|Titration Period 2|Non-compliance study medication|4
138745|NCT00463047|459488|P2|Titration Period 2|Lost to Follow-up|2
138746|NCT00463047|459489|P1|Titration Period 2|Lost to Follow-up|1
138747|NCT00463047|459488|P2|Titration Period 2|Protocol Violation|3
138748|NCT00463047|459489|P1|Titration Period 2|Protocol Violation|2
138749|NCT00463047|459488|P2|Titration Period 2|Withdrawal by Subject|0
138750|NCT00463047|459489|P1|Titration Period 2|Withdrawal by Subject|1
138751|NCT00463047|459488|P2|Titration Period 2|Lack of Efficacy|4
138752|NCT00463047|459489|P1|Titration Period 2|Lack of Efficacy|6
138753|NCT00463047|459488|P2|Titration Period 2|Adverse Event|9
138754|NCT00463047|459489|P1|Titration Period 2|Adverse Event|9
138755|NCT00463047|459488|P2|Titration Period 1|Not specified|2
138756|NCT00463047|459489|P1|Titration Period 1|Not specified|0
138757|NCT00463047|459488|P2|Titration Period 1|Non-compliance procedures|10
138758|NCT00463047|459489|P1|Titration Period 1|Non-compliance procedures|4
138759|NCT00463047|459488|P2|Titration Period 1|Withdrawal by Subject|5
138760|NCT00463047|459489|P1|Titration Period 1|Withdrawal by Subject|3
138761|NCT00463047|459488|P2|Titration Period 1|Protocol Violation|5
138762|NCT00463047|459489|P1|Titration Period 1|Protocol Violation|5
138763|NCT00463047|459488|P2|Titration Period 1|Non-compliance with study medication|5
138764|NCT00463047|459489|P1|Titration Period 1|Non-compliance with study medication|3
138765|NCT00463047|459488|P2|Titration Period 1|Lost to Follow-up|0
138766|NCT00463047|459489|P1|Titration Period 1|Lost to Follow-up|2
138767|NCT00463047|459488|P2|Titration Period 1|Lack of Efficacy|4
138768|NCT00463047|459489|P1|Titration Period 1|Lack of Efficacy|10
138769|NCT00463047|459488|P2|Titration Period 1|Adverse Event|8
138770|NCT00463047|459489|P1|Titration Period 1|Adverse Event|10
138771|NCT00462982|459574|P1|Overall Study|Patient Not Treated|2
138772|NCT00462982|459574|P1|Overall Study|Adverse Event|1
138773|NCT00462943|459581|P3|Overall Study|Withdrawal by Subject|0
138774|NCT00462943|459582|P2|Overall Study|Withdrawal by Subject|1
138775|NCT00462943|459583|P1|Overall Study|Withdrawal by Subject|0
138776|NCT00462943|459581|P3|Overall Study|Physician Decision|0
138777|NCT00462943|459582|P2|Overall Study|Physician Decision|0
138778|NCT00462943|459583|P1|Overall Study|Physician Decision|1
138779|NCT00462943|459581|P3|Overall Study|Transplant - not specified|1
138780|NCT00462943|459582|P2|Overall Study|Transplant - not specified|0
138781|NCT00462943|459583|P1|Overall Study|Transplant - not specified|1
138782|NCT00462943|459581|P3|Overall Study|Required Lymphocyte Infusion|0
138783|NCT00462943|459582|P2|Overall Study|Required Lymphocyte Infusion|0
138784|NCT00462943|459583|P1|Overall Study|Required Lymphocyte Infusion|1
138785|NCT00462943|459581|P3|Overall Study|Bone Marrow Transplant|0
138786|NCT00462943|459582|P2|Overall Study|Bone Marrow Transplant|0
138787|NCT00462943|459583|P1|Overall Study|Bone Marrow Transplant|1
138788|NCT00462943|459581|P3|Overall Study|Stem Cell Transplant|0
138789|NCT00462943|459582|P2|Overall Study|Stem Cell Transplant|1
138790|NCT00462943|459583|P1|Overall Study|Stem Cell Transplant|1
138791|NCT00462943|459581|P3|Overall Study|Death|7
138792|NCT00462943|459582|P2|Overall Study|Death|2
138793|NCT00462943|459583|P1|Overall Study|Death|5
138794|NCT00462943|459581|P3|Overall Study|Disease Progression|9
138795|NCT00462943|459582|P2|Overall Study|Disease Progression|15
138796|NCT00462943|459583|P1|Overall Study|Disease Progression|15
138797|NCT00462943|459581|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
138798|NCT00462943|459582|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
138799|NCT00462943|459583|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
138800|NCT00462943|459581|P3|Overall Study|Protocol Violation|0
138801|NCT00462943|459582|P2|Overall Study|Protocol Violation|0
138802|NCT00462943|459583|P1|Overall Study|Protocol Violation|1
138803|NCT00462943|459581|P3|Overall Study|Adverse Event|1
138804|NCT00462943|459582|P2|Overall Study|Adverse Event|4
138805|NCT00462943|459583|P1|Overall Study|Adverse Event|6
138806|NCT00462943|459581|P3|Overall Study|Failure to achieve a response|1
138807|NCT00462943|459582|P2|Overall Study|Failure to achieve a response|5
138808|NCT00462943|459583|P1|Overall Study|Failure to achieve a response|5
138809|NCT00462865|459675|P1|Overall Study|Adverse Event|1
138810|NCT00462826|459694|P1|Overall Study|Never treated|1
138811|NCT00462826|459694|P1|Overall Study|Ineligible - wrong primary|2
138812|NCT00462826|459694|P1|Overall Study|Ineligible - wrong cell type|1
138813|NCT00462826|459694|P1|Overall Study|Ineligible - second primary|1
138814|NCT00462748|459701|P3|Overall Study|Discontinued after 41 days Rx|0
138815|NCT00462748|459702|P2|Overall Study|Discontinued after 41 days Rx|0
138816|NCT00462748|459703|P1|Overall Study|Discontinued after 41 days Rx|1
138817|NCT00462748|459701|P3|Overall Study|Lost to Follow-up|1
138818|NCT00462748|459702|P2|Overall Study|Lost to Follow-up|1
138819|NCT00462748|459703|P1|Overall Study|Lost to Follow-up|1
138820|NCT00462748|459701|P3|Overall Study|Withdrew consent|0
138821|NCT00462748|459702|P2|Overall Study|Withdrew consent|3
138822|NCT00462748|459703|P1|Overall Study|Withdrew consent|3
138823|NCT00462748|459701|P3|Overall Study|Protocol Violation|1
138824|NCT00462748|459702|P2|Overall Study|Protocol Violation|2
138825|NCT00462748|459703|P1|Overall Study|Protocol Violation|0
138826|NCT00462748|459701|P3|Overall Study|Adverse Event|9
138827|NCT00462748|459702|P2|Overall Study|Adverse Event|5
138828|NCT00462748|459703|P1|Overall Study|Adverse Event|7
138829|NCT00462709|459748|P1|Overall Study|Withdrew to start treatment with Cetor|1
138830|NCT00462709|459748|P1|Overall Study|Physician Decision|1
138831|NCT00462709|459748|P1|Overall Study|Logistical reasons|2
138832|NCT00462709|459748|P1|Overall Study|Death|2
138833|NCT00462709|459748|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
138834|NCT00462709|459748|P1|Overall Study|Withdrawal by Subject|8
138835|NCT00462709|459748|P1|Overall Study|Lost to Follow-up|10
138836|NCT00462709|459748|P1|Overall Study|Transitioned to commercial C1INH-nf|40
138837|NCT00462670|459757|P2|Overall Study|Resolution of signs and symptoms|2
138838|NCT00462670|459758|P1|Overall Study|Resolution of signs and symptoms|0
138839|NCT00462670|459757|P2|Overall Study|Protocol Violation|0
138840|NCT00462670|459758|P1|Overall Study|Protocol Violation|1
138841|NCT00462670|459757|P2|Overall Study|Lack of Efficacy|0
138842|NCT00462670|459758|P1|Overall Study|Lack of Efficacy|1
138843|NCT00462670|459757|P2|Overall Study|Adverse Event|5
138844|NCT00462670|459758|P1|Overall Study|Adverse Event|3
138845|NCT00462501|459787|P1|Overall Study|Adverse Event|2
138846|NCT00462501|459787|P1|Overall Study|Not treated|3
138847|NCT00462462|459793|P2|Overall Study|Physician Decision|1
138848|NCT00462462|459794|P1|Overall Study|Physician Decision|0
138849|NCT00462384|459822|P1|Overall Study|Unspecified|4
138850|NCT00462384|459822|P1|Overall Study|Withdrawal by Subject|1
138851|NCT00462384|459822|P1|Overall Study|Death|2
138852|NCT00462384|459822|P1|Overall Study|Adverse Event|2
138853|NCT00462345|459830|P1|Overall Study|Did not complete second course|1
138854|NCT00462345|459830|P1|Overall Study|Withdrawal by Subject|2
138855|NCT00462306|459865|P2|Overall Study|insufficient data|13
138856|NCT00462306|459866|P1|Overall Study|insufficient data|0
138857|NCT00461981|459992|P2|Overall Study|Withdrawal by Subject|3
138858|NCT00461981|459993|P1|Overall Study|Withdrawal by Subject|2
138859|NCT00461981|459992|P2|Overall Study|Lost to Follow-up|6
138860|NCT00461981|459993|P1|Overall Study|Lost to Follow-up|9
138861|NCT00461786|460107|P1|Overall Study|Inevaluable (Never Treated)|1
138862|NCT00461786|460107|P1|Overall Study|Entry Criteria Not Met|2
138863|NCT00461708|460126|P2|Overall Study|Death|1
138864|NCT00461708|460127|P1|Overall Study|Death|8
138865|NCT00461708|460126|P2|Overall Study|Not specified|4
138866|NCT00461708|460127|P1|Overall Study|Not specified|4
138867|NCT00461708|460126|P2|Overall Study|Withdrawal by Subject|2
138868|NCT00461708|460127|P1|Overall Study|Withdrawal by Subject|8
138869|NCT00461708|460126|P2|Overall Study|Physician Decision|4
138870|NCT00461708|460127|P1|Overall Study|Physician Decision|10
138871|NCT00461708|460126|P2|Overall Study|Lack of Efficacy|20
138872|NCT00461708|460127|P1|Overall Study|Lack of Efficacy|68
138873|NCT00461708|460126|P2|Overall Study|Adverse Event|7
138874|NCT00461708|460127|P1|Overall Study|Adverse Event|17
138875|NCT00461630|460155|P2|Overall Study|Lost to Follow-up|95
138876|NCT00461630|460156|P1|Overall Study|Lost to Follow-up|108
138877|NCT00461630|460155|P2|Overall Study|Death|732
138878|NCT00461630|460156|P1|Overall Study|Death|798
138879|NCT00461500|460181|P2|Overall Study|Lost to Follow-up|2
138880|NCT00461500|460182|P1|Overall Study|Lost to Follow-up|2
138881|NCT00461500|460181|P2|Overall Study|No Longer Willing to Take Part in Study|0
138882|NCT00461500|460182|P1|Overall Study|No Longer Willing to Take Part in Study|1
138883|NCT00461500|460181|P2|Overall Study|Drug Treatment Misuse|0
138884|NCT00461500|460182|P1|Overall Study|Drug Treatment Misuse|1
138885|NCT00461500|460181|P2|Overall Study|Study Stopped|2
138886|NCT00461500|460182|P1|Overall Study|Study Stopped|1
138887|NCT00461500|460181|P2|Overall Study|Expired Drug Treatment|1
138888|NCT00461500|460182|P1|Overall Study|Expired Drug Treatment|1
138889|NCT00461500|460181|P2|Overall Study|Lack of Efficacy|1
138890|NCT00461500|460182|P1|Overall Study|Lack of Efficacy|0
138891|NCT00461500|460181|P2|Overall Study|Adverse Event|0
138892|NCT00461500|460182|P1|Overall Study|Adverse Event|1
138893|NCT00461305|460225|P2|Continued Treatment|Other (missing drug etc)|0
138894|NCT00461305|460226|P1|Continued Treatment|Other (missing drug etc)|2
138895|NCT00461305|460225|P2|Continued Treatment|Partially missing diary|0
138896|NCT00461305|460226|P1|Continued Treatment|Partially missing diary|2
138897|NCT00461305|460225|P2|Continued Treatment|Withdrawal by Subject|0
138898|NCT00461305|460226|P1|Continued Treatment|Withdrawal by Subject|48
138899|NCT00461305|460225|P2|Continued Treatment|Protocol Violation|0
138900|NCT00461305|460226|P1|Continued Treatment|Protocol Violation|13
138901|NCT00461305|460225|P2|Continued Treatment|Lost to Follow-up|0
138902|NCT00461305|460226|P1|Continued Treatment|Lost to Follow-up|4
138903|NCT00461305|460225|P2|Continued Treatment|Adverse Event|0
138904|NCT00461305|460226|P1|Continued Treatment|Adverse Event|26
138905|NCT00461305|460225|P2|Treatment|Other (missing drug etc)|0
138906|NCT00461305|460226|P1|Treatment|Other (missing drug etc)|2
138907|NCT00461305|460225|P2|Treatment|Partially missing diary|0
138908|NCT00461305|460226|P1|Treatment|Partially missing diary|2
138909|NCT00461305|460225|P2|Treatment|Study drug not taken|0
138910|NCT00461305|460226|P1|Treatment|Study drug not taken|1
138911|NCT00461305|460225|P2|Treatment|Never dispensed|0
138912|NCT00461305|460226|P1|Treatment|Never dispensed|5
138913|NCT00461305|460225|P2|Treatment|Withdrawal by Subject|2
138914|NCT00461305|460226|P1|Treatment|Withdrawal by Subject|48
138915|NCT00461305|460225|P2|Treatment|Protocol Violation|2
138916|NCT00461305|460226|P1|Treatment|Protocol Violation|13
138917|NCT00461305|460225|P2|Treatment|Lost to Follow-up|2
138918|NCT00461305|460226|P1|Treatment|Lost to Follow-up|4
138919|NCT00461305|460225|P2|Treatment|Adverse Event|3
138920|NCT00461305|460226|P1|Treatment|Adverse Event|26
138921|NCT00461253|460310|P2|Overall Study|administrative|7773
138922|NCT00461253|460311|P1|Overall Study|administrative|773
138923|NCT00461253|460310|P2|Overall Study|no response|11789
138924|NCT00461253|460311|P1|Overall Study|no response|2609
138925|NCT00461253|460310|P2|Overall Study|Protocol Violation|236
138926|NCT00461253|460311|P1|Overall Study|Protocol Violation|613
138927|NCT00461253|460310|P2|Overall Study|Death|0
138928|NCT00461253|460311|P1|Overall Study|Death|985
138929|NCT00461175|460319|P2|Overall Study|Protocol Violation|365
138930|NCT00461175|460320|P1|Overall Study|Protocol Violation|522
138931|NCT00461123|460330|P2|Overall Study|Withdrawal by Subject|3
138932|NCT00461123|460331|P1|Overall Study|Withdrawal by Subject|1
138933|NCT00461123|460330|P2|Overall Study|Protocol Violation|2
138934|NCT00461123|460331|P1|Overall Study|Protocol Violation|3
138935|NCT00461123|460330|P2|Overall Study|Lost to Follow-up|1
138936|NCT00461123|460331|P1|Overall Study|Lost to Follow-up|1
138937|NCT00461123|460330|P2|Overall Study|Adverse Event|0
138938|NCT00461123|460331|P1|Overall Study|Adverse Event|1
138939|NCT00461032|460366|P2|Overall Study|Not Specified|5
138940|NCT00461032|460367|P1|Overall Study|Not Specified|7
138941|NCT00461032|460366|P2|Overall Study|Patient Moved or Relocated|1
138942|NCT00461032|460367|P1|Overall Study|Patient Moved or Relocated|2
138943|NCT00461032|460366|P2|Overall Study|Withdrawal by Subject|15
138944|NCT00461032|460367|P1|Overall Study|Withdrawal by Subject|7
138945|NCT00461032|460366|P2|Overall Study|Protocol Violation|4
138946|NCT00461032|460367|P1|Overall Study|Protocol Violation|4
138947|NCT00461032|460366|P2|Overall Study|Lost to Follow-up|12
138948|NCT00461032|460367|P1|Overall Study|Lost to Follow-up|7
138949|NCT00461032|460366|P2|Overall Study|Lack of Efficacy|1
138950|NCT00461032|460367|P1|Overall Study|Lack of Efficacy|5
138951|NCT00461032|460366|P2|Overall Study|Adverse Event|6
138952|NCT00461032|460367|P1|Overall Study|Adverse Event|5
138953|NCT00460811|460384|P5|Overall Study|Lost to Follow-up|6
138954|NCT00460811|460385|P4|Overall Study|Lost to Follow-up|3
138955|NCT00460811|460386|P3|Overall Study|Lost to Follow-up|5
138956|NCT00460811|460387|P2|Overall Study|Lost to Follow-up|2
138957|NCT00460811|460388|P1|Overall Study|Lost to Follow-up|3
138958|NCT00460811|460384|P5|Overall Study|Physician Decision|0
138959|NCT00460811|460385|P4|Overall Study|Physician Decision|0
138960|NCT00460811|460386|P3|Overall Study|Physician Decision|0
138961|NCT00460811|460387|P2|Overall Study|Physician Decision|0
138962|NCT00460811|460388|P1|Overall Study|Physician Decision|1
138963|NCT00460811|460384|P5|Overall Study|Withdrawal by Subject|11
138964|NCT00460811|460385|P4|Overall Study|Withdrawal by Subject|3
138965|NCT00460811|460386|P3|Overall Study|Withdrawal by Subject|6
138966|NCT00460811|460387|P2|Overall Study|Withdrawal by Subject|7
138967|NCT00460811|460388|P1|Overall Study|Withdrawal by Subject|7
138968|NCT00460811|460384|P5|Overall Study|Noncompliance|1
138969|NCT00460811|460385|P4|Overall Study|Noncompliance|2
138970|NCT00460811|460386|P3|Overall Study|Noncompliance|0
138971|NCT00460811|460387|P2|Overall Study|Noncompliance|0
138972|NCT00460811|460388|P1|Overall Study|Noncompliance|1
138973|NCT00460811|460384|P5|Overall Study|Adverse Event|2
138974|NCT00460811|460385|P4|Overall Study|Adverse Event|10
138975|NCT00460811|460386|P3|Overall Study|Adverse Event|3
138976|NCT00460811|460387|P2|Overall Study|Adverse Event|6
138977|NCT00460811|460388|P1|Overall Study|Adverse Event|4
138978|NCT00460798|460430|P1|Overall Study|Missing/Incomplete Dosing Information|27
138979|NCT00460798|460430|P1|Overall Study|Ongoing at Date of Cut-Off|82
138980|NCT00460798|460430|P1|Overall Study|Unspecified|27
138981|NCT00460798|460430|P1|Overall Study|Progressive Disease|99
138982|NCT00460798|460430|P1|Overall Study|Lost to Follow-up|19
138983|NCT00460798|460430|P1|Overall Study|Adverse Event|27
138984|NCT00460798|460430|P1|Overall Study|Death|59
138985|NCT00460746|460438|P1|Overall Study|Lost to Follow-up|1
138986|NCT00460746|460438|P1|Overall Study|Adverse Event|1
138987|NCT00460655|460453|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
138988|NCT00460655|460454|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
138989|NCT00460655|460455|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
138990|NCT00460655|460456|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
138991|NCT00460655|460453|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
138992|NCT00460655|460454|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
138993|NCT00460655|460455|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
138994|NCT00460655|460456|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
138995|NCT00460655|460453|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
138996|NCT00460655|460454|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
138997|NCT00460655|460455|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
138998|NCT00460655|460456|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
138999|NCT00460655|460453|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
139000|NCT00460655|460454|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
139001|NCT00460655|460455|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
139002|NCT00460655|460456|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
139003|NCT00460655|460453|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
139004|NCT00460655|460454|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
139005|NCT00460655|460455|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
139006|NCT00460655|460456|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
139007|NCT00460655|460453|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
139008|NCT00460655|460454|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
139009|NCT00460655|460455|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
139010|NCT00460655|460456|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
139011|NCT00460603|460500|P12|Phase 2|Randomized, but not treated|0
139012|NCT00460603|460501|P11|Phase 2|Randomized, but not treated|0
139013|NCT00460603|460502|P10|Phase 2|Randomized, but not treated|3
139014|NCT00460603|460503|P9|Phase 2|Randomized, but not treated|0
139015|NCT00460603|460504|P8|Phase 2|Randomized, but not treated|0
139016|NCT00460603|460505|P7|Phase 2|Randomized, but not treated|0
139017|NCT00460603|460506|P6|Phase 2|Randomized, but not treated|0
139018|NCT00460603|460507|P5|Phase 2|Randomized, but not treated|0
139019|NCT00460603|460508|P4|Phase 2|Randomized, but not treated|0
139020|NCT00460603|460509|P3|Phase 2|Randomized, but not treated|0
139021|NCT00460603|460510|P2|Phase 2|Randomized, but not treated|0
139022|NCT00460603|460511|P1|Phase 2|Randomized, but not treated|0
139023|NCT00460603|460500|P12|Phase 2|Withdrawal by Subject|5
139024|NCT00460603|460501|P11|Phase 2|Withdrawal by Subject|4
139025|NCT00460603|460502|P10|Phase 2|Withdrawal by Subject|5
139026|NCT00460603|460503|P9|Phase 2|Withdrawal by Subject|0
139027|NCT00460603|460504|P8|Phase 2|Withdrawal by Subject|0
139028|NCT00460603|460505|P7|Phase 2|Withdrawal by Subject|0
139029|NCT00460603|460506|P6|Phase 2|Withdrawal by Subject|0
139030|NCT00460603|460507|P5|Phase 2|Withdrawal by Subject|0
139031|NCT00460603|460508|P4|Phase 2|Withdrawal by Subject|0
139032|NCT00460603|460509|P3|Phase 2|Withdrawal by Subject|0
139033|NCT00460603|460510|P2|Phase 2|Withdrawal by Subject|0
139034|NCT00460603|460511|P1|Phase 2|Withdrawal by Subject|0
139035|NCT00460603|460500|P12|Phase 2|Global Deterioration of Health Status|0
139036|NCT00460603|460501|P11|Phase 2|Global Deterioration of Health Status|1
139037|NCT00460603|460502|P10|Phase 2|Global Deterioration of Health Status|0
139038|NCT00460603|460503|P9|Phase 2|Global Deterioration of Health Status|0
139039|NCT00460603|460504|P8|Phase 2|Global Deterioration of Health Status|0
139040|NCT00460603|460505|P7|Phase 2|Global Deterioration of Health Status|0
139041|NCT00460603|460506|P6|Phase 2|Global Deterioration of Health Status|0
139042|NCT00460603|460507|P5|Phase 2|Global Deterioration of Health Status|0
139043|NCT00460603|460508|P4|Phase 2|Global Deterioration of Health Status|0
139044|NCT00460603|460509|P3|Phase 2|Global Deterioration of Health Status|0
139045|NCT00460603|460510|P2|Phase 2|Global Deterioration of Health Status|0
139046|NCT00460603|460511|P1|Phase 2|Global Deterioration of Health Status|0
139047|NCT00460603|460500|P12|Phase 2|Objective Progression or Relapse|17
139048|NCT00460603|460501|P11|Phase 2|Objective Progression or Relapse|10
139049|NCT00460603|460502|P10|Phase 2|Objective Progression or Relapse|9
139050|NCT00460603|460503|P9|Phase 2|Objective Progression or Relapse|0
139051|NCT00460603|460504|P8|Phase 2|Objective Progression or Relapse|0
139052|NCT00460603|460505|P7|Phase 2|Objective Progression or Relapse|0
139053|NCT00460603|460506|P6|Phase 2|Objective Progression or Relapse|0
139054|NCT00460603|460507|P5|Phase 2|Objective Progression or Relapse|0
139055|NCT00460603|460508|P4|Phase 2|Objective Progression or Relapse|0
139056|NCT00460603|460509|P3|Phase 2|Objective Progression or Relapse|0
139057|NCT00460603|460510|P2|Phase 2|Objective Progression or Relapse|0
139058|NCT00460603|460511|P1|Phase 2|Objective Progression or Relapse|0
139059|NCT00460603|460500|P12|Phase 2|Unspecified|7
139060|NCT00460603|460501|P11|Phase 2|Unspecified|16
139061|NCT00460603|460502|P10|Phase 2|Unspecified|6
139062|NCT00460603|460503|P9|Phase 2|Unspecified|0
139063|NCT00460603|460504|P8|Phase 2|Unspecified|0
139064|NCT00460603|460505|P7|Phase 2|Unspecified|0
139065|NCT00460603|460506|P6|Phase 2|Unspecified|0
139066|NCT00460603|460507|P5|Phase 2|Unspecified|0
139067|NCT00460603|460508|P4|Phase 2|Unspecified|0
139068|NCT00460603|460509|P3|Phase 2|Unspecified|0
139069|NCT00460603|460510|P2|Phase 2|Unspecified|0
139070|NCT00460603|460511|P1|Phase 2|Unspecified|0
139071|NCT00460603|460500|P12|Phase 2|Lost to Follow-up|0
139072|NCT00460603|460501|P11|Phase 2|Lost to Follow-up|0
139073|NCT00460603|460502|P10|Phase 2|Lost to Follow-up|1
139074|NCT00460603|460503|P9|Phase 2|Lost to Follow-up|0
139075|NCT00460603|460504|P8|Phase 2|Lost to Follow-up|0
139076|NCT00460603|460505|P7|Phase 2|Lost to Follow-up|0
139077|NCT00460603|460506|P6|Phase 2|Lost to Follow-up|0
139078|NCT00460603|460507|P5|Phase 2|Lost to Follow-up|0
139079|NCT00460603|460508|P4|Phase 2|Lost to Follow-up|0
139080|NCT00460603|460509|P3|Phase 2|Lost to Follow-up|0
139081|NCT00460603|460510|P2|Phase 2|Lost to Follow-up|0
139082|NCT00460603|460511|P1|Phase 2|Lost to Follow-up|0
139083|NCT00460603|460500|P12|Phase 2|Protocol Violation|0
139084|NCT00460603|460501|P11|Phase 2|Protocol Violation|1
139085|NCT00460603|460502|P10|Phase 2|Protocol Violation|1
139086|NCT00460603|460503|P9|Phase 2|Protocol Violation|0
139087|NCT00460603|460504|P8|Phase 2|Protocol Violation|0
139088|NCT00460603|460505|P7|Phase 2|Protocol Violation|0
139089|NCT00460603|460506|P6|Phase 2|Protocol Violation|0
139090|NCT00460603|460507|P5|Phase 2|Protocol Violation|0
139091|NCT00460603|460508|P4|Phase 2|Protocol Violation|0
139092|NCT00460603|460509|P3|Phase 2|Protocol Violation|0
139093|NCT00460603|460510|P2|Phase 2|Protocol Violation|0
139094|NCT00460603|460511|P1|Phase 2|Protocol Violation|0
139095|NCT00460603|460500|P12|Phase 2|Death|2
139096|NCT00460603|460501|P11|Phase 2|Death|2
139097|NCT00460603|460502|P10|Phase 2|Death|4
139098|NCT00460603|460503|P9|Phase 2|Death|0
139099|NCT00460603|460504|P8|Phase 2|Death|0
139100|NCT00460603|460505|P7|Phase 2|Death|0
139101|NCT00460603|460506|P6|Phase 2|Death|0
139102|NCT00460603|460507|P5|Phase 2|Death|0
139103|NCT00460603|460508|P4|Phase 2|Death|0
139104|NCT00460603|460509|P3|Phase 2|Death|0
139105|NCT00460603|460510|P2|Phase 2|Death|0
139106|NCT00460603|460511|P1|Phase 2|Death|0
139107|NCT00460603|460500|P12|Phase 2|Adverse Event|10
139108|NCT00460603|460501|P11|Phase 2|Adverse Event|9
139109|NCT00460603|460502|P10|Phase 2|Adverse Event|12
139110|NCT00460603|460503|P9|Phase 2|Adverse Event|0
139111|NCT00460603|460504|P8|Phase 2|Adverse Event|0
139112|NCT00460603|460505|P7|Phase 2|Adverse Event|0
139113|NCT00460603|460506|P6|Phase 2|Adverse Event|0
139114|NCT00460603|460507|P5|Phase 2|Adverse Event|0
139115|NCT00460603|460508|P4|Phase 2|Adverse Event|0
139116|NCT00460603|460509|P3|Phase 2|Adverse Event|0
139117|NCT00460603|460510|P2|Phase 2|Adverse Event|0
139118|NCT00460603|460511|P1|Phase 2|Adverse Event|0
139119|NCT00460603|460500|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
139120|NCT00460603|460501|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
139121|NCT00460603|460502|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
139122|NCT00460603|460503|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
139123|NCT00460603|460504|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
139124|NCT00460603|460505|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
139125|NCT00460603|460506|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
139126|NCT00460603|460507|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
139127|NCT00460603|460508|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
139128|NCT00460603|460509|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
139129|NCT00460603|460510|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
139130|NCT00460603|460511|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
139131|NCT00460603|460500|P12|Phase 1|Unspecified|0
139132|NCT00460603|460501|P11|Phase 1|Unspecified|0
139133|NCT00460603|460502|P10|Phase 1|Unspecified|0
139134|NCT00460603|460503|P9|Phase 1|Unspecified|0
139135|NCT00460603|460504|P8|Phase 1|Unspecified|1
139136|NCT00460603|460505|P7|Phase 1|Unspecified|0
139137|NCT00460603|460506|P6|Phase 1|Unspecified|2
139138|NCT00460603|460507|P5|Phase 1|Unspecified|1
139139|NCT00460603|460508|P4|Phase 1|Unspecified|1
139140|NCT00460603|460509|P3|Phase 1|Unspecified|1
139141|NCT00460603|460510|P2|Phase 1|Unspecified|3
139142|NCT00460603|460511|P1|Phase 1|Unspecified|0
139143|NCT00460603|460500|P12|Phase 1|Withdrawal by Subject|0
139144|NCT00460603|460501|P11|Phase 1|Withdrawal by Subject|0
139145|NCT00460603|460502|P10|Phase 1|Withdrawal by Subject|0
139146|NCT00460603|460503|P9|Phase 1|Withdrawal by Subject|2
139147|NCT00460603|460504|P8|Phase 1|Withdrawal by Subject|0
139148|NCT00460603|460505|P7|Phase 1|Withdrawal by Subject|1
139149|NCT00460603|460506|P6|Phase 1|Withdrawal by Subject|0
139150|NCT00460603|460507|P5|Phase 1|Withdrawal by Subject|3
139151|NCT00460603|460508|P4|Phase 1|Withdrawal by Subject|1
139152|NCT00460603|460509|P3|Phase 1|Withdrawal by Subject|1
139153|NCT00460603|460510|P2|Phase 1|Withdrawal by Subject|2
139154|NCT00460603|460511|P1|Phase 1|Withdrawal by Subject|1
139155|NCT00460603|460500|P12|Phase 1|Lack of Efficacy|0
139156|NCT00460603|460501|P11|Phase 1|Lack of Efficacy|0
139157|NCT00460603|460502|P10|Phase 1|Lack of Efficacy|0
139158|NCT00460603|460503|P9|Phase 1|Lack of Efficacy|11
139159|NCT00460603|460504|P8|Phase 1|Lack of Efficacy|2
139160|NCT00460603|460505|P7|Phase 1|Lack of Efficacy|2
139161|NCT00460603|460506|P6|Phase 1|Lack of Efficacy|2
139162|NCT00460603|460507|P5|Phase 1|Lack of Efficacy|2
139163|NCT00460603|460508|P4|Phase 1|Lack of Efficacy|2
139164|NCT00460603|460509|P3|Phase 1|Lack of Efficacy|1
139165|NCT00460603|460510|P2|Phase 1|Lack of Efficacy|0
139166|NCT00460603|460511|P1|Phase 1|Lack of Efficacy|1
139167|NCT00460603|460500|P12|Phase 1|Adverse Event|0
139168|NCT00460603|460501|P11|Phase 1|Adverse Event|0
139169|NCT00460603|460502|P10|Phase 1|Adverse Event|0
139170|NCT00460603|460503|P9|Phase 1|Adverse Event|4
139171|NCT00460603|460504|P8|Phase 1|Adverse Event|0
139172|NCT00460603|460505|P7|Phase 1|Adverse Event|3
139173|NCT00460603|460506|P6|Phase 1|Adverse Event|0
139174|NCT00460603|460507|P5|Phase 1|Adverse Event|0
139175|NCT00460603|460508|P4|Phase 1|Adverse Event|2
139176|NCT00460603|460509|P3|Phase 1|Adverse Event|1
139177|NCT00460603|460510|P2|Phase 1|Adverse Event|1
139178|NCT00460603|460511|P1|Phase 1|Adverse Event|3
139179|NCT00460603|460500|P12|Phase 1|Death|0
139180|NCT00460603|460501|P11|Phase 1|Death|0
139181|NCT00460603|460502|P10|Phase 1|Death|0
139182|NCT00460603|460503|P9|Phase 1|Death|1
139183|NCT00460603|460504|P8|Phase 1|Death|0
139184|NCT00460603|460505|P7|Phase 1|Death|0
139185|NCT00460603|460506|P6|Phase 1|Death|0
139186|NCT00460603|460507|P5|Phase 1|Death|0
139187|NCT00460603|460508|P4|Phase 1|Death|2
139188|NCT00460603|460509|P3|Phase 1|Death|0
139189|NCT00460603|460510|P2|Phase 1|Death|0
139190|NCT00460603|460511|P1|Phase 1|Death|1
139191|NCT00460577|460605|P2|Overall Study|Protocol Violation|6
139192|NCT00460577|460606|P1|Overall Study|Protocol Violation|2
139193|NCT00460564|460624|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
139194|NCT00460564|460625|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
139195|NCT00460564|460626|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
139196|NCT00460564|460627|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
139197|NCT00460564|460628|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
139198|NCT00460564|460629|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
139199|NCT00460564|460630|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
139200|NCT00460564|460631|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
139201|NCT00460564|460624|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
139202|NCT00460564|460625|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
139203|NCT00460564|460626|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
139204|NCT00460564|460627|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
139205|NCT00460564|460628|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
139206|NCT00460564|460629|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
139207|NCT00460564|460630|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
139208|NCT00460564|460631|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
139209|NCT00460564|460624|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
139210|NCT00460564|460625|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
139211|NCT00460564|460626|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
139212|NCT00460564|460627|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
139213|NCT00460564|460628|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
139214|NCT00460564|460629|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
139215|NCT00460564|460630|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
139216|NCT00460564|460631|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
139217|NCT00460564|460624|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
139218|NCT00460564|460625|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
139219|NCT00460564|460626|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
139220|NCT00460564|460627|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
139221|NCT00460564|460628|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
139222|NCT00460564|460629|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
139223|NCT00460564|460630|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
139224|NCT00460564|460631|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
139225|NCT00460564|460624|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
139226|NCT00460564|460625|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
139227|NCT00460564|460626|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
139228|NCT00460564|460627|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
139229|NCT00460564|460628|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
139230|NCT00460564|460629|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
139231|NCT00460564|460630|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
139232|NCT00460564|460631|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
139233|NCT00460408|460826|P4|Overall Study|Unspecified|0
139234|NCT00460408|460827|P3|Overall Study|Unspecified|0
139235|NCT00460408|460828|P2|Overall Study|Unspecified|2
139236|NCT00460408|460829|P1|Overall Study|Unspecified|12
139237|NCT00460408|460826|P4|Overall Study|Insufficient clinical response|0
139238|NCT00460408|460827|P3|Overall Study|Insufficient clinical response|5
139239|NCT00460408|460828|P2|Overall Study|Insufficient clinical response|1
139240|NCT00460408|460829|P1|Overall Study|Insufficient clinical response|5
139241|NCT00460408|460826|P4|Overall Study|Withdrawal by Subject|0
139242|NCT00460408|460827|P3|Overall Study|Withdrawal by Subject|0
139243|NCT00460408|460828|P2|Overall Study|Withdrawal by Subject|0
139244|NCT00460408|460829|P1|Overall Study|Withdrawal by Subject|31
139245|NCT00460408|460826|P4|Overall Study|Lost to Follow-up|0
139246|NCT00460408|460827|P3|Overall Study|Lost to Follow-up|1
139247|NCT00460408|460828|P2|Overall Study|Lost to Follow-up|0
139248|NCT00460408|460829|P1|Overall Study|Lost to Follow-up|11
139249|NCT00460408|460826|P4|Overall Study|Death|0
139250|NCT00460408|460827|P3|Overall Study|Death|0
139251|NCT00460408|460828|P2|Overall Study|Death|0
139252|NCT00460408|460829|P1|Overall Study|Death|7
139253|NCT00460408|460826|P4|Overall Study|Adverse Event|0
139254|NCT00460408|460827|P3|Overall Study|Adverse Event|0
139255|NCT00460408|460828|P2|Overall Study|Adverse Event|0
139256|NCT00460408|460829|P1|Overall Study|Adverse Event|1
139257|NCT00460265|460866|P2|Overall Study|Ongoing|47
139258|NCT00460265|460867|P1|Overall Study|Ongoing|60
139259|NCT00460265|460866|P2|Overall Study|Withdrawal by Subject|25
139260|NCT00460265|460867|P1|Overall Study|Withdrawal by Subject|10
139261|NCT00460265|460866|P2|Overall Study|Physician Decision|2
139262|NCT00460265|460867|P1|Overall Study|Physician Decision|1
139263|NCT00460265|460866|P2|Overall Study|Lost to Follow-up|15
139264|NCT00460265|460867|P1|Overall Study|Lost to Follow-up|14
139265|NCT00460031|460883|P1|Overall Study|Death|1
139266|NCT00460031|460883|P1|Overall Study|Withdrawal by Subject|5
139267|NCT00460031|460883|P1|Overall Study|Adverse Event|5
139268|NCT00459979|460891|P1|Overall Study|Protocol Violation|1
139269|NCT00459979|460891|P1|Overall Study|Withdrawal by Subject|1
139270|NCT00459953|460903|P2|Overall Study|not analyzed-household member in study|1
139271|NCT00459953|460904|P1|Overall Study|not analyzed-household member in study|1
139272|NCT00459875|460910|P1|Overall Study|Adverse Event|2
139273|NCT00459875|460910|P1|Overall Study|Ineligible participant|1
139274|NCT00459706|460946|P2|Overall Study|Unspecified|1
139275|NCT00459706|460947|P1|Overall Study|Unspecified|0
139276|NCT00459706|460946|P2|Overall Study|Failed to Return|0
139277|NCT00459706|460947|P1|Overall Study|Failed to Return|1
139278|NCT00459706|460946|P2|Overall Study|Protocol Violation|1
139279|NCT00459706|460947|P1|Overall Study|Protocol Violation|2
139280|NCT00459706|460946|P2|Overall Study|Discontinuation of Study by Sponsor|0
139281|NCT00459706|460947|P1|Overall Study|Discontinuation of Study by Sponsor|1
139282|NCT00459706|460946|P2|Overall Study|Physician Decision|0
139283|NCT00459706|460947|P1|Overall Study|Physician Decision|2
139284|NCT00459706|460946|P2|Overall Study|Withdrawal by Subject|6
139285|NCT00459706|460947|P1|Overall Study|Withdrawal by Subject|1
139286|NCT00459706|460946|P2|Overall Study|Adverse Event|13
139287|NCT00459706|460947|P1|Overall Study|Adverse Event|19
139288|NCT00459667|461090|P3|Overall Study|No treatment administered|1
139289|NCT00459667|461091|P2|Overall Study|No treatment administered|3
139290|NCT00459667|461092|P1|Overall Study|No treatment administered|6
139291|NCT00459667|461090|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
139292|NCT00459667|461091|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
139293|NCT00459667|461092|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
139294|NCT00459667|461090|P3|Overall Study|Other disease modifying treatment|1
139295|NCT00459667|461091|P2|Overall Study|Other disease modifying treatment|2
139296|NCT00459667|461092|P1|Overall Study|Other disease modifying treatment|1
139297|NCT00459667|461090|P3|Overall Study|Withdrawal by Subject|5
139298|NCT00459667|461091|P2|Overall Study|Withdrawal by Subject|5
139299|NCT00459667|461092|P1|Overall Study|Withdrawal by Subject|3
139300|NCT00459667|461090|P3|Overall Study|Protocol Violation|0
139301|NCT00459667|461091|P2|Overall Study|Protocol Violation|0
139302|NCT00459667|461092|P1|Overall Study|Protocol Violation|1
139303|NCT00459667|461090|P3|Overall Study|Pregnancy|1
139304|NCT00459667|461091|P2|Overall Study|Pregnancy|1
139305|NCT00459667|461092|P1|Overall Study|Pregnancy|1
139306|NCT00459667|461090|P3|Overall Study|Lost to Follow-up|3
139307|NCT00459667|461091|P2|Overall Study|Lost to Follow-up|9
139308|NCT00459667|461092|P1|Overall Study|Lost to Follow-up|5
139309|NCT00459667|461090|P3|Overall Study|Adverse Event|8
139310|NCT00459667|461091|P2|Overall Study|Adverse Event|12
139311|NCT00459667|461092|P1|Overall Study|Adverse Event|9
139312|NCT00459537|461114|P2|Overall Study|Missing|0
139313|NCT00459537|461115|P1|Overall Study|Missing|1
139314|NCT00459537|461114|P2|Overall Study|Protocol Violation|3
139315|NCT00459537|461115|P1|Overall Study|Protocol Violation|4
139316|NCT00459537|461114|P2|Overall Study|Administrative problems|0
139317|NCT00459537|461115|P1|Overall Study|Administrative problems|3
139318|NCT00459537|461114|P2|Overall Study|Lost to Follow-up|30
139319|NCT00459537|461115|P1|Overall Study|Lost to Follow-up|27
139320|NCT00459537|461114|P2|Overall Study|Withdrawal by Subject|26
139321|NCT00459537|461115|P1|Overall Study|Withdrawal by Subject|20
139322|NCT00459537|461114|P2|Overall Study|Lack of Efficacy|11
139323|NCT00459537|461115|P1|Overall Study|Lack of Efficacy|10
139324|NCT00459537|461114|P2|Overall Study|Adverse Event|6
139325|NCT00459537|461115|P1|Overall Study|Adverse Event|1
139326|NCT00459355|461140|P2|Overall Study|Subject no longer met inc criteria|18
139327|NCT00459355|461141|P1|Overall Study|Subject no longer met inc criteria|20
139328|NCT00459342|461153|P1|Overall Study|Not eligible|1
139329|NCT00459316|461162|P3|Step 3|Withdrawal by Subject|1
139330|NCT00459316|461163|P2|Step 3|Withdrawal by Subject|0
139331|NCT00459316|461164|P1|Step 3|Withdrawal by Subject|3
139332|NCT00459316|461162|P3|Steps 1 & 2|Lost to Follow-up|2
139333|NCT00459316|461163|P2|Steps 1 & 2|Lost to Follow-up|0
139334|NCT00459316|461164|P1|Steps 1 & 2|Lost to Follow-up|5
139335|NCT00459316|461162|P3|Steps 1 & 2|Not willing to adhere to regulations|0
139336|NCT00459316|461163|P2|Steps 1 & 2|Not willing to adhere to regulations|0
139337|NCT00459316|461164|P1|Steps 1 & 2|Not willing to adhere to regulations|1
139338|NCT00459316|461162|P3|Steps 1 & 2|Withdrawal by Subject|0
139339|NCT00459316|461163|P2|Steps 1 & 2|Withdrawal by Subject|1
139340|NCT00459316|461164|P1|Steps 1 & 2|Withdrawal by Subject|6
139341|NCT00459316|461162|P3|Steps 1 & 2|Not able to get to clinic|0
139342|NCT00459316|461163|P2|Steps 1 & 2|Not able to get to clinic|4
139343|NCT00459316|461164|P1|Steps 1 & 2|Not able to get to clinic|7
139344|NCT00459316|461162|P3|Steps 1 & 2|Death|0
139345|NCT00459316|461163|P2|Steps 1 & 2|Death|1
139346|NCT00459316|461164|P1|Steps 1 & 2|Death|1
139347|NCT00459316|461162|P3|Steps 1 & 2|Other eligibility failure|0
139348|NCT00459316|461163|P2|Steps 1 & 2|Other eligibility failure|1
139349|NCT00459316|461164|P1|Steps 1 & 2|Other eligibility failure|1
139350|NCT00459290|461229|P1|Overall Study|Ineligible|2
139351|NCT00459290|461229|P1|Overall Study|Adverse Event|3
139352|NCT00459186|461243|P1|PET Imaging and Assessment|Adverse Event|3
139353|NCT00459186|461243|P1|Single Agent RAD001|Withdrawal by Subject|1
139354|NCT00459134|461250|P2|Overall Study|Multiple Reasons|3
139355|NCT00459134|461251|P1|Overall Study|Multiple Reasons|2
139356|NCT00459134|461250|P2|Overall Study|Progression|0
139357|NCT00459134|461251|P1|Overall Study|Progression|1
139358|NCT00459134|461250|P2|Overall Study|Toxicity|5
139359|NCT00459134|461251|P1|Overall Study|Toxicity|4
139360|NCT00459134|461250|P2|Overall Study|Surgery|2
139361|NCT00459134|461251|P1|Overall Study|Surgery|1
139362|NCT00459134|461250|P2|Overall Study|Lost to Follow-up|7
139363|NCT00459134|461251|P1|Overall Study|Lost to Follow-up|6
139364|NCT00459134|461250|P2|Overall Study|Withdrawal by Subject|7
139365|NCT00459134|461251|P1|Overall Study|Withdrawal by Subject|8
139366|NCT00459134|461250|P2|Overall Study|Physician Decision|1
139367|NCT00459134|461251|P1|Overall Study|Physician Decision|1
139368|NCT00459108|461263|P1|Overall Study|Progression|1
139369|NCT00459108|461263|P1|Overall Study|Death|2
139370|NCT00459108|461263|P1|Overall Study|Adverse Event|3
139371|NCT00459108|461263|P1|Overall Study|Withdrawal by Subject|5
139372|NCT00459056|461270|P2|First Intervention (First Three Months)|Lost to Follow-up|1
139373|NCT00459056|461271|P1|First Intervention (First Three Months)|Lost to Follow-up|1
139374|NCT00459043|461279|P2|Overall Study|Withdrawal by Subject|0
139375|NCT00459043|461280|P1|Overall Study|Withdrawal by Subject|1
139376|NCT00458705|461301|P1|Overall Study|Not Treated|1
139377|NCT00458705|461301|P1|Overall Study|Adverse Event|4
139378|NCT00458536|461305|P1|Overall Study|Progressive disease during treatment|2
139379|NCT00458536|461305|P1|Overall Study|Withdrawal by Subject|1
139380|NCT00458536|461305|P1|Overall Study|Ineligible due to toxicity|1
139381|NCT00458536|461305|P1|Overall Study|Patient did not have surgery|1
139382|NCT00458536|461305|P1|Overall Study|Did not have renal cell carcinoma|2
139383|NCT00458536|461305|P1|Overall Study|No measurable disease after surgery|2
139384|NCT00458536|461305|P1|Overall Study|Unable to make vaccine|3
139385|NCT00458536|461305|P1|Overall Study|Disease progression prior to treatment|7
139386|NCT00458302|461332|P2|Overall Study|Other|2
139387|NCT00458302|461333|P1|Overall Study|Other|4
139388|NCT00458302|461332|P2|Overall Study|Lost to Follow-up|0
139389|NCT00458302|461333|P1|Overall Study|Lost to Follow-up|2
139390|NCT00458302|461332|P2|Overall Study|Study Termination By Sponsor|0
139391|NCT00458302|461333|P1|Overall Study|Study Termination By Sponsor|1
139392|NCT00458302|461332|P2|Overall Study|Inc/Exc Criteria Not Met|1
139393|NCT00458302|461333|P1|Overall Study|Inc/Exc Criteria Not Met|1
139394|NCT00458302|461332|P2|Overall Study|Withdrawal by Subject|4
139395|NCT00458302|461333|P1|Overall Study|Withdrawal by Subject|6
139396|NCT00458302|461332|P2|Overall Study|Protocol Violation|2
139397|NCT00458302|461333|P1|Overall Study|Protocol Violation|0
139398|NCT00458302|461332|P2|Overall Study|Pregnancy|1
139399|NCT00458302|461333|P1|Overall Study|Pregnancy|2
139400|NCT00458302|461332|P2|Overall Study|Adverse Event|14
139401|NCT00458302|461333|P1|Overall Study|Adverse Event|4
139402|NCT00458211|461378|P1|Overall Study|Protocol Violation|2
139403|NCT00458211|461378|P1|Overall Study|Withdrawal by Subject|2
139404|NCT00458211|461378|P1|Overall Study|Lack of Efficacy|12
139405|NCT00457821|461420|P8|Part 2|Withdrawal by Subject|1
139406|NCT00457821|461421|P7|Part 2|Withdrawal by Subject|0
139407|NCT00457821|461422|P6|Part 2|Withdrawal by Subject|0
139408|NCT00457821|461423|P5|Part 2|Withdrawal by Subject|0
139409|NCT00457821|461424|P4|Part 2|Withdrawal by Subject|0
139410|NCT00457821|461425|P3|Part 2|Withdrawal by Subject|0
139411|NCT00457821|461426|P2|Part 2|Withdrawal by Subject|0
139412|NCT00457821|461427|P1|Part 2|Withdrawal by Subject|0
139413|NCT00457743|461466|P3|Overall Study|Lack of Efficacy|3
139414|NCT00457743|461467|P2|Overall Study|Lack of Efficacy|23
139415|NCT00457743|461468|P1|Overall Study|Lack of Efficacy|3
139416|NCT00457743|461466|P3|Overall Study|Adverse Event|0
139417|NCT00457743|461467|P2|Overall Study|Adverse Event|4
139418|NCT00457743|461468|P1|Overall Study|Adverse Event|0
139419|NCT00457691|461525|P2|Overall Study|Disease progression, study terminated|196
139420|NCT00457691|461526|P1|Overall Study|Disease progression, study terminated|180
139421|NCT00457691|461525|P2|Overall Study|Subject refused (reason other than AE)|19
139422|NCT00457691|461526|P1|Overall Study|Subject refused (reason other than AE)|14
139423|NCT00457691|461525|P2|Overall Study|Study terminated by Sponsor|1
139424|NCT00457691|461526|P1|Overall Study|Study terminated by Sponsor|1
139425|NCT00457691|461525|P2|Overall Study|Lost to Follow-up|14
139426|NCT00457691|461526|P1|Overall Study|Lost to Follow-up|23
139427|NCT00457691|461525|P2|Overall Study|Protocol Violation|3
139428|NCT00457691|461526|P1|Overall Study|Protocol Violation|1
139429|NCT00457691|461525|P2|Overall Study|Death|148
139430|NCT00457691|461526|P1|Overall Study|Death|163
139431|NCT00457691|461525|P2|Overall Study|Adverse Event|1
139432|NCT00457691|461526|P1|Overall Study|Adverse Event|4
139433|NCT00456521|461563|P2|Overall Study|Drug non-compliance, moved, other|11
139434|NCT00456521|461564|P1|Overall Study|Drug non-compliance, moved, other|26
139435|NCT00456521|461563|P2|Overall Study|Pregnancy|1
139436|NCT00456521|461564|P1|Overall Study|Pregnancy|1
139437|NCT00456521|461563|P2|Overall Study|Protocol Violation|0
139438|NCT00456521|461564|P1|Overall Study|Protocol Violation|4
139439|NCT00456521|461563|P2|Overall Study|Lack of Efficacy|6
139440|NCT00456521|461564|P1|Overall Study|Lack of Efficacy|3
139441|NCT00456521|461563|P2|Overall Study|Lost to Follow-up|17
139442|NCT00456521|461564|P1|Overall Study|Lost to Follow-up|22
139443|NCT00456521|461563|P2|Overall Study|Withdrawal by Subject|24
139444|NCT00456521|461564|P1|Overall Study|Withdrawal by Subject|43
139445|NCT00456521|461563|P2|Overall Study|Adverse Event|25
139446|NCT00456521|461564|P1|Overall Study|Adverse Event|150
139447|NCT00456495|461610|P1|Overall Study|Physician Decision|2
139448|NCT00457418|461614|P1|Post PK Maintenance|Lost to Follow-up|1
139449|NCT00457418|461614|P1|Post PK Maintenance|Withdrawal by Subject|11
139450|NCT00457418|461614|P1|Post PK Maintenance|Progression of Disease|6
139451|NCT00457418|461614|P1|Post PK Maintenance|Adverse Event|10
139452|NCT00457418|461614|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
139453|NCT00457418|461614|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
139454|NCT00457418|461614|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
139455|NCT00457392|461626|P2|Overall Study|Randomized, Not Treated|3
139456|NCT00457392|461627|P1|Overall Study|Randomized, Not Treated|7
139457|NCT00457392|461626|P2|Overall Study|Study Terminated by Sponsor|4
139458|NCT00457392|461627|P1|Overall Study|Study Terminated by Sponsor|1
139459|NCT00457392|461626|P2|Overall Study|Unspecified|4
139460|NCT00457392|461627|P1|Overall Study|Unspecified|7
139461|NCT00457392|461626|P2|Overall Study|Protocol Violation|3
139462|NCT00457392|461627|P1|Overall Study|Protocol Violation|4
139463|NCT00457392|461626|P2|Overall Study|Lost to Follow-up|7
139464|NCT00457392|461627|P1|Overall Study|Lost to Follow-up|6
139465|NCT00457392|461626|P2|Overall Study|Withdrawal by Subject|8
139466|NCT00457392|461627|P1|Overall Study|Withdrawal by Subject|14
139467|NCT00457392|461626|P2|Overall Study|Global Deterioration of Health Status|8
139468|NCT00457392|461627|P1|Overall Study|Global Deterioration of Health Status|22
139469|NCT00457392|461626|P2|Overall Study|Adverse Event|41
139470|NCT00457392|461627|P1|Overall Study|Adverse Event|84
139471|NCT00457392|461626|P2|Overall Study|Death|106
139472|NCT00457392|461627|P1|Overall Study|Death|106
139473|NCT00457392|461626|P2|Overall Study|Objective Progression or Relapse|296
139474|NCT00457392|461627|P1|Overall Study|Objective Progression or Relapse|229
139475|NCT00457301|461645|P2|Overall Study|Death|7
139476|NCT00457301|461646|P1|Overall Study|Death|5
139477|NCT00457301|461645|P2|Overall Study|Censored out of the study|14
139478|NCT00457301|461646|P1|Overall Study|Censored out of the study|15
139479|NCT00457301|461645|P2|Overall Study|Withdrawal by Subject|3
139480|NCT00457301|461646|P1|Overall Study|Withdrawal by Subject|3
139481|NCT00457249|461660|P2|Overall Study|Serious Adverse Events|0
139482|NCT00457249|461661|P1|Overall Study|Serious Adverse Events|2
139483|NCT00457249|461660|P2|Overall Study|Withdrawal by Subject|1
139484|NCT00457249|461661|P1|Overall Study|Withdrawal by Subject|3
139485|NCT00457249|461660|P2|Overall Study|Protocol Violation|1
139486|NCT00457249|461661|P1|Overall Study|Protocol Violation|4
139487|NCT00457249|461660|P2|Overall Study|Lost to Follow-up|0
139488|NCT00457249|461661|P1|Overall Study|Lost to Follow-up|3
139489|NCT00457015|461700|P2|Overall Study|Left study site against medical advice|1
139490|NCT00457015|461701|P1|Overall Study|Left study site against medical advice|0
139491|NCT00457002|461717|P2|Overall Study|treated for 1 day; missing status/reason|0
139492|NCT00457002|461718|P1|Overall Study|treated for 1 day; missing status/reason|1
139493|NCT00457002|461717|P2|Overall Study|non-specified|38
139494|NCT00457002|461718|P1|Overall Study|non-specified|29
139495|NCT00457002|461717|P2|Overall Study|Administrative reason by Sponsor|0
139496|NCT00457002|461718|P1|Overall Study|Administrative reason by Sponsor|1
139497|NCT00457002|461717|P2|Overall Study|No longer met criteria|37
139498|NCT00457002|461718|P1|Overall Study|No longer met criteria|41
139499|NCT00457002|461717|P2|Overall Study|Poor/Non-compliance|33
139500|NCT00457002|461718|P1|Overall Study|Poor/Non-compliance|46
139501|NCT00457002|461717|P2|Overall Study|Lost to Follow-up|71
139502|NCT00457002|461718|P1|Overall Study|Lost to Follow-up|72
139503|NCT00457002|461717|P2|Overall Study|Withdrawal by Subject|271
139504|NCT00457002|461718|P1|Overall Study|Withdrawal by Subject|299
139505|NCT00457002|461717|P2|Overall Study|Adverse Event|260
139506|NCT00457002|461718|P1|Overall Study|Adverse Event|284
139507|NCT00457002|461717|P2|Overall Study|Death|47
139508|NCT00457002|461718|P1|Overall Study|Death|40
139509|NCT00456846|461792|P2|Overall Study|Unspecified|2
139510|NCT00456846|461793|P1|Overall Study|Unspecified|0
139511|NCT00456846|461792|P2|Overall Study|Participant Discretion|5
139512|NCT00456846|461793|P1|Overall Study|Participant Discretion|1
139513|NCT00456846|461792|P2|Overall Study|Protocol Deviation|0
139514|NCT00456846|461793|P1|Overall Study|Protocol Deviation|2
139515|NCT00456846|461792|P2|Overall Study|Physician Decision|6
139516|NCT00456846|461793|P1|Overall Study|Physician Decision|11
139517|NCT00456846|461792|P2|Overall Study|Adverse Event|15
139518|NCT00456846|461793|P1|Overall Study|Adverse Event|2
139519|NCT00456755|461834|P2|Overall Study|Lost to Follow-up|1
139520|NCT00456755|461835|P1|Overall Study|Lost to Follow-up|2
139521|NCT00456612|461849|P1|Overall Study|Withdrawal by Subject|3
139522|NCT00456599|461854|P1|Overall Study|Withdrawal by Subject|2
139523|NCT00456599|461854|P1|Overall Study|Non-compliance|1
139524|NCT00455858|461888|P1|Overall Study|Withdrawal|1
139525|NCT00455858|461888|P1|Overall Study|Well controlled FPG without insulin|1
139526|NCT00455858|461888|P1|Overall Study|Lack of Efficacy|1
139527|NCT00455858|461888|P1|Overall Study|Protocol Violation|1
139528|NCT00455858|461888|P1|Overall Study|Lost to Follow-up|2
139529|NCT00455533|461931|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
139530|NCT00455533|461932|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
139531|NCT00455533|461933|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
139532|NCT00455533|461931|P3|Period Two: Randomized Period|Study Drug Toxicity|0
139533|NCT00455533|461932|P2|Period Two: Randomized Period|Study Drug Toxicity|2
139534|NCT00455533|461933|P1|Period Two: Randomized Period|Study Drug Toxicity|0
139535|NCT00455533|461931|P3|Period Two: Randomized Period|Other - need reasons|0
139536|NCT00455533|461932|P2|Period Two: Randomized Period|Other - need reasons|1
139537|NCT00455533|461933|P1|Period Two: Randomized Period|Other - need reasons|0
139538|NCT00455533|461931|P3|Period Two: Randomized Period|Lost to Follow-up|1
139539|NCT00455533|461932|P2|Period Two: Randomized Period|Lost to Follow-up|0
139540|NCT00455533|461933|P1|Period Two: Randomized Period|Lost to Follow-up|0
139541|NCT00455533|461931|P3|Period Two: Randomized Period|Disease Progression|1
139542|NCT00455533|461932|P2|Period Two: Randomized Period|Disease Progression|1
139543|NCT00455533|461933|P1|Period Two: Randomized Period|Disease Progression|0
139544|NCT00455533|461931|P3|Period Two: Randomized Period|Death|3
139545|NCT00455533|461932|P2|Period Two: Randomized Period|Death|0
139546|NCT00455533|461933|P1|Period Two: Randomized Period|Death|0
139547|NCT00455533|461931|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
139548|NCT00455533|461932|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
139549|NCT00455533|461933|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
139550|NCT00455533|461931|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
139551|NCT00455533|461932|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
139552|NCT00455533|461933|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
139553|NCT00455533|461931|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
139554|NCT00455533|461932|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
139555|NCT00455533|461933|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
139556|NCT00455533|461931|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
139557|NCT00455533|461932|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
139558|NCT00455533|461933|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
139559|NCT00455533|461931|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
139560|NCT00455533|461932|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
139561|NCT00455533|461933|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
139562|NCT00455533|461931|P3|Period One: Initial Chemotherapy|Not Reported|0
139563|NCT00455533|461932|P2|Period One: Initial Chemotherapy|Not Reported|0
139564|NCT00455533|461933|P1|Period One: Initial Chemotherapy|Not Reported|1
139565|NCT00455533|461931|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
139566|NCT00455533|461932|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
139567|NCT00455533|461933|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
139568|NCT00455533|461931|P3|Period One: Initial Chemotherapy|Disease Progression|0
139569|NCT00455533|461932|P2|Period One: Initial Chemotherapy|Disease Progression|0
139570|NCT00455533|461933|P1|Period One: Initial Chemotherapy|Disease Progression|5
139571|NCT00455533|461931|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
139572|NCT00455533|461932|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
139573|NCT00455533|461933|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
139574|NCT00455520|461982|P2|Double Blind Tapentadol ER vs Placebo|All other|6
139575|NCT00455520|461983|P1|Double Blind Tapentadol ER vs Placebo|All other|4
139576|NCT00455520|461982|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
139577|NCT00455520|461983|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
139578|NCT00455520|461982|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
139579|NCT00455520|461983|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
139580|NCT00455520|461982|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
139581|NCT00455520|461983|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
139582|NCT00455520|461982|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
139583|NCT00455520|461983|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
139584|NCT00455520|461982|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
139585|NCT00455520|461983|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
139586|NCT00455520|461982|P2|Open Label Tapentadol Extended Release|All other|0
139587|NCT00455520|461983|P1|Open Label Tapentadol Extended Release|All other|33
139588|NCT00455520|461982|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
139589|NCT00455520|461983|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
139590|NCT00455520|461982|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
139591|NCT00455520|461983|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
139592|NCT00455520|461982|P2|Open Label Tapentadol Extended Release|Adverse Event|0
139593|NCT00455520|461983|P1|Open Label Tapentadol Extended Release|Adverse Event|100
139594|NCT00455520|461982|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
139595|NCT00455520|461983|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
139596|NCT00455520|461982|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
139597|NCT00455520|461983|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
139598|NCT00455455|461999|P2|Washout|Withdrawal by Subject|0
139599|NCT00455455|462000|P1|Washout|Withdrawal by Subject|1
139600|NCT00455455|461999|P2|Washout|Withdrawal by Subject|1
139601|NCT00455455|462000|P1|Washout|Withdrawal by Subject|0
139602|NCT00455429|462020|P4|Overall Study|Unspecified|1
139603|NCT00455429|462021|P3|Overall Study|Unspecified|0
139604|NCT00455429|462022|P2|Overall Study|Unspecified|2
139605|NCT00455429|462023|P1|Overall Study|Unspecified|0
139606|NCT00455429|462020|P4|Overall Study|Non-compliance|1
139607|NCT00455429|462021|P3|Overall Study|Non-compliance|0
139608|NCT00455429|462022|P2|Overall Study|Non-compliance|0
139609|NCT00455429|462023|P1|Overall Study|Non-compliance|0
139610|NCT00455429|462020|P4|Overall Study|Personal Reason|0
139611|NCT00455429|462021|P3|Overall Study|Personal Reason|0
139612|NCT00455429|462022|P2|Overall Study|Personal Reason|0
139613|NCT00455429|462023|P1|Overall Study|Personal Reason|1
139614|NCT00455429|462020|P4|Overall Study|Randomly assigned but not treated|2
139615|NCT00455429|462021|P3|Overall Study|Randomly assigned but not treated|0
139616|NCT00455429|462022|P2|Overall Study|Randomly assigned but not treated|0
139617|NCT00455429|462023|P1|Overall Study|Randomly assigned but not treated|0
139618|NCT00455429|462020|P4|Overall Study|Adverse Event|3
139619|NCT00455429|462021|P3|Overall Study|Adverse Event|0
139620|NCT00455429|462022|P2|Overall Study|Adverse Event|1
139621|NCT00455429|462023|P1|Overall Study|Adverse Event|0
139622|NCT00455429|462020|P4|Overall Study|Lack of Efficacy|1
139623|NCT00455429|462021|P3|Overall Study|Lack of Efficacy|0
139624|NCT00455429|462022|P2|Overall Study|Lack of Efficacy|1
139625|NCT00455429|462023|P1|Overall Study|Lack of Efficacy|0
139626|NCT00455429|462020|P4|Overall Study|Withdrawal by Subject|0
139627|NCT00455429|462021|P3|Overall Study|Withdrawal by Subject|1
139628|NCT00455429|462022|P2|Overall Study|Withdrawal by Subject|1
139629|NCT00455429|462023|P1|Overall Study|Withdrawal by Subject|0
139630|NCT00455429|462020|P4|Overall Study|Lost to Follow-up|3
139631|NCT00455429|462021|P3|Overall Study|Lost to Follow-up|0
139632|NCT00455429|462022|P2|Overall Study|Lost to Follow-up|0
139633|NCT00455429|462023|P1|Overall Study|Lost to Follow-up|1
139634|NCT00455429|462020|P4|Overall Study|Study Terminated by Sponsor|3
139635|NCT00455429|462021|P3|Overall Study|Study Terminated by Sponsor|0
139636|NCT00455429|462022|P2|Overall Study|Study Terminated by Sponsor|0
139637|NCT00455429|462023|P1|Overall Study|Study Terminated by Sponsor|0
139638|NCT00455195|462082|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
139639|NCT00455195|462083|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
139640|NCT00455195|462082|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
139641|NCT00455195|462083|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
139642|NCT00455195|462082|P2|Double-blind Study AGLU02704|Death|0
139643|NCT00455195|462083|P1|Double-blind Study AGLU02704|Death|1
139644|NCT00455195|462082|P2|Double-blind Study AGLU02704|Adverse Event|1
139645|NCT00455195|462083|P1|Double-blind Study AGLU02704|Adverse Event|2
139646|NCT00455013|462100|P3|Long Term Extension (LTE)|non-specified|1
139647|NCT00455013|462101|P2|Long Term Extension (LTE)|non-specified|0
139648|NCT00455013|462102|P1|Long Term Extension (LTE)|non-specified|0
139649|NCT00455013|462100|P3|Long Term Extension (LTE)|Poor non-compliance|0
139650|NCT00455013|462101|P2|Long Term Extension (LTE)|Poor non-compliance|1
139651|NCT00455013|462102|P1|Long Term Extension (LTE)|Poor non-compliance|0
139652|NCT00455013|462100|P3|Long Term Extension (LTE)|Subject Request or refused|3
139653|NCT00455013|462101|P2|Long Term Extension (LTE)|Subject Request or refused|0
139654|NCT00455013|462102|P1|Long Term Extension (LTE)|Subject Request or refused|0
139655|NCT00455013|462100|P3|Long Term Extension (LTE)|No longer met criteria|1
139656|NCT00455013|462101|P2|Long Term Extension (LTE)|No longer met criteria|0
139657|NCT00455013|462102|P1|Long Term Extension (LTE)|No longer met criteria|0
139658|NCT00455013|462100|P3|Long Term Extension (LTE)|Death|0
139659|NCT00455013|462101|P2|Long Term Extension (LTE)|Death|1
139660|NCT00455013|462102|P1|Long Term Extension (LTE)|Death|1
139661|NCT00455013|462100|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
139662|NCT00455013|462101|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
139663|NCT00455013|462102|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
139664|NCT00455013|462100|P3|Long Term Extension (LTE)|Adverse Event|1
139665|NCT00455013|462101|P2|Long Term Extension (LTE)|Adverse Event|1
139666|NCT00455013|462102|P1|Long Term Extension (LTE)|Adverse Event|0
139667|NCT00455013|462100|P3|Short Term Period|Unspecified|1
139668|NCT00455013|462101|P2|Short Term Period|Unspecified|0
139669|NCT00455013|462102|P1|Short Term Period|Unspecified|0
139670|NCT00455013|462100|P3|Short Term Period|Lack of Efficacy|0
139671|NCT00455013|462101|P2|Short Term Period|Lack of Efficacy|0
139672|NCT00455013|462102|P1|Short Term Period|Lack of Efficacy|4
139673|NCT00455013|462100|P3|Short Term Period|Withdrawal by Subject|1
139674|NCT00455013|462101|P2|Short Term Period|Withdrawal by Subject|0
139675|NCT00455013|462102|P1|Short Term Period|Withdrawal by Subject|0
139676|NCT00455013|462100|P3|Short Term Period|Adverse Event|0
139677|NCT00455013|462101|P2|Short Term Period|Adverse Event|5
139678|NCT00455013|462102|P1|Short Term Period|Adverse Event|2
139679|NCT00454987|462170|P3|Booster Period|Lost to Follow-up|0
139680|NCT00454987|462171|P2|Booster Period|Lost to Follow-up|0
139681|NCT00454987|462172|P1|Booster Period|Lost to Follow-up|1
139682|NCT00454987|462170|P3|Booster Period|Withdrawal by Subject|0
139683|NCT00454987|462171|P2|Booster Period|Withdrawal by Subject|1
139684|NCT00454987|462172|P1|Booster Period|Withdrawal by Subject|0
139685|NCT00454987|462170|P3|Booster Period|Adverse Event|0
139686|NCT00454987|462171|P2|Booster Period|Adverse Event|0
139687|NCT00454987|462172|P1|Booster Period|Adverse Event|1
139688|NCT00454857|462243|P1|Overall Study|Reason unknown|1
139689|NCT00454857|462243|P1|Overall Study|Other|11
139690|NCT00454857|462243|P1|Overall Study|Death|5
139691|NCT00454857|462243|P1|Overall Study|Noncompliance|6
139692|NCT00454857|462243|P1|Overall Study|Lost to Follow-up|16
139693|NCT00454857|462243|P1|Overall Study|Withdrawal by Subject|15
139694|NCT00454818|462268|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
139695|NCT00454818|462269|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
139696|NCT00454818|462270|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
139697|NCT00454818|462271|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
139698|NCT00454818|462272|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
139699|NCT00454818|462268|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
139700|NCT00454818|462269|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
139701|NCT00454818|462270|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
139702|NCT00454818|462271|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
139703|NCT00454818|462272|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
139704|NCT00454818|462268|P5|Phase 2: Randomized Double-blind|Death|1
139705|NCT00454818|462269|P4|Phase 2: Randomized Double-blind|Death|0
139706|NCT00454818|462270|P3|Phase 2: Randomized Double-blind|Death|0
139707|NCT00454818|462271|P2|Phase 2: Randomized Double-blind|Death|1
139708|NCT00454818|462272|P1|Phase 2: Randomized Double-blind|Death|0
139709|NCT00454818|462268|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
139710|NCT00454818|462269|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
139711|NCT00454818|462270|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
139712|NCT00454818|462271|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
139713|NCT00454818|462272|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
139714|NCT00454818|462268|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
139715|NCT00454818|462269|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
139716|NCT00454818|462270|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
139717|NCT00454818|462271|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
139718|NCT00454818|462272|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
139719|NCT00454818|462268|P5|Phase I: Open-label Dose-escalation|Death|0
139720|NCT00454818|462269|P4|Phase I: Open-label Dose-escalation|Death|0
139721|NCT00454818|462270|P3|Phase I: Open-label Dose-escalation|Death|0
139722|NCT00454818|462271|P2|Phase I: Open-label Dose-escalation|Death|1
139723|NCT00454818|462272|P1|Phase I: Open-label Dose-escalation|Death|0
139724|NCT00454818|462268|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
139725|NCT00454818|462269|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
139726|NCT00454818|462270|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
139727|NCT00454818|462271|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
139728|NCT00454818|462272|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
139729|NCT00454805|462351|P2|Overall Study|In order to begin radiotherapy|0
139730|NCT00454805|462352|P1|Overall Study|In order to begin radiotherapy|1
139731|NCT00454805|462351|P2|Overall Study|Disease progression|19
139732|NCT00454805|462352|P1|Overall Study|Disease progression|16
139733|NCT00454805|462351|P2|Overall Study|Death|2
139734|NCT00454805|462352|P1|Overall Study|Death|0
139735|NCT00454805|462351|P2|Overall Study|Withdrawal by Subject|2
139736|NCT00454805|462352|P1|Overall Study|Withdrawal by Subject|9
139737|NCT00454779|462368|P2|Second-line Treatment Phase|Ongoing|1
139738|NCT00454779|462369|P1|Second-line Treatment Phase|Ongoing|0
139739|NCT00454779|462368|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
139740|NCT00454779|462369|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
139741|NCT00454779|462368|P2|Second-line Treatment Phase|Withdrawal by Subject|1
139742|NCT00454779|462369|P1|Second-line Treatment Phase|Withdrawal by Subject|0
139743|NCT00454779|462368|P2|First-line Treatment Phase|Ongoing|0
139744|NCT00454779|462369|P1|First-line Treatment Phase|Ongoing|1
139745|NCT00454779|462368|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
139746|NCT00454779|462369|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
139747|NCT00454779|462368|P2|First-line Treatment Phase|Protocol Violation|1
139748|NCT00454779|462369|P1|First-line Treatment Phase|Protocol Violation|0
139749|NCT00454779|462368|P2|First-line Treatment Phase|Lost to Follow-up|0
139750|NCT00454779|462369|P1|First-line Treatment Phase|Lost to Follow-up|1
139751|NCT00454779|462368|P2|First-line Treatment Phase|Withdrawal by Subject|4
139752|NCT00454779|462369|P1|First-line Treatment Phase|Withdrawal by Subject|2
139753|NCT00454779|462368|P2|First-line Treatment Phase|Lack of Efficacy|2
139754|NCT00454779|462369|P1|First-line Treatment Phase|Lack of Efficacy|0
139755|NCT00454649|462407|P10|Overall Study|Withdrawal by Subject|0
139756|NCT00454649|462408|P9|Overall Study|Withdrawal by Subject|1
139757|NCT00454649|462409|P8|Overall Study|Withdrawal by Subject|2
139758|NCT00454649|462410|P7|Overall Study|Withdrawal by Subject|0
139759|NCT00454649|462411|P6|Overall Study|Withdrawal by Subject|1
139760|NCT00454649|462412|P5|Overall Study|Withdrawal by Subject|0
139761|NCT00454649|462413|P4|Overall Study|Withdrawal by Subject|0
139762|NCT00454649|462414|P3|Overall Study|Withdrawal by Subject|0
139763|NCT00454649|462415|P2|Overall Study|Withdrawal by Subject|0
139764|NCT00454649|462416|P1|Overall Study|Withdrawal by Subject|0
139765|NCT00454649|462407|P10|Overall Study|Unspecified|1
139766|NCT00454649|462408|P9|Overall Study|Unspecified|3
139767|NCT00454649|462409|P8|Overall Study|Unspecified|0
139768|NCT00454649|462410|P7|Overall Study|Unspecified|0
139769|NCT00454649|462411|P6|Overall Study|Unspecified|0
139770|NCT00454649|462412|P5|Overall Study|Unspecified|0
139771|NCT00454649|462413|P4|Overall Study|Unspecified|3
139772|NCT00454649|462414|P3|Overall Study|Unspecified|5
139773|NCT00454649|462415|P2|Overall Study|Unspecified|1
139774|NCT00454649|462416|P1|Overall Study|Unspecified|1
139775|NCT00454649|462407|P10|Overall Study|Lost to Follow-up|0
139776|NCT00454649|462408|P9|Overall Study|Lost to Follow-up|0
139777|NCT00454649|462409|P8|Overall Study|Lost to Follow-up|0
139778|NCT00454649|462410|P7|Overall Study|Lost to Follow-up|1
139779|NCT00454649|462411|P6|Overall Study|Lost to Follow-up|0
139780|NCT00454649|462412|P5|Overall Study|Lost to Follow-up|0
139781|NCT00454649|462413|P4|Overall Study|Lost to Follow-up|0
139782|NCT00454649|462414|P3|Overall Study|Lost to Follow-up|1
139783|NCT00454649|462415|P2|Overall Study|Lost to Follow-up|0
139784|NCT00454649|462416|P1|Overall Study|Lost to Follow-up|0
139785|NCT00454649|462407|P10|Overall Study|Adverse Event|2
139786|NCT00454649|462408|P9|Overall Study|Adverse Event|6
139787|NCT00454649|462409|P8|Overall Study|Adverse Event|4
139788|NCT00454649|462410|P7|Overall Study|Adverse Event|3
139789|NCT00454649|462411|P6|Overall Study|Adverse Event|2
139790|NCT00454649|462412|P5|Overall Study|Adverse Event|1
139791|NCT00454649|462413|P4|Overall Study|Adverse Event|0
139792|NCT00454649|462414|P3|Overall Study|Adverse Event|3
139793|NCT00454649|462415|P2|Overall Study|Adverse Event|1
139794|NCT00454649|462416|P1|Overall Study|Adverse Event|0
139795|NCT00454649|462407|P10|Overall Study|Lack of Efficacy|2
139796|NCT00454649|462408|P9|Overall Study|Lack of Efficacy|10
139797|NCT00454649|462409|P8|Overall Study|Lack of Efficacy|13
139798|NCT00454649|462410|P7|Overall Study|Lack of Efficacy|5
139799|NCT00454649|462411|P6|Overall Study|Lack of Efficacy|4
139800|NCT00454649|462412|P5|Overall Study|Lack of Efficacy|0
139801|NCT00454649|462413|P4|Overall Study|Lack of Efficacy|3
139802|NCT00454649|462414|P3|Overall Study|Lack of Efficacy|10
139803|NCT00454649|462415|P2|Overall Study|Lack of Efficacy|2
139804|NCT00454649|462416|P1|Overall Study|Lack of Efficacy|2
139805|NCT00454636|462545|P4|Overall Study|Lost to Follow-up|0
139806|NCT00454636|462546|P3|Overall Study|Lost to Follow-up|0
139807|NCT00454636|462547|P2|Overall Study|Lost to Follow-up|1
139808|NCT00454636|462548|P1|Overall Study|Lost to Follow-up|0
139809|NCT00454636|462545|P4|Overall Study|Patient refusal|2
139810|NCT00454636|462546|P3|Overall Study|Patient refusal|3
139811|NCT00454636|462547|P2|Overall Study|Patient refusal|1
139812|NCT00454636|462548|P1|Overall Study|Patient refusal|1
139813|NCT00454636|462545|P4|Overall Study|Death|1
139814|NCT00454636|462546|P3|Overall Study|Death|1
139815|NCT00454636|462547|P2|Overall Study|Death|1
139816|NCT00454636|462548|P1|Overall Study|Death|6
139817|NCT00454636|462545|P4|Overall Study|Protocol Violation|3
139818|NCT00454636|462546|P3|Overall Study|Protocol Violation|3
139819|NCT00454636|462547|P2|Overall Study|Protocol Violation|2
139820|NCT00454636|462548|P1|Overall Study|Protocol Violation|3
139821|NCT00454636|462545|P4|Overall Study|Disease Progression|11
139822|NCT00454636|462546|P3|Overall Study|Disease Progression|4
139823|NCT00454636|462547|P2|Overall Study|Disease Progression|12
139824|NCT00454636|462548|P1|Overall Study|Disease Progression|11
139825|NCT00454636|462545|P4|Overall Study|Adverse Event|15
139826|NCT00454636|462546|P3|Overall Study|Adverse Event|9
139827|NCT00454636|462547|P2|Overall Study|Adverse Event|6
139828|NCT00454636|462548|P1|Overall Study|Adverse Event|10
139829|NCT00454584|462581|P6|After Controlled Period|Unspecified|17
139830|NCT00454584|462582|P5|After Controlled Period|Unspecified|5
139831|NCT00454584|462583|P4|After Controlled Period|Unspecified|13
139832|NCT00454584|462584|P3|After Controlled Period|Unspecified|0
139833|NCT00454584|462585|P2|After Controlled Period|Unspecified|0
139834|NCT00454584|462586|P1|After Controlled Period|Unspecified|0
139835|NCT00454584|462581|P6|After Controlled Period|Unspecified|0
139836|NCT00454584|462582|P5|After Controlled Period|Unspecified|0
139837|NCT00454584|462583|P4|After Controlled Period|Unspecified|1
139838|NCT00454584|462584|P3|After Controlled Period|Unspecified|0
139839|NCT00454584|462585|P2|After Controlled Period|Unspecified|0
139840|NCT00454584|462586|P1|After Controlled Period|Unspecified|0
139841|NCT00454584|462581|P6|After Controlled Period|Lost to Follow-up|6
139842|NCT00454584|462582|P5|After Controlled Period|Lost to Follow-up|4
139843|NCT00454584|462583|P4|After Controlled Period|Lost to Follow-up|2
139844|NCT00454584|462584|P3|After Controlled Period|Lost to Follow-up|0
139845|NCT00454584|462585|P2|After Controlled Period|Lost to Follow-up|0
139846|NCT00454584|462586|P1|After Controlled Period|Lost to Follow-up|0
139847|NCT00454584|462581|P6|After Controlled Period|Lack of Efficacy|0
139848|NCT00454584|462582|P5|After Controlled Period|Lack of Efficacy|0
139849|NCT00454584|462583|P4|After Controlled Period|Lack of Efficacy|1
139850|NCT00454584|462584|P3|After Controlled Period|Lack of Efficacy|0
139851|NCT00454584|462585|P2|After Controlled Period|Lack of Efficacy|0
139852|NCT00454584|462586|P1|After Controlled Period|Lack of Efficacy|0
139853|NCT00454584|462581|P6|After Controlled Period|Adverse Event|9
139854|NCT00454584|462582|P5|After Controlled Period|Adverse Event|3
139855|NCT00454584|462583|P4|After Controlled Period|Adverse Event|9
139856|NCT00454584|462584|P3|After Controlled Period|Adverse Event|0
139857|NCT00454584|462585|P2|After Controlled Period|Adverse Event|0
139858|NCT00454584|462586|P1|After Controlled Period|Adverse Event|0
139859|NCT00454584|462581|P6|Controlled Period|unspecified|0
139860|NCT00454584|462582|P5|Controlled Period|unspecified|0
139861|NCT00454584|462583|P4|Controlled Period|unspecified|0
139862|NCT00454584|462584|P3|Controlled Period|unspecified|2
139863|NCT00454584|462585|P2|Controlled Period|unspecified|4
139864|NCT00454584|462586|P1|Controlled Period|unspecified|5
139865|NCT00454584|462581|P6|Controlled Period|Lost to Follow-up|0
139866|NCT00454584|462582|P5|Controlled Period|Lost to Follow-up|0
139867|NCT00454584|462583|P4|Controlled Period|Lost to Follow-up|0
139868|NCT00454584|462584|P3|Controlled Period|Lost to Follow-up|2
139869|NCT00454584|462585|P2|Controlled Period|Lost to Follow-up|2
139870|NCT00454584|462586|P1|Controlled Period|Lost to Follow-up|1
139871|NCT00454584|462581|P6|Controlled Period|Adverse Event|0
139872|NCT00454584|462582|P5|Controlled Period|Adverse Event|0
139873|NCT00454584|462583|P4|Controlled Period|Adverse Event|0
139874|NCT00454584|462584|P3|Controlled Period|Adverse Event|1
139875|NCT00454584|462585|P2|Controlled Period|Adverse Event|2
139876|NCT00454584|462586|P1|Controlled Period|Adverse Event|5
139877|NCT00454571|462608|P2|Overall Study|Withdrawal by Subject|5
139878|NCT00454571|462609|P1|Overall Study|Withdrawal by Subject|10
139879|NCT00454571|462608|P2|Overall Study|Protocol Violation|0
139880|NCT00454571|462609|P1|Overall Study|Protocol Violation|1
139881|NCT00454571|462608|P2|Overall Study|Physician Decision|1
139882|NCT00454571|462609|P1|Overall Study|Physician Decision|0
139883|NCT00454571|462608|P2|Overall Study|Adverse Event|0
139884|NCT00454571|462609|P1|Overall Study|Adverse Event|2
139885|NCT00454363|462644|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
139886|NCT00454363|462645|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
139887|NCT00454363|462644|P2|Overall Study|Adverse Event|2
139888|NCT00454363|462645|P1|Overall Study|Adverse Event|1
139889|NCT00454246|462655|P3|Overall Study|Early termination of study|9
139890|NCT00454246|462656|P2|Overall Study|Early termination of study|26
139891|NCT00454246|462657|P1|Overall Study|Early termination of study|62
139892|NCT00454246|462655|P3|Overall Study|Failure to return|0
139893|NCT00454246|462656|P2|Overall Study|Failure to return|0
139894|NCT00454246|462657|P1|Overall Study|Failure to return|1
139895|NCT00454246|462655|P3|Overall Study|Refused Treatment|0
139896|NCT00454246|462656|P2|Overall Study|Refused Treatment|1
139897|NCT00454246|462657|P1|Overall Study|Refused Treatment|1
139898|NCT00454246|462655|P3|Overall Study|Protocol Violation|0
139899|NCT00454246|462656|P2|Overall Study|Protocol Violation|0
139900|NCT00454246|462657|P1|Overall Study|Protocol Violation|1
139901|NCT00454246|462655|P3|Overall Study|Violation of selection criteria at entry|0
139902|NCT00454246|462656|P2|Overall Study|Violation of selection criteria at entry|0
139903|NCT00454246|462657|P1|Overall Study|Violation of selection criteria at entry|6
139904|NCT00454246|462655|P3|Overall Study|Adverse Event|0
139905|NCT00454246|462656|P2|Overall Study|Adverse Event|2
139906|NCT00454246|462657|P1|Overall Study|Adverse Event|2
139907|NCT00454207|462673|P2|Overall Study|Protocol Violation|1
139908|NCT00454207|462674|P1|Overall Study|Protocol Violation|0
139909|NCT00454207|462673|P2|Overall Study|Lack of Efficacy|0
139910|NCT00454207|462674|P1|Overall Study|Lack of Efficacy|1
139911|NCT00454207|462673|P2|Overall Study|Adverse Event|1
139912|NCT00454207|462674|P1|Overall Study|Adverse Event|3
139913|NCT00454194|462719|P2|Overall Study|Other Unspecified Reason|2
139914|NCT00454194|462720|P1|Overall Study|Other Unspecified Reason|2
139915|NCT00454194|462719|P2|Overall Study|Other Medical Problems|2
139916|NCT00454194|462720|P1|Overall Study|Other Medical Problems|1
139917|NCT00454194|462719|P2|Overall Study|Withdrawal by Subject|8
139918|NCT00454194|462720|P1|Overall Study|Withdrawal by Subject|12
139919|NCT00454194|462719|P2|Overall Study|Adverse Event|2
139920|NCT00454194|462720|P1|Overall Study|Adverse Event|7
139921|NCT00454181|462738|P2|Overall Study|Withdrawal by Subject|0
139922|NCT00454181|462739|P1|Overall Study|Withdrawal by Subject|2
139923|NCT00454181|462738|P2|Overall Study|Protocol Violation|1
139924|NCT00454181|462739|P1|Overall Study|Protocol Violation|1
139925|NCT00454181|462738|P2|Overall Study|Lost to Follow-up|1
139926|NCT00454181|462739|P1|Overall Study|Lost to Follow-up|11
139927|NCT00454181|462738|P2|Overall Study|Adverse Event|1
139928|NCT00454181|462739|P1|Overall Study|Adverse Event|1
139929|NCT00454142|462755|P1|Overall Study|Withdrawal by Subject|1
139930|NCT00453362|462770|P1|Overall Study|Screening Failure|14
139931|NCT00453362|462770|P1|Overall Study|Progression of disease|56
139932|NCT00453362|462770|P1|Overall Study|Withdrawal by Subject|3
139933|NCT00453362|462770|P1|Overall Study|Physician Decision|2
139934|NCT00453362|462770|P1|Overall Study|Death|7
139935|NCT00453362|462770|P1|Overall Study|Adverse Event|5
139936|NCT00453349|462796|P2|Completed Study|Lost to follow up after study treatment|11
139937|NCT00453349|462797|P1|Completed Study|Lost to follow up after study treatment|2
139938|NCT00453349|462796|P2|Completed Study|Withdrawal by Subject|5
139939|NCT00453349|462797|P1|Completed Study|Withdrawal by Subject|3
139940|NCT00453349|462796|P2|Completed Study|Protocol Violation|1
139941|NCT00453349|462797|P1|Completed Study|Protocol Violation|1
139942|NCT00453349|462796|P2|Completed Study|Lost to Follow-up|5
139943|NCT00453349|462797|P1|Completed Study|Lost to Follow-up|7
139944|NCT00453349|462796|P2|Completed Study|Lack of Efficacy|1
139945|NCT00453349|462797|P1|Completed Study|Lack of Efficacy|2
139946|NCT00453349|462796|P2|Completed Study|Adverse Event|11
139947|NCT00453349|462797|P1|Completed Study|Adverse Event|12
139948|NCT00453349|462796|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
139949|NCT00453349|462797|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
139950|NCT00453349|462796|P2|Randomized|Withdrawal by Subject|5
139951|NCT00453349|462797|P1|Randomized|Withdrawal by Subject|3
139952|NCT00453349|462796|P2|Randomized|Protocol Violation|1
139953|NCT00453349|462797|P1|Randomized|Protocol Violation|1
139954|NCT00453349|462796|P2|Randomized|Lost to Follow-up|5
139955|NCT00453349|462797|P1|Randomized|Lost to Follow-up|7
139956|NCT00453349|462796|P2|Randomized|Lack of Efficacy|1
139957|NCT00453349|462797|P1|Randomized|Lack of Efficacy|2
139958|NCT00453349|462796|P2|Randomized|Adverse Event|11
139959|NCT00453349|462797|P1|Randomized|Adverse Event|12
139960|NCT00453310|462828|P1|Overall Study|Progression of Disease|10
139961|NCT00454116|462835|P3|Overall Study|Other|0
139962|NCT00454116|462836|P2|Overall Study|Other|2
139963|NCT00454116|462837|P1|Overall Study|Other|2
139964|NCT00454116|462835|P3|Overall Study|Withdrawal by Subject|1
139965|NCT00454116|462836|P2|Overall Study|Withdrawal by Subject|3
139966|NCT00454116|462837|P1|Overall Study|Withdrawal by Subject|3
139967|NCT00454116|462835|P3|Overall Study|Condition under investigation worsened|18
139968|NCT00454116|462836|P2|Overall Study|Condition under investigation worsened|13
139969|NCT00454116|462837|P1|Overall Study|Condition under investigation worsened|17
139970|NCT00454116|462835|P3|Overall Study|Adverse Event|9
139971|NCT00454116|462836|P2|Overall Study|Adverse Event|11
139972|NCT00454116|462837|P1|Overall Study|Adverse Event|5
139973|NCT00454051|462847|P2|Overall Study|Protocol Violation|1
139974|NCT00454051|462848|P1|Overall Study|Protocol Violation|1
139975|NCT00454051|462847|P2|Overall Study|Withdrawal by Subject|0
139976|NCT00454051|462848|P1|Overall Study|Withdrawal by Subject|1
139977|NCT00454051|462847|P2|Overall Study|Adverse Event|2
139978|NCT00454051|462848|P1|Overall Study|Adverse Event|1
139979|NCT00453999|462881|P3|Overall Study|Subject Request|0
139980|NCT00453999|462882|P2|Overall Study|Subject Request|1
139981|NCT00453999|462883|P1|Overall Study|Subject Request|2
139982|NCT00453999|462881|P3|Overall Study|Withdrawal by Subject|1
139983|NCT00453999|462882|P2|Overall Study|Withdrawal by Subject|1
139984|NCT00453999|462883|P1|Overall Study|Withdrawal by Subject|2
139985|NCT00453999|462881|P3|Overall Study|Lost to Follow-up|1
139986|NCT00453999|462882|P2|Overall Study|Lost to Follow-up|1
139987|NCT00453999|462883|P1|Overall Study|Lost to Follow-up|0
139988|NCT00453999|462881|P3|Overall Study|Adverse Event|1
139989|NCT00453999|462882|P2|Overall Study|Adverse Event|2
139990|NCT00453999|462883|P1|Overall Study|Adverse Event|1
139991|NCT00453986|462911|P5|Overall Study|Lost to Follow-up|0
139992|NCT00453986|462912|P4|Overall Study|Lost to Follow-up|2
139993|NCT00453986|462913|P3|Overall Study|Lost to Follow-up|6
139994|NCT00453986|462914|P2|Overall Study|Lost to Follow-up|5
139995|NCT00453986|462915|P1|Overall Study|Lost to Follow-up|6
139996|NCT00453973|463010|P2|Overall Study|Sponsor Decision to Terminate Study|30
139997|NCT00453973|463011|P1|Overall Study|Sponsor Decision to Terminate Study|35
139998|NCT00453973|463010|P2|Overall Study|Site closed by sponsor|0
139999|NCT00453973|463011|P1|Overall Study|Site closed by sponsor|3
140000|NCT00453973|463010|P2|Overall Study|Renal transplant|1
140001|NCT00453973|463011|P1|Overall Study|Renal transplant|1
140002|NCT00453973|463010|P2|Overall Study|Relocation|0
140003|NCT00453973|463011|P1|Overall Study|Relocation|1
140004|NCT00453973|463010|P2|Overall Study|PI Decision|2
140005|NCT00453973|463011|P1|Overall Study|PI Decision|0
140006|NCT00453973|463010|P2|Overall Study|Withdrawal by Subject|6
140007|NCT00453973|463011|P1|Overall Study|Withdrawal by Subject|7
140008|NCT00453973|463010|P2|Overall Study|Adverse Event|9
140009|NCT00453973|463011|P1|Overall Study|Adverse Event|4
140010|NCT00453206|463017|P1|Overall Study|Death|1
140011|NCT00453154|463028|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
140012|NCT00453154|463029|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
140013|NCT00453154|463030|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
140014|NCT00453154|463031|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
140015|NCT00453154|463028|P4|Double BIind Maintenance|Medical Issues|1
140016|NCT00453154|463029|P3|Double BIind Maintenance|Medical Issues|3
140017|NCT00453154|463030|P2|Double BIind Maintenance|Medical Issues|0
140018|NCT00453154|463031|P1|Double BIind Maintenance|Medical Issues|0
140019|NCT00453154|463028|P4|Double BIind Maintenance|Progression|26
140020|NCT00453154|463029|P3|Double BIind Maintenance|Progression|29
140021|NCT00453154|463030|P2|Double BIind Maintenance|Progression|0
140022|NCT00453154|463031|P1|Double BIind Maintenance|Progression|0
140023|NCT00453154|463028|P4|Double BIind Maintenance|Withdrawal by Subject|4
140024|NCT00453154|463029|P3|Double BIind Maintenance|Withdrawal by Subject|4
140025|NCT00453154|463030|P2|Double BIind Maintenance|Withdrawal by Subject|0
140026|NCT00453154|463031|P1|Double BIind Maintenance|Withdrawal by Subject|0
140027|NCT00453154|463028|P4|Double BIind Maintenance|Death|1
140028|NCT00453154|463029|P3|Double BIind Maintenance|Death|2
140029|NCT00453154|463030|P2|Double BIind Maintenance|Death|0
140030|NCT00453154|463031|P1|Double BIind Maintenance|Death|0
140031|NCT00453154|463028|P4|Double BIind Maintenance|Adverse Event|12
140032|NCT00453154|463029|P3|Double BIind Maintenance|Adverse Event|3
140033|NCT00453154|463030|P2|Double BIind Maintenance|Adverse Event|0
140034|NCT00453154|463031|P1|Double BIind Maintenance|Adverse Event|0
140035|NCT00453102|463044|P1|Overall Study|Withdrawal by Subject|2
140036|NCT00453063|463055|P2|Overall Study|Protocol Violation|0
140037|NCT00453063|463056|P1|Overall Study|Protocol Violation|1
140038|NCT00453063|463055|P2|Overall Study|Withdrawal by Subject|1
140039|NCT00453063|463056|P1|Overall Study|Withdrawal by Subject|1
140040|NCT00453063|463055|P2|Overall Study|Adverse Event|2
140041|NCT00453063|463056|P1|Overall Study|Adverse Event|1
140042|NCT00452790|463076|P2|Toddler Dose|Parent/legal guardian request|1
140043|NCT00452790|463077|P1|Toddler Dose|Parent/legal guardian request|0
140044|NCT00452790|463076|P2|Toddler Dose|Failed to return|1
140045|NCT00452790|463077|P1|Toddler Dose|Failed to return|0
140046|NCT00452790|463076|P2|After Infant Series|Other reasons|0
140047|NCT00452790|463077|P1|After Infant Series|Other reasons|1
140048|NCT00452790|463076|P2|After Infant Series|Failed to return|0
140049|NCT00452790|463077|P1|After Infant Series|Failed to return|1
140050|NCT00452790|463076|P2|After Infant Series|Lost to Follow-up|0
140051|NCT00452790|463077|P1|After Infant Series|Lost to Follow-up|4
140052|NCT00452790|463076|P2|After Infant Series|Parent/legal guardian request|3
140053|NCT00452790|463077|P1|After Infant Series|Parent/legal guardian request|1
140054|NCT00452790|463076|P2|After Infant Series|Adverse Event|1
140055|NCT00452790|463077|P1|After Infant Series|Adverse Event|4
140056|NCT00452790|463076|P2|After Infant Series|Investigator request|10
140057|NCT00452790|463077|P1|After Infant Series|Investigator request|10
140058|NCT00452790|463076|P2|Infant Series|Death|1
140059|NCT00452790|463077|P1|Infant Series|Death|0
140060|NCT00452790|463076|P2|Infant Series|Investigator request|1
140061|NCT00452790|463077|P1|Infant Series|Investigator request|0
140062|NCT00452790|463076|P2|Infant Series|Other reasons|2
140063|NCT00452790|463077|P1|Infant Series|Other reasons|1
140064|NCT00452790|463076|P2|Infant Series|Adverse Event|2
140065|NCT00452790|463077|P1|Infant Series|Adverse Event|1
140066|NCT00452790|463076|P2|Infant Series|Lost to Follow-up|2
140067|NCT00452790|463077|P1|Infant Series|Lost to Follow-up|2
140068|NCT00452790|463076|P2|Infant Series|Protocol Violation|3
140069|NCT00452790|463077|P1|Infant Series|Protocol Violation|1
140070|NCT00452790|463076|P2|Infant Series|Failed to return|1
140071|NCT00452790|463077|P1|Infant Series|Failed to return|4
140072|NCT00452790|463076|P2|Infant Series|Parent/legal guardian request|6
140073|NCT00452790|463077|P1|Infant Series|Parent/legal guardian request|8
140074|NCT00452790|463076|P2|Infant Series|Clinical hold - consent withdrawn|123
140075|NCT00452790|463077|P1|Infant Series|Clinical hold - consent withdrawn|118
140076|NCT00452699|463113|P2|Overall Study|Other|7
140077|NCT00452699|463114|P1|Overall Study|Other|12
140078|NCT00452699|463113|P2|Overall Study|Withdrawal by Subject|25
140079|NCT00452699|463114|P1|Overall Study|Withdrawal by Subject|26
140080|NCT00452699|463113|P2|Overall Study|Protocol Violation|25
140081|NCT00452699|463114|P1|Overall Study|Protocol Violation|21
140082|NCT00452699|463113|P2|Overall Study|Lost to Follow-up|9
140083|NCT00452699|463114|P1|Overall Study|Lost to Follow-up|6
140084|NCT00452699|463113|P2|Overall Study|Lack of Efficacy|4
140085|NCT00452699|463114|P1|Overall Study|Lack of Efficacy|6
140086|NCT00452699|463113|P2|Overall Study|Adverse Event|3
140087|NCT00452699|463114|P1|Overall Study|Adverse Event|10
140088|NCT00452673|463130|P5|Dose Expansion Period|not specified|2
140089|NCT00452673|463131|P4|Dose Expansion Period|not specified|0
140090|NCT00452673|463132|P3|Dose Expansion Period|not specified|0
140091|NCT00452673|463133|P2|Dose Expansion Period|not specified|0
140092|NCT00452673|463134|P1|Dose Expansion Period|not specified|0
140093|NCT00452673|463130|P5|Dose Expansion Period|Disease Progression|19
140094|NCT00452673|463131|P4|Dose Expansion Period|Disease Progression|0
140095|NCT00452673|463132|P3|Dose Expansion Period|Disease Progression|0
140096|NCT00452673|463133|P2|Dose Expansion Period|Disease Progression|0
140097|NCT00452673|463134|P1|Dose Expansion Period|Disease Progression|0
140098|NCT00452673|463130|P5|Dose Escalation Period|Withdrawal by Subject|0
140099|NCT00452673|463131|P4|Dose Escalation Period|Withdrawal by Subject|1
140100|NCT00452673|463132|P3|Dose Escalation Period|Withdrawal by Subject|0
140101|NCT00452673|463133|P2|Dose Escalation Period|Withdrawal by Subject|0
140102|NCT00452673|463134|P1|Dose Escalation Period|Withdrawal by Subject|0
140103|NCT00452673|463130|P5|Dose Escalation Period|Adverse Event|0
140104|NCT00452673|463131|P4|Dose Escalation Period|Adverse Event|1
140105|NCT00452673|463132|P3|Dose Escalation Period|Adverse Event|0
140106|NCT00452673|463133|P2|Dose Escalation Period|Adverse Event|0
140107|NCT00452673|463134|P1|Dose Escalation Period|Adverse Event|0
140108|NCT00452673|463130|P5|Dose Escalation Period|not specified|0
140109|NCT00452673|463131|P4|Dose Escalation Period|not specified|0
140110|NCT00452673|463132|P3|Dose Escalation Period|not specified|1
140111|NCT00452673|463133|P2|Dose Escalation Period|not specified|0
140112|NCT00452673|463134|P1|Dose Escalation Period|not specified|0
140113|NCT00452673|463130|P5|Dose Escalation Period|study drug toxicity|0
140114|NCT00452673|463131|P4|Dose Escalation Period|study drug toxicity|1
140115|NCT00452673|463132|P3|Dose Escalation Period|study drug toxicity|3
140116|NCT00452673|463133|P2|Dose Escalation Period|study drug toxicity|3
140117|NCT00452673|463134|P1|Dose Escalation Period|study drug toxicity|1
140118|NCT00452673|463130|P5|Dose Escalation Period|Disease Progression|0
140119|NCT00452673|463131|P4|Dose Escalation Period|Disease Progression|6
140120|NCT00452673|463132|P3|Dose Escalation Period|Disease Progression|2
140121|NCT00452673|463133|P2|Dose Escalation Period|Disease Progression|6
140122|NCT00452673|463134|P1|Dose Escalation Period|Disease Progression|6
140123|NCT00452530|463181|P2|Overall Study|Not specified|11
140124|NCT00452530|463182|P1|Overall Study|Not specified|7
140125|NCT00452530|463181|P2|Overall Study|No longer met study criteria|22
140126|NCT00452530|463182|P1|Overall Study|No longer met study criteria|18
140127|NCT00452530|463181|P2|Overall Study|Poor compliance/noncompliance|2
140128|NCT00452530|463182|P1|Overall Study|Poor compliance/noncompliance|1
140129|NCT00452530|463181|P2|Overall Study|Lost to Follow-up|0
140130|NCT00452530|463182|P1|Overall Study|Lost to Follow-up|1
140131|NCT00452530|463181|P2|Overall Study|Withdrawal by Subject|57
140132|NCT00452530|463182|P1|Overall Study|Withdrawal by Subject|68
140133|NCT00452530|463181|P2|Overall Study|Adverse Event|44
140134|NCT00452530|463182|P1|Overall Study|Adverse Event|40
140135|NCT00452530|463181|P2|Overall Study|Death|0
140136|NCT00452530|463182|P1|Overall Study|Death|1
140137|NCT00452452|463203|P3|Overall Study|Lost to Follow-up|0
140138|NCT00452452|463204|P2|Overall Study|Lost to Follow-up|0
140139|NCT00452452|463205|P1|Overall Study|Lost to Follow-up|1
140140|NCT00452452|463203|P3|Overall Study|Withdrawal by Subject|0
140141|NCT00452452|463204|P2|Overall Study|Withdrawal by Subject|0
140142|NCT00452452|463205|P1|Overall Study|Withdrawal by Subject|1
140143|NCT00452452|463203|P3|Overall Study|Protocol Violation|1
140144|NCT00452452|463204|P2|Overall Study|Protocol Violation|0
140145|NCT00452452|463205|P1|Overall Study|Protocol Violation|0
140146|NCT00452400|463250|P5|Overall Study|Other reasons not listed above|1
140147|NCT00452400|463251|P4|Overall Study|Other reasons not listed above|1
140148|NCT00452400|463252|P3|Overall Study|Other reasons not listed above|0
140149|NCT00452400|463253|P2|Overall Study|Other reasons not listed above|0
140150|NCT00452400|463254|P1|Overall Study|Other reasons not listed above|0
140151|NCT00452400|463250|P5|Overall Study|Lack of Efficacy|0
140152|NCT00452400|463251|P4|Overall Study|Lack of Efficacy|0
140153|NCT00452400|463252|P3|Overall Study|Lack of Efficacy|0
140154|NCT00452400|463253|P2|Overall Study|Lack of Efficacy|0
140155|NCT00452400|463254|P1|Overall Study|Lack of Efficacy|2
140156|NCT00452400|463250|P5|Overall Study|Withdrawal by Subject|0
140157|NCT00452400|463251|P4|Overall Study|Withdrawal by Subject|0
140158|NCT00452400|463252|P3|Overall Study|Withdrawal by Subject|1
140159|NCT00452400|463253|P2|Overall Study|Withdrawal by Subject|0
140160|NCT00452400|463254|P1|Overall Study|Withdrawal by Subject|1
140161|NCT00452400|463250|P5|Overall Study|Lost to Follow-up|0
140162|NCT00452400|463251|P4|Overall Study|Lost to Follow-up|0
140163|NCT00452400|463252|P3|Overall Study|Lost to Follow-up|0
140164|NCT00452400|463253|P2|Overall Study|Lost to Follow-up|0
140165|NCT00452400|463254|P1|Overall Study|Lost to Follow-up|1
140166|NCT00452400|463250|P5|Overall Study|Protocol Violation|0
140167|NCT00452400|463251|P4|Overall Study|Protocol Violation|0
140168|NCT00452400|463252|P3|Overall Study|Protocol Violation|1
140169|NCT00452400|463253|P2|Overall Study|Protocol Violation|0
140170|NCT00452400|463254|P1|Overall Study|Protocol Violation|0
140171|NCT00452400|463250|P5|Overall Study|Adverse Event|2
140172|NCT00452400|463251|P4|Overall Study|Adverse Event|0
140173|NCT00452400|463252|P3|Overall Study|Adverse Event|5
140174|NCT00452400|463253|P2|Overall Study|Adverse Event|1
140175|NCT00452400|463254|P1|Overall Study|Adverse Event|1
140176|NCT00452361|463441|P2|Overall Study|Premature termination|9
140177|NCT00452361|463442|P1|Overall Study|Premature termination|13
140178|NCT00452361|463441|P2|Overall Study|Withdrawal by Subject|1
140179|NCT00452361|463442|P1|Overall Study|Withdrawal by Subject|0
140180|NCT00452361|463441|P2|Overall Study|Adverse Event|0
140181|NCT00452361|463442|P1|Overall Study|Adverse Event|8
140182|NCT00452348|463486|P2|Overall Study|Other|9
140183|NCT00452348|463487|P1|Overall Study|Other|9
140184|NCT00452348|463486|P2|Overall Study|Withdrawal by Subject|21
140185|NCT00452348|463487|P1|Overall Study|Withdrawal by Subject|18
140186|NCT00452348|463486|P2|Overall Study|Protocol Violation|28
140187|NCT00452348|463487|P1|Overall Study|Protocol Violation|22
140188|NCT00452348|463486|P2|Overall Study|Lost to Follow-up|8
140189|NCT00452348|463487|P1|Overall Study|Lost to Follow-up|14
140190|NCT00452348|463486|P2|Overall Study|Lack of Efficacy|9
140191|NCT00452348|463487|P1|Overall Study|Lack of Efficacy|10
140192|NCT00452348|463486|P2|Overall Study|Adverse Event|9
140193|NCT00452348|463487|P1|Overall Study|Adverse Event|6
140194|NCT00452114|463541|P2|Overall Study|Physician Decision|3
140195|NCT00452114|463542|P1|Overall Study|Physician Decision|3
140196|NCT00451958|463552|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
140197|NCT00451958|463553|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
140198|NCT00451958|463554|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
140199|NCT00451958|463555|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
140200|NCT00451958|463556|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
140201|NCT00451958|463552|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
140202|NCT00451958|463553|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
140203|NCT00451958|463554|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
140204|NCT00451958|463555|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
140205|NCT00451958|463556|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
140206|NCT00451958|463552|P5|CS21A (NCT00451958)|Physician Decision|0
140207|NCT00451958|463553|P4|CS21A (NCT00451958)|Physician Decision|4
140208|NCT00451958|463554|P3|CS21A (NCT00451958)|Physician Decision|4
140209|NCT00451958|463555|P2|CS21A (NCT00451958)|Physician Decision|4
140210|NCT00451958|463556|P1|CS21A (NCT00451958)|Physician Decision|2
140211|NCT00451958|463552|P5|CS21A (NCT00451958)|Protocol Violation|0
140212|NCT00451958|463553|P4|CS21A (NCT00451958)|Protocol Violation|0
140213|NCT00451958|463554|P3|CS21A (NCT00451958)|Protocol Violation|2
140214|NCT00451958|463555|P2|CS21A (NCT00451958)|Protocol Violation|3
140215|NCT00451958|463556|P1|CS21A (NCT00451958)|Protocol Violation|1
140216|NCT00451958|463552|P5|CS21A (NCT00451958)|Lost to Follow-up|0
140217|NCT00451958|463553|P4|CS21A (NCT00451958)|Lost to Follow-up|1
140218|NCT00451958|463554|P3|CS21A (NCT00451958)|Lost to Follow-up|1
140219|NCT00451958|463555|P2|CS21A (NCT00451958)|Lost to Follow-up|5
140220|NCT00451958|463556|P1|CS21A (NCT00451958)|Lost to Follow-up|6
140221|NCT00451958|463552|P5|CS21A (NCT00451958)|Adverse Event|0
140222|NCT00451958|463553|P4|CS21A (NCT00451958)|Adverse Event|17
140223|NCT00451958|463554|P3|CS21A (NCT00451958)|Adverse Event|14
140224|NCT00451958|463555|P2|CS21A (NCT00451958)|Adverse Event|34
140225|NCT00451958|463556|P1|CS21A (NCT00451958)|Adverse Event|21
140226|NCT00451906|463586|P1|Overall Study|Did not complete final visit|4
140227|NCT00451906|463586|P1|Overall Study|Other Reasons|121
140228|NCT00451906|463586|P1|Overall Study|Termination of the study|108
140229|NCT00451906|463586|P1|Overall Study|Progressive disease|1328
140230|NCT00451906|463586|P1|Overall Study|Protocol Violation|21
140231|NCT00451906|463586|P1|Overall Study|Withdrawal by Subject|111
140232|NCT00451906|463586|P1|Overall Study|Lost to Follow-up|31
140233|NCT00451906|463586|P1|Overall Study|Adverse Event|515
140234|NCT00451451|463609|P4|Overall Study|Other Reasons for Not Completing Study|14
140235|NCT00451451|463610|P3|Overall Study|Other Reasons for Not Completing Study|17
140236|NCT00451451|463611|P2|Overall Study|Other Reasons for Not Completing Study|30
140237|NCT00451451|463612|P1|Overall Study|Other Reasons for Not Completing Study|34
140238|NCT00451451|463609|P4|Overall Study|Death|1
140239|NCT00451451|463610|P3|Overall Study|Death|0
140240|NCT00451451|463611|P2|Overall Study|Death|0
140241|NCT00451451|463612|P1|Overall Study|Death|1
140242|NCT00451451|463609|P4|Overall Study|Subject Non-Compliance|3
140243|NCT00451451|463610|P3|Overall Study|Subject Non-Compliance|3
140244|NCT00451451|463611|P2|Overall Study|Subject Non-Compliance|4
140245|NCT00451451|463612|P1|Overall Study|Subject Non-Compliance|8
140246|NCT00451451|463609|P4|Overall Study|Investigator Decision|2
140247|NCT00451451|463610|P3|Overall Study|Investigator Decision|1
140248|NCT00451451|463611|P2|Overall Study|Investigator Decision|2
140249|NCT00451451|463612|P1|Overall Study|Investigator Decision|6
140250|NCT00451451|463609|P4|Overall Study|Consent Withdrawn|17
140251|NCT00451451|463610|P3|Overall Study|Consent Withdrawn|17
140252|NCT00451451|463611|P2|Overall Study|Consent Withdrawn|9
140253|NCT00451451|463612|P1|Overall Study|Consent Withdrawn|14
140254|NCT00451451|463609|P4|Overall Study|Lost to Follow-up|11
140255|NCT00451451|463610|P3|Overall Study|Lost to Follow-up|8
140256|NCT00451451|463611|P2|Overall Study|Lost to Follow-up|9
140257|NCT00451451|463612|P1|Overall Study|Lost to Follow-up|11
140258|NCT00451451|463609|P4|Overall Study|Adverse Event|10
140259|NCT00451451|463610|P3|Overall Study|Adverse Event|26
140260|NCT00451451|463611|P2|Overall Study|Adverse Event|21
140261|NCT00451451|463612|P1|Overall Study|Adverse Event|11
140262|NCT00451282|463641|P2|Overall Study|Lost to Follow-up|5
140263|NCT00451282|463642|P1|Overall Study|Lost to Follow-up|6
140264|NCT00451204|463656|P2|Overall Study|Other|2
140265|NCT00451204|463657|P1|Overall Study|Other|1
140266|NCT00451204|463656|P2|Overall Study|Patient refusal|4
140267|NCT00451204|463657|P1|Overall Study|Patient refusal|8
140268|NCT00451204|463656|P2|Overall Study|Protocol Violation|0
140269|NCT00451204|463657|P1|Overall Study|Protocol Violation|1
140270|NCT00451204|463656|P2|Overall Study|Lost to Follow-up|4
140271|NCT00451204|463657|P1|Overall Study|Lost to Follow-up|4
140272|NCT00451204|463656|P2|Overall Study|Lack of Efficacy|4
140273|NCT00451204|463657|P1|Overall Study|Lack of Efficacy|4
140274|NCT00451204|463656|P2|Overall Study|Adverse Event|6
140275|NCT00451204|463657|P1|Overall Study|Adverse Event|4
140276|NCT00451191|463675|P2|Overall Study|withdrawal or received alternate tx|11
140277|NCT00451191|463676|P1|Overall Study|withdrawal or received alternate tx|15
140278|NCT00450866|463686|P2|Overall Study|Physician Decision|0
140279|NCT00450866|463687|P1|Overall Study|Physician Decision|1
140280|NCT00450866|463686|P2|Overall Study|Death|0
140281|NCT00450866|463687|P1|Overall Study|Death|1
140282|NCT00450866|463686|P2|Overall Study|Withdrawal by Subject|2
140283|NCT00450866|463687|P1|Overall Study|Withdrawal by Subject|5
140284|NCT00450866|463686|P2|Overall Study|Adverse Event|1
140285|NCT00450866|463687|P1|Overall Study|Adverse Event|0
140286|NCT00450801|463697|P1|Overall Study|Death|1
140287|NCT00450749|463711|P3|Overall Study|Noncompliant|0
140288|NCT00450749|463712|P2|Overall Study|Noncompliant|1
140289|NCT00450749|463713|P1|Overall Study|Noncompliant|0
140290|NCT00450749|463711|P3|Overall Study|Withdrawal by Subject|2
140291|NCT00450749|463712|P2|Overall Study|Withdrawal by Subject|0
140292|NCT00450749|463713|P1|Overall Study|Withdrawal by Subject|0
140293|NCT00450723|463721|P1|Overall Study|Physician Decision|5
140294|NCT00450658|463729|P2|Overall Study|misc|10
140295|NCT00450658|463730|P1|Overall Study|misc|21
140296|NCT00450658|463729|P2|Overall Study|UGI ulcer|34
140297|NCT00450658|463730|P1|Overall Study|UGI ulcer|33
140298|NCT00450658|463729|P2|Overall Study|Lost to Follow-up|5
140299|NCT00450658|463730|P1|Overall Study|Lost to Follow-up|22
140300|NCT00450658|463729|P2|Overall Study|Withdrawal by Subject|26
140301|NCT00450658|463730|P1|Overall Study|Withdrawal by Subject|43
140302|NCT00450658|463729|P2|Overall Study|Adverse Event|15
140303|NCT00450658|463730|P1|Overall Study|Adverse Event|24
140304|NCT00450619|463744|P2|Overall Study|Adverse Event|0
140305|NCT00450619|463745|P1|Overall Study|Adverse Event|1
140306|NCT00450619|463744|P2|Overall Study|did not progress; refused further trmt|1
140307|NCT00450619|463745|P1|Overall Study|did not progress; refused further trmt|1
140308|NCT00450619|463744|P2|Overall Study|refused treatment after randomization|0
140309|NCT00450619|463745|P1|Overall Study|refused treatment after randomization|2
140310|NCT00450580|463771|P2|Overall Study|Withdrawal due to pregnancy|1
140311|NCT00450580|463772|P1|Overall Study|Withdrawal due to pregnancy|0
140312|NCT00450580|463771|P2|Overall Study|Patient could not swallow Norvir|0
140313|NCT00450580|463772|P1|Overall Study|Patient could not swallow Norvir|1
140314|NCT00450580|463771|P2|Overall Study|Patient went to Brazil|0
140315|NCT00450580|463772|P1|Overall Study|Patient went to Brazil|1
140316|NCT00450580|463771|P2|Overall Study|Could not comply with scheduled visits|0
140317|NCT00450580|463772|P1|Overall Study|Could not comply with scheduled visits|1
140318|NCT00450580|463771|P2|Overall Study|Protocol-defined virologic failure|0
140319|NCT00450580|463772|P1|Overall Study|Protocol-defined virologic failure|1
140320|NCT00450580|463771|P2|Overall Study|Protocol Violation|1
140321|NCT00450580|463772|P1|Overall Study|Protocol Violation|1
140322|NCT00450580|463771|P2|Overall Study|Withdrawal by Subject|2
140323|NCT00450580|463772|P1|Overall Study|Withdrawal by Subject|2
140324|NCT00450580|463771|P2|Overall Study|Lost to Follow-up|5
140325|NCT00450580|463772|P1|Overall Study|Lost to Follow-up|4
140326|NCT00450580|463771|P2|Overall Study|Adverse Event|7
140327|NCT00450580|463772|P1|Overall Study|Adverse Event|5
140328|NCT00450437|463792|P4|Overall Study|Unable to Classify|0
140329|NCT00450437|463793|P3|Overall Study|Unable to Classify|1
140330|NCT00450437|463794|P2|Overall Study|Unable to Classify|0
140331|NCT00450437|463795|P1|Overall Study|Unable to Classify|1
140332|NCT00450437|463792|P4|Overall Study|Administrative reason|0
140333|NCT00450437|463793|P3|Overall Study|Administrative reason|1
140334|NCT00450437|463794|P2|Overall Study|Administrative reason|0
140335|NCT00450437|463795|P1|Overall Study|Administrative reason|0
140336|NCT00450437|463792|P4|Overall Study|Inappropriate enrollment|0
140337|NCT00450437|463793|P3|Overall Study|Inappropriate enrollment|3
140338|NCT00450437|463794|P2|Overall Study|Inappropriate enrollment|1
140339|NCT00450437|463795|P1|Overall Study|Inappropriate enrollment|4
140340|NCT00450437|463792|P4|Overall Study|Protocol Violation|1
140341|NCT00450437|463793|P3|Overall Study|Protocol Violation|0
140342|NCT00450437|463794|P2|Overall Study|Protocol Violation|1
140343|NCT00450437|463795|P1|Overall Study|Protocol Violation|0
140344|NCT00450437|463792|P4|Overall Study|Lost to Follow-up|9
140345|NCT00450437|463793|P3|Overall Study|Lost to Follow-up|19
140346|NCT00450437|463794|P2|Overall Study|Lost to Follow-up|12
140347|NCT00450437|463795|P1|Overall Study|Lost to Follow-up|31
140348|NCT00450437|463792|P4|Overall Study|Withdrawal by Subject|1
140349|NCT00450437|463793|P3|Overall Study|Withdrawal by Subject|0
140350|NCT00450437|463794|P2|Overall Study|Withdrawal by Subject|2
140351|NCT00450437|463795|P1|Overall Study|Withdrawal by Subject|10
140352|NCT00450372|463826|P1|Overall Study|Physician Decision|1
140353|NCT00450333|463839|P4|Overall Study|Death|2
140354|NCT00450333|463840|P3|Overall Study|Death|2
140355|NCT00450333|463841|P2|Overall Study|Death|2
140356|NCT00450333|463842|P1|Overall Study|Death|3
140357|NCT00450333|463839|P4|Overall Study|Kidney transplant|3
140358|NCT00450333|463840|P3|Overall Study|Kidney transplant|1
140359|NCT00450333|463841|P2|Overall Study|Kidney transplant|0
140360|NCT00450333|463842|P1|Overall Study|Kidney transplant|1
140361|NCT00450333|463839|P4|Overall Study|Withdrawal by Subject|0
140362|NCT00450333|463840|P3|Overall Study|Withdrawal by Subject|3
140363|NCT00450333|463841|P2|Overall Study|Withdrawal by Subject|0
140364|NCT00450333|463842|P1|Overall Study|Withdrawal by Subject|1
140365|NCT00450333|463839|P4|Overall Study|Protocol Violation|0
140366|NCT00450333|463840|P3|Overall Study|Protocol Violation|1
140367|NCT00450333|463841|P2|Overall Study|Protocol Violation|0
140368|NCT00450333|463842|P1|Overall Study|Protocol Violation|1
140369|NCT00450333|463839|P4|Overall Study|Adverse Event|2
140370|NCT00450333|463840|P3|Overall Study|Adverse Event|2
140371|NCT00450333|463841|P2|Overall Study|Adverse Event|7
140372|NCT00450333|463842|P1|Overall Study|Adverse Event|1
140373|NCT00450333|463839|P4|Overall Study|Study terminated|21
140374|NCT00450333|463840|P3|Overall Study|Study terminated|16
140375|NCT00450333|463841|P2|Overall Study|Study terminated|54
140376|NCT00450333|463842|P1|Overall Study|Study terminated|47
140377|NCT00450255|463865|P1|Overall Study|Prior RFA ablation of liver|1
140378|NCT00450216|463888|P2|Overall Study|misc|20
140379|NCT00450216|463889|P1|Overall Study|misc|21
140380|NCT00450216|463888|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
140381|NCT00450216|463889|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
140382|NCT00450216|463888|P2|Overall Study|Lost to Follow-up|9
140383|NCT00450216|463889|P1|Overall Study|Lost to Follow-up|16
140384|NCT00450216|463888|P2|Overall Study|Withdrawal by Subject|26
140385|NCT00450216|463889|P1|Overall Study|Withdrawal by Subject|48
140386|NCT00450216|463888|P2|Overall Study|Adverse Event|23
140387|NCT00450216|463889|P1|Overall Study|Adverse Event|38
140388|NCT00450112|463903|P2|Overall Study|Others|3
140389|NCT00450112|463904|P1|Overall Study|Others|2
140390|NCT00450112|463903|P2|Overall Study|Lost to Follow-up|1
140391|NCT00450112|463904|P1|Overall Study|Lost to Follow-up|2
140392|NCT00450112|463903|P2|Overall Study|Withdrawal by Subject|1
140393|NCT00450112|463904|P1|Overall Study|Withdrawal by Subject|4
140394|NCT00450112|463903|P2|Overall Study|Other Treatment Required|1
140395|NCT00450112|463904|P1|Overall Study|Other Treatment Required|5
140396|NCT00449956|463942|P3|Overall Study|Physician Decision|1
140397|NCT00449956|463943|P2|Overall Study|Physician Decision|1
140398|NCT00449956|463944|P1|Overall Study|Physician Decision|2
140399|NCT00449956|463942|P3|Overall Study|Withdrawal by Subject|0
140400|NCT00449956|463943|P2|Overall Study|Withdrawal by Subject|1
140401|NCT00449956|463944|P1|Overall Study|Withdrawal by Subject|0
140402|NCT00449956|463942|P3|Overall Study|Protocol Violation|1
140403|NCT00449956|463943|P2|Overall Study|Protocol Violation|1
140404|NCT00449956|463944|P1|Overall Study|Protocol Violation|1
140405|NCT00449956|463942|P3|Overall Study|Lack of Efficacy|1
140406|NCT00449956|463943|P2|Overall Study|Lack of Efficacy|0
140407|NCT00449956|463944|P1|Overall Study|Lack of Efficacy|0
140408|NCT00449956|463942|P3|Overall Study|Adverse Event|6
140409|NCT00449956|463943|P2|Overall Study|Adverse Event|1
140410|NCT00449956|463944|P1|Overall Study|Adverse Event|7
140411|NCT00449930|463960|P2|Overall Study|Glycemic discontinuation criteria|1
140412|NCT00449930|463961|P1|Overall Study|Glycemic discontinuation criteria|1
140413|NCT00449930|463960|P2|Overall Study|Withdrawal by Subject|23
140414|NCT00449930|463961|P1|Overall Study|Withdrawal by Subject|16
140415|NCT00449930|463960|P2|Overall Study|Protocol Violation|15
140416|NCT00449930|463961|P1|Overall Study|Protocol Violation|14
140417|NCT00449930|463960|P2|Overall Study|Physician Decision|2
140418|NCT00449930|463961|P1|Overall Study|Physician Decision|1
140419|NCT00449930|463960|P2|Overall Study|Lost to Follow-up|14
140420|NCT00449930|463961|P1|Overall Study|Lost to Follow-up|9
140421|NCT00449930|463960|P2|Overall Study|Lack of Efficacy|1
140422|NCT00449930|463961|P1|Overall Study|Lack of Efficacy|10
140423|NCT00449930|463960|P2|Overall Study|Trial Terminated ( Site Closed)|0
140424|NCT00449930|463961|P1|Overall Study|Trial Terminated ( Site Closed)|1
140425|NCT00449930|463960|P2|Overall Study|Adverse Event|19
140426|NCT00449930|463961|P1|Overall Study|Adverse Event|9
140427|NCT00449865|463977|P2|Overall Study|Study was stopped|328
140428|NCT00449865|463978|P1|Overall Study|Study was stopped|324
140429|NCT00449865|463977|P2|Overall Study|Protocol Violation|7
140430|NCT00449865|463978|P1|Overall Study|Protocol Violation|8
140431|NCT00449865|463977|P2|Overall Study|Death|40
140432|NCT00449865|463978|P1|Overall Study|Death|31
140433|NCT00449865|463977|P2|Overall Study|Physician Decision|12
140434|NCT00449865|463978|P1|Overall Study|Physician Decision|13
140435|NCT00449865|463977|P2|Overall Study|Lost to Follow-up|37
140436|NCT00449865|463978|P1|Overall Study|Lost to Follow-up|36
140437|NCT00449865|463977|P2|Overall Study|Withdrawal by Subject|110
140438|NCT00449865|463978|P1|Overall Study|Withdrawal by Subject|110
140439|NCT00449787|463986|P2|Overall Study|Did not require medication|92
140440|NCT00449787|463987|P1|Overall Study|Did not require medication|95
140441|NCT00449787|463986|P2|Overall Study|Lost to Follow-up|8
140442|NCT00449787|463987|P1|Overall Study|Lost to Follow-up|10
140443|NCT00449696|464003|P2|Overall Study|Others|0
140444|NCT00449696|464004|P1|Overall Study|Others|7
140445|NCT00449696|464003|P2|Overall Study|Lost to Follow-up|3
140446|NCT00449696|464004|P1|Overall Study|Lost to Follow-up|2
140447|NCT00449696|464003|P2|Overall Study|Withdrawal by Subject|5
140448|NCT00449696|464004|P1|Overall Study|Withdrawal by Subject|5
140449|NCT00449696|464003|P2|Overall Study|Other Treatment Required|1
140450|NCT00449696|464004|P1|Overall Study|Other Treatment Required|6
140451|NCT00449644|464030|P4|Overall Study|Rolled-over to treatment with TMC207|1
140452|NCT00449644|464031|P3|Overall Study|Rolled-over to treatment with TMC207|0
140453|NCT00449644|464032|P2|Overall Study|Rolled-over to treatment with TMC207|0
140454|NCT00449644|464033|P1|Overall Study|Rolled-over to treatment with TMC207|0
140455|NCT00449644|464030|P4|Overall Study|Not specified|0
140456|NCT00449644|464031|P3|Overall Study|Not specified|1
140457|NCT00449644|464032|P2|Overall Study|Not specified|4
140458|NCT00449644|464033|P1|Overall Study|Not specified|1
140459|NCT00449644|464030|P4|Overall Study|Inclusion/exclusion criteria not met|6
140460|NCT00449644|464031|P3|Overall Study|Inclusion/exclusion criteria not met|2
140461|NCT00449644|464032|P2|Overall Study|Inclusion/exclusion criteria not met|0
140462|NCT00449644|464033|P1|Overall Study|Inclusion/exclusion criteria not met|0
140463|NCT00449644|464030|P4|Overall Study|Withdrawal by Subject|7
140464|NCT00449644|464031|P3|Overall Study|Withdrawal by Subject|6
140465|NCT00449644|464032|P2|Overall Study|Withdrawal by Subject|4
140466|NCT00449644|464033|P1|Overall Study|Withdrawal by Subject|3
140467|NCT00449644|464030|P4|Overall Study|Protocol Violation|7
140468|NCT00449644|464031|P3|Overall Study|Protocol Violation|3
140469|NCT00449644|464032|P2|Overall Study|Protocol Violation|4
140470|NCT00449644|464033|P1|Overall Study|Protocol Violation|4
140471|NCT00449644|464030|P4|Overall Study|Pregnancy|2
140472|NCT00449644|464031|P3|Overall Study|Pregnancy|3
140473|NCT00449644|464032|P2|Overall Study|Pregnancy|0
140474|NCT00449644|464033|P1|Overall Study|Pregnancy|0
140475|NCT00449644|464030|P4|Overall Study|Lost to Follow-up|3
140476|NCT00449644|464031|P3|Overall Study|Lost to Follow-up|5
140477|NCT00449644|464032|P2|Overall Study|Lost to Follow-up|1
140478|NCT00449644|464033|P1|Overall Study|Lost to Follow-up|1
140479|NCT00449644|464030|P4|Overall Study|Death|1
140480|NCT00449644|464031|P3|Overall Study|Death|6
140481|NCT00449644|464032|P2|Overall Study|Death|0
140482|NCT00449644|464033|P1|Overall Study|Death|1
140483|NCT00449644|464030|P4|Overall Study|Adverse Event|5
140484|NCT00449644|464031|P3|Overall Study|Adverse Event|3
140485|NCT00449644|464032|P2|Overall Study|Adverse Event|0
140486|NCT00449644|464033|P1|Overall Study|Adverse Event|0
140487|NCT00449540|464053|P3|Treatment Phase|did not experience or treat migraine|17
140488|NCT00449540|464054|P2|Treatment Phase|did not experience or treat migraine|20
140489|NCT00449540|464055|P1|Treatment Phase|did not experience or treat migraine|0
140490|NCT00449540|464053|P3|Pretreatment Phase|No migraine experienced|0
140491|NCT00449540|464054|P2|Pretreatment Phase|No migraine experienced|0
140492|NCT00449540|464055|P1|Pretreatment Phase|No migraine experienced|66
140493|NCT00449176|464072|P3|Overall Study|all other|20
140494|NCT00449176|464073|P2|Overall Study|all other|19
140495|NCT00449176|464074|P1|Overall Study|all other|22
140496|NCT00449176|464072|P3|Overall Study|Study drug non-compliant|11
140497|NCT00449176|464073|P2|Overall Study|Study drug non-compliant|11
140498|NCT00449176|464074|P1|Overall Study|Study drug non-compliant|14
140499|NCT00449176|464072|P3|Overall Study|Lack of Efficacy|50
140500|NCT00449176|464073|P2|Overall Study|Lack of Efficacy|7
140501|NCT00449176|464074|P1|Overall Study|Lack of Efficacy|13
140502|NCT00449176|464072|P3|Overall Study|Adverse Event|15
140503|NCT00449176|464073|P2|Overall Study|Adverse Event|107
140504|NCT00449176|464074|P1|Overall Study|Adverse Event|51
140505|NCT00449176|464072|P3|Overall Study|Lost to Follow-up|12
140506|NCT00449176|464073|P2|Overall Study|Lost to Follow-up|8
140507|NCT00449176|464074|P1|Overall Study|Lost to Follow-up|13
140508|NCT00449176|464072|P3|Overall Study|Withdrawal by Subject|59
140509|NCT00449176|464073|P2|Overall Study|Withdrawal by Subject|43
140510|NCT00449176|464074|P1|Overall Study|Withdrawal by Subject|39
140511|NCT00449163|464100|P1|Overall Study|Physician Decision|3
140512|NCT00449150|464109|P3|Overall Study|Protocol Violation|1
140513|NCT00449150|464110|P2|Overall Study|Protocol Violation|2
140514|NCT00449150|464111|P1|Overall Study|Protocol Violation|1
140515|NCT00449150|464109|P3|Overall Study|Withdrawal by Subject|21
140516|NCT00449150|464110|P2|Overall Study|Withdrawal by Subject|18
140517|NCT00449150|464111|P1|Overall Study|Withdrawal by Subject|17
140518|NCT00449150|464109|P3|Overall Study|Not specified|14
140519|NCT00449150|464110|P2|Overall Study|Not specified|13
140520|NCT00449150|464111|P1|Overall Study|Not specified|16
140521|NCT00449150|464109|P3|Overall Study|Lack of Efficacy|2
140522|NCT00449150|464110|P2|Overall Study|Lack of Efficacy|2
140523|NCT00449150|464111|P1|Overall Study|Lack of Efficacy|1
140524|NCT00449150|464109|P3|Overall Study|Adverse Event|9
140525|NCT00449150|464110|P2|Overall Study|Adverse Event|18
140526|NCT00449150|464111|P1|Overall Study|Adverse Event|11
140527|NCT00449072|464121|P2|Overall Study|Relocation|2
140528|NCT00449072|464122|P1|Overall Study|Relocation|3
140529|NCT00449072|464121|P2|Overall Study|Sponsor decision|3
140530|NCT00449072|464122|P1|Overall Study|Sponsor decision|1
140531|NCT00449072|464121|P2|Overall Study|Non-compliance|5
140532|NCT00449072|464122|P1|Overall Study|Non-compliance|2
140533|NCT00449072|464121|P2|Overall Study|Excluded medication|2
140534|NCT00449072|464122|P1|Overall Study|Excluded medication|0
140535|NCT00449072|464121|P2|Overall Study|Not treated|1
140536|NCT00449072|464122|P1|Overall Study|Not treated|0
140537|NCT00449072|464121|P2|Overall Study|Physician Decision|0
140538|NCT00449072|464122|P1|Overall Study|Physician Decision|1
140539|NCT00449072|464121|P2|Overall Study|Lack of Efficacy|1
140540|NCT00449072|464122|P1|Overall Study|Lack of Efficacy|1
140541|NCT00449072|464121|P2|Overall Study|Withdrawal by Subject|8
140542|NCT00449072|464122|P1|Overall Study|Withdrawal by Subject|11
140543|NCT00449072|464121|P2|Overall Study|Lost to Follow-up|7
140544|NCT00449072|464122|P1|Overall Study|Lost to Follow-up|5
140545|NCT00449072|464121|P2|Overall Study|Protocol Violation|12
140546|NCT00449072|464122|P1|Overall Study|Protocol Violation|14
140547|NCT00449072|464121|P2|Overall Study|Adverse Event|1
140548|NCT00449072|464122|P1|Overall Study|Adverse Event|3
140549|NCT00449033|464159|P2|Follow-up Period|Reason Missing|113
140550|NCT00449033|464160|P1|Follow-up Period|Reason Missing|120
140551|NCT00449033|464159|P2|Follow-up Period|Lost to Follow-up|10
140552|NCT00449033|464160|P1|Follow-up Period|Lost to Follow-up|6
140553|NCT00449033|464159|P2|Follow-up Period|Death|311
140554|NCT00449033|464160|P1|Follow-up Period|Death|299
140555|NCT00449033|464159|P2|Treatment Period|Treatment Ongoing|4
140556|NCT00449033|464160|P1|Treatment Period|Treatment Ongoing|6
140557|NCT00449033|464159|P2|Treatment Period|Reason Missing|4
140558|NCT00449033|464160|P1|Treatment Period|Reason Missing|0
140559|NCT00449033|464159|P2|Treatment Period|Second Malignancy|1
140560|NCT00449033|464160|P1|Treatment Period|Second Malignancy|0
140561|NCT00449033|464159|P2|Treatment Period|Non-compliance|8
140562|NCT00449033|464160|P1|Treatment Period|Non-compliance|7
140563|NCT00449033|464159|P2|Treatment Period|Amended Protocol Criteria|18
140564|NCT00449033|464160|P1|Treatment Period|Amended Protocol Criteria|22
140565|NCT00449033|464159|P2|Treatment Period|Consent Withdrawn|20
140566|NCT00449033|464160|P1|Treatment Period|Consent Withdrawn|36
140567|NCT00449033|464159|P2|Treatment Period|Disease Progression|288
140568|NCT00449033|464160|P1|Treatment Period|Disease Progression|231
140569|NCT00449033|464159|P2|Treatment Period|Protocol Violation|7
140570|NCT00449033|464160|P1|Treatment Period|Protocol Violation|8
140571|NCT00449033|464159|P2|Treatment Period|Physician Decision|5
140572|NCT00449033|464160|P1|Treatment Period|Physician Decision|4
140573|NCT00449033|464159|P2|Treatment Period|Lost to Follow-up|2
140574|NCT00449033|464160|P1|Treatment Period|Lost to Follow-up|0
140575|NCT00449033|464159|P2|Treatment Period|Death|12
140576|NCT00449033|464160|P1|Treatment Period|Death|21
140577|NCT00449033|464159|P2|Treatment Period|Adverse Event|83
140578|NCT00449033|464160|P1|Treatment Period|Adverse Event|117
140579|NCT00448916|464198|P4|Overall Study|Protocol Violation|1
140580|NCT00448916|464199|P3|Overall Study|Protocol Violation|0
140581|NCT00448916|464200|P2|Overall Study|Protocol Violation|0
140582|NCT00448916|464201|P1|Overall Study|Protocol Violation|0
140583|NCT00448916|464198|P4|Overall Study|Lost to Follow-up|1
140584|NCT00448916|464199|P3|Overall Study|Lost to Follow-up|0
140585|NCT00448916|464200|P2|Overall Study|Lost to Follow-up|1
140586|NCT00448916|464201|P1|Overall Study|Lost to Follow-up|0
140587|NCT00448916|464198|P4|Overall Study|Not specified|0
140588|NCT00448916|464199|P3|Overall Study|Not specified|0
140589|NCT00448916|464200|P2|Overall Study|Not specified|0
140590|NCT00448916|464201|P1|Overall Study|Not specified|1
140591|NCT00448916|464198|P4|Overall Study|Withdrawal by Subject|1
140592|NCT00448916|464199|P3|Overall Study|Withdrawal by Subject|1
140593|NCT00448916|464200|P2|Overall Study|Withdrawal by Subject|3
140594|NCT00448916|464201|P1|Overall Study|Withdrawal by Subject|3
140595|NCT00448916|464198|P4|Overall Study|Lack of Efficacy|1
140596|NCT00448916|464199|P3|Overall Study|Lack of Efficacy|2
140597|NCT00448916|464200|P2|Overall Study|Lack of Efficacy|0
140598|NCT00448916|464201|P1|Overall Study|Lack of Efficacy|1
140599|NCT00448916|464198|P4|Overall Study|Adverse Event|2
140600|NCT00448916|464199|P3|Overall Study|Adverse Event|3
140601|NCT00448916|464200|P2|Overall Study|Adverse Event|2
140602|NCT00448916|464201|P1|Overall Study|Adverse Event|2
140603|NCT00448864|464275|P3|Overall Study|Protocol Violation|0
140604|NCT00448864|464276|P2|Overall Study|Protocol Violation|2
140605|NCT00448864|464277|P1|Overall Study|Protocol Violation|0
140606|NCT00448864|464275|P3|Overall Study|Withdrawal by Subject|0
140607|NCT00448864|464276|P2|Overall Study|Withdrawal by Subject|2
140608|NCT00448864|464277|P1|Overall Study|Withdrawal by Subject|0
140609|NCT00448864|464275|P3|Overall Study|Physician Decision|1
140610|NCT00448864|464276|P2|Overall Study|Physician Decision|0
140611|NCT00448864|464277|P1|Overall Study|Physician Decision|1
140612|NCT00448864|464275|P3|Overall Study|Lost to Follow-up|0
140613|NCT00448864|464276|P2|Overall Study|Lost to Follow-up|1
140614|NCT00448864|464277|P1|Overall Study|Lost to Follow-up|3
140615|NCT00448864|464275|P3|Overall Study|Death|0
140616|NCT00448864|464276|P2|Overall Study|Death|0
140617|NCT00448864|464277|P1|Overall Study|Death|1
140618|NCT00448760|464293|P1|Overall Study|Death|3
140619|NCT00448708|464302|P2|Overall Study|not listed|2
140620|NCT00448708|464303|P1|Overall Study|not listed|0
140621|NCT00448708|464302|P2|Overall Study|Lost to Follow-up|8
140622|NCT00448708|464303|P1|Overall Study|Lost to Follow-up|6
140623|NCT00448708|464302|P2|Overall Study|Withdrawal by Subject|4
140624|NCT00448708|464303|P1|Overall Study|Withdrawal by Subject|8
140625|NCT00448708|464302|P2|Overall Study|Death|17
140626|NCT00448708|464303|P1|Overall Study|Death|21
140627|NCT00448591|464362|P1|Overall Study|Termination of Study|70
140628|NCT00448591|464362|P1|Overall Study|Not specified|154
140629|NCT00448591|464362|P1|Overall Study|Treatment Regimen Completed|70
140630|NCT00448591|464362|P1|Overall Study|Lost to Follow-up|19
140631|NCT00448591|464362|P1|Overall Study|Protocol Violation|41
140632|NCT00448591|464362|P1|Overall Study|Adverse Event|382
140633|NCT00448591|464362|P1|Overall Study|Progressive Disease|1382
140634|NCT00448591|464362|P1|Overall Study|Withdrawal by Subject|178
140635|NCT00448539|464373|P2|Overall Study|Lost to Follow-up|3
140636|NCT00448539|464374|P1|Overall Study|Lost to Follow-up|1
140637|NCT00448539|464373|P2|Overall Study|Change of meds|3
140638|NCT00448539|464374|P1|Overall Study|Change of meds|2
140639|NCT00448539|464373|P2|Overall Study|Miscellaneous|1
140640|NCT00448539|464374|P1|Overall Study|Miscellaneous|2
140641|NCT00448539|464373|P2|Overall Study|Lack of Efficacy|40
140642|NCT00448539|464374|P1|Overall Study|Lack of Efficacy|27
140643|NCT00448539|464373|P2|Overall Study|Adverse Event|26
140644|NCT00448539|464374|P1|Overall Study|Adverse Event|9
140645|NCT00448539|464373|P2|Overall Study|Diary non-compliance|0
140646|NCT00448539|464374|P1|Overall Study|Diary non-compliance|1
140647|NCT00448539|464373|P2|Overall Study|Withdrawal by Subject|24
140648|NCT00448539|464374|P1|Overall Study|Withdrawal by Subject|20
140649|NCT00448539|464373|P2|Overall Study|Request of the investigator or sponsor|54
140650|NCT00448539|464374|P1|Overall Study|Request of the investigator or sponsor|67
140651|NCT00448539|464373|P2|Overall Study|Protocol Violation|0
140652|NCT00448539|464374|P1|Overall Study|Protocol Violation|1
140653|NCT00448539|464373|P2|Overall Study|Medication non-compliance|1
140654|NCT00448539|464374|P1|Overall Study|Medication non-compliance|4
140655|NCT00448448|464382|P2|Overall Study|Wrong diagnosis (n=3) or other|2
140656|NCT00448448|464383|P1|Overall Study|Wrong diagnosis (n=3) or other|2
140657|NCT00448448|464382|P2|Overall Study|Lost to Follow-up|1
140658|NCT00448448|464383|P1|Overall Study|Lost to Follow-up|2
140659|NCT00448448|464382|P2|Overall Study|On protocol when study ended|36
140660|NCT00448448|464383|P1|Overall Study|On protocol when study ended|83
140661|NCT00448448|464382|P2|Overall Study|Withdrawal by Subject|2
140662|NCT00448448|464383|P1|Overall Study|Withdrawal by Subject|13
140663|NCT00448435|464389|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
140664|NCT00448435|464390|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
140665|NCT00448344|464418|P2|Overall Study|Physician Decision|2
140666|NCT00448344|464419|P1|Overall Study|Physician Decision|1
140667|NCT00448344|464418|P2|Overall Study|Death|4
140668|NCT00448344|464419|P1|Overall Study|Death|3
140669|NCT00448344|464418|P2|Overall Study|Withdrawal by Subject|8
140670|NCT00448344|464419|P1|Overall Study|Withdrawal by Subject|6
140671|NCT00448344|464418|P2|Overall Study|Lost to Follow-up|22
140672|NCT00448344|464419|P1|Overall Study|Lost to Follow-up|20
140673|NCT00448279|464429|P2|Overall Study|Protocol Violation|1
140674|NCT00448279|464430|P1|Overall Study|Protocol Violation|0
140675|NCT00448279|464429|P2|Overall Study|Not specified|4
140676|NCT00448279|464430|P1|Overall Study|Not specified|6
140677|NCT00448279|464429|P2|Overall Study|Withdrawal by Subject|3
140678|NCT00448279|464430|P1|Overall Study|Withdrawal by Subject|4
140679|NCT00448279|464429|P2|Overall Study|Disease progression|18
140680|NCT00448279|464430|P1|Overall Study|Disease progression|16
140681|NCT00448279|464429|P2|Overall Study|Adverse Event|1
140682|NCT00448279|464430|P1|Overall Study|Adverse Event|1
140683|NCT00448279|464429|P2|Overall Study|Lost to Follow-up|2
140684|NCT00448279|464430|P1|Overall Study|Lost to Follow-up|2
140685|NCT00448136|464484|P2|Overall Study|Investigator's decision (progression)|0
140686|NCT00448136|464485|P1|Overall Study|Investigator's decision (progression)|1
140687|NCT00448136|464484|P2|Overall Study|Death|8
140688|NCT00448136|464485|P1|Overall Study|Death|3
140689|NCT00448123|464523|P2|Overall Study|Physician Decision|6
140690|NCT00448123|464524|P1|Overall Study|Physician Decision|6
140691|NCT00448123|464523|P2|Overall Study|Lost to Follow-up|6
140692|NCT00448123|464524|P1|Overall Study|Lost to Follow-up|9
140693|NCT00448019|464534|P1|Overall Study|Insurance Issues|1
140694|NCT00448019|464534|P1|Overall Study|Death|2
140695|NCT00448019|464534|P1|Overall Study|Disease progression|1
140696|NCT00448019|464534|P1|Overall Study|Withdrawal by Subject|3
140697|NCT00447902|464542|P2|Overall Study|Lack of Efficacy|1
140698|NCT00447902|464543|P1|Overall Study|Lack of Efficacy|2
140699|NCT00447902|464542|P2|Overall Study|included patients who discontinued|1
140700|NCT00447902|464543|P1|Overall Study|included patients who discontinued|1
140701|NCT00447902|464542|P2|Overall Study|Withdrawal by Subject|1
140702|NCT00447902|464543|P1|Overall Study|Withdrawal by Subject|0
140703|NCT00447902|464542|P2|Overall Study|Protocol Violation|0
140704|NCT00447902|464543|P1|Overall Study|Protocol Violation|1
140705|NCT00447902|464542|P2|Overall Study|Adverse Event|3
140706|NCT00447902|464543|P1|Overall Study|Adverse Event|0
140707|NCT00447603|464583|P3|Filter Period|Study terminated by Sponsor|10
140708|NCT00447603|464584|P2|Filter Period|Study terminated by Sponsor|1
140709|NCT00447603|464585|P1|Filter Period|Study terminated by Sponsor|0
140710|NCT00447603|464583|P3|Filter Period|Screen Failure|4
140711|NCT00447603|464584|P2|Filter Period|Screen Failure|3
140712|NCT00447603|464585|P1|Filter Period|Screen Failure|0
140713|NCT00447603|464583|P3|Filter Period|Adverse Event|1
140714|NCT00447603|464584|P2|Filter Period|Adverse Event|0
140715|NCT00447603|464585|P1|Filter Period|Adverse Event|0
140716|NCT00447603|464583|P3|Screening|Study Terminated by Sponsor|0
140717|NCT00447603|464584|P2|Screening|Study Terminated by Sponsor|0
140718|NCT00447603|464585|P1|Screening|Study Terminated by Sponsor|15
140719|NCT00447603|464583|P3|Screening|Screen Failure|0
140720|NCT00447603|464584|P2|Screening|Screen Failure|0
140721|NCT00447603|464585|P1|Screening|Screen Failure|4
140722|NCT00447603|464583|P3|Screening|Protocol Violation|0
140723|NCT00447603|464584|P2|Screening|Protocol Violation|0
140724|NCT00447603|464585|P1|Screening|Protocol Violation|1
140725|NCT00447603|464583|P3|Screening|Withdrawal by Subject|0
140726|NCT00447603|464584|P2|Screening|Withdrawal by Subject|0
140727|NCT00447603|464585|P1|Screening|Withdrawal by Subject|1
140728|NCT00447590|464605|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
140729|NCT00447590|464605|P1|Overall Study|Lost to Follow-up|24
140730|NCT00447590|464605|P1|Overall Study|Withdrawal by Subject|26
140731|NCT00447499|464614|P1|Overall Study|Physician Decision|1
140732|NCT00447499|464614|P1|Overall Study|Sponsor Decision|1
140733|NCT00447499|464614|P1|Overall Study|Patient Decision|4
140734|NCT00447499|464614|P1|Overall Study|Adverse Event|1
140735|NCT00447421|464624|P1|Overall Study|Sponsor Decision|2
140736|NCT00447421|464624|P1|Overall Study|Adverse Event|3
140737|NCT00447421|464624|P1|Overall Study|Lack of Efficacy|1
140738|NCT00447382|464636|P2|Overall Study|Unclassified|5
140739|NCT00447382|464637|P1|Overall Study|Unclassified|2
140740|NCT00447382|464636|P2|Overall Study|Protocol Violation|0
140741|NCT00447382|464637|P1|Overall Study|Protocol Violation|2
140742|NCT00447382|464636|P2|Overall Study|Lack of Efficacy|0
140743|NCT00447382|464637|P1|Overall Study|Lack of Efficacy|1
140744|NCT00447382|464636|P2|Overall Study|Adverse Event|1
140745|NCT00447382|464637|P1|Overall Study|Adverse Event|1
140746|NCT00447278|464698|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
140747|NCT00447278|464699|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
140748|NCT00447278|464698|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
140749|NCT00447278|464699|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
140750|NCT00447278|464698|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
140751|NCT00447278|464699|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
140752|NCT00447278|464698|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
140753|NCT00447278|464699|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
140754|NCT00447278|464698|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
140755|NCT00447278|464699|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
140756|NCT00447278|464698|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
140757|NCT00447278|464699|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
140758|NCT00447278|464698|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
140759|NCT00447278|464699|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
140760|NCT00447278|464698|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
140761|NCT00447278|464699|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
140762|NCT00447278|464698|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
140763|NCT00447278|464699|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
140764|NCT00447278|464698|P2|Period II (6 Month Open-Label)|Physician Decision|1
140765|NCT00447278|464699|P1|Period II (6 Month Open-Label)|Physician Decision|4
140766|NCT00447278|464698|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
140767|NCT00447278|464699|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
140768|NCT00447278|464698|P2|Period II (6 Month Open-Label)|Protocol Violation|7
140769|NCT00447278|464699|P1|Period II (6 Month Open-Label)|Protocol Violation|10
140770|NCT00447278|464698|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
140771|NCT00447278|464699|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
140772|NCT00447278|464698|P2|Period II (6 Month Open-Label)|Adverse Event|3
140773|NCT00447278|464699|P1|Period II (6 Month Open-Label)|Adverse Event|7
140774|NCT00447265|464720|P2|Overall Study|Physician Decision|0
140775|NCT00447265|464721|P1|Overall Study|Physician Decision|1
140776|NCT00447226|464734|P2|Double-blind Phase|Disease Progression|3
140777|NCT00447226|464735|P1|Double-blind Phase|Disease Progression|4
140778|NCT00447226|464734|P2|12-Week Open-label Phase|Physician Decision|1
140779|NCT00447226|464735|P1|12-Week Open-label Phase|Physician Decision|0
140780|NCT00447226|464734|P2|12-Week Open-label Phase|Disease Progression|20
140781|NCT00447226|464735|P1|12-Week Open-label Phase|Disease Progression|0
140782|NCT00447226|464734|P2|12-Week Open-label Phase|Protocol Violation|1
140783|NCT00447226|464735|P1|12-Week Open-label Phase|Protocol Violation|0
140784|NCT00447226|464734|P2|12-Week Open-label Phase|Adverse Event|3
140785|NCT00447226|464735|P1|12-Week Open-label Phase|Adverse Event|0
140786|NCT00447057|464761|P4|Overall Study|Death, study drug related|0
140787|NCT00447057|464762|P3|Overall Study|Death, study drug related|0
140788|NCT00447057|464763|P2|Overall Study|Death, study drug related|1
140789|NCT00447057|464764|P1|Overall Study|Death, study drug related|0
140790|NCT00447057|464761|P4|Overall Study|Death due to adverse event|2
140791|NCT00447057|464762|P3|Overall Study|Death due to adverse event|1
140792|NCT00447057|464763|P2|Overall Study|Death due to adverse event|0
140793|NCT00447057|464764|P1|Overall Study|Death due to adverse event|0
140794|NCT00447057|464761|P4|Overall Study|Progressive disease|18
140795|NCT00447057|464762|P3|Overall Study|Progressive disease|13
140796|NCT00447057|464763|P2|Overall Study|Progressive disease|43
140797|NCT00447057|464764|P1|Overall Study|Progressive disease|58
140798|NCT00447057|464761|P4|Overall Study|Sponsor decision|0
140799|NCT00447057|464762|P3|Overall Study|Sponsor decision|0
140800|NCT00447057|464763|P2|Overall Study|Sponsor decision|1
140801|NCT00447057|464764|P1|Overall Study|Sponsor decision|1
140802|NCT00447057|464761|P4|Overall Study|Physician Decision|1
140803|NCT00447057|464762|P3|Overall Study|Physician Decision|3
140804|NCT00447057|464763|P2|Overall Study|Physician Decision|6
140805|NCT00447057|464764|P1|Overall Study|Physician Decision|9
140806|NCT00447057|464761|P4|Overall Study|Withdrawal by Subject|1
140807|NCT00447057|464762|P3|Overall Study|Withdrawal by Subject|1
140808|NCT00447057|464763|P2|Overall Study|Withdrawal by Subject|5
140809|NCT00447057|464764|P1|Overall Study|Withdrawal by Subject|4
140810|NCT00447057|464761|P4|Overall Study|Protocol Violation|0
140811|NCT00447057|464762|P3|Overall Study|Protocol Violation|0
140812|NCT00447057|464763|P2|Overall Study|Protocol Violation|1
140813|NCT00447057|464764|P1|Overall Study|Protocol Violation|0
140814|NCT00447057|464761|P4|Overall Study|Entry criteria not met|0
140815|NCT00447057|464762|P3|Overall Study|Entry criteria not met|0
140816|NCT00447057|464763|P2|Overall Study|Entry criteria not met|1
140817|NCT00447057|464764|P1|Overall Study|Entry criteria not met|1
140818|NCT00447057|464761|P4|Overall Study|Lost to Follow-up|0
140819|NCT00447057|464762|P3|Overall Study|Lost to Follow-up|0
140820|NCT00447057|464763|P2|Overall Study|Lost to Follow-up|1
140821|NCT00447057|464764|P1|Overall Study|Lost to Follow-up|0
140822|NCT00447057|464761|P4|Overall Study|Death due to study disease|1
140823|NCT00447057|464762|P3|Overall Study|Death due to study disease|1
140824|NCT00447057|464763|P2|Overall Study|Death due to study disease|4
140825|NCT00447057|464764|P1|Overall Study|Death due to study disease|6
140826|NCT00447057|464761|P4|Overall Study|Adverse Event|3
140827|NCT00447057|464762|P3|Overall Study|Adverse Event|0
140828|NCT00447057|464763|P2|Overall Study|Adverse Event|10
140829|NCT00447057|464764|P1|Overall Study|Adverse Event|4
140830|NCT00447005|464782|P1|Overall Study|Lack of Efficacy|11
140831|NCT00447005|464782|P1|Overall Study|Adverse Event|1
140832|NCT00446992|464796|P1|Overall Study|Lost to Follow-up|5
140833|NCT00446992|464796|P1|Overall Study|Adverse Event|11
140834|NCT00446849|464808|P1|Maintenance Phase|concomitant medication use|1
140835|NCT00446849|464808|P1|Maintenance Phase|hydrocodone use|1
140836|NCT00446849|464808|P1|Maintenance Phase|study closure|1
140837|NCT00446849|464808|P1|Maintenance Phase|antibiotic use|1
140838|NCT00446849|464808|P1|Maintenance Phase|prohibited medication use|2
140839|NCT00446849|464808|P1|Maintenance Phase|noncompliance|2
140840|NCT00446849|464808|P1|Maintenance Phase|Pregnancy|1
140841|NCT00446849|464808|P1|Maintenance Phase|Lost to Follow-up|3
140842|NCT00446849|464808|P1|Maintenance Phase|Consent withdrawn|5
140843|NCT00446849|464808|P1|Maintenance Phase|Adverse Event|6
140844|NCT00446849|464808|P1|Maintenance Phase|Protocol Violation|7
140845|NCT00446849|464808|P1|Maintenance Phase|Lack of Efficacy|40
140846|NCT00446849|464808|P1|Acute Phase|noncompliance|1
140847|NCT00446849|464808|P1|Acute Phase|Physician Decision|1
140848|NCT00446849|464808|P1|Acute Phase|Lost to Follow-up|2
140849|NCT00446849|464808|P1|Acute Phase|Consent withdrawn|4
140850|NCT00446849|464808|P1|Acute Phase|Protocol Violation|10
140851|NCT00446849|464808|P1|Acute Phase|Lack of Efficacy|64
140852|NCT00446797|464820|P2|Overall Study|did not meet entrance criteria|1
140853|NCT00446797|464821|P1|Overall Study|did not meet entrance criteria|0
140854|NCT00446797|464820|P2|Overall Study|subject entered at another site|1
140855|NCT00446797|464821|P1|Overall Study|subject entered at another site|0
140856|NCT00446797|464820|P2|Overall Study|Protocol Violation|3
140857|NCT00446797|464821|P1|Overall Study|Protocol Violation|1
140858|NCT00446797|464820|P2|Overall Study|Withdrawal by Subject|2
140859|NCT00446797|464821|P1|Overall Study|Withdrawal by Subject|2
140860|NCT00446797|464820|P2|Overall Study|Lost to Follow-up|3
140861|NCT00446797|464821|P1|Overall Study|Lost to Follow-up|5
140862|NCT00446797|464820|P2|Overall Study|Lack of Efficacy|2
140863|NCT00446797|464821|P1|Overall Study|Lack of Efficacy|0
140864|NCT00446654|464867|P2|Overall Study|Adverse Event|0
140865|NCT00446654|464868|P1|Overall Study|Adverse Event|1
140866|NCT00446654|464867|P2|Overall Study|Withdrawal by Subject|0
140867|NCT00446654|464868|P1|Overall Study|Withdrawal by Subject|1
140868|NCT00446641|464876|P2|Overall Study|Lost to Follow-up|1
140869|NCT00446641|464877|P1|Overall Study|Lost to Follow-up|1
140870|NCT00446641|464876|P2|Overall Study|poor compliance|6
140871|NCT00446641|464877|P1|Overall Study|poor compliance|8
140872|NCT00446641|464876|P2|Overall Study|Withdrawal by Subject|3
140873|NCT00446641|464877|P1|Overall Study|Withdrawal by Subject|8
140874|NCT00446563|464897|P2|Overall Study|Administrative problems|1
140875|NCT00446563|464898|P1|Overall Study|Administrative problems|0
140876|NCT00446563|464897|P2|Overall Study|Withdrawal by Subject|1
140877|NCT00446563|464898|P1|Overall Study|Withdrawal by Subject|2
140878|NCT00446563|464897|P2|Overall Study|Unsatisfactory therapeutic effect|3
140879|NCT00446563|464898|P1|Overall Study|Unsatisfactory therapeutic effect|0
140880|NCT00446563|464897|P2|Overall Study|Abnormal test procedure result(s)|0
140881|NCT00446563|464898|P1|Overall Study|Abnormal test procedure result(s)|1
140882|NCT00446563|464897|P2|Overall Study|Abnormal laboratory value(s)|1
140883|NCT00446563|464898|P1|Overall Study|Abnormal laboratory value(s)|0
140884|NCT00446563|464897|P2|Overall Study|Adverse Event|3
140885|NCT00446563|464898|P1|Overall Study|Adverse Event|4
140886|NCT00446511|464936|P4|Overall Study|Administrative Problems|1
140887|NCT00446511|464937|P3|Overall Study|Administrative Problems|4
140888|NCT00446511|464938|P2|Overall Study|Administrative Problems|0
140889|NCT00446511|464939|P1|Overall Study|Administrative Problems|3
140890|NCT00446511|464936|P4|Overall Study|Withdrawal by Subject|3
140891|NCT00446511|464937|P3|Overall Study|Withdrawal by Subject|0
140892|NCT00446511|464938|P2|Overall Study|Withdrawal by Subject|0
140893|NCT00446511|464939|P1|Overall Study|Withdrawal by Subject|0
140894|NCT00446511|464936|P4|Overall Study|Protocol Violation|1
140895|NCT00446511|464937|P3|Overall Study|Protocol Violation|0
140896|NCT00446511|464938|P2|Overall Study|Protocol Violation|0
140897|NCT00446511|464939|P1|Overall Study|Protocol Violation|0
140898|NCT00446511|464936|P4|Overall Study|Adverse Event|1
140899|NCT00446511|464937|P3|Overall Study|Adverse Event|3
140900|NCT00446511|464938|P2|Overall Study|Adverse Event|2
140901|NCT00446511|464939|P1|Overall Study|Adverse Event|7
140902|NCT00446459|464963|P1|12 Months|14 subjects to MMF + Rituximab Study|14
140903|NCT00446459|464963|P1|12 Months|Protocol Violation|4
140904|NCT00446459|464963|P1|8 Months|Protocol Violation|12
140905|NCT00446446|464971|P1|Overall Study|On Treatment at Time of Data Cut-off|1
140906|NCT00446446|464971|P1|Overall Study|Adverse Event|1
140907|NCT00446446|464971|P1|Overall Study|Disease Progession|2
140908|NCT00446446|464971|P1|Overall Study|Other|4
140909|NCT00446446|464971|P1|Overall Study|Withdrawal by Subject|6
140910|NCT00446446|464971|P1|Overall Study|Death|10
140911|NCT00446251|464995|P1|Overall Study|Lost to Follow-up|1
140912|NCT00446251|464995|P1|Overall Study|Rituximab Infusion Reaction|2
140913|NCT00446251|464995|P1|Overall Study|On-study Transplants|2
140914|NCT00446199|465005|P4|Overall Study|Move|0
140915|NCT00446199|465006|P3|Overall Study|Move|0
140916|NCT00446199|465007|P2|Overall Study|Move|1
140917|NCT00446199|465008|P1|Overall Study|Move|0
140918|NCT00446199|465005|P4|Overall Study|In-/Exclusion criterion violated|1
140919|NCT00446199|465006|P3|Overall Study|In-/Exclusion criterion violated|2
140920|NCT00446199|465007|P2|Overall Study|In-/Exclusion criterion violated|1
140921|NCT00446199|465008|P1|Overall Study|In-/Exclusion criterion violated|2
140922|NCT00446199|465005|P4|Overall Study|Lost interest in study participation|0
140923|NCT00446199|465006|P3|Overall Study|Lost interest in study participation|0
140924|NCT00446199|465007|P2|Overall Study|Lost interest in study participation|1
140925|NCT00446199|465008|P1|Overall Study|Lost interest in study participation|0
140926|NCT00446199|465005|P4|Overall Study|Hormone fear|1
140927|NCT00446199|465006|P3|Overall Study|Hormone fear|0
140928|NCT00446199|465007|P2|Overall Study|Hormone fear|0
140929|NCT00446199|465008|P1|Overall Study|Hormone fear|0
140930|NCT00446199|465005|P4|Overall Study|Non-compliant with visit schedule|2
140931|NCT00446199|465006|P3|Overall Study|Non-compliant with visit schedule|1
140932|NCT00446199|465007|P2|Overall Study|Non-compliant with visit schedule|1
140933|NCT00446199|465008|P1|Overall Study|Non-compliant with visit schedule|1
140934|NCT00446199|465005|P4|Overall Study|Non-compliant with study drug|0
140935|NCT00446199|465006|P3|Overall Study|Non-compliant with study drug|5
140936|NCT00446199|465007|P2|Overall Study|Non-compliant with study drug|0
140937|NCT00446199|465008|P1|Overall Study|Non-compliant with study drug|1
140938|NCT00446199|465005|P4|Overall Study|Lack of Efficacy|1
140939|NCT00446199|465006|P3|Overall Study|Lack of Efficacy|0
140940|NCT00446199|465007|P2|Overall Study|Lack of Efficacy|0
140941|NCT00446199|465008|P1|Overall Study|Lack of Efficacy|1
140942|NCT00446199|465005|P4|Overall Study|Randomization in Error|1
140943|NCT00446199|465006|P3|Overall Study|Randomization in Error|1
140944|NCT00446199|465007|P2|Overall Study|Randomization in Error|0
140945|NCT00446199|465008|P1|Overall Study|Randomization in Error|2
140946|NCT00446199|465005|P4|Overall Study|Site termination|1
140947|NCT00446199|465006|P3|Overall Study|Site termination|0
140948|NCT00446199|465007|P2|Overall Study|Site termination|0
140949|NCT00446199|465008|P1|Overall Study|Site termination|2
140950|NCT00446199|465005|P4|Overall Study|Withdrawal by Subject|10
140951|NCT00446199|465006|P3|Overall Study|Withdrawal by Subject|9
140952|NCT00446199|465007|P2|Overall Study|Withdrawal by Subject|5
140953|NCT00446199|465008|P1|Overall Study|Withdrawal by Subject|2
140954|NCT00446199|465005|P4|Overall Study|Protocol Violation|3
140955|NCT00446199|465006|P3|Overall Study|Protocol Violation|1
140956|NCT00446199|465007|P2|Overall Study|Protocol Violation|2
140957|NCT00446199|465008|P1|Overall Study|Protocol Violation|1
140958|NCT00446199|465005|P4|Overall Study|Lost to Follow-up|6
140959|NCT00446199|465006|P3|Overall Study|Lost to Follow-up|2
140960|NCT00446199|465007|P2|Overall Study|Lost to Follow-up|5
140961|NCT00446199|465008|P1|Overall Study|Lost to Follow-up|4
140962|NCT00446199|465005|P4|Overall Study|Adverse Event|4
140963|NCT00446199|465006|P3|Overall Study|Adverse Event|6
140964|NCT00446199|465007|P2|Overall Study|Adverse Event|4
140965|NCT00446199|465008|P1|Overall Study|Adverse Event|7
140966|NCT00446134|465101|P4|Overall Study|Reason Not Completed|2
140967|NCT00446134|465102|P3|Overall Study|Reason Not Completed|1
140968|NCT00446134|465103|P2|Overall Study|Reason Not Completed|0
140969|NCT00446134|465104|P1|Overall Study|Reason Not Completed|3
140970|NCT00446134|465101|P4|Overall Study|Adverse Event-Diarrhea|0
140971|NCT00446134|465102|P3|Overall Study|Adverse Event-Diarrhea|2
140972|NCT00446134|465103|P2|Overall Study|Adverse Event-Diarrhea|1
140973|NCT00446134|465104|P1|Overall Study|Adverse Event-Diarrhea|1
140974|NCT00446134|465101|P4|Overall Study|Physician Decision|2
140975|NCT00446134|465102|P3|Overall Study|Physician Decision|0
140976|NCT00446134|465103|P2|Overall Study|Physician Decision|0
140977|NCT00446134|465104|P1|Overall Study|Physician Decision|0
140978|NCT00446134|465101|P4|Overall Study|Withdrawal by Subject|3
140979|NCT00446134|465102|P3|Overall Study|Withdrawal by Subject|1
140980|NCT00446134|465103|P2|Overall Study|Withdrawal by Subject|3
140981|NCT00446134|465104|P1|Overall Study|Withdrawal by Subject|3
140982|NCT00446134|465101|P4|Overall Study|Lost to Follow-up|1
140983|NCT00446134|465102|P3|Overall Study|Lost to Follow-up|1
140984|NCT00446134|465103|P2|Overall Study|Lost to Follow-up|3
140985|NCT00446134|465104|P1|Overall Study|Lost to Follow-up|1
140986|NCT00446134|465101|P4|Overall Study|Protocol Violation|0
140987|NCT00446134|465102|P3|Overall Study|Protocol Violation|1
140988|NCT00446134|465103|P2|Overall Study|Protocol Violation|2
140989|NCT00446134|465104|P1|Overall Study|Protocol Violation|0
140990|NCT00446134|465101|P4|Overall Study|Lack of Efficacy|19
140991|NCT00446134|465102|P3|Overall Study|Lack of Efficacy|24
140992|NCT00446134|465103|P2|Overall Study|Lack of Efficacy|19
140993|NCT00446134|465104|P1|Overall Study|Lack of Efficacy|19
140994|NCT00446134|465101|P4|Overall Study|Adverse Event|18
140995|NCT00446134|465102|P3|Overall Study|Adverse Event|13
140996|NCT00446134|465103|P2|Overall Study|Adverse Event|17
140997|NCT00446134|465104|P1|Overall Study|Adverse Event|7
140998|NCT00446095|465131|P5|Phase I (28 Days)|Lack of Efficacy|3
140999|NCT00446095|465132|P4|Phase I (28 Days)|Lack of Efficacy|0
141000|NCT00446095|465133|P3|Phase I (28 Days)|Lack of Efficacy|0
141001|NCT00446095|465134|P2|Phase I (28 Days)|Lack of Efficacy|0
141002|NCT00446095|465135|P1|Phase I (28 Days)|Lack of Efficacy|0
141003|NCT00446095|465131|P5|Phase I (28 Days)|Adverse Event|0
141004|NCT00446095|465132|P4|Phase I (28 Days)|Adverse Event|1
141005|NCT00446095|465133|P3|Phase I (28 Days)|Adverse Event|0
141006|NCT00446095|465134|P2|Phase I (28 Days)|Adverse Event|0
141007|NCT00446095|465135|P1|Phase I (28 Days)|Adverse Event|0
141008|NCT00446095|465131|P5|Phase II (8 Weeks)|Ongoing|0
141009|NCT00446095|465132|P4|Phase II (8 Weeks)|Ongoing|0
141010|NCT00446095|465133|P3|Phase II (8 Weeks)|Ongoing|1
141011|NCT00446095|465134|P2|Phase II (8 Weeks)|Ongoing|0
141012|NCT00446095|465135|P1|Phase II (8 Weeks)|Ongoing|0
141013|NCT00446095|465131|P5|Phase II (8 Weeks)|Lack of Efficacy|0
141014|NCT00446095|465132|P4|Phase II (8 Weeks)|Lack of Efficacy|0
141015|NCT00446095|465133|P3|Phase II (8 Weeks)|Lack of Efficacy|1
141016|NCT00446095|465134|P2|Phase II (8 Weeks)|Lack of Efficacy|2
141017|NCT00446095|465135|P1|Phase II (8 Weeks)|Lack of Efficacy|9
141018|NCT00446095|465131|P5|Phase II (8 Weeks)|Physician Decision|0
141019|NCT00446095|465132|P4|Phase II (8 Weeks)|Physician Decision|0
141020|NCT00446095|465133|P3|Phase II (8 Weeks)|Physician Decision|0
141021|NCT00446095|465134|P2|Phase II (8 Weeks)|Physician Decision|0
141022|NCT00446095|465135|P1|Phase II (8 Weeks)|Physician Decision|1
141023|NCT00446095|465131|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
141024|NCT00446095|465132|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
141025|NCT00446095|465133|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
141026|NCT00446095|465134|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
141027|NCT00446095|465135|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
141028|NCT00446095|465131|P5|Phase II (8 Weeks)|Adverse Event|0
141029|NCT00446095|465132|P4|Phase II (8 Weeks)|Adverse Event|0
141030|NCT00446095|465133|P3|Phase II (8 Weeks)|Adverse Event|1
141031|NCT00446095|465134|P2|Phase II (8 Weeks)|Adverse Event|1
141032|NCT00446095|465135|P1|Phase II (8 Weeks)|Adverse Event|0
141033|NCT00446095|465131|P5|Phase II (8 Weeks)|Lost to Follow-up|0
141034|NCT00446095|465132|P4|Phase II (8 Weeks)|Lost to Follow-up|0
141035|NCT00446095|465133|P3|Phase II (8 Weeks)|Lost to Follow-up|0
141036|NCT00446095|465134|P2|Phase II (8 Weeks)|Lost to Follow-up|0
141037|NCT00446095|465135|P1|Phase II (8 Weeks)|Lost to Follow-up|1
141038|NCT00446030|465158|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
141039|NCT00446030|465159|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
141040|NCT00446030|465158|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
141041|NCT00446030|465159|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
141042|NCT00446030|465158|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
141043|NCT00446030|465159|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
141044|NCT00446030|465158|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
141045|NCT00446030|465159|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
141046|NCT00446030|465158|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
141047|NCT00446030|465159|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
141048|NCT00446030|465158|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
141049|NCT00446030|465159|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
141050|NCT00446030|465158|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
141051|NCT00446030|465159|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
141052|NCT00446030|465158|P2|FOLLOW-UP (up to 2-years)|Death|2
141053|NCT00446030|465159|P1|FOLLOW-UP (up to 2-years)|Death|2
141054|NCT00446030|465158|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
141055|NCT00446030|465159|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
141056|NCT00446030|465158|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
141057|NCT00446030|465159|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
141058|NCT00446030|465158|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
141059|NCT00446030|465159|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
141060|NCT00446030|465158|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
141061|NCT00446030|465159|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
141062|NCT00446030|465158|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
141063|NCT00446030|465159|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
141064|NCT00446030|465158|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
141065|NCT00446030|465159|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
141066|NCT00446030|465158|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
141067|NCT00446030|465159|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
141068|NCT00446030|465158|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
141069|NCT00446030|465159|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
141070|NCT00446030|465158|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
141071|NCT00446030|465159|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
141072|NCT00446030|465158|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
141073|NCT00446030|465159|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
141074|NCT00446030|465158|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
141075|NCT00446030|465159|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
141076|NCT00445939|465170|P4|Period B - Week 4 - Week 8|Adverse Event|1
141077|NCT00445939|465171|P3|Period B - Week 4 - Week 8|Adverse Event|0
141078|NCT00445939|465172|P2|Period B - Week 4 - Week 8|Adverse Event|0
141079|NCT00445939|465173|P1|Period B - Week 4 - Week 8|Adverse Event|2
141080|NCT00445939|465170|P4|Period A - Week 0 - Week 4|Adverse Event|0
141081|NCT00445939|465171|P3|Period A - Week 0 - Week 4|Adverse Event|0
141082|NCT00445939|465172|P2|Period A - Week 0 - Week 4|Adverse Event|2
141083|NCT00445939|465173|P1|Period A - Week 0 - Week 4|Adverse Event|1
141084|NCT00443898|465200|P4|Overall Study|Death|0
141085|NCT00443898|465201|P3|Overall Study|Death|0
141086|NCT00443898|465202|P2|Overall Study|Death|1
141087|NCT00443898|465203|P1|Overall Study|Death|0
141088|NCT00443898|465200|P4|Overall Study|Lost to Follow-up|10
141089|NCT00443898|465201|P3|Overall Study|Lost to Follow-up|14
141090|NCT00443898|465202|P2|Overall Study|Lost to Follow-up|10
141091|NCT00443898|465203|P1|Overall Study|Lost to Follow-up|10
141092|NCT00443898|465200|P4|Overall Study|Withdrawal by Subject|6
141093|NCT00443898|465201|P3|Overall Study|Withdrawal by Subject|10
141094|NCT00443898|465202|P2|Overall Study|Withdrawal by Subject|10
141095|NCT00443898|465203|P1|Overall Study|Withdrawal by Subject|11
141096|NCT00443898|465200|P4|Overall Study|Protocol Violation|0
141097|NCT00443898|465201|P3|Overall Study|Protocol Violation|1
141098|NCT00443898|465202|P2|Overall Study|Protocol Violation|1
141099|NCT00443898|465203|P1|Overall Study|Protocol Violation|1
141100|NCT00443898|465200|P4|Overall Study|Lack of Efficacy|1
141101|NCT00443898|465201|P3|Overall Study|Lack of Efficacy|3
141102|NCT00443898|465202|P2|Overall Study|Lack of Efficacy|3
141103|NCT00443898|465203|P1|Overall Study|Lack of Efficacy|2
141104|NCT00443898|465200|P4|Overall Study|Adverse Event|1
141105|NCT00443898|465201|P3|Overall Study|Adverse Event|1
141106|NCT00443898|465202|P2|Overall Study|Adverse Event|0
141107|NCT00443898|465203|P1|Overall Study|Adverse Event|0
141108|NCT00443872|465225|P1|Overall Study|Adverse Event|8
141109|NCT00443872|465225|P1|Overall Study|Lost to Follow-up|2
141110|NCT00443872|465225|P1|Overall Study|Protocol Violation|7
141111|NCT00443820|465242|P4|Overall Study|Death|0
141112|NCT00443820|465243|P3|Overall Study|Death|1
141113|NCT00443820|465244|P2|Overall Study|Death|0
141114|NCT00443820|465245|P1|Overall Study|Death|0
141115|NCT00443820|465242|P4|Overall Study|Administrative problems|1
141116|NCT00443820|465243|P3|Overall Study|Administrative problems|0
141117|NCT00443820|465244|P2|Overall Study|Administrative problems|0
141118|NCT00443820|465245|P1|Overall Study|Administrative problems|0
141119|NCT00443820|465242|P4|Overall Study|Lost to Follow-up|5
141120|NCT00443820|465243|P3|Overall Study|Lost to Follow-up|6
141121|NCT00443820|465244|P2|Overall Study|Lost to Follow-up|8
141122|NCT00443820|465245|P1|Overall Study|Lost to Follow-up|9
141123|NCT00443820|465242|P4|Overall Study|Withdrawal by Subject|9
141124|NCT00443820|465243|P3|Overall Study|Withdrawal by Subject|8
141125|NCT00443820|465244|P2|Overall Study|Withdrawal by Subject|7
141126|NCT00443820|465245|P1|Overall Study|Withdrawal by Subject|6
141127|NCT00443820|465242|P4|Overall Study|Protocol Violation|1
141128|NCT00443820|465243|P3|Overall Study|Protocol Violation|2
141129|NCT00443820|465244|P2|Overall Study|Protocol Violation|1
141130|NCT00443820|465245|P1|Overall Study|Protocol Violation|2
141131|NCT00443820|465242|P4|Overall Study|Lack of Efficacy|1
141132|NCT00443820|465243|P3|Overall Study|Lack of Efficacy|1
141133|NCT00443820|465244|P2|Overall Study|Lack of Efficacy|2
141134|NCT00443820|465245|P1|Overall Study|Lack of Efficacy|3
141135|NCT00443820|465242|P4|Overall Study|Adverse Event|0
141136|NCT00443820|465243|P3|Overall Study|Adverse Event|0
141137|NCT00443820|465244|P2|Overall Study|Adverse Event|1
141138|NCT00443820|465245|P1|Overall Study|Adverse Event|1
141139|NCT00443781|465267|P1|Overall Study|PD/FAD not done|1
141140|NCT00443781|465267|P1|Overall Study|Insurance not covered|2
141141|NCT00443781|465267|P1|Overall Study|Investigator terminated participation|1
141142|NCT00443781|465267|P1|Overall Study|Unable to comply with study follow up|2
141143|NCT00443781|465267|P1|Overall Study|Withdrawal by Subject|6
141144|NCT00443781|465267|P1|Overall Study|Protocol Violation|1
141145|NCT00443781|465267|P1|Overall Study|Physician Decision|2
141146|NCT00443781|465267|P1|Overall Study|Lost to Follow-up|10
141147|NCT00443755|465273|P2|Overall Study|Withdrawal by Subject|1
141148|NCT00443755|465274|P1|Overall Study|Withdrawal by Subject|2
141149|NCT00445848|465306|P1|Overall Study|Other-Not protocol specified|5
141150|NCT00445848|465306|P1|Overall Study|Progression|62
141151|NCT00445848|465306|P1|Overall Study|Withdrawal by Subject|4
141152|NCT00445848|465306|P1|Overall Study|Adverse Event|14
141153|NCT00445770|465316|P3|Overall Study|Not specified|6
141154|NCT00445770|465317|P2|Overall Study|Not specified|5
141155|NCT00445770|465318|P1|Overall Study|Not specified|6
141156|NCT00445770|465316|P3|Overall Study|Lost to Follow-up|0
141157|NCT00445770|465317|P2|Overall Study|Lost to Follow-up|2
141158|NCT00445770|465318|P1|Overall Study|Lost to Follow-up|0
141159|NCT00445770|465316|P3|Overall Study|Lack of Efficacy|6
141160|NCT00445770|465317|P2|Overall Study|Lack of Efficacy|13
141161|NCT00445770|465318|P1|Overall Study|Lack of Efficacy|38
141162|NCT00445770|465316|P3|Overall Study|Adverse Event|19
141163|NCT00445770|465317|P2|Overall Study|Adverse Event|15
141164|NCT00445770|465318|P1|Overall Study|Adverse Event|9
141165|NCT00445679|465418|P4|Overall Study|Lack of Efficacy|0
141166|NCT00445679|465419|P3|Overall Study|Lack of Efficacy|2
141167|NCT00445679|465420|P2|Overall Study|Lack of Efficacy|6
141168|NCT00445679|465421|P1|Overall Study|Lack of Efficacy|2
141169|NCT00445679|465418|P4|Overall Study|Withdrawal by Subject|18
141170|NCT00445679|465419|P3|Overall Study|Withdrawal by Subject|20
141171|NCT00445679|465420|P2|Overall Study|Withdrawal by Subject|14
141172|NCT00445679|465421|P1|Overall Study|Withdrawal by Subject|8
141173|NCT00445679|465418|P4|Overall Study|Protocol Violation|1
141174|NCT00445679|465419|P3|Overall Study|Protocol Violation|3
141175|NCT00445679|465420|P2|Overall Study|Protocol Violation|3
141176|NCT00445679|465421|P1|Overall Study|Protocol Violation|2
141177|NCT00445679|465418|P4|Overall Study|Withdrawal of Informed Consent|0
141178|NCT00445679|465419|P3|Overall Study|Withdrawal of Informed Consent|1
141179|NCT00445679|465420|P2|Overall Study|Withdrawal of Informed Consent|0
141180|NCT00445679|465421|P1|Overall Study|Withdrawal of Informed Consent|0
141181|NCT00445679|465418|P4|Overall Study|Compliance|2
141182|NCT00445679|465419|P3|Overall Study|Compliance|1
141183|NCT00445679|465420|P2|Overall Study|Compliance|2
141184|NCT00445679|465421|P1|Overall Study|Compliance|3
141185|NCT00445679|465418|P4|Overall Study|Lost to Follow-up|5
141186|NCT00445679|465419|P3|Overall Study|Lost to Follow-up|6
141187|NCT00445679|465420|P2|Overall Study|Lost to Follow-up|6
141188|NCT00445679|465421|P1|Overall Study|Lost to Follow-up|10
141189|NCT00445679|465418|P4|Overall Study|Physician Decision|0
141190|NCT00445679|465419|P3|Overall Study|Physician Decision|1
141191|NCT00445679|465420|P2|Overall Study|Physician Decision|0
141192|NCT00445679|465421|P1|Overall Study|Physician Decision|0
141193|NCT00445679|465418|P4|Overall Study|Failed to return|2
141194|NCT00445679|465419|P3|Overall Study|Failed to return|2
141195|NCT00445679|465420|P2|Overall Study|Failed to return|3
141196|NCT00445679|465421|P1|Overall Study|Failed to return|1
141197|NCT00445679|465418|P4|Overall Study|Adverse Event|19
141198|NCT00445679|465419|P3|Overall Study|Adverse Event|30
141199|NCT00445679|465420|P2|Overall Study|Adverse Event|12
141200|NCT00445679|465421|P1|Overall Study|Adverse Event|22
141201|NCT00445549|465460|P1|Overall Study|progressive disease|12
141202|NCT00445432|465483|P4|148 Weeks of Adalimumab Treatment|Not specified|9
141203|NCT00445432|465484|P3|148 Weeks of Adalimumab Treatment|Not specified|0
141204|NCT00445432|465485|P2|148 Weeks of Adalimumab Treatment|Not specified|0
141205|NCT00445432|465486|P1|148 Weeks of Adalimumab Treatment|Not specified|0
141206|NCT00445432|465483|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
141207|NCT00445432|465484|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
141208|NCT00445432|465485|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
141209|NCT00445432|465486|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
141210|NCT00445432|465483|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
141211|NCT00445432|465484|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
141212|NCT00445432|465485|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
141213|NCT00445432|465486|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
141214|NCT00445432|465483|P4|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
141215|NCT00445432|465484|P3|Through Week 52 of NCT00445432 (M06-837)|Not specified|2
141216|NCT00445432|465485|P2|Through Week 52 of NCT00445432 (M06-837)|Not specified|1
141217|NCT00445432|465486|P1|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
141218|NCT00445432|465483|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
141219|NCT00445432|465484|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
141220|NCT00445432|465485|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
141221|NCT00445432|465486|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
141222|NCT00445432|465483|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
141223|NCT00445432|465484|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
141224|NCT00445432|465485|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
141225|NCT00445432|465486|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
141226|NCT00445432|465483|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
141227|NCT00445432|465484|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
141228|NCT00445432|465485|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
141229|NCT00445432|465486|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
141230|NCT00445341|465519|P1|Overall Study|taken off treatment too early|1
141231|NCT00445341|465519|P1|Overall Study|refused further treatment|1
141232|NCT00445328|465526|P2|Overall Study|Protocol Violation|0
141233|NCT00445328|465527|P1|Overall Study|Protocol Violation|1
141234|NCT00445328|465526|P2|Overall Study|Withdrawal by Subject|0
141235|NCT00445328|465527|P1|Overall Study|Withdrawal by Subject|2
141236|NCT00445328|465526|P2|Overall Study|Other|2
141237|NCT00445328|465527|P1|Overall Study|Other|0
141238|NCT00445328|465526|P2|Overall Study|Adverse Event|3
141239|NCT00445328|465527|P1|Overall Study|Adverse Event|0
141240|NCT00445328|465526|P2|Overall Study|Death|1
141241|NCT00445328|465527|P1|Overall Study|Death|0
141242|NCT00445224|465688|P2|Specific Exercises|Withdrawal by Subject|0
141243|NCT00445224|465689|P1|Specific Exercises|Withdrawal by Subject|1
141244|NCT00445224|465688|P2|Specific Exercises|Withdrawal by Subject|3
141245|NCT00445224|465689|P1|Specific Exercises|Withdrawal by Subject|3
141246|NCT00445146|465699|P1|Overall Study|Pregnancy|1
141247|NCT00445146|465699|P1|Overall Study|Protocol Violation|4
141248|NCT00445146|465699|P1|Overall Study|Death|9
141249|NCT00445146|465699|P1|Overall Study|Lost to Follow-up|13
141250|NCT00445146|465699|P1|Overall Study|Adverse Event|13
141251|NCT00445146|465699|P1|Overall Study|Investigator’s Discretion|22
141252|NCT00445146|465699|P1|Overall Study|Lack of Efficacy|28
141253|NCT00445146|465699|P1|Overall Study|Withdrew Consent|29
141254|NCT00445003|465721|P3|Overall Study|Dropped|2
141255|NCT00445003|465722|P2|Overall Study|Dropped|3
141256|NCT00445003|465723|P1|Overall Study|Dropped|1
141257|NCT00445003|465721|P3|Overall Study|Missed Visit|1
141258|NCT00445003|465722|P2|Overall Study|Missed Visit|5
141259|NCT00445003|465723|P1|Overall Study|Missed Visit|3
141260|NCT00445003|465721|P3|Overall Study|Death|1
141261|NCT00445003|465722|P2|Overall Study|Death|2
141262|NCT00445003|465723|P1|Overall Study|Death|1
141263|NCT00444951|465755|P3|Overall Study|Withdrawal by Subject|3
141264|NCT00444951|465756|P2|Overall Study|Withdrawal by Subject|5
141265|NCT00444951|465757|P1|Overall Study|Withdrawal by Subject|4
141266|NCT00444951|465755|P3|Overall Study|Lost to Follow-up|0
141267|NCT00444951|465756|P2|Overall Study|Lost to Follow-up|1
141268|NCT00444951|465757|P1|Overall Study|Lost to Follow-up|1
141269|NCT00444925|465774|P3|Double-blind Treatment Period|Other|12
141270|NCT00444925|465775|P2|Double-blind Treatment Period|Other|7
141271|NCT00444925|465776|P1|Double-blind Treatment Period|Other|7
141272|NCT00444925|465774|P3|Double-blind Treatment Period|Withdrawal by Subject|7
141273|NCT00444925|465775|P2|Double-blind Treatment Period|Withdrawal by Subject|8
141274|NCT00444925|465776|P1|Double-blind Treatment Period|Withdrawal by Subject|6
141275|NCT00444925|465774|P3|Double-blind Treatment Period|Lost to Follow-up|5
141276|NCT00444925|465775|P2|Double-blind Treatment Period|Lost to Follow-up|8
141277|NCT00444925|465776|P1|Double-blind Treatment Period|Lost to Follow-up|4
141278|NCT00444925|465774|P3|Double-blind Treatment Period|Lack of Efficacy|13
141279|NCT00444925|465775|P2|Double-blind Treatment Period|Lack of Efficacy|5
141280|NCT00444925|465776|P1|Double-blind Treatment Period|Lack of Efficacy|5
141281|NCT00444925|465774|P3|Double-blind Treatment Period|Adverse Event|44
141282|NCT00444925|465775|P2|Double-blind Treatment Period|Adverse Event|28
141283|NCT00444925|465776|P1|Double-blind Treatment Period|Adverse Event|6
141284|NCT00444925|465774|P3|Double-blind Treatment Period|Death|0
141285|NCT00444925|465775|P2|Double-blind Treatment Period|Death|0
141286|NCT00444925|465776|P1|Double-blind Treatment Period|Death|2
141287|NCT00444925|465774|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
141288|NCT00444925|465775|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
141289|NCT00444925|465776|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
141290|NCT00444912|465840|P2|Overall Study|Participant Failed Mobilization|0
141291|NCT00444912|465841|P1|Overall Study|Participant Failed Mobilization|1
141292|NCT00444912|465840|P2|Overall Study|Lost to Follow-up|0
141293|NCT00444912|465841|P1|Overall Study|Lost to Follow-up|1
141294|NCT00444912|465840|P2|Overall Study|Death|2
141295|NCT00444912|465841|P1|Overall Study|Death|1
141296|NCT00444795|465869|P1|Overall Study|Treated Prior to the Contract Date|2
141297|NCT00444795|465869|P1|Overall Study|Not Treated|1
141298|NCT00444626|465874|P1|Initial Treatment Period|Lost to Follow-up|9
141299|NCT00444626|465874|P1|Initial Treatment Period|Adverse Event|1
141300|NCT00444626|465874|P1|Initial Treatment Period|Withdrawal by Subject|2
141301|NCT00444600|465904|P4|Overall Study|Missed visit|1
141302|NCT00444600|465905|P3|Overall Study|Missed visit|0
141303|NCT00444600|465906|P2|Overall Study|Missed visit|0
141304|NCT00444600|465907|P1|Overall Study|Missed visit|1
141305|NCT00444600|465904|P4|Overall Study|Dropped|7
141306|NCT00444600|465905|P3|Overall Study|Dropped|7
141307|NCT00444600|465906|P2|Overall Study|Dropped|11
141308|NCT00444600|465907|P1|Overall Study|Dropped|11
141309|NCT00444600|465904|P4|Overall Study|Death|2
141310|NCT00444600|465905|P3|Overall Study|Death|3
141311|NCT00444600|465906|P2|Overall Study|Death|5
141312|NCT00444600|465907|P1|Overall Study|Death|7
141313|NCT00444587|465999|P2|Overall Study|Missing|5
141314|NCT00444587|466000|P1|Overall Study|Missing|0
141315|NCT00444587|465999|P2|Overall Study|Protocol Violation|0
141316|NCT00444587|466000|P1|Overall Study|Protocol Violation|1
141317|NCT00444587|465999|P2|Overall Study|Investigator decision|0
141318|NCT00444587|466000|P1|Overall Study|Investigator decision|3
141319|NCT00444587|465999|P2|Overall Study|Refused treatment/did not cooperate|1
141320|NCT00444587|466000|P1|Overall Study|Refused treatment/did not cooperate|4
141321|NCT00444587|465999|P2|Overall Study|Progression of the disease|8
141322|NCT00444587|466000|P1|Overall Study|Progression of the disease|73
141323|NCT00444587|465999|P2|Overall Study|Death|1
141324|NCT00444587|466000|P1|Overall Study|Death|2
141325|NCT00444535|466021|P1|Overall Study|Adverse Event|3
141326|NCT00444535|466021|P1|Overall Study|Investigator decision|2
141327|NCT00444535|466021|P1|Overall Study|Withdrawal by Subject|3
141328|NCT00444535|466021|P1|Overall Study|Treatment is ongoing|16
141329|NCT00444457|466032|P4|Toddler Dose|Protocol Violation|1
141330|NCT00444457|466033|P3|Toddler Dose|Protocol Violation|0
141331|NCT00444457|466034|P2|Toddler Dose|Protocol Violation|0
141332|NCT00444457|466035|P1|Toddler Dose|Protocol Violation|1
141333|NCT00444457|466032|P4|Toddler Dose|Parent or legal guardian request|1
141334|NCT00444457|466033|P3|Toddler Dose|Parent or legal guardian request|2
141335|NCT00444457|466034|P2|Toddler Dose|Parent or legal guardian request|3
141336|NCT00444457|466035|P1|Toddler Dose|Parent or legal guardian request|0
141337|NCT00444457|466032|P4|Toddler Dose|Failed to return|3
141338|NCT00444457|466033|P3|Toddler Dose|Failed to return|1
141339|NCT00444457|466034|P2|Toddler Dose|Failed to return|2
141340|NCT00444457|466035|P1|Toddler Dose|Failed to return|2
141341|NCT00444457|466032|P4|Toddler Dose|Lost to Follow-up|3
141342|NCT00444457|466033|P3|Toddler Dose|Lost to Follow-up|1
141343|NCT00444457|466034|P2|Toddler Dose|Lost to Follow-up|1
141344|NCT00444457|466035|P1|Toddler Dose|Lost to Follow-up|4
141345|NCT00444457|466032|P4|After Infant Series|Unspecified|0
141346|NCT00444457|466033|P3|After Infant Series|Unspecified|0
141347|NCT00444457|466034|P2|After Infant Series|Unspecified|1
141348|NCT00444457|466035|P1|After Infant Series|Unspecified|0
141349|NCT00444457|466032|P4|After Infant Series|Investigator request|1
141350|NCT00444457|466033|P3|After Infant Series|Investigator request|0
141351|NCT00444457|466034|P2|After Infant Series|Investigator request|0
141352|NCT00444457|466035|P1|After Infant Series|Investigator request|0
141353|NCT00444457|466032|P4|After Infant Series|Adverse Event|0
141354|NCT00444457|466033|P3|After Infant Series|Adverse Event|0
141355|NCT00444457|466034|P2|After Infant Series|Adverse Event|2
141356|NCT00444457|466035|P1|After Infant Series|Adverse Event|2
141357|NCT00444457|466032|P4|After Infant Series|Protocol Violation|2
141358|NCT00444457|466033|P3|After Infant Series|Protocol Violation|2
141359|NCT00444457|466034|P2|After Infant Series|Protocol Violation|4
141360|NCT00444457|466035|P1|After Infant Series|Protocol Violation|2
141361|NCT00444457|466032|P4|After Infant Series|Lost to Follow-up|2
141362|NCT00444457|466033|P3|After Infant Series|Lost to Follow-up|5
141363|NCT00444457|466034|P2|After Infant Series|Lost to Follow-up|5
141364|NCT00444457|466035|P1|After Infant Series|Lost to Follow-up|5
141365|NCT00444457|466032|P4|After Infant Series|Failed to return|1
141366|NCT00444457|466033|P3|After Infant Series|Failed to return|5
141367|NCT00444457|466034|P2|After Infant Series|Failed to return|6
141368|NCT00444457|466035|P1|After Infant Series|Failed to return|7
141369|NCT00444457|466032|P4|After Infant Series|Parent or legal guardian request|3
141370|NCT00444457|466033|P3|After Infant Series|Parent or legal guardian request|6
141371|NCT00444457|466034|P2|After Infant Series|Parent or legal guardian request|11
141372|NCT00444457|466035|P1|After Infant Series|Parent or legal guardian request|4
141373|NCT00444457|466032|P4|After Infant Series|Other|1
141374|NCT00444457|466033|P3|After Infant Series|Other|1
141375|NCT00444457|466034|P2|After Infant Series|Other|1
141376|NCT00444457|466035|P1|After Infant Series|Other|0
141377|NCT00444457|466032|P4|Infant Series|Death|1
141378|NCT00444457|466033|P3|Infant Series|Death|1
141379|NCT00444457|466034|P2|Infant Series|Death|1
141380|NCT00444457|466035|P1|Infant Series|Death|0
141381|NCT00444457|466032|P4|Infant Series|Adverse Event|0
141382|NCT00444457|466033|P3|Infant Series|Adverse Event|2
141383|NCT00444457|466034|P2|Infant Series|Adverse Event|2
141384|NCT00444457|466035|P1|Infant Series|Adverse Event|1
141385|NCT00444457|466032|P4|Infant Series|Unspecified|0
141386|NCT00444457|466033|P3|Infant Series|Unspecified|4
141387|NCT00444457|466034|P2|Infant Series|Unspecified|2
141388|NCT00444457|466035|P1|Infant Series|Unspecified|0
141389|NCT00444457|466032|P4|Infant Series|Investigator request|2
141390|NCT00444457|466033|P3|Infant Series|Investigator request|3
141391|NCT00444457|466034|P2|Infant Series|Investigator request|3
141392|NCT00444457|466035|P1|Infant Series|Investigator request|4
141393|NCT00444457|466032|P4|Infant Series|Failed to return|2
141394|NCT00444457|466033|P3|Infant Series|Failed to return|4
141395|NCT00444457|466034|P2|Infant Series|Failed to return|4
141396|NCT00444457|466035|P1|Infant Series|Failed to return|5
141397|NCT00444457|466032|P4|Infant Series|Protocol Violation|3
141398|NCT00444457|466033|P3|Infant Series|Protocol Violation|6
141399|NCT00444457|466034|P2|Infant Series|Protocol Violation|8
141400|NCT00444457|466035|P1|Infant Series|Protocol Violation|16
141401|NCT00444457|466032|P4|Infant Series|Lost to Follow-up|6
141402|NCT00444457|466033|P3|Infant Series|Lost to Follow-up|7
141403|NCT00444457|466034|P2|Infant Series|Lost to Follow-up|11
141404|NCT00444457|466035|P1|Infant Series|Lost to Follow-up|10
141405|NCT00444457|466032|P4|Infant Series|Parent or legal guardian request|14
141406|NCT00444457|466033|P3|Infant Series|Parent or legal guardian request|34
141407|NCT00444457|466034|P2|Infant Series|Parent or legal guardian request|29
141408|NCT00444457|466035|P1|Infant Series|Parent or legal guardian request|18
141409|NCT00444457|466032|P4|Infant Series|Other|0
141410|NCT00444457|466033|P3|Infant Series|Other|0
141411|NCT00444457|466034|P2|Infant Series|Other|1
141412|NCT00444457|466035|P1|Infant Series|Other|0
141413|NCT00444275|466100|P5|Maintenance Treatment Phase|Ineffectiveness|14
141414|NCT00444275|466101|P4|Maintenance Treatment Phase|Ineffectiveness|3
141415|NCT00444275|466102|P3|Maintenance Treatment Phase|Ineffectiveness|5
141416|NCT00444275|466103|P2|Maintenance Treatment Phase|Ineffectiveness|0
141417|NCT00444275|466104|P1|Maintenance Treatment Phase|Ineffectiveness|0
141418|NCT00444275|466100|P5|Maintenance Treatment Phase|Protocol Violation|87
141419|NCT00444275|466101|P4|Maintenance Treatment Phase|Protocol Violation|88
141420|NCT00444275|466102|P3|Maintenance Treatment Phase|Protocol Violation|103
141421|NCT00444275|466103|P2|Maintenance Treatment Phase|Protocol Violation|0
141422|NCT00444275|466104|P1|Maintenance Treatment Phase|Protocol Violation|0
141423|NCT00444275|466100|P5|Maintenance Treatment Phase|Patient's wish|20
141424|NCT00444275|466101|P4|Maintenance Treatment Phase|Patient's wish|9
141425|NCT00444275|466102|P3|Maintenance Treatment Phase|Patient's wish|19
141426|NCT00444275|466103|P2|Maintenance Treatment Phase|Patient's wish|0
141427|NCT00444275|466104|P1|Maintenance Treatment Phase|Patient's wish|0
141428|NCT00444275|466100|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
141429|NCT00444275|466101|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
141430|NCT00444275|466102|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
141431|NCT00444275|466103|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
141432|NCT00444275|466104|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
141433|NCT00444275|466100|P5|Maintenance Treatment Phase|Adverse Event|13
141434|NCT00444275|466101|P4|Maintenance Treatment Phase|Adverse Event|2
141435|NCT00444275|466102|P3|Maintenance Treatment Phase|Adverse Event|3
141436|NCT00444275|466103|P2|Maintenance Treatment Phase|Adverse Event|0
141437|NCT00444275|466104|P1|Maintenance Treatment Phase|Adverse Event|0
141438|NCT00444275|466100|P5|Maintenance Treatment Phase|Lost to Follow-up|10
141439|NCT00444275|466101|P4|Maintenance Treatment Phase|Lost to Follow-up|14
141440|NCT00444275|466102|P3|Maintenance Treatment Phase|Lost to Follow-up|8
141441|NCT00444275|466103|P2|Maintenance Treatment Phase|Lost to Follow-up|0
141442|NCT00444275|466104|P1|Maintenance Treatment Phase|Lost to Follow-up|0
141443|NCT00444275|466100|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
141444|NCT00444275|466101|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
141445|NCT00444275|466102|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
141446|NCT00444275|466103|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
141447|NCT00444275|466104|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
141448|NCT00444106|466157|P3|Overall Study|Abnormal Test Procedure Results|1
141449|NCT00444106|466158|P2|Overall Study|Abnormal Test Procedure Results|0
141450|NCT00444106|466159|P1|Overall Study|Abnormal Test Procedure Results|0
141451|NCT00444106|466157|P3|Overall Study|Lost to Follow-up|0
141452|NCT00444106|466158|P2|Overall Study|Lost to Follow-up|1
141453|NCT00444106|466159|P1|Overall Study|Lost to Follow-up|2
141454|NCT00444067|466176|P2|Overall Study|Lost to Follow-up|1
141455|NCT00444067|466177|P1|Overall Study|Lost to Follow-up|0
141456|NCT00443729|466189|P2|Overall Study|Withdrawal by Subject|1
141457|NCT00443729|466190|P1|Overall Study|Withdrawal by Subject|3
141458|NCT00443729|466189|P2|Overall Study|Protocol Violation|1
141459|NCT00443729|466190|P1|Overall Study|Protocol Violation|1
141460|NCT00443729|466189|P2|Overall Study|Physician Decision|1
141461|NCT00443729|466190|P1|Overall Study|Physician Decision|2
141462|NCT00443729|466189|P2|Overall Study|Lost to Follow-up|1
141463|NCT00443729|466190|P1|Overall Study|Lost to Follow-up|0
141464|NCT00443729|466189|P2|Overall Study|Lack of Efficacy|2
141465|NCT00443729|466190|P1|Overall Study|Lack of Efficacy|4
141466|NCT00443729|466189|P2|Overall Study|Never Treated|1
141467|NCT00443729|466190|P1|Overall Study|Never Treated|0
141468|NCT00443703|466238|P2|Overall Study|Progressive Disease|0
141469|NCT00443703|466239|P1|Overall Study|Progressive Disease|1
141470|NCT00443703|466238|P2|Overall Study|Withdrawal by Subject|6
141471|NCT00443703|466239|P1|Overall Study|Withdrawal by Subject|9
141472|NCT00443703|466238|P2|Overall Study|Protocol Violation|1
141473|NCT00443703|466239|P1|Overall Study|Protocol Violation|1
141474|NCT00443703|466238|P2|Overall Study|Physician Decision|2
141475|NCT00443703|466239|P1|Overall Study|Physician Decision|4
141476|NCT00443703|466238|P2|Overall Study|Lost to Follow-up|4
141477|NCT00443703|466239|P1|Overall Study|Lost to Follow-up|0
141478|NCT00443703|466238|P2|Overall Study|Lack of Efficacy|1
141479|NCT00443703|466239|P1|Overall Study|Lack of Efficacy|3
141480|NCT00443703|466238|P2|Overall Study|Adverse Event|3
141481|NCT00443703|466239|P1|Overall Study|Adverse Event|7
141482|NCT00443703|466238|P2|Overall Study|Never Treated|1
141483|NCT00443703|466239|P1|Overall Study|Never Treated|3
141484|NCT00443651|466291|P2|Overall Study|Pregnancy|1
141485|NCT00443651|466292|P1|Overall Study|Pregnancy|0
141486|NCT00443651|466291|P2|Overall Study|Physician Decision|4
141487|NCT00443651|466292|P1|Overall Study|Physician Decision|13
141488|NCT00443651|466291|P2|Overall Study|Patient's/Guardian's Decision|30
141489|NCT00443651|466292|P1|Overall Study|Patient's/Guardian's Decision|58
141490|NCT00443651|466291|P2|Overall Study|Lost to Follow-up|12
141491|NCT00443651|466292|P1|Overall Study|Lost to Follow-up|18
141492|NCT00443651|466291|P2|Overall Study|Adverse Event|6
141493|NCT00443651|466292|P1|Overall Study|Adverse Event|5
141494|NCT00443651|466291|P2|Overall Study|Death|5
141495|NCT00443651|466292|P1|Overall Study|Death|1
141496|NCT00443599|466312|P2|Overall Study|Cardiopulmonary bypass canceled|1
141497|NCT00443599|466313|P1|Overall Study|Cardiopulmonary bypass canceled|3
141498|NCT00443599|466312|P2|Overall Study|Death|1
141499|NCT00443599|466313|P1|Overall Study|Death|1
141500|NCT00443599|466312|P2|Overall Study|Physician Decision|1
141501|NCT00443599|466313|P1|Overall Study|Physician Decision|2
141502|NCT00443560|466321|P2|Overall Study|Multiple pregnancies or fetal demise|4
141503|NCT00443560|466322|P1|Overall Study|Multiple pregnancies or fetal demise|2
141504|NCT00443560|466321|P2|Overall Study|No intrathecal dose|26
141505|NCT00443560|466322|P1|Overall Study|No intrathecal dose|58
141506|NCT00443534|466332|P1|Overall Study|Enrolled, Not Treated|1
141507|NCT00443534|466332|P1|Overall Study|Unspecified|10
141508|NCT00443534|466332|P1|Overall Study|Study Terminated by Sponsor|12
141509|NCT00443534|466332|P1|Overall Study|Withdrawal by Subject|8
141510|NCT00443534|466332|P1|Overall Study|Death|9
141511|NCT00443534|466332|P1|Overall Study|Adverse Event|16
141512|NCT00443534|466332|P1|Overall Study|Lack of Efficacy|67
141513|NCT00443456|466339|P1|Overall Study|Withdrawal by Subject|1
141514|NCT00443456|466339|P1|Overall Study|Move|1
141515|NCT00443456|466339|P1|Overall Study|Adverse Event|16
141516|NCT00443430|466374|P2|Overall Study|Adverse Event|1
141517|NCT00443430|466375|P1|Overall Study|Adverse Event|1
141518|NCT00443430|466374|P2|Overall Study|Lack of Efficacy|3
141519|NCT00443430|466375|P1|Overall Study|Lack of Efficacy|3
141520|NCT00443209|466391|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
141521|NCT00443209|466392|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
141522|NCT00443209|466391|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
141523|NCT00443209|466392|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
141524|NCT00443209|466391|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
141525|NCT00443209|466392|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
141526|NCT00443209|466391|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
141527|NCT00443209|466392|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
141528|NCT00443209|466391|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
141529|NCT00443209|466392|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
141530|NCT00443209|466391|P2|Months 13 to 18 Treatment Period|Adverse Event|0
141531|NCT00443209|466392|P1|Months 13 to 18 Treatment Period|Adverse Event|1
141532|NCT00443209|466391|P2|Months 1 to 12 Treatment Period|Not Treated|43
141533|NCT00443209|466392|P1|Months 1 to 12 Treatment Period|Not Treated|71
141534|NCT00443209|466391|P2|Months 1 to 12 Treatment Period|Missing|1
141535|NCT00443209|466392|P1|Months 1 to 12 Treatment Period|Missing|2
141536|NCT00443209|466391|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
141537|NCT00443209|466392|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
141538|NCT00443209|466391|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
141539|NCT00443209|466392|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
141540|NCT00443209|466391|P2|Months 1 to 12 Treatment Period|Pregnancy|4
141541|NCT00443209|466392|P1|Months 1 to 12 Treatment Period|Pregnancy|3
141542|NCT00443209|466391|P2|Months 1 to 12 Treatment Period|Physician Decision|4
141543|NCT00443209|466392|P1|Months 1 to 12 Treatment Period|Physician Decision|8
141544|NCT00443209|466391|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
141545|NCT00443209|466392|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
141546|NCT00443209|466391|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
141547|NCT00443209|466392|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
141548|NCT00443209|466391|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
141549|NCT00443209|466392|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
141550|NCT00443209|466391|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
141551|NCT00443209|466392|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
141552|NCT00443209|466391|P2|Months 1 to 12 Treatment Period|Adverse Event|11
141553|NCT00443209|466392|P1|Months 1 to 12 Treatment Period|Adverse Event|22
141554|NCT00443118|466409|P3|Overall Study|Withdrawal by Subject|0
141555|NCT00443118|466410|P2|Overall Study|Withdrawal by Subject|0
141556|NCT00443118|466411|P1|Overall Study|Withdrawal by Subject|1
141557|NCT00443118|466409|P3|Overall Study|unknown primary outcome|0
141558|NCT00443118|466410|P2|Overall Study|unknown primary outcome|1
141559|NCT00443118|466411|P1|Overall Study|unknown primary outcome|3
141560|NCT00443053|466457|P2|Overall Study|Physician Decision|4
141561|NCT00443053|466458|P1|Overall Study|Physician Decision|0
141562|NCT00443053|466457|P2|Overall Study|Other|4
141563|NCT00443053|466458|P1|Overall Study|Other|3
141564|NCT00443053|466457|P2|Overall Study|Noncompliance|1
141565|NCT00443053|466458|P1|Overall Study|Noncompliance|2
141566|NCT00443053|466457|P2|Overall Study|Did Not Meet Eligibility Criteria|0
141567|NCT00443053|466458|P1|Overall Study|Did Not Meet Eligibility Criteria|1
141568|NCT00443053|466457|P2|Overall Study|Lost to Follow-up|5
141569|NCT00443053|466458|P1|Overall Study|Lost to Follow-up|4
141570|NCT00443053|466457|P2|Overall Study|Withdrawal by Subject|18
141571|NCT00443053|466458|P1|Overall Study|Withdrawal by Subject|9
141572|NCT00443053|466457|P2|Overall Study|Adverse Event|1
141573|NCT00443053|466458|P1|Overall Study|Adverse Event|2
141574|NCT00443040|466479|P3|Overall Study|Converted to an open laparotomy|1
141575|NCT00443040|466480|P2|Overall Study|Converted to an open laparotomy|0
141576|NCT00443040|466481|P1|Overall Study|Converted to an open laparotomy|3
141577|NCT00443040|466479|P3|Overall Study|Withdrawal by Subject|0
141578|NCT00443040|466480|P2|Overall Study|Withdrawal by Subject|0
141579|NCT00443040|466481|P1|Overall Study|Withdrawal by Subject|1
141580|NCT00442962|466489|P1|Overall Study|Lost to Follow-up|7
141581|NCT00442962|466489|P1|Overall Study|Pregnancy|1
141582|NCT00442936|466507|P4|Overall Study|Protocol Violation|1
141583|NCT00442936|466508|P3|Overall Study|Protocol Violation|1
141584|NCT00442936|466509|P2|Overall Study|Protocol Violation|0
141585|NCT00442936|466510|P1|Overall Study|Protocol Violation|1
141586|NCT00442897|466558|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
141587|NCT00442897|466559|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
141588|NCT00442897|466558|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
141589|NCT00442897|466559|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
141590|NCT00442897|466558|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
141591|NCT00442897|466559|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
141592|NCT00442897|466558|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
141593|NCT00442897|466559|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
141594|NCT00442897|466558|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
141595|NCT00442897|466559|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
141596|NCT00442897|466558|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
141597|NCT00442897|466559|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
141598|NCT00442897|466558|P2|Base Study (12 Week Follow-up)|Death|1
141599|NCT00442897|466559|P1|Base Study (12 Week Follow-up)|Death|0
141600|NCT00442897|466558|P2|Base Study (12 Week Follow-up)|Adverse Event|0
141601|NCT00442897|466559|P1|Base Study (12 Week Follow-up)|Adverse Event|1
141602|NCT00442702|466569|P2|Evaluation Period|Site closure|1
141603|NCT00442702|466570|P1|Evaluation Period|Site closure|0
141604|NCT00442702|466569|P2|Evaluation Period|Failure to return|0
141605|NCT00442702|466570|P1|Evaluation Period|Failure to return|1
141606|NCT00442702|466569|P2|Evaluation Period|Renal transplant|1
141607|NCT00442702|466570|P1|Evaluation Period|Renal transplant|0
141608|NCT00442702|466569|P2|Evaluation Period|Refused treatment|1
141609|NCT00442702|466570|P1|Evaluation Period|Refused treatment|1
141610|NCT00442702|466569|P2|Evaluation Period|Insufficient Therapeutic Response|0
141611|NCT00442702|466570|P1|Evaluation Period|Insufficient Therapeutic Response|1
141612|NCT00442702|466569|P2|Evaluation Period|Death|1
141613|NCT00442702|466570|P1|Evaluation Period|Death|1
141614|NCT00442702|466569|P2|Evaluation Period|Adverse Event|0
141615|NCT00442702|466570|P1|Evaluation Period|Adverse Event|1
141616|NCT00442702|466569|P2|Titration Period|Hospitalized in another hospital|0
141617|NCT00442702|466570|P1|Titration Period|Hospitalized in another hospital|1
141618|NCT00442702|466569|P2|Titration Period|Failure to return|0
141619|NCT00442702|466570|P1|Titration Period|Failure to return|1
141620|NCT00442702|466569|P2|Titration Period|Refused Treatment|1
141621|NCT00442702|466570|P1|Titration Period|Refused Treatment|4
141622|NCT00442702|466569|P2|Titration Period|Insufficient Therapeutic Response|0
141623|NCT00442702|466570|P1|Titration Period|Insufficient Therapeutic Response|1
141624|NCT00442702|466569|P2|Titration Period|Death|2
141625|NCT00442702|466570|P1|Titration Period|Death|3
141626|NCT00442702|466569|P2|Titration Period|Adverse Event|0
141627|NCT00442702|466570|P1|Titration Period|Adverse Event|2
141628|NCT00442598|466629|P3|Overall Study|Death|0
141629|NCT00442598|466630|P2|Overall Study|Death|1
141630|NCT00442598|466631|P1|Overall Study|Death|0
141631|NCT00442598|466629|P3|Overall Study|Reduced creatinine clearance|0
141632|NCT00442598|466630|P2|Overall Study|Reduced creatinine clearance|0
141633|NCT00442598|466631|P1|Overall Study|Reduced creatinine clearance|1
141634|NCT00442598|466629|P3|Overall Study|CA125 progression|0
141635|NCT00442598|466630|P2|Overall Study|CA125 progression|1
141636|NCT00442598|466631|P1|Overall Study|CA125 progression|0
141637|NCT00442598|466629|P3|Overall Study|Clinical deterioration|0
141638|NCT00442598|466630|P2|Overall Study|Clinical deterioration|2
141639|NCT00442598|466631|P1|Overall Study|Clinical deterioration|1
141640|NCT00442598|466629|P3|Overall Study|Tumor progression|0
141641|NCT00442598|466630|P2|Overall Study|Tumor progression|4
141642|NCT00442598|466631|P1|Overall Study|Tumor progression|3
141643|NCT00442598|466629|P3|Overall Study|Adverse Event|0
141644|NCT00442598|466630|P2|Overall Study|Adverse Event|0
141645|NCT00442598|466631|P1|Overall Study|Adverse Event|1
141646|NCT00442572|466649|P2|Overall Study|Withdrawal by Subject|1
141647|NCT00442572|466650|P1|Overall Study|Withdrawal by Subject|0
141648|NCT00442572|466649|P2|Overall Study|Lost to Follow-up|1
141649|NCT00442572|466650|P1|Overall Study|Lost to Follow-up|0
141650|NCT00442572|466649|P2|Overall Study|Relapse|1
141651|NCT00442572|466650|P1|Overall Study|Relapse|8
141652|NCT00442559|466690|P2|Overall Study|Withdrawal by Subject|0
141653|NCT00442559|466691|P1|Overall Study|Withdrawal by Subject|1
141654|NCT00442559|466690|P2|Overall Study|Protocol Violation|1
141655|NCT00442559|466691|P1|Overall Study|Protocol Violation|1
141656|NCT00442559|466690|P2|Overall Study|Lost to Follow-up|34
141657|NCT00442559|466691|P1|Overall Study|Lost to Follow-up|32
141658|NCT00442546|466706|P3|Overall Study|Randomized But Not Treated|6
141659|NCT00442546|466707|P2|Overall Study|Randomized But Not Treated|4
141660|NCT00442546|466708|P1|Overall Study|Randomized But Not Treated|5
141661|NCT00442546|466706|P3|Overall Study|Withdrawal by Subject|7
141662|NCT00442546|466707|P2|Overall Study|Withdrawal by Subject|5
141663|NCT00442546|466708|P1|Overall Study|Withdrawal by Subject|5
141664|NCT00442546|466706|P3|Overall Study|Other|6
141665|NCT00442546|466707|P2|Overall Study|Other|9
141666|NCT00442546|466708|P1|Overall Study|Other|4
141667|NCT00442546|466706|P3|Overall Study|Lost to Follow-up|1
141668|NCT00442546|466707|P2|Overall Study|Lost to Follow-up|2
141669|NCT00442546|466708|P1|Overall Study|Lost to Follow-up|1
141670|NCT00442546|466706|P3|Overall Study|Adverse Event|13
141671|NCT00442546|466707|P2|Overall Study|Adverse Event|17
141672|NCT00442546|466708|P1|Overall Study|Adverse Event|11
141673|NCT00442468|466837|P1|Overall Study|Did not complete all study procedures|88
141674|NCT00442468|466837|P1|Overall Study|Withdrawal by Subject|91
141675|NCT00442468|466837|P1|Overall Study|Adverse Event|4
141676|NCT00442416|466867|P2|Overall Study|Administrative/Other|33
141677|NCT00442416|466868|P1|Overall Study|Administrative/Other|27
141678|NCT00442416|466867|P2|Overall Study|Withdrew consent|2
141679|NCT00442416|466868|P1|Overall Study|Withdrew consent|1
141680|NCT00442416|466867|P2|Overall Study|Protocol Violation|3
141681|NCT00442416|466868|P1|Overall Study|Protocol Violation|2
141682|NCT00442416|466867|P2|Overall Study|Lack of Efficacy|0
141683|NCT00442416|466868|P1|Overall Study|Lack of Efficacy|2
141684|NCT00442416|466867|P2|Overall Study|Death|0
141685|NCT00442416|466868|P1|Overall Study|Death|1
141686|NCT00442416|466867|P2|Overall Study|Adverse Event|1
141687|NCT00442416|466868|P1|Overall Study|Adverse Event|4
141688|NCT00442351|466907|P2|Overall Study|Not specified|1
141689|NCT00442351|466908|P1|Overall Study|Not specified|0
141690|NCT00442351|466907|P2|Overall Study|Did not meet protocol eligibility|0
141691|NCT00442351|466908|P1|Overall Study|Did not meet protocol eligibility|1
141692|NCT00442351|466907|P2|Overall Study|Administrative|5
141693|NCT00442351|466908|P1|Overall Study|Administrative|6
141694|NCT00442117|466978|P2|Overall Study|Met Withdrawal Criteria|1
141695|NCT00442117|466979|P1|Overall Study|Met Withdrawal Criteria|2
141696|NCT00442117|466978|P2|Overall Study|Non compliance with protocol|5
141697|NCT00442117|466979|P1|Overall Study|Non compliance with protocol|3
141698|NCT00442117|466978|P2|Overall Study|Major Deviation|20
141699|NCT00442117|466979|P1|Overall Study|Major Deviation|25
141700|NCT00442117|466978|P2|Overall Study|Withdrawal by Subject|2
141701|NCT00442117|466979|P1|Overall Study|Withdrawal by Subject|2
141702|NCT00442117|466978|P2|Overall Study|Lost to Follow-up|2
141703|NCT00442117|466979|P1|Overall Study|Lost to Follow-up|1
141704|NCT00442117|466978|P2|Overall Study|Lack of Efficacy|6
141705|NCT00442117|466979|P1|Overall Study|Lack of Efficacy|2
141706|NCT00442117|466978|P2|Overall Study|Adverse Event|2
141707|NCT00442117|466979|P1|Overall Study|Adverse Event|3
141708|NCT00441974|467010|P1|Overall Study|Protocol Violation|7
141709|NCT00441974|467010|P1|Overall Study|Lost to Follow-up|80
141710|NCT00441974|467010|P1|Overall Study|Consent Withdrawn|35
141711|NCT00441974|467010|P1|Overall Study|Adverse Event|6
141712|NCT00441792|467026|P2|Overall Study|Lost to Follow-up|2
141713|NCT00441792|467027|P1|Overall Study|Lost to Follow-up|0
141714|NCT00441727|467067|P3|Overall Study|Various reason specified|5
141715|NCT00441727|467068|P2|Overall Study|Various reason specified|8
141716|NCT00441727|467069|P1|Overall Study|Various reason specified|6
141717|NCT00441727|467067|P3|Overall Study|Safety Reasons|3
141718|NCT00441727|467068|P2|Overall Study|Safety Reasons|1
141719|NCT00441727|467069|P1|Overall Study|Safety Reasons|3
141720|NCT00441727|467067|P3|Overall Study|Lost to Follow-up|5
141721|NCT00441727|467068|P2|Overall Study|Lost to Follow-up|6
141722|NCT00441727|467069|P1|Overall Study|Lost to Follow-up|5
141723|NCT00441727|467067|P3|Overall Study|Withdrawal by Subject|47
141724|NCT00441727|467068|P2|Overall Study|Withdrawal by Subject|34
141725|NCT00441727|467069|P1|Overall Study|Withdrawal by Subject|40
141726|NCT00441727|467067|P3|Overall Study|Lack of Efficacy|48
141727|NCT00441727|467068|P2|Overall Study|Lack of Efficacy|8
141728|NCT00441727|467069|P1|Overall Study|Lack of Efficacy|7
141729|NCT00441727|467067|P3|Overall Study|Adverse Event|28
141730|NCT00441727|467068|P2|Overall Study|Adverse Event|33
141731|NCT00441727|467069|P1|Overall Study|Adverse Event|26
141732|NCT00441727|467067|P3|Overall Study|Protocol Violation|32
141733|NCT00441727|467068|P2|Overall Study|Protocol Violation|28
141734|NCT00441727|467069|P1|Overall Study|Protocol Violation|19
141735|NCT00441701|467102|P10|Overall Study|Withdrawal by Subject|0
141736|NCT00441701|467103|P9|Overall Study|Withdrawal by Subject|0
141737|NCT00441701|467104|P8|Overall Study|Withdrawal by Subject|0
141738|NCT00441701|467105|P7|Overall Study|Withdrawal by Subject|0
141739|NCT00441701|467106|P6|Overall Study|Withdrawal by Subject|0
141740|NCT00441701|467107|P5|Overall Study|Withdrawal by Subject|0
141741|NCT00441701|467108|P4|Overall Study|Withdrawal by Subject|1
141742|NCT00441701|467109|P3|Overall Study|Withdrawal by Subject|1
141743|NCT00441701|467110|P2|Overall Study|Withdrawal by Subject|2
141744|NCT00441701|467111|P1|Overall Study|Withdrawal by Subject|0
141745|NCT00441701|467102|P10|Overall Study|Lack of Efficacy|0
141746|NCT00441701|467103|P9|Overall Study|Lack of Efficacy|0
141747|NCT00441701|467104|P8|Overall Study|Lack of Efficacy|0
141748|NCT00441701|467105|P7|Overall Study|Lack of Efficacy|0
141749|NCT00441701|467106|P6|Overall Study|Lack of Efficacy|1
141750|NCT00441701|467107|P5|Overall Study|Lack of Efficacy|0
141751|NCT00441701|467108|P4|Overall Study|Lack of Efficacy|2
141752|NCT00441701|467109|P3|Overall Study|Lack of Efficacy|2
141753|NCT00441701|467110|P2|Overall Study|Lack of Efficacy|0
141754|NCT00441701|467111|P1|Overall Study|Lack of Efficacy|2
141755|NCT00441701|467102|P10|Overall Study|Adverse Event|0
141756|NCT00441701|467103|P9|Overall Study|Adverse Event|0
141757|NCT00441701|467104|P8|Overall Study|Adverse Event|0
141758|NCT00441701|467105|P7|Overall Study|Adverse Event|0
141759|NCT00441701|467106|P6|Overall Study|Adverse Event|2
141760|NCT00441701|467107|P5|Overall Study|Adverse Event|2
141761|NCT00441701|467108|P4|Overall Study|Adverse Event|0
141762|NCT00441701|467109|P3|Overall Study|Adverse Event|1
141763|NCT00441701|467110|P2|Overall Study|Adverse Event|2
141764|NCT00441701|467111|P1|Overall Study|Adverse Event|3
141765|NCT00441584|467193|P1|Overall Study|Failure to meet eligibility criteria|3
141766|NCT00441584|467193|P1|Overall Study|Lost to Follow-up|4
141767|NCT00441584|467193|P1|Overall Study|Protocol Violation|5
141768|NCT00441584|467193|P1|Overall Study|Adverse Event|6
141769|NCT00441584|467193|P1|Overall Study|Withdrawal by Subject|8
141770|NCT00441584|467193|P1|Overall Study|Lack of Efficacy|79
141771|NCT00441545|467201|P2|Second Intervention|Subject moved|1
141772|NCT00441545|467202|P1|Second Intervention|Subject moved|0
141773|NCT00441545|467201|P2|Second Intervention|Subject exceeded safety criteria|0
141774|NCT00441545|467202|P1|Second Intervention|Subject exceeded safety criteria|1
141775|NCT00441545|467201|P2|Second Intervention|Lack of Efficacy|1
141776|NCT00441545|467202|P1|Second Intervention|Lack of Efficacy|0
141777|NCT00441545|467201|P2|Second Intervention|Kidney Transplant|1
141778|NCT00441545|467202|P1|Second Intervention|Kidney Transplant|1
141779|NCT00441545|467201|P2|Second Intervention|Withdrawal by Subject|1
141780|NCT00441545|467202|P1|Second Intervention|Withdrawal by Subject|1
141781|NCT00441545|467201|P2|Second Intervention|Protocol Violation|1
141782|NCT00441545|467202|P1|Second Intervention|Protocol Violation|4
141783|NCT00441545|467201|P2|Second Intervention|Adverse Event|2
141784|NCT00441545|467202|P1|Second Intervention|Adverse Event|5
141785|NCT00441545|467201|P2|First Intervention|Sponsor's request|0
141786|NCT00441545|467202|P1|First Intervention|Sponsor's request|1
141787|NCT00441545|467201|P2|First Intervention|Site error|0
141788|NCT00441545|467202|P1|First Intervention|Site error|1
141789|NCT00441545|467201|P2|First Intervention|Extended hospitalization|0
141790|NCT00441545|467202|P1|First Intervention|Extended hospitalization|1
141791|NCT00441545|467201|P2|First Intervention|Subject met an exclusionary criteria|0
141792|NCT00441545|467202|P1|First Intervention|Subject met an exclusionary criteria|1
141793|NCT00441545|467201|P2|First Intervention|Subject exceeded safety criteria|1
141794|NCT00441545|467202|P1|First Intervention|Subject exceeded safety criteria|0
141795|NCT00441545|467201|P2|First Intervention|Lack of Efficacy|0
141796|NCT00441545|467202|P1|First Intervention|Lack of Efficacy|2
141797|NCT00441545|467201|P2|First Intervention|Kidney transplant|1
141798|NCT00441545|467202|P1|First Intervention|Kidney transplant|1
141799|NCT00441545|467201|P2|First Intervention|Withdrawal by Subject|3
141800|NCT00441545|467202|P1|First Intervention|Withdrawal by Subject|3
141801|NCT00441545|467201|P2|First Intervention|Protocol Violation|2
141802|NCT00441545|467202|P1|First Intervention|Protocol Violation|2
141803|NCT00441545|467201|P2|First Intervention|Adverse Event|5
141804|NCT00441545|467202|P1|First Intervention|Adverse Event|6
141805|NCT00441480|467216|P2|Overall Study|Withdrawal by Subject|3
141806|NCT00441480|467217|P1|Overall Study|Withdrawal by Subject|2
141807|NCT00441480|467216|P2|Overall Study|Protocol Violation|1
141808|NCT00441480|467217|P1|Overall Study|Protocol Violation|1
141809|NCT00441467|467249|P1|Overall Study|Progressive disease|9
141810|NCT00441467|467249|P1|Overall Study|Withdrawal by Subject|3
141811|NCT00441467|467249|P1|Overall Study|Adverse Event|6
141812|NCT00441441|467257|P2|Overall Study|Not specified|3
141813|NCT00441441|467258|P1|Overall Study|Not specified|3
141814|NCT00441441|467257|P2|Overall Study|Withdrawal by Subject|2
141815|NCT00441441|467258|P1|Overall Study|Withdrawal by Subject|1
141816|NCT00441441|467257|P2|Overall Study|Exacerbation of asthma|2
141817|NCT00441441|467258|P1|Overall Study|Exacerbation of asthma|1
141818|NCT00441441|467257|P2|Overall Study|Protocol Violation|6
141819|NCT00441441|467258|P1|Overall Study|Protocol Violation|4
141820|NCT00441441|467257|P2|Overall Study|Adverse Event|1
141821|NCT00441441|467258|P1|Overall Study|Adverse Event|2
141822|NCT00441363|467318|P2|Overall Study|not specified|0
141823|NCT00441363|467319|P1|Overall Study|not specified|2
141824|NCT00441363|467318|P2|Overall Study|Lost to Follow-up|2
141825|NCT00441363|467319|P1|Overall Study|Lost to Follow-up|2
141826|NCT00441363|467318|P2|Overall Study|Physician Decision|7
141827|NCT00441363|467319|P1|Overall Study|Physician Decision|6
141828|NCT00441363|467318|P2|Overall Study|Withdrawal by Subject|4
141829|NCT00441363|467319|P1|Overall Study|Withdrawal by Subject|3
141830|NCT00441363|467318|P2|Overall Study|Adverse Event|2
141831|NCT00441363|467319|P1|Overall Study|Adverse Event|4
141832|NCT00441337|467331|P4|Overall Study|Did not meet inclusion criteria|0
141833|NCT00441337|467332|P3|Overall Study|Did not meet inclusion criteria|1
141834|NCT00441337|467333|P2|Overall Study|Did not meet inclusion criteria|0
141835|NCT00441337|467334|P1|Overall Study|Did not meet inclusion criteria|0
141836|NCT00441337|467331|P4|Overall Study|Sponsor Decision|2
141837|NCT00441337|467332|P3|Overall Study|Sponsor Decision|1
141838|NCT00441337|467333|P2|Overall Study|Sponsor Decision|0
141839|NCT00441337|467334|P1|Overall Study|Sponsor Decision|0
141840|NCT00441337|467331|P4|Overall Study|Lost to Follow-up|1
141841|NCT00441337|467332|P3|Overall Study|Lost to Follow-up|0
141842|NCT00441337|467333|P2|Overall Study|Lost to Follow-up|0
141843|NCT00441337|467334|P1|Overall Study|Lost to Follow-up|0
141844|NCT00441337|467331|P4|Overall Study|Disease Progression|18
141845|NCT00441337|467332|P3|Overall Study|Disease Progression|4
141846|NCT00441337|467333|P2|Overall Study|Disease Progression|6
141847|NCT00441337|467334|P1|Overall Study|Disease Progression|6
141848|NCT00441272|467447|P2|Overall Study|Study terminated prior to enrollment|25
141849|NCT00441272|467448|P1|Overall Study|Study terminated prior to enrollment|25
141850|NCT00441168|467475|P2|Follow-up Period|Other|3
141851|NCT00441168|467476|P1|Follow-up Period|Other|1
141852|NCT00441168|467475|P2|Follow-up Period|Withdrawal by Subject|0
141853|NCT00441168|467476|P1|Follow-up Period|Withdrawal by Subject|3
141854|NCT00441168|467475|P2|Follow-up Period|Lost to Follow-up|6
141855|NCT00441168|467476|P1|Follow-up Period|Lost to Follow-up|5
141856|NCT00441168|467475|P2|Follow-up Period|Death|0
141857|NCT00441168|467476|P1|Follow-up Period|Death|3
141858|NCT00441168|467475|P2|Treatment Period|refractory disease|0
141859|NCT00441168|467476|P1|Treatment Period|refractory disease|1
141860|NCT00441168|467475|P2|Treatment Period|qualified for stem-cell transplantation|0
141861|NCT00441168|467476|P1|Treatment Period|qualified for stem-cell transplantation|3
141862|NCT00441168|467475|P2|Treatment Period|Withdrawal by Subject|0
141863|NCT00441168|467476|P1|Treatment Period|Withdrawal by Subject|3
141864|NCT00441168|467475|P2|Treatment Period|Lost to Follow-up|1
141865|NCT00441168|467476|P1|Treatment Period|Lost to Follow-up|0
141866|NCT00441168|467475|P2|Treatment Period|Protocol Violation|1
141867|NCT00441168|467476|P1|Treatment Period|Protocol Violation|0
141868|NCT00441168|467475|P2|Treatment Period|Progressive Disease|2
141869|NCT00441168|467476|P1|Treatment Period|Progressive Disease|0
141870|NCT00441168|467475|P2|Treatment Period|Adverse Event|2
141871|NCT00441168|467476|P1|Treatment Period|Adverse Event|1
141872|NCT00441168|467475|P2|Treatment Period|Death|0
141873|NCT00441168|467476|P1|Treatment Period|Death|3
141874|NCT00441142|467490|P4|Overall Study|Death|1
141875|NCT00441142|467491|P3|Overall Study|Death|0
141876|NCT00441142|467492|P2|Overall Study|Death|0
141877|NCT00441142|467493|P1|Overall Study|Death|0
141878|NCT00441142|467490|P4|Overall Study|Physician Decision|1
141879|NCT00441142|467491|P3|Overall Study|Physician Decision|0
141880|NCT00441142|467492|P2|Overall Study|Physician Decision|1
141881|NCT00441142|467493|P1|Overall Study|Physician Decision|0
141882|NCT00441142|467490|P4|Overall Study|Patient still receiving active study tx|2
141883|NCT00441142|467491|P3|Overall Study|Patient still receiving active study tx|0
141884|NCT00441142|467492|P2|Overall Study|Patient still receiving active study tx|0
141885|NCT00441142|467493|P1|Overall Study|Patient still receiving active study tx|1
141886|NCT00441142|467490|P4|Overall Study|Withdrawal by Subject|10
141887|NCT00441142|467491|P3|Overall Study|Withdrawal by Subject|2
141888|NCT00441142|467492|P2|Overall Study|Withdrawal by Subject|0
141889|NCT00441142|467493|P1|Overall Study|Withdrawal by Subject|0
141890|NCT00441142|467490|P4|Overall Study|Lack of Efficacy|32
141891|NCT00441142|467491|P3|Overall Study|Lack of Efficacy|17
141892|NCT00441142|467492|P2|Overall Study|Lack of Efficacy|3
141893|NCT00441142|467493|P1|Overall Study|Lack of Efficacy|3
141894|NCT00441142|467490|P4|Overall Study|Adverse Event|22
141895|NCT00441142|467491|P3|Overall Study|Adverse Event|3
141896|NCT00441142|467492|P2|Overall Study|Adverse Event|3
141897|NCT00441142|467493|P1|Overall Study|Adverse Event|2
141898|NCT00441116|467511|P2|Overall Study|Did not meet Eligibility Criteria|1
141899|NCT00441116|467512|P1|Overall Study|Did not meet Eligibility Criteria|1
141900|NCT00441116|467511|P2|Overall Study|Withdrawal by Subject|0
141901|NCT00441116|467512|P1|Overall Study|Withdrawal by Subject|1
141902|NCT00441116|467511|P2|Overall Study|Adverse Event|1
141903|NCT00441116|467512|P1|Overall Study|Adverse Event|1
141904|NCT00441103|467580|P2|Overall Study|Participant decided to stop|1
141905|NCT00441103|467581|P1|Overall Study|Participant decided to stop|0
141906|NCT00441103|467580|P2|Overall Study|Participant's reason|1
141907|NCT00441103|467581|P1|Overall Study|Participant's reason|0
141908|NCT00441103|467580|P2|Overall Study|Participant decided to withdraw|0
142391|NCT00439738|468073|P2|Overall Study|Protocol Violation|3
141909|NCT00441103|467581|P1|Overall Study|Participant decided to withdraw|1
141910|NCT00441103|467580|P2|Overall Study|Non-compliant|1
141911|NCT00441103|467581|P1|Overall Study|Non-compliant|0
141912|NCT00441103|467580|P2|Overall Study|Inclusion criteria absent|0
141913|NCT00441103|467581|P1|Overall Study|Inclusion criteria absent|1
141914|NCT00441103|467580|P2|Overall Study|Participant refused MRI|0
141915|NCT00441103|467581|P1|Overall Study|Participant refused MRI|1
141916|NCT00441103|467580|P2|Overall Study|Participant unable to use Rebiject II|0
141917|NCT00441103|467581|P1|Overall Study|Participant unable to use Rebiject II|1
141918|NCT00441103|467580|P2|Overall Study|Protocol Violation|0
141919|NCT00441103|467581|P1|Overall Study|Protocol Violation|1
141920|NCT00441103|467580|P2|Overall Study|Lost to Follow-up|0
141921|NCT00441103|467581|P1|Overall Study|Lost to Follow-up|1
141922|NCT00441103|467580|P2|Overall Study|Disease Progression|0
141923|NCT00441103|467581|P1|Overall Study|Disease Progression|2
141924|NCT00441103|467580|P2|Overall Study|Death|0
141925|NCT00441103|467581|P1|Overall Study|Death|1
141926|NCT00441103|467580|P2|Overall Study|Adverse Event|1
141927|NCT00441103|467581|P1|Overall Study|Adverse Event|2
141928|NCT00441064|467594|P2|Overall Study|Patient withdrew consent|2
141929|NCT00441064|467595|P1|Overall Study|Patient withdrew consent|5
141930|NCT00441064|467594|P2|Overall Study|Protocol Deviation|2
141931|NCT00441064|467595|P1|Overall Study|Protocol Deviation|3
141932|NCT00441064|467594|P2|Overall Study|Unsatisfactory therapeutic effect|0
141933|NCT00441064|467595|P1|Overall Study|Unsatisfactory therapeutic effect|1
141934|NCT00441064|467594|P2|Overall Study|Abnormal test procedure results|1
141935|NCT00441064|467595|P1|Overall Study|Abnormal test procedure results|0
141936|NCT00441064|467594|P2|Overall Study|Abnormal laboratory values|2
141937|NCT00441064|467595|P1|Overall Study|Abnormal laboratory values|0
141938|NCT00441064|467594|P2|Overall Study|Adverse Event|0
141939|NCT00441064|467595|P1|Overall Study|Adverse Event|1
141940|NCT00441012|467607|P2|Overall Study|Subject Randomized but Not Vaccinated|0
141941|NCT00441012|467608|P1|Overall Study|Subject Randomized but Not Vaccinated|1
141942|NCT00441012|467607|P2|Overall Study|Withdrawal by Subject|0
141943|NCT00441012|467608|P1|Overall Study|Withdrawal by Subject|4
141944|NCT00441012|467607|P2|Overall Study|Protocol Violation|9
141945|NCT00441012|467608|P1|Overall Study|Protocol Violation|10
141946|NCT00441012|467607|P2|Overall Study|Lost to Follow-up|3
141947|NCT00441012|467608|P1|Overall Study|Lost to Follow-up|3
141948|NCT00441012|467607|P2|Overall Study|Adverse Event|1
141949|NCT00441012|467608|P1|Overall Study|Adverse Event|0
141950|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
141951|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
141952|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
141953|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
141954|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
141955|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Physician Decision|1
141956|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Physician Decision|0
141957|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Physician Decision|0
141958|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Physician Decision|0
141959|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Physician Decision|0
141960|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Other|0
141961|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Other|1
141962|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Other|0
141963|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Other|0
141964|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Other|0
141965|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
141966|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
141967|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
141968|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
141969|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
141970|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Sponsor Request|1
141971|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Sponsor Request|1
141972|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Sponsor Request|0
141973|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Sponsor Request|0
141974|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Sponsor Request|0
141975|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Participant Moved|1
141976|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Participant Moved|1
141977|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Participant Moved|0
141978|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Participant Moved|0
141979|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Participant Moved|0
141980|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Pregnancy|0
141981|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Pregnancy|3
141982|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Pregnancy|0
141983|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Pregnancy|0
141984|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Pregnancy|0
141985|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
141986|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
141987|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
141988|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
141989|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
141990|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Protocol Violation|0
141991|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Protocol Violation|1
141992|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Protocol Violation|0
141993|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Protocol Violation|0
141994|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Protocol Violation|0
141995|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
141996|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
141997|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
141998|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
141999|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
142000|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Non-compliance|1
142001|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Non-compliance|1
142002|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Non-compliance|0
142003|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Non-compliance|0
142004|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Non-compliance|0
142005|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
142006|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
142007|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
142008|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
142009|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
142010|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
142011|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
142012|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
142013|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
142014|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
142015|NCT00440947|467622|P5|Optional 60-Week Extension Phase|Adverse Event|3
142016|NCT00440947|467623|P4|Optional 60-Week Extension Phase|Adverse Event|1
142017|NCT00440947|467624|P3|Optional 60-Week Extension Phase|Adverse Event|0
142018|NCT00440947|467625|P2|Optional 60-Week Extension Phase|Adverse Event|0
142019|NCT00440947|467626|P1|Optional 60-Week Extension Phase|Adverse Event|0
142020|NCT00440947|467622|P5|48-Week Randomization Phase|Physician Decision|0
142021|NCT00440947|467623|P4|48-Week Randomization Phase|Physician Decision|0
142022|NCT00440947|467624|P3|48-Week Randomization Phase|Physician Decision|0
142023|NCT00440947|467625|P2|48-Week Randomization Phase|Physician Decision|2
142024|NCT00440947|467626|P1|48-Week Randomization Phase|Physician Decision|0
142025|NCT00440947|467622|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
142026|NCT00440947|467623|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
142027|NCT00440947|467624|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
142028|NCT00440947|467625|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
142029|NCT00440947|467626|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
142030|NCT00440947|467622|P5|48-Week Randomization Phase|Incarceration|0
142031|NCT00440947|467623|P4|48-Week Randomization Phase|Incarceration|0
142032|NCT00440947|467624|P3|48-Week Randomization Phase|Incarceration|0
142033|NCT00440947|467625|P2|48-Week Randomization Phase|Incarceration|3
142034|NCT00440947|467626|P1|48-Week Randomization Phase|Incarceration|0
142035|NCT00440947|467622|P5|48-Week Randomization Phase|Pregnancy|0
142036|NCT00440947|467623|P4|48-Week Randomization Phase|Pregnancy|0
142037|NCT00440947|467624|P3|48-Week Randomization Phase|Pregnancy|1
142038|NCT00440947|467625|P2|48-Week Randomization Phase|Pregnancy|0
142039|NCT00440947|467626|P1|48-Week Randomization Phase|Pregnancy|0
142040|NCT00440947|467622|P5|48-Week Randomization Phase|Withdrawal by Subject|0
142041|NCT00440947|467623|P4|48-Week Randomization Phase|Withdrawal by Subject|0
142042|NCT00440947|467624|P3|48-Week Randomization Phase|Withdrawal by Subject|4
142043|NCT00440947|467625|P2|48-Week Randomization Phase|Withdrawal by Subject|2
142044|NCT00440947|467626|P1|48-Week Randomization Phase|Withdrawal by Subject|0
142045|NCT00440947|467622|P5|48-Week Randomization Phase|Protocol Violation|0
142046|NCT00440947|467623|P4|48-Week Randomization Phase|Protocol Violation|0
142047|NCT00440947|467624|P3|48-Week Randomization Phase|Protocol Violation|1
142048|NCT00440947|467625|P2|48-Week Randomization Phase|Protocol Violation|0
142049|NCT00440947|467626|P1|48-Week Randomization Phase|Protocol Violation|0
142050|NCT00440947|467622|P5|48-Week Randomization Phase|Lost to Follow-up|0
142051|NCT00440947|467623|P4|48-Week Randomization Phase|Lost to Follow-up|0
142052|NCT00440947|467624|P3|48-Week Randomization Phase|Lost to Follow-up|8
142053|NCT00440947|467625|P2|48-Week Randomization Phase|Lost to Follow-up|2
142054|NCT00440947|467626|P1|48-Week Randomization Phase|Lost to Follow-up|0
142055|NCT00440947|467622|P5|48-Week Randomization Phase|Non-compliance|0
142056|NCT00440947|467623|P4|48-Week Randomization Phase|Non-compliance|0
142057|NCT00440947|467624|P3|48-Week Randomization Phase|Non-compliance|4
142058|NCT00440947|467625|P2|48-Week Randomization Phase|Non-compliance|3
142059|NCT00440947|467626|P1|48-Week Randomization Phase|Non-compliance|0
142060|NCT00440947|467622|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
142061|NCT00440947|467623|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
142062|NCT00440947|467624|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
142063|NCT00440947|467625|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
142064|NCT00440947|467626|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
142065|NCT00440947|467622|P5|48-Week Randomization Phase|Adverse Event|0
142066|NCT00440947|467623|P4|48-Week Randomization Phase|Adverse Event|0
142067|NCT00440947|467624|P3|48-Week Randomization Phase|Adverse Event|5
142068|NCT00440947|467625|P2|48-Week Randomization Phase|Adverse Event|2
142069|NCT00440947|467626|P1|48-Week Randomization Phase|Adverse Event|0
142070|NCT00440947|467622|P5|36-Week Induction Phase|Pregnancy|0
142071|NCT00440947|467623|P4|36-Week Induction Phase|Pregnancy|0
142072|NCT00440947|467624|P3|36-Week Induction Phase|Pregnancy|0
142073|NCT00440947|467625|P2|36-Week Induction Phase|Pregnancy|0
142074|NCT00440947|467626|P1|36-Week Induction Phase|Pregnancy|1
142075|NCT00440947|467622|P5|36-Week Induction Phase|Incarceration|0
142076|NCT00440947|467623|P4|36-Week Induction Phase|Incarceration|0
142077|NCT00440947|467624|P3|36-Week Induction Phase|Incarceration|0
142078|NCT00440947|467625|P2|36-Week Induction Phase|Incarceration|0
142079|NCT00440947|467626|P1|36-Week Induction Phase|Incarceration|3
142080|NCT00440947|467622|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
142081|NCT00440947|467623|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
142082|NCT00440947|467624|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
142083|NCT00440947|467625|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
142084|NCT00440947|467626|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
142085|NCT00440947|467622|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
142086|NCT00440947|467623|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
142087|NCT00440947|467624|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
142088|NCT00440947|467625|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
142089|NCT00440947|467626|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
142090|NCT00440947|467622|P5|36-Week Induction Phase|Took Exclusionary Medications|0
142091|NCT00440947|467623|P4|36-Week Induction Phase|Took Exclusionary Medications|0
142092|NCT00440947|467624|P3|36-Week Induction Phase|Took Exclusionary Medications|0
142093|NCT00440947|467625|P2|36-Week Induction Phase|Took Exclusionary Medications|0
142094|NCT00440947|467626|P1|36-Week Induction Phase|Took Exclusionary Medications|1
142095|NCT00440947|467622|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
142096|NCT00440947|467623|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
142097|NCT00440947|467624|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
142098|NCT00440947|467625|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
142099|NCT00440947|467626|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
142100|NCT00440947|467622|P5|36-Week Induction Phase|Withdrawal by Subject|0
142101|NCT00440947|467623|P4|36-Week Induction Phase|Withdrawal by Subject|0
142102|NCT00440947|467624|P3|36-Week Induction Phase|Withdrawal by Subject|0
142103|NCT00440947|467625|P2|36-Week Induction Phase|Withdrawal by Subject|0
142104|NCT00440947|467626|P1|36-Week Induction Phase|Withdrawal by Subject|7
142105|NCT00440947|467622|P5|36-Week Induction Phase|Lost to Follow-up|0
142106|NCT00440947|467623|P4|36-Week Induction Phase|Lost to Follow-up|0
142107|NCT00440947|467624|P3|36-Week Induction Phase|Lost to Follow-up|0
142108|NCT00440947|467625|P2|36-Week Induction Phase|Lost to Follow-up|0
142109|NCT00440947|467626|P1|36-Week Induction Phase|Lost to Follow-up|16
142110|NCT00440947|467622|P5|36-Week Induction Phase|Non-compliance|0
142111|NCT00440947|467623|P4|36-Week Induction Phase|Non-compliance|0
142112|NCT00440947|467624|P3|36-Week Induction Phase|Non-compliance|0
142113|NCT00440947|467625|P2|36-Week Induction Phase|Non-compliance|0
142114|NCT00440947|467626|P1|36-Week Induction Phase|Non-compliance|10
142115|NCT00440947|467622|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
142116|NCT00440947|467623|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
142117|NCT00440947|467624|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
142118|NCT00440947|467625|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
142119|NCT00440947|467626|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
142120|NCT00440947|467622|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
142121|NCT00440947|467623|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
142122|NCT00440947|467624|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
142123|NCT00440947|467625|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
142124|NCT00440947|467626|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
142125|NCT00440947|467622|P5|36-Week Induction Phase|Adverse Event|0
142126|NCT00440947|467623|P4|36-Week Induction Phase|Adverse Event|0
142127|NCT00440947|467624|P3|36-Week Induction Phase|Adverse Event|0
142128|NCT00440947|467625|P2|36-Week Induction Phase|Adverse Event|0
142129|NCT00440947|467626|P1|36-Week Induction Phase|Adverse Event|16
142130|NCT00440700|467701|P3|Overall Study|Withdrawal by Subject|4
142131|NCT00440700|467702|P2|Overall Study|Withdrawal by Subject|8
142132|NCT00440700|467703|P1|Overall Study|Withdrawal by Subject|8
142133|NCT00440557|467726|P3|Overall Study|Patient had surgery|0
142134|NCT00440557|467727|P2|Overall Study|Patient had surgery|0
142135|NCT00440557|467728|P1|Overall Study|Patient had surgery|1
142136|NCT00440557|467726|P3|Overall Study|Patient transferred to nursing home|0
142137|NCT00440557|467727|P2|Overall Study|Patient transferred to nursing home|1
142138|NCT00440557|467728|P1|Overall Study|Patient transferred to nursing home|0
142139|NCT00440557|467726|P3|Overall Study|Principal Investigator's office closed|4
142140|NCT00440557|467727|P2|Overall Study|Principal Investigator's office closed|6
142141|NCT00440557|467728|P1|Overall Study|Principal Investigator's office closed|3
142142|NCT00440557|467726|P3|Overall Study|Patient moved|1
142143|NCT00440557|467727|P2|Overall Study|Patient moved|2
142144|NCT00440557|467728|P1|Overall Study|Patient moved|1
142145|NCT00440557|467726|P3|Overall Study|Principal Investigator decision|1
142146|NCT00440557|467727|P2|Overall Study|Principal Investigator decision|3
142147|NCT00440557|467728|P1|Overall Study|Principal Investigator decision|0
142148|NCT00440557|467726|P3|Overall Study|Began Dialysis|4
142149|NCT00440557|467727|P2|Overall Study|Began Dialysis|1
142150|NCT00440557|467728|P1|Overall Study|Began Dialysis|4
142151|NCT00440557|467726|P3|Overall Study|Death|3
142152|NCT00440557|467727|P2|Overall Study|Death|6
142153|NCT00440557|467728|P1|Overall Study|Death|2
142154|NCT00440557|467726|P3|Overall Study|Adverse Event|5
142155|NCT00440557|467727|P2|Overall Study|Adverse Event|3
142156|NCT00440557|467728|P1|Overall Study|Adverse Event|3
142157|NCT00440557|467726|P3|Overall Study|Lost to Follow-up|6
142158|NCT00440557|467727|P2|Overall Study|Lost to Follow-up|2
142159|NCT00440557|467728|P1|Overall Study|Lost to Follow-up|1
142160|NCT00440557|467726|P3|Overall Study|Withdrawal by Subject|11
142161|NCT00440557|467727|P2|Overall Study|Withdrawal by Subject|5
142162|NCT00440557|467728|P1|Overall Study|Withdrawal by Subject|10
142163|NCT00440531|467760|P3|Overall Study|see pre-assignment details|0
142164|NCT00440531|467761|P2|Overall Study|see pre-assignment details|0
142165|NCT00440531|467762|P1|Overall Study|see pre-assignment details|2
142166|NCT00440531|467760|P3|Overall Study|Lost to Follow-up|5
142167|NCT00440531|467761|P2|Overall Study|Lost to Follow-up|3
142168|NCT00440531|467762|P1|Overall Study|Lost to Follow-up|4
142169|NCT00440531|467760|P3|Overall Study|Protocol Violation|0
142170|NCT00440531|467761|P2|Overall Study|Protocol Violation|2
142171|NCT00440531|467762|P1|Overall Study|Protocol Violation|1
142172|NCT00440531|467760|P3|Overall Study|Withdrawal by Subject|0
142173|NCT00440531|467761|P2|Overall Study|Withdrawal by Subject|0
142174|NCT00440531|467762|P1|Overall Study|Withdrawal by Subject|2
142175|NCT00440531|467760|P3|Overall Study|Adverse Event|2
142176|NCT00440531|467761|P2|Overall Study|Adverse Event|0
142177|NCT00440531|467762|P1|Overall Study|Adverse Event|1
142178|NCT00440518|467779|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
142179|NCT00440518|467780|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
142180|NCT00440518|467781|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
142181|NCT00440518|467779|P3|Maintenance and Safety Follow-up Periods|Other|2
142182|NCT00440518|467780|P2|Maintenance and Safety Follow-up Periods|Other|0
142183|NCT00440518|467781|P1|Maintenance and Safety Follow-up Periods|Other|0
142184|NCT00440518|467779|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
142185|NCT00440518|467780|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
142186|NCT00440518|467781|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
142187|NCT00440518|467779|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
142188|NCT00440518|467780|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
142189|NCT00440518|467781|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
142190|NCT00440518|467779|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
142191|NCT00440518|467780|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
142192|NCT00440518|467781|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
142193|NCT00440518|467779|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
142194|NCT00440518|467780|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
142195|NCT00440518|467781|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
142196|NCT00440518|467779|P3|Randomized /Titration Period|Adverse Event|0
142197|NCT00440518|467780|P2|Randomized /Titration Period|Adverse Event|3
142198|NCT00440518|467781|P1|Randomized /Titration Period|Adverse Event|2
142199|NCT00440518|467779|P3|Randomized /Titration Period|Lost to Follow-up|1
142200|NCT00440518|467780|P2|Randomized /Titration Period|Lost to Follow-up|2
142201|NCT00440518|467781|P1|Randomized /Titration Period|Lost to Follow-up|2
142202|NCT00440518|467779|P3|Randomized /Titration Period|Other|0
142203|NCT00440518|467780|P2|Randomized /Titration Period|Other|0
142204|NCT00440518|467781|P1|Randomized /Titration Period|Other|1
142205|NCT00440518|467779|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
142206|NCT00440518|467780|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
142207|NCT00440518|467781|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
142208|NCT00440518|467779|P3|Randomized /Titration Period|Protocol Deviation|0
142209|NCT00440518|467780|P2|Randomized /Titration Period|Protocol Deviation|0
142210|NCT00440518|467781|P1|Randomized /Titration Period|Protocol Deviation|1
142211|NCT00440518|467779|P3|Randomized /Titration Period|Subject Withdrew Consent|0
142212|NCT00440518|467780|P2|Randomized /Titration Period|Subject Withdrew Consent|1
142213|NCT00440518|467781|P1|Randomized /Titration Period|Subject Withdrew Consent|4
142214|NCT00440518|467779|P3|Randomized /Titration Period|Lack of Efficacy|1
142215|NCT00440518|467780|P2|Randomized /Titration Period|Lack of Efficacy|0
142216|NCT00440518|467781|P1|Randomized /Titration Period|Lack of Efficacy|1
142217|NCT00440466|467826|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
142218|NCT00440466|467827|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
142219|NCT00440466|467828|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
142220|NCT00440466|467826|P3|Overall Study|Began Dialysis|1
142221|NCT00440466|467827|P2|Overall Study|Began Dialysis|0
142222|NCT00440466|467828|P1|Overall Study|Began Dialysis|0
142223|NCT00440466|467826|P3|Overall Study|Withdrawal by Subject|9
142224|NCT00440466|467827|P2|Overall Study|Withdrawal by Subject|5
142225|NCT00440466|467828|P1|Overall Study|Withdrawal by Subject|2
142226|NCT00440466|467826|P3|Overall Study|Protocol Violation|4
142227|NCT00440466|467827|P2|Overall Study|Protocol Violation|0
142228|NCT00440466|467828|P1|Overall Study|Protocol Violation|2
142229|NCT00440466|467826|P3|Overall Study|Physician Decision|1
142230|NCT00440466|467827|P2|Overall Study|Physician Decision|0
142231|NCT00440466|467828|P1|Overall Study|Physician Decision|2
142232|NCT00440466|467826|P3|Overall Study|Lost to Follow-up|2
142233|NCT00440466|467827|P2|Overall Study|Lost to Follow-up|0
142234|NCT00440466|467828|P1|Overall Study|Lost to Follow-up|1
142235|NCT00440466|467826|P3|Overall Study|Adverse Event|11
142236|NCT00440466|467827|P2|Overall Study|Adverse Event|4
142237|NCT00440466|467828|P1|Overall Study|Adverse Event|3
142238|NCT00440466|467826|P3|Overall Study|Death|9
142239|NCT00440466|467827|P2|Overall Study|Death|2
142240|NCT00440466|467828|P1|Overall Study|Death|3
142241|NCT00440401|467862|P2|Overall Study|Not specified|5
142242|NCT00440401|467863|P1|Overall Study|Not specified|2
142243|NCT00440401|467862|P2|Overall Study|Adverse Event|1
142244|NCT00440401|467863|P1|Overall Study|Adverse Event|2
142245|NCT00440310|467873|P2|Overall Study|Status Unknown|3
142246|NCT00440310|467874|P1|Overall Study|Status Unknown|1
142247|NCT00440310|467873|P2|Overall Study|Other|0
142248|NCT00440310|467874|P1|Overall Study|Other|1
142249|NCT00440310|467873|P2|Overall Study|No Reply at EOS|7
142250|NCT00440310|467874|P1|Overall Study|No Reply at EOS|7
142251|NCT00440310|467873|P2|Overall Study|Withdrawal by Subject|14
142252|NCT00440310|467874|P1|Overall Study|Withdrawal by Subject|15
142253|NCT00440310|467873|P2|Overall Study|Protocol Violation|1
142254|NCT00440310|467874|P1|Overall Study|Protocol Violation|0
142255|NCT00440310|467873|P2|Overall Study|Lost to Follow-up|5
142256|NCT00440310|467874|P1|Overall Study|Lost to Follow-up|4
142257|NCT00440297|467882|P2|Overall Study|Randomized by mistake|0
142258|NCT00440297|467883|P1|Overall Study|Randomized by mistake|1
142259|NCT00440297|467882|P2|Overall Study|Withdrawal by Subject|6
142260|NCT00440297|467883|P1|Overall Study|Withdrawal by Subject|1
142261|NCT00440297|467882|P2|Overall Study|Protocol Violation|7
142262|NCT00440297|467883|P1|Overall Study|Protocol Violation|11
142263|NCT00440297|467882|P2|Overall Study|Physician Decision|0
142264|NCT00440297|467883|P1|Overall Study|Physician Decision|1
142265|NCT00440297|467882|P2|Overall Study|Lost to Follow-up|0
142266|NCT00440297|467883|P1|Overall Study|Lost to Follow-up|1
142267|NCT00440297|467882|P2|Overall Study|Adverse Event|5
142268|NCT00440297|467883|P1|Overall Study|Adverse Event|8
142269|NCT00440271|467899|P2|Overall Study|Other|0
142270|NCT00440271|467900|P1|Overall Study|Other|2
142271|NCT00440271|467899|P2|Overall Study|Due to closure of trial|10
142272|NCT00440271|467900|P1|Overall Study|Due to closure of trial|8
142273|NCT00440271|467899|P2|Overall Study|Lack of Efficacy|1
142274|NCT00440271|467900|P1|Overall Study|Lack of Efficacy|0
142275|NCT00440271|467899|P2|Overall Study|Withdrawal by Subject|2
142276|NCT00440271|467900|P1|Overall Study|Withdrawal by Subject|0
142277|NCT00440271|467899|P2|Overall Study|Lost to Follow-up|0
142278|NCT00440271|467900|P1|Overall Study|Lost to Follow-up|1
142279|NCT00440271|467899|P2|Overall Study|Adverse Event|1
142280|NCT00440271|467900|P1|Overall Study|Adverse Event|0
142281|NCT00440271|467899|P2|Overall Study|Protocol Violation|1
142282|NCT00440271|467900|P1|Overall Study|Protocol Violation|1
142283|NCT00440232|467934|P2|Overall Study|Onset of headache within 4 hours of fast|2
142284|NCT00440232|467935|P1|Overall Study|Onset of headache within 4 hours of fast|2
142285|NCT00440232|467934|P2|Overall Study|Unable to treat within allowed time|1
142286|NCT00440232|467935|P1|Overall Study|Unable to treat within allowed time|0
142287|NCT00440232|467934|P2|Overall Study|Lost to Follow-up|1
142288|NCT00440232|467935|P1|Overall Study|Lost to Follow-up|1
142289|NCT00440193|467945|P2|Observational Period|Participant convenience|0
142290|NCT00440193|467946|P1|Observational Period|Participant convenience|2
142291|NCT00440193|467945|P2|Observational Period|Clinical endpoint reached|0
142292|NCT00440193|467946|P1|Observational Period|Clinical endpoint reached|1
142293|NCT00440193|467945|P2|Observational Period|Physician Decision|0
142294|NCT00440193|467946|P1|Observational Period|Physician Decision|1
142295|NCT00440193|467945|P2|Observational Period|Withdrawal by Subject|8
142296|NCT00440193|467946|P1|Observational Period|Withdrawal by Subject|11
142297|NCT00440193|467945|P2|Observational Period|Protocol Violation|0
142298|NCT00440193|467946|P1|Observational Period|Protocol Violation|1
142299|NCT00440193|467945|P2|Observational Period|Lost to Follow-up|8
142300|NCT00440193|467946|P1|Observational Period|Lost to Follow-up|12
142301|NCT00440193|467945|P2|Observational Period|Death|20
142302|NCT00440193|467946|P1|Observational Period|Death|15
142303|NCT00440193|467945|P2|Observational Period|Adverse Event|2
142304|NCT00440193|467946|P1|Observational Period|Adverse Event|2
142305|NCT00440193|467945|P2|Treatment Period|Site closed by investigator|2
142306|NCT00440193|467946|P1|Treatment Period|Site closed by investigator|0
142307|NCT00440193|467945|P2|Treatment Period|Participant did not receive treatment|13
142308|NCT00440193|467946|P1|Treatment Period|Participant did not receive treatment|7
142309|NCT00440193|467945|P2|Treatment Period|Participant convenience|2
142310|NCT00440193|467946|P1|Treatment Period|Participant convenience|5
142311|NCT00440193|467945|P2|Treatment Period|Technical problems|1
142312|NCT00440193|467946|P1|Treatment Period|Technical problems|1
142313|NCT00440193|467945|P2|Treatment Period|Switch to commercial drug|2
142314|NCT00440193|467946|P1|Treatment Period|Switch to commercial drug|0
142315|NCT00440193|467945|P2|Treatment Period|Protocol driven decision point|2
142316|NCT00440193|467946|P1|Treatment Period|Protocol driven decision point|2
142317|NCT00440193|467945|P2|Treatment Period|Study terminated by sponsor|94
142318|NCT00440193|467946|P1|Treatment Period|Study terminated by sponsor|102
142319|NCT00440193|467945|P2|Treatment Period|Clinical endpoint reached|25
142320|NCT00440193|467946|P1|Treatment Period|Clinical endpoint reached|28
142321|NCT00440193|467945|P2|Treatment Period|Withdrawal by Subject|77
142322|NCT00440193|467946|P1|Treatment Period|Withdrawal by Subject|36
142323|NCT00440193|467945|P2|Treatment Period|Protocol Violation|19
142324|NCT00440193|467946|P1|Treatment Period|Protocol Violation|16
142325|NCT00440193|467945|P2|Treatment Period|Physician Decision|6
142326|NCT00440193|467946|P1|Treatment Period|Physician Decision|3
142327|NCT00440193|467945|P2|Treatment Period|Lost to Follow-up|18
142328|NCT00440193|467946|P1|Treatment Period|Lost to Follow-up|12
142329|NCT00440193|467945|P2|Treatment Period|Lack of Efficacy|1
142330|NCT00440193|467946|P1|Treatment Period|Lack of Efficacy|0
142331|NCT00440193|467945|P2|Treatment Period|Death|22
142332|NCT00440193|467946|P1|Treatment Period|Death|19
142333|NCT00440193|467945|P2|Treatment Period|Adverse Event|67
142334|NCT00440193|467946|P1|Treatment Period|Adverse Event|74
142335|NCT00440011|468006|P2|Overall Study|Withdrawal by Subject|0
142336|NCT00440011|468007|P1|Overall Study|Withdrawal by Subject|1
142337|NCT00440011|468006|P2|Overall Study|Protocol Violation|1
142338|NCT00440011|468007|P1|Overall Study|Protocol Violation|1
142339|NCT00440011|468006|P2|Overall Study|Lost to Follow-up|2
142340|NCT00440011|468007|P1|Overall Study|Lost to Follow-up|0
142341|NCT00440011|468006|P2|Overall Study|Adverse Event|0
142342|NCT00440011|468007|P1|Overall Study|Adverse Event|2
142343|NCT00439777|468034|P2|Observational Period|Technical problems|1
142344|NCT00439777|468035|P1|Observational Period|Technical problems|0
142345|NCT00439777|468034|P2|Observational Period|Lack of Efficacy|0
142346|NCT00439777|468035|P1|Observational Period|Lack of Efficacy|1
142347|NCT00439777|468034|P2|Observational Period|Protocol driven decision point|1
142348|NCT00439777|468035|P1|Observational Period|Protocol driven decision point|0
142349|NCT00439777|468034|P2|Observational Period|Study terminated by sponsor|1
142350|NCT00439777|468035|P1|Observational Period|Study terminated by sponsor|3
142351|NCT00439777|468034|P2|Observational Period|Death|20
142352|NCT00439777|468035|P1|Observational Period|Death|27
142353|NCT00439777|468034|P2|Observational Period|Lost to Follow-up|11
142354|NCT00439777|468035|P1|Observational Period|Lost to Follow-up|1
142355|NCT00439777|468034|P2|Observational Period|Withdrawal by Subject|5
142356|NCT00439777|468035|P1|Observational Period|Withdrawal by Subject|9
142357|NCT00439777|468034|P2|Observational Period|Protocol Violation|2
142358|NCT00439777|468035|P1|Observational Period|Protocol Violation|0
142359|NCT00439777|468034|P2|Treatment Period|Participant convenience|8
142360|NCT00439777|468035|P1|Treatment Period|Participant convenience|12
142361|NCT00439777|468034|P2|Treatment Period|Technical problems|1
142362|NCT00439777|468035|P1|Treatment Period|Technical problems|3
142363|NCT00439777|468034|P2|Treatment Period|Clinical endpoint reached|13
142364|NCT00439777|468035|P1|Treatment Period|Clinical endpoint reached|26
142365|NCT00439777|468034|P2|Treatment Period|Physician Decision|18
142366|NCT00439777|468035|P1|Treatment Period|Physician Decision|7
142367|NCT00439777|468034|P2|Treatment Period|Protocol driven decision point|3
142368|NCT00439777|468035|P1|Treatment Period|Protocol driven decision point|1
142369|NCT00439777|468034|P2|Treatment Period|Lost to Follow-up|10
142370|NCT00439777|468035|P1|Treatment Period|Lost to Follow-up|8
142371|NCT00439777|468034|P2|Treatment Period|Lack of Efficacy|4
142372|NCT00439777|468035|P1|Treatment Period|Lack of Efficacy|1
142373|NCT00439777|468034|P2|Treatment Period|Withdrawal by Subject|118
142374|NCT00439777|468035|P1|Treatment Period|Withdrawal by Subject|66
142375|NCT00439777|468034|P2|Treatment Period|Protocol Violation|30
142376|NCT00439777|468035|P1|Treatment Period|Protocol Violation|23
142377|NCT00439777|468034|P2|Treatment Period|Adverse Event|92
142378|NCT00439777|468035|P1|Treatment Period|Adverse Event|111
142379|NCT00439777|468034|P2|Treatment Period|Did not take study treatment|8
142380|NCT00439777|468035|P1|Treatment Period|Did not take study treatment|7
142381|NCT00439777|468034|P2|Treatment Period|Site closed by investigator|1
142382|NCT00439777|468035|P1|Treatment Period|Site closed by investigator|0
142383|NCT00439777|468034|P2|Treatment Period|Study terminated by sponsor|132
142384|NCT00439777|468035|P1|Treatment Period|Study terminated by sponsor|125
142385|NCT00439777|468034|P2|Treatment Period|Death|21
142386|NCT00439777|468035|P1|Treatment Period|Death|29
142387|NCT00439738|468073|P2|Overall Study|Abnormal Lab Values|0
142388|NCT00439738|468074|P1|Overall Study|Abnormal Lab Values|1
142389|NCT00439738|468073|P2|Overall Study|Lack of Efficacy|2
142390|NCT00439738|468074|P1|Overall Study|Lack of Efficacy|2
142392|NCT00439738|468074|P1|Overall Study|Protocol Violation|6
142393|NCT00439738|468073|P2|Overall Study|Lost to Follow-up|6
142394|NCT00439738|468074|P1|Overall Study|Lost to Follow-up|5
142395|NCT00439738|468073|P2|Overall Study|Adverse Event|4
142396|NCT00439738|468074|P1|Overall Study|Adverse Event|6
142397|NCT00439738|468073|P2|Overall Study|Withdrawal by Subject|13
142398|NCT00439738|468074|P1|Overall Study|Withdrawal by Subject|16
142399|NCT00439725|468094|P2|Observational Period|Participant convenience|0
142400|NCT00439725|468095|P1|Observational Period|Participant convenience|1
142401|NCT00439725|468094|P2|Observational Period|Technical problems|0
142402|NCT00439725|468095|P1|Observational Period|Technical problems|1
142403|NCT00439725|468094|P2|Observational Period|Clinical endpoint reached|1
142404|NCT00439725|468095|P1|Observational Period|Clinical endpoint reached|3
142405|NCT00439725|468094|P2|Observational Period|Study termination by sponsor|1
142406|NCT00439725|468095|P1|Observational Period|Study termination by sponsor|1
142407|NCT00439725|468094|P2|Observational Period|Death|2
142408|NCT00439725|468095|P1|Observational Period|Death|0
142409|NCT00439725|468094|P2|Observational Period|Lost to Follow-up|1
142410|NCT00439725|468095|P1|Observational Period|Lost to Follow-up|0
142411|NCT00439725|468094|P2|Observational Period|Withdrawal by Subject|2
142412|NCT00439725|468095|P1|Observational Period|Withdrawal by Subject|2
142413|NCT00439725|468094|P2|Treatment Period|Participant did not receive treatment|4
142414|NCT00439725|468095|P1|Treatment Period|Participant did not receive treatment|4
142415|NCT00439725|468094|P2|Treatment Period|Death|1
142416|NCT00439725|468095|P1|Treatment Period|Death|1
142417|NCT00439725|468094|P2|Treatment Period|Protocol driven decision point|1
142418|NCT00439725|468095|P1|Treatment Period|Protocol driven decision point|1
142419|NCT00439725|468094|P2|Treatment Period|Participant convenience|0
142420|NCT00439725|468095|P1|Treatment Period|Participant convenience|1
142421|NCT00439725|468094|P2|Treatment Period|Lost to Follow-up|1
142422|NCT00439725|468095|P1|Treatment Period|Lost to Follow-up|1
142423|NCT00439725|468094|P2|Treatment Period|Technical problems|0
142424|NCT00439725|468095|P1|Treatment Period|Technical problems|1
142425|NCT00439725|468094|P2|Treatment Period|Clinical endpoint reached|50
142426|NCT00439725|468095|P1|Treatment Period|Clinical endpoint reached|6
142427|NCT00439725|468094|P2|Treatment Period|Protocol Violation|1
142428|NCT00439725|468095|P1|Treatment Period|Protocol Violation|2
142429|NCT00439725|468094|P2|Treatment Period|Physician Decision|1
142430|NCT00439725|468095|P1|Treatment Period|Physician Decision|1
142431|NCT00439725|468094|P2|Treatment Period|Adverse Event|18
142432|NCT00439725|468095|P1|Treatment Period|Adverse Event|39
142433|NCT00439725|468094|P2|Treatment Period|Site closed by investigator|2
142434|NCT00439725|468095|P1|Treatment Period|Site closed by investigator|1
142435|NCT00439725|468094|P2|Treatment Period|Study terminated by sponsor|148
142436|NCT00439725|468095|P1|Treatment Period|Study terminated by sponsor|156
142437|NCT00439725|468094|P2|Treatment Period|Withdrawal by Subject|19
142438|NCT00439725|468095|P1|Treatment Period|Withdrawal by Subject|22
142439|NCT00439647|468141|P2|Overall Study|Lack of Efficacy|4
142440|NCT00439647|468142|P1|Overall Study|Lack of Efficacy|0
142441|NCT00439647|468141|P2|Overall Study|Protocol Violation|4
142442|NCT00439647|468142|P1|Overall Study|Protocol Violation|3
142443|NCT00439647|468141|P2|Overall Study|Lost to Follow-up|12
142444|NCT00439647|468142|P1|Overall Study|Lost to Follow-up|4
142445|NCT00439647|468141|P2|Overall Study|Adverse Event|11
142446|NCT00439647|468142|P1|Overall Study|Adverse Event|11
142447|NCT00439647|468141|P2|Overall Study|Death|18
142448|NCT00439647|468142|P1|Overall Study|Death|15
142449|NCT00439647|468141|P2|Overall Study|Withdrawal by Subject|22
142450|NCT00439647|468142|P1|Overall Study|Withdrawal by Subject|25
142451|NCT00439569|468178|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
142452|NCT00439569|468178|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
142453|NCT00439569|468178|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
142454|NCT00439517|468191|P2|Overall Study|Subject in survival follow-up|0
142455|NCT00439517|468192|P1|Overall Study|Subject in survival follow-up|1
142456|NCT00439517|468191|P2|Overall Study|Subject on treatment|0
142457|NCT00439517|468192|P1|Overall Study|Subject on treatment|1
142458|NCT00439309|468260|P2|Follow-Up|Late response by subject|1
142459|NCT00439309|468261|P1|Follow-Up|Late response by subject|0
142460|NCT00439309|468260|P2|Follow-Up|Withdrawal by Subject|1
142461|NCT00439309|468261|P1|Follow-Up|Withdrawal by Subject|0
142462|NCT00439309|468260|P2|Follow-Up|Lost to Follow-up|0
142463|NCT00439309|468261|P1|Follow-Up|Lost to Follow-up|2
142464|NCT00439309|468260|P2|Follow-Up|Death|0
142465|NCT00439309|468261|P1|Follow-Up|Death|1
142466|NCT00439270|468280|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
142467|NCT00439270|468281|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
142468|NCT00439270|468282|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
142469|NCT00439270|468283|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
142470|NCT00439270|468284|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
142471|NCT00439270|468280|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
142472|NCT00439270|468281|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
142473|NCT00439270|468282|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
142474|NCT00439270|468283|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
142475|NCT00439270|468284|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
142476|NCT00439270|468280|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
142477|NCT00439270|468281|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
142478|NCT00439270|468282|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
142479|NCT00439270|468283|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
142480|NCT00439270|468284|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
142481|NCT00439270|468280|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
142482|NCT00439270|468281|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
142483|NCT00439270|468282|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
142484|NCT00439270|468283|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
142485|NCT00439270|468284|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
142486|NCT00439270|468280|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
142487|NCT00439270|468281|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
142488|NCT00439270|468282|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
142489|NCT00439270|468283|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
142490|NCT00439270|468284|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
142491|NCT00439270|468280|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
142492|NCT00439270|468281|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
142493|NCT00439270|468282|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
142494|NCT00439270|468283|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
142495|NCT00439270|468284|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
142496|NCT00439270|468280|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
142497|NCT00439270|468281|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
142498|NCT00439270|468282|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
142499|NCT00439270|468283|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
142500|NCT00439270|468284|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
142501|NCT00439270|468280|P5|Phase 2 (51.6 Months)|Disease progression|0
142502|NCT00439270|468281|P4|Phase 2 (51.6 Months)|Disease progression|18
142503|NCT00439270|468282|P3|Phase 2 (51.6 Months)|Disease progression|0
142504|NCT00439270|468283|P2|Phase 2 (51.6 Months)|Disease progression|0
142505|NCT00439270|468284|P1|Phase 2 (51.6 Months)|Disease progression|0
142506|NCT00439270|468280|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
142507|NCT00439270|468281|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
142508|NCT00439270|468282|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
142509|NCT00439270|468283|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
142510|NCT00439270|468284|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
142511|NCT00439270|468280|P5|Phase 1 (18.1 Months)|Disease progression|3
142512|NCT00439270|468281|P4|Phase 1 (18.1 Months)|Disease progression|0
142513|NCT00439270|468282|P3|Phase 1 (18.1 Months)|Disease progression|3
142514|NCT00439270|468283|P2|Phase 1 (18.1 Months)|Disease progression|2
142515|NCT00439270|468284|P1|Phase 1 (18.1 Months)|Disease progression|3
142516|NCT00439244|468326|P3|Overall Study|Administrative problems|0
142517|NCT00439244|468327|P2|Overall Study|Administrative problems|0
142518|NCT00439244|468328|P1|Overall Study|Administrative problems|1
142519|NCT00439244|468326|P3|Overall Study|Protocol Violation|0
142520|NCT00439244|468327|P2|Overall Study|Protocol Violation|1
142521|NCT00439244|468328|P1|Overall Study|Protocol Violation|0
142522|NCT00439244|468326|P3|Overall Study|Death|0
142523|NCT00439244|468327|P2|Overall Study|Death|1
142524|NCT00439244|468328|P1|Overall Study|Death|0
142525|NCT00439244|468326|P3|Overall Study|Lost to Follow-up|2
142526|NCT00439244|468327|P2|Overall Study|Lost to Follow-up|1
142527|NCT00439244|468328|P1|Overall Study|Lost to Follow-up|2
142528|NCT00439244|468326|P3|Overall Study|Withdrawal by Subject|2
142529|NCT00439244|468327|P2|Overall Study|Withdrawal by Subject|1
142530|NCT00439244|468328|P1|Overall Study|Withdrawal by Subject|3
142531|NCT00439244|468326|P3|Overall Study|Adverse Event|3
142532|NCT00439244|468327|P2|Overall Study|Adverse Event|2
142533|NCT00439244|468328|P1|Overall Study|Adverse Event|5
142534|NCT00439231|468348|P1|Overall Study|Lack of Efficacy|28
142535|NCT00439218|468352|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
142536|NCT00439179|468367|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
142537|NCT00439179|468368|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
142538|NCT00439179|468369|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
142539|NCT00439179|468370|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
142540|NCT00439140|468387|P3|Treatment Cycle 2|Lost to Follow-up|0
142541|NCT00439140|468388|P2|Treatment Cycle 2|Lost to Follow-up|1
142542|NCT00439140|468389|P1|Treatment Cycle 2|Lost to Follow-up|1
142543|NCT00439140|468387|P3|Treatment Cycle 2|Withdrawal by Subject|0
142544|NCT00439140|468388|P2|Treatment Cycle 2|Withdrawal by Subject|0
142545|NCT00439140|468389|P1|Treatment Cycle 2|Withdrawal by Subject|1
142546|NCT00439140|468387|P3|Treatment Cycle 1|Withdrawal by Subject|0
142547|NCT00439140|468388|P2|Treatment Cycle 1|Withdrawal by Subject|1
142548|NCT00439140|468389|P1|Treatment Cycle 1|Withdrawal by Subject|0
142549|NCT00439140|468387|P3|Treatment Cycle 1|Personal reasons|0
142550|NCT00439140|468388|P2|Treatment Cycle 1|Personal reasons|2
142551|NCT00439140|468389|P1|Treatment Cycle 1|Personal reasons|0
142552|NCT00439140|468387|P3|Treatment Cycle 1|Lost to Follow-up|1
142553|NCT00439140|468388|P2|Treatment Cycle 1|Lost to Follow-up|1
142554|NCT00439140|468389|P1|Treatment Cycle 1|Lost to Follow-up|1
142555|NCT00438815|468469|P1|Overall Study|Death|1
142556|NCT00438815|468469|P1|Overall Study|Withdrawal by Subject|6
142557|NCT00438815|468469|P1|Overall Study|Lost to Follow-up|6
142558|NCT00438815|468469|P1|Overall Study|Transitioned to commercial C1INH-nf|6
142559|NCT00438815|468469|P1|Overall Study|Noncompliance with protocol requirements|9
142560|NCT00438815|468469|P1|Overall Study|3-month follow-up no longer required|12
142561|NCT00438815|468469|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
142562|NCT00438672|468502|P2|Overall Study|Lost to Follow-up|9
142563|NCT00438672|468503|P1|Overall Study|Lost to Follow-up|7
142564|NCT00438659|468513|P2|Overall Study|Cancel|2
142565|NCT00438659|468514|P1|Overall Study|Cancel|5
142566|NCT00438659|468513|P2|Overall Study|Discontinued Mometasone/Placebo|2
142567|NCT00438659|468514|P1|Overall Study|Discontinued Mometasone/Placebo|1
142568|NCT00436748|468538|P2|Overall Study|Other|0
142569|NCT00436748|468539|P1|Overall Study|Other|3
142570|NCT00436748|468538|P2|Overall Study|Protocol-specified Criteria|4
142571|NCT00436748|468539|P1|Overall Study|Protocol-specified Criteria|5
142572|NCT00436748|468538|P2|Overall Study|Lost to Follow-up|1
142573|NCT00436748|468539|P1|Overall Study|Lost to Follow-up|0
142574|NCT00436748|468538|P2|Overall Study|Administrative Decision|0
142575|NCT00436748|468539|P1|Overall Study|Administrative Decision|1
142576|NCT00436748|468538|P2|Overall Study|Consent Withdrawn|4
142577|NCT00436748|468539|P1|Overall Study|Consent Withdrawn|1
142578|NCT00436748|468538|P2|Overall Study|Adverse Event|2
142579|NCT00436748|468539|P1|Overall Study|Adverse Event|0
142580|NCT00436748|468538|P2|Overall Study|Ineligibility Determined|1
142581|NCT00436748|468539|P1|Overall Study|Ineligibility Determined|1
142582|NCT00438464|468584|P2|Overall Study|Incomplete data submission|2
142583|NCT00438464|468585|P1|Overall Study|Incomplete data submission|0
142584|NCT00438464|468584|P2|Overall Study|Terminated Early|5
142585|NCT00438464|468585|P1|Overall Study|Terminated Early|14
142586|NCT00438399|468686|P6|Overall Study|Patien stopped study at visit 4 by error|0
142587|NCT00438399|468687|P5|Overall Study|Patien stopped study at visit 4 by error|0
142588|NCT00438399|468688|P4|Overall Study|Patien stopped study at visit 4 by error|0
142589|NCT00438399|468689|P3|Overall Study|Patien stopped study at visit 4 by error|0
142590|NCT00438399|468690|P2|Overall Study|Patien stopped study at visit 4 by error|0
142591|NCT00438399|468691|P1|Overall Study|Patien stopped study at visit 4 by error|1
142592|NCT00438399|468686|P6|Overall Study|Pregnancy|1
142593|NCT00438399|468687|P5|Overall Study|Pregnancy|0
142594|NCT00438399|468688|P4|Overall Study|Pregnancy|0
142595|NCT00438399|468689|P3|Overall Study|Pregnancy|0
142596|NCT00438399|468690|P2|Overall Study|Pregnancy|0
142597|NCT00438399|468691|P1|Overall Study|Pregnancy|0
142598|NCT00438399|468686|P6|Overall Study|Subje stopped study|0
142599|NCT00438399|468687|P5|Overall Study|Subje stopped study|0
142600|NCT00438399|468688|P4|Overall Study|Subje stopped study|0
142601|NCT00438399|468689|P3|Overall Study|Subje stopped study|1
142602|NCT00438399|468690|P2|Overall Study|Subje stopped study|0
142603|NCT00438399|468691|P1|Overall Study|Subje stopped study|0
142604|NCT00438399|468686|P6|Overall Study|Protocol Violation|1
142605|NCT00438399|468687|P5|Overall Study|Protocol Violation|0
142606|NCT00438399|468688|P4|Overall Study|Protocol Violation|0
142607|NCT00438399|468689|P3|Overall Study|Protocol Violation|1
142608|NCT00438399|468690|P2|Overall Study|Protocol Violation|0
142609|NCT00438399|468691|P1|Overall Study|Protocol Violation|0
142610|NCT00438399|468686|P6|Overall Study|Withdrawal by Subject|2
142611|NCT00438399|468687|P5|Overall Study|Withdrawal by Subject|2
142612|NCT00438399|468688|P4|Overall Study|Withdrawal by Subject|2
142613|NCT00438399|468689|P3|Overall Study|Withdrawal by Subject|3
142614|NCT00438399|468690|P2|Overall Study|Withdrawal by Subject|6
142615|NCT00438399|468691|P1|Overall Study|Withdrawal by Subject|5
142616|NCT00438399|468686|P6|Overall Study|Adverse Event|1
142617|NCT00438399|468687|P5|Overall Study|Adverse Event|0
142618|NCT00438399|468688|P4|Overall Study|Adverse Event|1
142619|NCT00438399|468689|P3|Overall Study|Adverse Event|1
142620|NCT00438399|468690|P2|Overall Study|Adverse Event|0
142621|NCT00438399|468691|P1|Overall Study|Adverse Event|0
142622|NCT00438399|468686|P6|Overall Study|Lost to Follow-up|1
142623|NCT00438399|468687|P5|Overall Study|Lost to Follow-up|1
142624|NCT00438399|468688|P4|Overall Study|Lost to Follow-up|1
142625|NCT00438399|468689|P3|Overall Study|Lost to Follow-up|1
142626|NCT00438399|468690|P2|Overall Study|Lost to Follow-up|2
142627|NCT00438399|468691|P1|Overall Study|Lost to Follow-up|2
142628|NCT00438360|468702|P2|Overall Study|not specified|15
142629|NCT00438360|468703|P1|Overall Study|not specified|24
142630|NCT00438360|468702|P2|Overall Study|Lack of Efficacy|27
142631|NCT00438360|468703|P1|Overall Study|Lack of Efficacy|42
142632|NCT00438360|468702|P2|Overall Study|Adverse Event|1
142633|NCT00438360|468703|P1|Overall Study|Adverse Event|6
142634|NCT00437983|468732|P2|Overall Study|Withdrawal by Subject|6
142635|NCT00437983|468733|P1|Overall Study|Withdrawal by Subject|5
142636|NCT00437983|468732|P2|Overall Study|Protocol Violation|1
142637|NCT00437983|468733|P1|Overall Study|Protocol Violation|2
142638|NCT00437983|468732|P2|Overall Study|Adverse Event|6
142639|NCT00437983|468733|P1|Overall Study|Adverse Event|6
142640|NCT00437645|468745|P2|Overall Study|Condition no longer requires study drug|1
142641|NCT00437645|468746|P1|Overall Study|Condition no longer requires study drug|1
142642|NCT00437645|468745|P2|Overall Study|Lack of Efficacy|1
142643|NCT00437645|468746|P1|Overall Study|Lack of Efficacy|2
142644|NCT00437645|468745|P2|Overall Study|Administrative problems|1
142645|NCT00437645|468746|P1|Overall Study|Administrative problems|2
142646|NCT00437645|468745|P2|Overall Study|Lost to Follow-up|3
142647|NCT00437645|468746|P1|Overall Study|Lost to Follow-up|2
142648|NCT00437645|468745|P2|Overall Study|Protocol Violation|3
142649|NCT00437645|468746|P1|Overall Study|Protocol Violation|3
142650|NCT00437645|468745|P2|Overall Study|Withdrawal by Subject|22
142651|NCT00437645|468746|P1|Overall Study|Withdrawal by Subject|10
142652|NCT00437645|468745|P2|Overall Study|Adverse Event|84
142653|NCT00437645|468746|P1|Overall Study|Adverse Event|15
142654|NCT00437489|468762|P2|Overall Study|Lost to Follow-up|1
142655|NCT00437489|468763|P1|Overall Study|Lost to Follow-up|0
142656|NCT00437489|468762|P2|Overall Study|Study terminated by sponsor|21
142657|NCT00437489|468763|P1|Overall Study|Study terminated by sponsor|23
142658|NCT00437281|468800|P20|Overall Study|Lost to Follow-up|1
142659|NCT00437281|468801|P19|Overall Study|Lost to Follow-up|0
142660|NCT00437281|468802|P18|Overall Study|Lost to Follow-up|0
142661|NCT00437281|468803|P17|Overall Study|Lost to Follow-up|0
142662|NCT00437281|468804|P16|Overall Study|Lost to Follow-up|0
142663|NCT00437281|468805|P15|Overall Study|Lost to Follow-up|0
142664|NCT00437281|468806|P14|Overall Study|Lost to Follow-up|0
142665|NCT00437281|468807|P13|Overall Study|Lost to Follow-up|0
142666|NCT00437281|468808|P12|Overall Study|Lost to Follow-up|0
142667|NCT00437281|468809|P11|Overall Study|Lost to Follow-up|0
142668|NCT00437281|468810|P10|Overall Study|Lost to Follow-up|0
142669|NCT00437281|468811|P9|Overall Study|Lost to Follow-up|0
142670|NCT00437281|468812|P8|Overall Study|Lost to Follow-up|0
142671|NCT00437281|468813|P7|Overall Study|Lost to Follow-up|0
142672|NCT00437281|468814|P6|Overall Study|Lost to Follow-up|0
142673|NCT00437281|468815|P5|Overall Study|Lost to Follow-up|0
142674|NCT00437281|468816|P4|Overall Study|Lost to Follow-up|0
142675|NCT00437281|468817|P3|Overall Study|Lost to Follow-up|0
142676|NCT00437281|468818|P2|Overall Study|Lost to Follow-up|0
142677|NCT00437281|468819|P1|Overall Study|Lost to Follow-up|0
142678|NCT00437281|468800|P20|Overall Study|Adverse Event|0
142679|NCT00437281|468801|P19|Overall Study|Adverse Event|1
142680|NCT00437281|468802|P18|Overall Study|Adverse Event|0
142681|NCT00437281|468803|P17|Overall Study|Adverse Event|0
142682|NCT00437281|468804|P16|Overall Study|Adverse Event|0
142683|NCT00437281|468805|P15|Overall Study|Adverse Event|1
142684|NCT00437281|468806|P14|Overall Study|Adverse Event|1
142685|NCT00437281|468807|P13|Overall Study|Adverse Event|0
142686|NCT00437281|468808|P12|Overall Study|Adverse Event|0
142687|NCT00437281|468809|P11|Overall Study|Adverse Event|0
142688|NCT00437281|468810|P10|Overall Study|Adverse Event|1
142689|NCT00437281|468811|P9|Overall Study|Adverse Event|0
142690|NCT00437281|468812|P8|Overall Study|Adverse Event|0
142691|NCT00437281|468813|P7|Overall Study|Adverse Event|0
142692|NCT00437281|468814|P6|Overall Study|Adverse Event|1
142693|NCT00437281|468815|P5|Overall Study|Adverse Event|0
142694|NCT00437281|468816|P4|Overall Study|Adverse Event|1
142695|NCT00437281|468817|P3|Overall Study|Adverse Event|0
142696|NCT00437281|468818|P2|Overall Study|Adverse Event|0
142697|NCT00437281|468819|P1|Overall Study|Adverse Event|0
142698|NCT00437203|469123|P10|Overall Study|Unspecified|0
142699|NCT00437203|469124|P9|Overall Study|Unspecified|0
142700|NCT00437203|469125|P8|Overall Study|Unspecified|0
142701|NCT00437203|469126|P7|Overall Study|Unspecified|1
142702|NCT00437203|469127|P6|Overall Study|Unspecified|0
142703|NCT00437203|469128|P5|Overall Study|Unspecified|0
142704|NCT00437203|469129|P4|Overall Study|Unspecified|0
142705|NCT00437203|469130|P3|Overall Study|Unspecified|0
142706|NCT00437203|469131|P2|Overall Study|Unspecified|1
142707|NCT00437203|469132|P1|Overall Study|Unspecified|0
142708|NCT00437203|469123|P10|Overall Study|Objective progression or relapse|2
142709|NCT00437203|469124|P9|Overall Study|Objective progression or relapse|2
142710|NCT00437203|469125|P8|Overall Study|Objective progression or relapse|1
142711|NCT00437203|469126|P7|Overall Study|Objective progression or relapse|6
142712|NCT00437203|469127|P6|Overall Study|Objective progression or relapse|3
142713|NCT00437203|469128|P5|Overall Study|Objective progression or relapse|3
142714|NCT00437203|469129|P4|Overall Study|Objective progression or relapse|3
142715|NCT00437203|469130|P3|Overall Study|Objective progression or relapse|2
142716|NCT00437203|469131|P2|Overall Study|Objective progression or relapse|6
142717|NCT00437203|469132|P1|Overall Study|Objective progression or relapse|5
142718|NCT00437203|469123|P10|Overall Study|Study terminated by sponsor|0
142719|NCT00437203|469124|P9|Overall Study|Study terminated by sponsor|1
142720|NCT00437203|469125|P8|Overall Study|Study terminated by sponsor|0
142721|NCT00437203|469126|P7|Overall Study|Study terminated by sponsor|0
142722|NCT00437203|469127|P6|Overall Study|Study terminated by sponsor|0
142723|NCT00437203|469128|P5|Overall Study|Study terminated by sponsor|0
142724|NCT00437203|469129|P4|Overall Study|Study terminated by sponsor|0
142725|NCT00437203|469130|P3|Overall Study|Study terminated by sponsor|0
142726|NCT00437203|469131|P2|Overall Study|Study terminated by sponsor|0
142727|NCT00437203|469132|P1|Overall Study|Study terminated by sponsor|0
142728|NCT00437203|469123|P10|Overall Study|Adverse Event|1
142729|NCT00437203|469124|P9|Overall Study|Adverse Event|0
142730|NCT00437203|469125|P8|Overall Study|Adverse Event|1
142731|NCT00437203|469126|P7|Overall Study|Adverse Event|0
142732|NCT00437203|469127|P6|Overall Study|Adverse Event|0
142733|NCT00437203|469128|P5|Overall Study|Adverse Event|0
142734|NCT00437203|469129|P4|Overall Study|Adverse Event|0
142735|NCT00437203|469130|P3|Overall Study|Adverse Event|0
142736|NCT00437203|469131|P2|Overall Study|Adverse Event|1
142737|NCT00437203|469132|P1|Overall Study|Adverse Event|1
142738|NCT00437203|469123|P10|Overall Study|Death|1
142739|NCT00437203|469124|P9|Overall Study|Death|0
142740|NCT00437203|469125|P8|Overall Study|Death|1
142741|NCT00437203|469126|P7|Overall Study|Death|0
142742|NCT00437203|469127|P6|Overall Study|Death|0
142743|NCT00437203|469128|P5|Overall Study|Death|0
142744|NCT00437203|469129|P4|Overall Study|Death|0
142745|NCT00437203|469130|P3|Overall Study|Death|1
142746|NCT00437203|469131|P2|Overall Study|Death|0
142747|NCT00437203|469132|P1|Overall Study|Death|0
142748|NCT00437125|469236|P1|Overall Study|Physician Decision|1
142749|NCT00437125|469236|P1|Overall Study|Withdrawal by Caregiver|2
142750|NCT00437125|469236|P1|Overall Study|Withdrawal by Subject|13
142751|NCT00437125|469236|P1|Overall Study|Lost to Follow-up|1
142752|NCT00437125|469236|P1|Overall Study|Lack of Efficacy|1
142753|NCT00437125|469236|P1|Overall Study|Clinical Relapse|1
142754|NCT00437125|469236|P1|Overall Study|Death|1
142755|NCT00437125|469236|P1|Overall Study|Adverse Event|12
142756|NCT00437073|469257|P2|Overall Study|Physician Decision|1
142757|NCT00437073|469258|P1|Overall Study|Physician Decision|0
142758|NCT00437073|469257|P2|Overall Study|Sponsor Terminated Study|0
142759|NCT00437073|469258|P1|Overall Study|Sponsor Terminated Study|1
142760|NCT00437034|469286|P1|Overall Study|Disease progression during treatment|5
142761|NCT00437034|469286|P1|Overall Study|Adverse Event|1
142762|NCT00436982|469292|P2|Overall Study|Did not receive allocated intervention|1
142763|NCT00436982|469293|P1|Overall Study|Did not receive allocated intervention|0
142764|NCT00436982|469292|P2|Overall Study|Withdrawal by Subject|1
142765|NCT00436982|469293|P1|Overall Study|Withdrawal by Subject|2
142766|NCT00436982|469292|P2|Overall Study|Adverse Event|3
142767|NCT00436982|469293|P1|Overall Study|Adverse Event|3
142768|NCT00436956|469350|P2|Overall Study|Not evaluable|0
142769|NCT00436956|469351|P1|Overall Study|Not evaluable|1
142770|NCT00436917|469360|P1|Overall Study|Still on treatment|47
142771|NCT00436917|469360|P1|Overall Study|Adverse Event|1
142772|NCT00436917|469360|P1|Overall Study|Withdrawal by Subject|6
142773|NCT00436852|469375|P2|Overall Study|Ineligible|0
142774|NCT00436852|469376|P1|Overall Study|Ineligible|1
142775|NCT00436852|469375|P2|Overall Study|Withdrawal by Subject|4
142776|NCT00436852|469376|P1|Overall Study|Withdrawal by Subject|2
142777|NCT00436852|469375|P2|Overall Study|Lack of Efficacy|7
142778|NCT00436852|469376|P1|Overall Study|Lack of Efficacy|9
142779|NCT00436852|469375|P2|Overall Study|Death|34
142780|NCT00436852|469376|P1|Overall Study|Death|23
142781|NCT00436826|469386|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
142782|NCT00436826|469387|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
142783|NCT00436826|469388|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
142784|NCT00436826|469389|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
142785|NCT00436826|469390|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
142786|NCT00436826|469391|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
142787|NCT00436826|469386|P6|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
142788|NCT00436826|469387|P5|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
142789|NCT00436826|469388|P4|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|24
142790|NCT00436826|469389|P3|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|44
142791|NCT00436826|469390|P2|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
142792|NCT00436826|469391|P1|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
142793|NCT00436826|469386|P6|Double Blind Period|Unspecified|0
142794|NCT00436826|469387|P5|Double Blind Period|Unspecified|0
142795|NCT00436826|469388|P4|Double Blind Period|Unspecified|0
142796|NCT00436826|469389|P3|Double Blind Period|Unspecified|0
142797|NCT00436826|469390|P2|Double Blind Period|Unspecified|11
142798|NCT00436826|469391|P1|Double Blind Period|Unspecified|10
142799|NCT00436826|469386|P6|Double Blind Period|Protocol Violation|0
142800|NCT00436826|469387|P5|Double Blind Period|Protocol Violation|0
142801|NCT00436826|469388|P4|Double Blind Period|Protocol Violation|0
142802|NCT00436826|469389|P3|Double Blind Period|Protocol Violation|0
142803|NCT00436826|469390|P2|Double Blind Period|Protocol Violation|0
142804|NCT00436826|469391|P1|Double Blind Period|Protocol Violation|1
142805|NCT00436826|469386|P6|Double Blind Period|Adverse Event|0
142806|NCT00436826|469387|P5|Double Blind Period|Adverse Event|0
142807|NCT00436826|469388|P4|Double Blind Period|Adverse Event|0
142808|NCT00436826|469389|P3|Double Blind Period|Adverse Event|0
142809|NCT00436826|469390|P2|Double Blind Period|Adverse Event|0
142810|NCT00436826|469391|P1|Double Blind Period|Adverse Event|2
142811|NCT00436644|469411|P1|Overall Study|Death|1
142812|NCT00436644|469411|P1|Overall Study|Adverse Event|2
142813|NCT00436618|469421|P3|Overall Study|Still on treatment|7
142814|NCT00436618|469422|P2|Overall Study|Still on treatment|2
142815|NCT00436618|469423|P1|Overall Study|Still on treatment|1
142816|NCT00436618|469421|P3|Overall Study|New Primary or Other Reasons|12
142817|NCT00436618|469422|P2|Overall Study|New Primary or Other Reasons|2
142818|NCT00436618|469423|P1|Overall Study|New Primary or Other Reasons|6
142819|NCT00436618|469421|P3|Overall Study|Death|3
142820|NCT00436618|469422|P2|Overall Study|Death|2
142821|NCT00436618|469423|P1|Overall Study|Death|4
142822|NCT00436618|469421|P3|Overall Study|Other Medical Problems|7
142823|NCT00436618|469422|P2|Overall Study|Other Medical Problems|1
142824|NCT00436618|469423|P1|Overall Study|Other Medical Problems|3
142825|NCT00436618|469421|P3|Overall Study|Alternate Treatment|12
142826|NCT00436618|469422|P2|Overall Study|Alternate Treatment|4
142827|NCT00436618|469423|P1|Overall Study|Alternate Treatment|3
142828|NCT00436618|469421|P3|Overall Study|Adverse Event|9
142829|NCT00436618|469422|P2|Overall Study|Adverse Event|8
142830|NCT00436618|469423|P1|Overall Study|Adverse Event|8
142831|NCT00436618|469421|P3|Overall Study|Withdrawal by Subject|11
142832|NCT00436618|469422|P2|Overall Study|Withdrawal by Subject|8
142833|NCT00436618|469423|P1|Overall Study|Withdrawal by Subject|5
142834|NCT00436605|469440|P1|Overall Study|Protocol Violation|3
142835|NCT00436566|469445|P1|Overall Study|Protocol Violation|1
142836|NCT00436566|469445|P1|Overall Study|Withdrawal by Subject|2
142837|NCT00436553|469452|P3|Overall Study|Withdrawal by Subject|3
142838|NCT00436553|469453|P2|Overall Study|Withdrawal by Subject|6
142839|NCT00436553|469454|P1|Overall Study|Withdrawal by Subject|5
142840|NCT00436553|469452|P3|Overall Study|Protocol Violation|0
142841|NCT00436553|469453|P2|Overall Study|Protocol Violation|0
142842|NCT00436553|469454|P1|Overall Study|Protocol Violation|1
142843|NCT00436553|469452|P3|Overall Study|Lost to Follow-up|0
142844|NCT00436553|469453|P2|Overall Study|Lost to Follow-up|2
142845|NCT00436553|469454|P1|Overall Study|Lost to Follow-up|0
142846|NCT00436553|469452|P3|Overall Study|Death|3
142847|NCT00436553|469453|P2|Overall Study|Death|1
142848|NCT00436553|469454|P1|Overall Study|Death|3
142849|NCT00436553|469452|P3|Overall Study|Adverse Event|4
142850|NCT00436553|469453|P2|Overall Study|Adverse Event|3
142851|NCT00436553|469454|P1|Overall Study|Adverse Event|4
142852|NCT00436501|469475|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
142853|NCT00436501|469476|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
142854|NCT00436501|469475|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
142855|NCT00436501|469476|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
142856|NCT00436345|469489|P2|Overall Study|ICU resident beyond follow-up period|0
142857|NCT00436345|469490|P1|Overall Study|ICU resident beyond follow-up period|3
142858|NCT00436332|469543|P1|Overall Study|Never Received Treatment|3
142859|NCT00436332|469543|P1|Overall Study|Ineligible|2
142860|NCT00436332|469543|P1|Overall Study|Not Protocol Specified|6
142861|NCT00436332|469543|P1|Overall Study|Death|2
142862|NCT00436332|469543|P1|Overall Study|Progression|59
142863|NCT00436332|469543|P1|Overall Study|Withdrawal by Subject|2
142864|NCT00436332|469543|P1|Overall Study|Adverse Event|9
142865|NCT00436215|469549|P1|Overall Study|Small bowel obstruction|1
142866|NCT00436215|469549|P1|Overall Study|Refused further treatment|3
142867|NCT00436163|469555|P1|Overall Study|Adverse Event|1
142868|NCT00436163|469555|P1|Overall Study|Lost to Follow-up|2
142869|NCT00436007|469603|P3|Overall Study|Unspecified|1
142870|NCT00436007|469604|P2|Overall Study|Unspecified|0
142871|NCT00436007|469605|P1|Overall Study|Unspecified|0
142872|NCT00436007|469603|P3|Overall Study|Death|3
142873|NCT00436007|469604|P2|Overall Study|Death|1
142874|NCT00436007|469605|P1|Overall Study|Death|0
142875|NCT00436007|469603|P3|Overall Study|Physician Decision|2
142876|NCT00436007|469604|P2|Overall Study|Physician Decision|0
142877|NCT00436007|469605|P1|Overall Study|Physician Decision|0
142878|NCT00436007|469603|P3|Overall Study|Lost to Follow-up|13
142879|NCT00436007|469604|P2|Overall Study|Lost to Follow-up|10
142880|NCT00436007|469605|P1|Overall Study|Lost to Follow-up|14
142881|NCT00436007|469603|P3|Overall Study|Withdrawal by Subject|4
142882|NCT00436007|469604|P2|Overall Study|Withdrawal by Subject|3
142883|NCT00436007|469605|P1|Overall Study|Withdrawal by Subject|5
142884|NCT00435994|469653|P3|Overall Study|Lost to Follow-up|0
142885|NCT00435994|469654|P2|Overall Study|Lost to Follow-up|0
142886|NCT00435994|469655|P1|Overall Study|Lost to Follow-up|7
142887|NCT00435825|469697|P4|Overall Study|Did not complete full follow-up period|5
142888|NCT00435825|469698|P3|Overall Study|Did not complete full follow-up period|4
142889|NCT00435825|469699|P2|Overall Study|Did not complete full follow-up period|6
142890|NCT00435825|469700|P1|Overall Study|Did not complete full follow-up period|6
142891|NCT00435825|469697|P4|Overall Study|Did not enter follow-up|3
142892|NCT00435825|469698|P3|Overall Study|Did not enter follow-up|1
142893|NCT00435825|469699|P2|Overall Study|Did not enter follow-up|4
142894|NCT00435825|469700|P1|Overall Study|Did not enter follow-up|0
142895|NCT00435825|469697|P4|Overall Study|Did not receive study drug|0
142896|NCT00435825|469698|P3|Overall Study|Did not receive study drug|2
142897|NCT00435825|469699|P2|Overall Study|Did not receive study drug|0
142898|NCT00435825|469700|P1|Overall Study|Did not receive study drug|1
142899|NCT00435825|469697|P4|Overall Study|Failure to return|0
142900|NCT00435825|469698|P3|Overall Study|Failure to return|4
142901|NCT00435825|469699|P2|Overall Study|Failure to return|0
142902|NCT00435825|469700|P1|Overall Study|Failure to return|5
142903|NCT00435825|469697|P4|Overall Study|Refused treatment|5
142904|NCT00435825|469698|P3|Overall Study|Refused treatment|0
142905|NCT00435825|469699|P2|Overall Study|Refused treatment|0
142906|NCT00435825|469700|P1|Overall Study|Refused treatment|2
142907|NCT00435825|469697|P4|Overall Study|Other Protocol Violation|0
142908|NCT00435825|469698|P3|Overall Study|Other Protocol Violation|0
142909|NCT00435825|469699|P2|Overall Study|Other Protocol Violation|0
142910|NCT00435825|469700|P1|Overall Study|Other Protocol Violation|1
142911|NCT00435825|469697|P4|Overall Study|Insufficient Therapeutic Response|3
142912|NCT00435825|469698|P3|Overall Study|Insufficient Therapeutic Response|0
142913|NCT00435825|469699|P2|Overall Study|Insufficient Therapeutic Response|1
142914|NCT00435825|469700|P1|Overall Study|Insufficient Therapeutic Response|3
142915|NCT00435825|469697|P4|Overall Study|Abnormality of Laboratory Test|0
142916|NCT00435825|469698|P3|Overall Study|Abnormality of Laboratory Test|0
142917|NCT00435825|469699|P2|Overall Study|Abnormality of Laboratory Test|1
142918|NCT00435825|469700|P1|Overall Study|Abnormality of Laboratory Test|0
142919|NCT00435487|469812|P2|Overall Study|Received Drug in Other Treatment Group|1
142920|NCT00435487|469813|P1|Overall Study|Received Drug in Other Treatment Group|0
142921|NCT00435487|469812|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
142922|NCT00435487|469813|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
142923|NCT00435487|469812|P2|Overall Study|Withdrawal by Subject|1
142924|NCT00435487|469813|P1|Overall Study|Withdrawal by Subject|2
142925|NCT00435487|469812|P2|Overall Study|Other|2
142926|NCT00435487|469813|P1|Overall Study|Other|5
142927|NCT00435487|469812|P2|Overall Study|Lost to Follow-up|2
142928|NCT00435487|469813|P1|Overall Study|Lost to Follow-up|2
142929|NCT00435487|469812|P2|Overall Study|Adverse Event|3
142930|NCT00435487|469813|P1|Overall Study|Adverse Event|0
142931|NCT00435487|469812|P2|Overall Study|Death|4
142932|NCT00435487|469813|P1|Overall Study|Death|3
142933|NCT00435409|469831|P3|Overall Study|Sponsor decision|0
142934|NCT00435409|469832|P2|Overall Study|Sponsor decision|3
142935|NCT00435409|469833|P1|Overall Study|Sponsor decision|0
142936|NCT00435409|469831|P3|Overall Study|Adverse Event|8
142937|NCT00435409|469832|P2|Overall Study|Adverse Event|0
142938|NCT00435409|469833|P1|Overall Study|Adverse Event|0
142939|NCT00435409|469831|P3|Overall Study|Not specified|1
142940|NCT00435409|469832|P2|Overall Study|Not specified|30
142941|NCT00435409|469833|P1|Overall Study|Not specified|45
142942|NCT00435409|469831|P3|Overall Study|Withdrawal by Subject|1
142943|NCT00435409|469832|P2|Overall Study|Withdrawal by Subject|7
142944|NCT00435409|469833|P1|Overall Study|Withdrawal by Subject|8
142945|NCT00435409|469831|P3|Overall Study|Global deterioration of health status|4
142946|NCT00435409|469832|P2|Overall Study|Global deterioration of health status|0
142947|NCT00435409|469833|P1|Overall Study|Global deterioration of health status|0
142948|NCT00435409|469831|P3|Overall Study|Objective progression or relapse|58
142949|NCT00435409|469832|P2|Overall Study|Objective progression or relapse|93
142950|NCT00435409|469833|P1|Overall Study|Objective progression or relapse|158
142951|NCT00435409|469831|P3|Overall Study|Death|6
142952|NCT00435409|469832|P2|Overall Study|Death|6
142953|NCT00435409|469833|P1|Overall Study|Death|8
142954|NCT00435409|469831|P3|Overall Study|Lost to Follow-up|0
142955|NCT00435409|469832|P2|Overall Study|Lost to Follow-up|2
142956|NCT00435409|469833|P1|Overall Study|Lost to Follow-up|1
142957|NCT00435409|469831|P3|Overall Study|Protocol Violation|0
142958|NCT00435409|469832|P2|Overall Study|Protocol Violation|2
142959|NCT00435409|469833|P1|Overall Study|Protocol Violation|1
142960|NCT00435370|469855|P2|Overall Study|Antipsychotic medication changed|2
142961|NCT00435370|469856|P1|Overall Study|Antipsychotic medication changed|4
142962|NCT00435370|469855|P2|Overall Study|Withdrawal by Subject|10
142963|NCT00435370|469856|P1|Overall Study|Withdrawal by Subject|10
142964|NCT00435370|469855|P2|Overall Study|Adverse Event|8
142965|NCT00435370|469856|P1|Overall Study|Adverse Event|8
142966|NCT00435188|469864|P2|Overall Study|Lost to Follow-up|6
142967|NCT00435188|469865|P1|Overall Study|Lost to Follow-up|5
142968|NCT00435188|469864|P2|Overall Study|Withdrawal by Subject|11
142969|NCT00435188|469865|P1|Overall Study|Withdrawal by Subject|16
142970|NCT00435188|469864|P2|Overall Study|Death|6
142971|NCT00435188|469865|P1|Overall Study|Death|1
142972|NCT00435162|469908|P6|Period 2 (2 Weeks)|Adverse Event|0
142973|NCT00435162|469909|P5|Period 2 (2 Weeks)|Adverse Event|0
142974|NCT00435162|469910|P4|Period 2 (2 Weeks)|Adverse Event|0
142975|NCT00435162|469911|P3|Period 2 (2 Weeks)|Adverse Event|0
142976|NCT00435162|469912|P2|Period 2 (2 Weeks)|Adverse Event|1
142977|NCT00435162|469913|P1|Period 2 (2 Weeks)|Adverse Event|0
142978|NCT00435045|469933|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
142979|NCT00435045|469934|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
142980|NCT00435045|469933|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
142981|NCT00435045|469934|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
142982|NCT00435045|469933|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
142983|NCT00435045|469934|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
142984|NCT00435045|469933|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
142985|NCT00435045|469934|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
142986|NCT00435045|469933|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
142987|NCT00435045|469934|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
142988|NCT00435045|469933|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
142989|NCT00435045|469934|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
142990|NCT00435045|469933|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
142991|NCT00435045|469934|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
142992|NCT00435045|469933|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
142993|NCT00435045|469934|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
142994|NCT00435045|469933|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
142995|NCT00435045|469934|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
142996|NCT00435045|469933|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
142997|NCT00435045|469934|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
142998|NCT00435045|469933|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
142999|NCT00435045|469934|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
143000|NCT00435019|469990|P2|Overall Study|Personal reasons for withdrawal|7
143001|NCT00435019|469991|P1|Overall Study|Personal reasons for withdrawal|8
143002|NCT00435019|469990|P2|Overall Study|Protocol Violation|1
143003|NCT00435019|469991|P1|Overall Study|Protocol Violation|3
143004|NCT00435019|469990|P2|Overall Study|Lack of Efficacy|2
143005|NCT00435019|469991|P1|Overall Study|Lack of Efficacy|1
143006|NCT00435019|469990|P2|Overall Study|Adverse Event|0
143007|NCT00435019|469991|P1|Overall Study|Adverse Event|1
143008|NCT00434967|470032|P4|Overall Study|Patient Disposition Challenges|3
143009|NCT00434967|470033|P3|Overall Study|Patient Disposition Challenges|0
143010|NCT00434967|470034|P2|Overall Study|Patient Disposition Challenges|0
143011|NCT00434967|470035|P1|Overall Study|Patient Disposition Challenges|2
143012|NCT00434967|470032|P4|Overall Study|Physician Decision|0
143013|NCT00434967|470033|P3|Overall Study|Physician Decision|1
143014|NCT00434967|470034|P2|Overall Study|Physician Decision|1
143015|NCT00434967|470035|P1|Overall Study|Physician Decision|1
143016|NCT00434967|470032|P4|Overall Study|Protocol Violation|1
143017|NCT00434967|470033|P3|Overall Study|Protocol Violation|0
143018|NCT00434967|470034|P2|Overall Study|Protocol Violation|1
143019|NCT00434967|470035|P1|Overall Study|Protocol Violation|0
143020|NCT00434967|470032|P4|Overall Study|Randomized in error|1
143021|NCT00434967|470033|P3|Overall Study|Randomized in error|0
143022|NCT00434967|470034|P2|Overall Study|Randomized in error|0
143023|NCT00434967|470035|P1|Overall Study|Randomized in error|0
143024|NCT00434967|470032|P4|Overall Study|Withdrawal by Subject|6
143025|NCT00434967|470033|P3|Overall Study|Withdrawal by Subject|4
143026|NCT00434967|470034|P2|Overall Study|Withdrawal by Subject|2
143027|NCT00434967|470035|P1|Overall Study|Withdrawal by Subject|2
143028|NCT00434967|470032|P4|Overall Study|Lost to Follow-up|0
143029|NCT00434967|470033|P3|Overall Study|Lost to Follow-up|1
143030|NCT00434967|470034|P2|Overall Study|Lost to Follow-up|0
143031|NCT00434967|470035|P1|Overall Study|Lost to Follow-up|0
143032|NCT00434967|470032|P4|Overall Study|Adverse Event|3
143033|NCT00434967|470033|P3|Overall Study|Adverse Event|3
143034|NCT00434967|470034|P2|Overall Study|Adverse Event|4
143035|NCT00434967|470035|P1|Overall Study|Adverse Event|2
143036|NCT00434954|470055|P2|Overall Study|Subject decision|22
143037|NCT00434954|470056|P1|Overall Study|Subject decision|8
143038|NCT00434954|470055|P2|Overall Study|Sponsor decision|0
143039|NCT00434954|470056|P1|Overall Study|Sponsor decision|1
143040|NCT00434954|470055|P2|Overall Study|Protocol Violation|27
143041|NCT00434954|470056|P1|Overall Study|Protocol Violation|36
143042|NCT00434954|470055|P2|Overall Study|Physician Decision|3
143043|NCT00434954|470056|P1|Overall Study|Physician Decision|6
143044|NCT00434954|470055|P2|Overall Study|Lost to Follow-up|1
143045|NCT00434954|470056|P1|Overall Study|Lost to Follow-up|0
143046|NCT00434954|470055|P2|Overall Study|Entry criteria not met|16
143047|NCT00434954|470056|P1|Overall Study|Entry criteria not met|14
143048|NCT00434954|470055|P2|Overall Study|Adverse Event|2
143049|NCT00434954|470056|P1|Overall Study|Adverse Event|17
143050|NCT00434876|470086|P2|Overall Study|Lost to Follow-up|1
143051|NCT00434876|470087|P1|Overall Study|Lost to Follow-up|1
143052|NCT00434759|470101|P2|Overall Study|family affairs|0
143053|NCT00434759|470102|P1|Overall Study|family affairs|2
143054|NCT00434759|470101|P2|Overall Study|Withdrawal by Subject|1
143055|NCT00434759|470102|P1|Overall Study|Withdrawal by Subject|17
143056|NCT00434759|470101|P2|Overall Study|Lack of Efficacy|4
143057|NCT00434759|470102|P1|Overall Study|Lack of Efficacy|5
143058|NCT00434642|470118|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
143059|NCT00434642|470119|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
143060|NCT00434642|470118|P2|Open-label Treatment Phase|Adverse Event|5
143061|NCT00434642|470119|P1|Open-label Treatment Phase|Adverse Event|0
143062|NCT00434642|470118|P2|Blinded Treatment Phase|Did not Receive Treatment|1
143063|NCT00434642|470119|P1|Blinded Treatment Phase|Did not Receive Treatment|4
143064|NCT00434642|470118|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
143065|NCT00434642|470119|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
143066|NCT00434642|470118|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
143067|NCT00434642|470119|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
143068|NCT00434642|470118|P2|Blinded Treatment Phase|Physician Decision|27
143069|NCT00434642|470119|P1|Blinded Treatment Phase|Physician Decision|19
143070|NCT00434642|470118|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
143071|NCT00434642|470119|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
143072|NCT00434642|470118|P2|Blinded Treatment Phase|Clinical Disease Progression|5
143073|NCT00434642|470119|P1|Blinded Treatment Phase|Clinical Disease Progression|4
143074|NCT00434642|470118|P2|Blinded Treatment Phase|Adverse Event|58
143075|NCT00434642|470119|P1|Blinded Treatment Phase|Adverse Event|12
143076|NCT00434590|470137|P2|Overall Study|Administrative problems|5
143077|NCT00434590|470138|P1|Overall Study|Administrative problems|5
143078|NCT00434421|470160|P1|Overall Study|Non-compliance with study treatment|1
143079|NCT00434421|470160|P1|Overall Study|Withdrawal by Subject|1
143080|NCT00434330|470188|P6|Overall Study|Subject Not Compliant With Study|0
143081|NCT00434330|470189|P5|Overall Study|Subject Not Compliant With Study|0
143082|NCT00434330|470190|P4|Overall Study|Subject Not Compliant With Study|0
143083|NCT00434330|470191|P3|Overall Study|Subject Not Compliant With Study|1
143084|NCT00434330|470192|P2|Overall Study|Subject Not Compliant With Study|0
143085|NCT00434330|470193|P1|Overall Study|Subject Not Compliant With Study|0
143086|NCT00434330|470188|P6|Overall Study|Renal transplant|0
143087|NCT00434330|470189|P5|Overall Study|Renal transplant|0
143088|NCT00434330|470190|P4|Overall Study|Renal transplant|1
143089|NCT00434330|470191|P3|Overall Study|Renal transplant|0
143090|NCT00434330|470192|P2|Overall Study|Renal transplant|0
143091|NCT00434330|470193|P1|Overall Study|Renal transplant|0
143092|NCT00434330|470188|P6|Overall Study|Withdrawal by Subject|0
143093|NCT00434330|470189|P5|Overall Study|Withdrawal by Subject|0
143094|NCT00434330|470190|P4|Overall Study|Withdrawal by Subject|1
143095|NCT00434330|470191|P3|Overall Study|Withdrawal by Subject|1
143096|NCT00434330|470192|P2|Overall Study|Withdrawal by Subject|0
143097|NCT00434330|470193|P1|Overall Study|Withdrawal by Subject|0
143098|NCT00434330|470188|P6|Overall Study|Death|1
143099|NCT00434330|470189|P5|Overall Study|Death|1
143100|NCT00434330|470190|P4|Overall Study|Death|0
143101|NCT00434330|470191|P3|Overall Study|Death|0
143102|NCT00434330|470192|P2|Overall Study|Death|0
143103|NCT00434330|470193|P1|Overall Study|Death|1
143104|NCT00434330|470188|P6|Overall Study|Adverse Event|0
143105|NCT00434330|470189|P5|Overall Study|Adverse Event|0
143106|NCT00434330|470190|P4|Overall Study|Adverse Event|0
143107|NCT00434330|470191|P3|Overall Study|Adverse Event|1
143108|NCT00434330|470192|P2|Overall Study|Adverse Event|0
143109|NCT00434330|470193|P1|Overall Study|Adverse Event|0
143110|NCT00434304|470225|P1|Overall Study|Withdrawal by Subject|4
143111|NCT00434304|470225|P1|Overall Study|Lack of Efficacy|2
143112|NCT00434304|470225|P1|Overall Study|Adverse Event|14
143113|NCT00434252|470274|P2|Overall Study|Withdrawal by Subject|7
143114|NCT00434252|470275|P1|Overall Study|Withdrawal by Subject|3
143115|NCT00434252|470274|P2|Overall Study|Physician Decision|8
143116|NCT00434252|470275|P1|Overall Study|Physician Decision|4
143117|NCT00434252|470274|P2|Overall Study|Lost to Follow-up|1
143118|NCT00434252|470275|P1|Overall Study|Lost to Follow-up|0
143119|NCT00434252|470274|P2|Overall Study|Death|2
143120|NCT00434252|470275|P1|Overall Study|Death|1
143121|NCT00434252|470274|P2|Overall Study|Adverse Event|13
143122|NCT00434252|470275|P1|Overall Study|Adverse Event|6
143123|NCT00434252|470274|P2|Overall Study|Lack of Efficacy|100
143124|NCT00434252|470275|P1|Overall Study|Lack of Efficacy|50
143125|NCT00434213|470309|P1|Overall Study|Non-compliant to study schedule|1
143126|NCT00434213|470309|P1|Overall Study|Application site reaction|1
143127|NCT00434213|470309|P1|Overall Study|Unable to comply with study visit window|2
143128|NCT00434213|470309|P1|Overall Study|Protocol Violation|3
143129|NCT00434213|470309|P1|Overall Study|Withdrawal by Subject|7
143130|NCT00434213|470309|P1|Overall Study|Lost to Follow-up|14
143131|NCT00434213|470309|P1|Overall Study|Lack of Efficacy|9
143132|NCT00434213|470309|P1|Overall Study|Adverse Event|12
143133|NCT00434161|470317|P3|Overall Study|Logistical error study assessments|3
143134|NCT00434161|470318|P2|Overall Study|Logistical error study assessments|0
143135|NCT00434161|470319|P1|Overall Study|Logistical error study assessments|1
143136|NCT00434161|470317|P3|Overall Study|Withdrawal by Subject|3
143137|NCT00434161|470318|P2|Overall Study|Withdrawal by Subject|0
143138|NCT00434161|470319|P1|Overall Study|Withdrawal by Subject|2
143139|NCT00434161|470317|P3|Overall Study|Non-Compliance|0
143140|NCT00434161|470318|P2|Overall Study|Non-Compliance|1
143141|NCT00434161|470319|P1|Overall Study|Non-Compliance|1
143142|NCT00434161|470317|P3|Overall Study|Death|1
143143|NCT00434161|470318|P2|Overall Study|Death|0
143144|NCT00434161|470319|P1|Overall Study|Death|1
143145|NCT00434161|470317|P3|Overall Study|Lost to Follow-up|0
143146|NCT00434161|470318|P2|Overall Study|Lost to Follow-up|1
143147|NCT00434161|470319|P1|Overall Study|Lost to Follow-up|0
143148|NCT00434161|470317|P3|Overall Study|Adverse Event|4
143149|NCT00434161|470318|P2|Overall Study|Adverse Event|1
143150|NCT00434161|470319|P1|Overall Study|Adverse Event|5
143151|NCT00434148|470363|P2|Overall Study|Abnormal test procedure result|1
143152|NCT00434148|470364|P1|Overall Study|Abnormal test procedure result|0
143153|NCT00434148|470363|P2|Overall Study|Condition no longer requires study drug|0
143154|NCT00434148|470364|P1|Overall Study|Condition no longer requires study drug|1
143155|NCT00434148|470363|P2|Overall Study|Lost to Follow-up|1
143156|NCT00434148|470364|P1|Overall Study|Lost to Follow-up|0
143157|NCT00434148|470363|P2|Overall Study|Administrative problems|10
143158|NCT00434148|470364|P1|Overall Study|Administrative problems|6
143159|NCT00434148|470363|P2|Overall Study|Protocol Violation|0
143160|NCT00434148|470364|P1|Overall Study|Protocol Violation|4
143161|NCT00434148|470363|P2|Overall Study|Withdrawal by Subject|15
143162|NCT00434148|470364|P1|Overall Study|Withdrawal by Subject|15
143163|NCT00434148|470363|P2|Overall Study|Lack of Efficacy|28
143164|NCT00434148|470364|P1|Overall Study|Lack of Efficacy|25
143165|NCT00434148|470363|P2|Overall Study|Adverse Event|18
143166|NCT00434148|470364|P1|Overall Study|Adverse Event|18
143167|NCT00434122|470400|P2|Overall Study|Travelling of subject.|0
143168|NCT00434122|470401|P1|Overall Study|Travelling of subject.|1
143169|NCT00434122|470400|P2|Overall Study|Low follicular response.|2
143170|NCT00434122|470401|P1|Overall Study|Low follicular response.|1
143171|NCT00434122|470400|P2|Overall Study|Large follicle size|2
143172|NCT00434122|470401|P1|Overall Study|Large follicle size|2
143173|NCT00434122|470400|P2|Overall Study|Personal reasons|1
143174|NCT00434122|470401|P1|Overall Study|Personal reasons|1
143175|NCT00434122|470400|P2|Overall Study|loss of subject contact|1
143176|NCT00434122|470401|P1|Overall Study|loss of subject contact|1
143177|NCT00434122|470400|P2|Overall Study|Non-compliance with protocol|1
143178|NCT00434122|470401|P1|Overall Study|Non-compliance with protocol|0
143179|NCT00434109|470410|P1|Overall Study|had embolism, did not receive sunitinib|3
143180|NCT00434109|470410|P1|Overall Study|Protocol Violation|1
143181|NCT00434109|470410|P1|Overall Study|Adverse Event|5
143182|NCT00434109|470410|P1|Overall Study|Physician Decision|9
143183|NCT00434057|470419|P1|Overall Study|Withdrawal by Subject|1
143184|NCT00433914|470444|P2|Overall Study|Lost to Follow-up|1
143185|NCT00433914|470445|P1|Overall Study|Lost to Follow-up|0
143186|NCT00433914|470444|P2|Overall Study|Withdrawal by Subject|2
143187|NCT00433914|470445|P1|Overall Study|Withdrawal by Subject|0
143188|NCT00433836|470465|P2|Overall Study|Abnormal laboratory values|1
143189|NCT00433836|470466|P1|Overall Study|Abnormal laboratory values|0
143190|NCT00433836|470465|P2|Overall Study|Condition no longer requires study drug|1
143191|NCT00433836|470466|P1|Overall Study|Condition no longer requires study drug|0
143192|NCT00433836|470465|P2|Overall Study|Protocol Violation|2
143193|NCT00433836|470466|P1|Overall Study|Protocol Violation|0
143194|NCT00433836|470465|P2|Overall Study|Unsatisfactory therapeutic effect|1
143195|NCT00433836|470466|P1|Overall Study|Unsatisfactory therapeutic effect|1
143196|NCT00433836|470465|P2|Overall Study|Withdrawal by Subject|1
143197|NCT00433836|470466|P1|Overall Study|Withdrawal by Subject|2
143198|NCT00433836|470465|P2|Overall Study|Lost to Follow-up|0
143199|NCT00433836|470466|P1|Overall Study|Lost to Follow-up|3
143200|NCT00433836|470465|P2|Overall Study|Adverse Event|0
143201|NCT00433836|470466|P1|Overall Study|Adverse Event|7
143202|NCT00433771|470478|P1|Overall Study|Failure to deploy stent|1
143203|NCT00433771|470478|P1|Overall Study|Death|2
143204|NCT00433771|470478|P1|Overall Study|Treated and later found to be ineligible|2
143205|NCT00433771|470478|P1|Overall Study|screen fail|14
143206|NCT00433654|470501|P2|Overall Study|Withdrawal by Subject|2
143207|NCT00433654|470502|P1|Overall Study|Withdrawal by Subject|1
143208|NCT00433654|470501|P2|Overall Study|Subject not yet due for visit|0
143209|NCT00433654|470502|P1|Overall Study|Subject not yet due for visit|4
143210|NCT00433654|470501|P2|Overall Study|Missed visit|3
143211|NCT00433654|470502|P1|Overall Study|Missed visit|6
143212|NCT00433654|470501|P2|Overall Study|Death|0
143213|NCT00433654|470502|P1|Overall Study|Death|4
143214|NCT00433537|470533|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
143215|NCT00433537|470534|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
143216|NCT00433537|470535|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
143217|NCT00433537|470533|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
143218|NCT00433537|470534|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
143219|NCT00433537|470535|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
143220|NCT00433537|470533|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
143221|NCT00433537|470534|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
143222|NCT00433537|470535|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
143223|NCT00433537|470533|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
143224|NCT00433537|470534|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
143225|NCT00433537|470535|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
143226|NCT00433537|470533|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
143227|NCT00433537|470534|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
143228|NCT00433537|470535|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
143229|NCT00433537|470533|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
143230|NCT00433537|470534|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
143231|NCT00433537|470535|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
143232|NCT00433537|470533|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
143233|NCT00433537|470534|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
143234|NCT00433537|470535|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
143235|NCT00433537|470533|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
143236|NCT00433537|470534|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
143237|NCT00433537|470535|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
143238|NCT00433537|470533|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
143239|NCT00433537|470534|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
143240|NCT00433537|470535|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
143241|NCT00433446|470544|P1|Overall Study|Ineligible|9
143242|NCT00433446|470544|P1|Overall Study|Other - Not Protocol specified|3
143243|NCT00433446|470544|P1|Overall Study|Progression|44
143244|NCT00433446|470544|P1|Overall Study|Refusal Unrelated to Adverse Event|1
143245|NCT00433446|470544|P1|Overall Study|Adverse Event|4
143246|NCT00433381|470554|P2|Overall Study|Lost to follow-up before 6 months|0
143247|NCT00433381|470555|P1|Overall Study|Lost to follow-up before 6 months|2
143248|NCT00433381|470554|P2|Overall Study|Ineligible / no protocol treatment|3
143249|NCT00433381|470555|P1|Overall Study|Ineligible / no protocol treatment|3
143250|NCT00433329|470561|P1|Overall Study|Physician Decision|1
143251|NCT00433329|470561|P1|Overall Study|Lost to Follow-up|1
143252|NCT00433329|470561|P1|Overall Study|Moved out of state|1
143253|NCT00433329|470561|P1|Overall Study|Discontinued sildenafil|2
143254|NCT00433329|470561|P1|Overall Study|Withdrew consent|3
143255|NCT00433329|470561|P1|Overall Study|Death|4
143256|NCT00433329|470561|P1|Overall Study|Adverse Event|9
143257|NCT00433290|470567|P2|Overall Study|Lost to Follow-up|0
143258|NCT00433290|470568|P1|Overall Study|Lost to Follow-up|1
143259|NCT00433290|470567|P2|Overall Study|Entry Criteria Not Met|1
143260|NCT00433290|470568|P1|Overall Study|Entry Criteria Not Met|0
143261|NCT00433290|470567|P2|Overall Study|Physician Decision|0
143262|NCT00433290|470568|P1|Overall Study|Physician Decision|2
143263|NCT00433290|470567|P2|Overall Study|Protocol Violation|2
143264|NCT00433290|470568|P1|Overall Study|Protocol Violation|3
143265|NCT00433290|470567|P2|Overall Study|Withdrawal by Subject|2
143266|NCT00433290|470568|P1|Overall Study|Withdrawal by Subject|4
143267|NCT00433290|470567|P2|Overall Study|Lack of Efficacy|5
143268|NCT00433290|470568|P1|Overall Study|Lack of Efficacy|1
143269|NCT00433290|470567|P2|Overall Study|Adverse Event|7
143270|NCT00433290|470568|P1|Overall Study|Adverse Event|24
143271|NCT00432237|470639|P4|Overall Study|Lack of Qualifying Event|84
143272|NCT00432237|470640|P3|Overall Study|Lack of Qualifying Event|69
143273|NCT00432237|470641|P2|Overall Study|Lack of Qualifying Event|71
143274|NCT00432237|470642|P1|Overall Study|Lack of Qualifying Event|38
143275|NCT00432237|470639|P4|Overall Study|Withdrawal by Subject|11
143276|NCT00432237|470640|P3|Overall Study|Withdrawal by Subject|9
143277|NCT00432237|470641|P2|Overall Study|Withdrawal by Subject|6
143278|NCT00432237|470642|P1|Overall Study|Withdrawal by Subject|5
143279|NCT00432237|470639|P4|Overall Study|Protocol Violation|8
143280|NCT00432237|470640|P3|Overall Study|Protocol Violation|11
143281|NCT00432237|470641|P2|Overall Study|Protocol Violation|10
143282|NCT00432237|470642|P1|Overall Study|Protocol Violation|13
143283|NCT00432237|470639|P4|Overall Study|Pregnancy|0
143284|NCT00432237|470640|P3|Overall Study|Pregnancy|0
143285|NCT00432237|470641|P2|Overall Study|Pregnancy|1
143286|NCT00432237|470642|P1|Overall Study|Pregnancy|0
143287|NCT00432237|470639|P4|Overall Study|Physician Decision|1
143288|NCT00432237|470640|P3|Overall Study|Physician Decision|2
143289|NCT00432237|470641|P2|Overall Study|Physician Decision|3
143290|NCT00432237|470642|P1|Overall Study|Physician Decision|1
143291|NCT00432237|470639|P4|Overall Study|Lost to Follow-up|18
143292|NCT00432237|470640|P3|Overall Study|Lost to Follow-up|18
143293|NCT00432237|470641|P2|Overall Study|Lost to Follow-up|10
143294|NCT00432237|470642|P1|Overall Study|Lost to Follow-up|10
143295|NCT00432237|470639|P4|Overall Study|Lack of Efficacy|1
143296|NCT00432237|470640|P3|Overall Study|Lack of Efficacy|0
143297|NCT00432237|470641|P2|Overall Study|Lack of Efficacy|0
143298|NCT00432237|470642|P1|Overall Study|Lack of Efficacy|0
143299|NCT00432237|470639|P4|Overall Study|Adverse Event|1
143300|NCT00432237|470640|P3|Overall Study|Adverse Event|0
143301|NCT00432237|470641|P2|Overall Study|Adverse Event|0
143302|NCT00432237|470642|P1|Overall Study|Adverse Event|0
143303|NCT00431067|470696|P1|Overall Study|Non-compliance,lost to follow-up|2
143304|NCT00431067|470696|P1|Overall Study|Progressive disease|30
143305|NCT00431067|470696|P1|Overall Study|Other Adverse Event|9
143306|NCT00433199|470721|P2|Open-Label Period|Administrative|1
143307|NCT00433199|470722|P1|Open-Label Period|Administrative|0
143308|NCT00433199|470721|P2|Open-Label Period|Protocol Violation|2
143309|NCT00433199|470722|P1|Open-Label Period|Protocol Violation|0
143310|NCT00433199|470721|P2|Open-Label Period|Withdrawal by Subject|7
143311|NCT00433199|470722|P1|Open-Label Period|Withdrawal by Subject|0
143312|NCT00433199|470721|P2|Open-Label Period|Lost to Follow-up|3
143313|NCT00433199|470722|P1|Open-Label Period|Lost to Follow-up|0
143314|NCT00433199|470721|P2|Open-Label Period|Lack of Efficacy|2
143315|NCT00433199|470722|P1|Open-Label Period|Lack of Efficacy|0
143316|NCT00433199|470721|P2|Open-Label Period|Adverse Event|19
143317|NCT00433199|470722|P1|Open-Label Period|Adverse Event|0
143318|NCT00433199|470721|P2|Double-Blind Period|Administrative|5
143319|NCT00433199|470722|P1|Double-Blind Period|Administrative|1
143320|NCT00433199|470721|P2|Double-Blind Period|Protocol Violation|10
143321|NCT00433199|470722|P1|Double-Blind Period|Protocol Violation|1
143322|NCT00433199|470721|P2|Double-Blind Period|Withdrawal by Subject|19
143323|NCT00433199|470722|P1|Double-Blind Period|Withdrawal by Subject|8
143324|NCT00433199|470721|P2|Double-Blind Period|Lost to Follow-up|5
143325|NCT00433199|470722|P1|Double-Blind Period|Lost to Follow-up|2
143326|NCT00433199|470721|P2|Double-Blind Period|Lack of Efficacy|2
143327|NCT00433199|470722|P1|Double-Blind Period|Lack of Efficacy|0
143328|NCT00433199|470721|P2|Double-Blind Period|Adverse Event|25
143329|NCT00433199|470722|P1|Double-Blind Period|Adverse Event|0
143330|NCT00433160|470742|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
143331|NCT00433160|470743|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
143332|NCT00433160|470742|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
143333|NCT00433160|470743|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
143334|NCT00433160|470742|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
143335|NCT00433160|470743|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
143336|NCT00433160|470742|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
143337|NCT00433160|470743|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
143338|NCT00433160|470742|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
143339|NCT00433160|470743|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
143340|NCT00433160|470742|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
143341|NCT00433160|470743|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
143342|NCT00433160|470742|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
143343|NCT00433160|470743|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
143344|NCT00433160|470742|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
143345|NCT00433160|470743|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
143346|NCT00433160|470742|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
143347|NCT00433160|470743|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
143348|NCT00433160|470742|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
143349|NCT00433160|470743|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
143350|NCT00433160|470742|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
143351|NCT00433160|470743|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
143352|NCT00433160|470742|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
143353|NCT00433160|470743|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
143354|NCT00433160|470742|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
143355|NCT00433160|470743|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
143356|NCT00433160|470742|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
143357|NCT00433160|470743|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
143358|NCT00433160|470742|P2|52-Week Double-Blind (DB) Period|Death|0
143359|NCT00433160|470743|P1|52-Week Double-Blind (DB) Period|Death|0
143360|NCT00433160|470742|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
143361|NCT00433160|470743|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
143362|NCT00433017|470793|P2|Overall Study|Subject no longer requires study drug|1
143363|NCT00433017|470794|P1|Overall Study|Subject no longer requires study drug|1
143364|NCT00433017|470793|P2|Overall Study|Death|2
143365|NCT00433017|470794|P1|Overall Study|Death|2
143366|NCT00433017|470793|P2|Overall Study|Protocol Violation|0
143367|NCT00433017|470794|P1|Overall Study|Protocol Violation|1
143368|NCT00433017|470793|P2|Overall Study|Administrative problems|86
143369|NCT00433017|470794|P1|Overall Study|Administrative problems|80
143370|NCT00433017|470793|P2|Overall Study|Lost to Follow-up|4
143371|NCT00433017|470794|P1|Overall Study|Lost to Follow-up|3
143372|NCT00433017|470793|P2|Overall Study|Withdrawal by Subject|5
143373|NCT00433017|470794|P1|Overall Study|Withdrawal by Subject|4
143374|NCT00433017|470793|P2|Overall Study|Adverse Event|3
143375|NCT00433017|470794|P1|Overall Study|Adverse Event|5
143376|NCT00432835|470810|P2|Overall Study|Adverse event: lead dislodgement.|7
143377|NCT00432835|470811|P1|Overall Study|Adverse event: lead dislodgement.|6
143378|NCT00432809|470824|P3|1 Year Follow-up|Withdrawal by Subject|1
143379|NCT00432809|470825|P2|1 Year Follow-up|Withdrawal by Subject|0
143380|NCT00432809|470826|P1|1 Year Follow-up|Withdrawal by Subject|7
143381|NCT00432809|470824|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
143382|NCT00432809|470825|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
143383|NCT00432809|470826|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
143384|NCT00432744|470899|P2|Months 7 - 12|Too disabled to score|1
143385|NCT00432744|470900|P1|Months 7 - 12|Too disabled to score|0
143386|NCT00432744|470899|P2|Months 7 - 12|Withdrawal by Subject|0
143387|NCT00432744|470900|P1|Months 7 - 12|Withdrawal by Subject|1
143388|NCT00432744|470899|P2|Months 0-6|Too disabled to score|0
143389|NCT00432744|470900|P1|Months 0-6|Too disabled to score|1
143390|NCT00432744|470899|P2|Months 0-6|Withdrawal by Subject|4
143391|NCT00432744|470900|P1|Months 0-6|Withdrawal by Subject|4
143392|NCT00432666|470912|P2|Open-Label Extension Period|Physician Decision|0
143393|NCT00432666|470913|P1|Open-Label Extension Period|Physician Decision|3
143394|NCT00432666|470912|P2|Open-Label Extension Period|Consent withdrawn|0
143395|NCT00432666|470913|P1|Open-Label Extension Period|Consent withdrawn|10
143396|NCT00432666|470912|P2|Open-Label Extension Period|Adverse Event|0
143397|NCT00432666|470913|P1|Open-Label Extension Period|Adverse Event|5
143398|NCT00432666|470912|P2|Open-Label Extension Period|Lack of Efficacy|0
143399|NCT00432666|470913|P1|Open-Label Extension Period|Lack of Efficacy|6
143400|NCT00432666|470912|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
143401|NCT00432666|470913|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
143402|NCT00432666|470912|P2|Main Period|Consent Withdrawn|0
143403|NCT00432666|470913|P1|Main Period|Consent Withdrawn|1
143404|NCT00432666|470912|P2|Main Period|Adverse Event|1
143405|NCT00432666|470913|P1|Main Period|Adverse Event|1
143406|NCT00432562|471086|P2|Overall Study|Death|0
143407|NCT00432562|471087|P1|Overall Study|Death|3
143408|NCT00432276|471165|P2|Overall Study|Other|3
143409|NCT00432276|471166|P1|Overall Study|Other|2
143410|NCT00432276|471165|P2|Overall Study|Physician Decision|8
143411|NCT00432276|471166|P1|Overall Study|Physician Decision|6
143412|NCT00432276|471165|P2|Overall Study|Withdrawal by Subject|20
143413|NCT00432276|471166|P1|Overall Study|Withdrawal by Subject|25
143414|NCT00432276|471165|P2|Overall Study|Lost to Follow-up|2
143415|NCT00432276|471166|P1|Overall Study|Lost to Follow-up|6
143416|NCT00432276|471165|P2|Overall Study|Protocol Violation|20
143417|NCT00432276|471166|P1|Overall Study|Protocol Violation|25
143418|NCT00432276|471165|P2|Overall Study|Adverse Event|16
143419|NCT00432276|471166|P1|Overall Study|Adverse Event|13
143420|NCT00432276|471165|P2|Overall Study|Hyperglycemic Rescue|87
143421|NCT00432276|471166|P1|Overall Study|Hyperglycemic Rescue|44
143422|NCT00432159|471257|P5|Overall Study|Missing NDI and/or neuro. assessment|7
143423|NCT00432159|471258|P4|Overall Study|Missing NDI and/or neuro. assessment|3
143424|NCT00432159|471259|P3|Overall Study|Missing NDI and/or neuro. assessment|1
143425|NCT00432159|471260|P2|Overall Study|Missing NDI and/or neuro. assessment|24
143426|NCT00432159|471261|P1|Overall Study|Missing NDI and/or neuro. assessment|13
143427|NCT00432159|471257|P5|Overall Study|Failure|3
143428|NCT00432159|471258|P4|Overall Study|Failure|2
143429|NCT00432159|471259|P3|Overall Study|Failure|3
143430|NCT00432159|471260|P2|Overall Study|Failure|5
143431|NCT00432159|471261|P1|Overall Study|Failure|9
143432|NCT00432159|471257|P5|Overall Study|Death|0
143433|NCT00432159|471258|P4|Overall Study|Death|0
143434|NCT00432159|471259|P3|Overall Study|Death|0
143435|NCT00432159|471260|P2|Overall Study|Death|1
143436|NCT00432159|471261|P1|Overall Study|Death|0
143437|NCT00431964|471367|P2|Overall Study|Due to Unstable Health|1
143438|NCT00431964|471368|P1|Overall Study|Due to Unstable Health|0
143439|NCT00431964|471367|P2|Overall Study|Parental Consent Withdrawn|2
143440|NCT00431964|471368|P1|Overall Study|Parental Consent Withdrawn|0
143441|NCT00431964|471367|P2|Overall Study|Withdrawal by Subject|1
143442|NCT00431964|471368|P1|Overall Study|Withdrawal by Subject|2
143443|NCT00431964|471367|P2|Overall Study|Physician Decision|2
143444|NCT00431964|471368|P1|Overall Study|Physician Decision|2
143445|NCT00431964|471367|P2|Overall Study|Lost to Follow-up|2
143446|NCT00431964|471368|P1|Overall Study|Lost to Follow-up|1
143447|NCT00431964|471367|P2|Overall Study|Adverse Event|0
143448|NCT00431964|471368|P1|Overall Study|Adverse Event|1
143449|NCT00431951|471378|P4|Overall Study|Adverse Event|0
143450|NCT00431951|471379|P3|Overall Study|Adverse Event|1
143451|NCT00431951|471380|P2|Overall Study|Adverse Event|0
143452|NCT00431951|471381|P1|Overall Study|Adverse Event|0
143453|NCT00431951|471378|P4|Overall Study|Withdrawal by Subject|0
143454|NCT00431951|471379|P3|Overall Study|Withdrawal by Subject|0
143455|NCT00431951|471380|P2|Overall Study|Withdrawal by Subject|1
143456|NCT00431951|471381|P1|Overall Study|Withdrawal by Subject|0
143457|NCT00431951|471378|P4|Overall Study|Lost to Follow-up|0
143458|NCT00431951|471379|P3|Overall Study|Lost to Follow-up|0
143459|NCT00431951|471380|P2|Overall Study|Lost to Follow-up|1
143460|NCT00431951|471381|P1|Overall Study|Lost to Follow-up|0
143461|NCT00431951|471378|P4|Overall Study|Inability to follow study procedures|2
143462|NCT00431951|471379|P3|Overall Study|Inability to follow study procedures|1
143463|NCT00431951|471380|P2|Overall Study|Inability to follow study procedures|0
143464|NCT00431951|471381|P1|Overall Study|Inability to follow study procedures|1
143465|NCT00431834|471439|P1|Overall Study|Lost to Follow-up|1
143466|NCT00431834|471439|P1|Overall Study|Missed Endpoint Visit|2
143467|NCT00431834|471439|P1|Overall Study|Death|3
143468|NCT00431834|471439|P1|Overall Study|Withdrawal by Subject|7
143469|NCT00431496|471455|P1|Overall Study|Protocol-specified criteria|5
143470|NCT00431496|471455|P1|Overall Study|Withdrawal by Subject|2
143471|NCT00431496|471455|P1|Overall Study|Lost to Follow-up|1
143472|NCT00431496|471455|P1|Overall Study|Adverse Event|3
143473|NCT00431444|471466|P2|Overall Study|Administrative Problems|1
143474|NCT00431444|471467|P1|Overall Study|Administrative Problems|0
143475|NCT00431444|471466|P2|Overall Study|Lost to Follow-up|0
143476|NCT00431444|471467|P1|Overall Study|Lost to Follow-up|1
143477|NCT00431444|471466|P2|Overall Study|Withdrawal by Subject|1
143478|NCT00431444|471467|P1|Overall Study|Withdrawal by Subject|1
143479|NCT00431444|471466|P2|Overall Study|Adverse Event|1
143480|NCT00431444|471467|P1|Overall Study|Adverse Event|2
143481|NCT00431444|471466|P2|Overall Study|Protocol Violation|4
143482|NCT00431444|471467|P1|Overall Study|Protocol Violation|1
143483|NCT00430950|471493|P2|Overall Study|concomitant medication,etc.|7
143484|NCT00430950|471494|P1|Overall Study|concomitant medication,etc.|5
143485|NCT00430950|471493|P2|Overall Study|Withdrawal by Subject|0
143486|NCT00430950|471494|P1|Overall Study|Withdrawal by Subject|1
143487|NCT00430950|471493|P2|Overall Study|Adverse Event|6
143488|NCT00430950|471494|P1|Overall Study|Adverse Event|7
143489|NCT00430937|471510|P2|Overall Study|Unable to classify|1
143490|NCT00430937|471511|P1|Overall Study|Unable to classify|0
143491|NCT00430937|471510|P2|Overall Study|Protocol discontinuation criteria met|2
143492|NCT00430937|471511|P1|Overall Study|Protocol discontinuation criteria met|1
143493|NCT00430937|471510|P2|Overall Study|Administrative reasons|0
143494|NCT00430937|471511|P1|Overall Study|Administrative reasons|1
143495|NCT00430937|471510|P2|Overall Study|Inappropriate enrollment|1
143496|NCT00430937|471511|P1|Overall Study|Inappropriate enrollment|2
143497|NCT00430937|471510|P2|Overall Study|Lack of Efficacy|5
143498|NCT00430937|471511|P1|Overall Study|Lack of Efficacy|6
143499|NCT00430937|471510|P2|Overall Study|Protocol Violation|2
143500|NCT00430937|471511|P1|Overall Study|Protocol Violation|3
143501|NCT00430937|471510|P2|Overall Study|Withdrawal by Subject|2
143502|NCT00430937|471511|P1|Overall Study|Withdrawal by Subject|5
143503|NCT00430937|471510|P2|Overall Study|Lost to Follow-up|6
143504|NCT00430937|471511|P1|Overall Study|Lost to Follow-up|6
143505|NCT00430937|471510|P2|Overall Study|Death|1
143506|NCT00430937|471511|P1|Overall Study|Death|0
143507|NCT00430937|471510|P2|Overall Study|Adverse Event|8
143508|NCT00430937|471511|P1|Overall Study|Adverse Event|3
143509|NCT00430781|471522|P3|End-of-Study Analysis; 28 July 2011|Other|0
143510|NCT00430781|471523|P2|End-of-Study Analysis; 28 July 2011|Other|1
143511|NCT00430781|471524|P1|End-of-Study Analysis; 28 July 2011|Other|4
143512|NCT00430781|471522|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
143513|NCT00430781|471523|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
143514|NCT00430781|471524|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
143515|NCT00430781|471522|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
143516|NCT00430781|471523|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
143517|NCT00430781|471524|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
143518|NCT00430781|471522|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
143519|NCT00430781|471523|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
143520|NCT00430781|471524|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
143521|NCT00430781|471522|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
143522|NCT00430781|471523|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
143523|NCT00430781|471524|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
143524|NCT00430781|471522|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
143525|NCT00430781|471523|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
143526|NCT00430781|471524|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
143527|NCT00430781|471522|P3|Final Analysis; 31 July 2008|Ongoing|32
143528|NCT00430781|471523|P2|Final Analysis; 31 July 2008|Ongoing|29
143529|NCT00430781|471524|P1|Final Analysis; 31 July 2008|Ongoing|0
143530|NCT00430781|471522|P3|Final Analysis; 31 July 2008|Other|0
143531|NCT00430781|471523|P2|Final Analysis; 31 July 2008|Other|1
143532|NCT00430781|471524|P1|Final Analysis; 31 July 2008|Other|0
143533|NCT00430781|471522|P3|Final Analysis; 31 July 2008|Physician Decision|6
143534|NCT00430781|471523|P2|Final Analysis; 31 July 2008|Physician Decision|6
143535|NCT00430781|471524|P1|Final Analysis; 31 July 2008|Physician Decision|0
143536|NCT00430781|471522|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
143537|NCT00430781|471523|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
143538|NCT00430781|471524|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
143539|NCT00430781|471522|P3|Final Analysis; 31 July 2008|Protocol Violation|0
143540|NCT00430781|471523|P2|Final Analysis; 31 July 2008|Protocol Violation|1
143541|NCT00430781|471524|P1|Final Analysis; 31 July 2008|Protocol Violation|0
143542|NCT00430781|471522|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
143543|NCT00430781|471523|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
143544|NCT00430781|471524|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
143545|NCT00430781|471522|P3|Interim Analysis; 11 February 2008|Ongoing|25
143546|NCT00430781|471523|P2|Interim Analysis; 11 February 2008|Ongoing|20
143547|NCT00430781|471524|P1|Interim Analysis; 11 February 2008|Ongoing|23
143548|NCT00430781|471522|P3|Interim Analysis; 11 February 2008|Physician Decision|3
143549|NCT00430781|471523|P2|Interim Analysis; 11 February 2008|Physician Decision|3
143550|NCT00430781|471524|P1|Interim Analysis; 11 February 2008|Physician Decision|2
143551|NCT00430781|471522|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
143552|NCT00430781|471523|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
143553|NCT00430781|471524|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
143554|NCT00430781|471522|P3|Interim Analysis; 11 February 2008|Death|0
143555|NCT00430781|471523|P2|Interim Analysis; 11 February 2008|Death|1
143556|NCT00430781|471524|P1|Interim Analysis; 11 February 2008|Death|0
143557|NCT00430781|471522|P3|Interim Analysis; 11 February 2008|Disease Progression|22
143558|NCT00430781|471523|P2|Interim Analysis; 11 February 2008|Disease Progression|30
143559|NCT00430781|471524|P1|Interim Analysis; 11 February 2008|Disease Progression|16
143560|NCT00430781|471522|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
143561|NCT00430781|471523|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
143562|NCT00430781|471524|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
143563|NCT00430781|471522|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
143564|NCT00430781|471523|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
143565|NCT00430781|471524|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
143566|NCT00430781|471522|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
143567|NCT00430781|471523|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
143568|NCT00430781|471524|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
143569|NCT00430781|471522|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
143570|NCT00430781|471523|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
143571|NCT00430781|471524|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
143572|NCT00430781|471522|P3|Interim Analysis; 11 February 2008|Adverse Event|7
143573|NCT00430781|471523|P2|Interim Analysis; 11 February 2008|Adverse Event|3
143574|NCT00430781|471524|P1|Interim Analysis; 11 February 2008|Adverse Event|10
143575|NCT00430755|471566|P1|Overall Study|Withdrawal by Subject|53
143576|NCT00430716|471573|P3|Open Label Phase|Study terminated by sponsor|4
143577|NCT00430716|471574|P2|Open Label Phase|Study terminated by sponsor|5
143578|NCT00430716|471575|P1|Open Label Phase|Study terminated by sponsor|4
143579|NCT00430716|471573|P3|Open Label Phase|Protocol Violation|0
143580|NCT00430716|471574|P2|Open Label Phase|Protocol Violation|0
143581|NCT00430716|471575|P1|Open Label Phase|Protocol Violation|1
143582|NCT00430716|471573|P3|Open Label Phase|Unspecified|1
143583|NCT00430716|471574|P2|Open Label Phase|Unspecified|1
143584|NCT00430716|471575|P1|Open Label Phase|Unspecified|3
143585|NCT00430716|471573|P3|Open Label Phase|No longer willing to participate|1
143586|NCT00430716|471574|P2|Open Label Phase|No longer willing to participate|1
143587|NCT00430716|471575|P1|Open Label Phase|No longer willing to participate|0
143588|NCT00430716|471573|P3|Open Label Phase|Lost to Follow-up|1
143589|NCT00430716|471574|P2|Open Label Phase|Lost to Follow-up|0
143590|NCT00430716|471575|P1|Open Label Phase|Lost to Follow-up|1
143591|NCT00430716|471573|P3|Double Blind Phase|Not met eligibility criteria|0
143592|NCT00430716|471574|P2|Double Blind Phase|Not met eligibility criteria|0
143593|NCT00430716|471575|P1|Double Blind Phase|Not met eligibility criteria|1
143594|NCT00430716|471573|P3|Double Blind Phase|Adverse Event|3
143595|NCT00430716|471574|P2|Double Blind Phase|Adverse Event|1
143596|NCT00430716|471575|P1|Double Blind Phase|Adverse Event|1
143597|NCT00430716|471573|P3|Double Blind Phase|Study terminated by sponsor|2
143598|NCT00430716|471574|P2|Double Blind Phase|Study terminated by sponsor|1
143599|NCT00430716|471575|P1|Double Blind Phase|Study terminated by sponsor|1
143600|NCT00430716|471573|P3|Double Blind Phase|Unspecified|0
143601|NCT00430716|471574|P2|Double Blind Phase|Unspecified|2
143602|NCT00430716|471575|P1|Double Blind Phase|Unspecified|0
143603|NCT00430716|471573|P3|Double Blind Phase|No longer willing to participate|1
143604|NCT00430716|471574|P2|Double Blind Phase|No longer willing to participate|1
143605|NCT00430716|471575|P1|Double Blind Phase|No longer willing to participate|2
143606|NCT00430716|471573|P3|Double Blind Phase|Death|0
143607|NCT00430716|471574|P2|Double Blind Phase|Death|0
143608|NCT00430716|471575|P1|Double Blind Phase|Death|1
143609|NCT00430677|471607|P3|Long-term Extension Period|Poor compliance/noncompliance|0
143610|NCT00430677|471608|P2|Long-term Extension Period|Poor compliance/noncompliance|0
143611|NCT00430677|471609|P1|Long-term Extension Period|Poor compliance/noncompliance|1
143612|NCT00430677|471607|P3|Long-term Extension Period|Not specified|1
143613|NCT00430677|471608|P2|Long-term Extension Period|Not specified|1
143614|NCT00430677|471609|P1|Long-term Extension Period|Not specified|2
143615|NCT00430677|471607|P3|Long-term Extension Period|Administrative reason by sponsor|46
143616|NCT00430677|471608|P2|Long-term Extension Period|Administrative reason by sponsor|49
143617|NCT00430677|471609|P1|Long-term Extension Period|Administrative reason by sponsor|41
143618|NCT00430677|471607|P3|Long-term Extension Period|Pregnancy|0
143619|NCT00430677|471608|P2|Long-term Extension Period|Pregnancy|1
143620|NCT00430677|471609|P1|Long-term Extension Period|Pregnancy|1
143621|NCT00430677|471607|P3|Long-term Extension Period|Withdrawal by Subject|2
143622|NCT00430677|471608|P2|Long-term Extension Period|Withdrawal by Subject|1
143623|NCT00430677|471609|P1|Long-term Extension Period|Withdrawal by Subject|5
143624|NCT00430677|471607|P3|Long-term Extension Period|Lost to Follow-up|1
143625|NCT00430677|471608|P2|Long-term Extension Period|Lost to Follow-up|1
143626|NCT00430677|471609|P1|Long-term Extension Period|Lost to Follow-up|1
143627|NCT00430677|471607|P3|Long-term Extension Period|Lack of Efficacy|8
143628|NCT00430677|471608|P2|Long-term Extension Period|Lack of Efficacy|3
143629|NCT00430677|471609|P1|Long-term Extension Period|Lack of Efficacy|5
143630|NCT00430677|471607|P3|Long-term Extension Period|Adverse Event|5
143631|NCT00430677|471608|P2|Long-term Extension Period|Adverse Event|2
143632|NCT00430677|471609|P1|Long-term Extension Period|Adverse Event|3
143633|NCT00430677|471607|P3|Long-term Extension Period|Death|0
143634|NCT00430677|471608|P2|Long-term Extension Period|Death|0
143635|NCT00430677|471609|P1|Long-term Extension Period|Death|1
143636|NCT00430677|471607|P3|Short-term Period|Pregnancy|0
143637|NCT00430677|471608|P2|Short-term Period|Pregnancy|2
143638|NCT00430677|471609|P1|Short-term Period|Pregnancy|0
143639|NCT00430677|471607|P3|Short-term Period|Poor compliance/ noncompliance|0
143640|NCT00430677|471608|P2|Short-term Period|Poor compliance/ noncompliance|1
143641|NCT00430677|471609|P1|Short-term Period|Poor compliance/ noncompliance|0
143642|NCT00430677|471607|P3|Short-term Period|Participant no longer met study criteria|2
143643|NCT00430677|471608|P2|Short-term Period|Participant no longer met study criteria|1
143644|NCT00430677|471609|P1|Short-term Period|Participant no longer met study criteria|1
143645|NCT00430677|471607|P3|Short-term Period|Withdrawal by Subject|2
143646|NCT00430677|471608|P2|Short-term Period|Withdrawal by Subject|1
143647|NCT00430677|471609|P1|Short-term Period|Withdrawal by Subject|1
143648|NCT00430677|471607|P3|Short-term Period|Lack of Efficacy|4
143649|NCT00430677|471608|P2|Short-term Period|Lack of Efficacy|6
143650|NCT00430677|471609|P1|Short-term Period|Lack of Efficacy|5
143651|NCT00430677|471607|P3|Short-term Period|Adverse Event|9
143652|NCT00430677|471608|P2|Short-term Period|Adverse Event|13
143653|NCT00430677|471609|P1|Short-term Period|Adverse Event|15
143654|NCT00430677|471607|P3|Short-term Period|Death|5
143655|NCT00430677|471608|P2|Short-term Period|Death|1
143656|NCT00430677|471609|P1|Short-term Period|Death|1
143657|NCT00430638|471732|P2|Overall Study|Not specified|2
143658|NCT00430638|471733|P1|Overall Study|Not specified|2
143659|NCT00430638|471732|P2|Overall Study|Non-compliant|1
143660|NCT00430638|471733|P1|Overall Study|Non-compliant|2
143661|NCT00430638|471732|P2|Overall Study|Withdrawal by Subject|6
143662|NCT00430638|471733|P1|Overall Study|Withdrawal by Subject|4
143663|NCT00430638|471732|P2|Overall Study|Protocol Violation|4
143664|NCT00430638|471733|P1|Overall Study|Protocol Violation|6
143665|NCT00430638|471732|P2|Overall Study|Lost to Follow-up|7
143666|NCT00430638|471733|P1|Overall Study|Lost to Follow-up|1
143667|NCT00430638|471732|P2|Overall Study|Uncontrolled blood pressure|13
143668|NCT00430638|471733|P1|Overall Study|Uncontrolled blood pressure|48
143669|NCT00430638|471732|P2|Overall Study|Adverse Event|15
143670|NCT00430638|471733|P1|Overall Study|Adverse Event|15
143671|NCT00430508|471772|P4|Overall Study|not specified|0
143672|NCT00430508|471773|P3|Overall Study|not specified|3
143673|NCT00430508|471774|P2|Overall Study|not specified|1
143674|NCT00430508|471775|P1|Overall Study|not specified|1
143675|NCT00430508|471772|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
143676|NCT00430508|471773|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
143677|NCT00430508|471774|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
143678|NCT00430508|471775|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
143679|NCT00430508|471772|P4|Overall Study|responder at visit 4|0
143680|NCT00430508|471773|P3|Overall Study|responder at visit 4|2
143681|NCT00430508|471774|P2|Overall Study|responder at visit 4|0
143682|NCT00430508|471775|P1|Overall Study|responder at visit 4|0
143683|NCT00430508|471772|P4|Overall Study|Withdrawal by Subject|1
143684|NCT00430508|471773|P3|Overall Study|Withdrawal by Subject|1
143685|NCT00430508|471774|P2|Overall Study|Withdrawal by Subject|1
143686|NCT00430508|471775|P1|Overall Study|Withdrawal by Subject|0
143687|NCT00430508|471772|P4|Overall Study|Adverse Event|3
143688|NCT00430508|471773|P3|Overall Study|Adverse Event|5
143689|NCT00430508|471774|P2|Overall Study|Adverse Event|3
143690|NCT00430508|471775|P1|Overall Study|Adverse Event|2
143691|NCT00430495|471813|P4|Overall Study|Randomized but not Treated|0
143692|NCT00430495|471814|P3|Overall Study|Randomized but not Treated|0
143693|NCT00430495|471815|P2|Overall Study|Randomized but not Treated|0
143694|NCT00430495|471816|P1|Overall Study|Randomized but not Treated|2
143695|NCT00430495|471813|P4|Overall Study|Unspecified|4
143696|NCT00430495|471814|P3|Overall Study|Unspecified|5
143697|NCT00430495|471815|P2|Overall Study|Unspecified|2
143698|NCT00430495|471816|P1|Overall Study|Unspecified|8
143699|NCT00430495|471813|P4|Overall Study|Disease Progression|0
143700|NCT00430495|471814|P3|Overall Study|Disease Progression|0
143701|NCT00430495|471815|P2|Overall Study|Disease Progression|1
143702|NCT00430495|471816|P1|Overall Study|Disease Progression|1
143703|NCT00430495|471813|P4|Overall Study|Protocol Violation|0
143704|NCT00430495|471814|P3|Overall Study|Protocol Violation|1
143705|NCT00430495|471815|P2|Overall Study|Protocol Violation|0
143706|NCT00430495|471816|P1|Overall Study|Protocol Violation|1
143707|NCT00430495|471813|P4|Overall Study|Lost to Follow-up|0
143708|NCT00430495|471814|P3|Overall Study|Lost to Follow-up|4
143709|NCT00430495|471815|P2|Overall Study|Lost to Follow-up|1
143710|NCT00430495|471816|P1|Overall Study|Lost to Follow-up|0
143711|NCT00430495|471813|P4|Overall Study|Death|0
143712|NCT00430495|471814|P3|Overall Study|Death|1
143713|NCT00430495|471815|P2|Overall Study|Death|0
143714|NCT00430495|471816|P1|Overall Study|Death|0
143715|NCT00430495|471813|P4|Overall Study|Adverse Event|0
143716|NCT00430495|471814|P3|Overall Study|Adverse Event|2
143717|NCT00430495|471815|P2|Overall Study|Adverse Event|3
143718|NCT00430495|471816|P1|Overall Study|Adverse Event|2
143719|NCT00430352|471854|P1|Overall Study|Not specified|48
143720|NCT00430352|471854|P1|Overall Study|Death|5
143721|NCT00430352|471854|P1|Overall Study|Adverse Event|16
143722|NCT00430352|471854|P1|Overall Study|Withdrawal by Subject|11
143723|NCT00430352|471854|P1|Overall Study|Disease progression|58
143724|NCT00430300|471872|P4|Overall Study|Unspecified|1
143725|NCT00430300|471873|P3|Overall Study|Unspecified|0
143726|NCT00430300|471874|P2|Overall Study|Unspecified|0
143727|NCT00430300|471875|P1|Overall Study|Unspecified|0
143728|NCT00430300|471872|P4|Overall Study|Laboratory abnormality|0
143729|NCT00430300|471873|P3|Overall Study|Laboratory abnormality|0
143730|NCT00430300|471874|P2|Overall Study|Laboratory abnormality|0
143731|NCT00430300|471875|P1|Overall Study|Laboratory abnormality|1
143732|NCT00430300|471872|P4|Overall Study|Withdrawal by Subject|0
143733|NCT00430300|471873|P3|Overall Study|Withdrawal by Subject|5
143734|NCT00430300|471874|P2|Overall Study|Withdrawal by Subject|0
143735|NCT00430300|471875|P1|Overall Study|Withdrawal by Subject|1
143736|NCT00430300|471872|P4|Overall Study|Adverse Event|1
143737|NCT00430300|471873|P3|Overall Study|Adverse Event|1
143738|NCT00430300|471874|P2|Overall Study|Adverse Event|2
143739|NCT00430300|471875|P1|Overall Study|Adverse Event|0
143740|NCT00430248|471980|P3|Overall Study|Reason Not Specified|11
143741|NCT00430248|471981|P2|Overall Study|Reason Not Specified|8
143742|NCT00430248|471982|P1|Overall Study|Reason Not Specified|8
143743|NCT00430248|471980|P3|Overall Study|Gout Flare|2
143744|NCT00430248|471981|P2|Overall Study|Gout Flare|7
143745|NCT00430248|471982|P1|Overall Study|Gout Flare|3
143746|NCT00430248|471980|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
143747|NCT00430248|471981|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
143748|NCT00430248|471982|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
143749|NCT00430248|471980|P3|Overall Study|Withdrawal by Subject|16
143750|NCT00430248|471981|P2|Overall Study|Withdrawal by Subject|20
143751|NCT00430248|471982|P1|Overall Study|Withdrawal by Subject|14
143752|NCT00430248|471980|P3|Overall Study|Therapeutic Failure|1
143753|NCT00430248|471981|P2|Overall Study|Therapeutic Failure|1
143754|NCT00430248|471982|P1|Overall Study|Therapeutic Failure|1
143755|NCT00430248|471980|P3|Overall Study|Lost to Follow-up|28
143756|NCT00430248|471981|P2|Overall Study|Lost to Follow-up|33
143757|NCT00430248|471982|P1|Overall Study|Lost to Follow-up|28
143758|NCT00430248|471980|P3|Overall Study|Personal Reasons|9
143759|NCT00430248|471981|P2|Overall Study|Personal Reasons|24
143760|NCT00430248|471982|P1|Overall Study|Personal Reasons|12
143761|NCT00430248|471980|P3|Overall Study|Protocol Violation|4
143762|NCT00430248|471981|P2|Overall Study|Protocol Violation|2
143763|NCT00430248|471982|P1|Overall Study|Protocol Violation|10
143764|NCT00430248|471980|P3|Overall Study|Adverse Event|64
143765|NCT00430248|471981|P2|Overall Study|Adverse Event|61
143766|NCT00430248|471982|P1|Overall Study|Adverse Event|49
143767|NCT00430092|472041|P3|Overall Study|Withdrawal by Subject|1
143768|NCT00430092|472042|P2|Overall Study|Withdrawal by Subject|1
143769|NCT00430092|472043|P1|Overall Study|Withdrawal by Subject|0
143770|NCT00430092|472041|P3|Overall Study|Protocol Violation|1
143771|NCT00430092|472042|P2|Overall Study|Protocol Violation|1
143772|NCT00430092|472043|P1|Overall Study|Protocol Violation|0
143773|NCT00430092|472041|P3|Overall Study|Lost to Follow-up|0
143774|NCT00430092|472042|P2|Overall Study|Lost to Follow-up|0
143775|NCT00430092|472043|P1|Overall Study|Lost to Follow-up|1
143776|NCT00430092|472041|P3|Overall Study|Lack of Efficacy|54
143777|NCT00430092|472042|P2|Overall Study|Lack of Efficacy|2
143778|NCT00430092|472043|P1|Overall Study|Lack of Efficacy|5
143779|NCT00430092|472041|P3|Overall Study|Adverse Event|1
143780|NCT00430092|472042|P2|Overall Study|Adverse Event|0
143781|NCT00430092|472043|P1|Overall Study|Adverse Event|0
143782|NCT00430027|472048|P1|Overall Study|Study terminated|8
143783|NCT00429923|472065|P3|Overall Study|Early Termination|0
143784|NCT00429923|472066|P2|Overall Study|Early Termination|1
143785|NCT00429923|472067|P1|Overall Study|Early Termination|0
143786|NCT00429923|472065|P3|Overall Study|Withdrew Consent|1
143787|NCT00429923|472066|P2|Overall Study|Withdrew Consent|0
143788|NCT00429923|472067|P1|Overall Study|Withdrew Consent|1
143789|NCT00429923|472065|P3|Overall Study|Lost to Follow-up|2
143790|NCT00429923|472066|P2|Overall Study|Lost to Follow-up|0
143791|NCT00429923|472067|P1|Overall Study|Lost to Follow-up|0
143792|NCT00429923|472065|P3|Overall Study|Lack of Efficacy|33
143793|NCT00429923|472066|P2|Overall Study|Lack of Efficacy|1
143794|NCT00429923|472067|P1|Overall Study|Lack of Efficacy|4
143795|NCT00429923|472065|P3|Overall Study|Adverse Event|3
143796|NCT00429923|472066|P2|Overall Study|Adverse Event|2
143797|NCT00429923|472067|P1|Overall Study|Adverse Event|0
143798|NCT00428844|472075|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
143799|NCT00428844|472076|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
143800|NCT00428844|472077|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
143801|NCT00428844|472075|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
143802|NCT00428844|472076|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
143803|NCT00428844|472077|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
143804|NCT00428844|472075|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
143805|NCT00428844|472076|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
143806|NCT00428844|472077|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
143807|NCT00428844|472075|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
143808|NCT00428844|472076|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
143809|NCT00428844|472077|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
143810|NCT00428844|472075|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
143811|NCT00428844|472076|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
143812|NCT00428844|472077|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
143813|NCT00428844|472075|P3|Completed Study Drug Treatment|Randomized Not Treated|1
143814|NCT00428844|472076|P2|Completed Study Drug Treatment|Randomized Not Treated|0
143815|NCT00428844|472077|P1|Completed Study Drug Treatment|Randomized Not Treated|0
143816|NCT00428844|472075|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
143817|NCT00428844|472076|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
143818|NCT00428844|472077|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
143819|NCT00428844|472075|P3|Completed Study Drug Treatment|Protocol Violation|1
143820|NCT00428844|472076|P2|Completed Study Drug Treatment|Protocol Violation|1
143821|NCT00428844|472077|P1|Completed Study Drug Treatment|Protocol Violation|0
143822|NCT00428844|472075|P3|Completed Study Drug Treatment|Adverse Event|4
143823|NCT00428844|472076|P2|Completed Study Drug Treatment|Adverse Event|4
143824|NCT00428844|472077|P1|Completed Study Drug Treatment|Adverse Event|2
143825|NCT00428792|472100|P2|Overall Study|Lost to Follow-up|1
143826|NCT00428792|472101|P1|Overall Study|Lost to Follow-up|0
143827|NCT00428792|472100|P2|Overall Study|Lack of Efficacy|3
143828|NCT00428792|472101|P1|Overall Study|Lack of Efficacy|1
143829|NCT00429793|472125|P1|Overall Study|Non-measurable|1
143830|NCT00429793|472125|P1|Overall Study|Never treated|1
143831|NCT00429793|472125|P1|Overall Study|Required test not done|1
143832|NCT00429793|472125|P1|Overall Study|Improper pre-protocol treatment|3
143833|NCT00429663|472145|P2|Overall Study|Death|0
143834|NCT00429663|472146|P1|Overall Study|Death|4
143835|NCT00429663|472145|P2|Overall Study|Withdrawal by Subject|5
143836|NCT00429663|472146|P1|Overall Study|Withdrawal by Subject|2
143837|NCT00429663|472145|P2|Overall Study|Physician Decision|3
143838|NCT00429663|472146|P1|Overall Study|Physician Decision|6
143839|NCT00429663|472145|P2|Overall Study|Lost to Follow-up|31
143840|NCT00429663|472146|P1|Overall Study|Lost to Follow-up|24
143841|NCT00429572|472160|P1|Overall Study|Disease progression|1
143842|NCT00429494|472172|P1|Overall Study|Death|6
143843|NCT00429494|472172|P1|Overall Study|Withdrawal by Subject|9
143844|NCT00429416|472176|P1|Overall Study|Death|1
143845|NCT00429364|472195|P2|Overall Study|Pregnancy|1
143846|NCT00429364|472196|P1|Overall Study|Pregnancy|0
143847|NCT00429364|472195|P2|Overall Study|Underwent aortic root surgery|18
143848|NCT00429364|472196|P1|Overall Study|Underwent aortic root surgery|10
143849|NCT00429364|472195|P2|Overall Study|Death|1
143850|NCT00429364|472196|P1|Overall Study|Death|0
143851|NCT00429364|472195|P2|Overall Study|Lost to Follow-up|6
143852|NCT00429364|472196|P1|Overall Study|Lost to Follow-up|7
143853|NCT00429364|472195|P2|Overall Study|Physician Decision|2
143854|NCT00429364|472196|P1|Overall Study|Physician Decision|4
143855|NCT00429364|472195|P2|Overall Study|Withdrawal by Subject|5
143856|NCT00429364|472196|P1|Overall Study|Withdrawal by Subject|11
143857|NCT00429299|472255|P3|Overall Study|Withdrawal by Subject|3
143858|NCT00429299|472256|P2|Overall Study|Withdrawal by Subject|1
143859|NCT00429299|472257|P1|Overall Study|Withdrawal by Subject|0
143860|NCT00429299|472255|P3|Overall Study|Protocol Violation|0
143861|NCT00429299|472256|P2|Overall Study|Protocol Violation|0
143862|NCT00429299|472257|P1|Overall Study|Protocol Violation|1
143863|NCT00429299|472255|P3|Overall Study|Adverse Event|1
143864|NCT00429299|472256|P2|Overall Study|Adverse Event|5
143865|NCT00429299|472257|P1|Overall Study|Adverse Event|2
143866|NCT00429299|472255|P3|Overall Study|Disease Progression|0
143867|NCT00429299|472256|P2|Overall Study|Disease Progression|1
143868|NCT00429299|472257|P1|Overall Study|Disease Progression|1
143869|NCT00429182|472286|P1|Overall Study|Not eligible|5
143870|NCT00429182|472286|P1|Overall Study|Not evaluable, Disease Progression|2
143871|NCT00429169|472293|P2|Overall Study|Ineligibility discovered after entry|1
143872|NCT00429169|472294|P1|Overall Study|Ineligibility discovered after entry|2
143873|NCT00429169|472293|P2|Overall Study|Lost to Follow-up|1
143874|NCT00429169|472294|P1|Overall Study|Lost to Follow-up|0
143875|NCT00429104|472312|P1|Overall Study|Protocol Violation|1
143876|NCT00429026|472317|P1|Overall Study|Inevaluable for response.|40
143877|NCT00428597|472351|P2|Overall Study|Death|3
143878|NCT00428597|472352|P1|Overall Study|Death|1
143879|NCT00428597|472351|P2|Overall Study|Pregnancy|0
143880|NCT00428597|472352|P1|Overall Study|Pregnancy|1
143881|NCT00428597|472351|P2|Overall Study|Lost to Follow-up|1
143882|NCT00428597|472352|P1|Overall Study|Lost to Follow-up|0
143883|NCT00428597|472351|P2|Overall Study|Other|1
143884|NCT00428597|472352|P1|Overall Study|Other|1
143885|NCT00428597|472351|P2|Overall Study|Withdrawal by Subject|1
143886|NCT00428597|472352|P1|Overall Study|Withdrawal by Subject|2
143887|NCT00428597|472351|P2|Overall Study|Protocol Violation|1
143888|NCT00428597|472352|P1|Overall Study|Protocol Violation|2
143889|NCT00428597|472351|P2|Overall Study|Global Deterioration of Health Status|5
143890|NCT00428597|472352|P1|Overall Study|Global Deterioration of Health Status|1
143891|NCT00428597|472351|P2|Overall Study|Adverse Event|7
143892|NCT00428597|472352|P1|Overall Study|Adverse Event|15
143893|NCT00428597|472351|P2|Overall Study|Study Terminated by Sponsor|16
143894|NCT00428597|472352|P1|Overall Study|Study Terminated by Sponsor|41
143895|NCT00428597|472351|P2|Overall Study|Objective Progression or Relapse|47
143896|NCT00428597|472352|P1|Overall Study|Objective Progression or Relapse|19
143897|NCT00428597|472351|P2|Overall Study|Randomized but not treated|3
143898|NCT00428597|472352|P1|Overall Study|Randomized but not treated|3
143899|NCT00428441|472419|P1|Overall Study|Lost to Follow-up|1
143900|NCT00428389|472425|P2|Extension Phase|Administrative problems|1
143901|NCT00428389|472426|P1|Extension Phase|Administrative problems|1
143902|NCT00428389|472425|P2|Extension Phase|Protocol Violation|2
143903|NCT00428389|472426|P1|Extension Phase|Protocol Violation|3
143904|NCT00428389|472425|P2|Extension Phase|Death|0
143905|NCT00428389|472426|P1|Extension Phase|Death|1
143906|NCT00428389|472425|P2|Extension Phase|Lost to Follow-up|3
143907|NCT00428389|472426|P1|Extension Phase|Lost to Follow-up|0
143908|NCT00428389|472425|P2|Extension Phase|Withdrawal by Subject|6
143909|NCT00428389|472426|P1|Extension Phase|Withdrawal by Subject|6
143910|NCT00428389|472425|P2|Extension Phase|Lack of Efficacy|3
143911|NCT00428389|472426|P1|Extension Phase|Lack of Efficacy|4
143912|NCT00428389|472425|P2|Extension Phase|Adverse Event|11
143913|NCT00428389|472426|P1|Extension Phase|Adverse Event|17
143914|NCT00428389|472425|P2|Core Phase|Protocol deviation|2
143915|NCT00428389|472426|P1|Core Phase|Protocol deviation|0
143916|NCT00428389|472425|P2|Core Phase|Withdrawal by Subject|4
143917|NCT00428389|472426|P1|Core Phase|Withdrawal by Subject|3
143918|NCT00428389|472425|P2|Core Phase|Abnormal test procedure result(s)|1
143919|NCT00428389|472426|P1|Core Phase|Abnormal test procedure result(s)|0
143920|NCT00428389|472425|P2|Core Phase|Lack of Efficacy|0
143921|NCT00428389|472426|P1|Core Phase|Lack of Efficacy|2
143922|NCT00428389|472425|P2|Core Phase|Adverse Event|4
143923|NCT00428389|472426|P1|Core Phase|Adverse Event|6
143924|NCT00428246|472447|P3|Overall Study|Adverse Event|0
143925|NCT00428246|472448|P2|Overall Study|Adverse Event|0
143926|NCT00428246|472449|P1|Overall Study|Adverse Event|1
143927|NCT00428246|472447|P3|Overall Study|Withdrawal by Subject|1
143928|NCT00428246|472448|P2|Overall Study|Withdrawal by Subject|0
143929|NCT00428246|472449|P1|Overall Study|Withdrawal by Subject|0
143930|NCT00428220|472457|P1|Overall Study|Other|23
143931|NCT00428220|472457|P1|Overall Study|Adverse Event|51
143932|NCT00428220|472457|P1|Overall Study|Participant refused continued treatment|7
143933|NCT00428220|472457|P1|Overall Study|Objective progression or relapse|123
143934|NCT00428220|472457|P1|Overall Study|Lost to Follow-up|4
143935|NCT00428220|472457|P1|Overall Study|Global deterioration of health status|7
143936|NCT00428220|472457|P1|Overall Study|Participant died|8
143937|NCT00428116|472475|P2|Overall Study|Lost to Follow-up|0
143938|NCT00428116|472476|P1|Overall Study|Lost to Follow-up|1
143939|NCT00428116|472475|P2|Overall Study|Withdrawal by Subject|0
143940|NCT00428116|472476|P1|Overall Study|Withdrawal by Subject|1
143941|NCT00428116|472475|P2|Overall Study|Death|0
143942|NCT00428116|472476|P1|Overall Study|Death|1
143943|NCT00427999|472488|P1|Overall Study|Death|1
143944|NCT00427999|472488|P1|Overall Study|Withdrawal by Subject|9
143945|NCT00427999|472488|P1|Overall Study|Protocol Violation|2
143946|NCT00427999|472488|P1|Overall Study|Unsatisfactory therapeutic effect|13
143947|NCT00427999|472488|P1|Overall Study|Abnormal laboratory values|1
143948|NCT00427999|472488|P1|Overall Study|Adverse Event|6
143949|NCT00427960|472506|P2|Overall Study|Not Specified|1
143950|NCT00427960|472507|P1|Overall Study|Not Specified|0
143951|NCT00427960|472506|P2|Overall Study|Withdrawal by Subject|3
143952|NCT00427960|472507|P1|Overall Study|Withdrawal by Subject|0
143953|NCT00427960|472506|P2|Overall Study|Adverse Event|0
143954|NCT00427960|472507|P1|Overall Study|Adverse Event|2
143955|NCT00427934|472545|P4|Overall Study|Withdrawal by Subject|3
143956|NCT00427934|472546|P3|Overall Study|Withdrawal by Subject|1
143957|NCT00427934|472547|P2|Overall Study|Withdrawal by Subject|0
143958|NCT00427934|472548|P1|Overall Study|Withdrawal by Subject|0
143959|NCT00427934|472545|P4|Overall Study|Other|5
143960|NCT00427934|472546|P3|Overall Study|Other|11
143961|NCT00427934|472547|P2|Overall Study|Other|0
143962|NCT00427934|472548|P1|Overall Study|Other|0
143963|NCT00427934|472545|P4|Overall Study|Randomized But Did Not Receive Treatment|1
143964|NCT00427934|472546|P3|Overall Study|Randomized But Did Not Receive Treatment|1
143965|NCT00427934|472547|P2|Overall Study|Randomized But Did Not Receive Treatment|0
143966|NCT00427934|472548|P1|Overall Study|Randomized But Did Not Receive Treatment|0
143967|NCT00427934|472545|P4|Overall Study|Lack of Efficacy|2
143968|NCT00427934|472546|P3|Overall Study|Lack of Efficacy|5
143969|NCT00427934|472547|P2|Overall Study|Lack of Efficacy|0
143970|NCT00427934|472548|P1|Overall Study|Lack of Efficacy|0
143971|NCT00427934|472545|P4|Overall Study|Adverse Event|4
143972|NCT00427934|472546|P3|Overall Study|Adverse Event|5
143973|NCT00427934|472547|P2|Overall Study|Adverse Event|0
143974|NCT00427934|472548|P1|Overall Study|Adverse Event|1
143975|NCT00427921|472616|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
143976|NCT00427921|472616|P1|Overall Study|Adverse Event + Withdrawn from Study|1
143977|NCT00427921|472616|P1|Overall Study|Adverse Event + Lost Response|1
143978|NCT00427921|472616|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
143979|NCT00427921|472616|P1|Overall Study|Adverse Event + Worsening of CD|1
143980|NCT00427921|472616|P1|Overall Study|Adverse Event + No Response|1
143981|NCT00427921|472616|P1|Overall Study|Adverse Event + Withdrew Consent|1
143982|NCT00427921|472616|P1|Overall Study|Adverse Event + Hospitalization|1
143983|NCT00427921|472616|P1|Overall Study|Other reason not specified|10
143984|NCT00427921|472616|P1|Overall Study|Lost to Follow-up|2
143985|NCT00427921|472616|P1|Overall Study|Withdrawal by Subject|4
143986|NCT00427921|472616|P1|Overall Study|Adverse Event|26
143987|NCT00427895|472639|P8|Vax 2/Year 3 to 4|Failed to Return|0
143988|NCT00427895|472640|P7|Vax 2/Year 3 to 4|Failed to Return|0
143989|NCT00427895|472641|P6|Vax 2/Year 3 to 4|Failed to Return|0
143990|NCT00427895|472642|P5|Vax 2/Year 3 to 4|Failed to Return|1
143991|NCT00427895|472643|P4|Vax 2/Year 3 to 4|Failed to Return|0
143992|NCT00427895|472644|P3|Vax 2/Year 3 to 4|Failed to Return|0
143993|NCT00427895|472645|P2|Vax 2/Year 3 to 4|Failed to Return|0
143994|NCT00427895|472646|P1|Vax 2/Year 3 to 4|Failed to Return|0
143995|NCT00427895|472639|P8|Vax 2/Year 3 to 4|Protocol Violation|1
143996|NCT00427895|472640|P7|Vax 2/Year 3 to 4|Protocol Violation|0
143997|NCT00427895|472641|P6|Vax 2/Year 3 to 4|Protocol Violation|0
143998|NCT00427895|472642|P5|Vax 2/Year 3 to 4|Protocol Violation|0
143999|NCT00427895|472643|P4|Vax 2/Year 3 to 4|Protocol Violation|0
144000|NCT00427895|472644|P3|Vax 2/Year 3 to 4|Protocol Violation|0
144001|NCT00427895|472645|P2|Vax 2/Year 3 to 4|Protocol Violation|0
144002|NCT00427895|472646|P1|Vax 2/Year 3 to 4|Protocol Violation|0
144003|NCT00427895|472639|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
144004|NCT00427895|472640|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
144005|NCT00427895|472641|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
144006|NCT00427895|472642|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
144007|NCT00427895|472643|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
144008|NCT00427895|472644|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
144009|NCT00427895|472645|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
144010|NCT00427895|472646|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
144011|NCT00427895|472639|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
144012|NCT00427895|472640|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
144013|NCT00427895|472641|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
144014|NCT00427895|472642|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
144015|NCT00427895|472643|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
144016|NCT00427895|472644|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
144017|NCT00427895|472645|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
144018|NCT00427895|472646|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
144019|NCT00427895|472639|P8|Vax 1/Year 1 Follow-up|Unspecified|0
144020|NCT00427895|472640|P7|Vax 1/Year 1 Follow-up|Unspecified|0
144021|NCT00427895|472641|P6|Vax 1/Year 1 Follow-up|Unspecified|0
144022|NCT00427895|472642|P5|Vax 1/Year 1 Follow-up|Unspecified|0
144023|NCT00427895|472643|P4|Vax 1/Year 1 Follow-up|Unspecified|2
144024|NCT00427895|472644|P3|Vax 1/Year 1 Follow-up|Unspecified|0
144025|NCT00427895|472645|P2|Vax 1/Year 1 Follow-up|Unspecified|0
144026|NCT00427895|472646|P1|Vax 1/Year 1 Follow-up|Unspecified|0
144027|NCT00427895|472639|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
144028|NCT00427895|472640|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
144029|NCT00427895|472641|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
144030|NCT00427895|472642|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
144031|NCT00427895|472643|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
144032|NCT00427895|472644|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
144033|NCT00427895|472645|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
144034|NCT00427895|472646|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
144035|NCT00427895|472639|P8|Vax 1/Year 1 Follow-up|Death|0
144036|NCT00427895|472640|P7|Vax 1/Year 1 Follow-up|Death|0
144037|NCT00427895|472641|P6|Vax 1/Year 1 Follow-up|Death|0
144038|NCT00427895|472642|P5|Vax 1/Year 1 Follow-up|Death|0
144039|NCT00427895|472643|P4|Vax 1/Year 1 Follow-up|Death|0
144040|NCT00427895|472644|P3|Vax 1/Year 1 Follow-up|Death|0
144041|NCT00427895|472645|P2|Vax 1/Year 1 Follow-up|Death|0
144042|NCT00427895|472646|P1|Vax 1/Year 1 Follow-up|Death|1
144043|NCT00427895|472639|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
144044|NCT00427895|472640|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
144045|NCT00427895|472641|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
144046|NCT00427895|472642|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
144047|NCT00427895|472643|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
144048|NCT00427895|472644|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
144049|NCT00427895|472645|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
144050|NCT00427895|472646|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
144051|NCT00427895|472639|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
144052|NCT00427895|472640|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
144053|NCT00427895|472641|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
144054|NCT00427895|472642|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
144055|NCT00427895|472643|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
144056|NCT00427895|472644|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
144057|NCT00427895|472645|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
144058|NCT00427895|472646|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
144059|NCT00427895|472639|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
144060|NCT00427895|472640|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
144061|NCT00427895|472641|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
144062|NCT00427895|472642|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
144063|NCT00427895|472643|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
144064|NCT00427895|472644|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
144065|NCT00427895|472645|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
144066|NCT00427895|472646|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
144067|NCT00427895|472639|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
144068|NCT00427895|472640|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
144069|NCT00427895|472641|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
144070|NCT00427895|472642|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
144071|NCT00427895|472643|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
144072|NCT00427895|472644|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
144073|NCT00427895|472645|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
144074|NCT00427895|472646|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
144075|NCT00427895|472639|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
144076|NCT00427895|472640|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
144077|NCT00427895|472641|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
144078|NCT00427895|472642|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
144079|NCT00427895|472643|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
144080|NCT00427895|472644|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
144081|NCT00427895|472645|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
144082|NCT00427895|472646|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
144083|NCT00427895|472639|P8|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
144084|NCT00427895|472640|P7|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
144085|NCT00427895|472641|P6|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
144086|NCT00427895|472642|P5|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
144087|NCT00427895|472643|P4|Vax 1 Baseline/6-Month Follow-up|Unspecified|2
144088|NCT00427895|472644|P3|Vax 1 Baseline/6-Month Follow-up|Unspecified|1
144089|NCT00427895|472645|P2|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
144090|NCT00427895|472646|P1|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
144091|NCT00427895|472639|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
144092|NCT00427895|472640|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
144093|NCT00427895|472641|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
144094|NCT00427895|472642|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
144095|NCT00427895|472643|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
144096|NCT00427895|472644|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
144097|NCT00427895|472645|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
144098|NCT00427895|472646|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
144099|NCT00427895|472639|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
144100|NCT00427895|472640|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
144101|NCT00427895|472641|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
144102|NCT00427895|472642|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
144103|NCT00427895|472643|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
144104|NCT00427895|472644|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
144105|NCT00427895|472645|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
144106|NCT00427895|472646|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
144107|NCT00427895|472639|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
144108|NCT00427895|472640|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
144109|NCT00427895|472641|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
144110|NCT00427895|472642|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
144111|NCT00427895|472643|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
144112|NCT00427895|472644|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
144113|NCT00427895|472645|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
144114|NCT00427895|472646|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
144115|NCT00427895|472639|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
144116|NCT00427895|472640|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
144117|NCT00427895|472641|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
144118|NCT00427895|472642|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
144119|NCT00427895|472643|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
144120|NCT00427895|472644|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
144121|NCT00427895|472645|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
144122|NCT00427895|472646|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
144123|NCT00427895|472639|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
144124|NCT00427895|472640|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
144125|NCT00427895|472641|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
144126|NCT00427895|472642|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
144127|NCT00427895|472643|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
144128|NCT00427895|472644|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
144129|NCT00427895|472645|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
144130|NCT00427895|472646|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
144131|NCT00427895|472639|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
144132|NCT00427895|472640|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
144133|NCT00427895|472641|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
144134|NCT00427895|472642|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
144135|NCT00427895|472643|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
144136|NCT00427895|472644|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
144137|NCT00427895|472645|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
144138|NCT00427895|472646|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
144139|NCT00427700|472727|P2|Overall Study|Pregnancy|2
144140|NCT00427700|472728|P1|Overall Study|Pregnancy|0
144141|NCT00427700|472727|P2|Overall Study|no induction of menses|4
144142|NCT00427700|472728|P1|Overall Study|no induction of menses|1
144143|NCT00427700|472727|P2|Overall Study|Lost to Follow-up|5
144144|NCT00427700|472728|P1|Overall Study|Lost to Follow-up|2
144145|NCT00427635|472744|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
144146|NCT00427635|472745|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
144147|NCT00427635|472744|P2|Treatment Phase|Withdrawal by Subject|0
144148|NCT00427635|472745|P1|Treatment Phase|Withdrawal by Subject|1
144149|NCT00427349|472777|P1|Overall Study|Never started therapy|1
144150|NCT00427349|472777|P1|Overall Study|Ineligible|1
144151|NCT00427349|472777|P1|Overall Study|Other|2
144152|NCT00427349|472777|P1|Overall Study|Alternative therapy|1
144153|NCT00427349|472777|P1|Overall Study|Withdrawal by Subject|3
144154|NCT00427349|472777|P1|Overall Study|Death|1
144155|NCT00427349|472777|P1|Overall Study|Adverse Event|14
144156|NCT00427349|472777|P1|Overall Study|Lack of Efficacy|23
144157|NCT00427011|472798|P1|Overall Study|Not specified|12
144158|NCT00427011|472798|P1|Overall Study|Lack of Efficacy|2
144159|NCT00427011|472798|P1|Overall Study|Withdrawal by Subject|1
144160|NCT00427011|472798|P1|Overall Study|Adverse Event|10
144161|NCT00426842|472813|P1|Overall Study|Lost to Follow-up|1
144162|NCT00426764|472819|P1|Overall Study|Other|2
144163|NCT00426764|472819|P1|Overall Study|Protocol Violation|1
144164|NCT00426764|472819|P1|Overall Study|Physician Decision|1
144165|NCT00426764|472819|P1|Overall Study|Withdrawal by Subject|3
144166|NCT00426764|472819|P1|Overall Study|Adverse Event|19
144167|NCT00426764|472819|P1|Overall Study|Progressive disease|72
144168|NCT00426751|472835|P2|Overall Study|Other Reasons|12
144169|NCT00426751|472836|P1|Overall Study|Other Reasons|7
144170|NCT00426751|472835|P2|Overall Study|Consent Withdrawn|1
144171|NCT00426751|472836|P1|Overall Study|Consent Withdrawn|0
144172|NCT00426751|472835|P2|Overall Study|Lost to Follow-up|6
144173|NCT00426751|472836|P1|Overall Study|Lost to Follow-up|7
144174|NCT00426751|472835|P2|Overall Study|Adverse Event|1
144175|NCT00426751|472836|P1|Overall Study|Adverse Event|8
144176|NCT00426660|472880|P1|Overall Study|Enrolled Not Treated|15
144177|NCT00426660|472880|P1|Overall Study|Protocol Violation|1
144178|NCT00426660|472880|P1|Overall Study|Withdrawal by Subject|18
144179|NCT00426660|472880|P1|Overall Study|Unspecified|23
144180|NCT00426660|472880|P1|Overall Study|Lost to Follow-up|15
144181|NCT00426660|472880|P1|Overall Study|Insufficient Clinical Response|22
144182|NCT00426660|472880|P1|Overall Study|Adverse Event|23
144183|NCT00426660|472880|P1|Overall Study|Death|14
144184|NCT00426556|472911|P4|Phase II - Extension Phase|Adverse Event|2
144185|NCT00426556|472912|P3|Phase II - Extension Phase|Adverse Event|0
144186|NCT00426556|472913|P2|Phase II - Extension Phase|Adverse Event|0
144187|NCT00426556|472914|P1|Phase II - Extension Phase|Adverse Event|0
144188|NCT00426556|472911|P4|Phase II - Extension Phase|Disease Progression|21
144189|NCT00426556|472912|P3|Phase II - Extension Phase|Disease Progression|0
144190|NCT00426556|472913|P2|Phase II - Extension Phase|Disease Progression|0
144191|NCT00426556|472914|P1|Phase II - Extension Phase|Disease Progression|0
144192|NCT00426556|472911|P4|Phase II - Core Phase|Adverse Event|8
144193|NCT00426556|472912|P3|Phase II - Core Phase|Adverse Event|0
144194|NCT00426556|472913|P2|Phase II - Core Phase|Adverse Event|0
144195|NCT00426556|472914|P1|Phase II - Core Phase|Adverse Event|0
144196|NCT00426556|472911|P4|Phase II - Core Phase|Disease Progression|16
144197|NCT00426556|472912|P3|Phase II - Core Phase|Disease Progression|0
144198|NCT00426556|472913|P2|Phase II - Core Phase|Disease Progression|0
144199|NCT00426556|472914|P1|Phase II - Core Phase|Disease Progression|0
144200|NCT00426556|472911|P4|Phase II - Core Phase|Withdrawal by Subject|3
144201|NCT00426556|472912|P3|Phase II - Core Phase|Withdrawal by Subject|0
144202|NCT00426556|472913|P2|Phase II - Core Phase|Withdrawal by Subject|0
144203|NCT00426556|472914|P1|Phase II - Core Phase|Withdrawal by Subject|0
144204|NCT00426556|472911|P4|Phase I - Extension Phase|Disease Progression|0
144205|NCT00426556|472912|P3|Phase I - Extension Phase|Disease Progression|6
144206|NCT00426556|472913|P2|Phase I - Extension Phase|Disease Progression|5
144207|NCT00426556|472914|P1|Phase I - Extension Phase|Disease Progression|5
144208|NCT00426556|472911|P4|Phase I - Extension Phase|Adverse Event|0
144209|NCT00426556|472912|P3|Phase I - Extension Phase|Adverse Event|1
144210|NCT00426556|472913|P2|Phase I - Extension Phase|Adverse Event|1
144211|NCT00426556|472914|P1|Phase I - Extension Phase|Adverse Event|0
144212|NCT00426556|472911|P4|Phase I - Core Phase|Death|0
144213|NCT00426556|472912|P3|Phase I - Core Phase|Death|0
144214|NCT00426556|472913|P2|Phase I - Core Phase|Death|1
144215|NCT00426556|472914|P1|Phase I - Core Phase|Death|0
144216|NCT00426556|472911|P4|Phase I - Core Phase|Adverse Event|0
144217|NCT00426556|472912|P3|Phase I - Core Phase|Adverse Event|1
144218|NCT00426556|472913|P2|Phase I - Core Phase|Adverse Event|3
144219|NCT00426556|472914|P1|Phase I - Core Phase|Adverse Event|1
144220|NCT00426556|472911|P4|Phase I - Core Phase|Disease Progression|0
144221|NCT00426556|472912|P3|Phase I - Core Phase|Disease Progression|2
144222|NCT00426556|472913|P2|Phase I - Core Phase|Disease Progression|6
144223|NCT00426556|472914|P1|Phase I - Core Phase|Disease Progression|0
144224|NCT00426361|472939|P3|Overall Study|Withdrawal by Subject|0
144225|NCT00426361|472940|P2|Overall Study|Withdrawal by Subject|3
144226|NCT00426361|472941|P1|Overall Study|Withdrawal by Subject|1
144227|NCT00426361|472939|P3|Overall Study|Lost to Follow-up|5
144228|NCT00426361|472940|P2|Overall Study|Lost to Follow-up|2
144229|NCT00426361|472941|P1|Overall Study|Lost to Follow-up|3
144230|NCT00426270|473000|P1|Overall Study|Adverse Event|5
144231|NCT00426270|473000|P1|Overall Study|Incorrectly Enrolled in the Study|1
144232|NCT00426231|473010|P2|Overall Study|Withdrawal by Subject|12
144233|NCT00426231|473011|P1|Overall Study|Withdrawal by Subject|9
144234|NCT00425373|473052|P9|Overall Study|Lack of Efficacy|5
144235|NCT00425373|473053|P8|Overall Study|Lack of Efficacy|0
144236|NCT00425373|473054|P7|Overall Study|Lack of Efficacy|3
144237|NCT00425373|473055|P6|Overall Study|Lack of Efficacy|3
144238|NCT00425373|473056|P5|Overall Study|Lack of Efficacy|1
144239|NCT00425373|473057|P4|Overall Study|Lack of Efficacy|0
144240|NCT00425373|473058|P3|Overall Study|Lack of Efficacy|0
144241|NCT00425373|473059|P2|Overall Study|Lack of Efficacy|0
144242|NCT00425373|473060|P1|Overall Study|Lack of Efficacy|0
144243|NCT00425373|473052|P9|Overall Study|Withdrawal by Subject|2
144244|NCT00425373|473053|P8|Overall Study|Withdrawal by Subject|2
144245|NCT00425373|473054|P7|Overall Study|Withdrawal by Subject|2
144246|NCT00425373|473055|P6|Overall Study|Withdrawal by Subject|0
144247|NCT00425373|473056|P5|Overall Study|Withdrawal by Subject|4
144248|NCT00425373|473057|P4|Overall Study|Withdrawal by Subject|1
144249|NCT00425373|473058|P3|Overall Study|Withdrawal by Subject|2
144250|NCT00425373|473059|P2|Overall Study|Withdrawal by Subject|0
144251|NCT00425373|473060|P1|Overall Study|Withdrawal by Subject|2
144252|NCT00425373|473052|P9|Overall Study|Protocol Violation|3
144253|NCT00425373|473053|P8|Overall Study|Protocol Violation|5
144254|NCT00425373|473054|P7|Overall Study|Protocol Violation|0
144255|NCT00425373|473055|P6|Overall Study|Protocol Violation|0
144256|NCT00425373|473056|P5|Overall Study|Protocol Violation|0
144257|NCT00425373|473057|P4|Overall Study|Protocol Violation|0
144258|NCT00425373|473058|P3|Overall Study|Protocol Violation|1
144259|NCT00425373|473059|P2|Overall Study|Protocol Violation|0
144260|NCT00425373|473060|P1|Overall Study|Protocol Violation|1
144261|NCT00425373|473052|P9|Overall Study|Lost to Follow-up|0
144262|NCT00425373|473053|P8|Overall Study|Lost to Follow-up|0
144263|NCT00425373|473054|P7|Overall Study|Lost to Follow-up|0
144264|NCT00425373|473055|P6|Overall Study|Lost to Follow-up|0
144265|NCT00425373|473056|P5|Overall Study|Lost to Follow-up|1
144266|NCT00425373|473057|P4|Overall Study|Lost to Follow-up|0
144267|NCT00425373|473058|P3|Overall Study|Lost to Follow-up|0
144268|NCT00425373|473059|P2|Overall Study|Lost to Follow-up|1
144269|NCT00425373|473060|P1|Overall Study|Lost to Follow-up|0
144270|NCT00425373|473052|P9|Overall Study|Adverse Event|8
144271|NCT00425373|473053|P8|Overall Study|Adverse Event|3
144272|NCT00425373|473054|P7|Overall Study|Adverse Event|2
144273|NCT00425373|473055|P6|Overall Study|Adverse Event|6
144274|NCT00425373|473056|P5|Overall Study|Adverse Event|4
144275|NCT00425373|473057|P4|Overall Study|Adverse Event|1
144276|NCT00425373|473058|P3|Overall Study|Adverse Event|0
144277|NCT00425373|473059|P2|Overall Study|Adverse Event|2
144278|NCT00425373|473060|P1|Overall Study|Adverse Event|2
144279|NCT00425308|473118|P2|Overall Study|Death|0
144280|NCT00425308|473119|P1|Overall Study|Death|1
144281|NCT00425308|473118|P2|Overall Study|Withdrawal by Subject|0
144282|NCT00425308|473119|P1|Overall Study|Withdrawal by Subject|1
144283|NCT00425308|473118|P2|Overall Study|Adverse Event|1
144284|NCT00425308|473119|P1|Overall Study|Adverse Event|2
144285|NCT00425945|473149|P2|Overall Study|Moved from area|1
144286|NCT00425945|473150|P1|Overall Study|Moved from area|0
144287|NCT00425945|473149|P2|Overall Study|Began cancer treatments|0
144288|NCT00425945|473150|P1|Overall Study|Began cancer treatments|1
144289|NCT00425945|473149|P2|Overall Study|Began hypertension medication|0
144290|NCT00425945|473150|P1|Overall Study|Began hypertension medication|1
144291|NCT00425945|473149|P2|Overall Study|Lost to Follow-up|2
144292|NCT00425945|473150|P1|Overall Study|Lost to Follow-up|0
144293|NCT00425945|473149|P2|Overall Study|Inconvenience|2
144294|NCT00425945|473150|P1|Overall Study|Inconvenience|0
144295|NCT00425945|473149|P2|Overall Study|Concern about Supplement|0
144296|NCT00425945|473150|P1|Overall Study|Concern about Supplement|2
144297|NCT00425854|473188|P2|Overall Study|Other Adverse Event|2
144298|NCT00425854|473189|P1|Overall Study|Other Adverse Event|2
144299|NCT00425854|473188|P2|Overall Study|Dose reduction toxicity AE|7
144300|NCT00425854|473189|P1|Overall Study|Dose reduction toxicity AE|8
144301|NCT00425854|473188|P2|Overall Study|Progressive Disease|12
144302|NCT00425854|473189|P1|Overall Study|Progressive Disease|19
144303|NCT00425750|473210|P1|Overall Study|Progression of disease|18
144304|NCT00425750|473210|P1|Overall Study|Adverse Event|3
144305|NCT00425750|473210|P1|Overall Study|Withdrawal by Subject|3
144306|NCT00425750|473210|P1|Overall Study|Death|1
144307|NCT00425698|473218|P2|Overall Study|Withdrawal by Subject|1
144308|NCT00425698|473219|P1|Overall Study|Withdrawal by Subject|0
144309|NCT00425698|473218|P2|Overall Study|Adverse Event|1
144310|NCT00425698|473219|P1|Overall Study|Adverse Event|3
144311|NCT00425503|473225|P1|Overall Study|Protocol Violation|1
144312|NCT00425503|473225|P1|Overall Study|Adverse Event|2
144313|NCT00425438|473231|P2|Overall Study|Termination by Sponsor|27
144314|NCT00425438|473232|P1|Overall Study|Termination by Sponsor|25
144315|NCT00425269|473250|P2|Overall Study|moved or medical reason|4
144316|NCT00425269|473251|P1|Overall Study|moved or medical reason|5
144317|NCT00425269|473250|P2|Overall Study|Lost to Follow-up|9
144318|NCT00425269|473251|P1|Overall Study|Lost to Follow-up|9
144319|NCT00425269|473250|P2|Overall Study|Pregnancy|7
144320|NCT00425269|473251|P1|Overall Study|Pregnancy|5
144321|NCT00425113|473329|P2|Overall Study|Withdrawal by Subject|0
144322|NCT00425113|473330|P1|Overall Study|Withdrawal by Subject|1
144323|NCT00425113|473329|P2|Overall Study|missing study drug more than 14 days|1
144324|NCT00425113|473330|P1|Overall Study|missing study drug more than 14 days|0
144325|NCT00425113|473329|P2|Overall Study|diagnosis of abdominal TB|1
144326|NCT00425113|473330|P1|Overall Study|diagnosis of abdominal TB|0
144327|NCT00425113|473329|P2|Overall Study|uncontrolled diabetes mellitus|0
144328|NCT00425113|473330|P1|Overall Study|uncontrolled diabetes mellitus|1
144329|NCT00425100|473338|P1|Overall Study|Withdrawal by Subject|7
144330|NCT00425100|473338|P1|Overall Study|Protocol Violation|4
144331|NCT00425100|473338|P1|Overall Study|Lost to Follow-up|2
144332|NCT00425100|473338|P1|Overall Study|Lack of Efficacy|4
144333|NCT00425100|473338|P1|Overall Study|Adverse Event|36
144334|NCT00425061|473382|P7|Overall Study|Unspecified|1
144335|NCT00425061|473383|P6|Overall Study|Unspecified|0
144336|NCT00425061|473384|P5|Overall Study|Unspecified|3
144337|NCT00425061|473385|P4|Overall Study|Unspecified|0
144338|NCT00425061|473386|P3|Overall Study|Unspecified|0
144339|NCT00425061|473387|P2|Overall Study|Unspecified|0
144340|NCT00425061|473388|P1|Overall Study|Unspecified|0
144341|NCT00425061|473382|P7|Overall Study|Physician Decision|0
144342|NCT00425061|473383|P6|Overall Study|Physician Decision|0
144343|NCT00425061|473384|P5|Overall Study|Physician Decision|1
144344|NCT00425061|473385|P4|Overall Study|Physician Decision|0
144345|NCT00425061|473386|P3|Overall Study|Physician Decision|0
144346|NCT00425061|473387|P2|Overall Study|Physician Decision|0
144347|NCT00425061|473388|P1|Overall Study|Physician Decision|0
144348|NCT00425061|473382|P7|Overall Study|Sponsor's request|15
144349|NCT00425061|473383|P6|Overall Study|Sponsor's request|4
144350|NCT00425061|473384|P5|Overall Study|Sponsor's request|19
144351|NCT00425061|473385|P4|Overall Study|Sponsor's request|0
144352|NCT00425061|473386|P3|Overall Study|Sponsor's request|0
144353|NCT00425061|473387|P2|Overall Study|Sponsor's request|0
144354|NCT00425061|473388|P1|Overall Study|Sponsor's request|0
144355|NCT00425061|473382|P7|Overall Study|Withdrawal by Subject|3
144356|NCT00425061|473383|P6|Overall Study|Withdrawal by Subject|0
144357|NCT00425061|473384|P5|Overall Study|Withdrawal by Subject|1
144358|NCT00425061|473385|P4|Overall Study|Withdrawal by Subject|0
144359|NCT00425061|473386|P3|Overall Study|Withdrawal by Subject|0
144360|NCT00425061|473387|P2|Overall Study|Withdrawal by Subject|1
144361|NCT00425061|473388|P1|Overall Study|Withdrawal by Subject|0
144362|NCT00425061|473382|P7|Overall Study|Protocol Violation|0
144363|NCT00425061|473383|P6|Overall Study|Protocol Violation|0
144364|NCT00425061|473384|P5|Overall Study|Protocol Violation|0
144365|NCT00425061|473385|P4|Overall Study|Protocol Violation|0
144366|NCT00425061|473386|P3|Overall Study|Protocol Violation|0
144367|NCT00425061|473387|P2|Overall Study|Protocol Violation|0
144368|NCT00425061|473388|P1|Overall Study|Protocol Violation|1
144369|NCT00425061|473382|P7|Overall Study|Lost to Follow-up|0
144370|NCT00425061|473383|P6|Overall Study|Lost to Follow-up|0
144371|NCT00425061|473384|P5|Overall Study|Lost to Follow-up|0
144372|NCT00425061|473385|P4|Overall Study|Lost to Follow-up|0
144373|NCT00425061|473386|P3|Overall Study|Lost to Follow-up|0
144374|NCT00425061|473387|P2|Overall Study|Lost to Follow-up|1
144375|NCT00425061|473388|P1|Overall Study|Lost to Follow-up|0
144376|NCT00425061|473382|P7|Overall Study|Adverse Event|0
144377|NCT00425061|473383|P6|Overall Study|Adverse Event|0
144378|NCT00425061|473384|P5|Overall Study|Adverse Event|2
144379|NCT00425061|473385|P4|Overall Study|Adverse Event|2
144380|NCT00425061|473386|P3|Overall Study|Adverse Event|0
144381|NCT00425061|473387|P2|Overall Study|Adverse Event|0
144382|NCT00425061|473388|P1|Overall Study|Adverse Event|1
144383|NCT00424775|473504|P2|Overall Study|Lack of Efficacy|0
144384|NCT00424775|473505|P1|Overall Study|Lack of Efficacy|1
144385|NCT00424775|473504|P2|Overall Study|Adverse Event|0
144386|NCT00424775|473505|P1|Overall Study|Adverse Event|2
144387|NCT00424762|473515|P2|Overall Study|Lost to Follow-up|3
144388|NCT00424762|473516|P1|Overall Study|Lost to Follow-up|2
144389|NCT00424762|473515|P2|Overall Study|Withdrawal by Subject|19
144390|NCT00424762|473516|P1|Overall Study|Withdrawal by Subject|18
144391|NCT00424749|473526|P1|Overall Study|Withdrawal by Subject|1
144392|NCT00424645|473533|P2|Overall Study|Death|0
144393|NCT00424645|473534|P1|Overall Study|Death|1
144394|NCT00424632|473542|P10|Overall Study|Unspecified|0
144395|NCT00424632|473543|P9|Overall Study|Unspecified|1
144396|NCT00424632|473544|P8|Overall Study|Unspecified|0
144397|NCT00424632|473545|P7|Overall Study|Unspecified|0
144398|NCT00424632|473546|P6|Overall Study|Unspecified|0
144399|NCT00424632|473547|P5|Overall Study|Unspecified|0
144400|NCT00424632|473548|P4|Overall Study|Unspecified|1
144401|NCT00424632|473549|P3|Overall Study|Unspecified|0
144402|NCT00424632|473550|P2|Overall Study|Unspecified|0
144403|NCT00424632|473551|P1|Overall Study|Unspecified|0
144404|NCT00424632|473542|P10|Overall Study|Objective progression or relapse|4
144405|NCT00424632|473543|P9|Overall Study|Objective progression or relapse|12
144406|NCT00424632|473544|P8|Overall Study|Objective progression or relapse|3
144407|NCT00424632|473545|P7|Overall Study|Objective progression or relapse|7
144408|NCT00424632|473546|P6|Overall Study|Objective progression or relapse|13
144409|NCT00424632|473547|P5|Overall Study|Objective progression or relapse|2
144410|NCT00424632|473548|P4|Overall Study|Objective progression or relapse|2
144411|NCT00424632|473549|P3|Overall Study|Objective progression or relapse|1
144412|NCT00424632|473550|P2|Overall Study|Objective progression or relapse|1
144413|NCT00424632|473551|P1|Overall Study|Objective progression or relapse|1
144414|NCT00424632|473542|P10|Overall Study|Global deterioration of health status|0
144415|NCT00424632|473543|P9|Overall Study|Global deterioration of health status|0
144416|NCT00424632|473544|P8|Overall Study|Global deterioration of health status|0
144417|NCT00424632|473545|P7|Overall Study|Global deterioration of health status|0
144418|NCT00424632|473546|P6|Overall Study|Global deterioration of health status|0
144419|NCT00424632|473547|P5|Overall Study|Global deterioration of health status|1
144420|NCT00424632|473548|P4|Overall Study|Global deterioration of health status|1
144421|NCT00424632|473549|P3|Overall Study|Global deterioration of health status|0
144422|NCT00424632|473550|P2|Overall Study|Global deterioration of health status|0
144423|NCT00424632|473551|P1|Overall Study|Global deterioration of health status|0
144424|NCT00424632|473542|P10|Overall Study|Adverse Event|2
144425|NCT00424632|473543|P9|Overall Study|Adverse Event|3
144426|NCT00424632|473544|P8|Overall Study|Adverse Event|0
144427|NCT00424632|473545|P7|Overall Study|Adverse Event|0
144428|NCT00424632|473546|P6|Overall Study|Adverse Event|0
144429|NCT00424632|473547|P5|Overall Study|Adverse Event|0
144430|NCT00424632|473548|P4|Overall Study|Adverse Event|0
144431|NCT00424632|473549|P3|Overall Study|Adverse Event|0
144432|NCT00424632|473550|P2|Overall Study|Adverse Event|0
144433|NCT00424632|473551|P1|Overall Study|Adverse Event|0
144434|NCT00424632|473542|P10|Overall Study|Death|0
144435|NCT00424632|473543|P9|Overall Study|Death|0
144436|NCT00424632|473544|P8|Overall Study|Death|0
144437|NCT00424632|473545|P7|Overall Study|Death|0
144438|NCT00424632|473546|P6|Overall Study|Death|2
144439|NCT00424632|473547|P5|Overall Study|Death|0
144440|NCT00424632|473548|P4|Overall Study|Death|0
144441|NCT00424632|473549|P3|Overall Study|Death|0
144442|NCT00424632|473550|P2|Overall Study|Death|0
144443|NCT00424632|473551|P1|Overall Study|Death|0
144444|NCT00424593|473721|P2|Dose-Blind Extension Period|Physician Decision|0
144445|NCT00424593|473722|P1|Dose-Blind Extension Period|Physician Decision|3
144446|NCT00424593|473721|P2|Dose-Blind Extension Period|Lost to Follow-up|0
144447|NCT00424593|473722|P1|Dose-Blind Extension Period|Lost to Follow-up|6
144448|NCT00424593|473721|P2|Dose-Blind Extension Period|Protocol Violation|0
144449|NCT00424593|473722|P1|Dose-Blind Extension Period|Protocol Violation|9
144450|NCT00424593|473721|P2|Dose-Blind Extension Period|Lack of Efficacy|0
144451|NCT00424593|473722|P1|Dose-Blind Extension Period|Lack of Efficacy|9
144452|NCT00424593|473721|P2|Dose-Blind Extension Period|Adverse Event|0
144453|NCT00424593|473722|P1|Dose-Blind Extension Period|Adverse Event|18
144454|NCT00424593|473721|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
144455|NCT00424593|473722|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
144456|NCT00424593|473721|P2|Acute Double-Blind Period|Lack of Efficacy|1
144457|NCT00424593|473722|P1|Acute Double-Blind Period|Lack of Efficacy|0
144458|NCT00424593|473721|P2|Acute Double-Blind Period|Lost to Follow-up|1
144459|NCT00424593|473722|P1|Acute Double-Blind Period|Lost to Follow-up|1
144460|NCT00424593|473721|P2|Acute Double-Blind Period|Physician Decision|2
144461|NCT00424593|473722|P1|Acute Double-Blind Period|Physician Decision|1
144462|NCT00424593|473721|P2|Acute Double-Blind Period|Protocol Violation|2
144463|NCT00424593|473722|P1|Acute Double-Blind Period|Protocol Violation|2
144464|NCT00424593|473721|P2|Acute Double-Blind Period|Withdrawal by Subject|10
144465|NCT00424593|473722|P1|Acute Double-Blind Period|Withdrawal by Subject|11
144466|NCT00424593|473721|P2|Acute Double-Blind Period|Adverse Event|7
144467|NCT00424593|473722|P1|Acute Double-Blind Period|Adverse Event|16
144468|NCT00424528|473786|P3|Overall Study|noncompliance with study requirements|2
144469|NCT00424528|473787|P2|Overall Study|noncompliance with study requirements|1
144470|NCT00424528|473788|P1|Overall Study|noncompliance with study requirements|2
144471|NCT00424528|473786|P3|Overall Study|Lost to Follow-up|0
144472|NCT00424528|473787|P2|Overall Study|Lost to Follow-up|1
144473|NCT00424528|473788|P1|Overall Study|Lost to Follow-up|0
144474|NCT00424528|473786|P3|Overall Study|Protocol Violation|0
144475|NCT00424528|473787|P2|Overall Study|Protocol Violation|1
144476|NCT00424528|473788|P1|Overall Study|Protocol Violation|1
144477|NCT00424528|473786|P3|Overall Study|Adverse Event|2
144478|NCT00424528|473787|P2|Overall Study|Adverse Event|1
144479|NCT00424528|473788|P1|Overall Study|Adverse Event|2
144480|NCT00424515|473843|P2|Overall Study|Withdrawal by Subject|0
144481|NCT00424515|473844|P1|Overall Study|Withdrawal by Subject|1
144482|NCT00424515|473843|P2|Overall Study|Intercurrent Illness|1
144483|NCT00424515|473844|P1|Overall Study|Intercurrent Illness|0
144484|NCT00424515|473843|P2|Overall Study|Adverse Event|1
144485|NCT00424515|473844|P1|Overall Study|Adverse Event|0
144486|NCT00424515|473843|P2|Overall Study|Progressive Disease|11
144487|NCT00424515|473844|P1|Overall Study|Progressive Disease|10
144488|NCT00424476|473866|P3|Overall Study|Other|9
144489|NCT00424476|473867|P2|Overall Study|Other|3
144490|NCT00424476|473868|P1|Overall Study|Other|4
144491|NCT00424476|473866|P3|Overall Study|Physician Decision|3
144492|NCT00424476|473867|P2|Overall Study|Physician Decision|2
144493|NCT00424476|473868|P1|Overall Study|Physician Decision|3
144494|NCT00424476|473866|P3|Overall Study|Protocol Violation|3
144495|NCT00424476|473867|P2|Overall Study|Protocol Violation|2
144496|NCT00424476|473868|P1|Overall Study|Protocol Violation|7
144497|NCT00424476|473866|P3|Overall Study|Lost to Follow-up|3
144498|NCT00424476|473867|P2|Overall Study|Lost to Follow-up|6
144499|NCT00424476|473868|P1|Overall Study|Lost to Follow-up|4
144500|NCT00424476|473866|P3|Overall Study|Lack of Compliance|1
144501|NCT00424476|473867|P2|Overall Study|Lack of Compliance|1
144502|NCT00424476|473868|P1|Overall Study|Lack of Compliance|1
144503|NCT00424476|473866|P3|Overall Study|Lack of Efficacy|12
144504|NCT00424476|473867|P2|Overall Study|Lack of Efficacy|12
144505|NCT00424476|473868|P1|Overall Study|Lack of Efficacy|16
144506|NCT00424476|473866|P3|Overall Study|Adverse Event|15
144507|NCT00424476|473867|P2|Overall Study|Adverse Event|16
144508|NCT00424476|473868|P1|Overall Study|Adverse Event|19
144509|NCT00424476|473866|P3|Overall Study|Withdrawal by Subject|3
144510|NCT00424476|473867|P2|Overall Study|Withdrawal by Subject|6
144511|NCT00424476|473868|P1|Overall Study|Withdrawal by Subject|7
144512|NCT00424398|473894|P3|Overall Study|Subject met exclusion criteria|0
144513|NCT00424398|473895|P2|Overall Study|Subject met exclusion criteria|0
144514|NCT00424398|473896|P1|Overall Study|Subject met exclusion criteria|1
144515|NCT00424398|473894|P3|Overall Study|Withdrawal by Subject|0
144516|NCT00424398|473895|P2|Overall Study|Withdrawal by Subject|1
144517|NCT00424398|473896|P1|Overall Study|Withdrawal by Subject|2
144518|NCT00424385|473940|P1|Cohort 1|Withdrawal by Subject|1
144519|NCT00424385|473940|P1|Cohort 0|Physician Decision|1
144520|NCT00424385|473940|P1|Cohort 0|Withdrawal by Subject|5
144521|NCT00424372|473947|P1|Overall Study|Lack of Efficacy|6
144522|NCT00424372|473947|P1|Overall Study|Protocol Violation|1
144523|NCT00424372|473947|P1|Overall Study|Withdrawal by Subject|4
144524|NCT00424372|473947|P1|Overall Study|Health deterioration|1
144525|NCT00424372|473947|P1|Overall Study|Adverse Event|18
144526|NCT00424372|473947|P1|Overall Study|Death|1
144527|NCT00424346|473959|P4|Extension Phase|Protocol Violation|0
144528|NCT00424346|473960|P3|Extension Phase|Protocol Violation|1
144529|NCT00424346|473961|P2|Extension Phase|Protocol Violation|1
144530|NCT00424346|473962|P1|Extension Phase|Protocol Violation|0
144531|NCT00424346|473959|P4|Extension Phase|Death|1
144532|NCT00424346|473960|P3|Extension Phase|Death|0
144533|NCT00424346|473961|P2|Extension Phase|Death|0
144534|NCT00424346|473962|P1|Extension Phase|Death|0
144535|NCT00424346|473959|P4|Extension Phase|Administrative Problems|35
144536|NCT00424346|473960|P3|Extension Phase|Administrative Problems|32
144537|NCT00424346|473961|P2|Extension Phase|Administrative Problems|69
144538|NCT00424346|473962|P1|Extension Phase|Administrative Problems|0
144539|NCT00424346|473959|P4|Extension Phase|Lost to Follow-up|0
144540|NCT00424346|473960|P3|Extension Phase|Lost to Follow-up|0
144541|NCT00424346|473961|P2|Extension Phase|Lost to Follow-up|2
144542|NCT00424346|473962|P1|Extension Phase|Lost to Follow-up|0
144543|NCT00424346|473959|P4|Extension Phase|Withdrawal by Subject|4
144544|NCT00424346|473960|P3|Extension Phase|Withdrawal by Subject|3
144545|NCT00424346|473961|P2|Extension Phase|Withdrawal by Subject|5
144546|NCT00424346|473962|P1|Extension Phase|Withdrawal by Subject|0
144547|NCT00424346|473959|P4|Extension Phase|Lack of Efficacy|11
144548|NCT00424346|473960|P3|Extension Phase|Lack of Efficacy|14
144549|NCT00424346|473961|P2|Extension Phase|Lack of Efficacy|16
144550|NCT00424346|473962|P1|Extension Phase|Lack of Efficacy|0
144551|NCT00424346|473959|P4|Extension Phase|Adverse Event|4
144552|NCT00424346|473960|P3|Extension Phase|Adverse Event|5
144553|NCT00424346|473961|P2|Extension Phase|Adverse Event|9
144554|NCT00424346|473962|P1|Extension Phase|Adverse Event|0
144555|NCT00424346|473959|P4|Core Study|Protocol Violation|0
144556|NCT00424346|473960|P3|Core Study|Protocol Violation|2
144557|NCT00424346|473961|P2|Core Study|Protocol Violation|0
144558|NCT00424346|473962|P1|Core Study|Protocol Violation|0
144559|NCT00424346|473959|P4|Core Study|Administrative Problems|0
144560|NCT00424346|473960|P3|Core Study|Administrative Problems|1
144561|NCT00424346|473961|P2|Core Study|Administrative Problems|0
144562|NCT00424346|473962|P1|Core Study|Administrative Problems|1
144563|NCT00424346|473959|P4|Core Study|Lost to Follow-up|0
144564|NCT00424346|473960|P3|Core Study|Lost to Follow-up|0
144565|NCT00424346|473961|P2|Core Study|Lost to Follow-up|1
144566|NCT00424346|473962|P1|Core Study|Lost to Follow-up|1
144567|NCT00424346|473959|P4|Core Study|Withdrawal by Subject|2
144568|NCT00424346|473960|P3|Core Study|Withdrawal by Subject|0
144569|NCT00424346|473961|P2|Core Study|Withdrawal by Subject|0
144570|NCT00424346|473962|P1|Core Study|Withdrawal by Subject|1
144571|NCT00424346|473959|P4|Core Study|Lack of Efficacy|4
144572|NCT00424346|473960|P3|Core Study|Lack of Efficacy|0
144573|NCT00424346|473961|P2|Core Study|Lack of Efficacy|3
144574|NCT00424346|473962|P1|Core Study|Lack of Efficacy|1
144575|NCT00424346|473959|P4|Core Study|Abnormal Laboratory Values|0
144576|NCT00424346|473960|P3|Core Study|Abnormal Laboratory Values|0
144577|NCT00424346|473961|P2|Core Study|Abnormal Laboratory Values|1
144578|NCT00424346|473962|P1|Core Study|Abnormal Laboratory Values|0
144579|NCT00424346|473959|P4|Core Study|Adverse Event|1
144580|NCT00424346|473960|P3|Core Study|Adverse Event|1
144581|NCT00424346|473961|P2|Core Study|Adverse Event|3
144582|NCT00424346|473962|P1|Core Study|Adverse Event|5
144583|NCT00424294|474077|P2|Overall Study|Randomized but not Treated|0
144584|NCT00424294|474078|P1|Overall Study|Randomized but not Treated|1
144585|NCT00424294|474077|P2|Overall Study|Unspecified|2
144586|NCT00424294|474078|P1|Overall Study|Unspecified|0
144587|NCT00424294|474077|P2|Overall Study|Withdrawal by Subject|2
144588|NCT00424294|474078|P1|Overall Study|Withdrawal by Subject|1
144589|NCT00424294|474077|P2|Overall Study|Lack of Efficacy|1
144590|NCT00424294|474078|P1|Overall Study|Lack of Efficacy|2
144591|NCT00424294|474077|P2|Overall Study|Adverse Event|10
144592|NCT00424294|474078|P1|Overall Study|Adverse Event|4
144593|NCT00424255|474145|P2|Overall Study|Sponsor Terminated Study|167
144594|NCT00424255|474146|P1|Overall Study|Sponsor Terminated Study|161
144595|NCT00424255|474145|P2|Overall Study|Disease Progression|2
144596|NCT00424255|474146|P1|Overall Study|Disease Progression|0
144597|NCT00424255|474145|P2|Overall Study|Fatigue|0
144598|NCT00424255|474146|P1|Overall Study|Fatigue|1
144599|NCT00424255|474145|P2|Overall Study|Non-compliance by Participants|0
144600|NCT00424255|474146|P1|Overall Study|Non-compliance by Participants|1
144601|NCT00424255|474145|P2|Overall Study|Cognitive Disturbance|0
144602|NCT00424255|474146|P1|Overall Study|Cognitive Disturbance|1
144603|NCT00424255|474145|P2|Overall Study|Physician Decision|7
144604|NCT00424255|474146|P1|Overall Study|Physician Decision|3
144605|NCT00424255|474145|P2|Overall Study|Withdrawal by Subject|38
144606|NCT00424255|474146|P1|Overall Study|Withdrawal by Subject|34
144607|NCT00424255|474145|P2|Overall Study|Protocol Violation|1
144608|NCT00424255|474146|P1|Overall Study|Protocol Violation|0
144609|NCT00424255|474145|P2|Overall Study|Lost to Follow-up|20
144610|NCT00424255|474146|P1|Overall Study|Lost to Follow-up|26
144611|NCT00424255|474145|P2|Overall Study|Death|111
144612|NCT00424255|474146|P1|Overall Study|Death|115
144613|NCT00424190|474194|P2|Overall Study|Other|21
144614|NCT00424190|474195|P1|Overall Study|Other|15
144615|NCT00424190|474194|P2|Overall Study|Diagnosis of osteomyelitis|1
144616|NCT00424190|474195|P1|Overall Study|Diagnosis of osteomyelitis|0
144617|NCT00424190|474194|P2|Overall Study|Request of sponsor or investigator|2
144618|NCT00424190|474195|P1|Overall Study|Request of sponsor or investigator|0
144619|NCT00424190|474194|P2|Overall Study|Noncompliance|2
144620|NCT00424190|474195|P1|Overall Study|Noncompliance|1
144621|NCT00424190|474194|P2|Overall Study|Death|0
144622|NCT00424190|474195|P1|Overall Study|Death|3
144623|NCT00424190|474194|P2|Overall Study|Withdrew consent|4
144624|NCT00424190|474195|P1|Overall Study|Withdrew consent|3
144625|NCT00424177|474201|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
144626|NCT00424177|474201|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
144627|NCT00424177|474201|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
144628|NCT00424177|474201|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
144629|NCT00424177|474201|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
144630|NCT00424177|474201|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
144631|NCT00424177|474201|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
144632|NCT00424177|474201|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
144633|NCT00424177|474201|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
144634|NCT00424177|474201|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
144635|NCT00424047|474230|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
144636|NCT00424047|474231|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
144637|NCT00424047|474230|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
144638|NCT00424047|474231|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
144639|NCT00424047|474230|P2|Long Term Extension (Up to 25 Jun 2013)|Unspecified|4
144640|NCT00424047|474231|P1|Long Term Extension (Up to 25 Jun 2013)|Unspecified|12
144641|NCT00424047|474230|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
144642|NCT00424047|474231|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
144643|NCT00424047|474230|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
144644|NCT00424047|474231|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
144645|NCT00424047|474230|P2|On Study at Time of Unblinding|Unspecified|4
144646|NCT00424047|474231|P1|On Study at Time of Unblinding|Unspecified|5
144647|NCT00424047|474230|P2|On Study at Time of Unblinding|Death|11
144648|NCT00424047|474231|P1|On Study at Time of Unblinding|Death|11
144649|NCT00424047|474230|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
144650|NCT00424047|474231|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
144651|NCT00424047|474230|P2|On Study at Time of Unblinding|Lack of Efficacy|3
144652|NCT00424047|474231|P1|On Study at Time of Unblinding|Lack of Efficacy|1
144653|NCT00424047|474230|P2|On Study at Time of Unblinding|Progression of disease|128
144654|NCT00424047|474231|P1|On Study at Time of Unblinding|Progression of disease|92
144655|NCT00424047|474230|P2|On Study at Time of Unblinding|Adverse Event|12
144656|NCT00424047|474231|P1|On Study at Time of Unblinding|Adverse Event|22
144657|NCT00424047|474230|P2|Blinded Treatment (Up to 03 Aug 2005)|Unspecified|1
144658|NCT00424047|474231|P1|Blinded Treatment (Up to 03 Aug 2005)|Unspecified|2
144659|NCT00424047|474230|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
144660|NCT00424047|474231|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
144661|NCT00424047|474230|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
144662|NCT00424047|474231|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
144663|NCT00424047|474230|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
144664|NCT00424047|474231|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
144665|NCT00424047|474230|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
144666|NCT00424047|474231|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
144667|NCT00424047|474230|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
144668|NCT00424047|474231|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
144669|NCT00424021|474263|P4|AMB-220-E Study Period|Physician Decision|1
144670|NCT00424021|474264|P3|AMB-220-E Study Period|Physician Decision|0
144671|NCT00424021|474265|P2|AMB-220-E Study Period|Physician Decision|0
144672|NCT00424021|474266|P1|AMB-220-E Study Period|Physician Decision|0
144673|NCT00424021|474263|P4|AMB-220-E Study Period|Lost to Follow-up|1
144674|NCT00424021|474264|P3|AMB-220-E Study Period|Lost to Follow-up|1
144675|NCT00424021|474265|P2|AMB-220-E Study Period|Lost to Follow-up|1
144676|NCT00424021|474266|P1|AMB-220-E Study Period|Lost to Follow-up|0
144677|NCT00424021|474263|P4|AMB-220-E Study Period|Death|1
144678|NCT00424021|474264|P3|AMB-220-E Study Period|Death|1
144679|NCT00424021|474265|P2|AMB-220-E Study Period|Death|0
144680|NCT00424021|474266|P1|AMB-220-E Study Period|Death|0
144681|NCT00424021|474263|P4|AMB-220-E Study Period|Adverse Event|7
144682|NCT00424021|474264|P3|AMB-220-E Study Period|Adverse Event|3
144683|NCT00424021|474265|P2|AMB-220-E Study Period|Adverse Event|1
144684|NCT00424021|474266|P1|AMB-220-E Study Period|Adverse Event|1
144685|NCT00424021|474263|P4|NCT00046319 Study Period|Lost to Follow-up|0
144686|NCT00424021|474264|P3|NCT00046319 Study Period|Lost to Follow-up|0
144687|NCT00424021|474265|P2|NCT00046319 Study Period|Lost to Follow-up|1
144688|NCT00424021|474266|P1|NCT00046319 Study Period|Lost to Follow-up|0
144689|NCT00424021|474263|P4|NCT00046319 Study Period|Sponsor discretion|0
144690|NCT00424021|474264|P3|NCT00046319 Study Period|Sponsor discretion|0
144691|NCT00424021|474265|P2|NCT00046319 Study Period|Sponsor discretion|1
144692|NCT00424021|474266|P1|NCT00046319 Study Period|Sponsor discretion|0
144693|NCT00424021|474263|P4|NCT00046319 Study Period|Withdrawal by Subject|0
144694|NCT00424021|474264|P3|NCT00046319 Study Period|Withdrawal by Subject|0
144695|NCT00424021|474265|P2|NCT00046319 Study Period|Withdrawal by Subject|1
144696|NCT00424021|474266|P1|NCT00046319 Study Period|Withdrawal by Subject|0
144697|NCT00424021|474263|P4|NCT00046319 Study Period|Adverse Event|1
144698|NCT00424021|474264|P3|NCT00046319 Study Period|Adverse Event|1
144699|NCT00424021|474265|P2|NCT00046319 Study Period|Adverse Event|0
144700|NCT00424021|474266|P1|NCT00046319 Study Period|Adverse Event|1
144701|NCT00424008|474309|P2|Overall Study|Administrative|257
144702|NCT00424008|474310|P1|Overall Study|Administrative|266
144703|NCT00424008|474309|P2|Overall Study|Did not meet protocol eligibility|21
144704|NCT00424008|474310|P1|Overall Study|Did not meet protocol eligibility|16
144705|NCT00424008|474309|P2|Overall Study|Noncompliance with protocol|7
144706|NCT00424008|474310|P1|Overall Study|Noncompliance with protocol|13
144707|NCT00424008|474309|P2|Overall Study|Withdrawal by Subject|8
144708|NCT00424008|474310|P1|Overall Study|Withdrawal by Subject|5
144709|NCT00424008|474309|P2|Overall Study|Lost to Follow-up|2
144710|NCT00424008|474310|P1|Overall Study|Lost to Follow-up|1
144711|NCT00424008|474309|P2|Overall Study|Lack of Efficacy|34
144712|NCT00424008|474310|P1|Overall Study|Lack of Efficacy|40
144713|NCT00424008|474309|P2|Overall Study|Adverse Event|6
144714|NCT00424008|474310|P1|Overall Study|Adverse Event|8
144715|NCT00423891|474326|P3|Post-Dosing Follow Up|Continuing Post Dosing Follow up|1
144716|NCT00423891|474327|P2|Post-Dosing Follow Up|Continuing Post Dosing Follow up|15
144717|NCT00423891|474328|P1|Post-Dosing Follow Up|Continuing Post Dosing Follow up|0
144718|NCT00423891|474326|P3|Post-Dosing Follow Up|Lost to Follow-up|0
144719|NCT00423891|474327|P2|Post-Dosing Follow Up|Lost to Follow-up|0
144720|NCT00423891|474328|P1|Post-Dosing Follow Up|Lost to Follow-up|2
144721|NCT00423891|474326|P3|Post-Dosing Follow Up|Withdrawal by Subject|0
144722|NCT00423891|474327|P2|Post-Dosing Follow Up|Withdrawal by Subject|2
144723|NCT00423891|474328|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
144724|NCT00423891|474326|P3|Treatment|continuing treatment|4
144725|NCT00423891|474327|P2|Treatment|continuing treatment|0
144726|NCT00423891|474328|P1|Treatment|continuing treatment|0
144727|NCT00423891|474326|P3|Treatment|Lost to Follow-up|0
144728|NCT00423891|474327|P2|Treatment|Lost to Follow-up|0
144729|NCT00423891|474328|P1|Treatment|Lost to Follow-up|1
144730|NCT00423891|474326|P3|Treatment|Withdrawal by Subject|0
144731|NCT00423891|474327|P2|Treatment|Withdrawal by Subject|0
144732|NCT00423891|474328|P1|Treatment|Withdrawal by Subject|1
144733|NCT00423891|474326|P3|Enrolled|No longer met criteria|1
144734|NCT00423891|474327|P2|Enrolled|No longer met criteria|2
144735|NCT00423891|474328|P1|Enrolled|No longer met criteria|11
144736|NCT00423891|474326|P3|Enrolled|Lost to Follow-up|1
144737|NCT00423891|474327|P2|Enrolled|Lost to Follow-up|0
144738|NCT00423891|474328|P1|Enrolled|Lost to Follow-up|0
144739|NCT00423891|474326|P3|Enrolled|Withdrawal by Subject|1
144740|NCT00423891|474327|P2|Enrolled|Withdrawal by Subject|0
144741|NCT00423891|474328|P1|Enrolled|Withdrawal by Subject|0
144742|NCT00423852|474406|P1|Overall Study|Removed pior to the high-dose portion|3
144743|NCT00423813|474414|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
144744|NCT00423813|474415|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
144745|NCT00423813|474416|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
144746|NCT00423813|474414|P3|Overall Study|Will start exclusionary medications|0
144747|NCT00423813|474415|P2|Overall Study|Will start exclusionary medications|1
144748|NCT00423813|474416|P1|Overall Study|Will start exclusionary medications|0
144749|NCT00423813|474414|P3|Overall Study|Subject started night shift work|0
144750|NCT00423813|474415|P2|Overall Study|Subject started night shift work|0
144751|NCT00423813|474416|P1|Overall Study|Subject started night shift work|1
144752|NCT00423813|474414|P3|Overall Study|Pregnancy|1
144753|NCT00423813|474415|P2|Overall Study|Pregnancy|0
144754|NCT00423813|474416|P1|Overall Study|Pregnancy|0
144755|NCT00423813|474414|P3|Overall Study|Protocol Violation|4
144756|NCT00423813|474415|P2|Overall Study|Protocol Violation|4
144757|NCT00423813|474416|P1|Overall Study|Protocol Violation|9
144758|NCT00423813|474414|P3|Overall Study|Sponsor Decision|0
144759|NCT00423813|474415|P2|Overall Study|Sponsor Decision|1
144760|NCT00423813|474416|P1|Overall Study|Sponsor Decision|0
144761|NCT00423813|474414|P3|Overall Study|Physician Decision|0
144762|NCT00423813|474415|P2|Overall Study|Physician Decision|0
144763|NCT00423813|474416|P1|Overall Study|Physician Decision|2
144764|NCT00423813|474414|P3|Overall Study|Lack of Efficacy|19
144765|NCT00423813|474415|P2|Overall Study|Lack of Efficacy|18
144766|NCT00423813|474416|P1|Overall Study|Lack of Efficacy|23
144767|NCT00423813|474414|P3|Overall Study|Lost to Follow-up|4
144768|NCT00423813|474415|P2|Overall Study|Lost to Follow-up|4
144769|NCT00423813|474416|P1|Overall Study|Lost to Follow-up|5
144770|NCT00423813|474414|P3|Overall Study|Withdrawal by Subject|5
144771|NCT00423813|474415|P2|Overall Study|Withdrawal by Subject|8
144772|NCT00423813|474416|P1|Overall Study|Withdrawal by Subject|6
144773|NCT00423813|474414|P3|Overall Study|Adverse Event|40
144774|NCT00423813|474415|P2|Overall Study|Adverse Event|30
144775|NCT00423813|474416|P1|Overall Study|Adverse Event|11
144776|NCT00423800|474426|P2|Overall Study|Protocol Violation|1
144777|NCT00423800|474427|P1|Overall Study|Protocol Violation|0
144778|NCT00423735|474439|P3|Overall Study|Ineligible / No protocol treatment|0
144779|NCT00423735|474440|P2|Overall Study|Ineligible / No protocol treatment|6
144780|NCT00423735|474441|P1|Overall Study|Ineligible / No protocol treatment|8
144781|NCT00423722|474452|P2|Overall Study|Withdrawal by Subject|2
144782|NCT00423722|474453|P1|Overall Study|Withdrawal by Subject|4
144783|NCT00423722|474452|P2|Overall Study|Unable to complete questionnaires|4
144784|NCT00423722|474453|P1|Overall Study|Unable to complete questionnaires|4
144785|NCT00423722|474452|P2|Overall Study|Declined to participate|3
144786|NCT00423722|474453|P1|Overall Study|Declined to participate|2
144787|NCT00423722|474452|P2|Overall Study|Death|4
144788|NCT00423722|474453|P1|Overall Study|Death|4
144789|NCT00423670|474495|P8|Follow-up Period|Non-compliance with protocol|2
144790|NCT00423670|474496|P7|Follow-up Period|Non-compliance with protocol|3
144791|NCT00423670|474497|P6|Follow-up Period|Non-compliance with protocol|0
144792|NCT00423670|474498|P5|Follow-up Period|Non-compliance with protocol|0
144793|NCT00423670|474499|P4|Follow-up Period|Non-compliance with protocol|1
144794|NCT00423670|474500|P3|Follow-up Period|Non-compliance with protocol|1
144795|NCT00423670|474501|P2|Follow-up Period|Non-compliance with protocol|0
144796|NCT00423670|474502|P1|Follow-up Period|Non-compliance with protocol|2
144797|NCT00423670|474495|P8|Follow-up Period|Subject withdrew (not treatment related)|1
144798|NCT00423670|474496|P7|Follow-up Period|Subject withdrew (not treatment related)|1
144799|NCT00423670|474497|P6|Follow-up Period|Subject withdrew (not treatment related)|0
144800|NCT00423670|474498|P5|Follow-up Period|Subject withdrew (not treatment related)|1
144801|NCT00423670|474499|P4|Follow-up Period|Subject withdrew (not treatment related)|1
144802|NCT00423670|474500|P3|Follow-up Period|Subject withdrew (not treatment related)|2
144803|NCT00423670|474501|P2|Follow-up Period|Subject withdrew (not treatment related)|4
144804|NCT00423670|474502|P1|Follow-up Period|Subject withdrew (not treatment related)|1
144805|NCT00423670|474495|P8|Follow-up Period|Lost to Follow-up|0
144806|NCT00423670|474496|P7|Follow-up Period|Lost to Follow-up|5
144807|NCT00423670|474497|P6|Follow-up Period|Lost to Follow-up|0
144808|NCT00423670|474498|P5|Follow-up Period|Lost to Follow-up|1
144809|NCT00423670|474499|P4|Follow-up Period|Lost to Follow-up|3
144810|NCT00423670|474500|P3|Follow-up Period|Lost to Follow-up|8
144811|NCT00423670|474501|P2|Follow-up Period|Lost to Follow-up|12
144812|NCT00423670|474502|P1|Follow-up Period|Lost to Follow-up|0
144813|NCT00423670|474495|P8|Treatment Period|Non-compliance with protocol|2
144814|NCT00423670|474496|P7|Treatment Period|Non-compliance with protocol|2
144815|NCT00423670|474497|P6|Treatment Period|Non-compliance with protocol|0
144816|NCT00423670|474498|P5|Treatment Period|Non-compliance with protocol|2
144817|NCT00423670|474499|P4|Treatment Period|Non-compliance with protocol|3
144818|NCT00423670|474500|P3|Treatment Period|Non-compliance with protocol|1
144819|NCT00423670|474501|P2|Treatment Period|Non-compliance with protocol|1
144820|NCT00423670|474502|P1|Treatment Period|Non-compliance with protocol|3
144821|NCT00423670|474495|P8|Treatment Period|Investigator decision|1
144822|NCT00423670|474496|P7|Treatment Period|Investigator decision|0
144823|NCT00423670|474497|P6|Treatment Period|Investigator decision|0
144824|NCT00423670|474498|P5|Treatment Period|Investigator decision|0
144825|NCT00423670|474499|P4|Treatment Period|Investigator decision|0
144826|NCT00423670|474500|P3|Treatment Period|Investigator decision|0
144827|NCT00423670|474501|P2|Treatment Period|Investigator decision|0
144828|NCT00423670|474502|P1|Treatment Period|Investigator decision|0
144829|NCT00423670|474495|P8|Treatment Period|Subject withdrew (not treatment related)|0
144830|NCT00423670|474496|P7|Treatment Period|Subject withdrew (not treatment related)|3
144831|NCT00423670|474497|P6|Treatment Period|Subject withdrew (not treatment related)|0
144832|NCT00423670|474498|P5|Treatment Period|Subject withdrew (not treatment related)|5
144833|NCT00423670|474499|P4|Treatment Period|Subject withdrew (not treatment related)|4
144834|NCT00423670|474500|P3|Treatment Period|Subject withdrew (not treatment related)|4
144835|NCT00423670|474501|P2|Treatment Period|Subject withdrew (not treatment related)|9
144836|NCT00423670|474502|P1|Treatment Period|Subject withdrew (not treatment related)|3
144837|NCT00423670|474495|P8|Treatment Period|Lost to Follow-up|1
144838|NCT00423670|474496|P7|Treatment Period|Lost to Follow-up|3
144839|NCT00423670|474497|P6|Treatment Period|Lost to Follow-up|0
144840|NCT00423670|474498|P5|Treatment Period|Lost to Follow-up|6
144841|NCT00423670|474499|P4|Treatment Period|Lost to Follow-up|1
144842|NCT00423670|474500|P3|Treatment Period|Lost to Follow-up|3
144843|NCT00423670|474501|P2|Treatment Period|Lost to Follow-up|1
144844|NCT00423670|474502|P1|Treatment Period|Lost to Follow-up|2
144845|NCT00423670|474495|P8|Treatment Period|Protocol-defined clinical event|15
144846|NCT00423670|474496|P7|Treatment Period|Protocol-defined clinical event|16
144847|NCT00423670|474497|P6|Treatment Period|Protocol-defined clinical event|4
144848|NCT00423670|474498|P5|Treatment Period|Protocol-defined clinical event|5
144849|NCT00423670|474499|P4|Treatment Period|Protocol-defined clinical event|12
144850|NCT00423670|474500|P3|Treatment Period|Protocol-defined clinical event|4
144851|NCT00423670|474501|P2|Treatment Period|Protocol-defined clinical event|7
144852|NCT00423670|474502|P1|Treatment Period|Protocol-defined clinical event|0
144853|NCT00423670|474495|P8|Treatment Period|Adverse Event|2
144854|NCT00423670|474496|P7|Treatment Period|Adverse Event|7
144855|NCT00423670|474497|P6|Treatment Period|Adverse Event|4
144856|NCT00423670|474498|P5|Treatment Period|Adverse Event|9
144857|NCT00423670|474499|P4|Treatment Period|Adverse Event|20
144858|NCT00423670|474500|P3|Treatment Period|Adverse Event|15
144859|NCT00423670|474501|P2|Treatment Period|Adverse Event|12
144860|NCT00423670|474502|P1|Treatment Period|Adverse Event|8
144861|NCT00423670|474495|P8|Treatment Period|Switched to Arm 8 at TW 24|0
144862|NCT00423670|474496|P7|Treatment Period|Switched to Arm 8 at TW 24|0
144863|NCT00423670|474497|P6|Treatment Period|Switched to Arm 8 at TW 24|0
144864|NCT00423670|474498|P5|Treatment Period|Switched to Arm 8 at TW 24|0
144865|NCT00423670|474499|P4|Treatment Period|Switched to Arm 8 at TW 24|0
144866|NCT00423670|474500|P3|Treatment Period|Switched to Arm 8 at TW 24|0
144867|NCT00423670|474501|P2|Treatment Period|Switched to Arm 8 at TW 24|0
144868|NCT00423670|474502|P1|Treatment Period|Switched to Arm 8 at TW 24|36
144869|NCT00423657|474560|P2|Overall Study|Request of sponsor/investigator|0
144870|NCT00423657|474561|P1|Overall Study|Request of sponsor/investigator|1
144871|NCT00423657|474560|P2|Overall Study|Other|16
144872|NCT00423657|474561|P1|Overall Study|Other|15
144873|NCT00423657|474560|P2|Overall Study|Non-compliance|1
144874|NCT00423657|474561|P1|Overall Study|Non-compliance|0
144875|NCT00423657|474560|P2|Overall Study|Withdrew consent|8
144876|NCT00423657|474561|P1|Overall Study|Withdrew consent|10
144877|NCT00423605|474567|P1|Overall Study|Not one of the pre-specified options|5
144878|NCT00423605|474567|P1|Overall Study|Protocol Violation|7
144879|NCT00423605|474567|P1|Overall Study|Physician Decision|8
144880|NCT00423605|474567|P1|Overall Study|Sponsor Decision|3
144881|NCT00423605|474567|P1|Overall Study|Lack of Efficacy|38
144882|NCT00423605|474567|P1|Overall Study|Lost to Follow-up|15
144883|NCT00423605|474567|P1|Overall Study|Withdrawal by Subject|36
144884|NCT00423605|474567|P1|Overall Study|Adverse Event|129
144885|NCT00423592|474571|P1|Overall Study|Adverse Event (post Week 12)|5
144886|NCT00423592|474571|P1|Overall Study|Adverse Event (through Week 12)|2
144887|NCT00423579|474592|P2|Overall Study|Diagnosis of diabetes|1
144888|NCT00423579|474593|P1|Overall Study|Diagnosis of diabetes|0
144889|NCT00423579|474592|P2|Overall Study|Protocol Violation|3
144890|NCT00423579|474593|P1|Overall Study|Protocol Violation|1
144891|NCT00423579|474592|P2|Overall Study|Lost to Follow-up|0
144892|NCT00423579|474593|P1|Overall Study|Lost to Follow-up|3
144893|NCT00423488|474601|P2|Overall Study|No post baseline data|0
144894|NCT00423488|474602|P1|Overall Study|No post baseline data|3
144895|NCT00423488|474601|P2|Overall Study|No evidence of study drug intake|1
144896|NCT00423488|474602|P1|Overall Study|No evidence of study drug intake|2
144897|NCT00423449|474608|P5|Overall Study|Protocol Violation|0
144898|NCT00423449|474609|P4|Overall Study|Protocol Violation|1
144899|NCT00423449|474610|P3|Overall Study|Protocol Violation|2
144900|NCT00423449|474611|P2|Overall Study|Protocol Violation|0
144901|NCT00423449|474612|P1|Overall Study|Protocol Violation|0
144902|NCT00423449|474608|P5|Overall Study|Not Specified|0
144903|NCT00423449|474609|P4|Overall Study|Not Specified|1
144904|NCT00423449|474610|P3|Overall Study|Not Specified|0
144905|NCT00423449|474611|P2|Overall Study|Not Specified|0
144906|NCT00423449|474612|P1|Overall Study|Not Specified|0
144907|NCT00423449|474608|P5|Overall Study|Laboratory Adverse Event|0
144908|NCT00423449|474609|P4|Overall Study|Laboratory Adverse Event|0
144909|NCT00423449|474610|P3|Overall Study|Laboratory Adverse Event|2
144910|NCT00423449|474611|P2|Overall Study|Laboratory Adverse Event|1
144911|NCT00423449|474612|P1|Overall Study|Laboratory Adverse Event|0
144912|NCT00423449|474608|P5|Overall Study|Progressive Disease|4
144913|NCT00423449|474609|P4|Overall Study|Progressive Disease|11
144914|NCT00423449|474610|P3|Overall Study|Progressive Disease|8
144915|NCT00423449|474611|P2|Overall Study|Progressive Disease|3
144916|NCT00423449|474612|P1|Overall Study|Progressive Disease|1
144917|NCT00423449|474608|P5|Overall Study|Death|1
144918|NCT00423449|474609|P4|Overall Study|Death|1
144919|NCT00423449|474610|P3|Overall Study|Death|2
144920|NCT00423449|474611|P2|Overall Study|Death|0
144921|NCT00423449|474612|P1|Overall Study|Death|1
144922|NCT00423449|474608|P5|Overall Study|Clinical Adverse Event|2
144923|NCT00423449|474609|P4|Overall Study|Clinical Adverse Event|8
144924|NCT00423449|474610|P3|Overall Study|Clinical Adverse Event|1
144925|NCT00423449|474611|P2|Overall Study|Clinical Adverse Event|0
144926|NCT00423449|474612|P1|Overall Study|Clinical Adverse Event|1
144927|NCT00423332|474659|P2|Overall Study|Unblinded before 12 weeks|3
144928|NCT00423332|474660|P1|Overall Study|Unblinded before 12 weeks|1
144929|NCT00423332|474659|P2|Overall Study|Progressive at Week 6|1
144930|NCT00423332|474660|P1|Overall Study|Progressive at Week 6|0
144931|NCT00423332|474659|P2|Overall Study|Condition under investigation worsened|1
144932|NCT00423332|474660|P1|Overall Study|Condition under investigation worsened|1
144933|NCT00423332|474659|P2|Overall Study|Withdrawal by Subject|0
144934|NCT00423332|474660|P1|Overall Study|Withdrawal by Subject|1
144935|NCT00423332|474659|P2|Overall Study|Adverse Event|2
144936|NCT00423332|474660|P1|Overall Study|Adverse Event|6
144937|NCT00423319|474679|P2|Overall Study|Not specified|22
144938|NCT00423319|474680|P1|Overall Study|Not specified|23
144939|NCT00423319|474679|P2|Overall Study|No longer meets study criteria|15
144940|NCT00423319|474680|P1|Overall Study|No longer meets study criteria|15
144941|NCT00423319|474679|P2|Overall Study|Poor compliance or noncompliance|1
144942|NCT00423319|474680|P1|Overall Study|Poor compliance or noncompliance|1
144943|NCT00423319|474679|P2|Overall Study|Lost to Follow-up|3
144944|NCT00423319|474680|P1|Overall Study|Lost to Follow-up|4
144945|NCT00423319|474679|P2|Overall Study|Withdrawal by Subject|99
144946|NCT00423319|474680|P1|Overall Study|Withdrawal by Subject|86
144947|NCT00423319|474679|P2|Overall Study|Adverse Event|112
144948|NCT00423319|474680|P1|Overall Study|Adverse Event|93
144949|NCT00423319|474679|P2|Overall Study|Death|0
144950|NCT00423319|474680|P1|Overall Study|Death|2
144951|NCT00423293|474712|P1|Overall Study|Ineligible / No protocol treatment|11
144952|NCT00423267|474718|P2|Period A|Administrative|0
144953|NCT00423267|474719|P1|Period A|Administrative|1
144954|NCT00423267|474718|P2|Period A|Non-compliance with protocol|0
144955|NCT00423267|474719|P1|Period A|Non-compliance with protocol|1
144956|NCT00423267|474718|P2|Period A|Withdrawal by Subject|1
144957|NCT00423267|474719|P1|Period A|Withdrawal by Subject|0
144958|NCT00423189|474739|P3|Overall Study|Death|0
144959|NCT00423189|474740|P2|Overall Study|Death|1
144960|NCT00423189|474741|P1|Overall Study|Death|0
144961|NCT00423176|474763|P2|Overall Study|Did not meet protocol eligibility|4
144962|NCT00423176|474764|P1|Overall Study|Did not meet protocol eligibility|2
144963|NCT00423176|474763|P2|Overall Study|Protocol Violation|3
144964|NCT00423176|474764|P1|Overall Study|Protocol Violation|1
144965|NCT00423176|474763|P2|Overall Study|Withdrawal by Subject|3
144966|NCT00423176|474764|P1|Overall Study|Withdrawal by Subject|4
144967|NCT00423176|474763|P2|Overall Study|Lost to Follow-up|7
144968|NCT00423176|474764|P1|Overall Study|Lost to Follow-up|4
144969|NCT00423176|474763|P2|Overall Study|Treatment Failure|6
144970|NCT00423176|474764|P1|Overall Study|Treatment Failure|1
144971|NCT00423176|474763|P2|Overall Study|Adverse Event|6
144972|NCT00423176|474764|P1|Overall Study|Adverse Event|4
144973|NCT00423150|474772|P1|Overall Study|Administrative|4
144974|NCT00423150|474772|P1|Overall Study|Non-compliance with protocol|1
144975|NCT00423150|474772|P1|Overall Study|Withdrawal by Subject|1
144976|NCT00423150|474772|P1|Overall Study|Progression of disease being studied|69
144977|NCT00423150|474772|P1|Overall Study|Adverse Event|11
144978|NCT00423098|474778|P2|Overall Study|Death|0
144979|NCT00423098|474779|P1|Overall Study|Death|2
144980|NCT00423098|474778|P2|Overall Study|Administrative problems|1
144981|NCT00423098|474779|P1|Overall Study|Administrative problems|0
144982|NCT00423098|474778|P2|Overall Study|Unsatisfactory therapeutic effect|1
144983|NCT00423098|474779|P1|Overall Study|Unsatisfactory therapeutic effect|0
144984|NCT00423098|474778|P2|Overall Study|Adverse Event|2
144985|NCT00423098|474779|P1|Overall Study|Adverse Event|1
144986|NCT00423085|474806|P4|52-Week Open-Label Extension Phase|Death|2
144987|NCT00423085|474807|P3|52-Week Open-Label Extension Phase|Death|0
144988|NCT00423085|474808|P2|52-Week Open-Label Extension Phase|Death|0
144989|NCT00423085|474809|P1|52-Week Open-Label Extension Phase|Death|0
144990|NCT00423085|474806|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
144991|NCT00423085|474807|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
144992|NCT00423085|474808|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
144993|NCT00423085|474809|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
144994|NCT00423085|474806|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
144995|NCT00423085|474807|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
144996|NCT00423085|474808|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
144997|NCT00423085|474809|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
144998|NCT00423085|474806|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
144999|NCT00423085|474807|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
145000|NCT00423085|474808|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
145001|NCT00423085|474809|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
145002|NCT00423085|474806|P4|52-Week Open-Label Extension Phase|Adverse Event|97
145003|NCT00423085|474807|P3|52-Week Open-Label Extension Phase|Adverse Event|0
145004|NCT00423085|474808|P2|52-Week Open-Label Extension Phase|Adverse Event|0
145005|NCT00423085|474809|P1|52-Week Open-Label Extension Phase|Adverse Event|0
145006|NCT00423085|474806|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
145007|NCT00423085|474807|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
145008|NCT00423085|474808|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
145009|NCT00423085|474809|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
145010|NCT00423085|474806|P4|24-Week Double-Blind Treatment Phase|Death|0
145011|NCT00423085|474807|P3|24-Week Double-Blind Treatment Phase|Death|0
145012|NCT00423085|474808|P2|24-Week Double-Blind Treatment Phase|Death|1
145013|NCT00423085|474809|P1|24-Week Double-Blind Treatment Phase|Death|1
145014|NCT00423085|474806|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
145015|NCT00423085|474807|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
145016|NCT00423085|474808|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
145017|NCT00423085|474809|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
145018|NCT00423085|474806|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
145019|NCT00423085|474807|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
145020|NCT00423085|474808|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
145021|NCT00423085|474809|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
145022|NCT00423085|474806|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
145023|NCT00423085|474807|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
145024|NCT00423085|474808|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
145025|NCT00423085|474809|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
145026|NCT00423085|474806|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
145027|NCT00423085|474807|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
145028|NCT00423085|474808|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
145029|NCT00423085|474809|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
145030|NCT00423046|474838|P2|Overall Study|Unspecified|345
145031|NCT00423046|474839|P1|Overall Study|Unspecified|340
145032|NCT00422942|474905|P1|Overall Study|Study terminated by Sponsor|3
145033|NCT00422903|474924|P2|Overall Study|Informed Consent Withdrawn|2
145034|NCT00422903|474925|P1|Overall Study|Informed Consent Withdrawn|1
145035|NCT00422903|474924|P2|Overall Study|Adverse Event|2
145036|NCT00422903|474925|P1|Overall Study|Adverse Event|0
145037|NCT00422903|474924|P2|Overall Study|Disease Progression|1
145038|NCT00422903|474925|P1|Overall Study|Disease Progression|3
145039|NCT00422734|474951|P2|Overall Study|Partner Decision|3
145040|NCT00422734|474952|P1|Overall Study|Partner Decision|0
145041|NCT00422734|474951|P2|Overall Study|Adverse Event|3
145042|NCT00422734|474952|P1|Overall Study|Adverse Event|0
145043|NCT00422734|474951|P2|Overall Study|Withdrawal by Subject|8
145044|NCT00422734|474952|P1|Overall Study|Withdrawal by Subject|12
145045|NCT00422734|474951|P2|Overall Study|Protocol Violation|6
145046|NCT00422734|474952|P1|Overall Study|Protocol Violation|1
145047|NCT00422734|474951|P2|Overall Study|Physician Decision|1
145048|NCT00422734|474952|P1|Overall Study|Physician Decision|1
145049|NCT00422669|474987|P3|Overall Study|The study was terminated early.|7
145050|NCT00422669|474988|P2|Overall Study|The study was terminated early.|100
145051|NCT00422669|474989|P1|Overall Study|The study was terminated early.|98
145052|NCT00422513|475016|P2|Overall Study|Death|7
145053|NCT00422513|475017|P1|Overall Study|Death|3
145054|NCT00422513|475016|P2|Overall Study|Adverse Event|4
145055|NCT00422513|475017|P1|Overall Study|Adverse Event|4
145056|NCT00422513|475016|P2|Overall Study|early termination of the study|80
145057|NCT00422513|475017|P1|Overall Study|early termination of the study|67
145058|NCT00422513|475016|P2|Overall Study|Withdrawal by Subject|1
145059|NCT00422513|475017|P1|Overall Study|Withdrawal by Subject|2
145060|NCT00422513|475016|P2|Overall Study|Refused Treatment|2
145061|NCT00422513|475017|P1|Overall Study|Refused Treatment|4
145062|NCT00422513|475016|P2|Overall Study|Protocol Violation|7
145063|NCT00422513|475017|P1|Overall Study|Protocol Violation|23
145064|NCT00422513|475016|P2|Overall Study|Lack of Efficacy|5
145065|NCT00422513|475017|P1|Overall Study|Lack of Efficacy|4
145066|NCT00422422|475034|P1|Overall Study|AE, non-serious non-fatal|5
145067|NCT00422422|475034|P1|Overall Study|SAE, non-fatal|1
145068|NCT00422422|475034|P1|Overall Study|Withdrawal by Subject|2
145069|NCT00422422|475034|P1|Overall Study|Protocol Violation|1
145070|NCT00422422|475034|P1|Overall Study|Lack of Efficacy|1
145071|NCT00422383|475051|P5|Overall Study|Withdrawal by Subject|1
145072|NCT00422383|475052|P4|Overall Study|Withdrawal by Subject|0
145073|NCT00422383|475053|P3|Overall Study|Withdrawal by Subject|0
145074|NCT00422383|475054|P2|Overall Study|Withdrawal by Subject|5
145075|NCT00422383|475055|P1|Overall Study|Withdrawal by Subject|5
145076|NCT00422383|475051|P5|Overall Study|Protocol Violation|0
145077|NCT00422383|475052|P4|Overall Study|Protocol Violation|0
145078|NCT00422383|475053|P3|Overall Study|Protocol Violation|1
145079|NCT00422383|475054|P2|Overall Study|Protocol Violation|1
145080|NCT00422383|475055|P1|Overall Study|Protocol Violation|1
145081|NCT00422383|475051|P5|Overall Study|Lost to Follow-up|1
145082|NCT00422383|475052|P4|Overall Study|Lost to Follow-up|0
145083|NCT00422383|475053|P3|Overall Study|Lost to Follow-up|0
145084|NCT00422383|475054|P2|Overall Study|Lost to Follow-up|1
145085|NCT00422383|475055|P1|Overall Study|Lost to Follow-up|0
145086|NCT00422383|475051|P5|Overall Study|Lack of Efficacy|1
145087|NCT00422383|475052|P4|Overall Study|Lack of Efficacy|1
145088|NCT00422383|475053|P3|Overall Study|Lack of Efficacy|2
145089|NCT00422383|475054|P2|Overall Study|Lack of Efficacy|4
145090|NCT00422383|475055|P1|Overall Study|Lack of Efficacy|4
145091|NCT00422383|475051|P5|Overall Study|Adverse Event|0
145092|NCT00422383|475052|P4|Overall Study|Adverse Event|1
145093|NCT00422383|475053|P3|Overall Study|Adverse Event|1
145094|NCT00422383|475054|P2|Overall Study|Adverse Event|3
145095|NCT00422383|475055|P1|Overall Study|Adverse Event|5
145096|NCT00422292|475198|P4|Overall Study|Withdrawal by Subject|13
145097|NCT00422292|475199|P3|Overall Study|Withdrawal by Subject|7
145098|NCT00422292|475200|P2|Overall Study|Withdrawal by Subject|25
145099|NCT00422292|475201|P1|Overall Study|Withdrawal by Subject|6
145100|NCT00422292|475198|P4|Overall Study|Lost to Follow-up|6
145101|NCT00422292|475199|P3|Overall Study|Lost to Follow-up|6
145102|NCT00422292|475200|P2|Overall Study|Lost to Follow-up|12
145103|NCT00422292|475201|P1|Overall Study|Lost to Follow-up|6
145104|NCT00422292|475198|P4|Overall Study|Protocol Violation|5
145105|NCT00422292|475199|P3|Overall Study|Protocol Violation|8
145106|NCT00422292|475200|P2|Overall Study|Protocol Violation|25
145107|NCT00422292|475201|P1|Overall Study|Protocol Violation|4
145108|NCT00422292|475198|P4|Overall Study|Adverse Event|0
145109|NCT00422292|475199|P3|Overall Study|Adverse Event|1
145110|NCT00422292|475200|P2|Overall Study|Adverse Event|0
145111|NCT00422292|475201|P1|Overall Study|Adverse Event|1
145112|NCT00422292|475198|P4|Overall Study|Serious adverse events|0
145113|NCT00422292|475199|P3|Overall Study|Serious adverse events|0
145114|NCT00422292|475200|P2|Overall Study|Serious adverse events|4
145115|NCT00422292|475201|P1|Overall Study|Serious adverse events|1
145116|NCT00422227|475240|P2|Overall Study|Withdrawal by Subject|4
145117|NCT00422227|475241|P1|Overall Study|Withdrawal by Subject|0
145118|NCT00422227|475240|P2|Overall Study|Lost to Follow-up|3
145119|NCT00422227|475241|P1|Overall Study|Lost to Follow-up|1
145120|NCT00422227|475240|P2|Overall Study|Adverse Event|8
145121|NCT00422227|475241|P1|Overall Study|Adverse Event|3
145122|NCT00422162|475271|P2|Overall Study|Didn't Receive Treatment|1
145123|NCT00422162|475272|P1|Overall Study|Didn't Receive Treatment|0
145124|NCT00422162|475271|P2|Overall Study|Not Specified|1
145125|NCT00422162|475272|P1|Overall Study|Not Specified|0
145126|NCT00422162|475271|P2|Overall Study|Non-Compliant with Protocol|1
145127|NCT00422162|475272|P1|Overall Study|Non-Compliant with Protocol|1
145128|NCT00422162|475271|P2|Overall Study|Lost to Follow-up|2
145129|NCT00422162|475272|P1|Overall Study|Lost to Follow-up|1
145130|NCT00422162|475271|P2|Overall Study|Withdrawal by Subject|6
145131|NCT00422162|475272|P1|Overall Study|Withdrawal by Subject|7
145132|NCT00422162|475271|P2|Overall Study|Lack of Efficacy|10
145133|NCT00422162|475272|P1|Overall Study|Lack of Efficacy|4
145134|NCT00422162|475271|P2|Overall Study|Adverse Event|9
145135|NCT00422162|475272|P1|Overall Study|Adverse Event|11
145136|NCT00422097|475332|P8|Dose Level 2|Still on treatment|0
145137|NCT00422097|475333|P7|Dose Level 2|Still on treatment|0
145138|NCT00422097|475334|P6|Dose Level 2|Still on treatment|0
145139|NCT00422097|475335|P5|Dose Level 2|Still on treatment|0
145140|NCT00422097|475336|P4|Dose Level 2|Still on treatment|0
145141|NCT00422097|475337|P3|Dose Level 2|Still on treatment|0
145142|NCT00422097|475338|P2|Dose Level 2|Still on treatment|1
145143|NCT00422097|475339|P1|Dose Level 2|Still on treatment|0
145144|NCT00422058|475404|P6|Open-Label Extension, Week 20-104|Other|18
145145|NCT00422058|475405|P5|Open-Label Extension, Week 20-104|Other|16
145146|NCT00422058|475406|P4|Open-Label Extension, Week 20-104|Other|13
145147|NCT00422058|475407|P3|Open-Label Extension, Week 20-104|Other|6
145148|NCT00422058|475408|P2|Open-Label Extension, Week 20-104|Other|14
145149|NCT00422058|475409|P1|Open-Label Extension, Week 20-104|Other|13
145150|NCT00422058|475404|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
145151|NCT00422058|475405|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
145152|NCT00422058|475406|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
145153|NCT00422058|475407|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
145154|NCT00422058|475408|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
145155|NCT00422058|475409|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
145156|NCT00422058|475404|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
145157|NCT00422058|475405|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
145158|NCT00422058|475406|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
145159|NCT00422058|475407|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
145160|NCT00422058|475408|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
145161|NCT00422058|475409|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
145162|NCT00422058|475404|P6|Open-Label Extension, Week 20-104|Adverse Event|0
145163|NCT00422058|475405|P5|Open-Label Extension, Week 20-104|Adverse Event|4
145164|NCT00422058|475406|P4|Open-Label Extension, Week 20-104|Adverse Event|4
145165|NCT00422058|475407|P3|Open-Label Extension, Week 20-104|Adverse Event|7
145166|NCT00422058|475408|P2|Open-Label Extension, Week 20-104|Adverse Event|4
145167|NCT00422058|475409|P1|Open-Label Extension, Week 20-104|Adverse Event|3
145168|NCT00422058|475404|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
145169|NCT00422058|475405|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
145170|NCT00422058|475406|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
145171|NCT00422058|475407|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
145172|NCT00422058|475408|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
145173|NCT00422058|475409|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
145174|NCT00422058|475404|P6|Double-Blind, Week 0-20|Other|10
145175|NCT00422058|475405|P5|Double-Blind, Week 0-20|Other|4
145176|NCT00422058|475406|P4|Double-Blind, Week 0-20|Other|8
145177|NCT00422058|475407|P3|Double-Blind, Week 0-20|Other|8
145178|NCT00422058|475408|P2|Double-Blind, Week 0-20|Other|3
145179|NCT00422058|475409|P1|Double-Blind, Week 0-20|Other|11
145180|NCT00422058|475404|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
145181|NCT00422058|475405|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
145182|NCT00422058|475406|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
145183|NCT00422058|475407|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
145184|NCT00422058|475408|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
145185|NCT00422058|475409|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
145186|NCT00422058|475404|P6|Double-Blind, Week 0-20|Protocol Violation|2
145187|NCT00422058|475405|P5|Double-Blind, Week 0-20|Protocol Violation|2
145188|NCT00422058|475406|P4|Double-Blind, Week 0-20|Protocol Violation|3
145189|NCT00422058|475407|P3|Double-Blind, Week 0-20|Protocol Violation|2
145190|NCT00422058|475408|P2|Double-Blind, Week 0-20|Protocol Violation|2
145191|NCT00422058|475409|P1|Double-Blind, Week 0-20|Protocol Violation|3
145192|NCT00422058|475404|P6|Double-Blind, Week 0-20|Adverse Event|3
145193|NCT00422058|475405|P5|Double-Blind, Week 0-20|Adverse Event|5
145194|NCT00422058|475406|P4|Double-Blind, Week 0-20|Adverse Event|9
145195|NCT00422058|475407|P3|Double-Blind, Week 0-20|Adverse Event|5
145196|NCT00422058|475408|P2|Double-Blind, Week 0-20|Adverse Event|4
145197|NCT00422058|475409|P1|Double-Blind, Week 0-20|Adverse Event|3
145198|NCT00421993|475550|P4|Overall Study|Subject transportation issues|1
145199|NCT00421993|475551|P3|Overall Study|Subject transportation issues|0
145200|NCT00421993|475552|P2|Overall Study|Subject transportation issues|0
145201|NCT00421993|475553|P1|Overall Study|Subject transportation issues|0
145202|NCT00421993|475550|P4|Overall Study|Pregnancy|2
145203|NCT00421993|475551|P3|Overall Study|Pregnancy|1
145204|NCT00421993|475552|P2|Overall Study|Pregnancy|1
145205|NCT00421993|475553|P1|Overall Study|Pregnancy|0
145206|NCT00421993|475550|P4|Overall Study|Lack of Efficacy|5
145207|NCT00421993|475551|P3|Overall Study|Lack of Efficacy|0
145208|NCT00421993|475552|P2|Overall Study|Lack of Efficacy|3
145209|NCT00421993|475553|P1|Overall Study|Lack of Efficacy|0
145210|NCT00421993|475550|P4|Overall Study|Protocol Violation|1
145211|NCT00421993|475551|P3|Overall Study|Protocol Violation|0
145212|NCT00421993|475552|P2|Overall Study|Protocol Violation|2
145213|NCT00421993|475553|P1|Overall Study|Protocol Violation|2
145214|NCT00421993|475550|P4|Overall Study|Adverse Event|4
145215|NCT00421993|475551|P3|Overall Study|Adverse Event|6
145216|NCT00421993|475552|P2|Overall Study|Adverse Event|1
145217|NCT00421993|475553|P1|Overall Study|Adverse Event|11
145218|NCT00421993|475550|P4|Overall Study|Lost to Follow-up|20
145219|NCT00421993|475551|P3|Overall Study|Lost to Follow-up|22
145220|NCT00421993|475552|P2|Overall Study|Lost to Follow-up|19
145221|NCT00421993|475553|P1|Overall Study|Lost to Follow-up|18
145222|NCT00421993|475550|P4|Overall Study|Withdrawal by Subject|24
145223|NCT00421993|475551|P3|Overall Study|Withdrawal by Subject|23
145224|NCT00421993|475552|P2|Overall Study|Withdrawal by Subject|23
145225|NCT00421993|475553|P1|Overall Study|Withdrawal by Subject|22
145226|NCT00421928|475590|P3|Overall Study|Death|0
145227|NCT00421928|475591|P2|Overall Study|Death|1
145228|NCT00421928|475592|P1|Overall Study|Death|0
145229|NCT00421928|475590|P3|Overall Study|All other|27
145230|NCT00421928|475591|P2|Overall Study|All other|21
145231|NCT00421928|475592|P1|Overall Study|All other|26
145232|NCT00421928|475590|P3|Overall Study|Study drug non-compliant|4
145233|NCT00421928|475591|P2|Overall Study|Study drug non-compliant|7
145234|NCT00421928|475592|P1|Overall Study|Study drug non-compliant|6
145235|NCT00421928|475590|P3|Overall Study|Lack of Efficacy|35
145236|NCT00421928|475591|P2|Overall Study|Lack of Efficacy|7
145237|NCT00421928|475592|P1|Overall Study|Lack of Efficacy|15
145238|NCT00421928|475590|P3|Overall Study|Withdrawal by Subject|43
145239|NCT00421928|475591|P2|Overall Study|Withdrawal by Subject|48
145240|NCT00421928|475592|P1|Overall Study|Withdrawal by Subject|50
145241|NCT00421928|475590|P3|Overall Study|Lost to Follow-up|3
145242|NCT00421928|475591|P2|Overall Study|Lost to Follow-up|0
145243|NCT00421928|475592|P1|Overall Study|Lost to Follow-up|5
145244|NCT00421928|475590|P3|Overall Study|Adverse Event|22
145245|NCT00421928|475591|P2|Overall Study|Adverse Event|140
145246|NCT00421928|475592|P1|Overall Study|Adverse Event|61
145247|NCT00421889|475627|P9|Overall Study|Lost to Follow-up|1
145248|NCT00421889|475628|P8|Overall Study|Lost to Follow-up|0
145249|NCT00421889|475629|P7|Overall Study|Lost to Follow-up|0
145250|NCT00421889|475630|P6|Overall Study|Lost to Follow-up|0
145251|NCT00421889|475631|P5|Overall Study|Lost to Follow-up|0
145252|NCT00421889|475632|P4|Overall Study|Lost to Follow-up|0
145253|NCT00421889|475633|P3|Overall Study|Lost to Follow-up|0
145254|NCT00421889|475634|P2|Overall Study|Lost to Follow-up|0
145255|NCT00421889|475635|P1|Overall Study|Lost to Follow-up|0
145256|NCT00421889|475627|P9|Overall Study|Patient/Investigator request|3
145257|NCT00421889|475628|P8|Overall Study|Patient/Investigator request|1
145258|NCT00421889|475629|P7|Overall Study|Patient/Investigator request|0
145259|NCT00421889|475630|P6|Overall Study|Patient/Investigator request|9
145260|NCT00421889|475631|P5|Overall Study|Patient/Investigator request|0
145261|NCT00421889|475632|P4|Overall Study|Patient/Investigator request|0
145262|NCT00421889|475633|P3|Overall Study|Patient/Investigator request|0
145263|NCT00421889|475634|P2|Overall Study|Patient/Investigator request|0
145264|NCT00421889|475635|P1|Overall Study|Patient/Investigator request|0
145265|NCT00421889|475627|P9|Overall Study|Progressive disease|5
145266|NCT00421889|475628|P8|Overall Study|Progressive disease|1
145267|NCT00421889|475629|P7|Overall Study|Progressive disease|3
145268|NCT00421889|475630|P6|Overall Study|Progressive disease|21
145269|NCT00421889|475631|P5|Overall Study|Progressive disease|2
145270|NCT00421889|475632|P4|Overall Study|Progressive disease|3
145271|NCT00421889|475633|P3|Overall Study|Progressive disease|2
145272|NCT00421889|475634|P2|Overall Study|Progressive disease|2
145273|NCT00421889|475635|P1|Overall Study|Progressive disease|3
145274|NCT00421889|475627|P9|Overall Study|Death|0
145275|NCT00421889|475628|P8|Overall Study|Death|0
145276|NCT00421889|475629|P7|Overall Study|Death|0
145277|NCT00421889|475630|P6|Overall Study|Death|1
145278|NCT00421889|475631|P5|Overall Study|Death|1
145279|NCT00421889|475632|P4|Overall Study|Death|0
145280|NCT00421889|475633|P3|Overall Study|Death|0
145281|NCT00421889|475634|P2|Overall Study|Death|0
145282|NCT00421889|475635|P1|Overall Study|Death|0
145283|NCT00421889|475627|P9|Overall Study|Withdrawal by Subject|0
145284|NCT00421889|475628|P8|Overall Study|Withdrawal by Subject|0
145285|NCT00421889|475629|P7|Overall Study|Withdrawal by Subject|0
145286|NCT00421889|475630|P6|Overall Study|Withdrawal by Subject|0
145287|NCT00421889|475631|P5|Overall Study|Withdrawal by Subject|2
145288|NCT00421889|475632|P4|Overall Study|Withdrawal by Subject|0
145289|NCT00421889|475633|P3|Overall Study|Withdrawal by Subject|0
145290|NCT00421889|475634|P2|Overall Study|Withdrawal by Subject|3
145291|NCT00421889|475635|P1|Overall Study|Withdrawal by Subject|1
145292|NCT00421889|475627|P9|Overall Study|Adverse Event|2
145293|NCT00421889|475628|P8|Overall Study|Adverse Event|0
145294|NCT00421889|475629|P7|Overall Study|Adverse Event|1
145295|NCT00421889|475630|P6|Overall Study|Adverse Event|4
145296|NCT00421889|475631|P5|Overall Study|Adverse Event|1
145297|NCT00421889|475632|P4|Overall Study|Adverse Event|1
145298|NCT00421889|475633|P3|Overall Study|Adverse Event|1
145299|NCT00421889|475634|P2|Overall Study|Adverse Event|0
145300|NCT00421889|475635|P1|Overall Study|Adverse Event|1
145301|NCT00421733|475680|P3|Overall Study|Protocol deviation|2
145302|NCT00421733|475681|P2|Overall Study|Protocol deviation|7
145303|NCT00421733|475682|P1|Overall Study|Protocol deviation|4
145304|NCT00421733|475680|P3|Overall Study|Sponsor request|3
145305|NCT00421733|475681|P2|Overall Study|Sponsor request|0
145306|NCT00421733|475682|P1|Overall Study|Sponsor request|1
145307|NCT00421733|475680|P3|Overall Study|Did not satisfy entry criteria|2
145308|NCT00421733|475681|P2|Overall Study|Did not satisfy entry criteria|3
145309|NCT00421733|475682|P1|Overall Study|Did not satisfy entry criteria|1
145310|NCT00421733|475680|P3|Overall Study|Administrative|0
145311|NCT00421733|475681|P2|Overall Study|Administrative|0
145312|NCT00421733|475682|P1|Overall Study|Administrative|2
145313|NCT00421733|475680|P3|Overall Study|Required dialysis|0
145314|NCT00421733|475681|P2|Overall Study|Required dialysis|0
145315|NCT00421733|475682|P1|Overall Study|Required dialysis|1
145316|NCT00421733|475680|P3|Overall Study|Death|0
145317|NCT00421733|475681|P2|Overall Study|Death|3
145318|NCT00421733|475682|P1|Overall Study|Death|0
145319|NCT00421733|475680|P3|Overall Study|Withdrawal by Subject|7
145320|NCT00421733|475681|P2|Overall Study|Withdrawal by Subject|2
145321|NCT00421733|475682|P1|Overall Study|Withdrawal by Subject|1
145322|NCT00421733|475680|P3|Overall Study|Lost to Follow-up|4
145323|NCT00421733|475681|P2|Overall Study|Lost to Follow-up|2
145324|NCT00421733|475682|P1|Overall Study|Lost to Follow-up|1
145325|NCT00421733|475680|P3|Overall Study|Adverse Event|2
145326|NCT00421733|475681|P2|Overall Study|Adverse Event|9
145327|NCT00421733|475682|P1|Overall Study|Adverse Event|4
145328|NCT00421408|475711|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
145329|NCT00421408|475712|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
145330|NCT00421408|475711|P2|Overall Study|Lost to Follow-up|20
145331|NCT00421408|475712|P1|Overall Study|Lost to Follow-up|30
145332|NCT00421343|475730|P1|Overall Study|Lost to follow-up|3
145333|NCT00421343|475730|P1|Overall Study|Withdrawal by Subject|2
145334|NCT00421343|475730|P1|Overall Study|Death|1
145335|NCT00421174|475736|P2|Overall Study|Ineligible due to infection|0
145336|NCT00421174|475737|P1|Overall Study|Ineligible due to infection|2
145337|NCT00421174|475736|P2|Overall Study|Withdrawal by Subject|1
145338|NCT00421174|475737|P1|Overall Study|Withdrawal by Subject|0
145339|NCT00420927|475782|P7|Period 2|Took prohibited medication|0
145340|NCT00420927|475783|P6|Period 2|Took prohibited medication|0
145341|NCT00420927|475784|P5|Period 2|Took prohibited medication|1
145342|NCT00420927|475785|P4|Period 2|Took prohibited medication|0
145343|NCT00420927|475786|P3|Period 2|Took prohibited medication|0
145344|NCT00420927|475787|P2|Period 2|Took prohibited medication|0
145345|NCT00420927|475788|P1|Period 2|Took prohibited medication|0
145346|NCT00420927|475782|P7|Period 2|Methotrexate intolerance|1
145347|NCT00420927|475783|P6|Period 2|Methotrexate intolerance|0
145348|NCT00420927|475784|P5|Period 2|Methotrexate intolerance|0
145349|NCT00420927|475785|P4|Period 2|Methotrexate intolerance|0
145350|NCT00420927|475786|P3|Period 2|Methotrexate intolerance|0
145351|NCT00420927|475787|P2|Period 2|Methotrexate intolerance|0
145352|NCT00420927|475788|P1|Period 2|Methotrexate intolerance|0
145353|NCT00420927|475782|P7|Period 2|Noncompliant with study drug|2
145354|NCT00420927|475783|P6|Period 2|Noncompliant with study drug|0
145355|NCT00420927|475784|P5|Period 2|Noncompliant with study drug|0
145356|NCT00420927|475785|P4|Period 2|Noncompliant with study drug|1
145357|NCT00420927|475786|P3|Period 2|Noncompliant with study drug|0
145358|NCT00420927|475787|P2|Period 2|Noncompliant with study drug|0
145359|NCT00420927|475788|P1|Period 2|Noncompliant with study drug|0
145360|NCT00420927|475782|P7|Period 2|Randomization error|0
145361|NCT00420927|475783|P6|Period 2|Randomization error|1
145362|NCT00420927|475784|P5|Period 2|Randomization error|1
145363|NCT00420927|475785|P4|Period 2|Randomization error|0
145364|NCT00420927|475786|P3|Period 2|Randomization error|0
145365|NCT00420927|475787|P2|Period 2|Randomization error|0
145366|NCT00420927|475788|P1|Period 2|Randomization error|0
145367|NCT00420927|475782|P7|Period 2|Sponsor decision|1
145368|NCT00420927|475783|P6|Period 2|Sponsor decision|0
145369|NCT00420927|475784|P5|Period 2|Sponsor decision|0
145370|NCT00420927|475785|P4|Period 2|Sponsor decision|0
145371|NCT00420927|475786|P3|Period 2|Sponsor decision|1
145372|NCT00420927|475787|P2|Period 2|Sponsor decision|0
145373|NCT00420927|475788|P1|Period 2|Sponsor decision|0
145374|NCT00420927|475782|P7|Period 2|Physician Decision|0
145375|NCT00420927|475783|P6|Period 2|Physician Decision|1
145376|NCT00420927|475784|P5|Period 2|Physician Decision|1
145377|NCT00420927|475785|P4|Period 2|Physician Decision|0
145378|NCT00420927|475786|P3|Period 2|Physician Decision|0
145379|NCT00420927|475787|P2|Period 2|Physician Decision|0
145380|NCT00420927|475788|P1|Period 2|Physician Decision|0
145381|NCT00420927|475782|P7|Period 2|Subject unable to find transportation|1
145382|NCT00420927|475783|P6|Period 2|Subject unable to find transportation|0
145383|NCT00420927|475784|P5|Period 2|Subject unable to find transportation|0
145384|NCT00420927|475785|P4|Period 2|Subject unable to find transportation|0
145385|NCT00420927|475786|P3|Period 2|Subject unable to find transportation|0
145386|NCT00420927|475787|P2|Period 2|Subject unable to find transportation|0
145387|NCT00420927|475788|P1|Period 2|Subject unable to find transportation|0
145388|NCT00420927|475782|P7|Period 2|Received wrong treatment/incorrect dose|1
145389|NCT00420927|475783|P6|Period 2|Received wrong treatment/incorrect dose|0
145390|NCT00420927|475784|P5|Period 2|Received wrong treatment/incorrect dose|0
145391|NCT00420927|475785|P4|Period 2|Received wrong treatment/incorrect dose|0
145392|NCT00420927|475786|P3|Period 2|Received wrong treatment/incorrect dose|0
145393|NCT00420927|475787|P2|Period 2|Received wrong treatment/incorrect dose|0
145394|NCT00420927|475788|P1|Period 2|Received wrong treatment/incorrect dose|0
145395|NCT00420927|475782|P7|Period 2|Lack of efficacy/Loss of efficacy|6
145396|NCT00420927|475783|P6|Period 2|Lack of efficacy/Loss of efficacy|2
145397|NCT00420927|475784|P5|Period 2|Lack of efficacy/Loss of efficacy|6
145398|NCT00420927|475785|P4|Period 2|Lack of efficacy/Loss of efficacy|1
145399|NCT00420927|475786|P3|Period 2|Lack of efficacy/Loss of efficacy|2
145400|NCT00420927|475787|P2|Period 2|Lack of efficacy/Loss of efficacy|0
145401|NCT00420927|475788|P1|Period 2|Lack of efficacy/Loss of efficacy|0
145402|NCT00420927|475782|P7|Period 2|Lost to Follow-up|9
145403|NCT00420927|475783|P6|Period 2|Lost to Follow-up|3
145404|NCT00420927|475784|P5|Period 2|Lost to Follow-up|6
145405|NCT00420927|475785|P4|Period 2|Lost to Follow-up|2
145406|NCT00420927|475786|P3|Period 2|Lost to Follow-up|2
145407|NCT00420927|475787|P2|Period 2|Lost to Follow-up|0
145408|NCT00420927|475788|P1|Period 2|Lost to Follow-up|0
145409|NCT00420927|475782|P7|Period 2|Withdrawal by Subject|12
145410|NCT00420927|475783|P6|Period 2|Withdrawal by Subject|2
145411|NCT00420927|475784|P5|Period 2|Withdrawal by Subject|11
145412|NCT00420927|475785|P4|Period 2|Withdrawal by Subject|3
145413|NCT00420927|475786|P3|Period 2|Withdrawal by Subject|1
145414|NCT00420927|475787|P2|Period 2|Withdrawal by Subject|0
145415|NCT00420927|475788|P1|Period 2|Withdrawal by Subject|0
145416|NCT00420927|475782|P7|Period 2|Adverse Event|20
145417|NCT00420927|475783|P6|Period 2|Adverse Event|6
145418|NCT00420927|475784|P5|Period 2|Adverse Event|17
145419|NCT00420927|475785|P4|Period 2|Adverse Event|3
145420|NCT00420927|475786|P3|Period 2|Adverse Event|7
145421|NCT00420927|475787|P2|Period 2|Adverse Event|0
145422|NCT00420927|475788|P1|Period 2|Adverse Event|0
145423|NCT00420927|475782|P7|Period 1|Took prohibited medication|0
145424|NCT00420927|475783|P6|Period 1|Took prohibited medication|0
145425|NCT00420927|475784|P5|Period 1|Took prohibited medication|0
145426|NCT00420927|475785|P4|Period 1|Took prohibited medication|0
145427|NCT00420927|475786|P3|Period 1|Took prohibited medication|0
145428|NCT00420927|475787|P2|Period 1|Took prohibited medication|3
145429|NCT00420927|475788|P1|Period 1|Took prohibited medication|1
145430|NCT00420927|475782|P7|Period 1|Failed to meet entry criteria|0
145431|NCT00420927|475783|P6|Period 1|Failed to meet entry criteria|0
145432|NCT00420927|475784|P5|Period 1|Failed to meet entry criteria|0
145433|NCT00420927|475785|P4|Period 1|Failed to meet entry criteria|0
145434|NCT00420927|475786|P3|Period 1|Failed to meet entry criteria|0
145435|NCT00420927|475787|P2|Period 1|Failed to meet entry criteria|7
145436|NCT00420927|475788|P1|Period 1|Failed to meet entry criteria|8
145437|NCT00420927|475782|P7|Period 1|Received wrong treatment/incorrect dose|0
145438|NCT00420927|475783|P6|Period 1|Received wrong treatment/incorrect dose|0
145439|NCT00420927|475784|P5|Period 1|Received wrong treatment/incorrect dose|0
145440|NCT00420927|475785|P4|Period 1|Received wrong treatment/incorrect dose|0
145441|NCT00420927|475786|P3|Period 1|Received wrong treatment/incorrect dose|0
145442|NCT00420927|475787|P2|Period 1|Received wrong treatment/incorrect dose|1
145443|NCT00420927|475788|P1|Period 1|Received wrong treatment/incorrect dose|0
145444|NCT00420927|475782|P7|Period 1|Subject received new diagnosis|0
145445|NCT00420927|475783|P6|Period 1|Subject received new diagnosis|0
145446|NCT00420927|475784|P5|Period 1|Subject received new diagnosis|0
145447|NCT00420927|475785|P4|Period 1|Subject received new diagnosis|0
145448|NCT00420927|475786|P3|Period 1|Subject received new diagnosis|0
145449|NCT00420927|475787|P2|Period 1|Subject received new diagnosis|2
145450|NCT00420927|475788|P1|Period 1|Subject received new diagnosis|0
145451|NCT00420927|475782|P7|Period 1|Study site closure|0
145452|NCT00420927|475783|P6|Period 1|Study site closure|0
145453|NCT00420927|475784|P5|Period 1|Study site closure|0
145454|NCT00420927|475785|P4|Period 1|Study site closure|0
145455|NCT00420927|475786|P3|Period 1|Study site closure|0
145456|NCT00420927|475787|P2|Period 1|Study site closure|1
145457|NCT00420927|475788|P1|Period 1|Study site closure|0
145458|NCT00420927|475782|P7|Period 1|Suspected tuberculosis/positive test|0
145459|NCT00420927|475783|P6|Period 1|Suspected tuberculosis/positive test|0
145460|NCT00420927|475784|P5|Period 1|Suspected tuberculosis/positive test|0
145461|NCT00420927|475785|P4|Period 1|Suspected tuberculosis/positive test|0
145462|NCT00420927|475786|P3|Period 1|Suspected tuberculosis/positive test|0
145463|NCT00420927|475787|P2|Period 1|Suspected tuberculosis/positive test|1
145464|NCT00420927|475788|P1|Period 1|Suspected tuberculosis/positive test|1
145465|NCT00420927|475782|P7|Period 1|Randomization error|0
145466|NCT00420927|475783|P6|Period 1|Randomization error|0
145467|NCT00420927|475784|P5|Period 1|Randomization error|0
145468|NCT00420927|475785|P4|Period 1|Randomization error|0
145469|NCT00420927|475786|P3|Period 1|Randomization error|0
145470|NCT00420927|475787|P2|Period 1|Randomization error|0
145471|NCT00420927|475788|P1|Period 1|Randomization error|1
145472|NCT00420927|475782|P7|Period 1|Noncompliant with study drug|0
145473|NCT00420927|475783|P6|Period 1|Noncompliant with study drug|0
145474|NCT00420927|475784|P5|Period 1|Noncompliant with study drug|0
145475|NCT00420927|475785|P4|Period 1|Noncompliant with study drug|0
145476|NCT00420927|475786|P3|Period 1|Noncompliant with study drug|0
145477|NCT00420927|475787|P2|Period 1|Noncompliant with study drug|1
145478|NCT00420927|475788|P1|Period 1|Noncompliant with study drug|1
145479|NCT00420927|475782|P7|Period 1|Subject moved/relocated|0
145480|NCT00420927|475783|P6|Period 1|Subject moved/relocated|0
145481|NCT00420927|475784|P5|Period 1|Subject moved/relocated|0
145482|NCT00420927|475785|P4|Period 1|Subject moved/relocated|0
145483|NCT00420927|475786|P3|Period 1|Subject moved/relocated|0
145484|NCT00420927|475787|P2|Period 1|Subject moved/relocated|2
145485|NCT00420927|475788|P1|Period 1|Subject moved/relocated|0
145486|NCT00420927|475782|P7|Period 1|Death|0
145487|NCT00420927|475783|P6|Period 1|Death|0
145488|NCT00420927|475784|P5|Period 1|Death|0
145489|NCT00420927|475785|P4|Period 1|Death|0
145490|NCT00420927|475786|P3|Period 1|Death|0
145491|NCT00420927|475787|P2|Period 1|Death|0
145492|NCT00420927|475788|P1|Period 1|Death|2
145493|NCT00420927|475782|P7|Period 1|Lack of efficacy/Loss of efficacy|0
145494|NCT00420927|475783|P6|Period 1|Lack of efficacy/Loss of efficacy|0
145495|NCT00420927|475784|P5|Period 1|Lack of efficacy/Loss of efficacy|0
145496|NCT00420927|475785|P4|Period 1|Lack of efficacy/Loss of efficacy|0
145497|NCT00420927|475786|P3|Period 1|Lack of efficacy/Loss of efficacy|0
145498|NCT00420927|475787|P2|Period 1|Lack of efficacy/Loss of efficacy|6
145499|NCT00420927|475788|P1|Period 1|Lack of efficacy/Loss of efficacy|1
145500|NCT00420927|475782|P7|Period 1|Lost to Follow-up|0
145501|NCT00420927|475783|P6|Period 1|Lost to Follow-up|0
145502|NCT00420927|475784|P5|Period 1|Lost to Follow-up|0
145503|NCT00420927|475785|P4|Period 1|Lost to Follow-up|0
145504|NCT00420927|475786|P3|Period 1|Lost to Follow-up|0
145505|NCT00420927|475787|P2|Period 1|Lost to Follow-up|6
145506|NCT00420927|475788|P1|Period 1|Lost to Follow-up|8
145507|NCT00420927|475782|P7|Period 1|Withdrawal by Subject|0
145508|NCT00420927|475783|P6|Period 1|Withdrawal by Subject|0
145509|NCT00420927|475784|P5|Period 1|Withdrawal by Subject|0
145510|NCT00420927|475785|P4|Period 1|Withdrawal by Subject|0
145511|NCT00420927|475786|P3|Period 1|Withdrawal by Subject|0
145512|NCT00420927|475787|P2|Period 1|Withdrawal by Subject|12
145513|NCT00420927|475788|P1|Period 1|Withdrawal by Subject|7
145514|NCT00420927|475782|P7|Period 1|Adverse Event|0
145515|NCT00420927|475783|P6|Period 1|Adverse Event|0
145516|NCT00420927|475784|P5|Period 1|Adverse Event|0
145517|NCT00420927|475785|P4|Period 1|Adverse Event|0
145518|NCT00420927|475786|P3|Period 1|Adverse Event|0
145519|NCT00420927|475787|P2|Period 1|Adverse Event|15
145520|NCT00420927|475788|P1|Period 1|Adverse Event|19
145521|NCT00418834|475894|P2|Overall Study|Withdrawal by Subject|7
145522|NCT00418834|475895|P1|Overall Study|Withdrawal by Subject|3
145523|NCT00418834|475894|P2|Overall Study|Protocol Violation|3
145524|NCT00418834|475895|P1|Overall Study|Protocol Violation|4
145525|NCT00418834|475894|P2|Overall Study|Lost to Follow-up|1
145526|NCT00418834|475895|P1|Overall Study|Lost to Follow-up|0
145527|NCT00418834|475894|P2|Overall Study|Adverse Event|9
145528|NCT00418834|475895|P1|Overall Study|Adverse Event|16
145529|NCT00418717|475955|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
145530|NCT00418717|475955|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
145531|NCT00418691|475963|P3|Overall Study|Progressive Disease|1
145532|NCT00418691|475964|P2|Overall Study|Progressive Disease|0
145533|NCT00418691|475965|P1|Overall Study|Progressive Disease|1
145534|NCT00418691|475963|P3|Overall Study|Started new medication voiding entry|1
145535|NCT00418691|475964|P2|Overall Study|Started new medication voiding entry|0
145536|NCT00418691|475965|P1|Overall Study|Started new medication voiding entry|0
145537|NCT00418691|475963|P3|Overall Study|Lost to Follow-up|3
145538|NCT00418691|475964|P2|Overall Study|Lost to Follow-up|2
145539|NCT00418691|475965|P1|Overall Study|Lost to Follow-up|1
145540|NCT00420849|475973|P1|Overall Study|Lost to Follow-up|1
145541|NCT00420849|475973|P1|Overall Study|Protocol Violation|1
145542|NCT00420849|475973|P1|Overall Study|Transplant|8
145543|NCT00420849|475973|P1|Overall Study|Not specified|14
145544|NCT00420849|475973|P1|Overall Study|Death|18
145545|NCT00420849|475973|P1|Overall Study|Withdrawal by Subject|28
145546|NCT00420849|475973|P1|Overall Study|Adverse Event|107
145547|NCT00420849|475973|P1|Overall Study|Lack of Efficacy|154
145548|NCT00420784|476042|P4|Overall Study|Unspecified|5
145549|NCT00420784|476043|P3|Overall Study|Unspecified|0
145550|NCT00420784|476044|P2|Overall Study|Unspecified|2
145551|NCT00420784|476045|P1|Overall Study|Unspecified|1
145552|NCT00420784|476042|P4|Overall Study|Virologic Stopping Rule|67
145553|NCT00420784|476043|P3|Overall Study|Virologic Stopping Rule|41
145554|NCT00420784|476044|P2|Overall Study|Virologic Stopping Rule|26
145555|NCT00420784|476045|P1|Overall Study|Virologic Stopping Rule|17
145556|NCT00420784|476042|P4|Overall Study|Lost to Follow-up|1
145557|NCT00420784|476043|P3|Overall Study|Lost to Follow-up|2
145558|NCT00420784|476044|P2|Overall Study|Lost to Follow-up|0
145559|NCT00420784|476045|P1|Overall Study|Lost to Follow-up|0
145560|NCT00420784|476042|P4|Overall Study|Withdrawal by Subject|0
145561|NCT00420784|476043|P3|Overall Study|Withdrawal by Subject|0
145562|NCT00420784|476044|P2|Overall Study|Withdrawal by Subject|1
145563|NCT00420784|476045|P1|Overall Study|Withdrawal by Subject|0
145564|NCT00420784|476042|P4|Overall Study|Adverse Event|5
145565|NCT00420784|476043|P3|Overall Study|Adverse Event|10
145566|NCT00420784|476044|P2|Overall Study|Adverse Event|29
145567|NCT00420784|476045|P1|Overall Study|Adverse Event|11
145568|NCT00420745|476074|P2|Overall Study|Age limit exceeded for Dose 2|0
145569|NCT00420745|476075|P1|Overall Study|Age limit exceeded for Dose 2|1
145570|NCT00420745|476074|P2|Overall Study|Recurrent pneumonia & bronchitis|1
145571|NCT00420745|476075|P1|Overall Study|Recurrent pneumonia & bronchitis|0
145572|NCT00420745|476074|P2|Overall Study|Physician Decision|1
145573|NCT00420745|476075|P1|Overall Study|Physician Decision|1
145574|NCT00420745|476074|P2|Overall Study|Protocol Violation|0
145575|NCT00420745|476075|P1|Overall Study|Protocol Violation|1
145576|NCT00420745|476074|P2|Overall Study|Lost to Follow-up|2
145577|NCT00420745|476075|P1|Overall Study|Lost to Follow-up|10
145578|NCT00420745|476074|P2|Overall Study|Adverse Event|2
145579|NCT00420745|476075|P1|Overall Study|Adverse Event|2
145580|NCT00420628|476093|P2|Overall Study|Adverse Event|0
145581|NCT00420628|476094|P1|Overall Study|Adverse Event|1
145582|NCT00420628|476093|P2|Overall Study|Lost to Follow-up|2
145583|NCT00420628|476094|P1|Overall Study|Lost to Follow-up|3
145584|NCT00420628|476093|P2|Overall Study|Withdrawn by parent or gaurdian|2
145585|NCT00420628|476094|P1|Overall Study|Withdrawn by parent or gaurdian|5
145586|NCT00420511|476110|P2|Overall Study|Lost to Follow-up|0
145587|NCT00420511|476111|P1|Overall Study|Lost to Follow-up|1
145588|NCT00420511|476110|P2|Overall Study|Adverse Event|1
145589|NCT00420511|476111|P1|Overall Study|Adverse Event|1
145590|NCT00418665|476124|P3|Treatment Extension|Death|1
145591|NCT00418665|476125|P2|Treatment Extension|Death|0
145592|NCT00418665|476126|P1|Treatment Extension|Death|0
145593|NCT00418665|476124|P3|Treatment Extension|Physician Decision|1
145594|NCT00418665|476125|P2|Treatment Extension|Physician Decision|2
145595|NCT00418665|476126|P1|Treatment Extension|Physician Decision|2
145596|NCT00418665|476124|P3|Treatment Extension|Requirement for alternative therapy|0
145597|NCT00418665|476125|P2|Treatment Extension|Requirement for alternative therapy|2
145598|NCT00418665|476126|P1|Treatment Extension|Requirement for alternative therapy|2
145599|NCT00418665|476124|P3|Treatment Extension|Withdrawal by Subject|0
145600|NCT00418665|476125|P2|Treatment Extension|Withdrawal by Subject|0
145601|NCT00418665|476126|P1|Treatment Extension|Withdrawal by Subject|1
145602|NCT00418665|476124|P3|Treatment Extension|Adverse Event|0
145603|NCT00418665|476125|P2|Treatment Extension|Adverse Event|0
145604|NCT00418665|476126|P1|Treatment Extension|Adverse Event|1
145605|NCT00418665|476124|P3|Treatment Period|Physician Decision|3
145606|NCT00418665|476125|P2|Treatment Period|Physician Decision|0
145607|NCT00418665|476126|P1|Treatment Period|Physician Decision|1
145608|NCT00418665|476124|P3|Treatment Period|Requirement for alternative therapy|0
145609|NCT00418665|476125|P2|Treatment Period|Requirement for alternative therapy|0
145610|NCT00418665|476126|P1|Treatment Period|Requirement for alternative therapy|1
145611|NCT00418665|476124|P3|Treatment Period|Withdrawal by Subject|1
145612|NCT00418665|476125|P2|Treatment Period|Withdrawal by Subject|3
145613|NCT00418665|476126|P1|Treatment Period|Withdrawal by Subject|0
145614|NCT00418665|476124|P3|Treatment Period|Adverse Event|0
145615|NCT00418665|476125|P2|Treatment Period|Adverse Event|2
145616|NCT00418665|476126|P1|Treatment Period|Adverse Event|2
145617|NCT00418665|476124|P3|Treatment Period|Ineligibility determined|0
145618|NCT00418665|476125|P2|Treatment Period|Ineligibility determined|1
145619|NCT00418665|476126|P1|Treatment Period|Ineligibility determined|1
145620|NCT00418561|476160|P3|Overall Study|Participant's (guardian's) decision|0
145621|NCT00418561|476161|P2|Overall Study|Participant's (guardian's) decision|1
145622|NCT00418561|476162|P1|Overall Study|Participant's (guardian's) decision|0
145623|NCT00418522|476232|P2|Overall Study|Randomized but did not receive treatment|4
145624|NCT00418522|476233|P1|Overall Study|Randomized but did not receive treatment|7
145625|NCT00418522|476232|P2|Overall Study|Other|23
145626|NCT00418522|476233|P1|Overall Study|Other|27
145627|NCT00418522|476232|P2|Overall Study|Withdrawal by Subject|7
145628|NCT00418522|476233|P1|Overall Study|Withdrawal by Subject|31
145629|NCT00418522|476232|P2|Overall Study|Lost to Follow-up|4
145630|NCT00418522|476233|P1|Overall Study|Lost to Follow-up|10
145631|NCT00418522|476232|P2|Overall Study|Lack of Efficacy|3
145632|NCT00418522|476233|P1|Overall Study|Lack of Efficacy|1
145633|NCT00418522|476232|P2|Overall Study|Adverse Event|1
145634|NCT00418522|476233|P1|Overall Study|Adverse Event|7
145635|NCT00420420|476279|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
145636|NCT00420420|476280|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
145637|NCT00420420|476279|P2|Overall Study|Withdrawal by Subject|0
145638|NCT00420420|476280|P1|Overall Study|Withdrawal by Subject|1
145639|NCT00420420|476279|P2|Overall Study|Protocol Violation|1
145640|NCT00420420|476280|P1|Overall Study|Protocol Violation|1
145641|NCT00420420|476279|P2|Overall Study|Adverse Event|3
145642|NCT00420420|476280|P1|Overall Study|Adverse Event|5
145643|NCT00420407|476298|P2|Overall Study|Withdrawal by Subject|2
145644|NCT00420407|476299|P1|Overall Study|Withdrawal by Subject|0
145645|NCT00420407|476298|P2|Overall Study|subject identified as Jehovah's witness|0
145646|NCT00420407|476299|P1|Overall Study|subject identified as Jehovah's witness|1
145647|NCT00420407|476298|P2|Overall Study|subject identified as detainee|0
145648|NCT00420407|476299|P1|Overall Study|subject identified as detainee|1
145649|NCT00420407|476298|P2|Overall Study|Physician Decision|1
145650|NCT00420407|476299|P1|Overall Study|Physician Decision|2
145651|NCT00420407|476298|P2|Overall Study|Lost to Follow-up|3
145652|NCT00420407|476299|P1|Overall Study|Lost to Follow-up|0
145653|NCT00420342|476308|P3|Overall Study|Withdrawal by Subject|0
145654|NCT00420342|476309|P2|Overall Study|Withdrawal by Subject|2
145655|NCT00420342|476310|P1|Overall Study|Withdrawal by Subject|0
145656|NCT00420342|476308|P3|Overall Study|Lost to Follow-up|1
145657|NCT00420342|476309|P2|Overall Study|Lost to Follow-up|0
145658|NCT00420342|476310|P1|Overall Study|Lost to Follow-up|1
145659|NCT00420303|476353|P2|Overall Study|Physician Decision|1
145660|NCT00420303|476354|P1|Overall Study|Physician Decision|0
145661|NCT00420303|476353|P2|Overall Study|Lack of Efficacy|3
145662|NCT00420303|476354|P1|Overall Study|Lack of Efficacy|0
145663|NCT00420303|476353|P2|Overall Study|Serious Adverse Event|0
145664|NCT00420303|476354|P1|Overall Study|Serious Adverse Event|1
145665|NCT00420290|476366|P2|Overall Study|did not meet inclusion/exclusion|1
145666|NCT00420290|476367|P1|Overall Study|did not meet inclusion/exclusion|1
145667|NCT00420290|476366|P2|Overall Study|Withdrawal by Subject|2
145668|NCT00420290|476367|P1|Overall Study|Withdrawal by Subject|0
145669|NCT00420290|476366|P2|Overall Study|Adverse Event|1
145670|NCT00420290|476367|P1|Overall Study|Adverse Event|3
145671|NCT00420238|476383|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
145672|NCT00420238|476384|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
145673|NCT00420238|476383|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
145674|NCT00420238|476384|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
145675|NCT00420238|476383|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
145676|NCT00420238|476384|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
145677|NCT00420238|476383|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
145678|NCT00420238|476384|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
145679|NCT00420238|476383|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
145680|NCT00420238|476384|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
145681|NCT00420238|476383|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
145682|NCT00420238|476384|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
145683|NCT00420212|476523|P3|Overall Study|Other-Unspecified|18
145684|NCT00420212|476524|P2|Overall Study|Other-Unspecified|14
145685|NCT00420212|476525|P1|Overall Study|Other-Unspecified|21
145686|NCT00420212|476523|P3|Overall Study|Death|1
145687|NCT00420212|476524|P2|Overall Study|Death|0
145688|NCT00420212|476525|P1|Overall Study|Death|0
145689|NCT00420212|476523|P3|Overall Study|Protocol Violation|8
145690|NCT00420212|476524|P2|Overall Study|Protocol Violation|4
145691|NCT00420212|476525|P1|Overall Study|Protocol Violation|4
145692|NCT00420212|476523|P3|Overall Study|Physician Decision|3
145693|NCT00420212|476524|P2|Overall Study|Physician Decision|4
145694|NCT00420212|476525|P1|Overall Study|Physician Decision|4
145695|NCT00420212|476523|P3|Overall Study|Withdrawal by Subject|19
145696|NCT00420212|476524|P2|Overall Study|Withdrawal by Subject|22
145697|NCT00420212|476525|P1|Overall Study|Withdrawal by Subject|31
145698|NCT00420212|476523|P3|Overall Study|Lost to Follow-up|11
145699|NCT00420212|476524|P2|Overall Study|Lost to Follow-up|11
145700|NCT00420212|476525|P1|Overall Study|Lost to Follow-up|9
145701|NCT00420212|476523|P3|Overall Study|Adverse Event|36
145702|NCT00420212|476524|P2|Overall Study|Adverse Event|40
145703|NCT00420212|476525|P1|Overall Study|Adverse Event|22
145704|NCT00420199|476551|P2|Overall Study|Participant no longer met study criteria|0
145705|NCT00420199|476552|P1|Overall Study|Participant no longer met study criteria|1
145706|NCT00420095|476607|P2|Overall Study|Lost to Follow-up|0
145707|NCT00420095|476608|P1|Overall Study|Lost to Follow-up|1
145708|NCT00420095|476607|P2|Overall Study|Protocol Violation|1
145709|NCT00420095|476608|P1|Overall Study|Protocol Violation|1
145710|NCT00420095|476607|P2|Overall Study|Adverse Event|0
145711|NCT00420095|476608|P1|Overall Study|Adverse Event|1
145712|NCT00420056|476626|P1|Overall Study|Objective progression or relapse|17
145713|NCT00419952|476665|P2|Overall Study|Abnormal ECG|0
145714|NCT00419952|476666|P1|Overall Study|Abnormal ECG|1
145715|NCT00419952|476665|P2|Overall Study|Diary or medication non-compliance|4
145716|NCT00419952|476666|P1|Overall Study|Diary or medication non-compliance|2
145717|NCT00419952|476665|P2|Overall Study|Occurence of 2 or more exacerbations|0
145718|NCT00419952|476666|P1|Overall Study|Occurence of 2 or more exacerbations|2
145719|NCT00419952|476665|P2|Overall Study|Intake of prohibited medication|2
145720|NCT00419952|476666|P1|Overall Study|Intake of prohibited medication|2
145721|NCT00419952|476665|P2|Overall Study|Incorrectly enrolled|3
145722|NCT00419952|476666|P1|Overall Study|Incorrectly enrolled|10
145723|NCT00419952|476665|P2|Overall Study|Physician Decision|3
145724|NCT00419952|476666|P1|Overall Study|Physician Decision|1
145725|NCT00419952|476665|P2|Overall Study|Pregnancy|2
145726|NCT00419952|476666|P1|Overall Study|Pregnancy|4
145727|NCT00419952|476665|P2|Overall Study|Protocol Violation|24
145728|NCT00419952|476666|P1|Overall Study|Protocol Violation|32
145729|NCT00419952|476665|P2|Overall Study|Lost to Follow-up|34
145730|NCT00419952|476666|P1|Overall Study|Lost to Follow-up|43
145731|NCT00419952|476665|P2|Overall Study|Withdrawal by Subject|43
145732|NCT00419952|476666|P1|Overall Study|Withdrawal by Subject|44
145733|NCT00419952|476665|P2|Overall Study|Adverse Event|10
145734|NCT00419952|476666|P1|Overall Study|Adverse Event|8
145735|NCT00419926|476700|P2|Overall Study|Death|1
145736|NCT00419926|476701|P1|Overall Study|Death|2
145737|NCT00419926|476700|P2|Overall Study|Lost to Follow-up|2
145738|NCT00419926|476701|P1|Overall Study|Lost to Follow-up|1
145739|NCT00419926|476700|P2|Overall Study|Administrative Problem|4
145740|NCT00419926|476701|P1|Overall Study|Administrative Problem|4
145741|NCT00419926|476700|P2|Overall Study|Withdrawal by Subject|3
145742|NCT00419926|476701|P1|Overall Study|Withdrawal by Subject|7
145743|NCT00419770|476717|P2|Overall Study|Withdrawal by Subject|1
145744|NCT00419770|476718|P1|Overall Study|Withdrawal by Subject|5
145745|NCT00419757|476726|P2|Overall Study|Multiple reasons|1
145746|NCT00419757|476727|P1|Overall Study|Multiple reasons|3
145747|NCT00419757|476726|P2|Overall Study|Study specific discontinuation criteria|8
145748|NCT00419757|476727|P1|Overall Study|Study specific discontinuation criteria|4
145749|NCT00419757|476726|P2|Overall Study|Protocol Violation|3
145750|NCT00419757|476727|P1|Overall Study|Protocol Violation|2
145751|NCT00419757|476726|P2|Overall Study|Withdrawal by Subject|1
145752|NCT00419757|476727|P1|Overall Study|Withdrawal by Subject|7
145753|NCT00419757|476726|P2|Overall Study|Lost to Follow-up|4
145754|NCT00419757|476727|P1|Overall Study|Lost to Follow-up|1
145755|NCT00419757|476726|P2|Overall Study|Adverse Event|4
145756|NCT00419757|476727|P1|Overall Study|Adverse Event|1
145757|NCT00419744|476766|P3|Overall Study|Incorrect medication kit dispensed|1
145758|NCT00419744|476767|P2|Overall Study|Incorrect medication kit dispensed|0
145759|NCT00419744|476768|P1|Overall Study|Incorrect medication kit dispensed|0
145760|NCT00419744|476766|P3|Overall Study|Spirometry mouthpiece issues|2
145761|NCT00419744|476767|P2|Overall Study|Spirometry mouthpiece issues|1
145762|NCT00419744|476768|P1|Overall Study|Spirometry mouthpiece issues|0
145763|NCT00419744|476766|P3|Overall Study|Physician Decision|6
145764|NCT00419744|476767|P2|Overall Study|Physician Decision|5
145765|NCT00419744|476768|P1|Overall Study|Physician Decision|10
145766|NCT00419744|476766|P3|Overall Study|Moving out of state|1
145767|NCT00419744|476767|P2|Overall Study|Moving out of state|0
145768|NCT00419744|476768|P1|Overall Study|Moving out of state|2
145769|NCT00419744|476766|P3|Overall Study|Randomized in error|7
145770|NCT00419744|476767|P2|Overall Study|Randomized in error|6
145771|NCT00419744|476768|P1|Overall Study|Randomized in error|9
145772|NCT00419744|476766|P3|Overall Study|Protocol Violation|8
145773|NCT00419744|476767|P2|Overall Study|Protocol Violation|7
145774|NCT00419744|476768|P1|Overall Study|Protocol Violation|4
145775|NCT00419744|476766|P3|Overall Study|Lost to Follow-up|6
145776|NCT00419744|476767|P2|Overall Study|Lost to Follow-up|10
145777|NCT00419744|476768|P1|Overall Study|Lost to Follow-up|8
145778|NCT00419744|476766|P3|Overall Study|Withdrawal by Subject|52
145779|NCT00419744|476767|P2|Overall Study|Withdrawal by Subject|49
145780|NCT00419744|476768|P1|Overall Study|Withdrawal by Subject|45
145781|NCT00419744|476766|P3|Overall Study|Adverse Event|50
145782|NCT00419744|476767|P2|Overall Study|Adverse Event|40
145783|NCT00419744|476768|P1|Overall Study|Adverse Event|39
145784|NCT00418379|476800|P3|Year 5|Any other reason not above-mentioned|3
145785|NCT00418379|476801|P2|Year 5|Any other reason not above-mentioned|4
145786|NCT00418379|476802|P1|Year 5|Any other reason not above-mentioned|2
145787|NCT00418379|476800|P3|Year 5|Adverse Event|0
145788|NCT00418379|476801|P2|Year 5|Adverse Event|1
145789|NCT00418379|476802|P1|Year 5|Adverse Event|0
145790|NCT00418379|476800|P3|Year 4|Any other reason not above-mentioned|0
145791|NCT00418379|476801|P2|Year 4|Any other reason not above-mentioned|1
145792|NCT00418379|476802|P1|Year 4|Any other reason not above-mentioned|1
145793|NCT00418379|476800|P3|Year 4|Withdrawal by Subject|2
145794|NCT00418379|476801|P2|Year 4|Withdrawal by Subject|3
145795|NCT00418379|476802|P1|Year 4|Withdrawal by Subject|2
145796|NCT00418379|476800|P3|Year 4|Adverse Event|0
145797|NCT00418379|476801|P2|Year 4|Adverse Event|1
145798|NCT00418379|476802|P1|Year 4|Adverse Event|0
145799|NCT00418379|476800|P3|Year 3|Any other reason not above-mentioned|1
145800|NCT00418379|476801|P2|Year 3|Any other reason not above-mentioned|1
145801|NCT00418379|476802|P1|Year 3|Any other reason not above-mentioned|2
145802|NCT00418379|476800|P3|Year 3|Withdrawal by Subject|2
145803|NCT00418379|476801|P2|Year 3|Withdrawal by Subject|1
145804|NCT00418379|476802|P1|Year 3|Withdrawal by Subject|1
145805|NCT00418379|476800|P3|Year 2|Any other reason not above-mentioned|6
145806|NCT00418379|476801|P2|Year 2|Any other reason not above-mentioned|1
145807|NCT00418379|476802|P1|Year 2|Any other reason not above-mentioned|2
145808|NCT00418379|476800|P3|Year 2|Withdrawal by Subject|3
145809|NCT00418379|476801|P2|Year 2|Withdrawal by Subject|1
145810|NCT00418379|476802|P1|Year 2|Withdrawal by Subject|1
145811|NCT00418379|476800|P3|Year 2|Adverse Event|1
145812|NCT00418379|476801|P2|Year 2|Adverse Event|2
145813|NCT00418379|476802|P1|Year 2|Adverse Event|5
145814|NCT00418379|476800|P3|Year 1|Any other reason not above-mentioned|7
145815|NCT00418379|476801|P2|Year 1|Any other reason not above-mentioned|5
145816|NCT00418379|476802|P1|Year 1|Any other reason not above-mentioned|2
145817|NCT00418379|476800|P3|Year 1|Withdrawal by Subject|5
145818|NCT00418379|476801|P2|Year 1|Withdrawal by Subject|8
145819|NCT00418379|476802|P1|Year 1|Withdrawal by Subject|7
145820|NCT00418379|476800|P3|Year 1|Adverse Event|3
145821|NCT00418379|476801|P2|Year 1|Adverse Event|15
145822|NCT00418379|476802|P1|Year 1|Adverse Event|9
145823|NCT00419393|476823|P1|Overall Study|Other: Investigator decision|1
145824|NCT00419393|476823|P1|Overall Study|Other: Other health problems|1
145825|NCT00419393|476823|P1|Overall Study|Other: Site closure|1
145826|NCT00419393|476823|P1|Overall Study|Other: Subject had temporal lobectomy|1
145827|NCT00419393|476823|P1|Overall Study|Other: Sponsor request|3
145828|NCT00419393|476823|P1|Overall Study|Withdrawal by Subject|7
145829|NCT00419393|476823|P1|Overall Study|Protocol Violation|5
145830|NCT00419393|476823|P1|Overall Study|Adverse Event|5
145831|NCT00419380|476833|P2|Overall Study|Withdrawal by Subject|1
145832|NCT00419380|476834|P1|Overall Study|Withdrawal by Subject|0
145833|NCT00419380|476833|P2|Overall Study|Lost to Follow-up|1
145834|NCT00419380|476834|P1|Overall Study|Lost to Follow-up|0
145835|NCT00419380|476833|P2|Overall Study|Physician Decision|1
145836|NCT00419380|476834|P1|Overall Study|Physician Decision|0
145837|NCT00419380|476833|P2|Overall Study|Lack of Efficacy|7
145838|NCT00419380|476834|P1|Overall Study|Lack of Efficacy|1
145839|NCT00419341|476842|P1|Efficacy Period|Termination of study site|1
145840|NCT00419341|476842|P1|Efficacy Period|Non-compliance|1
145841|NCT00419341|476842|P1|Efficacy Period|Lost to Follow-up|1
145842|NCT00419341|476842|P1|Efficacy Period|Protocol Violation|1
145843|NCT00419341|476842|P1|Efficacy Period|Withdrawal by Subject|6
145844|NCT00419341|476842|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
145845|NCT00419341|476842|P1|Wash in/Wash Out Period|Adverse Event|2
145846|NCT00419341|476842|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
145847|NCT00419263|476877|P3|Overall Study|Withdrawal by Subject|1
145848|NCT00419263|476878|P2|Overall Study|Withdrawal by Subject|0
145849|NCT00419263|476879|P1|Overall Study|Withdrawal by Subject|0
145850|NCT00419263|476877|P3|Overall Study|Adverse Event|1
145851|NCT00419263|476878|P2|Overall Study|Adverse Event|0
145852|NCT00419263|476879|P1|Overall Study|Adverse Event|0
145853|NCT00419263|476877|P3|Overall Study|Randomized in Error, Not Treated|0
145854|NCT00419263|476878|P2|Overall Study|Randomized in Error, Not Treated|1
145855|NCT00419263|476879|P1|Overall Study|Randomized in Error, Not Treated|1
145856|NCT00419263|476877|P3|Overall Study|Lost to Follow-up|1
145857|NCT00419263|476878|P2|Overall Study|Lost to Follow-up|1
145858|NCT00419263|476879|P1|Overall Study|Lost to Follow-up|2
145859|NCT00419159|476908|P2|Overall Study|Disease progression|76
145860|NCT00419159|476909|P1|Overall Study|Disease progression|79
145861|NCT00419159|476908|P2|Overall Study|Death|2
145862|NCT00419159|476909|P1|Overall Study|Death|2
145863|NCT00419159|476908|P2|Overall Study|Lost to Follow-up|1
145864|NCT00419159|476909|P1|Overall Study|Lost to Follow-up|0
145865|NCT00419159|476908|P2|Overall Study|Withdrawal by Subject|3
145866|NCT00419159|476909|P1|Overall Study|Withdrawal by Subject|10
145867|NCT00419159|476908|P2|Overall Study|Protocol Violation|0
145868|NCT00419159|476909|P1|Overall Study|Protocol Violation|1
145869|NCT00419159|476908|P2|Overall Study|Subject's no longer requires study drug|1
145870|NCT00419159|476909|P1|Overall Study|Subject's no longer requires study drug|0
145871|NCT00419159|476908|P2|Overall Study|Abnormal laboratory value(s)|2
145872|NCT00419159|476909|P1|Overall Study|Abnormal laboratory value(s)|0
145873|NCT00419159|476908|P2|Overall Study|Adverse Event|15
145874|NCT00419159|476909|P1|Overall Study|Adverse Event|7
145875|NCT00419120|476923|P1|Long Term Follow up Period|study ongoing|10
145876|NCT00419094|476930|P2|Overall Study|Other: No contact for extended period|1
145877|NCT00419094|476931|P1|Overall Study|Other: No contact for extended period|0
145878|NCT00419094|476930|P2|Overall Study|Other: Patient non-compliant|1
145879|NCT00419094|476931|P1|Overall Study|Other: Patient non-compliant|0
145880|NCT00419094|476930|P2|Overall Study|Other: Error determining exit criteria|0
145881|NCT00419094|476931|P1|Overall Study|Other: Error determining exit criteria|1
145882|NCT00419094|476930|P2|Overall Study|Withdrawal of consent|5
145883|NCT00419094|476931|P1|Overall Study|Withdrawal of consent|1
145884|NCT00419094|476930|P2|Overall Study|Protocol Violation|14
145885|NCT00419094|476931|P1|Overall Study|Protocol Violation|1
145886|NCT00419094|476930|P2|Overall Study|Lost to Follow-up|2
145887|NCT00419094|476931|P1|Overall Study|Lost to Follow-up|0
145888|NCT00419094|476930|P2|Overall Study|Lack of Efficacy|0
145889|NCT00419094|476931|P1|Overall Study|Lack of Efficacy|1
145890|NCT00419094|476930|P2|Overall Study|Adverse Event|7
145891|NCT00419094|476931|P1|Overall Study|Adverse Event|3
145892|NCT00419003|476945|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
145893|NCT00419003|476946|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
145894|NCT00419003|476945|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
145895|NCT00419003|476946|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
145896|NCT00418938|477000|P2|Overall Study|Ineligibility Determined|0
145897|NCT00418938|477001|P1|Overall Study|Ineligibility Determined|1
145898|NCT00418938|477000|P2|Overall Study|On-going|1
145899|NCT00418938|477001|P1|Overall Study|On-going|1
145900|NCT00418938|477000|P2|Overall Study|Adverse Event|1
145901|NCT00418938|477001|P1|Overall Study|Adverse Event|1
145902|NCT00418938|477000|P2|Overall Study|Lost to Follow-up|3
145903|NCT00418938|477001|P1|Overall Study|Lost to Follow-up|1
145904|NCT00418938|477000|P2|Overall Study|Withdrawal by Subject|15
145905|NCT00418938|477001|P1|Overall Study|Withdrawal by Subject|16
145906|NCT00418938|477000|P2|Overall Study|Administrative decision|3
145907|NCT00418938|477001|P1|Overall Study|Administrative decision|3
145908|NCT00418938|477000|P2|Overall Study|Reimbursement|0
145909|NCT00418938|477001|P1|Overall Study|Reimbursement|1
145910|NCT00418886|477021|P2|Overall Study|randomised but no treatment received|1
145911|NCT00418886|477022|P1|Overall Study|randomised but no treatment received|0
145912|NCT00418886|477021|P2|Overall Study|withdrawn due to other reason|0
145913|NCT00418886|477022|P1|Overall Study|withdrawn due to other reason|1
145914|NCT00418886|477021|P2|Overall Study|Lost to Follow-up|6
145915|NCT00418886|477022|P1|Overall Study|Lost to Follow-up|4
145916|NCT00418886|477021|P2|Overall Study|Withdrawal by Subject|10
145917|NCT00418886|477022|P1|Overall Study|Withdrawal by Subject|9
145918|NCT00418886|477021|P2|Overall Study|Death|147
145919|NCT00418886|477022|P1|Overall Study|Death|122
145920|NCT00418886|477021|P2|Overall Study|discontinue treatment survival follow up|91
145921|NCT00418886|477022|P1|Overall Study|discontinue treatment survival follow up|90
145922|NCT00418314|477048|P2|Overall Study|Withdrawal by Subject|2
145923|NCT00418314|477049|P1|Overall Study|Withdrawal by Subject|1
145924|NCT00418184|477061|P2|Double-blind Phase|Poor compliance|1
145925|NCT00418184|477062|P1|Double-blind Phase|Poor compliance|3
145926|NCT00418184|477061|P2|Double-blind Phase|Adverse Event|1
145927|NCT00418184|477062|P1|Double-blind Phase|Adverse Event|2
145928|NCT00418184|477061|P2|Double-blind Phase|Withdrawal by Subject|9
145929|NCT00418184|477062|P1|Double-blind Phase|Withdrawal by Subject|22
145930|NCT00417989|477112|P2|Overall Study|Physician Decision|2
145931|NCT00417989|477113|P1|Overall Study|Physician Decision|5
145932|NCT00417989|477112|P2|Overall Study|Death|1
145933|NCT00417989|477113|P1|Overall Study|Death|0
145934|NCT00417989|477112|P2|Overall Study|Protocol Violation|0
145935|NCT00417989|477113|P1|Overall Study|Protocol Violation|1
145936|NCT00417989|477112|P2|Overall Study|Lost to Follow-up|6
145937|NCT00417989|477113|P1|Overall Study|Lost to Follow-up|1
145938|NCT00417989|477112|P2|Overall Study|Withdrawal by Subject|13
145939|NCT00417989|477113|P1|Overall Study|Withdrawal by Subject|13
145940|NCT00417976|477133|P1|Overall Study|Treatment -related toxicity|2
145941|NCT00417976|477133|P1|Overall Study|Non compliance unrelated to toxicity|1
145942|NCT00417963|477138|P1|Overall Study|Study device could not be deployed|3
145943|NCT00417963|477138|P1|Overall Study|Death|17
145944|NCT00417963|477138|P1|Overall Study|Withdrawal by Subject|18
145945|NCT00417963|477138|P1|Overall Study|Lost to Follow-up|3
145946|NCT00417885|477155|P1|Overall Study|Transferred to Another Sunitinib Study|2
145947|NCT00417885|477155|P1|Overall Study|Objective Progression or Relapse|3
145948|NCT00417885|477155|P1|Overall Study|Adverse Event|1
145949|NCT00417612|477166|P2|Overall Study|Lost to Follow-up|0
145950|NCT00417612|477167|P1|Overall Study|Lost to Follow-up|1
145951|NCT00417612|477166|P2|Overall Study|Protocol Violation|2
145952|NCT00417612|477167|P1|Overall Study|Protocol Violation|0
145953|NCT00417612|477166|P2|Overall Study|Adverse Event|0
145954|NCT00417612|477167|P1|Overall Study|Adverse Event|2
145955|NCT00417612|477166|P2|Overall Study|Errant diagnosis|1
145956|NCT00417612|477167|P1|Overall Study|Errant diagnosis|0
145957|NCT00417482|477193|P3|Phase B 2nd 16 Weeks|Death|0
145958|NCT00417482|477194|P2|Phase B 2nd 16 Weeks|Death|1
145959|NCT00417482|477195|P1|Phase B 2nd 16 Weeks|Death|1
145960|NCT00417482|477193|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
145961|NCT00417482|477194|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
145962|NCT00417482|477195|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
145963|NCT00417482|477193|P3|Phase B 2nd 16 Weeks|Adverse Event|1
145964|NCT00417482|477194|P2|Phase B 2nd 16 Weeks|Adverse Event|0
145965|NCT00417482|477195|P1|Phase B 2nd 16 Weeks|Adverse Event|0
145966|NCT00417482|477193|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
145967|NCT00417482|477194|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
145968|NCT00417482|477195|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
145969|NCT00417482|477193|P3|Phase B 1st 16 Weeks|Death|0
145970|NCT00417482|477194|P2|Phase B 1st 16 Weeks|Death|0
145971|NCT00417482|477195|P1|Phase B 1st 16 Weeks|Death|1
145972|NCT00417482|477193|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
145973|NCT00417482|477194|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
145974|NCT00417482|477195|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
145975|NCT00417482|477193|P3|Phase B 1st 16 Weeks|Adverse Event|1
145976|NCT00417482|477194|P2|Phase B 1st 16 Weeks|Adverse Event|0
145977|NCT00417482|477195|P1|Phase B 1st 16 Weeks|Adverse Event|2
145978|NCT00417482|477193|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
145979|NCT00417482|477194|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
145980|NCT00417482|477195|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
145981|NCT00417248|477234|P1|Overall Study|Lack of Efficacy|1
145982|NCT00417248|477234|P1|Overall Study|Death|1
145983|NCT00417248|477234|P1|Overall Study|Study Terminated|6
145984|NCT00417170|477241|P2|Overall Study|Lost to Follow-up|1
145985|NCT00417170|477242|P1|Overall Study|Lost to Follow-up|0
145986|NCT00417170|477241|P2|Overall Study|Withdrawal by Subject|1
145987|NCT00417170|477242|P1|Overall Study|Withdrawal by Subject|1
145988|NCT00417170|477241|P2|Overall Study|Adverse Event|1
145989|NCT00417170|477242|P1|Overall Study|Adverse Event|1
145990|NCT00417079|477258|P2|Overall Study|abnormal liver function tests|1
145991|NCT00417079|477259|P1|Overall Study|abnormal liver function tests|0
145992|NCT00417079|477258|P2|Overall Study|Patient unable to come to the clinic|1
145993|NCT00417079|477259|P1|Overall Study|Patient unable to come to the clinic|0
145994|NCT00417079|477258|P2|Overall Study|Withdrawal by subject's family|1
145995|NCT00417079|477259|P1|Overall Study|Withdrawal by subject's family|0
145996|NCT00417079|477258|P2|Overall Study|Screening error|1
145997|NCT00417079|477259|P1|Overall Study|Screening error|2
145998|NCT00417079|477258|P2|Overall Study|Clinical deterioration|0
145999|NCT00417079|477259|P1|Overall Study|Clinical deterioration|1
146000|NCT00417079|477258|P2|Overall Study|Non-confirmed Disease progression|1
146001|NCT00417079|477259|P1|Overall Study|Non-confirmed Disease progression|1
146002|NCT00417079|477258|P2|Overall Study|Investigator's decision|4
146003|NCT00417079|477259|P1|Overall Study|Investigator's decision|1
146004|NCT00417079|477258|P2|Overall Study|Screened failure|1
146005|NCT00417079|477259|P1|Overall Study|Screened failure|2
146006|NCT00417079|477258|P2|Overall Study|Not treated|7
146007|NCT00417079|477259|P1|Overall Study|Not treated|6
146008|NCT00417079|477258|P2|Overall Study|Withdrawal by Subject|8
146009|NCT00417079|477259|P1|Overall Study|Withdrawal by Subject|17
146010|NCT00417079|477258|P2|Overall Study|Lost to Follow-up|0
146011|NCT00417079|477259|P1|Overall Study|Lost to Follow-up|2
146012|NCT00417079|477258|P2|Overall Study|Non-compliance to protocol|1
146013|NCT00417079|477259|P1|Overall Study|Non-compliance to protocol|0
146014|NCT00417079|477258|P2|Overall Study|Adverse Event|67
146015|NCT00417079|477259|P1|Overall Study|Adverse Event|32
146016|NCT00417079|477258|P2|Overall Study|Disease progression|180
146017|NCT00417079|477259|P1|Overall Study|Disease progression|267
146018|NCT00417027|477282|P3|Overall Study|Protocol Violation|5
146019|NCT00417027|477283|P2|Overall Study|Protocol Violation|5
146020|NCT00417027|477284|P1|Overall Study|Protocol Violation|0
146021|NCT00416884|477310|P1|Overall Study|Study terminated due to low accrual|1
146022|NCT00416624|477322|P4|Overall Study|Cancel|0
146023|NCT00416624|477323|P3|Overall Study|Cancel|0
146024|NCT00416624|477324|P2|Overall Study|Cancel|0
146025|NCT00416624|477325|P1|Overall Study|Cancel|1
146026|NCT00416624|477322|P4|Overall Study|Not Specified|5
146027|NCT00416624|477323|P3|Overall Study|Not Specified|5
146028|NCT00416624|477324|P2|Overall Study|Not Specified|11
146029|NCT00416624|477325|P1|Overall Study|Not Specified|8
146030|NCT00416624|477322|P4|Overall Study|Adverse Event|2
146031|NCT00416624|477323|P3|Overall Study|Adverse Event|2
146032|NCT00416624|477324|P2|Overall Study|Adverse Event|3
146033|NCT00416624|477325|P1|Overall Study|Adverse Event|8
146034|NCT00416624|477322|P4|Overall Study|Death|1
146035|NCT00416624|477323|P3|Overall Study|Death|7
146036|NCT00416624|477324|P2|Overall Study|Death|7
146037|NCT00416624|477325|P1|Overall Study|Death|4
146038|NCT00416624|477322|P4|Overall Study|Withdrawal by Subject|9
146039|NCT00416624|477323|P3|Overall Study|Withdrawal by Subject|4
146040|NCT00416624|477324|P2|Overall Study|Withdrawal by Subject|6
146041|NCT00416624|477325|P1|Overall Study|Withdrawal by Subject|1
146042|NCT00416598|477379|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
146043|NCT00416598|477379|P1|Decitabine Maintenance|Alternative treatment|2
146044|NCT00416598|477379|P1|Decitabine Maintenance|Progression/relapse|38
146045|NCT00416598|477379|P1|Decitabine Maintenance|Withdrawal by Subject|18
146046|NCT00416598|477379|P1|Decitabine Maintenance|Adverse Event|5
146047|NCT00416598|477379|P1|Induction & Intensification|Failed induction|87
146048|NCT00416598|477379|P1|Induction & Intensification|Relapse/progression|29
146049|NCT00416598|477379|P1|Induction & Intensification|Physician discretion/other medical issue|45
146050|NCT00416598|477379|P1|Induction & Intensification|Alternative Treatment|135
146051|NCT00416598|477379|P1|Induction & Intensification|Withdrawal by Subject|46
146052|NCT00416598|477379|P1|Induction & Intensification|Death|32
146053|NCT00416598|477379|P1|Induction & Intensification|Adverse Event|38
146054|NCT00416520|477405|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
146055|NCT00416520|477406|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
146056|NCT00416520|477407|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
146057|NCT00416520|477408|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
146058|NCT00416520|477405|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
146059|NCT00416520|477406|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
146060|NCT00416520|477407|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
146061|NCT00416520|477408|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
146062|NCT00416520|477405|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
146063|NCT00416520|477406|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
146064|NCT00416520|477407|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
146065|NCT00416520|477408|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
146066|NCT00416520|477405|P4|Open-label Period|Other Reasons|0
146067|NCT00416520|477406|P3|Open-label Period|Other Reasons|0
146068|NCT00416520|477407|P2|Open-label Period|Other Reasons|12
146069|NCT00416520|477408|P1|Open-label Period|Other Reasons|3
146070|NCT00416520|477405|P4|Open-label Period|Withdrawal by Subject|0
146071|NCT00416520|477406|P3|Open-label Period|Withdrawal by Subject|0
146072|NCT00416520|477407|P2|Open-label Period|Withdrawal by Subject|5
146073|NCT00416520|477408|P1|Open-label Period|Withdrawal by Subject|16
146074|NCT00416520|477405|P4|Open-label Period|Protocol Violation|0
146075|NCT00416520|477406|P3|Open-label Period|Protocol Violation|0
146076|NCT00416520|477407|P2|Open-label Period|Protocol Violation|3
146077|NCT00416520|477408|P1|Open-label Period|Protocol Violation|3
146078|NCT00416520|477405|P4|Open-label Period|Lack of Efficacy|0
146079|NCT00416520|477406|P3|Open-label Period|Lack of Efficacy|0
146080|NCT00416520|477407|P2|Open-label Period|Lack of Efficacy|1
146081|NCT00416520|477408|P1|Open-label Period|Lack of Efficacy|8
146082|NCT00416520|477405|P4|Open-label Period|Death|0
146083|NCT00416520|477406|P3|Open-label Period|Death|0
146084|NCT00416520|477407|P2|Open-label Period|Death|1
146085|NCT00416520|477408|P1|Open-label Period|Death|2
146086|NCT00416520|477405|P4|Open-label Period|Adverse Event|0
146087|NCT00416520|477406|P3|Open-label Period|Adverse Event|0
146088|NCT00416520|477407|P2|Open-label Period|Adverse Event|10
146089|NCT00416520|477408|P1|Open-label Period|Adverse Event|28
146090|NCT00416455|477437|P2|Overall Study|Inadequate pathology|2
146091|NCT00416455|477438|P1|Overall Study|Inadequate pathology|11
146092|NCT00416455|477437|P2|Overall Study|PET / CT poor quality|1
146093|NCT00416455|477438|P1|Overall Study|PET / CT poor quality|2
146094|NCT00416455|477437|P2|Overall Study|PET / CT not done|5
146095|NCT00416455|477438|P1|Overall Study|PET / CT not done|3
146096|NCT00415532|477452|P2|Safety Follow Up Period|Requirement for alternative therapy|1
146097|NCT00415532|477453|P1|Safety Follow Up Period|Requirement for alternative therapy|0
146098|NCT00415532|477452|P2|Safety Follow Up Period|Noncompliance|0
146099|NCT00415532|477453|P1|Safety Follow Up Period|Noncompliance|1
146100|NCT00415532|477452|P2|Safety Follow Up Period|Ineligibility determined|1
146101|NCT00415532|477453|P1|Safety Follow Up Period|Ineligibility determined|1
146102|NCT00415532|477452|P2|Safety Follow Up Period|Other|4
146103|NCT00415532|477453|P1|Safety Follow Up Period|Other|1
146104|NCT00415532|477452|P2|Safety Follow Up Period|Withdrawal by Subject|3
146105|NCT00415532|477453|P1|Safety Follow Up Period|Withdrawal by Subject|2
146106|NCT00415532|477452|P2|Safety Follow Up Period|Death|0
146107|NCT00415532|477453|P1|Safety Follow Up Period|Death|3
146108|NCT00415532|477452|P2|Safety Follow Up Period|Adverse Event|3
146109|NCT00415532|477453|P1|Safety Follow Up Period|Adverse Event|1
146110|NCT00415532|477452|P2|Treatment Period|Requirement for alternative therapy|0
146111|NCT00415532|477453|P1|Treatment Period|Requirement for alternative therapy|1
146112|NCT00415532|477452|P2|Treatment Period|Noncompliance|1
146113|NCT00415532|477453|P1|Treatment Period|Noncompliance|1
146114|NCT00415532|477452|P2|Treatment Period|Ineligibility determined|1
146115|NCT00415532|477453|P1|Treatment Period|Ineligibility determined|1
146116|NCT00415532|477452|P2|Treatment Period|Other|2
146117|NCT00415532|477453|P1|Treatment Period|Other|2
146118|NCT00415532|477452|P2|Treatment Period|Withdrawal by Subject|6
146119|NCT00415532|477453|P1|Treatment Period|Withdrawal by Subject|6
146120|NCT00415532|477452|P2|Treatment Period|Protocol Violation|0
146121|NCT00415532|477453|P1|Treatment Period|Protocol Violation|1
146122|NCT00415532|477452|P2|Treatment Period|Lost to Follow-up|1
146123|NCT00415532|477453|P1|Treatment Period|Lost to Follow-up|1
146124|NCT00415532|477452|P2|Treatment Period|Death|1
146125|NCT00415532|477453|P1|Treatment Period|Death|2
146126|NCT00415532|477452|P2|Treatment Period|Adverse Event|3
146127|NCT00415532|477453|P1|Treatment Period|Adverse Event|2
146128|NCT00416195|477495|P2|Overall Study|Not Specified|1
146129|NCT00416195|477496|P1|Overall Study|Not Specified|0
146130|NCT00416195|477495|P2|Overall Study|Protocol Violation|1
146131|NCT00416195|477496|P1|Overall Study|Protocol Violation|1
146132|NCT00416195|477495|P2|Overall Study|Adverse Event|2
146133|NCT00416195|477496|P1|Overall Study|Adverse Event|1
146134|NCT00416078|477521|P2|Overall Study|Lost to Follow-up|2
146135|NCT00416078|477522|P1|Overall Study|Lost to Follow-up|4
146136|NCT00416078|477521|P2|Overall Study|Physician Decision|0
146137|NCT00416078|477522|P1|Overall Study|Physician Decision|1
146138|NCT00416078|477521|P2|Overall Study|Withdrawal by Subject|2
146139|NCT00416078|477522|P1|Overall Study|Withdrawal by Subject|3
146140|NCT00416078|477521|P2|Overall Study|Death|4
146141|NCT00416078|477522|P1|Overall Study|Death|3
146142|NCT00415909|477538|P1|Overall Study|Death|1
146143|NCT00415909|477538|P1|Overall Study|Withdrawal by Subject|2
146144|NCT00415623|477564|P2|Overall Study|Withdrawal by Subject|1
146145|NCT00415623|477565|P1|Overall Study|Withdrawal by Subject|1
146146|NCT00415623|477564|P2|Overall Study|Death|0
146147|NCT00415623|477565|P1|Overall Study|Death|1
146148|NCT00415623|477564|P2|Overall Study|Adverse Event|4
146149|NCT00415623|477565|P1|Overall Study|Adverse Event|3
146150|NCT00415610|477592|P3|Overall Study|Death|5
146151|NCT00415610|477593|P2|Overall Study|Death|2
146152|NCT00415610|477594|P1|Overall Study|Death|3
146153|NCT00415597|477608|P1|Treatment|Multiple Reasons|1
146154|NCT00415597|477608|P1|Treatment|Sponsor Decision|1
146155|NCT00415597|477608|P1|Treatment|Administrative|3
146156|NCT00415597|477608|P1|Treatment|Drug Screen|2
146157|NCT00415597|477608|P1|Treatment|Lost to Follow-up|28
146158|NCT00415597|477608|P1|Treatment|Withdrawal by Subject|51
146159|NCT00415597|477608|P1|Treatment|Physician Decision|3
146160|NCT00415597|477608|P1|Treatment|Protocol Violation|67
146161|NCT00415597|477608|P1|Treatment|Lack of Efficacy|39
146162|NCT00415597|477608|P1|Treatment|Adverse Event|110
146163|NCT00415597|477608|P1|Enrollment|Protocol Violation|1
146164|NCT00415597|477608|P1|Enrollment|Withdrawal by Subject|1
146165|NCT00415194|477616|P2|Overall Study|Death Due to AE (Other Causes)|15
146166|NCT00415194|477617|P1|Overall Study|Death Due to AE (Other Causes)|27
146167|NCT00415194|477616|P2|Overall Study|Death Due to Procedural Related AE|1
146168|NCT00415194|477617|P1|Overall Study|Death Due to Procedural Related AE|0
146169|NCT00415194|477616|P2|Overall Study|Death Due to Study Drug Related AE|1
146170|NCT00415194|477617|P1|Overall Study|Death Due to Study Drug Related AE|11
146171|NCT00415194|477616|P2|Overall Study|Death Due to Study Disease|29
146172|NCT00415194|477617|P1|Overall Study|Death Due to Study Disease|26
146173|NCT00415194|477616|P2|Overall Study|Withdrawal by Subject|21
146174|NCT00415194|477617|P1|Overall Study|Withdrawal by Subject|28
146175|NCT00415194|477616|P2|Overall Study|Protocol Violation|2
146176|NCT00415194|477617|P1|Overall Study|Protocol Violation|4
146177|NCT00415194|477616|P2|Overall Study|Progressive Disease|217
146178|NCT00415194|477617|P1|Overall Study|Progressive Disease|180
146179|NCT00415194|477616|P2|Overall Study|Physician Decision|16
146180|NCT00415194|477617|P1|Overall Study|Physician Decision|10
146181|NCT00415194|477616|P2|Overall Study|Lost to Follow-up|0
146182|NCT00415194|477617|P1|Overall Study|Lost to Follow-up|1
146183|NCT00415194|477616|P2|Overall Study|Entry Criteria Not Met|8
146184|NCT00415194|477617|P1|Overall Study|Entry Criteria Not Met|4
146185|NCT00415194|477616|P2|Overall Study|Adverse Event|32
146186|NCT00415194|477617|P1|Overall Study|Adverse Event|37
146187|NCT00415168|477633|P1|Overall Study|Withdrawal by Subject|6
146188|NCT00415168|477633|P1|Overall Study|Sponsor Decision|4
146189|NCT00415168|477633|P1|Overall Study|Physician Decision|13
146190|NCT00415168|477633|P1|Overall Study|Lost to Follow-up|3
146191|NCT00415168|477633|P1|Overall Study|Death|26
146192|NCT00415051|477643|P1|Overall Study|Protocol Violation|1
146193|NCT00414973|477654|P4|Overall Study|Death|0
146194|NCT00414973|477655|P3|Overall Study|Death|1
146195|NCT00414973|477656|P2|Overall Study|Death|0
146196|NCT00414973|477657|P1|Overall Study|Death|0
146197|NCT00414973|477654|P4|Overall Study|Sponsor Decision|0
146198|NCT00414973|477655|P3|Overall Study|Sponsor Decision|0
146199|NCT00414973|477656|P2|Overall Study|Sponsor Decision|0
146200|NCT00414973|477657|P1|Overall Study|Sponsor Decision|1
146201|NCT00414973|477654|P4|Overall Study|Lost to Follow-up|0
146202|NCT00414973|477655|P3|Overall Study|Lost to Follow-up|0
146203|NCT00414973|477656|P2|Overall Study|Lost to Follow-up|2
146204|NCT00414973|477657|P1|Overall Study|Lost to Follow-up|0
146205|NCT00414973|477654|P4|Overall Study|Protocol Violation|0
146206|NCT00414973|477655|P3|Overall Study|Protocol Violation|0
146207|NCT00414973|477656|P2|Overall Study|Protocol Violation|4
146208|NCT00414973|477657|P1|Overall Study|Protocol Violation|3
146209|NCT00414973|477654|P4|Overall Study|Adverse Event|0
146210|NCT00414973|477655|P3|Overall Study|Adverse Event|1
146211|NCT00414973|477656|P2|Overall Study|Adverse Event|0
146212|NCT00414973|477657|P1|Overall Study|Adverse Event|10
146213|NCT00414973|477654|P4|Overall Study|Withdrawal by Subject|0
146214|NCT00414973|477655|P3|Overall Study|Withdrawal by Subject|1
146215|NCT00414973|477656|P2|Overall Study|Withdrawal by Subject|4
146216|NCT00414973|477657|P1|Overall Study|Withdrawal by Subject|14
146217|NCT00414908|477677|P2|Overall Study|Protocol Violation|1
146218|NCT00414908|477678|P1|Overall Study|Protocol Violation|1
146219|NCT00414726|477715|P2|Overall Study|Withdrawal by Subject|1
146220|NCT00414726|477716|P1|Overall Study|Withdrawal by Subject|0
146221|NCT00414661|477751|P4|Overall Study|Unspecified|0
146222|NCT00414661|477752|P3|Overall Study|Unspecified|0
146223|NCT00414661|477753|P2|Overall Study|Unspecified|3
146224|NCT00414661|477754|P1|Overall Study|Unspecified|6
146225|NCT00414661|477751|P4|Overall Study|Withdrawal by Subject|2
146226|NCT00414661|477752|P3|Overall Study|Withdrawal by Subject|2
146227|NCT00414661|477753|P2|Overall Study|Withdrawal by Subject|2
146228|NCT00414661|477754|P1|Overall Study|Withdrawal by Subject|5
146229|NCT00414661|477751|P4|Overall Study|Lost to Follow-up|1
146230|NCT00414661|477752|P3|Overall Study|Lost to Follow-up|0
146231|NCT00414661|477753|P2|Overall Study|Lost to Follow-up|4
146232|NCT00414661|477754|P1|Overall Study|Lost to Follow-up|1
146233|NCT00414661|477751|P4|Overall Study|Death|0
146234|NCT00414661|477752|P3|Overall Study|Death|0
146235|NCT00414661|477753|P2|Overall Study|Death|5
146236|NCT00414661|477754|P1|Overall Study|Death|2
146237|NCT00414609|477799|P3|Extension Study|Death|17
146238|NCT00414609|477800|P2|Extension Study|Death|0
146239|NCT00414609|477801|P1|Extension Study|Death|0
146240|NCT00414609|477799|P3|Extension Study|Administrative problems|1
146241|NCT00414609|477800|P2|Extension Study|Administrative problems|0
146242|NCT00414609|477801|P1|Extension Study|Administrative problems|0
146243|NCT00414609|477799|P3|Extension Study|Lost to Follow-up|10
146244|NCT00414609|477800|P2|Extension Study|Lost to Follow-up|0
146245|NCT00414609|477801|P1|Extension Study|Lost to Follow-up|0
146246|NCT00414609|477799|P3|Extension Study|Withdrawal by Subject|13
146247|NCT00414609|477800|P2|Extension Study|Withdrawal by Subject|0
146248|NCT00414609|477801|P1|Extension Study|Withdrawal by Subject|0
146249|NCT00414609|477799|P3|Extension Study|Unsatisfactory therapeutic effect|2
146250|NCT00414609|477800|P2|Extension Study|Unsatisfactory therapeutic effect|0
146251|NCT00414609|477801|P1|Extension Study|Unsatisfactory therapeutic effect|0
146252|NCT00414609|477799|P3|Extension Study|Adverse Event|14
146253|NCT00414609|477800|P2|Extension Study|Adverse Event|0
146254|NCT00414609|477801|P1|Extension Study|Adverse Event|0
146255|NCT00414609|477799|P3|Core Study|Death|0
146256|NCT00414609|477800|P2|Core Study|Death|14
146257|NCT00414609|477801|P1|Core Study|Death|7
146258|NCT00414609|477799|P3|Core Study|Administrative problems|0
146259|NCT00414609|477800|P2|Core Study|Administrative problems|2
146260|NCT00414609|477801|P1|Core Study|Administrative problems|0
146261|NCT00414609|477799|P3|Core Study|Lost to Follow-up|0
146262|NCT00414609|477800|P2|Core Study|Lost to Follow-up|4
146263|NCT00414609|477801|P1|Core Study|Lost to Follow-up|7
146264|NCT00414609|477799|P3|Core Study|Patient withdrew consent|0
146265|NCT00414609|477800|P2|Core Study|Patient withdrew consent|11
146266|NCT00414609|477801|P1|Core Study|Patient withdrew consent|10
146267|NCT00414609|477799|P3|Core Study|Protocol deviation|0
146268|NCT00414609|477800|P2|Core Study|Protocol deviation|1
146269|NCT00414609|477801|P1|Core Study|Protocol deviation|0
146270|NCT00414609|477799|P3|Core Study|Abnormal test procedure results|0
146271|NCT00414609|477800|P2|Core Study|Abnormal test procedure results|1
146272|NCT00414609|477801|P1|Core Study|Abnormal test procedure results|1
146273|NCT00414609|477799|P3|Core Study|Abnormal laboratory values|0
146274|NCT00414609|477800|P2|Core Study|Abnormal laboratory values|1
146275|NCT00414609|477801|P1|Core Study|Abnormal laboratory values|0
146276|NCT00414609|477799|P3|Core Study|Adverse Event|0
146277|NCT00414609|477800|P2|Core Study|Adverse Event|11
146278|NCT00414609|477801|P1|Core Study|Adverse Event|9
146279|NCT00414596|477824|P1|Overall Study|Protocol Violation|2
146280|NCT00414544|477833|P1|Overall Study|Lost to Follow-up|14
146281|NCT00414466|477856|P4|Overall Study|Withdrawn by Sponsor|0
146282|NCT00414466|477857|P3|Overall Study|Withdrawn by Sponsor|0
146283|NCT00414466|477858|P2|Overall Study|Withdrawn by Sponsor|0
146284|NCT00414466|477859|P1|Overall Study|Withdrawn by Sponsor|1
146285|NCT00414466|477856|P4|Overall Study|Lack of Efficacy|0
146286|NCT00414466|477857|P3|Overall Study|Lack of Efficacy|0
146287|NCT00414466|477858|P2|Overall Study|Lack of Efficacy|0
146288|NCT00414466|477859|P1|Overall Study|Lack of Efficacy|1
146289|NCT00414466|477856|P4|Overall Study|Adverse Event|1
146290|NCT00414466|477857|P3|Overall Study|Adverse Event|1
146291|NCT00414466|477858|P2|Overall Study|Adverse Event|0
146292|NCT00414466|477859|P1|Overall Study|Adverse Event|0
146293|NCT00414453|477877|P1|Overall Study|Abnormal lab work|16
146294|NCT00414440|477925|P2|Extension Period|Not included in follow up period|8
146295|NCT00414440|477926|P1|Extension Period|Not included in follow up period|18
146296|NCT00414440|477925|P2|Extension Period|Withdrawal by Subject|7
146297|NCT00414440|477926|P1|Extension Period|Withdrawal by Subject|9
146298|NCT00414440|477925|P2|Extension Period|Death|2
146299|NCT00414440|477926|P1|Extension Period|Death|1
146300|NCT00414440|477925|P2|Extension Period|Administrative|16
146301|NCT00414440|477926|P1|Extension Period|Administrative|16
146302|NCT00414440|477925|P2|Extension Period|Other|1
146303|NCT00414440|477926|P1|Extension Period|Other|1
146304|NCT00414440|477925|P2|Extension Period|Did not consent to continue follow up|54
146305|NCT00414440|477926|P1|Extension Period|Did not consent to continue follow up|61
146306|NCT00414440|477925|P2|Extension Period|Lost to Follow-up|52
146307|NCT00414440|477926|P1|Extension Period|Lost to Follow-up|44
146308|NCT00414440|477925|P2|Core Period|Withdrawal by Subject|32
146309|NCT00414440|477926|P1|Core Period|Withdrawal by Subject|70
146310|NCT00414388|477940|P1|Overall Study|Adverse Event|1
146311|NCT00414310|477948|P2|Overall Study|Not treated|0
146312|NCT00414310|477949|P1|Overall Study|Not treated|1
146313|NCT00414050|477983|P4|Overall Study|Subject Moved|1
146314|NCT00414050|477984|P3|Overall Study|Subject Moved|0
146315|NCT00414050|477985|P2|Overall Study|Subject Moved|0
146316|NCT00414050|477986|P1|Overall Study|Subject Moved|0
146317|NCT00414050|477983|P4|Overall Study|Subject discontinued for other reason|1
146318|NCT00414050|477984|P3|Overall Study|Subject discontinued for other reason|2
146319|NCT00414050|477985|P2|Overall Study|Subject discontinued for other reason|2
146320|NCT00414050|477986|P1|Overall Study|Subject discontinued for other reason|1
146321|NCT00414050|477983|P4|Overall Study|Withdrawal by Subject|4
146322|NCT00414050|477984|P3|Overall Study|Withdrawal by Subject|2
146323|NCT00414050|477985|P2|Overall Study|Withdrawal by Subject|3
146324|NCT00414050|477986|P1|Overall Study|Withdrawal by Subject|5
146325|NCT00414050|477983|P4|Overall Study|Lost to Follow-up|1
146326|NCT00414050|477984|P3|Overall Study|Lost to Follow-up|1
146327|NCT00414050|477985|P2|Overall Study|Lost to Follow-up|2
146328|NCT00414050|477986|P1|Overall Study|Lost to Follow-up|2
146329|NCT00414050|477983|P4|Overall Study|Adverse Event|1
146330|NCT00414050|477984|P3|Overall Study|Adverse Event|1
146331|NCT00414050|477985|P2|Overall Study|Adverse Event|1
146332|NCT00414050|477986|P1|Overall Study|Adverse Event|1
146333|NCT00414011|478000|P1|Overall Study|Withdrawal by Subject|2
146334|NCT00414011|478000|P1|Overall Study|Physician Decision|3
146335|NCT00413972|478009|P4|Overall Study|Not Specified|1
146336|NCT00413972|478010|P3|Overall Study|Not Specified|0
146337|NCT00413972|478011|P2|Overall Study|Not Specified|0
146338|NCT00413972|478012|P1|Overall Study|Not Specified|0
146339|NCT00413972|478009|P4|Overall Study|Protocol Violation|0
146340|NCT00413972|478010|P3|Overall Study|Protocol Violation|2
146341|NCT00413972|478011|P2|Overall Study|Protocol Violation|0
146342|NCT00413972|478012|P1|Overall Study|Protocol Violation|0
146343|NCT00413972|478009|P4|Overall Study|Withdrawal by Subject|2
146344|NCT00413972|478010|P3|Overall Study|Withdrawal by Subject|7
146345|NCT00413972|478011|P2|Overall Study|Withdrawal by Subject|5
146346|NCT00413972|478012|P1|Overall Study|Withdrawal by Subject|4
146347|NCT00413972|478009|P4|Overall Study|Lost to Follow-up|0
146348|NCT00413972|478010|P3|Overall Study|Lost to Follow-up|1
146349|NCT00413972|478011|P2|Overall Study|Lost to Follow-up|2
146350|NCT00413972|478012|P1|Overall Study|Lost to Follow-up|1
146351|NCT00413972|478009|P4|Overall Study|Adverse Event|0
146352|NCT00413972|478010|P3|Overall Study|Adverse Event|0
146353|NCT00413972|478011|P2|Overall Study|Adverse Event|1
146354|NCT00413972|478012|P1|Overall Study|Adverse Event|2
146355|NCT00413959|478022|P1|Overall Study|Pt had only one cycle.|1
146356|NCT00413920|478029|P2|Overall Study|Graft Loss|3
146357|NCT00413920|478030|P1|Overall Study|Graft Loss|5
146358|NCT00413920|478029|P2|Overall Study|Death|5
146359|NCT00413920|478030|P1|Overall Study|Death|3
146360|NCT00413920|478029|P2|Overall Study|Lack of Efficacy|9
146361|NCT00413920|478030|P1|Overall Study|Lack of Efficacy|11
146362|NCT00413920|478029|P2|Overall Study|Adverse Event|11
146363|NCT00413920|478030|P1|Overall Study|Adverse Event|9
146364|NCT00413894|478045|P1|Overall Study|Unspecified|18
146365|NCT00413894|478045|P1|Overall Study|Protocol Violation|11
146366|NCT00413894|478045|P1|Overall Study|Adverse Event|28
146367|NCT00413894|478045|P1|Overall Study|Hb <10 grams/deciliter|12
146368|NCT00413894|478045|P1|Overall Study|Administrative Reasons|1
146369|NCT00413894|478045|P1|Overall Study|Withdrawal by Subject|10
146370|NCT00413660|478067|P11|Post Week 12|Unspecified|0
146371|NCT00413660|478068|P10|Post Week 12|Unspecified|0
146372|NCT00413660|478069|P9|Post Week 12|Unspecified|0
146373|NCT00413660|478070|P8|Post Week 12|Unspecified|0
146374|NCT00413660|478071|P7|Post Week 12|Unspecified|1
146375|NCT00413660|478072|P6|Post Week 12|Unspecified|1
146376|NCT00413660|478073|P5|Post Week 12|Unspecified|1
146377|NCT00413660|478074|P4|Post Week 12|Unspecified|0
146378|NCT00413660|478075|P3|Post Week 12|Unspecified|3
146379|NCT00413660|478076|P2|Post Week 12|Unspecified|2
146380|NCT00413660|478077|P1|Post Week 12|Unspecified|1
146381|NCT00413660|478067|P11|Post Week 12|Withdrawal by Subject|1
146382|NCT00413660|478068|P10|Post Week 12|Withdrawal by Subject|0
146383|NCT00413660|478069|P9|Post Week 12|Withdrawal by Subject|0
146384|NCT00413660|478070|P8|Post Week 12|Withdrawal by Subject|0
146385|NCT00413660|478071|P7|Post Week 12|Withdrawal by Subject|0
146386|NCT00413660|478072|P6|Post Week 12|Withdrawal by Subject|0
146387|NCT00413660|478073|P5|Post Week 12|Withdrawal by Subject|1
146388|NCT00413660|478074|P4|Post Week 12|Withdrawal by Subject|0
146389|NCT00413660|478075|P3|Post Week 12|Withdrawal by Subject|1
146390|NCT00413660|478076|P2|Post Week 12|Withdrawal by Subject|1
146391|NCT00413660|478077|P1|Post Week 12|Withdrawal by Subject|0
146392|NCT00413660|478067|P11|Post Week 12|Lost to Follow-up|0
146393|NCT00413660|478068|P10|Post Week 12|Lost to Follow-up|0
146394|NCT00413660|478069|P9|Post Week 12|Lost to Follow-up|0
146395|NCT00413660|478070|P8|Post Week 12|Lost to Follow-up|0
146396|NCT00413660|478071|P7|Post Week 12|Lost to Follow-up|0
146397|NCT00413660|478072|P6|Post Week 12|Lost to Follow-up|0
146398|NCT00413660|478073|P5|Post Week 12|Lost to Follow-up|0
146399|NCT00413660|478074|P4|Post Week 12|Lost to Follow-up|0
146400|NCT00413660|478075|P3|Post Week 12|Lost to Follow-up|1
146401|NCT00413660|478076|P2|Post Week 12|Lost to Follow-up|1
146402|NCT00413660|478077|P1|Post Week 12|Lost to Follow-up|0
146403|NCT00413660|478067|P11|Post Week 12|Lack of Efficacy|0
146404|NCT00413660|478068|P10|Post Week 12|Lack of Efficacy|1
146405|NCT00413660|478069|P9|Post Week 12|Lack of Efficacy|0
146406|NCT00413660|478070|P8|Post Week 12|Lack of Efficacy|0
146407|NCT00413660|478071|P7|Post Week 12|Lack of Efficacy|0
146408|NCT00413660|478072|P6|Post Week 12|Lack of Efficacy|0
146409|NCT00413660|478073|P5|Post Week 12|Lack of Efficacy|0
146410|NCT00413660|478074|P4|Post Week 12|Lack of Efficacy|0
146411|NCT00413660|478075|P3|Post Week 12|Lack of Efficacy|1
146412|NCT00413660|478076|P2|Post Week 12|Lack of Efficacy|0
146413|NCT00413660|478077|P1|Post Week 12|Lack of Efficacy|0
146414|NCT00413660|478067|P11|Post Week 12|Adverse Event|0
146415|NCT00413660|478068|P10|Post Week 12|Adverse Event|0
146416|NCT00413660|478069|P9|Post Week 12|Adverse Event|0
146417|NCT00413660|478070|P8|Post Week 12|Adverse Event|0
146418|NCT00413660|478071|P7|Post Week 12|Adverse Event|2
146419|NCT00413660|478072|P6|Post Week 12|Adverse Event|2
146420|NCT00413660|478073|P5|Post Week 12|Adverse Event|4
146421|NCT00413660|478074|P4|Post Week 12|Adverse Event|1
146422|NCT00413660|478075|P3|Post Week 12|Adverse Event|2
146423|NCT00413660|478076|P2|Post Week 12|Adverse Event|0
146424|NCT00413660|478077|P1|Post Week 12|Adverse Event|2
146425|NCT00413660|478067|P11|Up To Week 12|Unspecified|0
146426|NCT00413660|478068|P10|Up To Week 12|Unspecified|0
146427|NCT00413660|478069|P9|Up To Week 12|Unspecified|0
146428|NCT00413660|478070|P8|Up To Week 12|Unspecified|0
146429|NCT00413660|478071|P7|Up To Week 12|Unspecified|3
146430|NCT00413660|478072|P6|Up To Week 12|Unspecified|4
146431|NCT00413660|478073|P5|Up To Week 12|Unspecified|2
146432|NCT00413660|478074|P4|Up To Week 12|Unspecified|1
146433|NCT00413660|478075|P3|Up To Week 12|Unspecified|6
146434|NCT00413660|478076|P2|Up To Week 12|Unspecified|1
146435|NCT00413660|478077|P1|Up To Week 12|Unspecified|3
146436|NCT00413660|478067|P11|Up To Week 12|Randomized, Not Treated|0
146437|NCT00413660|478068|P10|Up To Week 12|Randomized, Not Treated|0
146438|NCT00413660|478069|P9|Up To Week 12|Randomized, Not Treated|0
146439|NCT00413660|478070|P8|Up To Week 12|Randomized, Not Treated|0
146440|NCT00413660|478071|P7|Up To Week 12|Randomized, Not Treated|0
146441|NCT00413660|478072|P6|Up To Week 12|Randomized, Not Treated|0
146442|NCT00413660|478073|P5|Up To Week 12|Randomized, Not Treated|0
146443|NCT00413660|478074|P4|Up To Week 12|Randomized, Not Treated|1
146444|NCT00413660|478075|P3|Up To Week 12|Randomized, Not Treated|0
146445|NCT00413660|478076|P2|Up To Week 12|Randomized, Not Treated|0
146446|NCT00413660|478077|P1|Up To Week 12|Randomized, Not Treated|1
146447|NCT00413660|478067|P11|Up To Week 12|Withdrawal by Subject|0
146448|NCT00413660|478068|P10|Up To Week 12|Withdrawal by Subject|0
146449|NCT00413660|478069|P9|Up To Week 12|Withdrawal by Subject|0
146450|NCT00413660|478070|P8|Up To Week 12|Withdrawal by Subject|0
146451|NCT00413660|478071|P7|Up To Week 12|Withdrawal by Subject|2
146452|NCT00413660|478072|P6|Up To Week 12|Withdrawal by Subject|2
146453|NCT00413660|478073|P5|Up To Week 12|Withdrawal by Subject|0
146454|NCT00413660|478074|P4|Up To Week 12|Withdrawal by Subject|2
146455|NCT00413660|478075|P3|Up To Week 12|Withdrawal by Subject|0
146456|NCT00413660|478076|P2|Up To Week 12|Withdrawal by Subject|2
146457|NCT00413660|478077|P1|Up To Week 12|Withdrawal by Subject|0
146458|NCT00413660|478067|P11|Up To Week 12|Lost to Follow-up|0
146459|NCT00413660|478068|P10|Up To Week 12|Lost to Follow-up|0
146460|NCT00413660|478069|P9|Up To Week 12|Lost to Follow-up|0
146461|NCT00413660|478070|P8|Up To Week 12|Lost to Follow-up|0
146462|NCT00413660|478071|P7|Up To Week 12|Lost to Follow-up|0
146463|NCT00413660|478072|P6|Up To Week 12|Lost to Follow-up|0
146464|NCT00413660|478073|P5|Up To Week 12|Lost to Follow-up|1
146465|NCT00413660|478074|P4|Up To Week 12|Lost to Follow-up|0
146466|NCT00413660|478075|P3|Up To Week 12|Lost to Follow-up|0
146467|NCT00413660|478076|P2|Up To Week 12|Lost to Follow-up|1
146468|NCT00413660|478077|P1|Up To Week 12|Lost to Follow-up|0
146469|NCT00413660|478067|P11|Up To Week 12|Lack of Efficacy|0
146470|NCT00413660|478068|P10|Up To Week 12|Lack of Efficacy|0
146471|NCT00413660|478069|P9|Up To Week 12|Lack of Efficacy|0
146472|NCT00413660|478070|P8|Up To Week 12|Lack of Efficacy|0
146473|NCT00413660|478071|P7|Up To Week 12|Lack of Efficacy|5
146474|NCT00413660|478072|P6|Up To Week 12|Lack of Efficacy|0
146475|NCT00413660|478073|P5|Up To Week 12|Lack of Efficacy|0
146476|NCT00413660|478074|P4|Up To Week 12|Lack of Efficacy|0
146477|NCT00413660|478075|P3|Up To Week 12|Lack of Efficacy|0
146478|NCT00413660|478076|P2|Up To Week 12|Lack of Efficacy|0
146479|NCT00413660|478077|P1|Up To Week 12|Lack of Efficacy|2
146480|NCT00413660|478067|P11|Up To Week 12|Adverse Event|0
146481|NCT00413660|478068|P10|Up To Week 12|Adverse Event|0
146482|NCT00413660|478069|P9|Up To Week 12|Adverse Event|0
146483|NCT00413660|478070|P8|Up To Week 12|Adverse Event|0
146484|NCT00413660|478071|P7|Up To Week 12|Adverse Event|1
146485|NCT00413660|478072|P6|Up To Week 12|Adverse Event|4
146486|NCT00413660|478073|P5|Up To Week 12|Adverse Event|6
146487|NCT00413660|478074|P4|Up To Week 12|Adverse Event|4
146488|NCT00413660|478075|P3|Up To Week 12|Adverse Event|1
146489|NCT00413660|478076|P2|Up To Week 12|Adverse Event|3
146490|NCT00413660|478077|P1|Up To Week 12|Adverse Event|1
146491|NCT00413413|478480|P3|Double-Blind|Lost to Follow-up|2
146492|NCT00413413|478481|P2|Double-Blind|Lost to Follow-up|4
146493|NCT00413413|478482|P1|Double-Blind|Lost to Follow-up|3
146494|NCT00413413|478480|P3|Double-Blind|Subject withdrew consent|9
146495|NCT00413413|478481|P2|Double-Blind|Subject withdrew consent|6
146496|NCT00413413|478482|P1|Double-Blind|Subject withdrew consent|4
146497|NCT00413413|478480|P3|Double-Blind|Protocol deviation|1
146498|NCT00413413|478481|P2|Double-Blind|Protocol deviation|2
146499|NCT00413413|478482|P1|Double-Blind|Protocol deviation|1
146500|NCT00413413|478480|P3|Double-Blind|Unsatisfactory therapeutic effect|1
146501|NCT00413413|478481|P2|Double-Blind|Unsatisfactory therapeutic effect|2
146502|NCT00413413|478482|P1|Double-Blind|Unsatisfactory therapeutic effect|1
146503|NCT00413413|478480|P3|Double-Blind|Adverse Event|5
146504|NCT00413413|478481|P2|Double-Blind|Adverse Event|0
146505|NCT00413413|478482|P1|Double-Blind|Adverse Event|6
146506|NCT00413413|478480|P3|Single-Blind|Lost to Follow-up|0
146507|NCT00413413|478481|P2|Single-Blind|Lost to Follow-up|8
146508|NCT00413413|478482|P1|Single-Blind|Lost to Follow-up|0
146509|NCT00413413|478480|P3|Single-Blind|Withdrawal by Subject|0
146510|NCT00413413|478481|P2|Single-Blind|Withdrawal by Subject|27
146511|NCT00413413|478482|P1|Single-Blind|Withdrawal by Subject|0
146512|NCT00413413|478480|P3|Single-Blind|Protocol Violation|0
146513|NCT00413413|478481|P2|Single-Blind|Protocol Violation|16
146514|NCT00413413|478482|P1|Single-Blind|Protocol Violation|0
146515|NCT00413413|478480|P3|Single-Blind|Subject no longer requires study drug|0
146516|NCT00413413|478481|P2|Single-Blind|Subject no longer requires study drug|151
146517|NCT00413413|478482|P1|Single-Blind|Subject no longer requires study drug|0
146518|NCT00413413|478480|P3|Single-Blind|Lack of Efficacy|0
146519|NCT00413413|478481|P2|Single-Blind|Lack of Efficacy|5
146520|NCT00413413|478482|P1|Single-Blind|Lack of Efficacy|0
146521|NCT00413413|478480|P3|Single-Blind|Adverse Event|0
146522|NCT00413413|478481|P2|Single-Blind|Adverse Event|9
146523|NCT00413413|478482|P1|Single-Blind|Adverse Event|0
146524|NCT00413374|478533|P1|Overall Study|Surgery|1
146525|NCT00413374|478533|P1|Overall Study|Lost to Follow-up|1
146526|NCT00413374|478533|P1|Overall Study|Adverse Event|1
146527|NCT00413374|478533|P1|Overall Study|Ineligible due to screening criteria.|3
146528|NCT00413283|478559|P4|Overall Study|Not specified|0
146529|NCT00413283|478560|P3|Overall Study|Not specified|1
146530|NCT00413283|478561|P2|Overall Study|Not specified|0
146531|NCT00413283|478562|P1|Overall Study|Not specified|0
146532|NCT00413283|478559|P4|Overall Study|Requirement for alternative therapy|0
146533|NCT00413283|478560|P3|Overall Study|Requirement for alternative therapy|0
146534|NCT00413283|478561|P2|Overall Study|Requirement for alternative therapy|2
146535|NCT00413283|478562|P1|Overall Study|Requirement for alternative therapy|0
146536|NCT00413283|478559|P4|Overall Study|Protocol deviation|0
146537|NCT00413283|478560|P3|Overall Study|Protocol deviation|0
146538|NCT00413283|478561|P2|Overall Study|Protocol deviation|1
146539|NCT00413283|478562|P1|Overall Study|Protocol deviation|0
146540|NCT00413283|478559|P4|Overall Study|Ineligibility determined|1
146541|NCT00413283|478560|P3|Overall Study|Ineligibility determined|0
146542|NCT00413283|478561|P2|Overall Study|Ineligibility determined|0
146543|NCT00413283|478562|P1|Overall Study|Ineligibility determined|0
146544|NCT00413283|478559|P4|Overall Study|Adverse Event|1
146545|NCT00413283|478560|P3|Overall Study|Adverse Event|0
146546|NCT00413283|478561|P2|Overall Study|Adverse Event|0
146547|NCT00413283|478562|P1|Overall Study|Adverse Event|0
146548|NCT00413283|478559|P4|Overall Study|Death|1
146549|NCT00413283|478560|P3|Overall Study|Death|1
146550|NCT00413283|478561|P2|Overall Study|Death|0
146551|NCT00413283|478562|P1|Overall Study|Death|0
146552|NCT00413283|478559|P4|Overall Study|Withdrawal by Subject|1
146553|NCT00413283|478560|P3|Overall Study|Withdrawal by Subject|0
146554|NCT00413283|478561|P2|Overall Study|Withdrawal by Subject|0
146555|NCT00413283|478562|P1|Overall Study|Withdrawal by Subject|1
146556|NCT00413244|478594|P2|Overall Study|Withdrawal by Subject|1
146557|NCT00413244|478595|P1|Overall Study|Withdrawal by Subject|10
146558|NCT00413231|478623|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
146559|NCT00413231|478623|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
146560|NCT00413231|478623|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
146561|NCT00413231|478623|P1|365-day to 60-month Post Treatment|Death|36
146562|NCT00413231|478623|P1|30-day to 365-day Post Treatment|Death|13
146563|NCT00413231|478623|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
146564|NCT00413231|478623|P1|0 to 30-day Post Treatment|Death|5
146565|NCT00413153|478655|P2|Overall Study|Adverse Event|0
146566|NCT00413153|478656|P1|Overall Study|Adverse Event|1
146567|NCT00413153|478655|P2|Overall Study|Withdrawal by Subject|1
146568|NCT00413153|478656|P1|Overall Study|Withdrawal by Subject|1
146569|NCT00413062|478680|P2|Overall Study|Other reason|34
146570|NCT00413062|478681|P1|Overall Study|Other reason|70
146571|NCT00413062|478680|P2|Overall Study|Lost to Follow-up|73
146572|NCT00413062|478681|P1|Overall Study|Lost to Follow-up|175
146573|NCT00413062|478680|P2|Overall Study|Pregnancy wish|6
146574|NCT00413062|478681|P1|Overall Study|Pregnancy wish|17
146575|NCT00413062|478680|P2|Overall Study|Pregnancy|5
146576|NCT00413062|478681|P1|Overall Study|Pregnancy|15
146577|NCT00413062|478680|P2|Overall Study|Withdrawal of informed consent|36
146578|NCT00413062|478681|P1|Overall Study|Withdrawal of informed consent|111
146579|NCT00413062|478680|P2|Overall Study|Pre-treatment (serious) adverse event|0
146580|NCT00413062|478681|P1|Overall Study|Pre-treatment (serious) adverse event|1
146581|NCT00413062|478680|P2|Overall Study|Adverse event/serious adverse event|56
146582|NCT00413062|478681|P1|Overall Study|Adverse event/serious adverse event|289
146583|NCT00413049|478707|P2|Overall Study|Lack of Efficacy|0
146584|NCT00413049|478708|P1|Overall Study|Lack of Efficacy|1
146585|NCT00413049|478707|P2|Overall Study|Abnormal laboratory value(s)|0
146586|NCT00413049|478708|P1|Overall Study|Abnormal laboratory value(s)|1
146587|NCT00413049|478707|P2|Overall Study|Subject no longer requires study drug|1
146588|NCT00413049|478708|P1|Overall Study|Subject no longer requires study drug|0
146589|NCT00413049|478707|P2|Overall Study|Protocol Violation|1
146590|NCT00413049|478708|P1|Overall Study|Protocol Violation|3
146591|NCT00413049|478707|P2|Overall Study|Lost to Follow-up|3
146592|NCT00413049|478708|P1|Overall Study|Lost to Follow-up|2
146593|NCT00413049|478707|P2|Overall Study|Withdrawal by Subject|5
146594|NCT00413049|478708|P1|Overall Study|Withdrawal by Subject|7
146595|NCT00413049|478707|P2|Overall Study|Adverse Event|8
146596|NCT00413049|478708|P1|Overall Study|Adverse Event|10
146597|NCT00413036|478724|P1|Overall Study|Missing|2
146598|NCT00413036|478724|P1|Overall Study|Unspecified|26
146599|NCT00413036|478724|P1|Overall Study|Death|9
146600|NCT00413036|478724|P1|Overall Study|Withdrawal by Subject|7
146601|NCT00413036|478724|P1|Overall Study|Lack of Efficacy|129
146602|NCT00413036|478724|P1|Overall Study|Adverse Event|44
146603|NCT00413010|478734|P2|Overall Study|Due to termination of the study|52
146604|NCT00413010|478735|P1|Overall Study|Due to termination of the study|54
146605|NCT00413010|478734|P2|Overall Study|Withdrawal by Subject|2
146606|NCT00413010|478735|P1|Overall Study|Withdrawal by Subject|7
146607|NCT00413010|478734|P2|Overall Study|Lost to Follow-up|0
146608|NCT00413010|478735|P1|Overall Study|Lost to Follow-up|3
146609|NCT00413010|478734|P2|Overall Study|Lack of Efficacy|3
146610|NCT00413010|478735|P1|Overall Study|Lack of Efficacy|0
146611|NCT00413010|478734|P2|Overall Study|Laboratory abnormality|2
146612|NCT00413010|478735|P1|Overall Study|Laboratory abnormality|0
146613|NCT00413010|478734|P2|Overall Study|Adverse Event|4
146614|NCT00413010|478735|P1|Overall Study|Adverse Event|8
146615|NCT00412984|478757|P2|Overall Study|Not Reported|12
146616|NCT00412984|478758|P1|Overall Study|Not Reported|11
146617|NCT00412984|478757|P2|Overall Study|Other Reason|92
146618|NCT00412984|478758|P1|Overall Study|Other Reason|80
146619|NCT00412984|478757|P2|Overall Study|Physician Refused to Continue Treatment|89
146620|NCT00412984|478758|P1|Overall Study|Physician Refused to Continue Treatment|81
146621|NCT00412984|478757|P2|Overall Study|Administrative Reason by Sponsor|8
146622|NCT00412984|478758|P1|Overall Study|Administrative Reason by Sponsor|11
146623|NCT00412984|478757|P2|Overall Study|Subject No Longer Meets Study Criteria|100
146624|NCT00412984|478758|P1|Overall Study|Subject No Longer Meets Study Criteria|87
146625|NCT00412984|478757|P2|Overall Study|Pregnancy|0
146626|NCT00412984|478758|P1|Overall Study|Pregnancy|1
146627|NCT00412984|478757|P2|Overall Study|Poor/Noncompliance|77
146628|NCT00412984|478758|P1|Overall Study|Poor/Noncompliance|57
146629|NCT00412984|478757|P2|Overall Study|Lost to Follow-up|39
146630|NCT00412984|478758|P1|Overall Study|Lost to Follow-up|51
146631|NCT00412984|478757|P2|Overall Study|Withdrawal by Subject|989
146632|NCT00412984|478758|P1|Overall Study|Withdrawal by Subject|921
146633|NCT00412984|478757|P2|Overall Study|Adverse Event|738
146634|NCT00412984|478758|P1|Overall Study|Adverse Event|679
146635|NCT00412984|478757|P2|Overall Study|Death|349
146636|NCT00412984|478758|P1|Overall Study|Death|331
146637|NCT00412971|478802|P2|Overall Study|Protocol Violation|1
146638|NCT00412971|478803|P1|Overall Study|Protocol Violation|13
146639|NCT00412971|478802|P2|Overall Study|Lost to Follow-up|9
146640|NCT00412971|478803|P1|Overall Study|Lost to Follow-up|17
146641|NCT00412958|478816|P4|Overall Study|Transport issue|0
146642|NCT00412958|478817|P3|Overall Study|Transport issue|0
146643|NCT00412958|478818|P2|Overall Study|Transport issue|1
146644|NCT00412958|478819|P1|Overall Study|Transport issue|0
146645|NCT00412958|478816|P4|Overall Study|Death|0
146646|NCT00412958|478817|P3|Overall Study|Death|0
146647|NCT00412958|478818|P2|Overall Study|Death|1
146648|NCT00412958|478819|P1|Overall Study|Death|0
146649|NCT00412958|478816|P4|Overall Study|Lost to Follow-up|0
146650|NCT00412958|478817|P3|Overall Study|Lost to Follow-up|0
146651|NCT00412958|478818|P2|Overall Study|Lost to Follow-up|1
146652|NCT00412958|478819|P1|Overall Study|Lost to Follow-up|0
146653|NCT00412958|478816|P4|Overall Study|Adverse Event|0
146654|NCT00412958|478817|P3|Overall Study|Adverse Event|0
146655|NCT00412958|478818|P2|Overall Study|Adverse Event|1
146656|NCT00412958|478819|P1|Overall Study|Adverse Event|0
146657|NCT00412958|478816|P4|Overall Study|Withdrawal by Subject|1
146658|NCT00412958|478817|P3|Overall Study|Withdrawal by Subject|0
146659|NCT00412958|478818|P2|Overall Study|Withdrawal by Subject|0
146660|NCT00412958|478819|P1|Overall Study|Withdrawal by Subject|3
146661|NCT00412932|478829|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
146662|NCT00412932|478829|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
146663|NCT00412932|478829|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
146664|NCT00412932|478829|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
146665|NCT00412932|478829|P1|Olmesartan 40 mg|Withdrawal by Subject|1
146666|NCT00412932|478829|P1|Olmesartan 40 mg|Lack of Efficacy|3
146667|NCT00412932|478829|P1|Olmesartan 40 mg|Adverse Event|4
146668|NCT00412932|478829|P1|Olmesartan (Olm) 20 mg|Other|1
146669|NCT00412932|478829|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
146670|NCT00412932|478829|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
146671|NCT00412932|478829|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
146672|NCT00412932|478829|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
146673|NCT00412893|478840|P2|Overall Study|Randomized but Never Received Study Drug|6
146674|NCT00412893|478841|P1|Overall Study|Randomized but Never Received Study Drug|5
146675|NCT00412893|478840|P2|Overall Study|Administrative Reason|15
146676|NCT00412893|478841|P1|Overall Study|Administrative Reason|12
146677|NCT00412893|478840|P2|Overall Study|Did Not Cooperate|9
146678|NCT00412893|478841|P1|Overall Study|Did Not Cooperate|12
146679|NCT00412893|478840|P2|Overall Study|Other Protocol Violation|6
146680|NCT00412893|478841|P1|Overall Study|Other Protocol Violation|10
146681|NCT00412893|478840|P2|Overall Study|Violation of Selection at Entry|10
146682|NCT00412893|478841|P1|Overall Study|Violation of Selection at Entry|17
146683|NCT00412893|478840|P2|Overall Study|Lost to Follow-up|1
146684|NCT00412893|478841|P1|Overall Study|Lost to Follow-up|2
146685|NCT00412893|478840|P2|Overall Study|Insufficient Therapeutic Response|23
146686|NCT00412893|478841|P1|Overall Study|Insufficient Therapeutic Response|39
146687|NCT00412893|478840|P2|Overall Study|Death|21
146688|NCT00412893|478841|P1|Overall Study|Death|17
146689|NCT00412893|478840|P2|Overall Study|Adverse Event|53
146690|NCT00412893|478841|P1|Overall Study|Adverse Event|31
146691|NCT00412854|478876|P2|Overall Study|Withdrawn for other reasons|11
146692|NCT00412854|478877|P1|Overall Study|Withdrawn for other reasons|13
146693|NCT00412854|478876|P2|Overall Study|Withdrawn due to adverse events|5
146694|NCT00412854|478877|P1|Overall Study|Withdrawn due to adverse events|1
146695|NCT00412750|478917|P3|Overall Study|Lack of Efficacy|3
146696|NCT00412750|478918|P2|Overall Study|Lack of Efficacy|0
146697|NCT00412750|478919|P1|Overall Study|Lack of Efficacy|0
146698|NCT00412750|478917|P3|Overall Study|Withdrawal by Subject|2
146699|NCT00412750|478918|P2|Overall Study|Withdrawal by Subject|1
146700|NCT00412750|478919|P1|Overall Study|Withdrawal by Subject|0
146701|NCT00412750|478917|P3|Overall Study|Lost to Follow-up|1
146702|NCT00412750|478918|P2|Overall Study|Lost to Follow-up|0
146703|NCT00412750|478919|P1|Overall Study|Lost to Follow-up|1
146704|NCT00412750|478917|P3|Overall Study|Adverse Event|3
146705|NCT00412750|478918|P2|Overall Study|Adverse Event|3
146706|NCT00412750|478919|P1|Overall Study|Adverse Event|8
146707|NCT00412750|478917|P3|Overall Study|Administrative problems|14
146708|NCT00412750|478918|P2|Overall Study|Administrative problems|17
146709|NCT00412750|478919|P1|Overall Study|Administrative problems|21
146710|NCT00412750|478917|P3|Overall Study|Abnormal laboratory value(s)|0
146711|NCT00412750|478918|P2|Overall Study|Abnormal laboratory value(s)|0
146712|NCT00412750|478919|P1|Overall Study|Abnormal laboratory value(s)|1
146713|NCT00412737|478944|P2|Overall Study|Failure to Return|2
146714|NCT00412737|478945|P1|Overall Study|Failure to Return|6
146715|NCT00412737|478944|P2|Overall Study|Refused Treatment|2
146716|NCT00412737|478945|P1|Overall Study|Refused Treatment|6
146717|NCT00412737|478944|P2|Overall Study|Adverse Event|2
146718|NCT00412737|478945|P1|Overall Study|Adverse Event|3
146719|NCT00412737|478944|P2|Overall Study|Death|0
146720|NCT00412737|478945|P1|Overall Study|Death|1
146721|NCT00412607|478963|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
146722|NCT00412607|478963|P1|Overall Study|Death|61
146723|NCT00412607|478963|P1|Overall Study|Lost to Follow-up|19
146724|NCT00412607|478963|P1|Overall Study|Withdrawal by Subject|9
146725|NCT00412542|478976|P2|Overall Study|Not Eligible|1
146726|NCT00412542|478977|P1|Overall Study|Not Eligible|0
146727|NCT00412542|478976|P2|Overall Study|Withdrawal by Subject|2
146728|NCT00412542|478977|P1|Overall Study|Withdrawal by Subject|0
146729|NCT00412373|479062|P2|Overall Study|Not Specified|2
146730|NCT00412373|479063|P1|Overall Study|Not Specified|2
146731|NCT00412373|479062|P2|Overall Study|Withdrawal by Subject|27
146732|NCT00412373|479063|P1|Overall Study|Withdrawal by Subject|8
146733|NCT00412373|479062|P2|Overall Study|Lost to Follow-up|13
146734|NCT00412373|479063|P1|Overall Study|Lost to Follow-up|7
146735|NCT00412373|479062|P2|Overall Study|Lack of Efficacy|22
146736|NCT00412373|479063|P1|Overall Study|Lack of Efficacy|16
146737|NCT00412373|479062|P2|Overall Study|Adverse Event|13
146738|NCT00412373|479063|P1|Overall Study|Adverse Event|8
146739|NCT00412217|479136|P2|Overall Study|Not Specified|1
146740|NCT00412217|479137|P1|Overall Study|Not Specified|1
146741|NCT00412217|479136|P2|Overall Study|Study Terminated by Sponsor|33
146742|NCT00412217|479137|P1|Overall Study|Study Terminated by Sponsor|26
146743|NCT00412217|479136|P2|Overall Study|Lost to Follow-up|4
146744|NCT00412217|479137|P1|Overall Study|Lost to Follow-up|1
146745|NCT00412217|479136|P2|Overall Study|Withdrawal by Subject|0
146746|NCT00412217|479137|P1|Overall Study|Withdrawal by Subject|2
146747|NCT00412217|479136|P2|Overall Study|Investigator Decision|0
146748|NCT00412217|479137|P1|Overall Study|Investigator Decision|1
146749|NCT00412217|479136|P2|Overall Study|Disease Progression|3
146750|NCT00412217|479137|P1|Overall Study|Disease Progression|2
146751|NCT00412217|479136|P2|Overall Study|Death|4
146752|NCT00412217|479137|P1|Overall Study|Death|5
146753|NCT00412217|479136|P2|Overall Study|Insufficient Data Available|3
146754|NCT00412217|479137|P1|Overall Study|Insufficient Data Available|8
146755|NCT00412113|479151|P2|Overall Study|did not receive treatment|0
146756|NCT00412113|479152|P1|Overall Study|did not receive treatment|1
146757|NCT00412113|479151|P2|Overall Study|Adverse Event|15
146758|NCT00412113|479152|P1|Overall Study|Adverse Event|11
146759|NCT00412061|479236|P2|Open Label Phase|New Cancer Therapy|1
146760|NCT00412061|479237|P1|Open Label Phase|New Cancer Therapy|0
146761|NCT00412061|479236|P2|Open Label Phase|Lost to Follow-up|2
146762|NCT00412061|479237|P1|Open Label Phase|Lost to Follow-up|0
146763|NCT00412061|479236|P2|Open Label Phase|Death|7
146764|NCT00412061|479237|P1|Open Label Phase|Death|0
146765|NCT00412061|479236|P2|Open Label Phase|Administrative Problems|13
146766|NCT00412061|479237|P1|Open Label Phase|Administrative Problems|0
146767|NCT00412061|479236|P2|Open Label Phase|Withdrawal by Subject|15
146768|NCT00412061|479237|P1|Open Label Phase|Withdrawal by Subject|0
146769|NCT00412061|479236|P2|Open Label Phase|Adverse Event|46
146770|NCT00412061|479237|P1|Open Label Phase|Adverse Event|0
146771|NCT00412061|479236|P2|Open Label Phase|Disease Progression|86
146772|NCT00412061|479237|P1|Open Label Phase|Disease Progression|0
146773|NCT00412061|479236|P2|Double Blind Phase|Lost to Follow-up|1
146774|NCT00412061|479237|P1|Double Blind Phase|Lost to Follow-up|0
146775|NCT00412061|479236|P2|Double Blind Phase|New Cander Therapy|1
146776|NCT00412061|479237|P1|Double Blind Phase|New Cander Therapy|1
146777|NCT00412061|479236|P2|Double Blind Phase|Protocol Violation|4
146778|NCT00412061|479237|P1|Double Blind Phase|Protocol Violation|3
146779|NCT00412061|479236|P2|Double Blind Phase|Death|3
146780|NCT00412061|479237|P1|Double Blind Phase|Death|6
146781|NCT00412061|479236|P2|Double Blind Phase|Withdrawal by Subject|20
146782|NCT00412061|479237|P1|Double Blind Phase|Withdrawal by Subject|18
146783|NCT00412061|479236|P2|Double Blind Phase|Final Primary Analysis|14
146784|NCT00412061|479237|P1|Double Blind Phase|Final Primary Analysis|26
146785|NCT00412061|479236|P2|Double Blind Phase|Adverse Event|16
146786|NCT00412061|479237|P1|Double Blind Phase|Adverse Event|61
146787|NCT00412061|479236|P2|Double Blind Phase|Disease Progression|154
146788|NCT00412061|479237|P1|Double Blind Phase|Disease Progression|101
146789|NCT00411788|479255|P1|Overall Study|Adverse Event|1
146790|NCT00411788|479255|P1|Overall Study|Protocol Violation|1
146791|NCT00411762|479264|P1|Overall Study|Withdrawal by Subject|5
146792|NCT00411671|479288|P1|Overall Study|Lost to Follow-up|3
146793|NCT00411671|479288|P1|Overall Study|Death|2
146794|NCT00411671|479288|P1|Overall Study|Adverse Event|15
146795|NCT00411645|479296|P2|Overall Study|Lost to Follow-up|0
146796|NCT00411645|479297|P1|Overall Study|Lost to Follow-up|2
146797|NCT00411645|479296|P2|Overall Study|Investigator/Sponsor Decision|7
146798|NCT00411645|479297|P1|Overall Study|Investigator/Sponsor Decision|10
146799|NCT00411645|479296|P2|Overall Study|Death|135
146800|NCT00411645|479297|P1|Overall Study|Death|56
146801|NCT00411645|479296|P2|Overall Study|Consent Withdrawn|22
146802|NCT00411645|479297|P1|Overall Study|Consent Withdrawn|13
146803|NCT00411554|479328|P2|Overall Study|Patient Moved|0
146804|NCT00411554|479329|P1|Overall Study|Patient Moved|1
146805|NCT00411554|479328|P2|Overall Study|Withdrawal by Subject|0
146806|NCT00411554|479329|P1|Overall Study|Withdrawal by Subject|3
146807|NCT00411554|479328|P2|Overall Study|Lack of Efficacy|5
146808|NCT00411554|479329|P1|Overall Study|Lack of Efficacy|2
146809|NCT00411554|479328|P2|Overall Study|Adverse Event|4
146810|NCT00411554|479329|P1|Overall Study|Adverse Event|2
146811|NCT00411450|479339|P1|Overall Study|Ongoing at time of data cut-off.|3
146812|NCT00411216|479382|P2|Overall Study|Ten participants were entered into the c|2
146813|NCT00411216|479383|P1|Overall Study|Ten participants were entered into the c|0
146814|NCT00411151|479389|P1|Overall Study|Trial prematurely closed|4
146815|NCT00411151|479389|P1|Overall Study|Protocol Violation|1
146816|NCT00411151|479389|P1|Overall Study|Lost to Follow-up|2
146817|NCT00411151|479389|P1|Overall Study|Withdrawal by Subject|2
146818|NCT00411151|479389|P1|Overall Study|Death|38
146819|NCT00410761|479425|P2|Overall Study|Never received randomised treatment|1
146820|NCT00410761|479426|P1|Overall Study|Never received randomised treatment|0
146821|NCT00410761|479425|P2|Overall Study|Other|9
146822|NCT00410761|479426|P1|Overall Study|Other|12
146823|NCT00410761|479425|P2|Overall Study|Withdrawal by Subject|4
146824|NCT00410761|479426|P1|Overall Study|Withdrawal by Subject|8
146825|NCT00410761|479425|P2|Overall Study|objective disease progression|55
146826|NCT00410761|479426|P1|Overall Study|objective disease progression|71
146827|NCT00410761|479425|P2|Overall Study|Adverse Event|3
146828|NCT00410761|479426|P1|Overall Study|Adverse Event|29
146829|NCT00410514|479449|P3|Overall Study|Non-compliant with study procedures|2
146830|NCT00410514|479450|P2|Overall Study|Non-compliant with study procedures|0
146831|NCT00410514|479451|P1|Overall Study|Non-compliant with study procedures|0
146832|NCT00410514|479449|P3|Overall Study|Lost to Follow-up|2
146833|NCT00410514|479450|P2|Overall Study|Lost to Follow-up|0
146834|NCT00410514|479451|P1|Overall Study|Lost to Follow-up|0
146835|NCT00410514|479449|P3|Overall Study|Protocol Violation|1
146836|NCT00410514|479450|P2|Overall Study|Protocol Violation|1
146837|NCT00410514|479451|P1|Overall Study|Protocol Violation|0
146838|NCT00410514|479449|P3|Overall Study|Adverse Event|2
146839|NCT00410514|479450|P2|Overall Study|Adverse Event|2
146840|NCT00410514|479451|P1|Overall Study|Adverse Event|2
146841|NCT00410410|479524|P9|Open-Label Period (OL)|not specified|7
146842|NCT00410410|479525|P8|Open-Label Period (OL)|not specified|0
146843|NCT00410410|479526|P7|Open-Label Period (OL)|not specified|0
146844|NCT00410410|479527|P6|Open-Label Period (OL)|not specified|0
146845|NCT00410410|479528|P5|Open-Label Period (OL)|not specified|0
146846|NCT00410410|479529|P4|Open-Label Period (OL)|not specified|0
146847|NCT00410410|479530|P3|Open-Label Period (OL)|not specified|0
146848|NCT00410410|479531|P2|Open-Label Period (OL)|not specified|0
146849|NCT00410410|479532|P1|Open-Label Period (OL)|not specified|0
146850|NCT00410410|479524|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
146851|NCT00410410|479525|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
146852|NCT00410410|479526|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
146934|NCT00410410|479527|P6|Maintenance Period (MP)|Lost to Follow-up|0
146853|NCT00410410|479527|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
146854|NCT00410410|479528|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
146855|NCT00410410|479529|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
146856|NCT00410410|479530|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
146857|NCT00410410|479531|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
146858|NCT00410410|479532|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
146859|NCT00410410|479524|P9|Open-Label Period (OL)|Pregnancy|1
146860|NCT00410410|479525|P8|Open-Label Period (OL)|Pregnancy|0
146861|NCT00410410|479526|P7|Open-Label Period (OL)|Pregnancy|0
146862|NCT00410410|479527|P6|Open-Label Period (OL)|Pregnancy|0
146863|NCT00410410|479528|P5|Open-Label Period (OL)|Pregnancy|0
146864|NCT00410410|479529|P4|Open-Label Period (OL)|Pregnancy|0
146865|NCT00410410|479530|P3|Open-Label Period (OL)|Pregnancy|0
146866|NCT00410410|479531|P2|Open-Label Period (OL)|Pregnancy|0
146867|NCT00410410|479532|P1|Open-Label Period (OL)|Pregnancy|0
146868|NCT00410410|479524|P9|Open-Label Period (OL)|Withdrawal by Subject|20
146869|NCT00410410|479525|P8|Open-Label Period (OL)|Withdrawal by Subject|0
146870|NCT00410410|479526|P7|Open-Label Period (OL)|Withdrawal by Subject|0
146871|NCT00410410|479527|P6|Open-Label Period (OL)|Withdrawal by Subject|0
146872|NCT00410410|479528|P5|Open-Label Period (OL)|Withdrawal by Subject|0
146873|NCT00410410|479529|P4|Open-Label Period (OL)|Withdrawal by Subject|0
146874|NCT00410410|479530|P3|Open-Label Period (OL)|Withdrawal by Subject|0
146875|NCT00410410|479531|P2|Open-Label Period (OL)|Withdrawal by Subject|0
146876|NCT00410410|479532|P1|Open-Label Period (OL)|Withdrawal by Subject|0
146877|NCT00410410|479524|P9|Open-Label Period (OL)|Lost to Follow-up|4
146878|NCT00410410|479525|P8|Open-Label Period (OL)|Lost to Follow-up|0
146879|NCT00410410|479526|P7|Open-Label Period (OL)|Lost to Follow-up|0
146880|NCT00410410|479527|P6|Open-Label Period (OL)|Lost to Follow-up|0
146881|NCT00410410|479528|P5|Open-Label Period (OL)|Lost to Follow-up|0
146882|NCT00410410|479529|P4|Open-Label Period (OL)|Lost to Follow-up|0
146883|NCT00410410|479530|P3|Open-Label Period (OL)|Lost to Follow-up|0
146884|NCT00410410|479531|P2|Open-Label Period (OL)|Lost to Follow-up|0
146885|NCT00410410|479532|P1|Open-Label Period (OL)|Lost to Follow-up|0
146886|NCT00410410|479524|P9|Open-Label Period (OL)|Lack of Efficacy|161
146887|NCT00410410|479525|P8|Open-Label Period (OL)|Lack of Efficacy|0
146888|NCT00410410|479526|P7|Open-Label Period (OL)|Lack of Efficacy|0
146889|NCT00410410|479527|P6|Open-Label Period (OL)|Lack of Efficacy|0
146890|NCT00410410|479528|P5|Open-Label Period (OL)|Lack of Efficacy|0
146891|NCT00410410|479529|P4|Open-Label Period (OL)|Lack of Efficacy|0
146892|NCT00410410|479530|P3|Open-Label Period (OL)|Lack of Efficacy|0
146893|NCT00410410|479531|P2|Open-Label Period (OL)|Lack of Efficacy|0
146894|NCT00410410|479532|P1|Open-Label Period (OL)|Lack of Efficacy|0
146895|NCT00410410|479524|P9|Open-Label Period (OL)|Adverse Event|10
146896|NCT00410410|479525|P8|Open-Label Period (OL)|Adverse Event|0
146897|NCT00410410|479526|P7|Open-Label Period (OL)|Adverse Event|0
146898|NCT00410410|479527|P6|Open-Label Period (OL)|Adverse Event|0
146899|NCT00410410|479528|P5|Open-Label Period (OL)|Adverse Event|0
146900|NCT00410410|479529|P4|Open-Label Period (OL)|Adverse Event|0
146901|NCT00410410|479530|P3|Open-Label Period (OL)|Adverse Event|0
146902|NCT00410410|479531|P2|Open-Label Period (OL)|Adverse Event|0
146903|NCT00410410|479532|P1|Open-Label Period (OL)|Adverse Event|0
146904|NCT00410410|479524|P9|Open-Label Period (OL)|Death|1
146905|NCT00410410|479525|P8|Open-Label Period (OL)|Death|0
146906|NCT00410410|479526|P7|Open-Label Period (OL)|Death|0
146907|NCT00410410|479527|P6|Open-Label Period (OL)|Death|0
146908|NCT00410410|479528|P5|Open-Label Period (OL)|Death|0
146909|NCT00410410|479529|P4|Open-Label Period (OL)|Death|0
146910|NCT00410410|479530|P3|Open-Label Period (OL)|Death|0
146911|NCT00410410|479531|P2|Open-Label Period (OL)|Death|0
146912|NCT00410410|479532|P1|Open-Label Period (OL)|Death|0
146913|NCT00410410|479524|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
146914|NCT00410410|479525|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
146915|NCT00410410|479526|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
146916|NCT00410410|479527|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
146917|NCT00410410|479528|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
146918|NCT00410410|479529|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
146919|NCT00410410|479530|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
146920|NCT00410410|479531|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
146921|NCT00410410|479532|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
146922|NCT00410410|479524|P9|Maintenance Period (MP)|Withdrawal by Subject|0
146923|NCT00410410|479525|P8|Maintenance Period (MP)|Withdrawal by Subject|1
146924|NCT00410410|479526|P7|Maintenance Period (MP)|Withdrawal by Subject|1
146925|NCT00410410|479527|P6|Maintenance Period (MP)|Withdrawal by Subject|0
146926|NCT00410410|479528|P5|Maintenance Period (MP)|Withdrawal by Subject|0
146927|NCT00410410|479529|P4|Maintenance Period (MP)|Withdrawal by Subject|0
146928|NCT00410410|479530|P3|Maintenance Period (MP)|Withdrawal by Subject|0
146929|NCT00410410|479531|P2|Maintenance Period (MP)|Withdrawal by Subject|0
146930|NCT00410410|479532|P1|Maintenance Period (MP)|Withdrawal by Subject|0
146931|NCT00410410|479524|P9|Maintenance Period (MP)|Lost to Follow-up|0
146932|NCT00410410|479525|P8|Maintenance Period (MP)|Lost to Follow-up|2
146933|NCT00410410|479526|P7|Maintenance Period (MP)|Lost to Follow-up|1
146935|NCT00410410|479528|P5|Maintenance Period (MP)|Lost to Follow-up|0
146936|NCT00410410|479529|P4|Maintenance Period (MP)|Lost to Follow-up|0
146937|NCT00410410|479530|P3|Maintenance Period (MP)|Lost to Follow-up|0
146938|NCT00410410|479531|P2|Maintenance Period (MP)|Lost to Follow-up|0
146939|NCT00410410|479532|P1|Maintenance Period (MP)|Lost to Follow-up|0
146940|NCT00410410|479524|P9|Maintenance Period (MP)|Lack of Efficacy|0
146941|NCT00410410|479525|P8|Maintenance Period (MP)|Lack of Efficacy|24
146942|NCT00410410|479526|P7|Maintenance Period (MP)|Lack of Efficacy|25
146943|NCT00410410|479527|P6|Maintenance Period (MP)|Lack of Efficacy|0
146944|NCT00410410|479528|P5|Maintenance Period (MP)|Lack of Efficacy|0
146945|NCT00410410|479529|P4|Maintenance Period (MP)|Lack of Efficacy|0
146946|NCT00410410|479530|P3|Maintenance Period (MP)|Lack of Efficacy|0
146947|NCT00410410|479531|P2|Maintenance Period (MP)|Lack of Efficacy|0
146948|NCT00410410|479532|P1|Maintenance Period (MP)|Lack of Efficacy|0
146949|NCT00410410|479524|P9|Maintenance Period (MP)|Adverse Event|0
146950|NCT00410410|479525|P8|Maintenance Period (MP)|Adverse Event|3
146951|NCT00410410|479526|P7|Maintenance Period (MP)|Adverse Event|1
146952|NCT00410410|479527|P6|Maintenance Period (MP)|Adverse Event|0
146953|NCT00410410|479528|P5|Maintenance Period (MP)|Adverse Event|0
146954|NCT00410410|479529|P4|Maintenance Period (MP)|Adverse Event|0
146955|NCT00410410|479530|P3|Maintenance Period (MP)|Adverse Event|0
146956|NCT00410410|479531|P2|Maintenance Period (MP)|Adverse Event|0
146957|NCT00410410|479532|P1|Maintenance Period (MP)|Adverse Event|0
146958|NCT00410410|479524|P9|Maintenance Period (MP)|Death|0
146959|NCT00410410|479525|P8|Maintenance Period (MP)|Death|0
146960|NCT00410410|479526|P7|Maintenance Period (MP)|Death|1
146961|NCT00410410|479527|P6|Maintenance Period (MP)|Death|0
146962|NCT00410410|479528|P5|Maintenance Period (MP)|Death|0
146963|NCT00410410|479529|P4|Maintenance Period (MP)|Death|0
146964|NCT00410410|479530|P3|Maintenance Period (MP)|Death|0
146965|NCT00410410|479531|P2|Maintenance Period (MP)|Death|0
146966|NCT00410410|479532|P1|Maintenance Period (MP)|Death|0
146967|NCT00410410|479524|P9|Induction Period (IP)|not specified|0
146968|NCT00410410|479525|P8|Induction Period (IP)|not specified|0
146969|NCT00410410|479526|P7|Induction Period (IP)|not specified|0
146970|NCT00410410|479527|P6|Induction Period (IP)|not specified|0
146971|NCT00410410|479528|P5|Induction Period (IP)|not specified|0
146972|NCT00410410|479529|P4|Induction Period (IP)|not specified|0
146973|NCT00410410|479530|P3|Induction Period (IP)|not specified|1
146974|NCT00410410|479531|P2|Induction Period (IP)|not specified|0
146975|NCT00410410|479532|P1|Induction Period (IP)|not specified|0
146976|NCT00410410|479524|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
146977|NCT00410410|479525|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
146978|NCT00410410|479526|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
146979|NCT00410410|479527|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
146980|NCT00410410|479528|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
146981|NCT00410410|479529|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
146982|NCT00410410|479530|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
146983|NCT00410410|479531|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
146984|NCT00410410|479532|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
146985|NCT00410410|479524|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
146986|NCT00410410|479525|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
146987|NCT00410410|479526|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
146988|NCT00410410|479527|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
146989|NCT00410410|479528|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
146990|NCT00410410|479529|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
146991|NCT00410410|479530|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
146992|NCT00410410|479531|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
146993|NCT00410410|479532|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
146994|NCT00410410|479524|P9|Induction Period (IP)|Withdrawal by Subject|0
146995|NCT00410410|479525|P8|Induction Period (IP)|Withdrawal by Subject|0
146996|NCT00410410|479526|P7|Induction Period (IP)|Withdrawal by Subject|0
146997|NCT00410410|479527|P6|Induction Period (IP)|Withdrawal by Subject|0
146998|NCT00410410|479528|P5|Induction Period (IP)|Withdrawal by Subject|2
146999|NCT00410410|479529|P4|Induction Period (IP)|Withdrawal by Subject|5
147000|NCT00410410|479530|P3|Induction Period (IP)|Withdrawal by Subject|3
147001|NCT00410410|479531|P2|Induction Period (IP)|Withdrawal by Subject|5
147002|NCT00410410|479532|P1|Induction Period (IP)|Withdrawal by Subject|3
147003|NCT00410410|479524|P9|Induction Period (IP)|Lost to Follow-up|0
147004|NCT00410410|479525|P8|Induction Period (IP)|Lost to Follow-up|0
147005|NCT00410410|479526|P7|Induction Period (IP)|Lost to Follow-up|0
147006|NCT00410410|479527|P6|Induction Period (IP)|Lost to Follow-up|1
147007|NCT00410410|479528|P5|Induction Period (IP)|Lost to Follow-up|0
147008|NCT00410410|479529|P4|Induction Period (IP)|Lost to Follow-up|3
147009|NCT00410410|479530|P3|Induction Period (IP)|Lost to Follow-up|2
147010|NCT00410410|479531|P2|Induction Period (IP)|Lost to Follow-up|2
147011|NCT00410410|479532|P1|Induction Period (IP)|Lost to Follow-up|2
147012|NCT00410410|479524|P9|Induction Period (IP)|Lack of Efficacy|0
147013|NCT00410410|479525|P8|Induction Period (IP)|Lack of Efficacy|0
147014|NCT00410410|479526|P7|Induction Period (IP)|Lack of Efficacy|0
147015|NCT00410410|479527|P6|Induction Period (IP)|Lack of Efficacy|7
147016|NCT00410410|479528|P5|Induction Period (IP)|Lack of Efficacy|7
147017|NCT00410410|479529|P4|Induction Period (IP)|Lack of Efficacy|8
147018|NCT00410410|479530|P3|Induction Period (IP)|Lack of Efficacy|8
147019|NCT00410410|479531|P2|Induction Period (IP)|Lack of Efficacy|24
147020|NCT00410410|479532|P1|Induction Period (IP)|Lack of Efficacy|26
147021|NCT00410410|479524|P9|Induction Period (IP)|Adverse Event|0
147022|NCT00410410|479525|P8|Induction Period (IP)|Adverse Event|0
147023|NCT00410410|479526|P7|Induction Period (IP)|Adverse Event|0
147024|NCT00410410|479527|P6|Induction Period (IP)|Adverse Event|0
147025|NCT00410410|479528|P5|Induction Period (IP)|Adverse Event|1
147026|NCT00410410|479529|P4|Induction Period (IP)|Adverse Event|4
147027|NCT00410410|479530|P3|Induction Period (IP)|Adverse Event|2
147028|NCT00410410|479531|P2|Induction Period (IP)|Adverse Event|4
147029|NCT00410410|479532|P1|Induction Period (IP)|Adverse Event|3
147030|NCT00410410|479524|P9|Induction Period (IP)|Death|0
147031|NCT00410410|479525|P8|Induction Period (IP)|Death|0
147032|NCT00410410|479526|P7|Induction Period (IP)|Death|0
147033|NCT00410410|479527|P6|Induction Period (IP)|Death|0
147034|NCT00410410|479528|P5|Induction Period (IP)|Death|0
147035|NCT00410410|479529|P4|Induction Period (IP)|Death|0
147036|NCT00410410|479530|P3|Induction Period (IP)|Death|0
147037|NCT00410410|479531|P2|Induction Period (IP)|Death|0
147038|NCT00410410|479532|P1|Induction Period (IP)|Death|1
147039|NCT00410384|479693|P3|Overall Study|Other|4
147040|NCT00410384|479694|P2|Overall Study|Other|8
147041|NCT00410384|479695|P1|Overall Study|Other|3
147042|NCT00410384|479693|P3|Overall Study|Physician Decision|4
147043|NCT00410384|479694|P2|Overall Study|Physician Decision|3
147044|NCT00410384|479695|P1|Overall Study|Physician Decision|3
147045|NCT00410384|479693|P3|Overall Study|Protocol Violation|6
147046|NCT00410384|479694|P2|Overall Study|Protocol Violation|6
147047|NCT00410384|479695|P1|Overall Study|Protocol Violation|6
147048|NCT00410384|479693|P3|Overall Study|Lost to Follow-up|6
147049|NCT00410384|479694|P2|Overall Study|Lost to Follow-up|6
147050|NCT00410384|479695|P1|Overall Study|Lost to Follow-up|4
147051|NCT00410384|479693|P3|Overall Study|Lack of Compliance|2
147052|NCT00410384|479694|P2|Overall Study|Lack of Compliance|2
147053|NCT00410384|479695|P1|Overall Study|Lack of Compliance|2
147054|NCT00410384|479693|P3|Overall Study|Lack of Efficacy|17
147055|NCT00410384|479694|P2|Overall Study|Lack of Efficacy|12
147056|NCT00410384|479695|P1|Overall Study|Lack of Efficacy|20
147057|NCT00410384|479693|P3|Overall Study|Adverse Event|23
147058|NCT00410384|479694|P2|Overall Study|Adverse Event|18
147059|NCT00410384|479695|P1|Overall Study|Adverse Event|23
147060|NCT00410384|479693|P3|Overall Study|Withdrawal by Subject|20
147061|NCT00410384|479694|P2|Overall Study|Withdrawal by Subject|17
147062|NCT00410384|479695|P1|Overall Study|Withdrawal by Subject|28
147063|NCT00410202|479768|P3|Off-treatment Follow up|Lost to Follow-up|0
147064|NCT00410202|479769|P2|Off-treatment Follow up|Lost to Follow-up|0
147065|NCT00410202|479770|P1|Off-treatment Follow up|Lost to Follow-up|1
147066|NCT00410202|479768|P3|Off-treatment Follow up|Follow up not required per protocol|1
147067|NCT00410202|479769|P2|Off-treatment Follow up|Follow up not required per protocol|0
147068|NCT00410202|479770|P1|Off-treatment Follow up|Follow up not required per protocol|3
147069|NCT00410202|479768|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
147070|NCT00410202|479769|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
147071|NCT00410202|479770|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
147072|NCT00410202|479768|P3|On-Treatment|Other Reason|1
147073|NCT00410202|479769|P2|On-Treatment|Other Reason|0
147074|NCT00410202|479770|P1|On-Treatment|Other Reason|0
147075|NCT00410202|479768|P3|On-Treatment|Withdrawal by Subject|1
147076|NCT00410202|479769|P2|On-Treatment|Withdrawal by Subject|1
147077|NCT00410202|479770|P1|On-Treatment|Withdrawal by Subject|2
147078|NCT00410202|479768|P3|On-Treatment|Lack of Efficacy|0
147079|NCT00410202|479769|P2|On-Treatment|Lack of Efficacy|4
147080|NCT00410202|479770|P1|On-Treatment|Lack of Efficacy|1
147081|NCT00410202|479768|P3|On-Treatment|Lost to Follow-up|1
147082|NCT00410202|479769|P2|On-Treatment|Lost to Follow-up|0
147083|NCT00410202|479770|P1|On-Treatment|Lost to Follow-up|1
147084|NCT00410202|479768|P3|On-Treatment|Death|0
147085|NCT00410202|479769|P2|On-Treatment|Death|0
147086|NCT00410202|479770|P1|On-Treatment|Death|1
147087|NCT00410202|479768|P3|On-Treatment|Adverse Event|2
147088|NCT00410202|479769|P2|On-Treatment|Adverse Event|3
147089|NCT00410202|479770|P1|On-Treatment|Adverse Event|1
147090|NCT00410202|479768|P3|On-Treatment|Continuing treatment|66
147091|NCT00410202|479769|P2|On-Treatment|Continuing treatment|71
147092|NCT00410202|479770|P1|On-Treatment|Continuing treatment|69
147093|NCT00410163|479857|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
147094|NCT00410163|479858|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
147095|NCT00410163|479857|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
147096|NCT00410163|479858|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
147097|NCT00410163|479857|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
147098|NCT00410163|479858|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
147099|NCT00410163|479857|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
147100|NCT00410163|479858|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
147101|NCT00410163|479857|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
147102|NCT00410163|479858|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
147103|NCT00410163|479857|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
147104|NCT00410163|479858|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
147105|NCT00410163|479857|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
147106|NCT00410163|479858|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
147107|NCT00410163|479857|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
147108|NCT00410163|479858|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
147109|NCT00410163|479857|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
147110|NCT00410163|479858|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
147111|NCT00410163|479857|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
147112|NCT00410163|479858|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
147113|NCT00410163|479857|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
147114|NCT00410163|479858|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
147115|NCT00410163|479857|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
147116|NCT00410163|479858|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
147117|NCT00410163|479857|P2|Treatment and Follow-up Phase (2 Years)|Death|1
147118|NCT00410163|479858|P1|Treatment and Follow-up Phase (2 Years)|Death|1
147119|NCT00410163|479857|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
147120|NCT00410163|479858|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
147121|NCT00410124|479911|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
147122|NCT00410124|479912|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
147123|NCT00410124|479911|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
147124|NCT00410124|479912|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
147125|NCT00410124|479911|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
147126|NCT00410124|479912|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
147127|NCT00410124|479911|P2|Extension Phase - Open Label (45 Months)|Death|10
147128|NCT00410124|479912|P1|Extension Phase - Open Label (45 Months)|Death|2
147129|NCT00410124|479911|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
147130|NCT00410124|479912|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
147131|NCT00410124|479911|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
147132|NCT00410124|479912|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
147133|NCT00410124|479911|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
147134|NCT00410124|479912|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
147135|NCT00410124|479911|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
147136|NCT00410124|479912|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
147137|NCT00410124|479911|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
147138|NCT00410124|479912|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
147139|NCT00410124|479911|P2|Core Phase Double Blind (15 Months)|Death|4
147140|NCT00410124|479912|P1|Core Phase Double Blind (15 Months)|Death|7
147141|NCT00410124|479911|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
147142|NCT00410124|479912|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
147143|NCT00410124|479911|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
147144|NCT00410124|479912|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
147145|NCT00410124|479911|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
147146|NCT00410124|479912|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
147147|NCT00410124|479911|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
147148|NCT00410124|479912|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
147149|NCT00410124|479911|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
147150|NCT00410124|479912|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
147151|NCT00410124|479911|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
147152|NCT00410124|479912|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
147153|NCT00410072|479943|P2|After Week 48 to Week 96|Withdrawal by Subject|1
147154|NCT00410072|479944|P1|After Week 48 to Week 96|Withdrawal by Subject|0
147155|NCT00410072|479943|P2|After Week 48 to Week 96|Pregnancy|2
147156|NCT00410072|479944|P1|After Week 48 to Week 96|Pregnancy|0
147157|NCT00410072|479943|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
147158|NCT00410072|479944|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
147159|NCT00410072|479943|P2|After Week 48 to Week 96|Not specified|0
147160|NCT00410072|479944|P1|After Week 48 to Week 96|Not specified|2
147161|NCT00410072|479943|P2|After Week 48 to Week 96|Lost to Follow-up|4
147162|NCT00410072|479944|P1|After Week 48 to Week 96|Lost to Follow-up|2
147163|NCT00410072|479943|P2|After Week 48 to Week 96|Lack of Efficacy|0
147164|NCT00410072|479944|P1|After Week 48 to Week 96|Lack of Efficacy|1
147165|NCT00410072|479943|P2|After Week 48 to Week 96|Death|1
147166|NCT00410072|479944|P1|After Week 48 to Week 96|Death|0
147167|NCT00410072|479943|P2|After Week 48 to Week 96|Adverse Event|2
147168|NCT00410072|479944|P1|After Week 48 to Week 96|Adverse Event|1
147169|NCT00410072|479943|P2|Day 1 to Week 48|Withdrawal by Subject|2
147170|NCT00410072|479944|P1|Day 1 to Week 48|Withdrawal by Subject|0
147171|NCT00410072|479943|P2|Day 1 to Week 48|Pregnancy|2
147172|NCT00410072|479944|P1|Day 1 to Week 48|Pregnancy|0
147173|NCT00410072|479943|P2|Day 1 to Week 48|poor compliance/noncompliance|3
147174|NCT00410072|479944|P1|Day 1 to Week 48|poor compliance/noncompliance|0
147175|NCT00410072|479943|P2|Day 1 to Week 48|Not specified|1
147176|NCT00410072|479944|P1|Day 1 to Week 48|Not specified|0
147177|NCT00410072|479943|P2|Day 1 to Week 48|Lost to Follow-up|2
147178|NCT00410072|479944|P1|Day 1 to Week 48|Lost to Follow-up|5
147179|NCT00410072|479943|P2|Day 1 to Week 48|Adverse Event|2
147180|NCT00410072|479944|P1|Day 1 to Week 48|Adverse Event|1
147181|NCT00410046|479980|P1|Overall Study|Lost to Follow-up|1
147182|NCT00410046|479980|P1|Overall Study|Withdrawal by Subject|1
147183|NCT00410046|479980|P1|Overall Study|Adverse Event|3
147184|NCT00409838|480011|P2|Long-term Extension Period|Pregnancy|0
147185|NCT00409838|480012|P1|Long-term Extension Period|Pregnancy|1
147186|NCT00409838|480011|P2|Long-term Extension Period|Poor compliance/noncompliance|0
147187|NCT00409838|480012|P1|Long-term Extension Period|Poor compliance/noncompliance|1
147188|NCT00409838|480011|P2|Long-term Extension Period|Withdrawal by Subject|0
147189|NCT00409838|480012|P1|Long-term Extension Period|Withdrawal by Subject|3
147190|NCT00409838|480011|P2|Long-term Extension Period|Lack of Efficacy|0
147191|NCT00409838|480012|P1|Long-term Extension Period|Lack of Efficacy|2
147192|NCT00409838|480011|P2|Long-term Extension Period|Death|0
147193|NCT00409838|480012|P1|Long-term Extension Period|Death|1
147194|NCT00409838|480011|P2|Long-term Extension Period|Adverse Event|0
147195|NCT00409838|480012|P1|Long-term Extension Period|Adverse Event|10
147196|NCT00409838|480011|P2|Short-term Period|Never Treated|0
147197|NCT00409838|480012|P1|Short-term Period|Never Treated|1
147198|NCT00409838|480011|P2|Short-term Period|Withdrawal by Subject|3
147199|NCT00409838|480012|P1|Short-term Period|Withdrawal by Subject|2
147200|NCT00409838|480011|P2|Short-term Period|Lost to Follow-up|1
147201|NCT00409838|480012|P1|Short-term Period|Lost to Follow-up|0
147202|NCT00409838|480011|P2|Short-term Period|Adverse Event|1
147203|NCT00409838|480012|P1|Short-term Period|Adverse Event|0
147204|NCT00409786|480077|P1|Overall Study|Withdrawal by Subject|3
147205|NCT00409773|480086|P5|Overall Study|Lack of Eligibility|1
147206|NCT00409773|480087|P4|Overall Study|Lack of Eligibility|0
147207|NCT00409773|480088|P3|Overall Study|Lack of Eligibility|0
147208|NCT00409773|480089|P2|Overall Study|Lack of Eligibility|0
147209|NCT00409773|480090|P1|Overall Study|Lack of Eligibility|0
147210|NCT00409773|480086|P5|Overall Study|Withdrawal by Subject|1
147211|NCT00409773|480087|P4|Overall Study|Withdrawal by Subject|2
147212|NCT00409773|480088|P3|Overall Study|Withdrawal by Subject|0
147213|NCT00409773|480089|P2|Overall Study|Withdrawal by Subject|0
147214|NCT00409773|480090|P1|Overall Study|Withdrawal by Subject|0
147215|NCT00409773|480086|P5|Overall Study|Protocol Violation|1
147216|NCT00409773|480087|P4|Overall Study|Protocol Violation|3
147217|NCT00409773|480088|P3|Overall Study|Protocol Violation|3
147218|NCT00409773|480089|P2|Overall Study|Protocol Violation|2
147219|NCT00409773|480090|P1|Overall Study|Protocol Violation|0
147220|NCT00409773|480086|P5|Overall Study|Physician Decision|0
147221|NCT00409773|480087|P4|Overall Study|Physician Decision|2
147222|NCT00409773|480088|P3|Overall Study|Physician Decision|0
147223|NCT00409773|480089|P2|Overall Study|Physician Decision|0
147224|NCT00409773|480090|P1|Overall Study|Physician Decision|0
147225|NCT00409773|480086|P5|Overall Study|Lost to Follow-up|1
147226|NCT00409773|480087|P4|Overall Study|Lost to Follow-up|3
147227|NCT00409773|480088|P3|Overall Study|Lost to Follow-up|2
147228|NCT00409773|480089|P2|Overall Study|Lost to Follow-up|1
147229|NCT00409773|480090|P1|Overall Study|Lost to Follow-up|6
147230|NCT00409773|480086|P5|Overall Study|Adverse Event|6
147231|NCT00409773|480087|P4|Overall Study|Adverse Event|2
147232|NCT00409773|480088|P3|Overall Study|Adverse Event|4
147233|NCT00409773|480089|P2|Overall Study|Adverse Event|4
147234|NCT00409773|480090|P1|Overall Study|Adverse Event|3
147235|NCT00409747|480172|P1|Overall Study|Withdrawal by Subject|1
147236|NCT00409708|480179|P2|Washout|Lost to Follow-up|3
147237|NCT00409708|480180|P1|Washout|Lost to Follow-up|1
147238|NCT00409708|480179|P2|Washout|Withdrawal by Subject|5
147239|NCT00409708|480180|P1|Washout|Withdrawal by Subject|11
147240|NCT00409708|480179|P2|Washout|Protocol Violation|1
147241|NCT00409708|480180|P1|Washout|Protocol Violation|0
147242|NCT00409708|480179|P2|Washout|Lack of Efficacy|1
147243|NCT00409708|480180|P1|Washout|Lack of Efficacy|9
147244|NCT00409708|480179|P2|Treatment|Administrative problems|0
147245|NCT00409708|480180|P1|Treatment|Administrative problems|5
147246|NCT00409708|480179|P2|Treatment|Lost to Follow-up|6
147247|NCT00409708|480180|P1|Treatment|Lost to Follow-up|0
147248|NCT00409708|480179|P2|Treatment|Withdrawal by Subject|8
147249|NCT00409708|480180|P1|Treatment|Withdrawal by Subject|3
147250|NCT00409708|480179|P2|Treatment|Protocol Violation|2
147251|NCT00409708|480180|P1|Treatment|Protocol Violation|6
147252|NCT00409708|480179|P2|Treatment|Lack of Efficacy|1
147253|NCT00409708|480180|P1|Treatment|Lack of Efficacy|0
147254|NCT00409708|480179|P2|Treatment|Abnormal test procedure result(s)|0
147255|NCT00409708|480180|P1|Treatment|Abnormal test procedure result(s)|1
147256|NCT00409682|480201|P3|EOW Double-blind Maintenance Period|Non-compliance|1
147257|NCT00409682|480202|P2|EOW Double-blind Maintenance Period|Non-compliance|0
147258|NCT00409682|480203|P1|EOW Double-blind Maintenance Period|Non-compliance|0
147259|NCT00409682|480201|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
147260|NCT00409682|480202|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
147261|NCT00409682|480203|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
147262|NCT00409682|480201|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
147263|NCT00409682|480202|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
147264|NCT00409682|480203|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
147265|NCT00409682|480201|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
147266|NCT00409682|480202|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
147267|NCT00409682|480203|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
147268|NCT00409682|480201|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
147269|NCT00409682|480202|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
147270|NCT00409682|480203|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
147271|NCT00409682|480201|P3|EOW Double-blind Maintenance Period|Adverse Event|12
147272|NCT00409682|480202|P2|EOW Double-blind Maintenance Period|Adverse Event|10
147273|NCT00409682|480203|P1|EOW Double-blind Maintenance Period|Adverse Event|0
147274|NCT00409682|480201|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
147275|NCT00409682|480202|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
147276|NCT00409682|480203|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
147277|NCT00409682|480201|P3|Open-label Induction Period|Protocol Violation|0
147278|NCT00409682|480202|P2|Open-label Induction Period|Protocol Violation|0
147279|NCT00409682|480203|P1|Open-label Induction Period|Protocol Violation|1
147280|NCT00409682|480201|P3|Open-label Induction Period|Lack of Efficacy|0
147281|NCT00409682|480202|P2|Open-label Induction Period|Lack of Efficacy|0
147282|NCT00409682|480203|P1|Open-label Induction Period|Lack of Efficacy|1
147283|NCT00409682|480201|P3|Open-label Induction Period|Adverse Event|0
147284|NCT00409682|480202|P2|Open-label Induction Period|Adverse Event|0
147285|NCT00409682|480203|P1|Open-label Induction Period|Adverse Event|1
147286|NCT00409617|480220|P1|Overall Study|Not described|14
147287|NCT00409617|480220|P1|Overall Study|Administrative reasons|1
147288|NCT00409617|480220|P1|Overall Study|Withdrawal by Subject|8
147289|NCT00409617|480220|P1|Overall Study|Protocol Violation|24
147290|NCT00409617|480220|P1|Overall Study|Lost to Follow-up|2
147291|NCT00409617|480220|P1|Overall Study|Lack of Efficacy|54
147292|NCT00409617|480220|P1|Overall Study|Adverse Event|57
147293|NCT00409578|480236|P4|Overall Study|Missing|1
147294|NCT00409578|480237|P3|Overall Study|Missing|0
147295|NCT00409578|480238|P2|Overall Study|Missing|1
147296|NCT00409578|480239|P1|Overall Study|Missing|0
147297|NCT00409578|480236|P4|Overall Study|Protocol Violation|1
147298|NCT00409578|480237|P3|Overall Study|Protocol Violation|3
147299|NCT00409578|480238|P2|Overall Study|Protocol Violation|2
147300|NCT00409578|480239|P1|Overall Study|Protocol Violation|3
147301|NCT00409578|480236|P4|Overall Study|Death|2
147302|NCT00409578|480237|P3|Overall Study|Death|4
147303|NCT00409578|480238|P2|Overall Study|Death|4
147304|NCT00409578|480239|P1|Overall Study|Death|2
147305|NCT00409578|480236|P4|Overall Study|Administrative problems|4
147306|NCT00409578|480237|P3|Overall Study|Administrative problems|2
147307|NCT00409578|480238|P2|Overall Study|Administrative problems|9
147308|NCT00409578|480239|P1|Overall Study|Administrative problems|8
147309|NCT00409578|480236|P4|Overall Study|Lost to Follow-up|2
147310|NCT00409578|480237|P3|Overall Study|Lost to Follow-up|2
147311|NCT00409578|480238|P2|Overall Study|Lost to Follow-up|0
147312|NCT00409578|480239|P1|Overall Study|Lost to Follow-up|2
147313|NCT00409578|480236|P4|Overall Study|Withdrawal by Subject|17
147314|NCT00409578|480237|P3|Overall Study|Withdrawal by Subject|16
147315|NCT00409578|480238|P2|Overall Study|Withdrawal by Subject|15
147316|NCT00409578|480239|P1|Overall Study|Withdrawal by Subject|8
147317|NCT00409578|480236|P4|Overall Study|Subject no longer requires study drug|1
147318|NCT00409578|480237|P3|Overall Study|Subject no longer requires study drug|0
147319|NCT00409578|480238|P2|Overall Study|Subject no longer requires study drug|0
147320|NCT00409578|480239|P1|Overall Study|Subject no longer requires study drug|0
147321|NCT00409578|480236|P4|Overall Study|Lack of Efficacy|2
147322|NCT00409578|480237|P3|Overall Study|Lack of Efficacy|0
147323|NCT00409578|480238|P2|Overall Study|Lack of Efficacy|0
147324|NCT00409578|480239|P1|Overall Study|Lack of Efficacy|0
147325|NCT00409578|480236|P4|Overall Study|Abnormal laboratory value(s)|4
147326|NCT00409578|480237|P3|Overall Study|Abnormal laboratory value(s)|2
147327|NCT00409578|480238|P2|Overall Study|Abnormal laboratory value(s)|2
147328|NCT00409578|480239|P1|Overall Study|Abnormal laboratory value(s)|2
147329|NCT00409578|480236|P4|Overall Study|Adverse Event|33
147330|NCT00409578|480237|P3|Overall Study|Adverse Event|25
147331|NCT00409578|480238|P2|Overall Study|Adverse Event|37
147332|NCT00409578|480239|P1|Overall Study|Adverse Event|27
147333|NCT00409409|480294|P2|Overall Study|Any other reason not above-mentioned|1
147334|NCT00409409|480295|P1|Overall Study|Any other reason not above-mentioned|0
147335|NCT00409409|480294|P2|Overall Study|Withdrawal by Subject|1
147336|NCT00409409|480295|P1|Overall Study|Withdrawal by Subject|1
147337|NCT00409409|480294|P2|Overall Study|Adverse Event|2
147338|NCT00409409|480295|P1|Overall Study|Adverse Event|7
147339|NCT00409344|480303|P2|Overall Study|no enrollment|0
147340|NCT00409344|480304|P1|Overall Study|no enrollment|0
147341|NCT00409331|480322|P1|Overall Study|Physician Decision|1
147342|NCT00409188|480344|P2|Overall Study|Ongoing at data cut-off|175
147343|NCT00409188|480345|P1|Overall Study|Ongoing at data cut-off|383
147344|NCT00409175|480361|P2|Overall Study|Liver transplantation|13
147345|NCT00409175|480362|P1|Overall Study|Liver transplantation|13
147346|NCT00409175|480361|P2|Overall Study|Negative genotype|1
147347|NCT00409175|480362|P1|Overall Study|Negative genotype|0
147348|NCT00409175|480361|P2|Overall Study|Withdrawal by Subject|2
147349|NCT00409175|480362|P1|Overall Study|Withdrawal by Subject|1
147350|NCT00409175|480361|P2|Overall Study|Adverse Event|3
147351|NCT00409175|480362|P1|Overall Study|Adverse Event|4
147352|NCT00409006|480388|P2|Overall Study|Physician Decision|2
147353|NCT00409006|480389|P1|Overall Study|Physician Decision|1
147354|NCT00409006|480388|P2|Overall Study|Withdrawal by Subject|2
147355|NCT00409006|480389|P1|Overall Study|Withdrawal by Subject|3
147356|NCT00409006|480388|P2|Overall Study|Lost to Follow-up|2
147357|NCT00409006|480389|P1|Overall Study|Lost to Follow-up|1
147358|NCT00409006|480388|P2|Overall Study|Death|6
147359|NCT00409006|480389|P1|Overall Study|Death|15
147360|NCT00408993|480405|P2|Overall Study|Withdrawal by Subject|3
147361|NCT00408993|480406|P1|Overall Study|Withdrawal by Subject|2
147362|NCT00408993|480405|P2|Overall Study|Lack of Efficacy|4
147363|NCT00408993|480406|P1|Overall Study|Lack of Efficacy|1
147364|NCT00408993|480405|P2|Overall Study|Protocol Violation|6
147365|NCT00408993|480406|P1|Overall Study|Protocol Violation|1
147366|NCT00408993|480405|P2|Overall Study|Adverse Event|4
147367|NCT00408993|480406|P1|Overall Study|Adverse Event|15
147368|NCT00408928|480438|P1|Overall Study|Infection indistinguishable from GVHD|1
147369|NCT00408928|480438|P1|Overall Study|Death|1
147370|NCT00408928|480438|P1|Overall Study|Withdrawal by Subject|1
147371|NCT00408902|480443|P1|Overall Study|Adverse Event|3
147372|NCT00408902|480443|P1|Overall Study|Lack of Efficacy|7
147373|NCT00408876|480452|P4|Overall Study|Physician Decision|0
147374|NCT00408876|480453|P3|Overall Study|Physician Decision|3
147375|NCT00408876|480454|P2|Overall Study|Physician Decision|0
147376|NCT00408876|480455|P1|Overall Study|Physician Decision|1
147377|NCT00408876|480452|P4|Overall Study|Protocol Violation|3
147378|NCT00408876|480453|P3|Overall Study|Protocol Violation|4
147379|NCT00408876|480454|P2|Overall Study|Protocol Violation|3
147380|NCT00408876|480455|P1|Overall Study|Protocol Violation|0
147381|NCT00408876|480452|P4|Overall Study|Lost to Follow-up|2
147382|NCT00408876|480453|P3|Overall Study|Lost to Follow-up|5
147383|NCT00408876|480454|P2|Overall Study|Lost to Follow-up|6
147384|NCT00408876|480455|P1|Overall Study|Lost to Follow-up|1
147385|NCT00408876|480452|P4|Overall Study|Lack of Efficacy|6
147386|NCT00408876|480453|P3|Overall Study|Lack of Efficacy|5
147387|NCT00408876|480454|P2|Overall Study|Lack of Efficacy|4
147388|NCT00408876|480455|P1|Overall Study|Lack of Efficacy|2
147389|NCT00408876|480452|P4|Overall Study|Withdrawal by Subject|14
147390|NCT00408876|480453|P3|Overall Study|Withdrawal by Subject|6
147391|NCT00408876|480454|P2|Overall Study|Withdrawal by Subject|6
147392|NCT00408876|480455|P1|Overall Study|Withdrawal by Subject|3
147393|NCT00408876|480452|P4|Overall Study|Adverse Event|10
147394|NCT00408876|480453|P3|Overall Study|Adverse Event|27
147395|NCT00408876|480454|P2|Overall Study|Adverse Event|17
147396|NCT00408876|480455|P1|Overall Study|Adverse Event|9
147397|NCT00408694|480705|P1|Overall Study|No protocol treatment|1
147398|NCT00408694|480705|P1|Overall Study|Ineligible|1
147399|NCT00408681|480709|P1|Overall Study|Adverse Event|7
147400|NCT00408681|480709|P1|Overall Study|Lack of Efficacy|2
147401|NCT00408629|480728|P2|Overall Study|Miscellaneous|15
147402|NCT00408629|480729|P1|Overall Study|Miscellaneous|11
147403|NCT00408629|480728|P2|Overall Study|Protocol Violation|5
147404|NCT00408629|480729|P1|Overall Study|Protocol Violation|1
147405|NCT00408629|480728|P2|Overall Study|Lack of Efficacy|73
147406|NCT00408629|480729|P1|Overall Study|Lack of Efficacy|63
147407|NCT00408629|480728|P2|Overall Study|Lost to Follow-up|1
147408|NCT00408629|480729|P1|Overall Study|Lost to Follow-up|1
147409|NCT00408629|480728|P2|Overall Study|Withdrawal by Subject|4
147410|NCT00408629|480729|P1|Overall Study|Withdrawal by Subject|8
147411|NCT00408629|480728|P2|Overall Study|Adverse Event|27
147412|NCT00408629|480729|P1|Overall Study|Adverse Event|13
147413|NCT00408421|480770|P3|Treatment Re-Randomization|Withdrawal by Subject|0
147414|NCT00408421|480771|P2|Treatment Re-Randomization|Withdrawal by Subject|1
147415|NCT00408421|480772|P1|Treatment Re-Randomization|Withdrawal by Subject|2
147416|NCT00408421|480770|P3|Treatment Re-Randomization|Protocol Violation|0
147417|NCT00408421|480771|P2|Treatment Re-Randomization|Protocol Violation|1
147418|NCT00408421|480772|P1|Treatment Re-Randomization|Protocol Violation|1
147419|NCT00408421|480770|P3|Treatment Re-Randomization|Physician Decision|0
147420|NCT00408421|480771|P2|Treatment Re-Randomization|Physician Decision|3
147421|NCT00408421|480772|P1|Treatment Re-Randomization|Physician Decision|1
147422|NCT00408421|480770|P3|Treatment Re-Randomization|Lost to Follow-up|1
147423|NCT00408421|480771|P2|Treatment Re-Randomization|Lost to Follow-up|0
147424|NCT00408421|480772|P1|Treatment Re-Randomization|Lost to Follow-up|0
147425|NCT00408421|480770|P3|Treatment Re-Randomization|Lack of Efficacy|0
147426|NCT00408421|480771|P2|Treatment Re-Randomization|Lack of Efficacy|0
147427|NCT00408421|480772|P1|Treatment Re-Randomization|Lack of Efficacy|1
147428|NCT00408421|480770|P3|Treatment Re-Randomization|Adverse Event|4
147429|NCT00408421|480771|P2|Treatment Re-Randomization|Adverse Event|2
147430|NCT00408421|480772|P1|Treatment Re-Randomization|Adverse Event|2
147431|NCT00408421|480770|P3|Treatment Initial Randomization|Sponsor Decision|0
147432|NCT00408421|480771|P2|Treatment Initial Randomization|Sponsor Decision|0
147433|NCT00408421|480772|P1|Treatment Initial Randomization|Sponsor Decision|1
147434|NCT00408421|480770|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
147435|NCT00408421|480771|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
147436|NCT00408421|480772|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
147437|NCT00408421|480770|P3|Treatment Initial Randomization|Withdrawal by Subject|0
147438|NCT00408421|480771|P2|Treatment Initial Randomization|Withdrawal by Subject|7
147439|NCT00408421|480772|P1|Treatment Initial Randomization|Withdrawal by Subject|7
147440|NCT00408421|480770|P3|Treatment Initial Randomization|Protocol Violation|0
147441|NCT00408421|480771|P2|Treatment Initial Randomization|Protocol Violation|1
147442|NCT00408421|480772|P1|Treatment Initial Randomization|Protocol Violation|0
147443|NCT00408421|480770|P3|Treatment Initial Randomization|Physician Decision|0
147444|NCT00408421|480771|P2|Treatment Initial Randomization|Physician Decision|0
147445|NCT00408421|480772|P1|Treatment Initial Randomization|Physician Decision|1
147446|NCT00408421|480770|P3|Treatment Initial Randomization|Lost to Follow-up|0
147447|NCT00408421|480771|P2|Treatment Initial Randomization|Lost to Follow-up|3
147448|NCT00408421|480772|P1|Treatment Initial Randomization|Lost to Follow-up|0
147449|NCT00408421|480770|P3|Treatment Initial Randomization|Lack of Efficacy|0
147450|NCT00408421|480771|P2|Treatment Initial Randomization|Lack of Efficacy|2
147451|NCT00408421|480772|P1|Treatment Initial Randomization|Lack of Efficacy|2
147452|NCT00408421|480770|P3|Treatment Initial Randomization|Adverse Event|0
147453|NCT00408421|480771|P2|Treatment Initial Randomization|Adverse Event|9
147454|NCT00408421|480772|P1|Treatment Initial Randomization|Adverse Event|5
147455|NCT00408317|480846|P2|Second Intervention Period|Withdrawal of consent|1
147456|NCT00408317|480847|P1|Second Intervention Period|Withdrawal of consent|0
147457|NCT00408317|480846|P2|Second Intervention Period|Protocol Violation|1
147458|NCT00408317|480847|P1|Second Intervention Period|Protocol Violation|0
147459|NCT00408317|480846|P2|Second Intervention Period|Adverse Event|0
147460|NCT00408317|480847|P1|Second Intervention Period|Adverse Event|2
147461|NCT00408317|480846|P2|First Intervention Period|Adverse Event|1
147462|NCT00408317|480847|P1|First Intervention Period|Adverse Event|0
147463|NCT00407797|480878|P1|Overall Study|Withdrawal by Subject|3
147464|NCT00407797|480878|P1|Overall Study|Unspecified|7
147465|NCT00407797|480878|P1|Overall Study|Adverse Event|6
147466|NCT00407797|480878|P1|Overall Study|Lost to Follow-up|2
147467|NCT00407745|480895|P2|Overall Study|Randomized, unknown if treated|1
147468|NCT00407745|480896|P1|Overall Study|Randomized, unknown if treated|0
147469|NCT00407745|480895|P2|Overall Study|Unspecified|0
147470|NCT00407745|480896|P1|Overall Study|Unspecified|2
147471|NCT00407745|480895|P2|Overall Study|Adverse Event|8
147472|NCT00407745|480896|P1|Overall Study|Adverse Event|8
147473|NCT00407745|480895|P2|Overall Study|Protocol Violation|3
147474|NCT00407745|480896|P1|Overall Study|Protocol Violation|5
147475|NCT00407745|480895|P2|Overall Study|Withdrawal by Subject|3
147476|NCT00407745|480896|P1|Overall Study|Withdrawal by Subject|3
147477|NCT00407745|480895|P2|Overall Study|Lack of Efficacy|2
147478|NCT00407745|480896|P1|Overall Study|Lack of Efficacy|1
147479|NCT00407563|480980|P1|Overall Study|Patient continues on treatment|1
147480|NCT00407550|480990|P2|Overall Study|Insurance or Other medical condition|1
147481|NCT00407550|480991|P1|Overall Study|Insurance or Other medical condition|2
147482|NCT00407550|480990|P2|Overall Study|Death|0
147483|NCT00407550|480991|P1|Overall Study|Death|1
147484|NCT00407550|480990|P2|Overall Study|Withdrawal by Subject|2
147485|NCT00407550|480991|P1|Overall Study|Withdrawal by Subject|0
147486|NCT00407550|480990|P2|Overall Study|Adverse Event|1
147487|NCT00407550|480991|P1|Overall Study|Adverse Event|0
147488|NCT00407537|480999|P2|Overall Study|Withdrawal by Subject|16
147489|NCT00407537|481000|P1|Overall Study|Withdrawal by Subject|34
147490|NCT00407537|480999|P2|Overall Study|Unspecified|7
147491|NCT00407537|481000|P1|Overall Study|Unspecified|6
147492|NCT00407537|480999|P2|Overall Study|Lost to Follow-up|19
147493|NCT00407537|481000|P1|Overall Study|Lost to Follow-up|12
147494|NCT00407537|480999|P2|Overall Study|Adverse Event|0
147495|NCT00407537|481000|P1|Overall Study|Adverse Event|36
147496|NCT00407537|480999|P2|Overall Study|Death|2
147497|NCT00407537|481000|P1|Overall Study|Death|5
147498|NCT00407511|481048|P1|Overall Study|Withdrawal by Subject|4
147499|NCT00407511|481048|P1|Overall Study|Other|5
147500|NCT00407511|481048|P1|Overall Study|Lost to Follow-up|4
147501|NCT00407511|481048|P1|Overall Study|Adverse Event|9
147502|NCT00407030|481081|P3|Extension Period - up to 68 Weeks|Physician Decision|0
147503|NCT00407030|481082|P2|Extension Period - up to 68 Weeks|Physician Decision|2
147504|NCT00407030|481083|P1|Extension Period - up to 68 Weeks|Physician Decision|1
147505|NCT00407030|481081|P3|Extension Period - up to 68 Weeks|Patient Decision|0
147506|NCT00407030|481082|P2|Extension Period - up to 68 Weeks|Patient Decision|2
147507|NCT00407030|481083|P1|Extension Period - up to 68 Weeks|Patient Decision|1
147508|NCT00407030|481081|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
147509|NCT00407030|481082|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
147510|NCT00407030|481083|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
147511|NCT00407030|481081|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
147512|NCT00407030|481082|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
147513|NCT00407030|481083|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
147514|NCT00407030|481081|P3|Extension Period - up to 68 Weeks|Adverse Event|0
147515|NCT00407030|481082|P2|Extension Period - up to 68 Weeks|Adverse Event|0
147516|NCT00407030|481083|P1|Extension Period - up to 68 Weeks|Adverse Event|1
147517|NCT00407030|481081|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
147518|NCT00407030|481082|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
147519|NCT00407030|481083|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
147520|NCT00407030|481081|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
147521|NCT00407030|481082|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
147522|NCT00407030|481083|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
147523|NCT00407030|481081|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
147524|NCT00407030|481082|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
147525|NCT00407030|481083|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
147526|NCT00407030|481081|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
147527|NCT00407030|481082|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
147528|NCT00407030|481083|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
147529|NCT00407030|481081|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
147530|NCT00407030|481082|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
147531|NCT00407030|481083|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
147532|NCT00407030|481081|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
147533|NCT00407030|481082|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
147534|NCT00407030|481083|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
147535|NCT00407030|481081|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
147536|NCT00407030|481082|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
147537|NCT00407030|481083|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
147538|NCT00407030|481081|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
147539|NCT00407030|481082|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
147540|NCT00407030|481083|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
147541|NCT00406848|481111|P2|Overall Study|Sponsor Decision|1
147542|NCT00406848|481112|P1|Overall Study|Sponsor Decision|1
147543|NCT00406848|481111|P2|Overall Study|Physician Decision|2
147544|NCT00406848|481112|P1|Overall Study|Physician Decision|2
147545|NCT00406848|481111|P2|Overall Study|Lost to Follow-up|2
147546|NCT00406848|481112|P1|Overall Study|Lost to Follow-up|6
147547|NCT00406848|481111|P2|Overall Study|Protocol Violation|6
147548|NCT00406848|481112|P1|Overall Study|Protocol Violation|10
147549|NCT00406848|481111|P2|Overall Study|Lack of Efficacy|14
147550|NCT00406848|481112|P1|Overall Study|Lack of Efficacy|9
147551|NCT00406848|481111|P2|Overall Study|Adverse Event|7
147552|NCT00406848|481112|P1|Overall Study|Adverse Event|38
147553|NCT00406848|481111|P2|Overall Study|Withdrawal by Subject|22
147554|NCT00406848|481112|P1|Overall Study|Withdrawal by Subject|27
147555|NCT00406783|481176|P2|Overall Study|Protocol Violation|4
147556|NCT00406783|481177|P1|Overall Study|Protocol Violation|4
147557|NCT00406783|481176|P2|Overall Study|Withdrawal by Subject|4
147558|NCT00406783|481177|P1|Overall Study|Withdrawal by Subject|1
147559|NCT00406783|481176|P2|Overall Study|Lost to Follow-up|0
147560|NCT00406783|481177|P1|Overall Study|Lost to Follow-up|3
147561|NCT00406783|481176|P2|Overall Study|Treatment Failure|3
147562|NCT00406783|481177|P1|Overall Study|Treatment Failure|2
147563|NCT00406783|481176|P2|Overall Study|Adverse Event|4
147564|NCT00406783|481177|P1|Overall Study|Adverse Event|4
147565|NCT00406718|481192|P3|Overall Study|Lost to Follow-up|4
147566|NCT00406718|481193|P2|Overall Study|Lost to Follow-up|5
147567|NCT00406718|481194|P1|Overall Study|Lost to Follow-up|2
147568|NCT00406718|481192|P3|Overall Study|Withdrawal by Subject|4
147569|NCT00406718|481193|P2|Overall Study|Withdrawal by Subject|9
147570|NCT00406718|481194|P1|Overall Study|Withdrawal by Subject|2
147571|NCT00406692|481208|P1|Overall Study|Lack of Efficacy|1
147572|NCT00406692|481208|P1|Overall Study|Adverse Event|1
147573|NCT00406692|481208|P1|Overall Study|Physician Decision|1
147574|NCT00406692|481208|P1|Overall Study|Withdrawal by Subject|4
147575|NCT00406653|481218|P7|Open-Label Period|Refused followup|1
147576|NCT00406653|481219|P6|Open-Label Period|Refused followup|0
147577|NCT00406653|481220|P5|Open-Label Period|Refused followup|0
147578|NCT00406653|481221|P4|Open-Label Period|Refused followup|0
147579|NCT00406653|481222|P3|Open-Label Period|Refused followup|0
147580|NCT00406653|481223|P2|Open-Label Period|Refused followup|0
147581|NCT00406653|481224|P1|Open-Label Period|Refused followup|0
147582|NCT00406653|481218|P7|Open-Label Period|Discontinued by Sponsor|1
147583|NCT00406653|481219|P6|Open-Label Period|Discontinued by Sponsor|0
147584|NCT00406653|481220|P5|Open-Label Period|Discontinued by Sponsor|0
147585|NCT00406653|481221|P4|Open-Label Period|Discontinued by Sponsor|0
147586|NCT00406653|481222|P3|Open-Label Period|Discontinued by Sponsor|0
147587|NCT00406653|481223|P2|Open-Label Period|Discontinued by Sponsor|0
147588|NCT00406653|481224|P1|Open-Label Period|Discontinued by Sponsor|0
147589|NCT00406653|481218|P7|Open-Label Period|Declined participation but followup done|8
147590|NCT00406653|481219|P6|Open-Label Period|Declined participation but followup done|0
147591|NCT00406653|481220|P5|Open-Label Period|Declined participation but followup done|0
147592|NCT00406653|481221|P4|Open-Label Period|Declined participation but followup done|0
147593|NCT00406653|481222|P3|Open-Label Period|Declined participation but followup done|0
147594|NCT00406653|481223|P2|Open-Label Period|Declined participation but followup done|0
147595|NCT00406653|481224|P1|Open-Label Period|Declined participation but followup done|0
147596|NCT00406653|481218|P7|Open-Label Period|Administrative Reason By Sponsor|115
147597|NCT00406653|481219|P6|Open-Label Period|Administrative Reason By Sponsor|0
147598|NCT00406653|481220|P5|Open-Label Period|Administrative Reason By Sponsor|0
147599|NCT00406653|481221|P4|Open-Label Period|Administrative Reason By Sponsor|0
147600|NCT00406653|481222|P3|Open-Label Period|Administrative Reason By Sponsor|0
147601|NCT00406653|481223|P2|Open-Label Period|Administrative Reason By Sponsor|0
147602|NCT00406653|481224|P1|Open-Label Period|Administrative Reason By Sponsor|0
147603|NCT00406653|481218|P7|Open-Label Period|Pregnancy|2
147604|NCT00406653|481219|P6|Open-Label Period|Pregnancy|0
147605|NCT00406653|481220|P5|Open-Label Period|Pregnancy|0
147606|NCT00406653|481221|P4|Open-Label Period|Pregnancy|0
147607|NCT00406653|481222|P3|Open-Label Period|Pregnancy|0
147608|NCT00406653|481223|P2|Open-Label Period|Pregnancy|0
147609|NCT00406653|481224|P1|Open-Label Period|Pregnancy|0
147610|NCT00406653|481218|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
147611|NCT00406653|481219|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
147612|NCT00406653|481220|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
147613|NCT00406653|481221|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
147614|NCT00406653|481222|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
147615|NCT00406653|481223|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
147616|NCT00406653|481224|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
147617|NCT00406653|481218|P7|Open-Label Period|Withdrawal of Consent|11
147618|NCT00406653|481219|P6|Open-Label Period|Withdrawal of Consent|0
147619|NCT00406653|481220|P5|Open-Label Period|Withdrawal of Consent|0
147620|NCT00406653|481221|P4|Open-Label Period|Withdrawal of Consent|0
147621|NCT00406653|481222|P3|Open-Label Period|Withdrawal of Consent|0
147622|NCT00406653|481223|P2|Open-Label Period|Withdrawal of Consent|0
147623|NCT00406653|481224|P1|Open-Label Period|Withdrawal of Consent|0
147624|NCT00406653|481218|P7|Open-Label Period|Lost to Follow-up|6
147625|NCT00406653|481219|P6|Open-Label Period|Lost to Follow-up|0
147626|NCT00406653|481220|P5|Open-Label Period|Lost to Follow-up|0
147627|NCT00406653|481221|P4|Open-Label Period|Lost to Follow-up|0
147628|NCT00406653|481222|P3|Open-Label Period|Lost to Follow-up|0
147629|NCT00406653|481223|P2|Open-Label Period|Lost to Follow-up|0
147630|NCT00406653|481224|P1|Open-Label Period|Lost to Follow-up|0
147631|NCT00406653|481218|P7|Open-Label Period|Lack of Efficacy|160
147632|NCT00406653|481219|P6|Open-Label Period|Lack of Efficacy|0
147633|NCT00406653|481220|P5|Open-Label Period|Lack of Efficacy|0
147634|NCT00406653|481221|P4|Open-Label Period|Lack of Efficacy|0
147635|NCT00406653|481222|P3|Open-Label Period|Lack of Efficacy|0
147636|NCT00406653|481223|P2|Open-Label Period|Lack of Efficacy|0
147637|NCT00406653|481224|P1|Open-Label Period|Lack of Efficacy|0
147638|NCT00406653|481218|P7|Open-Label Period|Adverse Event|18
147639|NCT00406653|481219|P6|Open-Label Period|Adverse Event|0
147640|NCT00406653|481220|P5|Open-Label Period|Adverse Event|0
147641|NCT00406653|481221|P4|Open-Label Period|Adverse Event|0
147642|NCT00406653|481222|P3|Open-Label Period|Adverse Event|0
147643|NCT00406653|481223|P2|Open-Label Period|Adverse Event|0
147644|NCT00406653|481224|P1|Open-Label Period|Adverse Event|0
147645|NCT00406653|481218|P7|Open-Label Period|Death|1
147646|NCT00406653|481219|P6|Open-Label Period|Death|0
147647|NCT00406653|481220|P5|Open-Label Period|Death|0
147648|NCT00406653|481221|P4|Open-Label Period|Death|0
147649|NCT00406653|481222|P3|Open-Label Period|Death|0
147650|NCT00406653|481223|P2|Open-Label Period|Death|0
147651|NCT00406653|481224|P1|Open-Label Period|Death|0
147652|NCT00406653|481218|P7|Maintenance Period|Error in disease score evaluation|0
147653|NCT00406653|481219|P6|Maintenance Period|Error in disease score evaluation|0
147654|NCT00406653|481220|P5|Maintenance Period|Error in disease score evaluation|1
147655|NCT00406653|481221|P4|Maintenance Period|Error in disease score evaluation|0
147656|NCT00406653|481222|P3|Maintenance Period|Error in disease score evaluation|0
147657|NCT00406653|481223|P2|Maintenance Period|Error in disease score evaluation|0
147658|NCT00406653|481224|P1|Maintenance Period|Error in disease score evaluation|0
147659|NCT00406653|481218|P7|Maintenance Period|Administrative Reason By Sponsor|0
147660|NCT00406653|481219|P6|Maintenance Period|Administrative Reason By Sponsor|7
147661|NCT00406653|481220|P5|Maintenance Period|Administrative Reason By Sponsor|4
147662|NCT00406653|481221|P4|Maintenance Period|Administrative Reason By Sponsor|0
147663|NCT00406653|481222|P3|Maintenance Period|Administrative Reason By Sponsor|0
147664|NCT00406653|481223|P2|Maintenance Period|Administrative Reason By Sponsor|0
147665|NCT00406653|481224|P1|Maintenance Period|Administrative Reason By Sponsor|0
147666|NCT00406653|481218|P7|Maintenance Period|Pregnancy|0
147667|NCT00406653|481219|P6|Maintenance Period|Pregnancy|1
147668|NCT00406653|481220|P5|Maintenance Period|Pregnancy|0
147669|NCT00406653|481221|P4|Maintenance Period|Pregnancy|0
147670|NCT00406653|481222|P3|Maintenance Period|Pregnancy|0
147671|NCT00406653|481223|P2|Maintenance Period|Pregnancy|0
147672|NCT00406653|481224|P1|Maintenance Period|Pregnancy|0
147673|NCT00406653|481218|P7|Maintenance Period|Withdrawal of Consent|0
147674|NCT00406653|481219|P6|Maintenance Period|Withdrawal of Consent|0
147675|NCT00406653|481220|P5|Maintenance Period|Withdrawal of Consent|2
147676|NCT00406653|481221|P4|Maintenance Period|Withdrawal of Consent|0
147677|NCT00406653|481222|P3|Maintenance Period|Withdrawal of Consent|0
147678|NCT00406653|481223|P2|Maintenance Period|Withdrawal of Consent|0
147679|NCT00406653|481224|P1|Maintenance Period|Withdrawal of Consent|0
147680|NCT00406653|481218|P7|Maintenance Period|Lost to Follow-up|0
147681|NCT00406653|481219|P6|Maintenance Period|Lost to Follow-up|1
147682|NCT00406653|481220|P5|Maintenance Period|Lost to Follow-up|2
147683|NCT00406653|481221|P4|Maintenance Period|Lost to Follow-up|0
147684|NCT00406653|481222|P3|Maintenance Period|Lost to Follow-up|0
147685|NCT00406653|481223|P2|Maintenance Period|Lost to Follow-up|0
147686|NCT00406653|481224|P1|Maintenance Period|Lost to Follow-up|0
147687|NCT00406653|481218|P7|Maintenance Period|Lack of Efficacy|0
147688|NCT00406653|481219|P6|Maintenance Period|Lack of Efficacy|26
147689|NCT00406653|481220|P5|Maintenance Period|Lack of Efficacy|20
147690|NCT00406653|481221|P4|Maintenance Period|Lack of Efficacy|0
147691|NCT00406653|481222|P3|Maintenance Period|Lack of Efficacy|0
147692|NCT00406653|481223|P2|Maintenance Period|Lack of Efficacy|0
147693|NCT00406653|481224|P1|Maintenance Period|Lack of Efficacy|0
147694|NCT00406653|481218|P7|Maintenance Period|Adverse Event|0
147695|NCT00406653|481219|P6|Maintenance Period|Adverse Event|1
147696|NCT00406653|481220|P5|Maintenance Period|Adverse Event|1
147697|NCT00406653|481221|P4|Maintenance Period|Adverse Event|0
147698|NCT00406653|481222|P3|Maintenance Period|Adverse Event|0
147699|NCT00406653|481223|P2|Maintenance Period|Adverse Event|0
147700|NCT00406653|481224|P1|Maintenance Period|Adverse Event|0
147701|NCT00406653|481218|P7|Induction Period|Patient relocated|0
147702|NCT00406653|481219|P6|Induction Period|Patient relocated|0
147703|NCT00406653|481220|P5|Induction Period|Patient relocated|0
147704|NCT00406653|481221|P4|Induction Period|Patient relocated|0
147705|NCT00406653|481222|P3|Induction Period|Patient relocated|1
147706|NCT00406653|481223|P2|Induction Period|Patient relocated|0
147707|NCT00406653|481224|P1|Induction Period|Patient relocated|0
147708|NCT00406653|481218|P7|Induction Period|Incarcerated|0
147709|NCT00406653|481219|P6|Induction Period|Incarcerated|0
147710|NCT00406653|481220|P5|Induction Period|Incarcerated|0
147711|NCT00406653|481221|P4|Induction Period|Incarcerated|0
147712|NCT00406653|481222|P3|Induction Period|Incarcerated|1
147713|NCT00406653|481223|P2|Induction Period|Incarcerated|0
147714|NCT00406653|481224|P1|Induction Period|Incarcerated|0
147715|NCT00406653|481218|P7|Induction Period|Given prohibited drug|0
147716|NCT00406653|481219|P6|Induction Period|Given prohibited drug|0
147717|NCT00406653|481220|P5|Induction Period|Given prohibited drug|0
147718|NCT00406653|481221|P4|Induction Period|Given prohibited drug|0
147719|NCT00406653|481222|P3|Induction Period|Given prohibited drug|2
147720|NCT00406653|481223|P2|Induction Period|Given prohibited drug|1
147721|NCT00406653|481224|P1|Induction Period|Given prohibited drug|0
147722|NCT00406653|481218|P7|Induction Period|Declined participation but followup done|0
147723|NCT00406653|481219|P6|Induction Period|Declined participation but followup done|0
147724|NCT00406653|481220|P5|Induction Period|Declined participation but followup done|0
147725|NCT00406653|481221|P4|Induction Period|Declined participation but followup done|1
147726|NCT00406653|481222|P3|Induction Period|Declined participation but followup done|1
147727|NCT00406653|481223|P2|Induction Period|Declined participation but followup done|2
147728|NCT00406653|481224|P1|Induction Period|Declined participation but followup done|0
147729|NCT00406653|481218|P7|Induction Period|Pregnancy|0
147730|NCT00406653|481219|P6|Induction Period|Pregnancy|0
147731|NCT00406653|481220|P5|Induction Period|Pregnancy|0
147732|NCT00406653|481221|P4|Induction Period|Pregnancy|0
147733|NCT00406653|481222|P3|Induction Period|Pregnancy|0
147734|NCT00406653|481223|P2|Induction Period|Pregnancy|0
147735|NCT00406653|481224|P1|Induction Period|Pregnancy|1
147736|NCT00406653|481218|P7|Induction Period|Subject No Longer Meets Study Criteria|0
147737|NCT00406653|481219|P6|Induction Period|Subject No Longer Meets Study Criteria|0
147738|NCT00406653|481220|P5|Induction Period|Subject No Longer Meets Study Criteria|0
147739|NCT00406653|481221|P4|Induction Period|Subject No Longer Meets Study Criteria|2
147740|NCT00406653|481222|P3|Induction Period|Subject No Longer Meets Study Criteria|0
147741|NCT00406653|481223|P2|Induction Period|Subject No Longer Meets Study Criteria|0
147742|NCT00406653|481224|P1|Induction Period|Subject No Longer Meets Study Criteria|0
147743|NCT00406653|481218|P7|Induction Period|Withdrawal of Consent|0
147744|NCT00406653|481219|P6|Induction Period|Withdrawal of Consent|0
147745|NCT00406653|481220|P5|Induction Period|Withdrawal of Consent|0
147746|NCT00406653|481221|P4|Induction Period|Withdrawal of Consent|2
147747|NCT00406653|481222|P3|Induction Period|Withdrawal of Consent|1
147748|NCT00406653|481223|P2|Induction Period|Withdrawal of Consent|5
147749|NCT00406653|481224|P1|Induction Period|Withdrawal of Consent|2
147750|NCT00406653|481218|P7|Induction Period|Lost to Follow-up|0
147751|NCT00406653|481219|P6|Induction Period|Lost to Follow-up|0
147752|NCT00406653|481220|P5|Induction Period|Lost to Follow-up|0
147753|NCT00406653|481221|P4|Induction Period|Lost to Follow-up|0
147754|NCT00406653|481222|P3|Induction Period|Lost to Follow-up|0
147755|NCT00406653|481223|P2|Induction Period|Lost to Follow-up|2
147756|NCT00406653|481224|P1|Induction Period|Lost to Follow-up|0
147757|NCT00406653|481218|P7|Induction Period|Lack of Efficacy|0
147758|NCT00406653|481219|P6|Induction Period|Lack of Efficacy|0
147759|NCT00406653|481220|P5|Induction Period|Lack of Efficacy|0
147760|NCT00406653|481221|P4|Induction Period|Lack of Efficacy|10
147761|NCT00406653|481222|P3|Induction Period|Lack of Efficacy|8
147762|NCT00406653|481223|P2|Induction Period|Lack of Efficacy|14
147763|NCT00406653|481224|P1|Induction Period|Lack of Efficacy|11
147764|NCT00406653|481218|P7|Induction Period|Adverse Event|0
147765|NCT00406653|481219|P6|Induction Period|Adverse Event|0
147766|NCT00406653|481220|P5|Induction Period|Adverse Event|0
147767|NCT00406653|481221|P4|Induction Period|Adverse Event|11
147768|NCT00406653|481222|P3|Induction Period|Adverse Event|4
147769|NCT00406653|481223|P2|Induction Period|Adverse Event|10
147770|NCT00406653|481224|P1|Induction Period|Adverse Event|1
147771|NCT00406640|481305|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
147772|NCT00406640|481306|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
147773|NCT00406640|481305|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
147774|NCT00406640|481306|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
147775|NCT00406640|481305|P2|OL Extension Phase for Non-Responders|non-compliance|2
147776|NCT00406640|481306|P1|OL Extension Phase for Non-Responders|non-compliance|3
147777|NCT00406640|481305|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
147778|NCT00406640|481306|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
147779|NCT00406640|481305|P2|OL Extension Phase for Non-Responders|Physician Decision|0
147780|NCT00406640|481306|P1|OL Extension Phase for Non-Responders|Physician Decision|1
147781|NCT00406640|481305|P2|OL Extension Phase for Non-Responders|Failed to Return|0
147782|NCT00406640|481306|P1|OL Extension Phase for Non-Responders|Failed to Return|1
147783|NCT00406640|481305|P2|OL Extension Phase for Non-Responders|Adverse Event|6
147784|NCT00406640|481306|P1|OL Extension Phase for Non-Responders|Adverse Event|6
147785|NCT00406640|481305|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
147786|NCT00406640|481306|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
147787|NCT00406640|481305|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
147788|NCT00406640|481306|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
147789|NCT00406640|481305|P2|DB Continuation Phase for Responders|Protocol Violation|2
147790|NCT00406640|481306|P1|DB Continuation Phase for Responders|Protocol Violation|2
147791|NCT00406640|481305|P2|DB Continuation Phase for Responders|non-compliance|5
147792|NCT00406640|481306|P1|DB Continuation Phase for Responders|non-compliance|7
147793|NCT00406640|481305|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
147794|NCT00406640|481306|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
147795|NCT00406640|481305|P2|DB Continuation Phase for Responders|Physician Decision|3
147796|NCT00406640|481306|P1|DB Continuation Phase for Responders|Physician Decision|2
147797|NCT00406640|481305|P2|DB Continuation Phase for Responders|Failed to Return|2
147798|NCT00406640|481306|P1|DB Continuation Phase for Responders|Failed to Return|0
147799|NCT00406640|481305|P2|DB Continuation Phase for Responders|Death|0
147800|NCT00406640|481306|P1|DB Continuation Phase for Responders|Death|1
147801|NCT00406640|481305|P2|DB Continuation Phase for Responders|Adverse Event|11
147802|NCT00406640|481306|P1|DB Continuation Phase for Responders|Adverse Event|11
147803|NCT00406640|481305|P2|Acute Phase|Lack of Efficacy|3
147804|NCT00406640|481306|P1|Acute Phase|Lack of Efficacy|3
147805|NCT00406640|481305|P2|Acute Phase|Withdrawal by Subject|9
147806|NCT00406640|481306|P1|Acute Phase|Withdrawal by Subject|11
147807|NCT00406640|481305|P2|Acute Phase|Protocol Violation|2
147808|NCT00406640|481306|P1|Acute Phase|Protocol Violation|3
147809|NCT00406640|481305|P2|Acute Phase|Protocol deviation|10
147810|NCT00406640|481306|P1|Acute Phase|Protocol deviation|4
147811|NCT00406640|481305|P2|Acute Phase|Lost to Follow-up|4
147812|NCT00406640|481306|P1|Acute Phase|Lost to Follow-up|7
147813|NCT00406640|481305|P2|Acute Phase|Physician Decision|1
147814|NCT00406640|481306|P1|Acute Phase|Physician Decision|0
147815|NCT00406640|481305|P2|Acute Phase|Failed to Return|1
147816|NCT00406640|481306|P1|Acute Phase|Failed to Return|5
147817|NCT00406640|481305|P2|Acute Phase|Adverse Event|13
147818|NCT00406640|481306|P1|Acute Phase|Adverse Event|18
147819|NCT00406393|481338|P2|Overall Study|Did not undergo transplantation|1
147820|NCT00406393|481339|P1|Overall Study|Did not undergo transplantation|2
147821|NCT00406367|481369|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
147822|NCT00406367|481370|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
147823|NCT00406367|481369|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
147824|NCT00406367|481370|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
147825|NCT00406367|481369|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
147826|NCT00406367|481370|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
147827|NCT00406367|481369|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
147828|NCT00406367|481370|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
147829|NCT00406367|481369|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
147830|NCT00406367|481370|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
147831|NCT00406367|481369|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
147832|NCT00406367|481370|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
147833|NCT00406367|481369|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
147834|NCT00406367|481370|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
147835|NCT00406367|481369|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
147836|NCT00406367|481370|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
147837|NCT00406367|481369|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
147838|NCT00406367|481370|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
147839|NCT00406367|481369|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
147840|NCT00406367|481370|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
147841|NCT00406367|481369|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
147842|NCT00406367|481370|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
147843|NCT00406367|481369|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
147844|NCT00406367|481370|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
147845|NCT00406354|481385|P3|All Randomized and Treated Patients|Physician Decision|1
147846|NCT00406354|481386|P2|All Randomized and Treated Patients|Physician Decision|0
147847|NCT00406354|481387|P1|All Randomized and Treated Patients|Physician Decision|0
147848|NCT00406354|481385|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
147849|NCT00406354|481386|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
147850|NCT00406354|481387|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
147851|NCT00406354|481385|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
147852|NCT00406354|481386|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
147853|NCT00406354|481387|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
147854|NCT00406354|481385|P3|All Randomized and Treated Patients|Adverse Event|1
147855|NCT00406354|481386|P2|All Randomized and Treated Patients|Adverse Event|2
147856|NCT00406354|481387|P1|All Randomized and Treated Patients|Adverse Event|6
147857|NCT00406354|481385|P3|All Randomized and Treated Patients|Lack of Efficacy|17
147858|NCT00406354|481386|P2|All Randomized and Treated Patients|Lack of Efficacy|4
147859|NCT00406354|481387|P1|All Randomized and Treated Patients|Lack of Efficacy|7
147860|NCT00406354|481385|P3|All Randomized Patients|Protocol Violation|1
147861|NCT00406354|481386|P2|All Randomized Patients|Protocol Violation|0
147862|NCT00406354|481387|P1|All Randomized Patients|Protocol Violation|0
147863|NCT00406315|481458|P1|Overall Study|Withdrawal by Subject|30
147864|NCT00406315|481458|P1|Overall Study|Lost to Follow-up|21
147865|NCT00406315|481458|P1|Overall Study|Unspecified|33
147866|NCT00406315|481458|P1|Overall Study|Lack of Efficacy|13
147867|NCT00406315|481458|P1|Overall Study|Laboratory Abnormality|4
147868|NCT00406315|481458|P1|Overall Study|Adverse Event|39
147869|NCT00406315|481458|P1|Overall Study|Death|1
147870|NCT00406029|481560|P5|Overall Study|Randomized in Error|1
147871|NCT00406029|481561|P4|Overall Study|Randomized in Error|3
147872|NCT00406029|481562|P3|Overall Study|Randomized in Error|2
147873|NCT00406029|481563|P2|Overall Study|Randomized in Error|0
147874|NCT00406029|481564|P1|Overall Study|Randomized in Error|0
147875|NCT00406029|481560|P5|Overall Study|Did Not Meet Eligibility Criteria|0
147876|NCT00406029|481561|P4|Overall Study|Did Not Meet Eligibility Criteria|0
147877|NCT00406029|481562|P3|Overall Study|Did Not Meet Eligibility Criteria|1
147878|NCT00406029|481563|P2|Overall Study|Did Not Meet Eligibility Criteria|0
147879|NCT00406029|481564|P1|Overall Study|Did Not Meet Eligibility Criteria|0
147880|NCT00406029|481560|P5|Overall Study|Protocol Violation|0
147881|NCT00406029|481561|P4|Overall Study|Protocol Violation|2
147882|NCT00406029|481562|P3|Overall Study|Protocol Violation|0
147883|NCT00406029|481563|P2|Overall Study|Protocol Violation|2
147884|NCT00406029|481564|P1|Overall Study|Protocol Violation|1
147885|NCT00406029|481560|P5|Overall Study|Withdrawal by Subject|0
147886|NCT00406029|481561|P4|Overall Study|Withdrawal by Subject|2
147887|NCT00406029|481562|P3|Overall Study|Withdrawal by Subject|2
147888|NCT00406029|481563|P2|Overall Study|Withdrawal by Subject|4
147889|NCT00406029|481564|P1|Overall Study|Withdrawal by Subject|3
147890|NCT00406029|481560|P5|Overall Study|Adverse Event|7
147891|NCT00406029|481561|P4|Overall Study|Adverse Event|10
147892|NCT00406029|481562|P3|Overall Study|Adverse Event|5
147893|NCT00406029|481563|P2|Overall Study|Adverse Event|2
147894|NCT00406029|481564|P1|Overall Study|Adverse Event|12
147895|NCT00405964|481668|P2|Overall Study|Protocol Violation|6
147896|NCT00405964|481669|P1|Overall Study|Protocol Violation|11
147897|NCT00405964|481668|P2|Overall Study|Withdrawal by Subject|23
147898|NCT00405964|481669|P1|Overall Study|Withdrawal by Subject|19
147899|NCT00405964|481668|P2|Overall Study|Lost to Follow-up|5
147900|NCT00405964|481669|P1|Overall Study|Lost to Follow-up|5
147901|NCT00405964|481668|P2|Overall Study|Adverse Event|16
147902|NCT00405964|481669|P1|Overall Study|Adverse Event|7
147903|NCT00405964|481668|P2|Overall Study|Treatment Failure|45
147904|NCT00405964|481669|P1|Overall Study|Treatment Failure|17
147905|NCT00405912|481691|P3|Overall Study|Lost to Follow-up|4
147906|NCT00405912|481692|P2|Overall Study|Lost to Follow-up|8
147907|NCT00405912|481693|P1|Overall Study|Lost to Follow-up|4
147908|NCT00405912|481691|P3|Overall Study|Withdrawal by Subject|12
147909|NCT00405912|481692|P2|Overall Study|Withdrawal by Subject|11
147910|NCT00405912|481693|P1|Overall Study|Withdrawal by Subject|12
147911|NCT00405821|481706|P2|Overall Study|initiated ART|8
147912|NCT00405821|481707|P1|Overall Study|initiated ART|9
147913|NCT00405821|481706|P2|Overall Study|Protocol Violation|0
147914|NCT00405821|481707|P1|Overall Study|Protocol Violation|1
147915|NCT00405821|481706|P2|Overall Study|Lost to Follow-up|7
147916|NCT00405821|481707|P1|Overall Study|Lost to Follow-up|7
147917|NCT00405821|481706|P2|Overall Study|Death|7
147918|NCT00405821|481707|P1|Overall Study|Death|5
147919|NCT00405756|481720|P3|Follow-up|Lost to Follow-up|4
147920|NCT00405756|481721|P2|Follow-up|Lost to Follow-up|8
147921|NCT00405756|481722|P1|Follow-up|Lost to Follow-up|2
147922|NCT00405756|481720|P3|Follow-up|Death|24
147923|NCT00405756|481721|P2|Follow-up|Death|31
147924|NCT00405756|481722|P1|Follow-up|Death|21
147925|NCT00405756|481720|P3|Follow-up|Ongoing in Follow-up Period|60
147926|NCT00405756|481721|P2|Follow-up|Ongoing in Follow-up Period|51
147927|NCT00405756|481722|P1|Follow-up|Ongoing in Follow-up Period|52
147928|NCT00405756|481720|P3|Open-label Extension|Unspecified|7
147929|NCT00405756|481721|P2|Open-label Extension|Unspecified|1
147930|NCT00405756|481722|P1|Open-label Extension|Unspecified|0
147931|NCT00405756|481720|P3|Open-label Extension|Death|4
147932|NCT00405756|481721|P2|Open-label Extension|Death|2
147933|NCT00405756|481722|P1|Open-label Extension|Death|1
147934|NCT00405756|481720|P3|Open-label Extension|Withdrawal by Subject|3
147935|NCT00405756|481721|P2|Open-label Extension|Withdrawal by Subject|3
147936|NCT00405756|481722|P1|Open-label Extension|Withdrawal by Subject|2
147937|NCT00405756|481720|P3|Open-label Extension|Disease Progression|26
147938|NCT00405756|481721|P2|Open-label Extension|Disease Progression|23
147939|NCT00405756|481722|P1|Open-label Extension|Disease Progression|8
147940|NCT00405756|481720|P3|Open-label Extension|Adverse Event|7
147941|NCT00405756|481721|P2|Open-label Extension|Adverse Event|3
147942|NCT00405756|481722|P1|Open-label Extension|Adverse Event|1
147943|NCT00405756|481720|P3|Open-label Extension|Ongoing in Open Label Period|25
147944|NCT00405756|481721|P2|Open-label Extension|Ongoing in Open Label Period|15
147945|NCT00405756|481722|P1|Open-label Extension|Ongoing in Open Label Period|7
147946|NCT00405756|481720|P3|Double-blind Treatment|Not Specified|4
147947|NCT00405756|481721|P2|Double-blind Treatment|Not Specified|4
147948|NCT00405756|481722|P1|Double-blind Treatment|Not Specified|7
147949|NCT00405756|481720|P3|Double-blind Treatment|Protocol Violation|2
147950|NCT00405756|481721|P2|Double-blind Treatment|Protocol Violation|0
147951|NCT00405756|481722|P1|Double-blind Treatment|Protocol Violation|1
147952|NCT00405756|481720|P3|Double-blind Treatment|Death|4
147953|NCT00405756|481721|P2|Double-blind Treatment|Death|4
147954|NCT00405756|481722|P1|Double-blind Treatment|Death|4
147955|NCT00405756|481720|P3|Double-blind Treatment|Lost to Follow-up|0
147956|NCT00405756|481721|P2|Double-blind Treatment|Lost to Follow-up|0
147957|NCT00405756|481722|P1|Double-blind Treatment|Lost to Follow-up|1
147958|NCT00405756|481720|P3|Double-blind Treatment|Withdrawal by Subject|10
147959|NCT00405756|481721|P2|Double-blind Treatment|Withdrawal by Subject|9
147960|NCT00405756|481722|P1|Double-blind Treatment|Withdrawal by Subject|15
147961|NCT00405756|481720|P3|Double-blind Treatment|Lack of Efficacy|2
147962|NCT00405756|481721|P2|Double-blind Treatment|Lack of Efficacy|4
147963|NCT00405756|481722|P1|Double-blind Treatment|Lack of Efficacy|1
147964|NCT00405756|481720|P3|Double-blind Treatment|Disease Progression|102
147965|NCT00405756|481721|P2|Double-blind Treatment|Disease Progression|81
147966|NCT00405756|481722|P1|Double-blind Treatment|Disease Progression|47
147967|NCT00405756|481720|P3|Double-blind Treatment|Adverse Event|12
147968|NCT00405756|481721|P2|Double-blind Treatment|Adverse Event|27
147969|NCT00405756|481722|P1|Double-blind Treatment|Adverse Event|31
147970|NCT00405756|481720|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
147971|NCT00405756|481721|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
147972|NCT00405756|481722|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
147973|NCT00405652|481833|P1|Overall Study|Adverse Event|4
147974|NCT00405639|481840|P2|Overall Study|Seizure prior to receiving BNP|0
147975|NCT00405639|481841|P1|Overall Study|Seizure prior to receiving BNP|1
147976|NCT00405639|481840|P2|Overall Study|Adverse Event|0
147977|NCT00405639|481841|P1|Overall Study|Adverse Event|1
147978|NCT00405639|481840|P2|Overall Study|Withdrawal by Subject|0
147979|NCT00405639|481841|P1|Overall Study|Withdrawal by Subject|1
147980|NCT00405548|481855|P2|Overall Study|Withdrawal by Subject|0
147981|NCT00405548|481856|P1|Overall Study|Withdrawal by Subject|1
147982|NCT00405548|481855|P2|Overall Study|Venous access failed during study day|0
147983|NCT00405548|481856|P1|Overall Study|Venous access failed during study day|1
147984|NCT00405548|481855|P2|Overall Study|Unable to self-administer shots|0
147985|NCT00405548|481856|P1|Overall Study|Unable to self-administer shots|1
147986|NCT00405548|481855|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
147987|NCT00405548|481856|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
147988|NCT00405548|481855|P2|Overall Study|Cognitive Memory problems on study day|0
147989|NCT00405548|481856|P1|Overall Study|Cognitive Memory problems on study day|1
147990|NCT00405275|481918|P2|Overall Study|Unwilling to continue|9
147991|NCT00405275|481919|P1|Overall Study|Unwilling to continue|10
147992|NCT00405275|481918|P2|Overall Study|Withdrawal by Subject|9
147993|NCT00405275|481919|P1|Overall Study|Withdrawal by Subject|7
147994|NCT00405275|481918|P2|Overall Study|Lost to Follow-up|1
147995|NCT00405275|481919|P1|Overall Study|Lost to Follow-up|5
147996|NCT00405275|481918|P2|Overall Study|Death|0
147997|NCT00405275|481919|P1|Overall Study|Death|1
147998|NCT00405067|481928|P3|Overall Study|Lost to Follow-up|1
147999|NCT00405067|481929|P2|Overall Study|Lost to Follow-up|0
148000|NCT00405067|481930|P1|Overall Study|Lost to Follow-up|0
148001|NCT00405067|481928|P3|Overall Study|Adverse Event|4
148002|NCT00405067|481929|P2|Overall Study|Adverse Event|9
148003|NCT00405067|481930|P1|Overall Study|Adverse Event|4
148004|NCT00404924|481967|P2|Overall Study|Randomised but not received treatment|1
148005|NCT00404924|481968|P1|Overall Study|Randomised but not received treatment|1
148006|NCT00404924|481967|P2|Overall Study|Not Specified|11
148007|NCT00404924|481968|P1|Overall Study|Not Specified|25
148008|NCT00404924|481967|P2|Overall Study|Withdrawal by Subject|13
148009|NCT00404924|481968|P1|Overall Study|Withdrawal by Subject|26
148010|NCT00404924|481967|P2|Overall Study|Lost to Follow-up|1
148011|NCT00404924|481968|P1|Overall Study|Lost to Follow-up|1
148012|NCT00404924|481967|P2|Overall Study|Condition under investigation worsened|264
148013|NCT00404924|481968|P1|Overall Study|Condition under investigation worsened|475
148014|NCT00404924|481967|P2|Overall Study|Adverse Event|16
148015|NCT00404924|481968|P1|Overall Study|Adverse Event|75
148016|NCT00404820|481986|P2|Overall Study|Other|2
148017|NCT00404820|481987|P1|Overall Study|Other|0
148018|NCT00404820|481986|P2|Overall Study|Death|0
148019|NCT00404820|481987|P1|Overall Study|Death|1
148020|NCT00404820|481986|P2|Overall Study|Administrative problems|0
148021|NCT00404820|481987|P1|Overall Study|Administrative problems|2
148022|NCT00404820|481986|P2|Overall Study|Lost to Follow-up|3
148023|NCT00404820|481987|P1|Overall Study|Lost to Follow-up|7
148024|NCT00404820|481986|P2|Overall Study|Withdrawal by Subject|3
148025|NCT00404820|481987|P1|Overall Study|Withdrawal by Subject|5
148026|NCT00404820|481986|P2|Overall Study|Adverse Event|16
148027|NCT00404820|481987|P1|Overall Study|Adverse Event|4
148028|NCT00404651|482009|P4|Overall Study|Withdrawal by Subject|6
148029|NCT00404651|482010|P3|Overall Study|Withdrawal by Subject|16
148030|NCT00404651|482011|P2|Overall Study|Withdrawal by Subject|12
148031|NCT00404651|482012|P1|Overall Study|Withdrawal by Subject|14
148032|NCT00404651|482009|P4|Overall Study|Lost to Follow-up|10
148033|NCT00404651|482010|P3|Overall Study|Lost to Follow-up|13
148034|NCT00404651|482011|P2|Overall Study|Lost to Follow-up|11
148035|NCT00404651|482012|P1|Overall Study|Lost to Follow-up|15
148036|NCT00404651|482009|P4|Overall Study|Protocol Violation|5
148037|NCT00404651|482010|P3|Overall Study|Protocol Violation|14
148038|NCT00404651|482011|P2|Overall Study|Protocol Violation|5
148039|NCT00404651|482012|P1|Overall Study|Protocol Violation|10
148040|NCT00404651|482009|P4|Overall Study|Serious Adverse Event|0
148041|NCT00404651|482010|P3|Overall Study|Serious Adverse Event|2
148042|NCT00404651|482011|P2|Overall Study|Serious Adverse Event|0
148043|NCT00404651|482012|P1|Overall Study|Serious Adverse Event|0
148044|NCT00404547|482040|P2|Overall Study|Reason not stated|6
148045|NCT00404547|482041|P1|Overall Study|Reason not stated|3
148046|NCT00404547|482040|P2|Overall Study|Not known|0
148047|NCT00404547|482041|P1|Overall Study|Not known|4
148048|NCT00404547|482040|P2|Overall Study|Lack of compliance|1
148049|NCT00404547|482041|P1|Overall Study|Lack of compliance|5
148050|NCT00404547|482040|P2|Overall Study|Lost to Follow-up|9
148051|NCT00404547|482041|P1|Overall Study|Lost to Follow-up|20
148052|NCT00404547|482040|P2|Overall Study|Protocol Violation|1
148053|NCT00404547|482041|P1|Overall Study|Protocol Violation|0
148054|NCT00404547|482040|P2|Overall Study|Withdrawal by Subject|2
148055|NCT00404547|482041|P1|Overall Study|Withdrawal by Subject|19
148056|NCT00404547|482040|P2|Overall Study|Adverse Event|6
148057|NCT00404547|482041|P1|Overall Study|Adverse Event|39
148058|NCT00404495|482051|P2|Overall Study|Withdrawal by Subject|0
148059|NCT00404495|482052|P1|Overall Study|Withdrawal by Subject|1
148060|NCT00404495|482051|P2|Overall Study|Not specified|0
148061|NCT00404495|482052|P1|Overall Study|Not specified|1
148062|NCT00404495|482051|P2|Overall Study|Lost to Follow-up|0
148063|NCT00404495|482052|P1|Overall Study|Lost to Follow-up|5
148064|NCT00404495|482051|P2|Overall Study|Death|11
148065|NCT00404495|482052|P1|Overall Study|Death|37
148066|NCT00404352|482071|P9|Open Label Extension (up to 36 Months)|unspecified|2
148067|NCT00404352|482072|P8|Open Label Extension (up to 36 Months)|unspecified|0
148068|NCT00404352|482073|P7|Open Label Extension (up to 36 Months)|unspecified|0
148069|NCT00404352|482074|P6|Open Label Extension (up to 36 Months)|unspecified|0
148070|NCT00404352|482075|P5|Open Label Extension (up to 36 Months)|unspecified|0
148071|NCT00404352|482076|P4|Open Label Extension (up to 36 Months)|unspecified|0
148072|NCT00404352|482077|P3|Open Label Extension (up to 36 Months)|unspecified|0
148073|NCT00404352|482078|P2|Open Label Extension (up to 36 Months)|unspecified|0
148074|NCT00404352|482079|P1|Open Label Extension (up to 36 Months)|unspecified|0
148075|NCT00404352|482071|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
148076|NCT00404352|482072|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
148077|NCT00404352|482073|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
148078|NCT00404352|482074|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
148079|NCT00404352|482075|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
148080|NCT00404352|482076|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
148081|NCT00404352|482077|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
148082|NCT00404352|482078|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
148083|NCT00404352|482079|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
148084|NCT00404352|482071|P9|Open Label (up to 24 Month)|Disease progression|0
148085|NCT00404352|482072|P8|Open Label (up to 24 Month)|Disease progression|0
148086|NCT00404352|482073|P7|Open Label (up to 24 Month)|Disease progression|0
148087|NCT00404352|482074|P6|Open Label (up to 24 Month)|Disease progression|0
148088|NCT00404352|482075|P5|Open Label (up to 24 Month)|Disease progression|0
148089|NCT00404352|482076|P4|Open Label (up to 24 Month)|Disease progression|1
148090|NCT00404352|482077|P3|Open Label (up to 24 Month)|Disease progression|0
148091|NCT00404352|482078|P2|Open Label (up to 24 Month)|Disease progression|0
148092|NCT00404352|482079|P1|Open Label (up to 24 Month)|Disease progression|0
148093|NCT00404352|482071|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
148094|NCT00404352|482072|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
148095|NCT00404352|482073|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
148096|NCT00404352|482074|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
148097|NCT00404352|482075|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
148098|NCT00404352|482076|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
148099|NCT00404352|482077|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
148100|NCT00404352|482078|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
148101|NCT00404352|482079|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
148102|NCT00404352|482071|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
148103|NCT00404352|482072|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
148104|NCT00404352|482073|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
148105|NCT00404352|482074|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
148106|NCT00404352|482075|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
148107|NCT00404352|482076|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
148108|NCT00404352|482077|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
148109|NCT00404352|482078|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
148110|NCT00404352|482079|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
148111|NCT00404352|482071|P9|Open Label (up to 24 Month)|Pregnancy|0
148112|NCT00404352|482072|P8|Open Label (up to 24 Month)|Pregnancy|0
148113|NCT00404352|482073|P7|Open Label (up to 24 Month)|Pregnancy|0
148114|NCT00404352|482074|P6|Open Label (up to 24 Month)|Pregnancy|1
148115|NCT00404352|482075|P5|Open Label (up to 24 Month)|Pregnancy|0
148116|NCT00404352|482076|P4|Open Label (up to 24 Month)|Pregnancy|0
148117|NCT00404352|482077|P3|Open Label (up to 24 Month)|Pregnancy|0
148118|NCT00404352|482078|P2|Open Label (up to 24 Month)|Pregnancy|0
148119|NCT00404352|482079|P1|Open Label (up to 24 Month)|Pregnancy|0
148120|NCT00404352|482071|P9|Open Label (up to 24 Month)|Adverse Event|0
148121|NCT00404352|482072|P8|Open Label (up to 24 Month)|Adverse Event|0
148122|NCT00404352|482073|P7|Open Label (up to 24 Month)|Adverse Event|0
148123|NCT00404352|482074|P6|Open Label (up to 24 Month)|Adverse Event|1
148124|NCT00404352|482075|P5|Open Label (up to 24 Month)|Adverse Event|1
148125|NCT00404352|482076|P4|Open Label (up to 24 Month)|Adverse Event|2
148126|NCT00404352|482077|P3|Open Label (up to 24 Month)|Adverse Event|0
148127|NCT00404352|482078|P2|Open Label (up to 24 Month)|Adverse Event|0
148128|NCT00404352|482079|P1|Open Label (up to 24 Month)|Adverse Event|0
148129|NCT00404352|482071|P9|Double Blind (up to 24 Month)|Unspecified|0
148130|NCT00404352|482072|P8|Double Blind (up to 24 Month)|Unspecified|0
148131|NCT00404352|482073|P7|Double Blind (up to 24 Month)|Unspecified|0
148132|NCT00404352|482074|P6|Double Blind (up to 24 Month)|Unspecified|0
148133|NCT00404352|482075|P5|Double Blind (up to 24 Month)|Unspecified|0
148134|NCT00404352|482076|P4|Double Blind (up to 24 Month)|Unspecified|0
148135|NCT00404352|482077|P3|Double Blind (up to 24 Month)|Unspecified|0
148136|NCT00404352|482078|P2|Double Blind (up to 24 Month)|Unspecified|1
148137|NCT00404352|482079|P1|Double Blind (up to 24 Month)|Unspecified|0
148138|NCT00404352|482071|P9|Double Blind (up to 24 Month)|Physician Decision|0
148139|NCT00404352|482072|P8|Double Blind (up to 24 Month)|Physician Decision|0
148140|NCT00404352|482073|P7|Double Blind (up to 24 Month)|Physician Decision|0
148141|NCT00404352|482074|P6|Double Blind (up to 24 Month)|Physician Decision|0
148142|NCT00404352|482075|P5|Double Blind (up to 24 Month)|Physician Decision|0
148143|NCT00404352|482076|P4|Double Blind (up to 24 Month)|Physician Decision|0
148144|NCT00404352|482077|P3|Double Blind (up to 24 Month)|Physician Decision|1
148145|NCT00404352|482078|P2|Double Blind (up to 24 Month)|Physician Decision|0
148146|NCT00404352|482079|P1|Double Blind (up to 24 Month)|Physician Decision|0
148147|NCT00404352|482071|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
148148|NCT00404352|482072|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
148149|NCT00404352|482073|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
148150|NCT00404352|482074|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
148151|NCT00404352|482075|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
148152|NCT00404352|482076|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
148153|NCT00404352|482077|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
148154|NCT00404352|482078|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
148155|NCT00404352|482079|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
148156|NCT00404352|482071|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
148157|NCT00404352|482072|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
148158|NCT00404352|482073|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
148159|NCT00404352|482074|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
148160|NCT00404352|482075|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
148161|NCT00404352|482076|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
148162|NCT00404352|482077|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
148163|NCT00404352|482078|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
148164|NCT00404352|482079|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
148165|NCT00404352|482071|P9|Double Blind (up to 24 Month)|Poor compliance|0
148166|NCT00404352|482072|P8|Double Blind (up to 24 Month)|Poor compliance|0
148167|NCT00404352|482073|P7|Double Blind (up to 24 Month)|Poor compliance|0
148168|NCT00404352|482074|P6|Double Blind (up to 24 Month)|Poor compliance|0
148169|NCT00404352|482075|P5|Double Blind (up to 24 Month)|Poor compliance|0
148170|NCT00404352|482076|P4|Double Blind (up to 24 Month)|Poor compliance|0
148171|NCT00404352|482077|P3|Double Blind (up to 24 Month)|Poor compliance|0
148172|NCT00404352|482078|P2|Double Blind (up to 24 Month)|Poor compliance|0
148173|NCT00404352|482079|P1|Double Blind (up to 24 Month)|Poor compliance|1
148174|NCT00404352|482071|P9|Double Blind (up to 24 Month)|Disease progression|0
148175|NCT00404352|482072|P8|Double Blind (up to 24 Month)|Disease progression|0
148176|NCT00404352|482073|P7|Double Blind (up to 24 Month)|Disease progression|0
148177|NCT00404352|482074|P6|Double Blind (up to 24 Month)|Disease progression|0
148178|NCT00404352|482075|P5|Double Blind (up to 24 Month)|Disease progression|0
148179|NCT00404352|482076|P4|Double Blind (up to 24 Month)|Disease progression|0
148180|NCT00404352|482077|P3|Double Blind (up to 24 Month)|Disease progression|2
148181|NCT00404352|482078|P2|Double Blind (up to 24 Month)|Disease progression|0
148182|NCT00404352|482079|P1|Double Blind (up to 24 Month)|Disease progression|3
148183|NCT00404352|482071|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
148184|NCT00404352|482072|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
148185|NCT00404352|482073|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
148186|NCT00404352|482074|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
148187|NCT00404352|482075|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
148188|NCT00404352|482076|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
148189|NCT00404352|482077|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
148190|NCT00404352|482078|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
148191|NCT00404352|482079|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
148192|NCT00404352|482071|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
148193|NCT00404352|482072|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
148194|NCT00404352|482073|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
148195|NCT00404352|482074|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
148196|NCT00404352|482075|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
148197|NCT00404352|482076|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
148198|NCT00404352|482077|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
148199|NCT00404352|482078|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
148200|NCT00404352|482079|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
148201|NCT00404352|482071|P9|Double Blind (up to 24 Month)|Death|0
148202|NCT00404352|482072|P8|Double Blind (up to 24 Month)|Death|0
148203|NCT00404352|482073|P7|Double Blind (up to 24 Month)|Death|0
148204|NCT00404352|482074|P6|Double Blind (up to 24 Month)|Death|0
148205|NCT00404352|482075|P5|Double Blind (up to 24 Month)|Death|0
148206|NCT00404352|482076|P4|Double Blind (up to 24 Month)|Death|0
148207|NCT00404352|482077|P3|Double Blind (up to 24 Month)|Death|1
148208|NCT00404352|482078|P2|Double Blind (up to 24 Month)|Death|0
148209|NCT00404352|482079|P1|Double Blind (up to 24 Month)|Death|0
148210|NCT00404352|482071|P9|Double Blind (up to 24 Month)|Pregnancy|0
148211|NCT00404352|482072|P8|Double Blind (up to 24 Month)|Pregnancy|0
148212|NCT00404352|482073|P7|Double Blind (up to 24 Month)|Pregnancy|0
148213|NCT00404352|482074|P6|Double Blind (up to 24 Month)|Pregnancy|0
148214|NCT00404352|482075|P5|Double Blind (up to 24 Month)|Pregnancy|0
148215|NCT00404352|482076|P4|Double Blind (up to 24 Month)|Pregnancy|0
148216|NCT00404352|482077|P3|Double Blind (up to 24 Month)|Pregnancy|2
148217|NCT00404352|482078|P2|Double Blind (up to 24 Month)|Pregnancy|0
148218|NCT00404352|482079|P1|Double Blind (up to 24 Month)|Pregnancy|0
148219|NCT00404352|482071|P9|Double Blind (up to 24 Month)|Adverse Event|0
148220|NCT00404352|482072|P8|Double Blind (up to 24 Month)|Adverse Event|0
148221|NCT00404352|482073|P7|Double Blind (up to 24 Month)|Adverse Event|0
148222|NCT00404352|482074|P6|Double Blind (up to 24 Month)|Adverse Event|0
148223|NCT00404352|482075|P5|Double Blind (up to 24 Month)|Adverse Event|0
148224|NCT00404352|482076|P4|Double Blind (up to 24 Month)|Adverse Event|0
148225|NCT00404352|482077|P3|Double Blind (up to 24 Month)|Adverse Event|6
148226|NCT00404352|482078|P2|Double Blind (up to 24 Month)|Adverse Event|4
148227|NCT00404352|482079|P1|Double Blind (up to 24 Month)|Adverse Event|5
148228|NCT00404248|482114|P9|Overall Study|pts declining status|0
148229|NCT00404248|482115|P8|Overall Study|pts declining status|0
148230|NCT00404248|482116|P7|Overall Study|pts declining status|0
148231|NCT00404248|482117|P6|Overall Study|pts declining status|0
148232|NCT00404248|482118|P5|Overall Study|pts declining status|0
148233|NCT00404248|482119|P4|Overall Study|pts declining status|0
148234|NCT00404248|482120|P3|Overall Study|pts declining status|0
148235|NCT00404248|482121|P2|Overall Study|pts declining status|1
148236|NCT00404248|482122|P1|Overall Study|pts declining status|0
148237|NCT00404092|482157|P4|Overall Study|Adverse Event|0
148238|NCT00404092|482158|P3|Overall Study|Adverse Event|1
148239|NCT00404092|482159|P2|Overall Study|Adverse Event|0
148240|NCT00404092|482160|P1|Overall Study|Adverse Event|0
148241|NCT00404092|482157|P4|Overall Study|Death|0
148242|NCT00404092|482158|P3|Overall Study|Death|0
148243|NCT00404092|482159|P2|Overall Study|Death|0
148244|NCT00404092|482160|P1|Overall Study|Death|1
148245|NCT00404079|482176|P2|Overall Study|Lost to follow up, adverse event etc|20
148246|NCT00404079|482177|P1|Overall Study|Lost to follow up, adverse event etc|22
148247|NCT00403845|482183|P4|Treatment Period 3|Adverse Event|1
148248|NCT00403845|482184|P3|Treatment Period 3|Adverse Event|0
148249|NCT00403845|482185|P2|Treatment Period 3|Adverse Event|0
148250|NCT00403845|482186|P1|Treatment Period 3|Adverse Event|0
148251|NCT00403845|482183|P4|Treatment Period 3|Subject withdrew consent|1
148252|NCT00403845|482184|P3|Treatment Period 3|Subject withdrew consent|0
148253|NCT00403845|482185|P2|Treatment Period 3|Subject withdrew consent|0
148254|NCT00403845|482186|P1|Treatment Period 3|Subject withdrew consent|0
148255|NCT00403845|482183|P4|Treatment Period 2|Subject withdrew consent|0
148256|NCT00403845|482184|P3|Treatment Period 2|Subject withdrew consent|0
148257|NCT00403845|482185|P2|Treatment Period 2|Subject withdrew consent|0
148258|NCT00403845|482186|P1|Treatment Period 2|Subject withdrew consent|1
148259|NCT00403845|482183|P4|Treatment Period 1|Subject no longer needs study drug|1
148260|NCT00403845|482184|P3|Treatment Period 1|Subject no longer needs study drug|0
148261|NCT00403845|482185|P2|Treatment Period 1|Subject no longer needs study drug|0
148262|NCT00403845|482186|P1|Treatment Period 1|Subject no longer needs study drug|0
148263|NCT00403845|482183|P4|Treatment Period 1|Subject withdrew consent|0
148264|NCT00403845|482184|P3|Treatment Period 1|Subject withdrew consent|0
148265|NCT00403845|482185|P2|Treatment Period 1|Subject withdrew consent|0
148266|NCT00403845|482186|P1|Treatment Period 1|Subject withdrew consent|1
148267|NCT00403767|482210|P2|Overall Study|Missing/incomplete data|1
148268|NCT00403767|482211|P1|Overall Study|Missing/incomplete data|1
148269|NCT00403767|482210|P2|Overall Study|Study terminated by sponsor|69
148270|NCT00403767|482211|P1|Overall Study|Study terminated by sponsor|82
148271|NCT00403767|482210|P2|Overall Study|Clinical efficacy endpoint reached|332
148272|NCT00403767|482211|P1|Overall Study|Clinical efficacy endpoint reached|300
148273|NCT00403767|482210|P2|Overall Study|Protocol Violation|124
148274|NCT00403767|482211|P1|Overall Study|Protocol Violation|142
148275|NCT00403767|482210|P2|Overall Study|Lost to Follow-up|8
148276|NCT00403767|482211|P1|Overall Study|Lost to Follow-up|6
148277|NCT00403767|482210|P2|Overall Study|Investigator dec./not protocol-related|178
148278|NCT00403767|482211|P1|Overall Study|Investigator dec./not protocol-related|191
148279|NCT00403767|482210|P2|Overall Study|Consent withdrawn|673
148280|NCT00403767|482211|P1|Overall Study|Consent withdrawn|671
148281|NCT00403767|482210|P2|Overall Study|Non-compliant with study medication|164
148282|NCT00403767|482211|P1|Overall Study|Non-compliant with study medication|134
148283|NCT00403767|482210|P2|Overall Study|Adverse Event|919
148284|NCT00403767|482211|P1|Overall Study|Adverse Event|993
148285|NCT00403754|482235|P4|Core Treatment Period 2|Lack of Efficacy|0
148286|NCT00403754|482236|P3|Core Treatment Period 2|Lack of Efficacy|1
148287|NCT00403754|482237|P2|Core Treatment Period 2|Lack of Efficacy|0
148288|NCT00403754|482238|P1|Core Treatment Period 2|Lack of Efficacy|0
148289|NCT00403754|482235|P4|Core Treatment Period 1|Withdrawal by Subject|0
148290|NCT00403754|482236|P3|Core Treatment Period 1|Withdrawal by Subject|0
148291|NCT00403754|482237|P2|Core Treatment Period 1|Withdrawal by Subject|1
148292|NCT00403754|482238|P1|Core Treatment Period 1|Withdrawal by Subject|0
148293|NCT00403585|482265|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
148294|NCT00403585|482265|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
148295|NCT00403585|482265|P1|Initial Treatment Phase|Lost to Follow-up|2
148296|NCT00403481|482274|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
148297|NCT00403481|482274|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
148298|NCT00403481|482274|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
148299|NCT00403481|482274|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
148300|NCT00403481|482274|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
148301|NCT00403481|482274|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
148302|NCT00403481|482274|P1|Olm 40 mg|Other|1
148303|NCT00403481|482274|P1|Olm 40 mg|Withdrawal by Subject|1
148304|NCT00403481|482274|P1|Olm 40 mg|Protocol Violation|1
148305|NCT00403481|482274|P1|Olm 40 mg|Adverse Event|2
148306|NCT00403481|482274|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
148307|NCT00403481|482274|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
148308|NCT00403481|482274|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
148309|NCT00403481|482274|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
148310|NCT00403455|482289|P1|Overall Study|Withdrawal by Subject|1
148311|NCT00403273|482312|P2|Overall Study|pt. wanted to have a surgical procedure|1
148312|NCT00403273|482313|P1|Overall Study|pt. wanted to have a surgical procedure|0
148313|NCT00403273|482312|P2|Overall Study|Physician Decision|1
148314|NCT00403273|482313|P1|Overall Study|Physician Decision|0
148315|NCT00403273|482312|P2|Overall Study|Lost to Follow-up|2
148316|NCT00403273|482313|P1|Overall Study|Lost to Follow-up|3
148317|NCT00403234|482343|P4|Overall Study|Adverse Event|0
148318|NCT00403234|482344|P3|Overall Study|Adverse Event|1
148319|NCT00403234|482345|P2|Overall Study|Adverse Event|0
148320|NCT00403234|482346|P1|Overall Study|Adverse Event|1
148321|NCT00403234|482343|P4|Overall Study|Withdrawal by Subject|0
148322|NCT00403234|482344|P3|Overall Study|Withdrawal by Subject|0
148323|NCT00403234|482345|P2|Overall Study|Withdrawal by Subject|1
148324|NCT00403234|482346|P1|Overall Study|Withdrawal by Subject|0
148325|NCT00402987|482360|P4|Overall Study|Lack of Efficacy|0
148326|NCT00402987|482361|P3|Overall Study|Lack of Efficacy|1
148327|NCT00402987|482362|P2|Overall Study|Lack of Efficacy|0
148328|NCT00402987|482363|P1|Overall Study|Lack of Efficacy|0
148329|NCT00402740|482533|P1|Overall Study|Subject disposition unknown.|1
148330|NCT00402740|482533|P1|Overall Study|No stent. Completed FU at 30 days.|5
148331|NCT00402740|482533|P1|Overall Study|Lost to Follow-up|6
148332|NCT00402740|482533|P1|Overall Study|Death|50
148333|NCT00402740|482533|P1|Overall Study|Withdrawal by Subject|18
148334|NCT00402727|482545|P2|Overall Study|non-compliance|1
148335|NCT00402727|482546|P1|Overall Study|non-compliance|0
148336|NCT00402727|482545|P2|Overall Study|supply problems|1
148337|NCT00402727|482546|P1|Overall Study|supply problems|2
148338|NCT00402727|482545|P2|Overall Study|Withdrawal by Subject|7
148339|NCT00402727|482546|P1|Overall Study|Withdrawal by Subject|3
148340|NCT00402727|482545|P2|Overall Study|Protocol Violation|4
148341|NCT00402727|482546|P1|Overall Study|Protocol Violation|0
148342|NCT00402727|482545|P2|Overall Study|Physician Decision|1
148343|NCT00402727|482546|P1|Overall Study|Physician Decision|1
148344|NCT00402727|482545|P2|Overall Study|Lost to Follow-up|11
148345|NCT00402727|482546|P1|Overall Study|Lost to Follow-up|24
148346|NCT00402727|482545|P2|Overall Study|Lack of Efficacy|3
148347|NCT00402727|482546|P1|Overall Study|Lack of Efficacy|1
148348|NCT00402727|482545|P2|Overall Study|Death|0
148349|NCT00402727|482546|P1|Overall Study|Death|1
148350|NCT00402727|482545|P2|Overall Study|Adverse Event|6
148351|NCT00402727|482546|P1|Overall Study|Adverse Event|10
148352|NCT00402688|482588|P3|Overall Study|Patient Left Town and Forgot Medication|1
148353|NCT00402688|482589|P2|Overall Study|Patient Left Town and Forgot Medication|0
148354|NCT00402688|482590|P1|Overall Study|Patient Left Town and Forgot Medication|0
148355|NCT00402688|482588|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
148356|NCT00402688|482589|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
148357|NCT00402688|482590|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
148358|NCT00402688|482588|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
148359|NCT00402688|482589|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
148360|NCT00402688|482590|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
148361|NCT00402688|482588|P3|Overall Study|Lost to Follow-up|2
148362|NCT00402688|482589|P2|Overall Study|Lost to Follow-up|0
148363|NCT00402688|482590|P1|Overall Study|Lost to Follow-up|1
148364|NCT00402688|482588|P3|Overall Study|Protocol Violation|1
148365|NCT00402688|482589|P2|Overall Study|Protocol Violation|1
148366|NCT00402688|482590|P1|Overall Study|Protocol Violation|1
148367|NCT00402688|482588|P3|Overall Study|Lack of Efficacy|5
148368|NCT00402688|482589|P2|Overall Study|Lack of Efficacy|4
148369|NCT00402688|482590|P1|Overall Study|Lack of Efficacy|4
148370|NCT00402688|482588|P3|Overall Study|Physician Decision|1
148371|NCT00402688|482589|P2|Overall Study|Physician Decision|0
148372|NCT00402688|482590|P1|Overall Study|Physician Decision|0
148373|NCT00402688|482588|P3|Overall Study|Withdrawal by Subject|1
148374|NCT00402688|482589|P2|Overall Study|Withdrawal by Subject|1
148375|NCT00402688|482590|P1|Overall Study|Withdrawal by Subject|3
148376|NCT00402688|482588|P3|Overall Study|Adverse Event|3
148377|NCT00402688|482589|P2|Overall Study|Adverse Event|9
148378|NCT00402688|482590|P1|Overall Study|Adverse Event|12
148379|NCT00402649|482613|P1|Overall Study|Withdrawal by Subject|1
148380|NCT00402649|482613|P1|Overall Study|Lost to Follow-up|1
148381|NCT00402597|482628|P5|Overall Study|reason not specified|20
148382|NCT00402597|482629|P4|Overall Study|reason not specified|14
148383|NCT00402597|482630|P3|Overall Study|reason not specified|27
148384|NCT00402597|482631|P2|Overall Study|reason not specified|4
148385|NCT00402597|482632|P1|Overall Study|reason not specified|30
148386|NCT00402597|482628|P5|Overall Study|Withdrawal by Subject|24
148387|NCT00402597|482629|P4|Overall Study|Withdrawal by Subject|15
148388|NCT00402597|482630|P3|Overall Study|Withdrawal by Subject|65
148389|NCT00402597|482631|P2|Overall Study|Withdrawal by Subject|16
148390|NCT00402597|482632|P1|Overall Study|Withdrawal by Subject|57
148391|NCT00402597|482628|P5|Overall Study|Lost to Follow-up|3
148392|NCT00402597|482629|P4|Overall Study|Lost to Follow-up|2
148393|NCT00402597|482630|P3|Overall Study|Lost to Follow-up|8
148394|NCT00402597|482631|P2|Overall Study|Lost to Follow-up|1
148395|NCT00402597|482632|P1|Overall Study|Lost to Follow-up|8
148396|NCT00402597|482628|P5|Overall Study|Adverse Event|71
148397|NCT00402597|482629|P4|Overall Study|Adverse Event|39
148398|NCT00402597|482630|P3|Overall Study|Adverse Event|106
148399|NCT00402597|482631|P2|Overall Study|Adverse Event|18
148400|NCT00402597|482632|P1|Overall Study|Adverse Event|81
148401|NCT00402597|482628|P5|Overall Study|Death|6
148402|NCT00402597|482629|P4|Overall Study|Death|4
148403|NCT00402597|482630|P3|Overall Study|Death|6
148404|NCT00402597|482631|P2|Overall Study|Death|7
148405|NCT00402597|482632|P1|Overall Study|Death|15
148406|NCT00402363|482673|P4|Overall Study|"Captured as Other"|2
148407|NCT00402363|482674|P3|Overall Study|"Captured as Other"|2
148408|NCT00402363|482675|P2|Overall Study|"Captured as Other"|2
148409|NCT00402363|482676|P1|Overall Study|"Captured as Other"|6
148410|NCT00402363|482673|P4|Overall Study|Lost to Follow-up|2
148411|NCT00402363|482674|P3|Overall Study|Lost to Follow-up|0
148412|NCT00402363|482675|P2|Overall Study|Lost to Follow-up|4
148413|NCT00402363|482676|P1|Overall Study|Lost to Follow-up|5
148414|NCT00402363|482673|P4|Overall Study|Protocol Violation|3
148415|NCT00402363|482674|P3|Overall Study|Protocol Violation|0
148416|NCT00402363|482675|P2|Overall Study|Protocol Violation|5
148417|NCT00402363|482676|P1|Overall Study|Protocol Violation|3
148418|NCT00402363|482673|P4|Overall Study|Withdrew Consent|1
148419|NCT00402363|482674|P3|Overall Study|Withdrew Consent|2
148420|NCT00402363|482675|P2|Overall Study|Withdrew Consent|5
148421|NCT00402363|482676|P1|Overall Study|Withdrew Consent|10
148422|NCT00402363|482673|P4|Overall Study|Adverse Event|2
148423|NCT00402363|482674|P3|Overall Study|Adverse Event|2
148424|NCT00402363|482675|P2|Overall Study|Adverse Event|14
148425|NCT00402363|482676|P1|Overall Study|Adverse Event|9
148426|NCT00402337|482739|P5|Overall Study|Other Reason|0
148427|NCT00402337|482740|P4|Overall Study|Other Reason|0
148428|NCT00402337|482741|P3|Overall Study|Other Reason|0
148429|NCT00402337|482742|P2|Overall Study|Other Reason|1
148430|NCT00402337|482743|P1|Overall Study|Other Reason|0
148431|NCT00402337|482739|P5|Overall Study|Physician Decision|0
148432|NCT00402337|482740|P4|Overall Study|Physician Decision|1
148433|NCT00402337|482741|P3|Overall Study|Physician Decision|0
148434|NCT00402337|482742|P2|Overall Study|Physician Decision|0
148435|NCT00402337|482743|P1|Overall Study|Physician Decision|0
148436|NCT00402337|482739|P5|Overall Study|Lost to Follow-up|0
148437|NCT00402337|482740|P4|Overall Study|Lost to Follow-up|2
148438|NCT00402337|482741|P3|Overall Study|Lost to Follow-up|1
148439|NCT00402337|482742|P2|Overall Study|Lost to Follow-up|0
148440|NCT00402337|482743|P1|Overall Study|Lost to Follow-up|0
148441|NCT00402337|482739|P5|Overall Study|Withdrawal by Subject|4
148442|NCT00402337|482740|P4|Overall Study|Withdrawal by Subject|6
148443|NCT00402337|482741|P3|Overall Study|Withdrawal by Subject|1
148444|NCT00402337|482742|P2|Overall Study|Withdrawal by Subject|3
148445|NCT00402337|482743|P1|Overall Study|Withdrawal by Subject|5
148446|NCT00402337|482739|P5|Overall Study|Noncompliance|2
148447|NCT00402337|482740|P4|Overall Study|Noncompliance|0
148448|NCT00402337|482741|P3|Overall Study|Noncompliance|0
148449|NCT00402337|482742|P2|Overall Study|Noncompliance|0
148450|NCT00402337|482743|P1|Overall Study|Noncompliance|0
148451|NCT00402337|482739|P5|Overall Study|Adverse Event|2
148452|NCT00402337|482740|P4|Overall Study|Adverse Event|3
148453|NCT00402337|482741|P3|Overall Study|Adverse Event|2
148454|NCT00402337|482742|P2|Overall Study|Adverse Event|2
148455|NCT00402337|482743|P1|Overall Study|Adverse Event|0
148456|NCT00402324|482782|P2|Overall Study|Death|0
148457|NCT00402324|482783|P1|Overall Study|Death|1
148458|NCT00402324|482782|P2|Overall Study|Adverse Event|4
148459|NCT00402324|482783|P1|Overall Study|Adverse Event|6
148460|NCT00402324|482782|P2|Overall Study|Lack of Efficacy|4
148461|NCT00402324|482783|P1|Overall Study|Lack of Efficacy|1
148462|NCT00402324|482782|P2|Overall Study|Sponsor Decision|5
148463|NCT00402324|482783|P1|Overall Study|Sponsor Decision|4
148464|NCT00402324|482782|P2|Overall Study|Physician Decision|4
148465|NCT00402324|482783|P1|Overall Study|Physician Decision|2
148466|NCT00402324|482782|P2|Overall Study|Withdrawal by Subject|2
148467|NCT00402324|482783|P1|Overall Study|Withdrawal by Subject|5
148468|NCT00402324|482782|P2|Overall Study|Protocol Violation|7
148469|NCT00402324|482783|P1|Overall Study|Protocol Violation|8
148470|NCT00402324|482782|P2|Overall Study|Protocol Entry Criteria Not Met|4
148471|NCT00402324|482783|P1|Overall Study|Protocol Entry Criteria Not Met|5
148472|NCT00402324|482782|P2|Overall Study|Lost to Follow-up|11
148473|NCT00402324|482783|P1|Overall Study|Lost to Follow-up|11
148474|NCT00402285|482816|P3|Overall Study|insufficient RNA quality|2
148475|NCT00402285|482817|P2|Overall Study|insufficient RNA quality|6
148476|NCT00402285|482818|P1|Overall Study|insufficient RNA quality|7
148477|NCT00402246|482826|P2|Overall Study|Deterioriating Condition|2
148478|NCT00402246|482827|P1|Overall Study|Deterioriating Condition|3
148479|NCT00402246|482826|P2|Overall Study|Center Closure|3
148480|NCT00402246|482827|P1|Overall Study|Center Closure|5
148481|NCT00402246|482826|P2|Overall Study|Patient's device explanted|2
148482|NCT00402246|482827|P1|Overall Study|Patient's device explanted|6
148483|NCT00402246|482826|P2|Overall Study|Heart Transplant|1
148484|NCT00402246|482827|P1|Overall Study|Heart Transplant|0
148485|NCT00402246|482826|P2|Overall Study|Insurance Issues|1
148486|NCT00402246|482827|P1|Overall Study|Insurance Issues|2
148487|NCT00402246|482826|P2|Overall Study|Missed Final Visit|2
148488|NCT00402246|482827|P1|Overall Study|Missed Final Visit|1
148489|NCT00402246|482826|P2|Overall Study|Protocol Violation|24
148490|NCT00402246|482827|P1|Overall Study|Protocol Violation|25
148491|NCT00402246|482826|P2|Overall Study|Physician Decision|26
148492|NCT00402246|482827|P1|Overall Study|Physician Decision|24
148493|NCT00402246|482826|P2|Overall Study|Withdrawal by Subject|87
148494|NCT00402246|482827|P1|Overall Study|Withdrawal by Subject|72
148495|NCT00402246|482826|P2|Overall Study|Lost to Follow-up|28
148496|NCT00402246|482827|P1|Overall Study|Lost to Follow-up|20
148497|NCT00402246|482826|P2|Overall Study|Death|58
148498|NCT00402246|482827|P1|Overall Study|Death|62
148499|NCT00402233|482861|P4|Overall Study|Worsening of other pre-existing disease|0
148500|NCT00402233|482862|P3|Overall Study|Worsening of other pre-existing disease|0
148501|NCT00402233|482863|P2|Overall Study|Worsening of other pre-existing disease|1
148502|NCT00402233|482864|P1|Overall Study|Worsening of other pre-existing disease|0
148503|NCT00402233|482861|P4|Overall Study|Worsening of disease under study|0
148504|NCT00402233|482862|P3|Overall Study|Worsening of disease under study|0
148505|NCT00402233|482863|P2|Overall Study|Worsening of disease under study|0
148506|NCT00402233|482864|P1|Overall Study|Worsening of disease under study|2
148507|NCT00402233|482861|P4|Overall Study|Withdrawal by Subject|2
148508|NCT00402233|482862|P3|Overall Study|Withdrawal by Subject|2
148509|NCT00402233|482863|P2|Overall Study|Withdrawal by Subject|1
148510|NCT00402233|482864|P1|Overall Study|Withdrawal by Subject|2
148511|NCT00402233|482861|P4|Overall Study|Protocol Violation|0
148512|NCT00402233|482862|P3|Overall Study|Protocol Violation|0
148513|NCT00402233|482863|P2|Overall Study|Protocol Violation|1
148514|NCT00402233|482864|P1|Overall Study|Protocol Violation|0
148515|NCT00402233|482861|P4|Overall Study|Adverse Event|9
148516|NCT00402233|482862|P3|Overall Study|Adverse Event|9
148517|NCT00402233|482863|P2|Overall Study|Adverse Event|7
148518|NCT00402233|482864|P1|Overall Study|Adverse Event|1
148519|NCT00402168|482899|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
148520|NCT00402168|482900|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
148521|NCT00402168|482899|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
148522|NCT00402168|482900|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
148523|NCT00402168|482899|P2|Long Term (LT)|non-specified|2
148524|NCT00402168|482900|P1|Long Term (LT)|non-specified|1
148525|NCT00402168|482899|P2|Long Term (LT)|Lack of Efficacy|2
148526|NCT00402168|482900|P1|Long Term (LT)|Lack of Efficacy|0
148527|NCT00402168|482899|P2|Long Term (LT)|Death|0
148528|NCT00402168|482900|P1|Long Term (LT)|Death|4
148529|NCT00402168|482899|P2|Long Term (LT)|Lost to Follow-up|0
148530|NCT00402168|482900|P1|Long Term (LT)|Lost to Follow-up|1
148531|NCT00402168|482899|P2|Long Term (LT)|Pregnancy|1
148532|NCT00402168|482900|P1|Long Term (LT)|Pregnancy|0
148533|NCT00402168|482899|P2|Long Term (LT)|Withdrawal by Subject|7
148534|NCT00402168|482900|P1|Long Term (LT)|Withdrawal by Subject|4
148535|NCT00402168|482899|P2|Long Term (LT)|Adverse Event|5
148536|NCT00402168|482900|P1|Long Term (LT)|Adverse Event|1
148537|NCT00402168|482899|P2|Treatment (up to 12 Months)|non-specified|1
148538|NCT00402168|482900|P1|Treatment (up to 12 Months)|non-specified|0
148539|NCT00402168|482899|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
148540|NCT00402168|482900|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
148541|NCT00402168|482899|P2|Treatment (up to 12 Months)|Death|1
148542|NCT00402168|482900|P1|Treatment (up to 12 Months)|Death|0
148543|NCT00402168|482899|P2|Randomized|Withdrawal by Subject|1
148544|NCT00402168|482900|P1|Randomized|Withdrawal by Subject|0
148545|NCT00402168|482899|P2|Randomized|Lost to Follow-up|0
148546|NCT00402168|482900|P1|Randomized|Lost to Follow-up|1
148547|NCT00402103|482957|P2|Overall Study|Administrative problems|0
148548|NCT00402103|482958|P1|Overall Study|Administrative problems|2
148549|NCT00402103|482957|P2|Overall Study|Lost to Follow-up|3
148550|NCT00402103|482958|P1|Overall Study|Lost to Follow-up|6
148551|NCT00402103|482957|P2|Overall Study|Patient withdrew consent|1
148552|NCT00402103|482958|P1|Overall Study|Patient withdrew consent|12
148553|NCT00402103|482957|P2|Overall Study|Protocol Deviation|0
148554|NCT00402103|482958|P1|Overall Study|Protocol Deviation|8
148555|NCT00402103|482957|P2|Overall Study|Condition no longer requires study drug|0
148556|NCT00402103|482958|P1|Overall Study|Condition no longer requires study drug|2
148557|NCT00402103|482957|P2|Overall Study|Unsatisfactory therapeutic effect|2
148558|NCT00402103|482958|P1|Overall Study|Unsatisfactory therapeutic effect|1
148559|NCT00402103|482957|P2|Overall Study|Adverse Event|7
148560|NCT00402103|482958|P1|Overall Study|Adverse Event|60
148561|NCT00402051|482974|P2|Overall Study|Lost to Follow-up|0
148562|NCT00402051|482975|P1|Overall Study|Lost to Follow-up|1
148563|NCT00402051|482974|P2|Overall Study|Death Due to Adverse Event|2
148564|NCT00402051|482975|P1|Overall Study|Death Due to Adverse Event|0
148565|NCT00402051|482974|P2|Overall Study|Death Due to Study Disease|1
148566|NCT00402051|482975|P1|Overall Study|Death Due to Study Disease|2
148567|NCT00402051|482974|P2|Overall Study|Death - Related to Study Drug|2
148568|NCT00402051|482975|P1|Overall Study|Death - Related to Study Drug|1
148569|NCT00402051|482974|P2|Overall Study|Withdrawal by Subject|3
148570|NCT00402051|482975|P1|Overall Study|Withdrawal by Subject|3
148571|NCT00402051|482974|P2|Overall Study|Physician Decision|3
148572|NCT00402051|482975|P1|Overall Study|Physician Decision|7
148573|NCT00402051|482974|P2|Overall Study|Adverse Event|4
148574|NCT00402051|482975|P1|Overall Study|Adverse Event|11
148575|NCT00402051|482974|P2|Overall Study|Progressive Disease|20
148576|NCT00402051|482975|P1|Overall Study|Progressive Disease|13
148577|NCT00402025|482992|P3|Overall Study|Participant Decision|1
148578|NCT00402025|482993|P2|Overall Study|Participant Decision|0
148579|NCT00402025|482994|P1|Overall Study|Participant Decision|0
148580|NCT00402025|482992|P3|Overall Study|Physician Decision|0
148581|NCT00402025|482993|P2|Overall Study|Physician Decision|1
148582|NCT00402025|482994|P1|Overall Study|Physician Decision|1
148583|NCT00402025|482992|P3|Overall Study|Disease Progression|2
148584|NCT00402025|482993|P2|Overall Study|Disease Progression|1
148585|NCT00402025|482994|P1|Overall Study|Disease Progression|1
148586|NCT00402025|482992|P3|Overall Study|Death|5
148587|NCT00402025|482993|P2|Overall Study|Death|1
148588|NCT00402025|482994|P1|Overall Study|Death|0
148589|NCT00402025|482992|P3|Overall Study|Adverse Event|2
148590|NCT00402025|482993|P2|Overall Study|Adverse Event|0
148591|NCT00402025|482994|P1|Overall Study|Adverse Event|0
148592|NCT00401973|483020|P3|Overall Study|Withdrawal by Subject|9
148593|NCT00401973|483021|P2|Overall Study|Withdrawal by Subject|12
148594|NCT00401973|483022|P1|Overall Study|Withdrawal by Subject|4
148595|NCT00401973|483020|P3|Overall Study|Sponsor Decision|0
148596|NCT00401973|483021|P2|Overall Study|Sponsor Decision|1
148597|NCT00401973|483022|P1|Overall Study|Sponsor Decision|0
148598|NCT00401973|483020|P3|Overall Study|Protocol Violation|3
148599|NCT00401973|483021|P2|Overall Study|Protocol Violation|2
148600|NCT00401973|483022|P1|Overall Study|Protocol Violation|1
148601|NCT00401973|483020|P3|Overall Study|Physician Decision|1
148602|NCT00401973|483021|P2|Overall Study|Physician Decision|0
148603|NCT00401973|483022|P1|Overall Study|Physician Decision|2
148604|NCT00401973|483020|P3|Overall Study|Lost to Follow-up|2
148605|NCT00401973|483021|P2|Overall Study|Lost to Follow-up|2
148606|NCT00401973|483022|P1|Overall Study|Lost to Follow-up|2
148607|NCT00401973|483020|P3|Overall Study|Lack of Efficacy|3
148608|NCT00401973|483021|P2|Overall Study|Lack of Efficacy|0
148609|NCT00401973|483022|P1|Overall Study|Lack of Efficacy|0
148610|NCT00401973|483020|P3|Overall Study|Clinical Relapse|1
148611|NCT00401973|483021|P2|Overall Study|Clinical Relapse|1
148612|NCT00401973|483022|P1|Overall Study|Clinical Relapse|0
148613|NCT00401973|483020|P3|Overall Study|Adverse Event|4
148614|NCT00401973|483021|P2|Overall Study|Adverse Event|8
148615|NCT00401973|483022|P1|Overall Study|Adverse Event|2
148616|NCT00401843|483062|P3|Overall Study|Received incorrect treatment|0
148617|NCT00401843|483063|P2|Overall Study|Received incorrect treatment|3
148618|NCT00401843|483064|P1|Overall Study|Received incorrect treatment|0
148619|NCT00401843|483062|P3|Overall Study|Randomized but not Treated|3
148620|NCT00401843|483063|P2|Overall Study|Randomized but not Treated|2
148621|NCT00401843|483064|P1|Overall Study|Randomized but not Treated|0
148622|NCT00401843|483062|P3|Overall Study|Withdrawal of consent to study agent|17
148623|NCT00401843|483063|P2|Overall Study|Withdrawal of consent to study agent|15
148624|NCT00401843|483064|P1|Overall Study|Withdrawal of consent to study agent|1
148625|NCT00401843|483062|P3|Overall Study|Withdrawal by Subject|5
148626|NCT00401843|483063|P2|Overall Study|Withdrawal by Subject|5
148627|NCT00401843|483064|P1|Overall Study|Withdrawal by Subject|1
148628|NCT00401843|483062|P3|Overall Study|Protocol Violation|1
148629|NCT00401843|483063|P2|Overall Study|Protocol Violation|0
148630|NCT00401843|483064|P1|Overall Study|Protocol Violation|0
148631|NCT00401843|483062|P3|Overall Study|Physician Decision|10
148632|NCT00401843|483063|P2|Overall Study|Physician Decision|16
148633|NCT00401843|483064|P1|Overall Study|Physician Decision|0
148634|NCT00401843|483062|P3|Overall Study|Other Unspecified|5
148635|NCT00401843|483063|P2|Overall Study|Other Unspecified|3
148636|NCT00401843|483064|P1|Overall Study|Other Unspecified|0
148637|NCT00401843|483062|P3|Overall Study|Lost to Follow-up|2
148638|NCT00401843|483063|P2|Overall Study|Lost to Follow-up|0
148639|NCT00401843|483064|P1|Overall Study|Lost to Follow-up|0
148640|NCT00401843|483062|P3|Overall Study|End of Study|2
148641|NCT00401843|483063|P2|Overall Study|End of Study|1
148642|NCT00401843|483064|P1|Overall Study|End of Study|1
148643|NCT00401843|483062|P3|Overall Study|Disease progression|49
148644|NCT00401843|483063|P2|Overall Study|Disease progression|60
148645|NCT00401843|483064|P1|Overall Study|Disease progression|10
148646|NCT00401843|483062|P3|Overall Study|Death|10
148647|NCT00401843|483063|P2|Overall Study|Death|8
148648|NCT00401843|483064|P1|Overall Study|Death|0
148649|NCT00401843|483062|P3|Overall Study|Adverse Event|27
148650|NCT00401843|483063|P2|Overall Study|Adverse Event|26
148651|NCT00401843|483064|P1|Overall Study|Adverse Event|7
148652|NCT00401843|483062|P3|Overall Study|Achieved Complete Response|11
148653|NCT00401843|483063|P2|Overall Study|Achieved Complete Response|5
148654|NCT00401843|483064|P1|Overall Study|Achieved Complete Response|1
148655|NCT00401830|483082|P2|Overall Study|Other: Personal / Family problems|0
148656|NCT00401830|483083|P1|Overall Study|Other: Personal / Family problems|1
148657|NCT00401830|483082|P2|Overall Study|Lost to Follow-up|3
148658|NCT00401830|483083|P1|Overall Study|Lost to Follow-up|1
148659|NCT00401830|483082|P2|Overall Study|Non-compliance with drug study|0
148660|NCT00401830|483083|P1|Overall Study|Non-compliance with drug study|1
148661|NCT00401830|483082|P2|Overall Study|Protocol Violation|3
148662|NCT00401830|483083|P1|Overall Study|Protocol Violation|3
148663|NCT00401830|483082|P2|Overall Study|Withdrawal by Subject|3
148664|NCT00401830|483083|P1|Overall Study|Withdrawal by Subject|4
148665|NCT00401830|483082|P2|Overall Study|Lack of Efficacy|5
148666|NCT00401830|483083|P1|Overall Study|Lack of Efficacy|11
148667|NCT00401830|483082|P2|Overall Study|Adverse Event|18
148668|NCT00401830|483083|P1|Overall Study|Adverse Event|10
148669|NCT00401752|483134|P2|Overall Study|Physician Decision|1
148670|NCT00401752|483135|P1|Overall Study|Physician Decision|1
148671|NCT00401752|483134|P2|Overall Study|Development of any exclusion criteria|2
148672|NCT00401752|483135|P1|Overall Study|Development of any exclusion criteria|4
148673|NCT00401752|483134|P2|Overall Study|Lost to Follow-up|4
148674|NCT00401752|483135|P1|Overall Study|Lost to Follow-up|1
148675|NCT00401752|483134|P2|Overall Study|Withdrawal by Subject|6
148676|NCT00401752|483135|P1|Overall Study|Withdrawal by Subject|2
148677|NCT00401752|483134|P2|Overall Study|Adverse Event|5
148678|NCT00401752|483135|P1|Overall Study|Adverse Event|2
148679|NCT00401726|483153|P2|Overall Study|Protocol Deviation|4
148680|NCT00401726|483154|P1|Overall Study|Protocol Deviation|9
148681|NCT00401726|483153|P2|Overall Study|Lack of Efficacy|6
148682|NCT00401726|483154|P1|Overall Study|Lack of Efficacy|4
148683|NCT00401726|483153|P2|Overall Study|Withdrawal by Subject|24
148684|NCT00401726|483154|P1|Overall Study|Withdrawal by Subject|18
148685|NCT00401726|483153|P2|Overall Study|Protocol Violation|3
148686|NCT00401726|483154|P1|Overall Study|Protocol Violation|6
148687|NCT00401726|483153|P2|Overall Study|Lost to Follow-up|20
148688|NCT00401726|483154|P1|Overall Study|Lost to Follow-up|23
148689|NCT00401726|483153|P2|Overall Study|Physician Decision|6
148690|NCT00401726|483154|P1|Overall Study|Physician Decision|3
148691|NCT00401726|483153|P2|Overall Study|Sponsor Request|1
148692|NCT00401726|483154|P1|Overall Study|Sponsor Request|0
148693|NCT00401726|483153|P2|Overall Study|Death|3
148694|NCT00401726|483154|P1|Overall Study|Death|0
148695|NCT00401726|483153|P2|Overall Study|Adverse Event|45
148696|NCT00401726|483154|P1|Overall Study|Adverse Event|34
148697|NCT00401544|483189|P4|Overall Study|Other|2
148698|NCT00401544|483190|P3|Overall Study|Other|2
148699|NCT00401544|483191|P2|Overall Study|Other|0
148700|NCT00401544|483192|P1|Overall Study|Other|0
148701|NCT00401544|483189|P4|Overall Study|Disease progression|0
148702|NCT00401544|483190|P3|Overall Study|Disease progression|0
148703|NCT00401544|483191|P2|Overall Study|Disease progression|1
148704|NCT00401544|483192|P1|Overall Study|Disease progression|0
148705|NCT00401544|483189|P4|Overall Study|Ineligibility determined|2
148706|NCT00401544|483190|P3|Overall Study|Ineligibility determined|0
148707|NCT00401544|483191|P2|Overall Study|Ineligibility determined|1
148708|NCT00401544|483192|P1|Overall Study|Ineligibility determined|0
148709|NCT00401544|483189|P4|Overall Study|Physician Decision|0
148710|NCT00401544|483190|P3|Overall Study|Physician Decision|0
148711|NCT00401544|483191|P2|Overall Study|Physician Decision|3
148712|NCT00401544|483192|P1|Overall Study|Physician Decision|1
148713|NCT00401544|483189|P4|Overall Study|Withdrawal by Subject|5
148714|NCT00401544|483190|P3|Overall Study|Withdrawal by Subject|6
148715|NCT00401544|483191|P2|Overall Study|Withdrawal by Subject|6
148716|NCT00401544|483192|P1|Overall Study|Withdrawal by Subject|7
148717|NCT00401544|483189|P4|Overall Study|Lost to Follow-up|1
148718|NCT00401544|483190|P3|Overall Study|Lost to Follow-up|1
148719|NCT00401544|483191|P2|Overall Study|Lost to Follow-up|0
148720|NCT00401544|483192|P1|Overall Study|Lost to Follow-up|2
148721|NCT00401544|483189|P4|Overall Study|Death|5
148722|NCT00401544|483190|P3|Overall Study|Death|2
148723|NCT00401544|483191|P2|Overall Study|Death|6
148724|NCT00401544|483192|P1|Overall Study|Death|3
148725|NCT00401544|483189|P4|Overall Study|Adverse Event|1
148726|NCT00401544|483190|P3|Overall Study|Adverse Event|1
148727|NCT00401544|483191|P2|Overall Study|Adverse Event|1
148728|NCT00401544|483192|P1|Overall Study|Adverse Event|5
148729|NCT00401531|483232|P2|Overall Study|Withdrawal by Subject|2
148730|NCT00401531|483233|P1|Overall Study|Withdrawal by Subject|3
148731|NCT00401531|483232|P2|Overall Study|Lost to Follow-up|1
148732|NCT00401531|483233|P1|Overall Study|Lost to Follow-up|1
148733|NCT00401531|483232|P2|Overall Study|Protocol Violation|7
148734|NCT00401531|483233|P1|Overall Study|Protocol Violation|3
148735|NCT00401531|483232|P2|Overall Study|Adverse Event|0
148736|NCT00401531|483233|P1|Overall Study|Adverse Event|2
148737|NCT00401258|483303|P1|Overall Study|Adverse Event|7
148738|NCT00401245|483311|P8|Double Blind Tapering Phase|Lack of Efficacy|0
148739|NCT00401245|483312|P7|Double Blind Tapering Phase|Lack of Efficacy|0
148740|NCT00401245|483313|P6|Double Blind Tapering Phase|Lack of Efficacy|1
148741|NCT00401245|483314|P5|Double Blind Tapering Phase|Lack of Efficacy|0
148742|NCT00401245|483315|P4|Double Blind Tapering Phase|Lack of Efficacy|0
148743|NCT00401245|483316|P3|Double Blind Tapering Phase|Lack of Efficacy|0
148744|NCT00401245|483317|P2|Double Blind Tapering Phase|Lack of Efficacy|0
148745|NCT00401245|483318|P1|Double Blind Tapering Phase|Lack of Efficacy|0
148746|NCT00401245|483311|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
148747|NCT00401245|483312|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
148748|NCT00401245|483313|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
148749|NCT00401245|483314|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
148750|NCT00401245|483315|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
148751|NCT00401245|483316|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
148752|NCT00401245|483317|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
148753|NCT00401245|483318|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
148754|NCT00401245|483311|P8|Double Blind Tapering Phase|Unspecified|2
148755|NCT00401245|483312|P7|Double Blind Tapering Phase|Unspecified|2
148756|NCT00401245|483313|P6|Double Blind Tapering Phase|Unspecified|0
148757|NCT00401245|483314|P5|Double Blind Tapering Phase|Unspecified|1
148758|NCT00401245|483315|P4|Double Blind Tapering Phase|Unspecified|0
148759|NCT00401245|483316|P3|Double Blind Tapering Phase|Unspecified|0
148760|NCT00401245|483317|P2|Double Blind Tapering Phase|Unspecified|0
148761|NCT00401245|483318|P1|Double Blind Tapering Phase|Unspecified|0
148762|NCT00401245|483311|P8|Double Blind Tapering Phase|Investigator request|1
148763|NCT00401245|483312|P7|Double Blind Tapering Phase|Investigator request|0
148764|NCT00401245|483313|P6|Double Blind Tapering Phase|Investigator request|0
148765|NCT00401245|483314|P5|Double Blind Tapering Phase|Investigator request|0
148766|NCT00401245|483315|P4|Double Blind Tapering Phase|Investigator request|0
148767|NCT00401245|483316|P3|Double Blind Tapering Phase|Investigator request|0
148768|NCT00401245|483317|P2|Double Blind Tapering Phase|Investigator request|0
148769|NCT00401245|483318|P1|Double Blind Tapering Phase|Investigator request|0
148770|NCT00401245|483311|P8|Double Blind Tapering Phase|Adverse Event|4
148771|NCT00401245|483312|P7|Double Blind Tapering Phase|Adverse Event|2
148772|NCT00401245|483313|P6|Double Blind Tapering Phase|Adverse Event|1
148773|NCT00401245|483314|P5|Double Blind Tapering Phase|Adverse Event|1
148774|NCT00401245|483315|P4|Double Blind Tapering Phase|Adverse Event|0
148775|NCT00401245|483316|P3|Double Blind Tapering Phase|Adverse Event|0
148776|NCT00401245|483317|P2|Double Blind Tapering Phase|Adverse Event|0
148777|NCT00401245|483318|P1|Double Blind Tapering Phase|Adverse Event|0
148778|NCT00401245|483311|P8|Open Label Phase|Lack of Efficacy|0
148779|NCT00401245|483312|P7|Open Label Phase|Lack of Efficacy|0
148780|NCT00401245|483313|P6|Open Label Phase|Lack of Efficacy|0
148781|NCT00401245|483314|P5|Open Label Phase|Lack of Efficacy|0
148782|NCT00401245|483315|P4|Open Label Phase|Lack of Efficacy|0
148783|NCT00401245|483316|P3|Open Label Phase|Lack of Efficacy|3
148784|NCT00401245|483317|P2|Open Label Phase|Lack of Efficacy|2
148785|NCT00401245|483318|P1|Open Label Phase|Lack of Efficacy|4
148786|NCT00401245|483311|P8|Open Label Phase|Withdrawal by Subject|0
148787|NCT00401245|483312|P7|Open Label Phase|Withdrawal by Subject|0
148788|NCT00401245|483313|P6|Open Label Phase|Withdrawal by Subject|0
148789|NCT00401245|483314|P5|Open Label Phase|Withdrawal by Subject|0
148790|NCT00401245|483315|P4|Open Label Phase|Withdrawal by Subject|1
148791|NCT00401245|483316|P3|Open Label Phase|Withdrawal by Subject|2
148792|NCT00401245|483317|P2|Open Label Phase|Withdrawal by Subject|3
148793|NCT00401245|483318|P1|Open Label Phase|Withdrawal by Subject|3
148794|NCT00401245|483311|P8|Open Label Phase|Protocol Violation|0
148795|NCT00401245|483312|P7|Open Label Phase|Protocol Violation|0
148796|NCT00401245|483313|P6|Open Label Phase|Protocol Violation|0
148797|NCT00401245|483314|P5|Open Label Phase|Protocol Violation|0
148798|NCT00401245|483315|P4|Open Label Phase|Protocol Violation|1
148799|NCT00401245|483316|P3|Open Label Phase|Protocol Violation|0
148800|NCT00401245|483317|P2|Open Label Phase|Protocol Violation|1
148801|NCT00401245|483318|P1|Open Label Phase|Protocol Violation|0
148802|NCT00401245|483311|P8|Open Label Phase|Unspecified|0
148803|NCT00401245|483312|P7|Open Label Phase|Unspecified|0
148804|NCT00401245|483313|P6|Open Label Phase|Unspecified|0
148805|NCT00401245|483314|P5|Open Label Phase|Unspecified|0
148806|NCT00401245|483315|P4|Open Label Phase|Unspecified|8
148807|NCT00401245|483316|P3|Open Label Phase|Unspecified|7
148808|NCT00401245|483317|P2|Open Label Phase|Unspecified|8
148809|NCT00401245|483318|P1|Open Label Phase|Unspecified|4
148810|NCT00401245|483311|P8|Open Label Phase|Lost to Follow-up|0
148811|NCT00401245|483312|P7|Open Label Phase|Lost to Follow-up|0
148812|NCT00401245|483313|P6|Open Label Phase|Lost to Follow-up|0
148813|NCT00401245|483314|P5|Open Label Phase|Lost to Follow-up|0
148814|NCT00401245|483315|P4|Open Label Phase|Lost to Follow-up|4
148815|NCT00401245|483316|P3|Open Label Phase|Lost to Follow-up|5
148816|NCT00401245|483317|P2|Open Label Phase|Lost to Follow-up|7
148817|NCT00401245|483318|P1|Open Label Phase|Lost to Follow-up|5
148818|NCT00401245|483311|P8|Open Label Phase|Adverse Event|0
148819|NCT00401245|483312|P7|Open Label Phase|Adverse Event|0
148820|NCT00401245|483313|P6|Open Label Phase|Adverse Event|0
148821|NCT00401245|483314|P5|Open Label Phase|Adverse Event|0
148822|NCT00401245|483315|P4|Open Label Phase|Adverse Event|7
148823|NCT00401245|483316|P3|Open Label Phase|Adverse Event|6
148824|NCT00401245|483317|P2|Open Label Phase|Adverse Event|14
148825|NCT00401245|483318|P1|Open Label Phase|Adverse Event|5
148826|NCT00401245|483311|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
148827|NCT00401245|483312|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
148828|NCT00401245|483313|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
148829|NCT00401245|483314|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
148830|NCT00401245|483315|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
148831|NCT00401245|483316|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
148832|NCT00401245|483317|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
148833|NCT00401245|483318|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
148834|NCT00401245|483311|P8|Double Blind Titration Phase|Withdrawal by Subject|0
148835|NCT00401245|483312|P7|Double Blind Titration Phase|Withdrawal by Subject|0
148836|NCT00401245|483313|P6|Double Blind Titration Phase|Withdrawal by Subject|0
148837|NCT00401245|483314|P5|Double Blind Titration Phase|Withdrawal by Subject|0
148838|NCT00401245|483315|P4|Double Blind Titration Phase|Withdrawal by Subject|2
148839|NCT00401245|483316|P3|Double Blind Titration Phase|Withdrawal by Subject|0
148840|NCT00401245|483317|P2|Double Blind Titration Phase|Withdrawal by Subject|1
148841|NCT00401245|483318|P1|Double Blind Titration Phase|Withdrawal by Subject|1
148842|NCT00401245|483311|P8|Double Blind Titration Phase|Protocol Violation|0
148843|NCT00401245|483312|P7|Double Blind Titration Phase|Protocol Violation|0
148844|NCT00401245|483313|P6|Double Blind Titration Phase|Protocol Violation|0
148845|NCT00401245|483314|P5|Double Blind Titration Phase|Protocol Violation|0
148846|NCT00401245|483315|P4|Double Blind Titration Phase|Protocol Violation|1
148847|NCT00401245|483316|P3|Double Blind Titration Phase|Protocol Violation|0
148848|NCT00401245|483317|P2|Double Blind Titration Phase|Protocol Violation|0
148849|NCT00401245|483318|P1|Double Blind Titration Phase|Protocol Violation|0
148850|NCT00401245|483311|P8|Double Blind Titration Phase|Unspecified|0
148851|NCT00401245|483312|P7|Double Blind Titration Phase|Unspecified|0
148852|NCT00401245|483313|P6|Double Blind Titration Phase|Unspecified|0
148853|NCT00401245|483314|P5|Double Blind Titration Phase|Unspecified|0
148854|NCT00401245|483315|P4|Double Blind Titration Phase|Unspecified|0
148855|NCT00401245|483316|P3|Double Blind Titration Phase|Unspecified|1
148856|NCT00401245|483317|P2|Double Blind Titration Phase|Unspecified|0
148857|NCT00401245|483318|P1|Double Blind Titration Phase|Unspecified|0
148858|NCT00401245|483311|P8|Double Blind Titration Phase|Adverse Event|0
148859|NCT00401245|483312|P7|Double Blind Titration Phase|Adverse Event|0
148860|NCT00401245|483313|P6|Double Blind Titration Phase|Adverse Event|0
148861|NCT00401245|483314|P5|Double Blind Titration Phase|Adverse Event|0
148862|NCT00401245|483315|P4|Double Blind Titration Phase|Adverse Event|12
148863|NCT00401245|483316|P3|Double Blind Titration Phase|Adverse Event|5
148864|NCT00401245|483317|P2|Double Blind Titration Phase|Adverse Event|2
148865|NCT00401245|483318|P1|Double Blind Titration Phase|Adverse Event|3
148866|NCT00401193|483386|P3|Overall Study|Other Event|2
148867|NCT00401193|483387|P2|Overall Study|Other Event|2
148868|NCT00401193|483388|P1|Overall Study|Other Event|3
148869|NCT00401193|483386|P3|Overall Study|Withdrawal by Subject|1
148870|NCT00401193|483387|P2|Overall Study|Withdrawal by Subject|0
148871|NCT00401193|483388|P1|Overall Study|Withdrawal by Subject|2
148872|NCT00401193|483386|P3|Overall Study|Lost to Follow-up|1
148873|NCT00401193|483387|P2|Overall Study|Lost to Follow-up|5
148874|NCT00401193|483388|P1|Overall Study|Lost to Follow-up|6
148875|NCT00401193|483386|P3|Overall Study|Protocol Violation|1
148876|NCT00401193|483387|P2|Overall Study|Protocol Violation|1
148877|NCT00401193|483388|P1|Overall Study|Protocol Violation|3
148878|NCT00401193|483386|P3|Overall Study|Adverse Event|1
148879|NCT00401193|483387|P2|Overall Study|Adverse Event|3
148880|NCT00401193|483388|P1|Overall Study|Adverse Event|1
148881|NCT00400764|483439|P5|Phase II|Withdrawal by Subject|0
148882|NCT00400764|483440|P4|Phase II|Withdrawal by Subject|1
148883|NCT00400764|483441|P3|Phase II|Withdrawal by Subject|1
148884|NCT00400764|483442|P2|Phase II|Withdrawal by Subject|0
148885|NCT00400764|483443|P1|Phase II|Withdrawal by Subject|0
148886|NCT00400764|483439|P5|Phase II|Patient began new, non-protocol, therapy|0
148887|NCT00400764|483440|P4|Phase II|Patient began new, non-protocol, therapy|0
148888|NCT00400764|483441|P3|Phase II|Patient began new, non-protocol, therapy|1
148889|NCT00400764|483442|P2|Phase II|Patient began new, non-protocol, therapy|0
148890|NCT00400764|483443|P1|Phase II|Patient began new, non-protocol, therapy|0
148891|NCT00400764|483439|P5|Phase II|Sponsor’s decision to terminate|11
148892|NCT00400764|483440|P4|Phase II|Sponsor’s decision to terminate|22
148893|NCT00400764|483441|P3|Phase II|Sponsor’s decision to terminate|18
148894|NCT00400764|483442|P2|Phase II|Sponsor’s decision to terminate|0
148895|NCT00400764|483443|P1|Phase II|Sponsor’s decision to terminate|0
148896|NCT00400764|483439|P5|Phase II|Physician Decision|0
148897|NCT00400764|483440|P4|Phase II|Physician Decision|1
148898|NCT00400764|483441|P3|Phase II|Physician Decision|1
148899|NCT00400764|483442|P2|Phase II|Physician Decision|0
148900|NCT00400764|483443|P1|Phase II|Physician Decision|0
148901|NCT00400764|483439|P5|Phase II|Lost to Follow-up|0
148902|NCT00400764|483440|P4|Phase II|Lost to Follow-up|0
148903|NCT00400764|483441|P3|Phase II|Lost to Follow-up|1
148904|NCT00400764|483442|P2|Phase II|Lost to Follow-up|0
148905|NCT00400764|483443|P1|Phase II|Lost to Follow-up|0
148906|NCT00400764|483439|P5|Phase II|Death|0
148907|NCT00400764|483440|P4|Phase II|Death|2
148908|NCT00400764|483441|P3|Phase II|Death|1
148909|NCT00400764|483442|P2|Phase II|Death|0
148910|NCT00400764|483443|P1|Phase II|Death|0
148911|NCT00400764|483439|P5|Phase Ib|Disease Progression|0
148912|NCT00400764|483440|P4|Phase Ib|Disease Progression|0
148913|NCT00400764|483441|P3|Phase Ib|Disease Progression|0
148914|NCT00400764|483442|P2|Phase Ib|Disease Progression|4
148915|NCT00400764|483443|P1|Phase Ib|Disease Progression|4
148916|NCT00400764|483439|P5|Phase Ib|Death|0
148917|NCT00400764|483440|P4|Phase Ib|Death|0
148918|NCT00400764|483441|P3|Phase Ib|Death|0
148919|NCT00400764|483442|P2|Phase Ib|Death|0
148920|NCT00400764|483443|P1|Phase Ib|Death|1
148921|NCT00400764|483439|P5|Phase Ib|Adverse Event|0
148922|NCT00400764|483440|P4|Phase Ib|Adverse Event|0
148923|NCT00400764|483441|P3|Phase Ib|Adverse Event|0
148924|NCT00400764|483442|P2|Phase Ib|Adverse Event|0
148925|NCT00400764|483443|P1|Phase Ib|Adverse Event|1
148926|NCT00400712|483496|P2|Overall Study|Physician Decision|4
148927|NCT00400712|483497|P1|Overall Study|Physician Decision|5
148928|NCT00400712|483496|P2|Overall Study|Withdrawal by Subject|12
148929|NCT00400712|483497|P1|Overall Study|Withdrawal by Subject|11
148930|NCT00400712|483496|P2|Overall Study|Death|0
148931|NCT00400712|483497|P1|Overall Study|Death|1
148932|NCT00400569|483532|P1|Overall Study|Death|1
148933|NCT00400400|483545|P2|Overall Study|Did not receive study drug|3
148934|NCT00400400|483546|P1|Overall Study|Did not receive study drug|1
148935|NCT00400400|483545|P2|Overall Study|Lost to Follow-up|1
148936|NCT00400400|483546|P1|Overall Study|Lost to Follow-up|0
148937|NCT00400400|483545|P2|Overall Study|Administrative Problem|0
148938|NCT00400400|483546|P1|Overall Study|Administrative Problem|1
148939|NCT00400400|483545|P2|Overall Study|Withdrawal by Subject|3
148940|NCT00400400|483546|P1|Overall Study|Withdrawal by Subject|1
148941|NCT00400400|483545|P2|Overall Study|Protocol Violation|0
148942|NCT00400400|483546|P1|Overall Study|Protocol Violation|2
148943|NCT00400400|483545|P2|Overall Study|Adverse Event|8
148944|NCT00400400|483546|P1|Overall Study|Adverse Event|9
148945|NCT00400179|483570|P2|Overall Study|Randomization error/patient ineligible|6
148946|NCT00400179|483571|P1|Overall Study|Randomization error/patient ineligible|1
148947|NCT00400179|483570|P2|Overall Study|Investigator judgment|1
148948|NCT00400179|483571|P1|Overall Study|Investigator judgment|0
148949|NCT00400179|483570|P2|Overall Study|Intercurrent illness|1
148950|NCT00400179|483571|P1|Overall Study|Intercurrent illness|0
148951|NCT00400179|483570|P2|Overall Study|Disease progression|1
148952|NCT00400179|483571|P1|Overall Study|Disease progression|1
148953|NCT00400179|483570|P2|Overall Study|Withdrew Consent|5
148954|NCT00400179|483571|P1|Overall Study|Withdrew Consent|1
148955|NCT00400179|483570|P2|Overall Study|Death|2
148956|NCT00400179|483571|P1|Overall Study|Death|1
148957|NCT00400179|483570|P2|Overall Study|Adverse Event|2
148958|NCT00400179|483571|P1|Overall Study|Adverse Event|2
148959|NCT00400153|483588|P3|Overall Study|Other reasons - not mentioned above|3
148960|NCT00400153|483589|P2|Overall Study|Other reasons - not mentioned above|5
148961|NCT00400153|483590|P1|Overall Study|Other reasons - not mentioned above|8
148962|NCT00400153|483588|P3|Overall Study|Withdrawal by Subject|10
148963|NCT00400153|483589|P2|Overall Study|Withdrawal by Subject|11
148964|NCT00400153|483590|P1|Overall Study|Withdrawal by Subject|12
148965|NCT00400153|483588|P3|Overall Study|Lost to Follow-up|4
148966|NCT00400153|483589|P2|Overall Study|Lost to Follow-up|1
148967|NCT00400153|483590|P1|Overall Study|Lost to Follow-up|2
148968|NCT00400153|483588|P3|Overall Study|Protocol Violation|9
148969|NCT00400153|483589|P2|Overall Study|Protocol Violation|4
148970|NCT00400153|483590|P1|Overall Study|Protocol Violation|7
148971|NCT00400153|483588|P3|Overall Study|AE due to other condition|15
148972|NCT00400153|483589|P2|Overall Study|AE due to other condition|14
148973|NCT00400153|483590|P1|Overall Study|AE due to other condition|3
148974|NCT00400153|483588|P3|Overall Study|AE due to other disease worsening|0
148975|NCT00400153|483589|P2|Overall Study|AE due to other disease worsening|1
148976|NCT00400153|483590|P1|Overall Study|AE due to other disease worsening|2
148977|NCT00400153|483588|P3|Overall Study|AE due to study disease worsening|20
148978|NCT00400153|483589|P2|Overall Study|AE due to study disease worsening|19
148979|NCT00400153|483590|P1|Overall Study|AE due to study disease worsening|14
148980|NCT00399893|483837|P2|Overall Study|Withdrawal by Subject|0
148981|NCT00399893|483838|P1|Overall Study|Withdrawal by Subject|1
148982|NCT00399763|483866|P2|Overall Study|Lost to Follow-up|3
148983|NCT00399763|483867|P1|Overall Study|Lost to Follow-up|2
148984|NCT00399568|483879|P2|Overall Study|Lost to Follow-up|2
148985|NCT00399568|483880|P1|Overall Study|Lost to Follow-up|2
148986|NCT00399568|483879|P2|Overall Study|Protocol non-compliance|2
148987|NCT00399568|483880|P1|Overall Study|Protocol non-compliance|2
148988|NCT00399568|483879|P2|Overall Study|Withdrawal by Subject|3
148989|NCT00399568|483880|P1|Overall Study|Withdrawal by Subject|7
148990|NCT00399568|483879|P2|Overall Study|Adverse Event|2
148991|NCT00399568|483880|P1|Overall Study|Adverse Event|1
148992|NCT00399542|483894|P2|Overall Study|Physician Decision|1
148993|NCT00399542|483895|P1|Overall Study|Physician Decision|0
148994|NCT00399542|483894|P2|Overall Study|Unspecified|0
148995|NCT00399542|483895|P1|Overall Study|Unspecified|1
148996|NCT00399542|483894|P2|Overall Study|Lost to Follow-up|6
148997|NCT00399542|483895|P1|Overall Study|Lost to Follow-up|6
148998|NCT00399542|483894|P2|Overall Study|Lack of Efficacy|8
148999|NCT00399542|483895|P1|Overall Study|Lack of Efficacy|18
149000|NCT00399542|483894|P2|Overall Study|Withdrawal by Subject|10
149001|NCT00399542|483895|P1|Overall Study|Withdrawal by Subject|28
149002|NCT00399542|483894|P2|Overall Study|Protocol Violation|3
149003|NCT00399542|483895|P1|Overall Study|Protocol Violation|13
149004|NCT00399542|483894|P2|Overall Study|Adverse Event|15
149005|NCT00399542|483895|P1|Overall Study|Adverse Event|18
149006|NCT00399516|483957|P1|Overall Study|Lost to Follow-up|2
149007|NCT00399360|483965|P4|Overall Study|Withdrawal by Subject|2
149008|NCT00399360|483966|P3|Overall Study|Withdrawal by Subject|0
149009|NCT00399360|483967|P2|Overall Study|Withdrawal by Subject|2
149010|NCT00399360|483968|P1|Overall Study|Withdrawal by Subject|0
149011|NCT00399360|483965|P4|Overall Study|Adverse Event|0
149012|NCT00399360|483966|P3|Overall Study|Adverse Event|1
149013|NCT00399360|483967|P2|Overall Study|Adverse Event|0
149014|NCT00399360|483968|P1|Overall Study|Adverse Event|0
149015|NCT00399360|483965|P4|Overall Study|Lost to Follow-up|4
149016|NCT00399360|483966|P3|Overall Study|Lost to Follow-up|2
149017|NCT00399360|483967|P2|Overall Study|Lost to Follow-up|1
149018|NCT00399360|483968|P1|Overall Study|Lost to Follow-up|2
149019|NCT00399035|484039|P3|Overall Study|Severe non-compliance with protocol|0
149020|NCT00399035|484040|P2|Overall Study|Severe non-compliance with protocol|1
149021|NCT00399035|484041|P1|Overall Study|Severe non-compliance with protocol|2
149022|NCT00399035|484039|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
149023|NCT00399035|484040|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
149024|NCT00399035|484041|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
149025|NCT00399035|484039|P3|Overall Study|Withdrawal by Subject|12
149026|NCT00399035|484040|P2|Overall Study|Withdrawal by Subject|15
149027|NCT00399035|484041|P1|Overall Study|Withdrawal by Subject|19
149028|NCT00399035|484039|P3|Overall Study|Lost to Follow-up|5
149029|NCT00399035|484040|P2|Overall Study|Lost to Follow-up|1
149030|NCT00399035|484041|P1|Overall Study|Lost to Follow-up|2
149031|NCT00399035|484039|P3|Overall Study|Death|234
149032|NCT00399035|484040|P2|Overall Study|Death|141
149033|NCT00399035|484041|P1|Overall Study|Death|289
149034|NCT00398632|484074|P1|Overall Study|Lack of Efficacy|1
149035|NCT00398632|484074|P1|Overall Study|Withdrawal by Subject|1
149036|NCT00398411|484080|P2|Overall Study|Death|1
149037|NCT00398411|484081|P1|Overall Study|Death|0
149038|NCT00398320|484104|P1|Overall Study|Physician Decision|1
149039|NCT00398320|484104|P1|Overall Study|Adverse Event|4
149040|NCT00398320|484104|P1|Overall Study|Death|1
149041|NCT00398216|484117|P5|Overall Study|entrance criteria|2
149042|NCT00398216|484118|P4|Overall Study|entrance criteria|0
149043|NCT00398216|484119|P3|Overall Study|entrance criteria|0
149044|NCT00398216|484120|P2|Overall Study|entrance criteria|0
149045|NCT00398216|484121|P1|Overall Study|entrance criteria|0
149046|NCT00398216|484117|P5|Overall Study|administrative reasons|3
149047|NCT00398216|484118|P4|Overall Study|administrative reasons|3
149048|NCT00398216|484119|P3|Overall Study|administrative reasons|4
149049|NCT00398216|484120|P2|Overall Study|administrative reasons|4
149050|NCT00398216|484121|P1|Overall Study|administrative reasons|3
149051|NCT00398216|484117|P5|Overall Study|Withdrawal by Subject|2
149052|NCT00398216|484118|P4|Overall Study|Withdrawal by Subject|1
149053|NCT00398216|484119|P3|Overall Study|Withdrawal by Subject|3
149054|NCT00398216|484120|P2|Overall Study|Withdrawal by Subject|0
149055|NCT00398216|484121|P1|Overall Study|Withdrawal by Subject|1
149056|NCT00398216|484117|P5|Overall Study|Death|0
149057|NCT00398216|484118|P4|Overall Study|Death|0
149058|NCT00398216|484119|P3|Overall Study|Death|0
149059|NCT00398216|484120|P2|Overall Study|Death|3
149060|NCT00398216|484121|P1|Overall Study|Death|0
149061|NCT00398216|484117|P5|Overall Study|Lost to Follow-up|1
149062|NCT00398216|484118|P4|Overall Study|Lost to Follow-up|4
149063|NCT00398216|484119|P3|Overall Study|Lost to Follow-up|4
149064|NCT00398216|484120|P2|Overall Study|Lost to Follow-up|6
149065|NCT00398216|484121|P1|Overall Study|Lost to Follow-up|1
149066|NCT00398216|484117|P5|Overall Study|Protocol Violation|5
149067|NCT00398216|484118|P4|Overall Study|Protocol Violation|7
149068|NCT00398216|484119|P3|Overall Study|Protocol Violation|5
149069|NCT00398216|484120|P2|Overall Study|Protocol Violation|4
149070|NCT00398216|484121|P1|Overall Study|Protocol Violation|2
149071|NCT00398216|484117|P5|Overall Study|Adverse Event|2
149072|NCT00398216|484118|P4|Overall Study|Adverse Event|7
149073|NCT00398216|484119|P3|Overall Study|Adverse Event|5
149074|NCT00398216|484120|P2|Overall Study|Adverse Event|2
149075|NCT00398216|484121|P1|Overall Study|Adverse Event|4
149076|NCT00398138|484148|P1|Overall Study|Adverse Event|2
149077|NCT00398112|484153|P1|Overall Study|Death|1
149078|NCT00398112|484153|P1|Overall Study|Withdrawal by Subject|3
149079|NCT00398112|484153|P1|Overall Study|Alternative treatment|1
149080|NCT00398112|484153|P1|Overall Study|Disease progression|9
149081|NCT00398112|484153|P1|Overall Study|Adverse Event|4
149082|NCT00398086|484164|P3|Overall Study|Withdrawal by Subject|0
149083|NCT00398086|484165|P2|Overall Study|Withdrawal by Subject|7
149084|NCT00398086|484166|P1|Overall Study|Withdrawal by Subject|5
149085|NCT00398086|484164|P3|Overall Study|Physician Decision|0
149086|NCT00398086|484165|P2|Overall Study|Physician Decision|4
149087|NCT00398086|484166|P1|Overall Study|Physician Decision|1
149088|NCT00398086|484164|P3|Overall Study|Adverse Event|0
149089|NCT00398086|484165|P2|Overall Study|Adverse Event|4
149090|NCT00398086|484166|P1|Overall Study|Adverse Event|1
149091|NCT00398086|484164|P3|Overall Study|Unacceptable Toxicity|2
149092|NCT00398086|484165|P2|Overall Study|Unacceptable Toxicity|8
149093|NCT00398086|484166|P1|Overall Study|Unacceptable Toxicity|2
149094|NCT00398047|484198|P1|Overall Study|all patient progressed before completion|3
149095|NCT00397930|484210|P2|Overall Study|Missing data|4
149096|NCT00397930|484211|P1|Overall Study|Missing data|0
149097|NCT00397930|484210|P2|Overall Study|Withdrawal by Subject|8
149098|NCT00397930|484211|P1|Overall Study|Withdrawal by Subject|0
149099|NCT00397930|484210|P2|Overall Study|Did not want to be in control group|1
149100|NCT00397930|484211|P1|Overall Study|Did not want to be in control group|0
149101|NCT00397930|484210|P2|Overall Study|Started own yoga program|1
149102|NCT00397930|484211|P1|Overall Study|Started own yoga program|1
149103|NCT00397930|484210|P2|Overall Study|Too time-consuming|9
149104|NCT00397930|484211|P1|Overall Study|Too time-consuming|2
149105|NCT00397930|484210|P2|Overall Study|Noncompliant|2
149106|NCT00397930|484211|P1|Overall Study|Noncompliant|3
149107|NCT00397930|484210|P2|Overall Study|Unknown reasons|14
149108|NCT00397930|484211|P1|Overall Study|Unknown reasons|9
149109|NCT00397930|484210|P2|Overall Study|Other medical|4
149110|NCT00397930|484211|P1|Overall Study|Other medical|9
149111|NCT00397930|484210|P2|Overall Study|Personal reasons|8
149112|NCT00397930|484211|P1|Overall Study|Personal reasons|14
149113|NCT00397891|484226|P5|Overall Study|Withdrawal by Subject|1
149114|NCT00397891|484227|P4|Overall Study|Withdrawal by Subject|0
149115|NCT00397891|484228|P3|Overall Study|Withdrawal by Subject|0
149116|NCT00397891|484229|P2|Overall Study|Withdrawal by Subject|0
149117|NCT00397891|484230|P1|Overall Study|Withdrawal by Subject|1
149118|NCT00397631|484351|P2|Overall Study|protocol discontinuation criteria|4
149119|NCT00397631|484352|P1|Overall Study|protocol discontinuation criteria|1
149120|NCT00397631|484351|P2|Overall Study|Withdrawal by Subject|14
149121|NCT00397631|484352|P1|Overall Study|Withdrawal by Subject|7
149122|NCT00397631|484351|P2|Overall Study|Protocol Violation|1
149123|NCT00397631|484352|P1|Overall Study|Protocol Violation|0
149124|NCT00397631|484351|P2|Overall Study|Physician Decision|0
149125|NCT00397631|484352|P1|Overall Study|Physician Decision|2
149126|NCT00397631|484351|P2|Overall Study|Lost to Follow-up|9
149127|NCT00397631|484352|P1|Overall Study|Lost to Follow-up|8
149128|NCT00397631|484351|P2|Overall Study|Lack of Efficacy|10
149129|NCT00397631|484352|P1|Overall Study|Lack of Efficacy|7
149130|NCT00397631|484351|P2|Overall Study|Adverse Event|6
149131|NCT00397631|484352|P1|Overall Study|Adverse Event|5
149132|NCT00397540|484364|P2|Overall Study|short follow-up duration < 12 months|0
149133|NCT00397540|484365|P1|Overall Study|short follow-up duration < 12 months|1
149134|NCT00397514|484371|P1|Overall Study|poor echocardiographic windows|1
149135|NCT00397514|484371|P1|Overall Study|early extubation|2
149136|NCT00397514|484371|P1|Overall Study|Not able to capture & pace LV intraoper.|4
149137|NCT00397514|484371|P1|Overall Study|Pacing wire malfunction|1
149138|NCT00397514|484371|P1|Overall Study|Withdrawal by Subject|1
149139|NCT00397488|484381|P1|Overall Study|Death|1
149140|NCT00397488|484381|P1|Overall Study|Adverse Event|3
149141|NCT00397488|484381|P1|Overall Study|Withdrawal by Subject|3
149142|NCT00397254|484401|P2|Overall Study|Lost to Follow-up|2
149143|NCT00397254|484402|P1|Overall Study|Lost to Follow-up|2
149144|NCT00397215|484424|P4|Month 6 (Day 180)|Unspecified|0
149145|NCT00397215|484425|P3|Month 6 (Day 180)|Unspecified|3
149146|NCT00397215|484426|P2|Month 6 (Day 180)|Unspecified|0
149147|NCT00397215|484427|P1|Month 6 (Day 180)|Unspecified|2
149148|NCT00397215|484424|P4|Month 6 (Day 180)|Adverse Event|0
149149|NCT00397215|484425|P3|Month 6 (Day 180)|Adverse Event|2
149150|NCT00397215|484426|P2|Month 6 (Day 180)|Adverse Event|3
149151|NCT00397215|484427|P1|Month 6 (Day 180)|Adverse Event|0
149152|NCT00397215|484424|P4|Month 0 (Day 0)|Unspecified|3
149153|NCT00397215|484425|P3|Month 0 (Day 0)|Unspecified|3
149154|NCT00397215|484426|P2|Month 0 (Day 0)|Unspecified|1
149155|NCT00397215|484427|P1|Month 0 (Day 0)|Unspecified|4
149156|NCT00397215|484424|P4|Month 0 (Day 0)|Withdrawal by Subject|1
149157|NCT00397215|484425|P3|Month 0 (Day 0)|Withdrawal by Subject|3
149158|NCT00397215|484426|P2|Month 0 (Day 0)|Withdrawal by Subject|3
149159|NCT00397215|484427|P1|Month 0 (Day 0)|Withdrawal by Subject|3
149160|NCT00397215|484424|P4|Month 0 (Day 0)|Adverse Event|0
149161|NCT00397215|484425|P3|Month 0 (Day 0)|Adverse Event|0
149162|NCT00397215|484426|P2|Month 0 (Day 0)|Adverse Event|1
149163|NCT00397215|484427|P1|Month 0 (Day 0)|Adverse Event|0
149164|NCT00397189|484563|P2|3 Weeks Period|Other|2
149165|NCT00397189|484564|P1|3 Weeks Period|Other|0
149166|NCT00397189|484563|P2|3 Weeks Period|Protocol Violation|3
149167|NCT00397189|484564|P1|3 Weeks Period|Protocol Violation|0
149168|NCT00397189|484563|P2|3 Weeks Period|Physician Decision|2
149169|NCT00397189|484564|P1|3 Weeks Period|Physician Decision|0
149170|NCT00397189|484563|P2|3 Weeks Period|Withdrawal by Subject|9
149171|NCT00397189|484564|P1|3 Weeks Period|Withdrawal by Subject|13
149172|NCT00397189|484563|P2|3 Weeks Period|Adverse Event|2
149173|NCT00397189|484564|P1|3 Weeks Period|Adverse Event|3
149174|NCT00397189|484563|P2|3 Weeks Period|Lost to Follow-up|4
149175|NCT00397189|484564|P1|3 Weeks Period|Lost to Follow-up|5
149176|NCT00397033|484588|P3|Overall Study|Other|2
149177|NCT00397033|484589|P2|Overall Study|Other|5
149178|NCT00397033|484590|P1|Overall Study|Other|0
149179|NCT00397033|484588|P3|Overall Study|Withdrawal by Subject|5
149180|NCT00397033|484589|P2|Overall Study|Withdrawal by Subject|7
149181|NCT00397033|484590|P1|Overall Study|Withdrawal by Subject|12
149182|NCT00397033|484588|P3|Overall Study|Lost to Follow-up|3
149183|NCT00397033|484589|P2|Overall Study|Lost to Follow-up|3
149184|NCT00397033|484590|P1|Overall Study|Lost to Follow-up|3
149185|NCT00397033|484588|P3|Overall Study|Lack of Efficacy|9
149186|NCT00397033|484589|P2|Overall Study|Lack of Efficacy|12
149187|NCT00397033|484590|P1|Overall Study|Lack of Efficacy|22
149188|NCT00397033|484588|P3|Overall Study|Adverse Event|4
149189|NCT00397033|484589|P2|Overall Study|Adverse Event|10
149190|NCT00397033|484590|P1|Overall Study|Adverse Event|7
149191|NCT00396877|484672|P2|Overall Study|Parent(s)/guardian(s)'s request|7
149192|NCT00396877|484673|P1|Overall Study|Parent(s)/guardian(s)'s request|4
149193|NCT00396877|484672|P2|Overall Study|Lost to Follow-up|1
149194|NCT00396877|484673|P1|Overall Study|Lost to Follow-up|2
149195|NCT00396812|484683|P1|Overall Study|Physician Decision|1
149196|NCT00396656|484695|P2|Second Treatment Period|Adverse Event|1
149197|NCT00396656|484696|P1|Second Treatment Period|Adverse Event|0
149198|NCT00396656|484695|P2|First Treatment Period|Withdrawal by Subject|2
149199|NCT00396656|484696|P1|First Treatment Period|Withdrawal by Subject|0
149200|NCT00396630|484714|P2|Overall Study|Not vaccinated at Visit 3|3
149201|NCT00396630|484715|P1|Overall Study|Not vaccinated at Visit 3|3
149202|NCT00396630|484714|P2|Overall Study|Withdrawal by Subject|1
149203|NCT00396630|484715|P1|Overall Study|Withdrawal by Subject|1
149204|NCT00396630|484714|P2|Overall Study|Lost to Follow-up|1
149205|NCT00396630|484715|P1|Overall Study|Lost to Follow-up|1
149206|NCT00396591|484732|P1|Overall Study|Participant request|1
149207|NCT00396591|484732|P1|Overall Study|Adverse Event|2
149208|NCT00396591|484732|P1|Overall Study|Disease Progression|13
149209|NCT00396565|484745|P3|Overall Study|Lack of Efficacy|11
149210|NCT00396565|484746|P2|Overall Study|Lack of Efficacy|64
149211|NCT00396565|484747|P1|Overall Study|Lack of Efficacy|32
149212|NCT00396565|484745|P3|Overall Study|Withdrawal by Subject|1
149213|NCT00396565|484746|P2|Overall Study|Withdrawal by Subject|13
149214|NCT00396565|484747|P1|Overall Study|Withdrawal by Subject|8
149215|NCT00396565|484745|P3|Overall Study|Adverse Event|3
149216|NCT00396565|484746|P2|Overall Study|Adverse Event|13
149217|NCT00396565|484747|P1|Overall Study|Adverse Event|5
149218|NCT00396565|484745|P3|Overall Study|Physician Decision|2
149219|NCT00396565|484746|P2|Overall Study|Physician Decision|1
149220|NCT00396565|484747|P1|Overall Study|Physician Decision|3
149221|NCT00395863|484801|P2|Overall Study|Patients did not complete both exams|3
149222|NCT00395863|484802|P1|Overall Study|Patients did not complete both exams|2
149223|NCT00395850|484837|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
149224|NCT00395850|484838|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
149225|NCT00395850|484839|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
149226|NCT00395850|484840|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
149227|NCT00395850|484837|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
149228|NCT00395850|484838|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
149229|NCT00395850|484839|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
149230|NCT00395850|484840|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
149231|NCT00395850|484837|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
149232|NCT00395850|484838|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
149233|NCT00395850|484839|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
149234|NCT00395850|484840|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
149235|NCT00395850|484837|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
149236|NCT00395850|484838|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
149237|NCT00395850|484839|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
149238|NCT00395850|484840|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
149239|NCT00395850|484837|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
149240|NCT00395850|484838|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
149241|NCT00395850|484839|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
149242|NCT00395850|484840|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
149243|NCT00395850|484837|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
149244|NCT00395850|484838|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
149245|NCT00395850|484839|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
149246|NCT00395850|484840|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
149247|NCT00395850|484837|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
149248|NCT00395850|484838|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
149249|NCT00395850|484839|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
149250|NCT00395850|484840|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
149251|NCT00395746|484857|P3|Overall Study|Unable to visit site on schedule|0
149252|NCT00395746|484858|P2|Overall Study|Unable to visit site on schedule|0
149253|NCT00395746|484859|P1|Overall Study|Unable to visit site on schedule|1
149254|NCT00395746|484857|P3|Overall Study|Difficultulty in use of device|1
149255|NCT00395746|484858|P2|Overall Study|Difficultulty in use of device|0
149256|NCT00395746|484859|P1|Overall Study|Difficultulty in use of device|0
149257|NCT00395746|484857|P3|Overall Study|Withdrawal of consent|1
149258|NCT00395746|484858|P2|Overall Study|Withdrawal of consent|0
149259|NCT00395746|484859|P1|Overall Study|Withdrawal of consent|0
149260|NCT00395746|484857|P3|Overall Study|Subject decision|1
149261|NCT00395746|484858|P2|Overall Study|Subject decision|0
149262|NCT00395746|484859|P1|Overall Study|Subject decision|0
149263|NCT00395746|484857|P3|Overall Study|Hypoglycaemia|0
149264|NCT00395746|484858|P2|Overall Study|Hypoglycaemia|1
149265|NCT00395746|484859|P1|Overall Study|Hypoglycaemia|2
149266|NCT00395746|484857|P3|Overall Study|Lack of Efficacy|17
149267|NCT00395746|484858|P2|Overall Study|Lack of Efficacy|0
149268|NCT00395746|484859|P1|Overall Study|Lack of Efficacy|2
149269|NCT00395746|484857|P3|Overall Study|Protocol Violation|0
149270|NCT00395746|484858|P2|Overall Study|Protocol Violation|1
149271|NCT00395746|484859|P1|Overall Study|Protocol Violation|0
149272|NCT00395746|484857|P3|Overall Study|Adverse Event|2
149273|NCT00395746|484858|P2|Overall Study|Adverse Event|2
149274|NCT00395746|484859|P1|Overall Study|Adverse Event|5
149275|NCT00395733|484905|P2|Period 2|Technical problems|0
149276|NCT00395733|484906|P1|Period 2|Technical problems|1
149277|NCT00395733|484905|P2|Period 2|Adverse Event|2
149278|NCT00395733|484906|P1|Period 2|Adverse Event|0
149279|NCT00395733|484905|P2|Period 2|Protocol Violation|1
149280|NCT00395733|484906|P1|Period 2|Protocol Violation|0
149281|NCT00395733|484905|P2|Period 2|Withdrawal by Subject|2
149282|NCT00395733|484906|P1|Period 2|Withdrawal by Subject|1
149283|NCT00395694|484930|P2|Continuation Phase|Withdrawal by Subject|2
149284|NCT00395694|484931|P1|Continuation Phase|Withdrawal by Subject|0
149285|NCT00395694|484930|P2|Continuation Phase|Poor Compliance|0
149286|NCT00395694|484931|P1|Continuation Phase|Poor Compliance|1
149287|NCT00395694|484930|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
149288|NCT00395694|484931|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
149289|NCT00395694|484930|P2|Continuation Phase|Lack of Efficacy|11
149290|NCT00395694|484931|P1|Continuation Phase|Lack of Efficacy|12
149291|NCT00395694|484930|P2|Continuation Phase|Adverse Event|0
149292|NCT00395694|484931|P1|Continuation Phase|Adverse Event|1
149293|NCT00395694|484930|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
149294|NCT00395694|484931|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
149295|NCT00396409|484964|P2|Period 2 - 2008|Lost to Follow-up|1
149296|NCT00396409|484965|P1|Period 2 - 2008|Lost to Follow-up|3
149297|NCT00396409|484964|P2|Period 2 - 2008|Withdrawal by Subject|1
149298|NCT00396409|484965|P1|Period 2 - 2008|Withdrawal by Subject|3
149299|NCT00396409|484964|P2|Period 2 - 2008|Protocol Violation|0
149300|NCT00396409|484965|P1|Period 2 - 2008|Protocol Violation|1
149301|NCT00396409|484964|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
149302|NCT00396409|484965|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
149303|NCT00396409|484964|P2|Period 1 - 2007|Lost to Follow-up|3
149304|NCT00396409|484965|P1|Period 1 - 2007|Lost to Follow-up|2
149305|NCT00396409|484964|P2|Period 1 - 2007|Withdrawal by Subject|1
149306|NCT00396409|484965|P1|Period 1 - 2007|Withdrawal by Subject|1
149307|NCT00396409|484964|P2|Period 1 - 2007|Lack of Efficacy|1
149308|NCT00396409|484965|P1|Period 1 - 2007|Lack of Efficacy|0
149309|NCT00396409|484964|P2|Period 1 - 2007|Adverse Event|1
149310|NCT00396409|484965|P1|Period 1 - 2007|Adverse Event|0
149311|NCT00396383|484995|P1|Overall Study|Lost to Follow-up|1
149312|NCT00396383|484995|P1|Overall Study|Death|2
149313|NCT00396331|485008|P1|Overall Study|Death|16
149314|NCT00396331|485008|P1|Overall Study|Lost to Follow-up|3
149315|NCT00396331|485008|P1|Overall Study|Did not go on to transplant|5
149316|NCT00396331|485008|P1|Overall Study|Failed to mobilize - no transplant|8
149317|NCT00396318|485061|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
149318|NCT00396279|485081|P1|Overall Study|Physician Decision|1
149319|NCT00396279|485081|P1|Overall Study|Withdrawal by Subject|1
149320|NCT00396279|485081|P1|Overall Study|Disease progression|2
149321|NCT00396279|485081|P1|Overall Study|Ongoing in study|26
149322|NCT00396253|485114|P1|Overall Study|Change in eligibility status|1
149323|NCT00396253|485114|P1|Overall Study|Physician Decision|1
149324|NCT00396253|485114|P1|Overall Study|Death|3
149325|NCT00396253|485114|P1|Overall Study|Withdrawal by Subject|7
149326|NCT00396253|485114|P1|Overall Study|Protocol Violation|1
149327|NCT00396162|485145|P2|Overall Study|Withdrawal by Subject|3
149328|NCT00396162|485146|P1|Overall Study|Withdrawal by Subject|2
149329|NCT00396136|485158|P1|Overall Study|Study device explanted|8
149330|NCT00396136|485158|P1|Overall Study|Lost to Follow-up|15
149331|NCT00396136|485158|P1|Overall Study|Withdrawal by Subject|59
149332|NCT00396136|485158|P1|Overall Study|Death|43
149333|NCT00396097|485165|P2|Overall Study|Insufficient Clinical Response|4
149334|NCT00396097|485166|P1|Overall Study|Insufficient Clinical Response|1
149335|NCT00396097|485165|P2|Overall Study|Adverse Event|5
149336|NCT00396097|485166|P1|Overall Study|Adverse Event|1
149337|NCT00396097|485165|P2|Overall Study|Protocol Violation|6
149338|NCT00396097|485166|P1|Overall Study|Protocol Violation|0
149339|NCT00396097|485165|P2|Overall Study|Not specified|5
149340|NCT00396097|485166|P1|Overall Study|Not specified|3
149341|NCT00396097|485165|P2|Overall Study|Lost to Follow-up|9
149342|NCT00396097|485166|P1|Overall Study|Lost to Follow-up|4
149343|NCT00396097|485165|P2|Overall Study|Withdrawal by Subject|17
149344|NCT00396097|485166|P1|Overall Study|Withdrawal by Subject|17
149345|NCT00396084|485194|P6|Overall Study|Withdrawal by Subject|0
149346|NCT00396084|485195|P5|Overall Study|Withdrawal by Subject|0
149347|NCT00396084|485196|P4|Overall Study|Withdrawal by Subject|1
149348|NCT00396084|485197|P3|Overall Study|Withdrawal by Subject|0
149349|NCT00396084|485198|P2|Overall Study|Withdrawal by Subject|0
149350|NCT00396084|485199|P1|Overall Study|Withdrawal by Subject|0
149351|NCT00396084|485194|P6|Overall Study|Adverse Event|2
149352|NCT00396084|485195|P5|Overall Study|Adverse Event|1
149353|NCT00396084|485196|P4|Overall Study|Adverse Event|0
149354|NCT00396084|485197|P3|Overall Study|Adverse Event|0
149355|NCT00396084|485198|P2|Overall Study|Adverse Event|0
149356|NCT00396084|485199|P1|Overall Study|Adverse Event|0
149357|NCT00395967|485313|P1|Follow-up Period|Lost to Follow-up|1
149358|NCT00395967|485313|P1|Follow-up Period|Death|1
149359|NCT00395967|485313|P1|Treatment Period|Failed Mobilization|1
149360|NCT00395642|485322|P1|Overall Study|Withdrawal by Subject|1
149361|NCT00395642|485322|P1|Overall Study|Physician Decision|7
149362|NCT00395642|485322|P1|Overall Study|Lost to Follow-up|1
149363|NCT00395642|485322|P1|Overall Study|Death|4
149364|NCT00395629|485329|P3|Extension Study|Administrative problems|1
149365|NCT00395629|485330|P2|Extension Study|Administrative problems|0
149366|NCT00395629|485331|P1|Extension Study|Administrative problems|0
149367|NCT00395629|485329|P3|Extension Study|Adverse Event|2
149368|NCT00395629|485330|P2|Extension Study|Adverse Event|0
149369|NCT00395629|485331|P1|Extension Study|Adverse Event|0
149370|NCT00395629|485329|P3|Core Study|Lost to Follow-up|1
149371|NCT00395629|485330|P2|Core Study|Lost to Follow-up|0
149372|NCT00395629|485331|P1|Core Study|Lost to Follow-up|0
149373|NCT00395629|485329|P3|Core Study|Withdrawal by Subject|1
149374|NCT00395629|485330|P2|Core Study|Withdrawal by Subject|1
149375|NCT00395629|485331|P1|Core Study|Withdrawal by Subject|0
149376|NCT00395629|485329|P3|Core Study|Protocol Violation|0
149377|NCT00395629|485330|P2|Core Study|Protocol Violation|0
149378|NCT00395629|485331|P1|Core Study|Protocol Violation|1
149379|NCT00395629|485329|P3|Core Study|Abnormal laboratory value(s)|1
149380|NCT00395629|485330|P2|Core Study|Abnormal laboratory value(s)|0
149381|NCT00395629|485331|P1|Core Study|Abnormal laboratory value(s)|0
149382|NCT00395629|485329|P3|Core Study|Adverse Event|4
149383|NCT00395629|485330|P2|Core Study|Adverse Event|3
149384|NCT00395629|485331|P1|Core Study|Adverse Event|0
149385|NCT00395512|485349|P4|Overall Study|Hyperglycemic Rescue|6
149386|NCT00395512|485350|P3|Overall Study|Hyperglycemic Rescue|4
149387|NCT00395512|485351|P2|Overall Study|Hyperglycemic Rescue|10
149388|NCT00395512|485352|P1|Overall Study|Hyperglycemic Rescue|18
149389|NCT00395512|485349|P4|Overall Study|Other|0
149390|NCT00395512|485350|P3|Overall Study|Other|0
149391|NCT00395512|485351|P2|Overall Study|Other|1
149392|NCT00395512|485352|P1|Overall Study|Other|1
149393|NCT00395512|485349|P4|Overall Study|Physician Decision|2
149394|NCT00395512|485350|P3|Overall Study|Physician Decision|2
149395|NCT00395512|485351|P2|Overall Study|Physician Decision|4
149396|NCT00395512|485352|P1|Overall Study|Physician Decision|6
149397|NCT00395512|485349|P4|Overall Study|Withdrawal by Subject|12
149398|NCT00395512|485350|P3|Overall Study|Withdrawal by Subject|5
149399|NCT00395512|485351|P2|Overall Study|Withdrawal by Subject|5
149400|NCT00395512|485352|P1|Overall Study|Withdrawal by Subject|6
149401|NCT00395512|485349|P4|Overall Study|Lost to Follow-up|5
149402|NCT00395512|485350|P3|Overall Study|Lost to Follow-up|5
149403|NCT00395512|485351|P2|Overall Study|Lost to Follow-up|6
149404|NCT00395512|485352|P1|Overall Study|Lost to Follow-up|2
149405|NCT00395512|485349|P4|Overall Study|Protocol Violation|7
149406|NCT00395512|485350|P3|Overall Study|Protocol Violation|6
149407|NCT00395512|485351|P2|Overall Study|Protocol Violation|3
149408|NCT00395512|485352|P1|Overall Study|Protocol Violation|2
149409|NCT00395512|485349|P4|Overall Study|Adverse Event|6
149410|NCT00395512|485350|P3|Overall Study|Adverse Event|6
149411|NCT00395512|485351|P2|Overall Study|Adverse Event|8
149412|NCT00395512|485352|P1|Overall Study|Adverse Event|3
149413|NCT00395486|485524|P2|Overall Study|Lost to Follow-up|1
149414|NCT00395486|485525|P1|Overall Study|Lost to Follow-up|0
149415|NCT00395486|485524|P2|Overall Study|Withdrawal by Subject|2
149416|NCT00395486|485525|P1|Overall Study|Withdrawal by Subject|5
149417|NCT00395486|485524|P2|Overall Study|Adverse Event|2
149418|NCT00395486|485525|P1|Overall Study|Adverse Event|1
149419|NCT00395460|485555|P2|Overall Study|Withdrawal by Subject|0
149420|NCT00395460|485556|P1|Overall Study|Withdrawal by Subject|1
149421|NCT00395447|485580|P2|Overall Study|Withdrawl - Other (not subject)|17
149422|NCT00395447|485581|P1|Overall Study|Withdrawl - Other (not subject)|8
149423|NCT00395447|485580|P2|Overall Study|Withdrawal by Subject|19
149424|NCT00395447|485581|P1|Overall Study|Withdrawal by Subject|24
149425|NCT00395447|485580|P2|Overall Study|Lost to Follow-up|43
149426|NCT00395447|485581|P1|Overall Study|Lost to Follow-up|52
149427|NCT00395447|485580|P2|Overall Study|Death|32
149428|NCT00395447|485581|P1|Overall Study|Death|37
149429|NCT00395343|485589|P2|Overall Study|Unspecified|2
149430|NCT00395343|485590|P1|Overall Study|Unspecified|5
149431|NCT00395343|485589|P2|Overall Study|Withdrawal by Subject|12
149432|NCT00395343|485590|P1|Overall Study|Withdrawal by Subject|11
149433|NCT00395343|485589|P2|Overall Study|Protocol Violation|8
149434|NCT00395343|485590|P1|Overall Study|Protocol Violation|6
149435|NCT00395343|485589|P2|Overall Study|Physician Decision|4
149436|NCT00395343|485590|P1|Overall Study|Physician Decision|2
149437|NCT00395343|485589|P2|Overall Study|Lost to Follow-up|4
149438|NCT00395343|485590|P1|Overall Study|Lost to Follow-up|4
149439|NCT00395343|485589|P2|Overall Study|Lack of Efficacy|1
149440|NCT00395343|485590|P1|Overall Study|Lack of Efficacy|0
149441|NCT00395343|485589|P2|Overall Study|Adverse Event|5
149442|NCT00395343|485590|P1|Overall Study|Adverse Event|13
149443|NCT00395304|485608|P6|Treatment Period 3|Other|0
149444|NCT00395304|485609|P5|Treatment Period 3|Other|0
149445|NCT00395304|485610|P4|Treatment Period 3|Other|1
149446|NCT00395304|485611|P3|Treatment Period 3|Other|0
149447|NCT00395304|485612|P2|Treatment Period 3|Other|0
149448|NCT00395304|485613|P1|Treatment Period 3|Other|0
149449|NCT00395304|485608|P6|Treatment Period 3|Physician Decision|0
149450|NCT00395304|485609|P5|Treatment Period 3|Physician Decision|0
149451|NCT00395304|485610|P4|Treatment Period 3|Physician Decision|0
149452|NCT00395304|485611|P3|Treatment Period 3|Physician Decision|0
149453|NCT00395304|485612|P2|Treatment Period 3|Physician Decision|1
149454|NCT00395304|485613|P1|Treatment Period 3|Physician Decision|0
149455|NCT00395304|485608|P6|Treatment Period 3|Lost to Follow-up|0
149456|NCT00395304|485609|P5|Treatment Period 3|Lost to Follow-up|0
149457|NCT00395304|485610|P4|Treatment Period 3|Lost to Follow-up|0
149458|NCT00395304|485611|P3|Treatment Period 3|Lost to Follow-up|0
149459|NCT00395304|485612|P2|Treatment Period 3|Lost to Follow-up|1
149460|NCT00395304|485613|P1|Treatment Period 3|Lost to Follow-up|1
149461|NCT00395304|485608|P6|Treatment Period 3|Withdrawal by Subject|1
149462|NCT00395304|485609|P5|Treatment Period 3|Withdrawal by Subject|0
149463|NCT00395304|485610|P4|Treatment Period 3|Withdrawal by Subject|1
149464|NCT00395304|485611|P3|Treatment Period 3|Withdrawal by Subject|0
149465|NCT00395304|485612|P2|Treatment Period 3|Withdrawal by Subject|0
149466|NCT00395304|485613|P1|Treatment Period 3|Withdrawal by Subject|0
149467|NCT00395304|485608|P6|Treatment Period 2|Other|0
149468|NCT00395304|485609|P5|Treatment Period 2|Other|0
149469|NCT00395304|485610|P4|Treatment Period 2|Other|0
149470|NCT00395304|485611|P3|Treatment Period 2|Other|0
149471|NCT00395304|485612|P2|Treatment Period 2|Other|1
149472|NCT00395304|485613|P1|Treatment Period 2|Other|0
149473|NCT00395304|485608|P6|Treatment Period 2|Physician Decision|0
149474|NCT00395304|485609|P5|Treatment Period 2|Physician Decision|0
149475|NCT00395304|485610|P4|Treatment Period 2|Physician Decision|0
149476|NCT00395304|485611|P3|Treatment Period 2|Physician Decision|1
149477|NCT00395304|485612|P2|Treatment Period 2|Physician Decision|0
149478|NCT00395304|485613|P1|Treatment Period 2|Physician Decision|0
149479|NCT00395304|485608|P6|Treatment Period 2|Lost to Follow-up|0
149480|NCT00395304|485609|P5|Treatment Period 2|Lost to Follow-up|0
149481|NCT00395304|485610|P4|Treatment Period 2|Lost to Follow-up|0
149482|NCT00395304|485611|P3|Treatment Period 2|Lost to Follow-up|0
149483|NCT00395304|485612|P2|Treatment Period 2|Lost to Follow-up|3
149484|NCT00395304|485613|P1|Treatment Period 2|Lost to Follow-up|0
149485|NCT00395304|485608|P6|Treatment Period 2|Withdrawal by Subject|2
149486|NCT00395304|485609|P5|Treatment Period 2|Withdrawal by Subject|0
149487|NCT00395304|485610|P4|Treatment Period 2|Withdrawal by Subject|1
149488|NCT00395304|485611|P3|Treatment Period 2|Withdrawal by Subject|0
149489|NCT00395304|485612|P2|Treatment Period 2|Withdrawal by Subject|0
149490|NCT00395304|485613|P1|Treatment Period 2|Withdrawal by Subject|0
149491|NCT00395304|485608|P6|Treatment Period 1|Physician Decision|0
149492|NCT00395304|485609|P5|Treatment Period 1|Physician Decision|0
149493|NCT00395304|485610|P4|Treatment Period 1|Physician Decision|0
149494|NCT00395304|485611|P3|Treatment Period 1|Physician Decision|0
149495|NCT00395304|485612|P2|Treatment Period 1|Physician Decision|1
149496|NCT00395304|485613|P1|Treatment Period 1|Physician Decision|0
149497|NCT00395304|485608|P6|Treatment Period 1|Lost to Follow-up|1
149498|NCT00395304|485609|P5|Treatment Period 1|Lost to Follow-up|0
149499|NCT00395304|485610|P4|Treatment Period 1|Lost to Follow-up|1
149500|NCT00395304|485611|P3|Treatment Period 1|Lost to Follow-up|0
149501|NCT00395304|485612|P2|Treatment Period 1|Lost to Follow-up|0
149502|NCT00395304|485613|P1|Treatment Period 1|Lost to Follow-up|1
149503|NCT00395304|485608|P6|Treatment Period 1|Withdrawal by Subject|1
149504|NCT00395304|485609|P5|Treatment Period 1|Withdrawal by Subject|1
149505|NCT00395304|485610|P4|Treatment Period 1|Withdrawal by Subject|2
149506|NCT00395304|485611|P3|Treatment Period 1|Withdrawal by Subject|0
149507|NCT00395304|485612|P2|Treatment Period 1|Withdrawal by Subject|3
149508|NCT00395304|485613|P1|Treatment Period 1|Withdrawal by Subject|0
149509|NCT00395226|485650|P2|Overall Study|Lost to Follow-up|1
149510|NCT00395226|485651|P1|Overall Study|Lost to Follow-up|0
149511|NCT00395226|485650|P2|Overall Study|Withdrawal by Subject|1
149512|NCT00395226|485651|P1|Overall Study|Withdrawal by Subject|0
149513|NCT00395226|485650|P2|Overall Study|Adverse Event|3
149514|NCT00395226|485651|P1|Overall Study|Adverse Event|4
149515|NCT00395083|485698|P2|Overall Study|Developed another disease|3
149516|NCT00395083|485699|P1|Overall Study|Developed another disease|4
149517|NCT00395083|485698|P2|Overall Study|Withdrawal by Subject|5
149518|NCT00395083|485699|P1|Overall Study|Withdrawal by Subject|6
149519|NCT00395018|485765|P1|Off-Treatment Follow-up|Poor/non-compliance|1
149520|NCT00395018|485765|P1|Off-Treatment Follow-up|Lost to Follow-up|2
149521|NCT00395018|485765|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
149522|NCT00395018|485765|P1|On-Treatment|Subject no longer meets study criteria|2
149523|NCT00395018|485765|P1|On-Treatment|Poor/non-compliance|2
149524|NCT00395018|485765|P1|On-Treatment|Other Reason|2
149525|NCT00395018|485765|P1|On-Treatment|Death|4
149526|NCT00394953|485786|P2|Second Treatment Period|Not defined|8
149527|NCT00394953|485787|P1|Second Treatment Period|Not defined|3
149528|NCT00394953|485786|P2|Second Treatment Period|Renal transplant|6
149529|NCT00394953|485787|P1|Second Treatment Period|Renal transplant|4
149530|NCT00394953|485786|P2|Second Treatment Period|Lost to Follow-up|1
149531|NCT00394953|485787|P1|Second Treatment Period|Lost to Follow-up|0
149532|NCT00394953|485786|P2|Second Treatment Period|Withdrawal by Subject|3
149533|NCT00394953|485787|P1|Second Treatment Period|Withdrawal by Subject|3
149534|NCT00394953|485786|P2|Second Treatment Period|Lack of Efficacy|47
149535|NCT00394953|485787|P1|Second Treatment Period|Lack of Efficacy|9
149536|NCT00394953|485786|P2|Second Treatment Period|Death|4
149537|NCT00394953|485787|P1|Second Treatment Period|Death|8
149538|NCT00394953|485786|P2|Second Treatment Period|Adverse Event|5
149539|NCT00394953|485787|P1|Second Treatment Period|Adverse Event|2
149540|NCT00394953|485786|P2|First Treatment Period|Not defined|1
149541|NCT00394953|485787|P1|First Treatment Period|Not defined|4
149542|NCT00394953|485786|P2|First Treatment Period|Renal transplant|7
149543|NCT00394953|485787|P1|First Treatment Period|Renal transplant|11
149544|NCT00394953|485786|P2|First Treatment Period|Lost to Follow-up|1
149545|NCT00394953|485787|P1|First Treatment Period|Lost to Follow-up|0
149546|NCT00394953|485786|P2|First Treatment Period|Withdrawal by Subject|3
149547|NCT00394953|485787|P1|First Treatment Period|Withdrawal by Subject|6
149548|NCT00394953|485786|P2|First Treatment Period|Lack of Efficacy|1
149549|NCT00394953|485787|P1|First Treatment Period|Lack of Efficacy|1
149550|NCT00394953|485786|P2|First Treatment Period|Death|7
149551|NCT00394953|485787|P1|First Treatment Period|Death|6
149552|NCT00394953|485786|P2|First Treatment Period|Adverse Event|2
149553|NCT00394953|485787|P1|First Treatment Period|Adverse Event|1
149554|NCT00394914|485805|P3|Treatment Period|Did not meet protocol eligibility|1
149555|NCT00394914|485806|P2|Treatment Period|Did not meet protocol eligibility|1
149556|NCT00394914|485807|P1|Treatment Period|Did not meet protocol eligibility|0
149557|NCT00394914|485805|P3|Treatment Period|Noncompliance with protocol|2
149558|NCT00394914|485806|P2|Treatment Period|Noncompliance with protocol|3
149559|NCT00394914|485807|P1|Treatment Period|Noncompliance with protocol|0
149560|NCT00394914|485805|P3|Treatment Period|Withdrawal by Subject|2
149561|NCT00394914|485806|P2|Treatment Period|Withdrawal by Subject|2
149562|NCT00394914|485807|P1|Treatment Period|Withdrawal by Subject|0
149563|NCT00394914|485805|P3|Treatment Period|Lost to Follow-up|0
149564|NCT00394914|485806|P2|Treatment Period|Lost to Follow-up|1
149565|NCT00394914|485807|P1|Treatment Period|Lost to Follow-up|0
149566|NCT00394914|485805|P3|Treatment Period|Adverse Event|1
149567|NCT00394914|485806|P2|Treatment Period|Adverse Event|3
149568|NCT00394914|485807|P1|Treatment Period|Adverse Event|0
149569|NCT00394901|485835|P4|Double-blind Phase|Found not to meet entrance criteria|1
149570|NCT00394901|485836|P3|Double-blind Phase|Found not to meet entrance criteria|0
149571|NCT00394901|485837|P2|Double-blind Phase|Found not to meet entrance criteria|0
149572|NCT00394901|485838|P1|Double-blind Phase|Found not to meet entrance criteria|0
149573|NCT00394901|485835|P4|Double-blind Phase|Entry into another study was found|0
149574|NCT00394901|485836|P3|Double-blind Phase|Entry into another study was found|1
149575|NCT00394901|485837|P2|Double-blind Phase|Entry into another study was found|0
149576|NCT00394901|485838|P1|Double-blind Phase|Entry into another study was found|0
149577|NCT00394901|485835|P4|Double-blind Phase|Lack of Compliance|0
149578|NCT00394901|485836|P3|Double-blind Phase|Lack of Compliance|0
149579|NCT00394901|485837|P2|Double-blind Phase|Lack of Compliance|3
149580|NCT00394901|485838|P1|Double-blind Phase|Lack of Compliance|0
149581|NCT00394901|485835|P4|Double-blind Phase|Subject's Personal Reason|1
149582|NCT00394901|485836|P3|Double-blind Phase|Subject's Personal Reason|0
149583|NCT00394901|485837|P2|Double-blind Phase|Subject's Personal Reason|0
149584|NCT00394901|485838|P1|Double-blind Phase|Subject's Personal Reason|1
149585|NCT00394901|485835|P4|Double-blind Phase|Death|0
149586|NCT00394901|485836|P3|Double-blind Phase|Death|0
149587|NCT00394901|485837|P2|Double-blind Phase|Death|0
149588|NCT00394901|485838|P1|Double-blind Phase|Death|1
149589|NCT00394901|485835|P4|Double-blind Phase|Protocol Violation|1
149590|NCT00394901|485836|P3|Double-blind Phase|Protocol Violation|0
149591|NCT00394901|485837|P2|Double-blind Phase|Protocol Violation|0
149592|NCT00394901|485838|P1|Double-blind Phase|Protocol Violation|0
149593|NCT00394901|485835|P4|Double-blind Phase|Lost to Follow-up|1
149594|NCT00394901|485836|P3|Double-blind Phase|Lost to Follow-up|0
149595|NCT00394901|485837|P2|Double-blind Phase|Lost to Follow-up|0
149596|NCT00394901|485838|P1|Double-blind Phase|Lost to Follow-up|0
149597|NCT00394901|485835|P4|Double-blind Phase|Withdrawal by Subject|0
149598|NCT00394901|485836|P3|Double-blind Phase|Withdrawal by Subject|0
149599|NCT00394901|485837|P2|Double-blind Phase|Withdrawal by Subject|0
149600|NCT00394901|485838|P1|Double-blind Phase|Withdrawal by Subject|2
149601|NCT00394901|485835|P4|Double-blind Phase|Lack of Efficacy|3
149602|NCT00394901|485836|P3|Double-blind Phase|Lack of Efficacy|1
149603|NCT00394901|485837|P2|Double-blind Phase|Lack of Efficacy|4
149604|NCT00394901|485838|P1|Double-blind Phase|Lack of Efficacy|6
149605|NCT00394901|485835|P4|Double-blind Phase|Adverse Event|20
149606|NCT00394901|485836|P3|Double-blind Phase|Adverse Event|16
149607|NCT00394901|485837|P2|Double-blind Phase|Adverse Event|7
149608|NCT00394901|485838|P1|Double-blind Phase|Adverse Event|5
149609|NCT00394901|485835|P4|Baseline Phase|Protocol Violation|0
149610|NCT00394901|485836|P3|Baseline Phase|Protocol Violation|1
149611|NCT00394901|485837|P2|Baseline Phase|Protocol Violation|0
149612|NCT00394901|485838|P1|Baseline Phase|Protocol Violation|0
149613|NCT00394836|486081|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
149614|NCT00394836|486082|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
149615|NCT00394836|486081|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
149616|NCT00394836|486082|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
149617|NCT00394836|486081|P2|Extended Follow-up Phase (2-5 Years)|Death|1
149618|NCT00394836|486082|P1|Extended Follow-up Phase (2-5 Years)|Death|0
149619|NCT00394836|486081|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
149620|NCT00394836|486082|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
149621|NCT00394836|486081|P2|Teatment or Follow-up Phase|Non compliance|1
149622|NCT00394836|486082|P1|Teatment or Follow-up Phase|Non compliance|0
149623|NCT00394836|486081|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
149624|NCT00394836|486082|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
149625|NCT00394836|486081|P2|Teatment or Follow-up Phase|Physician Decision|1
149626|NCT00394836|486082|P1|Teatment or Follow-up Phase|Physician Decision|0
149627|NCT00394836|486081|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
149628|NCT00394836|486082|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
149629|NCT00394836|486081|P2|Teatment or Follow-up Phase|Started alternative treatment|6
149630|NCT00394836|486082|P1|Teatment or Follow-up Phase|Started alternative treatment|0
149631|NCT00394836|486081|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
149632|NCT00394836|486082|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
149633|NCT00394836|486081|P2|Teatment or Follow-up Phase|Death|1
149634|NCT00394836|486082|P1|Teatment or Follow-up Phase|Death|0
149635|NCT00394836|486081|P2|Teatment or Follow-up Phase|Patient Refusal|2
149636|NCT00394836|486082|P1|Teatment or Follow-up Phase|Patient Refusal|1
149637|NCT00394836|486081|P2|Teatment or Follow-up Phase|Disease Progression|60
149638|NCT00394836|486082|P1|Teatment or Follow-up Phase|Disease Progression|27
149639|NCT00394836|486081|P2|Teatment or Follow-up Phase|Protocol Violation|2
149640|NCT00394836|486082|P1|Teatment or Follow-up Phase|Protocol Violation|0
149641|NCT00394836|486081|P2|Teatment or Follow-up Phase|Adverse Event|2
149642|NCT00394836|486082|P1|Teatment or Follow-up Phase|Adverse Event|0
149643|NCT00394771|486128|P4|Overall Study|Not specified|0
149644|NCT00394771|486129|P3|Overall Study|Not specified|1
149645|NCT00394771|486130|P2|Overall Study|Not specified|3
149646|NCT00394771|486131|P1|Overall Study|Not specified|3
149647|NCT00394771|486128|P4|Overall Study|Lost to Follow-up|10
149648|NCT00394771|486129|P3|Overall Study|Lost to Follow-up|13
149649|NCT00394771|486130|P2|Overall Study|Lost to Follow-up|15
149650|NCT00394771|486131|P1|Overall Study|Lost to Follow-up|15
149651|NCT00394771|486128|P4|Overall Study|Participant pregnant|2
149652|NCT00394771|486129|P3|Overall Study|Participant pregnant|2
149653|NCT00394771|486130|P2|Overall Study|Participant pregnant|1
149654|NCT00394771|486131|P1|Overall Study|Participant pregnant|0
149655|NCT00394771|486128|P4|Overall Study|Adverse Event|8
149656|NCT00394771|486129|P3|Overall Study|Adverse Event|12
149657|NCT00394771|486130|P2|Overall Study|Adverse Event|5
149658|NCT00394771|486131|P1|Overall Study|Adverse Event|10
149659|NCT00394771|486128|P4|Overall Study|Withdrawal by Subject|12
149660|NCT00394771|486129|P3|Overall Study|Withdrawal by Subject|8
149661|NCT00394771|486130|P2|Overall Study|Withdrawal by Subject|6
149662|NCT00394771|486131|P1|Overall Study|Withdrawal by Subject|10
149663|NCT00394771|486128|P4|Overall Study|Protocol Violation|7
149664|NCT00394771|486129|P3|Overall Study|Protocol Violation|9
149665|NCT00394771|486130|P2|Overall Study|Protocol Violation|4
149666|NCT00394771|486131|P1|Overall Study|Protocol Violation|2
149667|NCT00394771|486128|P4|Overall Study|Did not meet protocol requirements|0
149668|NCT00394771|486129|P3|Overall Study|Did not meet protocol requirements|2
149669|NCT00394771|486130|P2|Overall Study|Did not meet protocol requirements|0
149670|NCT00394771|486131|P1|Overall Study|Did not meet protocol requirements|1
149671|NCT00394706|486201|P8|Overall Study|Lost to Follow-up|0
149672|NCT00394706|486202|P7|Overall Study|Lost to Follow-up|2
149673|NCT00394706|486203|P6|Overall Study|Lost to Follow-up|5
149674|NCT00394706|486204|P5|Overall Study|Lost to Follow-up|2
149675|NCT00394706|486205|P4|Overall Study|Lost to Follow-up|1
149676|NCT00394706|486206|P3|Overall Study|Lost to Follow-up|8
149677|NCT00394706|486207|P2|Overall Study|Lost to Follow-up|2
149678|NCT00394706|486208|P1|Overall Study|Lost to Follow-up|2
149679|NCT00394706|486201|P8|Overall Study|Withdrawal by Subject|0
149680|NCT00394706|486202|P7|Overall Study|Withdrawal by Subject|1
149681|NCT00394706|486203|P6|Overall Study|Withdrawal by Subject|2
149682|NCT00394706|486204|P5|Overall Study|Withdrawal by Subject|0
149683|NCT00394706|486205|P4|Overall Study|Withdrawal by Subject|0
149684|NCT00394706|486206|P3|Overall Study|Withdrawal by Subject|1
149685|NCT00394706|486207|P2|Overall Study|Withdrawal by Subject|0
149686|NCT00394706|486208|P1|Overall Study|Withdrawal by Subject|2
149687|NCT00394654|486228|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
149688|NCT00394654|486229|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
149689|NCT00394654|486228|P2|Overall Study|Lost to Follow-up|0
149690|NCT00394654|486229|P1|Overall Study|Lost to Follow-up|1
149691|NCT00394589|486294|P3|Overall Study|Protocol Violation|2
149692|NCT00394589|486295|P2|Overall Study|Protocol Violation|0
149693|NCT00394589|486296|P1|Overall Study|Protocol Violation|4
149694|NCT00394589|486294|P3|Overall Study|Lack of Efficacy|3
149695|NCT00394589|486295|P2|Overall Study|Lack of Efficacy|2
149696|NCT00394589|486296|P1|Overall Study|Lack of Efficacy|2
149697|NCT00394589|486294|P3|Overall Study|Adverse Event|2
149698|NCT00394589|486295|P2|Overall Study|Adverse Event|1
149699|NCT00394589|486296|P1|Overall Study|Adverse Event|2
149700|NCT00394524|486306|P2|Overall Study|Withdrawal by Subject|10
149701|NCT00394524|486307|P1|Overall Study|Withdrawal by Subject|11
149702|NCT00394472|486319|P2|Overall Study|Lost to Follow-up|1
149703|NCT00394472|486320|P1|Overall Study|Lost to Follow-up|0
149704|NCT00394472|486319|P2|Overall Study|Physician Decision|1
149705|NCT00394472|486320|P1|Overall Study|Physician Decision|0
149706|NCT00394472|486319|P2|Overall Study|Withdrawal by Subject|2
149707|NCT00394472|486320|P1|Overall Study|Withdrawal by Subject|0
149708|NCT00394472|486319|P2|Overall Study|Adverse Event|2
149709|NCT00394472|486320|P1|Overall Study|Adverse Event|4
149710|NCT00394472|486319|P2|Overall Study|incorrect enrolment|2
149711|NCT00394472|486320|P1|Overall Study|incorrect enrolment|4
149712|NCT00394472|486319|P2|Overall Study|Protocol Violation|3
149713|NCT00394472|486320|P1|Overall Study|Protocol Violation|1
149714|NCT00394433|486328|P1|Overall Study|Alternative Therapy|1
149715|NCT00394433|486328|P1|Overall Study|Adverse Event|2
149716|NCT00394355|486339|P4|Overall Study|Lack of Efficacy|3
149717|NCT00394355|486340|P3|Overall Study|Lack of Efficacy|2
149718|NCT00394355|486341|P2|Overall Study|Lack of Efficacy|0
149719|NCT00394355|486342|P1|Overall Study|Lack of Efficacy|0
149720|NCT00394355|486339|P4|Overall Study|Administrative|1
149721|NCT00394355|486340|P3|Overall Study|Administrative|1
149722|NCT00394355|486341|P2|Overall Study|Administrative|1
149723|NCT00394355|486342|P1|Overall Study|Administrative|0
149724|NCT00394355|486339|P4|Overall Study|Noncompliance with protocol|8
149725|NCT00394355|486340|P3|Overall Study|Noncompliance with protocol|10
149726|NCT00394355|486341|P2|Overall Study|Noncompliance with protocol|3
149727|NCT00394355|486342|P1|Overall Study|Noncompliance with protocol|4
149728|NCT00394355|486339|P4|Overall Study|Lost to Follow-up|3
149729|NCT00394355|486340|P3|Overall Study|Lost to Follow-up|4
149730|NCT00394355|486341|P2|Overall Study|Lost to Follow-up|5
149731|NCT00394355|486342|P1|Overall Study|Lost to Follow-up|7
149732|NCT00394355|486339|P4|Overall Study|Subject withdrawal - related to drug|0
149733|NCT00394355|486340|P3|Overall Study|Subject withdrawal - related to drug|0
149734|NCT00394355|486341|P2|Overall Study|Subject withdrawal - related to drug|0
149735|NCT00394355|486342|P1|Overall Study|Subject withdrawal - related to drug|1
149736|NCT00394355|486339|P4|Overall Study|Subject withdrawal - unrelated to drug|6
149737|NCT00394355|486340|P3|Overall Study|Subject withdrawal - unrelated to drug|10
149738|NCT00394355|486341|P2|Overall Study|Subject withdrawal - unrelated to drug|14
149739|NCT00394355|486342|P1|Overall Study|Subject withdrawal - unrelated to drug|12
149740|NCT00394355|486339|P4|Overall Study|Did not meet protocol eligibility|2
149741|NCT00394355|486340|P3|Overall Study|Did not meet protocol eligibility|4
149742|NCT00394355|486341|P2|Overall Study|Did not meet protocol eligibility|5
149743|NCT00394355|486342|P1|Overall Study|Did not meet protocol eligibility|1
149744|NCT00394355|486339|P4|Overall Study|Adverse Event|8
149745|NCT00394355|486340|P3|Overall Study|Adverse Event|7
149746|NCT00394355|486341|P2|Overall Study|Adverse Event|6
149747|NCT00394355|486342|P1|Overall Study|Adverse Event|10
149748|NCT00394251|486412|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
149749|NCT00394251|486413|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
149750|NCT00394251|486412|P2|Overall Study|Withdrawal by Subject|11
149751|NCT00394251|486413|P1|Overall Study|Withdrawal by Subject|7
149752|NCT00394251|486412|P2|Overall Study|Protocol Violation|1
149753|NCT00394251|486413|P1|Overall Study|Protocol Violation|0
149754|NCT00394251|486412|P2|Overall Study|Physician Decision|1
149755|NCT00394251|486413|P1|Overall Study|Physician Decision|1
149756|NCT00394251|486412|P2|Overall Study|Unacceptable Toxicity|18
149757|NCT00394251|486413|P1|Overall Study|Unacceptable Toxicity|20
149758|NCT00394251|486412|P2|Overall Study|Adverse Event|5
149759|NCT00394251|486413|P1|Overall Study|Adverse Event|7
149760|NCT00394212|486441|P2|Overall Study|Withdrawal by Subject|1
149761|NCT00394212|486442|P1|Overall Study|Withdrawal by Subject|4
149762|NCT00394212|486441|P2|Overall Study|Lost to Follow-up|0
149763|NCT00394212|486442|P1|Overall Study|Lost to Follow-up|3
149764|NCT00394095|486456|P2|Overall Study|Adverse Event|0
149765|NCT00394095|486457|P1|Overall Study|Adverse Event|1
149766|NCT00394082|486465|P1|Overall Study|Not specified|1
149767|NCT00394082|486465|P1|Overall Study|Withdrawal by Subject|2
149768|NCT00394082|486465|P1|Overall Study|Physician Decision|4
149769|NCT00394082|486465|P1|Overall Study|Adverse Event|4
149770|NCT00394082|486465|P1|Overall Study|Unacceptable toxicity|15
149771|NCT00393939|486476|P2|Overall Study|Not specified|45
149772|NCT00393939|486477|P1|Overall Study|Not specified|37
149773|NCT00393939|486476|P2|Overall Study|Withdrawal by Subject|7
149774|NCT00393939|486477|P1|Overall Study|Withdrawal by Subject|2
149775|NCT00393939|486476|P2|Overall Study|Objective progression or relapse|223
149776|NCT00393939|486477|P1|Overall Study|Objective progression or relapse|239
149777|NCT00393939|486476|P2|Overall Study|Sponsor|13
149778|NCT00393939|486477|P1|Overall Study|Sponsor|5
149779|NCT00393939|486476|P2|Overall Study|Death|4
149780|NCT00393939|486477|P1|Overall Study|Death|10
149781|NCT00393939|486476|P2|Overall Study|Lost to Follow-up|4
149782|NCT00393939|486477|P1|Overall Study|Lost to Follow-up|2
149783|NCT00393939|486476|P2|Overall Study|Protocol Violation|1
149784|NCT00393939|486477|P1|Overall Study|Protocol Violation|1
149785|NCT00393913|486495|P1|CPAP|TEchnical problem with CPAP|3
149786|NCT00393913|486495|P1|CPAP|Physician Decision|1
149787|NCT00393913|486495|P1|CPAP|Withdrawal by Subject|3
149788|NCT00393913|486495|P1|Initial Assessment|Withdrawal by Subject|16
149789|NCT00393913|486495|P1|Initial Assessment|diagnosed with other sleep disorder|21
149790|NCT00393887|486503|P2|Overall Study|Lost to Follow-up|9
149791|NCT00393887|486504|P1|Overall Study|Lost to Follow-up|11
149792|NCT00393887|486503|P2|Overall Study|Physician Decision|0
149793|NCT00393887|486504|P1|Overall Study|Physician Decision|5
149794|NCT00393861|486532|P1|Overall Study|Disease Progression|24
149795|NCT00393861|486532|P1|Overall Study|Adverse Event|2
149796|NCT00393848|486543|P4|Overall Study|Personal reasons|0
149797|NCT00393848|486544|P3|Overall Study|Personal reasons|2
149798|NCT00393848|486545|P2|Overall Study|Personal reasons|0
149799|NCT00393848|486546|P1|Overall Study|Personal reasons|0
149800|NCT00393848|486543|P4|Overall Study|Surgical schedule|1
149801|NCT00393848|486544|P3|Overall Study|Surgical schedule|0
149802|NCT00393848|486545|P2|Overall Study|Surgical schedule|0
149803|NCT00393848|486546|P1|Overall Study|Surgical schedule|0
149804|NCT00393718|486569|P2|Overall Study|Move|0
149805|NCT00393718|486570|P1|Overall Study|Move|1
149806|NCT00393718|486569|P2|Overall Study|Missed measurement|0
149807|NCT00393718|486570|P1|Overall Study|Missed measurement|1
149808|NCT00393718|486569|P2|Overall Study|Withdrawal of consent|1
149809|NCT00393718|486570|P1|Overall Study|Withdrawal of consent|2
149810|NCT00393718|486569|P2|Overall Study|Subject decision|0
149811|NCT00393718|486570|P1|Overall Study|Subject decision|5
149812|NCT00393718|486569|P2|Overall Study|Hypoglycaemia|2
149813|NCT00393718|486570|P1|Overall Study|Hypoglycaemia|3
149814|NCT00393718|486569|P2|Overall Study|Lack of Efficacy|9
149815|NCT00393718|486570|P1|Overall Study|Lack of Efficacy|10
149816|NCT00393718|486569|P2|Overall Study|Protocol Violation|2
149817|NCT00393718|486570|P1|Overall Study|Protocol Violation|1
149818|NCT00393718|486569|P2|Overall Study|Adverse Event|8
149819|NCT00393718|486570|P1|Overall Study|Adverse Event|20
149820|NCT00393705|486602|P2|Overall Study|Physician Decision|2
149821|NCT00393705|486603|P1|Overall Study|Physician Decision|2
149822|NCT00393705|486602|P2|Overall Study|Withdrawal by Subject|3
149823|NCT00393705|486603|P1|Overall Study|Withdrawal by Subject|5
149824|NCT00393705|486602|P2|Overall Study|Protocol Violation|3
149825|NCT00393705|486603|P1|Overall Study|Protocol Violation|4
149826|NCT00393705|486602|P2|Overall Study|Entry Criteria Not Met|10
149827|NCT00393705|486603|P1|Overall Study|Entry Criteria Not Met|10
149828|NCT00393705|486602|P2|Overall Study|Lost to Follow-up|2
149829|NCT00393705|486603|P1|Overall Study|Lost to Follow-up|2
149830|NCT00393705|486602|P2|Overall Study|Death|1
149831|NCT00393705|486603|P1|Overall Study|Death|0
149832|NCT00393705|486602|P2|Overall Study|Adverse Event|2
149833|NCT00393705|486603|P1|Overall Study|Adverse Event|0
149834|NCT00393523|486632|P5|Overall Study|Vaccine supply issue|0
149835|NCT00393523|486633|P4|Overall Study|Vaccine supply issue|0
149836|NCT00393523|486634|P3|Overall Study|Vaccine supply issue|1
149837|NCT00393523|486635|P2|Overall Study|Vaccine supply issue|0
149838|NCT00393523|486636|P1|Overall Study|Vaccine supply issue|0
149839|NCT00393523|486632|P5|Overall Study|Difficulties in specimen collection|0
149840|NCT00393523|486633|P4|Overall Study|Difficulties in specimen collection|0
149841|NCT00393523|486634|P3|Overall Study|Difficulties in specimen collection|1
149842|NCT00393523|486635|P2|Overall Study|Difficulties in specimen collection|0
149843|NCT00393523|486636|P1|Overall Study|Difficulties in specimen collection|0
149844|NCT00393523|486632|P5|Overall Study|Withdrawal by Subject|0
149845|NCT00393523|486633|P4|Overall Study|Withdrawal by Subject|3
149846|NCT00393523|486634|P3|Overall Study|Withdrawal by Subject|2
149847|NCT00393523|486635|P2|Overall Study|Withdrawal by Subject|7
149848|NCT00393523|486636|P1|Overall Study|Withdrawal by Subject|6
149849|NCT00393523|486632|P5|Overall Study|Protocol Violation|0
149850|NCT00393523|486633|P4|Overall Study|Protocol Violation|1
149851|NCT00393523|486634|P3|Overall Study|Protocol Violation|0
149852|NCT00393523|486635|P2|Overall Study|Protocol Violation|2
149853|NCT00393523|486636|P1|Overall Study|Protocol Violation|6
149854|NCT00393523|486632|P5|Overall Study|Lost to Follow-up|1
149855|NCT00393523|486633|P4|Overall Study|Lost to Follow-up|2
149856|NCT00393523|486634|P3|Overall Study|Lost to Follow-up|0
149857|NCT00393523|486635|P2|Overall Study|Lost to Follow-up|0
149858|NCT00393523|486636|P1|Overall Study|Lost to Follow-up|0
149859|NCT00393510|486653|P2|Overall Study|Physician Decision|9
149860|NCT00393510|486654|P1|Overall Study|Physician Decision|3
149861|NCT00393484|486666|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
149862|NCT00393484|486667|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
149863|NCT00393484|486666|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
149864|NCT00393484|486667|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
149865|NCT00393484|486666|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
149866|NCT00393484|486667|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
149867|NCT00393484|486666|P2|Open-label Period (Weeks 96 to 240)|Death|0
149868|NCT00393484|486667|P1|Open-label Period (Weeks 96 to 240)|Death|1
149869|NCT00393484|486666|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
149870|NCT00393484|486667|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
149871|NCT00393484|486666|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
149872|NCT00393484|486667|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
149873|NCT00393484|486666|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
149874|NCT00393484|486667|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
149875|NCT00393484|486666|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
149876|NCT00393484|486667|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
149877|NCT00393484|486666|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
149878|NCT00393484|486667|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
149879|NCT00393484|486666|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
149880|NCT00393484|486667|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
149881|NCT00393458|486703|P4|Overall Study|Subject no longer requires study drug|0
149882|NCT00393458|486704|P3|Overall Study|Subject no longer requires study drug|0
149883|NCT00393458|486705|P2|Overall Study|Subject no longer requires study drug|1
149884|NCT00393458|486706|P1|Overall Study|Subject no longer requires study drug|0
149885|NCT00393458|486703|P4|Overall Study|Abnormal test procedure result(s)|2
149886|NCT00393458|486704|P3|Overall Study|Abnormal test procedure result(s)|1
149887|NCT00393458|486705|P2|Overall Study|Abnormal test procedure result(s)|1
149888|NCT00393458|486706|P1|Overall Study|Abnormal test procedure result(s)|0
149889|NCT00393458|486703|P4|Overall Study|Death|5
149890|NCT00393458|486704|P3|Overall Study|Death|5
149891|NCT00393458|486705|P2|Overall Study|Death|1
149892|NCT00393458|486706|P1|Overall Study|Death|1
149893|NCT00393458|486703|P4|Overall Study|Abnormal laboratory value(s)|0
149894|NCT00393458|486704|P3|Overall Study|Abnormal laboratory value(s)|0
149895|NCT00393458|486705|P2|Overall Study|Abnormal laboratory value(s)|1
149896|NCT00393458|486706|P1|Overall Study|Abnormal laboratory value(s)|1
149897|NCT00393458|486703|P4|Overall Study|Lost to Follow-up|3
149898|NCT00393458|486704|P3|Overall Study|Lost to Follow-up|5
149899|NCT00393458|486705|P2|Overall Study|Lost to Follow-up|6
149900|NCT00393458|486706|P1|Overall Study|Lost to Follow-up|5
149901|NCT00393458|486703|P4|Overall Study|Administrative problems|2
149902|NCT00393458|486704|P3|Overall Study|Administrative problems|5
149903|NCT00393458|486705|P2|Overall Study|Administrative problems|8
149904|NCT00393458|486706|P1|Overall Study|Administrative problems|7
149905|NCT00393458|486703|P4|Overall Study|Protocol deviation|10
149906|NCT00393458|486704|P3|Overall Study|Protocol deviation|11
149907|NCT00393458|486705|P2|Overall Study|Protocol deviation|11
149908|NCT00393458|486706|P1|Overall Study|Protocol deviation|11
149909|NCT00393458|486703|P4|Overall Study|Unsatisfactory therapeutic effect|30
149910|NCT00393458|486704|P3|Overall Study|Unsatisfactory therapeutic effect|12
149911|NCT00393458|486705|P2|Overall Study|Unsatisfactory therapeutic effect|9
149912|NCT00393458|486706|P1|Overall Study|Unsatisfactory therapeutic effect|12
149913|NCT00393458|486703|P4|Overall Study|Subject withdrew consent|50
149914|NCT00393458|486704|P3|Overall Study|Subject withdrew consent|33
149915|NCT00393458|486705|P2|Overall Study|Subject withdrew consent|40
149916|NCT00393458|486706|P1|Overall Study|Subject withdrew consent|27
149917|NCT00393458|486703|P4|Overall Study|Adverse Event|35
149918|NCT00393458|486704|P3|Overall Study|Adverse Event|40
149919|NCT00393458|486705|P2|Overall Study|Adverse Event|24
149920|NCT00393458|486706|P1|Overall Study|Adverse Event|35
149921|NCT00393367|486733|P2|Overall Study|Withdrawal by Subject|2
149922|NCT00393367|486734|P1|Overall Study|Withdrawal by Subject|0
149923|NCT00393367|486733|P2|Overall Study|Protocol Violation|5
149924|NCT00393367|486734|P1|Overall Study|Protocol Violation|2
149925|NCT00393094|486762|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
149926|NCT00393094|486762|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
149927|NCT00393029|486775|P2|Overall Study|Not treated|1
149928|NCT00393029|486776|P1|Overall Study|Not treated|0
149929|NCT00392925|486789|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
149930|NCT00392925|486790|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
149931|NCT00392925|486791|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
149932|NCT00392925|486792|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
149933|NCT00392925|486789|P4|Randomization to Treatment Group Period|Protocol Violation|1
149934|NCT00392925|486790|P3|Randomization to Treatment Group Period|Protocol Violation|2
149935|NCT00392925|486791|P2|Randomization to Treatment Group Period|Protocol Violation|0
149936|NCT00392925|486792|P1|Randomization to Treatment Group Period|Protocol Violation|0
149937|NCT00392925|486789|P4|Randomization to Treatment Group Period|Adverse Event|5
149938|NCT00392925|486790|P3|Randomization to Treatment Group Period|Adverse Event|3
149939|NCT00392925|486791|P2|Randomization to Treatment Group Period|Adverse Event|3
149940|NCT00392925|486792|P1|Randomization to Treatment Group Period|Adverse Event|0
149941|NCT00392925|486789|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
149942|NCT00392925|486790|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
149943|NCT00392925|486791|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
149944|NCT00392925|486792|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
149945|NCT00392925|486789|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
149946|NCT00392925|486790|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
149947|NCT00392925|486791|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
149948|NCT00392925|486792|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
149949|NCT00392925|486789|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
149950|NCT00392925|486790|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
149951|NCT00392925|486791|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
149952|NCT00392925|486792|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
149953|NCT00392925|486789|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
149954|NCT00392925|486790|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
149955|NCT00392925|486791|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
149956|NCT00392925|486792|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
149957|NCT00392925|486789|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
149958|NCT00392925|486790|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
149959|NCT00392925|486791|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
149960|NCT00392925|486792|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
149961|NCT00392925|486789|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
149962|NCT00392925|486790|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
149963|NCT00392925|486791|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
149964|NCT00392925|486792|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
149965|NCT00392808|486906|P4|Overall Study|Unable to withdraw blood|2
149966|NCT00392808|486907|P3|Overall Study|Unable to withdraw blood|1
149967|NCT00392808|486908|P2|Overall Study|Unable to withdraw blood|1
149968|NCT00392808|486909|P1|Overall Study|Unable to withdraw blood|3
149969|NCT00392808|486906|P4|Overall Study|Lost to Follow-up|2
149970|NCT00392808|486907|P3|Overall Study|Lost to Follow-up|1
149971|NCT00392808|486908|P2|Overall Study|Lost to Follow-up|2
149972|NCT00392808|486909|P1|Overall Study|Lost to Follow-up|3
149973|NCT00392769|486933|P1|Overall Study|Adverse Event|1
149974|NCT00392769|486933|P1|Overall Study|Clinical Deterioration|9
149975|NCT00392379|486997|P2|Overall Study|Adverse Event|1
149976|NCT00392379|486998|P1|Overall Study|Adverse Event|1
149977|NCT00392379|486997|P2|Overall Study|Lost to Follow-up|9
149978|NCT00392379|486998|P1|Overall Study|Lost to Follow-up|4
149979|NCT00392379|486997|P2|Overall Study|Withdrawal by Subject|28
149980|NCT00392379|486998|P1|Overall Study|Withdrawal by Subject|17
149981|NCT00392288|487011|P3|Overall Study|Other|1
149982|NCT00392288|487012|P2|Overall Study|Other|4
149983|NCT00392288|487013|P1|Overall Study|Other|3
149984|NCT00392288|487011|P3|Overall Study|Parent/legal guardian withdrawal|1
149985|NCT00392288|487012|P2|Overall Study|Parent/legal guardian withdrawal|2
149986|NCT00392288|487013|P1|Overall Study|Parent/legal guardian withdrawal|1
149987|NCT00392288|487011|P3|Overall Study|Withdrawal by Subject|2
149988|NCT00392288|487012|P2|Overall Study|Withdrawal by Subject|0
149989|NCT00392288|487013|P1|Overall Study|Withdrawal by Subject|1
149990|NCT00392288|487011|P3|Overall Study|Lost to Follow-up|1
149991|NCT00392288|487012|P2|Overall Study|Lost to Follow-up|1
149992|NCT00392288|487013|P1|Overall Study|Lost to Follow-up|1
149993|NCT00392288|487011|P3|Overall Study|Protocol Violation|1
149994|NCT00392288|487012|P2|Overall Study|Protocol Violation|3
149995|NCT00392288|487013|P1|Overall Study|Protocol Violation|1
149996|NCT00392288|487011|P3|Overall Study|Lack of Efficacy|3
149997|NCT00392288|487012|P2|Overall Study|Lack of Efficacy|5
149998|NCT00392288|487013|P1|Overall Study|Lack of Efficacy|8
149999|NCT00392288|487011|P3|Overall Study|Adverse Event|8
150000|NCT00392288|487012|P2|Overall Study|Adverse Event|7
150001|NCT00392288|487013|P1|Overall Study|Adverse Event|17
150002|NCT00392223|487038|P2|Overall Study|Withdrawal by Subject|2
150003|NCT00392223|487039|P1|Overall Study|Withdrawal by Subject|3
150004|NCT00392223|487038|P2|Overall Study|Protocol Violation|3
150005|NCT00392223|487039|P1|Overall Study|Protocol Violation|0
150006|NCT00392223|487038|P2|Overall Study|Lost to Follow-up|4
150007|NCT00392223|487039|P1|Overall Study|Lost to Follow-up|1
150008|NCT00392223|487038|P2|Overall Study|Adverse Event|4
150009|NCT00392223|487039|P1|Overall Study|Adverse Event|5
150010|NCT00392197|487057|P2|Overall Study|Withdrawal by Subject|6
150011|NCT00392197|487058|P1|Overall Study|Withdrawal by Subject|4
150012|NCT00392197|487057|P2|Overall Study|Protocol Violation|5
150013|NCT00392197|487058|P1|Overall Study|Protocol Violation|7
150014|NCT00392197|487057|P2|Overall Study|Physician Decision|2
150015|NCT00392197|487058|P1|Overall Study|Physician Decision|3
150016|NCT00392197|487057|P2|Overall Study|Lost to Follow-up|1
150017|NCT00392197|487058|P1|Overall Study|Lost to Follow-up|0
150018|NCT00392197|487057|P2|Overall Study|Lack of Efficacy|4
150019|NCT00392197|487058|P1|Overall Study|Lack of Efficacy|3
150020|NCT00392197|487057|P2|Overall Study|Adverse Event|12
150021|NCT00392197|487058|P1|Overall Study|Adverse Event|4
150022|NCT00392171|487066|P1|Overall Study|Disease progression|101
150023|NCT00392171|487066|P1|Overall Study|Did not meet inclusion criteria|4
150024|NCT00391976|487077|P3|Overall Study|Positive P. aeruginosa antibody test|31
150025|NCT00391976|487078|P2|Overall Study|Positive P. aeruginosa antibody test|0
150026|NCT00391976|487079|P1|Overall Study|Positive P. aeruginosa antibody test|0
150027|NCT00391976|487077|P3|Overall Study|Unable to classify|1
150028|NCT00391976|487078|P2|Overall Study|Unable to classify|0
150029|NCT00391976|487079|P1|Overall Study|Unable to classify|0
150030|NCT00391976|487077|P3|Overall Study|Recurrence/no eradication of infection|0
150031|NCT00391976|487078|P2|Overall Study|Recurrence/no eradication of infection|19
150032|NCT00391976|487079|P1|Overall Study|Recurrence/no eradication of infection|21
150033|NCT00391976|487077|P3|Overall Study|Protocol deviation/violation|1
150034|NCT00391976|487078|P2|Overall Study|Protocol deviation/violation|2
150035|NCT00391976|487079|P1|Overall Study|Protocol deviation/violation|4
150036|NCT00391976|487077|P3|Overall Study|Inappropriate enrollment|0
150037|NCT00391976|487078|P2|Overall Study|Inappropriate enrollment|1
150038|NCT00391976|487079|P1|Overall Study|Inappropriate enrollment|1
150039|NCT00391976|487077|P3|Overall Study|Lost to Follow-up|0
150040|NCT00391976|487078|P2|Overall Study|Lost to Follow-up|2
150041|NCT00391976|487079|P1|Overall Study|Lost to Follow-up|1
150042|NCT00391976|487077|P3|Overall Study|Withdrawal of consent|1
150043|NCT00391976|487078|P2|Overall Study|Withdrawal of consent|1
150044|NCT00391976|487079|P1|Overall Study|Withdrawal of consent|0
150045|NCT00391976|487077|P3|Overall Study|Adverse Event|1
150046|NCT00391976|487078|P2|Overall Study|Adverse Event|0
150047|NCT00391976|487079|P1|Overall Study|Adverse Event|0
150048|NCT00391898|487103|P2|Overall Study|Other|10
150049|NCT00391898|487104|P1|Overall Study|Other|8
150050|NCT00391898|487103|P2|Overall Study|Adverse Event|0
150051|NCT00391898|487104|P1|Overall Study|Adverse Event|3
150052|NCT00391872|487124|P2|Overall Study|Lost to Follow-up|0
150053|NCT00391872|487125|P1|Overall Study|Lost to Follow-up|2
150054|NCT00391872|487124|P2|Overall Study|Reason unknown|4
150055|NCT00391872|487125|P1|Overall Study|Reason unknown|2
150056|NCT00391872|487124|P2|Overall Study|Withdrawal by Subject|249
150057|NCT00391872|487125|P1|Overall Study|Withdrawal by Subject|296
150058|NCT00391872|487124|P2|Overall Study|Protocol Violation|2
150059|NCT00391872|487125|P1|Overall Study|Protocol Violation|7
150060|NCT00391846|487163|P2|Overall Study|Developed study specific DC criteria|1
150061|NCT00391846|487164|P1|Overall Study|Developed study specific DC criteria|0
150062|NCT00391846|487163|P2|Overall Study|Withdrawal by Subject|3
150063|NCT00391846|487164|P1|Overall Study|Withdrawal by Subject|2
150064|NCT00391846|487163|P2|Overall Study|Did not meet the required elig. crit|2
150065|NCT00391846|487164|P1|Overall Study|Did not meet the required elig. crit|2
150066|NCT00391846|487163|P2|Overall Study|Adverse Event|1
150067|NCT00391846|487164|P1|Overall Study|Adverse Event|4
150068|NCT00391807|487184|P1|Overall Study|Various|96
150069|NCT00391807|487184|P1|Overall Study|Protocol Violation|20
150070|NCT00391807|487184|P1|Overall Study|Withdrawal by Subject|147
150071|NCT00391807|487184|P1|Overall Study|Lost to Follow-up|227
150072|NCT00391807|487184|P1|Overall Study|Pregnancy|25
150073|NCT00391807|487184|P1|Overall Study|Adverse Event|177
150074|NCT00391807|487184|P1|Overall Study|Did not receive study medication|23
150075|NCT00391768|487211|P7|Overall Study|Lost to Follow-up|3
150076|NCT00391768|487212|P6|Overall Study|Lost to Follow-up|2
150077|NCT00391768|487213|P5|Overall Study|Lost to Follow-up|2
150078|NCT00391768|487214|P4|Overall Study|Lost to Follow-up|1
150079|NCT00391768|487215|P3|Overall Study|Lost to Follow-up|0
150080|NCT00391768|487216|P2|Overall Study|Lost to Follow-up|0
150081|NCT00391768|487217|P1|Overall Study|Lost to Follow-up|0
150082|NCT00391768|487211|P7|Overall Study|Withdrawal by Subject|1
150083|NCT00391768|487212|P6|Overall Study|Withdrawal by Subject|1
150084|NCT00391768|487213|P5|Overall Study|Withdrawal by Subject|0
150085|NCT00391768|487214|P4|Overall Study|Withdrawal by Subject|0
150086|NCT00391768|487215|P3|Overall Study|Withdrawal by Subject|1
150087|NCT00391768|487216|P2|Overall Study|Withdrawal by Subject|0
150088|NCT00391768|487217|P1|Overall Study|Withdrawal by Subject|0
150089|NCT00391625|487304|P1|Month 50|Physician Decision|1
150090|NCT00391625|487304|P1|Month 14|Withdrawal by Subject|1
150091|NCT00391586|487357|P1|Overall Study|Death|4
150092|NCT00391586|487357|P1|Overall Study|Physician Decision|2
150093|NCT00391586|487357|P1|Overall Study|Adverse Event|5
150094|NCT00391586|487357|P1|Overall Study|Progressive disease|13
150095|NCT00391391|487394|P4|Overall Study|Withdrawal by Subject|7
150096|NCT00391391|487395|P3|Overall Study|Withdrawal by Subject|10
150097|NCT00391391|487396|P2|Overall Study|Withdrawal by Subject|4
150098|NCT00391391|487397|P1|Overall Study|Withdrawal by Subject|6
150099|NCT00391391|487394|P4|Overall Study|Protocol Violation|7
150100|NCT00391391|487395|P3|Overall Study|Protocol Violation|6
150101|NCT00391391|487396|P2|Overall Study|Protocol Violation|3
150102|NCT00391391|487397|P1|Overall Study|Protocol Violation|2
150103|NCT00391391|487394|P4|Overall Study|Lost to Follow-up|4
150104|NCT00391391|487395|P3|Overall Study|Lost to Follow-up|7
150105|NCT00391391|487396|P2|Overall Study|Lost to Follow-up|3
150106|NCT00391391|487397|P1|Overall Study|Lost to Follow-up|1
150107|NCT00391391|487394|P4|Overall Study|Adverse Event|1
150108|NCT00391391|487395|P3|Overall Study|Adverse Event|0
150109|NCT00391391|487396|P2|Overall Study|Adverse Event|0
150110|NCT00391391|487397|P1|Overall Study|Adverse Event|0
150111|NCT00391274|487442|P2|Overall Study|Death Not Study Related|1
150112|NCT00391274|487443|P1|Overall Study|Death Not Study Related|0
150113|NCT00391274|487442|P2|Overall Study|Death Due to Indeterminate Cause|0
150114|NCT00391274|487443|P1|Overall Study|Death Due to Indeterminate Cause|1
150115|NCT00391274|487442|P2|Overall Study|Death Due to Adverse Event|3
150116|NCT00391274|487443|P1|Overall Study|Death Due to Adverse Event|1
150117|NCT00391274|487442|P2|Overall Study|Withdrawal by Subject|3
150118|NCT00391274|487443|P1|Overall Study|Withdrawal by Subject|0
150119|NCT00391274|487442|P2|Overall Study|Physician Decision|2
150120|NCT00391274|487443|P1|Overall Study|Physician Decision|4
150121|NCT00391274|487442|P2|Overall Study|Lost to Follow-up|3
150122|NCT00391274|487443|P1|Overall Study|Lost to Follow-up|0
150123|NCT00391274|487442|P2|Overall Study|Death Due to Study Disease|45
150124|NCT00391274|487443|P1|Overall Study|Death Due to Study Disease|55
150125|NCT00391222|487462|P4|Period III (Double-Blind Treatment)|Other|0
150126|NCT00391222|487463|P3|Period III (Double-Blind Treatment)|Other|6
150127|NCT00391222|487464|P2|Period III (Double-Blind Treatment)|Other|1
150128|NCT00391222|487465|P1|Period III (Double-Blind Treatment)|Other|6
150129|NCT00391222|487462|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
150130|NCT00391222|487463|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
150213|NCT00390806|487633|P2|Overall Study|Death|0
150131|NCT00391222|487464|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
150132|NCT00391222|487465|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
150133|NCT00391222|487462|P4|Period III (Double-Blind Treatment)|Pregnancy|0
150134|NCT00391222|487463|P3|Period III (Double-Blind Treatment)|Pregnancy|0
150135|NCT00391222|487464|P2|Period III (Double-Blind Treatment)|Pregnancy|2
150136|NCT00391222|487465|P1|Period III (Double-Blind Treatment)|Pregnancy|0
150137|NCT00391222|487462|P4|Period III (Double-Blind Treatment)|Adverse Event|0
150138|NCT00391222|487463|P3|Period III (Double-Blind Treatment)|Adverse Event|4
150139|NCT00391222|487464|P2|Period III (Double-Blind Treatment)|Adverse Event|2
150140|NCT00391222|487465|P1|Period III (Double-Blind Treatment)|Adverse Event|5
150141|NCT00391222|487462|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
150142|NCT00391222|487463|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
150143|NCT00391222|487464|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
150144|NCT00391222|487465|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
150145|NCT00391222|487462|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
150146|NCT00391222|487463|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
150147|NCT00391222|487464|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
150148|NCT00391222|487465|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
150149|NCT00391222|487462|P4|Period II (Open-label Risperidone LAI)|Other|24
150150|NCT00391222|487463|P3|Period II (Open-label Risperidone LAI)|Other|0
150151|NCT00391222|487464|P2|Period II (Open-label Risperidone LAI)|Other|0
150152|NCT00391222|487465|P1|Period II (Open-label Risperidone LAI)|Other|0
150153|NCT00391222|487462|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
150154|NCT00391222|487463|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
150155|NCT00391222|487464|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
150156|NCT00391222|487465|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
150157|NCT00391222|487462|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
150158|NCT00391222|487463|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
150159|NCT00391222|487464|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
150160|NCT00391222|487465|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
150161|NCT00391222|487462|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
150162|NCT00391222|487463|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
150163|NCT00391222|487464|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
150164|NCT00391222|487465|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
150165|NCT00391222|487462|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
150166|NCT00391222|487463|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
150167|NCT00391222|487464|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
150168|NCT00391222|487465|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
150169|NCT00391092|487491|P2|Overall Study|Alive in follow-up|84
150170|NCT00391092|487492|P1|Overall Study|Alive in follow-up|88
150171|NCT00391092|487491|P2|Overall Study|Alive on treatment|33
150172|NCT00391092|487492|P1|Overall Study|Alive on treatment|29
150173|NCT00391092|487491|P2|Overall Study|Lost to Follow-up|18
150174|NCT00391092|487492|P1|Overall Study|Lost to Follow-up|13
150175|NCT00391092|487491|P2|Overall Study|Death|81
150176|NCT00391092|487492|P1|Overall Study|Death|78
150177|NCT00391053|487535|P4|Overall Study|Withdrawal by Subject|1
150178|NCT00391053|487536|P3|Overall Study|Withdrawal by Subject|1
150179|NCT00391053|487537|P2|Overall Study|Withdrawal by Subject|1
150180|NCT00391053|487538|P1|Overall Study|Withdrawal by Subject|5
150181|NCT00391053|487535|P4|Overall Study|Lost to Follow-up|5
150182|NCT00391053|487536|P3|Overall Study|Lost to Follow-up|0
150183|NCT00391053|487537|P2|Overall Study|Lost to Follow-up|0
150184|NCT00391053|487538|P1|Overall Study|Lost to Follow-up|1
150185|NCT00391053|487535|P4|Overall Study|Protocol Violation|0
150186|NCT00391053|487536|P3|Overall Study|Protocol Violation|0
150187|NCT00391053|487537|P2|Overall Study|Protocol Violation|0
150188|NCT00391053|487538|P1|Overall Study|Protocol Violation|2
150189|NCT00391053|487535|P4|Overall Study|Serious Adverse Events|4
150190|NCT00391053|487536|P3|Overall Study|Serious Adverse Events|1
150191|NCT00391053|487537|P2|Overall Study|Serious Adverse Events|0
150192|NCT00391053|487538|P1|Overall Study|Serious Adverse Events|1
150193|NCT00391027|487562|P2|Overall Study|Other|3
150194|NCT00391027|487563|P1|Overall Study|Other|4
150195|NCT00391027|487562|P2|Overall Study|Withdrawal by Subject|1
150196|NCT00391027|487563|P1|Overall Study|Withdrawal by Subject|10
150197|NCT00391027|487562|P2|Overall Study|Lack of Efficacy|0
150198|NCT00391027|487563|P1|Overall Study|Lack of Efficacy|3
150199|NCT00391027|487562|P2|Overall Study|Adverse Event|8
150200|NCT00391027|487563|P1|Overall Study|Adverse Event|8
150201|NCT00390884|487603|P2|Overall Study|Withdrawal by Subject|2
150202|NCT00390884|487604|P1|Overall Study|Withdrawal by Subject|2
150203|NCT00390858|487616|P2|Overall Study|Withdrawal by Subject|4
150204|NCT00390858|487617|P1|Overall Study|Withdrawal by Subject|3
150205|NCT00390858|487616|P2|Overall Study|Lack of Efficacy|1
150206|NCT00390858|487617|P1|Overall Study|Lack of Efficacy|0
150207|NCT00390858|487616|P2|Overall Study|Adverse Event|2
150208|NCT00390858|487617|P1|Overall Study|Adverse Event|6
150209|NCT00390806|487633|P2|Overall Study|Ongoing|2
150210|NCT00390806|487634|P1|Overall Study|Ongoing|4
150211|NCT00390806|487633|P2|Overall Study|Physician Decision|1
150212|NCT00390806|487634|P1|Overall Study|Physician Decision|0
150214|NCT00390806|487634|P1|Overall Study|Death|1
150215|NCT00390806|487633|P2|Overall Study|Investigator Decision|6
150216|NCT00390806|487634|P1|Overall Study|Investigator Decision|4
150217|NCT00390806|487633|P2|Overall Study|Withdrawal by Subject|15
150218|NCT00390806|487634|P1|Overall Study|Withdrawal by Subject|12
150219|NCT00390806|487633|P2|Overall Study|Protocol Violation|2
150220|NCT00390806|487634|P1|Overall Study|Protocol Violation|2
150221|NCT00390806|487633|P2|Overall Study|Lost to Follow-up|6
150222|NCT00390806|487634|P1|Overall Study|Lost to Follow-up|7
150223|NCT00390780|487702|P2|Overall Study|SAE, death|1
150224|NCT00390780|487703|P1|Overall Study|SAE, death|0
150225|NCT00390780|487702|P2|Overall Study|Investigator decision, SAE, other reason|1
150226|NCT00390780|487703|P1|Overall Study|Investigator decision, SAE, other reason|0
150227|NCT00390780|487702|P2|Overall Study|Lost to follow up and other reasons|1
150228|NCT00390780|487703|P1|Overall Study|Lost to follow up and other reasons|0
150229|NCT00390780|487702|P2|Overall Study|Inclusion criteria not satisfied|2
150230|NCT00390780|487703|P1|Overall Study|Inclusion criteria not satisfied|0
150231|NCT00390780|487702|P2|Overall Study|Withdrawal by Subject|2
150232|NCT00390780|487703|P1|Overall Study|Withdrawal by Subject|1
150233|NCT00390780|487702|P2|Overall Study|Death|3
150234|NCT00390780|487703|P1|Overall Study|Death|1
150235|NCT00390780|487702|P2|Overall Study|Adverse Event|3
150236|NCT00390780|487703|P1|Overall Study|Adverse Event|2
150237|NCT00390780|487702|P2|Overall Study|Lost to Follow-up|6
150238|NCT00390780|487703|P1|Overall Study|Lost to Follow-up|3
150239|NCT00390780|487702|P2|Overall Study|Protocol Violation|4
150240|NCT00390780|487703|P1|Overall Study|Protocol Violation|6
150241|NCT00390780|487702|P2|Overall Study|Not completed|4
150242|NCT00390780|487703|P1|Overall Study|Not completed|10
150243|NCT00390689|487736|P3|Overall Study|Investigator's judgement|0
150244|NCT00390689|487737|P2|Overall Study|Investigator's judgement|0
150245|NCT00390689|487738|P1|Overall Study|Investigator's judgement|2
150246|NCT00390689|487736|P3|Overall Study|Protocol Violation|0
150247|NCT00390689|487737|P2|Overall Study|Protocol Violation|0
150248|NCT00390689|487738|P1|Overall Study|Protocol Violation|1
150249|NCT00390689|487736|P3|Overall Study|Lack of Efficacy|1
150250|NCT00390689|487737|P2|Overall Study|Lack of Efficacy|0
150251|NCT00390689|487738|P1|Overall Study|Lack of Efficacy|0
150252|NCT00390689|487736|P3|Overall Study|Adverse Event|2
150253|NCT00390689|487737|P2|Overall Study|Adverse Event|5
150254|NCT00390689|487738|P1|Overall Study|Adverse Event|2
150255|NCT00390572|487813|P2|Overall Study|health condition|1
150256|NCT00390572|487814|P1|Overall Study|health condition|0
150257|NCT00390572|487813|P2|Overall Study|Lost to Follow-up|4
150258|NCT00390572|487814|P1|Overall Study|Lost to Follow-up|8
150259|NCT00390546|487840|P2|Overall Study|Physician Decision|5
150260|NCT00390546|487841|P1|Overall Study|Physician Decision|5
150261|NCT00390546|487840|P2|Overall Study|Renal impairment|0
150262|NCT00390546|487841|P1|Overall Study|Renal impairment|1
150263|NCT00390468|487851|P1|Overall Study|Lack of Efficacy|1
150264|NCT00390468|487851|P1|Overall Study|Protocol Violation|2
150265|NCT00390455|487857|P2|Overall Study|Other Medical Reasons|11
150266|NCT00390455|487858|P1|Overall Study|Other Medical Reasons|7
150267|NCT00390455|487857|P2|Overall Study|Alternate Treatment|1
150268|NCT00390455|487858|P1|Overall Study|Alternate Treatment|0
150269|NCT00390455|487857|P2|Overall Study|Withdrawal by Subject|8
150270|NCT00390455|487858|P1|Overall Study|Withdrawal by Subject|8
150271|NCT00390455|487857|P2|Overall Study|Adverse Event|3
150272|NCT00390455|487858|P1|Overall Study|Adverse Event|17
150273|NCT00390416|487876|P1|Overall Study|Not treated|3
150274|NCT00390416|487876|P1|Overall Study|Withdrawal by Subject|1
150275|NCT00390221|487897|P3|Overall Study|Not Specified|2
150276|NCT00390221|487898|P2|Overall Study|Not Specified|4
150277|NCT00390221|487899|P1|Overall Study|Not Specified|3
150278|NCT00390221|487897|P3|Overall Study|Subject Non-compliance|2
150279|NCT00390221|487898|P2|Overall Study|Subject Non-compliance|0
150280|NCT00390221|487899|P1|Overall Study|Subject Non-compliance|1
150281|NCT00390221|487897|P3|Overall Study|Withdrawal by Subject|7
150282|NCT00390221|487898|P2|Overall Study|Withdrawal by Subject|9
150283|NCT00390221|487899|P1|Overall Study|Withdrawal by Subject|13
150284|NCT00390221|487897|P3|Overall Study|Investigator Decision|1
150285|NCT00390221|487898|P2|Overall Study|Investigator Decision|0
150286|NCT00390221|487899|P1|Overall Study|Investigator Decision|0
150287|NCT00390221|487897|P3|Overall Study|Adverse Event|3
150288|NCT00390221|487898|P2|Overall Study|Adverse Event|4
150289|NCT00390221|487899|P1|Overall Study|Adverse Event|1
150290|NCT00390221|487897|P3|Overall Study|Lost to Follow-up|0
150291|NCT00390221|487898|P2|Overall Study|Lost to Follow-up|3
150292|NCT00390221|487899|P1|Overall Study|Lost to Follow-up|0
150293|NCT00389831|487945|P2|Overall Study|Lost to Follow-up|1
150294|NCT00389831|487946|P1|Overall Study|Lost to Follow-up|0
150295|NCT00389831|487945|P2|Overall Study|Other reasons|2
150296|NCT00389831|487946|P1|Overall Study|Other reasons|0
150297|NCT00389831|487945|P2|Overall Study|Did not receive treatment.|2
150298|NCT00389831|487946|P1|Overall Study|Did not receive treatment.|0
150299|NCT00389831|487945|P2|Overall Study|Lack of Efficacy|2
150300|NCT00389831|487946|P1|Overall Study|Lack of Efficacy|0
150301|NCT00389597|487980|P4|Overall Study|Lost to Follow-up|6
150302|NCT00389597|487981|P3|Overall Study|Lost to Follow-up|4
150303|NCT00389597|487982|P2|Overall Study|Lost to Follow-up|6
150304|NCT00389597|487983|P1|Overall Study|Lost to Follow-up|8
150305|NCT00389519|488008|P4|Treated|Reason not specified|2
150306|NCT00389519|488009|P3|Treated|Reason not specified|0
150307|NCT00389519|488010|P2|Treated|Reason not specified|1
150308|NCT00389519|488011|P1|Treated|Reason not specified|1
150309|NCT00389519|488008|P4|Treated|Adverse Event|2
150310|NCT00389519|488009|P3|Treated|Adverse Event|0
150311|NCT00389519|488010|P2|Treated|Adverse Event|0
150312|NCT00389519|488011|P1|Treated|Adverse Event|1
150313|NCT00389519|488008|P4|Randomized|Did not receive study drug|0
150314|NCT00389519|488009|P3|Randomized|Did not receive study drug|0
150315|NCT00389519|488010|P2|Randomized|Did not receive study drug|0
150316|NCT00389519|488011|P1|Randomized|Did not receive study drug|2
150317|NCT00389519|488008|P4|Placebo Run-In|Reason not specified|0
150318|NCT00389519|488009|P3|Placebo Run-In|Reason not specified|0
150319|NCT00389519|488010|P2|Placebo Run-In|Reason not specified|0
150320|NCT00389519|488011|P1|Placebo Run-In|Reason not specified|40
150321|NCT00389519|488008|P4|Placebo Run-In|Withdrawal by Subject|0
150322|NCT00389519|488009|P3|Placebo Run-In|Withdrawal by Subject|0
150323|NCT00389519|488010|P2|Placebo Run-In|Withdrawal by Subject|0
150324|NCT00389519|488011|P1|Placebo Run-In|Withdrawal by Subject|19
150325|NCT00389519|488008|P4|Placebo Run-In|Did not meet blood pressure criteria|0
150326|NCT00389519|488009|P3|Placebo Run-In|Did not meet blood pressure criteria|0
150327|NCT00389519|488010|P2|Placebo Run-In|Did not meet blood pressure criteria|0
150328|NCT00389519|488011|P1|Placebo Run-In|Did not meet blood pressure criteria|119
150329|NCT00389441|488088|P1|Overall Study|Clinical progression|1
150330|NCT00389441|488088|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
150331|NCT00389441|488088|P1|Overall Study|Objective progression or relapse|26
150332|NCT00389441|488088|P1|Overall Study|Global deterioration of health status|4
150333|NCT00389441|488088|P1|Overall Study|Protocol Violation|1
150334|NCT00389441|488088|P1|Overall Study|Physician Decision|1
150335|NCT00389441|488088|P1|Overall Study|Withdrawal by Subject|4
150336|NCT00389441|488088|P1|Overall Study|Lost to Follow-up|2
150337|NCT00389441|488088|P1|Overall Study|Death|4
150338|NCT00389441|488088|P1|Overall Study|Adverse Event|7
150339|NCT00389324|488097|P1|Subcutaneous Phase|Lost to Follow-up|1
150340|NCT00389324|488097|P1|Subcutaneous Phase|Withdrawal by Subject|2
150341|NCT00389324|488097|P1|Subcutaneous Phase|Non-compliance with study medication|2
150342|NCT00389324|488097|P1|Subcutaneous Phase|Adverse Event|2
150343|NCT00389324|488097|P1|Run-In Phase|Withdrawal by Subject|1
150344|NCT00389324|488097|P1|Run-In Phase|Lost to Follow-up|1
150345|NCT00389324|488097|P1|Run-In Phase|Adverse Event|1
150346|NCT00389207|488107|P3|Overall Study|Not specified|9
150347|NCT00389207|488108|P2|Overall Study|Not specified|23
150348|NCT00389207|488109|P1|Overall Study|Not specified|17
150349|NCT00389207|488107|P3|Overall Study|Withdrawal by Subject|11
150350|NCT00389207|488108|P2|Overall Study|Withdrawal by Subject|7
150351|NCT00389207|488109|P1|Overall Study|Withdrawal by Subject|5
150352|NCT00389207|488107|P3|Overall Study|Lost to Follow-up|7
150353|NCT00389207|488108|P2|Overall Study|Lost to Follow-up|9
150354|NCT00389207|488109|P1|Overall Study|Lost to Follow-up|12
150355|NCT00389207|488107|P3|Overall Study|Protocol Violation|4
150356|NCT00389207|488108|P2|Overall Study|Protocol Violation|1
150357|NCT00389207|488109|P1|Overall Study|Protocol Violation|3
150358|NCT00389207|488107|P3|Overall Study|Adverse Event|10
150359|NCT00389207|488108|P2|Overall Study|Adverse Event|32
150360|NCT00389207|488109|P1|Overall Study|Adverse Event|26
150361|NCT00389064|488232|P2|Overall Study|Multiple Reasons|11
150362|NCT00389064|488233|P1|Overall Study|Multiple Reasons|9
150363|NCT00389064|488232|P2|Overall Study|Protocol Violation|0
150364|NCT00389064|488233|P1|Overall Study|Protocol Violation|2
150365|NCT00389064|488232|P2|Overall Study|Lost to Follow-up|2
150366|NCT00389064|488233|P1|Overall Study|Lost to Follow-up|1
150367|NCT00389064|488232|P2|Overall Study|Physician Decision|2
150368|NCT00389064|488233|P1|Overall Study|Physician Decision|2
150369|NCT00389064|488232|P2|Overall Study|Withdrawal by Subject|27
150370|NCT00389064|488233|P1|Overall Study|Withdrawal by Subject|17
150371|NCT00389064|488232|P2|Overall Study|Lack of Efficacy|14
150372|NCT00389064|488233|P1|Overall Study|Lack of Efficacy|3
150373|NCT00389064|488232|P2|Overall Study|Adverse Event|3
150374|NCT00389064|488233|P1|Overall Study|Adverse Event|11
150375|NCT00388973|488261|P2|Overall Study|Did not complete 2-week follow-up visit|17
150376|NCT00388973|488262|P1|Overall Study|Did not complete 2-week follow-up visit|17
150377|NCT00388973|488261|P2|Overall Study|Left region|1
150378|NCT00388973|488262|P1|Overall Study|Left region|0
150379|NCT00388973|488261|P2|Overall Study|Did not complete 61 days of treatment|4
150380|NCT00388973|488262|P1|Overall Study|Did not complete 61 days of treatment|5
150381|NCT00388973|488261|P2|Overall Study|Study specific Discontinuation Criteria|1
150382|NCT00388973|488262|P1|Overall Study|Study specific Discontinuation Criteria|0
150383|NCT00388973|488261|P2|Overall Study|Withdrawal by Subject|17
150384|NCT00388973|488262|P1|Overall Study|Withdrawal by Subject|14
150385|NCT00388973|488261|P2|Overall Study|Protocol Violation|0
150386|NCT00388973|488262|P1|Overall Study|Protocol Violation|3
150387|NCT00388973|488261|P2|Overall Study|Lack of Efficacy|12
150388|NCT00388973|488262|P1|Overall Study|Lack of Efficacy|1
150389|NCT00388973|488261|P2|Overall Study|Adverse Event|6
150390|NCT00388973|488262|P1|Overall Study|Adverse Event|16
150391|NCT00388947|488282|P1|Overall Study|Protocol Violation|47
150392|NCT00388037|488296|P1|Overall Study|Protocol Violation|1
150393|NCT00387153|488300|P1|Overall Study|Lack of Response|4
150394|NCT00387153|488300|P1|Overall Study|Disease Progression|3
150395|NCT00387153|488300|P1|Overall Study|Adverse Event|1
150396|NCT00388726|488306|P2|Overall Study|Death|2
150397|NCT00388726|488307|P1|Overall Study|Death|3
150398|NCT00388726|488306|P2|Overall Study|Physician Decision|13
150399|NCT00388726|488307|P1|Overall Study|Physician Decision|18
150400|NCT00388726|488306|P2|Overall Study|Administrative|9
150401|NCT00388726|488307|P1|Overall Study|Administrative|6
150402|NCT00388726|488306|P2|Overall Study|Withdrawal by Subject|7
150403|NCT00388726|488307|P1|Overall Study|Withdrawal by Subject|10
150404|NCT00388726|488306|P2|Overall Study|Clinical Progression|36
150405|NCT00388726|488307|P1|Overall Study|Clinical Progression|61
150406|NCT00388726|488306|P2|Overall Study|Progressive Disease|153
150407|NCT00388726|488307|P1|Overall Study|Progressive Disease|336
150408|NCT00388726|488306|P2|Overall Study|Adverse Event|24
150409|NCT00388726|488307|P1|Overall Study|Adverse Event|50
150410|NCT00388583|488321|P2|Overall Study|Did not receive vaccine|1
150411|NCT00388583|488322|P1|Overall Study|Did not receive vaccine|0
150412|NCT00388583|488321|P2|Overall Study|Serious Adverse Event|0
150413|NCT00388583|488322|P1|Overall Study|Serious Adverse Event|2
150414|NCT00388583|488321|P2|Overall Study|Withdrawal by Subject|3
150415|NCT00388583|488322|P1|Overall Study|Withdrawal by Subject|3
150416|NCT00388583|488321|P2|Overall Study|Protocol Violation|0
150417|NCT00388583|488322|P1|Overall Study|Protocol Violation|1
150418|NCT00388505|488336|P2|Overall Study|Unable to classify|3
150419|NCT00388505|488337|P1|Overall Study|Unable to classify|4
150420|NCT00388505|488336|P2|Overall Study|Protocol Violation|5
150421|NCT00388505|488337|P1|Overall Study|Protocol Violation|6
150422|NCT00388505|488336|P2|Overall Study|Administrative Reason|0
150423|NCT00388505|488337|P1|Overall Study|Administrative Reason|1
150424|NCT00388505|488336|P2|Overall Study|Inappropriate Enrollment|1
150425|NCT00388505|488337|P1|Overall Study|Inappropriate Enrollment|0
150426|NCT00388505|488336|P2|Overall Study|Lost to Follow-up|3
150427|NCT00388505|488337|P1|Overall Study|Lost to Follow-up|5
150428|NCT00388505|488336|P2|Overall Study|Withdrawal by Subject|9
150429|NCT00388505|488337|P1|Overall Study|Withdrawal by Subject|24
150430|NCT00388505|488336|P2|Overall Study|Adverse Event or Death|17
150431|NCT00388505|488337|P1|Overall Study|Adverse Event or Death|43
150432|NCT00388154|488359|P1|Overall Study|Withdrawal by Subject|1
150433|NCT00387894|488368|P1|Overall Study|Withdrawal by Subject|1
150434|NCT00387881|488375|P2|Overall Study|Not otherwise specified|7
150435|NCT00387881|488376|P1|Overall Study|Not otherwise specified|11
150436|NCT00387881|488375|P2|Overall Study|No opportunity to treat headache|34
150437|NCT00387881|488376|P1|Overall Study|No opportunity to treat headache|32
150438|NCT00387881|488375|P2|Overall Study|Not eligible|7
150439|NCT00387881|488376|P1|Overall Study|Not eligible|6
150440|NCT00387881|488375|P2|Overall Study|Sponsor terminated Study|1
150441|NCT00387881|488376|P1|Overall Study|Sponsor terminated Study|0
150442|NCT00387881|488375|P2|Overall Study|Withdrawal by Subject|18
150443|NCT00387881|488376|P1|Overall Study|Withdrawal by Subject|15
150444|NCT00387881|488375|P2|Overall Study|Protocol Violation|12
150445|NCT00387881|488376|P1|Overall Study|Protocol Violation|2
150446|NCT00387881|488375|P2|Overall Study|Lost to Follow-up|23
150447|NCT00387881|488376|P1|Overall Study|Lost to Follow-up|23
150448|NCT00387790|488409|P1|Overall Study|Ineligible for study|2
150449|NCT00387790|488409|P1|Overall Study|Withdrawal by Subject|3
150450|NCT00387790|488409|P1|Overall Study|Physician Decision|2
150451|NCT00387790|488409|P1|Overall Study|Lack of Efficacy|2
150452|NCT00387790|488409|P1|Overall Study|Adverse Event|5
150453|NCT00387764|488413|P1|Overall Study|Death|7
150454|NCT00387764|488413|P1|Overall Study|Other|2
150455|NCT00387764|488413|P1|Overall Study|Physician Decision|1
150456|NCT00387764|488413|P1|Overall Study|Sponsor Terminated Study|1
150457|NCT00387764|488413|P1|Overall Study|Withdrawal by Subject|8
150458|NCT00387764|488413|P1|Overall Study|Adverse Event|12
150459|NCT00387725|488439|P4|Overall Study|Parent/legal guardian request|1
150460|NCT00387725|488440|P3|Overall Study|Parent/legal guardian request|1
150461|NCT00387725|488441|P2|Overall Study|Parent/legal guardian request|0
150462|NCT00387725|488442|P1|Overall Study|Parent/legal guardian request|0
150463|NCT00387725|488439|P4|Overall Study|Withdrawal by Subject|0
150464|NCT00387725|488440|P3|Overall Study|Withdrawal by Subject|1
150465|NCT00387725|488441|P2|Overall Study|Withdrawal by Subject|0
150466|NCT00387725|488442|P1|Overall Study|Withdrawal by Subject|1
150467|NCT00387725|488439|P4|Overall Study|Protocol Violation|0
150468|NCT00387725|488440|P3|Overall Study|Protocol Violation|0
150469|NCT00387725|488441|P2|Overall Study|Protocol Violation|1
150470|NCT00387725|488442|P1|Overall Study|Protocol Violation|0
150471|NCT00387725|488439|P4|Overall Study|Adverse Event|1
150472|NCT00387725|488440|P3|Overall Study|Adverse Event|0
150473|NCT00387725|488441|P2|Overall Study|Adverse Event|0
150474|NCT00387725|488442|P1|Overall Study|Adverse Event|0
150475|NCT00387647|488460|P1|Overall Study|Death|18
150476|NCT00387426|488500|P1|Overall Study|Disease Progression|3
150477|NCT00387426|488500|P1|Overall Study|Toxicities|4
150478|NCT00387426|488500|P1|Overall Study|Lack of Response|7
150479|NCT00387348|488507|P3|Overall Study|Adverse Event|1
150480|NCT00387348|488508|P2|Overall Study|Adverse Event|0
150481|NCT00387348|488509|P1|Overall Study|Adverse Event|1
150482|NCT00387348|488507|P3|Overall Study|Withdrawal by Subject|2
150483|NCT00387348|488508|P2|Overall Study|Withdrawal by Subject|2
150484|NCT00387348|488509|P1|Overall Study|Withdrawal by Subject|0
150485|NCT00387348|488507|P3|Overall Study|Physician Decision|1
150486|NCT00387348|488508|P2|Overall Study|Physician Decision|0
150487|NCT00387348|488509|P1|Overall Study|Physician Decision|1
150488|NCT00387348|488507|P3|Overall Study|Death|0
150489|NCT00387348|488508|P2|Overall Study|Death|1
150490|NCT00387348|488509|P1|Overall Study|Death|1
150491|NCT00387127|488540|P2|Overall Study|Sponsor Unblinded|0
150492|NCT00387127|488541|P1|Overall Study|Sponsor Unblinded|1
150493|NCT00387127|488540|P2|Overall Study|Serious Adverse Event|1
150494|NCT00387127|488541|P1|Overall Study|Serious Adverse Event|1
150495|NCT00387127|488540|P2|Overall Study|Required by Protocol Amendment #4|10
150496|NCT00387127|488541|P1|Overall Study|Required by Protocol Amendment #4|12
150497|NCT00387127|488540|P2|Overall Study|Withdrawal by Subject|2
150498|NCT00387127|488541|P1|Overall Study|Withdrawal by Subject|3
150499|NCT00387127|488540|P2|Overall Study|Physician Decision|1
150500|NCT00387127|488541|P1|Overall Study|Physician Decision|0
150501|NCT00387127|488540|P2|Overall Study|Death|16
150502|NCT00387127|488541|P1|Overall Study|Death|16
150503|NCT00387127|488540|P2|Overall Study|Lost to Follow-up|4
150504|NCT00387127|488541|P1|Overall Study|Lost to Follow-up|0
150505|NCT00387088|488583|P2|Overall Study|Other|52
150506|NCT00387088|488584|P1|Overall Study|Other|58
150507|NCT00387088|488583|P2|Overall Study|Lost to Follow-up|28
150508|NCT00387088|488584|P1|Overall Study|Lost to Follow-up|22
150509|NCT00387088|488583|P2|Overall Study|Lack of Efficacy|67
150510|NCT00387088|488584|P1|Overall Study|Lack of Efficacy|28
150511|NCT00387088|488583|P2|Overall Study|Withdrawal by Subject|35
150512|NCT00387088|488584|P1|Overall Study|Withdrawal by Subject|20
150513|NCT00387088|488583|P2|Overall Study|Protocol Violation|35
150514|NCT00387088|488584|P1|Overall Study|Protocol Violation|47
150515|NCT00387088|488583|P2|Overall Study|Adverse Event|156
150516|NCT00387088|488584|P1|Overall Study|Adverse Event|143
150517|NCT00387010|488641|P1|Treatment Period|Participant reported study drug stolen|1
150518|NCT00387010|488641|P1|Treatment Period|Noncompliance with study procedures|3
150519|NCT00387010|488641|P1|Treatment Period|Noncompliance with study medication|2
150520|NCT00387010|488641|P1|Treatment Period|Withdrawal by Subject|1
150521|NCT00387010|488641|P1|Treatment Period|Adverse Event|4
150522|NCT00387010|488641|P1|Dose Titration Period|Noncompliance with study procedures|7
150523|NCT00387010|488641|P1|Dose Titration Period|Noncompliance with study medication|8
150524|NCT00387010|488641|P1|Dose Titration Period|Lost to Follow-up|2
150525|NCT00387010|488641|P1|Dose Titration Period|Protocol Violation|1
150526|NCT00387010|488641|P1|Dose Titration Period|Withdrawal by Subject|3
150527|NCT00387010|488641|P1|Dose Titration Period|Lack of Efficacy|5
150528|NCT00387010|488641|P1|Dose Titration Period|Adverse Event|12
150529|NCT00386776|488668|P1|Overall Study|Withdrawal by Subject|8
150530|NCT00386607|488678|P2|Extension|Unsatisfactory therapeutic effect|1
150531|NCT00386607|488679|P1|Extension|Unsatisfactory therapeutic effect|0
150532|NCT00386607|488678|P2|Extension|Patient withdrew consent|5
150533|NCT00386607|488679|P1|Extension|Patient withdrew consent|0
150534|NCT00386607|488678|P2|Extension|Lost to Follow-up|3
150535|NCT00386607|488679|P1|Extension|Lost to Follow-up|0
150536|NCT00386607|488678|P2|Extension|Administrative problems|1
150537|NCT00386607|488679|P1|Extension|Administrative problems|0
150538|NCT00386607|488678|P2|Extension|Abnormal laboratory value(s)|1
150539|NCT00386607|488679|P1|Extension|Abnormal laboratory value(s)|0
150540|NCT00386607|488678|P2|Extension|Adverse Event|6
150541|NCT00386607|488679|P1|Extension|Adverse Event|0
150542|NCT00386607|488678|P2|Core|Protocol Deviation|0
150543|NCT00386607|488679|P1|Core|Protocol Deviation|6
150544|NCT00386607|488678|P2|Core|Administrative problems|0
150545|NCT00386607|488679|P1|Core|Administrative problems|1
150546|NCT00386607|488678|P2|Core|Lost to Follow-up|0
150547|NCT00386607|488679|P1|Core|Lost to Follow-up|23
150548|NCT00386607|488678|P2|Core|Patient withdrew consent|0
150549|NCT00386607|488679|P1|Core|Patient withdrew consent|15
150550|NCT00386607|488678|P2|Core|Condition no longer requires study drug|0
150551|NCT00386607|488679|P1|Core|Condition no longer requires study drug|4
150552|NCT00386607|488678|P2|Core|Unsatisfactory therapeutic effect|0
150553|NCT00386607|488679|P1|Core|Unsatisfactory therapeutic effect|23
150554|NCT00386607|488678|P2|Core|Abnormal laboratory value(s)|0
150555|NCT00386607|488679|P1|Core|Abnormal laboratory value(s)|3
150556|NCT00386607|488678|P2|Core|Adverse Event|0
150557|NCT00386607|488679|P1|Core|Adverse Event|40
150558|NCT00386425|488707|P3|Overall Study|Withdrawal by Subject|0
150559|NCT00386425|488708|P2|Overall Study|Withdrawal by Subject|1
150560|NCT00386425|488709|P1|Overall Study|Withdrawal by Subject|0
150561|NCT00386425|488707|P3|Overall Study|Physician Decision|0
150562|NCT00386425|488708|P2|Overall Study|Physician Decision|0
150563|NCT00386425|488709|P1|Overall Study|Physician Decision|3
150564|NCT00386360|488735|P2|Overall Study|Did not take any study medication|2
150565|NCT00386360|488736|P1|Overall Study|Did not take any study medication|0
150566|NCT00386360|488735|P2|Overall Study|Withdrawal by Subject|6
150567|NCT00386360|488736|P1|Overall Study|Withdrawal by Subject|3
150568|NCT00386360|488735|P2|Overall Study|Protocol Violation|3
150569|NCT00386360|488736|P1|Overall Study|Protocol Violation|0
150570|NCT00386360|488735|P2|Overall Study|Lost to Follow-up|2
150571|NCT00386360|488736|P1|Overall Study|Lost to Follow-up|0
150572|NCT00386360|488735|P2|Overall Study|Physician Decision|2
150573|NCT00386360|488736|P1|Overall Study|Physician Decision|2
150574|NCT00386360|488735|P2|Overall Study|Adverse Event|2
150575|NCT00386360|488736|P1|Overall Study|Adverse Event|4
150576|NCT00386334|488770|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
150577|NCT00386334|488771|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
150578|NCT00386334|488770|P2|Double Blind Period|Other|3
150579|NCT00386334|488771|P1|Double Blind Period|Other|3
150580|NCT00386334|488770|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
150581|NCT00386334|488771|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
150582|NCT00386334|488770|P2|Double Blind Period|Lack of Efficacy|11
150583|NCT00386334|488771|P1|Double Blind Period|Lack of Efficacy|20
150584|NCT00386334|488770|P2|Double Blind Period|Withdrawal by Subject|13
150585|NCT00386334|488771|P1|Double Blind Period|Withdrawal by Subject|9
150586|NCT00386334|488770|P2|Double Blind Period|Protocol Violation|1
150587|NCT00386334|488771|P1|Double Blind Period|Protocol Violation|1
150588|NCT00386334|488770|P2|Double Blind Period|Adverse Event|14
150589|NCT00386334|488771|P1|Double Blind Period|Adverse Event|9
150590|NCT00386308|488915|P2|Overall Study|Other Event|1
150591|NCT00386308|488916|P1|Overall Study|Other Event|8
150592|NCT00386308|488915|P2|Overall Study|Withdrawal by Subject|2
150593|NCT00386308|488916|P1|Overall Study|Withdrawal by Subject|6
150594|NCT00386308|488915|P2|Overall Study|Lost to Follow-up|6
150595|NCT00386308|488916|P1|Overall Study|Lost to Follow-up|10
150596|NCT00386308|488915|P2|Overall Study|Lack of Efficacy|2
150597|NCT00386308|488916|P1|Overall Study|Lack of Efficacy|0
150598|NCT00386308|488915|P2|Overall Study|Protocol Violation|5
150599|NCT00386308|488916|P1|Overall Study|Protocol Violation|2
150600|NCT00386308|488915|P2|Overall Study|Adverse Event|3
150601|NCT00386308|488916|P1|Overall Study|Adverse Event|3
150602|NCT00386152|488963|P3|Overall Study|Withdrawal by Subject|10
150603|NCT00386152|488964|P2|Overall Study|Withdrawal by Subject|6
150604|NCT00386152|488965|P1|Overall Study|Withdrawal by Subject|3
150605|NCT00386152|488963|P3|Overall Study|Protocol Violation|2
150606|NCT00386152|488964|P2|Overall Study|Protocol Violation|5
150607|NCT00386152|488965|P1|Overall Study|Protocol Violation|3
150608|NCT00386152|488963|P3|Overall Study|Completed chemotherapy|1
150609|NCT00386152|488964|P2|Overall Study|Completed chemotherapy|5
150610|NCT00386152|488965|P1|Overall Study|Completed chemotherapy|4
150611|NCT00386152|488963|P3|Overall Study|Lost to Follow-up|0
150612|NCT00386152|488964|P2|Overall Study|Lost to Follow-up|0
150613|NCT00386152|488965|P1|Overall Study|Lost to Follow-up|1
150614|NCT00386152|488963|P3|Overall Study|Physician Decision|4
150615|NCT00386152|488964|P2|Overall Study|Physician Decision|10
150616|NCT00386152|488965|P1|Overall Study|Physician Decision|13
150617|NCT00386152|488963|P3|Overall Study|Disease progression|5
150618|NCT00386152|488964|P2|Overall Study|Disease progression|4
150619|NCT00386152|488965|P1|Overall Study|Disease progression|7
150620|NCT00386152|488963|P3|Overall Study|Death|1
150621|NCT00386152|488964|P2|Overall Study|Death|0
150622|NCT00386152|488965|P1|Overall Study|Death|3
150623|NCT00386152|488963|P3|Overall Study|Chang from original chemo stratification|6
150624|NCT00386152|488964|P2|Overall Study|Chang from original chemo stratification|5
150625|NCT00386152|488965|P1|Overall Study|Chang from original chemo stratification|4
150626|NCT00386152|488963|P3|Overall Study|Adverse Event|4
150627|NCT00386152|488964|P2|Overall Study|Adverse Event|5
150628|NCT00386152|488965|P1|Overall Study|Adverse Event|6
150629|NCT00386100|488984|P2|Overall Study|Participant randomized in error|0
150630|NCT00386100|488985|P1|Overall Study|Participant randomized in error|1
150631|NCT00386100|488984|P2|Overall Study|Hb1Ac >8%|1
150632|NCT00386100|488985|P1|Overall Study|Hb1Ac >8%|0
150633|NCT00386100|488984|P2|Overall Study|Out of country for 5 months|0
150634|NCT00386100|488985|P1|Overall Study|Out of country for 5 months|1
150635|NCT00386100|488984|P2|Overall Study|Positive pregnancy test|3
150636|NCT00386100|488985|P1|Overall Study|Positive pregnancy test|1
150637|NCT00386100|488984|P2|Overall Study|Osteoporosis|1
150638|NCT00386100|488985|P1|Overall Study|Osteoporosis|0
150639|NCT00386100|488984|P2|Overall Study|7.6% bone loss|0
150640|NCT00386100|488985|P1|Overall Study|7.6% bone loss|1
150641|NCT00386100|488984|P2|Overall Study|DBP 93 mmHg at randomization|0
150642|NCT00386100|488985|P1|Overall Study|DBP 93 mmHg at randomization|1
150643|NCT00386100|488984|P2|Overall Study|Bone loss by DXA bone scan|0
150644|NCT00386100|488985|P1|Overall Study|Bone loss by DXA bone scan|1
150645|NCT00386100|488984|P2|Overall Study|Bad metabolic control & patient security|0
150646|NCT00386100|488985|P1|Overall Study|Bad metabolic control & patient security|1
150647|NCT00386100|488984|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
150648|NCT00386100|488985|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
150649|NCT00386100|488984|P2|Overall Study|Participant's PCP wanted to stop drug|0
150650|NCT00386100|488985|P1|Overall Study|Participant's PCP wanted to stop drug|1
150651|NCT00386100|488984|P2|Overall Study|Didn't meet entry criteria|1
150652|NCT00386100|488985|P1|Overall Study|Didn't meet entry criteria|1
150653|NCT00386100|488984|P2|Overall Study|Excessive bone loss vs. baseline value|1
150654|NCT00386100|488985|P1|Overall Study|Excessive bone loss vs. baseline value|0
150655|NCT00386100|488984|P2|Overall Study|Participant moving out of state|0
150656|NCT00386100|488985|P1|Overall Study|Participant moving out of state|2
150657|NCT00386100|488984|P2|Overall Study|Participant's concern due to CPK levels|0
150658|NCT00386100|488985|P1|Overall Study|Participant's concern due to CPK levels|1
150659|NCT00386100|488984|P2|Overall Study|Laboratory findings|0
150660|NCT00386100|488985|P1|Overall Study|Laboratory findings|1
150661|NCT00386100|488984|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
150662|NCT00386100|488985|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
150663|NCT00386100|488984|P2|Overall Study|Consecutive elevated Hba1C|0
150664|NCT00386100|488985|P1|Overall Study|Consecutive elevated Hba1C|1
150665|NCT00386100|488984|P2|Overall Study|BMD <2.5|0
150666|NCT00386100|488985|P1|Overall Study|BMD <2.5|1
150667|NCT00386100|488984|P2|Overall Study|Bone mass density (BMD) loss >6%|4
150668|NCT00386100|488985|P1|Overall Study|Bone mass density (BMD) loss >6%|4
150669|NCT00386100|488984|P2|Overall Study|Withdrawal by Subject|31
150670|NCT00386100|488985|P1|Overall Study|Withdrawal by Subject|32
150671|NCT00386100|488984|P2|Overall Study|Protocol Violation|3
150672|NCT00386100|488985|P1|Overall Study|Protocol Violation|5
150673|NCT00386100|488984|P2|Overall Study|Non-compliance|19
150674|NCT00386100|488985|P1|Overall Study|Non-compliance|18
150675|NCT00386100|488984|P2|Overall Study|Lost to Follow-up|29
150676|NCT00386100|488985|P1|Overall Study|Lost to Follow-up|29
150677|NCT00386100|488984|P2|Overall Study|Insufficient therapeutic effect|6
150678|NCT00386100|488985|P1|Overall Study|Insufficient therapeutic effect|30
150679|NCT00386100|488984|P2|Overall Study|Death|1
150680|NCT00386100|488985|P1|Overall Study|Death|0
150681|NCT00386100|488984|P2|Overall Study|Adverse Event|25
150682|NCT00386100|488985|P1|Overall Study|Adverse Event|15
150683|NCT00386100|488984|P2|Overall Study|Did not receive study medication|4
150684|NCT00386100|488985|P1|Overall Study|Did not receive study medication|6
150685|NCT00386009|489049|P2|Overall Study|Withdrawal by Subject|4
150686|NCT00386009|489050|P1|Overall Study|Withdrawal by Subject|5
150687|NCT00386009|489049|P2|Overall Study|Sponsor Decision|1
150688|NCT00386009|489050|P1|Overall Study|Sponsor Decision|1
150689|NCT00386009|489049|P2|Overall Study|Protocol Violation|0
150690|NCT00386009|489050|P1|Overall Study|Protocol Violation|1
150691|NCT00386009|489049|P2|Overall Study|Lost to Follow-up|1
150692|NCT00386009|489050|P1|Overall Study|Lost to Follow-up|1
150693|NCT00386009|489049|P2|Overall Study|Entry Criteria Not Met|2
150694|NCT00386009|489050|P1|Overall Study|Entry Criteria Not Met|0
150695|NCT00386009|489049|P2|Overall Study|Death|0
150696|NCT00386009|489050|P1|Overall Study|Death|1
150697|NCT00386009|489049|P2|Overall Study|Adverse Event|2
150698|NCT00386009|489050|P1|Overall Study|Adverse Event|0
150699|NCT00385944|489095|P3|2nd Maintenance Dose Period|Invalid PD Data|0
150700|NCT00385944|489096|P2|2nd Maintenance Dose Period|Invalid PD Data|3
150701|NCT00385944|489097|P1|2nd Maintenance Dose Period|Invalid PD Data|2
150702|NCT00385944|489095|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
150703|NCT00385944|489096|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
150704|NCT00385944|489097|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
150705|NCT00385944|489095|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
150706|NCT00385944|489096|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
150707|NCT00385944|489097|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
150708|NCT00385944|489095|P3|1st Maintenance Dose Period|Physician Decision|0
150709|NCT00385944|489096|P2|1st Maintenance Dose Period|Physician Decision|0
150710|NCT00385944|489097|P1|1st Maintenance Dose Period|Physician Decision|1
150711|NCT00385918|489140|P3|Intervention Phase After Randomization|Lost to Follow-up|0
150712|NCT00385918|489141|P2|Intervention Phase After Randomization|Lost to Follow-up|0
150713|NCT00385918|489142|P1|Intervention Phase After Randomization|Lost to Follow-up|1
150714|NCT00385918|489140|P3|Intervention Phase After Randomization|Physician Decision|0
150715|NCT00385918|489141|P2|Intervention Phase After Randomization|Physician Decision|0
150716|NCT00385918|489142|P1|Intervention Phase After Randomization|Physician Decision|1
150717|NCT00385918|489140|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
150718|NCT00385918|489141|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
150719|NCT00385918|489142|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
150720|NCT00385918|489140|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
150721|NCT00385918|489141|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
150722|NCT00385918|489142|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
150723|NCT00385918|489140|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
150724|NCT00385918|489141|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
150725|NCT00385918|489142|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
150726|NCT00385918|489140|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
150727|NCT00385918|489141|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
150728|NCT00385918|489142|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
150729|NCT00385840|489166|P2|Overall Study|Lost to Follow-up|13
150730|NCT00385840|489167|P1|Overall Study|Lost to Follow-up|3
150731|NCT00385840|489166|P2|Overall Study|Adverse Event|1
150732|NCT00385840|489167|P1|Overall Study|Adverse Event|1
150733|NCT00385827|489190|P3|Part 2|Unspecified|21
150734|NCT00385827|489191|P2|Part 2|Unspecified|11
150735|NCT00385827|489192|P1|Part 2|Unspecified|0
150736|NCT00385827|489190|P3|Part 2|Randomized but not treated|2
150737|NCT00385827|489191|P2|Part 2|Randomized but not treated|2
150738|NCT00385827|489192|P1|Part 2|Randomized but not treated|0
150739|NCT00385827|489190|P3|Part 2|Lack of Efficacy|13
150740|NCT00385827|489191|P2|Part 2|Lack of Efficacy|14
150741|NCT00385827|489192|P1|Part 2|Lack of Efficacy|0
150742|NCT00385827|489190|P3|Part 2|Death|2
150743|NCT00385827|489191|P2|Part 2|Death|0
150744|NCT00385827|489192|P1|Part 2|Death|0
150745|NCT00385827|489190|P3|Part 2|Adverse Event|10
150746|NCT00385827|489191|P2|Part 2|Adverse Event|6
150747|NCT00385827|489192|P1|Part 2|Adverse Event|0
150748|NCT00385827|489190|P3|Part 1|Unspecified|0
150749|NCT00385827|489191|P2|Part 1|Unspecified|0
150750|NCT00385827|489192|P1|Part 1|Unspecified|1
150751|NCT00385827|489190|P3|Part 1|Lack of Efficacy|0
150752|NCT00385827|489191|P2|Part 1|Lack of Efficacy|0
150753|NCT00385827|489192|P1|Part 1|Lack of Efficacy|5
150754|NCT00385827|489190|P3|Part 1|Death|0
150755|NCT00385827|489191|P2|Part 1|Death|0
150756|NCT00385827|489192|P1|Part 1|Death|2
150757|NCT00385827|489190|P3|Part 1|Adverse Event|0
150758|NCT00385827|489191|P2|Part 1|Adverse Event|0
150759|NCT00385827|489192|P1|Part 1|Adverse Event|1
150760|NCT00385736|489215|P3|Safety Analysis Set|Other|4
150761|NCT00385736|489216|P2|Safety Analysis Set|Other|4
150762|NCT00385736|489217|P1|Safety Analysis Set|Other|1
150763|NCT00385736|489215|P3|Safety Analysis Set|Protocol Violation|6
150764|NCT00385736|489216|P2|Safety Analysis Set|Protocol Violation|1
150765|NCT00385736|489217|P1|Safety Analysis Set|Protocol Violation|2
150766|NCT00385736|489215|P3|Safety Analysis Set|Lack of Efficacy|31
150767|NCT00385736|489216|P2|Safety Analysis Set|Lack of Efficacy|16
150768|NCT00385736|489217|P1|Safety Analysis Set|Lack of Efficacy|38
150769|NCT00385736|489215|P3|Safety Analysis Set|Lost to Follow-up|2
150770|NCT00385736|489216|P2|Safety Analysis Set|Lost to Follow-up|2
150771|NCT00385736|489217|P1|Safety Analysis Set|Lost to Follow-up|0
150772|NCT00385736|489215|P3|Safety Analysis Set|Withdrawal by Subject|14
150773|NCT00385736|489216|P2|Safety Analysis Set|Withdrawal by Subject|6
150774|NCT00385736|489217|P1|Safety Analysis Set|Withdrawal by Subject|6
150775|NCT00385736|489215|P3|Safety Analysis Set|Adverse Event|23
150776|NCT00385736|489216|P2|Safety Analysis Set|Adverse Event|15
150777|NCT00385736|489217|P1|Safety Analysis Set|Adverse Event|23
150778|NCT00385736|489215|P3|Efficacy Analysis Set - Maintenance|Other|4
150779|NCT00385736|489216|P2|Efficacy Analysis Set - Maintenance|Other|4
150780|NCT00385736|489217|P1|Efficacy Analysis Set - Maintenance|Other|0
150781|NCT00385736|489215|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
150782|NCT00385736|489216|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
150783|NCT00385736|489217|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
150784|NCT00385736|489215|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
150785|NCT00385736|489216|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
150786|NCT00385736|489217|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
150787|NCT00385736|489215|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
150788|NCT00385736|489216|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
150789|NCT00385736|489217|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
150790|NCT00385736|489215|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
150791|NCT00385736|489216|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
150792|NCT00385736|489217|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
150793|NCT00385736|489215|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
150794|NCT00385736|489216|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
150795|NCT00385736|489217|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
150796|NCT00385736|489215|P3|Efficacy Analysis Set - Induction|Other|1
150797|NCT00385736|489216|P2|Efficacy Analysis Set - Induction|Other|0
150798|NCT00385736|489217|P1|Efficacy Analysis Set - Induction|Other|0
150799|NCT00385736|489215|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
150800|NCT00385736|489216|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
150801|NCT00385736|489217|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
150802|NCT00385736|489215|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
150803|NCT00385736|489216|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
150804|NCT00385736|489217|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
150805|NCT00385736|489215|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
150806|NCT00385736|489216|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
150807|NCT00385736|489217|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
150808|NCT00385736|489215|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
150809|NCT00385736|489216|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
150810|NCT00385736|489217|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
150811|NCT00385736|489215|P3|Efficacy Analysis Set - Induction|Adverse Event|4
150812|NCT00385736|489216|P2|Efficacy Analysis Set - Induction|Adverse Event|6
150813|NCT00385736|489217|P1|Efficacy Analysis Set - Induction|Adverse Event|5
150814|NCT00385723|489262|P3|Overall Study|Withdrawal by Subject|2
150815|NCT00385723|489263|P2|Overall Study|Withdrawal by Subject|0
150816|NCT00385723|489264|P1|Overall Study|Withdrawal by Subject|1
150817|NCT00385723|489262|P3|Overall Study|Lost to Follow-up|0
150818|NCT00385723|489263|P2|Overall Study|Lost to Follow-up|1
150819|NCT00385723|489264|P1|Overall Study|Lost to Follow-up|1
150820|NCT00385684|489278|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
150821|NCT00385684|489279|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
150822|NCT00385684|489278|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
150823|NCT00385684|489279|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
150824|NCT00385684|489278|P2|FIRST INTERVENTION OF PHASE A|Death|0
150825|NCT00385684|489279|P1|FIRST INTERVENTION OF PHASE A|Death|1
150826|NCT00385671|489288|P3|Overall Study|Withdrawal by Subject|4
150827|NCT00385671|489289|P2|Overall Study|Withdrawal by Subject|4
150828|NCT00385671|489290|P1|Overall Study|Withdrawal by Subject|4
150829|NCT00385671|489288|P3|Overall Study|Sponsor Decision|1
150830|NCT00385671|489289|P2|Overall Study|Sponsor Decision|2
150831|NCT00385671|489290|P1|Overall Study|Sponsor Decision|2
150832|NCT00385671|489288|P3|Overall Study|Protocol Violation|1
150833|NCT00385671|489289|P2|Overall Study|Protocol Violation|2
150834|NCT00385671|489290|P1|Overall Study|Protocol Violation|5
150835|NCT00385671|489288|P3|Overall Study|Physician Decision|2
150836|NCT00385671|489289|P2|Overall Study|Physician Decision|1
150837|NCT00385671|489290|P1|Overall Study|Physician Decision|2
150838|NCT00385671|489288|P3|Overall Study|Lost to Follow-up|5
150839|NCT00385671|489289|P2|Overall Study|Lost to Follow-up|6
150840|NCT00385671|489290|P1|Overall Study|Lost to Follow-up|6
150841|NCT00385671|489288|P3|Overall Study|Lack of Efficacy|5
150842|NCT00385671|489289|P2|Overall Study|Lack of Efficacy|9
150843|NCT00385671|489290|P1|Overall Study|Lack of Efficacy|5
150844|NCT00385671|489288|P3|Overall Study|Adverse Event|18
150845|NCT00385671|489289|P2|Overall Study|Adverse Event|27
150846|NCT00385671|489290|P1|Overall Study|Adverse Event|14
150847|NCT00385593|489446|P2|Overall Study|Incorrect randomization|1
150848|NCT00385593|489447|P1|Overall Study|Incorrect randomization|0
150849|NCT00385593|489446|P2|Overall Study|Incorrect inclusion|0
150850|NCT00385593|489447|P1|Overall Study|Incorrect inclusion|2
150851|NCT00385593|489446|P2|Overall Study|Several reasons|15
150852|NCT00385593|489447|P1|Overall Study|Several reasons|17
150853|NCT00385593|489446|P2|Overall Study|Protocol Violation|4
150854|NCT00385593|489447|P1|Overall Study|Protocol Violation|7
150855|NCT00385593|489446|P2|Overall Study|Lost to Follow-up|8
150856|NCT00385593|489447|P1|Overall Study|Lost to Follow-up|12
150857|NCT00385593|489446|P2|Overall Study|Withdrawal by Subject|7
150858|NCT00385593|489447|P1|Overall Study|Withdrawal by Subject|17
150859|NCT00385593|489446|P2|Overall Study|Adverse Event|2
150860|NCT00385593|489447|P1|Overall Study|Adverse Event|3
150861|NCT00385541|489557|P2|Overall Study|severe pain, clinician requested unblind|1
150862|NCT00385541|489558|P1|Overall Study|severe pain, clinician requested unblind|0
150863|NCT00385203|489605|P2|Overall Study|Incorrect enrollment|0
150864|NCT00385203|489606|P1|Overall Study|Incorrect enrollment|2
150865|NCT00385203|489605|P2|Overall Study|Condition under investigation worsened|3
150866|NCT00385203|489606|P1|Overall Study|Condition under investigation worsened|18
150867|NCT00385203|489605|P2|Overall Study|Death|0
150868|NCT00385203|489606|P1|Overall Study|Death|1
150869|NCT00385203|489605|P2|Overall Study|Adverse Event|4
150870|NCT00385203|489606|P1|Overall Study|Adverse Event|5
150871|NCT00384956|489671|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
150872|NCT00384930|489688|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
150873|NCT00384930|489689|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
150874|NCT00384930|489690|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
150875|NCT00384930|489691|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
150876|NCT00384930|489692|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
150877|NCT00384930|489688|P5|Overall Study|Withdrawal by Subject|16
150878|NCT00384930|489689|P4|Overall Study|Withdrawal by Subject|6
150879|NCT00384930|489690|P3|Overall Study|Withdrawal by Subject|7
150880|NCT00384930|489691|P2|Overall Study|Withdrawal by Subject|7
150881|NCT00384930|489692|P1|Overall Study|Withdrawal by Subject|9
150882|NCT00384930|489688|P5|Overall Study|Sponsor Decision|0
150883|NCT00384930|489689|P4|Overall Study|Sponsor Decision|5
150884|NCT00384930|489690|P3|Overall Study|Sponsor Decision|0
150885|NCT00384930|489691|P2|Overall Study|Sponsor Decision|4
150886|NCT00384930|489692|P1|Overall Study|Sponsor Decision|3
150887|NCT00384930|489688|P5|Overall Study|Protocol Violation|4
150888|NCT00384930|489689|P4|Overall Study|Protocol Violation|6
150889|NCT00384930|489690|P3|Overall Study|Protocol Violation|1
150890|NCT00384930|489691|P2|Overall Study|Protocol Violation|0
150891|NCT00384930|489692|P1|Overall Study|Protocol Violation|1
150892|NCT00384930|489688|P5|Overall Study|Physician Decision|1
150893|NCT00384930|489689|P4|Overall Study|Physician Decision|0
150894|NCT00384930|489690|P3|Overall Study|Physician Decision|1
150895|NCT00384930|489691|P2|Overall Study|Physician Decision|1
150896|NCT00384930|489692|P1|Overall Study|Physician Decision|0
150897|NCT00384930|489688|P5|Overall Study|Lost to Follow-up|6
150898|NCT00384930|489689|P4|Overall Study|Lost to Follow-up|4
150899|NCT00384930|489690|P3|Overall Study|Lost to Follow-up|0
150900|NCT00384930|489691|P2|Overall Study|Lost to Follow-up|3
150901|NCT00384930|489692|P1|Overall Study|Lost to Follow-up|5
150902|NCT00384930|489688|P5|Overall Study|Lack of Efficacy|2
150903|NCT00384930|489689|P4|Overall Study|Lack of Efficacy|1
150904|NCT00384930|489690|P3|Overall Study|Lack of Efficacy|2
150905|NCT00384930|489691|P2|Overall Study|Lack of Efficacy|1
150906|NCT00384930|489692|P1|Overall Study|Lack of Efficacy|1
150907|NCT00384930|489688|P5|Overall Study|Entry Criteria Not Met|4
150908|NCT00384930|489689|P4|Overall Study|Entry Criteria Not Met|8
150909|NCT00384930|489690|P3|Overall Study|Entry Criteria Not Met|7
150910|NCT00384930|489691|P2|Overall Study|Entry Criteria Not Met|6
150911|NCT00384930|489692|P1|Overall Study|Entry Criteria Not Met|2
150912|NCT00384930|489688|P5|Overall Study|Adverse Event|14
150913|NCT00384930|489689|P4|Overall Study|Adverse Event|11
150914|NCT00384930|489690|P3|Overall Study|Adverse Event|12
150915|NCT00384930|489691|P2|Overall Study|Adverse Event|4
150916|NCT00384930|489692|P1|Overall Study|Adverse Event|5
150917|NCT00384397|489777|P3|Overall Study|Withdrawal by Subject|15
150918|NCT00384397|489778|P2|Overall Study|Withdrawal by Subject|17
150919|NCT00384397|489779|P1|Overall Study|Withdrawal by Subject|14
150920|NCT00384397|489777|P3|Overall Study|Lost to Follow-up|3
150921|NCT00384397|489778|P2|Overall Study|Lost to Follow-up|13
150922|NCT00384397|489779|P1|Overall Study|Lost to Follow-up|11
150923|NCT00384397|489777|P3|Overall Study|Protocol Violation|13
150924|NCT00384397|489778|P2|Overall Study|Protocol Violation|15
150925|NCT00384397|489779|P1|Overall Study|Protocol Violation|7
150926|NCT00384397|489777|P3|Overall Study|Adverse Event|2
150927|NCT00384397|489778|P2|Overall Study|Adverse Event|1
150928|NCT00384397|489779|P1|Overall Study|Adverse Event|0
150929|NCT00384293|489798|P3|Post-randomization Period|Patient Randomized in Error|1
150930|NCT00384293|489799|P2|Post-randomization Period|Patient Randomized in Error|0
150931|NCT00384293|489800|P1|Post-randomization Period|Patient Randomized in Error|0
150932|NCT00384293|489798|P3|Post-randomization Period|Trial Termination|204
150933|NCT00384293|489799|P2|Post-randomization Period|Trial Termination|180
150934|NCT00384293|489800|P1|Post-randomization Period|Trial Termination|0
150935|NCT00384293|489798|P3|Post-randomization Period|Withdrawal by Subject|6
150936|NCT00384293|489799|P2|Post-randomization Period|Withdrawal by Subject|8
150937|NCT00384293|489800|P1|Post-randomization Period|Withdrawal by Subject|0
150938|NCT00384293|489798|P3|Post-randomization Period|Protocol Violation|0
150939|NCT00384293|489799|P2|Post-randomization Period|Protocol Violation|1
150940|NCT00384293|489800|P1|Post-randomization Period|Protocol Violation|0
150941|NCT00384293|489798|P3|Post-randomization Period|Lost to Follow-up|1
150942|NCT00384293|489799|P2|Post-randomization Period|Lost to Follow-up|2
150943|NCT00384293|489800|P1|Post-randomization Period|Lost to Follow-up|0
150944|NCT00384293|489798|P3|Post-randomization Period|Adverse Event|7
150945|NCT00384293|489799|P2|Post-randomization Period|Adverse Event|23
150946|NCT00384293|489800|P1|Post-randomization Period|Adverse Event|0
150947|NCT00384293|489798|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
150948|NCT00384293|489799|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
150949|NCT00384293|489800|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
150950|NCT00384293|489798|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
150951|NCT00384293|489799|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
150952|NCT00384293|489800|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
150953|NCT00384293|489798|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
150954|NCT00384293|489799|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
150955|NCT00384293|489800|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
150956|NCT00384293|489798|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
150957|NCT00384293|489799|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
150958|NCT00384293|489800|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
150959|NCT00384293|489798|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
150960|NCT00384293|489799|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
150961|NCT00384293|489800|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
150962|NCT00384293|489798|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
150963|NCT00384293|489799|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
150964|NCT00384293|489800|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
150965|NCT00384293|489798|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
150966|NCT00384293|489799|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
150967|NCT00384293|489800|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
150968|NCT00383552|489821|P4|Overall Study|Administrative|1
150969|NCT00383552|489822|P3|Overall Study|Administrative|1
150970|NCT00383552|489823|P2|Overall Study|Administrative|0
150971|NCT00383552|489824|P1|Overall Study|Administrative|1
150972|NCT00383552|489821|P4|Overall Study|Did not meet protocol eligibility|3
150973|NCT00383552|489822|P3|Overall Study|Did not meet protocol eligibility|2
150974|NCT00383552|489823|P2|Overall Study|Did not meet protocol eligibility|6
150975|NCT00383552|489824|P1|Overall Study|Did not meet protocol eligibility|8
150976|NCT00383552|489821|P4|Overall Study|Noncompliance with the protocol|10
150977|NCT00383552|489822|P3|Overall Study|Noncompliance with the protocol|8
150978|NCT00383552|489823|P2|Overall Study|Noncompliance with the protocol|6
150979|NCT00383552|489824|P1|Overall Study|Noncompliance with the protocol|11
150980|NCT00383552|489821|P4|Overall Study|Did not wish to continue (related)|3
150981|NCT00383552|489822|P3|Overall Study|Did not wish to continue (related)|2
150982|NCT00383552|489823|P2|Overall Study|Did not wish to continue (related)|0
150983|NCT00383552|489824|P1|Overall Study|Did not wish to continue (related)|1
150984|NCT00383552|489821|P4|Overall Study|Did not wish to continue (unrelated)|6
150985|NCT00383552|489822|P3|Overall Study|Did not wish to continue (unrelated)|5
150986|NCT00383552|489823|P2|Overall Study|Did not wish to continue (unrelated)|9
150987|NCT00383552|489824|P1|Overall Study|Did not wish to continue (unrelated)|4
150988|NCT00383552|489821|P4|Overall Study|Lost to Follow-up|1
150989|NCT00383552|489822|P3|Overall Study|Lost to Follow-up|5
150990|NCT00383552|489823|P2|Overall Study|Lost to Follow-up|1
150991|NCT00383552|489824|P1|Overall Study|Lost to Follow-up|0
150992|NCT00383552|489821|P4|Overall Study|Lack of Efficacy|42
150993|NCT00383552|489822|P3|Overall Study|Lack of Efficacy|29
150994|NCT00383552|489823|P2|Overall Study|Lack of Efficacy|13
150995|NCT00383552|489824|P1|Overall Study|Lack of Efficacy|4
150996|NCT00383552|489821|P4|Overall Study|Adverse Event|6
150997|NCT00383552|489822|P3|Overall Study|Adverse Event|9
150998|NCT00383552|489823|P2|Overall Study|Adverse Event|6
150999|NCT00383552|489824|P1|Overall Study|Adverse Event|7
151000|NCT00384189|489876|P4|Overall Study|Reason Not Specified|40
151001|NCT00384189|489877|P3|Overall Study|Reason Not Specified|58
151002|NCT00384189|489878|P2|Overall Study|Reason Not Specified|57
151003|NCT00384189|489879|P1|Overall Study|Reason Not Specified|50
151004|NCT00384176|489940|P3|Overall Study|Liver metastases, colon resec. planned|0
151005|NCT00384176|489941|P2|Overall Study|Liver metastases, colon resec. planned|0
151006|NCT00384176|489942|P1|Overall Study|Liver metastases, colon resec. planned|1
151007|NCT00384176|489940|P3|Overall Study|Physician Decision|0
151008|NCT00384176|489941|P2|Overall Study|Physician Decision|2
151009|NCT00384176|489942|P1|Overall Study|Physician Decision|0
151010|NCT00384176|489940|P3|Overall Study|Did not receive study treatment|1
151011|NCT00384176|489941|P2|Overall Study|Did not receive study treatment|1
151012|NCT00384176|489942|P1|Overall Study|Did not receive study treatment|0
151013|NCT00384176|489940|P3|Overall Study|Toxicity of treatment|0
151014|NCT00384176|489941|P2|Overall Study|Toxicity of treatment|0
151015|NCT00384176|489942|P1|Overall Study|Toxicity of treatment|1
151016|NCT00384176|489940|P3|Overall Study|Longer QTC as Visit 1|0
151017|NCT00384176|489941|P2|Overall Study|Longer QTC as Visit 1|0
151018|NCT00384176|489942|P1|Overall Study|Longer QTC as Visit 1|1
151019|NCT00384176|489940|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
151020|NCT00384176|489941|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
151021|NCT00384176|489942|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
151022|NCT00384176|489940|P3|Overall Study|Lost to Follow-up|4
151023|NCT00384176|489941|P2|Overall Study|Lost to Follow-up|18
151024|NCT00384176|489942|P1|Overall Study|Lost to Follow-up|16
151025|NCT00384176|489940|P3|Overall Study|Withdrawal by Subject|22
151026|NCT00384176|489941|P2|Overall Study|Withdrawal by Subject|48
151027|NCT00384176|489942|P1|Overall Study|Withdrawal by Subject|52
151028|NCT00384176|489940|P3|Overall Study|Death|105
151029|NCT00384176|489941|P2|Overall Study|Death|247
151030|NCT00384176|489942|P1|Overall Study|Death|239
151031|NCT00384085|489968|P3|Overall Study|Patient required surgery|0
151032|NCT00384085|489969|P2|Overall Study|Patient required surgery|1
151033|NCT00384085|489970|P1|Overall Study|Patient required surgery|0
151034|NCT00384085|489968|P3|Overall Study|Patient moved|1
151035|NCT00384085|489969|P2|Overall Study|Patient moved|0
151036|NCT00384085|489970|P1|Overall Study|Patient moved|1
151037|NCT00384085|489968|P3|Overall Study|Sponsor decision|1
151038|NCT00384085|489969|P2|Overall Study|Sponsor decision|2
151039|NCT00384085|489970|P1|Overall Study|Sponsor decision|1
151040|NCT00384085|489968|P3|Overall Study|Loss of site personnel|1
151041|NCT00384085|489969|P2|Overall Study|Loss of site personnel|0
151042|NCT00384085|489970|P1|Overall Study|Loss of site personnel|1
151043|NCT00384085|489968|P3|Overall Study|Physician Decision|0
151044|NCT00384085|489969|P2|Overall Study|Physician Decision|0
151045|NCT00384085|489970|P1|Overall Study|Physician Decision|1
151046|NCT00384085|489968|P3|Overall Study|Patient non-compliant|5
151047|NCT00384085|489969|P2|Overall Study|Patient non-compliant|4
151048|NCT00384085|489970|P1|Overall Study|Patient non-compliant|4
151049|NCT00384085|489968|P3|Overall Study|Withdrawal by Subject|29
151050|NCT00384085|489969|P2|Overall Study|Withdrawal by Subject|19
151051|NCT00384085|489970|P1|Overall Study|Withdrawal by Subject|14
151052|NCT00384085|489968|P3|Overall Study|Progressive Disease|0
151053|NCT00384085|489969|P2|Overall Study|Progressive Disease|1
151054|NCT00384085|489970|P1|Overall Study|Progressive Disease|0
151055|NCT00384085|489968|P3|Overall Study|Lost to Follow-up|10
151056|NCT00384085|489969|P2|Overall Study|Lost to Follow-up|9
151057|NCT00384085|489970|P1|Overall Study|Lost to Follow-up|9
151058|NCT00384085|489968|P3|Overall Study|Protocol Violation|2
151059|NCT00384085|489969|P2|Overall Study|Protocol Violation|2
151060|NCT00384085|489970|P1|Overall Study|Protocol Violation|2
151061|NCT00384085|489968|P3|Overall Study|No longer Requires Study Treatment|1
151062|NCT00384085|489969|P2|Overall Study|No longer Requires Study Treatment|0
151063|NCT00384085|489970|P1|Overall Study|No longer Requires Study Treatment|1
151064|NCT00384085|489968|P3|Overall Study|Lack of Efficacy|2
151065|NCT00384085|489969|P2|Overall Study|Lack of Efficacy|3
151066|NCT00384085|489970|P1|Overall Study|Lack of Efficacy|0
151067|NCT00384085|489968|P3|Overall Study|Adverse Event|4
151068|NCT00384085|489969|P2|Overall Study|Adverse Event|5
151069|NCT00384085|489970|P1|Overall Study|Adverse Event|5
151070|NCT00384059|489996|P2|Toddler Dose|Failed to return|1
151071|NCT00384059|489997|P1|Toddler Dose|Failed to return|0
151072|NCT00384059|489996|P2|Toddler Dose|Lost to Follow-up|1
151073|NCT00384059|489997|P1|Toddler Dose|Lost to Follow-up|1
151074|NCT00384059|489996|P2|After Infant Series|Lost to Follow-up|1
151075|NCT00384059|489997|P1|After Infant Series|Lost to Follow-up|0
151076|NCT00384059|489996|P2|After Infant Series|Physician Decision|1
151077|NCT00384059|489997|P1|After Infant Series|Physician Decision|0
151078|NCT00384059|489996|P2|After Infant Series|Adverse Event|1
151079|NCT00384059|489997|P1|After Infant Series|Adverse Event|0
151080|NCT00384059|489996|P2|After Infant Series|Failed to Return|2
151081|NCT00384059|489997|P1|After Infant Series|Failed to Return|0
151082|NCT00384059|489996|P2|After Infant Series|Withdrawal by Subject|2
151083|NCT00384059|489997|P1|After Infant Series|Withdrawal by Subject|2
151084|NCT00384059|489996|P2|After Infant Series|Protocol Violation|3
151085|NCT00384059|489997|P1|After Infant Series|Protocol Violation|2
151086|NCT00384059|489996|P2|Infant Series|Lost to Follow-up|1
151087|NCT00384059|489997|P1|Infant Series|Lost to Follow-up|0
151088|NCT00384059|489996|P2|Infant Series|Protocol Violation|2
151089|NCT00384059|489997|P1|Infant Series|Protocol Violation|1
151090|NCT00384059|489996|P2|Infant Series|Adverse Event|2
151091|NCT00384059|489997|P1|Infant Series|Adverse Event|1
151092|NCT00384059|489996|P2|Infant Series|Withdrawal by Subject|2
151093|NCT00384059|489997|P1|Infant Series|Withdrawal by Subject|2
151094|NCT00384059|489996|P2|Infant Series|Not consented|6
151095|NCT00384059|489997|P1|Infant Series|Not consented|2
151096|NCT00384033|490047|P4|Overall Study|Randomized but not treated|2
151097|NCT00384033|490048|P3|Overall Study|Randomized but not treated|10
151098|NCT00384033|490049|P2|Overall Study|Randomized but not treated|7
151099|NCT00384033|490050|P1|Overall Study|Randomized but not treated|3
151100|NCT00384033|490047|P4|Overall Study|Lack of Efficacy|1
151101|NCT00384033|490048|P3|Overall Study|Lack of Efficacy|3
151102|NCT00384033|490049|P2|Overall Study|Lack of Efficacy|3
151103|NCT00384033|490050|P1|Overall Study|Lack of Efficacy|7
151104|NCT00384033|490047|P4|Overall Study|Withdrawal by Subject|2
151105|NCT00384033|490048|P3|Overall Study|Withdrawal by Subject|5
151106|NCT00384033|490049|P2|Overall Study|Withdrawal by Subject|2
151107|NCT00384033|490050|P1|Overall Study|Withdrawal by Subject|6
151108|NCT00384033|490047|P4|Overall Study|Protocol Violation|6
151109|NCT00384033|490048|P3|Overall Study|Protocol Violation|5
151110|NCT00384033|490049|P2|Overall Study|Protocol Violation|0
151111|NCT00384033|490050|P1|Overall Study|Protocol Violation|5
151112|NCT00384033|490047|P4|Overall Study|Unspecified|0
151113|NCT00384033|490048|P3|Overall Study|Unspecified|0
151114|NCT00384033|490049|P2|Overall Study|Unspecified|0
151115|NCT00384033|490050|P1|Overall Study|Unspecified|2
151116|NCT00384033|490047|P4|Overall Study|Lost to Follow-up|7
151117|NCT00384033|490048|P3|Overall Study|Lost to Follow-up|7
151118|NCT00384033|490049|P2|Overall Study|Lost to Follow-up|12
151119|NCT00384033|490050|P1|Overall Study|Lost to Follow-up|6
151120|NCT00384033|490047|P4|Overall Study|Physician Decision|0
151121|NCT00384033|490048|P3|Overall Study|Physician Decision|0
151122|NCT00384033|490049|P2|Overall Study|Physician Decision|0
151123|NCT00384033|490050|P1|Overall Study|Physician Decision|1
151124|NCT00384033|490047|P4|Overall Study|Failed to return|2
151125|NCT00384033|490048|P3|Overall Study|Failed to return|2
151126|NCT00384033|490049|P2|Overall Study|Failed to return|3
151127|NCT00384033|490050|P1|Overall Study|Failed to return|1
151128|NCT00384033|490047|P4|Overall Study|Adverse Event|20
151129|NCT00384033|490048|P3|Overall Study|Adverse Event|11
151130|NCT00384033|490049|P2|Overall Study|Adverse Event|8
151131|NCT00384033|490050|P1|Overall Study|Adverse Event|10
151132|NCT00383786|490094|P2|Overall Study|Physician Decision|1
151133|NCT00383786|490095|P1|Overall Study|Physician Decision|0
151134|NCT00383786|490094|P2|Overall Study|Withdrawal by Subject|5
151135|NCT00383786|490095|P1|Overall Study|Withdrawal by Subject|2
151136|NCT00383786|490094|P2|Overall Study|Protocol Violation|6
151137|NCT00383786|490095|P1|Overall Study|Protocol Violation|2
151138|NCT00383721|490120|P5|26-Week Treatment Safety Extension|Administrative|0
151139|NCT00383721|490121|P4|26-Week Treatment Safety Extension|Administrative|1
151140|NCT00383721|490122|P3|26-Week Treatment Safety Extension|Administrative|3
151141|NCT00383721|490123|P2|26-Week Treatment Safety Extension|Administrative|2
151142|NCT00383721|490124|P1|26-Week Treatment Safety Extension|Administrative|1
151143|NCT00383721|490120|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
151144|NCT00383721|490121|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
151145|NCT00383721|490122|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
151146|NCT00383721|490123|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
151147|NCT00383721|490124|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
151148|NCT00383721|490120|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
151149|NCT00383721|490121|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
151150|NCT00383721|490122|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
151151|NCT00383721|490123|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
151152|NCT00383721|490124|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
151153|NCT00383721|490120|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
151154|NCT00383721|490121|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
151155|NCT00383721|490122|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
151156|NCT00383721|490123|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
151157|NCT00383721|490124|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
151158|NCT00383721|490120|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
151159|NCT00383721|490121|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
151160|NCT00383721|490122|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
151161|NCT00383721|490123|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
151162|NCT00383721|490124|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
151163|NCT00383721|490120|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
151164|NCT00383721|490121|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
151165|NCT00383721|490122|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
151166|NCT00383721|490123|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
151167|NCT00383721|490124|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
151168|NCT00383721|490120|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
151169|NCT00383721|490121|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
151170|NCT00383721|490122|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
151171|NCT00383721|490123|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
151172|NCT00383721|490124|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
151173|NCT00383721|490120|P5|26-Week Treatment Safety Extension|Adverse Event|0
151174|NCT00383721|490121|P4|26-Week Treatment Safety Extension|Adverse Event|1
151175|NCT00383721|490122|P3|26-Week Treatment Safety Extension|Adverse Event|10
151176|NCT00383721|490123|P2|26-Week Treatment Safety Extension|Adverse Event|7
151177|NCT00383721|490124|P1|26-Week Treatment Safety Extension|Adverse Event|6
151178|NCT00383721|490120|P5|26-Week Double-Blind Treatment Period|Ongoing|0
151179|NCT00383721|490121|P4|26-Week Double-Blind Treatment Period|Ongoing|0
151180|NCT00383721|490122|P3|26-Week Double-Blind Treatment Period|Ongoing|0
151181|NCT00383721|490123|P2|26-Week Double-Blind Treatment Period|Ongoing|0
151182|NCT00383721|490124|P1|26-Week Double-Blind Treatment Period|Ongoing|1
151183|NCT00383721|490120|P5|26-Week Double-Blind Treatment Period|Administrative|3
151184|NCT00383721|490121|P4|26-Week Double-Blind Treatment Period|Administrative|3
151185|NCT00383721|490122|P3|26-Week Double-Blind Treatment Period|Administrative|3
151186|NCT00383721|490123|P2|26-Week Double-Blind Treatment Period|Administrative|3
151187|NCT00383721|490124|P1|26-Week Double-Blind Treatment Period|Administrative|1
151188|NCT00383721|490120|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
151189|NCT00383721|490121|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
151190|NCT00383721|490122|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
151191|NCT00383721|490123|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
151192|NCT00383721|490124|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
151193|NCT00383721|490120|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
151194|NCT00383721|490121|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
151195|NCT00383721|490122|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
151196|NCT00383721|490123|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
151197|NCT00383721|490124|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
151198|NCT00383721|490120|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
151199|NCT00383721|490121|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
151200|NCT00383721|490122|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
151201|NCT00383721|490123|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
151202|NCT00383721|490124|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
151203|NCT00383721|490120|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
151204|NCT00383721|490121|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
151205|NCT00383721|490122|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
151206|NCT00383721|490123|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
151207|NCT00383721|490124|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
151208|NCT00383721|490120|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
151209|NCT00383721|490121|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
151210|NCT00383721|490122|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
151211|NCT00383721|490123|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
151212|NCT00383721|490124|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
151213|NCT00383721|490120|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
151214|NCT00383721|490121|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
151215|NCT00383721|490122|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
151216|NCT00383721|490123|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
151217|NCT00383721|490124|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
151218|NCT00383721|490120|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
151219|NCT00383721|490121|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
151220|NCT00383721|490122|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
151221|NCT00383721|490123|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
151222|NCT00383721|490124|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
151223|NCT00383435|490166|P5|26-Week Treatment Safety Extension|Administrative|0
151224|NCT00383435|490167|P4|26-Week Treatment Safety Extension|Administrative|1
151225|NCT00383435|490168|P3|26-Week Treatment Safety Extension|Administrative|0
151226|NCT00383435|490169|P2|26-Week Treatment Safety Extension|Administrative|1
151227|NCT00383435|490170|P1|26-Week Treatment Safety Extension|Administrative|1
151228|NCT00383435|490166|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
151229|NCT00383435|490167|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
151230|NCT00383435|490168|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
151231|NCT00383435|490169|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
151232|NCT00383435|490170|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
151233|NCT00383435|490166|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
151234|NCT00383435|490167|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
151235|NCT00383435|490168|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
151236|NCT00383435|490169|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
151237|NCT00383435|490170|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
151238|NCT00383435|490166|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
151239|NCT00383435|490167|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
151240|NCT00383435|490168|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
151241|NCT00383435|490169|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
151242|NCT00383435|490170|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
151243|NCT00383435|490166|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
151244|NCT00383435|490167|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
151245|NCT00383435|490168|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
151246|NCT00383435|490169|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
151247|NCT00383435|490170|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
151248|NCT00383435|490166|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
151249|NCT00383435|490167|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
151250|NCT00383435|490168|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
151251|NCT00383435|490169|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
151252|NCT00383435|490170|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
151253|NCT00383435|490166|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
151254|NCT00383435|490167|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
151255|NCT00383435|490168|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
151256|NCT00383435|490169|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
151257|NCT00383435|490170|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
151258|NCT00383435|490166|P5|26-Week Treatment Safety Extension|Adverse Event|1
151259|NCT00383435|490167|P4|26-Week Treatment Safety Extension|Adverse Event|5
151260|NCT00383435|490168|P3|26-Week Treatment Safety Extension|Adverse Event|5
151261|NCT00383435|490169|P2|26-Week Treatment Safety Extension|Adverse Event|2
151262|NCT00383435|490170|P1|26-Week Treatment Safety Extension|Adverse Event|4
151263|NCT00383435|490166|P5|26-Week Double-Blind Treatment Period|Administrative|1
151264|NCT00383435|490167|P4|26-Week Double-Blind Treatment Period|Administrative|1
151265|NCT00383435|490168|P3|26-Week Double-Blind Treatment Period|Administrative|1
151266|NCT00383435|490169|P2|26-Week Double-Blind Treatment Period|Administrative|3
151267|NCT00383435|490170|P1|26-Week Double-Blind Treatment Period|Administrative|5
151268|NCT00383435|490166|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
151269|NCT00383435|490167|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
151270|NCT00383435|490168|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
151271|NCT00383435|490169|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
151272|NCT00383435|490170|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
151273|NCT00383435|490166|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
151274|NCT00383435|490167|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
151275|NCT00383435|490168|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
151276|NCT00383435|490169|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
151277|NCT00383435|490170|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
151278|NCT00383435|490166|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
151279|NCT00383435|490167|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
151280|NCT00383435|490168|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
151281|NCT00383435|490169|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
151282|NCT00383435|490170|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
151283|NCT00383435|490166|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
151284|NCT00383435|490167|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
151285|NCT00383435|490168|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
151286|NCT00383435|490169|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
151287|NCT00383435|490170|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
151288|NCT00383435|490166|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
151289|NCT00383435|490167|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
151290|NCT00383435|490168|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
151291|NCT00383435|490169|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
151292|NCT00383435|490170|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
151293|NCT00383435|490166|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
151294|NCT00383435|490167|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
151295|NCT00383435|490168|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
151296|NCT00383435|490169|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
151297|NCT00383435|490170|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
151298|NCT00383435|490166|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
151299|NCT00383435|490167|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
151300|NCT00383435|490168|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
151301|NCT00383435|490169|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
151302|NCT00383435|490170|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
151303|NCT00383331|490209|P2|Overall Study|Protocol Violation|1
151304|NCT00383331|490210|P1|Overall Study|Protocol Violation|0
151305|NCT00383240|490239|P4|Overall Study|Administrative|0
151306|NCT00383240|490240|P3|Overall Study|Administrative|0
151307|NCT00383240|490241|P2|Overall Study|Administrative|1
151308|NCT00383240|490242|P1|Overall Study|Administrative|1
151309|NCT00383240|490239|P4|Overall Study|Did not meet protocol eligibility|3
151310|NCT00383240|490240|P3|Overall Study|Did not meet protocol eligibility|9
151311|NCT00383240|490241|P2|Overall Study|Did not meet protocol eligibility|4
151312|NCT00383240|490242|P1|Overall Study|Did not meet protocol eligibility|9
151313|NCT00383240|490239|P4|Overall Study|Protocol Violation|6
151314|NCT00383240|490240|P3|Overall Study|Protocol Violation|9
151315|NCT00383240|490241|P2|Overall Study|Protocol Violation|5
151316|NCT00383240|490242|P1|Overall Study|Protocol Violation|4
151317|NCT00383240|490239|P4|Overall Study|Withdrawal by subjects, reasons related|5
151318|NCT00383240|490240|P3|Overall Study|Withdrawal by subjects, reasons related|3
151319|NCT00383240|490241|P2|Overall Study|Withdrawal by subjects, reasons related|1
151320|NCT00383240|490242|P1|Overall Study|Withdrawal by subjects, reasons related|0
151321|NCT00383240|490239|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
151322|NCT00383240|490240|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
151323|NCT00383240|490241|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
151324|NCT00383240|490242|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
151325|NCT00383240|490239|P4|Overall Study|Lost to Follow-up|2
151326|NCT00383240|490240|P3|Overall Study|Lost to Follow-up|0
151327|NCT00383240|490241|P2|Overall Study|Lost to Follow-up|0
151328|NCT00383240|490242|P1|Overall Study|Lost to Follow-up|3
151329|NCT00383240|490239|P4|Overall Study|Treatment Failure|46
151330|NCT00383240|490240|P3|Overall Study|Treatment Failure|47
151331|NCT00383240|490241|P2|Overall Study|Treatment Failure|13
151332|NCT00383240|490242|P1|Overall Study|Treatment Failure|8
151333|NCT00383240|490239|P4|Overall Study|Adverse Event|7
151334|NCT00383240|490240|P3|Overall Study|Adverse Event|9
151335|NCT00383240|490241|P2|Overall Study|Adverse Event|6
151336|NCT00383240|490242|P1|Overall Study|Adverse Event|4
151337|NCT00383162|490273|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
151338|NCT00383162|490274|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
151339|NCT00383162|490273|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
151340|NCT00383162|490274|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
151341|NCT00383162|490273|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
151342|NCT00383162|490274|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
151343|NCT00383162|490273|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
151344|NCT00383162|490274|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
151345|NCT00383162|490273|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
151346|NCT00383162|490274|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
151347|NCT00383162|490273|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
151348|NCT00383162|490274|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
151349|NCT00383162|490273|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
151350|NCT00383162|490274|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
151351|NCT00383162|490273|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
151352|NCT00383162|490274|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
151353|NCT00383162|490273|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
151354|NCT00383162|490274|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
151355|NCT00383149|490316|P1|Overall Study|Participant Withdrew Consent|1
151356|NCT00383149|490316|P1|Overall Study|Request to Discontinue Treatment|4
151357|NCT00383149|490316|P1|Overall Study|Study Drug Toxicity|4
151358|NCT00383149|490316|P1|Overall Study|Other|1
151359|NCT00383149|490316|P1|Overall Study|Lost to Follow-up|1
151360|NCT00383149|490316|P1|Overall Study|Disease Progression|38
151361|NCT00383149|490316|P1|Overall Study|Death|2
151362|NCT00383149|490316|P1|Overall Study|Adverse Event not Related to Study Drug|3
151363|NCT00383123|490335|P2|Overall Study|Other reason|6
151364|NCT00383123|490336|P1|Overall Study|Other reason|10
151365|NCT00383123|490335|P2|Overall Study|Withdrawal by Subject|18
151366|NCT00383123|490336|P1|Overall Study|Withdrawal by Subject|27
151367|NCT00383123|490335|P2|Overall Study|Protocol Violation|1
151368|NCT00383123|490336|P1|Overall Study|Protocol Violation|5
151369|NCT00383123|490335|P2|Overall Study|Lost to Follow-up|61
151370|NCT00383123|490336|P1|Overall Study|Lost to Follow-up|68
151371|NCT00383123|490335|P2|Overall Study|Adverse Event|0
151372|NCT00383123|490336|P1|Overall Study|Adverse Event|1
151373|NCT00383084|490377|P2|Overall Study|Withdrawal by Subject|10
151374|NCT00383084|490378|P1|Overall Study|Withdrawal by Subject|12
151375|NCT00383019|490409|P2|Overall Study|Withdrawal by Subject|1
151376|NCT00383019|490410|P1|Overall Study|Withdrawal by Subject|0
151377|NCT00383019|490409|P2|Overall Study|Adverse Event|1
151378|NCT00383019|490410|P1|Overall Study|Adverse Event|5
151379|NCT00382993|490432|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
151380|NCT00382993|490433|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
151381|NCT00382993|490432|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
151382|NCT00382993|490433|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
151383|NCT00382993|490432|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
151384|NCT00382993|490433|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
151385|NCT00382993|490432|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
151386|NCT00382993|490433|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
151387|NCT00382993|490432|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
151388|NCT00382993|490433|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
151389|NCT00382993|490432|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
151390|NCT00382993|490433|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
151391|NCT00382993|490432|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
151392|NCT00382993|490433|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
151393|NCT00382993|490432|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
151394|NCT00382993|490433|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
151395|NCT00382993|490432|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
151396|NCT00382993|490433|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
151397|NCT00382993|490432|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
151398|NCT00382993|490433|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
151399|NCT00382967|490477|P2|Overall Study|Protocol Violation|1
151400|NCT00382967|490478|P1|Overall Study|Protocol Violation|1
151401|NCT00382863|490503|P2|Overall Study|Withdrawal by Subject|25
151402|NCT00382863|490504|P1|Overall Study|Withdrawal by Subject|5
151403|NCT00382863|490503|P2|Overall Study|Lost to Follow-up|2
151404|NCT00382863|490504|P1|Overall Study|Lost to Follow-up|1
151405|NCT00382863|490503|P2|Overall Study|Death|9
151406|NCT00382863|490504|P1|Overall Study|Death|9
151407|NCT00382733|490571|P5|Overall Study|Withdrawal by Subject|0
151408|NCT00382733|490572|P4|Overall Study|Withdrawal by Subject|0
151409|NCT00382733|490573|P3|Overall Study|Withdrawal by Subject|0
151410|NCT00382733|490574|P2|Overall Study|Withdrawal by Subject|1
151411|NCT00382733|490575|P1|Overall Study|Withdrawal by Subject|0
151412|NCT00382720|490596|P3|Overall Study|Discontinued at end of study|2
151413|NCT00382720|490597|P2|Overall Study|Discontinued at end of study|1
151414|NCT00382720|490598|P1|Overall Study|Discontinued at end of study|0
151415|NCT00382720|490596|P3|Overall Study|Investigator/Clinical decision|6
151416|NCT00382720|490597|P2|Overall Study|Investigator/Clinical decision|6
151417|NCT00382720|490598|P1|Overall Study|Investigator/Clinical decision|5
151418|NCT00382720|490596|P3|Overall Study|Good prognosis|0
151419|NCT00382720|490597|P2|Overall Study|Good prognosis|1
151420|NCT00382720|490598|P1|Overall Study|Good prognosis|0
151421|NCT00382720|490596|P3|Overall Study|Clinically progressive disease|0
151422|NCT00382720|490597|P2|Overall Study|Clinically progressive disease|1
151423|NCT00382720|490598|P1|Overall Study|Clinically progressive disease|0
151424|NCT00382720|490596|P3|Overall Study|Patient did not receive study medication|4
151425|NCT00382720|490597|P2|Overall Study|Patient did not receive study medication|1
151426|NCT00382720|490598|P1|Overall Study|Patient did not receive study medication|1
151427|NCT00382720|490596|P3|Overall Study|Surgery|4
151428|NCT00382720|490597|P2|Overall Study|Surgery|1
151429|NCT00382720|490598|P1|Overall Study|Surgery|1
151430|NCT00382720|490596|P3|Overall Study|Withdrawal by Subject|12
151431|NCT00382720|490597|P2|Overall Study|Withdrawal by Subject|20
151432|NCT00382720|490598|P1|Overall Study|Withdrawal by Subject|11
151433|NCT00382720|490596|P3|Overall Study|Withdrew consent|2
151434|NCT00382720|490597|P2|Overall Study|Withdrew consent|1
151435|NCT00382720|490598|P1|Overall Study|Withdrew consent|1
151436|NCT00382720|490596|P3|Overall Study|Progressive disease|38
151437|NCT00382720|490597|P2|Overall Study|Progressive disease|28
151438|NCT00382720|490598|P1|Overall Study|Progressive disease|37
151439|NCT00382720|490596|P3|Overall Study|Death|2
151440|NCT00382720|490597|P2|Overall Study|Death|1
151441|NCT00382720|490598|P1|Overall Study|Death|0
151442|NCT00382720|490596|P3|Overall Study|Protocol Violation|1
151443|NCT00382720|490597|P2|Overall Study|Protocol Violation|5
151444|NCT00382720|490598|P1|Overall Study|Protocol Violation|2
151445|NCT00382720|490596|P3|Overall Study|Adverse Event|15
151446|NCT00382720|490597|P2|Overall Study|Adverse Event|23
151447|NCT00382720|490598|P1|Overall Study|Adverse Event|21
151448|NCT00382408|490623|P2|Overall Study|Other|35
151449|NCT00382408|490624|P1|Overall Study|Other|100
151450|NCT00382408|490623|P2|Overall Study|Lost to Follow-up|8
151451|NCT00382408|490624|P1|Overall Study|Lost to Follow-up|19
151452|NCT00382408|490623|P2|Overall Study|Pregnancy|0
151453|NCT00382408|490624|P1|Overall Study|Pregnancy|2
151454|NCT00382408|490623|P2|Overall Study|Withdrawal by Subject|6
151455|NCT00382408|490624|P1|Overall Study|Withdrawal by Subject|17
151456|NCT00382408|490623|P2|Overall Study|Physician Decision|0
151457|NCT00382408|490624|P1|Overall Study|Physician Decision|1
151458|NCT00382408|490623|P2|Overall Study|Protocol Violation|2
151459|NCT00382408|490624|P1|Overall Study|Protocol Violation|2
151460|NCT00382408|490623|P2|Overall Study|Did not meet protocol requirement|3
151461|NCT00382408|490624|P1|Overall Study|Did not meet protocol requirement|3
151462|NCT00382291|490639|P3|Overall Study|Lack of Efficacy|1
151463|NCT00382291|490640|P2|Overall Study|Lack of Efficacy|0
151464|NCT00382291|490641|P1|Overall Study|Lack of Efficacy|0
151465|NCT00382291|490639|P3|Overall Study|Physician Decision|0
151466|NCT00382291|490640|P2|Overall Study|Physician Decision|1
151467|NCT00382291|490641|P1|Overall Study|Physician Decision|0
151468|NCT00382291|490639|P3|Overall Study|Withdrawal by Subject|0
151469|NCT00382291|490640|P2|Overall Study|Withdrawal by Subject|2
151470|NCT00382291|490641|P1|Overall Study|Withdrawal by Subject|0
151471|NCT00382291|490639|P3|Overall Study|Temporary study suspension|5
151472|NCT00382291|490640|P2|Overall Study|Temporary study suspension|2
151473|NCT00382291|490641|P1|Overall Study|Temporary study suspension|2
151474|NCT00382291|490639|P3|Overall Study|Protocol Violation|0
151475|NCT00382291|490640|P2|Overall Study|Protocol Violation|0
151476|NCT00382291|490641|P1|Overall Study|Protocol Violation|1
151477|NCT00382291|490639|P3|Overall Study|Adverse Event|2
151478|NCT00382291|490640|P2|Overall Study|Adverse Event|2
151479|NCT00382291|490641|P1|Overall Study|Adverse Event|1
151480|NCT00382174|490654|P3|Overall Study|Wounds merged|2
151481|NCT00382174|490655|P2|Overall Study|Wounds merged|2
151482|NCT00382174|490656|P1|Overall Study|Wounds merged|0
151483|NCT00382174|490654|P3|Overall Study|Failed to meet criteria|1
151484|NCT00382174|490655|P2|Overall Study|Failed to meet criteria|1
151485|NCT00382174|490656|P1|Overall Study|Failed to meet criteria|0
151486|NCT00382174|490654|P3|Overall Study|Physician Decision|2
151487|NCT00382174|490655|P2|Overall Study|Physician Decision|2
151488|NCT00382174|490656|P1|Overall Study|Physician Decision|0
151489|NCT00382174|490654|P3|Overall Study|Non compliance|1
151490|NCT00382174|490655|P2|Overall Study|Non compliance|0
151491|NCT00382174|490656|P1|Overall Study|Non compliance|1
151492|NCT00382174|490654|P3|Overall Study|Withdrawal by Subject|5
151493|NCT00382174|490655|P2|Overall Study|Withdrawal by Subject|4
151494|NCT00382174|490656|P1|Overall Study|Withdrawal by Subject|1
151495|NCT00382174|490654|P3|Overall Study|Adverse Event|5
151496|NCT00382174|490655|P2|Overall Study|Adverse Event|4
151497|NCT00382174|490656|P1|Overall Study|Adverse Event|1
151498|NCT00382174|490654|P3|Overall Study|Lost to Follow-up|5
151499|NCT00382174|490655|P2|Overall Study|Lost to Follow-up|4
151500|NCT00382174|490656|P1|Overall Study|Lost to Follow-up|1
151501|NCT00382109|490684|P2|Overall Study|consent withdrawal|1
151502|NCT00382109|490685|P1|Overall Study|consent withdrawal|0
151503|NCT00382109|490684|P2|Overall Study|Other|2
151504|NCT00382109|490685|P1|Overall Study|Other|0
151505|NCT00382109|490684|P2|Overall Study|ineligible|0
151506|NCT00382109|490685|P1|Overall Study|ineligible|2
151507|NCT00382109|490684|P2|Overall Study|Withdrawal by Subject|0
151508|NCT00382109|490685|P1|Overall Study|Withdrawal by Subject|1
151509|NCT00382109|490684|P2|Overall Study|Physician Decision|1
151510|NCT00382109|490685|P1|Overall Study|Physician Decision|6
151511|NCT00382109|490684|P2|Overall Study|Adverse Event|0
151512|NCT00382109|490685|P1|Overall Study|Adverse Event|3
151513|NCT00381940|490720|P1|Overall Study|Ineligible|1
151514|NCT00381940|490720|P1|Overall Study|Protocol Violation|1
151515|NCT00381940|490720|P1|Overall Study|Lack of Efficacy|3
151516|NCT00381888|490724|P1|Overall Study|Adverse Event|1
151517|NCT00381888|490724|P1|Overall Study|Surgery was cancelled|2
151518|NCT00381888|490724|P1|Overall Study|Had laparoscopic surgery|2
151519|NCT00381888|490724|P1|Overall Study|Protocol Violation|9
151520|NCT00381888|490724|P1|Overall Study|Physician Decision|1
151521|NCT00381888|490724|P1|Overall Study|Withdrawal by Subject|1
151522|NCT00381888|490724|P1|Overall Study|Death|1
151523|NCT00381849|490735|P2|Wash Out|Withdrawal by Subject|1
151524|NCT00381849|490736|P1|Wash Out|Withdrawal by Subject|0
151525|NCT00381797|490763|P5|Overall Study|Ineligible|0
151526|NCT00381797|490764|P4|Overall Study|Ineligible|1
151527|NCT00381797|490765|P3|Overall Study|Ineligible|0
151528|NCT00381797|490766|P2|Overall Study|Ineligible|0
151529|NCT00381797|490767|P1|Overall Study|Ineligible|0
151530|NCT00381797|490763|P5|Overall Study|Withdrawal by Subject|2
151531|NCT00381797|490764|P4|Overall Study|Withdrawal by Subject|0
151532|NCT00381797|490765|P3|Overall Study|Withdrawal by Subject|0
151533|NCT00381797|490766|P2|Overall Study|Withdrawal by Subject|1
151534|NCT00381797|490767|P1|Overall Study|Withdrawal by Subject|1
151535|NCT00381693|490817|P1|Overall Study|Progression|2
151536|NCT00381693|490817|P1|Overall Study|Patient Choice|1
151537|NCT00381693|490817|P1|Overall Study|Adverse Event|4
151538|NCT00381693|490817|P1|Overall Study|Death|1
151539|NCT00381615|490845|P4|Overall Study|Protocol Violation|0
151540|NCT00381615|490846|P3|Overall Study|Protocol Violation|1
151541|NCT00381615|490847|P2|Overall Study|Protocol Violation|0
151542|NCT00381615|490848|P1|Overall Study|Protocol Violation|0
151543|NCT00381615|490845|P4|Overall Study|Lost to Follow-up|1
151544|NCT00381615|490846|P3|Overall Study|Lost to Follow-up|0
151545|NCT00381615|490847|P2|Overall Study|Lost to Follow-up|2
151546|NCT00381615|490848|P1|Overall Study|Lost to Follow-up|3
151547|NCT00381615|490845|P4|Overall Study|Withdrawal by Subject|1
151548|NCT00381615|490846|P3|Overall Study|Withdrawal by Subject|0
151549|NCT00381615|490847|P2|Overall Study|Withdrawal by Subject|3
151550|NCT00381615|490848|P1|Overall Study|Withdrawal by Subject|1
151551|NCT00381485|490906|P4|Double-Blind Treatment Period|Administrative|1
151552|NCT00381485|490907|P3|Double-Blind Treatment Period|Administrative|0
151553|NCT00381485|490908|P2|Double-Blind Treatment Period|Administrative|1
151554|NCT00381485|490909|P1|Double-Blind Treatment Period|Administrative|0
151555|NCT00381485|490906|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
151556|NCT00381485|490907|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
151557|NCT00381485|490908|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
151558|NCT00381485|490909|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
151559|NCT00381485|490906|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
151560|NCT00381485|490907|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
151561|NCT00381485|490908|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
151562|NCT00381485|490909|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
151563|NCT00381485|490906|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
151564|NCT00381485|490907|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
151565|NCT00381485|490908|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
151566|NCT00381485|490909|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
151567|NCT00381485|490906|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
151568|NCT00381485|490907|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
151569|NCT00381485|490908|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
151570|NCT00381485|490909|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
151571|NCT00381485|490906|P4|Double-Blind Treatment Period|Lost to Follow-up|1
151572|NCT00381485|490907|P3|Double-Blind Treatment Period|Lost to Follow-up|1
151573|NCT00381485|490908|P2|Double-Blind Treatment Period|Lost to Follow-up|0
151574|NCT00381485|490909|P1|Double-Blind Treatment Period|Lost to Follow-up|0
151575|NCT00381485|490906|P4|Double-Blind Treatment Period|Lack of Efficacy|13
151576|NCT00381485|490907|P3|Double-Blind Treatment Period|Lack of Efficacy|11
151577|NCT00381485|490908|P2|Double-Blind Treatment Period|Lack of Efficacy|8
151578|NCT00381485|490909|P1|Double-Blind Treatment Period|Lack of Efficacy|0
151579|NCT00381485|490906|P4|Double-Blind Treatment Period|Adverse Event|5
151580|NCT00381485|490907|P3|Double-Blind Treatment Period|Adverse Event|2
151581|NCT00381485|490908|P2|Double-Blind Treatment Period|Adverse Event|2
151582|NCT00381485|490909|P1|Double-Blind Treatment Period|Adverse Event|0
151583|NCT00381485|490906|P4|Open-Label Run-In Period|Treatment failure|0
151584|NCT00381485|490907|P3|Open-Label Run-In Period|Treatment failure|0
151585|NCT00381485|490908|P2|Open-Label Run-In Period|Treatment failure|0
151586|NCT00381485|490909|P1|Open-Label Run-In Period|Treatment failure|1
151587|NCT00381485|490906|P4|Open-Label Run-In Period|Lost to Follow-up|0
151588|NCT00381485|490907|P3|Open-Label Run-In Period|Lost to Follow-up|0
151589|NCT00381485|490908|P2|Open-Label Run-In Period|Lost to Follow-up|0
151590|NCT00381485|490909|P1|Open-Label Run-In Period|Lost to Follow-up|3
151591|NCT00381485|490906|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
151592|NCT00381485|490907|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
151593|NCT00381485|490908|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
151594|NCT00381485|490909|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
151595|NCT00381485|490906|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
151596|NCT00381485|490907|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
151597|NCT00381485|490908|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
151598|NCT00381485|490909|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
151599|NCT00381485|490906|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
151600|NCT00381485|490907|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
151601|NCT00381485|490908|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
151602|NCT00381485|490909|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
151603|NCT00381485|490906|P4|Open-Label Run-In Period|Adverse Event|0
151604|NCT00381485|490907|P3|Open-Label Run-In Period|Adverse Event|0
151605|NCT00381485|490908|P2|Open-Label Run-In Period|Adverse Event|0
151606|NCT00381485|490909|P1|Open-Label Run-In Period|Adverse Event|9
151607|NCT00381381|490927|P1|Overall Study|Withdrawal by Subject|9
151608|NCT00381381|490927|P1|Overall Study|Lost to Follow-up|52
151609|NCT00381381|490927|P1|Overall Study|Adverse Event|3
151610|NCT00381303|490936|P2|Overall Study|Subject primary physician's decision|0
151611|NCT00381303|490937|P1|Overall Study|Subject primary physician's decision|1
151612|NCT00381303|490936|P2|Overall Study|Subject did not continue visits|0
151613|NCT00381303|490937|P1|Overall Study|Subject did not continue visits|1
151614|NCT00381303|490936|P2|Overall Study|Subject was too busy for appointments|0
151615|NCT00381303|490937|P1|Overall Study|Subject was too busy for appointments|1
151616|NCT00381303|490936|P2|Overall Study|No virologic response by week 12|0
151617|NCT00381303|490937|P1|Overall Study|No virologic response by week 12|1
151618|NCT00381303|490936|P2|Overall Study|Subject taking too many different meds|0
151619|NCT00381303|490937|P1|Overall Study|Subject taking too many different meds|1
151620|NCT00381303|490936|P2|Overall Study|Subject moved out of state|0
151621|NCT00381303|490937|P1|Overall Study|Subject moved out of state|2
151622|NCT00381303|490936|P2|Overall Study|Physician's decision to close the site|1
151623|NCT00381303|490937|P1|Overall Study|Physician's decision to close the site|3
151624|NCT00381303|490936|P2|Overall Study|Physician Decision|0
151625|NCT00381303|490937|P1|Overall Study|Physician Decision|1
151626|NCT00381303|490936|P2|Overall Study|Pregnancy|0
151627|NCT00381303|490937|P1|Overall Study|Pregnancy|2
151628|NCT00381303|490936|P2|Overall Study|Ineligible to continue the trial|1
151629|NCT00381303|490937|P1|Overall Study|Ineligible to continue the trial|2
151630|NCT00381303|490936|P2|Overall Study|Virologic failure|4
151631|NCT00381303|490937|P1|Overall Study|Virologic failure|6
151632|NCT00381303|490936|P2|Overall Study|Withdrawal by Subject|6
151633|NCT00381303|490937|P1|Overall Study|Withdrawal by Subject|13
151634|NCT00381303|490936|P2|Overall Study|Non-Adherence|6
151635|NCT00381303|490937|P1|Overall Study|Non-Adherence|13
151636|NCT00381303|490936|P2|Overall Study|AE/HIV-related event|6
151637|NCT00381303|490937|P1|Overall Study|AE/HIV-related event|22
151638|NCT00381303|490936|P2|Overall Study|Lost to Follow-up|9
151639|NCT00381303|490937|P1|Overall Study|Lost to Follow-up|25
151640|NCT00381095|490999|P2|Overall Study|Adverse Event|7
151641|NCT00381095|491000|P1|Overall Study|Adverse Event|2
151642|NCT00381095|490999|P2|Overall Study|Withdrawal by Subject|3
151643|NCT00381095|491000|P1|Overall Study|Withdrawal by Subject|3
151644|NCT00381095|490999|P2|Overall Study|Protocol Violation|1
151645|NCT00381095|491000|P1|Overall Study|Protocol Violation|1
151646|NCT00381095|490999|P2|Overall Study|Unspecified|2
151647|NCT00381095|491000|P1|Overall Study|Unspecified|2
151648|NCT00381095|490999|P2|Overall Study|Lack of Efficacy|4
151649|NCT00381095|491000|P1|Overall Study|Lack of Efficacy|2
151650|NCT00381095|490999|P2|Overall Study|Death|4
151651|NCT00381095|491000|P1|Overall Study|Death|3
151652|NCT00381043|491032|P2|Overall Study|incarcerated|0
151653|NCT00381043|491033|P1|Overall Study|incarcerated|1
151654|NCT00381043|491032|P2|Overall Study|wanted more care|1
151655|NCT00381043|491033|P1|Overall Study|wanted more care|0
151656|NCT00381043|491032|P2|Overall Study|Withdrawal by Subject|1
151657|NCT00381043|491033|P1|Overall Study|Withdrawal by Subject|3
151658|NCT00381043|491032|P2|Overall Study|Lost to Follow-up|6
151659|NCT00381043|491033|P1|Overall Study|Lost to Follow-up|8
151660|NCT00380978|491059|P2|Overall Study|Parous patient|0
151661|NCT00380978|491060|P1|Overall Study|Parous patient|1
151662|NCT00380978|491059|P2|Overall Study|Allocation prior to analgesia request|2
151663|NCT00380978|491060|P1|Overall Study|Allocation prior to analgesia request|1
151664|NCT00380978|491059|P2|Overall Study|Wrong study envelope|2
151665|NCT00380978|491060|P1|Overall Study|Wrong study envelope|0
151666|NCT00380978|491059|P2|Overall Study|Refused allocated intervention|6
151667|NCT00380978|491060|P1|Overall Study|Refused allocated intervention|0
151668|NCT00380874|491082|P2|Overall Study|Not related to study drug|2
151669|NCT00380874|491083|P1|Overall Study|Not related to study drug|3
151670|NCT00380874|491082|P2|Overall Study|Withdrawal by Subject|1
151671|NCT00380874|491083|P1|Overall Study|Withdrawal by Subject|2
151672|NCT00380874|491082|P2|Overall Study|Death|0
151673|NCT00380874|491083|P1|Overall Study|Death|1
151674|NCT00380874|491082|P2|Overall Study|Adverse Event|7
151675|NCT00380874|491083|P1|Overall Study|Adverse Event|7
151676|NCT00380718|491108|P1|Overall Study|Death after 30-day post-therapy followup|17
151677|NCT00380718|491108|P1|Overall Study|Adverse Event|1
151678|NCT00380692|491120|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
151679|NCT00380692|491121|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
151680|NCT00380692|491120|P2|Study Period III - Open Label|Lack of Efficacy|4
151681|NCT00380692|491121|P1|Study Period III - Open Label|Lack of Efficacy|0
151682|NCT00380692|491120|P2|Study Period III - Open Label|Physician Decision|3
151683|NCT00380692|491121|P1|Study Period III - Open Label|Physician Decision|0
151684|NCT00380692|491120|P2|Study Period III - Open Label|Withdrawal by Subject|1
151685|NCT00380692|491121|P1|Study Period III - Open Label|Withdrawal by Subject|0
151686|NCT00380692|491120|P2|Study Period III - Open Label|Protocol Violation|0
151687|NCT00380692|491121|P1|Study Period III - Open Label|Protocol Violation|0
151688|NCT00380692|491120|P2|Study Period III - Open Label|Adverse Event|3
151689|NCT00380692|491121|P1|Study Period III - Open Label|Adverse Event|5
151690|NCT00380692|491120|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
151691|NCT00380692|491121|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
151692|NCT00380692|491120|P2|Study Period II - Double Blind|Lack of Efficacy|0
151693|NCT00380692|491121|P1|Study Period II - Double Blind|Lack of Efficacy|1
151694|NCT00380692|491120|P2|Study Period II - Double Blind|Physician Decision|1
151695|NCT00380692|491121|P1|Study Period II - Double Blind|Physician Decision|0
151696|NCT00380692|491120|P2|Study Period II - Double Blind|Withdrawal by Subject|0
151697|NCT00380692|491121|P1|Study Period II - Double Blind|Withdrawal by Subject|0
151698|NCT00380692|491120|P2|Study Period II - Double Blind|Protocol Violation|2
151699|NCT00380692|491121|P1|Study Period II - Double Blind|Protocol Violation|2
151700|NCT00380692|491120|P2|Study Period II - Double Blind|Adverse Event|0
151701|NCT00380692|491121|P1|Study Period II - Double Blind|Adverse Event|1
151702|NCT00380588|491169|P2|Overall Study|Physician Decision|0
151703|NCT00380588|491170|P1|Overall Study|Physician Decision|2
151704|NCT00380588|491169|P2|Overall Study|Withdrawal by Subject|3
151705|NCT00380588|491170|P1|Overall Study|Withdrawal by Subject|1
151706|NCT00380588|491169|P2|Overall Study|Adverse Event|3
151707|NCT00380588|491170|P1|Overall Study|Adverse Event|7
151708|NCT00380588|491169|P2|Overall Study|Next Cycle Not Started|0
151709|NCT00380588|491170|P1|Overall Study|Next Cycle Not Started|4
151710|NCT00380588|491169|P2|Overall Study|Unequivocal Disease Progression|34
151711|NCT00380588|491170|P1|Overall Study|Unequivocal Disease Progression|25
151712|NCT00380367|491182|P1|Overall Study|Withdrawal by Subject|1
151713|NCT00380367|491182|P1|Overall Study|Lost to Follow-up|1
151714|NCT00380250|491189|P2|Overall Study|Physician Decision|0
151715|NCT00380250|491190|P1|Overall Study|Physician Decision|1
151716|NCT00380250|491189|P2|Overall Study|Lost to Follow-up|5
151717|NCT00380250|491190|P1|Overall Study|Lost to Follow-up|14
151718|NCT00380250|491189|P2|Overall Study|Protocol Violation|5
151719|NCT00380250|491190|P1|Overall Study|Protocol Violation|15
151720|NCT00380250|491189|P2|Overall Study|Lack of Efficacy|8
151721|NCT00380250|491190|P1|Overall Study|Lack of Efficacy|10
151722|NCT00380250|491189|P2|Overall Study|Adverse Event|9
151723|NCT00380250|491190|P1|Overall Study|Adverse Event|20
151724|NCT00380250|491189|P2|Overall Study|Withdrawal by Subject|28
151725|NCT00380250|491190|P1|Overall Study|Withdrawal by Subject|39
151726|NCT00380081|491258|P6|Overall Study|Family Emergency|1
151727|NCT00380081|491259|P5|Overall Study|Family Emergency|0
151728|NCT00380081|491260|P4|Overall Study|Family Emergency|0
151729|NCT00380081|491261|P3|Overall Study|Family Emergency|0
151730|NCT00380081|491262|P2|Overall Study|Family Emergency|0
151731|NCT00380081|491263|P1|Overall Study|Family Emergency|0
151732|NCT00380081|491258|P6|Overall Study|Withdrawal by Subject|0
151733|NCT00380081|491259|P5|Overall Study|Withdrawal by Subject|1
151734|NCT00380081|491260|P4|Overall Study|Withdrawal by Subject|0
151735|NCT00380081|491261|P3|Overall Study|Withdrawal by Subject|0
151736|NCT00380081|491262|P2|Overall Study|Withdrawal by Subject|0
151737|NCT00380081|491263|P1|Overall Study|Withdrawal by Subject|0
151738|NCT00380068|491313|P1|Overall Study|Lack of Efficacy|5
151739|NCT00380068|491313|P1|Overall Study|Partipant moved away|1
151740|NCT00380068|491313|P1|Overall Study|Physician Decision|2
151741|NCT00380068|491313|P1|Overall Study|Lung transplant|3
151742|NCT00380068|491313|P1|Overall Study|Addition of other PAH therapeutic agent|1
151743|NCT00380068|491313|P1|Overall Study|Lost to Follow-up|1
151744|NCT00380068|491313|P1|Overall Study|Not compliant|6
151745|NCT00380068|491313|P1|Overall Study|Withdrawal by Subject|10
151746|NCT00380068|491313|P1|Overall Study|Adverse Event|40
151747|NCT00379899|491335|P2|Overall Study|Other|1
151748|NCT00379899|491336|P1|Overall Study|Other|3
151749|NCT00379899|491335|P2|Overall Study|Other protocol-specified criteria|4
151750|NCT00379899|491336|P1|Overall Study|Other protocol-specified criteria|3
151751|NCT00379899|491335|P2|Overall Study|Coronary artery bypass graft|1
151752|NCT00379899|491336|P1|Overall Study|Coronary artery bypass graft|1
151753|NCT00379899|491335|P2|Overall Study|Renal transplantation|4
151754|NCT00379899|491336|P1|Overall Study|Renal transplantation|5
151755|NCT00379899|491335|P2|Overall Study|Parathyroidectomy|2
151756|NCT00379899|491336|P1|Overall Study|Parathyroidectomy|0
151757|NCT00379899|491335|P2|Overall Study|Noncompliance|1
151758|NCT00379899|491336|P1|Overall Study|Noncompliance|1
151759|NCT00379899|491335|P2|Overall Study|Ineligibility determined|1
151760|NCT00379899|491336|P1|Overall Study|Ineligibility determined|0
151761|NCT00379899|491335|P2|Overall Study|Withdrawal by Subject|5
151762|NCT00379899|491336|P1|Overall Study|Withdrawal by Subject|5
151763|NCT00379899|491335|P2|Overall Study|Physician Decision|4
151764|NCT00379899|491336|P1|Overall Study|Physician Decision|3
151765|NCT00379899|491335|P2|Overall Study|Lost to Follow-up|4
151766|NCT00379899|491336|P1|Overall Study|Lost to Follow-up|2
151767|NCT00379899|491335|P2|Overall Study|Death|10
151768|NCT00379899|491336|P1|Overall Study|Death|10
151769|NCT00379899|491335|P2|Overall Study|Adverse Event|3
151770|NCT00379899|491336|P1|Overall Study|Adverse Event|7
151771|NCT00379834|491364|P1|Overall Study|Time constraints|2
151772|NCT00379808|491516|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
151773|NCT00379808|491517|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
151774|NCT00379795|491538|P5|Overall Study|Sponsor's decision|10
151775|NCT00379795|491539|P4|Overall Study|Sponsor's decision|47
151776|NCT00379795|491540|P3|Overall Study|Sponsor's decision|54
151777|NCT00379795|491541|P2|Overall Study|Sponsor's decision|17
151778|NCT00379795|491542|P1|Overall Study|Sponsor's decision|257
151779|NCT00379795|491538|P5|Overall Study|Subjects condition mandated intervention|7
151780|NCT00379795|491539|P4|Overall Study|Subjects condition mandated intervention|5
151781|NCT00379795|491540|P3|Overall Study|Subjects condition mandated intervention|7
151782|NCT00379795|491541|P2|Overall Study|Subjects condition mandated intervention|9
151783|NCT00379795|491542|P1|Overall Study|Subjects condition mandated intervention|34
151784|NCT00379795|491538|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
151785|NCT00379795|491539|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
151786|NCT00379795|491540|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
151787|NCT00379795|491541|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
151788|NCT00379795|491542|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
151789|NCT00379795|491538|P5|Overall Study|Subject non-compliance|1
151790|NCT00379795|491539|P4|Overall Study|Subject non-compliance|0
151791|NCT00379795|491540|P3|Overall Study|Subject non-compliance|0
151792|NCT00379795|491541|P2|Overall Study|Subject non-compliance|2
151793|NCT00379795|491542|P1|Overall Study|Subject non-compliance|7
151794|NCT00379795|491538|P5|Overall Study|Withdrawal by Subject|14
151795|NCT00379795|491539|P4|Overall Study|Withdrawal by Subject|7
151796|NCT00379795|491540|P3|Overall Study|Withdrawal by Subject|19
151797|NCT00379795|491541|P2|Overall Study|Withdrawal by Subject|11
151798|NCT00379795|491542|P1|Overall Study|Withdrawal by Subject|94
151799|NCT00379795|491538|P5|Overall Study|Physician Decision|2
151800|NCT00379795|491539|P4|Overall Study|Physician Decision|2
151801|NCT00379795|491540|P3|Overall Study|Physician Decision|2
151802|NCT00379795|491541|P2|Overall Study|Physician Decision|0
151803|NCT00379795|491542|P1|Overall Study|Physician Decision|25
151804|NCT00379795|491538|P5|Overall Study|Lost to Follow-up|4
151805|NCT00379795|491539|P4|Overall Study|Lost to Follow-up|1
151806|NCT00379795|491540|P3|Overall Study|Lost to Follow-up|2
151807|NCT00379795|491541|P2|Overall Study|Lost to Follow-up|1
151808|NCT00379795|491542|P1|Overall Study|Lost to Follow-up|8
151809|NCT00379795|491538|P5|Overall Study|Adverse Event|4
151810|NCT00379795|491539|P4|Overall Study|Adverse Event|1
151811|NCT00379795|491540|P3|Overall Study|Adverse Event|3
151812|NCT00379795|491541|P2|Overall Study|Adverse Event|3
151813|NCT00379795|491542|P1|Overall Study|Adverse Event|17
151814|NCT00379795|491538|P5|Overall Study|Death|7
151815|NCT00379795|491539|P4|Overall Study|Death|4
151816|NCT00379795|491540|P3|Overall Study|Death|6
151817|NCT00379795|491541|P2|Overall Study|Death|8
151818|NCT00379795|491542|P1|Overall Study|Death|31
151819|NCT00379769|491572|P6|Observational Follow-up|Unknown; Reason Not Provided|1
151820|NCT00379769|491573|P5|Observational Follow-up|Unknown; Reason Not Provided|1
151821|NCT00379769|491574|P4|Observational Follow-up|Unknown; Reason Not Provided|0
151822|NCT00379769|491575|P3|Observational Follow-up|Unknown; Reason Not Provided|0
151823|NCT00379769|491576|P2|Observational Follow-up|Unknown; Reason Not Provided|0
151824|NCT00379769|491577|P1|Observational Follow-up|Unknown; Reason Not Provided|0
151825|NCT00379769|491572|P6|Observational Follow-up|Participant Moved|1
151826|NCT00379769|491573|P5|Observational Follow-up|Participant Moved|0
151827|NCT00379769|491574|P4|Observational Follow-up|Participant Moved|0
151828|NCT00379769|491575|P3|Observational Follow-up|Participant Moved|0
151829|NCT00379769|491576|P2|Observational Follow-up|Participant Moved|0
151830|NCT00379769|491577|P1|Observational Follow-up|Participant Moved|0
151831|NCT00379769|491572|P6|Observational Follow-up|Site Closed Early|7
151832|NCT00379769|491573|P5|Observational Follow-up|Site Closed Early|6
151833|NCT00379769|491574|P4|Observational Follow-up|Site Closed Early|0
151834|NCT00379769|491575|P3|Observational Follow-up|Site Closed Early|0
151835|NCT00379769|491576|P2|Observational Follow-up|Site Closed Early|0
151836|NCT00379769|491577|P1|Observational Follow-up|Site Closed Early|0
151837|NCT00379769|491572|P6|Observational Follow-up|Physician Decision|8
151838|NCT00379769|491573|P5|Observational Follow-up|Physician Decision|8
151839|NCT00379769|491574|P4|Observational Follow-up|Physician Decision|0
151840|NCT00379769|491575|P3|Observational Follow-up|Physician Decision|0
151841|NCT00379769|491576|P2|Observational Follow-up|Physician Decision|0
151842|NCT00379769|491577|P1|Observational Follow-up|Physician Decision|0
151843|NCT00379769|491572|P6|Observational Follow-up|Entered into Another Clinical Trial|22
151844|NCT00379769|491573|P5|Observational Follow-up|Entered into Another Clinical Trial|18
151845|NCT00379769|491574|P4|Observational Follow-up|Entered into Another Clinical Trial|0
151846|NCT00379769|491575|P3|Observational Follow-up|Entered into Another Clinical Trial|0
151847|NCT00379769|491576|P2|Observational Follow-up|Entered into Another Clinical Trial|0
151848|NCT00379769|491577|P1|Observational Follow-up|Entered into Another Clinical Trial|0
151849|NCT00379769|491572|P6|Observational Follow-up|Withdrawal by Subject|12
151850|NCT00379769|491573|P5|Observational Follow-up|Withdrawal by Subject|12
151851|NCT00379769|491574|P4|Observational Follow-up|Withdrawal by Subject|0
151852|NCT00379769|491575|P3|Observational Follow-up|Withdrawal by Subject|0
151853|NCT00379769|491576|P2|Observational Follow-up|Withdrawal by Subject|0
151854|NCT00379769|491577|P1|Observational Follow-up|Withdrawal by Subject|0
151855|NCT00379769|491572|P6|Observational Follow-up|Lost to Follow-up|27
151856|NCT00379769|491573|P5|Observational Follow-up|Lost to Follow-up|25
151857|NCT00379769|491574|P4|Observational Follow-up|Lost to Follow-up|0
151858|NCT00379769|491575|P3|Observational Follow-up|Lost to Follow-up|0
151859|NCT00379769|491576|P2|Observational Follow-up|Lost to Follow-up|0
151860|NCT00379769|491577|P1|Observational Follow-up|Lost to Follow-up|0
151861|NCT00379769|491572|P6|Observational Follow-up|Adverse Event|0
151862|NCT00379769|491573|P5|Observational Follow-up|Adverse Event|1
151863|NCT00379769|491574|P4|Observational Follow-up|Adverse Event|0
151864|NCT00379769|491575|P3|Observational Follow-up|Adverse Event|0
151865|NCT00379769|491576|P2|Observational Follow-up|Adverse Event|0
151866|NCT00379769|491577|P1|Observational Follow-up|Adverse Event|0
151867|NCT00379769|491572|P6|Observational Follow-up|Death|70
151868|NCT00379769|491573|P5|Observational Follow-up|Death|78
151869|NCT00379769|491574|P4|Observational Follow-up|Death|0
151870|NCT00379769|491575|P3|Observational Follow-up|Death|0
151871|NCT00379769|491576|P2|Observational Follow-up|Death|0
151872|NCT00379769|491577|P1|Observational Follow-up|Death|0
151873|NCT00379769|491572|P6|Main Study|Reason unspecified|0
151874|NCT00379769|491573|P5|Main Study|Reason unspecified|0
151875|NCT00379769|491574|P4|Main Study|Reason unspecified|0
151876|NCT00379769|491575|P3|Main Study|Reason unspecified|1
151877|NCT00379769|491576|P2|Main Study|Reason unspecified|0
151878|NCT00379769|491577|P1|Main Study|Reason unspecified|0
151879|NCT00379769|491572|P6|Main Study|Investigator refused to log temperature|0
151880|NCT00379769|491573|P5|Main Study|Investigator refused to log temperature|0
151881|NCT00379769|491574|P4|Main Study|Investigator refused to log temperature|0
151882|NCT00379769|491575|P3|Main Study|Investigator refused to log temperature|1
151883|NCT00379769|491576|P2|Main Study|Investigator refused to log temperature|0
151884|NCT00379769|491577|P1|Main Study|Investigator refused to log temperature|0
151885|NCT00379769|491572|P6|Main Study|Risk of heart failure|0
151886|NCT00379769|491573|P5|Main Study|Risk of heart failure|0
151887|NCT00379769|491574|P4|Main Study|Risk of heart failure|0
151888|NCT00379769|491575|P3|Main Study|Risk of heart failure|0
151889|NCT00379769|491576|P2|Main Study|Risk of heart failure|1
151890|NCT00379769|491577|P1|Main Study|Risk of heart failure|0
151891|NCT00379769|491572|P6|Main Study|Personal reasons|0
151892|NCT00379769|491573|P5|Main Study|Personal reasons|0
151893|NCT00379769|491574|P4|Main Study|Personal reasons|0
151894|NCT00379769|491575|P3|Main Study|Personal reasons|0
151895|NCT00379769|491576|P2|Main Study|Personal reasons|0
151896|NCT00379769|491577|P1|Main Study|Personal reasons|1
151897|NCT00379769|491572|P6|Main Study|Participant completed study at visit 27|0
151898|NCT00379769|491573|P5|Main Study|Participant completed study at visit 27|0
151899|NCT00379769|491574|P4|Main Study|Participant completed study at visit 27|0
151900|NCT00379769|491575|P3|Main Study|Participant completed study at visit 27|0
151901|NCT00379769|491576|P2|Main Study|Participant completed study at visit 27|0
151902|NCT00379769|491577|P1|Main Study|Participant completed study at visit 27|1
151903|NCT00379769|491572|P6|Main Study|Physician Decision|0
151904|NCT00379769|491573|P5|Main Study|Physician Decision|0
151905|NCT00379769|491574|P4|Main Study|Physician Decision|1
151906|NCT00379769|491575|P3|Main Study|Physician Decision|1
151907|NCT00379769|491576|P2|Main Study|Physician Decision|2
151908|NCT00379769|491577|P1|Main Study|Physician Decision|2
151909|NCT00379769|491572|P6|Main Study|Participant did not take study drug|0
151910|NCT00379769|491573|P5|Main Study|Participant did not take study drug|0
151911|NCT00379769|491574|P4|Main Study|Participant did not take study drug|0
151912|NCT00379769|491575|P3|Main Study|Participant did not take study drug|1
151913|NCT00379769|491576|P2|Main Study|Participant did not take study drug|0
151914|NCT00379769|491577|P1|Main Study|Participant did not take study drug|0
151915|NCT00379769|491572|P6|Main Study|Entry criteria violation|0
151916|NCT00379769|491573|P5|Main Study|Entry criteria violation|0
151917|NCT00379769|491574|P4|Main Study|Entry criteria violation|1
151918|NCT00379769|491575|P3|Main Study|Entry criteria violation|1
151919|NCT00379769|491576|P2|Main Study|Entry criteria violation|0
151920|NCT00379769|491577|P1|Main Study|Entry criteria violation|0
151921|NCT00379769|491572|P6|Main Study|Site closed|0
151922|NCT00379769|491573|P5|Main Study|Site closed|0
151923|NCT00379769|491574|P4|Main Study|Site closed|8
151924|NCT00379769|491575|P3|Main Study|Site closed|4
151925|NCT00379769|491576|P2|Main Study|Site closed|4
151926|NCT00379769|491577|P1|Main Study|Site closed|4
151927|NCT00379769|491572|P6|Main Study|Prohibited glucose lowering medication|0
151928|NCT00379769|491573|P5|Main Study|Prohibited glucose lowering medication|0
151929|NCT00379769|491574|P4|Main Study|Prohibited glucose lowering medication|1
151930|NCT00379769|491575|P3|Main Study|Prohibited glucose lowering medication|0
151931|NCT00379769|491576|P2|Main Study|Prohibited glucose lowering medication|3
151932|NCT00379769|491577|P1|Main Study|Prohibited glucose lowering medication|0
151933|NCT00379769|491572|P6|Main Study|Poor compliance|0
151934|NCT00379769|491573|P5|Main Study|Poor compliance|0
151935|NCT00379769|491574|P4|Main Study|Poor compliance|1
151936|NCT00379769|491575|P3|Main Study|Poor compliance|2
151937|NCT00379769|491576|P2|Main Study|Poor compliance|2
151938|NCT00379769|491577|P1|Main Study|Poor compliance|3
151939|NCT00379769|491572|P6|Main Study|Participant moved|0
151940|NCT00379769|491573|P5|Main Study|Participant moved|0
151941|NCT00379769|491574|P4|Main Study|Participant moved|3
151942|NCT00379769|491575|P3|Main Study|Participant moved|3
151943|NCT00379769|491576|P2|Main Study|Participant moved|2
151944|NCT00379769|491577|P1|Main Study|Participant moved|3
151945|NCT00379769|491572|P6|Main Study|Moved to survival status follow-up only|0
151946|NCT00379769|491573|P5|Main Study|Moved to survival status follow-up only|0
151947|NCT00379769|491574|P4|Main Study|Moved to survival status follow-up only|36
151948|NCT00379769|491575|P3|Main Study|Moved to survival status follow-up only|32
151949|NCT00379769|491576|P2|Main Study|Moved to survival status follow-up only|25
151950|NCT00379769|491577|P1|Main Study|Moved to survival status follow-up only|27
151951|NCT00379769|491572|P6|Main Study|Withdrawal by Subject|0
151952|NCT00379769|491573|P5|Main Study|Withdrawal by Subject|0
151953|NCT00379769|491574|P4|Main Study|Withdrawal by Subject|70
151954|NCT00379769|491575|P3|Main Study|Withdrawal by Subject|72
151955|NCT00379769|491576|P2|Main Study|Withdrawal by Subject|56
151956|NCT00379769|491577|P1|Main Study|Withdrawal by Subject|46
151957|NCT00379769|491572|P6|Main Study|Lost to Follow-up|0
151958|NCT00379769|491573|P5|Main Study|Lost to Follow-up|0
151959|NCT00379769|491574|P4|Main Study|Lost to Follow-up|26
151960|NCT00379769|491575|P3|Main Study|Lost to Follow-up|25
151961|NCT00379769|491576|P2|Main Study|Lost to Follow-up|29
151962|NCT00379769|491577|P1|Main Study|Lost to Follow-up|29
151963|NCT00379769|491572|P6|Main Study|Adverse Event|0
151964|NCT00379769|491573|P5|Main Study|Adverse Event|0
151965|NCT00379769|491574|P4|Main Study|Adverse Event|11
151966|NCT00379769|491575|P3|Main Study|Adverse Event|10
151967|NCT00379769|491576|P2|Main Study|Adverse Event|8
151968|NCT00379769|491577|P1|Main Study|Adverse Event|5
151969|NCT00379769|491572|P6|Main Study|Death|0
151970|NCT00379769|491573|P5|Main Study|Death|0
151971|NCT00379769|491574|P4|Main Study|Death|72
151972|NCT00379769|491575|P3|Main Study|Death|54
151973|NCT00379769|491576|P2|Main Study|Death|67
151974|NCT00379769|491577|P1|Main Study|Death|57
151975|NCT00379639|491736|P5|Overall Study|Other|0
151976|NCT00379639|491737|P4|Overall Study|Other|0
151977|NCT00379639|491738|P3|Overall Study|Other|3
151978|NCT00379639|491739|P2|Overall Study|Other|0
151979|NCT00379639|491740|P1|Overall Study|Other|0
151980|NCT00379639|491736|P5|Overall Study|Lost to Follow-up|0
151981|NCT00379639|491737|P4|Overall Study|Lost to Follow-up|1
151982|NCT00379639|491738|P3|Overall Study|Lost to Follow-up|0
151983|NCT00379639|491739|P2|Overall Study|Lost to Follow-up|0
151984|NCT00379639|491740|P1|Overall Study|Lost to Follow-up|0
151985|NCT00379639|491736|P5|Overall Study|Adverse Event|1
151986|NCT00379639|491737|P4|Overall Study|Adverse Event|0
151987|NCT00379639|491738|P3|Overall Study|Adverse Event|1
151988|NCT00379639|491739|P2|Overall Study|Adverse Event|0
151989|NCT00379639|491740|P1|Overall Study|Adverse Event|0
151990|NCT00379639|491736|P5|Overall Study|Symptomatic Deterioration|1
151991|NCT00379639|491737|P4|Overall Study|Symptomatic Deterioration|0
151992|NCT00379639|491738|P3|Overall Study|Symptomatic Deterioration|1
151993|NCT00379639|491739|P2|Overall Study|Symptomatic Deterioration|0
151994|NCT00379639|491740|P1|Overall Study|Symptomatic Deterioration|0
151995|NCT00379639|491736|P5|Overall Study|Physician Decision|0
151996|NCT00379639|491737|P4|Overall Study|Physician Decision|1
151997|NCT00379639|491738|P3|Overall Study|Physician Decision|1
151998|NCT00379639|491739|P2|Overall Study|Physician Decision|2
151999|NCT00379639|491740|P1|Overall Study|Physician Decision|0
152000|NCT00379639|491736|P5|Overall Study|Disease Progression|4
152001|NCT00379639|491737|P4|Overall Study|Disease Progression|4
152002|NCT00379639|491738|P3|Overall Study|Disease Progression|3
152003|NCT00379639|491739|P2|Overall Study|Disease Progression|3
152004|NCT00379639|491740|P1|Overall Study|Disease Progression|3
152005|NCT00379587|491762|P1|Overall Study|Lost to Follow-up|2
152006|NCT00379353|491776|P2|Overall Study|Conflicting drug treatment|1
152007|NCT00379353|491777|P1|Overall Study|Conflicting drug treatment|0
152008|NCT00379353|491776|P2|Overall Study|Non-compliance|0
152009|NCT00379353|491777|P1|Overall Study|Non-compliance|1
152010|NCT00379353|491776|P2|Overall Study|Cardiac Tamponade|0
152011|NCT00379353|491777|P1|Overall Study|Cardiac Tamponade|1
152012|NCT00379353|491776|P2|Overall Study|Death|0
152013|NCT00379353|491777|P1|Overall Study|Death|1
152014|NCT00379353|491776|P2|Overall Study|Withdrawal by Subject|2
152015|NCT00379353|491777|P1|Overall Study|Withdrawal by Subject|5
152016|NCT00379353|491776|P2|Overall Study|Hospitalization|3
152017|NCT00379353|491777|P1|Overall Study|Hospitalization|3
152018|NCT00379288|491811|P4|Overall Study|Administrative|1
152019|NCT00379288|491812|P3|Overall Study|Administrative|0
152020|NCT00379288|491813|P2|Overall Study|Administrative|2
152021|NCT00379288|491814|P1|Overall Study|Administrative|2
152022|NCT00379288|491811|P4|Overall Study|Did not meet protocol eligibility|2
152023|NCT00379288|491812|P3|Overall Study|Did not meet protocol eligibility|0
152024|NCT00379288|491813|P2|Overall Study|Did not meet protocol eligibility|1
152025|NCT00379288|491814|P1|Overall Study|Did not meet protocol eligibility|0
152026|NCT00379288|491811|P4|Overall Study|Noncompliance with protocol|1
152027|NCT00379288|491812|P3|Overall Study|Noncompliance with protocol|2
152028|NCT00379288|491813|P2|Overall Study|Noncompliance with protocol|6
152029|NCT00379288|491814|P1|Overall Study|Noncompliance with protocol|8
152030|NCT00379288|491811|P4|Overall Study|Subject withdrew-related to study drug|1
152031|NCT00379288|491812|P3|Overall Study|Subject withdrew-related to study drug|0
152032|NCT00379288|491813|P2|Overall Study|Subject withdrew-related to study drug|0
152033|NCT00379288|491814|P1|Overall Study|Subject withdrew-related to study drug|1
152034|NCT00379288|491811|P4|Overall Study|Subject withdrew-unrelated to study drug|2
152035|NCT00379288|491812|P3|Overall Study|Subject withdrew-unrelated to study drug|4
152036|NCT00379288|491813|P2|Overall Study|Subject withdrew-unrelated to study drug|3
152037|NCT00379288|491814|P1|Overall Study|Subject withdrew-unrelated to study drug|0
152038|NCT00379288|491811|P4|Overall Study|Lost to Follow-up|0
152039|NCT00379288|491812|P3|Overall Study|Lost to Follow-up|2
152040|NCT00379288|491813|P2|Overall Study|Lost to Follow-up|3
152041|NCT00379288|491814|P1|Overall Study|Lost to Follow-up|3
152042|NCT00379288|491811|P4|Overall Study|Treatment Failure|1
152043|NCT00379288|491812|P3|Overall Study|Treatment Failure|0
152044|NCT00379288|491813|P2|Overall Study|Treatment Failure|1
152045|NCT00379288|491814|P1|Overall Study|Treatment Failure|0
152046|NCT00379288|491811|P4|Overall Study|Adverse Event|0
152047|NCT00379288|491812|P3|Overall Study|Adverse Event|2
152048|NCT00379288|491813|P2|Overall Study|Adverse Event|6
152049|NCT00379288|491814|P1|Overall Study|Adverse Event|5
152050|NCT00379236|491826|P3|Open-label Extension|Not specified|7
152051|NCT00379236|491827|P2|Open-label Extension|Not specified|0
152052|NCT00379236|491828|P1|Open-label Extension|Not specified|0
152053|NCT00379236|491826|P3|Open-label Extension|Use of exclusionary medication|3
152054|NCT00379236|491827|P2|Open-label Extension|Use of exclusionary medication|0
152055|NCT00379236|491828|P1|Open-label Extension|Use of exclusionary medication|0
152056|NCT00379236|491826|P3|Open-label Extension|Lost to Follow-up|12
152057|NCT00379236|491827|P2|Open-label Extension|Lost to Follow-up|0
152058|NCT00379236|491828|P1|Open-label Extension|Lost to Follow-up|0
152059|NCT00379236|491826|P3|Open-label Extension|Withdrawal by Subject|13
152060|NCT00379236|491827|P2|Open-label Extension|Withdrawal by Subject|0
152061|NCT00379236|491828|P1|Open-label Extension|Withdrawal by Subject|0
152062|NCT00379236|491826|P3|Open-label Extension|Protocol Violation|7
152063|NCT00379236|491827|P2|Open-label Extension|Protocol Violation|0
152064|NCT00379236|491828|P1|Open-label Extension|Protocol Violation|0
152065|NCT00379236|491826|P3|Open-label Extension|Adverse Event|13
152066|NCT00379236|491827|P2|Open-label Extension|Adverse Event|0
152067|NCT00379236|491828|P1|Open-label Extension|Adverse Event|0
152068|NCT00379236|491826|P3|Double-blind|Data could not be retrieved|0
152069|NCT00379236|491827|P2|Double-blind|Data could not be retrieved|2
152070|NCT00379236|491828|P1|Double-blind|Data could not be retrieved|2
152071|NCT00379236|491826|P3|Double-blind|Not specified|0
152072|NCT00379236|491827|P2|Double-blind|Not specified|7
152073|NCT00379236|491828|P1|Double-blind|Not specified|3
152074|NCT00379236|491826|P3|Double-blind|Use of exclusionary medication|0
152075|NCT00379236|491827|P2|Double-blind|Use of exclusionary medication|2
152076|NCT00379236|491828|P1|Double-blind|Use of exclusionary medication|1
152077|NCT00379236|491826|P3|Double-blind|Lost to Follow-up|0
152078|NCT00379236|491827|P2|Double-blind|Lost to Follow-up|3
152079|NCT00379236|491828|P1|Double-blind|Lost to Follow-up|4
152080|NCT00379236|491826|P3|Double-blind|Withdrawal by Subject|0
152081|NCT00379236|491827|P2|Double-blind|Withdrawal by Subject|13
152082|NCT00379236|491828|P1|Double-blind|Withdrawal by Subject|12
152083|NCT00379236|491826|P3|Double-blind|Protocol Violation|0
152084|NCT00379236|491827|P2|Double-blind|Protocol Violation|3
152085|NCT00379236|491828|P1|Double-blind|Protocol Violation|3
152086|NCT00379236|491826|P3|Double-blind|Adverse Event|0
152087|NCT00379236|491827|P2|Double-blind|Adverse Event|6
152088|NCT00379236|491828|P1|Double-blind|Adverse Event|11
152089|NCT00379210|491873|P2|Overall Study|Withdrawal by Subject|7
152090|NCT00379210|491874|P1|Overall Study|Withdrawal by Subject|10
152091|NCT00378703|491884|P4|Overall Study|Other|3
152092|NCT00378703|491885|P3|Overall Study|Other|2
152093|NCT00378703|491886|P2|Overall Study|Other|1
152094|NCT00378703|491887|P1|Overall Study|Other|1
152095|NCT00378703|491884|P4|Overall Study|Never started treatment|0
152096|NCT00378703|491885|P3|Overall Study|Never started treatment|0
152097|NCT00378703|491886|P2|Overall Study|Never started treatment|4
152098|NCT00378703|491887|P1|Overall Study|Never started treatment|1
152099|NCT00378703|491884|P4|Overall Study|Ineligible|7
152100|NCT00378703|491885|P3|Overall Study|Ineligible|7
152101|NCT00378703|491886|P2|Overall Study|Ineligible|7
152102|NCT00378703|491887|P1|Overall Study|Ineligible|4
152103|NCT00378703|491884|P4|Overall Study|Relocation|0
152104|NCT00378703|491885|P3|Overall Study|Relocation|1
152105|NCT00378703|491886|P2|Overall Study|Relocation|0
152106|NCT00378703|491887|P1|Overall Study|Relocation|0
152107|NCT00378703|491884|P4|Overall Study|Adverse events and progressive disease|1
152108|NCT00378703|491885|P3|Overall Study|Adverse events and progressive disease|0
152109|NCT00378703|491886|P2|Overall Study|Adverse events and progressive disease|0
152110|NCT00378703|491887|P1|Overall Study|Adverse events and progressive disease|0
152111|NCT00378703|491884|P4|Overall Study|Joint decision of physician and patient|0
152112|NCT00378703|491885|P3|Overall Study|Joint decision of physician and patient|0
152113|NCT00378703|491886|P2|Overall Study|Joint decision of physician and patient|0
152114|NCT00378703|491887|P1|Overall Study|Joint decision of physician and patient|1
152115|NCT00378703|491884|P4|Overall Study|Surgery|1
152116|NCT00378703|491885|P3|Overall Study|Surgery|0
152117|NCT00378703|491886|P2|Overall Study|Surgery|0
152118|NCT00378703|491887|P1|Overall Study|Surgery|1
152119|NCT00378703|491884|P4|Overall Study|Symptomatic deterioration|2
152120|NCT00378703|491885|P3|Overall Study|Symptomatic deterioration|0
152121|NCT00378703|491886|P2|Overall Study|Symptomatic deterioration|1
152122|NCT00378703|491887|P1|Overall Study|Symptomatic deterioration|0
152123|NCT00378703|491884|P4|Overall Study|Other complicated disease|0
152124|NCT00378703|491885|P3|Overall Study|Other complicated disease|2
152125|NCT00378703|491886|P2|Overall Study|Other complicated disease|2
152126|NCT00378703|491887|P1|Overall Study|Other complicated disease|0
152127|NCT00378703|491884|P4|Overall Study|Alternative therapy|0
152128|NCT00378703|491885|P3|Overall Study|Alternative therapy|0
152129|NCT00378703|491886|P2|Overall Study|Alternative therapy|2
152130|NCT00378703|491887|P1|Overall Study|Alternative therapy|4
152131|NCT00378703|491884|P4|Overall Study|Physician Decision|0
152132|NCT00378703|491885|P3|Overall Study|Physician Decision|1
152133|NCT00378703|491886|P2|Overall Study|Physician Decision|4
152134|NCT00378703|491887|P1|Overall Study|Physician Decision|1
152135|NCT00378703|491884|P4|Overall Study|Withdrawal by Subject|7
152136|NCT00378703|491885|P3|Overall Study|Withdrawal by Subject|5
152137|NCT00378703|491886|P2|Overall Study|Withdrawal by Subject|8
152138|NCT00378703|491887|P1|Overall Study|Withdrawal by Subject|4
152139|NCT00378703|491884|P4|Overall Study|Death|3
152140|NCT00378703|491885|P3|Overall Study|Death|4
152141|NCT00378703|491886|P2|Overall Study|Death|2
152142|NCT00378703|491887|P1|Overall Study|Death|2
152143|NCT00378703|491884|P4|Overall Study|Adverse Event|18
152144|NCT00378703|491885|P3|Overall Study|Adverse Event|20
152145|NCT00378703|491886|P2|Overall Study|Adverse Event|17
152146|NCT00378703|491887|P1|Overall Study|Adverse Event|11
152147|NCT00378703|491884|P4|Overall Study|Disease progression|49
152148|NCT00378703|491885|P3|Overall Study|Disease progression|48
152149|NCT00378703|491886|P2|Overall Study|Disease progression|43
152150|NCT00378703|491887|P1|Overall Study|Disease progression|59
152151|NCT00378599|491909|P1|Overall Study|Withdrawal by Subject|5
152152|NCT00378599|491909|P1|Overall Study|Treatment failure|7
152153|NCT00378599|491909|P1|Overall Study|Protocol Violation|2
152154|NCT00378599|491909|P1|Overall Study|Adverse Event|38
152155|NCT00378573|491913|P1|Follow-up|Withdrawal by Subject|1
152156|NCT00378573|491913|P1|Follow-up|Lost to Follow-up|1
152157|NCT00378573|491913|P1|Follow-up|Death|12
152158|NCT00378573|491913|P1|Treatment Period|Sponsor decision to close study|1
152159|NCT00378573|491913|P1|Treatment Period|Disease Progression|4
152160|NCT00378573|491913|P1|Treatment Period|Withdrawal by Subject|2
152161|NCT00378573|491913|P1|Treatment Period|Physician Decision|1
152162|NCT00378573|491913|P1|Treatment Period|Adverse Event|9
152163|NCT00378560|491921|P2|Overall Study|Laboratory test values abnormal|0
152164|NCT00378560|491922|P1|Overall Study|Laboratory test values abnormal|1
152165|NCT00378560|491921|P2|Overall Study|Pregnancy|5
152166|NCT00378560|491922|P1|Overall Study|Pregnancy|7
152167|NCT00378560|491921|P2|Overall Study|Moved|3
152168|NCT00378560|491922|P1|Overall Study|Moved|4
152169|NCT00378560|491921|P2|Overall Study|Withdrawal by Subject|21
152170|NCT00378560|491922|P1|Overall Study|Withdrawal by Subject|17
152171|NCT00378560|491921|P2|Overall Study|Protocol Violation|0
152172|NCT00378560|491922|P1|Overall Study|Protocol Violation|2
152173|NCT00378560|491921|P2|Overall Study|Lost to Follow-up|29
152174|NCT00378560|491922|P1|Overall Study|Lost to Follow-up|24
152175|NCT00378560|491921|P2|Overall Study|Adverse Event|0
152176|NCT00378560|491922|P1|Overall Study|Adverse Event|1
152177|NCT00378534|491936|P1|Overall Study|Subjects did not receive a transplant|3
152178|NCT00378534|491936|P1|Overall Study|Donors|57
152179|NCT00378508|491942|P2|Overall Study|Lost to Follow-up|0
152180|NCT00378508|491943|P1|Overall Study|Lost to Follow-up|1
152181|NCT00378508|491942|P2|Overall Study|Withdrawal by Subject|3
152182|NCT00378508|491943|P1|Overall Study|Withdrawal by Subject|1
152183|NCT00378378|491962|P3|Overall Study|Non-compliance with protocol|1
152184|NCT00378378|491963|P2|Overall Study|Non-compliance with protocol|0
152185|NCT00378378|491964|P1|Overall Study|Non-compliance with protocol|0
152186|NCT00378378|491962|P3|Overall Study|Treatment Failure|1
152187|NCT00378378|491963|P2|Overall Study|Treatment Failure|0
152188|NCT00378378|491964|P1|Overall Study|Treatment Failure|0
152189|NCT00378378|491962|P3|Overall Study|Withdrawal by Subject|0
152190|NCT00378378|491963|P2|Overall Study|Withdrawal by Subject|1
152191|NCT00378378|491964|P1|Overall Study|Withdrawal by Subject|0
152192|NCT00378209|491981|P1|Overall Study|Treatment delay|1
152193|NCT00378209|491981|P1|Overall Study|Death|1
152194|NCT00378209|491981|P1|Overall Study|Physician Decision|3
152195|NCT00378209|491981|P1|Overall Study|Initiation of non-protocol therapy|3
152196|NCT00378209|491981|P1|Overall Study|Adverse Event|3
152197|NCT00378209|491981|P1|Overall Study|Progressive disease|11
152198|NCT00378105|491991|P2|Overall Study|necessity to increase lenalidomide dose|1
152199|NCT00378105|491992|P1|Overall Study|necessity to increase lenalidomide dose|0
152200|NCT00378105|491991|P2|Overall Study|Going non-protocol therapy|1
152201|NCT00378105|491992|P1|Overall Study|Going non-protocol therapy|0
152202|NCT00378105|491991|P2|Overall Study|Physician Decision|2
152203|NCT00378105|491992|P1|Overall Study|Physician Decision|0
152204|NCT00378105|491991|P2|Overall Study|remain on study|11
152205|NCT00378105|491992|P1|Overall Study|remain on study|3
152206|NCT00378105|491991|P2|Overall Study|Progressive disease|3
152207|NCT00378105|491992|P1|Overall Study|Progressive disease|3
152208|NCT00378105|491991|P2|Overall Study|Going to transplant|8
152209|NCT00378105|491992|P1|Overall Study|Going to transplant|7
152210|NCT00378105|491991|P2|Overall Study|Death|0
152211|NCT00378105|491992|P1|Overall Study|Death|1
152212|NCT00378105|491991|P2|Overall Study|Withdrawal by Subject|3
152213|NCT00378105|491992|P1|Overall Study|Withdrawal by Subject|3
152214|NCT00378105|491991|P2|Overall Study|Adverse Event|1
152215|NCT00378105|491992|P1|Overall Study|Adverse Event|3
152216|NCT00378079|492004|P3|Overall Study|Lost to Follow-up|0
152217|NCT00378079|492005|P2|Overall Study|Lost to Follow-up|1
152218|NCT00378079|492006|P1|Overall Study|Lost to Follow-up|6
152219|NCT00378014|492028|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
152220|NCT00378014|492029|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
152221|NCT00378014|492028|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
152222|NCT00378014|492029|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
152223|NCT00378014|492028|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
152224|NCT00378014|492029|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
152225|NCT00378014|492028|P2|Extension (Month 12 to Month 59)|Administrative problems|0
152226|NCT00378014|492029|P1|Extension (Month 12 to Month 59)|Administrative problems|1
152227|NCT00378014|492028|P2|Extension (Month 12 to Month 59)|Death|2
152228|NCT00378014|492029|P1|Extension (Month 12 to Month 59)|Death|1
152229|NCT00378014|492028|P2|Extension (Month 12 to Month 59)|Adverse Event|7
152230|NCT00378014|492029|P1|Extension (Month 12 to Month 59)|Adverse Event|8
152231|NCT00378014|492028|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
152232|NCT00378014|492029|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
152233|NCT00378014|492028|P2|Core (Randomization to Month 11)|Protocol deviation|1
152234|NCT00378014|492029|P1|Core (Randomization to Month 11)|Protocol deviation|0
152235|NCT00378014|492028|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
152236|NCT00378014|492029|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
152237|NCT00378014|492028|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
152238|NCT00378014|492029|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
152239|NCT00378014|492028|P2|Core (Randomization to Month 11)|Administrative Problems|2
152240|NCT00378014|492029|P1|Core (Randomization to Month 11)|Administrative Problems|2
152241|NCT00378014|492028|P2|Core (Randomization to Month 11)|Death|3
152242|NCT00378014|492029|P1|Core (Randomization to Month 11)|Death|5
152243|NCT00378014|492028|P2|Core (Randomization to Month 11)|Graft loss|2
152244|NCT00378014|492029|P1|Core (Randomization to Month 11)|Graft loss|1
152245|NCT00378014|492028|P2|Core (Randomization to Month 11)|Adverse Event|0
152246|NCT00378014|492029|P1|Core (Randomization to Month 11)|Adverse Event|1
152247|NCT00377962|492055|P2|Extension Study: 12-24 Months|Unspecified reason|3
152248|NCT00377962|492056|P1|Extension Study: 12-24 Months|Unspecified reason|0
152249|NCT00377962|492055|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
152250|NCT00377962|492056|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
152251|NCT00377962|492055|P2|Extension Study: 12-24 Months|Adverse Event|0
152252|NCT00377962|492056|P1|Extension Study: 12-24 Months|Adverse Event|8
152253|NCT00377962|492055|P2|Extension Study: 12-24 Months|Death|1
152254|NCT00377962|492056|P1|Extension Study: 12-24 Months|Death|1
152255|NCT00377962|492055|P2|Core Study: 0-12 Months|Unspecified reasons|4
152256|NCT00377962|492056|P1|Core Study: 0-12 Months|Unspecified reasons|1
152257|NCT00377962|492055|P2|Core Study: 0-12 Months|Administrative Reason|1
152258|NCT00377962|492056|P1|Core Study: 0-12 Months|Administrative Reason|1
152259|NCT00377962|492055|P2|Core Study: 0-12 Months|Withdrew Consent|2
152260|NCT00377962|492056|P1|Core Study: 0-12 Months|Withdrew Consent|5
152261|NCT00377962|492055|P2|Core Study: 0-12 Months|Death|0
152262|NCT00377962|492056|P1|Core Study: 0-12 Months|Death|3
152263|NCT00377962|492055|P2|Core Study: 0-12 Months|Adverse Event|2
152264|NCT00377962|492056|P1|Core Study: 0-12 Months|Adverse Event|18
152265|NCT00377858|492092|P2|Overall Study|Death|3
152266|NCT00377858|492093|P1|Overall Study|Death|0
152267|NCT00377858|492092|P2|Overall Study|Sponsor Decision|2
152268|NCT00377858|492093|P1|Overall Study|Sponsor Decision|1
152269|NCT00377858|492092|P2|Overall Study|Entry Criteria Not Met|0
152270|NCT00377858|492093|P1|Overall Study|Entry Criteria Not Met|2
152271|NCT00377858|492092|P2|Overall Study|Adverse Event|1
152272|NCT00377858|492093|P1|Overall Study|Adverse Event|2
152273|NCT00377858|492092|P2|Overall Study|Protocol Violation|4
152274|NCT00377858|492093|P1|Overall Study|Protocol Violation|3
152275|NCT00377858|492092|P2|Overall Study|Physician Decision|5
152276|NCT00377858|492093|P1|Overall Study|Physician Decision|5
152277|NCT00377858|492092|P2|Overall Study|Lost to Follow-up|1
152278|NCT00377858|492093|P1|Overall Study|Lost to Follow-up|6
152279|NCT00377858|492092|P2|Overall Study|Withdrawal by Subject|11
152280|NCT00377858|492093|P1|Overall Study|Withdrawal by Subject|12
152281|NCT00377819|492146|P2|Overall Study|Protocol Violation|1
152282|NCT00377819|492147|P1|Overall Study|Protocol Violation|1
152283|NCT00377819|492146|P2|Overall Study|Lost to Follow-up|1
152284|NCT00377819|492147|P1|Overall Study|Lost to Follow-up|0
152285|NCT00377819|492146|P2|Overall Study|Death|1
152286|NCT00377819|492147|P1|Overall Study|Death|0
152287|NCT00377819|492146|P2|Overall Study|Withdrawal by Subject|4
152288|NCT00377819|492147|P1|Overall Study|Withdrawal by Subject|10
152289|NCT00377819|492146|P2|Overall Study|Adverse Event|3
152290|NCT00377819|492147|P1|Overall Study|Adverse Event|2
152291|NCT00377676|492176|P2|Overall Study|not specified|58
152292|NCT00377676|492177|P1|Overall Study|not specified|118
152293|NCT00377676|492176|P2|Overall Study|Lost to Follow-up|56
152294|NCT00377676|492177|P1|Overall Study|Lost to Follow-up|120
152295|NCT00377676|492176|P2|Overall Study|Withdrawal by Subject|72
152296|NCT00377676|492177|P1|Overall Study|Withdrawal by Subject|187
152297|NCT00377676|492176|P2|Overall Study|Death|2
152298|NCT00377676|492177|P1|Overall Study|Death|5
152299|NCT00377676|492176|P2|Overall Study|Protocol Violation|27
152300|NCT00377676|492177|P1|Overall Study|Protocol Violation|33
152301|NCT00377676|492176|P2|Overall Study|Adverse Event|107
152302|NCT00377676|492177|P1|Overall Study|Adverse Event|498
152303|NCT00377637|492193|P4|Maintenance Phase|Death|1
152304|NCT00377637|492194|P3|Maintenance Phase|Death|0
152305|NCT00377637|492195|P2|Maintenance Phase|Death|0
152306|NCT00377637|492196|P1|Maintenance Phase|Death|0
152307|NCT00377637|492193|P4|Maintenance Phase|Study medication stopped > 14 days|1
152308|NCT00377637|492194|P3|Maintenance Phase|Study medication stopped > 14 days|0
152309|NCT00377637|492195|P2|Maintenance Phase|Study medication stopped > 14 days|0
152310|NCT00377637|492196|P1|Maintenance Phase|Study medication stopped > 14 days|0
152311|NCT00377637|492193|P4|Maintenance Phase|Non-compliance|1
152312|NCT00377637|492194|P3|Maintenance Phase|Non-compliance|1
152313|NCT00377637|492195|P2|Maintenance Phase|Non-compliance|0
152314|NCT00377637|492196|P1|Maintenance Phase|Non-compliance|0
152315|NCT00377637|492193|P4|Maintenance Phase|Sponsor decision|3
152316|NCT00377637|492194|P3|Maintenance Phase|Sponsor decision|2
152317|NCT00377637|492195|P2|Maintenance Phase|Sponsor decision|0
152318|NCT00377637|492196|P1|Maintenance Phase|Sponsor decision|0
152319|NCT00377637|492193|P4|Maintenance Phase|Withdrawal by Subject|3
152320|NCT00377637|492194|P3|Maintenance Phase|Withdrawal by Subject|3
152321|NCT00377637|492195|P2|Maintenance Phase|Withdrawal by Subject|0
152322|NCT00377637|492196|P1|Maintenance Phase|Withdrawal by Subject|0
152323|NCT00377637|492193|P4|Maintenance Phase|Lost to Follow-up|1
152324|NCT00377637|492194|P3|Maintenance Phase|Lost to Follow-up|3
152325|NCT00377637|492195|P2|Maintenance Phase|Lost to Follow-up|0
152326|NCT00377637|492196|P1|Maintenance Phase|Lost to Follow-up|0
152327|NCT00377637|492193|P4|Maintenance Phase|Physician Decision|4
152328|NCT00377637|492194|P3|Maintenance Phase|Physician Decision|5
152329|NCT00377637|492195|P2|Maintenance Phase|Physician Decision|0
152330|NCT00377637|492196|P1|Maintenance Phase|Physician Decision|0
152331|NCT00377637|492193|P4|Maintenance Phase|Adverse Event|43
152332|NCT00377637|492194|P3|Maintenance Phase|Adverse Event|29
152333|NCT00377637|492195|P2|Maintenance Phase|Adverse Event|0
152334|NCT00377637|492196|P1|Maintenance Phase|Adverse Event|0
152335|NCT00377637|492193|P4|Induction Phase|Reason for withdrawal is not noted|0
152336|NCT00377637|492194|P3|Induction Phase|Reason for withdrawal is not noted|0
152337|NCT00377637|492195|P2|Induction Phase|Reason for withdrawal is not noted|0
152338|NCT00377637|492196|P1|Induction Phase|Reason for withdrawal is not noted|2
152339|NCT00377637|492193|P4|Induction Phase|Non-Compliance|0
152340|NCT00377637|492194|P3|Induction Phase|Non-Compliance|0
152341|NCT00377637|492195|P2|Induction Phase|Non-Compliance|0
152342|NCT00377637|492196|P1|Induction Phase|Non-Compliance|1
152343|NCT00377637|492193|P4|Induction Phase|Sponsor decision|0
152344|NCT00377637|492194|P3|Induction Phase|Sponsor decision|0
152345|NCT00377637|492195|P2|Induction Phase|Sponsor decision|2
152346|NCT00377637|492196|P1|Induction Phase|Sponsor decision|1
152347|NCT00377637|492193|P4|Induction Phase|Physician Decision|0
152348|NCT00377637|492194|P3|Induction Phase|Physician Decision|0
152349|NCT00377637|492195|P2|Induction Phase|Physician Decision|1
152350|NCT00377637|492196|P1|Induction Phase|Physician Decision|3
152351|NCT00377637|492193|P4|Induction Phase|Withdrawal by Subject|0
152352|NCT00377637|492194|P3|Induction Phase|Withdrawal by Subject|0
152353|NCT00377637|492195|P2|Induction Phase|Withdrawal by Subject|6
152354|NCT00377637|492196|P1|Induction Phase|Withdrawal by Subject|5
152355|NCT00377637|492193|P4|Induction Phase|Death|0
152356|NCT00377637|492194|P3|Induction Phase|Death|0
152357|NCT00377637|492195|P2|Induction Phase|Death|3
152358|NCT00377637|492196|P1|Induction Phase|Death|1
152359|NCT00377637|492193|P4|Induction Phase|Lost to Follow-up|0
152360|NCT00377637|492194|P3|Induction Phase|Lost to Follow-up|0
152361|NCT00377637|492195|P2|Induction Phase|Lost to Follow-up|1
152362|NCT00377637|492196|P1|Induction Phase|Lost to Follow-up|2
152363|NCT00377637|492193|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
152364|NCT00377637|492194|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
152365|NCT00377637|492195|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
152366|NCT00377637|492196|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
152367|NCT00377637|492193|P4|Induction Phase|Deterioration/serum creatinine|0
152368|NCT00377637|492194|P3|Induction Phase|Deterioration/serum creatinine|0
152369|NCT00377637|492195|P2|Induction Phase|Deterioration/serum creatinine|0
152370|NCT00377637|492196|P1|Induction Phase|Deterioration/serum creatinine|2
152371|NCT00377637|492193|P4|Induction Phase|Adverse Event|0
152372|NCT00377637|492194|P3|Induction Phase|Adverse Event|0
152373|NCT00377637|492195|P2|Induction Phase|Adverse Event|21
152374|NCT00377637|492196|P1|Induction Phase|Adverse Event|12
152375|NCT00377520|492271|P1|Overall Study|Ineligible (Prior radiation)|1
152376|NCT00377455|492276|P1|Overall Study|Withdrawal by Subject|1
152377|NCT00377429|492280|P1|Overall Study|Patient non-compliance|1
152378|NCT00377429|492280|P1|Overall Study|Physician Decision|1
152379|NCT00377429|492280|P1|Overall Study|Adverse Event|8
152380|NCT00377429|492280|P1|Overall Study|Withdrawal by Subject|5
152381|NCT00377403|492291|P2|Overall Study|Unable to contact for telephone intervie|7
152382|NCT00377403|492292|P1|Overall Study|Unable to contact for telephone intervie|4
152383|NCT00377364|492300|P2|Overall Study|Withdrawal by Subject|0
152384|NCT00377364|492301|P1|Overall Study|Withdrawal by Subject|1
152385|NCT00377364|492300|P2|Overall Study|Lost to Follow-up|0
152386|NCT00377364|492301|P1|Overall Study|Lost to Follow-up|1
152387|NCT00377312|492327|P2|Overall Study|Adverse Event|1
152388|NCT00377312|492328|P1|Overall Study|Adverse Event|1
152389|NCT00377299|492360|P2|Overall Study|Withdrawal by Subject|4
152390|NCT00377299|492361|P1|Overall Study|Withdrawal by Subject|5
152391|NCT00377299|492360|P2|Overall Study|Adverse Event|1
152392|NCT00377299|492361|P1|Overall Study|Adverse Event|0
152393|NCT00377299|492360|P2|Overall Study|Lost to Follow-up|19
152394|NCT00377299|492361|P1|Overall Study|Lost to Follow-up|14
152395|NCT00377260|492377|P2|Overall Study|Withdrawal by Subject|4
152396|NCT00377260|492378|P1|Overall Study|Withdrawal by Subject|2
152397|NCT00377260|492377|P2|Overall Study|Lost to Follow-up|1
152398|NCT00377260|492378|P1|Overall Study|Lost to Follow-up|0
152399|NCT00377234|492432|P2|Overall Study|Not assigned|2
152400|NCT00377234|492433|P1|Overall Study|Not assigned|3
152401|NCT00377234|492432|P2|Overall Study|Administrative|1
152402|NCT00377234|492433|P1|Overall Study|Administrative|2
152403|NCT00377234|492432|P2|Overall Study|Lost to Follow-up|2
152404|NCT00377234|492433|P1|Overall Study|Lost to Follow-up|4
152405|NCT00377234|492432|P2|Overall Study|Withdrawal by Subject|9
152406|NCT00377234|492433|P1|Overall Study|Withdrawal by Subject|11
152407|NCT00377234|492432|P2|Overall Study|Adverse Event|17
152408|NCT00377234|492433|P1|Overall Study|Adverse Event|14
152409|NCT00376961|492449|P2|Maintenance|Ineligible|3
152410|NCT00376961|492450|P1|Maintenance|Ineligible|0
152411|NCT00376961|492449|P2|Maintenance|Progression/relapse|18
152412|NCT00376961|492450|P1|Maintenance|Progression/relapse|0
152413|NCT00376961|492449|P2|Maintenance|Refusal Unrelated to Adverse Event|1
152414|NCT00376961|492450|P1|Maintenance|Refusal Unrelated to Adverse Event|0
152415|NCT00376961|492449|P2|Maintenance|Adverse Event|1
152416|NCT00376961|492450|P1|Maintenance|Adverse Event|0
152417|NCT00376961|492449|P2|Initial Registration|Ineligible|0
152418|NCT00376961|492450|P1|Initial Registration|Ineligible|3
152419|NCT00376961|492449|P2|Initial Registration|Progression/relapse|0
152420|NCT00376961|492450|P1|Initial Registration|Progression/relapse|1
152421|NCT00376961|492449|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
152422|NCT00376961|492450|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
152423|NCT00376961|492449|P2|Initial Registration|Adverse Event|0
152424|NCT00376961|492450|P1|Initial Registration|Adverse Event|1
152425|NCT00376688|492516|P1|Overall Study|Death|1
152426|NCT00376688|492516|P1|Overall Study|Adverse Event|3
152427|NCT00376675|492522|P2|Overall Study|Other Reason|7
152428|NCT00376675|492523|P1|Overall Study|Other Reason|1
152429|NCT00376675|492522|P2|Overall Study|Adverse Event|5
152430|NCT00376675|492523|P1|Overall Study|Adverse Event|10
152431|NCT00376675|492522|P2|Overall Study|Withdrawal by Subject|2
152432|NCT00376675|492523|P1|Overall Study|Withdrawal by Subject|9
152433|NCT00376532|492557|P2|Overall Study|Lack sufficient blood sample|6
152434|NCT00376532|492558|P1|Overall Study|Lack sufficient blood sample|6
152435|NCT00376506|492568|P2|Overall Study|Death|2
152436|NCT00376506|492569|P1|Overall Study|Death|0
152437|NCT00376259|492600|P2|Overall Study|Patient request|0
152438|NCT00376259|492601|P1|Overall Study|Patient request|1
152439|NCT00376259|492600|P2|Overall Study|Sponsor request - study termination|21
152440|NCT00376259|492601|P1|Overall Study|Sponsor request - study termination|21
152441|NCT00376168|492615|P2|Overall Study|Pregnancy|0
152442|NCT00376168|492616|P1|Overall Study|Pregnancy|1
152443|NCT00376168|492615|P2|Overall Study|Adverse Event|1
152444|NCT00376168|492616|P1|Overall Study|Adverse Event|1
152445|NCT00375934|492657|P2|Overall Study|Physician Decision|1
152446|NCT00375934|492658|P1|Overall Study|Physician Decision|0
152447|NCT00375934|492657|P2|Overall Study|Lack of Efficacy|2
152448|NCT00375934|492658|P1|Overall Study|Lack of Efficacy|0
152449|NCT00375934|492657|P2|Overall Study|Withdrawal by Subject|2
152450|NCT00375934|492658|P1|Overall Study|Withdrawal by Subject|2
152451|NCT00375934|492657|P2|Overall Study|Adverse Event|1
152452|NCT00375934|492658|P1|Overall Study|Adverse Event|1
152453|NCT00375752|492686|P2|Overall Study|Administrative Problems|1
152454|NCT00375752|492687|P1|Overall Study|Administrative Problems|0
152455|NCT00375752|492686|P2|Overall Study|Protocol Violation|2
152456|NCT00375752|492687|P1|Overall Study|Protocol Violation|0
152457|NCT00375752|492686|P2|Overall Study|Abnormal Laboratory Value(s)|1
152458|NCT00375752|492687|P1|Overall Study|Abnormal Laboratory Value(s)|1
152459|NCT00375752|492686|P2|Overall Study|Withdrawal by Subject|1
152460|NCT00375752|492687|P1|Overall Study|Withdrawal by Subject|6
152461|NCT00375752|492686|P2|Overall Study|Adverse Event|6
152462|NCT00375752|492687|P1|Overall Study|Adverse Event|1
152463|NCT00375752|492686|P2|Overall Study|Lack of Efficacy|4
152464|NCT00375752|492687|P1|Overall Study|Lack of Efficacy|4
152465|NCT00375518|492716|P2|Overall Study|Death|1
152466|NCT00375518|492717|P1|Overall Study|Death|0
152467|NCT00375518|492716|P2|Overall Study|Patient Not Treated|6
152468|NCT00375518|492717|P1|Overall Study|Patient Not Treated|6
152469|NCT00375518|492716|P2|Overall Study|Withdrawal by Subject|10
152470|NCT00375518|492717|P1|Overall Study|Withdrawal by Subject|2
152471|NCT00375505|492725|P2|Overall Study|Adverse Event|2
152472|NCT00375505|492726|P1|Overall Study|Adverse Event|1
152473|NCT00375492|492770|P2|Overall Study|Withdrawal by Subject|6
152474|NCT00375492|492771|P1|Overall Study|Withdrawal by Subject|6
152475|NCT00375492|492770|P2|Overall Study|Sponsor Decision|1
152476|NCT00375492|492771|P1|Overall Study|Sponsor Decision|0
152477|NCT00375492|492770|P2|Overall Study|Protocol Violation|3
152478|NCT00375492|492771|P1|Overall Study|Protocol Violation|6
152479|NCT00375492|492770|P2|Overall Study|Physician Decision|4
152480|NCT00375492|492771|P1|Overall Study|Physician Decision|0
152481|NCT00375492|492770|P2|Overall Study|Lost to Follow-up|5
152482|NCT00375492|492771|P1|Overall Study|Lost to Follow-up|10
152483|NCT00375492|492770|P2|Overall Study|Loss of Glucose Control|1
152484|NCT00375492|492771|P1|Overall Study|Loss of Glucose Control|0
152485|NCT00375492|492770|P2|Overall Study|Entry Criteria Not Met|1
152486|NCT00375492|492771|P1|Overall Study|Entry Criteria Not Met|0
152487|NCT00375492|492770|P2|Overall Study|Adverse Event|5
152488|NCT00375492|492771|P1|Overall Study|Adverse Event|4
152489|NCT00375427|492801|P2|Overall Study|Death|10
152490|NCT00375427|492802|P1|Overall Study|Death|11
152491|NCT00375427|492801|P2|Overall Study|Administrative reasons|1
152492|NCT00375427|492802|P1|Overall Study|Administrative reasons|0
152493|NCT00375427|492801|P2|Overall Study|Lost to Follow-up|1
152494|NCT00375427|492802|P1|Overall Study|Lost to Follow-up|1
152495|NCT00375427|492801|P2|Overall Study|Withdrawal by Subject|13
152496|NCT00375427|492802|P1|Overall Study|Withdrawal by Subject|9
152497|NCT00375427|492801|P2|Overall Study|Protocol Violation|8
152498|NCT00375427|492802|P1|Overall Study|Protocol Violation|10
152499|NCT00375427|492801|P2|Overall Study|Patient no longer requires study drug|7
152500|NCT00375427|492802|P1|Overall Study|Patient no longer requires study drug|3
152501|NCT00375427|492801|P2|Overall Study|Unsatisfactory therapeutic effect|4
152502|NCT00375427|492802|P1|Overall Study|Unsatisfactory therapeutic effect|4
152503|NCT00375427|492801|P2|Overall Study|Abnormal laboratory value(s)|2
152504|NCT00375427|492802|P1|Overall Study|Abnormal laboratory value(s)|1
152505|NCT00375427|492801|P2|Overall Study|Abnormal test procedure result(s)|1
152506|NCT00375427|492802|P1|Overall Study|Abnormal test procedure result(s)|0
152507|NCT00375427|492801|P2|Overall Study|Adverse Event|27
152508|NCT00375427|492802|P1|Overall Study|Adverse Event|21
152509|NCT00375219|492827|P3|Overall Study|Withdrawal by Subject|0
152510|NCT00375219|492828|P2|Overall Study|Withdrawal by Subject|0
152511|NCT00375219|492829|P1|Overall Study|Withdrawal by Subject|1
152512|NCT00375219|492827|P3|Overall Study|Cord blood transplantation|0
152513|NCT00375219|492828|P2|Overall Study|Cord blood transplantation|0
152514|NCT00375219|492829|P1|Overall Study|Cord blood transplantation|1
152515|NCT00375219|492827|P3|Overall Study|Allograft|0
152516|NCT00375219|492828|P2|Overall Study|Allograft|0
152517|NCT00375219|492829|P1|Overall Study|Allograft|2
152518|NCT00375219|492827|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
152519|NCT00375219|492828|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
152520|NCT00375219|492829|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
152521|NCT00375219|492827|P3|Overall Study|Hematologic resistance|0
152522|NCT00375219|492828|P2|Overall Study|Hematologic resistance|0
152523|NCT00375219|492829|P1|Overall Study|Hematologic resistance|1
152524|NCT00375219|492827|P3|Overall Study|Death|7
152525|NCT00375219|492828|P2|Overall Study|Death|3
152526|NCT00375219|492829|P1|Overall Study|Death|4
152527|NCT00375219|492827|P3|Overall Study|Disease progression|12
152528|NCT00375219|492828|P2|Overall Study|Disease progression|9
152529|NCT00375219|492829|P1|Overall Study|Disease progression|18
152530|NCT00375219|492827|P3|Overall Study|Lost to Follow-up|0
152531|NCT00375219|492828|P2|Overall Study|Lost to Follow-up|1
152532|NCT00375219|492829|P1|Overall Study|Lost to Follow-up|1
152533|NCT00375219|492827|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
152534|NCT00375219|492828|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
152535|NCT00375219|492829|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
152536|NCT00375219|492827|P3|Overall Study|Protocol Violation|1
152537|NCT00375219|492828|P2|Overall Study|Protocol Violation|0
152538|NCT00375219|492829|P1|Overall Study|Protocol Violation|1
152539|NCT00375219|492827|P3|Overall Study|Adverse Event|1
152540|NCT00375219|492828|P2|Overall Study|Adverse Event|2
152541|NCT00375219|492829|P1|Overall Study|Adverse Event|8
152542|NCT00375219|492827|P3|Overall Study|Failure to achieve a response|0
152543|NCT00375219|492828|P2|Overall Study|Failure to achieve a response|2
152544|NCT00375219|492829|P1|Overall Study|Failure to achieve a response|16
152545|NCT00374907|492897|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
152546|NCT00374907|492898|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
152547|NCT00374907|492897|P2|116-Week Short-term + Long-term Period|Adverse Event|2
152548|NCT00374907|492898|P1|116-Week Short-term + Long-term Period|Adverse Event|0
152549|NCT00374907|492897|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
152550|NCT00374907|492898|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
152551|NCT00374907|492897|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
152552|NCT00374907|492898|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
152553|NCT00374907|492897|P2|12-Week Short-term Period|Subject Withdrew Consent|1
152554|NCT00374907|492898|P1|12-Week Short-term Period|Subject Withdrew Consent|3
152555|NCT00374868|492910|P1|Overall Study|Other - Not Specified|1
152556|NCT00374868|492910|P1|Overall Study|Death|2
152557|NCT00374868|492910|P1|Overall Study|Lost to Follow-up|1
152558|NCT00374868|492910|P1|Overall Study|Physician Decision|13
152559|NCT00374868|492910|P1|Overall Study|Progressive Disease|7
152560|NCT00374868|492910|P1|Overall Study|Adverse Event|12
152646|NCT00372567|493203|P3|Phase 3 Study|not specified|1
152561|NCT00374322|492988|P2|Overall Study|Did Not Receive Study Medication|6
152562|NCT00374322|492989|P1|Overall Study|Did Not Receive Study Medication|8
152563|NCT00374322|492988|P2|Overall Study|Withdrew Consent During Follow-up|5
152564|NCT00374322|492989|P1|Overall Study|Withdrew Consent During Follow-up|0
152565|NCT00374322|492988|P2|Overall Study|Noncompliance with Study Requirements|1
152566|NCT00374322|492989|P1|Overall Study|Noncompliance with Study Requirements|0
152567|NCT00374322|492988|P2|Overall Study|Started Another Chemotherapy Regimen|1
152568|NCT00374322|492989|P1|Overall Study|Started Another Chemotherapy Regimen|0
152569|NCT00374322|492988|P2|Overall Study|Participant Changed Physician|0
152570|NCT00374322|492989|P1|Overall Study|Participant Changed Physician|1
152571|NCT00374322|492988|P2|Overall Study|Site Closed|2
152572|NCT00374322|492989|P1|Overall Study|Site Closed|2
152573|NCT00374322|492988|P2|Overall Study|Severe Toxicity|0
152574|NCT00374322|492989|P1|Overall Study|Severe Toxicity|1
152575|NCT00374322|492988|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
152576|NCT00374322|492989|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
152577|NCT00374322|492988|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
152578|NCT00374322|492989|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
152579|NCT00374322|492988|P2|Overall Study|Sponsor Decision|3
152580|NCT00374322|492989|P1|Overall Study|Sponsor Decision|2
152581|NCT00374322|492988|P2|Overall Study|Par. Consented to Survival FU Only|1
152582|NCT00374322|492989|P1|Overall Study|Par. Consented to Survival FU Only|3
152583|NCT00374322|492988|P2|Overall Study|Physician Decision|32
152584|NCT00374322|492989|P1|Overall Study|Physician Decision|36
152585|NCT00374322|492988|P2|Overall Study|Sponsor Terminated Study|990
152586|NCT00374322|492989|P1|Overall Study|Sponsor Terminated Study|866
152587|NCT00374322|492988|P2|Overall Study|Withdrawal by Subject|167
152588|NCT00374322|492989|P1|Overall Study|Withdrawal by Subject|235
152589|NCT00374322|492988|P2|Overall Study|Protocol Violation|3
152590|NCT00374322|492989|P1|Overall Study|Protocol Violation|8
152591|NCT00374322|492988|P2|Overall Study|Lost to Follow-up|90
152592|NCT00374322|492989|P1|Overall Study|Lost to Follow-up|92
152593|NCT00374140|493080|P1|Overall Study|Protocol Violation|1
152594|NCT00374140|493080|P1|Overall Study|Lost to Follow-up|1
152595|NCT00373958|493099|P2|Toddler Dose|Withdrawn after infant series|25
152596|NCT00373958|493100|P1|Toddler Dose|Withdrawn after infant series|22
152597|NCT00373958|493099|P2|Toddler Dose|Protocol Violation|1
152598|NCT00373958|493100|P1|Toddler Dose|Protocol Violation|0
152599|NCT00373958|493099|P2|Toddler Dose|Failed to return|2
152600|NCT00373958|493100|P1|Toddler Dose|Failed to return|1
152601|NCT00373958|493099|P2|Toddler Dose|Withdrawal by Subject|2
152602|NCT00373958|493100|P1|Toddler Dose|Withdrawal by Subject|2
152603|NCT00373958|493099|P2|Toddler Dose|Lost to Follow-up|8
152604|NCT00373958|493100|P1|Toddler Dose|Lost to Follow-up|5
152605|NCT00373958|493099|P2|Infant Series|Physician Decision|1
152606|NCT00373958|493100|P1|Infant Series|Physician Decision|1
152607|NCT00373958|493099|P2|Infant Series|Adverse Event|1
152608|NCT00373958|493100|P1|Infant Series|Adverse Event|3
152609|NCT00373958|493099|P2|Infant Series|Consent was not received|0
152610|NCT00373958|493100|P1|Infant Series|Consent was not received|1
152611|NCT00373958|493099|P2|Infant Series|Child relocated|0
152612|NCT00373958|493100|P1|Infant Series|Child relocated|1
152613|NCT00373958|493099|P2|Infant Series|Lost Kaiser coverage|0
152614|NCT00373958|493100|P1|Infant Series|Lost Kaiser coverage|4
152615|NCT00373958|493099|P2|Infant Series|Protocol Violation|7
152616|NCT00373958|493100|P1|Infant Series|Protocol Violation|3
152617|NCT00373958|493099|P2|Infant Series|Lost to Follow-up|5
152618|NCT00373958|493100|P1|Infant Series|Lost to Follow-up|6
152619|NCT00373958|493099|P2|Infant Series|Failed to return|13
152620|NCT00373958|493100|P1|Infant Series|Failed to return|8
152621|NCT00373958|493099|P2|Infant Series|Withdrawal by Subject|15
152622|NCT00373958|493100|P1|Infant Series|Withdrawal by Subject|13
152623|NCT00373685|493165|P2|Overall Study|Randomized, not treated|77
152624|NCT00373685|493166|P1|Overall Study|Randomized, not treated|51
152625|NCT00373685|493165|P2|Overall Study|Final Status Unknown|4
152626|NCT00373685|493166|P1|Overall Study|Final Status Unknown|12
152627|NCT00373685|493165|P2|Overall Study|Protocol Violation|182
152628|NCT00373685|493166|P1|Overall Study|Protocol Violation|191
152629|NCT00373685|493165|P2|Overall Study|Unspecified|146
152630|NCT00373685|493166|P1|Overall Study|Unspecified|149
152631|NCT00373685|493165|P2|Overall Study|No longer willing to participate|352
152632|NCT00373685|493166|P1|Overall Study|No longer willing to participate|337
152633|NCT00373685|493165|P2|Overall Study|Lost to follow up|103
152634|NCT00373685|493166|P1|Overall Study|Lost to follow up|83
152635|NCT00373685|493165|P2|Overall Study|Did not meet entrance criteria|184
152636|NCT00373685|493166|P1|Overall Study|Did not meet entrance criteria|167
152637|NCT00373685|493165|P2|Overall Study|Insufficient clinical response|119
152638|NCT00373685|493166|P1|Overall Study|Insufficient clinical response|169
152639|NCT00373685|493165|P2|Overall Study|Adverse Event|253
152640|NCT00373685|493166|P1|Overall Study|Adverse Event|278
152641|NCT00373685|493165|P2|Overall Study|Death|1
152642|NCT00373685|493166|P1|Overall Study|Death|2
152643|NCT00372567|493203|P3|Phase 3 Study|study terminated by sponsor|5
152644|NCT00372567|493204|P2|Phase 3 Study|study terminated by sponsor|8
152645|NCT00372567|493205|P1|Phase 3 Study|study terminated by sponsor|13
152647|NCT00372567|493204|P2|Phase 3 Study|not specified|2
152648|NCT00372567|493205|P1|Phase 3 Study|not specified|2
152649|NCT00372567|493203|P3|Phase 3 Study|Global deterioration of health status|0
152650|NCT00372567|493204|P2|Phase 3 Study|Global deterioration of health status|1
152651|NCT00372567|493205|P1|Phase 3 Study|Global deterioration of health status|0
152652|NCT00372567|493203|P3|Phase 3 Study|Objective progression or relapse|4
152653|NCT00372567|493204|P2|Phase 3 Study|Objective progression or relapse|13
152654|NCT00372567|493205|P1|Phase 3 Study|Objective progression or relapse|10
152655|NCT00372567|493203|P3|Phase 3 Study|Protocol Violation|1
152656|NCT00372567|493204|P2|Phase 3 Study|Protocol Violation|0
152657|NCT00372567|493205|P1|Phase 3 Study|Protocol Violation|0
152658|NCT00372567|493203|P3|Phase 3 Study|Death|0
152659|NCT00372567|493204|P2|Phase 3 Study|Death|1
152660|NCT00372567|493205|P1|Phase 3 Study|Death|1
152661|NCT00372567|493203|P3|Phase 3 Study|Adverse Event|1
152662|NCT00372567|493204|P2|Phase 3 Study|Adverse Event|1
152663|NCT00372567|493205|P1|Phase 3 Study|Adverse Event|5
152664|NCT00372528|493233|P1|Overall Study|Unspecified|1
152665|NCT00372528|493233|P1|Overall Study|Study Terminated by Sponsor|18
152666|NCT00372528|493233|P1|Overall Study|Adverse Event|1
152667|NCT00372528|493233|P1|Overall Study|Lack of Efficacy|1
152668|NCT00373529|493238|P1|Overall Study|Consent violation|1
152669|NCT00373529|493238|P1|Overall Study|Failed independent confirmation of AML|3
152670|NCT00373529|493238|P1|Overall Study|Not specified|8
152671|NCT00373529|493238|P1|Overall Study|Need for treatment prohibited by study|1
152672|NCT00373529|493238|P1|Overall Study|Death|16
152673|NCT00373529|493238|P1|Overall Study|Disease recurrence|10
152674|NCT00373529|493238|P1|Overall Study|Treatment failure|36
152675|NCT00373529|493238|P1|Overall Study|Adverse Event|7
152676|NCT00373529|493238|P1|Overall Study|Withdrawal by Subject|7
152677|NCT00373529|493238|P1|Overall Study|Physician Decision|19
152678|NCT00373490|493250|P2|Overall Study|Withdrawal by Subject|1
152679|NCT00373490|493251|P1|Overall Study|Withdrawal by Subject|0
152680|NCT00373490|493250|P2|Overall Study|Lack of Efficacy|4
152681|NCT00373490|493251|P1|Overall Study|Lack of Efficacy|9
152682|NCT00373490|493250|P2|Overall Study|Adverse Event|1
152683|NCT00373490|493251|P1|Overall Study|Adverse Event|0
152684|NCT00373425|493274|P5|Overall Study|Death|0
152685|NCT00373425|493275|P4|Overall Study|Death|1
152686|NCT00373425|493276|P3|Overall Study|Death|3
152687|NCT00373425|493277|P2|Overall Study|Death|0
152688|NCT00373425|493278|P1|Overall Study|Death|7
152689|NCT00373425|493274|P5|Overall Study|Medical/ethical/noncompliance reason|5
152690|NCT00373425|493275|P4|Overall Study|Medical/ethical/noncompliance reason|2
152691|NCT00373425|493276|P3|Overall Study|Medical/ethical/noncompliance reason|10
152692|NCT00373425|493277|P2|Overall Study|Medical/ethical/noncompliance reason|9
152693|NCT00373425|493278|P1|Overall Study|Medical/ethical/noncompliance reason|21
152694|NCT00373425|493274|P5|Overall Study|Patient request|7
152695|NCT00373425|493275|P4|Overall Study|Patient request|6
152696|NCT00373425|493276|P3|Overall Study|Patient request|43
152697|NCT00373425|493277|P2|Overall Study|Patient request|18
152698|NCT00373425|493278|P1|Overall Study|Patient request|35
152699|NCT00373425|493274|P5|Overall Study|Adverse Event|34
152700|NCT00373425|493275|P4|Overall Study|Adverse Event|0
152701|NCT00373425|493276|P3|Overall Study|Adverse Event|59
152702|NCT00373425|493277|P2|Overall Study|Adverse Event|22
152703|NCT00373425|493278|P1|Overall Study|Adverse Event|191
152704|NCT00373425|493274|P5|Overall Study|Relapse of NSCLC|26
152705|NCT00373425|493275|P4|Overall Study|Relapse of NSCLC|2
152706|NCT00373425|493276|P3|Overall Study|Relapse of NSCLC|19
152707|NCT00373425|493277|P2|Overall Study|Relapse of NSCLC|104
152708|NCT00373425|493278|P1|Overall Study|Relapse of NSCLC|116
152709|NCT00373256|493363|P2|Overall Study|Study Terminated by Sponsor|13
152710|NCT00373256|493364|P1|Overall Study|Study Terminated by Sponsor|41
152711|NCT00373256|493363|P2|Overall Study|Protocol Violation|2
152712|NCT00373256|493364|P1|Overall Study|Protocol Violation|0
152713|NCT00373256|493363|P2|Overall Study|Unspecified|107
152714|NCT00373256|493364|P1|Overall Study|Unspecified|73
152715|NCT00373256|493363|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
152716|NCT00373256|493364|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
152717|NCT00373256|493363|P2|Overall Study|Objective Progression or Relapse|104
152718|NCT00373256|493364|P1|Overall Study|Objective Progression or Relapse|111
152719|NCT00373256|493363|P2|Overall Study|Death|8
152720|NCT00373256|493364|P1|Overall Study|Death|9
152721|NCT00373256|493363|P2|Overall Study|Lost to Follow-up|1
152722|NCT00373256|493364|P1|Overall Study|Lost to Follow-up|2
152723|NCT00373256|493363|P2|Overall Study|Adverse Event (AE)|5
152724|NCT00373256|493364|P1|Overall Study|Adverse Event (AE)|1
152725|NCT00373113|493390|P2|Overall Study|Withdrawal by Subject|15
152726|NCT00373113|493391|P1|Overall Study|Withdrawal by Subject|10
152727|NCT00373113|493390|P2|Overall Study|Protocol Violation|1
152728|NCT00373113|493391|P1|Overall Study|Protocol Violation|5
152729|NCT00373113|493390|P2|Overall Study|Unspecified|17
152730|NCT00373113|493391|P1|Overall Study|Unspecified|14
152731|NCT00373113|493390|P2|Overall Study|Objective progression or relapse|169
152732|NCT00373113|493391|P1|Overall Study|Objective progression or relapse|150
152733|NCT00373113|493390|P2|Overall Study|Lost to Follow-up|3
152734|NCT00373113|493391|P1|Overall Study|Lost to Follow-up|1
152735|NCT00373113|493390|P2|Overall Study|Global deterioration of health status|7
152736|NCT00373113|493391|P1|Overall Study|Global deterioration of health status|10
152737|NCT00373113|493390|P2|Overall Study|Study terminated by sponsor|1
152738|NCT00373113|493391|P1|Overall Study|Study terminated by sponsor|9
152739|NCT00373113|493390|P2|Overall Study|Adverse Event|24
152740|NCT00373113|493391|P1|Overall Study|Adverse Event|38
152741|NCT00373113|493390|P2|Overall Study|Death|7
152742|NCT00373113|493391|P1|Overall Study|Death|1
152743|NCT00372996|493413|P4|Overall Study|Not specified|7
152744|NCT00372996|493414|P3|Overall Study|Not specified|7
152745|NCT00372996|493415|P2|Overall Study|Not specified|2
152746|NCT00372996|493416|P1|Overall Study|Not specified|10
152747|NCT00372996|493413|P4|Overall Study|Study Terminated by Sponsor|0
152748|NCT00372996|493414|P3|Overall Study|Study Terminated by Sponsor|4
152749|NCT00372996|493415|P2|Overall Study|Study Terminated by Sponsor|0
152750|NCT00372996|493416|P1|Overall Study|Study Terminated by Sponsor|4
152751|NCT00372996|493413|P4|Overall Study|Withdrawal by Subject|5
152752|NCT00372996|493414|P3|Overall Study|Withdrawal by Subject|9
152753|NCT00372996|493415|P2|Overall Study|Withdrawal by Subject|6
152754|NCT00372996|493416|P1|Overall Study|Withdrawal by Subject|12
152755|NCT00372996|493413|P4|Overall Study|Lost to Follow-up|1
152756|NCT00372996|493414|P3|Overall Study|Lost to Follow-up|0
152757|NCT00372996|493415|P2|Overall Study|Lost to Follow-up|2
152758|NCT00372996|493416|P1|Overall Study|Lost to Follow-up|0
152759|NCT00372996|493413|P4|Overall Study|Death|7
152760|NCT00372996|493414|P3|Overall Study|Death|8
152761|NCT00372996|493415|P2|Overall Study|Death|4
152762|NCT00372996|493416|P1|Overall Study|Death|11
152763|NCT00372775|493449|P1|Overall Study|Not Treated|2
152764|NCT00372775|493449|P1|Overall Study|Not specified|1
152765|NCT00372775|493449|P1|Overall Study|Withdrawal by Subject|1
152766|NCT00372775|493449|P1|Overall Study|Global deterioration of health status|6
152767|NCT00372775|493449|P1|Overall Study|Objective progression or relapse|30
152768|NCT00372775|493449|P1|Overall Study|Death|15
152769|NCT00372775|493449|P1|Overall Study|Adverse Event|8
152770|NCT00372697|493471|P2|Overall Study|Protocol Violation|1
152771|NCT00372697|493472|P1|Overall Study|Protocol Violation|1
152772|NCT00372619|493497|P7|Overall Study|Inevaluable|0
152773|NCT00372619|493498|P6|Overall Study|Inevaluable|1
152774|NCT00372619|493499|P5|Overall Study|Inevaluable|0
152775|NCT00372619|493500|P4|Overall Study|Inevaluable|0
152776|NCT00372619|493501|P3|Overall Study|Inevaluable|0
152777|NCT00372619|493502|P2|Overall Study|Inevaluable|0
152778|NCT00372619|493503|P1|Overall Study|Inevaluable|0
152779|NCT00372619|493497|P7|Overall Study|Ineligible|0
152780|NCT00372619|493498|P6|Overall Study|Ineligible|2
152781|NCT00372619|493499|P5|Overall Study|Ineligible|0
152782|NCT00372619|493500|P4|Overall Study|Ineligible|0
152783|NCT00372619|493501|P3|Overall Study|Ineligible|0
152784|NCT00372619|493502|P2|Overall Study|Ineligible|0
152785|NCT00372619|493503|P1|Overall Study|Ineligible|0
152786|NCT00372593|493522|P3|Overall Study|Ineligible|1
152787|NCT00372593|493523|P2|Overall Study|Ineligible|21
152788|NCT00372593|493524|P1|Overall Study|Ineligible|20
152789|NCT00372593|493522|P3|Overall Study|Physician Decision|0
152790|NCT00372593|493523|P2|Overall Study|Physician Decision|41
152791|NCT00372593|493524|P1|Overall Study|Physician Decision|42
152792|NCT00372593|493522|P3|Overall Study|Lost to Follow-up|0
152793|NCT00372593|493523|P2|Overall Study|Lost to Follow-up|0
152794|NCT00372593|493524|P1|Overall Study|Lost to Follow-up|1
152795|NCT00372593|493522|P3|Overall Study|Lack of Efficacy|2
152796|NCT00372593|493523|P2|Overall Study|Lack of Efficacy|71
152797|NCT00372593|493524|P1|Overall Study|Lack of Efficacy|82
152798|NCT00372593|493522|P3|Overall Study|Death|1
152799|NCT00372593|493523|P2|Overall Study|Death|20
152800|NCT00372593|493524|P1|Overall Study|Death|16
152801|NCT00372593|493522|P3|Overall Study|Adverse Event|0
152802|NCT00372593|493523|P2|Overall Study|Adverse Event|45
152803|NCT00372593|493524|P1|Overall Study|Adverse Event|43
152804|NCT00372489|493535|P1|Overall Study|Sponsor Decision to Terminate Study|41
152805|NCT00372489|493535|P1|Overall Study|Renal transplant|6
152806|NCT00372489|493535|P1|Overall Study|Patient Relocation|2
152807|NCT00372489|493535|P1|Overall Study|Withdrawal by Subject|5
152808|NCT00372489|493535|P1|Overall Study|Physician Decision|3
152809|NCT00372489|493535|P1|Overall Study|Lost to Follow-up|3
152810|NCT00372489|493535|P1|Overall Study|Lack of Efficacy|1
152811|NCT00372489|493535|P1|Overall Study|Adverse Event|18
152812|NCT00372424|493539|P1|Overall Study|Enrolled, Not Treated|1
152813|NCT00372424|493539|P1|Overall Study|Unspecified|7
152814|NCT00372424|493539|P1|Overall Study|Objective Progression or Relapse|14
152815|NCT00372424|493539|P1|Overall Study|Death|1
152816|NCT00372424|493539|P1|Overall Study|Withdrawal by Subject|1
152817|NCT00372424|493539|P1|Overall Study|Adverse Event|2
152818|NCT00372411|493553|P3|Overall Study|Adverse Event|0
152819|NCT00372411|493554|P2|Overall Study|Adverse Event|1
152820|NCT00372411|493555|P1|Overall Study|Adverse Event|1
152821|NCT00372411|493553|P3|Overall Study|Lost to Follow-up|1
152822|NCT00372411|493554|P2|Overall Study|Lost to Follow-up|1
152823|NCT00372411|493555|P1|Overall Study|Lost to Follow-up|1
152824|NCT00372411|493553|P3|Overall Study|Death|1
152825|NCT00372411|493554|P2|Overall Study|Death|2
152826|NCT00372411|493555|P1|Overall Study|Death|0
152827|NCT00372411|493553|P3|Overall Study|Withdrawal by Subject|1
152828|NCT00372411|493554|P2|Overall Study|Withdrawal by Subject|4
152829|NCT00372411|493555|P1|Overall Study|Withdrawal by Subject|3
152830|NCT00372385|493579|P4|Overall Study|Virologic Stopping Rule|0
152831|NCT00372385|493580|P3|Overall Study|Virologic Stopping Rule|0
152832|NCT00372385|493581|P2|Overall Study|Virologic Stopping Rule|0
152833|NCT00372385|493582|P1|Overall Study|Virologic Stopping Rule|17
152834|NCT00372385|493579|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
152835|NCT00372385|493580|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
152836|NCT00372385|493581|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
152837|NCT00372385|493582|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
152838|NCT00372385|493579|P4|Overall Study|No Response|0
152839|NCT00372385|493580|P3|Overall Study|No Response|0
152840|NCT00372385|493581|P2|Overall Study|No Response|1
152841|NCT00372385|493582|P1|Overall Study|No Response|1
152842|NCT00372385|493579|P4|Overall Study|Refusal of Treatment|0
152843|NCT00372385|493580|P3|Overall Study|Refusal of Treatment|0
152844|NCT00372385|493581|P2|Overall Study|Refusal of Treatment|6
152845|NCT00372385|493582|P1|Overall Study|Refusal of Treatment|3
152846|NCT00372385|493579|P4|Overall Study|Withdrawal by Subject|0
152847|NCT00372385|493580|P3|Overall Study|Withdrawal by Subject|0
152848|NCT00372385|493581|P2|Overall Study|Withdrawal by Subject|1
152849|NCT00372385|493582|P1|Overall Study|Withdrawal by Subject|2
152850|NCT00372385|493579|P4|Overall Study|Lost to Follow-up|0
152851|NCT00372385|493580|P3|Overall Study|Lost to Follow-up|0
152852|NCT00372385|493581|P2|Overall Study|Lost to Follow-up|0
152853|NCT00372385|493582|P1|Overall Study|Lost to Follow-up|2
152854|NCT00372385|493579|P4|Overall Study|Physician Decision|0
152855|NCT00372385|493580|P3|Overall Study|Physician Decision|0
152856|NCT00372385|493581|P2|Overall Study|Physician Decision|0
152857|NCT00372385|493582|P1|Overall Study|Physician Decision|1
152858|NCT00372385|493579|P4|Overall Study|Noncompliance|1
152859|NCT00372385|493580|P3|Overall Study|Noncompliance|1
152860|NCT00372385|493581|P2|Overall Study|Noncompliance|1
152861|NCT00372385|493582|P1|Overall Study|Noncompliance|0
152862|NCT00372385|493579|P4|Overall Study|Adverse Event|7
152863|NCT00372385|493580|P3|Overall Study|Adverse Event|9
152864|NCT00372385|493581|P2|Overall Study|Adverse Event|11
152865|NCT00372385|493582|P1|Overall Study|Adverse Event|6
152866|NCT00372060|493611|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
152867|NCT00372060|493612|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
152868|NCT00372060|493611|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
152869|NCT00372060|493612|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
152870|NCT00372060|493611|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
152871|NCT00372060|493612|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
152872|NCT00372060|493611|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
152873|NCT00372060|493612|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
152874|NCT00372060|493611|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
152875|NCT00372060|493612|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
152876|NCT00372060|493611|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
152877|NCT00372060|493612|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
152878|NCT00371865|493627|P2|Overall Study|Withdrawal by Subject|10
152879|NCT00371865|493628|P1|Overall Study|Withdrawal by Subject|12
152880|NCT00371865|493627|P2|Overall Study|Protocol Violation|2
152881|NCT00371865|493628|P1|Overall Study|Protocol Violation|3
152882|NCT00371865|493627|P2|Overall Study|Lack of Efficacy|2
152883|NCT00371865|493628|P1|Overall Study|Lack of Efficacy|0
152884|NCT00371839|493645|P3|Overall Study|Lost to Follow-up|2
152885|NCT00371839|493646|P2|Overall Study|Lost to Follow-up|3
152886|NCT00371839|493647|P1|Overall Study|Lost to Follow-up|6
152887|NCT00371839|493645|P3|Overall Study|Withdrawal by Subject|0
152888|NCT00371839|493646|P2|Overall Study|Withdrawal by Subject|4
152889|NCT00371839|493647|P1|Overall Study|Withdrawal by Subject|7
152890|NCT00371839|493645|P3|Overall Study|Death|0
152891|NCT00371839|493646|P2|Overall Study|Death|0
152892|NCT00371839|493647|P1|Overall Study|Death|4
152893|NCT00371826|493656|P3|Extension Phase (24 Months)|Administrative problems|2
152894|NCT00371826|493657|P2|Extension Phase (24 Months)|Administrative problems|0
152895|NCT00371826|493658|P1|Extension Phase (24 Months)|Administrative problems|0
152896|NCT00371826|493656|P3|Extension Phase (24 Months)|Subject withdrew consent|0
152897|NCT00371826|493657|P2|Extension Phase (24 Months)|Subject withdrew consent|2
152898|NCT00371826|493658|P1|Extension Phase (24 Months)|Subject withdrew consent|1
152899|NCT00371826|493656|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
152900|NCT00371826|493657|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
152901|NCT00371826|493658|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
152902|NCT00371826|493656|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
152903|NCT00371826|493657|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
152904|NCT00371826|493658|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
152905|NCT00371826|493656|P3|Extension Phase (24 Months)|Adverse Event|0
152906|NCT00371826|493657|P2|Extension Phase (24 Months)|Adverse Event|5
152907|NCT00371826|493658|P1|Extension Phase (24 Months)|Adverse Event|4
152908|NCT00371826|493656|P3|Core Phase (12 Months)|Graft Loss|0
152909|NCT00371826|493657|P2|Core Phase (12 Months)|Graft Loss|1
152910|NCT00371826|493658|P1|Core Phase (12 Months)|Graft Loss|0
152911|NCT00371826|493656|P3|Core Phase (12 Months)|Administrative problems|8
152912|NCT00371826|493657|P2|Core Phase (12 Months)|Administrative problems|0
152913|NCT00371826|493658|P1|Core Phase (12 Months)|Administrative problems|1
152914|NCT00371826|493656|P3|Core Phase (12 Months)|Subject withdrew consent|3
152915|NCT00371826|493657|P2|Core Phase (12 Months)|Subject withdrew consent|0
152916|NCT00371826|493658|P1|Core Phase (12 Months)|Subject withdrew consent|0
152917|NCT00371826|493656|P3|Core Phase (12 Months)|Protocol Violation|1
152918|NCT00371826|493657|P2|Core Phase (12 Months)|Protocol Violation|0
152919|NCT00371826|493658|P1|Core Phase (12 Months)|Protocol Violation|1
152920|NCT00371826|493656|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
152921|NCT00371826|493657|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
152922|NCT00371826|493658|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
152923|NCT00371826|493656|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
152924|NCT00371826|493657|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
152925|NCT00371826|493658|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
152926|NCT00371826|493656|P3|Core Phase (12 Months)|Adverse Event|9
152927|NCT00371826|493657|P2|Core Phase (12 Months)|Adverse Event|4
152928|NCT00371826|493658|P1|Core Phase (12 Months)|Adverse Event|15
152929|NCT00371787|493782|P2|Overall Study|Withdrawal by Subject|1
152930|NCT00371787|493783|P1|Overall Study|Withdrawal by Subject|3
152931|NCT00371761|493797|P2|Overall Study|Study termination|3
152932|NCT00371761|493798|P1|Overall Study|Study termination|4
152933|NCT00371761|493797|P2|Overall Study|Investigator Judgment|3
152934|NCT00371761|493798|P1|Overall Study|Investigator Judgment|2
152935|NCT00371761|493797|P2|Overall Study|Withdrawal by Subject|3
152936|NCT00371761|493798|P1|Overall Study|Withdrawal by Subject|1
152937|NCT00371761|493797|P2|Overall Study|Adverse Event|1
152938|NCT00371761|493798|P1|Overall Study|Adverse Event|1
152939|NCT00371683|493806|P2|Follow-Up Period - Randomized Patients|non-specified|12
152940|NCT00371683|493807|P1|Follow-Up Period - Randomized Patients|non-specified|6
152941|NCT00371683|493806|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
152942|NCT00371683|493807|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
152943|NCT00371683|493806|P2|Follow-Up Period - Randomized Patients|Death|2
152944|NCT00371683|493807|P1|Follow-Up Period - Randomized Patients|Death|0
152945|NCT00371683|493806|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
152946|NCT00371683|493807|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
152947|NCT00371683|493806|P2|DB Treatment Period-Randomized Patients|non-specified|8
152948|NCT00371683|493807|P1|DB Treatment Period-Randomized Patients|non-specified|9
152949|NCT00371683|493806|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
152950|NCT00371683|493807|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
152951|NCT00371683|493806|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
152952|NCT00371683|493807|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
152953|NCT00371683|493806|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
152954|NCT00371683|493807|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
152955|NCT00371683|493806|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
152956|NCT00371683|493807|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
152957|NCT00371683|493806|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
152958|NCT00371683|493807|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
152959|NCT00371683|493806|P2|DB Treatment Period-Randomized Patients|Death|1
152960|NCT00371683|493807|P1|DB Treatment Period-Randomized Patients|Death|1
152961|NCT00371566|493875|P2|Follow Up Phase|Lost to Follow-up|0
152962|NCT00371566|493876|P1|Follow Up Phase|Lost to Follow-up|1
152963|NCT00371566|493875|P2|Follow Up Phase|Physician Decision|1
152964|NCT00371566|493876|P1|Follow Up Phase|Physician Decision|1
152965|NCT00371566|493875|P2|Follow Up Phase|Withdrawal by Subject|1
152966|NCT00371566|493876|P1|Follow Up Phase|Withdrawal by Subject|0
152967|NCT00371566|493875|P2|Follow Up Phase|Disease progression|0
152968|NCT00371566|493876|P1|Follow Up Phase|Disease progression|1
152969|NCT00371566|493875|P2|Follow Up Phase|Death|5
152970|NCT00371566|493876|P1|Follow Up Phase|Death|0
152971|NCT00371566|493875|P2|Chemoradiation Phase|Death|0
152972|NCT00371566|493876|P1|Chemoradiation Phase|Death|2
152973|NCT00371566|493875|P2|Chemoradiation Phase|Progressive Disease|1
152974|NCT00371566|493876|P1|Chemoradiation Phase|Progressive Disease|1
152975|NCT00371566|493875|P2|Chemoradiation Phase|Non compliant|1
152976|NCT00371566|493876|P1|Chemoradiation Phase|Non compliant|0
152977|NCT00371566|493875|P2|Chemoradiation Phase|Withdrawal by Subject|1
152978|NCT00371566|493876|P1|Chemoradiation Phase|Withdrawal by Subject|0
152979|NCT00371566|493875|P2|Chemoradiation Phase|Physician Decision|0
152980|NCT00371566|493876|P1|Chemoradiation Phase|Physician Decision|2
152981|NCT00371566|493875|P2|Treatment Phase|Protocol Violation|1
152982|NCT00371566|493876|P1|Treatment Phase|Protocol Violation|0
152983|NCT00371566|493875|P2|Treatment Phase|Adverse Event|1
152984|NCT00371566|493876|P1|Treatment Phase|Adverse Event|0
152985|NCT00371566|493875|P2|Treatment Phase|Withdrawal by Subject|1
152986|NCT00371566|493876|P1|Treatment Phase|Withdrawal by Subject|0
152987|NCT00371462|493961|P2|Overall Study|Other|8
152988|NCT00371462|493962|P1|Overall Study|Other|7
152989|NCT00371462|493961|P2|Overall Study|Withdrawal by Subject|0
152990|NCT00371462|493962|P1|Overall Study|Withdrawal by Subject|1
152991|NCT00371397|493986|P12|Session 1|Withdrawal by Subject|0
152992|NCT00371397|493987|P11|Session 1|Withdrawal by Subject|0
152993|NCT00371397|493988|P10|Session 1|Withdrawal by Subject|0
152994|NCT00371397|493989|P9|Session 1|Withdrawal by Subject|0
152995|NCT00371397|493990|P8|Session 1|Withdrawal by Subject|1
152996|NCT00371397|493991|P7|Session 1|Withdrawal by Subject|0
152997|NCT00371397|493992|P6|Session 1|Withdrawal by Subject|0
152998|NCT00371397|493993|P5|Session 1|Withdrawal by Subject|0
152999|NCT00371397|493994|P4|Session 1|Withdrawal by Subject|0
153000|NCT00371397|493995|P3|Session 1|Withdrawal by Subject|0
153001|NCT00371397|493996|P2|Session 1|Withdrawal by Subject|0
153002|NCT00371397|493997|P1|Session 1|Withdrawal by Subject|1
153003|NCT00371345|494005|P2|Overall Study|Participant Withdrew Consent|1
153004|NCT00371345|494006|P1|Overall Study|Participant Withdrew Consent|0
153005|NCT00371345|494005|P2|Overall Study|Participant Request|1
153006|NCT00371345|494006|P1|Overall Study|Participant Request|1
153007|NCT00371345|494005|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
153008|NCT00371345|494006|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
153009|NCT00371345|494005|P2|Overall Study|Study Drug Toxicity|7
153010|NCT00371345|494006|P1|Overall Study|Study Drug Toxicity|1
153011|NCT00371345|494005|P2|Overall Study|Disease Progression|35
153012|NCT00371345|494006|P1|Overall Study|Disease Progression|21
153013|NCT00371254|494082|P2|Overall Study|Withdrawal by Subject|1
153014|NCT00371254|494083|P1|Overall Study|Withdrawal by Subject|0
153015|NCT00371254|494082|P2|Overall Study|Lost to Follow-up|1
153016|NCT00371254|494083|P1|Overall Study|Lost to Follow-up|0
153017|NCT00371254|494082|P2|Overall Study|Adverse event unrelated to study drug|1
153018|NCT00371254|494083|P1|Overall Study|Adverse event unrelated to study drug|0
153019|NCT00371254|494082|P2|Overall Study|Investigator Decision|0
153020|NCT00371254|494083|P1|Overall Study|Investigator Decision|2
153021|NCT00371254|494082|P2|Overall Study|Subject request|0
153022|NCT00371254|494083|P1|Overall Study|Subject request|5
153023|NCT00371254|494082|P2|Overall Study|Study drug toxicity|5
153024|NCT00371254|494083|P1|Overall Study|Study drug toxicity|3
153025|NCT00371254|494082|P2|Overall Study|Disease progression|13
153026|NCT00371254|494083|P1|Overall Study|Disease progression|13
153027|NCT00371150|494166|P2|Overall Study|Lost to Follow-up|2
153028|NCT00371150|494167|P1|Overall Study|Lost to Follow-up|3
153029|NCT00371137|494202|P3|Overall Study|Protocol Violation|1
153030|NCT00371137|494203|P2|Overall Study|Protocol Violation|1
153031|NCT00371137|494204|P1|Overall Study|Protocol Violation|2
153032|NCT00371137|494202|P3|Overall Study|Physician Decision|1
153033|NCT00371137|494203|P2|Overall Study|Physician Decision|1
153034|NCT00371137|494204|P1|Overall Study|Physician Decision|1
153035|NCT00371137|494202|P3|Overall Study|Sponsor Decision|2
153036|NCT00371137|494203|P2|Overall Study|Sponsor Decision|1
153037|NCT00371137|494204|P1|Overall Study|Sponsor Decision|2
153038|NCT00371137|494202|P3|Overall Study|Lack of Efficacy|13
153039|NCT00371137|494203|P2|Overall Study|Lack of Efficacy|12
153040|NCT00371137|494204|P1|Overall Study|Lack of Efficacy|30
153041|NCT00371137|494202|P3|Overall Study|Lost to Follow-up|5
153042|NCT00371137|494203|P2|Overall Study|Lost to Follow-up|3
153043|NCT00371137|494204|P1|Overall Study|Lost to Follow-up|6
153044|NCT00371137|494202|P3|Overall Study|Withdrawal by Subject|15
153045|NCT00371137|494203|P2|Overall Study|Withdrawal by Subject|10
153046|NCT00371137|494204|P1|Overall Study|Withdrawal by Subject|11
153047|NCT00371137|494202|P3|Overall Study|Adverse Event|42
153048|NCT00371137|494203|P2|Overall Study|Adverse Event|35
153049|NCT00371137|494204|P1|Overall Study|Adverse Event|20
153050|NCT00370552|494247|P3|Overall Study|Planned radiation for palliation|0
153051|NCT00370552|494248|P2|Overall Study|Planned radiation for palliation|1
153052|NCT00370552|494249|P1|Overall Study|Planned radiation for palliation|0
153053|NCT00370552|494247|P3|Overall Study|High risk of allergic reaction|0
153054|NCT00370552|494248|P2|Overall Study|High risk of allergic reaction|1
153055|NCT00370552|494249|P1|Overall Study|High risk of allergic reaction|0
153056|NCT00370552|494247|P3|Overall Study|Investigator decision|0
153057|NCT00370552|494248|P2|Overall Study|Investigator decision|1
153058|NCT00370552|494249|P1|Overall Study|Investigator decision|2
153059|NCT00370552|494247|P3|Overall Study|Physician Decision|0
153060|NCT00370552|494248|P2|Overall Study|Physician Decision|1
153061|NCT00370552|494249|P1|Overall Study|Physician Decision|1
153062|NCT00370552|494247|P3|Overall Study|Never treated|0
153063|NCT00370552|494248|P2|Overall Study|Never treated|0
153064|NCT00370552|494249|P1|Overall Study|Never treated|1
153065|NCT00370552|494247|P3|Overall Study|Still on treatment|2
153066|NCT00370552|494248|P2|Overall Study|Still on treatment|3
153067|NCT00370552|494249|P1|Overall Study|Still on treatment|1
153068|NCT00370552|494247|P3|Overall Study|Withdrawal by Subject|1
153069|NCT00370552|494248|P2|Overall Study|Withdrawal by Subject|0
153070|NCT00370552|494249|P1|Overall Study|Withdrawal by Subject|2
153071|NCT00370552|494247|P3|Overall Study|Study drug toxicity|6
153072|NCT00370552|494248|P2|Overall Study|Study drug toxicity|8
153073|NCT00370552|494249|P1|Overall Study|Study drug toxicity|11
153074|NCT00370552|494247|P3|Overall Study|Poor or noncompliance|1
153075|NCT00370552|494248|P2|Overall Study|Poor or noncompliance|0
153076|NCT00370552|494249|P1|Overall Study|Poor or noncompliance|0
153077|NCT00370552|494247|P3|Overall Study|Maximum clinical benefit|5
153078|NCT00370552|494248|P2|Overall Study|Maximum clinical benefit|5
153079|NCT00370552|494249|P1|Overall Study|Maximum clinical benefit|3
153080|NCT00370552|494247|P3|Overall Study|Disease progression|15
153081|NCT00370552|494248|P2|Overall Study|Disease progression|23
153082|NCT00370552|494249|P1|Overall Study|Disease progression|23
153083|NCT00370552|494247|P3|Overall Study|Adverse Event|2
153084|NCT00370552|494248|P2|Overall Study|Adverse Event|2
153085|NCT00370552|494249|P1|Overall Study|Adverse Event|2
153086|NCT00370331|494289|P2|Overall Study|Protocol Violation|1
153087|NCT00370331|494290|P1|Overall Study|Protocol Violation|1
153088|NCT00370331|494289|P2|Overall Study|Non-compliance|1
153089|NCT00370331|494290|P1|Overall Study|Non-compliance|0
153090|NCT00370331|494289|P2|Overall Study|Lack of Efficacy|1
153091|NCT00370331|494290|P1|Overall Study|Lack of Efficacy|0
153092|NCT00370331|494289|P2|Overall Study|Lost to Follow-up|3
153093|NCT00370331|494290|P1|Overall Study|Lost to Follow-up|0
153094|NCT00370331|494289|P2|Overall Study|Withdrawal by Subject|4
153095|NCT00370331|494290|P1|Overall Study|Withdrawal by Subject|2
153096|NCT00370331|494289|P2|Overall Study|Adverse Event|13
153097|NCT00370331|494290|P1|Overall Study|Adverse Event|4
153098|NCT00370292|494316|P1|Overall Study|Physician Decision|2
153099|NCT00370292|494316|P1|Overall Study|Adverse Event|7
153100|NCT00370292|494316|P1|Overall Study|Disease Progression|4
153101|NCT00370149|494329|P2|Overall Study|Antibiotic coated dressing placed|1
153102|NCT00370149|494330|P1|Overall Study|Antibiotic coated dressing placed|0
153103|NCT00370149|494329|P2|Overall Study|Pre-existing infection|1
153104|NCT00370149|494330|P1|Overall Study|Pre-existing infection|0
153105|NCT00370149|494329|P2|Overall Study|Catheter inserted in wrong vessel-|1
153106|NCT00370149|494330|P1|Overall Study|Catheter inserted in wrong vessel-|2
153107|NCT00370149|494329|P2|Overall Study|Protocol Violation|0
153108|NCT00370149|494330|P1|Overall Study|Protocol Violation|1
153109|NCT00370149|494329|P2|Overall Study|Physician Decision|16
153110|NCT00370149|494330|P1|Overall Study|Physician Decision|16
153111|NCT00370071|494340|P1|Overall Study|Withdrawal by Subject|2
153112|NCT00370032|494357|P2|Follow-up Period|Withdrawal by Subject|0
153113|NCT00370032|494358|P1|Follow-up Period|Withdrawal by Subject|1
153114|NCT00370032|494357|P2|Washout Period|Adverse Event|0
153115|NCT00370032|494358|P1|Washout Period|Adverse Event|1
153116|NCT00370032|494357|P2|Washout Period|Lost to Follow-up|1
153117|NCT00370032|494358|P1|Washout Period|Lost to Follow-up|0
153118|NCT00370032|494357|P2|Washout Period|Withdrawal by Subject|1
153119|NCT00370032|494358|P1|Washout Period|Withdrawal by Subject|0
153120|NCT00370032|494357|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
153121|NCT00370032|494358|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
153122|NCT00369967|494378|P2|Overall Study|Lost to Follow-up|12
153123|NCT00369967|494379|P1|Overall Study|Lost to Follow-up|23
153124|NCT00369941|494397|P2|Overall Study|Miscellaneous|3
153125|NCT00369941|494398|P1|Overall Study|Miscellaneous|3
153126|NCT00369941|494397|P2|Overall Study|Study Site Terminated|0
153127|NCT00369941|494398|P1|Overall Study|Study Site Terminated|2
153128|NCT00369941|494397|P2|Overall Study|Employment Interfered with Study Visits|0
153129|NCT00369941|494398|P1|Overall Study|Employment Interfered with Study Visits|1
153130|NCT00369941|494397|P2|Overall Study|Treatment with Prohibited Medication|1
153131|NCT00369941|494398|P1|Overall Study|Treatment with Prohibited Medication|3
153132|NCT00369941|494397|P2|Overall Study|Moved|5
153133|NCT00369941|494398|P1|Overall Study|Moved|11
153134|NCT00369941|494397|P2|Overall Study|Completed, Did Not Enter Extension|6
153135|NCT00369941|494398|P1|Overall Study|Completed, Did Not Enter Extension|5
153136|NCT00369941|494397|P2|Overall Study|Pregnancy|2
153137|NCT00369941|494398|P1|Overall Study|Pregnancy|4
153138|NCT00369941|494397|P2|Overall Study|Withdrawal by Subject|18
153139|NCT00369941|494398|P1|Overall Study|Withdrawal by Subject|5
153140|NCT00369941|494397|P2|Overall Study|Protocol Violation|3
153141|NCT00369941|494398|P1|Overall Study|Protocol Violation|5
153142|NCT00369941|494397|P2|Overall Study|Lost to Follow-up|22
153143|NCT00369941|494398|P1|Overall Study|Lost to Follow-up|12
153144|NCT00369941|494397|P2|Overall Study|Lack of Efficacy|10
153145|NCT00369941|494398|P1|Overall Study|Lack of Efficacy|6
153146|NCT00369941|494397|P2|Overall Study|Adverse Event|28
153147|NCT00369941|494398|P1|Overall Study|Adverse Event|14
153148|NCT00369941|494397|P2|Overall Study|Never Treated|2
153149|NCT00369941|494398|P1|Overall Study|Never Treated|1
153150|NCT00369915|494563|P2|Overall Study|W/drawl by investigators|1
153151|NCT00369915|494564|P1|Overall Study|W/drawl by investigators|0
153152|NCT00369915|494563|P2|Overall Study|Withdrawal by Subject|1
153153|NCT00369915|494564|P1|Overall Study|Withdrawal by Subject|4
153154|NCT00369915|494563|P2|Overall Study|expected side effects|1
153155|NCT00369915|494564|P1|Overall Study|expected side effects|2
153156|NCT00369824|494578|P6|Overall Study|Other|3
153157|NCT00369824|494579|P5|Overall Study|Other|1
153158|NCT00369824|494580|P4|Overall Study|Other|2
153159|NCT00369824|494581|P3|Overall Study|Other|0
153160|NCT00369824|494582|P2|Overall Study|Other|0
153161|NCT00369824|494583|P1|Overall Study|Other|0
153162|NCT00369824|494578|P6|Overall Study|Lost to Follow-up|6
153163|NCT00369824|494579|P5|Overall Study|Lost to Follow-up|9
153164|NCT00369824|494580|P4|Overall Study|Lost to Follow-up|8
153165|NCT00369824|494581|P3|Overall Study|Lost to Follow-up|7
153166|NCT00369824|494582|P2|Overall Study|Lost to Follow-up|11
153167|NCT00369824|494583|P1|Overall Study|Lost to Follow-up|6
153168|NCT00369824|494578|P6|Overall Study|Withdrawal by Subject|2
153169|NCT00369824|494579|P5|Overall Study|Withdrawal by Subject|6
153170|NCT00369824|494580|P4|Overall Study|Withdrawal by Subject|4
153171|NCT00369824|494581|P3|Overall Study|Withdrawal by Subject|5
153172|NCT00369824|494582|P2|Overall Study|Withdrawal by Subject|5
153173|NCT00369824|494583|P1|Overall Study|Withdrawal by Subject|9
153174|NCT00369824|494578|P6|Overall Study|Protocol Violation|0
153175|NCT00369824|494579|P5|Overall Study|Protocol Violation|1
153176|NCT00369824|494580|P4|Overall Study|Protocol Violation|1
153177|NCT00369824|494581|P3|Overall Study|Protocol Violation|0
153178|NCT00369824|494582|P2|Overall Study|Protocol Violation|1
153179|NCT00369824|494583|P1|Overall Study|Protocol Violation|0
153180|NCT00369824|494578|P6|Overall Study|Adverse Event|0
153181|NCT00369824|494579|P5|Overall Study|Adverse Event|1
153182|NCT00369824|494580|P4|Overall Study|Adverse Event|0
153183|NCT00369824|494581|P3|Overall Study|Adverse Event|0
153184|NCT00369824|494582|P2|Overall Study|Adverse Event|2
153185|NCT00369824|494583|P1|Overall Study|Adverse Event|0
153186|NCT00369681|494694|P1|Overall Study|Inevaluable|1
153187|NCT00369668|494703|P3|Overall Study|Lack of Efficacy|7
153188|NCT00369668|494704|P2|Overall Study|Lack of Efficacy|5
153189|NCT00369668|494705|P1|Overall Study|Lack of Efficacy|4
153190|NCT00369655|494719|P1|Overall Study|Refusal of further treatment|2
153191|NCT00369486|494766|P5|34-Week Visit|Dropped|3
153192|NCT00369486|494767|P4|34-Week Visit|Dropped|3
153193|NCT00369486|494768|P3|34-Week Visit|Dropped|1
153194|NCT00369486|494769|P2|34-Week Visit|Dropped|1
153195|NCT00369486|494770|P1|34-Week Visit|Dropped|0
153196|NCT00369486|494766|P5|17-Week Visit|Missed visit|1
153197|NCT00369486|494767|P4|17-Week Visit|Missed visit|1
153198|NCT00369486|494768|P3|17-Week Visit|Missed visit|1
153199|NCT00369486|494769|P2|17-Week Visit|Missed visit|0
153200|NCT00369486|494770|P1|17-Week Visit|Missed visit|0
153201|NCT00369486|494766|P5|8-Week Visit|Dropped|0
153202|NCT00369486|494767|P4|8-Week Visit|Dropped|1
153203|NCT00369486|494768|P3|8-Week Visit|Dropped|0
153204|NCT00369486|494769|P2|8-Week Visit|Dropped|0
153205|NCT00369486|494770|P1|8-Week Visit|Dropped|0
153206|NCT00369486|494766|P5|8-Week Visit|Missed visit|1
153207|NCT00369486|494767|P4|8-Week Visit|Missed visit|0
153208|NCT00369486|494768|P3|8-Week Visit|Missed visit|0
153209|NCT00369486|494769|P2|8-Week Visit|Missed visit|1
153210|NCT00369486|494770|P1|8-Week Visit|Missed visit|0
153211|NCT00369486|494766|P5|4-Week Visit|Dropped|0
153212|NCT00369486|494767|P4|4-Week Visit|Dropped|0
153213|NCT00369486|494768|P3|4-Week Visit|Dropped|1
153214|NCT00369486|494769|P2|4-Week Visit|Dropped|0
153215|NCT00369486|494770|P1|4-Week Visit|Dropped|0
153216|NCT00369486|494766|P5|4-Week Visit|Missed visit|1
153217|NCT00369486|494767|P4|4-Week Visit|Missed visit|2
153218|NCT00369486|494768|P3|4-Week Visit|Missed visit|0
153219|NCT00369486|494769|P2|4-Week Visit|Missed visit|2
153220|NCT00369486|494770|P1|4-Week Visit|Missed visit|2
153221|NCT00369382|494809|P2|Overall Study|Unspecified|0
153222|NCT00369382|494810|P1|Overall Study|Unspecified|1
153223|NCT00369382|494809|P2|Overall Study|Randomized, not treated|0
153224|NCT00369382|494810|P1|Overall Study|Randomized, not treated|2
153225|NCT00369382|494809|P2|Overall Study|Withdrawal by Subject|0
153226|NCT00369382|494810|P1|Overall Study|Withdrawal by Subject|5
153227|NCT00369382|494809|P2|Overall Study|Physician Decision|1
153228|NCT00369382|494810|P1|Overall Study|Physician Decision|2
153229|NCT00369382|494809|P2|Overall Study|Death|2
153230|NCT00369382|494810|P1|Overall Study|Death|0
153231|NCT00369343|494843|P2|Open-label Phase|did not take study drug|2
153232|NCT00369343|494844|P1|Open-label Phase|did not take study drug|1
153233|NCT00369343|494843|P2|Open-label Phase|Lack of continuance tolerability|4
153234|NCT00369343|494844|P1|Open-label Phase|Lack of continuance tolerability|3
153235|NCT00369343|494843|P2|Open-label Phase|Lack of Efficacy|3
153236|NCT00369343|494844|P1|Open-label Phase|Lack of Efficacy|4
153237|NCT00369343|494843|P2|Open-label Phase|Withdrawal by Subject|6
153238|NCT00369343|494844|P1|Open-label Phase|Withdrawal by Subject|15
153239|NCT00369343|494843|P2|Open-label Phase|Protocol Violation|3
153240|NCT00369343|494844|P1|Open-label Phase|Protocol Violation|1
153241|NCT00369343|494843|P2|Open-label Phase|inadvertently reported study completers|2
153242|NCT00369343|494844|P1|Open-label Phase|inadvertently reported study completers|3
153243|NCT00369343|494843|P2|Open-label Phase|Lost to Follow-up|3
153244|NCT00369343|494844|P1|Open-label Phase|Lost to Follow-up|5
153245|NCT00369343|494843|P2|Open-label Phase|Physician Decision|0
153246|NCT00369343|494844|P1|Open-label Phase|Physician Decision|2
153247|NCT00369343|494843|P2|Open-label Phase|Failed to return|0
153248|NCT00369343|494844|P1|Open-label Phase|Failed to return|4
153249|NCT00369343|494843|P2|Open-label Phase|Adverse Event|7
153250|NCT00369343|494844|P1|Open-label Phase|Adverse Event|19
153251|NCT00369343|494843|P2|Double-blind Phase|Protocol deviation|0
153252|NCT00369343|494844|P1|Double-blind Phase|Protocol deviation|4
153253|NCT00369343|494843|P2|Double-blind Phase|Lack of Efficacy|4
153254|NCT00369343|494844|P1|Double-blind Phase|Lack of Efficacy|0
153255|NCT00369343|494843|P2|Double-blind Phase|Withdrawal by Subject|6
153256|NCT00369343|494844|P1|Double-blind Phase|Withdrawal by Subject|8
153257|NCT00369343|494843|P2|Double-blind Phase|Protocol Violation|0
153258|NCT00369343|494844|P1|Double-blind Phase|Protocol Violation|2
153259|NCT00369343|494843|P2|Double-blind Phase|Lost to Follow-up|2
153260|NCT00369343|494844|P1|Double-blind Phase|Lost to Follow-up|9
153261|NCT00369343|494843|P2|Double-blind Phase|Failed to return|0
153262|NCT00369343|494844|P1|Double-blind Phase|Failed to return|2
153263|NCT00369343|494843|P2|Double-blind Phase|Adverse Event|4
153264|NCT00369343|494844|P1|Double-blind Phase|Adverse Event|19
153265|NCT00369317|494877|P1|Overall Study|Ineligible|1
153266|NCT00369317|494877|P1|Overall Study|Withdrawal by Subject|8
153267|NCT00369317|494877|P1|Overall Study|Physician Decision|2
153268|NCT00369317|494877|P1|Overall Study|Lack of Efficacy|5
153269|NCT00369317|494877|P1|Overall Study|Death|1
153270|NCT00369317|494877|P1|Overall Study|Adverse Event|3
153271|NCT00369278|494884|P2|Overall Study|Graft loss|2
153272|NCT00369278|494885|P1|Overall Study|Graft loss|1
153273|NCT00369278|494884|P2|Overall Study|Lost to Follow-up|0
153274|NCT00369278|494885|P1|Overall Study|Lost to Follow-up|1
153275|NCT00369278|494884|P2|Overall Study|Withdrawal by Subject|2
153276|NCT00369278|494885|P1|Overall Study|Withdrawal by Subject|2
153277|NCT00369278|494884|P2|Overall Study|Protocol Violation|1
153278|NCT00369278|494885|P1|Overall Study|Protocol Violation|2
153279|NCT00369278|494884|P2|Overall Study|Unsatisfactory therapeutic effect|5
153280|NCT00369278|494885|P1|Overall Study|Unsatisfactory therapeutic effect|4
153281|NCT00369278|494884|P2|Overall Study|Adverse Event|11
153282|NCT00369278|494885|P1|Overall Study|Adverse Event|14
153283|NCT00369265|494901|P2|Overall Study|Study terminated|7
153284|NCT00369265|494902|P1|Overall Study|Study terminated|4
153285|NCT00369161|494923|P2|Overall Study|Administrative Problem|2
153286|NCT00369161|494924|P1|Overall Study|Administrative Problem|2
153287|NCT00369161|494923|P2|Overall Study|Graft loss|0
153288|NCT00369161|494924|P1|Overall Study|Graft loss|4
153289|NCT00369161|494923|P2|Overall Study|Death|2
153290|NCT00369161|494924|P1|Overall Study|Death|1
153291|NCT00369161|494923|P2|Overall Study|Withdrawal by Subject|3
153292|NCT00369161|494924|P1|Overall Study|Withdrawal by Subject|2
153293|NCT00369161|494923|P2|Overall Study|Protocol Violation|2
153294|NCT00369161|494924|P1|Overall Study|Protocol Violation|0
153295|NCT00369161|494923|P2|Overall Study|Lack of Efficacy|1
153296|NCT00369161|494924|P1|Overall Study|Lack of Efficacy|3
153297|NCT00369161|494923|P2|Overall Study|Abnormal laboratory value|1
153298|NCT00369161|494924|P1|Overall Study|Abnormal laboratory value|0
153299|NCT00369161|494923|P2|Overall Study|Adverse Event|13
153300|NCT00369161|494924|P1|Overall Study|Adverse Event|15
153301|NCT00369122|494934|P1|Overall Study|No protocol treatment|1
153302|NCT00369122|494934|P1|Overall Study|Ineligible|10
153303|NCT00368992|494938|P1|Overall Study|Not Specified|9
153304|NCT00368992|494938|P1|Overall Study|Death|4
153305|NCT00368992|494938|P1|Overall Study|Adverse Event|26
153306|NCT00368992|494938|P1|Overall Study|Lack of Efficacy|63
153307|NCT00368992|494938|P1|Overall Study|Refused treatment|3
153308|NCT00368992|494938|P1|Overall Study|Ineligible|5
153309|NCT00368979|494947|P2|Overall Study|Withdrawal by Subject|9
153310|NCT00368979|494948|P1|Overall Study|Withdrawal by Subject|5
153311|NCT00368979|494947|P2|Overall Study|Protocol Violation|1
153312|NCT00368979|494948|P1|Overall Study|Protocol Violation|2
153313|NCT00368979|494947|P2|Overall Study|Lost to Follow-up|0
153314|NCT00368979|494948|P1|Overall Study|Lost to Follow-up|1
153315|NCT00368979|494947|P2|Overall Study|Not specified|1
153316|NCT00368979|494948|P1|Overall Study|Not specified|3
153317|NCT00368979|494947|P2|Overall Study|Lack of Efficacy|3
153318|NCT00368979|494948|P1|Overall Study|Lack of Efficacy|5
153319|NCT00368979|494947|P2|Overall Study|Adverse Event|16
153320|NCT00368979|494948|P1|Overall Study|Adverse Event|9
153321|NCT00368966|494964|P2|Toddler Dose|Lost to Follow-up|2
153322|NCT00368966|494965|P1|Toddler Dose|Lost to Follow-up|0
153323|NCT00368966|494964|P2|Toddler Dose|Withdrawal by Subject|1
153324|NCT00368966|494965|P1|Toddler Dose|Withdrawal by Subject|1
153325|NCT00368966|494964|P2|After Infant|Lost to Follow-up|1
153326|NCT00368966|494965|P1|After Infant|Lost to Follow-up|0
153327|NCT00368966|494964|P2|After Infant|Death|0
153328|NCT00368966|494965|P1|After Infant|Death|1
153329|NCT00368966|494964|P2|After Infant|Withdrawal by Subject|1
153330|NCT00368966|494965|P1|After Infant|Withdrawal by Subject|1
153331|NCT00368966|494964|P2|After Infant|Adverse Event|2
153332|NCT00368966|494965|P1|After Infant|Adverse Event|1
153333|NCT00368966|494964|P2|After Infant|Failed to return|1
153334|NCT00368966|494965|P1|After Infant|Failed to return|3
153335|NCT00368966|494964|P2|Infant Series|Failed to return|0
153336|NCT00368966|494965|P1|Infant Series|Failed to return|1
153337|NCT00368966|494964|P2|Infant Series|Adverse Event|1
153338|NCT00368966|494965|P1|Infant Series|Adverse Event|0
153339|NCT00368966|494964|P2|Infant Series|Failed to meet eligibility criteria|1
153340|NCT00368966|494965|P1|Infant Series|Failed to meet eligibility criteria|0
153341|NCT00368966|494964|P2|Infant Series|Randomization error|1
153342|NCT00368966|494965|P1|Infant Series|Randomization error|0
153343|NCT00368966|494964|P2|Infant Series|Lost to Follow-up|0
153344|NCT00368966|494965|P1|Infant Series|Lost to Follow-up|2
153345|NCT00368966|494964|P2|Infant Series|Protocol Violation|1
153346|NCT00368966|494965|P1|Infant Series|Protocol Violation|2
153347|NCT00368966|494964|P2|Infant Series|Withdrawal by Subject|6
153348|NCT00368966|494965|P1|Infant Series|Withdrawal by Subject|11
153349|NCT00368927|495021|P2|Overall Study|Physician Decision|0
153350|NCT00368927|495022|P1|Overall Study|Physician Decision|1
153351|NCT00368927|495021|P2|Overall Study|Withdrawal by Subject|2
153352|NCT00368927|495022|P1|Overall Study|Withdrawal by Subject|1
153353|NCT00368927|495021|P2|Overall Study|Adverse Event|1
153354|NCT00368927|495022|P1|Overall Study|Adverse Event|1
153355|NCT00368927|495021|P2|Overall Study|Lost to Follow-up|0
153356|NCT00368927|495022|P1|Overall Study|Lost to Follow-up|2
153357|NCT00368875|495030|P2|Overall Study|Alternative Therapy|1
153358|NCT00368875|495031|P1|Overall Study|Alternative Therapy|1
153359|NCT00368875|495030|P2|Overall Study|Other Reason|2
153360|NCT00368875|495031|P1|Overall Study|Other Reason|0
153361|NCT00368875|495030|P2|Overall Study|Withdrawal by Subject|6
153362|NCT00368875|495031|P1|Overall Study|Withdrawal by Subject|2
153363|NCT00368875|495030|P2|Overall Study|Progressive disease|27
153364|NCT00368875|495031|P1|Overall Study|Progressive disease|3
153365|NCT00368875|495030|P2|Overall Study|Adverse Event|12
153366|NCT00368875|495031|P1|Overall Study|Adverse Event|0
153367|NCT00368849|495039|P2|Overall Study|Physician Decision|1
153368|NCT00368849|495040|P1|Overall Study|Physician Decision|0
153369|NCT00368849|495039|P2|Overall Study|Withdrawal by Subject|1
153370|NCT00368849|495040|P1|Overall Study|Withdrawal by Subject|0
153371|NCT00368745|495056|P2|Double-blind Treatment Period|Other|6
153372|NCT00368745|495057|P1|Double-blind Treatment Period|Other|7
153373|NCT00368745|495056|P2|Double-blind Treatment Period|Withdrawal by Subject|3
153374|NCT00368745|495057|P1|Double-blind Treatment Period|Withdrawal by Subject|5
153375|NCT00368745|495056|P2|Double-blind Treatment Period|Lost to Follow-up|0
153376|NCT00368745|495057|P1|Double-blind Treatment Period|Lost to Follow-up|1
153377|NCT00368745|495056|P2|Double-blind Treatment Period|Lack of Efficacy|16
153378|NCT00368745|495057|P1|Double-blind Treatment Period|Lack of Efficacy|7
153379|NCT00368745|495056|P2|Double-blind Treatment Period|Adverse Event|6
153380|NCT00368745|495057|P1|Double-blind Treatment Period|Adverse Event|6
153381|NCT00368641|495089|P2|Overall Study|Sponsor decision to terminate study|5
153382|NCT00368641|495090|P1|Overall Study|Sponsor decision to terminate study|2
153383|NCT00368641|495089|P2|Overall Study|Withdrawal by Subject|0
153384|NCT00368641|495090|P1|Overall Study|Withdrawal by Subject|1
153385|NCT00368641|495089|P2|Overall Study|Death|0
153386|NCT00368641|495090|P1|Overall Study|Death|1
153387|NCT00368641|495089|P2|Overall Study|Adverse Event|1
153388|NCT00368641|495090|P1|Overall Study|Adverse Event|2
153389|NCT00368550|495098|P2|Overall Study|Withdrawal by Subject|10
153390|NCT00368550|495099|P1|Overall Study|Withdrawal by Subject|17
153391|NCT00368550|495098|P2|Overall Study|Lack of Efficacy|9
153392|NCT00368550|495099|P1|Overall Study|Lack of Efficacy|4
153393|NCT00368550|495098|P2|Overall Study|Adverse Event|4
153394|NCT00368550|495099|P1|Overall Study|Adverse Event|7
153395|NCT00368537|495111|P2|Baseline Participants|Patient uncompliant|1
153396|NCT00368537|495112|P1|Baseline Participants|Patient uncompliant|0
153397|NCT00368537|495111|P2|Baseline Participants|No susceptibility|0
153398|NCT00368537|495112|P1|Baseline Participants|No susceptibility|1
153399|NCT00368537|495111|P2|Baseline Participants|Death|2
153400|NCT00368537|495112|P1|Baseline Participants|Death|1
153401|NCT00368537|495111|P2|Baseline Participants|Withdrawal by Subject|4
153402|NCT00368537|495112|P1|Baseline Participants|Withdrawal by Subject|6
153403|NCT00368537|495111|P2|Baseline Participants|Lost to Follow-up|17
153404|NCT00368537|495112|P1|Baseline Participants|Lost to Follow-up|16
153405|NCT00368537|495111|P2|Randomization|No study drug dosed|6
153406|NCT00368537|495112|P1|Randomization|No study drug dosed|13
153407|NCT00368472|495126|P1|Overall Study|Missing Final Disposition Date|1
153408|NCT00368472|495126|P1|Overall Study|Not Specified|32
153409|NCT00368472|495126|P1|Overall Study|Diary non-compliance|1
153410|NCT00368472|495126|P1|Overall Study|Withdrawal by Subject|40
153411|NCT00368472|495126|P1|Overall Study|Request of Investigator or Sponsor|3
153412|NCT00368472|495126|P1|Overall Study|Protocol Violation|2
153413|NCT00368472|495126|P1|Overall Study|Medication non-compliance|4
153414|NCT00368472|495126|P1|Overall Study|Adverse Event|22
153415|NCT00368277|495185|P2|Overall Study|Lost to Follow-up|6
153416|NCT00368277|495186|P1|Overall Study|Lost to Follow-up|8
153417|NCT00368277|495185|P2|Overall Study|Patient withdrew consent|28
153418|NCT00368277|495186|P1|Overall Study|Patient withdrew consent|32
153419|NCT00368277|495185|P2|Overall Study|Protocol deviation|0
153420|NCT00368277|495186|P1|Overall Study|Protocol deviation|7
153421|NCT00368277|495185|P2|Overall Study|Unsatisfactory therapeutic effect|24
153422|NCT00368277|495186|P1|Overall Study|Unsatisfactory therapeutic effect|31
153423|NCT00368277|495185|P2|Overall Study|Death|1
153424|NCT00368277|495186|P1|Overall Study|Death|2
153425|NCT00368277|495185|P2|Overall Study|Adverse Event|49
153426|NCT00368277|495186|P1|Overall Study|Adverse Event|33
153427|NCT00368251|495201|P3|Overall Study|AE, non-serious non-fatal|1
153428|NCT00368251|495202|P2|Overall Study|AE, non-serious non-fatal|0
153429|NCT00368251|495203|P1|Overall Study|AE, non-serious non-fatal|0
153430|NCT00368251|495201|P3|Overall Study|SAE, non-fatal|0
153431|NCT00368251|495202|P2|Overall Study|SAE, non-fatal|0
153432|NCT00368251|495203|P1|Overall Study|SAE, non-fatal|1
153433|NCT00368108|495226|P3|Overall Study|Not Specified|1
153434|NCT00368108|495227|P2|Overall Study|Not Specified|7
153435|NCT00368108|495228|P1|Overall Study|Not Specified|3
153436|NCT00368108|495226|P3|Overall Study|Physician Decision|1
153437|NCT00368108|495227|P2|Overall Study|Physician Decision|0
153438|NCT00368108|495228|P1|Overall Study|Physician Decision|2
153439|NCT00368108|495226|P3|Overall Study|Lack of Efficacy|5
153440|NCT00368108|495227|P2|Overall Study|Lack of Efficacy|8
153441|NCT00368108|495228|P1|Overall Study|Lack of Efficacy|7
153442|NCT00368108|495226|P3|Overall Study|Withdrawal by Subject|5
153443|NCT00368108|495227|P2|Overall Study|Withdrawal by Subject|3
153444|NCT00368108|495228|P1|Overall Study|Withdrawal by Subject|9
153445|NCT00368108|495226|P3|Overall Study|Protocol Violation|9
153446|NCT00368108|495227|P2|Overall Study|Protocol Violation|9
153447|NCT00368108|495228|P1|Overall Study|Protocol Violation|5
153448|NCT00368108|495226|P3|Overall Study|Abnormal Laboratory Value|3
153449|NCT00368108|495227|P2|Overall Study|Abnormal Laboratory Value|0
153450|NCT00368108|495228|P1|Overall Study|Abnormal Laboratory Value|0
153451|NCT00368108|495226|P3|Overall Study|Adverse Event|44
153452|NCT00368108|495227|P2|Overall Study|Adverse Event|26
153453|NCT00368108|495228|P1|Overall Study|Adverse Event|38
153454|NCT00368069|495247|P2|Overall Study|no blood sampling possible|1
153455|NCT00368069|495248|P1|Overall Study|no blood sampling possible|0
153456|NCT00368069|495247|P2|Overall Study|Withdrawal of Consent|1
153457|NCT00368069|495248|P1|Overall Study|Withdrawal of Consent|2
153458|NCT00368069|495247|P2|Overall Study|Protocol Violation|2
153459|NCT00368069|495248|P1|Overall Study|Protocol Violation|0
153460|NCT00368069|495247|P2|Overall Study|Lost to Follow-up|0
153461|NCT00368069|495248|P1|Overall Study|Lost to Follow-up|1
153462|NCT00368069|495247|P2|Overall Study|Lack of Efficacy|1
153463|NCT00368069|495248|P1|Overall Study|Lack of Efficacy|0
153464|NCT00368069|495247|P2|Overall Study|Adverse Event|2
153465|NCT00368069|495248|P1|Overall Study|Adverse Event|5
153466|NCT00367991|495266|P2|Overall Study|Adverse Event|1
153467|NCT00367991|495267|P1|Overall Study|Adverse Event|1
153468|NCT00367991|495266|P2|Overall Study|Withdrawal by Subject|1
153469|NCT00367991|495267|P1|Overall Study|Withdrawal by Subject|1
153470|NCT00366678|495275|P3|Toddler Dose|protocol deviation|0
153471|NCT00366678|495276|P2|Toddler Dose|protocol deviation|0
153472|NCT00366678|495277|P1|Toddler Dose|protocol deviation|1
153473|NCT00366678|495275|P3|Toddler Dose|Withdrawal by Subject|0
153474|NCT00366678|495276|P2|Toddler Dose|Withdrawal by Subject|0
153475|NCT00366678|495277|P1|Toddler Dose|Withdrawal by Subject|1
153476|NCT00366678|495275|P3|Toddler Dose|Failed to return|0
153477|NCT00366678|495276|P2|Toddler Dose|Failed to return|0
153478|NCT00366678|495277|P1|Toddler Dose|Failed to return|1
153479|NCT00366678|495275|P3|Toddler Dose|Protocol Violation|0
153480|NCT00366678|495276|P2|Toddler Dose|Protocol Violation|1
153481|NCT00366678|495277|P1|Toddler Dose|Protocol Violation|2
153482|NCT00366678|495275|P3|After Infant|Protocol Violation|0
153483|NCT00366678|495276|P2|After Infant|Protocol Violation|0
153484|NCT00366678|495277|P1|After Infant|Protocol Violation|1
153485|NCT00366678|495275|P3|After Infant|Adverse Event|0
153486|NCT00366678|495276|P2|After Infant|Adverse Event|0
153487|NCT00366678|495277|P1|After Infant|Adverse Event|1
153488|NCT00366678|495275|P3|After Infant|Failed to return|0
153489|NCT00366678|495276|P2|After Infant|Failed to return|5
153490|NCT00366678|495277|P1|After Infant|Failed to return|5
153491|NCT00366678|495275|P3|After Infant|Lost to Follow-up|0
153492|NCT00366678|495276|P2|After Infant|Lost to Follow-up|1
153493|NCT00366678|495277|P1|After Infant|Lost to Follow-up|2
153494|NCT00366678|495275|P3|After Infant|Withdrawal by Subject|0
153495|NCT00366678|495276|P2|After Infant|Withdrawal by Subject|4
153496|NCT00366678|495277|P1|After Infant|Withdrawal by Subject|8
153497|NCT00366678|495275|P3|Infant Series|Adverse Event|0
153498|NCT00366678|495276|P2|Infant Series|Adverse Event|0
153499|NCT00366678|495277|P1|Infant Series|Adverse Event|1
153500|NCT00366678|495275|P3|Infant Series|Failed to return|0
153501|NCT00366678|495276|P2|Infant Series|Failed to return|1
153502|NCT00366678|495277|P1|Infant Series|Failed to return|1
153503|NCT00366678|495275|P3|Infant Series|Protocol Violation|0
153504|NCT00366678|495276|P2|Infant Series|Protocol Violation|3
153505|NCT00366678|495277|P1|Infant Series|Protocol Violation|4
153506|NCT00366678|495275|P3|Infant Series|Withdrawal by Subject|0
153507|NCT00366678|495276|P2|Infant Series|Withdrawal by Subject|6
153508|NCT00366678|495277|P1|Infant Series|Withdrawal by Subject|8
153509|NCT00367835|495359|P2|Overall Study|History of lead poisoning|1
153510|NCT00367835|495360|P1|Overall Study|History of lead poisoning|0
153511|NCT00367835|495359|P2|Overall Study|Did not respond to calls|0
153512|NCT00367835|495360|P1|Overall Study|Did not respond to calls|1
153513|NCT00367835|495359|P2|Overall Study|refused blood collection|0
153514|NCT00367835|495360|P1|Overall Study|refused blood collection|1
153515|NCT00367835|495359|P2|Overall Study|Subject in juvenile detention center|0
153516|NCT00367835|495360|P1|Overall Study|Subject in juvenile detention center|1
153517|NCT00367835|495359|P2|Overall Study|Lack of Efficacy|12
153518|NCT00367835|495360|P1|Overall Study|Lack of Efficacy|3
153519|NCT00367835|495359|P2|Overall Study|Lost to Follow-up|4
153520|NCT00367835|495360|P1|Overall Study|Lost to Follow-up|1
153521|NCT00367835|495359|P2|Overall Study|Withdrawal by Subject|6
153522|NCT00367835|495360|P1|Overall Study|Withdrawal by Subject|7
153523|NCT00367835|495359|P2|Overall Study|Protocol Violation|7
153524|NCT00367835|495360|P1|Overall Study|Protocol Violation|1
153525|NCT00367835|495359|P2|Overall Study|Adverse Event|1
153526|NCT00367835|495360|P1|Overall Study|Adverse Event|14
153527|NCT00367770|495386|P1|Overall Study|Withdrawal by Subject|1
153528|NCT00367770|495386|P1|Overall Study|Adverse Event|1
153529|NCT00367744|495394|P2|Overall Study|Lost to Follow-up|5
153530|NCT00367744|495395|P1|Overall Study|Lost to Follow-up|4
153531|NCT00367640|495424|P4|Overall Study|Any other reason not above-mentioned|4
153532|NCT00367640|495425|P3|Overall Study|Any other reason not above-mentioned|3
153533|NCT00367640|495426|P2|Overall Study|Any other reason not above-mentioned|5
153534|NCT00367640|495427|P1|Overall Study|Any other reason not above-mentioned|7
153535|NCT00367640|495424|P4|Overall Study|Withdrawal by Subject|6
153536|NCT00367640|495425|P3|Overall Study|Withdrawal by Subject|8
153537|NCT00367640|495426|P2|Overall Study|Withdrawal by Subject|11
153538|NCT00367640|495427|P1|Overall Study|Withdrawal by Subject|8
153539|NCT00367640|495424|P4|Overall Study|Adverse Event|0
153540|NCT00367640|495425|P3|Overall Study|Adverse Event|8
153541|NCT00367640|495426|P2|Overall Study|Adverse Event|6
153542|NCT00367640|495427|P1|Overall Study|Adverse Event|3
153543|NCT00367484|495443|P1|Overall Study|Lack of Efficacy|1
153544|NCT00367484|495443|P1|Overall Study|The choice of the patient|1
153545|NCT00367484|495443|P1|Overall Study|Protocol Violation|1
153546|NCT00367484|495443|P1|Overall Study|Lost to Follow-up|1
153547|NCT00367484|495443|P1|Overall Study|Travel to USA|1
153548|NCT00367484|495443|P1|Overall Study|Withdrew informed consent|5
153549|NCT00367484|495443|P1|Overall Study|Adverse Event|7
153550|NCT00367432|495447|P2|Second Period (up to 54 Months)|Other Reason|2
153551|NCT00367432|495448|P1|Second Period (up to 54 Months)|Other Reason|6
153552|NCT00367432|495447|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
153553|NCT00367432|495448|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
153554|NCT00367432|495447|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
153555|NCT00367432|495448|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
153556|NCT00367432|495447|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
153557|NCT00367432|495448|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
153558|NCT00367432|495447|P2|Second Period (up to 54 Months)|Adverse Event|3
153559|NCT00367432|495448|P1|Second Period (up to 54 Months)|Adverse Event|14
153560|NCT00367432|495447|P2|First Period (16 Weeks)|Other Reason|0
153561|NCT00367432|495448|P1|First Period (16 Weeks)|Other Reason|2
153562|NCT00367432|495447|P2|First Period (16 Weeks)|Withdrawal by Subject|0
153563|NCT00367432|495448|P1|First Period (16 Weeks)|Withdrawal by Subject|6
153564|NCT00367432|495447|P2|First Period (16 Weeks)|Lack of Efficacy|0
153565|NCT00367432|495448|P1|First Period (16 Weeks)|Lack of Efficacy|24
153566|NCT00367432|495447|P2|First Period (16 Weeks)|Adverse Event|0
153567|NCT00367432|495448|P1|First Period (16 Weeks)|Adverse Event|6
153568|NCT00367341|495475|P2|Overall Study|Protocol Violation|0
153569|NCT00367341|495476|P1|Overall Study|Protocol Violation|1
153570|NCT00367341|495475|P2|Overall Study|Physician Decision|0
153571|NCT00367341|495476|P1|Overall Study|Physician Decision|1
153572|NCT00367237|495486|P2|Overall Study|Protocol Violation|5
153573|NCT00367237|495487|P1|Overall Study|Protocol Violation|2
153574|NCT00367237|495486|P2|Overall Study|Withdrawal by Subject|4
153575|NCT00367237|495487|P1|Overall Study|Withdrawal by Subject|0
153576|NCT00367237|495486|P2|Overall Study|Lost to Follow-up|0
153577|NCT00367237|495487|P1|Overall Study|Lost to Follow-up|1
153578|NCT00367237|495486|P2|Overall Study|Adverse Event|2
153579|NCT00367237|495487|P1|Overall Study|Adverse Event|7
153580|NCT00367133|495496|P3|2 Years|Missed visit|4
153581|NCT00367133|495497|P2|2 Years|Missed visit|5
153582|NCT00367133|495498|P1|2 Years|Missed visit|4
153583|NCT00367133|495496|P3|2 Years|Dropped|33
153584|NCT00367133|495497|P2|2 Years|Dropped|19
153585|NCT00367133|495498|P1|2 Years|Dropped|34
153586|NCT00367133|495496|P3|2 Years|Death|12
153587|NCT00367133|495497|P2|2 Years|Death|12
153588|NCT00367133|495498|P1|2 Years|Death|20
153589|NCT00367055|495550|P2|Overall Study|Participant Living too Far from Hospital|1
153590|NCT00367055|495551|P1|Overall Study|Participant Living too Far from Hospital|0
153591|NCT00367055|495550|P2|Overall Study|Stopping Criterion Met|1
153592|NCT00367055|495551|P1|Overall Study|Stopping Criterion Met|0
153593|NCT00367055|495550|P2|Overall Study|Protocol Violation|1
153594|NCT00367055|495551|P1|Overall Study|Protocol Violation|0
153595|NCT00367055|495550|P2|Overall Study|Lost to Follow-up|1
153596|NCT00367055|495551|P1|Overall Study|Lost to Follow-up|1
153597|NCT00367055|495550|P2|Overall Study|Lack of Efficacy|2
153598|NCT00367055|495551|P1|Overall Study|Lack of Efficacy|1
153599|NCT00367055|495550|P2|Overall Study|Patient's Willing|2
153600|NCT00367055|495551|P1|Overall Study|Patient's Willing|3
153601|NCT00367055|495550|P2|Overall Study|Adverse Event|3
153602|NCT00367055|495551|P1|Overall Study|Adverse Event|6
153603|NCT00366899|495567|P2|Toddler Dose|Protocol Violation|0
153604|NCT00366899|495568|P1|Toddler Dose|Protocol Violation|1
153605|NCT00366899|495567|P2|Toddler Dose|Withdrawal by Subject|1
153606|NCT00366899|495568|P1|Toddler Dose|Withdrawal by Subject|1
153607|NCT00366899|495567|P2|After Infant Series|Protocol Violation|0
153608|NCT00366899|495568|P1|After Infant Series|Protocol Violation|1
153609|NCT00366899|495567|P2|After Infant Series|Adverse Event|2
153610|NCT00366899|495568|P1|After Infant Series|Adverse Event|1
153611|NCT00366899|495567|P2|After Infant Series|Withdrawal by Subject|4
153612|NCT00366899|495568|P1|After Infant Series|Withdrawal by Subject|1
153613|NCT00366899|495567|P2|After Infant Series|Lost to Follow-up|3
153614|NCT00366899|495568|P1|After Infant Series|Lost to Follow-up|4
153615|NCT00366899|495567|P2|Infant Series|Randomized but not consented|0
153616|NCT00366899|495568|P1|Infant Series|Randomized but not consented|1
153617|NCT00366899|495567|P2|Infant Series|Physician Decision|0
153618|NCT00366899|495568|P1|Infant Series|Physician Decision|1
153619|NCT00366899|495567|P2|Infant Series|Adverse Event|1
153620|NCT00366899|495568|P1|Infant Series|Adverse Event|0
153621|NCT00366899|495567|P2|Infant Series|Lost to Follow-up|2
153622|NCT00366899|495568|P1|Infant Series|Lost to Follow-up|0
153623|NCT00366899|495567|P2|Infant Series|Failed to return|1
153624|NCT00366899|495568|P1|Infant Series|Failed to return|1
153625|NCT00366899|495567|P2|Infant Series|Protocol Violation|1
153626|NCT00366899|495568|P1|Infant Series|Protocol Violation|2
153627|NCT00366899|495567|P2|Infant Series|Withdrawal by Subject|7
153628|NCT00366899|495568|P1|Infant Series|Withdrawal by Subject|4
153629|NCT00366548|495628|P2|After Infant Series|Lost to Follow-up|0
153630|NCT00366548|495629|P1|After Infant Series|Lost to Follow-up|1
153631|NCT00366548|495628|P2|After Infant Series|Adverse Event|0
153632|NCT00366548|495629|P1|After Infant Series|Adverse Event|2
153633|NCT00366548|495628|P2|After Infant Series|Withdrawal by Subject|1
153634|NCT00366548|495629|P1|After Infant Series|Withdrawal by Subject|3
153635|NCT00366548|495628|P2|Infant Series|Withdrawal by Subject|1
153636|NCT00366548|495629|P1|Infant Series|Withdrawal by Subject|3
153637|NCT00366548|495628|P2|Infant Series|Protocol Violation|1
153638|NCT00366548|495629|P1|Infant Series|Protocol Violation|0
153639|NCT00366548|495628|P2|Infant Series|Adverse Event|3
153640|NCT00366548|495629|P1|Infant Series|Adverse Event|1
153641|NCT00366444|495665|P2|Overall Study|Lack of Efficacy|1
153642|NCT00366444|495666|P1|Overall Study|Lack of Efficacy|0
153643|NCT00366444|495665|P2|Overall Study|Withdrawal by Subject|1
153644|NCT00366444|495666|P1|Overall Study|Withdrawal by Subject|1
153645|NCT00366340|495694|P2|Toddler Dose|Parent/legal guardian request|1
153646|NCT00366340|495695|P1|Toddler Dose|Parent/legal guardian request|0
153647|NCT00366340|495694|P2|Toddler Dose|Failed to return|0
153648|NCT00366340|495695|P1|Toddler Dose|Failed to return|1
153649|NCT00366340|495694|P2|After the Infant Series|Lost to Follow-up|1
153650|NCT00366340|495695|P1|After the Infant Series|Lost to Follow-up|0
153651|NCT00366340|495694|P2|After the Infant Series|Adverse Event|1
153652|NCT00366340|495695|P1|After the Infant Series|Adverse Event|0
153653|NCT00366340|495694|P2|After the Infant Series|Protocol Violation|2
153654|NCT00366340|495695|P1|After the Infant Series|Protocol Violation|2
153655|NCT00366340|495694|P2|After the Infant Series|Failed to return|1
153656|NCT00366340|495695|P1|After the Infant Series|Failed to return|0
153657|NCT00366340|495694|P2|After the Infant Series|Parent/legal guardian request|1
153658|NCT00366340|495695|P1|After the Infant Series|Parent/legal guardian request|1
153659|NCT00366340|495694|P2|Infant Series|Failure to return|0
153660|NCT00366340|495695|P1|Infant Series|Failure to return|1
153661|NCT00366340|495694|P2|Infant Series|Lost to Follow-up|1
153662|NCT00366340|495695|P1|Infant Series|Lost to Follow-up|1
153663|NCT00366340|495694|P2|Infant Series|Adverse Event|2
153664|NCT00366340|495695|P1|Infant Series|Adverse Event|0
153665|NCT00366340|495694|P2|Infant Series|Withdrawal by Subject|3
153666|NCT00366340|495695|P1|Infant Series|Withdrawal by Subject|3
153667|NCT00366340|495694|P2|Infant Series|Protocol Violation|4
153668|NCT00366340|495695|P1|Infant Series|Protocol Violation|3
153669|NCT00366301|495753|P4|Overall Study|Withdrawal by Subject|1
153670|NCT00366301|495754|P3|Overall Study|Withdrawal by Subject|1
153671|NCT00366301|495755|P2|Overall Study|Withdrawal by Subject|2
153672|NCT00366301|495756|P1|Overall Study|Withdrawal by Subject|4
153673|NCT00366301|495753|P4|Overall Study|Lost to Follow-up|7
153674|NCT00366301|495754|P3|Overall Study|Lost to Follow-up|3
153675|NCT00366301|495755|P2|Overall Study|Lost to Follow-up|4
153676|NCT00366301|495756|P1|Overall Study|Lost to Follow-up|4
153677|NCT00366249|495772|P2|Overall Study|Most due to osteomylitis status|20
153678|NCT00366249|495773|P1|Overall Study|Most due to osteomylitis status|31
153679|NCT00366249|495772|P2|Overall Study|Lack of Efficacy|21
153680|NCT00366249|495773|P1|Overall Study|Lack of Efficacy|21
153681|NCT00366249|495772|P2|Overall Study|Withdrawal by Subject|4
153682|NCT00366249|495773|P1|Overall Study|Withdrawal by Subject|18
153683|NCT00366249|495772|P2|Overall Study|Protocol Violation|2
153684|NCT00366249|495773|P1|Overall Study|Protocol Violation|1
153685|NCT00366249|495772|P2|Overall Study|Lost to Follow-up|0
153686|NCT00366249|495773|P1|Overall Study|Lost to Follow-up|2
153687|NCT00366249|495772|P2|Overall Study|Physician Decision|2
153688|NCT00366249|495773|P1|Overall Study|Physician Decision|5
153689|NCT00366249|495772|P2|Overall Study|Death|1
153690|NCT00366249|495773|P1|Overall Study|Death|0
153691|NCT00366249|495772|P2|Overall Study|Adverse Event|28
153692|NCT00366249|495773|P1|Overall Study|Adverse Event|53
153693|NCT00365976|495807|P2|Overall Study|Withdrawal by Subject|5
153694|NCT00365976|495808|P1|Overall Study|Withdrawal by Subject|1
153695|NCT00365846|495946|P1|Overall Study|Lost to Follow-up|1
153696|NCT00365716|495971|P7|Extension 2|Withdrawal by Subject|5
153697|NCT00365716|495972|P6|Extension 2|Withdrawal by Subject|0
153698|NCT00365716|495973|P5|Extension 2|Withdrawal by Subject|0
153699|NCT00365716|495974|P4|Extension 2|Withdrawal by Subject|0
153700|NCT00365716|495975|P3|Extension 2|Withdrawal by Subject|0
153701|NCT00365716|495976|P2|Extension 2|Withdrawal by Subject|0
153702|NCT00365716|495977|P1|Extension 2|Withdrawal by Subject|0
153703|NCT00365716|495971|P7|Extension 2|Unspecified|3
153704|NCT00365716|495972|P6|Extension 2|Unspecified|0
153705|NCT00365716|495973|P5|Extension 2|Unspecified|0
153706|NCT00365716|495974|P4|Extension 2|Unspecified|0
153707|NCT00365716|495975|P3|Extension 2|Unspecified|0
153708|NCT00365716|495976|P2|Extension 2|Unspecified|0
153709|NCT00365716|495977|P1|Extension 2|Unspecified|0
153710|NCT00365716|495971|P7|Extension 2|Lost to Follow-up|2
153711|NCT00365716|495972|P6|Extension 2|Lost to Follow-up|0
153712|NCT00365716|495973|P5|Extension 2|Lost to Follow-up|0
153713|NCT00365716|495974|P4|Extension 2|Lost to Follow-up|0
153714|NCT00365716|495975|P3|Extension 2|Lost to Follow-up|0
153715|NCT00365716|495976|P2|Extension 2|Lost to Follow-up|0
153716|NCT00365716|495977|P1|Extension 2|Lost to Follow-up|0
153717|NCT00365716|495971|P7|Extension 1|Protocol Violation|0
153718|NCT00365716|495972|P6|Extension 1|Protocol Violation|1
153719|NCT00365716|495973|P5|Extension 1|Protocol Violation|0
153720|NCT00365716|495974|P4|Extension 1|Protocol Violation|0
153721|NCT00365716|495975|P3|Extension 1|Protocol Violation|0
153722|NCT00365716|495976|P2|Extension 1|Protocol Violation|0
153723|NCT00365716|495977|P1|Extension 1|Protocol Violation|0
153724|NCT00365716|495971|P7|Extension 1|Pregnancy|0
153725|NCT00365716|495972|P6|Extension 1|Pregnancy|4
153726|NCT00365716|495973|P5|Extension 1|Pregnancy|0
153727|NCT00365716|495974|P4|Extension 1|Pregnancy|0
153728|NCT00365716|495975|P3|Extension 1|Pregnancy|0
153729|NCT00365716|495976|P2|Extension 1|Pregnancy|0
153730|NCT00365716|495977|P1|Extension 1|Pregnancy|0
153731|NCT00365716|495971|P7|Extension 1|Withdrawal by Subject|0
153732|NCT00365716|495972|P6|Extension 1|Withdrawal by Subject|3
153733|NCT00365716|495973|P5|Extension 1|Withdrawal by Subject|0
153734|NCT00365716|495974|P4|Extension 1|Withdrawal by Subject|0
153735|NCT00365716|495975|P3|Extension 1|Withdrawal by Subject|0
153736|NCT00365716|495976|P2|Extension 1|Withdrawal by Subject|0
153737|NCT00365716|495977|P1|Extension 1|Withdrawal by Subject|0
153738|NCT00365716|495971|P7|Extension 1|Moved|0
153739|NCT00365716|495972|P6|Extension 1|Moved|4
153740|NCT00365716|495973|P5|Extension 1|Moved|0
153741|NCT00365716|495974|P4|Extension 1|Moved|0
153742|NCT00365716|495975|P3|Extension 1|Moved|0
153743|NCT00365716|495976|P2|Extension 1|Moved|0
153744|NCT00365716|495977|P1|Extension 1|Moved|0
153745|NCT00365716|495971|P7|Extension 1|Unspecified|0
153746|NCT00365716|495972|P6|Extension 1|Unspecified|9
153747|NCT00365716|495973|P5|Extension 1|Unspecified|0
153748|NCT00365716|495974|P4|Extension 1|Unspecified|0
153749|NCT00365716|495975|P3|Extension 1|Unspecified|0
153750|NCT00365716|495976|P2|Extension 1|Unspecified|0
153751|NCT00365716|495977|P1|Extension 1|Unspecified|0
153752|NCT00365716|495971|P7|Extension 1|Lost to Follow-up|0
153753|NCT00365716|495972|P6|Extension 1|Lost to Follow-up|1
153754|NCT00365716|495973|P5|Extension 1|Lost to Follow-up|0
153755|NCT00365716|495974|P4|Extension 1|Lost to Follow-up|0
153756|NCT00365716|495975|P3|Extension 1|Lost to Follow-up|0
153757|NCT00365716|495976|P2|Extension 1|Lost to Follow-up|0
153758|NCT00365716|495977|P1|Extension 1|Lost to Follow-up|0
153759|NCT00365716|495971|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
153760|NCT00365716|495972|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
153761|NCT00365716|495973|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
153762|NCT00365716|495974|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
153763|NCT00365716|495975|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
153764|NCT00365716|495976|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
153765|NCT00365716|495977|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
153766|NCT00365716|495971|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
153767|NCT00365716|495972|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
153768|NCT00365716|495973|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
153769|NCT00365716|495974|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
153770|NCT00365716|495975|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
153771|NCT00365716|495976|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
153772|NCT00365716|495977|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
153773|NCT00365716|495971|P7|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
153774|NCT00365716|495972|P6|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
153775|NCT00365716|495973|P5|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|1
153776|NCT00365716|495974|P4|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
153777|NCT00365716|495975|P3|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
153778|NCT00365716|495976|P2|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
153779|NCT00365716|495977|P1|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|2
153780|NCT00365716|495971|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
153781|NCT00365716|495972|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
153782|NCT00365716|495973|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
153783|NCT00365716|495974|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
153784|NCT00365716|495975|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
153785|NCT00365716|495976|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
153786|NCT00365716|495977|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
153787|NCT00365716|495971|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
153788|NCT00365716|495972|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
153789|NCT00365716|495973|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
153790|NCT00365716|495974|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
153791|NCT00365716|495975|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
153792|NCT00365716|495976|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
153793|NCT00365716|495977|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
153794|NCT00365716|495971|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
153795|NCT00365716|495972|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
153796|NCT00365716|495973|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
153797|NCT00365716|495974|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
153798|NCT00365716|495975|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
153799|NCT00365716|495976|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
153800|NCT00365716|495977|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
153801|NCT00365716|495971|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
153802|NCT00365716|495972|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
153803|NCT00365716|495973|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
153804|NCT00365716|495974|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
153805|NCT00365716|495975|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
153806|NCT00365716|495976|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
153807|NCT00365716|495977|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
153808|NCT00365716|495971|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
153809|NCT00365716|495972|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
153810|NCT00365716|495973|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
153811|NCT00365716|495974|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
153812|NCT00365716|495975|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
153813|NCT00365716|495976|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
153814|NCT00365716|495977|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
153815|NCT00365716|495971|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
153816|NCT00365716|495972|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
153817|NCT00365716|495973|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
153818|NCT00365716|495974|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
153819|NCT00365716|495975|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
153820|NCT00365716|495976|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
153821|NCT00365716|495977|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
153822|NCT00365716|495971|P7|Base Study (Day 1 to Month 7)|Unspecified|0
153823|NCT00365716|495972|P6|Base Study (Day 1 to Month 7)|Unspecified|0
153824|NCT00365716|495973|P5|Base Study (Day 1 to Month 7)|Unspecified|0
153825|NCT00365716|495974|P4|Base Study (Day 1 to Month 7)|Unspecified|0
153826|NCT00365716|495975|P3|Base Study (Day 1 to Month 7)|Unspecified|0
153827|NCT00365716|495976|P2|Base Study (Day 1 to Month 7)|Unspecified|1
153828|NCT00365716|495977|P1|Base Study (Day 1 to Month 7)|Unspecified|0
153829|NCT00365716|495971|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
153830|NCT00365716|495972|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
153831|NCT00365716|495973|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
153832|NCT00365716|495974|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
153833|NCT00365716|495975|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
153834|NCT00365716|495976|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
153835|NCT00365716|495977|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
153836|NCT00365716|495971|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
153837|NCT00365716|495972|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
153838|NCT00365716|495973|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
153839|NCT00365716|495974|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
153840|NCT00365716|495975|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
153841|NCT00365716|495976|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
153842|NCT00365716|495977|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
153843|NCT00365716|495971|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
153844|NCT00365716|495972|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
153845|NCT00365716|495973|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
153846|NCT00365716|495974|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
153847|NCT00365716|495975|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
153848|NCT00365716|495976|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
153849|NCT00365716|495977|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
153850|NCT00365547|495998|P1|Overall Study|Withdrawal by Subject|1
153851|NCT00365547|495998|P1|Overall Study|Screen failure|1
153852|NCT00365547|495998|P1|Overall Study|Insurance did not cover Avastin|1
153853|NCT00365508|496008|P2|Overall Study|Lost to Follow-up|154
153854|NCT00365508|496009|P1|Overall Study|Lost to Follow-up|139
153855|NCT00365456|496017|P2|Trial Period III (12 Months)|Other|1
153856|NCT00365456|496018|P1|Trial Period III (12 Months)|Other|1
153857|NCT00365456|496017|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
153858|NCT00365456|496018|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
153859|NCT00365456|496017|P2|Trial Period III (12 Months)|Adverse Event|3
153860|NCT00365456|496018|P1|Trial Period III (12 Months)|Adverse Event|13
153861|NCT00365456|496017|P2|Trial Period II (12 Months)|Other|1
153862|NCT00365456|496018|P1|Trial Period II (12 Months)|Other|0
153863|NCT00365456|496017|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
153864|NCT00365456|496018|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
153865|NCT00365456|496017|P2|Trial Period II (12 Months)|Non-compliance|2
153866|NCT00365456|496018|P1|Trial Period II (12 Months)|Non-compliance|0
153867|NCT00365456|496017|P2|Trial Period II (12 Months)|Adverse Event|6
153868|NCT00365456|496018|P1|Trial Period II (12 Months)|Adverse Event|0
153869|NCT00365456|496017|P2|Trial Period I (12 Months)|Other|0
153870|NCT00365456|496018|P1|Trial Period I (12 Months)|Other|11
153871|NCT00365456|496017|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
153872|NCT00365456|496018|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
153873|NCT00365456|496017|P2|Trial Period I (12 Months)|Non-compliance|0
153874|NCT00365456|496018|P1|Trial Period I (12 Months)|Non-compliance|3
153875|NCT00365456|496017|P2|Trial Period I (12 Months)|Adverse Event|0
153876|NCT00365456|496018|P1|Trial Period I (12 Months)|Adverse Event|84
153877|NCT00365378|496040|P3|Extension|Unspecified|31
153878|NCT00365378|496041|P2|Extension|Unspecified|0
153879|NCT00365378|496042|P1|Extension|Unspecified|0
153880|NCT00365378|496040|P3|Extension|Withdrawal by Subject|98
153881|NCT00365378|496041|P2|Extension|Withdrawal by Subject|0
153882|NCT00365378|496042|P1|Extension|Withdrawal by Subject|0
153883|NCT00365378|496040|P3|Extension|Protocol Violation|2
153884|NCT00365378|496041|P2|Extension|Protocol Violation|0
153885|NCT00365378|496042|P1|Extension|Protocol Violation|0
153886|NCT00365378|496040|P3|Extension|Lost to Follow-up|57
153887|NCT00365378|496041|P2|Extension|Lost to Follow-up|0
153888|NCT00365378|496042|P1|Extension|Lost to Follow-up|0
153889|NCT00365378|496040|P3|Extension|Moved|8
153890|NCT00365378|496041|P2|Extension|Moved|0
153891|NCT00365378|496042|P1|Extension|Moved|0
153892|NCT00365378|496040|P3|Extension|Adverse Event|1
153893|NCT00365378|496041|P2|Extension|Adverse Event|0
153894|NCT00365378|496042|P1|Extension|Adverse Event|0
153895|NCT00365378|496040|P3|Follow-up (Month 7 Though Month 48)|Unspecified|0
153896|NCT00365378|496041|P2|Follow-up (Month 7 Though Month 48)|Unspecified|21
153897|NCT00365378|496042|P1|Follow-up (Month 7 Though Month 48)|Unspecified|11
153898|NCT00365378|496040|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
153899|NCT00365378|496041|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
153900|NCT00365378|496042|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
153901|NCT00365378|496040|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
153902|NCT00365378|496041|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
153903|NCT00365378|496042|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
153904|NCT00365378|496040|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
153905|NCT00365378|496041|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
153906|NCT00365378|496042|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
153907|NCT00365378|496040|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
153908|NCT00365378|496041|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
153909|NCT00365378|496042|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
153910|NCT00365378|496040|P3|Follow-up (Month 7 Though Month 48)|Moved|0
153911|NCT00365378|496041|P2|Follow-up (Month 7 Though Month 48)|Moved|5
153912|NCT00365378|496042|P1|Follow-up (Month 7 Though Month 48)|Moved|6
153913|NCT00365378|496040|P3|Vaccination (Day 1 to Month 7)|Unspecified|0
153914|NCT00365378|496041|P2|Vaccination (Day 1 to Month 7)|Unspecified|9
153915|NCT00365378|496042|P1|Vaccination (Day 1 to Month 7)|Unspecified|17
153916|NCT00365378|496040|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
153917|NCT00365378|496041|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
153918|NCT00365378|496042|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
153919|NCT00365378|496040|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
153920|NCT00365378|496041|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
153921|NCT00365378|496042|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
153922|NCT00365378|496040|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
153923|NCT00365378|496041|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
153924|NCT00365378|496042|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
153925|NCT00365378|496040|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
153926|NCT00365378|496041|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
153927|NCT00365378|496042|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
153928|NCT00365378|496040|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
153929|NCT00365378|496041|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
153930|NCT00365378|496042|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
153931|NCT00365378|496040|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
153932|NCT00365378|496041|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
153933|NCT00365378|496042|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
153934|NCT00365365|496056|P3|Overall Study|Patient/physician decision|1
153935|NCT00365365|496057|P2|Overall Study|Patient/physician decision|0
153936|NCT00365365|496058|P1|Overall Study|Patient/physician decision|0
153937|NCT00365365|496056|P3|Overall Study|Second malignancy|0
153938|NCT00365365|496057|P2|Overall Study|Second malignancy|1
153939|NCT00365365|496058|P1|Overall Study|Second malignancy|0
153940|NCT00365365|496056|P3|Overall Study|Withdrew consent|0
153941|NCT00365365|496057|P2|Overall Study|Withdrew consent|1
153942|NCT00365365|496058|P1|Overall Study|Withdrew consent|1
153943|NCT00365365|496056|P3|Overall Study|New cancer|0
153944|NCT00365365|496057|P2|Overall Study|New cancer|0
153945|NCT00365365|496058|P1|Overall Study|New cancer|1
153946|NCT00365365|496056|P3|Overall Study|Moved|0
153947|NCT00365365|496057|P2|Overall Study|Moved|0
153948|NCT00365365|496058|P1|Overall Study|Moved|2
153949|NCT00365365|496056|P3|Overall Study|Adverse Event|3
153950|NCT00365365|496057|P2|Overall Study|Adverse Event|6
153951|NCT00365365|496058|P1|Overall Study|Adverse Event|6
153952|NCT00365365|496056|P3|Overall Study|Disease progression/relapse|7
153953|NCT00365365|496057|P2|Overall Study|Disease progression/relapse|6
153954|NCT00365365|496058|P1|Overall Study|Disease progression/relapse|9
153955|NCT00365365|496056|P3|Overall Study|Subject's request|1
153956|NCT00365365|496057|P2|Overall Study|Subject's request|13
153957|NCT00365365|496058|P1|Overall Study|Subject's request|11
153958|NCT00365365|496056|P3|Overall Study|Death|0
153959|NCT00365365|496057|P2|Overall Study|Death|3
153960|NCT00365365|496058|P1|Overall Study|Death|1
153961|NCT00365365|496056|P3|Overall Study|Lost to Follow-up|3
153962|NCT00365365|496057|P2|Overall Study|Lost to Follow-up|3
153963|NCT00365365|496058|P1|Overall Study|Lost to Follow-up|3
153964|NCT00365365|496056|P3|Overall Study|Poor compliance to protocol|0
153965|NCT00365365|496057|P2|Overall Study|Poor compliance to protocol|1
153966|NCT00365365|496058|P1|Overall Study|Poor compliance to protocol|0
153967|NCT00365365|496056|P3|Overall Study|Randomized but not treated|0
153968|NCT00365365|496057|P2|Overall Study|Randomized but not treated|2
153969|NCT00365365|496058|P1|Overall Study|Randomized but not treated|0
153970|NCT00365352|496075|P3|Overall Study|Withdrawal of Participant by Sponsor|0
153971|NCT00365352|496076|P2|Overall Study|Withdrawal of Participant by Sponsor|0
153972|NCT00365352|496077|P1|Overall Study|Withdrawal of Participant by Sponsor|1
153973|NCT00365352|496075|P3|Overall Study|Lost to Follow-up|0
153974|NCT00365352|496076|P2|Overall Study|Lost to Follow-up|1
153975|NCT00365352|496077|P1|Overall Study|Lost to Follow-up|1
153976|NCT00365352|496075|P3|Overall Study|Non-Compliance (after Randomization)|1
153977|NCT00365352|496076|P2|Overall Study|Non-Compliance (after Randomization)|0
153978|NCT00365352|496077|P1|Overall Study|Non-Compliance (after Randomization)|1
153979|NCT00365352|496075|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
153980|NCT00365352|496076|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
153981|NCT00365352|496077|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
153982|NCT00365352|496075|P3|Overall Study|Lack of Efficacy|0
153983|NCT00365352|496076|P2|Overall Study|Lack of Efficacy|0
153984|NCT00365352|496077|P1|Overall Study|Lack of Efficacy|3
153985|NCT00365352|496075|P3|Overall Study|Participant Withdrew Consent|4
153986|NCT00365352|496076|P2|Overall Study|Participant Withdrew Consent|3
153987|NCT00365352|496077|P1|Overall Study|Participant Withdrew Consent|8
153988|NCT00365352|496075|P3|Overall Study|Adverse Event|8
153989|NCT00365352|496076|P2|Overall Study|Adverse Event|7
153990|NCT00365352|496077|P1|Overall Study|Adverse Event|6
153991|NCT00365300|496161|P2|Double-blind Phase|Lack of Efficacy|6
153992|NCT00365300|496162|P1|Double-blind Phase|Lack of Efficacy|6
153993|NCT00365300|496161|P2|Double-blind Phase|Protocol Violation|1
153994|NCT00365300|496162|P1|Double-blind Phase|Protocol Violation|3
153995|NCT00365300|496161|P2|Double-blind Phase|Withdrawal by Subject|1
153996|NCT00365300|496162|P1|Double-blind Phase|Withdrawal by Subject|0
153997|NCT00365300|496161|P2|Double-blind Phase|Noncompliance|1
153998|NCT00365300|496162|P1|Double-blind Phase|Noncompliance|1
153999|NCT00365300|496161|P2|Double-blind Phase|Failed to return|0
154000|NCT00365300|496162|P1|Double-blind Phase|Failed to return|1
154001|NCT00365300|496161|P2|Open-label Phase|Patient skipped open label phase|0
154002|NCT00365300|496162|P1|Open-label Phase|Patient skipped open label phase|1
154003|NCT00365300|496161|P2|Open-label Phase|Lack of Efficacy|0
154004|NCT00365300|496162|P1|Open-label Phase|Lack of Efficacy|1
154005|NCT00365300|496161|P2|Open-label Phase|Protocol Violation|0
154006|NCT00365300|496162|P1|Open-label Phase|Protocol Violation|1
154007|NCT00365300|496161|P2|Open-label Phase|Parent/Legal Guardian Request|0
154008|NCT00365300|496162|P1|Open-label Phase|Parent/Legal Guardian Request|4
154009|NCT00365300|496161|P2|Open-label Phase|Noncompliance|0
154010|NCT00365300|496162|P1|Open-label Phase|Noncompliance|9
154011|NCT00365300|496161|P2|Open-label Phase|Physician Decision|0
154012|NCT00365300|496162|P1|Open-label Phase|Physician Decision|1
154013|NCT00365300|496161|P2|Open-label Phase|Failed to Return|0
154014|NCT00365300|496162|P1|Open-label Phase|Failed to Return|1
154015|NCT00365300|496161|P2|Open-label Phase|Adverse Event|0
154016|NCT00365300|496162|P1|Open-label Phase|Adverse Event|4
154017|NCT00365105|496225|P2|Overall Study|Lost to Follow-up|0
154018|NCT00365105|496226|P1|Overall Study|Lost to Follow-up|1
154019|NCT00365105|496225|P2|Overall Study|Withdrawal by Subject|1
154020|NCT00365105|496226|P1|Overall Study|Withdrawal by Subject|1
154021|NCT00365105|496225|P2|Overall Study|Protocol Violation|3
154022|NCT00365105|496226|P1|Overall Study|Protocol Violation|4
154023|NCT00364182|496245|P3|Third Intervention|Lost to Follow-up|1
154024|NCT00364182|496246|P2|Third Intervention|Lost to Follow-up|0
154025|NCT00364182|496247|P1|Third Intervention|Lost to Follow-up|0
154026|NCT00364182|496245|P3|Third Intervention|non-compliance|0
154027|NCT00364182|496246|P2|Third Intervention|non-compliance|1
154028|NCT00364182|496247|P1|Third Intervention|non-compliance|0
154029|NCT00364182|496245|P3|Second Intervention|Adverse Event|1
154030|NCT00364182|496246|P2|Second Intervention|Adverse Event|0
154031|NCT00364182|496247|P1|Second Intervention|Adverse Event|0
154032|NCT00364182|496245|P3|Second Intervention|Protocol Violation|0
154033|NCT00364182|496246|P2|Second Intervention|Protocol Violation|1
154034|NCT00364182|496247|P1|Second Intervention|Protocol Violation|0
154035|NCT00364182|496245|P3|Second Intervention|non-compliance|1
154036|NCT00364182|496246|P2|Second Intervention|non-compliance|1
154037|NCT00364182|496247|P1|Second Intervention|non-compliance|0
154038|NCT00364182|496245|P3|First Intervention|Withdrawal by Subject|0
154039|NCT00364182|496246|P2|First Intervention|Withdrawal by Subject|0
154040|NCT00364182|496247|P1|First Intervention|Withdrawal by Subject|2
154041|NCT00364182|496245|P3|First Intervention|Secondary prophylaxis|0
154042|NCT00364182|496246|P2|First Intervention|Secondary prophylaxis|0
154043|NCT00364182|496247|P1|First Intervention|Secondary prophylaxis|1
154044|NCT00364156|496281|P2|Overall Study|Protocol Violation|1
154045|NCT00364156|496282|P1|Overall Study|Protocol Violation|6
154046|NCT00364156|496281|P2|Overall Study|Withdrawal by Subject|80
154047|NCT00364156|496282|P1|Overall Study|Withdrawal by Subject|73
154048|NCT00364923|496309|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
154049|NCT00364923|496309|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
154050|NCT00364858|496318|P2|Overall Study|Clinical baseline issue|1
154051|NCT00364858|496319|P1|Overall Study|Clinical baseline issue|0
154052|NCT00364858|496318|P2|Overall Study|Return to Q2 regimen|1
154053|NCT00364858|496319|P1|Overall Study|Return to Q2 regimen|0
154054|NCT00364858|496318|P2|Overall Study|Non-compliant|0
154055|NCT00364858|496319|P1|Overall Study|Non-compliant|1
154056|NCT00364858|496318|P2|Overall Study|Discontinuation at baseline|0
154057|NCT00364858|496319|P1|Overall Study|Discontinuation at baseline|1
154058|NCT00364858|496318|P2|Overall Study|Clinical failure|13
154059|NCT00364858|496319|P1|Overall Study|Clinical failure|2
154060|NCT00364858|496318|P2|Overall Study|Pregnancy|1
154061|NCT00364858|496319|P1|Overall Study|Pregnancy|1
154062|NCT00364858|496318|P2|Overall Study|Withdrawal by Subject|1
154063|NCT00364858|496319|P1|Overall Study|Withdrawal by Subject|1
154064|NCT00364858|496318|P2|Overall Study|Adverse Event|5
154065|NCT00364858|496319|P1|Overall Study|Adverse Event|1
154066|NCT00364845|496334|P2|Overall Study|Death|1
154067|NCT00364845|496335|P1|Overall Study|Death|0
154068|NCT00364845|496334|P2|Overall Study|Lost to Follow-up|1
154069|NCT00364845|496335|P1|Overall Study|Lost to Follow-up|0
154070|NCT00364845|496334|P2|Overall Study|Physician Decision|8
154071|NCT00364845|496335|P1|Overall Study|Physician Decision|8
154072|NCT00364845|496334|P2|Overall Study|Withdrawal by Subject|1
154073|NCT00364845|496335|P1|Overall Study|Withdrawal by Subject|2
154074|NCT00364845|496334|P2|Overall Study|Adverse Event|0
154075|NCT00364845|496335|P1|Overall Study|Adverse Event|1
154076|NCT00364832|496356|P12|Extension Year 2|Early Withdrawals|3
154077|NCT00364832|496357|P11|Extension Year 2|Early Withdrawals|5
154078|NCT00364832|496358|P10|Extension Year 2|Early Withdrawals|5
154079|NCT00364832|496359|P9|Extension Year 2|Early Withdrawals|0
154080|NCT00364832|496360|P8|Extension Year 2|Early Withdrawals|0
154081|NCT00364832|496361|P7|Extension Year 2|Early Withdrawals|0
154082|NCT00364832|496362|P6|Extension Year 2|Early Withdrawals|0
154083|NCT00364832|496363|P5|Extension Year 2|Early Withdrawals|0
154084|NCT00364832|496364|P4|Extension Year 2|Early Withdrawals|0
154085|NCT00364832|496365|P3|Extension Year 2|Early Withdrawals|0
154086|NCT00364832|496366|P2|Extension Year 2|Early Withdrawals|0
154087|NCT00364832|496367|P1|Extension Year 2|Early Withdrawals|0
154088|NCT00364832|496356|P12|Extension Year 1|Early Withdrawals|10
154089|NCT00364832|496357|P11|Extension Year 1|Early Withdrawals|2
154090|NCT00364832|496358|P10|Extension Year 1|Early Withdrawals|4
154091|NCT00364832|496359|P9|Extension Year 1|Early Withdrawals|0
154092|NCT00364832|496360|P8|Extension Year 1|Early Withdrawals|0
154093|NCT00364832|496361|P7|Extension Year 1|Early Withdrawals|0
154094|NCT00364832|496362|P6|Extension Year 1|Early Withdrawals|0
154095|NCT00364832|496363|P5|Extension Year 1|Early Withdrawals|0
154096|NCT00364832|496364|P4|Extension Year 1|Early Withdrawals|0
154097|NCT00364832|496365|P3|Extension Year 1|Early Withdrawals|0
154098|NCT00364832|496366|P2|Extension Year 1|Early Withdrawals|0
154099|NCT00364832|496367|P1|Extension Year 1|Early Withdrawals|0
154100|NCT00364832|496356|P12|Core Period|Early Withdrawals|0
154101|NCT00364832|496357|P11|Core Period|Early Withdrawals|0
154102|NCT00364832|496358|P10|Core Period|Early Withdrawals|0
154103|NCT00364832|496359|P9|Core Period|Early Withdrawals|0
154104|NCT00364832|496360|P8|Core Period|Early Withdrawals|1
154105|NCT00364832|496361|P7|Core Period|Early Withdrawals|4
154106|NCT00364832|496362|P6|Core Period|Early Withdrawals|0
154107|NCT00364832|496363|P5|Core Period|Early Withdrawals|0
154108|NCT00364832|496364|P4|Core Period|Early Withdrawals|1
154109|NCT00364832|496365|P3|Core Period|Early Withdrawals|1
154110|NCT00364832|496366|P2|Core Period|Early Withdrawals|2
154111|NCT00364832|496367|P1|Core Period|Early Withdrawals|2
154112|NCT00364793|496424|P4|Overall Study|Withdrawal by Subject|0
154113|NCT00364793|496425|P3|Overall Study|Withdrawal by Subject|0
154114|NCT00364793|496426|P2|Overall Study|Withdrawal by Subject|1
154115|NCT00364793|496427|P1|Overall Study|Withdrawal by Subject|0
154116|NCT00364793|496424|P4|Overall Study|No longer meets criteria|1
154117|NCT00364793|496425|P3|Overall Study|No longer meets criteria|0
154118|NCT00364793|496426|P2|Overall Study|No longer meets criteria|0
154119|NCT00364793|496427|P1|Overall Study|No longer meets criteria|0
154120|NCT00364793|496424|P4|Overall Study|Poor or non-compliance|1
154121|NCT00364793|496425|P3|Overall Study|Poor or non-compliance|0
154122|NCT00364793|496426|P2|Overall Study|Poor or non-compliance|1
154123|NCT00364793|496427|P1|Overall Study|Poor or non-compliance|1
154124|NCT00364793|496424|P4|Overall Study|Lost to Follow-up|0
154125|NCT00364793|496425|P3|Overall Study|Lost to Follow-up|2
154126|NCT00364793|496426|P2|Overall Study|Lost to Follow-up|0
154127|NCT00364793|496427|P1|Overall Study|Lost to Follow-up|1
154128|NCT00364793|496424|P4|Overall Study|Lack of Efficacy|1
154129|NCT00364793|496425|P3|Overall Study|Lack of Efficacy|1
154130|NCT00364793|496426|P2|Overall Study|Lack of Efficacy|3
154131|NCT00364793|496427|P1|Overall Study|Lack of Efficacy|3
154132|NCT00364793|496424|P4|Overall Study|Death|0
154133|NCT00364793|496425|P3|Overall Study|Death|1
154134|NCT00364793|496426|P2|Overall Study|Death|0
154135|NCT00364793|496427|P1|Overall Study|Death|1
154136|NCT00364793|496424|P4|Overall Study|Adverse Event|0
154137|NCT00364793|496425|P3|Overall Study|Adverse Event|0
154138|NCT00364793|496426|P2|Overall Study|Adverse Event|0
154139|NCT00364793|496427|P1|Overall Study|Adverse Event|2
154140|NCT00364611|496563|P2|Overall Study|Receiving Liver Ablation|1
154141|NCT00364611|496564|P1|Overall Study|Receiving Liver Ablation|0
154142|NCT00364611|496563|P2|Overall Study|Presumed CR on Study|1
154143|NCT00364611|496564|P1|Overall Study|Presumed CR on Study|0
154144|NCT00364611|496563|P2|Overall Study|Found Ineligible|0
154145|NCT00364611|496564|P1|Overall Study|Found Ineligible|1
154146|NCT00364611|496563|P2|Overall Study|Investigator decision|2
154147|NCT00364611|496564|P1|Overall Study|Investigator decision|2
154148|NCT00364611|496563|P2|Overall Study|Disease Progression|8
154149|NCT00364611|496564|P1|Overall Study|Disease Progression|38
154150|NCT00364611|496563|P2|Overall Study|Participant's Request|4
154151|NCT00364611|496564|P1|Overall Study|Participant's Request|3
154152|NCT00364611|496563|P2|Overall Study|Adverse Event|4
154153|NCT00364611|496564|P1|Overall Study|Adverse Event|7
154154|NCT00364611|496563|P2|Overall Study|Did not receive study medication|1
154155|NCT00364611|496564|P1|Overall Study|Did not receive study medication|0
154156|NCT00364533|496587|P5|Overall Study|Protocol Violation|0
154157|NCT00364533|496588|P4|Overall Study|Protocol Violation|0
154158|NCT00364533|496589|P3|Overall Study|Protocol Violation|0
154159|NCT00364533|496590|P2|Overall Study|Protocol Violation|1
154160|NCT00364533|496591|P1|Overall Study|Protocol Violation|1
154161|NCT00364533|496587|P5|Overall Study|Non-compliance|0
154162|NCT00364533|496588|P4|Overall Study|Non-compliance|0
154163|NCT00364533|496589|P3|Overall Study|Non-compliance|0
154164|NCT00364533|496590|P2|Overall Study|Non-compliance|0
154165|NCT00364533|496591|P1|Overall Study|Non-compliance|1
154166|NCT00364533|496587|P5|Overall Study|Variations in drug compliance|0
154167|NCT00364533|496588|P4|Overall Study|Variations in drug compliance|0
154168|NCT00364533|496589|P3|Overall Study|Variations in drug compliance|1
154169|NCT00364533|496590|P2|Overall Study|Variations in drug compliance|1
154170|NCT00364533|496591|P1|Overall Study|Variations in drug compliance|2
154171|NCT00364533|496587|P5|Overall Study|Subject discharged from hospital|1
154172|NCT00364533|496588|P4|Overall Study|Subject discharged from hospital|3
154173|NCT00364533|496589|P3|Overall Study|Subject discharged from hospital|2
154174|NCT00364533|496590|P2|Overall Study|Subject discharged from hospital|1
154175|NCT00364533|496591|P1|Overall Study|Subject discharged from hospital|4
154176|NCT00364533|496587|P5|Overall Study|Lack of Efficacy|42
154177|NCT00364533|496588|P4|Overall Study|Lack of Efficacy|17
154178|NCT00364533|496589|P3|Overall Study|Lack of Efficacy|21
154179|NCT00364533|496590|P2|Overall Study|Lack of Efficacy|22
154180|NCT00364533|496591|P1|Overall Study|Lack of Efficacy|22
154181|NCT00364533|496587|P5|Overall Study|Withdrawal by Subject|6
154182|NCT00364533|496588|P4|Overall Study|Withdrawal by Subject|6
154183|NCT00364533|496589|P3|Overall Study|Withdrawal by Subject|6
154184|NCT00364533|496590|P2|Overall Study|Withdrawal by Subject|8
154185|NCT00364533|496591|P1|Overall Study|Withdrawal by Subject|4
154186|NCT00364533|496587|P5|Overall Study|Adverse Event|2
154187|NCT00364533|496588|P4|Overall Study|Adverse Event|5
154188|NCT00364533|496589|P3|Overall Study|Adverse Event|15
154189|NCT00364533|496590|P2|Overall Study|Adverse Event|7
154190|NCT00364533|496591|P1|Overall Study|Adverse Event|8
154191|NCT00364351|496624|P2|Overall Study|Randomised treatment not started|3
154192|NCT00364351|496625|P1|Overall Study|Randomised treatment not started|0
154193|NCT00364351|496624|P2|Overall Study|Patient could not travel to site|1
154194|NCT00364351|496625|P1|Overall Study|Patient could not travel to site|0
154195|NCT00364351|496624|P2|Overall Study|Investigator error|2
154196|NCT00364351|496625|P1|Overall Study|Investigator error|0
154197|NCT00364351|496624|P2|Overall Study|Poor treatment compliance|3
154198|NCT00364351|496625|P1|Overall Study|Poor treatment compliance|0
154199|NCT00364351|496624|P2|Overall Study|Sponsor decision|0
154200|NCT00364351|496625|P1|Overall Study|Sponsor decision|1
154201|NCT00364351|496624|P2|Overall Study|Incorrect enrollment|1
154202|NCT00364351|496625|P1|Overall Study|Incorrect enrollment|1
154203|NCT00364351|496624|P2|Overall Study|Withdrawal by Subject|29
154204|NCT00364351|496625|P1|Overall Study|Withdrawal by Subject|30
154205|NCT00364351|496624|P2|Overall Study|Lost to Follow-up|1
154206|NCT00364351|496625|P1|Overall Study|Lost to Follow-up|1
154207|NCT00364351|496624|P2|Overall Study|Prohibited concomitant medication|2
154208|NCT00364351|496625|P1|Overall Study|Prohibited concomitant medication|0
154209|NCT00364351|496624|P2|Overall Study|Condition under investigation worsened|497
154210|NCT00364351|496625|P1|Overall Study|Condition under investigation worsened|469
154211|NCT00364351|496624|P2|Overall Study|Adverse Event|44
154212|NCT00364351|496625|P1|Overall Study|Adverse Event|90
154213|NCT00364130|496645|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
154214|NCT00364130|496646|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
154215|NCT00364130|496645|P2|Intervention Period|Withdrawal by Subject|5
154216|NCT00364130|496646|P1|Intervention Period|Withdrawal by Subject|4
154217|NCT00364130|496645|P2|Intervention Period|Pregnancy|0
154218|NCT00364130|496646|P1|Intervention Period|Pregnancy|1
154219|NCT00364130|496645|P2|Intervention Period|Lost to Follow-up|3
154220|NCT00364130|496646|P1|Intervention Period|Lost to Follow-up|4
154221|NCT00364013|496668|P2|Overall Study|Ongoing|13
154222|NCT00364013|496669|P1|Overall Study|Ongoing|20
154223|NCT00364013|496668|P2|Overall Study|Other|47
154224|NCT00364013|496669|P1|Overall Study|Other|41
154225|NCT00364013|496668|P2|Overall Study|Protocol-specified criteria|6
154226|NCT00364013|496669|P1|Overall Study|Protocol-specified criteria|6
154227|NCT00364013|496668|P2|Overall Study|Lost to Follow-up|3
154228|NCT00364013|496669|P1|Overall Study|Lost to Follow-up|10
154229|NCT00364013|496668|P2|Overall Study|Physician Decision|3
154230|NCT00364013|496669|P1|Overall Study|Physician Decision|3
154231|NCT00364013|496668|P2|Overall Study|Withdrawal by Subject|18
154232|NCT00364013|496669|P1|Overall Study|Withdrawal by Subject|13
154233|NCT00364013|496668|P2|Overall Study|Adverse Event|3
154234|NCT00364013|496669|P1|Overall Study|Adverse Event|4
154235|NCT00364013|496668|P2|Overall Study|Ineligibility determined|2
154236|NCT00364013|496669|P1|Overall Study|Ineligibility determined|4
154237|NCT00363896|496697|P2|Overall Study|Other|2
154238|NCT00363896|496698|P1|Overall Study|Other|1
154239|NCT00363896|496697|P2|Overall Study|Non-fulfilment of entry criteria|0
154240|NCT00363896|496698|P1|Overall Study|Non-fulfilment of entry criteria|1
154241|NCT00363896|496697|P2|Overall Study|Lost to Follow-up|0
154242|NCT00363896|496698|P1|Overall Study|Lost to Follow-up|3
154243|NCT00363896|496697|P2|Overall Study|Protocol Violation|1
154244|NCT00363896|496698|P1|Overall Study|Protocol Violation|6
154245|NCT00363896|496697|P2|Overall Study|Lack of Efficacy|8
154246|NCT00363896|496698|P1|Overall Study|Lack of Efficacy|12
154247|NCT00363896|496697|P2|Overall Study|COPD exacerbation|7
154248|NCT00363896|496698|P1|Overall Study|COPD exacerbation|13
154249|NCT00363896|496697|P2|Overall Study|Adverse Event|13
154250|NCT00363896|496698|P1|Overall Study|Adverse Event|24
154251|NCT00363896|496697|P2|Overall Study|Withdrawal by Subject|16
154252|NCT00363896|496698|P1|Overall Study|Withdrawal by Subject|29
154253|NCT00363467|496744|P1|Overall Study|Physician Decision|1
154254|NCT00363415|496754|P2|Overall Study|Protocol Violation|4
154255|NCT00363415|496755|P1|Overall Study|Protocol Violation|1
154256|NCT00363415|496754|P2|Overall Study|Lost to Follow-up|3
154257|NCT00363415|496755|P1|Overall Study|Lost to Follow-up|3
154258|NCT00363415|496754|P2|Overall Study|Withdrawal by Subject|15
154259|NCT00363415|496755|P1|Overall Study|Withdrawal by Subject|9
154260|NCT00363415|496754|P2|Overall Study|Entry Criteria Not Met|10
154261|NCT00363415|496755|P1|Overall Study|Entry Criteria Not Met|11
154262|NCT00363415|496754|P2|Overall Study|Physician Decision|35
154263|NCT00363415|496755|P1|Overall Study|Physician Decision|18
154264|NCT00363415|496754|P2|Overall Study|Adverse Event|15
154265|NCT00363415|496755|P1|Overall Study|Adverse Event|24
154266|NCT00363415|496754|P2|Overall Study|Death|29
154267|NCT00363415|496755|P1|Overall Study|Death|32
154268|NCT00363415|496754|P2|Overall Study|Sponsor Decision|31
154269|NCT00363415|496755|P1|Overall Study|Sponsor Decision|67
154270|NCT00363415|496754|P2|Overall Study|Progressive Disease|107
154271|NCT00363415|496755|P1|Overall Study|Progressive Disease|196
154272|NCT00363311|496773|P2|Overall Study|Participant Moved to Louisiana|1
154273|NCT00363311|496774|P1|Overall Study|Participant Moved to Louisiana|0
154274|NCT00363311|496773|P2|Overall Study|Withdrawn per Instructions of Monitor|1
154275|NCT00363311|496774|P1|Overall Study|Withdrawn per Instructions of Monitor|0
154276|NCT00363311|496773|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
154277|NCT00363311|496774|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
154278|NCT00363311|496773|P2|Overall Study|Participant Moved to Another Country|0
154279|NCT00363311|496774|P1|Overall Study|Participant Moved to Another Country|1
154280|NCT00363311|496773|P2|Overall Study|Participant Opted for Treatment|0
154281|NCT00363311|496774|P1|Overall Study|Participant Opted for Treatment|1
154282|NCT00363311|496773|P2|Overall Study|Prostate Volume/PSA Doubled|0
154283|NCT00363311|496774|P1|Overall Study|Prostate Volume/PSA Doubled|1
154284|NCT00363311|496773|P2|Overall Study|Participant Refused Biopsy|0
154285|NCT00363311|496774|P1|Overall Study|Participant Refused Biopsy|1
154286|NCT00363311|496773|P2|Overall Study|Non-Compliance|1
154287|NCT00363311|496774|P1|Overall Study|Non-Compliance|1
154288|NCT00363311|496773|P2|Overall Study|Disease Progression|26
154289|NCT00363311|496774|P1|Overall Study|Disease Progression|46
154290|NCT00363311|496773|P2|Overall Study|Sponsor Terminated Study|2
154291|NCT00363311|496774|P1|Overall Study|Sponsor Terminated Study|2
154292|NCT00363311|496773|P2|Overall Study|Physician Decision|1
154293|NCT00363311|496774|P1|Overall Study|Physician Decision|1
154294|NCT00363311|496773|P2|Overall Study|Withdrawal by Subject|6
154295|NCT00363311|496774|P1|Overall Study|Withdrawal by Subject|12
154296|NCT00363311|496773|P2|Overall Study|Protocol Violation|2
154297|NCT00363311|496774|P1|Overall Study|Protocol Violation|1
154298|NCT00363311|496773|P2|Overall Study|Lost to Follow-up|0
154299|NCT00363311|496774|P1|Overall Study|Lost to Follow-up|3
154300|NCT00363311|496773|P2|Overall Study|Adverse Event|4
154301|NCT00363311|496774|P1|Overall Study|Adverse Event|6
154302|NCT00363246|496838|P1|Overall Study|Eligibility changed due to Hospice move|5
154303|NCT00363246|496838|P1|Overall Study|Subject expressed security concerns|2
154304|NCT00363246|496838|P1|Overall Study|Stopped using wheelchair|11
154305|NCT00363246|496838|P1|Overall Study|Bad health|6
154306|NCT00363246|496838|P1|Overall Study|Lost to Follow-up|14
154307|NCT00363246|496838|P1|Overall Study|Withdrawal by Subject|19
154308|NCT00363246|496838|P1|Overall Study|Death|40
154309|NCT00363142|496856|P2|Overall Study|Withdrawal by Subject|1
154310|NCT00363142|496857|P1|Overall Study|Withdrawal by Subject|3
154311|NCT00363142|496856|P2|Overall Study|Non-compliance|1
154312|NCT00363142|496857|P1|Overall Study|Non-compliance|1
154313|NCT00363142|496856|P2|Overall Study|Lost to Follow-up|0
154314|NCT00363142|496857|P1|Overall Study|Lost to Follow-up|1
154315|NCT00363142|496856|P2|Overall Study|Lack of Efficacy|1
154316|NCT00363142|496857|P1|Overall Study|Lack of Efficacy|0
154317|NCT00363142|496856|P2|Overall Study|Adverse Event|0
154318|NCT00363142|496857|P1|Overall Study|Adverse Event|2
154319|NCT00363129|496886|P2|Overall Study|Other Reasons|3
154320|NCT00363129|496887|P1|Overall Study|Other Reasons|6
154321|NCT00363129|496886|P2|Overall Study|Death|1
154322|NCT00363129|496887|P1|Overall Study|Death|0
154323|NCT00363129|496886|P2|Overall Study|Other Medical Problems|4
154324|NCT00363129|496887|P1|Overall Study|Other Medical Problems|2
154325|NCT00363129|496886|P2|Overall Study|Alternate Treatment|4
154326|NCT00363129|496887|P1|Overall Study|Alternate Treatment|2
154327|NCT00363129|496886|P2|Overall Study|Adverse Event|3
154328|NCT00363129|496887|P1|Overall Study|Adverse Event|8
154329|NCT00363129|496886|P2|Overall Study|Withdrawal by Subject|18
154330|NCT00363129|496887|P1|Overall Study|Withdrawal by Subject|11
154331|NCT00363051|496930|P2|Overall Study|Death|2
154332|NCT00363051|496931|P1|Overall Study|Death|3
154333|NCT00363051|496930|P2|Overall Study|Protocol Violation|2
154334|NCT00363051|496931|P1|Overall Study|Protocol Violation|0
154335|NCT00363051|496930|P2|Overall Study|Lost to Follow-up|1
154336|NCT00363051|496931|P1|Overall Study|Lost to Follow-up|0
154337|NCT00363051|496930|P2|Overall Study|Withdrawal by Subject|3
154338|NCT00363051|496931|P1|Overall Study|Withdrawal by Subject|11
154339|NCT00363051|496930|P2|Overall Study|New Cancer Therapy|1
154340|NCT00363051|496931|P1|Overall Study|New Cancer Therapy|2
154341|NCT00363051|496930|P2|Overall Study|Adverse Event|12
154342|NCT00363051|496931|P1|Overall Study|Adverse Event|21
154343|NCT00363051|496930|P2|Overall Study|Adminstrative problems|1
154344|NCT00363051|496931|P1|Overall Study|Adminstrative problems|1
154345|NCT00362648|496978|P4|Overall Study|Withdrawal by Subject|6
154346|NCT00362648|496979|P3|Overall Study|Withdrawal by Subject|2
154347|NCT00362648|496980|P2|Overall Study|Withdrawal by Subject|42
154348|NCT00362648|496981|P1|Overall Study|Withdrawal by Subject|48
154349|NCT00362648|496978|P4|Overall Study|Protocol Violation|2
154350|NCT00362648|496979|P3|Overall Study|Protocol Violation|2
154351|NCT00362648|496980|P2|Overall Study|Protocol Violation|2
154352|NCT00362648|496981|P1|Overall Study|Protocol Violation|4
154353|NCT00362648|496978|P4|Overall Study|Lost to Follow-up|3
154354|NCT00362648|496979|P3|Overall Study|Lost to Follow-up|4
154355|NCT00362648|496980|P2|Overall Study|Lost to Follow-up|69
154356|NCT00362648|496981|P1|Overall Study|Lost to Follow-up|62
154357|NCT00362648|496978|P4|Overall Study|Adverse Event|0
154358|NCT00362648|496979|P3|Overall Study|Adverse Event|1
154359|NCT00362648|496980|P2|Overall Study|Adverse Event|21
154360|NCT00362648|496981|P1|Overall Study|Adverse Event|12
154361|NCT00362609|496999|P2|Overall Study|Protocol Violation|1
154362|NCT00362609|497000|P1|Overall Study|Protocol Violation|0
154363|NCT00362609|496999|P2|Overall Study|Withdrawal by Subject|1
154364|NCT00362609|497000|P1|Overall Study|Withdrawal by Subject|0
154365|NCT00362414|497068|P1|Overall Study|Adverse Event|1
154366|NCT00362414|497068|P1|Overall Study|Death|2
154367|NCT00362375|497097|P2|Overall Study|Lost to Follow-up|35
154368|NCT00362375|497098|P1|Overall Study|Lost to Follow-up|40
154369|NCT00362336|497115|P3|Overall Study|Withdrawal by Subject|1
154370|NCT00362336|497116|P2|Overall Study|Withdrawal by Subject|3
154371|NCT00362336|497117|P1|Overall Study|Withdrawal by Subject|3
154372|NCT00362336|497115|P3|Overall Study|Lost to Follow-up|0
154373|NCT00362336|497116|P2|Overall Study|Lost to Follow-up|4
154374|NCT00362336|497117|P1|Overall Study|Lost to Follow-up|6
154375|NCT00362336|497115|P3|Overall Study|Protocol Violation|1
154376|NCT00362336|497116|P2|Overall Study|Protocol Violation|0
154377|NCT00362336|497117|P1|Overall Study|Protocol Violation|0
154378|NCT00362336|497115|P3|Overall Study|Serious Adverse Event|1
154379|NCT00362336|497116|P2|Overall Study|Serious Adverse Event|0
154380|NCT00362336|497117|P1|Overall Study|Serious Adverse Event|1
154381|NCT00362297|497145|P2|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|4
154382|NCT00362297|497146|P1|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|0
154383|NCT00362232|497154|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
154384|NCT00362232|497155|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
154385|NCT00362232|497154|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
154386|NCT00362232|497155|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
154387|NCT00362232|497154|P2|Follow-up (30 (+ 5) Days)|Death|1
154388|NCT00362232|497155|P1|Follow-up (30 (+ 5) Days)|Death|1
154389|NCT00362232|497154|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
154390|NCT00362232|497155|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
154391|NCT00362232|497154|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
154392|NCT00362232|497155|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
154393|NCT00362232|497154|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
154394|NCT00362232|497155|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
154395|NCT00362232|497154|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
154396|NCT00362232|497155|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
154397|NCT00362232|497154|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
154398|NCT00362232|497155|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
154399|NCT00362232|497154|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
154400|NCT00362232|497155|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
154401|NCT00362232|497154|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
154402|NCT00362232|497155|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
154403|NCT00362232|497154|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
154404|NCT00362232|497155|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
154405|NCT00362232|497154|P2|Treatment (12 +/- 2 Days)|Death|3
154406|NCT00362232|497155|P1|Treatment (12 +/- 2 Days)|Death|1
154407|NCT00362232|497154|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
154408|NCT00362232|497155|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
154409|NCT00362180|497200|P9|Treated Period|Adverse Event|0
154410|NCT00362180|497201|P8|Treated Period|Adverse Event|1
154411|NCT00362180|497202|P7|Treated Period|Adverse Event|0
154412|NCT00362180|497203|P6|Treated Period|Adverse Event|1
154413|NCT00362180|497204|P5|Treated Period|Adverse Event|0
154414|NCT00362180|497205|P4|Treated Period|Adverse Event|0
154415|NCT00362180|497206|P3|Treated Period|Adverse Event|0
154416|NCT00362180|497207|P2|Treated Period|Adverse Event|0
154417|NCT00362180|497208|P1|Treated Period|Adverse Event|0
154418|NCT00362180|497200|P9|Treated Period|Withdrawal by Subject|0
154419|NCT00362180|497201|P8|Treated Period|Withdrawal by Subject|0
154420|NCT00362180|497202|P7|Treated Period|Withdrawal by Subject|0
154421|NCT00362180|497203|P6|Treated Period|Withdrawal by Subject|0
154422|NCT00362180|497204|P5|Treated Period|Withdrawal by Subject|0
154423|NCT00362180|497205|P4|Treated Period|Withdrawal by Subject|0
154424|NCT00362180|497206|P3|Treated Period|Withdrawal by Subject|0
154425|NCT00362180|497207|P2|Treated Period|Withdrawal by Subject|0
154426|NCT00362180|497208|P1|Treated Period|Withdrawal by Subject|1
154427|NCT00362115|497280|P7|Overall Study|Other|0
154428|NCT00362115|497281|P6|Overall Study|Other|1
154429|NCT00362115|497282|P5|Overall Study|Other|0
154430|NCT00362115|497283|P4|Overall Study|Other|1
154431|NCT00362115|497284|P3|Overall Study|Other|0
154432|NCT00362115|497285|P2|Overall Study|Other|1
154433|NCT00362115|497286|P1|Overall Study|Other|0
154434|NCT00362115|497280|P7|Overall Study|Physician Decision|3
154435|NCT00362115|497281|P6|Overall Study|Physician Decision|0
154436|NCT00362115|497282|P5|Overall Study|Physician Decision|0
154437|NCT00362115|497283|P4|Overall Study|Physician Decision|0
154438|NCT00362115|497284|P3|Overall Study|Physician Decision|0
154439|NCT00362115|497285|P2|Overall Study|Physician Decision|0
154440|NCT00362115|497286|P1|Overall Study|Physician Decision|0
154441|NCT00362115|497280|P7|Overall Study|Lack of Efficacy|3
154442|NCT00362115|497281|P6|Overall Study|Lack of Efficacy|0
154443|NCT00362115|497282|P5|Overall Study|Lack of Efficacy|2
154444|NCT00362115|497283|P4|Overall Study|Lack of Efficacy|2
154445|NCT00362115|497284|P3|Overall Study|Lack of Efficacy|5
154446|NCT00362115|497285|P2|Overall Study|Lack of Efficacy|0
154447|NCT00362115|497286|P1|Overall Study|Lack of Efficacy|1
154448|NCT00362115|497280|P7|Overall Study|Withdrawal by Subject|4
154449|NCT00362115|497281|P6|Overall Study|Withdrawal by Subject|3
154450|NCT00362115|497282|P5|Overall Study|Withdrawal by Subject|1
154451|NCT00362115|497283|P4|Overall Study|Withdrawal by Subject|0
154452|NCT00362115|497284|P3|Overall Study|Withdrawal by Subject|1
154453|NCT00362115|497285|P2|Overall Study|Withdrawal by Subject|3
154454|NCT00362115|497286|P1|Overall Study|Withdrawal by Subject|1
154455|NCT00362115|497280|P7|Overall Study|Lost to Follow-up|1
154456|NCT00362115|497281|P6|Overall Study|Lost to Follow-up|0
154457|NCT00362115|497282|P5|Overall Study|Lost to Follow-up|2
154458|NCT00362115|497283|P4|Overall Study|Lost to Follow-up|0
154459|NCT00362115|497284|P3|Overall Study|Lost to Follow-up|0
154460|NCT00362115|497285|P2|Overall Study|Lost to Follow-up|1
154461|NCT00362115|497286|P1|Overall Study|Lost to Follow-up|0
154462|NCT00362115|497280|P7|Overall Study|Protocol Violation|0
154463|NCT00362115|497281|P6|Overall Study|Protocol Violation|1
154464|NCT00362115|497282|P5|Overall Study|Protocol Violation|0
154465|NCT00362115|497283|P4|Overall Study|Protocol Violation|0
154466|NCT00362115|497284|P3|Overall Study|Protocol Violation|0
154467|NCT00362115|497285|P2|Overall Study|Protocol Violation|0
154468|NCT00362115|497286|P1|Overall Study|Protocol Violation|0
154469|NCT00362115|497280|P7|Overall Study|Adverse Event|1
154470|NCT00362115|497281|P6|Overall Study|Adverse Event|2
154471|NCT00362115|497282|P5|Overall Study|Adverse Event|2
154472|NCT00362115|497283|P4|Overall Study|Adverse Event|1
154473|NCT00362115|497284|P3|Overall Study|Adverse Event|1
154474|NCT00362115|497285|P2|Overall Study|Adverse Event|1
154475|NCT00362115|497286|P1|Overall Study|Adverse Event|0
154476|NCT00361634|497446|P1|Overall Study|Withdrawal by Subject|1
154477|NCT00361634|497446|P1|Overall Study|Lost to Follow-up|1
154478|NCT00361569|497475|P4|Overall Study|Not specified by investigator|1
154479|NCT00361569|497476|P3|Overall Study|Not specified by investigator|0
154480|NCT00361569|497477|P2|Overall Study|Not specified by investigator|0
154481|NCT00361569|497478|P1|Overall Study|Not specified by investigator|2
154482|NCT00361569|497475|P4|Overall Study|Lost to Follow-up|2
154483|NCT00361569|497476|P3|Overall Study|Lost to Follow-up|3
154484|NCT00361569|497477|P2|Overall Study|Lost to Follow-up|3
154485|NCT00361569|497478|P1|Overall Study|Lost to Follow-up|2
154486|NCT00361569|497475|P4|Overall Study|Adverse Event|2
154487|NCT00361569|497476|P3|Overall Study|Adverse Event|2
154488|NCT00361569|497477|P2|Overall Study|Adverse Event|5
154489|NCT00361569|497478|P1|Overall Study|Adverse Event|3
154490|NCT00361569|497475|P4|Overall Study|Withdrawal by Subject|14
154491|NCT00361569|497476|P3|Overall Study|Withdrawal by Subject|9
154492|NCT00361569|497477|P2|Overall Study|Withdrawal by Subject|1
154493|NCT00361569|497478|P1|Overall Study|Withdrawal by Subject|2
154494|NCT00361569|497475|P4|Overall Study|Protocol Violation|2
154495|NCT00361569|497476|P3|Overall Study|Protocol Violation|4
154496|NCT00361569|497477|P2|Overall Study|Protocol Violation|2
154497|NCT00361569|497478|P1|Overall Study|Protocol Violation|3
154498|NCT00361504|497502|P2|Overall Study|All other|3
154499|NCT00361504|497503|P1|Overall Study|All other|28
154500|NCT00361504|497502|P2|Overall Study|Study medication non compliant|15
154501|NCT00361504|497503|P1|Overall Study|Study medication non compliant|42
154502|NCT00361504|497502|P2|Overall Study|Resolution of Pain|0
154503|NCT00361504|497503|P1|Overall Study|Resolution of Pain|2
154504|NCT00361504|497502|P2|Overall Study|Lack of Efficacy|7
154505|NCT00361504|497503|P1|Overall Study|Lack of Efficacy|72
154506|NCT00361504|497502|P2|Overall Study|Adverse Event|82
154507|NCT00361504|497503|P1|Overall Study|Adverse Event|203
154508|NCT00361504|497502|P2|Overall Study|Lost to Follow-up|7
154509|NCT00361504|497503|P1|Overall Study|Lost to Follow-up|40
154510|NCT00361504|497502|P2|Overall Study|Withdrawal by Subject|31
154511|NCT00361504|497503|P1|Overall Study|Withdrawal by Subject|94
154512|NCT00361335|497544|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
154513|NCT00361335|497545|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
154514|NCT00361335|497546|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
154515|NCT00361335|497547|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
154516|NCT00361335|497548|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
154517|NCT00361335|497549|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
154518|NCT00361335|497550|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
154519|NCT00361335|497544|P7|SC Period: Week E0 to Week E24|Not specified|2
154520|NCT00361335|497545|P6|SC Period: Week E0 to Week E24|Not specified|1
154521|NCT00361335|497546|P5|SC Period: Week E0 to Week E24|Not specified|0
154522|NCT00361335|497547|P4|SC Period: Week E0 to Week E24|Not specified|1
154523|NCT00361335|497548|P3|SC Period: Week E0 to Week E24|Not specified|0
154524|NCT00361335|497549|P2|SC Period: Week E0 to Week E24|Not specified|0
154525|NCT00361335|497550|P1|SC Period: Week E0 to Week E24|Not specified|1
154526|NCT00361335|497544|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
154527|NCT00361335|497545|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
154528|NCT00361335|497546|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
154529|NCT00361335|497547|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
154530|NCT00361335|497548|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
154531|NCT00361335|497549|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
154532|NCT00361335|497550|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
154533|NCT00361335|497544|P7|SC Period: Week E0 to Week E24|Death|1
154534|NCT00361335|497545|P6|SC Period: Week E0 to Week E24|Death|0
154535|NCT00361335|497546|P5|SC Period: Week E0 to Week E24|Death|0
154536|NCT00361335|497547|P4|SC Period: Week E0 to Week E24|Death|0
154537|NCT00361335|497548|P3|SC Period: Week E0 to Week E24|Death|0
154538|NCT00361335|497549|P2|SC Period: Week E0 to Week E24|Death|0
154539|NCT00361335|497550|P1|SC Period: Week E0 to Week E24|Death|0
154540|NCT00361335|497544|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
154541|NCT00361335|497545|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
154542|NCT00361335|497546|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
154543|NCT00361335|497547|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
154544|NCT00361335|497548|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
154545|NCT00361335|497549|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
154546|NCT00361335|497550|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
154547|NCT00361335|497544|P7|SC Period: Week E0 to Week E24|Adverse Event|2
154548|NCT00361335|497545|P6|SC Period: Week E0 to Week E24|Adverse Event|0
154549|NCT00361335|497546|P5|SC Period: Week E0 to Week E24|Adverse Event|0
154550|NCT00361335|497547|P4|SC Period: Week E0 to Week E24|Adverse Event|2
154551|NCT00361335|497548|P3|SC Period: Week E0 to Week E24|Adverse Event|1
154552|NCT00361335|497549|P2|SC Period: Week E0 to Week E24|Adverse Event|2
154553|NCT00361335|497550|P1|SC Period: Week E0 to Week E24|Adverse Event|0
154554|NCT00361335|497544|P7|IV Period: Baseline to E0|Lack of Efficacy|0
154555|NCT00361335|497545|P6|IV Period: Baseline to E0|Lack of Efficacy|0
154556|NCT00361335|497546|P5|IV Period: Baseline to E0|Lack of Efficacy|8
154557|NCT00361335|497547|P4|IV Period: Baseline to E0|Lack of Efficacy|7
154558|NCT00361335|497548|P3|IV Period: Baseline to E0|Lack of Efficacy|3
154559|NCT00361335|497549|P2|IV Period: Baseline to E0|Lack of Efficacy|9
154560|NCT00361335|497550|P1|IV Period: Baseline to E0|Lack of Efficacy|5
154561|NCT00361335|497544|P7|IV Period: Baseline to E0|Not specified|0
154562|NCT00361335|497545|P6|IV Period: Baseline to E0|Not specified|0
154563|NCT00361335|497546|P5|IV Period: Baseline to E0|Not specified|2
154564|NCT00361335|497547|P4|IV Period: Baseline to E0|Not specified|3
154565|NCT00361335|497548|P3|IV Period: Baseline to E0|Not specified|9
154566|NCT00361335|497549|P2|IV Period: Baseline to E0|Not specified|9
154567|NCT00361335|497550|P1|IV Period: Baseline to E0|Not specified|2
154568|NCT00361335|497544|P7|IV Period: Baseline to E0|Worsening of RA|0
154569|NCT00361335|497545|P6|IV Period: Baseline to E0|Worsening of RA|0
154570|NCT00361335|497546|P5|IV Period: Baseline to E0|Worsening of RA|2
154571|NCT00361335|497547|P4|IV Period: Baseline to E0|Worsening of RA|4
154572|NCT00361335|497548|P3|IV Period: Baseline to E0|Worsening of RA|1
154573|NCT00361335|497549|P2|IV Period: Baseline to E0|Worsening of RA|5
154574|NCT00361335|497550|P1|IV Period: Baseline to E0|Worsening of RA|0
154575|NCT00361335|497544|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
154576|NCT00361335|497545|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
154577|NCT00361335|497546|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
154578|NCT00361335|497547|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
154579|NCT00361335|497548|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
154580|NCT00361335|497549|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
154581|NCT00361335|497550|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
154582|NCT00361335|497544|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
154583|NCT00361335|497545|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
154584|NCT00361335|497546|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
154585|NCT00361335|497547|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
154586|NCT00361335|497548|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
154587|NCT00361335|497549|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
154588|NCT00361335|497550|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
154589|NCT00361335|497544|P7|IV Period: Baseline to E0|Death|0
154590|NCT00361335|497545|P6|IV Period: Baseline to E0|Death|0
154591|NCT00361335|497546|P5|IV Period: Baseline to E0|Death|0
154592|NCT00361335|497547|P4|IV Period: Baseline to E0|Death|1
154593|NCT00361335|497548|P3|IV Period: Baseline to E0|Death|1
154594|NCT00361335|497549|P2|IV Period: Baseline to E0|Death|1
154595|NCT00361335|497550|P1|IV Period: Baseline to E0|Death|1
154596|NCT00361335|497544|P7|IV Period: Baseline to E0|Lost to Follow-up|0
154597|NCT00361335|497545|P6|IV Period: Baseline to E0|Lost to Follow-up|0
154598|NCT00361335|497546|P5|IV Period: Baseline to E0|Lost to Follow-up|2
154599|NCT00361335|497547|P4|IV Period: Baseline to E0|Lost to Follow-up|2
154600|NCT00361335|497548|P3|IV Period: Baseline to E0|Lost to Follow-up|0
154601|NCT00361335|497549|P2|IV Period: Baseline to E0|Lost to Follow-up|0
154602|NCT00361335|497550|P1|IV Period: Baseline to E0|Lost to Follow-up|1
154603|NCT00361335|497544|P7|IV Period: Baseline to E0|Adverse Event|0
154604|NCT00361335|497545|P6|IV Period: Baseline to E0|Adverse Event|0
154605|NCT00361335|497546|P5|IV Period: Baseline to E0|Adverse Event|8
154606|NCT00361335|497547|P4|IV Period: Baseline to E0|Adverse Event|9
154607|NCT00361335|497548|P3|IV Period: Baseline to E0|Adverse Event|5
154608|NCT00361335|497549|P2|IV Period: Baseline to E0|Adverse Event|4
154609|NCT00361335|497550|P1|IV Period: Baseline to E0|Adverse Event|9
154610|NCT00361283|497594|P1|Overall Study|Lost to Follow-up|27
154611|NCT00361270|497602|P4|Overall Study|Adverse Event|0
154612|NCT00361270|497603|P3|Overall Study|Adverse Event|1
154613|NCT00361270|497604|P2|Overall Study|Adverse Event|1
154614|NCT00361270|497605|P1|Overall Study|Adverse Event|0
154615|NCT00361270|497602|P4|Overall Study|Problems with Transportation|0
154616|NCT00361270|497603|P3|Overall Study|Problems with Transportation|0
154617|NCT00361270|497604|P2|Overall Study|Problems with Transportation|0
154618|NCT00361270|497605|P1|Overall Study|Problems with Transportation|4
154619|NCT00361270|497602|P4|Overall Study|Afraid of Hypnosis|0
154620|NCT00361270|497603|P3|Overall Study|Afraid of Hypnosis|0
154621|NCT00361270|497604|P2|Overall Study|Afraid of Hypnosis|2
154622|NCT00361270|497605|P1|Overall Study|Afraid of Hypnosis|1
154623|NCT00361270|497602|P4|Overall Study|Withdrawal by Subject|7
154624|NCT00361270|497603|P3|Overall Study|Withdrawal by Subject|3
154625|NCT00361270|497604|P2|Overall Study|Withdrawal by Subject|6
154626|NCT00361270|497605|P1|Overall Study|Withdrawal by Subject|6
154627|NCT00361270|497602|P4|Overall Study|Protocol Violation|4
154628|NCT00361270|497603|P3|Overall Study|Protocol Violation|5
154629|NCT00361270|497604|P2|Overall Study|Protocol Violation|4
154630|NCT00361270|497605|P1|Overall Study|Protocol Violation|9
154631|NCT00361270|497602|P4|Overall Study|Physician Decision|0
154632|NCT00361270|497603|P3|Overall Study|Physician Decision|1
154633|NCT00361270|497604|P2|Overall Study|Physician Decision|0
154634|NCT00361270|497605|P1|Overall Study|Physician Decision|0
154635|NCT00361270|497602|P4|Overall Study|Lost to Follow-up|0
154636|NCT00361270|497603|P3|Overall Study|Lost to Follow-up|0
154637|NCT00361270|497604|P2|Overall Study|Lost to Follow-up|1
154638|NCT00361270|497605|P1|Overall Study|Lost to Follow-up|4
154639|NCT00361270|497602|P4|Overall Study|Death|2
154640|NCT00361270|497603|P3|Overall Study|Death|0
154641|NCT00361270|497604|P2|Overall Study|Death|0
154642|NCT00361270|497605|P1|Overall Study|Death|0
154643|NCT00361231|497678|P1|Overall Study|Adverse Event|6
154644|NCT00361231|497678|P1|Overall Study|Withdrawal by Subject|4
154645|NCT00361231|497678|P1|Overall Study|Radiographic disease progression|16
154646|NCT00361231|497678|P1|Overall Study|Symptomatic deterioration|5
154647|NCT00361231|497678|P1|Overall Study|Physician Decision|3
154648|NCT00361218|497683|P1|Overall Study|terminated / withdrawn due to toxicity /|5
154649|NCT00361218|497683|P1|Overall Study|Personal Reasons|7
154650|NCT00361218|497683|P1|Overall Study|Lost to Follow-up|11
154651|NCT00360698|497747|P2|Treatment Period|Early termination by error|1
154652|NCT00360698|497748|P1|Treatment Period|Early termination by error|0
154653|NCT00360698|497747|P2|Treatment Period|Non compliance with treatment procedure|0
154654|NCT00360698|497748|P1|Treatment Period|Non compliance with treatment procedure|1
154655|NCT00360698|497747|P2|Run-In|Need of insulin with meals|1
154656|NCT00360698|497748|P1|Run-In|Need of insulin with meals|0
154657|NCT00360698|497747|P2|Run-In|Patient personal reasons|2
154658|NCT00360698|497748|P1|Run-In|Patient personal reasons|0
154659|NCT00360698|497747|P2|Run-In|Patient did not meet inclusion criteria|1
154660|NCT00360698|497748|P1|Run-In|Patient did not meet inclusion criteria|0
154661|NCT00360698|497747|P2|Run-In|Sponsor request|2
154662|NCT00360698|497748|P1|Run-In|Sponsor request|0
154663|NCT00360698|497747|P2|Run-In|Non compliance with treatment procedure|1
154664|NCT00360698|497748|P1|Run-In|Non compliance with treatment procedure|0
154665|NCT00360698|497747|P2|Run-In|Withdrawal by Subject|2
154666|NCT00360698|497748|P1|Run-In|Withdrawal by Subject|0
154667|NCT00360698|497747|P2|Run-In|Physician Decision|1
154668|NCT00360698|497748|P1|Run-In|Physician Decision|0
154669|NCT00360568|497793|P2|Overall Study|Withdrawal by Subject|3
154670|NCT00360568|497794|P1|Overall Study|Withdrawal by Subject|0
154671|NCT00360568|497793|P2|Overall Study|Lack of Efficacy|0
154672|NCT00360568|497794|P1|Overall Study|Lack of Efficacy|1
154673|NCT00360568|497793|P2|Overall Study|Adverse Event|2
154674|NCT00360568|497794|P1|Overall Study|Adverse Event|1
154675|NCT00360529|497925|P3|Overall Study|Reason discontinued not explained above|11
154676|NCT00360529|497926|P2|Overall Study|Reason discontinued not explained above|9
154677|NCT00360529|497927|P1|Overall Study|Reason discontinued not explained above|4
154678|NCT00360529|497925|P3|Overall Study|Lack of Efficacy|5
154679|NCT00360529|497926|P2|Overall Study|Lack of Efficacy|6
154680|NCT00360529|497927|P1|Overall Study|Lack of Efficacy|8
154681|NCT00360529|497925|P3|Overall Study|Withdrawal by Subject|18
154682|NCT00360529|497926|P2|Overall Study|Withdrawal by Subject|14
154683|NCT00360529|497927|P1|Overall Study|Withdrawal by Subject|22
154684|NCT00360529|497925|P3|Overall Study|Lost to Follow-up|13
154685|NCT00360529|497926|P2|Overall Study|Lost to Follow-up|10
154686|NCT00360529|497927|P1|Overall Study|Lost to Follow-up|14
154687|NCT00360529|497925|P3|Overall Study|Protocol Violation|11
154688|NCT00360529|497926|P2|Overall Study|Protocol Violation|3
154689|NCT00360529|497927|P1|Overall Study|Protocol Violation|3
154690|NCT00360529|497925|P3|Overall Study|Adverse Event|33
154691|NCT00360529|497926|P2|Overall Study|Adverse Event|23
154692|NCT00360529|497927|P1|Overall Study|Adverse Event|10
154693|NCT00360490|497955|P2|Overall Study|Withdrawal by Subject|3
154694|NCT00360490|497956|P1|Overall Study|Withdrawal by Subject|1
154695|NCT00360490|497955|P2|Overall Study|Protocol Violation|4
154696|NCT00360490|497956|P1|Overall Study|Protocol Violation|0
154697|NCT00360490|497955|P2|Overall Study|Physician Decision|1
154698|NCT00360490|497956|P1|Overall Study|Physician Decision|2
154699|NCT00360490|497955|P2|Overall Study|Lost to Follow-up|1
154700|NCT00360490|497956|P1|Overall Study|Lost to Follow-up|2
154701|NCT00360490|497955|P2|Overall Study|Adverse Event|2
154702|NCT00360490|497956|P1|Overall Study|Adverse Event|4
154703|NCT00360412|497991|P2|Overall Study|Study termination by Sponsor|469
154704|NCT00360412|497992|P1|Overall Study|Study termination by Sponsor|214
154705|NCT00360412|497991|P2|Overall Study|Not specified|6
154706|NCT00360412|497992|P1|Overall Study|Not specified|5
154707|NCT00360412|497991|P2|Overall Study|Physician Decision|4
154708|NCT00360412|497992|P1|Overall Study|Physician Decision|2
154709|NCT00360412|497991|P2|Overall Study|Lack of therapeutic efficacy|61
154710|NCT00360412|497992|P1|Overall Study|Lack of therapeutic efficacy|46
154711|NCT00360412|497991|P2|Overall Study|Patient withdrew consent|52
154712|NCT00360412|497992|P1|Overall Study|Patient withdrew consent|27
154713|NCT00360412|497991|P2|Overall Study|Protocol Violation|5
154714|NCT00360412|497992|P1|Overall Study|Protocol Violation|2
154715|NCT00360412|497991|P2|Overall Study|Adverse Event|65
154716|NCT00360412|497992|P1|Overall Study|Adverse Event|37
154717|NCT00360334|498039|P2|Overall Study|Subject decision|2
154718|NCT00360334|498040|P1|Overall Study|Subject decision|8
154719|NCT00360334|498039|P2|Overall Study|Entry criterion not met|2
154720|NCT00360334|498040|P1|Overall Study|Entry criterion not met|1
154721|NCT00360334|498039|P2|Overall Study|Lack of Efficacy|1
154722|NCT00360334|498040|P1|Overall Study|Lack of Efficacy|0
154723|NCT00360334|498039|P2|Overall Study|Physician Decision|3
154724|NCT00360334|498040|P1|Overall Study|Physician Decision|2
154725|NCT00360334|498039|P2|Overall Study|Protocol Violation|1
154726|NCT00360334|498040|P1|Overall Study|Protocol Violation|1
154727|NCT00360334|498039|P2|Overall Study|Adverse Event|4
154728|NCT00360334|498040|P1|Overall Study|Adverse Event|7
154729|NCT00360308|498103|P3|Overall Study|Study termination by sponsor|44
154730|NCT00360308|498104|P2|Overall Study|Study termination by sponsor|55
154731|NCT00360308|498105|P1|Overall Study|Study termination by sponsor|43
154732|NCT00360308|498103|P3|Overall Study|Not Specified|1
154733|NCT00360308|498104|P2|Overall Study|Not Specified|1
154734|NCT00360308|498105|P1|Overall Study|Not Specified|2
154735|NCT00360308|498103|P3|Overall Study|Lack of Efficacy|2
154736|NCT00360308|498104|P2|Overall Study|Lack of Efficacy|0
154737|NCT00360308|498105|P1|Overall Study|Lack of Efficacy|3
154738|NCT00360308|498103|P3|Overall Study|Withdrawal by Subject|14
154739|NCT00360308|498104|P2|Overall Study|Withdrawal by Subject|7
154740|NCT00360308|498105|P1|Overall Study|Withdrawal by Subject|11
154741|NCT00360308|498103|P3|Overall Study|Protocol Violation|2
154742|NCT00360308|498104|P2|Overall Study|Protocol Violation|1
154743|NCT00360308|498105|P1|Overall Study|Protocol Violation|2
154744|NCT00360308|498103|P3|Overall Study|Abnormal Laboratory Value(s)|0
154745|NCT00360308|498104|P2|Overall Study|Abnormal Laboratory Value(s)|1
154746|NCT00360308|498105|P1|Overall Study|Abnormal Laboratory Value(s)|0
154747|NCT00360308|498103|P3|Overall Study|Adverse Event|25
154748|NCT00360308|498104|P2|Overall Study|Adverse Event|14
154749|NCT00360308|498105|P1|Overall Study|Adverse Event|15
154750|NCT00360282|498122|P4|Second Intervention|Adverse Event|0
154751|NCT00360282|498123|P3|Second Intervention|Adverse Event|0
154752|NCT00360282|498124|P2|Second Intervention|Adverse Event|1
154753|NCT00360282|498125|P1|Second Intervention|Adverse Event|0
154754|NCT00360282|498122|P4|Washout 1-3 Weeks|Lost to Follow-up|0
154755|NCT00360282|498123|P3|Washout 1-3 Weeks|Lost to Follow-up|1
154756|NCT00360282|498124|P2|Washout 1-3 Weeks|Lost to Follow-up|0
154757|NCT00360282|498125|P1|Washout 1-3 Weeks|Lost to Follow-up|0
154758|NCT00360269|498137|P2|Overall Study|Withdrawal by Subject|1
154759|NCT00360269|498138|P1|Overall Study|Withdrawal by Subject|1
154760|NCT00360269|498137|P2|Overall Study|Adverse Event|0
154761|NCT00360269|498138|P1|Overall Study|Adverse Event|1
154762|NCT00360269|498137|P2|Overall Study|Physician Decision|2
154763|NCT00360269|498138|P1|Overall Study|Physician Decision|1
154764|NCT00360269|498137|P2|Overall Study|Lost to Follow-up|9
154765|NCT00360269|498138|P1|Overall Study|Lost to Follow-up|7
154766|NCT00359801|498274|P2|Overall Study|Sponsor Decision|16
154767|NCT00359801|498275|P1|Overall Study|Sponsor Decision|17
154768|NCT00359801|498274|P2|Overall Study|Final Status Unknown: missing data|4
154769|NCT00359801|498275|P1|Overall Study|Final Status Unknown: missing data|7
154770|NCT00359801|498274|P2|Overall Study|Unspecified|46
154771|NCT00359801|498275|P1|Overall Study|Unspecified|66
154772|NCT00359801|498274|P2|Overall Study|Withdrawal by Subject|96
154773|NCT00359801|498275|P1|Overall Study|Withdrawal by Subject|143
154774|NCT00359801|498274|P2|Overall Study|Lost to Follow-up|58
154775|NCT00359801|498275|P1|Overall Study|Lost to Follow-up|72
154776|NCT00359788|498309|P2|Overall Study|Protocol Violation|2
154777|NCT00359788|498310|P1|Overall Study|Protocol Violation|4
154778|NCT00359788|498309|P2|Overall Study|Withdrawal by Subject|1
154779|NCT00359788|498310|P1|Overall Study|Withdrawal by Subject|4
154780|NCT00359788|498309|P2|Overall Study|Lost to Follow-up|2
154781|NCT00359788|498310|P1|Overall Study|Lost to Follow-up|3
154782|NCT00359788|498309|P2|Overall Study|Lack of Efficacy|2
154783|NCT00359788|498310|P1|Overall Study|Lack of Efficacy|1
154784|NCT00359788|498309|P2|Overall Study|Adverse Event|10
154785|NCT00359788|498310|P1|Overall Study|Adverse Event|11
154786|NCT00359762|498544|P5|Period III|Subject Decision|0
154787|NCT00359762|498545|P4|Period III|Subject Decision|20
154788|NCT00359762|498546|P3|Period III|Subject Decision|8
154789|NCT00359762|498547|P2|Period III|Subject Decision|7
154790|NCT00359762|498548|P1|Period III|Subject Decision|0
154791|NCT00359762|498544|P5|Period III|Entry Criteria Not Met|0
154792|NCT00359762|498545|P4|Period III|Entry Criteria Not Met|1
154793|NCT00359762|498546|P3|Period III|Entry Criteria Not Met|0
154794|NCT00359762|498547|P2|Period III|Entry Criteria Not Met|1
154795|NCT00359762|498548|P1|Period III|Entry Criteria Not Met|0
154796|NCT00359762|498544|P5|Period III|Lost to follow up|0
154797|NCT00359762|498545|P4|Period III|Lost to follow up|2
154798|NCT00359762|498546|P3|Period III|Lost to follow up|1
154799|NCT00359762|498547|P2|Period III|Lost to follow up|1
154800|NCT00359762|498548|P1|Period III|Lost to follow up|0
154801|NCT00359762|498544|P5|Period III|Lack of Efficacy|0
154802|NCT00359762|498545|P4|Period III|Lack of Efficacy|9
154803|NCT00359762|498546|P3|Period III|Lack of Efficacy|5
154804|NCT00359762|498547|P2|Period III|Lack of Efficacy|7
154805|NCT00359762|498548|P1|Period III|Lack of Efficacy|0
154806|NCT00359762|498544|P5|Period III|Physician Decision|0
154807|NCT00359762|498545|P4|Period III|Physician Decision|15
154808|NCT00359762|498546|P3|Period III|Physician Decision|9
154809|NCT00359762|498547|P2|Period III|Physician Decision|5
154810|NCT00359762|498548|P1|Period III|Physician Decision|0
154811|NCT00359762|498544|P5|Period III|Adverse Event|0
154812|NCT00359762|498545|P4|Period III|Adverse Event|10
154813|NCT00359762|498546|P3|Period III|Adverse Event|4
154814|NCT00359762|498547|P2|Period III|Adverse Event|3
154815|NCT00359762|498548|P1|Period III|Adverse Event|0
154816|NCT00359762|498544|P5|Period III|Protocol Violation|0
154817|NCT00359762|498545|P4|Period III|Protocol Violation|8
154818|NCT00359762|498546|P3|Period III|Protocol Violation|3
154819|NCT00359762|498547|P2|Period III|Protocol Violation|5
154820|NCT00359762|498548|P1|Period III|Protocol Violation|0
154821|NCT00359762|498544|P5|Period II|Subject Decision|70
154822|NCT00359762|498545|P4|Period II|Subject Decision|0
154823|NCT00359762|498546|P3|Period II|Subject Decision|0
154824|NCT00359762|498547|P2|Period II|Subject Decision|0
154825|NCT00359762|498548|P1|Period II|Subject Decision|50
154826|NCT00359762|498544|P5|Period II|Entry Criteria Not Met|4
154827|NCT00359762|498545|P4|Period II|Entry Criteria Not Met|0
154828|NCT00359762|498546|P3|Period II|Entry Criteria Not Met|0
154829|NCT00359762|498547|P2|Period II|Entry Criteria Not Met|0
154830|NCT00359762|498548|P1|Period II|Entry Criteria Not Met|8
154831|NCT00359762|498544|P5|Period II|Lost to follow up|5
154832|NCT00359762|498545|P4|Period II|Lost to follow up|0
154833|NCT00359762|498546|P3|Period II|Lost to follow up|0
154834|NCT00359762|498547|P2|Period II|Lost to follow up|0
154835|NCT00359762|498548|P1|Period II|Lost to follow up|5
154836|NCT00359762|498544|P5|Period II|Lack of Efficacy|8
154837|NCT00359762|498545|P4|Period II|Lack of Efficacy|0
154838|NCT00359762|498546|P3|Period II|Lack of Efficacy|0
154839|NCT00359762|498547|P2|Period II|Lack of Efficacy|0
154840|NCT00359762|498548|P1|Period II|Lack of Efficacy|11
154841|NCT00359762|498544|P5|Period II|Death|4
154842|NCT00359762|498545|P4|Period II|Death|0
154843|NCT00359762|498546|P3|Period II|Death|0
154844|NCT00359762|498547|P2|Period II|Death|0
154845|NCT00359762|498548|P1|Period II|Death|2
154846|NCT00359762|498544|P5|Period II|Physician Decision|23
154847|NCT00359762|498545|P4|Period II|Physician Decision|0
154848|NCT00359762|498546|P3|Period II|Physician Decision|0
154849|NCT00359762|498547|P2|Period II|Physician Decision|0
154850|NCT00359762|498548|P1|Period II|Physician Decision|17
154851|NCT00359762|498544|P5|Period II|Protocol Violation|11
154852|NCT00359762|498545|P4|Period II|Protocol Violation|0
154853|NCT00359762|498546|P3|Period II|Protocol Violation|0
154854|NCT00359762|498547|P2|Period II|Protocol Violation|0
154855|NCT00359762|498548|P1|Period II|Protocol Violation|18
154856|NCT00359762|498544|P5|Period II|Adverse Event|49
154857|NCT00359762|498545|P4|Period II|Adverse Event|0
154858|NCT00359762|498546|P3|Period II|Adverse Event|0
154859|NCT00359762|498547|P2|Period II|Adverse Event|0
154860|NCT00359762|498548|P1|Period II|Adverse Event|17
154861|NCT00359632|498622|P2|Overall Study|Non-compliance with visit schedule|0
154862|NCT00359632|498623|P1|Overall Study|Non-compliance with visit schedule|1
154863|NCT00359632|498622|P2|Overall Study|Adverse Event|0
154864|NCT00359632|498623|P1|Overall Study|Adverse Event|1
154865|NCT00359632|498622|P2|Overall Study|Death|0
154866|NCT00359632|498623|P1|Overall Study|Death|2
154867|NCT00359619|498637|P7|Overall Study|Lost to Follow-up|0
154868|NCT00359619|498638|P6|Overall Study|Lost to Follow-up|5
154869|NCT00359619|498639|P5|Overall Study|Lost to Follow-up|1
154870|NCT00359619|498640|P4|Overall Study|Lost to Follow-up|1
154871|NCT00359619|498641|P3|Overall Study|Lost to Follow-up|2
154872|NCT00359619|498642|P2|Overall Study|Lost to Follow-up|4
154873|NCT00359619|498643|P1|Overall Study|Lost to Follow-up|4
154874|NCT00359619|498637|P7|Overall Study|Unspecified|0
154875|NCT00359619|498638|P6|Overall Study|Unspecified|0
154876|NCT00359619|498639|P5|Overall Study|Unspecified|0
154877|NCT00359619|498640|P4|Overall Study|Unspecified|0
154878|NCT00359619|498641|P3|Overall Study|Unspecified|0
154879|NCT00359619|498642|P2|Overall Study|Unspecified|0
154880|NCT00359619|498643|P1|Overall Study|Unspecified|1
154881|NCT00359619|498637|P7|Overall Study|Withdrawal by Subject|3
154882|NCT00359619|498638|P6|Overall Study|Withdrawal by Subject|0
154883|NCT00359619|498639|P5|Overall Study|Withdrawal by Subject|2
154884|NCT00359619|498640|P4|Overall Study|Withdrawal by Subject|2
154885|NCT00359619|498641|P3|Overall Study|Withdrawal by Subject|4
154886|NCT00359619|498642|P2|Overall Study|Withdrawal by Subject|1
154887|NCT00359619|498643|P1|Overall Study|Withdrawal by Subject|3
154888|NCT00359619|498637|P7|Overall Study|Adverse Event|1
154889|NCT00359619|498638|P6|Overall Study|Adverse Event|0
154890|NCT00359619|498639|P5|Overall Study|Adverse Event|0
154891|NCT00359619|498640|P4|Overall Study|Adverse Event|0
154892|NCT00359619|498641|P3|Overall Study|Adverse Event|1
154893|NCT00359619|498642|P2|Overall Study|Adverse Event|0
154894|NCT00359619|498643|P1|Overall Study|Adverse Event|0
154895|NCT00359424|498773|P2|Overall Study|follow up not conducted|0
154896|NCT00359424|498774|P1|Overall Study|follow up not conducted|2
154897|NCT00359424|498773|P2|Overall Study|Withdrawal by Subject|2
154898|NCT00359424|498774|P1|Overall Study|Withdrawal by Subject|10
154899|NCT00359424|498773|P2|Overall Study|Lost to Follow-up|7
154900|NCT00359424|498774|P1|Overall Study|Lost to Follow-up|19
154901|NCT00359424|498773|P2|Overall Study|Death|58
154902|NCT00359424|498774|P1|Overall Study|Death|99
154903|NCT00359281|498813|P9|Overall Study|Withdrawal by Subject|0
154904|NCT00359281|498814|P8|Overall Study|Withdrawal by Subject|0
154905|NCT00359281|498815|P7|Overall Study|Withdrawal by Subject|1
154906|NCT00359281|498816|P6|Overall Study|Withdrawal by Subject|0
154907|NCT00359281|498817|P5|Overall Study|Withdrawal by Subject|0
154908|NCT00359281|498818|P4|Overall Study|Withdrawal by Subject|0
154909|NCT00359281|498819|P3|Overall Study|Withdrawal by Subject|0
154910|NCT00359281|498820|P2|Overall Study|Withdrawal by Subject|0
154911|NCT00359281|498821|P1|Overall Study|Withdrawal by Subject|0
154912|NCT00359281|498813|P9|Overall Study|Adverse Event|0
154913|NCT00359281|498814|P8|Overall Study|Adverse Event|0
154914|NCT00359281|498815|P7|Overall Study|Adverse Event|1
154915|NCT00359281|498816|P6|Overall Study|Adverse Event|0
154916|NCT00359281|498817|P5|Overall Study|Adverse Event|0
154917|NCT00359281|498818|P4|Overall Study|Adverse Event|0
154918|NCT00359281|498819|P3|Overall Study|Adverse Event|0
154919|NCT00359281|498820|P2|Overall Study|Adverse Event|0
154920|NCT00359281|498821|P1|Overall Study|Adverse Event|1
154921|NCT00359021|498884|P2|Overall Study|Pregnancy|0
154922|NCT00359021|498885|P1|Overall Study|Pregnancy|1
154923|NCT00359021|498884|P2|Overall Study|Not specified|1
154924|NCT00359021|498885|P1|Overall Study|Not specified|4
154925|NCT00359021|498884|P2|Overall Study|Lost to Follow-up|0
154926|NCT00359021|498885|P1|Overall Study|Lost to Follow-up|1
154927|NCT00359021|498884|P2|Overall Study|Withdrawal by Subject|9
154928|NCT00359021|498885|P1|Overall Study|Withdrawal by Subject|2
154929|NCT00359021|498884|P2|Overall Study|Subject Reached A Virologic Endpoint|32
154930|NCT00359021|498885|P1|Overall Study|Subject Reached A Virologic Endpoint|45
154931|NCT00359021|498884|P2|Overall Study|Subject Ineligible To Continue The Trial|0
154932|NCT00359021|498885|P1|Overall Study|Subject Ineligible To Continue The Trial|1
154933|NCT00359021|498884|P2|Overall Study|Subject Non-Compliant|2
154934|NCT00359021|498885|P1|Overall Study|Subject Non-Compliant|1
154935|NCT00359021|498884|P2|Overall Study|Adverse Event|8
154936|NCT00359021|498885|P1|Overall Study|Adverse Event|26
154937|NCT00358956|498897|P1|Overall Study|Withdrawal by Subject|1
154938|NCT00358956|498897|P1|Overall Study|condition under investigation worsened|4
154939|NCT00358956|498897|P1|Overall Study|Adverse Event|3
154940|NCT00358917|498909|P2|Overall Study|Unable to Continue Participation|2
154941|NCT00358917|498910|P1|Overall Study|Unable to Continue Participation|2
154942|NCT00358917|498909|P2|Overall Study|Virologic failure|8
154943|NCT00358917|498910|P1|Overall Study|Virologic failure|11
154944|NCT00358917|498909|P2|Overall Study|Death|3
154945|NCT00358917|498910|P1|Overall Study|Death|2
154946|NCT00358917|498909|P2|Overall Study|Noncompliance|11
154947|NCT00358917|498910|P1|Overall Study|Noncompliance|12
154948|NCT00358917|498909|P2|Overall Study|Lost to Follow-up|17
154949|NCT00358917|498910|P1|Overall Study|Lost to Follow-up|20
154950|NCT00358917|498909|P2|Overall Study|Withdrawal by Subject|7
154951|NCT00358917|498910|P1|Overall Study|Withdrawal by Subject|5
154952|NCT00358917|498909|P2|Overall Study|Adverse Event|21
154953|NCT00358917|498910|P1|Overall Study|Adverse Event|14
154954|NCT00358826|498928|P8|MDCT Substudy|Withdrawal by Subject|0
154955|NCT00358826|498929|P7|MDCT Substudy|Withdrawal by Subject|0
154956|NCT00358826|498930|P6|MDCT Substudy|Withdrawal by Subject|1
154957|NCT00358826|498931|P5|MDCT Substudy|Withdrawal by Subject|0
154958|NCT00358826|498932|P4|MDCT Substudy|Withdrawal by Subject|0
154959|NCT00358826|498933|P3|MDCT Substudy|Withdrawal by Subject|0
154960|NCT00358826|498934|P2|MDCT Substudy|Withdrawal by Subject|0
154961|NCT00358826|498935|P1|MDCT Substudy|Withdrawal by Subject|0
154962|NCT00358826|498928|P8|MDCT Substudy|Lost to Follow-up|0
154963|NCT00358826|498929|P7|MDCT Substudy|Lost to Follow-up|0
154964|NCT00358826|498930|P6|MDCT Substudy|Lost to Follow-up|1
154965|NCT00358826|498931|P5|MDCT Substudy|Lost to Follow-up|0
154966|NCT00358826|498932|P4|MDCT Substudy|Lost to Follow-up|0
154967|NCT00358826|498933|P3|MDCT Substudy|Lost to Follow-up|0
154968|NCT00358826|498934|P2|MDCT Substudy|Lost to Follow-up|0
154969|NCT00358826|498935|P1|MDCT Substudy|Lost to Follow-up|0
154970|NCT00358826|498928|P8|MDCT Substudy|Adverse Event|0
154971|NCT00358826|498929|P7|MDCT Substudy|Adverse Event|0
154972|NCT00358826|498930|P6|MDCT Substudy|Adverse Event|0
154973|NCT00358826|498931|P5|MDCT Substudy|Adverse Event|1
154974|NCT00358826|498932|P4|MDCT Substudy|Adverse Event|0
154975|NCT00358826|498933|P3|MDCT Substudy|Adverse Event|0
154976|NCT00358826|498934|P2|MDCT Substudy|Adverse Event|0
154977|NCT00358826|498935|P1|MDCT Substudy|Adverse Event|0
154978|NCT00358826|498928|P8|Core Study|Physician Decision|0
154979|NCT00358826|498929|P7|Core Study|Physician Decision|0
154980|NCT00358826|498930|P6|Core Study|Physician Decision|0
154981|NCT00358826|498931|P5|Core Study|Physician Decision|0
154982|NCT00358826|498932|P4|Core Study|Physician Decision|0
154983|NCT00358826|498933|P3|Core Study|Physician Decision|1
154984|NCT00358826|498934|P2|Core Study|Physician Decision|0
154985|NCT00358826|498935|P1|Core Study|Physician Decision|0
154986|NCT00358826|498928|P8|Core Study|Lost to Follow-up|0
154987|NCT00358826|498929|P7|Core Study|Lost to Follow-up|0
154988|NCT00358826|498930|P6|Core Study|Lost to Follow-up|0
154989|NCT00358826|498931|P5|Core Study|Lost to Follow-up|0
154990|NCT00358826|498932|P4|Core Study|Lost to Follow-up|1
154991|NCT00358826|498933|P3|Core Study|Lost to Follow-up|0
154992|NCT00358826|498934|P2|Core Study|Lost to Follow-up|0
154993|NCT00358826|498935|P1|Core Study|Lost to Follow-up|0
154994|NCT00358826|498928|P8|Core Study|Withdrawal by Subject|0
154995|NCT00358826|498929|P7|Core Study|Withdrawal by Subject|0
154996|NCT00358826|498930|P6|Core Study|Withdrawal by Subject|0
154997|NCT00358826|498931|P5|Core Study|Withdrawal by Subject|0
154998|NCT00358826|498932|P4|Core Study|Withdrawal by Subject|0
154999|NCT00358826|498933|P3|Core Study|Withdrawal by Subject|0
155000|NCT00358826|498934|P2|Core Study|Withdrawal by Subject|2
155001|NCT00358826|498935|P1|Core Study|Withdrawal by Subject|2
155002|NCT00358826|498928|P8|Core Study|Adverse Event|0
155003|NCT00358826|498929|P7|Core Study|Adverse Event|0
155004|NCT00358826|498930|P6|Core Study|Adverse Event|0
155005|NCT00358826|498931|P5|Core Study|Adverse Event|0
155006|NCT00358826|498932|P4|Core Study|Adverse Event|1
155007|NCT00358826|498933|P3|Core Study|Adverse Event|1
155008|NCT00358826|498934|P2|Core Study|Adverse Event|3
155009|NCT00358826|498935|P1|Core Study|Adverse Event|1
155010|NCT00358670|499002|P2|Overall Study|Administrative|125
155011|NCT00358670|499003|P1|Overall Study|Administrative|153
155012|NCT00358670|499002|P2|Overall Study|Did Not Meet Protocol Eligibility|3
155013|NCT00358670|499003|P1|Overall Study|Did Not Meet Protocol Eligibility|0
155014|NCT00358670|499002|P2|Overall Study|Protocol Defined Clinical Event|1
155015|NCT00358670|499003|P1|Overall Study|Protocol Defined Clinical Event|0
155016|NCT00358670|499002|P2|Overall Study|Withdrawal by Subject|24
155017|NCT00358670|499003|P1|Overall Study|Withdrawal by Subject|13
155018|NCT00358670|499002|P2|Overall Study|Lost to Follow-up|5
155019|NCT00358670|499003|P1|Overall Study|Lost to Follow-up|4
155020|NCT00358670|499002|P2|Overall Study|Protocol Violation|9
155021|NCT00358670|499003|P1|Overall Study|Protocol Violation|6
155022|NCT00358670|499002|P2|Overall Study|Lack of Efficacy|23
155023|NCT00358670|499003|P1|Overall Study|Lack of Efficacy|20
155024|NCT00358670|499002|P2|Overall Study|Adverse Event|29
155025|NCT00358670|499003|P1|Overall Study|Adverse Event|26
155026|NCT00358644|499017|P1|Overall Study|Patient not eligible for study|1
155027|NCT00358644|499017|P1|Overall Study|Physician Decision|6
155028|NCT00358644|499017|P1|Overall Study|Withdrawal by Subject|4
155029|NCT00358644|499017|P1|Overall Study|Death|11
155030|NCT00358644|499017|P1|Overall Study|Adverse Event|7
155031|NCT00358644|499017|P1|Overall Study|Progressive Disease|21
155032|NCT00358527|499040|P2|Overall Study|Administrative|1
155033|NCT00358527|499041|P1|Overall Study|Administrative|2
155034|NCT00358527|499040|P2|Overall Study|Non-compliance with protocol|1
155035|NCT00358527|499041|P1|Overall Study|Non-compliance with protocol|6
155036|NCT00358527|499040|P2|Overall Study|Withdrawal by Subject|1
155037|NCT00358527|499041|P1|Overall Study|Withdrawal by Subject|1
155038|NCT00358527|499040|P2|Overall Study|Adverse Event|0
155039|NCT00358527|499041|P1|Overall Study|Adverse Event|4
155040|NCT00358449|499079|P3|Overall Study|Steriod Inhaler was Increased|1
155041|NCT00358449|499080|P2|Overall Study|Steriod Inhaler was Increased|0
155042|NCT00358449|499081|P1|Overall Study|Steriod Inhaler was Increased|0
155043|NCT00358449|499079|P3|Overall Study|Lack of Efficacy|0
155044|NCT00358449|499080|P2|Overall Study|Lack of Efficacy|1
155045|NCT00358449|499081|P1|Overall Study|Lack of Efficacy|0
155046|NCT00358449|499079|P3|Overall Study|Withdrawal by Subject|0
155047|NCT00358449|499080|P2|Overall Study|Withdrawal by Subject|0
155048|NCT00358449|499081|P1|Overall Study|Withdrawal by Subject|2
155049|NCT00358449|499079|P3|Overall Study|Lost to Follow-up|0
155050|NCT00358449|499080|P2|Overall Study|Lost to Follow-up|0
155051|NCT00358449|499081|P1|Overall Study|Lost to Follow-up|1
155052|NCT00358449|499079|P3|Overall Study|Adverse Event|1
155053|NCT00358449|499080|P2|Overall Study|Adverse Event|0
155054|NCT00358449|499081|P1|Overall Study|Adverse Event|1
155055|NCT00358436|499184|P2|Overall Study|Other|1
155056|NCT00358436|499185|P1|Overall Study|Other|6
155057|NCT00358436|499184|P2|Overall Study|COPD exacerbation|10
155058|NCT00358436|499185|P1|Overall Study|COPD exacerbation|22
155059|NCT00358436|499184|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
155060|NCT00358436|499185|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
155061|NCT00358436|499184|P2|Overall Study|Withdrawal by Subject|17
155062|NCT00358436|499185|P1|Overall Study|Withdrawal by Subject|40
155063|NCT00358436|499184|P2|Overall Study|Protocol Violation|3
155064|NCT00358436|499185|P1|Overall Study|Protocol Violation|8
155065|NCT00358436|499184|P2|Overall Study|Lost to Follow-up|6
155066|NCT00358436|499185|P1|Overall Study|Lost to Follow-up|11
155067|NCT00358436|499184|P2|Overall Study|Lack of Efficacy|36
155068|NCT00358436|499185|P1|Overall Study|Lack of Efficacy|34
155069|NCT00358436|499184|P2|Overall Study|Adverse Event|13
155070|NCT00358436|499185|P1|Overall Study|Adverse Event|29
155071|NCT00358215|499256|P2|Overall Study|Did not receive investigational product|3
155072|NCT00358215|499257|P1|Overall Study|Did not receive investigational product|2
155073|NCT00358215|499256|P2|Overall Study|Other|14
155074|NCT00358215|499257|P1|Overall Study|Other|21
155075|NCT00358215|499256|P2|Overall Study|Pregnancy|0
155076|NCT00358215|499257|P1|Overall Study|Pregnancy|1
155077|NCT00358215|499256|P2|Overall Study|Protocol Violation|59
155078|NCT00358215|499257|P1|Overall Study|Protocol Violation|64
155079|NCT00358215|499256|P2|Overall Study|Death|281
155080|NCT00358215|499257|P1|Overall Study|Death|265
155081|NCT00358215|499256|P2|Overall Study|Lost to Follow-up|22
155082|NCT00358215|499257|P1|Overall Study|Lost to Follow-up|16
155083|NCT00358215|499256|P2|Overall Study|Physician Decision|39
155084|NCT00358215|499257|P1|Overall Study|Physician Decision|47
155085|NCT00358215|499256|P2|Overall Study|Participant request|64
155086|NCT00358215|499257|P1|Overall Study|Participant request|65
155087|NCT00358215|499256|P2|Overall Study|Withdrawal by Subject|102
155088|NCT00358215|499257|P1|Overall Study|Withdrawal by Subject|111
155089|NCT00358215|499256|P2|Overall Study|Adverse Event|65
155090|NCT00358215|499257|P1|Overall Study|Adverse Event|83
155091|NCT00358215|499256|P2|Overall Study|Ineligibility determined|3
155092|NCT00358215|499257|P1|Overall Study|Ineligibility determined|4
155093|NCT00358150|499271|P1|Overall Study|Undefined|3
155094|NCT00358150|499271|P1|Overall Study|Withdrawal by Subject|1
155095|NCT00358150|499271|P1|Overall Study|Adverse Event|3
155096|NCT00357994|499300|P2|Overall Study|Protocol Violation|0
155097|NCT00357994|499301|P1|Overall Study|Protocol Violation|1
155098|NCT00357994|499300|P2|Overall Study|Lack of Efficacy|1
155099|NCT00357994|499301|P1|Overall Study|Lack of Efficacy|0
155100|NCT00357994|499300|P2|Overall Study|Adverse Event|2
155101|NCT00357994|499301|P1|Overall Study|Adverse Event|1
155102|NCT00357968|499355|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
155103|NCT00357968|499356|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
155104|NCT00357968|499355|P2|First Maintenance Dose Phase|Not a PCI patient|42
155105|NCT00357968|499356|P1|First Maintenance Dose Phase|Not a PCI patient|47
155106|NCT00357903|499409|P2|Overall Study|Other|10
155107|NCT00357903|499410|P1|Overall Study|Other|49
155108|NCT00357903|499409|P2|Overall Study|Response status|9
155109|NCT00357903|499410|P1|Overall Study|Response status|61
155110|NCT00357903|499409|P2|Overall Study|Protocol issues|3
155111|NCT00357903|499410|P1|Overall Study|Protocol issues|14
155112|NCT00357903|499409|P2|Overall Study|Completed month 12 only|1
155113|NCT00357903|499410|P1|Overall Study|Completed month 12 only|0
155114|NCT00357903|499409|P2|Overall Study|Withdrawal by Subject|7
155115|NCT00357903|499410|P1|Overall Study|Withdrawal by Subject|57
155116|NCT00357903|499409|P2|Overall Study|Physician Decision|5
155117|NCT00357903|499410|P1|Overall Study|Physician Decision|39
155118|NCT00357903|499409|P2|Overall Study|Lost to Follow-up|4
155119|NCT00357903|499410|P1|Overall Study|Lost to Follow-up|23
155120|NCT00357903|499409|P2|Overall Study|Death|0
155121|NCT00357903|499410|P1|Overall Study|Death|33
155122|NCT00357903|499409|P2|Overall Study|Adverse Event|4
155123|NCT00357903|499410|P1|Overall Study|Adverse Event|87
155124|NCT00357552|499457|P1|Weeks 24 to 104|Not able to get to clinic|2
155125|NCT00357552|499457|P1|Weeks 24 to 104|Death|3
155126|NCT00357552|499457|P1|Weeks 0 to 24|Death|1
155127|NCT00357552|499457|P1|Screening|Did not meet eligibility criteria|84
155128|NCT00357500|499470|P1|Overall Study|Not Started Protocol Therapy|4
155129|NCT00357500|499470|P1|Overall Study|Progressive Disease|65
155130|NCT00357500|499470|P1|Overall Study|Withdrawal by Subject|5
155131|NCT00357500|499470|P1|Overall Study|Adverse Event|3
155132|NCT00357396|499479|P2|Overall Study|Adverse Event|0
155133|NCT00357396|499480|P1|Overall Study|Adverse Event|1
155134|NCT00357110|499495|P2|Overall Study|Early study termination|5
155135|NCT00357110|499496|P1|Overall Study|Early study termination|5
155136|NCT00357097|499504|P2|Overall Study|Increase of RLS Symptoms|1
155137|NCT00357097|499505|P1|Overall Study|Increase of RLS Symptoms|0
155138|NCT00357097|499504|P2|Overall Study|Other|1
155139|NCT00357097|499505|P1|Overall Study|Other|1
155140|NCT00357097|499504|P2|Overall Study|Met Exclusion Criteria|1
155141|NCT00357097|499505|P1|Overall Study|Met Exclusion Criteria|3
155142|NCT00357097|499504|P2|Overall Study|Lack of Efficacy|8
155143|NCT00357097|499505|P1|Overall Study|Lack of Efficacy|2
155144|NCT00357097|499504|P2|Overall Study|Non-compliance|2
155145|NCT00357097|499505|P1|Overall Study|Non-compliance|1
155146|NCT00357097|499504|P2|Overall Study|Withdrawal by Subject|7
155147|NCT00357097|499505|P1|Overall Study|Withdrawal by Subject|8
155148|NCT00357097|499504|P2|Overall Study|Adverse Event|6
155149|NCT00357097|499505|P1|Overall Study|Adverse Event|34
155150|NCT00357097|499504|P2|Overall Study|Did not meet inclusion criteria|3
155151|NCT00357097|499505|P1|Overall Study|Did not meet inclusion criteria|5
155152|NCT00357006|499557|P3|Overall Study|Withdrawal by Subject|2
155153|NCT00357006|499558|P2|Overall Study|Withdrawal by Subject|3
155154|NCT00357006|499559|P1|Overall Study|Withdrawal by Subject|1
155155|NCT00357006|499557|P3|Overall Study|Lost to Follow-up|1
155156|NCT00357006|499558|P2|Overall Study|Lost to Follow-up|2
155157|NCT00357006|499559|P1|Overall Study|Lost to Follow-up|1
155158|NCT00356915|499570|P3|Overall Study|Miscellaneous reasons|3
155159|NCT00356915|499571|P2|Overall Study|Miscellaneous reasons|8
155160|NCT00356915|499572|P1|Overall Study|Miscellaneous reasons|11
155161|NCT00356915|499570|P3|Overall Study|Adverse Event|8
155162|NCT00356915|499571|P2|Overall Study|Adverse Event|31
155163|NCT00356915|499572|P1|Overall Study|Adverse Event|21
155164|NCT00356915|499570|P3|Overall Study|Physician Decision|0
155165|NCT00356915|499571|P2|Overall Study|Physician Decision|2
155166|NCT00356915|499572|P1|Overall Study|Physician Decision|0
155167|NCT00356915|499570|P3|Overall Study|Administrative Decision|1
155168|NCT00356915|499571|P2|Overall Study|Administrative Decision|0
155169|NCT00356915|499572|P1|Overall Study|Administrative Decision|0
155170|NCT00356915|499570|P3|Overall Study|Lost to Follow-up|14
155171|NCT00356915|499571|P2|Overall Study|Lost to Follow-up|34
155172|NCT00356915|499572|P1|Overall Study|Lost to Follow-up|27
155173|NCT00356915|499570|P3|Overall Study|Lack of Efficacy|3
155174|NCT00356915|499571|P2|Overall Study|Lack of Efficacy|0
155175|NCT00356915|499572|P1|Overall Study|Lack of Efficacy|0
155176|NCT00356915|499570|P3|Overall Study|Withdrawal by Subject|10
155177|NCT00356915|499571|P2|Overall Study|Withdrawal by Subject|14
155178|NCT00356915|499572|P1|Overall Study|Withdrawal by Subject|14
155179|NCT00356915|499570|P3|Overall Study|Protocol Violation|2
155180|NCT00356915|499571|P2|Overall Study|Protocol Violation|3
155181|NCT00356915|499572|P1|Overall Study|Protocol Violation|2
155182|NCT00356915|499570|P3|Overall Study|Non compliance|1
155183|NCT00356915|499571|P2|Overall Study|Non compliance|2
155184|NCT00356915|499572|P1|Overall Study|Non compliance|1
155185|NCT00356889|499589|P1|Overall Study|Adverse Event|1
155186|NCT00356889|499589|P1|Overall Study|Protocol Violation|2
155187|NCT00356863|499598|P2|Overall Study|Lost to Follow-up|43
155188|NCT00356863|499599|P1|Overall Study|Lost to Follow-up|76
155189|NCT00356863|499598|P2|Overall Study|Death|32
155190|NCT00356863|499599|P1|Overall Study|Death|16
155191|NCT00356811|499625|P1|Overall Study|Site Closed during Follow-up|2
155192|NCT00356811|499625|P1|Overall Study|Study Is Terminating|3
155193|NCT00356811|499625|P1|Overall Study|Participant Could Not Make a Checkup|1
155194|NCT00356811|499625|P1|Overall Study|Withdrawal by Subject|6
155195|NCT00356811|499625|P1|Overall Study|Lost to Follow-up|2
155196|NCT00356811|499625|P1|Overall Study|Death|35
155197|NCT00356590|499638|P1|Overall Study|Other|52
155198|NCT00356590|499638|P1|Overall Study|Response status|28
155199|NCT00356590|499638|P1|Overall Study|Protocol issues|6
155200|NCT00356590|499638|P1|Overall Study|Completed month 12 only|2
155201|NCT00356590|499638|P1|Overall Study|Withdrawal by Subject|41
155202|NCT00356590|499638|P1|Overall Study|Physician Decision|46
155203|NCT00356590|499638|P1|Overall Study|Lost to Follow-up|35
155204|NCT00356590|499638|P1|Overall Study|Death|10
155205|NCT00356590|499638|P1|Overall Study|Adverse Event|54
155206|NCT00356525|499674|P4|Overall Study|Sponsor Decision|1
155207|NCT00356525|499675|P3|Overall Study|Sponsor Decision|0
155208|NCT00356525|499676|P2|Overall Study|Sponsor Decision|0
155209|NCT00356525|499677|P1|Overall Study|Sponsor Decision|0
155210|NCT00356525|499674|P4|Overall Study|Death|1
155211|NCT00356525|499675|P3|Overall Study|Death|0
155212|NCT00356525|499676|P2|Overall Study|Death|0
155213|NCT00356525|499677|P1|Overall Study|Death|0
155214|NCT00356525|499674|P4|Overall Study|Withdrawal by Subject|3
155215|NCT00356525|499675|P3|Overall Study|Withdrawal by Subject|0
155216|NCT00356525|499676|P2|Overall Study|Withdrawal by Subject|1
155217|NCT00356525|499677|P1|Overall Study|Withdrawal by Subject|1
155218|NCT00356525|499674|P4|Overall Study|Protocol Entry Criteria Not Met|0
155219|NCT00356525|499675|P3|Overall Study|Protocol Entry Criteria Not Met|0
155220|NCT00356525|499676|P2|Overall Study|Protocol Entry Criteria Not Met|0
155221|NCT00356525|499677|P1|Overall Study|Protocol Entry Criteria Not Met|1
155222|NCT00356525|499674|P4|Overall Study|Physician Decision|1
155223|NCT00356525|499675|P3|Overall Study|Physician Decision|2
155224|NCT00356525|499676|P2|Overall Study|Physician Decision|2
155225|NCT00356525|499677|P1|Overall Study|Physician Decision|2
155226|NCT00356525|499674|P4|Overall Study|Lost to Follow-up|0
155227|NCT00356525|499675|P3|Overall Study|Lost to Follow-up|0
155228|NCT00356525|499676|P2|Overall Study|Lost to Follow-up|0
155229|NCT00356525|499677|P1|Overall Study|Lost to Follow-up|1
155230|NCT00356525|499674|P4|Overall Study|Adverse Event|1
155231|NCT00356525|499675|P3|Overall Study|Adverse Event|1
155232|NCT00356525|499676|P2|Overall Study|Adverse Event|3
155233|NCT00356525|499677|P1|Overall Study|Adverse Event|1
155234|NCT00356525|499674|P4|Overall Study|Progressive Disease|2
155235|NCT00356525|499675|P3|Overall Study|Progressive Disease|4
155236|NCT00356525|499676|P2|Overall Study|Progressive Disease|5
155237|NCT00356525|499677|P1|Overall Study|Progressive Disease|8
155238|NCT00356421|499705|P2|Overall Study|Not related to study drug|3
155239|NCT00356421|499706|P1|Overall Study|Not related to study drug|5
155240|NCT00356421|499705|P2|Overall Study|Related to study drug|12
155241|NCT00356421|499706|P1|Overall Study|Related to study drug|15
155242|NCT00356421|499705|P2|Overall Study|Withdrawal by Subject|2
155243|NCT00356421|499706|P1|Overall Study|Withdrawal by Subject|9
155244|NCT00356421|499705|P2|Overall Study|Lack of Efficacy|0
155245|NCT00356421|499706|P1|Overall Study|Lack of Efficacy|3
155246|NCT00356408|499746|P1|Overall Study|Other: Subject chose commerical dosing|1
155247|NCT00356408|499746|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
155248|NCT00356408|499746|P1|Overall Study|Other: Azathioprine stopped|1
155249|NCT00356408|499746|P1|Overall Study|Other: Sponsor request|1
155250|NCT00356408|499746|P1|Overall Study|Other: Principal investigator discretion|3
155251|NCT00356408|499746|P1|Overall Study|Withdrawal by Subject|6
155252|NCT00356408|499746|P1|Overall Study|Lost to Follow-up|2
155253|NCT00356408|499746|P1|Overall Study|Lack of Efficacy|36
155254|NCT00356408|499746|P1|Overall Study|Adverse Event|9
155255|NCT00356278|499775|P3|Overall Study|Withdrawal by Subject|19
155256|NCT00356278|499776|P2|Overall Study|Withdrawal by Subject|15
155257|NCT00356278|499777|P1|Overall Study|Withdrawal by Subject|25
155258|NCT00356200|499814|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
155259|NCT00356200|499815|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
155260|NCT00356200|499814|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
155261|NCT00356200|499815|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
155262|NCT00356148|499829|P2|Overall Study|Reoperation within 30 days|1
155263|NCT00356148|499830|P1|Overall Study|Reoperation within 30 days|2
155264|NCT00356135|499841|P3|Overall Study|Subject non-compliance|3
155265|NCT00356135|499842|P2|Overall Study|Subject non-compliance|1
155266|NCT00356135|499843|P1|Overall Study|Subject non-compliance|1
155267|NCT00356135|499841|P3|Overall Study|Physician Decision|1
155268|NCT00356135|499842|P2|Overall Study|Physician Decision|1
155269|NCT00356135|499843|P1|Overall Study|Physician Decision|1
155270|NCT00356135|499841|P3|Overall Study|Lost to Follow-up|1
155271|NCT00356135|499842|P2|Overall Study|Lost to Follow-up|0
155272|NCT00356135|499843|P1|Overall Study|Lost to Follow-up|0
155273|NCT00356135|499841|P3|Overall Study|Adverse Event|0
155274|NCT00356135|499842|P2|Overall Study|Adverse Event|0
155275|NCT00356135|499843|P1|Overall Study|Adverse Event|1
155276|NCT00356135|499841|P3|Overall Study|Protocol Violation|0
155277|NCT00356135|499842|P2|Overall Study|Protocol Violation|0
155278|NCT00356135|499843|P1|Overall Study|Protocol Violation|1
155279|NCT00356122|499865|P1|FOLLOW-UP|Other|2
155280|NCT00356122|499865|P1|FOLLOW-UP|Lost to Follow-up|2
155281|NCT00356122|499865|P1|FOLLOW-UP|Death|37
155282|NCT00356122|499865|P1|TREATMENT|Did not receive study medication|1
155283|NCT00356122|499865|P1|TREATMENT|Other|4
155284|NCT00356122|499865|P1|TREATMENT|Subject's request|4
155285|NCT00356122|499865|P1|TREATMENT|Adverse Event|10
155286|NCT00356122|499865|P1|TREATMENT|Lack of Efficacy|26
155287|NCT00355784|499932|P3|Overall Study|Withdrawal by Subject|2
155288|NCT00355784|499933|P2|Overall Study|Withdrawal by Subject|0
155289|NCT00355784|499934|P1|Overall Study|Withdrawal by Subject|0
155290|NCT00355615|499983|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
155291|NCT00355615|499984|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
155292|NCT00355615|499985|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
155293|NCT00355615|499986|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
155294|NCT00355615|499987|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
155295|NCT00355615|499983|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
155296|NCT00355615|499984|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
155297|NCT00355615|499985|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
155298|NCT00355615|499986|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
155299|NCT00355615|499987|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
155300|NCT00355615|499983|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
155301|NCT00355615|499984|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
155302|NCT00355615|499985|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
155303|NCT00355615|499986|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
155304|NCT00355615|499987|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
155305|NCT00355615|499983|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
155306|NCT00355615|499984|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
155307|NCT00355615|499985|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
155308|NCT00355615|499986|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
155309|NCT00355615|499987|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
155310|NCT00355615|499983|P5|Randomized Double Blind Period|Protocol Violation|0
155311|NCT00355615|499984|P4|Randomized Double Blind Period|Protocol Violation|1
155312|NCT00355615|499985|P3|Randomized Double Blind Period|Protocol Violation|1
155313|NCT00355615|499986|P2|Randomized Double Blind Period|Protocol Violation|0
155314|NCT00355615|499987|P1|Randomized Double Blind Period|Protocol Violation|0
155315|NCT00355615|499983|P5|Randomized Double Blind Period|Adverse Event|0
155316|NCT00355615|499984|P4|Randomized Double Blind Period|Adverse Event|0
155317|NCT00355615|499985|P3|Randomized Double Blind Period|Adverse Event|0
155318|NCT00355615|499986|P2|Randomized Double Blind Period|Adverse Event|0
155319|NCT00355615|499987|P1|Randomized Double Blind Period|Adverse Event|1
155320|NCT00355472|500046|P1|Overall Study|Physician Decision|1
155321|NCT00355368|500092|P2|Overall Study|cardiac arrest prior to intubation|2
155322|NCT00355368|500093|P1|Overall Study|cardiac arrest prior to intubation|2
155323|NCT00355368|500092|P2|Overall Study|Protocol Violation|7
155324|NCT00355368|500093|P1|Overall Study|Protocol Violation|8
155325|NCT00355147|500107|P2|Overall Study|Withdrawal by Subject|12
155326|NCT00355147|500108|P1|Overall Study|Withdrawal by Subject|8
155327|NCT00355147|500107|P2|Overall Study|Lost to Follow-up|8
155328|NCT00355147|500108|P1|Overall Study|Lost to Follow-up|10
155329|NCT00355134|500127|P5|Extension Phase|Protocol Violation|0
155330|NCT00355134|500128|P4|Extension Phase|Protocol Violation|1
155331|NCT00355134|500129|P3|Extension Phase|Protocol Violation|0
155332|NCT00355134|500130|P2|Extension Phase|Protocol Violation|0
155333|NCT00355134|500131|P1|Extension Phase|Protocol Violation|0
155334|NCT00355134|500127|P5|Extension Phase|Abnormal test procedure result(s)|1
155335|NCT00355134|500128|P4|Extension Phase|Abnormal test procedure result(s)|0
155336|NCT00355134|500129|P3|Extension Phase|Abnormal test procedure result(s)|0
155337|NCT00355134|500130|P2|Extension Phase|Abnormal test procedure result(s)|1
155338|NCT00355134|500131|P1|Extension Phase|Abnormal test procedure result(s)|0
155339|NCT00355134|500127|P5|Extension Phase|Unsatisfactory therapeutic effect|1
155340|NCT00355134|500128|P4|Extension Phase|Unsatisfactory therapeutic effect|0
155341|NCT00355134|500129|P3|Extension Phase|Unsatisfactory therapeutic effect|0
155342|NCT00355134|500130|P2|Extension Phase|Unsatisfactory therapeutic effect|4
155343|NCT00355134|500131|P1|Extension Phase|Unsatisfactory therapeutic effect|3
155344|NCT00355134|500127|P5|Extension Phase|Administrative problems|1
155345|NCT00355134|500128|P4|Extension Phase|Administrative problems|1
155346|NCT00355134|500129|P3|Extension Phase|Administrative problems|0
155347|NCT00355134|500130|P2|Extension Phase|Administrative problems|4
155348|NCT00355134|500131|P1|Extension Phase|Administrative problems|2
155349|NCT00355134|500127|P5|Extension Phase|Abnormal laboratory value(s)|2
155350|NCT00355134|500128|P4|Extension Phase|Abnormal laboratory value(s)|2
155351|NCT00355134|500129|P3|Extension Phase|Abnormal laboratory value(s)|0
155352|NCT00355134|500130|P2|Extension Phase|Abnormal laboratory value(s)|2
155353|NCT00355134|500131|P1|Extension Phase|Abnormal laboratory value(s)|4
155354|NCT00355134|500127|P5|Extension Phase|Lost to Follow-up|4
155355|NCT00355134|500128|P4|Extension Phase|Lost to Follow-up|2
155356|NCT00355134|500129|P3|Extension Phase|Lost to Follow-up|0
155357|NCT00355134|500130|P2|Extension Phase|Lost to Follow-up|6
155358|NCT00355134|500131|P1|Extension Phase|Lost to Follow-up|2
155359|NCT00355134|500127|P5|Extension Phase|Adverse Event|5
155360|NCT00355134|500128|P4|Extension Phase|Adverse Event|3
155361|NCT00355134|500129|P3|Extension Phase|Adverse Event|0
155362|NCT00355134|500130|P2|Extension Phase|Adverse Event|9
155363|NCT00355134|500131|P1|Extension Phase|Adverse Event|13
155364|NCT00355134|500127|P5|Extension Phase|Withdrawal by Subject|5
155365|NCT00355134|500128|P4|Extension Phase|Withdrawal by Subject|7
155366|NCT00355134|500129|P3|Extension Phase|Withdrawal by Subject|0
155367|NCT00355134|500130|P2|Extension Phase|Withdrawal by Subject|11
155368|NCT00355134|500131|P1|Extension Phase|Withdrawal by Subject|7
155369|NCT00355134|500127|P5|Core Phase|Condition no longer requires study drug|0
155370|NCT00355134|500128|P4|Core Phase|Condition no longer requires study drug|0
155371|NCT00355134|500129|P3|Core Phase|Condition no longer requires study drug|1
155372|NCT00355134|500130|P2|Core Phase|Condition no longer requires study drug|0
155373|NCT00355134|500131|P1|Core Phase|Condition no longer requires study drug|1
155374|NCT00355134|500127|P5|Core Phase|Abnormal test procedure result(s)|0
155375|NCT00355134|500128|P4|Core Phase|Abnormal test procedure result(s)|0
155376|NCT00355134|500129|P3|Core Phase|Abnormal test procedure result(s)|1
155377|NCT00355134|500130|P2|Core Phase|Abnormal test procedure result(s)|2
155378|NCT00355134|500131|P1|Core Phase|Abnormal test procedure result(s)|1
155379|NCT00355134|500127|P5|Core Phase|Protocol Violation|0
155380|NCT00355134|500128|P4|Core Phase|Protocol Violation|0
155381|NCT00355134|500129|P3|Core Phase|Protocol Violation|2
155382|NCT00355134|500130|P2|Core Phase|Protocol Violation|2
155383|NCT00355134|500131|P1|Core Phase|Protocol Violation|3
155384|NCT00355134|500127|P5|Core Phase|Administrative problems|0
155385|NCT00355134|500128|P4|Core Phase|Administrative problems|0
155386|NCT00355134|500129|P3|Core Phase|Administrative problems|5
155387|NCT00355134|500130|P2|Core Phase|Administrative problems|3
155388|NCT00355134|500131|P1|Core Phase|Administrative problems|5
155389|NCT00355134|500127|P5|Core Phase|Unsatisfactory therapeutic effect|0
155390|NCT00355134|500128|P4|Core Phase|Unsatisfactory therapeutic effect|0
155391|NCT00355134|500129|P3|Core Phase|Unsatisfactory therapeutic effect|17
155392|NCT00355134|500130|P2|Core Phase|Unsatisfactory therapeutic effect|6
155393|NCT00355134|500131|P1|Core Phase|Unsatisfactory therapeutic effect|10
155394|NCT00355134|500127|P5|Core Phase|Abnormal laboratory value(s)|0
155395|NCT00355134|500128|P4|Core Phase|Abnormal laboratory value(s)|0
155396|NCT00355134|500129|P3|Core Phase|Abnormal laboratory value(s)|2
155397|NCT00355134|500130|P2|Core Phase|Abnormal laboratory value(s)|14
155398|NCT00355134|500131|P1|Core Phase|Abnormal laboratory value(s)|19
155399|NCT00355134|500127|P5|Core Phase|Lost to Follow-up|0
155400|NCT00355134|500128|P4|Core Phase|Lost to Follow-up|0
155401|NCT00355134|500129|P3|Core Phase|Lost to Follow-up|21
155402|NCT00355134|500130|P2|Core Phase|Lost to Follow-up|13
155403|NCT00355134|500131|P1|Core Phase|Lost to Follow-up|17
155404|NCT00355134|500127|P5|Core Phase|Adverse Event|0
155405|NCT00355134|500128|P4|Core Phase|Adverse Event|0
155406|NCT00355134|500129|P3|Core Phase|Adverse Event|16
155407|NCT00355134|500130|P2|Core Phase|Adverse Event|22
155408|NCT00355134|500131|P1|Core Phase|Adverse Event|28
155409|NCT00355134|500127|P5|Core Phase|Withdrawal by Subject|0
155410|NCT00355134|500128|P4|Core Phase|Withdrawal by Subject|0
155411|NCT00355134|500129|P3|Core Phase|Withdrawal by Subject|35
155412|NCT00355134|500130|P2|Core Phase|Withdrawal by Subject|24
155413|NCT00355134|500131|P1|Core Phase|Withdrawal by Subject|35
155414|NCT00355121|500174|P3|Overall Study|Serious adverse events|0
155415|NCT00355121|500175|P2|Overall Study|Serious adverse events|2
155416|NCT00355121|500176|P1|Overall Study|Serious adverse events|0
155417|NCT00355121|500174|P3|Overall Study|Withdrawal by Subject|2
155418|NCT00355121|500175|P2|Overall Study|Withdrawal by Subject|10
155419|NCT00355121|500176|P1|Overall Study|Withdrawal by Subject|9
155420|NCT00355121|500174|P3|Overall Study|Lost to Follow-up|1
155421|NCT00355121|500175|P2|Overall Study|Lost to Follow-up|7
155422|NCT00355121|500176|P1|Overall Study|Lost to Follow-up|4
155423|NCT00355121|500174|P3|Overall Study|Protocol Violation|1
155424|NCT00355121|500175|P2|Overall Study|Protocol Violation|9
155425|NCT00355121|500176|P1|Overall Study|Protocol Violation|7
155426|NCT00355121|500174|P3|Overall Study|Adverse Event|0
155427|NCT00355121|500175|P2|Overall Study|Adverse Event|1
155428|NCT00355121|500176|P1|Overall Study|Adverse Event|0
155429|NCT00355121|500174|P3|Overall Study|Did not receive study vaccine|1
155430|NCT00355121|500175|P2|Overall Study|Did not receive study vaccine|0
155431|NCT00355121|500176|P1|Overall Study|Did not receive study vaccine|1
155432|NCT00355082|500207|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
155433|NCT00355082|500208|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
155434|NCT00355082|500209|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
155435|NCT00355082|500207|P3|Continuation Phase|Scheduling Error|0
155436|NCT00355082|500208|P2|Continuation Phase|Scheduling Error|0
155437|NCT00355082|500209|P1|Continuation Phase|Scheduling Error|1
155438|NCT00355082|500207|P3|Continuation Phase|Site Closed by Sponsor|0
155439|NCT00355082|500208|P2|Continuation Phase|Site Closed by Sponsor|0
155440|NCT00355082|500209|P1|Continuation Phase|Site Closed by Sponsor|8
155441|NCT00355082|500207|P3|Continuation Phase|Lack of Efficacy|0
155442|NCT00355082|500208|P2|Continuation Phase|Lack of Efficacy|0
155443|NCT00355082|500209|P1|Continuation Phase|Lack of Efficacy|5
155444|NCT00355082|500207|P3|Continuation Phase|Withdrawal by Subject|0
155445|NCT00355082|500208|P2|Continuation Phase|Withdrawal by Subject|0
155446|NCT00355082|500209|P1|Continuation Phase|Withdrawal by Subject|4
155447|NCT00355082|500207|P3|Continuation Phase|Protocol Violation|1
155448|NCT00355082|500208|P2|Continuation Phase|Protocol Violation|0
155449|NCT00355082|500209|P1|Continuation Phase|Protocol Violation|1
155450|NCT00355082|500207|P3|Continuation Phase|Lost to Follow-up|1
155451|NCT00355082|500208|P2|Continuation Phase|Lost to Follow-up|0
155452|NCT00355082|500209|P1|Continuation Phase|Lost to Follow-up|2
155453|NCT00355082|500207|P3|Continuation Phase|Adverse Event|1
155454|NCT00355082|500208|P2|Continuation Phase|Adverse Event|0
155455|NCT00355082|500209|P1|Continuation Phase|Adverse Event|2
155456|NCT00355082|500207|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
155457|NCT00355082|500208|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
155458|NCT00355082|500209|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
155459|NCT00355082|500207|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
155460|NCT00355082|500208|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
155461|NCT00355082|500209|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
155462|NCT00355082|500207|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
155463|NCT00355082|500208|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
155464|NCT00355082|500209|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
155465|NCT00355082|500207|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
155466|NCT00355082|500208|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
155467|NCT00355082|500209|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
155468|NCT00355082|500207|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
155469|NCT00355082|500208|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
155470|NCT00355082|500209|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
155471|NCT00355082|500207|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
155472|NCT00355082|500208|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
155473|NCT00355082|500209|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
155474|NCT00355030|500231|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
155475|NCT00355030|500232|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
155476|NCT00355030|500231|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
155477|NCT00355030|500232|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
155478|NCT00355030|500231|P2|Study Period 1 Treatment|Other|6
155479|NCT00355030|500232|P1|Study Period 1 Treatment|Other|2
155480|NCT00355030|500231|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
155481|NCT00355030|500232|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
155482|NCT00355030|500231|P2|Study Period 1 Treatment|Sponsor Decision|32
155483|NCT00355030|500232|P1|Study Period 1 Treatment|Sponsor Decision|34
155484|NCT00355030|500231|P2|Study Period 1 Treatment|Physician Decision|1
155485|NCT00355030|500232|P1|Study Period 1 Treatment|Physician Decision|0
155486|NCT00355030|500231|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
155487|NCT00355030|500232|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
155488|NCT00355030|500231|P2|Study Period 1 Treatment|Withdrawal by Subject|1
155489|NCT00355030|500232|P1|Study Period 1 Treatment|Withdrawal by Subject|4
155490|NCT00355030|500231|P2|Study Period 1 Treatment|Lost to Follow-up|0
155491|NCT00355030|500232|P1|Study Period 1 Treatment|Lost to Follow-up|3
155492|NCT00355030|500231|P2|Study Period 1 Treatment|Adverse Event|1
155493|NCT00355030|500232|P1|Study Period 1 Treatment|Adverse Event|1
155494|NCT00354744|500278|P1|Overall Study|Withdrawal by Subject|14
155495|NCT00354744|500278|P1|Overall Study|Physician Decision|11
155496|NCT00354744|500278|P1|Overall Study|Lost to Follow-up|2
155497|NCT00354744|500278|P1|Overall Study|Lack of Efficacy|11
155498|NCT00354744|500278|P1|Overall Study|Death|2
155499|NCT00354744|500278|P1|Overall Study|Adverse Event|2
155500|NCT00354679|500283|P1|Overall Study|Patient Not Treated|1
155501|NCT00354601|500292|P1|Overall Study|progression|1
155502|NCT00354601|500292|P1|Overall Study|Protocol Violation|1
155503|NCT00354341|500310|P2|Overall Study|Unspecified|2
155504|NCT00354341|500311|P1|Overall Study|Unspecified|1
155505|NCT00354341|500310|P2|Overall Study|Failure to return|1
155506|NCT00354341|500311|P1|Overall Study|Failure to return|0
155507|NCT00354341|500310|P2|Overall Study|Refused treatment|2
155508|NCT00354341|500311|P1|Overall Study|Refused treatment|1
155509|NCT00354341|500310|P2|Overall Study|Death|2
155510|NCT00354341|500311|P1|Overall Study|Death|0
155511|NCT00354341|500310|P2|Overall Study|Adverse Event|0
155512|NCT00354341|500311|P1|Overall Study|Adverse Event|1
155513|NCT00354172|500327|P1|Overall Study|Did not receive transplant|1
155514|NCT00354159|500347|P2|Long-term Follow-up|Study Closed|34
155515|NCT00354159|500348|P1|Long-term Follow-up|Study Closed|29
155516|NCT00354159|500347|P2|Long-term Follow-up|Death|11
155517|NCT00354159|500348|P1|Long-term Follow-up|Death|14
155518|NCT00354159|500347|P2|Long-term Follow-up|Lost to Follow-up|0
155519|NCT00354159|500348|P1|Long-term Follow-up|Lost to Follow-up|1
155520|NCT00354159|500347|P2|Long-term Follow-up|Physician Decision|122
155521|NCT00354159|500348|P1|Long-term Follow-up|Physician Decision|127
155522|NCT00354159|500347|P2|Long-term Follow-up|Withdrawal by Subject|9
155523|NCT00354159|500348|P1|Long-term Follow-up|Withdrawal by Subject|9
155524|NCT00354159|500347|P2|Randomized Study Period|Death|9
155525|NCT00354159|500348|P1|Randomized Study Period|Death|7
155526|NCT00354159|500347|P2|Randomized Study Period|Lost to Follow-up|0
155527|NCT00354159|500348|P1|Randomized Study Period|Lost to Follow-up|4
155528|NCT00354159|500347|P2|Randomized Study Period|Physician Decision|10
155529|NCT00354159|500348|P1|Randomized Study Period|Physician Decision|6
155530|NCT00354159|500347|P2|Randomized Study Period|Withdrawal by Subject|3
155531|NCT00354159|500348|P1|Randomized Study Period|Withdrawal by Subject|5
155532|NCT00354107|500391|P1|Overall Study|Withdrawal by Subject|1
155533|NCT00354107|500391|P1|Overall Study|Physician Decision|2
155534|NCT00354107|500391|P1|Overall Study|Adverse Event|2
155535|NCT00354029|500397|P2|Overall Study|Protocol Violation|2
155536|NCT00354029|500398|P1|Overall Study|Protocol Violation|4
155537|NCT00353704|500414|P2|Overall Study|Protocol Violation|1
155538|NCT00353704|500415|P1|Overall Study|Protocol Violation|3
155539|NCT00353496|500450|P2|Overall Study|Not otherwise specified|2
155540|NCT00353496|500451|P1|Overall Study|Not otherwise specified|4
155541|NCT00353496|500450|P2|Overall Study|Physician Decision|9
155542|NCT00353496|500451|P1|Overall Study|Physician Decision|6
155543|NCT00353496|500450|P2|Overall Study|Withdrawal by Subject|4
155544|NCT00353496|500451|P1|Overall Study|Withdrawal by Subject|3
155545|NCT00353496|500450|P2|Overall Study|Protocol Violation|2
155546|NCT00353496|500451|P1|Overall Study|Protocol Violation|2
155547|NCT00353496|500450|P2|Overall Study|Adverse Event|0
155548|NCT00353496|500451|P1|Overall Study|Adverse Event|1
155549|NCT00353366|500504|P1|Overall Study|Unspecified|135
155550|NCT00353366|500504|P1|Overall Study|Adverse Event|8
155551|NCT00353262|500525|P1|Overall Study|Break from Chemotherapy|1
155552|NCT00353262|500525|P1|Overall Study|Surgery|4
155553|NCT00353262|500525|P1|Overall Study|Progression|1
155554|NCT00353262|500525|P1|Overall Study|Insufficient Therapeutic Response|13
155555|NCT00353262|500525|P1|Overall Study|Withdrawal by Subject|2
155556|NCT00353262|500525|P1|Overall Study|Adverse Event|8
155557|NCT00352118|500542|P1|Overall Study|Physician Decision|4
155558|NCT00352105|500552|P1|Overall Study|Protocol Violation|2
155559|NCT00352105|500552|P1|Overall Study|Adverse Event|19
155560|NCT00352105|500552|P1|Overall Study|Lack of Efficacy|9
155561|NCT00352105|500552|P1|Overall Study|Withdrawal by Subject|5
155562|NCT00352105|500552|P1|Overall Study|Death|5
155563|NCT00352053|500563|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
155564|NCT00352053|500564|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
155565|NCT00352053|500563|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
155566|NCT00352053|500564|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
155567|NCT00352053|500563|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
155568|NCT00352053|500564|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
155569|NCT00352053|500563|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
155570|NCT00352053|500564|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
155571|NCT00352053|500563|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
155572|NCT00352053|500564|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
155573|NCT00352053|500563|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
155574|NCT00352053|500564|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
155575|NCT00352053|500563|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
155576|NCT00352053|500564|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
155577|NCT00352053|500563|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
155578|NCT00352053|500564|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
155579|NCT00352053|500563|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
155580|NCT00352053|500564|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
155581|NCT00352053|500563|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
155582|NCT00352053|500564|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
155583|NCT00352053|500563|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
155584|NCT00352053|500564|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
155585|NCT00352053|500563|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
155586|NCT00352053|500564|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
155587|NCT00352053|500563|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
155588|NCT00352053|500564|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
155589|NCT00352027|500731|P1|Overall Study|Progressive disease|3
155590|NCT00352846|501033|P2|Overall Study|Death|1
155591|NCT00352846|501034|P1|Overall Study|Death|0
155592|NCT00352846|501033|P2|Overall Study|Non-compliance|0
155593|NCT00352846|501034|P1|Overall Study|Non-compliance|2
155594|NCT00352846|501033|P2|Overall Study|Ineligible|2
155595|NCT00352846|501034|P1|Overall Study|Ineligible|3
155596|NCT00352846|501033|P2|Overall Study|Withdrawal by Subject|8
155597|NCT00352846|501034|P1|Overall Study|Withdrawal by Subject|3
155598|NCT00352846|501033|P2|Overall Study|Disease progression|2
155599|NCT00352846|501034|P1|Overall Study|Disease progression|0
155600|NCT00352755|501045|P1|Overall Study|Adverse Event|1
155601|NCT00352755|501045|P1|Overall Study|Physician Decision|1
155602|NCT00352690|501055|P2|Overall Study|Determined to be ineligible|0
155603|NCT00352690|501056|P1|Overall Study|Determined to be ineligible|2
155604|NCT00352664|501076|P2|Overall Study|Withdrawal by Subject|0
155605|NCT00352664|501077|P1|Overall Study|Withdrawal by Subject|7
155606|NCT00352417|501094|P2|Overall Study|Schedule Change|1
155607|NCT00352417|501095|P1|Overall Study|Schedule Change|2
155608|NCT00352417|501094|P2|Overall Study|Lost to Follow-up|0
155609|NCT00352417|501095|P1|Overall Study|Lost to Follow-up|1
155610|NCT00352417|501094|P2|Overall Study|Withdrawal by Subject|2
155611|NCT00352417|501095|P1|Overall Study|Withdrawal by Subject|1
155612|NCT00352417|501094|P2|Overall Study|Protocol Violation|2
155613|NCT00352417|501095|P1|Overall Study|Protocol Violation|0
155614|NCT00352417|501094|P2|Overall Study|Adverse Event|0
155615|NCT00352417|501095|P1|Overall Study|Adverse Event|1
155616|NCT00352365|501109|P1|Maintenance Therapy|Not eligible|4
155617|NCT00352365|501109|P1|Maintenance Therapy|Not protocol specified|3
155618|NCT00352365|501109|P1|Maintenance Therapy|Death|2
155619|NCT00352365|501109|P1|Maintenance Therapy|Progression/Relapse|3
155620|NCT00352365|501109|P1|Induction Therapy|Death before starting protocol therapy|1
155621|NCT00352365|501109|P1|Induction Therapy|Not eligible|3
155622|NCT00352365|501109|P1|Induction Therapy|Not protocol specified|1
155623|NCT00352365|501109|P1|Induction Therapy|Death|7
155624|NCT00352365|501109|P1|Induction Therapy|Progression/Relapse|8
155625|NCT00352365|501109|P1|Induction Therapy|Adverse Event|7
155626|NCT00351533|501159|P2|Overall Study|Withdrawal by Subject|1
155627|NCT00351533|501160|P1|Overall Study|Withdrawal by Subject|0
155628|NCT00351533|501159|P2|Overall Study|Physician Decision|1
155629|NCT00351533|501160|P1|Overall Study|Physician Decision|0
155630|NCT00351533|501159|P2|Overall Study|Lost to Follow-up|3
155631|NCT00351533|501160|P1|Overall Study|Lost to Follow-up|1
155632|NCT00351533|501159|P2|Overall Study|Extubated before first BAL|0
155633|NCT00351533|501160|P1|Overall Study|Extubated before first BAL|1
155634|NCT00351377|501220|P1|Overall Study|Unsatisfactory therapeutic effect|1
155635|NCT00351377|501220|P1|Overall Study|Death|1
155636|NCT00351377|501220|P1|Overall Study|Adverse Event|5
155637|NCT00351351|501234|P2|Overall Study|surgical access pbs; device issues|4
155638|NCT00351351|501235|P1|Overall Study|surgical access pbs; device issues|9
155639|NCT00351273|501244|P3|Overall Study|Lost to Follow-up|5
155640|NCT00351273|501245|P2|Overall Study|Lost to Follow-up|2
155641|NCT00351273|501246|P1|Overall Study|Lost to Follow-up|1
155642|NCT00350870|501274|P4|Overall Study|Physician Decision|1
155643|NCT00350870|501275|P3|Overall Study|Physician Decision|1
155644|NCT00350870|501276|P2|Overall Study|Physician Decision|0
155645|NCT00350870|501277|P1|Overall Study|Physician Decision|1
155646|NCT00350870|501274|P4|Overall Study|Withdrawal by Subject|14
155647|NCT00350870|501275|P3|Overall Study|Withdrawal by Subject|15
155648|NCT00350870|501276|P2|Overall Study|Withdrawal by Subject|17
155649|NCT00350870|501277|P1|Overall Study|Withdrawal by Subject|21
155650|NCT00350844|501291|P1|Overall Study|Lost to Follow-up|1
155651|NCT00350792|501295|P1|Overall Study|Lack of Efficacy|11
155652|NCT00350792|501295|P1|Overall Study|Physician Decision|2
155653|NCT00350792|501295|P1|Overall Study|Withdrawal by Subject|4
155654|NCT00350792|501295|P1|Overall Study|Protocol Violation|1
155655|NCT00350792|501295|P1|Overall Study|Death Not Study Drug Related|2
155656|NCT00350792|501295|P1|Overall Study|Death from Study Drug Toxicity|1
155657|NCT00350792|501295|P1|Overall Study|Death from Study Disease|1
155658|NCT00350792|501295|P1|Overall Study|Adverse Event|11
155659|NCT00350779|501305|P2|Overall Study|Non-compliance with study procedures|1
155660|NCT00350779|501306|P1|Overall Study|Non-compliance with study procedures|0
155661|NCT00350779|501305|P2|Overall Study|Patient Moved|1
155662|NCT00350779|501306|P1|Overall Study|Patient Moved|2
155663|NCT00350779|501305|P2|Overall Study|Withdrawal by Subject|8
155664|NCT00350779|501306|P1|Overall Study|Withdrawal by Subject|9
155665|NCT00350779|501305|P2|Overall Study|Protocol Violation|1
155666|NCT00350779|501306|P1|Overall Study|Protocol Violation|3
155667|NCT00350779|501305|P2|Overall Study|Physician Decision|4
155668|NCT00350779|501306|P1|Overall Study|Physician Decision|2
155669|NCT00350779|501305|P2|Overall Study|Lost to Follow-up|0
155670|NCT00350779|501306|P1|Overall Study|Lost to Follow-up|2
155671|NCT00350779|501305|P2|Overall Study|Lack of Efficacy|4
155672|NCT00350779|501306|P1|Overall Study|Lack of Efficacy|0
155673|NCT00350779|501305|P2|Overall Study|Adverse Event|2
155674|NCT00350779|501306|P1|Overall Study|Adverse Event|4
155675|NCT00350727|501327|P3|Phase II|Enrolled in Rollover Study|1
155676|NCT00350727|501328|P2|Phase II|Enrolled in Rollover Study|0
155677|NCT00350727|501329|P1|Phase II|Enrolled in Rollover Study|0
155678|NCT00350727|501327|P3|Phase II|Sponsor Terminated Study|1
155679|NCT00350727|501328|P2|Phase II|Sponsor Terminated Study|0
155680|NCT00350727|501329|P1|Phase II|Sponsor Terminated Study|0
155681|NCT00350727|501327|P3|Phase II|Death|2
155682|NCT00350727|501328|P2|Phase II|Death|0
155683|NCT00350727|501329|P1|Phase II|Death|0
155684|NCT00350727|501327|P3|Phase II|Adverse Event|1
155685|NCT00350727|501328|P2|Phase II|Adverse Event|1
155686|NCT00350727|501329|P1|Phase II|Adverse Event|0
155687|NCT00350727|501327|P3|Phase II|Withdrawal by Subject|1
155688|NCT00350727|501328|P2|Phase II|Withdrawal by Subject|2
155689|NCT00350727|501329|P1|Phase II|Withdrawal by Subject|0
155690|NCT00350727|501327|P3|Phase II|Clinical Deterioration|0
155691|NCT00350727|501328|P2|Phase II|Clinical Deterioration|1
155692|NCT00350727|501329|P1|Phase II|Clinical Deterioration|0
155693|NCT00350727|501327|P3|Phase II|Disease Progression|16
155694|NCT00350727|501328|P2|Phase II|Disease Progression|15
155695|NCT00350727|501329|P1|Phase II|Disease Progression|0
155696|NCT00350727|501327|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
155697|NCT00350727|501328|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
155698|NCT00350727|501329|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
155699|NCT00350727|501327|P3|Phase I: Dose Escalation|Physician Decision|0
155700|NCT00350727|501328|P2|Phase I: Dose Escalation|Physician Decision|0
155701|NCT00350727|501329|P1|Phase I: Dose Escalation|Physician Decision|1
155702|NCT00350727|501327|P3|Phase I: Dose Escalation|Death|0
155703|NCT00350727|501328|P2|Phase I: Dose Escalation|Death|0
155704|NCT00350727|501329|P1|Phase I: Dose Escalation|Death|1
155705|NCT00350727|501327|P3|Phase I: Dose Escalation|Lack of Efficacy|0
155706|NCT00350727|501328|P2|Phase I: Dose Escalation|Lack of Efficacy|0
155707|NCT00350727|501329|P1|Phase I: Dose Escalation|Lack of Efficacy|25
155708|NCT00350727|501327|P3|Phase I: Dose Escalation|Adverse Event|0
155709|NCT00350727|501328|P2|Phase I: Dose Escalation|Adverse Event|0
155710|NCT00350727|501329|P1|Phase I: Dose Escalation|Adverse Event|4
155711|NCT00350636|501473|P2|Overall Study|Other|2
155712|NCT00350636|501474|P1|Overall Study|Other|1
155713|NCT00350636|501473|P2|Overall Study|Physician Decision|2
155714|NCT00350636|501474|P1|Overall Study|Physician Decision|0
155715|NCT00350636|501473|P2|Overall Study|Lost to Follow-up|8
155716|NCT00350636|501474|P1|Overall Study|Lost to Follow-up|9
155717|NCT00350636|501473|P2|Overall Study|Withdrawal by Subject|17
155718|NCT00350636|501474|P1|Overall Study|Withdrawal by Subject|13
155719|NCT00350636|501473|P2|Overall Study|Protocol Violation|3
155720|NCT00350636|501474|P1|Overall Study|Protocol Violation|1
155721|NCT00350636|501473|P2|Overall Study|Adverse Event|13
155722|NCT00350636|501474|P1|Overall Study|Adverse Event|19
155723|NCT00350623|501493|P3|Overall Study|patient traveling outside the country|1
155724|NCT00350623|501494|P2|Overall Study|patient traveling outside the country|0
155725|NCT00350623|501495|P1|Overall Study|patient traveling outside the country|0
155726|NCT00350623|501493|P3|Overall Study|Withdrawal by Subject|1
155727|NCT00350623|501494|P2|Overall Study|Withdrawal by Subject|1
155728|NCT00350623|501495|P1|Overall Study|Withdrawal by Subject|0
155729|NCT00350623|501493|P3|Overall Study|Lost to Follow-up|4
155730|NCT00350623|501494|P2|Overall Study|Lost to Follow-up|3
155731|NCT00350623|501495|P1|Overall Study|Lost to Follow-up|8
155732|NCT00350519|501514|P2|Overall Study|Withdrawal by Subject|2
155733|NCT00350519|501515|P1|Overall Study|Withdrawal by Subject|3
155734|NCT00350519|501514|P2|Overall Study|Protocol Violation|2
155735|NCT00350519|501515|P1|Overall Study|Protocol Violation|1
155736|NCT00350519|501514|P2|Overall Study|Physician Decision|1
155737|NCT00350519|501515|P1|Overall Study|Physician Decision|0
155738|NCT00350519|501514|P2|Overall Study|Death|1
155739|NCT00350519|501515|P1|Overall Study|Death|0
155740|NCT00350402|501529|P2|Overall Study|Lost to Follow-up|1
155741|NCT00350402|501530|P1|Overall Study|Lost to Follow-up|1
155742|NCT00350272|501548|P2|Open-Label 84 Week Treatment|Sponsor decision|1
155743|NCT00350272|501549|P1|Open-Label 84 Week Treatment|Sponsor decision|2
155744|NCT00350272|501548|P2|Open-Label 84 Week Treatment|Physician Decision|2
155745|NCT00350272|501549|P1|Open-Label 84 Week Treatment|Physician Decision|1
155746|NCT00350272|501548|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
155747|NCT00350272|501549|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
155748|NCT00350272|501548|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
155749|NCT00350272|501549|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
155750|NCT00350272|501548|P2|Open-Label 84 Week Treatment|Adverse Event|1
155751|NCT00350272|501549|P1|Open-Label 84 Week Treatment|Adverse Event|2
155752|NCT00350272|501548|P2|Blinded 12 Week Treatment|Sponsor decision|1
155753|NCT00350272|501549|P1|Blinded 12 Week Treatment|Sponsor decision|0
155754|NCT00350272|501548|P2|Blinded 12 Week Treatment|Physician Decision|1
155755|NCT00350272|501549|P1|Blinded 12 Week Treatment|Physician Decision|2
155756|NCT00350272|501548|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
155757|NCT00350272|501549|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
155758|NCT00350272|501548|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
155759|NCT00350272|501549|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
155760|NCT00350272|501548|P2|Blinded 12 Week Treatment|Death|0
155761|NCT00350272|501549|P1|Blinded 12 Week Treatment|Death|1
155762|NCT00350272|501548|P2|Blinded 12 Week Treatment|Adverse Event|0
155763|NCT00350272|501549|P1|Blinded 12 Week Treatment|Adverse Event|1
155764|NCT00348374|501559|P2|Overall Study|randomized but did not receive treatment|7
155765|NCT00348374|501560|P1|Overall Study|randomized but did not receive treatment|0
155766|NCT00348374|501559|P2|Overall Study|ongoing at date of cutoff|1
155767|NCT00348374|501560|P1|Overall Study|ongoing at date of cutoff|1
155768|NCT00348374|501559|P2|Overall Study|Other|12
155769|NCT00348374|501560|P1|Overall Study|Other|11
155770|NCT00348374|501559|P2|Overall Study|Withdrawal by Subject|5
155771|NCT00348374|501560|P1|Overall Study|Withdrawal by Subject|5
155772|NCT00348374|501559|P2|Overall Study|Lost to Follow-up|3
155773|NCT00348374|501560|P1|Overall Study|Lost to Follow-up|1
155774|NCT00348374|501559|P2|Overall Study|Adverse Event|4
155775|NCT00348374|501560|P1|Overall Study|Adverse Event|1
155776|NCT00348348|501607|P2|Overall Study|Adverse event probably related to study|0
155777|NCT00348348|501608|P1|Overall Study|Adverse event probably related to study|1
155778|NCT00348348|501607|P2|Overall Study|Worsening of BC - Unlikely related|2
155779|NCT00348348|501608|P1|Overall Study|Worsening of BC - Unlikely related|1
155780|NCT00348348|501607|P2|Overall Study|Worsening of BC - Unrelated to study|3
155781|NCT00348348|501608|P1|Overall Study|Worsening of BC - Unrelated to study|0
155782|NCT00348348|501607|P2|Overall Study|Dissallowed Meds - possibly releated|1
155783|NCT00348348|501608|P1|Overall Study|Dissallowed Meds - possibly releated|1
155784|NCT00348348|501607|P2|Overall Study|Dissallowed Meds - unlikley related|1
155785|NCT00348348|501608|P1|Overall Study|Dissallowed Meds - unlikley related|1
155786|NCT00348348|501607|P2|Overall Study|Dissallowed Meds - unrelated to study|3
155787|NCT00348348|501608|P1|Overall Study|Dissallowed Meds - unrelated to study|1
155788|NCT00348348|501607|P2|Overall Study|Not specified|4
155789|NCT00348348|501608|P1|Overall Study|Not specified|7
155790|NCT00348348|501607|P2|Overall Study|Withdrawal by Subject|1
155791|NCT00348348|501608|P1|Overall Study|Withdrawal by Subject|4
155792|NCT00348348|501607|P2|Overall Study|Lost to Follow-up|10
155793|NCT00348348|501608|P1|Overall Study|Lost to Follow-up|8
155794|NCT00348348|501607|P2|Overall Study|Lack of Efficacy|1
155795|NCT00348348|501608|P1|Overall Study|Lack of Efficacy|1
155796|NCT00348348|501607|P2|Overall Study|Adverse event - unrelated to study drug|1
155797|NCT00348348|501608|P1|Overall Study|Adverse event - unrelated to study drug|0
155798|NCT00348283|501622|P2|Open Label|Sponsor decision|1
155799|NCT00348283|501623|P1|Open Label|Sponsor decision|0
155800|NCT00348283|501622|P2|Open Label|Pregnancy|1
155801|NCT00348283|501623|P1|Open Label|Pregnancy|0
155802|NCT00348283|501622|P2|Open Label|Subject moved to the United States|1
155803|NCT00348283|501623|P1|Open Label|Subject moved to the United States|0
155804|NCT00348283|501622|P2|Open Label|Administrative reasons|5
155805|NCT00348283|501623|P1|Open Label|Administrative reasons|0
155806|NCT00348283|501622|P2|Open Label|Lack of Efficacy|13
155807|NCT00348283|501623|P1|Open Label|Lack of Efficacy|0
155808|NCT00348283|501622|P2|Open Label|Lost to Follow-up|1
155809|NCT00348283|501623|P1|Open Label|Lost to Follow-up|0
155810|NCT00348283|501622|P2|Open Label|Withdrawal by Subject|4
155811|NCT00348283|501623|P1|Open Label|Withdrawal by Subject|0
155812|NCT00348283|501622|P2|Open Label|Adverse Event|8
155813|NCT00348283|501623|P1|Open Label|Adverse Event|0
155814|NCT00348283|501622|P2|Double Blind|Pregnancy|1
155815|NCT00348283|501623|P1|Double Blind|Pregnancy|0
155816|NCT00348283|501622|P2|Double Blind|Lack of Efficacy|2
155817|NCT00348283|501623|P1|Double Blind|Lack of Efficacy|2
155818|NCT00348283|501622|P2|Double Blind|Protocol Violation|1
155819|NCT00348283|501623|P1|Double Blind|Protocol Violation|0
155820|NCT00348283|501622|P2|Double Blind|Withdrawal by Subject|1
155821|NCT00348283|501623|P1|Double Blind|Withdrawal by Subject|1
155822|NCT00348283|501622|P2|Double Blind|Adverse Event|5
155823|NCT00348283|501623|P1|Double Blind|Adverse Event|2
155824|NCT00348283|501622|P2|Induction|Protocol Violation|4
155825|NCT00348283|501623|P1|Induction|Protocol Violation|0
155826|NCT00348283|501622|P2|Induction|Adverse Event|2
155827|NCT00348283|501623|P1|Induction|Adverse Event|0
155828|NCT00350207|501653|P3|Overall Study|Other|1
155829|NCT00350207|501654|P2|Overall Study|Other|3
155830|NCT00350207|501655|P1|Overall Study|Other|1
155831|NCT00350207|501653|P3|Overall Study|Withdrawal by Subject|1
155832|NCT00350207|501654|P2|Overall Study|Withdrawal by Subject|1
155833|NCT00350207|501655|P1|Overall Study|Withdrawal by Subject|0
155834|NCT00350207|501653|P3|Overall Study|Lost to Follow-up|1
155835|NCT00350207|501654|P2|Overall Study|Lost to Follow-up|0
155836|NCT00350207|501655|P1|Overall Study|Lost to Follow-up|1
155837|NCT00350207|501653|P3|Overall Study|Lack of Efficacy|2
155838|NCT00350207|501654|P2|Overall Study|Lack of Efficacy|0
155839|NCT00350207|501655|P1|Overall Study|Lack of Efficacy|1
155840|NCT00350207|501653|P3|Overall Study|Adverse Event|2
155841|NCT00350207|501654|P2|Overall Study|Adverse Event|2
155842|NCT00350207|501655|P1|Overall Study|Adverse Event|5
155843|NCT00349921|501858|P4|First Spinal Injection|Adverse Event|0
155844|NCT00349921|501859|P3|First Spinal Injection|Adverse Event|1
155845|NCT00349921|501860|P2|First Spinal Injection|Adverse Event|0
155846|NCT00349921|501861|P1|First Spinal Injection|Adverse Event|0
155847|NCT00349921|501858|P4|First Spinal Injection|Physician Decision|0
155848|NCT00349921|501859|P3|First Spinal Injection|Physician Decision|0
155849|NCT00349921|501860|P2|First Spinal Injection|Physician Decision|0
155850|NCT00349921|501861|P1|First Spinal Injection|Physician Decision|1
155851|NCT00349908|501872|P2|Overall Study|Withdrawal by Subject|4
155852|NCT00349908|501873|P1|Overall Study|Withdrawal by Subject|0
155853|NCT00349752|501893|P2|Overall Study|Other:History of squamous cell carcinoma|0
155854|NCT00349752|501894|P1|Overall Study|Other:History of squamous cell carcinoma|1
155855|NCT00349752|501893|P2|Overall Study|Other: Inadvertently unblinded|0
155856|NCT00349752|501894|P1|Overall Study|Other: Inadvertently unblinded|1
155857|NCT00349752|501893|P2|Overall Study|Other: Ineligible|0
155858|NCT00349752|501894|P1|Overall Study|Other: Ineligible|1
155859|NCT00349752|501893|P2|Overall Study|Other: Patient's steroid use|0
155860|NCT00349752|501894|P1|Overall Study|Other: Patient's steroid use|1
155861|NCT00349752|501893|P2|Overall Study|Other: Patient stopped steroids|1
155862|NCT00349752|501894|P1|Overall Study|Other: Patient stopped steroids|0
155863|NCT00349752|501893|P2|Overall Study|Other: Non compliance|1
155864|NCT00349752|501894|P1|Overall Study|Other: Non compliance|0
155865|NCT00349752|501893|P2|Overall Study|Other: Required exclusionary medication|1
155866|NCT00349752|501894|P1|Overall Study|Other: Required exclusionary medication|0
155867|NCT00349752|501893|P2|Overall Study|Personal reasons|5
155868|NCT00349752|501894|P1|Overall Study|Personal reasons|6
155869|NCT00349752|501893|P2|Overall Study|Lost to Follow-up|2
155870|NCT00349752|501894|P1|Overall Study|Lost to Follow-up|4
155871|NCT00349752|501893|P2|Overall Study|Lack of Efficacy|42
155872|NCT00349752|501894|P1|Overall Study|Lack of Efficacy|37
155873|NCT00349752|501893|P2|Overall Study|Adverse Event|12
155874|NCT00349752|501894|P1|Overall Study|Adverse Event|8
155875|NCT00349622|501922|P2|Overall Study|Withdrawal by Subject|9
155876|NCT00349622|501923|P1|Overall Study|Withdrawal by Subject|5
155877|NCT00349622|501922|P2|Overall Study|Lost to Follow-up|1
155878|NCT00349622|501923|P1|Overall Study|Lost to Follow-up|5
155879|NCT00349622|501922|P2|Overall Study|Death|86
155880|NCT00349622|501923|P1|Overall Study|Death|168
155881|NCT00349349|501960|P3|Overall Study|New Malignancy (Bladder Cancer)|0
155882|NCT00349349|501961|P2|Overall Study|New Malignancy (Bladder Cancer)|1
155883|NCT00349349|501962|P1|Overall Study|New Malignancy (Bladder Cancer)|0
155884|NCT00349349|501960|P3|Overall Study|No Response|0
155885|NCT00349349|501961|P2|Overall Study|No Response|3
155886|NCT00349349|501962|P1|Overall Study|No Response|0
155887|NCT00349349|501960|P3|Overall Study|Physician Decision|1
155888|NCT00349349|501961|P2|Overall Study|Physician Decision|2
155889|NCT00349349|501962|P1|Overall Study|Physician Decision|1
155890|NCT00349349|501960|P3|Overall Study|Participant Reduced General Condition|0
155891|NCT00349349|501961|P2|Overall Study|Participant Reduced General Condition|1
155892|NCT00349349|501962|P1|Overall Study|Participant Reduced General Condition|0
155893|NCT00349349|501960|P3|Overall Study|Other Treatment Selected|0
155894|NCT00349349|501961|P2|Overall Study|Other Treatment Selected|0
155895|NCT00349349|501962|P1|Overall Study|Other Treatment Selected|2
155896|NCT00349349|501960|P3|Overall Study|Death|1
155897|NCT00349349|501961|P2|Overall Study|Death|10
155898|NCT00349349|501962|P1|Overall Study|Death|13
155899|NCT00349349|501960|P3|Overall Study|Withdrawn due to Disease Progression|1
155900|NCT00349349|501961|P2|Overall Study|Withdrawn due to Disease Progression|37
155901|NCT00349349|501962|P1|Overall Study|Withdrawn due to Disease Progression|27
155902|NCT00349349|501960|P3|Overall Study|Withdrawal by Subject|1
155903|NCT00349349|501961|P2|Overall Study|Withdrawal by Subject|2
155904|NCT00349349|501962|P1|Overall Study|Withdrawal by Subject|5
155905|NCT00349349|501960|P3|Overall Study|Adverse Event|2
155906|NCT00349349|501961|P2|Overall Study|Adverse Event|6
155907|NCT00349349|501962|P1|Overall Study|Adverse Event|5
155908|NCT00348933|502051|P1|Overall Study|Adverse Event|7
155909|NCT00348933|502051|P1|Overall Study|Protocol Violation|2
155910|NCT00348933|502051|P1|Overall Study|Lost to Follow-up|6
155911|NCT00348933|502051|P1|Overall Study|Withdrawal by Subject|10
155912|NCT00348881|502059|P2|Overall Study|Serious Adverse Event|2
155913|NCT00348881|502060|P1|Overall Study|Serious Adverse Event|0
155914|NCT00348881|502059|P2|Overall Study|Adverse Event|0
155915|NCT00348881|502060|P1|Overall Study|Adverse Event|2
155916|NCT00348881|502059|P2|Overall Study|Withdrawal by Subject|4
155917|NCT00348881|502060|P1|Overall Study|Withdrawal by Subject|3
155918|NCT00348881|502059|P2|Overall Study|Lost to Follow-up|6
155919|NCT00348881|502060|P1|Overall Study|Lost to Follow-up|12
155920|NCT00348790|502072|P1|Completed Treatment|Unable to travel to study site|1
155921|NCT00348790|502072|P1|Completed Treatment|Required surgery|2
155922|NCT00348790|502072|P1|Completed Treatment|Adverse Event|4
155923|NCT00348790|502072|P1|Completed Treatment|Disease progression|14
155924|NCT00348790|502072|P1|Completed Treatment|Withdrawal by Subject|4
155925|NCT00348686|502077|P1|Overall Study|Multiple Reasons|8
155926|NCT00348686|502077|P1|Overall Study|Lost to Follow-up|2
155927|NCT00348686|502077|P1|Overall Study|Protocol Violation|6
155928|NCT00348686|502077|P1|Overall Study|Adverse Event|5
155929|NCT00348686|502077|P1|Overall Study|Withdrawal by Subject|45
155930|NCT00348673|502094|P9|Stage 1|Randomized but not Treated|0
155931|NCT00348673|502095|P8|Stage 1|Randomized but not Treated|0
155932|NCT00348673|502096|P7|Stage 1|Randomized but not Treated|0
155933|NCT00348673|502097|P6|Stage 1|Randomized but not Treated|0
155934|NCT00348673|502098|P5|Stage 1|Randomized but not Treated|0
155935|NCT00348673|502099|P4|Stage 1|Randomized but not Treated|0
155936|NCT00348673|502100|P3|Stage 1|Randomized but not Treated|1
155937|NCT00348673|502101|P2|Stage 1|Randomized but not Treated|0
155938|NCT00348673|502102|P1|Stage 1|Randomized but not Treated|0
155939|NCT00348556|502149|P1|Overall Study|Adverse Event|1
155940|NCT00347958|502154|P1|Overall Study|Withdrawal by Subject|1
155941|NCT00347958|502154|P1|Overall Study|Protocol Violation|2
155942|NCT00347958|502154|P1|Overall Study|Adverse Event|1
155943|NCT00347932|502163|P2|Overall Study|Did not meet inclusion criteria|8
155944|NCT00347932|502164|P1|Overall Study|Did not meet inclusion criteria|4
155945|NCT00347932|502163|P2|Overall Study|Withdrawal by Subject|16
155946|NCT00347932|502164|P1|Overall Study|Withdrawal by Subject|10
155947|NCT00347932|502163|P2|Overall Study|Lost to Follow-up|9
155948|NCT00347932|502164|P1|Overall Study|Lost to Follow-up|10
155949|NCT00347932|502163|P2|Overall Study|Lack of Efficacy|14
155950|NCT00347932|502164|P1|Overall Study|Lack of Efficacy|3
155951|NCT00347932|502163|P2|Overall Study|Adverse Event|5
155952|NCT00347932|502164|P1|Overall Study|Adverse Event|4
155953|NCT00347919|502179|P3|Overall Study|Missing|2
155954|NCT00347919|502180|P2|Overall Study|Missing|1
155955|NCT00347919|502181|P1|Overall Study|Missing|2
155956|NCT00347919|502179|P3|Overall Study|Par. Started Other Treatment|1
155957|NCT00347919|502180|P2|Overall Study|Par. Started Other Treatment|1
155958|NCT00347919|502181|P1|Overall Study|Par. Started Other Treatment|1
155959|NCT00347919|502179|P3|Overall Study|Death|19
155960|NCT00347919|502180|P2|Overall Study|Death|42
155961|NCT00347919|502181|P1|Overall Study|Death|35
155962|NCT00347919|502179|P3|Overall Study|Sponsor terminated study|16
155963|NCT00347919|502180|P2|Overall Study|Sponsor terminated study|10
155964|NCT00347919|502181|P1|Overall Study|Sponsor terminated study|15
155965|NCT00347919|502179|P3|Overall Study|Physician Decision|0
155966|NCT00347919|502180|P2|Overall Study|Physician Decision|1
155967|NCT00347919|502181|P1|Overall Study|Physician Decision|1
155968|NCT00347919|502179|P3|Overall Study|Withdrawal by Subject|0
155969|NCT00347919|502180|P2|Overall Study|Withdrawal by Subject|8
155970|NCT00347919|502181|P1|Overall Study|Withdrawal by Subject|6
155971|NCT00347919|502179|P3|Overall Study|Lost to Follow-up|0
155972|NCT00347919|502180|P2|Overall Study|Lost to Follow-up|13
155973|NCT00347919|502181|P1|Overall Study|Lost to Follow-up|11
155974|NCT00347438|502201|P1|Overall Study|Physician Decision|1
155975|NCT00347438|502201|P1|Overall Study|Withdrawal by Subject|1
155976|NCT00347360|502223|P15|Overall Study|Visits conflicted with new job|0
155977|NCT00347360|502224|P14|Overall Study|Visits conflicted with new job|0
155978|NCT00347360|502225|P13|Overall Study|Visits conflicted with new job|0
155979|NCT00347360|502226|P12|Overall Study|Visits conflicted with new job|0
155980|NCT00347360|502227|P11|Overall Study|Visits conflicted with new job|0
155981|NCT00347360|502228|P10|Overall Study|Visits conflicted with new job|0
155982|NCT00347360|502229|P9|Overall Study|Visits conflicted with new job|0
155983|NCT00347360|502230|P8|Overall Study|Visits conflicted with new job|0
155984|NCT00347360|502231|P7|Overall Study|Visits conflicted with new job|1
155985|NCT00347360|502232|P6|Overall Study|Visits conflicted with new job|0
155986|NCT00347360|502233|P5|Overall Study|Visits conflicted with new job|0
155987|NCT00347360|502234|P4|Overall Study|Visits conflicted with new job|0
155988|NCT00347360|502235|P3|Overall Study|Visits conflicted with new job|0
155989|NCT00347360|502236|P2|Overall Study|Visits conflicted with new job|0
155990|NCT00347360|502237|P1|Overall Study|Visits conflicted with new job|0
155991|NCT00347360|502223|P15|Overall Study|Subject refuse to sign updated consent|1
155992|NCT00347360|502224|P14|Overall Study|Subject refuse to sign updated consent|0
155993|NCT00347360|502225|P13|Overall Study|Subject refuse to sign updated consent|0
155994|NCT00347360|502226|P12|Overall Study|Subject refuse to sign updated consent|0
155995|NCT00347360|502227|P11|Overall Study|Subject refuse to sign updated consent|0
155996|NCT00347360|502228|P10|Overall Study|Subject refuse to sign updated consent|0
155997|NCT00347360|502229|P9|Overall Study|Subject refuse to sign updated consent|0
155998|NCT00347360|502230|P8|Overall Study|Subject refuse to sign updated consent|0
155999|NCT00347360|502231|P7|Overall Study|Subject refuse to sign updated consent|0
156000|NCT00347360|502232|P6|Overall Study|Subject refuse to sign updated consent|0
156001|NCT00347360|502233|P5|Overall Study|Subject refuse to sign updated consent|0
156002|NCT00347360|502234|P4|Overall Study|Subject refuse to sign updated consent|0
156003|NCT00347360|502235|P3|Overall Study|Subject refuse to sign updated consent|0
156004|NCT00347360|502236|P2|Overall Study|Subject refuse to sign updated consent|0
156005|NCT00347360|502237|P1|Overall Study|Subject refuse to sign updated consent|0
156006|NCT00347360|502223|P15|Overall Study|Subject left town, ran out of study drug|0
156007|NCT00347360|502224|P14|Overall Study|Subject left town, ran out of study drug|1
156008|NCT00347360|502225|P13|Overall Study|Subject left town, ran out of study drug|0
156009|NCT00347360|502226|P12|Overall Study|Subject left town, ran out of study drug|0
156010|NCT00347360|502227|P11|Overall Study|Subject left town, ran out of study drug|0
156011|NCT00347360|502228|P10|Overall Study|Subject left town, ran out of study drug|0
156012|NCT00347360|502229|P9|Overall Study|Subject left town, ran out of study drug|0
156013|NCT00347360|502230|P8|Overall Study|Subject left town, ran out of study drug|0
156014|NCT00347360|502231|P7|Overall Study|Subject left town, ran out of study drug|0
156015|NCT00347360|502232|P6|Overall Study|Subject left town, ran out of study drug|0
156016|NCT00347360|502233|P5|Overall Study|Subject left town, ran out of study drug|0
156017|NCT00347360|502234|P4|Overall Study|Subject left town, ran out of study drug|0
156018|NCT00347360|502235|P3|Overall Study|Subject left town, ran out of study drug|0
156019|NCT00347360|502236|P2|Overall Study|Subject left town, ran out of study drug|0
156020|NCT00347360|502237|P1|Overall Study|Subject left town, ran out of study drug|0
156021|NCT00347360|502223|P15|Overall Study|Prolonged duration between visits|0
156022|NCT00347360|502224|P14|Overall Study|Prolonged duration between visits|0
156023|NCT00347360|502225|P13|Overall Study|Prolonged duration between visits|1
156024|NCT00347360|502226|P12|Overall Study|Prolonged duration between visits|0
156025|NCT00347360|502227|P11|Overall Study|Prolonged duration between visits|0
156026|NCT00347360|502228|P10|Overall Study|Prolonged duration between visits|0
156027|NCT00347360|502229|P9|Overall Study|Prolonged duration between visits|0
156028|NCT00347360|502230|P8|Overall Study|Prolonged duration between visits|0
156029|NCT00347360|502231|P7|Overall Study|Prolonged duration between visits|0
156030|NCT00347360|502232|P6|Overall Study|Prolonged duration between visits|0
156031|NCT00347360|502233|P5|Overall Study|Prolonged duration between visits|0
156032|NCT00347360|502234|P4|Overall Study|Prolonged duration between visits|0
156033|NCT00347360|502235|P3|Overall Study|Prolonged duration between visits|0
156034|NCT00347360|502236|P2|Overall Study|Prolonged duration between visits|0
156035|NCT00347360|502237|P1|Overall Study|Prolonged duration between visits|0
156036|NCT00347360|502223|P15|Overall Study|Failed inclusion criteria #4|0
156037|NCT00347360|502224|P14|Overall Study|Failed inclusion criteria #4|0
156038|NCT00347360|502225|P13|Overall Study|Failed inclusion criteria #4|0
156039|NCT00347360|502226|P12|Overall Study|Failed inclusion criteria #4|1
156040|NCT00347360|502227|P11|Overall Study|Failed inclusion criteria #4|0
156041|NCT00347360|502228|P10|Overall Study|Failed inclusion criteria #4|0
156042|NCT00347360|502229|P9|Overall Study|Failed inclusion criteria #4|0
156043|NCT00347360|502230|P8|Overall Study|Failed inclusion criteria #4|0
156044|NCT00347360|502231|P7|Overall Study|Failed inclusion criteria #4|0
156045|NCT00347360|502232|P6|Overall Study|Failed inclusion criteria #4|0
156046|NCT00347360|502233|P5|Overall Study|Failed inclusion criteria #4|0
156047|NCT00347360|502234|P4|Overall Study|Failed inclusion criteria #4|0
156048|NCT00347360|502235|P3|Overall Study|Failed inclusion criteria #4|0
156049|NCT00347360|502236|P2|Overall Study|Failed inclusion criteria #4|0
156050|NCT00347360|502237|P1|Overall Study|Failed inclusion criteria #4|0
156051|NCT00347360|502223|P15|Overall Study|Randomized in error|0
156052|NCT00347360|502224|P14|Overall Study|Randomized in error|0
156053|NCT00347360|502225|P13|Overall Study|Randomized in error|0
156054|NCT00347360|502226|P12|Overall Study|Randomized in error|1
156055|NCT00347360|502227|P11|Overall Study|Randomized in error|0
156056|NCT00347360|502228|P10|Overall Study|Randomized in error|0
156057|NCT00347360|502229|P9|Overall Study|Randomized in error|0
156058|NCT00347360|502230|P8|Overall Study|Randomized in error|0
156059|NCT00347360|502231|P7|Overall Study|Randomized in error|0
156060|NCT00347360|502232|P6|Overall Study|Randomized in error|0
156061|NCT00347360|502233|P5|Overall Study|Randomized in error|0
156062|NCT00347360|502234|P4|Overall Study|Randomized in error|0
156063|NCT00347360|502235|P3|Overall Study|Randomized in error|0
156064|NCT00347360|502236|P2|Overall Study|Randomized in error|0
156065|NCT00347360|502237|P1|Overall Study|Randomized in error|0
156066|NCT00347360|502223|P15|Overall Study|Did not meet criteria before ABPM|0
156067|NCT00347360|502224|P14|Overall Study|Did not meet criteria before ABPM|0
156068|NCT00347360|502225|P13|Overall Study|Did not meet criteria before ABPM|0
156069|NCT00347360|502226|P12|Overall Study|Did not meet criteria before ABPM|0
156070|NCT00347360|502227|P11|Overall Study|Did not meet criteria before ABPM|1
156071|NCT00347360|502228|P10|Overall Study|Did not meet criteria before ABPM|0
156072|NCT00347360|502229|P9|Overall Study|Did not meet criteria before ABPM|0
156073|NCT00347360|502230|P8|Overall Study|Did not meet criteria before ABPM|0
156074|NCT00347360|502231|P7|Overall Study|Did not meet criteria before ABPM|0
156075|NCT00347360|502232|P6|Overall Study|Did not meet criteria before ABPM|0
156076|NCT00347360|502233|P5|Overall Study|Did not meet criteria before ABPM|0
156077|NCT00347360|502234|P4|Overall Study|Did not meet criteria before ABPM|0
156078|NCT00347360|502235|P3|Overall Study|Did not meet criteria before ABPM|0
156079|NCT00347360|502236|P2|Overall Study|Did not meet criteria before ABPM|0
156080|NCT00347360|502237|P1|Overall Study|Did not meet criteria before ABPM|0
156081|NCT00347360|502223|P15|Overall Study|PI recommended early withdrawal|0
156082|NCT00347360|502224|P14|Overall Study|PI recommended early withdrawal|0
156083|NCT00347360|502225|P13|Overall Study|PI recommended early withdrawal|0
156084|NCT00347360|502226|P12|Overall Study|PI recommended early withdrawal|0
156085|NCT00347360|502227|P11|Overall Study|PI recommended early withdrawal|0
156086|NCT00347360|502228|P10|Overall Study|PI recommended early withdrawal|1
156087|NCT00347360|502229|P9|Overall Study|PI recommended early withdrawal|0
156088|NCT00347360|502230|P8|Overall Study|PI recommended early withdrawal|0
156089|NCT00347360|502231|P7|Overall Study|PI recommended early withdrawal|0
156090|NCT00347360|502232|P6|Overall Study|PI recommended early withdrawal|0
156091|NCT00347360|502233|P5|Overall Study|PI recommended early withdrawal|0
156092|NCT00347360|502234|P4|Overall Study|PI recommended early withdrawal|0
156093|NCT00347360|502235|P3|Overall Study|PI recommended early withdrawal|0
156094|NCT00347360|502236|P2|Overall Study|PI recommended early withdrawal|0
156095|NCT00347360|502237|P1|Overall Study|PI recommended early withdrawal|0
156096|NCT00347360|502223|P15|Overall Study|Abnormal lab values|0
156097|NCT00347360|502224|P14|Overall Study|Abnormal lab values|0
156098|NCT00347360|502225|P13|Overall Study|Abnormal lab values|0
156099|NCT00347360|502226|P12|Overall Study|Abnormal lab values|0
156100|NCT00347360|502227|P11|Overall Study|Abnormal lab values|0
156101|NCT00347360|502228|P10|Overall Study|Abnormal lab values|0
156102|NCT00347360|502229|P9|Overall Study|Abnormal lab values|0
156103|NCT00347360|502230|P8|Overall Study|Abnormal lab values|0
156104|NCT00347360|502231|P7|Overall Study|Abnormal lab values|1
156105|NCT00347360|502232|P6|Overall Study|Abnormal lab values|0
156106|NCT00347360|502233|P5|Overall Study|Abnormal lab values|0
156107|NCT00347360|502234|P4|Overall Study|Abnormal lab values|0
156108|NCT00347360|502235|P3|Overall Study|Abnormal lab values|0
156109|NCT00347360|502236|P2|Overall Study|Abnormal lab values|0
156110|NCT00347360|502237|P1|Overall Study|Abnormal lab values|0
156111|NCT00347360|502223|P15|Overall Study|Subject did not meet end of study ABPM|0
156112|NCT00347360|502224|P14|Overall Study|Subject did not meet end of study ABPM|1
156113|NCT00347360|502225|P13|Overall Study|Subject did not meet end of study ABPM|1
156114|NCT00347360|502226|P12|Overall Study|Subject did not meet end of study ABPM|0
156115|NCT00347360|502227|P11|Overall Study|Subject did not meet end of study ABPM|1
156116|NCT00347360|502228|P10|Overall Study|Subject did not meet end of study ABPM|0
156117|NCT00347360|502229|P9|Overall Study|Subject did not meet end of study ABPM|0
156118|NCT00347360|502230|P8|Overall Study|Subject did not meet end of study ABPM|0
156119|NCT00347360|502231|P7|Overall Study|Subject did not meet end of study ABPM|1
156120|NCT00347360|502232|P6|Overall Study|Subject did not meet end of study ABPM|0
156121|NCT00347360|502233|P5|Overall Study|Subject did not meet end of study ABPM|0
156122|NCT00347360|502234|P4|Overall Study|Subject did not meet end of study ABPM|0
156123|NCT00347360|502235|P3|Overall Study|Subject did not meet end of study ABPM|0
156124|NCT00347360|502236|P2|Overall Study|Subject did not meet end of study ABPM|0
156125|NCT00347360|502237|P1|Overall Study|Subject did not meet end of study ABPM|0
156126|NCT00347360|502223|P15|Overall Study|P.I. recommended due to blood pressure|0
156127|NCT00347360|502224|P14|Overall Study|P.I. recommended due to blood pressure|0
156128|NCT00347360|502225|P13|Overall Study|P.I. recommended due to blood pressure|0
156129|NCT00347360|502226|P12|Overall Study|P.I. recommended due to blood pressure|0
156130|NCT00347360|502227|P11|Overall Study|P.I. recommended due to blood pressure|0
156131|NCT00347360|502228|P10|Overall Study|P.I. recommended due to blood pressure|0
156132|NCT00347360|502229|P9|Overall Study|P.I. recommended due to blood pressure|0
156133|NCT00347360|502230|P8|Overall Study|P.I. recommended due to blood pressure|0
156134|NCT00347360|502231|P7|Overall Study|P.I. recommended due to blood pressure|0
156135|NCT00347360|502232|P6|Overall Study|P.I. recommended due to blood pressure|0
156136|NCT00347360|502233|P5|Overall Study|P.I. recommended due to blood pressure|1
156137|NCT00347360|502234|P4|Overall Study|P.I. recommended due to blood pressure|0
156138|NCT00347360|502235|P3|Overall Study|P.I. recommended due to blood pressure|0
156139|NCT00347360|502236|P2|Overall Study|P.I. recommended due to blood pressure|0
156140|NCT00347360|502237|P1|Overall Study|P.I. recommended due to blood pressure|0
156141|NCT00347360|502223|P15|Overall Study|Per sponsors instruction|0
156142|NCT00347360|502224|P14|Overall Study|Per sponsors instruction|0
156143|NCT00347360|502225|P13|Overall Study|Per sponsors instruction|0
156144|NCT00347360|502226|P12|Overall Study|Per sponsors instruction|0
156145|NCT00347360|502227|P11|Overall Study|Per sponsors instruction|0
156146|NCT00347360|502228|P10|Overall Study|Per sponsors instruction|0
156147|NCT00347360|502229|P9|Overall Study|Per sponsors instruction|0
156148|NCT00347360|502230|P8|Overall Study|Per sponsors instruction|0
156149|NCT00347360|502231|P7|Overall Study|Per sponsors instruction|0
156150|NCT00347360|502232|P6|Overall Study|Per sponsors instruction|0
156151|NCT00347360|502233|P5|Overall Study|Per sponsors instruction|0
156152|NCT00347360|502234|P4|Overall Study|Per sponsors instruction|0
156153|NCT00347360|502235|P3|Overall Study|Per sponsors instruction|0
156154|NCT00347360|502236|P2|Overall Study|Per sponsors instruction|1
156155|NCT00347360|502237|P1|Overall Study|Per sponsors instruction|0
156156|NCT00347360|502223|P15|Overall Study|Reason not listed/blank|0
156157|NCT00347360|502224|P14|Overall Study|Reason not listed/blank|1
156158|NCT00347360|502225|P13|Overall Study|Reason not listed/blank|0
156159|NCT00347360|502226|P12|Overall Study|Reason not listed/blank|0
156160|NCT00347360|502227|P11|Overall Study|Reason not listed/blank|0
156161|NCT00347360|502228|P10|Overall Study|Reason not listed/blank|0
156162|NCT00347360|502229|P9|Overall Study|Reason not listed/blank|0
156163|NCT00347360|502230|P8|Overall Study|Reason not listed/blank|0
156164|NCT00347360|502231|P7|Overall Study|Reason not listed/blank|1
156165|NCT00347360|502232|P6|Overall Study|Reason not listed/blank|0
156166|NCT00347360|502233|P5|Overall Study|Reason not listed/blank|0
156167|NCT00347360|502234|P4|Overall Study|Reason not listed/blank|0
156168|NCT00347360|502235|P3|Overall Study|Reason not listed/blank|0
156169|NCT00347360|502236|P2|Overall Study|Reason not listed/blank|0
156170|NCT00347360|502237|P1|Overall Study|Reason not listed/blank|1
156171|NCT00347360|502223|P15|Overall Study|Lack of Efficacy|0
156172|NCT00347360|502224|P14|Overall Study|Lack of Efficacy|0
156173|NCT00347360|502225|P13|Overall Study|Lack of Efficacy|0
156174|NCT00347360|502226|P12|Overall Study|Lack of Efficacy|0
156175|NCT00347360|502227|P11|Overall Study|Lack of Efficacy|0
156176|NCT00347360|502228|P10|Overall Study|Lack of Efficacy|0
156177|NCT00347360|502229|P9|Overall Study|Lack of Efficacy|1
156178|NCT00347360|502230|P8|Overall Study|Lack of Efficacy|1
156179|NCT00347360|502231|P7|Overall Study|Lack of Efficacy|0
156180|NCT00347360|502232|P6|Overall Study|Lack of Efficacy|1
156181|NCT00347360|502233|P5|Overall Study|Lack of Efficacy|0
156182|NCT00347360|502234|P4|Overall Study|Lack of Efficacy|1
156183|NCT00347360|502235|P3|Overall Study|Lack of Efficacy|3
156184|NCT00347360|502236|P2|Overall Study|Lack of Efficacy|1
156185|NCT00347360|502237|P1|Overall Study|Lack of Efficacy|1
156186|NCT00347360|502223|P15|Overall Study|Withdrawal by Subject|1
156187|NCT00347360|502224|P14|Overall Study|Withdrawal by Subject|2
156188|NCT00347360|502225|P13|Overall Study|Withdrawal by Subject|4
156189|NCT00347360|502226|P12|Overall Study|Withdrawal by Subject|3
156190|NCT00347360|502227|P11|Overall Study|Withdrawal by Subject|0
156191|NCT00347360|502228|P10|Overall Study|Withdrawal by Subject|1
156192|NCT00347360|502229|P9|Overall Study|Withdrawal by Subject|1
156193|NCT00347360|502230|P8|Overall Study|Withdrawal by Subject|1
156194|NCT00347360|502231|P7|Overall Study|Withdrawal by Subject|1
156195|NCT00347360|502232|P6|Overall Study|Withdrawal by Subject|2
156196|NCT00347360|502233|P5|Overall Study|Withdrawal by Subject|1
156197|NCT00347360|502234|P4|Overall Study|Withdrawal by Subject|4
156198|NCT00347360|502235|P3|Overall Study|Withdrawal by Subject|2
156199|NCT00347360|502236|P2|Overall Study|Withdrawal by Subject|1
156200|NCT00347360|502237|P1|Overall Study|Withdrawal by Subject|0
156201|NCT00347360|502223|P15|Overall Study|Protocol Violation|0
156202|NCT00347360|502224|P14|Overall Study|Protocol Violation|1
156203|NCT00347360|502225|P13|Overall Study|Protocol Violation|0
156204|NCT00347360|502226|P12|Overall Study|Protocol Violation|0
156205|NCT00347360|502227|P11|Overall Study|Protocol Violation|0
156206|NCT00347360|502228|P10|Overall Study|Protocol Violation|2
156207|NCT00347360|502229|P9|Overall Study|Protocol Violation|1
156208|NCT00347360|502230|P8|Overall Study|Protocol Violation|0
156209|NCT00347360|502231|P7|Overall Study|Protocol Violation|0
156210|NCT00347360|502232|P6|Overall Study|Protocol Violation|2
156211|NCT00347360|502233|P5|Overall Study|Protocol Violation|1
156212|NCT00347360|502234|P4|Overall Study|Protocol Violation|2
156213|NCT00347360|502235|P3|Overall Study|Protocol Violation|1
156214|NCT00347360|502236|P2|Overall Study|Protocol Violation|3
156215|NCT00347360|502237|P1|Overall Study|Protocol Violation|2
156216|NCT00347360|502223|P15|Overall Study|Lost to Follow-up|0
156217|NCT00347360|502224|P14|Overall Study|Lost to Follow-up|0
156218|NCT00347360|502225|P13|Overall Study|Lost to Follow-up|1
156219|NCT00347360|502226|P12|Overall Study|Lost to Follow-up|0
156220|NCT00347360|502227|P11|Overall Study|Lost to Follow-up|0
156221|NCT00347360|502228|P10|Overall Study|Lost to Follow-up|2
156222|NCT00347360|502229|P9|Overall Study|Lost to Follow-up|1
156223|NCT00347360|502230|P8|Overall Study|Lost to Follow-up|1
156224|NCT00347360|502231|P7|Overall Study|Lost to Follow-up|0
156225|NCT00347360|502232|P6|Overall Study|Lost to Follow-up|1
156226|NCT00347360|502233|P5|Overall Study|Lost to Follow-up|1
156227|NCT00347360|502234|P4|Overall Study|Lost to Follow-up|2
156228|NCT00347360|502235|P3|Overall Study|Lost to Follow-up|0
156229|NCT00347360|502236|P2|Overall Study|Lost to Follow-up|0
156230|NCT00347360|502237|P1|Overall Study|Lost to Follow-up|0
156231|NCT00347360|502223|P15|Overall Study|Adverse Event|2
156232|NCT00347360|502224|P14|Overall Study|Adverse Event|2
156233|NCT00347360|502225|P13|Overall Study|Adverse Event|3
156234|NCT00347360|502226|P12|Overall Study|Adverse Event|1
156235|NCT00347360|502227|P11|Overall Study|Adverse Event|3
156236|NCT00347360|502228|P10|Overall Study|Adverse Event|3
156237|NCT00347360|502229|P9|Overall Study|Adverse Event|2
156238|NCT00347360|502230|P8|Overall Study|Adverse Event|0
156239|NCT00347360|502231|P7|Overall Study|Adverse Event|2
156240|NCT00347360|502232|P6|Overall Study|Adverse Event|2
156241|NCT00347360|502233|P5|Overall Study|Adverse Event|1
156242|NCT00347360|502234|P4|Overall Study|Adverse Event|4
156243|NCT00347360|502235|P3|Overall Study|Adverse Event|0
156244|NCT00347360|502236|P2|Overall Study|Adverse Event|2
156245|NCT00347360|502237|P1|Overall Study|Adverse Event|1
156246|NCT00347009|502432|P1|Overall Study|Serious Adverse Event|1
156247|NCT00347009|502432|P1|Overall Study|Increased ALT/HBV DNA|1
156248|NCT00347009|502432|P1|Overall Study|Insufficient Viral Suppression|3
156249|NCT00347009|502432|P1|Overall Study|Adverse Laboratory Experience|1
156250|NCT00347009|502432|P1|Overall Study|Protocol Violation|2
156251|NCT00347009|502432|P1|Overall Study|Lost to Follow-up|4
156252|NCT00347009|502432|P1|Overall Study|Physician Decision|5
156253|NCT00347009|502432|P1|Overall Study|Withdrawal by Subject|3
156254|NCT00347009|502432|P1|Overall Study|Adverse Event|6
156255|NCT00347009|502432|P1|Overall Study|Death|1
156256|NCT00345683|502451|P2|Overall Study|Unspecified|2
156257|NCT00345683|502452|P1|Overall Study|Unspecified|6
156258|NCT00345683|502451|P2|Overall Study|Lost to Follow-up|7
156259|NCT00345683|502452|P1|Overall Study|Lost to Follow-up|19
156260|NCT00345631|502475|P3|Overall Study|Other reasons|1
156261|NCT00345631|502476|P2|Overall Study|Other reasons|0
156262|NCT00345631|502477|P1|Overall Study|Other reasons|0
156263|NCT00345631|502475|P3|Overall Study|Lost to Follow-up|4
156264|NCT00345631|502476|P2|Overall Study|Lost to Follow-up|7
156265|NCT00345631|502477|P1|Overall Study|Lost to Follow-up|3
156266|NCT00345631|502475|P3|Overall Study|Adverse Event|0
156267|NCT00345631|502476|P2|Overall Study|Adverse Event|1
156268|NCT00345631|502477|P1|Overall Study|Adverse Event|0
156269|NCT00345631|502475|P3|Overall Study|Withdrawal by Subject|1
156270|NCT00345631|502476|P2|Overall Study|Withdrawal by Subject|0
156271|NCT00345631|502477|P1|Overall Study|Withdrawal by Subject|1
156272|NCT00345605|502509|P2|Arm 2, Opposite Treatment|Adverse Event|0
156273|NCT00345605|502510|P1|Arm 2, Opposite Treatment|Adverse Event|1
156274|NCT00345605|502509|P2|Arm 1|Adverse Event|1
156275|NCT00345605|502510|P1|Arm 1|Adverse Event|0
156276|NCT00345592|502530|P2|Overall Study|Withdrawal by Subject|8
156277|NCT00345592|502531|P1|Overall Study|Withdrawal by Subject|11
156278|NCT00345592|502530|P2|Overall Study|Death|16
156279|NCT00345592|502531|P1|Overall Study|Death|14
156280|NCT00346697|502539|P2|Overall Study|Lost to Follow-up|1
156281|NCT00346697|502540|P1|Overall Study|Lost to Follow-up|0
156282|NCT00346632|502576|P10|Overall Study|Not Stated|1
156283|NCT00346632|502577|P9|Overall Study|Not Stated|2
156284|NCT00346632|502578|P8|Overall Study|Not Stated|2
156285|NCT00346632|502579|P7|Overall Study|Not Stated|0
156286|NCT00346632|502580|P6|Overall Study|Not Stated|0
156287|NCT00346632|502581|P5|Overall Study|Not Stated|0
156288|NCT00346632|502582|P4|Overall Study|Not Stated|0
156289|NCT00346632|502583|P3|Overall Study|Not Stated|0
156290|NCT00346632|502584|P2|Overall Study|Not Stated|1
156291|NCT00346632|502585|P1|Overall Study|Not Stated|1
156292|NCT00346632|502576|P10|Overall Study|Switched to alternative treatment|0
156293|NCT00346632|502577|P9|Overall Study|Switched to alternative treatment|0
156294|NCT00346632|502578|P8|Overall Study|Switched to alternative treatment|0
156295|NCT00346632|502579|P7|Overall Study|Switched to alternative treatment|0
156296|NCT00346632|502580|P6|Overall Study|Switched to alternative treatment|0
156297|NCT00346632|502581|P5|Overall Study|Switched to alternative treatment|0
156298|NCT00346632|502582|P4|Overall Study|Switched to alternative treatment|0
156299|NCT00346632|502583|P3|Overall Study|Switched to alternative treatment|1
156300|NCT00346632|502584|P2|Overall Study|Switched to alternative treatment|0
156301|NCT00346632|502585|P1|Overall Study|Switched to alternative treatment|0
156302|NCT00346632|502576|P10|Overall Study|Withdrawal by Subject|0
156303|NCT00346632|502577|P9|Overall Study|Withdrawal by Subject|0
156304|NCT00346632|502578|P8|Overall Study|Withdrawal by Subject|0
156305|NCT00346632|502579|P7|Overall Study|Withdrawal by Subject|1
156306|NCT00346632|502580|P6|Overall Study|Withdrawal by Subject|0
156307|NCT00346632|502581|P5|Overall Study|Withdrawal by Subject|0
156308|NCT00346632|502582|P4|Overall Study|Withdrawal by Subject|0
156309|NCT00346632|502583|P3|Overall Study|Withdrawal by Subject|0
156310|NCT00346632|502584|P2|Overall Study|Withdrawal by Subject|0
156311|NCT00346632|502585|P1|Overall Study|Withdrawal by Subject|0
156312|NCT00346632|502576|P10|Overall Study|Protocol Violation|0
156313|NCT00346632|502577|P9|Overall Study|Protocol Violation|0
156314|NCT00346632|502578|P8|Overall Study|Protocol Violation|0
156315|NCT00346632|502579|P7|Overall Study|Protocol Violation|1
156316|NCT00346632|502580|P6|Overall Study|Protocol Violation|0
156317|NCT00346632|502581|P5|Overall Study|Protocol Violation|0
156318|NCT00346632|502582|P4|Overall Study|Protocol Violation|0
156319|NCT00346632|502583|P3|Overall Study|Protocol Violation|0
156320|NCT00346632|502584|P2|Overall Study|Protocol Violation|0
156321|NCT00346632|502585|P1|Overall Study|Protocol Violation|0
156322|NCT00346632|502576|P10|Overall Study|Death|0
156323|NCT00346632|502577|P9|Overall Study|Death|0
156324|NCT00346632|502578|P8|Overall Study|Death|0
156325|NCT00346632|502579|P7|Overall Study|Death|0
156326|NCT00346632|502580|P6|Overall Study|Death|0
156327|NCT00346632|502581|P5|Overall Study|Death|0
156328|NCT00346632|502582|P4|Overall Study|Death|0
156329|NCT00346632|502583|P3|Overall Study|Death|1
156330|NCT00346632|502584|P2|Overall Study|Death|0
156331|NCT00346632|502585|P1|Overall Study|Death|0
156332|NCT00346632|502576|P10|Overall Study|Adverse Event|0
156333|NCT00346632|502577|P9|Overall Study|Adverse Event|0
156334|NCT00346632|502578|P8|Overall Study|Adverse Event|0
156335|NCT00346632|502579|P7|Overall Study|Adverse Event|1
156336|NCT00346632|502580|P6|Overall Study|Adverse Event|1
156337|NCT00346632|502581|P5|Overall Study|Adverse Event|1
156338|NCT00346632|502582|P4|Overall Study|Adverse Event|0
156339|NCT00346632|502583|P3|Overall Study|Adverse Event|0
156340|NCT00346632|502584|P2|Overall Study|Adverse Event|0
156341|NCT00346632|502585|P1|Overall Study|Adverse Event|0
156342|NCT00346632|502576|P10|Overall Study|Progressive Disease|2
156343|NCT00346632|502577|P9|Overall Study|Progressive Disease|2
156344|NCT00346632|502578|P8|Overall Study|Progressive Disease|2
156345|NCT00346632|502579|P7|Overall Study|Progressive Disease|2
156346|NCT00346632|502580|P6|Overall Study|Progressive Disease|1
156347|NCT00346632|502581|P5|Overall Study|Progressive Disease|3
156348|NCT00346632|502582|P4|Overall Study|Progressive Disease|3
156349|NCT00346632|502583|P3|Overall Study|Progressive Disease|4
156350|NCT00346632|502584|P2|Overall Study|Progressive Disease|2
156351|NCT00346632|502585|P1|Overall Study|Progressive Disease|2
156352|NCT00346398|502735|P2|Overall Study|Withdrawal by Subject|2
156353|NCT00346398|502736|P1|Overall Study|Withdrawal by Subject|0
156354|NCT00346398|502735|P2|Overall Study|Lost to Follow-up|0
156355|NCT00346398|502736|P1|Overall Study|Lost to Follow-up|3
156356|NCT00346333|502748|P2|Overall Study|unwilling or unable to continue|8
156357|NCT00346333|502749|P1|Overall Study|unwilling or unable to continue|4
156358|NCT00346333|502748|P2|Overall Study|Death|0
156359|NCT00346333|502749|P1|Overall Study|Death|1
156360|NCT00346268|502765|P2|Overall Study|Participant refused|3
156361|NCT00346268|502766|P1|Overall Study|Participant refused|0
156362|NCT00346268|502765|P2|Overall Study|Protocol Violation|0
156363|NCT00346268|502766|P1|Overall Study|Protocol Violation|1
156364|NCT00346268|502765|P2|Overall Study|Adverse Event|0
156365|NCT00346268|502766|P1|Overall Study|Adverse Event|1
156366|NCT00346151|502798|P1|Overall Study|Withdrawal by Subject|3
156367|NCT00346034|502816|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
156368|NCT00346034|502816|P1|Overall Study|Patient Stopped Taking Study Drug|1
156369|NCT00346034|502816|P1|Overall Study|Withdrawal by Subject|13
156370|NCT00346034|502816|P1|Overall Study|Lack of Efficacy|8
156371|NCT00346034|502816|P1|Overall Study|Adverse Event|34
156372|NCT00345878|502823|P2|Overall Study|Other|0
156373|NCT00345878|502824|P1|Overall Study|Other|1
156374|NCT00345878|502823|P2|Overall Study|Lost to Follow-up|1
156375|NCT00345878|502824|P1|Overall Study|Lost to Follow-up|2
156376|NCT00345878|502823|P2|Overall Study|Adverse Event|0
156377|NCT00345878|502824|P1|Overall Study|Adverse Event|1
156378|NCT00345839|502842|P2|Overall Study|Lost to Follow-up|61
156379|NCT00345839|502843|P1|Overall Study|Lost to Follow-up|58
156380|NCT00345839|502842|P2|Overall Study|Withdrawal by Subject|98
156381|NCT00345839|502843|P1|Overall Study|Withdrawal by Subject|91
156382|NCT00345579|502869|P2|Overall Study|Unspecified|1
156383|NCT00345579|502870|P1|Overall Study|Unspecified|9
156384|NCT00345579|502869|P2|Overall Study|Lost to Follow-up|36
156385|NCT00345579|502870|P1|Overall Study|Lost to Follow-up|82
156386|NCT00345579|502869|P2|Overall Study|Withdrawal by Subject|17
156387|NCT00345579|502870|P1|Overall Study|Withdrawal by Subject|50
156388|NCT00345579|502869|P2|Overall Study|Protocol Violation|5
156389|NCT00345579|502870|P1|Overall Study|Protocol Violation|14
156390|NCT00345579|502869|P2|Overall Study|Adverse Event|6
156391|NCT00345579|502870|P1|Overall Study|Adverse Event|9
156392|NCT00345540|502890|P1|Overall Study|Withdrawal by Subject|1
156393|NCT00345397|502896|P1|Overall Study|Death|1
156394|NCT00345293|502912|P2|Overall Study|Withdrawal by Subject|0
156395|NCT00345293|502913|P1|Overall Study|Withdrawal by Subject|1
156396|NCT00345293|502912|P2|Overall Study|Unable to access line for sample|0
156397|NCT00345293|502913|P1|Overall Study|Unable to access line for sample|1
156398|NCT00345046|502959|P3|Overall Study|Protocol Violation|2
156399|NCT00345046|502960|P2|Overall Study|Protocol Violation|1
156400|NCT00345046|502961|P1|Overall Study|Protocol Violation|1
156401|NCT00344968|502991|P3|Overall Study|Other|0
156402|NCT00344968|502992|P2|Overall Study|Other|1
156403|NCT00344968|502993|P1|Overall Study|Other|0
156404|NCT00344968|502991|P3|Overall Study|Death|31
156405|NCT00344968|502992|P2|Overall Study|Death|27
156406|NCT00344968|502993|P1|Overall Study|Death|11
156407|NCT00344968|502991|P3|Overall Study|Lost to Follow-up|37
156408|NCT00344968|502992|P2|Overall Study|Lost to Follow-up|37
156409|NCT00344968|502993|P1|Overall Study|Lost to Follow-up|24
156410|NCT00344968|502991|P3|Overall Study|Withdrawal by Subject|27
156411|NCT00344968|502992|P2|Overall Study|Withdrawal by Subject|31
156412|NCT00344968|502993|P1|Overall Study|Withdrawal by Subject|14
156413|NCT00344968|502991|P3|Overall Study|Protocol Violation|5
156414|NCT00344968|502992|P2|Overall Study|Protocol Violation|2
156415|NCT00344968|502993|P1|Overall Study|Protocol Violation|2
156416|NCT00344968|502991|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
156417|NCT00344968|502992|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
156418|NCT00344968|502993|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
156419|NCT00344968|502991|P3|Overall Study|Adverse Event|15
156420|NCT00344968|502992|P2|Overall Study|Adverse Event|4
156421|NCT00344968|502993|P1|Overall Study|Adverse Event|5
156422|NCT00344773|503004|P1|Overall Study|Not Eligible for the study|2
156423|NCT00344773|503004|P1|Overall Study|Withdrawal by Subject|1
156424|NCT00344773|503004|P1|Overall Study|Objective Disease Progression|16
156425|NCT00344773|503004|P1|Overall Study|Adverse Event|2
156426|NCT00344500|503027|P3|Overall Study|Not Noted|0
156427|NCT00344500|503028|P2|Overall Study|Not Noted|3
156428|NCT00344500|503029|P1|Overall Study|Not Noted|1
156429|NCT00344500|503027|P3|Overall Study|Protocol Violation|1
156430|NCT00344500|503028|P2|Overall Study|Protocol Violation|7
156431|NCT00344500|503029|P1|Overall Study|Protocol Violation|4
156432|NCT00344500|503027|P3|Overall Study|Withdrawal by Subject|0
156433|NCT00344500|503028|P2|Overall Study|Withdrawal by Subject|10
156434|NCT00344500|503029|P1|Overall Study|Withdrawal by Subject|7
156435|NCT00344500|503027|P3|Overall Study|Lost to Follow-up|1
156436|NCT00344500|503028|P2|Overall Study|Lost to Follow-up|13
156437|NCT00344500|503029|P1|Overall Study|Lost to Follow-up|5
156438|NCT00344500|503027|P3|Overall Study|Adverse Event|0
156439|NCT00344500|503028|P2|Overall Study|Adverse Event|2
156440|NCT00344500|503029|P1|Overall Study|Adverse Event|6
156441|NCT00344487|503040|P1|Overall Study|immunologic failure|1
156442|NCT00344448|503046|P2|Open Label|Study terminated|0
156443|NCT00344448|503047|P1|Open Label|Study terminated|1
156444|NCT00344448|503046|P2|Open Label|Withdrawal by Subject|1
156445|NCT00344448|503047|P1|Open Label|Withdrawal by Subject|1
156446|NCT00344448|503046|P2|Double Blind, Placebo Controlled|Study terminated|0
156447|NCT00344448|503047|P1|Double Blind, Placebo Controlled|Study terminated|1
156448|NCT00344448|503046|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
156449|NCT00344448|503047|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
156450|NCT00344448|503046|P2|Screening|Withdrawal by Subject|1
156451|NCT00344448|503047|P1|Screening|Withdrawal by Subject|0
156452|NCT00344305|503066|P2|Overall Study|Subject was not contacted in window|1
156453|NCT00344305|503067|P1|Overall Study|Subject was not contacted in window|0
156454|NCT00344305|503066|P2|Overall Study|Lost to Follow-up|0
156455|NCT00344305|503067|P1|Overall Study|Lost to Follow-up|2
156456|NCT00344032|503111|P2|Overall Study|Physician Decision|1
156457|NCT00344032|503112|P1|Overall Study|Physician Decision|4
156458|NCT00344032|503111|P2|Overall Study|Lost to Follow-up|6
156459|NCT00344032|503112|P1|Overall Study|Lost to Follow-up|4
156460|NCT00344032|503111|P2|Overall Study|Withdrawal by Subject|2
156461|NCT00344032|503112|P1|Overall Study|Withdrawal by Subject|6
156462|NCT00344032|503111|P2|Overall Study|Adverse Event|1
156463|NCT00344032|503112|P1|Overall Study|Adverse Event|0
156464|NCT00343915|503130|P2|Primary Study|Unspecified|0
156465|NCT00343915|503131|P1|Primary Study|Unspecified|1
156466|NCT00343915|503130|P2|Primary Study|Lost to Follow-up|3
156467|NCT00343915|503131|P1|Primary Study|Lost to Follow-up|2
156468|NCT00343915|503130|P2|Primary Study|Withdrawal by Subject|0
156469|NCT00343915|503131|P1|Primary Study|Withdrawal by Subject|1
156470|NCT00343889|503157|P2|Overall Study|Protocol Violation|0
156471|NCT00343889|503158|P1|Overall Study|Protocol Violation|1
156472|NCT00343889|503157|P2|Overall Study|Withdrawal by Subject|1
156473|NCT00343889|503158|P1|Overall Study|Withdrawal by Subject|0
156474|NCT00343889|503157|P2|Overall Study|Lost to Follow-up|0
156475|NCT00343889|503158|P1|Overall Study|Lost to Follow-up|2
156476|NCT00343512|503210|P1|Overall Study|Withdrawal by Subject|2
156477|NCT00343382|503298|P3|Overall Study|Other Reason Not Specified|4
156478|NCT00343382|503299|P2|Overall Study|Other Reason Not Specified|2
156479|NCT00343382|503300|P1|Overall Study|Other Reason Not Specified|1
156480|NCT00343382|503298|P3|Overall Study|Withdrawal by Subject|6
156481|NCT00343382|503299|P2|Overall Study|Withdrawal by Subject|2
156482|NCT00343382|503300|P1|Overall Study|Withdrawal by Subject|1
156483|NCT00343382|503298|P3|Overall Study|Adverse Event|7
156484|NCT00343382|503299|P2|Overall Study|Adverse Event|10
156485|NCT00343382|503300|P1|Overall Study|Adverse Event|2
156486|NCT00343291|503319|P2|Overall Study|Other|5
156487|NCT00343291|503320|P1|Overall Study|Other|8
156488|NCT00343291|503319|P2|Overall Study|Withdrawal by Subject|2
156489|NCT00343291|503320|P1|Overall Study|Withdrawal by Subject|0
156490|NCT00343291|503319|P2|Overall Study|Progressive disease|34
156491|NCT00343291|503320|P1|Overall Study|Progressive disease|33
156492|NCT00343291|503319|P2|Overall Study|Death|2
156493|NCT00343291|503320|P1|Overall Study|Death|3
156494|NCT00343291|503319|P2|Overall Study|Adverse Event|13
156495|NCT00343291|503320|P1|Overall Study|Adverse Event|13
156496|NCT00343252|503336|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
156497|NCT00343252|503337|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
156498|NCT00343252|503336|P2|18 Months (All Treated Participants)|Sponsor Decision|5
156499|NCT00343252|503337|P1|18 Months (All Treated Participants)|Sponsor Decision|8
156500|NCT00343252|503336|P2|18 Months (All Treated Participants)|Protocol Violation|3
156501|NCT00343252|503337|P1|18 Months (All Treated Participants)|Protocol Violation|3
156502|NCT00343252|503336|P2|18 Months (All Treated Participants)|Physician Decision|7
156503|NCT00343252|503337|P1|18 Months (All Treated Participants)|Physician Decision|4
156504|NCT00343252|503336|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
156505|NCT00343252|503337|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
156506|NCT00343252|503336|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
156507|NCT00343252|503337|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
156508|NCT00343252|503336|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
156509|NCT00343252|503337|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
156510|NCT00343252|503336|P2|18 Months (All Treated Participants)|Death|5
156511|NCT00343252|503337|P1|18 Months (All Treated Participants)|Death|4
156512|NCT00343252|503336|P2|18 Months (All Treated Participants)|Adverse Event|23
156513|NCT00343252|503337|P1|18 Months (All Treated Participants)|Adverse Event|31
156514|NCT00343252|503336|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
156515|NCT00343252|503337|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
156516|NCT00343252|503336|P2|12 Months (All Treated Participants)|Sponsor Decision|6
156517|NCT00343252|503337|P1|12 Months (All Treated Participants)|Sponsor Decision|9
156518|NCT00343252|503336|P2|12 Months (All Treated Participants)|Protocol Violation|2
156519|NCT00343252|503337|P1|12 Months (All Treated Participants)|Protocol Violation|3
156520|NCT00343252|503336|P2|12 Months (All Treated Participants)|Physician Decision|5
156521|NCT00343252|503337|P1|12 Months (All Treated Participants)|Physician Decision|4
156522|NCT00343252|503336|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
156523|NCT00343252|503337|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
156524|NCT00343252|503336|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
156525|NCT00343252|503337|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
156526|NCT00343252|503336|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
156527|NCT00343252|503337|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
156528|NCT00343252|503336|P2|12 Months (All Treated Participants)|Death|3
156529|NCT00343252|503337|P1|12 Months (All Treated Participants)|Death|3
156530|NCT00343252|503336|P2|12 Months (All Treated Participants)|Adverse Event|20
156531|NCT00343252|503337|P1|12 Months (All Treated Participants)|Adverse Event|22
156532|NCT00343252|503336|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
156533|NCT00343252|503337|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
156534|NCT00343252|503336|P2|6 Months (All Treated Participants)|Sponsor Decision|4
156535|NCT00343252|503337|P1|6 Months (All Treated Participants)|Sponsor Decision|7
156536|NCT00343252|503336|P2|6 Months (All Treated Participants)|Protocol Violation|2
156537|NCT00343252|503337|P1|6 Months (All Treated Participants)|Protocol Violation|2
156538|NCT00343252|503336|P2|6 Months (All Treated Participants)|Physician Decision|3
156539|NCT00343252|503337|P1|6 Months (All Treated Participants)|Physician Decision|1
156540|NCT00343252|503336|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
156541|NCT00343252|503337|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
156542|NCT00343252|503336|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
156543|NCT00343252|503337|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
156544|NCT00343252|503336|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
156545|NCT00343252|503337|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
156546|NCT00343252|503336|P2|6 Months (All Treated Participants)|Death|2
156547|NCT00343252|503337|P1|6 Months (All Treated Participants)|Death|0
156548|NCT00343252|503336|P2|6 Months (All Treated Participants)|Adverse Event|11
156549|NCT00343252|503337|P1|6 Months (All Treated Participants)|Adverse Event|17
156550|NCT00342628|503402|P3|Overall Study|moved residence|1
156551|NCT00342628|503403|P2|Overall Study|moved residence|1
156552|NCT00342628|503404|P1|Overall Study|moved residence|0
156553|NCT00342628|503402|P3|Overall Study|Death|0
156554|NCT00342628|503403|P2|Overall Study|Death|1
156555|NCT00342628|503404|P1|Overall Study|Death|1
156556|NCT00342628|503402|P3|Overall Study|Withdrawal by Subject|18
156557|NCT00342628|503403|P2|Overall Study|Withdrawal by Subject|19
156558|NCT00342628|503404|P1|Overall Study|Withdrawal by Subject|19
156559|NCT00340834|503447|P5|Extension Phase of Study|Death|1
156560|NCT00340834|503448|P4|Extension Phase of Study|Death|0
156561|NCT00340834|503449|P3|Extension Phase of Study|Death|0
156562|NCT00340834|503450|P2|Extension Phase of Study|Death|0
156563|NCT00340834|503451|P1|Extension Phase of Study|Death|0
156564|NCT00340834|503447|P5|Extension Phase of Study|Protocol Violation|0
156565|NCT00340834|503448|P4|Extension Phase of Study|Protocol Violation|0
156566|NCT00340834|503449|P3|Extension Phase of Study|Protocol Violation|0
156567|NCT00340834|503450|P2|Extension Phase of Study|Protocol Violation|0
156568|NCT00340834|503451|P1|Extension Phase of Study|Protocol Violation|3
156569|NCT00340834|503447|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
156570|NCT00340834|503448|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
156571|NCT00340834|503449|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
156572|NCT00340834|503450|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
156573|NCT00340834|503451|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
156574|NCT00340834|503447|P5|Extension Phase of Study|Administrative problems|1
156575|NCT00340834|503448|P4|Extension Phase of Study|Administrative problems|1
156576|NCT00340834|503449|P3|Extension Phase of Study|Administrative problems|0
156577|NCT00340834|503450|P2|Extension Phase of Study|Administrative problems|0
156578|NCT00340834|503451|P1|Extension Phase of Study|Administrative problems|3
156579|NCT00340834|503447|P5|Extension Phase of Study|Subject no longer requires study drug|2
156580|NCT00340834|503448|P4|Extension Phase of Study|Subject no longer requires study drug|0
156581|NCT00340834|503449|P3|Extension Phase of Study|Subject no longer requires study drug|0
156582|NCT00340834|503450|P2|Extension Phase of Study|Subject no longer requires study drug|0
156583|NCT00340834|503451|P1|Extension Phase of Study|Subject no longer requires study drug|4
156584|NCT00340834|503447|P5|Extension Phase of Study|Lost to Follow-up|3
156585|NCT00340834|503448|P4|Extension Phase of Study|Lost to Follow-up|2
156586|NCT00340834|503449|P3|Extension Phase of Study|Lost to Follow-up|0
156587|NCT00340834|503450|P2|Extension Phase of Study|Lost to Follow-up|1
156588|NCT00340834|503451|P1|Extension Phase of Study|Lost to Follow-up|1
156589|NCT00340834|503447|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
156590|NCT00340834|503448|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
156591|NCT00340834|503449|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
156592|NCT00340834|503450|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
156593|NCT00340834|503451|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
156594|NCT00340834|503447|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
156595|NCT00340834|503448|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
156596|NCT00340834|503449|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
156597|NCT00340834|503450|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
156598|NCT00340834|503451|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
156599|NCT00340834|503447|P5|Extension Phase of Study|Adverse Event|7
156600|NCT00340834|503448|P4|Extension Phase of Study|Adverse Event|19
156601|NCT00340834|503449|P3|Extension Phase of Study|Adverse Event|0
156602|NCT00340834|503450|P2|Extension Phase of Study|Adverse Event|22
156603|NCT00340834|503451|P1|Extension Phase of Study|Adverse Event|21
156604|NCT00340834|503447|P5|Extension Phase of Study|Subject withdrew consent|15
156605|NCT00340834|503448|P4|Extension Phase of Study|Subject withdrew consent|12
156606|NCT00340834|503449|P3|Extension Phase of Study|Subject withdrew consent|0
156607|NCT00340834|503450|P2|Extension Phase of Study|Subject withdrew consent|31
156608|NCT00340834|503451|P1|Extension Phase of Study|Subject withdrew consent|26
156609|NCT00340834|503447|P5|Extension Phase of Study|Subject did not receive study drug|0
156610|NCT00340834|503448|P4|Extension Phase of Study|Subject did not receive study drug|2
156611|NCT00340834|503449|P3|Extension Phase of Study|Subject did not receive study drug|0
156612|NCT00340834|503450|P2|Extension Phase of Study|Subject did not receive study drug|1
156613|NCT00340834|503451|P1|Extension Phase of Study|Subject did not receive study drug|0
156614|NCT00340834|503447|P5|Core Phase of Study|Protocol Violation|0
156615|NCT00340834|503448|P4|Core Phase of Study|Protocol Violation|0
156616|NCT00340834|503449|P3|Core Phase of Study|Protocol Violation|2
156617|NCT00340834|503450|P2|Core Phase of Study|Protocol Violation|0
156618|NCT00340834|503451|P1|Core Phase of Study|Protocol Violation|0
156619|NCT00340834|503447|P5|Core Phase of Study|Death|0
156620|NCT00340834|503448|P4|Core Phase of Study|Death|0
156621|NCT00340834|503449|P3|Core Phase of Study|Death|0
156622|NCT00340834|503450|P2|Core Phase of Study|Death|0
156623|NCT00340834|503451|P1|Core Phase of Study|Death|2
156624|NCT00340834|503447|P5|Core Phase of Study|Lost to Follow-up|0
156625|NCT00340834|503448|P4|Core Phase of Study|Lost to Follow-up|0
156626|NCT00340834|503449|P3|Core Phase of Study|Lost to Follow-up|4
156627|NCT00340834|503450|P2|Core Phase of Study|Lost to Follow-up|1
156628|NCT00340834|503451|P1|Core Phase of Study|Lost to Follow-up|1
156629|NCT00340834|503447|P5|Core Phase of Study|Abnormal test procedure result(s)|0
156630|NCT00340834|503448|P4|Core Phase of Study|Abnormal test procedure result(s)|0
156631|NCT00340834|503449|P3|Core Phase of Study|Abnormal test procedure result(s)|3
156632|NCT00340834|503450|P2|Core Phase of Study|Abnormal test procedure result(s)|3
156633|NCT00340834|503451|P1|Core Phase of Study|Abnormal test procedure result(s)|4
156634|NCT00340834|503447|P5|Core Phase of Study|Abnormal laboratory value(s)|0
156635|NCT00340834|503448|P4|Core Phase of Study|Abnormal laboratory value(s)|0
156636|NCT00340834|503449|P3|Core Phase of Study|Abnormal laboratory value(s)|1
156637|NCT00340834|503450|P2|Core Phase of Study|Abnormal laboratory value(s)|6
156638|NCT00340834|503451|P1|Core Phase of Study|Abnormal laboratory value(s)|4
156639|NCT00340834|503447|P5|Core Phase of Study|Lack of Efficacy|0
156640|NCT00340834|503448|P4|Core Phase of Study|Lack of Efficacy|0
156641|NCT00340834|503449|P3|Core Phase of Study|Lack of Efficacy|7
156642|NCT00340834|503450|P2|Core Phase of Study|Lack of Efficacy|3
156643|NCT00340834|503451|P1|Core Phase of Study|Lack of Efficacy|3
156644|NCT00340834|503447|P5|Core Phase of Study|Administrative Problems|0
156645|NCT00340834|503448|P4|Core Phase of Study|Administrative Problems|0
156646|NCT00340834|503449|P3|Core Phase of Study|Administrative Problems|7
156647|NCT00340834|503450|P2|Core Phase of Study|Administrative Problems|2
156648|NCT00340834|503451|P1|Core Phase of Study|Administrative Problems|6
156649|NCT00340834|503447|P5|Core Phase of Study|Withdrawal by Subject|0
156650|NCT00340834|503448|P4|Core Phase of Study|Withdrawal by Subject|0
156651|NCT00340834|503449|P3|Core Phase of Study|Withdrawal by Subject|16
156652|NCT00340834|503450|P2|Core Phase of Study|Withdrawal by Subject|9
156653|NCT00340834|503451|P1|Core Phase of Study|Withdrawal by Subject|11
156654|NCT00340834|503447|P5|Core Phase of Study|Adverse Event|0
156655|NCT00340834|503448|P4|Core Phase of Study|Adverse Event|0
156656|NCT00340834|503449|P3|Core Phase of Study|Adverse Event|9
156657|NCT00340834|503450|P2|Core Phase of Study|Adverse Event|9
156658|NCT00340834|503451|P1|Core Phase of Study|Adverse Event|26
156659|NCT00340704|503485|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
156660|NCT00340704|503486|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
156661|NCT00340704|503487|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
156662|NCT00340704|503488|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
156663|NCT00340704|503489|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
156664|NCT00340704|503490|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
156665|NCT00340704|503491|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
156666|NCT00340704|503492|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
156667|NCT00340704|503493|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
156668|NCT00340704|503485|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
156669|NCT00340704|503486|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
156670|NCT00340704|503487|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
156671|NCT00340704|503488|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
156672|NCT00340704|503489|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
156673|NCT00340704|503490|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
156674|NCT00340704|503491|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
156675|NCT00340704|503492|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
156676|NCT00340704|503493|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
156677|NCT00340704|503485|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
156678|NCT00340704|503486|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
156679|NCT00340704|503487|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
156680|NCT00340704|503488|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
156681|NCT00340704|503489|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
156682|NCT00340704|503490|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
156683|NCT00340704|503491|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
156684|NCT00340704|503492|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
156685|NCT00340704|503493|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
156686|NCT00340704|503485|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
156687|NCT00340704|503486|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
156688|NCT00340704|503487|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
156689|NCT00340704|503488|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
156690|NCT00340704|503489|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
156691|NCT00340704|503490|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
156692|NCT00340704|503491|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
156693|NCT00340704|503492|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
156694|NCT00340704|503493|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
156695|NCT00340704|503485|P9|PK Study|Not treated|0
156696|NCT00340704|503486|P8|PK Study|Not treated|0
156697|NCT00340704|503487|P7|PK Study|Not treated|0
156698|NCT00340704|503488|P6|PK Study|Not treated|0
156699|NCT00340704|503489|P5|PK Study|Not treated|0
156700|NCT00340704|503490|P4|PK Study|Not treated|0
156701|NCT00340704|503491|P3|PK Study|Not treated|1
156702|NCT00340704|503492|P2|PK Study|Not treated|0
156703|NCT00340704|503493|P1|PK Study|Not treated|0
156704|NCT00340704|503485|P9|PK Study|Adverse Event|0
156705|NCT00340704|503486|P8|PK Study|Adverse Event|0
156706|NCT00340704|503487|P7|PK Study|Adverse Event|0
156707|NCT00340704|503488|P6|PK Study|Adverse Event|0
156708|NCT00340704|503489|P5|PK Study|Adverse Event|0
156709|NCT00340704|503490|P4|PK Study|Adverse Event|0
156710|NCT00340704|503491|P3|PK Study|Adverse Event|0
156711|NCT00340704|503492|P2|PK Study|Adverse Event|1
156712|NCT00340704|503493|P1|PK Study|Adverse Event|0
156713|NCT00340678|503599|P4|Overall Study|Lost to Follow-up|0
156714|NCT00340678|503600|P3|Overall Study|Lost to Follow-up|0
156715|NCT00340678|503601|P2|Overall Study|Lost to Follow-up|0
156716|NCT00340678|503602|P1|Overall Study|Lost to Follow-up|1
156717|NCT00339833|503629|P2|Overall Study|Error in data records|0
156718|NCT00339833|503630|P1|Overall Study|Error in data records|1
156719|NCT00339833|503629|P2|Overall Study|anaemia or excess drop in glycaemia|0
156720|NCT00339833|503630|P1|Overall Study|anaemia or excess drop in glycaemia|2
156721|NCT00339833|503629|P2|Overall Study|Poor venous access|2
156722|NCT00339833|503630|P1|Overall Study|Poor venous access|2
156723|NCT00339833|503629|P2|Overall Study|minor infection|1
156724|NCT00339833|503630|P1|Overall Study|minor infection|0
156725|NCT00339833|503629|P2|Overall Study|Chest pain|1
156726|NCT00339833|503630|P1|Overall Study|Chest pain|0
156727|NCT00339833|503629|P2|Overall Study|indigestion|1
156728|NCT00339833|503630|P1|Overall Study|indigestion|0
156729|NCT00339833|503629|P2|Overall Study|toothache|1
156730|NCT00339833|503630|P1|Overall Study|toothache|0
156731|NCT00339833|503629|P2|Overall Study|Withdrawal by Subject|2
156732|NCT00339833|503630|P1|Overall Study|Withdrawal by Subject|1
156733|NCT00339183|503640|P2|Overall Study|Ongoing|13
156734|NCT00339183|503641|P1|Overall Study|Ongoing|20
156735|NCT00339183|503640|P2|Overall Study|Other|40
156736|NCT00339183|503641|P1|Overall Study|Other|46
156737|NCT00339183|503640|P2|Overall Study|Missing reason|1
156738|NCT00339183|503641|P1|Overall Study|Missing reason|3
156739|NCT00339183|503640|P2|Overall Study|Protocol-specified criteria|8
156740|NCT00339183|503641|P1|Overall Study|Protocol-specified criteria|12
156741|NCT00339183|503640|P2|Overall Study|Lost to Follow-up|17
156742|NCT00339183|503641|P1|Overall Study|Lost to Follow-up|17
156743|NCT00339183|503640|P2|Overall Study|Physician Decision|4
156744|NCT00339183|503641|P1|Overall Study|Physician Decision|2
156745|NCT00339183|503640|P2|Overall Study|Withdrawal by Subject|19
156746|NCT00339183|503641|P1|Overall Study|Withdrawal by Subject|16
156747|NCT00339183|503640|P2|Overall Study|Adverse Event|3
156748|NCT00339183|503641|P1|Overall Study|Adverse Event|5
156749|NCT00339144|503670|P3|Overall Study|Participant's request to discontinuation|1
156750|NCT00339144|503671|P2|Overall Study|Participant's request to discontinuation|0
156751|NCT00339144|503672|P1|Overall Study|Participant's request to discontinuation|1
156752|NCT00339144|503670|P3|Overall Study|Study drug toxicity|1
156753|NCT00339144|503671|P2|Overall Study|Study drug toxicity|1
156754|NCT00339144|503672|P1|Overall Study|Study drug toxicity|3
156755|NCT00339144|503670|P3|Overall Study|Disease progression|2
156756|NCT00339144|503671|P2|Overall Study|Disease progression|2
156757|NCT00339144|503672|P1|Overall Study|Disease progression|5
156758|NCT00339040|503756|P2|Stage II|Site closing|0
156759|NCT00339040|503757|P1|Stage II|Site closing|2
156760|NCT00339040|503756|P2|Stage II|Not able to attend clinic|0
156761|NCT00339040|503757|P1|Stage II|Not able to attend clinic|1
156762|NCT00339040|503756|P2|Stage II|Protocol Violation|0
156763|NCT00339040|503757|P1|Stage II|Protocol Violation|3
156764|NCT00339040|503756|P2|Stage II|Withdrawal by Subject|2
156765|NCT00339040|503757|P1|Stage II|Withdrawal by Subject|1
156766|NCT00339040|503756|P2|Stage II|Lost to Follow-up|0
156767|NCT00339040|503757|P1|Stage II|Lost to Follow-up|3
156768|NCT00339040|503756|P2|Stage I|Protocol Violation|1
156769|NCT00339040|503757|P1|Stage I|Protocol Violation|1
156770|NCT00339040|503756|P2|Stage I|Not able to attend clinic|0
156771|NCT00339040|503757|P1|Stage I|Not able to attend clinic|1
156772|NCT00338962|503784|P4|Overall Study|Poor Compliance|0
156773|NCT00338962|503785|P3|Overall Study|Poor Compliance|2
156774|NCT00338962|503786|P2|Overall Study|Poor Compliance|0
156775|NCT00338962|503787|P1|Overall Study|Poor Compliance|0
156776|NCT00338962|503784|P4|Overall Study|Adverse Event|0
156777|NCT00338962|503785|P3|Overall Study|Adverse Event|2
156778|NCT00338962|503786|P2|Overall Study|Adverse Event|0
156779|NCT00338962|503787|P1|Overall Study|Adverse Event|0
156780|NCT00338962|503784|P4|Overall Study|Moved|0
156781|NCT00338962|503785|P3|Overall Study|Moved|0
156782|NCT00338962|503786|P2|Overall Study|Moved|1
156783|NCT00338962|503787|P1|Overall Study|Moved|0
156784|NCT00338962|503784|P4|Overall Study|Time Constraint|0
156785|NCT00338962|503785|P3|Overall Study|Time Constraint|0
156786|NCT00338962|503786|P2|Overall Study|Time Constraint|0
156787|NCT00338962|503787|P1|Overall Study|Time Constraint|2
156788|NCT00338962|503784|P4|Overall Study|No Transportation|0
156789|NCT00338962|503785|P3|Overall Study|No Transportation|0
156790|NCT00338962|503786|P2|Overall Study|No Transportation|0
156791|NCT00338962|503787|P1|Overall Study|No Transportation|2
156792|NCT00338962|503784|P4|Overall Study|Withdrawal by Subject|0
156793|NCT00338962|503785|P3|Overall Study|Withdrawal by Subject|0
156794|NCT00338962|503786|P2|Overall Study|Withdrawal by Subject|0
156795|NCT00338962|503787|P1|Overall Study|Withdrawal by Subject|1
156796|NCT00338962|503784|P4|Overall Study|Lost to Follow-up|3
156797|NCT00338962|503785|P3|Overall Study|Lost to Follow-up|2
156798|NCT00338962|503786|P2|Overall Study|Lost to Follow-up|3
156799|NCT00338962|503787|P1|Overall Study|Lost to Follow-up|3
156800|NCT00338884|503809|P1|Overall Study|Randomized But Did Not Receive Treatment|1
156801|NCT00338884|503809|P1|Overall Study|Lost to Follow-up|1
156802|NCT00338884|503809|P1|Overall Study|Withdrawal by Subject|3
156803|NCT00338884|503809|P1|Overall Study|Global Deterioration of Health Status|3
156804|NCT00338884|503809|P1|Overall Study|Unspecified|4
156805|NCT00338884|503809|P1|Overall Study|Death|8
156806|NCT00338884|503809|P1|Overall Study|Adverse Event|14
156807|NCT00338884|503809|P1|Overall Study|Objective Disease Progression or Relapse|44
156808|NCT00337779|503843|P2|Overall Study|Death|1
156809|NCT00337779|503844|P1|Overall Study|Death|0
156810|NCT00337779|503843|P2|Overall Study|Pregnancy|2
156811|NCT00337779|503844|P1|Overall Study|Pregnancy|3
156812|NCT00337779|503843|P2|Overall Study|Adverse Event|51
156813|NCT00337779|503844|P1|Overall Study|Adverse Event|28
156814|NCT00337779|503843|P2|Overall Study|Lost to Follow-up|5
156815|NCT00337779|503844|P1|Overall Study|Lost to Follow-up|6
156816|NCT00337779|503843|P2|Overall Study|Protocol Violation|1
156817|NCT00337779|503844|P1|Overall Study|Protocol Violation|1
156818|NCT00337779|503843|P2|Overall Study|Physician Decision|6
156819|NCT00337779|503844|P1|Overall Study|Physician Decision|3
156820|NCT00337779|503843|P2|Overall Study|Sponsor decision|1
156821|NCT00337779|503844|P1|Overall Study|Sponsor decision|1
156822|NCT00337779|503843|P2|Overall Study|Withdrawal by Subject|12
156823|NCT00337779|503844|P1|Overall Study|Withdrawal by Subject|10
156824|NCT00338741|503856|P2|Overall Study|Lost to Follow-up|0
156825|NCT00338741|503857|P1|Overall Study|Lost to Follow-up|2
156826|NCT00338455|503867|P2|Overall Study|Physician Decision|0
156827|NCT00338455|503868|P1|Overall Study|Physician Decision|1
156828|NCT00338455|503867|P2|Overall Study|Death|1
156829|NCT00338455|503868|P1|Overall Study|Death|2
156830|NCT00338286|503882|P2|Overall Study|undefined|4
156831|NCT00338286|503883|P1|Overall Study|undefined|3
156832|NCT00338286|503882|P2|Overall Study|ongoing|272
156833|NCT00338286|503883|P1|Overall Study|ongoing|297
156834|NCT00338286|503882|P2|Overall Study|Lost to Follow-up|50
156835|NCT00338286|503883|P1|Overall Study|Lost to Follow-up|53
156836|NCT00338286|503882|P2|Overall Study|Withdrawal by Subject|44
156837|NCT00338286|503883|P1|Overall Study|Withdrawal by Subject|40
156838|NCT00338104|503900|P3|Overall Study|Protocol Violation|3
156839|NCT00338104|503901|P2|Overall Study|Protocol Violation|1
156840|NCT00338104|503902|P1|Overall Study|Protocol Violation|2
156841|NCT00337935|503925|P2|Overall Study|Lack of Efficacy|1
156842|NCT00337935|503926|P1|Overall Study|Lack of Efficacy|0
156843|NCT00337935|503925|P2|Overall Study|Other|1
156844|NCT00337935|503926|P1|Overall Study|Other|0
156845|NCT00337935|503925|P2|Overall Study|Withdrawal by Subject|7
156846|NCT00337935|503926|P1|Overall Study|Withdrawal by Subject|1
156847|NCT00337935|503925|P2|Overall Study|Protocol Violation|3
156848|NCT00337935|503926|P1|Overall Study|Protocol Violation|4
156849|NCT00337935|503925|P2|Overall Study|Lost to Follow-up|1
156850|NCT00337935|503926|P1|Overall Study|Lost to Follow-up|0
156851|NCT00337935|503925|P2|Overall Study|Physician Decision|1
156852|NCT00337935|503926|P1|Overall Study|Physician Decision|1
156853|NCT00337935|503925|P2|Overall Study|Death|8
156854|NCT00337935|503926|P1|Overall Study|Death|2
156855|NCT00337935|503925|P2|Overall Study|Adverse Event|5
156856|NCT00337935|503926|P1|Overall Study|Adverse Event|2
156857|NCT00337818|503939|P3|Overall Study|Lost to Follow-up|107
156858|NCT00337818|503940|P2|Overall Study|Lost to Follow-up|91
156859|NCT00337818|503941|P1|Overall Study|Lost to Follow-up|289
156860|NCT00337727|503963|P2|Overall Study|Withdrawal by Subject|5
156861|NCT00337727|503964|P1|Overall Study|Withdrawal by Subject|3
156862|NCT00337727|503963|P2|Overall Study|Protocol Violation|0
156863|NCT00337727|503964|P1|Overall Study|Protocol Violation|4
156864|NCT00337727|503963|P2|Overall Study|Physician Decision|0
156865|NCT00337727|503964|P1|Overall Study|Physician Decision|1
156866|NCT00337727|503963|P2|Overall Study|Lost to Follow-up|4
156867|NCT00337727|503964|P1|Overall Study|Lost to Follow-up|5
156868|NCT00337727|503963|P2|Overall Study|Adverse Event|3
156869|NCT00337727|503964|P1|Overall Study|Adverse Event|5
156870|NCT00337675|503975|P3|Overall Study|Trial Terminated|2
156871|NCT00337675|503976|P2|Overall Study|Trial Terminated|0
156872|NCT00337675|503977|P1|Overall Study|Trial Terminated|0
156873|NCT00337675|503975|P3|Overall Study|Progressive Disease|0
156874|NCT00337675|503976|P2|Overall Study|Progressive Disease|2
156875|NCT00337675|503977|P1|Overall Study|Progressive Disease|0
156876|NCT00337675|503975|P3|Overall Study|Withdrawal by Subject|19
156877|NCT00337675|503976|P2|Overall Study|Withdrawal by Subject|25
156878|NCT00337675|503977|P1|Overall Study|Withdrawal by Subject|25
156879|NCT00337675|503975|P3|Overall Study|Protocol Violation|19
156880|NCT00337675|503976|P2|Overall Study|Protocol Violation|24
156881|NCT00337675|503977|P1|Overall Study|Protocol Violation|21
156882|NCT00337675|503975|P3|Overall Study|Physician Decision|14
156883|NCT00337675|503976|P2|Overall Study|Physician Decision|17
156884|NCT00337675|503977|P1|Overall Study|Physician Decision|9
156885|NCT00337675|503975|P3|Overall Study|Lost to Follow-up|17
156886|NCT00337675|503976|P2|Overall Study|Lost to Follow-up|19
156887|NCT00337675|503977|P1|Overall Study|Lost to Follow-up|22
156888|NCT00337675|503975|P3|Overall Study|Lack of Efficacy|9
156889|NCT00337675|503976|P2|Overall Study|Lack of Efficacy|7
156890|NCT00337675|503977|P1|Overall Study|Lack of Efficacy|10
156891|NCT00337675|503975|P3|Overall Study|Adverse Event|19
156892|NCT00337675|503976|P2|Overall Study|Adverse Event|9
156893|NCT00337675|503977|P1|Overall Study|Adverse Event|10
156894|NCT00337662|503994|P4|Study Period III|Clinical Relapse|0
156895|NCT00337662|503995|P3|Study Period III|Clinical Relapse|0
156896|NCT00337662|503996|P2|Study Period III|Clinical Relapse|0
156897|NCT00337662|503997|P1|Study Period III|Clinical Relapse|1
156898|NCT00337662|503994|P4|Study Period III|Sponsor Decision|0
156899|NCT00337662|503995|P3|Study Period III|Sponsor Decision|1
156900|NCT00337662|503996|P2|Study Period III|Sponsor Decision|0
156901|NCT00337662|503997|P1|Study Period III|Sponsor Decision|1
156902|NCT00337662|503994|P4|Study Period III|Parent/Caregiver Decision|0
156903|NCT00337662|503995|P3|Study Period III|Parent/Caregiver Decision|2
156904|NCT00337662|503996|P2|Study Period III|Parent/Caregiver Decision|0
156905|NCT00337662|503997|P1|Study Period III|Parent/Caregiver Decision|0
156906|NCT00337662|503994|P4|Study Period III|Lack of Efficacy|0
156907|NCT00337662|503995|P3|Study Period III|Lack of Efficacy|2
156908|NCT00337662|503996|P2|Study Period III|Lack of Efficacy|4
156909|NCT00337662|503997|P1|Study Period III|Lack of Efficacy|4
156910|NCT00337662|503994|P4|Study Period III|Entry Criteria Not Met|0
156911|NCT00337662|503995|P3|Study Period III|Entry Criteria Not Met|3
156912|NCT00337662|503996|P2|Study Period III|Entry Criteria Not Met|1
156913|NCT00337662|503997|P1|Study Period III|Entry Criteria Not Met|4
156914|NCT00337662|503994|P4|Study Period III|Physician Decision|0
156915|NCT00337662|503995|P3|Study Period III|Physician Decision|0
156916|NCT00337662|503996|P2|Study Period III|Physician Decision|5
156917|NCT00337662|503997|P1|Study Period III|Physician Decision|6
156918|NCT00337662|503994|P4|Study Period III|Protocol Violation|0
156919|NCT00337662|503995|P3|Study Period III|Protocol Violation|2
156920|NCT00337662|503996|P2|Study Period III|Protocol Violation|8
156921|NCT00337662|503997|P1|Study Period III|Protocol Violation|3
156922|NCT00337662|503994|P4|Study Period III|Adverse Event|0
156923|NCT00337662|503995|P3|Study Period III|Adverse Event|8
156924|NCT00337662|503996|P2|Study Period III|Adverse Event|10
156925|NCT00337662|503997|P1|Study Period III|Adverse Event|9
156926|NCT00337662|503994|P4|Study Period III|Withdrawal by Subject|0
156927|NCT00337662|503995|P3|Study Period III|Withdrawal by Subject|12
156928|NCT00337662|503996|P2|Study Period III|Withdrawal by Subject|14
156929|NCT00337662|503997|P1|Study Period III|Withdrawal by Subject|18
156930|NCT00337662|503994|P4|Study Period III|Lost to Follow-up|0
156931|NCT00337662|503995|P3|Study Period III|Lost to Follow-up|14
156932|NCT00337662|503996|P2|Study Period III|Lost to Follow-up|16
156933|NCT00337662|503997|P1|Study Period III|Lost to Follow-up|14
156934|NCT00337662|503994|P4|Study Period II|Parent/Caregiver Decision|1
156935|NCT00337662|503995|P3|Study Period II|Parent/Caregiver Decision|0
156936|NCT00337662|503996|P2|Study Period II|Parent/Caregiver Decision|0
156937|NCT00337662|503997|P1|Study Period II|Parent/Caregiver Decision|0
156938|NCT00337662|503994|P4|Study Period II|Sponsor Decision|2
156939|NCT00337662|503995|P3|Study Period II|Sponsor Decision|0
156940|NCT00337662|503996|P2|Study Period II|Sponsor Decision|0
156941|NCT00337662|503997|P1|Study Period II|Sponsor Decision|0
156942|NCT00337662|503994|P4|Study Period II|Lack of Efficacy|7
156943|NCT00337662|503995|P3|Study Period II|Lack of Efficacy|0
156944|NCT00337662|503996|P2|Study Period II|Lack of Efficacy|0
156945|NCT00337662|503997|P1|Study Period II|Lack of Efficacy|0
156946|NCT00337662|503994|P4|Study Period II|Protocol Violation|6
156947|NCT00337662|503995|P3|Study Period II|Protocol Violation|0
156948|NCT00337662|503996|P2|Study Period II|Protocol Violation|0
156949|NCT00337662|503997|P1|Study Period II|Protocol Violation|0
156950|NCT00337662|503994|P4|Study Period II|Entry Criteria Not Met|6
156951|NCT00337662|503995|P3|Study Period II|Entry Criteria Not Met|0
156952|NCT00337662|503996|P2|Study Period II|Entry Criteria Not Met|0
156953|NCT00337662|503997|P1|Study Period II|Entry Criteria Not Met|0
156954|NCT00337662|503994|P4|Study Period II|Physician Decision|13
156955|NCT00337662|503995|P3|Study Period II|Physician Decision|0
156956|NCT00337662|503996|P2|Study Period II|Physician Decision|0
156957|NCT00337662|503997|P1|Study Period II|Physician Decision|0
156958|NCT00337662|503994|P4|Study Period II|Adverse Event|16
156959|NCT00337662|503995|P3|Study Period II|Adverse Event|0
156960|NCT00337662|503996|P2|Study Period II|Adverse Event|0
156961|NCT00337662|503997|P1|Study Period II|Adverse Event|0
156962|NCT00337662|503994|P4|Study Period II|Withdrawal by Subject|20
156963|NCT00337662|503995|P3|Study Period II|Withdrawal by Subject|0
156964|NCT00337662|503996|P2|Study Period II|Withdrawal by Subject|0
156965|NCT00337662|503997|P1|Study Period II|Withdrawal by Subject|0
156966|NCT00337662|503994|P4|Study Period II|Lost to Follow-up|35
156967|NCT00337662|503995|P3|Study Period II|Lost to Follow-up|0
156968|NCT00337662|503996|P2|Study Period II|Lost to Follow-up|0
156969|NCT00337662|503997|P1|Study Period II|Lost to Follow-up|0
156970|NCT00337610|504051|P2|Overall Study|Withdrawal by Subject|5
156971|NCT00337610|504052|P1|Overall Study|Withdrawal by Subject|6
156972|NCT00337610|504051|P2|Overall Study|Lost to Follow-up|3
156973|NCT00337610|504052|P1|Overall Study|Lost to Follow-up|3
156974|NCT00337610|504051|P2|Overall Study|Lack of Efficacy|3
156975|NCT00337610|504052|P1|Overall Study|Lack of Efficacy|6
156976|NCT00337610|504051|P2|Overall Study|Death|1
156977|NCT00337610|504052|P1|Overall Study|Death|0
156978|NCT00337610|504051|P2|Overall Study|Adverse Event|2
156979|NCT00337610|504052|P1|Overall Study|Adverse Event|2
156980|NCT00337571|504068|P4|Overall Study|High Potassium level|1
156981|NCT00337571|504069|P3|Overall Study|High Potassium level|0
156982|NCT00337571|504070|P2|Overall Study|High Potassium level|0
156983|NCT00337571|504071|P1|Overall Study|High Potassium level|0
156984|NCT00337571|504068|P4|Overall Study|No longer met study criteria|0
156985|NCT00337571|504069|P3|Overall Study|No longer met study criteria|0
156986|NCT00337571|504070|P2|Overall Study|No longer met study criteria|0
156987|NCT00337571|504071|P1|Overall Study|No longer met study criteria|1
156988|NCT00337571|504068|P4|Overall Study|Poor/noncompliance|1
156989|NCT00337571|504069|P3|Overall Study|Poor/noncompliance|1
156990|NCT00337571|504070|P2|Overall Study|Poor/noncompliance|1
156991|NCT00337571|504071|P1|Overall Study|Poor/noncompliance|1
156992|NCT00337571|504068|P4|Overall Study|Lost to Follow-up|1
156993|NCT00337571|504069|P3|Overall Study|Lost to Follow-up|0
156994|NCT00337571|504070|P2|Overall Study|Lost to Follow-up|1
156995|NCT00337571|504071|P1|Overall Study|Lost to Follow-up|3
156996|NCT00337571|504068|P4|Overall Study|Withdrawal by Subject|0
156997|NCT00337571|504069|P3|Overall Study|Withdrawal by Subject|1
156998|NCT00337571|504070|P2|Overall Study|Withdrawal by Subject|2
156999|NCT00337571|504071|P1|Overall Study|Withdrawal by Subject|2
157000|NCT00337571|504068|P4|Overall Study|Adverse Event|4
157001|NCT00337571|504069|P3|Overall Study|Adverse Event|8
157002|NCT00337571|504070|P2|Overall Study|Adverse Event|5
157003|NCT00337571|504071|P1|Overall Study|Adverse Event|4
157004|NCT00337571|504068|P4|Overall Study|Lack of Efficacy|0
157005|NCT00337571|504069|P3|Overall Study|Lack of Efficacy|0
157006|NCT00337571|504070|P2|Overall Study|Lack of Efficacy|0
157007|NCT00337571|504071|P1|Overall Study|Lack of Efficacy|3
157008|NCT00337467|504109|P1|Overall Study|Subject No Longer Met Study Criteria|2
157009|NCT00337467|504109|P1|Overall Study|Lost to Follow-up|2
157010|NCT00337467|504109|P1|Overall Study|Pregnancy|1
157011|NCT00337467|504109|P1|Overall Study|Subject Withdrew Consent|2
157012|NCT00337467|504109|P1|Overall Study|Adverse Event|3
157013|NCT00337428|504128|P2|Overall Study|Anorexia|0
157014|NCT00337428|504129|P1|Overall Study|Anorexia|1
157015|NCT00337428|504128|P2|Overall Study|Unwilling to Continue|0
157016|NCT00337428|504129|P1|Overall Study|Unwilling to Continue|1
157017|NCT00337428|504128|P2|Overall Study|Lack of Time|1
157018|NCT00337428|504129|P1|Overall Study|Lack of Time|1
157019|NCT00337428|504128|P2|Overall Study|Withdrawal by Subject|2
157020|NCT00337428|504129|P1|Overall Study|Withdrawal by Subject|1
157021|NCT00337285|504180|P1|Overall Study|Lack of protocol compliance|7
157022|NCT00337285|504180|P1|Overall Study|Physician Decision|1
157023|NCT00337285|504180|P1|Overall Study|Death|1
157024|NCT00337285|504180|P1|Overall Study|Lack of Efficacy|11
157025|NCT00337285|504180|P1|Overall Study|Protocol Violation|27
157026|NCT00337285|504180|P1|Overall Study|Adverse Event|28
157027|NCT00337285|504180|P1|Overall Study|Lost to Follow-up|41
157028|NCT00337285|504180|P1|Overall Study|Withdrawal by Subject|42
157029|NCT00337272|504188|P2|Withdrawal Period|Non-compliance|1
157030|NCT00337272|504189|P1|Withdrawal Period|Non-compliance|0
157031|NCT00337272|504188|P2|Treatment Period|Withdrawal by Subject|1
157032|NCT00337272|504189|P1|Treatment Period|Withdrawal by Subject|0
157033|NCT00337272|504188|P2|Treatment Period|Non-compliance|1
157034|NCT00337272|504189|P1|Treatment Period|Non-compliance|1
157035|NCT00337272|504188|P2|Screening Period (Pre-randomization)|Screen failure|0
157036|NCT00337272|504189|P1|Screening Period (Pre-randomization)|Screen failure|3
157037|NCT00337272|504188|P2|Screening Period (Pre-randomization)|Non-compliance|0
157038|NCT00337272|504189|P1|Screening Period (Pre-randomization)|Non-compliance|1
157039|NCT00337272|504188|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
157040|NCT00337272|504189|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
157041|NCT00337207|504209|P1|Overall Study|Withdrawal by Subject|3
157042|NCT00337194|504215|P2|Overall Study|Subsequent non-protocol therapy|1
157043|NCT00337194|504216|P1|Overall Study|Subsequent non-protocol therapy|3
157044|NCT00337194|504215|P2|Overall Study|Disease progression|2
157045|NCT00337194|504216|P1|Overall Study|Disease progression|1
157046|NCT00337194|504215|P2|Overall Study|Withdrawal by Subject|0
157047|NCT00337194|504216|P1|Overall Study|Withdrawal by Subject|1
157048|NCT00337194|504215|P2|Overall Study|Death|0
157049|NCT00337194|504216|P1|Overall Study|Death|2
157050|NCT00337194|504215|P2|Overall Study|Adverse Event|1
157051|NCT00337194|504216|P1|Overall Study|Adverse Event|5
157052|NCT00337168|504231|P1|Overall Study|Did not start therapy|1
157053|NCT00337168|504231|P1|Overall Study|Not protocol specified|2
157054|NCT00337168|504231|P1|Overall Study|Death|5
157055|NCT00337129|504238|P1|Overall Study|not protocol specified|1
157056|NCT00337129|504238|P1|Overall Study|Death|2
157057|NCT00337129|504238|P1|Overall Study|Lack of Efficacy|32
157058|NCT00337129|504238|P1|Overall Study|Withdrawal by Subject|1
157059|NCT00337129|504238|P1|Overall Study|Adverse Event|4
157060|NCT00337103|504247|P2|Overall Study|Death|0
157061|NCT00337103|504248|P1|Overall Study|Death|1
157062|NCT00337103|504247|P2|Overall Study|Lost to Follow-up|2
157063|NCT00337103|504248|P1|Overall Study|Lost to Follow-up|1
157064|NCT00337103|504247|P2|Overall Study|Entry Criteria Not Met|1
157065|NCT00337103|504248|P1|Overall Study|Entry Criteria Not Met|4
157066|NCT00337103|504247|P2|Overall Study|Not specified|6
157067|NCT00337103|504248|P1|Overall Study|Not specified|5
157068|NCT00337103|504247|P2|Overall Study|Withdrawal by Subject|5
157069|NCT00337103|504248|P1|Overall Study|Withdrawal by Subject|8
157070|NCT00337103|504247|P2|Overall Study|Physician Decision|14
157071|NCT00337103|504248|P1|Overall Study|Physician Decision|15
157072|NCT00337103|504247|P2|Overall Study|Clinical Progression|24
157073|NCT00337103|504248|P1|Overall Study|Clinical Progression|27
157074|NCT00337103|504247|P2|Overall Study|Subject Choice|27
157075|NCT00337103|504248|P1|Overall Study|Subject Choice|34
157076|NCT00337103|504247|P2|Overall Study|Adverse Event|59
157077|NCT00337103|504248|P1|Overall Study|Adverse Event|45
157078|NCT00337103|504247|P2|Overall Study|Progressive Disease|405
157079|NCT00337103|504248|P1|Overall Study|Progressive Disease|409
157080|NCT00337077|504259|P3|Overall Study|Ineligible|1
157081|NCT00337077|504260|P2|Overall Study|Ineligible|1
157082|NCT00337077|504261|P1|Overall Study|Ineligible|1
157083|NCT00337077|504259|P3|Overall Study|Never started treatment|0
157084|NCT00337077|504260|P2|Overall Study|Never started treatment|1
157085|NCT00337077|504261|P1|Overall Study|Never started treatment|1
157086|NCT00337077|504259|P3|Overall Study|Physician Decision|2
157087|NCT00337077|504260|P2|Overall Study|Physician Decision|4
157088|NCT00337077|504261|P1|Overall Study|Physician Decision|1
157089|NCT00337077|504259|P3|Overall Study|Alternative therapy|0
157090|NCT00337077|504260|P2|Overall Study|Alternative therapy|0
157091|NCT00337077|504261|P1|Overall Study|Alternative therapy|1
157092|NCT00337077|504259|P3|Overall Study|Withdrawal by Subject|2
157093|NCT00337077|504260|P2|Overall Study|Withdrawal by Subject|2
157094|NCT00337077|504261|P1|Overall Study|Withdrawal by Subject|7
157095|NCT00337077|504259|P3|Overall Study|Death|0
157096|NCT00337077|504260|P2|Overall Study|Death|1
157097|NCT00337077|504261|P1|Overall Study|Death|0
157098|NCT00337077|504259|P3|Overall Study|Adverse Event|1
157099|NCT00337077|504260|P2|Overall Study|Adverse Event|7
157100|NCT00337077|504261|P1|Overall Study|Adverse Event|7
157101|NCT00337077|504259|P3|Overall Study|Progressive disease|19
157102|NCT00337077|504260|P2|Overall Study|Progressive disease|37
157103|NCT00337077|504261|P1|Overall Study|Progressive disease|25
157104|NCT00336895|504276|P1|Overall Study|screen failed|1
157105|NCT00336895|504276|P1|Overall Study|Physician Decision|1
157106|NCT00336895|504276|P1|Overall Study|nausea and upset stomach|1
157107|NCT00336895|504276|P1|Overall Study|diarrhea|1
157108|NCT00336856|504282|P1|Overall Study|Found ineligible at time of analysis|1
157109|NCT00336856|504282|P1|Overall Study|Withdrawal by Subject|3
157110|NCT00336583|504297|P1|Overall Study|Death|1
157111|NCT00336583|504297|P1|Overall Study|Lost to Follow-up|1
157112|NCT00336544|504304|P2|Overall Study|Other|5
157113|NCT00336544|504305|P1|Overall Study|Other|3
157114|NCT00336544|504304|P2|Overall Study|Withdrawal by Subject|3
157115|NCT00336544|504305|P1|Overall Study|Withdrawal by Subject|4
157116|NCT00336544|504304|P2|Overall Study|Adverse Event|9
157117|NCT00336544|504305|P1|Overall Study|Adverse Event|4
157118|NCT00336544|504304|P2|Overall Study|Lack of Efficacy|5
157119|NCT00336544|504305|P1|Overall Study|Lack of Efficacy|8
157120|NCT00336505|504319|P2|Overall Study|Other|7
157121|NCT00336505|504320|P1|Overall Study|Other|7
157122|NCT00336505|504319|P2|Overall Study|Withdrawal by Subject|3
157123|NCT00336505|504320|P1|Overall Study|Withdrawal by Subject|5
157124|NCT00336505|504319|P2|Overall Study|Lost to Follow-up|4
157125|NCT00336505|504320|P1|Overall Study|Lost to Follow-up|7
157126|NCT00336505|504319|P2|Overall Study|Lack of Efficacy|4
157127|NCT00336505|504320|P1|Overall Study|Lack of Efficacy|8
157128|NCT00336505|504319|P2|Overall Study|Adverse Event|9
157129|NCT00336505|504320|P1|Overall Study|Adverse Event|10
157130|NCT00336492|504335|P3|Overall Study|Other|1
157131|NCT00336492|504336|P2|Overall Study|Other|0
157132|NCT00336492|504337|P1|Overall Study|Other|5
157133|NCT00336492|504335|P3|Overall Study|Lack of Efficacy|4
157134|NCT00336492|504336|P2|Overall Study|Lack of Efficacy|1
157135|NCT00336492|504337|P1|Overall Study|Lack of Efficacy|6
157136|NCT00336492|504335|P3|Overall Study|Adverse Event|6
157137|NCT00336492|504336|P2|Overall Study|Adverse Event|3
157138|NCT00336492|504337|P1|Overall Study|Adverse Event|4
157139|NCT00336479|504349|P4|Overall Study|Virologic Stopping Rule|0
157140|NCT00336479|504350|P3|Overall Study|Virologic Stopping Rule|0
157141|NCT00336479|504351|P2|Overall Study|Virologic Stopping Rule|0
157142|NCT00336479|504352|P1|Overall Study|Virologic Stopping Rule|20
157143|NCT00336479|504349|P4|Overall Study|Unspecified|0
157144|NCT00336479|504350|P3|Overall Study|Unspecified|1
157145|NCT00336479|504351|P2|Overall Study|Unspecified|0
157146|NCT00336479|504352|P1|Overall Study|Unspecified|0
157147|NCT00336479|504349|P4|Overall Study|Withdrawal by Subject|0
157148|NCT00336479|504350|P3|Overall Study|Withdrawal by Subject|3
157149|NCT00336479|504351|P2|Overall Study|Withdrawal by Subject|2
157150|NCT00336479|504352|P1|Overall Study|Withdrawal by Subject|3
157151|NCT00336479|504349|P4|Overall Study|Lost to Follow-up|0
157152|NCT00336479|504350|P3|Overall Study|Lost to Follow-up|0
157153|NCT00336479|504351|P2|Overall Study|Lost to Follow-up|2
157154|NCT00336479|504352|P1|Overall Study|Lost to Follow-up|3
157155|NCT00336479|504349|P4|Overall Study|Physician Decision|0
157156|NCT00336479|504350|P3|Overall Study|Physician Decision|1
157157|NCT00336479|504351|P2|Overall Study|Physician Decision|3
157158|NCT00336479|504352|P1|Overall Study|Physician Decision|2
157159|NCT00336479|504349|P4|Overall Study|Noncompliant|0
157160|NCT00336479|504350|P3|Overall Study|Noncompliant|3
157161|NCT00336479|504351|P2|Overall Study|Noncompliant|7
157162|NCT00336479|504352|P1|Overall Study|Noncompliant|1
157163|NCT00336479|504349|P4|Overall Study|Adverse Event|4
157164|NCT00336479|504350|P3|Overall Study|Adverse Event|18
157165|NCT00336479|504351|P2|Overall Study|Adverse Event|11
157166|NCT00336479|504352|P1|Overall Study|Adverse Event|8
157167|NCT00336284|504441|P2|Overall Study|Withdrawal by Physician or Subject|64
157168|NCT00336284|504442|P1|Overall Study|Withdrawal by Physician or Subject|102
157169|NCT00336284|504441|P2|Overall Study|Lost to Follow-up|61
157170|NCT00336284|504442|P1|Overall Study|Lost to Follow-up|82
157171|NCT00336284|504441|P2|Overall Study|Death|26
157172|NCT00336284|504442|P1|Overall Study|Death|52
157173|NCT00335959|504458|P1|Overall Study|Ineligible|1
157174|NCT00335959|504458|P1|Overall Study|Adverse Event|2
157175|NCT00335777|504463|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
157176|NCT00335777|504463|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
157177|NCT00335777|504463|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
157178|NCT00335777|504463|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
157179|NCT00335777|504463|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
157180|NCT00335452|504520|P4|Overall Study|Lost to Follow-up|2
157181|NCT00335452|504521|P3|Overall Study|Lost to Follow-up|1
157182|NCT00335452|504522|P2|Overall Study|Lost to Follow-up|3
157183|NCT00335452|504523|P1|Overall Study|Lost to Follow-up|2
157184|NCT00335452|504520|P4|Overall Study|Death|129
157185|NCT00335452|504521|P3|Overall Study|Death|158
157186|NCT00335452|504522|P2|Overall Study|Death|144
157187|NCT00335452|504523|P1|Overall Study|Death|156
157188|NCT00335322|504548|P3|Overall Study|Randomised but withdrew prior to ART sta|2
157189|NCT00335322|504549|P2|Overall Study|Randomised but withdrew prior to ART sta|2
157190|NCT00335322|504550|P1|Overall Study|Randomised but withdrew prior to ART sta|1
157191|NCT00335153|504595|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
157192|NCT00335153|504595|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
157193|NCT00335153|504595|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
157194|NCT00335153|504595|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
157195|NCT00335153|504595|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
157196|NCT00335153|504595|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
157197|NCT00335153|504595|P1|Nasojejunal (NJ) Test Period|Administrative|1
157198|NCT00335153|504595|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
157199|NCT00335153|504595|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
157200|NCT00335153|504595|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
157201|NCT00334958|504634|P2|Overall Study|Not specified|2
157202|NCT00334958|504635|P1|Overall Study|Not specified|1
157203|NCT00334958|504634|P2|Overall Study|Adverse Event|12
157204|NCT00334958|504635|P1|Overall Study|Adverse Event|27
157205|NCT00334958|504634|P2|Overall Study|Withdrawal by Subject|4
157206|NCT00334958|504635|P1|Overall Study|Withdrawal by Subject|7
157207|NCT00334958|504634|P2|Overall Study|Request of the investigator or sponsor|1
157208|NCT00334958|504635|P1|Overall Study|Request of the investigator or sponsor|0
157209|NCT00334958|504634|P2|Overall Study|Protocol Violation|2
157210|NCT00334958|504635|P1|Overall Study|Protocol Violation|2
157211|NCT00334958|504634|P2|Overall Study|Medication Noncompliance|3
157212|NCT00334958|504635|P1|Overall Study|Medication Noncompliance|0
157213|NCT00334893|504649|P2|Overall Study|Not Treated|0
157214|NCT00334893|504650|P1|Overall Study|Not Treated|1
157215|NCT00334815|504658|P2|Overall Study|Physician Decision|4
157216|NCT00334815|504659|P1|Overall Study|Physician Decision|2
157217|NCT00334815|504658|P2|Overall Study|patient refused treatment|1
157218|NCT00334815|504659|P1|Overall Study|patient refused treatment|0
157219|NCT00334815|504658|P2|Overall Study|ineligible|1
157220|NCT00334815|504659|P1|Overall Study|ineligible|1
157221|NCT00334815|504658|P2|Overall Study|Progression|0
157222|NCT00334815|504659|P1|Overall Study|Progression|1
157223|NCT00334815|504658|P2|Overall Study|Death|2
157224|NCT00334815|504659|P1|Overall Study|Death|0
157225|NCT00334815|504658|P2|Overall Study|Adverse Event|2
157226|NCT00334815|504659|P1|Overall Study|Adverse Event|3
157227|NCT00334802|504673|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
157228|NCT00334802|504674|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
157229|NCT00334802|504673|P2|Overall Study|Adverse Event|3
157230|NCT00334802|504674|P1|Overall Study|Adverse Event|0
157231|NCT00334802|504673|P2|Overall Study|Withdrawal by Subject|4
157232|NCT00334802|504674|P1|Overall Study|Withdrawal by Subject|0
157233|NCT00334802|504673|P2|Overall Study|Physician Decision|0
157234|NCT00334802|504674|P1|Overall Study|Physician Decision|1
157235|NCT00334802|504673|P2|Overall Study|Patient Condition Aggrevated|0
157236|NCT00334802|504674|P1|Overall Study|Patient Condition Aggrevated|1
157237|NCT00334802|504673|P2|Overall Study|Lack of Efficacy|3
157238|NCT00334802|504674|P1|Overall Study|Lack of Efficacy|1
157239|NCT00334802|504673|P2|Overall Study|Toxicity|5
157240|NCT00334802|504674|P1|Overall Study|Toxicity|1
157241|NCT00334802|504673|P2|Overall Study|Progressive Disease|24
157242|NCT00334802|504674|P1|Overall Study|Progressive Disease|2
157243|NCT00334542|504704|P1|Overall Study|New cancer diagnosis|1
157244|NCT00334542|504704|P1|Overall Study|Withdrawal by Subject|1
157245|NCT00334542|504704|P1|Overall Study|Adverse Event|3
157246|NCT00334295|504709|P1|Overall Study|Patients received fewer than 3 injection|5
157247|NCT00334282|504719|P2|Overall Study|Death|100
157248|NCT00334282|504720|P1|Overall Study|Death|194
157249|NCT00334282|504719|P2|Overall Study|Withdrawal by Subject|3
157250|NCT00334282|504720|P1|Overall Study|Withdrawal by Subject|17
157251|NCT00334282|504719|P2|Overall Study|Lost to Follow-up|5
157252|NCT00334282|504720|P1|Overall Study|Lost to Follow-up|11
157253|NCT00334113|504751|P2|Overall Study|Withdrawal by Subject|1
157254|NCT00334113|504752|P1|Overall Study|Withdrawal by Subject|0
157255|NCT00334113|504751|P2|Overall Study|Lost to Follow-up|2
157256|NCT00334113|504752|P1|Overall Study|Lost to Follow-up|2
157257|NCT00333983|504775|P3|Overall Study|Withdrawal by Subject|1
157258|NCT00333983|504776|P2|Overall Study|Withdrawal by Subject|3
157259|NCT00333983|504777|P1|Overall Study|Withdrawal by Subject|0
157260|NCT00333983|504775|P3|Overall Study|Adverse Event|1
157261|NCT00333983|504776|P2|Overall Study|Adverse Event|1
157262|NCT00333983|504777|P1|Overall Study|Adverse Event|1
157263|NCT00333983|504775|P3|Overall Study|Lost to Follow-up|0
157264|NCT00333983|504776|P2|Overall Study|Lost to Follow-up|1
157265|NCT00333983|504777|P1|Overall Study|Lost to Follow-up|2
157266|NCT00333970|504787|P2|Overall Study|Withdrawal by Subject|7
157267|NCT00333970|504788|P1|Overall Study|Withdrawal by Subject|13
157268|NCT00333866|504803|P4|Overall Study|Randomized but not Treated|1
157269|NCT00333866|504804|P3|Overall Study|Randomized but not Treated|2
157270|NCT00333866|504805|P2|Overall Study|Randomized but not Treated|3
157271|NCT00333866|504806|P1|Overall Study|Randomized but not Treated|5
157272|NCT00333866|504803|P4|Overall Study|Withdrawal by Subject|9
157273|NCT00333866|504804|P3|Overall Study|Withdrawal by Subject|4
157274|NCT00333866|504805|P2|Overall Study|Withdrawal by Subject|14
157275|NCT00333866|504806|P1|Overall Study|Withdrawal by Subject|8
157276|NCT00333866|504803|P4|Overall Study|Lost to Follow-up|2
157277|NCT00333866|504804|P3|Overall Study|Lost to Follow-up|2
157278|NCT00333866|504805|P2|Overall Study|Lost to Follow-up|2
157279|NCT00333866|504806|P1|Overall Study|Lost to Follow-up|1
157280|NCT00333866|504803|P4|Overall Study|Lack of Efficacy|5
157281|NCT00333866|504804|P3|Overall Study|Lack of Efficacy|3
157282|NCT00333866|504805|P2|Overall Study|Lack of Efficacy|6
157283|NCT00333866|504806|P1|Overall Study|Lack of Efficacy|8
157284|NCT00333866|504803|P4|Overall Study|Unspecified|2
157285|NCT00333866|504804|P3|Overall Study|Unspecified|2
157286|NCT00333866|504805|P2|Overall Study|Unspecified|2
157287|NCT00333866|504806|P1|Overall Study|Unspecified|3
157288|NCT00333866|504803|P4|Overall Study|Adverse Event|47
157289|NCT00333866|504804|P3|Overall Study|Adverse Event|38
157290|NCT00333866|504805|P2|Overall Study|Adverse Event|37
157291|NCT00333866|504806|P1|Overall Study|Adverse Event|23
157292|NCT00333840|504866|P4|Second-line Treatment Period|Death|9
157293|NCT00333840|504867|P3|Second-line Treatment Period|Death|0
157294|NCT00333840|504868|P2|Second-line Treatment Period|Death|0
157295|NCT00333840|504869|P1|Second-line Treatment Period|Death|0
157296|NCT00333840|504866|P4|Second-line Treatment Period|Administrative problems|7
157297|NCT00333840|504867|P3|Second-line Treatment Period|Administrative problems|0
157298|NCT00333840|504868|P2|Second-line Treatment Period|Administrative problems|0
157299|NCT00333840|504869|P1|Second-line Treatment Period|Administrative problems|0
157300|NCT00333840|504866|P4|Second-line Treatment Period|Lost to Follow-up|6
157301|NCT00333840|504867|P3|Second-line Treatment Period|Lost to Follow-up|0
157302|NCT00333840|504868|P2|Second-line Treatment Period|Lost to Follow-up|0
157303|NCT00333840|504869|P1|Second-line Treatment Period|Lost to Follow-up|0
157304|NCT00333840|504866|P4|Second-line Treatment Period|Subject withdrew consent|34
157305|NCT00333840|504867|P3|Second-line Treatment Period|Subject withdrew consent|0
157306|NCT00333840|504868|P2|Second-line Treatment Period|Subject withdrew consent|0
157307|NCT00333840|504869|P1|Second-line Treatment Period|Subject withdrew consent|0
157308|NCT00333840|504866|P4|Second-line Treatment Period|Protocol Violation|10
157309|NCT00333840|504867|P3|Second-line Treatment Period|Protocol Violation|1
157310|NCT00333840|504868|P2|Second-line Treatment Period|Protocol Violation|0
157311|NCT00333840|504869|P1|Second-line Treatment Period|Protocol Violation|0
157312|NCT00333840|504866|P4|Second-line Treatment Period|No longer required study drug|14
157313|NCT00333840|504867|P3|Second-line Treatment Period|No longer required study drug|1
157314|NCT00333840|504868|P2|Second-line Treatment Period|No longer required study drug|0
157315|NCT00333840|504869|P1|Second-line Treatment Period|No longer required study drug|0
157316|NCT00333840|504866|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
157317|NCT00333840|504867|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
157318|NCT00333840|504868|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
157319|NCT00333840|504869|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
157320|NCT00333840|504866|P4|Second-line Treatment Period|Abnormal procedure|1
157321|NCT00333840|504867|P3|Second-line Treatment Period|Abnormal procedure|0
157322|NCT00333840|504868|P2|Second-line Treatment Period|Abnormal procedure|0
157323|NCT00333840|504869|P1|Second-line Treatment Period|Abnormal procedure|0
157324|NCT00333840|504866|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
157325|NCT00333840|504867|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
157326|NCT00333840|504868|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
157327|NCT00333840|504869|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
157328|NCT00333840|504866|P4|Second-line Treatment Period|Adverse Event|34
157329|NCT00333840|504867|P3|Second-line Treatment Period|Adverse Event|3
157330|NCT00333840|504868|P2|Second-line Treatment Period|Adverse Event|0
157331|NCT00333840|504869|P1|Second-line Treatment Period|Adverse Event|0
157332|NCT00333840|504866|P4|First-line Treatment Period|Crossed over to other treatment arm|0
157333|NCT00333840|504867|P3|First-line Treatment Period|Crossed over to other treatment arm|0
157334|NCT00333840|504868|P2|First-line Treatment Period|Crossed over to other treatment arm|363
157335|NCT00333840|504869|P1|First-line Treatment Period|Crossed over to other treatment arm|14
157336|NCT00333840|504866|P4|First-line Treatment Period|Death|0
157337|NCT00333840|504867|P3|First-line Treatment Period|Death|0
157338|NCT00333840|504868|P2|First-line Treatment Period|Death|2
157339|NCT00333840|504869|P1|First-line Treatment Period|Death|19
157340|NCT00333840|504866|P4|First-line Treatment Period|Administrative problems|0
157341|NCT00333840|504867|P3|First-line Treatment Period|Administrative problems|0
157342|NCT00333840|504868|P2|First-line Treatment Period|Administrative problems|6
157343|NCT00333840|504869|P1|First-line Treatment Period|Administrative problems|12
157344|NCT00333840|504866|P4|First-line Treatment Period|Lost to Follow-up|0
157345|NCT00333840|504867|P3|First-line Treatment Period|Lost to Follow-up|0
157346|NCT00333840|504868|P2|First-line Treatment Period|Lost to Follow-up|6
157347|NCT00333840|504869|P1|First-line Treatment Period|Lost to Follow-up|15
157348|NCT00333840|504866|P4|First-line Treatment Period|Subject withdrew consent|0
157349|NCT00333840|504867|P3|First-line Treatment Period|Subject withdrew consent|0
157350|NCT00333840|504868|P2|First-line Treatment Period|Subject withdrew consent|77
157351|NCT00333840|504869|P1|First-line Treatment Period|Subject withdrew consent|57
157352|NCT00333840|504866|P4|First-line Treatment Period|Protocol Violation|0
157353|NCT00333840|504867|P3|First-line Treatment Period|Protocol Violation|0
157354|NCT00333840|504868|P2|First-line Treatment Period|Protocol Violation|17
157355|NCT00333840|504869|P1|First-line Treatment Period|Protocol Violation|17
157356|NCT00333840|504866|P4|First-line Treatment Period|No longer required study drug|0
157357|NCT00333840|504867|P3|First-line Treatment Period|No longer required study drug|0
157358|NCT00333840|504868|P2|First-line Treatment Period|No longer required study drug|8
157359|NCT00333840|504869|P1|First-line Treatment Period|No longer required study drug|21
157360|NCT00333840|504866|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
157361|NCT00333840|504867|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
157362|NCT00333840|504868|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
157363|NCT00333840|504869|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
157364|NCT00333840|504866|P4|First-line Treatment Period|Abnormal procedure|0
157365|NCT00333840|504867|P3|First-line Treatment Period|Abnormal procedure|0
157366|NCT00333840|504868|P2|First-line Treatment Period|Abnormal procedure|0
157367|NCT00333840|504869|P1|First-line Treatment Period|Abnormal procedure|2
157368|NCT00333840|504866|P4|First-line Treatment Period|Abnormal laboratory values|0
157369|NCT00333840|504867|P3|First-line Treatment Period|Abnormal laboratory values|0
157370|NCT00333840|504868|P2|First-line Treatment Period|Abnormal laboratory values|1
157371|NCT00333840|504869|P1|First-line Treatment Period|Abnormal laboratory values|3
157372|NCT00333840|504866|P4|First-line Treatment Period|Adverse Event|0
157373|NCT00333840|504867|P3|First-line Treatment Period|Adverse Event|0
157374|NCT00333840|504868|P2|First-line Treatment Period|Adverse Event|37
157375|NCT00333840|504869|P1|First-line Treatment Period|Adverse Event|38
157376|NCT00333801|504915|P2|Overall Study|Withdrawal by Subject|1
157377|NCT00333801|504916|P1|Overall Study|Withdrawal by Subject|0
157378|NCT00333801|504915|P2|Overall Study|Incarcerated|2
157379|NCT00333801|504916|P1|Overall Study|Incarcerated|1
157380|NCT00333801|504915|P2|Overall Study|Lost to Follow-up|0
157381|NCT00333801|504916|P1|Overall Study|Lost to Follow-up|2
157382|NCT00333801|504915|P2|Overall Study|Moved to another state|3
157383|NCT00333801|504916|P1|Overall Study|Moved to another state|5
157384|NCT00333788|504934|P1|Overall Study|Other: Signed consent for another study|1
157385|NCT00333788|504934|P1|Overall Study|Other: Physician decision|1
157386|NCT00333788|504934|P1|Overall Study|Other: Medical monitor decision|1
157387|NCT00333788|504934|P1|Overall Study|Other: Subject in need of an Entocort|1
157388|NCT00333788|504934|P1|Overall Study|Other: Sponsor decision|1
157389|NCT00333788|504934|P1|Overall Study|Other: Quality of life concern|1
157390|NCT00333788|504934|P1|Overall Study|Other: Investigator decision|1
157391|NCT00333788|504934|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
157392|NCT00333788|504934|P1|Overall Study|Other: Moved|2
157393|NCT00333788|504934|P1|Overall Study|Other: Non-compliance|2
157394|NCT00333788|504934|P1|Overall Study|Withdrawal by Subject|24
157395|NCT00333788|504934|P1|Overall Study|Lost to Follow-up|2
157396|NCT00333788|504934|P1|Overall Study|Lack of Efficacy|80
157397|NCT00333788|504934|P1|Overall Study|Adverse Event|44
157398|NCT00333775|504964|P3|Overall Study|Lost to Follow-up|8
157399|NCT00333775|504965|P2|Overall Study|Lost to Follow-up|7
157400|NCT00333775|504966|P1|Overall Study|Lost to Follow-up|10
157401|NCT00333775|504964|P3|Overall Study|In Follow−up When Study Stopped|96
157402|NCT00333775|504965|P2|Overall Study|In Follow−up When Study Stopped|92
157403|NCT00333775|504966|P1|Overall Study|In Follow−up When Study Stopped|87
157404|NCT00333775|504964|P3|Overall Study|Death|143
157405|NCT00333775|504965|P2|Overall Study|Death|149
157406|NCT00333775|504966|P1|Overall Study|Death|144
157407|NCT00333619|505005|P2|Overall Study|Lost to Follow-up|3
157408|NCT00333619|505006|P1|Overall Study|Lost to Follow-up|3
157409|NCT00333619|505005|P2|Overall Study|Withdrawal by Subject|1
157410|NCT00333619|505006|P1|Overall Study|Withdrawal by Subject|6
157411|NCT00333619|505005|P2|Overall Study|Death|6
157412|NCT00333619|505006|P1|Overall Study|Death|12
157413|NCT00333359|505024|P2|Overall Study|Withdrew before Receiving One Dose|6
157414|NCT00333359|505025|P1|Overall Study|Withdrew before Receiving One Dose|2
157415|NCT00333359|505024|P2|Overall Study|Treatment Failure|8
157416|NCT00333359|505025|P1|Overall Study|Treatment Failure|3
157417|NCT00333359|505024|P2|Overall Study|Termination or Withdrawal by Sponsor|1
157418|NCT00333359|505025|P1|Overall Study|Termination or Withdrawal by Sponsor|1
157419|NCT00333359|505024|P2|Overall Study|Lost to Follow-up|25
157420|NCT00333359|505025|P1|Overall Study|Lost to Follow-up|15
157421|NCT00333359|505024|P2|Overall Study|Protocol Non-compliance|8
157422|NCT00333359|505025|P1|Overall Study|Protocol Non-compliance|2
157423|NCT00333359|505024|P2|Overall Study|Physician Decision|2
157424|NCT00333359|505025|P1|Overall Study|Physician Decision|2
157425|NCT00333359|505024|P2|Overall Study|Withdrawal by Subject|37
157426|NCT00333359|505025|P1|Overall Study|Withdrawal by Subject|19
157427|NCT00333359|505024|P2|Overall Study|Adverse Event|35
157428|NCT00333359|505025|P1|Overall Study|Adverse Event|29
157429|NCT00333229|505068|P2|Overall Study|Lack of Efficacy|1
157430|NCT00333229|505069|P1|Overall Study|Lack of Efficacy|0
157431|NCT00333138|505086|P3|Extension Study (Month6 to End of Study)|Death|0
157432|NCT00333138|505087|P2|Extension Study (Month6 to End of Study)|Death|1
157433|NCT00333138|505088|P1|Extension Study (Month6 to End of Study)|Death|0
157434|NCT00333138|505086|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
157435|NCT00333138|505087|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
157436|NCT00333138|505088|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
157437|NCT00333138|505086|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
157438|NCT00333138|505087|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
157439|NCT00333138|505088|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
157440|NCT00333138|505086|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
157441|NCT00333138|505087|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
157442|NCT00333138|505088|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
157443|NCT00333138|505086|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
157444|NCT00333138|505087|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
157445|NCT00333138|505088|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
157446|NCT00333138|505086|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
157447|NCT00333138|505087|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
157448|NCT00333138|505088|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
157449|NCT00333138|505086|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
157450|NCT00333138|505087|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
157451|NCT00333138|505088|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
157452|NCT00333138|505086|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
157453|NCT00333138|505087|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
157454|NCT00333138|505088|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
157455|NCT00333138|505086|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
157456|NCT00333138|505087|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
157457|NCT00333138|505088|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
157458|NCT00333138|505086|P3|Core Study (6 Months)|Laboratory abnormality|1
157459|NCT00333138|505087|P2|Core Study (6 Months)|Laboratory abnormality|0
157460|NCT00333138|505088|P1|Core Study (6 Months)|Laboratory abnormality|0
157461|NCT00333138|505086|P3|Core Study (6 Months)|Protocol Violation|1
157462|NCT00333138|505087|P2|Core Study (6 Months)|Protocol Violation|0
157463|NCT00333138|505088|P1|Core Study (6 Months)|Protocol Violation|1
157464|NCT00333138|505086|P3|Core Study (6 Months)|Lack of Efficacy|0
157465|NCT00333138|505087|P2|Core Study (6 Months)|Lack of Efficacy|0
157466|NCT00333138|505088|P1|Core Study (6 Months)|Lack of Efficacy|1
157467|NCT00333138|505086|P3|Core Study (6 Months)|Withdrawal by Subject|2
157468|NCT00333138|505087|P2|Core Study (6 Months)|Withdrawal by Subject|1
157469|NCT00333138|505088|P1|Core Study (6 Months)|Withdrawal by Subject|1
157470|NCT00333138|505086|P3|Core Study (6 Months)|Adverse Event|8
157471|NCT00333138|505087|P2|Core Study (6 Months)|Adverse Event|5
157472|NCT00333138|505088|P1|Core Study (6 Months)|Adverse Event|4
157473|NCT00332839|505127|P2|Follow-up (Months 12 - 60)|Death|1
157474|NCT00332839|505128|P1|Follow-up (Months 12 - 60)|Death|1
157475|NCT00332839|505127|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
157476|NCT00332839|505128|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
157477|NCT00332839|505127|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
157478|NCT00332839|505128|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
157479|NCT00332839|505127|P2|Core (Months 0 - 12)|Adverse Event|15
157480|NCT00332839|505128|P1|Core (Months 0 - 12)|Adverse Event|5
157481|NCT00332839|505127|P2|Core (Months 0 - 12)|Protocol deviation|1
157482|NCT00332839|505128|P1|Core (Months 0 - 12)|Protocol deviation|1
157483|NCT00332839|505127|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
157484|NCT00332839|505128|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
157485|NCT00332839|505127|P2|Core (Months 0 - 12)|Administrative problems|1
157486|NCT00332839|505128|P1|Core (Months 0 - 12)|Administrative problems|1
157487|NCT00332709|505159|P2|Overall Study|Abnormal test procedure result|0
157488|NCT00332709|505160|P1|Overall Study|Abnormal test procedure result|1
157489|NCT00332709|505159|P2|Overall Study|Administrative Problems|3
157490|NCT00332709|505160|P1|Overall Study|Administrative Problems|0
157491|NCT00332709|505159|P2|Overall Study|Lost to Follow-up|0
157492|NCT00332709|505160|P1|Overall Study|Lost to Follow-up|2
157493|NCT00332709|505159|P2|Overall Study|Withdrawal by Subject|3
157494|NCT00332709|505160|P1|Overall Study|Withdrawal by Subject|2
157495|NCT00332709|505159|P2|Overall Study|Adverse Event|14
157496|NCT00332709|505160|P1|Overall Study|Adverse Event|11
157497|NCT00332696|505184|P2|Overall Study|Withdrawal by Subject|0
157498|NCT00332696|505185|P1|Overall Study|Withdrawal by Subject|1
157499|NCT00332696|505184|P2|Overall Study|Lost to Follow-up|1
157500|NCT00332696|505185|P1|Overall Study|Lost to Follow-up|0
157501|NCT00332696|505184|P2|Overall Study|Condition does not justify treatment|2
157502|NCT00332696|505185|P1|Overall Study|Condition does not justify treatment|0
157503|NCT00332696|505184|P2|Overall Study|Adverse Event|2
157504|NCT00332696|505185|P1|Overall Study|Adverse Event|1
157505|NCT00332696|505184|P2|Overall Study|Insufficient therapeutic effect|11
157506|NCT00332696|505185|P1|Overall Study|Insufficient therapeutic effect|4
157507|NCT00332696|505184|P2|Overall Study|Death|14
157508|NCT00332696|505185|P1|Overall Study|Death|24
157509|NCT00332488|505261|P3|Transfer Treatment Phase (Weeks 12 – 24)|Various|5
157510|NCT00332488|505262|P2|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
157511|NCT00332488|505263|P1|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
157512|NCT00332488|505261|P3|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|8
157513|NCT00332488|505262|P2|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
157514|NCT00332488|505263|P1|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
157515|NCT00332488|505261|P3|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|1
157516|NCT00332488|505262|P2|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
157517|NCT00332488|505263|P1|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
157518|NCT00332488|505261|P3|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|3
157519|NCT00332488|505262|P2|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
157520|NCT00332488|505263|P1|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
157521|NCT00332488|505261|P3|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|1
157522|NCT00332488|505262|P2|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
157523|NCT00332488|505263|P1|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
157524|NCT00332488|505261|P3|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|3
157525|NCT00332488|505262|P2|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
157526|NCT00332488|505263|P1|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
157527|NCT00332488|505261|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
157528|NCT00332488|505262|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
157529|NCT00332488|505263|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
157530|NCT00332488|505261|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
157531|NCT00332488|505262|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
157532|NCT00332488|505263|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
157533|NCT00332488|505261|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
157534|NCT00332488|505262|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
157535|NCT00332488|505263|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
157536|NCT00332488|505261|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
157537|NCT00332488|505262|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
157538|NCT00332488|505263|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
157539|NCT00332488|505261|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
157540|NCT00332488|505262|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
157541|NCT00332488|505263|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
157542|NCT00332488|505261|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
157543|NCT00332488|505262|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
157544|NCT00332488|505263|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
157545|NCT00332462|505275|P1|Overall Study|Graft Loss|2
157546|NCT00332462|505275|P1|Overall Study|Death|3
157547|NCT00332462|505275|P1|Overall Study|no longer requires study drug|1
157548|NCT00332462|505275|P1|Overall Study|Unsatisfactory therapeutic effect|4
157549|NCT00332462|505275|P1|Overall Study|Abnormal Lab Value|1
157550|NCT00332462|505275|P1|Overall Study|Adverse Event|5
157551|NCT00330759|505284|P2|Overall Study|Other|44
157552|NCT00330759|505285|P1|Overall Study|Other|36
157553|NCT00330759|505284|P2|Overall Study|Ineligibility determined|1
157554|NCT00330759|505285|P1|Overall Study|Ineligibility determined|2
157555|NCT00330759|505284|P2|Overall Study|Protocol deviation|2
157556|NCT00330759|505285|P1|Overall Study|Protocol deviation|0
157557|NCT00330759|505284|P2|Overall Study|Physician Decision|2
157558|NCT00330759|505285|P1|Overall Study|Physician Decision|1
157559|NCT00330759|505284|P2|Overall Study|Noncompliance|17
157560|NCT00330759|505285|P1|Overall Study|Noncompliance|15
157561|NCT00330759|505284|P2|Overall Study|Lost to Follow-up|22
157562|NCT00330759|505285|P1|Overall Study|Lost to Follow-up|16
157563|NCT00330759|505284|P2|Overall Study|Participant request|22
157564|NCT00330759|505285|P1|Overall Study|Participant request|31
157565|NCT00330759|505284|P2|Overall Study|Adverse Event|36
157566|NCT00330759|505285|P1|Overall Study|Adverse Event|48
157567|NCT00330759|505284|P2|Overall Study|Withdrawal by Subject|124
157568|NCT00330759|505285|P1|Overall Study|Withdrawal by Subject|143
157569|NCT00330759|505284|P2|Overall Study|Disease progression|126
157570|NCT00330759|505285|P1|Overall Study|Disease progression|104
157571|NCT00330759|505284|P2|Overall Study|Death|310
157572|NCT00330759|505285|P1|Overall Study|Death|316
157573|NCT00330668|505304|P1|Overall Study|Patient started Lupron|1
157574|NCT00330668|505304|P1|Overall Study|Use of exclusionary medication|1
157575|NCT00330668|505304|P1|Overall Study|Lack of Efficacy|1
157576|NCT00330668|505304|P1|Overall Study|Sponsor's decision|76
157577|NCT00330668|505304|P1|Overall Study|Withdrawal by Subject|20
157578|NCT00330668|505304|P1|Overall Study|Non-Compliance|5
157579|NCT00330668|505304|P1|Overall Study|Lost to Follow-up|9
157580|NCT00330668|505304|P1|Overall Study|Adverse Event|1
157581|NCT00330616|505311|P1|Overall Study|Not specified|1
157582|NCT00330616|505311|P1|Overall Study|Withdrawal by Subject|4
157583|NCT00330616|505311|P1|Overall Study|Lost to Follow-up|2
157584|NCT00330616|505311|P1|Overall Study|Lack of Efficacy|1
157585|NCT00330616|505311|P1|Overall Study|Adverse Event|13
157586|NCT00332332|505335|P1|Overall Study|Did not receive study treatment|16
157587|NCT00332332|505335|P1|Overall Study|Not specified|18
157588|NCT00332332|505335|P1|Overall Study|Disease progression|2
157589|NCT00332332|505335|P1|Overall Study|Noncompliance|2
157590|NCT00332332|505335|P1|Overall Study|Protocol deviation|4
157591|NCT00332332|505335|P1|Overall Study|Lost to Follow-up|3
157592|NCT00332332|505335|P1|Overall Study|Physician Decision|1
157593|NCT00332332|505335|P1|Overall Study|Withdrawal by Subject|8
157594|NCT00332332|505335|P1|Overall Study|Death|1
157595|NCT00332332|505335|P1|Overall Study|Adverse Event|13
157596|NCT00332241|505344|P2|Overall Study|Lost to Follow-up|1
157597|NCT00332241|505345|P1|Overall Study|Lost to Follow-up|4
157598|NCT00332241|505344|P2|Overall Study|Withdrawal by Subject|1
157599|NCT00332241|505345|P1|Overall Study|Withdrawal by Subject|2
157600|NCT00332241|505344|P2|Overall Study|Adverse Event|5
157601|NCT00332241|505345|P1|Overall Study|Adverse Event|3
157602|NCT00332241|505344|P2|Overall Study|Lack of Efficacy|1
157603|NCT00332241|505345|P1|Overall Study|Lack of Efficacy|6
157604|NCT00332189|505365|P1|Overall Study|Moved out of country|2
157605|NCT00332189|505365|P1|Overall Study|Lack of Efficacy|4
157606|NCT00332189|505365|P1|Overall Study|Withdrawal by Subject|9
157607|NCT00332189|505365|P1|Overall Study|Uncooperative/Noncompliant|3
157608|NCT00332189|505365|P1|Overall Study|Adverse Event|3
157609|NCT00330460|505407|P2|Overall Study|Other|0
157610|NCT00330460|505408|P1|Overall Study|Other|1
157611|NCT00330460|505407|P2|Overall Study|Noncompliance|1
157612|NCT00330460|505408|P1|Overall Study|Noncompliance|2
157613|NCT00330460|505407|P2|Overall Study|Lost to Follow-up|3
157614|NCT00330460|505408|P1|Overall Study|Lost to Follow-up|8
157615|NCT00330460|505407|P2|Overall Study|Ineligibility determined|3
157616|NCT00330460|505408|P1|Overall Study|Ineligibility determined|1
157617|NCT00330460|505407|P2|Overall Study|Death|1
157618|NCT00330460|505408|P1|Overall Study|Death|1
157619|NCT00330460|505407|P2|Overall Study|Withdrawal by Subject|17
157620|NCT00330460|505408|P1|Overall Study|Withdrawal by Subject|18
157621|NCT00330460|505407|P2|Overall Study|Adverse Event|8
157622|NCT00330460|505408|P1|Overall Study|Adverse Event|10
157623|NCT00330460|505407|P2|Overall Study|Physician Decision|0
157624|NCT00330460|505408|P1|Overall Study|Physician Decision|1
157625|NCT00331864|505453|P2|Overall Study|Death|0
157626|NCT00331864|505454|P1|Overall Study|Death|6
157627|NCT00331864|505453|P2|Overall Study|Administrative Problems|0
157628|NCT00331864|505454|P1|Overall Study|Administrative Problems|1
157629|NCT00331864|505453|P2|Overall Study|Lost to Follow-up|3
157630|NCT00331864|505454|P1|Overall Study|Lost to Follow-up|4
157631|NCT00331864|505453|P2|Overall Study|Withdrawal by Subject|0
157632|NCT00331864|505454|P1|Overall Study|Withdrawal by Subject|10
157633|NCT00331864|505453|P2|Overall Study|Protocol Violation|0
157634|NCT00331864|505454|P1|Overall Study|Protocol Violation|3
157635|NCT00331864|505453|P2|Overall Study|Lack of Efficacy|0
157636|NCT00331864|505454|P1|Overall Study|Lack of Efficacy|4
157637|NCT00331864|505453|P2|Overall Study|Adverse Event|1
157638|NCT00331864|505454|P1|Overall Study|Adverse Event|30
157639|NCT00331799|505473|P1|Overall Study|Sedation|1
157640|NCT00331799|505473|P1|Overall Study|Withdrawal by Subject|2
157641|NCT00331760|505479|P2|Overall Study|Ineligible / no protocol treatment|8
157642|NCT00331760|505480|P1|Overall Study|Ineligible / no protocol treatment|15
157643|NCT00331682|505486|P1|Overall Study|Adverse Event|1
157644|NCT00331422|505492|P1|Overall Study|Did not receive entire study regimen|5
157645|NCT00331409|505501|P1|Overall Study|Lack of Efficacy|4
157646|NCT00331006|505508|P1|Follow-Up Phase II|Lost to Follow-up|3
157647|NCT00331006|505508|P1|Follow-Up Phase I|Lost to Follow-up|1
157648|NCT00331006|505508|P1|Treatment Phase|Withdrawal by Subject|1
157649|NCT00331006|505508|P1|Screening Phase|Ineligible for treatment phase|4
157650|NCT00331006|505508|P1|Screening Phase|Lost to Follow-up|1
157651|NCT00331006|505508|P1|Screening Phase|enrollment halted|1
157652|NCT00331006|505508|P1|Screening Phase|Withdrawal by Subject|1
157653|NCT00330967|505521|P2|Overall Study|Physician Decision|9
157654|NCT00330967|505522|P1|Overall Study|Physician Decision|0
157655|NCT00330967|505521|P2|Overall Study|Withdrawal by Subject|5
157656|NCT00330967|505522|P1|Overall Study|Withdrawal by Subject|0
157657|NCT00330928|505533|P1|Overall Study|IVUS could not be performed.|1
157658|NCT00330928|505533|P1|Overall Study|Death|1
157659|NCT00330928|505533|P1|Overall Study|Physician Decision|9
157660|NCT00330928|505533|P1|Overall Study|Lost to Follow-up|6
157661|NCT00330174|505556|P2|Overall Study|Miscellaneous reasons|1
157662|NCT00330174|505557|P1|Overall Study|Miscellaneous reasons|7
157663|NCT00330174|505556|P2|Overall Study|Excessive missed visits|8
157664|NCT00330174|505557|P1|Overall Study|Excessive missed visits|3
157665|NCT00330174|505556|P2|Overall Study|Clinical deterioration|2
157666|NCT00330174|505557|P1|Overall Study|Clinical deterioration|1
157667|NCT00330174|505556|P2|Overall Study|Lost to Follow-up|1
157668|NCT00330174|505557|P1|Overall Study|Lost to Follow-up|4
157669|NCT00330174|505556|P2|Overall Study|Withdrawal by Subject|7
157670|NCT00330174|505557|P1|Overall Study|Withdrawal by Subject|7
157671|NCT00329901|505581|P3|Overall Study|Unable to classify|0
157672|NCT00329901|505582|P2|Overall Study|Unable to classify|2
157673|NCT00329901|505583|P1|Overall Study|Unable to classify|2
157674|NCT00329901|505581|P3|Overall Study|Protocol Violation|1
157675|NCT00329901|505582|P2|Overall Study|Protocol Violation|0
157676|NCT00329901|505583|P1|Overall Study|Protocol Violation|1
157677|NCT00329901|505581|P3|Overall Study|Lost to Follow-up|1
157678|NCT00329901|505582|P2|Overall Study|Lost to Follow-up|0
157679|NCT00329901|505583|P1|Overall Study|Lost to Follow-up|2
157680|NCT00329901|505581|P3|Overall Study|Withdrawal by Subject|2
157681|NCT00329901|505582|P2|Overall Study|Withdrawal by Subject|3
157682|NCT00329901|505583|P1|Overall Study|Withdrawal by Subject|4
157683|NCT00329849|505613|P2|Overall Study|Withdrawal by Subject|4
157684|NCT00329849|505614|P1|Overall Study|Withdrawal by Subject|6
157685|NCT00329784|505642|P2|Overall Study|Unspecified|2
157686|NCT00329784|505643|P1|Overall Study|Unspecified|1
157687|NCT00329784|505642|P2|Overall Study|Withdrawal by Subject|2
157688|NCT00329784|505643|P1|Overall Study|Withdrawal by Subject|4
157689|NCT00329784|505642|P2|Overall Study|Lost to Follow-up|1
157690|NCT00329784|505643|P1|Overall Study|Lost to Follow-up|0
157691|NCT00329745|505671|P2|Overall Study|Lost to Follow-up|101
157692|NCT00329745|505672|P1|Overall Study|Lost to Follow-up|86
157693|NCT00329745|505671|P2|Overall Study|Withdrawal by Subject|1
157694|NCT00329745|505672|P1|Overall Study|Withdrawal by Subject|0
157695|NCT00329745|505671|P2|Overall Study|Protocol Violation|0
157696|NCT00329745|505672|P1|Overall Study|Protocol Violation|1
157697|NCT00329719|505692|P4|Overall Study|Lost to Follow-up|1
157698|NCT00329719|505693|P3|Overall Study|Lost to Follow-up|0
157699|NCT00329719|505694|P2|Overall Study|Lost to Follow-up|0
157700|NCT00329719|505695|P1|Overall Study|Lost to Follow-up|0
157701|NCT00329641|505717|P1|Overall Study|Other reason, not protocol specified|1
157702|NCT00329641|505717|P1|Overall Study|Adverse Event|3
157703|NCT00329641|505717|P1|Overall Study|Not eligible|1
157704|NCT00329641|505717|P1|Overall Study|Did not start treatment|1
157705|NCT00329602|505726|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
157706|NCT00329602|505727|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
157707|NCT00329602|505728|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
157708|NCT00329602|505726|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
157709|NCT00329602|505727|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
157710|NCT00329602|505728|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
157711|NCT00329602|505726|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
157712|NCT00329602|505727|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
157713|NCT00329602|505728|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
157714|NCT00329602|505726|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
157715|NCT00329602|505727|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
157716|NCT00329602|505728|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
157717|NCT00329602|505726|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
157718|NCT00329602|505727|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
157719|NCT00329602|505728|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
157720|NCT00329602|505726|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
157721|NCT00329602|505727|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
157722|NCT00329602|505728|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
157723|NCT00329550|505766|P3|Overall Study|Due to Relocation|1
157724|NCT00329550|505767|P2|Overall Study|Due to Relocation|0
157725|NCT00329550|505768|P1|Overall Study|Due to Relocation|0
157726|NCT00329550|505766|P3|Overall Study|Withdrawal of Consent|1
157727|NCT00329550|505767|P2|Overall Study|Withdrawal of Consent|0
157728|NCT00329550|505768|P1|Overall Study|Withdrawal of Consent|1
157729|NCT00329550|505766|P3|Overall Study|Adverse Event|2
157730|NCT00329550|505767|P2|Overall Study|Adverse Event|4
157731|NCT00329550|505768|P1|Overall Study|Adverse Event|3
157732|NCT00329420|506033|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
157733|NCT00329420|506034|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
157734|NCT00329420|506035|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
157735|NCT00329420|506033|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
157736|NCT00329420|506034|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
157737|NCT00329420|506035|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
157738|NCT00329420|506033|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
157739|NCT00329420|506034|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
157740|NCT00329420|506035|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
157741|NCT00329420|506033|P3|Re-induction Phase|Did not respond to re-induction|7
157742|NCT00329420|506034|P2|Re-induction Phase|Did not respond to re-induction|5
157743|NCT00329420|506035|P1|Re-induction Phase|Did not respond to re-induction|6
157744|NCT00329420|506033|P3|Re-induction Phase|Withdrawal of Consent|1
157745|NCT00329420|506034|P2|Re-induction Phase|Withdrawal of Consent|0
157746|NCT00329420|506035|P1|Re-induction Phase|Withdrawal of Consent|0
157747|NCT00329420|506033|P3|Re-induction Phase|Lack of Efficacy|0
157748|NCT00329420|506034|P2|Re-induction Phase|Lack of Efficacy|1
157749|NCT00329420|506035|P1|Re-induction Phase|Lack of Efficacy|0
157750|NCT00329407|506414|P1|Overall Study|Withdrawal by Subject|1
157751|NCT00329238|506421|P2|Overall Study|Other reason (not specified)|54
157752|NCT00329238|506422|P1|Overall Study|Other reason (not specified)|40
157753|NCT00329238|506421|P2|Overall Study|Withdrawal by Subject|58
157754|NCT00329238|506422|P1|Overall Study|Withdrawal by Subject|64
157755|NCT00329238|506421|P2|Overall Study|Lost to Follow-up|6
157756|NCT00329238|506422|P1|Overall Study|Lost to Follow-up|2
157757|NCT00329238|506421|P2|Overall Study|Protocol Violation|34
157758|NCT00329238|506422|P1|Overall Study|Protocol Violation|23
157759|NCT00329238|506421|P2|Overall Study|Adverse Event|129
157760|NCT00329238|506422|P1|Overall Study|Adverse Event|147
157761|NCT00329160|506458|P1|Overall Study|Incomplete IVUS|45
157762|NCT00329160|506458|P1|Overall Study|Did not Receive Study Drug|1
157763|NCT00329160|506458|P1|Overall Study|Protocol Violation|2
157764|NCT00329160|506458|P1|Overall Study|Withdrawal by Subject|13
157765|NCT00329160|506458|P1|Overall Study|Adverse Event|27
157766|NCT00329108|506467|P2|Overall Study|Protocol Violation|2
157767|NCT00329108|506468|P1|Overall Study|Protocol Violation|0
157768|NCT00329108|506467|P2|Overall Study|withdrew patient after SAE resolved|0
157769|NCT00329108|506468|P1|Overall Study|withdrew patient after SAE resolved|1
157770|NCT00329108|506467|P2|Overall Study|study terminated by sponsor|0
157771|NCT00329108|506468|P1|Overall Study|study terminated by sponsor|1
157772|NCT00329108|506467|P2|Overall Study|Subject no longer willing to participate|2
157773|NCT00329108|506468|P1|Overall Study|Subject no longer willing to participate|2
157774|NCT00329108|506467|P2|Overall Study|symptomatic deterioration|1
157775|NCT00329108|506468|P1|Overall Study|symptomatic deterioration|1
157776|NCT00329108|506467|P2|Overall Study|Withdrawal by Subject|2
157777|NCT00329108|506468|P1|Overall Study|Withdrawal by Subject|0
157778|NCT00329108|506467|P2|Overall Study|Lack of Efficacy|3
157779|NCT00329108|506468|P1|Overall Study|Lack of Efficacy|3
157780|NCT00329108|506467|P2|Overall Study|Adverse Event|2
157781|NCT00329108|506468|P1|Overall Study|Adverse Event|2
157782|NCT00329030|506476|P2|Overall Study|Ineligible Pathology|1
157783|NCT00329030|506477|P1|Overall Study|Ineligible Pathology|1
157784|NCT00329030|506476|P2|Overall Study|Progressive Disease|2
157785|NCT00329030|506477|P1|Overall Study|Progressive Disease|6
157786|NCT00329030|506476|P2|Overall Study|Withdrawal by Subject|3
157787|NCT00329030|506477|P1|Overall Study|Withdrawal by Subject|1
157788|NCT00328926|506508|P3|Overall Study|Lack of ovarian response|0
157789|NCT00328926|506509|P2|Overall Study|Lack of ovarian response|1
157790|NCT00328926|506510|P1|Overall Study|Lack of ovarian response|0
157791|NCT00328926|506508|P3|Overall Study|In vitro fertilization treatment|1
157792|NCT00328926|506509|P2|Overall Study|In vitro fertilization treatment|0
157793|NCT00328926|506510|P1|Overall Study|In vitro fertilization treatment|0
157794|NCT00328926|506508|P3|Overall Study|Death|1
157795|NCT00328926|506509|P2|Overall Study|Death|0
157796|NCT00328926|506510|P1|Overall Study|Death|0
157797|NCT00328926|506508|P3|Overall Study|Lost to Follow-up|0
157798|NCT00328926|506509|P2|Overall Study|Lost to Follow-up|1
157799|NCT00328926|506510|P1|Overall Study|Lost to Follow-up|0
157800|NCT00328926|506508|P3|Overall Study|Pregnancy|0
157801|NCT00328926|506509|P2|Overall Study|Pregnancy|1
157802|NCT00328926|506510|P1|Overall Study|Pregnancy|2
157803|NCT00328783|506535|P1|Overall Study|Withdrawal by Subject|1
157804|NCT00328783|506535|P1|Overall Study|No heart in RT field|4
157805|NCT00328783|506535|P1|Overall Study|Could not tolerate ABC|21
157806|NCT00328627|506558|P12|Overall Study|Other|0
157807|NCT00328627|506559|P11|Overall Study|Other|1
157808|NCT00328627|506560|P10|Overall Study|Other|1
157809|NCT00328627|506561|P9|Overall Study|Other|0
157810|NCT00328627|506562|P8|Overall Study|Other|0
157811|NCT00328627|506563|P7|Overall Study|Other|1
157812|NCT00328627|506564|P6|Overall Study|Other|0
157813|NCT00328627|506565|P5|Overall Study|Other|0
157814|NCT00328627|506566|P4|Overall Study|Other|1
157815|NCT00328627|506567|P3|Overall Study|Other|0
157816|NCT00328627|506568|P2|Overall Study|Other|0
157817|NCT00328627|506569|P1|Overall Study|Other|0
157818|NCT00328627|506558|P12|Overall Study|Physician Decision|0
157819|NCT00328627|506559|P11|Overall Study|Physician Decision|1
157820|NCT00328627|506560|P10|Overall Study|Physician Decision|2
157821|NCT00328627|506561|P9|Overall Study|Physician Decision|3
157822|NCT00328627|506562|P8|Overall Study|Physician Decision|0
157823|NCT00328627|506563|P7|Overall Study|Physician Decision|1
157824|NCT00328627|506564|P6|Overall Study|Physician Decision|1
157825|NCT00328627|506565|P5|Overall Study|Physician Decision|1
157826|NCT00328627|506566|P4|Overall Study|Physician Decision|2
157827|NCT00328627|506567|P3|Overall Study|Physician Decision|1
157828|NCT00328627|506568|P2|Overall Study|Physician Decision|3
157829|NCT00328627|506569|P1|Overall Study|Physician Decision|4
157830|NCT00328627|506558|P12|Overall Study|Pregnancy|0
157831|NCT00328627|506559|P11|Overall Study|Pregnancy|0
157832|NCT00328627|506560|P10|Overall Study|Pregnancy|0
157833|NCT00328627|506561|P9|Overall Study|Pregnancy|0
157834|NCT00328627|506562|P8|Overall Study|Pregnancy|0
157835|NCT00328627|506563|P7|Overall Study|Pregnancy|0
157836|NCT00328627|506564|P6|Overall Study|Pregnancy|0
157837|NCT00328627|506565|P5|Overall Study|Pregnancy|0
157838|NCT00328627|506566|P4|Overall Study|Pregnancy|0
157839|NCT00328627|506567|P3|Overall Study|Pregnancy|0
157840|NCT00328627|506568|P2|Overall Study|Pregnancy|1
157841|NCT00328627|506569|P1|Overall Study|Pregnancy|0
157842|NCT00328627|506558|P12|Overall Study|Withdrawal by Subject|7
157843|NCT00328627|506559|P11|Overall Study|Withdrawal by Subject|2
157844|NCT00328627|506560|P10|Overall Study|Withdrawal by Subject|5
157845|NCT00328627|506561|P9|Overall Study|Withdrawal by Subject|4
157846|NCT00328627|506562|P8|Overall Study|Withdrawal by Subject|4
157847|NCT00328627|506563|P7|Overall Study|Withdrawal by Subject|4
157848|NCT00328627|506564|P6|Overall Study|Withdrawal by Subject|5
157849|NCT00328627|506565|P5|Overall Study|Withdrawal by Subject|2
157850|NCT00328627|506566|P4|Overall Study|Withdrawal by Subject|6
157851|NCT00328627|506567|P3|Overall Study|Withdrawal by Subject|5
157852|NCT00328627|506568|P2|Overall Study|Withdrawal by Subject|4
157853|NCT00328627|506569|P1|Overall Study|Withdrawal by Subject|5
157854|NCT00328627|506558|P12|Overall Study|Lost to Follow-up|1
157855|NCT00328627|506559|P11|Overall Study|Lost to Follow-up|0
157856|NCT00328627|506560|P10|Overall Study|Lost to Follow-up|2
157857|NCT00328627|506561|P9|Overall Study|Lost to Follow-up|3
157858|NCT00328627|506562|P8|Overall Study|Lost to Follow-up|0
157859|NCT00328627|506563|P7|Overall Study|Lost to Follow-up|3
157860|NCT00328627|506564|P6|Overall Study|Lost to Follow-up|2
157861|NCT00328627|506565|P5|Overall Study|Lost to Follow-up|0
157862|NCT00328627|506566|P4|Overall Study|Lost to Follow-up|4
157863|NCT00328627|506567|P3|Overall Study|Lost to Follow-up|2
157864|NCT00328627|506568|P2|Overall Study|Lost to Follow-up|2
157865|NCT00328627|506569|P1|Overall Study|Lost to Follow-up|4
157866|NCT00328627|506558|P12|Overall Study|Protocol Violation|2
157867|NCT00328627|506559|P11|Overall Study|Protocol Violation|6
157868|NCT00328627|506560|P10|Overall Study|Protocol Violation|4
157869|NCT00328627|506561|P9|Overall Study|Protocol Violation|1
157870|NCT00328627|506562|P8|Overall Study|Protocol Violation|2
157871|NCT00328627|506563|P7|Overall Study|Protocol Violation|6
157872|NCT00328627|506564|P6|Overall Study|Protocol Violation|5
157873|NCT00328627|506565|P5|Overall Study|Protocol Violation|5
157874|NCT00328627|506566|P4|Overall Study|Protocol Violation|8
157875|NCT00328627|506567|P3|Overall Study|Protocol Violation|2
157876|NCT00328627|506568|P2|Overall Study|Protocol Violation|2
157877|NCT00328627|506569|P1|Overall Study|Protocol Violation|2
157878|NCT00328627|506558|P12|Overall Study|Adverse Event|4
157879|NCT00328627|506559|P11|Overall Study|Adverse Event|5
157880|NCT00328627|506560|P10|Overall Study|Adverse Event|7
157881|NCT00328627|506561|P9|Overall Study|Adverse Event|0
157882|NCT00328627|506562|P8|Overall Study|Adverse Event|2
157883|NCT00328627|506563|P7|Overall Study|Adverse Event|1
157884|NCT00328627|506564|P6|Overall Study|Adverse Event|2
157885|NCT00328627|506565|P5|Overall Study|Adverse Event|1
157886|NCT00328627|506566|P4|Overall Study|Adverse Event|3
157887|NCT00328627|506567|P3|Overall Study|Adverse Event|2
157888|NCT00328627|506568|P2|Overall Study|Adverse Event|1
157889|NCT00328627|506569|P1|Overall Study|Adverse Event|3
157890|NCT00328627|506558|P12|Overall Study|Hyperglycemic Rescue|2
157891|NCT00328627|506559|P11|Overall Study|Hyperglycemic Rescue|3
157892|NCT00328627|506560|P10|Overall Study|Hyperglycemic Rescue|11
157893|NCT00328627|506561|P9|Overall Study|Hyperglycemic Rescue|6
157894|NCT00328627|506562|P8|Overall Study|Hyperglycemic Rescue|6
157895|NCT00328627|506563|P7|Overall Study|Hyperglycemic Rescue|19
157896|NCT00328627|506564|P6|Overall Study|Hyperglycemic Rescue|5
157897|NCT00328627|506565|P5|Overall Study|Hyperglycemic Rescue|6
157898|NCT00328627|506566|P4|Overall Study|Hyperglycemic Rescue|13
157899|NCT00328627|506567|P3|Overall Study|Hyperglycemic Rescue|16
157900|NCT00328627|506568|P2|Overall Study|Hyperglycemic Rescue|18
157901|NCT00328627|506569|P1|Overall Study|Hyperglycemic Rescue|41
157902|NCT00328562|508106|P1|Overall Study|Disease progression|1
157903|NCT00328510|508115|P2|Overall Study|Treatment changed to a single fraction|1
157904|NCT00328510|508116|P1|Overall Study|Treatment changed to a single fraction|1
157905|NCT00328510|508115|P2|Overall Study|Severe kyphosis, could not use mask|1
157906|NCT00328510|508116|P1|Overall Study|Severe kyphosis, could not use mask|0
157907|NCT00328510|508115|P2|Overall Study|Withdrawal by Subject|2
157908|NCT00328510|508116|P1|Overall Study|Withdrawal by Subject|4
157909|NCT00328510|508115|P2|Overall Study|Dentition problems, could not use frame|0
157910|NCT00328510|508116|P1|Overall Study|Dentition problems, could not use frame|1
157911|NCT00328510|508115|P2|Overall Study|Gag disorder, could not use frame|0
157912|NCT00328510|508116|P1|Overall Study|Gag disorder, could not use frame|4
157913|NCT00328198|508131|P1|Follow-up|Death|31
157914|NCT00328198|508131|P1|Follow-up|Lost to Follow-up|4
157915|NCT00328198|508131|P1|Treatment|Confirmed complete response, MRD -|3
157916|NCT00328198|508131|P1|Treatment|Non-compliance|1
157917|NCT00328198|508131|P1|Treatment|Evidence of disease progression|2
157918|NCT00328198|508131|P1|Treatment|Withdrawal by Subject|5
157919|NCT00328198|508131|P1|Treatment|Physician Decision|5
157920|NCT00328198|508131|P1|Treatment|Death|1
157921|NCT00328198|508131|P1|Treatment|Adverse Event|21
157922|NCT00328172|508146|P5|Overall Study|Other reason (not specified)|0
157923|NCT00328172|508147|P4|Overall Study|Other reason (not specified)|0
157924|NCT00328172|508148|P3|Overall Study|Other reason (not specified)|1
157925|NCT00328172|508149|P2|Overall Study|Other reason (not specified)|0
157926|NCT00328172|508150|P1|Overall Study|Other reason (not specified)|3
157927|NCT00328172|508146|P5|Overall Study|Lack of Efficacy|3
157928|NCT00328172|508147|P4|Overall Study|Lack of Efficacy|4
157929|NCT00328172|508148|P3|Overall Study|Lack of Efficacy|4
157930|NCT00328172|508149|P2|Overall Study|Lack of Efficacy|9
157931|NCT00328172|508150|P1|Overall Study|Lack of Efficacy|14
157932|NCT00328172|508146|P5|Overall Study|Withdrawal by Subject|0
157933|NCT00328172|508147|P4|Overall Study|Withdrawal by Subject|6
157934|NCT00328172|508148|P3|Overall Study|Withdrawal by Subject|1
157935|NCT00328172|508149|P2|Overall Study|Withdrawal by Subject|1
157936|NCT00328172|508150|P1|Overall Study|Withdrawal by Subject|1
157937|NCT00328172|508146|P5|Overall Study|Lost to Follow-up|1
157938|NCT00328172|508147|P4|Overall Study|Lost to Follow-up|1
157939|NCT00328172|508148|P3|Overall Study|Lost to Follow-up|2
157940|NCT00328172|508149|P2|Overall Study|Lost to Follow-up|1
157941|NCT00328172|508150|P1|Overall Study|Lost to Follow-up|1
157942|NCT00328172|508146|P5|Overall Study|Protocol Violation|0
157943|NCT00328172|508147|P4|Overall Study|Protocol Violation|0
157944|NCT00328172|508148|P3|Overall Study|Protocol Violation|1
157945|NCT00328172|508149|P2|Overall Study|Protocol Violation|1
157946|NCT00328172|508150|P1|Overall Study|Protocol Violation|0
157947|NCT00328172|508146|P5|Overall Study|Adverse Event|1
157948|NCT00328172|508147|P4|Overall Study|Adverse Event|2
157949|NCT00328172|508148|P3|Overall Study|Adverse Event|1
157950|NCT00328172|508149|P2|Overall Study|Adverse Event|2
157951|NCT00328172|508150|P1|Overall Study|Adverse Event|3
157952|NCT00328094|508174|P2|Overall Study|Physician Decision|3
157953|NCT00328094|508175|P1|Overall Study|Physician Decision|3
157954|NCT00327717|508196|P2|Overall Study|Withdrawal by Subject|7
157955|NCT00327717|508197|P1|Overall Study|Withdrawal by Subject|3
157956|NCT00327717|508196|P2|Overall Study|Lack of Efficacy|1
157957|NCT00327717|508197|P1|Overall Study|Lack of Efficacy|0
157958|NCT00327717|508196|P2|Overall Study|Adverse Event|6
157959|NCT00327717|508197|P1|Overall Study|Adverse Event|6
157960|NCT00327470|508223|P2|Overall Study|Death|4
157961|NCT00327470|508224|P1|Overall Study|Death|1
157962|NCT00327470|508223|P2|Overall Study|Withdrawal by Subject|12
157963|NCT00327470|508224|P1|Overall Study|Withdrawal by Subject|6
157964|NCT00327470|508223|P2|Overall Study|Lost to Follow-up|3
157965|NCT00327470|508224|P1|Overall Study|Lost to Follow-up|1
157966|NCT00327470|508223|P2|Overall Study|Other|9
157967|NCT00327470|508224|P1|Overall Study|Other|5
157968|NCT00327470|508223|P2|Overall Study|Lack of Efficacy|19
157969|NCT00327470|508224|P1|Overall Study|Lack of Efficacy|7
157970|NCT00327470|508223|P2|Overall Study|Adverse Event|14
157971|NCT00327470|508224|P1|Overall Study|Adverse Event|9
157972|NCT00327470|508223|P2|Overall Study|Randomized, but not treated|2
157973|NCT00327470|508224|P1|Overall Study|Randomized, but not treated|0
157974|NCT00327444|508244|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
157975|NCT00327444|508245|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
157976|NCT00327444|508244|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
157977|NCT00327444|508245|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
157978|NCT00327444|508244|P2|Open Label Treatment (OL) Period|Adverse Event|2
157979|NCT00327444|508245|P1|Open Label Treatment (OL) Period|Adverse Event|2
157980|NCT00327444|508244|P2|Open Label Treatment (OL) Period|Disease progression|7
157981|NCT00327444|508245|P1|Open Label Treatment (OL) Period|Disease progression|8
157982|NCT00327444|508244|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
157983|NCT00327444|508245|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
157984|NCT00327444|508244|P2|Double Blind Treatment (DB) Period|Subject request|1
157985|NCT00327444|508245|P1|Double Blind Treatment (DB) Period|Subject request|0
157986|NCT00327444|508244|P2|Double Blind Treatment (DB) Period|Adverse Event|5
157987|NCT00327444|508245|P1|Double Blind Treatment (DB) Period|Adverse Event|5
157988|NCT00327444|508244|P2|Double Blind Treatment (DB) Period|Disease progression|13
157989|NCT00327444|508245|P1|Double Blind Treatment (DB) Period|Disease progression|10
157990|NCT00327340|508263|P2|Overall Study|Adverse Event|3
157991|NCT00327340|508264|P1|Overall Study|Adverse Event|3
157992|NCT00327340|508263|P2|Overall Study|Symptomatic Disease|2
157993|NCT00327340|508264|P1|Overall Study|Symptomatic Disease|0
157994|NCT00327340|508263|P2|Overall Study|Disease Progression|19
157995|NCT00327340|508264|P1|Overall Study|Disease Progression|10
157996|NCT00327340|508263|P2|Overall Study|Physician Decision|1
157997|NCT00327340|508264|P1|Overall Study|Physician Decision|1
157998|NCT00327340|508263|P2|Overall Study|Withdrawal by Subject|5
157999|NCT00327340|508264|P1|Overall Study|Withdrawal by Subject|1
158000|NCT00327171|508278|P2|Overall Study|Unspecified|0
158001|NCT00327171|508279|P1|Overall Study|Unspecified|1
158002|NCT00327171|508278|P2|Overall Study|Undisclosed history of ischemia|1
158003|NCT00327171|508279|P1|Overall Study|Undisclosed history of ischemia|0
158004|NCT00327171|508278|P2|Overall Study|Clinical progression|8
158005|NCT00327171|508279|P1|Overall Study|Clinical progression|12
158006|NCT00327171|508278|P2|Overall Study|Investigator/participant request|8
158007|NCT00327171|508279|P1|Overall Study|Investigator/participant request|1
158008|NCT00327171|508278|P2|Overall Study|Disease progression/lack of efficacy|69
158009|NCT00327171|508279|P1|Overall Study|Disease progression/lack of efficacy|68
158010|NCT00327171|508278|P2|Overall Study|Adverse Event|23
158011|NCT00327171|508279|P1|Overall Study|Adverse Event|23
158012|NCT00327171|508278|P2|Overall Study|Did not receive study medication|0
158013|NCT00327171|508279|P1|Overall Study|Did not receive study medication|3
158014|NCT00327015|508311|P4|Overall Study|Administrative Reason by Sponsor|1
158015|NCT00327015|508312|P3|Overall Study|Administrative Reason by Sponsor|2
158016|NCT00327015|508313|P2|Overall Study|Administrative Reason by Sponsor|2
158017|NCT00327015|508314|P1|Overall Study|Administrative Reason by Sponsor|1
158018|NCT00327015|508311|P4|Overall Study|Pregnancy|1
158019|NCT00327015|508312|P3|Overall Study|Pregnancy|1
158020|NCT00327015|508313|P2|Overall Study|Pregnancy|2
158021|NCT00327015|508314|P1|Overall Study|Pregnancy|0
158022|NCT00327015|508311|P4|Overall Study|Death|3
158023|NCT00327015|508312|P3|Overall Study|Death|2
158024|NCT00327015|508313|P2|Overall Study|Death|2
158025|NCT00327015|508314|P1|Overall Study|Death|1
158026|NCT00327015|508311|P4|Overall Study|Physician Decision|2
158027|NCT00327015|508312|P3|Overall Study|Physician Decision|3
158028|NCT00327015|508313|P2|Overall Study|Physician Decision|1
158029|NCT00327015|508314|P1|Overall Study|Physician Decision|0
158030|NCT00327015|508311|P4|Overall Study|Poor/Noncompliance|5
158031|NCT00327015|508312|P3|Overall Study|Poor/Noncompliance|4
158032|NCT00327015|508313|P2|Overall Study|Poor/Noncompliance|8
158033|NCT00327015|508314|P1|Overall Study|Poor/Noncompliance|11
158034|NCT00327015|508311|P4|Overall Study|Subject no longer meets study criteria|7
158035|NCT00327015|508312|P3|Overall Study|Subject no longer meets study criteria|8
158036|NCT00327015|508313|P2|Overall Study|Subject no longer meets study criteria|2
158037|NCT00327015|508314|P1|Overall Study|Subject no longer meets study criteria|4
158038|NCT00327015|508311|P4|Overall Study|Adverse Event|14
158039|NCT00327015|508312|P3|Overall Study|Adverse Event|14
158040|NCT00327015|508313|P2|Overall Study|Adverse Event|10
158041|NCT00327015|508314|P1|Overall Study|Adverse Event|14
158042|NCT00327015|508311|P4|Overall Study|Lost to Follow-up|22
158043|NCT00327015|508312|P3|Overall Study|Lost to Follow-up|29
158044|NCT00327015|508313|P2|Overall Study|Lost to Follow-up|23
158045|NCT00327015|508314|P1|Overall Study|Lost to Follow-up|22
158046|NCT00327015|508311|P4|Overall Study|Withdrawal of Consent by Subject|25
158047|NCT00327015|508312|P3|Overall Study|Withdrawal of Consent by Subject|28
158048|NCT00327015|508313|P2|Overall Study|Withdrawal of Consent by Subject|24
158049|NCT00327015|508314|P1|Overall Study|Withdrawal of Consent by Subject|20
158050|NCT00327015|508311|P4|Overall Study|Lack of Efficacy|29
158051|NCT00327015|508312|P3|Overall Study|Lack of Efficacy|35
158052|NCT00327015|508313|P2|Overall Study|Lack of Efficacy|18
158053|NCT00327015|508314|P1|Overall Study|Lack of Efficacy|18
158054|NCT00326963|508356|P1|Overall Study|Administrative / other|1
158055|NCT00326963|508356|P1|Overall Study|Other protocol violation|1
158056|NCT00326963|508356|P1|Overall Study|Violation of selection criteria at entry|2
158057|NCT00326963|508356|P1|Overall Study|Refused treatment / did not cooperate|5
158058|NCT00326963|508356|P1|Overall Study|Withdrawal by Subject|10
158059|NCT00326963|508356|P1|Overall Study|Failure to return|10
158060|NCT00326963|508356|P1|Overall Study|Death|1
158061|NCT00326963|508356|P1|Overall Study|Injection site reaction|1
158062|NCT00326963|508356|P1|Overall Study|Adverse Event|2
158063|NCT00326950|508376|P1|Overall Study|Progressive Disease|1
158064|NCT00326911|508383|P2|Overall Study|Withdrawal by subject prior to treatment|1
158065|NCT00326911|508384|P1|Overall Study|Withdrawal by subject prior to treatment|0
158066|NCT00326911|508383|P2|Overall Study|Physician decision prior to treatment|0
158067|NCT00326911|508384|P1|Overall Study|Physician decision prior to treatment|1
158068|NCT00326911|508383|P2|Overall Study|Hospitalization prior to treatment|1
158069|NCT00326911|508384|P1|Overall Study|Hospitalization prior to treatment|0
158070|NCT00326898|508437|P3|Overall Study|Other/Missing/Unknown|32
158071|NCT00326898|508438|P2|Overall Study|Other/Missing/Unknown|28
158072|NCT00326898|508439|P1|Overall Study|Other/Missing/Unknown|33
158073|NCT00326898|508437|P3|Overall Study|Other complicating disease|4
158074|NCT00326898|508438|P2|Overall Study|Other complicating disease|5
158075|NCT00326898|508439|P1|Overall Study|Other complicating disease|5
158076|NCT00326898|508437|P3|Overall Study|Alternative therapy|0
158077|NCT00326898|508438|P2|Overall Study|Alternative therapy|0
158078|NCT00326898|508439|P1|Overall Study|Alternative therapy|1
158079|NCT00326898|508437|P3|Overall Study|Withdrawal by Subject|32
158080|NCT00326898|508438|P2|Overall Study|Withdrawal by Subject|128
158081|NCT00326898|508439|P1|Overall Study|Withdrawal by Subject|134
158082|NCT00326898|508437|P3|Overall Study|Death|0
158083|NCT00326898|508438|P2|Overall Study|Death|0
158084|NCT00326898|508439|P1|Overall Study|Death|2
158085|NCT00326898|508437|P3|Overall Study|Adverse Event|33
158086|NCT00326898|508438|P2|Overall Study|Adverse Event|128
158087|NCT00326898|508439|P1|Overall Study|Adverse Event|124
158088|NCT00326898|508437|P3|Overall Study|Disease progression|102
158089|NCT00326898|508438|P2|Overall Study|Disease progression|54
158090|NCT00326898|508439|P1|Overall Study|Disease progression|52
158091|NCT00326885|508456|P1|Overall Study|Hospice withdrew consent|2
158092|NCT00326885|508456|P1|Overall Study|Physician Decision|1
158093|NCT00326885|508456|P1|Overall Study|Withdrawal by Subject|3
158094|NCT00326885|508456|P1|Overall Study|Adverse Event|1
158095|NCT00326716|508487|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
158096|NCT00326716|508488|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
158097|NCT00326716|508489|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
158098|NCT00326716|508490|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
158099|NCT00326612|508562|P2|Overall Study|They did not have a seizure requiring tx|137
158100|NCT00326612|508563|P1|Overall Study|They did not have a seizure requiring tx|129
158101|NCT00326599|508585|P4|Overall Study|Other Unspecified Reason|1
158102|NCT00326599|508586|P3|Overall Study|Other Unspecified Reason|2
158103|NCT00326599|508587|P2|Overall Study|Other Unspecified Reason|0
158104|NCT00326599|508588|P1|Overall Study|Other Unspecified Reason|0
158105|NCT00326599|508585|P4|Overall Study|Death|2
158106|NCT00326599|508586|P3|Overall Study|Death|1
158107|NCT00326599|508587|P2|Overall Study|Death|0
158108|NCT00326599|508588|P1|Overall Study|Death|0
158109|NCT00326599|508585|P4|Overall Study|Alternate Treatment|0
158110|NCT00326599|508586|P3|Overall Study|Alternate Treatment|0
158111|NCT00326599|508587|P2|Overall Study|Alternate Treatment|0
158112|NCT00326599|508588|P1|Overall Study|Alternate Treatment|1
158113|NCT00326599|508585|P4|Overall Study|Disease Progression|11
158114|NCT00326599|508586|P3|Overall Study|Disease Progression|13
158115|NCT00326599|508587|P2|Overall Study|Disease Progression|1
158116|NCT00326599|508588|P1|Overall Study|Disease Progression|3
158117|NCT00326599|508585|P4|Overall Study|Adverse Event|3
158118|NCT00326599|508586|P3|Overall Study|Adverse Event|32
158119|NCT00326599|508587|P2|Overall Study|Adverse Event|0
158120|NCT00326599|508588|P1|Overall Study|Adverse Event|1
158121|NCT00326599|508585|P4|Overall Study|Withdrawal by Subject|2
158122|NCT00326599|508586|P3|Overall Study|Withdrawal by Subject|5
158123|NCT00326599|508587|P2|Overall Study|Withdrawal by Subject|0
158124|NCT00326599|508588|P1|Overall Study|Withdrawal by Subject|1
158125|NCT00326495|508607|P1|Overall Study|Subject off study before assessment|1
158126|NCT00326495|508607|P1|Overall Study|Refused further treatment|2
158127|NCT00326495|508607|P1|Overall Study|Disease progression before treatment|1
158128|NCT00326495|508607|P1|Overall Study|Switched to alternative treatment|1
158129|NCT00326417|508614|P4|Overall Study|Death|0
158130|NCT00326417|508615|P3|Overall Study|Death|0
158131|NCT00326417|508616|P2|Overall Study|Death|0
158132|NCT00326417|508617|P1|Overall Study|Death|7
158133|NCT00326417|508614|P4|Overall Study|Arm Closed|3
158134|NCT00326417|508615|P3|Overall Study|Arm Closed|0
158135|NCT00326417|508616|P2|Overall Study|Arm Closed|0
158136|NCT00326417|508617|P1|Overall Study|Arm Closed|7
158137|NCT00326417|508614|P4|Overall Study|Withdrawal by Subject|0
158138|NCT00326417|508615|P3|Overall Study|Withdrawal by Subject|1
158139|NCT00326417|508616|P2|Overall Study|Withdrawal by Subject|0
158140|NCT00326417|508617|P1|Overall Study|Withdrawal by Subject|0
158141|NCT00326183|508644|P2|Overall Study|Adverse Event|0
158142|NCT00326183|508645|P1|Overall Study|Adverse Event|1
158143|NCT00326183|508644|P2|Overall Study|Unspecified|13
158144|NCT00326183|508645|P1|Overall Study|Unspecified|47
158145|NCT00326183|508644|P2|Overall Study|Subject Moved|4
158146|NCT00326183|508645|P1|Overall Study|Subject Moved|7
158147|NCT00326183|508644|P2|Overall Study|Withdrawal by Subject|7
158148|NCT00326183|508645|P1|Overall Study|Withdrawal by Subject|35
158149|NCT00326183|508644|P2|Overall Study|Protocol Violation|3
158150|NCT00326183|508645|P1|Overall Study|Protocol Violation|6
158151|NCT00326183|508644|P2|Overall Study|Lost to Follow-up|56
158152|NCT00326183|508645|P1|Overall Study|Lost to Follow-up|104
158153|NCT00326118|508677|P2|Active Phase|Withdrawal by Subject|1
158154|NCT00326118|508678|P1|Active Phase|Withdrawal by Subject|4
158155|NCT00326001|508714|P2|Overall Study|Physician Decision|3
158156|NCT00326001|508715|P1|Overall Study|Physician Decision|3
158157|NCT00326001|508714|P2|Overall Study|Adverse Event|5
158158|NCT00326001|508715|P1|Overall Study|Adverse Event|4
158159|NCT00325897|508729|P2|Overall Study|Lost to Follow-up|13
158160|NCT00325897|508730|P1|Overall Study|Lost to Follow-up|12
158161|NCT00325819|508750|P2|Overall Study|Lost to Follow-up|3
158162|NCT00325819|508751|P1|Overall Study|Lost to Follow-up|3
158163|NCT00325819|508750|P2|Overall Study|Did not take a dose of study product|9
158164|NCT00325819|508751|P1|Overall Study|Did not take a dose of study product|4
158165|NCT00325819|508750|P2|Overall Study|Study product lost in mail|1
158166|NCT00325819|508751|P1|Overall Study|Study product lost in mail|2
158167|NCT00325754|508778|P2|Overall Study|Adverse Event|1
158168|NCT00325754|508779|P1|Overall Study|Adverse Event|4
158169|NCT00325468|508811|P5|Overall Study|site closure etc|1
158170|NCT00325468|508812|P4|Overall Study|site closure etc|8
158171|NCT00325468|508813|P3|Overall Study|site closure etc|1
158172|NCT00325468|508814|P2|Overall Study|site closure etc|2
158173|NCT00325468|508815|P1|Overall Study|site closure etc|4
158174|NCT00325468|508811|P5|Overall Study|Withdrawal by Subject|4
158175|NCT00325468|508812|P4|Overall Study|Withdrawal by Subject|14
158176|NCT00325468|508813|P3|Overall Study|Withdrawal by Subject|0
158177|NCT00325468|508814|P2|Overall Study|Withdrawal by Subject|1
158178|NCT00325468|508815|P1|Overall Study|Withdrawal by Subject|3
158179|NCT00325468|508811|P5|Overall Study|Physician Decision|0
158180|NCT00325468|508812|P4|Overall Study|Physician Decision|1
158181|NCT00325468|508813|P3|Overall Study|Physician Decision|0
158182|NCT00325468|508814|P2|Overall Study|Physician Decision|1
158183|NCT00325468|508815|P1|Overall Study|Physician Decision|1
158184|NCT00325468|508811|P5|Overall Study|Lost to Follow-up|2
158185|NCT00325468|508812|P4|Overall Study|Lost to Follow-up|2
158186|NCT00325468|508813|P3|Overall Study|Lost to Follow-up|1
158187|NCT00325468|508814|P2|Overall Study|Lost to Follow-up|0
158188|NCT00325468|508815|P1|Overall Study|Lost to Follow-up|0
158189|NCT00325468|508811|P5|Overall Study|Death|0
158190|NCT00325468|508812|P4|Overall Study|Death|4
158191|NCT00325468|508813|P3|Overall Study|Death|2
158192|NCT00325468|508814|P2|Overall Study|Death|0
158193|NCT00325468|508815|P1|Overall Study|Death|2
158194|NCT00325468|508811|P5|Overall Study|Adverse Event|1
158195|NCT00325468|508812|P4|Overall Study|Adverse Event|5
158196|NCT00325468|508813|P3|Overall Study|Adverse Event|0
158197|NCT00325468|508814|P2|Overall Study|Adverse Event|1
158198|NCT00325468|508815|P1|Overall Study|Adverse Event|1
158199|NCT00325416|508898|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
158200|NCT00325416|508899|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
158201|NCT00325416|508898|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
158202|NCT00325416|508899|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
158203|NCT00325416|508898|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
158204|NCT00325416|508899|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
158205|NCT00325416|508898|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
158206|NCT00325416|508899|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
158207|NCT00325416|508898|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
158208|NCT00325416|508899|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
158209|NCT00325416|508898|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
158210|NCT00325416|508899|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
158211|NCT00325234|508952|P2|Overall Study|Progressive Disease|37
158212|NCT00325234|508953|P1|Overall Study|Progressive Disease|34
158213|NCT00325234|508952|P2|Overall Study|Physician Decision|12
158214|NCT00325234|508953|P1|Overall Study|Physician Decision|17
158215|NCT00325234|508952|P2|Overall Study|Subject Decision|8
158216|NCT00325234|508953|P1|Overall Study|Subject Decision|6
158217|NCT00325234|508952|P2|Overall Study|Entry Criteria Not Met|2
158218|NCT00325234|508953|P1|Overall Study|Entry Criteria Not Met|1
158219|NCT00325234|508952|P2|Overall Study|Death due to Study Disease|0
158220|NCT00325234|508953|P1|Overall Study|Death due to Study Disease|1
158221|NCT00325234|508952|P2|Overall Study|Adverse Event|7
158222|NCT00325234|508953|P1|Overall Study|Adverse Event|10
158223|NCT00325195|508972|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
158224|NCT00325195|508973|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
158225|NCT00325195|508974|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
158226|NCT00325195|508972|P3|Received Intervention: ITT Population|Lost to Follow-up|2
158227|NCT00325195|508973|P2|Received Intervention: ITT Population|Lost to Follow-up|0
158228|NCT00325195|508974|P1|Received Intervention: ITT Population|Lost to Follow-up|0
158229|NCT00325195|508972|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
158230|NCT00325195|508973|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
158231|NCT00325195|508974|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
158232|NCT00325195|508972|P3|Received Intervention: ITT Population|Death|0
158233|NCT00325195|508973|P2|Received Intervention: ITT Population|Death|1
158234|NCT00325195|508974|P1|Received Intervention: ITT Population|Death|3
158235|NCT00325195|508972|P3|Received Intervention: ITT Population|Adverse Event|1
158236|NCT00325195|508973|P2|Received Intervention: ITT Population|Adverse Event|17
158237|NCT00325195|508974|P1|Received Intervention: ITT Population|Adverse Event|15
158238|NCT00325195|508972|P3|Randomized|Not dosed|3
158239|NCT00325195|508973|P2|Randomized|Not dosed|5
158240|NCT00325195|508974|P1|Randomized|Not dosed|5
158241|NCT00325156|508997|P1|Overall Study|Withdrawal by Subject|31
158242|NCT00325156|508997|P1|Overall Study|Unspecified|1
158243|NCT00325156|508997|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
158244|NCT00325156|508997|P1|Overall Study|Adverse event, non-fatal|3
158245|NCT00325156|508997|P1|Overall Study|Migrated/moved from study area|12
158246|NCT00325156|508997|P1|Overall Study|Lost to follow-up (complete vaccination)|41
158247|NCT00325156|508997|P1|Overall Study|Protocol Violation|8
158248|NCT00325143|509004|P1|Overall Study|Withdrawal by Subject|8
158249|NCT00325143|509004|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
158250|NCT00325143|509004|P1|Overall Study|Migrated/moved from study area|1
158251|NCT00325143|509004|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
158252|NCT00325130|509013|P2|Overall Study|Patient Discontinued for Other|0
158253|NCT00325130|509014|P1|Overall Study|Patient Discontinued for Other|1
158254|NCT00325130|509013|P2|Overall Study|Moved|1
158255|NCT00325130|509014|P1|Overall Study|Moved|0
158256|NCT00325130|509013|P2|Overall Study|Protocol Deviation|1
158257|NCT00325130|509014|P1|Overall Study|Protocol Deviation|0
158258|NCT00325130|509013|P2|Overall Study|Withdrawal by Subject|14
158259|NCT00325130|509014|P1|Overall Study|Withdrawal by Subject|12
158260|NCT00325130|509013|P2|Overall Study|Lost to Follow-up|14
158261|NCT00325130|509014|P1|Overall Study|Lost to Follow-up|6
158262|NCT00325039|509071|P2|Overall Study|Lost to Follow-up|14
158263|NCT00325039|509072|P1|Overall Study|Lost to Follow-up|18
158264|NCT00324961|509086|P1|Overall Study|Other|2
158265|NCT00324961|509086|P1|Overall Study|Protocol Violation|3
158266|NCT00324961|509086|P1|Overall Study|Lost to Follow-up|22
158267|NCT00324961|509086|P1|Overall Study|Consent Withdrawn|11
158268|NCT00324961|509086|P1|Overall Study|Adverse Event|5
158269|NCT00324740|509131|P3|Overall Study|Withdrawal by Subject|1
158270|NCT00324740|509132|P2|Overall Study|Withdrawal by Subject|0
158271|NCT00324740|509133|P1|Overall Study|Withdrawal by Subject|1
158272|NCT00324675|509153|P2|Overall Study|Adverse Event|0
158273|NCT00324675|509154|P1|Overall Study|Adverse Event|1
158274|NCT00324649|509162|P2|Overall Study|Noncompliance|0
158275|NCT00324649|509163|P1|Overall Study|Noncompliance|1
158276|NCT00324649|509162|P2|Overall Study|Withdrawal by Subject|1
158277|NCT00324649|509163|P1|Overall Study|Withdrawal by Subject|0
158278|NCT00324649|509162|P2|Overall Study|Adverse Event|4
158279|NCT00324649|509163|P1|Overall Study|Adverse Event|1
158280|NCT00324233|509294|P2|Second Period|Protocol Violation|6
158281|NCT00324233|509295|P1|Second Period|Protocol Violation|4
158282|NCT00324233|509294|P2|Second Period|unable to insert catheter|1
158283|NCT00324233|509295|P1|Second Period|unable to insert catheter|1
158284|NCT00324233|509294|P2|First Period|unable to insert catheter|0
158285|NCT00324233|509295|P1|First Period|unable to insert catheter|1
158286|NCT00324168|509303|P2|Overall Study|Patient did not visit in f/u window|9
158287|NCT00324168|509304|P1|Overall Study|Patient did not visit in f/u window|6
158288|NCT00324168|509303|P2|Overall Study|Death|3
158289|NCT00324168|509304|P1|Overall Study|Death|3
158290|NCT00324168|509303|P2|Overall Study|Lost to Follow-up|18
158291|NCT00324168|509304|P1|Overall Study|Lost to Follow-up|19
158292|NCT00324155|509332|P2|Follow-up Phase|On-going participants still on drug|6
158293|NCT00324155|509333|P1|Follow-up Phase|On-going participants still on drug|11
158294|NCT00324155|509332|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
158295|NCT00324155|509333|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
158296|NCT00324155|509332|P2|Received Treatment in Maintenance Phase|Adverse Event|3
158297|NCT00324155|509333|P1|Received Treatment in Maintenance Phase|Adverse Event|0
158298|NCT00324155|509332|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
158299|NCT00324155|509333|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
158300|NCT00324155|509332|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
158301|NCT00324155|509333|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
158302|NCT00324155|509332|P2|Received Treatment in Maintenance Phase|Disease Progression|41
158303|NCT00324155|509333|P1|Received Treatment in Maintenance Phase|Disease Progression|26
158304|NCT00324155|509332|P2|Received Treatment in Induction Phase|Physician Decision|0
158305|NCT00324155|509333|P1|Received Treatment in Induction Phase|Physician Decision|2
158306|NCT00324155|509332|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
158307|NCT00324155|509333|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
158308|NCT00324155|509332|P2|Received Treatment in Induction Phase|Adverse Event|7
158309|NCT00324155|509333|P1|Received Treatment in Induction Phase|Adverse Event|6
158310|NCT00324155|509332|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
158311|NCT00324155|509333|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
158312|NCT00324155|509332|P2|Received Treatment in Induction Phase|Death|15
158313|NCT00324155|509333|P1|Received Treatment in Induction Phase|Death|8
158314|NCT00324155|509332|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
158315|NCT00324155|509333|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
158316|NCT00324155|509332|P2|Received Treatment in Induction Phase|Disease Progression|152
158317|NCT00324155|509333|P1|Received Treatment in Induction Phase|Disease Progression|88
158318|NCT00324155|509332|P2|Enrolled and Randomized|Lost to Follow-up|1
158319|NCT00324155|509333|P1|Enrolled and Randomized|Lost to Follow-up|0
158320|NCT00324155|509332|P2|Enrolled and Randomized|No longer met study criteria|0
158321|NCT00324155|509333|P1|Enrolled and Randomized|No longer met study criteria|3
158322|NCT00324116|509363|P1|Overall Study|Other|5
158323|NCT00324116|509363|P1|Overall Study|Withdrawal by Subject|5
158324|NCT00324116|509363|P1|Overall Study|Lack of Efficacy|17
158325|NCT00324116|509363|P1|Overall Study|Adverse Event|5
158326|NCT00324038|509375|P2|Overall Study|Other|13
158327|NCT00324038|509376|P1|Overall Study|Other|6
158328|NCT00324038|509375|P2|Overall Study|Lost to Follow-up|2
158329|NCT00324038|509376|P1|Overall Study|Lost to Follow-up|0
158330|NCT00324038|509375|P2|Overall Study|Lack of Efficacy|13
158331|NCT00324038|509376|P1|Overall Study|Lack of Efficacy|5
158332|NCT00324038|509375|P2|Overall Study|Adverse Event|23
158333|NCT00324038|509376|P1|Overall Study|Adverse Event|38
158334|NCT00323882|509387|P5|Overall Study|Not Specified|1
158335|NCT00323882|509388|P4|Overall Study|Not Specified|1
158336|NCT00323882|509389|P3|Overall Study|Not Specified|0
158337|NCT00323882|509390|P2|Overall Study|Not Specified|0
158338|NCT00323882|509391|P1|Overall Study|Not Specified|0
158339|NCT00323882|509387|P5|Overall Study|Lost to Follow-up|1
158340|NCT00323882|509388|P4|Overall Study|Lost to Follow-up|0
158341|NCT00323882|509389|P3|Overall Study|Lost to Follow-up|1
158342|NCT00323882|509390|P2|Overall Study|Lost to Follow-up|0
158343|NCT00323882|509391|P1|Overall Study|Lost to Follow-up|0
158344|NCT00323882|509387|P5|Overall Study|Death|5
158345|NCT00323882|509388|P4|Overall Study|Death|0
158346|NCT00323882|509389|P3|Overall Study|Death|1
158347|NCT00323882|509390|P2|Overall Study|Death|1
158348|NCT00323882|509391|P1|Overall Study|Death|0
158349|NCT00323882|509387|P5|Overall Study|Disease Progression|22
158350|NCT00323882|509388|P4|Overall Study|Disease Progression|5
158351|NCT00323882|509389|P3|Overall Study|Disease Progression|10
158352|NCT00323882|509390|P2|Overall Study|Disease Progression|4
158353|NCT00323882|509391|P1|Overall Study|Disease Progression|6
158354|NCT00323882|509387|P5|Overall Study|Adverse Event|3
158355|NCT00323882|509388|P4|Overall Study|Adverse Event|1
158356|NCT00323882|509389|P3|Overall Study|Adverse Event|1
158357|NCT00323882|509390|P2|Overall Study|Adverse Event|1
158358|NCT00323882|509391|P1|Overall Study|Adverse Event|2
158359|NCT00323869|509462|P1|Overall Study|Death|1
158360|NCT00321789|509476|P2|Overall Study|Protocol Violation|3
158361|NCT00321789|509477|P1|Overall Study|Protocol Violation|5
158362|NCT00321789|509476|P2|Overall Study|Withdrawal by Subject|6
158363|NCT00321789|509477|P1|Overall Study|Withdrawal by Subject|6
158364|NCT00321789|509476|P2|Overall Study|Lost to Follow-up|7
158365|NCT00321789|509477|P1|Overall Study|Lost to Follow-up|4
158366|NCT00321763|509509|P4|Overall Study|Lost to Follow-up|4
158367|NCT00321763|509510|P3|Overall Study|Lost to Follow-up|5
158368|NCT00321763|509511|P2|Overall Study|Lost to Follow-up|1
158369|NCT00321763|509512|P1|Overall Study|Lost to Follow-up|3
158370|NCT00321763|509509|P4|Overall Study|Withdrawal by Subject|0
158371|NCT00321763|509510|P3|Overall Study|Withdrawal by Subject|1
158372|NCT00321763|509511|P2|Overall Study|Withdrawal by Subject|0
158373|NCT00321763|509512|P1|Overall Study|Withdrawal by Subject|2
158374|NCT00321763|509509|P4|Overall Study|Adverse Event|1
158375|NCT00321763|509510|P3|Overall Study|Adverse Event|0
158376|NCT00321763|509511|P2|Overall Study|Adverse Event|1
158377|NCT00321763|509512|P1|Overall Study|Adverse Event|1
158378|NCT00321737|509572|P3|Overall Study|Subject Request/ Subject Unavailable|2
158379|NCT00321737|509573|P2|Overall Study|Subject Request/ Subject Unavailable|0
158380|NCT00321737|509574|P1|Overall Study|Subject Request/ Subject Unavailable|0
158381|NCT00321737|509572|P3|Overall Study|Noncompliance|0
158382|NCT00321737|509573|P2|Overall Study|Noncompliance|0
158383|NCT00321737|509574|P1|Overall Study|Noncompliance|2
158384|NCT00321737|509572|P3|Overall Study|Pregnancy|0
158385|NCT00321737|509573|P2|Overall Study|Pregnancy|2
158386|NCT00321737|509574|P1|Overall Study|Pregnancy|0
158387|NCT00321737|509572|P3|Overall Study|Therapeutic Failure|2
158388|NCT00321737|509573|P2|Overall Study|Therapeutic Failure|0
158389|NCT00321737|509574|P1|Overall Study|Therapeutic Failure|6
158390|NCT00321737|509572|P3|Overall Study|Possible Barrett's Esophagus|1
158391|NCT00321737|509573|P2|Overall Study|Possible Barrett's Esophagus|1
158392|NCT00321737|509574|P1|Overall Study|Possible Barrett's Esophagus|2
158393|NCT00321737|509572|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
158394|NCT00321737|509573|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
158395|NCT00321737|509574|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
158396|NCT00321737|509572|P3|Overall Study|Protocol Violation|1
158397|NCT00321737|509573|P2|Overall Study|Protocol Violation|0
158398|NCT00321737|509574|P1|Overall Study|Protocol Violation|0
158399|NCT00321737|509572|P3|Overall Study|Withdrawal by Subject|17
158400|NCT00321737|509573|P2|Overall Study|Withdrawal by Subject|12
158401|NCT00321737|509574|P1|Overall Study|Withdrawal by Subject|19
158402|NCT00321737|509572|P3|Overall Study|Lost to Follow-up|6
158403|NCT00321737|509573|P2|Overall Study|Lost to Follow-up|5
158404|NCT00321737|509574|P1|Overall Study|Lost to Follow-up|5
158405|NCT00321737|509572|P3|Overall Study|Adverse Event|6
158406|NCT00321737|509573|P2|Overall Study|Adverse Event|3
158407|NCT00321737|509574|P1|Overall Study|Adverse Event|11
158408|NCT00321737|509572|P3|Overall Study|Relapse of Erosive Esophagitis|19
158409|NCT00321737|509573|P2|Overall Study|Relapse of Erosive Esophagitis|25
158410|NCT00321737|509574|P1|Overall Study|Relapse of Erosive Esophagitis|76
158411|NCT00321711|509602|P5|Part B|Death|1
158412|NCT00321711|509603|P4|Part B|Death|2
158413|NCT00321711|509604|P3|Part B|Death|0
158414|NCT00321711|509605|P2|Part B|Death|0
158415|NCT00321711|509606|P1|Part B|Death|0
158416|NCT00321711|509602|P5|Part B|Physician Decision|2
158417|NCT00321711|509603|P4|Part B|Physician Decision|1
158418|NCT00321711|509604|P3|Part B|Physician Decision|0
158419|NCT00321711|509605|P2|Part B|Physician Decision|0
158420|NCT00321711|509606|P1|Part B|Physician Decision|0
158421|NCT00321711|509602|P5|Part B|Disease progression|0
158422|NCT00321711|509603|P4|Part B|Disease progression|1
158423|NCT00321711|509604|P3|Part B|Disease progression|0
158424|NCT00321711|509605|P2|Part B|Disease progression|0
158425|NCT00321711|509606|P1|Part B|Disease progression|0
158426|NCT00321711|509602|P5|Part B|Adverse Event|1
158427|NCT00321711|509603|P4|Part B|Adverse Event|2
158428|NCT00321711|509604|P3|Part B|Adverse Event|0
158429|NCT00321711|509605|P2|Part B|Adverse Event|0
158430|NCT00321711|509606|P1|Part B|Adverse Event|0
158431|NCT00321711|509602|P5|Part B|Noncompliance|1
158432|NCT00321711|509603|P4|Part B|Noncompliance|0
158433|NCT00321711|509604|P3|Part B|Noncompliance|0
158434|NCT00321711|509605|P2|Part B|Noncompliance|0
158435|NCT00321711|509606|P1|Part B|Noncompliance|0
158436|NCT00321711|509602|P5|Part A|Protocol deviation|0
158437|NCT00321711|509603|P4|Part A|Protocol deviation|0
158438|NCT00321711|509604|P3|Part A|Protocol deviation|1
158439|NCT00321711|509605|P2|Part A|Protocol deviation|0
158440|NCT00321711|509606|P1|Part A|Protocol deviation|0
158441|NCT00321711|509602|P5|Part A|Other|0
158442|NCT00321711|509603|P4|Part A|Other|0
158443|NCT00321711|509604|P3|Part A|Other|3
158444|NCT00321711|509605|P2|Part A|Other|2
158445|NCT00321711|509606|P1|Part A|Other|1
158446|NCT00321711|509602|P5|Part A|Physician Decision|0
158447|NCT00321711|509603|P4|Part A|Physician Decision|0
158448|NCT00321711|509604|P3|Part A|Physician Decision|3
158449|NCT00321711|509605|P2|Part A|Physician Decision|1
158450|NCT00321711|509606|P1|Part A|Physician Decision|0
158451|NCT00321711|509602|P5|Part A|Requirement for alternative therapy|0
158452|NCT00321711|509603|P4|Part A|Requirement for alternative therapy|0
158453|NCT00321711|509604|P3|Part A|Requirement for alternative therapy|1
158454|NCT00321711|509605|P2|Part A|Requirement for alternative therapy|2
158455|NCT00321711|509606|P1|Part A|Requirement for alternative therapy|0
158456|NCT00321711|509602|P5|Part A|Disease progression|0
158457|NCT00321711|509603|P4|Part A|Disease progression|0
158458|NCT00321711|509604|P3|Part A|Disease progression|0
158459|NCT00321711|509605|P2|Part A|Disease progression|1
158460|NCT00321711|509606|P1|Part A|Disease progression|0
158461|NCT00321711|509602|P5|Part A|Withdrawal by Subject|0
158462|NCT00321711|509603|P4|Part A|Withdrawal by Subject|0
158463|NCT00321711|509604|P3|Part A|Withdrawal by Subject|1
158464|NCT00321711|509605|P2|Part A|Withdrawal by Subject|1
158465|NCT00321711|509606|P1|Part A|Withdrawal by Subject|1
158466|NCT00321711|509602|P5|Part A|Adverse Event|0
158467|NCT00321711|509603|P4|Part A|Adverse Event|0
158468|NCT00321711|509604|P3|Part A|Adverse Event|2
158469|NCT00321711|509605|P2|Part A|Adverse Event|3
158470|NCT00321711|509606|P1|Part A|Adverse Event|3
158471|NCT00321685|509656|P1|Overall Study|Ineligible|2
158472|NCT00321685|509656|P1|Overall Study|Not start protocol therapy|2
158473|NCT00321685|509656|P1|Overall Study|Other|5
158474|NCT00321685|509656|P1|Overall Study|Complicating disese|1
158475|NCT00321685|509656|P1|Overall Study|Alternative therapy|1
158476|NCT00321685|509656|P1|Overall Study|Withdrawal by Subject|8
158477|NCT00321685|509656|P1|Overall Study|Death|2
158478|NCT00321685|509656|P1|Overall Study|Adverse Event|18
158479|NCT00321672|509668|P4|Overall Study|Extensive travel required for new job|0
158480|NCT00321672|509669|P3|Overall Study|Extensive travel required for new job|0
158481|NCT00321672|509670|P2|Overall Study|Extensive travel required for new job|1
158482|NCT00321672|509671|P1|Overall Study|Extensive travel required for new job|0
158483|NCT00321672|509668|P4|Overall Study|Diagnosis of testicular cancer|0
158484|NCT00321672|509669|P3|Overall Study|Diagnosis of testicular cancer|0
158485|NCT00321672|509670|P2|Overall Study|Diagnosis of testicular cancer|1
158486|NCT00321672|509671|P1|Overall Study|Diagnosis of testicular cancer|0
158487|NCT00321672|509668|P4|Overall Study|Protocol Violation|0
158488|NCT00321672|509669|P3|Overall Study|Protocol Violation|1
158489|NCT00321672|509670|P2|Overall Study|Protocol Violation|0
158490|NCT00321672|509671|P1|Overall Study|Protocol Violation|0
158491|NCT00321672|509668|P4|Overall Study|Moved out of state|0
158492|NCT00321672|509669|P3|Overall Study|Moved out of state|1
158493|NCT00321672|509670|P2|Overall Study|Moved out of state|1
158494|NCT00321672|509671|P1|Overall Study|Moved out of state|0
158495|NCT00321672|509668|P4|Overall Study|Incarcerated|0
158496|NCT00321672|509669|P3|Overall Study|Incarcerated|2
158497|NCT00321672|509670|P2|Overall Study|Incarcerated|0
158498|NCT00321672|509671|P1|Overall Study|Incarcerated|0
158499|NCT00321672|509668|P4|Overall Study|Too far to travel for visits|0
158500|NCT00321672|509669|P3|Overall Study|Too far to travel for visits|0
158501|NCT00321672|509670|P2|Overall Study|Too far to travel for visits|0
158502|NCT00321672|509671|P1|Overall Study|Too far to travel for visits|1
158503|NCT00321672|509668|P4|Overall Study|Death|0
158504|NCT00321672|509669|P3|Overall Study|Death|0
158505|NCT00321672|509670|P2|Overall Study|Death|0
158506|NCT00321672|509671|P1|Overall Study|Death|1
158507|NCT00321672|509668|P4|Overall Study|Lost to Follow-up|2
158508|NCT00321672|509669|P3|Overall Study|Lost to Follow-up|4
158509|NCT00321672|509670|P2|Overall Study|Lost to Follow-up|0
158510|NCT00321672|509671|P1|Overall Study|Lost to Follow-up|2
158511|NCT00321672|509668|P4|Overall Study|Lack of Efficacy|0
158512|NCT00321672|509669|P3|Overall Study|Lack of Efficacy|0
158513|NCT00321672|509670|P2|Overall Study|Lack of Efficacy|1
158514|NCT00321672|509671|P1|Overall Study|Lack of Efficacy|1
158515|NCT00321672|509668|P4|Overall Study|Adverse Event|0
158516|NCT00321672|509669|P3|Overall Study|Adverse Event|0
158517|NCT00321672|509670|P2|Overall Study|Adverse Event|1
158518|NCT00321672|509671|P1|Overall Study|Adverse Event|1
158519|NCT00321672|509668|P4|Overall Study|Noncompliance|0
158520|NCT00321672|509669|P3|Overall Study|Noncompliance|1
158521|NCT00321672|509670|P2|Overall Study|Noncompliance|2
158522|NCT00321672|509671|P1|Overall Study|Noncompliance|1
158523|NCT00321672|509668|P4|Overall Study|Withdrawal by Subject|0
158524|NCT00321672|509669|P3|Overall Study|Withdrawal by Subject|2
158525|NCT00321672|509670|P2|Overall Study|Withdrawal by Subject|1
158526|NCT00321672|509671|P1|Overall Study|Withdrawal by Subject|5
158527|NCT00323622|509729|P8|Overall Study|Death|2
158528|NCT00323622|509730|P7|Overall Study|Death|0
158529|NCT00323622|509731|P6|Overall Study|Death|0
158530|NCT00323622|509732|P5|Overall Study|Death|7
158531|NCT00323622|509733|P4|Overall Study|Death|0
158532|NCT00323622|509734|P3|Overall Study|Death|0
158533|NCT00323622|509735|P2|Overall Study|Death|1
158534|NCT00323622|509736|P1|Overall Study|Death|1
158535|NCT00323622|509729|P8|Overall Study|Unspecified|13
158536|NCT00323622|509730|P7|Overall Study|Unspecified|5
158537|NCT00323622|509731|P6|Overall Study|Unspecified|74
158538|NCT00323622|509732|P5|Overall Study|Unspecified|32
158539|NCT00323622|509733|P4|Overall Study|Unspecified|12
158540|NCT00323622|509734|P3|Overall Study|Unspecified|4
158541|NCT00323622|509735|P2|Overall Study|Unspecified|91
158542|NCT00323622|509736|P1|Overall Study|Unspecified|30
158543|NCT00323609|509778|P4|Overall Study|Other reason|9
158544|NCT00323609|509779|P3|Overall Study|Other reason|4
158545|NCT00323609|509780|P2|Overall Study|Other reason|8
158546|NCT00323609|509781|P1|Overall Study|Other reason|11
158547|NCT00323609|509778|P4|Overall Study|Logistical withdrawal|1
158548|NCT00323609|509779|P3|Overall Study|Logistical withdrawal|0
158549|NCT00323609|509780|P2|Overall Study|Logistical withdrawal|5
158550|NCT00323609|509781|P1|Overall Study|Logistical withdrawal|9
158551|NCT00323609|509778|P4|Overall Study|Unrelenting or severe back pain|0
158552|NCT00323609|509779|P3|Overall Study|Unrelenting or severe back pain|0
158553|NCT00323609|509780|P2|Overall Study|Unrelenting or severe back pain|1
158554|NCT00323609|509781|P1|Overall Study|Unrelenting or severe back pain|1
158555|NCT00323609|509778|P4|Overall Study|Sponsor discontinued trial|0
158556|NCT00323609|509779|P3|Overall Study|Sponsor discontinued trial|0
158557|NCT00323609|509780|P2|Overall Study|Sponsor discontinued trial|29
158558|NCT00323609|509781|P1|Overall Study|Sponsor discontinued trial|29
158559|NCT00323609|509778|P4|Overall Study|Other non-VCF-related medical condition|0
158560|NCT00323609|509779|P3|Overall Study|Other non-VCF-related medical condition|0
158561|NCT00323609|509780|P2|Overall Study|Other non-VCF-related medical condition|2
158562|NCT00323609|509781|P1|Overall Study|Other non-VCF-related medical condition|3
158563|NCT00323609|509778|P4|Overall Study|Withdrawal by Subject|4
158564|NCT00323609|509779|P3|Overall Study|Withdrawal by Subject|4
158565|NCT00323609|509780|P2|Overall Study|Withdrawal by Subject|23
158566|NCT00323609|509781|P1|Overall Study|Withdrawal by Subject|11
158567|NCT00323609|509778|P4|Overall Study|Physician Decision|1
158568|NCT00323609|509779|P3|Overall Study|Physician Decision|0
158569|NCT00323609|509780|P2|Overall Study|Physician Decision|0
158570|NCT00323609|509781|P1|Overall Study|Physician Decision|2
158571|NCT00323609|509778|P4|Overall Study|Lost to Follow-up|0
158572|NCT00323609|509779|P3|Overall Study|Lost to Follow-up|0
158573|NCT00323609|509780|P2|Overall Study|Lost to Follow-up|10
158574|NCT00323609|509781|P1|Overall Study|Lost to Follow-up|9
158575|NCT00323609|509778|P4|Overall Study|Death|0
158576|NCT00323609|509779|P3|Overall Study|Death|0
158577|NCT00323609|509780|P2|Overall Study|Death|21
158578|NCT00323609|509781|P1|Overall Study|Death|16
158579|NCT00323557|509817|P2|Overall Study|Physician Decision|0
158580|NCT00323557|509818|P1|Overall Study|Physician Decision|1
158581|NCT00323492|509827|P3|Study Phase 2|Protocol Violation|0
158582|NCT00323492|509828|P2|Study Phase 2|Protocol Violation|0
158583|NCT00323492|509829|P1|Study Phase 2|Protocol Violation|1
158584|NCT00323492|509827|P3|Study Phase 2|Noncompliance with study schedule|1
158585|NCT00323492|509828|P2|Study Phase 2|Noncompliance with study schedule|0
158586|NCT00323492|509829|P1|Study Phase 2|Noncompliance with study schedule|0
158587|NCT00323492|509827|P3|Study Phase 2|Withdrawal by Subject|0
158588|NCT00323492|509828|P2|Study Phase 2|Withdrawal by Subject|1
158589|NCT00323492|509829|P1|Study Phase 2|Withdrawal by Subject|0
158590|NCT00323492|509827|P3|Study Phase 2|Lost to Follow-up|0
158591|NCT00323492|509828|P2|Study Phase 2|Lost to Follow-up|0
158592|NCT00323492|509829|P1|Study Phase 2|Lost to Follow-up|1
158593|NCT00323492|509827|P3|Study Phase 2|Physician Decision|0
158594|NCT00323492|509828|P2|Study Phase 2|Physician Decision|0
158595|NCT00323492|509829|P1|Study Phase 2|Physician Decision|1
158596|NCT00323492|509827|P3|Study Phase 2|Adverse Event|0
158597|NCT00323492|509828|P2|Study Phase 2|Adverse Event|0
158598|NCT00323492|509829|P1|Study Phase 2|Adverse Event|1
158599|NCT00323492|509827|P3|Study Phase 1|Adverse Event|0
158600|NCT00323492|509828|P2|Study Phase 1|Adverse Event|0
158601|NCT00323492|509829|P1|Study Phase 1|Adverse Event|2
158602|NCT00323479|509860|P1|Overall Study|house moving|1
158603|NCT00323479|509860|P1|Overall Study|Protocol Violation|3
158604|NCT00323479|509860|P1|Overall Study|Withdrawal by Subject|2
158605|NCT00323479|509860|P1|Overall Study|Adverse Event|2
158606|NCT00321646|509882|P1|Neoadjuvant Chemotherapy|Disease progression|1
158607|NCT00321646|509882|P1|Neoadjuvant Chemotherapy|Adverse Event|2
158608|NCT00321646|509882|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
158609|NCT00321620|509889|P2|Overall Study|Other|33
158610|NCT00321620|509890|P1|Overall Study|Other|42
158611|NCT00321620|509889|P2|Overall Study|Participant request|52
158612|NCT00321620|509890|P1|Overall Study|Participant request|75
158613|NCT00321620|509889|P2|Overall Study|Ineligibility determined|3
158614|NCT00321620|509890|P1|Overall Study|Ineligibility determined|2
158615|NCT00321620|509889|P2|Overall Study|Protocol deviation|3
158616|NCT00321620|509890|P1|Overall Study|Protocol deviation|4
158617|NCT00321620|509889|P2|Overall Study|Noncompliance|7
158618|NCT00321620|509890|P1|Overall Study|Noncompliance|14
158619|NCT00321620|509889|P2|Overall Study|Physician Decision|1
158620|NCT00321620|509890|P1|Overall Study|Physician Decision|4
158621|NCT00321620|509889|P2|Overall Study|Lost to Follow-up|9
158622|NCT00321620|509890|P1|Overall Study|Lost to Follow-up|13
158623|NCT00321620|509889|P2|Overall Study|Adverse Event|56
158624|NCT00321620|509890|P1|Overall Study|Adverse Event|43
158625|NCT00321620|509889|P2|Overall Study|Disease progression|117
158626|NCT00321620|509890|P1|Overall Study|Disease progression|113
158627|NCT00321620|509889|P2|Overall Study|Withdrawal by Subject|147
158628|NCT00321620|509890|P1|Overall Study|Withdrawal by Subject|164
158629|NCT00321620|509889|P2|Overall Study|Death|294
158630|NCT00321620|509890|P1|Overall Study|Death|269
158631|NCT00321464|509902|P2|Overall Study|Other|18
158632|NCT00321464|509903|P1|Overall Study|Other|21
158633|NCT00321464|509902|P2|Overall Study|Ineligibility determined|1
158634|NCT00321464|509903|P1|Overall Study|Ineligibility determined|2
158635|NCT00321464|509902|P2|Overall Study|Protocol deviation|2
158636|NCT00321464|509903|P1|Overall Study|Protocol deviation|0
158637|NCT00321464|509902|P2|Overall Study|Lost to Follow-up|8
158638|NCT00321464|509903|P1|Overall Study|Lost to Follow-up|7
158639|NCT00321464|509902|P2|Overall Study|Noncompliance|10
158640|NCT00321464|509903|P1|Overall Study|Noncompliance|4
158641|NCT00321464|509902|P2|Overall Study|Physician Decision|14
158642|NCT00321464|509903|P1|Overall Study|Physician Decision|15
158643|NCT00321464|509902|P2|Overall Study|Adverse Event|28
158644|NCT00321464|509903|P1|Overall Study|Adverse Event|43
158645|NCT00321464|509902|P2|Overall Study|Participant request|61
158646|NCT00321464|509903|P1|Overall Study|Participant request|57
158647|NCT00321464|509902|P2|Overall Study|Withdrawal by Subject|118
158648|NCT00321464|509903|P1|Overall Study|Withdrawal by Subject|117
158649|NCT00321464|509902|P2|Overall Study|Disease progression|124
158650|NCT00321464|509903|P1|Overall Study|Disease progression|124
158651|NCT00321464|509902|P2|Overall Study|Death|174
158652|NCT00321464|509903|P1|Overall Study|Death|169
158653|NCT00323310|509919|P1|Overall Study|did not complete the 24-hr f-up visit|1
158654|NCT00323310|509919|P1|Overall Study|a parent refused blood draw|1
158655|NCT00323310|509919|P1|Overall Study|Withdrawal by Subject|1
158656|NCT00323297|509934|P2|Part B (Open-label)|Protocol Violation|1
158657|NCT00323297|509935|P1|Part B (Open-label)|Protocol Violation|0
158658|NCT00323297|509934|P2|Part B (Open-label)|Adverse Event|5
158659|NCT00323297|509935|P1|Part B (Open-label)|Adverse Event|5
158660|NCT00323297|509934|P2|Part B (Open-label)|Lack of Efficacy|1
158661|NCT00323297|509935|P1|Part B (Open-label)|Lack of Efficacy|3
158662|NCT00323297|509934|P2|Part B (Open-label)|Withdrawal by Subject|3
158663|NCT00323297|509935|P1|Part B (Open-label)|Withdrawal by Subject|1
158664|NCT00323297|509934|P2|Part B (Open-label)|Reason unspecified|1
158665|NCT00323297|509935|P1|Part B (Open-label)|Reason unspecified|0
158666|NCT00323297|509934|P2|Part B (Open-label)|Death|1
158667|NCT00323297|509935|P1|Part B (Open-label)|Death|0
158668|NCT00323297|509934|P2|Part A (Double Blind Randomized)|Related adverse event|2
158669|NCT00323297|509935|P1|Part A (Double Blind Randomized)|Related adverse event|2
158670|NCT00323297|509934|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
158671|NCT00323297|509935|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
158672|NCT00323297|509934|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
158673|NCT00323297|509935|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
158674|NCT00323297|509934|P2|Part A (Double Blind Randomized)|Protocol Violation|3
158675|NCT00323297|509935|P1|Part A (Double Blind Randomized)|Protocol Violation|1
158676|NCT00323297|509934|P2|Part A (Double Blind Randomized)|Death|1
158677|NCT00323297|509935|P1|Part A (Double Blind Randomized)|Death|0
158678|NCT00323297|509934|P2|Part A (Double Blind Randomized)|Reason unspecified|1
158679|NCT00323297|509935|P1|Part A (Double Blind Randomized)|Reason unspecified|0
158680|NCT00323258|509975|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
158681|NCT00323258|509976|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
158682|NCT00323258|509975|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
158683|NCT00323258|509976|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
158684|NCT00323258|509975|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
158685|NCT00323258|509976|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
158686|NCT00323258|509975|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
158687|NCT00323258|509976|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
158688|NCT00323258|509975|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
158689|NCT00323258|509976|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
158690|NCT00323258|509975|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
158691|NCT00323258|509976|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
158692|NCT00323258|509975|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
158693|NCT00323258|509976|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
158694|NCT00323115|510001|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
158695|NCT00323115|510001|P1|Vaccine Administration|Adverse Event|1
158696|NCT00322881|510013|P1|Overall Study|Disease Progression|2
158697|NCT00322881|510013|P1|Overall Study|Adverse Event|1
158698|NCT00322881|510013|P1|Overall Study|Death|2
158699|NCT00322842|510023|P2|Overall Study|Death|0
158700|NCT00322842|510024|P1|Overall Study|Death|1
158701|NCT00322842|510023|P2|Overall Study|Refused transplant|0
158702|NCT00322842|510024|P1|Overall Study|Refused transplant|1
158703|NCT00322842|510023|P2|Overall Study|Lost to Follow-up|1
158704|NCT00322842|510024|P1|Overall Study|Lost to Follow-up|0
158705|NCT00322842|510023|P2|Overall Study|Withdrawal by Subject|1
158706|NCT00322842|510024|P1|Overall Study|Withdrawal by Subject|0
158707|NCT00321373|510052|P3|Overall Study|Unspecified|1
158708|NCT00321373|510053|P2|Overall Study|Unspecified|0
158709|NCT00321373|510054|P1|Overall Study|Unspecified|0
158710|NCT00321373|510052|P3|Overall Study|Withdrawal by Subject|0
158711|NCT00321373|510053|P2|Overall Study|Withdrawal by Subject|0
158712|NCT00321373|510054|P1|Overall Study|Withdrawal by Subject|1
158713|NCT00321373|510052|P3|Overall Study|Lost to Follow-up|1
158714|NCT00321373|510053|P2|Overall Study|Lost to Follow-up|0
158715|NCT00321373|510054|P1|Overall Study|Lost to Follow-up|1
158716|NCT00321373|510052|P3|Overall Study|Adverse Event|1
158717|NCT00321373|510053|P2|Overall Study|Adverse Event|0
158718|NCT00321373|510054|P1|Overall Study|Adverse Event|0
158719|NCT00322712|510094|P1|Overall Study|treated with bevacizumab not cetuximab|1
158720|NCT00322621|510098|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
158721|NCT00322621|510099|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
158722|NCT00322621|510100|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
158723|NCT00322621|510098|P3|Period III - Maintenance / Rescue Phase|Death|0
158724|NCT00322621|510099|P2|Period III - Maintenance / Rescue Phase|Death|1
158725|NCT00322621|510100|P1|Period III - Maintenance / Rescue Phase|Death|0
158726|NCT00322621|510098|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
158727|NCT00322621|510099|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
158728|NCT00322621|510100|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
158729|NCT00322621|510098|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
158730|NCT00322621|510099|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
158731|NCT00322621|510100|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
158732|NCT00322621|510098|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
158733|NCT00322621|510099|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
158734|NCT00322621|510100|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
158735|NCT00322621|510098|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
158736|NCT00322621|510099|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
158737|NCT00322621|510100|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
158738|NCT00322621|510098|P3|Period II - Acute Therapy Phase|Physician Decision|0
158739|NCT00322621|510099|P2|Period II - Acute Therapy Phase|Physician Decision|0
158740|NCT00322621|510100|P1|Period II - Acute Therapy Phase|Physician Decision|1
158741|NCT00322621|510098|P3|Period II - Acute Therapy Phase|Protocol Violation|0
158742|NCT00322621|510099|P2|Period II - Acute Therapy Phase|Protocol Violation|0
158743|NCT00322621|510100|P1|Period II - Acute Therapy Phase|Protocol Violation|2
158744|NCT00322621|510098|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
158745|NCT00322621|510099|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
158746|NCT00322621|510100|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
158747|NCT00322621|510098|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
158748|NCT00322621|510099|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
158749|NCT00322621|510100|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
158750|NCT00322621|510098|P3|Period II - Acute Therapy Phase|Adverse Event|0
158751|NCT00322621|510099|P2|Period II - Acute Therapy Phase|Adverse Event|0
158752|NCT00322621|510100|P1|Period II - Acute Therapy Phase|Adverse Event|20
158753|NCT00322556|510152|P1|Overall Study|Other Reason|7
158754|NCT00322556|510152|P1|Overall Study|Lost to Follow-up|3
158755|NCT00322556|510152|P1|Overall Study|Withdrawal by Subject|1
158756|NCT00322556|510152|P1|Overall Study|Adverse Event|1
158757|NCT00322491|510168|P2|Overall Study|Death|2
158758|NCT00322491|510169|P1|Overall Study|Death|1
158759|NCT00322491|510168|P2|Overall Study|Adverse Event|0
158760|NCT00322491|510169|P1|Overall Study|Adverse Event|1
158761|NCT00322452|510259|P2|Overall Study|Death|227
158762|NCT00322452|510260|P1|Overall Study|Death|223
158763|NCT00322452|510259|P2|Overall Study|Withdrawal by Subject|46
158764|NCT00322452|510260|P1|Overall Study|Withdrawal by Subject|19
158765|NCT00322452|510259|P2|Overall Study|Lost to Follow-up|2
158766|NCT00322452|510260|P1|Overall Study|Lost to Follow-up|5
158767|NCT00322452|510259|P2|Overall Study|Eligibility criteria not fulfilled|1
158768|NCT00322452|510260|P1|Overall Study|Eligibility criteria not fulfilled|0
158769|NCT00322387|510311|P2|Follow-up Period|Death|0
158770|NCT00322387|510312|P1|Follow-up Period|Death|1
158771|NCT00322387|510311|P2|Follow-up Period|Final assessment not done|3
158772|NCT00322387|510312|P1|Follow-up Period|Final assessment not done|1
158773|NCT00322387|510311|P2|Treatment Period|Adverse Event|1
158774|NCT00322387|510312|P1|Treatment Period|Adverse Event|0
158775|NCT00322374|510346|P4|Second Escalation|Study Drug Toxicity|0
158776|NCT00322374|510347|P3|Second Escalation|Study Drug Toxicity|1
158777|NCT00322374|510348|P2|Second Escalation|Study Drug Toxicity|0
158778|NCT00322374|510349|P1|Second Escalation|Study Drug Toxicity|0
158779|NCT00322374|510346|P4|Second Escalation|Physician Decision|0
158780|NCT00322374|510347|P3|Second Escalation|Physician Decision|5
158781|NCT00322374|510348|P2|Second Escalation|Physician Decision|0
158782|NCT00322374|510349|P1|Second Escalation|Physician Decision|0
158783|NCT00322374|510346|P4|First Escalation|Participant Request|0
158784|NCT00322374|510347|P3|First Escalation|Participant Request|0
158785|NCT00322374|510348|P2|First Escalation|Participant Request|1
158786|NCT00322374|510349|P1|First Escalation|Participant Request|0
158787|NCT00322374|510346|P4|First Escalation|Study Drug Toxicity|0
158788|NCT00322374|510347|P3|First Escalation|Study Drug Toxicity|0
158789|NCT00322374|510348|P2|First Escalation|Study Drug Toxicity|11
158790|NCT00322374|510349|P1|First Escalation|Study Drug Toxicity|0
158791|NCT00322374|510346|P4|First Escalation|Physician Decision|0
158792|NCT00322374|510347|P3|First Escalation|Physician Decision|0
158793|NCT00322374|510348|P2|First Escalation|Physician Decision|12
158794|NCT00322374|510349|P1|First Escalation|Physician Decision|0
158795|NCT00322374|510346|P4|First Escalation|Documented Disease Progression|0
158796|NCT00322374|510347|P3|First Escalation|Documented Disease Progression|0
158797|NCT00322374|510348|P2|First Escalation|Documented Disease Progression|6
158798|NCT00322374|510349|P1|First Escalation|Documented Disease Progression|0
158799|NCT00322374|510346|P4|Starting Dose|Study Drug Toxicity|0
158800|NCT00322374|510347|P3|Starting Dose|Study Drug Toxicity|0
158801|NCT00322374|510348|P2|Starting Dose|Study Drug Toxicity|0
158802|NCT00322374|510349|P1|Starting Dose|Study Drug Toxicity|4
158803|NCT00322374|510346|P4|Starting Dose|Physician Decision|0
158804|NCT00322374|510347|P3|Starting Dose|Physician Decision|0
158805|NCT00322374|510348|P2|Starting Dose|Physician Decision|0
158806|NCT00322374|510349|P1|Starting Dose|Physician Decision|2
158807|NCT00322348|510399|P2|Overall Study|Reasons not specified|1
158808|NCT00322348|510400|P1|Overall Study|Reasons not specified|5
158809|NCT00322348|510399|P2|Overall Study|Disease Progression|25
158810|NCT00322348|510400|P1|Overall Study|Disease Progression|30
158811|NCT00322348|510399|P2|Overall Study|Death|2
158812|NCT00322348|510400|P1|Overall Study|Death|0
158813|NCT00322348|510399|P2|Overall Study|Lost to Follow-up|0
158814|NCT00322348|510400|P1|Overall Study|Lost to Follow-up|1
158815|NCT00322348|510399|P2|Overall Study|Withdrawal by Subject|4
158816|NCT00322348|510400|P1|Overall Study|Withdrawal by Subject|1
158817|NCT00322348|510399|P2|Overall Study|Adverse Event|1
158818|NCT00322348|510400|P1|Overall Study|Adverse Event|0
158819|NCT00322153|510474|P2|Overall Study|Withdrawn for other reasons|4
158820|NCT00322153|510475|P1|Overall Study|Withdrawn for other reasons|5
158821|NCT00322153|510474|P2|Overall Study|Lost to Follow-up|4
158822|NCT00322153|510475|P1|Overall Study|Lost to Follow-up|5
158823|NCT00322153|510474|P2|Overall Study|Lack of Efficacy|3
158824|NCT00322153|510475|P1|Overall Study|Lack of Efficacy|8
158825|NCT00322153|510474|P2|Overall Study|Withdrawal by Subject|10
158826|NCT00322153|510475|P1|Overall Study|Withdrawal by Subject|18
158827|NCT00322153|510474|P2|Overall Study|Protocol Violation|14
158828|NCT00322153|510475|P1|Overall Study|Protocol Violation|6
158829|NCT00322153|510474|P2|Overall Study|Adverse Event|34
158830|NCT00322153|510475|P1|Overall Study|Adverse Event|21
158831|NCT00321984|510507|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
158832|NCT00321984|510508|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
158833|NCT00321984|510509|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
158834|NCT00321984|510507|P3|Overall Study|Per Investigator Request|0
158835|NCT00321984|510508|P2|Overall Study|Per Investigator Request|0
158836|NCT00321984|510509|P1|Overall Study|Per Investigator Request|1
158837|NCT00321984|510507|P3|Overall Study|Per Subject Request|0
158838|NCT00321984|510508|P2|Overall Study|Per Subject Request|0
158839|NCT00321984|510509|P1|Overall Study|Per Subject Request|1
158840|NCT00321984|510507|P3|Overall Study|Pregnancy|0
158841|NCT00321984|510508|P2|Overall Study|Pregnancy|1
158842|NCT00321984|510509|P1|Overall Study|Pregnancy|0
158843|NCT00321984|510507|P3|Overall Study|Noncompliant|2
158844|NCT00321984|510508|P2|Overall Study|Noncompliant|0
158845|NCT00321984|510509|P1|Overall Study|Noncompliant|0
158846|NCT00321984|510507|P3|Overall Study|Lack of Efficacy|3
158847|NCT00321984|510508|P2|Overall Study|Lack of Efficacy|1
158848|NCT00321984|510509|P1|Overall Study|Lack of Efficacy|3
158849|NCT00321984|510507|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
158850|NCT00321984|510508|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
158851|NCT00321984|510509|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
158852|NCT00321984|510507|P3|Overall Study|Withdrawal by Subject|5
158853|NCT00321984|510508|P2|Overall Study|Withdrawal by Subject|6
158854|NCT00321984|510509|P1|Overall Study|Withdrawal by Subject|8
158855|NCT00321984|510507|P3|Overall Study|Lost to Follow-up|2
158856|NCT00321984|510508|P2|Overall Study|Lost to Follow-up|4
158857|NCT00321984|510509|P1|Overall Study|Lost to Follow-up|2
158858|NCT00321984|510507|P3|Overall Study|Protocol Violation|1
158859|NCT00321984|510508|P2|Overall Study|Protocol Violation|1
158860|NCT00321984|510509|P1|Overall Study|Protocol Violation|0
158861|NCT00321984|510507|P3|Overall Study|Adverse Event|8
158862|NCT00321984|510508|P2|Overall Study|Adverse Event|6
158863|NCT00321984|510509|P1|Overall Study|Adverse Event|9
158864|NCT00321932|510528|P2|Overall Study|Missing data|1
158865|NCT00321932|510529|P1|Overall Study|Missing data|2
158866|NCT00321932|510528|P2|Overall Study|Early relapse|8
158867|NCT00321932|510529|P1|Overall Study|Early relapse|2
158868|NCT00321932|510528|P2|Overall Study|Withdrawal by Subject|6
158869|NCT00321932|510529|P1|Overall Study|Withdrawal by Subject|3
158870|NCT00321932|510528|P2|Overall Study|Death|6
158871|NCT00321932|510529|P1|Overall Study|Death|3
158872|NCT00321919|510553|P2|Overall Study|Other withdrawal reason|6
158873|NCT00321919|510554|P1|Overall Study|Other withdrawal reason|7
158874|NCT00321919|510553|P2|Overall Study|Failure to Return|1
158875|NCT00321919|510554|P1|Overall Study|Failure to Return|3
158876|NCT00321919|510553|P2|Overall Study|Other Protocol Violation|3
158877|NCT00321919|510554|P1|Overall Study|Other Protocol Violation|2
158878|NCT00321919|510553|P2|Overall Study|Refused Treatment|14
158879|NCT00321919|510554|P1|Overall Study|Refused Treatment|23
158880|NCT00321919|510553|P2|Overall Study|Violation of Selection Criteria at Entry|1
158881|NCT00321919|510554|P1|Overall Study|Violation of Selection Criteria at Entry|1
158882|NCT00321919|510553|P2|Overall Study|Insufficient Therapeutic Response|0
158883|NCT00321919|510554|P1|Overall Study|Insufficient Therapeutic Response|1
158884|NCT00321919|510553|P2|Overall Study|Death|17
158885|NCT00321919|510554|P1|Overall Study|Death|21
158886|NCT00321919|510553|P2|Overall Study|Adverse Event|10
158887|NCT00321919|510554|P1|Overall Study|Adverse Event|17
158888|NCT00321906|510596|P2|Overall Study|Withdrawal by Subject|4
158889|NCT00321906|510597|P1|Overall Study|Withdrawal by Subject|0
158890|NCT00321906|510596|P2|Overall Study|Lost to Follow-up|2
158891|NCT00321906|510597|P1|Overall Study|Lost to Follow-up|1
158892|NCT00321906|510596|P2|Overall Study|Death|6
158893|NCT00321906|510597|P1|Overall Study|Death|9
158894|NCT00321906|510596|P2|Overall Study|Adverse Event|44
158895|NCT00321906|510597|P1|Overall Study|Adverse Event|36
158896|NCT00321893|510619|P2|Overall Study|Adverse Event|3
158897|NCT00321893|510620|P1|Overall Study|Adverse Event|6
158898|NCT00321893|510619|P2|Overall Study|Lost to Follow-up|1
158899|NCT00321893|510620|P1|Overall Study|Lost to Follow-up|2
158900|NCT00321893|510619|P2|Overall Study|Non-Compliance/Refusal|10
158901|NCT00321893|510620|P1|Overall Study|Non-Compliance/Refusal|16
158902|NCT00321854|510634|P2|Overall Study|Other|1
158903|NCT00321854|510635|P1|Overall Study|Other|1
158904|NCT00321854|510634|P2|Overall Study|Withdrawal by Subject|17
158905|NCT00321854|510635|P1|Overall Study|Withdrawal by Subject|6
158906|NCT00321854|510634|P2|Overall Study|Lost to Follow-up|2
158907|NCT00321854|510635|P1|Overall Study|Lost to Follow-up|0
158908|NCT00321854|510634|P2|Overall Study|Protocol Violation|5
158909|NCT00321854|510635|P1|Overall Study|Protocol Violation|6
158910|NCT00321854|510634|P2|Overall Study|Lack of Efficacy|14
158911|NCT00321854|510635|P1|Overall Study|Lack of Efficacy|9
158912|NCT00321854|510634|P2|Overall Study|Adverse Event|43
158913|NCT00321854|510635|P1|Overall Study|Adverse Event|41
158914|NCT00321828|510753|P1|Overall Study|No follow up data|1
158915|NCT00321828|510753|P1|Overall Study|Ineligible|3
158916|NCT00320801|510770|P4|Extension Phase|Lost to Follow-up|3
158917|NCT00320801|510771|P3|Extension Phase|Lost to Follow-up|0
158918|NCT00320801|510772|P2|Extension Phase|Lost to Follow-up|0
158919|NCT00320801|510773|P1|Extension Phase|Lost to Follow-up|0
158920|NCT00320801|510770|P4|Extension Phase|Lack of Efficacy|2
158921|NCT00320801|510771|P3|Extension Phase|Lack of Efficacy|0
158922|NCT00320801|510772|P2|Extension Phase|Lack of Efficacy|0
158923|NCT00320801|510773|P1|Extension Phase|Lack of Efficacy|0
158924|NCT00320801|510770|P4|Extension Phase|Administrative|29
158925|NCT00320801|510771|P3|Extension Phase|Administrative|0
158926|NCT00320801|510772|P2|Extension Phase|Administrative|0
158927|NCT00320801|510773|P1|Extension Phase|Administrative|0
158928|NCT00320801|510770|P4|Extension Phase|Adverse Event|8
158929|NCT00320801|510771|P3|Extension Phase|Adverse Event|0
158930|NCT00320801|510772|P2|Extension Phase|Adverse Event|0
158931|NCT00320801|510773|P1|Extension Phase|Adverse Event|0
158932|NCT00320801|510770|P4|Extension Phase|Withdrawal by Subject|6
158933|NCT00320801|510771|P3|Extension Phase|Withdrawal by Subject|0
158934|NCT00320801|510772|P2|Extension Phase|Withdrawal by Subject|0
158935|NCT00320801|510773|P1|Extension Phase|Withdrawal by Subject|0
158936|NCT00320801|510770|P4|Double-blind Phase|Lack of Efficacy|0
158937|NCT00320801|510771|P3|Double-blind Phase|Lack of Efficacy|1
158938|NCT00320801|510772|P2|Double-blind Phase|Lack of Efficacy|9
158939|NCT00320801|510773|P1|Double-blind Phase|Lack of Efficacy|0
158940|NCT00320801|510770|P4|Double-blind Phase|Administrative|0
158941|NCT00320801|510771|P3|Double-blind Phase|Administrative|4
158942|NCT00320801|510772|P2|Double-blind Phase|Administrative|0
158943|NCT00320801|510773|P1|Double-blind Phase|Administrative|0
158944|NCT00320801|510770|P4|Double-blind Phase|Adverse Event|0
158945|NCT00320801|510771|P3|Double-blind Phase|Adverse Event|8
158946|NCT00320801|510772|P2|Double-blind Phase|Adverse Event|2
158947|NCT00320801|510773|P1|Double-blind Phase|Adverse Event|0
158948|NCT00320801|510770|P4|Double-blind Phase|Withdrawal by Subject|0
158949|NCT00320801|510771|P3|Double-blind Phase|Withdrawal by Subject|1
158950|NCT00320801|510772|P2|Double-blind Phase|Withdrawal by Subject|0
158951|NCT00320801|510773|P1|Double-blind Phase|Withdrawal by Subject|0
158952|NCT00320801|510770|P4|Open-label Run-in Period|Did not qualify|0
158953|NCT00320801|510771|P3|Open-label Run-in Period|Did not qualify|0
158954|NCT00320801|510772|P2|Open-label Run-in Period|Did not qualify|0
158955|NCT00320801|510773|P1|Open-label Run-in Period|Did not qualify|1
158956|NCT00320801|510770|P4|Open-label Run-in Period|Lost to Follow-up|0
158957|NCT00320801|510771|P3|Open-label Run-in Period|Lost to Follow-up|0
158958|NCT00320801|510772|P2|Open-label Run-in Period|Lost to Follow-up|0
158959|NCT00320801|510773|P1|Open-label Run-in Period|Lost to Follow-up|2
158960|NCT00320801|510770|P4|Open-label Run-in Period|Lack of Efficacy|0
158961|NCT00320801|510771|P3|Open-label Run-in Period|Lack of Efficacy|0
158962|NCT00320801|510772|P2|Open-label Run-in Period|Lack of Efficacy|0
158963|NCT00320801|510773|P1|Open-label Run-in Period|Lack of Efficacy|44
158964|NCT00320801|510770|P4|Open-label Run-in Period|Administrative|0
158965|NCT00320801|510771|P3|Open-label Run-in Period|Administrative|0
158966|NCT00320801|510772|P2|Open-label Run-in Period|Administrative|0
158967|NCT00320801|510773|P1|Open-label Run-in Period|Administrative|10
158968|NCT00320801|510770|P4|Open-label Run-in Period|Adverse Event|0
158969|NCT00320801|510771|P3|Open-label Run-in Period|Adverse Event|0
158970|NCT00320801|510772|P2|Open-label Run-in Period|Adverse Event|0
158971|NCT00320801|510773|P1|Open-label Run-in Period|Adverse Event|33
158972|NCT00320801|510770|P4|Open-label Run-in Period|Withdrawal by Subject|0
158973|NCT00320801|510771|P3|Open-label Run-in Period|Withdrawal by Subject|0
158974|NCT00320801|510772|P2|Open-label Run-in Period|Withdrawal by Subject|0
158975|NCT00320801|510773|P1|Open-label Run-in Period|Withdrawal by Subject|2
158976|NCT00320788|510788|P5|Overall Study|Withdrawal by Subject|1
158977|NCT00320788|510789|P4|Overall Study|Withdrawal by Subject|3
158978|NCT00320788|510790|P3|Overall Study|Withdrawal by Subject|0
158979|NCT00320788|510791|P2|Overall Study|Withdrawal by Subject|0
158980|NCT00320788|510792|P1|Overall Study|Withdrawal by Subject|3
158981|NCT00320788|510788|P5|Overall Study|Protocol Violation|1
158982|NCT00320788|510789|P4|Overall Study|Protocol Violation|0
158983|NCT00320788|510790|P3|Overall Study|Protocol Violation|0
158984|NCT00320788|510791|P2|Overall Study|Protocol Violation|0
158985|NCT00320788|510792|P1|Overall Study|Protocol Violation|0
158986|NCT00320788|510788|P5|Overall Study|Physician Decision|0
158987|NCT00320788|510789|P4|Overall Study|Physician Decision|0
158988|NCT00320788|510790|P3|Overall Study|Physician Decision|0
158989|NCT00320788|510791|P2|Overall Study|Physician Decision|1
158990|NCT00320788|510792|P1|Overall Study|Physician Decision|1
158991|NCT00320788|510788|P5|Overall Study|Other|1
158992|NCT00320788|510789|P4|Overall Study|Other|1
158993|NCT00320788|510790|P3|Overall Study|Other|1
158994|NCT00320788|510791|P2|Overall Study|Other|2
158995|NCT00320788|510792|P1|Overall Study|Other|1
158996|NCT00320788|510788|P5|Overall Study|Decision by the Sponsor|1
158997|NCT00320788|510789|P4|Overall Study|Decision by the Sponsor|0
158998|NCT00320788|510790|P3|Overall Study|Decision by the Sponsor|0
158999|NCT00320788|510791|P2|Overall Study|Decision by the Sponsor|1
159000|NCT00320788|510792|P1|Overall Study|Decision by the Sponsor|1
159001|NCT00320788|510788|P5|Overall Study|Lost to Follow-up|0
159002|NCT00320788|510789|P4|Overall Study|Lost to Follow-up|0
159003|NCT00320788|510790|P3|Overall Study|Lost to Follow-up|1
159004|NCT00320788|510791|P2|Overall Study|Lost to Follow-up|2
159005|NCT00320788|510792|P1|Overall Study|Lost to Follow-up|0
159006|NCT00320788|510788|P5|Overall Study|Death|1
159007|NCT00320788|510789|P4|Overall Study|Death|0
159008|NCT00320788|510790|P3|Overall Study|Death|1
159009|NCT00320788|510791|P2|Overall Study|Death|0
159010|NCT00320788|510792|P1|Overall Study|Death|0
159011|NCT00320788|510788|P5|Overall Study|Adverse Event|0
159012|NCT00320788|510789|P4|Overall Study|Adverse Event|1
159013|NCT00320788|510790|P3|Overall Study|Adverse Event|0
159014|NCT00320788|510791|P2|Overall Study|Adverse Event|0
159015|NCT00320788|510792|P1|Overall Study|Adverse Event|0
159016|NCT00320710|510846|P3|Overall Study|Lost to Follow-up|0
159017|NCT00320710|510847|P2|Overall Study|Lost to Follow-up|0
159018|NCT00320710|510848|P1|Overall Study|Lost to Follow-up|1
159019|NCT00320710|510846|P3|Overall Study|Adverse Event|1
159020|NCT00320710|510847|P2|Overall Study|Adverse Event|14
159021|NCT00320710|510848|P1|Overall Study|Adverse Event|18
159022|NCT00320710|510846|P3|Overall Study|Abnormal laboratory value(s)|0
159023|NCT00320710|510847|P2|Overall Study|Abnormal laboratory value(s)|3
159024|NCT00320710|510848|P1|Overall Study|Abnormal laboratory value(s)|12
159025|NCT00320710|510846|P3|Overall Study|Abnormal test procedure result(s)|0
159026|NCT00320710|510847|P2|Overall Study|Abnormal test procedure result(s)|0
159027|NCT00320710|510848|P1|Overall Study|Abnormal test procedure result(s)|2
159028|NCT00320710|510846|P3|Overall Study|Protocol Violation|0
159029|NCT00320710|510847|P2|Overall Study|Protocol Violation|5
159030|NCT00320710|510848|P1|Overall Study|Protocol Violation|6
159031|NCT00320710|510846|P3|Overall Study|Withdrawal by Subject|1
159032|NCT00320710|510847|P2|Overall Study|Withdrawal by Subject|26
159033|NCT00320710|510848|P1|Overall Study|Withdrawal by Subject|20
159034|NCT00320710|510846|P3|Overall Study|Administrative problems|0
159035|NCT00320710|510847|P2|Overall Study|Administrative problems|2
159036|NCT00320710|510848|P1|Overall Study|Administrative problems|1
159037|NCT00320710|510846|P3|Overall Study|Death|1
159038|NCT00320710|510847|P2|Overall Study|Death|7
159039|NCT00320710|510848|P1|Overall Study|Death|10
159040|NCT00320710|510846|P3|Overall Study|Disease progression|2
159041|NCT00320710|510847|P2|Overall Study|Disease progression|19
159042|NCT00320710|510848|P1|Overall Study|Disease progression|24
159043|NCT00320606|510878|P1|Overall Study|Ongoing in study|12
159044|NCT00320606|510878|P1|Overall Study|Protocol Violation|1
159045|NCT00320606|510878|P1|Overall Study|Adverse Event|1
159046|NCT00320593|510884|P2|Overall Study|Withdrawal by clinical center|0
159047|NCT00320593|510885|P1|Overall Study|Withdrawal by clinical center|1
159048|NCT00320593|510884|P2|Overall Study|Withdrawal by Subject|1
159049|NCT00320593|510885|P1|Overall Study|Withdrawal by Subject|2
159050|NCT00320593|510884|P2|Overall Study|Moved to another state|0
159051|NCT00320593|510885|P1|Overall Study|Moved to another state|1
159052|NCT00320593|510884|P2|Overall Study|Lost to Follow-up|0
159053|NCT00320593|510885|P1|Overall Study|Lost to Follow-up|3
159054|NCT00320541|510909|P2|Overall Study|Protocol Entry Criterion Not Met|0
159055|NCT00320541|510910|P1|Overall Study|Protocol Entry Criterion Not Met|1
159056|NCT00320541|510909|P2|Overall Study|Death due to Adverse Event(s)|0
159057|NCT00320541|510910|P1|Overall Study|Death due to Adverse Event(s)|1
159058|NCT00320541|510909|P2|Overall Study|Death due to Study Disease|3
159059|NCT00320541|510910|P1|Overall Study|Death due to Study Disease|1
159060|NCT00320541|510909|P2|Overall Study|Sponsor Decision|1
159061|NCT00320541|510910|P1|Overall Study|Sponsor Decision|2
159062|NCT00320541|510909|P2|Overall Study|Other|4
159063|NCT00320541|510910|P1|Overall Study|Other|3
159064|NCT00320541|510909|P2|Overall Study|Physician Decision|13
159065|NCT00320541|510910|P1|Overall Study|Physician Decision|9
159066|NCT00320541|510909|P2|Overall Study|Withdrawal by Subject|16
159067|NCT00320541|510910|P1|Overall Study|Withdrawal by Subject|12
159068|NCT00320541|510909|P2|Overall Study|Protocol Violation|1
159069|NCT00320541|510910|P1|Overall Study|Protocol Violation|0
159070|NCT00320541|510909|P2|Overall Study|Adverse Event|19
159071|NCT00320541|510910|P1|Overall Study|Adverse Event|21
159072|NCT00320528|510937|P3|Study Period III|Atomoxetine Commercially Available|90
159073|NCT00320528|510938|P2|Study Period III|Atomoxetine Commercially Available|25
159074|NCT00320528|510939|P1|Study Period III|Atomoxetine Commercially Available|68
159075|NCT00320528|510937|P3|Study Period III|Sponsor Decision|1
159076|NCT00320528|510938|P2|Study Period III|Sponsor Decision|0
159077|NCT00320528|510939|P1|Study Period III|Sponsor Decision|0
159078|NCT00320528|510937|P3|Study Period III|Physician Decision|2
159079|NCT00320528|510938|P2|Study Period III|Physician Decision|1
159080|NCT00320528|510939|P1|Study Period III|Physician Decision|0
159081|NCT00320528|510937|P3|Study Period III|Protocol Violation|0
159082|NCT00320528|510938|P2|Study Period III|Protocol Violation|1
159083|NCT00320528|510939|P1|Study Period III|Protocol Violation|0
159084|NCT00320528|510937|P3|Study Period III|Parent/Caregiver Decision|11
159085|NCT00320528|510938|P2|Study Period III|Parent/Caregiver Decision|3
159086|NCT00320528|510939|P1|Study Period III|Parent/Caregiver Decision|14
159087|NCT00320528|510937|P3|Study Period III|Lack of Efficacy|0
159088|NCT00320528|510938|P2|Study Period III|Lack of Efficacy|0
159089|NCT00320528|510939|P1|Study Period III|Lack of Efficacy|2
159090|NCT00320528|510937|P3|Study Period III|Withdrawal by Subject|2
159091|NCT00320528|510938|P2|Study Period III|Withdrawal by Subject|1
159092|NCT00320528|510939|P1|Study Period III|Withdrawal by Subject|1
159093|NCT00320528|510937|P3|Study Period III|Lost to Follow-up|0
159094|NCT00320528|510938|P2|Study Period III|Lost to Follow-up|0
159095|NCT00320528|510939|P1|Study Period III|Lost to Follow-up|1
159096|NCT00320528|510937|P3|Study Period III|Adverse Event|0
159097|NCT00320528|510938|P2|Study Period III|Adverse Event|0
159098|NCT00320528|510939|P1|Study Period III|Adverse Event|1
159099|NCT00320528|510937|P3|Study Period II|Entry Criteria Exclusion|2
159100|NCT00320528|510938|P2|Study Period II|Entry Criteria Exclusion|2
159101|NCT00320528|510939|P1|Study Period II|Entry Criteria Exclusion|0
159102|NCT00320528|510937|P3|Study Period II|Withdrawal by Subject|1
159103|NCT00320528|510938|P2|Study Period II|Withdrawal by Subject|1
159104|NCT00320528|510939|P1|Study Period II|Withdrawal by Subject|0
159105|NCT00320528|510937|P3|Study Period II|Parent/Caregiver Decision|11
159106|NCT00320528|510938|P2|Study Period II|Parent/Caregiver Decision|3
159107|NCT00320528|510939|P1|Study Period II|Parent/Caregiver Decision|8
159108|NCT00320528|510937|P3|Study Period II|Adverse Event|8
159109|NCT00320528|510938|P2|Study Period II|Adverse Event|4
159110|NCT00320528|510939|P1|Study Period II|Adverse Event|3
159111|NCT00320515|510974|P1|Overall Study|Withdrawal by Subject|8
159112|NCT00320515|510974|P1|Overall Study|Physician Decision|2
159113|NCT00320515|510974|P1|Overall Study|Lost to Follow-up|6
159114|NCT00320515|510974|P1|Overall Study|Death|33
159115|NCT00320489|510983|P2|Overall Study|Withdrawal by Subject|41
159116|NCT00320489|510984|P1|Overall Study|Withdrawal by Subject|39
159117|NCT00320489|510983|P2|Overall Study|Sponsor Decision|3
159118|NCT00320489|510984|P1|Overall Study|Sponsor Decision|3
159119|NCT00320489|510983|P2|Overall Study|Protocol Violation|4
159120|NCT00320489|510984|P1|Overall Study|Protocol Violation|4
159121|NCT00320489|510983|P2|Overall Study|Physician Decision|8
159122|NCT00320489|510984|P1|Overall Study|Physician Decision|8
159123|NCT00320489|510983|P2|Overall Study|Lost to Follow-up|22
159124|NCT00320489|510984|P1|Overall Study|Lost to Follow-up|21
159125|NCT00320489|510983|P2|Overall Study|Lack of Efficacy|7
159126|NCT00320489|510984|P1|Overall Study|Lack of Efficacy|16
159127|NCT00320489|510983|P2|Overall Study|Entry Criteria Exclusion|4
159128|NCT00320489|510984|P1|Overall Study|Entry Criteria Exclusion|2
159129|NCT00320489|510983|P2|Overall Study|Death|2
159130|NCT00320489|510984|P1|Overall Study|Death|0
159131|NCT00320489|510983|P2|Overall Study|Clinical Relapse|20
159132|NCT00320489|510984|P1|Overall Study|Clinical Relapse|26
159133|NCT00320489|510983|P2|Overall Study|Adverse Event|25
159134|NCT00320489|510984|P1|Overall Study|Adverse Event|26
159135|NCT00320411|511040|P1|Overall Study|No investigational product admin.|4
159136|NCT00320385|511063|P2|Overall Study|Adverse Event|1
159137|NCT00320385|511064|P1|Overall Study|Adverse Event|0
159138|NCT00320385|511063|P2|Overall Study|Withdrew Consent|0
159139|NCT00320385|511064|P1|Overall Study|Withdrew Consent|1
159140|NCT00320385|511063|P2|Overall Study|Serious Adverse Event|0
159141|NCT00320385|511064|P1|Overall Study|Serious Adverse Event|1
159142|NCT00320385|511063|P2|Overall Study|Death|2
159143|NCT00320385|511064|P1|Overall Study|Death|1
159144|NCT00320385|511063|P2|Overall Study|Investigator Decision|1
159145|NCT00320385|511064|P1|Overall Study|Investigator Decision|0
159146|NCT00320385|511063|P2|Overall Study|Sponsor Terminated Study|1
159147|NCT00320385|511064|P1|Overall Study|Sponsor Terminated Study|2
159148|NCT00320385|511063|P2|Overall Study|Withdrawal by Subject|7
159149|NCT00320385|511064|P1|Overall Study|Withdrawal by Subject|6
159150|NCT00320385|511063|P2|Overall Study|Lost to Follow-up|10
159151|NCT00320385|511064|P1|Overall Study|Lost to Follow-up|7
159152|NCT00320372|511087|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
159153|NCT00320372|511088|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
159154|NCT00320372|511087|P2|Overall Study|Did not Meet (I/E)|1
159155|NCT00320372|511088|P1|Overall Study|Did not Meet (I/E)|3
159156|NCT00320372|511087|P2|Overall Study|Non-Compliance|39
159157|NCT00320372|511088|P1|Overall Study|Non-Compliance|40
159158|NCT00320372|511087|P2|Overall Study|Withdrawal by Subject|37
159159|NCT00320372|511088|P1|Overall Study|Withdrawal by Subject|55
159160|NCT00320372|511087|P2|Overall Study|Death|8
159161|NCT00320372|511088|P1|Overall Study|Death|7
159162|NCT00320372|511087|P2|Overall Study|Physician Decision|7
159163|NCT00320372|511088|P1|Overall Study|Physician Decision|4
159164|NCT00320255|511139|P6|Overall Study|Not specified|0
159165|NCT00320255|511140|P5|Overall Study|Not specified|0
159166|NCT00320255|511141|P4|Overall Study|Not specified|0
159167|NCT00320255|511142|P3|Overall Study|Not specified|1
159168|NCT00320255|511143|P2|Overall Study|Not specified|2
159169|NCT00320255|511144|P1|Overall Study|Not specified|3
159170|NCT00320255|511139|P6|Overall Study|No longer meets study criteria|0
159171|NCT00320255|511140|P5|Overall Study|No longer meets study criteria|0
159172|NCT00320255|511141|P4|Overall Study|No longer meets study criteria|1
159173|NCT00320255|511142|P3|Overall Study|No longer meets study criteria|0
159174|NCT00320255|511143|P2|Overall Study|No longer meets study criteria|0
159175|NCT00320255|511144|P1|Overall Study|No longer meets study criteria|0
159176|NCT00320255|511139|P6|Overall Study|Poor compliance/noncompliance|0
159177|NCT00320255|511140|P5|Overall Study|Poor compliance/noncompliance|0
159178|NCT00320255|511141|P4|Overall Study|Poor compliance/noncompliance|1
159179|NCT00320255|511142|P3|Overall Study|Poor compliance/noncompliance|0
159180|NCT00320255|511143|P2|Overall Study|Poor compliance/noncompliance|1
159181|NCT00320255|511144|P1|Overall Study|Poor compliance/noncompliance|1
159182|NCT00320255|511139|P6|Overall Study|Withdrawal by Subject|0
159183|NCT00320255|511140|P5|Overall Study|Withdrawal by Subject|0
159184|NCT00320255|511141|P4|Overall Study|Withdrawal by Subject|4
159185|NCT00320255|511142|P3|Overall Study|Withdrawal by Subject|2
159186|NCT00320255|511143|P2|Overall Study|Withdrawal by Subject|2
159187|NCT00320255|511144|P1|Overall Study|Withdrawal by Subject|1
159188|NCT00320255|511139|P6|Overall Study|Adverse Event|0
159189|NCT00320255|511140|P5|Overall Study|Adverse Event|0
159190|NCT00320255|511141|P4|Overall Study|Adverse Event|2
159191|NCT00320255|511142|P3|Overall Study|Adverse Event|3
159192|NCT00320255|511143|P2|Overall Study|Adverse Event|2
159193|NCT00320255|511144|P1|Overall Study|Adverse Event|5
159194|NCT00320255|511139|P6|Overall Study|Lack of Efficacy|0
159195|NCT00320255|511140|P5|Overall Study|Lack of Efficacy|0
159196|NCT00320255|511141|P4|Overall Study|Lack of Efficacy|0
159197|NCT00320255|511142|P3|Overall Study|Lack of Efficacy|0
159198|NCT00320255|511143|P2|Overall Study|Lack of Efficacy|0
159199|NCT00320255|511144|P1|Overall Study|Lack of Efficacy|1
159200|NCT00320216|511229|P5|Overall Study|Other|3
159201|NCT00320216|511230|P4|Overall Study|Other|1
159202|NCT00320216|511231|P3|Overall Study|Other|5
159203|NCT00320216|511232|P2|Overall Study|Other|2
159204|NCT00320216|511233|P1|Overall Study|Other|7
159205|NCT00320216|511229|P5|Overall Study|Lost to Follow-up|0
159206|NCT00320216|511230|P4|Overall Study|Lost to Follow-up|0
159207|NCT00320216|511231|P3|Overall Study|Lost to Follow-up|0
159208|NCT00320216|511232|P2|Overall Study|Lost to Follow-up|0
159209|NCT00320216|511233|P1|Overall Study|Lost to Follow-up|3
159210|NCT00320216|511229|P5|Overall Study|Lack of Efficacy|1
159211|NCT00320216|511230|P4|Overall Study|Lack of Efficacy|0
159212|NCT00320216|511231|P3|Overall Study|Lack of Efficacy|1
159213|NCT00320216|511232|P2|Overall Study|Lack of Efficacy|2
159214|NCT00320216|511233|P1|Overall Study|Lack of Efficacy|6
159215|NCT00320216|511229|P5|Overall Study|Adverse Event|2
159216|NCT00320216|511230|P4|Overall Study|Adverse Event|2
159217|NCT00320216|511231|P3|Overall Study|Adverse Event|0
159218|NCT00320216|511232|P2|Overall Study|Adverse Event|6
159219|NCT00320216|511233|P1|Overall Study|Adverse Event|0
159220|NCT00320190|511267|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
159221|NCT00320190|511268|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
159222|NCT00320190|511267|P2|Long-term (12-month) Extension|Lack of major molecular response|2
159223|NCT00320190|511268|P1|Long-term (12-month) Extension|Lack of major molecular response|1
159224|NCT00320190|511267|P2|Long-term (12-month) Extension|Sponsor terminated study|0
159225|NCT00320190|511268|P1|Long-term (12-month) Extension|Sponsor terminated study|7
159226|NCT00320190|511267|P2|First 12 Months|Withdrawal by Subject|1
159227|NCT00320190|511268|P1|First 12 Months|Withdrawal by Subject|0
159228|NCT00320190|511267|P2|First 12 Months|Study drug toxicity|1
159229|NCT00320190|511268|P1|First 12 Months|Study drug toxicity|0
159230|NCT00320190|511267|P2|First 12 Months|Investigator request|1
159231|NCT00320190|511268|P1|First 12 Months|Investigator request|0
159232|NCT00320190|511267|P2|First 12 Months|Adverse event unrelated to study drug|0
159233|NCT00320190|511268|P1|First 12 Months|Adverse event unrelated to study drug|1
159234|NCT00320190|511267|P2|First 12 Months|Enrollment failure|1
159235|NCT00320190|511268|P1|First 12 Months|Enrollment failure|0
159236|NCT00320190|511267|P2|First 12 Months|Lost to Follow-up|1
159237|NCT00320190|511268|P1|First 12 Months|Lost to Follow-up|0
159238|NCT00320190|511267|P2|First 12 Months|Sponsor terminated study|2
159239|NCT00320190|511268|P1|First 12 Months|Sponsor terminated study|2
159240|NCT00320190|511267|P2|First 12 Months|Completed but did not enter extension|3
159241|NCT00320190|511268|P1|First 12 Months|Completed but did not enter extension|5
159242|NCT00320112|511288|P2|Overall Study|Death|1
159243|NCT00320112|511289|P1|Overall Study|Death|2
159244|NCT00320112|511288|P2|Overall Study|Withdrawal by Subject|0
159245|NCT00320112|511289|P1|Overall Study|Withdrawal by Subject|3
159246|NCT00320112|511288|P2|Overall Study|Lost to Follow-up|4
159247|NCT00320112|511289|P1|Overall Study|Lost to Follow-up|3
159248|NCT00319982|511303|P2|Overall Study|Withdrawal by Subject|0
159249|NCT00319982|511304|P1|Overall Study|Withdrawal by Subject|1
159250|NCT00319735|511332|P1|Overall Study|Death|2
159251|NCT00319696|511345|P1|Overall Study|Lost to Follow-up|3
159252|NCT00319696|511345|P1|Overall Study|administrative|7
159253|NCT00319696|511345|P1|Overall Study|withdrawal of consent|14
159254|NCT00319696|511345|P1|Overall Study|Adverse Event|36
159255|NCT00319592|511371|P2|Overall Study|Physician Decision|1
159256|NCT00319592|511372|P1|Overall Study|Physician Decision|0
159257|NCT00319592|511371|P2|Overall Study|Protocol Violation|0
159258|NCT00319592|511372|P1|Overall Study|Protocol Violation|1
159259|NCT00319553|511388|P2|Overall Study|Withdrawal by Subject|1
159260|NCT00319553|511389|P1|Overall Study|Withdrawal by Subject|1
159261|NCT00319553|511388|P2|Overall Study|Lost to Follow-up|1
159262|NCT00319553|511389|P1|Overall Study|Lost to Follow-up|2
159263|NCT00319553|511388|P2|Overall Study|Protocol Violation|2
159264|NCT00319553|511389|P1|Overall Study|Protocol Violation|1
159265|NCT00319501|511403|P2|Open-label Extension Period|Withdrawal by Subject|0
159266|NCT00319501|511404|P1|Open-label Extension Period|Withdrawal by Subject|2
159267|NCT00319501|511403|P2|Open-label Extension Period|Sponsor request|0
159268|NCT00319501|511404|P1|Open-label Extension Period|Sponsor request|26
159269|NCT00319501|511403|P2|Open-label Extension Period|Principal investigator decision|0
159270|NCT00319501|511404|P1|Open-label Extension Period|Principal investigator decision|2
159271|NCT00319501|511403|P2|Open-label Extension Period|Not specified|0
159272|NCT00319501|511404|P1|Open-label Extension Period|Not specified|1
159273|NCT00319501|511403|P2|Open-label Extension Period|Did not receive treatment|0
159274|NCT00319501|511404|P1|Open-label Extension Period|Did not receive treatment|18
159275|NCT00319501|511403|P2|Open-label Extension Period|Adverse Event|0
159276|NCT00319501|511404|P1|Open-label Extension Period|Adverse Event|2
159277|NCT00319501|511403|P2|Open-label Period|Not specified|0
159278|NCT00319501|511404|P1|Open-label Period|Not specified|11
159279|NCT00319501|511403|P2|Open-label Period|Did not receive treatment|0
159280|NCT00319501|511404|P1|Open-label Period|Did not receive treatment|33
159281|NCT00319501|511403|P2|Open-label Period|Lost to Follow-up|0
159282|NCT00319501|511404|P1|Open-label Period|Lost to Follow-up|5
159283|NCT00319501|511403|P2|Open-label Period|Sponsor request|0
159284|NCT00319501|511404|P1|Open-label Period|Sponsor request|12
159285|NCT00319501|511403|P2|Open-label Period|Principal Investigator decision|0
159286|NCT00319501|511404|P1|Open-label Period|Principal Investigator decision|6
159287|NCT00319501|511403|P2|Open-label Period|Withdrawal by Subject|0
159288|NCT00319501|511404|P1|Open-label Period|Withdrawal by Subject|38
159289|NCT00319501|511403|P2|Open-label Period|Protocol Violation|0
159290|NCT00319501|511404|P1|Open-label Period|Protocol Violation|6
159291|NCT00319501|511403|P2|Open-label Period|Adverse Event|0
159292|NCT00319501|511404|P1|Open-label Period|Adverse Event|5
159293|NCT00319501|511403|P2|Double-blind Period|Did not receive treatment|29
159294|NCT00319501|511404|P1|Double-blind Period|Did not receive treatment|42
159295|NCT00319501|511403|P2|Double-blind Period|Sponsor Request|0
159296|NCT00319501|511404|P1|Double-blind Period|Sponsor Request|1
159297|NCT00319501|511403|P2|Double-blind Period|Withdrawal by Subject|3
159298|NCT00319501|511404|P1|Double-blind Period|Withdrawal by Subject|0
159299|NCT00319449|511430|P2|Overall Study|Noncompliance with the protocol|0
159300|NCT00319449|511431|P1|Overall Study|Noncompliance with the protocol|1
159301|NCT00319449|511430|P2|Overall Study|Subject did not wish to continue|0
159302|NCT00319449|511431|P1|Overall Study|Subject did not wish to continue|1
159303|NCT00319436|511443|P2|Overall Study|Withdrawal by Subject|7
159304|NCT00319436|511444|P1|Overall Study|Withdrawal by Subject|6
159305|NCT00319254|511462|P1|Overall Study|Enrolled, Not Treated|2
159306|NCT00319254|511462|P1|Overall Study|Lost to Follow-up|2
159307|NCT00319254|511462|P1|Overall Study|Death|46
159308|NCT00319254|511462|P1|Overall Study|Withdrawal by Subject|4
159309|NCT00319111|511475|P1|Overall Study|Treatment failure|1
159310|NCT00319111|511475|P1|Overall Study|Administrative|2
159311|NCT00319111|511475|P1|Overall Study|Lack of clinical improvement|4
159312|NCT00319111|511475|P1|Overall Study|Death|9
159313|NCT00319111|511475|P1|Overall Study|Withdrawal of consent|11
159314|NCT00319111|511475|P1|Overall Study|Adverse Event|20
159315|NCT00319046|511485|P1|Overall Study|administrative reason|1
159316|NCT00319046|511485|P1|Overall Study|withdrawal of subject's consent|7
159317|NCT00318656|511520|P2|Overall Study|Did not receive any treatment|1
159318|NCT00318656|511521|P1|Overall Study|Did not receive any treatment|0
159319|NCT00318656|511520|P2|Overall Study|Took Avandamet instead of Glim/Met|1
159320|NCT00318656|511521|P1|Overall Study|Took Avandamet instead of Glim/Met|0
159321|NCT00318565|511578|P1|Overall Study|Excluded per protocol|24
159322|NCT00318474|511585|P2|Overall Study|Trial terminated|7
159323|NCT00318474|511586|P1|Overall Study|Trial terminated|10
159324|NCT00318474|511585|P2|Overall Study|Post-therapy hyperflycemia|1
159325|NCT00318474|511586|P1|Overall Study|Post-therapy hyperflycemia|0
159326|NCT00318474|511585|P2|Overall Study|Fall in GFR|3
159327|NCT00318474|511586|P1|Overall Study|Fall in GFR|3
159328|NCT00318474|511585|P2|Overall Study|Withdrawal by Subject|2
159329|NCT00318474|511586|P1|Overall Study|Withdrawal by Subject|3
159330|NCT00318474|511585|P2|Overall Study|Protocol Violation|0
159331|NCT00318474|511586|P1|Overall Study|Protocol Violation|1
159332|NCT00318474|511585|P2|Overall Study|Pregnancy|2
159333|NCT00318474|511586|P1|Overall Study|Pregnancy|0
159334|NCT00318474|511585|P2|Overall Study|Lost to Follow-up|1
159335|NCT00318474|511586|P1|Overall Study|Lost to Follow-up|0
159336|NCT00318474|511585|P2|Overall Study|Adverse Event|1
159337|NCT00318474|511586|P1|Overall Study|Adverse Event|1
159338|NCT00318461|511597|P5|Open-Label Extension, 18 Months|Protocol Violation|6
159339|NCT00318461|511598|P4|Open-Label Extension, 18 Months|Protocol Violation|4
159340|NCT00318461|511599|P3|Open-Label Extension, 18 Months|Protocol Violation|3
159341|NCT00318461|511600|P2|Open-Label Extension, 18 Months|Protocol Violation|5
159342|NCT00318461|511601|P1|Open-Label Extension, 18 Months|Protocol Violation|7
159343|NCT00318461|511597|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
159344|NCT00318461|511598|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
159345|NCT00318461|511599|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
159346|NCT00318461|511600|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
159347|NCT00318461|511601|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
159348|NCT00318461|511597|P5|Open-Label Extension, 18 Months|Adverse Event|6
159349|NCT00318461|511598|P4|Open-Label Extension, 18 Months|Adverse Event|1
159350|NCT00318461|511599|P3|Open-Label Extension, 18 Months|Adverse Event|6
159351|NCT00318461|511600|P2|Open-Label Extension, 18 Months|Adverse Event|8
159352|NCT00318461|511601|P1|Open-Label Extension, 18 Months|Adverse Event|11
159353|NCT00318461|511597|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
159354|NCT00318461|511598|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
159355|NCT00318461|511599|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
159356|NCT00318461|511600|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
159357|NCT00318461|511601|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
159358|NCT00318461|511597|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
159359|NCT00318461|511598|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
159360|NCT00318461|511599|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
159361|NCT00318461|511600|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
159362|NCT00318461|511601|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
159363|NCT00318461|511597|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
159364|NCT00318461|511598|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
159365|NCT00318461|511599|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
159366|NCT00318461|511600|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
159367|NCT00318461|511601|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
159368|NCT00318461|511597|P5|Double-Blind, 6 Months|Hyperglicaemia|0
159369|NCT00318461|511598|P4|Double-Blind, 6 Months|Hyperglicaemia|1
159370|NCT00318461|511599|P3|Double-Blind, 6 Months|Hyperglicaemia|0
159371|NCT00318461|511600|P2|Double-Blind, 6 Months|Hyperglicaemia|0
159372|NCT00318461|511601|P1|Double-Blind, 6 Months|Hyperglicaemia|0
159373|NCT00318461|511597|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
159374|NCT00318461|511598|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
159375|NCT00318461|511599|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
159376|NCT00318461|511600|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
159377|NCT00318461|511601|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
159378|NCT00318461|511597|P5|Double-Blind, 6 Months|Lack of time|0
159379|NCT00318461|511598|P4|Double-Blind, 6 Months|Lack of time|0
159380|NCT00318461|511599|P3|Double-Blind, 6 Months|Lack of time|0
159381|NCT00318461|511600|P2|Double-Blind, 6 Months|Lack of time|0
159382|NCT00318461|511601|P1|Double-Blind, 6 Months|Lack of time|1
159383|NCT00318461|511597|P5|Double-Blind, 6 Months|Investigator decision|1
159384|NCT00318461|511598|P4|Double-Blind, 6 Months|Investigator decision|0
159385|NCT00318461|511599|P3|Double-Blind, 6 Months|Investigator decision|0
159386|NCT00318461|511600|P2|Double-Blind, 6 Months|Investigator decision|0
159387|NCT00318461|511601|P1|Double-Blind, 6 Months|Investigator decision|0
159388|NCT00318461|511597|P5|Double-Blind, 6 Months|Work commitment|1
159389|NCT00318461|511598|P4|Double-Blind, 6 Months|Work commitment|0
159390|NCT00318461|511599|P3|Double-Blind, 6 Months|Work commitment|0
159391|NCT00318461|511600|P2|Double-Blind, 6 Months|Work commitment|0
159392|NCT00318461|511601|P1|Double-Blind, 6 Months|Work commitment|0
159393|NCT00318461|511597|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
159394|NCT00318461|511598|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
159395|NCT00318461|511599|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
159396|NCT00318461|511600|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
159397|NCT00318461|511601|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
159398|NCT00318461|511597|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
159399|NCT00318461|511598|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
159400|NCT00318461|511599|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
159401|NCT00318461|511600|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
159402|NCT00318461|511601|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
159403|NCT00318461|511597|P5|Double-Blind, 6 Months|Move|0
159404|NCT00318461|511598|P4|Double-Blind, 6 Months|Move|0
159405|NCT00318461|511599|P3|Double-Blind, 6 Months|Move|0
159406|NCT00318461|511600|P2|Double-Blind, 6 Months|Move|1
159407|NCT00318461|511601|P1|Double-Blind, 6 Months|Move|0
159408|NCT00318461|511597|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
159409|NCT00318461|511598|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
159410|NCT00318461|511599|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
159411|NCT00318461|511600|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
159412|NCT00318461|511601|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
159413|NCT00318461|511597|P5|Double-Blind, 6 Months|Consent withdrawn|4
159414|NCT00318461|511598|P4|Double-Blind, 6 Months|Consent withdrawn|10
159415|NCT00318461|511599|P3|Double-Blind, 6 Months|Consent withdrawn|4
159416|NCT00318461|511600|P2|Double-Blind, 6 Months|Consent withdrawn|3
159417|NCT00318461|511601|P1|Double-Blind, 6 Months|Consent withdrawn|0
159418|NCT00318461|511597|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
159419|NCT00318461|511598|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
159420|NCT00318461|511599|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
159421|NCT00318461|511600|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
159422|NCT00318461|511601|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
159423|NCT00318461|511597|P5|Double-Blind, 6 Months|Lost to follow up|0
159424|NCT00318461|511598|P4|Double-Blind, 6 Months|Lost to follow up|0
159425|NCT00318461|511599|P3|Double-Blind, 6 Months|Lost to follow up|0
159426|NCT00318461|511600|P2|Double-Blind, 6 Months|Lost to follow up|1
159427|NCT00318461|511601|P1|Double-Blind, 6 Months|Lost to follow up|0
159428|NCT00318461|511597|P5|Double-Blind, 6 Months|Protocol Violation|5
159429|NCT00318461|511598|P4|Double-Blind, 6 Months|Protocol Violation|4
159430|NCT00318461|511599|P3|Double-Blind, 6 Months|Protocol Violation|4
159431|NCT00318461|511600|P2|Double-Blind, 6 Months|Protocol Violation|4
159432|NCT00318461|511601|P1|Double-Blind, 6 Months|Protocol Violation|2
159433|NCT00318461|511597|P5|Double-Blind, 6 Months|Lack of Efficacy|9
159434|NCT00318461|511598|P4|Double-Blind, 6 Months|Lack of Efficacy|29
159435|NCT00318461|511599|P3|Double-Blind, 6 Months|Lack of Efficacy|13
159436|NCT00318461|511600|P2|Double-Blind, 6 Months|Lack of Efficacy|8
159437|NCT00318461|511601|P1|Double-Blind, 6 Months|Lack of Efficacy|19
159438|NCT00318461|511597|P5|Double-Blind, 6 Months|Adverse Event|8
159439|NCT00318461|511598|P4|Double-Blind, 6 Months|Adverse Event|2
159440|NCT00318461|511599|P3|Double-Blind, 6 Months|Adverse Event|29
159441|NCT00318461|511600|P2|Double-Blind, 6 Months|Adverse Event|23
159442|NCT00318461|511601|P1|Double-Blind, 6 Months|Adverse Event|11
159443|NCT00318370|511700|P3|Period 3|Other|3
159444|NCT00318370|511701|P2|Period 3|Other|0
159445|NCT00318370|511702|P1|Period 3|Other|0
159446|NCT00318370|511700|P3|Period 3|Withdrawal by Subject|3
159447|NCT00318370|511701|P2|Period 3|Withdrawal by Subject|0
159448|NCT00318370|511702|P1|Period 3|Withdrawal by Subject|0
159449|NCT00318370|511700|P3|Period 3|Physician Decision|1
159450|NCT00318370|511701|P2|Period 3|Physician Decision|0
159451|NCT00318370|511702|P1|Period 3|Physician Decision|0
159452|NCT00318370|511700|P3|Period 3|Death|1
159453|NCT00318370|511701|P2|Period 3|Death|0
159454|NCT00318370|511702|P1|Period 3|Death|0
159455|NCT00318370|511700|P3|Period 3|Lack of Efficacy|24
159456|NCT00318370|511701|P2|Period 3|Lack of Efficacy|0
159457|NCT00318370|511702|P1|Period 3|Lack of Efficacy|0
159458|NCT00318370|511700|P3|Period 3|Adverse Event|1
159459|NCT00318370|511701|P2|Period 3|Adverse Event|0
159460|NCT00318370|511702|P1|Period 3|Adverse Event|0
159461|NCT00318370|511700|P3|Period 2|Other|0
159462|NCT00318370|511701|P2|Period 2|Other|1
159463|NCT00318370|511702|P1|Period 2|Other|0
159464|NCT00318370|511700|P3|Period 2|Withdrawal by Subject|0
159465|NCT00318370|511701|P2|Period 2|Withdrawal by Subject|1
159466|NCT00318370|511702|P1|Period 2|Withdrawal by Subject|0
159467|NCT00318370|511700|P3|Period 2|Physician Decision|0
159468|NCT00318370|511701|P2|Period 2|Physician Decision|1
159469|NCT00318370|511702|P1|Period 2|Physician Decision|0
159470|NCT00318370|511700|P3|Period 2|Lack of Efficacy|0
159471|NCT00318370|511701|P2|Period 2|Lack of Efficacy|5
159472|NCT00318370|511702|P1|Period 2|Lack of Efficacy|0
159473|NCT00318370|511700|P3|Period 2|Adverse Event|0
159474|NCT00318370|511701|P2|Period 2|Adverse Event|3
159475|NCT00318370|511702|P1|Period 2|Adverse Event|0
159476|NCT00318370|511700|P3|Period 1|Withdrawal by Subject|0
159477|NCT00318370|511701|P2|Period 1|Withdrawal by Subject|0
159478|NCT00318370|511702|P1|Period 1|Withdrawal by Subject|1
159479|NCT00318370|511700|P3|Period 1|Physician Decision|0
159480|NCT00318370|511701|P2|Period 1|Physician Decision|0
159481|NCT00318370|511702|P1|Period 1|Physician Decision|1
159482|NCT00318370|511700|P3|Period 1|Lack of Efficacy|0
159483|NCT00318370|511701|P2|Period 1|Lack of Efficacy|0
159484|NCT00318370|511702|P1|Period 1|Lack of Efficacy|5
159485|NCT00317642|511781|P2|Overall Study|AML Not Centrally Confirmed|5
159486|NCT00317642|511782|P1|Overall Study|AML Not Centrally Confirmed|1
159487|NCT00317642|511781|P2|Overall Study|Referred For Transplantation|0
159488|NCT00317642|511782|P1|Overall Study|Referred For Transplantation|1
159489|NCT00317642|511781|P2|Overall Study|Withdrawal by Subject|1
159490|NCT00317642|511782|P1|Overall Study|Withdrawal by Subject|0
159491|NCT00317642|511781|P2|Overall Study|Not Continue to Consolidation|0
159492|NCT00317642|511782|P1|Overall Study|Not Continue to Consolidation|2
159493|NCT00317642|511781|P2|Overall Study|Death|7
159494|NCT00317642|511782|P1|Overall Study|Death|14
159495|NCT00317642|511781|P2|Overall Study|Disease Recurrence|2
159496|NCT00317642|511782|P1|Overall Study|Disease Recurrence|1
159497|NCT00317642|511781|P2|Overall Study|Treatment Failure|102
159498|NCT00317642|511782|P1|Overall Study|Treatment Failure|56
159499|NCT00317642|511781|P2|Overall Study|Adverse Event|5
159500|NCT00317642|511782|P1|Overall Study|Adverse Event|17
159501|NCT00317642|511781|P2|Overall Study|Participant declined treatment|3
159502|NCT00317642|511782|P1|Overall Study|Participant declined treatment|14
159503|NCT00317642|511781|P2|Overall Study|Physician Decision|7
159504|NCT00317642|511782|P1|Overall Study|Physician Decision|15
159505|NCT00317642|511781|P2|Overall Study|Not Received Either Study Drug|3
159506|NCT00317642|511782|P1|Overall Study|Not Received Either Study Drug|1
159507|NCT00317044|511871|P3|Overall Study|Multiple Reasons|6
159508|NCT00317044|511872|P2|Overall Study|Multiple Reasons|2
159509|NCT00317044|511873|P1|Overall Study|Multiple Reasons|6
159510|NCT00317044|511871|P3|Overall Study|Lost to Follow-up|3
159511|NCT00317044|511872|P2|Overall Study|Lost to Follow-up|2
159512|NCT00317044|511873|P1|Overall Study|Lost to Follow-up|0
159513|NCT00317044|511871|P3|Overall Study|Withdrawal by Subject|12
159514|NCT00317044|511872|P2|Overall Study|Withdrawal by Subject|7
159515|NCT00317044|511873|P1|Overall Study|Withdrawal by Subject|10
159516|NCT00317044|511871|P3|Overall Study|Adverse Event|4
159517|NCT00317044|511872|P2|Overall Study|Adverse Event|7
159518|NCT00317044|511873|P1|Overall Study|Adverse Event|4
159519|NCT00317044|511871|P3|Overall Study|Protocol Violation|20
159520|NCT00317044|511872|P2|Overall Study|Protocol Violation|22
159521|NCT00317044|511873|P1|Overall Study|Protocol Violation|28
159522|NCT00316914|511919|P2|Overall Study|Missing end of treatment documentation|15
159523|NCT00316914|511920|P1|Overall Study|Missing end of treatment documentation|14
159524|NCT00316914|511919|P2|Overall Study|Other Problems|11
159525|NCT00316914|511920|P1|Overall Study|Other Problems|6
159526|NCT00316914|511919|P2|Overall Study|Adverse Event|7
159527|NCT00316914|511920|P1|Overall Study|Adverse Event|8
159528|NCT00316914|511919|P2|Overall Study|Withdrawal by Subject|3
159529|NCT00316914|511920|P1|Overall Study|Withdrawal by Subject|5
159530|NCT00316888|511950|P2|Overall Study|Not start protocol therapy|1
159531|NCT00316888|511951|P1|Overall Study|Not start protocol therapy|0
159532|NCT00316888|511950|P2|Overall Study|Withdrawal by Subject|2
159533|NCT00316888|511951|P1|Overall Study|Withdrawal by Subject|2
159534|NCT00316888|511950|P2|Overall Study|Adverse Event|5
159535|NCT00316888|511951|P1|Overall Study|Adverse Event|4
159536|NCT00316719|511967|P2|Overall Study|Consent withdrawn|0
159537|NCT00316719|511968|P1|Overall Study|Consent withdrawn|2
159538|NCT00316719|511967|P2|Overall Study|Adverse Event|6
159539|NCT00316719|511968|P1|Overall Study|Adverse Event|0
159540|NCT00316706|511994|P2|Overall Study|Lost to Follow-up|48
159541|NCT00316706|511995|P1|Overall Study|Lost to Follow-up|38
159542|NCT00316693|512011|P2|Overall Study|Other|44
159543|NCT00316693|512012|P1|Overall Study|Other|38
159544|NCT00316693|512011|P2|Overall Study|Lost to Follow-up|34
159545|NCT00316693|512012|P1|Overall Study|Lost to Follow-up|26
159546|NCT00316693|512011|P2|Overall Study|Withdrawal by Subject|6
159547|NCT00316693|512012|P1|Overall Study|Withdrawal by Subject|6
159548|NCT00316693|512011|P2|Overall Study|Protocol Violation|0
159549|NCT00316693|512012|P1|Overall Study|Protocol Violation|1
159550|NCT00316693|512011|P2|Overall Study|Adverse Event|1
159551|NCT00316693|512012|P1|Overall Study|Adverse Event|6
159552|NCT00316303|512065|P2|Overall Study|Lost to Follow-up|16
159553|NCT00316303|512066|P1|Overall Study|Lost to Follow-up|11
159554|NCT00316277|512082|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
159555|NCT00316277|512083|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
159556|NCT00316277|512082|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
159557|NCT00316277|512083|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
159558|NCT00316277|512082|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
159559|NCT00316277|512083|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
159560|NCT00316277|512082|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
159561|NCT00316277|512083|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
159562|NCT00316277|512082|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
159563|NCT00316277|512083|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
159564|NCT00316264|512104|P3|Overall Study|not specified|0
159565|NCT00316264|512105|P2|Overall Study|not specified|1
159566|NCT00316264|512106|P1|Overall Study|not specified|1
159567|NCT00316264|512104|P3|Overall Study|Death|0
159568|NCT00316264|512105|P2|Overall Study|Death|0
159569|NCT00316264|512106|P1|Overall Study|Death|2
159570|NCT00316264|512104|P3|Overall Study|Withdrawal of Consent|6
159571|NCT00316264|512105|P2|Overall Study|Withdrawal of Consent|5
159572|NCT00316264|512106|P1|Overall Study|Withdrawal of Consent|3
159573|NCT00316264|512104|P3|Overall Study|Lost to Follow-up|0
159574|NCT00316264|512105|P2|Overall Study|Lost to Follow-up|1
159575|NCT00316264|512106|P1|Overall Study|Lost to Follow-up|0
159576|NCT00316225|512174|P1|Overall Study|Death|2
159577|NCT00316225|512174|P1|Overall Study|Withdrawal by Subject|3
159578|NCT00316225|512174|P1|Overall Study|Progressive Disease|15
159579|NCT00316225|512174|P1|Overall Study|Physician Decision|3
159580|NCT00316225|512174|P1|Overall Study|Adverse Event|2
159581|NCT00316199|512183|P1|Overall Study|Lost to Follow-up|2
159582|NCT00316199|512183|P1|Overall Study|Death|8
159583|NCT00316199|512183|P1|Overall Study|Adverse Event|2
159584|NCT00316186|512191|P1|Overall Study|Other|1
159585|NCT00316186|512191|P1|Overall Study|Lost to Follow-up|1
159586|NCT00316186|512191|P1|Overall Study|Disease Progression|4
159587|NCT00316186|512191|P1|Overall Study|Adverse Event|6
159588|NCT00316173|512205|P2|Treatment Phase|Study Follow-up Stopped|34
159589|NCT00316173|512206|P1|Treatment Phase|Study Follow-up Stopped|0
159590|NCT00316173|512205|P2|Treatment Phase|Withdrawal by Subject|1
159591|NCT00316173|512206|P1|Treatment Phase|Withdrawal by Subject|0
159592|NCT00316173|512205|P2|Treatment Phase|Lost to Follow-up|3
159593|NCT00316173|512206|P1|Treatment Phase|Lost to Follow-up|0
159594|NCT00316173|512205|P2|Treatment Phase|Lack of Efficacy|3
159595|NCT00316173|512206|P1|Treatment Phase|Lack of Efficacy|0
159596|NCT00316173|512205|P2|Treatment Phase|Adverse Event|1
159597|NCT00316173|512206|P1|Treatment Phase|Adverse Event|0
159598|NCT00316173|512205|P2|Run-in Phase|Study Follow-up Stopped|0
159599|NCT00316173|512206|P1|Run-in Phase|Study Follow-up Stopped|5
159600|NCT00316173|512205|P2|Run-in Phase|Protocol Violation|0
159601|NCT00316173|512206|P1|Run-in Phase|Protocol Violation|1
159602|NCT00316173|512205|P2|Run-in Phase|Adverse Event|0
159603|NCT00316173|512206|P1|Run-in Phase|Adverse Event|1
159604|NCT00316121|512219|P2|Overall Study|Subject did not have 24 month visit|0
159605|NCT00316121|512220|P1|Overall Study|Subject did not have 24 month visit|1
159606|NCT00316121|512219|P2|Overall Study|Subject no show for visit x 3|0
159607|NCT00316121|512220|P1|Overall Study|Subject no show for visit x 3|1
159608|NCT00316121|512219|P2|Overall Study|Subject refused to return|0
159609|NCT00316121|512220|P1|Overall Study|Subject refused to return|1
159610|NCT00316121|512219|P2|Overall Study|Subject relocated|1
159611|NCT00316121|512220|P1|Overall Study|Subject relocated|1
159612|NCT00316121|512219|P2|Overall Study|Reason is missing|0
159613|NCT00316121|512220|P1|Overall Study|Reason is missing|1
159614|NCT00316121|512219|P2|Overall Study|Withdrawal by Subject|0
159615|NCT00316121|512220|P1|Overall Study|Withdrawal by Subject|2
159616|NCT00316121|512219|P2|Overall Study|Lost to Follow-up|8
159617|NCT00316121|512220|P1|Overall Study|Lost to Follow-up|14
159618|NCT00316121|512219|P2|Overall Study|Death|0
159619|NCT00316121|512220|P1|Overall Study|Death|1
159620|NCT00316082|512231|P5|Overall Study|Administrative reason by sponsor|0
159621|NCT00316082|512232|P4|Overall Study|Administrative reason by sponsor|0
159622|NCT00316082|512233|P3|Overall Study|Administrative reason by sponsor|1
159623|NCT00316082|512234|P2|Overall Study|Administrative reason by sponsor|0
159624|NCT00316082|512235|P1|Overall Study|Administrative reason by sponsor|0
159625|NCT00316082|512231|P5|Overall Study|Death|0
159626|NCT00316082|512232|P4|Overall Study|Death|0
159627|NCT00316082|512233|P3|Overall Study|Death|1
159628|NCT00316082|512234|P2|Overall Study|Death|0
159629|NCT00316082|512235|P1|Overall Study|Death|0
159630|NCT00316082|512231|P5|Overall Study|Physician Decision|1
159631|NCT00316082|512232|P4|Overall Study|Physician Decision|1
159632|NCT00316082|512233|P3|Overall Study|Physician Decision|2
159633|NCT00316082|512234|P2|Overall Study|Physician Decision|1
159634|NCT00316082|512235|P1|Overall Study|Physician Decision|1
159635|NCT00316082|512231|P5|Overall Study|Subject no longer meets study criteria|1
159636|NCT00316082|512232|P4|Overall Study|Subject no longer meets study criteria|2
159637|NCT00316082|512233|P3|Overall Study|Subject no longer meets study criteria|2
159638|NCT00316082|512234|P2|Overall Study|Subject no longer meets study criteria|1
159639|NCT00316082|512235|P1|Overall Study|Subject no longer meets study criteria|3
159640|NCT00316082|512231|P5|Overall Study|Adverse Event|3
159641|NCT00316082|512232|P4|Overall Study|Adverse Event|1
159642|NCT00316082|512233|P3|Overall Study|Adverse Event|5
159643|NCT00316082|512234|P2|Overall Study|Adverse Event|2
159644|NCT00316082|512235|P1|Overall Study|Adverse Event|4
159645|NCT00316082|512231|P5|Overall Study|Poor/noncompliance|4
159646|NCT00316082|512232|P4|Overall Study|Poor/noncompliance|1
159647|NCT00316082|512233|P3|Overall Study|Poor/noncompliance|4
159648|NCT00316082|512234|P2|Overall Study|Poor/noncompliance|1
159649|NCT00316082|512235|P1|Overall Study|Poor/noncompliance|6
159650|NCT00316082|512231|P5|Overall Study|Lost to Follow-up|6
159651|NCT00316082|512232|P4|Overall Study|Lost to Follow-up|8
159652|NCT00316082|512233|P3|Overall Study|Lost to Follow-up|7
159653|NCT00316082|512234|P2|Overall Study|Lost to Follow-up|6
159654|NCT00316082|512235|P1|Overall Study|Lost to Follow-up|7
159655|NCT00316082|512231|P5|Overall Study|Withdrawal of Consent by Subject|5
159656|NCT00316082|512232|P4|Overall Study|Withdrawal of Consent by Subject|9
159657|NCT00316082|512233|P3|Overall Study|Withdrawal of Consent by Subject|2
159658|NCT00316082|512234|P2|Overall Study|Withdrawal of Consent by Subject|8
159659|NCT00316082|512235|P1|Overall Study|Withdrawal of Consent by Subject|10
159660|NCT00316082|512231|P5|Overall Study|Lack of Efficacy|6
159661|NCT00316082|512232|P4|Overall Study|Lack of Efficacy|4
159662|NCT00316082|512233|P3|Overall Study|Lack of Efficacy|3
159663|NCT00316082|512234|P2|Overall Study|Lack of Efficacy|3
159664|NCT00316082|512235|P1|Overall Study|Lack of Efficacy|2
159665|NCT00316017|512266|P3|Overall Study|Protocol Violation|19
159666|NCT00316017|512267|P2|Overall Study|Protocol Violation|13
159667|NCT00316017|512268|P1|Overall Study|Protocol Violation|11
159668|NCT00316004|512342|P3|Overall Study|Subject was not given study fluid.|21
159669|NCT00316004|512343|P2|Overall Study|Subject was not given study fluid.|14
159670|NCT00316004|512344|P1|Overall Study|Subject was not given study fluid.|14
159671|NCT00315731|512406|P1|Overall Study|Death|5
159672|NCT00315731|512406|P1|Overall Study|Lost to Follow-up|1
159673|NCT00315705|512434|P1|Phase 2|Death|7
159674|NCT00315705|512434|P1|Phase 2|Unspecified|1
159675|NCT00315705|512434|P1|Phase 2|Scheduled for transplant|8
159676|NCT00315705|512434|P1|Phase 2|Disease relapse|1
159677|NCT00315705|512434|P1|Phase 2|Failure to achieve response|3
159678|NCT00315705|512434|P1|Phase 2|Adverse Event|1
159679|NCT00315705|512434|P1|Phase 2|Physician Decision|4
159680|NCT00315705|512434|P1|Phase 1|Death|3
159681|NCT00315705|512434|P1|Phase 1|Scheduled for transplant|9
159682|NCT00315705|512434|P1|Phase 1|Disease relapse|4
159683|NCT00315705|512434|P1|Phase 1|Failure to achieve response|8
159684|NCT00315705|512434|P1|Phase 1|Refused further treatment|1
159685|NCT00315458|512477|P4|Overall Study|Did not qualify|0
159686|NCT00315458|512478|P3|Overall Study|Did not qualify|1
159687|NCT00315458|512479|P2|Overall Study|Did not qualify|0
159688|NCT00315458|512480|P1|Overall Study|Did not qualify|0
159689|NCT00315458|512477|P4|Overall Study|Lack of Efficacy|1
159690|NCT00315458|512478|P3|Overall Study|Lack of Efficacy|20
159691|NCT00315458|512479|P2|Overall Study|Lack of Efficacy|0
159692|NCT00315458|512480|P1|Overall Study|Lack of Efficacy|0
159693|NCT00315458|512477|P4|Overall Study|Withdrawal by Subject|2
159694|NCT00315458|512478|P3|Overall Study|Withdrawal by Subject|0
159695|NCT00315458|512479|P2|Overall Study|Withdrawal by Subject|3
159696|NCT00315458|512480|P1|Overall Study|Withdrawal by Subject|0
159697|NCT00315458|512477|P4|Overall Study|Lost to Follow-up|2
159698|NCT00315458|512478|P3|Overall Study|Lost to Follow-up|0
159699|NCT00315458|512479|P2|Overall Study|Lost to Follow-up|2
159700|NCT00315458|512480|P1|Overall Study|Lost to Follow-up|1
159701|NCT00315458|512477|P4|Overall Study|Adverse Event|3
159702|NCT00315458|512478|P3|Overall Study|Adverse Event|23
159703|NCT00315458|512479|P2|Overall Study|Adverse Event|4
159704|NCT00315458|512480|P1|Overall Study|Adverse Event|2
159705|NCT00315458|512477|P4|Overall Study|Administrative|21
159706|NCT00315458|512478|P3|Overall Study|Administrative|8
159707|NCT00315458|512479|P2|Overall Study|Administrative|3
159708|NCT00315458|512480|P1|Overall Study|Administrative|0
159709|NCT00315445|512493|P3|Overall Study|Other|0
159710|NCT00315445|512494|P2|Overall Study|Other|3
159711|NCT00315445|512495|P1|Overall Study|Other|1
159712|NCT00315445|512493|P3|Overall Study|Protocol Violation|1
159713|NCT00315445|512494|P2|Overall Study|Protocol Violation|0
159714|NCT00315445|512495|P1|Overall Study|Protocol Violation|2
159715|NCT00315445|512493|P3|Overall Study|Lost to Follow-up|1
159716|NCT00315445|512494|P2|Overall Study|Lost to Follow-up|0
159717|NCT00315445|512495|P1|Overall Study|Lost to Follow-up|1
159718|NCT00315445|512493|P3|Overall Study|Lack of Efficacy|7
159719|NCT00315445|512494|P2|Overall Study|Lack of Efficacy|1
159720|NCT00315445|512495|P1|Overall Study|Lack of Efficacy|16
159721|NCT00315445|512493|P3|Overall Study|Adverse Event|15
159722|NCT00315445|512494|P2|Overall Study|Adverse Event|12
159723|NCT00315445|512495|P1|Overall Study|Adverse Event|7
159724|NCT00315055|512785|P2|Overall Study|Lost to Follow-up|1
159725|NCT00315055|512786|P1|Overall Study|Lost to Follow-up|1
159726|NCT00315055|512785|P2|Overall Study|Protocol Violation|4
159727|NCT00315055|512786|P1|Overall Study|Protocol Violation|2
159728|NCT00314951|512804|P2|Follow-up|mITT failure|34
159729|NCT00314951|512805|P1|Follow-up|mITT failure|44
159730|NCT00314951|512804|P2|Treatment|Didn't meet criteria for mITT population|11
159731|NCT00314951|512805|P1|Treatment|Didn't meet criteria for mITT population|16
159732|NCT00314808|512815|P1|Overall Study|Withdrawal by Subject/PI without AE|4
159733|NCT00314808|512815|P1|Overall Study|Disease Progression without AE|4
159734|NCT00314574|512825|P2|Overall Study|Data unknown at database lock|1
159735|NCT00314574|512826|P1|Overall Study|Data unknown at database lock|0
159736|NCT00314574|512825|P2|Overall Study|Pregnancy|4
159737|NCT00314574|512826|P1|Overall Study|Pregnancy|6
159738|NCT00314574|512825|P2|Overall Study|Physician Decision|15
159739|NCT00314574|512826|P1|Overall Study|Physician Decision|22
159740|NCT00314574|512825|P2|Overall Study|Withdrawal by Subject|22
159741|NCT00314574|512826|P1|Overall Study|Withdrawal by Subject|33
159742|NCT00314574|512825|P2|Overall Study|Lost to Follow-up|25
159743|NCT00314574|512826|P1|Overall Study|Lost to Follow-up|19
159744|NCT00314574|512825|P2|Overall Study|Adverse Event|16
159745|NCT00314574|512826|P1|Overall Study|Adverse Event|11
159746|NCT00314574|512825|P2|Overall Study|Death|0
159747|NCT00314574|512826|P1|Overall Study|Death|3
159748|NCT00314366|512853|P2|Overall Study|not treated due to patient medical condi|0
159749|NCT00314366|512854|P1|Overall Study|not treated due to patient medical condi|1
159750|NCT00314340|512891|P1|Overall Study|lost interest|1
159751|NCT00314327|512897|P1|Overall Study|Withdrawal by Subject|1
159752|NCT00314262|512901|P1|Overall Study|Physician Decision|1
159753|NCT00314262|512901|P1|Overall Study|Withdrawal by Subject|2
159754|NCT00314262|512901|P1|Overall Study|Adverse Event|2
159755|NCT00314249|512909|P2|Overall Study|Non-Compliant|6
159756|NCT00314249|512910|P1|Overall Study|Non-Compliant|5
159757|NCT00314249|512909|P2|Overall Study|Withdrawn for other reasons|1
159758|NCT00314249|512910|P1|Overall Study|Withdrawn for other reasons|4
159759|NCT00314249|512909|P2|Overall Study|Physician Decision|1
159760|NCT00314249|512910|P1|Overall Study|Physician Decision|1
159761|NCT00314249|512909|P2|Overall Study|Lost to Follow-up|9
159762|NCT00314249|512910|P1|Overall Study|Lost to Follow-up|15
159763|NCT00314249|512909|P2|Overall Study|Withdrawal by Subject|28
159764|NCT00314249|512910|P1|Overall Study|Withdrawal by Subject|21
159765|NCT00314249|512909|P2|Overall Study|Lack of Efficacy|24
159766|NCT00314249|512910|P1|Overall Study|Lack of Efficacy|33
159767|NCT00314249|512909|P2|Overall Study|Adverse Event|94
159768|NCT00314249|512910|P1|Overall Study|Adverse Event|73
159769|NCT00314145|512943|P2|Overall Study|Sponsor Decision|0
159770|NCT00314145|512944|P1|Overall Study|Sponsor Decision|2
159771|NCT00314145|512943|P2|Overall Study|Protocol Violation|0
159772|NCT00314145|512944|P1|Overall Study|Protocol Violation|3
159773|NCT00314145|512943|P2|Overall Study|Adverse Event|3
159774|NCT00314145|512944|P1|Overall Study|Adverse Event|0
159775|NCT00314145|512943|P2|Overall Study|Physician Decision|4
159776|NCT00314145|512944|P1|Overall Study|Physician Decision|3
159777|NCT00314145|512943|P2|Overall Study|Lost to Follow-up|12
159778|NCT00314145|512944|P1|Overall Study|Lost to Follow-up|5
159779|NCT00314145|512943|P2|Overall Study|Withdrawal by Subject|10
159780|NCT00314145|512944|P1|Overall Study|Withdrawal by Subject|8
159781|NCT00314132|512958|P2|Overall Study|Physician Decision|0
159782|NCT00314132|512959|P1|Overall Study|Physician Decision|1
159783|NCT00314132|512958|P2|Overall Study|Adverse Event|0
159784|NCT00314132|512959|P1|Overall Study|Adverse Event|1
159785|NCT00314132|512958|P2|Overall Study|Withdrawal by Subject|5
159786|NCT00314132|512959|P1|Overall Study|Withdrawal by Subject|3
159787|NCT00314132|512958|P2|Overall Study|Lost to Follow-up|13
159788|NCT00314132|512959|P1|Overall Study|Lost to Follow-up|3
159789|NCT00313911|512969|P2|Overall Study|Did not meet age criteria|1
159790|NCT00313911|512970|P1|Overall Study|Did not meet age criteria|1
159791|NCT00313911|512969|P2|Overall Study|Withdrawal by Subject|12
159792|NCT00313911|512970|P1|Overall Study|Withdrawal by Subject|39
159793|NCT00313911|512969|P2|Overall Study|Lost to Follow-up|14
159794|NCT00313911|512970|P1|Overall Study|Lost to Follow-up|27
159795|NCT00313911|512969|P2|Overall Study|Protocol Violation|10
159796|NCT00313911|512970|P1|Overall Study|Protocol Violation|19
159797|NCT00313911|512969|P2|Overall Study|Adverse Event|3
159798|NCT00313911|512970|P1|Overall Study|Adverse Event|2
159799|NCT00313911|512969|P2|Overall Study|Serious adverse event|1
159800|NCT00313911|512970|P1|Overall Study|Serious adverse event|6
159801|NCT00313846|512984|P2|Overall Study|Administrative|3
159802|NCT00313846|512985|P1|Overall Study|Administrative|2
159803|NCT00313846|512984|P2|Overall Study|Adverse Event|8
159804|NCT00313846|512985|P1|Overall Study|Adverse Event|1
159805|NCT00313846|512984|P2|Overall Study|Withdrawal by Subject|0
159806|NCT00313846|512985|P1|Overall Study|Withdrawal by Subject|2
159807|NCT00313820|512996|P2|Pregabalin or Placebo Treatment Period|Other|3
159808|NCT00313820|512997|P1|Pregabalin or Placebo Treatment Period|Other|2
159809|NCT00313820|512996|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
159810|NCT00313820|512997|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
159811|NCT00313820|512996|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
159812|NCT00313820|512997|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
159813|NCT00313820|512996|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
159814|NCT00313820|512997|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
159815|NCT00313820|512996|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
159816|NCT00313820|512997|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
159817|NCT00313820|512996|P2|Assigned to Treatment|Other|0
159818|NCT00313820|512997|P1|Assigned to Treatment|Other|1
159819|NCT00313781|513035|P3|After Crossover|Unspecified|18
159820|NCT00313781|513036|P2|After Crossover|Unspecified|0
159821|NCT00313781|513037|P1|After Crossover|Unspecified|0
159822|NCT00313781|513035|P3|After Crossover|Withdrawal by Subject|3
159823|NCT00313781|513036|P2|After Crossover|Withdrawal by Subject|0
159824|NCT00313781|513037|P1|After Crossover|Withdrawal by Subject|0
159825|NCT00313781|513035|P3|After Crossover|Death|6
159826|NCT00313781|513036|P2|After Crossover|Death|0
159827|NCT00313781|513037|P1|After Crossover|Death|0
159828|NCT00313781|513035|P3|Before Crossover|Randomized, not treated|0
159829|NCT00313781|513036|P2|Before Crossover|Randomized, not treated|0
159830|NCT00313781|513037|P1|Before Crossover|Randomized, not treated|5
159831|NCT00313781|513035|P3|Before Crossover|Crossover|0
159832|NCT00313781|513036|P2|Before Crossover|Crossover|37
159833|NCT00313781|513037|P1|Before Crossover|Crossover|0
159834|NCT00313781|513035|P3|Before Crossover|Unspecified|0
159835|NCT00313781|513036|P2|Before Crossover|Unspecified|30
159836|NCT00313781|513037|P1|Before Crossover|Unspecified|45
159837|NCT00313781|513035|P3|Before Crossover|Withdrawal by Subject|0
159838|NCT00313781|513036|P2|Before Crossover|Withdrawal by Subject|1
159839|NCT00313781|513037|P1|Before Crossover|Withdrawal by Subject|3
159840|NCT00313781|513035|P3|Before Crossover|Lost to Follow-up|0
159841|NCT00313781|513036|P2|Before Crossover|Lost to Follow-up|3
159842|NCT00313781|513037|P1|Before Crossover|Lost to Follow-up|0
159843|NCT00313781|513035|P3|Before Crossover|Death|0
159844|NCT00313781|513036|P2|Before Crossover|Death|8
159845|NCT00313781|513037|P1|Before Crossover|Death|22
159846|NCT00313716|513077|P6|Overall Study|Withdrawal by Subject|0
159847|NCT00313716|513078|P5|Overall Study|Withdrawal by Subject|1
159848|NCT00313716|513079|P4|Overall Study|Withdrawal by Subject|0
159849|NCT00313716|513080|P3|Overall Study|Withdrawal by Subject|1
159850|NCT00313716|513081|P2|Overall Study|Withdrawal by Subject|1
159851|NCT00313716|513082|P1|Overall Study|Withdrawal by Subject|0
159852|NCT00313716|513077|P6|Overall Study|Lost to Follow-up|4
159853|NCT00313716|513078|P5|Overall Study|Lost to Follow-up|0
159854|NCT00313716|513079|P4|Overall Study|Lost to Follow-up|1
159855|NCT00313716|513080|P3|Overall Study|Lost to Follow-up|2
159856|NCT00313716|513081|P2|Overall Study|Lost to Follow-up|5
159857|NCT00313716|513082|P1|Overall Study|Lost to Follow-up|2
159858|NCT00313716|513077|P6|Overall Study|Death|9
159859|NCT00313716|513078|P5|Overall Study|Death|5
159860|NCT00313716|513079|P4|Overall Study|Death|3
159861|NCT00313716|513080|P3|Overall Study|Death|9
159862|NCT00313716|513081|P2|Overall Study|Death|2
159863|NCT00313716|513082|P1|Overall Study|Death|3
159864|NCT00313703|513109|P4|Overall Study|Lost to Follow-up|12
159865|NCT00313703|513110|P3|Overall Study|Lost to Follow-up|5
159866|NCT00313703|513111|P2|Overall Study|Lost to Follow-up|2
159867|NCT00313703|513112|P1|Overall Study|Lost to Follow-up|11
159868|NCT00313612|513128|P2|Overall Study|Patient never received treatment|1
159869|NCT00313612|513129|P1|Overall Study|Patient never received treatment|0
159870|NCT00313586|513141|P4|Overall Study|Death before starting treatment|0
159871|NCT00313586|513142|P3|Overall Study|Death before starting treatment|0
159872|NCT00313586|513143|P2|Overall Study|Death before starting treatment|0
159873|NCT00313586|513144|P1|Overall Study|Death before starting treatment|1
159874|NCT00313586|513141|P4|Overall Study|Moved|0
159875|NCT00313586|513142|P3|Overall Study|Moved|0
159876|NCT00313586|513143|P2|Overall Study|Moved|1
159877|NCT00313586|513144|P1|Overall Study|Moved|0
159878|NCT00313586|513141|P4|Overall Study|Lost insurance|0
159879|NCT00313586|513142|P3|Overall Study|Lost insurance|0
159880|NCT00313586|513143|P2|Overall Study|Lost insurance|1
159881|NCT00313586|513144|P1|Overall Study|Lost insurance|0
159882|NCT00313586|513141|P4|Overall Study|Absolute neutrophil count not recovered|0
159883|NCT00313586|513142|P3|Overall Study|Absolute neutrophil count not recovered|0
159884|NCT00313586|513143|P2|Overall Study|Absolute neutrophil count not recovered|1
159885|NCT00313586|513144|P1|Overall Study|Absolute neutrophil count not recovered|2
159886|NCT00313586|513141|P4|Overall Study|Physician Decision|0
159887|NCT00313586|513142|P3|Overall Study|Physician Decision|0
159888|NCT00313586|513143|P2|Overall Study|Physician Decision|1
159889|NCT00313586|513144|P1|Overall Study|Physician Decision|2
159890|NCT00313586|513141|P4|Overall Study|Did not achieve HI-major/better response|1
159891|NCT00313586|513142|P3|Overall Study|Did not achieve HI-major/better response|2
159892|NCT00313586|513143|P2|Overall Study|Did not achieve HI-major/better response|7
159893|NCT00313586|513144|P1|Overall Study|Did not achieve HI-major/better response|10
159894|NCT00313586|513141|P4|Overall Study|Other complicating disease|0
159895|NCT00313586|513142|P3|Overall Study|Other complicating disease|0
159896|NCT00313586|513143|P2|Overall Study|Other complicating disease|2
159897|NCT00313586|513144|P1|Overall Study|Other complicating disease|2
159898|NCT00313586|513141|P4|Overall Study|Alternative therapy|0
159899|NCT00313586|513142|P3|Overall Study|Alternative therapy|2
159900|NCT00313586|513143|P2|Overall Study|Alternative therapy|6
159901|NCT00313586|513144|P1|Overall Study|Alternative therapy|3
159902|NCT00313586|513141|P4|Overall Study|Withdrawal by Subject|2
159903|NCT00313586|513142|P3|Overall Study|Withdrawal by Subject|6
159904|NCT00313586|513143|P2|Overall Study|Withdrawal by Subject|6
159905|NCT00313586|513144|P1|Overall Study|Withdrawal by Subject|13
159906|NCT00313586|513141|P4|Overall Study|Death|7
159907|NCT00313586|513142|P3|Overall Study|Death|1
159908|NCT00313586|513143|P2|Overall Study|Death|8
159909|NCT00313586|513144|P1|Overall Study|Death|11
159910|NCT00313586|513141|P4|Overall Study|Adverse Event|10
159911|NCT00313586|513142|P3|Overall Study|Adverse Event|3
159912|NCT00313586|513143|P2|Overall Study|Adverse Event|18
159913|NCT00313586|513144|P1|Overall Study|Adverse Event|12
159914|NCT00313586|513141|P4|Overall Study|Disease progression|3
159915|NCT00313586|513142|P3|Overall Study|Disease progression|10
159916|NCT00313586|513143|P2|Overall Study|Disease progression|19
159917|NCT00313586|513144|P1|Overall Study|Disease progression|14
159918|NCT00313313|513163|P3|Overall Study|Subject No Longer Meets Study Criteria|2
159919|NCT00313313|513164|P2|Overall Study|Subject No Longer Meets Study Criteria|3
159920|NCT00313313|513165|P1|Overall Study|Subject No Longer Meets Study Criteria|0
159921|NCT00313313|513163|P3|Overall Study|Death|2
159922|NCT00313313|513164|P2|Overall Study|Death|0
159923|NCT00313313|513165|P1|Overall Study|Death|0
159924|NCT00313313|513163|P3|Overall Study|Pregnancy|0
159925|NCT00313313|513164|P2|Overall Study|Pregnancy|2
159926|NCT00313313|513165|P1|Overall Study|Pregnancy|1
159927|NCT00313313|513163|P3|Overall Study|Poor/Noncompliance|2
159928|NCT00313313|513164|P2|Overall Study|Poor/Noncompliance|6
159929|NCT00313313|513165|P1|Overall Study|Poor/Noncompliance|3
159930|NCT00313313|513163|P3|Overall Study|Physician Decision|4
159931|NCT00313313|513164|P2|Overall Study|Physician Decision|6
159932|NCT00313313|513165|P1|Overall Study|Physician Decision|2
159933|NCT00313313|513163|P3|Overall Study|Adverse Event|12
159934|NCT00313313|513164|P2|Overall Study|Adverse Event|16
159935|NCT00313313|513165|P1|Overall Study|Adverse Event|15
159936|NCT00313313|513163|P3|Overall Study|Lost to Follow-up|9
159937|NCT00313313|513164|P2|Overall Study|Lost to Follow-up|7
159938|NCT00313313|513165|P1|Overall Study|Lost to Follow-up|10
159939|NCT00313313|513163|P3|Overall Study|Withdrawal of consent by subject|31
159940|NCT00313313|513164|P2|Overall Study|Withdrawal of consent by subject|17
159941|NCT00313313|513165|P1|Overall Study|Withdrawal of consent by subject|18
159942|NCT00313313|513163|P3|Overall Study|Lack of Efficacy|20
159943|NCT00313313|513164|P2|Overall Study|Lack of Efficacy|9
159944|NCT00313313|513165|P1|Overall Study|Lack of Efficacy|14
159945|NCT00313300|513187|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
159946|NCT00313300|513188|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
159947|NCT00313300|513189|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
159948|NCT00313300|513190|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
159949|NCT00313300|513191|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
159950|NCT00313300|513187|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
159951|NCT00313300|513188|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
159952|NCT00313300|513189|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
159953|NCT00313300|513190|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
159954|NCT00313300|513191|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
159955|NCT00313300|513187|P5|Follow-Up(30days)-Randomized Phase B|Death|0
159956|NCT00313300|513188|P4|Follow-Up(30days)-Randomized Phase B|Death|0
159957|NCT00313300|513189|P3|Follow-Up(30days)-Randomized Phase B|Death|0
159958|NCT00313300|513190|P2|Follow-Up(30days)-Randomized Phase B|Death|0
159959|NCT00313300|513191|P1|Follow-Up(30days)-Randomized Phase B|Death|1
159960|NCT00313300|513187|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
159961|NCT00313300|513188|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
159962|NCT00313300|513189|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
159963|NCT00313300|513190|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
159964|NCT00313300|513191|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
159965|NCT00313300|513187|P5|Follow-Up(30days)-Randomized Phase A|Death|0
159966|NCT00313300|513188|P4|Follow-Up(30days)-Randomized Phase A|Death|0
159967|NCT00313300|513189|P3|Follow-Up(30days)-Randomized Phase A|Death|0
159968|NCT00313300|513190|P2|Follow-Up(30days)-Randomized Phase A|Death|1
159969|NCT00313300|513191|P1|Follow-Up(30days)-Randomized Phase A|Death|0
159970|NCT00313300|513187|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
159971|NCT00313300|513188|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
159972|NCT00313300|513189|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
159973|NCT00313300|513190|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
159974|NCT00313300|513191|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
159975|NCT00313300|513187|P5|Randomized in Phase B (26 Weeks)|non-specified|0
159976|NCT00313300|513188|P4|Randomized in Phase B (26 Weeks)|non-specified|0
159977|NCT00313300|513189|P3|Randomized in Phase B (26 Weeks)|non-specified|0
159978|NCT00313300|513190|P2|Randomized in Phase B (26 Weeks)|non-specified|0
159979|NCT00313300|513191|P1|Randomized in Phase B (26 Weeks)|non-specified|1
159980|NCT00313300|513187|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
159981|NCT00313300|513188|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
159982|NCT00313300|513189|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
159983|NCT00313300|513190|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
159984|NCT00313300|513191|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
159985|NCT00313300|513187|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
159986|NCT00313300|513188|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
159987|NCT00313300|513189|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
159988|NCT00313300|513190|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
159989|NCT00313300|513191|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
159990|NCT00313300|513187|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
159991|NCT00313300|513188|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
159992|NCT00313300|513189|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
159993|NCT00313300|513190|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
159994|NCT00313300|513191|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
159995|NCT00313300|513187|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
159996|NCT00313300|513188|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
159997|NCT00313300|513189|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
159998|NCT00313300|513190|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
159999|NCT00313300|513191|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
160000|NCT00313300|513187|P5|Randomized in Phase B (26 Weeks)|Death|1
160001|NCT00313300|513188|P4|Randomized in Phase B (26 Weeks)|Death|0
160002|NCT00313300|513189|P3|Randomized in Phase B (26 Weeks)|Death|1
160003|NCT00313300|513190|P2|Randomized in Phase B (26 Weeks)|Death|3
160004|NCT00313300|513191|P1|Randomized in Phase B (26 Weeks)|Death|5
160005|NCT00313300|513187|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
160006|NCT00313300|513188|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
160007|NCT00313300|513189|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
160008|NCT00313300|513190|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
160009|NCT00313300|513191|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
160010|NCT00313300|513187|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
160011|NCT00313300|513188|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
160012|NCT00313300|513189|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
160013|NCT00313300|513190|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
160014|NCT00313300|513191|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
160015|NCT00313300|513187|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
160016|NCT00313300|513188|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
160017|NCT00313300|513189|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
160018|NCT00313300|513190|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
160019|NCT00313300|513191|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
160020|NCT00313300|513187|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
160021|NCT00313300|513188|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
160022|NCT00313300|513189|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
160023|NCT00313300|513190|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
160024|NCT00313300|513191|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
160025|NCT00313300|513187|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
160026|NCT00313300|513188|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
160027|NCT00313300|513189|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
160028|NCT00313300|513190|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
160029|NCT00313300|513191|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
160030|NCT00313300|513187|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
160031|NCT00313300|513188|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
160032|NCT00313300|513189|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
160033|NCT00313300|513190|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
160034|NCT00313300|513191|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
160035|NCT00313300|513187|P5|Randomized in Phase A (26 Weeks)|Death|0
160036|NCT00313300|513188|P4|Randomized in Phase A (26 Weeks)|Death|0
160037|NCT00313300|513189|P3|Randomized in Phase A (26 Weeks)|Death|0
160038|NCT00313300|513190|P2|Randomized in Phase A (26 Weeks)|Death|4
160039|NCT00313300|513191|P1|Randomized in Phase A (26 Weeks)|Death|3
160040|NCT00313300|513187|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
160041|NCT00313300|513188|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
160042|NCT00313300|513189|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
160043|NCT00313300|513190|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
160044|NCT00313300|513191|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
160045|NCT00313300|513187|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
160046|NCT00313300|513188|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
160047|NCT00313300|513189|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
160048|NCT00313300|513190|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
160049|NCT00313300|513191|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
160050|NCT00313170|513261|P3|Overall Study|brain mets. after randomisation|1
160051|NCT00313170|513262|P2|Overall Study|brain mets. after randomisation|0
160052|NCT00313170|513263|P1|Overall Study|brain mets. after randomisation|0
160053|NCT00313170|513261|P3|Overall Study|dosing error|1
160054|NCT00313170|513262|P2|Overall Study|dosing error|0
160055|NCT00313170|513263|P1|Overall Study|dosing error|0
160056|NCT00313170|513261|P3|Overall Study|Clinical progression|0
160057|NCT00313170|513262|P2|Overall Study|Clinical progression|0
160058|NCT00313170|513263|P1|Overall Study|Clinical progression|1
160059|NCT00313170|513261|P3|Overall Study|Lost to Follow-up|1
160060|NCT00313170|513262|P2|Overall Study|Lost to Follow-up|0
160061|NCT00313170|513263|P1|Overall Study|Lost to Follow-up|0
160062|NCT00313170|513261|P3|Overall Study|Incorrect enrollment|1
160063|NCT00313170|513262|P2|Overall Study|Incorrect enrollment|2
160064|NCT00313170|513263|P1|Overall Study|Incorrect enrollment|0
160065|NCT00313170|513261|P3|Overall Study|Withdrawal by Subject|1
160066|NCT00313170|513262|P2|Overall Study|Withdrawal by Subject|1
160067|NCT00313170|513263|P1|Overall Study|Withdrawal by Subject|1
160068|NCT00313170|513261|P3|Overall Study|Disease progression|27
160069|NCT00313170|513262|P2|Overall Study|Disease progression|26
160070|NCT00313170|513263|P1|Overall Study|Disease progression|31
160071|NCT00313170|513261|P3|Overall Study|Adverse Event|0
160072|NCT00313170|513262|P2|Overall Study|Adverse Event|2
160073|NCT00313170|513263|P1|Overall Study|Adverse Event|2
160074|NCT00313170|513261|P3|Overall Study|Death|0
160075|NCT00313170|513262|P2|Overall Study|Death|4
160076|NCT00313170|513263|P1|Overall Study|Death|1
160077|NCT00313144|513279|P1|Overall Study|Due to termination of the study|66
160078|NCT00313144|513279|P1|Overall Study|Change to different product|1
160079|NCT00313144|513279|P1|Overall Study|Insurance (homecare provider) change|1
160080|NCT00313144|513279|P1|Overall Study|Liver transplant|1
160081|NCT00313144|513279|P1|Overall Study|Adverse event - transient|5
160082|NCT00313144|513279|P1|Overall Study|Physician Decision|4
160083|NCT00313144|513279|P1|Overall Study|Terminated by sponsor/ homecare provider|4
160084|NCT00313144|513279|P1|Overall Study|Withdrawal by Subject|4
160085|NCT00313144|513279|P1|Overall Study|Lost to Follow-up|5
160086|NCT00313144|513279|P1|Overall Study|Death|7
160087|NCT00313144|513279|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
160088|NCT00313014|513366|P3|Overall Study|Lack of Efficacy|16
160089|NCT00313014|513367|P2|Overall Study|Lack of Efficacy|25
160090|NCT00313014|513368|P1|Overall Study|Lack of Efficacy|52
160091|NCT00313014|513366|P3|Overall Study|Administrative|14
160092|NCT00313014|513367|P2|Overall Study|Administrative|6
160093|NCT00313014|513368|P1|Overall Study|Administrative|9
160094|NCT00313014|513366|P3|Overall Study|Lost to Follow-up|10
160095|NCT00313014|513367|P2|Overall Study|Lost to Follow-up|6
160096|NCT00313014|513368|P1|Overall Study|Lost to Follow-up|7
160097|NCT00313014|513366|P3|Overall Study|Adverse Event|16
160098|NCT00313014|513367|P2|Overall Study|Adverse Event|29
160099|NCT00313014|513368|P1|Overall Study|Adverse Event|14
160100|NCT00313014|513366|P3|Overall Study|Withdrawal by Subject|5
160101|NCT00313014|513367|P2|Overall Study|Withdrawal by Subject|7
160102|NCT00313014|513368|P1|Overall Study|Withdrawal by Subject|11
160103|NCT00312858|513414|P2|Overall Study|Unspecified|12
160104|NCT00312858|513415|P1|Overall Study|Unspecified|9
160105|NCT00312858|513414|P2|Overall Study|Participant Moved|10
160106|NCT00312858|513415|P1|Overall Study|Participant Moved|11
160107|NCT00312858|513414|P2|Overall Study|Withdraw by Participant|20
160108|NCT00312858|513415|P1|Overall Study|Withdraw by Participant|20
160109|NCT00312858|513414|P2|Overall Study|Protocol Violation|8
160110|NCT00312858|513415|P1|Overall Study|Protocol Violation|3
160111|NCT00312858|513414|P2|Overall Study|Lost to Follow-up|42
160112|NCT00312858|513415|P1|Overall Study|Lost to Follow-up|25
160113|NCT00312858|513414|P2|Overall Study|Adverse Event|1
160114|NCT00312858|513415|P1|Overall Study|Adverse Event|0
160115|NCT00312845|513469|P2|Overall Study|Other|5
160116|NCT00312845|513470|P1|Overall Study|Other|6
160117|NCT00312845|513469|P2|Overall Study|Lost to Follow-up|0
160118|NCT00312845|513470|P1|Overall Study|Lost to Follow-up|2
160119|NCT00312845|513469|P2|Overall Study|Disease Progression|77
160120|NCT00312845|513470|P1|Overall Study|Disease Progression|56
160121|NCT00312845|513469|P2|Overall Study|Withdrawal by Subject|6
160122|NCT00312845|513470|P1|Overall Study|Withdrawal by Subject|14
160123|NCT00312845|513469|P2|Overall Study|Death|2
160124|NCT00312845|513470|P1|Overall Study|Death|2
160125|NCT00312845|513469|P2|Overall Study|Adverse Event|5
160126|NCT00312845|513470|P1|Overall Study|Adverse Event|19
160127|NCT00312728|513478|P1|Overall Study|Other|1
160128|NCT00312728|513478|P1|Overall Study|Other|10
160129|NCT00312728|513478|P1|Overall Study|Protocol Violation|2
160130|NCT00312728|513478|P1|Overall Study|Required non-protocol cancer treatment|2
160131|NCT00312728|513478|P1|Overall Study|Withdrawal by Subject|10
160132|NCT00312728|513478|P1|Overall Study|Adverse Event|32
160133|NCT00312728|513478|P1|Overall Study|Progressive disease|53
160134|NCT00312572|513489|P2|Overall Study|Lack of Efficacy|2
160135|NCT00312572|513490|P1|Overall Study|Lack of Efficacy|1
160136|NCT00312572|513489|P2|Overall Study|Administrative|2
160137|NCT00312572|513490|P1|Overall Study|Administrative|4
160138|NCT00312572|513489|P2|Overall Study|Lost to Follow-up|1
160139|NCT00312572|513490|P1|Overall Study|Lost to Follow-up|1
160140|NCT00312572|513489|P2|Overall Study|Adverse Event|16
160141|NCT00312572|513490|P1|Overall Study|Adverse Event|10
160142|NCT00312494|513501|P3|Overall Study|Unspecified|1
160143|NCT00312494|513502|P2|Overall Study|Unspecified|10
160144|NCT00312494|513503|P1|Overall Study|Unspecified|10
160145|NCT00312494|513501|P3|Overall Study|Withdrawal by Subject|10
160146|NCT00312494|513502|P2|Overall Study|Withdrawal by Subject|9
160147|NCT00312494|513503|P1|Overall Study|Withdrawal by Subject|6
160148|NCT00312494|513501|P3|Overall Study|Lost to Follow-up|8
160149|NCT00312494|513502|P2|Overall Study|Lost to Follow-up|8
160150|NCT00312494|513503|P1|Overall Study|Lost to Follow-up|8
160151|NCT00312494|513501|P3|Overall Study|Laboratory abnormality|0
160152|NCT00312494|513502|P2|Overall Study|Laboratory abnormality|0
160153|NCT00312494|513503|P1|Overall Study|Laboratory abnormality|1
160154|NCT00312494|513501|P3|Overall Study|Lack of Efficacy|8
160155|NCT00312494|513502|P2|Overall Study|Lack of Efficacy|6
160156|NCT00312494|513503|P1|Overall Study|Lack of Efficacy|4
160157|NCT00312494|513501|P3|Overall Study|Adverse Event|11
160158|NCT00312494|513502|P2|Overall Study|Adverse Event|15
160159|NCT00312494|513503|P1|Overall Study|Adverse Event|33
160160|NCT00312494|513501|P3|Overall Study|Randomized; not treated with study drug|5
160161|NCT00312494|513502|P2|Overall Study|Randomized; not treated with study drug|10
160162|NCT00312494|513503|P1|Overall Study|Randomized; not treated with study drug|9
160163|NCT00312377|513537|P2|Overall Study|Site ended participation in study|0
160164|NCT00312377|513538|P1|Overall Study|Site ended participation in study|1
160165|NCT00312377|513537|P2|Overall Study|Discontinue treatment survival follow up|200
160166|NCT00312377|513538|P1|Overall Study|Discontinue treatment survival follow up|202
160167|NCT00312377|513537|P2|Overall Study|Randomised but never received treatment|6
160168|NCT00312377|513538|P1|Overall Study|Randomised but never received treatment|6
160169|NCT00312377|513537|P2|Overall Study|Non-compliance|2
160170|NCT00312377|513538|P1|Overall Study|Non-compliance|0
160171|NCT00312377|513537|P2|Overall Study|Lost to Follow-up|12
160172|NCT00312377|513538|P1|Overall Study|Lost to Follow-up|9
160173|NCT00312377|513537|P2|Overall Study|Withdrawal by Subject|30
160174|NCT00312377|513538|P1|Overall Study|Withdrawal by Subject|23
160175|NCT00312377|513537|P2|Overall Study|Death|418
160176|NCT00312377|513538|P1|Overall Study|Death|403
160177|NCT00312338|513562|P2|Overall Study|Subsequent infection|0
160178|NCT00312338|513563|P1|Overall Study|Subsequent infection|2
160179|NCT00312338|513562|P2|Overall Study|Withdrawal by Subject|0
160180|NCT00312338|513563|P1|Overall Study|Withdrawal by Subject|4
160181|NCT00312338|513562|P2|Overall Study|Lost to Follow-up|1
160182|NCT00312338|513563|P1|Overall Study|Lost to Follow-up|9
160183|NCT00312338|513562|P2|Overall Study|Adverse Event|2
160184|NCT00312338|513563|P1|Overall Study|Adverse Event|7
160185|NCT00312221|513576|P4|Double-blind Phase|Lack of Efficacy|10
160186|NCT00312221|513577|P3|Double-blind Phase|Lack of Efficacy|6
160187|NCT00312221|513578|P2|Double-blind Phase|Lack of Efficacy|17
160188|NCT00312221|513579|P1|Double-blind Phase|Lack of Efficacy|0
160189|NCT00312221|513576|P4|Double-blind Phase|Administrative|33
160190|NCT00312221|513577|P3|Double-blind Phase|Administrative|37
160191|NCT00312221|513578|P2|Double-blind Phase|Administrative|26
160192|NCT00312221|513579|P1|Double-blind Phase|Administrative|0
160193|NCT00312221|513576|P4|Double-blind Phase|Lost to Follow-up|2
160194|NCT00312221|513577|P3|Double-blind Phase|Lost to Follow-up|2
160195|NCT00312221|513578|P2|Double-blind Phase|Lost to Follow-up|0
160196|NCT00312221|513579|P1|Double-blind Phase|Lost to Follow-up|0
160197|NCT00312221|513576|P4|Double-blind Phase|Adverse Event|18
160198|NCT00312221|513577|P3|Double-blind Phase|Adverse Event|19
160199|NCT00312221|513578|P2|Double-blind Phase|Adverse Event|10
160200|NCT00312221|513579|P1|Double-blind Phase|Adverse Event|0
160201|NCT00312221|513576|P4|Double-blind Phase|Withdrawal by Subject|7
160202|NCT00312221|513577|P3|Double-blind Phase|Withdrawal by Subject|8
160203|NCT00312221|513578|P2|Double-blind Phase|Withdrawal by Subject|6
160204|NCT00312221|513579|P1|Double-blind Phase|Withdrawal by Subject|0
160205|NCT00312221|513576|P4|Open-label Run-in Period|Did not qualify|0
160206|NCT00312221|513577|P3|Open-label Run-in Period|Did not qualify|0
160207|NCT00312221|513578|P2|Open-label Run-in Period|Did not qualify|0
160208|NCT00312221|513579|P1|Open-label Run-in Period|Did not qualify|5
160209|NCT00312221|513576|P4|Open-label Run-in Period|Lack of Efficacy|0
160210|NCT00312221|513577|P3|Open-label Run-in Period|Lack of Efficacy|0
160211|NCT00312221|513578|P2|Open-label Run-in Period|Lack of Efficacy|0
160212|NCT00312221|513579|P1|Open-label Run-in Period|Lack of Efficacy|102
160213|NCT00312221|513576|P4|Open-label Run-in Period|Administrative|0
160214|NCT00312221|513577|P3|Open-label Run-in Period|Administrative|0
160215|NCT00312221|513578|P2|Open-label Run-in Period|Administrative|0
160216|NCT00312221|513579|P1|Open-label Run-in Period|Administrative|42
160217|NCT00312221|513576|P4|Open-label Run-in Period|Lost to Follow-up|0
160218|NCT00312221|513577|P3|Open-label Run-in Period|Lost to Follow-up|0
160219|NCT00312221|513578|P2|Open-label Run-in Period|Lost to Follow-up|0
160220|NCT00312221|513579|P1|Open-label Run-in Period|Lost to Follow-up|5
160221|NCT00312221|513576|P4|Open-label Run-in Period|Adverse Event|0
160222|NCT00312221|513577|P3|Open-label Run-in Period|Adverse Event|0
160223|NCT00312221|513578|P2|Open-label Run-in Period|Adverse Event|0
160224|NCT00312221|513579|P1|Open-label Run-in Period|Adverse Event|74
160225|NCT00312221|513576|P4|Open-label Run-in Period|Withdrawal by Subject|0
160226|NCT00312221|513577|P3|Open-label Run-in Period|Withdrawal by Subject|0
160227|NCT00312221|513578|P2|Open-label Run-in Period|Withdrawal by Subject|0
160228|NCT00312221|513579|P1|Open-label Run-in Period|Withdrawal by Subject|6
160229|NCT00312208|513599|P2|Overall Study|Not specified|7
160230|NCT00312208|513600|P1|Overall Study|Not specified|5
160231|NCT00312208|513599|P2|Overall Study|Withdrawal by Subject|42
160232|NCT00312208|513600|P1|Overall Study|Withdrawal by Subject|53
160233|NCT00312208|513599|P2|Overall Study|Lost to Follow-up|5
160234|NCT00312208|513600|P1|Overall Study|Lost to Follow-up|3
160235|NCT00312208|513599|P2|Overall Study|Lack of Efficacy|4
160236|NCT00312208|513600|P1|Overall Study|Lack of Efficacy|7
160237|NCT00312208|513599|P2|Overall Study|Death|1
160238|NCT00312208|513600|P1|Overall Study|Death|2
160239|NCT00312208|513599|P2|Overall Study|Protocol Violation|3
160240|NCT00312208|513600|P1|Overall Study|Protocol Violation|5
160241|NCT00312208|513599|P2|Overall Study|Adverse Event|61
160242|NCT00312208|513600|P1|Overall Study|Adverse Event|97
160243|NCT00312195|513610|P2|Overall Study|Protocol Violation|0
160244|NCT00312195|513611|P1|Overall Study|Protocol Violation|1
160245|NCT00312195|513610|P2|Overall Study|Lost to Follow-up|0
160246|NCT00312195|513611|P1|Overall Study|Lost to Follow-up|1
160247|NCT00312195|513610|P2|Overall Study|Adverse Event|6
160248|NCT00312195|513611|P1|Overall Study|Adverse Event|4
160249|NCT00311584|513638|P2|Overall Study|ineligible|2
160250|NCT00311584|513639|P1|Overall Study|ineligible|2
160251|NCT00311584|513638|P2|Overall Study|Withdrawal by Subject|1
160252|NCT00311584|513639|P1|Overall Study|Withdrawal by Subject|1
160253|NCT00311584|513638|P2|Overall Study|Physician Decision|5
160254|NCT00311584|513639|P1|Overall Study|Physician Decision|4
160255|NCT00311584|513638|P2|Overall Study|Lack of Efficacy|15
160256|NCT00311584|513639|P1|Overall Study|Lack of Efficacy|12
160257|NCT00311584|513638|P2|Overall Study|Death|0
160258|NCT00311584|513639|P1|Overall Study|Death|1
160259|NCT00311402|513647|P2|Overall Study|IRB's rejection etc.|3
160260|NCT00311402|513648|P1|Overall Study|IRB's rejection etc.|10
160261|NCT00311402|513647|P2|Overall Study|Protocol Violation|6
160262|NCT00311402|513648|P1|Overall Study|Protocol Violation|7
160263|NCT00311402|513647|P2|Overall Study|Lack of Efficacy|42
160264|NCT00311402|513648|P1|Overall Study|Lack of Efficacy|58
160265|NCT00311402|513647|P2|Overall Study|Withdrawal by Subject|18
160266|NCT00311402|513648|P1|Overall Study|Withdrawal by Subject|17
160267|NCT00311402|513647|P2|Overall Study|Lost to Follow-up|3
160268|NCT00311402|513648|P1|Overall Study|Lost to Follow-up|0
160269|NCT00311402|513647|P2|Overall Study|Adverse Event|105
160270|NCT00311402|513648|P1|Overall Study|Adverse Event|118
160271|NCT00311363|513697|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
160272|NCT00311363|513698|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
160273|NCT00311363|513699|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
160274|NCT00311363|513697|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
160275|NCT00311363|513698|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
160276|NCT00311363|513699|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
160277|NCT00311363|513697|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
160278|NCT00311363|513698|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
160279|NCT00311363|513699|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
160280|NCT00311363|513697|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
160281|NCT00311363|513698|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
160282|NCT00311363|513699|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
160283|NCT00311363|513697|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
160284|NCT00311363|513698|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
160285|NCT00311363|513699|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
160286|NCT00311363|513697|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
160287|NCT00311363|513698|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
160288|NCT00311363|513699|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
160289|NCT00311363|513697|P3|24-Week Single-Blind Treatment Period|Death|0
160290|NCT00311363|513698|P2|24-Week Single-Blind Treatment Period|Death|0
160291|NCT00311363|513699|P1|24-Week Single-Blind Treatment Period|Death|1
160292|NCT00311363|513697|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
160293|NCT00311363|513698|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
160294|NCT00311363|513699|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
160295|NCT00311363|513697|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
160296|NCT00311363|513698|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
160297|NCT00311363|513699|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
160298|NCT00311363|513697|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
160299|NCT00311363|513698|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
160300|NCT00311363|513699|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
160301|NCT00311363|513697|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
160302|NCT00311363|513698|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
160303|NCT00311363|513699|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
160304|NCT00311363|513697|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
160305|NCT00311363|513698|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
160306|NCT00311363|513699|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
160307|NCT00311363|513697|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
160308|NCT00311363|513698|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
160309|NCT00311363|513699|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
160310|NCT00311363|513697|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
160311|NCT00311363|513698|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
160312|NCT00311363|513699|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
160313|NCT00311363|513697|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
160314|NCT00311363|513698|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
160315|NCT00311363|513699|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
160316|NCT00311311|513759|P2|Overall Study|Lack of ancillary assistance|1
160317|NCT00311311|513760|P1|Overall Study|Lack of ancillary assistance|0
160318|NCT00311311|513759|P2|Overall Study|Death|0
160319|NCT00311311|513760|P1|Overall Study|Death|1
160320|NCT00311311|513759|P2|Overall Study|Study Termination by Sponsor|4
160321|NCT00311311|513760|P1|Overall Study|Study Termination by Sponsor|3
160322|NCT00311311|513759|P2|Overall Study|Noncompliance|1
160323|NCT00311311|513760|P1|Overall Study|Noncompliance|0
160324|NCT00311311|513759|P2|Overall Study|Withdrawal by Subject|1
160325|NCT00311311|513760|P1|Overall Study|Withdrawal by Subject|1
160326|NCT00311311|513759|P2|Overall Study|Adverse Event|2
160327|NCT00311311|513760|P1|Overall Study|Adverse Event|3
160328|NCT00311181|513810|P1|Overall Study|Final DFTs were not obtained|96
160329|NCT00311155|513816|P1|Overall Study|Did not meet entry criteria|55
160330|NCT00311155|513816|P1|Overall Study|Withdrawal by Subject|17
160331|NCT00311155|513816|P1|Overall Study|Adverse Event|21
160332|NCT00310856|513828|P3|Overall Study|Unable to classify|0
160333|NCT00310856|513829|P2|Overall Study|Unable to classify|0
160334|NCT00310856|513830|P1|Overall Study|Unable to classify|1
160335|NCT00310856|513828|P3|Overall Study|Inappropriate enrollment|0
160336|NCT00310856|513829|P2|Overall Study|Inappropriate enrollment|1
160337|NCT00310856|513830|P1|Overall Study|Inappropriate enrollment|1
160338|NCT00310856|513828|P3|Overall Study|Lost to Follow-up|6
160339|NCT00310856|513829|P2|Overall Study|Lost to Follow-up|2
160340|NCT00310856|513830|P1|Overall Study|Lost to Follow-up|1
160341|NCT00310856|513828|P3|Overall Study|Withdrawal by Subject|2
160342|NCT00310856|513829|P2|Overall Study|Withdrawal by Subject|2
160343|NCT00310856|513830|P1|Overall Study|Withdrawal by Subject|2
160344|NCT00310817|513854|P4|Overall Study|Unable to classify|0
160345|NCT00310817|513855|P3|Overall Study|Unable to classify|0
160346|NCT00310817|513856|P2|Overall Study|Unable to classify|1
160347|NCT00310817|513857|P1|Overall Study|Unable to classify|3
160348|NCT00310817|513854|P4|Overall Study|Protocol Violation|1
160349|NCT00310817|513855|P3|Overall Study|Protocol Violation|1
160350|NCT00310817|513856|P2|Overall Study|Protocol Violation|1
160351|NCT00310817|513857|P1|Overall Study|Protocol Violation|1
160352|NCT00310817|513854|P4|Overall Study|Inappropriate Enrollment|0
160353|NCT00310817|513855|P3|Overall Study|Inappropriate Enrollment|1
160354|NCT00310817|513856|P2|Overall Study|Inappropriate Enrollment|0
160355|NCT00310817|513857|P1|Overall Study|Inappropriate Enrollment|1
160356|NCT00310817|513854|P4|Overall Study|Lost to Follow-up|0
160357|NCT00310817|513855|P3|Overall Study|Lost to Follow-up|0
160358|NCT00310817|513856|P2|Overall Study|Lost to Follow-up|1
160359|NCT00310817|513857|P1|Overall Study|Lost to Follow-up|2
160360|NCT00310817|513854|P4|Overall Study|Withdrawal by Subject|7
160361|NCT00310817|513855|P3|Overall Study|Withdrawal by Subject|6
160362|NCT00310817|513856|P2|Overall Study|Withdrawal by Subject|4
160363|NCT00310817|513857|P1|Overall Study|Withdrawal by Subject|1
160364|NCT00310817|513854|P4|Overall Study|AE or Death|0
160365|NCT00310817|513855|P3|Overall Study|AE or Death|0
160366|NCT00310817|513856|P2|Overall Study|AE or Death|1
160367|NCT00310817|513857|P1|Overall Study|AE or Death|3
160368|NCT00310804|513945|P2|Overall Study|Withdrawal by Subject|0
160369|NCT00310804|513946|P1|Overall Study|Withdrawal by Subject|3
160370|NCT00310804|513945|P2|Overall Study|Lost to Follow-up|0
160371|NCT00310804|513946|P1|Overall Study|Lost to Follow-up|2
160372|NCT00309985|513990|P2|Overall Study|Chemotherapy discontinued only|0
160373|NCT00309985|513991|P1|Overall Study|Chemotherapy discontinued only|1
160374|NCT00309985|513990|P2|Overall Study|Non-compliance|0
160375|NCT00309985|513991|P1|Overall Study|Non-compliance|1
160376|NCT00309985|513990|P2|Overall Study|Complicating disease|0
160377|NCT00309985|513991|P1|Overall Study|Complicating disease|1
160378|NCT00309985|513990|P2|Overall Study|Never started treatment|0
160379|NCT00309985|513991|P1|Overall Study|Never started treatment|7
160380|NCT00309985|513990|P2|Overall Study|Physician Decision|0
160381|NCT00309985|513991|P1|Overall Study|Physician Decision|3
160382|NCT00309985|513990|P2|Overall Study|Withdrawal by Subject|1
160383|NCT00309985|513991|P1|Overall Study|Withdrawal by Subject|5
160384|NCT00309985|513990|P2|Overall Study|Death|0
160385|NCT00309985|513991|P1|Overall Study|Death|2
160386|NCT00309985|513990|P2|Overall Study|Adverse Event|0
160387|NCT00309985|513991|P1|Overall Study|Adverse Event|30
160388|NCT00309985|513990|P2|Overall Study|Disease progression|0
160389|NCT00309985|513991|P1|Overall Study|Disease progression|12
160390|NCT00309946|514007|P1|Overall Study|Withdrawal by Subject|1
160391|NCT00309907|514013|P1|Overall Study|Major infectious event|4
160392|NCT00309907|514013|P1|Overall Study|Ineligible|11
160393|NCT00309907|514013|P1|Overall Study|Physician Decision|1
160394|NCT00309907|514013|P1|Overall Study|Death|4
160395|NCT00309777|514021|P4|Overall Study|Death|0
160396|NCT00309777|514022|P3|Overall Study|Death|0
160397|NCT00309777|514023|P2|Overall Study|Death|1
160398|NCT00309777|514024|P1|Overall Study|Death|0
160399|NCT00309777|514021|P4|Overall Study|Lost to Follow-up|0
160400|NCT00309777|514022|P3|Overall Study|Lost to Follow-up|1
160401|NCT00309777|514023|P2|Overall Study|Lost to Follow-up|0
160402|NCT00309777|514024|P1|Overall Study|Lost to Follow-up|0
160403|NCT00309777|514021|P4|Overall Study|Withdrawal by Subject|2
160404|NCT00309777|514022|P3|Overall Study|Withdrawal by Subject|7
160405|NCT00309777|514023|P2|Overall Study|Withdrawal by Subject|5
160406|NCT00309777|514024|P1|Overall Study|Withdrawal by Subject|6
160407|NCT00309777|514021|P4|Overall Study|Protocol Violation|1
160408|NCT00309777|514022|P3|Overall Study|Protocol Violation|3
160409|NCT00309777|514023|P2|Overall Study|Protocol Violation|1
160410|NCT00309777|514024|P1|Overall Study|Protocol Violation|4
160411|NCT00309777|514021|P4|Overall Study|Adverse Event|1
160412|NCT00309777|514022|P3|Overall Study|Adverse Event|8
160413|NCT00309777|514023|P2|Overall Study|Adverse Event|2
160414|NCT00309777|514024|P1|Overall Study|Adverse Event|13
160415|NCT00310440|514055|P2|Overall Study|Missed 12 Month Visit|4
160416|NCT00310440|514056|P1|Overall Study|Missed 12 Month Visit|7
160417|NCT00310440|514055|P2|Overall Study|Withdrawal by Subject|1
160418|NCT00310440|514056|P1|Overall Study|Withdrawal by Subject|2
160419|NCT00310440|514055|P2|Overall Study|Lost to Follow-up|8
160420|NCT00310440|514056|P1|Overall Study|Lost to Follow-up|17
160421|NCT00310375|514114|P2|Overall Study|Request of Ethics Committee|1
160422|NCT00310375|514115|P1|Overall Study|Request of Ethics Committee|0
160423|NCT00310375|514114|P2|Overall Study|Par. switched to commercial product|1
160424|NCT00310375|514115|P1|Overall Study|Par. switched to commercial product|0
160425|NCT00310375|514114|P2|Overall Study|Missed study drug for 2 months|0
160426|NCT00310375|514115|P1|Overall Study|Missed study drug for 2 months|1
160427|NCT00310375|514114|P2|Overall Study|Site closure|0
160428|NCT00310375|514115|P1|Overall Study|Site closure|3
160429|NCT00310375|514114|P2|Overall Study|Missed study drug >5 days|0
160430|NCT00310375|514115|P1|Overall Study|Missed study drug >5 days|1
160431|NCT00310375|514114|P2|Overall Study|Going for temporal lobectomy|0
160432|NCT00310375|514115|P1|Overall Study|Going for temporal lobectomy|1
160433|NCT00310375|514114|P2|Overall Study|Participant request unrelated to study|2
160434|NCT00310375|514115|P1|Overall Study|Participant request unrelated to study|1
160435|NCT00310375|514114|P2|Overall Study|Failed to return|3
160436|NCT00310375|514115|P1|Overall Study|Failed to return|1
160437|NCT00310375|514114|P2|Overall Study|Request of the sponsor|2
160438|NCT00310375|514115|P1|Overall Study|Request of the sponsor|2
160439|NCT00310375|514114|P2|Overall Study|Physician Decision|3
160440|NCT00310375|514115|P1|Overall Study|Physician Decision|5
160441|NCT00310375|514114|P2|Overall Study|Transaminase >5 upper limit of normal|1
160442|NCT00310375|514115|P1|Overall Study|Transaminase >5 upper limit of normal|2
160443|NCT00310375|514114|P2|Overall Study|Change in Par medical condition|0
160444|NCT00310375|514115|P1|Overall Study|Change in Par medical condition|2
160445|NCT00310375|514114|P2|Overall Study|Protocol Violation|5
160446|NCT00310375|514115|P1|Overall Study|Protocol Violation|8
160447|NCT00310375|514114|P2|Overall Study|Withdrawal by Subject|7
160448|NCT00310375|514115|P1|Overall Study|Withdrawal by Subject|10
160449|NCT00310375|514114|P2|Overall Study|Pregnancy|2
160450|NCT00310375|514115|P1|Overall Study|Pregnancy|2
160451|NCT00310375|514114|P2|Overall Study|Lack of Efficacy|19
160452|NCT00310375|514115|P1|Overall Study|Lack of Efficacy|24
160453|NCT00310375|514114|P2|Overall Study|Adverse Event|22
160454|NCT00310375|514115|P1|Overall Study|Adverse Event|28
160455|NCT00309608|514197|P5|Overall Study|Other incl. Lack of efficacy|0
160456|NCT00309608|514198|P4|Overall Study|Other incl. Lack of efficacy|4
160457|NCT00309608|514199|P3|Overall Study|Other incl. Lack of efficacy|3
160458|NCT00309608|514200|P2|Overall Study|Other incl. Lack of efficacy|4
160459|NCT00309608|514201|P1|Overall Study|Other incl. Lack of efficacy|10
160460|NCT00309608|514197|P5|Overall Study|Withdrawal by Subject|0
160461|NCT00309608|514198|P4|Overall Study|Withdrawal by Subject|0
160462|NCT00309608|514199|P3|Overall Study|Withdrawal by Subject|2
160463|NCT00309608|514200|P2|Overall Study|Withdrawal by Subject|4
160464|NCT00309608|514201|P1|Overall Study|Withdrawal by Subject|1
160465|NCT00309608|514197|P5|Overall Study|Lost to Follow-up|1
160466|NCT00309608|514198|P4|Overall Study|Lost to Follow-up|0
160467|NCT00309608|514199|P3|Overall Study|Lost to Follow-up|2
160468|NCT00309608|514200|P2|Overall Study|Lost to Follow-up|0
160469|NCT00309608|514201|P1|Overall Study|Lost to Follow-up|0
160470|NCT00309608|514197|P5|Overall Study|Protocol Violation|0
160471|NCT00309608|514198|P4|Overall Study|Protocol Violation|0
160472|NCT00309608|514199|P3|Overall Study|Protocol Violation|0
160473|NCT00309608|514200|P2|Overall Study|Protocol Violation|0
160474|NCT00309608|514201|P1|Overall Study|Protocol Violation|2
160475|NCT00309608|514197|P5|Overall Study|Adverse Event|3
160476|NCT00309608|514198|P4|Overall Study|Adverse Event|2
160477|NCT00309608|514199|P3|Overall Study|Adverse Event|3
160478|NCT00309608|514200|P2|Overall Study|Adverse Event|5
160479|NCT00309608|514201|P1|Overall Study|Adverse Event|1
160480|NCT00309452|514249|P2|Overall Study|Withdrawal by Subject|0
160481|NCT00309452|514250|P1|Overall Study|Withdrawal by Subject|3
160482|NCT00309387|514278|P2|Overall Study|Lost to Follow-up|86
160483|NCT00309387|514279|P1|Overall Study|Lost to Follow-up|70
160484|NCT00309387|514278|P2|Overall Study|Death|73
160485|NCT00309387|514279|P1|Overall Study|Death|72
160486|NCT00309244|514297|P2|Overall Study|Death|1
160487|NCT00309244|514298|P1|Overall Study|Death|4
160488|NCT00309244|514297|P2|Overall Study|Randomized but not dosed|12
160489|NCT00309244|514298|P1|Overall Study|Randomized but not dosed|11
160490|NCT00309244|514297|P2|Overall Study|Various|7
160491|NCT00309244|514298|P1|Overall Study|Various|7
160492|NCT00309244|514297|P2|Overall Study|Withdrawal by Subject|32
160493|NCT00309244|514298|P1|Overall Study|Withdrawal by Subject|50
160494|NCT00309244|514297|P2|Overall Study|Protocol Violation|3
160495|NCT00309244|514298|P1|Overall Study|Protocol Violation|6
160496|NCT00309244|514297|P2|Overall Study|Physician Decision|8
160497|NCT00309244|514298|P1|Overall Study|Physician Decision|5
160498|NCT00309244|514297|P2|Overall Study|Lost to Follow-up|22
160499|NCT00309244|514298|P1|Overall Study|Lost to Follow-up|6
160500|NCT00309244|514297|P2|Overall Study|Adverse Event|12
160501|NCT00309244|514298|P1|Overall Study|Adverse Event|29
160502|NCT00308997|514320|P2|Overall Study|Unable to tolerate intervention|0
160503|NCT00308997|514321|P1|Overall Study|Unable to tolerate intervention|1
160504|NCT00308997|514320|P2|Overall Study|Subject feigned clinical data|1
160505|NCT00308997|514321|P1|Overall Study|Subject feigned clinical data|0
160506|NCT00308737|514340|P3|Overall Study|Various|8
160507|NCT00308737|514341|P2|Overall Study|Various|20
160508|NCT00308737|514342|P1|Overall Study|Various|32
160509|NCT00308737|514340|P3|Overall Study|Withdrawal by Subject|18
160510|NCT00308737|514341|P2|Overall Study|Withdrawal by Subject|166
160511|NCT00308737|514342|P1|Overall Study|Withdrawal by Subject|218
160512|NCT00308737|514340|P3|Overall Study|Protocol Violation|5
160513|NCT00308737|514341|P2|Overall Study|Protocol Violation|9
160514|NCT00308737|514342|P1|Overall Study|Protocol Violation|34
160515|NCT00308737|514340|P3|Overall Study|Physician Decision|1
160516|NCT00308737|514341|P2|Overall Study|Physician Decision|2
160517|NCT00308737|514342|P1|Overall Study|Physician Decision|15
160518|NCT00308737|514340|P3|Overall Study|Lost to Follow-up|5
160519|NCT00308737|514341|P2|Overall Study|Lost to Follow-up|80
160520|NCT00308737|514342|P1|Overall Study|Lost to Follow-up|56
160521|NCT00308737|514340|P3|Overall Study|Death|0
160522|NCT00308737|514341|P2|Overall Study|Death|3
160523|NCT00308737|514342|P1|Overall Study|Death|4
160524|NCT00308737|514340|P3|Overall Study|Adverse Event|0
160525|NCT00308737|514341|P2|Overall Study|Adverse Event|9
160526|NCT00308737|514342|P1|Overall Study|Adverse Event|104
160527|NCT00308711|514382|P3|Overall Study|Subject incarcerated, data not allowed|1
160528|NCT00308711|514383|P2|Overall Study|Subject incarcerated, data not allowed|0
160529|NCT00308711|514384|P1|Overall Study|Subject incarcerated, data not allowed|0
160530|NCT00308711|514382|P3|Overall Study|Baby not born within 7 days of treatment|2
160531|NCT00308711|514383|P2|Overall Study|Baby not born within 7 days of treatment|2
160532|NCT00308711|514384|P1|Overall Study|Baby not born within 7 days of treatment|1
160533|NCT00308711|514382|P3|Overall Study|Lost to Follow-up|0
160534|NCT00308711|514383|P2|Overall Study|Lost to Follow-up|1
160535|NCT00308711|514384|P1|Overall Study|Lost to Follow-up|0
160536|NCT00308711|514382|P3|Overall Study|Protocol Violation|1
160537|NCT00308711|514383|P2|Overall Study|Protocol Violation|1
160538|NCT00308711|514384|P1|Overall Study|Protocol Violation|0
160539|NCT00308711|514382|P3|Overall Study|Withdrawal by Subject|1
160540|NCT00308711|514383|P2|Overall Study|Withdrawal by Subject|0
160541|NCT00308711|514384|P1|Overall Study|Withdrawal by Subject|1
160542|NCT00308620|514419|P3|Overall Study|Lost to Follow-up|1
160543|NCT00308620|514420|P2|Overall Study|Lost to Follow-up|0
160544|NCT00308620|514421|P1|Overall Study|Lost to Follow-up|0
160545|NCT00308620|514419|P3|Overall Study|Death|0
160546|NCT00308620|514420|P2|Overall Study|Death|1
160547|NCT00308620|514421|P1|Overall Study|Death|1
160548|NCT00308581|514430|P3|Randomized Maintenance Phase|Unknown reason|0
160549|NCT00308581|514431|P2|Randomized Maintenance Phase|Unknown reason|0
160550|NCT00308581|514432|P1|Randomized Maintenance Phase|Unknown reason|3
160551|NCT00308581|514430|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
160552|NCT00308581|514431|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
160553|NCT00308581|514432|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
160554|NCT00308581|514430|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
160555|NCT00308581|514431|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
160556|NCT00308581|514432|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
160557|NCT00308581|514430|P3|Randomized Maintenance Phase|Lost to Follow-up|0
160558|NCT00308581|514431|P2|Randomized Maintenance Phase|Lost to Follow-up|2
160559|NCT00308581|514432|P1|Randomized Maintenance Phase|Lost to Follow-up|0
160560|NCT00308581|514430|P3|Randomized Maintenance Phase|Lack of Efficacy|0
160561|NCT00308581|514431|P2|Randomized Maintenance Phase|Lack of Efficacy|21
160562|NCT00308581|514432|P1|Randomized Maintenance Phase|Lack of Efficacy|9
160563|NCT00308581|514430|P3|Randomized Maintenance Phase|Adverse Event|0
160564|NCT00308581|514431|P2|Randomized Maintenance Phase|Adverse Event|17
160565|NCT00308581|514432|P1|Randomized Maintenance Phase|Adverse Event|10
160566|NCT00308581|514430|P3|Induction Phase|Unknown reason|3
160567|NCT00308581|514431|P2|Induction Phase|Unknown reason|0
160568|NCT00308581|514432|P1|Induction Phase|Unknown reason|0
160569|NCT00308581|514430|P3|Induction Phase|Withdrawal by Subject|5
160570|NCT00308581|514431|P2|Induction Phase|Withdrawal by Subject|0
160571|NCT00308581|514432|P1|Induction Phase|Withdrawal by Subject|0
160572|NCT00308581|514430|P3|Induction Phase|Lack of Efficacy|121
160573|NCT00308581|514431|P2|Induction Phase|Lack of Efficacy|0
160574|NCT00308581|514432|P1|Induction Phase|Lack of Efficacy|0
160575|NCT00308581|514430|P3|Induction Phase|Adverse Event|37
160576|NCT00308581|514431|P2|Induction Phase|Adverse Event|0
160577|NCT00308581|514432|P1|Induction Phase|Adverse Event|0
160578|NCT00308555|514558|P2|Overall Study|Physician Decision|0
160579|NCT00308555|514559|P1|Overall Study|Physician Decision|2
160580|NCT00308555|514558|P2|Overall Study|Withdrawal by Subject|0
160581|NCT00308555|514559|P1|Overall Study|Withdrawal by Subject|1
160582|NCT00308308|514576|P2|Overall Study|Other|0
160583|NCT00308308|514577|P1|Overall Study|Other|1
160584|NCT00308308|514576|P2|Overall Study|Randomized but not dosed|16
160585|NCT00308308|514577|P1|Overall Study|Randomized but not dosed|8
160586|NCT00308308|514576|P2|Overall Study|Various|5
160587|NCT00308308|514577|P1|Overall Study|Various|7
160588|NCT00308308|514576|P2|Overall Study|Withdrawal by Subject|19
160589|NCT00308308|514577|P1|Overall Study|Withdrawal by Subject|47
160590|NCT00308308|514576|P2|Overall Study|Protocol Violation|14
160591|NCT00308308|514577|P1|Overall Study|Protocol Violation|3
160592|NCT00308308|514576|P2|Overall Study|Physician Decision|7
160593|NCT00308308|514577|P1|Overall Study|Physician Decision|15
160594|NCT00308308|514576|P2|Overall Study|Lost to Follow-up|5
160595|NCT00308308|514577|P1|Overall Study|Lost to Follow-up|5
160596|NCT00308308|514576|P2|Overall Study|Adverse Event|2
160597|NCT00308308|514577|P1|Overall Study|Adverse Event|17
160598|NCT00308139|514612|P2|Overall Study|Other|0
160599|NCT00308139|514613|P1|Overall Study|Other|1
160600|NCT00308139|514612|P2|Overall Study|Administrative|4
160601|NCT00308139|514613|P1|Overall Study|Administrative|1
160602|NCT00308139|514612|P2|Overall Study|Loss of Glucose Control|7
160603|NCT00308139|514613|P1|Overall Study|Loss of Glucose Control|5
160604|NCT00308139|514612|P2|Overall Study|Investigator Decision|10
160605|NCT00308139|514613|P1|Overall Study|Investigator Decision|11
160606|NCT00308139|514612|P2|Overall Study|Withdrawal of Consent|42
160607|NCT00308139|514613|P1|Overall Study|Withdrawal of Consent|40
160608|NCT00308139|514612|P2|Overall Study|Protocol Violation|2
160609|NCT00308139|514613|P1|Overall Study|Protocol Violation|3
160610|NCT00308139|514612|P2|Overall Study|Lost to Follow-up|8
160611|NCT00308139|514613|P1|Overall Study|Lost to Follow-up|13
160612|NCT00308139|514612|P2|Overall Study|Adverse Event|14
160613|NCT00308139|514613|P1|Overall Study|Adverse Event|20
160614|NCT00308113|514687|P4|Overall Study|Protocol closure|1
160615|NCT00308113|514688|P3|Overall Study|Protocol closure|0
160616|NCT00308113|514689|P2|Overall Study|Protocol closure|0
160617|NCT00308113|514690|P1|Overall Study|Protocol closure|0
160618|NCT00308087|514710|P2|Overall Study|Not Specified|3
160619|NCT00308087|514711|P1|Overall Study|Not Specified|4
160620|NCT00308087|514710|P2|Overall Study|Withdrawal by Subject|1
160621|NCT00308087|514711|P1|Overall Study|Withdrawal by Subject|2
160622|NCT00308087|514710|P2|Overall Study|Study Closure|12
160623|NCT00308087|514711|P1|Overall Study|Study Closure|11
160624|NCT00308087|514710|P2|Overall Study|Progressive Disease|21
160625|NCT00308087|514711|P1|Overall Study|Progressive Disease|19
160626|NCT00308074|514727|P1|Overall Study|Withdrawal by Subject|1
160627|NCT00307931|514734|P1|Overall Study|Adverse Event|1
160628|NCT00307801|514751|P2|Overall Study|Pregnancy|1
160629|NCT00307801|514752|P1|Overall Study|Pregnancy|0
160630|NCT00307801|514751|P2|Overall Study|No reason specified|0
160631|NCT00307801|514752|P1|Overall Study|No reason specified|2
160632|NCT00307801|514751|P2|Overall Study|Protocol Violation|2
160633|NCT00307801|514752|P1|Overall Study|Protocol Violation|3
160634|NCT00307801|514751|P2|Overall Study|Frustration with e-diary|0
160635|NCT00307801|514752|P1|Overall Study|Frustration with e-diary|1
160636|NCT00307801|514751|P2|Overall Study|Lost to Follow-up, moved abroad|1
160637|NCT00307801|514752|P1|Overall Study|Lost to Follow-up, moved abroad|1
160638|NCT00307801|514751|P2|Overall Study|Lack of Efficacy|2
160639|NCT00307801|514752|P1|Overall Study|Lack of Efficacy|0
160640|NCT00307801|514751|P2|Overall Study|Wrong Randomization|0
160641|NCT00307801|514752|P1|Overall Study|Wrong Randomization|1
160642|NCT00307801|514751|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
160643|NCT00307801|514752|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
160644|NCT00307801|514751|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
160645|NCT00307801|514752|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
160646|NCT00307801|514751|P2|Overall Study|Non-compliance, not taken all tablets|2
160647|NCT00307801|514752|P1|Overall Study|Non-compliance, not taken all tablets|1
160648|NCT00307801|514751|P2|Overall Study|Withdrawal by Subject|4
160649|NCT00307801|514752|P1|Overall Study|Withdrawal by Subject|9
160650|NCT00307801|514751|P2|Overall Study|Adverse Event|4
160651|NCT00307801|514752|P1|Overall Study|Adverse Event|12
160652|NCT00307684|514864|P3|Double Blind Phase|Lack of Efficacy|0
160653|NCT00307684|514865|P2|Double Blind Phase|Lack of Efficacy|5
160654|NCT00307684|514866|P1|Double Blind Phase|Lack of Efficacy|2
160655|NCT00307684|514864|P3|Open Label Phase|other|6
160656|NCT00307684|514865|P2|Open Label Phase|other|0
160657|NCT00307684|514866|P1|Open Label Phase|other|0
160658|NCT00307684|514864|P3|Open Label Phase|non compliance|5
160659|NCT00307684|514865|P2|Open Label Phase|non compliance|0
160660|NCT00307684|514866|P1|Open Label Phase|non compliance|0
160661|NCT00307684|514864|P3|Open Label Phase|Lost to Follow-up|11
160662|NCT00307684|514865|P2|Open Label Phase|Lost to Follow-up|0
160663|NCT00307684|514866|P1|Open Label Phase|Lost to Follow-up|0
160664|NCT00307684|514864|P3|Open Label Phase|Withdrawal by Subject|15
160665|NCT00307684|514865|P2|Open Label Phase|Withdrawal by Subject|0
160666|NCT00307684|514866|P1|Open Label Phase|Withdrawal by Subject|0
160667|NCT00307684|514864|P3|Open Label Phase|Adverse Event|16
160668|NCT00307684|514865|P2|Open Label Phase|Adverse Event|0
160669|NCT00307684|514866|P1|Open Label Phase|Adverse Event|0
160670|NCT00307684|514864|P3|Open Label Phase|Lack of Efficacy|3
160671|NCT00307684|514865|P2|Open Label Phase|Lack of Efficacy|0
160672|NCT00307684|514866|P1|Open Label Phase|Lack of Efficacy|0
160673|NCT00307489|514894|P2|Week 48 Through Week 168|Seroconversion|0
160674|NCT00307489|514895|P1|Week 48 Through Week 168|Seroconversion|1
160675|NCT00307489|514894|P2|Week 48 Through Week 168|Lost to Follow-up|1
160676|NCT00307489|514895|P1|Week 48 Through Week 168|Lost to Follow-up|0
160677|NCT00307489|514894|P2|Week 48 Through Week 168|Death|1
160678|NCT00307489|514895|P1|Week 48 Through Week 168|Death|0
160679|NCT00307489|514894|P2|Week 48 Through Week 168|Lack of Efficacy|2
160680|NCT00307489|514895|P1|Week 48 Through Week 168|Lack of Efficacy|2
160681|NCT00307489|514894|P2|Week 48 Through Week 168|Withdrawal by Subject|2
160682|NCT00307489|514895|P1|Week 48 Through Week 168|Withdrawal by Subject|1
160683|NCT00307489|514894|P2|Week 48 Through Week 168|Physician Decision|0
160684|NCT00307489|514895|P1|Week 48 Through Week 168|Physician Decision|1
160685|NCT00307489|514894|P2|Week 48 Through Week 168|Adverse Event|0
160686|NCT00307489|514895|P1|Week 48 Through Week 168|Adverse Event|1
160687|NCT00307489|514894|P2|Baseline Through Week 48|Withdrawal by Subject|1
160688|NCT00307489|514895|P1|Baseline Through Week 48|Withdrawal by Subject|0
160689|NCT00307489|514894|P2|Baseline Through Week 48|Physician Decision|0
160690|NCT00307489|514895|P1|Baseline Through Week 48|Physician Decision|1
160691|NCT00307489|514894|P2|Baseline Through Week 48|Lost to Follow-up|1
160692|NCT00307489|514895|P1|Baseline Through Week 48|Lost to Follow-up|0
160693|NCT00307437|514940|P7|After Controlled Period|Unspecified|28
160694|NCT00307437|514941|P6|After Controlled Period|Unspecified|40
160695|NCT00307437|514942|P5|After Controlled Period|Unspecified|9
160696|NCT00307437|514943|P4|After Controlled Period|Unspecified|15
160697|NCT00307437|514944|P3|After Controlled Period|Unspecified|0
160698|NCT00307437|514945|P2|After Controlled Period|Unspecified|0
160699|NCT00307437|514946|P1|After Controlled Period|Unspecified|0
160700|NCT00307437|514940|P7|After Controlled Period|Lost to Follow-up|18
160701|NCT00307437|514941|P6|After Controlled Period|Lost to Follow-up|13
160702|NCT00307437|514942|P5|After Controlled Period|Lost to Follow-up|12
160703|NCT00307437|514943|P4|After Controlled Period|Lost to Follow-up|7
160704|NCT00307437|514944|P3|After Controlled Period|Lost to Follow-up|0
160705|NCT00307437|514945|P2|After Controlled Period|Lost to Follow-up|0
160706|NCT00307437|514946|P1|After Controlled Period|Lost to Follow-up|0
160707|NCT00307437|514940|P7|After Controlled Period|Lack of Efficacy|24
160708|NCT00307437|514941|P6|After Controlled Period|Lack of Efficacy|37
160709|NCT00307437|514942|P5|After Controlled Period|Lack of Efficacy|17
160710|NCT00307437|514943|P4|After Controlled Period|Lack of Efficacy|15
160711|NCT00307437|514944|P3|After Controlled Period|Lack of Efficacy|0
160712|NCT00307437|514945|P2|After Controlled Period|Lack of Efficacy|0
160713|NCT00307437|514946|P1|After Controlled Period|Lack of Efficacy|0
160714|NCT00307437|514940|P7|After Controlled Period|Death|3
160715|NCT00307437|514941|P6|After Controlled Period|Death|1
160716|NCT00307437|514942|P5|After Controlled Period|Death|1
160717|NCT00307437|514943|P4|After Controlled Period|Death|3
160718|NCT00307437|514944|P3|After Controlled Period|Death|0
160719|NCT00307437|514945|P2|After Controlled Period|Death|0
160720|NCT00307437|514946|P1|After Controlled Period|Death|0
160721|NCT00307437|514940|P7|After Controlled Period|Adverse Event|40
160722|NCT00307437|514941|P6|After Controlled Period|Adverse Event|31
160723|NCT00307437|514942|P5|After Controlled Period|Adverse Event|16
160724|NCT00307437|514943|P4|After Controlled Period|Adverse Event|18
160725|NCT00307437|514944|P3|After Controlled Period|Adverse Event|0
160726|NCT00307437|514945|P2|After Controlled Period|Adverse Event|0
160727|NCT00307437|514946|P1|After Controlled Period|Adverse Event|0
160728|NCT00307437|514940|P7|Controlled Period|Unspecified|0
160729|NCT00307437|514941|P6|Controlled Period|Unspecified|0
160730|NCT00307437|514942|P5|Controlled Period|Unspecified|0
160731|NCT00307437|514943|P4|Controlled Period|Unspecified|0
160732|NCT00307437|514944|P3|Controlled Period|Unspecified|3
160733|NCT00307437|514945|P2|Controlled Period|Unspecified|1
160734|NCT00307437|514946|P1|Controlled Period|Unspecified|5
160735|NCT00307437|514940|P7|Controlled Period|Lost to Follow-up|0
160736|NCT00307437|514941|P6|Controlled Period|Lost to Follow-up|0
160737|NCT00307437|514942|P5|Controlled Period|Lost to Follow-up|0
160738|NCT00307437|514943|P4|Controlled Period|Lost to Follow-up|0
160739|NCT00307437|514944|P3|Controlled Period|Lost to Follow-up|0
160740|NCT00307437|514945|P2|Controlled Period|Lost to Follow-up|3
160741|NCT00307437|514946|P1|Controlled Period|Lost to Follow-up|2
160742|NCT00307437|514940|P7|Controlled Period|Lack of Efficacy|0
160743|NCT00307437|514941|P6|Controlled Period|Lack of Efficacy|0
160744|NCT00307437|514942|P5|Controlled Period|Lack of Efficacy|0
160745|NCT00307437|514943|P4|Controlled Period|Lack of Efficacy|0
160746|NCT00307437|514944|P3|Controlled Period|Lack of Efficacy|0
160747|NCT00307437|514945|P2|Controlled Period|Lack of Efficacy|0
160748|NCT00307437|514946|P1|Controlled Period|Lack of Efficacy|2
160749|NCT00307437|514940|P7|Controlled Period|Death|0
160750|NCT00307437|514941|P6|Controlled Period|Death|0
160751|NCT00307437|514942|P5|Controlled Period|Death|0
160752|NCT00307437|514943|P4|Controlled Period|Death|0
160753|NCT00307437|514944|P3|Controlled Period|Death|1
160754|NCT00307437|514945|P2|Controlled Period|Death|0
160755|NCT00307437|514946|P1|Controlled Period|Death|0
160756|NCT00307437|514940|P7|Controlled Period|Adverse Event|0
160757|NCT00307437|514941|P6|Controlled Period|Adverse Event|0
160758|NCT00307437|514942|P5|Controlled Period|Adverse Event|0
160759|NCT00307437|514943|P4|Controlled Period|Adverse Event|0
160760|NCT00307437|514944|P3|Controlled Period|Adverse Event|5
160761|NCT00307437|514945|P2|Controlled Period|Adverse Event|2
160762|NCT00307437|514946|P1|Controlled Period|Adverse Event|7
160763|NCT00307333|514972|P2|Overall Study|Lost to Follow-up|3
160764|NCT00307333|514973|P1|Overall Study|Lost to Follow-up|11
160765|NCT00307164|514991|P2|Overall Study|Lost to Follow-up|1
160766|NCT00307164|514992|P1|Overall Study|Lost to Follow-up|6
160767|NCT00307164|514991|P2|Overall Study|Not compliant with requirements|4
160768|NCT00307164|514992|P1|Overall Study|Not compliant with requirements|4
160769|NCT00307164|514991|P2|Overall Study|Withdrawal by Subject|8
160770|NCT00307164|514992|P1|Overall Study|Withdrawal by Subject|1
160771|NCT00307164|514991|P2|Overall Study|Subject/parent not able to get to clinic|1
160772|NCT00307164|514992|P1|Overall Study|Subject/parent not able to get to clinic|2
160773|NCT00307164|514991|P2|Overall Study|Severe debilitation, unable to continue|0
160774|NCT00307164|514992|P1|Overall Study|Severe debilitation, unable to continue|1
160775|NCT00307164|514991|P2|Overall Study|Death|0
160776|NCT00307164|514992|P1|Overall Study|Death|1
160777|NCT00307151|515032|P4|Overall Study|Clinic unable to contact subject|1
160778|NCT00307151|515033|P3|Overall Study|Clinic unable to contact subject|1
160779|NCT00307151|515034|P2|Overall Study|Clinic unable to contact subject|3
160780|NCT00307151|515035|P1|Overall Study|Clinic unable to contact subject|3
160781|NCT00307151|515032|P4|Overall Study|Not willing to adhere to study reqs|2
160782|NCT00307151|515033|P3|Overall Study|Not willing to adhere to study reqs|2
160783|NCT00307151|515034|P2|Overall Study|Not willing to adhere to study reqs|0
160784|NCT00307151|515035|P1|Overall Study|Not willing to adhere to study reqs|2
160785|NCT00307151|515032|P4|Overall Study|Withdrew consent|3
160786|NCT00307151|515033|P3|Overall Study|Withdrew consent|1
160787|NCT00307151|515034|P2|Overall Study|Withdrew consent|1
160788|NCT00307151|515035|P1|Overall Study|Withdrew consent|0
160789|NCT00307151|515032|P4|Overall Study|Subject unable to get to clinic|2
160790|NCT00307151|515033|P3|Overall Study|Subject unable to get to clinic|6
160791|NCT00307151|515034|P2|Overall Study|Subject unable to get to clinic|0
160792|NCT00307151|515035|P1|Overall Study|Subject unable to get to clinic|1
160878|NCT00307125|515081|P1|Screening Phase|Protocol Violation|27
160793|NCT00307151|515032|P4|Overall Study|Severe debilitation, unable to continue|0
160794|NCT00307151|515033|P3|Overall Study|Severe debilitation, unable to continue|0
160795|NCT00307151|515034|P2|Overall Study|Severe debilitation, unable to continue|0
160796|NCT00307151|515035|P1|Overall Study|Severe debilitation, unable to continue|1
160797|NCT00307151|515032|P4|Overall Study|Death|3
160798|NCT00307151|515033|P3|Overall Study|Death|10
160799|NCT00307151|515034|P2|Overall Study|Death|3
160800|NCT00307151|515035|P1|Overall Study|Death|4
160801|NCT00307125|515079|P3|Pilot Phase|Withdrawal by Subject|1
160802|NCT00307125|515080|P2|Pilot Phase|Withdrawal by Subject|1
160803|NCT00307125|515081|P1|Pilot Phase|Withdrawal by Subject|0
160804|NCT00307125|515079|P3|Pilot Phase|Lost to Follow-up|0
160805|NCT00307125|515080|P2|Pilot Phase|Lost to Follow-up|1
160806|NCT00307125|515081|P1|Pilot Phase|Lost to Follow-up|0
160807|NCT00307125|515079|P3|Screening Phase|Coronary artery bypass|0
160808|NCT00307125|515080|P2|Screening Phase|Coronary artery bypass|0
160809|NCT00307125|515081|P1|Screening Phase|Coronary artery bypass|1
160810|NCT00307125|515079|P3|Screening Phase|AMR and treated with rituximab|0
160811|NCT00307125|515080|P2|Screening Phase|AMR and treated with rituximab|0
160812|NCT00307125|515081|P1|Screening Phase|AMR and treated with rituximab|1
160813|NCT00307125|515079|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
160814|NCT00307125|515080|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
160815|NCT00307125|515081|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
160816|NCT00307125|515079|P3|Screening Phase|Screen Error|0
160817|NCT00307125|515080|P2|Screening Phase|Screen Error|0
160818|NCT00307125|515081|P1|Screening Phase|Screen Error|1
160819|NCT00307125|515079|P3|Screening Phase|Ineligible|0
160820|NCT00307125|515080|P2|Screening Phase|Ineligible|0
160821|NCT00307125|515081|P1|Screening Phase|Ineligible|1
160822|NCT00307125|515079|P3|Screening Phase|PAK|0
160823|NCT00307125|515080|P2|Screening Phase|PAK|0
160824|NCT00307125|515081|P1|Screening Phase|PAK|1
160825|NCT00307125|515079|P3|Screening Phase|Malignancy|0
160826|NCT00307125|515080|P2|Screening Phase|Malignancy|0
160827|NCT00307125|515081|P1|Screening Phase|Malignancy|1
160828|NCT00307125|515079|P3|Screening Phase|Metastatic colon cancer|0
160829|NCT00307125|515080|P2|Screening Phase|Metastatic colon cancer|0
160830|NCT00307125|515081|P1|Screening Phase|Metastatic colon cancer|1
160831|NCT00307125|515079|P3|Screening Phase|Developed acute leukemia|0
160832|NCT00307125|515080|P2|Screening Phase|Developed acute leukemia|0
160833|NCT00307125|515081|P1|Screening Phase|Developed acute leukemia|1
160834|NCT00307125|515079|P3|Screening Phase|Try to get pregnant|0
160835|NCT00307125|515080|P2|Screening Phase|Try to get pregnant|0
160836|NCT00307125|515081|P1|Screening Phase|Try to get pregnant|1
160837|NCT00307125|515079|P3|Screening Phase|Ineligible for pilot|0
160838|NCT00307125|515080|P2|Screening Phase|Ineligible for pilot|0
160839|NCT00307125|515081|P1|Screening Phase|Ineligible for pilot|4
160840|NCT00307125|515079|P3|Screening Phase|Received Pancreas Transplant|0
160841|NCT00307125|515080|P2|Screening Phase|Received Pancreas Transplant|0
160842|NCT00307125|515081|P1|Screening Phase|Received Pancreas Transplant|8
160843|NCT00307125|515079|P3|Screening Phase|Moved or transferred facilities|0
160844|NCT00307125|515080|P2|Screening Phase|Moved or transferred facilities|0
160845|NCT00307125|515081|P1|Screening Phase|Moved or transferred facilities|34
160846|NCT00307125|515079|P3|Screening Phase|Scheduling issues/Non-compliance|0
160847|NCT00307125|515080|P2|Screening Phase|Scheduling issues/Non-compliance|0
160848|NCT00307125|515081|P1|Screening Phase|Scheduling issues/Non-compliance|55
160849|NCT00307125|515079|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
160850|NCT00307125|515080|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
160851|NCT00307125|515081|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
160852|NCT00307125|515079|P3|Screening Phase|Graft Failure|0
160853|NCT00307125|515080|P2|Screening Phase|Graft Failure|0
160854|NCT00307125|515081|P1|Screening Phase|Graft Failure|8
160855|NCT00307125|515079|P3|Screening Phase|Graft Loss|0
160856|NCT00307125|515080|P2|Screening Phase|Graft Loss|0
160857|NCT00307125|515081|P1|Screening Phase|Graft Loss|3
160858|NCT00307125|515079|P3|Screening Phase|Study Terminated|0
160859|NCT00307125|515080|P2|Screening Phase|Study Terminated|0
160860|NCT00307125|515081|P1|Screening Phase|Study Terminated|17
160861|NCT00307125|515079|P3|Screening Phase|Sponsor Decision|0
160862|NCT00307125|515080|P2|Screening Phase|Sponsor Decision|0
160863|NCT00307125|515081|P1|Screening Phase|Sponsor Decision|4
160864|NCT00307125|515079|P3|Screening Phase|Physician Decision|0
160865|NCT00307125|515080|P2|Screening Phase|Physician Decision|0
160866|NCT00307125|515081|P1|Screening Phase|Physician Decision|26
160867|NCT00307125|515079|P3|Screening Phase|Withdrawal by Subject|0
160868|NCT00307125|515080|P2|Screening Phase|Withdrawal by Subject|0
160869|NCT00307125|515081|P1|Screening Phase|Withdrawal by Subject|77
160870|NCT00307125|515079|P3|Screening Phase|Death|0
160871|NCT00307125|515080|P2|Screening Phase|Death|0
160872|NCT00307125|515081|P1|Screening Phase|Death|10
160873|NCT00307125|515079|P3|Screening Phase|Lost to Follow-up|0
160874|NCT00307125|515080|P2|Screening Phase|Lost to Follow-up|0
160875|NCT00307125|515081|P1|Screening Phase|Lost to Follow-up|87
160876|NCT00307125|515079|P3|Screening Phase|Protocol Violation|0
160877|NCT00307125|515080|P2|Screening Phase|Protocol Violation|0
160879|NCT00307125|515079|P3|Screening Phase|Adverse Event|0
160880|NCT00307125|515080|P2|Screening Phase|Adverse Event|0
160881|NCT00307125|515081|P1|Screening Phase|Adverse Event|1
160882|NCT00307086|515103|P1|Overall Study|ineligible|5
160883|NCT00307047|515109|P2|Overall Study|All death, all MI, all Revascularization|16
160884|NCT00307047|515110|P1|Overall Study|All death, all MI, all Revascularization|27
160885|NCT00307047|515109|P2|Overall Study|Lost to follow-up for other reasons|1
160886|NCT00307047|515110|P1|Overall Study|Lost to follow-up for other reasons|0
160887|NCT00307047|515109|P2|Overall Study|Physician Decision|2
160888|NCT00307047|515110|P1|Overall Study|Physician Decision|1
160889|NCT00307047|515109|P2|Overall Study|Withdrawal by Subject|6
160890|NCT00307047|515110|P1|Overall Study|Withdrawal by Subject|6
160891|NCT00307047|515109|P2|Overall Study|Lost to Follow-up|24
160892|NCT00307047|515110|P1|Overall Study|Lost to Follow-up|35
160893|NCT00306891|515259|P4|Part B|Development of study specific disc crit.|1
160894|NCT00306891|515260|P3|Part B|Development of study specific disc crit.|0
160895|NCT00306891|515261|P2|Part B|Development of study specific disc crit.|0
160896|NCT00306891|515262|P1|Part B|Development of study specific disc crit.|0
160897|NCT00306891|515259|P4|Part B|Condition under investigation worsened|8
160898|NCT00306891|515260|P3|Part B|Condition under investigation worsened|2
160899|NCT00306891|515261|P2|Part B|Condition under investigation worsened|0
160900|NCT00306891|515262|P1|Part B|Condition under investigation worsened|0
160901|NCT00306891|515259|P4|Part B|Withdrawal by Subject|1
160902|NCT00306891|515260|P3|Part B|Withdrawal by Subject|3
160903|NCT00306891|515261|P2|Part B|Withdrawal by Subject|0
160904|NCT00306891|515262|P1|Part B|Withdrawal by Subject|0
160905|NCT00306891|515259|P4|Part B|Adverse Event|5
160906|NCT00306891|515260|P3|Part B|Adverse Event|5
160907|NCT00306891|515261|P2|Part B|Adverse Event|0
160908|NCT00306891|515262|P1|Part B|Adverse Event|0
160909|NCT00306891|515259|P4|Part B|Death|2
160910|NCT00306891|515260|P3|Part B|Death|1
160911|NCT00306891|515261|P2|Part B|Death|0
160912|NCT00306891|515262|P1|Part B|Death|0
160913|NCT00306891|515259|P4|Part A|QTC interval outwith elig. criteria|0
160914|NCT00306891|515260|P3|Part A|QTC interval outwith elig. criteria|0
160915|NCT00306891|515261|P2|Part A|QTC interval outwith elig. criteria|0
160916|NCT00306891|515262|P1|Part A|QTC interval outwith elig. criteria|1
160917|NCT00306891|515259|P4|Part A|Suspicion of second malignancy|0
160918|NCT00306891|515260|P3|Part A|Suspicion of second malignancy|0
160919|NCT00306891|515261|P2|Part A|Suspicion of second malignancy|1
160920|NCT00306891|515262|P1|Part A|Suspicion of second malignancy|0
160921|NCT00306891|515259|P4|Part A|Reaccumul. of ascites following drainage|0
160922|NCT00306891|515260|P3|Part A|Reaccumul. of ascites following drainage|0
160923|NCT00306891|515261|P2|Part A|Reaccumul. of ascites following drainage|1
160924|NCT00306891|515262|P1|Part A|Reaccumul. of ascites following drainage|0
160925|NCT00306891|515259|P4|Part A|Partial bowel obstruction|0
160926|NCT00306891|515260|P3|Part A|Partial bowel obstruction|0
160927|NCT00306891|515261|P2|Part A|Partial bowel obstruction|0
160928|NCT00306891|515262|P1|Part A|Partial bowel obstruction|1
160929|NCT00306891|515259|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
160930|NCT00306891|515260|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
160931|NCT00306891|515261|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
160932|NCT00306891|515262|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
160933|NCT00306891|515259|P4|Part A|Condition under investigation worsened|0
160934|NCT00306891|515260|P3|Part A|Condition under investigation worsened|0
160935|NCT00306891|515261|P2|Part A|Condition under investigation worsened|2
160936|NCT00306891|515262|P1|Part A|Condition under investigation worsened|2
160937|NCT00306891|515259|P4|Part A|Withdrawal by Subject|0
160938|NCT00306891|515260|P3|Part A|Withdrawal by Subject|0
160939|NCT00306891|515261|P2|Part A|Withdrawal by Subject|1
160940|NCT00306891|515262|P1|Part A|Withdrawal by Subject|1
160941|NCT00306852|515285|P2|Overall Study|Lost to Follow-up|24
160942|NCT00306852|515286|P1|Overall Study|Lost to Follow-up|15
160943|NCT00306852|515285|P2|Overall Study|Death|14
160944|NCT00306852|515286|P1|Overall Study|Death|14
160945|NCT00306787|515304|P2|Overall Study|Abnormal laboratory value(s)|0
160946|NCT00306787|515305|P1|Overall Study|Abnormal laboratory value(s)|1
160947|NCT00306787|515304|P2|Overall Study|Administrative problems|0
160948|NCT00306787|515305|P1|Overall Study|Administrative problems|4
160949|NCT00306787|515304|P2|Overall Study|Lost to Follow-up|6
160950|NCT00306787|515305|P1|Overall Study|Lost to Follow-up|9
160951|NCT00306787|515304|P2|Overall Study|Withdrawal by Subject|9
160952|NCT00306787|515305|P1|Overall Study|Withdrawal by Subject|2
160953|NCT00306787|515304|P2|Overall Study|Protocol Violation|10
160954|NCT00306787|515305|P1|Overall Study|Protocol Violation|8
160955|NCT00306787|515304|P2|Overall Study|Lack of Efficacy|0
160956|NCT00306787|515305|P1|Overall Study|Lack of Efficacy|1
160957|NCT00306787|515304|P2|Overall Study|Adverse Event|1
160958|NCT00306787|515305|P1|Overall Study|Adverse Event|1
160959|NCT00306787|515304|P2|Overall Study|Discontinued without taking study drug|215
160960|NCT00306787|515305|P1|Overall Study|Discontinued without taking study drug|208
160961|NCT00306670|515323|P2|Overall Study|patients recruited; Genentech, the st|2
160962|NCT00306670|515324|P1|Overall Study|patients recruited; Genentech, the st|0
160963|NCT00306592|515330|P2|Overall Study|48-week Treatment Period Ongoing|20
160964|NCT00306592|515331|P1|Overall Study|48-week Treatment Period Ongoing|0
160965|NCT00306592|515330|P2|Overall Study|Other|2
160966|NCT00306592|515331|P1|Overall Study|Other|1
160967|NCT00306592|515330|P2|Overall Study|Not Specified|10
160968|NCT00306592|515331|P1|Overall Study|Not Specified|5
160969|NCT00306592|515330|P2|Overall Study|Voluntary|6
160970|NCT00306592|515331|P1|Overall Study|Voluntary|10
160971|NCT00306592|515330|P2|Overall Study|Persistent Antibodies|3
160972|NCT00306592|515331|P1|Overall Study|Persistent Antibodies|6
160973|NCT00306592|515330|P2|Overall Study|Noncompliance|2
160974|NCT00306592|515331|P1|Overall Study|Noncompliance|0
160975|NCT00306592|515330|P2|Overall Study|Lost to Follow-up|0
160976|NCT00306592|515331|P1|Overall Study|Lost to Follow-up|1
160977|NCT00306592|515330|P2|Overall Study|Adverse Event|15
160978|NCT00306592|515331|P1|Overall Study|Adverse Event|8
160979|NCT00306527|515341|P4|Overall Study|Death|2
160980|NCT00306527|515342|P3|Overall Study|Death|1
160981|NCT00306527|515343|P2|Overall Study|Death|0
160982|NCT00306527|515344|P1|Overall Study|Death|1
160983|NCT00306527|515341|P4|Overall Study|Adverse Event|1
160984|NCT00306527|515342|P3|Overall Study|Adverse Event|1
160985|NCT00306527|515343|P2|Overall Study|Adverse Event|0
160986|NCT00306527|515344|P1|Overall Study|Adverse Event|0
160987|NCT00306527|515341|P4|Overall Study|Withdrawal by Subject|3
160988|NCT00306527|515342|P3|Overall Study|Withdrawal by Subject|0
160989|NCT00306527|515343|P2|Overall Study|Withdrawal by Subject|3
160990|NCT00306527|515344|P1|Overall Study|Withdrawal by Subject|2
160991|NCT00306527|515341|P4|Overall Study|Lost to Follow-up|0
160992|NCT00306527|515342|P3|Overall Study|Lost to Follow-up|3
160993|NCT00306527|515343|P2|Overall Study|Lost to Follow-up|4
160994|NCT00306527|515344|P1|Overall Study|Lost to Follow-up|3
160995|NCT00306384|515413|P3|Overall Study|Site closure|0
160996|NCT00306384|515414|P2|Overall Study|Site closure|0
160997|NCT00306384|515415|P1|Overall Study|Site closure|2
160998|NCT00306384|515413|P3|Overall Study|Other|32
160999|NCT00306384|515414|P2|Overall Study|Other|70
161000|NCT00306384|515415|P1|Overall Study|Other|80
161001|NCT00306384|515413|P3|Overall Study|Investigator discretion|21
161002|NCT00306384|515414|P2|Overall Study|Investigator discretion|31
161003|NCT00306384|515415|P1|Overall Study|Investigator discretion|28
161004|NCT00306384|515413|P3|Overall Study|Lack of Efficacy|38
161005|NCT00306384|515414|P2|Overall Study|Lack of Efficacy|40
161006|NCT00306384|515415|P1|Overall Study|Lack of Efficacy|26
161007|NCT00306384|515413|P3|Overall Study|Pregnancy|1
161008|NCT00306384|515414|P2|Overall Study|Pregnancy|1
161009|NCT00306384|515415|P1|Overall Study|Pregnancy|3
161010|NCT00306384|515413|P3|Overall Study|Study termination|1
161011|NCT00306384|515414|P2|Overall Study|Study termination|0
161012|NCT00306384|515415|P1|Overall Study|Study termination|1
161013|NCT00306384|515413|P3|Overall Study|Voluntary withdrawal|91
161014|NCT00306384|515414|P2|Overall Study|Voluntary withdrawal|187
161015|NCT00306384|515415|P1|Overall Study|Voluntary withdrawal|199
161016|NCT00306384|515413|P3|Overall Study|Lost to Follow-up|35
161017|NCT00306384|515414|P2|Overall Study|Lost to Follow-up|41
161018|NCT00306384|515415|P1|Overall Study|Lost to Follow-up|57
161019|NCT00306384|515413|P3|Overall Study|Major protocol deviation|18
161020|NCT00306384|515414|P2|Overall Study|Major protocol deviation|51
161021|NCT00306384|515415|P1|Overall Study|Major protocol deviation|43
161022|NCT00306384|515413|P3|Overall Study|Adverse Event|40
161023|NCT00306384|515414|P2|Overall Study|Adverse Event|87
161024|NCT00306384|515415|P1|Overall Study|Adverse Event|103
161025|NCT00306202|515450|P3|Overall Study|Still on treatment|0
161026|NCT00306202|515451|P2|Overall Study|Still on treatment|1
161027|NCT00306202|515452|P1|Overall Study|Still on treatment|6
161028|NCT00306189|515612|P4|Overall Study|Other|0
161029|NCT00306189|515613|P3|Overall Study|Other|0
161030|NCT00306189|515614|P2|Overall Study|Other|0
161031|NCT00306189|515615|P1|Overall Study|Other|1
161032|NCT00306189|515612|P4|Overall Study|Ineligibility determined|1
161033|NCT00306189|515613|P3|Overall Study|Ineligibility determined|1
161034|NCT00306189|515614|P2|Overall Study|Ineligibility determined|1
161035|NCT00306189|515615|P1|Overall Study|Ineligibility determined|1
161036|NCT00306189|515612|P4|Overall Study|Withdrawal by Subject|1
161037|NCT00306189|515613|P3|Overall Study|Withdrawal by Subject|8
161038|NCT00306189|515614|P2|Overall Study|Withdrawal by Subject|2
161039|NCT00306189|515615|P1|Overall Study|Withdrawal by Subject|4
161040|NCT00306189|515612|P4|Overall Study|Adverse Event|2
161041|NCT00306189|515613|P3|Overall Study|Adverse Event|2
161042|NCT00306189|515614|P2|Overall Study|Adverse Event|3
161043|NCT00306189|515615|P1|Overall Study|Adverse Event|3
161044|NCT00306189|515612|P4|Overall Study|Physician Decision|1
161045|NCT00306189|515613|P3|Overall Study|Physician Decision|0
161046|NCT00306189|515614|P2|Overall Study|Physician Decision|0
161047|NCT00306189|515615|P1|Overall Study|Physician Decision|0
161048|NCT00305877|515642|P2|Overall Study|Transportation issue with daily RT|1
161049|NCT00305877|515643|P1|Overall Study|Transportation issue with daily RT|0
161050|NCT00305877|515642|P2|Overall Study|Ineligible|1
161051|NCT00305877|515643|P1|Overall Study|Ineligible|2
161052|NCT00305877|515642|P2|Overall Study|Never start treatment|5
161053|NCT00305877|515643|P1|Overall Study|Never start treatment|2
161054|NCT00305877|515642|P2|Overall Study|Physician Decision|1
161055|NCT00305877|515643|P1|Overall Study|Physician Decision|1
161056|NCT00305877|515642|P2|Overall Study|Withdrawal by Subject|2
161057|NCT00305877|515643|P1|Overall Study|Withdrawal by Subject|4
161058|NCT00305877|515642|P2|Overall Study|Death|1
161059|NCT00305877|515643|P1|Overall Study|Death|0
161060|NCT00305877|515642|P2|Overall Study|Adverse Event|14
161061|NCT00305877|515643|P1|Overall Study|Adverse Event|9
161062|NCT00305877|515642|P2|Overall Study|Lack of Efficacy|9
161063|NCT00305877|515643|P1|Overall Study|Lack of Efficacy|6
161064|NCT00305864|515657|P4|Overall Study|Ineligible / No protocol treatment|13
161065|NCT00305864|515658|P3|Overall Study|Ineligible / No protocol treatment|1
161066|NCT00305864|515659|P2|Overall Study|Ineligible / No protocol treatment|1
161067|NCT00305864|515660|P1|Overall Study|Ineligible / No protocol treatment|0
161068|NCT00305773|515672|P2|Overall Study|All other reasons|2
161069|NCT00305773|515673|P1|Overall Study|All other reasons|3
161070|NCT00305773|515672|P2|Overall Study|Disease Progression|3
161071|NCT00305773|515673|P1|Overall Study|Disease Progression|1
161072|NCT00305773|515672|P2|Overall Study|Withdrawal by Subject|4
161073|NCT00305773|515673|P1|Overall Study|Withdrawal by Subject|1
161074|NCT00305773|515672|P2|Overall Study|Physician Decision|1
161075|NCT00305773|515673|P1|Overall Study|Physician Decision|1
161076|NCT00305773|515672|P2|Overall Study|Alternative Treatment|4
161077|NCT00305773|515673|P1|Overall Study|Alternative Treatment|4
161078|NCT00305773|515672|P2|Overall Study|Adverse Event|2
161079|NCT00305773|515673|P1|Overall Study|Adverse Event|1
161080|NCT00305773|515672|P2|Overall Study|Death|2
161081|NCT00305773|515673|P1|Overall Study|Death|3
161082|NCT00305604|515704|P2|Overall Study|Patient moved|0
161083|NCT00305604|515705|P1|Overall Study|Patient moved|1
161084|NCT00305604|515704|P2|Overall Study|Withdrawal by Subject|21
161085|NCT00305604|515705|P1|Overall Study|Withdrawal by Subject|12
161086|NCT00305604|515704|P2|Overall Study|Protocol Violation|1
161087|NCT00305604|515705|P1|Overall Study|Protocol Violation|2
161088|NCT00305604|515704|P2|Overall Study|Lost to Follow-up|4
161089|NCT00305604|515705|P1|Overall Study|Lost to Follow-up|0
161090|NCT00305604|515704|P2|Overall Study|Lack of Efficacy|18
161091|NCT00305604|515705|P1|Overall Study|Lack of Efficacy|11
161092|NCT00305604|515704|P2|Overall Study|Adverse Event|3
161093|NCT00305604|515705|P1|Overall Study|Adverse Event|6
161094|NCT00305448|515849|P3|Overall Study|Tumor Marker Elevation|1
161095|NCT00305448|515850|P2|Overall Study|Tumor Marker Elevation|0
161096|NCT00305448|515851|P1|Overall Study|Tumor Marker Elevation|0
161097|NCT00305448|515849|P3|Overall Study|Subjective Disease Progression|2
161098|NCT00305448|515850|P2|Overall Study|Subjective Disease Progression|2
161099|NCT00305448|515851|P1|Overall Study|Subjective Disease Progression|1
161100|NCT00305448|515849|P3|Overall Study|Disease Progression|28
161101|NCT00305448|515850|P2|Overall Study|Disease Progression|31
161102|NCT00305448|515851|P1|Overall Study|Disease Progression|27
161103|NCT00305448|515849|P3|Overall Study|Adverse Event|1
161104|NCT00305448|515850|P2|Overall Study|Adverse Event|0
161105|NCT00305448|515851|P1|Overall Study|Adverse Event|1
161106|NCT00305448|515849|P3|Overall Study|Withdrawal by Subject|1
161107|NCT00305448|515850|P2|Overall Study|Withdrawal by Subject|0
161108|NCT00305448|515851|P1|Overall Study|Withdrawal by Subject|2
161109|NCT00305448|515849|P3|Overall Study|Protocol Violation|0
161110|NCT00305448|515850|P2|Overall Study|Protocol Violation|1
161111|NCT00305448|515851|P1|Overall Study|Protocol Violation|0
161112|NCT00305253|515873|P2|Overall Study|Withdrawal by Subject|1
161113|NCT00305253|515874|P1|Overall Study|Withdrawal by Subject|0
161114|NCT00305227|515886|P2|Overall Study|Lost to Follow-up|6
161115|NCT00305227|515887|P1|Overall Study|Lost to Follow-up|7
161116|NCT00304954|515938|P4|Overall Study|Adverse Event|0
161117|NCT00304954|515939|P3|Overall Study|Adverse Event|0
161118|NCT00304954|515940|P2|Overall Study|Adverse Event|0
161119|NCT00304954|515941|P1|Overall Study|Adverse Event|1
161120|NCT00304954|515938|P4|Overall Study|Withdrawal by Subject|0
161121|NCT00304954|515939|P3|Overall Study|Withdrawal by Subject|1
161122|NCT00304954|515940|P2|Overall Study|Withdrawal by Subject|0
161123|NCT00304954|515941|P1|Overall Study|Withdrawal by Subject|0
161124|NCT00304915|515961|P2|Overall Study|Withdrawal by Subject|0
161125|NCT00304915|515962|P1|Overall Study|Withdrawal by Subject|3
161126|NCT00304915|515961|P2|Overall Study|Death|5
161127|NCT00304915|515962|P1|Overall Study|Death|4
161128|NCT00304915|515961|P2|Overall Study|Lost to Follow-up|11
161129|NCT00304915|515962|P1|Overall Study|Lost to Follow-up|11
161130|NCT00304031|516022|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
161131|NCT00304031|516023|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
161132|NCT00304031|516024|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
161133|NCT00304031|516022|P3|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
161134|NCT00304031|516023|P2|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
161135|NCT00304031|516024|P1|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|37
161136|NCT00304031|516022|P3|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
161137|NCT00304031|516023|P2|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
161138|NCT00304031|516024|P1|Concomitant Radiation Therapy and TMZ|Other complicating disease|1
161139|NCT00304031|516022|P3|Concomitant Radiation Therapy and TMZ|Toxicity|0
161140|NCT00304031|516023|P2|Concomitant Radiation Therapy and TMZ|Toxicity|0
161141|NCT00304031|516024|P1|Concomitant Radiation Therapy and TMZ|Toxicity|10
161142|NCT00304031|516022|P3|Concomitant Radiation Therapy and TMZ|Physician preference|0
161143|NCT00304031|516023|P2|Concomitant Radiation Therapy and TMZ|Physician preference|0
161144|NCT00304031|516024|P1|Concomitant Radiation Therapy and TMZ|Physician preference|15
161145|NCT00304031|516022|P3|Concomitant Radiation Therapy and TMZ|Death|0
161146|NCT00304031|516023|P2|Concomitant Radiation Therapy and TMZ|Death|0
161147|NCT00304031|516024|P1|Concomitant Radiation Therapy and TMZ|Death|18
161148|NCT00304031|516022|P3|Concomitant Radiation Therapy and TMZ|Patient refusal|0
161149|NCT00304031|516023|P2|Concomitant Radiation Therapy and TMZ|Patient refusal|0
161150|NCT00304031|516024|P1|Concomitant Radiation Therapy and TMZ|Patient refusal|19
161151|NCT00304031|516022|P3|Concomitant Radiation Therapy and TMZ|Disease progression|0
161152|NCT00304031|516023|P2|Concomitant Radiation Therapy and TMZ|Disease progression|0
161153|NCT00304031|516024|P1|Concomitant Radiation Therapy and TMZ|Disease progression|48
161154|NCT00304031|516022|P3|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
161155|NCT00304031|516023|P2|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
161156|NCT00304031|516024|P1|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|144
161157|NCT00304031|516022|P3|Registration|Ineligible|0
161158|NCT00304031|516023|P2|Registration|Ineligible|0
161159|NCT00304031|516024|P1|Registration|Ineligible|48
161160|NCT00303953|516055|P1|Overall Study|Physician Decision|1
161161|NCT00303953|516055|P1|Overall Study|Lack of Efficacy|12
161162|NCT00303953|516055|P1|Overall Study|Adverse Event|4
161163|NCT00303953|516055|P1|Overall Study|Death|1
161164|NCT00303953|516055|P1|Overall Study|Ineligible|1
161165|NCT00303667|516090|P2|Overall Study|Death|4
161166|NCT00303667|516091|P1|Overall Study|Death|0
161167|NCT00303628|516115|P2|Overall Study|Other|9
161168|NCT00303628|516116|P1|Overall Study|Other|8
161169|NCT00303628|516115|P2|Overall Study|Not start protocol therapy|5
161170|NCT00303628|516116|P1|Overall Study|Not start protocol therapy|3
161171|NCT00303628|516115|P2|Overall Study|Other complicating disease|1
161172|NCT00303628|516116|P1|Overall Study|Other complicating disease|0
161173|NCT00303628|516115|P2|Overall Study|Alternative therapy|0
161174|NCT00303628|516116|P1|Overall Study|Alternative therapy|2
161175|NCT00303628|516115|P2|Overall Study|Withdrawal by Subject|20
161176|NCT00303628|516116|P1|Overall Study|Withdrawal by Subject|11
161177|NCT00303628|516115|P2|Overall Study|Death|1
161178|NCT00303628|516116|P1|Overall Study|Death|0
161179|NCT00303628|516115|P2|Overall Study|Adverse Event|36
161180|NCT00303628|516116|P1|Overall Study|Adverse Event|26
161181|NCT00303628|516115|P2|Overall Study|Disease progression|1
161182|NCT00303628|516116|P1|Overall Study|Disease progression|0
161183|NCT00303602|516134|P2|Overall Study|Protocol Violation|0
161184|NCT00303602|516135|P1|Overall Study|Protocol Violation|1
161185|NCT00303602|516134|P2|Overall Study|Noncompliance|2
161186|NCT00303602|516135|P1|Overall Study|Noncompliance|2
161187|NCT00303602|516134|P2|Overall Study|Physician Decision|1
161188|NCT00303602|516135|P1|Overall Study|Physician Decision|2
161189|NCT00303602|516134|P2|Overall Study|Protocol entry criteria not met|2
161190|NCT00303602|516135|P1|Overall Study|Protocol entry criteria not met|2
161191|NCT00303602|516134|P2|Overall Study|Lost to Follow-up|2
161192|NCT00303602|516135|P1|Overall Study|Lost to Follow-up|5
161193|NCT00303602|516134|P2|Overall Study|Withdrawal by Subject|6
161194|NCT00303602|516135|P1|Overall Study|Withdrawal by Subject|5
161195|NCT00303602|516134|P2|Overall Study|Adverse Event|2
161196|NCT00303602|516135|P1|Overall Study|Adverse Event|2
161197|NCT00303485|516181|P2|Overall Study|Withdrawal by Subject|0
161198|NCT00303485|516182|P1|Overall Study|Withdrawal by Subject|1
161199|NCT00303485|516181|P2|Overall Study|Failure to return|1
161200|NCT00303485|516182|P1|Overall Study|Failure to return|0
161201|NCT00303485|516181|P2|Overall Study|Adverse Event/Intercurrent Illness|1
161202|NCT00303485|516182|P1|Overall Study|Adverse Event/Intercurrent Illness|0
161203|NCT00303472|516213|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
161204|NCT00303472|516214|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
161205|NCT00303472|516215|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
161206|NCT00303472|516216|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
161207|NCT00303472|516217|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
161208|NCT00303472|516218|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
161209|NCT00303472|516219|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
161210|NCT00303472|516213|P7|Treatment Extension (Optional)|Not specified|0
161211|NCT00303472|516214|P6|Treatment Extension (Optional)|Not specified|0
161212|NCT00303472|516215|P5|Treatment Extension (Optional)|Not specified|1
161213|NCT00303472|516216|P4|Treatment Extension (Optional)|Not specified|2
161214|NCT00303472|516217|P3|Treatment Extension (Optional)|Not specified|4
161215|NCT00303472|516218|P2|Treatment Extension (Optional)|Not specified|2
161216|NCT00303472|516219|P1|Treatment Extension (Optional)|Not specified|0
161217|NCT00303472|516213|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
161218|NCT00303472|516214|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
161219|NCT00303472|516215|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
161220|NCT00303472|516216|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
161221|NCT00303472|516217|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
161222|NCT00303472|516218|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
161223|NCT00303472|516219|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
161224|NCT00303472|516213|P7|Treatment Extension (Optional)|Physician Decision|0
161225|NCT00303472|516214|P6|Treatment Extension (Optional)|Physician Decision|0
161226|NCT00303472|516215|P5|Treatment Extension (Optional)|Physician Decision|2
161227|NCT00303472|516216|P4|Treatment Extension (Optional)|Physician Decision|3
161228|NCT00303472|516217|P3|Treatment Extension (Optional)|Physician Decision|2
161229|NCT00303472|516218|P2|Treatment Extension (Optional)|Physician Decision|4
161230|NCT00303472|516219|P1|Treatment Extension (Optional)|Physician Decision|0
161231|NCT00303472|516213|P7|Treatment Extension (Optional)|Lost to Follow-up|0
161232|NCT00303472|516214|P6|Treatment Extension (Optional)|Lost to Follow-up|0
161233|NCT00303472|516215|P5|Treatment Extension (Optional)|Lost to Follow-up|0
161234|NCT00303472|516216|P4|Treatment Extension (Optional)|Lost to Follow-up|1
161235|NCT00303472|516217|P3|Treatment Extension (Optional)|Lost to Follow-up|0
161236|NCT00303472|516218|P2|Treatment Extension (Optional)|Lost to Follow-up|0
161237|NCT00303472|516219|P1|Treatment Extension (Optional)|Lost to Follow-up|0
161238|NCT00303472|516213|P7|Treatment Extension (Optional)|Death|0
161239|NCT00303472|516214|P6|Treatment Extension (Optional)|Death|0
161240|NCT00303472|516215|P5|Treatment Extension (Optional)|Death|0
161241|NCT00303472|516216|P4|Treatment Extension (Optional)|Death|0
161242|NCT00303472|516217|P3|Treatment Extension (Optional)|Death|1
161243|NCT00303472|516218|P2|Treatment Extension (Optional)|Death|0
161244|NCT00303472|516219|P1|Treatment Extension (Optional)|Death|2
161245|NCT00303472|516213|P7|Treatment Extension (Optional)|Adverse Event|0
161246|NCT00303472|516214|P6|Treatment Extension (Optional)|Adverse Event|0
161247|NCT00303472|516215|P5|Treatment Extension (Optional)|Adverse Event|0
161248|NCT00303472|516216|P4|Treatment Extension (Optional)|Adverse Event|0
161249|NCT00303472|516217|P3|Treatment Extension (Optional)|Adverse Event|1
161250|NCT00303472|516218|P2|Treatment Extension (Optional)|Adverse Event|0
161251|NCT00303472|516219|P1|Treatment Extension (Optional)|Adverse Event|1
161252|NCT00303472|516213|P7|Treatment Period|Disease Progression (to AML)|0
161253|NCT00303472|516214|P6|Treatment Period|Disease Progression (to AML)|0
161254|NCT00303472|516215|P5|Treatment Period|Disease Progression (to AML)|1
161255|NCT00303472|516216|P4|Treatment Period|Disease Progression (to AML)|0
161256|NCT00303472|516217|P3|Treatment Period|Disease Progression (to AML)|0
161257|NCT00303472|516218|P2|Treatment Period|Disease Progression (to AML)|0
161258|NCT00303472|516219|P1|Treatment Period|Disease Progression (to AML)|0
161259|NCT00303472|516213|P7|Treatment Period|Not specified|1
161260|NCT00303472|516214|P6|Treatment Period|Not specified|0
161261|NCT00303472|516215|P5|Treatment Period|Not specified|1
161262|NCT00303472|516216|P4|Treatment Period|Not specified|0
161263|NCT00303472|516217|P3|Treatment Period|Not specified|0
161264|NCT00303472|516218|P2|Treatment Period|Not specified|0
161265|NCT00303472|516219|P1|Treatment Period|Not specified|0
161266|NCT00303472|516213|P7|Treatment Period|Withdrawal by Subject|0
161267|NCT00303472|516214|P6|Treatment Period|Withdrawal by Subject|1
161268|NCT00303472|516215|P5|Treatment Period|Withdrawal by Subject|0
161269|NCT00303472|516216|P4|Treatment Period|Withdrawal by Subject|1
161270|NCT00303472|516217|P3|Treatment Period|Withdrawal by Subject|0
161271|NCT00303472|516218|P2|Treatment Period|Withdrawal by Subject|0
161272|NCT00303472|516219|P1|Treatment Period|Withdrawal by Subject|0
161273|NCT00303472|516213|P7|Treatment Period|Death|1
161274|NCT00303472|516214|P6|Treatment Period|Death|0
161275|NCT00303472|516215|P5|Treatment Period|Death|0
161276|NCT00303472|516216|P4|Treatment Period|Death|1
161277|NCT00303472|516217|P3|Treatment Period|Death|0
161278|NCT00303472|516218|P2|Treatment Period|Death|0
161279|NCT00303472|516219|P1|Treatment Period|Death|0
161280|NCT00303472|516213|P7|Treatment Period|Adverse Event|0
161281|NCT00303472|516214|P6|Treatment Period|Adverse Event|0
161282|NCT00303472|516215|P5|Treatment Period|Adverse Event|1
161283|NCT00303472|516216|P4|Treatment Period|Adverse Event|0
161284|NCT00303472|516217|P3|Treatment Period|Adverse Event|0
161285|NCT00303472|516218|P2|Treatment Period|Adverse Event|0
161286|NCT00303472|516219|P1|Treatment Period|Adverse Event|0
161287|NCT00303459|516279|P2|Overall Study|Lung transplantation|1
161288|NCT00303459|516280|P1|Overall Study|Lung transplantation|1
161289|NCT00303459|516279|P2|Overall Study|Decision by the investigator|7
161290|NCT00303459|516280|P1|Overall Study|Decision by the investigator|5
161291|NCT00303459|516279|P2|Overall Study|Administrative reason|7
161292|NCT00303459|516280|P1|Overall Study|Administrative reason|7
161293|NCT00303459|516279|P2|Overall Study|Lost to Follow-up|4
161294|NCT00303459|516280|P1|Overall Study|Lost to Follow-up|5
161295|NCT00303459|516279|P2|Overall Study|Withdrawal of consent|26
161296|NCT00303459|516280|P1|Overall Study|Withdrawal of consent|32
161297|NCT00303459|516279|P2|Overall Study|Death|44
161298|NCT00303459|516280|P1|Overall Study|Death|33
161299|NCT00303446|516306|P2|Overall Study|Physician Decision|1
161300|NCT00303446|516307|P1|Overall Study|Physician Decision|0
161301|NCT00303446|516306|P2|Overall Study|Death|1
161302|NCT00303446|516307|P1|Overall Study|Death|0
161303|NCT00303446|516306|P2|Overall Study|Withdrawal by Subject|2
161304|NCT00303446|516307|P1|Overall Study|Withdrawal by Subject|2
161305|NCT00303329|516343|P2|Overall Study|Stopped at end of extension 1|0
161306|NCT00303329|516344|P1|Overall Study|Stopped at end of extension 1|1
161307|NCT00303329|516343|P2|Overall Study|Stopped at end of core|9
161308|NCT00303329|516344|P1|Overall Study|Stopped at end of core|3
161309|NCT00303329|516343|P2|Overall Study|Death|12
161310|NCT00303329|516344|P1|Overall Study|Death|2
161311|NCT00303329|516343|P2|Overall Study|Administrative problems|0
161312|NCT00303329|516344|P1|Overall Study|Administrative problems|1
161313|NCT00303329|516343|P2|Overall Study|Lost to Follow-up|1
161314|NCT00303329|516344|P1|Overall Study|Lost to Follow-up|0
161315|NCT00303329|516343|P2|Overall Study|Withdrawal by Subject|15
161316|NCT00303329|516344|P1|Overall Study|Withdrawal by Subject|9
161317|NCT00303329|516343|P2|Overall Study|Protocol Violation|0
161318|NCT00303329|516344|P1|Overall Study|Protocol Violation|3
161319|NCT00303329|516343|P2|Overall Study|Condition no longer requires study drug|8
161320|NCT00303329|516344|P1|Overall Study|Condition no longer requires study drug|0
161321|NCT00303329|516343|P2|Overall Study|Unsatisfactory therapeutic effect|2
161322|NCT00303329|516344|P1|Overall Study|Unsatisfactory therapeutic effect|9
161323|NCT00303329|516343|P2|Overall Study|Abnormal Laboratory Values|1
161324|NCT00303329|516344|P1|Overall Study|Abnormal Laboratory Values|0
161325|NCT00303329|516343|P2|Overall Study|Adverse Event|14
161326|NCT00303329|516344|P1|Overall Study|Adverse Event|7
161327|NCT00303316|516358|P2|Overall Study|Withdrawal by Subject|2
161328|NCT00303316|516359|P1|Overall Study|Withdrawal by Subject|1
161329|NCT00303316|516358|P2|Overall Study|Lost to Follow-up|1
161330|NCT00303316|516359|P1|Overall Study|Lost to Follow-up|0
161331|NCT00303316|516358|P2|Overall Study|Protocol Violation|0
161332|NCT00303316|516359|P1|Overall Study|Protocol Violation|1
161333|NCT00303186|516371|P1|Overall Study|Unspecified|52
161334|NCT00303108|516405|P3|Overall Study|ineligible|0
161335|NCT00303108|516406|P2|Overall Study|ineligible|1
161336|NCT00303108|516407|P1|Overall Study|ineligible|2
161337|NCT00303108|516405|P3|Overall Study|Failed Entry|1
161338|NCT00303108|516406|P2|Overall Study|Failed Entry|0
161339|NCT00303108|516407|P1|Overall Study|Failed Entry|1
161340|NCT00303108|516405|P3|Overall Study|Patient Request|8
161341|NCT00303108|516406|P2|Overall Study|Patient Request|2
161342|NCT00303108|516407|P1|Overall Study|Patient Request|4
161343|NCT00303108|516405|P3|Overall Study|Adverse Event|7
161344|NCT00303108|516406|P2|Overall Study|Adverse Event|6
161345|NCT00303108|516407|P1|Overall Study|Adverse Event|5
161346|NCT00303069|516427|P4|Overall Study|Recruitment into Army Reserves|0
161347|NCT00303069|516428|P3|Overall Study|Recruitment into Army Reserves|1
161348|NCT00303069|516429|P2|Overall Study|Recruitment into Army Reserves|0
161349|NCT00303069|516430|P1|Overall Study|Recruitment into Army Reserves|0
161350|NCT00303069|516427|P4|Overall Study|subject moved|0
161351|NCT00303069|516428|P3|Overall Study|subject moved|0
161352|NCT00303069|516429|P2|Overall Study|subject moved|0
161353|NCT00303069|516430|P1|Overall Study|subject moved|1
161354|NCT00303069|516427|P4|Overall Study|Lost to Follow-up|2
161355|NCT00303069|516428|P3|Overall Study|Lost to Follow-up|0
161356|NCT00303069|516429|P2|Overall Study|Lost to Follow-up|0
161357|NCT00303069|516430|P1|Overall Study|Lost to Follow-up|1
161358|NCT00302952|516450|P2|Overall Study|Elevated SGOT (AST) lab value|1
161359|NCT00302952|516451|P1|Overall Study|Elevated SGOT (AST) lab value|0
161360|NCT00302952|516450|P2|Overall Study|Withdrawal by Subject|3
161361|NCT00302952|516451|P1|Overall Study|Withdrawal by Subject|2
161362|NCT00302952|516450|P2|Overall Study|Physician Decision|1
161363|NCT00302952|516451|P1|Overall Study|Physician Decision|1
161364|NCT00302718|516501|P4|Overall Study|Participant left primary care setting|1
161365|NCT00302718|516502|P3|Overall Study|Participant left primary care setting|2
161366|NCT00302718|516503|P2|Overall Study|Participant left primary care setting|0
161367|NCT00302718|516504|P1|Overall Study|Participant left primary care setting|0
161368|NCT00302718|516501|P4|Overall Study|Withdrawal by Subject|0
161369|NCT00302718|516502|P3|Overall Study|Withdrawal by Subject|0
161370|NCT00302718|516503|P2|Overall Study|Withdrawal by Subject|1
161371|NCT00302718|516504|P1|Overall Study|Withdrawal by Subject|0
161372|NCT00302718|516501|P4|Overall Study|Participant left the hospital|1
161373|NCT00302718|516502|P3|Overall Study|Participant left the hospital|0
161374|NCT00302718|516503|P2|Overall Study|Participant left the hospital|0
161375|NCT00302718|516504|P1|Overall Study|Participant left the hospital|1
161376|NCT00302458|516536|P1|Overall Study|Withdrawal by Subject|1
161377|NCT00302458|516536|P1|Overall Study|Ineligible after screening|1
161378|NCT00302458|516536|P1|Overall Study|Lost to Follow-up|1
161379|NCT00302328|516547|P3|Overall Study|Physician Decision|0
161380|NCT00302328|516548|P2|Overall Study|Physician Decision|1
161381|NCT00302328|516549|P1|Overall Study|Physician Decision|0
161382|NCT00302211|516566|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
161383|NCT00302211|516567|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
161384|NCT00302211|516568|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
161385|NCT00302211|516569|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
161386|NCT00302211|516570|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
161387|NCT00302211|516566|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
161388|NCT00302211|516567|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
161389|NCT00302211|516568|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
161390|NCT00302211|516569|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
161391|NCT00302211|516570|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
161392|NCT00302211|516566|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
161393|NCT00302211|516567|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
161394|NCT00302211|516568|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
161395|NCT00302211|516569|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
161396|NCT00302211|516570|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
161397|NCT00302211|516566|P5|Open Label-Patients From Double-Blind|Death|1
161398|NCT00302211|516567|P4|Open Label-Patients From Double-Blind|Death|1
161399|NCT00302211|516568|P3|Open Label-Patients From Double-Blind|Death|0
161400|NCT00302211|516569|P2|Open Label-Patients From Double-Blind|Death|0
161401|NCT00302211|516570|P1|Open Label-Patients From Double-Blind|Death|0
161402|NCT00302211|516566|P5|Open Label-Patients From Double-Blind|Disease progression|2
161403|NCT00302211|516567|P4|Open Label-Patients From Double-Blind|Disease progression|1
161404|NCT00302211|516568|P3|Open Label-Patients From Double-Blind|Disease progression|0
161405|NCT00302211|516569|P2|Open Label-Patients From Double-Blind|Disease progression|0
161406|NCT00302211|516570|P1|Open Label-Patients From Double-Blind|Disease progression|0
161407|NCT00302211|516566|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
161408|NCT00302211|516567|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
161409|NCT00302211|516568|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
161410|NCT00302211|516569|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
161411|NCT00302211|516570|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
161412|NCT00302211|516566|P5|Open Label-Patients From Double-Blind|Adverse Event|0
161413|NCT00302211|516567|P4|Open Label-Patients From Double-Blind|Adverse Event|1
161414|NCT00302211|516568|P3|Open Label-Patients From Double-Blind|Adverse Event|0
161415|NCT00302211|516569|P2|Open Label-Patients From Double-Blind|Adverse Event|0
161416|NCT00302211|516570|P1|Open Label-Patients From Double-Blind|Adverse Event|0
161417|NCT00302211|516566|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
161418|NCT00302211|516567|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
161419|NCT00302211|516568|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
161420|NCT00302211|516569|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
161421|NCT00302211|516570|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
161422|NCT00302211|516566|P5|Double Blind Period (New Patients)|Disease progression|0
161423|NCT00302211|516567|P4|Double Blind Period (New Patients)|Disease progression|0
161424|NCT00302211|516568|P3|Double Blind Period (New Patients)|Disease progression|1
161425|NCT00302211|516569|P2|Double Blind Period (New Patients)|Disease progression|1
161426|NCT00302211|516570|P1|Double Blind Period (New Patients)|Disease progression|0
161427|NCT00302211|516566|P5|Double Blind Period (New Patients)|Investigator's judgement|0
161428|NCT00302211|516567|P4|Double Blind Period (New Patients)|Investigator's judgement|0
161429|NCT00302211|516568|P3|Double Blind Period (New Patients)|Investigator's judgement|0
161430|NCT00302211|516569|P2|Double Blind Period (New Patients)|Investigator's judgement|0
161431|NCT00302211|516570|P1|Double Blind Period (New Patients)|Investigator's judgement|1
161432|NCT00302211|516566|P5|Double Blind Period (New Patients)|Adverse Event|0
161433|NCT00302211|516567|P4|Double Blind Period (New Patients)|Adverse Event|0
161434|NCT00302211|516568|P3|Double Blind Period (New Patients)|Adverse Event|3
161435|NCT00302211|516569|P2|Double Blind Period (New Patients)|Adverse Event|0
161436|NCT00302211|516570|P1|Double Blind Period (New Patients)|Adverse Event|0
161437|NCT00302211|516566|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
161438|NCT00302211|516567|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
161439|NCT00302211|516568|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
161440|NCT00302211|516569|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
161441|NCT00302211|516570|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
161442|NCT00302159|516582|P1|Overall Study|pt started Avastin|1
161443|NCT00302159|516582|P1|Overall Study|pt declined before treatment started|1
161444|NCT00302107|516604|P2|Overall Study|Adverse Event|0
161445|NCT00302107|516605|P1|Overall Study|Adverse Event|1
161446|NCT00302107|516604|P2|Overall Study|Withdrawal by Subject|3
161447|NCT00302107|516605|P1|Overall Study|Withdrawal by Subject|0
161448|NCT00302107|516604|P2|Overall Study|Relocation|1
161449|NCT00302107|516605|P1|Overall Study|Relocation|0
161450|NCT00302107|516604|P2|Overall Study|Protocol Violation|0
161451|NCT00302107|516605|P1|Overall Study|Protocol Violation|1
161452|NCT00302107|516604|P2|Overall Study|Lost to Follow-up|5
161453|NCT00302107|516605|P1|Overall Study|Lost to Follow-up|6
161454|NCT00302081|516614|P3|Overall Study|Other|5
161455|NCT00302081|516615|P2|Overall Study|Other|6
161456|NCT00302081|516616|P1|Overall Study|Other|13
161457|NCT00302081|516614|P3|Overall Study|Death|0
161458|NCT00302081|516615|P2|Overall Study|Death|1
161459|NCT00302081|516616|P1|Overall Study|Death|2
161460|NCT00302081|516614|P3|Overall Study|Lack of Efficacy|5
161461|NCT00302081|516615|P2|Overall Study|Lack of Efficacy|0
161462|NCT00302081|516616|P1|Overall Study|Lack of Efficacy|1
161463|NCT00302081|516614|P3|Overall Study|Protocol Violation|2
161464|NCT00302081|516615|P2|Overall Study|Protocol Violation|1
161465|NCT00302081|516616|P1|Overall Study|Protocol Violation|5
161466|NCT00302081|516614|P3|Overall Study|Withdrawal by Subject|8
161467|NCT00302081|516615|P2|Overall Study|Withdrawal by Subject|12
161468|NCT00302081|516616|P1|Overall Study|Withdrawal by Subject|8
161469|NCT00302081|516614|P3|Overall Study|Lost to Follow-up|28
161470|NCT00302081|516615|P2|Overall Study|Lost to Follow-up|18
161471|NCT00302081|516616|P1|Overall Study|Lost to Follow-up|21
161472|NCT00302081|516614|P3|Overall Study|Adverse Event|4
161473|NCT00302081|516615|P2|Overall Study|Adverse Event|5
161474|NCT00302081|516616|P1|Overall Study|Adverse Event|6
161475|NCT00302003|516673|P1|Overall Study|Protocol Violation|1
161476|NCT00302003|516673|P1|Overall Study|Ineligible|9
161477|NCT00302003|516673|P1|Overall Study|Withdrawal by Subject|5
161478|NCT00302003|516673|P1|Overall Study|Physician Decision|2
161479|NCT00302003|516673|P1|Overall Study|Lost to Follow-up|1
161480|NCT00302003|516673|P1|Overall Study|Lack of Efficacy|62
161481|NCT00301964|516680|P1|Overall Study|Inadequate pathology|1
161482|NCT00301964|516680|P1|Overall Study|Wrong primary|1
161483|NCT00301964|516680|P1|Overall Study|Second primary|2
161484|NCT00301834|516691|P1|Overall Study|Death|1
161485|NCT00301821|516700|P1|Overall Study|Cancel|1
161486|NCT00301821|516700|P1|Overall Study|Ineligible|25
161487|NCT00301808|516707|P1|Overall Study|Lack of Efficacy|4
161488|NCT00301808|516707|P1|Overall Study|Death|3
161489|NCT00301808|516707|P1|Overall Study|Adverse Event|5
161490|NCT00301366|516726|P1|Overall Study|Adverse Event|1
161491|NCT00301262|516732|P2|Open Label Phase (OL)|Other|0
161492|NCT00301262|516733|P1|Open Label Phase (OL)|Other|2
161493|NCT00301262|516732|P2|Open Label Phase (OL)|Lost to Follow-up|2
161494|NCT00301262|516733|P1|Open Label Phase (OL)|Lost to Follow-up|1
161495|NCT00301262|516732|P2|Open Label Phase (OL)|Adverse Event|0
161496|NCT00301262|516733|P1|Open Label Phase (OL)|Adverse Event|1
161497|NCT00301262|516732|P2|Double Blind Phase (DB)|Other|4
161498|NCT00301262|516733|P1|Double Blind Phase (DB)|Other|1
161499|NCT00301262|516732|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
161500|NCT00301262|516733|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
161501|NCT00301262|516732|P2|Double Blind Phase (DB)|Lost to Follow-up|3
161502|NCT00301262|516733|P1|Double Blind Phase (DB)|Lost to Follow-up|3
161503|NCT00301262|516732|P2|Double Blind Phase (DB)|Lack of Efficacy|1
161504|NCT00301262|516733|P1|Double Blind Phase (DB)|Lack of Efficacy|0
161505|NCT00301262|516732|P2|Double Blind Phase (DB)|Adverse Event|0
161506|NCT00301262|516733|P1|Double Blind Phase (DB)|Adverse Event|1
161507|NCT00301080|516891|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
161508|NCT00301080|516892|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
161509|NCT00301080|516893|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
161510|NCT00301080|516894|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
161511|NCT00301080|516895|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
161512|NCT00300885|516930|P2|Follow-up|Withdrawal by Subject|25
161513|NCT00300885|516931|P1|Follow-up|Withdrawal by Subject|26
161514|NCT00300885|516930|P2|Follow-up|Lost to Follow-up|7
161515|NCT00300885|516931|P1|Follow-up|Lost to Follow-up|11
161516|NCT00300885|516930|P2|Follow-up|Death|163
161517|NCT00300885|516931|P1|Follow-up|Death|141
161518|NCT00300885|516930|P2|Treatment|Non-compliant with study medication|4
161519|NCT00300885|516931|P1|Treatment|Non-compliant with study medication|3
161520|NCT00300885|516930|P2|Treatment|Random code broken (subject died)|1
161521|NCT00300885|516931|P1|Treatment|Random code broken (subject died)|0
161522|NCT00300885|516930|P2|Treatment|Disease progression|238
161523|NCT00300885|516931|P1|Treatment|Disease progression|171
161524|NCT00300885|516930|P2|Treatment|Withdrawal by Subject|23
161525|NCT00300885|516931|P1|Treatment|Withdrawal by Subject|26
161526|NCT00300885|516930|P2|Treatment|Protocol Violation|11
161527|NCT00300885|516931|P1|Treatment|Protocol Violation|11
161528|NCT00300885|516930|P2|Treatment|Physician Decision|5
161529|NCT00300885|516931|P1|Treatment|Physician Decision|4
161530|NCT00300885|516930|P2|Treatment|Lost to Follow-up|2
161531|NCT00300885|516931|P1|Treatment|Lost to Follow-up|3
161532|NCT00300885|516930|P2|Treatment|Lack of Efficacy|1
161533|NCT00300885|516931|P1|Treatment|Lack of Efficacy|1
161534|NCT00300885|516930|P2|Treatment|Death|7
161535|NCT00300885|516931|P1|Treatment|Death|20
161536|NCT00300885|516930|P2|Treatment|Adverse Event|82
161537|NCT00300885|516931|P1|Treatment|Adverse Event|134
161538|NCT00300755|516950|P3|Overall Study|Protocol Violation|1
161539|NCT00300755|516951|P2|Overall Study|Protocol Violation|0
161540|NCT00300755|516952|P1|Overall Study|Protocol Violation|0
161541|NCT00300755|516950|P3|Overall Study|Withdrawal by Subject|0
161542|NCT00300755|516951|P2|Overall Study|Withdrawal by Subject|2
161543|NCT00300755|516952|P1|Overall Study|Withdrawal by Subject|0
161544|NCT00300755|516950|P3|Overall Study|Adverse Event|1
161545|NCT00300755|516951|P2|Overall Study|Adverse Event|2
161546|NCT00300755|516952|P1|Overall Study|Adverse Event|1
161547|NCT00300274|517217|P3|Overall Study|Re-transplant|1
161548|NCT00300274|517218|P2|Overall Study|Re-transplant|0
161549|NCT00300274|517219|P1|Overall Study|Re-transplant|0
161550|NCT00300274|517217|P3|Overall Study|Death|25
161551|NCT00300274|517218|P2|Overall Study|Death|20
161552|NCT00300274|517219|P1|Overall Study|Death|31
161553|NCT00300274|517217|P3|Overall Study|Lost to Follow-up|5
161554|NCT00300274|517218|P2|Overall Study|Lost to Follow-up|4
161555|NCT00300274|517219|P1|Overall Study|Lost to Follow-up|3
161556|NCT00300274|517217|P3|Overall Study|Withdrawal by Subject|14
161557|NCT00300274|517218|P2|Overall Study|Withdrawal by Subject|3
161558|NCT00300274|517219|P1|Overall Study|Withdrawal by Subject|12
161559|NCT00299975|517278|P3|Overall Study|Physician Decision|1
161560|NCT00299975|517279|P2|Overall Study|Physician Decision|0
161561|NCT00299975|517280|P1|Overall Study|Physician Decision|0
161562|NCT00299975|517278|P3|Overall Study|Withdrawal by Subject|3
161563|NCT00299975|517279|P2|Overall Study|Withdrawal by Subject|1
161564|NCT00299975|517280|P1|Overall Study|Withdrawal by Subject|0
161565|NCT00299975|517278|P3|Overall Study|Lost to Follow-up|0
161566|NCT00299975|517279|P2|Overall Study|Lost to Follow-up|0
161567|NCT00299975|517280|P1|Overall Study|Lost to Follow-up|1
161568|NCT00299975|517278|P3|Overall Study|Lack of Efficacy|1
161569|NCT00299975|517279|P2|Overall Study|Lack of Efficacy|0
161570|NCT00299975|517280|P1|Overall Study|Lack of Efficacy|1
161571|NCT00299975|517278|P3|Overall Study|Pregnancy|1
161572|NCT00299975|517279|P2|Overall Study|Pregnancy|0
161573|NCT00299975|517280|P1|Overall Study|Pregnancy|0
161574|NCT00299975|517278|P3|Overall Study|Adverse Event|2
161575|NCT00299975|517279|P2|Overall Study|Adverse Event|0
161576|NCT00299975|517280|P1|Overall Study|Adverse Event|1
161577|NCT00299702|517337|P2|Overall Study|Admin issues, sponsor decision, etc.|9
161578|NCT00299702|517338|P1|Overall Study|Admin issues, sponsor decision, etc.|5
161579|NCT00299702|517337|P2|Overall Study|Insufficient Response|3
161580|NCT00299702|517338|P1|Overall Study|Insufficient Response|4
161581|NCT00299702|517337|P2|Overall Study|Pregnancy|1
161582|NCT00299702|517338|P1|Overall Study|Pregnancy|0
161583|NCT00299702|517337|P2|Overall Study|Withdrawal by Subject|23
161584|NCT00299702|517338|P1|Overall Study|Withdrawal by Subject|25
161585|NCT00299702|517337|P2|Overall Study|Lost to Follow-up|10
161586|NCT00299702|517338|P1|Overall Study|Lost to Follow-up|18
161587|NCT00299702|517337|P2|Overall Study|Adverse Event|4
161588|NCT00299702|517338|P1|Overall Study|Adverse Event|0
161589|NCT00299702|517337|P2|Overall Study|Death|0
161590|NCT00299702|517338|P1|Overall Study|Death|1
161591|NCT00299546|517353|P3|Overall Study|Not treated|1
161592|NCT00299546|517354|P2|Overall Study|Not treated|1
161593|NCT00299546|517355|P1|Overall Study|Not treated|0
161594|NCT00299546|517353|P3|Overall Study|Not specified|19
161595|NCT00299546|517354|P2|Overall Study|Not specified|26
161596|NCT00299546|517355|P1|Overall Study|Not specified|24
161597|NCT00299546|517353|P3|Overall Study|Unsatisfactory therapeutic effect|34
161598|NCT00299546|517354|P2|Overall Study|Unsatisfactory therapeutic effect|39
161599|NCT00299546|517355|P1|Overall Study|Unsatisfactory therapeutic effect|34
161600|NCT00299546|517353|P3|Overall Study|Adverse Event|27
161601|NCT00299546|517354|P2|Overall Study|Adverse Event|22
161602|NCT00299546|517355|P1|Overall Study|Adverse Event|37
161603|NCT00299546|517353|P3|Overall Study|Lost to Follow-up|5
161604|NCT00299546|517354|P2|Overall Study|Lost to Follow-up|2
161605|NCT00299546|517355|P1|Overall Study|Lost to Follow-up|2
161606|NCT00299546|517353|P3|Overall Study|Death|0
161607|NCT00299546|517354|P2|Overall Study|Death|2
161608|NCT00299546|517355|P1|Overall Study|Death|3
161609|NCT00299156|517406|P3|Period 2 (Randomized)|Screen Failure|0
161610|NCT00299156|517407|P2|Period 2 (Randomized)|Screen Failure|1
161611|NCT00299156|517408|P1|Period 2 (Randomized)|Screen Failure|0
161612|NCT00299130|517419|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
161613|NCT00299130|517420|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
161614|NCT00299130|517421|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
161615|NCT00299130|517419|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
161616|NCT00299130|517420|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
161617|NCT00299130|517421|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
161618|NCT00299130|517419|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
161619|NCT00299130|517420|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
161620|NCT00299130|517421|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
161621|NCT00299130|517419|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
161622|NCT00299130|517420|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
161623|NCT00299130|517421|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
161624|NCT00299130|517419|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
161625|NCT00299130|517420|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
161626|NCT00299130|517421|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
161627|NCT00299130|517419|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
161628|NCT00299130|517420|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
161629|NCT00299130|517421|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
161630|NCT00299130|517419|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
161631|NCT00299130|517420|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
161632|NCT00299130|517421|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
161633|NCT00299130|517419|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
161634|NCT00299130|517420|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
161635|NCT00299130|517421|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
161636|NCT00299130|517419|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
161637|NCT00299130|517420|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
161638|NCT00299130|517421|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
161639|NCT00299130|517419|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
161640|NCT00299130|517420|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
161641|NCT00299130|517421|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
161642|NCT00299130|517419|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
161643|NCT00299130|517420|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
161644|NCT00299130|517421|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
161645|NCT00299130|517419|P3|Treatment Period (up to 5 Years)|Failure to Return|6
161646|NCT00299130|517420|P2|Treatment Period (up to 5 Years)|Failure to Return|6
161647|NCT00299130|517421|P1|Treatment Period (up to 5 Years)|Failure to Return|4
161648|NCT00299130|517419|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
161649|NCT00299130|517420|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
161650|NCT00299130|517421|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
161651|NCT00299130|517419|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
161652|NCT00299130|517420|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
161653|NCT00299130|517421|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
161654|NCT00299130|517419|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
161655|NCT00299130|517420|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
161656|NCT00299130|517421|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
161657|NCT00299130|517419|P3|Treatment Period (up to 5 Years)|Death|1
161658|NCT00299130|517420|P2|Treatment Period (up to 5 Years)|Death|3
161659|NCT00299130|517421|P1|Treatment Period (up to 5 Years)|Death|1
161660|NCT00299130|517419|P3|Treatment Period (up to 5 Years)|Adverse Event|13
161661|NCT00299130|517420|P2|Treatment Period (up to 5 Years)|Adverse Event|8
161662|NCT00299130|517421|P1|Treatment Period (up to 5 Years)|Adverse Event|13
161663|NCT00299104|517526|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
161664|NCT00299104|517527|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
161665|NCT00299104|517528|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
161666|NCT00299104|517526|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
161667|NCT00299104|517527|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
161668|NCT00299104|517528|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
161669|NCT00299104|517526|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
161670|NCT00299104|517527|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
161671|NCT00299104|517528|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
161672|NCT00299104|517526|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
161673|NCT00299104|517527|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
161674|NCT00299104|517528|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
161675|NCT00299104|517526|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
161676|NCT00299104|517527|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
161677|NCT00299104|517528|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
161678|NCT00299104|517526|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
161679|NCT00299104|517527|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
161680|NCT00299104|517528|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
161681|NCT00299104|517526|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
161682|NCT00299104|517527|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
161683|NCT00299104|517528|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
161684|NCT00299104|517526|P3|Safety Follow-Up (SFU) Period|Death|1
161685|NCT00299104|517527|P2|Safety Follow-Up (SFU) Period|Death|2
161686|NCT00299104|517528|P1|Safety Follow-Up (SFU) Period|Death|3
161687|NCT00299104|517526|P3|Treatment Period|Administrative reasons|137
161688|NCT00299104|517527|P2|Treatment Period|Administrative reasons|120
161689|NCT00299104|517528|P1|Treatment Period|Administrative reasons|106
161690|NCT00299104|517526|P3|Treatment Period|Withdrew consent|9
161691|NCT00299104|517527|P2|Treatment Period|Withdrew consent|19
161692|NCT00299104|517528|P1|Treatment Period|Withdrew consent|14
161693|NCT00299104|517526|P3|Treatment Period|Refused treatment|2
161694|NCT00299104|517527|P2|Treatment Period|Refused treatment|2
161695|NCT00299104|517528|P1|Treatment Period|Refused treatment|9
161696|NCT00299104|517526|P3|Treatment Period|Protocol Violation|0
161697|NCT00299104|517527|P2|Treatment Period|Protocol Violation|1
161698|NCT00299104|517528|P1|Treatment Period|Protocol Violation|1
161699|NCT00299104|517526|P3|Treatment Period|Violation of selection criteria|0
161700|NCT00299104|517527|P2|Treatment Period|Violation of selection criteria|2
161701|NCT00299104|517528|P1|Treatment Period|Violation of selection criteria|1
161702|NCT00299104|517526|P3|Treatment Period|Failure to return|8
161703|NCT00299104|517527|P2|Treatment Period|Failure to return|8
161704|NCT00299104|517528|P1|Treatment Period|Failure to return|9
161705|NCT00299104|517526|P3|Treatment Period|Insufficient therapeutic response|8
161706|NCT00299104|517527|P2|Treatment Period|Insufficient therapeutic response|13
161707|NCT00299104|517528|P1|Treatment Period|Insufficient therapeutic response|34
161708|NCT00299104|517526|P3|Treatment Period|Death|1
161709|NCT00299104|517527|P2|Treatment Period|Death|1
161710|NCT00299104|517528|P1|Treatment Period|Death|1
161711|NCT00299104|517526|P3|Treatment Period|Adverse Event|7
161712|NCT00299104|517527|P2|Treatment Period|Adverse Event|9
161713|NCT00299104|517528|P1|Treatment Period|Adverse Event|14
161714|NCT00298766|517638|P1|Overall Study|Other|4
161715|NCT00298766|517638|P1|Overall Study|Subjects overall condition deterioration|4
161716|NCT00298766|517638|P1|Overall Study|Deterioration in KPS and organ function|1
161717|NCT00298766|517638|P1|Overall Study|Progression of amyloid markers|4
161718|NCT00298766|517638|P1|Overall Study|Treatment ongoing|4
161719|NCT00298766|517638|P1|Overall Study|Withdrawal by Subject|9
161720|NCT00298766|517638|P1|Overall Study|Death|2
161721|NCT00298766|517638|P1|Overall Study|Adverse Event|18
161722|NCT00298363|517687|P3|Overall Study|Lack of Efficacy|0
161723|NCT00298363|517688|P2|Overall Study|Lack of Efficacy|3
161724|NCT00298363|517689|P1|Overall Study|Lack of Efficacy|2
161725|NCT00298363|517687|P3|Overall Study|Adverse Event|2
161726|NCT00298363|517688|P2|Overall Study|Adverse Event|2
161727|NCT00298363|517689|P1|Overall Study|Adverse Event|5
161728|NCT00298363|517687|P3|Overall Study|Withdrawal by Subject|3
161729|NCT00298363|517688|P2|Overall Study|Withdrawal by Subject|1
161730|NCT00298363|517689|P1|Overall Study|Withdrawal by Subject|5
161731|NCT00298363|517687|P3|Overall Study|Protocol Violation|0
161732|NCT00298363|517688|P2|Overall Study|Protocol Violation|1
161733|NCT00298363|517689|P1|Overall Study|Protocol Violation|1
161734|NCT00298363|517687|P3|Overall Study|Physician Decision|0
161735|NCT00298363|517688|P2|Overall Study|Physician Decision|1
161736|NCT00298363|517689|P1|Overall Study|Physician Decision|4
161737|NCT00298363|517687|P3|Overall Study|Lost to Follow-up|1
161738|NCT00298363|517688|P2|Overall Study|Lost to Follow-up|0
161739|NCT00298363|517689|P1|Overall Study|Lost to Follow-up|0
161740|NCT00298272|517847|P2|Safety Follow-up Phase|Administrative/Other Reason|1
161741|NCT00298272|517848|P1|Safety Follow-up Phase|Administrative/Other Reason|1
161742|NCT00298272|517847|P2|Safety Follow-up Phase|Withdrawal by Subject|2
161743|NCT00298272|517848|P1|Safety Follow-up Phase|Withdrawal by Subject|2
161744|NCT00298272|517847|P2|Safety Follow-up Phase|Failure to Return|1
161745|NCT00298272|517848|P1|Safety Follow-up Phase|Failure to Return|1
161746|NCT00298272|517847|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
161747|NCT00298272|517848|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
161748|NCT00298272|517847|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
161749|NCT00298272|517848|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
161750|NCT00298272|517847|P2|Open Label Retreatment Phase|Protocol Violation|1
161751|NCT00298272|517848|P1|Open Label Retreatment Phase|Protocol Violation|2
161752|NCT00298272|517847|P2|Open Label Retreatment Phase|Failure to Return|0
161753|NCT00298272|517848|P1|Open Label Retreatment Phase|Failure to Return|1
161754|NCT00298272|517847|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
161755|NCT00298272|517848|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
161756|NCT00298272|517847|P2|Open Label Retreatment Phase|Adverse Event|2
161757|NCT00298272|517848|P1|Open Label Retreatment Phase|Adverse Event|1
161758|NCT00298272|517847|P2|Double-blind Phase|Withdrawal by Subject|0
161759|NCT00298272|517848|P1|Double-blind Phase|Withdrawal by Subject|2
161760|NCT00298272|517847|P2|Double-blind Phase|Protocol Violation|0
161761|NCT00298272|517848|P1|Double-blind Phase|Protocol Violation|2
161762|NCT00298272|517847|P2|Double-blind Phase|Failure to Return|0
161763|NCT00298272|517848|P1|Double-blind Phase|Failure to Return|2
161764|NCT00298272|517847|P2|Double-blind Phase|Adverse Event|0
161765|NCT00298272|517848|P1|Double-blind Phase|Adverse Event|2
161766|NCT00297830|517897|P3|12 Month Visit|Withdrawal by Subject|0
161767|NCT00297830|517898|P2|12 Month Visit|Withdrawal by Subject|3
161768|NCT00297830|517899|P1|12 Month Visit|Withdrawal by Subject|0
161769|NCT00297830|517897|P3|12 Month Visit|Adverse Event|0
161770|NCT00297830|517898|P2|12 Month Visit|Adverse Event|3
161771|NCT00297830|517899|P1|12 Month Visit|Adverse Event|0
161772|NCT00297830|517897|P3|12 Month Visit|Lost to Follow-up|0
161773|NCT00297830|517898|P2|12 Month Visit|Lost to Follow-up|0
161774|NCT00297830|517899|P1|12 Month Visit|Lost to Follow-up|1
161775|NCT00297830|517897|P3|6 Month Visit|Adverse Event|0
161776|NCT00297830|517898|P2|6 Month Visit|Adverse Event|1
161777|NCT00297830|517899|P1|6 Month Visit|Adverse Event|0
161778|NCT00297830|517897|P3|6 Month Visit|Withdrawal by Subject|1
161779|NCT00297830|517898|P2|6 Month Visit|Withdrawal by Subject|1
161780|NCT00297830|517899|P1|6 Month Visit|Withdrawal by Subject|2
161781|NCT00297830|517897|P3|6 Month Visit|Death|2
161782|NCT00297830|517898|P2|6 Month Visit|Death|0
161783|NCT00297830|517899|P1|6 Month Visit|Death|1
161784|NCT00297778|517918|P2|Overall Study|Other|1
161785|NCT00297778|517919|P1|Overall Study|Other|0
161786|NCT00297778|517918|P2|Overall Study|Non-compliant with trial protocol|3
161787|NCT00297778|517919|P1|Overall Study|Non-compliant with trial protocol|0
161788|NCT00297778|517918|P2|Overall Study|Lack of Efficacy|1
161789|NCT00297778|517919|P1|Overall Study|Lack of Efficacy|2
161790|NCT00297778|517918|P2|Overall Study|Withdrawal by Subject|5
161791|NCT00297778|517919|P1|Overall Study|Withdrawal by Subject|1
161792|NCT00297778|517918|P2|Overall Study|Adverse Event|10
161793|NCT00297778|517919|P1|Overall Study|Adverse Event|16
161794|NCT00297648|517953|P1|Overall Study|Other: Incompliance|1
161795|NCT00297648|517953|P1|Overall Study|Withdrawal by Subject|3
161796|NCT00297648|517953|P1|Overall Study|Lost to Follow-up|1
161797|NCT00297648|517953|P1|Overall Study|Lack of Efficacy|18
161798|NCT00297648|517953|P1|Overall Study|Adverse Event|13
161799|NCT00297492|517999|P3|6 Month Follow-up|Lost to Follow-up|27
161800|NCT00297492|518000|P2|6 Month Follow-up|Lost to Follow-up|49
161801|NCT00297492|518001|P1|6 Month Follow-up|Lost to Follow-up|63
161802|NCT00297492|517999|P3|Set Quit Date|Lost to Follow-up|5
161803|NCT00297492|518000|P2|Set Quit Date|Lost to Follow-up|13
161804|NCT00297492|518001|P1|Set Quit Date|Lost to Follow-up|7
161805|NCT00297427|518011|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
161806|NCT00297427|518012|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
161807|NCT00297427|518011|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
161808|NCT00297427|518012|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
161809|NCT00297427|518011|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
161810|NCT00297427|518012|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
161811|NCT00297427|518011|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
161812|NCT00297427|518012|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
161813|NCT00297427|518011|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
161814|NCT00297427|518012|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
161815|NCT00297427|518011|P2|Phase 1: Initial Intervention|Death|1
161816|NCT00297427|518012|P1|Phase 1: Initial Intervention|Death|0
161817|NCT00297427|518011|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
161818|NCT00297427|518012|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
161819|NCT00297427|518011|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
161820|NCT00297427|518012|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
161821|NCT00297258|518053|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
161822|NCT00297258|518053|P1|Overall Study|Switch to Commercial Treatment|1
161823|NCT00297258|518053|P1|Overall Study|Surgery Performed on Target Lesion|1
161824|NCT00297258|518053|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
161825|NCT00297258|518053|P1|Overall Study|Deteriorization of General Condition|1
161826|NCT00297258|518053|P1|Overall Study|Intercurrent Death|2
161827|NCT00297258|518053|P1|Overall Study|Intercurrent Illness|3
161828|NCT00297258|518053|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
161829|NCT00297258|518053|P1|Overall Study|Toxicity (or Toxic Death)|10
161830|NCT00297258|518053|P1|Overall Study|Disease Progression, Relapse, Death|120
161831|NCT00297232|518072|P1|Overall Study|Other|1
161832|NCT00297232|518072|P1|Overall Study|No data available after Week 264|161
161833|NCT00297232|518072|P1|Overall Study|Did Not Enroll to Week 480|17
161834|NCT00297232|518072|P1|Overall Study|Did Not Enroll to Week 264|34
161835|NCT00297232|518072|P1|Overall Study|Investigator Withdrew From Program|19
161836|NCT00297232|518072|P1|Overall Study|Persistently Positive Antibodies|11
161837|NCT00297232|518072|P1|Overall Study|Subject Withdrew Consent|37
161838|NCT00297232|518072|P1|Overall Study|Subject Relocated|7
161839|NCT00297232|518072|P1|Overall Study|Sponsor Decision|34
161840|NCT00297232|518072|P1|Overall Study|Miscellaneous|5
161841|NCT00297232|518072|P1|Overall Study|Anti-JCV Antibody Positive|13
161842|NCT00297232|518072|P1|Overall Study|Fear of PML|10
161843|NCT00297232|518072|P1|Overall Study|Disease Progression|8
161844|NCT00297232|518072|P1|Overall Study|Switched to Commercial Tysabri|22
161845|NCT00297232|518072|P1|Overall Study|Anti-natalizumab Positive|8
161846|NCT00297232|518072|P1|Overall Study|Death|9
161847|NCT00297232|518072|P1|Overall Study|Subject was Noncompliant|9
161848|NCT00297232|518072|P1|Overall Study|Voluntary Withdrawal|120
161849|NCT00297232|518072|P1|Overall Study|Adverse Event|63
161850|NCT00297232|518072|P1|Overall Study|Lost to Follow-up|10
161851|NCT00297232|518072|P1|Overall Study|Lack of Efficacy|7
161852|NCT00297167|518078|P3|Second Double-blind Intervention Period|Protocol Violation|0
161853|NCT00297167|518079|P2|Second Double-blind Intervention Period|Protocol Violation|0
161854|NCT00297167|518080|P1|Second Double-blind Intervention Period|Protocol Violation|1
161855|NCT00297167|518078|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
161856|NCT00297167|518079|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
161857|NCT00297167|518080|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
161858|NCT00297037|518144|P2|Overall Study|Withdrawal by Subject|0
161859|NCT00297037|518145|P1|Overall Study|Withdrawal by Subject|2
161860|NCT00296816|518157|P1|Overall Study|ineligibility due to radiation treatment|1
161861|NCT00296816|518157|P1|Overall Study|Proteinuria|1
161862|NCT00296816|518157|P1|Overall Study|Neuropathy/patient preference|1
161863|NCT00296816|518157|P1|Overall Study|Urine protein/creatinine ratio delay|1
161864|NCT00296816|518157|P1|Overall Study|Noncompliance/decision to discontinue|1
161865|NCT00296816|518157|P1|Overall Study|Relocation to Florida|1
161866|NCT00296816|518157|P1|Overall Study|Poor performance status|1
161867|NCT00296816|518157|P1|Overall Study|Progression based on CA-125 (biomarker)|2
161868|NCT00296816|518157|P1|Overall Study|Missing for end of treatment|4
161869|NCT00296816|518157|P1|Overall Study|Non-compliance|1
161870|NCT00296816|518157|P1|Overall Study|Investigator/Participant request|5
161871|NCT00296816|518157|P1|Overall Study|Adverse Event|18
161872|NCT00296816|518157|P1|Overall Study|Disease Progression|37
161873|NCT00296647|518174|P5|Overall Study|Withdrawal by Subject|19
161874|NCT00296647|518175|P4|Overall Study|Withdrawal by Subject|16
161875|NCT00296647|518176|P3|Overall Study|Withdrawal by Subject|32
161876|NCT00296647|518177|P2|Overall Study|Withdrawal by Subject|27
161877|NCT00296647|518178|P1|Overall Study|Withdrawal by Subject|28
161878|NCT00296647|518174|P5|Overall Study|Death|1
161879|NCT00296647|518175|P4|Overall Study|Death|1
161880|NCT00296647|518176|P3|Overall Study|Death|2
161881|NCT00296647|518177|P2|Overall Study|Death|1
161882|NCT00296647|518178|P1|Overall Study|Death|4
161883|NCT00296517|518192|P2|Dose Level 3 - Weeks 3-12|Not specified|2
161884|NCT00296517|518193|P1|Dose Level 3 - Weeks 3-12|Not specified|0
161885|NCT00296517|518192|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
161886|NCT00296517|518193|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
161887|NCT00296517|518192|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
161888|NCT00296517|518193|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
161889|NCT00296517|518192|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
161890|NCT00296517|518193|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
161891|NCT00296517|518192|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
161892|NCT00296517|518193|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
161893|NCT00296517|518192|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
161894|NCT00296517|518193|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
161895|NCT00296517|518192|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
161896|NCT00296517|518193|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
161897|NCT00296517|518192|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
161898|NCT00296517|518193|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
161899|NCT00296517|518192|P2|Dose Level 2 - Week 2|Adverse Event|5
161900|NCT00296517|518193|P1|Dose Level 2 - Week 2|Adverse Event|1
161901|NCT00296504|518229|P9|Final Analysis|Poor Adherence|1
161902|NCT00296504|518230|P8|Final Analysis|Poor Adherence|0
161903|NCT00296504|518231|P7|Final Analysis|Poor Adherence|0
161904|NCT00296504|518232|P6|Final Analysis|Poor Adherence|0
161905|NCT00296504|518233|P5|Final Analysis|Poor Adherence|0
161906|NCT00296504|518234|P4|Final Analysis|Poor Adherence|0
161907|NCT00296504|518235|P3|Final Analysis|Poor Adherence|0
161908|NCT00296504|518236|P2|Final Analysis|Poor Adherence|0
161909|NCT00296504|518237|P1|Final Analysis|Poor Adherence|0
161910|NCT00296504|518229|P9|Final Analysis|Participant Moved to Another Country|1
161911|NCT00296504|518230|P8|Final Analysis|Participant Moved to Another Country|0
161912|NCT00296504|518231|P7|Final Analysis|Participant Moved to Another Country|0
161913|NCT00296504|518232|P6|Final Analysis|Participant Moved to Another Country|0
161914|NCT00296504|518233|P5|Final Analysis|Participant Moved to Another Country|0
161915|NCT00296504|518234|P4|Final Analysis|Participant Moved to Another Country|0
161916|NCT00296504|518235|P3|Final Analysis|Participant Moved to Another Country|0
161917|NCT00296504|518236|P2|Final Analysis|Participant Moved to Another Country|0
161918|NCT00296504|518237|P1|Final Analysis|Participant Moved to Another Country|0
161919|NCT00296504|518229|P9|Final Analysis|Tuberculosis|1
161920|NCT00296504|518230|P8|Final Analysis|Tuberculosis|0
161921|NCT00296504|518231|P7|Final Analysis|Tuberculosis|0
161922|NCT00296504|518232|P6|Final Analysis|Tuberculosis|0
161923|NCT00296504|518233|P5|Final Analysis|Tuberculosis|0
161924|NCT00296504|518234|P4|Final Analysis|Tuberculosis|0
161925|NCT00296504|518235|P3|Final Analysis|Tuberculosis|0
161926|NCT00296504|518236|P2|Final Analysis|Tuberculosis|0
161927|NCT00296504|518237|P1|Final Analysis|Tuberculosis|0
161928|NCT00296504|518229|P9|Final Analysis|Pregnancy|4
161929|NCT00296504|518230|P8|Final Analysis|Pregnancy|0
161930|NCT00296504|518231|P7|Final Analysis|Pregnancy|0
161931|NCT00296504|518232|P6|Final Analysis|Pregnancy|0
161932|NCT00296504|518233|P5|Final Analysis|Pregnancy|0
161933|NCT00296504|518234|P4|Final Analysis|Pregnancy|0
161934|NCT00296504|518235|P3|Final Analysis|Pregnancy|0
161935|NCT00296504|518236|P2|Final Analysis|Pregnancy|0
161936|NCT00296504|518237|P1|Final Analysis|Pregnancy|0
161937|NCT00296504|518229|P9|Final Analysis|Adverse Event|2
161938|NCT00296504|518230|P8|Final Analysis|Adverse Event|0
161939|NCT00296504|518231|P7|Final Analysis|Adverse Event|0
161940|NCT00296504|518232|P6|Final Analysis|Adverse Event|0
161941|NCT00296504|518233|P5|Final Analysis|Adverse Event|0
161942|NCT00296504|518234|P4|Final Analysis|Adverse Event|0
161943|NCT00296504|518235|P3|Final Analysis|Adverse Event|0
161944|NCT00296504|518236|P2|Final Analysis|Adverse Event|0
161945|NCT00296504|518237|P1|Final Analysis|Adverse Event|0
161946|NCT00296504|518229|P9|Final Analysis|Insufficient Viral Load Response|6
161947|NCT00296504|518230|P8|Final Analysis|Insufficient Viral Load Response|0
161948|NCT00296504|518231|P7|Final Analysis|Insufficient Viral Load Response|0
161949|NCT00296504|518232|P6|Final Analysis|Insufficient Viral Load Response|0
161950|NCT00296504|518233|P5|Final Analysis|Insufficient Viral Load Response|0
161951|NCT00296504|518234|P4|Final Analysis|Insufficient Viral Load Response|0
161952|NCT00296504|518235|P3|Final Analysis|Insufficient Viral Load Response|0
161953|NCT00296504|518236|P2|Final Analysis|Insufficient Viral Load Response|0
161954|NCT00296504|518237|P1|Final Analysis|Insufficient Viral Load Response|0
161955|NCT00296504|518229|P9|Final Analysis|Lost to Follow-up|5
161956|NCT00296504|518230|P8|Final Analysis|Lost to Follow-up|0
161957|NCT00296504|518231|P7|Final Analysis|Lost to Follow-up|0
161958|NCT00296504|518232|P6|Final Analysis|Lost to Follow-up|0
161959|NCT00296504|518233|P5|Final Analysis|Lost to Follow-up|0
161960|NCT00296504|518234|P4|Final Analysis|Lost to Follow-up|0
161961|NCT00296504|518235|P3|Final Analysis|Lost to Follow-up|0
161962|NCT00296504|518236|P2|Final Analysis|Lost to Follow-up|0
161963|NCT00296504|518237|P1|Final Analysis|Lost to Follow-up|0
161964|NCT00296504|518229|P9|Final Analysis|Withdrawal by Subject|1
161965|NCT00296504|518230|P8|Final Analysis|Withdrawal by Subject|0
161966|NCT00296504|518231|P7|Final Analysis|Withdrawal by Subject|0
161967|NCT00296504|518232|P6|Final Analysis|Withdrawal by Subject|0
161968|NCT00296504|518233|P5|Final Analysis|Withdrawal by Subject|0
161969|NCT00296504|518234|P4|Final Analysis|Withdrawal by Subject|0
161970|NCT00296504|518235|P3|Final Analysis|Withdrawal by Subject|0
161971|NCT00296504|518236|P2|Final Analysis|Withdrawal by Subject|0
161972|NCT00296504|518237|P1|Final Analysis|Withdrawal by Subject|0
161973|NCT00296504|518229|P9|Interim Analysis|Ongoing|0
161974|NCT00296504|518230|P8|Interim Analysis|Ongoing|1
161975|NCT00296504|518231|P7|Interim Analysis|Ongoing|30
161976|NCT00296504|518232|P6|Interim Analysis|Ongoing|0
161977|NCT00296504|518233|P5|Interim Analysis|Ongoing|0
161978|NCT00296504|518234|P4|Interim Analysis|Ongoing|22
161979|NCT00296504|518235|P3|Interim Analysis|Ongoing|16
161980|NCT00296504|518236|P2|Interim Analysis|Ongoing|12
161981|NCT00296504|518237|P1|Interim Analysis|Ongoing|32
161982|NCT00296504|518229|P9|Interim Analysis|Participant Needed Interferon|0
161983|NCT00296504|518230|P8|Interim Analysis|Participant Needed Interferon|1
161984|NCT00296504|518231|P7|Interim Analysis|Participant Needed Interferon|0
161985|NCT00296504|518232|P6|Interim Analysis|Participant Needed Interferon|0
161986|NCT00296504|518233|P5|Interim Analysis|Participant Needed Interferon|0
161987|NCT00296504|518234|P4|Interim Analysis|Participant Needed Interferon|0
161988|NCT00296504|518235|P3|Interim Analysis|Participant Needed Interferon|0
161989|NCT00296504|518236|P2|Interim Analysis|Participant Needed Interferon|0
161990|NCT00296504|518237|P1|Interim Analysis|Participant Needed Interferon|0
161991|NCT00296504|518229|P9|Interim Analysis|Study Ended|0
161992|NCT00296504|518230|P8|Interim Analysis|Study Ended|0
161993|NCT00296504|518231|P7|Interim Analysis|Study Ended|1
161994|NCT00296504|518232|P6|Interim Analysis|Study Ended|0
161995|NCT00296504|518233|P5|Interim Analysis|Study Ended|0
161996|NCT00296504|518234|P4|Interim Analysis|Study Ended|0
161997|NCT00296504|518235|P3|Interim Analysis|Study Ended|0
161998|NCT00296504|518236|P2|Interim Analysis|Study Ended|0
161999|NCT00296504|518237|P1|Interim Analysis|Study Ended|0
162000|NCT00296504|518229|P9|Interim Analysis|Participant Stopped HIV Medications|0
162001|NCT00296504|518230|P8|Interim Analysis|Participant Stopped HIV Medications|0
162002|NCT00296504|518231|P7|Interim Analysis|Participant Stopped HIV Medications|1
162003|NCT00296504|518232|P6|Interim Analysis|Participant Stopped HIV Medications|0
162004|NCT00296504|518233|P5|Interim Analysis|Participant Stopped HIV Medications|0
162005|NCT00296504|518234|P4|Interim Analysis|Participant Stopped HIV Medications|0
162006|NCT00296504|518235|P3|Interim Analysis|Participant Stopped HIV Medications|0
162007|NCT00296504|518236|P2|Interim Analysis|Participant Stopped HIV Medications|0
162008|NCT00296504|518237|P1|Interim Analysis|Participant Stopped HIV Medications|0
162009|NCT00296504|518229|P9|Interim Analysis|Physician and Participant Decision|0
162010|NCT00296504|518230|P8|Interim Analysis|Physician and Participant Decision|0
162011|NCT00296504|518231|P7|Interim Analysis|Physician and Participant Decision|0
162012|NCT00296504|518232|P6|Interim Analysis|Physician and Participant Decision|1
162013|NCT00296504|518233|P5|Interim Analysis|Physician and Participant Decision|0
162014|NCT00296504|518234|P4|Interim Analysis|Physician and Participant Decision|0
162015|NCT00296504|518235|P3|Interim Analysis|Physician and Participant Decision|0
162016|NCT00296504|518236|P2|Interim Analysis|Physician and Participant Decision|0
162017|NCT00296504|518237|P1|Interim Analysis|Physician and Participant Decision|0
162018|NCT00296504|518229|P9|Interim Analysis|Participant Stopped|0
162019|NCT00296504|518230|P8|Interim Analysis|Participant Stopped|0
162020|NCT00296504|518231|P7|Interim Analysis|Participant Stopped|0
162021|NCT00296504|518232|P6|Interim Analysis|Participant Stopped|0
162022|NCT00296504|518233|P5|Interim Analysis|Participant Stopped|1
162023|NCT00296504|518234|P4|Interim Analysis|Participant Stopped|0
162024|NCT00296504|518235|P3|Interim Analysis|Participant Stopped|0
162025|NCT00296504|518236|P2|Interim Analysis|Participant Stopped|0
162026|NCT00296504|518237|P1|Interim Analysis|Participant Stopped|0
162027|NCT00296504|518229|P9|Interim Analysis|Inclusion in Other Protocol|0
162028|NCT00296504|518230|P8|Interim Analysis|Inclusion in Other Protocol|0
162029|NCT00296504|518231|P7|Interim Analysis|Inclusion in Other Protocol|0
162030|NCT00296504|518232|P6|Interim Analysis|Inclusion in Other Protocol|0
162031|NCT00296504|518233|P5|Interim Analysis|Inclusion in Other Protocol|0
162032|NCT00296504|518234|P4|Interim Analysis|Inclusion in Other Protocol|1
162033|NCT00296504|518235|P3|Interim Analysis|Inclusion in Other Protocol|0
162034|NCT00296504|518236|P2|Interim Analysis|Inclusion in Other Protocol|0
162035|NCT00296504|518237|P1|Interim Analysis|Inclusion in Other Protocol|0
162036|NCT00296504|518229|P9|Interim Analysis|Missed Schedule Date|0
162037|NCT00296504|518230|P8|Interim Analysis|Missed Schedule Date|0
162038|NCT00296504|518231|P7|Interim Analysis|Missed Schedule Date|0
162039|NCT00296504|518232|P6|Interim Analysis|Missed Schedule Date|0
162040|NCT00296504|518233|P5|Interim Analysis|Missed Schedule Date|0
162041|NCT00296504|518234|P4|Interim Analysis|Missed Schedule Date|0
162042|NCT00296504|518235|P3|Interim Analysis|Missed Schedule Date|0
162043|NCT00296504|518236|P2|Interim Analysis|Missed Schedule Date|0
162044|NCT00296504|518237|P1|Interim Analysis|Missed Schedule Date|1
162045|NCT00296504|518229|P9|Interim Analysis|Lack of Personnel at Site|0
162046|NCT00296504|518230|P8|Interim Analysis|Lack of Personnel at Site|0
162047|NCT00296504|518231|P7|Interim Analysis|Lack of Personnel at Site|0
162048|NCT00296504|518232|P6|Interim Analysis|Lack of Personnel at Site|0
162049|NCT00296504|518233|P5|Interim Analysis|Lack of Personnel at Site|0
162050|NCT00296504|518234|P4|Interim Analysis|Lack of Personnel at Site|0
162051|NCT00296504|518235|P3|Interim Analysis|Lack of Personnel at Site|0
162052|NCT00296504|518236|P2|Interim Analysis|Lack of Personnel at Site|0
162053|NCT00296504|518237|P1|Interim Analysis|Lack of Personnel at Site|1
162054|NCT00296504|518229|P9|Interim Analysis|Site Closing|0
162055|NCT00296504|518230|P8|Interim Analysis|Site Closing|0
162056|NCT00296504|518231|P7|Interim Analysis|Site Closing|2
162057|NCT00296504|518232|P6|Interim Analysis|Site Closing|1
162058|NCT00296504|518233|P5|Interim Analysis|Site Closing|0
162059|NCT00296504|518234|P4|Interim Analysis|Site Closing|0
162060|NCT00296504|518235|P3|Interim Analysis|Site Closing|0
162061|NCT00296504|518236|P2|Interim Analysis|Site Closing|0
162062|NCT00296504|518237|P1|Interim Analysis|Site Closing|1
162063|NCT00296504|518229|P9|Interim Analysis|Non-adherence|0
162064|NCT00296504|518230|P8|Interim Analysis|Non-adherence|1
162065|NCT00296504|518231|P7|Interim Analysis|Non-adherence|0
162066|NCT00296504|518232|P6|Interim Analysis|Non-adherence|0
162067|NCT00296504|518233|P5|Interim Analysis|Non-adherence|1
162068|NCT00296504|518234|P4|Interim Analysis|Non-adherence|0
162069|NCT00296504|518235|P3|Interim Analysis|Non-adherence|0
162070|NCT00296504|518236|P2|Interim Analysis|Non-adherence|0
162071|NCT00296504|518237|P1|Interim Analysis|Non-adherence|2
162072|NCT00296504|518229|P9|Interim Analysis|Principle Investigator Terminated Study|0
162073|NCT00296504|518230|P8|Interim Analysis|Principle Investigator Terminated Study|0
162074|NCT00296504|518231|P7|Interim Analysis|Principle Investigator Terminated Study|0
162075|NCT00296504|518232|P6|Interim Analysis|Principle Investigator Terminated Study|0
162076|NCT00296504|518233|P5|Interim Analysis|Principle Investigator Terminated Study|0
162077|NCT00296504|518234|P4|Interim Analysis|Principle Investigator Terminated Study|0
162078|NCT00296504|518235|P3|Interim Analysis|Principle Investigator Terminated Study|1
162079|NCT00296504|518236|P2|Interim Analysis|Principle Investigator Terminated Study|0
162080|NCT00296504|518237|P1|Interim Analysis|Principle Investigator Terminated Study|0
162081|NCT00296504|518229|P9|Interim Analysis|Principle Investigator Discretion|0
162082|NCT00296504|518230|P8|Interim Analysis|Principle Investigator Discretion|0
162083|NCT00296504|518231|P7|Interim Analysis|Principle Investigator Discretion|0
162084|NCT00296504|518232|P6|Interim Analysis|Principle Investigator Discretion|0
162085|NCT00296504|518233|P5|Interim Analysis|Principle Investigator Discretion|0
162086|NCT00296504|518234|P4|Interim Analysis|Principle Investigator Discretion|1
162087|NCT00296504|518235|P3|Interim Analysis|Principle Investigator Discretion|1
162088|NCT00296504|518236|P2|Interim Analysis|Principle Investigator Discretion|0
162089|NCT00296504|518237|P1|Interim Analysis|Principle Investigator Discretion|2
162090|NCT00296504|518229|P9|Interim Analysis|Physician Decision|0
162091|NCT00296504|518230|P8|Interim Analysis|Physician Decision|0
162092|NCT00296504|518231|P7|Interim Analysis|Physician Decision|0
162093|NCT00296504|518232|P6|Interim Analysis|Physician Decision|0
162094|NCT00296504|518233|P5|Interim Analysis|Physician Decision|0
162095|NCT00296504|518234|P4|Interim Analysis|Physician Decision|0
162096|NCT00296504|518235|P3|Interim Analysis|Physician Decision|1
162097|NCT00296504|518236|P2|Interim Analysis|Physician Decision|0
162098|NCT00296504|518237|P1|Interim Analysis|Physician Decision|0
162099|NCT00296504|518229|P9|Interim Analysis|Resistance to FPV|0
162100|NCT00296504|518230|P8|Interim Analysis|Resistance to FPV|0
162101|NCT00296504|518231|P7|Interim Analysis|Resistance to FPV|0
162102|NCT00296504|518232|P6|Interim Analysis|Resistance to FPV|0
162103|NCT00296504|518233|P5|Interim Analysis|Resistance to FPV|0
162104|NCT00296504|518234|P4|Interim Analysis|Resistance to FPV|0
162105|NCT00296504|518235|P3|Interim Analysis|Resistance to FPV|1
162106|NCT00296504|518236|P2|Interim Analysis|Resistance to FPV|0
162107|NCT00296504|518237|P1|Interim Analysis|Resistance to FPV|0
162108|NCT00296504|518229|P9|Interim Analysis|Participant Was Incarcerated|0
162109|NCT00296504|518230|P8|Interim Analysis|Participant Was Incarcerated|0
162110|NCT00296504|518231|P7|Interim Analysis|Participant Was Incarcerated|0
162111|NCT00296504|518232|P6|Interim Analysis|Participant Was Incarcerated|0
162112|NCT00296504|518233|P5|Interim Analysis|Participant Was Incarcerated|0
162113|NCT00296504|518234|P4|Interim Analysis|Participant Was Incarcerated|0
162114|NCT00296504|518235|P3|Interim Analysis|Participant Was Incarcerated|1
162115|NCT00296504|518236|P2|Interim Analysis|Participant Was Incarcerated|0
162116|NCT00296504|518237|P1|Interim Analysis|Participant Was Incarcerated|2
162117|NCT00296504|518229|P9|Interim Analysis|Participant Moved|0
162118|NCT00296504|518230|P8|Interim Analysis|Participant Moved|0
162119|NCT00296504|518231|P7|Interim Analysis|Participant Moved|1
162120|NCT00296504|518232|P6|Interim Analysis|Participant Moved|1
162121|NCT00296504|518233|P5|Interim Analysis|Participant Moved|0
162122|NCT00296504|518234|P4|Interim Analysis|Participant Moved|0
162123|NCT00296504|518235|P3|Interim Analysis|Participant Moved|1
162124|NCT00296504|518236|P2|Interim Analysis|Participant Moved|0
162125|NCT00296504|518237|P1|Interim Analysis|Participant Moved|1
162126|NCT00296504|518229|P9|Interim Analysis|Participant Had Problems with Alcohol|0
162127|NCT00296504|518230|P8|Interim Analysis|Participant Had Problems with Alcohol|0
162128|NCT00296504|518231|P7|Interim Analysis|Participant Had Problems with Alcohol|0
162129|NCT00296504|518232|P6|Interim Analysis|Participant Had Problems with Alcohol|0
162130|NCT00296504|518233|P5|Interim Analysis|Participant Had Problems with Alcohol|0
162131|NCT00296504|518234|P4|Interim Analysis|Participant Had Problems with Alcohol|0
162132|NCT00296504|518235|P3|Interim Analysis|Participant Had Problems with Alcohol|1
162133|NCT00296504|518236|P2|Interim Analysis|Participant Had Problems with Alcohol|0
162134|NCT00296504|518237|P1|Interim Analysis|Participant Had Problems with Alcohol|0
162135|NCT00296504|518229|P9|Interim Analysis|To Simplify Treatment|0
162136|NCT00296504|518230|P8|Interim Analysis|To Simplify Treatment|0
162137|NCT00296504|518231|P7|Interim Analysis|To Simplify Treatment|2
162138|NCT00296504|518232|P6|Interim Analysis|To Simplify Treatment|0
162139|NCT00296504|518233|P5|Interim Analysis|To Simplify Treatment|0
162140|NCT00296504|518234|P4|Interim Analysis|To Simplify Treatment|0
162141|NCT00296504|518235|P3|Interim Analysis|To Simplify Treatment|1
162142|NCT00296504|518236|P2|Interim Analysis|To Simplify Treatment|0
162143|NCT00296504|518237|P1|Interim Analysis|To Simplify Treatment|0
162144|NCT00296504|518229|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
162145|NCT00296504|518230|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
162146|NCT00296504|518231|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
162147|NCT00296504|518232|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
162148|NCT00296504|518233|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
162149|NCT00296504|518234|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
162150|NCT00296504|518235|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
162151|NCT00296504|518236|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
162152|NCT00296504|518237|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
162153|NCT00296504|518229|P9|Interim Analysis|Participant Non-compliant|0
162154|NCT00296504|518230|P8|Interim Analysis|Participant Non-compliant|2
162155|NCT00296504|518231|P7|Interim Analysis|Participant Non-compliant|6
162156|NCT00296504|518232|P6|Interim Analysis|Participant Non-compliant|3
162157|NCT00296504|518233|P5|Interim Analysis|Participant Non-compliant|1
162158|NCT00296504|518234|P4|Interim Analysis|Participant Non-compliant|1
162159|NCT00296504|518235|P3|Interim Analysis|Participant Non-compliant|2
162160|NCT00296504|518236|P2|Interim Analysis|Participant Non-compliant|1
162161|NCT00296504|518237|P1|Interim Analysis|Participant Non-compliant|0
162162|NCT00296504|518229|P9|Interim Analysis|Death|0
162163|NCT00296504|518230|P8|Interim Analysis|Death|0
162164|NCT00296504|518231|P7|Interim Analysis|Death|0
162165|NCT00296504|518232|P6|Interim Analysis|Death|0
162166|NCT00296504|518233|P5|Interim Analysis|Death|0
162167|NCT00296504|518234|P4|Interim Analysis|Death|0
162168|NCT00296504|518235|P3|Interim Analysis|Death|3
162169|NCT00296504|518236|P2|Interim Analysis|Death|0
162170|NCT00296504|518237|P1|Interim Analysis|Death|1
162171|NCT00296504|518229|P9|Interim Analysis|Pregnancy|0
162172|NCT00296504|518230|P8|Interim Analysis|Pregnancy|1
162173|NCT00296504|518231|P7|Interim Analysis|Pregnancy|1
162174|NCT00296504|518232|P6|Interim Analysis|Pregnancy|1
162175|NCT00296504|518233|P5|Interim Analysis|Pregnancy|0
162176|NCT00296504|518234|P4|Interim Analysis|Pregnancy|2
162177|NCT00296504|518235|P3|Interim Analysis|Pregnancy|4
162178|NCT00296504|518236|P2|Interim Analysis|Pregnancy|1
162179|NCT00296504|518237|P1|Interim Analysis|Pregnancy|4
162180|NCT00296504|518229|P9|Interim Analysis|Switched to Commercially Available Drug|0
162181|NCT00296504|518230|P8|Interim Analysis|Switched to Commercially Available Drug|4
162182|NCT00296504|518231|P7|Interim Analysis|Switched to Commercially Available Drug|3
162183|NCT00296504|518232|P6|Interim Analysis|Switched to Commercially Available Drug|5
162184|NCT00296504|518233|P5|Interim Analysis|Switched to Commercially Available Drug|0
162185|NCT00296504|518234|P4|Interim Analysis|Switched to Commercially Available Drug|1
162186|NCT00296504|518235|P3|Interim Analysis|Switched to Commercially Available Drug|4
162187|NCT00296504|518236|P2|Interim Analysis|Switched to Commercially Available Drug|0
162188|NCT00296504|518237|P1|Interim Analysis|Switched to Commercially Available Drug|2
162189|NCT00296504|518229|P9|Interim Analysis|Insufficient CD4 Response|0
162190|NCT00296504|518230|P8|Interim Analysis|Insufficient CD4 Response|0
162191|NCT00296504|518231|P7|Interim Analysis|Insufficient CD4 Response|0
162192|NCT00296504|518232|P6|Interim Analysis|Insufficient CD4 Response|1
162193|NCT00296504|518233|P5|Interim Analysis|Insufficient CD4 Response|1
162194|NCT00296504|518234|P4|Interim Analysis|Insufficient CD4 Response|0
162195|NCT00296504|518235|P3|Interim Analysis|Insufficient CD4 Response|0
162196|NCT00296504|518236|P2|Interim Analysis|Insufficient CD4 Response|0
162197|NCT00296504|518237|P1|Interim Analysis|Insufficient CD4 Response|0
162198|NCT00296504|518229|P9|Interim Analysis|Protocol Violation|0
162199|NCT00296504|518230|P8|Interim Analysis|Protocol Violation|1
162200|NCT00296504|518231|P7|Interim Analysis|Protocol Violation|0
162201|NCT00296504|518232|P6|Interim Analysis|Protocol Violation|0
162202|NCT00296504|518233|P5|Interim Analysis|Protocol Violation|1
162203|NCT00296504|518234|P4|Interim Analysis|Protocol Violation|0
162204|NCT00296504|518235|P3|Interim Analysis|Protocol Violation|2
162205|NCT00296504|518236|P2|Interim Analysis|Protocol Violation|0
162206|NCT00296504|518237|P1|Interim Analysis|Protocol Violation|0
162207|NCT00296504|518229|P9|Interim Analysis|Adverse Event|0
162208|NCT00296504|518230|P8|Interim Analysis|Adverse Event|5
162209|NCT00296504|518231|P7|Interim Analysis|Adverse Event|4
162210|NCT00296504|518232|P6|Interim Analysis|Adverse Event|3
162211|NCT00296504|518233|P5|Interim Analysis|Adverse Event|6
162212|NCT00296504|518234|P4|Interim Analysis|Adverse Event|4
162213|NCT00296504|518235|P3|Interim Analysis|Adverse Event|13
162214|NCT00296504|518236|P2|Interim Analysis|Adverse Event|0
162215|NCT00296504|518237|P1|Interim Analysis|Adverse Event|0
162216|NCT00296504|518229|P9|Interim Analysis|Insufficient Viral Load Response|0
162302|NCT00296400|518363|P2|Overall Study|Adverse Event|7
162217|NCT00296504|518230|P8|Interim Analysis|Insufficient Viral Load Response|24
162218|NCT00296504|518231|P7|Interim Analysis|Insufficient Viral Load Response|2
162219|NCT00296504|518232|P6|Interim Analysis|Insufficient Viral Load Response|9
162220|NCT00296504|518233|P5|Interim Analysis|Insufficient Viral Load Response|7
162221|NCT00296504|518234|P4|Interim Analysis|Insufficient Viral Load Response|2
162222|NCT00296504|518235|P3|Interim Analysis|Insufficient Viral Load Response|12
162223|NCT00296504|518236|P2|Interim Analysis|Insufficient Viral Load Response|1
162224|NCT00296504|518237|P1|Interim Analysis|Insufficient Viral Load Response|5
162225|NCT00296504|518229|P9|Interim Analysis|Clinical Progression|0
162226|NCT00296504|518230|P8|Interim Analysis|Clinical Progression|2
162227|NCT00296504|518231|P7|Interim Analysis|Clinical Progression|1
162228|NCT00296504|518232|P6|Interim Analysis|Clinical Progression|2
162229|NCT00296504|518233|P5|Interim Analysis|Clinical Progression|0
162230|NCT00296504|518234|P4|Interim Analysis|Clinical Progression|1
162231|NCT00296504|518235|P3|Interim Analysis|Clinical Progression|1
162232|NCT00296504|518236|P2|Interim Analysis|Clinical Progression|0
162233|NCT00296504|518237|P1|Interim Analysis|Clinical Progression|1
162234|NCT00296504|518229|P9|Interim Analysis|Lost to Follow-up|0
162235|NCT00296504|518230|P8|Interim Analysis|Lost to Follow-up|4
162236|NCT00296504|518231|P7|Interim Analysis|Lost to Follow-up|11
162237|NCT00296504|518232|P6|Interim Analysis|Lost to Follow-up|4
162238|NCT00296504|518233|P5|Interim Analysis|Lost to Follow-up|14
162239|NCT00296504|518234|P4|Interim Analysis|Lost to Follow-up|8
162240|NCT00296504|518235|P3|Interim Analysis|Lost to Follow-up|26
162241|NCT00296504|518236|P2|Interim Analysis|Lost to Follow-up|3
162242|NCT00296504|518237|P1|Interim Analysis|Lost to Follow-up|13
162243|NCT00296504|518229|P9|Interim Analysis|Withdrawal by Subject|0
162244|NCT00296504|518230|P8|Interim Analysis|Withdrawal by Subject|3
162245|NCT00296504|518231|P7|Interim Analysis|Withdrawal by Subject|9
162246|NCT00296504|518232|P6|Interim Analysis|Withdrawal by Subject|5
162247|NCT00296504|518233|P5|Interim Analysis|Withdrawal by Subject|5
162248|NCT00296504|518234|P4|Interim Analysis|Withdrawal by Subject|0
162249|NCT00296504|518235|P3|Interim Analysis|Withdrawal by Subject|12
162250|NCT00296504|518236|P2|Interim Analysis|Withdrawal by Subject|0
162251|NCT00296504|518237|P1|Interim Analysis|Withdrawal by Subject|8
162252|NCT00296491|518330|P4|Overall Study|Lost to Follow-up|0
162253|NCT00296491|518331|P3|Overall Study|Lost to Follow-up|2
162254|NCT00296491|518332|P2|Overall Study|Lost to Follow-up|2
162255|NCT00296491|518333|P1|Overall Study|Lost to Follow-up|0
162256|NCT00296491|518330|P4|Overall Study|Non-Compliance|14
162257|NCT00296491|518331|P3|Overall Study|Non-Compliance|10
162258|NCT00296491|518332|P2|Overall Study|Non-Compliance|13
162259|NCT00296491|518333|P1|Overall Study|Non-Compliance|12
162260|NCT00296491|518330|P4|Overall Study|Withdrawal by Subject|2
162261|NCT00296491|518331|P3|Overall Study|Withdrawal by Subject|3
162262|NCT00296491|518332|P2|Overall Study|Withdrawal by Subject|3
162263|NCT00296491|518333|P1|Overall Study|Withdrawal by Subject|7
162264|NCT00296491|518330|P4|Overall Study|Withdrawn due to Asthma|4
162265|NCT00296491|518331|P3|Overall Study|Withdrawn due to Asthma|0
162266|NCT00296491|518332|P2|Overall Study|Withdrawn due to Asthma|0
162267|NCT00296491|518333|P1|Overall Study|Withdrawn due to Asthma|0
162268|NCT00296491|518330|P4|Overall Study|Adverse Event|4
162269|NCT00296491|518331|P3|Overall Study|Adverse Event|1
162270|NCT00296491|518332|P2|Overall Study|Adverse Event|3
162271|NCT00296491|518333|P1|Overall Study|Adverse Event|1
162272|NCT00296491|518330|P4|Overall Study|Protocol Violation|3
162273|NCT00296491|518331|P3|Overall Study|Protocol Violation|2
162274|NCT00296491|518332|P2|Overall Study|Protocol Violation|6
162275|NCT00296491|518333|P1|Overall Study|Protocol Violation|4
162276|NCT00296491|518330|P4|Overall Study|Low Pollen Counts|16
162277|NCT00296491|518331|P3|Overall Study|Low Pollen Counts|25
162278|NCT00296491|518332|P2|Overall Study|Low Pollen Counts|26
162279|NCT00296491|518333|P1|Overall Study|Low Pollen Counts|18
162280|NCT00296400|518362|P3|Overall Study|Pregnancy|0
162281|NCT00296400|518363|P2|Overall Study|Pregnancy|2
162282|NCT00296400|518364|P1|Overall Study|Pregnancy|1
162283|NCT00296400|518362|P3|Overall Study|Visit 10 was performed earlier|0
162284|NCT00296400|518363|P2|Overall Study|Visit 10 was performed earlier|1
162285|NCT00296400|518364|P1|Overall Study|Visit 10 was performed earlier|0
162286|NCT00296400|518362|P3|Overall Study|Study specific discontinuation criteria|1
162287|NCT00296400|518363|P2|Overall Study|Study specific discontinuation criteria|0
162288|NCT00296400|518364|P1|Overall Study|Study specific discontinuation criteria|0
162289|NCT00296400|518362|P3|Overall Study|Lost to Follow-up|2
162290|NCT00296400|518363|P2|Overall Study|Lost to Follow-up|1
162291|NCT00296400|518364|P1|Overall Study|Lost to Follow-up|1
162292|NCT00296400|518362|P3|Overall Study|Protocol Violation|1
162293|NCT00296400|518363|P2|Overall Study|Protocol Violation|1
162294|NCT00296400|518364|P1|Overall Study|Protocol Violation|1
162295|NCT00296400|518362|P3|Overall Study|Incorrect enrollment|0
162296|NCT00296400|518363|P2|Overall Study|Incorrect enrollment|0
162297|NCT00296400|518364|P1|Overall Study|Incorrect enrollment|2
162298|NCT00296400|518362|P3|Overall Study|Withdrawal by Subject|2
162299|NCT00296400|518363|P2|Overall Study|Withdrawal by Subject|6
162300|NCT00296400|518364|P1|Overall Study|Withdrawal by Subject|5
162301|NCT00296400|518362|P3|Overall Study|Adverse Event|7
162303|NCT00296400|518364|P1|Overall Study|Adverse Event|7
162304|NCT00296374|518588|P3|Overall Study|Not specified|1
162305|NCT00296374|518589|P2|Overall Study|Not specified|0
162306|NCT00296374|518590|P1|Overall Study|Not specified|0
162307|NCT00296374|518588|P3|Overall Study|Pregnancy|2
162308|NCT00296374|518589|P2|Overall Study|Pregnancy|0
162309|NCT00296374|518590|P1|Overall Study|Pregnancy|0
162310|NCT00296374|518588|P3|Overall Study|Nephrologist introduced ACE|0
162311|NCT00296374|518589|P2|Overall Study|Nephrologist introduced ACE|1
162312|NCT00296374|518590|P1|Overall Study|Nephrologist introduced ACE|0
162313|NCT00296374|518588|P3|Overall Study|Stopped drug before end of study visit|0
162314|NCT00296374|518589|P2|Overall Study|Stopped drug before end of study visit|1
162315|NCT00296374|518590|P1|Overall Study|Stopped drug before end of study visit|0
162316|NCT00296374|518588|P3|Overall Study|Relocated to another state|0
162317|NCT00296374|518589|P2|Overall Study|Relocated to another state|0
162318|NCT00296374|518590|P1|Overall Study|Relocated to another state|1
162319|NCT00296374|518588|P3|Overall Study|Lost to Follow-up|1
162320|NCT00296374|518589|P2|Overall Study|Lost to Follow-up|1
162321|NCT00296374|518590|P1|Overall Study|Lost to Follow-up|3
162322|NCT00296374|518588|P3|Overall Study|Protocol Violation|3
162323|NCT00296374|518589|P2|Overall Study|Protocol Violation|2
162324|NCT00296374|518590|P1|Overall Study|Protocol Violation|1
162325|NCT00296374|518588|P3|Overall Study|Incorrect enrollment|4
162326|NCT00296374|518589|P2|Overall Study|Incorrect enrollment|3
162327|NCT00296374|518590|P1|Overall Study|Incorrect enrollment|3
162328|NCT00296374|518588|P3|Overall Study|Withdrawal by Subject|11
162329|NCT00296374|518589|P2|Overall Study|Withdrawal by Subject|5
162330|NCT00296374|518590|P1|Overall Study|Withdrawal by Subject|3
162331|NCT00296374|518588|P3|Overall Study|Adverse Event|7
162332|NCT00296374|518589|P2|Overall Study|Adverse Event|10
162333|NCT00296374|518590|P1|Overall Study|Adverse Event|14
162334|NCT00296335|518813|P2|Overall Study|Physician Decision|11
162335|NCT00296335|518814|P1|Overall Study|Physician Decision|3
162336|NCT00296335|518813|P2|Overall Study|Lost to Follow-up|33
162337|NCT00296335|518814|P1|Overall Study|Lost to Follow-up|7
162338|NCT00296335|518813|P2|Overall Study|Adverse Event|27
162339|NCT00296335|518814|P1|Overall Study|Adverse Event|17
162340|NCT00296335|518813|P2|Overall Study|Recurrence|51
162341|NCT00296335|518814|P1|Overall Study|Recurrence|3
162342|NCT00296244|518839|P2|Overall Study|Underwent retransplant|1
162343|NCT00296244|518840|P1|Overall Study|Underwent retransplant|0
162344|NCT00295880|518902|P1|Overall Study|Unit randomization did not occur|1
162345|NCT00295880|518902|P1|Overall Study|IBMI unit could not be volume reduced|1
162346|NCT00295854|518916|P3|Overall Study|not specified|1
162347|NCT00295854|518917|P2|Overall Study|not specified|5
162348|NCT00295854|518918|P1|Overall Study|not specified|3
162349|NCT00295854|518916|P3|Overall Study|required a prohibited medication|0
162350|NCT00295854|518917|P2|Overall Study|required a prohibited medication|0
162351|NCT00295854|518918|P1|Overall Study|required a prohibited medication|1
162352|NCT00295854|518916|P3|Overall Study|did not continue to meet criteria|2
162353|NCT00295854|518917|P2|Overall Study|did not continue to meet criteria|1
162354|NCT00295854|518918|P1|Overall Study|did not continue to meet criteria|1
162355|NCT00295854|518916|P3|Overall Study|Withdrawal by Subject|4
162356|NCT00295854|518917|P2|Overall Study|Withdrawal by Subject|7
162357|NCT00295854|518918|P1|Overall Study|Withdrawal by Subject|3
162358|NCT00295854|518916|P3|Overall Study|Lost to Follow-up|1
162359|NCT00295854|518917|P2|Overall Study|Lost to Follow-up|0
162360|NCT00295854|518918|P1|Overall Study|Lost to Follow-up|2
162361|NCT00295854|518916|P3|Overall Study|Protocol Violation|1
162362|NCT00295854|518917|P2|Overall Study|Protocol Violation|1
162363|NCT00295854|518918|P1|Overall Study|Protocol Violation|1
162364|NCT00295854|518916|P3|Overall Study|Adverse Event|6
162365|NCT00295854|518917|P2|Overall Study|Adverse Event|7
162366|NCT00295854|518918|P1|Overall Study|Adverse Event|7
162367|NCT00295750|518932|P3|Overall Study|Protocol Violation|2
162368|NCT00295750|518933|P2|Overall Study|Protocol Violation|4
162369|NCT00295750|518934|P1|Overall Study|Protocol Violation|2
162370|NCT00295750|518932|P3|Overall Study|Withdrawal by Subject|7
162371|NCT00295750|518933|P2|Overall Study|Withdrawal by Subject|4
162372|NCT00295750|518934|P1|Overall Study|Withdrawal by Subject|9
162373|NCT00295750|518932|P3|Overall Study|Randomized but never received trial drug|3
162374|NCT00295750|518933|P2|Overall Study|Randomized but never received trial drug|3
162375|NCT00295750|518934|P1|Overall Study|Randomized but never received trial drug|4
162376|NCT00295750|518932|P3|Overall Study|Personal reasons|0
162377|NCT00295750|518933|P2|Overall Study|Personal reasons|1
162378|NCT00295750|518934|P1|Overall Study|Personal reasons|0
162379|NCT00295750|518932|P3|Overall Study|Disease progression|0
162380|NCT00295750|518933|P2|Overall Study|Disease progression|1
162381|NCT00295750|518934|P1|Overall Study|Disease progression|2
162382|NCT00295750|518932|P3|Overall Study|Trial drug errors|0
162383|NCT00295750|518933|P2|Overall Study|Trial drug errors|1
162384|NCT00295750|518934|P1|Overall Study|Trial drug errors|1
162385|NCT00295750|518932|P3|Overall Study|Administrative errors|5
162386|NCT00295750|518933|P2|Overall Study|Administrative errors|4
162387|NCT00295750|518934|P1|Overall Study|Administrative errors|2
162388|NCT00295750|518932|P3|Overall Study|Taking prohibited therapy|2
162389|NCT00295750|518933|P2|Overall Study|Taking prohibited therapy|3
162390|NCT00295750|518934|P1|Overall Study|Taking prohibited therapy|2
162391|NCT00295750|518932|P3|Overall Study|Lost to Follow-up|1
162392|NCT00295750|518933|P2|Overall Study|Lost to Follow-up|4
162393|NCT00295750|518934|P1|Overall Study|Lost to Follow-up|1
162394|NCT00295750|518932|P3|Overall Study|Lack of Efficacy|0
162395|NCT00295750|518933|P2|Overall Study|Lack of Efficacy|1
162396|NCT00295750|518934|P1|Overall Study|Lack of Efficacy|1
162397|NCT00295750|518932|P3|Overall Study|Adverse Event|12
162398|NCT00295750|518933|P2|Overall Study|Adverse Event|15
162399|NCT00295750|518934|P1|Overall Study|Adverse Event|19
162400|NCT00295633|518969|P3|Overall Study|Administrative reason by sponsor|1
162401|NCT00295633|518970|P2|Overall Study|Administrative reason by sponsor|0
162402|NCT00295633|518971|P1|Overall Study|Administrative reason by sponsor|0
162403|NCT00295633|518969|P3|Overall Study|Death|0
162404|NCT00295633|518970|P2|Overall Study|Death|1
162405|NCT00295633|518971|P1|Overall Study|Death|1
162406|NCT00295633|518969|P3|Overall Study|Subject No Longer Meets Study Criteria|3
162407|NCT00295633|518970|P2|Overall Study|Subject No Longer Meets Study Criteria|3
162408|NCT00295633|518971|P1|Overall Study|Subject No Longer Meets Study Criteria|0
162409|NCT00295633|518969|P3|Overall Study|Poor/Noncompliance|6
162410|NCT00295633|518970|P2|Overall Study|Poor/Noncompliance|2
162411|NCT00295633|518971|P1|Overall Study|Poor/Noncompliance|2
162412|NCT00295633|518969|P3|Overall Study|Physician Decision|8
162413|NCT00295633|518970|P2|Overall Study|Physician Decision|10
162414|NCT00295633|518971|P1|Overall Study|Physician Decision|9
162415|NCT00295633|518969|P3|Overall Study|Lost to Follow-up|7
162416|NCT00295633|518970|P2|Overall Study|Lost to Follow-up|11
162417|NCT00295633|518971|P1|Overall Study|Lost to Follow-up|6
162418|NCT00295633|518969|P3|Overall Study|Adverse Event|9
162419|NCT00295633|518970|P2|Overall Study|Adverse Event|17
162420|NCT00295633|518971|P1|Overall Study|Adverse Event|9
162421|NCT00295633|518969|P3|Overall Study|Withdrawal of consent by subject|26
162422|NCT00295633|518970|P2|Overall Study|Withdrawal of consent by subject|16
162423|NCT00295633|518971|P1|Overall Study|Withdrawal of consent by subject|16
162424|NCT00295633|518969|P3|Overall Study|Lack of Efficacy|16
162425|NCT00295633|518970|P2|Overall Study|Lack of Efficacy|7
162426|NCT00295633|518971|P1|Overall Study|Lack of Efficacy|19
162427|NCT00295490|518998|P4|Overall Study|Other|1
162428|NCT00295490|518999|P3|Overall Study|Other|0
162429|NCT00295490|519000|P2|Overall Study|Other|2
162430|NCT00295490|519001|P1|Overall Study|Other|0
162431|NCT00295490|518998|P4|Overall Study|Adverse Event|0
162432|NCT00295490|518999|P3|Overall Study|Adverse Event|0
162433|NCT00295490|519000|P2|Overall Study|Adverse Event|0
162434|NCT00295490|519001|P1|Overall Study|Adverse Event|1
162435|NCT00295490|518998|P4|Overall Study|Lost to Follow-up|0
162436|NCT00295490|518999|P3|Overall Study|Lost to Follow-up|1
162437|NCT00295490|519000|P2|Overall Study|Lost to Follow-up|0
162438|NCT00295490|519001|P1|Overall Study|Lost to Follow-up|0
162439|NCT00295490|518998|P4|Overall Study|Withdrawal by Subject|1
162440|NCT00295490|518999|P3|Overall Study|Withdrawal by Subject|0
162441|NCT00295490|519000|P2|Overall Study|Withdrawal by Subject|2
162442|NCT00295490|519001|P1|Overall Study|Withdrawal by Subject|0
162443|NCT00295490|518998|P4|Overall Study|Protocol Violation|3
162444|NCT00295490|518999|P3|Overall Study|Protocol Violation|3
162445|NCT00295490|519000|P2|Overall Study|Protocol Violation|0
162446|NCT00295490|519001|P1|Overall Study|Protocol Violation|0
162447|NCT00294762|519081|P2|Overall Study|Did not receive study treatment|3
162448|NCT00294762|519082|P1|Overall Study|Did not receive study treatment|3
162449|NCT00294723|519101|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
162450|NCT00294723|519102|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
162451|NCT00294723|519103|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
162452|NCT00294723|519101|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
162453|NCT00294723|519102|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
162454|NCT00294723|519103|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
162455|NCT00294723|519101|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
162456|NCT00294723|519102|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
162457|NCT00294723|519103|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
162458|NCT00294723|519101|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
162459|NCT00294723|519102|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
162460|NCT00294723|519103|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
162461|NCT00294723|519101|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
162462|NCT00294723|519102|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
162463|NCT00294723|519103|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
162464|NCT00294723|519101|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
162465|NCT00294723|519102|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
162466|NCT00294723|519103|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
162467|NCT00294723|519101|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
162468|NCT00294723|519102|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
162469|NCT00294723|519103|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
162470|NCT00294723|519101|P3|Open-Label Extension 52 Weeks|Adverse Event|2
162471|NCT00294723|519102|P2|Open-Label Extension 52 Weeks|Adverse Event|5
162472|NCT00294723|519103|P1|Open-Label Extension 52 Weeks|Adverse Event|5
162473|NCT00294723|519101|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
162474|NCT00294723|519102|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
162475|NCT00294723|519103|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
162476|NCT00294723|519101|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
162477|NCT00294723|519102|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
162478|NCT00294723|519103|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
162479|NCT00294723|519101|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
162480|NCT00294723|519102|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
162481|NCT00294723|519103|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
162482|NCT00294723|519101|P3|Double-Blind Period 52 Weeks|Adverse Event|15
162483|NCT00294723|519102|P2|Double-Blind Period 52 Weeks|Adverse Event|25
162484|NCT00294723|519103|P1|Double-Blind Period 52 Weeks|Adverse Event|18
162485|NCT00294658|519164|P2|Overall Study|Patient and family were not satisfied|1
162486|NCT00294658|519165|P1|Overall Study|Patient and family were not satisfied|0
162487|NCT00294658|519164|P2|Overall Study|Found to have invasive thymoma|0
162488|NCT00294658|519165|P1|Overall Study|Found to have invasive thymoma|1
162489|NCT00294658|519164|P2|Overall Study|Withdrawal by Subject|4
162490|NCT00294658|519165|P1|Overall Study|Withdrawal by Subject|0
162491|NCT00294658|519164|P2|Overall Study|Pregnancy|1
162492|NCT00294658|519165|P1|Overall Study|Pregnancy|0
162493|NCT00294658|519164|P2|Overall Study|Physician Decision|2
162494|NCT00294658|519165|P1|Overall Study|Physician Decision|1
162495|NCT00294658|519164|P2|Overall Study|Lost to Follow-up|0
162496|NCT00294658|519165|P1|Overall Study|Lost to Follow-up|4
162497|NCT00294658|519164|P2|Overall Study|Death|1
162498|NCT00294658|519165|P1|Overall Study|Death|0
162499|NCT00294645|519229|P2|Overall Study|Other|10
162500|NCT00294645|519230|P1|Overall Study|Other|4
162501|NCT00294645|519229|P2|Overall Study|Physician Decision|20
162502|NCT00294645|519230|P1|Overall Study|Physician Decision|15
162503|NCT00294645|519229|P2|Overall Study|Withdrawal by Subject|34
162504|NCT00294645|519230|P1|Overall Study|Withdrawal by Subject|18
162505|NCT00294645|519229|P2|Overall Study|Lost to Follow-up|10
162506|NCT00294645|519230|P1|Overall Study|Lost to Follow-up|1
162507|NCT00294645|519229|P2|Overall Study|Death|18
162508|NCT00294645|519230|P1|Overall Study|Death|10
162509|NCT00294398|519281|P2|Overall Study|Lost to Follow-up|26
162510|NCT00294398|519282|P1|Overall Study|Lost to Follow-up|21
162511|NCT00294060|519290|P1|Overall Study|Device explanted/not replaced|23
162512|NCT00294060|519290|P1|Overall Study|Medical condition|3
162513|NCT00294060|519290|P1|Overall Study|Physician Decision|797
162514|NCT00294060|519290|P1|Overall Study|Withdrawal by Subject|11
162515|NCT00294060|519290|P1|Overall Study|Lost to Follow-up|55
162516|NCT00294060|519290|P1|Overall Study|Other|59
162517|NCT00294060|519290|P1|Overall Study|Death|225
162518|NCT00294047|519298|P2|Month 84|No consent for Month 84 Follow-up|754
162519|NCT00294047|519299|P1|Month 84|No consent for Month 84 Follow-up|731
162520|NCT00294047|519298|P2|Month 84|Visit missed|1
162521|NCT00294047|519299|P1|Month 84|Visit missed|0
162522|NCT00294047|519298|P2|Month 84|Under investigation locally|0
162523|NCT00294047|519299|P1|Month 84|Under investigation locally|1
162524|NCT00294047|519298|P2|Month 84|Unable to reach study site|0
162525|NCT00294047|519299|P1|Month 84|Unable to reach study site|1
162526|NCT00294047|519298|P2|Month 84|Transport reimbursement delayed|1
162527|NCT00294047|519299|P1|Month 84|Transport reimbursement delayed|0
162528|NCT00294047|519298|P2|Month 84|Subject does not want male physician|0
162529|NCT00294047|519299|P1|Month 84|Subject does not want male physician|1
162530|NCT00294047|519298|P2|Month 84|Personal reason|4
162531|NCT00294047|519299|P1|Month 84|Personal reason|2
162532|NCT00294047|519298|P2|Month 84|Lack of time|1
162533|NCT00294047|519299|P1|Month 84|Lack of time|3
162534|NCT00294047|519298|P2|Month 84|Family problems|2
162535|NCT00294047|519299|P1|Month 84|Family problems|2
162536|NCT00294047|519298|P2|Month 84|Center closed, subject did not transfer|0
162537|NCT00294047|519299|P1|Month 84|Center closed, subject did not transfer|1
162538|NCT00294047|519298|P2|Month 84|Work related reasons|2
162539|NCT00294047|519299|P1|Month 84|Work related reasons|4
162540|NCT00294047|519298|P2|Month 84|Absent Cervix|0
162541|NCT00294047|519299|P1|Month 84|Absent Cervix|2
162542|NCT00294047|519298|P2|Month 84|Lost to Follow-up|190
162543|NCT00294047|519299|P1|Month 84|Lost to Follow-up|187
162544|NCT00294047|519298|P2|Month 84|Withdrawal by Subject|31
162545|NCT00294047|519299|P1|Month 84|Withdrawal by Subject|33
162546|NCT00294047|519298|P2|Month 84|Protocol Violation|1
162547|NCT00294047|519299|P1|Month 84|Protocol Violation|1
162548|NCT00294047|519298|P2|Month 84|Adverse Event|2
162549|NCT00294047|519299|P1|Month 84|Adverse Event|4
162550|NCT00294047|519298|P2|Month 48|Unspecified|14
162551|NCT00294047|519299|P1|Month 48|Unspecified|10
162552|NCT00294047|519298|P2|Month 48|Lost to Follow-up|287
162553|NCT00294047|519299|P1|Month 48|Lost to Follow-up|272
162554|NCT00294047|519298|P2|Month 48|Withdrawal by Subject|115
162555|NCT00294047|519299|P1|Month 48|Withdrawal by Subject|111
162556|NCT00294047|519298|P2|Month 48|Protocol Violation|4
162557|NCT00294047|519299|P1|Month 48|Protocol Violation|4
162558|NCT00294047|519298|P2|Month 48|Adverse Event|13
162559|NCT00294047|519299|P1|Month 48|Adverse Event|28
162560|NCT00293813|519404|P3|Overall Study|Noncompliance|0
162561|NCT00293813|519405|P2|Overall Study|Noncompliance|1
162562|NCT00293813|519406|P1|Overall Study|Noncompliance|0
162563|NCT00293813|519404|P3|Overall Study|Lost to Follow-up|3
162564|NCT00293813|519405|P2|Overall Study|Lost to Follow-up|2
162565|NCT00293813|519406|P1|Overall Study|Lost to Follow-up|3
162566|NCT00293813|519404|P3|Overall Study|Withdrawal by Subject|4
162567|NCT00293813|519405|P2|Overall Study|Withdrawal by Subject|4
162568|NCT00293813|519406|P1|Overall Study|Withdrawal by Subject|7
162569|NCT00293813|519404|P3|Overall Study|Adverse Event|1
162570|NCT00293813|519405|P2|Overall Study|Adverse Event|1
162571|NCT00293813|519406|P1|Overall Study|Adverse Event|3
162572|NCT00293813|519404|P3|Overall Study|Physician Decision|0
162573|NCT00293813|519405|P2|Overall Study|Physician Decision|1
162574|NCT00293813|519406|P1|Overall Study|Physician Decision|0
162575|NCT00293722|519417|P1|Overall Study|Unspecified|427
162576|NCT00293709|519431|P1|Overall Study|Unspecified|47
162577|NCT00293579|519445|P1|Overall Study|Withdrawal by Subject|1
162578|NCT00293462|519464|P3|Overall Study|Physician Decision|0
162579|NCT00293462|519465|P2|Overall Study|Physician Decision|1
162580|NCT00293462|519466|P1|Overall Study|Physician Decision|0
162581|NCT00293462|519464|P3|Overall Study|Low radiation dose in oral cavity|0
162582|NCT00293462|519465|P2|Overall Study|Low radiation dose in oral cavity|1
162583|NCT00293462|519466|P1|Overall Study|Low radiation dose in oral cavity|0
162584|NCT00293462|519464|P3|Overall Study|Possible Tracheostomy leakage|0
162585|NCT00293462|519465|P2|Overall Study|Possible Tracheostomy leakage|1
162586|NCT00293462|519466|P1|Overall Study|Possible Tracheostomy leakage|0
162587|NCT00293462|519464|P3|Overall Study|Ischemic stroke after chemotherapy|1
162588|NCT00293462|519465|P2|Overall Study|Ischemic stroke after chemotherapy|0
162589|NCT00293462|519466|P1|Overall Study|Ischemic stroke after chemotherapy|0
162590|NCT00293462|519464|P3|Overall Study|Blood clot after chemotherapy|1
162591|NCT00293462|519465|P2|Overall Study|Blood clot after chemotherapy|0
162592|NCT00293462|519466|P1|Overall Study|Blood clot after chemotherapy|0
162593|NCT00293462|519464|P3|Overall Study|Went back to his home country|1
162594|NCT00293462|519465|P2|Overall Study|Went back to his home country|0
162595|NCT00293462|519466|P1|Overall Study|Went back to his home country|0
162596|NCT00293462|519464|P3|Overall Study|No Show|1
162597|NCT00293462|519465|P2|Overall Study|No Show|0
162598|NCT00293462|519466|P1|Overall Study|No Show|0
162599|NCT00293462|519464|P3|Overall Study|Refuse Radiation Treatment|0
162600|NCT00293462|519465|P2|Overall Study|Refuse Radiation Treatment|0
162601|NCT00293462|519466|P1|Overall Study|Refuse Radiation Treatment|1
162602|NCT00293462|519464|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
162603|NCT00293462|519465|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
162604|NCT00293462|519466|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
162605|NCT00293462|519464|P3|Overall Study|Change Treatment Regimen (ineligible)|0
162606|NCT00293462|519465|P2|Overall Study|Change Treatment Regimen (ineligible)|0
162607|NCT00293462|519466|P1|Overall Study|Change Treatment Regimen (ineligible)|1
162608|NCT00293462|519464|P3|Overall Study|Lost to Follow-up|0
162609|NCT00293462|519465|P2|Overall Study|Lost to Follow-up|1
162610|NCT00293462|519466|P1|Overall Study|Lost to Follow-up|0
162611|NCT00293462|519464|P3|Overall Study|Death|0
162612|NCT00293462|519465|P2|Overall Study|Death|0
162613|NCT00293462|519466|P1|Overall Study|Death|1
162614|NCT00293462|519464|P3|Overall Study|Withdrawal by Subject|6
162615|NCT00293462|519465|P2|Overall Study|Withdrawal by Subject|3
162616|NCT00293462|519466|P1|Overall Study|Withdrawal by Subject|4
162617|NCT00293384|519485|P1|Overall Study|Ineligible|2
162618|NCT00293384|519485|P1|Overall Study|Missed dosage/study drug|1
162619|NCT00293384|519485|P1|Overall Study|Non-compliance|2
162620|NCT00293293|519494|P2|Overall Study|Patient discontinued chemotherapy|1
162621|NCT00293293|519495|P1|Overall Study|Patient discontinued chemotherapy|0
162622|NCT00293293|519494|P2|Overall Study|"Patient too anxious to complete trial"|0
162623|NCT00293293|519495|P1|Overall Study|"Patient too anxious to complete trial"|1
162624|NCT00293293|519494|P2|Overall Study|Withdrawal by Subject|1
162625|NCT00293293|519495|P1|Overall Study|Withdrawal by Subject|1
162626|NCT00293267|519523|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
162627|NCT00293267|519524|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
162628|NCT00293267|519523|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
162629|NCT00293267|519524|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
162630|NCT00293267|519523|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
162631|NCT00293267|519524|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
162632|NCT00293267|519523|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
162633|NCT00293267|519524|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
162634|NCT00293267|519523|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
162635|NCT00293267|519524|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
162636|NCT00293267|519523|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
162637|NCT00293267|519524|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
162638|NCT00293267|519523|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
162639|NCT00293267|519524|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
162640|NCT00293267|519523|P2|Extension - Open-Label Week 157-240|Other Reason|1
162641|NCT00293267|519524|P1|Extension - Open-Label Week 157-240|Other Reason|3
162881|NCT00289848|520151|P1|Overall Study|Lack of Efficacy|20
162642|NCT00293267|519523|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
162643|NCT00293267|519524|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
162644|NCT00293267|519523|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
162645|NCT00293267|519524|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
162646|NCT00293267|519523|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
162647|NCT00293267|519524|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
162648|NCT00293267|519523|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
162649|NCT00293267|519524|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
162650|NCT00293267|519523|P2|Extension - Open-Label Week 157-240|Adverse Event|0
162651|NCT00293267|519524|P1|Extension - Open-Label Week 157-240|Adverse Event|5
162652|NCT00293267|519523|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
162653|NCT00293267|519524|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
162654|NCT00293267|519523|P2|Extension - Double-Blind Week 49-156|Other Reason|0
162655|NCT00293267|519524|P1|Extension - Double-Blind Week 49-156|Other Reason|7
162656|NCT00293267|519523|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
162657|NCT00293267|519524|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
162658|NCT00293267|519523|P2|Extension - Double-Blind Week 49-156|Death|0
162659|NCT00293267|519524|P1|Extension - Double-Blind Week 49-156|Death|3
162660|NCT00293267|519523|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
162661|NCT00293267|519524|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
162662|NCT00293267|519523|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
162663|NCT00293267|519524|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
162664|NCT00293267|519523|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
162665|NCT00293267|519524|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
162666|NCT00293267|519523|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
162667|NCT00293267|519524|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
162668|NCT00293267|519523|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
162669|NCT00293267|519524|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
162670|NCT00293267|519523|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
162671|NCT00293267|519524|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
162672|NCT00293267|519523|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
162673|NCT00293267|519524|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
162674|NCT00293267|519523|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
162675|NCT00293267|519524|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
162676|NCT00293267|519523|P2|Primary Study - Double-Blind Week 0-48|Death|3
162677|NCT00293267|519524|P1|Primary Study - Double-Blind Week 0-48|Death|3
162678|NCT00293267|519523|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
162679|NCT00293267|519524|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
162680|NCT00293267|519523|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
162681|NCT00293267|519524|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
162682|NCT00293254|519564|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
162683|NCT00293254|519565|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
162684|NCT00293254|519564|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
162685|NCT00293254|519565|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
162686|NCT00293254|519564|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
162687|NCT00293254|519565|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
162688|NCT00293254|519564|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
162689|NCT00293254|519565|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
162690|NCT00293254|519564|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
162691|NCT00293254|519565|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
162692|NCT00293254|519564|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
162693|NCT00293254|519565|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
162694|NCT00293254|519564|P2|Extension - Open-Label Week 157-240|Other Reason|0
162695|NCT00293254|519565|P1|Extension - Open-Label Week 157-240|Other Reason|4
162696|NCT00293254|519564|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
162697|NCT00293254|519565|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
162698|NCT00293254|519564|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
162699|NCT00293254|519565|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
162700|NCT00293254|519564|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
162701|NCT00293254|519565|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
162702|NCT00293254|519564|P2|Extension - Open-Label Week 157-240|Adverse Event|1
162703|NCT00293254|519565|P1|Extension - Open-Label Week 157-240|Adverse Event|2
162704|NCT00293254|519564|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
162705|NCT00293254|519565|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
162706|NCT00293254|519564|P2|Extension - Double-Blind Week 49-156|Other Reason|2
162707|NCT00293254|519565|P1|Extension - Double-Blind Week 49-156|Other Reason|10
162708|NCT00293254|519564|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
162709|NCT00293254|519565|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
162710|NCT00293254|519564|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
162711|NCT00293254|519565|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
162712|NCT00293254|519564|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
162713|NCT00293254|519565|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
162714|NCT00293254|519564|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
162715|NCT00293254|519565|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
162716|NCT00293254|519564|P2|Extension - Double-Blind Week 49-156|Death|1
162717|NCT00293254|519565|P1|Extension - Double-Blind Week 49-156|Death|4
162718|NCT00293254|519564|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
162719|NCT00293254|519565|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
162720|NCT00293254|519564|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
162721|NCT00293254|519565|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
162722|NCT00293254|519564|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
162723|NCT00293254|519565|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
162724|NCT00293254|519564|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
162725|NCT00293254|519565|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
162726|NCT00293254|519564|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
162727|NCT00293254|519565|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
162728|NCT00293254|519564|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
162729|NCT00293254|519565|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
162730|NCT00293254|519564|P2|Primary Study - Double-Blind Week 0-48|Death|2
162731|NCT00293254|519565|P1|Primary Study - Double-Blind Week 0-48|Death|5
162732|NCT00293254|519564|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
162733|NCT00293254|519565|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
162734|NCT00293254|519564|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
162735|NCT00293254|519565|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
162736|NCT00293241|519605|P2|Overall Study|Withdrawal by Subject|8
162737|NCT00293241|519606|P1|Overall Study|Withdrawal by Subject|4
162738|NCT00293241|519605|P2|Overall Study|Physician Decision|17
162739|NCT00293241|519606|P1|Overall Study|Physician Decision|23
162740|NCT00293241|519605|P2|Overall Study|Lost to Follow-up|16
162741|NCT00293241|519606|P1|Overall Study|Lost to Follow-up|9
162742|NCT00293059|519650|P2|Overall Study|missing|5
162743|NCT00293059|519651|P1|Overall Study|missing|3
162744|NCT00293059|519650|P2|Overall Study|Noncompliant - sanitary pads collection|1
162745|NCT00293059|519651|P1|Overall Study|Noncompliant - sanitary pads collection|0
162746|NCT00293059|519650|P2|Overall Study|Participant stopped study drug|0
162747|NCT00293059|519651|P1|Overall Study|Participant stopped study drug|1
162748|NCT00293059|519650|P2|Overall Study|Participant moved out of state|0
162749|NCT00293059|519651|P1|Overall Study|Participant moved out of state|1
162750|NCT00293059|519650|P2|Overall Study|Withdrawal by Subject|5
162751|NCT00293059|519651|P1|Overall Study|Withdrawal by Subject|11
162752|NCT00293059|519650|P2|Overall Study|Protocol Violation|0
162753|NCT00293059|519651|P1|Overall Study|Protocol Violation|2
162754|NCT00293059|519650|P2|Overall Study|Pregnancy|1
162755|NCT00293059|519651|P1|Overall Study|Pregnancy|1
162756|NCT00293059|519650|P2|Overall Study|Lost to Follow-up|3
162757|NCT00293059|519651|P1|Overall Study|Lost to Follow-up|2
162758|NCT00293059|519650|P2|Overall Study|Lack of Efficacy|0
162759|NCT00293059|519651|P1|Overall Study|Lack of Efficacy|2
162760|NCT00293059|519650|P2|Overall Study|Adverse Event|4
162761|NCT00293059|519651|P1|Overall Study|Adverse Event|12
162762|NCT00293020|519775|P1|Overall Study|No dose taken|1
162763|NCT00293020|519775|P1|Overall Study|Other Reason|22
162764|NCT00293020|519775|P1|Overall Study|Physician Decision|21
162765|NCT00293020|519775|P1|Overall Study|Protocol Violation|6
162766|NCT00293020|519775|P1|Overall Study|Lost to Follow-up|4
162767|NCT00293020|519775|P1|Overall Study|Lack of Efficacy|12
162768|NCT00293020|519775|P1|Overall Study|Death|32
162769|NCT00293020|519775|P1|Overall Study|Adverse Event|30
162770|NCT00293020|519775|P1|Overall Study|Withdrawal by Subject|34
162771|NCT00292981|519779|P1|Overall Study|Not specified|3
162772|NCT00292981|519779|P1|Overall Study|Withdrawal by Subject|22
162773|NCT00292981|519779|P1|Overall Study|Lost to Follow-up|13
162774|NCT00292981|519779|P1|Overall Study|Adverse Event|1
162775|NCT00292461|519801|P2|Overall Study|Lost to Follow-up|0
162776|NCT00292461|519802|P1|Overall Study|Lost to Follow-up|1
162777|NCT00292461|519801|P2|Overall Study|Protocol Violation|3
162778|NCT00292461|519802|P1|Overall Study|Protocol Violation|4
162779|NCT00292461|519801|P2|Overall Study|Withdrawal by Subject|1
162780|NCT00292461|519802|P1|Overall Study|Withdrawal by Subject|0
162781|NCT00292461|519801|P2|Overall Study|Lack of Efficacy|0
162782|NCT00292461|519802|P1|Overall Study|Lack of Efficacy|1
162783|NCT00292461|519801|P2|Overall Study|Adverse Event|2
162784|NCT00292461|519802|P1|Overall Study|Adverse Event|4
162785|NCT00292370|519817|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
162786|NCT00292370|519818|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
162787|NCT00292370|519819|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
162788|NCT00292370|519817|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
162789|NCT00292370|519818|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
162790|NCT00292370|519819|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
162791|NCT00292370|519817|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
162792|NCT00292370|519818|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
162793|NCT00292370|519819|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
162794|NCT00292370|519817|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
162795|NCT00292370|519818|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
162796|NCT00292370|519819|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
162797|NCT00292370|519817|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
162798|NCT00292370|519818|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
162799|NCT00292370|519819|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
162800|NCT00292370|519817|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
162801|NCT00292370|519818|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
162802|NCT00292370|519819|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
162803|NCT00292318|519828|P2|Overall Study|Study terminated by officials|1
162804|NCT00292318|519829|P1|Overall Study|Study terminated by officials|2
162805|NCT00292227|519839|P3|Patch Period|Withdrawal by Subject|1
162806|NCT00292227|519840|P2|Patch Period|Withdrawal by Subject|0
162807|NCT00292227|519841|P1|Patch Period|Withdrawal by Subject|0
162808|NCT00292227|519839|P3|Patch Period|Adverse Event|2
162809|NCT00292227|519840|P2|Patch Period|Adverse Event|0
162810|NCT00292227|519841|P1|Patch Period|Adverse Event|1
162811|NCT00292188|519923|P3|Double-Blind|Laboratory Abnormality|1
162812|NCT00292188|519924|P2|Double-Blind|Laboratory Abnormality|0
162813|NCT00292188|519925|P1|Double-Blind|Laboratory Abnormality|0
162814|NCT00292188|519923|P3|Double-Blind|Withdrawal by Subject|3
162815|NCT00292188|519924|P2|Double-Blind|Withdrawal by Subject|0
162816|NCT00292188|519925|P1|Double-Blind|Withdrawal by Subject|0
162817|NCT00292188|519923|P3|Double-Blind|Other|4
162818|NCT00292188|519924|P2|Double-Blind|Other|3
162819|NCT00292188|519925|P1|Double-Blind|Other|0
162820|NCT00292188|519923|P3|Double-Blind|Lost to Follow-up|0
162821|NCT00292188|519924|P2|Double-Blind|Lost to Follow-up|1
162822|NCT00292188|519925|P1|Double-Blind|Lost to Follow-up|0
162823|NCT00292188|519923|P3|Double-Blind|Lack of Efficacy|12
162824|NCT00292188|519924|P2|Double-Blind|Lack of Efficacy|2
162825|NCT00292188|519925|P1|Double-Blind|Lack of Efficacy|0
162826|NCT00292188|519923|P3|Double-Blind|Adverse Event|9
162827|NCT00292188|519924|P2|Double-Blind|Adverse Event|25
162828|NCT00292188|519925|P1|Double-Blind|Adverse Event|0
162829|NCT00292188|519923|P3|Single-Blind|Did not receive treatment|0
162830|NCT00292188|519924|P2|Single-Blind|Did not receive treatment|0
162831|NCT00292188|519925|P1|Single-Blind|Did not receive treatment|1
162832|NCT00292188|519923|P3|Single-Blind|Withdrawal by Subject|0
162833|NCT00292188|519924|P2|Single-Blind|Withdrawal by Subject|0
162834|NCT00292188|519925|P1|Single-Blind|Withdrawal by Subject|12
162835|NCT00292188|519923|P3|Single-Blind|Other|0
162836|NCT00292188|519924|P2|Single-Blind|Other|0
162837|NCT00292188|519925|P1|Single-Blind|Other|77
162838|NCT00292188|519923|P3|Single-Blind|Lost to Follow-up|0
162839|NCT00292188|519924|P2|Single-Blind|Lost to Follow-up|0
162840|NCT00292188|519925|P1|Single-Blind|Lost to Follow-up|3
162841|NCT00292188|519923|P3|Single-Blind|Laboratory Abnormality|0
162842|NCT00292188|519924|P2|Single-Blind|Laboratory Abnormality|0
162843|NCT00292188|519925|P1|Single-Blind|Laboratory Abnormality|5
162844|NCT00292188|519923|P3|Single-Blind|Lack of Efficacy|0
162845|NCT00292188|519924|P2|Single-Blind|Lack of Efficacy|0
162846|NCT00292188|519925|P1|Single-Blind|Lack of Efficacy|2
162847|NCT00292188|519923|P3|Single-Blind|Adverse Event|0
162848|NCT00292188|519924|P2|Single-Blind|Adverse Event|0
162849|NCT00292188|519925|P1|Single-Blind|Adverse Event|14
162850|NCT00291577|520025|P1|Overall Study|Lack of Efficacy|14
162851|NCT00291577|520025|P1|Overall Study|Withdrawal by Subject|2
162852|NCT00291577|520025|P1|Overall Study|Other|4
162853|NCT00291577|520025|P1|Overall Study|Adverse Event|1
162854|NCT00291551|520044|P1|Overall Study|Withdrawal by Subject|6
162855|NCT00291551|520044|P1|Overall Study|Death|7
162856|NCT00291330|520061|P2|Overall Study|Other|1
162857|NCT00291330|520062|P1|Overall Study|Other|3
162858|NCT00291330|520061|P2|Overall Study|Withdrawal by Subject|25
162859|NCT00291330|520062|P1|Overall Study|Withdrawal by Subject|22
162860|NCT00291330|520061|P2|Overall Study|Lost to Follow-up|11
162861|NCT00291330|520062|P1|Overall Study|Lost to Follow-up|16
162862|NCT00291330|520061|P2|Overall Study|Protocol Violation|20
162863|NCT00291330|520062|P1|Overall Study|Protocol Violation|13
162864|NCT00291330|520061|P2|Overall Study|Adverse Event|40
162865|NCT00291330|520062|P1|Overall Study|Adverse Event|47
162866|NCT00291187|520104|P4|Overall Study|Protocol Violation- No Drug Administered|0
162867|NCT00291187|520105|P3|Overall Study|Protocol Violation- No Drug Administered|1
162868|NCT00291187|520106|P2|Overall Study|Protocol Violation- No Drug Administered|0
162869|NCT00291187|520107|P1|Overall Study|Protocol Violation- No Drug Administered|0
162870|NCT00289848|520150|P2|Overall Study|Open-Label AHA Treatment Requested|1
162871|NCT00289848|520151|P1|Overall Study|Open-Label AHA Treatment Requested|0
162872|NCT00289848|520150|P2|Overall Study|Patient Moved|2
162873|NCT00289848|520151|P1|Overall Study|Patient Moved|6
162874|NCT00289848|520150|P2|Overall Study|Withdrawal by Subject|11
162875|NCT00289848|520151|P1|Overall Study|Withdrawal by Subject|5
162876|NCT00289848|520150|P2|Overall Study|Protocol Violation|2
162877|NCT00289848|520151|P1|Overall Study|Protocol Violation|5
162878|NCT00289848|520150|P2|Overall Study|Lost to Follow-up|1
162879|NCT00289848|520151|P1|Overall Study|Lost to Follow-up|3
162880|NCT00289848|520150|P2|Overall Study|Lack of Efficacy|24
162882|NCT00289848|520150|P2|Overall Study|Death|0
162883|NCT00289848|520151|P1|Overall Study|Death|1
162884|NCT00289848|520150|P2|Overall Study|Adverse Event|4
162885|NCT00289848|520151|P1|Overall Study|Adverse Event|6
162886|NCT00289783|520163|P2|Fourth Dose Phase|Unspecified|10
162887|NCT00289783|520164|P1|Fourth Dose Phase|Unspecified|22
162888|NCT00289783|520163|P2|Fourth Dose Phase|Migration from the study area|1
162889|NCT00289783|520164|P1|Fourth Dose Phase|Migration from the study area|1
162890|NCT00289783|520163|P2|Fourth Dose Phase|Lost to Follow-up|12
162891|NCT00289783|520164|P1|Fourth Dose Phase|Lost to Follow-up|53
162892|NCT00289783|520163|P2|Fourth Dose Phase|Withdrawal by Subject|1
162893|NCT00289783|520164|P1|Fourth Dose Phase|Withdrawal by Subject|10
162894|NCT00289783|520163|P2|Fourth Dose Phase|Adverse Event|0
162895|NCT00289783|520164|P1|Fourth Dose Phase|Adverse Event|1
162896|NCT00289783|520163|P2|Primary Phase|Unspecified|12
162897|NCT00289783|520164|P1|Primary Phase|Unspecified|32
162898|NCT00289783|520163|P2|Primary Phase|Migration from the study area|10
162899|NCT00289783|520164|P1|Primary Phase|Migration from the study area|26
162900|NCT00289783|520163|P2|Primary Phase|Lost to Follow-up|14
162901|NCT00289783|520164|P1|Primary Phase|Lost to Follow-up|60
162902|NCT00289783|520163|P2|Primary Phase|Withdrawal by Subject|40
162903|NCT00289783|520164|P1|Primary Phase|Withdrawal by Subject|93
162904|NCT00289783|520163|P2|Primary Phase|Protocol Violation|6
162905|NCT00289783|520164|P1|Primary Phase|Protocol Violation|27
162906|NCT00289783|520163|P2|Primary Phase|Adverse Event|1
162907|NCT00289783|520164|P1|Primary Phase|Adverse Event|10
162908|NCT00289770|520342|P1|Year 15|Withdrawal by Subject|1
162909|NCT00290888|520399|P2|Overall Study|Physician Decision|1
162910|NCT00290888|520400|P1|Overall Study|Physician Decision|3
162911|NCT00290771|520417|P2|Overall Study|Lost to Follow-up|1
162912|NCT00290771|520418|P1|Overall Study|Lost to Follow-up|0
162913|NCT00290771|520417|P2|Overall Study|Protocol Violation|0
162914|NCT00290771|520418|P1|Overall Study|Protocol Violation|2
162915|NCT00290771|520417|P2|Overall Study|Administrative problems|1
162916|NCT00290771|520418|P1|Overall Study|Administrative problems|2
162917|NCT00290771|520417|P2|Overall Study|Withdrawal by Subject|6
162918|NCT00290771|520418|P1|Overall Study|Withdrawal by Subject|5
162919|NCT00290771|520417|P2|Overall Study|Adverse Event|6
162920|NCT00290771|520418|P1|Overall Study|Adverse Event|12
162921|NCT00290771|520417|P2|Overall Study|Death|10
162922|NCT00290771|520418|P1|Overall Study|Death|11
162923|NCT00290771|520417|P2|Overall Study|Disease progression|73
162924|NCT00290771|520418|P1|Overall Study|Disease progression|95
162925|NCT00290758|520442|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
162926|NCT00290758|520443|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
162927|NCT00290758|520442|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
162928|NCT00290758|520443|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
162929|NCT00290758|520442|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
162930|NCT00290758|520443|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
162931|NCT00290758|520442|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
162932|NCT00290758|520443|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
162933|NCT00290758|520442|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
162934|NCT00290758|520443|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
162935|NCT00290758|520442|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
162936|NCT00290758|520443|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
162937|NCT00290758|520442|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
162938|NCT00290758|520443|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
162939|NCT00290758|520442|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
162940|NCT00290758|520443|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
162941|NCT00290732|520465|P5|Overall Study|Inability to instill drug intraductally.|0
162942|NCT00290732|520466|P4|Overall Study|Inability to instill drug intraductally.|0
162943|NCT00290732|520467|P3|Overall Study|Inability to instill drug intraductally.|1
162944|NCT00290732|520468|P2|Overall Study|Inability to instill drug intraductally.|1
162945|NCT00290732|520469|P1|Overall Study|Inability to instill drug intraductally.|0
162946|NCT00290290|520539|P2|Overall Study|Underwent clean surgical procedure|12
162947|NCT00290290|520540|P1|Overall Study|Underwent clean surgical procedure|13
162948|NCT00290290|520539|P2|Overall Study|Withdrawal by Subject|2
162949|NCT00290290|520540|P1|Overall Study|Withdrawal by Subject|2
162950|NCT00290290|520539|P2|Overall Study|Death|4
162951|NCT00290290|520540|P1|Overall Study|Death|3
162952|NCT00290251|520546|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
162953|NCT00290251|520547|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
162954|NCT00290251|520548|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
162955|NCT00290251|520546|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
162956|NCT00290251|520547|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
162957|NCT00290251|520548|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
162958|NCT00290251|520546|P3|Treatment 1 (Months 1 - 3)|headache|0
162959|NCT00290251|520547|P2|Treatment 1 (Months 1 - 3)|headache|1
162960|NCT00290251|520548|P1|Treatment 1 (Months 1 - 3)|headache|0
162961|NCT00290251|520546|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
162962|NCT00290251|520547|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
162963|NCT00290251|520548|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
162964|NCT00290238|520560|P2|Overall Study|Withdrawal by Subject|13
162965|NCT00290238|520561|P1|Overall Study|Withdrawal by Subject|15
162966|NCT00290238|520560|P2|Overall Study|Lost to Follow-up|1
162967|NCT00290238|520561|P1|Overall Study|Lost to Follow-up|0
162968|NCT00290238|520560|P2|Overall Study|Study terminated|27
162969|NCT00290238|520561|P1|Overall Study|Study terminated|27
162970|NCT00290186|520586|P2|Overall Study|Withdrawal by Subject|1
162971|NCT00290186|520587|P1|Overall Study|Withdrawal by Subject|0
162972|NCT00290186|520586|P2|Overall Study|Study was terminated prior to 3-month te|1
162973|NCT00290186|520587|P1|Overall Study|Study was terminated prior to 3-month te|1
162974|NCT00290186|520586|P2|Overall Study|Lost to Follow-up|2
162975|NCT00290186|520587|P1|Overall Study|Lost to Follow-up|3
162976|NCT00290186|520586|P2|Overall Study|Adverse Event|1
162977|NCT00290186|520587|P1|Overall Study|Adverse Event|1
162978|NCT00289991|520627|P2|Overall Study|Unspecified|14
162979|NCT00289991|520628|P1|Overall Study|Unspecified|5
162980|NCT00289991|520627|P2|Overall Study|Withdrawal by Subject|12
162981|NCT00289991|520628|P1|Overall Study|Withdrawal by Subject|2
162982|NCT00289991|520627|P2|Overall Study|Lost to Follow-up|1
162983|NCT00289991|520628|P1|Overall Study|Lost to Follow-up|0
162984|NCT00289991|520627|P2|Overall Study|Fungal breakthrough infection|1
162985|NCT00289991|520628|P1|Overall Study|Fungal breakthrough infection|0
162986|NCT00289991|520627|P2|Overall Study|Failure of prophylaxis|1
162987|NCT00289991|520628|P1|Overall Study|Failure of prophylaxis|1
162988|NCT00289991|520627|P2|Overall Study|Adverse Event|13
162989|NCT00289991|520628|P1|Overall Study|Adverse Event|15
162990|NCT00289991|520627|P2|Overall Study|Death|38
162991|NCT00289991|520628|P1|Overall Study|Death|35
162992|NCT00289978|520653|P3|Overall Study|Death|2
162993|NCT00289978|520654|P2|Overall Study|Death|0
162994|NCT00289978|520655|P1|Overall Study|Death|1
162995|NCT00289978|520653|P3|Overall Study|Abnormal test procedure result(s)|1
162996|NCT00289978|520654|P2|Overall Study|Abnormal test procedure result(s)|1
162997|NCT00289978|520655|P1|Overall Study|Abnormal test procedure result(s)|2
162998|NCT00289978|520653|P3|Overall Study|Protocol Violation|4
162999|NCT00289978|520654|P2|Overall Study|Protocol Violation|5
163000|NCT00289978|520655|P1|Overall Study|Protocol Violation|5
163001|NCT00289978|520653|P3|Overall Study|Lost to Follow-up|7
163002|NCT00289978|520654|P2|Overall Study|Lost to Follow-up|5
163003|NCT00289978|520655|P1|Overall Study|Lost to Follow-up|3
163004|NCT00289978|520653|P3|Overall Study|Abnormal laboratory value(s)|1
163005|NCT00289978|520654|P2|Overall Study|Abnormal laboratory value(s)|9
163006|NCT00289978|520655|P1|Overall Study|Abnormal laboratory value(s)|20
163007|NCT00289978|520653|P3|Overall Study|Lack of Efficacy|25
163008|NCT00289978|520654|P2|Overall Study|Lack of Efficacy|6
163009|NCT00289978|520655|P1|Overall Study|Lack of Efficacy|13
163010|NCT00289978|520653|P3|Overall Study|Adverse Event|18
163011|NCT00289978|520654|P2|Overall Study|Adverse Event|13
163012|NCT00289978|520655|P1|Overall Study|Adverse Event|22
163013|NCT00289978|520653|P3|Overall Study|Withdrawal by Subject|28
163014|NCT00289978|520654|P2|Overall Study|Withdrawal by Subject|17
163015|NCT00289978|520655|P1|Overall Study|Withdrawal by Subject|31
163016|NCT00289913|520674|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
163017|NCT00289913|520675|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
163018|NCT00289913|520676|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
163019|NCT00289913|520677|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
163020|NCT00289913|520678|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
163021|NCT00289913|520674|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
163022|NCT00289913|520675|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
163023|NCT00289913|520676|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
163024|NCT00289913|520677|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
163025|NCT00289913|520678|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
163026|NCT00289913|520674|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
163027|NCT00289913|520675|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
163028|NCT00289913|520676|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
163029|NCT00289913|520677|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
163030|NCT00289913|520678|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
163031|NCT00289913|520674|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
163032|NCT00289913|520675|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
163033|NCT00289913|520676|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
163034|NCT00289913|520677|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
163035|NCT00289913|520678|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
163036|NCT00289913|520674|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
163037|NCT00289913|520675|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
163038|NCT00289913|520676|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
163039|NCT00289913|520677|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
163040|NCT00289913|520678|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
163041|NCT00289913|520674|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
163042|NCT00289913|520675|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
163043|NCT00289913|520676|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
163044|NCT00289913|520677|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
163045|NCT00289913|520678|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
163046|NCT00289913|520674|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
163047|NCT00289913|520675|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
163048|NCT00289913|520676|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
163049|NCT00289913|520677|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
163050|NCT00289913|520678|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
163051|NCT00289913|520674|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
163052|NCT00289913|520675|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
163053|NCT00289913|520676|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
163054|NCT00289913|520677|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
163055|NCT00289913|520678|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
163056|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
163057|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
163058|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
163059|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
163060|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
163061|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
163062|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
163063|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
163064|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
163065|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
163066|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
163067|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
163068|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
163069|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
163070|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
163071|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
163072|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
163073|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
163074|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
163075|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
163076|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
163077|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
163078|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
163079|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
163080|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
163081|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
163082|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
163083|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
163084|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
163085|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
163086|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
163087|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
163088|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
163089|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
163090|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
163091|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
163092|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
163093|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
163094|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
163095|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
163096|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
163097|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
163098|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
163099|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
163100|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
163101|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
163102|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
163103|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
163104|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
163105|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
163106|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
163107|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
163108|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
163109|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
163110|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
163111|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
163112|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
163113|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
163114|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
163115|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
163116|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
163117|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
163118|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
163119|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
163120|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
163121|NCT00289913|520674|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
163122|NCT00289913|520675|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
163123|NCT00289913|520676|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
163124|NCT00289913|520677|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
163125|NCT00289913|520678|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
163126|NCT00289913|520674|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
163127|NCT00289913|520675|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
163128|NCT00289913|520676|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
163129|NCT00289913|520677|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
163130|NCT00289913|520678|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
163131|NCT00289913|520674|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
163132|NCT00289913|520675|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
163133|NCT00289913|520676|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
163134|NCT00289913|520677|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
163135|NCT00289913|520678|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
163136|NCT00289913|520674|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
163137|NCT00289913|520675|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
163138|NCT00289913|520676|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
163139|NCT00289913|520677|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
163140|NCT00289913|520678|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
163141|NCT00289913|520674|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
163142|NCT00289913|520675|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
163143|NCT00289913|520676|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
163144|NCT00289913|520677|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
163145|NCT00289913|520678|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
163146|NCT00289913|520674|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
163147|NCT00289913|520675|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
163148|NCT00289913|520676|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
163149|NCT00289913|520677|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
163150|NCT00289913|520678|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
163151|NCT00289913|520674|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
163152|NCT00289913|520675|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
163153|NCT00289913|520676|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
163154|NCT00289913|520677|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
163155|NCT00289913|520678|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
163156|NCT00289913|520674|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
163157|NCT00289913|520675|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
163158|NCT00289913|520676|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
163159|NCT00289913|520677|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
163160|NCT00289913|520678|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
163161|NCT00289913|520674|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
163162|NCT00289913|520675|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
163163|NCT00289913|520676|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
163164|NCT00289913|520677|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
163165|NCT00289913|520678|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
163166|NCT00289913|520674|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
163167|NCT00289913|520675|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
163168|NCT00289913|520676|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
163169|NCT00289913|520677|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
163170|NCT00289913|520678|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
163171|NCT00289900|520709|P6|Overall Study|Not treated|0
163172|NCT00289900|520710|P5|Overall Study|Not treated|0
163173|NCT00289900|520711|P4|Overall Study|Not treated|0
163174|NCT00289900|520712|P3|Overall Study|Not treated|0
163175|NCT00289900|520713|P2|Overall Study|Not treated|1
163176|NCT00289900|520714|P1|Overall Study|Not treated|0
163177|NCT00289900|520709|P6|Overall Study|site terminated|0
163178|NCT00289900|520710|P5|Overall Study|site terminated|0
163179|NCT00289900|520711|P4|Overall Study|site terminated|0
163180|NCT00289900|520712|P3|Overall Study|site terminated|1
163181|NCT00289900|520713|P2|Overall Study|site terminated|0
163182|NCT00289900|520714|P1|Overall Study|site terminated|1
163183|NCT00289900|520709|P6|Overall Study|Protocol Violation|4
163184|NCT00289900|520710|P5|Overall Study|Protocol Violation|7
163185|NCT00289900|520711|P4|Overall Study|Protocol Violation|6
163186|NCT00289900|520712|P3|Overall Study|Protocol Violation|2
163187|NCT00289900|520713|P2|Overall Study|Protocol Violation|9
163188|NCT00289900|520714|P1|Overall Study|Protocol Violation|3
163189|NCT00289900|520709|P6|Overall Study|Withdrawal by Subject|11
163190|NCT00289900|520710|P5|Overall Study|Withdrawal by Subject|12
163191|NCT00289900|520711|P4|Overall Study|Withdrawal by Subject|18
163192|NCT00289900|520712|P3|Overall Study|Withdrawal by Subject|8
163193|NCT00289900|520713|P2|Overall Study|Withdrawal by Subject|21
163194|NCT00289900|520714|P1|Overall Study|Withdrawal by Subject|10
163195|NCT00289900|520709|P6|Overall Study|Participant moved|1
163196|NCT00289900|520710|P5|Overall Study|Participant moved|1
163197|NCT00289900|520711|P4|Overall Study|Participant moved|1
163198|NCT00289900|520712|P3|Overall Study|Participant moved|0
163199|NCT00289900|520713|P2|Overall Study|Participant moved|0
163200|NCT00289900|520714|P1|Overall Study|Participant moved|1
163201|NCT00289900|520709|P6|Overall Study|Other|0
163202|NCT00289900|520710|P5|Overall Study|Other|1
163203|NCT00289900|520711|P4|Overall Study|Other|5
163204|NCT00289900|520712|P3|Overall Study|Other|0
163205|NCT00289900|520713|P2|Overall Study|Other|0
163206|NCT00289900|520714|P1|Overall Study|Other|0
163207|NCT00289900|520709|P6|Overall Study|Participant had flushing|4
163208|NCT00289900|520710|P5|Overall Study|Participant had flushing|0
163209|NCT00289900|520711|P4|Overall Study|Participant had flushing|2
163210|NCT00289900|520712|P3|Overall Study|Participant had flushing|1
163211|NCT00289900|520713|P2|Overall Study|Participant had flushing|42
163212|NCT00289900|520714|P1|Overall Study|Participant had flushing|18
163213|NCT00289900|520709|P6|Overall Study|Lost to Follow-up|8
163214|NCT00289900|520710|P5|Overall Study|Lost to Follow-up|4
163215|NCT00289900|520711|P4|Overall Study|Lost to Follow-up|8
163216|NCT00289900|520712|P3|Overall Study|Lost to Follow-up|8
163217|NCT00289900|520713|P2|Overall Study|Lost to Follow-up|7
163218|NCT00289900|520714|P1|Overall Study|Lost to Follow-up|7
163219|NCT00289900|520709|P6|Overall Study|Adverse Event|33
163220|NCT00289900|520710|P5|Overall Study|Adverse Event|20
163221|NCT00289900|520711|P4|Overall Study|Adverse Event|19
163222|NCT00289900|520712|P3|Overall Study|Adverse Event|13
163223|NCT00289900|520713|P2|Overall Study|Adverse Event|40
163224|NCT00289900|520714|P1|Overall Study|Adverse Event|28
163225|NCT00289887|520818|P2|Overall Study|Unspecified|3
163226|NCT00289887|520819|P1|Overall Study|Unspecified|7
163227|NCT00289887|520818|P2|Overall Study|Withdrawal by Subject|8
163228|NCT00289887|520819|P1|Overall Study|Withdrawal by Subject|3
163229|NCT00289887|520818|P2|Overall Study|Protocol Violation|1
163230|NCT00289887|520819|P1|Overall Study|Protocol Violation|3
163231|NCT00289887|520818|P2|Overall Study|Lost to Follow-up|3
163232|NCT00289887|520819|P1|Overall Study|Lost to Follow-up|3
163233|NCT00289887|520818|P2|Overall Study|Lack of Efficacy|11
163234|NCT00289887|520819|P1|Overall Study|Lack of Efficacy|3
163235|NCT00289887|520818|P2|Overall Study|Adverse Event|3
163236|NCT00289887|520819|P1|Overall Study|Adverse Event|3
163237|NCT00289874|520837|P2|Overall Study|Did not meet eligibility|0
163238|NCT00289874|520838|P1|Overall Study|Did not meet eligibility|1
163239|NCT00289874|520837|P2|Overall Study|Protocol Violation|2
163240|NCT00289874|520838|P1|Overall Study|Protocol Violation|3
163241|NCT00289874|520837|P2|Overall Study|Lost to Follow-up|1
163242|NCT00289874|520838|P1|Overall Study|Lost to Follow-up|1
163243|NCT00289874|520837|P2|Overall Study|Adverse Event|5
163244|NCT00289874|520838|P1|Overall Study|Adverse Event|1
163245|NCT00289536|520846|P3|Period 3|Lost to Follow-up|1
163246|NCT00289536|520847|P2|Period 3|Lost to Follow-up|0
163247|NCT00289536|520848|P1|Period 3|Lost to Follow-up|0
163248|NCT00289458|520894|P3|Overall Study|Withdrawal by Subject|4
163249|NCT00289458|520895|P2|Overall Study|Withdrawal by Subject|2
163250|NCT00289458|520896|P1|Overall Study|Withdrawal by Subject|2
163251|NCT00289458|520894|P3|Overall Study|Physician Decision|2
163252|NCT00289458|520895|P2|Overall Study|Physician Decision|4
163253|NCT00289458|520896|P1|Overall Study|Physician Decision|3
163254|NCT00289458|520894|P3|Overall Study|Death|0
163255|NCT00289458|520895|P2|Overall Study|Death|0
163256|NCT00289458|520896|P1|Overall Study|Death|1
163257|NCT00289289|520935|P3|Overall Study|Other Exit Reason|12
163258|NCT00289289|520936|P2|Overall Study|Other Exit Reason|4
163259|NCT00289289|520937|P1|Overall Study|Other Exit Reason|6
163260|NCT00289289|520935|P3|Overall Study|Did not meet inclusion/exclusion|6
163261|NCT00289289|520936|P2|Overall Study|Did not meet inclusion/exclusion|0
163262|NCT00289289|520937|P1|Overall Study|Did not meet inclusion/exclusion|0
163263|NCT00289289|520935|P3|Overall Study|Non-study device implanted|3
163264|NCT00289289|520936|P2|Overall Study|Non-study device implanted|1
163265|NCT00289289|520937|P1|Overall Study|Non-study device implanted|2
163266|NCT00289289|520935|P3|Overall Study|Physician Decision|6
163267|NCT00289289|520936|P2|Overall Study|Physician Decision|0
163268|NCT00289289|520937|P1|Overall Study|Physician Decision|1
163269|NCT00289289|520935|P3|Overall Study|No implant attempted|1
163270|NCT00289289|520936|P2|Overall Study|No implant attempted|0
163271|NCT00289289|520937|P1|Overall Study|No implant attempted|0
163272|NCT00289289|520935|P3|Overall Study|Death|5
163273|NCT00289289|520936|P2|Overall Study|Death|2
163274|NCT00289289|520937|P1|Overall Study|Death|4
163275|NCT00289289|520935|P3|Overall Study|Lost to Follow-up|1
163276|NCT00289289|520936|P2|Overall Study|Lost to Follow-up|0
163277|NCT00289289|520937|P1|Overall Study|Lost to Follow-up|1
163278|NCT00289289|520935|P3|Overall Study|Withdrawal by Subject|15
163279|NCT00289289|520936|P2|Overall Study|Withdrawal by Subject|3
163280|NCT00289289|520937|P1|Overall Study|Withdrawal by Subject|5
163281|NCT00289276|520952|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
163282|NCT00289276|520953|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
163283|NCT00289276|520952|P2|Second Part of FAST Study (Expansion)|Death|2
163284|NCT00289276|520953|P1|Second Part of FAST Study (Expansion)|Death|0
163285|NCT00289185|520988|P2|Overall Study|Death|1
163286|NCT00289185|520989|P1|Overall Study|Death|1
163287|NCT00289185|520988|P2|Overall Study|Lost to Follow-up|17
163288|NCT00289185|520989|P1|Overall Study|Lost to Follow-up|23
163289|NCT00289185|520988|P2|Overall Study|Withdrawal by Subject|8
163290|NCT00289185|520989|P1|Overall Study|Withdrawal by Subject|4
163291|NCT00289133|521036|P2|Overall Study|Lost to Follow-up|115
163292|NCT00289133|521037|P1|Overall Study|Lost to Follow-up|92
163293|NCT00289133|521036|P2|Overall Study|Revision|6
163294|NCT00289133|521037|P1|Overall Study|Revision|8
163295|NCT00289133|521036|P2|Overall Study|Physician Decision|45
163296|NCT00289133|521037|P1|Overall Study|Physician Decision|41
163297|NCT00289133|521036|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
163298|NCT00289133|521037|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
163299|NCT00289133|521036|P2|Overall Study|Death|10
163300|NCT00289133|521037|P1|Overall Study|Death|5
163301|NCT00289133|521036|P2|Overall Study|Withdrawal by Subject|10
163302|NCT00289133|521037|P1|Overall Study|Withdrawal by Subject|9
163303|NCT00289133|521036|P2|Overall Study|Protocol Violation|38
163304|NCT00289133|521037|P1|Overall Study|Protocol Violation|32
163305|NCT00289133|521036|P2|Overall Study|Non-study device implanted|0
163306|NCT00289133|521037|P1|Overall Study|Non-study device implanted|12
163307|NCT00289016|521093|P1|Overall Study|Other|1
163308|NCT00289016|521093|P1|Overall Study|Adverse Event|1
163309|NCT00289016|521093|P1|Overall Study|Withdrawal by Subject|2
163310|NCT00289016|521093|P1|Overall Study|Unrelated Medical Condition or Accident|2
163311|NCT00289016|521093|P1|Overall Study|Death|2
163312|NCT00289016|521093|P1|Overall Study|Disease Progression|29
163313|NCT00288912|521105|P3|Overall Study|Withdrawal by Subject|12
163314|NCT00288912|521106|P2|Overall Study|Withdrawal by Subject|5
163315|NCT00288912|521107|P1|Overall Study|Withdrawal by Subject|4
163316|NCT00288912|521105|P3|Overall Study|Lost to Follow-up|9
163317|NCT00288912|521106|P2|Overall Study|Lost to Follow-up|6
163318|NCT00288912|521107|P1|Overall Study|Lost to Follow-up|9
163319|NCT00288912|521105|P3|Overall Study|Developed exclusion criterion|7
163320|NCT00288912|521106|P2|Overall Study|Developed exclusion criterion|6
163321|NCT00288912|521107|P1|Overall Study|Developed exclusion criterion|4
163322|NCT00288860|521147|P2|Overall Study|Lost to Follow-up|71
163323|NCT00288860|521148|P1|Overall Study|Lost to Follow-up|74
163324|NCT00288860|521147|P2|Overall Study|Withdrawal by Subject|15
163325|NCT00288860|521148|P1|Overall Study|Withdrawal by Subject|20
163326|NCT00288860|521147|P2|Overall Study|Death|3
163327|NCT00288860|521148|P1|Overall Study|Death|4
163328|NCT00288860|521147|P2|Overall Study|Did not complete intake|8
163329|NCT00288860|521148|P1|Overall Study|Did not complete intake|4
163330|NCT00288704|521161|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
163331|NCT00288704|521162|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
163332|NCT00288704|521163|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
163333|NCT00288704|521161|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
163334|NCT00288704|521162|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
163335|NCT00288704|521163|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
163336|NCT00288704|521161|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
163337|NCT00288704|521162|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
163338|NCT00288704|521163|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
163339|NCT00288704|521161|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
163340|NCT00288704|521162|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
163341|NCT00288704|521163|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
163342|NCT00288704|521161|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
163343|NCT00288704|521162|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
163344|NCT00288704|521163|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
163345|NCT00288704|521161|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
163346|NCT00288704|521162|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
163347|NCT00288704|521163|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
163348|NCT00288704|521161|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
163349|NCT00288704|521162|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
163350|NCT00288704|521163|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
163351|NCT00288639|521190|P1|Overall Study|Other|1
163352|NCT00288639|521190|P1|Overall Study|Withdrawal by Subject|2
163353|NCT00288639|521190|P1|Overall Study|Lack of Efficacy|4
163354|NCT00288639|521190|P1|Overall Study|Adverse Event|5
163355|NCT00288587|521218|P2|Overall Study|Severe Aortic Stenosis|0
163356|NCT00288587|521219|P1|Overall Study|Severe Aortic Stenosis|1
163357|NCT00288587|521218|P2|Overall Study|Physician Decision|2
163358|NCT00288587|521219|P1|Overall Study|Physician Decision|0
163359|NCT00288587|521218|P2|Overall Study|Adverse Event|1
163360|NCT00288587|521219|P1|Overall Study|Adverse Event|0
163361|NCT00288587|521218|P2|Overall Study|Transplant|3
163362|NCT00288587|521219|P1|Overall Study|Transplant|0
163363|NCT00288587|521218|P2|Overall Study|Death|4
163364|NCT00288587|521219|P1|Overall Study|Death|4
163365|NCT00288509|521242|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
163366|NCT00288509|521242|P1|Treatment Cycle 4|Physician Decision|4
163367|NCT00288509|521242|P1|Treatment Cycle 4|Withdrawal by Subject|3
163368|NCT00288509|521242|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
163369|NCT00288509|521242|P1|Treatment Cycle 3|Lost to Follow-up|2
163370|NCT00288509|521242|P1|Treatment Cycle 3|Withdrawal by Subject|1
163371|NCT00288509|521242|P1|Treatment Cycle 3|Lack of Efficacy|1
163372|NCT00288509|521242|P1|Treatment Cycle 2|Withdrawal by Subject|2
163373|NCT00288509|521242|P1|Treatment Cycle 2|Lack of Efficacy|1
163374|NCT00288509|521242|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
163375|NCT00288509|521242|P1|Treatment Cycle 1|Lost to Follow-up|2
163376|NCT00288509|521242|P1|Treatment Cycle 1|Withdrawal by Subject|1
163377|NCT00288509|521242|P1|Treatment Cycle 1|Lack of Efficacy|1
163378|NCT00288509|521242|P1|Treatment Cycle 1|Adverse Event|1
163379|NCT00288080|521251|P2|Overall Study|Protocol Violation|20
163380|NCT00288080|521252|P1|Overall Study|Protocol Violation|25
163381|NCT00288080|521251|P2|Overall Study|Withdrawal by Subject|3
163382|NCT00288080|521252|P1|Overall Study|Withdrawal by Subject|1
163383|NCT00288054|521274|P1|Overall Study|Not protocol specified|2
163384|NCT00288054|521274|P1|Overall Study|Withdrawal by Subject|1
163385|NCT00288054|521274|P1|Overall Study|Adverse Event|3
163386|NCT00288054|521274|P1|Overall Study|Lack of Efficacy|16
163387|NCT00288054|521274|P1|Overall Study|Protocol Violation|2
163388|NCT00287079|521359|P2|Overall Study|Unspecified|0
163389|NCT00287079|521360|P1|Overall Study|Unspecified|3
163390|NCT00287079|521359|P2|Overall Study|Protocol Violation|0
163391|NCT00287079|521360|P1|Overall Study|Protocol Violation|1
163392|NCT00287079|521359|P2|Overall Study|Adverse Event|0
163393|NCT00287079|521360|P1|Overall Study|Adverse Event|5
163394|NCT00287079|521359|P2|Overall Study|Non-qualifying relapse|0
163395|NCT00287079|521360|P1|Overall Study|Non-qualifying relapse|1
163396|NCT00287079|521359|P2|Overall Study|Qualifying relapse|1
163397|NCT00287079|521360|P1|Overall Study|Qualifying relapse|12
163398|NCT00286754|521382|P3|Overall Study|Moved out of state|1
163399|NCT00286754|521383|P2|Overall Study|Moved out of state|0
163400|NCT00286754|521384|P1|Overall Study|Moved out of state|0
163401|NCT00286754|521382|P3|Overall Study|Lost to Follow-up|6
163402|NCT00286754|521383|P2|Overall Study|Lost to Follow-up|14
163403|NCT00286754|521384|P1|Overall Study|Lost to Follow-up|12
163404|NCT00286754|521382|P3|Overall Study|Withdrawal by Subject|0
163405|NCT00286754|521383|P2|Overall Study|Withdrawal by Subject|2
163406|NCT00286754|521384|P1|Overall Study|Withdrawal by Subject|6
163407|NCT00286754|521382|P3|Overall Study|Adverse Event|3
163408|NCT00286754|521383|P2|Overall Study|Adverse Event|2
163409|NCT00286754|521384|P1|Overall Study|Adverse Event|2
163410|NCT00286494|521439|P3|Overall Study|Protocol Violation|2
163411|NCT00286494|521440|P2|Overall Study|Protocol Violation|1
163412|NCT00286494|521441|P1|Overall Study|Protocol Violation|1
163413|NCT00286494|521439|P3|Overall Study|Lost to Follow-up|3
163414|NCT00286494|521440|P2|Overall Study|Lost to Follow-up|1
163415|NCT00286494|521441|P1|Overall Study|Lost to Follow-up|3
163416|NCT00286494|521439|P3|Overall Study|Physician Decision|1
163417|NCT00286494|521440|P2|Overall Study|Physician Decision|5
163418|NCT00286494|521441|P1|Overall Study|Physician Decision|5
163419|NCT00286494|521439|P3|Overall Study|Adverse Event|6
163420|NCT00286494|521440|P2|Overall Study|Adverse Event|8
163421|NCT00286494|521441|P1|Overall Study|Adverse Event|3
163422|NCT00286494|521439|P3|Overall Study|Withdrawal by Subject|9
163423|NCT00286494|521440|P2|Overall Study|Withdrawal by Subject|10
163424|NCT00286494|521441|P1|Overall Study|Withdrawal by Subject|2
163425|NCT00286494|521439|P3|Overall Study|Hyperglycemic rescue|18
163426|NCT00286494|521440|P2|Overall Study|Hyperglycemic rescue|19
163427|NCT00286494|521441|P1|Overall Study|Hyperglycemic rescue|12
163428|NCT00286468|521602|P3|Overall Study|Physician Decision|1
163429|NCT00286468|521603|P2|Overall Study|Physician Decision|2
163430|NCT00286468|521604|P1|Overall Study|Physician Decision|3
163431|NCT00286468|521602|P3|Overall Study|Withdrawal by Subject|11
163432|NCT00286468|521603|P2|Overall Study|Withdrawal by Subject|8
163433|NCT00286468|521604|P1|Overall Study|Withdrawal by Subject|3
163434|NCT00286468|521602|P3|Overall Study|Lost to Follow-up|2
163435|NCT00286468|521603|P2|Overall Study|Lost to Follow-up|1
163436|NCT00286468|521604|P1|Overall Study|Lost to Follow-up|1
163437|NCT00286468|521602|P3|Overall Study|Protocol Violation|1
163438|NCT00286468|521603|P2|Overall Study|Protocol Violation|3
163439|NCT00286468|521604|P1|Overall Study|Protocol Violation|0
163440|NCT00286468|521602|P3|Overall Study|Adverse Event|4
163441|NCT00286468|521603|P2|Overall Study|Adverse Event|6
163442|NCT00286468|521604|P1|Overall Study|Adverse Event|2
163443|NCT00286468|521602|P3|Overall Study|Hyperglycemic Rescue|31
163444|NCT00286468|521603|P2|Overall Study|Hyperglycemic Rescue|30
163445|NCT00286468|521604|P1|Overall Study|Hyperglycemic Rescue|28
163446|NCT00286455|521765|P3|Overall Study|Withdrawal by Subject|7
163447|NCT00286455|521766|P2|Overall Study|Withdrawal by Subject|8
163448|NCT00286455|521767|P1|Overall Study|Withdrawal by Subject|0
163449|NCT00286455|521765|P3|Overall Study|Participant Non-compliance|0
163450|NCT00286455|521766|P2|Overall Study|Participant Non-compliance|0
163451|NCT00286455|521767|P1|Overall Study|Participant Non-compliance|1
163452|NCT00286455|521765|P3|Overall Study|Protocol Violation|0
163453|NCT00286455|521766|P2|Overall Study|Protocol Violation|1
163454|NCT00286455|521767|P1|Overall Study|Protocol Violation|1
163455|NCT00286455|521765|P3|Overall Study|Physician Decision|2
163456|NCT00286455|521766|P2|Overall Study|Physician Decision|0
163457|NCT00286455|521767|P1|Overall Study|Physician Decision|3
163458|NCT00286455|521765|P3|Overall Study|Lost to Follow-up|3
163459|NCT00286455|521766|P2|Overall Study|Lost to Follow-up|3
163460|NCT00286455|521767|P1|Overall Study|Lost to Follow-up|0
163461|NCT00286455|521765|P3|Overall Study|Adverse Event|2
163462|NCT00286455|521766|P2|Overall Study|Adverse Event|3
163463|NCT00286455|521767|P1|Overall Study|Adverse Event|1
163464|NCT00286455|521765|P3|Overall Study|Hyperglycemia rescue|10
163465|NCT00286455|521766|P2|Overall Study|Hyperglycemia rescue|13
163466|NCT00286455|521767|P1|Overall Study|Hyperglycemia rescue|19
163467|NCT00286442|521946|P3|Overall Study|Withdrawal by Subject|2
163468|NCT00286442|521947|P2|Overall Study|Withdrawal by Subject|14
163469|NCT00286442|521948|P1|Overall Study|Withdrawal by Subject|2
163470|NCT00286442|521946|P3|Overall Study|Administrative Error|0
163471|NCT00286442|521947|P2|Overall Study|Administrative Error|1
163472|NCT00286442|521948|P1|Overall Study|Administrative Error|1
163473|NCT00286442|521946|P3|Overall Study|Physician Decision|1
163474|NCT00286442|521947|P2|Overall Study|Physician Decision|1
163475|NCT00286442|521948|P1|Overall Study|Physician Decision|1
163476|NCT00286442|521946|P3|Overall Study|Lost to Follow-up|1
163477|NCT00286442|521947|P2|Overall Study|Lost to Follow-up|2
163478|NCT00286442|521948|P1|Overall Study|Lost to Follow-up|5
163479|NCT00286442|521946|P3|Overall Study|Protocol Violation|2
163480|NCT00286442|521947|P2|Overall Study|Protocol Violation|4
163481|NCT00286442|521948|P1|Overall Study|Protocol Violation|2
163482|NCT00286442|521946|P3|Overall Study|Adverse Event|1
163483|NCT00286442|521947|P2|Overall Study|Adverse Event|6
163484|NCT00286442|521948|P1|Overall Study|Adverse Event|7
163485|NCT00286442|521946|P3|Overall Study|Hyperglycemic Rescue|25
163486|NCT00286442|521947|P2|Overall Study|Hyperglycemic Rescue|17
163487|NCT00286442|521948|P1|Overall Study|Hyperglycemic Rescue|19
163488|NCT00286429|522109|P3|Overall Study|Administrative Decision|0
163489|NCT00286429|522110|P2|Overall Study|Administrative Decision|1
163490|NCT00286429|522111|P1|Overall Study|Administrative Decision|0
163491|NCT00286429|522109|P3|Overall Study|Administrative Error|1
163492|NCT00286429|522110|P2|Overall Study|Administrative Error|1
163493|NCT00286429|522111|P1|Overall Study|Administrative Error|1
163494|NCT00286429|522109|P3|Overall Study|Withdrawal by Subject|6
163495|NCT00286429|522110|P2|Overall Study|Withdrawal by Subject|2
163496|NCT00286429|522111|P1|Overall Study|Withdrawal by Subject|3
163497|NCT00286429|522109|P3|Overall Study|Protocol Violation|4
163498|NCT00286429|522110|P2|Overall Study|Protocol Violation|5
163499|NCT00286429|522111|P1|Overall Study|Protocol Violation|3
163500|NCT00286429|522109|P3|Overall Study|Physician Decision|7
163501|NCT00286429|522110|P2|Overall Study|Physician Decision|7
163502|NCT00286429|522111|P1|Overall Study|Physician Decision|10
163503|NCT00286429|522109|P3|Overall Study|Lost to Follow-up|3
163504|NCT00286429|522110|P2|Overall Study|Lost to Follow-up|4
163505|NCT00286429|522111|P1|Overall Study|Lost to Follow-up|2
163506|NCT00286429|522109|P3|Overall Study|Lack of Efficacy|25
163507|NCT00286429|522110|P2|Overall Study|Lack of Efficacy|27
163508|NCT00286429|522111|P1|Overall Study|Lack of Efficacy|52
163509|NCT00286429|522109|P3|Overall Study|Adverse Event|6
163510|NCT00286429|522110|P2|Overall Study|Adverse Event|1
163511|NCT00286429|522111|P1|Overall Study|Adverse Event|4
163512|NCT00286156|522235|P3|Overall Study|AE: pneumonia|0
163513|NCT00286156|522236|P2|Overall Study|AE: pneumonia|0
163514|NCT00286156|522237|P1|Overall Study|AE: pneumonia|1
163515|NCT00286156|522235|P3|Overall Study|AE: nephrotic-range proteinuruia|0
163516|NCT00286156|522236|P2|Overall Study|AE: nephrotic-range proteinuruia|0
163517|NCT00286156|522237|P1|Overall Study|AE: nephrotic-range proteinuruia|1
163518|NCT00286156|522235|P3|Overall Study|AE: pulmonary embolus|0
163519|NCT00286156|522236|P2|Overall Study|AE: pulmonary embolus|1
163520|NCT00286156|522237|P1|Overall Study|AE: pulmonary embolus|0
163521|NCT00286156|522235|P3|Overall Study|Missed 12 month visit|1
163522|NCT00286156|522236|P2|Overall Study|Missed 12 month visit|0
163523|NCT00286156|522237|P1|Overall Study|Missed 12 month visit|0
163524|NCT00286091|522250|P2|Open-label Treatment Phase|Missing End of Study Information|1
163525|NCT00286091|522251|P1|Open-label Treatment Phase|Missing End of Study Information|0
163526|NCT00286091|522250|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
163527|NCT00286091|522251|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
163528|NCT00286091|522250|P2|Open-label Treatment Phase|Lost to Follow-up|1
163529|NCT00286091|522251|P1|Open-label Treatment Phase|Lost to Follow-up|0
163530|NCT00286091|522250|P2|Open-label Treatment Phase|Noncompliance|1
163531|NCT00286091|522251|P1|Open-label Treatment Phase|Noncompliance|3
163532|NCT00286091|522250|P2|Open-label Treatment Phase|Disease Progression|3
163533|NCT00286091|522251|P1|Open-label Treatment Phase|Disease Progression|9
163534|NCT00286091|522250|P2|Open-label Treatment Phase|Death|7
163535|NCT00286091|522251|P1|Open-label Treatment Phase|Death|10
163536|NCT00286091|522250|P2|Open-label Treatment Phase|Withdrawal by Subject|10
163537|NCT00286091|522251|P1|Open-label Treatment Phase|Withdrawal by Subject|14
163538|NCT00286091|522250|P2|Open-label Treatment Phase|Other|11
163539|NCT00286091|522251|P1|Open-label Treatment Phase|Other|11
163540|NCT00286091|522250|P2|Open-label Treatment Phase|Adverse Event|16
163541|NCT00286091|522251|P1|Open-label Treatment Phase|Adverse Event|5
163542|NCT00286091|522250|P2|Open-label Treatment Phase|Physician Decision|21
163543|NCT00286091|522251|P1|Open-label Treatment Phase|Physician Decision|24
163544|NCT00286091|522250|P2|Double-blind Treatment Phase|Ineligibility Determined|2
163545|NCT00286091|522251|P1|Double-blind Treatment Phase|Ineligibility Determined|1
163546|NCT00286091|522250|P2|Double-blind Treatment Phase|Protocol Deviation|3
163547|NCT00286091|522251|P1|Double-blind Treatment Phase|Protocol Deviation|1
163548|NCT00286091|522250|P2|Double-blind Treatment Phase|Lost to Follow-up|4
163549|NCT00286091|522251|P1|Double-blind Treatment Phase|Lost to Follow-up|11
163550|NCT00286091|522250|P2|Double-blind Treatment Phase|Noncompliance|8
163551|NCT00286091|522251|P1|Double-blind Treatment Phase|Noncompliance|8
163552|NCT00286091|522250|P2|Double-blind Treatment Phase|Administrative Decision|21
163553|NCT00286091|522251|P1|Double-blind Treatment Phase|Administrative Decision|20
163554|NCT00286091|522250|P2|Double-blind Treatment Phase|Other|33
163555|NCT00286091|522251|P1|Double-blind Treatment Phase|Other|25
163556|NCT00286091|522250|P2|Double-blind Treatment Phase|Disease Progression|35
163557|NCT00286091|522251|P1|Double-blind Treatment Phase|Disease Progression|22
163558|NCT00286091|522250|P2|Double-blind Treatment Phase|Adverse Event|40
163559|NCT00286091|522251|P1|Double-blind Treatment Phase|Adverse Event|28
163560|NCT00286091|522250|P2|Double-blind Treatment Phase|Death|65
163561|NCT00286091|522251|P1|Double-blind Treatment Phase|Death|58
163562|NCT00286091|522250|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
163563|NCT00286091|522251|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
163564|NCT00286091|522250|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
163565|NCT00286091|522251|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
163566|NCT00285818|522289|P2|Overall Study|Lost to Follow-up|0
163567|NCT00285818|522290|P1|Overall Study|Lost to Follow-up|1
163568|NCT00285818|522289|P2|Overall Study|Withdrawal by Subject|2
163569|NCT00285818|522290|P1|Overall Study|Withdrawal by Subject|3
163570|NCT00285584|522307|P2|Month 6|Lost to Follow-up|1
163571|NCT00285584|522308|P1|Month 6|Lost to Follow-up|0
163572|NCT00285584|522307|P2|Month 3|Withdrawal by Subject|0
163573|NCT00285584|522308|P1|Month 3|Withdrawal by Subject|1
163574|NCT00285584|522307|P2|Month 3|Lost to Follow-up|3
163575|NCT00285584|522308|P1|Month 3|Lost to Follow-up|3
163576|NCT00285207|522340|P2|Overall Study|non-compliance|1
163577|NCT00285207|522341|P1|Overall Study|non-compliance|0
163578|NCT00285207|522340|P2|Overall Study|Pregnancy|1
163579|NCT00285207|522341|P1|Overall Study|Pregnancy|1
163580|NCT00285207|522340|P2|Overall Study|Withdrawal by Subject|2
163581|NCT00285207|522341|P1|Overall Study|Withdrawal by Subject|5
163582|NCT00285207|522340|P2|Overall Study|Lost to Follow-up|2
163583|NCT00285207|522341|P1|Overall Study|Lost to Follow-up|3
163584|NCT00284141|522363|P1|Overall Study|Ongoing treatment|2
163585|NCT00284141|522363|P1|Overall Study|Did not take study medication|2
163586|NCT00284141|522363|P1|Overall Study|Pneumonia|1
163587|NCT00284141|522363|P1|Overall Study|General decline|1
163588|NCT00284141|522363|P1|Overall Study|Clinical deterioration / death|2
163589|NCT00284141|522363|P1|Overall Study|Symptomatic / Clinical Progression|11
163590|NCT00284141|522363|P1|Overall Study|Participant's request|9
163591|NCT00284141|522363|P1|Overall Study|Adverse Event|19
163592|NCT00284141|522363|P1|Overall Study|Disease Progression / Lack of efficacy|51
163593|NCT00284089|522386|P4|Extension Phase|Withdrawal by Subject|3
163594|NCT00284089|522387|P3|Extension Phase|Withdrawal by Subject|1
163595|NCT00284089|522388|P2|Extension Phase|Withdrawal by Subject|0
163596|NCT00284089|522389|P1|Extension Phase|Withdrawal by Subject|0
163597|NCT00284089|522386|P4|Extension Phase|Protocol Violation|0
163598|NCT00284089|522387|P3|Extension Phase|Protocol Violation|1
163599|NCT00284089|522388|P2|Extension Phase|Protocol Violation|0
163600|NCT00284089|522389|P1|Extension Phase|Protocol Violation|0
163601|NCT00284089|522386|P4|Extension Phase|condition no longer requires study drug|7
163602|NCT00284089|522387|P3|Extension Phase|condition no longer requires study drug|2
163603|NCT00284089|522388|P2|Extension Phase|condition no longer requires study drug|0
163604|NCT00284089|522389|P1|Extension Phase|condition no longer requires study drug|2
163605|NCT00284089|522386|P4|Extension Phase|Adverse Event|2
163606|NCT00284089|522387|P3|Extension Phase|Adverse Event|2
163607|NCT00284089|522388|P2|Extension Phase|Adverse Event|0
163608|NCT00284089|522389|P1|Extension Phase|Adverse Event|0
163609|NCT00284089|522386|P4|Multiple Dose Phase|Death|1
163610|NCT00284089|522387|P3|Multiple Dose Phase|Death|1
163611|NCT00284089|522388|P2|Multiple Dose Phase|Death|0
163612|NCT00284089|522389|P1|Multiple Dose Phase|Death|0
163613|NCT00284089|522386|P4|Multiple Dose Phase|Withdrawal by Subject|2
163614|NCT00284089|522387|P3|Multiple Dose Phase|Withdrawal by Subject|1
163615|NCT00284089|522388|P2|Multiple Dose Phase|Withdrawal by Subject|0
163616|NCT00284089|522389|P1|Multiple Dose Phase|Withdrawal by Subject|0
163617|NCT00284089|522386|P4|Multiple Dose Phase|Protocol Violation|0
163618|NCT00284089|522387|P3|Multiple Dose Phase|Protocol Violation|1
163619|NCT00284089|522388|P2|Multiple Dose Phase|Protocol Violation|0
163620|NCT00284089|522389|P1|Multiple Dose Phase|Protocol Violation|0
163621|NCT00284089|522386|P4|Multiple Dose Phase|Adverse Event|1
163622|NCT00284089|522387|P3|Multiple Dose Phase|Adverse Event|1
163623|NCT00284089|522388|P2|Multiple Dose Phase|Adverse Event|0
163624|NCT00284089|522389|P1|Multiple Dose Phase|Adverse Event|1
163625|NCT00285012|522417|P2|Received Study Tx|Other|5
163626|NCT00285012|522418|P1|Received Study Tx|Other|5
163627|NCT00285012|522417|P2|Received Study Tx|Withdrawal by Subject|43
163628|NCT00285012|522418|P1|Received Study Tx|Withdrawal by Subject|31
163629|NCT00285012|522417|P2|Received Study Tx|Lost to Follow-up|31
163630|NCT00285012|522418|P1|Received Study Tx|Lost to Follow-up|29
163631|NCT00285012|522417|P2|Received Study Tx|Lack of Efficacy|3
163632|NCT00285012|522418|P1|Received Study Tx|Lack of Efficacy|0
163633|NCT00285012|522417|P2|Received Study Tx|Adverse Event|11
163634|NCT00285012|522418|P1|Received Study Tx|Adverse Event|5
163635|NCT00285012|522417|P2|Received Study Tx|Death|1
163636|NCT00285012|522418|P1|Received Study Tx|Death|2
163637|NCT00285012|522417|P2|Assigned to Study Treatment (Tx)|Other|3
163638|NCT00285012|522418|P1|Assigned to Study Treatment (Tx)|Other|2
163639|NCT00284934|522444|P2|Overall Study|Other reasons|1
163640|NCT00284934|522445|P1|Overall Study|Other reasons|3
163641|NCT00284934|522444|P2|Overall Study|Adverse Event|2
163642|NCT00284934|522445|P1|Overall Study|Adverse Event|1
163643|NCT00284856|522460|P3|Overall Study|Unspecified|4
163644|NCT00284856|522461|P2|Overall Study|Unspecified|5
163645|NCT00284856|522462|P1|Overall Study|Unspecified|4
163646|NCT00284856|522460|P3|Overall Study|Withdrawal by Subject|18
163647|NCT00284856|522461|P2|Overall Study|Withdrawal by Subject|16
163648|NCT00284856|522462|P1|Overall Study|Withdrawal by Subject|12
163649|NCT00284856|522460|P3|Overall Study|Protocol Violation|5
163650|NCT00284856|522461|P2|Overall Study|Protocol Violation|4
163651|NCT00284856|522462|P1|Overall Study|Protocol Violation|5
163652|NCT00284856|522460|P3|Overall Study|Lost to Follow-up|22
163653|NCT00284856|522461|P2|Overall Study|Lost to Follow-up|21
163654|NCT00284856|522462|P1|Overall Study|Lost to Follow-up|25
163655|NCT00284856|522460|P3|Overall Study|Lack of Efficacy|8
163656|NCT00284856|522461|P2|Overall Study|Lack of Efficacy|1
163657|NCT00284856|522462|P1|Overall Study|Lack of Efficacy|2
163658|NCT00284856|522460|P3|Overall Study|Adverse Event|3
163659|NCT00284856|522461|P2|Overall Study|Adverse Event|3
163660|NCT00284856|522462|P1|Overall Study|Adverse Event|3
163661|NCT00284050|522535|P3|Overall Study|Death|0
163662|NCT00284050|522536|P2|Overall Study|Death|0
163663|NCT00284050|522537|P1|Overall Study|Death|1
163664|NCT00284050|522535|P3|Overall Study|Lost to Follow-up|1
163665|NCT00284050|522536|P2|Overall Study|Lost to Follow-up|0
163666|NCT00284050|522537|P1|Overall Study|Lost to Follow-up|1
163667|NCT00284050|522535|P3|Overall Study|Withdrawal by Subject|2
163668|NCT00284050|522536|P2|Overall Study|Withdrawal by Subject|2
163669|NCT00284050|522537|P1|Overall Study|Withdrawal by Subject|2
163670|NCT00284050|522535|P3|Overall Study|Protocol Violation|2
163671|NCT00284050|522536|P2|Overall Study|Protocol Violation|1
163672|NCT00284050|522537|P1|Overall Study|Protocol Violation|0
163673|NCT00284050|522535|P3|Overall Study|Lack of Efficacy|3
163674|NCT00284050|522536|P2|Overall Study|Lack of Efficacy|1
163675|NCT00284050|522537|P1|Overall Study|Lack of Efficacy|0
163676|NCT00284050|522535|P3|Overall Study|Adverse Event|1
163677|NCT00284050|522536|P2|Overall Study|Adverse Event|1
163678|NCT00284050|522537|P1|Overall Study|Adverse Event|1
163679|NCT00283868|522553|P2|Overall Study|Lost to Follow-up|8
163680|NCT00283868|522554|P1|Overall Study|Lost to Follow-up|7
163681|NCT00283842|522571|P5|Overall Study|Lost to Follow-up|1
163682|NCT00283842|522572|P4|Overall Study|Lost to Follow-up|1
163683|NCT00283842|522573|P3|Overall Study|Lost to Follow-up|4
163684|NCT00283842|522574|P2|Overall Study|Lost to Follow-up|2
163685|NCT00283842|522575|P1|Overall Study|Lost to Follow-up|0
163686|NCT00283842|522571|P5|Overall Study|Lack of Efficacy|3
163687|NCT00283842|522572|P4|Overall Study|Lack of Efficacy|0
163688|NCT00283842|522573|P3|Overall Study|Lack of Efficacy|1
163689|NCT00283842|522574|P2|Overall Study|Lack of Efficacy|3
163690|NCT00283842|522575|P1|Overall Study|Lack of Efficacy|1
163691|NCT00283842|522571|P5|Overall Study|Withdrawal by Subject|4
163692|NCT00283842|522572|P4|Overall Study|Withdrawal by Subject|5
163693|NCT00283842|522573|P3|Overall Study|Withdrawal by Subject|1
163694|NCT00283842|522574|P2|Overall Study|Withdrawal by Subject|1
163695|NCT00283842|522575|P1|Overall Study|Withdrawal by Subject|2
163696|NCT00283842|522571|P5|Overall Study|Protocol deviation|2
163697|NCT00283842|522572|P4|Overall Study|Protocol deviation|0
163698|NCT00283842|522573|P3|Overall Study|Protocol deviation|0
163699|NCT00283842|522574|P2|Overall Study|Protocol deviation|0
163700|NCT00283842|522575|P1|Overall Study|Protocol deviation|0
163701|NCT00283842|522571|P5|Overall Study|Protocol Violation|0
163702|NCT00283842|522572|P4|Overall Study|Protocol Violation|0
163703|NCT00283842|522573|P3|Overall Study|Protocol Violation|4
163704|NCT00283842|522574|P2|Overall Study|Protocol Violation|5
163705|NCT00283842|522575|P1|Overall Study|Protocol Violation|1
163706|NCT00283842|522571|P5|Overall Study|Adverse Event|5
163707|NCT00283842|522572|P4|Overall Study|Adverse Event|21
163708|NCT00283842|522573|P3|Overall Study|Adverse Event|21
163709|NCT00283842|522574|P2|Overall Study|Adverse Event|7
163710|NCT00283842|522575|P1|Overall Study|Adverse Event|8
163711|NCT00283712|522609|P2|Overall Study|Death|1
163712|NCT00283712|522610|P1|Overall Study|Death|0
163713|NCT00283686|522648|P4|Overall Study|Less than full participation|12
163714|NCT00283686|522649|P3|Overall Study|Less than full participation|6
163715|NCT00283686|522650|P2|Overall Study|Less than full participation|9
163716|NCT00283686|522651|P1|Overall Study|Less than full participation|7
163717|NCT00283686|522648|P4|Overall Study|Lost to Follow-up|20
163718|NCT00283686|522649|P3|Overall Study|Lost to Follow-up|26
163719|NCT00283686|522650|P2|Overall Study|Lost to Follow-up|31
163720|NCT00283686|522651|P1|Overall Study|Lost to Follow-up|21
163721|NCT00283686|522648|P4|Overall Study|Death|0
163722|NCT00283686|522649|P3|Overall Study|Death|1
163723|NCT00283686|522650|P2|Overall Study|Death|1
163724|NCT00283686|522651|P1|Overall Study|Death|1
163725|NCT00283595|522695|P2|Overall Study|Withdrawal by Subject|2
163726|NCT00283595|522696|P1|Overall Study|Withdrawal by Subject|1
163727|NCT00283439|522708|P4|Overall Study|Not specified|0
163728|NCT00283439|522709|P3|Overall Study|Not specified|0
163729|NCT00283439|522710|P2|Overall Study|Not specified|0
163730|NCT00283439|522711|P1|Overall Study|Not specified|1
163731|NCT00283439|522708|P4|Overall Study|Treatment discontinued|3
163732|NCT00283439|522709|P3|Overall Study|Treatment discontinued|1
163733|NCT00283439|522710|P2|Overall Study|Treatment discontinued|2
163734|NCT00283439|522711|P1|Overall Study|Treatment discontinued|0
163735|NCT00283439|522708|P4|Overall Study|Stem cell transplant|3
163736|NCT00283439|522709|P3|Overall Study|Stem cell transplant|4
163737|NCT00283439|522710|P2|Overall Study|Stem cell transplant|6
163738|NCT00283439|522711|P1|Overall Study|Stem cell transplant|6
163739|NCT00283439|522708|P4|Overall Study|Requirement for alternative therapy|2
163740|NCT00283439|522709|P3|Overall Study|Requirement for alternative therapy|5
163741|NCT00283439|522710|P2|Overall Study|Requirement for alternative therapy|2
163742|NCT00283439|522711|P1|Overall Study|Requirement for alternative therapy|1
163743|NCT00283439|522708|P4|Overall Study|Disease progression|0
163744|NCT00283439|522709|P3|Overall Study|Disease progression|0
163745|NCT00283439|522710|P2|Overall Study|Disease progression|1
163746|NCT00283439|522711|P1|Overall Study|Disease progression|0
163747|NCT00283439|522708|P4|Overall Study|Death|0
163748|NCT00283439|522709|P3|Overall Study|Death|1
163749|NCT00283439|522710|P2|Overall Study|Death|0
163750|NCT00283439|522711|P1|Overall Study|Death|0
163751|NCT00283439|522708|P4|Overall Study|Adverse Event|1
163752|NCT00283439|522709|P3|Overall Study|Adverse Event|0
163753|NCT00283439|522710|P2|Overall Study|Adverse Event|0
163754|NCT00283439|522711|P1|Overall Study|Adverse Event|0
163755|NCT00283400|522737|P4|Overall Study|Death|0
163756|NCT00283400|522738|P3|Overall Study|Death|1
163757|NCT00283400|522739|P2|Overall Study|Death|0
163758|NCT00283400|522740|P1|Overall Study|Death|1
163759|NCT00283400|522737|P4|Overall Study|Withdrawal by Subject|0
163760|NCT00283400|522738|P3|Overall Study|Withdrawal by Subject|0
163761|NCT00283400|522739|P2|Overall Study|Withdrawal by Subject|1
163762|NCT00283400|522740|P1|Overall Study|Withdrawal by Subject|1
163763|NCT00283387|522758|P2|First Intervention|Withdrawal by Subject|1
163764|NCT00283387|522759|P1|First Intervention|Withdrawal by Subject|0
163765|NCT00283387|522758|P2|First Intervention|Subject non-compliant|1
163766|NCT00283387|522759|P1|First Intervention|Subject non-compliant|1
163767|NCT00283296|522765|P1|Overall Study|in-home trial not completed|5
163768|NCT00283062|522787|P4|Overall Study|chemotherapy not completed (cycle 6)|0
163769|NCT00283062|522788|P3|Overall Study|chemotherapy not completed (cycle 6)|0
163770|NCT00283062|522789|P2|Overall Study|chemotherapy not completed (cycle 6)|0
163771|NCT00283062|522790|P1|Overall Study|chemotherapy not completed (cycle 6)|1
163772|NCT00283062|522787|P4|Overall Study|Undefined|4
163773|NCT00283062|522788|P3|Overall Study|Undefined|1
163774|NCT00283062|522789|P2|Overall Study|Undefined|1
163775|NCT00283062|522790|P1|Overall Study|Undefined|0
163776|NCT00283062|522787|P4|Overall Study|Participant did not wish to continue|0
163777|NCT00283062|522788|P3|Overall Study|Participant did not wish to continue|1
163778|NCT00283062|522789|P2|Overall Study|Participant did not wish to continue|2
163779|NCT00283062|522790|P1|Overall Study|Participant did not wish to continue|3
163780|NCT00283062|522787|P4|Overall Study|Progressive disease|0
163781|NCT00283062|522788|P3|Overall Study|Progressive disease|1
163782|NCT00283062|522789|P2|Overall Study|Progressive disease|0
163783|NCT00283062|522790|P1|Overall Study|Progressive disease|0
163784|NCT00283062|522787|P4|Overall Study|Lost to Follow-up|0
163785|NCT00283062|522788|P3|Overall Study|Lost to Follow-up|1
163786|NCT00283062|522789|P2|Overall Study|Lost to Follow-up|0
163787|NCT00283062|522790|P1|Overall Study|Lost to Follow-up|1
163788|NCT00283062|522787|P4|Overall Study|Adverse Event|0
163789|NCT00283062|522788|P3|Overall Study|Adverse Event|1
163790|NCT00283062|522789|P2|Overall Study|Adverse Event|0
163791|NCT00283062|522790|P1|Overall Study|Adverse Event|2
163792|NCT00283062|522787|P4|Overall Study|Did not receive any study medication|45
163793|NCT00283062|522788|P3|Overall Study|Did not receive any study medication|36
163794|NCT00283062|522789|P2|Overall Study|Did not receive any study medication|4
163795|NCT00283062|522790|P1|Overall Study|Did not receive any study medication|5
163796|NCT00283049|522823|P3|Overall Study|No longer requires study treatment|1
163797|NCT00283049|522824|P2|Overall Study|No longer requires study treatment|0
163798|NCT00283049|522825|P1|Overall Study|No longer requires study treatment|0
163799|NCT00283049|522823|P3|Overall Study|Discontinuation of Study|20
163800|NCT00283049|522824|P2|Overall Study|Discontinuation of Study|16
163801|NCT00283049|522825|P1|Overall Study|Discontinuation of Study|18
163802|NCT00283049|522823|P3|Overall Study|Withdrawal by Subject|19
163803|NCT00283049|522824|P2|Overall Study|Withdrawal by Subject|24
163804|NCT00283049|522825|P1|Overall Study|Withdrawal by Subject|26
163805|NCT00283049|522823|P3|Overall Study|Lost to Follow-up|5
163806|NCT00283049|522824|P2|Overall Study|Lost to Follow-up|2
163807|NCT00283049|522825|P1|Overall Study|Lost to Follow-up|4
163808|NCT00283049|522823|P3|Overall Study|Lack of Efficacy|1
163809|NCT00283049|522824|P2|Overall Study|Lack of Efficacy|1
163810|NCT00283049|522825|P1|Overall Study|Lack of Efficacy|0
163811|NCT00283049|522823|P3|Overall Study|Death|1
163812|NCT00283049|522824|P2|Overall Study|Death|1
163813|NCT00283049|522825|P1|Overall Study|Death|1
163814|NCT00283049|522823|P3|Overall Study|Protocol Violation|3
163815|NCT00283049|522824|P2|Overall Study|Protocol Violation|0
163816|NCT00283049|522825|P1|Overall Study|Protocol Violation|3
163817|NCT00283049|522823|P3|Overall Study|Adverse Event|4
163818|NCT00283049|522824|P2|Overall Study|Adverse Event|1
163819|NCT00283049|522825|P1|Overall Study|Adverse Event|6
163820|NCT00282984|522853|P2|Overall Study|Protocol Violation|0
163821|NCT00282984|522854|P1|Overall Study|Protocol Violation|2
163822|NCT00282984|522853|P2|Overall Study|in prison|1
163823|NCT00282984|522854|P1|Overall Study|in prison|0
163824|NCT00282984|522853|P2|Overall Study|lack of motivation|0
163825|NCT00282984|522854|P1|Overall Study|lack of motivation|1
163826|NCT00282984|522853|P2|Overall Study|Participant used antipsychosis meds|1
163827|NCT00282984|522854|P1|Overall Study|Participant used antipsychosis meds|0
163828|NCT00282984|522853|P2|Overall Study|Participant only allowed phone follow-up|1
163829|NCT00282984|522854|P1|Overall Study|Participant only allowed phone follow-up|0
163830|NCT00282984|522853|P2|Overall Study|Participant stopped study medication|2
163831|NCT00282984|522854|P1|Overall Study|Participant stopped study medication|2
163832|NCT00282984|522853|P2|Overall Study|Withdrawal by Participant|34
163833|NCT00282984|522854|P1|Overall Study|Withdrawal by Participant|22
163834|NCT00282984|522853|P2|Overall Study|Lost to Follow-up|10
163835|NCT00282984|522854|P1|Overall Study|Lost to Follow-up|14
163836|NCT00282984|522853|P2|Overall Study|Lack of Efficacy|2
163837|NCT00282984|522854|P1|Overall Study|Lack of Efficacy|0
163838|NCT00282984|522853|P2|Overall Study|Adverse Event|5
163839|NCT00282984|522854|P1|Overall Study|Adverse Event|8
163840|NCT00282984|522853|P2|Overall Study|Death|5
163841|NCT00282984|522854|P1|Overall Study|Death|2
163842|NCT00282919|522891|P1|Overall Study|Asymptomatic Parasitemia|2
163843|NCT00282919|522891|P1|Overall Study|Withdrawal by Subject|1
163844|NCT00282919|522891|P1|Overall Study|Lack of Efficacy|4
163845|NCT00282867|522906|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
163846|NCT00282867|522907|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
163847|NCT00282867|522908|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
163848|NCT00281697|522952|P2|Overall Study|Did not receive study drug|2
163849|NCT00281697|522953|P1|Overall Study|Did not receive study drug|3
163850|NCT00281697|522952|P2|Overall Study|Subject/guardian's decision to withdraw|6
163851|NCT00281697|522953|P1|Overall Study|Subject/guardian's decision to withdraw|33
163852|NCT00281697|522952|P2|Overall Study|Physician's decision to withdraw|12
163853|NCT00281697|522953|P1|Overall Study|Physician's decision to withdraw|15
163854|NCT00281697|522952|P2|Overall Study|Not specified|6
163855|NCT00281697|522953|P1|Overall Study|Not specified|5
163856|NCT00281697|522952|P2|Overall Study|Disease progression|149
163857|NCT00281697|522953|P1|Overall Study|Disease progression|279
163858|NCT00281697|522952|P2|Overall Study|Death|3
163859|NCT00281697|522953|P1|Overall Study|Death|8
163860|NCT00281697|522952|P2|Overall Study|Adverse Event|15
163861|NCT00281697|522953|P1|Overall Study|Adverse Event|54
163862|NCT00281697|522952|P2|Overall Study|> 60 days since last dose of study drug|4
163863|NCT00281697|522953|P1|Overall Study|> 60 days since last dose of study drug|4
163864|NCT00281658|522971|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
163865|NCT00281658|522972|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
163866|NCT00281658|522973|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
163867|NCT00281658|522971|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
163868|NCT00281658|522972|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
163869|NCT00281658|522973|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
163870|NCT00281658|522971|P3|Open-label Monotherapy Extension Phase|Death|97
163871|NCT00281658|522972|P2|Open-label Monotherapy Extension Phase|Death|0
163872|NCT00281658|522973|P1|Open-label Monotherapy Extension Phase|Death|0
163873|NCT00281658|522971|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
163874|NCT00281658|522972|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
163875|NCT00281658|522973|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
163876|NCT00281658|522971|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
163877|NCT00281658|522972|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
163878|NCT00281658|522973|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
163879|NCT00281658|522971|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
163880|NCT00281658|522972|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
163881|NCT00281658|522973|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
163882|NCT00281658|522971|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
163883|NCT00281658|522972|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
163884|NCT00281658|522973|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
163885|NCT00281658|522971|P3|Double-blind, Randomized Phase|Death|0
163886|NCT00281658|522972|P2|Double-blind, Randomized Phase|Death|46
163887|NCT00281658|522973|P1|Double-blind, Randomized Phase|Death|120
163888|NCT00281632|522990|P1|Overall Study|Ongoing|3
163889|NCT00281632|522990|P1|Overall Study|Physician Decision|1
163890|NCT00281632|522990|P1|Overall Study|Death|1
163891|NCT00281632|522990|P1|Overall Study|Disease Progression|22
163892|NCT00281632|522990|P1|Overall Study|Withdrawal by Subject|2
163893|NCT00281632|522990|P1|Overall Study|Adverse Event|7
163894|NCT00282568|523069|P1|Extended Treatment Period|Lost to Follow-up|2
163895|NCT00282568|523069|P1|Extended Treatment Period|Physician Decision|1
163896|NCT00282568|523069|P1|Extended Treatment Period|Non-compliance|4
163897|NCT00282568|523069|P1|Extended Treatment Period|Adverse Event|17
163898|NCT00282568|523069|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
163899|NCT00282568|523069|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
163900|NCT00282464|523095|P2|Overall Study|dropped due to missed visits|1
163901|NCT00282464|523096|P1|Overall Study|dropped due to missed visits|0
163902|NCT00282464|523095|P2|Overall Study|dispensed wrong kit|1
163903|NCT00282464|523096|P1|Overall Study|dispensed wrong kit|0
163904|NCT00282464|523095|P2|Overall Study|family crisis|1
163905|NCT00282464|523096|P1|Overall Study|family crisis|0
163906|NCT00282464|523095|P2|Overall Study|patient incarcerated|1
163907|NCT00282464|523096|P1|Overall Study|patient incarcerated|0
163908|NCT00282464|523095|P2|Overall Study|patient no show|1
163909|NCT00282464|523096|P1|Overall Study|patient no show|0
163910|NCT00282464|523095|P2|Overall Study|patient non-compliant|0
163911|NCT00282464|523096|P1|Overall Study|patient non-compliant|3
163912|NCT00282464|523095|P2|Overall Study|Patient moved|0
163913|NCT00282464|523096|P1|Overall Study|Patient moved|1
163914|NCT00282464|523095|P2|Overall Study|Protocol Violation|7
163915|NCT00282464|523096|P1|Overall Study|Protocol Violation|0
163916|NCT00282464|523095|P2|Overall Study|laboratory abnormality|2
163917|NCT00282464|523096|P1|Overall Study|laboratory abnormality|1
163918|NCT00282464|523095|P2|Overall Study|Withdrawal by Subject|10
163919|NCT00282464|523096|P1|Overall Study|Withdrawal by Subject|24
163920|NCT00282464|523095|P2|Overall Study|Lost to Follow-up|10
163921|NCT00282464|523096|P1|Overall Study|Lost to Follow-up|10
163922|NCT00282464|523095|P2|Overall Study|Lack of Efficacy|8
163923|NCT00282464|523096|P1|Overall Study|Lack of Efficacy|8
163924|NCT00282464|523095|P2|Overall Study|Adverse Event|20
163925|NCT00282464|523096|P1|Overall Study|Adverse Event|26
163926|NCT00282347|523146|P2|B Cell Follow-up Period|Reason Not Specified|0
163927|NCT00282347|523147|P1|B Cell Follow-up Period|Reason Not Specified|2
163928|NCT00282347|523146|P2|B Cell Follow-up Period|Physician Decision|0
163929|NCT00282347|523147|P1|B Cell Follow-up Period|Physician Decision|1
163930|NCT00282347|523146|P2|B Cell Follow-up Period|Withdrawal by Subject|0
163931|NCT00282347|523147|P1|B Cell Follow-up Period|Withdrawal by Subject|2
163932|NCT00282347|523146|P2|Safety Follow-up Period|Protocol Deviation|2
163933|NCT00282347|523147|P1|Safety Follow-up Period|Protocol Deviation|0
163934|NCT00282347|523146|P2|Safety Follow-up Period|Physician Decision|1
163935|NCT00282347|523147|P1|Safety Follow-up Period|Physician Decision|1
163936|NCT00282347|523146|P2|Safety Follow-up Period|Withdrawal by Subject|1
163937|NCT00282347|523147|P1|Safety Follow-up Period|Withdrawal by Subject|2
163938|NCT00282347|523146|P2|Safety Follow-up Period|Lost to Follow-up|2
163939|NCT00282347|523147|P1|Safety Follow-up Period|Lost to Follow-up|0
163940|NCT00282347|523146|P2|Treatment Period|Physician Decision|1
163941|NCT00282347|523147|P1|Treatment Period|Physician Decision|0
163942|NCT00282347|523146|P2|Treatment Period|Withdrawal by Subject|3
163943|NCT00282347|523147|P1|Treatment Period|Withdrawal by Subject|1
163944|NCT00282347|523146|P2|Treatment Period|Lost to Follow-up|5
163945|NCT00282347|523147|P1|Treatment Period|Lost to Follow-up|2
163946|NCT00282347|523146|P2|Treatment Period|Death|0
163947|NCT00282347|523147|P1|Treatment Period|Death|2
163948|NCT00282334|523173|P2|Overall Study|Withdrawal by Subject|5
163949|NCT00282334|523174|P1|Overall Study|Withdrawal by Subject|8
163950|NCT00282308|523182|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
163951|NCT00282308|523183|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
163952|NCT00282308|523184|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
163953|NCT00282308|523182|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
163954|NCT00282308|523183|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
163955|NCT00282308|523184|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
163956|NCT00282308|523182|P3|Safety Follow-up Period|Lost to Follow-up|5
163957|NCT00282308|523183|P2|Safety Follow-up Period|Lost to Follow-up|0
163958|NCT00282308|523184|P1|Safety Follow-up Period|Lost to Follow-up|0
163959|NCT00282308|523182|P3|Safety Follow-up Period|Adverse Event|1
163960|NCT00282308|523183|P2|Safety Follow-up Period|Adverse Event|0
163961|NCT00282308|523184|P1|Safety Follow-up Period|Adverse Event|0
163962|NCT00282308|523182|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
163963|NCT00282308|523183|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
163964|NCT00282308|523184|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
163965|NCT00282308|523182|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
163966|NCT00282308|523183|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
163967|NCT00282308|523184|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
163968|NCT00282308|523182|P3|Optional Extension Re-treatment Period|Adverse Event|4
163969|NCT00282308|523183|P2|Optional Extension Re-treatment Period|Adverse Event|0
163970|NCT00282308|523184|P1|Optional Extension Re-treatment Period|Adverse Event|0
163971|NCT00282308|523182|P3|Treatment Period|Not Treated with Study Drug|0
163972|NCT00282308|523183|P2|Treatment Period|Not Treated with Study Drug|0
163973|NCT00282308|523184|P1|Treatment Period|Not Treated with Study Drug|1
163974|NCT00282308|523182|P3|Treatment Period|Adverse Event|0
163975|NCT00282308|523183|P2|Treatment Period|Adverse Event|2
163976|NCT00282308|523184|P1|Treatment Period|Adverse Event|0
163977|NCT00282308|523182|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
163978|NCT00282308|523183|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
163979|NCT00282308|523184|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
163980|NCT00282308|523182|P3|Treatment Period|Lost to Follow-up|0
163981|NCT00282308|523183|P2|Treatment Period|Lost to Follow-up|0
163982|NCT00282308|523184|P1|Treatment Period|Lost to Follow-up|1
163983|NCT00282256|523217|P1|Extension Treatment Period|Adverse Event|2
163984|NCT00282256|523217|P1|Pharmacokinetic Treatment Period|Poor venous access|1
163985|NCT00282243|523238|P1|Extension Treatment Period|Physician Decision|1
163986|NCT00282243|523238|P1|Extension Treatment Period|Non-compliance|2
163987|NCT00282243|523238|P1|Extension Treatment Period|Withdrawal by Subject|4
163988|NCT00282243|523238|P1|Extension Treatment Period|Adverse Event|15
163989|NCT00282243|523238|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
163990|NCT00282243|523238|P1|Pharmacokinetic Treatment Period|Adverse Event|3
163991|NCT00282113|523265|P3|Overall Study|Removed at parents request|0
163992|NCT00282113|523266|P2|Overall Study|Removed at parents request|0
163993|NCT00282113|523267|P1|Overall Study|Removed at parents request|1
163994|NCT00282087|523281|P1|Overall Study|Death|1
163995|NCT00282048|523294|P1|Overall Study|Ongoing|1
163996|NCT00282048|523294|P1|Overall Study|Unspecified|8
163997|NCT00282048|523294|P1|Overall Study|Withdrawal by Subject|1
163998|NCT00282048|523294|P1|Overall Study|Adverse Event|22
163999|NCT00282048|523294|P1|Overall Study|Lack of Efficacy|30
164000|NCT00281957|523308|P2|Overall Study|Refusal unrelated to adverse events|1
164001|NCT00281957|523309|P1|Overall Study|Refusal unrelated to adverse events|0
164002|NCT00281957|523308|P2|Overall Study|Did not start treatment|1
164003|NCT00281957|523309|P1|Overall Study|Did not start treatment|3
164004|NCT00281957|523308|P2|Overall Study|Not eligible|2
164005|NCT00281957|523309|P1|Overall Study|Not eligible|1
164006|NCT00281957|523308|P2|Overall Study|Not protocol specified|1
164007|NCT00281957|523309|P1|Overall Study|Not protocol specified|8
164008|NCT00281957|523308|P2|Overall Study|Progression/relapse|35
164009|NCT00281957|523309|P1|Overall Study|Progression/relapse|47
164010|NCT00281957|523308|P2|Overall Study|Death|0
164011|NCT00281957|523309|P1|Overall Study|Death|1
164012|NCT00281957|523308|P2|Overall Study|Adverse Event|2
164013|NCT00281957|523309|P1|Overall Study|Adverse Event|7
164014|NCT00281840|523383|P1|Overall Study|Complicating Disease|1
164015|NCT00281840|523383|P1|Overall Study|exceed maximum delay in treatment|1
164016|NCT00281840|523383|P1|Overall Study|Disease Progression|2
164017|NCT00281840|523383|P1|Overall Study|Withdrawal by Subject|3
164018|NCT00281840|523383|P1|Overall Study|Physician Decision|6
164019|NCT00281840|523383|P1|Overall Study|Adverse Event|12
164020|NCT00281580|523413|P16|Overall Study|Randomised in error; pregnancy; moving|2
164021|NCT00281580|523414|P15|Overall Study|Randomised in error; pregnancy; moving|1
164022|NCT00281580|523415|P14|Overall Study|Randomised in error; pregnancy; moving|0
164023|NCT00281580|523416|P13|Overall Study|Randomised in error; pregnancy; moving|2
164024|NCT00281580|523417|P12|Overall Study|Randomised in error; pregnancy; moving|1
164025|NCT00281580|523418|P11|Overall Study|Randomised in error; pregnancy; moving|1
164026|NCT00281580|523419|P10|Overall Study|Randomised in error; pregnancy; moving|1
164027|NCT00281580|523420|P9|Overall Study|Randomised in error; pregnancy; moving|2
164028|NCT00281580|523421|P8|Overall Study|Randomised in error; pregnancy; moving|0
164029|NCT00281580|523422|P7|Overall Study|Randomised in error; pregnancy; moving|1
164030|NCT00281580|523423|P6|Overall Study|Randomised in error; pregnancy; moving|0
164031|NCT00281580|523424|P5|Overall Study|Randomised in error; pregnancy; moving|0
164032|NCT00281580|523425|P4|Overall Study|Randomised in error; pregnancy; moving|2
164033|NCT00281580|523426|P3|Overall Study|Randomised in error; pregnancy; moving|0
164034|NCT00281580|523427|P2|Overall Study|Randomised in error; pregnancy; moving|0
164035|NCT00281580|523428|P1|Overall Study|Randomised in error; pregnancy; moving|0
164036|NCT00281580|523413|P16|Overall Study|Lost to Follow-up|0
164037|NCT00281580|523414|P15|Overall Study|Lost to Follow-up|0
164038|NCT00281580|523415|P14|Overall Study|Lost to Follow-up|0
164039|NCT00281580|523416|P13|Overall Study|Lost to Follow-up|1
164040|NCT00281580|523417|P12|Overall Study|Lost to Follow-up|0
164041|NCT00281580|523418|P11|Overall Study|Lost to Follow-up|1
164042|NCT00281580|523419|P10|Overall Study|Lost to Follow-up|1
164043|NCT00281580|523420|P9|Overall Study|Lost to Follow-up|2
164044|NCT00281580|523421|P8|Overall Study|Lost to Follow-up|1
164045|NCT00281580|523422|P7|Overall Study|Lost to Follow-up|0
164046|NCT00281580|523423|P6|Overall Study|Lost to Follow-up|1
164047|NCT00281580|523424|P5|Overall Study|Lost to Follow-up|0
164048|NCT00281580|523425|P4|Overall Study|Lost to Follow-up|3
164049|NCT00281580|523426|P3|Overall Study|Lost to Follow-up|0
164050|NCT00281580|523427|P2|Overall Study|Lost to Follow-up|0
164051|NCT00281580|523428|P1|Overall Study|Lost to Follow-up|0
164052|NCT00281580|523413|P16|Overall Study|Lack of Efficacy|0
164053|NCT00281580|523414|P15|Overall Study|Lack of Efficacy|1
164054|NCT00281580|523415|P14|Overall Study|Lack of Efficacy|2
164055|NCT00281580|523416|P13|Overall Study|Lack of Efficacy|0
164056|NCT00281580|523417|P12|Overall Study|Lack of Efficacy|1
164057|NCT00281580|523418|P11|Overall Study|Lack of Efficacy|0
164058|NCT00281580|523419|P10|Overall Study|Lack of Efficacy|0
164059|NCT00281580|523420|P9|Overall Study|Lack of Efficacy|0
164060|NCT00281580|523421|P8|Overall Study|Lack of Efficacy|0
164061|NCT00281580|523422|P7|Overall Study|Lack of Efficacy|0
164062|NCT00281580|523423|P6|Overall Study|Lack of Efficacy|0
164063|NCT00281580|523424|P5|Overall Study|Lack of Efficacy|2
164064|NCT00281580|523425|P4|Overall Study|Lack of Efficacy|6
164065|NCT00281580|523426|P3|Overall Study|Lack of Efficacy|1
164066|NCT00281580|523427|P2|Overall Study|Lack of Efficacy|1
164067|NCT00281580|523428|P1|Overall Study|Lack of Efficacy|2
164068|NCT00281580|523413|P16|Overall Study|Withdrawal by Subject|5
164069|NCT00281580|523414|P15|Overall Study|Withdrawal by Subject|1
164070|NCT00281580|523415|P14|Overall Study|Withdrawal by Subject|2
164071|NCT00281580|523416|P13|Overall Study|Withdrawal by Subject|2
164072|NCT00281580|523417|P12|Overall Study|Withdrawal by Subject|1
164073|NCT00281580|523418|P11|Overall Study|Withdrawal by Subject|1
164074|NCT00281580|523419|P10|Overall Study|Withdrawal by Subject|4
164075|NCT00281580|523420|P9|Overall Study|Withdrawal by Subject|1
164076|NCT00281580|523421|P8|Overall Study|Withdrawal by Subject|0
164077|NCT00281580|523422|P7|Overall Study|Withdrawal by Subject|2
164078|NCT00281580|523423|P6|Overall Study|Withdrawal by Subject|2
164079|NCT00281580|523424|P5|Overall Study|Withdrawal by Subject|1
164080|NCT00281580|523425|P4|Overall Study|Withdrawal by Subject|1
164081|NCT00281580|523426|P3|Overall Study|Withdrawal by Subject|1
164082|NCT00281580|523427|P2|Overall Study|Withdrawal by Subject|0
164083|NCT00281580|523428|P1|Overall Study|Withdrawal by Subject|3
164084|NCT00281580|523413|P16|Overall Study|Protocol Violation|3
164085|NCT00281580|523414|P15|Overall Study|Protocol Violation|1
164086|NCT00281580|523415|P14|Overall Study|Protocol Violation|1
164087|NCT00281580|523416|P13|Overall Study|Protocol Violation|0
164088|NCT00281580|523417|P12|Overall Study|Protocol Violation|2
164089|NCT00281580|523418|P11|Overall Study|Protocol Violation|1
164090|NCT00281580|523419|P10|Overall Study|Protocol Violation|0
164091|NCT00281580|523420|P9|Overall Study|Protocol Violation|2
164092|NCT00281580|523421|P8|Overall Study|Protocol Violation|0
164093|NCT00281580|523422|P7|Overall Study|Protocol Violation|1
164094|NCT00281580|523423|P6|Overall Study|Protocol Violation|0
164095|NCT00281580|523424|P5|Overall Study|Protocol Violation|0
164096|NCT00281580|523425|P4|Overall Study|Protocol Violation|1
164097|NCT00281580|523426|P3|Overall Study|Protocol Violation|1
164098|NCT00281580|523427|P2|Overall Study|Protocol Violation|0
164099|NCT00281580|523428|P1|Overall Study|Protocol Violation|0
164100|NCT00281580|523413|P16|Overall Study|Adverse Event|3
164101|NCT00281580|523414|P15|Overall Study|Adverse Event|3
164102|NCT00281580|523415|P14|Overall Study|Adverse Event|2
164103|NCT00281580|523416|P13|Overall Study|Adverse Event|8
164104|NCT00281580|523417|P12|Overall Study|Adverse Event|5
164105|NCT00281580|523418|P11|Overall Study|Adverse Event|0
164106|NCT00281580|523419|P10|Overall Study|Adverse Event|6
164107|NCT00281580|523420|P9|Overall Study|Adverse Event|1
164108|NCT00281580|523421|P8|Overall Study|Adverse Event|0
164109|NCT00281580|523422|P7|Overall Study|Adverse Event|1
164110|NCT00281580|523423|P6|Overall Study|Adverse Event|0
164111|NCT00281580|523424|P5|Overall Study|Adverse Event|1
164112|NCT00281580|523425|P4|Overall Study|Adverse Event|4
164113|NCT00281580|523426|P3|Overall Study|Adverse Event|2
164114|NCT00281580|523427|P2|Overall Study|Adverse Event|0
164115|NCT00281580|523428|P1|Overall Study|Adverse Event|2
164116|NCT00281528|523775|P3|Overall Study|Unspecified|5
164117|NCT00281528|523776|P2|Overall Study|Unspecified|3
164118|NCT00281528|523777|P1|Overall Study|Unspecified|6
164119|NCT00281528|523775|P3|Overall Study|Withdrawal by Subject|7
164120|NCT00281528|523776|P2|Overall Study|Withdrawal by Subject|5
164121|NCT00281528|523777|P1|Overall Study|Withdrawal by Subject|5
164122|NCT00281528|523775|P3|Overall Study|Protocol Violation|1
164123|NCT00281528|523776|P2|Overall Study|Protocol Violation|0
164124|NCT00281528|523777|P1|Overall Study|Protocol Violation|1
164125|NCT00281528|523775|P3|Overall Study|Physician Decision|5
164126|NCT00281528|523776|P2|Overall Study|Physician Decision|4
164127|NCT00281528|523777|P1|Overall Study|Physician Decision|11
164128|NCT00281528|523775|P3|Overall Study|Adverse Event-unrelated to treatment|2
164129|NCT00281528|523776|P2|Overall Study|Adverse Event-unrelated to treatment|0
164298|NCT00279201|524201|P2|Intensification Addendum|Protocol Violation|0
164130|NCT00281528|523777|P1|Overall Study|Adverse Event-unrelated to treatment|3
164131|NCT00281528|523775|P3|Overall Study|Unacceptable Toxicity-related to trt|32
164132|NCT00281528|523776|P2|Overall Study|Unacceptable Toxicity-related to trt|24
164133|NCT00281528|523777|P1|Overall Study|Unacceptable Toxicity-related to trt|21
164134|NCT00281528|523775|P3|Overall Study|Progressive Disease|27
164135|NCT00281528|523776|P2|Overall Study|Progressive Disease|18
164136|NCT00281528|523777|P1|Overall Study|Progressive Disease|28
164137|NCT00281320|523828|P2|Overall Study|Not specified|1
164138|NCT00281320|523829|P1|Overall Study|Not specified|3
164139|NCT00281320|523828|P2|Overall Study|Lost to Follow-up|2
164140|NCT00281320|523829|P1|Overall Study|Lost to Follow-up|1
164141|NCT00281320|523828|P2|Overall Study|Withdrawal by Subject|6
164142|NCT00281320|523829|P1|Overall Study|Withdrawal by Subject|5
164143|NCT00281320|523828|P2|Overall Study|Lack of Efficacy|3
164144|NCT00281320|523829|P1|Overall Study|Lack of Efficacy|4
164145|NCT00281320|523828|P2|Overall Study|Adverse Event|9
164146|NCT00281320|523829|P1|Overall Study|Adverse Event|12
164147|NCT00281099|523851|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
164148|NCT00281099|523852|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
164149|NCT00281099|523851|P2|Overall Study|Physician Decision|72
164150|NCT00281099|523852|P1|Overall Study|Physician Decision|79
164151|NCT00281099|523851|P2|Overall Study|Withdrawal by Subject|70
164152|NCT00281099|523852|P1|Overall Study|Withdrawal by Subject|65
164153|NCT00281099|523851|P2|Overall Study|Lost to Follow-up|19
164154|NCT00281099|523852|P1|Overall Study|Lost to Follow-up|10
164155|NCT00281099|523851|P2|Overall Study|Death|57
164156|NCT00281099|523852|P1|Overall Study|Death|46
164157|NCT00280917|523901|P4|Overall Study|Noncompliance|0
164158|NCT00280917|523902|P3|Overall Study|Noncompliance|2
164159|NCT00280917|523903|P2|Overall Study|Noncompliance|1
164160|NCT00280917|523904|P1|Overall Study|Noncompliance|0
164161|NCT00280917|523901|P4|Overall Study|Withdrawal by Subject|1
164162|NCT00280917|523902|P3|Overall Study|Withdrawal by Subject|0
164163|NCT00280917|523903|P2|Overall Study|Withdrawal by Subject|2
164164|NCT00280917|523904|P1|Overall Study|Withdrawal by Subject|0
164165|NCT00280917|523901|P4|Overall Study|Change Therapy|0
164166|NCT00280917|523902|P3|Overall Study|Change Therapy|0
164167|NCT00280917|523903|P2|Overall Study|Change Therapy|2
164168|NCT00280917|523904|P1|Overall Study|Change Therapy|1
164169|NCT00280917|523901|P4|Overall Study|Adverse Event|1
164170|NCT00280917|523902|P3|Overall Study|Adverse Event|4
164171|NCT00280917|523903|P2|Overall Study|Adverse Event|1
164172|NCT00280917|523904|P1|Overall Study|Adverse Event|1
164173|NCT00280059|523921|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
164174|NCT00280059|523922|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
164175|NCT00280059|523921|P2|Efficacy Assessment Phase|Unspecified|8
164176|NCT00280059|523922|P1|Efficacy Assessment Phase|Unspecified|7
164177|NCT00280059|523921|P2|Efficacy Assessment Phase|Lost to Follow-up|13
164178|NCT00280059|523922|P1|Efficacy Assessment Phase|Lost to Follow-up|6
164179|NCT00280059|523921|P2|Efficacy Assessment Phase|Lack of Efficacy|3
164180|NCT00280059|523922|P1|Efficacy Assessment Phase|Lack of Efficacy|19
164181|NCT00280059|523921|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
164182|NCT00280059|523922|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
164183|NCT00280059|523921|P2|Efficacy Assessment Phase|Adverse Event|31
164184|NCT00280059|523922|P1|Efficacy Assessment Phase|Adverse Event|33
164185|NCT00280059|523921|P2|Efficacy Assessment Phase|Death|0
164186|NCT00280059|523922|P1|Efficacy Assessment Phase|Death|2
164187|NCT00280683|523994|P2|Overall Study|Adverse Event|1
164188|NCT00280683|523995|P1|Overall Study|Adverse Event|1
164189|NCT00280683|523994|P2|Overall Study|Withdrawal by Subject|2
164190|NCT00280683|523995|P1|Overall Study|Withdrawal by Subject|1
164191|NCT00280566|524005|P3|Period 2 Double Blind|miscellaneous|5
164192|NCT00280566|524006|P2|Period 2 Double Blind|miscellaneous|10
164193|NCT00280566|524007|P1|Period 2 Double Blind|miscellaneous|0
164194|NCT00280566|524005|P3|Period 2 Double Blind|Withdrawal by Subject|9
164195|NCT00280566|524006|P2|Period 2 Double Blind|Withdrawal by Subject|9
164196|NCT00280566|524007|P1|Period 2 Double Blind|Withdrawal by Subject|0
164197|NCT00280566|524005|P3|Period 2 Double Blind|Lost to Follow-up|6
164198|NCT00280566|524006|P2|Period 2 Double Blind|Lost to Follow-up|3
164199|NCT00280566|524007|P1|Period 2 Double Blind|Lost to Follow-up|0
164200|NCT00280566|524005|P3|Period 2 Double Blind|Adverse Event|15
164201|NCT00280566|524006|P2|Period 2 Double Blind|Adverse Event|11
164202|NCT00280566|524007|P1|Period 2 Double Blind|Adverse Event|0
164203|NCT00280566|524005|P3|Period 2 Double Blind|Laboratory Abnormality|0
164204|NCT00280566|524006|P2|Period 2 Double Blind|Laboratory Abnormality|1
164205|NCT00280566|524007|P1|Period 2 Double Blind|Laboratory Abnormality|0
164206|NCT00280566|524005|P3|Period 2 Double Blind|Lack of Efficacy|22
164207|NCT00280566|524006|P2|Period 2 Double Blind|Lack of Efficacy|9
164208|NCT00280566|524007|P1|Period 2 Double Blind|Lack of Efficacy|0
164209|NCT00280566|524005|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
164210|NCT00280566|524006|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
164211|NCT00280566|524007|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
164212|NCT00280566|524005|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
164213|NCT00280566|524006|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
164214|NCT00280566|524007|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
164215|NCT00280566|524005|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
164216|NCT00280566|524006|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
164217|NCT00280566|524007|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
164218|NCT00280566|524005|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
164219|NCT00280566|524006|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
164220|NCT00280566|524007|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
164221|NCT00280566|524005|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
164222|NCT00280566|524006|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
164223|NCT00280566|524007|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
164224|NCT00280566|524005|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
164225|NCT00280566|524006|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
164226|NCT00280566|524007|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
164227|NCT00280397|524032|P1|Overall Study|Adverse Event|1
164228|NCT00280293|524098|P2|Overall Study|Adverse Event|1
164229|NCT00280293|524099|P1|Overall Study|Adverse Event|0
164230|NCT00280293|524098|P2|Overall Study|Incarceration/Legal Reasons|1
164231|NCT00280293|524099|P1|Overall Study|Incarceration/Legal Reasons|1
164232|NCT00280293|524098|P2|Overall Study|Withdrawal by Subject|5
164233|NCT00280293|524099|P1|Overall Study|Withdrawal by Subject|3
164234|NCT00280293|524098|P2|Overall Study|Lost to Follow-up|12
164235|NCT00280293|524099|P1|Overall Study|Lost to Follow-up|14
164236|NCT00280293|524098|P2|Overall Study|Physician Decision|4
164237|NCT00280293|524099|P1|Overall Study|Physician Decision|5
164238|NCT00280293|524098|P2|Overall Study|Protocol Violation|0
164239|NCT00280293|524099|P1|Overall Study|Protocol Violation|3
164240|NCT00279916|524120|P2|Overall Study|Lost to Follow-up|2
164241|NCT00279916|524121|P1|Overall Study|Lost to Follow-up|3
164242|NCT00279916|524120|P2|Overall Study|Withdrawal by Subject|3
164243|NCT00279916|524121|P1|Overall Study|Withdrawal by Subject|4
164244|NCT00279708|524131|P2|Overall Study|Adverse Event|1
164245|NCT00279708|524132|P1|Overall Study|Adverse Event|1
164246|NCT00279708|524131|P2|Overall Study|Withdrawal by Subject|4
164247|NCT00279708|524132|P1|Overall Study|Withdrawal by Subject|2
164248|NCT00279305|524157|P2|Overall Study|FDA Safety Alert|1
164249|NCT00279305|524158|P1|Overall Study|FDA Safety Alert|4
164250|NCT00279305|524157|P2|Overall Study|Dificulting establishing IV|0
164251|NCT00279305|524158|P1|Overall Study|Dificulting establishing IV|1
164252|NCT00279305|524157|P2|Overall Study|Withdrawal by Subject|0
164253|NCT00279305|524158|P1|Overall Study|Withdrawal by Subject|2
164254|NCT00279305|524157|P2|Overall Study|Pregnancy|0
164255|NCT00279305|524158|P1|Overall Study|Pregnancy|1
164256|NCT00279214|524166|P2|Overall Study|Physician Decision|2
164257|NCT00279214|524167|P1|Overall Study|Physician Decision|3
164258|NCT00279201|524197|P6|Intensification Addendum|Death|0
164259|NCT00279201|524198|P5|Intensification Addendum|Death|1
164260|NCT00279201|524199|P4|Intensification Addendum|Death|0
164261|NCT00279201|524200|P3|Intensification Addendum|Death|0
164262|NCT00279201|524201|P2|Intensification Addendum|Death|0
164263|NCT00279201|524202|P1|Intensification Addendum|Death|0
164264|NCT00279201|524197|P6|Intensification Addendum|Lack of Efficacy|0
164265|NCT00279201|524198|P5|Intensification Addendum|Lack of Efficacy|1
164266|NCT00279201|524199|P4|Intensification Addendum|Lack of Efficacy|1
164267|NCT00279201|524200|P3|Intensification Addendum|Lack of Efficacy|0
164268|NCT00279201|524201|P2|Intensification Addendum|Lack of Efficacy|0
164269|NCT00279201|524202|P1|Intensification Addendum|Lack of Efficacy|0
164270|NCT00279201|524197|P6|Intensification Addendum|Entry Criteria Exclusion|0
164271|NCT00279201|524198|P5|Intensification Addendum|Entry Criteria Exclusion|0
164272|NCT00279201|524199|P4|Intensification Addendum|Entry Criteria Exclusion|0
164273|NCT00279201|524200|P3|Intensification Addendum|Entry Criteria Exclusion|1
164274|NCT00279201|524201|P2|Intensification Addendum|Entry Criteria Exclusion|0
164275|NCT00279201|524202|P1|Intensification Addendum|Entry Criteria Exclusion|0
164276|NCT00279201|524197|P6|Intensification Addendum|Sponsor Decision|1
164277|NCT00279201|524198|P5|Intensification Addendum|Sponsor Decision|1
164278|NCT00279201|524199|P4|Intensification Addendum|Sponsor Decision|0
164279|NCT00279201|524200|P3|Intensification Addendum|Sponsor Decision|0
164280|NCT00279201|524201|P2|Intensification Addendum|Sponsor Decision|0
164281|NCT00279201|524202|P1|Intensification Addendum|Sponsor Decision|0
164282|NCT00279201|524197|P6|Intensification Addendum|Physician Decision|2
164283|NCT00279201|524198|P5|Intensification Addendum|Physician Decision|3
164284|NCT00279201|524199|P4|Intensification Addendum|Physician Decision|1
164285|NCT00279201|524200|P3|Intensification Addendum|Physician Decision|4
164286|NCT00279201|524201|P2|Intensification Addendum|Physician Decision|0
164287|NCT00279201|524202|P1|Intensification Addendum|Physician Decision|0
164288|NCT00279201|524197|P6|Intensification Addendum|Adverse Event|3
164289|NCT00279201|524198|P5|Intensification Addendum|Adverse Event|1
164290|NCT00279201|524199|P4|Intensification Addendum|Adverse Event|4
164291|NCT00279201|524200|P3|Intensification Addendum|Adverse Event|0
164292|NCT00279201|524201|P2|Intensification Addendum|Adverse Event|0
164293|NCT00279201|524202|P1|Intensification Addendum|Adverse Event|0
164294|NCT00279201|524197|P6|Intensification Addendum|Protocol Violation|6
164295|NCT00279201|524198|P5|Intensification Addendum|Protocol Violation|6
164296|NCT00279201|524199|P4|Intensification Addendum|Protocol Violation|2
164297|NCT00279201|524200|P3|Intensification Addendum|Protocol Violation|2
164299|NCT00279201|524202|P1|Intensification Addendum|Protocol Violation|0
164300|NCT00279201|524197|P6|Intensification Addendum|Lost to Follow-up|7
164301|NCT00279201|524198|P5|Intensification Addendum|Lost to Follow-up|7
164302|NCT00279201|524199|P4|Intensification Addendum|Lost to Follow-up|6
164303|NCT00279201|524200|P3|Intensification Addendum|Lost to Follow-up|4
164304|NCT00279201|524201|P2|Intensification Addendum|Lost to Follow-up|0
164305|NCT00279201|524202|P1|Intensification Addendum|Lost to Follow-up|0
164306|NCT00279201|524197|P6|Intensification Addendum|Withdrawal by Subject|18
164307|NCT00279201|524198|P5|Intensification Addendum|Withdrawal by Subject|9
164308|NCT00279201|524199|P4|Intensification Addendum|Withdrawal by Subject|14
164309|NCT00279201|524200|P3|Intensification Addendum|Withdrawal by Subject|12
164310|NCT00279201|524201|P2|Intensification Addendum|Withdrawal by Subject|0
164311|NCT00279201|524202|P1|Intensification Addendum|Withdrawal by Subject|0
164312|NCT00279201|524197|P6|Maintenance|HbA1c>7.5%|0
164313|NCT00279201|524198|P5|Maintenance|HbA1c>7.5%|0
164314|NCT00279201|524199|P4|Maintenance|HbA1c>7.5%|0
164315|NCT00279201|524200|P3|Maintenance|HbA1c>7.5%|0
164316|NCT00279201|524201|P2|Maintenance|HbA1c>7.5%|126
164317|NCT00279201|524202|P1|Maintenance|HbA1c>7.5%|123
164318|NCT00279201|524197|P6|Maintenance|Sponsor Decision|0
164319|NCT00279201|524198|P5|Maintenance|Sponsor Decision|0
164320|NCT00279201|524199|P4|Maintenance|Sponsor Decision|0
164321|NCT00279201|524200|P3|Maintenance|Sponsor Decision|0
164322|NCT00279201|524201|P2|Maintenance|Sponsor Decision|0
164323|NCT00279201|524202|P1|Maintenance|Sponsor Decision|4
164324|NCT00279201|524197|P6|Maintenance|Physician Decision|0
164325|NCT00279201|524198|P5|Maintenance|Physician Decision|0
164326|NCT00279201|524199|P4|Maintenance|Physician Decision|0
164327|NCT00279201|524200|P3|Maintenance|Physician Decision|0
164328|NCT00279201|524201|P2|Maintenance|Physician Decision|9
164329|NCT00279201|524202|P1|Maintenance|Physician Decision|9
164330|NCT00279201|524197|P6|Maintenance|Withdrawal by Subject|0
164331|NCT00279201|524198|P5|Maintenance|Withdrawal by Subject|0
164332|NCT00279201|524199|P4|Maintenance|Withdrawal by Subject|0
164333|NCT00279201|524200|P3|Maintenance|Withdrawal by Subject|0
164334|NCT00279201|524201|P2|Maintenance|Withdrawal by Subject|18
164335|NCT00279201|524202|P1|Maintenance|Withdrawal by Subject|18
164336|NCT00279201|524197|P6|Maintenance|Protocol Violation|0
164337|NCT00279201|524198|P5|Maintenance|Protocol Violation|0
164338|NCT00279201|524199|P4|Maintenance|Protocol Violation|0
164339|NCT00279201|524200|P3|Maintenance|Protocol Violation|0
164340|NCT00279201|524201|P2|Maintenance|Protocol Violation|24
164341|NCT00279201|524202|P1|Maintenance|Protocol Violation|16
164342|NCT00279201|524197|P6|Maintenance|Entry Criteria Exclusion|0
164343|NCT00279201|524198|P5|Maintenance|Entry Criteria Exclusion|0
164344|NCT00279201|524199|P4|Maintenance|Entry Criteria Exclusion|0
164345|NCT00279201|524200|P3|Maintenance|Entry Criteria Exclusion|0
164346|NCT00279201|524201|P2|Maintenance|Entry Criteria Exclusion|4
164347|NCT00279201|524202|P1|Maintenance|Entry Criteria Exclusion|1
164348|NCT00279201|524197|P6|Maintenance|Lost to Follow-up|0
164349|NCT00279201|524198|P5|Maintenance|Lost to Follow-up|0
164350|NCT00279201|524199|P4|Maintenance|Lost to Follow-up|0
164351|NCT00279201|524200|P3|Maintenance|Lost to Follow-up|0
164352|NCT00279201|524201|P2|Maintenance|Lost to Follow-up|13
164353|NCT00279201|524202|P1|Maintenance|Lost to Follow-up|17
164354|NCT00279201|524197|P6|Maintenance|Death|0
164355|NCT00279201|524198|P5|Maintenance|Death|0
164356|NCT00279201|524199|P4|Maintenance|Death|0
164357|NCT00279201|524200|P3|Maintenance|Death|0
164358|NCT00279201|524201|P2|Maintenance|Death|4
164359|NCT00279201|524202|P1|Maintenance|Death|4
164360|NCT00279201|524197|P6|Maintenance|Adverse Event|0
164361|NCT00279201|524198|P5|Maintenance|Adverse Event|0
164362|NCT00279201|524199|P4|Maintenance|Adverse Event|0
164363|NCT00279201|524200|P3|Maintenance|Adverse Event|0
164364|NCT00279201|524201|P2|Maintenance|Adverse Event|4
164365|NCT00279201|524202|P1|Maintenance|Adverse Event|4
164366|NCT00279201|524197|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
164367|NCT00279201|524198|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
164368|NCT00279201|524199|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
164369|NCT00279201|524200|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
164370|NCT00279201|524201|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
164371|NCT00279201|524202|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
164372|NCT00279201|524197|P6|Maintenance|Lack of Efficacy|0
164373|NCT00279201|524198|P5|Maintenance|Lack of Efficacy|0
164374|NCT00279201|524199|P4|Maintenance|Lack of Efficacy|0
164375|NCT00279201|524200|P3|Maintenance|Lack of Efficacy|0
164376|NCT00279201|524201|P2|Maintenance|Lack of Efficacy|30
164377|NCT00279201|524202|P1|Maintenance|Lack of Efficacy|32
164378|NCT00279201|524197|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
164379|NCT00279201|524198|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
164380|NCT00279201|524199|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
164381|NCT00279201|524200|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
164382|NCT00279201|524201|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
164383|NCT00279201|524202|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
164384|NCT00279201|524197|P6|Initiation|Sponsor Decision|0
164385|NCT00279201|524198|P5|Initiation|Sponsor Decision|0
164386|NCT00279201|524199|P4|Initiation|Sponsor Decision|0
164387|NCT00279201|524200|P3|Initiation|Sponsor Decision|0
164388|NCT00279201|524201|P2|Initiation|Sponsor Decision|5
164389|NCT00279201|524202|P1|Initiation|Sponsor Decision|13
164390|NCT00279201|524197|P6|Initiation|Physician Decision|0
164391|NCT00279201|524198|P5|Initiation|Physician Decision|0
164392|NCT00279201|524199|P4|Initiation|Physician Decision|0
164393|NCT00279201|524200|P3|Initiation|Physician Decision|0
164394|NCT00279201|524201|P2|Initiation|Physician Decision|18
164395|NCT00279201|524202|P1|Initiation|Physician Decision|15
164396|NCT00279201|524197|P6|Initiation|Withdrawal by Subject|0
164397|NCT00279201|524198|P5|Initiation|Withdrawal by Subject|0
164398|NCT00279201|524199|P4|Initiation|Withdrawal by Subject|0
164399|NCT00279201|524200|P3|Initiation|Withdrawal by Subject|0
164400|NCT00279201|524201|P2|Initiation|Withdrawal by Subject|41
164401|NCT00279201|524202|P1|Initiation|Withdrawal by Subject|35
164402|NCT00279201|524197|P6|Initiation|Protocol Violation|0
164403|NCT00279201|524198|P5|Initiation|Protocol Violation|0
164404|NCT00279201|524199|P4|Initiation|Protocol Violation|0
164405|NCT00279201|524200|P3|Initiation|Protocol Violation|0
164406|NCT00279201|524201|P2|Initiation|Protocol Violation|10
164407|NCT00279201|524202|P1|Initiation|Protocol Violation|9
164408|NCT00279201|524197|P6|Initiation|Entry Criteria Exclusion|0
164409|NCT00279201|524198|P5|Initiation|Entry Criteria Exclusion|0
164410|NCT00279201|524199|P4|Initiation|Entry Criteria Exclusion|0
164411|NCT00279201|524200|P3|Initiation|Entry Criteria Exclusion|0
164412|NCT00279201|524201|P2|Initiation|Entry Criteria Exclusion|9
164413|NCT00279201|524202|P1|Initiation|Entry Criteria Exclusion|7
164414|NCT00279201|524197|P6|Initiation|Lost to Follow-up|0
164415|NCT00279201|524198|P5|Initiation|Lost to Follow-up|0
164416|NCT00279201|524199|P4|Initiation|Lost to Follow-up|0
164417|NCT00279201|524200|P3|Initiation|Lost to Follow-up|0
164418|NCT00279201|524201|P2|Initiation|Lost to Follow-up|41
164419|NCT00279201|524202|P1|Initiation|Lost to Follow-up|42
164420|NCT00279201|524197|P6|Initiation|Adverse Event|0
164421|NCT00279201|524198|P5|Initiation|Adverse Event|0
164422|NCT00279201|524199|P4|Initiation|Adverse Event|0
164423|NCT00279201|524200|P3|Initiation|Adverse Event|0
164424|NCT00279201|524201|P2|Initiation|Adverse Event|15
164425|NCT00279201|524202|P1|Initiation|Adverse Event|6
164426|NCT00279201|524197|P6|Initiation|Death|0
164427|NCT00279201|524198|P5|Initiation|Death|0
164428|NCT00279201|524199|P4|Initiation|Death|0
164429|NCT00279201|524200|P3|Initiation|Death|0
164430|NCT00279201|524201|P2|Initiation|Death|5
164431|NCT00279201|524202|P1|Initiation|Death|1
164432|NCT00278993|524346|P1|Overall Study|Not Otherwise Specified|4
164433|NCT00278993|524346|P1|Overall Study|Physician Decision|9
164434|NCT00278993|524346|P1|Overall Study|Progressive Disease|65
164435|NCT00278993|524346|P1|Overall Study|Withdrawal by Subject|5
164436|NCT00278993|524346|P1|Overall Study|Adverse Event|24
164437|NCT00278954|524354|P1|Overall Study|Withdrawal by Subject|1
164438|NCT00278954|524354|P1|Overall Study|Lost to Follow-up|1
164439|NCT00278954|524354|P1|Overall Study|Adverse Event|3
164440|NCT00278915|524362|P1|Overall Study|Lack of Efficacy|1
164441|NCT00278889|524398|P3|Overall Study|Death|17
164442|NCT00278889|524399|P2|Overall Study|Death|21
164443|NCT00278889|524400|P1|Overall Study|Death|24
164444|NCT00278889|524398|P3|Overall Study|Lost to Follow-up|0
164445|NCT00278889|524399|P2|Overall Study|Lost to Follow-up|1
164446|NCT00278889|524400|P1|Overall Study|Lost to Follow-up|1
164447|NCT00278889|524398|P3|Overall Study|Withdrawal by Subject|3
164448|NCT00278889|524399|P2|Overall Study|Withdrawal by Subject|5
164449|NCT00278889|524400|P1|Overall Study|Withdrawal by Subject|0
164450|NCT00278395|524459|P1|Overall Study|Nonevaluable|1
164451|NCT00278395|524459|P1|Overall Study|Adverse Event|2
164452|NCT00277355|524505|P2|Overall Study|Physician Decision|0
164453|NCT00277355|524506|P1|Overall Study|Physician Decision|1
164454|NCT00277355|524505|P2|Overall Study|Death|0
164455|NCT00277355|524506|P1|Overall Study|Death|3
164456|NCT00277355|524505|P2|Overall Study|Adverse Event|0
164457|NCT00277355|524506|P1|Overall Study|Adverse Event|5
164458|NCT00277355|524505|P2|Overall Study|Lost to Follow-up|2
164459|NCT00277355|524506|P1|Overall Study|Lost to Follow-up|2
164460|NCT00277355|524505|P2|Overall Study|Withdrawal by Subject|3
164461|NCT00277355|524506|P1|Overall Study|Withdrawal by Subject|3
164462|NCT00277212|524514|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
164463|NCT00277212|524515|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
164464|NCT00277212|524516|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
164465|NCT00277212|524514|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
164466|NCT00277212|524515|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
164467|NCT00277212|524516|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
164468|NCT00277212|524514|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
164469|NCT00277212|524515|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
164470|NCT00277212|524516|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
164471|NCT00277212|524514|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
164472|NCT00277212|524515|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
164473|NCT00277212|524516|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
164474|NCT00277212|524514|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
164554|NCT00276094|524733|P1|Overall Study|Other-Refused follow-up visit|1
164475|NCT00277212|524515|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
164476|NCT00277212|524516|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
164477|NCT00277212|524514|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
164478|NCT00277212|524515|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
164479|NCT00277212|524516|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
164480|NCT00277212|524514|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
164481|NCT00277212|524515|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
164482|NCT00277212|524516|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
164483|NCT00277212|524514|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
164484|NCT00277212|524515|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
164485|NCT00277212|524516|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
164486|NCT00277212|524514|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
164487|NCT00277212|524515|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
164488|NCT00277212|524516|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
164489|NCT00277212|524514|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
164490|NCT00277212|524515|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
164491|NCT00277212|524516|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
164492|NCT00277212|524514|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
164493|NCT00277212|524515|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
164494|NCT00277212|524516|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
164495|NCT00277212|524514|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
164496|NCT00277212|524515|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
164497|NCT00277212|524516|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
164498|NCT00277212|524514|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
164499|NCT00277212|524515|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
164500|NCT00277212|524516|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
164501|NCT00277212|524514|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
164502|NCT00277212|524515|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
164503|NCT00277212|524516|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
164504|NCT00277212|524514|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
164505|NCT00277212|524515|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
164506|NCT00277212|524516|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
164507|NCT00277212|524514|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
164508|NCT00277212|524515|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
164509|NCT00277212|524516|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
164510|NCT00277212|524514|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
164511|NCT00277212|524515|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
164512|NCT00277212|524516|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
164513|NCT00277212|524514|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
164514|NCT00277212|524515|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
164515|NCT00277212|524516|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
164516|NCT00277095|524554|P1|Overall Study|Physician Decision|1
164517|NCT00277095|524554|P1|Overall Study|Missed Follow-up|9
164518|NCT00277095|524554|P1|Overall Study|Lost to Follow-up|2
164519|NCT00277095|524554|P1|Overall Study|Explanted|7
164520|NCT00277095|524554|P1|Overall Study|Death|2
164521|NCT00276614|524563|P1|Overall Study|Progression of disease under study|3
164522|NCT00276484|524574|P2|Overall Study|Could not take time off work|1
164523|NCT00276484|524575|P1|Overall Study|Could not take time off work|0
164524|NCT00276484|524574|P2|Overall Study|Withdrawal by Subject|3
164525|NCT00276484|524575|P1|Overall Study|Withdrawal by Subject|4
164526|NCT00276484|524574|P2|Overall Study|Protocol Violation|1
164527|NCT00276484|524575|P1|Overall Study|Protocol Violation|0
164528|NCT00276484|524574|P2|Overall Study|Lost to Follow-up|1
164529|NCT00276484|524575|P1|Overall Study|Lost to Follow-up|1
164530|NCT00276484|524574|P2|Overall Study|Adverse Event|7
164531|NCT00276484|524575|P1|Overall Study|Adverse Event|4
164532|NCT00276458|524607|P2|Overall Study|Protocol Violation|3
164533|NCT00276458|524608|P1|Overall Study|Protocol Violation|4
164534|NCT00276458|524607|P2|Overall Study|Lost to Follow-up|2
164535|NCT00276458|524608|P1|Overall Study|Lost to Follow-up|2
164536|NCT00276458|524607|P2|Overall Study|Adverse Event|2
164537|NCT00276458|524608|P1|Overall Study|Adverse Event|0
164538|NCT00276419|524642|P2|First Intervention|Withdrawal by Subject|2
164539|NCT00276419|524643|P1|First Intervention|Withdrawal by Subject|0
164540|NCT00276419|524642|P2|First Intervention|Adverse Event|0
164541|NCT00276419|524643|P1|First Intervention|Adverse Event|1
164542|NCT00276159|524721|P1|Overall Study|Did not receive all 24 doses of 852A|6
164543|NCT00276094|524731|P3|Overall Study|Other-Study medication lost|1
164544|NCT00276094|524732|P2|Overall Study|Other-Study medication lost|0
164545|NCT00276094|524733|P1|Overall Study|Other-Study medication lost|0
164546|NCT00276094|524731|P3|Overall Study|Other-Relocation|0
164547|NCT00276094|524732|P2|Overall Study|Other-Relocation|1
164548|NCT00276094|524733|P1|Overall Study|Other-Relocation|0
164549|NCT00276094|524731|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
164550|NCT00276094|524732|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
164551|NCT00276094|524733|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
164552|NCT00276094|524731|P3|Overall Study|Other-Refused follow-up visit|0
164553|NCT00276094|524732|P2|Overall Study|Other-Refused follow-up visit|0
164555|NCT00276094|524731|P3|Overall Study|Other-Lack of efficacy|0
164556|NCT00276094|524732|P2|Overall Study|Other-Lack of efficacy|0
164557|NCT00276094|524733|P1|Overall Study|Other-Lack of efficacy|1
164558|NCT00276094|524731|P3|Overall Study|Other-Scheduled gastroplasty|0
164559|NCT00276094|524732|P2|Overall Study|Other-Scheduled gastroplasty|0
164560|NCT00276094|524733|P1|Overall Study|Other-Scheduled gastroplasty|1
164561|NCT00276094|524731|P3|Overall Study|Other-Subject moved out of country|0
164562|NCT00276094|524732|P2|Overall Study|Other-Subject moved out of country|0
164563|NCT00276094|524733|P1|Overall Study|Other-Subject moved out of country|1
164564|NCT00276094|524731|P3|Overall Study|Lost to Follow-up|4
164565|NCT00276094|524732|P2|Overall Study|Lost to Follow-up|6
164566|NCT00276094|524733|P1|Overall Study|Lost to Follow-up|8
164567|NCT00276094|524731|P3|Overall Study|Protocol Violation|10
164568|NCT00276094|524732|P2|Overall Study|Protocol Violation|7
164569|NCT00276094|524733|P1|Overall Study|Protocol Violation|16
164570|NCT00276094|524731|P3|Overall Study|Withdrawal by Subject|12
164571|NCT00276094|524732|P2|Overall Study|Withdrawal by Subject|14
164572|NCT00276094|524733|P1|Overall Study|Withdrawal by Subject|14
164573|NCT00276094|524731|P3|Overall Study|Adverse Event|11
164574|NCT00276094|524732|P2|Overall Study|Adverse Event|13
164575|NCT00276094|524733|P1|Overall Study|Adverse Event|15
164576|NCT00276016|524786|P6|Intervention 1|Withdrawal by Subject|0
164577|NCT00276016|524787|P5|Intervention 1|Withdrawal by Subject|0
164578|NCT00276016|524788|P4|Intervention 1|Withdrawal by Subject|0
164579|NCT00276016|524789|P3|Intervention 1|Withdrawal by Subject|0
164580|NCT00276016|524790|P2|Intervention 1|Withdrawal by Subject|1
164581|NCT00276016|524791|P1|Intervention 1|Withdrawal by Subject|0
164582|NCT00275821|524837|P3|Overall Study|Protocol Violation|0
164583|NCT00275821|524838|P2|Overall Study|Protocol Violation|1
164584|NCT00275821|524839|P1|Overall Study|Protocol Violation|5
164585|NCT00275821|524837|P3|Overall Study|Lack of Efficacy|0
164586|NCT00275821|524838|P2|Overall Study|Lack of Efficacy|1
164587|NCT00275821|524839|P1|Overall Study|Lack of Efficacy|2
164588|NCT00275821|524837|P3|Overall Study|Death|1
164589|NCT00275821|524838|P2|Overall Study|Death|2
164590|NCT00275821|524839|P1|Overall Study|Death|0
164591|NCT00275821|524837|P3|Overall Study|Lost to Follow-up|1
164592|NCT00275821|524838|P2|Overall Study|Lost to Follow-up|1
164593|NCT00275821|524839|P1|Overall Study|Lost to Follow-up|0
164594|NCT00275821|524837|P3|Overall Study|Withdrawal by Subject|1
164595|NCT00275821|524838|P2|Overall Study|Withdrawal by Subject|2
164596|NCT00275821|524839|P1|Overall Study|Withdrawal by Subject|0
164597|NCT00275821|524837|P3|Overall Study|Administrative problems|4
164598|NCT00275821|524838|P2|Overall Study|Administrative problems|4
164599|NCT00275821|524839|P1|Overall Study|Administrative problems|3
164600|NCT00275821|524837|P3|Overall Study|Adverse Event|5
164601|NCT00275821|524838|P2|Overall Study|Adverse Event|12
164602|NCT00275821|524839|P1|Overall Study|Adverse Event|4
164603|NCT00275561|524858|P2|Overall Study|Family Issues|2
164604|NCT00275561|524859|P1|Overall Study|Family Issues|0
164605|NCT00275561|524858|P2|Overall Study|Scheduling|2
164606|NCT00275561|524859|P1|Overall Study|Scheduling|1
164607|NCT00275561|524858|P2|Overall Study|Travel|1
164608|NCT00275561|524859|P1|Overall Study|Travel|1
164609|NCT00275561|524858|P2|Overall Study|Withdrawal by Subject|1
164610|NCT00275561|524859|P1|Overall Study|Withdrawal by Subject|0
164611|NCT00275340|524882|P2|Overall Study|Lost to Follow-up|4
164612|NCT00275340|524883|P1|Overall Study|Lost to Follow-up|2
164613|NCT00275262|524902|P2|Overall Study|Started Chemotherapy|0
164614|NCT00275262|524903|P1|Overall Study|Started Chemotherapy|1
164615|NCT00275262|524902|P2|Overall Study|Death|0
164616|NCT00275262|524903|P1|Overall Study|Death|1
164617|NCT00275262|524902|P2|Overall Study|Protocol Violation|2
164618|NCT00275262|524903|P1|Overall Study|Protocol Violation|0
164619|NCT00275262|524902|P2|Overall Study|Lost to Follow-up|2
164620|NCT00275262|524903|P1|Overall Study|Lost to Follow-up|0
164621|NCT00275262|524902|P2|Overall Study|Disease progression|5
164622|NCT00275262|524903|P1|Overall Study|Disease progression|2
164623|NCT00275262|524902|P2|Overall Study|Adverse Event|0
164624|NCT00275262|524903|P1|Overall Study|Adverse Event|2
164625|NCT00275028|524917|P1|Overall Study|Physician Decision|2
164626|NCT00275028|524917|P1|Overall Study|Progressive Disease|30
164627|NCT00275028|524917|P1|Overall Study|Adverse Event|9
164628|NCT00275028|524917|P1|Overall Study|Withdrawal by Subject|5
164629|NCT00275028|524917|P1|Overall Study|Withdrew consent before treatment began|1
164630|NCT00275002|524924|P2|Overall Study|Adverse Event|1
164631|NCT00275002|524925|P1|Overall Study|Adverse Event|0
164632|NCT00275002|524924|P2|Overall Study|Disease progression|15
164633|NCT00275002|524925|P1|Overall Study|Disease progression|21
164634|NCT00275002|524924|P2|Overall Study|Death|0
164635|NCT00275002|524925|P1|Overall Study|Death|1
164636|NCT00274937|524933|P1|Overall Study|Progressive Disease|4
164637|NCT00274937|524933|P1|Overall Study|Withdrawal by Subject|6
164638|NCT00274937|524933|P1|Overall Study|Physician Decision|10
164639|NCT00274924|524945|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
164640|NCT00274924|524946|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
164641|NCT00274924|524947|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
164642|NCT00274924|524945|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
164643|NCT00274924|524946|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
164644|NCT00274924|524947|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
164645|NCT00274924|524945|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
164646|NCT00274924|524946|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
164647|NCT00274924|524947|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
164648|NCT00274924|524945|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
164649|NCT00274924|524946|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
164650|NCT00274924|524947|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
164651|NCT00274924|524945|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
164652|NCT00274924|524946|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
164653|NCT00274924|524947|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
164654|NCT00274924|524945|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
164655|NCT00274924|524946|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
164656|NCT00274924|524947|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
164657|NCT00274924|524945|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
164658|NCT00274924|524946|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
164659|NCT00274924|524947|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
164660|NCT00274924|524945|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
164661|NCT00274924|524946|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
164662|NCT00274924|524947|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
164663|NCT00274924|524945|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
164664|NCT00274924|524946|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
164665|NCT00274924|524947|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
164666|NCT00274924|524945|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
164667|NCT00274924|524946|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
164668|NCT00274924|524947|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
164669|NCT00274924|524945|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
164670|NCT00274924|524946|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
164671|NCT00274924|524947|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
164672|NCT00274924|524945|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
164673|NCT00274924|524946|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
164674|NCT00274924|524947|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
164675|NCT00274924|524945|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
164676|NCT00274924|524946|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
164677|NCT00274924|524947|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
164678|NCT00274846|524956|P1|Overall Study|Did not receive adequate NK cells|1
164679|NCT00274742|524980|P6|Overall Study|Other|0
164680|NCT00274742|524981|P5|Overall Study|Other|2
164681|NCT00274742|524982|P4|Overall Study|Other|0
164682|NCT00274742|524983|P3|Overall Study|Other|0
164683|NCT00274742|524984|P2|Overall Study|Other|3
164684|NCT00274742|524985|P1|Overall Study|Other|0
164685|NCT00274742|524980|P6|Overall Study|Disease Progression|0
164686|NCT00274742|524981|P5|Overall Study|Disease Progression|1
164687|NCT00274742|524982|P4|Overall Study|Disease Progression|0
164688|NCT00274742|524983|P3|Overall Study|Disease Progression|1
164689|NCT00274742|524984|P2|Overall Study|Disease Progression|1
164690|NCT00274742|524985|P1|Overall Study|Disease Progression|0
164691|NCT00274742|524980|P6|Overall Study|End of Study|0
164692|NCT00274742|524981|P5|Overall Study|End of Study|0
164693|NCT00274742|524982|P4|Overall Study|End of Study|1
164694|NCT00274742|524983|P3|Overall Study|End of Study|0
164695|NCT00274742|524984|P2|Overall Study|End of Study|0
164696|NCT00274742|524985|P1|Overall Study|End of Study|0
164697|NCT00274742|524980|P6|Overall Study|Lost to Follow-up|0
164698|NCT00274742|524981|P5|Overall Study|Lost to Follow-up|1
164699|NCT00274742|524982|P4|Overall Study|Lost to Follow-up|0
164700|NCT00274742|524983|P3|Overall Study|Lost to Follow-up|0
164701|NCT00274742|524984|P2|Overall Study|Lost to Follow-up|0
164702|NCT00274742|524985|P1|Overall Study|Lost to Follow-up|0
164703|NCT00274742|524980|P6|Overall Study|Adverse Event|3
164704|NCT00274742|524981|P5|Overall Study|Adverse Event|12
164705|NCT00274742|524982|P4|Overall Study|Adverse Event|4
164706|NCT00274742|524983|P3|Overall Study|Adverse Event|1
164707|NCT00274742|524984|P2|Overall Study|Adverse Event|4
164708|NCT00274742|524985|P1|Overall Study|Adverse Event|0
164709|NCT00274716|525023|P6|Phase B|Lost to Follow-up|0
164710|NCT00274716|525024|P5|Phase B|Lost to Follow-up|0
164711|NCT00274716|525025|P4|Phase B|Lost to Follow-up|0
164712|NCT00274716|525026|P3|Phase B|Lost to Follow-up|0
164713|NCT00274716|525027|P2|Phase B|Lost to Follow-up|1
164714|NCT00274716|525028|P1|Phase B|Lost to Follow-up|0
164715|NCT00274716|525023|P6|Phase B|Other non-reported reason|0
164716|NCT00274716|525024|P5|Phase B|Other non-reported reason|0
164717|NCT00274716|525025|P4|Phase B|Other non-reported reason|1
164718|NCT00274716|525026|P3|Phase B|Other non-reported reason|1
164719|NCT00274716|525027|P2|Phase B|Other non-reported reason|0
164720|NCT00274716|525028|P1|Phase B|Other non-reported reason|0
164721|NCT00274716|525023|P6|Phase B|Participant moved|0
164722|NCT00274716|525024|P5|Phase B|Participant moved|0
164723|NCT00274716|525025|P4|Phase B|Participant moved|0
164724|NCT00274716|525026|P3|Phase B|Participant moved|0
164725|NCT00274716|525027|P2|Phase B|Participant moved|0
164726|NCT00274716|525028|P1|Phase B|Participant moved|1
164727|NCT00274716|525023|P6|Phase B|Withdrawal by Subject|0
164728|NCT00274716|525024|P5|Phase B|Withdrawal by Subject|0
164729|NCT00274716|525025|P4|Phase B|Withdrawal by Subject|0
164730|NCT00274716|525026|P3|Phase B|Withdrawal by Subject|0
164731|NCT00274716|525027|P2|Phase B|Withdrawal by Subject|1
164732|NCT00274716|525028|P1|Phase B|Withdrawal by Subject|0
164733|NCT00274716|525023|P6|Phase B|Protocol Violation|0
164734|NCT00274716|525024|P5|Phase B|Protocol Violation|0
164735|NCT00274716|525025|P4|Phase B|Protocol Violation|0
164736|NCT00274716|525026|P3|Phase B|Protocol Violation|0
164737|NCT00274716|525027|P2|Phase B|Protocol Violation|2
164738|NCT00274716|525028|P1|Phase B|Protocol Violation|0
164739|NCT00274716|525023|P6|Phase B|Adverse Event|1
164740|NCT00274716|525024|P5|Phase B|Adverse Event|0
164741|NCT00274716|525025|P4|Phase B|Adverse Event|0
164742|NCT00274716|525026|P3|Phase B|Adverse Event|2
164743|NCT00274716|525027|P2|Phase B|Adverse Event|0
164744|NCT00274716|525028|P1|Phase B|Adverse Event|0
164745|NCT00274716|525023|P6|Phase A|Completed but did not enter Phase B|1
164746|NCT00274716|525024|P5|Phase A|Completed but did not enter Phase B|1
164747|NCT00274716|525025|P4|Phase A|Completed but did not enter Phase B|2
164748|NCT00274716|525026|P3|Phase A|Completed but did not enter Phase B|2
164749|NCT00274716|525027|P2|Phase A|Completed but did not enter Phase B|2
164750|NCT00274716|525028|P1|Phase A|Completed but did not enter Phase B|1
164751|NCT00274716|525023|P6|Phase A|Adverse Event|0
164752|NCT00274716|525024|P5|Phase A|Adverse Event|2
164753|NCT00274716|525025|P4|Phase A|Adverse Event|0
164754|NCT00274716|525026|P3|Phase A|Adverse Event|3
164755|NCT00274716|525027|P2|Phase A|Adverse Event|3
164756|NCT00274716|525028|P1|Phase A|Adverse Event|2
164757|NCT00274716|525023|P6|Phase A|Withdrawal by Subject|1
164758|NCT00274716|525024|P5|Phase A|Withdrawal by Subject|0
164759|NCT00274716|525025|P4|Phase A|Withdrawal by Subject|3
164760|NCT00274716|525026|P3|Phase A|Withdrawal by Subject|1
164761|NCT00274716|525027|P2|Phase A|Withdrawal by Subject|2
164762|NCT00274716|525028|P1|Phase A|Withdrawal by Subject|2
164763|NCT00274716|525023|P6|Phase A|Met criteria for discontinuation|0
164764|NCT00274716|525024|P5|Phase A|Met criteria for discontinuation|0
164765|NCT00274716|525025|P4|Phase A|Met criteria for discontinuation|0
164766|NCT00274716|525026|P3|Phase A|Met criteria for discontinuation|0
164767|NCT00274716|525027|P2|Phase A|Met criteria for discontinuation|1
164768|NCT00274716|525028|P1|Phase A|Met criteria for discontinuation|1
164769|NCT00274716|525023|P6|Phase A|Protocol Violation|0
164770|NCT00274716|525024|P5|Phase A|Protocol Violation|0
164771|NCT00274716|525025|P4|Phase A|Protocol Violation|1
164772|NCT00274716|525026|P3|Phase A|Protocol Violation|0
164773|NCT00274716|525027|P2|Phase A|Protocol Violation|0
164774|NCT00274716|525028|P1|Phase A|Protocol Violation|1
164775|NCT00274716|525023|P6|Phase A|Site Terminated|0
164776|NCT00274716|525024|P5|Phase A|Site Terminated|0
164777|NCT00274716|525025|P4|Phase A|Site Terminated|1
164778|NCT00274716|525026|P3|Phase A|Site Terminated|0
164779|NCT00274716|525027|P2|Phase A|Site Terminated|0
164780|NCT00274716|525028|P1|Phase A|Site Terminated|0
164781|NCT00274716|525023|P6|Phase A|Participant moved|1
164782|NCT00274716|525024|P5|Phase A|Participant moved|0
164783|NCT00274716|525025|P4|Phase A|Participant moved|0
164784|NCT00274716|525026|P3|Phase A|Participant moved|1
164785|NCT00274716|525027|P2|Phase A|Participant moved|0
164786|NCT00274716|525028|P1|Phase A|Participant moved|0
164787|NCT00274716|525023|P6|Phase A|Other non-reported reason|1
164788|NCT00274716|525024|P5|Phase A|Other non-reported reason|0
164789|NCT00274716|525025|P4|Phase A|Other non-reported reason|2
164790|NCT00274716|525026|P3|Phase A|Other non-reported reason|1
164791|NCT00274716|525027|P2|Phase A|Other non-reported reason|2
164792|NCT00274716|525028|P1|Phase A|Other non-reported reason|4
164793|NCT00274651|525090|P2|Overall Study|Physician Decision|7
164794|NCT00274651|525091|P1|Overall Study|Physician Decision|8
164795|NCT00274651|525090|P2|Overall Study|Withdrawal by Subject|1
164796|NCT00274651|525091|P1|Overall Study|Withdrawal by Subject|0
164797|NCT00274651|525090|P2|Overall Study|Death|3
164798|NCT00274651|525091|P1|Overall Study|Death|1
164799|NCT00274651|525090|P2|Overall Study|Lack of Efficacy|6
164800|NCT00274651|525091|P1|Overall Study|Lack of Efficacy|13
164801|NCT00274651|525090|P2|Overall Study|Adverse Event|3
164802|NCT00274651|525091|P1|Overall Study|Adverse Event|6
164803|NCT00274625|525106|P2|Overall Study|Excluded from analysis|8
164804|NCT00274625|525107|P1|Overall Study|Excluded from analysis|14
164805|NCT00274625|525106|P2|Overall Study|Lost to Follow-up|54
164806|NCT00274625|525107|P1|Overall Study|Lost to Follow-up|46
164807|NCT00274469|525115|P2|Overall Study|Reasons not specified|8
164808|NCT00274469|525116|P1|Overall Study|Reasons not specified|5
164809|NCT00274469|525115|P2|Overall Study|Withdrawal by Subject|0
164810|NCT00274469|525116|P1|Overall Study|Withdrawal by Subject|2
164811|NCT00274469|525115|P2|Overall Study|Condition under investigation worsened|38
164812|NCT00274469|525116|P1|Overall Study|Condition under investigation worsened|28
164813|NCT00274469|525115|P2|Overall Study|Adverse Event|3
164814|NCT00274469|525116|P1|Overall Study|Adverse Event|2
164815|NCT00274469|525115|P2|Overall Study|Death|1
164816|NCT00274469|525116|P1|Overall Study|Death|1
164817|NCT00274456|525134|P4|Overall Study|Withdrawal by Subject|13
164818|NCT00274456|525135|P3|Overall Study|Withdrawal by Subject|9
164819|NCT00274456|525136|P2|Overall Study|Withdrawal by Subject|13
164820|NCT00274456|525137|P1|Overall Study|Withdrawal by Subject|18
164821|NCT00274456|525134|P4|Overall Study|Lost to Follow-up|0
164822|NCT00274456|525135|P3|Overall Study|Lost to Follow-up|1
164823|NCT00274456|525136|P2|Overall Study|Lost to Follow-up|0
164824|NCT00274456|525137|P1|Overall Study|Lost to Follow-up|0
164825|NCT00274456|525134|P4|Overall Study|Physician Decision|13
164826|NCT00274456|525135|P3|Overall Study|Physician Decision|6
164827|NCT00274456|525136|P2|Overall Study|Physician Decision|5
164828|NCT00274456|525137|P1|Overall Study|Physician Decision|7
164829|NCT00274456|525134|P4|Overall Study|Adverse Event|2
164830|NCT00274456|525135|P3|Overall Study|Adverse Event|2
164831|NCT00274456|525136|P2|Overall Study|Adverse Event|1
164832|NCT00274456|525137|P1|Overall Study|Adverse Event|0
164833|NCT00274456|525134|P4|Overall Study|Unacceptable toxicity|16
164834|NCT00274456|525135|P3|Overall Study|Unacceptable toxicity|12
164835|NCT00274456|525136|P2|Overall Study|Unacceptable toxicity|5
164836|NCT00274456|525137|P1|Overall Study|Unacceptable toxicity|10
164837|NCT00274456|525134|P4|Overall Study|Still on treatment|1
164838|NCT00274456|525135|P3|Overall Study|Still on treatment|5
164839|NCT00274456|525136|P2|Overall Study|Still on treatment|3
164840|NCT00274456|525137|P1|Overall Study|Still on treatment|2
164841|NCT00274287|525179|P1|Overall Study|subject non-compliance|1
164842|NCT00274287|525179|P1|Overall Study|Withdrawal by Subject|1
164843|NCT00274261|525185|P2|Overall Study|Lost to Follow-up|75
164844|NCT00274261|525186|P1|Overall Study|Lost to Follow-up|106
164845|NCT00274261|525185|P2|Overall Study|Protocol Violation|42
164846|NCT00274261|525186|P1|Overall Study|Protocol Violation|71
164847|NCT00274261|525185|P2|Overall Study|Withdrawal by Subject|126
164848|NCT00274261|525186|P1|Overall Study|Withdrawal by Subject|179
164849|NCT00274261|525185|P2|Overall Study|Pregnancy|83
164850|NCT00274261|525186|P1|Overall Study|Pregnancy|114
164851|NCT00274261|525185|P2|Overall Study|Adverse Event|11
164852|NCT00274261|525186|P1|Overall Study|Adverse Event|19
164853|NCT00273858|525223|P1|Overall Study|Adverse Event|81
164854|NCT00273858|525223|P1|Overall Study|Withdrawal by Subject|21
164855|NCT00273858|525223|P1|Overall Study|Lost to Follow-up|101
164856|NCT00273858|525223|P1|Overall Study|Not completed 24 month observation time|334
164857|NCT00273182|525282|P1|Overall Study|Site exit, system change, 36 m FU missed|36
164858|NCT00273182|525282|P1|Overall Study|Device/System Explant|154
164859|NCT00273182|525282|P1|Overall Study|Withdrawal by Subject|257
164860|NCT00273182|525282|P1|Overall Study|Lost to Follow-up|88
164861|NCT00273182|525282|P1|Overall Study|Death|450
164862|NCT00273052|525292|P2|Overall Study|Worsening serum lipid levels|2
164863|NCT00273052|525293|P1|Overall Study|Worsening serum lipid levels|0
164864|NCT00273052|525292|P2|Overall Study|Not specified|0
164865|NCT00273052|525293|P1|Overall Study|Not specified|2
164866|NCT00273052|525292|P2|Overall Study|Non-Compliance|1
164867|NCT00273052|525293|P1|Overall Study|Non-Compliance|3
164868|NCT00273052|525292|P2|Overall Study|Lack of Efficacy|4
164869|NCT00273052|525293|P1|Overall Study|Lack of Efficacy|6
164870|NCT00273052|525292|P2|Overall Study|Lost to Follow-up|25
164871|NCT00273052|525293|P1|Overall Study|Lost to Follow-up|7
164872|NCT00273052|525292|P2|Overall Study|Protocol Violation|18
164873|NCT00273052|525293|P1|Overall Study|Protocol Violation|14
164874|NCT00273052|525292|P2|Overall Study|Adverse Event|19
164875|NCT00273052|525293|P1|Overall Study|Adverse Event|21
164876|NCT00273052|525292|P2|Overall Study|Withdrawal by Subject|19
164877|NCT00273052|525293|P1|Overall Study|Withdrawal by Subject|16
164878|NCT00272987|525328|P3|Overall Study|Ongoing|15
164879|NCT00272987|525329|P2|Overall Study|Ongoing|14
164880|NCT00272987|525330|P1|Overall Study|Ongoing|20
164881|NCT00272987|525328|P3|Overall Study|Missed >3 Visits|1
164882|NCT00272987|525329|P2|Overall Study|Missed >3 Visits|0
164883|NCT00272987|525330|P1|Overall Study|Missed >3 Visits|0
164884|NCT00272987|525328|P3|Overall Study|Withdrawal by Subject|3
164885|NCT00272987|525329|P2|Overall Study|Withdrawal by Subject|0
164886|NCT00272987|525330|P1|Overall Study|Withdrawal by Subject|0
164887|NCT00272987|525328|P3|Overall Study|Adverse Event|0
164888|NCT00272987|525329|P2|Overall Study|Adverse Event|0
164889|NCT00272987|525330|P1|Overall Study|Adverse Event|1
164890|NCT00272961|525394|P5|Treatment Phase: Week 3 Up to Week 12|Unspecified|2
164891|NCT00272961|525395|P4|Treatment Phase: Week 3 Up to Week 12|Unspecified|2
164892|NCT00272961|525396|P3|Treatment Phase: Week 3 Up to Week 12|Unspecified|3
164893|NCT00272961|525397|P2|Treatment Phase: Week 3 Up to Week 12|Unspecified|3
164894|NCT00272961|525398|P1|Treatment Phase: Week 3 Up to Week 12|Unspecified|1
164895|NCT00272961|525394|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
164896|NCT00272961|525395|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
164897|NCT00272961|525396|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
164898|NCT00272961|525397|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
164899|NCT00272961|525398|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
164900|NCT00272961|525394|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
164901|NCT00272961|525395|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
164902|NCT00272961|525396|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
164903|NCT00272961|525397|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
164904|NCT00272961|525398|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
164905|NCT00272961|525394|P5|Placebo Run-in Phase: Up to Week 2|Unspecified|0
164906|NCT00272961|525395|P4|Placebo Run-in Phase: Up to Week 2|Unspecified|0
164907|NCT00272961|525396|P3|Placebo Run-in Phase: Up to Week 2|Unspecified|0
164908|NCT00272961|525397|P2|Placebo Run-in Phase: Up to Week 2|Unspecified|0
164909|NCT00272961|525398|P1|Placebo Run-in Phase: Up to Week 2|Unspecified|2
164910|NCT00272961|525394|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
164911|NCT00272961|525395|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
164912|NCT00272961|525396|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
164913|NCT00272961|525397|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
164914|NCT00272961|525398|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
164915|NCT00272961|525394|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
164916|NCT00272961|525395|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
164917|NCT00272961|525396|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
164918|NCT00272961|525397|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
164919|NCT00272961|525398|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
164920|NCT00272961|525394|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
164921|NCT00272961|525395|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
164922|NCT00272961|525396|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
164923|NCT00272961|525397|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
164924|NCT00272961|525398|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
164925|NCT00272961|525394|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
164926|NCT00272961|525395|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
164927|NCT00272961|525396|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
164928|NCT00272961|525397|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
164929|NCT00272961|525398|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
164930|NCT00272792|525457|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
164931|NCT00272792|525458|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
164932|NCT00272792|525457|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
164933|NCT00272792|525458|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
164934|NCT00272792|525457|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
164935|NCT00272792|525458|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
164936|NCT00272792|525457|P2|Part 1: Responsiveness|Lost to Follow-up|0
164937|NCT00272792|525458|P1|Part 1: Responsiveness|Lost to Follow-up|1
164938|NCT00272779|525468|P2|Baseline Through Week 96|Continuing on treatment|38
164939|NCT00272779|525469|P1|Baseline Through Week 96|Continuing on treatment|61
164940|NCT00272779|525468|P2|Baseline Through Week 96|Never treated|3
164941|NCT00272779|525469|P1|Baseline Through Week 96|Never treated|2
164942|NCT00272779|525468|P2|Baseline Through Week 96|Pregnancy at Week 96|0
164943|NCT00272779|525469|P1|Baseline Through Week 96|Pregnancy at Week 96|1
164944|NCT00272779|525468|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
164945|NCT00272779|525469|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
164946|NCT00272779|525468|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
164947|NCT00272779|525469|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
164948|NCT00272779|525468|P2|Baseline Through Week 96|Changed address before Week 96|1
164949|NCT00272779|525469|P1|Baseline Through Week 96|Changed address before Week 96|0
164950|NCT00272779|525468|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
164951|NCT00272779|525469|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
164952|NCT00272779|525468|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
164953|NCT00272779|525469|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
164954|NCT00272779|525468|P2|Baseline Through Week 96|Pregnancy before Week 96|7
164955|NCT00272779|525469|P1|Baseline Through Week 96|Pregnancy before Week 96|5
164956|NCT00272779|525468|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
164957|NCT00272779|525469|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
164958|NCT00272779|525468|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
164959|NCT00272779|525469|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
164960|NCT00272779|525468|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
164961|NCT00272779|525469|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
164962|NCT00272779|525468|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
164963|NCT00272779|525469|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
164964|NCT00272779|525468|P2|Baseline Through Week 96|Death before Week 96|5
164965|NCT00272779|525469|P1|Baseline Through Week 96|Death before Week 96|6
164966|NCT00272779|525468|P2|Baseline Through Week 96|Adverse event before Week 96|22
164967|NCT00272779|525469|P1|Baseline Through Week 96|Adverse event before Week 96|13
164968|NCT00272779|525468|P2|Baseline Through Week 48|Never treated|3
164969|NCT00272779|525469|P1|Baseline Through Week 48|Never treated|2
164970|NCT00272779|525468|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
164971|NCT00272779|525469|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
164972|NCT00272779|525468|P2|Baseline Through Week 48|Continuing treatment|368
164973|NCT00272779|525469|P1|Baseline Through Week 48|Continuing treatment|385
164974|NCT00272779|525468|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
164975|NCT00272779|525469|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
164976|NCT00272779|525468|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
164977|NCT00272779|525469|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
164978|NCT00272779|525468|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
164979|NCT00272779|525469|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
164980|NCT00272779|525468|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
164981|NCT00272779|525469|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
164982|NCT00272779|525468|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
164983|NCT00272779|525469|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
164984|NCT00272779|525468|P2|Baseline Through Week 48|Death on/after Week 48|1
164985|NCT00272779|525469|P1|Baseline Through Week 48|Death on/after Week 48|1
164986|NCT00272779|525468|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
164987|NCT00272779|525469|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
164988|NCT00272779|525468|P2|Baseline Through Week 48|Chose different site before wk 48|1
164989|NCT00272779|525469|P1|Baseline Through Week 48|Chose different site before wk 48|0
164990|NCT00272779|525468|P2|Baseline Through Week 48|Participant's decision before wk 48|1
164991|NCT00272779|525469|P1|Baseline Through Week 48|Participant's decision before wk 48|0
164992|NCT00272779|525468|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
164993|NCT00272779|525469|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
164994|NCT00272779|525468|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
164995|NCT00272779|525469|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
164996|NCT00272779|525468|P2|Baseline Through Week 48|Pregnancy before Week 48|2
164997|NCT00272779|525469|P1|Baseline Through Week 48|Pregnancy before Week 48|2
164998|NCT00272779|525468|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
164999|NCT00272779|525469|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
165000|NCT00272779|525468|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
165001|NCT00272779|525469|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
165002|NCT00272779|525468|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
165003|NCT00272779|525469|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
165004|NCT00272779|525468|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
165005|NCT00272779|525469|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
165006|NCT00272779|525468|P2|Baseline Through Week 48|Death before Week 48|4
165007|NCT00272779|525469|P1|Baseline Through Week 48|Death before Week 48|4
165008|NCT00272779|525468|P2|Baseline Through Week 48|Adverse event before Week 48|14
165009|NCT00272779|525469|P1|Baseline Through Week 48|Adverse event before Week 48|10
165010|NCT00272038|525709|P1|Overall Study|withdrew before they received 2 cycles|7
165011|NCT00271947|525715|P1|Overall Study|Lost to Follow-up|1
165012|NCT00271856|525721|P2|Overall Study|Lost to Follow-up|11
165013|NCT00271856|525722|P1|Overall Study|Lost to Follow-up|10
165014|NCT00271856|525721|P2|Overall Study|Withdrawal by Subject|7
165015|NCT00271856|525722|P1|Overall Study|Withdrawal by Subject|1
165016|NCT00271817|525741|P3|Part 2|LDL < 50 mg/dL|4
165017|NCT00271817|525742|P2|Part 2|LDL < 50 mg/dL|3
165018|NCT00271817|525743|P1|Part 2|LDL < 50 mg/dL|0
165019|NCT00271817|525741|P3|Part 2|Withdrawal by Subject|13
165020|NCT00271817|525742|P2|Part 2|Withdrawal by Subject|2
165021|NCT00271817|525743|P1|Part 2|Withdrawal by Subject|0
165022|NCT00271817|525741|P3|Part 2|Patient Moved|5
165023|NCT00271817|525742|P2|Part 2|Patient Moved|0
165024|NCT00271817|525743|P1|Part 2|Patient Moved|0
165025|NCT00271817|525741|P3|Part 2|Protocol Violation|5
165026|NCT00271817|525742|P2|Part 2|Protocol Violation|3
165027|NCT00271817|525743|P1|Part 2|Protocol Violation|0
165028|NCT00271817|525741|P3|Part 2|Lost to Follow-up|18
165029|NCT00271817|525742|P2|Part 2|Lost to Follow-up|6
165030|NCT00271817|525743|P1|Part 2|Lost to Follow-up|0
165031|NCT00271817|525741|P3|Part 2|Lack of Efficacy|6
165032|NCT00271817|525742|P2|Part 2|Lack of Efficacy|1
165033|NCT00271817|525743|P1|Part 2|Lack of Efficacy|0
165034|NCT00271817|525741|P3|Part 2|Adverse Event|33
165035|NCT00271817|525742|P2|Part 2|Adverse Event|17
165036|NCT00271817|525743|P1|Part 2|Adverse Event|0
165037|NCT00271817|525741|P3|Part 1|LDL < 50 mg/dL|48
165038|NCT00271817|525742|P2|Part 1|LDL < 50 mg/dL|4
165039|NCT00271817|525743|P1|Part 1|LDL < 50 mg/dL|1
165040|NCT00271817|525741|P3|Part 1|Withdrawal by Subject|45
165041|NCT00271817|525742|P2|Part 1|Withdrawal by Subject|17
165042|NCT00271817|525743|P1|Part 1|Withdrawal by Subject|23
165043|NCT00271817|525741|P3|Part 1|Patient Moved|5
165044|NCT00271817|525742|P2|Part 1|Patient Moved|1
165045|NCT00271817|525743|P1|Part 1|Patient Moved|3
165046|NCT00271817|525741|P3|Part 1|Protocol Violation|7
165047|NCT00271817|525742|P2|Part 1|Protocol Violation|4
165048|NCT00271817|525743|P1|Part 1|Protocol Violation|5
165049|NCT00271817|525741|P3|Part 1|Lost to Follow-up|24
165050|NCT00271817|525742|P2|Part 1|Lost to Follow-up|8
165051|NCT00271817|525743|P1|Part 1|Lost to Follow-up|6
165052|NCT00271817|525741|P3|Part 1|Adverse Event|156
165053|NCT00271817|525742|P2|Part 1|Adverse Event|25
165054|NCT00271817|525743|P1|Part 1|Adverse Event|68
165055|NCT00271609|525785|P2|Overall Study|Withdrawal by Subject|0
165056|NCT00271609|525786|P1|Overall Study|Withdrawal by Subject|2
165057|NCT00271609|525785|P2|Overall Study|Adverse Event|3
165058|NCT00271609|525786|P1|Overall Study|Adverse Event|11
165059|NCT00271596|525796|P2|Overall Study|Withdrawal by Subject|1
165060|NCT00271596|525797|P1|Overall Study|Withdrawal by Subject|0
165061|NCT00271596|525796|P2|Overall Study|Protocol Violation|0
165062|NCT00271596|525797|P1|Overall Study|Protocol Violation|1
165063|NCT00271544|525832|P1|Overall Study|Implant not attempted|4
165064|NCT00271544|525832|P1|Overall Study|Model 4196 lead not attempted|9
165065|NCT00271544|525832|P1|Overall Study|Subjects did not receive a 4196 lead|7
165066|NCT00271024|525937|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
165067|NCT00271024|525938|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
165068|NCT00271024|525939|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
165069|NCT00271024|525940|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
165070|NCT00271024|525937|P4|Overall Study|Unpleasant Reaction To Tablet|2
165071|NCT00271024|525938|P3|Overall Study|Unpleasant Reaction To Tablet|4
165072|NCT00271024|525939|P2|Overall Study|Unpleasant Reaction To Tablet|3
165073|NCT00271024|525940|P1|Overall Study|Unpleasant Reaction To Tablet|1
165074|NCT00271024|525937|P4|Overall Study|Protocol Violation|11
165075|NCT00271024|525938|P3|Overall Study|Protocol Violation|5
165076|NCT00271024|525939|P2|Overall Study|Protocol Violation|6
165077|NCT00271024|525940|P1|Overall Study|Protocol Violation|1
165078|NCT00271024|525937|P4|Overall Study|Unknown/Unspecified|4
165079|NCT00271024|525938|P3|Overall Study|Unknown/Unspecified|8
165080|NCT00271024|525939|P2|Overall Study|Unknown/Unspecified|11
165081|NCT00271024|525940|P1|Overall Study|Unknown/Unspecified|11
165082|NCT00271024|525937|P4|Overall Study|Lost Interest|3
165083|NCT00271024|525938|P3|Overall Study|Lost Interest|2
165084|NCT00271024|525939|P2|Overall Study|Lost Interest|4
165085|NCT00271024|525940|P1|Overall Study|Lost Interest|3
165086|NCT00270894|525987|P1|Overall Study|Withdrawal by Subject|1
165087|NCT00270894|525987|P1|Overall Study|Adverse Event|1
165088|NCT00270257|526061|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
165089|NCT00270257|526062|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
165090|NCT00270231|526080|P2|Second Intervention|Lost to Follow-up|1
165091|NCT00270231|526081|P1|Second Intervention|Lost to Follow-up|0
165092|NCT00270231|526080|P2|Washout Period|Lost to Follow-up|0
165093|NCT00270231|526081|P1|Washout Period|Lost to Follow-up|1
165094|NCT00270231|526080|P2|First Intervention|Lost to Follow-up|1
165095|NCT00270231|526081|P1|First Intervention|Lost to Follow-up|1
165096|NCT00270205|526091|P4|Overall Study|Lost to Follow-up|1
165097|NCT00270205|526092|P3|Overall Study|Lost to Follow-up|0
165098|NCT00270205|526093|P2|Overall Study|Lost to Follow-up|0
165099|NCT00270205|526094|P1|Overall Study|Lost to Follow-up|1
165100|NCT00269919|526204|P1|Overall Study|Started but not treated|1
165101|NCT00269919|526204|P1|Overall Study|Unspecified|26
165102|NCT00269633|526223|P2|Overall Study|Withdrawal by Subject|0
165103|NCT00269633|526224|P1|Overall Study|Withdrawal by Subject|1
165104|NCT00269477|526234|P4|Overall Study|Missed post-vaccination blood draw|0
165105|NCT00269477|526235|P3|Overall Study|Missed post-vaccination blood draw|0
165106|NCT00269477|526236|P2|Overall Study|Missed post-vaccination blood draw|1
165107|NCT00269477|526237|P1|Overall Study|Missed post-vaccination blood draw|0
165108|NCT00269477|526234|P4|Overall Study|Protocol Violation|0
165109|NCT00269477|526235|P3|Overall Study|Protocol Violation|1
165110|NCT00269477|526236|P2|Overall Study|Protocol Violation|5
165111|NCT00269477|526237|P1|Overall Study|Protocol Violation|5
165112|NCT00269152|526253|P2|Overall Study|Protocol Violation|1
165113|NCT00269152|526254|P1|Overall Study|Protocol Violation|0
165114|NCT00269152|526253|P2|Overall Study|Physician Decision|3
165115|NCT00269152|526254|P1|Overall Study|Physician Decision|2
165116|NCT00269152|526253|P2|Overall Study|Withdrawal by Subject|3
165117|NCT00269152|526254|P1|Overall Study|Withdrawal by Subject|7
165118|NCT00269152|526253|P2|Overall Study|Adverse Event|3
165119|NCT00269152|526254|P1|Overall Study|Adverse Event|9
165120|NCT00269113|526270|P2|Overall Study|Not specified|2
165121|NCT00269113|526271|P1|Overall Study|Not specified|0
165122|NCT00269113|526270|P2|Overall Study|Protocol Violation|5
165123|NCT00269113|526271|P1|Overall Study|Protocol Violation|15
165124|NCT00269113|526270|P2|Overall Study|Lost to Follow-up|1
165125|NCT00269113|526271|P1|Overall Study|Lost to Follow-up|2
165126|NCT00269113|526270|P2|Overall Study|Death|2
165127|NCT00269113|526271|P1|Overall Study|Death|6
165128|NCT00269113|526270|P2|Overall Study|Withdrawal by Subject|2
165129|NCT00269113|526271|P1|Overall Study|Withdrawal by Subject|0
165130|NCT00269113|526270|P2|Overall Study|Early Improvement|0
165131|NCT00269113|526271|P1|Overall Study|Early Improvement|2
165132|NCT00269113|526270|P2|Overall Study|Lack of Efficacy|18
165133|NCT00269113|526271|P1|Overall Study|Lack of Efficacy|35
165134|NCT00269113|526270|P2|Overall Study|Adverse Event|7
165135|NCT00269113|526271|P1|Overall Study|Adverse Event|14
165136|NCT00268983|526291|P2|Overall Study|Death|0
165137|NCT00268983|526292|P1|Overall Study|Death|3
165138|NCT00268905|526335|P3|Overall Study|Clinical Progression|1
165139|NCT00268905|526336|P2|Overall Study|Clinical Progression|4
165140|NCT00268905|526337|P1|Overall Study|Clinical Progression|9
165141|NCT00268905|526335|P3|Overall Study|Physician Decision|1
165142|NCT00268905|526336|P2|Overall Study|Physician Decision|0
165143|NCT00268905|526337|P1|Overall Study|Physician Decision|3
165144|NCT00268905|526335|P3|Overall Study|Progressive Disease|3
165145|NCT00268905|526336|P2|Overall Study|Progressive Disease|4
165146|NCT00268905|526337|P1|Overall Study|Progressive Disease|28
165147|NCT00268905|526335|P3|Overall Study|Withdrawal by Subject|3
165148|NCT00268905|526336|P2|Overall Study|Withdrawal by Subject|0
165149|NCT00268905|526337|P1|Overall Study|Withdrawal by Subject|0
165150|NCT00268905|526335|P3|Overall Study|Lost to Follow-up|0
165151|NCT00268905|526336|P2|Overall Study|Lost to Follow-up|1
165152|NCT00268905|526337|P1|Overall Study|Lost to Follow-up|0
165153|NCT00268905|526335|P3|Overall Study|Adverse Event|4
165154|NCT00268905|526336|P2|Overall Study|Adverse Event|0
165155|NCT00268905|526337|P1|Overall Study|Adverse Event|3
165156|NCT00268892|526354|P3|Overall Study|Trial Site Closed|2
165157|NCT00268892|526355|P2|Overall Study|Trial Site Closed|2
165158|NCT00268892|526356|P1|Overall Study|Trial Site Closed|4
165159|NCT00268892|526354|P3|Overall Study|Disease Progression|0
165160|NCT00268892|526355|P2|Overall Study|Disease Progression|1
165161|NCT00268892|526356|P1|Overall Study|Disease Progression|1
165162|NCT00268892|526354|P3|Overall Study|Protocol Violation|0
165163|NCT00268892|526355|P2|Overall Study|Protocol Violation|1
165164|NCT00268892|526356|P1|Overall Study|Protocol Violation|0
165165|NCT00268892|526354|P3|Overall Study|Lost to Follow-up|4
165166|NCT00268892|526355|P2|Overall Study|Lost to Follow-up|2
165167|NCT00268892|526356|P1|Overall Study|Lost to Follow-up|5
165168|NCT00268892|526354|P3|Overall Study|Physician Decision|0
165169|NCT00268892|526355|P2|Overall Study|Physician Decision|1
165170|NCT00268892|526356|P1|Overall Study|Physician Decision|0
165171|NCT00268892|526354|P3|Overall Study|Withdrawal by Subject|13
165172|NCT00268892|526355|P2|Overall Study|Withdrawal by Subject|15
165173|NCT00268892|526356|P1|Overall Study|Withdrawal by Subject|14
165174|NCT00268892|526354|P3|Overall Study|Lack of Efficacy|0
165175|NCT00268892|526355|P2|Overall Study|Lack of Efficacy|3
165176|NCT00268892|526356|P1|Overall Study|Lack of Efficacy|1
165177|NCT00268892|526354|P3|Overall Study|Adverse Event|20
165178|NCT00268892|526355|P2|Overall Study|Adverse Event|17
165179|NCT00268892|526356|P1|Overall Study|Adverse Event|14
165180|NCT00268463|526375|P2|Overall Study|study terminated due to low accrual|12
165181|NCT00268463|526376|P1|Overall Study|study terminated due to low accrual|10
165182|NCT00268437|526382|P1|Overall Study|Ineligible|1
165183|NCT00268346|526389|P2|Overall Study|Withdrawal by Subject|1
165184|NCT00268346|526390|P1|Overall Study|Withdrawal by Subject|0
165185|NCT00268346|526389|P2|Overall Study|Death|1
165186|NCT00268346|526390|P1|Overall Study|Death|0
165187|NCT00268346|526389|P2|Overall Study|Adverse Event|1
165188|NCT00268346|526390|P1|Overall Study|Adverse Event|0
165189|NCT00268242|526396|P1|Overall Study|Death|1
165190|NCT00268203|526405|P1|Overall Study|Completed 2 Years of Follow-up|62
165191|NCT00268203|526405|P1|Overall Study|Reason Not Specified|34
165192|NCT00268203|526405|P1|Overall Study|Death|84
165193|NCT00268203|526405|P1|Overall Study|Progressive Disease|359
165194|NCT00268203|526405|P1|Overall Study|Received Other NHL Therapy|7
165195|NCT00268203|526405|P1|Overall Study|Withdrawal by Subject|9
165196|NCT00268203|526405|P1|Overall Study|Lost to Follow-up|92
165197|NCT00267969|526419|P7|After Controlled Period|Not specified|25
165198|NCT00267969|526420|P6|After Controlled Period|Not specified|22
165199|NCT00267969|526421|P5|After Controlled Period|Not specified|11
165200|NCT00267969|526422|P4|After Controlled Period|Not specified|13
165201|NCT00267969|526423|P3|After Controlled Period|Not specified|0
165202|NCT00267969|526424|P2|After Controlled Period|Not specified|0
165203|NCT00267969|526425|P1|After Controlled Period|Not specified|0
165204|NCT00267969|526419|P7|After Controlled Period|Lost to Follow-up|10
165205|NCT00267969|526420|P6|After Controlled Period|Lost to Follow-up|9
165206|NCT00267969|526421|P5|After Controlled Period|Lost to Follow-up|8
165207|NCT00267969|526422|P4|After Controlled Period|Lost to Follow-up|5
165208|NCT00267969|526423|P3|After Controlled Period|Lost to Follow-up|0
165209|NCT00267969|526424|P2|After Controlled Period|Lost to Follow-up|0
165210|NCT00267969|526425|P1|After Controlled Period|Lost to Follow-up|0
165211|NCT00267969|526419|P7|After Controlled Period|Lack of Efficacy|15
165212|NCT00267969|526420|P6|After Controlled Period|Lack of Efficacy|28
165213|NCT00267969|526421|P5|After Controlled Period|Lack of Efficacy|6
165214|NCT00267969|526422|P4|After Controlled Period|Lack of Efficacy|10
165215|NCT00267969|526423|P3|After Controlled Period|Lack of Efficacy|0
165216|NCT00267969|526424|P2|After Controlled Period|Lack of Efficacy|0
165217|NCT00267969|526425|P1|After Controlled Period|Lack of Efficacy|0
165218|NCT00267969|526419|P7|After Controlled Period|Death|1
165219|NCT00267969|526420|P6|After Controlled Period|Death|0
165220|NCT00267969|526421|P5|After Controlled Period|Death|2
165221|NCT00267969|526422|P4|After Controlled Period|Death|1
165222|NCT00267969|526423|P3|After Controlled Period|Death|0
165223|NCT00267969|526424|P2|After Controlled Period|Death|0
165224|NCT00267969|526425|P1|After Controlled Period|Death|0
165225|NCT00267969|526419|P7|After Controlled Period|Adverse Event|21
165226|NCT00267969|526420|P6|After Controlled Period|Adverse Event|23
165227|NCT00267969|526421|P5|After Controlled Period|Adverse Event|8
165228|NCT00267969|526422|P4|After Controlled Period|Adverse Event|7
165229|NCT00267969|526423|P3|After Controlled Period|Adverse Event|0
165230|NCT00267969|526424|P2|After Controlled Period|Adverse Event|0
165231|NCT00267969|526425|P1|After Controlled Period|Adverse Event|0
165232|NCT00267969|526419|P7|Controlled Period|Not specified|0
165233|NCT00267969|526420|P6|Controlled Period|Not specified|0
165234|NCT00267969|526421|P5|Controlled Period|Not specified|0
165235|NCT00267969|526422|P4|Controlled Period|Not specified|0
165236|NCT00267969|526423|P3|Controlled Period|Not specified|6
165237|NCT00267969|526424|P2|Controlled Period|Not specified|1
165238|NCT00267969|526425|P1|Controlled Period|Not specified|2
165239|NCT00267969|526419|P7|Controlled Period|Randomized but not treated|0
165240|NCT00267969|526420|P6|Controlled Period|Randomized but not treated|0
165241|NCT00267969|526421|P5|Controlled Period|Randomized but not treated|0
165242|NCT00267969|526422|P4|Controlled Period|Randomized but not treated|0
165243|NCT00267969|526423|P3|Controlled Period|Randomized but not treated|1
165244|NCT00267969|526424|P2|Controlled Period|Randomized but not treated|0
165245|NCT00267969|526425|P1|Controlled Period|Randomized but not treated|0
165246|NCT00267969|526419|P7|Controlled Period|Lost to Follow-up|0
165247|NCT00267969|526420|P6|Controlled Period|Lost to Follow-up|0
165248|NCT00267969|526421|P5|Controlled Period|Lost to Follow-up|0
165249|NCT00267969|526422|P4|Controlled Period|Lost to Follow-up|0
165250|NCT00267969|526423|P3|Controlled Period|Lost to Follow-up|1
165251|NCT00267969|526424|P2|Controlled Period|Lost to Follow-up|0
165252|NCT00267969|526425|P1|Controlled Period|Lost to Follow-up|1
165253|NCT00267969|526419|P7|Controlled Period|Lack of Efficacy|0
165254|NCT00267969|526420|P6|Controlled Period|Lack of Efficacy|0
165255|NCT00267969|526421|P5|Controlled Period|Lack of Efficacy|0
165256|NCT00267969|526422|P4|Controlled Period|Lack of Efficacy|0
165257|NCT00267969|526423|P3|Controlled Period|Lack of Efficacy|1
165258|NCT00267969|526424|P2|Controlled Period|Lack of Efficacy|0
165259|NCT00267969|526425|P1|Controlled Period|Lack of Efficacy|3
165260|NCT00267969|526419|P7|Controlled Period|Adverse Event|0
165261|NCT00267969|526420|P6|Controlled Period|Adverse Event|0
165262|NCT00267969|526421|P5|Controlled Period|Adverse Event|0
165263|NCT00267969|526422|P4|Controlled Period|Adverse Event|0
165264|NCT00267969|526423|P3|Controlled Period|Adverse Event|2
165265|NCT00267969|526424|P2|Controlled Period|Adverse Event|0
165266|NCT00267969|526425|P1|Controlled Period|Adverse Event|6
165267|NCT00267956|526451|P4|After Controlled Period|Withdrew consent|0
165268|NCT00267956|526452|P3|After Controlled Period|Withdrew consent|1
165269|NCT00267956|526453|P2|After Controlled Period|Withdrew consent|0
165270|NCT00267956|526454|P1|After Controlled Period|Withdrew consent|0
165271|NCT00267956|526451|P4|After Controlled Period|Lost to Follow-up|0
165272|NCT00267956|526452|P3|After Controlled Period|Lost to Follow-up|1
165273|NCT00267956|526453|P2|After Controlled Period|Lost to Follow-up|0
165274|NCT00267956|526454|P1|After Controlled Period|Lost to Follow-up|0
165275|NCT00267956|526451|P4|After Controlled Period|Lack of Efficacy|1
165276|NCT00267956|526452|P3|After Controlled Period|Lack of Efficacy|1
165277|NCT00267956|526453|P2|After Controlled Period|Lack of Efficacy|0
165278|NCT00267956|526454|P1|After Controlled Period|Lack of Efficacy|0
165279|NCT00267956|526451|P4|After Controlled Period|Adverse Event|1
165280|NCT00267956|526452|P3|After Controlled Period|Adverse Event|2
165281|NCT00267956|526453|P2|After Controlled Period|Adverse Event|0
165282|NCT00267956|526454|P1|After Controlled Period|Adverse Event|0
165283|NCT00267956|526451|P4|Controlled Period|Withdrew consent|0
165284|NCT00267956|526452|P3|Controlled Period|Withdrew consent|0
165285|NCT00267956|526453|P2|Controlled Period|Withdrew consent|1
165286|NCT00267956|526454|P1|Controlled Period|Withdrew consent|3
165287|NCT00267956|526451|P4|Controlled Period|Lost to Follow-up|0
165288|NCT00267956|526452|P3|Controlled Period|Lost to Follow-up|0
165289|NCT00267956|526453|P2|Controlled Period|Lost to Follow-up|0
165290|NCT00267956|526454|P1|Controlled Period|Lost to Follow-up|2
165291|NCT00267956|526451|P4|Controlled Period|Lack of Efficacy|0
165292|NCT00267956|526452|P3|Controlled Period|Lack of Efficacy|0
165293|NCT00267956|526453|P2|Controlled Period|Lack of Efficacy|2
165294|NCT00267956|526454|P1|Controlled Period|Lack of Efficacy|4
165295|NCT00267956|526451|P4|Controlled Period|Adverse Event|0
165296|NCT00267956|526452|P3|Controlled Period|Adverse Event|0
165297|NCT00267956|526453|P2|Controlled Period|Adverse Event|1
165298|NCT00267956|526454|P1|Controlled Period|Adverse Event|4
165299|NCT00267748|526484|P3|Randomized Period|randomized but not treated|3
165300|NCT00267748|526485|P2|Randomized Period|randomized but not treated|0
165301|NCT00267748|526486|P1|Randomized Period|randomized but not treated|0
165302|NCT00267748|526484|P3|Randomized Period|Unspecified|6
165303|NCT00267748|526485|P2|Randomized Period|Unspecified|9
165304|NCT00267748|526486|P1|Randomized Period|Unspecified|0
165305|NCT00267748|526484|P3|Randomized Period|Withdrawal by Subject|2
165306|NCT00267748|526485|P2|Randomized Period|Withdrawal by Subject|9
165307|NCT00267748|526486|P1|Randomized Period|Withdrawal by Subject|0
165308|NCT00267748|526484|P3|Randomized Period|Objective progression or relapse|86
165309|NCT00267748|526485|P2|Randomized Period|Objective progression or relapse|77
165310|NCT00267748|526486|P1|Randomized Period|Objective progression or relapse|0
165311|NCT00267748|526484|P3|Randomized Period|Lost to Follow-up|0
165312|NCT00267748|526485|P2|Randomized Period|Lost to Follow-up|1
165313|NCT00267748|526486|P1|Randomized Period|Lost to Follow-up|0
165314|NCT00267748|526484|P3|Randomized Period|Global deterioration of health status|7
165315|NCT00267748|526485|P2|Randomized Period|Global deterioration of health status|6
165316|NCT00267748|526486|P1|Randomized Period|Global deterioration of health status|0
165317|NCT00267748|526484|P3|Randomized Period|Adverse Event|25
165318|NCT00267748|526485|P2|Randomized Period|Adverse Event|23
165319|NCT00267748|526486|P1|Randomized Period|Adverse Event|0
165320|NCT00267748|526484|P3|Randomized Period|Death|3
165321|NCT00267748|526485|P2|Randomized Period|Death|2
165322|NCT00267748|526486|P1|Randomized Period|Death|0
165323|NCT00267748|526484|P3|Non-randomized Period|Unspecified|0
165324|NCT00267748|526485|P2|Non-randomized Period|Unspecified|0
165325|NCT00267748|526486|P1|Non-randomized Period|Unspecified|3
165326|NCT00267748|526484|P3|Non-randomized Period|Participant not willing to participate|0
165327|NCT00267748|526485|P2|Non-randomized Period|Participant not willing to participate|0
165328|NCT00267748|526486|P1|Non-randomized Period|Participant not willing to participate|1
165329|NCT00267748|526484|P3|Non-randomized Period|Death|0
165330|NCT00267748|526485|P2|Non-randomized Period|Death|0
165331|NCT00267748|526486|P1|Non-randomized Period|Death|1
165332|NCT00267748|526484|P3|Non-randomized Period|Adverse Event|0
165333|NCT00267748|526485|P2|Non-randomized Period|Adverse Event|0
165334|NCT00267748|526486|P1|Non-randomized Period|Adverse Event|8
165335|NCT00267748|526484|P3|Non-randomized Period|Progressive disease|0
165336|NCT00267748|526485|P2|Non-randomized Period|Progressive disease|0
165337|NCT00267748|526486|P1|Non-randomized Period|Progressive disease|10
165338|NCT00267488|526543|P1|Overall Study|Other (Disease Progression)|1
165339|NCT00267488|526543|P1|Overall Study|Protocol Violation|1
165340|NCT00267488|526543|P1|Overall Study|Sponsor Terminated Study|9
165341|NCT00264875|526552|P1|Overall Study|Withdrawal by Subject|7
165342|NCT00264875|526552|P1|Overall Study|Protocol Violation|11
165343|NCT00264875|526552|P1|Overall Study|Lost to Follow-up|6
165344|NCT00264875|526552|P1|Overall Study|Adverse Event|6
165345|NCT00267202|526571|P2|Overall Study|Lost to Follow-up|0
165346|NCT00267202|526572|P1|Overall Study|Lost to Follow-up|3
165347|NCT00267202|526571|P2|Overall Study|Administrative problems|1
165348|NCT00267202|526572|P1|Overall Study|Administrative problems|2
165349|NCT00267202|526571|P2|Overall Study|Protocol Violation|3
165350|NCT00267202|526572|P1|Overall Study|Protocol Violation|2
165351|NCT00267202|526571|P2|Overall Study|Adverse Event|7
165352|NCT00267202|526572|P1|Overall Study|Adverse Event|13
165353|NCT00267202|526571|P2|Overall Study|Withdrawal by Subject|15
165354|NCT00267202|526572|P1|Overall Study|Withdrawal by Subject|12
165355|NCT00267202|526571|P2|Overall Study|Unsatisfactory therapeutic effect|8
165356|NCT00267202|526572|P1|Overall Study|Unsatisfactory therapeutic effect|21
165357|NCT00267189|526593|P2|Overall Study|Missing|0
165358|NCT00267189|526594|P1|Overall Study|Missing|3
165359|NCT00267189|526593|P2|Overall Study|Death|0
165360|NCT00267189|526594|P1|Overall Study|Death|1
165361|NCT00267189|526593|P2|Overall Study|Patient withdrew consent|1
165362|NCT00267189|526594|P1|Overall Study|Patient withdrew consent|1
165363|NCT00267150|526604|P1|Overall Study|Adverse Event|1
165364|NCT00267098|526628|P8|Overall Study|Sponsor withdrew subject|0
165365|NCT00267098|526629|P7|Overall Study|Sponsor withdrew subject|0
165366|NCT00267098|526630|P6|Overall Study|Sponsor withdrew subject|0
165367|NCT00267098|526631|P5|Overall Study|Sponsor withdrew subject|0
165368|NCT00267098|526632|P4|Overall Study|Sponsor withdrew subject|1
165369|NCT00267098|526633|P3|Overall Study|Sponsor withdrew subject|0
165370|NCT00267098|526634|P2|Overall Study|Sponsor withdrew subject|0
165371|NCT00267098|526635|P1|Overall Study|Sponsor withdrew subject|0
165372|NCT00267098|526628|P8|Overall Study|Subject listed for heart transplant|0
165373|NCT00267098|526629|P7|Overall Study|Subject listed for heart transplant|1
165374|NCT00267098|526630|P6|Overall Study|Subject listed for heart transplant|0
165375|NCT00267098|526631|P5|Overall Study|Subject listed for heart transplant|0
165376|NCT00267098|526632|P4|Overall Study|Subject listed for heart transplant|0
165377|NCT00267098|526633|P3|Overall Study|Subject listed for heart transplant|0
165378|NCT00267098|526634|P2|Overall Study|Subject listed for heart transplant|0
165379|NCT00267098|526635|P1|Overall Study|Subject listed for heart transplant|0
165380|NCT00267098|526628|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
165381|NCT00267098|526629|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
165382|NCT00267098|526630|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
165383|NCT00267098|526631|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
165384|NCT00267098|526632|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
165385|NCT00267098|526633|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
165386|NCT00267098|526634|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
165387|NCT00267098|526635|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
165388|NCT00267098|526628|P8|Overall Study|Explanted Medtronic device|0
165389|NCT00267098|526629|P7|Overall Study|Explanted Medtronic device|0
165390|NCT00267098|526630|P6|Overall Study|Explanted Medtronic device|0
165391|NCT00267098|526631|P5|Overall Study|Explanted Medtronic device|0
165392|NCT00267098|526632|P4|Overall Study|Explanted Medtronic device|1
165393|NCT00267098|526633|P3|Overall Study|Explanted Medtronic device|0
165394|NCT00267098|526634|P2|Overall Study|Explanted Medtronic device|0
165395|NCT00267098|526635|P1|Overall Study|Explanted Medtronic device|0
165396|NCT00267098|526628|P8|Overall Study|Site closure|0
165397|NCT00267098|526629|P7|Overall Study|Site closure|1
165398|NCT00267098|526630|P6|Overall Study|Site closure|1
165399|NCT00267098|526631|P5|Overall Study|Site closure|0
165400|NCT00267098|526632|P4|Overall Study|Site closure|1
165401|NCT00267098|526633|P3|Overall Study|Site closure|0
165402|NCT00267098|526634|P2|Overall Study|Site closure|0
165403|NCT00267098|526635|P1|Overall Study|Site closure|0
165404|NCT00267098|526628|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
165405|NCT00267098|526629|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
165406|NCT00267098|526630|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
165407|NCT00267098|526631|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
165408|NCT00267098|526632|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
165409|NCT00267098|526633|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
165410|NCT00267098|526634|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
165411|NCT00267098|526635|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
165412|NCT00267098|526628|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
165413|NCT00267098|526629|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
165414|NCT00267098|526630|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
165415|NCT00267098|526631|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
165416|NCT00267098|526632|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
165417|NCT00267098|526633|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
165418|NCT00267098|526634|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
165419|NCT00267098|526635|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
165420|NCT00267098|526628|P8|Overall Study|Physician Decision|0
165421|NCT00267098|526629|P7|Overall Study|Physician Decision|3
165422|NCT00267098|526630|P6|Overall Study|Physician Decision|4
165423|NCT00267098|526631|P5|Overall Study|Physician Decision|5
165424|NCT00267098|526632|P4|Overall Study|Physician Decision|11
165425|NCT00267098|526633|P3|Overall Study|Physician Decision|7
165426|NCT00267098|526634|P2|Overall Study|Physician Decision|0
165427|NCT00267098|526635|P1|Overall Study|Physician Decision|5
165428|NCT00267098|526628|P8|Overall Study|Withdrawal by Subject|5
165429|NCT00267098|526629|P7|Overall Study|Withdrawal by Subject|12
165430|NCT00267098|526630|P6|Overall Study|Withdrawal by Subject|9
165431|NCT00267098|526631|P5|Overall Study|Withdrawal by Subject|12
165432|NCT00267098|526632|P4|Overall Study|Withdrawal by Subject|21
165433|NCT00267098|526633|P3|Overall Study|Withdrawal by Subject|24
165434|NCT00267098|526634|P2|Overall Study|Withdrawal by Subject|0
165435|NCT00267098|526635|P1|Overall Study|Withdrawal by Subject|8
165436|NCT00267098|526628|P8|Overall Study|Lost to Follow-up|1
165437|NCT00267098|526629|P7|Overall Study|Lost to Follow-up|1
165438|NCT00267098|526630|P6|Overall Study|Lost to Follow-up|3
165439|NCT00267098|526631|P5|Overall Study|Lost to Follow-up|2
165440|NCT00267098|526632|P4|Overall Study|Lost to Follow-up|5
165441|NCT00267098|526633|P3|Overall Study|Lost to Follow-up|6
165442|NCT00267098|526634|P2|Overall Study|Lost to Follow-up|0
165443|NCT00267098|526635|P1|Overall Study|Lost to Follow-up|0
165444|NCT00267098|526628|P8|Overall Study|Death|9
165445|NCT00267098|526629|P7|Overall Study|Death|28
165446|NCT00267098|526630|P6|Overall Study|Death|23
165447|NCT00267098|526631|P5|Overall Study|Death|14
165448|NCT00267098|526632|P4|Overall Study|Death|66
165449|NCT00267098|526633|P3|Overall Study|Death|57
165450|NCT00267098|526634|P2|Overall Study|Death|0
165451|NCT00267098|526635|P1|Overall Study|Death|0
165452|NCT00267046|526778|P2|Overall Study|Radiation|1
165453|NCT00267046|526779|P1|Overall Study|Radiation|0
165454|NCT00267046|526778|P2|Overall Study|Withdrawal by Subject|0
165455|NCT00267046|526779|P1|Overall Study|Withdrawal by Subject|1
165456|NCT00267046|526778|P2|Overall Study|Surgery|1
165457|NCT00267046|526779|P1|Overall Study|Surgery|3
165458|NCT00267046|526778|P2|Overall Study|Open-label palifermin|7
165459|NCT00267046|526779|P1|Overall Study|Open-label palifermin|2
165460|NCT00267046|526778|P2|Overall Study|Chemotoxicity|0
165461|NCT00267046|526779|P1|Overall Study|Chemotoxicity|2
165462|NCT00267046|526778|P2|Overall Study|Disease progression|2
165463|NCT00267046|526779|P1|Overall Study|Disease progression|4
165464|NCT00267007|526789|P2|Overall Study|Adverse Event|0
165465|NCT00267007|526790|P1|Overall Study|Adverse Event|1
165466|NCT00267007|526789|P2|Overall Study|Non-compliance|1
165467|NCT00267007|526790|P1|Overall Study|Non-compliance|0
165468|NCT00267007|526789|P2|Overall Study|Lost to Follow-up|0
165469|NCT00267007|526790|P1|Overall Study|Lost to Follow-up|1
165470|NCT00267007|526789|P2|Overall Study|Withdrawal by Subject|0
165471|NCT00267007|526790|P1|Overall Study|Withdrawal by Subject|6
165472|NCT00266864|526800|P2|Overall Study|Withdrawal by Subject|1
165473|NCT00266864|526801|P1|Overall Study|Withdrawal by Subject|1
165474|NCT00266864|526800|P2|Overall Study|Lost to Follow-up|1
165475|NCT00266864|526801|P1|Overall Study|Lost to Follow-up|4
165476|NCT00266825|526810|P2|Completed Follow-Up|Withdrawal by Subject|5
165477|NCT00266825|526811|P1|Completed Follow-Up|Withdrawal by Subject|11
165478|NCT00266825|526810|P2|Completed Follow-Up|Lost to Follow-up|19
165479|NCT00266825|526811|P1|Completed Follow-Up|Lost to Follow-up|14
165480|NCT00266812|526837|P2|Overall Study|Discontinued before starting study drug|0
165481|NCT00266812|526838|P1|Overall Study|Discontinued before starting study drug|4
165482|NCT00266812|526837|P2|Overall Study|Withdrawal by Subject|2
165483|NCT00266812|526838|P1|Overall Study|Withdrawal by Subject|0
165484|NCT00266812|526837|P2|Overall Study|Protocol Violation|1
165485|NCT00266812|526838|P1|Overall Study|Protocol Violation|0
165486|NCT00266812|526837|P2|Overall Study|Adverse Event|1
165487|NCT00266812|526838|P1|Overall Study|Adverse Event|3
165488|NCT00266812|526837|P2|Overall Study|Death|4
165489|NCT00266812|526838|P1|Overall Study|Death|5
165490|NCT00266812|526837|P2|Overall Study|Disease Progression|3
165491|NCT00266812|526838|P1|Overall Study|Disease Progression|9
165492|NCT00266695|526861|P1|Overall Study|Withdrawal by Subject|15
165493|NCT00266695|526861|P1|Overall Study|Lost to Follow-up|3
165494|NCT00266695|526861|P1|Overall Study|Physician Decision|1
165495|NCT00266695|526861|P1|Overall Study|Death|9
165496|NCT00266695|526861|P1|Overall Study|Adverse Event|1
165497|NCT00266656|526873|P2|Overall Study|Parent/Caregiver Decision|2
165498|NCT00266656|526874|P1|Overall Study|Parent/Caregiver Decision|1
165499|NCT00266656|526873|P2|Overall Study|Did Not Reach Final Height|8
165500|NCT00266656|526874|P1|Overall Study|Did Not Reach Final Height|4
165501|NCT00266656|526873|P2|Overall Study|Withdrawal by Subject|2
165502|NCT00266656|526874|P1|Overall Study|Withdrawal by Subject|4
165503|NCT00266656|526873|P2|Overall Study|Lost to Follow-up|1
165504|NCT00266656|526874|P1|Overall Study|Lost to Follow-up|4
165505|NCT00266656|526873|P2|Overall Study|Death|0
165506|NCT00266656|526874|P1|Overall Study|Death|1
165507|NCT00266630|526898|P2|Overall Study|Not Specified|11
165508|NCT00266630|526899|P1|Overall Study|Not Specified|19
165509|NCT00266630|526898|P2|Overall Study|Lost to Follow-up|0
165510|NCT00266630|526899|P1|Overall Study|Lost to Follow-up|1
165511|NCT00266630|526898|P2|Overall Study|Withdrawal by Subject|2
165512|NCT00266630|526899|P1|Overall Study|Withdrawal by Subject|10
165513|NCT00266630|526898|P2|Overall Study|Physician Decision|2
165514|NCT00266630|526899|P1|Overall Study|Physician Decision|1
165515|NCT00266630|526898|P2|Overall Study|Protocol Violation|3
165516|NCT00266630|526899|P1|Overall Study|Protocol Violation|1
165517|NCT00266630|526898|P2|Overall Study|Entry Criteria not met|0
165518|NCT00266630|526899|P1|Overall Study|Entry Criteria not met|1
165519|NCT00266630|526898|P2|Overall Study|Lack of Efficacy|4
165520|NCT00266630|526899|P1|Overall Study|Lack of Efficacy|1
165521|NCT00266630|526898|P2|Overall Study|Adverse Event|6
165522|NCT00266630|526899|P1|Overall Study|Adverse Event|8
165523|NCT00264849|526939|P2|Overall Study|Administrative Problems|0
165524|NCT00264849|526940|P1|Overall Study|Administrative Problems|2
165525|NCT00264849|526939|P2|Overall Study|Death|1
165526|NCT00264849|526940|P1|Overall Study|Death|0
165527|NCT00264849|526939|P2|Overall Study|Lost to Follow-up|2
165528|NCT00264849|526940|P1|Overall Study|Lost to Follow-up|0
165529|NCT00264849|526939|P2|Overall Study|Lack of Efficacy|6
165530|NCT00264849|526940|P1|Overall Study|Lack of Efficacy|1
165531|NCT00264849|526939|P2|Overall Study|Protocol Violation|3
165532|NCT00264849|526940|P1|Overall Study|Protocol Violation|5
165533|NCT00264849|526939|P2|Overall Study|Withdrawal by Subject|11
165534|NCT00264849|526940|P1|Overall Study|Withdrawal by Subject|7
165535|NCT00264849|526939|P2|Overall Study|Adverse Event|2
165536|NCT00264849|526940|P1|Overall Study|Adverse Event|7
165537|NCT00264810|526976|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
165538|NCT00264810|526977|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
165539|NCT00264810|526976|P2|Open Label Evaluation Period|Death|2
165540|NCT00264810|526977|P1|Open Label Evaluation Period|Death|3
165541|NCT00264810|526976|P2|Open Label Evaluation Period|Explant due to infection|1
165542|NCT00264810|526977|P1|Open Label Evaluation Period|Explant due to infection|1
165543|NCT00264810|526976|P2|Blinded Evaluation Period|Explant due to infection|1
165544|NCT00264810|526977|P1|Blinded Evaluation Period|Explant due to infection|1
165545|NCT00264810|526976|P2|Stimulation Optimization Period|Death|1
165546|NCT00264810|526977|P1|Stimulation Optimization Period|Death|0
165547|NCT00264810|526976|P2|Stimulation Optimization Period|Withdrawal by Subject|0
165548|NCT00264810|526977|P1|Stimulation Optimization Period|Withdrawal by Subject|1
165549|NCT00264810|526976|P2|Baseline|Other|1
165550|NCT00264810|526977|P1|Baseline|Other|0
165551|NCT00264810|526976|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
165552|NCT00264810|526977|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
165553|NCT00264810|526976|P2|Baseline|Insufficient Seizure Frequency|2
165554|NCT00264810|526977|P1|Baseline|Insufficient Seizure Frequency|2
165555|NCT00264810|526976|P2|Baseline|Subject Compliance Failure|3
165556|NCT00264810|526977|P1|Baseline|Subject Compliance Failure|3
165557|NCT00264810|526976|P2|Baseline|Physician Decision|8
165558|NCT00264810|526977|P1|Baseline|Physician Decision|7
165559|NCT00264810|526976|P2|Baseline|Withdrawal by Subject|10
165560|NCT00264810|526977|P1|Baseline|Withdrawal by Subject|10
165561|NCT00266409|526989|P4|Overall Study|unspecified|0
165562|NCT00266409|526990|P3|Overall Study|unspecified|2
165563|NCT00266409|526991|P2|Overall Study|unspecified|4
165564|NCT00266409|526992|P1|Overall Study|unspecified|7
165565|NCT00266409|526989|P4|Overall Study|Protocol Violation|2
165566|NCT00266409|526990|P3|Overall Study|Protocol Violation|4
165567|NCT00266409|526991|P2|Overall Study|Protocol Violation|3
165568|NCT00266409|526992|P1|Overall Study|Protocol Violation|5
165569|NCT00266409|526989|P4|Overall Study|Withdrawal by Subject|9
165570|NCT00266409|526990|P3|Overall Study|Withdrawal by Subject|3
165571|NCT00266409|526991|P2|Overall Study|Withdrawal by Subject|10
165572|NCT00266409|526992|P1|Overall Study|Withdrawal by Subject|6
165573|NCT00266409|526989|P4|Overall Study|Lost to Follow-up|8
165574|NCT00266409|526990|P3|Overall Study|Lost to Follow-up|6
165575|NCT00266409|526991|P2|Overall Study|Lost to Follow-up|21
165576|NCT00266409|526992|P1|Overall Study|Lost to Follow-up|18
165577|NCT00266409|526989|P4|Overall Study|Adverse Event|1
165578|NCT00266409|526990|P3|Overall Study|Adverse Event|1
165579|NCT00266409|526991|P2|Overall Study|Adverse Event|2
165580|NCT00266409|526992|P1|Overall Study|Adverse Event|7
165581|NCT00266409|526989|P4|Overall Study|Lack of Efficacy|2
165582|NCT00266409|526990|P3|Overall Study|Lack of Efficacy|1
165583|NCT00266409|526991|P2|Overall Study|Lack of Efficacy|6
165584|NCT00266409|526992|P1|Overall Study|Lack of Efficacy|2
165585|NCT00266227|527280|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
165586|NCT00266227|527281|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
165587|NCT00266227|527282|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
165588|NCT00266227|527280|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
165589|NCT00266227|527281|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
165590|NCT00266227|527282|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
165591|NCT00266227|527280|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
165592|NCT00266227|527281|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
165593|NCT00266227|527282|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
165594|NCT00266227|527280|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
165595|NCT00266227|527281|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
165596|NCT00266227|527282|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
165597|NCT00266227|527280|P3|Retreatment: Week 48 to Week 72|Death|0
165598|NCT00266227|527281|P2|Retreatment: Week 48 to Week 72|Death|1
165599|NCT00266227|527282|P1|Retreatment: Week 48 to Week 72|Death|1
165600|NCT00266227|527280|P3|Retreatment: Up to Week 48|Pregnancy|0
165601|NCT00266227|527281|P2|Retreatment: Up to Week 48|Pregnancy|0
165602|NCT00266227|527282|P1|Retreatment: Up to Week 48|Pregnancy|1
165603|NCT00266227|527280|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
165604|NCT00266227|527281|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
165605|NCT00266227|527282|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
165606|NCT00266227|527280|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
165607|NCT00266227|527281|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
165608|NCT00266227|527282|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
165609|NCT00266227|527280|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
165610|NCT00266227|527281|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
165611|NCT00266227|527282|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
165612|NCT00266227|527280|P3|Retreatment: Up to Week 48|Adverse Event|0
165613|NCT00266227|527281|P2|Retreatment: Up to Week 48|Adverse Event|7
165614|NCT00266227|527282|P1|Retreatment: Up to Week 48|Adverse Event|7
165615|NCT00266227|527280|P3|Retreatment: Up to Week 48|Death|0
165616|NCT00266227|527281|P2|Retreatment: Up to Week 48|Death|0
165617|NCT00266227|527282|P1|Retreatment: Up to Week 48|Death|1
165618|NCT00266227|527280|P3|Initial Treatment|Pregnancy|1
165619|NCT00266227|527281|P2|Initial Treatment|Pregnancy|0
165620|NCT00266227|527282|P1|Initial Treatment|Pregnancy|0
165621|NCT00266227|527280|P3|Initial Treatment|Physician decision to withdraw|12
165622|NCT00266227|527281|P2|Initial Treatment|Physician decision to withdraw|0
165623|NCT00266227|527282|P1|Initial Treatment|Physician decision to withdraw|0
165624|NCT00266227|527280|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
165625|NCT00266227|527281|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
165626|NCT00266227|527282|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
165627|NCT00266227|527280|P3|Initial Treatment|Lost to Follow-up|6
165628|NCT00266227|527281|P2|Initial Treatment|Lost to Follow-up|0
165629|NCT00266227|527282|P1|Initial Treatment|Lost to Follow-up|0
165630|NCT00266227|527280|P3|Initial Treatment|Adverse Event|13
165631|NCT00266227|527281|P2|Initial Treatment|Adverse Event|0
165632|NCT00266227|527282|P1|Initial Treatment|Adverse Event|0
165633|NCT00264797|527329|P2|Overall Study|Other|4
165634|NCT00264797|527330|P1|Overall Study|Other|3
165635|NCT00264797|527329|P2|Overall Study|Feels treatment not necessary, not worki|1
165636|NCT00264797|527330|P1|Overall Study|Feels treatment not necessary, not worki|0
165637|NCT00264797|527329|P2|Overall Study|Pressure/advice from Outsiders|1
165638|NCT00264797|527330|P1|Overall Study|Pressure/advice from Outsiders|1
165639|NCT00264797|527329|P2|Overall Study|Incarceration|5
165640|NCT00264797|527330|P1|Overall Study|Incarceration|4
165641|NCT00264797|527329|P2|Overall Study|Practical Problems|3
165642|NCT00264797|527330|P1|Overall Study|Practical Problems|2
165643|NCT00264797|527329|P2|Overall Study|Moved from area|1
165644|NCT00264797|527330|P1|Overall Study|Moved from area|3
165645|NCT00264797|527329|P2|Overall Study|Lost to Follow-up|17
165646|NCT00264797|527330|P1|Overall Study|Lost to Follow-up|9
165647|NCT00264797|527329|P2|Overall Study|Withdrawal by Subject|11
165648|NCT00264797|527330|P1|Overall Study|Withdrawal by Subject|11
165649|NCT00266032|527345|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
165650|NCT00266032|527346|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
165651|NCT00266032|527347|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
165652|NCT00266032|527345|P3|Open-label Safety Extension|Withdrawal by Subject|12
165653|NCT00266032|527346|P2|Open-label Safety Extension|Withdrawal by Subject|3
165654|NCT00266032|527347|P1|Open-label Safety Extension|Withdrawal by Subject|19
165655|NCT00266032|527345|P3|Open-label Safety Extension|Protocol Violation|2
165656|NCT00266032|527346|P2|Open-label Safety Extension|Protocol Violation|3
165657|NCT00266032|527347|P1|Open-label Safety Extension|Protocol Violation|1
165658|NCT00266032|527345|P3|Open-label Safety Extension|Pregnancy|2
165659|NCT00266032|527346|P2|Open-label Safety Extension|Pregnancy|1
165660|NCT00266032|527347|P1|Open-label Safety Extension|Pregnancy|4
165661|NCT00266032|527345|P3|Open-label Safety Extension|Lost to Follow-up|4
165662|NCT00266032|527346|P2|Open-label Safety Extension|Lost to Follow-up|5
165663|NCT00266032|527347|P1|Open-label Safety Extension|Lost to Follow-up|2
165664|NCT00266032|527345|P3|Open-label Safety Extension|Adverse Event|4
165665|NCT00266032|527346|P2|Open-label Safety Extension|Adverse Event|0
165666|NCT00266032|527347|P1|Open-label Safety Extension|Adverse Event|5
165667|NCT00266032|527345|P3|Treatment|patient moved/wish for pregnancy/no need|8
165668|NCT00266032|527346|P2|Treatment|patient moved/wish for pregnancy/no need|5
165669|NCT00266032|527347|P1|Treatment|patient moved/wish for pregnancy/no need|13
165670|NCT00266032|527345|P3|Treatment|Withdrawal by Subject|12
165671|NCT00266032|527346|P2|Treatment|Withdrawal by Subject|13
165672|NCT00266032|527347|P1|Treatment|Withdrawal by Subject|28
165673|NCT00266032|527345|P3|Treatment|Protocol Violation|13
165674|NCT00266032|527346|P2|Treatment|Protocol Violation|14
165675|NCT00266032|527347|P1|Treatment|Protocol Violation|6
165676|NCT00266032|527345|P3|Treatment|Pregnancy|2
165677|NCT00266032|527346|P2|Treatment|Pregnancy|2
165678|NCT00266032|527347|P1|Treatment|Pregnancy|3
165679|NCT00266032|527345|P3|Treatment|Lost to Follow-up|2
165680|NCT00266032|527346|P2|Treatment|Lost to Follow-up|4
165681|NCT00266032|527347|P1|Treatment|Lost to Follow-up|19
165682|NCT00266032|527345|P3|Treatment|Adverse Event|10
165683|NCT00266032|527346|P2|Treatment|Adverse Event|26
165684|NCT00266032|527347|P1|Treatment|Adverse Event|42
165685|NCT00265889|527375|P1|Overall Study|Insurance denied the request|3
165686|NCT00265889|527375|P1|Overall Study|Protocol Violation|1
165687|NCT00265889|527375|P1|Overall Study|Physician Decision|1
165688|NCT00265785|527387|P1|Overall Study|Did not receive protocol treatment|2
165689|NCT00265785|527387|P1|Overall Study|Ineligible|1
165690|NCT00265785|527387|P1|Overall Study|Not protocol specified|2
165691|NCT00265785|527387|P1|Overall Study|Progression/Relapse|15
165692|NCT00265785|527387|P1|Overall Study|Withdrawal by Subject|3
165693|NCT00265785|527387|P1|Overall Study|Adverse Event|4
165694|NCT00265395|527432|P2|Overall Study|Administrative|1
165695|NCT00265395|527433|P1|Overall Study|Administrative|0
165696|NCT00265395|527432|P2|Overall Study|Lack of Efficacy|1
165697|NCT00265395|527433|P1|Overall Study|Lack of Efficacy|0
165698|NCT00265395|527432|P2|Overall Study|Protocol Violation|2
165699|NCT00265395|527433|P1|Overall Study|Protocol Violation|2
165700|NCT00265395|527432|P2|Overall Study|Withdrawal by Subject|6
165701|NCT00265395|527433|P1|Overall Study|Withdrawal by Subject|1
165702|NCT00265395|527432|P2|Overall Study|Lost to Follow-up|1
165703|NCT00265395|527433|P1|Overall Study|Lost to Follow-up|2
165704|NCT00265395|527432|P2|Overall Study|Adverse Event|6
165705|NCT00265395|527433|P1|Overall Study|Adverse Event|3
165706|NCT00265382|527438|P1|Overall Study|Death|1
165707|NCT00265382|527438|P1|Overall Study|Study terminated by sponsor|94
165708|NCT00265382|527438|P1|Overall Study|Withdrawal by Subject|13
165709|NCT00265382|527438|P1|Overall Study|Miscellaneous|6
165710|NCT00265382|527438|P1|Overall Study|Lack of Efficacy|6
165711|NCT00265382|527438|P1|Overall Study|Lost to Follow-up|3
165712|NCT00265382|527438|P1|Overall Study|Laboratory Abnormality|1
165713|NCT00265382|527438|P1|Overall Study|Adverse Event|21
165714|NCT00265343|527458|P2|Overall Study|Other|3
165715|NCT00265343|527459|P1|Overall Study|Other|8
165716|NCT00265343|527458|P2|Overall Study|Withdrawal by Subject|9
165717|NCT00265343|527459|P1|Overall Study|Withdrawal by Subject|3
165718|NCT00265343|527458|P2|Overall Study|Adverse Event|7
165719|NCT00265343|527459|P1|Overall Study|Adverse Event|10
165720|NCT00265330|527467|P1|Overall Study|Protocol Violation|1
165721|NCT00265330|527467|P1|Overall Study|Withdrew Consent|1
165722|NCT00265330|527467|P1|Overall Study|Principal Investigators Request|1
165723|NCT00265330|527467|P1|Overall Study|Site Closed by Sponsor|1
165724|NCT00265330|527467|P1|Overall Study|Discharged from Unit for Long Term Care|1
165725|NCT00265330|527467|P1|Overall Study|Began Taking Formulary Geodon|1
165726|NCT00265330|527467|P1|Overall Study|Family Scheduling Conflicts|1
165727|NCT00265330|527467|P1|Overall Study|Lack of Efficacy|4
165728|NCT00265330|527467|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
165729|NCT00265330|527467|P1|Overall Study|Withdrawal by Subject|34
165730|NCT00265330|527467|P1|Overall Study|Lost to Follow-up|8
165731|NCT00265330|527467|P1|Overall Study|Adverse Event|41
165732|NCT00265317|527493|P4|Phase 2|Unspecified|1
165733|NCT00265317|527494|P3|Phase 2|Unspecified|1
165734|NCT00265317|527495|P2|Phase 2|Unspecified|0
165735|NCT00265317|527496|P1|Phase 2|Unspecified|0
165736|NCT00265317|527493|P4|Phase 2|Study terminated by sponsor|0
165737|NCT00265317|527494|P3|Phase 2|Study terminated by sponsor|1
165738|NCT00265317|527495|P2|Phase 2|Study terminated by sponsor|0
165739|NCT00265317|527496|P1|Phase 2|Study terminated by sponsor|0
165740|NCT00265317|527493|P4|Phase 2|Withdrawal/other than adverse event|1
165741|NCT00265317|527494|P3|Phase 2|Withdrawal/other than adverse event|2
165742|NCT00265317|527495|P2|Phase 2|Withdrawal/other than adverse event|0
165743|NCT00265317|527496|P1|Phase 2|Withdrawal/other than adverse event|0
165744|NCT00265317|527493|P4|Phase 2|Lost to Follow-up|1
165745|NCT00265317|527494|P3|Phase 2|Lost to Follow-up|0
165746|NCT00265317|527495|P2|Phase 2|Lost to Follow-up|0
165747|NCT00265317|527496|P1|Phase 2|Lost to Follow-up|0
165748|NCT00265317|527493|P4|Phase 2|Protocol Violation|4
165749|NCT00265317|527494|P3|Phase 2|Protocol Violation|1
165750|NCT00265317|527495|P2|Phase 2|Protocol Violation|0
165751|NCT00265317|527496|P1|Phase 2|Protocol Violation|0
165752|NCT00265317|527493|P4|Phase 2|Death|15
165753|NCT00265317|527494|P3|Phase 2|Death|12
165754|NCT00265317|527495|P2|Phase 2|Death|0
165755|NCT00265317|527496|P1|Phase 2|Death|0
165756|NCT00265317|527493|P4|Phase 2|Adverse Event|5
165757|NCT00265317|527494|P3|Phase 2|Adverse Event|7
165758|NCT00265317|527495|P2|Phase 2|Adverse Event|0
165759|NCT00265317|527496|P1|Phase 2|Adverse Event|0
165760|NCT00265317|527493|P4|Phase 2|Global deterioration of health status|0
165761|NCT00265317|527494|P3|Phase 2|Global deterioration of health status|3
165762|NCT00265317|527495|P2|Phase 2|Global deterioration of health status|0
165763|NCT00265317|527496|P1|Phase 2|Global deterioration of health status|0
165764|NCT00265317|527493|P4|Phase 2|Objective progression or relapse|38
165765|NCT00265317|527494|P3|Phase 2|Objective progression or relapse|37
165766|NCT00265317|527495|P2|Phase 2|Objective progression or relapse|0
165767|NCT00265317|527496|P1|Phase 2|Objective progression or relapse|0
165768|NCT00265317|527493|P4|Lead-In|Withdrawal/other than adverse event|0
165769|NCT00265317|527494|P3|Lead-In|Withdrawal/other than adverse event|0
165770|NCT00265317|527495|P2|Lead-In|Withdrawal/other than adverse event|0
165771|NCT00265317|527496|P1|Lead-In|Withdrawal/other than adverse event|1
165772|NCT00265317|527493|P4|Lead-In|Death|0
165773|NCT00265317|527494|P3|Lead-In|Death|0
165774|NCT00265317|527495|P2|Lead-In|Death|5
165775|NCT00265317|527496|P1|Lead-In|Death|3
165776|NCT00265317|527493|P4|Lead-In|Adverse Event|0
165777|NCT00265317|527494|P3|Lead-In|Adverse Event|0
165778|NCT00265317|527495|P2|Lead-In|Adverse Event|1
165779|NCT00265317|527496|P1|Lead-In|Adverse Event|2
165780|NCT00265317|527493|P4|Lead-In|Objective progression or relapse|0
165781|NCT00265317|527494|P3|Lead-In|Objective progression or relapse|0
165782|NCT00265317|527495|P2|Lead-In|Objective progression or relapse|11
165783|NCT00265317|527496|P1|Lead-In|Objective progression or relapse|6
165784|NCT00265239|527611|P2|Overall Study|Adverse Event|1
165785|NCT00265239|527612|P1|Overall Study|Adverse Event|2
165786|NCT00265122|527630|P6|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
165787|NCT00265122|527631|P5|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
165788|NCT00265122|527632|P4|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
165789|NCT00265122|527633|P3|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
165790|NCT00265122|527634|P2|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
165791|NCT00265122|527635|P1|Intervention Period 2 (Weeks 8 to 28):|Not specified|4
165792|NCT00265122|527630|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
165793|NCT00265122|527631|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
165794|NCT00265122|527632|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
165795|NCT00265122|527633|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
165796|NCT00265122|527634|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
165797|NCT00265122|527635|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
165798|NCT00265122|527630|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
165799|NCT00265122|527631|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
165800|NCT00265122|527632|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
165801|NCT00265122|527633|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
165802|NCT00265122|527634|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
165803|NCT00265122|527635|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
165804|NCT00265122|527630|P6|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
165805|NCT00265122|527631|P5|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
165806|NCT00265122|527632|P4|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
165807|NCT00265122|527633|P3|Intervention Period 1 (Weeks 0 to 8):|Not specified|2
165808|NCT00265122|527634|P2|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
165809|NCT00265122|527635|P1|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
165810|NCT00265122|527630|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
165811|NCT00265122|527631|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
165812|NCT00265122|527632|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
165813|NCT00265122|527633|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
165814|NCT00265122|527634|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
165815|NCT00265122|527635|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
165816|NCT00265122|527630|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
165817|NCT00265122|527631|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
165818|NCT00265122|527632|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
165819|NCT00265122|527633|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
165820|NCT00265122|527634|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
165821|NCT00265122|527635|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
165822|NCT00265109|527657|P1|Overall Study|Adverse Event|1
165823|NCT00265109|527657|P1|Overall Study|Withdrawal by Subject|5
165824|NCT00265096|527664|P3|Overall Study|Not Specified|10
165825|NCT00265096|527665|P2|Overall Study|Not Specified|19
165826|NCT00265096|527666|P1|Overall Study|Not Specified|11
165827|NCT00265096|527664|P3|Overall Study|Unsatisfactory therapeutic effect|6
165828|NCT00265096|527665|P2|Overall Study|Unsatisfactory therapeutic effect|8
165829|NCT00265096|527666|P1|Overall Study|Unsatisfactory therapeutic effect|9
165830|NCT00265096|527664|P3|Overall Study|Death|2
165831|NCT00265096|527665|P2|Overall Study|Death|1
165832|NCT00265096|527666|P1|Overall Study|Death|0
165833|NCT00265096|527664|P3|Overall Study|Lost to Follow-up|3
165834|NCT00265096|527665|P2|Overall Study|Lost to Follow-up|5
165835|NCT00265096|527666|P1|Overall Study|Lost to Follow-up|2
165836|NCT00265096|527664|P3|Overall Study|Adverse Event|18
165837|NCT00265096|527665|P2|Overall Study|Adverse Event|18
165838|NCT00265096|527666|P1|Overall Study|Adverse Event|14
165839|NCT00265083|527698|P3|Overall Study|Not specified|9
165840|NCT00265083|527699|P2|Overall Study|Not specified|12
165841|NCT00265083|527700|P1|Overall Study|Not specified|1
165842|NCT00265083|527698|P3|Overall Study|Unsatisfactory therapeutic effect|14
165843|NCT00265083|527699|P2|Overall Study|Unsatisfactory therapeutic effect|13
165844|NCT00265083|527700|P1|Overall Study|Unsatisfactory therapeutic effect|8
165845|NCT00265083|527698|P3|Overall Study|Lost to Follow-up|4
165846|NCT00265083|527699|P2|Overall Study|Lost to Follow-up|4
165847|NCT00265083|527700|P1|Overall Study|Lost to Follow-up|3
165848|NCT00265083|527698|P3|Overall Study|Adverse Event|15
165849|NCT00265083|527699|P2|Overall Study|Adverse Event|13
165850|NCT00265083|527700|P1|Overall Study|Adverse Event|5
165851|NCT00264576|527723|P2|Overall Study|Lost to Follow-up|1
165852|NCT00264576|527724|P1|Overall Study|Lost to Follow-up|1
165853|NCT00264550|527748|P4|Overall Study|Not specified|9
165854|NCT00264550|527749|P3|Overall Study|Not specified|3
165855|NCT00264550|527750|P2|Overall Study|Not specified|7
165856|NCT00264550|527751|P1|Overall Study|Not specified|13
165857|NCT00264550|527748|P4|Overall Study|Discontinued oral study agent|0
165858|NCT00264550|527749|P3|Overall Study|Discontinued oral study agent|0
165859|NCT00264550|527750|P2|Overall Study|Discontinued oral study agent|1
165860|NCT00264550|527751|P1|Overall Study|Discontinued oral study agent|0
165861|NCT00264550|527748|P4|Overall Study|Unsatisfactory therapeutic effect|6
165862|NCT00264550|527749|P3|Overall Study|Unsatisfactory therapeutic effect|4
165863|NCT00264550|527750|P2|Overall Study|Unsatisfactory therapeutic effect|11
165864|NCT00264550|527751|P1|Overall Study|Unsatisfactory therapeutic effect|4
165865|NCT00264550|527748|P4|Overall Study|Adverse Event|14
165866|NCT00264550|527749|P3|Overall Study|Adverse Event|9
165867|NCT00264550|527750|P2|Overall Study|Adverse Event|18
165868|NCT00264550|527751|P1|Overall Study|Adverse Event|23
165869|NCT00264550|527748|P4|Overall Study|Lost to Follow-up|1
165870|NCT00264550|527749|P3|Overall Study|Lost to Follow-up|1
165871|NCT00264550|527750|P2|Overall Study|Lost to Follow-up|1
165872|NCT00264550|527751|P1|Overall Study|Lost to Follow-up|3
165873|NCT00264550|527748|P4|Overall Study|Death|0
165874|NCT00264550|527749|P3|Overall Study|Death|0
165875|NCT00264550|527750|P2|Overall Study|Death|3
165876|NCT00264550|527751|P1|Overall Study|Death|0
165877|NCT00264537|527790|P4|Overall Study|Not treated|0
165878|NCT00264537|527791|P3|Overall Study|Not treated|1
165879|NCT00264537|527792|P2|Overall Study|Not treated|2
165880|NCT00264537|527793|P1|Overall Study|Not treated|0
165881|NCT00264537|527790|P4|Overall Study|Not specified|11
165882|NCT00264537|527791|P3|Overall Study|Not specified|10
165883|NCT00264537|527792|P2|Overall Study|Not specified|11
165884|NCT00264537|527793|P1|Overall Study|Not specified|21
165885|NCT00264537|527790|P4|Overall Study|Unsatisfactory therapeutic effect|7
165886|NCT00264537|527791|P3|Overall Study|Unsatisfactory therapeutic effect|5
165887|NCT00264537|527792|P2|Overall Study|Unsatisfactory therapeutic effect|6
165888|NCT00264537|527793|P1|Overall Study|Unsatisfactory therapeutic effect|5
165889|NCT00264537|527790|P4|Overall Study|Adverse Event|34
165890|NCT00264537|527791|P3|Overall Study|Adverse Event|24
165891|NCT00264537|527792|P2|Overall Study|Adverse Event|32
165892|NCT00264537|527793|P1|Overall Study|Adverse Event|21
165893|NCT00264537|527790|P4|Overall Study|Lost to Follow-up|6
165894|NCT00264537|527791|P3|Overall Study|Lost to Follow-up|7
165895|NCT00264537|527792|P2|Overall Study|Lost to Follow-up|4
165896|NCT00264537|527793|P1|Overall Study|Lost to Follow-up|3
165897|NCT00264537|527790|P4|Overall Study|Death|2
165898|NCT00264537|527791|P3|Overall Study|Death|3
165899|NCT00264537|527792|P2|Overall Study|Death|3
165900|NCT00264537|527793|P1|Overall Study|Death|0
165901|NCT00264498|527825|P2|Crossover Treatment|Withdrawal by Subject|0
165902|NCT00264498|527826|P1|Crossover Treatment|Withdrawal by Subject|1
165903|NCT00264498|527825|P2|Crossover Treatment|Study closure|1
165904|NCT00264498|527826|P1|Crossover Treatment|Study closure|0
165905|NCT00264498|527825|P2|Crossover Treatment|Objective disease progression|5
165906|NCT00264498|527826|P1|Crossover Treatment|Objective disease progression|4
165907|NCT00264498|527825|P2|Crossover Treatment|Death|3
165908|NCT00264498|527826|P1|Crossover Treatment|Death|1
165909|NCT00264498|527825|P2|Randomized Treatment|Protocol Violation|0
165910|NCT00264498|527826|P1|Randomized Treatment|Protocol Violation|1
165911|NCT00264498|527825|P2|Randomized Treatment|Study Closure|0
165912|NCT00264498|527826|P1|Randomized Treatment|Study Closure|1
165913|NCT00264498|527825|P2|Randomized Treatment|Incorrectly randomized|0
165914|NCT00264498|527826|P1|Randomized Treatment|Incorrectly randomized|1
165915|NCT00264498|527825|P2|Randomized Treatment|Physician Decision|0
165916|NCT00264498|527826|P1|Randomized Treatment|Physician Decision|1
165917|NCT00264498|527825|P2|Randomized Treatment|Objective disease Progression|14
165918|NCT00264498|527826|P1|Randomized Treatment|Objective disease Progression|13
165919|NCT00264498|527825|P2|Randomized Treatment|Withdrawal by Subject|1
165920|NCT00264498|527826|P1|Randomized Treatment|Withdrawal by Subject|0
165921|NCT00264498|527825|P2|Randomized Treatment|Death|3
165922|NCT00264498|527826|P1|Randomized Treatment|Death|0
165923|NCT00264303|527849|P2|Overall Study|Various reasons listed in study report|7
165924|NCT00264303|527850|P1|Overall Study|Various reasons listed in study report|6
165925|NCT00264303|527849|P2|Overall Study|Withdrawal by Subject|3
165926|NCT00264303|527850|P1|Overall Study|Withdrawal by Subject|2
165927|NCT00264303|527849|P2|Overall Study|Lost to Follow-up|3
165928|NCT00264303|527850|P1|Overall Study|Lost to Follow-up|3
165929|NCT00264303|527849|P2|Overall Study|Lack of Efficacy|13
165930|NCT00264303|527850|P1|Overall Study|Lack of Efficacy|10
165931|NCT00264303|527849|P2|Overall Study|Adverse Event|3
165932|NCT00264303|527850|P1|Overall Study|Adverse Event|4
165933|NCT00264290|527868|P2|Intervention (8 Weeks)|Adverse Event|0
165934|NCT00264290|527869|P1|Intervention (8 Weeks)|Adverse Event|1
165935|NCT00264147|527880|P6|Treatment II Period|Pre-scheduled total hip replacement|1
165936|NCT00264147|527881|P5|Treatment II Period|Pre-scheduled total hip replacement|0
165937|NCT00264147|527882|P4|Treatment II Period|Pre-scheduled total hip replacement|0
165938|NCT00264147|527883|P3|Treatment II Period|Pre-scheduled total hip replacement|0
165939|NCT00264147|527884|P2|Treatment II Period|Pre-scheduled total hip replacement|0
165940|NCT00264147|527885|P1|Treatment II Period|Pre-scheduled total hip replacement|0
165941|NCT00264147|527880|P6|Treatment II Period|Withdrawal by Subject|2
165942|NCT00264147|527881|P5|Treatment II Period|Withdrawal by Subject|3
165943|NCT00264147|527882|P4|Treatment II Period|Withdrawal by Subject|0
165944|NCT00264147|527883|P3|Treatment II Period|Withdrawal by Subject|0
165945|NCT00264147|527884|P2|Treatment II Period|Withdrawal by Subject|0
165946|NCT00264147|527885|P1|Treatment II Period|Withdrawal by Subject|0
165947|NCT00264147|527880|P6|Treatment II Period|Lost to Follow-up|1
165948|NCT00264147|527881|P5|Treatment II Period|Lost to Follow-up|1
165949|NCT00264147|527882|P4|Treatment II Period|Lost to Follow-up|0
165950|NCT00264147|527883|P3|Treatment II Period|Lost to Follow-up|0
165951|NCT00264147|527884|P2|Treatment II Period|Lost to Follow-up|0
165952|NCT00264147|527885|P1|Treatment II Period|Lost to Follow-up|0
165953|NCT00264147|527880|P6|Treatment II Period|Lack of Efficacy|19
165954|NCT00264147|527881|P5|Treatment II Period|Lack of Efficacy|20
165955|NCT00264147|527882|P4|Treatment II Period|Lack of Efficacy|0
165956|NCT00264147|527883|P3|Treatment II Period|Lack of Efficacy|0
165957|NCT00264147|527884|P2|Treatment II Period|Lack of Efficacy|0
165958|NCT00264147|527885|P1|Treatment II Period|Lack of Efficacy|0
165959|NCT00264147|527880|P6|Treatment II Period|Laboratory Adverse Event|1
165960|NCT00264147|527881|P5|Treatment II Period|Laboratory Adverse Event|0
165961|NCT00264147|527882|P4|Treatment II Period|Laboratory Adverse Event|0
165962|NCT00264147|527883|P3|Treatment II Period|Laboratory Adverse Event|0
165963|NCT00264147|527884|P2|Treatment II Period|Laboratory Adverse Event|0
165964|NCT00264147|527885|P1|Treatment II Period|Laboratory Adverse Event|0
165965|NCT00264147|527880|P6|Treatment II Period|Adverse Event|9
165966|NCT00264147|527881|P5|Treatment II Period|Adverse Event|9
165967|NCT00264147|527882|P4|Treatment II Period|Adverse Event|0
165968|NCT00264147|527883|P3|Treatment II Period|Adverse Event|0
165969|NCT00264147|527884|P2|Treatment II Period|Adverse Event|0
165970|NCT00264147|527885|P1|Treatment II Period|Adverse Event|0
165971|NCT00264147|527880|P6|Treatment I Period|Reassigned to Treatment II Period|0
165972|NCT00264147|527881|P5|Treatment I Period|Reassigned to Treatment II Period|45
165973|NCT00264147|527882|P4|Treatment I Period|Reassigned to Treatment II Period|63
165974|NCT00264147|527883|P3|Treatment I Period|Reassigned to Treatment II Period|65
165975|NCT00264147|527884|P2|Treatment I Period|Reassigned to Treatment II Period|72
165976|NCT00264147|527885|P1|Treatment I Period|Reassigned to Treatment II Period|84
165977|NCT00264147|527880|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
165978|NCT00264147|527881|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
165979|NCT00264147|527882|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
165980|NCT00264147|527883|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
165981|NCT00264147|527884|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
165982|NCT00264147|527885|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
165983|NCT00264147|527880|P6|Treatment I Period|Patient out of town for an extended time|0
165984|NCT00264147|527881|P5|Treatment I Period|Patient out of town for an extended time|0
165985|NCT00264147|527882|P4|Treatment I Period|Patient out of town for an extended time|0
165986|NCT00264147|527883|P3|Treatment I Period|Patient out of town for an extended time|0
165987|NCT00264147|527884|P2|Treatment I Period|Patient out of town for an extended time|1
165988|NCT00264147|527885|P1|Treatment I Period|Patient out of town for an extended time|0
165989|NCT00264147|527880|P6|Treatment I Period|Withdrawal by Subject|0
165990|NCT00264147|527881|P5|Treatment I Period|Withdrawal by Subject|2
165991|NCT00264147|527882|P4|Treatment I Period|Withdrawal by Subject|2
165992|NCT00264147|527883|P3|Treatment I Period|Withdrawal by Subject|0
165993|NCT00264147|527884|P2|Treatment I Period|Withdrawal by Subject|0
165994|NCT00264147|527885|P1|Treatment I Period|Withdrawal by Subject|2
165995|NCT00264147|527880|P6|Treatment I Period|Protocol Violation|0
165996|NCT00264147|527881|P5|Treatment I Period|Protocol Violation|0
165997|NCT00264147|527882|P4|Treatment I Period|Protocol Violation|0
165998|NCT00264147|527883|P3|Treatment I Period|Protocol Violation|0
165999|NCT00264147|527884|P2|Treatment I Period|Protocol Violation|2
166000|NCT00264147|527885|P1|Treatment I Period|Protocol Violation|2
166001|NCT00264147|527880|P6|Treatment I Period|Lost to Follow-up|0
166002|NCT00264147|527881|P5|Treatment I Period|Lost to Follow-up|1
166003|NCT00264147|527882|P4|Treatment I Period|Lost to Follow-up|1
166004|NCT00264147|527883|P3|Treatment I Period|Lost to Follow-up|0
166005|NCT00264147|527884|P2|Treatment I Period|Lost to Follow-up|0
166006|NCT00264147|527885|P1|Treatment I Period|Lost to Follow-up|1
166007|NCT00264147|527880|P6|Treatment I Period|Lack of Efficacy|0
166008|NCT00264147|527881|P5|Treatment I Period|Lack of Efficacy|1
166009|NCT00264147|527882|P4|Treatment I Period|Lack of Efficacy|0
166010|NCT00264147|527883|P3|Treatment I Period|Lack of Efficacy|8
166011|NCT00264147|527884|P2|Treatment I Period|Lack of Efficacy|2
166012|NCT00264147|527885|P1|Treatment I Period|Lack of Efficacy|6
166013|NCT00264147|527880|P6|Treatment I Period|Laboratory Adverse Event|0
166014|NCT00264147|527881|P5|Treatment I Period|Laboratory Adverse Event|0
166015|NCT00264147|527882|P4|Treatment I Period|Laboratory Adverse Event|1
166016|NCT00264147|527883|P3|Treatment I Period|Laboratory Adverse Event|0
166017|NCT00264147|527884|P2|Treatment I Period|Laboratory Adverse Event|0
166018|NCT00264147|527885|P1|Treatment I Period|Laboratory Adverse Event|0
166019|NCT00264147|527880|P6|Treatment I Period|Adverse Event|0
166020|NCT00264147|527881|P5|Treatment I Period|Adverse Event|7
166021|NCT00264147|527882|P4|Treatment I Period|Adverse Event|5
166022|NCT00264147|527883|P3|Treatment I Period|Adverse Event|3
166023|NCT00264147|527884|P2|Treatment I Period|Adverse Event|6
166024|NCT00264147|527885|P1|Treatment I Period|Adverse Event|3
166025|NCT00264004|527928|P4|Overall Study|Not treated|2
166026|NCT00264004|527929|P3|Overall Study|Not treated|2
166027|NCT00264004|527930|P2|Overall Study|Not treated|0
166028|NCT00264004|527931|P1|Overall Study|Not treated|3
166029|NCT00264004|527928|P4|Overall Study|Cond. under inv. worsened|4
166030|NCT00264004|527929|P3|Overall Study|Cond. under inv. worsened|3
166031|NCT00264004|527930|P2|Overall Study|Cond. under inv. worsened|5
166032|NCT00264004|527931|P1|Overall Study|Cond. under inv. worsened|9
166033|NCT00264004|527928|P4|Overall Study|Development study specific disc. crit.|0
166034|NCT00264004|527929|P3|Overall Study|Development study specific disc. crit.|1
166035|NCT00264004|527930|P2|Overall Study|Development study specific disc. crit.|0
166036|NCT00264004|527931|P1|Overall Study|Development study specific disc. crit.|1
166037|NCT00264004|527928|P4|Overall Study|Not specified|3
166038|NCT00264004|527929|P3|Overall Study|Not specified|0
166039|NCT00264004|527930|P2|Overall Study|Not specified|2
166040|NCT00264004|527931|P1|Overall Study|Not specified|2
166041|NCT00264004|527928|P4|Overall Study|Withdrawal by Subject|2
166042|NCT00264004|527929|P3|Overall Study|Withdrawal by Subject|2
166043|NCT00264004|527930|P2|Overall Study|Withdrawal by Subject|1
166044|NCT00264004|527931|P1|Overall Study|Withdrawal by Subject|0
166045|NCT00264004|527928|P4|Overall Study|Adverse Event|4
166046|NCT00264004|527929|P3|Overall Study|Adverse Event|6
166047|NCT00264004|527930|P2|Overall Study|Adverse Event|3
166048|NCT00264004|527931|P1|Overall Study|Adverse Event|2
166049|NCT00263887|527959|P2|Overall Study|Lack of Efficacy|1
166050|NCT00263887|527960|P1|Overall Study|Lack of Efficacy|0
166051|NCT00263887|527959|P2|Overall Study|Disease progression|1
166052|NCT00263887|527960|P1|Overall Study|Disease progression|0
166053|NCT00263887|527959|P2|Overall Study|Adverse Event|2
166054|NCT00263887|527960|P1|Overall Study|Adverse Event|0
166055|NCT00263887|527959|P2|Overall Study|Too ill to attend visit|0
166056|NCT00263887|527960|P1|Overall Study|Too ill to attend visit|1
166057|NCT00263887|527959|P2|Overall Study|Lung transplantation|2
166058|NCT00263887|527960|P1|Overall Study|Lung transplantation|1
166059|NCT00263887|527959|P2|Overall Study|Withdrawal by Subject|1
166060|NCT00263887|527960|P1|Overall Study|Withdrawal by Subject|1
166061|NCT00263757|527968|P2|Overall Study|Adverse Event|3
166062|NCT00263757|527969|P1|Overall Study|Adverse Event|3
166063|NCT00263757|527968|P2|Overall Study|Screen failure|1
166064|NCT00263757|527969|P1|Overall Study|Screen failure|0
166065|NCT00263757|527968|P2|Overall Study|Withdrawal by Subject|4
166066|NCT00263757|527969|P1|Overall Study|Withdrawal by Subject|5
166067|NCT00263666|527981|P2|Overall Study|Withdrawal by Subject|1
166068|NCT00263666|527982|P1|Overall Study|Withdrawal by Subject|0
166069|NCT00263666|527981|P2|Overall Study|Lost to Follow-up|2
166070|NCT00263666|527982|P1|Overall Study|Lost to Follow-up|1
166071|NCT00263666|527981|P2|Overall Study|Adverse Event|8
166072|NCT00263666|527982|P1|Overall Study|Adverse Event|6
166073|NCT00263328|528036|P3|Overall Study|Adverse Event|4
166074|NCT00263328|528037|P2|Overall Study|Adverse Event|1
166075|NCT00263328|528038|P1|Overall Study|Adverse Event|1
166076|NCT00263328|528036|P3|Overall Study|Not specified|1
166077|NCT00263328|528037|P2|Overall Study|Not specified|0
166078|NCT00263328|528038|P1|Overall Study|Not specified|3
166079|NCT00263328|528036|P3|Overall Study|Withdrawal by Subject|1
166080|NCT00263328|528037|P2|Overall Study|Withdrawal by Subject|0
166081|NCT00263328|528038|P1|Overall Study|Withdrawal by Subject|3
166082|NCT00263328|528036|P3|Overall Study|Lost to Follow-up|0
166083|NCT00263328|528037|P2|Overall Study|Lost to Follow-up|1
166084|NCT00263328|528038|P1|Overall Study|Lost to Follow-up|1
166085|NCT00263328|528036|P3|Overall Study|Death|1
166086|NCT00263328|528037|P2|Overall Study|Death|0
166087|NCT00263328|528038|P1|Overall Study|Death|0
166088|NCT00262951|528229|P1|Overall Study|Off treatment for other disease|1
166089|NCT00262951|528229|P1|Overall Study|Alternative treatment|3
166090|NCT00262951|528229|P1|Overall Study|Withdrawal by Subject|1
166091|NCT00262951|528229|P1|Overall Study|Death|1
166092|NCT00262951|528229|P1|Overall Study|Adverse Event|7
166093|NCT00262951|528229|P1|Overall Study|Progressive disease/relapse|3
166094|NCT00262925|528234|P1|Overall Study|Other|1
166095|NCT00262925|528234|P1|Overall Study|alternative therapy|1
166096|NCT00262925|528234|P1|Overall Study|Death|2
166097|NCT00262925|528234|P1|Overall Study|Adverse Event|4
166098|NCT00262925|528234|P1|Overall Study|Lack of Efficacy|3
166099|NCT00262873|528240|P1|Overall Study|Withdrawal by Subject|5
166100|NCT00262873|528240|P1|Overall Study|Adverse Event|3
166101|NCT00262860|528251|P1|Overall Study|Adverse Event|2
166102|NCT00262847|528260|P3|Overall Study|Did not receive study treatment|4
166103|NCT00262847|528261|P2|Overall Study|Did not receive study treatment|1
166104|NCT00262847|528262|P1|Overall Study|Did not receive study treatment|4
166105|NCT00262847|528260|P3|Overall Study|Other Reasons|27
166106|NCT00262847|528261|P2|Overall Study|Other Reasons|88
166107|NCT00262847|528262|P1|Overall Study|Other Reasons|79
166108|NCT00262847|528260|P3|Overall Study|Concomitant disease|4
166109|NCT00262847|528261|P2|Overall Study|Concomitant disease|2
166110|NCT00262847|528262|P1|Overall Study|Concomitant disease|3
166111|NCT00262847|528260|P3|Overall Study|Death|11
166112|NCT00262847|528261|P2|Overall Study|Death|8
166113|NCT00262847|528262|P1|Overall Study|Death|8
166114|NCT00262847|528260|P3|Overall Study|Adverse Event|108
166115|NCT00262847|528261|P2|Overall Study|Adverse Event|88
166116|NCT00262847|528262|P1|Overall Study|Adverse Event|74
166117|NCT00262847|528260|P3|Overall Study|Patient Refusal|47
166118|NCT00262847|528261|P2|Overall Study|Patient Refusal|52
166119|NCT00262847|528262|P1|Overall Study|Patient Refusal|41
166120|NCT00262847|528260|P3|Overall Study|Disease Progression|195
166121|NCT00262847|528261|P2|Overall Study|Disease Progression|274
166122|NCT00262847|528262|P1|Overall Study|Disease Progression|309
166123|NCT00262834|528278|P2|Overall Study|Surgery delayed/tissue not collected|4
166124|NCT00262834|528279|P1|Overall Study|Surgery delayed/tissue not collected|1
166125|NCT00262743|528289|P2|Overall Study|Disease progression|3
166126|NCT00262743|528290|P1|Overall Study|Disease progression|0
166127|NCT00262743|528289|P2|Overall Study|Adverse Event|9
166128|NCT00262743|528290|P1|Overall Study|Adverse Event|0
166129|NCT00262600|528325|P3|Overall Study|Not Specified|62
166130|NCT00262600|528326|P2|Overall Study|Not Specified|59
166131|NCT00262600|528327|P1|Overall Study|Not Specified|58
166132|NCT00262600|528325|P3|Overall Study|Not Treated|24
166133|NCT00262600|528326|P2|Overall Study|Not Treated|17
166134|NCT00262600|528327|P1|Overall Study|Not Treated|32
166135|NCT00262600|528325|P3|Overall Study|Withdrawal by Subject|139
166136|NCT00262600|528326|P2|Overall Study|Withdrawal by Subject|145
166137|NCT00262600|528327|P1|Overall Study|Withdrawal by Subject|128
166138|NCT00262600|528325|P3|Overall Study|Lost to Follow-up|41
166139|NCT00262600|528326|P2|Overall Study|Lost to Follow-up|31
166140|NCT00262600|528327|P1|Overall Study|Lost to Follow-up|17
166141|NCT00262522|528354|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
166142|NCT00262522|528355|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
166143|NCT00262522|528356|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
166144|NCT00262522|528357|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
166145|NCT00262522|528354|P4|Study Start Through 96 Weeks|Virologic failure|0
166146|NCT00262522|528355|P3|Study Start Through 96 Weeks|Virologic failure|8
166147|NCT00262522|528356|P2|Study Start Through 96 Weeks|Virologic failure|0
166148|NCT00262522|528357|P1|Study Start Through 96 Weeks|Virologic failure|5
166149|NCT00262522|528354|P4|Study Start Through 96 Weeks|Death|0
166150|NCT00262522|528355|P3|Study Start Through 96 Weeks|Death|2
166151|NCT00262522|528356|P2|Study Start Through 96 Weeks|Death|0
166152|NCT00262522|528357|P1|Study Start Through 96 Weeks|Death|2
166153|NCT00262522|528354|P4|Study Start Through 96 Weeks|Noncompliance|0
166154|NCT00262522|528355|P3|Study Start Through 96 Weeks|Noncompliance|11
166155|NCT00262522|528356|P2|Study Start Through 96 Weeks|Noncompliance|0
166156|NCT00262522|528357|P1|Study Start Through 96 Weeks|Noncompliance|6
166157|NCT00262522|528354|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
166158|NCT00262522|528355|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
166159|NCT00262522|528356|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
166160|NCT00262522|528357|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
166161|NCT00262522|528354|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
166162|NCT00262522|528355|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
166163|NCT00262522|528356|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
166164|NCT00262522|528357|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
166165|NCT00262522|528354|P4|Study Start Through 96 Weeks|Adverse Event|0
166166|NCT00262522|528355|P3|Study Start Through 96 Weeks|Adverse Event|16
166167|NCT00262522|528356|P2|Study Start Through 96 Weeks|Adverse Event|0
166168|NCT00262522|528357|P1|Study Start Through 96 Weeks|Adverse Event|20
166169|NCT00262522|528354|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
166170|NCT00262522|528355|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
166171|NCT00262522|528356|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
166172|NCT00262522|528357|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
166173|NCT00262522|528354|P4|Study Start Through 48 Weeks|Virologic failure|0
166174|NCT00262522|528355|P3|Study Start Through 48 Weeks|Virologic failure|4
166175|NCT00262522|528356|P2|Study Start Through 48 Weeks|Virologic failure|0
166176|NCT00262522|528357|P1|Study Start Through 48 Weeks|Virologic failure|2
166177|NCT00262522|528354|P4|Study Start Through 48 Weeks|Death|0
166178|NCT00262522|528355|P3|Study Start Through 48 Weeks|Death|1
166179|NCT00262522|528356|P2|Study Start Through 48 Weeks|Death|0
166180|NCT00262522|528357|P1|Study Start Through 48 Weeks|Death|2
166181|NCT00262522|528354|P4|Study Start Through 48 Weeks|Noncompliance|0
166182|NCT00262522|528355|P3|Study Start Through 48 Weeks|Noncompliance|8
166183|NCT00262522|528356|P2|Study Start Through 48 Weeks|Noncompliance|0
166184|NCT00262522|528357|P1|Study Start Through 48 Weeks|Noncompliance|3
166185|NCT00262522|528354|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
166186|NCT00262522|528355|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
166187|NCT00262522|528356|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
166188|NCT00262522|528357|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
166189|NCT00262522|528354|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
166190|NCT00262522|528355|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
166191|NCT00262522|528356|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
166192|NCT00262522|528357|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
166193|NCT00262522|528354|P4|Study Start Through 48 Weeks|Adverse Event|0
166194|NCT00262522|528355|P3|Study Start Through 48 Weeks|Adverse Event|10
166195|NCT00262522|528356|P2|Study Start Through 48 Weeks|Adverse Event|0
166196|NCT00262522|528357|P1|Study Start Through 48 Weeks|Adverse Event|16
166197|NCT00262522|528354|P4|Study Start Through 8 Weeks|Death|0
166198|NCT00262522|528355|P3|Study Start Through 8 Weeks|Death|0
166199|NCT00262522|528356|P2|Study Start Through 8 Weeks|Death|0
166200|NCT00262522|528357|P1|Study Start Through 8 Weeks|Death|1
166201|NCT00262522|528354|P4|Study Start Through 8 Weeks|Noncompliance|2
166202|NCT00262522|528355|P3|Study Start Through 8 Weeks|Noncompliance|2
166203|NCT00262522|528356|P2|Study Start Through 8 Weeks|Noncompliance|0
166204|NCT00262522|528357|P1|Study Start Through 8 Weeks|Noncompliance|0
166205|NCT00262522|528354|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
166206|NCT00262522|528355|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
166207|NCT00262522|528356|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
166208|NCT00262522|528357|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
166209|NCT00262522|528354|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
166210|NCT00262522|528355|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
166211|NCT00262522|528356|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
166212|NCT00262522|528357|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
166213|NCT00262522|528354|P4|Study Start Through 8 Weeks|Adverse Event|1
166214|NCT00262522|528355|P3|Study Start Through 8 Weeks|Adverse Event|3
166215|NCT00262522|528356|P2|Study Start Through 8 Weeks|Adverse Event|2
166216|NCT00262522|528357|P1|Study Start Through 8 Weeks|Adverse Event|1
166217|NCT00262314|528386|P1|Overall Study|Administrative withdrawal|30
166218|NCT00262314|528386|P1|Overall Study|Lost to Follow-up|70
166219|NCT00262314|528386|P1|Overall Study|Not specified|95
166220|NCT00262314|528386|P1|Overall Study|Patient's decision|92
166221|NCT00262314|528386|P1|Overall Study|Death|12
166222|NCT00262314|528386|P1|Overall Study|Changing physicians|38
166223|NCT00262301|528404|P3|Double-blind Phase|"worsening of HAE symptoms"|0
166224|NCT00262301|528405|P2|Double-blind Phase|"worsening of HAE symptoms"|1
166225|NCT00262301|528406|P1|Double-blind Phase|"worsening of HAE symptoms"|0
166226|NCT00262301|528404|P3|Double-blind Phase|Lost to Follow-up|0
166227|NCT00262301|528405|P2|Double-blind Phase|Lost to Follow-up|0
166228|NCT00262301|528406|P1|Double-blind Phase|Lost to Follow-up|1
166229|NCT00262223|528419|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
166230|NCT00262223|528420|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
166231|NCT00262223|528419|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
166232|NCT00262223|528420|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
166233|NCT00262223|528419|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
166234|NCT00262223|528420|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
166235|NCT00262223|528419|P2|Treatment Phase|Adverse Event|2
166236|NCT00262223|528420|P1|Treatment Phase|Adverse Event|1
166237|NCT00262223|528419|P2|Treatment Phase|Withdrawal by Subject|6
166238|NCT00262223|528420|P1|Treatment Phase|Withdrawal by Subject|3
166239|NCT00262119|528431|P3|Overall Study|Death|16
166240|NCT00262119|528432|P2|Overall Study|Death|19
166241|NCT00262119|528433|P1|Overall Study|Death|20
166242|NCT00262119|528431|P3|Overall Study|Lost to Follow-up|42
166243|NCT00262119|528432|P2|Overall Study|Lost to Follow-up|51
166244|NCT00262119|528433|P1|Overall Study|Lost to Follow-up|38
166245|NCT00262080|528453|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
166246|NCT00262080|528454|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
166247|NCT00262080|528455|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
166248|NCT00262080|528453|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
166249|NCT00262080|528454|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
166250|NCT00262080|528455|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
166251|NCT00262080|528453|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
166252|NCT00262080|528454|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
166253|NCT00262080|528455|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
166254|NCT00262080|528453|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
166255|NCT00262080|528454|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
166256|NCT00262080|528455|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
166257|NCT00262080|528453|P3|Repeat Dose Treatment Period|Adverse Event|0
166258|NCT00262080|528454|P2|Repeat Dose Treatment Period|Adverse Event|0
166259|NCT00262080|528455|P1|Repeat Dose Treatment Period|Adverse Event|1
166260|NCT00262080|528453|P3|Double Blind Treatment Period|Lost to Follow-up|0
166261|NCT00262080|528454|P2|Double Blind Treatment Period|Lost to Follow-up|0
166262|NCT00262080|528455|P1|Double Blind Treatment Period|Lost to Follow-up|1
166263|NCT00262067|528475|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
166264|NCT00262067|528476|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
166265|NCT00262067|528477|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
166266|NCT00262067|528478|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
166267|NCT00262067|528475|P4|Overall Study|Sponsor's Decision to Terminate Study|0
166268|NCT00262067|528476|P3|Overall Study|Sponsor's Decision to Terminate Study|0
166269|NCT00262067|528477|P2|Overall Study|Sponsor's Decision to Terminate Study|0
166270|NCT00262067|528478|P1|Overall Study|Sponsor's Decision to Terminate Study|1
166271|NCT00262067|528475|P4|Overall Study|Lost to Follow-up|5
166272|NCT00262067|528476|P3|Overall Study|Lost to Follow-up|7
166273|NCT00262067|528477|P2|Overall Study|Lost to Follow-up|4
166274|NCT00262067|528478|P1|Overall Study|Lost to Follow-up|5
166275|NCT00262067|528475|P4|Overall Study|Death|99
166276|NCT00262067|528476|P3|Overall Study|Death|186
166277|NCT00262067|528477|P2|Overall Study|Death|89
166278|NCT00262067|528478|P1|Overall Study|Death|190
166279|NCT00262041|528512|P3|Overall Study|Unable to classify|0
166280|NCT00262041|528513|P2|Overall Study|Unable to classify|0
166281|NCT00262041|528514|P1|Overall Study|Unable to classify|1
166282|NCT00262041|528512|P3|Overall Study|Lost to Follow-up|5
166283|NCT00262041|528513|P2|Overall Study|Lost to Follow-up|1
166284|NCT00262041|528514|P1|Overall Study|Lost to Follow-up|1
166285|NCT00262041|528512|P3|Overall Study|Withdrawal by Subject|1
166286|NCT00262041|528513|P2|Overall Study|Withdrawal by Subject|3
166287|NCT00262041|528514|P1|Overall Study|Withdrawal by Subject|0
166288|NCT00262028|528543|P9|Overall Study|Unable to classify|1
166289|NCT00262028|528544|P8|Overall Study|Unable to classify|0
166290|NCT00262028|528545|P7|Overall Study|Unable to classify|0
166291|NCT00262028|528546|P6|Overall Study|Unable to classify|0
166292|NCT00262028|528547|P5|Overall Study|Unable to classify|0
166293|NCT00262028|528548|P4|Overall Study|Unable to classify|0
166294|NCT00262028|528549|P3|Overall Study|Unable to classify|0
166295|NCT00262028|528550|P2|Overall Study|Unable to classify|3
166296|NCT00262028|528551|P1|Overall Study|Unable to classify|0
166297|NCT00262028|528543|P9|Overall Study|Protocol Violation|0
166298|NCT00262028|528544|P8|Overall Study|Protocol Violation|0
166299|NCT00262028|528545|P7|Overall Study|Protocol Violation|0
166300|NCT00262028|528546|P6|Overall Study|Protocol Violation|0
166301|NCT00262028|528547|P5|Overall Study|Protocol Violation|0
166302|NCT00262028|528548|P4|Overall Study|Protocol Violation|1
166303|NCT00262028|528549|P3|Overall Study|Protocol Violation|0
166304|NCT00262028|528550|P2|Overall Study|Protocol Violation|0
166305|NCT00262028|528551|P1|Overall Study|Protocol Violation|0
166306|NCT00262028|528543|P9|Overall Study|Administrative Reason|10
166307|NCT00262028|528544|P8|Overall Study|Administrative Reason|6
166308|NCT00262028|528545|P7|Overall Study|Administrative Reason|4
166309|NCT00262028|528546|P6|Overall Study|Administrative Reason|7
166310|NCT00262028|528547|P5|Overall Study|Administrative Reason|6
166311|NCT00262028|528548|P4|Overall Study|Administrative Reason|12
166312|NCT00262028|528549|P3|Overall Study|Administrative Reason|9
166313|NCT00262028|528550|P2|Overall Study|Administrative Reason|14
166314|NCT00262028|528551|P1|Overall Study|Administrative Reason|11
166315|NCT00262028|528543|P9|Overall Study|Lost to Follow-up|6
166316|NCT00262028|528544|P8|Overall Study|Lost to Follow-up|5
166317|NCT00262028|528545|P7|Overall Study|Lost to Follow-up|3
166318|NCT00262028|528546|P6|Overall Study|Lost to Follow-up|3
166319|NCT00262028|528547|P5|Overall Study|Lost to Follow-up|4
166320|NCT00262028|528548|P4|Overall Study|Lost to Follow-up|5
166321|NCT00262028|528549|P3|Overall Study|Lost to Follow-up|5
166322|NCT00262028|528550|P2|Overall Study|Lost to Follow-up|7
166323|NCT00262028|528551|P1|Overall Study|Lost to Follow-up|7
166324|NCT00262028|528543|P9|Overall Study|Withdrawal by Subject|2
166325|NCT00262028|528544|P8|Overall Study|Withdrawal by Subject|7
166326|NCT00262028|528545|P7|Overall Study|Withdrawal by Subject|5
166327|NCT00262028|528546|P6|Overall Study|Withdrawal by Subject|3
166328|NCT00262028|528547|P5|Overall Study|Withdrawal by Subject|2
166329|NCT00262028|528548|P4|Overall Study|Withdrawal by Subject|5
166330|NCT00262028|528549|P3|Overall Study|Withdrawal by Subject|6
166331|NCT00262028|528550|P2|Overall Study|Withdrawal by Subject|3
166332|NCT00262028|528551|P1|Overall Study|Withdrawal by Subject|6
166333|NCT00262002|528613|P7|Overall Study|Unable to classify|2
166334|NCT00262002|528614|P6|Overall Study|Unable to classify|0
166335|NCT00262002|528615|P5|Overall Study|Unable to classify|0
166336|NCT00262002|528616|P4|Overall Study|Unable to classify|0
166337|NCT00262002|528617|P3|Overall Study|Unable to classify|0
166338|NCT00262002|528618|P2|Overall Study|Unable to classify|0
166339|NCT00262002|528619|P1|Overall Study|Unable to classify|0
166340|NCT00262002|528613|P7|Overall Study|Protocol Violation|2
166341|NCT00262002|528614|P6|Overall Study|Protocol Violation|3
166342|NCT00262002|528615|P5|Overall Study|Protocol Violation|5
166343|NCT00262002|528616|P4|Overall Study|Protocol Violation|2
166344|NCT00262002|528617|P3|Overall Study|Protocol Violation|0
166345|NCT00262002|528618|P2|Overall Study|Protocol Violation|2
166346|NCT00262002|528619|P1|Overall Study|Protocol Violation|3
166347|NCT00262002|528613|P7|Overall Study|Inapropriate enrollment|0
166348|NCT00262002|528614|P6|Overall Study|Inapropriate enrollment|0
166349|NCT00262002|528615|P5|Overall Study|Inapropriate enrollment|0
166350|NCT00262002|528616|P4|Overall Study|Inapropriate enrollment|0
166351|NCT00262002|528617|P3|Overall Study|Inapropriate enrollment|0
166352|NCT00262002|528618|P2|Overall Study|Inapropriate enrollment|1
166353|NCT00262002|528619|P1|Overall Study|Inapropriate enrollment|0
166354|NCT00262002|528613|P7|Overall Study|Lost to Follow-up|0
166355|NCT00262002|528614|P6|Overall Study|Lost to Follow-up|1
166356|NCT00262002|528615|P5|Overall Study|Lost to Follow-up|0
166357|NCT00262002|528616|P4|Overall Study|Lost to Follow-up|2
166358|NCT00262002|528617|P3|Overall Study|Lost to Follow-up|0
166359|NCT00262002|528618|P2|Overall Study|Lost to Follow-up|0
166360|NCT00262002|528619|P1|Overall Study|Lost to Follow-up|2
166361|NCT00262002|528613|P7|Overall Study|Withdrawal by Subject|2
166362|NCT00262002|528614|P6|Overall Study|Withdrawal by Subject|2
166363|NCT00262002|528615|P5|Overall Study|Withdrawal by Subject|2
166364|NCT00262002|528616|P4|Overall Study|Withdrawal by Subject|1
166365|NCT00262002|528617|P3|Overall Study|Withdrawal by Subject|0
166366|NCT00262002|528618|P2|Overall Study|Withdrawal by Subject|2
166367|NCT00262002|528619|P1|Overall Study|Withdrawal by Subject|4
166368|NCT00262002|528613|P7|Overall Study|Adverse Event|0
166369|NCT00262002|528614|P6|Overall Study|Adverse Event|1
166370|NCT00262002|528615|P5|Overall Study|Adverse Event|0
166371|NCT00262002|528616|P4|Overall Study|Adverse Event|0
166372|NCT00262002|528617|P3|Overall Study|Adverse Event|0
166373|NCT00262002|528618|P2|Overall Study|Adverse Event|1
166374|NCT00262002|528619|P1|Overall Study|Adverse Event|2
166375|NCT00261950|528712|P1|Overall Study|Protocol specified Criteria|11
166376|NCT00261950|528712|P1|Overall Study|Physician Decision|1
166377|NCT00261950|528712|P1|Overall Study|not specified|1
166378|NCT00261950|528712|P1|Overall Study|Withdrawal by Subject|5
166379|NCT00261950|528712|P1|Overall Study|Death|6
166380|NCT00261950|528712|P1|Overall Study|Lost to Follow-up|2
166381|NCT00261846|528739|P14|Part 2: Efficacy|Randomized, not treated|0
166382|NCT00261846|528740|P13|Part 2: Efficacy|Randomized, not treated|0
166383|NCT00261846|528741|P12|Part 2: Efficacy|Randomized, not treated|0
166384|NCT00261846|528742|P11|Part 2: Efficacy|Randomized, not treated|0
166385|NCT00261846|528743|P10|Part 2: Efficacy|Randomized, not treated|1
166386|NCT00261846|528744|P9|Part 2: Efficacy|Randomized, not treated|0
166387|NCT00261846|528745|P8|Part 2: Efficacy|Randomized, not treated|0
166388|NCT00261846|528746|P7|Part 2: Efficacy|Randomized, not treated|0
166389|NCT00261846|528747|P6|Part 2: Efficacy|Randomized, not treated|0
166390|NCT00261846|528748|P5|Part 2: Efficacy|Randomized, not treated|0
166391|NCT00261846|528749|P4|Part 2: Efficacy|Randomized, not treated|0
166392|NCT00261846|528750|P3|Part 2: Efficacy|Randomized, not treated|0
166393|NCT00261846|528751|P2|Part 2: Efficacy|Randomized, not treated|0
166394|NCT00261846|528752|P1|Part 2: Efficacy|Randomized, not treated|0
166395|NCT00261846|528739|P14|Part 2: Efficacy|Unspecified|0
166396|NCT00261846|528740|P13|Part 2: Efficacy|Unspecified|0
166397|NCT00261846|528741|P12|Part 2: Efficacy|Unspecified|1
166398|NCT00261846|528742|P11|Part 2: Efficacy|Unspecified|0
166399|NCT00261846|528743|P10|Part 2: Efficacy|Unspecified|1
166400|NCT00261846|528744|P9|Part 2: Efficacy|Unspecified|0
166401|NCT00261846|528745|P8|Part 2: Efficacy|Unspecified|0
166402|NCT00261846|528746|P7|Part 2: Efficacy|Unspecified|2
166403|NCT00261846|528747|P6|Part 2: Efficacy|Unspecified|1
166404|NCT00261846|528748|P5|Part 2: Efficacy|Unspecified|1
166405|NCT00261846|528749|P4|Part 2: Efficacy|Unspecified|1
166406|NCT00261846|528750|P3|Part 2: Efficacy|Unspecified|0
166407|NCT00261846|528751|P2|Part 2: Efficacy|Unspecified|0
166408|NCT00261846|528752|P1|Part 2: Efficacy|Unspecified|0
166409|NCT00261846|528739|P14|Part 2: Efficacy|Withdrawal by Subject|0
166410|NCT00261846|528740|P13|Part 2: Efficacy|Withdrawal by Subject|0
166411|NCT00261846|528741|P12|Part 2: Efficacy|Withdrawal by Subject|0
166412|NCT00261846|528742|P11|Part 2: Efficacy|Withdrawal by Subject|1
166413|NCT00261846|528743|P10|Part 2: Efficacy|Withdrawal by Subject|1
166414|NCT00261846|528744|P9|Part 2: Efficacy|Withdrawal by Subject|0
166415|NCT00261846|528745|P8|Part 2: Efficacy|Withdrawal by Subject|0
166416|NCT00261846|528746|P7|Part 2: Efficacy|Withdrawal by Subject|2
166417|NCT00261846|528747|P6|Part 2: Efficacy|Withdrawal by Subject|3
166418|NCT00261846|528748|P5|Part 2: Efficacy|Withdrawal by Subject|3
166419|NCT00261846|528749|P4|Part 2: Efficacy|Withdrawal by Subject|7
166420|NCT00261846|528750|P3|Part 2: Efficacy|Withdrawal by Subject|0
166421|NCT00261846|528751|P2|Part 2: Efficacy|Withdrawal by Subject|0
166422|NCT00261846|528752|P1|Part 2: Efficacy|Withdrawal by Subject|0
166423|NCT00261846|528739|P14|Part 2: Efficacy|Lost to Follow-up|0
166424|NCT00261846|528740|P13|Part 2: Efficacy|Lost to Follow-up|1
166425|NCT00261846|528741|P12|Part 2: Efficacy|Lost to Follow-up|1
166426|NCT00261846|528742|P11|Part 2: Efficacy|Lost to Follow-up|1
166427|NCT00261846|528743|P10|Part 2: Efficacy|Lost to Follow-up|3
166428|NCT00261846|528744|P9|Part 2: Efficacy|Lost to Follow-up|0
166429|NCT00261846|528745|P8|Part 2: Efficacy|Lost to Follow-up|1
166430|NCT00261846|528746|P7|Part 2: Efficacy|Lost to Follow-up|0
166431|NCT00261846|528747|P6|Part 2: Efficacy|Lost to Follow-up|4
166432|NCT00261846|528748|P5|Part 2: Efficacy|Lost to Follow-up|3
166433|NCT00261846|528749|P4|Part 2: Efficacy|Lost to Follow-up|7
166434|NCT00261846|528750|P3|Part 2: Efficacy|Lost to Follow-up|0
166435|NCT00261846|528751|P2|Part 2: Efficacy|Lost to Follow-up|0
166436|NCT00261846|528752|P1|Part 2: Efficacy|Lost to Follow-up|0
166437|NCT00261846|528739|P14|Part 2: Efficacy|Death|22
166438|NCT00261846|528740|P13|Part 2: Efficacy|Death|23
166439|NCT00261846|528741|P12|Part 2: Efficacy|Death|19
166440|NCT00261846|528742|P11|Part 2: Efficacy|Death|15
166441|NCT00261846|528743|P10|Part 2: Efficacy|Death|14
166442|NCT00261846|528744|P9|Part 2: Efficacy|Death|1
166443|NCT00261846|528745|P8|Part 2: Efficacy|Death|4
166444|NCT00261846|528746|P7|Part 2: Efficacy|Death|7
166445|NCT00261846|528747|P6|Part 2: Efficacy|Death|10
166446|NCT00261846|528748|P5|Part 2: Efficacy|Death|4
166447|NCT00261846|528749|P4|Part 2: Efficacy|Death|28
166448|NCT00261846|528750|P3|Part 2: Efficacy|Death|0
166449|NCT00261846|528751|P2|Part 2: Efficacy|Death|0
166450|NCT00261846|528752|P1|Part 2: Efficacy|Death|0
166451|NCT00261846|528739|P14|Part 2: Efficacy|Active on long term follow-up|0
166452|NCT00261846|528740|P13|Part 2: Efficacy|Active on long term follow-up|0
166453|NCT00261846|528741|P12|Part 2: Efficacy|Active on long term follow-up|4
166454|NCT00261846|528742|P11|Part 2: Efficacy|Active on long term follow-up|3
166455|NCT00261846|528743|P10|Part 2: Efficacy|Active on long term follow-up|12
166456|NCT00261846|528744|P9|Part 2: Efficacy|Active on long term follow-up|0
166457|NCT00261846|528745|P8|Part 2: Efficacy|Active on long term follow-up|10
166458|NCT00261846|528746|P7|Part 2: Efficacy|Active on long term follow-up|6
166459|NCT00261846|528747|P6|Part 2: Efficacy|Active on long term follow-up|9
166460|NCT00261846|528748|P5|Part 2: Efficacy|Active on long term follow-up|12
166461|NCT00261846|528749|P4|Part 2: Efficacy|Active on long term follow-up|27
166462|NCT00261846|528750|P3|Part 2: Efficacy|Active on long term follow-up|0
166463|NCT00261846|528751|P2|Part 2: Efficacy|Active on long term follow-up|0
166464|NCT00261846|528752|P1|Part 2: Efficacy|Active on long term follow-up|0
166465|NCT00261846|528739|P14|Part 2: Efficacy|Active on treatment|1
166466|NCT00261846|528740|P13|Part 2: Efficacy|Active on treatment|2
166467|NCT00261846|528741|P12|Part 2: Efficacy|Active on treatment|1
166468|NCT00261846|528742|P11|Part 2: Efficacy|Active on treatment|5
166469|NCT00261846|528743|P10|Part 2: Efficacy|Active on treatment|10
166470|NCT00261846|528744|P9|Part 2: Efficacy|Active on treatment|1
166471|NCT00261846|528745|P8|Part 2: Efficacy|Active on treatment|11
166472|NCT00261846|528746|P7|Part 2: Efficacy|Active on treatment|16
166473|NCT00261846|528747|P6|Part 2: Efficacy|Active on treatment|6
166474|NCT00261846|528748|P5|Part 2: Efficacy|Active on treatment|37
166475|NCT00261846|528749|P4|Part 2: Efficacy|Active on treatment|92
166476|NCT00261846|528750|P3|Part 2: Efficacy|Active on treatment|0
166477|NCT00261846|528751|P2|Part 2: Efficacy|Active on treatment|0
166478|NCT00261846|528752|P1|Part 2: Efficacy|Active on treatment|0
166479|NCT00261846|528739|P14|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
166480|NCT00261846|528740|P13|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
166481|NCT00261846|528741|P12|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
166482|NCT00261846|528742|P11|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
166483|NCT00261846|528743|P10|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
166484|NCT00261846|528744|P9|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
166485|NCT00261846|528745|P8|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
166486|NCT00261846|528746|P7|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
166487|NCT00261846|528747|P6|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
166488|NCT00261846|528748|P5|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
166489|NCT00261846|528749|P4|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|0
166490|NCT00261846|528750|P3|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|12
166491|NCT00261846|528751|P2|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|3
166492|NCT00261846|528752|P1|Part 1: Dose-escalation Phase|Continued in to Part 2: Efficacy|3
166493|NCT00261833|528968|P2|Overall Study|Not interested in being participant|1
166494|NCT00261833|528969|P1|Overall Study|Not interested in being participant|0
166495|NCT00261833|528968|P2|Overall Study|Missing reason|0
166496|NCT00261833|528969|P1|Overall Study|Missing reason|1
166497|NCT00261833|528968|P2|Overall Study|Lung transplantation|1
166498|NCT00261833|528969|P1|Overall Study|Lung transplantation|1
166499|NCT00261833|528968|P2|Overall Study|Suspicion of pulmonary cancer|1
166500|NCT00261833|528969|P1|Overall Study|Suspicion of pulmonary cancer|0
166501|NCT00261833|528968|P2|Overall Study|Protocol Violation|1
166502|NCT00261833|528969|P1|Overall Study|Protocol Violation|0
166503|NCT00261833|528968|P2|Overall Study|Withdrawal by Subject|7
166504|NCT00261833|528969|P1|Overall Study|Withdrawal by Subject|5
166505|NCT00261833|528968|P2|Overall Study|Adverse Event|4
166506|NCT00261833|528969|P1|Overall Study|Adverse Event|1
166507|NCT00261833|528968|P2|Overall Study|Death|3
166508|NCT00261833|528969|P1|Overall Study|Death|1
166509|NCT00261716|529003|P2|Overall Study|Lost to Follow-up|2
166510|NCT00261716|529004|P1|Overall Study|Lost to Follow-up|0
166511|NCT00261716|529003|P2|Overall Study|Withdrawal by Subject|8
166512|NCT00261716|529004|P1|Overall Study|Withdrawal by Subject|6
166513|NCT00261495|529024|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
166514|NCT00261495|529025|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
166515|NCT00261495|529024|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
166516|NCT00261495|529025|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
166517|NCT00261495|529024|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
166518|NCT00261495|529025|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
166519|NCT00261495|529024|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
166520|NCT00261495|529025|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
166521|NCT00261495|529024|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
166522|NCT00261495|529025|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
166523|NCT00261495|529024|P2|Extension Phase (Weeks 24 to 52)|Other|2
166524|NCT00261495|529025|P1|Extension Phase (Weeks 24 to 52)|Other|4
166525|NCT00261495|529024|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
166526|NCT00261495|529025|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
166527|NCT00261495|529024|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
166528|NCT00261495|529025|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
166529|NCT00261495|529024|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
166530|NCT00261495|529025|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
166531|NCT00261495|529024|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
166532|NCT00261495|529025|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
166533|NCT00261495|529024|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
166534|NCT00261495|529025|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
166535|NCT00261495|529024|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
166536|NCT00261495|529025|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
166537|NCT00261495|529024|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
166538|NCT00261495|529025|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
166539|NCT00261495|529024|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
166540|NCT00261495|529025|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
166541|NCT00261495|529024|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
166542|NCT00261495|529025|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
166543|NCT00261495|529024|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
166544|NCT00261495|529025|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
166545|NCT00261495|529024|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
166546|NCT00261495|529025|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
166547|NCT00261495|529024|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
166548|NCT00261495|529025|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
166549|NCT00261495|529024|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
166550|NCT00261495|529025|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
166551|NCT00261495|529024|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
166552|NCT00261495|529025|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
166553|NCT00261495|529024|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
166554|NCT00261495|529025|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
166555|NCT00261443|529189|P3|4: Extension Phase|Lost to Follow-up|0
166556|NCT00261443|529190|P2|4: Extension Phase|Lost to Follow-up|1
166557|NCT00261443|529191|P1|4: Extension Phase|Lost to Follow-up|0
166558|NCT00261443|529189|P3|4: Extension Phase|Withdrawal by Subject|2
166559|NCT00261443|529190|P2|4: Extension Phase|Withdrawal by Subject|1
166560|NCT00261443|529191|P1|4: Extension Phase|Withdrawal by Subject|0
166561|NCT00261443|529189|P3|4: Extension Phase|Adverse Event|0
166562|NCT00261443|529190|P2|4: Extension Phase|Adverse Event|1
166563|NCT00261443|529191|P1|4: Extension Phase|Adverse Event|0
166564|NCT00261443|529189|P3|3: Assessment of Relapse|Other Reasons|3
166565|NCT00261443|529190|P2|3: Assessment of Relapse|Other Reasons|4
166566|NCT00261443|529191|P1|3: Assessment of Relapse|Other Reasons|0
166567|NCT00261443|529189|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
166568|NCT00261443|529190|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
166569|NCT00261443|529191|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
166570|NCT00261443|529189|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
166571|NCT00261443|529190|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
166572|NCT00261443|529191|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
166573|NCT00261443|529189|P3|3: Assessment of Relapse|Pregnancy|1
166574|NCT00261443|529190|P2|3: Assessment of Relapse|Pregnancy|2
166575|NCT00261443|529191|P1|3: Assessment of Relapse|Pregnancy|0
166576|NCT00261443|529189|P3|3: Assessment of Relapse|Poor/Noncompliance|3
166577|NCT00261443|529190|P2|3: Assessment of Relapse|Poor/Noncompliance|5
166578|NCT00261443|529191|P1|3: Assessment of Relapse|Poor/Noncompliance|0
166579|NCT00261443|529189|P3|3: Assessment of Relapse|Lost to Follow-up|6
166580|NCT00261443|529190|P2|3: Assessment of Relapse|Lost to Follow-up|7
166581|NCT00261443|529191|P1|3: Assessment of Relapse|Lost to Follow-up|0
166582|NCT00261443|529189|P3|3: Assessment of Relapse|Death|1
166583|NCT00261443|529190|P2|3: Assessment of Relapse|Death|0
166584|NCT00261443|529191|P1|3: Assessment of Relapse|Death|0
166585|NCT00261443|529189|P3|3: Assessment of Relapse|Withdrawal by Subject|15
166586|NCT00261443|529190|P2|3: Assessment of Relapse|Withdrawal by Subject|14
166587|NCT00261443|529191|P1|3: Assessment of Relapse|Withdrawal by Subject|0
166588|NCT00261443|529189|P3|3: Assessment of Relapse|Adverse Event|19
166589|NCT00261443|529190|P2|3: Assessment of Relapse|Adverse Event|15
166590|NCT00261443|529191|P1|3: Assessment of Relapse|Adverse Event|0
166591|NCT00261443|529189|P3|3: Assessment of Relapse|Lack of Efficacy|14
166592|NCT00261443|529190|P2|3: Assessment of Relapse|Lack of Efficacy|31
166593|NCT00261443|529191|P1|3: Assessment of Relapse|Lack of Efficacy|0
166594|NCT00261443|529189|P3|2: Stability & Maintenance of Stability|Other Reasons|0
166595|NCT00261443|529190|P2|2: Stability & Maintenance of Stability|Other Reasons|0
166596|NCT00261443|529191|P1|2: Stability & Maintenance of Stability|Other Reasons|13
166597|NCT00261443|529189|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
166598|NCT00261443|529190|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
166599|NCT00261443|529191|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
166600|NCT00261443|529189|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
166601|NCT00261443|529190|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
166602|NCT00261443|529191|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
166603|NCT00261443|529189|P3|2: Stability & Maintenance of Stability|Pregnancy|0
166604|NCT00261443|529190|P2|2: Stability & Maintenance of Stability|Pregnancy|0
166605|NCT00261443|529191|P1|2: Stability & Maintenance of Stability|Pregnancy|1
166606|NCT00261443|529189|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
166607|NCT00261443|529190|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
166608|NCT00261443|529191|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
166609|NCT00261443|529189|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
166610|NCT00261443|529190|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
166611|NCT00261443|529191|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
166612|NCT00261443|529189|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
166613|NCT00261443|529190|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
166614|NCT00261443|529191|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
166615|NCT00261443|529189|P3|2: Stability & Maintenance of Stability|Adverse Event|0
166616|NCT00261443|529190|P2|2: Stability & Maintenance of Stability|Adverse Event|0
166617|NCT00261443|529191|P1|2: Stability & Maintenance of Stability|Adverse Event|93
166618|NCT00261443|529189|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
166619|NCT00261443|529190|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
166620|NCT00261443|529191|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
166621|NCT00261443|529189|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
166622|NCT00261443|529190|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
166623|NCT00261443|529191|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
166624|NCT00261443|529189|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
166625|NCT00261443|529190|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
166626|NCT00261443|529191|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
166627|NCT00261443|529189|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
166628|NCT00261443|529190|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
166629|NCT00261443|529191|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
166630|NCT00261443|529189|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
166631|NCT00261443|529190|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
166632|NCT00261443|529191|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
166633|NCT00261443|529189|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
166634|NCT00261443|529190|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
166635|NCT00261443|529191|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
166636|NCT00261443|529189|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
166637|NCT00261443|529190|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
166638|NCT00261443|529191|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
166639|NCT00261443|529189|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
166640|NCT00261443|529190|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
166641|NCT00261443|529191|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
166642|NCT00260832|529448|P2|Overall Study|Protocol Violation|1
166643|NCT00260832|529449|P1|Overall Study|Protocol Violation|3
166644|NCT00260832|529448|P2|Overall Study|Not Specified|7
166645|NCT00260832|529449|P1|Overall Study|Not Specified|10
166646|NCT00260832|529448|P2|Overall Study|Death|62
166647|NCT00260832|529449|P1|Overall Study|Death|43
166648|NCT00260832|529448|P2|Overall Study|Physician Decision|9
166649|NCT00260832|529449|P1|Overall Study|Physician Decision|15
166650|NCT00260832|529448|P2|Overall Study|Withdrawal by Subject|17
166651|NCT00260832|529449|P1|Overall Study|Withdrawal by Subject|15
166652|NCT00260832|529448|P2|Overall Study|Progression|96
166653|NCT00260832|529449|P1|Overall Study|Progression|116
166654|NCT00260832|529448|P2|Overall Study|Adverse Event|19
166655|NCT00260832|529449|P1|Overall Study|Adverse Event|26
166656|NCT00260533|529457|P2|Overall Study|Not Known|3
166657|NCT00260533|529458|P1|Overall Study|Not Known|3
166658|NCT00260429|529466|P2|Overall Study|scheduled hand surgery|0
166659|NCT00260429|529467|P1|Overall Study|scheduled hand surgery|1
166660|NCT00260429|529466|P2|Overall Study|failure to follow appointments|0
166661|NCT00260429|529467|P1|Overall Study|failure to follow appointments|1
166662|NCT00260208|529475|P2|Overall Study|Missing|16
166663|NCT00260208|529476|P1|Overall Study|Missing|18
166664|NCT00260208|529475|P2|Overall Study|Death|10
166665|NCT00260208|529476|P1|Overall Study|Death|12
166666|NCT00260208|529475|P2|Overall Study|Lost to Follow-up|1
166667|NCT00260208|529476|P1|Overall Study|Lost to Follow-up|6
166668|NCT00260208|529475|P2|Overall Study|Subject withdrew consent|7
166669|NCT00260208|529476|P1|Overall Study|Subject withdrew consent|11
166670|NCT00260065|529519|P1|Overall Study|Medication Noncompliance|1
166671|NCT00260065|529519|P1|Overall Study|Not otherwise specified|8
166672|NCT00260065|529519|P1|Overall Study|Physician Decision|19
166673|NCT00260065|529519|P1|Overall Study|Withdrawal by Subject|13
166674|NCT00260065|529519|P1|Overall Study|Death|13
166675|NCT00260065|529519|P1|Overall Study|Adverse Event|17
166676|NCT00260065|529519|P1|Overall Study|Progressive Disease|22
166677|NCT00259857|529526|P2|24 Months Treatment|Lost to Follow-up|3
166678|NCT00259857|529527|P1|24 Months Treatment|Lost to Follow-up|0
166679|NCT00259857|529526|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
166680|NCT00259857|529527|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
166681|NCT00259740|529545|P2|Overall Study|Requirement for alternative therapy|4
166682|NCT00259740|529546|P1|Overall Study|Requirement for alternative therapy|0
166683|NCT00259740|529545|P2|Overall Study|Other|0
166684|NCT00259740|529546|P1|Overall Study|Other|3
166685|NCT00259740|529545|P2|Overall Study|Ongoing|3
166686|NCT00259740|529546|P1|Overall Study|Ongoing|17
166687|NCT00259740|529545|P2|Overall Study|Disease progression|36
166688|NCT00259740|529546|P1|Overall Study|Disease progression|19
166689|NCT00259740|529545|P2|Overall Study|Death|1
166690|NCT00259740|529546|P1|Overall Study|Death|1
166691|NCT00259740|529545|P2|Overall Study|Withdrawal by Subject|6
166692|NCT00259740|529546|P1|Overall Study|Withdrawal by Subject|2
166693|NCT00259740|529545|P2|Overall Study|Adverse Event|2
166694|NCT00259740|529546|P1|Overall Study|Adverse Event|0
166695|NCT00259740|529545|P2|Overall Study|Physician Decision|1
166696|NCT00259740|529546|P1|Overall Study|Physician Decision|1
166697|NCT00259649|529556|P1|Overall Study|irregular menses|3
166698|NCT00259649|529556|P1|Overall Study|Lost to Follow-up|7
166699|NCT00259610|529564|P4|Overall Study|Serious Adverse Event|2
166700|NCT00259610|529565|P3|Overall Study|Serious Adverse Event|2
166701|NCT00259610|529566|P2|Overall Study|Serious Adverse Event|2
166702|NCT00259610|529567|P1|Overall Study|Serious Adverse Event|8
166703|NCT00259610|529564|P4|Overall Study|Adverse Event|2
166704|NCT00259610|529565|P3|Overall Study|Adverse Event|5
166705|NCT00259610|529566|P2|Overall Study|Adverse Event|4
166706|NCT00259610|529567|P1|Overall Study|Adverse Event|3
166707|NCT00259610|529564|P4|Overall Study|non medical reason|3
166708|NCT00259610|529565|P3|Overall Study|non medical reason|10
166709|NCT00259610|529566|P2|Overall Study|non medical reason|2
166710|NCT00259610|529567|P1|Overall Study|non medical reason|6
166711|NCT00259610|529564|P4|Overall Study|Death|0
166712|NCT00259610|529565|P3|Overall Study|Death|2
166713|NCT00259610|529566|P2|Overall Study|Death|1
166714|NCT00259610|529567|P1|Overall Study|Death|1
166715|NCT00259610|529564|P4|Overall Study|Physician Decision|2
166716|NCT00259610|529565|P3|Overall Study|Physician Decision|7
166717|NCT00259610|529566|P2|Overall Study|Physician Decision|4
166718|NCT00259610|529567|P1|Overall Study|Physician Decision|6
166719|NCT00259610|529564|P4|Overall Study|Lost to Follow-up|15
166720|NCT00259610|529565|P3|Overall Study|Lost to Follow-up|18
166721|NCT00259610|529566|P2|Overall Study|Lost to Follow-up|8
166722|NCT00259610|529567|P1|Overall Study|Lost to Follow-up|19
166723|NCT00259610|529564|P4|Overall Study|Withdrawal by Subject|19
166724|NCT00259610|529565|P3|Overall Study|Withdrawal by Subject|29
166725|NCT00259610|529566|P2|Overall Study|Withdrawal by Subject|25
166726|NCT00259610|529567|P1|Overall Study|Withdrawal by Subject|33
166727|NCT00259298|529581|P1|Overall Study|Physician Decision|2
166728|NCT00259298|529581|P1|Overall Study|Withdrawal by Subject|1
166729|NCT00259272|529599|P4|Overall Study|Lost to Follow-up|1
166730|NCT00259272|529600|P3|Overall Study|Lost to Follow-up|0
166731|NCT00259272|529601|P2|Overall Study|Lost to Follow-up|0
166732|NCT00259272|529602|P1|Overall Study|Lost to Follow-up|1
166733|NCT00259272|529599|P4|Overall Study|Withdrawal by Subject|7
166734|NCT00259272|529600|P3|Overall Study|Withdrawal by Subject|2
166735|NCT00259272|529601|P2|Overall Study|Withdrawal by Subject|2
166736|NCT00259272|529602|P1|Overall Study|Withdrawal by Subject|4
166737|NCT00259272|529599|P4|Overall Study|Sponsor Decision|0
166738|NCT00259272|529600|P3|Overall Study|Sponsor Decision|0
166739|NCT00259272|529601|P2|Overall Study|Sponsor Decision|1
166740|NCT00259272|529602|P1|Overall Study|Sponsor Decision|0
166741|NCT00259272|529599|P4|Overall Study|Protocol Violation|1
166742|NCT00259272|529600|P3|Overall Study|Protocol Violation|0
166743|NCT00259272|529601|P2|Overall Study|Protocol Violation|0
166744|NCT00259272|529602|P1|Overall Study|Protocol Violation|2
166745|NCT00259272|529599|P4|Overall Study|Physician Decision|3
166746|NCT00259272|529600|P3|Overall Study|Physician Decision|1
166747|NCT00259272|529601|P2|Overall Study|Physician Decision|2
166748|NCT00259272|529602|P1|Overall Study|Physician Decision|1
166749|NCT00259272|529599|P4|Overall Study|Lack of Efficacy|6
166750|NCT00259272|529600|P3|Overall Study|Lack of Efficacy|2
166751|NCT00259272|529601|P2|Overall Study|Lack of Efficacy|1
166752|NCT00259272|529602|P1|Overall Study|Lack of Efficacy|5
166753|NCT00259272|529599|P4|Overall Study|Adverse Event|3
166754|NCT00259272|529600|P3|Overall Study|Adverse Event|0
166755|NCT00259272|529601|P2|Overall Study|Adverse Event|1
166756|NCT00259272|529602|P1|Overall Study|Adverse Event|2
166757|NCT00259012|529698|P2|Overall Study|Protocol Violation|1
166758|NCT00259012|529699|P1|Overall Study|Protocol Violation|1
166759|NCT00259012|529698|P2|Overall Study|Lost to Follow-up|1
166760|NCT00259012|529699|P1|Overall Study|Lost to Follow-up|0
166761|NCT00259012|529698|P2|Overall Study|Physician Decision|1
166762|NCT00259012|529699|P1|Overall Study|Physician Decision|0
166763|NCT00259012|529698|P2|Overall Study|Withdrawal by Subject|0
166764|NCT00259012|529699|P1|Overall Study|Withdrawal by Subject|1
166765|NCT00259012|529698|P2|Overall Study|Adverse Event|1
166766|NCT00259012|529699|P1|Overall Study|Adverse Event|0
166767|NCT00258895|529739|P2|Overall Study|Withdrawal by Subject|0
166768|NCT00258895|529740|P1|Overall Study|Withdrawal by Subject|1
166769|NCT00258895|529739|P2|Overall Study|Protocol Violation|2
166770|NCT00258895|529740|P1|Overall Study|Protocol Violation|6
166771|NCT00258895|529739|P2|Overall Study|Lost to Follow-up|1
166772|NCT00258895|529740|P1|Overall Study|Lost to Follow-up|3
166773|NCT00258856|529776|P4|Overall Study|Non-compliance|1
166774|NCT00258856|529777|P3|Overall Study|Non-compliance|0
166775|NCT00258856|529778|P2|Overall Study|Non-compliance|0
166776|NCT00258856|529779|P1|Overall Study|Non-compliance|2
166777|NCT00258856|529776|P4|Overall Study|Lost to Follow-up|0
166778|NCT00258856|529777|P3|Overall Study|Lost to Follow-up|2
166779|NCT00258856|529778|P2|Overall Study|Lost to Follow-up|0
166780|NCT00258856|529779|P1|Overall Study|Lost to Follow-up|1
166781|NCT00258674|529820|P3|Overall Study|Death|34
166782|NCT00258674|529821|P2|Overall Study|Death|53
166783|NCT00258674|529822|P1|Overall Study|Death|32
166784|NCT00258440|529881|P3|Overall Study|Withdrawal by Subject|1
166785|NCT00258440|529882|P2|Overall Study|Withdrawal by Subject|0
166786|NCT00258440|529883|P1|Overall Study|Withdrawal by Subject|0
166787|NCT00258154|529916|P2|Overall Study|Patient Moved|1
166788|NCT00258154|529917|P1|Overall Study|Patient Moved|3
166789|NCT00258154|529916|P2|Overall Study|Withdrawal by Subject|4
166790|NCT00258154|529917|P1|Overall Study|Withdrawal by Subject|3
166791|NCT00258154|529916|P2|Overall Study|Protocol Violation|1
166792|NCT00258154|529917|P1|Overall Study|Protocol Violation|2
166793|NCT00258154|529916|P2|Overall Study|Lost to Follow-up|1
166794|NCT00258154|529917|P1|Overall Study|Lost to Follow-up|0
166795|NCT00258154|529916|P2|Overall Study|Adverse Event|0
166796|NCT00258154|529917|P1|Overall Study|Adverse Event|1
166797|NCT00257920|530001|P2|Period: Second Intervention|Other|1
166798|NCT00257920|530002|P1|Period: Second Intervention|Other|2
166799|NCT00257920|530001|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
166800|NCT00257920|530002|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
166801|NCT00257660|530058|P2|Overall Study|No longer wanted to do blood draws|0
166802|NCT00257660|530059|P1|Overall Study|No longer wanted to do blood draws|1
166803|NCT00257660|530058|P2|Overall Study|PI & Subject Schedule Conflicts|0
166804|NCT00257660|530059|P1|Overall Study|PI & Subject Schedule Conflicts|1
166805|NCT00257660|530058|P2|Overall Study|Lost to Follow-up|0
166806|NCT00257660|530059|P1|Overall Study|Lost to Follow-up|1
166807|NCT00257660|530058|P2|Overall Study|Withdrawal by Subject|0
166808|NCT00257660|530059|P1|Overall Study|Withdrawal by Subject|2
166809|NCT00257660|530058|P2|Overall Study|Lack of Efficacy|23
166810|NCT00257660|530059|P1|Overall Study|Lack of Efficacy|5
166811|NCT00257608|530089|P3|Post Chemotherapy Phase|Not treated|7
166812|NCT00257608|530090|P2|Post Chemotherapy Phase|Not treated|4
166813|NCT00257608|530091|P1|Post Chemotherapy Phase|Not treated|0
166814|NCT00257608|530089|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
166815|NCT00257608|530090|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
166816|NCT00257608|530091|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
166817|NCT00257608|530089|P3|Post Chemotherapy Phase|Physician Decision|11
166818|NCT00257608|530090|P2|Post Chemotherapy Phase|Physician Decision|8
166819|NCT00257608|530091|P1|Post Chemotherapy Phase|Physician Decision|0
166820|NCT00257608|530089|P3|Post Chemotherapy Phase|Lost to Follow-up|1
166821|NCT00257608|530090|P2|Post Chemotherapy Phase|Lost to Follow-up|0
166822|NCT00257608|530091|P1|Post Chemotherapy Phase|Lost to Follow-up|0
166823|NCT00257608|530089|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
166824|NCT00257608|530090|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
166825|NCT00257608|530091|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
166826|NCT00257608|530089|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
166827|NCT00257608|530090|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
166828|NCT00257608|530091|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
166829|NCT00257608|530089|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
166830|NCT00257608|530090|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
166831|NCT00257608|530091|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
166832|NCT00257608|530089|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
166833|NCT00257608|530090|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
166834|NCT00257608|530091|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
166835|NCT00257608|530089|P3|Post Chemotherapy Phase|Disease progression|168
166836|NCT00257608|530090|P2|Post Chemotherapy Phase|Disease progression|204
166837|NCT00257608|530091|P1|Post Chemotherapy Phase|Disease progression|0
166838|NCT00257608|530089|P3|Post Chemotherapy Phase|Adverse Event|38
166839|NCT00257608|530090|P2|Post Chemotherapy Phase|Adverse Event|34
166840|NCT00257608|530091|P1|Post Chemotherapy Phase|Adverse Event|0
166841|NCT00257608|530089|P3|Chemotherapy Phase|Physician Decision|0
166842|NCT00257608|530090|P2|Chemotherapy Phase|Physician Decision|0
166843|NCT00257608|530091|P1|Chemotherapy Phase|Physician Decision|28
166844|NCT00257608|530089|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
166845|NCT00257608|530090|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
166846|NCT00257608|530091|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
166847|NCT00257608|530089|P3|Chemotherapy Phase|Patient's decision to discontinue|0
166848|NCT00257608|530090|P2|Chemotherapy Phase|Patient's decision to discontinue|0
166849|NCT00257608|530091|P1|Chemotherapy Phase|Patient's decision to discontinue|35
166850|NCT00257608|530089|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
166851|NCT00257608|530090|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
166852|NCT00257608|530091|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
166853|NCT00257608|530089|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
166854|NCT00257608|530090|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
166855|NCT00257608|530091|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
166856|NCT00257608|530089|P3|Chemotherapy Phase|Disease progression|0
166857|NCT00257608|530090|P2|Chemotherapy Phase|Disease progression|0
166858|NCT00257608|530091|P1|Chemotherapy Phase|Disease progression|139
166859|NCT00257608|530089|P3|Chemotherapy Phase|Adverse Event|0
166860|NCT00257608|530090|P2|Chemotherapy Phase|Adverse Event|0
166861|NCT00257608|530091|P1|Chemotherapy Phase|Adverse Event|138
166862|NCT00257556|530117|P2|Overall Study|other reason|6
166863|NCT00257556|530118|P1|Overall Study|other reason|4
166864|NCT00257556|530117|P2|Overall Study|Did not meet hCG criterion|0
166865|NCT00257556|530118|P1|Overall Study|Did not meet hCG criterion|3
166866|NCT00257556|530117|P2|Overall Study|Physician Decision|0
166867|NCT00257556|530118|P1|Overall Study|Physician Decision|6
166868|NCT00257556|530117|P2|Overall Study|Adverse Event|4
166869|NCT00257556|530118|P1|Overall Study|Adverse Event|1
166870|NCT00257192|530162|P2|Overall Study|Miscellaneous|4
166871|NCT00257192|530163|P1|Overall Study|Miscellaneous|0
166872|NCT00257192|530162|P2|Overall Study|Study terminated by sponsor|0
166873|NCT00257192|530163|P1|Overall Study|Study terminated by sponsor|1
166874|NCT00257192|530162|P2|Overall Study|Randomized but not treated|1
166875|NCT00257192|530163|P1|Overall Study|Randomized but not treated|0
166876|NCT00257192|530162|P2|Overall Study|Withdrawal by Subject|2
166877|NCT00257192|530163|P1|Overall Study|Withdrawal by Subject|14
166878|NCT00257192|530162|P2|Overall Study|Insufficient clinical response|18
166879|NCT00257192|530163|P1|Overall Study|Insufficient clinical response|18
166880|NCT00257192|530162|P2|Overall Study|Lost to Follow-up|3
166881|NCT00257192|530163|P1|Overall Study|Lost to Follow-up|3
166882|NCT00257192|530162|P2|Overall Study|Laboratory abnormality|1
166883|NCT00257192|530163|P1|Overall Study|Laboratory abnormality|1
166884|NCT00257192|530162|P2|Overall Study|Adverse Event|10
166885|NCT00257192|530163|P1|Overall Study|Adverse Event|21
166886|NCT00257166|530207|P2|Overall Study|Randomized, but not treated|0
166887|NCT00257166|530208|P1|Overall Study|Randomized, but not treated|1
166888|NCT00257166|530207|P2|Overall Study|Unspecified|21
166889|NCT00257166|530208|P1|Overall Study|Unspecified|16
166890|NCT00257166|530207|P2|Overall Study|Withdrawal by Subject|2
166891|NCT00257166|530208|P1|Overall Study|Withdrawal by Subject|9
166892|NCT00257166|530207|P2|Overall Study|Lost to Follow-up|1
166893|NCT00257166|530208|P1|Overall Study|Lost to Follow-up|8
166894|NCT00257166|530207|P2|Overall Study|Laboratory abnormality|0
166895|NCT00257166|530208|P1|Overall Study|Laboratory abnormality|1
166896|NCT00257166|530207|P2|Overall Study|Adverse Event|13
166897|NCT00257166|530208|P1|Overall Study|Adverse Event|18
166898|NCT00257010|530220|P1|Overall Study|no headache reported|9
166899|NCT00257010|530220|P1|Overall Study|various|11
166900|NCT00257010|530220|P1|Overall Study|Adverse Event|10
166901|NCT00257010|530220|P1|Overall Study|Withdrawal by Subject|34
166902|NCT00257010|530220|P1|Overall Study|Lost to Follow-up|53
166903|NCT00257010|530220|P1|Overall Study|Lack of Efficacy|11
166904|NCT00256997|530231|P2|Overall Study|Investigator Withdrew Participant|1
166905|NCT00256997|530232|P1|Overall Study|Investigator Withdrew Participant|2
166906|NCT00256997|530231|P2|Overall Study|Participant Non-compliant|6
166907|NCT00256997|530232|P1|Overall Study|Participant Non-compliant|3
166908|NCT00256997|530231|P2|Overall Study|End of Study (As Per Sponsor)|24
166909|NCT00256997|530232|P1|Overall Study|End of Study (As Per Sponsor)|12
166910|NCT00256997|530231|P2|Overall Study|Unspecified|8
166911|NCT00256997|530232|P1|Overall Study|Unspecified|5
166912|NCT00256997|530231|P2|Overall Study|Started but not treated|0
166913|NCT00256997|530232|P1|Overall Study|Started but not treated|2
166914|NCT00256997|530231|P2|Overall Study|Withdrawal by Subject|3
166915|NCT00256997|530232|P1|Overall Study|Withdrawal by Subject|13
166916|NCT00256997|530231|P2|Overall Study|Lost to Follow-up|5
166917|NCT00256997|530232|P1|Overall Study|Lost to Follow-up|3
166918|NCT00256997|530231|P2|Overall Study|Adverse Event|0
166919|NCT00256997|530232|P1|Overall Study|Adverse Event|4
166920|NCT00256997|530231|P2|Overall Study|Death|0
166921|NCT00256997|530232|P1|Overall Study|Death|2
166922|NCT00256997|530231|P2|Overall Study|Lack of Efficacy|4
166923|NCT00256997|530232|P1|Overall Study|Lack of Efficacy|1
166924|NCT00256997|530231|P2|Overall Study|Protocol Violation|4
166925|NCT00256997|530232|P1|Overall Study|Protocol Violation|1
166926|NCT00256750|530269|P3|Long Term Extension (LTE; 84 Months)|Not Specified|5
166927|NCT00256750|530270|P2|Long Term Extension (LTE; 84 Months)|Not Specified|4
166928|NCT00256750|530271|P1|Long Term Extension (LTE; 84 Months)|Not Specified|5
166929|NCT00256750|530269|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
166930|NCT00256750|530270|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
166931|NCT00256750|530271|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
166932|NCT00256750|530269|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
166933|NCT00256750|530270|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
166934|NCT00256750|530271|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
166935|NCT00256750|530269|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
166936|NCT00256750|530270|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
166937|NCT00256750|530271|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
166938|NCT00256750|530269|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
166939|NCT00256750|530270|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
166940|NCT00256750|530271|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
166941|NCT00256750|530269|P3|Long Term Extension (LTE; 84 Months)|Death|4
166942|NCT00256750|530270|P2|Long Term Extension (LTE; 84 Months)|Death|4
166943|NCT00256750|530271|P1|Long Term Extension (LTE; 84 Months)|Death|9
166944|NCT00256750|530269|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
166945|NCT00256750|530270|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
166946|NCT00256750|530271|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
166947|NCT00256750|530269|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
166948|NCT00256750|530270|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
166949|NCT00256750|530271|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
166950|NCT00256750|530269|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
166951|NCT00256750|530270|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
166952|NCT00256750|530271|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
166953|NCT00256750|530269|P3|Post-Transplant Treated (36 Months)|Not specified|1
166954|NCT00256750|530270|P2|Post-Transplant Treated (36 Months)|Not specified|1
166955|NCT00256750|530271|P1|Post-Transplant Treated (36 Months)|Not specified|0
166956|NCT00256750|530269|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
166957|NCT00256750|530270|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
166958|NCT00256750|530271|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
166959|NCT00256750|530269|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
166960|NCT00256750|530270|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
166961|NCT00256750|530271|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
166962|NCT00256750|530269|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
166963|NCT00256750|530270|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
166964|NCT00256750|530271|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
166965|NCT00256750|530269|P3|Post-Transplant Treated (36 Months)|Death|1
166966|NCT00256750|530270|P2|Post-Transplant Treated (36 Months)|Death|2
166967|NCT00256750|530271|P1|Post-Transplant Treated (36 Months)|Death|0
166968|NCT00256750|530269|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
166969|NCT00256750|530270|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
166970|NCT00256750|530271|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
166971|NCT00256750|530269|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
166972|NCT00256750|530270|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
166973|NCT00256750|530271|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
166974|NCT00256750|530269|P3|Post-Transplant Treated (24 Months)|Not Specified|1
166975|NCT00256750|530270|P2|Post-Transplant Treated (24 Months)|Not Specified|0
166976|NCT00256750|530271|P1|Post-Transplant Treated (24 Months)|Not Specified|2
166977|NCT00256750|530269|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
166978|NCT00256750|530270|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
166979|NCT00256750|530271|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
166980|NCT00256750|530269|P3|Post-Transplant Treated (24 Months)|Death|0
166981|NCT00256750|530270|P2|Post-Transplant Treated (24 Months)|Death|0
166982|NCT00256750|530271|P1|Post-Transplant Treated (24 Months)|Death|3
166983|NCT00256750|530269|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
166984|NCT00256750|530270|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
166985|NCT00256750|530271|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
166986|NCT00256750|530269|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
166987|NCT00256750|530270|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
166988|NCT00256750|530271|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
166989|NCT00256750|530269|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
166990|NCT00256750|530270|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
166991|NCT00256750|530271|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
166992|NCT00256750|530269|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
166993|NCT00256750|530270|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
166994|NCT00256750|530271|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
166995|NCT00256750|530269|P3|Post-Transplant Treated (12 Months)|Not Specified|2
166996|NCT00256750|530270|P2|Post-Transplant Treated (12 Months)|Not Specified|4
166997|NCT00256750|530271|P1|Post-Transplant Treated (12 Months)|Not Specified|5
166998|NCT00256750|530269|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
166999|NCT00256750|530270|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
167000|NCT00256750|530271|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
167001|NCT00256750|530269|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
167002|NCT00256750|530270|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
167003|NCT00256750|530271|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
167004|NCT00256750|530269|P3|Post-Transplant Treated (12 Months)|Death|4
167005|NCT00256750|530270|P2|Post-Transplant Treated (12 Months)|Death|2
167006|NCT00256750|530271|P1|Post-Transplant Treated (12 Months)|Death|3
167007|NCT00256750|530269|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
167008|NCT00256750|530270|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
167009|NCT00256750|530271|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
167010|NCT00256750|530269|P3|Transplanted Pre-Treatment|Death|0
167011|NCT00256750|530270|P2|Transplanted Pre-Treatment|Death|0
167012|NCT00256750|530271|P1|Transplanted Pre-Treatment|Death|1
167013|NCT00256750|530269|P3|Transplanted Pre-Treatment|Not Specified|0
167014|NCT00256750|530270|P2|Transplanted Pre-Treatment|Not Specified|0
167015|NCT00256750|530271|P1|Transplanted Pre-Treatment|Not Specified|2
167016|NCT00256750|530269|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
167017|NCT00256750|530270|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
167018|NCT00256750|530271|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
167019|NCT00256724|530407|P2|Overall Study|Protocol Violation|3
167020|NCT00256724|530408|P1|Overall Study|Protocol Violation|3
167021|NCT00256724|530407|P2|Overall Study|Physician Decision|5
167022|NCT00256724|530408|P1|Overall Study|Physician Decision|2
167023|NCT00256698|530418|P2|Overall Study|Prematurely Discontinued|0
167024|NCT00256698|530419|P1|Overall Study|Prematurely Discontinued|1
167025|NCT00256698|530418|P2|Overall Study|withdrawn due to osteoporosis|0
167026|NCT00256698|530419|P1|Overall Study|withdrawn due to osteoporosis|1
167027|NCT00256698|530418|P2|Overall Study|still ongoing at data cut-off|46
167028|NCT00256698|530419|P1|Overall Study|still ongoing at data cut-off|41
167029|NCT00256698|530418|P2|Overall Study|disease progression|105
167030|NCT00256698|530419|P1|Overall Study|disease progression|97
167031|NCT00256698|530418|P2|Overall Study|Lost to Follow-up|3
167032|NCT00256698|530419|P1|Overall Study|Lost to Follow-up|1
167033|NCT00256698|530418|P2|Overall Study|Protocol Violation|5
167034|NCT00256698|530419|P1|Overall Study|Protocol Violation|6
167035|NCT00256698|530418|P2|Overall Study|Adverse Event|6
167036|NCT00256698|530419|P1|Overall Study|Adverse Event|13
167037|NCT00256698|530418|P2|Overall Study|Withdrawal by Subject|7
167038|NCT00256698|530419|P1|Overall Study|Withdrawal by Subject|7
167039|NCT00256295|530437|P1|Overall Study|Death|1
167040|NCT00256295|530437|P1|Overall Study|Withdrawal by Subject|3
167041|NCT00256243|530443|P1|Overall Study|Not treated|1
167042|NCT00256243|530443|P1|Overall Study|Death|7
167043|NCT00256243|530443|P1|Overall Study|Lost to Follow-up|2
167044|NCT00256204|530452|P4|Overall Study|Need for additional prohibited treatment|25
167045|NCT00256204|530453|P3|Overall Study|Need for additional prohibited treatment|27
167046|NCT00256204|530454|P2|Overall Study|Need for additional prohibited treatment|28
167047|NCT00256204|530455|P1|Overall Study|Need for additional prohibited treatment|38
167048|NCT00256204|530452|P4|Overall Study|Withdrawal by Subject|5
167049|NCT00256204|530453|P3|Overall Study|Withdrawal by Subject|7
167050|NCT00256204|530454|P2|Overall Study|Withdrawal by Subject|6
167051|NCT00256204|530455|P1|Overall Study|Withdrawal by Subject|17
167052|NCT00256204|530452|P4|Overall Study|Physician Decision|2
167053|NCT00256204|530453|P3|Overall Study|Physician Decision|1
167054|NCT00256204|530454|P2|Overall Study|Physician Decision|0
167055|NCT00256204|530455|P1|Overall Study|Physician Decision|0
167056|NCT00256204|530452|P4|Overall Study|Protocol Violation|1
167057|NCT00256204|530453|P3|Overall Study|Protocol Violation|2
167058|NCT00256204|530454|P2|Overall Study|Protocol Violation|0
167059|NCT00256204|530455|P1|Overall Study|Protocol Violation|1
167060|NCT00256204|530452|P4|Overall Study|Lost to Follow-up|2
167061|NCT00256204|530453|P3|Overall Study|Lost to Follow-up|1
167062|NCT00256204|530454|P2|Overall Study|Lost to Follow-up|1
167063|NCT00256204|530455|P1|Overall Study|Lost to Follow-up|1
167064|NCT00256204|530452|P4|Overall Study|Death|0
167065|NCT00256204|530453|P3|Overall Study|Death|0
167066|NCT00256204|530454|P2|Overall Study|Death|1
167067|NCT00256204|530455|P1|Overall Study|Death|0
167068|NCT00256204|530452|P4|Overall Study|Adverse Event|14
167069|NCT00256204|530453|P3|Overall Study|Adverse Event|16
167070|NCT00256204|530454|P2|Overall Study|Adverse Event|14
167071|NCT00256204|530455|P1|Overall Study|Adverse Event|10
167072|NCT00255840|530491|P2|Overall Study|Discontinued intervention|56
167073|NCT00255840|530492|P1|Overall Study|Discontinued intervention|53
167074|NCT00255840|530491|P2|Overall Study|Lost to Follow-up|14
167075|NCT00255840|530492|P1|Overall Study|Lost to Follow-up|10
167076|NCT00255723|530500|P2|Overall Study|Response Data Not Available|0
167077|NCT00255723|530501|P1|Overall Study|Response Data Not Available|1
167078|NCT00255723|530500|P2|Overall Study|Death|1
167079|NCT00255723|530501|P1|Overall Study|Death|0
167080|NCT00255723|530500|P2|Overall Study|Adverse Event|1
167081|NCT00255723|530501|P1|Overall Study|Adverse Event|1
167082|NCT00255190|530514|P2|Overall Study|Various|23
167083|NCT00255190|530515|P1|Overall Study|Various|4
167084|NCT00255190|530514|P2|Overall Study|Erosive esophagitis not healed|20
167085|NCT00255190|530515|P1|Overall Study|Erosive esophagitis not healed|0
167086|NCT00255190|530514|P2|Overall Study|Inclusion/Exclusion criteria not met|1
167087|NCT00255190|530515|P1|Overall Study|Inclusion/Exclusion criteria not met|0
167088|NCT00255190|530514|P2|Overall Study|Withdrew Consent|48
167089|NCT00255190|530515|P1|Overall Study|Withdrew Consent|17
167090|NCT00255190|530514|P2|Overall Study|Lost to Follow-up|27
167091|NCT00255190|530515|P1|Overall Study|Lost to Follow-up|10
167092|NCT00255190|530514|P2|Overall Study|Protocol Violation|2
167093|NCT00255190|530515|P1|Overall Study|Protocol Violation|2
167094|NCT00255190|530514|P2|Overall Study|Adverse Event|36
167095|NCT00255190|530515|P1|Overall Study|Adverse Event|17
167096|NCT00255164|530599|P3|Overall Study|Therapeutic Failure|3
167097|NCT00255164|530600|P2|Overall Study|Therapeutic Failure|2
167098|NCT00255164|530601|P1|Overall Study|Therapeutic Failure|11
167099|NCT00255164|530599|P3|Overall Study|Esophageal Stricture|1
167100|NCT00255164|530600|P2|Overall Study|Esophageal Stricture|0
167101|NCT00255164|530601|P1|Overall Study|Esophageal Stricture|0
167102|NCT00255164|530599|P3|Overall Study|Possible Barrett's Esophagus|8
167103|NCT00255164|530600|P2|Overall Study|Possible Barrett's Esophagus|3
167104|NCT00255164|530601|P1|Overall Study|Possible Barrett's Esophagus|1
167105|NCT00255164|530599|P3|Overall Study|Relapse of Erosive Esophagitis|12
167106|NCT00255164|530600|P2|Overall Study|Relapse of Erosive Esophagitis|16
167107|NCT00255164|530601|P1|Overall Study|Relapse of Erosive Esophagitis|78
167108|NCT00255164|530599|P3|Overall Study|Subject Request/Subject Unavailable|2
167109|NCT00255164|530600|P2|Overall Study|Subject Request/Subject Unavailable|1
167110|NCT00255164|530601|P1|Overall Study|Subject Request/Subject Unavailable|1
167111|NCT00255164|530599|P3|Overall Study|Noncompliance|2
167112|NCT00255164|530600|P2|Overall Study|Noncompliance|1
167113|NCT00255164|530601|P1|Overall Study|Noncompliance|0
167114|NCT00255164|530599|P3|Overall Study|Withdrawal by Subject|8
167115|NCT00255164|530600|P2|Overall Study|Withdrawal by Subject|17
167116|NCT00255164|530601|P1|Overall Study|Withdrawal by Subject|18
167117|NCT00255164|530599|P3|Overall Study|Lost to Follow-up|4
167118|NCT00255164|530600|P2|Overall Study|Lost to Follow-up|3
167119|NCT00255164|530601|P1|Overall Study|Lost to Follow-up|4
167120|NCT00255164|530599|P3|Overall Study|Adverse Event|9
167121|NCT00255164|530600|P2|Overall Study|Adverse Event|6
167122|NCT00255164|530601|P1|Overall Study|Adverse Event|10
167123|NCT00255151|530627|P3|Overall Study|Therapeutic Failure|3
167124|NCT00255151|530628|P2|Overall Study|Therapeutic Failure|2
167125|NCT00255151|530629|P1|Overall Study|Therapeutic Failure|11
167126|NCT00255151|530627|P3|Overall Study|Esophageal Stricture|1
167127|NCT00255151|530628|P2|Overall Study|Esophageal Stricture|0
167128|NCT00255151|530629|P1|Overall Study|Esophageal Stricture|0
167129|NCT00255151|530627|P3|Overall Study|Possible Barrett's Esophagus|8
167130|NCT00255151|530628|P2|Overall Study|Possible Barrett's Esophagus|3
167131|NCT00255151|530629|P1|Overall Study|Possible Barrett's Esophagus|1
167132|NCT00255151|530627|P3|Overall Study|Relapse of Erosive Esophagitis|12
167133|NCT00255151|530628|P2|Overall Study|Relapse of Erosive Esophagitis|16
167134|NCT00255151|530629|P1|Overall Study|Relapse of Erosive Esophagitis|78
167135|NCT00255151|530627|P3|Overall Study|Subject Request/Subject Unavailable|2
167136|NCT00255151|530628|P2|Overall Study|Subject Request/Subject Unavailable|1
167137|NCT00255151|530629|P1|Overall Study|Subject Request/Subject Unavailable|1
167138|NCT00255151|530627|P3|Overall Study|Noncompliance|2
167139|NCT00255151|530628|P2|Overall Study|Noncompliance|1
167140|NCT00255151|530629|P1|Overall Study|Noncompliance|0
167141|NCT00255151|530627|P3|Overall Study|Withdrawal by Subject|8
167142|NCT00255151|530628|P2|Overall Study|Withdrawal by Subject|17
167143|NCT00255151|530629|P1|Overall Study|Withdrawal by Subject|18
167144|NCT00255151|530627|P3|Overall Study|Lost to Follow-up|4
167145|NCT00255151|530628|P2|Overall Study|Lost to Follow-up|3
167146|NCT00255151|530629|P1|Overall Study|Lost to Follow-up|4
167147|NCT00255151|530627|P3|Overall Study|Adverse Event|9
167148|NCT00255151|530628|P2|Overall Study|Adverse Event|6
167149|NCT00255151|530629|P1|Overall Study|Adverse Event|10
167150|NCT00255047|530665|P4|Overall Study|Withdrawal by Subject|18
167151|NCT00255047|530666|P3|Overall Study|Withdrawal by Subject|25
167152|NCT00255047|530667|P2|Overall Study|Withdrawal by Subject|23
167153|NCT00255047|530668|P1|Overall Study|Withdrawal by Subject|24
167154|NCT00255047|530665|P4|Overall Study|Lost to Follow-up|6
167155|NCT00255047|530666|P3|Overall Study|Lost to Follow-up|5
167156|NCT00255047|530667|P2|Overall Study|Lost to Follow-up|8
167157|NCT00255047|530668|P1|Overall Study|Lost to Follow-up|9
167158|NCT00255047|530665|P4|Overall Study|Protocol Violation|20
167159|NCT00255047|530666|P3|Overall Study|Protocol Violation|16
167160|NCT00255047|530667|P2|Overall Study|Protocol Violation|13
167161|NCT00255047|530668|P1|Overall Study|Protocol Violation|13
167162|NCT00255047|530665|P4|Overall Study|Adverse Event|1
167163|NCT00255047|530666|P3|Overall Study|Adverse Event|2
167164|NCT00255047|530667|P2|Overall Study|Adverse Event|3
167165|NCT00255047|530668|P1|Overall Study|Adverse Event|0
167166|NCT00255047|530665|P4|Overall Study|Serious Adverse Events|1
167167|NCT00255047|530666|P3|Overall Study|Serious Adverse Events|2
167168|NCT00255047|530667|P2|Overall Study|Serious Adverse Events|1
167169|NCT00255047|530668|P1|Overall Study|Serious Adverse Events|2
167170|NCT00255034|530692|P2|Overall Study|Withdrawal by Subject|38
167171|NCT00255034|530693|P1|Overall Study|Withdrawal by Subject|15
167172|NCT00255008|530703|P4|Overall Study|Other|2
167173|NCT00255008|530704|P3|Overall Study|Other|3
167174|NCT00255008|530705|P2|Overall Study|Other|0
167175|NCT00255008|530706|P1|Overall Study|Other|7
167176|NCT00255008|530703|P4|Overall Study|Adverse lab experience|0
167177|NCT00255008|530704|P3|Overall Study|Adverse lab experience|0
167178|NCT00255008|530705|P2|Overall Study|Adverse lab experience|0
167179|NCT00255008|530706|P1|Overall Study|Adverse lab experience|1
167180|NCT00255008|530703|P4|Overall Study|Sponsor request|17
167181|NCT00255008|530704|P3|Overall Study|Sponsor request|8
167182|NCT00255008|530705|P2|Overall Study|Sponsor request|3
167183|NCT00255008|530706|P1|Overall Study|Sponsor request|18
167184|NCT00255008|530703|P4|Overall Study|Withdrew consent|0
167185|NCT00255008|530704|P3|Overall Study|Withdrew consent|2
167186|NCT00255008|530705|P2|Overall Study|Withdrew consent|0
167187|NCT00255008|530706|P1|Overall Study|Withdrew consent|0
167188|NCT00255008|530703|P4|Overall Study|Did not meet viral reduction criteria|1
167189|NCT00255008|530704|P3|Overall Study|Did not meet viral reduction criteria|0
167190|NCT00255008|530705|P2|Overall Study|Did not meet viral reduction criteria|5
167191|NCT00255008|530706|P1|Overall Study|Did not meet viral reduction criteria|4
167192|NCT00255008|530703|P4|Overall Study|Lost to Follow-up|2
167193|NCT00255008|530704|P3|Overall Study|Lost to Follow-up|1
167194|NCT00255008|530705|P2|Overall Study|Lost to Follow-up|0
167195|NCT00255008|530706|P1|Overall Study|Lost to Follow-up|1
167196|NCT00255008|530703|P4|Overall Study|Adverse Event|0
167197|NCT00255008|530704|P3|Overall Study|Adverse Event|2
167198|NCT00255008|530705|P2|Overall Study|Adverse Event|1
167199|NCT00255008|530706|P1|Overall Study|Adverse Event|1
167200|NCT00254982|530742|P2|Overall Study|Abnormal liver function tests|1
167201|NCT00254982|530743|P1|Overall Study|Abnormal liver function tests|2
167202|NCT00254982|530742|P2|Overall Study|Opportunistic infection|0
167203|NCT00254982|530743|P1|Overall Study|Opportunistic infection|1
167204|NCT00254982|530742|P2|Overall Study|Malignancy|2
167205|NCT00254982|530743|P1|Overall Study|Malignancy|0
167206|NCT00254982|530742|P2|Overall Study|Diagnosis of Tuberculosis|1
167207|NCT00254982|530743|P1|Overall Study|Diagnosis of Tuberculosis|1
167208|NCT00254982|530742|P2|Overall Study|Protocol deviation|1
167209|NCT00254982|530743|P1|Overall Study|Protocol deviation|1
167210|NCT00254982|530742|P2|Overall Study|Inclusion/exclusion criteria violation|2
167211|NCT00254982|530743|P1|Overall Study|Inclusion/exclusion criteria violation|0
167212|NCT00254982|530742|P2|Overall Study|Withdrawal by Subject|1
167213|NCT00254982|530743|P1|Overall Study|Withdrawal by Subject|1
167214|NCT00254982|530742|P2|Overall Study|Adverse Event|16
167215|NCT00254982|530743|P1|Overall Study|Adverse Event|18
167216|NCT00254982|530742|P2|Overall Study|Lost to Follow-up|3
167217|NCT00254982|530743|P1|Overall Study|Lost to Follow-up|5
167218|NCT00254982|530742|P2|Overall Study|Lack of Efficacy|3
167219|NCT00254982|530743|P1|Overall Study|Lack of Efficacy|5
167220|NCT00254982|530742|P2|Overall Study|Not specified|1
167221|NCT00254982|530743|P1|Overall Study|Not specified|2
167222|NCT00253747|530751|P2|Overall Study|Administrative Discharge (1), Other (2)|2
167223|NCT00253747|530752|P1|Overall Study|Administrative Discharge (1), Other (2)|1
167224|NCT00253747|530751|P2|Overall Study|Withdrawal by Subject|11
167225|NCT00253747|530752|P1|Overall Study|Withdrawal by Subject|10
167226|NCT00253747|530751|P2|Overall Study|Lost to Follow-up|14
167227|NCT00253747|530752|P1|Overall Study|Lost to Follow-up|13
167228|NCT00253643|530774|P4|Overall Study|Non-Compliance|2
167229|NCT00253643|530775|P3|Overall Study|Non-Compliance|0
167230|NCT00253643|530776|P2|Overall Study|Non-Compliance|0
167231|NCT00253643|530777|P1|Overall Study|Non-Compliance|0
167232|NCT00253643|530774|P4|Overall Study|Withdrawal by Subject|1
167233|NCT00253643|530775|P3|Overall Study|Withdrawal by Subject|1
167234|NCT00253643|530776|P2|Overall Study|Withdrawal by Subject|0
167235|NCT00253643|530777|P1|Overall Study|Withdrawal by Subject|0
167236|NCT00254566|530797|P2|Overall Study|Lost to Follow-up|2
167237|NCT00254566|530798|P1|Overall Study|Lost to Follow-up|7
167238|NCT00254566|530797|P2|Overall Study|Withdrawal by Subject|6
167239|NCT00254566|530798|P1|Overall Study|Withdrawal by Subject|5
167240|NCT00254566|530797|P2|Overall Study|Other|5
167241|NCT00254566|530798|P1|Overall Study|Other|1
167242|NCT00254566|530797|P2|Overall Study|Lack of Efficacy|9
167243|NCT00254566|530798|P1|Overall Study|Lack of Efficacy|12
167244|NCT00254566|530797|P2|Overall Study|Adverse Event|4
167245|NCT00254566|530798|P1|Overall Study|Adverse Event|5
167246|NCT00254566|530797|P2|Overall Study|Death|0
167247|NCT00254566|530798|P1|Overall Study|Death|1
167248|NCT00254540|530822|P2|Overall Study|Laboratory Test Abnormality|1
167249|NCT00254540|530823|P1|Overall Study|Laboratory Test Abnormality|0
167250|NCT00254540|530822|P2|Overall Study|Death|1
167251|NCT00254540|530823|P1|Overall Study|Death|0
167252|NCT00254540|530822|P2|Overall Study|Lack of Efficacy|13
167253|NCT00254540|530823|P1|Overall Study|Lack of Efficacy|13
167254|NCT00254540|530822|P2|Overall Study|Adverse Event|7
167255|NCT00254540|530823|P1|Overall Study|Adverse Event|6
167256|NCT00254501|530852|P2|Overall Study|Lost to Follow-up|1
167257|NCT00254501|530853|P1|Overall Study|Lost to Follow-up|1
167258|NCT00254293|530882|P7|LTE Open Label Fixed Dosing|not specified|1
167259|NCT00254293|530883|P6|LTE Open Label Fixed Dosing|not specified|0
167260|NCT00254293|530884|P5|LTE Open Label Fixed Dosing|not specified|0
167261|NCT00254293|530885|P4|LTE Open Label Fixed Dosing|not specified|0
167262|NCT00254293|530886|P3|LTE Open Label Fixed Dosing|not specified|0
167263|NCT00254293|530887|P2|LTE Open Label Fixed Dosing|not specified|0
167264|NCT00254293|530888|P1|LTE Open Label Fixed Dosing|not specified|0
167265|NCT00254293|530882|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
167266|NCT00254293|530883|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
167267|NCT00254293|530884|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
167268|NCT00254293|530885|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
167269|NCT00254293|530886|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
167270|NCT00254293|530887|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
167271|NCT00254293|530888|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
167272|NCT00254293|530882|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
167273|NCT00254293|530883|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
167274|NCT00254293|530884|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
167275|NCT00254293|530885|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
167276|NCT00254293|530886|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
167277|NCT00254293|530887|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
167278|NCT00254293|530888|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
167279|NCT00254293|530882|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
167280|NCT00254293|530883|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
167281|NCT00254293|530884|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
167282|NCT00254293|530885|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
167283|NCT00254293|530886|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
167284|NCT00254293|530887|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
167285|NCT00254293|530888|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
167286|NCT00254293|530882|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
167287|NCT00254293|530883|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
167288|NCT00254293|530884|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
167289|NCT00254293|530885|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
167290|NCT00254293|530886|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
167291|NCT00254293|530887|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
167292|NCT00254293|530888|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
167293|NCT00254293|530882|P7|LTE Open Label Fixed Dosing|Adverse Event|1
167294|NCT00254293|530883|P6|LTE Open Label Fixed Dosing|Adverse Event|0
167295|NCT00254293|530884|P5|LTE Open Label Fixed Dosing|Adverse Event|0
167296|NCT00254293|530885|P4|LTE Open Label Fixed Dosing|Adverse Event|0
167297|NCT00254293|530886|P3|LTE Open Label Fixed Dosing|Adverse Event|0
167298|NCT00254293|530887|P2|LTE Open Label Fixed Dosing|Adverse Event|0
167299|NCT00254293|530888|P1|LTE Open Label Fixed Dosing|Adverse Event|0
167300|NCT00254293|530882|P7|LTE Open Label Fixed Dosing|Death|3
167301|NCT00254293|530883|P6|LTE Open Label Fixed Dosing|Death|0
167302|NCT00254293|530884|P5|LTE Open Label Fixed Dosing|Death|0
167303|NCT00254293|530885|P4|LTE Open Label Fixed Dosing|Death|0
167304|NCT00254293|530886|P3|LTE Open Label Fixed Dosing|Death|0
167305|NCT00254293|530887|P2|LTE Open Label Fixed Dosing|Death|0
167306|NCT00254293|530888|P1|LTE Open Label Fixed Dosing|Death|0
167307|NCT00254293|530882|P7|LTE Open Label Variable SC Dosing|not specified|0
167308|NCT00254293|530883|P6|LTE Open Label Variable SC Dosing|not specified|0
167309|NCT00254293|530884|P5|LTE Open Label Variable SC Dosing|not specified|0
167310|NCT00254293|530885|P4|LTE Open Label Variable SC Dosing|not specified|0
167311|NCT00254293|530886|P3|LTE Open Label Variable SC Dosing|not specified|2
167312|NCT00254293|530887|P2|LTE Open Label Variable SC Dosing|not specified|0
167313|NCT00254293|530888|P1|LTE Open Label Variable SC Dosing|not specified|0
167314|NCT00254293|530882|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
167315|NCT00254293|530883|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
167316|NCT00254293|530884|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
167317|NCT00254293|530885|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
167318|NCT00254293|530886|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
167319|NCT00254293|530887|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
167320|NCT00254293|530888|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
167321|NCT00254293|530882|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
167322|NCT00254293|530883|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
167323|NCT00254293|530884|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
167324|NCT00254293|530885|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
167325|NCT00254293|530886|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
167326|NCT00254293|530887|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
167327|NCT00254293|530888|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
167328|NCT00254293|530882|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
167329|NCT00254293|530883|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
167330|NCT00254293|530884|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
167331|NCT00254293|530885|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
167332|NCT00254293|530886|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
167333|NCT00254293|530887|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
167334|NCT00254293|530888|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
167335|NCT00254293|530882|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
167336|NCT00254293|530883|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
167337|NCT00254293|530884|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
167338|NCT00254293|530885|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
167339|NCT00254293|530886|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
167340|NCT00254293|530887|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
167341|NCT00254293|530888|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
167342|NCT00254293|530882|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
167343|NCT00254293|530883|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
167344|NCT00254293|530884|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
167345|NCT00254293|530885|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
167346|NCT00254293|530886|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
167347|NCT00254293|530887|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
167348|NCT00254293|530888|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
167349|NCT00254293|530882|P7|LTE Open Label Variable SC Dosing|Death|0
167350|NCT00254293|530883|P6|LTE Open Label Variable SC Dosing|Death|0
167351|NCT00254293|530884|P5|LTE Open Label Variable SC Dosing|Death|0
167352|NCT00254293|530885|P4|LTE Open Label Variable SC Dosing|Death|0
167353|NCT00254293|530886|P3|LTE Open Label Variable SC Dosing|Death|1
167354|NCT00254293|530887|P2|LTE Open Label Variable SC Dosing|Death|0
167355|NCT00254293|530888|P1|LTE Open Label Variable SC Dosing|Death|0
167356|NCT00254293|530882|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
167357|NCT00254293|530883|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
167358|NCT00254293|530884|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
167359|NCT00254293|530885|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
167360|NCT00254293|530886|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
167361|NCT00254293|530887|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
167362|NCT00254293|530888|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
167363|NCT00254293|530882|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
167364|NCT00254293|530883|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
167365|NCT00254293|530884|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
167366|NCT00254293|530885|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
167367|NCT00254293|530886|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
167368|NCT00254293|530887|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
167369|NCT00254293|530888|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
167370|NCT00254293|530882|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
167371|NCT00254293|530883|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
167372|NCT00254293|530884|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
167373|NCT00254293|530885|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
167374|NCT00254293|530886|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
167375|NCT00254293|530887|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
167376|NCT00254293|530888|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
167377|NCT00254163|530971|P2|Overall Study|Other|8
167378|NCT00254163|530972|P1|Overall Study|Other|8
167379|NCT00254163|530971|P2|Overall Study|Death|1
167380|NCT00254163|530972|P1|Overall Study|Death|0
167381|NCT00254163|530971|P2|Overall Study|Progressive disease|1
167382|NCT00254163|530972|P1|Overall Study|Progressive disease|0
167383|NCT00254163|530971|P2|Overall Study|Failed entry|3
167384|NCT00254163|530972|P1|Overall Study|Failed entry|1
167385|NCT00254163|530971|P2|Overall Study|Investigator request|3
167386|NCT00254163|530972|P1|Overall Study|Investigator request|1
167387|NCT00254163|530971|P2|Overall Study|Patient request/withdrew consent|4
167388|NCT00254163|530972|P1|Overall Study|Patient request/withdrew consent|6
167389|NCT00254163|530971|P2|Overall Study|Adverse Event|26
167390|NCT00254163|530972|P1|Overall Study|Adverse Event|29
167391|NCT00253448|531028|P1|Overall Study|Withdrawal by Subject|1
167392|NCT00253370|531047|P1|Overall Study|Abdominal pain due to disease|1
167393|NCT00253370|531047|P1|Overall Study|Protocol Violation|1
167394|NCT00253370|531047|P1|Overall Study|Physician Decision|1
167395|NCT00253370|531047|P1|Overall Study|Non-protocol therapy|1
167396|NCT00253370|531047|P1|Overall Study|Withdrawal by Subject|6
167397|NCT00253370|531047|P1|Overall Study|Death|2
167398|NCT00253370|531047|P1|Overall Study|Disease progression|13
167399|NCT00253370|531047|P1|Overall Study|Adverse Event|18
167400|NCT00252733|531093|P2|Overall Study|Multiple Reasons|14
167401|NCT00252733|531094|P1|Overall Study|Multiple Reasons|14
167402|NCT00252733|531093|P2|Overall Study|Lost to Follow-up|6
167403|NCT00252733|531094|P1|Overall Study|Lost to Follow-up|12
167404|NCT00252733|531093|P2|Overall Study|Death|5
167405|NCT00252733|531094|P1|Overall Study|Death|7
167406|NCT00252733|531093|P2|Overall Study|Withdrawal by Subject|67
167407|NCT00252733|531094|P1|Overall Study|Withdrawal by Subject|73
167408|NCT00252720|531104|P2|Overall Study|Mainly patients lost to follow-up|18
167409|NCT00252720|531105|P1|Overall Study|Mainly patients lost to follow-up|7
167410|NCT00252720|531104|P2|Overall Study|Moving|42
167411|NCT00252720|531105|P1|Overall Study|Moving|23
167412|NCT00252720|531104|P2|Overall Study|Death|8
167413|NCT00252720|531105|P1|Overall Study|Death|7
167414|NCT00252720|531104|P2|Overall Study|Withdrawal by Subject|97
167415|NCT00252720|531105|P1|Overall Study|Withdrawal by Subject|95
167416|NCT00252694|531119|P2|Overall Study|Patient Moving|16
167417|NCT00252694|531120|P1|Overall Study|Patient Moving|17
167418|NCT00252694|531119|P2|Overall Study|Mostly Lost to Follow Up|13
167419|NCT00252694|531120|P1|Overall Study|Mostly Lost to Follow Up|8
167420|NCT00252694|531119|P2|Overall Study|Death|34
167421|NCT00252694|531120|P1|Overall Study|Death|36
167422|NCT00252694|531119|P2|Overall Study|Withdrawal by Subject|91
167423|NCT00252694|531120|P1|Overall Study|Withdrawal by Subject|83
167424|NCT00252564|531168|P2|Overall Study|Withdrawal by Subject|2
167425|NCT00252564|531169|P1|Overall Study|Withdrawal by Subject|0
167426|NCT00252564|531168|P2|Overall Study|Patient Request|5
167427|NCT00252564|531169|P1|Overall Study|Patient Request|4
167428|NCT00252564|531168|P2|Overall Study|Lost to Follow-up|0
167429|NCT00252564|531169|P1|Overall Study|Lost to Follow-up|1
167430|NCT00252564|531168|P2|Overall Study|Physician Decision|0
167431|NCT00252564|531169|P1|Overall Study|Physician Decision|1
167432|NCT00252564|531168|P2|Overall Study|Protocol Violation|0
167433|NCT00252564|531169|P1|Overall Study|Protocol Violation|0
167434|NCT00252564|531168|P2|Overall Study|Death|3
167435|NCT00252564|531169|P1|Overall Study|Death|0
167436|NCT00252564|531168|P2|Overall Study|Disease Progression|20
167437|NCT00252564|531169|P1|Overall Study|Disease Progression|14
167438|NCT00252564|531168|P2|Overall Study|Unrelated Complication|1
167439|NCT00252564|531169|P1|Overall Study|Unrelated Complication|2
167440|NCT00252564|531168|P2|Overall Study|Adverse Event|13
167441|NCT00252564|531169|P1|Overall Study|Adverse Event|17
167442|NCT00252499|531199|P3|Overall Study|Lost to Follow-up|0
167443|NCT00252499|531200|P2|Overall Study|Lost to Follow-up|0
167444|NCT00252499|531201|P1|Overall Study|Lost to Follow-up|1
167445|NCT00252239|531228|P4|Overall Study|Lost to Follow-up|0
167446|NCT00252239|531229|P3|Overall Study|Lost to Follow-up|2
167447|NCT00252239|531230|P2|Overall Study|Lost to Follow-up|0
167448|NCT00252239|531231|P1|Overall Study|Lost to Follow-up|0
167449|NCT00252239|531228|P4|Overall Study|Withdrawal by Subject|1
167450|NCT00252239|531229|P3|Overall Study|Withdrawal by Subject|0
167451|NCT00252239|531230|P2|Overall Study|Withdrawal by Subject|0
167452|NCT00252239|531231|P1|Overall Study|Withdrawal by Subject|1
167453|NCT00252187|531243|P2|Overall Study|Withdrawal by Subject|0
167454|NCT00252187|531244|P1|Overall Study|Withdrawal by Subject|1
167455|NCT00252187|531243|P2|Overall Study|Adverse Event|1
167456|NCT00252187|531244|P1|Overall Study|Adverse Event|3
167457|NCT00252057|531266|P2|Overall Study|Participant previously enrolled|1
167458|NCT00252057|531267|P1|Overall Study|Participant previously enrolled|0
167459|NCT00252057|531266|P2|Overall Study|Death|2
167460|NCT00252057|531267|P1|Overall Study|Death|1
167461|NCT00252057|531266|P2|Overall Study|Withdrawal by Subject|5
167462|NCT00252057|531267|P1|Overall Study|Withdrawal by Subject|2
167463|NCT00251979|531273|P2|Overall Study|Death|5
167464|NCT00251979|531274|P1|Overall Study|Death|3
167465|NCT00251979|531273|P2|Overall Study|Lost to Follow-up|6
167466|NCT00251979|531274|P1|Overall Study|Lost to Follow-up|8
167467|NCT00251979|531273|P2|Overall Study|Withdrawal by Subject|7
167468|NCT00251979|531274|P1|Overall Study|Withdrawal by Subject|13
167469|NCT00251979|531273|P2|Overall Study|Adverse Event|17
167470|NCT00251979|531274|P1|Overall Study|Adverse Event|11
167471|NCT00251979|531273|P2|Overall Study|Protocol Violation|5
167472|NCT00251979|531274|P1|Overall Study|Protocol Violation|3
167473|NCT00251927|531306|P2|Overall Study|Study procedure non-compliance|6
167474|NCT00251927|531307|P1|Overall Study|Study procedure non-compliance|5
167475|NCT00251927|531306|P2|Overall Study|Study-specific discont. achieved|2
167476|NCT00251927|531307|P1|Overall Study|Study-specific discont. achieved|13
167477|NCT00251927|531306|P2|Overall Study|Withdrawal by Subject|25
167478|NCT00251927|531307|P1|Overall Study|Withdrawal by Subject|40
167479|NCT00251927|531306|P2|Overall Study|Pregnancy|0
167480|NCT00251927|531307|P1|Overall Study|Pregnancy|2
167481|NCT00251927|531306|P2|Overall Study|Protocol Violation|2
167482|NCT00251927|531307|P1|Overall Study|Protocol Violation|1
167483|NCT00251927|531306|P2|Overall Study|Lost to Follow-up|8
167484|NCT00251927|531307|P1|Overall Study|Lost to Follow-up|22
167485|NCT00251927|531306|P2|Overall Study|Lack of Efficacy|16
167486|NCT00251927|531307|P1|Overall Study|Lack of Efficacy|22
167487|NCT00251927|531306|P2|Overall Study|Adverse Event|15
167488|NCT00251927|531307|P1|Overall Study|Adverse Event|3
167489|NCT00251004|531359|P3|Overall Study|Graft Loss|8
167490|NCT00251004|531360|P2|Overall Study|Graft Loss|13
167491|NCT00251004|531361|P1|Overall Study|Graft Loss|12
167492|NCT00251004|531359|P3|Overall Study|Lost to Follow-up|1
167493|NCT00251004|531360|P2|Overall Study|Lost to Follow-up|2
167494|NCT00251004|531361|P1|Overall Study|Lost to Follow-up|1
167495|NCT00251004|531359|P3|Overall Study|Death|8
167496|NCT00251004|531360|P2|Overall Study|Death|10
167497|NCT00251004|531361|P1|Overall Study|Death|9
167498|NCT00251004|531359|P3|Overall Study|Withdrawal by Subject|14
167499|NCT00251004|531360|P2|Overall Study|Withdrawal by Subject|16
167500|NCT00251004|531361|P1|Overall Study|Withdrawal by Subject|23
167501|NCT00250835|531385|P1|Overall Study|Withdrawal by Subject|1
167502|NCT00251758|531397|P3|Overall Study|Per Investigator Request|0
167503|NCT00251758|531398|P2|Overall Study|Per Investigator Request|0
167504|NCT00251758|531399|P1|Overall Study|Per Investigator Request|1
167505|NCT00251758|531397|P3|Overall Study|Per Subject Request|1
167506|NCT00251758|531398|P2|Overall Study|Per Subject Request|0
167507|NCT00251758|531399|P1|Overall Study|Per Subject Request|0
167508|NCT00251758|531397|P3|Overall Study|Pregnancy|0
167509|NCT00251758|531398|P2|Overall Study|Pregnancy|1
167510|NCT00251758|531399|P1|Overall Study|Pregnancy|0
167511|NCT00251758|531397|P3|Overall Study|Noncompliant|2
167512|NCT00251758|531398|P2|Overall Study|Noncompliant|2
167513|NCT00251758|531399|P1|Overall Study|Noncompliant|0
167514|NCT00251758|531397|P3|Overall Study|Lack of Efficacy|0
167515|NCT00251758|531398|P2|Overall Study|Lack of Efficacy|0
167516|NCT00251758|531399|P1|Overall Study|Lack of Efficacy|3
167517|NCT00251758|531397|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
167518|NCT00251758|531398|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
167519|NCT00251758|531399|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
167520|NCT00251758|531397|P3|Overall Study|Withdrawal by Subject|3
167521|NCT00251758|531398|P2|Overall Study|Withdrawal by Subject|7
167522|NCT00251758|531399|P1|Overall Study|Withdrawal by Subject|13
167523|NCT00251758|531397|P3|Overall Study|Lost to Follow-up|5
167524|NCT00251758|531398|P2|Overall Study|Lost to Follow-up|2
167525|NCT00251758|531399|P1|Overall Study|Lost to Follow-up|4
167526|NCT00251758|531397|P3|Overall Study|Adverse Event|11
167527|NCT00251758|531398|P2|Overall Study|Adverse Event|9
167528|NCT00251758|531399|P1|Overall Study|Adverse Event|7
167529|NCT00251745|531419|P3|Overall Study|Per Investigator Request|0
167530|NCT00251745|531420|P2|Overall Study|Per Investigator Request|0
167531|NCT00251745|531421|P1|Overall Study|Per Investigator Request|1
167532|NCT00251745|531419|P3|Overall Study|Per Subject Request|1
167533|NCT00251745|531420|P2|Overall Study|Per Subject Request|0
167534|NCT00251745|531421|P1|Overall Study|Per Subject Request|0
167535|NCT00251745|531419|P3|Overall Study|Pregnancy|0
167536|NCT00251745|531420|P2|Overall Study|Pregnancy|1
167537|NCT00251745|531421|P1|Overall Study|Pregnancy|0
167538|NCT00251745|531419|P3|Overall Study|Noncompliant|2
167539|NCT00251745|531420|P2|Overall Study|Noncompliant|2
167540|NCT00251745|531421|P1|Overall Study|Noncompliant|0
167541|NCT00251745|531419|P3|Overall Study|Lack of Efficacy|0
167542|NCT00251745|531420|P2|Overall Study|Lack of Efficacy|0
167543|NCT00251745|531421|P1|Overall Study|Lack of Efficacy|3
167544|NCT00251745|531419|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
167545|NCT00251745|531420|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
167546|NCT00251745|531421|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
167547|NCT00251745|531419|P3|Overall Study|Withdrawal by Subject|3
167548|NCT00251745|531420|P2|Overall Study|Withdrawal by Subject|7
167549|NCT00251745|531421|P1|Overall Study|Withdrawal by Subject|13
167550|NCT00251745|531419|P3|Overall Study|Lost to Follow-up|5
167551|NCT00251745|531420|P2|Overall Study|Lost to Follow-up|2
167552|NCT00251745|531421|P1|Overall Study|Lost to Follow-up|4
167553|NCT00251745|531419|P3|Overall Study|Adverse Event|11
167554|NCT00251745|531420|P2|Overall Study|Adverse Event|9
167555|NCT00251745|531421|P1|Overall Study|Adverse Event|7
167556|NCT00251719|531441|P3|Overall Study|Barrett's esophagus|0
167557|NCT00251719|531442|P2|Overall Study|Barrett's esophagus|2
167558|NCT00251719|531443|P1|Overall Study|Barrett's esophagus|2
167559|NCT00251719|531441|P3|Overall Study|Noncompliance|1
167560|NCT00251719|531442|P2|Overall Study|Noncompliance|3
167561|NCT00251719|531443|P1|Overall Study|Noncompliance|2
167562|NCT00251719|531441|P3|Overall Study|Investigator decision|0
167563|NCT00251719|531442|P2|Overall Study|Investigator decision|1
167564|NCT00251719|531443|P1|Overall Study|Investigator decision|1
167565|NCT00251719|531441|P3|Overall Study|Inclusion/exclusion criteria not met|2
167566|NCT00251719|531442|P2|Overall Study|Inclusion/exclusion criteria not met|6
167567|NCT00251719|531443|P1|Overall Study|Inclusion/exclusion criteria not met|12
167568|NCT00251719|531441|P3|Overall Study|Lack of Efficacy|0
167569|NCT00251719|531442|P2|Overall Study|Lack of Efficacy|1
167570|NCT00251719|531443|P1|Overall Study|Lack of Efficacy|2
167571|NCT00251719|531441|P3|Overall Study|Withdrawal by Subject|11
167572|NCT00251719|531442|P2|Overall Study|Withdrawal by Subject|12
167573|NCT00251719|531443|P1|Overall Study|Withdrawal by Subject|14
167574|NCT00251719|531441|P3|Overall Study|Lost to Follow-up|8
167575|NCT00251719|531442|P2|Overall Study|Lost to Follow-up|11
167576|NCT00251719|531443|P1|Overall Study|Lost to Follow-up|5
167577|NCT00251719|531441|P3|Overall Study|Protocol Violation|1
167578|NCT00251719|531442|P2|Overall Study|Protocol Violation|1
167579|NCT00251719|531443|P1|Overall Study|Protocol Violation|1
167580|NCT00251719|531441|P3|Overall Study|Adverse Event|7
167581|NCT00251719|531442|P2|Overall Study|Adverse Event|8
167582|NCT00251719|531443|P1|Overall Study|Adverse Event|14
167583|NCT00251693|531469|P3|Overall Study|Abnormal laboratory findings|1
167584|NCT00251693|531470|P2|Overall Study|Abnormal laboratory findings|0
167585|NCT00251693|531471|P1|Overall Study|Abnormal laboratory findings|0
167586|NCT00251693|531469|P3|Overall Study|Subject request/subject unavailable|0
167587|NCT00251693|531470|P2|Overall Study|Subject request/subject unavailable|2
167588|NCT00251693|531471|P1|Overall Study|Subject request/subject unavailable|1
167589|NCT00251693|531469|P3|Overall Study|Possible Barrett's esophagus|2
167590|NCT00251693|531470|P2|Overall Study|Possible Barrett's esophagus|5
167591|NCT00251693|531471|P1|Overall Study|Possible Barrett's esophagus|3
167592|NCT00251693|531469|P3|Overall Study|Noncompliant|2
167593|NCT00251693|531470|P2|Overall Study|Noncompliant|0
167594|NCT00251693|531471|P1|Overall Study|Noncompliant|0
167595|NCT00251693|531469|P3|Overall Study|Inclusion/exclusion criteria not met|8
167596|NCT00251693|531470|P2|Overall Study|Inclusion/exclusion criteria not met|3
167597|NCT00251693|531471|P1|Overall Study|Inclusion/exclusion criteria not met|5
167598|NCT00251693|531469|P3|Overall Study|Lack of Efficacy|0
167599|NCT00251693|531470|P2|Overall Study|Lack of Efficacy|1
167600|NCT00251693|531471|P1|Overall Study|Lack of Efficacy|0
167601|NCT00251693|531469|P3|Overall Study|Withdrawal by Subject|14
167602|NCT00251693|531470|P2|Overall Study|Withdrawal by Subject|17
167603|NCT00251693|531471|P1|Overall Study|Withdrawal by Subject|11
167604|NCT00251693|531469|P3|Overall Study|Lost to Follow-up|8
167605|NCT00251693|531470|P2|Overall Study|Lost to Follow-up|7
167606|NCT00251693|531471|P1|Overall Study|Lost to Follow-up|12
167607|NCT00251693|531469|P3|Overall Study|Protocol Violation|2
167608|NCT00251693|531470|P2|Overall Study|Protocol Violation|0
167609|NCT00251693|531471|P1|Overall Study|Protocol Violation|2
167610|NCT00251693|531469|P3|Overall Study|Adverse Event|9
167611|NCT00251693|531470|P2|Overall Study|Adverse Event|9
167612|NCT00251693|531471|P1|Overall Study|Adverse Event|17
167613|NCT00251641|531496|P2|Overall Study|Switched Treatment|63
167614|NCT00251641|531497|P1|Overall Study|Switched Treatment|9
167615|NCT00251641|531496|P2|Overall Study|Did not Meet protocol Eligibility|1
167616|NCT00251641|531497|P1|Overall Study|Did not Meet protocol Eligibility|2
167617|NCT00251641|531496|P2|Overall Study|Protocol Violation|2
167618|NCT00251641|531497|P1|Overall Study|Protocol Violation|10
167619|NCT00251641|531496|P2|Overall Study|Withdrawal by Subject|8
167620|NCT00251641|531497|P1|Overall Study|Withdrawal by Subject|6
167621|NCT00251641|531496|P2|Overall Study|Lost to Follow-up|3
167622|NCT00251641|531497|P1|Overall Study|Lost to Follow-up|3
167623|NCT00251641|531496|P2|Overall Study|Progression of Disease|2
167624|NCT00251641|531497|P1|Overall Study|Progression of Disease|0
167625|NCT00251641|531496|P2|Overall Study|Lack of Efficacy|1
167626|NCT00251641|531497|P1|Overall Study|Lack of Efficacy|2
167627|NCT00251641|531496|P2|Overall Study|Adverse Event|8
167628|NCT00251641|531497|P1|Overall Study|Adverse Event|80
167629|NCT00251589|531515|P4|Overall Study|Discontinued due to progressive disease|1
167630|NCT00251589|531516|P3|Overall Study|Discontinued due to progressive disease|0
167631|NCT00251589|531517|P2|Overall Study|Discontinued due to progressive disease|1
167632|NCT00251589|531518|P1|Overall Study|Discontinued due to progressive disease|9
167633|NCT00251589|531515|P4|Overall Study|Withdrawal by Subject|0
167634|NCT00251589|531516|P3|Overall Study|Withdrawal by Subject|0
167635|NCT00251589|531517|P2|Overall Study|Withdrawal by Subject|1
167636|NCT00251589|531518|P1|Overall Study|Withdrawal by Subject|1
167637|NCT00251589|531515|P4|Overall Study|Adverse Event|1
167638|NCT00251589|531516|P3|Overall Study|Adverse Event|2
167639|NCT00251589|531517|P2|Overall Study|Adverse Event|1
167640|NCT00251589|531518|P1|Overall Study|Adverse Event|5
167641|NCT00251316|531555|P2|Overall Study|Physician Decision|3
167642|NCT00251316|531556|P1|Overall Study|Physician Decision|2
167643|NCT00250718|531573|P1|Overall Study|Withdrawal by Subject|1
167644|NCT00250718|531573|P1|Overall Study|Adverse Event|1
167645|NCT00250718|531573|P1|Overall Study|Death|1
167646|NCT00250679|531581|P3|Overall Study|various single events: hip surgery,diary|1
167647|NCT00250679|531582|P2|Overall Study|various single events: hip surgery,diary|1
167648|NCT00250679|531583|P1|Overall Study|various single events: hip surgery,diary|3
167649|NCT00250679|531581|P3|Overall Study|Non-compliance|0
167650|NCT00250679|531582|P2|Overall Study|Non-compliance|1
167651|NCT00250679|531583|P1|Overall Study|Non-compliance|1
167652|NCT00250679|531581|P3|Overall Study|Moved|0
167653|NCT00250679|531582|P2|Overall Study|Moved|1
167654|NCT00250679|531583|P1|Overall Study|Moved|1
167655|NCT00250679|531581|P3|Overall Study|Technical Holter issues|2
167656|NCT00250679|531582|P2|Overall Study|Technical Holter issues|0
167657|NCT00250679|531583|P1|Overall Study|Technical Holter issues|1
167658|NCT00250679|531581|P3|Overall Study|Lack of Efficacy|3
167659|NCT00250679|531582|P2|Overall Study|Lack of Efficacy|1
167660|NCT00250679|531583|P1|Overall Study|Lack of Efficacy|0
167661|NCT00250679|531581|P3|Overall Study|Does Not Meet Entry Criteria|2
167662|NCT00250679|531582|P2|Overall Study|Does Not Meet Entry Criteria|4
167663|NCT00250679|531583|P1|Overall Study|Does Not Meet Entry Criteria|1
167664|NCT00250679|531581|P3|Overall Study|Lost to Follow-up|2
167665|NCT00250679|531582|P2|Overall Study|Lost to Follow-up|4
167666|NCT00250679|531583|P1|Overall Study|Lost to Follow-up|3
167667|NCT00250679|531581|P3|Overall Study|Withdrawal by Subject|15
167668|NCT00250679|531582|P2|Overall Study|Withdrawal by Subject|18
167669|NCT00250679|531583|P1|Overall Study|Withdrawal by Subject|15
167670|NCT00250679|531581|P3|Overall Study|Protocol Violation|3
167671|NCT00250679|531582|P2|Overall Study|Protocol Violation|4
167672|NCT00250679|531583|P1|Overall Study|Protocol Violation|2
167673|NCT00250679|531581|P3|Overall Study|Adverse Event|16
167674|NCT00250679|531582|P2|Overall Study|Adverse Event|15
167675|NCT00250679|531583|P1|Overall Study|Adverse Event|12
167676|NCT00250588|531684|P3|Overall Study|Lost to Follow-up|13
167677|NCT00250588|531685|P2|Overall Study|Lost to Follow-up|13
167678|NCT00250588|531686|P1|Overall Study|Lost to Follow-up|6
167679|NCT00250588|531684|P3|Overall Study|Withdrawal by Subject|0
167680|NCT00250588|531685|P2|Overall Study|Withdrawal by Subject|6
167681|NCT00250588|531686|P1|Overall Study|Withdrawal by Subject|3
167682|NCT00250458|531732|P2|Overall Study|Not Specified|0
167683|NCT00250458|531733|P1|Overall Study|Not Specified|1
167684|NCT00250458|531732|P2|Overall Study|Qualifying migraine but did not treat|3
167685|NCT00250458|531733|P1|Overall Study|Qualifying migraine but did not treat|3
167686|NCT00250458|531732|P2|Overall Study|Lack of Migraine Attack|9
167687|NCT00250458|531733|P1|Overall Study|Lack of Migraine Attack|20
167688|NCT00250458|531732|P2|Overall Study|Withdrawal by Subject|2
167689|NCT00250458|531733|P1|Overall Study|Withdrawal by Subject|4
167690|NCT00250458|531732|P2|Overall Study|Protocol Violation|1
167691|NCT00250458|531733|P1|Overall Study|Protocol Violation|0
167692|NCT00250458|531732|P2|Overall Study|Lost to Follow-up|2
167693|NCT00250458|531733|P1|Overall Study|Lost to Follow-up|4
167694|NCT00250432|531743|P2|Overall Study|Pt was considered untreatable|1
167695|NCT00250432|531744|P1|Overall Study|Pt was considered untreatable|0
167696|NCT00250432|531743|P2|Overall Study|Pt died out of posttherapy report period|5
167697|NCT00250432|531744|P1|Overall Study|Pt died out of posttherapy report period|6
167698|NCT00250432|531743|P2|Overall Study|Withdrawal by Subject|2
167699|NCT00250432|531744|P1|Overall Study|Withdrawal by Subject|6
167700|NCT00250432|531743|P2|Overall Study|Protocol Violation|3
167701|NCT00250432|531744|P1|Overall Study|Protocol Violation|0
167702|NCT00250432|531743|P2|Overall Study|Patient Moved|1
167703|NCT00250432|531744|P1|Overall Study|Patient Moved|0
167704|NCT00250432|531743|P2|Overall Study|Lost to Follow-up|5
167705|NCT00250432|531744|P1|Overall Study|Lost to Follow-up|6
167706|NCT00250432|531743|P2|Overall Study|Lack of Efficacy|1
167707|NCT00250432|531744|P1|Overall Study|Lack of Efficacy|2
167708|NCT00250432|531743|P2|Overall Study|Adverse Event|29
167709|NCT00250432|531744|P1|Overall Study|Adverse Event|25
167710|NCT00249873|531754|P2|Overall Study|Thromboembolic/outcome event|122
167711|NCT00249873|531755|P1|Overall Study|Thromboembolic/outcome event|82
167712|NCT00249873|531754|P2|Overall Study|Event related to cardiac condition|21
167713|NCT00249873|531755|P1|Overall Study|Event related to cardiac condition|12
167714|NCT00249873|531754|P2|Overall Study|Surgery/ procedure|9
167715|NCT00249873|531755|P1|Overall Study|Surgery/ procedure|9
167716|NCT00249873|531754|P2|Overall Study|Study drug intolerance|0
167717|NCT00249873|531755|P1|Overall Study|Study drug intolerance|5
167718|NCT00249873|531754|P2|Overall Study|Oral anticoagulant required|157
167719|NCT00249873|531755|P1|Overall Study|Oral anticoagulant required|159
167720|NCT00249873|531754|P2|Overall Study|Angiotensin II receptor blocker required|0
167721|NCT00249873|531755|P1|Overall Study|Angiotensin II receptor blocker required|1
167722|NCT00249873|531754|P2|Overall Study|Open label clopidogrel required|42
167723|NCT00249873|531755|P1|Overall Study|Open label clopidogrel required|31
167724|NCT00249873|531754|P2|Overall Study|Physician withdrew consent|60
167725|NCT00249873|531755|P1|Overall Study|Physician withdrew consent|59
167726|NCT00249873|531754|P2|Overall Study|Patient not wish to continue after May08|4
167727|NCT00249873|531755|P1|Overall Study|Patient not wish to continue after May08|3
167728|NCT00249873|531754|P2|Overall Study|Other contraindicated medication|0
167729|NCT00249873|531755|P1|Overall Study|Other contraindicated medication|1
167730|NCT00249873|531754|P2|Overall Study|Other non serious Adverse Event|108
167731|NCT00249873|531755|P1|Overall Study|Other non serious Adverse Event|112
167732|NCT00249873|531754|P2|Overall Study|Non-compliance|46
167733|NCT00249873|531755|P1|Overall Study|Non-compliance|41
167734|NCT00249873|531754|P2|Overall Study|Minor bleeding|37
167735|NCT00249873|531755|P1|Overall Study|Minor bleeding|99
167736|NCT00249873|531754|P2|Overall Study|Lost to Follow-up|7
167737|NCT00249873|531755|P1|Overall Study|Lost to Follow-up|4
167738|NCT00249873|531754|P2|Overall Study|Withdrawal by Subject|466
167739|NCT00249873|531755|P1|Overall Study|Withdrawal by Subject|504
167740|NCT00249873|531754|P2|Overall Study|Contraindication to oral anticoagulant|8
167741|NCT00249873|531755|P1|Overall Study|Contraindication to oral anticoagulant|4
167742|NCT00249873|531754|P2|Overall Study|Qualifying condition not present|23
167743|NCT00249873|531755|P1|Overall Study|Qualifying condition not present|20
167744|NCT00249873|531754|P2|Overall Study|Other Serious Adverse Event|97
167745|NCT00249873|531755|P1|Overall Study|Other Serious Adverse Event|86
167746|NCT00249873|531754|P2|Overall Study|Serious haemorrhagic Adverse Event|30
167747|NCT00249873|531755|P1|Overall Study|Serious haemorrhagic Adverse Event|74
167748|NCT00249873|531754|P2|Overall Study|Severe allergic reaction|1
167749|NCT00249873|531755|P1|Overall Study|Severe allergic reaction|8
167750|NCT00249873|531754|P2|Overall Study|Significant thrombocytopenia|8
167751|NCT00249873|531755|P1|Overall Study|Significant thrombocytopenia|9
167752|NCT00249873|531754|P2|Overall Study|Not treated|8
167753|NCT00249873|531755|P1|Overall Study|Not treated|7
167754|NCT00249821|531769|P2|Overall Study|Technical problem|1
167755|NCT00249821|531770|P1|Overall Study|Technical problem|0
167756|NCT00249795|531792|P2|Overall Study|Missing|1
167757|NCT00249795|531793|P1|Overall Study|Missing|0
167758|NCT00249795|531792|P2|Overall Study|Lost to Follow-up|2
167759|NCT00249795|531793|P1|Overall Study|Lost to Follow-up|0
167760|NCT00249795|531792|P2|Overall Study|Site not agree to continue after May08|1
167761|NCT00249795|531793|P1|Overall Study|Site not agree to continue after May08|1
167762|NCT00249795|531792|P2|Overall Study|Patient not wish to continue after May08|6
167763|NCT00249795|531793|P1|Overall Study|Patient not wish to continue after May08|4
167764|NCT00249795|531792|P2|Overall Study|Event related to cardiac condition|16
167765|NCT00249795|531793|P1|Overall Study|Event related to cardiac condition|17
167766|NCT00249795|531792|P2|Overall Study|Other contraindicated medication|1
167767|NCT00249795|531793|P1|Overall Study|Other contraindicated medication|1
167768|NCT00249795|531792|P2|Overall Study|Hypotension (non-symptomatic)|5
167769|NCT00249795|531793|P1|Overall Study|Hypotension (non-symptomatic)|5
167770|NCT00249795|531792|P2|Overall Study|Lightheadedness / dizziness|11
167771|NCT00249795|531793|P1|Overall Study|Lightheadedness / dizziness|15
167772|NCT00249795|531792|P2|Overall Study|Angiotensin II receptor blocker required|58
167773|NCT00249795|531793|P1|Overall Study|Angiotensin II receptor blocker required|35
167774|NCT00249795|531792|P2|Overall Study|Surgery / procedure|5
167775|NCT00249795|531793|P1|Overall Study|Surgery / procedure|4
167776|NCT00249795|531792|P2|Overall Study|Physician withdrew consent|63
167777|NCT00249795|531793|P1|Overall Study|Physician withdrew consent|71
167778|NCT00249795|531792|P2|Overall Study|Other adverse events (non-serious)|159
167779|NCT00249795|531793|P1|Overall Study|Other adverse events (non-serious)|188
167780|NCT00249795|531792|P2|Overall Study|Study drug intolerance|3
167781|NCT00249795|531793|P1|Overall Study|Study drug intolerance|3
167782|NCT00249795|531792|P2|Overall Study|Non-compliance|69
167783|NCT00249795|531793|P1|Overall Study|Non-compliance|71
167784|NCT00249795|531792|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
167785|NCT00249795|531793|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
167786|NCT00249795|531792|P2|Overall Study|Oral anticoagulant required|0
167787|NCT00249795|531793|P1|Overall Study|Oral anticoagulant required|2
167788|NCT00249795|531792|P2|Overall Study|Thromboembolic / outcome event|45
167789|NCT00249795|531793|P1|Overall Study|Thromboembolic / outcome event|39
167790|NCT00249795|531792|P2|Overall Study|Withdrawal by Subject|742
167791|NCT00249795|531793|P1|Overall Study|Withdrawal by Subject|678
167792|NCT00249795|531792|P2|Overall Study|Qualifying condition not present|29
167793|NCT00249795|531793|P1|Overall Study|Qualifying condition not present|26
167794|NCT00249795|531792|P2|Overall Study|Other Serious Adverse Event|93
167795|NCT00249795|531793|P1|Overall Study|Other Serious Adverse Event|84
167796|NCT00249795|531792|P2|Overall Study|Symptomatic hypotension|64
167797|NCT00249795|531793|P1|Overall Study|Symptomatic hypotension|127
167798|NCT00249795|531792|P2|Overall Study|Not treated|14
167799|NCT00249795|531793|P1|Overall Study|Not treated|16
167800|NCT00249613|531813|P2|12 Month Follow-up|Lost to Follow-up|8
167801|NCT00249613|531814|P1|12 Month Follow-up|Lost to Follow-up|10
167802|NCT00249613|531813|P2|12 Month Follow-up|Withdrawal by Subject|6
167803|NCT00249613|531814|P1|12 Month Follow-up|Withdrawal by Subject|6
167804|NCT00249613|531813|P2|12 Month Follow-up|Death|1
167805|NCT00249613|531814|P1|12 Month Follow-up|Death|1
167806|NCT00249288|531858|P2|Overall Study|Withdrawal by Subject|2
167807|NCT00249288|531859|P1|Overall Study|Withdrawal by Subject|2
167808|NCT00249288|531858|P2|Overall Study|Lost to Follow-up|3
167809|NCT00249288|531859|P1|Overall Study|Lost to Follow-up|3
167810|NCT00247962|531928|P2|Overall Study|Lack of Efficacy|2
167811|NCT00247962|531929|P1|Overall Study|Lack of Efficacy|4
167812|NCT00247962|531928|P2|Overall Study|Withdrawal by Subject|2
167813|NCT00247962|531929|P1|Overall Study|Withdrawal by Subject|3
167814|NCT00247962|531928|P2|Overall Study|Protocol Violation|1
167815|NCT00247962|531929|P1|Overall Study|Protocol Violation|1
167816|NCT00247962|531928|P2|Overall Study|Physician Decision|1
167817|NCT00247962|531929|P1|Overall Study|Physician Decision|0
167818|NCT00247962|531928|P2|Overall Study|Lost to Follow-up|1
167819|NCT00247962|531929|P1|Overall Study|Lost to Follow-up|3
167820|NCT00247962|531928|P2|Overall Study|Adverse Event|12
167821|NCT00247962|531929|P1|Overall Study|Adverse Event|15
167822|NCT00249002|531937|P1|Overall Study|Unspecified|2
167823|NCT00249002|531937|P1|Overall Study|Study cancellation|3
167824|NCT00249002|531937|P1|Overall Study|Adverse Event|2
167825|NCT00248794|531973|P3|Overall Study|Lost to Follow-up|3
167826|NCT00248794|531974|P2|Overall Study|Lost to Follow-up|8
167827|NCT00248794|531975|P1|Overall Study|Lost to Follow-up|6
167828|NCT00248651|532025|P3|Overall Study|Withdrawal by Subject|32
167829|NCT00248651|532026|P2|Overall Study|Withdrawal by Subject|40
167830|NCT00248651|532027|P1|Overall Study|Withdrawal by Subject|28
167831|NCT00248625|532057|P2|Overall Study|Withdrawal by Subject|2
167832|NCT00248625|532058|P1|Overall Study|Withdrawal by Subject|0
167833|NCT00248287|532093|P2|Overall Study|Other|2
167834|NCT00248287|532094|P1|Overall Study|Other|3
167835|NCT00248287|532093|P2|Overall Study|Patient Request|3
167836|NCT00248287|532094|P1|Overall Study|Patient Request|5
167837|NCT00248287|532093|P2|Overall Study|Investigator Request|3
167838|NCT00248287|532094|P1|Overall Study|Investigator Request|4
167839|NCT00248287|532093|P2|Overall Study|Lost to Follow-up|1
167840|NCT00248287|532094|P1|Overall Study|Lost to Follow-up|0
167841|NCT00248287|532093|P2|Overall Study|Death|0
167842|NCT00248287|532094|P1|Overall Study|Death|1
167843|NCT00248287|532093|P2|Overall Study|Adverse Event|10
167844|NCT00248287|532094|P1|Overall Study|Adverse Event|11
167845|NCT00248170|532108|P2|Overall Study|Protocol deviation|19
167846|NCT00248170|532109|P1|Overall Study|Protocol deviation|17
167847|NCT00248170|532108|P2|Overall Study|Abnormal laboratory values|0
167848|NCT00248170|532109|P1|Overall Study|Abnormal laboratory values|4
167849|NCT00248170|532108|P2|Overall Study|Abnormal test procedure(s) result|61
167850|NCT00248170|532109|P1|Overall Study|Abnormal test procedure(s) result|49
167851|NCT00248170|532108|P2|Overall Study|Administrative problems|25
167852|NCT00248170|532109|P1|Overall Study|Administrative problems|22
167853|NCT00248170|532108|P2|Overall Study|Adverse Event|296
167854|NCT00248170|532109|P1|Overall Study|Adverse Event|311
167855|NCT00248170|532108|P2|Overall Study|Death|47
167856|NCT00248170|532109|P1|Overall Study|Death|28
167857|NCT00248170|532108|P2|Overall Study|Disease progression|216
167858|NCT00248170|532109|P1|Overall Study|Disease progression|196
167859|NCT00248170|532108|P2|Overall Study|Lost to Follow-up|35
167860|NCT00248170|532109|P1|Overall Study|Lost to Follow-up|28
167861|NCT00248170|532108|P2|Overall Study|Protocol Violation|30
167862|NCT00248170|532109|P1|Overall Study|Protocol Violation|35
167863|NCT00248170|532108|P2|Overall Study|Withdrawal by Subject|79
167864|NCT00248170|532109|P1|Overall Study|Withdrawal by Subject|71
167865|NCT00247676|532129|P1|Overall Study|Withdrawal by Subject|2
167866|NCT00247676|532129|P1|Overall Study|Unspecified|3
167867|NCT00247676|532129|P1|Overall Study|Lack of Efficacy|15
167868|NCT00247676|532129|P1|Overall Study|Adverse Event|11
167869|NCT00247676|532129|P1|Overall Study|Death|5
167870|NCT00247611|532159|P2|Baselined|Completed baseline only|8
167871|NCT00247611|532160|P1|Baselined|Completed baseline only|9
167872|NCT00247611|532159|P2|Baselined|Completed baseline, never placed on ARVs|5
167873|NCT00247611|532160|P1|Baselined|Completed baseline, never placed on ARVs|8
167874|NCT00247416|532178|P2|Overall Study|3 patients were found to be ineligible|2
167875|NCT00247416|532179|P1|Overall Study|3 patients were found to be ineligible|1
167876|NCT00247273|532220|P2|Overall Study|Did not take any study drug|0
167877|NCT00247273|532221|P1|Overall Study|Did not take any study drug|2
167878|NCT00247273|532220|P2|Overall Study|Withdrawal by Subject|47
167879|NCT00247273|532221|P1|Overall Study|Withdrawal by Subject|46
167880|NCT00247273|532220|P2|Overall Study|Lost to Follow-up|7
167881|NCT00247273|532221|P1|Overall Study|Lost to Follow-up|7
167882|NCT00247273|532220|P2|Overall Study|Physician Decision|3
167883|NCT00247273|532221|P1|Overall Study|Physician Decision|6
167884|NCT00247273|532220|P2|Overall Study|Adverse Event|80
167885|NCT00247273|532221|P1|Overall Study|Adverse Event|85
167886|NCT00246805|532267|P2|Phase 1|Lost to Follow-up|0
167887|NCT00246805|532268|P1|Phase 1|Lost to Follow-up|1
167888|NCT00246571|532276|P2|Overall Study|Crossover participants|74
167889|NCT00246571|532277|P1|Overall Study|Crossover participants|0
167890|NCT00246571|532276|P2|Overall Study|Laboratory abnormalities|0
167891|NCT00246571|532277|P1|Overall Study|Laboratory abnormalities|1
167892|NCT00246571|532276|P2|Overall Study|Did not meet entrance criteria|1
167893|NCT00246571|532277|P1|Overall Study|Did not meet entrance criteria|2
167894|NCT00246571|532276|P2|Overall Study|Sponsor|1
167895|NCT00246571|532277|P1|Overall Study|Sponsor|0
167896|NCT00246571|532276|P2|Overall Study|Death|3
167897|NCT00246571|532277|P1|Overall Study|Death|17
167898|NCT00246571|532276|P2|Overall Study|Lack of Efficacy|21
167899|NCT00246571|532277|P1|Overall Study|Lack of Efficacy|84
167900|NCT00246571|532276|P2|Overall Study|Withdrawal by Subject|3
167901|NCT00246571|532277|P1|Overall Study|Withdrawal by Subject|2
167902|NCT00246571|532276|P2|Overall Study|Protocol Violation|1
167903|NCT00246571|532277|P1|Overall Study|Protocol Violation|0
167904|NCT00246571|532276|P2|Overall Study|Adverse Event|0
167905|NCT00246571|532277|P1|Overall Study|Adverse Event|7
167906|NCT00246376|532329|P5|Overall Study|Lost to Follow-up|13
167907|NCT00246376|532330|P4|Overall Study|Lost to Follow-up|16
167908|NCT00246376|532331|P3|Overall Study|Lost to Follow-up|11
167909|NCT00246376|532332|P2|Overall Study|Lost to Follow-up|11
167910|NCT00246376|532333|P1|Overall Study|Lost to Follow-up|2
167911|NCT00246376|532329|P5|Overall Study|Adverse Event|1
167912|NCT00246376|532330|P4|Overall Study|Adverse Event|3
167913|NCT00246376|532331|P3|Overall Study|Adverse Event|1
167914|NCT00246376|532332|P2|Overall Study|Adverse Event|3
167915|NCT00246376|532333|P1|Overall Study|Adverse Event|2
167916|NCT00246376|532329|P5|Overall Study|Dropped/withdrew during dietary run-in|3
167917|NCT00246376|532330|P4|Overall Study|Dropped/withdrew during dietary run-in|7
167918|NCT00246376|532331|P3|Overall Study|Dropped/withdrew during dietary run-in|4
167919|NCT00246376|532332|P2|Overall Study|Dropped/withdrew during dietary run-in|5
167920|NCT00246376|532333|P1|Overall Study|Dropped/withdrew during dietary run-in|11
167921|NCT00246337|532384|P9|Overall Study|Reported as completing trial in error|0
167922|NCT00246337|532385|P8|Overall Study|Reported as completing trial in error|1
167923|NCT00246337|532386|P7|Overall Study|Reported as completing trial in error|0
167924|NCT00246337|532387|P6|Overall Study|Reported as completing trial in error|0
167925|NCT00246337|532388|P5|Overall Study|Reported as completing trial in error|0
167926|NCT00246337|532389|P4|Overall Study|Reported as completing trial in error|0
167927|NCT00246337|532390|P3|Overall Study|Reported as completing trial in error|0
167928|NCT00246337|532391|P2|Overall Study|Reported as completing trial in error|0
167929|NCT00246337|532392|P1|Overall Study|Reported as completing trial in error|0
167930|NCT00246337|532384|P9|Overall Study|Protocol Violator|0
167931|NCT00246337|532385|P8|Overall Study|Protocol Violator|0
167932|NCT00246337|532386|P7|Overall Study|Protocol Violator|0
167933|NCT00246337|532387|P6|Overall Study|Protocol Violator|0
167934|NCT00246337|532388|P5|Overall Study|Protocol Violator|0
167935|NCT00246337|532389|P4|Overall Study|Protocol Violator|0
167936|NCT00246337|532390|P3|Overall Study|Protocol Violator|0
167937|NCT00246337|532391|P2|Overall Study|Protocol Violator|0
167938|NCT00246337|532392|P1|Overall Study|Protocol Violator|1
167939|NCT00246337|532384|P9|Overall Study|Overwhelmed|0
167940|NCT00246337|532385|P8|Overall Study|Overwhelmed|0
167941|NCT00246337|532386|P7|Overall Study|Overwhelmed|0
167942|NCT00246337|532387|P6|Overall Study|Overwhelmed|1
167943|NCT00246337|532388|P5|Overall Study|Overwhelmed|0
167944|NCT00246337|532389|P4|Overall Study|Overwhelmed|0
167945|NCT00246337|532390|P3|Overall Study|Overwhelmed|0
167946|NCT00246337|532391|P2|Overall Study|Overwhelmed|0
167947|NCT00246337|532392|P1|Overall Study|Overwhelmed|0
167948|NCT00246337|532384|P9|Overall Study|Abnormal baseline lab values|4
167949|NCT00246337|532385|P8|Overall Study|Abnormal baseline lab values|0
167950|NCT00246337|532386|P7|Overall Study|Abnormal baseline lab values|2
167951|NCT00246337|532387|P6|Overall Study|Abnormal baseline lab values|2
167952|NCT00246337|532388|P5|Overall Study|Abnormal baseline lab values|0
167953|NCT00246337|532389|P4|Overall Study|Abnormal baseline lab values|0
167954|NCT00246337|532390|P3|Overall Study|Abnormal baseline lab values|2
167955|NCT00246337|532391|P2|Overall Study|Abnormal baseline lab values|0
167956|NCT00246337|532392|P1|Overall Study|Abnormal baseline lab values|7
167957|NCT00246337|532384|P9|Overall Study|Site Terminated|2
167958|NCT00246337|532385|P8|Overall Study|Site Terminated|6
167959|NCT00246337|532386|P7|Overall Study|Site Terminated|1
167960|NCT00246337|532387|P6|Overall Study|Site Terminated|7
167961|NCT00246337|532388|P5|Overall Study|Site Terminated|0
167962|NCT00246337|532389|P4|Overall Study|Site Terminated|0
167963|NCT00246337|532390|P3|Overall Study|Site Terminated|0
167964|NCT00246337|532391|P2|Overall Study|Site Terminated|0
167965|NCT00246337|532392|P1|Overall Study|Site Terminated|10
167966|NCT00246337|532384|P9|Overall Study|Lack of Qualifying Event|5
167967|NCT00246337|532385|P8|Overall Study|Lack of Qualifying Event|2
167968|NCT00246337|532386|P7|Overall Study|Lack of Qualifying Event|3
167969|NCT00246337|532387|P6|Overall Study|Lack of Qualifying Event|3
167970|NCT00246337|532388|P5|Overall Study|Lack of Qualifying Event|1
167971|NCT00246337|532389|P4|Overall Study|Lack of Qualifying Event|1
167972|NCT00246337|532390|P3|Overall Study|Lack of Qualifying Event|1
167973|NCT00246337|532391|P2|Overall Study|Lack of Qualifying Event|2
167974|NCT00246337|532392|P1|Overall Study|Lack of Qualifying Event|8
167975|NCT00246337|532384|P9|Overall Study|Withdrawal by Subject|0
167976|NCT00246337|532385|P8|Overall Study|Withdrawal by Subject|1
167977|NCT00246337|532386|P7|Overall Study|Withdrawal by Subject|1
167978|NCT00246337|532387|P6|Overall Study|Withdrawal by Subject|0
167979|NCT00246337|532388|P5|Overall Study|Withdrawal by Subject|0
167980|NCT00246337|532389|P4|Overall Study|Withdrawal by Subject|0
167981|NCT00246337|532390|P3|Overall Study|Withdrawal by Subject|0
167982|NCT00246337|532391|P2|Overall Study|Withdrawal by Subject|0
167983|NCT00246337|532392|P1|Overall Study|Withdrawal by Subject|2
167984|NCT00246337|532384|P9|Overall Study|Protocol Violation|0
167985|NCT00246337|532385|P8|Overall Study|Protocol Violation|1
167986|NCT00246337|532386|P7|Overall Study|Protocol Violation|1
167987|NCT00246337|532387|P6|Overall Study|Protocol Violation|0
167988|NCT00246337|532388|P5|Overall Study|Protocol Violation|1
167989|NCT00246337|532389|P4|Overall Study|Protocol Violation|0
167990|NCT00246337|532390|P3|Overall Study|Protocol Violation|0
167991|NCT00246337|532391|P2|Overall Study|Protocol Violation|0
167992|NCT00246337|532392|P1|Overall Study|Protocol Violation|1
167993|NCT00246337|532384|P9|Overall Study|Lost to Follow-up|0
167994|NCT00246337|532385|P8|Overall Study|Lost to Follow-up|2
167995|NCT00246337|532386|P7|Overall Study|Lost to Follow-up|1
167996|NCT00246337|532387|P6|Overall Study|Lost to Follow-up|2
167997|NCT00246337|532388|P5|Overall Study|Lost to Follow-up|2
167998|NCT00246337|532389|P4|Overall Study|Lost to Follow-up|0
167999|NCT00246337|532390|P3|Overall Study|Lost to Follow-up|0
168000|NCT00246337|532391|P2|Overall Study|Lost to Follow-up|0
168001|NCT00246337|532392|P1|Overall Study|Lost to Follow-up|3
168002|NCT00246324|532439|P1|Overall Study|Withdrawal by Subject|1
168003|NCT00246259|532446|P2|Overall Study|randomly assigned, not eligible for ITT|6
168004|NCT00246259|532447|P1|Overall Study|randomly assigned, not eligible for ITT|2
168005|NCT00246259|532446|P2|Overall Study|Withdrawal by Subject|1
168006|NCT00246259|532447|P1|Overall Study|Withdrawal by Subject|5
168007|NCT00246259|532446|P2|Overall Study|Lost to Follow-up|4
168008|NCT00246259|532447|P1|Overall Study|Lost to Follow-up|3
168009|NCT00246259|532446|P2|Overall Study|Adverse Event|0
168010|NCT00246259|532447|P1|Overall Study|Adverse Event|5
168011|NCT00246259|532446|P2|Overall Study|Investigator withdrew participant|0
168012|NCT00246259|532447|P1|Overall Study|Investigator withdrew participant|2
168013|NCT00246259|532446|P2|Overall Study|Lack of Efficacy|2
168014|NCT00246259|532447|P1|Overall Study|Lack of Efficacy|2
168015|NCT00246259|532446|P2|Overall Study|Participant non-compliant|9
168016|NCT00246259|532447|P1|Overall Study|Participant non-compliant|4
168017|NCT00246259|532446|P2|Overall Study|Not stable by Week 18|1
168018|NCT00246259|532447|P1|Overall Study|Not stable by Week 18|2
168019|NCT00246259|532446|P2|Overall Study|Unspecified|3
168020|NCT00246259|532447|P1|Overall Study|Unspecified|3
168021|NCT00246090|532481|P1|Overall Study|Not Otherwise Specified|10
168022|NCT00246090|532481|P1|Overall Study|Physician Decision|11
168023|NCT00246090|532481|P1|Overall Study|Clinical Progression|30
168024|NCT00246090|532481|P1|Overall Study|Progressive Disease|212
168025|NCT00246090|532481|P1|Overall Study|Withdrawal by Subject|7
168026|NCT00246090|532481|P1|Overall Study|Adverse Event|25
168027|NCT00246025|532490|P4|Overall Study|unsuitable medical history was found|1
168028|NCT00246025|532491|P3|Overall Study|unsuitable medical history was found|0
168029|NCT00246025|532492|P2|Overall Study|unsuitable medical history was found|0
168030|NCT00246025|532493|P1|Overall Study|unsuitable medical history was found|0
168031|NCT00246025|532490|P4|Overall Study|Withdrawal by Subject|2
168032|NCT00246025|532491|P3|Overall Study|Withdrawal by Subject|1
168033|NCT00246025|532492|P2|Overall Study|Withdrawal by Subject|0
168034|NCT00246025|532493|P1|Overall Study|Withdrawal by Subject|3
168035|NCT00246025|532490|P4|Overall Study|Adverse Event|10
168036|NCT00246025|532491|P3|Overall Study|Adverse Event|9
168037|NCT00246025|532492|P2|Overall Study|Adverse Event|9
168038|NCT00246025|532493|P1|Overall Study|Adverse Event|7
168039|NCT00246012|532552|P9|Overall Study|Randomly assigned but not treated|0
168040|NCT00246012|532553|P8|Overall Study|Randomly assigned but not treated|0
168041|NCT00246012|532554|P7|Overall Study|Randomly assigned but not treated|1
168042|NCT00246012|532555|P6|Overall Study|Randomly assigned but not treated|1
168043|NCT00246012|532556|P5|Overall Study|Randomly assigned but not treated|0
168044|NCT00246012|532557|P4|Overall Study|Randomly assigned but not treated|0
168045|NCT00246012|532558|P3|Overall Study|Randomly assigned but not treated|0
168046|NCT00246012|532559|P2|Overall Study|Randomly assigned but not treated|0
168047|NCT00246012|532560|P1|Overall Study|Randomly assigned but not treated|0
168048|NCT00246012|532552|P9|Overall Study|unspecified|0
168049|NCT00246012|532553|P8|Overall Study|unspecified|1
168050|NCT00246012|532554|P7|Overall Study|unspecified|0
168051|NCT00246012|532555|P6|Overall Study|unspecified|0
168052|NCT00246012|532556|P5|Overall Study|unspecified|0
168053|NCT00246012|532557|P4|Overall Study|unspecified|0
168054|NCT00246012|532558|P3|Overall Study|unspecified|0
168055|NCT00246012|532559|P2|Overall Study|unspecified|0
168056|NCT00246012|532560|P1|Overall Study|unspecified|0
168057|NCT00246012|532552|P9|Overall Study|Disease progression|26
168058|NCT00246012|532553|P8|Overall Study|Disease progression|27
168059|NCT00246012|532554|P7|Overall Study|Disease progression|30
168060|NCT00246012|532555|P6|Overall Study|Disease progression|25
168061|NCT00246012|532556|P5|Overall Study|Disease progression|3
168062|NCT00246012|532557|P4|Overall Study|Disease progression|3
168063|NCT00246012|532558|P3|Overall Study|Disease progression|2
168064|NCT00246012|532559|P2|Overall Study|Disease progression|1
168065|NCT00246012|532560|P1|Overall Study|Disease progression|3
168066|NCT00246012|532552|P9|Overall Study|Withdrawal by Subject|0
168067|NCT00246012|532553|P8|Overall Study|Withdrawal by Subject|0
168068|NCT00246012|532554|P7|Overall Study|Withdrawal by Subject|0
168069|NCT00246012|532555|P6|Overall Study|Withdrawal by Subject|1
168070|NCT00246012|532556|P5|Overall Study|Withdrawal by Subject|0
168071|NCT00246012|532557|P4|Overall Study|Withdrawal by Subject|0
168072|NCT00246012|532558|P3|Overall Study|Withdrawal by Subject|0
168073|NCT00246012|532559|P2|Overall Study|Withdrawal by Subject|0
168074|NCT00246012|532560|P1|Overall Study|Withdrawal by Subject|0
168075|NCT00246012|532552|P9|Overall Study|Adverse Event|2
168076|NCT00246012|532553|P8|Overall Study|Adverse Event|0
168077|NCT00246012|532554|P7|Overall Study|Adverse Event|0
168078|NCT00246012|532555|P6|Overall Study|Adverse Event|1
168079|NCT00246012|532556|P5|Overall Study|Adverse Event|0
168080|NCT00246012|532557|P4|Overall Study|Adverse Event|0
168081|NCT00246012|532558|P3|Overall Study|Adverse Event|0
168082|NCT00246012|532559|P2|Overall Study|Adverse Event|0
168083|NCT00246012|532560|P1|Overall Study|Adverse Event|0
168084|NCT00245960|532655|P2|Overall Study|Lack of Efficacy|6
168085|NCT00245960|532656|P1|Overall Study|Lack of Efficacy|4
168086|NCT00245960|532655|P2|Overall Study|Withdrawal by Subject|7
168087|NCT00245960|532656|P1|Overall Study|Withdrawal by Subject|5
168088|NCT00245960|532655|P2|Overall Study|Protocol Violation|3
168089|NCT00245960|532656|P1|Overall Study|Protocol Violation|4
168090|NCT00245960|532655|P2|Overall Study|Lost to Follow-up|2
168091|NCT00245960|532656|P1|Overall Study|Lost to Follow-up|2
168092|NCT00245960|532655|P2|Overall Study|Adverse Event|10
168093|NCT00245960|532656|P1|Overall Study|Adverse Event|14
168094|NCT00245856|532664|P2|Period Two|Withdrawal by Subject|1
168095|NCT00245856|532665|P1|Period Two|Withdrawal by Subject|0
168096|NCT00245570|532681|P6|Washout Between Periods III and IV|Adverse Event|0
168097|NCT00245570|532682|P5|Washout Between Periods III and IV|Adverse Event|0
168098|NCT00245570|532683|P4|Washout Between Periods III and IV|Adverse Event|0
168099|NCT00245570|532684|P3|Washout Between Periods III and IV|Adverse Event|0
168100|NCT00245570|532685|P2|Washout Between Periods III and IV|Adverse Event|1
168101|NCT00245570|532686|P1|Washout Between Periods III and IV|Adverse Event|0
168102|NCT00245466|532742|P3|Overall Study|Administrative reasons|0
168103|NCT00245466|532743|P2|Overall Study|Administrative reasons|1
168104|NCT00245466|532744|P1|Overall Study|Administrative reasons|0
168105|NCT00245466|532742|P3|Overall Study|Death|0
168106|NCT00245466|532743|P2|Overall Study|Death|2
168107|NCT00245466|532744|P1|Overall Study|Death|0
168108|NCT00245466|532742|P3|Overall Study|Protocol Violation|2
168109|NCT00245466|532743|P2|Overall Study|Protocol Violation|2
168110|NCT00245466|532744|P1|Overall Study|Protocol Violation|1
168111|NCT00245466|532742|P3|Overall Study|Disease progression|1
168112|NCT00245466|532743|P2|Overall Study|Disease progression|3
168113|NCT00245466|532744|P1|Overall Study|Disease progression|0
168114|NCT00245466|532742|P3|Overall Study|Lost to Follow-up|0
168115|NCT00245466|532743|P2|Overall Study|Lost to Follow-up|0
168116|NCT00245466|532744|P1|Overall Study|Lost to Follow-up|3
168117|NCT00245466|532742|P3|Overall Study|Withdrawal by Subject|1
168118|NCT00245466|532743|P2|Overall Study|Withdrawal by Subject|2
168119|NCT00245466|532744|P1|Overall Study|Withdrawal by Subject|2
168120|NCT00245466|532742|P3|Overall Study|Insufficient PSA and testosterone suppr|3
168121|NCT00245466|532743|P2|Overall Study|Insufficient PSA and testosterone suppr|0
168122|NCT00245466|532744|P1|Overall Study|Insufficient PSA and testosterone suppr|0
168123|NCT00245466|532742|P3|Overall Study|Insufficient testosterone suppr|21
168124|NCT00245466|532743|P2|Overall Study|Insufficient testosterone suppr|12
168125|NCT00245466|532744|P1|Overall Study|Insufficient testosterone suppr|12
168126|NCT00245466|532742|P3|Overall Study|Low prostate specific antigen suppr|5
168127|NCT00245466|532743|P2|Overall Study|Low prostate specific antigen suppr|14
168128|NCT00245466|532744|P1|Overall Study|Low prostate specific antigen suppr|16
168129|NCT00245466|532742|P3|Overall Study|Adverse Event|4
168130|NCT00245466|532743|P2|Overall Study|Adverse Event|8
168131|NCT00245466|532744|P1|Overall Study|Adverse Event|2
168132|NCT00245102|532787|P6|Overall Study|Clinical progression|0
168133|NCT00245102|532788|P5|Overall Study|Clinical progression|0
168134|NCT00245102|532789|P4|Overall Study|Clinical progression|0
168135|NCT00245102|532790|P3|Overall Study|Clinical progression|0
168136|NCT00245102|532791|P2|Overall Study|Clinical progression|0
168137|NCT00245102|532792|P1|Overall Study|Clinical progression|1
168138|NCT00245102|532787|P6|Overall Study|Participant needed surgery|0
168139|NCT00245102|532788|P5|Overall Study|Participant needed surgery|0
168140|NCT00245102|532789|P4|Overall Study|Participant needed surgery|0
168141|NCT00245102|532790|P3|Overall Study|Participant needed surgery|1
168142|NCT00245102|532791|P2|Overall Study|Participant needed surgery|0
168143|NCT00245102|532792|P1|Overall Study|Participant needed surgery|0
168144|NCT00245102|532787|P6|Overall Study|Decline in performance|2
168145|NCT00245102|532788|P5|Overall Study|Decline in performance|0
168146|NCT00245102|532789|P4|Overall Study|Decline in performance|1
168147|NCT00245102|532790|P3|Overall Study|Decline in performance|0
168148|NCT00245102|532791|P2|Overall Study|Decline in performance|2
168149|NCT00245102|532792|P1|Overall Study|Decline in performance|0
168150|NCT00245102|532787|P6|Overall Study|Adverse Event|2
168151|NCT00245102|532788|P5|Overall Study|Adverse Event|0
168152|NCT00245102|532789|P4|Overall Study|Adverse Event|1
168153|NCT00245102|532790|P3|Overall Study|Adverse Event|5
168154|NCT00245102|532791|P2|Overall Study|Adverse Event|2
168155|NCT00245102|532792|P1|Overall Study|Adverse Event|4
168156|NCT00245102|532787|P6|Overall Study|Death|0
168157|NCT00245102|532788|P5|Overall Study|Death|0
168158|NCT00245102|532789|P4|Overall Study|Death|1
168159|NCT00245102|532790|P3|Overall Study|Death|0
168160|NCT00245102|532791|P2|Overall Study|Death|0
168161|NCT00245102|532792|P1|Overall Study|Death|0
168162|NCT00245102|532787|P6|Overall Study|Protocol Violation|0
168163|NCT00245102|532788|P5|Overall Study|Protocol Violation|0
168164|NCT00245102|532789|P4|Overall Study|Protocol Violation|0
168165|NCT00245102|532790|P3|Overall Study|Protocol Violation|0
168166|NCT00245102|532791|P2|Overall Study|Protocol Violation|0
168167|NCT00245102|532792|P1|Overall Study|Protocol Violation|1
168168|NCT00245102|532787|P6|Overall Study|Not Treated|0
168169|NCT00245102|532788|P5|Overall Study|Not Treated|0
168170|NCT00245102|532789|P4|Overall Study|Not Treated|0
168171|NCT00245102|532790|P3|Overall Study|Not Treated|1
168172|NCT00245102|532791|P2|Overall Study|Not Treated|0
168173|NCT00245102|532792|P1|Overall Study|Not Treated|1
168174|NCT00245063|532808|P2|Overall Study|Death|0
168175|NCT00245063|532809|P1|Overall Study|Death|1
168176|NCT00245063|532808|P2|Overall Study|Adverse Event|5
168177|NCT00245063|532809|P1|Overall Study|Adverse Event|6
168178|NCT00245050|532817|P2|Overall Study|Adverse Event|2
168179|NCT00245050|532818|P1|Overall Study|Adverse Event|3
168180|NCT00245011|532826|P1|Overall Study|Lack of Efficacy|1
168181|NCT00244933|532830|P1|Overall Study|Not response evaluable|2
168182|NCT00244881|532834|P1|Overall Study|Withdrawal by Subject|3
168183|NCT00244764|532840|P1|Overall Study|Developed Secondary Malignancy|1
168184|NCT00244764|532840|P1|Overall Study|Sponsor Terminated Study|2
168185|NCT00244764|532840|P1|Overall Study|Primary Investigator Discretion|2
168186|NCT00244764|532840|P1|Overall Study|Participant was Hospitalized until Death|1
168187|NCT00244764|532840|P1|Overall Study|Declining Performance Status|1
168188|NCT00244764|532840|P1|Overall Study|Off Study Medication for >21 Days|1
168189|NCT00244764|532840|P1|Overall Study|Death|1
168190|NCT00244764|532840|P1|Overall Study|Protocol Violation|2
168191|NCT00244764|532840|P1|Overall Study|Disease Progression|13
168192|NCT00244764|532840|P1|Overall Study|Withdrawal by Subject|12
168193|NCT00244764|532840|P1|Overall Study|Lost to Follow-up|23
168194|NCT00244764|532840|P1|Overall Study|Adverse Event|37
168195|NCT00244712|532849|P2|Overall Study|Protocol Violation, disease progression|11
168196|NCT00244712|532850|P1|Overall Study|Protocol Violation, disease progression|13
168197|NCT00244712|532849|P2|Overall Study|Withdrawal by Subject|23
168198|NCT00244712|532850|P1|Overall Study|Withdrawal by Subject|13
168199|NCT00244712|532849|P2|Overall Study|Lost to Follow-up|52
168200|NCT00244712|532850|P1|Overall Study|Lost to Follow-up|45
168201|NCT00244712|532849|P2|Overall Study|Lack of Compliance|11
168202|NCT00244712|532850|P1|Overall Study|Lack of Compliance|10
168203|NCT00244712|532849|P2|Overall Study|Protocol-Defined Virologic Failure|6
168204|NCT00244712|532850|P1|Overall Study|Protocol-Defined Virologic Failure|8
168205|NCT00244712|532849|P2|Overall Study|Adverse Event|21
168206|NCT00244712|532850|P1|Overall Study|Adverse Event|20
168207|NCT00244621|532885|P3|Open-label Treatment Period|Moved abroad|1
168208|NCT00244621|532886|P2|Open-label Treatment Period|Moved abroad|0
168209|NCT00244621|532887|P1|Open-label Treatment Period|Moved abroad|0
168210|NCT00244621|532885|P3|Open-label Treatment Period|Adverse Event|1
168211|NCT00244621|532886|P2|Open-label Treatment Period|Adverse Event|0
168212|NCT00244621|532887|P1|Open-label Treatment Period|Adverse Event|0
168213|NCT00244621|532885|P3|Open-label Treatment Period|Withdrawal by Subject|0
168214|NCT00244621|532886|P2|Open-label Treatment Period|Withdrawal by Subject|0
168215|NCT00244621|532887|P1|Open-label Treatment Period|Withdrawal by Subject|1
168216|NCT00244621|532885|P3|Open-label Treatment Period|Lost to Follow-up|0
168217|NCT00244621|532886|P2|Open-label Treatment Period|Lost to Follow-up|1
168218|NCT00244621|532887|P1|Open-label Treatment Period|Lost to Follow-up|0
168219|NCT00244621|532885|P3|Double-blind Treatment Period|Multiple Reasons|1
168220|NCT00244621|532886|P2|Double-blind Treatment Period|Multiple Reasons|1
168221|NCT00244621|532887|P1|Double-blind Treatment Period|Multiple Reasons|2
168222|NCT00244621|532885|P3|Double-blind Treatment Period|Lack of Efficacy|0
168223|NCT00244621|532886|P2|Double-blind Treatment Period|Lack of Efficacy|1
168224|NCT00244621|532887|P1|Double-blind Treatment Period|Lack of Efficacy|0
168225|NCT00244621|532885|P3|Double-blind Treatment Period|Withdrawal by Subject|0
168226|NCT00244621|532886|P2|Double-blind Treatment Period|Withdrawal by Subject|1
168227|NCT00244621|532887|P1|Double-blind Treatment Period|Withdrawal by Subject|0
168228|NCT00244621|532885|P3|Double-blind Treatment Period|Lost to Follow-up|1
168229|NCT00244621|532886|P2|Double-blind Treatment Period|Lost to Follow-up|0
168230|NCT00244621|532887|P1|Double-blind Treatment Period|Lost to Follow-up|0
168231|NCT00244374|532904|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
168232|NCT00244374|532905|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
168233|NCT00244374|532906|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
168234|NCT00244374|532907|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
168235|NCT00244374|532908|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
168236|NCT00244374|532904|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
168237|NCT00244374|532905|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
168238|NCT00244374|532906|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
168239|NCT00244374|532907|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
168240|NCT00244374|532908|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
168241|NCT00244374|532904|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
168242|NCT00244374|532905|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
168243|NCT00244374|532906|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
168244|NCT00244374|532907|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
168245|NCT00244374|532908|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
168246|NCT00244374|532904|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
168247|NCT00244374|532905|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
168248|NCT00244374|532906|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
168249|NCT00244374|532907|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
168250|NCT00244374|532908|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
168251|NCT00244374|532904|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
168252|NCT00244374|532905|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
168253|NCT00244374|532906|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
168254|NCT00244374|532907|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
168255|NCT00244374|532908|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
168256|NCT00244374|532904|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
168257|NCT00244374|532905|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
168258|NCT00244374|532906|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
168259|NCT00244374|532907|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
168260|NCT00244374|532908|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
168261|NCT00244374|532904|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
168262|NCT00244374|532905|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
168263|NCT00244374|532906|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
168264|NCT00244374|532907|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
168265|NCT00244374|532908|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
168266|NCT00244374|532904|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
168267|NCT00244374|532905|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
168268|NCT00244374|532906|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
168269|NCT00244374|532907|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
168270|NCT00244374|532908|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
168271|NCT00244374|532904|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
168272|NCT00244374|532905|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
168273|NCT00244374|532906|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
168274|NCT00244374|532907|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
168275|NCT00244374|532908|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
168276|NCT00243932|532964|P3|Stage 1: Dose Selection|Lost to Follow-up|0
168277|NCT00243932|532965|P2|Stage 1: Dose Selection|Lost to Follow-up|0
168278|NCT00243932|532966|P1|Stage 1: Dose Selection|Lost to Follow-up|2
168279|NCT00243919|532977|P3|Overall Study|Physician Decision|0
168280|NCT00243919|532978|P2|Overall Study|Physician Decision|1
168281|NCT00243919|532979|P1|Overall Study|Physician Decision|1
168282|NCT00243919|532977|P3|Overall Study|Administrative Error|0
168283|NCT00243919|532978|P2|Overall Study|Administrative Error|0
168284|NCT00243919|532979|P1|Overall Study|Administrative Error|1
168285|NCT00243919|532977|P3|Overall Study|Lost to Follow-up|3
168286|NCT00243919|532978|P2|Overall Study|Lost to Follow-up|7
168287|NCT00243919|532979|P1|Overall Study|Lost to Follow-up|6
168288|NCT00243919|532977|P3|Overall Study|Withdrawal by Subject|2
168289|NCT00243919|532978|P2|Overall Study|Withdrawal by Subject|6
168290|NCT00243919|532979|P1|Overall Study|Withdrawal by Subject|6
168291|NCT00243919|532977|P3|Overall Study|Death|6
168292|NCT00243919|532978|P2|Overall Study|Death|4
168293|NCT00243919|532979|P1|Overall Study|Death|3
168294|NCT00243659|533022|P2|Overall Study|Protocol Violation|2
168295|NCT00243659|533023|P1|Overall Study|Protocol Violation|1
168296|NCT00243659|533022|P2|Overall Study|Withdrawal by Subject|1
168297|NCT00243659|533023|P1|Overall Study|Withdrawal by Subject|1
168298|NCT00243503|533031|P1|Overall Study|Unspecified|1
168299|NCT00243503|533031|P1|Overall Study|Death|1
168300|NCT00243503|533031|P1|Overall Study|Lack of Efficacy|44
168301|NCT00243503|533031|P1|Overall Study|Withdrawal by Subject|1
168302|NCT00243503|533031|P1|Overall Study|Adverse Event|11
168303|NCT00243412|533048|P2|Overall Study|not specified|1
168304|NCT00243412|533049|P1|Overall Study|not specified|1
168305|NCT00243412|533048|P2|Overall Study|Withdrawal by Subject|5
168306|NCT00243412|533049|P1|Overall Study|Withdrawal by Subject|4
168307|NCT00243412|533048|P2|Overall Study|Physician Decision|1
168308|NCT00243412|533049|P1|Overall Study|Physician Decision|1
168309|NCT00243412|533048|P2|Overall Study|Lost to Follow-up|1
168310|NCT00243412|533049|P1|Overall Study|Lost to Follow-up|0
168311|NCT00243412|533048|P2|Overall Study|Adverse Event|2
168312|NCT00243412|533049|P1|Overall Study|Adverse Event|4
168313|NCT00243412|533048|P2|Overall Study|Death|1
168314|NCT00243412|533049|P1|Overall Study|Death|0
168315|NCT00243386|533075|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
168316|NCT00243386|533076|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
168317|NCT00243386|533077|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
168318|NCT00243386|533075|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
168319|NCT00243386|533076|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
168320|NCT00243386|533077|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
168321|NCT00243386|533075|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
168322|NCT00243386|533076|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
168323|NCT00243386|533077|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
168324|NCT00243386|533075|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
168325|NCT00243386|533076|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
168326|NCT00243386|533077|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
168327|NCT00243386|533075|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
168328|NCT00243386|533076|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
168329|NCT00243386|533077|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
168330|NCT00243386|533075|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
168331|NCT00243386|533076|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
168332|NCT00243386|533077|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
168333|NCT00243386|533075|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
168334|NCT00243386|533076|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
168335|NCT00243386|533077|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
168336|NCT00243386|533075|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
168337|NCT00243386|533076|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
168338|NCT00243386|533077|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
168339|NCT00243347|533142|P1|Overall Study|Condition worsened|7
168340|NCT00243347|533142|P1|Overall Study|Withdrawal by Subject|5
168341|NCT00243347|533142|P1|Overall Study|Death|1
168342|NCT00243347|533142|P1|Overall Study|Adverse Event|2
168343|NCT00243347|533142|P1|Overall Study|Lack of Efficacy|4
168344|NCT00243269|533151|P4|Overall Study|Lost to Follow-up|3
168345|NCT00243269|533152|P3|Overall Study|Lost to Follow-up|1
168346|NCT00243269|533153|P2|Overall Study|Lost to Follow-up|0
168347|NCT00243269|533154|P1|Overall Study|Lost to Follow-up|1
168348|NCT00243269|533151|P4|Overall Study|Protocol Violation|1
168349|NCT00243269|533152|P3|Overall Study|Protocol Violation|0
168350|NCT00243269|533153|P2|Overall Study|Protocol Violation|1
168351|NCT00243269|533154|P1|Overall Study|Protocol Violation|2
168352|NCT00243074|533181|P1|Overall Study|Did not receive any treatment|1
168353|NCT00243074|533181|P1|Overall Study|not protocol specified|1
168354|NCT00243074|533181|P1|Overall Study|Death|2
168355|NCT00243074|533181|P1|Overall Study|Lack of Efficacy|36
168356|NCT00243074|533181|P1|Overall Study|Withdrawal by Subject|2
168357|NCT00243074|533181|P1|Overall Study|Adverse Event|6
168358|NCT00243074|533181|P1|Overall Study|Ineligible|6
168359|NCT00243022|533201|P2|Overall Study|Difficult Travel Distance|1
168360|NCT00243022|533202|P1|Overall Study|Difficult Travel Distance|0
168361|NCT00243022|533201|P2|Overall Study|Death|0
168362|NCT00243022|533202|P1|Overall Study|Death|1
168363|NCT00243022|533201|P2|Overall Study|Withdrawal by Subject|0
168364|NCT00243022|533202|P1|Overall Study|Withdrawal by Subject|1
168365|NCT00242710|533224|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
168366|NCT00242710|533225|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
168367|NCT00242710|533226|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
168368|NCT00242710|533227|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
168369|NCT00242710|533224|P4|Study Extension (up to Year 2)|Protocol Violation|1
168370|NCT00242710|533225|P3|Study Extension (up to Year 2)|Protocol Violation|0
168371|NCT00242710|533226|P2|Study Extension (up to Year 2)|Protocol Violation|2
168372|NCT00242710|533227|P1|Study Extension (up to Year 2)|Protocol Violation|0
168373|NCT00242710|533224|P4|Study Extension (up to Year 2)|Unspecified|3
168374|NCT00242710|533225|P3|Study Extension (up to Year 2)|Unspecified|4
168375|NCT00242710|533226|P2|Study Extension (up to Year 2)|Unspecified|5
168376|NCT00242710|533227|P1|Study Extension (up to Year 2)|Unspecified|3
168377|NCT00242710|533224|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
168378|NCT00242710|533225|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
168379|NCT00242710|533226|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
168380|NCT00242710|533227|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
168381|NCT00242710|533224|P4|Study Extension (up to Year 2)|Death|1
168382|NCT00242710|533225|P3|Study Extension (up to Year 2)|Death|0
168383|NCT00242710|533226|P2|Study Extension (up to Year 2)|Death|0
168384|NCT00242710|533227|P1|Study Extension (up to Year 2)|Death|0
168385|NCT00242710|533224|P4|Study Extension (up to Year 2)|Adverse Event|4
168386|NCT00242710|533225|P3|Study Extension (up to Year 2)|Adverse Event|2
168387|NCT00242710|533226|P2|Study Extension (up to Year 2)|Adverse Event|9
168388|NCT00242710|533227|P1|Study Extension (up to Year 2)|Adverse Event|7
168389|NCT00242710|533224|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
168390|NCT00242710|533225|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
168391|NCT00242710|533226|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
168392|NCT00242710|533227|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
168393|NCT00242710|533224|P4|Period Between Core Study and Extension|Protocol Violation|1
168394|NCT00242710|533225|P3|Period Between Core Study and Extension|Protocol Violation|2
168395|NCT00242710|533226|P2|Period Between Core Study and Extension|Protocol Violation|0
168396|NCT00242710|533227|P1|Period Between Core Study and Extension|Protocol Violation|0
168397|NCT00242710|533224|P4|Period Between Core Study and Extension|Extension not Available|7
168398|NCT00242710|533225|P3|Period Between Core Study and Extension|Extension not Available|8
168399|NCT00242710|533226|P2|Period Between Core Study and Extension|Extension not Available|21
168400|NCT00242710|533227|P1|Period Between Core Study and Extension|Extension not Available|17
168401|NCT00242710|533224|P4|Period Between Core Study and Extension|Unspecified|11
168402|NCT00242710|533225|P3|Period Between Core Study and Extension|Unspecified|9
168403|NCT00242710|533226|P2|Period Between Core Study and Extension|Unspecified|24
168404|NCT00242710|533227|P1|Period Between Core Study and Extension|Unspecified|24
168405|NCT00242710|533224|P4|Period Between Core Study and Extension|Physician Decision|0
168406|NCT00242710|533225|P3|Period Between Core Study and Extension|Physician Decision|0
168407|NCT00242710|533226|P2|Period Between Core Study and Extension|Physician Decision|1
168408|NCT00242710|533227|P1|Period Between Core Study and Extension|Physician Decision|1
168409|NCT00242710|533224|P4|Period Between Core Study and Extension|Adverse Event|2
168410|NCT00242710|533225|P3|Period Between Core Study and Extension|Adverse Event|5
168411|NCT00242710|533226|P2|Period Between Core Study and Extension|Adverse Event|3
168412|NCT00242710|533227|P1|Period Between Core Study and Extension|Adverse Event|2
168413|NCT00242710|533224|P4|Core Study (up to Year 1)|Randomized but not Treated|2
168414|NCT00242710|533225|P3|Core Study (up to Year 1)|Randomized but not Treated|4
168415|NCT00242710|533226|P2|Core Study (up to Year 1)|Randomized but not Treated|4
168416|NCT00242710|533227|P1|Core Study (up to Year 1)|Randomized but not Treated|12
168417|NCT00242710|533224|P4|Core Study (up to Year 1)|Lack of Efficacy|0
168418|NCT00242710|533225|P3|Core Study (up to Year 1)|Lack of Efficacy|0
168419|NCT00242710|533226|P2|Core Study (up to Year 1)|Lack of Efficacy|0
168420|NCT00242710|533227|P1|Core Study (up to Year 1)|Lack of Efficacy|1
168421|NCT00242710|533224|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
168422|NCT00242710|533225|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
168423|NCT00242710|533226|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
168424|NCT00242710|533227|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
168425|NCT00242710|533224|P4|Core Study (up to Year 1)|Protocol Violation|3
168426|NCT00242710|533225|P3|Core Study (up to Year 1)|Protocol Violation|1
168427|NCT00242710|533226|P2|Core Study (up to Year 1)|Protocol Violation|9
168428|NCT00242710|533227|P1|Core Study (up to Year 1)|Protocol Violation|2
168429|NCT00242710|533224|P4|Core Study (up to Year 1)|Unspecified|2
168430|NCT00242710|533225|P3|Core Study (up to Year 1)|Unspecified|0
168431|NCT00242710|533226|P2|Core Study (up to Year 1)|Unspecified|1
168432|NCT00242710|533227|P1|Core Study (up to Year 1)|Unspecified|6
168433|NCT00242710|533224|P4|Core Study (up to Year 1)|Lost to Follow-up|3
168434|NCT00242710|533225|P3|Core Study (up to Year 1)|Lost to Follow-up|7
168435|NCT00242710|533226|P2|Core Study (up to Year 1)|Lost to Follow-up|8
168436|NCT00242710|533227|P1|Core Study (up to Year 1)|Lost to Follow-up|8
168437|NCT00242710|533224|P4|Core Study (up to Year 1)|Physician Decision|1
168438|NCT00242710|533225|P3|Core Study (up to Year 1)|Physician Decision|0
168439|NCT00242710|533226|P2|Core Study (up to Year 1)|Physician Decision|1
168440|NCT00242710|533227|P1|Core Study (up to Year 1)|Physician Decision|0
168441|NCT00242710|533224|P4|Core Study (up to Year 1)|Death|0
168442|NCT00242710|533225|P3|Core Study (up to Year 1)|Death|1
168443|NCT00242710|533226|P2|Core Study (up to Year 1)|Death|0
168444|NCT00242710|533227|P1|Core Study (up to Year 1)|Death|0
168445|NCT00242710|533224|P4|Core Study (up to Year 1)|Adverse Event|14
168446|NCT00242710|533225|P3|Core Study (up to Year 1)|Adverse Event|23
168447|NCT00242710|533226|P2|Core Study (up to Year 1)|Adverse Event|25
168448|NCT00242710|533227|P1|Core Study (up to Year 1)|Adverse Event|30
168449|NCT00242658|533284|P2|Overall Study|Lost to Follow-up|19
168450|NCT00242658|533285|P1|Overall Study|Lost to Follow-up|22
168451|NCT00242580|533307|P3|Overall Study|Death|1
168452|NCT00242580|533308|P2|Overall Study|Death|2
168453|NCT00242580|533309|P1|Overall Study|Death|1
168454|NCT00242580|533307|P3|Overall Study|Lost to Follow-up|0
168455|NCT00242580|533308|P2|Overall Study|Lost to Follow-up|3
168456|NCT00242580|533309|P1|Overall Study|Lost to Follow-up|0
168457|NCT00242580|533307|P3|Overall Study|Subject withdrew consent|5
168458|NCT00242580|533308|P2|Overall Study|Subject withdrew consent|2
168459|NCT00242580|533309|P1|Overall Study|Subject withdrew consent|2
168460|NCT00242580|533307|P3|Overall Study|Protocol Violation|1
168461|NCT00242580|533308|P2|Overall Study|Protocol Violation|0
168462|NCT00242580|533309|P1|Overall Study|Protocol Violation|0
168463|NCT00242580|533307|P3|Overall Study|Unsatisfactory therapeutic effect|5
168464|NCT00242580|533308|P2|Overall Study|Unsatisfactory therapeutic effect|5
168465|NCT00242580|533309|P1|Overall Study|Unsatisfactory therapeutic effect|4
168466|NCT00242580|533307|P3|Overall Study|Adverse Event|2
168467|NCT00242580|533308|P2|Overall Study|Adverse Event|0
168468|NCT00242580|533309|P1|Overall Study|Adverse Event|3
168469|NCT00242567|533334|P2|Overall Study|Other|9
168470|NCT00242567|533335|P1|Overall Study|Other|14
168471|NCT00242567|533334|P2|Overall Study|Use of an inhibitor of bone resorption|2
168472|NCT00242567|533335|P1|Overall Study|Use of an inhibitor of bone resorption|0
168473|NCT00242567|533334|P2|Overall Study|Protocol Violation|12
168474|NCT00242567|533335|P1|Overall Study|Protocol Violation|12
168475|NCT00242567|533334|P2|Overall Study|Withdrawal by Subject|28
168476|NCT00242567|533335|P1|Overall Study|Withdrawal by Subject|33
168477|NCT00242567|533334|P2|Overall Study|Lost to Follow-up|19
168478|NCT00242567|533335|P1|Overall Study|Lost to Follow-up|9
168479|NCT00242567|533334|P2|Overall Study|Lack of Efficacy|2
168480|NCT00242567|533335|P1|Overall Study|Lack of Efficacy|2
168481|NCT00242567|533334|P2|Overall Study|Symptomatic deterioration|3
168482|NCT00242567|533335|P1|Overall Study|Symptomatic deterioration|9
168483|NCT00242567|533334|P2|Overall Study|Disease Progression|22
168484|NCT00242567|533335|P1|Overall Study|Disease Progression|17
168485|NCT00242567|533334|P2|Overall Study|Adverse Event|43
168486|NCT00242567|533335|P1|Overall Study|Adverse Event|70
168487|NCT00242216|533382|P2|Overall Study|no medicaiton dispensed|1
168488|NCT00242216|533383|P1|Overall Study|no medicaiton dispensed|1
168489|NCT00242216|533382|P2|Overall Study|Lack of Efficacy|2
168490|NCT00242216|533383|P1|Overall Study|Lack of Efficacy|1
168491|NCT00242216|533382|P2|Overall Study|Death|2
168492|NCT00242216|533383|P1|Overall Study|Death|4
168493|NCT00242216|533382|P2|Overall Study|Lost to Follow-up|17
168494|NCT00242216|533383|P1|Overall Study|Lost to Follow-up|12
168495|NCT00241839|533393|P2|Overall Study|Adverse Event|1
168496|NCT00241839|533394|P1|Overall Study|Adverse Event|1
168497|NCT00241839|533393|P2|Overall Study|Withdrawal by Subject|17
168498|NCT00241839|533394|P1|Overall Study|Withdrawal by Subject|18
168499|NCT00241644|533410|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
168500|NCT00241644|533411|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
168501|NCT00241644|533412|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
168502|NCT00241644|533413|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
168503|NCT00241644|533410|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
168504|NCT00241644|533411|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
168505|NCT00241644|533412|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
168506|NCT00241644|533413|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
168507|NCT00241644|533410|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
168508|NCT00241644|533411|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
168509|NCT00241644|533412|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
168510|NCT00241644|533413|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
168511|NCT00241644|533410|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
168512|NCT00241644|533411|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
168513|NCT00241644|533412|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
168514|NCT00241644|533413|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
168515|NCT00241644|533410|P4|Second Efficacy Period (Year 2)|Adverse Event|20
168516|NCT00241644|533411|P3|Second Efficacy Period (Year 2)|Adverse Event|12
168517|NCT00241644|533412|P2|Second Efficacy Period (Year 2)|Adverse Event|9
168518|NCT00241644|533413|P1|Second Efficacy Period (Year 2)|Adverse Event|11
168519|NCT00241644|533410|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
168520|NCT00241644|533411|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
168521|NCT00241644|533412|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
168522|NCT00241644|533413|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
168523|NCT00241644|533410|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
168524|NCT00241644|533411|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
168525|NCT00241644|533412|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
168526|NCT00241644|533413|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
168527|NCT00241644|533410|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
168528|NCT00241644|533411|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
168529|NCT00241644|533412|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
168530|NCT00241644|533413|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
168531|NCT00241644|533410|P4|First Efficacy Period (Year 1)|Non-compliance|3
168532|NCT00241644|533411|P3|First Efficacy Period (Year 1)|Non-compliance|2
168533|NCT00241644|533412|P2|First Efficacy Period (Year 1)|Non-compliance|1
168534|NCT00241644|533413|P1|First Efficacy Period (Year 1)|Non-compliance|2
168535|NCT00241644|533410|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
168536|NCT00241644|533411|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
168537|NCT00241644|533412|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
168538|NCT00241644|533413|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
168539|NCT00241644|533410|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
168540|NCT00241644|533411|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
168541|NCT00241644|533412|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
168542|NCT00241644|533413|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
168543|NCT00241644|533410|P4|First Efficacy Period (Year 1)|Protocol Violation|8
168544|NCT00241644|533411|P3|First Efficacy Period (Year 1)|Protocol Violation|4
168545|NCT00241644|533412|P2|First Efficacy Period (Year 1)|Protocol Violation|5
168546|NCT00241644|533413|P1|First Efficacy Period (Year 1)|Protocol Violation|3
168547|NCT00241644|533410|P4|First Efficacy Period (Year 1)|Adverse Event|91
168548|NCT00241644|533411|P3|First Efficacy Period (Year 1)|Adverse Event|45
168549|NCT00241644|533412|P2|First Efficacy Period (Year 1)|Adverse Event|45
168550|NCT00241644|533413|P1|First Efficacy Period (Year 1)|Adverse Event|46
168551|NCT00241280|533497|P2|Overall Study|Excessive Dryness|1
168552|NCT00241280|533498|P1|Overall Study|Excessive Dryness|0
168553|NCT00241280|533497|P2|Overall Study|Coating on Lens|0
168554|NCT00241280|533498|P1|Overall Study|Coating on Lens|1
168555|NCT00241280|533497|P2|Overall Study|History of Ocular Surgery|1
168556|NCT00241280|533498|P1|Overall Study|History of Ocular Surgery|0
168557|NCT00241280|533497|P2|Overall Study|Scheduling Conflict|2
168558|NCT00241280|533498|P1|Overall Study|Scheduling Conflict|0
168559|NCT00241280|533497|P2|Overall Study|Unacceptable Fit|1
168560|NCT00241280|533498|P1|Overall Study|Unacceptable Fit|0
168561|NCT00241280|533497|P2|Overall Study|Dispensed incorrect test article|2
168562|NCT00241280|533498|P1|Overall Study|Dispensed incorrect test article|1
168563|NCT00241280|533497|P2|Overall Study|Subject Ineligible/Dispensed|6
168564|NCT00241280|533498|P1|Overall Study|Subject Ineligible/Dispensed|9
168565|NCT00241280|533497|P2|Overall Study|Diabetic|0
168566|NCT00241280|533498|P1|Overall Study|Diabetic|1
168567|NCT00241280|533497|P2|Overall Study|Unsatisfactory Visual Response|1
168568|NCT00241280|533498|P1|Overall Study|Unsatisfactory Visual Response|1
168569|NCT00241280|533497|P2|Overall Study|Unsatisfactory Physiological Response|1
168570|NCT00241280|533498|P1|Overall Study|Unsatisfactory Physiological Response|1
168571|NCT00241280|533497|P2|Overall Study|Relocation|4
168572|NCT00241280|533498|P1|Overall Study|Relocation|4
168573|NCT00241280|533497|P2|Overall Study|Protocol Violation|10
168574|NCT00241280|533498|P1|Overall Study|Protocol Violation|4
168575|NCT00241280|533497|P2|Overall Study|Withdrawal by Subject|4
168576|NCT00241280|533498|P1|Overall Study|Withdrawal by Subject|7
168577|NCT00241280|533497|P2|Overall Study|Lost to Follow-up|8
168578|NCT00241280|533498|P1|Overall Study|Lost to Follow-up|5
168579|NCT00241280|533497|P2|Overall Study|Pregnancy|5
168580|NCT00241280|533498|P1|Overall Study|Pregnancy|1
168581|NCT00241280|533497|P2|Overall Study|Discomfort|16
168582|NCT00241280|533498|P1|Overall Study|Discomfort|11
168583|NCT00241280|533497|P2|Overall Study|Adverse Event|6
168584|NCT00241280|533498|P1|Overall Study|Adverse Event|2
168585|NCT00240994|533513|P1|Overall Study|Graft failure|1
168586|NCT00240994|533513|P1|Overall Study|Protocol Violation|1
168587|NCT00240994|533513|P1|Overall Study|Lost to Follow-up|1
168588|NCT00240331|533621|P2|Overall Study|Option selected by investigator|2
168589|NCT00240331|533622|P1|Overall Study|Option selected by investigator|1
168590|NCT00240331|533621|P2|Overall Study|Withdrawal by Subject|132
168591|NCT00240331|533622|P1|Overall Study|Withdrawal by Subject|125
168592|NCT00240110|533655|P2|Overall Study|Lost to Follow-up|7
168593|NCT00240110|533656|P1|Overall Study|Lost to Follow-up|6
168594|NCT00240097|533664|P1|Part II|did not continue from Part I|23
168595|NCT00240097|533664|P1|Part I|unevaluable|1
168596|NCT00240097|533664|P1|Part I|histology|1
168597|NCT00240097|533664|P1|Part I|Death|1
168598|NCT00240097|533664|P1|Part I|Adverse Event|1
168599|NCT00239928|533678|P1|Overall Study|Withdrawal by Subject|2
168600|NCT00239928|533678|P1|Overall Study|Not need to continue study|3
168601|NCT00239928|533678|P1|Overall Study|Adverse Event|4
168602|NCT00239928|533678|P1|Overall Study|Lack of Efficacy|1
168603|NCT00239837|533690|P2|Overall Study|Lost to Follow-up|7
168604|NCT00239837|533691|P1|Overall Study|Lost to Follow-up|3
168605|NCT00239720|533713|P2|Overall Study|Lost to Follow-up|1
168606|NCT00239720|533714|P1|Overall Study|Lost to Follow-up|0
168607|NCT00239720|533713|P2|Overall Study|Adverse Event|0
168608|NCT00239720|533714|P1|Overall Study|Adverse Event|1
168609|NCT00239681|533722|P2|Overall Study|No information chacked on CaseReportForm|84
168610|NCT00239681|533723|P1|Overall Study|No information chacked on CaseReportForm|90
168611|NCT00239681|533722|P2|Overall Study|Physician Decision|17
168612|NCT00239681|533723|P1|Overall Study|Physician Decision|13
168613|NCT00239681|533722|P2|Overall Study|Protocol Violation|4
168614|NCT00239681|533723|P1|Overall Study|Protocol Violation|4
168615|NCT00239681|533722|P2|Overall Study|Lost to Follow-up|22
168616|NCT00239681|533723|P1|Overall Study|Lost to Follow-up|28
168617|NCT00239681|533722|P2|Overall Study|Withdrawal by Subject|489
168618|NCT00239681|533723|P1|Overall Study|Withdrawal by Subject|458
168619|NCT00239681|533722|P2|Overall Study|Adverse Event|99
168620|NCT00239681|533723|P1|Overall Study|Adverse Event|100
168621|NCT00239356|533778|P2|Overall Study|Drug available on market|2
168622|NCT00239356|533779|P1|Overall Study|Drug available on market|11
168623|NCT00239356|533778|P2|Overall Study|Administrative reason|1
168624|NCT00239356|533779|P1|Overall Study|Administrative reason|0
168625|NCT00239356|533778|P2|Overall Study|Pregnancy|0
168626|NCT00239356|533779|P1|Overall Study|Pregnancy|1
168627|NCT00239356|533778|P2|Overall Study|poor/non-compliance|0
168628|NCT00239356|533779|P1|Overall Study|poor/non-compliance|2
168629|NCT00239356|533778|P2|Overall Study|Lost to Follow-up|0
168630|NCT00239356|533779|P1|Overall Study|Lost to Follow-up|3
168631|NCT00239356|533778|P2|Overall Study|Withdrawal by Subject|6
168632|NCT00239356|533779|P1|Overall Study|Withdrawal by Subject|15
168633|NCT00239356|533778|P2|Overall Study|Adverse Event|0
168634|NCT00239356|533779|P1|Overall Study|Adverse Event|6
168635|NCT00239356|533778|P2|Overall Study|Lack of Efficacy|0
168636|NCT00239356|533779|P1|Overall Study|Lack of Efficacy|1
168637|NCT00239226|533801|P4|Overall Study|Lost to Follow-up|0
168638|NCT00239226|533802|P3|Overall Study|Lost to Follow-up|1
168639|NCT00239226|533803|P2|Overall Study|Lost to Follow-up|0
168640|NCT00239226|533804|P1|Overall Study|Lost to Follow-up|1
168641|NCT00239226|533801|P4|Overall Study|permAF during stabilization period|3
168642|NCT00239226|533802|P3|Overall Study|permAF during stabilization period|0
168643|NCT00239226|533803|P2|Overall Study|permAF during stabilization period|0
168644|NCT00239226|533804|P1|Overall Study|permAF during stabilization period|0
168645|NCT00239005|533816|P2|Overall Study|Death|0
168646|NCT00239005|533817|P1|Overall Study|Death|0
168647|NCT00239005|533816|P2|Overall Study|Lost to Follow-up|1
168648|NCT00239005|533817|P1|Overall Study|Lost to Follow-up|0
168649|NCT00239005|533816|P2|Overall Study|Subj. cond. no longer needs study drug|1
168650|NCT00239005|533817|P1|Overall Study|Subj. cond. no longer needs study drug|0
168651|NCT00239005|533816|P2|Overall Study|Protocol Violation|0
168652|NCT00239005|533817|P1|Overall Study|Protocol Violation|1
168653|NCT00239005|533816|P2|Overall Study|Unsatisfactory Therapeutic effect|0
168654|NCT00239005|533817|P1|Overall Study|Unsatisfactory Therapeutic effect|2
168655|NCT00239005|533816|P2|Overall Study|Withdrawal by Subject|4
168656|NCT00239005|533817|P1|Overall Study|Withdrawal by Subject|3
168657|NCT00239005|533816|P2|Overall Study|Adverse Event|6
168658|NCT00239005|533817|P1|Overall Study|Adverse Event|6
168659|NCT00238420|533835|P2|Overall Study|Protocol Violation|1
168660|NCT00238420|533836|P1|Overall Study|Protocol Violation|1
168661|NCT00238303|533853|P3|Overall Study|Adverse Event|3
168662|NCT00238303|533854|P2|Overall Study|Adverse Event|1
168663|NCT00238303|533855|P1|Overall Study|Adverse Event|0
168664|NCT00238303|533853|P3|Overall Study|Poor tolerance of study treatment|1
168665|NCT00238303|533854|P2|Overall Study|Poor tolerance of study treatment|0
168666|NCT00238303|533855|P1|Overall Study|Poor tolerance of study treatment|1
168667|NCT00238303|533853|P3|Overall Study|Other Medical Problems|2
168668|NCT00238303|533854|P2|Overall Study|Other Medical Problems|0
168669|NCT00238303|533855|P1|Overall Study|Other Medical Problems|2
168670|NCT00238303|533853|P3|Overall Study|Death|1
168671|NCT00238303|533854|P2|Overall Study|Death|0
168672|NCT00238303|533855|P1|Overall Study|Death|1
168673|NCT00238303|533853|P3|Overall Study|Withdrawal by Subject|2
168674|NCT00238303|533854|P2|Overall Study|Withdrawal by Subject|1
168675|NCT00238303|533855|P1|Overall Study|Withdrawal by Subject|11
168676|NCT00238238|533875|P3|Overall Study|Withdrawal by Subject|0
168677|NCT00238238|533876|P2|Overall Study|Withdrawal by Subject|3
168678|NCT00238238|533877|P1|Overall Study|Withdrawal by Subject|0
168679|NCT00238121|533890|P2|Overall Study|Adverse Event|1
168680|NCT00238121|533891|P1|Overall Study|Adverse Event|2
168681|NCT00238121|533890|P2|Overall Study|Withdrawal by Subject|1
168682|NCT00238121|533891|P1|Overall Study|Withdrawal by Subject|1
168683|NCT00237796|533913|P2|Overall Study|Baseline and one other ILSS required|5
168684|NCT00237796|533914|P1|Overall Study|Baseline and one other ILSS required|10
168685|NCT00237744|533948|P3|Overall Study|Withdrawal by Subject|0
168686|NCT00237744|533949|P2|Overall Study|Withdrawal by Subject|1
168687|NCT00237744|533950|P1|Overall Study|Withdrawal by Subject|3
168688|NCT00237692|533976|P4|Overall Study|Withdrawal by Subject|4
168689|NCT00237692|533977|P3|Overall Study|Withdrawal by Subject|10
168690|NCT00237692|533978|P2|Overall Study|Withdrawal by Subject|6
168691|NCT00237692|533979|P1|Overall Study|Withdrawal by Subject|4
168692|NCT00237692|533976|P4|Overall Study|Excluded - did not meet criteria|9
168693|NCT00237692|533977|P3|Overall Study|Excluded - did not meet criteria|5
168694|NCT00237692|533978|P2|Overall Study|Excluded - did not meet criteria|3
168695|NCT00237692|533979|P1|Overall Study|Excluded - did not meet criteria|4
168696|NCT00237692|533976|P4|Overall Study|Death|3
168697|NCT00237692|533977|P3|Overall Study|Death|2
168698|NCT00237692|533978|P2|Overall Study|Death|2
168699|NCT00237692|533979|P1|Overall Study|Death|1
168700|NCT00237692|533976|P4|Overall Study|Lost to Follow-up|3
168701|NCT00237692|533977|P3|Overall Study|Lost to Follow-up|5
168702|NCT00237692|533978|P2|Overall Study|Lost to Follow-up|3
168703|NCT00237692|533979|P1|Overall Study|Lost to Follow-up|9
168704|NCT00237458|534019|P1|Overall Study|Withdrawal by Subject|1
168705|NCT00237458|534019|P1|Overall Study|Adverse Event|1
168706|NCT00237458|534019|P1|Overall Study|Lack of Efficacy|1
168707|NCT00237185|534037|P2|Extension|Death|1
168708|NCT00237185|534038|P1|Extension|Death|1
168709|NCT00237185|534037|P2|Extension|Administrative problems|0
168710|NCT00237185|534038|P1|Extension|Administrative problems|1
168711|NCT00237185|534037|P2|Extension|Lost to Follow-up|0
168712|NCT00237185|534038|P1|Extension|Lost to Follow-up|1
168713|NCT00237185|534037|P2|Extension|Withdrawal by Subject|2
168714|NCT00237185|534038|P1|Extension|Withdrawal by Subject|3
168715|NCT00237185|534037|P2|Extension|Condition no longer required study drug|1
168716|NCT00237185|534038|P1|Extension|Condition no longer required study drug|0
168717|NCT00237185|534037|P2|Extension|Lack of Efficacy|14
168718|NCT00237185|534038|P1|Extension|Lack of Efficacy|9
168719|NCT00237185|534037|P2|Extension|Abnormal laboratory value|1
168720|NCT00237185|534038|P1|Extension|Abnormal laboratory value|0
168721|NCT00237185|534037|P2|Extension|Adverse Event|0
168722|NCT00237185|534038|P1|Extension|Adverse Event|1
168723|NCT00237185|534037|P2|Core|Determined ineligible post randomization|0
168724|NCT00237185|534038|P1|Core|Determined ineligible post randomization|1
168725|NCT00237185|534037|P2|Core|Death|0
168726|NCT00237185|534038|P1|Core|Death|4
168727|NCT00237185|534037|P2|Core|Administrative problems|1
168728|NCT00237185|534038|P1|Core|Administrative problems|0
168729|NCT00237185|534037|P2|Core|Withdrawal by Subject|4
168730|NCT00237185|534038|P1|Core|Withdrawal by Subject|4
168731|NCT00237185|534037|P2|Core|Protocol Violation|1
168732|NCT00237185|534038|P1|Core|Protocol Violation|1
168733|NCT00237185|534037|P2|Core|Lack of Efficacy|23
168734|NCT00237185|534038|P1|Core|Lack of Efficacy|30
168735|NCT00237185|534037|P2|Core|Abnormal test procedure results|0
168736|NCT00237185|534038|P1|Core|Abnormal test procedure results|1
168737|NCT00237185|534037|P2|Core|Abnormal laboratory value|4
168738|NCT00237185|534038|P1|Core|Abnormal laboratory value|0
168739|NCT00237185|534037|P2|Core|Adverse Event|4
168740|NCT00237185|534038|P1|Core|Adverse Event|3
168741|NCT00237042|534069|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
168742|NCT00237042|534070|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
168743|NCT00237042|534071|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
168744|NCT00237042|534069|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
168745|NCT00237042|534070|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
168746|NCT00237042|534071|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
168747|NCT00237042|534069|P3|Treatment|Completed no treatment|21
168748|NCT00237042|534070|P2|Treatment|Completed no treatment|5
168749|NCT00237042|534071|P1|Treatment|Completed no treatment|5
168750|NCT00237042|534069|P3|Treatment|Moved out of state|1
168751|NCT00237042|534070|P2|Treatment|Moved out of state|1
168752|NCT00237042|534071|P1|Treatment|Moved out of state|1
168753|NCT00237042|534069|P3|Treatment|Became ineligible post-randomization|16
168754|NCT00237042|534070|P2|Treatment|Became ineligible post-randomization|1
168755|NCT00237042|534071|P1|Treatment|Became ineligible post-randomization|0
168756|NCT00236899|534145|P4|Overall Study|Lack of Efficacy|23
168757|NCT00236899|534146|P3|Overall Study|Lack of Efficacy|25
168758|NCT00236899|534147|P2|Overall Study|Lack of Efficacy|18
168759|NCT00236899|534148|P1|Overall Study|Lack of Efficacy|18
168760|NCT00236899|534145|P4|Overall Study|Satisfactory Response|1
168761|NCT00236899|534146|P3|Overall Study|Satisfactory Response|0
168762|NCT00236899|534147|P2|Overall Study|Satisfactory Response|0
168763|NCT00236899|534148|P1|Overall Study|Satisfactory Response|2
168764|NCT00236899|534145|P4|Overall Study|Physician Decision|6
168765|NCT00236899|534146|P3|Overall Study|Physician Decision|7
168766|NCT00236899|534147|P2|Overall Study|Physician Decision|8
168767|NCT00236899|534148|P1|Overall Study|Physician Decision|7
168768|NCT00236899|534145|P4|Overall Study|Withdrawal by Subject|2
168769|NCT00236899|534146|P3|Overall Study|Withdrawal by Subject|5
168770|NCT00236899|534147|P2|Overall Study|Withdrawal by Subject|4
168771|NCT00236899|534148|P1|Overall Study|Withdrawal by Subject|6
168772|NCT00236899|534145|P4|Overall Study|Protocol Violation|0
168773|NCT00236899|534146|P3|Overall Study|Protocol Violation|0
168774|NCT00236899|534147|P2|Overall Study|Protocol Violation|0
168775|NCT00236899|534148|P1|Overall Study|Protocol Violation|1
168776|NCT00236899|534145|P4|Overall Study|Entry Criteria Exclusion|0
168777|NCT00236899|534146|P3|Overall Study|Entry Criteria Exclusion|1
168778|NCT00236899|534147|P2|Overall Study|Entry Criteria Exclusion|1
168779|NCT00236899|534148|P1|Overall Study|Entry Criteria Exclusion|0
168780|NCT00236899|534145|P4|Overall Study|Lost to Follow-up|0
168781|NCT00236899|534146|P3|Overall Study|Lost to Follow-up|0
168782|NCT00236899|534147|P2|Overall Study|Lost to Follow-up|1
168783|NCT00236899|534148|P1|Overall Study|Lost to Follow-up|0
168784|NCT00236899|534145|P4|Overall Study|Death (Study Drug Toxicity)|0
168785|NCT00236899|534146|P3|Overall Study|Death (Study Drug Toxicity)|0
168786|NCT00236899|534147|P2|Overall Study|Death (Study Drug Toxicity)|0
168787|NCT00236899|534148|P1|Overall Study|Death (Study Drug Toxicity)|1
168788|NCT00236899|534145|P4|Overall Study|Death (Not Study Related)|0
168789|NCT00236899|534146|P3|Overall Study|Death (Not Study Related)|0
168790|NCT00236899|534147|P2|Overall Study|Death (Not Study Related)|0
168791|NCT00236899|534148|P1|Overall Study|Death (Not Study Related)|2
168792|NCT00236899|534145|P4|Overall Study|Death (Study Disease)|0
168793|NCT00236899|534146|P3|Overall Study|Death (Study Disease)|0
168794|NCT00236899|534147|P2|Overall Study|Death (Study Disease)|4
168795|NCT00236899|534148|P1|Overall Study|Death (Study Disease)|1
168796|NCT00236899|534145|P4|Overall Study|Adverse Event (Not Study Related)|7
168797|NCT00236899|534146|P3|Overall Study|Adverse Event (Not Study Related)|4
168798|NCT00236899|534147|P2|Overall Study|Adverse Event (Not Study Related)|3
168799|NCT00236899|534148|P1|Overall Study|Adverse Event (Not Study Related)|3
168800|NCT00236899|534145|P4|Overall Study|Adverse Event (Study Related)|1
168801|NCT00236899|534146|P3|Overall Study|Adverse Event (Study Related)|2
168802|NCT00236899|534147|P2|Overall Study|Adverse Event (Study Related)|1
168803|NCT00236899|534148|P1|Overall Study|Adverse Event (Study Related)|1
168804|NCT00236197|534180|P2|Overall Study|Other|2
168805|NCT00236197|534181|P1|Overall Study|Other|0
168806|NCT00236197|534180|P2|Overall Study|Medication non-compliance|2
168807|NCT00236197|534181|P1|Overall Study|Medication non-compliance|1
168808|NCT00236197|534180|P2|Overall Study|Protocol Violation|3
168809|NCT00236197|534181|P1|Overall Study|Protocol Violation|0
168810|NCT00236197|534180|P2|Overall Study|Lost to Follow-up|5
168811|NCT00236197|534181|P1|Overall Study|Lost to Follow-up|1
168812|NCT00236197|534180|P2|Overall Study|Withdrawal by Subject|2
168813|NCT00236197|534181|P1|Overall Study|Withdrawal by Subject|3
168814|NCT00236184|534189|P2|Overall Study|other|2
168815|NCT00236184|534190|P1|Overall Study|other|1
168816|NCT00236184|534189|P2|Overall Study|non-compliance with study drug|1
168817|NCT00236184|534190|P1|Overall Study|non-compliance with study drug|2
168818|NCT00236184|534189|P2|Overall Study|Protocol Violation|0
168819|NCT00236184|534190|P1|Overall Study|Protocol Violation|3
168820|NCT00236184|534189|P2|Overall Study|Withdrawal by Subject|0
168821|NCT00236184|534190|P1|Overall Study|Withdrawal by Subject|3
168822|NCT00236184|534189|P2|Overall Study|Physician Decision|1
168823|NCT00236184|534190|P1|Overall Study|Physician Decision|1
168824|NCT00236184|534189|P2|Overall Study|Lost to Follow-up|4
168825|NCT00236184|534190|P1|Overall Study|Lost to Follow-up|3
168826|NCT00236184|534189|P2|Overall Study|Lack of Efficacy|1
168827|NCT00236184|534190|P1|Overall Study|Lack of Efficacy|0
168828|NCT00236184|534189|P2|Overall Study|Adverse Event|2
168829|NCT00236184|534190|P1|Overall Study|Adverse Event|5
168830|NCT00236080|534201|P5|Overall Study|Miscellaneous|0
168831|NCT00236080|534202|P4|Overall Study|Miscellaneous|0
168832|NCT00236080|534203|P3|Overall Study|Miscellaneous|1
168833|NCT00236080|534204|P2|Overall Study|Miscellaneous|0
168834|NCT00236080|534205|P1|Overall Study|Miscellaneous|0
168835|NCT00236080|534201|P5|Overall Study|Withdrawal by Subject|0
168836|NCT00236080|534202|P4|Overall Study|Withdrawal by Subject|0
168837|NCT00236080|534203|P3|Overall Study|Withdrawal by Subject|0
168838|NCT00236080|534204|P2|Overall Study|Withdrawal by Subject|0
168839|NCT00236080|534205|P1|Overall Study|Withdrawal by Subject|1
168840|NCT00236080|534201|P5|Overall Study|Physician Decision|1
168841|NCT00236080|534202|P4|Overall Study|Physician Decision|1
168842|NCT00236080|534203|P3|Overall Study|Physician Decision|1
168843|NCT00236080|534204|P2|Overall Study|Physician Decision|0
168844|NCT00236080|534205|P1|Overall Study|Physician Decision|1
168845|NCT00236080|534201|P5|Overall Study|Lost to Follow-up|0
168846|NCT00236080|534202|P4|Overall Study|Lost to Follow-up|0
168847|NCT00236080|534203|P3|Overall Study|Lost to Follow-up|0
168848|NCT00236080|534204|P2|Overall Study|Lost to Follow-up|1
168849|NCT00236080|534205|P1|Overall Study|Lost to Follow-up|0
168850|NCT00236080|534201|P5|Overall Study|Adverse Event|0
168851|NCT00236080|534202|P4|Overall Study|Adverse Event|1
168852|NCT00236080|534203|P3|Overall Study|Adverse Event|3
168853|NCT00236080|534204|P2|Overall Study|Adverse Event|0
168854|NCT00236080|534205|P1|Overall Study|Adverse Event|0
168855|NCT00235989|534226|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
168856|NCT00235989|534227|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
168857|NCT00235989|534228|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
168858|NCT00235989|534229|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
168859|NCT00235989|534230|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
168860|NCT00235989|534231|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
168861|NCT00235989|534226|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
168862|NCT00235989|534227|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
168863|NCT00235989|534228|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
168864|NCT00235989|534229|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
168865|NCT00235989|534230|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
168866|NCT00235989|534231|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
168867|NCT00235989|534226|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
168868|NCT00235989|534227|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
168869|NCT00235989|534228|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
168870|NCT00235989|534229|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
168871|NCT00235989|534230|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
168872|NCT00235989|534231|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
168873|NCT00235989|534226|P6|Extension Treatment Period (ET)|Adverse Event|0
168874|NCT00235989|534227|P5|Extension Treatment Period (ET)|Adverse Event|0
168875|NCT00235989|534228|P4|Extension Treatment Period (ET)|Adverse Event|0
168876|NCT00235989|534229|P3|Extension Treatment Period (ET)|Adverse Event|2
168877|NCT00235989|534230|P2|Extension Treatment Period (ET)|Adverse Event|0
168878|NCT00235989|534231|P1|Extension Treatment Period (ET)|Adverse Event|3
168879|NCT00235989|534226|P6|Core Treatment Period (CT)|Lost to Follow-up|2
168880|NCT00235989|534227|P5|Core Treatment Period (CT)|Lost to Follow-up|0
168881|NCT00235989|534228|P4|Core Treatment Period (CT)|Lost to Follow-up|0
168882|NCT00235989|534229|P3|Core Treatment Period (CT)|Lost to Follow-up|0
168883|NCT00235989|534230|P2|Core Treatment Period (CT)|Lost to Follow-up|0
168884|NCT00235989|534231|P1|Core Treatment Period (CT)|Lost to Follow-up|0
168885|NCT00235872|534245|P1|Overall Study|Administrative reason|61
168886|NCT00235872|534245|P1|Overall Study|Withdrawal by Subject|50
168887|NCT00235872|534245|P1|Overall Study|Lost to Follow-up|1
168888|NCT00235872|534245|P1|Overall Study|Death|1
168889|NCT00235872|534245|P1|Overall Study|Adverse Event|34
168890|NCT00235755|534276|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
168891|NCT00235755|534277|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
168892|NCT00235755|534278|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
168893|NCT00235755|534276|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
168894|NCT00235755|534277|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
168895|NCT00235755|534278|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
168896|NCT00235755|534276|P3|12-Week Maintenance Phase|Protocol Violation|2
168897|NCT00235755|534277|P2|12-Week Maintenance Phase|Protocol Violation|4
168898|NCT00235755|534278|P1|12-Week Maintenance Phase|Protocol Violation|0
168899|NCT00235755|534276|P3|12-Week Maintenance Phase|Lack of Efficacy|0
168900|NCT00235755|534277|P2|12-Week Maintenance Phase|Lack of Efficacy|0
168901|NCT00235755|534278|P1|12-Week Maintenance Phase|Lack of Efficacy|5
168902|NCT00235755|534276|P3|12-Week Maintenance Phase|Lost to Follow-up|0
168903|NCT00235755|534277|P2|12-Week Maintenance Phase|Lost to Follow-up|3
168904|NCT00235755|534278|P1|12-Week Maintenance Phase|Lost to Follow-up|2
168905|NCT00235755|534276|P3|12-Week Maintenance Phase|Adverse Event|26
168906|NCT00235755|534277|P2|12-Week Maintenance Phase|Adverse Event|12
168907|NCT00235755|534278|P1|12-Week Maintenance Phase|Adverse Event|8
168908|NCT00235755|534276|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
168909|NCT00235755|534277|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
168910|NCT00235755|534278|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
168911|NCT00235755|534276|P3|4-Week Titration Phase|Randomization Occurred in Error|0
168912|NCT00235755|534277|P2|4-Week Titration Phase|Randomization Occurred in Error|0
168913|NCT00235755|534278|P1|4-Week Titration Phase|Randomization Occurred in Error|1
168914|NCT00235755|534276|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
168915|NCT00235755|534277|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
168916|NCT00235755|534278|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
168917|NCT00235755|534276|P3|4-Week Titration Phase|Withdrawal by Subject|3
168918|NCT00235755|534277|P2|4-Week Titration Phase|Withdrawal by Subject|2
168919|NCT00235755|534278|P1|4-Week Titration Phase|Withdrawal by Subject|1
168920|NCT00235755|534276|P3|4-Week Titration Phase|Protocol Violation|1
168921|NCT00235755|534277|P2|4-Week Titration Phase|Protocol Violation|2
168922|NCT00235755|534278|P1|4-Week Titration Phase|Protocol Violation|2
168923|NCT00235755|534276|P3|4-Week Titration Phase|Lost to Follow-up|1
168924|NCT00235755|534277|P2|4-Week Titration Phase|Lost to Follow-up|1
168925|NCT00235755|534278|P1|4-Week Titration Phase|Lost to Follow-up|0
168926|NCT00235755|534276|P3|4-Week Titration Phase|Adverse Event|20
168927|NCT00235755|534277|P2|4-Week Titration Phase|Adverse Event|14
168928|NCT00235755|534278|P1|4-Week Titration Phase|Adverse Event|6
168929|NCT00235716|534356|P4|Overall Study|Physician Decision|3
168930|NCT00235716|534357|P3|Overall Study|Physician Decision|1
168931|NCT00235716|534358|P2|Overall Study|Physician Decision|1
168932|NCT00235716|534359|P1|Overall Study|Physician Decision|0
168933|NCT00235716|534356|P4|Overall Study|Adverse Event|0
168934|NCT00235716|534357|P3|Overall Study|Adverse Event|1
168935|NCT00235716|534358|P2|Overall Study|Adverse Event|1
168936|NCT00235716|534359|P1|Overall Study|Adverse Event|1
168937|NCT00235716|534356|P4|Overall Study|Lost to Follow-up|10
168938|NCT00235716|534357|P3|Overall Study|Lost to Follow-up|14
168939|NCT00235716|534358|P2|Overall Study|Lost to Follow-up|7
168940|NCT00235716|534359|P1|Overall Study|Lost to Follow-up|12
168941|NCT00235716|534356|P4|Overall Study|Withdrawal by Subject|18
168942|NCT00235716|534357|P3|Overall Study|Withdrawal by Subject|17
168943|NCT00235716|534358|P2|Overall Study|Withdrawal by Subject|19
168944|NCT00235716|534359|P1|Overall Study|Withdrawal by Subject|23
168945|NCT00235716|534356|P4|Overall Study|Death|31
168946|NCT00235716|534357|P3|Overall Study|Death|32
168947|NCT00235716|534358|P2|Overall Study|Death|39
168948|NCT00235716|534359|P1|Overall Study|Death|26
168949|NCT00235443|534422|P6|Overall Study|Other reasons for premature termination|6
168950|NCT00235443|534423|P5|Overall Study|Other reasons for premature termination|3
168951|NCT00235443|534424|P4|Overall Study|Other reasons for premature termination|7
168952|NCT00235443|534425|P3|Overall Study|Other reasons for premature termination|6
168953|NCT00235443|534426|P2|Overall Study|Other reasons for premature termination|6
168954|NCT00235443|534427|P1|Overall Study|Other reasons for premature termination|1
168955|NCT00235443|534422|P6|Overall Study|Unsatisfactory compliance|0
168956|NCT00235443|534423|P5|Overall Study|Unsatisfactory compliance|1
168957|NCT00235443|534424|P4|Overall Study|Unsatisfactory compliance|4
168958|NCT00235443|534425|P3|Overall Study|Unsatisfactory compliance|3
168959|NCT00235443|534426|P2|Overall Study|Unsatisfactory compliance|2
168960|NCT00235443|534427|P1|Overall Study|Unsatisfactory compliance|0
168961|NCT00235443|534422|P6|Overall Study|Lost to Follow-up|3
168962|NCT00235443|534423|P5|Overall Study|Lost to Follow-up|4
168963|NCT00235443|534424|P4|Overall Study|Lost to Follow-up|6
168964|NCT00235443|534425|P3|Overall Study|Lost to Follow-up|6
168965|NCT00235443|534426|P2|Overall Study|Lost to Follow-up|8
168966|NCT00235443|534427|P1|Overall Study|Lost to Follow-up|0
168967|NCT00235443|534422|P6|Overall Study|Withdrawal by Subject|12
168968|NCT00235443|534423|P5|Overall Study|Withdrawal by Subject|10
168969|NCT00235443|534424|P4|Overall Study|Withdrawal by Subject|24
168970|NCT00235443|534425|P3|Overall Study|Withdrawal by Subject|25
168971|NCT00235443|534426|P2|Overall Study|Withdrawal by Subject|9
168972|NCT00235443|534427|P1|Overall Study|Withdrawal by Subject|3
168973|NCT00235443|534422|P6|Overall Study|Lack of Efficacy|9
168974|NCT00235443|534423|P5|Overall Study|Lack of Efficacy|2
168975|NCT00235443|534424|P4|Overall Study|Lack of Efficacy|12
168976|NCT00235443|534425|P3|Overall Study|Lack of Efficacy|5
168977|NCT00235443|534426|P2|Overall Study|Lack of Efficacy|1
168978|NCT00235443|534427|P1|Overall Study|Lack of Efficacy|0
168979|NCT00235443|534422|P6|Overall Study|Adverse Event|15
168980|NCT00235443|534423|P5|Overall Study|Adverse Event|10
168981|NCT00235443|534424|P4|Overall Study|Adverse Event|44
168982|NCT00235443|534425|P3|Overall Study|Adverse Event|17
168983|NCT00235443|534426|P2|Overall Study|Adverse Event|12
168984|NCT00235443|534427|P1|Overall Study|Adverse Event|4
168985|NCT00235391|534568|P6|Overall Study|Death|0
168986|NCT00235391|534569|P5|Overall Study|Death|0
168987|NCT00235391|534570|P4|Overall Study|Death|4
168988|NCT00235391|534571|P3|Overall Study|Death|1
168989|NCT00235391|534572|P2|Overall Study|Death|0
168990|NCT00235391|534573|P1|Overall Study|Death|0
168991|NCT00235391|534568|P6|Overall Study|Administrative problems|0
168992|NCT00235391|534569|P5|Overall Study|Administrative problems|0
168993|NCT00235391|534570|P4|Overall Study|Administrative problems|1
168994|NCT00235391|534571|P3|Overall Study|Administrative problems|0
168995|NCT00235391|534572|P2|Overall Study|Administrative problems|0
168996|NCT00235391|534573|P1|Overall Study|Administrative problems|0
168997|NCT00235391|534568|P6|Overall Study|Lost to Follow-up|0
168998|NCT00235391|534569|P5|Overall Study|Lost to Follow-up|0
168999|NCT00235391|534570|P4|Overall Study|Lost to Follow-up|16
169000|NCT00235391|534571|P3|Overall Study|Lost to Follow-up|3
169001|NCT00235391|534572|P2|Overall Study|Lost to Follow-up|3
169002|NCT00235391|534573|P1|Overall Study|Lost to Follow-up|0
169003|NCT00235391|534568|P6|Overall Study|Withdrawal by Subject|0
169004|NCT00235391|534569|P5|Overall Study|Withdrawal by Subject|5
169005|NCT00235391|534570|P4|Overall Study|Withdrawal by Subject|61
169006|NCT00235391|534571|P3|Overall Study|Withdrawal by Subject|3
169007|NCT00235391|534572|P2|Overall Study|Withdrawal by Subject|3
169008|NCT00235391|534573|P1|Overall Study|Withdrawal by Subject|2
169009|NCT00235391|534568|P6|Overall Study|Protocol deviation|0
169010|NCT00235391|534569|P5|Overall Study|Protocol deviation|0
169011|NCT00235391|534570|P4|Overall Study|Protocol deviation|11
169012|NCT00235391|534571|P3|Overall Study|Protocol deviation|1
169013|NCT00235391|534572|P2|Overall Study|Protocol deviation|0
169014|NCT00235391|534573|P1|Overall Study|Protocol deviation|0
169015|NCT00235391|534568|P6|Overall Study|Condition no longer requires treatment|0
169016|NCT00235391|534569|P5|Overall Study|Condition no longer requires treatment|1
169017|NCT00235391|534570|P4|Overall Study|Condition no longer requires treatment|11
169018|NCT00235391|534571|P3|Overall Study|Condition no longer requires treatment|0
169019|NCT00235391|534572|P2|Overall Study|Condition no longer requires treatment|0
169020|NCT00235391|534573|P1|Overall Study|Condition no longer requires treatment|3
169021|NCT00235391|534568|P6|Overall Study|Unsatisfactory therapeutic effect|0
169022|NCT00235391|534569|P5|Overall Study|Unsatisfactory therapeutic effect|0
169023|NCT00235391|534570|P4|Overall Study|Unsatisfactory therapeutic effect|17
169024|NCT00235391|534571|P3|Overall Study|Unsatisfactory therapeutic effect|2
169025|NCT00235391|534572|P2|Overall Study|Unsatisfactory therapeutic effect|2
169026|NCT00235391|534573|P1|Overall Study|Unsatisfactory therapeutic effect|0
169027|NCT00235391|534568|P6|Overall Study|Abnormal laboratory value(s)|2
169028|NCT00235391|534569|P5|Overall Study|Abnormal laboratory value(s)|1
169029|NCT00235391|534570|P4|Overall Study|Abnormal laboratory value(s)|27
169030|NCT00235391|534571|P3|Overall Study|Abnormal laboratory value(s)|4
169031|NCT00235391|534572|P2|Overall Study|Abnormal laboratory value(s)|5
169032|NCT00235391|534573|P1|Overall Study|Abnormal laboratory value(s)|3
169033|NCT00235391|534568|P6|Overall Study|Adverse Event|2
169034|NCT00235391|534569|P5|Overall Study|Adverse Event|5
169035|NCT00235391|534570|P4|Overall Study|Adverse Event|72
169036|NCT00235391|534571|P3|Overall Study|Adverse Event|10
169037|NCT00235391|534572|P2|Overall Study|Adverse Event|5
169038|NCT00235391|534573|P1|Overall Study|Adverse Event|4
169039|NCT00235326|534590|P2|Overall Study|Lost to Follow-up|1400
169040|NCT00235326|534591|P1|Overall Study|Lost to Follow-up|746
169041|NCT00234494|534631|P1|Overall Study|Protocol Violation|2
169042|NCT00233454|534647|P1|Overall Study|Death|6
169043|NCT00233402|534654|P2|Overall Study|Lost to follow up etc|21
169044|NCT00233402|534655|P1|Overall Study|Lost to follow up etc|3
169045|NCT00233402|534654|P2|Overall Study|No Ta/T1|94
169046|NCT00233402|534655|P1|Overall Study|No Ta/T1|89
169047|NCT00233402|534654|P2|Overall Study|No pathology data|9
169048|NCT00233402|534655|P1|Overall Study|No pathology data|12
169049|NCT00234104|534705|P4|Overall Study|Physician Decision|2
169050|NCT00234104|534706|P3|Overall Study|Physician Decision|2
169051|NCT00234104|534707|P2|Overall Study|Physician Decision|1
169052|NCT00234104|534708|P1|Overall Study|Physician Decision|0
169053|NCT00234104|534705|P4|Overall Study|Protocol Violation|1
169054|NCT00234104|534706|P3|Overall Study|Protocol Violation|0
169055|NCT00234104|534707|P2|Overall Study|Protocol Violation|0
169056|NCT00234104|534708|P1|Overall Study|Protocol Violation|0
169057|NCT00234104|534705|P4|Overall Study|Adverse Event|5
169058|NCT00234104|534706|P3|Overall Study|Adverse Event|3
169059|NCT00234104|534707|P2|Overall Study|Adverse Event|0
169060|NCT00234104|534708|P1|Overall Study|Adverse Event|4
169061|NCT00234065|534749|P2|Overall Study|Not Classified|112
169062|NCT00234065|534750|P1|Overall Study|Not Classified|111
169063|NCT00234065|534749|P2|Overall Study|Physician Decision|22
169064|NCT00234065|534750|P1|Overall Study|Physician Decision|23
169065|NCT00234065|534749|P2|Overall Study|Withdrawal by Subject|56
169066|NCT00234065|534750|P1|Overall Study|Withdrawal by Subject|73
169067|NCT00234065|534749|P2|Overall Study|Adverse Event|166
169068|NCT00234065|534750|P1|Overall Study|Adverse Event|268
169069|NCT00234039|534766|P1|Overall Study|No Protocol Treatment Received|2
169070|NCT00234039|534766|P1|Overall Study|Ineligible|9
169071|NCT00234039|534766|P1|Overall Study|Other - Not Protocol Specified|3
169072|NCT00234039|534766|P1|Overall Study|Progression/relapse|34
169073|NCT00234039|534766|P1|Overall Study|Adverse Event|2
169074|NCT00233987|534773|P1|Overall Study|Ineligible|4
169075|NCT00233987|534773|P1|Overall Study|Eligible but No Treatment Received|2
169076|NCT00233987|534773|P1|Overall Study|Other - Not Protocol Specified|5
169077|NCT00233987|534773|P1|Overall Study|Reason Under Review|1
169078|NCT00233987|534773|P1|Overall Study|Lack of Efficacy|2
169079|NCT00233987|534773|P1|Overall Study|Withdrawal by Subject|1
169080|NCT00233948|534782|P6|Overall Study|Adverse Event|0
169081|NCT00233948|534783|P5|Overall Study|Adverse Event|0
169082|NCT00233948|534784|P4|Overall Study|Adverse Event|0
169083|NCT00233948|534785|P3|Overall Study|Adverse Event|0
169084|NCT00233948|534786|P2|Overall Study|Adverse Event|0
169085|NCT00233948|534787|P1|Overall Study|Adverse Event|1
169086|NCT00233324|534806|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
169087|NCT00233324|534807|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
169088|NCT00233324|534808|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
169089|NCT00233324|534809|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
169090|NCT00233324|534806|P4|Follow up at 18-22 Months Corrected Age|Death|4
169091|NCT00233324|534807|P3|Follow up at 18-22 Months Corrected Age|Death|5
169092|NCT00233324|534808|P2|Follow up at 18-22 Months Corrected Age|Death|7
169093|NCT00233324|534809|P1|Follow up at 18-22 Months Corrected Age|Death|5
169094|NCT00233324|534806|P4|Main Study|Death|47
169095|NCT00233324|534807|P3|Main Study|Death|62
169096|NCT00233324|534808|P2|Main Study|Death|60
169097|NCT00233324|534809|P1|Main Study|Death|68
169098|NCT00233064|534863|P2|Overall Study|Moved to Dom. Republic|0
169099|NCT00233064|534864|P1|Overall Study|Moved to Dom. Republic|1
169100|NCT00233064|534863|P2|Overall Study|Protocol Violation|0
169101|NCT00233064|534864|P1|Overall Study|Protocol Violation|1
169102|NCT00233064|534863|P2|Overall Study|Relocation|1
169103|NCT00233064|534864|P1|Overall Study|Relocation|0
169104|NCT00233064|534863|P2|Overall Study|Death|1
169105|NCT00233064|534864|P1|Overall Study|Death|0
169106|NCT00233064|534863|P2|Overall Study|Withdrawal by Subject|3
169107|NCT00233064|534864|P1|Overall Study|Withdrawal by Subject|5
169108|NCT00233064|534863|P2|Overall Study|Lost to Follow-up|7
169109|NCT00233064|534864|P1|Overall Study|Lost to Follow-up|7
169110|NCT00232596|534890|P2|12-Week Maintenance Phase|Other|3
169111|NCT00232596|534891|P1|12-Week Maintenance Phase|Other|1
169112|NCT00232596|534890|P2|12-Week Maintenance Phase|Protocol Violation|1
169113|NCT00232596|534891|P1|12-Week Maintenance Phase|Protocol Violation|3
169114|NCT00232596|534890|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
169115|NCT00232596|534891|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
169116|NCT00232596|534890|P2|12-Week Maintenance Phase|Adverse Event|22
169117|NCT00232596|534891|P1|12-Week Maintenance Phase|Adverse Event|7
169118|NCT00232596|534890|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
169119|NCT00232596|534891|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
169120|NCT00232596|534890|P2|6-Week Titration Phase|Other|3
169121|NCT00232596|534891|P1|6-Week Titration Phase|Other|3
169122|NCT00232596|534890|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
169123|NCT00232596|534891|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
169124|NCT00232596|534890|P2|6-Week Titration Phase|Protocol Violation|3
169125|NCT00232596|534891|P1|6-Week Titration Phase|Protocol Violation|1
169126|NCT00232596|534890|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
169127|NCT00232596|534891|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
169128|NCT00232596|534890|P2|6-Week Titration Phase|Failed to Return|1
169129|NCT00232596|534891|P1|6-Week Titration Phase|Failed to Return|2
169130|NCT00232596|534890|P2|6-Week Titration Phase|Adverse Event|19
169131|NCT00232596|534891|P1|6-Week Titration Phase|Adverse Event|6
169132|NCT00232557|534952|P2|Overall Study|Lost to Follow-up|5
169133|NCT00232557|534953|P1|Overall Study|Lost to Follow-up|3
169134|NCT00232544|534963|P2|Overall Study|Lost to Follow-up|15
169135|NCT00232544|534964|P1|Overall Study|Lost to Follow-up|20
169136|NCT00232180|534979|P3|Open Label Phase|Randomized but not treated|1
169137|NCT00232180|534980|P2|Open Label Phase|Randomized but not treated|0
169138|NCT00232180|534981|P1|Open Label Phase|Randomized but not treated|0
169139|NCT00232180|534979|P3|Open Label Phase|Laboratory abnormality|10
169140|NCT00232180|534980|P2|Open Label Phase|Laboratory abnormality|0
169141|NCT00232180|534981|P1|Open Label Phase|Laboratory abnormality|0
169142|NCT00232180|534979|P3|Open Label Phase|Adverse Event|25
169143|NCT00232180|534980|P2|Open Label Phase|Adverse Event|0
169144|NCT00232180|534981|P1|Open Label Phase|Adverse Event|0
169145|NCT00232180|534979|P3|Open Label Phase|Unspecified|16
169146|NCT00232180|534980|P2|Open Label Phase|Unspecified|0
169147|NCT00232180|534981|P1|Open Label Phase|Unspecified|0
169148|NCT00232180|534979|P3|Open Label Phase|Withdrawal by Subject|37
169149|NCT00232180|534980|P2|Open Label Phase|Withdrawal by Subject|0
169150|NCT00232180|534981|P1|Open Label Phase|Withdrawal by Subject|0
169151|NCT00232180|534979|P3|Open Label Phase|Study terminated by sponsor|3
169152|NCT00232180|534980|P2|Open Label Phase|Study terminated by sponsor|0
169153|NCT00232180|534981|P1|Open Label Phase|Study terminated by sponsor|0
169154|NCT00232180|534979|P3|Open Label Phase|Protocol Violation|3
169155|NCT00232180|534980|P2|Open Label Phase|Protocol Violation|0
169156|NCT00232180|534981|P1|Open Label Phase|Protocol Violation|0
169157|NCT00232180|534979|P3|Open Label Phase|Lost to Follow-up|5
169158|NCT00232180|534980|P2|Open Label Phase|Lost to Follow-up|0
169159|NCT00232180|534981|P1|Open Label Phase|Lost to Follow-up|0
169160|NCT00232180|534979|P3|Open Label Phase|Death|48
169161|NCT00232180|534980|P2|Open Label Phase|Death|0
169162|NCT00232180|534981|P1|Open Label Phase|Death|0
169163|NCT00232180|534979|P3|Double-blind (DB) Phase|Laboratory abnormality|0
169164|NCT00232180|534980|P2|Double-blind (DB) Phase|Laboratory abnormality|7
169165|NCT00232180|534981|P1|Double-blind (DB) Phase|Laboratory abnormality|6
169166|NCT00232180|534979|P3|Double-blind (DB) Phase|Randomized but not treated|0
169167|NCT00232180|534980|P2|Double-blind (DB) Phase|Randomized but not treated|4
169168|NCT00232180|534981|P1|Double-blind (DB) Phase|Randomized but not treated|3
169169|NCT00232180|534979|P3|Double-blind (DB) Phase|Unspecified|0
169170|NCT00232180|534980|P2|Double-blind (DB) Phase|Unspecified|75
169171|NCT00232180|534981|P1|Double-blind (DB) Phase|Unspecified|70
169172|NCT00232180|534979|P3|Double-blind (DB) Phase|Adverse Event|0
169173|NCT00232180|534980|P2|Double-blind (DB) Phase|Adverse Event|100
169174|NCT00232180|534981|P1|Double-blind (DB) Phase|Adverse Event|83
169175|NCT00232180|534979|P3|Double-blind (DB) Phase|Protocol Violation|0
169176|NCT00232180|534980|P2|Double-blind (DB) Phase|Protocol Violation|21
169177|NCT00232180|534981|P1|Double-blind (DB) Phase|Protocol Violation|28
169178|NCT00232180|534979|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
169179|NCT00232180|534980|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
169180|NCT00232180|534981|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
169181|NCT00232180|534979|P3|Double-blind (DB) Phase|Lost to Follow-up|0
169182|NCT00232180|534980|P2|Double-blind (DB) Phase|Lost to Follow-up|28
169183|NCT00232180|534981|P1|Double-blind (DB) Phase|Lost to Follow-up|34
169184|NCT00232180|534979|P3|Double-blind (DB) Phase|Death|0
169185|NCT00232180|534980|P2|Double-blind (DB) Phase|Death|222
169186|NCT00232180|534981|P1|Double-blind (DB) Phase|Death|186
169187|NCT00232141|535026|P2|Overall Study|Withdrawal by Subject|3
169188|NCT00232141|535027|P1|Overall Study|Withdrawal by Subject|5
169189|NCT00232141|535026|P2|Overall Study|Other|10
169190|NCT00232141|535027|P1|Overall Study|Other|8
169191|NCT00232141|535026|P2|Overall Study|Lost to Follow-up|6
169192|NCT00232141|535027|P1|Overall Study|Lost to Follow-up|9
169193|NCT00232141|535026|P2|Overall Study|Lack of Efficacy|3
169194|NCT00232141|535027|P1|Overall Study|Lack of Efficacy|0
169195|NCT00232141|535026|P2|Overall Study|Adverse Event|4
169196|NCT00232141|535027|P1|Overall Study|Adverse Event|9
169197|NCT00231816|535097|P2|Overall Study|Not Specified|1
169198|NCT00231816|535098|P1|Overall Study|Not Specified|2
169199|NCT00231816|535097|P2|Overall Study|Withdrawal by Subject|3
169200|NCT00231816|535098|P1|Overall Study|Withdrawal by Subject|3
169201|NCT00231816|535097|P2|Overall Study|Protocol Violation|3
169202|NCT00231816|535098|P1|Overall Study|Protocol Violation|2
169203|NCT00231816|535097|P2|Overall Study|Lost to Follow-up|5
169204|NCT00231816|535098|P1|Overall Study|Lost to Follow-up|8
169205|NCT00231816|535097|P2|Overall Study|Adverse Event|0
169206|NCT00231816|535098|P1|Overall Study|Adverse Event|1
169207|NCT00231777|535113|P2|Overall Study|Unspecified|2
169208|NCT00231777|535114|P1|Overall Study|Unspecified|3
169209|NCT00231777|535113|P2|Overall Study|Lost to Follow-up|0
169210|NCT00231777|535114|P1|Overall Study|Lost to Follow-up|3
169211|NCT00231478|535128|P2|Overall Study|Administrative|2
169212|NCT00231478|535129|P1|Overall Study|Administrative|3
169213|NCT00231478|535128|P2|Overall Study|Adverse Event|1
169214|NCT00231478|535129|P1|Overall Study|Adverse Event|0
169215|NCT00231478|535128|P2|Overall Study|Withdrawal by Subject|0
169216|NCT00231478|535129|P1|Overall Study|Withdrawal by Subject|1
169217|NCT00231478|535128|P2|Overall Study|Refused Treatment|1
169218|NCT00231478|535129|P1|Overall Study|Refused Treatment|1
169219|NCT00231478|535128|P2|Overall Study|Protocol Violation|2
169220|NCT00231478|535129|P1|Overall Study|Protocol Violation|3
169221|NCT00231465|535141|P1|Overall Study|Did not have follow up CT scans|1
169222|NCT00231465|535141|P1|Overall Study|Completed only one cycle|1
169223|NCT00231179|535161|P2|Overall Study|Withdrawal by Subject|3
169224|NCT00231179|535162|P1|Overall Study|Withdrawal by Subject|3
169225|NCT00231179|535161|P2|Overall Study|Lost to Follow-up|21
169226|NCT00231179|535162|P1|Overall Study|Lost to Follow-up|21
169227|NCT00231114|535189|P2|Post-Treatment Period|Withdrawal by Subject|0
169228|NCT00231114|535190|P1|Post-Treatment Period|Withdrawal by Subject|1
169229|NCT00231114|535189|P2|Post-Treatment Period|Physician Decision|0
169230|NCT00231114|535190|P1|Post-Treatment Period|Physician Decision|1
169231|NCT00231114|535189|P2|Post-Treatment Period|Lost to Follow-up|1
169232|NCT00231114|535190|P1|Post-Treatment Period|Lost to Follow-up|6
169233|NCT00231114|535189|P2|Treatment Period|Death: Motor Vehicle Accident|0
169234|NCT00231114|535190|P1|Treatment Period|Death: Motor Vehicle Accident|1
169235|NCT00231114|535189|P2|Randomized|Withdrawal by Subject|3
169236|NCT00231114|535190|P1|Randomized|Withdrawal by Subject|6
169237|NCT00231062|535226|P1|Overall Study|Physician Decision|6
169238|NCT00230971|535234|P2|Baseline Participants|Reintervention|0
169239|NCT00230971|535235|P1|Baseline Participants|Reintervention|1
169240|NCT00230971|535234|P2|Baseline Participants|Failure to return|1
169241|NCT00230971|535235|P1|Baseline Participants|Failure to return|1
169242|NCT00230971|535234|P2|Baseline Participants|No bacteria observed|0
169243|NCT00230971|535235|P1|Baseline Participants|No bacteria observed|1
169244|NCT00230971|535234|P2|Baseline Participants|Adverse Event|0
169245|NCT00230971|535235|P1|Baseline Participants|Adverse Event|1
169246|NCT00230971|535234|P2|Baseline Participants|Withdrawal by Subject|1
169247|NCT00230971|535235|P1|Baseline Participants|Withdrawal by Subject|7
169248|NCT00230971|535234|P2|Baseline Participants|Death|5
169249|NCT00230971|535235|P1|Baseline Participants|Death|6
169250|NCT00230971|535234|P2|Baseline Participants|Lost to Follow-up|12
169251|NCT00230971|535235|P1|Baseline Participants|Lost to Follow-up|5
169252|NCT00230971|535234|P2|Randomization|No study drug administered|3
169253|NCT00230971|535235|P1|Randomization|No study drug administered|3
169254|NCT00230282|535260|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
169255|NCT00230282|535260|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
169256|NCT00230282|535260|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
169257|NCT00230282|535260|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
169258|NCT00230178|535268|P3|Overall Study|Various other reasons|4
169259|NCT00230178|535269|P2|Overall Study|Various other reasons|2
169260|NCT00230178|535270|P1|Overall Study|Various other reasons|3
169261|NCT00230178|535268|P3|Overall Study|Withdrawal by Subject|1
169262|NCT00230178|535269|P2|Overall Study|Withdrawal by Subject|0
169263|NCT00230178|535270|P1|Overall Study|Withdrawal by Subject|0
169264|NCT00230178|535268|P3|Overall Study|Adverse Event|2
169265|NCT00230178|535269|P2|Overall Study|Adverse Event|5
169266|NCT00230178|535270|P1|Overall Study|Adverse Event|1
169267|NCT00230048|535322|P2|Overall Study|Lost to Follow-up|18
169268|NCT00230048|535323|P1|Overall Study|Lost to Follow-up|13
169269|NCT00229723|535386|P7|Maintenance Phase|Unspecified|1
169270|NCT00229723|535387|P6|Maintenance Phase|Unspecified|3
169271|NCT00229723|535388|P5|Maintenance Phase|Unspecified|3
169272|NCT00229723|535389|P4|Maintenance Phase|Unspecified|2
169273|NCT00229723|535390|P3|Maintenance Phase|Unspecified|1
169274|NCT00229723|535391|P2|Maintenance Phase|Unspecified|4
169275|NCT00229723|535392|P1|Maintenance Phase|Unspecified|5
169276|NCT00229723|535386|P7|Maintenance Phase|Severe non-compliance|0
169277|NCT00229723|535387|P6|Maintenance Phase|Severe non-compliance|0
169278|NCT00229723|535388|P5|Maintenance Phase|Severe non-compliance|1
169279|NCT00229723|535389|P4|Maintenance Phase|Severe non-compliance|0
169280|NCT00229723|535390|P3|Maintenance Phase|Severe non-compliance|0
169281|NCT00229723|535391|P2|Maintenance Phase|Severe non-compliance|1
169282|NCT00229723|535392|P1|Maintenance Phase|Severe non-compliance|3
169283|NCT00229723|535386|P7|Maintenance Phase|Informed consent withdrawn|0
169284|NCT00229723|535387|P6|Maintenance Phase|Informed consent withdrawn|1
169285|NCT00229723|535388|P5|Maintenance Phase|Informed consent withdrawn|1
169286|NCT00229723|535389|P4|Maintenance Phase|Informed consent withdrawn|1
169287|NCT00229723|535390|P3|Maintenance Phase|Informed consent withdrawn|0
169288|NCT00229723|535391|P2|Maintenance Phase|Informed consent withdrawn|0
169289|NCT00229723|535392|P1|Maintenance Phase|Informed consent withdrawn|1
169290|NCT00229723|535386|P7|Maintenance Phase|Lost to Follow-up|1
169291|NCT00229723|535387|P6|Maintenance Phase|Lost to Follow-up|0
169292|NCT00229723|535388|P5|Maintenance Phase|Lost to Follow-up|0
169293|NCT00229723|535389|P4|Maintenance Phase|Lost to Follow-up|2
169294|NCT00229723|535390|P3|Maintenance Phase|Lost to Follow-up|2
169295|NCT00229723|535391|P2|Maintenance Phase|Lost to Follow-up|1
169296|NCT00229723|535392|P1|Maintenance Phase|Lost to Follow-up|0
169297|NCT00229723|535386|P7|Maintenance Phase|Clinical progression|1
169298|NCT00229723|535387|P6|Maintenance Phase|Clinical progression|1
169299|NCT00229723|535388|P5|Maintenance Phase|Clinical progression|1
169300|NCT00229723|535389|P4|Maintenance Phase|Clinical progression|2
169301|NCT00229723|535390|P3|Maintenance Phase|Clinical progression|2
169302|NCT00229723|535391|P2|Maintenance Phase|Clinical progression|1
169303|NCT00229723|535392|P1|Maintenance Phase|Clinical progression|4
169304|NCT00229723|535386|P7|Maintenance Phase|Objective disease progression|5
169305|NCT00229723|535387|P6|Maintenance Phase|Objective disease progression|9
169306|NCT00229723|535388|P5|Maintenance Phase|Objective disease progression|2
169307|NCT00229723|535389|P4|Maintenance Phase|Objective disease progression|6
169308|NCT00229723|535390|P3|Maintenance Phase|Objective disease progression|3
169309|NCT00229723|535391|P2|Maintenance Phase|Objective disease progression|5
169310|NCT00229723|535392|P1|Maintenance Phase|Objective disease progression|5
169311|NCT00229723|535386|P7|Maintenance Phase|Adverse Event|2
169312|NCT00229723|535387|P6|Maintenance Phase|Adverse Event|5
169313|NCT00229723|535388|P5|Maintenance Phase|Adverse Event|7
169314|NCT00229723|535389|P4|Maintenance Phase|Adverse Event|4
169315|NCT00229723|535390|P3|Maintenance Phase|Adverse Event|1
169316|NCT00229723|535391|P2|Maintenance Phase|Adverse Event|2
169317|NCT00229723|535392|P1|Maintenance Phase|Adverse Event|7
169318|NCT00229723|535386|P7|Concomitant Phase|Unspecified|0
169319|NCT00229723|535387|P6|Concomitant Phase|Unspecified|2
169320|NCT00229723|535388|P5|Concomitant Phase|Unspecified|0
169321|NCT00229723|535389|P4|Concomitant Phase|Unspecified|1
169322|NCT00229723|535390|P3|Concomitant Phase|Unspecified|1
169323|NCT00229723|535391|P2|Concomitant Phase|Unspecified|0
169324|NCT00229723|535392|P1|Concomitant Phase|Unspecified|3
169325|NCT00229723|535386|P7|Concomitant Phase|Severe non-compliance|0
169326|NCT00229723|535387|P6|Concomitant Phase|Severe non-compliance|0
169327|NCT00229723|535388|P5|Concomitant Phase|Severe non-compliance|1
169328|NCT00229723|535389|P4|Concomitant Phase|Severe non-compliance|0
169329|NCT00229723|535390|P3|Concomitant Phase|Severe non-compliance|0
169330|NCT00229723|535391|P2|Concomitant Phase|Severe non-compliance|1
169331|NCT00229723|535392|P1|Concomitant Phase|Severe non-compliance|0
169332|NCT00229723|535386|P7|Concomitant Phase|Informed consent withdrawn|0
169333|NCT00229723|535387|P6|Concomitant Phase|Informed consent withdrawn|0
169334|NCT00229723|535388|P5|Concomitant Phase|Informed consent withdrawn|0
169335|NCT00229723|535389|P4|Concomitant Phase|Informed consent withdrawn|2
169336|NCT00229723|535390|P3|Concomitant Phase|Informed consent withdrawn|0
169337|NCT00229723|535391|P2|Concomitant Phase|Informed consent withdrawn|2
169338|NCT00229723|535392|P1|Concomitant Phase|Informed consent withdrawn|3
169339|NCT00229723|535386|P7|Concomitant Phase|Lost to Follow-up|0
169340|NCT00229723|535387|P6|Concomitant Phase|Lost to Follow-up|0
169341|NCT00229723|535388|P5|Concomitant Phase|Lost to Follow-up|1
169342|NCT00229723|535389|P4|Concomitant Phase|Lost to Follow-up|0
169343|NCT00229723|535390|P3|Concomitant Phase|Lost to Follow-up|0
169344|NCT00229723|535391|P2|Concomitant Phase|Lost to Follow-up|0
169345|NCT00229723|535392|P1|Concomitant Phase|Lost to Follow-up|0
169346|NCT00229723|535386|P7|Concomitant Phase|Clinical progression|1
169347|NCT00229723|535387|P6|Concomitant Phase|Clinical progression|0
169348|NCT00229723|535388|P5|Concomitant Phase|Clinical progression|0
169349|NCT00229723|535389|P4|Concomitant Phase|Clinical progression|0
169350|NCT00229723|535390|P3|Concomitant Phase|Clinical progression|0
169351|NCT00229723|535391|P2|Concomitant Phase|Clinical progression|0
169352|NCT00229723|535392|P1|Concomitant Phase|Clinical progression|0
169353|NCT00229723|535386|P7|Concomitant Phase|Objective disease progression|0
169354|NCT00229723|535387|P6|Concomitant Phase|Objective disease progression|0
169355|NCT00229723|535388|P5|Concomitant Phase|Objective disease progression|0
169356|NCT00229723|535389|P4|Concomitant Phase|Objective disease progression|0
169357|NCT00229723|535390|P3|Concomitant Phase|Objective disease progression|0
169358|NCT00229723|535391|P2|Concomitant Phase|Objective disease progression|0
169359|NCT00229723|535392|P1|Concomitant Phase|Objective disease progression|0
169360|NCT00229723|535386|P7|Concomitant Phase|Adverse Event|2
169361|NCT00229723|535387|P6|Concomitant Phase|Adverse Event|1
169362|NCT00229723|535388|P5|Concomitant Phase|Adverse Event|0
169363|NCT00229723|535389|P4|Concomitant Phase|Adverse Event|2
169364|NCT00229723|535390|P3|Concomitant Phase|Adverse Event|5
169365|NCT00229723|535391|P2|Concomitant Phase|Adverse Event|2
169366|NCT00229723|535392|P1|Concomitant Phase|Adverse Event|4
169367|NCT00229658|535445|P2|Overall Study|Withdrawal of consent|39
169368|NCT00229658|535446|P1|Overall Study|Withdrawal of consent|46
169369|NCT00229658|535445|P2|Overall Study|Serious Adverse Event|2
169370|NCT00229658|535446|P1|Overall Study|Serious Adverse Event|2
169371|NCT00229658|535445|P2|Overall Study|Lost to Follow-up|55
169372|NCT00229658|535446|P1|Overall Study|Lost to Follow-up|82
169373|NCT00229658|535445|P2|Overall Study|Other|60
169374|NCT00229658|535446|P1|Overall Study|Other|80
169375|NCT00229658|535445|P2|Overall Study|Investigator decision|10
169376|NCT00229658|535446|P1|Overall Study|Investigator decision|13
169377|NCT00229658|535445|P2|Overall Study|Administrative|1
169378|NCT00229658|535446|P1|Overall Study|Administrative|2
169379|NCT00228813|535478|P1|Overall Study|Death|4
169380|NCT00228566|535484|P1|Overall Study|Miscellaneous|1
169381|NCT00228566|535484|P1|Overall Study|Withdrawal by Subject|4
169382|NCT00228566|535484|P1|Overall Study|Physician Decision|5
169383|NCT00228566|535484|P1|Overall Study|Lost to Follow-up|16
169384|NCT00228566|535484|P1|Overall Study|Lack of Efficacy|14
169385|NCT00228566|535484|P1|Overall Study|Adverse Event|31
169386|NCT00228553|535488|P1|Overall Study|Miscellaneous|46
169387|NCT00228553|535488|P1|Overall Study|Pregnancy|2
169388|NCT00228553|535488|P1|Overall Study|Withdrawal by Subject|115
169389|NCT00228553|535488|P1|Overall Study|Protocol Violation|6
169390|NCT00228553|535488|P1|Overall Study|Physician Decision|48
169391|NCT00228553|535488|P1|Overall Study|Lost to Follow-up|67
169392|NCT00228553|535488|P1|Overall Study|Lack of Efficacy|34
169393|NCT00228553|535488|P1|Overall Study|Adverse Event|112
169394|NCT00229203|535494|P2|Overall Study|Withdrawal by Subject|4
169395|NCT00229203|535495|P1|Overall Study|Withdrawal by Subject|1
169396|NCT00229203|535494|P2|Overall Study|Other|3
169397|NCT00229203|535495|P1|Overall Study|Other|3
169398|NCT00229203|535494|P2|Overall Study|Death|2
169399|NCT00229203|535495|P1|Overall Study|Death|4
169400|NCT00229203|535494|P2|Overall Study|Toxicity|1
169401|NCT00229203|535495|P1|Overall Study|Toxicity|6
169402|NCT00229203|535494|P2|Overall Study|Progressive disease|9
169403|NCT00229203|535495|P1|Overall Study|Progressive disease|18
169404|NCT00228384|535517|P2|Overall Study|Physician Decision|1
169405|NCT00228384|535518|P1|Overall Study|Physician Decision|0
169406|NCT00228384|535517|P2|Overall Study|Withdrawal by Subject|10
169407|NCT00228384|535518|P1|Overall Study|Withdrawal by Subject|9
169408|NCT00228384|535517|P2|Overall Study|Surgical Intervention (bypass)|5
169409|NCT00228384|535518|P1|Overall Study|Surgical Intervention (bypass)|5
169410|NCT00228384|535517|P2|Overall Study|Lost to Follow-up|10
169411|NCT00228384|535518|P1|Overall Study|Lost to Follow-up|6
169412|NCT00228384|535517|P2|Overall Study|Death|3
169413|NCT00228384|535518|P1|Overall Study|Death|9
169414|NCT00227903|535569|P2|Overall Study|Miscarriage|0
169415|NCT00227903|535570|P1|Overall Study|Miscarriage|1
169416|NCT00227903|535569|P2|Overall Study|Lost to Follow-up|3
169417|NCT00227903|535570|P1|Overall Study|Lost to Follow-up|1
169418|NCT00227903|535569|P2|Overall Study|Subject moved out of area|2
169419|NCT00227903|535570|P1|Overall Study|Subject moved out of area|1
169420|NCT00227903|535569|P2|Overall Study|Withdrawal by Subject|5
169421|NCT00227903|535570|P1|Overall Study|Withdrawal by Subject|2
169422|NCT00227721|535636|P1|Overall Study|On study, but never treated.|1
169423|NCT00227591|535640|P1|Overall Study|Withdrawal by Subject|1
169424|NCT00227370|535646|P2|Overall Study|Other reasons|1
169425|NCT00227370|535647|P1|Overall Study|Other reasons|2
169426|NCT00227370|535646|P2|Overall Study|Physician Decision|6
169427|NCT00227370|535647|P1|Overall Study|Physician Decision|9
169428|NCT00227370|535646|P2|Overall Study|Adverse Event|11
169429|NCT00227370|535647|P1|Overall Study|Adverse Event|6
169430|NCT00227370|535646|P2|Overall Study|Death|4
169431|NCT00227370|535647|P1|Overall Study|Death|3
169432|NCT00227370|535646|P2|Overall Study|Withdrawal by Subject|2
169433|NCT00227370|535647|P1|Overall Study|Withdrawal by Subject|1
169434|NCT00227344|535667|P2|Overall Study|study terminated early|5
169435|NCT00227344|535668|P1|Overall Study|study terminated early|12
169436|NCT00227305|535688|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
169437|NCT00227305|535688|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
169438|NCT00227305|535688|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
169439|NCT00227305|535688|P1|Overall Study|Physician Decision|3
169440|NCT00227305|535688|P1|Overall Study|Lack of Efficacy|7
169441|NCT00227305|535688|P1|Overall Study|MOVED OUT OF AREA|3
169442|NCT00227305|535688|P1|Overall Study|Study specific discontinuation|13
169443|NCT00227305|535688|P1|Overall Study|Lost to Follow-up|33
169444|NCT00227305|535688|P1|Overall Study|Withdrawal by Subject|42
169445|NCT00227305|535688|P1|Overall Study|Adverse Event|40
169446|NCT00227266|535705|P3|Overall Study|Excessive weight gain|2
169447|NCT00227266|535706|P2|Overall Study|Excessive weight gain|0
169448|NCT00227266|535707|P1|Overall Study|Excessive weight gain|0
169449|NCT00227266|535705|P3|Overall Study|Protocol Violation|1
169450|NCT00227266|535706|P2|Overall Study|Protocol Violation|0
169451|NCT00227266|535707|P1|Overall Study|Protocol Violation|1
169452|NCT00227266|535705|P3|Overall Study|Withdrawal by Subject|1
169453|NCT00227266|535706|P2|Overall Study|Withdrawal by Subject|0
169454|NCT00227266|535707|P1|Overall Study|Withdrawal by Subject|0
169455|NCT00226811|535727|P1|Overall Study|Withdrawal by Subject|2
169456|NCT00226811|535727|P1|Overall Study|Lack of Efficacy|55
169457|NCT00226811|535727|P1|Overall Study|Adverse Event|11
169458|NCT00226811|535727|P1|Overall Study|Death|8
169459|NCT00226655|535737|P1|Overall Study|Clinical deterioration|10
169460|NCT00226655|535737|P1|Overall Study|Physician Decision|6
169461|NCT00226655|535737|P1|Overall Study|Adverse Event|35
169462|NCT00226655|535737|P1|Overall Study|Withdrawal by Subject|15
169463|NCT00226655|535737|P1|Overall Study|Death|13
169464|NCT00225277|535782|P2|Overall Study|Other|9
169465|NCT00225277|535783|P1|Overall Study|Other|7
169466|NCT00225277|535782|P2|Overall Study|Withdrawal by Subject|34
169467|NCT00225277|535783|P1|Overall Study|Withdrawal by Subject|40
169468|NCT00225277|535782|P2|Overall Study|Protocol Violation|3
169469|NCT00225277|535783|P1|Overall Study|Protocol Violation|6
169470|NCT00225277|535782|P2|Overall Study|Physician Decision|8
169471|NCT00225277|535783|P1|Overall Study|Physician Decision|6
169472|NCT00225277|535782|P2|Overall Study|Lost to Follow-up|6
169473|NCT00225277|535783|P1|Overall Study|Lost to Follow-up|4
169474|NCT00225277|535782|P2|Overall Study|Lack of Efficacy|1
169475|NCT00225277|535783|P1|Overall Study|Lack of Efficacy|4
169476|NCT00225277|535782|P2|Overall Study|Adverse Event|34
169477|NCT00225277|535783|P1|Overall Study|Adverse Event|30
169478|NCT00225251|535801|P2|Overall Study|Withdrawal by Subject|1
169479|NCT00225251|535802|P1|Overall Study|Withdrawal by Subject|1
169480|NCT00225212|535816|P1|Overall Study|Intercurrent illness|1
169481|NCT00225212|535816|P1|Overall Study|Adverse Event|2
169482|NCT00225212|535816|P1|Overall Study|Death|1
169483|NCT00225212|535816|P1|Overall Study|Disease progression|2
169484|NCT00225147|535825|P4|Open-label Phase|Withdrawal by Subject|6
169485|NCT00225147|535826|P3|Open-label Phase|Withdrawal by Subject|0
169486|NCT00225147|535827|P2|Open-label Phase|Withdrawal by Subject|0
169487|NCT00225147|535828|P1|Open-label Phase|Withdrawal by Subject|0
169488|NCT00225147|535825|P4|Open-label Phase|Lost to Follow-up|4
169489|NCT00225147|535826|P3|Open-label Phase|Lost to Follow-up|0
169490|NCT00225147|535827|P2|Open-label Phase|Lost to Follow-up|0
169491|NCT00225147|535828|P1|Open-label Phase|Lost to Follow-up|0
169492|NCT00224874|535859|P4|Overall Study|Withdrawal by Subject|0
169493|NCT00224874|535860|P3|Overall Study|Withdrawal by Subject|1
169494|NCT00224874|535861|P2|Overall Study|Withdrawal by Subject|0
169495|NCT00224874|535862|P1|Overall Study|Withdrawal by Subject|0
169496|NCT00224770|535907|P3|Overall Study|Lost to Follow-up|0
169497|NCT00224770|535908|P2|Overall Study|Lost to Follow-up|2
169498|NCT00224770|535909|P1|Overall Study|Lost to Follow-up|4
169499|NCT00224133|535946|P1|Overall Study|Not specified|14
169500|NCT00224133|535946|P1|Overall Study|Physician Decision|1
169501|NCT00224133|535946|P1|Overall Study|Lost to Follow-up|21
169502|NCT00224133|535946|P1|Overall Study|Lack of Efficacy|58
169503|NCT00224133|535946|P1|Overall Study|Withdrawal by Subject|33
169504|NCT00224133|535946|P1|Overall Study|Protocol Violation|6
169505|NCT00224133|535946|P1|Overall Study|Adverse Event|93
169506|NCT00224120|535952|P2|Overall Study|Not specified|5
169507|NCT00224120|535953|P1|Overall Study|Not specified|4
169508|NCT00224120|535952|P2|Overall Study|Lost to Follow-up|3
169509|NCT00224120|535953|P1|Overall Study|Lost to Follow-up|2
169510|NCT00224120|535952|P2|Overall Study|Lack of Efficacy|2
169511|NCT00224120|535953|P1|Overall Study|Lack of Efficacy|0
169512|NCT00224120|535952|P2|Overall Study|Withdrawal by Subject|10
169513|NCT00224120|535953|P1|Overall Study|Withdrawal by Subject|5
169514|NCT00224120|535952|P2|Overall Study|Protocol Violation|0
169515|NCT00224120|535953|P1|Overall Study|Protocol Violation|1
169516|NCT00224120|535952|P2|Overall Study|Adverse Event|4
169517|NCT00224120|535953|P1|Overall Study|Adverse Event|10
169518|NCT00224107|535963|P2|Overall Study|Not specified|1
169519|NCT00224107|535964|P1|Overall Study|Not specified|1
169520|NCT00224107|535963|P2|Overall Study|Physician Decision|0
169521|NCT00224107|535964|P1|Overall Study|Physician Decision|1
169522|NCT00224107|535963|P2|Overall Study|Lost to Follow-up|0
169523|NCT00224107|535964|P1|Overall Study|Lost to Follow-up|4
169524|NCT00224107|535963|P2|Overall Study|Lack of Efficacy|0
169525|NCT00224107|535964|P1|Overall Study|Lack of Efficacy|2
169526|NCT00224107|535963|P2|Overall Study|Withdrawal by Subject|4
169527|NCT00224107|535964|P1|Overall Study|Withdrawal by Subject|1
169528|NCT00224107|535963|P2|Overall Study|Protocol Violation|3
169529|NCT00224107|535964|P1|Overall Study|Protocol Violation|2
169530|NCT00224107|535963|P2|Overall Study|Adverse Event|6
169531|NCT00224107|535964|P1|Overall Study|Adverse Event|20
169532|NCT00224055|535974|P2|Overall Study|Not Specified|0
169533|NCT00224055|535975|P1|Overall Study|Not Specified|1
169534|NCT00224055|535974|P2|Overall Study|Withdrawal by Subject|2
169535|NCT00224055|535975|P1|Overall Study|Withdrawal by Subject|0
169536|NCT00224055|535974|P2|Overall Study|Inclusion Violation|6
169537|NCT00224055|535975|P1|Overall Study|Inclusion Violation|3
169538|NCT00224055|535974|P2|Overall Study|Protocol Violation|1
169539|NCT00224055|535975|P1|Overall Study|Protocol Violation|1
169540|NCT00224055|535974|P2|Overall Study|Lost to Follow-up|2
169541|NCT00224055|535975|P1|Overall Study|Lost to Follow-up|1
169542|NCT00224055|535974|P2|Overall Study|Adverse Event|3
169543|NCT00224055|535975|P1|Overall Study|Adverse Event|9
169544|NCT00224042|535985|P2|Overall Study|Not specified|0
169545|NCT00224042|535986|P1|Overall Study|Not specified|2
169546|NCT00224042|535985|P2|Overall Study|Did not meet lab incusion criteria|3
169547|NCT00224042|535986|P1|Overall Study|Did not meet lab incusion criteria|2
169548|NCT00224042|535985|P2|Overall Study|Physician Decision|1
169549|NCT00224042|535986|P1|Overall Study|Physician Decision|0
169550|NCT00224042|535985|P2|Overall Study|Protocol Violation|1
169551|NCT00224042|535986|P1|Overall Study|Protocol Violation|0
169552|NCT00224042|535985|P2|Overall Study|Adverse Event|1
169553|NCT00224042|535986|P1|Overall Study|Adverse Event|2
169554|NCT00224029|535998|P1|Overall Study|Other|1
169555|NCT00224029|535998|P1|Overall Study|Withdrawal by Subject|4
169556|NCT00224029|535998|P1|Overall Study|Lost to Follow-up|1
169557|NCT00224016|536004|P2|Maintenance Period|Lost to Follow-up|1
169558|NCT00224016|536005|P1|Maintenance Period|Lost to Follow-up|0
169559|NCT00224016|536004|P2|Maintenance Period|Withdrawal by Subject|0
169560|NCT00224016|536005|P1|Maintenance Period|Withdrawal by Subject|2
169561|NCT00224016|536004|P2|Titration Period|Lost to Follow-up|0
169562|NCT00224016|536005|P1|Titration Period|Lost to Follow-up|1
169563|NCT00224016|536004|P2|Titration Period|Withdrawal by Subject|1
169564|NCT00224016|536005|P1|Titration Period|Withdrawal by Subject|0
169565|NCT00224003|536013|P1|Overall Study|unk|3
169566|NCT00224003|536013|P1|Overall Study|Withdrawal by Subject|1
169567|NCT00224003|536013|P1|Overall Study|Protocol Violation|2
169568|NCT00224003|536013|P1|Overall Study|Adverse Event|1
169569|NCT00223977|536020|P3|Overall Study|not specified|0
169570|NCT00223977|536021|P2|Overall Study|not specified|0
169571|NCT00223977|536022|P1|Overall Study|not specified|1
169572|NCT00223977|536020|P3|Overall Study|Withdrawal by Subject|2
169573|NCT00223977|536021|P2|Overall Study|Withdrawal by Subject|1
169574|NCT00223977|536022|P1|Overall Study|Withdrawal by Subject|1
169575|NCT00223977|536020|P3|Overall Study|Protocol Violation|1
169576|NCT00223977|536021|P2|Overall Study|Protocol Violation|0
169577|NCT00223977|536022|P1|Overall Study|Protocol Violation|0
169578|NCT00223977|536020|P3|Overall Study|Adverse Event|0
169579|NCT00223977|536021|P2|Overall Study|Adverse Event|10
169580|NCT00223977|536022|P1|Overall Study|Adverse Event|7
169581|NCT00223808|536056|P3|Overall Study|<5 hrs therapy before discharge|5
169582|NCT00223808|536057|P2|Overall Study|<5 hrs therapy before discharge|5
169583|NCT00223808|536058|P1|Overall Study|<5 hrs therapy before discharge|3
169584|NCT00223795|536075|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
169585|NCT00223795|536076|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
169586|NCT00223795|536075|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
169587|NCT00223795|536076|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
169588|NCT00223496|536127|P1|Overall Study|Physician Decision|2
169589|NCT00223496|536127|P1|Overall Study|Withdrawal by Subject|1
169590|NCT00223496|536127|P1|Overall Study|Lack of Efficacy|6
169591|NCT00223496|536127|P1|Overall Study|Lost to Follow-up|4
169592|NCT00223496|536127|P1|Overall Study|screen failure|9
169593|NCT00222729|536146|P1|Overall Study|Adverse Event|3
169594|NCT00221195|536169|P2|Overall Study|Lost to Follow-up|1
169595|NCT00221195|536170|P1|Overall Study|Lost to Follow-up|0
169596|NCT00221195|536169|P2|Overall Study|Death|1
169597|NCT00221195|536170|P1|Overall Study|Death|1
169598|NCT00221195|536169|P2|Overall Study|Withdrawal by Subject|1
169599|NCT00221195|536170|P1|Overall Study|Withdrawal by Subject|4
169600|NCT00220805|536196|P2|Overall Study|Develop. of choroidal neovascularization|8
169601|NCT00220805|536197|P1|Overall Study|Develop. of choroidal neovascularization|3
169602|NCT00220805|536196|P2|Overall Study|Lack of Efficacy|0
169603|NCT00220805|536197|P1|Overall Study|Lack of Efficacy|1
169604|NCT00220805|536196|P2|Overall Study|Withdrawal by Subject|0
169605|NCT00220805|536197|P1|Overall Study|Withdrawal by Subject|3
169606|NCT00220805|536196|P2|Overall Study|Adverse Event|3
169607|NCT00220805|536197|P1|Overall Study|Adverse Event|1
169608|NCT00220779|536218|P3|Overall Study|Lack of Efficacy|1
169609|NCT00220779|536219|P2|Overall Study|Lack of Efficacy|0
169610|NCT00220779|536220|P1|Overall Study|Lack of Efficacy|3
169611|NCT00220779|536218|P3|Overall Study|Pregnancy|2
169612|NCT00220779|536219|P2|Overall Study|Pregnancy|0
169613|NCT00220779|536220|P1|Overall Study|Pregnancy|0
169614|NCT00220779|536218|P3|Overall Study|Too time consuming|0
169615|NCT00220779|536219|P2|Overall Study|Too time consuming|0
169616|NCT00220779|536220|P1|Overall Study|Too time consuming|1
169617|NCT00220779|536218|P3|Overall Study|Non-compliance|0
169618|NCT00220779|536219|P2|Overall Study|Non-compliance|0
169619|NCT00220779|536220|P1|Overall Study|Non-compliance|1
169620|NCT00220779|536218|P3|Overall Study|Withdrawal by Subject|1
169621|NCT00220779|536219|P2|Overall Study|Withdrawal by Subject|4
169622|NCT00220779|536220|P1|Overall Study|Withdrawal by Subject|1
169623|NCT00220779|536218|P3|Overall Study|Adverse Event|0
169624|NCT00220779|536219|P2|Overall Study|Adverse Event|0
169625|NCT00220779|536220|P1|Overall Study|Adverse Event|1
169626|NCT00220740|536230|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
169627|NCT00220740|536231|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
169628|NCT00220740|536230|P2|Efficacy Period|Protocol Violation|0
169629|NCT00220740|536231|P1|Efficacy Period|Protocol Violation|1
169630|NCT00220740|536230|P2|Efficacy Period|Withdrawal by Subject|0
169631|NCT00220740|536231|P1|Efficacy Period|Withdrawal by Subject|1
169632|NCT00220740|536230|P2|Efficacy Period|Adverse Event|1
169633|NCT00220740|536231|P1|Efficacy Period|Adverse Event|1
169634|NCT00220740|536230|P2|Efficacy Period|Entered rescue treatment with placebo|0
169635|NCT00220740|536231|P1|Efficacy Period|Entered rescue treatment with placebo|23
169636|NCT00220727|536245|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
169637|NCT00220727|536246|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
169638|NCT00220701|536262|P2|Overall Study|Lost to Follow-up|4
169639|NCT00220701|536263|P1|Overall Study|Lost to Follow-up|5
169640|NCT00220636|536279|P1|Overall Study|Withdrawal by Subject|4
169641|NCT00219557|536289|P3|Phase 2|Treatment not received|3
169642|NCT00219557|536290|P2|Phase 2|Treatment not received|1
169643|NCT00219557|536291|P1|Phase 2|Treatment not received|0
169644|NCT00219557|536289|P3|Phase 2|Withdrawal by Subject|5
169645|NCT00219557|536290|P2|Phase 2|Withdrawal by Subject|9
169646|NCT00219557|536291|P1|Phase 2|Withdrawal by Subject|0
169647|NCT00219557|536289|P3|Phase 2|Unspecified|6
169648|NCT00219557|536290|P2|Phase 2|Unspecified|8
169649|NCT00219557|536291|P1|Phase 2|Unspecified|0
169650|NCT00219557|536289|P3|Phase 2|Death|2
169651|NCT00219557|536290|P2|Phase 2|Death|8
169652|NCT00219557|536291|P1|Phase 2|Death|0
169653|NCT00219557|536289|P3|Phase 2|Adverse Event|2
169654|NCT00219557|536290|P2|Phase 2|Adverse Event|22
169655|NCT00219557|536291|P1|Phase 2|Adverse Event|0
169656|NCT00219557|536289|P3|Phase 2|Lack of Efficacy|15
169657|NCT00219557|536290|P2|Phase 2|Lack of Efficacy|21
169658|NCT00219557|536291|P1|Phase 2|Lack of Efficacy|0
169659|NCT00219557|536289|P3|Phase 1|Started chemotherapy at other institute|0
169660|NCT00219557|536290|P2|Phase 1|Started chemotherapy at other institute|0
169661|NCT00219557|536291|P1|Phase 1|Started chemotherapy at other institute|1
169662|NCT00219557|536289|P3|Phase 1|Withdrawal by Subject|0
169663|NCT00219557|536290|P2|Phase 1|Withdrawal by Subject|0
169664|NCT00219557|536291|P1|Phase 1|Withdrawal by Subject|1
169665|NCT00219557|536289|P3|Phase 1|Adverse Event|0
169666|NCT00219557|536290|P2|Phase 1|Adverse Event|0
169667|NCT00219557|536291|P1|Phase 1|Adverse Event|2
169668|NCT00219557|536289|P3|Phase 1|Lack of Efficacy|0
169669|NCT00219557|536290|P2|Phase 1|Lack of Efficacy|0
169670|NCT00219557|536291|P1|Phase 1|Lack of Efficacy|3
169671|NCT00219544|536319|P2|Single Blind Treatment Period|Withdrawal by Subject|0
169672|NCT00219544|536320|P1|Single Blind Treatment Period|Withdrawal by Subject|1
169673|NCT00219544|536319|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
169674|NCT00219544|536320|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
169675|NCT00219544|536319|P2|Single Blind Treatment Period|Lost to Follow-up|0
169676|NCT00219544|536320|P1|Single Blind Treatment Period|Lost to Follow-up|2
169677|NCT00219544|536319|P2|Single Blind Treatment Period|Protocol Violation|0
169678|NCT00219544|536320|P1|Single Blind Treatment Period|Protocol Violation|4
169679|NCT00219544|536319|P2|Single Blind Treatment Period|Adverse Event|0
169680|NCT00219544|536320|P1|Single Blind Treatment Period|Adverse Event|9
169681|NCT00219544|536319|P2|Single Blind Treatment Period|Lack of Efficacy|0
169682|NCT00219544|536320|P1|Single Blind Treatment Period|Lack of Efficacy|5
169683|NCT00219349|536358|P1|Escitalopram Phase|Physician Decision|7
169684|NCT00219349|536358|P1|Escitalopram Phase|Withdrawal by Subject|4
169685|NCT00219349|536358|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
169686|NCT00219349|536358|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
169687|NCT00219349|536358|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
169688|NCT00219284|536364|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
169689|NCT00219284|536365|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
169690|NCT00219284|536364|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
169691|NCT00219284|536365|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
169692|NCT00219284|536364|P2|Extension Phase - 8 Weeks|Adverse Event|3
169693|NCT00219284|536365|P1|Extension Phase - 8 Weeks|Adverse Event|2
169694|NCT00219284|536364|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
169695|NCT00219284|536365|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
169696|NCT00219284|536364|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
169697|NCT00219284|536365|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
169698|NCT00219284|536364|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
169699|NCT00219284|536365|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
169700|NCT00219284|536364|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
169701|NCT00219284|536365|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
169702|NCT00219284|536364|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
169703|NCT00219284|536365|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
169704|NCT00219284|536364|P2|Treatment Phase - 16 Weeks|Adverse Event|24
169705|NCT00219284|536365|P1|Treatment Phase - 16 Weeks|Adverse Event|26
169706|NCT00219141|536390|P3|Overall Study|Condition no longer requires study drug|0
169707|NCT00219141|536391|P2|Overall Study|Condition no longer requires study drug|0
169708|NCT00219141|536392|P1|Overall Study|Condition no longer requires study drug|1
169709|NCT00219141|536390|P3|Overall Study|Withdrawal by Subject|5
169710|NCT00219141|536391|P2|Overall Study|Withdrawal by Subject|3
169711|NCT00219141|536392|P1|Overall Study|Withdrawal by Subject|1
169712|NCT00219141|536390|P3|Overall Study|Protocol Violation|1
169713|NCT00219141|536391|P2|Overall Study|Protocol Violation|1
169714|NCT00219141|536392|P1|Overall Study|Protocol Violation|3
169715|NCT00219141|536390|P3|Overall Study|Lost to Follow-up|1
169716|NCT00219141|536391|P2|Overall Study|Lost to Follow-up|4
169717|NCT00219141|536392|P1|Overall Study|Lost to Follow-up|2
169718|NCT00219141|536390|P3|Overall Study|Administrative problems|0
169719|NCT00219141|536391|P2|Overall Study|Administrative problems|1
169720|NCT00219141|536392|P1|Overall Study|Administrative problems|0
169721|NCT00219141|536390|P3|Overall Study|Lack of Efficacy|0
169722|NCT00219141|536391|P2|Overall Study|Lack of Efficacy|2
169723|NCT00219141|536392|P1|Overall Study|Lack of Efficacy|3
169724|NCT00219141|536390|P3|Overall Study|Adverse Event|5
169725|NCT00219141|536391|P2|Overall Study|Adverse Event|10
169726|NCT00219141|536392|P1|Overall Study|Adverse Event|4
169727|NCT00218634|536438|P2|Overall Study|Lost to Follow-up|15
169728|NCT00218634|536439|P1|Overall Study|Lost to Follow-up|8
169729|NCT00218543|536459|P1|Overall Study|Adverse Event|2
169730|NCT00218543|536459|P1|Overall Study|Physician Decision|3
169731|NCT00218543|536459|P1|Overall Study|Withdrawal by Subject|1
169732|NCT00218543|536459|P1|Overall Study|relocated|1
169733|NCT00218543|536459|P1|Overall Study|Lost to Follow-up|8
169734|NCT00218296|536565|P2|Overall Study|Randomized but did not enter treatment|67
169735|NCT00218296|536566|P1|Overall Study|Randomized but did not enter treatment|66
169736|NCT00218296|536565|P2|Overall Study|Withdrawal by Subject|47
169737|NCT00218296|536566|P1|Overall Study|Withdrawal by Subject|36
169738|NCT00218296|536565|P2|Overall Study|Lost to Follow-up|7
169739|NCT00218296|536566|P1|Overall Study|Lost to Follow-up|9
169740|NCT00217971|536584|P2|Overall Study|non compliant|0
169741|NCT00217971|536585|P1|Overall Study|non compliant|1
169742|NCT00217971|536584|P2|Overall Study|Withdrawal by Subject|12
169743|NCT00217971|536585|P1|Overall Study|Withdrawal by Subject|7
169744|NCT00217971|536584|P2|Overall Study|Physician Decision|1
169745|NCT00217971|536585|P1|Overall Study|Physician Decision|0
169746|NCT00217971|536584|P2|Overall Study|Lost to Follow-up|19
169747|NCT00217971|536585|P1|Overall Study|Lost to Follow-up|15
169748|NCT00217971|536584|P2|Overall Study|Adverse Event|1
169749|NCT00217971|536585|P1|Overall Study|Adverse Event|1
169750|NCT00217672|536600|P2|Follow-up|Lost to Follow-up|0
169751|NCT00217672|536601|P1|Follow-up|Lost to Follow-up|1
169752|NCT00217672|536600|P2|Follow-up|Withdrawal by Subject|0
169753|NCT00217672|536601|P1|Follow-up|Withdrawal by Subject|4
169754|NCT00217672|536600|P2|Treatment|secondary malignancy|0
169755|NCT00217672|536601|P1|Treatment|secondary malignancy|1
169756|NCT00217672|536600|P2|Treatment|Death|0
169757|NCT00217672|536601|P1|Treatment|Death|2
169758|NCT00217672|536600|P2|Treatment|insurance issues|1
169759|NCT00217672|536601|P1|Treatment|insurance issues|1
169760|NCT00217672|536600|P2|Treatment|Physician Decision|0
169761|NCT00217672|536601|P1|Treatment|Physician Decision|6
169762|NCT00217672|536600|P2|Treatment|reqd treatment not permitted by protocol|0
169763|NCT00217672|536601|P1|Treatment|reqd treatment not permitted by protocol|6
169764|NCT00217672|536600|P2|Treatment|Adverse Event|2
169765|NCT00217672|536601|P1|Treatment|Adverse Event|18
169766|NCT00217672|536600|P2|Treatment|disease progression|4
169767|NCT00217672|536601|P1|Treatment|disease progression|33
169768|NCT00217672|536600|P2|Allocation|Ineligible|0
169769|NCT00217672|536601|P1|Allocation|Ineligible|2
169770|NCT00217620|536607|P1|Overall Study|Never received treatment|1
169771|NCT00217620|536607|P1|Overall Study|Ineligible|13
169772|NCT00217620|536607|P1|Overall Study|Not Protocol Specified|4
169773|NCT00217620|536607|P1|Overall Study|Progression|31
169774|NCT00217620|536607|P1|Overall Study|Adverse Event|2
169775|NCT00217581|536618|P1|Overall Study|Withdrawal by Subject|1
169776|NCT00217464|536622|P1|Overall Study|not specified|2
169777|NCT00217464|536622|P1|Overall Study|Progression|15
169778|NCT00217425|536638|P1|Overall Study|Other|4
169779|NCT00217425|536638|P1|Overall Study|Other complicating disease|1
169780|NCT00217425|536638|P1|Overall Study|Withdrawal by Subject|4
169781|NCT00217425|536638|P1|Overall Study|Adverse Event|8
169782|NCT00217425|536638|P1|Overall Study|Lack of Efficacy|13
169783|NCT00217425|536638|P1|Overall Study|Patient ineligible|5
169784|NCT00217425|536638|P1|Overall Study|Never started treatment|2
169785|NCT00217087|536652|P2|Overall Study|completed less than 12 months return|18
169786|NCT00217087|536653|P1|Overall Study|completed less than 12 months return|10
169787|NCT00217087|536652|P2|Overall Study|decided to have esophagectomy|2
169788|NCT00217087|536653|P1|Overall Study|decided to have esophagectomy|1
169789|NCT00217022|536667|P2|Overall Study|Withdrawal by Subject|1
169790|NCT00217022|536668|P1|Overall Study|Withdrawal by Subject|1
169791|NCT00216736|536678|P2|Overall Study|Lost to Follow-up|1
169792|NCT00216736|536679|P1|Overall Study|Lost to Follow-up|1
169793|NCT00216671|536693|P2|Overall Study|Insufficient Response Adverse Event|1
169794|NCT00216671|536694|P1|Overall Study|Insufficient Response Adverse Event|2
169795|NCT00216671|536693|P2|Overall Study|Ineligible, no efficacy data|2
169796|NCT00216671|536694|P1|Overall Study|Ineligible, no efficacy data|2
169797|NCT00216671|536693|P2|Overall Study|Patient Moved|1
169798|NCT00216671|536694|P1|Overall Study|Patient Moved|0
169799|NCT00216671|536693|P2|Overall Study|Investigator Illness|1
169800|NCT00216671|536694|P1|Overall Study|Investigator Illness|0
169801|NCT00216671|536693|P2|Overall Study|Relapse|0
169802|NCT00216671|536694|P1|Overall Study|Relapse|1
169803|NCT00216671|536693|P2|Overall Study|Protocol Violation|5
169804|NCT00216671|536694|P1|Overall Study|Protocol Violation|3
169805|NCT00216671|536693|P2|Overall Study|Physician Decision|1
169806|NCT00216671|536694|P1|Overall Study|Physician Decision|1
169807|NCT00216671|536693|P2|Overall Study|Ineligible|2
169808|NCT00216671|536694|P1|Overall Study|Ineligible|0
169809|NCT00216671|536693|P2|Overall Study|Non compliant|2
169810|NCT00216671|536694|P1|Overall Study|Non compliant|2
169811|NCT00216671|536693|P2|Overall Study|Lost to Follow-up|5
169812|NCT00216671|536694|P1|Overall Study|Lost to Follow-up|3
169813|NCT00216671|536693|P2|Overall Study|Insufficient Response|4
169814|NCT00216671|536694|P1|Overall Study|Insufficient Response|9
169815|NCT00216671|536693|P2|Overall Study|No Need to Continue Medication|1
169816|NCT00216671|536694|P1|Overall Study|No Need to Continue Medication|1
169817|NCT00216671|536693|P2|Overall Study|Refused Injections|13
169818|NCT00216671|536694|P1|Overall Study|Refused Injections|3
169819|NCT00216671|536693|P2|Overall Study|Withdrawal by Subject|2
169820|NCT00216671|536694|P1|Overall Study|Withdrawal by Subject|4
169821|NCT00216671|536693|P2|Overall Study|Pregnancy|1
169822|NCT00216671|536694|P1|Overall Study|Pregnancy|0
169823|NCT00216671|536693|P2|Overall Study|Adverse Event|9
169824|NCT00216671|536694|P1|Overall Study|Adverse Event|4
169825|NCT00216476|536712|P3|Overall Study|Patient Moved|0
169826|NCT00216476|536713|P2|Overall Study|Patient Moved|2
169827|NCT00216476|536714|P1|Overall Study|Patient Moved|2
169828|NCT00216476|536712|P3|Overall Study|Protocol Deviation|0
169829|NCT00216476|536713|P2|Overall Study|Protocol Deviation|1
169830|NCT00216476|536714|P1|Overall Study|Protocol Deviation|5
169831|NCT00216476|536712|P3|Overall Study|Administrative Reasons|0
169832|NCT00216476|536713|P2|Overall Study|Administrative Reasons|1
169833|NCT00216476|536714|P1|Overall Study|Administrative Reasons|1
169834|NCT00216476|536712|P3|Overall Study|Higher dose/Extra Medication Required|2
169835|NCT00216476|536713|P2|Overall Study|Higher dose/Extra Medication Required|0
169836|NCT00216476|536714|P1|Overall Study|Higher dose/Extra Medication Required|2
169837|NCT00216476|536712|P3|Overall Study|Non-compliance|1
169838|NCT00216476|536713|P2|Overall Study|Non-compliance|4
169839|NCT00216476|536714|P1|Overall Study|Non-compliance|0
169840|NCT00216476|536712|P3|Overall Study|No Further Need for Treatment|1
169841|NCT00216476|536713|P2|Overall Study|No Further Need for Treatment|4
169842|NCT00216476|536714|P1|Overall Study|No Further Need for Treatment|3
169843|NCT00216476|536712|P3|Overall Study|Refuses Injection|0
169844|NCT00216476|536713|P2|Overall Study|Refuses Injection|0
169845|NCT00216476|536714|P1|Overall Study|Refuses Injection|11
169846|NCT00216476|536712|P3|Overall Study|Other|1
169847|NCT00216476|536713|P2|Overall Study|Other|0
169848|NCT00216476|536714|P1|Overall Study|Other|0
169849|NCT00216476|536712|P3|Overall Study|Pregnancy|1
169850|NCT00216476|536713|P2|Overall Study|Pregnancy|1
169851|NCT00216476|536714|P1|Overall Study|Pregnancy|0
169852|NCT00216476|536712|P3|Overall Study|Death|0
169853|NCT00216476|536713|P2|Overall Study|Death|0
169854|NCT00216476|536714|P1|Overall Study|Death|2
169855|NCT00216476|536712|P3|Overall Study|Lack of Efficacy|0
169856|NCT00216476|536713|P2|Overall Study|Lack of Efficacy|3
169857|NCT00216476|536714|P1|Overall Study|Lack of Efficacy|4
169858|NCT00216476|536712|P3|Overall Study|Adverse Event|1
169859|NCT00216476|536713|P2|Overall Study|Adverse Event|10
169860|NCT00216476|536714|P1|Overall Study|Adverse Event|6
169861|NCT00216476|536712|P3|Overall Study|Lost to Follow-up|1
169862|NCT00216476|536713|P2|Overall Study|Lost to Follow-up|9
169863|NCT00216476|536714|P1|Overall Study|Lost to Follow-up|10
169864|NCT00216476|536712|P3|Overall Study|Withdrawal by Subject|9
169865|NCT00216476|536713|P2|Overall Study|Withdrawal by Subject|72
169866|NCT00216476|536714|P1|Overall Study|Withdrawal by Subject|59
169867|NCT00216203|536751|P1|Overall Study|Withdrawal by Subject|2
169868|NCT00216086|536781|P1|Overall Study|Social Reasons|2
169869|NCT00216086|536781|P1|Overall Study|Diagnosis of Metastatic Disease|1
169870|NCT00216086|536781|P1|Overall Study|Protocol Violation|1
169871|NCT00215943|536813|P2|Overall Study|Other complications|1
169872|NCT00215943|536814|P1|Overall Study|Other complications|3
169873|NCT00215943|536813|P2|Overall Study|Other disease|1
169874|NCT00215943|536814|P1|Overall Study|Other disease|0
169875|NCT00215943|536813|P2|Overall Study|Adverse Event|6
169876|NCT00215943|536814|P1|Overall Study|Adverse Event|3
169877|NCT00215943|536813|P2|Overall Study|Alternate therapy|1
169878|NCT00215943|536814|P1|Overall Study|Alternate therapy|0
169879|NCT00215943|536813|P2|Overall Study|Disease Progression|5
169880|NCT00215943|536814|P1|Overall Study|Disease Progression|3
169881|NCT00215683|536839|P3|Overall Study|Intermittent therapy required|0
169882|NCT00215683|536840|P2|Overall Study|Intermittent therapy required|1
169883|NCT00215683|536841|P1|Overall Study|Intermittent therapy required|0
169884|NCT00215683|536839|P3|Overall Study|No study drug available|0
169885|NCT00215683|536840|P2|Overall Study|No study drug available|1
169886|NCT00215683|536841|P1|Overall Study|No study drug available|0
169887|NCT00215683|536839|P3|Overall Study|Difficult to attend visits|0
169888|NCT00215683|536840|P2|Overall Study|Difficult to attend visits|1
169889|NCT00215683|536841|P1|Overall Study|Difficult to attend visits|0
169890|NCT00215683|536839|P3|Overall Study|Physician Decision|1
169891|NCT00215683|536840|P2|Overall Study|Physician Decision|0
169892|NCT00215683|536841|P1|Overall Study|Physician Decision|0
169893|NCT00215683|536839|P3|Overall Study|Withdrawal by Subject|13
169894|NCT00215683|536840|P2|Overall Study|Withdrawal by Subject|4
169895|NCT00215683|536841|P1|Overall Study|Withdrawal by Subject|9
169896|NCT00215683|536839|P3|Overall Study|Lost to Follow-up|1
169897|NCT00215683|536840|P2|Overall Study|Lost to Follow-up|2
169898|NCT00215683|536841|P1|Overall Study|Lost to Follow-up|0
169899|NCT00215683|536839|P3|Overall Study|Lack of Efficacy|2
169900|NCT00215683|536840|P2|Overall Study|Lack of Efficacy|1
169901|NCT00215683|536841|P1|Overall Study|Lack of Efficacy|5
169902|NCT00215683|536839|P3|Overall Study|Adverse Event|15
169903|NCT00215683|536840|P2|Overall Study|Adverse Event|16
169904|NCT00215683|536841|P1|Overall Study|Adverse Event|15
169905|NCT00215657|536860|P8|Overall Study|Not specified|1
169906|NCT00215657|536861|P7|Overall Study|Not specified|6
169907|NCT00215657|536862|P6|Overall Study|Not specified|4
169908|NCT00215657|536863|P5|Overall Study|Not specified|5
169909|NCT00215657|536864|P4|Overall Study|Not specified|3
169910|NCT00215657|536865|P3|Overall Study|Not specified|2
169911|NCT00215657|536866|P2|Overall Study|Not specified|1
169912|NCT00215657|536867|P1|Overall Study|Not specified|3
169913|NCT00215657|536860|P8|Overall Study|Insufficient testosterone response|7
169914|NCT00215657|536861|P7|Overall Study|Insufficient testosterone response|4
169915|NCT00215657|536862|P6|Overall Study|Insufficient testosterone response|12
169916|NCT00215657|536863|P5|Overall Study|Insufficient testosterone response|8
169917|NCT00215657|536864|P4|Overall Study|Insufficient testosterone response|12
169918|NCT00215657|536865|P3|Overall Study|Insufficient testosterone response|1
169919|NCT00215657|536866|P2|Overall Study|Insufficient testosterone response|4
169920|NCT00215657|536867|P1|Overall Study|Insufficient testosterone response|5
169921|NCT00215657|536860|P8|Overall Study|Insuff prostate specific antigen resp|2
169922|NCT00215657|536861|P7|Overall Study|Insuff prostate specific antigen resp|3
169923|NCT00215657|536862|P6|Overall Study|Insuff prostate specific antigen resp|2
169924|NCT00215657|536863|P5|Overall Study|Insuff prostate specific antigen resp|1
169925|NCT00215657|536864|P4|Overall Study|Insuff prostate specific antigen resp|2
169926|NCT00215657|536865|P3|Overall Study|Insuff prostate specific antigen resp|2
169927|NCT00215657|536866|P2|Overall Study|Insuff prostate specific antigen resp|2
169928|NCT00215657|536867|P1|Overall Study|Insuff prostate specific antigen resp|3
169929|NCT00215657|536860|P8|Overall Study|Withdrawal by Subject|3
169930|NCT00215657|536861|P7|Overall Study|Withdrawal by Subject|10
169931|NCT00215657|536862|P6|Overall Study|Withdrawal by Subject|1
169932|NCT00215657|536863|P5|Overall Study|Withdrawal by Subject|6
169933|NCT00215657|536864|P4|Overall Study|Withdrawal by Subject|1
169934|NCT00215657|536865|P3|Overall Study|Withdrawal by Subject|3
169935|NCT00215657|536866|P2|Overall Study|Withdrawal by Subject|3
169936|NCT00215657|536867|P1|Overall Study|Withdrawal by Subject|6
169937|NCT00215657|536860|P8|Overall Study|Adverse Event|3
169938|NCT00215657|536861|P7|Overall Study|Adverse Event|0
169939|NCT00215657|536862|P6|Overall Study|Adverse Event|1
169940|NCT00215657|536863|P5|Overall Study|Adverse Event|3
169941|NCT00215657|536864|P4|Overall Study|Adverse Event|0
169942|NCT00215657|536865|P3|Overall Study|Adverse Event|3
169943|NCT00215657|536866|P2|Overall Study|Adverse Event|1
169944|NCT00215657|536867|P1|Overall Study|Adverse Event|5
169945|NCT00215540|536939|P3|Overall Study|Withdrew from study medication|0
169946|NCT00215540|536940|P2|Overall Study|Withdrew from study medication|0
169947|NCT00215540|536941|P1|Overall Study|Withdrew from study medication|1
169948|NCT00215150|536976|P1|Randomization Phase Placebo|Withdrawal by Subject|1
169949|NCT00215150|536976|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
169950|NCT00215150|536976|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
169951|NCT00215150|536976|P1|Open Label Phase|Did not meet randomization criteria|9
169952|NCT00215150|536976|P1|Open Label Phase|Did not complete a post base visit|13
169953|NCT00215150|536976|P1|Open Label Phase|Withdrawal by Subject|1
169954|NCT00215150|536976|P1|Open Label Phase|Lost to Follow-up|7
169955|NCT00215137|536984|P3|Randomization Period|Withdrawal by Subject|0
169956|NCT00215137|536985|P2|Randomization Period|Withdrawal by Subject|1
169957|NCT00215137|536986|P1|Randomization Period|Withdrawal by Subject|0
169958|NCT00215137|536984|P3|Randomization Period|Lost to Follow-up|0
169959|NCT00215137|536985|P2|Randomization Period|Lost to Follow-up|1
169960|NCT00215137|536986|P1|Randomization Period|Lost to Follow-up|0
169961|NCT00215137|536984|P3|Open Label Escitalopram|Lack of Efficacy|0
169962|NCT00215137|536985|P2|Open Label Escitalopram|Lack of Efficacy|0
169963|NCT00215137|536986|P1|Open Label Escitalopram|Lack of Efficacy|1
169964|NCT00214201|536996|P2|Overall Study|Death|2
169965|NCT00214201|536997|P1|Overall Study|Death|0
169966|NCT00214201|536996|P2|Overall Study|Withdrawal by Subject|0
169967|NCT00214201|536997|P1|Overall Study|Withdrawal by Subject|2
169968|NCT00214461|537110|P4|Overall Study|Withdrawal by Subject|0
169969|NCT00214461|537111|P3|Overall Study|Withdrawal by Subject|1
169970|NCT00214461|537112|P2|Overall Study|Withdrawal by Subject|0
169971|NCT00214461|537113|P1|Overall Study|Withdrawal by Subject|0
169972|NCT00214461|537110|P4|Overall Study|Adverse Event|1
169973|NCT00214461|537111|P3|Overall Study|Adverse Event|1
169974|NCT00214461|537112|P2|Overall Study|Adverse Event|0
169975|NCT00214461|537113|P1|Overall Study|Adverse Event|0
169976|NCT00214383|537129|P2|Overall Study|Lost to Follow-up|26
169977|NCT00214383|537130|P1|Overall Study|Lost to Follow-up|16
169978|NCT00214019|537140|P1|Overall Study|Screen failed|17
169979|NCT00214019|537140|P1|Overall Study|Withdrawal by Subject|2
169980|NCT00214019|537140|P1|Overall Study|Lost to Follow-up|11
169981|NCT00213135|537150|P3|Overall Study|Unspecified|15
169982|NCT00213135|537151|P2|Overall Study|Unspecified|12
169983|NCT00213135|537152|P1|Overall Study|Unspecified|21
169984|NCT00213135|537150|P3|Overall Study|Disease progression|21
169985|NCT00213135|537151|P2|Overall Study|Disease progression|5
169986|NCT00213135|537152|P1|Overall Study|Disease progression|4
169987|NCT00213135|537150|P3|Overall Study|Death|2
169988|NCT00213135|537151|P2|Overall Study|Death|1
169989|NCT00213135|537152|P1|Overall Study|Death|1
169990|NCT00213135|537150|P3|Overall Study|Protocol Violation|10
169991|NCT00213135|537151|P2|Overall Study|Protocol Violation|4
169992|NCT00213135|537152|P1|Overall Study|Protocol Violation|4
169993|NCT00213135|537150|P3|Overall Study|Lost to Follow-up|4
169994|NCT00213135|537151|P2|Overall Study|Lost to Follow-up|8
169995|NCT00213135|537152|P1|Overall Study|Lost to Follow-up|11
169996|NCT00213135|537150|P3|Overall Study|Adverse Event|5
169997|NCT00213135|537151|P2|Overall Study|Adverse Event|5
169998|NCT00213135|537152|P1|Overall Study|Adverse Event|9
169999|NCT00211536|537171|P2|Overall Study|Adverse Event|0
170000|NCT00211536|537172|P1|Overall Study|Adverse Event|2
170001|NCT00211536|537171|P2|Overall Study|Physician Decision|5
170002|NCT00211536|537172|P1|Overall Study|Physician Decision|0
170003|NCT00211536|537171|P2|Overall Study|Withdrawal by Subject|2
170004|NCT00211536|537172|P1|Overall Study|Withdrawal by Subject|2
170005|NCT00211510|537188|P2|Overall Study|Withdrawal by Subject|1
170006|NCT00211510|537189|P1|Overall Study|Withdrawal by Subject|3
170007|NCT00211510|537188|P2|Overall Study|Physician Decision|1
170008|NCT00211510|537189|P1|Overall Study|Physician Decision|3
170009|NCT00212758|537205|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
170010|NCT00212758|537206|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
170011|NCT00212758|537205|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
170012|NCT00212758|537206|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
170013|NCT00212355|537212|P1|Overall Study|A change of address|1
170014|NCT00212355|537212|P1|Overall Study|Withdrawal by Subject|1
170015|NCT00212355|537212|P1|Overall Study|Adverse Event|1
170016|NCT00211887|537255|P3|Overall Study|Side effects|5
170017|NCT00211887|537256|P2|Overall Study|Side effects|13
170018|NCT00211887|537257|P1|Overall Study|Side effects|19
170019|NCT00211887|537255|P3|Overall Study|Other medical reason|7
170020|NCT00211887|537256|P2|Overall Study|Other medical reason|11
170021|NCT00211887|537257|P1|Overall Study|Other medical reason|15
170022|NCT00211887|537255|P3|Overall Study|Non-medical reason|8
170023|NCT00211887|537256|P2|Overall Study|Non-medical reason|14
170024|NCT00211887|537257|P1|Overall Study|Non-medical reason|31
170025|NCT00211887|537255|P3|Overall Study|Lost to Follow-up|9
170026|NCT00211887|537256|P2|Overall Study|Lost to Follow-up|13
170027|NCT00211887|537257|P1|Overall Study|Lost to Follow-up|28
170028|NCT00211887|537255|P3|Overall Study|Death|1
170029|NCT00211887|537256|P2|Overall Study|Death|1
170030|NCT00211887|537257|P1|Overall Study|Death|1
170031|NCT00211887|537255|P3|Overall Study|Adverse Event|6
170032|NCT00211887|537256|P2|Overall Study|Adverse Event|4
170033|NCT00211887|537257|P1|Overall Study|Adverse Event|8
170034|NCT00211237|537287|P2|Overall Study|Physician Decision|2
170035|NCT00211237|537288|P1|Overall Study|Physician Decision|0
170036|NCT00211237|537287|P2|Overall Study|Withdrawal by Subject|14
170037|NCT00211237|537288|P1|Overall Study|Withdrawal by Subject|5
170038|NCT00211237|537287|P2|Overall Study|Lost to Follow-up|2
170039|NCT00211237|537288|P1|Overall Study|Lost to Follow-up|2
170040|NCT00211237|537287|P2|Overall Study|Death|12
170041|NCT00211237|537288|P1|Overall Study|Death|23
170042|NCT00211172|537296|P2|Overall Study|Died or lost health plan eligibility|32
170043|NCT00211172|537297|P1|Overall Study|Died or lost health plan eligibility|39
170044|NCT00211081|537303|P1|Overall Study|Withdrawal by Subject|2
170045|NCT00210639|537309|P2|Overall Study|Not specified|12
170046|NCT00210639|537310|P1|Overall Study|Not specified|18
170047|NCT00210639|537309|P2|Overall Study|Withdrawal by Subject|1
170048|NCT00210639|537310|P1|Overall Study|Withdrawal by Subject|8
170049|NCT00210639|537309|P2|Overall Study|Lost to Follow-up|29
170050|NCT00210639|537310|P1|Overall Study|Lost to Follow-up|37
170051|NCT00210626|537318|P2|Overall Study|Not Specified|5
170052|NCT00210626|537319|P1|Overall Study|Not Specified|4
170053|NCT00210626|537318|P2|Overall Study|Sponser Request|0
170054|NCT00210626|537319|P1|Overall Study|Sponser Request|1
170055|NCT00210626|537318|P2|Overall Study|Physician Decision|2
170056|NCT00210626|537319|P1|Overall Study|Physician Decision|0
170057|NCT00210626|537318|P2|Overall Study|Withdrawal by Subject|20
170058|NCT00210626|537319|P1|Overall Study|Withdrawal by Subject|29
170059|NCT00210626|537318|P2|Overall Study|Death|0
170060|NCT00210626|537319|P1|Overall Study|Death|1
170061|NCT00210626|537318|P2|Overall Study|Lost to Follow-up|11
170062|NCT00210626|537319|P1|Overall Study|Lost to Follow-up|11
170063|NCT00210626|537318|P2|Overall Study|Protocol Violation|5
170064|NCT00210626|537319|P1|Overall Study|Protocol Violation|1
170065|NCT00210626|537318|P2|Overall Study|Adverse Event|2
170066|NCT00210626|537319|P1|Overall Study|Adverse Event|1
170067|NCT00210470|537327|P1|Overall Study|Subject did not continue to surgery|1
170068|NCT00209560|537333|P2|Overall Study|Lack of Efficacy|0
170069|NCT00209560|537334|P1|Overall Study|Lack of Efficacy|1
170070|NCT00209339|537353|P1|At 5 Years Follow-up|Death|1
170071|NCT00209339|537353|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
170072|NCT00209339|537353|P1|At 5 Years Follow-up|Withdrawal by Subject|2
170073|NCT00209339|537353|P1|At 4 Years Follow-up|Death|1
170074|NCT00209339|537353|P1|At 4 Years Follow-up|Withdrawal by Subject|4
170075|NCT00209339|537353|P1|At 3 Years Follow-up|Withdrawal by Subject|1
170076|NCT00209339|537353|P1|At 24 Months Follow-up|Death|1
170077|NCT00209339|537353|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
170078|NCT00209339|537353|P1|At 24 Months Follow-up|Withdrawal by Subject|4
170079|NCT00209339|537353|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
170080|NCT00209339|537353|P1|At 12 Months Follow-up|Death|1
170081|NCT00209339|537353|P1|At 12 Months Follow-up|Withdrawal by Subject|8
170082|NCT00209170|537437|P2|Overall Study|Lack of Efficacy|1
170083|NCT00209170|537438|P1|Overall Study|Lack of Efficacy|0
170084|NCT00209170|537437|P2|Overall Study|Withdrawal by Subject|1
170085|NCT00209170|537438|P1|Overall Study|Withdrawal by Subject|2
170086|NCT00209170|537437|P2|Overall Study|Adverse Event|1
170087|NCT00209170|537438|P1|Overall Study|Adverse Event|0
170088|NCT00209131|537446|P2|Overall Study|Lack of personnel due to turnovers.|11
170089|NCT00209131|537447|P1|Overall Study|Lack of personnel due to turnovers.|15
170090|NCT00209092|537457|P2|Overall Study|Withdrawal by Subject|0
170091|NCT00209092|537458|P1|Overall Study|Withdrawal by Subject|1
170092|NCT00209092|537457|P2|Overall Study|Adverse Event|1
170093|NCT00209092|537458|P1|Overall Study|Adverse Event|0
170094|NCT00209092|537457|P2|Overall Study|Progression of disease|1
170095|NCT00209092|537458|P1|Overall Study|Progression of disease|7
170096|NCT00209027|537468|P2|Overall Study|study terminated|0
170097|NCT00209027|537469|P1|Overall Study|study terminated|10
170098|NCT00208767|537493|P2|Overall Study|Lost to Follow-up|3
170099|NCT00208767|537494|P1|Overall Study|Lost to Follow-up|3
170100|NCT00208767|537493|P2|Overall Study|Death|0
170101|NCT00208767|537494|P1|Overall Study|Death|1
170102|NCT00208767|537493|P2|Overall Study|Withdrawal by Subject|3
170103|NCT00208767|537494|P1|Overall Study|Withdrawal by Subject|14
170104|NCT00208767|537493|P2|Overall Study|Adverse Event|1
170105|NCT00208767|537494|P1|Overall Study|Adverse Event|9
170106|NCT00208325|537522|P4|Overall Study|Mis-Randomized|0
170107|NCT00208325|537523|P3|Overall Study|Mis-Randomized|0
170108|NCT00208325|537524|P2|Overall Study|Mis-Randomized|20
170109|NCT00208325|537525|P1|Overall Study|Mis-Randomized|17
170110|NCT00208325|537522|P4|Overall Study|Other|0
170111|NCT00208325|537523|P3|Overall Study|Other|1
170112|NCT00208325|537524|P2|Overall Study|Other|1
170113|NCT00208325|537525|P1|Overall Study|Other|2
170114|NCT00208325|537522|P4|Overall Study|Does not wish to Continue in Study|2
170115|NCT00208325|537523|P3|Overall Study|Does not wish to Continue in Study|3
170116|NCT00208325|537524|P2|Overall Study|Does not wish to Continue in Study|8
170117|NCT00208325|537525|P1|Overall Study|Does not wish to Continue in Study|5
170118|NCT00208325|537522|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
170119|NCT00208325|537523|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
170120|NCT00208325|537524|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
170121|NCT00208325|537525|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
170122|NCT00208325|537522|P4|Overall Study|Lost to Follow-up|0
170123|NCT00208325|537523|P3|Overall Study|Lost to Follow-up|2
170124|NCT00208325|537524|P2|Overall Study|Lost to Follow-up|0
170125|NCT00208325|537525|P1|Overall Study|Lost to Follow-up|1
170126|NCT00208325|537522|P4|Overall Study|Revision|4
170127|NCT00208325|537523|P3|Overall Study|Revision|0
170128|NCT00208325|537524|P2|Overall Study|Revision|1
170129|NCT00208325|537525|P1|Overall Study|Revision|4
170130|NCT00208325|537522|P4|Overall Study|Withdrawal by Subject|0
170131|NCT00208325|537523|P3|Overall Study|Withdrawal by Subject|0
170132|NCT00208325|537524|P2|Overall Study|Withdrawal by Subject|1
170133|NCT00208325|537525|P1|Overall Study|Withdrawal by Subject|0
170134|NCT00208325|537522|P4|Overall Study|Death|5
170135|NCT00208325|537523|P3|Overall Study|Death|7
170136|NCT00208325|537524|P2|Overall Study|Death|19
170137|NCT00208325|537525|P1|Overall Study|Death|18
170138|NCT00207740|537649|P4|Overall Study|Not Specified|5
170139|NCT00207740|537650|P3|Overall Study|Not Specified|7
170140|NCT00207740|537651|P2|Overall Study|Not Specified|10
170141|NCT00207740|537652|P1|Overall Study|Not Specified|2
170142|NCT00207740|537649|P4|Overall Study|Sponsor Directive|21
170143|NCT00207740|537650|P3|Overall Study|Sponsor Directive|16
170144|NCT00207740|537651|P2|Overall Study|Sponsor Directive|15
170145|NCT00207740|537652|P1|Overall Study|Sponsor Directive|22
170146|NCT00207740|537649|P4|Overall Study|Death|1
170147|NCT00207740|537650|P3|Overall Study|Death|0
170148|NCT00207740|537651|P2|Overall Study|Death|0
170149|NCT00207740|537652|P1|Overall Study|Death|0
170150|NCT00207740|537649|P4|Overall Study|Lost to Follow-up|1
170151|NCT00207740|537650|P3|Overall Study|Lost to Follow-up|1
170152|NCT00207740|537651|P2|Overall Study|Lost to Follow-up|2
170153|NCT00207740|537652|P1|Overall Study|Lost to Follow-up|0
170154|NCT00207740|537649|P4|Overall Study|Unsatisfactory therapeutic effect|4
170155|NCT00207740|537650|P3|Overall Study|Unsatisfactory therapeutic effect|2
170156|NCT00207740|537651|P2|Overall Study|Unsatisfactory therapeutic effect|0
170157|NCT00207740|537652|P1|Overall Study|Unsatisfactory therapeutic effect|1
170158|NCT00207740|537649|P4|Overall Study|Adverse Event|11
170159|NCT00207740|537650|P3|Overall Study|Adverse Event|14
170160|NCT00207740|537651|P2|Overall Study|Adverse Event|14
170161|NCT00207740|537652|P1|Overall Study|Adverse Event|4
170162|NCT00207727|537698|P5|Overall Study|Not specified|33
170163|NCT00207727|537699|P4|Overall Study|Not specified|37
170164|NCT00207727|537700|P3|Overall Study|Not specified|41
170165|NCT00207727|537701|P2|Overall Study|Not specified|41
170166|NCT00207727|537702|P1|Overall Study|Not specified|38
170167|NCT00207727|537698|P5|Overall Study|Lost to Follow-up|0
170168|NCT00207727|537699|P4|Overall Study|Lost to Follow-up|0
170169|NCT00207727|537700|P3|Overall Study|Lost to Follow-up|0
170170|NCT00207727|537701|P2|Overall Study|Lost to Follow-up|1
170171|NCT00207727|537702|P1|Overall Study|Lost to Follow-up|0
170172|NCT00207727|537698|P5|Overall Study|Withdrawal by Subject|1
170173|NCT00207727|537699|P4|Overall Study|Withdrawal by Subject|0
170174|NCT00207727|537700|P3|Overall Study|Withdrawal by Subject|0
170175|NCT00207727|537701|P2|Overall Study|Withdrawal by Subject|0
170176|NCT00207727|537702|P1|Overall Study|Withdrawal by Subject|0
170177|NCT00207714|537729|P5|Overall Study|Unspecified|0
170178|NCT00207714|537730|P4|Overall Study|Unspecified|1
170179|NCT00207714|537731|P3|Overall Study|Unspecified|5
170180|NCT00207714|537732|P2|Overall Study|Unspecified|2
170181|NCT00207714|537733|P1|Overall Study|Unspecified|3
170182|NCT00207714|537729|P5|Overall Study|Unsatisfactory therapeutic effect|4
170183|NCT00207714|537730|P4|Overall Study|Unsatisfactory therapeutic effect|4
170184|NCT00207714|537731|P3|Overall Study|Unsatisfactory therapeutic effect|1
170185|NCT00207714|537732|P2|Overall Study|Unsatisfactory therapeutic effect|3
170186|NCT00207714|537733|P1|Overall Study|Unsatisfactory therapeutic effect|5
170187|NCT00207714|537729|P5|Overall Study|Adverse Event|1
170188|NCT00207714|537730|P4|Overall Study|Adverse Event|3
170189|NCT00207714|537731|P3|Overall Study|Adverse Event|4
170190|NCT00207714|537732|P2|Overall Study|Adverse Event|2
170191|NCT00207714|537733|P1|Overall Study|Adverse Event|6
170192|NCT00206440|537754|P2|Overall Study|Adverse Event|2
170193|NCT00206440|537755|P1|Overall Study|Adverse Event|4
170194|NCT00206440|537754|P2|Overall Study|Protocol Violation|2
170195|NCT00206440|537755|P1|Overall Study|Protocol Violation|1
170196|NCT00206427|537761|P1|Overall Study|Adverse Event|2
170197|NCT00207142|537768|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
170198|NCT00207142|537769|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
170199|NCT00207142|537770|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
170200|NCT00207142|537771|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
170201|NCT00207142|537768|P4|Maintenance Phase/Rescue Phase|Death|1
170202|NCT00207142|537769|P3|Maintenance Phase/Rescue Phase|Death|0
170203|NCT00207142|537770|P2|Maintenance Phase/Rescue Phase|Death|0
170204|NCT00207142|537771|P1|Maintenance Phase/Rescue Phase|Death|0
170205|NCT00207142|537768|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
170206|NCT00207142|537769|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
170207|NCT00207142|537770|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
170208|NCT00207142|537771|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
170209|NCT00207142|537768|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
170210|NCT00207142|537769|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
170211|NCT00207142|537770|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
170212|NCT00207142|537771|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
170213|NCT00207142|537768|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
170214|NCT00207142|537769|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
170215|NCT00207142|537770|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
170216|NCT00207142|537771|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
170217|NCT00207142|537768|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
170218|NCT00207142|537769|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
170219|NCT00207142|537770|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
170220|NCT00207142|537771|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
170221|NCT00207142|537768|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
170222|NCT00207142|537769|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
170223|NCT00207142|537770|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
170224|NCT00207142|537771|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
170225|NCT00207142|537768|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
170226|NCT00207142|537769|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
170227|NCT00207142|537770|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
170228|NCT00207142|537771|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
170229|NCT00207142|537768|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
170230|NCT00207142|537769|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
170231|NCT00207142|537770|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
170232|NCT00207142|537771|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
170233|NCT00207142|537768|P4|Induction Phase|Missing lab data|0
170234|NCT00207142|537769|P3|Induction Phase|Missing lab data|0
170235|NCT00207142|537770|P2|Induction Phase|Missing lab data|0
170236|NCT00207142|537771|P1|Induction Phase|Missing lab data|1
170237|NCT00207142|537768|P4|Induction Phase|Incarceration|0
170238|NCT00207142|537769|P3|Induction Phase|Incarceration|0
170239|NCT00207142|537770|P2|Induction Phase|Incarceration|0
170240|NCT00207142|537771|P1|Induction Phase|Incarceration|1
170241|NCT00207142|537768|P4|Induction Phase|Withdrawal by Subject|0
170242|NCT00207142|537769|P3|Induction Phase|Withdrawal by Subject|0
170243|NCT00207142|537770|P2|Induction Phase|Withdrawal by Subject|0
170244|NCT00207142|537771|P1|Induction Phase|Withdrawal by Subject|4
170245|NCT00207142|537768|P4|Induction Phase|Subject no longer meets study criteria|0
170246|NCT00207142|537769|P3|Induction Phase|Subject no longer meets study criteria|0
170247|NCT00207142|537770|P2|Induction Phase|Subject no longer meets study criteria|0
170248|NCT00207142|537771|P1|Induction Phase|Subject no longer meets study criteria|3
170249|NCT00207142|537768|P4|Induction Phase|Pregnancy|0
170250|NCT00207142|537769|P3|Induction Phase|Pregnancy|0
170251|NCT00207142|537770|P2|Induction Phase|Pregnancy|0
170252|NCT00207142|537771|P1|Induction Phase|Pregnancy|1
170253|NCT00207142|537768|P4|Induction Phase|Poor/noncompliance|0
170254|NCT00207142|537769|P3|Induction Phase|Poor/noncompliance|0
170255|NCT00207142|537770|P2|Induction Phase|Poor/noncompliance|0
170256|NCT00207142|537771|P1|Induction Phase|Poor/noncompliance|2
170257|NCT00207142|537768|P4|Induction Phase|Physician Decision|0
170258|NCT00207142|537769|P3|Induction Phase|Physician Decision|0
170259|NCT00207142|537770|P2|Induction Phase|Physician Decision|0
170260|NCT00207142|537771|P1|Induction Phase|Physician Decision|2
170261|NCT00207142|537768|P4|Induction Phase|Lost to Follow-up|0
170262|NCT00207142|537769|P3|Induction Phase|Lost to Follow-up|0
170263|NCT00207142|537770|P2|Induction Phase|Lost to Follow-up|0
170264|NCT00207142|537771|P1|Induction Phase|Lost to Follow-up|5
170265|NCT00207142|537768|P4|Induction Phase|Lack of Efficacy|0
170266|NCT00207142|537769|P3|Induction Phase|Lack of Efficacy|0
170267|NCT00207142|537770|P2|Induction Phase|Lack of Efficacy|0
170268|NCT00207142|537771|P1|Induction Phase|Lack of Efficacy|1
170269|NCT00207142|537768|P4|Induction Phase|Death|0
170270|NCT00207142|537769|P3|Induction Phase|Death|0
170271|NCT00207142|537770|P2|Induction Phase|Death|0
170272|NCT00207142|537771|P1|Induction Phase|Death|1
170273|NCT00207142|537768|P4|Induction Phase|Adverse Event|0
170274|NCT00207142|537769|P3|Induction Phase|Adverse Event|0
170275|NCT00207142|537770|P2|Induction Phase|Adverse Event|0
170276|NCT00207142|537771|P1|Induction Phase|Adverse Event|9
170277|NCT00207090|537808|P1|Overall Study|Physician Decision|1
170278|NCT00207090|537808|P1|Overall Study|Disease progression/relapse|2
170279|NCT00207090|537808|P1|Overall Study|Chest wall mass larger|1
170280|NCT00207090|537808|P1|Overall Study|Study drug toxicity|3
170281|NCT00206726|537837|P1|Overall Study|Withdrawal by Subject|8
170282|NCT00206726|537837|P1|Overall Study|Protocol Violation|1
170283|NCT00206726|537837|P1|Overall Study|Death|4
170284|NCT00206726|537837|P1|Overall Study|Adverse Event|17
170285|NCT00206726|537837|P1|Overall Study|Bone marrow transplant|1
170286|NCT00206726|537837|P1|Overall Study|Placed on new protocol|1
170287|NCT00206726|537837|P1|Overall Study|Progressive disease or relapsed disease|18
170288|NCT00206726|537837|P1|Overall Study|Delayed recovery of blood counts|1
170289|NCT00206102|537848|P2|Overall Study|None of those categories|36
170290|NCT00206102|537849|P1|Overall Study|None of those categories|42
170291|NCT00206102|537848|P2|Overall Study|Study-specific discontinuation criteria|17
170292|NCT00206102|537849|P1|Overall Study|Study-specific discontinuation criteria|18
170293|NCT00206102|537848|P2|Overall Study|Withdrawal by Subject|101
170294|NCT00206102|537849|P1|Overall Study|Withdrawal by Subject|118
170295|NCT00206102|537848|P2|Overall Study|Lost to Follow-up|66
170296|NCT00206102|537849|P1|Overall Study|Lost to Follow-up|95
170297|NCT00206102|537848|P2|Overall Study|Lack of therapeutic response|11
170298|NCT00206102|537849|P1|Overall Study|Lack of therapeutic response|16
170299|NCT00206102|537848|P2|Overall Study|Protocol Violation|2
170300|NCT00206102|537849|P1|Overall Study|Protocol Violation|0
170301|NCT00206102|537848|P2|Overall Study|Adverse Event|82
170302|NCT00206102|537849|P1|Overall Study|Adverse Event|119
170303|NCT00206076|537885|P2|Overall Study|Withdrawal by Subject|1
170304|NCT00206076|537886|P1|Overall Study|Withdrawal by Subject|1
170305|NCT00206076|537885|P2|Overall Study|Physician Decision|0
170306|NCT00206076|537886|P1|Overall Study|Physician Decision|2
170307|NCT00205881|537896|P1|Overall Study|Withdrawal by Subject|16
170308|NCT00205855|537901|P1|Overall Study|Withdrawal by Subject|5
170309|NCT00205855|537901|P1|Overall Study|Only received temporary implants|16
170310|NCT00205803|537907|P2|Toddler Dose|Lost to Follow-up|3
170311|NCT00205803|537908|P1|Toddler Dose|Lost to Follow-up|2
170312|NCT00205803|537907|P2|After Infant Series|Unspecified|4
170313|NCT00205803|537908|P1|After Infant Series|Unspecified|10
170314|NCT00205803|537907|P2|After Infant Series|Withdrawal by Subject|4
170315|NCT00205803|537908|P1|After Infant Series|Withdrawal by Subject|1
170316|NCT00205803|537907|P2|After Infant Series|Physician Decision|2
170317|NCT00205803|537908|P1|After Infant Series|Physician Decision|3
170318|NCT00205803|537907|P2|After Infant Series|Lost to Follow-up|1
170319|NCT00205803|537908|P1|After Infant Series|Lost to Follow-up|2
170320|NCT00205803|537907|P2|After Infant Series|Protocol Violation|1
170321|NCT00205803|537908|P1|After Infant Series|Protocol Violation|1
170322|NCT00205803|537907|P2|After Infant Series|Adverse Event|1
170323|NCT00205803|537908|P1|After Infant Series|Adverse Event|1
170324|NCT00205803|537907|P2|Infant Series|Sponsor request|0
170325|NCT00205803|537908|P1|Infant Series|Sponsor request|1
170326|NCT00205803|537907|P2|Infant Series|Non-compliant|0
170327|NCT00205803|537908|P1|Infant Series|Non-compliant|1
170328|NCT00205803|537907|P2|Infant Series|Lost Kaiser coverage|1
170329|NCT00205803|537908|P1|Infant Series|Lost Kaiser coverage|0
170330|NCT00205803|537907|P2|Infant Series|Protocol Violation|0
170331|NCT00205803|537908|P1|Infant Series|Protocol Violation|1
170332|NCT00205803|537907|P2|Infant Series|Physician Decision|1
170333|NCT00205803|537908|P1|Infant Series|Physician Decision|3
170334|NCT00205803|537907|P2|Infant Series|Withdrawal by Subject|5
170335|NCT00205803|537908|P1|Infant Series|Withdrawal by Subject|2
170336|NCT00205803|537907|P2|Infant Series|Lost to Follow-up|4
170337|NCT00205803|537908|P1|Infant Series|Lost to Follow-up|10
170338|NCT00205777|537964|P6|Study Extension II|Enrolled but not treated|131
170339|NCT00205777|537965|P5|Study Extension II|Enrolled but not treated|0
170340|NCT00205777|537966|P4|Study Extension II|Enrolled but not treated|71
170341|NCT00205777|537967|P3|Study Extension II|Enrolled but not treated|0
170342|NCT00205777|537968|P2|Study Extension II|Enrolled but not treated|0
170343|NCT00205777|537969|P1|Study Extension II|Enrolled but not treated|0
170344|NCT00205777|537964|P6|Study Extension II|Other Event|20
170345|NCT00205777|537965|P5|Study Extension II|Other Event|0
170346|NCT00205777|537966|P4|Study Extension II|Other Event|12
170347|NCT00205777|537967|P3|Study Extension II|Other Event|0
170348|NCT00205777|537968|P2|Study Extension II|Other Event|0
170349|NCT00205777|537969|P1|Study Extension II|Other Event|0
170350|NCT00205777|537964|P6|Study Extension II|Failed to return|26
170351|NCT00205777|537965|P5|Study Extension II|Failed to return|0
170352|NCT00205777|537966|P4|Study Extension II|Failed to return|14
170353|NCT00205777|537967|P3|Study Extension II|Failed to return|0
170354|NCT00205777|537968|P2|Study Extension II|Failed to return|0
170355|NCT00205777|537969|P1|Study Extension II|Failed to return|0
170356|NCT00205777|537964|P6|Study Extension II|Lack of Efficacy|1
170357|NCT00205777|537965|P5|Study Extension II|Lack of Efficacy|0
170358|NCT00205777|537966|P4|Study Extension II|Lack of Efficacy|0
170359|NCT00205777|537967|P3|Study Extension II|Lack of Efficacy|0
170360|NCT00205777|537968|P2|Study Extension II|Lack of Efficacy|0
170361|NCT00205777|537969|P1|Study Extension II|Lack of Efficacy|0
170362|NCT00205777|537964|P6|Study Extension II|Protocol Violation|10
170363|NCT00205777|537965|P5|Study Extension II|Protocol Violation|0
170364|NCT00205777|537966|P4|Study Extension II|Protocol Violation|1
170365|NCT00205777|537967|P3|Study Extension II|Protocol Violation|0
170366|NCT00205777|537968|P2|Study Extension II|Protocol Violation|0
170367|NCT00205777|537969|P1|Study Extension II|Protocol Violation|0
170368|NCT00205777|537964|P6|Study Extension II|Withdrawal by Subject|59
170369|NCT00205777|537965|P5|Study Extension II|Withdrawal by Subject|0
170370|NCT00205777|537966|P4|Study Extension II|Withdrawal by Subject|35
170371|NCT00205777|537967|P3|Study Extension II|Withdrawal by Subject|0
170372|NCT00205777|537968|P2|Study Extension II|Withdrawal by Subject|0
170373|NCT00205777|537969|P1|Study Extension II|Withdrawal by Subject|0
170374|NCT00205777|537964|P6|Study Extension II|Death|5
170375|NCT00205777|537965|P5|Study Extension II|Death|0
170376|NCT00205777|537966|P4|Study Extension II|Death|2
170377|NCT00205777|537967|P3|Study Extension II|Death|0
170378|NCT00205777|537968|P2|Study Extension II|Death|0
170379|NCT00205777|537969|P1|Study Extension II|Death|0
170380|NCT00205777|537964|P6|Study Extension II|Adverse Event|30
170381|NCT00205777|537965|P5|Study Extension II|Adverse Event|0
170382|NCT00205777|537966|P4|Study Extension II|Adverse Event|14
170383|NCT00205777|537967|P3|Study Extension II|Adverse Event|0
170384|NCT00205777|537968|P2|Study Extension II|Adverse Event|0
170385|NCT00205777|537969|P1|Study Extension II|Adverse Event|0
170386|NCT00205777|537964|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
170387|NCT00205777|537965|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
170388|NCT00205777|537966|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
170389|NCT00205777|537967|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
170390|NCT00205777|537968|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
170391|NCT00205777|537969|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
170392|NCT00205777|537964|P6|Study Extension I|Withdrawn as per protocol|0
170393|NCT00205777|537965|P5|Study Extension I|Withdrawn as per protocol|0
170394|NCT00205777|537966|P4|Study Extension I|Withdrawn as per protocol|0
170395|NCT00205777|537967|P3|Study Extension I|Withdrawn as per protocol|1070
170396|NCT00205777|537968|P2|Study Extension I|Withdrawn as per protocol|0
170397|NCT00205777|537969|P1|Study Extension I|Withdrawn as per protocol|0
170398|NCT00205777|537964|P6|Study Extension I|Other Event|0
170399|NCT00205777|537965|P5|Study Extension I|Other Event|29
170400|NCT00205777|537966|P4|Study Extension I|Other Event|34
170401|NCT00205777|537967|P3|Study Extension I|Other Event|0
170402|NCT00205777|537968|P2|Study Extension I|Other Event|0
170403|NCT00205777|537969|P1|Study Extension I|Other Event|34
170404|NCT00205777|537964|P6|Study Extension I|Failed to return|0
170405|NCT00205777|537965|P5|Study Extension I|Failed to return|13
170406|NCT00205777|537966|P4|Study Extension I|Failed to return|17
170407|NCT00205777|537967|P3|Study Extension I|Failed to return|0
170408|NCT00205777|537968|P2|Study Extension I|Failed to return|0
170409|NCT00205777|537969|P1|Study Extension I|Failed to return|15
170410|NCT00205777|537964|P6|Study Extension I|Lack of Efficacy|0
170411|NCT00205777|537965|P5|Study Extension I|Lack of Efficacy|2
170412|NCT00205777|537966|P4|Study Extension I|Lack of Efficacy|1
170413|NCT00205777|537967|P3|Study Extension I|Lack of Efficacy|0
170414|NCT00205777|537968|P2|Study Extension I|Lack of Efficacy|0
170415|NCT00205777|537969|P1|Study Extension I|Lack of Efficacy|0
170416|NCT00205777|537964|P6|Study Extension I|Protocol Violation|0
170417|NCT00205777|537965|P5|Study Extension I|Protocol Violation|8
170418|NCT00205777|537966|P4|Study Extension I|Protocol Violation|8
170419|NCT00205777|537967|P3|Study Extension I|Protocol Violation|0
170420|NCT00205777|537968|P2|Study Extension I|Protocol Violation|0
170421|NCT00205777|537969|P1|Study Extension I|Protocol Violation|4
170422|NCT00205777|537964|P6|Study Extension I|Withdrawal by Subject|0
170423|NCT00205777|537965|P5|Study Extension I|Withdrawal by Subject|89
170424|NCT00205777|537966|P4|Study Extension I|Withdrawal by Subject|106
170425|NCT00205777|537967|P3|Study Extension I|Withdrawal by Subject|0
170426|NCT00205777|537968|P2|Study Extension I|Withdrawal by Subject|0
170427|NCT00205777|537969|P1|Study Extension I|Withdrawal by Subject|99
170428|NCT00205777|537964|P6|Study Extension I|Death|0
170429|NCT00205777|537965|P5|Study Extension I|Death|2
170430|NCT00205777|537966|P4|Study Extension I|Death|1
170431|NCT00205777|537967|P3|Study Extension I|Death|0
170432|NCT00205777|537968|P2|Study Extension I|Death|0
170433|NCT00205777|537969|P1|Study Extension I|Death|5
170434|NCT00205777|537964|P6|Study Extension I|Adverse Event|0
170435|NCT00205777|537965|P5|Study Extension I|Adverse Event|58
170436|NCT00205777|537966|P4|Study Extension I|Adverse Event|61
170437|NCT00205777|537967|P3|Study Extension I|Adverse Event|0
170438|NCT00205777|537968|P2|Study Extension I|Adverse Event|0
170439|NCT00205777|537969|P1|Study Extension I|Adverse Event|57
170440|NCT00205777|537964|P6|Completed Core Study, Entered SE I|Other Event|0
170441|NCT00205777|537965|P5|Completed Core Study, Entered SE I|Other Event|0
170442|NCT00205777|537966|P4|Completed Core Study, Entered SE I|Other Event|50
170443|NCT00205777|537967|P3|Completed Core Study, Entered SE I|Other Event|47
170444|NCT00205777|537968|P2|Completed Core Study, Entered SE I|Other Event|46
170445|NCT00205777|537969|P1|Completed Core Study, Entered SE I|Other Event|52
170446|NCT00205777|537964|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
170447|NCT00205777|537965|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
170448|NCT00205777|537966|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
170449|NCT00205777|537967|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
170450|NCT00205777|537968|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
170451|NCT00205777|537969|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
170452|NCT00205777|537964|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
170453|NCT00205777|537965|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
170454|NCT00205777|537966|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
170455|NCT00205777|537967|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
170456|NCT00205777|537968|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
170457|NCT00205777|537969|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
170458|NCT00205777|537964|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
170459|NCT00205777|537965|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
170460|NCT00205777|537966|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
170461|NCT00205777|537967|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
170462|NCT00205777|537968|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
170463|NCT00205777|537969|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
170464|NCT00205777|537964|P6|Core Study (Up to 3 Years)|Protocol Violation|0
170465|NCT00205777|537965|P5|Core Study (Up to 3 Years)|Protocol Violation|0
170466|NCT00205777|537966|P4|Core Study (Up to 3 Years)|Protocol Violation|42
170467|NCT00205777|537967|P3|Core Study (Up to 3 Years)|Protocol Violation|50
170468|NCT00205777|537968|P2|Core Study (Up to 3 Years)|Protocol Violation|55
170469|NCT00205777|537969|P1|Core Study (Up to 3 Years)|Protocol Violation|53
170470|NCT00205777|537964|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
170471|NCT00205777|537965|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
170472|NCT00205777|537966|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
170473|NCT00205777|537967|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
170474|NCT00205777|537968|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
170475|NCT00205777|537969|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
170476|NCT00205777|537964|P6|Core Study (Up to 3 Years)|Other Event|0
170477|NCT00205777|537965|P5|Core Study (Up to 3 Years)|Other Event|0
170478|NCT00205777|537966|P4|Core Study (Up to 3 Years)|Other Event|58
170479|NCT00205777|537967|P3|Core Study (Up to 3 Years)|Other Event|41
170480|NCT00205777|537968|P2|Core Study (Up to 3 Years)|Other Event|52
170481|NCT00205777|537969|P1|Core Study (Up to 3 Years)|Other Event|49
170482|NCT00205777|537964|P6|Core Study (Up to 3 Years)|Failed to return|0
170483|NCT00205777|537965|P5|Core Study (Up to 3 Years)|Failed to return|0
170484|NCT00205777|537966|P4|Core Study (Up to 3 Years)|Failed to return|27
170485|NCT00205777|537967|P3|Core Study (Up to 3 Years)|Failed to return|27
170486|NCT00205777|537968|P2|Core Study (Up to 3 Years)|Failed to return|25
170487|NCT00205777|537969|P1|Core Study (Up to 3 Years)|Failed to return|40
170488|NCT00205777|537964|P6|Core Study (Up to 3 Years)|Death|0
170489|NCT00205777|537965|P5|Core Study (Up to 3 Years)|Death|0
170490|NCT00205777|537966|P4|Core Study (Up to 3 Years)|Death|7
170491|NCT00205777|537967|P3|Core Study (Up to 3 Years)|Death|14
170492|NCT00205777|537968|P2|Core Study (Up to 3 Years)|Death|7
170493|NCT00205777|537969|P1|Core Study (Up to 3 Years)|Death|9
170494|NCT00205777|537964|P6|Core Study (Up to 3 Years)|Adverse Event|0
170495|NCT00205777|537965|P5|Core Study (Up to 3 Years)|Adverse Event|0
170496|NCT00205777|537966|P4|Core Study (Up to 3 Years)|Adverse Event|232
170497|NCT00205777|537967|P3|Core Study (Up to 3 Years)|Adverse Event|252
170498|NCT00205777|537968|P2|Core Study (Up to 3 Years)|Adverse Event|267
170499|NCT00205777|537969|P1|Core Study (Up to 3 Years)|Adverse Event|260
170500|NCT00205712|538178|P2|Overall Study|Lost to Follow-up|1
170501|NCT00205712|538179|P1|Overall Study|Lost to Follow-up|0
170502|NCT00203996|538245|P10|Overall Study|Scheduling issue|0
170503|NCT00203996|538246|P9|Overall Study|Scheduling issue|0
170504|NCT00203996|538247|P8|Overall Study|Scheduling issue|2
170505|NCT00203996|538248|P7|Overall Study|Scheduling issue|0
170506|NCT00203996|538249|P6|Overall Study|Scheduling issue|0
170507|NCT00203996|538250|P5|Overall Study|Scheduling issue|0
170508|NCT00203996|538251|P4|Overall Study|Scheduling issue|0
170509|NCT00203996|538252|P3|Overall Study|Scheduling issue|0
170510|NCT00203996|538253|P2|Overall Study|Scheduling issue|0
170511|NCT00203996|538254|P1|Overall Study|Scheduling issue|0
170512|NCT00203996|538245|P10|Overall Study|CPAP machine malfunction|0
170513|NCT00203996|538246|P9|Overall Study|CPAP machine malfunction|0
170514|NCT00203996|538247|P8|Overall Study|CPAP machine malfunction|0
170515|NCT00203996|538248|P7|Overall Study|CPAP machine malfunction|0
170516|NCT00203996|538249|P6|Overall Study|CPAP machine malfunction|0
170517|NCT00203996|538250|P5|Overall Study|CPAP machine malfunction|0
170518|NCT00203996|538251|P4|Overall Study|CPAP machine malfunction|1
170519|NCT00203996|538252|P3|Overall Study|CPAP machine malfunction|0
170520|NCT00203996|538253|P2|Overall Study|CPAP machine malfunction|0
170521|NCT00203996|538254|P1|Overall Study|CPAP machine malfunction|0
170522|NCT00203996|538245|P10|Overall Study|Physician Decision|1
170523|NCT00203996|538246|P9|Overall Study|Physician Decision|0
170524|NCT00203996|538247|P8|Overall Study|Physician Decision|0
170525|NCT00203996|538248|P7|Overall Study|Physician Decision|0
170526|NCT00203996|538249|P6|Overall Study|Physician Decision|0
170527|NCT00203996|538250|P5|Overall Study|Physician Decision|0
170528|NCT00203996|538251|P4|Overall Study|Physician Decision|2
170529|NCT00203996|538252|P3|Overall Study|Physician Decision|0
170530|NCT00203996|538253|P2|Overall Study|Physician Decision|0
170531|NCT00203996|538254|P1|Overall Study|Physician Decision|0
170532|NCT00203996|538245|P10|Overall Study|Protocol Violation|0
170533|NCT00203996|538246|P9|Overall Study|Protocol Violation|0
170534|NCT00203996|538247|P8|Overall Study|Protocol Violation|0
170535|NCT00203996|538248|P7|Overall Study|Protocol Violation|0
170536|NCT00203996|538249|P6|Overall Study|Protocol Violation|0
170537|NCT00203996|538250|P5|Overall Study|Protocol Violation|1
170538|NCT00203996|538251|P4|Overall Study|Protocol Violation|6
170539|NCT00203996|538252|P3|Overall Study|Protocol Violation|0
170540|NCT00203996|538253|P2|Overall Study|Protocol Violation|0
170541|NCT00203996|538254|P1|Overall Study|Protocol Violation|0
170542|NCT00203996|538245|P10|Overall Study|Lost to Follow-up|0
170543|NCT00203996|538246|P9|Overall Study|Lost to Follow-up|0
170544|NCT00203996|538247|P8|Overall Study|Lost to Follow-up|0
170545|NCT00203996|538248|P7|Overall Study|Lost to Follow-up|0
170546|NCT00203996|538249|P6|Overall Study|Lost to Follow-up|0
170547|NCT00203996|538250|P5|Overall Study|Lost to Follow-up|0
170548|NCT00203996|538251|P4|Overall Study|Lost to Follow-up|1
170549|NCT00203996|538252|P3|Overall Study|Lost to Follow-up|0
170550|NCT00203996|538253|P2|Overall Study|Lost to Follow-up|0
170551|NCT00203996|538254|P1|Overall Study|Lost to Follow-up|0
170552|NCT00203892|538321|P3|Overall Study|Death|0
170553|NCT00203892|538322|P2|Overall Study|Death|0
170554|NCT00203892|538323|P1|Overall Study|Death|1
170555|NCT00203892|538321|P3|Overall Study|Physician Decision|0
170556|NCT00203892|538322|P2|Overall Study|Physician Decision|2
170557|NCT00203892|538323|P1|Overall Study|Physician Decision|1
170558|NCT00203502|538334|P1|Overall Study|Death|1
170559|NCT00203476|538345|P3|Overall Study|Withdrawal by Subject|0
170560|NCT00203476|538346|P2|Overall Study|Withdrawal by Subject|1
170561|NCT00203476|538347|P1|Overall Study|Withdrawal by Subject|0
170562|NCT00203476|538345|P3|Overall Study|Lost to Follow-up|0
170563|NCT00203476|538346|P2|Overall Study|Lost to Follow-up|0
170564|NCT00203476|538347|P1|Overall Study|Lost to Follow-up|1
170565|NCT00203424|538364|P1|Follow-up Period|Lost to Follow-up|1
170566|NCT00203424|538364|P1|Follow-up Period|progressive disease|4
170567|NCT00203424|538364|P1|Follow-up Period|Withdrawal by Subject|1
170568|NCT00203424|538364|P1|Treatment Period|progressive disease|2
170569|NCT00203424|538364|P1|Treatment Period|Adverse Event|5
170570|NCT00203424|538364|P1|Treatment Period|Withdrawal by Subject|4
170571|NCT00203411|538371|P1|Follow-up|Progressive Disease|4
170572|NCT00203307|538380|P2|First Intervention|Adverse Event|0
170573|NCT00203307|538381|P1|First Intervention|Adverse Event|2
170574|NCT00203294|538389|P2|Overall Study|Withdrawal by Subject|13
170575|NCT00203294|538390|P1|Overall Study|Withdrawal by Subject|8
170576|NCT00203268|538396|P1|Early Treatment|Withdrawal by Subject|1
170577|NCT00203268|538396|P1|Early Treatment|Lost to Follow-up|1
170578|NCT00203268|538396|P1|Early Treatment|only treated one headache|2
170579|NCT00203242|538402|P1|Overall Study|Lost to Follow-up|1
170580|NCT00203047|538454|P2|Overall Study|Not specified|5
170581|NCT00203047|538455|P1|Overall Study|Not specified|5
170582|NCT00203047|538454|P2|Overall Study|Pregnancy|0
170583|NCT00203047|538455|P1|Overall Study|Pregnancy|3
170584|NCT00203047|538454|P2|Overall Study|Death|2
170585|NCT00203047|538455|P1|Overall Study|Death|1
170586|NCT00203047|538454|P2|Overall Study|Adverse Event|18
170587|NCT00203047|538455|P1|Overall Study|Adverse Event|8
170588|NCT00203047|538454|P2|Overall Study|Lost to Follow-up|5
170589|NCT00203047|538455|P1|Overall Study|Lost to Follow-up|11
170590|NCT00203047|538454|P2|Overall Study|Protocol Violation|0
170591|NCT00203047|538455|P1|Overall Study|Protocol Violation|1
170592|NCT00203047|538454|P2|Overall Study|Non-compliance|8
170593|NCT00203047|538455|P1|Overall Study|Non-compliance|4
170594|NCT00203047|538454|P2|Overall Study|Physician Decision|7
170595|NCT00203047|538455|P1|Overall Study|Physician Decision|8
170596|NCT00203047|538454|P2|Overall Study|Teva requested participant withdrawal|1
170597|NCT00203047|538455|P1|Overall Study|Teva requested participant withdrawal|1
170598|NCT00203047|538454|P2|Overall Study|Withdrawal by Subject|47
170599|NCT00203047|538455|P1|Overall Study|Withdrawal by Subject|13
170600|NCT00203047|538454|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
170601|NCT00203047|538455|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
170602|NCT00203047|538454|P2|Overall Study|Ongoing: in database - January 29, 2009|109
170603|NCT00203047|538455|P1|Overall Study|Ongoing: in database - January 29, 2009|131
170604|NCT00202878|538469|P2|Overall Study|Withdrawal by Subject|808
170605|NCT00202878|538470|P1|Overall Study|Withdrawal by Subject|795
170606|NCT00202878|538469|P2|Overall Study|Site Closure|36
170607|NCT00202878|538470|P1|Overall Study|Site Closure|39
170608|NCT00202878|538469|P2|Overall Study|Lost to Follow-up|49
170609|NCT00202878|538470|P1|Overall Study|Lost to Follow-up|44
170610|NCT00202878|538469|P2|Overall Study|Only Vital Status Known|356
170611|NCT00202878|538470|P1|Overall Study|Only Vital Status Known|357
170612|NCT00202878|538469|P2|Overall Study|Death|968
170613|NCT00202878|538470|P1|Overall Study|Death|964
170614|NCT00202839|538484|P2|Overall Study|Lost to Follow-up|2
170615|NCT00202839|538485|P1|Overall Study|Lost to Follow-up|3
170616|NCT00202839|538484|P2|Overall Study|Protocol Violation|1
170617|NCT00202839|538485|P1|Overall Study|Protocol Violation|2
170618|NCT00202839|538484|P2|Overall Study|Withdrawal by Subject|2
170619|NCT00202839|538485|P1|Overall Study|Withdrawal by Subject|6
170620|NCT00202839|538484|P2|Overall Study|Physician Decision|0
170621|NCT00202839|538485|P1|Overall Study|Physician Decision|12
170622|NCT00202839|538484|P2|Overall Study|Adverse Event|5
170623|NCT00202839|538485|P1|Overall Study|Adverse Event|1
170624|NCT00201851|538534|P3|Overall Study|Ineligible post enrollment|1
170625|NCT00201851|538535|P2|Overall Study|Ineligible post enrollment|1
170626|NCT00201851|538536|P1|Overall Study|Ineligible post enrollment|6
170627|NCT00201851|538534|P3|Overall Study|Lost to Follow-up|0
170628|NCT00201851|538535|P2|Overall Study|Lost to Follow-up|1
170629|NCT00201851|538536|P1|Overall Study|Lost to Follow-up|2
170630|NCT00201643|538595|P2|Overall Study|Withdrawal by Subject|4
170631|NCT00201643|538596|P1|Overall Study|Withdrawal by Subject|5
170632|NCT00201201|538660|P2|Overall Study|Withdrawal by Subject|5
170633|NCT00201201|538661|P1|Overall Study|Withdrawal by Subject|5
170634|NCT00201201|538660|P2|Overall Study|Death|2
170635|NCT00201201|538661|P1|Overall Study|Death|0
170636|NCT00201006|538699|P3|Overall Study|Adverse Event|1
170637|NCT00201006|538700|P2|Overall Study|Adverse Event|0
170638|NCT00201006|538701|P1|Overall Study|Adverse Event|1
170639|NCT00201006|538699|P3|Overall Study|Withdrawal by Subject|3
170640|NCT00201006|538700|P2|Overall Study|Withdrawal by Subject|2
170641|NCT00201006|538701|P1|Overall Study|Withdrawal by Subject|7
170642|NCT00200967|538711|P2|Run-out Period|Lost to Follow-up|0
170643|NCT00200967|538712|P1|Run-out Period|Lost to Follow-up|1
170644|NCT00200967|538711|P2|Second Treatment Period|Withdrawal by Subject|2
170645|NCT00200967|538712|P1|Second Treatment Period|Withdrawal by Subject|1
170646|NCT00200967|538711|P2|Wash-out Period|Lost to Follow-up|1
170647|NCT00200967|538712|P1|Wash-out Period|Lost to Follow-up|0
170648|NCT00200967|538711|P2|First Treatment Period|Pregnancy|0
170649|NCT00200967|538712|P1|First Treatment Period|Pregnancy|1
170650|NCT00200967|538711|P2|First Treatment Period|Withdrawal by Subject|1
170651|NCT00200967|538712|P1|First Treatment Period|Withdrawal by Subject|5
170652|NCT00200356|538753|P2|Overall Study|Nontreatment|0
170653|NCT00200356|538754|P1|Overall Study|Nontreatment|1
170654|NCT00200356|538753|P2|Overall Study|Protocol Violation|4
170655|NCT00200356|538754|P1|Overall Study|Protocol Violation|4
170656|NCT00200356|538753|P2|Overall Study|Lack of Efficacy|3
170657|NCT00200356|538754|P1|Overall Study|Lack of Efficacy|3
170658|NCT00200057|538806|P1|Overall Study|Death|1
170659|NCT00200057|538806|P1|Overall Study|Infection|1
170660|NCT00200057|538806|P1|Overall Study|Change in medical condition|1
170661|NCT00200057|538806|P1|Overall Study|Withdrawal by Subject|1
170662|NCT00200057|538806|P1|Overall Study|Exited due to terminal illness of PI|2
170663|NCT00200057|538806|P1|Overall Study|Lack of Efficacy|3
170664|NCT00199381|538825|P1|Overall Study|Study termination by Sponsor|323
170665|NCT00199381|538825|P1|Overall Study|Not including due to early termination|37
170666|NCT00199381|538825|P1|Overall Study|Lack of Efficacy|27
170667|NCT00199381|538825|P1|Overall Study|Protocol Violation|6
170668|NCT00199381|538825|P1|Overall Study|Adverse Event|73
170669|NCT00199381|538825|P1|Overall Study|Withdrawal by Subject|38
170670|NCT00198822|538832|P3|Overall Study|Lost to Follow-up|21
170671|NCT00198822|538833|P2|Overall Study|Lost to Follow-up|20
170672|NCT00198822|538834|P1|Overall Study|Lost to Follow-up|14
170673|NCT00197106|538866|P3|Overall Treatment Period|Withdrawal by Subject|2
170674|NCT00197106|538867|P2|Overall Treatment Period|Withdrawal by Subject|0
170675|NCT00197106|538868|P1|Overall Treatment Period|Withdrawal by Subject|0
170676|NCT00197106|538866|P3|Overall Treatment Period|Protocol Violation|2
170677|NCT00197106|538867|P2|Overall Treatment Period|Protocol Violation|0
170678|NCT00197106|538868|P1|Overall Treatment Period|Protocol Violation|0
170679|NCT00197106|538866|P3|Overall Treatment Period|Lost to Follow-up|2
170680|NCT00197106|538867|P2|Overall Treatment Period|Lost to Follow-up|0
170681|NCT00197106|538868|P1|Overall Treatment Period|Lost to Follow-up|0
170682|NCT00197106|538866|P3|Overall Treatment Period|Lack of Efficacy|0
170683|NCT00197106|538867|P2|Overall Treatment Period|Lack of Efficacy|1
170684|NCT00197106|538868|P1|Overall Treatment Period|Lack of Efficacy|0
170685|NCT00197106|538866|P3|4-Week Run-In Period|Did not meet entry criteria|0
170686|NCT00197106|538867|P2|4-Week Run-In Period|Did not meet entry criteria|0
170687|NCT00197106|538868|P1|4-Week Run-In Period|Did not meet entry criteria|99
170688|NCT00198133|538904|P2|Overall Study|Physician Decision|0
170689|NCT00198133|538905|P1|Overall Study|Physician Decision|1
170690|NCT00198133|538904|P2|Overall Study|Withdrawal by Subject|0
170691|NCT00198133|538905|P1|Overall Study|Withdrawal by Subject|1
170692|NCT00198133|538904|P2|Overall Study|Adverse Event|3
170693|NCT00198133|538905|P1|Overall Study|Adverse Event|1
170694|NCT00198133|538904|P2|Overall Study|Disease progression|5
170695|NCT00198133|538905|P1|Overall Study|Disease progression|2
170696|NCT00198029|538944|P1|Overall Study|Withdrawal by Subject|4
170697|NCT00197028|538951|P2|Overall Study|Unspecified|6
170698|NCT00197028|538952|P1|Overall Study|Unspecified|3
170699|NCT00197028|538951|P2|Overall Study|Lost to Follow-up|0
170700|NCT00197028|538952|P1|Overall Study|Lost to Follow-up|1
170701|NCT00197028|538951|P2|Overall Study|Withdrawal by Subject|12
170702|NCT00197028|538952|P1|Overall Study|Withdrawal by Subject|8
170703|NCT00197028|538951|P2|Overall Study|Protocol Violation|1
170704|NCT00197028|538952|P1|Overall Study|Protocol Violation|2
170705|NCT00197028|538951|P2|Overall Study|Adverse Event|2
170706|NCT00197028|538952|P1|Overall Study|Adverse Event|2
170707|NCT00197015|538995|P3|Overall Study|Other|2
170708|NCT00197015|538996|P2|Overall Study|Other|3
170709|NCT00197015|538997|P1|Overall Study|Other|2
170710|NCT00197015|538995|P3|Overall Study|Lost to Follow-up|37
170711|NCT00197015|538996|P2|Overall Study|Lost to Follow-up|46
170712|NCT00197015|538997|P1|Overall Study|Lost to Follow-up|28
170713|NCT00197015|538995|P3|Overall Study|Withdrawal by Subject|34
170714|NCT00197015|538996|P2|Overall Study|Withdrawal by Subject|37
170715|NCT00197015|538997|P1|Overall Study|Withdrawal by Subject|17
170716|NCT00197015|538995|P3|Overall Study|Protocol Violation|3
170717|NCT00197015|538996|P2|Overall Study|Protocol Violation|3
170718|NCT00197015|538997|P1|Overall Study|Protocol Violation|0
170719|NCT00197015|538995|P3|Overall Study|Adverse Event|1
170720|NCT00197015|538996|P2|Overall Study|Adverse Event|0
170721|NCT00197015|538997|P1|Overall Study|Adverse Event|3
170722|NCT00196937|539056|P3|Overall Study|Withdrawal by Subject|3
170723|NCT00196937|539057|P2|Overall Study|Withdrawal by Subject|0
170724|NCT00196937|539058|P1|Overall Study|Withdrawal by Subject|0
170725|NCT00196937|539056|P3|Overall Study|Lost to Follow-up|3
170726|NCT00196937|539057|P2|Overall Study|Lost to Follow-up|3
170727|NCT00196937|539058|P1|Overall Study|Lost to Follow-up|4
170728|NCT00196937|539056|P3|Overall Study|Subject did not come due to holidays|0
170729|NCT00196937|539057|P2|Overall Study|Subject did not come due to holidays|1
170730|NCT00196937|539058|P1|Overall Study|Subject did not come due to holidays|3
170731|NCT00196937|539056|P3|Overall Study|Adverse Event|1
170732|NCT00196937|539057|P2|Overall Study|Adverse Event|1
170733|NCT00196937|539058|P1|Overall Study|Adverse Event|2
170734|NCT00197236|539131|P3|Overall Study|Returned out of specified time window|1
170735|NCT00197236|539132|P2|Overall Study|Returned out of specified time window|0
170736|NCT00197236|539133|P1|Overall Study|Returned out of specified time window|0
170737|NCT00197236|539131|P3|Overall Study|Study drug/medication expiration|3
170738|NCT00197236|539132|P2|Overall Study|Study drug/medication expiration|0
170739|NCT00197236|539133|P1|Overall Study|Study drug/medication expiration|1
170740|NCT00197236|539131|P3|Overall Study|Withdrawal by Subject|11
170741|NCT00197236|539132|P2|Overall Study|Withdrawal by Subject|3
170742|NCT00197236|539133|P1|Overall Study|Withdrawal by Subject|7
170743|NCT00197236|539131|P3|Overall Study|Protocol Violation|1
170744|NCT00197236|539132|P2|Overall Study|Protocol Violation|0
170745|NCT00197236|539133|P1|Overall Study|Protocol Violation|0
170746|NCT00197236|539131|P3|Overall Study|Lost to Follow-up|6
170747|NCT00197236|539132|P2|Overall Study|Lost to Follow-up|14
170748|NCT00197236|539133|P1|Overall Study|Lost to Follow-up|5
170749|NCT00197236|539131|P3|Overall Study|Adverse Event|1
170750|NCT00197236|539132|P2|Overall Study|Adverse Event|0
170751|NCT00197236|539133|P1|Overall Study|Adverse Event|1
170752|NCT00196326|539215|P1|Overall Study|Not specified|22
170753|NCT00196326|539215|P1|Overall Study|Lost to Follow-up|304
170754|NCT00196326|539215|P1|Overall Study|Pregnancy|34
170755|NCT00196326|539215|P1|Overall Study|Adverse Event|253
170756|NCT00196326|539215|P1|Overall Study|Withdrawal by Subject|225
170757|NCT00196326|539215|P1|Overall Study|Physician Decision|3
170758|NCT00196326|539215|P1|Overall Study|Non-compliance with the protocol|81
170759|NCT00196326|539215|P1|Overall Study|Did not meet protocol requirements|64
170760|NCT00196313|539223|P2|Overall Study|Lost to Follow-up|2
170761|NCT00196313|539224|P1|Overall Study|Lost to Follow-up|2
170762|NCT00196313|539223|P2|Overall Study|Subject Pregnant|1
170763|NCT00196313|539224|P1|Overall Study|Subject Pregnant|1
170764|NCT00196313|539223|P2|Overall Study|Adverse Event|1
170765|NCT00196313|539224|P1|Overall Study|Adverse Event|3
170766|NCT00196313|539223|P2|Overall Study|Withdrawal by Subject|1
170767|NCT00196313|539224|P1|Overall Study|Withdrawal by Subject|3
170768|NCT00196313|539223|P2|Overall Study|Protocol Violation|3
170769|NCT00196313|539224|P1|Overall Study|Protocol Violation|2
170770|NCT00196196|539238|P1|Overall Study|Did not have required condition (hydroce|5
170771|NCT00196196|539238|P1|Overall Study|Withdrawal by Subject|2
170772|NCT00196105|539246|P3|Overall Study|Lost to Follow-up|7
170773|NCT00196105|539247|P2|Overall Study|Lost to Follow-up|5
170774|NCT00196105|539248|P1|Overall Study|Lost to Follow-up|4
170775|NCT00195819|539268|P2|Open-label|Withdrawal by Subject|5
170776|NCT00195819|539269|P1|Open-label|Withdrawal by Subject|0
170777|NCT00195819|539268|P2|Open-label|Moved|1
170778|NCT00195819|539269|P1|Open-label|Moved|0
170779|NCT00195819|539268|P2|Open-label|Protocol Violation|2
170780|NCT00195819|539269|P1|Open-label|Protocol Violation|0
170781|NCT00195819|539268|P2|Open-label|Pregnancy|1
170782|NCT00195819|539269|P1|Open-label|Pregnancy|0
170783|NCT00195819|539268|P2|Open-label|Lack of Efficacy|2
170784|NCT00195819|539269|P1|Open-label|Lack of Efficacy|0
170785|NCT00195819|539268|P2|Open-label|Adverse Event|9
170786|NCT00195819|539269|P1|Open-label|Adverse Event|0
170787|NCT00195819|539268|P2|Double-Blind|Moved|0
170788|NCT00195819|539269|P1|Double-Blind|Moved|1
170789|NCT00195819|539268|P2|Double-Blind|Withdrawal by Subject|0
170790|NCT00195819|539269|P1|Double-Blind|Withdrawal by Subject|1
170791|NCT00195715|539319|P1|Overall Study|Sponsor discretion - trial ended early|1
170792|NCT00195715|539319|P1|Overall Study|Sponsor discontinued trial|1
170793|NCT00195715|539319|P1|Overall Study|Colonic stricture|1
170794|NCT00195715|539319|P1|Overall Study|Ineligible|1
170795|NCT00195715|539319|P1|Overall Study|Increased infection rate|1
170796|NCT00195715|539319|P1|Overall Study|Planned surgery|2
170797|NCT00195715|539319|P1|Overall Study|Use of prohibited medication|2
170798|NCT00195715|539319|P1|Overall Study|Subject wants to get pregnant|4
170799|NCT00195715|539319|P1|Overall Study|Investigator's decision|2
170800|NCT00195715|539319|P1|Overall Study|Administrative reasons|2
170801|NCT00195715|539319|P1|Overall Study|Sponsor stopped study|1
170802|NCT00195715|539319|P1|Overall Study|Loss of response/no improvement|3
170803|NCT00195715|539319|P1|Overall Study|Subject choice|3
170804|NCT00195715|539319|P1|Overall Study|Subject started commercial Humira|5
170805|NCT00195715|539319|P1|Overall Study|Subject non-compliance|6
170806|NCT00195715|539319|P1|Overall Study|Subject moved/relocated|7
170807|NCT00195715|539319|P1|Overall Study|Investigative site closure|8
170808|NCT00195715|539319|P1|Overall Study|Pregnancy|14
170809|NCT00195715|539319|P1|Overall Study|Lack of Efficacy|93
170810|NCT00195715|539319|P1|Overall Study|Protocol Violation|13
170811|NCT00195715|539319|P1|Overall Study|Lost to Follow-up|27
170812|NCT00195715|539319|P1|Overall Study|Withdrawal by Subject|58
170813|NCT00195715|539319|P1|Overall Study|Adverse Event|122
170814|NCT00195676|539419|P1|Period R - Retreatment 16 Weeks|Other reasons|6
170815|NCT00195676|539419|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
170816|NCT00195676|539419|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
170817|NCT00195676|539419|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
170818|NCT00195676|539419|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
170819|NCT00195676|539419|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
170820|NCT00195676|539419|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
170821|NCT00195676|539419|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
170822|NCT00195676|539419|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
170823|NCT00195676|539419|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
170824|NCT00195676|539419|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
170825|NCT00195676|539419|P1|Period W (Withdrawal) - No Treatment|Death|2
170826|NCT00195676|539419|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
170827|NCT00195676|539419|P1|Period O - Open-label Treatment|Other reasons|68
170828|NCT00195676|539419|P1|Period O - Open-label Treatment|Administrative reasons|2
170829|NCT00195676|539419|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
170830|NCT00195676|539419|P1|Period O - Open-label Treatment|Protocol Violation|12
170831|NCT00195676|539419|P1|Period O - Open-label Treatment|Lost to Follow-up|91
170832|NCT00195676|539419|P1|Period O - Open-label Treatment|Lack of Efficacy|198
170833|NCT00195676|539419|P1|Period O - Open-label Treatment|Death|6
170834|NCT00195676|539419|P1|Period O - Open-label Treatment|Adverse Event|82
170835|NCT00195663|539433|P3|Open-Label Extension Period|Administrative reasons|13
170836|NCT00195663|539434|P2|Open-Label Extension Period|Administrative reasons|11
170837|NCT00195663|539435|P1|Open-Label Extension Period|Administrative reasons|11
170838|NCT00195663|539433|P3|Open-Label Extension Period|Lack of Efficacy|12
170839|NCT00195663|539434|P2|Open-Label Extension Period|Lack of Efficacy|6
170840|NCT00195663|539435|P1|Open-Label Extension Period|Lack of Efficacy|14
170841|NCT00195663|539433|P3|Open-Label Extension Period|Withdrawal by Subject|22
170842|NCT00195663|539434|P2|Open-Label Extension Period|Withdrawal by Subject|15
170843|NCT00195663|539435|P1|Open-Label Extension Period|Withdrawal by Subject|16
170844|NCT00195663|539433|P3|Open-Label Extension Period|Death|2
170845|NCT00195663|539434|P2|Open-Label Extension Period|Death|2
170846|NCT00195663|539435|P1|Open-Label Extension Period|Death|2
170847|NCT00195663|539433|P3|Open-Label Extension Period|Protocol Violation|4
170848|NCT00195663|539434|P2|Open-Label Extension Period|Protocol Violation|4
170849|NCT00195663|539435|P1|Open-Label Extension Period|Protocol Violation|3
170850|NCT00195663|539433|P3|Open-Label Extension Period|Recovery|2
170851|NCT00195663|539434|P2|Open-Label Extension Period|Recovery|2
170852|NCT00195663|539435|P1|Open-Label Extension Period|Recovery|0
170853|NCT00195663|539433|P3|Open-Label Extension Period|Lost to Follow-up|6
170854|NCT00195663|539434|P2|Open-Label Extension Period|Lost to Follow-up|2
170855|NCT00195663|539435|P1|Open-Label Extension Period|Lost to Follow-up|9
170856|NCT00195663|539433|P3|Open-Label Extension Period|Adverse Event|36
170857|NCT00195663|539434|P2|Open-Label Extension Period|Adverse Event|32
170858|NCT00195663|539435|P1|Open-Label Extension Period|Adverse Event|21
170859|NCT00195663|539433|P3|2-year Double-blind Treatment Period|Administrative reasons|9
170860|NCT00195663|539434|P2|2-year Double-blind Treatment Period|Administrative reasons|2
170861|NCT00195663|539435|P1|2-year Double-blind Treatment Period|Administrative reasons|3
170862|NCT00195663|539433|P3|2-year Double-blind Treatment Period|Recovery|1
170863|NCT00195663|539434|P2|2-year Double-blind Treatment Period|Recovery|0
170864|NCT00195663|539435|P1|2-year Double-blind Treatment Period|Recovery|1
170865|NCT00195663|539433|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
170866|NCT00195663|539434|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
170867|NCT00195663|539435|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
170868|NCT00195663|539433|P3|2-year Double-blind Treatment Period|Protocol Violation|4
170869|NCT00195663|539434|P2|2-year Double-blind Treatment Period|Protocol Violation|6
170870|NCT00195663|539435|P1|2-year Double-blind Treatment Period|Protocol Violation|6
170871|NCT00195663|539433|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
170872|NCT00195663|539434|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
170873|NCT00195663|539435|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
170874|NCT00195663|539433|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
170875|NCT00195663|539434|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
170876|NCT00195663|539435|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
170877|NCT00195663|539433|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
170878|NCT00195663|539434|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
170879|NCT00195663|539435|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
170880|NCT00195663|539433|P3|2-year Double-blind Treatment Period|Death|0
170881|NCT00195663|539434|P2|2-year Double-blind Treatment Period|Death|2
170882|NCT00195663|539435|P1|2-year Double-blind Treatment Period|Death|0
170883|NCT00195663|539433|P3|2-year Double-blind Treatment Period|Adverse Event|32
170884|NCT00195663|539434|P2|2-year Double-blind Treatment Period|Adverse Event|27
170885|NCT00195663|539435|P1|2-year Double-blind Treatment Period|Adverse Event|21
170886|NCT00195650|539529|P1|Overall Study|Administrative reasons|83
170887|NCT00195650|539529|P1|Overall Study|Protocol Violation|15
170888|NCT00195650|539529|P1|Overall Study|Death|23
170889|NCT00195650|539529|P1|Overall Study|Lost to Follow-up|44
170890|NCT00195650|539529|P1|Overall Study|Withdrawal by Subject|67
170891|NCT00195650|539529|P1|Overall Study|Lack of Efficacy|99
170892|NCT00195650|539529|P1|Overall Study|Adverse Event|194
170893|NCT00195507|539545|P2|Overall Study|Protocol Deviation|3
170894|NCT00195507|539546|P1|Overall Study|Protocol Deviation|6
170895|NCT00195507|539545|P2|Overall Study|Withdrawal by Subject|23
170896|NCT00195507|539546|P1|Overall Study|Withdrawal by Subject|16
170897|NCT00195507|539545|P2|Overall Study|Lack of Efficacy|67
170898|NCT00195507|539546|P1|Overall Study|Lack of Efficacy|40
170899|NCT00195507|539545|P2|Overall Study|Protocol Violation|4
170900|NCT00195507|539546|P1|Overall Study|Protocol Violation|5
170901|NCT00195507|539545|P2|Overall Study|Lost to Follow-up|2
170902|NCT00195507|539546|P1|Overall Study|Lost to Follow-up|3
170903|NCT00195507|539545|P2|Overall Study|Physician Decision|2
170904|NCT00195507|539546|P1|Overall Study|Physician Decision|1
170905|NCT00195507|539545|P2|Overall Study|Failed to Return|3
170906|NCT00195507|539546|P1|Overall Study|Failed to Return|4
170907|NCT00195507|539545|P2|Overall Study|Death|1
170908|NCT00195507|539546|P1|Overall Study|Death|0
170909|NCT00195507|539545|P2|Overall Study|Adverse Event|13
170910|NCT00195507|539546|P1|Overall Study|Adverse Event|24
170911|NCT00195494|539560|P6|Year 2|System toxicity|0
170912|NCT00195494|539561|P5|Year 2|System toxicity|0
170913|NCT00195494|539562|P4|Year 2|System toxicity|1
170914|NCT00195494|539563|P3|Year 2|System toxicity|0
170915|NCT00195494|539564|P2|Year 2|System toxicity|0
170916|NCT00195494|539565|P1|Year 2|System toxicity|0
170917|NCT00195494|539560|P6|Year 2|Withdrawal by Subject|0
170918|NCT00195494|539561|P5|Year 2|Withdrawal by Subject|0
170919|NCT00195494|539562|P4|Year 2|Withdrawal by Subject|3
170920|NCT00195494|539563|P3|Year 2|Withdrawal by Subject|4
170921|NCT00195494|539564|P2|Year 2|Withdrawal by Subject|5
170922|NCT00195494|539565|P1|Year 2|Withdrawal by Subject|1
170923|NCT00195494|539560|P6|Year 2|Physician Decision|0
170924|NCT00195494|539561|P5|Year 2|Physician Decision|0
170925|NCT00195494|539562|P4|Year 2|Physician Decision|0
170926|NCT00195494|539563|P3|Year 2|Physician Decision|0
170927|NCT00195494|539564|P2|Year 2|Physician Decision|1
170928|NCT00195494|539565|P1|Year 2|Physician Decision|1
170929|NCT00195494|539560|P6|Year 2|Protocol deviation|0
170930|NCT00195494|539561|P5|Year 2|Protocol deviation|0
170931|NCT00195494|539562|P4|Year 2|Protocol deviation|0
170932|NCT00195494|539563|P3|Year 2|Protocol deviation|0
170933|NCT00195494|539564|P2|Year 2|Protocol deviation|1
170934|NCT00195494|539565|P1|Year 2|Protocol deviation|0
170935|NCT00195494|539560|P6|Year 2|Missed >4 consecutive doses|0
170936|NCT00195494|539561|P5|Year 2|Missed >4 consecutive doses|0
170937|NCT00195494|539562|P4|Year 2|Missed >4 consecutive doses|0
170938|NCT00195494|539563|P3|Year 2|Missed >4 consecutive doses|1
170939|NCT00195494|539564|P2|Year 2|Missed >4 consecutive doses|1
170940|NCT00195494|539565|P1|Year 2|Missed >4 consecutive doses|1
170941|NCT00195494|539560|P6|Year 2|Lost to Follow-up|0
170942|NCT00195494|539561|P5|Year 2|Lost to Follow-up|0
170943|NCT00195494|539562|P4|Year 2|Lost to Follow-up|1
170944|NCT00195494|539563|P3|Year 2|Lost to Follow-up|1
170945|NCT00195494|539564|P2|Year 2|Lost to Follow-up|0
170946|NCT00195494|539565|P1|Year 2|Lost to Follow-up|0
170947|NCT00195494|539560|P6|Year 2|Compliance|0
170948|NCT00195494|539561|P5|Year 2|Compliance|0
170949|NCT00195494|539562|P4|Year 2|Compliance|2
170950|NCT00195494|539563|P3|Year 2|Compliance|0
170951|NCT00195494|539564|P2|Year 2|Compliance|0
170952|NCT00195494|539565|P1|Year 2|Compliance|1
170953|NCT00195494|539560|P6|Year 2|Lack of Efficacy|0
170954|NCT00195494|539561|P5|Year 2|Lack of Efficacy|0
170955|NCT00195494|539562|P4|Year 2|Lack of Efficacy|7
170956|NCT00195494|539563|P3|Year 2|Lack of Efficacy|7
170957|NCT00195494|539564|P2|Year 2|Lack of Efficacy|1
170958|NCT00195494|539565|P1|Year 2|Lack of Efficacy|0
170959|NCT00195494|539560|P6|Year 2|Adverse Event|0
170960|NCT00195494|539561|P5|Year 2|Adverse Event|0
170961|NCT00195494|539562|P4|Year 2|Adverse Event|9
170962|NCT00195494|539563|P3|Year 2|Adverse Event|5
170963|NCT00195494|539564|P2|Year 2|Adverse Event|7
170964|NCT00195494|539565|P1|Year 2|Adverse Event|3
170965|NCT00195494|539560|P6|Year 1|Protocol Violation|1
170966|NCT00195494|539561|P5|Year 1|Protocol Violation|1
170967|NCT00195494|539562|P4|Year 1|Protocol Violation|0
170968|NCT00195494|539563|P3|Year 1|Protocol Violation|0
170969|NCT00195494|539564|P2|Year 1|Protocol Violation|0
170970|NCT00195494|539565|P1|Year 1|Protocol Violation|0
170971|NCT00195494|539560|P6|Year 1|Withdrawal by Subject|9
170972|NCT00195494|539561|P5|Year 1|Withdrawal by Subject|8
170973|NCT00195494|539562|P4|Year 1|Withdrawal by Subject|0
170974|NCT00195494|539563|P3|Year 1|Withdrawal by Subject|0
170975|NCT00195494|539564|P2|Year 1|Withdrawal by Subject|0
170976|NCT00195494|539565|P1|Year 1|Withdrawal by Subject|0
170977|NCT00195494|539560|P6|Year 1|Physician Decision|0
170978|NCT00195494|539561|P5|Year 1|Physician Decision|1
170979|NCT00195494|539562|P4|Year 1|Physician Decision|0
170980|NCT00195494|539563|P3|Year 1|Physician Decision|0
170981|NCT00195494|539564|P2|Year 1|Physician Decision|0
170982|NCT00195494|539565|P1|Year 1|Physician Decision|0
170983|NCT00195494|539560|P6|Year 1|Protocol deviation|3
170984|NCT00195494|539561|P5|Year 1|Protocol deviation|2
170985|NCT00195494|539562|P4|Year 1|Protocol deviation|0
170986|NCT00195494|539563|P3|Year 1|Protocol deviation|0
170987|NCT00195494|539564|P2|Year 1|Protocol deviation|0
170988|NCT00195494|539565|P1|Year 1|Protocol deviation|0
170989|NCT00195494|539560|P6|Year 1|Missed >4 consecutive doses|2
170990|NCT00195494|539561|P5|Year 1|Missed >4 consecutive doses|3
170991|NCT00195494|539562|P4|Year 1|Missed >4 consecutive doses|0
170992|NCT00195494|539563|P3|Year 1|Missed >4 consecutive doses|0
170993|NCT00195494|539564|P2|Year 1|Missed >4 consecutive doses|0
170994|NCT00195494|539565|P1|Year 1|Missed >4 consecutive doses|0
170995|NCT00195494|539560|P6|Year 1|Lost to Follow-up|0
170996|NCT00195494|539561|P5|Year 1|Lost to Follow-up|1
170997|NCT00195494|539562|P4|Year 1|Lost to Follow-up|0
170998|NCT00195494|539563|P3|Year 1|Lost to Follow-up|0
170999|NCT00195494|539564|P2|Year 1|Lost to Follow-up|0
171000|NCT00195494|539565|P1|Year 1|Lost to Follow-up|0
171001|NCT00195494|539560|P6|Year 1|Compliance|1
171002|NCT00195494|539561|P5|Year 1|Compliance|5
171003|NCT00195494|539562|P4|Year 1|Compliance|0
171004|NCT00195494|539563|P3|Year 1|Compliance|0
171005|NCT00195494|539564|P2|Year 1|Compliance|0
171006|NCT00195494|539565|P1|Year 1|Compliance|0
171007|NCT00195494|539560|P6|Year 1|Lack of Efficacy|9
171008|NCT00195494|539561|P5|Year 1|Lack of Efficacy|24
171009|NCT00195494|539562|P4|Year 1|Lack of Efficacy|0
171010|NCT00195494|539563|P3|Year 1|Lack of Efficacy|0
171011|NCT00195494|539564|P2|Year 1|Lack of Efficacy|0
171012|NCT00195494|539565|P1|Year 1|Lack of Efficacy|0
171013|NCT00195494|539560|P6|Year 1|System Toxicity|1
171014|NCT00195494|539561|P5|Year 1|System Toxicity|0
171015|NCT00195494|539562|P4|Year 1|System Toxicity|0
171016|NCT00195494|539563|P3|Year 1|System Toxicity|0
171017|NCT00195494|539564|P2|Year 1|System Toxicity|0
171018|NCT00195494|539565|P1|Year 1|System Toxicity|0
171019|NCT00195494|539560|P6|Year 1|Adverse Event|27
171020|NCT00195494|539561|P5|Year 1|Adverse Event|34
171021|NCT00195494|539562|P4|Year 1|Adverse Event|0
171022|NCT00195494|539563|P3|Year 1|Adverse Event|0
171023|NCT00195494|539564|P2|Year 1|Adverse Event|0
171024|NCT00195494|539565|P1|Year 1|Adverse Event|0
171025|NCT00195442|539583|P1|Overall Study|Other|14
171026|NCT00195442|539583|P1|Overall Study|Poor cooperation|2
171027|NCT00195442|539583|P1|Overall Study|No reason specified|4
171028|NCT00195442|539583|P1|Overall Study|Death|7
171029|NCT00195442|539583|P1|Overall Study|Intermittent product shortage|21
171030|NCT00195442|539583|P1|Overall Study|Switch to other Factor VIII preparation|23
171031|NCT00195442|539583|P1|Overall Study|Lost to Follow-up|27
171032|NCT00195442|539583|P1|Overall Study|Less than expected therapeutic effect|38
171033|NCT00195429|539602|P2|Overall Study|Lost to Follow-up|0
171034|NCT00195429|539603|P1|Overall Study|Lost to Follow-up|1
171035|NCT00195429|539602|P2|Overall Study|Lack of Efficacy|1
171036|NCT00195429|539603|P1|Overall Study|Lack of Efficacy|2
171037|NCT00195429|539602|P2|Overall Study|Adverse Event|4
171038|NCT00195429|539603|P1|Overall Study|Adverse Event|2
171039|NCT00195351|539619|P2|Overall Study|Lack of Efficacy|1
171040|NCT00195351|539620|P1|Overall Study|Lack of Efficacy|0
171041|NCT00195351|539619|P2|Overall Study|Death|1
171042|NCT00195351|539620|P1|Overall Study|Death|3
171043|NCT00195351|539619|P2|Overall Study|Protocol Deviation|2
171044|NCT00195351|539620|P1|Overall Study|Protocol Deviation|3
171045|NCT00195351|539619|P2|Overall Study|Withdrawal by Subject|3
171046|NCT00195351|539620|P1|Overall Study|Withdrawal by Subject|6
171047|NCT00195351|539619|P2|Overall Study|Lost to Follow-up|9
171048|NCT00195351|539620|P1|Overall Study|Lost to Follow-up|9
171049|NCT00195338|539630|P1|Overall Study|Early closure of the site|4
171050|NCT00195338|539630|P1|Overall Study|Lack of Efficacy|1
171051|NCT00195338|539630|P1|Overall Study|Adverse Event|5
171052|NCT00195338|539630|P1|Overall Study|Lost to Follow-up|2
171053|NCT00195273|539640|P2|Overall Study|Procedural complications|3
171054|NCT00195273|539641|P1|Overall Study|Procedural complications|9
171055|NCT00195273|539640|P2|Overall Study|Lack of Efficacy|1
171056|NCT00195273|539641|P1|Overall Study|Lack of Efficacy|3
171057|NCT00195273|539640|P2|Overall Study|Protocol deviation|1
171058|NCT00195273|539641|P1|Overall Study|Protocol deviation|0
171059|NCT00195273|539640|P2|Overall Study|Adverse Event|9
171060|NCT00195273|539641|P1|Overall Study|Adverse Event|9
171061|NCT00195260|539655|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|3
171062|NCT00195260|539656|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|4
171063|NCT00195260|539657|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|6
171064|NCT00195260|539658|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
171065|NCT00195260|539659|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
171066|NCT00195260|539660|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
171067|NCT00195260|539661|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
171068|NCT00195260|539662|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
171069|NCT00195260|539663|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
171070|NCT00195260|539664|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
171071|NCT00195260|539665|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
171072|NCT00195260|539655|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
171073|NCT00195260|539656|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
171074|NCT00195260|539657|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
171075|NCT00195260|539658|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
171076|NCT00195260|539659|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
171077|NCT00195260|539660|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
171078|NCT00195260|539661|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
171079|NCT00195260|539662|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
171080|NCT00195260|539663|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
171081|NCT00195260|539664|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
171082|NCT00195260|539665|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
171083|NCT00195260|539655|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
171084|NCT00195260|539656|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
171085|NCT00195260|539657|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
171086|NCT00195260|539658|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
171087|NCT00195260|539659|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
171088|NCT00195260|539660|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
171089|NCT00195260|539661|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
171090|NCT00195260|539662|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
171091|NCT00195260|539663|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
171092|NCT00195260|539664|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
171093|NCT00195260|539665|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
171094|NCT00195260|539655|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
171095|NCT00195260|539656|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
171096|NCT00195260|539657|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
171097|NCT00195260|539658|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
171098|NCT00195260|539659|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
171099|NCT00195260|539660|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
171100|NCT00195260|539661|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
171101|NCT00195260|539662|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
171102|NCT00195260|539663|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
171103|NCT00195260|539664|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
171104|NCT00195260|539665|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
171105|NCT00195260|539655|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
171106|NCT00195260|539656|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
171107|NCT00195260|539657|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
171108|NCT00195260|539658|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
171109|NCT00195260|539659|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
171110|NCT00195260|539660|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
171111|NCT00195260|539661|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
171112|NCT00195260|539662|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
171113|NCT00195260|539663|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
171114|NCT00195260|539664|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
171115|NCT00195260|539665|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
171116|NCT00195260|539655|P11|Part 1: Dose Escalation|Disease Progression|0
171117|NCT00195260|539656|P10|Part 1: Dose Escalation|Disease Progression|0
171118|NCT00195260|539657|P9|Part 1: Dose Escalation|Disease Progression|0
171119|NCT00195260|539658|P8|Part 1: Dose Escalation|Disease Progression|4
171120|NCT00195260|539659|P7|Part 1: Dose Escalation|Disease Progression|7
171121|NCT00195260|539660|P6|Part 1: Dose Escalation|Disease Progression|6
171122|NCT00195260|539661|P5|Part 1: Dose Escalation|Disease Progression|4
171123|NCT00195260|539662|P4|Part 1: Dose Escalation|Disease Progression|6
171124|NCT00195260|539663|P3|Part 1: Dose Escalation|Disease Progression|5
171125|NCT00195260|539664|P2|Part 1: Dose Escalation|Disease Progression|2
171126|NCT00195260|539665|P1|Part 1: Dose Escalation|Disease Progression|3
171127|NCT00195260|539655|P11|Part 1: Dose Escalation|Death|0
171128|NCT00195260|539656|P10|Part 1: Dose Escalation|Death|0
171129|NCT00195260|539657|P9|Part 1: Dose Escalation|Death|0
171130|NCT00195260|539658|P8|Part 1: Dose Escalation|Death|1
171131|NCT00195260|539659|P7|Part 1: Dose Escalation|Death|0
171132|NCT00195260|539660|P6|Part 1: Dose Escalation|Death|0
171133|NCT00195260|539661|P5|Part 1: Dose Escalation|Death|0
171134|NCT00195260|539662|P4|Part 1: Dose Escalation|Death|0
171135|NCT00195260|539663|P3|Part 1: Dose Escalation|Death|0
171136|NCT00195260|539664|P2|Part 1: Dose Escalation|Death|0
171137|NCT00195260|539665|P1|Part 1: Dose Escalation|Death|0
171138|NCT00195260|539655|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
171139|NCT00195260|539656|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
171140|NCT00195260|539657|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
171141|NCT00195260|539658|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
171142|NCT00195260|539659|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
171143|NCT00195260|539660|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
171144|NCT00195260|539661|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
171145|NCT00195260|539662|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
171146|NCT00195260|539663|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
171147|NCT00195260|539664|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
171148|NCT00195260|539665|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
171149|NCT00195260|539655|P11|Part 1: Dose Escalation|Adverse Event|0
171150|NCT00195260|539656|P10|Part 1: Dose Escalation|Adverse Event|0
171151|NCT00195260|539657|P9|Part 1: Dose Escalation|Adverse Event|0
171152|NCT00195260|539658|P8|Part 1: Dose Escalation|Adverse Event|0
171153|NCT00195260|539659|P7|Part 1: Dose Escalation|Adverse Event|3
171154|NCT00195260|539660|P6|Part 1: Dose Escalation|Adverse Event|0
171155|NCT00195260|539661|P5|Part 1: Dose Escalation|Adverse Event|1
171156|NCT00195260|539662|P4|Part 1: Dose Escalation|Adverse Event|1
171157|NCT00195260|539663|P3|Part 1: Dose Escalation|Adverse Event|0
171158|NCT00195260|539664|P2|Part 1: Dose Escalation|Adverse Event|1
171159|NCT00195260|539665|P1|Part 1: Dose Escalation|Adverse Event|0
171160|NCT00194675|539834|P2|Overall Study|Death|0
171161|NCT00194675|539835|P1|Overall Study|Death|1
171162|NCT00194675|539834|P2|Overall Study|Protocol Violation|0
171163|NCT00194675|539835|P1|Overall Study|Protocol Violation|1
171164|NCT00194675|539834|P2|Overall Study|"withdrew due to edgy feeling"|0
171165|NCT00194675|539835|P1|Overall Study|"withdrew due to edgy feeling"|1
171166|NCT00194675|539834|P2|Overall Study|lack of interest|1
171167|NCT00194675|539835|P1|Overall Study|lack of interest|1
171168|NCT00194675|539834|P2|Overall Study|Lost to Follow-up|1
171169|NCT00194675|539835|P1|Overall Study|Lost to Follow-up|1
171170|NCT00194077|539882|P2|Overall Study|Withdrawal by Subject|1
171171|NCT00194077|539883|P1|Overall Study|Withdrawal by Subject|1
171172|NCT00194077|539882|P2|Overall Study|Study nonadherence|0
171173|NCT00194077|539883|P1|Overall Study|Study nonadherence|1
171174|NCT00194077|539882|P2|Overall Study|Lack of Efficacy|29
171175|NCT00194077|539883|P1|Overall Study|Lack of Efficacy|22
171176|NCT00194025|539889|P1|Overall Study|non-adherence with study medication|4
171177|NCT00194025|539889|P1|Overall Study|Adverse Event|1
171178|NCT00194012|539904|P2|Open Label Extension|Pregnancy|1
171179|NCT00194012|539905|P1|Open Label Extension|Pregnancy|1
171180|NCT00194012|539904|P2|Open Label Extension|Withdrawal by Subject|1
171181|NCT00194012|539905|P1|Open Label Extension|Withdrawal by Subject|2
171182|NCT00194012|539904|P2|Open Label Extension|Study nonadherence|4
171183|NCT00194012|539905|P1|Open Label Extension|Study nonadherence|1
171184|NCT00194012|539904|P2|Open Label Extension|Lack of Efficacy|1
171185|NCT00194012|539905|P1|Open Label Extension|Lack of Efficacy|2
171186|NCT00194012|539904|P2|Randomized Phase|Adverse Event|1
171187|NCT00194012|539905|P1|Randomized Phase|Adverse Event|2
171188|NCT00194012|539904|P2|Randomized Phase|Withdrawal by Subject|3
171189|NCT00194012|539905|P1|Randomized Phase|Withdrawal by Subject|3
171190|NCT00194012|539904|P2|Randomized Phase|Study nonadherence|1
171191|NCT00194012|539905|P1|Randomized Phase|Study nonadherence|2
171192|NCT00194012|539904|P2|Randomized Phase|Lack of Efficacy|18
171193|NCT00194012|539905|P1|Randomized Phase|Lack of Efficacy|8
171194|NCT00193609|539913|P1|Overall Study|Adverse Event|2
171195|NCT00193609|539913|P1|Overall Study|Lack of Efficacy|2
171196|NCT00193479|539940|P1|Induction Chemotherapy|Disease Progression|1
171197|NCT00193479|539940|P1|Induction Chemotherapy|Adverse Event|2
171198|NCT00193206|539981|P1|Postoperative Therapy|Protocol Violation|1
171199|NCT00193206|539981|P1|Postoperative Therapy|Lack of Efficacy|1
171200|NCT00193206|539981|P1|Postoperative Therapy|Intercurrent Illness|2
171201|NCT00193206|539981|P1|Postoperative Therapy|Physician Decision|3
171202|NCT00193206|539981|P1|Postoperative Therapy|Withdrawal by Subject|7
171203|NCT00193206|539981|P1|Preoperative Therapy|False Positive Pregnancy Test|1
171204|NCT00193206|539981|P1|Preoperative Therapy|Withdrawal by Subject|2
171205|NCT00193206|539981|P1|Preoperative Therapy|Adverse Event|2
171206|NCT00193206|539981|P1|Preoperative Therapy|Lack of Efficacy|2
171207|NCT00193180|539985|P1|Overall Study|Protocol Violation|1
171208|NCT00193180|539985|P1|Overall Study|Adverse Event|8
171209|NCT00193180|539985|P1|Overall Study|Lack of Efficacy|1
171210|NCT00193063|540000|P1|Overall Study|Adverse Event|1
171211|NCT00193063|540000|P1|Overall Study|Lack of Efficacy|3
171212|NCT00193050|540006|P1|Adjuvant|Lack of Efficacy|2
171213|NCT00193050|540006|P1|Adjuvant|Intercurrent Hospitalization|3
171214|NCT00193050|540006|P1|Adjuvant|Physician Decision|5
171215|NCT00193050|540006|P1|Neoadjuvant Treatment|Adverse Event|2
171216|NCT00193050|540006|P1|Neoadjuvant Treatment|Physician Decision|2
171217|NCT00193050|540006|P1|Neoadjuvant Treatment|Intercurrent Illness|3
171218|NCT00193050|540006|P1|Neoadjuvant Treatment|Lack of Efficacy|2
171219|NCT00192296|540025|P4|Overall Study|Withdrawal by Subject|0
171220|NCT00192296|540026|P3|Overall Study|Withdrawal by Subject|0
171221|NCT00192296|540027|P2|Overall Study|Withdrawal by Subject|1
171222|NCT00192296|540028|P1|Overall Study|Withdrawal by Subject|0
171223|NCT00192647|540084|P2|Overall Study|Other/Administrative|3
171224|NCT00192647|540085|P1|Overall Study|Other/Administrative|5
171225|NCT00192647|540084|P2|Overall Study|Failure to Return|13
171226|NCT00192647|540085|P1|Overall Study|Failure to Return|11
171227|NCT00192647|540084|P2|Overall Study|Refused Treatment/Did not Cooperate|8
171228|NCT00192647|540085|P1|Overall Study|Refused Treatment/Did not Cooperate|10
171229|NCT00192647|540084|P2|Overall Study|Protocol Violation|1
171230|NCT00192647|540085|P1|Overall Study|Protocol Violation|3
171231|NCT00192647|540084|P2|Overall Study|Entry Criteria Violation|6
171232|NCT00192647|540085|P1|Overall Study|Entry Criteria Violation|6
171233|NCT00192647|540084|P2|Overall Study|Insufficient Therapeutic Response|83
171234|NCT00192647|540085|P1|Overall Study|Insufficient Therapeutic Response|53
171235|NCT00192647|540084|P2|Overall Study|Laboratory Test Abnormality|2
171236|NCT00192647|540085|P1|Overall Study|Laboratory Test Abnormality|4
171237|NCT00192647|540084|P2|Overall Study|Adverse Event|29
171238|NCT00192647|540085|P1|Overall Study|Adverse Event|35
171239|NCT00192647|540084|P2|Overall Study|Death|1
171240|NCT00192647|540085|P1|Overall Study|Death|1
171241|NCT00192075|540103|P2|Overall Study|Other|2
171242|NCT00192075|540104|P1|Overall Study|Other|5
171243|NCT00192075|540103|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
171244|NCT00192075|540104|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
171245|NCT00192075|540103|P2|Overall Study|Patient Non-Compliance|1
171246|NCT00192075|540104|P1|Overall Study|Patient Non-Compliance|0
171247|NCT00192075|540103|P2|Overall Study|Withdrawal by Subject|5
171248|NCT00192075|540104|P1|Overall Study|Withdrawal by Subject|5
171249|NCT00192075|540103|P2|Overall Study|Physician Decision|0
171250|NCT00192075|540104|P1|Overall Study|Physician Decision|3
171251|NCT00192075|540103|P2|Overall Study|Lack of Efficacy|0
171252|NCT00192075|540104|P1|Overall Study|Lack of Efficacy|0
171253|NCT00192075|540103|P2|Overall Study|Death|1
171254|NCT00192075|540104|P1|Overall Study|Death|0
171255|NCT00192075|540103|P2|Overall Study|Adverse Event|3
171256|NCT00192075|540104|P1|Overall Study|Adverse Event|1
171257|NCT00192075|540103|P2|Overall Study|Disease Progression|6
171258|NCT00192075|540104|P1|Overall Study|Disease Progression|23
171259|NCT00192036|540129|P1|Overall Study|Unknown or Not Specified|5
171260|NCT00192036|540129|P1|Overall Study|Death|1
171261|NCT00192036|540129|P1|Overall Study|Clinical Disease Progression|1
171262|NCT00192036|540129|P1|Overall Study|Objective Tumor Progression|4
171263|NCT00192036|540129|P1|Overall Study|Patient/Physician Perception|1
171264|NCT00192036|540129|P1|Overall Study|Adverse Event|6
171265|NCT00192036|540129|P1|Overall Study|Protocol Violation|3
171266|NCT00192023|540139|P2|Period IV - Optional Open-Label|Physician Decision|0
171267|NCT00192023|540140|P1|Period IV - Optional Open-Label|Physician Decision|9
171268|NCT00192023|540139|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
171269|NCT00192023|540140|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
171270|NCT00192023|540139|P2|Period IV - Optional Open-Label|Protocol Violation|0
171271|NCT00192023|540140|P1|Period IV - Optional Open-Label|Protocol Violation|1
171272|NCT00192023|540139|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
171273|NCT00192023|540140|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
171274|NCT00192023|540139|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
171275|NCT00192023|540140|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
171276|NCT00192023|540139|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
171277|NCT00192023|540140|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
171278|NCT00192023|540139|P2|Period IV - Optional Open-Label|Adverse Event|0
171279|NCT00192023|540140|P1|Period IV - Optional Open-Label|Adverse Event|6
171280|NCT00192023|540139|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
171281|NCT00192023|540140|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
171282|NCT00192023|540139|P2|Period III - Double-Blind|Physician Decision|0
171283|NCT00192023|540140|P1|Period III - Double-Blind|Physician Decision|2
171284|NCT00192023|540139|P2|Period III - Double-Blind|Adverse Event|0
171285|NCT00192023|540140|P1|Period III - Double-Blind|Adverse Event|3
171286|NCT00191984|540162|P1|Overall Study|Physician Decision|4
171287|NCT00191984|540162|P1|Overall Study|Withdrawal by Subject|7
171288|NCT00191984|540162|P1|Overall Study|Entry Criteria Exclusion|1
171289|NCT00191984|540162|P1|Overall Study|Death|2
171290|NCT00191984|540162|P1|Overall Study|Adverse Event|4
171291|NCT00191984|540162|P1|Overall Study|Disease Progression|21
171292|NCT00191945|540172|P2|Double-Blind Acute Treatment|Physician Decision|2
171293|NCT00191945|540173|P1|Double-Blind Acute Treatment|Physician Decision|0
171294|NCT00191945|540172|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
171295|NCT00191945|540173|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
171296|NCT00191945|540172|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
171297|NCT00191945|540173|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
171298|NCT00191945|540172|P2|Double-Blind Acute Treatment|Parent's Decision|0
171299|NCT00191945|540173|P1|Double-Blind Acute Treatment|Parent's Decision|3
171300|NCT00191906|540209|P4|Study Period III|Lack of Efficacy|0
171301|NCT00191906|540210|P3|Study Period III|Lack of Efficacy|0
171302|NCT00191906|540211|P2|Study Period III|Lack of Efficacy|3
171303|NCT00191906|540212|P1|Study Period III|Lack of Efficacy|3
171304|NCT00191906|540209|P4|Study Period III|Parent/Caregiver Decision|0
171305|NCT00191906|540210|P3|Study Period III|Parent/Caregiver Decision|0
171306|NCT00191906|540211|P2|Study Period III|Parent/Caregiver Decision|0
171307|NCT00191906|540212|P1|Study Period III|Parent/Caregiver Decision|1
171308|NCT00191906|540209|P4|Study Period III|Lost to Follow-up|0
171309|NCT00191906|540210|P3|Study Period III|Lost to Follow-up|0
171310|NCT00191906|540211|P2|Study Period III|Lost to Follow-up|1
171311|NCT00191906|540212|P1|Study Period III|Lost to Follow-up|0
171312|NCT00191906|540209|P4|Study Period III|Adverse Event|0
171313|NCT00191906|540210|P3|Study Period III|Adverse Event|0
171314|NCT00191906|540211|P2|Study Period III|Adverse Event|0
171315|NCT00191906|540212|P1|Study Period III|Adverse Event|1
171316|NCT00191906|540209|P4|Study Period II|Entry Criteria Exclusion|0
171317|NCT00191906|540210|P3|Study Period II|Entry Criteria Exclusion|1
171318|NCT00191906|540211|P2|Study Period II|Entry Criteria Exclusion|0
171319|NCT00191906|540212|P1|Study Period II|Entry Criteria Exclusion|0
171320|NCT00191906|540209|P4|Study Period II|Parent/Caregiver Decision|0
171321|NCT00191906|540210|P3|Study Period II|Parent/Caregiver Decision|0
171322|NCT00191906|540211|P2|Study Period II|Parent/Caregiver Decision|1
171323|NCT00191906|540212|P1|Study Period II|Parent/Caregiver Decision|0
171324|NCT00191906|540209|P4|Study Period II|Withdrawal by Subject|0
171325|NCT00191906|540210|P3|Study Period II|Withdrawal by Subject|0
171326|NCT00191906|540211|P2|Study Period II|Withdrawal by Subject|3
171327|NCT00191906|540212|P1|Study Period II|Withdrawal by Subject|0
171328|NCT00191906|540209|P4|Study Period II|Adverse Event|0
171329|NCT00191906|540210|P3|Study Period II|Adverse Event|0
171330|NCT00191906|540211|P2|Study Period II|Adverse Event|1
171331|NCT00191906|540212|P1|Study Period II|Adverse Event|0
171332|NCT00191854|540255|P3|Overall Study|Screen Failure|1
171333|NCT00191854|540256|P2|Overall Study|Screen Failure|0
171334|NCT00191854|540257|P1|Overall Study|Screen Failure|0
171335|NCT00191854|540255|P3|Overall Study|Sponsor Decision|1
171336|NCT00191854|540256|P2|Overall Study|Sponsor Decision|0
171337|NCT00191854|540257|P1|Overall Study|Sponsor Decision|0
171338|NCT00191854|540255|P3|Overall Study|Withdrawal by Subject|3
171339|NCT00191854|540256|P2|Overall Study|Withdrawal by Subject|2
171340|NCT00191854|540257|P1|Overall Study|Withdrawal by Subject|4
171341|NCT00191854|540255|P3|Overall Study|Lost to Follow-up|5
171342|NCT00191854|540256|P2|Overall Study|Lost to Follow-up|5
171343|NCT00191854|540257|P1|Overall Study|Lost to Follow-up|7
171344|NCT00191854|540255|P3|Overall Study|Death|29
171345|NCT00191854|540256|P2|Overall Study|Death|23
171346|NCT00191854|540257|P1|Overall Study|Death|26
171347|NCT00191815|540277|P1|Overall Study|Withdrawal by Subject|7
171348|NCT00191815|540277|P1|Overall Study|Physician Decision|2
171349|NCT00191815|540277|P1|Overall Study|Protocol Violation|3
171350|NCT00191815|540277|P1|Overall Study|Death|2
171351|NCT00191815|540277|P1|Overall Study|Disease progression or relapse|24
171352|NCT00191815|540277|P1|Overall Study|Adverse Event|2
171353|NCT00191789|540289|P1|Overall Study|Death - Not Study-Drug Related|1
171354|NCT00191789|540289|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
171355|NCT00191789|540289|P1|Overall Study|Death - Possibly Study Drug Related|4
171356|NCT00191789|540289|P1|Overall Study|Withdrawal by Subject|4
171357|NCT00191789|540289|P1|Overall Study|Patient/Physician: Satisfactory Response|4
171358|NCT00191789|540289|P1|Overall Study|Patient: Satisfactory Response|5
171359|NCT00191789|540289|P1|Overall Study|Adverse Event|5
171360|NCT00191724|540306|P5|Overall Study|Withdrawal by Subject|0
171361|NCT00191724|540307|P4|Overall Study|Withdrawal by Subject|1
171362|NCT00191724|540308|P3|Overall Study|Withdrawal by Subject|0
171363|NCT00191724|540309|P2|Overall Study|Withdrawal by Subject|0
171364|NCT00191724|540310|P1|Overall Study|Withdrawal by Subject|0
171365|NCT00191724|540306|P5|Overall Study|Lost to Follow-up|3
171366|NCT00191724|540307|P4|Overall Study|Lost to Follow-up|2
171367|NCT00191724|540308|P3|Overall Study|Lost to Follow-up|0
171368|NCT00191724|540309|P2|Overall Study|Lost to Follow-up|1
171369|NCT00191724|540310|P1|Overall Study|Lost to Follow-up|1
171370|NCT00191724|540306|P5|Overall Study|Adverse Event|0
171371|NCT00191724|540307|P4|Overall Study|Adverse Event|0
171372|NCT00191724|540308|P3|Overall Study|Adverse Event|1
171373|NCT00191724|540309|P2|Overall Study|Adverse Event|0
171374|NCT00191724|540310|P1|Overall Study|Adverse Event|0
171375|NCT00191646|540339|P2|Overall Study|Missing Data|11
171376|NCT00191646|540340|P1|Overall Study|Missing Data|18
171377|NCT00191646|540339|P2|Overall Study|Other|34
171378|NCT00191646|540340|P1|Overall Study|Other|33
171379|NCT00191646|540339|P2|Overall Study|Death|8
171380|NCT00191646|540340|P1|Overall Study|Death|6
171381|NCT00191646|540339|P2|Overall Study|Protocol Violation|7
171382|NCT00191646|540340|P1|Overall Study|Protocol Violation|5
171383|NCT00191646|540339|P2|Overall Study|Withdrawal by Subject|39
171384|NCT00191646|540340|P1|Overall Study|Withdrawal by Subject|58
171385|NCT00191646|540339|P2|Overall Study|Physician Decision|11
171386|NCT00191646|540340|P1|Overall Study|Physician Decision|20
171387|NCT00191646|540339|P2|Overall Study|Disease Progression|6
171388|NCT00191646|540340|P1|Overall Study|Disease Progression|5
171389|NCT00191646|540339|P2|Overall Study|Toxicity|37
171390|NCT00191646|540340|P1|Overall Study|Toxicity|26
171391|NCT00191477|540360|P2|Overall Study|Discontinued Prior to Instillation|14
171392|NCT00191477|540361|P1|Overall Study|Discontinued Prior to Instillation|13
171393|NCT00191477|540360|P2|Overall Study|Pathological Specimen Lost|0
171394|NCT00191477|540361|P1|Overall Study|Pathological Specimen Lost|1
171395|NCT00191477|540360|P2|Overall Study|Not Eligible|38
171396|NCT00191477|540361|P1|Overall Study|Not Eligible|41
171397|NCT00191477|540360|P2|Overall Study|Unspecified|0
171398|NCT00191477|540361|P1|Overall Study|Unspecified|2
171399|NCT00191477|540360|P2|Overall Study|Withdrawal by Subject|0
171400|NCT00191477|540361|P1|Overall Study|Withdrawal by Subject|2
171401|NCT00191477|540360|P2|Overall Study|Treatment Change|0
171402|NCT00191477|540361|P1|Overall Study|Treatment Change|2
171403|NCT00191477|540360|P2|Overall Study|Protocol Violation|1
171404|NCT00191477|540361|P1|Overall Study|Protocol Violation|1
171405|NCT00191477|540360|P2|Overall Study|Lost to Follow-up|21
171406|NCT00191477|540361|P1|Overall Study|Lost to Follow-up|23
171407|NCT00191477|540360|P2|Overall Study|Death, Other Cause|6
171408|NCT00191477|540361|P1|Overall Study|Death, Other Cause|3
171409|NCT00191477|540360|P2|Overall Study|Death, Study Disease|1
171410|NCT00191477|540361|P1|Overall Study|Death, Study Disease|1
171411|NCT00191477|540360|P2|Overall Study|Tumor Recurrence|48
171412|NCT00191477|540361|P1|Overall Study|Tumor Recurrence|49
171413|NCT00191451|540380|P3|Overall Study|Reason Not Specified|3
171414|NCT00191451|540381|P2|Overall Study|Reason Not Specified|1
171415|NCT00191451|540382|P1|Overall Study|Reason Not Specified|2
171416|NCT00191451|540380|P3|Overall Study|Ineligible|0
171417|NCT00191451|540381|P2|Overall Study|Ineligible|1
171418|NCT00191451|540382|P1|Overall Study|Ineligible|0
171419|NCT00191451|540380|P3|Overall Study|Sponsor Decision|0
171420|NCT00191451|540381|P2|Overall Study|Sponsor Decision|0
171421|NCT00191451|540382|P1|Overall Study|Sponsor Decision|1
171422|NCT00191451|540380|P3|Overall Study|Physician Decision|6
171423|NCT00191451|540381|P2|Overall Study|Physician Decision|9
171424|NCT00191451|540382|P1|Overall Study|Physician Decision|2
171425|NCT00191451|540380|P3|Overall Study|Withdrawal by Subject|5
171426|NCT00191451|540381|P2|Overall Study|Withdrawal by Subject|3
171427|NCT00191451|540382|P1|Overall Study|Withdrawal by Subject|2
171428|NCT00191386|540402|P1|Overall Study|Lack of Efficacy|15
171429|NCT00191386|540402|P1|Overall Study|Physician Decision|11
171430|NCT00191386|540402|P1|Overall Study|Withdrawal by Subject|96
171431|NCT00191386|540402|P1|Overall Study|Protocol Violation|18
171432|NCT00191386|540402|P1|Overall Study|Entry Criteria Exclusion|3
171433|NCT00191386|540402|P1|Overall Study|Lost to Follow-up|1
171434|NCT00191386|540402|P1|Overall Study|Adverse Event|16
171435|NCT00191334|540409|P1|Overall Study|Withdrawal by Subject|4
171436|NCT00191334|540409|P1|Overall Study|Physician Decision|1
171437|NCT00191334|540409|P1|Overall Study|Disease Progression or Relapse|8
171438|NCT00191334|540409|P1|Overall Study|Adverse Event|4
171439|NCT00191308|540417|P1|Overall Study|Adverse Event|1
171440|NCT00191282|540427|P2|Overall Study|Lost to Follow-up|31
171441|NCT00191282|540428|P1|Overall Study|Lost to Follow-up|24
171442|NCT00191282|540427|P2|Overall Study|Sponsor's decision|2
171443|NCT00191282|540428|P1|Overall Study|Sponsor's decision|2
171444|NCT00191282|540427|P2|Overall Study|Severity of outcome|5
171445|NCT00191282|540428|P1|Overall Study|Severity of outcome|2
171446|NCT00191282|540427|P2|Overall Study|Protocol Violation|12
171447|NCT00191282|540428|P1|Overall Study|Protocol Violation|9
171448|NCT00191282|540427|P2|Overall Study|Protocol entry criteria not met|9
171449|NCT00191282|540428|P1|Overall Study|Protocol entry criteria not met|14
171450|NCT00191282|540427|P2|Overall Study|Physician Decision|15
171451|NCT00191282|540428|P1|Overall Study|Physician Decision|18
171452|NCT00191282|540427|P2|Overall Study|Withdrawal by Subject|44
171453|NCT00191282|540428|P1|Overall Study|Withdrawal by Subject|59
171454|NCT00191282|540427|P2|Overall Study|Patient moved|14
171455|NCT00191282|540428|P1|Overall Study|Patient moved|11
171456|NCT00191282|540427|P2|Overall Study|Noncompliance|17
171457|NCT00191282|540428|P1|Overall Study|Noncompliance|14
171458|NCT00191282|540427|P2|Overall Study|Lack of Efficacy|6
171459|NCT00191282|540428|P1|Overall Study|Lack of Efficacy|11
171460|NCT00191282|540427|P2|Overall Study|Death|51
171461|NCT00191282|540428|P1|Overall Study|Death|51
171462|NCT00191282|540427|P2|Overall Study|Adverse Event|6
171463|NCT00191282|540428|P1|Overall Study|Adverse Event|5
171464|NCT00191269|540488|P2|Overall Study|Physician Decision|3
171465|NCT00191269|540489|P1|Overall Study|Physician Decision|0
171466|NCT00191269|540488|P2|Overall Study|Pathologic Aggrevation|1
171467|NCT00191269|540489|P1|Overall Study|Pathologic Aggrevation|0
171468|NCT00191269|540488|P2|Overall Study|Withdrawal by Subject|1
171469|NCT00191269|540489|P1|Overall Study|Withdrawal by Subject|0
171470|NCT00191269|540488|P2|Overall Study|Lack of Efficacy|5
171471|NCT00191269|540489|P1|Overall Study|Lack of Efficacy|1
171472|NCT00191269|540488|P2|Overall Study|Progression of Disease|42
171473|NCT00191269|540489|P1|Overall Study|Progression of Disease|4
171474|NCT00191269|540488|P2|Overall Study|Adverse Event|4
171475|NCT00191269|540489|P1|Overall Study|Adverse Event|1
171476|NCT00191269|540488|P2|Overall Study|Protocol Violation|2
171477|NCT00191269|540489|P1|Overall Study|Protocol Violation|0
171478|NCT00191191|540505|P2|Overall Study|Good Clinical Practice Violation|1
171479|NCT00191191|540506|P1|Overall Study|Good Clinical Practice Violation|0
171480|NCT00191191|540505|P2|Overall Study|Physician Decision|2
171481|NCT00191191|540506|P1|Overall Study|Physician Decision|3
171482|NCT00191191|540505|P2|Overall Study|Lost to Follow-up|0
171483|NCT00191191|540506|P1|Overall Study|Lost to Follow-up|1
171484|NCT00191191|540505|P2|Overall Study|Family/Caregiver Decision|7
171485|NCT00191191|540506|P1|Overall Study|Family/Caregiver Decision|5
171486|NCT00191191|540505|P2|Overall Study|Toxicity After Dose Reduction|8
171487|NCT00191191|540506|P1|Overall Study|Toxicity After Dose Reduction|7
171488|NCT00191191|540505|P2|Overall Study|Progressive Disease|72
171489|NCT00191191|540506|P1|Overall Study|Progressive Disease|84
171490|NCT00191191|540505|P2|Overall Study|Adverse Event|21
171491|NCT00191191|540506|P1|Overall Study|Adverse Event|11
171492|NCT00191191|540505|P2|Overall Study|Treated with Another Systemic Agent|1
171493|NCT00191191|540506|P1|Overall Study|Treated with Another Systemic Agent|1
171494|NCT00191191|540505|P2|Overall Study|Entry Criteria Exclusion|0
171495|NCT00191191|540506|P1|Overall Study|Entry Criteria Exclusion|2
171496|NCT00191165|540522|P2|Overall Study|Participant Moved Away|1
171497|NCT00191165|540523|P1|Overall Study|Participant Moved Away|0
171498|NCT00191165|540522|P2|Overall Study|Protocol Violation|1
171499|NCT00191165|540523|P1|Overall Study|Protocol Violation|0
171500|NCT00191165|540522|P2|Overall Study|Adverse Event|0
171501|NCT00191165|540523|P1|Overall Study|Adverse Event|2
171502|NCT00191152|540535|P2|Crossover Treatment|Not Specified|3
171503|NCT00191152|540536|P1|Crossover Treatment|Not Specified|4
171504|NCT00191152|540535|P2|Crossover Treatment|Lost to Follow-up|1
171505|NCT00191152|540536|P1|Crossover Treatment|Lost to Follow-up|2
171506|NCT00191152|540535|P2|Crossover Treatment|Withdrawal by Subject|9
171507|NCT00191152|540536|P1|Crossover Treatment|Withdrawal by Subject|6
171508|NCT00191152|540535|P2|Crossover Treatment|Physician Decision|7
171509|NCT00191152|540536|P1|Crossover Treatment|Physician Decision|7
171510|NCT00191152|540535|P2|Crossover Treatment|Adverse Event|8
171511|NCT00191152|540536|P1|Crossover Treatment|Adverse Event|8
171512|NCT00191152|540535|P2|Initial Treatment|not specified|21
171513|NCT00191152|540536|P1|Initial Treatment|not specified|18
171514|NCT00191152|540535|P2|Initial Treatment|Lost to Follow-up|6
171515|NCT00191152|540536|P1|Initial Treatment|Lost to Follow-up|0
171516|NCT00191152|540535|P2|Initial Treatment|Withdrawal by Subject|28
171517|NCT00191152|540536|P1|Initial Treatment|Withdrawal by Subject|40
171518|NCT00191152|540535|P2|Initial Treatment|Physician Decision|31
171519|NCT00191152|540536|P1|Initial Treatment|Physician Decision|40
171520|NCT00191152|540535|P2|Initial Treatment|Adverse Event|67
171521|NCT00191152|540536|P1|Initial Treatment|Adverse Event|43
171522|NCT00191139|540568|P2|Overall Study|Other|2
171523|NCT00191139|540569|P1|Overall Study|Other|1
171524|NCT00191139|540568|P2|Overall Study|Disease Progression|1
171525|NCT00191139|540569|P1|Overall Study|Disease Progression|0
171526|NCT00191139|540568|P2|Overall Study|Withdrawal by Subject|3
171527|NCT00191139|540569|P1|Overall Study|Withdrawal by Subject|0
171528|NCT00191139|540568|P2|Overall Study|Death|0
171529|NCT00191139|540569|P1|Overall Study|Death|2
171530|NCT00191139|540568|P2|Overall Study|Adverse Event|6
171531|NCT00191139|540569|P1|Overall Study|Adverse Event|2
171532|NCT00191113|540585|P2|Core Study|Death|0
171533|NCT00191113|540586|P1|Core Study|Death|1
171534|NCT00191113|540585|P2|Core Study|Lack of Efficacy|2
171535|NCT00191113|540586|P1|Core Study|Lack of Efficacy|0
171536|NCT00191113|540585|P2|Core Study|Adverse Event|2
171537|NCT00191113|540586|P1|Core Study|Adverse Event|0
171538|NCT00191113|540585|P2|Core Study|Lost to Follow-up|0
171539|NCT00191113|540586|P1|Core Study|Lost to Follow-up|3
171540|NCT00191113|540585|P2|Core Study|Protocol Violation|2
171541|NCT00191113|540586|P1|Core Study|Protocol Violation|6
171542|NCT00191113|540585|P2|Core Study|Withdrawal by Subject|9
171543|NCT00191113|540586|P1|Core Study|Withdrawal by Subject|25
171544|NCT00191100|540628|P2|Overall Study|Reason Not Specified|1
171545|NCT00191100|540629|P1|Overall Study|Reason Not Specified|0
171546|NCT00191100|540628|P2|Overall Study|Death from Other Cause|0
171547|NCT00191100|540629|P1|Overall Study|Death from Other Cause|1
171548|NCT00191100|540628|P2|Overall Study|Protocol Violation|1
171549|NCT00191100|540629|P1|Overall Study|Protocol Violation|1
171550|NCT00191100|540628|P2|Overall Study|Death from Study Drug Toxicity|0
171551|NCT00191100|540629|P1|Overall Study|Death from Study Drug Toxicity|2
171552|NCT00191100|540628|P2|Overall Study|Physician Decision|1
171553|NCT00191100|540629|P1|Overall Study|Physician Decision|3
171554|NCT00191100|540628|P2|Overall Study|Lack of Efficacy, Stable Disease|0
171555|NCT00191100|540629|P1|Overall Study|Lack of Efficacy, Stable Disease|1
171556|NCT00191100|540628|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
171557|NCT00191100|540629|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
171558|NCT00191100|540628|P2|Overall Study|Clinical Relapse|1
171559|NCT00191100|540629|P1|Overall Study|Clinical Relapse|2
171560|NCT00191100|540628|P2|Overall Study|Protocol Entry Criteria Not Met|1
171561|NCT00191100|540629|P1|Overall Study|Protocol Entry Criteria Not Met|2
171562|NCT00191100|540628|P2|Overall Study|Withdrawal by Subject|3
171563|NCT00191100|540629|P1|Overall Study|Withdrawal by Subject|9
171564|NCT00191100|540628|P2|Overall Study|Patient Moved|1
171565|NCT00191100|540629|P1|Overall Study|Patient Moved|0
171566|NCT00191100|540628|P2|Overall Study|Lost to Follow-up|0
171567|NCT00191100|540629|P1|Overall Study|Lost to Follow-up|2
171568|NCT00191100|540628|P2|Overall Study|Adverse Event|1
171569|NCT00191100|540629|P1|Overall Study|Adverse Event|18
171570|NCT00190983|540645|P1|Overall Study|Inevaluable (never treated)|2
171571|NCT00190775|540654|P2|Overall Study|Exclusion Criteria Met|3
171572|NCT00190775|540655|P1|Overall Study|Exclusion Criteria Met|1
171573|NCT00190775|540654|P2|Overall Study|Protocol Violation|1
171574|NCT00190775|540655|P1|Overall Study|Protocol Violation|0
171575|NCT00190775|540654|P2|Overall Study|Noncompliance|5
171576|NCT00190775|540655|P1|Overall Study|Noncompliance|3
171577|NCT00190775|540654|P2|Overall Study|Physician Decision|0
171578|NCT00190775|540655|P1|Overall Study|Physician Decision|3
171579|NCT00190775|540654|P2|Overall Study|Sponsor Decision|0
171580|NCT00190775|540655|P1|Overall Study|Sponsor Decision|1
171581|NCT00190775|540654|P2|Overall Study|Withdrawal by Subject|13
171582|NCT00190775|540655|P1|Overall Study|Withdrawal by Subject|24
171583|NCT00190775|540654|P2|Overall Study|Participant Moved|1
171584|NCT00190775|540655|P1|Overall Study|Participant Moved|0
171585|NCT00190775|540654|P2|Overall Study|Lost to Follow-up|23
171586|NCT00190775|540655|P1|Overall Study|Lost to Follow-up|31
171587|NCT00190775|540654|P2|Overall Study|Lack of Efficacy|32
171588|NCT00190775|540655|P1|Overall Study|Lack of Efficacy|28
171589|NCT00190775|540654|P2|Overall Study|Satisfactory Response|0
171590|NCT00190775|540655|P1|Overall Study|Satisfactory Response|1
171591|NCT00190775|540654|P2|Overall Study|Adverse Event|22
171592|NCT00190775|540655|P1|Overall Study|Adverse Event|57
171593|NCT00190749|540726|P2|Overall Study|Sponsor Decision|0
171594|NCT00190749|540727|P1|Overall Study|Sponsor Decision|1
171595|NCT00190749|540726|P2|Overall Study|Reason Not Specified|2
171596|NCT00190749|540727|P1|Overall Study|Reason Not Specified|0
171597|NCT00190749|540726|P2|Overall Study|Lack of Efficacy|3
171598|NCT00190749|540727|P1|Overall Study|Lack of Efficacy|2
171599|NCT00190749|540726|P2|Overall Study|Adverse Event|5
171600|NCT00190749|540727|P1|Overall Study|Adverse Event|0
171601|NCT00190749|540726|P2|Overall Study|Protocol Violation|4
171602|NCT00190749|540727|P1|Overall Study|Protocol Violation|5
171603|NCT00190749|540726|P2|Overall Study|Withdrawal by Subject|6
171604|NCT00190749|540727|P1|Overall Study|Withdrawal by Subject|10
171605|NCT00190749|540726|P2|Overall Study|Lost to Follow-up|11
171606|NCT00190749|540727|P1|Overall Study|Lost to Follow-up|8
171607|NCT00190684|540791|P1|Overall Study|Study Period V Completed|1
171608|NCT00190684|540791|P1|Overall Study|Study Period III Completed|103
171609|NCT00190684|540791|P1|Overall Study|Protocol Violation|123
171610|NCT00190684|540791|P1|Overall Study|Physician Decision|84
171611|NCT00190684|540791|P1|Overall Study|Sponsor's decision|17
171612|NCT00190684|540791|P1|Overall Study|Clinical relapse|67
171613|NCT00190684|540791|P1|Overall Study|Patient Decision|432
171614|NCT00190684|540791|P1|Overall Study|Patient moved|60
171615|NCT00190684|540791|P1|Overall Study|Lost to Follow-up|232
171616|NCT00190684|540791|P1|Overall Study|Lack of efficacy|204
171617|NCT00190684|540791|P1|Overall Study|Satisfactory response|80
171618|NCT00190684|540791|P1|Overall Study|Adverse Event|86
171619|NCT00190671|540812|P2|Overall Study|Withdrawal by Subject|2
171620|NCT00190671|540813|P1|Overall Study|Withdrawal by Subject|0
171621|NCT00190671|540812|P2|Overall Study|Protocol Violation|1
171622|NCT00190671|540813|P1|Overall Study|Protocol Violation|0
171623|NCT00190671|540812|P2|Overall Study|Death from Other Causes|2
171624|NCT00190671|540813|P1|Overall Study|Death from Other Causes|0
171625|NCT00190671|540812|P2|Overall Study|Death from Study-Drug Toxicity|2
171626|NCT00190671|540813|P1|Overall Study|Death from Study-Drug Toxicity|0
171627|NCT00190671|540812|P2|Overall Study|Clinical Relapse|1
171628|NCT00190671|540813|P1|Overall Study|Clinical Relapse|0
171629|NCT00190671|540812|P2|Overall Study|Adverse Event|2
171630|NCT00190671|540813|P1|Overall Study|Adverse Event|3
171631|NCT00190671|540812|P2|Overall Study|Death from Study Disease|1
171632|NCT00190671|540813|P1|Overall Study|Death from Study Disease|1
171633|NCT00190671|540812|P2|Overall Study|Lack of Efficacy|24
171634|NCT00190671|540813|P1|Overall Study|Lack of Efficacy|19
171635|NCT00190671|540812|P2|Overall Study|Satisfactory Response|7
171636|NCT00190671|540813|P1|Overall Study|Satisfactory Response|4
171637|NCT00189540|540858|P2|Overall Study|Death|1
171638|NCT00189540|540859|P1|Overall Study|Death|4
171639|NCT00189540|540858|P2|Overall Study|Withdrawal by Subject|0
171640|NCT00189540|540859|P1|Overall Study|Withdrawal by Subject|3
171641|NCT00189488|540877|P2|Overall Study|Other|0
171642|NCT00189488|540878|P1|Overall Study|Other|1
171643|NCT00189488|540877|P2|Overall Study|Death|8
171644|NCT00189488|540878|P1|Overall Study|Death|5
171645|NCT00189488|540877|P2|Overall Study|Administrative Decision|2
171646|NCT00189488|540878|P1|Overall Study|Administrative Decision|0
171647|NCT00189488|540877|P2|Overall Study|Disease progression|4
171648|NCT00189488|540878|P1|Overall Study|Disease progression|2
171649|NCT00189488|540877|P2|Overall Study|Withdrawal by Subject|6
171650|NCT00189488|540878|P1|Overall Study|Withdrawal by Subject|2
171651|NCT00189488|540877|P2|Overall Study|Adverse Event|1
171652|NCT00189488|540878|P1|Overall Study|Adverse Event|2
171653|NCT00189488|540877|P2|Overall Study|Protocol deviation|1
171654|NCT00189488|540878|P1|Overall Study|Protocol deviation|2
171655|NCT00189488|540877|P2|Overall Study|Ineligibility determined|0
171656|NCT00189488|540878|P1|Overall Study|Ineligibility determined|1
171657|NCT00189462|540909|P2|Overall Study|Lost to Follow-up|20
171658|NCT00189462|540910|P1|Overall Study|Lost to Follow-up|18
171659|NCT00189462|540909|P2|Overall Study|Lack of Efficacy|1
171660|NCT00189462|540910|P1|Overall Study|Lack of Efficacy|5
171661|NCT00189423|540927|P2|Overall Study|Lost to Follow-up|10
171662|NCT00189423|540928|P1|Overall Study|Lost to Follow-up|10
171663|NCT00189423|540927|P2|Overall Study|Withdrawal by Subject|9
171664|NCT00189423|540928|P1|Overall Study|Withdrawal by Subject|9
171665|NCT00189423|540927|P2|Overall Study|Death|747
171666|NCT00189423|540928|P1|Overall Study|Death|746
171667|NCT00189306|540948|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
171668|NCT00189306|540948|P1|Long-Term Follow-up|Lost to Follow-up|9
171669|NCT00189306|540948|P1|Long-Term Follow-up|Intercurrent disease|2
171670|NCT00189306|540948|P1|Long-Term Follow-up|Withdrawal by Subject|1
171671|NCT00189306|540948|P1|Long-Term Follow-up|Death|4
171672|NCT00189306|540948|P1|Long-Term Follow-up|Adverse Event|2
171673|NCT00189306|540948|P1|Posttreatment Period|Local skin reaction/sign|1
171674|NCT00189306|540948|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
171675|NCT00189306|540948|P1|Posttreatment Period|Protocol Violation|1
171676|NCT00189306|540948|P1|Posttreatment Period|Target lesion excised|1
171677|NCT00189306|540948|P1|Posttreatment Period|Noncompliance|1
171678|NCT00189306|540948|P1|Posttreatment Period|Withdrawal by Subject|2
171679|NCT00189306|540948|P1|Posttreatment Period|Death|1
171680|NCT00189306|540948|P1|Treatment Period|Protocol Violation|1
171681|NCT00189306|540948|P1|Treatment Period|Adverse Event|2
171682|NCT00189306|540948|P1|Treatment Period|Withdrawal by Subject|2
171683|NCT00187889|540985|P2|Overall Study|Withdrawal by Subject|4
171684|NCT00187889|540986|P1|Overall Study|Withdrawal by Subject|6
171685|NCT00187486|541003|P1|Overall Study|Protocol Violation|1
171686|NCT00187135|541054|P6|Visit Three|Study Discontinued|6
171687|NCT00187135|541055|P5|Visit Three|Study Discontinued|7
171688|NCT00187135|541056|P4|Visit Three|Study Discontinued|7
171689|NCT00187135|541057|P3|Visit Three|Study Discontinued|7
171690|NCT00187135|541058|P2|Visit Three|Study Discontinued|6
171691|NCT00187135|541059|P1|Visit Three|Study Discontinued|7
171692|NCT00187135|541054|P6|Visit Three|Withdrawal by Subject|0
171693|NCT00187135|541055|P5|Visit Three|Withdrawal by Subject|0
171694|NCT00187135|541056|P4|Visit Three|Withdrawal by Subject|2
171695|NCT00187135|541057|P3|Visit Three|Withdrawal by Subject|1
171696|NCT00187135|541058|P2|Visit Three|Withdrawal by Subject|1
171697|NCT00187135|541059|P1|Visit Three|Withdrawal by Subject|0
171698|NCT00187135|541054|P6|Visit Three|Death|0
171699|NCT00187135|541055|P5|Visit Three|Death|1
171700|NCT00187135|541056|P4|Visit Three|Death|0
171701|NCT00187135|541057|P3|Visit Three|Death|1
171702|NCT00187135|541058|P2|Visit Three|Death|0
171703|NCT00187135|541059|P1|Visit Three|Death|0
171704|NCT00187135|541054|P6|Visit Two|Study Discontinued|6
171705|NCT00187135|541055|P5|Visit Two|Study Discontinued|5
171706|NCT00187135|541056|P4|Visit Two|Study Discontinued|7
171707|NCT00187135|541057|P3|Visit Two|Study Discontinued|1
171708|NCT00187135|541058|P2|Visit Two|Study Discontinued|2
171709|NCT00187135|541059|P1|Visit Two|Study Discontinued|3
171710|NCT00187135|541054|P6|Visit Two|Withdrawal by Subject|1
171711|NCT00187135|541055|P5|Visit Two|Withdrawal by Subject|1
171712|NCT00187135|541056|P4|Visit Two|Withdrawal by Subject|0
171713|NCT00187135|541057|P3|Visit Two|Withdrawal by Subject|1
171714|NCT00187135|541058|P2|Visit Two|Withdrawal by Subject|1
171715|NCT00187135|541059|P1|Visit Two|Withdrawal by Subject|1
171716|NCT00187135|541054|P6|Visit Two|Physician Decision|0
171717|NCT00187135|541055|P5|Visit Two|Physician Decision|0
171718|NCT00187135|541056|P4|Visit Two|Physician Decision|0
171719|NCT00187135|541057|P3|Visit Two|Physician Decision|0
171720|NCT00187135|541058|P2|Visit Two|Physician Decision|0
171721|NCT00187135|541059|P1|Visit Two|Physician Decision|1
171722|NCT00187135|541054|P6|Visit Two|Death|1
171723|NCT00187135|541055|P5|Visit Two|Death|0
171724|NCT00187135|541056|P4|Visit Two|Death|1
171725|NCT00187135|541057|P3|Visit Two|Death|0
171726|NCT00187135|541058|P2|Visit Two|Death|0
171727|NCT00187135|541059|P1|Visit Two|Death|0
171728|NCT00187135|541054|P6|Visit One|Physician Decision|1
171729|NCT00187135|541055|P5|Visit One|Physician Decision|0
171730|NCT00187135|541056|P4|Visit One|Physician Decision|0
171731|NCT00187135|541057|P3|Visit One|Physician Decision|0
171732|NCT00187135|541058|P2|Visit One|Physician Decision|1
171733|NCT00187135|541059|P1|Visit One|Physician Decision|3
171734|NCT00187135|541054|P6|Visit One|Withdrawal by Subject|1
171735|NCT00187135|541055|P5|Visit One|Withdrawal by Subject|0
171736|NCT00187135|541056|P4|Visit One|Withdrawal by Subject|0
171737|NCT00187135|541057|P3|Visit One|Withdrawal by Subject|0
171738|NCT00187135|541058|P2|Visit One|Withdrawal by Subject|0
171739|NCT00187135|541059|P1|Visit One|Withdrawal by Subject|1
171740|NCT00187096|541082|P3|Overall Study|unacceptable toxicity|1
171741|NCT00187096|541083|P2|Overall Study|unacceptable toxicity|0
171742|NCT00187096|541084|P1|Overall Study|unacceptable toxicity|0
171743|NCT00186901|541122|P3|Overall Study|Bone Mineral Density > 0|149
171744|NCT00186901|541123|P2|Overall Study|Bone Mineral Density > 0|0
171745|NCT00186901|541124|P1|Overall Study|Bone Mineral Density > 0|0
171746|NCT00186901|541122|P3|Overall Study|Limited adherence to study requirements|0
171747|NCT00186901|541123|P2|Overall Study|Limited adherence to study requirements|23
171748|NCT00186901|541124|P1|Overall Study|Limited adherence to study requirements|20
171749|NCT00186901|541122|P3|Overall Study|Open label|0
171750|NCT00186901|541123|P2|Overall Study|Open label|2
171751|NCT00186901|541124|P1|Overall Study|Open label|3
171752|NCT00186901|541122|P3|Overall Study|Withdrawal by Subject|0
171753|NCT00186901|541123|P2|Overall Study|Withdrawal by Subject|5
171754|NCT00186901|541124|P1|Overall Study|Withdrawal by Subject|4
171755|NCT00186901|541122|P3|Overall Study|ALL relapse or second malignancy|0
171756|NCT00186901|541123|P2|Overall Study|ALL relapse or second malignancy|2
171757|NCT00186901|541124|P1|Overall Study|ALL relapse or second malignancy|1
171758|NCT00186901|541122|P3|Overall Study|Bone Mineral Density dropped > 5%|0
171759|NCT00186901|541123|P2|Overall Study|Bone Mineral Density dropped > 5%|7
171760|NCT00186901|541124|P1|Overall Study|Bone Mineral Density dropped > 5%|9
171761|NCT00186901|541122|P3|Overall Study|Lost to Follow-up|0
171762|NCT00186901|541123|P2|Overall Study|Lost to Follow-up|3
171763|NCT00186901|541124|P1|Overall Study|Lost to Follow-up|6
171764|NCT00186901|541122|P3|Overall Study|Pregnancy|0
171765|NCT00186901|541123|P2|Overall Study|Pregnancy|3
171766|NCT00186901|541124|P1|Overall Study|Pregnancy|6
171767|NCT00186888|541164|P3|Overall Study|Relapse or progression of disease|0
171768|NCT00186888|541165|P2|Overall Study|Relapse or progression of disease|2
171769|NCT00186888|541166|P1|Overall Study|Relapse or progression of disease|4
171770|NCT00186888|541164|P3|Overall Study|Toxicity|0
171771|NCT00186888|541165|P2|Overall Study|Toxicity|1
171772|NCT00186888|541166|P1|Overall Study|Toxicity|0
171773|NCT00186537|541242|P3|Overall Study|ALT > 1.5 x ULN|0
171774|NCT00186537|541243|P2|Overall Study|ALT > 1.5 x ULN|0
171775|NCT00186537|541244|P1|Overall Study|ALT > 1.5 x ULN|3
171776|NCT00186537|541242|P3|Overall Study|Withdrawal by Subject|3
171777|NCT00186537|541243|P2|Overall Study|Withdrawal by Subject|0
171778|NCT00186537|541244|P1|Overall Study|Withdrawal by Subject|4
171779|NCT00185965|541260|P2|Overall Study|Adverse Event|1
171780|NCT00185965|541261|P1|Overall Study|Adverse Event|0
171781|NCT00185588|541282|P4|Overall Study|Physician Decision|0
171782|NCT00185588|541283|P3|Overall Study|Physician Decision|1
171783|NCT00185588|541284|P2|Overall Study|Physician Decision|0
171784|NCT00185588|541285|P1|Overall Study|Physician Decision|0
171785|NCT00185588|541282|P4|Overall Study|Withdrawal by Subject|0
171786|NCT00185588|541283|P3|Overall Study|Withdrawal by Subject|0
171787|NCT00185588|541284|P2|Overall Study|Withdrawal by Subject|1
171788|NCT00185588|541285|P1|Overall Study|Withdrawal by Subject|0
171789|NCT00185588|541282|P4|Overall Study|Lost to Follow-up|2
171790|NCT00185588|541283|P3|Overall Study|Lost to Follow-up|1
171791|NCT00185588|541284|P2|Overall Study|Lost to Follow-up|0
171792|NCT00185588|541285|P1|Overall Study|Lost to Follow-up|0
171793|NCT00185588|541282|P4|Overall Study|Adverse Event|2
171794|NCT00185588|541283|P3|Overall Study|Adverse Event|4
171795|NCT00185588|541284|P2|Overall Study|Adverse Event|1
171796|NCT00185588|541285|P1|Overall Study|Adverse Event|3
171797|NCT00185458|541299|P1|HRT Phase|Withdrawal by Subject|3
171798|NCT00185458|541299|P1|HRT Phase|Protocol Violation|2
171799|NCT00185458|541299|P1|HRT Phase|Lost to Follow-up|4
171800|NCT00185458|541299|P1|HRT Phase|Adverse Event|18
171801|NCT00185458|541299|P1|Contraception Phase|Withdrawal by Subject|7
171802|NCT00185458|541299|P1|Contraception Phase|Physician Decision|2
171803|NCT00185458|541299|P1|Contraception Phase|Protocol Violation|2
171804|NCT00185458|541299|P1|Contraception Phase|Lost to Follow-up|10
171805|NCT00185458|541299|P1|Contraception Phase|Adverse Event|37
171806|NCT00185380|541362|P3|Overall Study|personal reason|1
171807|NCT00185380|541363|P2|Overall Study|personal reason|1
171808|NCT00185380|541364|P1|Overall Study|personal reason|6
171809|NCT00185380|541362|P3|Overall Study|Could not attend visits|4
171810|NCT00185380|541363|P2|Overall Study|Could not attend visits|0
171811|NCT00185380|541364|P1|Overall Study|Could not attend visits|2
171812|NCT00185380|541362|P3|Overall Study|No need for contraception|3
171813|NCT00185380|541363|P2|Overall Study|No need for contraception|3
171814|NCT00185380|541364|P1|Overall Study|No need for contraception|3
171815|NCT00185380|541362|P3|Overall Study|Planned pregnancy|12
171816|NCT00185380|541363|P2|Overall Study|Planned pregnancy|12
171817|NCT00185380|541364|P1|Overall Study|Planned pregnancy|9
171818|NCT00185380|541362|P3|Overall Study|Failed insertion|2
171819|NCT00185380|541363|P2|Overall Study|Failed insertion|1
171820|NCT00185380|541364|P1|Overall Study|Failed insertion|1
171821|NCT00185380|541362|P3|Overall Study|Withdrawal by Subject|0
171822|NCT00185380|541363|P2|Overall Study|Withdrawal by Subject|2
171823|NCT00185380|541364|P1|Overall Study|Withdrawal by Subject|1
171824|NCT00185380|541362|P3|Overall Study|Protocol Violation|1
171825|NCT00185380|541363|P2|Overall Study|Protocol Violation|2
171826|NCT00185380|541364|P1|Overall Study|Protocol Violation|2
171827|NCT00185380|541362|P3|Overall Study|Pregnancy|0
171828|NCT00185380|541363|P2|Overall Study|Pregnancy|4
171829|NCT00185380|541364|P1|Overall Study|Pregnancy|1
171830|NCT00185380|541362|P3|Overall Study|Lost to Follow-up|3
171831|NCT00185380|541363|P2|Overall Study|Lost to Follow-up|4
171832|NCT00185380|541364|P1|Overall Study|Lost to Follow-up|0
171833|NCT00185380|541362|P3|Overall Study|Adverse Event|48
171834|NCT00185380|541363|P2|Overall Study|Adverse Event|43
171835|NCT00185380|541364|P1|Overall Study|Adverse Event|41
171836|NCT00185211|541392|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
171837|NCT00185211|541393|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
171838|NCT00185211|541392|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
171839|NCT00185211|541393|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
171840|NCT00185211|541392|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
171841|NCT00185211|541393|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
171842|NCT00185211|541392|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
171843|NCT00185211|541393|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
171844|NCT00185211|541392|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
171845|NCT00185211|541393|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
171846|NCT00185211|541392|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
171847|NCT00185211|541393|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
171848|NCT00185211|541392|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
171849|NCT00185211|541393|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
171850|NCT00185211|541392|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
171851|NCT00185211|541393|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
171852|NCT00185211|541392|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
171853|NCT00185211|541393|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
171854|NCT00185211|541392|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
171855|NCT00185211|541393|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
171856|NCT00185211|541392|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
171857|NCT00185211|541393|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
171858|NCT00185211|541392|P2|Placebo-controlled Study (92012)|Adverse Event|0
171859|NCT00185211|541393|P1|Placebo-controlled Study (92012)|Adverse Event|8
171860|NCT00184600|541466|P3|Overall Study|Unclassified|3
171861|NCT00184600|541467|P2|Overall Study|Unclassified|5
171862|NCT00184600|541468|P1|Overall Study|Unclassified|4
171863|NCT00184600|541466|P3|Overall Study|Withdrawal by Subject|12
171864|NCT00184600|541467|P2|Overall Study|Withdrawal by Subject|28
171865|NCT00184600|541468|P1|Overall Study|Withdrawal by Subject|20
171866|NCT00184600|541466|P3|Overall Study|Protocol Violation|3
171867|NCT00184600|541467|P2|Overall Study|Protocol Violation|2
171868|NCT00184600|541468|P1|Overall Study|Protocol Violation|2
171869|NCT00184600|541466|P3|Overall Study|Lost to Follow-up|1
171870|NCT00184600|541467|P2|Overall Study|Lost to Follow-up|6
171871|NCT00184600|541468|P1|Overall Study|Lost to Follow-up|4
171872|NCT00184600|541466|P3|Overall Study|Lack of Efficacy|3
171873|NCT00184600|541467|P2|Overall Study|Lack of Efficacy|1
171874|NCT00184600|541468|P1|Overall Study|Lack of Efficacy|3
171875|NCT00184600|541466|P3|Overall Study|Death|7
171876|NCT00184600|541467|P2|Overall Study|Death|9
171877|NCT00184600|541468|P1|Overall Study|Death|3
171878|NCT00184600|541466|P3|Overall Study|Adverse Event|5
171879|NCT00184600|541467|P2|Overall Study|Adverse Event|0
171880|NCT00184600|541468|P1|Overall Study|Adverse Event|9
171881|NCT00184054|541559|P1|Overall Study|Adverse Event|1
171882|NCT00184028|541564|P1|Overall Study|Non-compliance|2
171883|NCT00184028|541564|P1|Overall Study|Withdrawal by Subject|1
171884|NCT00184028|541564|P1|Overall Study|Adverse Event|2
171885|NCT00184028|541564|P1|Overall Study|Lack of Efficacy|4
171886|NCT00184028|541564|P1|Overall Study|Death|1
171887|NCT00183625|541610|P4|Overall Study|Withdrawal by Subject|14
171888|NCT00183625|541611|P3|Overall Study|Withdrawal by Subject|19
171889|NCT00183625|541612|P2|Overall Study|Withdrawal by Subject|18
171890|NCT00183625|541613|P1|Overall Study|Withdrawal by Subject|18
171891|NCT00183430|541685|P2|Overall Study|Withdrawal by Subject|0
171892|NCT00183430|541686|P1|Overall Study|Withdrawal by Subject|1
171893|NCT00183430|541685|P2|Overall Study|did not meet inclusion criteria|0
171894|NCT00183430|541686|P1|Overall Study|did not meet inclusion criteria|1
171895|NCT00183430|541685|P2|Overall Study|Lost to Follow-up|0
171896|NCT00183430|541686|P1|Overall Study|Lost to Follow-up|3
171897|NCT00183430|541685|P2|Overall Study|Adverse Event|0
171898|NCT00183430|541686|P1|Overall Study|Adverse Event|1
171899|NCT00183274|541711|P6|Phase 3: Double-Blind|Relapsed|2
171900|NCT00183274|541712|P5|Phase 3: Double-Blind|Relapsed|11
171901|NCT00183274|541713|P4|Phase 3: Double-Blind|Relapsed|1
171902|NCT00183274|541714|P3|Phase 3: Double-Blind|Relapsed|0
171903|NCT00183274|541715|P2|Phase 3: Double-Blind|Relapsed|0
171904|NCT00183274|541716|P1|Phase 3: Double-Blind|Relapsed|0
171905|NCT00183274|541711|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
171906|NCT00183274|541712|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
171907|NCT00183274|541713|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
171908|NCT00183274|541714|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
171909|NCT00183274|541715|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
171910|NCT00183274|541716|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
171911|NCT00183274|541711|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
171912|NCT00183274|541712|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
171913|NCT00183274|541713|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
171914|NCT00183274|541714|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
171915|NCT00183274|541715|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
171916|NCT00183274|541716|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
171917|NCT00183274|541711|P6|Phase 2: Double-Blind|Relapsed|0
171918|NCT00183274|541712|P5|Phase 2: Double-Blind|Relapsed|0
171919|NCT00183274|541713|P4|Phase 2: Double-Blind|Relapsed|0
171920|NCT00183274|541714|P3|Phase 2: Double-Blind|Relapsed|29
171921|NCT00183274|541715|P2|Phase 2: Double-Blind|Relapsed|8
171922|NCT00183274|541716|P1|Phase 2: Double-Blind|Relapsed|0
171923|NCT00183274|541711|P6|Phase 1: Open-Label|Other|0
171924|NCT00183274|541712|P5|Phase 1: Open-Label|Other|0
171925|NCT00183274|541713|P4|Phase 1: Open-Label|Other|0
171926|NCT00183274|541714|P3|Phase 1: Open-Label|Other|0
171927|NCT00183274|541715|P2|Phase 1: Open-Label|Other|0
171928|NCT00183274|541716|P1|Phase 1: Open-Label|Other|9
171929|NCT00183274|541711|P6|Phase 1: Open-Label|Lost to Follow-up|0
171930|NCT00183274|541712|P5|Phase 1: Open-Label|Lost to Follow-up|0
171931|NCT00183274|541713|P4|Phase 1: Open-Label|Lost to Follow-up|0
171932|NCT00183274|541714|P3|Phase 1: Open-Label|Lost to Follow-up|0
171933|NCT00183274|541715|P2|Phase 1: Open-Label|Lost to Follow-up|0
171934|NCT00183274|541716|P1|Phase 1: Open-Label|Lost to Follow-up|33
171935|NCT00183274|541711|P6|Phase 1: Open-Label|Withdrawal by Subject|0
171936|NCT00183274|541712|P5|Phase 1: Open-Label|Withdrawal by Subject|0
171937|NCT00183274|541713|P4|Phase 1: Open-Label|Withdrawal by Subject|0
171938|NCT00183274|541714|P3|Phase 1: Open-Label|Withdrawal by Subject|0
171939|NCT00183274|541715|P2|Phase 1: Open-Label|Withdrawal by Subject|0
171940|NCT00183274|541716|P1|Phase 1: Open-Label|Withdrawal by Subject|13
171941|NCT00183274|541711|P6|Phase 1: Open-Label|Protocol Violation|0
171942|NCT00183274|541712|P5|Phase 1: Open-Label|Protocol Violation|0
171943|NCT00183274|541713|P4|Phase 1: Open-Label|Protocol Violation|0
171944|NCT00183274|541714|P3|Phase 1: Open-Label|Protocol Violation|0
171945|NCT00183274|541715|P2|Phase 1: Open-Label|Protocol Violation|0
171946|NCT00183274|541716|P1|Phase 1: Open-Label|Protocol Violation|11
171947|NCT00183274|541711|P6|Phase 1: Open-Label|Lack of Efficacy|0
171948|NCT00183274|541712|P5|Phase 1: Open-Label|Lack of Efficacy|0
171949|NCT00183274|541713|P4|Phase 1: Open-Label|Lack of Efficacy|0
171950|NCT00183274|541714|P3|Phase 1: Open-Label|Lack of Efficacy|0
171951|NCT00183274|541715|P2|Phase 1: Open-Label|Lack of Efficacy|0
171952|NCT00183274|541716|P1|Phase 1: Open-Label|Lack of Efficacy|13
171953|NCT00183274|541711|P6|Phase 1: Open-Label|Adverse Event|0
171954|NCT00183274|541712|P5|Phase 1: Open-Label|Adverse Event|0
171955|NCT00183274|541713|P4|Phase 1: Open-Label|Adverse Event|0
171956|NCT00183274|541714|P3|Phase 1: Open-Label|Adverse Event|0
171957|NCT00183274|541715|P2|Phase 1: Open-Label|Adverse Event|0
171958|NCT00183274|541716|P1|Phase 1: Open-Label|Adverse Event|31
171959|NCT00183248|541733|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
171960|NCT00183248|541734|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
171961|NCT00183248|541733|P2|Overall Study|Lost to Follow-up|1
171962|NCT00183248|541734|P1|Overall Study|Lost to Follow-up|0
171963|NCT00183196|541755|P3|Overall Study|Required more intensive care|2
171964|NCT00183196|541756|P2|Overall Study|Required more intensive care|1
171965|NCT00183196|541757|P1|Overall Study|Required more intensive care|0
171966|NCT00183196|541755|P3|Overall Study|Legal event|1
171967|NCT00183196|541756|P2|Overall Study|Legal event|1
171968|NCT00183196|541757|P1|Overall Study|Legal event|1
171969|NCT00183196|541755|P3|Overall Study|Adverse Event|2
171970|NCT00183196|541756|P2|Overall Study|Adverse Event|2
171971|NCT00183196|541757|P1|Overall Study|Adverse Event|1
171972|NCT00183196|541755|P3|Overall Study|Withdrawal by Subject|13
171973|NCT00183196|541756|P2|Overall Study|Withdrawal by Subject|11
171974|NCT00183196|541757|P1|Overall Study|Withdrawal by Subject|18
171975|NCT00182689|541812|P2|Overall Study|Never received treatment|0
171976|NCT00182689|541813|P1|Overall Study|Never received treatment|1
171977|NCT00182689|541812|P2|Overall Study|Ineligible|4
171978|NCT00182689|541813|P1|Overall Study|Ineligible|1
171979|NCT00182689|541812|P2|Overall Study|not protocol specified|3
171980|NCT00182689|541813|P1|Overall Study|not protocol specified|0
171981|NCT00182689|541812|P2|Overall Study|Death|0
171982|NCT00182689|541813|P1|Overall Study|Death|1
171983|NCT00182689|541812|P2|Overall Study|Progression|29
171984|NCT00182689|541813|P1|Overall Study|Progression|27
171985|NCT00182689|541812|P2|Overall Study|Withdrawal by Subject|2
171986|NCT00182689|541813|P1|Overall Study|Withdrawal by Subject|2
171987|NCT00182689|541812|P2|Overall Study|Adverse Event|11
171988|NCT00182689|541813|P1|Overall Study|Adverse Event|8
171989|NCT00182637|541823|P1|Overall Study|Disease Progression|1
171990|NCT00182637|541823|P1|Overall Study|Adverse Event|2
171991|NCT00182091|541833|P4|Overall Study|Withdrawal by Subject|0
171992|NCT00182091|541834|P3|Overall Study|Withdrawal by Subject|0
171993|NCT00182091|541835|P2|Overall Study|Withdrawal by Subject|0
171994|NCT00182091|541836|P1|Overall Study|Withdrawal by Subject|1
171995|NCT00182078|541852|P2|Overall Study|Withdrawal by Subject|0
171996|NCT00182078|541853|P1|Overall Study|Withdrawal by Subject|1
171997|NCT00181883|541872|P1|Overall Study|Lost to Follow-up|1
171998|NCT00181883|541872|P1|Overall Study|Withdrawal by Subject|4
171999|NCT00181883|541872|P1|Overall Study|Treatment Limiting AEs|3
172000|NCT00181883|541872|P1|Overall Study|Lack of Efficacy|2
172001|NCT00181844|541876|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
172002|NCT00181844|541876|P1|Exposed to Study Medication|Withdrawal by Subject|1
172003|NCT00181844|541876|P1|Exposed to Study Medication|Non-compliance|2
172004|NCT00181844|541876|P1|Exposed to Study Medication|Lack of Efficacy|2
172005|NCT00181844|541876|P1|Exposed to Study Medication|Adverse Event|10
172006|NCT00181844|541876|P1|Signed Consent|Did not meet entrance criteria|7
172007|NCT00181844|541876|P1|Signed Consent|Withdrawal by Subject|5
172008|NCT00181766|541880|P1|Overall Study|non-compliance|2
172009|NCT00181766|541880|P1|Overall Study|Adverse Event|4
172010|NCT00181766|541880|P1|Overall Study|Lost to Follow-up|6
172011|NCT00181155|541906|P2|Overall Study|Withdrawal by Subject|0
172012|NCT00181155|541907|P1|Overall Study|Withdrawal by Subject|1
172013|NCT00181155|541906|P2|Overall Study|Physician Decision|0
172014|NCT00181155|541907|P1|Overall Study|Physician Decision|1
172015|NCT00180479|541946|P2|Overall Study|Informed consent not signed|1
172016|NCT00180479|541947|P1|Overall Study|Informed consent not signed|0
172017|NCT00180479|541946|P2|Overall Study|Withdrawal by Subject|3
172018|NCT00180479|541947|P1|Overall Study|Withdrawal by Subject|3
172019|NCT00180479|541946|P2|Overall Study|Lost to Follow-up|7
172020|NCT00180479|541947|P1|Overall Study|Lost to Follow-up|9
172021|NCT00180479|541946|P2|Overall Study|Death|2
172022|NCT00180479|541947|P1|Overall Study|Death|4
172023|NCT00179959|542057|P2|Overall Study|Withdrawal by Subject|2
172024|NCT00179959|542058|P1|Overall Study|Withdrawal by Subject|3
172025|NCT00179959|542057|P2|Overall Study|Lost to Follow-up|1
172026|NCT00179959|542058|P1|Overall Study|Lost to Follow-up|3
172027|NCT00179673|542064|P1|Overall Study|Other Observations and options|14
172028|NCT00179673|542064|P1|Overall Study|Death|4
172029|NCT00179673|542064|P1|Overall Study|Withdrawal by Subject|3
172030|NCT00179673|542064|P1|Overall Study|Lack of Efficacy|15
172031|NCT00179673|542064|P1|Overall Study|Adverse Event|7
172032|NCT00179660|542072|P1|Overall Study|Other - Unspecified|9
172033|NCT00179660|542072|P1|Overall Study|Death|3
172034|NCT00179660|542072|P1|Overall Study|Lost to Follow-up|1
172035|NCT00179660|542072|P1|Overall Study|Withdrawal by Subject|2
172036|NCT00179660|542072|P1|Overall Study|Lack of therapeutic effect|28
172037|NCT00179660|542072|P1|Overall Study|Adverse Event|7
172038|NCT00179647|542081|P1|Overall Study|Not specified|960
172039|NCT00179647|542081|P1|Overall Study|Death|94
172040|NCT00179647|542081|P1|Overall Study|Lost to Follow-up|4
172041|NCT00179647|542081|P1|Overall Study|Withdrawal by Subject|83
172042|NCT00179647|542081|P1|Overall Study|Lack of Efficacy|478
172043|NCT00179647|542081|P1|Overall Study|Adverse Event|294
172044|NCT00179621|542088|P4|Open-Label Period|Unspecified|2
172045|NCT00179621|542089|P3|Open-Label Period|Unspecified|1
172046|NCT00179621|542090|P2|Open-Label Period|Unspecified|1
172047|NCT00179621|542091|P1|Open-Label Period|Unspecified|0
172048|NCT00179621|542088|P4|Open-Label Period|Death|2
172049|NCT00179621|542089|P3|Open-Label Period|Death|1
172050|NCT00179621|542090|P2|Open-Label Period|Death|0
172051|NCT00179621|542091|P1|Open-Label Period|Death|0
172052|NCT00179621|542088|P4|Open-Label Period|Withdrawal by Subject|2
172053|NCT00179621|542089|P3|Open-Label Period|Withdrawal by Subject|2
172054|NCT00179621|542090|P2|Open-Label Period|Withdrawal by Subject|2
172055|NCT00179621|542091|P1|Open-Label Period|Withdrawal by Subject|0
172056|NCT00179621|542088|P4|Open-Label Period|Adverse Event|6
172057|NCT00179621|542089|P3|Open-Label Period|Adverse Event|5
172058|NCT00179621|542090|P2|Open-Label Period|Adverse Event|6
172059|NCT00179621|542091|P1|Open-Label Period|Adverse Event|0
172060|NCT00179621|542088|P4|Open-Label Period|Lack of Therapeutic Effect|31
172061|NCT00179621|542089|P3|Open-Label Period|Lack of Therapeutic Effect|19
172062|NCT00179621|542090|P2|Open-Label Period|Lack of Therapeutic Effect|19
172063|NCT00179621|542091|P1|Open-Label Period|Lack of Therapeutic Effect|0
172064|NCT00179621|542088|P4|Double-Blind Period|Unspecified|0
172065|NCT00179621|542089|P3|Double-Blind Period|Unspecified|2
172066|NCT00179621|542090|P2|Double-Blind Period|Unspecified|2
172067|NCT00179621|542091|P1|Double-Blind Period|Unspecified|0
172068|NCT00179621|542088|P4|Double-Blind Period|Protocol Violation|0
172069|NCT00179621|542089|P3|Double-Blind Period|Protocol Violation|0
172070|NCT00179621|542090|P2|Double-Blind Period|Protocol Violation|0
172071|NCT00179621|542091|P1|Double-Blind Period|Protocol Violation|1
172072|NCT00179621|542088|P4|Double-Blind Period|Death|0
172073|NCT00179621|542089|P3|Double-Blind Period|Death|2
172074|NCT00179621|542090|P2|Double-Blind Period|Death|1
172075|NCT00179621|542091|P1|Double-Blind Period|Death|0
172076|NCT00179621|542088|P4|Double-Blind Period|Withdrawal by Subject|0
172077|NCT00179621|542089|P3|Double-Blind Period|Withdrawal by Subject|3
172078|NCT00179621|542090|P2|Double-Blind Period|Withdrawal by Subject|1
172079|NCT00179621|542091|P1|Double-Blind Period|Withdrawal by Subject|2
172080|NCT00179621|542088|P4|Double-Blind Period|Adverse Event|0
172081|NCT00179621|542089|P3|Double-Blind Period|Adverse Event|4
172082|NCT00179621|542090|P2|Double-Blind Period|Adverse Event|7
172083|NCT00179621|542091|P1|Double-Blind Period|Adverse Event|2
172084|NCT00179621|542088|P4|Double-Blind Period|Lack of Therapeutic Effect|0
172085|NCT00179621|542089|P3|Double-Blind Period|Lack of Therapeutic Effect|19
172086|NCT00179621|542090|P2|Double-Blind Period|Lack of Therapeutic Effect|35
172087|NCT00179621|542091|P1|Double-Blind Period|Lack of Therapeutic Effect|59
172088|NCT00179309|542144|P2|Treatment|Allergy|0
172089|NCT00179309|542145|P1|Treatment|Allergy|1
172090|NCT00179309|542144|P2|Treatment|Withdrawal by Subject|2
172091|NCT00179309|542145|P1|Treatment|Withdrawal by Subject|1
172092|NCT00179309|542144|P2|Treatment|Toxicity|3
172093|NCT00179309|542145|P1|Treatment|Toxicity|2
172094|NCT00178685|542184|P3|Overall Study|Withdrawal by Subject|7
172095|NCT00178685|542185|P2|Overall Study|Withdrawal by Subject|14
172096|NCT00178685|542186|P1|Overall Study|Withdrawal by Subject|8
172097|NCT00178685|542184|P3|Overall Study|Lost to Follow-up|183
172098|NCT00178685|542185|P2|Overall Study|Lost to Follow-up|187
172099|NCT00178685|542186|P1|Overall Study|Lost to Follow-up|100
172100|NCT00178685|542184|P3|Overall Study|Death|6
172101|NCT00178685|542185|P2|Overall Study|Death|3
172102|NCT00178685|542186|P1|Overall Study|Death|3
172103|NCT00178633|542197|P1|Overall Study|Lost to Follow-up|6
172104|NCT00178464|542227|P1|Overall Study|Physician Decision|1
172105|NCT00178464|542227|P1|Overall Study|Withdrawal by Subject|1
172106|NCT00178256|542232|P4|Overall Study|Cancer progression|1
172107|NCT00178256|542233|P3|Overall Study|Cancer progression|0
172108|NCT00178256|542234|P2|Overall Study|Cancer progression|0
172109|NCT00178256|542235|P1|Overall Study|Cancer progression|2
172110|NCT00178256|542232|P4|Overall Study|Death|1
172111|NCT00178256|542233|P3|Overall Study|Death|0
172112|NCT00178256|542234|P2|Overall Study|Death|1
172113|NCT00178256|542235|P1|Overall Study|Death|0
172114|NCT00178256|542232|P4|Overall Study|Adverse Event|0
172115|NCT00178256|542233|P3|Overall Study|Adverse Event|0
172116|NCT00178256|542234|P2|Overall Study|Adverse Event|0
172117|NCT00178256|542235|P1|Overall Study|Adverse Event|2
172118|NCT00177671|542308|P2|Overall Study|Physician Decision|8
172119|NCT00177671|542309|P1|Overall Study|Physician Decision|12
172120|NCT00177671|542308|P2|Overall Study|Adverse Event|0
172121|NCT00177671|542309|P1|Overall Study|Adverse Event|6
172122|NCT00177671|542308|P2|Overall Study|medical complications|0
172123|NCT00177671|542309|P1|Overall Study|medical complications|2
172124|NCT00177671|542308|P2|Overall Study|Withdrawal by Subject|6
172125|NCT00177671|542309|P1|Overall Study|Withdrawal by Subject|5
172126|NCT00177307|542321|P1|Overall Study|Withdrawal by Subject|1
172127|NCT00177294|542330|P2|Overall Study|Withdrawal by Subject|5
172128|NCT00177294|542331|P1|Overall Study|Withdrawal by Subject|7
172129|NCT00177216|542345|P3|Overall Study|Withdrawal by Subject|1
172130|NCT00177216|542346|P2|Overall Study|Withdrawal by Subject|3
172131|NCT00177216|542347|P1|Overall Study|Withdrawal by Subject|6
172132|NCT00177164|542363|P2|Overall Study|Pregnancy|1
172133|NCT00177164|542364|P1|Overall Study|Pregnancy|0
172134|NCT00177164|542363|P2|Overall Study|Lack of Efficacy|1
172135|NCT00177164|542364|P1|Overall Study|Lack of Efficacy|2
172136|NCT00177164|542363|P2|Overall Study|discharge from hospital|0
172137|NCT00177164|542364|P1|Overall Study|discharge from hospital|1
172138|NCT00177164|542363|P2|Overall Study|Adverse Event|0
172139|NCT00177164|542364|P1|Overall Study|Adverse Event|1
172140|NCT00177164|542363|P2|Overall Study|increase in alcohol and drug use|2
172141|NCT00177164|542364|P1|Overall Study|increase in alcohol and drug use|1
172142|NCT00177164|542363|P2|Overall Study|Lost to Follow-up|5
172143|NCT00177164|542364|P1|Overall Study|Lost to Follow-up|4
172144|NCT00177164|542363|P2|Overall Study|Protocol Violation|7
172145|NCT00177164|542364|P1|Overall Study|Protocol Violation|0
172146|NCT00176644|542425|P1|Overall Study|Withdrawal by Subject|1
172147|NCT00176605|542438|P1|Overall Study|Withdrawal by Subject|2
172148|NCT00176488|542449|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
172149|NCT00176462|542457|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
172150|NCT00176462|542458|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
172151|NCT00176462|542457|P2|Intensive Continuation (8X8-week Cycles)|Death|0
172152|NCT00176462|542458|P1|Intensive Continuation (8X8-week Cycles)|Death|1
172153|NCT00176462|542457|P2|Consolidation (12 Weeks)|Not documented|1
172154|NCT00176462|542458|P1|Consolidation (12 Weeks)|Not documented|0
172155|NCT00176462|542457|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
172156|NCT00176462|542458|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
172157|NCT00176462|542457|P2|Consolidation (12 Weeks)|Adverse Event|1
172158|NCT00176462|542458|P1|Consolidation (12 Weeks)|Adverse Event|0
172159|NCT00176462|542457|P2|Consolidation (12 Weeks)|Patient moved to another state|1
172160|NCT00176462|542458|P1|Consolidation (12 Weeks)|Patient moved to another state|0
172161|NCT00176462|542457|P2|Induction (4 Weeks)|Lack of Efficacy|1
172162|NCT00176462|542458|P1|Induction (4 Weeks)|Lack of Efficacy|0
172163|NCT00176462|542457|P2|Induction (4 Weeks)|Death|2
172164|NCT00176462|542458|P1|Induction (4 Weeks)|Death|1
172165|NCT00176462|542457|P2|Induction (4 Weeks)|Withdrawal by Subject|2
172166|NCT00176462|542458|P1|Induction (4 Weeks)|Withdrawal by Subject|0
172167|NCT00176254|542478|P1|Overall Study|Lost to Follow-up|1
172168|NCT00175877|542506|P1|Overall Study|Withdrawal by subject & Other|1
172169|NCT00175877|542506|P1|Overall Study|AE & Other|1
172170|NCT00175877|542506|P1|Overall Study|Other Reason|20
172171|NCT00175877|542506|P1|Overall Study|Protocol Violation|15
172172|NCT00175877|542506|P1|Overall Study|Lack of Efficacy|26
172173|NCT00175877|542506|P1|Overall Study|Lost to Follow-up|9
172174|NCT00175877|542506|P1|Overall Study|Withdrawal by Subject|141
172175|NCT00175877|542506|P1|Overall Study|Adverse Event|136
172176|NCT00175019|542540|P3|Overall Study|Reason Not Specified|11
172177|NCT00175019|542541|P2|Overall Study|Reason Not Specified|34
172178|NCT00175019|542542|P1|Overall Study|Reason Not Specified|40
172179|NCT00175019|542540|P3|Overall Study|Gout Flare|0
172180|NCT00175019|542541|P2|Overall Study|Gout Flare|3
172181|NCT00175019|542542|P1|Overall Study|Gout Flare|2
172182|NCT00175019|542540|P3|Overall Study|Therapeutic Failure|22
172183|NCT00175019|542541|P2|Overall Study|Therapeutic Failure|38
172184|NCT00175019|542542|P1|Overall Study|Therapeutic Failure|10
172185|NCT00175019|542540|P3|Overall Study|Personal Reason(s)|8
172186|NCT00175019|542541|P2|Overall Study|Personal Reason(s)|31
172187|NCT00175019|542542|P1|Overall Study|Personal Reason(s)|39
172188|NCT00175019|542540|P3|Overall Study|Did not continue under Amendment 4|2
172189|NCT00175019|542541|P2|Overall Study|Did not continue under Amendment 4|1
172190|NCT00175019|542542|P1|Overall Study|Did not continue under Amendment 4|1
172191|NCT00175019|542540|P3|Overall Study|Lost to Follow-up|9
172192|NCT00175019|542541|P2|Overall Study|Lost to Follow-up|39
172193|NCT00175019|542542|P1|Overall Study|Lost to Follow-up|42
172194|NCT00175019|542540|P3|Overall Study|Protocol Violation|3
172195|NCT00175019|542541|P2|Overall Study|Protocol Violation|3
172196|NCT00175019|542542|P1|Overall Study|Protocol Violation|6
172197|NCT00175019|542540|P3|Overall Study|Adverse Event|2
172198|NCT00175019|542541|P2|Overall Study|Adverse Event|22
172199|NCT00175019|542542|P1|Overall Study|Adverse Event|54
172200|NCT00174967|542595|P4|Overall Study|Not Specified|0
172201|NCT00174967|542596|P3|Overall Study|Not Specified|0
172202|NCT00174967|542597|P2|Overall Study|Not Specified|1
172203|NCT00174967|542598|P1|Overall Study|Not Specified|0
172204|NCT00174967|542595|P4|Overall Study|Gout Flare|1
172205|NCT00174967|542596|P3|Overall Study|Gout Flare|0
172206|NCT00174967|542597|P2|Overall Study|Gout Flare|0
172207|NCT00174967|542598|P1|Overall Study|Gout Flare|0
172208|NCT00174967|542595|P4|Overall Study|Adverse Event|1
172209|NCT00174967|542596|P3|Overall Study|Adverse Event|2
172210|NCT00174967|542597|P2|Overall Study|Adverse Event|2
172211|NCT00174967|542598|P1|Overall Study|Adverse Event|1
172212|NCT00174954|542644|P1|Overall Study|Physician Decision|1
172213|NCT00174954|542644|P1|Overall Study|No tophi found in MRI|1
172214|NCT00174954|542644|P1|Overall Study|Adverse Event|2
172215|NCT00174941|542652|P4|Overall Study|Reason Not Specified|9
172216|NCT00174941|542653|P3|Overall Study|Reason Not Specified|2
172217|NCT00174941|542654|P2|Overall Study|Reason Not Specified|6
172218|NCT00174941|542655|P1|Overall Study|Reason Not Specified|1
172219|NCT00174941|542652|P4|Overall Study|Gout Flare|8
172220|NCT00174941|542653|P3|Overall Study|Gout Flare|4
172221|NCT00174941|542654|P2|Overall Study|Gout Flare|4
172222|NCT00174941|542655|P1|Overall Study|Gout Flare|0
172223|NCT00174941|542652|P4|Overall Study|Personal Reason(s)|22
172224|NCT00174941|542653|P3|Overall Study|Personal Reason(s)|8
172225|NCT00174941|542654|P2|Overall Study|Personal Reason(s)|14
172226|NCT00174941|542655|P1|Overall Study|Personal Reason(s)|0
172227|NCT00174941|542652|P4|Overall Study|Lost to Follow-up|5
172228|NCT00174941|542653|P3|Overall Study|Lost to Follow-up|2
172229|NCT00174941|542654|P2|Overall Study|Lost to Follow-up|3
172230|NCT00174941|542655|P1|Overall Study|Lost to Follow-up|0
172231|NCT00174941|542652|P4|Overall Study|Protocol Violation|1
172232|NCT00174941|542653|P3|Overall Study|Protocol Violation|0
172233|NCT00174941|542654|P2|Overall Study|Protocol Violation|1
172234|NCT00174941|542655|P1|Overall Study|Protocol Violation|0
172235|NCT00174941|542652|P4|Overall Study|Adverse Event|13
172236|NCT00174941|542653|P3|Overall Study|Adverse Event|2
172237|NCT00174941|542654|P2|Overall Study|Adverse Event|10
172238|NCT00174941|542655|P1|Overall Study|Adverse Event|1
172239|NCT00174915|542730|P5|Overall Study|Therapeutic Failure|3
172240|NCT00174915|542731|P4|Overall Study|Therapeutic Failure|1
172241|NCT00174915|542732|P3|Overall Study|Therapeutic Failure|2
172242|NCT00174915|542733|P2|Overall Study|Therapeutic Failure|3
172243|NCT00174915|542734|P1|Overall Study|Therapeutic Failure|6
172244|NCT00174915|542730|P5|Overall Study|Protocol Violation|3
172245|NCT00174915|542731|P4|Overall Study|Protocol Violation|6
172246|NCT00174915|542732|P3|Overall Study|Protocol Violation|3
172247|NCT00174915|542733|P2|Overall Study|Protocol Violation|3
172248|NCT00174915|542734|P1|Overall Study|Protocol Violation|6
172249|NCT00174915|542730|P5|Overall Study|Gout Flare|0
172250|NCT00174915|542731|P4|Overall Study|Gout Flare|1
172251|NCT00174915|542732|P3|Overall Study|Gout Flare|8
172252|NCT00174915|542733|P2|Overall Study|Gout Flare|6
172253|NCT00174915|542734|P1|Overall Study|Gout Flare|13
172254|NCT00174915|542730|P5|Overall Study|Other|3
172255|NCT00174915|542731|P4|Overall Study|Other|5
172256|NCT00174915|542732|P3|Overall Study|Other|6
172257|NCT00174915|542733|P2|Overall Study|Other|8
172258|NCT00174915|542734|P1|Overall Study|Other|15
172259|NCT00174915|542730|P5|Overall Study|Personal Reason(s)|9
172260|NCT00174915|542731|P4|Overall Study|Personal Reason(s)|9
172261|NCT00174915|542732|P3|Overall Study|Personal Reason(s)|9
172262|NCT00174915|542733|P2|Overall Study|Personal Reason(s)|16
172263|NCT00174915|542734|P1|Overall Study|Personal Reason(s)|16
172264|NCT00174915|542730|P5|Overall Study|Adverse Event|5
172265|NCT00174915|542731|P4|Overall Study|Adverse Event|18
172266|NCT00174915|542732|P3|Overall Study|Adverse Event|11
172267|NCT00174915|542733|P2|Overall Study|Adverse Event|16
172268|NCT00174915|542734|P1|Overall Study|Adverse Event|18
172269|NCT00174915|542730|P5|Overall Study|Lost to Follow-up|10
172270|NCT00174915|542731|P4|Overall Study|Lost to Follow-up|17
172271|NCT00174915|542732|P3|Overall Study|Lost to Follow-up|9
172272|NCT00174915|542733|P2|Overall Study|Lost to Follow-up|17
172273|NCT00174915|542734|P1|Overall Study|Lost to Follow-up|19
172274|NCT00174785|542793|P2|Overall Study|Not pre-specified/Not coded|70
172275|NCT00174785|542794|P1|Overall Study|Not pre-specified/Not coded|56
172276|NCT00174785|542793|P2|Overall Study|Family request|8
172277|NCT00174785|542794|P1|Overall Study|Family request|6
172278|NCT00174785|542793|P2|Overall Study|Other prohibited medication|3
172279|NCT00174785|542794|P1|Overall Study|Other prohibited medication|5
172280|NCT00174785|542793|P2|Overall Study|Prohibited antiarrhythmic medication|88
172281|NCT00174785|542794|P1|Overall Study|Prohibited antiarrhythmic medication|39
172282|NCT00174785|542793|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
172283|NCT00174785|542794|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
172284|NCT00174785|542793|P2|Overall Study|Withdrawal by Subject|175
172285|NCT00174785|542794|P1|Overall Study|Withdrawal by Subject|173
172286|NCT00174785|542793|P2|Overall Study|Protocol Violation|14
172287|NCT00174785|542794|P1|Overall Study|Protocol Violation|14
172288|NCT00174785|542793|P2|Overall Study|Adverse Event|191
172289|NCT00174785|542794|P1|Overall Study|Adverse Event|293
172290|NCT00174460|542810|P2|Overall Study|Withdrawal by Subject|1
172291|NCT00174460|542811|P1|Overall Study|Withdrawal by Subject|0
172292|NCT00174447|542857|P1|Overall Study|Administrative reason/Other|2
172293|NCT00174447|542857|P1|Overall Study|Lack of Efficacy|1
172294|NCT00174447|542857|P1|Overall Study|Protocol Violation|1
172295|NCT00174447|542857|P1|Overall Study|Withdrawal by Subject|15
172296|NCT00174447|542857|P1|Overall Study|Adverse Event|19
172297|NCT00174382|542866|P1|Overall Study|Lost to Follow-up|1
172298|NCT00174382|542866|P1|Overall Study|Subject felt pill not effective enough|1
172299|NCT00174382|542866|P1|Overall Study|Arrived early for last visit in error|1
172300|NCT00174382|542866|P1|Overall Study|Protocol Violation|3
172301|NCT00174382|542866|P1|Overall Study|Withdrawal by Subject|6
172302|NCT00174382|542866|P1|Overall Study|Adverse Event|19
172303|NCT00174382|542866|P1|Overall Study|Death|2
172304|NCT00174291|542885|P2|Overall Study|Withdrawal by Subject|3
172305|NCT00174291|542886|P1|Overall Study|Withdrawal by Subject|3
172306|NCT00174291|542885|P2|Overall Study|Study terminated by sponsor|0
172307|NCT00174291|542886|P1|Overall Study|Study terminated by sponsor|1
172308|NCT00174291|542885|P2|Overall Study|Protocol Violation|2
172309|NCT00174291|542886|P1|Overall Study|Protocol Violation|0
172310|NCT00174291|542885|P2|Overall Study|Lost to Follow-up|1
172311|NCT00174291|542886|P1|Overall Study|Lost to Follow-up|1
172312|NCT00174265|542916|P2|Overall Study|Other (Not specified)|10
172313|NCT00174265|542917|P1|Overall Study|Other (Not specified)|16
172314|NCT00174265|542916|P2|Overall Study|Lost to Follow-up|0
172315|NCT00174265|542917|P1|Overall Study|Lost to Follow-up|1
172316|NCT00174265|542916|P2|Overall Study|Withdrawal by Subject|5
172317|NCT00174265|542917|P1|Overall Study|Withdrawal by Subject|3
172318|NCT00174265|542916|P2|Overall Study|Lack of Efficacy|2
172319|NCT00174265|542917|P1|Overall Study|Lack of Efficacy|2
172320|NCT00174265|542916|P2|Overall Study|Adverse Event|4
172321|NCT00174265|542917|P1|Overall Study|Adverse Event|7
172322|NCT00174252|542925|P1|Overall Study|Protocol Violation|2
172323|NCT00174187|542960|P3|Period 2 (After 3 Years)|Unspecified|5
172324|NCT00174187|542961|P2|Period 2 (After 3 Years)|Unspecified|0
172325|NCT00174187|542962|P1|Period 2 (After 3 Years)|Unspecified|0
172326|NCT00174187|542960|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
172327|NCT00174187|542961|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
172328|NCT00174187|542962|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
172329|NCT00174187|542960|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
172330|NCT00174187|542961|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
172331|NCT00174187|542962|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
172332|NCT00174187|542960|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
172333|NCT00174187|542961|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
172334|NCT00174187|542962|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
172335|NCT00174187|542960|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
172336|NCT00174187|542961|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
172337|NCT00174187|542962|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
172338|NCT00174187|542960|P3|Period 1 (up to 3 Years)|Unspecified|0
172339|NCT00174187|542961|P2|Period 1 (up to 3 Years)|Unspecified|1
172340|NCT00174187|542962|P1|Period 1 (up to 3 Years)|Unspecified|0
172341|NCT00174187|542960|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
172342|NCT00174187|542961|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
172343|NCT00174187|542962|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
172344|NCT00174187|542960|P3|Period 1 (up to 3 Years)|Non compliance|0
172345|NCT00174187|542961|P2|Period 1 (up to 3 Years)|Non compliance|1
172346|NCT00174187|542962|P1|Period 1 (up to 3 Years)|Non compliance|0
172347|NCT00174187|542960|P3|Period 1 (up to 3 Years)|Serious adverse event|0
172348|NCT00174187|542961|P2|Period 1 (up to 3 Years)|Serious adverse event|1
172349|NCT00174187|542962|P1|Period 1 (up to 3 Years)|Serious adverse event|0
172350|NCT00172042|543025|P2|Overall Study|Death|42
172351|NCT00172042|543026|P1|Overall Study|Death|42
172352|NCT00172042|543025|P2|Overall Study|Administrative problems|10
172353|NCT00172042|543026|P1|Overall Study|Administrative problems|13
172354|NCT00172042|543025|P2|Overall Study|Lost to Follow-up|5
172355|NCT00172042|543026|P1|Overall Study|Lost to Follow-up|3
172356|NCT00172042|543025|P2|Overall Study|Withdrawal by Subject|25
172357|NCT00172042|543026|P1|Overall Study|Withdrawal by Subject|37
172358|NCT00172042|543025|P2|Overall Study|Protocol Violation|7
172359|NCT00172042|543026|P1|Overall Study|Protocol Violation|8
172360|NCT00172042|543025|P2|Overall Study|Patient no longer requires study drug|8
172361|NCT00172042|543026|P1|Overall Study|Patient no longer requires study drug|10
172362|NCT00172042|543025|P2|Overall Study|Unsatisfactory therapeutic effect|11
172363|NCT00172042|543026|P1|Overall Study|Unsatisfactory therapeutic effect|13
172364|NCT00172042|543025|P2|Overall Study|Abnormal test procedure(s)|3
172365|NCT00172042|543026|P1|Overall Study|Abnormal test procedure(s)|0
172366|NCT00172042|543025|P2|Overall Study|Abnormal laboratory value(s)|1
172367|NCT00172042|543026|P1|Overall Study|Abnormal laboratory value(s)|5
172368|NCT00172042|543025|P2|Overall Study|Adverse Event|13
172369|NCT00172042|543026|P1|Overall Study|Adverse Event|27
172370|NCT00171925|543048|P2|Overall Study|Death|2
172371|NCT00171925|543049|P1|Overall Study|Death|1
172372|NCT00171925|543048|P2|Overall Study|Administrative problems|11
172373|NCT00171925|543049|P1|Overall Study|Administrative problems|10
172374|NCT00171925|543048|P2|Overall Study|Lost to Follow-up|2
172375|NCT00171925|543049|P1|Overall Study|Lost to Follow-up|2
172376|NCT00171925|543048|P2|Overall Study|Withdrawal by Subject|9
172377|NCT00171925|543049|P1|Overall Study|Withdrawal by Subject|6
172378|NCT00171925|543048|P2|Overall Study|Protocol Violation|1
172379|NCT00171925|543049|P1|Overall Study|Protocol Violation|1
172380|NCT00171925|543048|P2|Overall Study|Adverse Event|6
172381|NCT00171925|543049|P1|Overall Study|Adverse Event|10
172382|NCT00171873|543061|P2|Overall Study|Switched to Octreotide|1
172383|NCT00171873|543062|P1|Overall Study|Switched to Octreotide|0
172384|NCT00171873|543061|P2|Overall Study|Adverse Event|0
172385|NCT00171873|543062|P1|Overall Study|Adverse Event|5
172386|NCT00171873|543061|P2|Overall Study|Withdrawal by Subject|2
172387|NCT00171873|543062|P1|Overall Study|Withdrawal by Subject|4
172388|NCT00171834|543075|P7|Overall Study|Treatment Duration Completed|0
172389|NCT00171834|543076|P6|Overall Study|Treatment Duration Completed|1
172390|NCT00171834|543077|P5|Overall Study|Treatment Duration Completed|2
172391|NCT00171834|543078|P4|Overall Study|Treatment Duration Completed|0
172392|NCT00171834|543079|P3|Overall Study|Treatment Duration Completed|1
172393|NCT00171834|543080|P2|Overall Study|Treatment Duration Completed|0
172394|NCT00171834|543081|P1|Overall Study|Treatment Duration Completed|0
172395|NCT00171834|543075|P7|Overall Study|Disease Progression|3
172396|NCT00171834|543076|P6|Overall Study|Disease Progression|18
172397|NCT00171834|543077|P5|Overall Study|Disease Progression|2
172398|NCT00171834|543078|P4|Overall Study|Disease Progression|9
172399|NCT00171834|543079|P3|Overall Study|Disease Progression|8
172400|NCT00171834|543080|P2|Overall Study|Disease Progression|8
172401|NCT00171834|543081|P1|Overall Study|Disease Progression|4
172402|NCT00171834|543075|P7|Overall Study|Death from study indication|0
172403|NCT00171834|543076|P6|Overall Study|Death from study indication|0
172404|NCT00171834|543077|P5|Overall Study|Death from study indication|1
172405|NCT00171834|543078|P4|Overall Study|Death from study indication|0
172406|NCT00171834|543079|P3|Overall Study|Death from study indication|0
172407|NCT00171834|543080|P2|Overall Study|Death from study indication|1
172408|NCT00171834|543081|P1|Overall Study|Death from study indication|0
172409|NCT00171834|543075|P7|Overall Study|Withdrawal by Subject|0
172410|NCT00171834|543076|P6|Overall Study|Withdrawal by Subject|1
172411|NCT00171834|543077|P5|Overall Study|Withdrawal by Subject|1
172412|NCT00171834|543078|P4|Overall Study|Withdrawal by Subject|1
172413|NCT00171834|543079|P3|Overall Study|Withdrawal by Subject|0
172414|NCT00171834|543080|P2|Overall Study|Withdrawal by Subject|2
172415|NCT00171834|543081|P1|Overall Study|Withdrawal by Subject|0
172416|NCT00171834|543075|P7|Overall Study|Adverse Event|1
172417|NCT00171834|543076|P6|Overall Study|Adverse Event|15
172418|NCT00171834|543077|P5|Overall Study|Adverse Event|2
172419|NCT00171834|543078|P4|Overall Study|Adverse Event|2
172420|NCT00171834|543079|P3|Overall Study|Adverse Event|3
172421|NCT00171834|543080|P2|Overall Study|Adverse Event|1
172422|NCT00171834|543081|P1|Overall Study|Adverse Event|2
172423|NCT00171704|543121|P2|Overall Study|Protocol Violation|1
172424|NCT00171704|543122|P1|Overall Study|Protocol Violation|0
172425|NCT00171704|543121|P2|Overall Study|Withdrawal by Subject|3
172426|NCT00171704|543122|P1|Overall Study|Withdrawal by Subject|1
172427|NCT00171704|543121|P2|Overall Study|Death|2
172428|NCT00171704|543122|P1|Overall Study|Death|2
172429|NCT00171704|543121|P2|Overall Study|Administrative Problems|1
172430|NCT00171704|543122|P1|Overall Study|Administrative Problems|2
172431|NCT00171704|543121|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
172432|NCT00171704|543122|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
172433|NCT00171704|543121|P2|Overall Study|Disease Progression|9
172434|NCT00171704|543122|P1|Overall Study|Disease Progression|14
172435|NCT00171704|543121|P2|Overall Study|Adverse Event|33
172436|NCT00171704|543122|P1|Overall Study|Adverse Event|24
172437|NCT00172185|543146|P4|Overall Study|Withdrawal by Subject|0
172438|NCT00172185|543147|P3|Overall Study|Withdrawal by Subject|1
172439|NCT00172185|543148|P2|Overall Study|Withdrawal by Subject|0
172440|NCT00172185|543149|P1|Overall Study|Withdrawal by Subject|0
172441|NCT00172185|543146|P4|Overall Study|SPONSOR Decision|0
172442|NCT00172185|543147|P3|Overall Study|SPONSOR Decision|0
172443|NCT00172185|543148|P2|Overall Study|SPONSOR Decision|1
172444|NCT00172185|543149|P1|Overall Study|SPONSOR Decision|0
172445|NCT00172185|543146|P4|Overall Study|Physician Decision|0
172446|NCT00172185|543147|P3|Overall Study|Physician Decision|1
172447|NCT00172185|543148|P2|Overall Study|Physician Decision|0
172448|NCT00172185|543149|P1|Overall Study|Physician Decision|0
172449|NCT00172185|543146|P4|Overall Study|Adverse Event|4
172450|NCT00172185|543147|P3|Overall Study|Adverse Event|3
172451|NCT00172185|543148|P2|Overall Study|Adverse Event|1
172452|NCT00172185|543149|P1|Overall Study|Adverse Event|0
172453|NCT00171340|543165|P2|Overall Study|Death|6
172454|NCT00171340|543166|P1|Overall Study|Death|6
172455|NCT00171340|543165|P2|Overall Study|Administrative Problems|2
172456|NCT00171340|543166|P1|Overall Study|Administrative Problems|5
172457|NCT00171340|543165|P2|Overall Study|No Longer Required Study Drug|1
172458|NCT00171340|543166|P1|Overall Study|No Longer Required Study Drug|1
172459|NCT00171340|543165|P2|Overall Study|Abnormal Test Procedure Results|11
172460|NCT00171340|543166|P1|Overall Study|Abnormal Test Procedure Results|6
172461|NCT00171340|543165|P2|Overall Study|Abnormal Laboratory Results|0
172462|NCT00171340|543166|P1|Overall Study|Abnormal Laboratory Results|2
172463|NCT00171340|543165|P2|Overall Study|Lost to Follow-up|5
172464|NCT00171340|543166|P1|Overall Study|Lost to Follow-up|0
172465|NCT00171340|543165|P2|Overall Study|Withdrawal by Subject|19
172466|NCT00171340|543166|P1|Overall Study|Withdrawal by Subject|22
172467|NCT00171340|543165|P2|Overall Study|Protocol Violation|8
172468|NCT00171340|543166|P1|Overall Study|Protocol Violation|7
172469|NCT00171340|543165|P2|Overall Study|Lack of Efficacy|41
172470|NCT00171340|543166|P1|Overall Study|Lack of Efficacy|29
172471|NCT00171340|543165|P2|Overall Study|Adverse Event|42
172472|NCT00171340|543166|P1|Overall Study|Adverse Event|46
172473|NCT00171314|543182|P2|Overall Study|Death|1
172474|NCT00171314|543183|P1|Overall Study|Death|2
172475|NCT00171314|543182|P2|Overall Study|Lost to Follow-up|3
172476|NCT00171314|543183|P1|Overall Study|Lost to Follow-up|1
172477|NCT00171314|543182|P2|Overall Study|Administrative Problems|3
172478|NCT00171314|543183|P1|Overall Study|Administrative Problems|4
172479|NCT00171314|543182|P2|Overall Study|Protocol Violation|7
172480|NCT00171314|543183|P1|Overall Study|Protocol Violation|3
172481|NCT00171314|543182|P2|Overall Study|Abnormal Test Procedure Results|3
172482|NCT00171314|543183|P1|Overall Study|Abnormal Test Procedure Results|9
172483|NCT00171314|543182|P2|Overall Study|Withdrawal by Subject|6
172484|NCT00171314|543183|P1|Overall Study|Withdrawal by Subject|9
172485|NCT00171314|543182|P2|Overall Study|Lack of Efficacy|14
172486|NCT00171314|543183|P1|Overall Study|Lack of Efficacy|19
172487|NCT00171314|543182|P2|Overall Study|Adverse Event|41
172488|NCT00171314|543183|P1|Overall Study|Adverse Event|44
172489|NCT00171301|543199|P2|Overall Study|Withdrawal by Subject|1
172490|NCT00171301|543200|P1|Overall Study|Withdrawal by Subject|0
172491|NCT00171301|543199|P2|Overall Study|Protocol Violation|2
172492|NCT00171301|543200|P1|Overall Study|Protocol Violation|0
172493|NCT00171301|543199|P2|Overall Study|Lost to Follow-up|2
172494|NCT00171301|543200|P1|Overall Study|Lost to Follow-up|6
172495|NCT00171301|543199|P2|Overall Study|Adverse Event|2
172496|NCT00171301|543200|P1|Overall Study|Adverse Event|1
172497|NCT00171301|543199|P2|Overall Study|Death|2
172498|NCT00171301|543200|P1|Overall Study|Death|1
172499|NCT00171210|543213|P2|Overall Study|Stopped at end of extension 1|1
172500|NCT00171210|543214|P1|Overall Study|Stopped at end of extension 1|0
172501|NCT00171210|543213|P2|Overall Study|Stopped at end of core|32
172502|NCT00171210|543214|P1|Overall Study|Stopped at end of core|0
172503|NCT00171210|543213|P2|Overall Study|Death|3
172504|NCT00171210|543214|P1|Overall Study|Death|2
172505|NCT00171210|543213|P2|Overall Study|Administrative problems|1
172506|NCT00171210|543214|P1|Overall Study|Administrative problems|1
172507|NCT00171210|543213|P2|Overall Study|Lost to Follow-up|0
172508|NCT00171210|543214|P1|Overall Study|Lost to Follow-up|1
172509|NCT00171210|543213|P2|Overall Study|Withdrawal by Subject|30
172510|NCT00171210|543214|P1|Overall Study|Withdrawal by Subject|32
172511|NCT00171210|543213|P2|Overall Study|Protocol Violation|2
172512|NCT00171210|543214|P1|Overall Study|Protocol Violation|0
172513|NCT00171210|543213|P2|Overall Study|Unsatisfactory therapeutic effect|15
172514|NCT00171210|543214|P1|Overall Study|Unsatisfactory therapeutic effect|11
172515|NCT00171210|543213|P2|Overall Study|Abnormal test procedure result(s)|1
172516|NCT00171210|543214|P1|Overall Study|Abnormal test procedure result(s)|0
172517|NCT00171210|543213|P2|Overall Study|Abnormal laboratory value(s)|3
172518|NCT00171210|543214|P1|Overall Study|Abnormal laboratory value(s)|6
172519|NCT00171210|543213|P2|Overall Study|Adverse Event|27
172520|NCT00171210|543214|P1|Overall Study|Adverse Event|16
172521|NCT00171054|543244|P2|Overall Study|Condition no longer required study drug|1
172522|NCT00171054|543245|P1|Overall Study|Condition no longer required study drug|0
172523|NCT00171054|543244|P2|Overall Study|Adverse Event|8
172524|NCT00171054|543245|P1|Overall Study|Adverse Event|8
172525|NCT00171054|543244|P2|Overall Study|Lost to Follow-up|1
172526|NCT00171054|543245|P1|Overall Study|Lost to Follow-up|0
172527|NCT00171054|543244|P2|Overall Study|Patient withdrew consent|0
172528|NCT00171054|543245|P1|Overall Study|Patient withdrew consent|1
172529|NCT00171054|543244|P2|Overall Study|Protocol Violation|2
172530|NCT00171054|543245|P1|Overall Study|Protocol Violation|1
172531|NCT00170950|543277|P2|Overall Study|Termination Data Not Recorded|22
172532|NCT00170950|543278|P1|Overall Study|Termination Data Not Recorded|17
172533|NCT00170950|543277|P2|Overall Study|Missing|1
172534|NCT00170950|543278|P1|Overall Study|Missing|2
172535|NCT00170950|543277|P2|Overall Study|Lost to Follow-up|115
172536|NCT00170950|543278|P1|Overall Study|Lost to Follow-up|134
172537|NCT00170950|543277|P2|Overall Study|Withdrawal by Subject|498
172538|NCT00170950|543278|P1|Overall Study|Withdrawal by Subject|496
172539|NCT00170950|543277|P2|Overall Study|Death|274
172540|NCT00170950|543278|P1|Overall Study|Death|236
172541|NCT00170846|543291|P3|Overall Study|Reason Missing|0
172542|NCT00170846|543292|P2|Overall Study|Reason Missing|1
172543|NCT00170846|543293|P1|Overall Study|Reason Missing|0
172544|NCT00170846|543291|P3|Overall Study|Death|3
172545|NCT00170846|543292|P2|Overall Study|Death|3
172546|NCT00170846|543293|P1|Overall Study|Death|0
172547|NCT00170846|543291|P3|Overall Study|Lost to Follow-up|2
172548|NCT00170846|543292|P2|Overall Study|Lost to Follow-up|3
172549|NCT00170846|543293|P1|Overall Study|Lost to Follow-up|6
172550|NCT00170846|543291|P3|Overall Study|Subject withdrew Informed Consent|8
172551|NCT00170846|543292|P2|Overall Study|Subject withdrew Informed Consent|12
172552|NCT00170846|543293|P1|Overall Study|Subject withdrew Informed Consent|5
172553|NCT00168844|543321|P3|Overall Study|Other|9
172554|NCT00168844|543322|P2|Overall Study|Other|7
172555|NCT00168844|543323|P1|Overall Study|Other|6
172556|NCT00168844|543321|P3|Overall Study|Protocol Violation|4
172557|NCT00168844|543322|P2|Overall Study|Protocol Violation|2
172558|NCT00168844|543323|P1|Overall Study|Protocol Violation|2
172559|NCT00168844|543321|P3|Overall Study|Withdrawal by Subject|19
172560|NCT00168844|543322|P2|Overall Study|Withdrawal by Subject|9
172561|NCT00168844|543323|P1|Overall Study|Withdrawal by Subject|12
172562|NCT00168844|543321|P3|Overall Study|Lost to Follow-up|11
172563|NCT00168844|543322|P2|Overall Study|Lost to Follow-up|5
172564|NCT00168844|543323|P1|Overall Study|Lost to Follow-up|4
172565|NCT00168844|543321|P3|Overall Study|Adverse Event|48
172566|NCT00168844|543322|P2|Overall Study|Adverse Event|32
172567|NCT00168844|543323|P1|Overall Study|Adverse Event|31
172568|NCT00168831|543505|P3|Overall Study|Other|6
172569|NCT00168831|543506|P2|Overall Study|Other|3
172570|NCT00168831|543507|P1|Overall Study|Other|6
172571|NCT00168831|543505|P3|Overall Study|Protocol Violation|11
172572|NCT00168831|543506|P2|Overall Study|Protocol Violation|11
172573|NCT00168831|543507|P1|Overall Study|Protocol Violation|6
172574|NCT00168831|543505|P3|Overall Study|Withdrawal by Subject|19
172575|NCT00168831|543506|P2|Overall Study|Withdrawal by Subject|14
172576|NCT00168831|543507|P1|Overall Study|Withdrawal by Subject|7
172577|NCT00168831|543505|P3|Overall Study|Lost to Follow-up|4
172578|NCT00168831|543506|P2|Overall Study|Lost to Follow-up|6
172579|NCT00168831|543507|P1|Overall Study|Lost to Follow-up|5
172580|NCT00168831|543505|P3|Overall Study|Adverse Event|74
172581|NCT00168831|543506|P2|Overall Study|Adverse Event|47
172582|NCT00168831|543507|P1|Overall Study|Adverse Event|36
172583|NCT00168818|543689|P3|Treatment|not specified|31
172584|NCT00168818|543690|P2|Treatment|not specified|29
172585|NCT00168818|543691|P1|Treatment|not specified|23
172586|NCT00168818|543689|P3|Treatment|Withdrawal by Subject|22
172587|NCT00168818|543690|P2|Treatment|Withdrawal by Subject|20
172588|NCT00168818|543691|P1|Treatment|Withdrawal by Subject|25
172589|NCT00168818|543689|P3|Treatment|Lost to Follow-up|1
172590|NCT00168818|543690|P2|Treatment|Lost to Follow-up|2
172591|NCT00168818|543691|P1|Treatment|Lost to Follow-up|0
172592|NCT00168818|543689|P3|Treatment|Protocol Violation|11
172593|NCT00168818|543690|P2|Treatment|Protocol Violation|11
172594|NCT00168818|543691|P1|Treatment|Protocol Violation|8
172595|NCT00168818|543689|P3|Treatment|Adverse Event|68
172596|NCT00168818|543690|P2|Treatment|Adverse Event|89
172597|NCT00168818|543691|P1|Treatment|Adverse Event|77
172598|NCT00168818|543689|P3|Overall Study|not specified|30
172599|NCT00168818|543690|P2|Overall Study|not specified|24
172600|NCT00168818|543691|P1|Overall Study|not specified|22
172601|NCT00168818|543689|P3|Overall Study|Withdrawal by Subject|37
172602|NCT00168818|543690|P2|Overall Study|Withdrawal by Subject|41
172603|NCT00168818|543691|P1|Overall Study|Withdrawal by Subject|43
172604|NCT00168818|543689|P3|Overall Study|Lost to Follow-up|15
172605|NCT00168818|543690|P2|Overall Study|Lost to Follow-up|4
172606|NCT00168818|543691|P1|Overall Study|Lost to Follow-up|13
172607|NCT00168818|543689|P3|Overall Study|Protocol Violation|11
172608|NCT00168818|543690|P2|Overall Study|Protocol Violation|11
172609|NCT00168818|543691|P1|Overall Study|Protocol Violation|16
172610|NCT00168818|543689|P3|Overall Study|Adverse Event|31
172611|NCT00168818|543690|P2|Overall Study|Adverse Event|29
172612|NCT00168818|543691|P1|Overall Study|Adverse Event|23
172613|NCT00168805|543735|P3|Treatment|not specified|17
172614|NCT00168805|543736|P2|Treatment|not specified|18
172615|NCT00168805|543737|P1|Treatment|not specified|18
172616|NCT00168805|543735|P3|Treatment|Withdrawal by Subject|8
172617|NCT00168805|543736|P2|Treatment|Withdrawal by Subject|7
172618|NCT00168805|543737|P1|Treatment|Withdrawal by Subject|3
172619|NCT00168805|543735|P3|Treatment|Protocol Violation|5
172620|NCT00168805|543736|P2|Treatment|Protocol Violation|5
172621|NCT00168805|543737|P1|Treatment|Protocol Violation|3
172622|NCT00168805|543735|P3|Treatment|Adverse Event|32
172623|NCT00168805|543736|P2|Treatment|Adverse Event|26
172624|NCT00168805|543737|P1|Treatment|Adverse Event|25
172625|NCT00168805|543735|P3|Overall Study|not specified|22
172626|NCT00168805|543736|P2|Overall Study|not specified|21
172627|NCT00168805|543737|P1|Overall Study|not specified|24
172628|NCT00168805|543735|P3|Overall Study|Withdrawal by Subject|21
172629|NCT00168805|543736|P2|Overall Study|Withdrawal by Subject|18
172630|NCT00168805|543737|P1|Overall Study|Withdrawal by Subject|16
172631|NCT00168805|543735|P3|Overall Study|Lost to Follow-up|11
172632|NCT00168805|543736|P2|Overall Study|Lost to Follow-up|17
172633|NCT00168805|543737|P1|Overall Study|Lost to Follow-up|12
172634|NCT00168805|543735|P3|Overall Study|Protocol Violation|8
172635|NCT00168805|543736|P2|Overall Study|Protocol Violation|11
172636|NCT00168805|543737|P1|Overall Study|Protocol Violation|12
172637|NCT00168805|543735|P3|Overall Study|Adverse Event|16
172638|NCT00168805|543736|P2|Overall Study|Adverse Event|11
172639|NCT00168805|543737|P1|Overall Study|Adverse Event|7
172640|NCT00166296|543885|P2|Overall Study|Lost to Follow-up|2
172641|NCT00166296|543886|P1|Overall Study|Lost to Follow-up|4
172642|NCT00166296|543885|P2|Overall Study|Adverse Event|4
172643|NCT00166296|543886|P1|Overall Study|Adverse Event|2
172644|NCT00166296|543885|P2|Overall Study|Withdrawal by Subject|3
172645|NCT00166296|543886|P1|Overall Study|Withdrawal by Subject|1
172646|NCT00168103|544002|P4|Overall Study|Lost to Follow-up|0
172647|NCT00168103|544003|P3|Overall Study|Lost to Follow-up|0
172648|NCT00168103|544004|P2|Overall Study|Lost to Follow-up|3
172649|NCT00168103|544005|P1|Overall Study|Lost to Follow-up|1
172650|NCT00168103|544002|P4|Overall Study|Withdrawal by Subject|0
172651|NCT00168103|544003|P3|Overall Study|Withdrawal by Subject|1
172652|NCT00168103|544004|P2|Overall Study|Withdrawal by Subject|2
172653|NCT00168103|544005|P1|Overall Study|Withdrawal by Subject|1
172654|NCT00168064|544027|P2|Overall Study|Various|3
172655|NCT00168064|544028|P1|Overall Study|Various|4
172656|NCT00168064|544027|P2|Overall Study|Subject's Best interest|2
172657|NCT00168064|544028|P1|Overall Study|Subject's Best interest|2
172658|NCT00168064|544027|P2|Overall Study|Concurrent Illness|3
172659|NCT00168064|544028|P1|Overall Study|Concurrent Illness|4
172660|NCT00168064|544027|P2|Overall Study|Non-compliance|3
172661|NCT00168064|544028|P1|Overall Study|Non-compliance|2
172662|NCT00168064|544027|P2|Overall Study|Lost to Follow-up|3
172663|NCT00168064|544028|P1|Overall Study|Lost to Follow-up|4
172664|NCT00168064|544027|P2|Overall Study|Lack of Efficacy|4
172665|NCT00168064|544028|P1|Overall Study|Lack of Efficacy|4
172666|NCT00168064|544027|P2|Overall Study|Withdrawal by Subject|4
172667|NCT00168064|544028|P1|Overall Study|Withdrawal by Subject|3
172668|NCT00168064|544027|P2|Overall Study|Adverse Event|22
172669|NCT00168064|544028|P1|Overall Study|Adverse Event|26
172670|NCT00168038|544036|P1|Overall Study|Therapy failure|1
172671|NCT00168038|544036|P1|Overall Study|Adverse Event|1
172672|NCT00167778|544048|P1|Overall Study|Withdrawal by Subject|1
172673|NCT00166114|544123|P2|Overall Study|Adverse Event|1
172674|NCT00166114|544124|P1|Overall Study|Adverse Event|2
172675|NCT00166114|544123|P2|Overall Study|Withdrawal by Subject|4
172676|NCT00166114|544124|P1|Overall Study|Withdrawal by Subject|10
172677|NCT00166114|544123|P2|Overall Study|Protocol Violation|1
172678|NCT00166114|544124|P1|Overall Study|Protocol Violation|2
172679|NCT00167245|544149|P2|Overall Study|Drowsy|0
172680|NCT00167245|544150|P1|Overall Study|Drowsy|1
172681|NCT00167245|544149|P2|Overall Study|Incarcerated|2
172682|NCT00167245|544150|P1|Overall Study|Incarcerated|3
172683|NCT00167245|544149|P2|Overall Study|Withdrawal by Subject|8
172684|NCT00167245|544150|P1|Overall Study|Withdrawal by Subject|5
172685|NCT00167245|544149|P2|Overall Study|Lost to Follow-up|31
172686|NCT00167245|544150|P1|Overall Study|Lost to Follow-up|20
172687|NCT00165984|544192|P1|Overall Study|Death|15
172688|NCT00165841|544210|P2|Overall Study|Medication Noncompliance|1
172689|NCT00165841|544211|P1|Overall Study|Medication Noncompliance|1
172690|NCT00165841|544210|P2|Overall Study|Other|5
172691|NCT00165841|544211|P1|Overall Study|Other|3
172692|NCT00165841|544210|P2|Overall Study|Protocol Violation|8
172693|NCT00165841|544211|P1|Overall Study|Protocol Violation|6
172694|NCT00165841|544210|P2|Overall Study|Physician Decision|0
172695|NCT00165841|544211|P1|Overall Study|Physician Decision|1
172696|NCT00165841|544210|P2|Overall Study|Withdrawal by Subject|8
172697|NCT00165841|544211|P1|Overall Study|Withdrawal by Subject|7
172698|NCT00165841|544210|P2|Overall Study|Lost to Follow-up|4
172699|NCT00165841|544211|P1|Overall Study|Lost to Follow-up|4
172700|NCT00165841|544210|P2|Overall Study|Lack of Efficacy|33
172701|NCT00165841|544211|P1|Overall Study|Lack of Efficacy|6
172702|NCT00165841|544210|P2|Overall Study|Adverse Event|3
172703|NCT00165841|544211|P1|Overall Study|Adverse Event|2
172704|NCT00166712|544219|P2|Overall Study|Physician Decision|2
172705|NCT00166712|544220|P1|Overall Study|Physician Decision|0
172706|NCT00166712|544219|P2|Overall Study|Withdrawal by Subject|2
172707|NCT00166712|544220|P1|Overall Study|Withdrawal by Subject|1
172708|NCT00166712|544219|P2|Overall Study|Adverse Event|0
172709|NCT00166712|544220|P1|Overall Study|Adverse Event|1
172710|NCT00166712|544219|P2|Overall Study|Death|1
172711|NCT00166712|544220|P1|Overall Study|Death|0
172712|NCT00166517|544237|P2|Overall Study|Withdrawal by Subject|1
172713|NCT00166517|544238|P1|Overall Study|Withdrawal by Subject|0
172714|NCT00166517|544237|P2|Overall Study|Protocol Violation|1
172715|NCT00166517|544238|P1|Overall Study|Protocol Violation|4
172716|NCT00166517|544237|P2|Overall Study|Lost to Follow-up|0
172717|NCT00166517|544238|P1|Overall Study|Lost to Follow-up|1
172718|NCT00166504|544248|P2|Overall Study|Withdrawal by Subject|0
172719|NCT00166504|544249|P1|Overall Study|Withdrawal by Subject|1
172720|NCT00166504|544248|P2|Overall Study|Lost to Follow-up|1
172721|NCT00166504|544249|P1|Overall Study|Lost to Follow-up|1
172722|NCT00166504|544248|P2|Overall Study|Adverse Event|3
172723|NCT00166504|544249|P1|Overall Study|Adverse Event|3
172724|NCT00165789|544268|P4|Overall Study|Withdrawal by Subject|2
172725|NCT00165789|544269|P3|Overall Study|Withdrawal by Subject|1
172726|NCT00165789|544270|P2|Overall Study|Withdrawal by Subject|1
172727|NCT00165789|544271|P1|Overall Study|Withdrawal by Subject|0
172728|NCT00165789|544268|P4|Overall Study|Adverse Event|12
172729|NCT00165789|544269|P3|Overall Study|Adverse Event|0
172730|NCT00165789|544270|P2|Overall Study|Adverse Event|3
172731|NCT00165789|544271|P1|Overall Study|Adverse Event|0
172732|NCT00165776|544325|P4|Overall Study|Worsening of Cervical Dystonia|1
172733|NCT00165776|544326|P3|Overall Study|Worsening of Cervical Dystonia|0
172734|NCT00165776|544327|P2|Overall Study|Worsening of Cervical Dystonia|0
172735|NCT00165776|544328|P1|Overall Study|Worsening of Cervical Dystonia|0
172736|NCT00165776|544325|P4|Overall Study|Withdrawal by Subject|0
172737|NCT00165776|544326|P3|Overall Study|Withdrawal by Subject|2
172738|NCT00165776|544327|P2|Overall Study|Withdrawal by Subject|1
172739|NCT00165776|544328|P1|Overall Study|Withdrawal by Subject|4
172740|NCT00165776|544325|P4|Overall Study|Lack of Efficacy|1
172741|NCT00165776|544326|P3|Overall Study|Lack of Efficacy|0
172742|NCT00165776|544327|P2|Overall Study|Lack of Efficacy|0
172743|NCT00165776|544328|P1|Overall Study|Lack of Efficacy|0
172744|NCT00165698|544364|P2|Overall Study|Not Taken/Lost the medicine|2
172745|NCT00165698|544365|P1|Overall Study|Not Taken/Lost the medicine|1
172746|NCT00165698|544364|P2|Overall Study|Protocol Violation|0
172747|NCT00165698|544365|P1|Overall Study|Protocol Violation|1
172748|NCT00165698|544364|P2|Overall Study|Withdrawal by Subject|1
172749|NCT00165698|544365|P1|Overall Study|Withdrawal by Subject|2
172750|NCT00165698|544364|P2|Overall Study|Lost to Follow-up|2
172751|NCT00165698|544365|P1|Overall Study|Lost to Follow-up|2
172752|NCT00165698|544364|P2|Overall Study|Adverse Event|10
172753|NCT00165698|544365|P1|Overall Study|Adverse Event|2
172754|NCT00165672|544391|P2|Overall Study|Adverse Event|1
172755|NCT00165672|544392|P1|Overall Study|Adverse Event|0
172756|NCT00165646|544401|P3|Overall Study|Protocol Violation|0
172757|NCT00165646|544402|P2|Overall Study|Protocol Violation|0
172758|NCT00165646|544403|P1|Overall Study|Protocol Violation|1
172759|NCT00165646|544401|P3|Overall Study|Physician Decision|2
172760|NCT00165646|544402|P2|Overall Study|Physician Decision|0
172761|NCT00165646|544403|P1|Overall Study|Physician Decision|2
172762|NCT00165646|544401|P3|Overall Study|Withdrawal by Subject|1
172763|NCT00165646|544402|P2|Overall Study|Withdrawal by Subject|2
172764|NCT00165646|544403|P1|Overall Study|Withdrawal by Subject|0
172765|NCT00165646|544401|P3|Overall Study|Lack of Efficacy|0
172766|NCT00165646|544402|P2|Overall Study|Lack of Efficacy|2
172767|NCT00165646|544403|P1|Overall Study|Lack of Efficacy|1
172768|NCT00165646|544401|P3|Overall Study|Adverse Event|1
172769|NCT00165646|544402|P2|Overall Study|Adverse Event|1
172770|NCT00165646|544403|P1|Overall Study|Adverse Event|1
172771|NCT00165503|544411|P1|Overall Study|Unresectable|3
172772|NCT00165503|544411|P1|Overall Study|Lost to Follow-up|12
172773|NCT00165503|544411|P1|Overall Study|Death|1
172774|NCT00163657|544437|P3|Overall Study|Other reason|3
172775|NCT00163657|544438|P2|Overall Study|Other reason|1
172776|NCT00163657|544439|P1|Overall Study|Other reason|0
172777|NCT00163657|544437|P3|Overall Study|Lost to Follow-up|10
172778|NCT00163657|544438|P2|Overall Study|Lost to Follow-up|3
172779|NCT00163657|544439|P1|Overall Study|Lost to Follow-up|1
172780|NCT00163657|544437|P3|Overall Study|Non Compliance|0
172781|NCT00163657|544438|P2|Overall Study|Non Compliance|0
172782|NCT00163657|544439|P1|Overall Study|Non Compliance|1
172783|NCT00163657|544437|P3|Overall Study|Physician Decision|1
172784|NCT00163657|544438|P2|Overall Study|Physician Decision|1
172785|NCT00163657|544439|P1|Overall Study|Physician Decision|0
172786|NCT00163657|544437|P3|Overall Study|Withdrawal by Subject|2
172787|NCT00163657|544438|P2|Overall Study|Withdrawal by Subject|3
172788|NCT00163657|544439|P1|Overall Study|Withdrawal by Subject|2
172789|NCT00163657|544437|P3|Overall Study|graft loss|2
172790|NCT00163657|544438|P2|Overall Study|graft loss|1
172791|NCT00163657|544439|P1|Overall Study|graft loss|4
172792|NCT00163657|544437|P3|Overall Study|Death|19
172793|NCT00163657|544438|P2|Overall Study|Death|14
172794|NCT00163657|544439|P1|Overall Study|Death|12
172795|NCT00163215|544450|P1|Overall Study|Unspecified|7
172796|NCT00163215|544450|P1|Overall Study|Withdrawal by Subject|5
172797|NCT00163215|544450|P1|Overall Study|Lack of Efficacy|3
172798|NCT00163189|544470|P1|Overall Study|Did not meet continuation criterion|16
172799|NCT00163189|544470|P1|Overall Study|Withdrawal by Subject|11
172800|NCT00163189|544470|P1|Overall Study|Study terminated by sponsor|11
172801|NCT00163189|544470|P1|Overall Study|Lack of Efficacy|7
172802|NCT00163189|544470|P1|Overall Study|Adverse Event|6
172803|NCT00163189|544470|P1|Overall Study|Death|3
172804|NCT00163189|544470|P1|Overall Study|Protocol Violation|2
172805|NCT00163189|544470|P1|Overall Study|Lost to Follow-up|1
172806|NCT00163189|544470|P1|Overall Study|Unspecified|6
172807|NCT00163020|544494|P2|Overall Study|Lost to Follow-up|2
172808|NCT00163020|544495|P1|Overall Study|Lost to Follow-up|0
172809|NCT00162981|544535|P2|Overall Study|Physician Decision|0
172810|NCT00162981|544536|P1|Overall Study|Physician Decision|1
172811|NCT00162981|544535|P2|Overall Study|Withdrawal by Subject|1
172812|NCT00162981|544536|P1|Overall Study|Withdrawal by Subject|1
172813|NCT00162981|544535|P2|Overall Study|Adverse Event|5
172814|NCT00162981|544536|P1|Overall Study|Adverse Event|2
172815|NCT00162942|544552|P2|Overall Study|2 or more consecutive treatments missed|0
172816|NCT00162942|544553|P1|Overall Study|2 or more consecutive treatments missed|1
172817|NCT00162942|544552|P2|Overall Study|Flare During Active Treatment|3
172818|NCT00162942|544553|P1|Overall Study|Flare During Active Treatment|7
172819|NCT00162942|544552|P2|Overall Study|Lack of Efficacy|0
172820|NCT00162942|544553|P1|Overall Study|Lack of Efficacy|1
172821|NCT00162942|544552|P2|Overall Study|Alternate Therapy|2
172822|NCT00162942|544553|P1|Overall Study|Alternate Therapy|6
172823|NCT00162942|544552|P2|Overall Study|Enter Open-Label Study|35
172824|NCT00162942|544553|P1|Overall Study|Enter Open-Label Study|76
172825|NCT00162942|544552|P2|Overall Study|Physician Decision|0
172826|NCT00162942|544553|P1|Overall Study|Physician Decision|1
172827|NCT00162942|544552|P2|Overall Study|Withdrawal by Subject|6
172828|NCT00162942|544553|P1|Overall Study|Withdrawal by Subject|3
172829|NCT00162942|544552|P2|Overall Study|Death|0
172830|NCT00162942|544553|P1|Overall Study|Death|1
172831|NCT00162942|544552|P2|Overall Study|Adverse Event|6
172832|NCT00162942|544553|P1|Overall Study|Adverse Event|10
172833|NCT00162370|544601|P1|Efficacy Population|Lost to Follow-up|51
172834|NCT00162266|544609|P4|Open-Label Period|Other Reasons|15
172835|NCT00162266|544610|P3|Open-Label Period|Other Reasons|0
172836|NCT00162266|544611|P2|Open-Label Period|Other Reasons|0
172837|NCT00162266|544612|P1|Open-Label Period|Other Reasons|0
172838|NCT00162266|544609|P4|Open-Label Period|Administrative Reason By Sponsor|9
172839|NCT00162266|544610|P3|Open-Label Period|Administrative Reason By Sponsor|0
172840|NCT00162266|544611|P2|Open-Label Period|Administrative Reason By Sponsor|0
172841|NCT00162266|544612|P1|Open-Label Period|Administrative Reason By Sponsor|0
172842|NCT00162266|544609|P4|Open-Label Period|Withdrawal by Subject|31
172843|NCT00162266|544610|P3|Open-Label Period|Withdrawal by Subject|0
172844|NCT00162266|544611|P2|Open-Label Period|Withdrawal by Subject|0
172845|NCT00162266|544612|P1|Open-Label Period|Withdrawal by Subject|0
172846|NCT00162266|544609|P4|Open-Label Period|Lost to Follow-up|3
172847|NCT00162266|544610|P3|Open-Label Period|Lost to Follow-up|0
172848|NCT00162266|544611|P2|Open-Label Period|Lost to Follow-up|0
172849|NCT00162266|544612|P1|Open-Label Period|Lost to Follow-up|0
172850|NCT00162266|544609|P4|Open-Label Period|Lack of Efficacy|26
172851|NCT00162266|544610|P3|Open-Label Period|Lack of Efficacy|0
172852|NCT00162266|544611|P2|Open-Label Period|Lack of Efficacy|0
172853|NCT00162266|544612|P1|Open-Label Period|Lack of Efficacy|0
172854|NCT00162266|544609|P4|Open-Label Period|Adverse Event|46
172855|NCT00162266|544610|P3|Open-Label Period|Adverse Event|0
172856|NCT00162266|544611|P2|Open-Label Period|Adverse Event|0
172857|NCT00162266|544612|P1|Open-Label Period|Adverse Event|0
172858|NCT00162266|544609|P4|Open-Label Period|Death|7
172859|NCT00162266|544610|P3|Open-Label Period|Death|0
172860|NCT00162266|544611|P2|Open-Label Period|Death|0
172861|NCT00162266|544612|P1|Open-Label Period|Death|0
172862|NCT00162266|544609|P4|Double-Blind Period|Withdrawal by Subject|0
172863|NCT00162266|544610|P3|Double-Blind Period|Withdrawal by Subject|6
172864|NCT00162266|544611|P2|Double-Blind Period|Withdrawal by Subject|2
172865|NCT00162266|544612|P1|Double-Blind Period|Withdrawal by Subject|5
172866|NCT00162266|544609|P4|Double-Blind Period|Lack of Efficacy|0
172867|NCT00162266|544610|P3|Double-Blind Period|Lack of Efficacy|30
172868|NCT00162266|544611|P2|Double-Blind Period|Lack of Efficacy|17
172869|NCT00162266|544612|P1|Double-Blind Period|Lack of Efficacy|13
172870|NCT00162266|544609|P4|Double-Blind Period|Other Reason|0
172871|NCT00162266|544610|P3|Double-Blind Period|Other Reason|1
172872|NCT00162266|544611|P2|Double-Blind Period|Other Reason|0
172873|NCT00162266|544612|P1|Double-Blind Period|Other Reason|1
172874|NCT00162266|544609|P4|Double-Blind Period|Lost to Follow-up|0
172875|NCT00162266|544610|P3|Double-Blind Period|Lost to Follow-up|0
172876|NCT00162266|544611|P2|Double-Blind Period|Lost to Follow-up|2
172877|NCT00162266|544612|P1|Double-Blind Period|Lost to Follow-up|1
172878|NCT00162266|544609|P4|Double-Blind Period|Death|0
172879|NCT00162266|544610|P3|Double-Blind Period|Death|0
172880|NCT00162266|544611|P2|Double-Blind Period|Death|1
172881|NCT00162266|544612|P1|Double-Blind Period|Death|0
172882|NCT00162266|544609|P4|Double-Blind Period|Adverse Event|0
172883|NCT00162266|544610|P3|Double-Blind Period|Adverse Event|11
172884|NCT00162266|544611|P2|Double-Blind Period|Adverse Event|9
172885|NCT00162266|544612|P1|Double-Blind Period|Adverse Event|5
172886|NCT00162136|544813|P1|Overall Study|Withdrawal by Subject|1
172887|NCT00162136|544813|P1|Overall Study|Study Drug Toxicity|4
172888|NCT00162136|544813|P1|Overall Study|Investigator Request|5
172889|NCT00162136|544813|P1|Overall Study|Disease Progression/Relapse|23
172890|NCT00162136|544813|P1|Overall Study|Death|1
172891|NCT00162136|544813|P1|Overall Study|Adverse Event|1
172892|NCT00162123|544845|P8|Overall Study|Follow-up only (not treated or assessed)|57
172893|NCT00162123|544846|P7|Overall Study|Follow-up only (not treated or assessed)|0
172894|NCT00162123|544847|P6|Overall Study|Follow-up only (not treated or assessed)|0
172895|NCT00162123|544848|P5|Overall Study|Follow-up only (not treated or assessed)|0
172896|NCT00162123|544849|P4|Overall Study|Follow-up only (not treated or assessed)|0
172897|NCT00162123|544850|P3|Overall Study|Follow-up only (not treated or assessed)|0
172898|NCT00162123|544851|P2|Overall Study|Follow-up only (not treated or assessed)|0
172899|NCT00162123|544852|P1|Overall Study|Follow-up only (not treated or assessed)|0
172900|NCT00162123|544845|P8|Overall Study|Tumor assessment only (not treated)|1
172901|NCT00162123|544846|P7|Overall Study|Tumor assessment only (not treated)|0
172902|NCT00162123|544847|P6|Overall Study|Tumor assessment only (not treated)|0
172903|NCT00162123|544848|P5|Overall Study|Tumor assessment only (not treated)|0
172904|NCT00162123|544849|P4|Overall Study|Tumor assessment only (not treated)|0
172905|NCT00162123|544850|P3|Overall Study|Tumor assessment only (not treated)|0
172906|NCT00162123|544851|P2|Overall Study|Tumor assessment only (not treated)|0
172907|NCT00162123|544852|P1|Overall Study|Tumor assessment only (not treated)|0
172908|NCT00162123|544845|P8|Overall Study|Physician Decision|0
172909|NCT00162123|544846|P7|Overall Study|Physician Decision|1
172910|NCT00162123|544847|P6|Overall Study|Physician Decision|1
172911|NCT00162123|544848|P5|Overall Study|Physician Decision|0
172912|NCT00162123|544849|P4|Overall Study|Physician Decision|0
172913|NCT00162123|544850|P3|Overall Study|Physician Decision|0
172914|NCT00162123|544851|P2|Overall Study|Physician Decision|2
172915|NCT00162123|544852|P1|Overall Study|Physician Decision|1
172916|NCT00162123|544845|P8|Overall Study|Not specified (after start of treatment)|0
172917|NCT00162123|544846|P7|Overall Study|Not specified (after start of treatment)|0
172918|NCT00162123|544847|P6|Overall Study|Not specified (after start of treatment)|0
172919|NCT00162123|544848|P5|Overall Study|Not specified (after start of treatment)|3
172920|NCT00162123|544849|P4|Overall Study|Not specified (after start of treatment)|0
172921|NCT00162123|544850|P3|Overall Study|Not specified (after start of treatment)|0
172922|NCT00162123|544851|P2|Overall Study|Not specified (after start of treatment)|0
172923|NCT00162123|544852|P1|Overall Study|Not specified (after start of treatment)|0
172924|NCT00162123|544845|P8|Overall Study|Not specified (before treatment)|0
172925|NCT00162123|544846|P7|Overall Study|Not specified (before treatment)|0
172926|NCT00162123|544847|P6|Overall Study|Not specified (before treatment)|1
172927|NCT00162123|544848|P5|Overall Study|Not specified (before treatment)|12
172928|NCT00162123|544849|P4|Overall Study|Not specified (before treatment)|0
172929|NCT00162123|544850|P3|Overall Study|Not specified (before treatment)|0
172930|NCT00162123|544851|P2|Overall Study|Not specified (before treatment)|0
172931|NCT00162123|544852|P1|Overall Study|Not specified (before treatment)|2
172932|NCT00162123|544845|P8|Overall Study|Adverse Event|0
172933|NCT00162123|544846|P7|Overall Study|Adverse Event|0
172934|NCT00162123|544847|P6|Overall Study|Adverse Event|0
172935|NCT00162123|544848|P5|Overall Study|Adverse Event|1
172936|NCT00162123|544849|P4|Overall Study|Adverse Event|2
172937|NCT00162123|544850|P3|Overall Study|Adverse Event|0
172938|NCT00162123|544851|P2|Overall Study|Adverse Event|2
172939|NCT00162123|544852|P1|Overall Study|Adverse Event|1
172940|NCT00162123|544845|P8|Overall Study|Deterioration without progression|0
172941|NCT00162123|544846|P7|Overall Study|Deterioration without progression|0
172942|NCT00162123|544847|P6|Overall Study|Deterioration without progression|0
172943|NCT00162123|544848|P5|Overall Study|Deterioration without progression|1
172944|NCT00162123|544849|P4|Overall Study|Deterioration without progression|0
172945|NCT00162123|544850|P3|Overall Study|Deterioration without progression|3
172946|NCT00162123|544851|P2|Overall Study|Deterioration without progression|2
172947|NCT00162123|544852|P1|Overall Study|Deterioration without progression|2
172948|NCT00162123|544845|P8|Overall Study|Withdrawal by Subject|0
172949|NCT00162123|544846|P7|Overall Study|Withdrawal by Subject|1
172950|NCT00162123|544847|P6|Overall Study|Withdrawal by Subject|2
172951|NCT00162123|544848|P5|Overall Study|Withdrawal by Subject|1
172952|NCT00162123|544849|P4|Overall Study|Withdrawal by Subject|1
172953|NCT00162123|544850|P3|Overall Study|Withdrawal by Subject|2
172954|NCT00162123|544851|P2|Overall Study|Withdrawal by Subject|0
172955|NCT00162123|544852|P1|Overall Study|Withdrawal by Subject|2
172956|NCT00162123|544845|P8|Overall Study|Death|0
172957|NCT00162123|544846|P7|Overall Study|Death|0
172958|NCT00162123|544847|P6|Overall Study|Death|1
172959|NCT00162123|544848|P5|Overall Study|Death|1
172960|NCT00162123|544849|P4|Overall Study|Death|1
172961|NCT00162123|544850|P3|Overall Study|Death|1
172962|NCT00162123|544851|P2|Overall Study|Death|3
172963|NCT00162123|544852|P1|Overall Study|Death|3
172964|NCT00162123|544845|P8|Overall Study|Study drug toxicity|0
172965|NCT00162123|544846|P7|Overall Study|Study drug toxicity|1
172966|NCT00162123|544847|P6|Overall Study|Study drug toxicity|1
172967|NCT00162123|544848|P5|Overall Study|Study drug toxicity|4
172968|NCT00162123|544849|P4|Overall Study|Study drug toxicity|0
172969|NCT00162123|544850|P3|Overall Study|Study drug toxicity|5
172970|NCT00162123|544851|P2|Overall Study|Study drug toxicity|1
172971|NCT00162123|544852|P1|Overall Study|Study drug toxicity|6
172972|NCT00162123|544845|P8|Overall Study|Disease progression|0
172973|NCT00162123|544846|P7|Overall Study|Disease progression|1
172974|NCT00162123|544847|P6|Overall Study|Disease progression|3
172975|NCT00162123|544848|P5|Overall Study|Disease progression|8
172976|NCT00162123|544849|P4|Overall Study|Disease progression|4
172977|NCT00162123|544850|P3|Overall Study|Disease progression|10
172978|NCT00162123|544851|P2|Overall Study|Disease progression|19
172979|NCT00162123|544852|P1|Overall Study|Disease progression|27
172980|NCT00162097|544885|P4|Overall Study|Participant no longer met study criteria|1
172981|NCT00162097|544886|P3|Overall Study|Participant no longer met study criteria|0
172982|NCT00162097|544887|P2|Overall Study|Participant no longer met study criteria|0
172983|NCT00162097|544888|P1|Overall Study|Participant no longer met study criteria|0
172984|NCT00162032|544950|P2|Overall Study|Reason not specified|0
172985|NCT00162032|544951|P1|Overall Study|Reason not specified|1
172986|NCT00162032|544950|P2|Overall Study|Lost to Follow-up|2
172987|NCT00162032|544951|P1|Overall Study|Lost to Follow-up|4
172988|NCT00161616|544961|P2|Overall Study|Protocol deviation|0
172989|NCT00161616|544962|P1|Overall Study|Protocol deviation|1
172990|NCT00161616|544961|P2|Overall Study|Lost to Follow-up|13
172991|NCT00161616|544962|P1|Overall Study|Lost to Follow-up|17
172992|NCT00161616|544961|P2|Overall Study|Death|1
172993|NCT00161616|544962|P1|Overall Study|Death|1
172994|NCT00161616|544961|P2|Overall Study|Physician Decision|0
172995|NCT00161616|544962|P1|Overall Study|Physician Decision|1
172996|NCT00161616|544961|P2|Overall Study|Withdrawal by Subject|5
172997|NCT00161616|544962|P1|Overall Study|Withdrawal by Subject|6
172998|NCT00161213|544994|P1|Overall Study|Evaluable for toxicity but not response|1
172999|NCT00161213|544994|P1|Overall Study|Withdrawal by Subject|1
173000|NCT00160706|545001|P1|Overall Study|Other Reason|11
173001|NCT00160706|545001|P1|Overall Study|Lack of Efficacy and Other|1
173002|NCT00160706|545001|P1|Overall Study|Lack of Efficacy|42
173003|NCT00160706|545001|P1|Overall Study|Lost to Follow-up and Other|1
173004|NCT00160706|545001|P1|Overall Study|Lost to Follow-up|4
173005|NCT00160706|545001|P1|Overall Study|Physician Decision and Other|3
173006|NCT00160706|545001|P1|Overall Study|Physician Decision|10
173007|NCT00160706|545001|P1|Overall Study|Withdrawal by Subject and Other|12
173008|NCT00160706|545001|P1|Overall Study|Withdrawal by Subject|41
173009|NCT00160706|545001|P1|Overall Study|Protocol Violation|3
173010|NCT00160706|545001|P1|Overall Study|Adverse Event and Other Reason|105
173011|NCT00160706|545001|P1|Overall Study|Adverse Event|53
173012|NCT00160693|545013|P1|Overall Study|Study terminated by sponsor|15
173013|NCT00160693|545013|P1|Overall Study|Withdrawal by Subject|54
173014|NCT00160693|545013|P1|Overall Study|Lost to Follow-up|15
173015|NCT00160693|545013|P1|Overall Study|Protocol Violation|24
173016|NCT00160693|545013|P1|Overall Study|Lack of Efficacy|30
173017|NCT00160693|545013|P1|Overall Study|Adverse Event|97
173018|NCT00160641|545030|P1|Overall Study|Unspecified|9
173019|NCT00160641|545030|P1|Overall Study|Protocol Violation|3
173020|NCT00160641|545030|P1|Overall Study|Lack of Efficacy|12
173021|NCT00160641|545030|P1|Overall Study|Lost to Follow-up|8
173022|NCT00160641|545030|P1|Overall Study|Withdrawal by Subject|87
173023|NCT00160641|545030|P1|Overall Study|Adverse Event|102
173024|NCT00160563|545064|P3|Overall Study|Missing reason|0
173025|NCT00160563|545065|P2|Overall Study|Missing reason|1
173026|NCT00160563|545066|P1|Overall Study|Missing reason|0
173027|NCT00160563|545064|P3|Overall Study|Other (listed in the study report)|81
173028|NCT00160563|545065|P2|Overall Study|Other (listed in the study report)|40
173029|NCT00160563|545066|P1|Overall Study|Other (listed in the study report)|48
173030|NCT00160563|545064|P3|Overall Study|Withdrawal by Subject|3
173031|NCT00160563|545065|P2|Overall Study|Withdrawal by Subject|2
173032|NCT00160563|545066|P1|Overall Study|Withdrawal by Subject|1
173033|NCT00160563|545064|P3|Overall Study|Protocol Violation|3
173034|NCT00160563|545065|P2|Overall Study|Protocol Violation|0
173035|NCT00160563|545066|P1|Overall Study|Protocol Violation|0
173036|NCT00160563|545064|P3|Overall Study|Lost to Follow-up|2
173037|NCT00160563|545065|P2|Overall Study|Lost to Follow-up|1
173038|NCT00160563|545066|P1|Overall Study|Lost to Follow-up|1
173039|NCT00160563|545064|P3|Overall Study|Adverse Event|1
173040|NCT00160563|545065|P2|Overall Study|Adverse Event|1
173041|NCT00160563|545066|P1|Overall Study|Adverse Event|1
173042|NCT00160524|545078|P1|Overall Study|Other|20
173043|NCT00160524|545078|P1|Overall Study|Lack of Efficacy and Other|1
173044|NCT00160524|545078|P1|Overall Study|Lack of Efficacy|21
173045|NCT00160524|545078|P1|Overall Study|Lost to Follow-up and Other|1
173046|NCT00160524|545078|P1|Overall Study|Lost to Follow-up|13
173047|NCT00160524|545078|P1|Overall Study|Physician Decision and Other|6
173048|NCT00160524|545078|P1|Overall Study|Physician Decision|27
173049|NCT00160524|545078|P1|Overall Study|Withdrawal by Subject and Other|17
173050|NCT00160524|545078|P1|Overall Study|Withdrawal by Subject|141
173051|NCT00160524|545078|P1|Overall Study|Protocol Violation and Other|2
173052|NCT00160524|545078|P1|Overall Study|Protocol Violation|16
173053|NCT00160524|545078|P1|Overall Study|Adverse Event and Other|94
173054|NCT00160524|545078|P1|Overall Study|Adverse Event|119
173055|NCT00160251|545095|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
173056|NCT00160251|545096|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
173057|NCT00160251|545097|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
173058|NCT00160251|545098|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
173059|NCT00160251|545099|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
173060|NCT00160251|545100|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
173061|NCT00160251|545101|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
173062|NCT00160251|545102|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
173063|NCT00160251|545095|P8|Post-amendment 2|Lack of Efficacy|24
173064|NCT00160251|545096|P7|Post-amendment 2|Lack of Efficacy|0
173065|NCT00160251|545097|P6|Post-amendment 2|Lack of Efficacy|0
173066|NCT00160251|545098|P5|Post-amendment 2|Lack of Efficacy|0
173067|NCT00160251|545099|P4|Post-amendment 2|Lack of Efficacy|0
173068|NCT00160251|545100|P3|Post-amendment 2|Lack of Efficacy|0
173069|NCT00160251|545101|P2|Post-amendment 2|Lack of Efficacy|0
173070|NCT00160251|545102|P1|Post-amendment 2|Lack of Efficacy|0
173071|NCT00160251|545095|P8|Post-amendment 2|Adverse Event|20
173072|NCT00160251|545096|P7|Post-amendment 2|Adverse Event|0
173073|NCT00160251|545097|P6|Post-amendment 2|Adverse Event|0
173074|NCT00160251|545098|P5|Post-amendment 2|Adverse Event|0
173075|NCT00160251|545099|P4|Post-amendment 2|Adverse Event|0
173076|NCT00160251|545100|P3|Post-amendment 2|Adverse Event|0
173077|NCT00160251|545101|P2|Post-amendment 2|Adverse Event|0
173078|NCT00160251|545102|P1|Post-amendment 2|Adverse Event|0
173079|NCT00160251|545095|P8|Prior to Amendment 2|Completed Treatment Phase|0
173080|NCT00160251|545096|P7|Prior to Amendment 2|Completed Treatment Phase|0
173081|NCT00160251|545097|P6|Prior to Amendment 2|Completed Treatment Phase|23
173082|NCT00160251|545098|P5|Prior to Amendment 2|Completed Treatment Phase|0
173083|NCT00160251|545099|P4|Prior to Amendment 2|Completed Treatment Phase|0
173084|NCT00160251|545100|P3|Prior to Amendment 2|Completed Treatment Phase|0
173085|NCT00160251|545101|P2|Prior to Amendment 2|Completed Treatment Phase|0
173086|NCT00160251|545102|P1|Prior to Amendment 2|Completed Treatment Phase|3
173087|NCT00160251|545095|P8|Prior to Amendment 2|Noncompliance with protocol|0
173088|NCT00160251|545096|P7|Prior to Amendment 2|Noncompliance with protocol|0
173089|NCT00160251|545097|P6|Prior to Amendment 2|Noncompliance with protocol|0
173090|NCT00160251|545098|P5|Prior to Amendment 2|Noncompliance with protocol|0
173091|NCT00160251|545099|P4|Prior to Amendment 2|Noncompliance with protocol|0
173092|NCT00160251|545100|P3|Prior to Amendment 2|Noncompliance with protocol|0
173093|NCT00160251|545101|P2|Prior to Amendment 2|Noncompliance with protocol|0
173094|NCT00160251|545102|P1|Prior to Amendment 2|Noncompliance with protocol|1
173095|NCT00160251|545095|P8|Prior to Amendment 2|Withdrawal by Subject|0
173096|NCT00160251|545096|P7|Prior to Amendment 2|Withdrawal by Subject|3
173097|NCT00160251|545097|P6|Prior to Amendment 2|Withdrawal by Subject|3
173098|NCT00160251|545098|P5|Prior to Amendment 2|Withdrawal by Subject|2
173099|NCT00160251|545099|P4|Prior to Amendment 2|Withdrawal by Subject|4
173100|NCT00160251|545100|P3|Prior to Amendment 2|Withdrawal by Subject|3
173101|NCT00160251|545101|P2|Prior to Amendment 2|Withdrawal by Subject|1
173102|NCT00160251|545102|P1|Prior to Amendment 2|Withdrawal by Subject|3
173103|NCT00160251|545095|P8|Prior to Amendment 2|Lost to Follow-up|0
173104|NCT00160251|545096|P7|Prior to Amendment 2|Lost to Follow-up|0
173105|NCT00160251|545097|P6|Prior to Amendment 2|Lost to Follow-up|1
173106|NCT00160251|545098|P5|Prior to Amendment 2|Lost to Follow-up|1
173107|NCT00160251|545099|P4|Prior to Amendment 2|Lost to Follow-up|0
173108|NCT00160251|545100|P3|Prior to Amendment 2|Lost to Follow-up|1
173109|NCT00160251|545101|P2|Prior to Amendment 2|Lost to Follow-up|0
173110|NCT00160251|545102|P1|Prior to Amendment 2|Lost to Follow-up|0
173111|NCT00160251|545095|P8|Prior to Amendment 2|Lack of Efficacy|0
173112|NCT00160251|545096|P7|Prior to Amendment 2|Lack of Efficacy|0
173113|NCT00160251|545097|P6|Prior to Amendment 2|Lack of Efficacy|55
173114|NCT00160251|545098|P5|Prior to Amendment 2|Lack of Efficacy|24
173115|NCT00160251|545099|P4|Prior to Amendment 2|Lack of Efficacy|35
173116|NCT00160251|545100|P3|Prior to Amendment 2|Lack of Efficacy|37
173117|NCT00160251|545101|P2|Prior to Amendment 2|Lack of Efficacy|4
173118|NCT00160251|545102|P1|Prior to Amendment 2|Lack of Efficacy|0
173119|NCT00160251|545095|P8|Prior to Amendment 2|Adverse Event|0
173120|NCT00160251|545096|P7|Prior to Amendment 2|Adverse Event|1
173121|NCT00160251|545097|P6|Prior to Amendment 2|Adverse Event|1
173122|NCT00160251|545098|P5|Prior to Amendment 2|Adverse Event|1
173123|NCT00160251|545099|P4|Prior to Amendment 2|Adverse Event|1
173124|NCT00160251|545100|P3|Prior to Amendment 2|Adverse Event|3
173125|NCT00160251|545101|P2|Prior to Amendment 2|Adverse Event|1
173126|NCT00160251|545102|P1|Prior to Amendment 2|Adverse Event|2
173127|NCT00160199|545178|P2|Overall Study|Protocol Violation|8
173128|NCT00160199|545179|P1|Overall Study|Protocol Violation|8
173129|NCT00160199|545178|P2|Overall Study|Administrative|1
173130|NCT00160199|545179|P1|Overall Study|Administrative|0
173131|NCT00160199|545178|P2|Overall Study|Withdrawal by Subject|6
173132|NCT00160199|545179|P1|Overall Study|Withdrawal by Subject|4
173133|NCT00160199|545178|P2|Overall Study|Lost to Follow-up|7
173134|NCT00160199|545179|P1|Overall Study|Lost to Follow-up|7
173135|NCT00160199|545178|P2|Overall Study|Lack of Efficacy|1
173136|NCT00160199|545179|P1|Overall Study|Lack of Efficacy|0
173137|NCT00160199|545178|P2|Overall Study|Adverse Event|14
173138|NCT00160199|545179|P1|Overall Study|Adverse Event|5
173139|NCT00159913|545236|P4|Overall Study|Protocol Violation|0
173140|NCT00159913|545237|P3|Overall Study|Protocol Violation|1
173141|NCT00159913|545238|P2|Overall Study|Protocol Violation|0
173142|NCT00159913|545239|P1|Overall Study|Protocol Violation|1
173143|NCT00159913|545236|P4|Overall Study|Lost to Follow-up|1
173144|NCT00159913|545237|P3|Overall Study|Lost to Follow-up|0
173145|NCT00159913|545238|P2|Overall Study|Lost to Follow-up|0
173146|NCT00159913|545239|P1|Overall Study|Lost to Follow-up|0
173147|NCT00159913|545236|P4|Overall Study|Withdrawal by Subject|1
173148|NCT00159913|545237|P3|Overall Study|Withdrawal by Subject|0
173149|NCT00159913|545238|P2|Overall Study|Withdrawal by Subject|0
173150|NCT00159913|545239|P1|Overall Study|Withdrawal by Subject|0
173151|NCT00159913|545236|P4|Overall Study|Adverse Event|0
173152|NCT00159913|545237|P3|Overall Study|Adverse Event|1
173153|NCT00159913|545238|P2|Overall Study|Adverse Event|0
173154|NCT00159913|545239|P1|Overall Study|Adverse Event|1
173155|NCT00159874|545313|P7|Overall Study|Pregnancy|0
173156|NCT00159874|545314|P6|Overall Study|Pregnancy|0
173157|NCT00159874|545315|P5|Overall Study|Pregnancy|0
173158|NCT00159874|545316|P4|Overall Study|Pregnancy|0
173159|NCT00159874|545317|P3|Overall Study|Pregnancy|0
173160|NCT00159874|545318|P2|Overall Study|Pregnancy|1
173161|NCT00159874|545319|P1|Overall Study|Pregnancy|1
173162|NCT00159874|545313|P7|Overall Study|Withdrawal by Subject|1
173163|NCT00159874|545314|P6|Overall Study|Withdrawal by Subject|2
173164|NCT00159874|545315|P5|Overall Study|Withdrawal by Subject|3
173165|NCT00159874|545316|P4|Overall Study|Withdrawal by Subject|4
173166|NCT00159874|545317|P3|Overall Study|Withdrawal by Subject|8
173167|NCT00159874|545318|P2|Overall Study|Withdrawal by Subject|6
173168|NCT00159874|545319|P1|Overall Study|Withdrawal by Subject|2
173169|NCT00159874|545313|P7|Overall Study|Death|0
173170|NCT00159874|545314|P6|Overall Study|Death|2
173171|NCT00159874|545315|P5|Overall Study|Death|1
173172|NCT00159874|545316|P4|Overall Study|Death|0
173173|NCT00159874|545317|P3|Overall Study|Death|15
173174|NCT00159874|545318|P2|Overall Study|Death|8
173175|NCT00159874|545319|P1|Overall Study|Death|3
173176|NCT00159874|545313|P7|Overall Study|Protocol Violation|0
173177|NCT00159874|545314|P6|Overall Study|Protocol Violation|0
173178|NCT00159874|545315|P5|Overall Study|Protocol Violation|0
173179|NCT00159874|545316|P4|Overall Study|Protocol Violation|0
173180|NCT00159874|545317|P3|Overall Study|Protocol Violation|2
173181|NCT00159874|545318|P2|Overall Study|Protocol Violation|5
173182|NCT00159874|545319|P1|Overall Study|Protocol Violation|0
173183|NCT00159874|545313|P7|Overall Study|Not specified|3
173184|NCT00159874|545314|P6|Overall Study|Not specified|1
173185|NCT00159874|545315|P5|Overall Study|Not specified|2
173186|NCT00159874|545316|P4|Overall Study|Not specified|0
173187|NCT00159874|545317|P3|Overall Study|Not specified|8
173188|NCT00159874|545318|P2|Overall Study|Not specified|8
173189|NCT00159874|545319|P1|Overall Study|Not specified|8
173190|NCT00159874|545313|P7|Overall Study|Lost to Follow-up|1
173191|NCT00159874|545314|P6|Overall Study|Lost to Follow-up|2
173192|NCT00159874|545315|P5|Overall Study|Lost to Follow-up|1
173193|NCT00159874|545316|P4|Overall Study|Lost to Follow-up|0
173194|NCT00159874|545317|P3|Overall Study|Lost to Follow-up|3
173195|NCT00159874|545318|P2|Overall Study|Lost to Follow-up|0
173196|NCT00159874|545319|P1|Overall Study|Lost to Follow-up|1
173197|NCT00159874|545313|P7|Overall Study|Lack of Efficacy|0
173198|NCT00159874|545314|P6|Overall Study|Lack of Efficacy|3
173199|NCT00159874|545315|P5|Overall Study|Lack of Efficacy|0
173200|NCT00159874|545316|P4|Overall Study|Lack of Efficacy|1
173201|NCT00159874|545317|P3|Overall Study|Lack of Efficacy|1
173202|NCT00159874|545318|P2|Overall Study|Lack of Efficacy|0
173203|NCT00159874|545319|P1|Overall Study|Lack of Efficacy|2
173204|NCT00159874|545313|P7|Overall Study|Does Not Meet Entrance Criteria|0
173205|NCT00159874|545314|P6|Overall Study|Does Not Meet Entrance Criteria|0
173206|NCT00159874|545315|P5|Overall Study|Does Not Meet Entrance Criteria|0
173207|NCT00159874|545316|P4|Overall Study|Does Not Meet Entrance Criteria|0
173208|NCT00159874|545317|P3|Overall Study|Does Not Meet Entrance Criteria|1
173209|NCT00159874|545318|P2|Overall Study|Does Not Meet Entrance Criteria|0
173210|NCT00159874|545319|P1|Overall Study|Does Not Meet Entrance Criteria|1
173211|NCT00159874|545313|P7|Overall Study|Adverse Event|0
173212|NCT00159874|545314|P6|Overall Study|Adverse Event|2
173213|NCT00159874|545315|P5|Overall Study|Adverse Event|1
173214|NCT00159874|545316|P4|Overall Study|Adverse Event|1
173215|NCT00159874|545317|P3|Overall Study|Adverse Event|5
173216|NCT00159874|545318|P2|Overall Study|Adverse Event|2
173217|NCT00159874|545319|P1|Overall Study|Adverse Event|2
173218|NCT00159861|545489|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
173219|NCT00159861|545490|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
173220|NCT00159861|545489|P2|Extension Study - up to 3 Years|Reason Unspecified|19
173221|NCT00159861|545490|P1|Extension Study - up to 3 Years|Reason Unspecified|12
173222|NCT00159861|545489|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
173223|NCT00159861|545490|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
173224|NCT00159861|545489|P2|Extension Study - up to 3 Years|Adverse Event|14
173225|NCT00159861|545490|P1|Extension Study - up to 3 Years|Adverse Event|14
173226|NCT00159861|545489|P2|Extension Study - up to 3 Years|Death|28
173227|NCT00159861|545490|P1|Extension Study - up to 3 Years|Death|24
173228|NCT00159861|545489|P2|Core Study - 16 Weeks|Randomized but not Treated|0
173229|NCT00159861|545490|P1|Core Study - 16 Weeks|Randomized but not Treated|2
173230|NCT00159861|545489|P2|Core Study - 16 Weeks|Subject Defaulted|0
173231|NCT00159861|545490|P1|Core Study - 16 Weeks|Subject Defaulted|1
173232|NCT00159861|545489|P2|Core Study - 16 Weeks|Reason Unspecified|3
173233|NCT00159861|545490|P1|Core Study - 16 Weeks|Reason Unspecified|5
173234|NCT00159861|545489|P2|Core Study - 16 Weeks|Lack of Efficacy|3
173235|NCT00159861|545490|P1|Core Study - 16 Weeks|Lack of Efficacy|2
173236|NCT00159861|545489|P2|Core Study - 16 Weeks|Adverse Event|6
173237|NCT00159861|545490|P1|Core Study - 16 Weeks|Adverse Event|12
173238|NCT00159861|545489|P2|Core Study - 16 Weeks|Death|0
173239|NCT00159861|545490|P1|Core Study - 16 Weeks|Death|3
173240|NCT00159822|545511|P1|Post-treatment Follow-up Period|Reason unspecified|1
173241|NCT00159822|545511|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
173242|NCT00159822|545511|P1|Post-treatment Follow-up Period|Death|1
173243|NCT00159822|545511|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
173244|NCT00159822|545511|P1|Voriconazole Treatment Period|Lost to Follow-up|2
173245|NCT00159822|545511|P1|Voriconazole Treatment Period|Protocol Violation|2
173246|NCT00159822|545511|P1|Voriconazole Treatment Period|Death|4
173247|NCT00159822|545511|P1|Voriconazole Treatment Period|Adverse Event|9
173248|NCT00159822|545511|P1|Voriconazole Treatment Period|Lack of Efficacy|3
173249|NCT00159783|545529|P3|Overall Study|not specified|4
173250|NCT00159783|545530|P2|Overall Study|not specified|2
173251|NCT00159783|545531|P1|Overall Study|not specified|0
173252|NCT00159783|545529|P3|Overall Study|Lost to Follow-up|11
173253|NCT00159783|545530|P2|Overall Study|Lost to Follow-up|5
173254|NCT00159783|545531|P1|Overall Study|Lost to Follow-up|6
173255|NCT00159783|545529|P3|Overall Study|Withdrawal by Subject|12
173256|NCT00159783|545530|P2|Overall Study|Withdrawal by Subject|11
173257|NCT00159783|545531|P1|Overall Study|Withdrawal by Subject|7
173258|NCT00159783|545529|P3|Overall Study|Lack of Efficacy|3
173259|NCT00159783|545530|P2|Overall Study|Lack of Efficacy|2
173260|NCT00159783|545531|P1|Overall Study|Lack of Efficacy|1
173261|NCT00159783|545529|P3|Overall Study|Adverse Event|9
173262|NCT00159783|545530|P2|Overall Study|Adverse Event|7
173263|NCT00159783|545531|P1|Overall Study|Adverse Event|5
173264|NCT00159432|545561|P1|Overall Study|Lack of Efficacy|8
173265|NCT00159432|545561|P1|Overall Study|Death|1
173266|NCT00159432|545561|P1|Overall Study|Adverse Event|1
173267|NCT00158600|545586|P2|Overall Study|Withdrawal by Subject|2
173268|NCT00158600|545587|P1|Overall Study|Withdrawal by Subject|2
173269|NCT00158600|545586|P2|Overall Study|Death|0
173270|NCT00158600|545587|P1|Overall Study|Death|1
173271|NCT00158600|545586|P2|Overall Study|Adverse Event|1
173272|NCT00158600|545587|P1|Overall Study|Adverse Event|2
173273|NCT00158600|545586|P2|Overall Study|unable to commit time to study|1
173274|NCT00158600|545587|P1|Overall Study|unable to commit time to study|0
173275|NCT00158054|545661|P2|Overall Study|Unavailable for follow up|3
173276|NCT00158054|545662|P1|Overall Study|Unavailable for follow up|7
173277|NCT00158054|545661|P2|Overall Study|Refused to continue|0
173278|NCT00158054|545662|P1|Overall Study|Refused to continue|3
173279|NCT00157950|545676|P2|Overall Study|Death|0
173280|NCT00157950|545677|P1|Overall Study|Death|1
173281|NCT00157820|545694|P3|2nd 8 Months|Premature cross-over|9
173282|NCT00157820|545695|P2|2nd 8 Months|Premature cross-over|7
173283|NCT00157820|545696|P1|2nd 8 Months|Premature cross-over|1
173284|NCT00157820|545694|P3|2nd 8 Months|Lost to Follow-up|2
173285|NCT00157820|545695|P2|2nd 8 Months|Lost to Follow-up|5
173286|NCT00157820|545696|P1|2nd 8 Months|Lost to Follow-up|1
173287|NCT00157820|545694|P3|2nd 8 Months|Death|3
173288|NCT00157820|545695|P2|2nd 8 Months|Death|1
173289|NCT00157820|545696|P1|2nd 8 Months|Death|3
173290|NCT00157820|545694|P3|1st 8 Month|Premature cross-over|2
173291|NCT00157820|545695|P2|1st 8 Month|Premature cross-over|2
173292|NCT00157820|545696|P1|1st 8 Month|Premature cross-over|0
173293|NCT00157820|545694|P3|1st 8 Month|Lost to Follow-up|1
173294|NCT00157820|545695|P2|1st 8 Month|Lost to Follow-up|2
173295|NCT00157820|545696|P1|1st 8 Month|Lost to Follow-up|1
173296|NCT00157820|545694|P3|1st 8 Month|Death|3
173297|NCT00157820|545695|P2|1st 8 Month|Death|8
173298|NCT00157820|545696|P1|1st 8 Month|Death|7
173299|NCT00157820|545694|P3|Randomized|Protocol Violation|2
173300|NCT00157820|545695|P2|Randomized|Protocol Violation|1
173301|NCT00157820|545696|P1|Randomized|Protocol Violation|2
173302|NCT00157820|545694|P3|Randomized|Withdrawal by Subject|3
173303|NCT00157820|545695|P2|Randomized|Withdrawal by Subject|2
173304|NCT00157820|545696|P1|Randomized|Withdrawal by Subject|1
173305|NCT00157820|545694|P3|Randomized|Physician Decision|3
173306|NCT00157820|545695|P2|Randomized|Physician Decision|2
173307|NCT00157820|545696|P1|Randomized|Physician Decision|4
173308|NCT00157755|545709|P6|Overall Study|Study completion|2
173309|NCT00157755|545710|P5|Overall Study|Study completion|1
173310|NCT00157755|545711|P4|Overall Study|Study completion|0
173311|NCT00157755|545712|P3|Overall Study|Study completion|0
173312|NCT00157755|545713|P2|Overall Study|Study completion|0
173313|NCT00157755|545714|P1|Overall Study|Study completion|0
173314|NCT00157755|545709|P6|Overall Study|Subject non-compliance|1
173315|NCT00157755|545710|P5|Overall Study|Subject non-compliance|0
173316|NCT00157755|545711|P4|Overall Study|Subject non-compliance|0
173317|NCT00157755|545712|P3|Overall Study|Subject non-compliance|0
173318|NCT00157755|545713|P2|Overall Study|Subject non-compliance|0
173319|NCT00157755|545714|P1|Overall Study|Subject non-compliance|0
173320|NCT00157755|545709|P6|Overall Study|Study site closure|0
173321|NCT00157755|545710|P5|Overall Study|Study site closure|0
173322|NCT00157755|545711|P4|Overall Study|Study site closure|0
173323|NCT00157755|545712|P3|Overall Study|Study site closure|0
173324|NCT00157755|545713|P2|Overall Study|Study site closure|1
173325|NCT00157755|545714|P1|Overall Study|Study site closure|0
173326|NCT00157755|545709|P6|Overall Study|Medical reason|0
173327|NCT00157755|545710|P5|Overall Study|Medical reason|0
173328|NCT00157755|545711|P4|Overall Study|Medical reason|1
173329|NCT00157755|545712|P3|Overall Study|Medical reason|1
173330|NCT00157755|545713|P2|Overall Study|Medical reason|0
173331|NCT00157755|545714|P1|Overall Study|Medical reason|0
173332|NCT00157755|545709|P6|Overall Study|Explant due to infection|0
173333|NCT00157755|545710|P5|Overall Study|Explant due to infection|0
173334|NCT00157755|545711|P4|Overall Study|Explant due to infection|0
173335|NCT00157755|545712|P3|Overall Study|Explant due to infection|1
173336|NCT00157755|545713|P2|Overall Study|Explant due to infection|0
173337|NCT00157755|545714|P1|Overall Study|Explant due to infection|0
173338|NCT00157755|545709|P6|Overall Study|Withdrawal by Subject|2
173339|NCT00157755|545710|P5|Overall Study|Withdrawal by Subject|1
173340|NCT00157755|545711|P4|Overall Study|Withdrawal by Subject|1
173341|NCT00157755|545712|P3|Overall Study|Withdrawal by Subject|1
173342|NCT00157755|545713|P2|Overall Study|Withdrawal by Subject|0
173343|NCT00157755|545714|P1|Overall Study|Withdrawal by Subject|0
173344|NCT00157755|545709|P6|Overall Study|Lost to Follow-up|0
173345|NCT00157755|545710|P5|Overall Study|Lost to Follow-up|0
173346|NCT00157755|545711|P4|Overall Study|Lost to Follow-up|0
173347|NCT00157755|545712|P3|Overall Study|Lost to Follow-up|1
173348|NCT00157755|545713|P2|Overall Study|Lost to Follow-up|0
173349|NCT00157755|545714|P1|Overall Study|Lost to Follow-up|0
173350|NCT00157755|545709|P6|Overall Study|Death|0
173351|NCT00157755|545710|P5|Overall Study|Death|0
173352|NCT00157755|545711|P4|Overall Study|Death|2
173353|NCT00157755|545712|P3|Overall Study|Death|3
173354|NCT00157755|545713|P2|Overall Study|Death|3
173355|NCT00157755|545714|P1|Overall Study|Death|2
173356|NCT00157248|545740|P4|Overall Study|site closures, subject moving|9
173357|NCT00157248|545741|P3|Overall Study|site closures, subject moving|3
173358|NCT00157248|545742|P2|Overall Study|site closures, subject moving|7
173359|NCT00157248|545743|P1|Overall Study|site closures, subject moving|7
173360|NCT00157248|545740|P4|Overall Study|Withdrawal by Subject|3
173361|NCT00157248|545741|P3|Overall Study|Withdrawal by Subject|3
173362|NCT00157248|545742|P2|Overall Study|Withdrawal by Subject|4
173363|NCT00157248|545743|P1|Overall Study|Withdrawal by Subject|1
173364|NCT00157248|545740|P4|Overall Study|Lost to Follow-up|0
173365|NCT00157248|545741|P3|Overall Study|Lost to Follow-up|0
173366|NCT00157248|545742|P2|Overall Study|Lost to Follow-up|1
173367|NCT00157248|545743|P1|Overall Study|Lost to Follow-up|0
173368|NCT00157248|545740|P4|Overall Study|Protocol Violation|2
173369|NCT00157248|545741|P3|Overall Study|Protocol Violation|2
173370|NCT00157248|545742|P2|Overall Study|Protocol Violation|0
173371|NCT00157248|545743|P1|Overall Study|Protocol Violation|4
173372|NCT00157248|545740|P4|Overall Study|Adverse Event|33
173373|NCT00157248|545741|P3|Overall Study|Adverse Event|13
173374|NCT00157248|545742|P2|Overall Study|Adverse Event|25
173375|NCT00157248|545743|P1|Overall Study|Adverse Event|36
173376|NCT00157209|545849|P2|Overall Study|Ongoing at data cut-off|0
173377|NCT00157209|545850|P1|Overall Study|Ongoing at data cut-off|10
173378|NCT00157196|545864|P1|Overall Study|Ongoing at data cut-off|9
173379|NCT00157157|545870|P1|Overall Study|Inclusion not met- baseline FVIII value|1
173380|NCT00157157|545870|P1|Overall Study|Met exclusion criteria|1
173381|NCT00157157|545870|P1|Overall Study|Enrolled in another study|1
173382|NCT00157157|545870|P1|Overall Study|Lost to Follow-up|1
173383|NCT00157157|545870|P1|Overall Study|Physician Decision|1
173384|NCT00157157|545870|P1|Overall Study|Withdrawal by Subject|6
173385|NCT00156819|546016|P3|Overall Study|Lost to Follow-up|3
173386|NCT00156819|546017|P2|Overall Study|Lost to Follow-up|1
173387|NCT00156819|546018|P1|Overall Study|Lost to Follow-up|1
173388|NCT00156533|546035|P4|Overall Study|Failed Screening|1
173389|NCT00156533|546036|P3|Overall Study|Failed Screening|1
173390|NCT00156533|546037|P2|Overall Study|Failed Screening|0
173391|NCT00156533|546038|P1|Overall Study|Failed Screening|1
173392|NCT00156533|546035|P4|Overall Study|Withdrawal by Subject|1
173393|NCT00156533|546036|P3|Overall Study|Withdrawal by Subject|0
173394|NCT00156533|546037|P2|Overall Study|Withdrawal by Subject|0
173395|NCT00156533|546038|P1|Overall Study|Withdrawal by Subject|1
173396|NCT00156533|546035|P4|Overall Study|Withdrawn - Medication Expiration|0
173397|NCT00156533|546036|P3|Overall Study|Withdrawn - Medication Expiration|1
173398|NCT00156533|546037|P2|Overall Study|Withdrawn - Medication Expiration|2
173399|NCT00156533|546038|P1|Overall Study|Withdrawn - Medication Expiration|0
173400|NCT00156065|546070|P3|Overall Study|Unspecified|3
173401|NCT00156065|546071|P2|Overall Study|Unspecified|9
173402|NCT00156065|546072|P1|Overall Study|Unspecified|2
173403|NCT00156065|546070|P3|Overall Study|Lost to Follow-up|1
173404|NCT00156065|546071|P2|Overall Study|Lost to Follow-up|7
173405|NCT00156065|546072|P1|Overall Study|Lost to Follow-up|5
173406|NCT00156065|546070|P3|Overall Study|Withdrawal by Subject|16
173407|NCT00156065|546071|P2|Overall Study|Withdrawal by Subject|26
173408|NCT00156065|546072|P1|Overall Study|Withdrawal by Subject|13
173409|NCT00156065|546070|P3|Overall Study|Lack of Efficacy|3
173410|NCT00156065|546071|P2|Overall Study|Lack of Efficacy|9
173411|NCT00156065|546072|P1|Overall Study|Lack of Efficacy|2
173412|NCT00156065|546070|P3|Overall Study|Adverse Event|4
173413|NCT00156065|546071|P2|Overall Study|Adverse Event|11
173414|NCT00156065|546072|P1|Overall Study|Adverse Event|8
173415|NCT00156065|546070|P3|Overall Study|Enrolled But Never Received Treatment|0
173416|NCT00156065|546071|P2|Overall Study|Enrolled But Never Received Treatment|1
173417|NCT00156065|546072|P1|Overall Study|Enrolled But Never Received Treatment|1
173418|NCT00153920|546087|P1|Overall Study|Progressive Disease before Trt|1
173419|NCT00153920|546087|P1|Overall Study|Withdrawal of Consent before Trt|1
173420|NCT00153920|546087|P1|Overall Study|Non-Protocol Therapy|1
173421|NCT00153920|546087|P1|Overall Study|Withdrawal by Subject|1
173422|NCT00153920|546087|P1|Overall Study|Death|2
173423|NCT00153920|546087|P1|Overall Study|Lack of Response|3
173424|NCT00153920|546087|P1|Overall Study|Physician Decision|3
173425|NCT00153920|546087|P1|Overall Study|Progressive Disease|9
173426|NCT00153920|546087|P1|Overall Study|Adverse Event|9
173427|NCT00153816|546102|P6|Overall Study|Follow-up exam done, histology missing|2
173428|NCT00153816|546103|P5|Overall Study|Follow-up exam done, histology missing|1
173429|NCT00153816|546104|P4|Overall Study|Follow-up exam done, histology missing|3
173430|NCT00153816|546105|P3|Overall Study|Follow-up exam done, histology missing|3
173431|NCT00153816|546106|P2|Overall Study|Follow-up exam done, histology missing|3
173432|NCT00153816|546107|P1|Overall Study|Follow-up exam done, histology missing|2
173433|NCT00153816|546102|P6|Overall Study|Follow-up exam not done|9
173434|NCT00153816|546103|P5|Overall Study|Follow-up exam not done|8
173435|NCT00153816|546104|P4|Overall Study|Follow-up exam not done|10
173436|NCT00153816|546105|P3|Overall Study|Follow-up exam not done|11
173437|NCT00153816|546106|P2|Overall Study|Follow-up exam not done|7
173438|NCT00153816|546107|P1|Overall Study|Follow-up exam not done|8
173439|NCT00153816|546102|P6|Overall Study|Withdrawal by Subject|5
173440|NCT00153816|546103|P5|Overall Study|Withdrawal by Subject|1
173441|NCT00153816|546104|P4|Overall Study|Withdrawal by Subject|4
173442|NCT00153816|546105|P3|Overall Study|Withdrawal by Subject|9
173443|NCT00153816|546106|P2|Overall Study|Withdrawal by Subject|9
173444|NCT00153816|546107|P1|Overall Study|Withdrawal by Subject|9
173445|NCT00153816|546102|P6|Overall Study|Lost to Follow-up|9
173446|NCT00153816|546103|P5|Overall Study|Lost to Follow-up|7
173447|NCT00153816|546104|P4|Overall Study|Lost to Follow-up|8
173448|NCT00153816|546105|P3|Overall Study|Lost to Follow-up|5
173449|NCT00153816|546106|P2|Overall Study|Lost to Follow-up|8
173450|NCT00153816|546107|P1|Overall Study|Lost to Follow-up|7
173451|NCT00153816|546102|P6|Overall Study|Death|2
173452|NCT00153816|546103|P5|Overall Study|Death|0
173453|NCT00153816|546104|P4|Overall Study|Death|6
173454|NCT00153816|546105|P3|Overall Study|Death|4
173455|NCT00153816|546106|P2|Overall Study|Death|5
173456|NCT00153816|546107|P1|Overall Study|Death|6
173457|NCT00154375|546144|P2|Overall Study|Suspected progression of disease|30
173458|NCT00154375|546145|P1|Overall Study|Suspected progression of disease|44
173459|NCT00154375|546144|P2|Overall Study|Protocol Violation|1
173460|NCT00154375|546145|P1|Overall Study|Protocol Violation|0
173461|NCT00154375|546144|P2|Overall Study|Abnormal laboratory value(s)|2
173462|NCT00154375|546145|P1|Overall Study|Abnormal laboratory value(s)|0
173463|NCT00154375|546144|P2|Overall Study|Lost to Follow-up|1
173464|NCT00154375|546145|P1|Overall Study|Lost to Follow-up|2
173465|NCT00154375|546144|P2|Overall Study|Study drug no longer required|3
173466|NCT00154375|546145|P1|Overall Study|Study drug no longer required|5
173467|NCT00154375|546144|P2|Overall Study|Death|13
173468|NCT00154375|546145|P1|Overall Study|Death|5
173469|NCT00154375|546144|P2|Overall Study|Withdrawal by Subject|10
173470|NCT00154375|546145|P1|Overall Study|Withdrawal by Subject|14
173471|NCT00154375|546144|P2|Overall Study|Adverse Event|20
173472|NCT00154375|546145|P1|Overall Study|Adverse Event|18
173473|NCT00154375|546144|P2|Overall Study|Unsatisfactory therapeutic effect|26
173474|NCT00154375|546145|P1|Overall Study|Unsatisfactory therapeutic effect|25
173475|NCT00154310|546156|P2|Overall Study|Death|1
173476|NCT00154310|546157|P1|Overall Study|Death|0
173477|NCT00154310|546156|P2|Overall Study|Administrative problems|1
173478|NCT00154310|546157|P1|Overall Study|Administrative problems|0
173479|NCT00154310|546156|P2|Overall Study|Lost to Follow-up|8
173480|NCT00154310|546157|P1|Overall Study|Lost to Follow-up|0
173481|NCT00154310|546156|P2|Overall Study|Withdrawal by Subject|3
173482|NCT00154310|546157|P1|Overall Study|Withdrawal by Subject|9
173483|NCT00154310|546156|P2|Overall Study|Protocol Violation|2
173484|NCT00154310|546157|P1|Overall Study|Protocol Violation|4
173485|NCT00154310|546156|P2|Overall Study|Lack of Efficacy|4
173486|NCT00154310|546157|P1|Overall Study|Lack of Efficacy|5
173487|NCT00154310|546156|P2|Overall Study|Adverse Event|9
173488|NCT00154310|546157|P1|Overall Study|Adverse Event|19
173489|NCT00154297|546173|P2|Overall Study|Lost to Follow-up|0
173490|NCT00154297|546174|P1|Overall Study|Lost to Follow-up|3
173491|NCT00154297|546173|P2|Overall Study|Withdrawal by Subject|5
173492|NCT00154297|546174|P1|Overall Study|Withdrawal by Subject|0
173493|NCT00154297|546173|P2|Overall Study|Death|2
173494|NCT00154297|546174|P1|Overall Study|Death|5
173495|NCT00154284|546192|P2|Overall Study|Graft loss|0
173496|NCT00154284|546193|P1|Overall Study|Graft loss|0
173497|NCT00154284|546192|P2|Overall Study|Administrative problems|0
173498|NCT00154284|546193|P1|Overall Study|Administrative problems|0
173499|NCT00154284|546192|P2|Overall Study|Withdrawal by Subject|0
173500|NCT00154284|546193|P1|Overall Study|Withdrawal by Subject|0
173501|NCT00154284|546192|P2|Overall Study|Protocol Violation|1
173502|NCT00154284|546193|P1|Overall Study|Protocol Violation|0
173503|NCT00154284|546192|P2|Overall Study|Lack of Efficacy|2
173504|NCT00154284|546193|P1|Overall Study|Lack of Efficacy|1
173505|NCT00154284|546192|P2|Overall Study|Abnormal laboratory value(s)|1
173506|NCT00154284|546193|P1|Overall Study|Abnormal laboratory value(s)|0
173507|NCT00154284|546192|P2|Overall Study|Adverse Event|9
173508|NCT00154284|546193|P1|Overall Study|Adverse Event|6
173509|NCT00154102|546207|P2|Overall Study|investigational study phase ongoing|2
173510|NCT00154102|546208|P1|Overall Study|investigational study phase ongoing|7
173511|NCT00154063|546244|P2|Overall Study|Not specified|3
173512|NCT00154063|546245|P1|Overall Study|Not specified|3
173513|NCT00154063|546244|P2|Overall Study|Withdrawal by Subject|9
173514|NCT00154063|546245|P1|Overall Study|Withdrawal by Subject|4
173515|NCT00154063|546244|P2|Overall Study|Investigator or Sponsor Request|1
173516|NCT00154063|546245|P1|Overall Study|Investigator or Sponsor Request|0
173517|NCT00154063|546244|P2|Overall Study|Protocol Violation|1
173518|NCT00154063|546245|P1|Overall Study|Protocol Violation|1
173519|NCT00154063|546244|P2|Overall Study|Adverse Event|8
173520|NCT00154063|546245|P1|Overall Study|Adverse Event|4
173521|NCT00152516|546307|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
173522|NCT00152516|546307|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
173523|NCT00152516|546307|P1|Overall Study|Other: Moved Out Of State|1
173524|NCT00152516|546307|P1|Overall Study|Other: Primary Care Physician's Decision|1
173525|NCT00152516|546307|P1|Overall Study|Other: Non-Compliance|2
173526|NCT00152516|546307|P1|Overall Study|Other: Parents Withdrew Consent|2
173527|NCT00152516|546307|P1|Overall Study|Other: Given Commercial Drug in Error|2
173528|NCT00152516|546307|P1|Overall Study|Other: Mother Refused To Cooperate|1
173529|NCT00152516|546307|P1|Overall Study|Protocol Violation|3
173530|NCT00152516|546307|P1|Overall Study|Withdrawal by Subject|8
173531|NCT00152516|546307|P1|Overall Study|Lost to Follow-up|5
173532|NCT00152516|546307|P1|Overall Study|Lack and Loss of Efficacy|30
173533|NCT00152516|546307|P1|Overall Study|Adverse Event|18
173534|NCT00153101|546366|P5|Overall Study|Withdrawal by Subject|5
173535|NCT00153101|546367|P4|Overall Study|Withdrawal by Subject|3
173536|NCT00153101|546368|P3|Overall Study|Withdrawal by Subject|3
173537|NCT00153101|546369|P2|Overall Study|Withdrawal by Subject|4
173538|NCT00153101|546370|P1|Overall Study|Withdrawal by Subject|3
173539|NCT00153101|546366|P5|Overall Study|Lost to Follow-up|5
173540|NCT00153101|546367|P4|Overall Study|Lost to Follow-up|5
173541|NCT00153101|546368|P3|Overall Study|Lost to Follow-up|12
173542|NCT00153101|546369|P2|Overall Study|Lost to Follow-up|14
173543|NCT00153101|546370|P1|Overall Study|Lost to Follow-up|14
173544|NCT00153062|546478|P4|Overall Study|Other|0
173545|NCT00153062|546479|P3|Overall Study|Other|1
173546|NCT00153062|546480|P2|Overall Study|Other|0
173547|NCT00153062|546481|P1|Overall Study|Other|0
173548|NCT00153062|546478|P4|Overall Study|No disposition data available|1
173549|NCT00153062|546479|P3|Overall Study|No disposition data available|1
173550|NCT00153062|546480|P2|Overall Study|No disposition data available|1
173551|NCT00153062|546481|P1|Overall Study|No disposition data available|1
173552|NCT00153062|546478|P4|Overall Study|Protocol Violation|1
173553|NCT00153062|546479|P3|Overall Study|Protocol Violation|1
173554|NCT00153062|546480|P2|Overall Study|Protocol Violation|2
173555|NCT00153062|546481|P1|Overall Study|Protocol Violation|0
173556|NCT00153062|546478|P4|Overall Study|Adverse Event|0
173557|NCT00153062|546479|P3|Overall Study|Adverse Event|1
173558|NCT00153062|546480|P2|Overall Study|Adverse Event|1
173559|NCT00153062|546481|P1|Overall Study|Adverse Event|0
173560|NCT00153062|546478|P4|Overall Study|Lost to Follow-up|16
173561|NCT00153062|546479|P3|Overall Study|Lost to Follow-up|15
173562|NCT00153062|546480|P2|Overall Study|Lost to Follow-up|20
173563|NCT00153062|546481|P1|Overall Study|Lost to Follow-up|12
173564|NCT00153062|546478|P4|Overall Study|Withdrawal by Subject|28
173565|NCT00153062|546479|P3|Overall Study|Withdrawal by Subject|27
173566|NCT00153062|546480|P2|Overall Study|Withdrawal by Subject|30
173567|NCT00153062|546481|P1|Overall Study|Withdrawal by Subject|14
173568|NCT00153062|546478|P4|Overall Study|Death|365
173569|NCT00153062|546479|P3|Overall Study|Death|369
173570|NCT00153062|546480|P2|Overall Study|Death|352
173571|NCT00153062|546481|P1|Overall Study|Death|360
173572|NCT00152971|546500|P3|Treatment|not specified|10
173573|NCT00152971|546501|P2|Treatment|not specified|11
173574|NCT00152971|546502|P1|Treatment|not specified|9
173575|NCT00152971|546500|P3|Treatment|Withdrawal by Subject|5
173576|NCT00152971|546501|P2|Treatment|Withdrawal by Subject|4
173577|NCT00152971|546502|P1|Treatment|Withdrawal by Subject|4
173578|NCT00152971|546500|P3|Treatment|Lost to Follow-up|1
173579|NCT00152971|546501|P2|Treatment|Lost to Follow-up|2
173580|NCT00152971|546502|P1|Treatment|Lost to Follow-up|1
173581|NCT00152971|546500|P3|Treatment|Protocol Violation|10
173582|NCT00152971|546501|P2|Treatment|Protocol Violation|6
173583|NCT00152971|546502|P1|Treatment|Protocol Violation|8
173584|NCT00152971|546500|P3|Treatment|Adverse Event|54
173585|NCT00152971|546501|P2|Treatment|Adverse Event|40
173586|NCT00152971|546502|P1|Treatment|Adverse Event|49
173587|NCT00152971|546500|P3|Overall Study|not specified|5
173588|NCT00152971|546501|P2|Overall Study|not specified|5
173589|NCT00152971|546502|P1|Overall Study|not specified|3
173590|NCT00152971|546500|P3|Overall Study|Withdrawal by Subject|14
173591|NCT00152971|546501|P2|Overall Study|Withdrawal by Subject|8
173592|NCT00152971|546502|P1|Overall Study|Withdrawal by Subject|9
173593|NCT00152971|546500|P3|Overall Study|Lost to Follow-up|13
173594|NCT00152971|546501|P2|Overall Study|Lost to Follow-up|14
173595|NCT00152971|546502|P1|Overall Study|Lost to Follow-up|17
173596|NCT00152971|546500|P3|Overall Study|Protocol Violation|8
173597|NCT00152971|546501|P2|Overall Study|Protocol Violation|11
173598|NCT00152971|546502|P1|Overall Study|Protocol Violation|10
173599|NCT00152971|546500|P3|Overall Study|Adverse Event|9
173600|NCT00152971|546501|P2|Overall Study|Adverse Event|10
173601|NCT00152971|546502|P1|Overall Study|Adverse Event|12
173602|NCT00152763|546538|P4|Overall Study|Lost to Follow-up|13
173603|NCT00152763|546539|P3|Overall Study|Lost to Follow-up|2
173604|NCT00152763|546540|P2|Overall Study|Lost to Follow-up|4
173605|NCT00152763|546541|P1|Overall Study|Lost to Follow-up|6
173606|NCT00152763|546538|P4|Overall Study|Death|1
173607|NCT00152763|546539|P3|Overall Study|Death|2
173608|NCT00152763|546540|P2|Overall Study|Death|1
173609|NCT00152763|546541|P1|Overall Study|Death|4
173610|NCT00152009|546661|P4|Overall Study|Sponsor's decision|3
173611|NCT00152009|546662|P3|Overall Study|Sponsor's decision|1
173612|NCT00152009|546663|P2|Overall Study|Sponsor's decision|3
173613|NCT00152009|546664|P1|Overall Study|Sponsor's decision|3
173614|NCT00152009|546661|P4|Overall Study|ECG abnormalities|1
173615|NCT00152009|546662|P3|Overall Study|ECG abnormalities|2
173616|NCT00152009|546663|P2|Overall Study|ECG abnormalities|2
173617|NCT00152009|546664|P1|Overall Study|ECG abnormalities|2
173618|NCT00152009|546661|P4|Overall Study|Lack of Efficacy|15
173619|NCT00152009|546662|P3|Overall Study|Lack of Efficacy|7
173620|NCT00152009|546663|P2|Overall Study|Lack of Efficacy|6
173621|NCT00152009|546664|P1|Overall Study|Lack of Efficacy|8
173622|NCT00152009|546661|P4|Overall Study|Lost to Follow-up|3
173623|NCT00152009|546662|P3|Overall Study|Lost to Follow-up|3
173624|NCT00152009|546663|P2|Overall Study|Lost to Follow-up|4
173625|NCT00152009|546664|P1|Overall Study|Lost to Follow-up|2
173626|NCT00152009|546661|P4|Overall Study|Withdrawal by Subject|9
173627|NCT00152009|546662|P3|Overall Study|Withdrawal by Subject|4
173628|NCT00152009|546663|P2|Overall Study|Withdrawal by Subject|3
173629|NCT00152009|546664|P1|Overall Study|Withdrawal by Subject|2
173630|NCT00152009|546661|P4|Overall Study|Protocol Violation|1
173631|NCT00152009|546662|P3|Overall Study|Protocol Violation|0
173632|NCT00152009|546663|P2|Overall Study|Protocol Violation|0
173633|NCT00152009|546664|P1|Overall Study|Protocol Violation|3
173634|NCT00152009|546661|P4|Overall Study|Adverse Event|1
173635|NCT00152009|546662|P3|Overall Study|Adverse Event|20
173636|NCT00152009|546663|P2|Overall Study|Adverse Event|13
173637|NCT00152009|546664|P1|Overall Study|Adverse Event|9
173638|NCT00151996|546696|P2|Overall Study|Sponsor's decision|2
173639|NCT00151996|546697|P1|Overall Study|Sponsor's decision|0
173640|NCT00151996|546696|P2|Overall Study|Protocol Violation|2
173641|NCT00151996|546697|P1|Overall Study|Protocol Violation|1
173642|NCT00151996|546696|P2|Overall Study|Withdrawal by Subject|1
173643|NCT00151996|546697|P1|Overall Study|Withdrawal by Subject|1
173644|NCT00151996|546696|P2|Overall Study|Adverse Event|2
173645|NCT00151996|546697|P1|Overall Study|Adverse Event|3
173646|NCT00151892|546713|P2|Overall Study|Lack of study medication at center|1
173647|NCT00151892|546714|P1|Overall Study|Lack of study medication at center|0
173648|NCT00151892|546713|P2|Overall Study|Used prohibited corticosteroids|0
173649|NCT00151892|546714|P1|Overall Study|Used prohibited corticosteroids|1
173650|NCT00151892|546713|P2|Overall Study|Did not return for a visit|0
173651|NCT00151892|546714|P1|Overall Study|Did not return for a visit|1
173652|NCT00151892|546713|P2|Overall Study|Pregnancy|1
173653|NCT00151892|546714|P1|Overall Study|Pregnancy|0
173654|NCT00151892|546713|P2|Overall Study|Non-compliance|1
173655|NCT00151892|546714|P1|Overall Study|Non-compliance|0
173656|NCT00151892|546713|P2|Overall Study|Protocol Violation|3
173657|NCT00151892|546714|P1|Overall Study|Protocol Violation|3
173658|NCT00151892|546713|P2|Overall Study|Adverse Event|3
173659|NCT00151892|546714|P1|Overall Study|Adverse Event|6
173660|NCT00151892|546713|P2|Overall Study|Lost to Follow-up|10
173661|NCT00151892|546714|P1|Overall Study|Lost to Follow-up|5
173662|NCT00151892|546713|P2|Overall Study|Patient request|7
173663|NCT00151892|546714|P1|Overall Study|Patient request|10
173664|NCT00151892|546713|P2|Overall Study|Lack of Efficacy|57
173665|NCT00151892|546714|P1|Overall Study|Lack of Efficacy|50
173666|NCT00151775|546759|P12|Period 4: Open Label|Protocol Violation|0
173667|NCT00151775|546760|P11|Period 4: Open Label|Protocol Violation|0
173668|NCT00151775|546761|P10|Period 4: Open Label|Protocol Violation|0
173669|NCT00151775|546762|P9|Period 4: Open Label|Protocol Violation|0
173670|NCT00151775|546763|P8|Period 4: Open Label|Protocol Violation|0
173671|NCT00151775|546764|P7|Period 4: Open Label|Protocol Violation|0
173672|NCT00151775|546765|P6|Period 4: Open Label|Protocol Violation|0
173673|NCT00151775|546766|P5|Period 4: Open Label|Protocol Violation|1
173674|NCT00151775|546767|P4|Period 4: Open Label|Protocol Violation|0
173675|NCT00151775|546768|P3|Period 4: Open Label|Protocol Violation|0
173676|NCT00151775|546769|P2|Period 4: Open Label|Protocol Violation|0
173677|NCT00151775|546770|P1|Period 4: Open Label|Protocol Violation|0
173678|NCT00151775|546759|P12|Period 4: Open Label|Physician Decision|0
173679|NCT00151775|546760|P11|Period 4: Open Label|Physician Decision|0
173680|NCT00151775|546761|P10|Period 4: Open Label|Physician Decision|2
173681|NCT00151775|546762|P9|Period 4: Open Label|Physician Decision|0
173682|NCT00151775|546763|P8|Period 4: Open Label|Physician Decision|0
173683|NCT00151775|546764|P7|Period 4: Open Label|Physician Decision|0
173684|NCT00151775|546765|P6|Period 4: Open Label|Physician Decision|0
173685|NCT00151775|546766|P5|Period 4: Open Label|Physician Decision|0
173686|NCT00151775|546767|P4|Period 4: Open Label|Physician Decision|0
173687|NCT00151775|546768|P3|Period 4: Open Label|Physician Decision|0
173688|NCT00151775|546769|P2|Period 4: Open Label|Physician Decision|0
173689|NCT00151775|546770|P1|Period 4: Open Label|Physician Decision|0
173690|NCT00151775|546759|P12|Period 4: Open Label|Other|0
173691|NCT00151775|546760|P11|Period 4: Open Label|Other|0
173692|NCT00151775|546761|P10|Period 4: Open Label|Other|3
173693|NCT00151775|546762|P9|Period 4: Open Label|Other|0
173694|NCT00151775|546763|P8|Period 4: Open Label|Other|0
173695|NCT00151775|546764|P7|Period 4: Open Label|Other|0
173696|NCT00151775|546765|P6|Period 4: Open Label|Other|0
173697|NCT00151775|546766|P5|Period 4: Open Label|Other|1
173698|NCT00151775|546767|P4|Period 4: Open Label|Other|0
173699|NCT00151775|546768|P3|Period 4: Open Label|Other|0
173700|NCT00151775|546769|P2|Period 4: Open Label|Other|0
173701|NCT00151775|546770|P1|Period 4: Open Label|Other|0
173702|NCT00151775|546759|P12|Period 4: Open Label|Non-compliance with protocol|0
173703|NCT00151775|546760|P11|Period 4: Open Label|Non-compliance with protocol|0
173704|NCT00151775|546761|P10|Period 4: Open Label|Non-compliance with protocol|4
173705|NCT00151775|546762|P9|Period 4: Open Label|Non-compliance with protocol|0
173706|NCT00151775|546763|P8|Period 4: Open Label|Non-compliance with protocol|0
173707|NCT00151775|546764|P7|Period 4: Open Label|Non-compliance with protocol|0
173708|NCT00151775|546765|P6|Period 4: Open Label|Non-compliance with protocol|0
173709|NCT00151775|546766|P5|Period 4: Open Label|Non-compliance with protocol|4
173710|NCT00151775|546767|P4|Period 4: Open Label|Non-compliance with protocol|0
173711|NCT00151775|546768|P3|Period 4: Open Label|Non-compliance with protocol|0
173712|NCT00151775|546769|P2|Period 4: Open Label|Non-compliance with protocol|0
173713|NCT00151775|546770|P1|Period 4: Open Label|Non-compliance with protocol|0
173714|NCT00151775|546759|P12|Period 4: Open Label|Lost to Follow-up|0
173715|NCT00151775|546760|P11|Period 4: Open Label|Lost to Follow-up|0
173716|NCT00151775|546761|P10|Period 4: Open Label|Lost to Follow-up|7
173717|NCT00151775|546762|P9|Period 4: Open Label|Lost to Follow-up|0
173718|NCT00151775|546763|P8|Period 4: Open Label|Lost to Follow-up|0
173719|NCT00151775|546764|P7|Period 4: Open Label|Lost to Follow-up|0
173720|NCT00151775|546765|P6|Period 4: Open Label|Lost to Follow-up|0
173721|NCT00151775|546766|P5|Period 4: Open Label|Lost to Follow-up|17
173722|NCT00151775|546767|P4|Period 4: Open Label|Lost to Follow-up|0
173723|NCT00151775|546768|P3|Period 4: Open Label|Lost to Follow-up|0
173724|NCT00151775|546769|P2|Period 4: Open Label|Lost to Follow-up|0
173725|NCT00151775|546770|P1|Period 4: Open Label|Lost to Follow-up|0
173726|NCT00151775|546759|P12|Period 4: Open Label|Adverse Event|0
173727|NCT00151775|546760|P11|Period 4: Open Label|Adverse Event|0
173728|NCT00151775|546761|P10|Period 4: Open Label|Adverse Event|2
173729|NCT00151775|546762|P9|Period 4: Open Label|Adverse Event|0
173730|NCT00151775|546763|P8|Period 4: Open Label|Adverse Event|0
173731|NCT00151775|546764|P7|Period 4: Open Label|Adverse Event|0
173732|NCT00151775|546765|P6|Period 4: Open Label|Adverse Event|0
173733|NCT00151775|546766|P5|Period 4: Open Label|Adverse Event|1
173734|NCT00151775|546767|P4|Period 4: Open Label|Adverse Event|0
173735|NCT00151775|546768|P3|Period 4: Open Label|Adverse Event|0
173736|NCT00151775|546769|P2|Period 4: Open Label|Adverse Event|0
173737|NCT00151775|546770|P1|Period 4: Open Label|Adverse Event|0
173738|NCT00151775|546759|P12|Period 4: Open Label|Withdrawal by Subject|0
173739|NCT00151775|546760|P11|Period 4: Open Label|Withdrawal by Subject|0
173740|NCT00151775|546761|P10|Period 4: Open Label|Withdrawal by Subject|2
173741|NCT00151775|546762|P9|Period 4: Open Label|Withdrawal by Subject|0
173742|NCT00151775|546763|P8|Period 4: Open Label|Withdrawal by Subject|0
173743|NCT00151775|546764|P7|Period 4: Open Label|Withdrawal by Subject|0
173744|NCT00151775|546765|P6|Period 4: Open Label|Withdrawal by Subject|0
173745|NCT00151775|546766|P5|Period 4: Open Label|Withdrawal by Subject|5
173746|NCT00151775|546767|P4|Period 4: Open Label|Withdrawal by Subject|0
173747|NCT00151775|546768|P3|Period 4: Open Label|Withdrawal by Subject|0
173748|NCT00151775|546769|P2|Period 4: Open Label|Withdrawal by Subject|0
173749|NCT00151775|546770|P1|Period 4: Open Label|Withdrawal by Subject|0
173750|NCT00151775|546759|P12|Period 4: Open Label|Increased blood pressure|0
173751|NCT00151775|546760|P11|Period 4: Open Label|Increased blood pressure|0
173752|NCT00151775|546761|P10|Period 4: Open Label|Increased blood pressure|1
173753|NCT00151775|546762|P9|Period 4: Open Label|Increased blood pressure|0
173754|NCT00151775|546763|P8|Period 4: Open Label|Increased blood pressure|0
173755|NCT00151775|546764|P7|Period 4: Open Label|Increased blood pressure|0
173756|NCT00151775|546765|P6|Period 4: Open Label|Increased blood pressure|0
173757|NCT00151775|546766|P5|Period 4: Open Label|Increased blood pressure|1
173758|NCT00151775|546767|P4|Period 4: Open Label|Increased blood pressure|0
173759|NCT00151775|546768|P3|Period 4: Open Label|Increased blood pressure|0
173760|NCT00151775|546769|P2|Period 4: Open Label|Increased blood pressure|0
173761|NCT00151775|546770|P1|Period 4: Open Label|Increased blood pressure|0
173762|NCT00151775|546759|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
173763|NCT00151775|546760|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
173764|NCT00151775|546761|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
173765|NCT00151775|546762|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
173766|NCT00151775|546763|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
173767|NCT00151775|546764|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
173768|NCT00151775|546765|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
173769|NCT00151775|546766|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
173770|NCT00151775|546767|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
173771|NCT00151775|546768|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
173772|NCT00151775|546769|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
173773|NCT00151775|546770|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
173774|NCT00151775|546759|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
173775|NCT00151775|546760|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
173776|NCT00151775|546761|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
173777|NCT00151775|546762|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
173778|NCT00151775|546763|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
173779|NCT00151775|546764|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
173780|NCT00151775|546765|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
173781|NCT00151775|546766|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
173782|NCT00151775|546767|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
173783|NCT00151775|546768|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
173784|NCT00151775|546769|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
173785|NCT00151775|546770|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
173786|NCT00151775|546759|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
173787|NCT00151775|546760|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
173788|NCT00151775|546761|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
173789|NCT00151775|546762|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
173790|NCT00151775|546763|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
173791|NCT00151775|546764|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
173792|NCT00151775|546765|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
173793|NCT00151775|546766|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
173794|NCT00151775|546767|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
173795|NCT00151775|546768|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
173796|NCT00151775|546769|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
173797|NCT00151775|546770|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
173798|NCT00151775|546759|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
173799|NCT00151775|546760|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
173800|NCT00151775|546761|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
173801|NCT00151775|546762|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
173802|NCT00151775|546763|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
173803|NCT00151775|546764|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
173804|NCT00151775|546765|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
173805|NCT00151775|546766|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
173806|NCT00151775|546767|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
173807|NCT00151775|546768|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
173808|NCT00151775|546769|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
173809|NCT00151775|546770|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
173810|NCT00151775|546759|P12|Period 3: Double-blind, Withdrawal|Other|0
173811|NCT00151775|546760|P11|Period 3: Double-blind, Withdrawal|Other|0
173812|NCT00151775|546761|P10|Period 3: Double-blind, Withdrawal|Other|0
173813|NCT00151775|546762|P9|Period 3: Double-blind, Withdrawal|Other|0
173814|NCT00151775|546763|P8|Period 3: Double-blind, Withdrawal|Other|1
173815|NCT00151775|546764|P7|Period 3: Double-blind, Withdrawal|Other|0
173816|NCT00151775|546765|P6|Period 3: Double-blind, Withdrawal|Other|0
173817|NCT00151775|546766|P5|Period 3: Double-blind, Withdrawal|Other|0
173818|NCT00151775|546767|P4|Period 3: Double-blind, Withdrawal|Other|0
173819|NCT00151775|546768|P3|Period 3: Double-blind, Withdrawal|Other|1
173820|NCT00151775|546769|P2|Period 3: Double-blind, Withdrawal|Other|0
173821|NCT00151775|546770|P1|Period 3: Double-blind, Withdrawal|Other|0
173822|NCT00151775|546759|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
173823|NCT00151775|546760|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
173824|NCT00151775|546761|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
173825|NCT00151775|546762|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
173826|NCT00151775|546763|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
173827|NCT00151775|546764|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
173828|NCT00151775|546765|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
173829|NCT00151775|546766|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
173830|NCT00151775|546767|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
173831|NCT00151775|546768|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
173832|NCT00151775|546769|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
173833|NCT00151775|546770|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
173834|NCT00151775|546759|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
173835|NCT00151775|546760|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
173836|NCT00151775|546761|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
173837|NCT00151775|546762|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
173838|NCT00151775|546763|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
173839|NCT00151775|546764|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
173840|NCT00151775|546765|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
173841|NCT00151775|546766|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
173842|NCT00151775|546767|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
173843|NCT00151775|546768|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
173844|NCT00151775|546769|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
173845|NCT00151775|546770|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
173846|NCT00151775|546759|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
173847|NCT00151775|546760|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
173848|NCT00151775|546761|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
173849|NCT00151775|546762|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
173850|NCT00151775|546763|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
173851|NCT00151775|546764|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
173852|NCT00151775|546765|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
173853|NCT00151775|546766|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
173854|NCT00151775|546767|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
173855|NCT00151775|546768|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
173856|NCT00151775|546769|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
173857|NCT00151775|546770|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
173858|NCT00151775|546759|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
173859|NCT00151775|546760|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
173860|NCT00151775|546761|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
173861|NCT00151775|546762|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
173862|NCT00151775|546763|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
173863|NCT00151775|546764|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
173864|NCT00151775|546765|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
173865|NCT00151775|546766|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
173866|NCT00151775|546767|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
173867|NCT00151775|546768|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
173868|NCT00151775|546769|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
173869|NCT00151775|546770|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
173870|NCT00151775|546759|P12|Period 2 - Double-Blind Dose Response|Other|0
173871|NCT00151775|546760|P11|Period 2 - Double-Blind Dose Response|Other|0
173872|NCT00151775|546761|P10|Period 2 - Double-Blind Dose Response|Other|0
173873|NCT00151775|546762|P9|Period 2 - Double-Blind Dose Response|Other|0
173874|NCT00151775|546763|P8|Period 2 - Double-Blind Dose Response|Other|0
173875|NCT00151775|546764|P7|Period 2 - Double-Blind Dose Response|Other|1
173876|NCT00151775|546765|P6|Period 2 - Double-Blind Dose Response|Other|0
173877|NCT00151775|546766|P5|Period 2 - Double-Blind Dose Response|Other|0
173878|NCT00151775|546767|P4|Period 2 - Double-Blind Dose Response|Other|0
173879|NCT00151775|546768|P3|Period 2 - Double-Blind Dose Response|Other|0
173880|NCT00151775|546769|P2|Period 2 - Double-Blind Dose Response|Other|0
173881|NCT00151775|546770|P1|Period 2 - Double-Blind Dose Response|Other|0
173882|NCT00151775|546759|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
173883|NCT00151775|546760|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
173884|NCT00151775|546761|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
173885|NCT00151775|546762|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
173886|NCT00151775|546763|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
173887|NCT00151775|546764|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
173888|NCT00151775|546765|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
173889|NCT00151775|546766|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
173890|NCT00151775|546767|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
173891|NCT00151775|546768|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
173892|NCT00151775|546769|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
173893|NCT00151775|546770|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
173894|NCT00151775|546759|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
173895|NCT00151775|546760|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
173896|NCT00151775|546761|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
173897|NCT00151775|546762|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
173898|NCT00151775|546763|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
173899|NCT00151775|546764|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
173900|NCT00151775|546765|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
173901|NCT00151775|546766|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
173902|NCT00151775|546767|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
173903|NCT00151775|546768|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
173904|NCT00151775|546769|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
173905|NCT00151775|546770|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
173906|NCT00151775|546759|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
173907|NCT00151775|546760|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
173908|NCT00151775|546761|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
173909|NCT00151775|546762|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
173910|NCT00151775|546763|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
173911|NCT00151775|546764|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
173912|NCT00151775|546765|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
173913|NCT00151775|546766|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
173914|NCT00151775|546767|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
173915|NCT00151775|546768|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
173916|NCT00151775|546769|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
173917|NCT00151775|546770|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
173918|NCT00151476|546814|P2|FAP Analyzed Subjects|Other study participation|1
173919|NCT00151476|546815|P1|FAP Analyzed Subjects|Other study participation|0
173920|NCT00151476|546814|P2|FAP Analyzed Subjects|Lost to Follow-up|2
173921|NCT00151476|546815|P1|FAP Analyzed Subjects|Lost to Follow-up|0
173922|NCT00151476|546814|P2|FAP Identified Subjects|Protocol Violation|1
173923|NCT00151476|546815|P1|FAP Identified Subjects|Protocol Violation|0
173924|NCT00151411|546872|P2|Overall Study|Pregnancy|4
173925|NCT00151411|546873|P1|Overall Study|Pregnancy|0
173926|NCT00151411|546872|P2|Overall Study|Adverse Event|0
173927|NCT00151411|546873|P1|Overall Study|Adverse Event|6
173928|NCT00151411|546872|P2|Overall Study|Withdrawal by Subject|20
173929|NCT00151411|546873|P1|Overall Study|Withdrawal by Subject|12
173930|NCT00151411|546872|P2|Overall Study|Lost to Follow-up|19
173931|NCT00151411|546873|P1|Overall Study|Lost to Follow-up|15
173932|NCT00151372|546881|P2|Overall Study|Withdrawal by Subject|7
173933|NCT00151372|546882|P1|Overall Study|Withdrawal by Subject|7
173934|NCT00151372|546881|P2|Overall Study|Too sick medically to continue|6
173935|NCT00151372|546882|P1|Overall Study|Too sick medically to continue|5
173936|NCT00151372|546881|P2|Overall Study|Lost to Follow-up|5
173937|NCT00151372|546882|P1|Overall Study|Lost to Follow-up|5
173938|NCT00151372|546881|P2|Overall Study|Death|11
173939|NCT00151372|546882|P1|Overall Study|Death|12
173940|NCT00150969|546892|P2|24-48 Month Extension|Other Reason|91
173941|NCT00150969|546893|P1|24-48 Month Extension|Other Reason|81
173942|NCT00150969|546892|P2|24-48 Month Extension|Adverse Event|3
173943|NCT00150969|546893|P1|24-48 Month Extension|Adverse Event|1
173944|NCT00150969|546892|P2|24-48 Month Extension|Lack of Efficacy|1
173945|NCT00150969|546893|P1|24-48 Month Extension|Lack of Efficacy|0
173946|NCT00150969|546892|P2|24-48 Month Extension|Withdrawal by Subject|5
173947|NCT00150969|546893|P1|24-48 Month Extension|Withdrawal by Subject|6
173948|NCT00150969|546892|P2|24 Month Main Study|Withdrawal by Subject|4
173949|NCT00150969|546893|P1|24 Month Main Study|Withdrawal by Subject|7
173950|NCT00150969|546892|P2|24 Month Main Study|Protocol Violation|2
173951|NCT00150969|546893|P1|24 Month Main Study|Protocol Violation|4
173952|NCT00150969|546892|P2|24 Month Main Study|Lost to Follow-up|2
173953|NCT00150969|546893|P1|24 Month Main Study|Lost to Follow-up|3
173954|NCT00150969|546892|P2|24 Month Main Study|Lack of Efficacy|8
173955|NCT00150969|546893|P1|24 Month Main Study|Lack of Efficacy|1
173956|NCT00150969|546892|P2|24 Month Main Study|Death|1
173957|NCT00150969|546893|P1|24 Month Main Study|Death|1
173958|NCT00150969|546892|P2|24 Month Main Study|Adverse Event|4
173959|NCT00150969|546893|P1|24 Month Main Study|Adverse Event|3
173960|NCT00150618|546930|P5|Overall Study|Sponsor's decision|0
173961|NCT00150618|546931|P4|Overall Study|Sponsor's decision|1
173962|NCT00150618|546932|P3|Overall Study|Sponsor's decision|0
173963|NCT00150618|546933|P2|Overall Study|Sponsor's decision|0
173964|NCT00150618|546934|P1|Overall Study|Sponsor's decision|0
173965|NCT00150618|546930|P5|Overall Study|Abnormal ECG|0
173966|NCT00150618|546931|P4|Overall Study|Abnormal ECG|0
173967|NCT00150618|546932|P3|Overall Study|Abnormal ECG|0
173968|NCT00150618|546933|P2|Overall Study|Abnormal ECG|0
173969|NCT00150618|546934|P1|Overall Study|Abnormal ECG|1
173970|NCT00150618|546930|P5|Overall Study|Lack of compliance|1
173971|NCT00150618|546931|P4|Overall Study|Lack of compliance|0
173972|NCT00150618|546932|P3|Overall Study|Lack of compliance|1
173973|NCT00150618|546933|P2|Overall Study|Lack of compliance|1
173974|NCT00150618|546934|P1|Overall Study|Lack of compliance|2
173975|NCT00150618|546930|P5|Overall Study|Physician Decision|1
173976|NCT00150618|546931|P4|Overall Study|Physician Decision|0
173977|NCT00150618|546932|P3|Overall Study|Physician Decision|0
173978|NCT00150618|546933|P2|Overall Study|Physician Decision|2
173979|NCT00150618|546934|P1|Overall Study|Physician Decision|0
173980|NCT00150618|546930|P5|Overall Study|No study meds|2
173981|NCT00150618|546931|P4|Overall Study|No study meds|0
173982|NCT00150618|546932|P3|Overall Study|No study meds|0
173983|NCT00150618|546933|P2|Overall Study|No study meds|0
173984|NCT00150618|546934|P1|Overall Study|No study meds|0
173985|NCT00150618|546930|P5|Overall Study|Lack of Efficacy|6
173986|NCT00150618|546931|P4|Overall Study|Lack of Efficacy|4
173987|NCT00150618|546932|P3|Overall Study|Lack of Efficacy|7
173988|NCT00150618|546933|P2|Overall Study|Lack of Efficacy|4
173989|NCT00150618|546934|P1|Overall Study|Lack of Efficacy|1
173990|NCT00150618|546930|P5|Overall Study|Protocol Violation|1
173991|NCT00150618|546931|P4|Overall Study|Protocol Violation|0
173992|NCT00150618|546932|P3|Overall Study|Protocol Violation|0
173993|NCT00150618|546933|P2|Overall Study|Protocol Violation|0
173994|NCT00150618|546934|P1|Overall Study|Protocol Violation|1
173995|NCT00150618|546930|P5|Overall Study|Lost to Follow-up|4
173996|NCT00150618|546931|P4|Overall Study|Lost to Follow-up|8
173997|NCT00150618|546932|P3|Overall Study|Lost to Follow-up|5
173998|NCT00150618|546933|P2|Overall Study|Lost to Follow-up|1
173999|NCT00150618|546934|P1|Overall Study|Lost to Follow-up|4
174000|NCT00150618|546930|P5|Overall Study|Withdrawal by Subject|5
174001|NCT00150618|546931|P4|Overall Study|Withdrawal by Subject|4
174002|NCT00150618|546932|P3|Overall Study|Withdrawal by Subject|8
174003|NCT00150618|546933|P2|Overall Study|Withdrawal by Subject|8
174004|NCT00150618|546934|P1|Overall Study|Withdrawal by Subject|6
174005|NCT00150618|546930|P5|Overall Study|Adverse Event|5
174006|NCT00150618|546931|P4|Overall Study|Adverse Event|9
174007|NCT00150618|546932|P3|Overall Study|Adverse Event|6
174008|NCT00150618|546933|P2|Overall Study|Adverse Event|2
174009|NCT00150618|546934|P1|Overall Study|Adverse Event|2
174010|NCT00150592|546968|P2|Overall Study|Non-compliance|0
174011|NCT00150592|546969|P1|Overall Study|Non-compliance|1
174012|NCT00150592|546968|P2|Overall Study|Withdrawal by Subject|2
174013|NCT00150592|546969|P1|Overall Study|Withdrawal by Subject|1
174014|NCT00150592|546968|P2|Overall Study|Protocol Violation|0
174015|NCT00150592|546969|P1|Overall Study|Protocol Violation|1
174016|NCT00150592|546968|P2|Overall Study|Adverse Event|1
174017|NCT00150592|546969|P1|Overall Study|Adverse Event|4
174018|NCT00150462|547000|P11|Overall Study|Other|1
174019|NCT00150462|547001|P10|Overall Study|Other|1
174020|NCT00150462|547002|P9|Overall Study|Other|0
174021|NCT00150462|547003|P8|Overall Study|Other|0
174022|NCT00150462|547004|P7|Overall Study|Other|0
174023|NCT00150462|547005|P6|Overall Study|Other|0
174024|NCT00150462|547006|P5|Overall Study|Other|0
174025|NCT00150462|547007|P4|Overall Study|Other|0
174026|NCT00150462|547008|P3|Overall Study|Other|0
174027|NCT00150462|547009|P2|Overall Study|Other|0
174028|NCT00150462|547010|P1|Overall Study|Other|0
174029|NCT00150462|547000|P11|Overall Study|Physician Decision|0
174030|NCT00150462|547001|P10|Overall Study|Physician Decision|0
174031|NCT00150462|547002|P9|Overall Study|Physician Decision|0
174032|NCT00150462|547003|P8|Overall Study|Physician Decision|0
174033|NCT00150462|547004|P7|Overall Study|Physician Decision|0
174034|NCT00150462|547005|P6|Overall Study|Physician Decision|0
174035|NCT00150462|547006|P5|Overall Study|Physician Decision|0
174036|NCT00150462|547007|P4|Overall Study|Physician Decision|1
174037|NCT00150462|547008|P3|Overall Study|Physician Decision|1
174038|NCT00150462|547009|P2|Overall Study|Physician Decision|0
174039|NCT00150462|547010|P1|Overall Study|Physician Decision|0
174040|NCT00150462|547000|P11|Overall Study|Adverse Event|0
174041|NCT00150462|547001|P10|Overall Study|Adverse Event|1
174042|NCT00150462|547002|P9|Overall Study|Adverse Event|0
174043|NCT00150462|547003|P8|Overall Study|Adverse Event|2
174044|NCT00150462|547004|P7|Overall Study|Adverse Event|0
174045|NCT00150462|547005|P6|Overall Study|Adverse Event|0
174046|NCT00150462|547006|P5|Overall Study|Adverse Event|0
174047|NCT00150462|547007|P4|Overall Study|Adverse Event|1
174048|NCT00150462|547008|P3|Overall Study|Adverse Event|0
174049|NCT00150462|547009|P2|Overall Study|Adverse Event|0
174050|NCT00150462|547010|P1|Overall Study|Adverse Event|0
174051|NCT00150462|547000|P11|Overall Study|Death|0
174052|NCT00150462|547001|P10|Overall Study|Death|0
174053|NCT00150462|547002|P9|Overall Study|Death|1
174054|NCT00150462|547003|P8|Overall Study|Death|0
174055|NCT00150462|547004|P7|Overall Study|Death|0
174056|NCT00150462|547005|P6|Overall Study|Death|0
174057|NCT00150462|547006|P5|Overall Study|Death|0
174058|NCT00150462|547007|P4|Overall Study|Death|0
174059|NCT00150462|547008|P3|Overall Study|Death|0
174060|NCT00150462|547009|P2|Overall Study|Death|1
174061|NCT00150462|547010|P1|Overall Study|Death|0
174062|NCT00150462|547000|P11|Overall Study|Withdrawal by Subject|0
174063|NCT00150462|547001|P10|Overall Study|Withdrawal by Subject|1
174064|NCT00150462|547002|P9|Overall Study|Withdrawal by Subject|0
174065|NCT00150462|547003|P8|Overall Study|Withdrawal by Subject|1
174066|NCT00150462|547004|P7|Overall Study|Withdrawal by Subject|0
174067|NCT00150462|547005|P6|Overall Study|Withdrawal by Subject|2
174068|NCT00150462|547006|P5|Overall Study|Withdrawal by Subject|1
174069|NCT00150462|547007|P4|Overall Study|Withdrawal by Subject|0
174070|NCT00150462|547008|P3|Overall Study|Withdrawal by Subject|1
174071|NCT00150462|547009|P2|Overall Study|Withdrawal by Subject|1
174072|NCT00150462|547010|P1|Overall Study|Withdrawal by Subject|0
174073|NCT00150462|547000|P11|Overall Study|Disease Progression or Relapse|2
174074|NCT00150462|547001|P10|Overall Study|Disease Progression or Relapse|3
174075|NCT00150462|547002|P9|Overall Study|Disease Progression or Relapse|5
174076|NCT00150462|547003|P8|Overall Study|Disease Progression or Relapse|5
174077|NCT00150462|547004|P7|Overall Study|Disease Progression or Relapse|3
174078|NCT00150462|547005|P6|Overall Study|Disease Progression or Relapse|2
174079|NCT00150462|547006|P5|Overall Study|Disease Progression or Relapse|2
174080|NCT00150462|547007|P4|Overall Study|Disease Progression or Relapse|1
174081|NCT00150462|547008|P3|Overall Study|Disease Progression or Relapse|2
174082|NCT00150462|547009|P2|Overall Study|Disease Progression or Relapse|1
174083|NCT00150462|547010|P1|Overall Study|Disease Progression or Relapse|3
174084|NCT00150345|547120|P2|Overall Study|Unspecified|14
174085|NCT00150345|547121|P1|Overall Study|Unspecified|12
174086|NCT00150345|547120|P2|Overall Study|Laboratory abnormality|2
174087|NCT00150345|547121|P1|Overall Study|Laboratory abnormality|1
174088|NCT00150345|547120|P2|Overall Study|Withdrawal by Subject|4
174089|NCT00150345|547121|P1|Overall Study|Withdrawal by Subject|3
174090|NCT00150345|547120|P2|Overall Study|Lack of Efficacy|4
174091|NCT00150345|547121|P1|Overall Study|Lack of Efficacy|5
174092|NCT00150345|547120|P2|Overall Study|Adverse Event|6
174093|NCT00150345|547121|P1|Overall Study|Adverse Event|8
174094|NCT00150345|547120|P2|Overall Study|Death|2
174095|NCT00150345|547121|P1|Overall Study|Death|5
174096|NCT00150176|547185|P2|Overall Study|OTHER|13
174097|NCT00150176|547186|P1|Overall Study|OTHER|11
174098|NCT00150176|547185|P2|Overall Study|Lost to Follow-up|3
174099|NCT00150176|547186|P1|Overall Study|Lost to Follow-up|3
174100|NCT00150176|547185|P2|Overall Study|Withdrawal by Subject|12
174101|NCT00150176|547186|P1|Overall Study|Withdrawal by Subject|19
174102|NCT00150176|547185|P2|Overall Study|Relapse/Impending relapse, non-AE|39
174103|NCT00150176|547186|P1|Overall Study|Relapse/Impending relapse, non-AE|10
174104|NCT00150176|547185|P2|Overall Study|Adverse Event|53
174105|NCT00150176|547186|P1|Overall Study|Adverse Event|16
174106|NCT00149994|547197|P2|Overall Study|Protocol Violation|1
174107|NCT00149994|547198|P1|Overall Study|Protocol Violation|0
174108|NCT00149994|547197|P2|Overall Study|Administrative problems:|0
174109|NCT00149994|547198|P1|Overall Study|Administrative problems:|1
174110|NCT00149890|547206|P2|Overall Study|Graft Loss|1
174111|NCT00149890|547207|P1|Overall Study|Graft Loss|2
174112|NCT00149890|547206|P2|Overall Study|Lost to Follow-up|0
174113|NCT00149890|547207|P1|Overall Study|Lost to Follow-up|1
174114|NCT00149890|547206|P2|Overall Study|Protocol Violation|0
174115|NCT00149890|547207|P1|Overall Study|Protocol Violation|1
174116|NCT00149890|547206|P2|Overall Study|Lack of Efficacy|9
174117|NCT00149890|547207|P1|Overall Study|Lack of Efficacy|8
174118|NCT00149890|547206|P2|Overall Study|Adverse Event|8
174119|NCT00149890|547207|P1|Overall Study|Adverse Event|1
174120|NCT00149825|547227|P2|Overall Study|Other|0
174121|NCT00149825|547228|P1|Overall Study|Other|1
174122|NCT00149825|547227|P2|Overall Study|Not liking insomnia therapy|0
174123|NCT00149825|547228|P1|Overall Study|Not liking insomnia therapy|1
174124|NCT00149825|547227|P2|Overall Study|Time commitments|1
174125|NCT00149825|547228|P1|Overall Study|Time commitments|2
174126|NCT00149825|547227|P2|Overall Study|Intolerance to medication side effects|2
174127|NCT00149825|547228|P1|Overall Study|Intolerance to medication side effects|1
174128|NCT00149747|547250|P2|Overall Study|Withdrawal by Subject|3
174129|NCT00149747|547251|P1|Overall Study|Withdrawal by Subject|3
174130|NCT00149747|547250|P2|Overall Study|Death|0
174131|NCT00149747|547251|P1|Overall Study|Death|1
174132|NCT00149630|547276|P2|Overall Study|Adverse Event|0
174133|NCT00149630|547277|P1|Overall Study|Adverse Event|2
174134|NCT00149630|547276|P2|Overall Study|Treatment Programs|5
174135|NCT00149630|547277|P1|Overall Study|Treatment Programs|4
174136|NCT00149630|547276|P2|Overall Study|Incarceration|0
174137|NCT00149630|547277|P1|Overall Study|Incarceration|2
174138|NCT00149214|547316|P2|Overall Study|Progressive Disease|3
174139|NCT00149214|547317|P1|Overall Study|Progressive Disease|7
174140|NCT00149214|547316|P2|Overall Study|Sponsor Decision|1
174141|NCT00149214|547317|P1|Overall Study|Sponsor Decision|0
174142|NCT00149214|547316|P2|Overall Study|Physician Decision|3
174143|NCT00149214|547317|P1|Overall Study|Physician Decision|3
174144|NCT00149214|547316|P2|Overall Study|Withdrawal by Subject|1
174145|NCT00149214|547317|P1|Overall Study|Withdrawal by Subject|4
174146|NCT00149214|547316|P2|Overall Study|Adverse Event|9
174147|NCT00149214|547317|P1|Overall Study|Adverse Event|12
174148|NCT00148759|547365|P2|Overall Study|Lost to Follow-up|0
174149|NCT00148759|547366|P1|Overall Study|Lost to Follow-up|1
174150|NCT00148759|547365|P2|Overall Study|Withdrawal by Subject|1
174151|NCT00148759|547366|P1|Overall Study|Withdrawal by Subject|1
174152|NCT00148122|547392|P1|Overall Study|Withdrawal by Subject|2
174153|NCT00148109|547400|P2|Overall Study|Withdrawal by Subject|0
174154|NCT00148109|547401|P1|Overall Study|Withdrawal by Subject|2
174155|NCT00148109|547400|P2|Overall Study|Adverse Event|2
174156|NCT00148109|547401|P1|Overall Study|Adverse Event|0
174157|NCT00148109|547400|P2|Overall Study|Lack of Efficacy|18
174158|NCT00148109|547401|P1|Overall Study|Lack of Efficacy|10
174159|NCT00147823|547417|P2|Overall Study|Did not receive vitoss due to infection|2
174160|NCT00147823|547418|P1|Overall Study|Did not receive vitoss due to infection|6
174161|NCT00147823|547417|P2|Overall Study|Withdrawal by Subject|1
174162|NCT00147823|547418|P1|Overall Study|Withdrawal by Subject|0
174163|NCT00147823|547417|P2|Overall Study|Physician Decision|0
174164|NCT00147823|547418|P1|Overall Study|Physician Decision|1
174165|NCT00147823|547417|P2|Overall Study|Lost to Follow-up|12
174166|NCT00147823|547418|P1|Overall Study|Lost to Follow-up|6
174167|NCT00147745|547449|P3|Overall Study|Withdrawal by Subject|0
174168|NCT00147745|547450|P2|Overall Study|Withdrawal by Subject|0
174169|NCT00147745|547451|P1|Overall Study|Withdrawal by Subject|1
174170|NCT00147537|547473|P11|Phase 2|Randomized but not treated|1
174171|NCT00147537|547474|P10|Phase 2|Randomized but not treated|1
174172|NCT00147537|547475|P9|Phase 2|Randomized but not treated|0
174173|NCT00147537|547476|P8|Phase 2|Randomized but not treated|0
174174|NCT00147537|547477|P7|Phase 2|Randomized but not treated|0
174175|NCT00147537|547478|P6|Phase 2|Randomized but not treated|0
174176|NCT00147537|547479|P5|Phase 2|Randomized but not treated|0
174177|NCT00147537|547480|P4|Phase 2|Randomized but not treated|0
174178|NCT00147537|547481|P3|Phase 2|Randomized but not treated|0
174179|NCT00147537|547482|P2|Phase 2|Randomized but not treated|0
174180|NCT00147537|547483|P1|Phase 2|Randomized but not treated|0
174181|NCT00147537|547473|P11|Phase 2|Withdrawal by Subject|4
174182|NCT00147537|547474|P10|Phase 2|Withdrawal by Subject|16
174183|NCT00147537|547475|P9|Phase 2|Withdrawal by Subject|0
174184|NCT00147537|547476|P8|Phase 2|Withdrawal by Subject|0
174185|NCT00147537|547477|P7|Phase 2|Withdrawal by Subject|0
174186|NCT00147537|547478|P6|Phase 2|Withdrawal by Subject|0
174187|NCT00147537|547479|P5|Phase 2|Withdrawal by Subject|0
174188|NCT00147537|547480|P4|Phase 2|Withdrawal by Subject|0
174189|NCT00147537|547481|P3|Phase 2|Withdrawal by Subject|0
174190|NCT00147537|547482|P2|Phase 2|Withdrawal by Subject|0
174191|NCT00147537|547483|P1|Phase 2|Withdrawal by Subject|0
174192|NCT00147537|547473|P11|Phase 2|unspecified|12
174193|NCT00147537|547474|P10|Phase 2|unspecified|47
174194|NCT00147537|547475|P9|Phase 2|unspecified|0
174195|NCT00147537|547476|P8|Phase 2|unspecified|0
174196|NCT00147537|547477|P7|Phase 2|unspecified|0
174197|NCT00147537|547478|P6|Phase 2|unspecified|0
174198|NCT00147537|547479|P5|Phase 2|unspecified|0
174199|NCT00147537|547480|P4|Phase 2|unspecified|0
174200|NCT00147537|547481|P3|Phase 2|unspecified|0
174201|NCT00147537|547482|P2|Phase 2|unspecified|0
174202|NCT00147537|547483|P1|Phase 2|unspecified|0
174203|NCT00147537|547473|P11|Phase 2|Lost to Follow-up|4
174204|NCT00147537|547474|P10|Phase 2|Lost to Follow-up|12
174205|NCT00147537|547475|P9|Phase 2|Lost to Follow-up|0
174206|NCT00147537|547476|P8|Phase 2|Lost to Follow-up|0
174207|NCT00147537|547477|P7|Phase 2|Lost to Follow-up|0
174208|NCT00147537|547478|P6|Phase 2|Lost to Follow-up|0
174209|NCT00147537|547479|P5|Phase 2|Lost to Follow-up|0
174210|NCT00147537|547480|P4|Phase 2|Lost to Follow-up|0
174211|NCT00147537|547481|P3|Phase 2|Lost to Follow-up|0
174212|NCT00147537|547482|P2|Phase 2|Lost to Follow-up|0
174213|NCT00147537|547483|P1|Phase 2|Lost to Follow-up|0
174214|NCT00147537|547473|P11|Phase 2|Death|31
174215|NCT00147537|547474|P10|Phase 2|Death|85
174216|NCT00147537|547475|P9|Phase 2|Death|0
174217|NCT00147537|547476|P8|Phase 2|Death|0
174218|NCT00147537|547477|P7|Phase 2|Death|0
174219|NCT00147537|547478|P6|Phase 2|Death|0
174220|NCT00147537|547479|P5|Phase 2|Death|0
174221|NCT00147537|547480|P4|Phase 2|Death|0
174222|NCT00147537|547481|P3|Phase 2|Death|0
174223|NCT00147537|547482|P2|Phase 2|Death|0
174224|NCT00147537|547483|P1|Phase 2|Death|0
174225|NCT00147537|547473|P11|Phase 1b|Randomized but not treated|0
174226|NCT00147537|547474|P10|Phase 1b|Randomized but not treated|0
174227|NCT00147537|547475|P9|Phase 1b|Randomized but not treated|1
174228|NCT00147537|547476|P8|Phase 1b|Randomized but not treated|0
174229|NCT00147537|547477|P7|Phase 1b|Randomized but not treated|1
174230|NCT00147537|547478|P6|Phase 1b|Randomized but not treated|0
174231|NCT00147537|547479|P5|Phase 1b|Randomized but not treated|0
174232|NCT00147537|547480|P4|Phase 1b|Randomized but not treated|0
174233|NCT00147537|547481|P3|Phase 1b|Randomized but not treated|0
174234|NCT00147537|547482|P2|Phase 1b|Randomized but not treated|0
174235|NCT00147537|547483|P1|Phase 1b|Randomized but not treated|0
174236|NCT00147537|547473|P11|Phase 1b|Withdrawal by Subject|0
174237|NCT00147537|547474|P10|Phase 1b|Withdrawal by Subject|0
174238|NCT00147537|547475|P9|Phase 1b|Withdrawal by Subject|2
174239|NCT00147537|547476|P8|Phase 1b|Withdrawal by Subject|0
174240|NCT00147537|547477|P7|Phase 1b|Withdrawal by Subject|0
174241|NCT00147537|547478|P6|Phase 1b|Withdrawal by Subject|0
174242|NCT00147537|547479|P5|Phase 1b|Withdrawal by Subject|0
174243|NCT00147537|547480|P4|Phase 1b|Withdrawal by Subject|0
174244|NCT00147537|547481|P3|Phase 1b|Withdrawal by Subject|0
174245|NCT00147537|547482|P2|Phase 1b|Withdrawal by Subject|0
174246|NCT00147537|547483|P1|Phase 1b|Withdrawal by Subject|0
174247|NCT00147537|547473|P11|Phase 1b|unspecified|0
174248|NCT00147537|547474|P10|Phase 1b|unspecified|0
174249|NCT00147537|547475|P9|Phase 1b|unspecified|4
174250|NCT00147537|547476|P8|Phase 1b|unspecified|4
174251|NCT00147537|547477|P7|Phase 1b|unspecified|14
174252|NCT00147537|547478|P6|Phase 1b|unspecified|1
174253|NCT00147537|547479|P5|Phase 1b|unspecified|1
174254|NCT00147537|547480|P4|Phase 1b|unspecified|1
174255|NCT00147537|547481|P3|Phase 1b|unspecified|2
174256|NCT00147537|547482|P2|Phase 1b|unspecified|0
174257|NCT00147537|547483|P1|Phase 1b|unspecified|0
174258|NCT00147537|547473|P11|Phase 1b|Lost to Follow-up|0
174259|NCT00147537|547474|P10|Phase 1b|Lost to Follow-up|0
174260|NCT00147537|547475|P9|Phase 1b|Lost to Follow-up|1
174261|NCT00147537|547476|P8|Phase 1b|Lost to Follow-up|0
174262|NCT00147537|547477|P7|Phase 1b|Lost to Follow-up|2
174263|NCT00147537|547478|P6|Phase 1b|Lost to Follow-up|0
174264|NCT00147537|547479|P5|Phase 1b|Lost to Follow-up|0
174265|NCT00147537|547480|P4|Phase 1b|Lost to Follow-up|0
174266|NCT00147537|547481|P3|Phase 1b|Lost to Follow-up|0
174267|NCT00147537|547482|P2|Phase 1b|Lost to Follow-up|1
174268|NCT00147537|547483|P1|Phase 1b|Lost to Follow-up|2
174269|NCT00147537|547473|P11|Phase 1b|Death|0
174270|NCT00147537|547474|P10|Phase 1b|Death|0
174271|NCT00147537|547475|P9|Phase 1b|Death|9
174272|NCT00147537|547476|P8|Phase 1b|Death|3
174273|NCT00147537|547477|P7|Phase 1b|Death|1
174274|NCT00147537|547478|P6|Phase 1b|Death|2
174275|NCT00147537|547479|P5|Phase 1b|Death|2
174276|NCT00147537|547480|P4|Phase 1b|Death|1
174277|NCT00147537|547481|P3|Phase 1b|Death|2
174278|NCT00147537|547482|P2|Phase 1b|Death|1
174279|NCT00147537|547483|P1|Phase 1b|Death|0
174280|NCT00146328|547665|P3|Overall Study|Interaction with other medication|1
174281|NCT00146328|547666|P2|Overall Study|Interaction with other medication|0
174282|NCT00146328|547667|P1|Overall Study|Interaction with other medication|2
174283|NCT00146328|547665|P3|Overall Study|Moved|0
174284|NCT00146328|547666|P2|Overall Study|Moved|0
174285|NCT00146328|547667|P1|Overall Study|Moved|2
174286|NCT00146328|547665|P3|Overall Study|Death|1
174287|NCT00146328|547666|P2|Overall Study|Death|1
174288|NCT00146328|547667|P1|Overall Study|Death|0
174289|NCT00146328|547665|P3|Overall Study|Enroll into other trial|2
174290|NCT00146328|547666|P2|Overall Study|Enroll into other trial|4
174291|NCT00146328|547667|P1|Overall Study|Enroll into other trial|2
174292|NCT00146328|547665|P3|Overall Study|Patient decision to end|6
174293|NCT00146328|547666|P2|Overall Study|Patient decision to end|1
174294|NCT00146328|547667|P1|Overall Study|Patient decision to end|0
174295|NCT00146328|547665|P3|Overall Study|Trial ended/site closed|19
174296|NCT00146328|547666|P2|Overall Study|Trial ended/site closed|2
174297|NCT00146328|547667|P1|Overall Study|Trial ended/site closed|8
174298|NCT00146328|547665|P3|Overall Study|Virologic Failure/lack of efficacy|142
174299|NCT00146328|547666|P2|Overall Study|Virologic Failure/lack of efficacy|72
174300|NCT00146328|547667|P1|Overall Study|Virologic Failure/lack of efficacy|54
174301|NCT00146328|547665|P3|Overall Study|Withdrawal by Subject|22
174302|NCT00146328|547666|P2|Overall Study|Withdrawal by Subject|16
174303|NCT00146328|547667|P1|Overall Study|Withdrawal by Subject|16
174304|NCT00146328|547665|P3|Overall Study|Lost to Follow-up|7
174305|NCT00146328|547666|P2|Overall Study|Lost to Follow-up|4
174306|NCT00146328|547667|P1|Overall Study|Lost to Follow-up|7
174307|NCT00146328|547665|P3|Overall Study|Protocol Violation|12
174308|NCT00146328|547666|P2|Overall Study|Protocol Violation|6
174309|NCT00146328|547667|P1|Overall Study|Protocol Violation|11
174310|NCT00146328|547665|P3|Overall Study|Adverse Event|79
174311|NCT00146328|547666|P2|Overall Study|Adverse Event|48
174312|NCT00146328|547667|P1|Overall Study|Adverse Event|39
174313|NCT00147498|547754|P4|Overall Study|Unspecified|3
174314|NCT00147498|547755|P3|Overall Study|Unspecified|3
174315|NCT00147498|547756|P2|Overall Study|Unspecified|1
174316|NCT00147498|547757|P1|Overall Study|Unspecified|1
174317|NCT00147498|547754|P4|Overall Study|Participant defaulted|3
174318|NCT00147498|547755|P3|Overall Study|Participant defaulted|4
174319|NCT00147498|547756|P2|Overall Study|Participant defaulted|1
174320|NCT00147498|547757|P1|Overall Study|Participant defaulted|0
174321|NCT00147498|547754|P4|Overall Study|Laboratory abnormality|0
174322|NCT00147498|547755|P3|Overall Study|Laboratory abnormality|2
174323|NCT00147498|547756|P2|Overall Study|Laboratory abnormality|0
174324|NCT00147498|547757|P1|Overall Study|Laboratory abnormality|0
174325|NCT00147498|547754|P4|Overall Study|Lack of Efficacy|8
174326|NCT00147498|547755|P3|Overall Study|Lack of Efficacy|1
174327|NCT00147498|547756|P2|Overall Study|Lack of Efficacy|1
174328|NCT00147498|547757|P1|Overall Study|Lack of Efficacy|1
174329|NCT00147498|547754|P4|Overall Study|Adverse Event|3
174330|NCT00147498|547755|P3|Overall Study|Adverse Event|7
174331|NCT00147498|547756|P2|Overall Study|Adverse Event|6
174332|NCT00147498|547757|P1|Overall Study|Adverse Event|1
174333|NCT00147238|547881|P1|Overall Study|Inevaluable|8
174334|NCT00147225|547891|P6|Overall Study|Chemotherapy Changed|1
174335|NCT00147225|547892|P5|Overall Study|Chemotherapy Changed|0
174336|NCT00147225|547893|P4|Overall Study|Chemotherapy Changed|0
174337|NCT00147225|547894|P3|Overall Study|Chemotherapy Changed|0
174338|NCT00147225|547895|P2|Overall Study|Chemotherapy Changed|0
174339|NCT00147225|547896|P1|Overall Study|Chemotherapy Changed|0
174340|NCT00147225|547891|P6|Overall Study|Screen Failure|0
174341|NCT00147225|547892|P5|Overall Study|Screen Failure|1
174342|NCT00147225|547893|P4|Overall Study|Screen Failure|0
174343|NCT00147225|547894|P3|Overall Study|Screen Failure|0
174344|NCT00147225|547895|P2|Overall Study|Screen Failure|0
174345|NCT00147225|547896|P1|Overall Study|Screen Failure|0
174346|NCT00147225|547891|P6|Overall Study|Adverse Event|0
174347|NCT00147225|547892|P5|Overall Study|Adverse Event|0
174348|NCT00147225|547893|P4|Overall Study|Adverse Event|1
174349|NCT00147225|547894|P3|Overall Study|Adverse Event|1
174350|NCT00147225|547895|P2|Overall Study|Adverse Event|0
174351|NCT00147225|547896|P1|Overall Study|Adverse Event|0
174352|NCT00147225|547891|P6|Overall Study|Withdrawal by Subject|1
174353|NCT00147225|547892|P5|Overall Study|Withdrawal by Subject|0
174354|NCT00147225|547893|P4|Overall Study|Withdrawal by Subject|0
174355|NCT00147225|547894|P3|Overall Study|Withdrawal by Subject|1
174356|NCT00147225|547895|P2|Overall Study|Withdrawal by Subject|0
174357|NCT00147225|547896|P1|Overall Study|Withdrawal by Subject|1
174358|NCT00146848|547999|P3|Post-randomization|Withdrawn|27
174359|NCT00146848|548000|P2|Post-randomization|Withdrawn|32
174360|NCT00146848|548001|P1|Post-randomization|Withdrawn|26
174361|NCT00146848|547999|P3|Post-randomization|Lost to Follow-up|12
174362|NCT00146848|548000|P2|Post-randomization|Lost to Follow-up|15
174363|NCT00146848|548001|P1|Post-randomization|Lost to Follow-up|12
174364|NCT00146848|547999|P3|Pre-randomization|Withdrawal by Subject|0
174365|NCT00146848|548000|P2|Pre-randomization|Withdrawal by Subject|0
174366|NCT00146848|548001|P1|Pre-randomization|Withdrawal by Subject|40
174367|NCT00146848|547999|P3|Pre-randomization|Protocol Violation|0
174368|NCT00146848|548000|P2|Pre-randomization|Protocol Violation|0
174369|NCT00146848|548001|P1|Pre-randomization|Protocol Violation|172
174370|NCT00146848|547999|P3|Pre-randomization|Physician Decision|0
174371|NCT00146848|548000|P2|Pre-randomization|Physician Decision|0
174372|NCT00146848|548001|P1|Pre-randomization|Physician Decision|8
174373|NCT00146848|547999|P3|Pre-randomization|Lost to Follow-up|0
174374|NCT00146848|548000|P2|Pre-randomization|Lost to Follow-up|0
174375|NCT00146848|548001|P1|Pre-randomization|Lost to Follow-up|70
174376|NCT00146848|547999|P3|Pre-randomization|Death|0
174377|NCT00146848|548000|P2|Pre-randomization|Death|0
174378|NCT00146848|548001|P1|Pre-randomization|Death|19
174379|NCT00146770|548017|P2|Overall Study|Withdrawal by Subject|0
174380|NCT00146770|548018|P1|Overall Study|Withdrawal by Subject|2
174381|NCT00146770|548017|P2|Overall Study|Pregnancy|0
174382|NCT00146770|548018|P1|Overall Study|Pregnancy|1
174383|NCT00146770|548017|P2|Overall Study|Adverse Event|0
174384|NCT00146770|548018|P1|Overall Study|Adverse Event|2
174385|NCT00146757|548036|P2|Overall Study|Adverse Event|0
174386|NCT00146757|548037|P1|Overall Study|Adverse Event|1
174387|NCT00146757|548036|P2|Overall Study|Death|0
174388|NCT00146757|548037|P1|Overall Study|Death|1
174389|NCT00145795|548056|P2|Overall Study|Adverse Event|0
174390|NCT00145795|548057|P1|Overall Study|Adverse Event|1
174391|NCT00145626|548092|P1|Overall Study|Withdrawal by Subject|1
174392|NCT00145626|548092|P1|Overall Study|Death|1
174393|NCT00145626|548092|P1|Overall Study|Turned 2 years old before treatment|1
174394|NCT00145626|548092|P1|Overall Study|Did not have NK infusions|2
174395|NCT00145600|548124|P4|Overall Study|Withdrawal by Subject|1
174396|NCT00145600|548125|P3|Overall Study|Withdrawal by Subject|0
174397|NCT00145600|548126|P2|Overall Study|Withdrawal by Subject|2
174398|NCT00145600|548127|P1|Overall Study|Withdrawal by Subject|1
174399|NCT00145600|548124|P4|Overall Study|Noncompliance|0
174400|NCT00145600|548125|P3|Overall Study|Noncompliance|0
174401|NCT00145600|548126|P2|Overall Study|Noncompliance|0
174402|NCT00145600|548127|P1|Overall Study|Noncompliance|1
174403|NCT00145600|548124|P4|Overall Study|Lost to Follow-up|4
174404|NCT00145600|548125|P3|Overall Study|Lost to Follow-up|2
174405|NCT00145600|548126|P2|Overall Study|Lost to Follow-up|6
174406|NCT00145600|548127|P1|Overall Study|Lost to Follow-up|2
174407|NCT00145600|548124|P4|Overall Study|Ineligible|5
174408|NCT00145600|548125|P3|Overall Study|Ineligible|1
174409|NCT00145600|548126|P2|Overall Study|Ineligible|0
174410|NCT00145600|548127|P1|Overall Study|Ineligible|3
174411|NCT00145600|548124|P4|Overall Study|Death|6
174412|NCT00145600|548125|P3|Overall Study|Death|2
174413|NCT00145600|548126|P2|Overall Study|Death|2
174414|NCT00145600|548127|P1|Overall Study|Death|1
174415|NCT00145574|548251|P3|Open Label Long-term Extension|required restricted medicine|1
174416|NCT00145574|548252|P2|Open Label Long-term Extension|required restricted medicine|0
174417|NCT00145574|548253|P1|Open Label Long-term Extension|required restricted medicine|0
174418|NCT00145574|548251|P3|Open Label Long-term Extension|Withdrawal by Subject|4
174419|NCT00145574|548252|P2|Open Label Long-term Extension|Withdrawal by Subject|0
174420|NCT00145574|548253|P1|Open Label Long-term Extension|Withdrawal by Subject|0
174421|NCT00145574|548251|P3|Open Label Long-term Extension|Lost to Follow-up|1
174422|NCT00145574|548252|P2|Open Label Long-term Extension|Lost to Follow-up|0
174423|NCT00145574|548253|P1|Open Label Long-term Extension|Lost to Follow-up|0
174424|NCT00145574|548251|P3|Open Label Long-term Extension|Adverse Event|5
174425|NCT00145574|548252|P2|Open Label Long-term Extension|Adverse Event|0
174426|NCT00145574|548253|P1|Open Label Long-term Extension|Adverse Event|0
174427|NCT00145574|548251|P3|Double Blind|required restricted medicine|0
174428|NCT00145574|548252|P2|Double Blind|required restricted medicine|1
174429|NCT00145574|548253|P1|Double Blind|required restricted medicine|0
174430|NCT00145574|548251|P3|Double Blind|Withdrawal by Subject|1
174431|NCT00145574|548252|P2|Double Blind|Withdrawal by Subject|1
174432|NCT00145574|548253|P1|Double Blind|Withdrawal by Subject|1
174433|NCT00145574|548251|P3|Double Blind|Adverse Event|1
174434|NCT00145574|548252|P2|Double Blind|Adverse Event|3
174435|NCT00145574|548253|P1|Double Blind|Adverse Event|0
174436|NCT00145509|548310|P2|Overall Study|Reason not provided|1
174437|NCT00145509|548311|P1|Overall Study|Reason not provided|2
174438|NCT00145509|548310|P2|Overall Study|Withdrew Consent|7
174439|NCT00145509|548311|P1|Overall Study|Withdrew Consent|2
174440|NCT00145509|548310|P2|Overall Study|Lost to Follow-up|9
174441|NCT00145509|548311|P1|Overall Study|Lost to Follow-up|5
174442|NCT00145509|548310|P2|Overall Study|Lack of Efficacy|1
174443|NCT00145509|548311|P1|Overall Study|Lack of Efficacy|3
174444|NCT00145509|548310|P2|Overall Study|Adverse Event|3
174445|NCT00145509|548311|P1|Overall Study|Adverse Event|10
174446|NCT00145496|548325|P2|Overall Study|Other|13
174447|NCT00145496|548326|P1|Overall Study|Other|25
174448|NCT00145496|548325|P2|Overall Study|Lost to Follow-up|5
174449|NCT00145496|548326|P1|Overall Study|Lost to Follow-up|12
174450|NCT00145496|548325|P2|Overall Study|Withdrawal by Subject|26
174451|NCT00145496|548326|P1|Overall Study|Withdrawal by Subject|32
174452|NCT00145496|548325|P2|Overall Study|Lack of Efficacy|7
174453|NCT00145496|548326|P1|Overall Study|Lack of Efficacy|12
174454|NCT00145496|548325|P2|Overall Study|Adverse Event|30
174455|NCT00145496|548326|P1|Overall Study|Adverse Event|42
174456|NCT00145327|548346|P3|Overall Study|Missing – not stated|1
174457|NCT00145327|548347|P2|Overall Study|Missing – not stated|0
174458|NCT00145327|548348|P1|Overall Study|Missing – not stated|1
174459|NCT00145327|548346|P3|Overall Study|Abnormal laboratory value(s)|2
174460|NCT00145327|548347|P2|Overall Study|Abnormal laboratory value(s)|0
174461|NCT00145327|548348|P1|Overall Study|Abnormal laboratory value(s)|1
174462|NCT00145327|548346|P3|Overall Study|Protocol Violation|2
174463|NCT00145327|548347|P2|Overall Study|Protocol Violation|0
174464|NCT00145327|548348|P1|Overall Study|Protocol Violation|2
174465|NCT00145327|548346|P3|Overall Study|Administrative problems|13
174466|NCT00145327|548347|P2|Overall Study|Administrative problems|9
174467|NCT00145327|548348|P1|Overall Study|Administrative problems|12
174468|NCT00145327|548346|P3|Overall Study|Lost to Follow-up|14
174469|NCT00145327|548347|P2|Overall Study|Lost to Follow-up|14
174470|NCT00145327|548348|P1|Overall Study|Lost to Follow-up|9
174471|NCT00145327|548346|P3|Overall Study|Adverse Event|22
174472|NCT00145327|548347|P2|Overall Study|Adverse Event|11
174473|NCT00145327|548348|P1|Overall Study|Adverse Event|14
174474|NCT00145327|548346|P3|Overall Study|Death|30
174475|NCT00145327|548347|P2|Overall Study|Death|18
174476|NCT00145327|548348|P1|Overall Study|Death|26
174477|NCT00145327|548346|P3|Overall Study|Withdrawal by Subject|164
174478|NCT00145327|548347|P2|Overall Study|Withdrawal by Subject|72
174479|NCT00145327|548348|P1|Overall Study|Withdrawal by Subject|77
174480|NCT00145119|548447|P1|Overall Study|Death|45
174481|NCT00144781|548465|P4|Overall Study|Non-compliant|0
174482|NCT00144781|548466|P3|Overall Study|Non-compliant|0
174483|NCT00144781|548467|P2|Overall Study|Non-compliant|1
174484|NCT00144781|548468|P1|Overall Study|Non-compliant|0
174485|NCT00144781|548465|P4|Overall Study|Adverse Event|0
174486|NCT00144781|548466|P3|Overall Study|Adverse Event|0
174487|NCT00144781|548467|P2|Overall Study|Adverse Event|1
174488|NCT00144781|548468|P1|Overall Study|Adverse Event|0
174489|NCT00144339|548488|P2|Overall Study|Other|60
174490|NCT00144339|548489|P1|Overall Study|Other|58
174491|NCT00144339|548488|P2|Overall Study|Lost to Follow-up|64
174492|NCT00144339|548489|P1|Overall Study|Lost to Follow-up|76
174493|NCT00144339|548488|P2|Overall Study|Withdrawal by Subject|300
174494|NCT00144339|548489|P1|Overall Study|Withdrawal by Subject|403
174495|NCT00144339|548488|P2|Overall Study|Protocol Violation|48
174496|NCT00144339|548489|P1|Overall Study|Protocol Violation|75
174497|NCT00144339|548488|P2|Overall Study|Adverse Event|627
174498|NCT00144339|548489|P1|Overall Study|Adverse Event|746
174499|NCT00144300|548697|P2|Overall Study|Other reason (not specified)|3
174500|NCT00144300|548698|P1|Overall Study|Other reason (not specified)|1
174501|NCT00144300|548697|P2|Overall Study|Withdrawal by Subject|6
174502|NCT00144300|548698|P1|Overall Study|Withdrawal by Subject|6
174503|NCT00144300|548697|P2|Overall Study|Lost to Follow-up|0
174504|NCT00144300|548698|P1|Overall Study|Lost to Follow-up|3
174505|NCT00144300|548697|P2|Overall Study|Protocol Violation|3
174506|NCT00144300|548698|P1|Overall Study|Protocol Violation|1
174507|NCT00144300|548697|P2|Overall Study|Adverse Event|16
174508|NCT00144300|548698|P1|Overall Study|Adverse Event|18
174509|NCT00144170|548746|P2|Overall Study|Other reason not defined above|316
174510|NCT00144170|548747|P1|Overall Study|Other reason not defined above|211
174511|NCT00144170|548746|P2|Overall Study|Withdrawal by Subject|13
174512|NCT00144170|548747|P1|Overall Study|Withdrawal by Subject|29
174513|NCT00144170|548746|P2|Overall Study|Lost to Follow-up|10
174514|NCT00144170|548747|P1|Overall Study|Lost to Follow-up|5
174515|NCT00144170|548746|P2|Overall Study|Protocol Violation|16
174516|NCT00144170|548747|P1|Overall Study|Protocol Violation|23
174517|NCT00144170|548746|P2|Overall Study|Adverse Event|41
174518|NCT00144170|548747|P1|Overall Study|Adverse Event|84
174519|NCT00144027|548937|P2|Overall Study|did not complete baseline assessment|6
174520|NCT00144027|548938|P1|Overall Study|did not complete baseline assessment|0
174521|NCT00144027|548937|P2|Overall Study|Withdrawal by Subject|2
174522|NCT00144027|548938|P1|Overall Study|Withdrawal by Subject|2
174523|NCT00144027|548937|P2|Overall Study|Lost to Follow-up|3
174524|NCT00144027|548938|P1|Overall Study|Lost to Follow-up|1
174525|NCT00142935|548952|P3|Overall Study|Death|1
174526|NCT00142935|548953|P2|Overall Study|Death|2
174527|NCT00142935|548954|P1|Overall Study|Death|0
174528|NCT00142935|548952|P3|Overall Study|Lost to Follow-up|5
174529|NCT00142935|548953|P2|Overall Study|Lost to Follow-up|5
174530|NCT00142935|548954|P1|Overall Study|Lost to Follow-up|2
174531|NCT00142935|548952|P3|Overall Study|Other reason|1
174532|NCT00142935|548953|P2|Overall Study|Other reason|1
174533|NCT00142935|548954|P1|Overall Study|Other reason|1
174534|NCT00142909|548979|P2|Medications Begin|Withdrawal by Subject|0
174535|NCT00142909|548980|P1|Medications Begin|Withdrawal by Subject|2
174536|NCT00142909|548979|P2|Medications Begin|Withdrawal by Subject|3
174537|NCT00142909|548980|P1|Medications Begin|Withdrawal by Subject|5
174538|NCT00142909|548979|P2|Medications Begin|Protocol Violation|0
174539|NCT00142909|548980|P1|Medications Begin|Protocol Violation|2
174540|NCT00142909|548979|P2|Randomization|Various Reasons|10
174541|NCT00142909|548980|P1|Randomization|Various Reasons|7
174542|NCT00143598|548998|P2|Overall Study|Death|36
174543|NCT00143598|548999|P1|Overall Study|Death|36
174544|NCT00143598|548998|P2|Overall Study|Withdrawal by Subject|37
174545|NCT00143598|548999|P1|Overall Study|Withdrawal by Subject|33
174546|NCT00143598|548998|P2|Overall Study|Lost to Follow-up|21
174547|NCT00143598|548999|P1|Overall Study|Lost to Follow-up|23
174548|NCT00143507|549013|P2|Overall Study|Withdrawn by sponsor's decision|3
174549|NCT00143507|549014|P1|Overall Study|Withdrawn by sponsor's decision|0
174550|NCT00143507|549013|P2|Overall Study|Lost to Follow-up|0
174551|NCT00143507|549014|P1|Overall Study|Lost to Follow-up|1
174552|NCT00143507|549013|P2|Overall Study|Withdrawal by Subject|102
174553|NCT00143507|549014|P1|Overall Study|Withdrawal by Subject|114
174554|NCT00143507|549013|P2|Overall Study|Death|547
174555|NCT00143507|549014|P1|Overall Study|Death|572
174556|NCT00143455|549048|P4|Cohort 2|Randomized But Not Treated|1
174557|NCT00143455|549049|P3|Cohort 2|Randomized But Not Treated|1
174558|NCT00143455|549050|P2|Cohort 2|Randomized But Not Treated|0
174559|NCT00143455|549051|P1|Cohort 2|Randomized But Not Treated|0
174560|NCT00143455|549048|P4|Cohort 2|Unspecified|6
174561|NCT00143455|549049|P3|Cohort 2|Unspecified|7
174562|NCT00143455|549050|P2|Cohort 2|Unspecified|0
174563|NCT00143455|549051|P1|Cohort 2|Unspecified|0
174564|NCT00143455|549048|P4|Cohort 2|Withdrawal by Subject|12
174565|NCT00143455|549049|P3|Cohort 2|Withdrawal by Subject|13
174566|NCT00143455|549050|P2|Cohort 2|Withdrawal by Subject|0
174567|NCT00143455|549051|P1|Cohort 2|Withdrawal by Subject|0
174568|NCT00143455|549048|P4|Cohort 2|Progressive Disease|27
174569|NCT00143455|549049|P3|Cohort 2|Progressive Disease|20
174570|NCT00143455|549050|P2|Cohort 2|Progressive Disease|0
174571|NCT00143455|549051|P1|Cohort 2|Progressive Disease|0
174572|NCT00143455|549048|P4|Cohort 2|Death|12
174573|NCT00143455|549049|P3|Cohort 2|Death|20
174574|NCT00143455|549050|P2|Cohort 2|Death|0
174575|NCT00143455|549051|P1|Cohort 2|Death|0
174576|NCT00143455|549048|P4|Cohort 2|Lost to Follow-up|4
174577|NCT00143455|549049|P3|Cohort 2|Lost to Follow-up|1
174578|NCT00143455|549050|P2|Cohort 2|Lost to Follow-up|0
174579|NCT00143455|549051|P1|Cohort 2|Lost to Follow-up|0
174580|NCT00143455|549048|P4|Cohort 2|Protocol Violation|1
174581|NCT00143455|549049|P3|Cohort 2|Protocol Violation|1
174582|NCT00143455|549050|P2|Cohort 2|Protocol Violation|0
174583|NCT00143455|549051|P1|Cohort 2|Protocol Violation|0
174584|NCT00143455|549048|P4|Cohort 2|No Longer Required Study Treatment|0
174585|NCT00143455|549049|P3|Cohort 2|No Longer Required Study Treatment|1
174586|NCT00143455|549050|P2|Cohort 2|No Longer Required Study Treatment|0
174587|NCT00143455|549051|P1|Cohort 2|No Longer Required Study Treatment|0
174588|NCT00143455|549048|P4|Cohort 2|Adverse Event|30
174589|NCT00143455|549049|P3|Cohort 2|Adverse Event|42
174590|NCT00143455|549050|P2|Cohort 2|Adverse Event|0
174591|NCT00143455|549051|P1|Cohort 2|Adverse Event|0
174592|NCT00143455|549048|P4|Cohort 1|Randomized But Not Treated|0
174593|NCT00143455|549049|P3|Cohort 1|Randomized But Not Treated|0
174594|NCT00143455|549050|P2|Cohort 1|Randomized But Not Treated|1
174595|NCT00143455|549051|P1|Cohort 1|Randomized But Not Treated|0
174596|NCT00143455|549048|P4|Cohort 1|Withdrawal by Subject|0
174597|NCT00143455|549049|P3|Cohort 1|Withdrawal by Subject|0
174598|NCT00143455|549050|P2|Cohort 1|Withdrawal by Subject|4
174599|NCT00143455|549051|P1|Cohort 1|Withdrawal by Subject|1
174600|NCT00143455|549048|P4|Cohort 1|Progressive Disease|0
174601|NCT00143455|549049|P3|Cohort 1|Progressive Disease|0
174602|NCT00143455|549050|P2|Cohort 1|Progressive Disease|6
174603|NCT00143455|549051|P1|Cohort 1|Progressive Disease|0
174604|NCT00143455|549048|P4|Cohort 1|Death|0
174605|NCT00143455|549049|P3|Cohort 1|Death|0
174606|NCT00143455|549050|P2|Cohort 1|Death|2
174607|NCT00143455|549051|P1|Cohort 1|Death|5
174608|NCT00143455|549048|P4|Cohort 1|Adverse Event|0
174609|NCT00143455|549049|P3|Cohort 1|Adverse Event|0
174610|NCT00143455|549050|P2|Cohort 1|Adverse Event|4
174611|NCT00143455|549051|P1|Cohort 1|Adverse Event|8
174612|NCT00143403|549085|P2|Overall Study|Randomized Not Treated|8
174613|NCT00143403|549086|P1|Overall Study|Randomized Not Treated|7
174614|NCT00143403|549085|P2|Overall Study|specified by site|9
174615|NCT00143403|549086|P1|Overall Study|specified by site|4
174616|NCT00143403|549085|P2|Overall Study|Protocol Violation|2
174617|NCT00143403|549086|P1|Overall Study|Protocol Violation|2
174618|NCT00143403|549085|P2|Overall Study|Relapse|7
174619|NCT00143403|549086|P1|Overall Study|Relapse|15
174620|NCT00143403|549085|P2|Overall Study|Withdrawal by Subject|12
174621|NCT00143403|549086|P1|Overall Study|Withdrawal by Subject|3
174622|NCT00143403|549085|P2|Overall Study|Death|0
174623|NCT00143403|549086|P1|Overall Study|Death|1
174624|NCT00143403|549085|P2|Overall Study|Adverse Event|8
174625|NCT00143403|549086|P1|Overall Study|Adverse Event|3
174626|NCT00143390|549096|P2|Overall Study|Other|2
174627|NCT00143390|549097|P1|Overall Study|Other|1
174628|NCT00143390|549096|P2|Overall Study|Adverse Event|8
174629|NCT00143390|549097|P1|Overall Study|Adverse Event|9
174630|NCT00143390|549096|P2|Overall Study|Study termination|15
174631|NCT00143390|549097|P1|Overall Study|Study termination|10
174632|NCT00143390|549096|P2|Overall Study|Protocol Violation|0
174633|NCT00143390|549097|P1|Overall Study|Protocol Violation|2
174634|NCT00143390|549096|P2|Overall Study|Progressive disease|115
174635|NCT00143390|549097|P1|Overall Study|Progressive disease|119
174636|NCT00143390|549096|P2|Overall Study|Withdrawal by Subject|4
174637|NCT00143390|549097|P1|Overall Study|Withdrawal by Subject|4
174638|NCT00143390|549096|P2|Overall Study|Not meeting entry criteria|5
174639|NCT00143390|549097|P1|Overall Study|Not meeting entry criteria|2
174640|NCT00143390|549096|P2|Overall Study|Death|0
174641|NCT00143390|549097|P1|Overall Study|Death|2
174642|NCT00143312|549113|P1|Overall Study|Withdrawal by Subject|1
174643|NCT00143312|549113|P1|Overall Study|Other|1
174644|NCT00143312|549113|P1|Overall Study|Lost to Follow-up|1
174645|NCT00143312|549113|P1|Overall Study|Adverse Event|2
174646|NCT00143312|549113|P1|Overall Study|Death|11
174647|NCT00143247|549123|P1|Overall Study|Other|12
174648|NCT00143247|549123|P1|Overall Study|following inaccurate lab adverse event|1
174649|NCT00143247|549123|P1|Overall Study|Lost to Follow-up|12
174650|NCT00143247|549123|P1|Overall Study|Protocol Violation|15
174651|NCT00143247|549123|P1|Overall Study|Study terminated by sponsor|31
174652|NCT00143247|549123|P1|Overall Study|Withdrawal by Subject|55
174653|NCT00143247|549123|P1|Overall Study|Lack of Efficacy|3
174654|NCT00143247|549123|P1|Overall Study|Adverse Event|19
174655|NCT00143247|549123|P1|Overall Study|Death|8
174656|NCT00142298|549173|P10|Overall Study|Treatment Failure|0
174657|NCT00142298|549174|P9|Overall Study|Treatment Failure|0
174658|NCT00142298|549175|P8|Overall Study|Treatment Failure|0
174659|NCT00142298|549176|P7|Overall Study|Treatment Failure|2
174660|NCT00142298|549177|P6|Overall Study|Treatment Failure|2
174661|NCT00142298|549178|P5|Overall Study|Treatment Failure|0
174662|NCT00142298|549179|P4|Overall Study|Treatment Failure|0
174663|NCT00142298|549180|P3|Overall Study|Treatment Failure|0
174664|NCT00142298|549181|P2|Overall Study|Treatment Failure|0
174665|NCT00142298|549182|P1|Overall Study|Treatment Failure|0
174666|NCT00142298|549173|P10|Overall Study|Lost to Follow-up|0
174667|NCT00142298|549174|P9|Overall Study|Lost to Follow-up|0
174668|NCT00142298|549175|P8|Overall Study|Lost to Follow-up|0
174669|NCT00142298|549176|P7|Overall Study|Lost to Follow-up|2
174670|NCT00142298|549177|P6|Overall Study|Lost to Follow-up|0
174671|NCT00142298|549178|P5|Overall Study|Lost to Follow-up|0
174672|NCT00142298|549179|P4|Overall Study|Lost to Follow-up|0
174673|NCT00142298|549180|P3|Overall Study|Lost to Follow-up|0
174674|NCT00142298|549181|P2|Overall Study|Lost to Follow-up|0
174675|NCT00142298|549182|P1|Overall Study|Lost to Follow-up|0
174676|NCT00142298|549173|P10|Overall Study|Other- not specified|0
174677|NCT00142298|549174|P9|Overall Study|Other- not specified|0
174678|NCT00142298|549175|P8|Overall Study|Other- not specified|0
174679|NCT00142298|549176|P7|Overall Study|Other- not specified|0
174680|NCT00142298|549177|P6|Overall Study|Other- not specified|0
174681|NCT00142298|549178|P5|Overall Study|Other- not specified|0
174682|NCT00142298|549179|P4|Overall Study|Other- not specified|1
174683|NCT00142298|549180|P3|Overall Study|Other- not specified|0
174684|NCT00142298|549181|P2|Overall Study|Other- not specified|3
174685|NCT00142298|549182|P1|Overall Study|Other- not specified|0
174686|NCT00142298|549173|P10|Overall Study|Virologic breakthrough|0
174687|NCT00142298|549174|P9|Overall Study|Virologic breakthrough|0
174688|NCT00142298|549175|P8|Overall Study|Virologic breakthrough|0
174689|NCT00142298|549176|P7|Overall Study|Virologic breakthrough|3
174690|NCT00142298|549177|P6|Overall Study|Virologic breakthrough|3
174691|NCT00142298|549178|P5|Overall Study|Virologic breakthrough|2
174692|NCT00142298|549179|P4|Overall Study|Virologic breakthrough|7
174693|NCT00142298|549180|P3|Overall Study|Virologic breakthrough|9
174694|NCT00142298|549181|P2|Overall Study|Virologic breakthrough|23
174695|NCT00142298|549182|P1|Overall Study|Virologic breakthrough|19
174696|NCT00142298|549173|P10|Overall Study|Pregnancy|0
174697|NCT00142298|549174|P9|Overall Study|Pregnancy|1
174698|NCT00142298|549175|P8|Overall Study|Pregnancy|0
174699|NCT00142298|549176|P7|Overall Study|Pregnancy|0
174700|NCT00142298|549177|P6|Overall Study|Pregnancy|0
174701|NCT00142298|549178|P5|Overall Study|Pregnancy|0
174702|NCT00142298|549179|P4|Overall Study|Pregnancy|3
174703|NCT00142298|549180|P3|Overall Study|Pregnancy|2
174704|NCT00142298|549181|P2|Overall Study|Pregnancy|4
174705|NCT00142298|549182|P1|Overall Study|Pregnancy|4
174706|NCT00142298|549173|P10|Overall Study|Patient, Investigator,or Sponsor request|0
174707|NCT00142298|549174|P9|Overall Study|Patient, Investigator,or Sponsor request|1
174708|NCT00142298|549175|P8|Overall Study|Patient, Investigator,or Sponsor request|4
174709|NCT00142298|549176|P7|Overall Study|Patient, Investigator,or Sponsor request|1
174710|NCT00142298|549177|P6|Overall Study|Patient, Investigator,or Sponsor request|3
174711|NCT00142298|549178|P5|Overall Study|Patient, Investigator,or Sponsor request|4
174712|NCT00142298|549179|P4|Overall Study|Patient, Investigator,or Sponsor request|51
174713|NCT00142298|549180|P3|Overall Study|Patient, Investigator,or Sponsor request|11
174714|NCT00142298|549181|P2|Overall Study|Patient, Investigator,or Sponsor request|60
174715|NCT00142298|549182|P1|Overall Study|Patient, Investigator,or Sponsor request|66
174716|NCT00142298|549173|P10|Overall Study|Non-compliance|0
174717|NCT00142298|549174|P9|Overall Study|Non-compliance|3
174718|NCT00142298|549175|P8|Overall Study|Non-compliance|3
174719|NCT00142298|549176|P7|Overall Study|Non-compliance|0
174720|NCT00142298|549177|P6|Overall Study|Non-compliance|0
174721|NCT00142298|549178|P5|Overall Study|Non-compliance|1
174722|NCT00142298|549179|P4|Overall Study|Non-compliance|6
174723|NCT00142298|549180|P3|Overall Study|Non-compliance|0
174724|NCT00142298|549181|P2|Overall Study|Non-compliance|13
174725|NCT00142298|549182|P1|Overall Study|Non-compliance|15
174726|NCT00142298|549173|P10|Overall Study|Lack of Efficacy|0
174727|NCT00142298|549174|P9|Overall Study|Lack of Efficacy|0
174728|NCT00142298|549175|P8|Overall Study|Lack of Efficacy|1
174729|NCT00142298|549176|P7|Overall Study|Lack of Efficacy|0
174730|NCT00142298|549177|P6|Overall Study|Lack of Efficacy|0
174731|NCT00142298|549178|P5|Overall Study|Lack of Efficacy|1
174732|NCT00142298|549179|P4|Overall Study|Lack of Efficacy|12
174733|NCT00142298|549180|P3|Overall Study|Lack of Efficacy|9
174734|NCT00142298|549181|P2|Overall Study|Lack of Efficacy|62
174735|NCT00142298|549182|P1|Overall Study|Lack of Efficacy|44
174736|NCT00142298|549173|P10|Overall Study|Death|0
174737|NCT00142298|549174|P9|Overall Study|Death|0
174738|NCT00142298|549175|P8|Overall Study|Death|0
174739|NCT00142298|549176|P7|Overall Study|Death|0
174740|NCT00142298|549177|P6|Overall Study|Death|6
174741|NCT00142298|549178|P5|Overall Study|Death|0
174742|NCT00142298|549179|P4|Overall Study|Death|0
174743|NCT00142298|549180|P3|Overall Study|Death|1
174744|NCT00142298|549181|P2|Overall Study|Death|1
174745|NCT00142298|549182|P1|Overall Study|Death|1
174746|NCT00142298|549173|P10|Overall Study|Clinical disease progression|0
174747|NCT00142298|549174|P9|Overall Study|Clinical disease progression|0
174748|NCT00142298|549175|P8|Overall Study|Clinical disease progression|0
174749|NCT00142298|549176|P7|Overall Study|Clinical disease progression|0
174750|NCT00142298|549177|P6|Overall Study|Clinical disease progression|0
174751|NCT00142298|549178|P5|Overall Study|Clinical disease progression|0
174752|NCT00142298|549179|P4|Overall Study|Clinical disease progression|0
174753|NCT00142298|549180|P3|Overall Study|Clinical disease progression|0
174754|NCT00142298|549181|P2|Overall Study|Clinical disease progression|0
174755|NCT00142298|549182|P1|Overall Study|Clinical disease progression|1
174756|NCT00142298|549173|P10|Overall Study|Adverse Event|0
174757|NCT00142298|549174|P9|Overall Study|Adverse Event|0
174758|NCT00142298|549175|P8|Overall Study|Adverse Event|0
174759|NCT00142298|549176|P7|Overall Study|Adverse Event|0
174760|NCT00142298|549177|P6|Overall Study|Adverse Event|2
174761|NCT00142298|549178|P5|Overall Study|Adverse Event|2
174762|NCT00142298|549179|P4|Overall Study|Adverse Event|5
174763|NCT00142298|549180|P3|Overall Study|Adverse Event|1
174764|NCT00142298|549181|P2|Overall Study|Adverse Event|10
174765|NCT00142298|549182|P1|Overall Study|Adverse Event|10
174766|NCT00141921|549216|P1|Overall Study|Other|8
174767|NCT00141921|549216|P1|Overall Study|Ineligibility Determined|2
174768|NCT00141921|549216|P1|Overall Study|Pregnancy|4
174769|NCT00141921|549216|P1|Overall Study|Administrative Decision|2
174770|NCT00141921|549216|P1|Overall Study|Adverse Event|5
174771|NCT00141921|549216|P1|Overall Study|Protocol Deviation|7
174772|NCT00141921|549216|P1|Overall Study|Disease Progression|7
174773|NCT00141921|549216|P1|Overall Study|Noncompliance|17
174774|NCT00141921|549216|P1|Overall Study|Lost to Follow-up|19
174775|NCT00141921|549216|P1|Overall Study|Withdrawal by Subject|42
174776|NCT00141921|549216|P1|Overall Study|Remain on Study|28
174777|NCT00141817|549242|P4|Overall Study|Parent request|0
174778|NCT00141817|549243|P3|Overall Study|Parent request|0
174779|NCT00141817|549244|P2|Overall Study|Parent request|0
174780|NCT00141817|549245|P1|Overall Study|Parent request|1
174781|NCT00141817|549242|P4|Overall Study|Protocol Violation|0
174782|NCT00141817|549243|P3|Overall Study|Protocol Violation|1
174783|NCT00141817|549244|P2|Overall Study|Protocol Violation|0
174784|NCT00141817|549245|P1|Overall Study|Protocol Violation|0
174785|NCT00141778|549286|P3|Started Study Medication|Chest Discomfort|1
174786|NCT00141778|549287|P2|Started Study Medication|Chest Discomfort|0
174787|NCT00141778|549288|P1|Started Study Medication|Chest Discomfort|0
174788|NCT00141778|549286|P3|Started Study Medication|Difficulty Swallowing|0
174789|NCT00141778|549287|P2|Started Study Medication|Difficulty Swallowing|1
174790|NCT00141778|549288|P1|Started Study Medication|Difficulty Swallowing|0
174791|NCT00141778|549286|P3|Started Study Medication|Withdrawal by Subject|0
174792|NCT00141778|549287|P2|Started Study Medication|Withdrawal by Subject|2
174793|NCT00141778|549288|P1|Started Study Medication|Withdrawal by Subject|0
174794|NCT00141778|549286|P3|Started Study Medication|Met safety criteria for discontinuation|3
174795|NCT00141778|549287|P2|Started Study Medication|Met safety criteria for discontinuation|4
174796|NCT00141778|549288|P1|Started Study Medication|Met safety criteria for discontinuation|2
174797|NCT00141778|549286|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
174798|NCT00141778|549287|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
174799|NCT00141778|549288|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
174800|NCT00141726|549341|P1|Overall Study|Completed <50% Scheduled Dosing|3
174801|NCT00141518|549349|P3|Overall Study|Lack of Efficacy|0
174802|NCT00141518|549350|P2|Overall Study|Lack of Efficacy|0
174803|NCT00141518|549351|P1|Overall Study|Lack of Efficacy|5
174804|NCT00141518|549349|P3|Overall Study|Protocol Violation|2
174805|NCT00141518|549350|P2|Overall Study|Protocol Violation|1
174806|NCT00141518|549351|P1|Overall Study|Protocol Violation|1
174807|NCT00141518|549349|P3|Overall Study|Withdrawal by Subject|2
174808|NCT00141518|549350|P2|Overall Study|Withdrawal by Subject|0
174809|NCT00141518|549351|P1|Overall Study|Withdrawal by Subject|2
174810|NCT00141518|549349|P3|Overall Study|Adverse Event|2
174811|NCT00141518|549350|P2|Overall Study|Adverse Event|5
174812|NCT00141518|549351|P1|Overall Study|Adverse Event|7
174813|NCT00141518|549349|P3|Overall Study|Withdrew Consent Prior to Treatment|0
174814|NCT00141518|549350|P2|Overall Study|Withdrew Consent Prior to Treatment|0
174815|NCT00141518|549351|P1|Overall Study|Withdrew Consent Prior to Treatment|1
174816|NCT00141453|549540|P2|Overall Study|Protocol Violation|5
174817|NCT00141453|549541|P1|Overall Study|Protocol Violation|6
174818|NCT00141297|549555|P10|Overall Study|Transitioned|0
174819|NCT00141297|549556|P9|Overall Study|Transitioned|0
174820|NCT00141297|549557|P8|Overall Study|Transitioned|0
174821|NCT00141297|549558|P7|Overall Study|Transitioned|0
174822|NCT00141297|549559|P6|Overall Study|Transitioned|0
174823|NCT00141297|549560|P5|Overall Study|Transitioned|1
174824|NCT00141297|549561|P4|Overall Study|Transitioned|0
174825|NCT00141297|549562|P3|Overall Study|Transitioned|0
174826|NCT00141297|549563|P2|Overall Study|Transitioned|0
174827|NCT00141297|549564|P1|Overall Study|Transitioned|0
174828|NCT00141297|549555|P10|Overall Study|Progressive Disease|6
174829|NCT00141297|549556|P9|Overall Study|Progressive Disease|15
174830|NCT00141297|549557|P8|Overall Study|Progressive Disease|3
174831|NCT00141297|549558|P7|Overall Study|Progressive Disease|3
174832|NCT00141297|549559|P6|Overall Study|Progressive Disease|2
174833|NCT00141297|549560|P5|Overall Study|Progressive Disease|15
174834|NCT00141297|549561|P4|Overall Study|Progressive Disease|2
174835|NCT00141297|549562|P3|Overall Study|Progressive Disease|6
174836|NCT00141297|549563|P2|Overall Study|Progressive Disease|3
174837|NCT00141297|549564|P1|Overall Study|Progressive Disease|2
174838|NCT00141297|549555|P10|Overall Study|Unspecified|0
174839|NCT00141297|549556|P9|Overall Study|Unspecified|2
174840|NCT00141297|549557|P8|Overall Study|Unspecified|0
174841|NCT00141297|549558|P7|Overall Study|Unspecified|0
174842|NCT00141297|549559|P6|Overall Study|Unspecified|0
174843|NCT00141297|549560|P5|Overall Study|Unspecified|5
174844|NCT00141297|549561|P4|Overall Study|Unspecified|1
174845|NCT00141297|549562|P3|Overall Study|Unspecified|0
174846|NCT00141297|549563|P2|Overall Study|Unspecified|0
174847|NCT00141297|549564|P1|Overall Study|Unspecified|0
174848|NCT00141297|549555|P10|Overall Study|Withdrawal by Subject|0
174849|NCT00141297|549556|P9|Overall Study|Withdrawal by Subject|1
174850|NCT00141297|549557|P8|Overall Study|Withdrawal by Subject|0
174851|NCT00141297|549558|P7|Overall Study|Withdrawal by Subject|0
174852|NCT00141297|549559|P6|Overall Study|Withdrawal by Subject|0
174853|NCT00141297|549560|P5|Overall Study|Withdrawal by Subject|0
174854|NCT00141297|549561|P4|Overall Study|Withdrawal by Subject|0
174855|NCT00141297|549562|P3|Overall Study|Withdrawal by Subject|0
174856|NCT00141297|549563|P2|Overall Study|Withdrawal by Subject|0
174857|NCT00141297|549564|P1|Overall Study|Withdrawal by Subject|0
174858|NCT00141297|549555|P10|Overall Study|Death|0
174859|NCT00141297|549556|P9|Overall Study|Death|1
174860|NCT00141297|549557|P8|Overall Study|Death|0
174861|NCT00141297|549558|P7|Overall Study|Death|0
174862|NCT00141297|549559|P6|Overall Study|Death|0
174863|NCT00141297|549560|P5|Overall Study|Death|0
174864|NCT00141297|549561|P4|Overall Study|Death|0
174865|NCT00141297|549562|P3|Overall Study|Death|0
174866|NCT00141297|549563|P2|Overall Study|Death|0
174867|NCT00141297|549564|P1|Overall Study|Death|1
174868|NCT00141297|549555|P10|Overall Study|Adverse Event|0
174869|NCT00141297|549556|P9|Overall Study|Adverse Event|1
174870|NCT00141297|549557|P8|Overall Study|Adverse Event|1
174871|NCT00141297|549558|P7|Overall Study|Adverse Event|0
174872|NCT00141297|549559|P6|Overall Study|Adverse Event|1
174873|NCT00141297|549560|P5|Overall Study|Adverse Event|1
174874|NCT00141297|549561|P4|Overall Study|Adverse Event|0
174875|NCT00141297|549562|P3|Overall Study|Adverse Event|1
174876|NCT00141297|549563|P2|Overall Study|Adverse Event|0
174877|NCT00141297|549564|P1|Overall Study|Adverse Event|0
174878|NCT00141271|549842|P3|Overall Study|Other|5
174879|NCT00141271|549843|P2|Overall Study|Other|12
174880|NCT00141271|549844|P1|Overall Study|Other|11
174881|NCT00141271|549842|P3|Overall Study|Withdrawal by Subject|10
174882|NCT00141271|549843|P2|Overall Study|Withdrawal by Subject|9
174883|NCT00141271|549844|P1|Overall Study|Withdrawal by Subject|14
174884|NCT00141271|549842|P3|Overall Study|Lost to Follow-up|21
174885|NCT00141271|549843|P2|Overall Study|Lost to Follow-up|15
174886|NCT00141271|549844|P1|Overall Study|Lost to Follow-up|15
174887|NCT00141271|549842|P3|Overall Study|Lack of Efficacy|3
174888|NCT00141271|549843|P2|Overall Study|Lack of Efficacy|7
174889|NCT00141271|549844|P1|Overall Study|Lack of Efficacy|7
174890|NCT00141271|549842|P3|Overall Study|Laboratory Abnormality|1
174891|NCT00141271|549843|P2|Overall Study|Laboratory Abnormality|1
174892|NCT00141271|549844|P1|Overall Study|Laboratory Abnormality|2
174893|NCT00141271|549842|P3|Overall Study|Adverse Event|17
174894|NCT00141271|549843|P2|Overall Study|Adverse Event|19
174895|NCT00141271|549844|P1|Overall Study|Adverse Event|31
174896|NCT00141219|549965|P2|Overall Study|Withdrawal by Subject|2
174897|NCT00141219|549966|P1|Overall Study|Withdrawal by Subject|6
174898|NCT00141219|549965|P2|Overall Study|Lack of Efficacy|4
174899|NCT00141219|549966|P1|Overall Study|Lack of Efficacy|5
174900|NCT00141219|549965|P2|Overall Study|Adverse Event|6
174901|NCT00141219|549966|P1|Overall Study|Adverse Event|8
174902|NCT00141219|549965|P2|Overall Study|Protocol violations|4
174903|NCT00141219|549966|P1|Overall Study|Protocol violations|5
174904|NCT00141102|550018|P2|Overall Study|Death|2
174905|NCT00141102|550019|P1|Overall Study|Death|2
174906|NCT00141102|550018|P2|Overall Study|Randomized But Did Not Receive Treatment|9
174907|NCT00141102|550019|P1|Overall Study|Randomized But Did Not Receive Treatment|15
174908|NCT00141102|550018|P2|Overall Study|Withdrawal by Subject|142
174909|NCT00141102|550019|P1|Overall Study|Withdrawal by Subject|112
174910|NCT00141102|550018|P2|Overall Study|Unspecified|76
174911|NCT00141102|550019|P1|Overall Study|Unspecified|87
174912|NCT00141102|550018|P2|Overall Study|Lost to Follow-up|32
174913|NCT00141102|550019|P1|Overall Study|Lost to Follow-up|29
174914|NCT00141102|550018|P2|Overall Study|Lack of Efficacy|26
174915|NCT00141102|550019|P1|Overall Study|Lack of Efficacy|21
174916|NCT00141102|550018|P2|Overall Study|Laboratory Abnormality|33
174917|NCT00141102|550019|P1|Overall Study|Laboratory Abnormality|9
174918|NCT00141102|550018|P2|Overall Study|Adverse Event|305
174919|NCT00141102|550019|P1|Overall Study|Adverse Event|233
174920|NCT00141037|550059|P2|Overall Study|Graft Failure|4
174921|NCT00141037|550060|P1|Overall Study|Graft Failure|3
174922|NCT00141037|550059|P2|Overall Study|Moved from area|7
174923|NCT00141037|550060|P1|Overall Study|Moved from area|1
174924|NCT00141037|550059|P2|Overall Study|Other|1
174925|NCT00141037|550060|P1|Overall Study|Other|0
174926|NCT00141037|550059|P2|Overall Study|Withdrawal by Subject|1
174927|NCT00141037|550060|P1|Overall Study|Withdrawal by Subject|2
174928|NCT00141037|550059|P2|Overall Study|Protocol Violation|2
174929|NCT00141037|550060|P1|Overall Study|Protocol Violation|0
174930|NCT00141037|550059|P2|Overall Study|Lost to Follow-up|1
174931|NCT00141037|550060|P1|Overall Study|Lost to Follow-up|3
174932|NCT00141037|550059|P2|Overall Study|Physician Decision|2
174933|NCT00141037|550060|P1|Overall Study|Physician Decision|1
174934|NCT00140426|550095|P2|Overall Study|Withdrawal by Subject|3
174935|NCT00140426|550096|P1|Overall Study|Withdrawal by Subject|0
174936|NCT00140413|550129|P2|Overall Study|Withdrawal by Subject|0
174937|NCT00140413|550130|P1|Overall Study|Withdrawal by Subject|2
174938|NCT00140413|550129|P2|Overall Study|Lost to Follow-up|0
174939|NCT00140413|550130|P1|Overall Study|Lost to Follow-up|1
174940|NCT00140140|550140|P3|Overall Study|Physician Decision|0
174941|NCT00140140|550141|P2|Overall Study|Physician Decision|1
174942|NCT00140140|550142|P1|Overall Study|Physician Decision|1
174943|NCT00140140|550140|P3|Overall Study|Unacceptable toxicity|2
174944|NCT00140140|550141|P2|Overall Study|Unacceptable toxicity|1
174945|NCT00140140|550142|P1|Overall Study|Unacceptable toxicity|1
174946|NCT00139776|550192|P4|Period III|Withdrawal by Subject|21
174947|NCT00139776|550193|P3|Period III|Withdrawal by Subject|16
174948|NCT00139776|550194|P2|Period III|Withdrawal by Subject|0
174949|NCT00139776|550195|P1|Period III|Withdrawal by Subject|0
174950|NCT00139776|550192|P4|Period III|Lost to Follow-up|4
174951|NCT00139776|550193|P3|Period III|Lost to Follow-up|5
174952|NCT00139776|550194|P2|Period III|Lost to Follow-up|0
174953|NCT00139776|550195|P1|Period III|Lost to Follow-up|0
174954|NCT00139776|550192|P4|Period III|Lack of Efficacy|24
174955|NCT00139776|550193|P3|Period III|Lack of Efficacy|10
174956|NCT00139776|550194|P2|Period III|Lack of Efficacy|0
174957|NCT00139776|550195|P1|Period III|Lack of Efficacy|0
174958|NCT00139776|550192|P4|Period III|Other|34
174959|NCT00139776|550193|P3|Period III|Other|23
174960|NCT00139776|550194|P2|Period III|Other|0
174961|NCT00139776|550195|P1|Period III|Other|0
174962|NCT00139776|550192|P4|Period III|Adverse Event|23
174963|NCT00139776|550193|P3|Period III|Adverse Event|22
174964|NCT00139776|550194|P2|Period III|Adverse Event|0
174965|NCT00139776|550195|P1|Period III|Adverse Event|0
174966|NCT00139776|550192|P4|Period II|Not Randomized into Period III|0
174967|NCT00139776|550193|P3|Period II|Not Randomized into Period III|0
174968|NCT00139776|550194|P2|Period II|Not Randomized into Period III|322
174969|NCT00139776|550195|P1|Period II|Not Randomized into Period III|0
174970|NCT00139776|550192|P4|Period I|Did not enter Period II|0
174971|NCT00139776|550193|P3|Period I|Did not enter Period II|0
174972|NCT00139776|550194|P2|Period I|Did not enter Period II|0
174973|NCT00139776|550195|P1|Period I|Did not enter Period II|575
174974|NCT00139737|550230|P1|Overall Study|Screened, Not Treated|13
174975|NCT00139737|550230|P1|Overall Study|Did Not Meet Entrance Criteria|1
174976|NCT00139737|550230|P1|Overall Study|Withdrew During Screening Phase|8
174977|NCT00139737|550230|P1|Overall Study|Protocol Violation|18
174978|NCT00139737|550230|P1|Overall Study|Laboratory Abnormality|2
174979|NCT00139737|550230|P1|Overall Study|Death|3
174980|NCT00139737|550230|P1|Overall Study|Lost to Follow-up|8
174981|NCT00139737|550230|P1|Overall Study|Lack of Efficacy|40
174982|NCT00139737|550230|P1|Overall Study|Adverse Event|58
174983|NCT00139737|550230|P1|Overall Study|Withdrawal by Subject|190
174984|NCT00139659|550236|P2|Overall Study|Withdrawal by Subject|10
174985|NCT00139659|550237|P1|Overall Study|Withdrawal by Subject|14
174986|NCT00139659|550236|P2|Overall Study|Reason not Specified|3
174987|NCT00139659|550237|P1|Overall Study|Reason not Specified|6
174988|NCT00139659|550236|P2|Overall Study|Lost to Follow-up|3
174989|NCT00139659|550237|P1|Overall Study|Lost to Follow-up|7
174990|NCT00139659|550236|P2|Overall Study|Lack of Efficacy|1
174991|NCT00139659|550237|P1|Overall Study|Lack of Efficacy|1
174992|NCT00139659|550236|P2|Overall Study|Adverse Event|1
174993|NCT00139659|550237|P1|Overall Study|Adverse Event|12
174994|NCT00139477|550315|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
174995|NCT00139477|550316|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
174996|NCT00139477|550315|P2|Second Intervention -6Months to 12Months|Relocation|0
174997|NCT00139477|550316|P1|Second Intervention -6Months to 12Months|Relocation|1
174998|NCT00139477|550315|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
174999|NCT00139477|550316|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
175000|NCT00139477|550315|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
175001|NCT00139477|550316|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
175002|NCT00139477|550315|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
175003|NCT00139477|550316|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
175004|NCT00139477|550315|P2|First Intervention -Baseline to 6Months|Relocation|2
175005|NCT00139477|550316|P1|First Intervention -Baseline to 6Months|Relocation|1
175006|NCT00139477|550315|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
175007|NCT00139477|550316|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
175008|NCT00138671|550338|P2|Overall Study|Other|3
175009|NCT00138671|550339|P1|Overall Study|Other|3
175010|NCT00138671|550338|P2|Overall Study|Withdrawal by Subject|5
175011|NCT00138671|550339|P1|Overall Study|Withdrawal by Subject|3
175012|NCT00138671|550338|P2|Overall Study|Lost to Follow-up|2
175013|NCT00138671|550339|P1|Overall Study|Lost to Follow-up|1
175014|NCT00138671|550338|P2|Overall Study|Adverse Event|3
175015|NCT00138671|550339|P1|Overall Study|Adverse Event|6
175016|NCT00138671|550338|P2|Overall Study|Death|3
175017|NCT00138671|550339|P1|Overall Study|Death|0
175018|NCT00138658|550389|P1|Overall Study|Withdrawal by Subject|5
175019|NCT00138658|550389|P1|Overall Study|Physician Decision|11
175020|NCT00138658|550389|P1|Overall Study|Disease Progression|21
175021|NCT00138658|550389|P1|Overall Study|Death|1
175022|NCT00138658|550389|P1|Overall Study|Adverse Event|23
175023|NCT00138424|550412|P4|Overall Study|Physician Decision|0
175024|NCT00138424|550413|P3|Overall Study|Physician Decision|0
175025|NCT00138424|550414|P2|Overall Study|Physician Decision|1
175026|NCT00138424|550415|P1|Overall Study|Physician Decision|0
175027|NCT00138151|550487|P1|Overall Study|Physician Decision|1
175028|NCT00138151|550487|P1|Overall Study|Withdrawal by Subject|3
175029|NCT00138073|550497|P1|Overall Study|lack of resources|55
175030|NCT00137631|550538|P2|Overall Study|Lost to Follow-up|41
175031|NCT00137631|550539|P1|Overall Study|Lost to Follow-up|37
175032|NCT00137449|550555|P2|Overall Study|Withdrawal by Subject|1
175033|NCT00137449|550556|P1|Overall Study|Withdrawal by Subject|1
175034|NCT00137449|550555|P2|Overall Study|Adverse Event|1
175035|NCT00137449|550556|P1|Overall Study|Adverse Event|3
175036|NCT00137449|550555|P2|Overall Study|Death|3
175037|NCT00137449|550556|P1|Overall Study|Death|4
175038|NCT00137449|550555|P2|Overall Study|Disease Progression|13
175039|NCT00137449|550556|P1|Overall Study|Disease Progression|8
175040|NCT00137436|550593|P1|Overall Study|Unspecified|5
175041|NCT00137436|550593|P1|Overall Study|Withdrawal by Subject|6
175042|NCT00137436|550593|P1|Overall Study|Lack of Efficacy|17
175043|NCT00137436|550593|P1|Overall Study|Death|2
175044|NCT00137436|550593|P1|Overall Study|Adverse Event|13
175045|NCT00137423|550612|P2|Overall Study|Death|1
175046|NCT00137423|550613|P1|Overall Study|Death|0
175047|NCT00137423|550612|P2|Overall Study|Lack of Efficacy|33
175048|NCT00137423|550613|P1|Overall Study|Lack of Efficacy|31
175049|NCT00137423|550612|P2|Overall Study|consent withdrawn|1
175050|NCT00137423|550613|P1|Overall Study|consent withdrawn|1
175051|NCT00137423|550612|P2|Overall Study|Adverse Event|9
175052|NCT00137423|550613|P1|Overall Study|Adverse Event|7
175053|NCT00137267|550650|P2|Overall Study|Lost to Follow-up|21
175054|NCT00137267|550651|P1|Overall Study|Lost to Follow-up|15
175055|NCT00137111|550663|P4|Total Therapy|Non Compliance|0
175056|NCT00137111|550664|P3|Total Therapy|Non Compliance|0
175057|NCT00137111|550665|P2|Total Therapy|Non Compliance|0
175058|NCT00137111|550666|P1|Total Therapy|Non Compliance|5
175059|NCT00137111|550663|P4|Total Therapy|Death|0
175060|NCT00137111|550664|P3|Total Therapy|Death|0
175061|NCT00137111|550665|P2|Total Therapy|Death|0
175062|NCT00137111|550666|P1|Total Therapy|Death|35
175063|NCT00137046|550680|P2|Overall Study|Withdrew prior to study treatment|1
175064|NCT00137046|550681|P1|Overall Study|Withdrew prior to study treatment|1
175065|NCT00137046|550680|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
175066|NCT00137046|550681|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
175067|NCT00137046|550680|P2|Overall Study|Withdrawal by Subject|42
175068|NCT00137046|550681|P1|Overall Study|Withdrawal by Subject|33
175069|NCT00137046|550680|P2|Overall Study|Unspecified|19
175070|NCT00137046|550681|P1|Overall Study|Unspecified|23
175071|NCT00137046|550680|P2|Overall Study|Lost to Follow-up|24
175072|NCT00137046|550681|P1|Overall Study|Lost to Follow-up|8
175073|NCT00137046|550680|P2|Overall Study|Lack of Efficacy|1
175074|NCT00137046|550681|P1|Overall Study|Lack of Efficacy|13
175075|NCT00137046|550680|P2|Overall Study|Laboratory Abnormality|0
175076|NCT00137046|550681|P1|Overall Study|Laboratory Abnormality|2
175077|NCT00137046|550680|P2|Overall Study|Adverse Event|5
175078|NCT00137046|550681|P1|Overall Study|Adverse Event|16
175079|NCT00137046|550680|P2|Overall Study|Death|1
175080|NCT00137046|550681|P1|Overall Study|Death|2
175081|NCT00136955|550729|P1|Overall Study|Incl. prog. disease, protocol violation|12
175082|NCT00136955|550729|P1|Overall Study|Withdrawal by Subject|2
175083|NCT00136955|550729|P1|Overall Study|Lost to Follow-up|1
175084|NCT00136955|550729|P1|Overall Study|Adverse Event|8
175085|NCT00136916|550738|P2|Overall Study|Discontinued in follow up period|0
175086|NCT00136916|550739|P1|Overall Study|Discontinued in follow up period|3
175087|NCT00136916|550738|P2|Overall Study|Unspecified|24
175088|NCT00136916|550739|P1|Overall Study|Unspecified|22
175089|NCT00136916|550738|P2|Overall Study|Withdrawal by Subject|46
175090|NCT00136916|550739|P1|Overall Study|Withdrawal by Subject|44
175091|NCT00136916|550738|P2|Overall Study|Lost to Follow-up|14
175092|NCT00136916|550739|P1|Overall Study|Lost to Follow-up|12
175093|NCT00136916|550738|P2|Overall Study|Lack of Efficacy|3
175094|NCT00136916|550739|P1|Overall Study|Lack of Efficacy|13
175095|NCT00136916|550738|P2|Overall Study|Laboratory abnormality|1
175096|NCT00136916|550739|P1|Overall Study|Laboratory abnormality|0
175097|NCT00136916|550738|P2|Overall Study|Adverse Event|8
175098|NCT00136916|550739|P1|Overall Study|Adverse Event|27
175099|NCT00136916|550738|P2|Overall Study|Death|3
175100|NCT00136916|550739|P1|Overall Study|Death|1
175101|NCT00136916|550738|P2|Overall Study|Never received study treatment|5
175102|NCT00136916|550739|P1|Overall Study|Never received study treatment|3
175103|NCT00136357|550843|P2|Overall Study|Withdrawal by Subject|2
175104|NCT00136357|550844|P1|Overall Study|Withdrawal by Subject|3
175105|NCT00136318|550852|P2|Overall Study|Withdrawal by Subject|2
175106|NCT00136318|550853|P1|Overall Study|Withdrawal by Subject|2
175107|NCT00136318|550852|P2|Overall Study|Adverse Event|5
175108|NCT00136318|550853|P1|Overall Study|Adverse Event|5
175109|NCT00136084|550869|P2|Overall Study|Withdrawal by Subject|1
175110|NCT00136084|550870|P1|Overall Study|Withdrawal by Subject|5
175111|NCT00136084|550869|P2|Overall Study|No Response|2
175112|NCT00136084|550870|P1|Overall Study|No Response|1
175113|NCT00136084|550869|P2|Overall Study|Lost to Follow-up|0
175114|NCT00136084|550870|P1|Overall Study|Lost to Follow-up|2
175115|NCT00136084|550869|P2|Overall Study|Relapse|23
175116|NCT00136084|550870|P1|Overall Study|Relapse|20
175117|NCT00136084|550869|P2|Overall Study|Unacceptable toxicity|11
175118|NCT00136084|550870|P1|Overall Study|Unacceptable toxicity|8
175119|NCT00136084|550869|P2|Overall Study|Death|5
175120|NCT00136084|550870|P1|Overall Study|Death|12
175121|NCT00135694|550907|P3|Overall Study|Ineligible for Random assignment|0
175122|NCT00135694|550908|P2|Overall Study|Ineligible for Random assignment|0
175123|NCT00135694|550909|P1|Overall Study|Ineligible for Random assignment|42
175124|NCT00135694|550907|P3|Overall Study|Hepatitis C related reasons|0
175125|NCT00135694|550908|P2|Overall Study|Hepatitis C related reasons|1
175126|NCT00135694|550909|P1|Overall Study|Hepatitis C related reasons|39
175127|NCT00135694|550907|P3|Overall Study|Protocol Violation|0
175128|NCT00135694|550908|P2|Overall Study|Protocol Violation|1
175129|NCT00135694|550909|P1|Overall Study|Protocol Violation|19
175130|NCT00135694|550907|P3|Overall Study|Withdrawal by Subject|4
175131|NCT00135694|550908|P2|Overall Study|Withdrawal by Subject|7
175132|NCT00135694|550909|P1|Overall Study|Withdrawal by Subject|41
175133|NCT00135694|550907|P3|Overall Study|Lost to Follow-up|1
175134|NCT00135694|550908|P2|Overall Study|Lost to Follow-up|7
175135|NCT00135694|550909|P1|Overall Study|Lost to Follow-up|8
175136|NCT00135694|550907|P3|Overall Study|Death|2
175137|NCT00135694|550908|P2|Overall Study|Death|1
175138|NCT00135694|550909|P1|Overall Study|Death|14
175139|NCT00135694|550907|P3|Overall Study|Adverse Event|0
175140|NCT00135694|550908|P2|Overall Study|Adverse Event|4
175141|NCT00135694|550909|P1|Overall Study|Adverse Event|17
175142|NCT00135356|550929|P2|Overall Study|Withdrawal by Subject|4
175143|NCT00135356|550930|P1|Overall Study|Withdrawal by Subject|2
175144|NCT00135356|550929|P2|Overall Study|No longer meets study criteria|0
175145|NCT00135356|550930|P1|Overall Study|No longer meets study criteria|2
175146|NCT00135356|550929|P2|Overall Study|Poor/noncompliance|1
175147|NCT00135356|550930|P1|Overall Study|Poor/noncompliance|1
175148|NCT00135356|550929|P2|Overall Study|Change in antiviral regimen|1
175149|NCT00135356|550930|P1|Overall Study|Change in antiviral regimen|0
175150|NCT00135356|550929|P2|Overall Study|Surgery for abdominal fat|0
175151|NCT00135356|550930|P1|Overall Study|Surgery for abdominal fat|1
175152|NCT00135356|550929|P2|Overall Study|Lost to Follow-up|1
175153|NCT00135356|550930|P1|Overall Study|Lost to Follow-up|3
175154|NCT00135356|550929|P2|Overall Study|Lack of Efficacy|0
175155|NCT00135356|550930|P1|Overall Study|Lack of Efficacy|2
175156|NCT00135356|550929|P2|Overall Study|Adverse Event|2
175157|NCT00135356|550930|P1|Overall Study|Adverse Event|6
175158|NCT00135330|550973|P3|Overall Study|Sponsor Decision|0
175159|NCT00135330|550974|P2|Overall Study|Sponsor Decision|1
175160|NCT00135330|550975|P1|Overall Study|Sponsor Decision|0
175161|NCT00135330|550973|P3|Overall Study|Patient Decision|4
175162|NCT00135330|550974|P2|Overall Study|Patient Decision|1
175163|NCT00135330|550975|P1|Overall Study|Patient Decision|5
175164|NCT00135330|550973|P3|Overall Study|Protocol Violation|3
175165|NCT00135330|550974|P2|Overall Study|Protocol Violation|3
175166|NCT00135330|550975|P1|Overall Study|Protocol Violation|4
175167|NCT00135330|550973|P3|Overall Study|Physician Decision|0
175168|NCT00135330|550974|P2|Overall Study|Physician Decision|1
175169|NCT00135330|550975|P1|Overall Study|Physician Decision|1
175170|NCT00135330|550973|P3|Overall Study|Lost to Follow-up|3
175171|NCT00135330|550974|P2|Overall Study|Lost to Follow-up|2
175172|NCT00135330|550975|P1|Overall Study|Lost to Follow-up|0
175173|NCT00135330|550973|P3|Overall Study|Adverse Event|1
175174|NCT00135330|550974|P2|Overall Study|Adverse Event|5
175175|NCT00135330|550975|P1|Overall Study|Adverse Event|2
175176|NCT00134901|551074|P2|Overall Study|discontinued intervention|10
175177|NCT00134901|551075|P1|Overall Study|discontinued intervention|12
175178|NCT00134901|551074|P2|Overall Study|Lost to Follow-up|5
175179|NCT00134901|551075|P1|Overall Study|Lost to Follow-up|5
175180|NCT00134784|551087|P4|Overall Study|Withdrawal by Subject|1
175181|NCT00134784|551088|P3|Overall Study|Withdrawal by Subject|2
175182|NCT00134784|551089|P2|Overall Study|Withdrawal by Subject|2
175183|NCT00134784|551090|P1|Overall Study|Withdrawal by Subject|2
175184|NCT00134719|551100|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
175185|NCT00134719|551101|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
175186|NCT00134719|551102|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
175187|NCT00134719|551100|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
175188|NCT00134719|551101|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
175189|NCT00134719|551102|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
175190|NCT00134719|551100|P3|Primary Vaccination Phase|Lost to Follow-up|3
175191|NCT00134719|551101|P2|Primary Vaccination Phase|Lost to Follow-up|3
175192|NCT00134719|551102|P1|Primary Vaccination Phase|Lost to Follow-up|7
175193|NCT00134719|551100|P3|Primary Vaccination Phase|Withdrawal by Subject|2
175194|NCT00134719|551101|P2|Primary Vaccination Phase|Withdrawal by Subject|3
175195|NCT00134719|551102|P1|Primary Vaccination Phase|Withdrawal by Subject|2
175196|NCT00134719|551100|P3|Primary Vaccination Phase|Protocol Violation|0
175197|NCT00134719|551101|P2|Primary Vaccination Phase|Protocol Violation|0
175198|NCT00134719|551102|P1|Primary Vaccination Phase|Protocol Violation|1
175199|NCT00134719|551100|P3|Primary Vaccination Phase|Adverse Event|0
175200|NCT00134719|551101|P2|Primary Vaccination Phase|Adverse Event|0
175201|NCT00134719|551102|P1|Primary Vaccination Phase|Adverse Event|4
175202|NCT00134563|551233|P3|Overall Study|Reason other than above|5
175203|NCT00134563|551234|P2|Overall Study|Reason other than above|2
175204|NCT00134563|551235|P1|Overall Study|Reason other than above|0
175205|NCT00134563|551233|P3|Overall Study|did not wish to continue|26
175206|NCT00134563|551234|P2|Overall Study|did not wish to continue|32
175207|NCT00134563|551235|P1|Overall Study|did not wish to continue|33
175208|NCT00134563|551233|P3|Overall Study|progressive disease|2
175209|NCT00134563|551234|P2|Overall Study|progressive disease|4
175210|NCT00134563|551235|P1|Overall Study|progressive disease|11
175211|NCT00134563|551233|P3|Overall Study|Lost to Follow-up|2
175212|NCT00134563|551234|P2|Overall Study|Lost to Follow-up|0
175213|NCT00134563|551235|P1|Overall Study|Lost to Follow-up|4
175214|NCT00134563|551233|P3|Overall Study|Protocol Violation|5
175215|NCT00134563|551234|P2|Overall Study|Protocol Violation|2
175216|NCT00134563|551235|P1|Overall Study|Protocol Violation|3
175217|NCT00134563|551233|P3|Overall Study|Lack of Efficacy|17
175218|NCT00134563|551234|P2|Overall Study|Lack of Efficacy|14
175219|NCT00134563|551235|P1|Overall Study|Lack of Efficacy|24
175220|NCT00134563|551233|P3|Overall Study|Adverse Event|38
175221|NCT00134563|551234|P2|Overall Study|Adverse Event|37
175222|NCT00134563|551235|P1|Overall Study|Adverse Event|29
175223|NCT00134563|551233|P3|Overall Study|Not treated due to protocol violation|1
175224|NCT00134563|551234|P2|Overall Study|Not treated due to protocol violation|1
175225|NCT00134563|551235|P1|Overall Study|Not treated due to protocol violation|0
175226|NCT00133952|551305|P2|Overall Study|Sponsor Decision|1
175227|NCT00133952|551306|P1|Overall Study|Sponsor Decision|0
175228|NCT00133952|551305|P2|Overall Study|Physician Decision|3
175229|NCT00133952|551306|P1|Overall Study|Physician Decision|4
175230|NCT00133952|551305|P2|Overall Study|Withdrawal by Subject|4
175231|NCT00133952|551306|P1|Overall Study|Withdrawal by Subject|20
175232|NCT00133952|551305|P2|Overall Study|Protocol Violation|1
175233|NCT00133952|551306|P1|Overall Study|Protocol Violation|1
175234|NCT00133952|551305|P2|Overall Study|Protocol Entry Criteria Exclusion|1
175235|NCT00133952|551306|P1|Overall Study|Protocol Entry Criteria Exclusion|4
175236|NCT00133952|551305|P2|Overall Study|Lost to Follow-up|14
175237|NCT00133952|551306|P1|Overall Study|Lost to Follow-up|9
175238|NCT00133952|551305|P2|Overall Study|Death|2
175239|NCT00133952|551306|P1|Overall Study|Death|3
175240|NCT00133952|551305|P2|Overall Study|Adverse Event|2
175241|NCT00133952|551306|P1|Overall Study|Adverse Event|1
175242|NCT00133705|551337|P2|Overall Study|Withdrawal by Subject|3
175243|NCT00133705|551338|P1|Overall Study|Withdrawal by Subject|2
175244|NCT00132873|551464|P1|Overall Study|Planned Pregnancy|1
175245|NCT00132873|551464|P1|Overall Study|Withdrawal by Subject|3
175246|NCT00132873|551464|P1|Overall Study|Lack of Efficacy|1
175247|NCT00132873|551464|P1|Overall Study|Lost to Follow-up|1
175248|NCT00132873|551464|P1|Overall Study|Adverse Event|3
175249|NCT00132808|551472|P3|Stratum II|Withdrawal by Subject|6
175250|NCT00132808|551473|P2|Stratum II|Withdrawal by Subject|9
175251|NCT00132808|551474|P1|Stratum II|Withdrawal by Subject|4
175252|NCT00132808|551472|P3|Stratum II|Protocol Violation|1
175253|NCT00132808|551473|P2|Stratum II|Protocol Violation|2
175254|NCT00132808|551474|P1|Stratum II|Protocol Violation|0
175255|NCT00132808|551472|P3|Stratum II|Lost to Follow-up|1
175256|NCT00132808|551473|P2|Stratum II|Lost to Follow-up|2
175257|NCT00132808|551474|P1|Stratum II|Lost to Follow-up|2
175258|NCT00132808|551472|P3|Stratum II|Death|0
175259|NCT00132808|551473|P2|Stratum II|Death|0
175260|NCT00132808|551474|P1|Stratum II|Death|1
175261|NCT00132808|551472|P3|Stratum II|Adverse Event|1
175262|NCT00132808|551473|P2|Stratum II|Adverse Event|2
175263|NCT00132808|551474|P1|Stratum II|Adverse Event|1
175264|NCT00132808|551472|P3|Stratum I|Abnormal test procedure result (s)|1
175265|NCT00132808|551473|P2|Stratum I|Abnormal test procedure result (s)|0
175266|NCT00132808|551474|P1|Stratum I|Abnormal test procedure result (s)|0
175267|NCT00132808|551472|P3|Stratum I|Withdrawal by Subject|3
175268|NCT00132808|551473|P2|Stratum I|Withdrawal by Subject|7
175269|NCT00132808|551474|P1|Stratum I|Withdrawal by Subject|4
175270|NCT00132808|551472|P3|Stratum I|Lost to Follow-up|1
175271|NCT00132808|551473|P2|Stratum I|Lost to Follow-up|4
175272|NCT00132808|551474|P1|Stratum I|Lost to Follow-up|3
175273|NCT00132808|551472|P3|Stratum I|Adverse Event|0
175274|NCT00132808|551473|P2|Stratum I|Adverse Event|1
175275|NCT00132808|551474|P1|Stratum I|Adverse Event|2
175276|NCT00132769|551499|P2|Overall Study|Protocol Violation|1
175277|NCT00132769|551500|P1|Overall Study|Protocol Violation|1
175278|NCT00132769|551499|P2|Overall Study|Adverse Event|1
175279|NCT00132769|551500|P1|Overall Study|Adverse Event|2
175280|NCT00132769|551499|P2|Overall Study|Lack of Efficacy|6
175281|NCT00132769|551500|P1|Overall Study|Lack of Efficacy|7
175282|NCT00132769|551499|P2|Overall Study|Withdrawal by Subject|3
175283|NCT00132769|551500|P1|Overall Study|Withdrawal by Subject|1
175284|NCT00132730|551526|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
175285|NCT00132730|551527|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
175286|NCT00132730|551528|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
175287|NCT00132730|551529|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
175288|NCT00132730|551530|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
175289|NCT00132730|551531|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
175290|NCT00132730|551526|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
175291|NCT00132730|551527|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
175292|NCT00132730|551528|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
175293|NCT00132730|551529|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
175294|NCT00132730|551530|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
175295|NCT00132730|551531|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
175296|NCT00132730|551526|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
175297|NCT00132730|551527|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
175298|NCT00132730|551528|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
175299|NCT00132730|551529|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
175300|NCT00132730|551530|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
175301|NCT00132730|551531|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
175302|NCT00132730|551526|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
175303|NCT00132730|551527|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
175304|NCT00132730|551528|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
175305|NCT00132730|551529|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
175306|NCT00132730|551530|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
175307|NCT00132730|551531|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
175308|NCT00132730|551526|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
175309|NCT00132730|551527|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
175310|NCT00132730|551528|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
175311|NCT00132730|551529|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
175312|NCT00132730|551530|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
175313|NCT00132730|551531|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
175314|NCT00132730|551526|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
175315|NCT00132730|551527|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
175316|NCT00132730|551528|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
175317|NCT00132730|551529|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
175318|NCT00132730|551530|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
175319|NCT00132730|551531|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
175320|NCT00132730|551526|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
175321|NCT00132730|551527|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
175322|NCT00132730|551528|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
175323|NCT00132730|551529|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
175324|NCT00132730|551530|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
175325|NCT00132730|551531|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
175326|NCT00132730|551526|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
175327|NCT00132730|551527|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
175328|NCT00132730|551528|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
175329|NCT00132730|551529|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
175330|NCT00132730|551530|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
175331|NCT00132730|551531|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
175332|NCT00132730|551526|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
175333|NCT00132730|551527|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
175334|NCT00132730|551528|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
175335|NCT00132730|551529|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
175336|NCT00132730|551530|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
175337|NCT00132730|551531|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
175338|NCT00132730|551526|P6|Period II - 12-week Treatment (Base)|Other reasons|0
175339|NCT00132730|551527|P5|Period II - 12-week Treatment (Base)|Other reasons|0
175340|NCT00132730|551528|P4|Period II - 12-week Treatment (Base)|Other reasons|13
175341|NCT00132730|551529|P3|Period II - 12-week Treatment (Base)|Other reasons|9
175342|NCT00132730|551530|P2|Period II - 12-week Treatment (Base)|Other reasons|10
175343|NCT00132730|551531|P1|Period II - 12-week Treatment (Base)|Other reasons|11
175344|NCT00132730|551526|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
175345|NCT00132730|551527|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
175346|NCT00132730|551528|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
175347|NCT00132730|551529|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
175348|NCT00132730|551530|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
175349|NCT00132730|551531|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
175350|NCT00132730|551526|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
175351|NCT00132730|551527|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
175352|NCT00132730|551528|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
175353|NCT00132730|551529|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
175354|NCT00132730|551530|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
175355|NCT00132730|551531|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
175356|NCT00132691|551575|P2|Overall Study|Death|0
175357|NCT00132691|551576|P1|Overall Study|Death|2
175358|NCT00132691|551575|P2|Overall Study|Missed 2-year visit|4
175359|NCT00132691|551576|P1|Overall Study|Missed 2-year visit|4
175360|NCT00132691|551575|P2|Overall Study|Lost to Follow-up|8
175361|NCT00132691|551576|P1|Overall Study|Lost to Follow-up|5
175362|NCT00132678|551616|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
175363|NCT00132678|551617|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
175364|NCT00132678|551618|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
175365|NCT00132678|551616|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
175366|NCT00132678|551617|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
175367|NCT00132678|551618|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
175368|NCT00132678|551616|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
175369|NCT00132678|551617|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
175370|NCT00132678|551618|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
175371|NCT00132678|551616|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
175372|NCT00132678|551617|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
175373|NCT00132678|551618|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
175374|NCT00132678|551616|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
175375|NCT00132678|551617|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
175376|NCT00132678|551618|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
175377|NCT00132678|551616|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
175378|NCT00132678|551617|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
175379|NCT00132678|551618|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
175380|NCT00132678|551616|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
175381|NCT00132678|551617|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
175382|NCT00132678|551618|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
175383|NCT00132678|551616|P3|Period III (Open-Label Stabilization)|Pregnancy|0
175384|NCT00132678|551617|P2|Period III (Open-Label Stabilization)|Pregnancy|0
175385|NCT00132678|551618|P1|Period III (Open-Label Stabilization)|Pregnancy|2
175386|NCT00132678|551616|P3|Period III (Open-Label Stabilization)|Physician Decision|0
175387|NCT00132678|551617|P2|Period III (Open-Label Stabilization)|Physician Decision|0
175388|NCT00132678|551618|P1|Period III (Open-Label Stabilization)|Physician Decision|1
175389|NCT00132678|551616|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
175390|NCT00132678|551617|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
175391|NCT00132678|551618|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
175392|NCT00132678|551616|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
175393|NCT00132678|551617|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
175394|NCT00132678|551618|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
175395|NCT00132678|551616|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
175396|NCT00132678|551617|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
175397|NCT00132678|551618|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
175398|NCT00132678|551616|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
175399|NCT00132678|551617|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
175400|NCT00132678|551618|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
175401|NCT00132678|551616|P3|Period III (Open-Label Stabilization)|Non responder|0
175402|NCT00132678|551617|P2|Period III (Open-Label Stabilization)|Non responder|0
175403|NCT00132678|551618|P1|Period III (Open-Label Stabilization)|Non responder|107
175404|NCT00132678|551616|P3|Period III (Open-Label Stabilization)|Adverse Event|0
175405|NCT00132678|551617|P2|Period III (Open-Label Stabilization)|Adverse Event|0
175406|NCT00132678|551618|P1|Period III (Open-Label Stabilization)|Adverse Event|12
175407|NCT00132678|551616|P3|Period III (Open-Label Stabilization)|Death|0
175408|NCT00132678|551617|P2|Period III (Open-Label Stabilization)|Death|0
175409|NCT00132678|551618|P1|Period III (Open-Label Stabilization)|Death|2
175410|NCT00132678|551616|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
175411|NCT00132678|551617|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
175412|NCT00132678|551618|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
175413|NCT00132678|551616|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
175414|NCT00132678|551617|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
175415|NCT00132678|551618|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
175416|NCT00132678|551616|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
175417|NCT00132678|551617|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
175418|NCT00132678|551618|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
175419|NCT00132678|551616|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
175420|NCT00132678|551617|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
175421|NCT00132678|551618|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
175422|NCT00132678|551616|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
175423|NCT00132678|551617|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
175424|NCT00132678|551618|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
175425|NCT00132678|551616|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
175426|NCT00132678|551617|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
175427|NCT00132678|551618|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
175428|NCT00132678|551616|P3|Period II (Open-Label Oral Risperidone)|Death|1
175429|NCT00132678|551617|P2|Period II (Open-Label Oral Risperidone)|Death|0
175430|NCT00132678|551618|P1|Period II (Open-Label Oral Risperidone)|Death|0
175431|NCT00132496|551632|P2|Overall Study|Physician Decision|0
175432|NCT00132496|551633|P1|Overall Study|Physician Decision|1
175433|NCT00132496|551632|P2|Overall Study|Withdrawal by Subject|2
175434|NCT00132496|551633|P1|Overall Study|Withdrawal by Subject|1
175435|NCT00132314|551641|P2|Overall Study|Refused intervention at baseline|7
175436|NCT00132314|551642|P1|Overall Study|Refused intervention at baseline|2
175437|NCT00132314|551641|P2|Overall Study|Lacked SSN|3
175438|NCT00132314|551642|P1|Overall Study|Lacked SSN|1
175439|NCT00132314|551641|P2|Overall Study|Lost to Follow-up|62
175440|NCT00132314|551642|P1|Overall Study|Lost to Follow-up|70
175441|NCT00132132|551652|P2|Overall Study|Lost to Follow-up|2
175442|NCT00132132|551653|P1|Overall Study|Lost to Follow-up|7
175443|NCT00132028|551661|P1|Overall Study|Physician Decision|3
175444|NCT00132028|551661|P1|Overall Study|not eligible|2
175445|NCT00132028|551661|P1|Overall Study|Withdrawal by Subject|2
175446|NCT00132028|551661|P1|Overall Study|Lack of Efficacy|11
175447|NCT00132028|551661|P1|Overall Study|Death|2
175448|NCT00132028|551661|P1|Overall Study|Adverse Event|7
175449|NCT00131937|551673|P1|Overall Study|Alternative therapy|1
175450|NCT00131937|551673|P1|Overall Study|Disease Progression|7
175451|NCT00131937|551673|P1|Overall Study|Physician Decision|1
175452|NCT00131937|551673|P1|Overall Study|Withdrawal by Subject|2
175453|NCT00131937|551673|P1|Overall Study|Adverse Event|3
175454|NCT00131911|551681|P2|Overall Study|Withdrawal by Subject|0
175455|NCT00131911|551682|P1|Overall Study|Withdrawal by Subject|1
175456|NCT00131664|551752|P6|Second Period (Additional Drug Added)|Administrative reasons|0
175457|NCT00131664|551753|P5|Second Period (Additional Drug Added)|Administrative reasons|1
175458|NCT00131664|551754|P4|Second Period (Additional Drug Added)|Administrative reasons|0
175459|NCT00131664|551755|P3|Second Period (Additional Drug Added)|Administrative reasons|0
175460|NCT00131664|551756|P2|Second Period (Additional Drug Added)|Administrative reasons|2
175461|NCT00131664|551757|P1|Second Period (Additional Drug Added)|Administrative reasons|4
175462|NCT00131664|551752|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
175463|NCT00131664|551753|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
175464|NCT00131664|551754|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
175465|NCT00131664|551755|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
175466|NCT00131664|551756|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
175467|NCT00131664|551757|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
175468|NCT00131664|551752|P6|Second Period (Additional Drug Added)|Adverse Event|1
175469|NCT00131664|551753|P5|Second Period (Additional Drug Added)|Adverse Event|0
175470|NCT00131664|551754|P4|Second Period (Additional Drug Added)|Adverse Event|0
175471|NCT00131664|551755|P3|Second Period (Additional Drug Added)|Adverse Event|0
175472|NCT00131664|551756|P2|Second Period (Additional Drug Added)|Adverse Event|1
175473|NCT00131664|551757|P1|Second Period (Additional Drug Added)|Adverse Event|0
175474|NCT00131664|551752|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
175475|NCT00131664|551753|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
175476|NCT00131664|551754|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
175477|NCT00131664|551755|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
175478|NCT00131664|551756|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
175479|NCT00131664|551757|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
175480|NCT00131664|551752|P6|Second Period (Additional Drug Added)|Protocol Violation|0
175481|NCT00131664|551753|P5|Second Period (Additional Drug Added)|Protocol Violation|0
175482|NCT00131664|551754|P4|Second Period (Additional Drug Added)|Protocol Violation|0
175483|NCT00131664|551755|P3|Second Period (Additional Drug Added)|Protocol Violation|1
175484|NCT00131664|551756|P2|Second Period (Additional Drug Added)|Protocol Violation|1
175485|NCT00131664|551757|P1|Second Period (Additional Drug Added)|Protocol Violation|0
175486|NCT00131664|551752|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
175487|NCT00131664|551753|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
175488|NCT00131664|551754|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
175489|NCT00131664|551755|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
175490|NCT00131664|551756|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
175491|NCT00131664|551757|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
175492|NCT00131664|551752|P6|First Period (First 6 Months)|Administrative reasons|0
175493|NCT00131664|551753|P5|First Period (First 6 Months)|Administrative reasons|0
175494|NCT00131664|551754|P4|First Period (First 6 Months)|Administrative reasons|0
175495|NCT00131664|551755|P3|First Period (First 6 Months)|Administrative reasons|5
175496|NCT00131664|551756|P2|First Period (First 6 Months)|Administrative reasons|0
175497|NCT00131664|551757|P1|First Period (First 6 Months)|Administrative reasons|2
175498|NCT00131664|551752|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
175499|NCT00131664|551753|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
175500|NCT00131664|551754|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
175501|NCT00131664|551755|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
175502|NCT00131664|551756|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
175503|NCT00131664|551757|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
175504|NCT00131664|551752|P6|First Period (First 6 Months)|Adverse Event|0
175505|NCT00131664|551753|P5|First Period (First 6 Months)|Adverse Event|0
175506|NCT00131664|551754|P4|First Period (First 6 Months)|Adverse Event|0
175507|NCT00131664|551755|P3|First Period (First 6 Months)|Adverse Event|5
175508|NCT00131664|551756|P2|First Period (First 6 Months)|Adverse Event|4
175509|NCT00131664|551757|P1|First Period (First 6 Months)|Adverse Event|9
175510|NCT00131664|551752|P6|First Period (First 6 Months)|Withdrawal by Subject|0
175511|NCT00131664|551753|P5|First Period (First 6 Months)|Withdrawal by Subject|0
175512|NCT00131664|551754|P4|First Period (First 6 Months)|Withdrawal by Subject|0
175513|NCT00131664|551755|P3|First Period (First 6 Months)|Withdrawal by Subject|2
175514|NCT00131664|551756|P2|First Period (First 6 Months)|Withdrawal by Subject|6
175515|NCT00131664|551757|P1|First Period (First 6 Months)|Withdrawal by Subject|4
175516|NCT00131664|551752|P6|First Period (First 6 Months)|Protocol Violation|0
175517|NCT00131664|551753|P5|First Period (First 6 Months)|Protocol Violation|0
175518|NCT00131664|551754|P4|First Period (First 6 Months)|Protocol Violation|0
175519|NCT00131664|551755|P3|First Period (First 6 Months)|Protocol Violation|1
175520|NCT00131664|551756|P2|First Period (First 6 Months)|Protocol Violation|2
175521|NCT00131664|551757|P1|First Period (First 6 Months)|Protocol Violation|2
175522|NCT00131664|551752|P6|First Period (First 6 Months)|Death|0
175523|NCT00131664|551753|P5|First Period (First 6 Months)|Death|0
175524|NCT00131664|551754|P4|First Period (First 6 Months)|Death|0
175525|NCT00131664|551755|P3|First Period (First 6 Months)|Death|0
175526|NCT00131664|551756|P2|First Period (First 6 Months)|Death|1
175527|NCT00131664|551757|P1|First Period (First 6 Months)|Death|0
175528|NCT00131664|551752|P6|First Period (First 6 Months)|Lost to Follow-up|0
175529|NCT00131664|551753|P5|First Period (First 6 Months)|Lost to Follow-up|0
175530|NCT00131664|551754|P4|First Period (First 6 Months)|Lost to Follow-up|0
175531|NCT00131664|551755|P3|First Period (First 6 Months)|Lost to Follow-up|3
175532|NCT00131664|551756|P2|First Period (First 6 Months)|Lost to Follow-up|3
175533|NCT00131664|551757|P1|First Period (First 6 Months)|Lost to Follow-up|7
175534|NCT00131508|551829|P2|Overall Study|Withdrawal by Subject|2
175535|NCT00131508|551830|P1|Overall Study|Withdrawal by Subject|1
175536|NCT00131508|551829|P2|Overall Study|Non-Compliance|4
175537|NCT00131508|551830|P1|Overall Study|Non-Compliance|2
175538|NCT00131508|551829|P2|Overall Study|Disease progression|2
175539|NCT00131508|551830|P1|Overall Study|Disease progression|0
175540|NCT00131352|551892|P2|Repeat Treatment Period|Unspecified|0
175541|NCT00131352|551893|P1|Repeat Treatment Period|Unspecified|1
175542|NCT00131352|551892|P2|Repeat Treatment Period|Adverse Event|0
175543|NCT00131352|551893|P1|Repeat Treatment Period|Adverse Event|1
175544|NCT00131352|551892|P2|Initial Treatment Period|Unspecified|2
175545|NCT00131352|551893|P1|Initial Treatment Period|Unspecified|0
175546|NCT00131352|551892|P2|Initial Treatment Period|Lack of Efficacy|4
175547|NCT00131352|551893|P1|Initial Treatment Period|Lack of Efficacy|6
175548|NCT00131352|551892|P2|Initial Treatment Period|Withdrawal by Subject|1
175549|NCT00131352|551893|P1|Initial Treatment Period|Withdrawal by Subject|1
175550|NCT00131352|551892|P2|Initial Treatment Period|Non-compliant|2
175551|NCT00131352|551893|P1|Initial Treatment Period|Non-compliant|1
175552|NCT00131352|551892|P2|Initial Treatment Period|Adverse Event|3
175553|NCT00131352|551893|P1|Initial Treatment Period|Adverse Event|1
175554|NCT00131248|551915|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
175555|NCT00131248|551916|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
175556|NCT00130832|551933|P2|Overall Study|Unspecified|3
175557|NCT00130832|551934|P1|Overall Study|Unspecified|0
175558|NCT00130832|551933|P2|Overall Study|Moved|2
175559|NCT00130832|551934|P1|Overall Study|Moved|2
175560|NCT00130832|551933|P2|Overall Study|Withdrawal by Subject|1
175561|NCT00130832|551934|P1|Overall Study|Withdrawal by Subject|6
175562|NCT00130832|551933|P2|Overall Study|Protocol Violation|8
175563|NCT00130832|551934|P1|Overall Study|Protocol Violation|6
175564|NCT00130832|551933|P2|Overall Study|Lost to Follow-up|2
175565|NCT00130832|551934|P1|Overall Study|Lost to Follow-up|1
175566|NCT00130832|551933|P2|Overall Study|Adverse Event|1
175567|NCT00130832|551934|P1|Overall Study|Adverse Event|1
175568|NCT00130793|551946|P2|Overall Study|Withdrew consent|0
175569|NCT00130793|551947|P1|Overall Study|Withdrew consent|2
175570|NCT00130793|551946|P2|Overall Study|Lost to Follow-up|4
175571|NCT00130793|551947|P1|Overall Study|Lost to Follow-up|1
175572|NCT00130728|551968|P2|Overall Study|Withdrawal by Subject|2
175573|NCT00130728|551969|P1|Overall Study|Withdrawal by Subject|0
175574|NCT00130728|551968|P2|Overall Study|Lost to Follow-up|0
175575|NCT00130728|551969|P1|Overall Study|Lost to Follow-up|4
175576|NCT00130728|551968|P2|Overall Study|Death|211
175577|NCT00130728|551969|P1|Overall Study|Death|207
175578|NCT00130689|551981|P1|Overall Study|Ineligible|6
175579|NCT00130689|551981|P1|Overall Study|Withdrawal by Subject|3
175580|NCT00130689|551981|P1|Overall Study|Clinical Deterioration|4
175581|NCT00130689|551981|P1|Overall Study|Death|1
175582|NCT00130689|551981|P1|Overall Study|Progressive Disease|29
175583|NCT00130637|551985|P1|Overall Study|Withdrawal by Subject|1
175584|NCT00130637|551985|P1|Overall Study|Adverse Event|2
175585|NCT00130520|551990|P1|Overall Study|Did not meet re-treatment criteria|1
175586|NCT00130520|551990|P1|Overall Study|Protocol non-compliance|1
175587|NCT00130520|551990|P1|Overall Study|Disease Progression|23
175588|NCT00130520|551990|P1|Overall Study|Withdrawal by Subject|1
175589|NCT00130520|551990|P1|Overall Study|Physician Decision|1
175590|NCT00130520|551990|P1|Overall Study|Death|1
175591|NCT00130520|551990|P1|Overall Study|Adverse Event|11
175592|NCT00130286|552000|P4|Overall Study|Missing lab specimens|0
175593|NCT00130286|552001|P3|Overall Study|Missing lab specimens|0
175594|NCT00130286|552002|P2|Overall Study|Missing lab specimens|2
175595|NCT00130286|552003|P1|Overall Study|Missing lab specimens|0
175596|NCT00130286|552000|P4|Overall Study|Adverse Event|0
175597|NCT00130286|552001|P3|Overall Study|Adverse Event|2
175598|NCT00130286|552002|P2|Overall Study|Adverse Event|0
175599|NCT00130286|552003|P1|Overall Study|Adverse Event|0
175600|NCT00130286|552000|P4|Overall Study|Withdrawal by Subject|2
175601|NCT00130286|552001|P3|Overall Study|Withdrawal by Subject|2
175602|NCT00130286|552002|P2|Overall Study|Withdrawal by Subject|1
175603|NCT00130286|552003|P1|Overall Study|Withdrawal by Subject|0
175604|NCT00130247|552023|P2|Overall Study|Not compliant with DOT|2
175605|NCT00130247|552024|P1|Overall Study|Not compliant with DOT|0
175606|NCT00130247|552023|P2|Overall Study|Post-randomization exclusion|2
175607|NCT00130247|552024|P1|Overall Study|Post-randomization exclusion|1
175608|NCT00130247|552023|P2|Overall Study|Pregnancy|0
175609|NCT00130247|552024|P1|Overall Study|Pregnancy|1
175610|NCT00130039|552042|P2|Overall Study|clinical events without follow up MRI|4
175611|NCT00130039|552043|P1|Overall Study|clinical events without follow up MRI|5
175612|NCT00130039|552042|P2|Overall Study|Physician Decision|0
175613|NCT00130039|552043|P1|Overall Study|Physician Decision|3
175614|NCT00130039|552042|P2|Overall Study|Adverse Event|2
175615|NCT00130039|552043|P1|Overall Study|Adverse Event|4
175616|NCT00130039|552042|P2|Overall Study|Lost to Follow-up|1
175617|NCT00130039|552043|P1|Overall Study|Lost to Follow-up|3
175618|NCT00130039|552042|P2|Overall Study|Withdrawal by Subject|11
175619|NCT00130039|552043|P1|Overall Study|Withdrawal by Subject|15
175620|NCT00129961|552061|P2|Overall Study|Missing Record|1
175621|NCT00129961|552062|P1|Overall Study|Missing Record|0
175622|NCT00129961|552061|P2|Overall Study|Withdrawal by Subject|1
175623|NCT00129961|552062|P1|Overall Study|Withdrawal by Subject|2
175624|NCT00129961|552061|P2|Overall Study|Physician Decision|0
175625|NCT00129961|552062|P1|Overall Study|Physician Decision|1
175626|NCT00129961|552061|P2|Overall Study|Withdrawal by Sponsor|20
175627|NCT00129961|552062|P1|Overall Study|Withdrawal by Sponsor|14
175628|NCT00129961|552061|P2|Overall Study|Death|1
175629|NCT00129961|552062|P1|Overall Study|Death|1
175630|NCT00129961|552061|P2|Overall Study|Adverse Event|0
175631|NCT00129961|552062|P1|Overall Study|Adverse Event|1
175632|NCT00129766|552098|P2|Overall Study|Lost to Follow-up|21
175633|NCT00129766|552099|P1|Overall Study|Lost to Follow-up|26
175634|NCT00129766|552098|P2|Overall Study|Withdrawal of consent|30
175635|NCT00129766|552099|P1|Overall Study|Withdrawal of consent|31
175636|NCT00129766|552098|P2|Overall Study|Death|8
175637|NCT00129766|552099|P1|Overall Study|Death|3
175638|NCT00129623|552145|P2|Overall Study|Uncertainty to return|1
175639|NCT00129623|552146|P1|Overall Study|Uncertainty to return|0
175640|NCT00129623|552145|P2|Overall Study|Relocated job out of state|0
175641|NCT00129623|552146|P1|Overall Study|Relocated job out of state|1
175642|NCT00129623|552145|P2|Overall Study|Failure to Return|1
175643|NCT00129623|552146|P1|Overall Study|Failure to Return|1
175644|NCT00129623|552145|P2|Overall Study|Refused Treatment|3
175645|NCT00129623|552146|P1|Overall Study|Refused Treatment|5
175646|NCT00129623|552145|P2|Overall Study|Adverse Event|7
175647|NCT00129623|552146|P1|Overall Study|Adverse Event|3
175648|NCT00129545|552171|P3|Overall Study|Device not implanted|0
175649|NCT00129545|552172|P2|Overall Study|Device not implanted|61
175650|NCT00129545|552173|P1|Overall Study|Device not implanted|16
175651|NCT00129545|552171|P3|Overall Study|Physician Decision|10
175652|NCT00129545|552172|P2|Overall Study|Physician Decision|3
175653|NCT00129545|552173|P1|Overall Study|Physician Decision|0
175654|NCT00129545|552171|P3|Overall Study|Lost to Follow-up|13
175655|NCT00129545|552172|P2|Overall Study|Lost to Follow-up|22
175656|NCT00129545|552173|P1|Overall Study|Lost to Follow-up|2
175657|NCT00129545|552171|P3|Overall Study|Withdrawal by Subject|44
175658|NCT00129545|552172|P2|Overall Study|Withdrawal by Subject|18
175659|NCT00129545|552173|P1|Overall Study|Withdrawal by Subject|3
175660|NCT00129545|552171|P3|Overall Study|Death|44
175661|NCT00129545|552172|P2|Overall Study|Death|60
175662|NCT00129545|552173|P1|Overall Study|Death|5
175663|NCT00129467|552194|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
175664|NCT00129467|552195|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
175665|NCT00129467|552194|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
175666|NCT00129467|552195|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
175667|NCT00129467|552194|P2|Received Intervention|Dizzyness, fatigue|1
175668|NCT00129467|552195|P1|Received Intervention|Dizzyness, fatigue|0
175669|NCT00129467|552194|P2|Received Intervention|Intolerance to citalopram|1
175670|NCT00129467|552195|P1|Received Intervention|Intolerance to citalopram|0
175671|NCT00129467|552194|P2|Received Intervention|Nausea|0
175672|NCT00129467|552195|P1|Received Intervention|Nausea|1
175673|NCT00129467|552194|P2|Received Intervention|Withdrawal by Subject|0
175674|NCT00129467|552195|P1|Received Intervention|Withdrawal by Subject|1
175675|NCT00129467|552194|P2|Received Intervention|Delirium|0
175676|NCT00129467|552195|P1|Received Intervention|Delirium|2
175677|NCT00129467|552194|P2|Received Intervention|Cardiac SAE (hypertension)|1
175678|NCT00129467|552195|P1|Received Intervention|Cardiac SAE (hypertension)|1
175679|NCT00129467|552194|P2|Received Intervention|Death|1
175680|NCT00129467|552195|P1|Received Intervention|Death|1
175681|NCT00129402|552226|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
175682|NCT00129402|552227|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
175683|NCT00129402|552228|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
175684|NCT00129402|552229|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
175685|NCT00129402|552230|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
175686|NCT00129402|552231|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
175687|NCT00129402|552232|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
175688|NCT00129402|552226|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
175689|NCT00129402|552227|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
175690|NCT00129402|552228|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
175691|NCT00129402|552229|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
175692|NCT00129402|552230|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
175693|NCT00129402|552231|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
175694|NCT00129402|552232|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
175695|NCT00129402|552226|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
175696|NCT00129402|552227|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
175697|NCT00129402|552228|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
175698|NCT00129402|552229|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
175699|NCT00129402|552230|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
175700|NCT00129402|552231|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
175701|NCT00129402|552232|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
175702|NCT00129402|552226|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
175703|NCT00129402|552227|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
175704|NCT00129402|552228|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
175705|NCT00129402|552229|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
175706|NCT00129402|552230|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
175707|NCT00129402|552231|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
175708|NCT00129402|552232|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
175709|NCT00129402|552226|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
175710|NCT00129402|552227|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
175711|NCT00129402|552228|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
175712|NCT00129402|552229|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
175713|NCT00129402|552230|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
175714|NCT00129402|552231|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
175715|NCT00129402|552232|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
175716|NCT00129402|552226|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
175717|NCT00129402|552227|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
175718|NCT00129402|552228|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
175719|NCT00129402|552229|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
175720|NCT00129402|552230|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
175721|NCT00129402|552231|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
175722|NCT00129402|552232|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
175723|NCT00129402|552226|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
175724|NCT00129402|552227|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
175725|NCT00129402|552228|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
175726|NCT00129402|552229|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
175727|NCT00129402|552230|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
175728|NCT00129402|552231|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
175729|NCT00129402|552232|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
175730|NCT00129402|552226|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
175731|NCT00129402|552227|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
175732|NCT00129402|552228|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
175733|NCT00129402|552229|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
175734|NCT00129402|552230|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
175735|NCT00129402|552231|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
175736|NCT00129402|552232|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
175737|NCT00129402|552226|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
175738|NCT00129402|552227|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
175739|NCT00129402|552228|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
175740|NCT00129402|552229|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
175819|NCT00129129|552336|P2|Fourth Dose Phase|Protocol Violation|0
175741|NCT00129402|552230|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
175742|NCT00129402|552231|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
175743|NCT00129402|552232|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
175744|NCT00129402|552226|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
175745|NCT00129402|552227|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
175746|NCT00129402|552228|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
175747|NCT00129402|552229|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
175748|NCT00129402|552230|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
175749|NCT00129402|552231|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
175750|NCT00129402|552232|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
175751|NCT00129402|552226|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
175752|NCT00129402|552227|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
175753|NCT00129402|552228|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
175754|NCT00129402|552229|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
175755|NCT00129402|552230|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
175756|NCT00129402|552231|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
175757|NCT00129402|552232|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
175758|NCT00129402|552226|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
175759|NCT00129402|552227|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
175760|NCT00129402|552228|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
175761|NCT00129402|552229|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
175762|NCT00129402|552230|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
175763|NCT00129402|552231|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
175764|NCT00129402|552232|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
175765|NCT00129402|552226|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
175766|NCT00129402|552227|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
175767|NCT00129402|552228|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
175768|NCT00129402|552229|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
175769|NCT00129402|552230|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
175770|NCT00129402|552231|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
175771|NCT00129402|552232|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
175772|NCT00129311|552251|P2|Overall Study|Withdrawal by Subject|19
175773|NCT00129311|552252|P1|Overall Study|Withdrawal by Subject|12
175774|NCT00129259|552262|P2|Overall Study|Only available minimal phone assessments|1
175775|NCT00129259|552263|P1|Overall Study|Only available minimal phone assessments|0
175776|NCT00129259|552262|P2|Overall Study|Withdrawal by Subject|1
175777|NCT00129259|552263|P1|Overall Study|Withdrawal by Subject|2
175778|NCT00129259|552262|P2|Overall Study|Lost to Follow-up|1
175779|NCT00129259|552263|P1|Overall Study|Lost to Follow-up|1
175780|NCT00129220|552291|P3|Study Period III|Reason Not Specified|2
175781|NCT00129220|552292|P2|Study Period III|Reason Not Specified|0
175782|NCT00129220|552293|P1|Study Period III|Reason Not Specified|9
175783|NCT00129220|552291|P3|Study Period III|Sponsor Decision|0
175784|NCT00129220|552292|P2|Study Period III|Sponsor Decision|0
175785|NCT00129220|552293|P1|Study Period III|Sponsor Decision|1
175786|NCT00129220|552291|P3|Study Period III|Withdrawal by Subject|3
175787|NCT00129220|552292|P2|Study Period III|Withdrawal by Subject|0
175788|NCT00129220|552293|P1|Study Period III|Withdrawal by Subject|1
175789|NCT00129220|552291|P3|Study Period III|Protocol Violation|2
175790|NCT00129220|552292|P2|Study Period III|Protocol Violation|1
175791|NCT00129220|552293|P1|Study Period III|Protocol Violation|1
175792|NCT00129220|552291|P3|Study Period III|Adverse Event|3
175793|NCT00129220|552292|P2|Study Period III|Adverse Event|0
175794|NCT00129220|552293|P1|Study Period III|Adverse Event|1
175795|NCT00129220|552291|P3|Study Period II|Reason Not Specified|5
175796|NCT00129220|552292|P2|Study Period II|Reason Not Specified|0
175797|NCT00129220|552293|P1|Study Period II|Reason Not Specified|2
175798|NCT00129220|552291|P3|Study Period II|Withdrawal by Subject|4
175799|NCT00129220|552292|P2|Study Period II|Withdrawal by Subject|3
175800|NCT00129220|552293|P1|Study Period II|Withdrawal by Subject|1
175801|NCT00129220|552291|P3|Study Period II|Physician Decision|0
175802|NCT00129220|552292|P2|Study Period II|Physician Decision|1
175803|NCT00129220|552293|P1|Study Period II|Physician Decision|0
175804|NCT00129220|552291|P3|Study Period II|Protocol Violation|1
175805|NCT00129220|552292|P2|Study Period II|Protocol Violation|2
175806|NCT00129220|552293|P1|Study Period II|Protocol Violation|4
175807|NCT00129220|552291|P3|Study Period II|Entry Criteria Not Met|2
175808|NCT00129220|552292|P2|Study Period II|Entry Criteria Not Met|0
175809|NCT00129220|552293|P1|Study Period II|Entry Criteria Not Met|2
175810|NCT00129220|552291|P3|Study Period II|Lack of Efficacy|28
175811|NCT00129220|552292|P2|Study Period II|Lack of Efficacy|1
175812|NCT00129220|552293|P1|Study Period II|Lack of Efficacy|15
175813|NCT00129220|552291|P3|Study Period II|Adverse Event|7
175814|NCT00129220|552292|P2|Study Period II|Adverse Event|5
175815|NCT00129220|552293|P1|Study Period II|Adverse Event|9
175816|NCT00129129|552333|P5|Fourth Dose Phase|Protocol Violation|0
175817|NCT00129129|552334|P4|Fourth Dose Phase|Protocol Violation|1
175818|NCT00129129|552335|P3|Fourth Dose Phase|Protocol Violation|0
175820|NCT00129129|552337|P1|Fourth Dose Phase|Protocol Violation|0
175821|NCT00129129|552333|P5|Fourth Dose Phase|Unspecified|1
175822|NCT00129129|552334|P4|Fourth Dose Phase|Unspecified|1
175823|NCT00129129|552335|P3|Fourth Dose Phase|Unspecified|0
175824|NCT00129129|552336|P2|Fourth Dose Phase|Unspecified|0
175825|NCT00129129|552337|P1|Fourth Dose Phase|Unspecified|0
175826|NCT00129129|552333|P5|Fourth Dose Phase|Migration from study area|2
175827|NCT00129129|552334|P4|Fourth Dose Phase|Migration from study area|0
175828|NCT00129129|552335|P3|Fourth Dose Phase|Migration from study area|0
175829|NCT00129129|552336|P2|Fourth Dose Phase|Migration from study area|0
175830|NCT00129129|552337|P1|Fourth Dose Phase|Migration from study area|0
175831|NCT00129129|552333|P5|Fourth Dose Phase|Withdrawal by Subject|1
175832|NCT00129129|552334|P4|Fourth Dose Phase|Withdrawal by Subject|0
175833|NCT00129129|552335|P3|Fourth Dose Phase|Withdrawal by Subject|0
175834|NCT00129129|552336|P2|Fourth Dose Phase|Withdrawal by Subject|0
175835|NCT00129129|552337|P1|Fourth Dose Phase|Withdrawal by Subject|0
175836|NCT00129129|552333|P5|Fourth Dose Phase|Lost to Follow-up|2
175837|NCT00129129|552334|P4|Fourth Dose Phase|Lost to Follow-up|2
175838|NCT00129129|552335|P3|Fourth Dose Phase|Lost to Follow-up|0
175839|NCT00129129|552336|P2|Fourth Dose Phase|Lost to Follow-up|0
175840|NCT00129129|552337|P1|Fourth Dose Phase|Lost to Follow-up|4
175841|NCT00129129|552333|P5|Primary Phase|Unspecified|0
175842|NCT00129129|552334|P4|Primary Phase|Unspecified|0
175843|NCT00129129|552335|P3|Primary Phase|Unspecified|0
175844|NCT00129129|552336|P2|Primary Phase|Unspecified|5
175845|NCT00129129|552337|P1|Primary Phase|Unspecified|2
175846|NCT00129129|552333|P5|Primary Phase|Lost to Follow-up|0
175847|NCT00129129|552334|P4|Primary Phase|Lost to Follow-up|0
175848|NCT00129129|552335|P3|Primary Phase|Lost to Follow-up|0
175849|NCT00129129|552336|P2|Primary Phase|Lost to Follow-up|6
175850|NCT00129129|552337|P1|Primary Phase|Lost to Follow-up|8
175851|NCT00129129|552333|P5|Primary Phase|Migration from study area|0
175852|NCT00129129|552334|P4|Primary Phase|Migration from study area|0
175853|NCT00129129|552335|P3|Primary Phase|Migration from study area|0
175854|NCT00129129|552336|P2|Primary Phase|Migration from study area|3
175855|NCT00129129|552337|P1|Primary Phase|Migration from study area|1
175856|NCT00129129|552333|P5|Primary Phase|Withdrawal by Subject|0
175857|NCT00129129|552334|P4|Primary Phase|Withdrawal by Subject|0
175858|NCT00129129|552335|P3|Primary Phase|Withdrawal by Subject|0
175859|NCT00129129|552336|P2|Primary Phase|Withdrawal by Subject|10
175860|NCT00129129|552337|P1|Primary Phase|Withdrawal by Subject|12
175861|NCT00129129|552333|P5|Primary Phase|Adverse Event|0
175862|NCT00129129|552334|P4|Primary Phase|Adverse Event|0
175863|NCT00129129|552335|P3|Primary Phase|Adverse Event|0
175864|NCT00129129|552336|P2|Primary Phase|Adverse Event|1
175865|NCT00129129|552337|P1|Primary Phase|Adverse Event|2
175866|NCT00129116|552544|P5|Booster Phase|Lost to Follow-up|1
175867|NCT00129116|552545|P4|Booster Phase|Lost to Follow-up|0
175868|NCT00129116|552546|P3|Booster Phase|Lost to Follow-up|0
175869|NCT00129116|552547|P2|Booster Phase|Lost to Follow-up|0
175870|NCT00129116|552548|P1|Booster Phase|Lost to Follow-up|2
175871|NCT00129116|552544|P5|Primary Phase|Unspecified|0
175872|NCT00129116|552545|P4|Primary Phase|Unspecified|0
175873|NCT00129116|552546|P3|Primary Phase|Unspecified|1
175874|NCT00129116|552547|P2|Primary Phase|Unspecified|0
175875|NCT00129116|552548|P1|Primary Phase|Unspecified|0
175876|NCT00129116|552544|P5|Primary Phase|Withdrawal by Subject|0
175877|NCT00129116|552545|P4|Primary Phase|Withdrawal by Subject|0
175878|NCT00129116|552546|P3|Primary Phase|Withdrawal by Subject|0
175879|NCT00129116|552547|P2|Primary Phase|Withdrawal by Subject|1
175880|NCT00129116|552548|P1|Primary Phase|Withdrawal by Subject|0
175881|NCT00129116|552544|P5|Primary Phase|Adverse Event|0
175882|NCT00129116|552545|P4|Primary Phase|Adverse Event|0
175883|NCT00129116|552546|P3|Primary Phase|Adverse Event|0
175884|NCT00129116|552547|P2|Primary Phase|Adverse Event|1
175885|NCT00129116|552548|P1|Primary Phase|Adverse Event|1
175886|NCT00129116|552544|P5|Primary Phase|Protocol Violation|0
175887|NCT00129116|552545|P4|Primary Phase|Protocol Violation|0
175888|NCT00129116|552546|P3|Primary Phase|Protocol Violation|0
175889|NCT00129116|552547|P2|Primary Phase|Protocol Violation|1
175890|NCT00129116|552548|P1|Primary Phase|Protocol Violation|0
175891|NCT00129116|552544|P5|Primary Phase|Lost to Follow-up|1
175892|NCT00129116|552545|P4|Primary Phase|Lost to Follow-up|1
175893|NCT00129116|552546|P3|Primary Phase|Lost to Follow-up|0
175894|NCT00129116|552547|P2|Primary Phase|Lost to Follow-up|1
175895|NCT00129116|552548|P1|Primary Phase|Lost to Follow-up|1
175896|NCT00128830|552832|P1|Overall Study|Unspecified|9
175897|NCT00128830|552832|P1|Overall Study|Discontinued or ineligible for study|2
175898|NCT00128830|552832|P1|Overall Study|Non-compliant|4
175899|NCT00128830|552832|P1|Overall Study|Reached a virologic endpoint|29
175900|NCT00128830|552832|P1|Overall Study|Lost to Follow-up|4
175901|NCT00128830|552832|P1|Overall Study|Withdrawal by Subject|14
175902|NCT00128830|552832|P1|Overall Study|Adverse Event|10
175903|NCT00128661|552874|P2|Overall Study|Unspecified|8
175904|NCT00128661|552875|P1|Overall Study|Unspecified|7
175905|NCT00128661|552874|P2|Overall Study|Withdrawal by Subject|232
175906|NCT00128661|552875|P1|Overall Study|Withdrawal by Subject|243
175907|NCT00128661|552874|P2|Overall Study|Lost to Follow-up|7
175908|NCT00128661|552875|P1|Overall Study|Lost to Follow-up|10
175909|NCT00128661|552874|P2|Overall Study|Adverse Event|11
175910|NCT00128661|552875|P1|Overall Study|Adverse Event|14
175911|NCT00128492|552921|P2|Overall Study|Pregnancy|1
175912|NCT00128492|552922|P1|Overall Study|Pregnancy|0
175913|NCT00128492|552921|P2|Overall Study|Withdrawal by Subject|5
175914|NCT00128492|552922|P1|Overall Study|Withdrawal by Subject|3
175915|NCT00128492|552921|P2|Overall Study|Personal or administrative|22
175916|NCT00128492|552922|P1|Overall Study|Personal or administrative|10
175917|NCT00128492|552921|P2|Overall Study|Noncompliance|5
175918|NCT00128492|552922|P1|Overall Study|Noncompliance|0
175919|NCT00128492|552921|P2|Overall Study|Lost to Follow-up|5
175920|NCT00128492|552922|P1|Overall Study|Lost to Follow-up|1
175921|NCT00128492|552921|P2|Overall Study|Death|0
175922|NCT00128492|552922|P1|Overall Study|Death|1
175923|NCT00128492|552921|P2|Overall Study|AE related to study|4
175924|NCT00128492|552922|P1|Overall Study|AE related to study|1
175925|NCT00128492|552921|P2|Overall Study|Study drug intolerance (AE)|8
175926|NCT00128492|552922|P1|Overall Study|Study drug intolerance (AE)|2
175927|NCT00128492|552921|P2|Overall Study|AE unrelated to study|9
175928|NCT00128492|552922|P1|Overall Study|AE unrelated to study|2
175929|NCT00128206|553079|P2|Overall Study|Adverse Event|2
175930|NCT00128206|553080|P1|Overall Study|Adverse Event|0
175931|NCT00128206|553079|P2|Overall Study|Lost to Follow-up|118
175932|NCT00128206|553080|P1|Overall Study|Lost to Follow-up|137
175933|NCT00127933|553372|P2|Overall Study|Randomized but not dosed|0
175934|NCT00127933|553373|P1|Overall Study|Randomized but not dosed|1
175935|NCT00127855|553394|P5|Primary Vaccination Course|Unspecified|1
175936|NCT00127855|553395|P4|Primary Vaccination Course|Unspecified|0
175937|NCT00127855|553396|P3|Primary Vaccination Course|Unspecified|0
175938|NCT00127855|553397|P2|Primary Vaccination Course|Unspecified|0
175939|NCT00127855|553398|P1|Primary Vaccination Course|Unspecified|0
175940|NCT00127855|553394|P5|Primary Vaccination Course|Lost to Follow-up|2
175941|NCT00127855|553395|P4|Primary Vaccination Course|Lost to Follow-up|0
175942|NCT00127855|553396|P3|Primary Vaccination Course|Lost to Follow-up|1
175943|NCT00127855|553397|P2|Primary Vaccination Course|Lost to Follow-up|1
175944|NCT00127855|553398|P1|Primary Vaccination Course|Lost to Follow-up|1
175945|NCT00127855|553394|P5|Primary Vaccination Course|Withdrawal by Subject|1
175946|NCT00127855|553395|P4|Primary Vaccination Course|Withdrawal by Subject|0
175947|NCT00127855|553396|P3|Primary Vaccination Course|Withdrawal by Subject|0
175948|NCT00127855|553397|P2|Primary Vaccination Course|Withdrawal by Subject|0
175949|NCT00127855|553398|P1|Primary Vaccination Course|Withdrawal by Subject|1
175950|NCT00127855|553394|P5|Primary Vaccination Course|Adverse Event|0
175951|NCT00127855|553395|P4|Primary Vaccination Course|Adverse Event|0
175952|NCT00127855|553396|P3|Primary Vaccination Course|Adverse Event|1
175953|NCT00127855|553397|P2|Primary Vaccination Course|Adverse Event|0
175954|NCT00127855|553398|P1|Primary Vaccination Course|Adverse Event|0
175955|NCT00127842|553580|P1|Overall Study|Other|5
175956|NCT00127842|553580|P1|Overall Study|Protocol Violation|1
175957|NCT00127842|553580|P1|Overall Study|Noncompliance|2
175958|NCT00127842|553580|P1|Overall Study|Lack of Efficacy|12
175959|NCT00127842|553580|P1|Overall Study|Lost to Follow-up|1
175960|NCT00127842|553580|P1|Overall Study|Withdrawal by Subject|3
175961|NCT00127842|553580|P1|Overall Study|Adverse Event|15
175962|NCT00127803|553598|P4|Overall Study|Lost to Follow-up|1
175963|NCT00127803|553599|P3|Overall Study|Lost to Follow-up|0
175964|NCT00127803|553600|P2|Overall Study|Lost to Follow-up|0
175965|NCT00127803|553601|P1|Overall Study|Lost to Follow-up|0
175966|NCT00127803|553598|P4|Overall Study|Withdrawal by Subject|0
175967|NCT00127803|553599|P3|Overall Study|Withdrawal by Subject|0
175968|NCT00127803|553600|P2|Overall Study|Withdrawal by Subject|0
175969|NCT00127803|553601|P1|Overall Study|Withdrawal by Subject|1
175970|NCT00127803|553598|P4|Overall Study|Adverse Event|0
175971|NCT00127803|553599|P3|Overall Study|Adverse Event|0
175972|NCT00127803|553600|P2|Overall Study|Adverse Event|0
175973|NCT00127803|553601|P1|Overall Study|Adverse Event|2
175974|NCT00127712|553650|P2|Overall Study|Lack of GI access to continue|0
175975|NCT00127712|553651|P1|Overall Study|Lack of GI access to continue|2
175976|NCT00127712|553650|P2|Overall Study|Adverse Event|0
175977|NCT00127712|553651|P1|Overall Study|Adverse Event|3
175978|NCT00127413|553676|P4|Overall Study|Lost to Follow-up|2
175979|NCT00127413|553677|P3|Overall Study|Lost to Follow-up|8
175980|NCT00127413|553678|P2|Overall Study|Lost to Follow-up|4
175981|NCT00127413|553679|P1|Overall Study|Lost to Follow-up|6
175982|NCT00127192|553703|P5|Overall Study|Adverse event in pre-treatment period|0
175983|NCT00127192|553704|P4|Overall Study|Adverse event in pre-treatment period|0
175984|NCT00127192|553705|P3|Overall Study|Adverse event in pre-treatment period|0
175985|NCT00127192|553706|P2|Overall Study|Adverse event in pre-treatment period|0
175986|NCT00127192|553707|P1|Overall Study|Adverse event in pre-treatment period|1
175987|NCT00127192|553703|P5|Overall Study|Withdrawal by Subject|3
175988|NCT00127192|553704|P4|Overall Study|Withdrawal by Subject|0
175989|NCT00127192|553705|P3|Overall Study|Withdrawal by Subject|1
175990|NCT00127192|553706|P2|Overall Study|Withdrawal by Subject|0
175991|NCT00127192|553707|P1|Overall Study|Withdrawal by Subject|0
175992|NCT00127192|553703|P5|Overall Study|Lack of Efficacy|2
175993|NCT00127192|553704|P4|Overall Study|Lack of Efficacy|0
175994|NCT00127192|553705|P3|Overall Study|Lack of Efficacy|0
175995|NCT00127192|553706|P2|Overall Study|Lack of Efficacy|0
175996|NCT00127192|553707|P1|Overall Study|Lack of Efficacy|2
175997|NCT00127192|553703|P5|Overall Study|Adverse Event|0
175998|NCT00127192|553704|P4|Overall Study|Adverse Event|1
175999|NCT00127192|553705|P3|Overall Study|Adverse Event|1
176000|NCT00127192|553706|P2|Overall Study|Adverse Event|1
176001|NCT00127192|553707|P1|Overall Study|Adverse Event|0
176002|NCT00127166|553731|P2|Period II|Patient did not perform Visit 6 exercise|0
176003|NCT00127166|553732|P1|Period II|Patient did not perform Visit 6 exercise|1
176004|NCT00127166|553731|P2|Period II|Withdrawal by Subject|0
176005|NCT00127166|553732|P1|Period II|Withdrawal by Subject|2
176006|NCT00127166|553731|P2|Washout Period|Patient did not meet inclusion criteria|1
176007|NCT00127166|553732|P1|Washout Period|Patient did not meet inclusion criteria|0
176008|NCT00127166|553731|P2|Period I|Patient did not meet inclusion criteria|0
176009|NCT00127166|553732|P1|Period I|Patient did not meet inclusion criteria|1
176010|NCT00127166|553731|P2|Period I|Withdrawal by Subject|0
176011|NCT00127166|553732|P1|Period I|Withdrawal by Subject|2
176012|NCT00127166|553731|P2|Period I|Protocol Violation|2
176013|NCT00127166|553732|P1|Period I|Protocol Violation|0
176014|NCT00127101|553752|P6|Continuation Phase|Withdrawal by Subject|1
176015|NCT00127101|553753|P5|Continuation Phase|Withdrawal by Subject|2
176016|NCT00127101|553754|P4|Continuation Phase|Withdrawal by Subject|0
176017|NCT00127101|553755|P3|Continuation Phase|Withdrawal by Subject|1
176018|NCT00127101|553756|P2|Continuation Phase|Withdrawal by Subject|0
176019|NCT00127101|553757|P1|Continuation Phase|Withdrawal by Subject|0
176020|NCT00127101|553752|P6|Continuation Phase|Lack of Efficacy|1
176021|NCT00127101|553753|P5|Continuation Phase|Lack of Efficacy|0
176022|NCT00127101|553754|P4|Continuation Phase|Lack of Efficacy|0
176023|NCT00127101|553755|P3|Continuation Phase|Lack of Efficacy|0
176024|NCT00127101|553756|P2|Continuation Phase|Lack of Efficacy|0
176025|NCT00127101|553757|P1|Continuation Phase|Lack of Efficacy|0
176026|NCT00127101|553752|P6|Continuation Phase|Adverse Event|1
176027|NCT00127101|553753|P5|Continuation Phase|Adverse Event|1
176028|NCT00127101|553754|P4|Continuation Phase|Adverse Event|0
176029|NCT00127101|553755|P3|Continuation Phase|Adverse Event|0
176030|NCT00127101|553756|P2|Continuation Phase|Adverse Event|0
176031|NCT00127101|553757|P1|Continuation Phase|Adverse Event|0
176032|NCT00127101|553752|P6|Base Protocol|Withdrawal by Subject|1
176033|NCT00127101|553753|P5|Base Protocol|Withdrawal by Subject|0
176034|NCT00127101|553754|P4|Base Protocol|Withdrawal by Subject|0
176035|NCT00127101|553755|P3|Base Protocol|Withdrawal by Subject|1
176036|NCT00127101|553756|P2|Base Protocol|Withdrawal by Subject|2
176037|NCT00127101|553757|P1|Base Protocol|Withdrawal by Subject|1
176038|NCT00127101|553752|P6|Base Protocol|Lack of Efficacy|0
176039|NCT00127101|553753|P5|Base Protocol|Lack of Efficacy|2
176040|NCT00127101|553754|P4|Base Protocol|Lack of Efficacy|0
176041|NCT00127101|553755|P3|Base Protocol|Lack of Efficacy|0
176042|NCT00127101|553756|P2|Base Protocol|Lack of Efficacy|0
176043|NCT00127101|553757|P1|Base Protocol|Lack of Efficacy|1
176044|NCT00127101|553752|P6|Base Protocol|Adverse Event|0
176045|NCT00127101|553753|P5|Base Protocol|Adverse Event|0
176046|NCT00127101|553754|P4|Base Protocol|Adverse Event|0
176047|NCT00127101|553755|P3|Base Protocol|Adverse Event|1
176048|NCT00127101|553756|P2|Base Protocol|Adverse Event|2
176049|NCT00127101|553757|P1|Base Protocol|Adverse Event|0
176050|NCT00127036|553779|P2|Overall Study|Screen Failure|0
176051|NCT00127036|553780|P1|Overall Study|Screen Failure|2
176052|NCT00127036|553779|P2|Overall Study|Insufficient Data for Analysis|11
176053|NCT00127036|553780|P1|Overall Study|Insufficient Data for Analysis|6
176054|NCT00126776|553792|P2|Overall Study|follow up complete on all patients|0
176055|NCT00126776|553793|P1|Overall Study|follow up complete on all patients|0
176056|NCT00126659|553842|P3|Overall Study|Adverse Event|2
176057|NCT00126659|553843|P2|Overall Study|Adverse Event|0
176058|NCT00126659|553844|P1|Overall Study|Adverse Event|0
176059|NCT00126594|553852|P2|Overall Study|Disease Progression|24
176060|NCT00126594|553853|P1|Overall Study|Disease Progression|29
176061|NCT00126594|553852|P2|Overall Study|Non-compliance|1
176062|NCT00126594|553853|P1|Overall Study|Non-compliance|0
176063|NCT00126594|553852|P2|Overall Study|Adverse Event|5
176064|NCT00126594|553853|P1|Overall Study|Adverse Event|7
176065|NCT00126594|553852|P2|Overall Study|Physician Decision|3
176066|NCT00126594|553853|P1|Overall Study|Physician Decision|1
176067|NCT00126594|553852|P2|Overall Study|Withdrawal by Subject|4
176068|NCT00126594|553853|P1|Overall Study|Withdrawal by Subject|0
176069|NCT00126594|553852|P2|Overall Study|Ineligible|0
176070|NCT00126594|553853|P1|Overall Study|Ineligible|2
176071|NCT00126581|553870|P2|Overall Study|Other illness/MD discretion|4
176072|NCT00126581|553871|P1|Overall Study|Other illness/MD discretion|3
176073|NCT00126581|553870|P2|Overall Study|Alternative therapy|3
176074|NCT00126581|553871|P1|Overall Study|Alternative therapy|3
176075|NCT00126581|553870|P2|Overall Study|Withdrawal by Subject|4
176076|NCT00126581|553871|P1|Overall Study|Withdrawal by Subject|1
176077|NCT00126581|553870|P2|Overall Study|Death|2
176078|NCT00126581|553871|P1|Overall Study|Death|3
176079|NCT00126581|553870|P2|Overall Study|Adverse Event|7
176080|NCT00126581|553871|P1|Overall Study|Adverse Event|3
176081|NCT00126568|553891|P1|Overall Study|Death|2
176082|NCT00126555|553897|P1|Overall Study|Progressive Disease|3
176083|NCT00126555|553897|P1|Overall Study|Adverse Event|2
176084|NCT00126555|553897|P1|Overall Study|Withdrawal by Subject|1
176085|NCT00126503|553913|P2|Overall Study|Physician Decision|1
176086|NCT00126503|553914|P1|Overall Study|Physician Decision|2
176087|NCT00126503|553913|P2|Overall Study|non-compliant|0
176088|NCT00126503|553914|P1|Overall Study|non-compliant|1
176089|NCT00126503|553913|P2|Overall Study|Adverse Event|3
176090|NCT00126503|553914|P1|Overall Study|Adverse Event|13
176091|NCT00126503|553913|P2|Overall Study|Death|0
176092|NCT00126503|553914|P1|Overall Study|Death|3
176093|NCT00126503|553913|P2|Overall Study|other complicating disease|1
176094|NCT00126503|553914|P1|Overall Study|other complicating disease|4
176095|NCT00126503|553913|P2|Overall Study|alternative therapy|1
176096|NCT00126503|553914|P1|Overall Study|alternative therapy|1
176097|NCT00126503|553913|P2|Overall Study|Withdrawal by Subject|1
176098|NCT00126503|553914|P1|Overall Study|Withdrawal by Subject|0
176099|NCT00126503|553913|P2|Overall Study|disease progression|14
176100|NCT00126503|553914|P1|Overall Study|disease progression|23
176101|NCT00126490|553926|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
176102|NCT00126425|553936|P2|Overall Study|Unspecified|0
176103|NCT00126425|553937|P1|Overall Study|Unspecified|5
176104|NCT00126425|553936|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
176105|NCT00126425|553937|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
176106|NCT00126425|553936|P2|Overall Study|Adverse Event|0
176107|NCT00126425|553937|P1|Overall Study|Adverse Event|1
176108|NCT00126425|553936|P2|Overall Study|Protocol Violation|6
176109|NCT00126425|553937|P1|Overall Study|Protocol Violation|9
176110|NCT00126425|553936|P2|Overall Study|Lost to Follow-up|4
176111|NCT00126425|553937|P1|Overall Study|Lost to Follow-up|8
176112|NCT00126425|553936|P2|Overall Study|Withdrawal by Subject|1
176113|NCT00126425|553937|P1|Overall Study|Withdrawal by Subject|17
176114|NCT00126191|553945|P2|Overall Study|Death|1
176115|NCT00126191|553946|P1|Overall Study|Death|0
176116|NCT00126191|553945|P2|Overall Study|Physician Decision|1
176117|NCT00126191|553946|P1|Overall Study|Physician Decision|0
176118|NCT00126126|553956|P2|Overall Study|Lost to Follow-up|2
176119|NCT00126126|553957|P1|Overall Study|Lost to Follow-up|0
176120|NCT00125268|554064|P2|Overall Study|Withdrawal by Subject|1
176121|NCT00125268|554065|P1|Overall Study|Withdrawal by Subject|1
176122|NCT00125242|554077|P2|Overall Study|did not qualify|2
176123|NCT00125242|554078|P1|Overall Study|did not qualify|7
176124|NCT00125190|554083|P1|Overall Study|Non-compliance|2
176125|NCT00125190|554083|P1|Overall Study|other|1
176126|NCT00125190|554083|P1|Overall Study|Patient/Parent Decision|7
176127|NCT00125190|554083|P1|Overall Study|Lost to Follow-up|4
176128|NCT00125190|554083|P1|Overall Study|Adverse Event|1
176129|NCT00125164|554101|P4|Overall Study|Withdrawal by Subject|1
176130|NCT00125164|554102|P3|Overall Study|Withdrawal by Subject|1
176131|NCT00125164|554103|P2|Overall Study|Withdrawal by Subject|0
176132|NCT00125164|554104|P1|Overall Study|Withdrawal by Subject|2
176133|NCT00125164|554101|P4|Overall Study|Lost to Follow-up|1
176134|NCT00125164|554102|P3|Overall Study|Lost to Follow-up|1
176135|NCT00125164|554103|P2|Overall Study|Lost to Follow-up|0
176136|NCT00125164|554104|P1|Overall Study|Lost to Follow-up|0
176137|NCT00125164|554101|P4|Overall Study|Adverse Event|4
176138|NCT00125164|554102|P3|Overall Study|Adverse Event|2
176139|NCT00125164|554103|P2|Overall Study|Adverse Event|0
176140|NCT00125164|554104|P1|Overall Study|Adverse Event|0
176141|NCT00125138|554158|P4|Overall Study|Sponsor decision-pt moved to assist care|1
176142|NCT00125138|554159|P3|Overall Study|Sponsor decision-pt moved to assist care|0
176143|NCT00125138|554160|P2|Overall Study|Sponsor decision-pt moved to assist care|0
176144|NCT00125138|554161|P1|Overall Study|Sponsor decision-pt moved to assist care|0
176145|NCT00125138|554158|P4|Overall Study|Lack of Efficacy|1
176146|NCT00125138|554159|P3|Overall Study|Lack of Efficacy|0
176147|NCT00125138|554160|P2|Overall Study|Lack of Efficacy|0
176148|NCT00125138|554161|P1|Overall Study|Lack of Efficacy|0
176149|NCT00125138|554158|P4|Overall Study|Withdrawal by Subject|1
176150|NCT00125138|554159|P3|Overall Study|Withdrawal by Subject|1
176151|NCT00125138|554160|P2|Overall Study|Withdrawal by Subject|3
176152|NCT00125138|554161|P1|Overall Study|Withdrawal by Subject|2
176153|NCT00125138|554158|P4|Overall Study|Adverse Event|2
176154|NCT00125138|554159|P3|Overall Study|Adverse Event|3
176155|NCT00125138|554160|P2|Overall Study|Adverse Event|0
176156|NCT00125138|554161|P1|Overall Study|Adverse Event|1
176157|NCT00124982|554210|P3|Long-term Period|Neurologist Recommendation|1
176158|NCT00124982|554211|P2|Long-term Period|Neurologist Recommendation|0
176159|NCT00124982|554212|P1|Long-term Period|Neurologist Recommendation|0
176160|NCT00124982|554210|P3|Long-term Period|Administrative Reason by Sponsor|1
176161|NCT00124982|554211|P2|Long-term Period|Administrative Reason by Sponsor|0
176162|NCT00124982|554212|P1|Long-term Period|Administrative Reason by Sponsor|0
176163|NCT00124982|554210|P3|Long-term Period|Poor/Non-compliance|2
176164|NCT00124982|554211|P2|Long-term Period|Poor/Non-compliance|0
176165|NCT00124982|554212|P1|Long-term Period|Poor/Non-compliance|0
176166|NCT00124982|554210|P3|Long-term Period|Pregnancy|1
176167|NCT00124982|554211|P2|Long-term Period|Pregnancy|0
176168|NCT00124982|554212|P1|Long-term Period|Pregnancy|0
176169|NCT00124982|554210|P3|Long-term Period|Withdrawal by Subject|16
176170|NCT00124982|554211|P2|Long-term Period|Withdrawal by Subject|0
176171|NCT00124982|554212|P1|Long-term Period|Withdrawal by Subject|0
176172|NCT00124982|554210|P3|Long-term Period|Lost to Follow-up|4
176173|NCT00124982|554211|P2|Long-term Period|Lost to Follow-up|0
176174|NCT00124982|554212|P1|Long-term Period|Lost to Follow-up|0
176175|NCT00124982|554210|P3|Long-term Period|Lack of Efficacy|46
176176|NCT00124982|554211|P2|Long-term Period|Lack of Efficacy|0
176177|NCT00124982|554212|P1|Long-term Period|Lack of Efficacy|0
176178|NCT00124982|554210|P3|Long-term Period|Adverse Event|17
176179|NCT00124982|554211|P2|Long-term Period|Adverse Event|0
176180|NCT00124982|554212|P1|Long-term Period|Adverse Event|0
176181|NCT00124982|554210|P3|Long-term Period|Death|1
176182|NCT00124982|554211|P2|Long-term Period|Death|0
176183|NCT00124982|554212|P1|Long-term Period|Death|0
176184|NCT00124982|554210|P3|Short-term Period|Participant Had Lymphopenia|0
176185|NCT00124982|554211|P2|Short-term Period|Participant Had Lymphopenia|0
176186|NCT00124982|554212|P1|Short-term Period|Participant Had Lymphopenia|1
176187|NCT00124982|554210|P3|Short-term Period|Investigator Decision-No Specific AE|0
176188|NCT00124982|554211|P2|Short-term Period|Investigator Decision-No Specific AE|0
176189|NCT00124982|554212|P1|Short-term Period|Investigator Decision-No Specific AE|1
176190|NCT00124982|554210|P3|Short-term Period|Participant Chose Own Doctor|0
176191|NCT00124982|554211|P2|Short-term Period|Participant Chose Own Doctor|1
176192|NCT00124982|554212|P1|Short-term Period|Participant Chose Own Doctor|0
176193|NCT00124982|554210|P3|Short-term Period|Participant Decision|0
176194|NCT00124982|554211|P2|Short-term Period|Participant Decision|0
176195|NCT00124982|554212|P1|Short-term Period|Participant Decision|1
176196|NCT00124982|554210|P3|Short-term Period|No Longer Meets Study Criteria|0
176197|NCT00124982|554211|P2|Short-term Period|No Longer Meets Study Criteria|2
176198|NCT00124982|554212|P1|Short-term Period|No Longer Meets Study Criteria|1
176199|NCT00124982|554210|P3|Short-term Period|Poor/Non-compliance|0
176200|NCT00124982|554211|P2|Short-term Period|Poor/Non-compliance|1
176201|NCT00124982|554212|P1|Short-term Period|Poor/Non-compliance|3
176202|NCT00124982|554210|P3|Short-term Period|Withdrawal of Consent|0
176203|NCT00124982|554211|P2|Short-term Period|Withdrawal of Consent|9
176204|NCT00124982|554212|P1|Short-term Period|Withdrawal of Consent|7
176205|NCT00124982|554210|P3|Short-term Period|Lost to Follow-up|0
176206|NCT00124982|554211|P2|Short-term Period|Lost to Follow-up|5
176207|NCT00124982|554212|P1|Short-term Period|Lost to Follow-up|8
176208|NCT00124982|554210|P3|Short-term Period|Lack of Efficacy|0
176209|NCT00124982|554211|P2|Short-term Period|Lack of Efficacy|73
176210|NCT00124982|554212|P1|Short-term Period|Lack of Efficacy|32
176211|NCT00124982|554210|P3|Short-term Period|Adverse Event|0
176212|NCT00124982|554211|P2|Short-term Period|Adverse Event|22
176213|NCT00124982|554212|P1|Short-term Period|Adverse Event|17
176214|NCT00124982|554210|P3|Short-term Period|Death|0
176215|NCT00124982|554211|P2|Short-term Period|Death|1
176216|NCT00124982|554212|P1|Short-term Period|Death|1
176217|NCT00124943|554294|P4|Phase II|Withdrawal by Subject|2
176218|NCT00124943|554295|P3|Phase II|Withdrawal by Subject|0
176219|NCT00124943|554296|P2|Phase II|Withdrawal by Subject|0
176220|NCT00124943|554297|P1|Phase II|Withdrawal by Subject|0
176221|NCT00124943|554294|P4|Phase II|Lost to Follow-up|1
176222|NCT00124943|554295|P3|Phase II|Lost to Follow-up|0
176223|NCT00124943|554296|P2|Phase II|Lost to Follow-up|0
176224|NCT00124943|554297|P1|Phase II|Lost to Follow-up|0
176225|NCT00124943|554294|P4|Phase II|Protocol Violation|1
176226|NCT00124943|554295|P3|Phase II|Protocol Violation|0
176227|NCT00124943|554296|P2|Phase II|Protocol Violation|0
176228|NCT00124943|554297|P1|Phase II|Protocol Violation|0
176229|NCT00124943|554294|P4|Phase II|Adverse Event|1
176230|NCT00124943|554295|P3|Phase II|Adverse Event|0
176231|NCT00124943|554296|P2|Phase II|Adverse Event|2
176232|NCT00124943|554297|P1|Phase II|Adverse Event|0
176233|NCT00124748|554337|P2|Overall Study|Death|3
176234|NCT00124748|554338|P1|Overall Study|Death|1
176235|NCT00124748|554337|P2|Overall Study|Administrative Problem(Study Terminated)|174
176236|NCT00124748|554338|P1|Overall Study|Administrative Problem(Study Terminated)|101
176237|NCT00124748|554337|P2|Overall Study|Lost to Follow-up|7
176238|NCT00124748|554338|P1|Overall Study|Lost to Follow-up|2
176239|NCT00124748|554337|P2|Overall Study|Withdrawal by Subject|15
176240|NCT00124748|554338|P1|Overall Study|Withdrawal by Subject|5
176241|NCT00124748|554337|P2|Overall Study|Protocol Violation|1
176242|NCT00124748|554338|P1|Overall Study|Protocol Violation|3
176243|NCT00124748|554337|P2|Overall Study|No longer requires study drug|1
176244|NCT00124748|554338|P1|Overall Study|No longer requires study drug|1
176245|NCT00124748|554337|P2|Overall Study|Lack of Efficacy|41
176246|NCT00124748|554338|P1|Overall Study|Lack of Efficacy|20
176247|NCT00124748|554337|P2|Overall Study|Abnormal Procedure|1
176248|NCT00124748|554338|P1|Overall Study|Abnormal Procedure|0
176249|NCT00124748|554337|P2|Overall Study|Abnormal laboratory Value|2
176250|NCT00124748|554338|P1|Overall Study|Abnormal laboratory Value|2
176251|NCT00124748|554337|P2|Overall Study|Adverse Event|39
176252|NCT00124748|554338|P1|Overall Study|Adverse Event|8
176253|NCT00124709|554445|P2|Overall Study|Lost to Follow-up|120
176254|NCT00124709|554446|P1|Overall Study|Lost to Follow-up|114
176255|NCT00124709|554445|P2|Overall Study|Withdrawal by Subject|136
176256|NCT00124709|554446|P1|Overall Study|Withdrawal by Subject|127
176257|NCT00124709|554445|P2|Overall Study|Protocol Violation|5
176258|NCT00124709|554446|P1|Overall Study|Protocol Violation|3
176259|NCT00124709|554445|P2|Overall Study|Lack of Efficacy|10
176260|NCT00124709|554446|P1|Overall Study|Lack of Efficacy|5
176261|NCT00124709|554445|P2|Overall Study|Adverse Event|0
176262|NCT00124709|554446|P1|Overall Study|Adverse Event|3
176263|NCT00124709|554445|P2|Overall Study|Randomized but did not take medication|1
176264|NCT00124709|554446|P1|Overall Study|Randomized but did not take medication|3
176265|NCT00124657|554463|P3|Overall Study|Intercurrent illness|0
176266|NCT00124657|554464|P2|Overall Study|Intercurrent illness|0
176267|NCT00124657|554465|P1|Overall Study|Intercurrent illness|1
176268|NCT00124657|554463|P3|Overall Study|Progressive disease|27
176269|NCT00124657|554464|P2|Overall Study|Progressive disease|5
176270|NCT00124657|554465|P1|Overall Study|Progressive disease|14
176271|NCT00124657|554463|P3|Overall Study|Non-compliance|4
176272|NCT00124657|554464|P2|Overall Study|Non-compliance|0
176273|NCT00124657|554465|P1|Overall Study|Non-compliance|1
176274|NCT00124657|554463|P3|Overall Study|Toxicity|1
176275|NCT00124657|554464|P2|Overall Study|Toxicity|0
176276|NCT00124657|554465|P1|Overall Study|Toxicity|0
176277|NCT00124618|554500|P1|Overall Study|Ineligible|1
176278|NCT00124449|554515|P2|18-Month Untreated Observation Period|Relocated|0
176279|NCT00124449|554516|P1|18-Month Untreated Observation Period|Relocated|1
176280|NCT00124449|554515|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
176281|NCT00124449|554516|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
176282|NCT00124449|554515|P2|18-Month Untreated Observation Period|Pregnancy|0
176283|NCT00124449|554516|P1|18-Month Untreated Observation Period|Pregnancy|1
176284|NCT00124449|554515|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
176285|NCT00124449|554516|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
176286|NCT00124449|554515|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
176287|NCT00124449|554516|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
176288|NCT00124449|554515|P2|18-Month Untreated Observation Period|Adverse Event|1
176289|NCT00124449|554516|P1|18-Month Untreated Observation Period|Adverse Event|0
176290|NCT00124449|554515|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
176291|NCT00124449|554516|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
176292|NCT00124449|554515|P2|6-month Double-Blind Treatment Period|Sponsor request|1
176293|NCT00124449|554516|P1|6-month Double-Blind Treatment Period|Sponsor request|0
176294|NCT00124449|554515|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
176295|NCT00124449|554516|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
176296|NCT00124449|554515|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
176297|NCT00124449|554516|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
176298|NCT00124449|554515|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
176299|NCT00124449|554516|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
176300|NCT00124449|554515|P2|6-month Double-Blind Treatment Period|Adverse Event|0
176301|NCT00124449|554516|P1|6-month Double-Blind Treatment Period|Adverse Event|1
176302|NCT00124072|554570|P4|Overall Study|Death|480
176303|NCT00124072|554571|P3|Overall Study|Death|471
176304|NCT00124072|554572|P2|Overall Study|Death|484
176305|NCT00124072|554573|P1|Overall Study|Death|499
176306|NCT00124072|554570|P4|Overall Study|Lost to Follow-up for Morbidity|18
176307|NCT00124072|554571|P3|Overall Study|Lost to Follow-up for Morbidity|19
176308|NCT00124072|554572|P2|Overall Study|Lost to Follow-up for Morbidity|25
176309|NCT00124072|554573|P1|Overall Study|Lost to Follow-up for Morbidity|15
176310|NCT00124072|554570|P4|Overall Study|Lost to Follow-up for Mortality|2
176311|NCT00124072|554571|P3|Overall Study|Lost to Follow-up for Mortality|2
176312|NCT00124072|554572|P2|Overall Study|Lost to Follow-up for Mortality|3
176313|NCT00124072|554573|P1|Overall Study|Lost to Follow-up for Mortality|0
176314|NCT00124020|554585|P2|Overall Study|Transfer to another hospital|0
176315|NCT00124020|554586|P1|Overall Study|Transfer to another hospital|2
176316|NCT00124020|554585|P2|Overall Study|Other|1
176317|NCT00124020|554586|P1|Overall Study|Other|1
176318|NCT00124020|554585|P2|Overall Study|Lost to Follow-up|8
176319|NCT00124020|554586|P1|Overall Study|Lost to Follow-up|5
176320|NCT00124020|554585|P2|Overall Study|Withdrawal by Subject|11
176321|NCT00124020|554586|P1|Overall Study|Withdrawal by Subject|13
176322|NCT00124020|554585|P2|Overall Study|Death|71
176323|NCT00124020|554586|P1|Overall Study|Death|67
176324|NCT00123955|554594|P2|Overall Study|Death|1
176325|NCT00123955|554595|P1|Overall Study|Death|0
176326|NCT00123955|554594|P2|Overall Study|Withdrawal by Subject|3
176327|NCT00123955|554595|P1|Overall Study|Withdrawal by Subject|4
176328|NCT00123955|554594|P2|Overall Study|Adverse Event|0
176329|NCT00123955|554595|P1|Overall Study|Adverse Event|1
176330|NCT00123734|554601|P1|Overall Study|Withdrawal by Subject|1
176331|NCT00123734|554601|P1|Overall Study|Dropout|1
176332|NCT00123734|554601|P1|Overall Study|Lost to Follow-up|3
176333|NCT00123734|554601|P1|Overall Study|Death|3
176334|NCT00123487|554686|P2|Treated With Study Drug|Unknown (case report form lost)|1
176335|NCT00123487|554687|P1|Treated With Study Drug|Unknown (case report form lost)|0
176336|NCT00123487|554686|P2|Treated With Study Drug|Withdrawal by Subject|13
176337|NCT00123487|554687|P1|Treated With Study Drug|Withdrawal by Subject|11
176338|NCT00123487|554686|P2|Treated With Study Drug|Study Drug Toxicity|80
176339|NCT00123487|554687|P1|Treated With Study Drug|Study Drug Toxicity|62
176340|NCT00123487|554686|P2|Treated With Study Drug|Not Specified|58
176341|NCT00123487|554687|P1|Treated With Study Drug|Not Specified|59
176342|NCT00123487|554686|P2|Treated With Study Drug|Physician Decision|9
176343|NCT00123487|554687|P1|Treated With Study Drug|Physician Decision|8
176344|NCT00123487|554686|P2|Treated With Study Drug|Disease Progression|122
176345|NCT00123487|554687|P1|Treated With Study Drug|Disease Progression|141
176346|NCT00123487|554686|P2|Treated With Study Drug|Adverse Event|22
176347|NCT00123487|554687|P1|Treated With Study Drug|Adverse Event|23
176348|NCT00123487|554686|P2|Randomized|SAE prior to starting treatment|0
176349|NCT00123487|554687|P1|Randomized|SAE prior to starting treatment|1
176350|NCT00123487|554686|P2|Randomized|Death prior to starting treatment|1
176351|NCT00123487|554687|P1|Randomized|Death prior to starting treatment|0
176352|NCT00123474|554731|P4|As Treated at Study Closure|Withdrawal by Subject|16
176353|NCT00123474|554732|P3|As Treated at Study Closure|Withdrawal by Subject|18
176354|NCT00123474|554733|P2|As Treated at Study Closure|Withdrawal by Subject|19
176355|NCT00123474|554734|P1|As Treated at Study Closure|Withdrawal by Subject|14
176356|NCT00123474|554731|P4|As Treated at Study Closure|Study Drug Toxicity|51
176357|NCT00123474|554732|P3|As Treated at Study Closure|Study Drug Toxicity|45
176358|NCT00123474|554733|P2|As Treated at Study Closure|Study Drug Toxicity|45
176359|NCT00123474|554734|P1|As Treated at Study Closure|Study Drug Toxicity|39
176360|NCT00123474|554731|P4|As Treated at Study Closure|non-specified|60
176361|NCT00123474|554732|P3|As Treated at Study Closure|non-specified|57
176362|NCT00123474|554733|P2|As Treated at Study Closure|non-specified|47
176363|NCT00123474|554734|P1|As Treated at Study Closure|non-specified|54
176364|NCT00123474|554731|P4|As Treated at Study Closure|Investigator Request|5
176365|NCT00123474|554732|P3|As Treated at Study Closure|Investigator Request|7
176366|NCT00123474|554733|P2|As Treated at Study Closure|Investigator Request|6
176367|NCT00123474|554734|P1|As Treated at Study Closure|Investigator Request|12
176368|NCT00123474|554731|P4|As Treated at Study Closure|Disease Progression|27
176369|NCT00123474|554732|P3|As Treated at Study Closure|Disease Progression|29
176370|NCT00123474|554733|P2|As Treated at Study Closure|Disease Progression|42
176371|NCT00123474|554734|P1|As Treated at Study Closure|Disease Progression|35
176372|NCT00123474|554731|P4|As Treated at Study Closure|Adverse Event|8
176373|NCT00123474|554732|P3|As Treated at Study Closure|Adverse Event|10
176374|NCT00123474|554733|P2|As Treated at Study Closure|Adverse Event|4
176375|NCT00123474|554734|P1|As Treated at Study Closure|Adverse Event|10
176376|NCT00123474|554731|P4|As Treated at Study Closure|not reported when site closed|0
176377|NCT00123474|554732|P3|As Treated at Study Closure|not reported when site closed|1
176378|NCT00123474|554733|P2|As Treated at Study Closure|not reported when site closed|0
176379|NCT00123474|554734|P1|As Treated at Study Closure|not reported when site closed|1
176380|NCT00123474|554731|P4|Randomized to Treatment|Randomized, never treated|1
176381|NCT00123474|554732|P3|Randomized to Treatment|Randomized, never treated|2
176382|NCT00123474|554733|P2|Randomized to Treatment|Randomized, never treated|4
176383|NCT00123474|554734|P1|Randomized to Treatment|Randomized, never treated|1
176384|NCT00123422|554828|P3|Overall Study|Lost to Follow-up|2
176385|NCT00123422|554829|P2|Overall Study|Lost to Follow-up|2
176386|NCT00123422|554830|P1|Overall Study|Lost to Follow-up|1
176387|NCT00123422|554828|P3|Overall Study|Withdrawal by Subject|2
176388|NCT00123422|554829|P2|Overall Study|Withdrawal by Subject|2
176389|NCT00123422|554830|P1|Overall Study|Withdrawal by Subject|1
176390|NCT00123422|554828|P3|Overall Study|Physician Decision|6
176391|NCT00123422|554829|P2|Overall Study|Physician Decision|2
176392|NCT00123422|554830|P1|Overall Study|Physician Decision|2
176393|NCT00122980|554881|P2|Overall Study|Study termination|35
176394|NCT00122980|554882|P1|Overall Study|Study termination|27
176395|NCT00122980|554881|P2|Overall Study|Adjudicated stroke (study endpoint)|0
176396|NCT00122980|554882|P1|Overall Study|Adjudicated stroke (study endpoint)|7
176397|NCT00122980|554881|P2|Overall Study|Withdrawal by Subject|3
176398|NCT00122980|554882|P1|Overall Study|Withdrawal by Subject|2
176399|NCT00122980|554881|P2|Overall Study|Protocol Violation|1
176400|NCT00122980|554882|P1|Overall Study|Protocol Violation|5
176401|NCT00122980|554881|P2|Overall Study|Physician Decision|0
176402|NCT00122980|554882|P1|Overall Study|Physician Decision|2
176403|NCT00122980|554881|P2|Overall Study|Death|1
176404|NCT00122980|554882|P1|Overall Study|Death|0
176405|NCT00122954|554904|P2|Overall Study|Protocol Violation|1
176406|NCT00122954|554905|P1|Overall Study|Protocol Violation|0
176407|NCT00122954|554904|P2|Overall Study|Withdrawal by Subject|2
176408|NCT00122954|554905|P1|Overall Study|Withdrawal by Subject|2
176409|NCT00122681|554913|P2|Overall Study|Personal reasons|147
176410|NCT00122681|554914|P1|Overall Study|Personal reasons|150
176411|NCT00122681|554913|P2|Overall Study|Withdrawal by Subject|251
176412|NCT00122681|554914|P1|Overall Study|Withdrawal by Subject|257
176413|NCT00122681|554913|P2|Overall Study|Protocol Violation|10
176414|NCT00122681|554914|P1|Overall Study|Protocol Violation|7
176415|NCT00122681|554913|P2|Overall Study|Lost to Follow-up|1097
176416|NCT00122681|554914|P1|Overall Study|Lost to Follow-up|1080
176417|NCT00122681|554913|P2|Overall Study|Adverse Event|16
176418|NCT00122681|554914|P1|Overall Study|Adverse Event|20
176419|NCT00122460|554980|P2|Overall Study|investigational study phase ongoing|1
176420|NCT00122460|554981|P1|Overall Study|investigational study phase ongoing|7
176421|NCT00122382|555030|P3|Open-Label Study|Withdrawal of Consent|4
176422|NCT00122382|555031|P2|Open-Label Study|Withdrawal of Consent|0
176423|NCT00122382|555032|P1|Open-Label Study|Withdrawal of Consent|0
176424|NCT00122382|555030|P3|Open-Label Study|Poor/Non-Compliance|1
176425|NCT00122382|555031|P2|Open-Label Study|Poor/Non-Compliance|0
176426|NCT00122382|555032|P1|Open-Label Study|Poor/Non-Compliance|0
176427|NCT00122382|555030|P3|Open-Label Study|Pregnancy|2
176428|NCT00122382|555031|P2|Open-Label Study|Pregnancy|0
176429|NCT00122382|555032|P1|Open-Label Study|Pregnancy|0
176430|NCT00122382|555030|P3|Open-Label Study|Lost to Follow-up|3
176431|NCT00122382|555031|P2|Open-Label Study|Lost to Follow-up|0
176432|NCT00122382|555032|P1|Open-Label Study|Lost to Follow-up|0
176433|NCT00122382|555030|P3|Open-Label Study|Lack of Efficacy|3
176434|NCT00122382|555031|P2|Open-Label Study|Lack of Efficacy|0
176435|NCT00122382|555032|P1|Open-Label Study|Lack of Efficacy|0
176436|NCT00122382|555030|P3|Open-Label Study|Death|2
176437|NCT00122382|555031|P2|Open-Label Study|Death|0
176438|NCT00122382|555032|P1|Open-Label Study|Death|0
176439|NCT00122382|555030|P3|Open-Label Study|Adverse Event|11
176440|NCT00122382|555031|P2|Open-Label Study|Adverse Event|0
176441|NCT00122382|555032|P1|Open-Label Study|Adverse Event|0
176442|NCT00122382|555030|P3|Double-Blind Study|Randomized but not treated|0
176443|NCT00122382|555031|P2|Double-Blind Study|Randomized but not treated|2
176444|NCT00122382|555032|P1|Double-Blind Study|Randomized but not treated|0
176445|NCT00122382|555030|P3|Double-Blind Study|Methotrexate Discontinued|0
176446|NCT00122382|555031|P2|Double-Blind Study|Methotrexate Discontinued|1
176447|NCT00122382|555032|P1|Double-Blind Study|Methotrexate Discontinued|0
176448|NCT00122382|555030|P3|Double-Blind Study|Protocol Violation|0
176449|NCT00122382|555031|P2|Double-Blind Study|Protocol Violation|0
176450|NCT00122382|555032|P1|Double-Blind Study|Protocol Violation|1
176451|NCT00122382|555030|P3|Double-Blind Study|Withdrawal of Consent|0
176452|NCT00122382|555031|P2|Double-Blind Study|Withdrawal of Consent|3
176453|NCT00122382|555032|P1|Double-Blind Study|Withdrawal of Consent|7
176454|NCT00122382|555030|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
176455|NCT00122382|555031|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
176456|NCT00122382|555032|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
176457|NCT00122382|555030|P3|Double-Blind Study|Pregnancy|0
176458|NCT00122382|555031|P2|Double-Blind Study|Pregnancy|0
176459|NCT00122382|555032|P1|Double-Blind Study|Pregnancy|2
176460|NCT00122382|555030|P3|Double-Blind Study|Lost to Follow-up|0
176461|NCT00122382|555031|P2|Double-Blind Study|Lost to Follow-up|1
176462|NCT00122382|555032|P1|Double-Blind Study|Lost to Follow-up|2
176463|NCT00122382|555030|P3|Double-Blind Study|Lack of Efficacy|0
176464|NCT00122382|555031|P2|Double-Blind Study|Lack of Efficacy|8
176465|NCT00122382|555032|P1|Double-Blind Study|Lack of Efficacy|0
176466|NCT00122382|555030|P3|Double-Blind Study|Death|0
176467|NCT00122382|555031|P2|Double-Blind Study|Death|2
176468|NCT00122382|555032|P1|Double-Blind Study|Death|2
176469|NCT00122382|555030|P3|Double-Blind Study|Adverse Event|0
176470|NCT00122382|555031|P2|Double-Blind Study|Adverse Event|11
176471|NCT00122382|555032|P1|Double-Blind Study|Adverse Event|9
176472|NCT00122187|555178|P2|Overall Study|Withdrew because of resource limitations|2
176473|NCT00122187|555179|P1|Overall Study|Withdrew because of resource limitations|2
176474|NCT00122135|555193|P2|Overall Study|Withdrawal by Subject|0
176475|NCT00122135|555194|P1|Overall Study|Withdrawal by Subject|3
176476|NCT00122109|555202|P2|Overall Study|Did not meet criteria|7
176477|NCT00122109|555203|P1|Overall Study|Did not meet criteria|6
176478|NCT00121719|555267|P14|Overall Study|Continuing/ongoing patients|0
176479|NCT00121719|555268|P13|Overall Study|Continuing/ongoing patients|3
176480|NCT00121719|555269|P12|Overall Study|Continuing/ongoing patients|1
176481|NCT00121719|555270|P11|Overall Study|Continuing/ongoing patients|1
176482|NCT00121719|555271|P10|Overall Study|Continuing/ongoing patients|0
176483|NCT00121719|555272|P9|Overall Study|Continuing/ongoing patients|0
176484|NCT00121719|555273|P8|Overall Study|Continuing/ongoing patients|1
176485|NCT00121719|555274|P7|Overall Study|Continuing/ongoing patients|0
176486|NCT00121719|555275|P6|Overall Study|Continuing/ongoing patients|0
176487|NCT00121719|555276|P5|Overall Study|Continuing/ongoing patients|0
176488|NCT00121719|555277|P4|Overall Study|Continuing/ongoing patients|0
176489|NCT00121719|555278|P3|Overall Study|Continuing/ongoing patients|0
176490|NCT00121719|555279|P2|Overall Study|Continuing/ongoing patients|0
176491|NCT00121719|555280|P1|Overall Study|Continuing/ongoing patients|0
176492|NCT00121719|555267|P14|Overall Study|Not specified|1
176493|NCT00121719|555268|P13|Overall Study|Not specified|1
176494|NCT00121719|555269|P12|Overall Study|Not specified|0
176495|NCT00121719|555270|P11|Overall Study|Not specified|0
176496|NCT00121719|555271|P10|Overall Study|Not specified|0
176497|NCT00121719|555272|P9|Overall Study|Not specified|1
176498|NCT00121719|555273|P8|Overall Study|Not specified|0
176499|NCT00121719|555274|P7|Overall Study|Not specified|1
176500|NCT00121719|555275|P6|Overall Study|Not specified|0
176501|NCT00121719|555276|P5|Overall Study|Not specified|0
176502|NCT00121719|555277|P4|Overall Study|Not specified|1
176503|NCT00121719|555278|P3|Overall Study|Not specified|1
176504|NCT00121719|555279|P2|Overall Study|Not specified|0
176505|NCT00121719|555280|P1|Overall Study|Not specified|0
176506|NCT00121719|555267|P14|Overall Study|Physician Decision|0
176507|NCT00121719|555268|P13|Overall Study|Physician Decision|1
176508|NCT00121719|555269|P12|Overall Study|Physician Decision|0
176509|NCT00121719|555270|P11|Overall Study|Physician Decision|0
176510|NCT00121719|555271|P10|Overall Study|Physician Decision|0
176511|NCT00121719|555272|P9|Overall Study|Physician Decision|0
176512|NCT00121719|555273|P8|Overall Study|Physician Decision|0
176513|NCT00121719|555274|P7|Overall Study|Physician Decision|0
176514|NCT00121719|555275|P6|Overall Study|Physician Decision|0
176515|NCT00121719|555276|P5|Overall Study|Physician Decision|0
176516|NCT00121719|555277|P4|Overall Study|Physician Decision|0
176517|NCT00121719|555278|P3|Overall Study|Physician Decision|0
176518|NCT00121719|555279|P2|Overall Study|Physician Decision|1
176519|NCT00121719|555280|P1|Overall Study|Physician Decision|0
176520|NCT00121719|555267|P14|Overall Study|Clinical deterioration|2
176521|NCT00121719|555268|P13|Overall Study|Clinical deterioration|2
176522|NCT00121719|555269|P12|Overall Study|Clinical deterioration|1
176523|NCT00121719|555270|P11|Overall Study|Clinical deterioration|0
176524|NCT00121719|555271|P10|Overall Study|Clinical deterioration|2
176525|NCT00121719|555272|P9|Overall Study|Clinical deterioration|2
176526|NCT00121719|555273|P8|Overall Study|Clinical deterioration|1
176527|NCT00121719|555274|P7|Overall Study|Clinical deterioration|2
176528|NCT00121719|555275|P6|Overall Study|Clinical deterioration|0
176529|NCT00121719|555276|P5|Overall Study|Clinical deterioration|1
176530|NCT00121719|555277|P4|Overall Study|Clinical deterioration|0
176531|NCT00121719|555278|P3|Overall Study|Clinical deterioration|1
176532|NCT00121719|555279|P2|Overall Study|Clinical deterioration|1
176533|NCT00121719|555280|P1|Overall Study|Clinical deterioration|0
176534|NCT00121719|555267|P14|Overall Study|Progressive disease|4
176535|NCT00121719|555268|P13|Overall Study|Progressive disease|13
176536|NCT00121719|555269|P12|Overall Study|Progressive disease|3
176537|NCT00121719|555270|P11|Overall Study|Progressive disease|4
176538|NCT00121719|555271|P10|Overall Study|Progressive disease|1
176539|NCT00121719|555272|P9|Overall Study|Progressive disease|3
176540|NCT00121719|555273|P8|Overall Study|Progressive disease|5
176541|NCT00121719|555274|P7|Overall Study|Progressive disease|7
176542|NCT00121719|555275|P6|Overall Study|Progressive disease|1
176543|NCT00121719|555276|P5|Overall Study|Progressive disease|2
176544|NCT00121719|555277|P4|Overall Study|Progressive disease|2
176545|NCT00121719|555278|P3|Overall Study|Progressive disease|0
176546|NCT00121719|555279|P2|Overall Study|Progressive disease|1
176547|NCT00121719|555280|P1|Overall Study|Progressive disease|2
176548|NCT00121719|555267|P14|Overall Study|Withdrawal by Subject|0
176549|NCT00121719|555268|P13|Overall Study|Withdrawal by Subject|0
176550|NCT00121719|555269|P12|Overall Study|Withdrawal by Subject|0
176551|NCT00121719|555270|P11|Overall Study|Withdrawal by Subject|0
176552|NCT00121719|555271|P10|Overall Study|Withdrawal by Subject|0
176553|NCT00121719|555272|P9|Overall Study|Withdrawal by Subject|0
176554|NCT00121719|555273|P8|Overall Study|Withdrawal by Subject|0
176555|NCT00121719|555274|P7|Overall Study|Withdrawal by Subject|0
176556|NCT00121719|555275|P6|Overall Study|Withdrawal by Subject|0
176557|NCT00121719|555276|P5|Overall Study|Withdrawal by Subject|0
176558|NCT00121719|555277|P4|Overall Study|Withdrawal by Subject|0
176559|NCT00121719|555278|P3|Overall Study|Withdrawal by Subject|0
176560|NCT00121719|555279|P2|Overall Study|Withdrawal by Subject|0
176561|NCT00121719|555280|P1|Overall Study|Withdrawal by Subject|1
176562|NCT00121719|555267|P14|Overall Study|Protocol deviation|0
176563|NCT00121719|555268|P13|Overall Study|Protocol deviation|0
176564|NCT00121719|555269|P12|Overall Study|Protocol deviation|0
176565|NCT00121719|555270|P11|Overall Study|Protocol deviation|0
176566|NCT00121719|555271|P10|Overall Study|Protocol deviation|0
176567|NCT00121719|555272|P9|Overall Study|Protocol deviation|0
176568|NCT00121719|555273|P8|Overall Study|Protocol deviation|0
176569|NCT00121719|555274|P7|Overall Study|Protocol deviation|0
176570|NCT00121719|555275|P6|Overall Study|Protocol deviation|0
176571|NCT00121719|555276|P5|Overall Study|Protocol deviation|0
176572|NCT00121719|555277|P4|Overall Study|Protocol deviation|0
176573|NCT00121719|555278|P3|Overall Study|Protocol deviation|1
176574|NCT00121719|555279|P2|Overall Study|Protocol deviation|0
176575|NCT00121719|555280|P1|Overall Study|Protocol deviation|0
176576|NCT00121719|555267|P14|Overall Study|Abnormal laboratory value|0
176577|NCT00121719|555268|P13|Overall Study|Abnormal laboratory value|1
176578|NCT00121719|555269|P12|Overall Study|Abnormal laboratory value|0
176579|NCT00121719|555270|P11|Overall Study|Abnormal laboratory value|0
176580|NCT00121719|555271|P10|Overall Study|Abnormal laboratory value|0
176581|NCT00121719|555272|P9|Overall Study|Abnormal laboratory value|0
176582|NCT00121719|555273|P8|Overall Study|Abnormal laboratory value|1
176583|NCT00121719|555274|P7|Overall Study|Abnormal laboratory value|0
176584|NCT00121719|555275|P6|Overall Study|Abnormal laboratory value|0
176585|NCT00121719|555276|P5|Overall Study|Abnormal laboratory value|0
176586|NCT00121719|555277|P4|Overall Study|Abnormal laboratory value|0
176587|NCT00121719|555278|P3|Overall Study|Abnormal laboratory value|0
176588|NCT00121719|555279|P2|Overall Study|Abnormal laboratory value|1
176589|NCT00121719|555280|P1|Overall Study|Abnormal laboratory value|1
176590|NCT00121719|555267|P14|Overall Study|Adverse Event|0
176591|NCT00121719|555268|P13|Overall Study|Adverse Event|3
176592|NCT00121719|555269|P12|Overall Study|Adverse Event|0
176593|NCT00121719|555270|P11|Overall Study|Adverse Event|1
176594|NCT00121719|555271|P10|Overall Study|Adverse Event|0
176595|NCT00121719|555272|P9|Overall Study|Adverse Event|0
176596|NCT00121719|555273|P8|Overall Study|Adverse Event|1
176597|NCT00121719|555274|P7|Overall Study|Adverse Event|2
176598|NCT00121719|555275|P6|Overall Study|Adverse Event|2
176599|NCT00121719|555276|P5|Overall Study|Adverse Event|0
176600|NCT00121719|555277|P4|Overall Study|Adverse Event|0
176601|NCT00121719|555278|P3|Overall Study|Adverse Event|1
176602|NCT00121719|555279|P2|Overall Study|Adverse Event|0
176603|NCT00121719|555280|P1|Overall Study|Adverse Event|0
176604|NCT00121667|555457|P4|Short Term (ST) + Long Term (LT) Period|Death|2
176605|NCT00121667|555458|P3|Short Term (ST) + Long Term (LT) Period|Death|0
176606|NCT00121667|555459|P2|Short Term (ST) + Long Term (LT) Period|Death|0
176607|NCT00121667|555460|P1|Short Term (ST) + Long Term (LT) Period|Death|1
176608|NCT00121667|555457|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
176609|NCT00121667|555458|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
176610|NCT00121667|555459|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
176611|NCT00121667|555460|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
176612|NCT00121667|555457|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
176613|NCT00121667|555458|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
176614|NCT00121667|555459|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
176615|NCT00121667|555460|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
176616|NCT00121667|555457|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
176617|NCT00121667|555458|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
176618|NCT00121667|555459|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
176619|NCT00121667|555460|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
176620|NCT00121667|555457|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
176621|NCT00121667|555458|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
176622|NCT00121667|555459|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
176623|NCT00121667|555460|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
176624|NCT00121667|555457|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
176625|NCT00121667|555458|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
176626|NCT00121667|555459|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
176627|NCT00121667|555460|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
176628|NCT00121667|555457|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
176629|NCT00121667|555458|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
176630|NCT00121667|555459|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
176631|NCT00121667|555460|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
176632|NCT00121667|555457|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
176633|NCT00121667|555458|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
176634|NCT00121667|555459|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
176635|NCT00121667|555460|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
176636|NCT00121667|555457|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
176637|NCT00121667|555458|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
176638|NCT00121667|555459|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
176639|NCT00121667|555460|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
176640|NCT00121667|555457|P4|Short Term (ST) Period|Pregnancy|1
176641|NCT00121667|555458|P3|Short Term (ST) Period|Pregnancy|0
176642|NCT00121667|555459|P2|Short Term (ST) Period|Pregnancy|0
176643|NCT00121667|555460|P1|Short Term (ST) Period|Pregnancy|0
176644|NCT00121667|555457|P4|Short Term (ST) Period|Death|1
176645|NCT00121667|555458|P3|Short Term (ST) Period|Death|0
176646|NCT00121667|555459|P2|Short Term (ST) Period|Death|0
176647|NCT00121667|555460|P1|Short Term (ST) Period|Death|0
176648|NCT00121667|555457|P4|Short Term (ST) Period|Other Reason|0
176649|NCT00121667|555458|P3|Short Term (ST) Period|Other Reason|0
176650|NCT00121667|555459|P2|Short Term (ST) Period|Other Reason|0
176651|NCT00121667|555460|P1|Short Term (ST) Period|Other Reason|3
176652|NCT00121667|555457|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
176653|NCT00121667|555458|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
176654|NCT00121667|555459|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
176655|NCT00121667|555460|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
176656|NCT00121667|555457|P4|Short Term (ST) Period|Poor / Non-compliance|2
176657|NCT00121667|555458|P3|Short Term (ST) Period|Poor / Non-compliance|1
176658|NCT00121667|555459|P2|Short Term (ST) Period|Poor / Non-compliance|1
176659|NCT00121667|555460|P1|Short Term (ST) Period|Poor / Non-compliance|0
176660|NCT00121667|555457|P4|Short Term (ST) Period|Lost to Follow-up|3
176661|NCT00121667|555458|P3|Short Term (ST) Period|Lost to Follow-up|4
176662|NCT00121667|555459|P2|Short Term (ST) Period|Lost to Follow-up|4
176663|NCT00121667|555460|P1|Short Term (ST) Period|Lost to Follow-up|3
176664|NCT00121667|555457|P4|Short Term (ST) Period|Adverse Event|3
176665|NCT00121667|555458|P3|Short Term (ST) Period|Adverse Event|5
176666|NCT00121667|555459|P2|Short Term (ST) Period|Adverse Event|6
176667|NCT00121667|555460|P1|Short Term (ST) Period|Adverse Event|5
176668|NCT00121667|555457|P4|Short Term (ST) Period|Subject Withdrew Consent|11
176669|NCT00121667|555458|P3|Short Term (ST) Period|Subject Withdrew Consent|4
176670|NCT00121667|555459|P2|Short Term (ST) Period|Subject Withdrew Consent|13
176671|NCT00121667|555460|P1|Short Term (ST) Period|Subject Withdrew Consent|8
176672|NCT00121667|555457|P4|Short Term (ST) Period|Lack of Efficacy|44
176673|NCT00121667|555458|P3|Short Term (ST) Period|Lack of Efficacy|27
176674|NCT00121667|555459|P2|Short Term (ST) Period|Lack of Efficacy|22
176675|NCT00121667|555460|P1|Short Term (ST) Period|Lack of Efficacy|25
176676|NCT00121641|555558|P5|48-month Short Term + Long Term Period|Other Reason|1
176677|NCT00121641|555559|P4|48-month Short Term + Long Term Period|Other Reason|0
176678|NCT00121641|555560|P3|48-month Short Term + Long Term Period|Other Reason|2
176679|NCT00121641|555561|P2|48-month Short Term + Long Term Period|Other Reason|3
176680|NCT00121641|555562|P1|48-month Short Term + Long Term Period|Other Reason|5
176681|NCT00121641|555558|P5|48-month Short Term + Long Term Period|Missing|0
176682|NCT00121641|555559|P4|48-month Short Term + Long Term Period|Missing|0
176683|NCT00121641|555560|P3|48-month Short Term + Long Term Period|Missing|1
176684|NCT00121641|555561|P2|48-month Short Term + Long Term Period|Missing|0
176685|NCT00121641|555562|P1|48-month Short Term + Long Term Period|Missing|0
176686|NCT00121641|555558|P5|48-month Short Term + Long Term Period|Death|0
176687|NCT00121641|555559|P4|48-month Short Term + Long Term Period|Death|1
176688|NCT00121641|555560|P3|48-month Short Term + Long Term Period|Death|0
176689|NCT00121641|555561|P2|48-month Short Term + Long Term Period|Death|0
176690|NCT00121641|555562|P1|48-month Short Term + Long Term Period|Death|0
176691|NCT00121641|555558|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
176692|NCT00121641|555559|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
176693|NCT00121641|555560|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
176694|NCT00121641|555561|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
176695|NCT00121641|555562|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
176696|NCT00121641|555558|P5|48-month Short Term + Long Term Period|Pregnancy|0
176697|NCT00121641|555559|P4|48-month Short Term + Long Term Period|Pregnancy|1
176698|NCT00121641|555560|P3|48-month Short Term + Long Term Period|Pregnancy|0
176699|NCT00121641|555561|P2|48-month Short Term + Long Term Period|Pregnancy|1
176700|NCT00121641|555562|P1|48-month Short Term + Long Term Period|Pregnancy|0
176701|NCT00121641|555558|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
176702|NCT00121641|555559|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
176703|NCT00121641|555560|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
176704|NCT00121641|555561|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
176705|NCT00121641|555562|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
176706|NCT00121641|555558|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
176707|NCT00121641|555559|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
176708|NCT00121641|555560|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
176709|NCT00121641|555561|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
176710|NCT00121641|555562|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
176711|NCT00121641|555558|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
176712|NCT00121641|555559|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
176713|NCT00121641|555560|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
176714|NCT00121641|555561|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
176715|NCT00121641|555562|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
176716|NCT00121641|555558|P5|48-month Short Term + Long Term Period|Adverse Event|5
176717|NCT00121641|555559|P4|48-month Short Term + Long Term Period|Adverse Event|5
176718|NCT00121641|555560|P3|48-month Short Term + Long Term Period|Adverse Event|10
176719|NCT00121641|555561|P2|48-month Short Term + Long Term Period|Adverse Event|10
176720|NCT00121641|555562|P1|48-month Short Term + Long Term Period|Adverse Event|9
176721|NCT00121641|555558|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
176722|NCT00121641|555559|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
176723|NCT00121641|555560|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
176724|NCT00121641|555561|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
176725|NCT00121641|555562|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
176726|NCT00121641|555558|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
176727|NCT00121641|555559|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
176728|NCT00121641|555560|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
176729|NCT00121641|555561|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
176730|NCT00121641|555562|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
176731|NCT00121641|555558|P5|24-week Short-term Treatment Period|Other Reason|0
176732|NCT00121641|555559|P4|24-week Short-term Treatment Period|Other Reason|0
176733|NCT00121641|555560|P3|24-week Short-term Treatment Period|Other Reason|0
176734|NCT00121641|555561|P2|24-week Short-term Treatment Period|Other Reason|0
176735|NCT00121641|555562|P1|24-week Short-term Treatment Period|Other Reason|1
176736|NCT00121641|555558|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
176737|NCT00121641|555559|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
176738|NCT00121641|555560|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
176739|NCT00121641|555561|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
176740|NCT00121641|555562|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
176741|NCT00121641|555558|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
176742|NCT00121641|555559|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
176743|NCT00121641|555560|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
176744|NCT00121641|555561|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
176745|NCT00121641|555562|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
176746|NCT00121641|555558|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
176747|NCT00121641|555559|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
176748|NCT00121641|555560|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
176749|NCT00121641|555561|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
176750|NCT00121641|555562|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
176751|NCT00121641|555558|P5|24-week Short-term Treatment Period|Adverse Event|2
176752|NCT00121641|555559|P4|24-week Short-term Treatment Period|Adverse Event|0
176753|NCT00121641|555560|P3|24-week Short-term Treatment Period|Adverse Event|4
176754|NCT00121641|555561|P2|24-week Short-term Treatment Period|Adverse Event|3
176755|NCT00121641|555562|P1|24-week Short-term Treatment Period|Adverse Event|3
176756|NCT00121641|555558|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
176757|NCT00121641|555559|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
176758|NCT00121641|555560|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
176759|NCT00121641|555561|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
176760|NCT00121641|555562|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
176761|NCT00121641|555558|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
176762|NCT00121641|555559|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
176763|NCT00121641|555560|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
176764|NCT00121641|555561|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
176765|NCT00121641|555562|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
176766|NCT00121485|555675|P2|Overall Study|Crossover|2
176767|NCT00121485|555676|P1|Overall Study|Crossover|0
176768|NCT00121485|555675|P2|Overall Study|Not implanted|5
176769|NCT00121485|555676|P1|Overall Study|Not implanted|1
176770|NCT00121238|555721|P1|Overall Study|Protocol Violation|2
176771|NCT00121238|555721|P1|Overall Study|disease progression before intervention|1
176772|NCT00121199|555733|P1|Overall Study|Ineligible|9
176773|NCT00121199|555733|P1|Overall Study|Other - Not Protocol Specified|3
176774|NCT00121199|555733|P1|Overall Study|Death|3
176775|NCT00121199|555733|P1|Overall Study|Progression/Relapse|1
176776|NCT00121199|555733|P1|Overall Study|Refusal Unrelated to Adverse Event|1
176777|NCT00121199|555733|P1|Overall Study|Adverse Event|11
176778|NCT00121134|555749|P4|Overall Study|Patient Personal Reasons|0
176779|NCT00121134|555750|P3|Overall Study|Patient Personal Reasons|0
176780|NCT00121134|555751|P2|Overall Study|Patient Personal Reasons|1
176781|NCT00121134|555752|P1|Overall Study|Patient Personal Reasons|0
176782|NCT00121134|555749|P4|Overall Study|Intercurrent Illness|1
176783|NCT00121134|555750|P3|Overall Study|Intercurrent Illness|0
176784|NCT00121134|555751|P2|Overall Study|Intercurrent Illness|0
176785|NCT00121134|555752|P1|Overall Study|Intercurrent Illness|0
176786|NCT00121134|555749|P4|Overall Study|Treatment Delay|0
176787|NCT00121134|555750|P3|Overall Study|Treatment Delay|0
176788|NCT00121134|555751|P2|Overall Study|Treatment Delay|0
176789|NCT00121134|555752|P1|Overall Study|Treatment Delay|1
176790|NCT00121134|555749|P4|Overall Study|Physician Decision|1
176791|NCT00121134|555750|P3|Overall Study|Physician Decision|4
176792|NCT00121134|555751|P2|Overall Study|Physician Decision|4
176793|NCT00121134|555752|P1|Overall Study|Physician Decision|6
176794|NCT00121134|555749|P4|Overall Study|Toxicity|5
176795|NCT00121134|555750|P3|Overall Study|Toxicity|13
176796|NCT00121134|555751|P2|Overall Study|Toxicity|7
176797|NCT00121134|555752|P1|Overall Study|Toxicity|4
176798|NCT00121134|555749|P4|Overall Study|Progression of Disease|2
176799|NCT00121134|555750|P3|Overall Study|Progression of Disease|4
176800|NCT00121134|555751|P2|Overall Study|Progression of Disease|3
176801|NCT00121134|555752|P1|Overall Study|Progression of Disease|5
176802|NCT00120874|555764|P2|Overall Study|Death|1
176803|NCT00120874|555765|P1|Overall Study|Death|0
176804|NCT00120627|555803|P2|Overall Study|Withdrawal by Subject|5
176805|NCT00120627|555804|P1|Overall Study|Withdrawal by Subject|5
176806|NCT00120406|555855|P2|Overall Study|patient moved but has not withdrawn|1
176807|NCT00120406|555856|P1|Overall Study|patient moved but has not withdrawn|0
176808|NCT00120406|555855|P2|Overall Study|received non-study stent|2
176809|NCT00120406|555856|P1|Overall Study|received non-study stent|0
176810|NCT00120406|555855|P2|Overall Study|Lost to Follow-up|2
176811|NCT00120406|555856|P1|Overall Study|Lost to Follow-up|5
176812|NCT00120406|555855|P2|Overall Study|Withdrawal by Subject|7
176813|NCT00120406|555856|P1|Overall Study|Withdrawal by Subject|5
176814|NCT00120406|555855|P2|Overall Study|Death|4
176815|NCT00120406|555856|P1|Overall Study|Death|9
176816|NCT00120289|555866|P2|Overall Study|Withdrawal by Subject|13
176817|NCT00120289|555867|P1|Overall Study|Withdrawal by Subject|14
176818|NCT00120289|555866|P2|Overall Study|Lost to Follow-up|14
176819|NCT00120289|555867|P1|Overall Study|Lost to Follow-up|11
176820|NCT00120289|555866|P2|Overall Study|Death|82
176821|NCT00120289|555867|P1|Overall Study|Death|96
176822|NCT00120250|555879|P2|Overall Study|Protocol Violation|1
176823|NCT00120250|555880|P1|Overall Study|Protocol Violation|0
176824|NCT00120250|555879|P2|Overall Study|Lost to Follow-up|1
176825|NCT00120250|555880|P1|Overall Study|Lost to Follow-up|1
176826|NCT00120042|555896|P3|Overall Study|all completed protocl|0
176827|NCT00120042|555897|P2|Overall Study|all completed protocl|0
176828|NCT00120042|555898|P1|Overall Study|all completed protocl|0
176829|NCT00119678|555908|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
176830|NCT00119678|555909|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
176831|NCT00119678|555908|P2|Open-label Treatment Period|Pregnancy|0
176832|NCT00119678|555909|P1|Open-label Treatment Period|Pregnancy|1
176833|NCT00119678|555908|P2|Open-label Treatment Period|Participants not meeting study criteria|0
176834|NCT00119678|555909|P1|Open-label Treatment Period|Participants not meeting study criteria|2
176835|NCT00119678|555908|P2|Open-label Treatment Period|Participant withdrew consent|0
176836|NCT00119678|555909|P1|Open-label Treatment Period|Participant withdrew consent|4
176837|NCT00119678|555908|P2|Open-label Treatment Period|Lost to Follow-up|0
176838|NCT00119678|555909|P1|Open-label Treatment Period|Lost to Follow-up|3
176839|NCT00119678|555908|P2|Open-label Treatment Period|Lack of Efficacy|0
176840|NCT00119678|555909|P1|Open-label Treatment Period|Lack of Efficacy|9
176841|NCT00119678|555908|P2|Open-label Treatment Period|Adverse Event|0
176842|NCT00119678|555909|P1|Open-label Treatment Period|Adverse Event|3
176843|NCT00119678|555908|P2|Open-label Treatment Period|Death|0
176844|NCT00119678|555909|P1|Open-label Treatment Period|Death|1
176845|NCT00119678|555908|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
176846|NCT00119678|555909|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
176847|NCT00119678|555908|P2|Double-blind Treatment Period|Not treated|2
176848|NCT00119678|555909|P1|Double-blind Treatment Period|Not treated|1
176849|NCT00119678|555908|P2|Double-blind Treatment Period|Pregnancy|2
176850|NCT00119678|555909|P1|Double-blind Treatment Period|Pregnancy|0
176851|NCT00119678|555908|P2|Double-blind Treatment Period|Poor/Non-compliance|0
176852|NCT00119678|555909|P1|Double-blind Treatment Period|Poor/Non-compliance|3
176853|NCT00119678|555908|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
176854|NCT00119678|555909|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
176855|NCT00119678|555908|P2|Double-blind Treatment Period|Participant withdrew consent|4
176856|NCT00119678|555909|P1|Double-blind Treatment Period|Participant withdrew consent|4
176857|NCT00119678|555908|P2|Double-blind Treatment Period|Lost to Follow-up|2
176858|NCT00119678|555909|P1|Double-blind Treatment Period|Lost to Follow-up|1
176859|NCT00119678|555908|P2|Double-blind Treatment Period|Lack of Efficacy|12
176860|NCT00119678|555909|P1|Double-blind Treatment Period|Lack of Efficacy|21
176861|NCT00119678|555908|P2|Double-blind Treatment Period|Adverse Event|1
176862|NCT00119678|555909|P1|Double-blind Treatment Period|Adverse Event|7
176863|NCT00119678|555908|P2|Double-blind Treatment Period|Death|0
176864|NCT00119678|555909|P1|Double-blind Treatment Period|Death|1
176865|NCT00119262|555957|P2|Overall Study|others|5
176866|NCT00119262|555958|P1|Overall Study|others|0
176867|NCT00119262|555957|P2|Overall Study|ineligble|2
176868|NCT00119262|555958|P1|Overall Study|ineligble|1
176869|NCT00119262|555957|P2|Overall Study|other disease|2
176870|NCT00119262|555958|P1|Overall Study|other disease|0
176871|NCT00119262|555957|P2|Overall Study|Adverse Event|35
176872|NCT00119262|555958|P1|Overall Study|Adverse Event|33
176873|NCT00119262|555957|P2|Overall Study|Withdrawal by Subject|11
176874|NCT00119262|555958|P1|Overall Study|Withdrawal by Subject|12
176875|NCT00119262|555957|P2|Overall Study|Lack of Efficacy|3
176876|NCT00119262|555958|P1|Overall Study|Lack of Efficacy|0
176877|NCT00119015|555995|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
176878|NCT00119015|555996|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
176879|NCT00119015|555997|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
176880|NCT00118911|556013|P2|Overall Study|Withdrawal by Subject|5
176881|NCT00118911|556014|P1|Overall Study|Withdrawal by Subject|2
176882|NCT00118898|556026|P4|Overall Study|Not able to get to clinic|40
176883|NCT00118898|556027|P3|Overall Study|Not able to get to clinic|31
176884|NCT00118898|556028|P2|Overall Study|Not able to get to clinic|43
176885|NCT00118898|556029|P1|Overall Study|Not able to get to clinic|34
176886|NCT00118898|556026|P4|Overall Study|Not compliant with requirements|11
176887|NCT00118898|556027|P3|Overall Study|Not compliant with requirements|11
176888|NCT00118898|556028|P2|Overall Study|Not compliant with requirements|13
176889|NCT00118898|556029|P1|Overall Study|Not compliant with requirements|11
176890|NCT00118898|556026|P4|Overall Study|Severe debilitation|4
176891|NCT00118898|556027|P3|Overall Study|Severe debilitation|6
176892|NCT00118898|556028|P2|Overall Study|Severe debilitation|4
176893|NCT00118898|556029|P1|Overall Study|Severe debilitation|1
176894|NCT00118898|556026|P4|Overall Study|Site Closure|37
176895|NCT00118898|556027|P3|Overall Study|Site Closure|28
176896|NCT00118898|556028|P2|Overall Study|Site Closure|31
176897|NCT00118898|556029|P1|Overall Study|Site Closure|33
176898|NCT00118898|556026|P4|Overall Study|Withdrawal by Subject|8
176899|NCT00118898|556027|P3|Overall Study|Withdrawal by Subject|8
176900|NCT00118898|556028|P2|Overall Study|Withdrawal by Subject|5
176901|NCT00118898|556029|P1|Overall Study|Withdrawal by Subject|10
176902|NCT00118898|556026|P4|Overall Study|Lost to Follow-up|33
176903|NCT00118898|556027|P3|Overall Study|Lost to Follow-up|33
176904|NCT00118898|556028|P2|Overall Study|Lost to Follow-up|34
176905|NCT00118898|556029|P1|Overall Study|Lost to Follow-up|26
176906|NCT00118898|556026|P4|Overall Study|Death|8
176907|NCT00118898|556027|P3|Overall Study|Death|6
176908|NCT00118898|556028|P2|Overall Study|Death|11
176909|NCT00118898|556029|P1|Overall Study|Death|6
176910|NCT00118417|556238|P2|Phase II (Weeks 6 to 12)|Remission|2
176911|NCT00118417|556239|P1|Phase II (Weeks 6 to 12)|Remission|1
176912|NCT00118417|556238|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
176913|NCT00118417|556239|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
176914|NCT00118417|556238|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
176915|NCT00118417|556239|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
176916|NCT00118417|556238|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
176917|NCT00118417|556239|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
176918|NCT00118417|556238|P2|Phase I (Weeks 0 to 6)|Remission|0
176919|NCT00118417|556239|P1|Phase I (Weeks 0 to 6)|Remission|8
176920|NCT00118157|556368|P1|Overall Study|Withdrawal by Subject|2
176921|NCT00118157|556368|P1|Overall Study|Death|8
176922|NCT00118157|556368|P1|Overall Study|Adverse Event|2
176923|NCT00118040|556395|P3|Overall Study|Other|1
176924|NCT00118040|556396|P2|Overall Study|Other|0
176925|NCT00118040|556397|P1|Overall Study|Other|0
176926|NCT00118040|556395|P3|Overall Study|Non-Compliant Participant|2
176927|NCT00118040|556396|P2|Overall Study|Non-Compliant Participant|1
176928|NCT00118040|556397|P1|Overall Study|Non-Compliant Participant|1
176929|NCT00118040|556395|P3|Overall Study|Medical Contraindication|1
176930|NCT00118040|556396|P2|Overall Study|Medical Contraindication|0
176931|NCT00118040|556397|P1|Overall Study|Medical Contraindication|0
176932|NCT00118040|556395|P3|Overall Study|Withdrawal by Subject|2
176933|NCT00118040|556396|P2|Overall Study|Withdrawal by Subject|0
176934|NCT00118040|556397|P1|Overall Study|Withdrawal by Subject|0
176935|NCT00118040|556395|P3|Overall Study|Adverse Event|0
176936|NCT00118040|556396|P2|Overall Study|Adverse Event|1
176937|NCT00118040|556397|P1|Overall Study|Adverse Event|0
176938|NCT00117988|556458|P1|Overall Study|Adverse Event|1
176939|NCT00117988|556458|P1|Overall Study|Death|3
176940|NCT00117949|556481|P4|Overall Study|Hepatic abnormalities|1
176941|NCT00117949|556482|P3|Overall Study|Hepatic abnormalities|0
176942|NCT00117949|556483|P2|Overall Study|Hepatic abnormalities|1
176943|NCT00117949|556484|P1|Overall Study|Hepatic abnormalities|0
176944|NCT00117949|556481|P4|Overall Study|PSA reduction <=50%|4
176945|NCT00117949|556482|P3|Overall Study|PSA reduction <=50%|2
176946|NCT00117949|556483|P2|Overall Study|PSA reduction <=50%|2
176947|NCT00117949|556484|P1|Overall Study|PSA reduction <=50%|0
176948|NCT00117949|556481|P4|Overall Study|PSA increase >=10ng/mL|0
176949|NCT00117949|556482|P3|Overall Study|PSA increase >=10ng/mL|1
176950|NCT00117949|556483|P2|Overall Study|PSA increase >=10ng/mL|1
176951|NCT00117949|556484|P1|Overall Study|PSA increase >=10ng/mL|0
176952|NCT00117949|556481|P4|Overall Study|Prostate-specific antigen increase >=25%|2
176953|NCT00117949|556482|P3|Overall Study|Prostate-specific antigen increase >=25%|1
176954|NCT00117949|556483|P2|Overall Study|Prostate-specific antigen increase >=25%|1
176955|NCT00117949|556484|P1|Overall Study|Prostate-specific antigen increase >=25%|0
176956|NCT00117949|556481|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
176957|NCT00117949|556482|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
176958|NCT00117949|556483|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
176959|NCT00117949|556484|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
176960|NCT00117949|556481|P4|Overall Study|Testosterone >1.0 ng/mL|15
176961|NCT00117949|556482|P3|Overall Study|Testosterone >1.0 ng/mL|17
176962|NCT00117949|556483|P2|Overall Study|Testosterone >1.0 ng/mL|18
176963|NCT00117949|556484|P1|Overall Study|Testosterone >1.0 ng/mL|10
176964|NCT00117845|556518|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
176965|NCT00117793|556536|P1|Overall Study|Withdrawal by Subject|12
176966|NCT00117676|556553|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
176967|NCT00117676|556554|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
176968|NCT00117676|556553|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
176969|NCT00117676|556554|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
176970|NCT00117676|556553|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
176971|NCT00117676|556554|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
176972|NCT00117676|556553|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
176973|NCT00117676|556554|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
176974|NCT00117676|556553|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
176975|NCT00117676|556554|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
176976|NCT00117676|556553|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
176977|NCT00117676|556554|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
176978|NCT00117676|556553|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
176979|NCT00117676|556554|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
176980|NCT00117676|556553|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
176981|NCT00117676|556554|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
176982|NCT00117676|556553|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
176983|NCT00117676|556554|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
176984|NCT00117676|556553|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
176985|NCT00117676|556554|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
176986|NCT00117676|556553|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
176987|NCT00117676|556554|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
176988|NCT00117676|556553|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
176989|NCT00117676|556554|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
176990|NCT00117676|556553|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
176991|NCT00117676|556554|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
176992|NCT00117676|556553|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
176993|NCT00117676|556554|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
176994|NCT00117676|556553|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
176995|NCT00117676|556554|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
176996|NCT00117676|556553|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
176997|NCT00117676|556554|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
176998|NCT00117676|556553|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
176999|NCT00117676|556554|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
177000|NCT00117676|556553|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
177001|NCT00117676|556554|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
177002|NCT00117676|556553|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
177003|NCT00117676|556554|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
177004|NCT00117676|556553|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
177005|NCT00117676|556554|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
177006|NCT00117676|556553|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
177007|NCT00117676|556554|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
177008|NCT00117676|556553|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
177009|NCT00117676|556554|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
177010|NCT00117676|556553|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
177011|NCT00117676|556554|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
177012|NCT00117676|556553|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
177013|NCT00117676|556554|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
177014|NCT00117676|556553|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
177015|NCT00117676|556554|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
177016|NCT00117676|556553|P2|Double-blind Period Through Week 48|Withdrew Consent|1
177017|NCT00117676|556554|P1|Double-blind Period Through Week 48|Withdrew Consent|0
177018|NCT00117676|556553|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
177019|NCT00117676|556554|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
177020|NCT00117676|556553|P2|Double-blind Period Through Week 48|Protocol Violation|1
177021|NCT00117676|556554|P1|Double-blind Period Through Week 48|Protocol Violation|0
177022|NCT00117676|556553|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
177023|NCT00117676|556554|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
177024|NCT00117637|556631|P2|Second Intervention (Period 2)|reason not reported|0
177025|NCT00117637|556632|P1|Second Intervention (Period 2)|reason not reported|1
177026|NCT00117637|556631|P2|Second Intervention (Period 2)|non compliant with study medication|1
177027|NCT00117637|556632|P1|Second Intervention (Period 2)|non compliant with study medication|1
177028|NCT00117637|556631|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
177029|NCT00117637|556632|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
177030|NCT00117637|556631|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
177031|NCT00117637|556632|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
177032|NCT00117637|556631|P2|Second Intervention (Period 2)|Protocol Violation|0
177033|NCT00117637|556632|P1|Second Intervention (Period 2)|Protocol Violation|1
177034|NCT00117637|556631|P2|Second Intervention (Period 2)|Lost to Follow-up|0
177035|NCT00117637|556632|P1|Second Intervention (Period 2)|Lost to Follow-up|1
177036|NCT00117637|556631|P2|Second Intervention (Period 2)|Adverse Event|9
177037|NCT00117637|556632|P1|Second Intervention (Period 2)|Adverse Event|0
177038|NCT00117637|556631|P2|First Intervention (Period 1)|reason not reported|1
177039|NCT00117637|556632|P1|First Intervention (Period 1)|reason not reported|0
177040|NCT00117637|556631|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
177041|NCT00117637|556632|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
177042|NCT00117637|556631|P2|First Intervention (Period 1)|protocol driven decision point|0
177043|NCT00117637|556632|P1|First Intervention (Period 1)|protocol driven decision point|1
177044|NCT00117637|556631|P2|First Intervention (Period 1)|study terminated by the sponsor|1
177045|NCT00117637|556632|P1|First Intervention (Period 1)|study terminated by the sponsor|3
177046|NCT00117637|556631|P2|First Intervention (Period 1)|Withdrawal by Subject|4
177047|NCT00117637|556632|P1|First Intervention (Period 1)|Withdrawal by Subject|2
177048|NCT00117637|556631|P2|First Intervention (Period 1)|Protocol Violation|0
177049|NCT00117637|556632|P1|First Intervention (Period 1)|Protocol Violation|1
177050|NCT00117637|556631|P2|First Intervention (Period 1)|Lost to Follow-up|2
177051|NCT00117637|556632|P1|First Intervention (Period 1)|Lost to Follow-up|0
177052|NCT00117637|556631|P2|First Intervention (Period 1)|Adverse Event|16
177053|NCT00117637|556632|P1|First Intervention (Period 1)|Adverse Event|11
177054|NCT00117598|556707|P5|After Treament Cross Over|Unspecified|2
177055|NCT00117598|556708|P4|After Treament Cross Over|Unspecified|1
177056|NCT00117598|556709|P3|After Treament Cross Over|Unspecified|0
177057|NCT00117598|556710|P2|After Treament Cross Over|Unspecified|0
177058|NCT00117598|556711|P1|After Treament Cross Over|Unspecified|0
177059|NCT00117598|556707|P5|After Treament Cross Over|Withdrawal by Subject|0
177060|NCT00117598|556708|P4|After Treament Cross Over|Withdrawal by Subject|1
177061|NCT00117598|556709|P3|After Treament Cross Over|Withdrawal by Subject|0
177062|NCT00117598|556710|P2|After Treament Cross Over|Withdrawal by Subject|0
177063|NCT00117598|556711|P1|After Treament Cross Over|Withdrawal by Subject|0
177064|NCT00117598|556707|P5|After Treament Cross Over|Death|2
177065|NCT00117598|556708|P4|After Treament Cross Over|Death|1
177066|NCT00117598|556709|P3|After Treament Cross Over|Death|0
177067|NCT00117598|556710|P2|After Treament Cross Over|Death|0
177068|NCT00117598|556711|P1|After Treament Cross Over|Death|0
177069|NCT00117598|556707|P5|Prior to Treatment Cross Over|Unspecified|0
177070|NCT00117598|556708|P4|Prior to Treatment Cross Over|Unspecified|0
177071|NCT00117598|556709|P3|Prior to Treatment Cross Over|Unspecified|9
177072|NCT00117598|556710|P2|Prior to Treatment Cross Over|Unspecified|9
177073|NCT00117598|556711|P1|Prior to Treatment Cross Over|Unspecified|15
177074|NCT00117598|556707|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
177075|NCT00117598|556708|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
177076|NCT00117598|556709|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
177077|NCT00117598|556710|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
177078|NCT00117598|556711|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
177079|NCT00117598|556707|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
177080|NCT00117598|556708|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
177081|NCT00117598|556709|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
177082|NCT00117598|556710|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
177083|NCT00117598|556711|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
177084|NCT00117598|556707|P5|Prior to Treatment Cross Over|Death|0
177085|NCT00117598|556708|P4|Prior to Treatment Cross Over|Death|0
177086|NCT00117598|556709|P3|Prior to Treatment Cross Over|Death|37
177087|NCT00117598|556710|P2|Prior to Treatment Cross Over|Death|41
177088|NCT00117598|556711|P1|Prior to Treatment Cross Over|Death|40
177089|NCT00117338|556754|P2|Overall Study|Lack of Efficacy|1
177090|NCT00117338|556755|P1|Overall Study|Lack of Efficacy|0
177091|NCT00117338|556754|P2|Overall Study|Did not meet Inclusion Criteria|0
177092|NCT00117338|556755|P1|Overall Study|Did not meet Inclusion Criteria|1
177093|NCT00117338|556754|P2|Overall Study|Withdrawal by Subject|0
177094|NCT00117338|556755|P1|Overall Study|Withdrawal by Subject|1
177095|NCT00117338|556754|P2|Overall Study|Protocol Violation|2
177096|NCT00117338|556755|P1|Overall Study|Protocol Violation|3
177097|NCT00117338|556754|P2|Overall Study|Adverse Event|1
177098|NCT00117338|556755|P1|Overall Study|Adverse Event|0
177099|NCT00117312|556777|P4|Overall Study|Withdrawal by Subject|0
177100|NCT00117312|556778|P3|Overall Study|Withdrawal by Subject|0
177101|NCT00117312|556779|P2|Overall Study|Withdrawal by Subject|2
177102|NCT00117312|556780|P1|Overall Study|Withdrawal by Subject|0
177103|NCT00117312|556777|P4|Overall Study|Hepatic abnormality|1
177104|NCT00117312|556778|P3|Overall Study|Hepatic abnormality|0
177105|NCT00117312|556779|P2|Overall Study|Hepatic abnormality|1
177106|NCT00117312|556780|P1|Overall Study|Hepatic abnormality|0
177107|NCT00117312|556777|P4|Overall Study|PSA increase >= 10ng/mL|0
177108|NCT00117312|556778|P3|Overall Study|PSA increase >= 10ng/mL|1
177109|NCT00117312|556779|P2|Overall Study|PSA increase >= 10ng/mL|1
177110|NCT00117312|556780|P1|Overall Study|PSA increase >= 10ng/mL|0
177111|NCT00117312|556777|P4|Overall Study|PSA decrease <=50%|4
177112|NCT00117312|556778|P3|Overall Study|PSA decrease <=50%|2
177113|NCT00117312|556779|P2|Overall Study|PSA decrease <=50%|2
177114|NCT00117312|556780|P1|Overall Study|PSA decrease <=50%|0
177115|NCT00117312|556777|P4|Overall Study|Protocol Violation|0
177116|NCT00117312|556778|P3|Overall Study|Protocol Violation|3
177117|NCT00117312|556779|P2|Overall Study|Protocol Violation|1
177118|NCT00117312|556780|P1|Overall Study|Protocol Violation|0
177119|NCT00117312|556777|P4|Overall Study|Adverse Event|0
177120|NCT00117312|556778|P3|Overall Study|Adverse Event|0
177121|NCT00117312|556779|P2|Overall Study|Adverse Event|2
177122|NCT00117312|556780|P1|Overall Study|Adverse Event|0
177123|NCT00117312|556777|P4|Overall Study|Patient choice|1
177124|NCT00117312|556778|P3|Overall Study|Patient choice|2
177125|NCT00117312|556779|P2|Overall Study|Patient choice|0
177126|NCT00117312|556780|P1|Overall Study|Patient choice|0
177127|NCT00117312|556777|P4|Overall Study|Not specified|1
177128|NCT00117312|556778|P3|Overall Study|Not specified|3
177129|NCT00117312|556779|P2|Overall Study|Not specified|1
177130|NCT00117312|556780|P1|Overall Study|Not specified|0
177131|NCT00117312|556777|P4|Overall Study|Prostate-specific antigen increase >=25%|3
177132|NCT00117312|556778|P3|Overall Study|Prostate-specific antigen increase >=25%|5
177133|NCT00117312|556779|P2|Overall Study|Prostate-specific antigen increase >=25%|1
177134|NCT00117312|556780|P1|Overall Study|Prostate-specific antigen increase >=25%|0
177135|NCT00117312|556777|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
177136|NCT00117312|556778|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
177137|NCT00117312|556779|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
177138|NCT00117312|556780|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
177139|NCT00117312|556777|P4|Overall Study|Testosterone >1.0 ng/mL|9
177140|NCT00117312|556778|P3|Overall Study|Testosterone >1.0 ng/mL|5
177141|NCT00117312|556779|P2|Overall Study|Testosterone >1.0 ng/mL|9
177142|NCT00117312|556780|P1|Overall Study|Testosterone >1.0 ng/mL|9
177143|NCT00117286|556796|P2|Overall Study|Research site closing|2
177144|NCT00117286|556797|P1|Overall Study|Research site closing|0
177145|NCT00117286|556796|P2|Overall Study|Lack of Efficacy|1
177146|NCT00117286|556797|P1|Overall Study|Lack of Efficacy|2
177147|NCT00117286|556796|P2|Overall Study|Physician Decision|7
177148|NCT00117286|556797|P1|Overall Study|Physician Decision|3
177149|NCT00117286|556796|P2|Overall Study|Withdrawal by Subject|2
177150|NCT00117286|556797|P1|Overall Study|Withdrawal by Subject|6
177151|NCT00117286|556796|P2|Overall Study|Protocol Violation|3
177152|NCT00117286|556797|P1|Overall Study|Protocol Violation|3
177153|NCT00117286|556796|P2|Overall Study|Lost to Follow-up|0
177154|NCT00117286|556797|P1|Overall Study|Lost to Follow-up|2
177155|NCT00117286|556796|P2|Overall Study|Adverse Event|6
177156|NCT00117286|556797|P1|Overall Study|Adverse Event|12
177157|NCT00117156|556805|P1|Overall Study|Trt for Pre-Exist Second Primary|1
177158|NCT00117156|556805|P1|Overall Study|Physician Decision|1
177159|NCT00117156|556805|P1|Overall Study|Adverse Event|9
177160|NCT00116831|556824|P2|Overall Study|Missing data for participant|0
177161|NCT00116831|556825|P1|Overall Study|Missing data for participant|1
177162|NCT00116831|556824|P2|Overall Study|Insufficient therapeutic effect|1
177163|NCT00116831|556825|P1|Overall Study|Insufficient therapeutic effect|0
177164|NCT00116831|556824|P2|Overall Study|Withdrawal by Subject|32
177165|NCT00116831|556825|P1|Overall Study|Withdrawal by Subject|32
177166|NCT00116831|556824|P2|Overall Study|Withdrawn investigational product|0
177167|NCT00116831|556825|P1|Overall Study|Withdrawn investigational product|1
177168|NCT00116831|556824|P2|Overall Study|Low haemoglobin on screening|0
177169|NCT00116831|556825|P1|Overall Study|Low haemoglobin on screening|1
177170|NCT00116831|556824|P2|Overall Study|Hypoglycaemic events|0
177171|NCT00116831|556825|P1|Overall Study|Hypoglycaemic events|1
177172|NCT00116831|556824|P2|Overall Study|Protocol Violation|6
177173|NCT00116831|556825|P1|Overall Study|Protocol Violation|3
177174|NCT00116831|556824|P2|Overall Study|Lost to Follow-up|6
177175|NCT00116831|556825|P1|Overall Study|Lost to Follow-up|8
177176|NCT00116831|556824|P2|Overall Study|Baseline IVUS determined unevaluable|11
177177|NCT00116831|556825|P1|Overall Study|Baseline IVUS determined unevaluable|12
177178|NCT00116831|556824|P2|Overall Study|Adverse Event|16
177179|NCT00116831|556825|P1|Overall Study|Adverse Event|14
177180|NCT00116805|556903|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
177181|NCT00116805|556904|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
177182|NCT00116805|556903|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
177183|NCT00116805|556904|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
177184|NCT00116805|556903|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
177185|NCT00116805|556904|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
177186|NCT00116805|556903|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
177187|NCT00116805|556904|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
177188|NCT00116805|556903|P2|Open-label Period Weeks 337 - 384|Completed Study|0
177189|NCT00116805|556904|P1|Open-label Period Weeks 337 - 384|Completed Study|1
177190|NCT00116805|556903|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
177191|NCT00116805|556904|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
177192|NCT00116805|556903|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
177193|NCT00116805|556904|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
177194|NCT00116805|556903|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
177195|NCT00116805|556904|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
177196|NCT00116805|556903|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
177197|NCT00116805|556904|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
177198|NCT00116805|556903|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
177199|NCT00116805|556904|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
177200|NCT00116805|556903|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
177201|NCT00116805|556904|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
177202|NCT00116805|556903|P2|Open-label Period Weeks 289 - 336|Completed Study|1
177203|NCT00116805|556904|P1|Open-label Period Weeks 289 - 336|Completed Study|0
177204|NCT00116805|556903|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
177205|NCT00116805|556904|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
177206|NCT00116805|556903|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
177207|NCT00116805|556904|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
177208|NCT00116805|556903|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
177209|NCT00116805|556904|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
177210|NCT00116805|556903|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
177211|NCT00116805|556904|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
177212|NCT00116805|556903|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
177213|NCT00116805|556904|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
177214|NCT00116805|556903|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
177215|NCT00116805|556904|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
177216|NCT00116805|556903|P2|Open-label Period Weeks 193 - 240|Completed Study|1
177217|NCT00116805|556904|P1|Open-label Period Weeks 193 - 240|Completed Study|0
177218|NCT00116805|556903|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
177219|NCT00116805|556904|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
177220|NCT00116805|556903|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
177221|NCT00116805|556904|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
177300|NCT00116753|557021|P1|Overall Study|Adverse Event|16
177222|NCT00116805|556903|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
177223|NCT00116805|556904|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
177224|NCT00116805|556903|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
177225|NCT00116805|556904|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
177226|NCT00116805|556903|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
177227|NCT00116805|556904|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
177228|NCT00116805|556903|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
177229|NCT00116805|556904|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
177230|NCT00116805|556903|P2|Open-label Period Weeks 145 - 192|Completed Study|1
177231|NCT00116805|556904|P1|Open-label Period Weeks 145 - 192|Completed Study|1
177232|NCT00116805|556903|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
177233|NCT00116805|556904|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
177234|NCT00116805|556903|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
177235|NCT00116805|556904|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
177236|NCT00116805|556903|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
177237|NCT00116805|556904|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
177238|NCT00116805|556903|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
177239|NCT00116805|556904|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
177240|NCT00116805|556903|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
177241|NCT00116805|556904|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
177242|NCT00116805|556903|P2|Open-label Period Weeks 97 - 144|Completed Study|0
177243|NCT00116805|556904|P1|Open-label Period Weeks 97 - 144|Completed Study|1
177244|NCT00116805|556903|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
177245|NCT00116805|556904|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
177246|NCT00116805|556903|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
177247|NCT00116805|556904|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
177248|NCT00116805|556903|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
177249|NCT00116805|556904|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
177250|NCT00116805|556903|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
177251|NCT00116805|556904|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
177252|NCT00116805|556903|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
177253|NCT00116805|556904|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
177254|NCT00116805|556903|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
177255|NCT00116805|556904|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
177256|NCT00116805|556903|P2|Double-blind Period Through Week 48|Withdrew Consent|2
177257|NCT00116805|556904|P1|Double-blind Period Through Week 48|Withdrew Consent|4
177258|NCT00116805|556903|P2|Double-blind Period Through Week 48|Protocol Violation|1
177259|NCT00116805|556904|P1|Double-blind Period Through Week 48|Protocol Violation|1
177260|NCT00116805|556903|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
177261|NCT00116805|556904|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
177262|NCT00116779|556985|P2|Overall Study|Elevated PSA levels|2
177263|NCT00116779|556986|P1|Overall Study|Elevated PSA levels|2
177264|NCT00116779|556985|P2|Overall Study|Physician Decision|1
177265|NCT00116779|556986|P1|Overall Study|Physician Decision|3
177266|NCT00116779|556985|P2|Overall Study|Inadequate testosterone suppression|9
177267|NCT00116779|556986|P1|Overall Study|Inadequate testosterone suppression|7
177268|NCT00116779|556985|P2|Overall Study|Withdrawal by Subject|1
177269|NCT00116779|556986|P1|Overall Study|Withdrawal by Subject|4
177270|NCT00116779|556985|P2|Overall Study|Protocol Violation|4
177271|NCT00116779|556986|P1|Overall Study|Protocol Violation|1
177272|NCT00116779|556985|P2|Overall Study|Adverse Event|2
177273|NCT00116779|556986|P1|Overall Study|Adverse Event|4
177274|NCT00116753|557019|P3|Overall Study|Dosing Error|0
177275|NCT00116753|557020|P2|Overall Study|Dosing Error|1
177276|NCT00116753|557021|P1|Overall Study|Dosing Error|0
177277|NCT00116753|557019|P3|Overall Study|Progressive Parkinson's Disease|0
177278|NCT00116753|557020|P2|Overall Study|Progressive Parkinson's Disease|0
177279|NCT00116753|557021|P1|Overall Study|Progressive Parkinson's Disease|1
177280|NCT00116753|557019|P3|Overall Study|Abnormal Echocardiogram|1
177281|NCT00116753|557020|P2|Overall Study|Abnormal Echocardiogram|0
177282|NCT00116753|557021|P1|Overall Study|Abnormal Echocardiogram|0
177283|NCT00116753|557019|P3|Overall Study|Disease Progression|3
177284|NCT00116753|557020|P2|Overall Study|Disease Progression|4
177285|NCT00116753|557021|P1|Overall Study|Disease Progression|3
177286|NCT00116753|557019|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
177287|NCT00116753|557020|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
177288|NCT00116753|557021|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
177289|NCT00116753|557019|P3|Overall Study|Protocol Violation|1
177290|NCT00116753|557020|P2|Overall Study|Protocol Violation|0
177291|NCT00116753|557021|P1|Overall Study|Protocol Violation|0
177292|NCT00116753|557019|P3|Overall Study|Lost to Follow-up|1
177293|NCT00116753|557020|P2|Overall Study|Lost to Follow-up|2
177294|NCT00116753|557021|P1|Overall Study|Lost to Follow-up|0
177295|NCT00116753|557019|P3|Overall Study|Withdrawal by Subject|8
177296|NCT00116753|557020|P2|Overall Study|Withdrawal by Subject|12
177297|NCT00116753|557021|P1|Overall Study|Withdrawal by Subject|11
177298|NCT00116753|557019|P3|Overall Study|Adverse Event|7
177299|NCT00116753|557020|P2|Overall Study|Adverse Event|10
177301|NCT00116688|557043|P2|Overall Study|Other|0
177302|NCT00116688|557044|P1|Overall Study|Other|11
177303|NCT00116688|557043|P2|Overall Study|Pregnancy|0
177304|NCT00116688|557044|P1|Overall Study|Pregnancy|1
177305|NCT00116688|557043|P2|Overall Study|Protocol-specified criteria|0
177306|NCT00116688|557044|P1|Overall Study|Protocol-specified criteria|3
177307|NCT00116688|557043|P2|Overall Study|Death|0
177308|NCT00116688|557044|P1|Overall Study|Death|15
177309|NCT00116688|557043|P2|Overall Study|Lost to Follow-up|0
177310|NCT00116688|557044|P1|Overall Study|Lost to Follow-up|3
177311|NCT00116688|557043|P2|Overall Study|Physician Decision|0
177312|NCT00116688|557044|P1|Overall Study|Physician Decision|7
177313|NCT00116688|557043|P2|Overall Study|Requirement for alternative therapy|1
177314|NCT00116688|557044|P1|Overall Study|Requirement for alternative therapy|11
177315|NCT00116688|557043|P2|Overall Study|Withdrawal by Subject|2
177316|NCT00116688|557044|P1|Overall Study|Withdrawal by Subject|26
177317|NCT00116688|557043|P2|Overall Study|Adverse Event|0
177318|NCT00116688|557044|P1|Overall Study|Adverse Event|11
177319|NCT00116688|557043|P2|Overall Study|Noncompliance|1
177320|NCT00116688|557044|P1|Overall Study|Noncompliance|3
177321|NCT00116688|557043|P2|Overall Study|Protocol deviation|0
177322|NCT00116688|557044|P1|Overall Study|Protocol deviation|1
177323|NCT00116649|557059|P1|Overall Study|Protocol Specified|7
177324|NCT00116649|557059|P1|Overall Study|Various Reasons|18
177325|NCT00116649|557059|P1|Overall Study|Local Skin Reaction|9
177326|NCT00116649|557059|P1|Overall Study|Withdrawal by Subject|68
177327|NCT00116649|557059|P1|Overall Study|Lost to Follow-up|32
177328|NCT00116649|557059|P1|Overall Study|Lack of Efficacy|1
177329|NCT00116649|557059|P1|Overall Study|Adverse Event|20
177330|NCT00116428|557066|P2|Overall Study|Did not meet inclusion criteria|0
177331|NCT00116428|557067|P1|Overall Study|Did not meet inclusion criteria|1
177332|NCT00116428|557066|P2|Overall Study|Withdrawal by Subject|5
177333|NCT00116428|557067|P1|Overall Study|Withdrawal by Subject|2
177334|NCT00116272|557085|P2|Overall Study|Lost to Follow-up|6
177335|NCT00116272|557086|P1|Overall Study|Lost to Follow-up|11
177336|NCT00116168|557155|P4|Overall Study|Lost to Follow-up|0
177337|NCT00116168|557156|P3|Overall Study|Lost to Follow-up|0
177338|NCT00116168|557157|P2|Overall Study|Lost to Follow-up|5
177339|NCT00116168|557158|P1|Overall Study|Lost to Follow-up|6
177340|NCT00115349|557222|P2|Overall Study|Study closed due to low enrollment.|9
177341|NCT00115349|557223|P1|Overall Study|Study closed due to low enrollment.|11
177342|NCT00115934|557244|P2|Overall Study|Did not receive intervention|2
177343|NCT00115934|557245|P1|Overall Study|Did not receive intervention|3
177344|NCT00115934|557244|P2|Overall Study|Lost to Follow-up|0
177345|NCT00115934|557245|P1|Overall Study|Lost to Follow-up|1
177346|NCT00115804|557294|P1|Overall Study|Adverse Event|2
177347|NCT00115765|557309|P4|Overall Study|Not specified|2
177348|NCT00115765|557310|P3|Overall Study|Not specified|9
177349|NCT00115765|557311|P2|Overall Study|Not specified|12
177350|NCT00115765|557312|P1|Overall Study|Not specified|6
177351|NCT00115765|557309|P4|Overall Study|Lost to Follow-up|1
177352|NCT00115765|557310|P3|Overall Study|Lost to Follow-up|18
177353|NCT00115765|557311|P2|Overall Study|Lost to Follow-up|20
177354|NCT00115765|557312|P1|Overall Study|Lost to Follow-up|3
177355|NCT00115765|557309|P4|Overall Study|Physician Decision|13
177356|NCT00115765|557310|P3|Overall Study|Physician Decision|18
177357|NCT00115765|557311|P2|Overall Study|Physician Decision|15
177358|NCT00115765|557312|P1|Overall Study|Physician Decision|4
177359|NCT00115765|557309|P4|Overall Study|Withdrawal by Subject|15
177360|NCT00115765|557310|P3|Overall Study|Withdrawal by Subject|76
177361|NCT00115765|557311|P2|Overall Study|Withdrawal by Subject|53
177362|NCT00115765|557312|P1|Overall Study|Withdrawal by Subject|22
177363|NCT00115739|557350|P1|Overall Study|Lost to Follow-up|3
177364|NCT00115063|557359|P2|Overall Study|Death|0
177365|NCT00115063|557360|P1|Overall Study|Death|1
177366|NCT00115063|557359|P2|Overall Study|Lost to Follow-up|104
177367|NCT00115063|557360|P1|Overall Study|Lost to Follow-up|98
177368|NCT00114972|557378|P2|Overall Study|Lost to Follow-up|5
177369|NCT00114972|557379|P1|Overall Study|Lost to Follow-up|8
177370|NCT00114972|557378|P2|Overall Study|Withdrawal by Subject|7
177371|NCT00114972|557379|P1|Overall Study|Withdrawal by Subject|40
177372|NCT00114959|557399|P1|Overall Study|Death|1
177373|NCT00114959|557399|P1|Overall Study|Physician Decision|1
177374|NCT00114959|557399|P1|Overall Study|Lack of Efficacy|6
177375|NCT00114634|557406|P1|Overall Study|failure to return forms|3
177376|NCT00114244|557435|P2|Overall Study|Withdrawal by Subject|2
177377|NCT00114244|557436|P1|Overall Study|Withdrawal by Subject|0
177378|NCT00114244|557435|P2|Overall Study|Adverse Event|5
177379|NCT00114244|557436|P1|Overall Study|Adverse Event|2
177380|NCT00114166|557446|P1|Overall Study|Wrong primary|1
177381|NCT00114127|557454|P2|Overall Study|Withdrawal by Subject|3
177382|NCT00114127|557455|P1|Overall Study|Withdrawal by Subject|1
177383|NCT00114127|557454|P2|Overall Study|Lost to Follow-up|0
177384|NCT00114127|557455|P1|Overall Study|Lost to Follow-up|1
177385|NCT00114127|557454|P2|Overall Study|Adverse Event|1
177386|NCT00114127|557455|P1|Overall Study|Adverse Event|2
177387|NCT00113919|557487|P1|Overall Study|Death|6
177388|NCT00113919|557487|P1|Overall Study|Physician Decision|8
177389|NCT00113841|557555|P2|Overall Study|Non-compliant|0
177390|NCT00113841|557556|P1|Overall Study|Non-compliant|1
177391|NCT00113841|557555|P2|Overall Study|Disease progression|2
177392|NCT00113841|557556|P1|Overall Study|Disease progression|0
177393|NCT00113763|557564|P2|Overall Study|Ongoing|0
177394|NCT00113763|557565|P1|Overall Study|Ongoing|1
177395|NCT00113763|557564|P2|Overall Study|Non-compliance|0
177396|NCT00113763|557565|P1|Overall Study|Non-compliance|1
177397|NCT00113763|557564|P2|Overall Study|Not specified|6
177398|NCT00113763|557565|P1|Overall Study|Not specified|27
177399|NCT00113763|557564|P2|Overall Study|Withdrawal by Subject|4
177400|NCT00113763|557565|P1|Overall Study|Withdrawal by Subject|1
177401|NCT00113763|557564|P2|Overall Study|Lost to Follow-up|0
177402|NCT00113763|557565|P1|Overall Study|Lost to Follow-up|10
177403|NCT00113763|557564|P2|Overall Study|Disease Progression|14
177404|NCT00113763|557565|P1|Overall Study|Disease Progression|28
177405|NCT00113763|557564|P2|Overall Study|Adverse Event|2
177406|NCT00113763|557565|P1|Overall Study|Adverse Event|5
177407|NCT00113607|557591|P2|Overall Study|Unspecified|32
177408|NCT00113607|557592|P1|Overall Study|Unspecified|43
177409|NCT00113607|557591|P2|Overall Study|Complete Response (Confirmed)|24
177410|NCT00113607|557592|P1|Overall Study|Complete Response (Confirmed)|14
177411|NCT00113607|557591|P2|Overall Study|Disease Progression|142
177412|NCT00113607|557592|P1|Overall Study|Disease Progression|180
177413|NCT00113607|557591|P2|Overall Study|Lost to Follow-up|2
177414|NCT00113607|557592|P1|Overall Study|Lost to Follow-up|0
177415|NCT00113607|557591|P2|Overall Study|Withdrawal by Subject|58
177416|NCT00113607|557592|P1|Overall Study|Withdrawal by Subject|50
177417|NCT00113607|557591|P2|Overall Study|Death|8
177418|NCT00113607|557592|P1|Overall Study|Death|8
177419|NCT00113607|557591|P2|Overall Study|Adverse Event|71
177420|NCT00113607|557592|P1|Overall Study|Adverse Event|40
177421|NCT00113568|557606|P1|Overall Study|Other|112
177422|NCT00113568|557606|P1|Overall Study|Withdrawal by Subject|117
177423|NCT00113568|557606|P1|Overall Study|Protocol Violation|32
177424|NCT00113568|557606|P1|Overall Study|Lost to Follow-up|156
177425|NCT00113568|557606|P1|Overall Study|Lack of Efficacy|30
177426|NCT00113568|557606|P1|Overall Study|Death|1
177427|NCT00113568|557606|P1|Overall Study|Adverse Event|97
177428|NCT00113529|557618|P1|Overall Study|Withdrawal by Subject|4
177429|NCT00113529|557618|P1|Overall Study|Decision of sponsor|6
177430|NCT00113529|557618|P1|Overall Study|Lack of Efficacy|20
177431|NCT00113529|557618|P1|Overall Study|Adverse Event|4
177432|NCT00113516|557651|P2|Part 2|Ongoing|1
177433|NCT00113516|557652|P1|Part 2|Ongoing|0
177434|NCT00113516|557651|P2|Part 2|Laboratory Abnormality|1
177435|NCT00113516|557652|P1|Part 2|Laboratory Abnormality|0
177436|NCT00113516|557651|P2|Part 2|Unspecified|3
177437|NCT00113516|557652|P1|Part 2|Unspecified|0
177438|NCT00113516|557651|P2|Part 2|Withdrawal by Subject|3
177439|NCT00113516|557652|P1|Part 2|Withdrawal by Subject|0
177440|NCT00113516|557651|P2|Part 2|Lack of Efficacy|37
177441|NCT00113516|557652|P1|Part 2|Lack of Efficacy|0
177442|NCT00113516|557651|P2|Part 2|Death|5
177443|NCT00113516|557652|P1|Part 2|Death|0
177444|NCT00113516|557651|P2|Part 2|Adverse Event|16
177445|NCT00113516|557652|P1|Part 2|Adverse Event|0
177446|NCT00113516|557651|P2|Part 1|Missing|0
177447|NCT00113516|557652|P1|Part 1|Missing|65
177448|NCT00113516|557651|P2|Part 1|Ongoing|0
177449|NCT00113516|557652|P1|Part 1|Ongoing|1
177450|NCT00113516|557651|P2|Part 1|Laboratory Abnormality|0
177451|NCT00113516|557652|P1|Part 1|Laboratory Abnormality|1
177452|NCT00113516|557651|P2|Part 1|Did Not Meet Entrance Criteria|0
177453|NCT00113516|557652|P1|Part 1|Did Not Meet Entrance Criteria|1
177454|NCT00113516|557651|P2|Part 1|Lack of Efficacy|0
177455|NCT00113516|557652|P1|Part 1|Lack of Efficacy|2
177456|NCT00113516|557651|P2|Part 1|Withdrawal by Subject|0
177457|NCT00113516|557652|P1|Part 1|Withdrawal by Subject|2
177458|NCT00113516|557651|P2|Part 1|Unspecified|0
177459|NCT00113516|557652|P1|Part 1|Unspecified|3
177460|NCT00113516|557651|P2|Part 1|Death|0
177461|NCT00113516|557652|P1|Part 1|Death|3
177462|NCT00113516|557651|P2|Part 1|Adverse Event|0
177463|NCT00113516|557652|P1|Part 1|Adverse Event|6
177464|NCT00113490|557695|P2|Overall Study|Lost to Follow-up|0
177465|NCT00113490|557696|P1|Overall Study|Lost to Follow-up|1
177466|NCT00113490|557695|P2|Overall Study|Withdrawal by Subject|3
177467|NCT00113490|557696|P1|Overall Study|Withdrawal by Subject|1
177468|NCT00113399|557729|P2|Overall Study|Other|1
177469|NCT00113399|557730|P1|Overall Study|Other|0
177470|NCT00113399|557729|P2|Overall Study|Complete Response|1
177471|NCT00113399|557730|P1|Overall Study|Complete Response|0
177472|NCT00113399|557729|P2|Overall Study|Withdrawal by Subject|2
177473|NCT00113399|557730|P1|Overall Study|Withdrawal by Subject|1
177474|NCT00113399|557729|P2|Overall Study|Death|1
177475|NCT00113399|557730|P1|Overall Study|Death|1
177476|NCT00113386|557738|P2|Overall Study|Unknown - Lost to Follow-Up|1
177477|NCT00113386|557739|P1|Overall Study|Unknown - Lost to Follow-Up|2
177478|NCT00113386|557738|P2|Overall Study|Ineligible|2
177479|NCT00113386|557739|P1|Overall Study|Ineligible|1
177480|NCT00113386|557738|P2|Overall Study|Toxicity|0
177481|NCT00113386|557739|P1|Overall Study|Toxicity|3
177482|NCT00113386|557738|P2|Overall Study|Physician Decision|1
177483|NCT00113386|557739|P1|Overall Study|Physician Decision|0
177484|NCT00113386|557738|P2|Overall Study|Withdrawal by Subject|0
177485|NCT00113386|557739|P1|Overall Study|Withdrawal by Subject|1
177486|NCT00113373|557745|P1|Overall Study|Never Treated|1
177487|NCT00113373|557745|P1|Overall Study|Ineligible: second primary|1
177488|NCT00113373|557745|P1|Overall Study|Ineligible: wrong primary|1
177489|NCT00113360|557751|P1|Overall Study|Did not meet eligibility criteria|3
177490|NCT00113360|557751|P1|Overall Study|Subject required surgery|1
177491|NCT00113360|557751|P1|Overall Study|Adverse Event|3
177492|NCT00113295|557765|P2|Overall Study|Unrelated Medical Illness|0
177493|NCT00113295|557766|P1|Overall Study|Unrelated Medical Illness|1
177494|NCT00113295|557765|P2|Overall Study|Adverse Event|1
177495|NCT00113295|557766|P1|Overall Study|Adverse Event|4
177496|NCT00113269|557785|P4|Overall Study|Unable to return for follow up|0
177497|NCT00113269|557786|P3|Overall Study|Unable to return for follow up|0
177498|NCT00113269|557787|P2|Overall Study|Unable to return for follow up|1
177499|NCT00113269|557788|P1|Overall Study|Unable to return for follow up|2
177500|NCT00113269|557785|P4|Overall Study|Did not meet eligibility criteria|1
177501|NCT00113269|557786|P3|Overall Study|Did not meet eligibility criteria|0
177502|NCT00113269|557787|P2|Overall Study|Did not meet eligibility criteria|0
177503|NCT00113269|557788|P1|Overall Study|Did not meet eligibility criteria|1
177504|NCT00113269|557785|P4|Overall Study|Withdrew consent, Prednisone initiated|1
177505|NCT00113269|557786|P3|Overall Study|Withdrew consent, Prednisone initiated|0
177506|NCT00113269|557787|P2|Overall Study|Withdrew consent, Prednisone initiated|0
177507|NCT00113269|557788|P1|Overall Study|Withdrew consent, Prednisone initiated|0
177508|NCT00113269|557785|P4|Overall Study|Received pancreas transplant|2
177509|NCT00113269|557786|P3|Overall Study|Received pancreas transplant|0
177510|NCT00113269|557787|P2|Overall Study|Received pancreas transplant|0
177511|NCT00113269|557788|P1|Overall Study|Received pancreas transplant|0
177512|NCT00113269|557785|P4|Overall Study|Moved|3
177513|NCT00113269|557786|P3|Overall Study|Moved|0
177514|NCT00113269|557787|P2|Overall Study|Moved|1
177515|NCT00113269|557788|P1|Overall Study|Moved|0
177516|NCT00113269|557785|P4|Overall Study|Discontinued due to rejection|0
177517|NCT00113269|557786|P3|Overall Study|Discontinued due to rejection|1
177518|NCT00113269|557787|P2|Overall Study|Discontinued due to rejection|0
177519|NCT00113269|557788|P1|Overall Study|Discontinued due to rejection|0
177520|NCT00113269|557785|P4|Overall Study|Sponsor elected to discontinue patient|1
177521|NCT00113269|557786|P3|Overall Study|Sponsor elected to discontinue patient|0
177522|NCT00113269|557787|P2|Overall Study|Sponsor elected to discontinue patient|0
177523|NCT00113269|557788|P1|Overall Study|Sponsor elected to discontinue patient|1
177524|NCT00113269|557785|P4|Overall Study|Lost to Follow-up|3
177525|NCT00113269|557786|P3|Overall Study|Lost to Follow-up|6
177526|NCT00113269|557787|P2|Overall Study|Lost to Follow-up|3
177527|NCT00113269|557788|P1|Overall Study|Lost to Follow-up|2
177528|NCT00113269|557785|P4|Overall Study|Protocol Violation|2
177529|NCT00113269|557786|P3|Overall Study|Protocol Violation|4
177530|NCT00113269|557787|P2|Overall Study|Protocol Violation|0
177531|NCT00113269|557788|P1|Overall Study|Protocol Violation|1
177532|NCT00113269|557785|P4|Overall Study|Graft loss|9
177533|NCT00113269|557786|P3|Overall Study|Graft loss|4
177534|NCT00113269|557787|P2|Overall Study|Graft loss|6
177535|NCT00113269|557788|P1|Overall Study|Graft loss|6
177536|NCT00113269|557785|P4|Overall Study|Withdrawal by Subject|2
177537|NCT00113269|557786|P3|Overall Study|Withdrawal by Subject|4
177538|NCT00113269|557787|P2|Overall Study|Withdrawal by Subject|3
177539|NCT00113269|557788|P1|Overall Study|Withdrawal by Subject|4
177540|NCT00113269|557785|P4|Overall Study|Adverse Event|7
177541|NCT00113269|557786|P3|Overall Study|Adverse Event|11
177542|NCT00113269|557787|P2|Overall Study|Adverse Event|7
177543|NCT00113269|557788|P1|Overall Study|Adverse Event|2
177544|NCT00113269|557785|P4|Overall Study|Did not meet eligibility – pre-treatment|2
177545|NCT00113269|557786|P3|Overall Study|Did not meet eligibility – pre-treatment|0
177546|NCT00113269|557787|P2|Overall Study|Did not meet eligibility – pre-treatment|0
177547|NCT00113269|557788|P1|Overall Study|Did not meet eligibility – pre-treatment|0
177548|NCT00113269|557785|P4|Overall Study|Death in operating room|1
177549|NCT00113269|557786|P3|Overall Study|Death in operating room|0
177550|NCT00113269|557787|P2|Overall Study|Death in operating room|0
177551|NCT00113269|557788|P1|Overall Study|Death in operating room|0
177552|NCT00113269|557785|P4|Overall Study|Early graft loss, technical|0
177553|NCT00113269|557786|P3|Overall Study|Early graft loss, technical|2
177554|NCT00113269|557787|P2|Overall Study|Early graft loss, technical|0
177555|NCT00113269|557788|P1|Overall Study|Early graft loss, technical|0
177556|NCT00113269|557785|P4|Overall Study|Not transplanted, recipient issues|4
177557|NCT00113269|557786|P3|Overall Study|Not transplanted, recipient issues|7
177558|NCT00113269|557787|P2|Overall Study|Not transplanted, recipient issues|1
177559|NCT00113269|557788|P1|Overall Study|Not transplanted, recipient issues|2
177560|NCT00113269|557785|P4|Overall Study|Not transplanted, donor issues|2
177561|NCT00113269|557786|P3|Overall Study|Not transplanted, donor issues|2
177562|NCT00113269|557787|P2|Overall Study|Not transplanted, donor issues|0
177563|NCT00113269|557788|P1|Overall Study|Not transplanted, donor issues|4
177564|NCT00113087|557848|P2|Overall Study|Family or MD withdrew subject|5
177565|NCT00113087|557849|P1|Overall Study|Family or MD withdrew subject|10
177566|NCT00113087|557848|P2|Overall Study|Death or Transplant|16
177567|NCT00113087|557849|P1|Overall Study|Death or Transplant|14
177568|NCT00112905|557939|P1|Overall Study|performance status was deteiorating|1
177569|NCT00112905|557939|P1|Overall Study|Alternative treatment|1
177570|NCT00112905|557939|P1|Overall Study|Ineligibility|5
177571|NCT00112905|557939|P1|Overall Study|Death|1
177572|NCT00112905|557939|P1|Overall Study|Adverse Event|4
177573|NCT00112840|557949|P3|Overall Study|Protocol Violation|5
177574|NCT00112840|557950|P2|Overall Study|Protocol Violation|0
177575|NCT00112840|557951|P1|Overall Study|Protocol Violation|0
177576|NCT00112840|557949|P3|Overall Study|Withdrawal by Subject|1
177577|NCT00112840|557950|P2|Overall Study|Withdrawal by Subject|0
177578|NCT00112840|557951|P1|Overall Study|Withdrawal by Subject|1
177579|NCT00112840|557949|P3|Overall Study|Physician Decision|0
177580|NCT00112840|557950|P2|Overall Study|Physician Decision|0
177581|NCT00112840|557951|P1|Overall Study|Physician Decision|1
177582|NCT00112736|557970|P2|Overall Study|1 pt never had had RX due rapid decline|0
177583|NCT00112736|557971|P1|Overall Study|1 pt never had had RX due rapid decline|1
177584|NCT00112489|558017|P1|Overall Study|Ineligible|7
177585|NCT00112489|558017|P1|Overall Study|Patient never treated|2
177586|NCT00112489|558017|P1|Overall Study|Other, Not Specified|9
177587|NCT00112489|558017|P1|Overall Study|Death|2
177588|NCT00112489|558017|P1|Overall Study|Adverse Event|12
177589|NCT00112489|558017|P1|Overall Study|Refused further treatment|8
177590|NCT00112437|558026|P15|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
177591|NCT00112437|558027|P14|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
177592|NCT00112437|558028|P13|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
177593|NCT00112437|558029|P12|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
177594|NCT00112437|558030|P11|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
177595|NCT00112437|558031|P10|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
177596|NCT00112437|558032|P9|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
177597|NCT00112437|558033|P8|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
177598|NCT00112437|558034|P7|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|1
177599|NCT00112437|558035|P6|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|1
177600|NCT00112437|558036|P5|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
177601|NCT00112437|558037|P4|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
177602|NCT00112437|558038|P3|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
177603|NCT00112437|558039|P2|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
177604|NCT00112437|558040|P1|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
177605|NCT00112437|558026|P15|12 Month Extension (Year 3)|Withdrawal by Subject|0
177606|NCT00112437|558027|P14|12 Month Extension (Year 3)|Withdrawal by Subject|0
177607|NCT00112437|558028|P13|12 Month Extension (Year 3)|Withdrawal by Subject|0
177608|NCT00112437|558029|P12|12 Month Extension (Year 3)|Withdrawal by Subject|0
177609|NCT00112437|558030|P11|12 Month Extension (Year 3)|Withdrawal by Subject|0
177610|NCT00112437|558031|P10|12 Month Extension (Year 3)|Withdrawal by Subject|1
177611|NCT00112437|558032|P9|12 Month Extension (Year 3)|Withdrawal by Subject|0
177612|NCT00112437|558033|P8|12 Month Extension (Year 3)|Withdrawal by Subject|0
177613|NCT00112437|558034|P7|12 Month Extension (Year 3)|Withdrawal by Subject|3
177614|NCT00112437|558035|P6|12 Month Extension (Year 3)|Withdrawal by Subject|0
177615|NCT00112437|558036|P5|12 Month Extension (Year 3)|Withdrawal by Subject|0
177616|NCT00112437|558037|P4|12 Month Extension (Year 3)|Withdrawal by Subject|0
177617|NCT00112437|558038|P3|12 Month Extension (Year 3)|Withdrawal by Subject|0
177618|NCT00112437|558039|P2|12 Month Extension (Year 3)|Withdrawal by Subject|0
177619|NCT00112437|558040|P1|12 Month Extension (Year 3)|Withdrawal by Subject|0
177620|NCT00112437|558026|P15|12 Month Extension (Year 3)|Protocol Violation|0
177621|NCT00112437|558027|P14|12 Month Extension (Year 3)|Protocol Violation|0
177622|NCT00112437|558028|P13|12 Month Extension (Year 3)|Protocol Violation|0
177623|NCT00112437|558029|P12|12 Month Extension (Year 3)|Protocol Violation|0
177624|NCT00112437|558030|P11|12 Month Extension (Year 3)|Protocol Violation|1
177625|NCT00112437|558031|P10|12 Month Extension (Year 3)|Protocol Violation|0
177626|NCT00112437|558032|P9|12 Month Extension (Year 3)|Protocol Violation|0
177627|NCT00112437|558033|P8|12 Month Extension (Year 3)|Protocol Violation|0
177628|NCT00112437|558034|P7|12 Month Extension (Year 3)|Protocol Violation|0
177629|NCT00112437|558035|P6|12 Month Extension (Year 3)|Protocol Violation|0
177630|NCT00112437|558036|P5|12 Month Extension (Year 3)|Protocol Violation|0
177631|NCT00112437|558037|P4|12 Month Extension (Year 3)|Protocol Violation|0
177632|NCT00112437|558038|P3|12 Month Extension (Year 3)|Protocol Violation|0
177633|NCT00112437|558039|P2|12 Month Extension (Year 3)|Protocol Violation|0
177634|NCT00112437|558040|P1|12 Month Extension (Year 3)|Protocol Violation|0
177635|NCT00112437|558026|P15|12 Month Extension (Year 3)|Lost to Follow-up|0
177636|NCT00112437|558027|P14|12 Month Extension (Year 3)|Lost to Follow-up|0
177637|NCT00112437|558028|P13|12 Month Extension (Year 3)|Lost to Follow-up|0
177638|NCT00112437|558029|P12|12 Month Extension (Year 3)|Lost to Follow-up|0
177639|NCT00112437|558030|P11|12 Month Extension (Year 3)|Lost to Follow-up|1
177640|NCT00112437|558031|P10|12 Month Extension (Year 3)|Lost to Follow-up|0
177641|NCT00112437|558032|P9|12 Month Extension (Year 3)|Lost to Follow-up|0
177642|NCT00112437|558033|P8|12 Month Extension (Year 3)|Lost to Follow-up|0
177643|NCT00112437|558034|P7|12 Month Extension (Year 3)|Lost to Follow-up|0
177644|NCT00112437|558035|P6|12 Month Extension (Year 3)|Lost to Follow-up|0
177645|NCT00112437|558036|P5|12 Month Extension (Year 3)|Lost to Follow-up|0
177646|NCT00112437|558037|P4|12 Month Extension (Year 3)|Lost to Follow-up|0
177647|NCT00112437|558038|P3|12 Month Extension (Year 3)|Lost to Follow-up|0
177648|NCT00112437|558039|P2|12 Month Extension (Year 3)|Lost to Follow-up|0
177649|NCT00112437|558040|P1|12 Month Extension (Year 3)|Lost to Follow-up|0
177650|NCT00112437|558026|P15|12 Month Extension (Year 3)|Lack of Efficacy|0
177651|NCT00112437|558027|P14|12 Month Extension (Year 3)|Lack of Efficacy|2
177652|NCT00112437|558028|P13|12 Month Extension (Year 3)|Lack of Efficacy|0
177653|NCT00112437|558029|P12|12 Month Extension (Year 3)|Lack of Efficacy|0
177654|NCT00112437|558030|P11|12 Month Extension (Year 3)|Lack of Efficacy|1
177655|NCT00112437|558031|P10|12 Month Extension (Year 3)|Lack of Efficacy|0
177656|NCT00112437|558032|P9|12 Month Extension (Year 3)|Lack of Efficacy|1
177657|NCT00112437|558033|P8|12 Month Extension (Year 3)|Lack of Efficacy|0
177658|NCT00112437|558034|P7|12 Month Extension (Year 3)|Lack of Efficacy|1
177659|NCT00112437|558035|P6|12 Month Extension (Year 3)|Lack of Efficacy|0
177660|NCT00112437|558036|P5|12 Month Extension (Year 3)|Lack of Efficacy|0
177661|NCT00112437|558037|P4|12 Month Extension (Year 3)|Lack of Efficacy|0
177662|NCT00112437|558038|P3|12 Month Extension (Year 3)|Lack of Efficacy|0
177663|NCT00112437|558039|P2|12 Month Extension (Year 3)|Lack of Efficacy|0
177664|NCT00112437|558040|P1|12 Month Extension (Year 3)|Lack of Efficacy|0
177665|NCT00112437|558026|P15|12 Month Extension (Year 3)|Adverse Event|1
177666|NCT00112437|558027|P14|12 Month Extension (Year 3)|Adverse Event|0
177667|NCT00112437|558028|P13|12 Month Extension (Year 3)|Adverse Event|1
177668|NCT00112437|558029|P12|12 Month Extension (Year 3)|Adverse Event|3
177669|NCT00112437|558030|P11|12 Month Extension (Year 3)|Adverse Event|1
177670|NCT00112437|558031|P10|12 Month Extension (Year 3)|Adverse Event|0
177671|NCT00112437|558032|P9|12 Month Extension (Year 3)|Adverse Event|0
177672|NCT00112437|558033|P8|12 Month Extension (Year 3)|Adverse Event|0
177673|NCT00112437|558034|P7|12 Month Extension (Year 3)|Adverse Event|0
177674|NCT00112437|558035|P6|12 Month Extension (Year 3)|Adverse Event|1
177675|NCT00112437|558036|P5|12 Month Extension (Year 3)|Adverse Event|0
177676|NCT00112437|558037|P4|12 Month Extension (Year 3)|Adverse Event|0
177677|NCT00112437|558038|P3|12 Month Extension (Year 3)|Adverse Event|0
177678|NCT00112437|558039|P2|12 Month Extension (Year 3)|Adverse Event|0
177679|NCT00112437|558040|P1|12 Month Extension (Year 3)|Adverse Event|0
177680|NCT00112437|558026|P15|12 Month Extension|Moved|0
177681|NCT00112437|558027|P14|12 Month Extension|Moved|0
177682|NCT00112437|558028|P13|12 Month Extension|Moved|0
177683|NCT00112437|558029|P12|12 Month Extension|Moved|0
177684|NCT00112437|558030|P11|12 Month Extension|Moved|0
177685|NCT00112437|558031|P10|12 Month Extension|Moved|0
177686|NCT00112437|558032|P9|12 Month Extension|Moved|0
177687|NCT00112437|558033|P8|12 Month Extension|Moved|0
177688|NCT00112437|558034|P7|12 Month Extension|Moved|0
177689|NCT00112437|558035|P6|12 Month Extension|Moved|0
177690|NCT00112437|558036|P5|12 Month Extension|Moved|1
177691|NCT00112437|558037|P4|12 Month Extension|Moved|0
177692|NCT00112437|558038|P3|12 Month Extension|Moved|0
177693|NCT00112437|558039|P2|12 Month Extension|Moved|0
177694|NCT00112437|558040|P1|12 Month Extension|Moved|0
177695|NCT00112437|558026|P15|12 Month Extension|patient was out of windows|0
177696|NCT00112437|558027|P14|12 Month Extension|patient was out of windows|0
177697|NCT00112437|558028|P13|12 Month Extension|patient was out of windows|0
177698|NCT00112437|558029|P12|12 Month Extension|patient was out of windows|0
177699|NCT00112437|558030|P11|12 Month Extension|patient was out of windows|0
177700|NCT00112437|558031|P10|12 Month Extension|patient was out of windows|0
177701|NCT00112437|558032|P9|12 Month Extension|patient was out of windows|0
177702|NCT00112437|558033|P8|12 Month Extension|patient was out of windows|0
177703|NCT00112437|558034|P7|12 Month Extension|patient was out of windows|0
177704|NCT00112437|558035|P6|12 Month Extension|patient was out of windows|0
177705|NCT00112437|558036|P5|12 Month Extension|patient was out of windows|1
177706|NCT00112437|558037|P4|12 Month Extension|patient was out of windows|0
177707|NCT00112437|558038|P3|12 Month Extension|patient was out of windows|0
177708|NCT00112437|558039|P2|12 Month Extension|patient was out of windows|0
177709|NCT00112437|558040|P1|12 Month Extension|patient was out of windows|0
177710|NCT00112437|558026|P15|12 Month Extension|Patient stopped taking medication|0
177711|NCT00112437|558027|P14|12 Month Extension|Patient stopped taking medication|0
177712|NCT00112437|558028|P13|12 Month Extension|Patient stopped taking medication|0
177713|NCT00112437|558029|P12|12 Month Extension|Patient stopped taking medication|0
177714|NCT00112437|558030|P11|12 Month Extension|Patient stopped taking medication|0
177715|NCT00112437|558031|P10|12 Month Extension|Patient stopped taking medication|0
177716|NCT00112437|558032|P9|12 Month Extension|Patient stopped taking medication|0
177717|NCT00112437|558033|P8|12 Month Extension|Patient stopped taking medication|0
177718|NCT00112437|558034|P7|12 Month Extension|Patient stopped taking medication|0
177719|NCT00112437|558035|P6|12 Month Extension|Patient stopped taking medication|0
177720|NCT00112437|558036|P5|12 Month Extension|Patient stopped taking medication|1
177721|NCT00112437|558037|P4|12 Month Extension|Patient stopped taking medication|0
177722|NCT00112437|558038|P3|12 Month Extension|Patient stopped taking medication|0
177723|NCT00112437|558039|P2|12 Month Extension|Patient stopped taking medication|0
177724|NCT00112437|558040|P1|12 Month Extension|Patient stopped taking medication|0
177725|NCT00112437|558026|P15|12 Month Extension|Withdrawal by Subject|0
177726|NCT00112437|558027|P14|12 Month Extension|Withdrawal by Subject|0
177727|NCT00112437|558028|P13|12 Month Extension|Withdrawal by Subject|0
177728|NCT00112437|558029|P12|12 Month Extension|Withdrawal by Subject|0
177729|NCT00112437|558030|P11|12 Month Extension|Withdrawal by Subject|0
177730|NCT00112437|558031|P10|12 Month Extension|Withdrawal by Subject|0
177731|NCT00112437|558032|P9|12 Month Extension|Withdrawal by Subject|0
177732|NCT00112437|558033|P8|12 Month Extension|Withdrawal by Subject|0
177733|NCT00112437|558034|P7|12 Month Extension|Withdrawal by Subject|0
177734|NCT00112437|558035|P6|12 Month Extension|Withdrawal by Subject|0
177735|NCT00112437|558036|P5|12 Month Extension|Withdrawal by Subject|1
177736|NCT00112437|558037|P4|12 Month Extension|Withdrawal by Subject|4
177737|NCT00112437|558038|P3|12 Month Extension|Withdrawal by Subject|2
177738|NCT00112437|558039|P2|12 Month Extension|Withdrawal by Subject|1
177739|NCT00112437|558040|P1|12 Month Extension|Withdrawal by Subject|1
177740|NCT00112437|558026|P15|12 Month Extension|Protocol Violation|0
177741|NCT00112437|558027|P14|12 Month Extension|Protocol Violation|0
177742|NCT00112437|558028|P13|12 Month Extension|Protocol Violation|0
177743|NCT00112437|558029|P12|12 Month Extension|Protocol Violation|0
177744|NCT00112437|558030|P11|12 Month Extension|Protocol Violation|0
177745|NCT00112437|558031|P10|12 Month Extension|Protocol Violation|0
177746|NCT00112437|558032|P9|12 Month Extension|Protocol Violation|0
177747|NCT00112437|558033|P8|12 Month Extension|Protocol Violation|0
177748|NCT00112437|558034|P7|12 Month Extension|Protocol Violation|0
177749|NCT00112437|558035|P6|12 Month Extension|Protocol Violation|0
177750|NCT00112437|558036|P5|12 Month Extension|Protocol Violation|0
177751|NCT00112437|558037|P4|12 Month Extension|Protocol Violation|1
177752|NCT00112437|558038|P3|12 Month Extension|Protocol Violation|0
177753|NCT00112437|558039|P2|12 Month Extension|Protocol Violation|0
177754|NCT00112437|558040|P1|12 Month Extension|Protocol Violation|0
177755|NCT00112437|558026|P15|12 Month Extension|Lost to Follow-up|0
177756|NCT00112437|558027|P14|12 Month Extension|Lost to Follow-up|0
177757|NCT00112437|558028|P13|12 Month Extension|Lost to Follow-up|0
177758|NCT00112437|558029|P12|12 Month Extension|Lost to Follow-up|0
177759|NCT00112437|558030|P11|12 Month Extension|Lost to Follow-up|0
177760|NCT00112437|558031|P10|12 Month Extension|Lost to Follow-up|0
177761|NCT00112437|558032|P9|12 Month Extension|Lost to Follow-up|0
177762|NCT00112437|558033|P8|12 Month Extension|Lost to Follow-up|0
177763|NCT00112437|558034|P7|12 Month Extension|Lost to Follow-up|0
177764|NCT00112437|558035|P6|12 Month Extension|Lost to Follow-up|0
177765|NCT00112437|558036|P5|12 Month Extension|Lost to Follow-up|0
177766|NCT00112437|558037|P4|12 Month Extension|Lost to Follow-up|1
177767|NCT00112437|558038|P3|12 Month Extension|Lost to Follow-up|0
177768|NCT00112437|558039|P2|12 Month Extension|Lost to Follow-up|0
177769|NCT00112437|558040|P1|12 Month Extension|Lost to Follow-up|0
177770|NCT00112437|558026|P15|12 Month Extension|Lack of Efficacy|0
177771|NCT00112437|558027|P14|12 Month Extension|Lack of Efficacy|0
177772|NCT00112437|558028|P13|12 Month Extension|Lack of Efficacy|0
177773|NCT00112437|558029|P12|12 Month Extension|Lack of Efficacy|0
177774|NCT00112437|558030|P11|12 Month Extension|Lack of Efficacy|0
177775|NCT00112437|558031|P10|12 Month Extension|Lack of Efficacy|0
177776|NCT00112437|558032|P9|12 Month Extension|Lack of Efficacy|0
177777|NCT00112437|558033|P8|12 Month Extension|Lack of Efficacy|0
177778|NCT00112437|558034|P7|12 Month Extension|Lack of Efficacy|0
177779|NCT00112437|558035|P6|12 Month Extension|Lack of Efficacy|0
177780|NCT00112437|558036|P5|12 Month Extension|Lack of Efficacy|2
177781|NCT00112437|558037|P4|12 Month Extension|Lack of Efficacy|0
177782|NCT00112437|558038|P3|12 Month Extension|Lack of Efficacy|0
177783|NCT00112437|558039|P2|12 Month Extension|Lack of Efficacy|6
177784|NCT00112437|558040|P1|12 Month Extension|Lack of Efficacy|1
177785|NCT00112437|558026|P15|12 Month Extension|Adverse Event|0
177786|NCT00112437|558027|P14|12 Month Extension|Adverse Event|0
177787|NCT00112437|558028|P13|12 Month Extension|Adverse Event|0
177788|NCT00112437|558029|P12|12 Month Extension|Adverse Event|0
177789|NCT00112437|558030|P11|12 Month Extension|Adverse Event|0
177790|NCT00112437|558031|P10|12 Month Extension|Adverse Event|0
177791|NCT00112437|558032|P9|12 Month Extension|Adverse Event|0
177792|NCT00112437|558033|P8|12 Month Extension|Adverse Event|0
177793|NCT00112437|558034|P7|12 Month Extension|Adverse Event|0
177794|NCT00112437|558035|P6|12 Month Extension|Adverse Event|0
177795|NCT00112437|558036|P5|12 Month Extension|Adverse Event|7
177796|NCT00112437|558037|P4|12 Month Extension|Adverse Event|1
177797|NCT00112437|558038|P3|12 Month Extension|Adverse Event|6
177798|NCT00112437|558039|P2|12 Month Extension|Adverse Event|2
177799|NCT00112437|558040|P1|12 Month Extension|Adverse Event|1
177800|NCT00112437|558026|P15|12 Month Base Study|DXA was lower by more than 8%|0
177801|NCT00112437|558027|P14|12 Month Base Study|DXA was lower by more than 8%|0
177802|NCT00112437|558028|P13|12 Month Base Study|DXA was lower by more than 8%|0
177803|NCT00112437|558029|P12|12 Month Base Study|DXA was lower by more than 8%|0
177804|NCT00112437|558030|P11|12 Month Base Study|DXA was lower by more than 8%|0
177805|NCT00112437|558031|P10|12 Month Base Study|DXA was lower by more than 8%|0
177806|NCT00112437|558032|P9|12 Month Base Study|DXA was lower by more than 8%|0
177807|NCT00112437|558033|P8|12 Month Base Study|DXA was lower by more than 8%|0
177808|NCT00112437|558034|P7|12 Month Base Study|DXA was lower by more than 8%|0
177809|NCT00112437|558035|P6|12 Month Base Study|DXA was lower by more than 8%|0
177810|NCT00112437|558036|P5|12 Month Base Study|DXA was lower by more than 8%|1
177811|NCT00112437|558037|P4|12 Month Base Study|DXA was lower by more than 8%|0
177812|NCT00112437|558038|P3|12 Month Base Study|DXA was lower by more than 8%|0
177813|NCT00112437|558039|P2|12 Month Base Study|DXA was lower by more than 8%|0
177814|NCT00112437|558040|P1|12 Month Base Study|DXA was lower by more than 8%|0
177815|NCT00112437|558026|P15|12 Month Base Study|patient was unsure that they needed drug|0
177816|NCT00112437|558027|P14|12 Month Base Study|patient was unsure that they needed drug|0
177817|NCT00112437|558028|P13|12 Month Base Study|patient was unsure that they needed drug|0
177818|NCT00112437|558029|P12|12 Month Base Study|patient was unsure that they needed drug|0
177819|NCT00112437|558030|P11|12 Month Base Study|patient was unsure that they needed drug|0
177820|NCT00112437|558031|P10|12 Month Base Study|patient was unsure that they needed drug|0
177821|NCT00112437|558032|P9|12 Month Base Study|patient was unsure that they needed drug|0
177822|NCT00112437|558033|P8|12 Month Base Study|patient was unsure that they needed drug|0
177823|NCT00112437|558034|P7|12 Month Base Study|patient was unsure that they needed drug|0
177824|NCT00112437|558035|P6|12 Month Base Study|patient was unsure that they needed drug|0
177825|NCT00112437|558036|P5|12 Month Base Study|patient was unsure that they needed drug|0
177826|NCT00112437|558037|P4|12 Month Base Study|patient was unsure that they needed drug|2
177827|NCT00112437|558038|P3|12 Month Base Study|patient was unsure that they needed drug|0
177828|NCT00112437|558039|P2|12 Month Base Study|patient was unsure that they needed drug|0
177829|NCT00112437|558040|P1|12 Month Base Study|patient was unsure that they needed drug|0
177830|NCT00112437|558026|P15|12 Month Base Study|moved|0
177831|NCT00112437|558027|P14|12 Month Base Study|moved|0
177832|NCT00112437|558028|P13|12 Month Base Study|moved|0
177833|NCT00112437|558029|P12|12 Month Base Study|moved|0
177834|NCT00112437|558030|P11|12 Month Base Study|moved|0
177835|NCT00112437|558031|P10|12 Month Base Study|moved|0
177836|NCT00112437|558032|P9|12 Month Base Study|moved|0
177837|NCT00112437|558033|P8|12 Month Base Study|moved|0
177838|NCT00112437|558034|P7|12 Month Base Study|moved|0
177839|NCT00112437|558035|P6|12 Month Base Study|moved|0
177840|NCT00112437|558036|P5|12 Month Base Study|moved|0
177841|NCT00112437|558037|P4|12 Month Base Study|moved|0
177842|NCT00112437|558038|P3|12 Month Base Study|moved|1
177843|NCT00112437|558039|P2|12 Month Base Study|moved|1
177844|NCT00112437|558040|P1|12 Month Base Study|moved|0
177845|NCT00112437|558026|P15|12 Month Base Study|Withdrawal by Subject|0
177846|NCT00112437|558027|P14|12 Month Base Study|Withdrawal by Subject|0
177847|NCT00112437|558028|P13|12 Month Base Study|Withdrawal by Subject|0
177848|NCT00112437|558029|P12|12 Month Base Study|Withdrawal by Subject|0
177849|NCT00112437|558030|P11|12 Month Base Study|Withdrawal by Subject|0
177850|NCT00112437|558031|P10|12 Month Base Study|Withdrawal by Subject|0
177851|NCT00112437|558032|P9|12 Month Base Study|Withdrawal by Subject|0
177852|NCT00112437|558033|P8|12 Month Base Study|Withdrawal by Subject|0
177853|NCT00112437|558034|P7|12 Month Base Study|Withdrawal by Subject|0
177854|NCT00112437|558035|P6|12 Month Base Study|Withdrawal by Subject|0
177855|NCT00112437|558036|P5|12 Month Base Study|Withdrawal by Subject|7
177856|NCT00112437|558037|P4|12 Month Base Study|Withdrawal by Subject|1
177857|NCT00112437|558038|P3|12 Month Base Study|Withdrawal by Subject|2
177858|NCT00112437|558039|P2|12 Month Base Study|Withdrawal by Subject|5
177859|NCT00112437|558040|P1|12 Month Base Study|Withdrawal by Subject|5
177860|NCT00112437|558026|P15|12 Month Base Study|Protocol Violation|0
177861|NCT00112437|558027|P14|12 Month Base Study|Protocol Violation|0
177862|NCT00112437|558028|P13|12 Month Base Study|Protocol Violation|0
177863|NCT00112437|558029|P12|12 Month Base Study|Protocol Violation|0
177864|NCT00112437|558030|P11|12 Month Base Study|Protocol Violation|0
177865|NCT00112437|558031|P10|12 Month Base Study|Protocol Violation|0
177866|NCT00112437|558032|P9|12 Month Base Study|Protocol Violation|0
177867|NCT00112437|558033|P8|12 Month Base Study|Protocol Violation|0
177868|NCT00112437|558034|P7|12 Month Base Study|Protocol Violation|0
177869|NCT00112437|558035|P6|12 Month Base Study|Protocol Violation|0
177870|NCT00112437|558036|P5|12 Month Base Study|Protocol Violation|1
177871|NCT00112437|558037|P4|12 Month Base Study|Protocol Violation|1
177872|NCT00112437|558038|P3|12 Month Base Study|Protocol Violation|3
177873|NCT00112437|558039|P2|12 Month Base Study|Protocol Violation|0
177874|NCT00112437|558040|P1|12 Month Base Study|Protocol Violation|1
177875|NCT00112437|558026|P15|12 Month Base Study|Lost to Follow-up|0
177876|NCT00112437|558027|P14|12 Month Base Study|Lost to Follow-up|0
177877|NCT00112437|558028|P13|12 Month Base Study|Lost to Follow-up|0
177878|NCT00112437|558029|P12|12 Month Base Study|Lost to Follow-up|0
177879|NCT00112437|558030|P11|12 Month Base Study|Lost to Follow-up|0
177880|NCT00112437|558031|P10|12 Month Base Study|Lost to Follow-up|0
177881|NCT00112437|558032|P9|12 Month Base Study|Lost to Follow-up|0
177882|NCT00112437|558033|P8|12 Month Base Study|Lost to Follow-up|0
177883|NCT00112437|558034|P7|12 Month Base Study|Lost to Follow-up|0
177884|NCT00112437|558035|P6|12 Month Base Study|Lost to Follow-up|0
177885|NCT00112437|558036|P5|12 Month Base Study|Lost to Follow-up|0
177886|NCT00112437|558037|P4|12 Month Base Study|Lost to Follow-up|0
177887|NCT00112437|558038|P3|12 Month Base Study|Lost to Follow-up|0
177888|NCT00112437|558039|P2|12 Month Base Study|Lost to Follow-up|1
177889|NCT00112437|558040|P1|12 Month Base Study|Lost to Follow-up|0
177890|NCT00112437|558026|P15|12 Month Base Study|Lack of Efficacy|0
177891|NCT00112437|558027|P14|12 Month Base Study|Lack of Efficacy|0
177892|NCT00112437|558028|P13|12 Month Base Study|Lack of Efficacy|0
177893|NCT00112437|558029|P12|12 Month Base Study|Lack of Efficacy|0
177894|NCT00112437|558030|P11|12 Month Base Study|Lack of Efficacy|0
177895|NCT00112437|558031|P10|12 Month Base Study|Lack of Efficacy|0
177896|NCT00112437|558032|P9|12 Month Base Study|Lack of Efficacy|0
177897|NCT00112437|558033|P8|12 Month Base Study|Lack of Efficacy|0
177898|NCT00112437|558034|P7|12 Month Base Study|Lack of Efficacy|0
177899|NCT00112437|558035|P6|12 Month Base Study|Lack of Efficacy|0
177900|NCT00112437|558036|P5|12 Month Base Study|Lack of Efficacy|0
177901|NCT00112437|558037|P4|12 Month Base Study|Lack of Efficacy|0
177902|NCT00112437|558038|P3|12 Month Base Study|Lack of Efficacy|0
177903|NCT00112437|558039|P2|12 Month Base Study|Lack of Efficacy|1
177904|NCT00112437|558040|P1|12 Month Base Study|Lack of Efficacy|0
177905|NCT00112437|558026|P15|12 Month Base Study|Adverse Event|0
177906|NCT00112437|558027|P14|12 Month Base Study|Adverse Event|0
177907|NCT00112437|558028|P13|12 Month Base Study|Adverse Event|0
177908|NCT00112437|558029|P12|12 Month Base Study|Adverse Event|0
177909|NCT00112437|558030|P11|12 Month Base Study|Adverse Event|0
177910|NCT00112437|558031|P10|12 Month Base Study|Adverse Event|0
177911|NCT00112437|558032|P9|12 Month Base Study|Adverse Event|0
177912|NCT00112437|558033|P8|12 Month Base Study|Adverse Event|0
177913|NCT00112437|558034|P7|12 Month Base Study|Adverse Event|0
177914|NCT00112437|558035|P6|12 Month Base Study|Adverse Event|0
177915|NCT00112437|558036|P5|12 Month Base Study|Adverse Event|3
177916|NCT00112437|558037|P4|12 Month Base Study|Adverse Event|4
177917|NCT00112437|558038|P3|12 Month Base Study|Adverse Event|6
177918|NCT00112437|558039|P2|12 Month Base Study|Adverse Event|10
177919|NCT00112437|558040|P1|12 Month Base Study|Adverse Event|9
177920|NCT00112385|558299|P2|Overall Study|Withdrawal by Subject|1
177921|NCT00112385|558300|P1|Overall Study|Withdrawal by Subject|0
177922|NCT00112385|558299|P2|Overall Study|Lost to Follow-up|0
177923|NCT00112385|558300|P1|Overall Study|Lost to Follow-up|1
177924|NCT00112359|558390|P2|Overall Study|Other|0
177925|NCT00112359|558391|P1|Overall Study|Other|3
177926|NCT00112359|558390|P2|Overall Study|Personal/administrative|1
177927|NCT00112359|558391|P1|Overall Study|Personal/administrative|1
177928|NCT00112359|558390|P2|Overall Study|Lost to Follow-up|1
177929|NCT00112359|558391|P1|Overall Study|Lost to Follow-up|0
177930|NCT00112359|558390|P2|Overall Study|Related adverse event|3
177931|NCT00112359|558391|P1|Overall Study|Related adverse event|5
177932|NCT00112359|558390|P2|Overall Study|Trial drug intolerance (adverse event)|0
177933|NCT00112359|558391|P1|Overall Study|Trial drug intolerance (adverse event)|2
177934|NCT00112359|558390|P2|Overall Study|Unrelated adverse event|8
177935|NCT00112359|558391|P1|Overall Study|Unrelated adverse event|16
177936|NCT00112294|558417|P2|Overall Study|Still on study|0
177937|NCT00112294|558418|P1|Overall Study|Still on study|5
177938|NCT00112047|558599|P2|Atripla Phase|Not specified|1
177939|NCT00112047|558600|P1|Atripla Phase|Not specified|3
177940|NCT00112047|558599|P2|Atripla Phase|Non-compliance|0
177941|NCT00112047|558600|P1|Atripla Phase|Non-compliance|1
177942|NCT00112047|558599|P2|Atripla Phase|Sub-optimal virological response|1
177943|NCT00112047|558600|P1|Atripla Phase|Sub-optimal virological response|0
177944|NCT00112047|558599|P2|Atripla Phase|Withdrew consent|7
177945|NCT00112047|558600|P1|Atripla Phase|Withdrew consent|7
177946|NCT00112047|558599|P2|Atripla Phase|Death|2
177947|NCT00112047|558600|P1|Atripla Phase|Death|0
177948|NCT00112047|558599|P2|Atripla Phase|Pregnancy|1
177949|NCT00112047|558600|P1|Atripla Phase|Pregnancy|0
177950|NCT00112047|558599|P2|Atripla Phase|Lost to Follow-up|7
177951|NCT00112047|558600|P1|Atripla Phase|Lost to Follow-up|5
177952|NCT00112047|558599|P2|Atripla Phase|Adverse Event|1
177953|NCT00112047|558600|P1|Atripla Phase|Adverse Event|2
177954|NCT00112047|558599|P2|Randomized Phase|High Hepatitis B DNA|1
177955|NCT00112047|558600|P1|Randomized Phase|High Hepatitis B DNA|0
177956|NCT00112047|558599|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
177957|NCT00112047|558600|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
177958|NCT00112047|558599|P2|Randomized Phase|Moved out of State|1
177959|NCT00112047|558600|P1|Randomized Phase|Moved out of State|0
177960|NCT00112047|558599|P2|Randomized Phase|Incarceration|2
177961|NCT00112047|558600|P1|Randomized Phase|Incarceration|3
177962|NCT00112047|558599|P2|Randomized Phase|Inability to swallow pills|1
177963|NCT00112047|558600|P1|Randomized Phase|Inability to swallow pills|0
177964|NCT00112047|558599|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
177965|NCT00112047|558600|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
177966|NCT00112047|558599|P2|Randomized Phase|Death|3
177967|NCT00112047|558600|P1|Randomized Phase|Death|1
177968|NCT00112047|558599|P2|Randomized Phase|Pregnancy|1
177969|NCT00112047|558600|P1|Randomized Phase|Pregnancy|3
177970|NCT00112047|558599|P2|Randomized Phase|Protocol Violation|0
177971|NCT00112047|558600|P1|Randomized Phase|Protocol Violation|2
177972|NCT00112047|558599|P2|Randomized Phase|Noncompliance|4
177973|NCT00112047|558600|P1|Randomized Phase|Noncompliance|8
177974|NCT00112047|558599|P2|Randomized Phase|Sub-optimal virological response|13
177975|NCT00112047|558600|P1|Randomized Phase|Sub-optimal virological response|3
177976|NCT00112047|558599|P2|Randomized Phase|Withrawal of consent|18
177977|NCT00112047|558600|P1|Randomized Phase|Withrawal of consent|10
177978|NCT00112047|558599|P2|Randomized Phase|Adverse Event|10
177979|NCT00112047|558600|P1|Randomized Phase|Adverse Event|10
177980|NCT00112047|558599|P2|Randomized Phase|Lost to Follow-up|33
177981|NCT00112047|558600|P1|Randomized Phase|Lost to Follow-up|26
177982|NCT00111917|558700|P2|Overall Study|Withdrawal by Subject|1
177983|NCT00111917|558701|P1|Overall Study|Withdrawal by Subject|1
177984|NCT00111813|558713|P6|Overall Study|Not specified|0
177985|NCT00111813|558714|P5|Overall Study|Not specified|0
177986|NCT00111813|558715|P4|Overall Study|Not specified|0
177987|NCT00111813|558716|P3|Overall Study|Not specified|1
177988|NCT00111813|558717|P2|Overall Study|Not specified|0
177989|NCT00111813|558718|P1|Overall Study|Not specified|0
177990|NCT00111813|558713|P6|Overall Study|Lack of Efficacy|1
177991|NCT00111813|558714|P5|Overall Study|Lack of Efficacy|0
177992|NCT00111813|558715|P4|Overall Study|Lack of Efficacy|0
177993|NCT00111813|558716|P3|Overall Study|Lack of Efficacy|0
177994|NCT00111813|558717|P2|Overall Study|Lack of Efficacy|0
177995|NCT00111813|558718|P1|Overall Study|Lack of Efficacy|0
177996|NCT00111813|558713|P6|Overall Study|Progressive disease|3
177997|NCT00111813|558714|P5|Overall Study|Progressive disease|4
177998|NCT00111813|558715|P4|Overall Study|Progressive disease|3
177999|NCT00111813|558716|P3|Overall Study|Progressive disease|5
178000|NCT00111813|558717|P2|Overall Study|Progressive disease|1
178001|NCT00111813|558718|P1|Overall Study|Progressive disease|2
178002|NCT00111813|558713|P6|Overall Study|Adverse Event|2
178003|NCT00111813|558714|P5|Overall Study|Adverse Event|2
178004|NCT00111813|558715|P4|Overall Study|Adverse Event|2
178005|NCT00111813|558716|P3|Overall Study|Adverse Event|4
178006|NCT00111813|558717|P2|Overall Study|Adverse Event|2
178007|NCT00111813|558718|P1|Overall Study|Adverse Event|1
178008|NCT00111761|558753|P2|Part 2|Other|0
178009|NCT00111761|558754|P1|Part 2|Other|1
178010|NCT00111761|558753|P2|Part 2|Protocol-specified criteria|0
178011|NCT00111761|558754|P1|Part 2|Protocol-specified criteria|1
178012|NCT00111761|558753|P2|Part 2|Disease progression|0
178013|NCT00111761|558754|P1|Part 2|Disease progression|3
178014|NCT00111761|558753|P2|Part 2|Death|0
178015|NCT00111761|558754|P1|Part 2|Death|1
178016|NCT00111761|558753|P2|Part 2|Physician Decision|0
178017|NCT00111761|558754|P1|Part 2|Physician Decision|1
178018|NCT00111761|558753|P2|Part 2|Adverse Event|0
178019|NCT00111761|558754|P1|Part 2|Adverse Event|1
178020|NCT00111761|558753|P2|Part 1|Withdrawal by Subject|1
178021|NCT00111761|558754|P1|Part 1|Withdrawal by Subject|0
178022|NCT00111761|558753|P2|Part 1|Other|1
178023|NCT00111761|558754|P1|Part 1|Other|0
178024|NCT00111761|558753|P2|Part 1|Death|2
178025|NCT00111761|558754|P1|Part 1|Death|0
178026|NCT00111761|558753|P2|Part 1|Physician Decision|1
178027|NCT00111761|558754|P1|Part 1|Physician Decision|0
178028|NCT00111007|558783|P2|Long Term Follow-up|Missing|3
178029|NCT00111007|558784|P1|Long Term Follow-up|Missing|10
178030|NCT00111007|558783|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
178031|NCT00111007|558784|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
178032|NCT00111007|558783|P2|Long Term Follow-up|Withdrawal by Subject|1
178033|NCT00111007|558784|P1|Long Term Follow-up|Withdrawal by Subject|0
178034|NCT00111007|558783|P2|Long Term Follow-up|Lost to Follow-up|1
178035|NCT00111007|558784|P1|Long Term Follow-up|Lost to Follow-up|1
178036|NCT00111007|558783|P2|Long Term Follow-up|Death|39
178037|NCT00111007|558784|P1|Long Term Follow-up|Death|34
178038|NCT00111007|558783|P2|Active Follow-up|Disease progression/recurrence/relapse|2
178039|NCT00111007|558784|P1|Active Follow-up|Disease progression/recurrence/relapse|3
178040|NCT00111007|558783|P2|Active Follow-up|Death|0
178041|NCT00111007|558784|P1|Active Follow-up|Death|2
178042|NCT00111007|558783|P2|Active Follow-up|Adverse Event|0
178043|NCT00111007|558784|P1|Active Follow-up|Adverse Event|1
178044|NCT00111007|558783|P2|Double-blind (DB) Treatment|Primary reason with other category|1
178045|NCT00111007|558784|P1|Double-blind (DB) Treatment|Primary reason with other category|0
178046|NCT00111007|558783|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
178047|NCT00111007|558784|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
178048|NCT00111007|558783|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
178049|NCT00111007|558784|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
178050|NCT00111007|558783|P2|Double-blind (DB) Treatment|Relapse|0
178051|NCT00111007|558784|P1|Double-blind (DB) Treatment|Relapse|1
178052|NCT00111007|558783|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
178053|NCT00111007|558784|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
178054|NCT00111007|558783|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
178055|NCT00111007|558784|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
178056|NCT00111007|558783|P2|Double-blind (DB) Treatment|Protocol Violation|1
178057|NCT00111007|558784|P1|Double-blind (DB) Treatment|Protocol Violation|0
178058|NCT00111007|558783|P2|Double-blind (DB) Treatment|Death|2
178059|NCT00111007|558784|P1|Double-blind (DB) Treatment|Death|5
178060|NCT00111007|558783|P2|Double-blind (DB) Treatment|Adverse Event|4
178061|NCT00111007|558784|P1|Double-blind (DB) Treatment|Adverse Event|12
178062|NCT00110994|558800|P2|Long Term Follow-up|Death|17
178063|NCT00110994|558801|P1|Long Term Follow-up|Death|19
178064|NCT00110994|558800|P2|Active Follow-up|Other reasons|2
178065|NCT00110994|558801|P1|Active Follow-up|Other reasons|0
178066|NCT00110994|558800|P2|Active Follow-up|Disease progression/recurrence/replace|0
178067|NCT00110994|558801|P1|Active Follow-up|Disease progression/recurrence/replace|1
178068|NCT00110994|558800|P2|Double-blind (DB) Treatment|other reasons|3
178069|NCT00110994|558801|P1|Double-blind (DB) Treatment|other reasons|2
178070|NCT00110994|558800|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
178071|NCT00110994|558801|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
178072|NCT00110994|558800|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
178073|NCT00110994|558801|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
178074|NCT00110994|558800|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
178075|NCT00110994|558801|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
178076|NCT00110994|558800|P2|Double-blind (DB) Treatment|Death|0
178077|NCT00110994|558801|P1|Double-blind (DB) Treatment|Death|1
178078|NCT00110994|558800|P2|Double-blind (DB) Treatment|Adverse Event|0
178079|NCT00110994|558801|P1|Double-blind (DB) Treatment|Adverse Event|3
178080|NCT00110890|558827|P2|Overall Study|Did not enter follow-up phase|4
178081|NCT00110890|558828|P1|Overall Study|Did not enter follow-up phase|10
178082|NCT00110890|558827|P2|Overall Study|Parathyroidectomy|1
178083|NCT00110890|558828|P1|Overall Study|Parathyroidectomy|0
178084|NCT00110890|558827|P2|Overall Study|Disease progression|1
178085|NCT00110890|558828|P1|Overall Study|Disease progression|0
178086|NCT00110890|558827|P2|Overall Study|Requirement for alternative therapy|1
178087|NCT00110890|558828|P1|Overall Study|Requirement for alternative therapy|0
178088|NCT00110890|558827|P2|Overall Study|Ineligibility determined|0
178089|NCT00110890|558828|P1|Overall Study|Ineligibility determined|3
178090|NCT00110890|558827|P2|Overall Study|Other|23
178091|NCT00110890|558828|P1|Overall Study|Other|34
178092|NCT00110890|558827|P2|Overall Study|Invest. Product Commercially Available|110
178093|NCT00110890|558828|P1|Overall Study|Invest. Product Commercially Available|217
178094|NCT00110890|558827|P2|Overall Study|Kidney Transplant|12
178095|NCT00110890|558828|P1|Overall Study|Kidney Transplant|16
178096|NCT00110890|558827|P2|Overall Study|Noncompliance|0
178097|NCT00110890|558828|P1|Overall Study|Noncompliance|10
178098|NCT00110890|558827|P2|Overall Study|Protocol Deviation|0
178099|NCT00110890|558828|P1|Overall Study|Protocol Deviation|1
178100|NCT00110890|558827|P2|Overall Study|Withdrawal by Subject|5
178101|NCT00110890|558828|P1|Overall Study|Withdrawal by Subject|17
178102|NCT00110890|558827|P2|Overall Study|Physician Decision|5
178103|NCT00110890|558828|P1|Overall Study|Physician Decision|4
178104|NCT00110890|558827|P2|Overall Study|Lost to Follow-up|1
178105|NCT00110890|558828|P1|Overall Study|Lost to Follow-up|3
178106|NCT00110890|558827|P2|Overall Study|Death|9
178107|NCT00110890|558828|P1|Overall Study|Death|16
178108|NCT00110890|558827|P2|Overall Study|Adverse Event|7
178109|NCT00110890|558828|P1|Overall Study|Adverse Event|30
178110|NCT00110812|558845|P3|Extended Follow-up|Lost to Follow-up|1
178111|NCT00110812|558846|P2|Extended Follow-up|Lost to Follow-up|3
178112|NCT00110812|558847|P1|Extended Follow-up|Lost to Follow-up|1
178113|NCT00110812|558845|P3|Extended Follow-up|Withdrawal by Subject|0
178114|NCT00110812|558846|P2|Extended Follow-up|Withdrawal by Subject|1
178115|NCT00110812|558847|P1|Extended Follow-up|Withdrawal by Subject|0
178116|NCT00110812|558845|P3|Extended Follow-up|Death|3
178117|NCT00110812|558846|P2|Extended Follow-up|Death|0
178118|NCT00110812|558847|P1|Extended Follow-up|Death|1
178119|NCT00110812|558845|P3|Main Study|Lost to Follow-up|10
178120|NCT00110812|558846|P2|Main Study|Lost to Follow-up|11
178121|NCT00110812|558847|P1|Main Study|Lost to Follow-up|8
178122|NCT00110812|558845|P3|Main Study|Withdrawal by Subject|1
178123|NCT00110812|558846|P2|Main Study|Withdrawal by Subject|0
178124|NCT00110812|558847|P1|Main Study|Withdrawal by Subject|0
178125|NCT00110812|558845|P3|Main Study|Death|2
178126|NCT00110812|558846|P2|Main Study|Death|0
178127|NCT00110812|558847|P1|Main Study|Death|0
178128|NCT00110617|558892|P2|Overall Study|Did not receive study drug|12
178129|NCT00110617|558893|P1|Overall Study|Did not receive study drug|0
178130|NCT00110617|558892|P2|Overall Study|Death|1
178131|NCT00110617|558893|P1|Overall Study|Death|1
178132|NCT00110617|558892|P2|Overall Study|Administrative problems|5
178133|NCT00110617|558893|P1|Overall Study|Administrative problems|6
178134|NCT00110617|558892|P2|Overall Study|Lost to Follow-up|1
178135|NCT00110617|558893|P1|Overall Study|Lost to Follow-up|9
178136|NCT00110617|558892|P2|Overall Study|Withdrawal by Subject|4
178137|NCT00110617|558893|P1|Overall Study|Withdrawal by Subject|10
178138|NCT00110617|558892|P2|Overall Study|Protocol Violation|0
178139|NCT00110617|558893|P1|Overall Study|Protocol Violation|5
178140|NCT00110617|558892|P2|Overall Study|Patient no longer requires study drug|0
178141|NCT00110617|558893|P1|Overall Study|Patient no longer requires study drug|1
178142|NCT00110617|558892|P2|Overall Study|Lack of Efficacy|0
178143|NCT00110617|558893|P1|Overall Study|Lack of Efficacy|1
178144|NCT00110617|558892|P2|Overall Study|Abnormal Laboratory Value|2
178145|NCT00110617|558893|P1|Overall Study|Abnormal Laboratory Value|4
178146|NCT00110617|558892|P2|Overall Study|Adverse Event|4
178147|NCT00110617|558893|P1|Overall Study|Adverse Event|2
178148|NCT00110396|559010|P1|Overall Study|Patient is to be administered copaxone|1
178149|NCT00110396|559010|P1|Overall Study|The patient has refused to visit site|1
178150|NCT00110396|559010|P1|Overall Study|The patient has refused|2
178151|NCT00110396|559010|P1|Overall Study|Patient refused to come back|1
178152|NCT00110396|559010|P1|Overall Study|Protocol Violation|2
178153|NCT00110396|559010|P1|Overall Study|Pregnancy (Protocol violation)|2
178154|NCT00110396|559010|P1|Overall Study|Pregnancy|1
178155|NCT00110396|559010|P1|Overall Study|Participation in MS vaccine study|1
178156|NCT00110396|559010|P1|Overall Study|Patient's decision|1
178157|NCT00110396|559010|P1|Overall Study|Patient will|1
178158|NCT00110396|559010|P1|Overall Study|Patient refused to participate|1
178159|NCT00110396|559010|P1|Overall Study|Patient refused to continue|1
178160|NCT00110396|559010|P1|Overall Study|Patient non-compliance|1
178161|NCT00110396|559010|P1|Overall Study|Decided not to continue treatment|1
178162|NCT00110396|559010|P1|Overall Study|Lack of Efficacy|1
178163|NCT00110396|559010|P1|Overall Study|Initiated mitoxantrone therapy|1
178164|NCT00110396|559010|P1|Overall Study|Administration of plasmapheresis|1
178165|NCT00110396|559010|P1|Overall Study|Lost to Follow-up|1
178166|NCT00110396|559010|P1|Overall Study|Adverse Event|15
178167|NCT00110357|559018|P2|Overall Study|Withdrawal by Subject|1
178168|NCT00110357|559019|P1|Overall Study|Withdrawal by Subject|3
178169|NCT00110357|559018|P2|Overall Study|Study Drug Toxicity|3
178170|NCT00110357|559019|P1|Overall Study|Study Drug Toxicity|1
178171|NCT00110357|559018|P2|Overall Study|Study Closure|0
178172|NCT00110357|559019|P1|Overall Study|Study Closure|1
178173|NCT00110357|559018|P2|Overall Study|Disease progression/relapse|15
178174|NCT00110357|559019|P1|Overall Study|Disease progression/relapse|20
178175|NCT00110357|559018|P2|Overall Study|Deterioration without progression|0
178176|NCT00110357|559019|P1|Overall Study|Deterioration without progression|2
178177|NCT00110305|559107|P2|Overall Study|Unspecified|2
178178|NCT00110305|559108|P1|Overall Study|Unspecified|8
178179|NCT00110305|559107|P2|Overall Study|Lost to Follow-up|3
178180|NCT00110305|559108|P1|Overall Study|Lost to Follow-up|20
178181|NCT00110305|559107|P2|Overall Study|Withdrawal by Subject|7
178182|NCT00110305|559108|P1|Overall Study|Withdrawal by Subject|7
178183|NCT00110305|559107|P2|Overall Study|Protocol Violation|1
178184|NCT00110305|559108|P1|Overall Study|Protocol Violation|0
178185|NCT00110305|559107|P2|Overall Study|Subject Reached A Virologic Endpoint|3
178186|NCT00110305|559108|P1|Overall Study|Subject Reached A Virologic Endpoint|21
178187|NCT00110305|559107|P2|Overall Study|Subject Ineligible To Continue The Trial|1
178188|NCT00110305|559108|P1|Overall Study|Subject Ineligible To Continue The Trial|2
178189|NCT00110305|559107|P2|Overall Study|Subject Non-Compliant|2
178190|NCT00110305|559108|P1|Overall Study|Subject Non-Compliant|9
178191|NCT00110305|559107|P2|Overall Study|Sponsors Decision|0
178192|NCT00110305|559108|P1|Overall Study|Sponsors Decision|1
178193|NCT00110305|559107|P2|Overall Study|Adverse Event|13
178194|NCT00110305|559108|P1|Overall Study|Adverse Event|46
178195|NCT00110214|559161|P2|Overall Study|Other (not specified)|75
178196|NCT00110214|559162|P1|Overall Study|Other (not specified)|61
178197|NCT00110214|559161|P2|Overall Study|Refused further treatment|65
178198|NCT00110214|559162|P1|Overall Study|Refused further treatment|52
178199|NCT00110214|559161|P2|Overall Study|Adverse Event|192
178200|NCT00110214|559162|P1|Overall Study|Adverse Event|115
178201|NCT00110214|559161|P2|Overall Study|Disease progression or death|151
178202|NCT00110214|559162|P1|Overall Study|Disease progression or death|260
178203|NCT00110214|559161|P2|Overall Study|Never started treatment|20
178204|NCT00110214|559162|P1|Overall Study|Never started treatment|21
178205|NCT00110084|559183|P1|Overall Study|Other|2
178206|NCT00110084|559183|P1|Overall Study|Intercurrent Illness|1
178207|NCT00110084|559183|P1|Overall Study|Alternate Therapy|5
178208|NCT00110084|559183|P1|Overall Study|Patient Refusal|10
178209|NCT00110084|559183|P1|Overall Study|Death|1
178210|NCT00110084|559183|P1|Overall Study|Adverse Event|9
178211|NCT00110019|559192|P2|Overall Study|other reasons|30
178212|NCT00110019|559193|P1|Overall Study|other reasons|22
178213|NCT00110019|559192|P2|Overall Study|Not start protocol therapy|16
178214|NCT00110019|559193|P1|Overall Study|Not start protocol therapy|17
178215|NCT00110019|559192|P2|Overall Study|symptom deterioration|16
178216|NCT00110019|559193|P1|Overall Study|symptom deterioration|13
178217|NCT00110019|559192|P2|Overall Study|complicating disease|1
178218|NCT00110019|559193|P1|Overall Study|complicating disease|1
178219|NCT00110019|559192|P2|Overall Study|alternative therapy|1
178220|NCT00110019|559193|P1|Overall Study|alternative therapy|5
178221|NCT00110019|559192|P2|Overall Study|Withdrawal by Subject|9
178222|NCT00110019|559193|P1|Overall Study|Withdrawal by Subject|21
178223|NCT00110019|559192|P2|Overall Study|Death|15
178224|NCT00110019|559193|P1|Overall Study|Death|13
178225|NCT00110019|559192|P2|Overall Study|Adverse Event|40
178226|NCT00110019|559193|P1|Overall Study|Adverse Event|61
178227|NCT00110019|559192|P2|Overall Study|Lack of Efficacy|285
178228|NCT00110019|559193|P1|Overall Study|Lack of Efficacy|253
178229|NCT00109967|559205|P2|Overall Study|Death|2
178230|NCT00109967|559206|P1|Overall Study|Death|0
178231|NCT00109967|559205|P2|Overall Study|Physician Decision|3
178232|NCT00109967|559206|P1|Overall Study|Physician Decision|1
178233|NCT00109967|559205|P2|Overall Study|Withdrawal by Subject|0
178234|NCT00109967|559206|P1|Overall Study|Withdrawal by Subject|5
178235|NCT00109967|559205|P2|Overall Study|Adverse Event|1
178236|NCT00109967|559206|P1|Overall Study|Adverse Event|12
178237|NCT00109967|559205|P2|Overall Study|Cancel Prior to Treatment|0
178238|NCT00109967|559206|P1|Overall Study|Cancel Prior to Treatment|2
178239|NCT00109928|559220|P1|Overall Study|not eligible|1
178240|NCT00109928|559220|P1|Overall Study|not protocol specified|2
178241|NCT00109928|559220|P1|Overall Study|Death|2
178242|NCT00109928|559220|P1|Overall Study|Progression|6
178243|NCT00109928|559220|P1|Overall Study|Adverse Event|2
178244|NCT00109850|559237|P1|Overall Study|Ineligible|1
178245|NCT00109850|559237|P1|Overall Study|Death|2
178246|NCT00109850|559237|P1|Overall Study|Adverse Event|1
178247|NCT00109837|559244|P1|Overall Study|Ineligible|1
178248|NCT00109837|559244|P1|Overall Study|Not treated|1
178249|NCT00109837|559244|P1|Overall Study|BCR/ABL+ or Ph+|17
178250|NCT00109837|559244|P1|Overall Study|Death|1
178251|NCT00109837|559244|P1|Overall Study|Refusal unrelated to adverse effects|1
178252|NCT00109837|559244|P1|Overall Study|Adverse Event|2
178253|NCT00109772|559254|P2|Open-label Extension|not specified|10
178254|NCT00109772|559255|P1|Open-label Extension|not specified|4
178255|NCT00109772|559254|P2|Open-label Extension|Protocol Violation|2
178256|NCT00109772|559255|P1|Open-label Extension|Protocol Violation|2
178257|NCT00109772|559254|P2|Open-label Extension|Death|1
178258|NCT00109772|559255|P1|Open-label Extension|Death|0
178259|NCT00109772|559254|P2|Open-label Extension|Lost to Follow-up|0
178260|NCT00109772|559255|P1|Open-label Extension|Lost to Follow-up|1
178261|NCT00109772|559254|P2|Open-label Extension|Withdrawal by Subject|6
178262|NCT00109772|559255|P1|Open-label Extension|Withdrawal by Subject|9
178263|NCT00109772|559254|P2|Open-label Extension|Lack of Efficacy|11
178264|NCT00109772|559255|P1|Open-label Extension|Lack of Efficacy|19
178265|NCT00109772|559254|P2|Open-label Extension|Adverse Event|19
178266|NCT00109772|559255|P1|Open-label Extension|Adverse Event|10
178267|NCT00109772|559254|P2|Double-blind Treatment|Withdrew prior to treatment|1
178268|NCT00109772|559255|P1|Double-blind Treatment|Withdrew prior to treatment|3
178269|NCT00109772|559254|P2|Double-blind Treatment|not specified|4
178270|NCT00109772|559255|P1|Double-blind Treatment|not specified|0
178271|NCT00109772|559254|P2|Double-blind Treatment|Protocol Violation|1
178272|NCT00109772|559255|P1|Double-blind Treatment|Protocol Violation|0
178273|NCT00109772|559254|P2|Double-blind Treatment|Lost to Follow-up|3
178274|NCT00109772|559255|P1|Double-blind Treatment|Lost to Follow-up|2
178275|NCT00109772|559254|P2|Double-blind Treatment|Withdrawal by Subject|1
178276|NCT00109772|559255|P1|Double-blind Treatment|Withdrawal by Subject|2
178277|NCT00109772|559254|P2|Double-blind Treatment|Lack of Efficacy|0
178278|NCT00109772|559255|P1|Double-blind Treatment|Lack of Efficacy|1
178279|NCT00109772|559254|P2|Double-blind Treatment|Adverse Event|5
178280|NCT00109772|559255|P1|Double-blind Treatment|Adverse Event|14
178281|NCT00109733|559295|P2|Overall Study|Could not commit time for study|1
178282|NCT00109733|559296|P1|Overall Study|Could not commit time for study|1
178283|NCT00109733|559295|P2|Overall Study|Non-compliant|1
178284|NCT00109733|559296|P1|Overall Study|Non-compliant|0
178285|NCT00109733|559295|P2|Overall Study|Stopped taking study drug|1
178286|NCT00109733|559296|P1|Overall Study|Stopped taking study drug|1
178287|NCT00109733|559295|P2|Overall Study|Protocol Violation|1
178288|NCT00109733|559296|P1|Overall Study|Protocol Violation|0
178289|NCT00109590|559313|P3|Overall Study|Never Started Treatment|3
178290|NCT00109590|559314|P2|Overall Study|Never Started Treatment|2
178291|NCT00109590|559315|P1|Overall Study|Never Started Treatment|1
178292|NCT00109590|559313|P3|Overall Study|Lost to Follow-up|1
178293|NCT00109590|559314|P2|Overall Study|Lost to Follow-up|0
178294|NCT00109590|559315|P1|Overall Study|Lost to Follow-up|1
178295|NCT00109577|559357|P2|Overall Study|Withdrawal by Subject|3
178296|NCT00109577|559358|P1|Overall Study|Withdrawal by Subject|3
178297|NCT00109343|559389|P3|Overall Study|Unspecified|1
178298|NCT00109343|559390|P2|Overall Study|Unspecified|2
178299|NCT00109343|559391|P1|Overall Study|Unspecified|5
178300|NCT00109343|559389|P3|Overall Study|Subject Moved|1
178301|NCT00109343|559390|P2|Overall Study|Subject Moved|2
178302|NCT00109343|559391|P1|Overall Study|Subject Moved|6
178303|NCT00109343|559389|P3|Overall Study|Withdrawal by Subject|10
178304|NCT00109343|559390|P2|Overall Study|Withdrawal by Subject|11
178305|NCT00109343|559391|P1|Overall Study|Withdrawal by Subject|15
178306|NCT00109343|559389|P3|Overall Study|Protocol Violation|2
178307|NCT00109343|559390|P2|Overall Study|Protocol Violation|2
178308|NCT00109343|559391|P1|Overall Study|Protocol Violation|1
178309|NCT00109343|559389|P3|Overall Study|Lost to Follow-up|14
178310|NCT00109343|559390|P2|Overall Study|Lost to Follow-up|20
178311|NCT00109343|559391|P1|Overall Study|Lost to Follow-up|35
178312|NCT00109343|559389|P3|Overall Study|Lack of Efficacy|0
178313|NCT00109343|559390|P2|Overall Study|Lack of Efficacy|0
178314|NCT00109343|559391|P1|Overall Study|Lack of Efficacy|1
178315|NCT00109343|559389|P3|Overall Study|Adverse Event|2
178316|NCT00109343|559390|P2|Overall Study|Adverse Event|0
178317|NCT00109343|559391|P1|Overall Study|Adverse Event|1
178318|NCT00107900|559438|P6|Overall Study|Administrative Reasons|0
178319|NCT00107900|559439|P5|Overall Study|Administrative Reasons|2
178320|NCT00107900|559440|P4|Overall Study|Administrative Reasons|2
178321|NCT00107900|559441|P3|Overall Study|Administrative Reasons|2
178322|NCT00107900|559442|P2|Overall Study|Administrative Reasons|0
178323|NCT00107900|559443|P1|Overall Study|Administrative Reasons|1
178324|NCT00107900|559438|P6|Overall Study|Withdrawal by Subject|1
178325|NCT00107900|559439|P5|Overall Study|Withdrawal by Subject|1
178326|NCT00107900|559440|P4|Overall Study|Withdrawal by Subject|0
178327|NCT00107900|559441|P3|Overall Study|Withdrawal by Subject|5
178328|NCT00107900|559442|P2|Overall Study|Withdrawal by Subject|0
178329|NCT00107900|559443|P1|Overall Study|Withdrawal by Subject|1
178330|NCT00107900|559438|P6|Overall Study|Protocol Violation|0
178331|NCT00107900|559439|P5|Overall Study|Protocol Violation|7
178332|NCT00107900|559440|P4|Overall Study|Protocol Violation|5
178333|NCT00107900|559441|P3|Overall Study|Protocol Violation|5
178334|NCT00107900|559442|P2|Overall Study|Protocol Violation|0
178335|NCT00107900|559443|P1|Overall Study|Protocol Violation|1
178336|NCT00107900|559438|P6|Overall Study|Lost to Follow-up|5
178337|NCT00107900|559439|P5|Overall Study|Lost to Follow-up|5
178338|NCT00107900|559440|P4|Overall Study|Lost to Follow-up|2
178339|NCT00107900|559441|P3|Overall Study|Lost to Follow-up|3
178340|NCT00107900|559442|P2|Overall Study|Lost to Follow-up|1
178341|NCT00107900|559443|P1|Overall Study|Lost to Follow-up|4
178342|NCT00107900|559438|P6|Overall Study|Death|0
178343|NCT00107900|559439|P5|Overall Study|Death|1
178344|NCT00107900|559440|P4|Overall Study|Death|0
178345|NCT00107900|559441|P3|Overall Study|Death|0
178346|NCT00107900|559442|P2|Overall Study|Death|0
178347|NCT00107900|559443|P1|Overall Study|Death|0
178348|NCT00107900|559438|P6|Overall Study|Adverse Event|3
178349|NCT00107900|559439|P5|Overall Study|Adverse Event|5
178350|NCT00107900|559440|P4|Overall Study|Adverse Event|3
178351|NCT00107900|559441|P3|Overall Study|Adverse Event|10
178352|NCT00107900|559442|P2|Overall Study|Adverse Event|2
178353|NCT00107900|559443|P1|Overall Study|Adverse Event|3
178354|NCT00109031|559479|P4|Overall Study|Protocol Violation|0
178355|NCT00109031|559480|P3|Overall Study|Protocol Violation|1
178356|NCT00109031|559481|P2|Overall Study|Protocol Violation|0
178357|NCT00109031|559482|P1|Overall Study|Protocol Violation|0
178358|NCT00109031|559479|P4|Overall Study|Physician Decision|0
178359|NCT00109031|559480|P3|Overall Study|Physician Decision|0
178360|NCT00109031|559481|P2|Overall Study|Physician Decision|1
178361|NCT00109031|559482|P1|Overall Study|Physician Decision|0
178362|NCT00109031|559479|P4|Overall Study|Withdrawal by Subject|0
178363|NCT00109031|559480|P3|Overall Study|Withdrawal by Subject|0
178364|NCT00109031|559481|P2|Overall Study|Withdrawal by Subject|1
178365|NCT00109031|559482|P1|Overall Study|Withdrawal by Subject|0
178366|NCT00109031|559479|P4|Overall Study|Adverse Event|0
178367|NCT00109031|559480|P3|Overall Study|Adverse Event|1
178368|NCT00109031|559481|P2|Overall Study|Adverse Event|0
178369|NCT00109031|559482|P1|Overall Study|Adverse Event|0
178370|NCT00108953|559533|P2|Follow-up|Study terminated by sponsor|6
178371|NCT00108953|559534|P1|Follow-up|Study terminated by sponsor|10
178372|NCT00108953|559533|P2|Follow-up|Lost to Follow-up|1
178373|NCT00108953|559534|P1|Follow-up|Lost to Follow-up|1
178374|NCT00108953|559533|P2|Follow-up|Death|26
178375|NCT00108953|559534|P1|Follow-up|Death|18
178376|NCT00108862|559556|P2|Overall Study|Lost to Follow-up|19
178377|NCT00108862|559557|P1|Overall Study|Lost to Follow-up|27
178378|NCT00108862|559556|P2|Overall Study|Withdrawal by Subject|6
178379|NCT00108862|559557|P1|Overall Study|Withdrawal by Subject|10
178380|NCT00108862|559556|P2|Overall Study|Death|37
178381|NCT00108862|559557|P1|Overall Study|Death|31
178382|NCT00108732|559585|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
178383|NCT00108732|559585|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
178384|NCT00108732|559585|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
178385|NCT00108732|559585|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
178386|NCT00108732|559585|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
178387|NCT00108732|559585|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
178388|NCT00108732|559585|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
178389|NCT00108628|559594|P2|Overall Study|Death|0
178390|NCT00108628|559595|P1|Overall Study|Death|1
178391|NCT00108628|559594|P2|Overall Study|Lack of Efficacy|1
178392|NCT00108628|559595|P1|Overall Study|Lack of Efficacy|2
178393|NCT00108628|559594|P2|Overall Study|Withdrawal by Subject|9
178394|NCT00108628|559595|P1|Overall Study|Withdrawal by Subject|17
178395|NCT00108485|559645|P2|Overall Study|Lost to Follow-up|2
178396|NCT00108485|559646|P1|Overall Study|Lost to Follow-up|0
178397|NCT00108485|559645|P2|Overall Study|Withdrawal by Subject|0
178398|NCT00108485|559646|P1|Overall Study|Withdrawal by Subject|3
178399|NCT00108433|559654|P2|Overall Study|Unspecified|14
178400|NCT00108433|559655|P1|Overall Study|Unspecified|14
178401|NCT00108433|559654|P2|Overall Study|Adverse Event|1
178402|NCT00108433|559655|P1|Overall Study|Adverse Event|3
178403|NCT00108433|559654|P2|Overall Study|Death|0
178404|NCT00108433|559655|P1|Overall Study|Death|3
178405|NCT00108433|559654|P2|Overall Study|Lack of Efficacy|2
178406|NCT00108433|559655|P1|Overall Study|Lack of Efficacy|1
178407|NCT00108355|559671|P2|Overall Study|Loculated ascites, limiting paracentesis|1
178408|NCT00108355|559672|P1|Overall Study|Loculated ascites, limiting paracentesis|1
178409|NCT00108355|559671|P2|Overall Study|Peritonitis at index paracentesis|1
178410|NCT00108355|559672|P1|Overall Study|Peritonitis at index paracentesis|1
178411|NCT00107783|559691|P2|Overall Study|Second hip replacement|1
178412|NCT00107783|559692|P1|Overall Study|Second hip replacement|1
178413|NCT00107783|559691|P2|Overall Study|Withdrawal by Subject|0
178414|NCT00107783|559692|P1|Overall Study|Withdrawal by Subject|2
178415|NCT00107783|559691|P2|Overall Study|Death|1
178416|NCT00107783|559692|P1|Overall Study|Death|0
178417|NCT00107783|559691|P2|Overall Study|Adverse Event|2
178418|NCT00107783|559692|P1|Overall Study|Adverse Event|0
178419|NCT00107653|559708|P2|Overall Study|Administrative Reasons|3
178420|NCT00107653|559709|P1|Overall Study|Administrative Reasons|3
178421|NCT00107653|559708|P2|Overall Study|Lost to Follow-up|5
178422|NCT00107653|559709|P1|Overall Study|Lost to Follow-up|13
178423|NCT00107653|559708|P2|Overall Study|Withdrawal by Subject|13
178424|NCT00107653|559709|P1|Overall Study|Withdrawal by Subject|12
178425|NCT00107653|559708|P2|Overall Study|Protocol Violation|0
178426|NCT00107653|559709|P1|Overall Study|Protocol Violation|1
178427|NCT00107653|559708|P2|Overall Study|Violation of Selection Criteria at Entry|1
178428|NCT00107653|559709|P1|Overall Study|Violation of Selection Criteria at Entry|1
178429|NCT00107653|559708|P2|Overall Study|Insufficient Therapeutic Response|11
178430|NCT00107653|559709|P1|Overall Study|Insufficient Therapeutic Response|25
178431|NCT00107653|559708|P2|Overall Study|Adverse Event|43
178432|NCT00107653|559709|P1|Overall Study|Adverse Event|24
178433|NCT00107614|559755|P1|Overall Study|Death|2
178434|NCT00107614|559755|P1|Overall Study|Physician Decision|10
178435|NCT00108160|559808|P2|Overall Study|Protocol Violation|5
178436|NCT00108160|559809|P1|Overall Study|Protocol Violation|9
178437|NCT00108160|559808|P2|Overall Study|Withdrawal by Subject|2
178438|NCT00108160|559809|P1|Overall Study|Withdrawal by Subject|4
178439|NCT00108160|559808|P2|Overall Study|Death|2
178440|NCT00108160|559809|P1|Overall Study|Death|1
178441|NCT00108160|559808|P2|Overall Study|Lost to Follow-up|12
178442|NCT00108160|559809|P1|Overall Study|Lost to Follow-up|25
178443|NCT00108082|559822|P3|Overall Study|Blood Pressure Not Controlled|0
178444|NCT00108082|559823|P2|Overall Study|Blood Pressure Not Controlled|0
178445|NCT00108082|559824|P1|Overall Study|Blood Pressure Not Controlled|1
178446|NCT00108082|559822|P3|Overall Study|Investigator Not at Site|0
178447|NCT00108082|559823|P2|Overall Study|Investigator Not at Site|0
178448|NCT00108082|559824|P1|Overall Study|Investigator Not at Site|1
178449|NCT00108082|559822|P3|Overall Study|Subject Left Site Location|0
178450|NCT00108082|559823|P2|Overall Study|Subject Left Site Location|0
178451|NCT00108082|559824|P1|Overall Study|Subject Left Site Location|1
178452|NCT00108082|559822|P3|Overall Study|Study Medication Not Tapered|0
178453|NCT00108082|559823|P2|Overall Study|Study Medication Not Tapered|1
178454|NCT00108082|559824|P1|Overall Study|Study Medication Not Tapered|0
178455|NCT00108082|559822|P3|Overall Study|Protocol Amendment|0
178456|NCT00108082|559823|P2|Overall Study|Protocol Amendment|1
178457|NCT00108082|559824|P1|Overall Study|Protocol Amendment|0
178458|NCT00108082|559822|P3|Overall Study|Site Closed Study|0
178459|NCT00108082|559823|P2|Overall Study|Site Closed Study|2
178460|NCT00108082|559824|P1|Overall Study|Site Closed Study|0
178461|NCT00108082|559822|P3|Overall Study|Stopped Study Medication|1
178462|NCT00108082|559823|P2|Overall Study|Stopped Study Medication|0
178463|NCT00108082|559824|P1|Overall Study|Stopped Study Medication|0
178464|NCT00108082|559822|P3|Overall Study|Non-compliance|2
178465|NCT00108082|559823|P2|Overall Study|Non-compliance|0
178466|NCT00108082|559824|P1|Overall Study|Non-compliance|1
178467|NCT00108082|559822|P3|Overall Study|Incorrectly Randomized|2
178468|NCT00108082|559823|P2|Overall Study|Incorrectly Randomized|0
178469|NCT00108082|559824|P1|Overall Study|Incorrectly Randomized|0
178470|NCT00108082|559822|P3|Overall Study|Woman of Child-bearing Potential|2
178471|NCT00108082|559823|P2|Overall Study|Woman of Child-bearing Potential|0
178472|NCT00108082|559824|P1|Overall Study|Woman of Child-bearing Potential|2
178473|NCT00108082|559822|P3|Overall Study|Amendment 4: > Month 12|5
178474|NCT00108082|559823|P2|Overall Study|Amendment 4: > Month 12|7
178475|NCT00108082|559824|P1|Overall Study|Amendment 4: > Month 12|5
178476|NCT00108082|559822|P3|Overall Study|Lack of Efficacy|2
178477|NCT00108082|559823|P2|Overall Study|Lack of Efficacy|1
178478|NCT00108082|559824|P1|Overall Study|Lack of Efficacy|3
178479|NCT00108082|559822|P3|Overall Study|Protocol Violation|0
178480|NCT00108082|559823|P2|Overall Study|Protocol Violation|2
178481|NCT00108082|559824|P1|Overall Study|Protocol Violation|1
178482|NCT00108082|559822|P3|Overall Study|Consent Withdrawn|5
178483|NCT00108082|559823|P2|Overall Study|Consent Withdrawn|3
178484|NCT00108082|559824|P1|Overall Study|Consent Withdrawn|3
178485|NCT00108082|559822|P3|Overall Study|Lost to Follow-up|7
178486|NCT00108082|559823|P2|Overall Study|Lost to Follow-up|3
178487|NCT00108082|559824|P1|Overall Study|Lost to Follow-up|6
178488|NCT00108082|559822|P3|Overall Study|Adverse Event|17
178489|NCT00108082|559823|P2|Overall Study|Adverse Event|12
178490|NCT00108082|559824|P1|Overall Study|Adverse Event|14
178491|NCT00108069|559873|P2|Overall Study|Progessive disease|11
178492|NCT00108069|559874|P1|Overall Study|Progessive disease|27
178493|NCT00108069|559873|P2|Overall Study|Death|0
178494|NCT00108069|559874|P1|Overall Study|Death|1
178495|NCT00108069|559873|P2|Overall Study|Withdrawal by Subject|0
178496|NCT00108069|559874|P1|Overall Study|Withdrawal by Subject|1
178497|NCT00108069|559873|P2|Overall Study|Adverse Event|1
178498|NCT00108069|559874|P1|Overall Study|Adverse Event|1
178499|NCT00108069|559873|P2|Overall Study|Never rec'd study drug|1
178500|NCT00108069|559874|P1|Overall Study|Never rec'd study drug|0
178501|NCT00107991|559888|P1|18-Week Post Treatment Assessment|Adverse Event|2
178502|NCT00107991|559888|P1|12 Week Treatment Period|Incarcerated|1
178503|NCT00107991|559888|P1|12 Week Treatment Period|Protocol Violation|1
178504|NCT00107991|559888|P1|12 Week Treatment Period|Adverse Event|1
178505|NCT00107991|559888|P1|12 Week Treatment Period|Lack of Efficacy|2
178506|NCT00107991|559888|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
178507|NCT00107991|559888|P1|Eligibility Assessment|chronic uncontrolled asthma|1
178508|NCT00107991|559888|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
178509|NCT00107991|559888|P1|Eligibility Assessment|Abnormal labs|2
178510|NCT00107991|559888|P1|Eligibility Assessment|Postive PPD|4
178511|NCT00107991|559888|P1|Eligibility Assessment|Unwilling to participate|7
178512|NCT00107991|559888|P1|Eligibility Assessment|Disease not severe enough|7
178513|NCT00107978|559898|P2|Overall Study|Other|4
178514|NCT00107978|559899|P1|Overall Study|Other|5
178515|NCT00107978|559898|P2|Overall Study|Protocol Violation|1
178516|NCT00107978|559899|P1|Overall Study|Protocol Violation|0
178517|NCT00107978|559898|P2|Overall Study|Withdrawal by Subject|9
178518|NCT00107978|559899|P1|Overall Study|Withdrawal by Subject|4
178519|NCT00107978|559898|P2|Overall Study|Lost to Follow-up|28
178520|NCT00107978|559899|P1|Overall Study|Lost to Follow-up|20
178521|NCT00107978|559898|P2|Overall Study|Death|3
178522|NCT00107978|559899|P1|Overall Study|Death|3
178523|NCT00107978|559898|P2|Overall Study|Adverse Event|5
178524|NCT00107978|559899|P1|Overall Study|Adverse Event|1
178525|NCT00107952|559907|P2|Overall Study|Never received study treatment|6
178526|NCT00107952|559908|P1|Overall Study|Never received study treatment|9
178527|NCT00107952|559907|P2|Overall Study|Other|5
178528|NCT00107952|559908|P1|Overall Study|Other|2
178529|NCT00107952|559907|P2|Overall Study|Withdrawal by Subject|6
178530|NCT00107952|559908|P1|Overall Study|Withdrawal by Subject|9
178531|NCT00107952|559907|P2|Overall Study|Lost to Follow-up|3
178532|NCT00107952|559908|P1|Overall Study|Lost to Follow-up|0
178533|NCT00107952|559907|P2|Overall Study|Death|61
178534|NCT00107952|559908|P1|Overall Study|Death|75
178535|NCT00107380|559924|P1|Overall Study|Ineligible|2
178536|NCT00107380|559924|P1|Overall Study|Other - not protocol specified|7
178537|NCT00107380|559924|P1|Overall Study|Death|3
178538|NCT00107380|559924|P1|Overall Study|Progression/relapse|4
178539|NCT00107380|559924|P1|Overall Study|Refusal Unrelated to Adverse Event|7
178540|NCT00107380|559924|P1|Overall Study|Adverse Event|7
178541|NCT00107315|559930|P1|Overall Study|Withdrawal by Subject|2
178542|NCT00107315|559930|P1|Overall Study|Adverse Event|4
178543|NCT00107315|559930|P1|Overall Study|Disease Progression|9
178544|NCT00107276|559937|P1|Overall Study|Ineligible|16
178545|NCT00107276|559937|P1|Overall Study|Death|1
178546|NCT00107276|559937|P1|Overall Study|Patient refusal|1
178547|NCT00107276|559937|P1|Overall Study|M.D. decision|2
178548|NCT00107276|559937|P1|Overall Study|Adverse Event|6
178549|NCT00107276|559937|P1|Overall Study|Progression|46
178550|NCT00107198|559943|P1|Overall Study|Ineligible|5
178551|NCT00107198|559943|P1|Overall Study|Withdrawal by Subject|6
178552|NCT00107198|559943|P1|Overall Study|Protocol Violation|1
178553|NCT00107198|559943|P1|Overall Study|Lost to Follow-up|12
178554|NCT00107198|559943|P1|Overall Study|Lack of Efficacy|28
178555|NCT00107172|559953|P2|Overall Study|Other Reason|3
178556|NCT00107172|559954|P1|Overall Study|Other Reason|4
178557|NCT00107172|559953|P2|Overall Study|Death|2
178558|NCT00107172|559954|P1|Overall Study|Death|0
178559|NCT00107172|559953|P2|Overall Study|Withdrawal by Subject|0
178560|NCT00107172|559954|P1|Overall Study|Withdrawal by Subject|1
178561|NCT00107120|559984|P2|Overall Study|death of parent|1
178562|NCT00107120|559985|P1|Overall Study|death of parent|0
178563|NCT00107120|559984|P2|Overall Study|moving away from site|1
178564|NCT00107120|559985|P1|Overall Study|moving away from site|1
178565|NCT00107120|559984|P2|Overall Study|Pregnancy|1
178566|NCT00107120|559985|P1|Overall Study|Pregnancy|0
178567|NCT00107120|559984|P2|Overall Study|Lost to Follow-up|6
178568|NCT00107120|559985|P1|Overall Study|Lost to Follow-up|8
178569|NCT00107120|559984|P2|Overall Study|Withdrawal by Subject|9
178570|NCT00107120|559985|P1|Overall Study|Withdrawal by Subject|8
178571|NCT00107120|559984|P2|Overall Study|Protocol Violation|0
178572|NCT00107120|559985|P1|Overall Study|Protocol Violation|3
178573|NCT00107120|559984|P2|Overall Study|Lack of Efficacy|5
178574|NCT00107120|559985|P1|Overall Study|Lack of Efficacy|5
178575|NCT00107120|559984|P2|Overall Study|Adverse Event|1
178576|NCT00107120|559985|P1|Overall Study|Adverse Event|4
178577|NCT00107042|559997|P2|Overall Study|Disallowed medications|2
178578|NCT00107042|559998|P1|Overall Study|Disallowed medications|0
178579|NCT00107042|559997|P2|Overall Study|vaccinated outside window|1
178580|NCT00107042|559998|P1|Overall Study|vaccinated outside window|1
178581|NCT00107042|559997|P2|Overall Study|Inadvertent enrollment|1
178582|NCT00107042|559998|P1|Overall Study|Inadvertent enrollment|0
178583|NCT00107042|559997|P2|Overall Study|Pregnancy|1
178584|NCT00107042|559998|P1|Overall Study|Pregnancy|1
178585|NCT00107042|559997|P2|Overall Study|Moved out of area|3
178586|NCT00107042|559998|P1|Overall Study|Moved out of area|5
178587|NCT00107042|559997|P2|Overall Study|Withdrawal by Subject|1
178588|NCT00107042|559998|P1|Overall Study|Withdrawal by Subject|6
178589|NCT00107042|559997|P2|Overall Study|Lost to Follow-up|7
178590|NCT00107042|559998|P1|Overall Study|Lost to Follow-up|9
178591|NCT00106964|560064|P3|Overall Study|Required disallowed medication|0
178592|NCT00106964|560065|P2|Overall Study|Required disallowed medication|1
178593|NCT00106964|560066|P1|Overall Study|Required disallowed medication|0
178594|NCT00106964|560064|P3|Overall Study|Did not meet eligibility criteria|2
178595|NCT00106964|560065|P2|Overall Study|Did not meet eligibility criteria|2
178596|NCT00106964|560066|P1|Overall Study|Did not meet eligibility criteria|0
178597|NCT00106964|560064|P3|Overall Study|Failure to adhere|0
178598|NCT00106964|560065|P2|Overall Study|Failure to adhere|0
178599|NCT00106964|560066|P1|Overall Study|Failure to adhere|2
178600|NCT00106964|560064|P3|Overall Study|Site Funding Terminated|1
178601|NCT00106964|560065|P2|Overall Study|Site Funding Terminated|1
178602|NCT00106964|560066|P1|Overall Study|Site Funding Terminated|0
178603|NCT00106964|560064|P3|Overall Study|Incarceration|0
178604|NCT00106964|560065|P2|Overall Study|Incarceration|1
178605|NCT00106964|560066|P1|Overall Study|Incarceration|0
178606|NCT00106964|560064|P3|Overall Study|Death|0
178607|NCT00106964|560065|P2|Overall Study|Death|1
178608|NCT00106964|560066|P1|Overall Study|Death|1
178609|NCT00106964|560064|P3|Overall Study|Pregnancy|2
178610|NCT00106964|560065|P2|Overall Study|Pregnancy|3
178611|NCT00106964|560066|P1|Overall Study|Pregnancy|2
178612|NCT00106964|560064|P3|Overall Study|Lost to Follow-up|2
178613|NCT00106964|560065|P2|Overall Study|Lost to Follow-up|6
178614|NCT00106964|560066|P1|Overall Study|Lost to Follow-up|8
178615|NCT00106704|560139|P2|Overall Study|Laboratory test|1
178616|NCT00106704|560140|P1|Overall Study|Laboratory test|1
178617|NCT00106704|560139|P2|Overall Study|Unable to re-enter US|0
178618|NCT00106704|560140|P1|Overall Study|Unable to re-enter US|1
178619|NCT00106704|560139|P2|Overall Study|Patient Received Glycemic Medication|41
178620|NCT00106704|560140|P1|Overall Study|Patient Received Glycemic Medication|22
178621|NCT00106704|560139|P2|Overall Study|Planned major surgery|0
178622|NCT00106704|560140|P1|Overall Study|Planned major surgery|1
178623|NCT00106704|560139|P2|Overall Study|Site terminated|1
178624|NCT00106704|560140|P1|Overall Study|Site terminated|0
178625|NCT00106704|560139|P2|Overall Study|Patient moved|0
178626|NCT00106704|560140|P1|Overall Study|Patient moved|1
178627|NCT00106704|560139|P2|Overall Study|Withdrawal by Subject|21
178628|NCT00106704|560140|P1|Overall Study|Withdrawal by Subject|14
178629|NCT00106704|560139|P2|Overall Study|Protocol Violation|7
178630|NCT00106704|560140|P1|Overall Study|Protocol Violation|4
178631|NCT00106704|560139|P2|Overall Study|Pregnancy|0
178632|NCT00106704|560140|P1|Overall Study|Pregnancy|1
178633|NCT00106704|560139|P2|Overall Study|Lost to Follow-up|3
178634|NCT00106704|560140|P1|Overall Study|Lost to Follow-up|7
178635|NCT00106704|560139|P2|Overall Study|Lack of Efficacy|69
178636|NCT00106704|560140|P1|Overall Study|Lack of Efficacy|67
178637|NCT00106704|560139|P2|Overall Study|Death|1
178638|NCT00106704|560140|P1|Overall Study|Death|2
178639|NCT00106704|560139|P2|Overall Study|Adverse Event|7
178640|NCT00106704|560140|P1|Overall Study|Adverse Event|10
178641|NCT00106639|560151|P3|Overall Study|Participant defaulted|1
178642|NCT00106639|560152|P2|Overall Study|Participant defaulted|1
178643|NCT00106639|560153|P1|Overall Study|Participant defaulted|0
178644|NCT00106639|560151|P3|Overall Study|Withdrawal by Subject|0
178645|NCT00106639|560152|P2|Overall Study|Withdrawal by Subject|1
178646|NCT00106639|560153|P1|Overall Study|Withdrawal by Subject|0
178647|NCT00106639|560151|P3|Overall Study|Protocol Violation|0
178648|NCT00106639|560152|P2|Overall Study|Protocol Violation|1
178649|NCT00106639|560153|P1|Overall Study|Protocol Violation|0
178650|NCT00106639|560151|P3|Overall Study|Adverse Event|1
178651|NCT00106639|560152|P2|Overall Study|Adverse Event|4
178652|NCT00106639|560153|P1|Overall Study|Adverse Event|3
178653|NCT00106626|560280|P4|Overall Study|> 14 day delay in therapy start|0
178654|NCT00106626|560281|P3|Overall Study|> 14 day delay in therapy start|0
178655|NCT00106626|560282|P2|Overall Study|> 14 day delay in therapy start|1
178656|NCT00106626|560283|P1|Overall Study|> 14 day delay in therapy start|0
178657|NCT00106626|560280|P4|Overall Study|Received radiation on new therapy|0
178658|NCT00106626|560281|P3|Overall Study|Received radiation on new therapy|0
178659|NCT00106626|560282|P2|Overall Study|Received radiation on new therapy|0
178660|NCT00106626|560283|P1|Overall Study|Received radiation on new therapy|1
178661|NCT00106626|560280|P4|Overall Study|Progressive Disease|10
178662|NCT00106626|560281|P3|Overall Study|Progressive Disease|9
178663|NCT00106626|560282|P2|Overall Study|Progressive Disease|1
178664|NCT00106626|560283|P1|Overall Study|Progressive Disease|4
178665|NCT00106626|560280|P4|Overall Study|Adverse Event|3
178666|NCT00106626|560281|P3|Overall Study|Adverse Event|3
178667|NCT00106626|560282|P2|Overall Study|Adverse Event|4
178668|NCT00106626|560283|P1|Overall Study|Adverse Event|5
178669|NCT00106353|560628|P7|Part 2|Physician Decision|0
178670|NCT00106353|560629|P6|Part 2|Physician Decision|1
178671|NCT00106353|560630|P5|Part 2|Physician Decision|0
178672|NCT00106353|560631|P4|Part 2|Physician Decision|0
178673|NCT00106353|560632|P3|Part 2|Physician Decision|0
178674|NCT00106353|560633|P2|Part 2|Physician Decision|0
178675|NCT00106353|560634|P1|Part 2|Physician Decision|0
178676|NCT00106353|560628|P7|Part 2|Withdrawal by Subject|0
178677|NCT00106353|560629|P6|Part 2|Withdrawal by Subject|0
178678|NCT00106353|560630|P5|Part 2|Withdrawal by Subject|1
178679|NCT00106353|560631|P4|Part 2|Withdrawal by Subject|0
178680|NCT00106353|560632|P3|Part 2|Withdrawal by Subject|0
178681|NCT00106353|560633|P2|Part 2|Withdrawal by Subject|0
178682|NCT00106353|560634|P1|Part 2|Withdrawal by Subject|0
178683|NCT00106353|560628|P7|Part 2|Unspecified|1
178684|NCT00106353|560629|P6|Part 2|Unspecified|1
178685|NCT00106353|560630|P5|Part 2|Unspecified|1
178686|NCT00106353|560631|P4|Part 2|Unspecified|0
178687|NCT00106353|560632|P3|Part 2|Unspecified|0
178688|NCT00106353|560633|P2|Part 2|Unspecified|0
178689|NCT00106353|560634|P1|Part 2|Unspecified|0
178690|NCT00106353|560628|P7|Part 2|Adverse Event|1
178691|NCT00106353|560629|P6|Part 2|Adverse Event|2
178692|NCT00106353|560630|P5|Part 2|Adverse Event|0
178693|NCT00106353|560631|P4|Part 2|Adverse Event|0
178694|NCT00106353|560632|P3|Part 2|Adverse Event|0
178695|NCT00106353|560633|P2|Part 2|Adverse Event|0
178696|NCT00106353|560634|P1|Part 2|Adverse Event|0
178697|NCT00106353|560628|P7|Part 2|Symptomatic deterioration|0
178698|NCT00106353|560629|P6|Part 2|Symptomatic deterioration|0
178699|NCT00106353|560630|P5|Part 2|Symptomatic deterioration|3
178700|NCT00106353|560631|P4|Part 2|Symptomatic deterioration|0
178701|NCT00106353|560632|P3|Part 2|Symptomatic deterioration|0
178702|NCT00106353|560633|P2|Part 2|Symptomatic deterioration|0
178703|NCT00106353|560634|P1|Part 2|Symptomatic deterioration|0
178704|NCT00106353|560628|P7|Part 2|Death|1
178705|NCT00106353|560629|P6|Part 2|Death|0
178706|NCT00106353|560630|P5|Part 2|Death|3
178707|NCT00106353|560631|P4|Part 2|Death|0
178708|NCT00106353|560632|P3|Part 2|Death|0
178709|NCT00106353|560633|P2|Part 2|Death|0
178710|NCT00106353|560634|P1|Part 2|Death|0
178711|NCT00106353|560628|P7|Part 2|Disease progression|13
178712|NCT00106353|560629|P6|Part 2|Disease progression|14
178713|NCT00106353|560630|P5|Part 2|Disease progression|8
178714|NCT00106353|560631|P4|Part 2|Disease progression|0
178715|NCT00106353|560632|P3|Part 2|Disease progression|0
178716|NCT00106353|560633|P2|Part 2|Disease progression|0
178717|NCT00106353|560634|P1|Part 2|Disease progression|0
178718|NCT00106353|560628|P7|Part 1|Adverse Event|0
178719|NCT00106353|560629|P6|Part 1|Adverse Event|0
178720|NCT00106353|560630|P5|Part 1|Adverse Event|0
178721|NCT00106353|560631|P4|Part 1|Adverse Event|1
178722|NCT00106353|560632|P3|Part 1|Adverse Event|0
178723|NCT00106353|560633|P2|Part 1|Adverse Event|0
178724|NCT00106353|560634|P1|Part 1|Adverse Event|0
178725|NCT00106353|560628|P7|Part 1|Entered follow-up phase|0
178726|NCT00106353|560629|P6|Part 1|Entered follow-up phase|0
178727|NCT00106353|560630|P5|Part 1|Entered follow-up phase|0
178728|NCT00106353|560631|P4|Part 1|Entered follow-up phase|1
178729|NCT00106353|560632|P3|Part 1|Entered follow-up phase|0
178730|NCT00106353|560633|P2|Part 1|Entered follow-up phase|1
178731|NCT00106353|560634|P1|Part 1|Entered follow-up phase|1
178732|NCT00106353|560628|P7|Part 1|Symptomatic deterioration|0
178733|NCT00106353|560629|P6|Part 1|Symptomatic deterioration|0
178734|NCT00106353|560630|P5|Part 1|Symptomatic deterioration|0
178735|NCT00106353|560631|P4|Part 1|Symptomatic deterioration|0
178736|NCT00106353|560632|P3|Part 1|Symptomatic deterioration|1
178737|NCT00106353|560633|P2|Part 1|Symptomatic deterioration|0
178738|NCT00106353|560634|P1|Part 1|Symptomatic deterioration|0
178739|NCT00106353|560628|P7|Part 1|Withdrawal by Subject|0
178740|NCT00106353|560629|P6|Part 1|Withdrawal by Subject|0
178741|NCT00106353|560630|P5|Part 1|Withdrawal by Subject|0
178742|NCT00106353|560631|P4|Part 1|Withdrawal by Subject|2
178743|NCT00106353|560632|P3|Part 1|Withdrawal by Subject|1
178744|NCT00106353|560633|P2|Part 1|Withdrawal by Subject|0
178745|NCT00106353|560634|P1|Part 1|Withdrawal by Subject|0
178746|NCT00106353|560628|P7|Part 1|Disease progression|0
178747|NCT00106353|560629|P6|Part 1|Disease progression|0
178748|NCT00106353|560630|P5|Part 1|Disease progression|0
178749|NCT00106353|560631|P4|Part 1|Disease progression|3
178750|NCT00106353|560632|P3|Part 1|Disease progression|1
178751|NCT00106353|560633|P2|Part 1|Disease progression|4
178752|NCT00106353|560634|P1|Part 1|Disease progression|3
178753|NCT00106249|560761|P2|Overall Study|Lost to Follow-up|2
178754|NCT00106249|560762|P1|Overall Study|Lost to Follow-up|3
178755|NCT00106184|560774|P2|Overall Study|Withdrawal by Subject|2
178756|NCT00106184|560775|P1|Overall Study|Withdrawal by Subject|3
178757|NCT00106080|560817|P2|Overall Study|Withdrew/Loss to follow-up|27
178758|NCT00106080|560818|P1|Overall Study|Withdrew/Loss to follow-up|43
178759|NCT00106028|560828|P2|Overall Study|Lost to Follow-up|1
178760|NCT00106028|560829|P1|Overall Study|Lost to Follow-up|0
178761|NCT00106028|560828|P2|Overall Study|Withdrawal by Subject|8
178762|NCT00106028|560829|P1|Overall Study|Withdrawal by Subject|2
178763|NCT00106028|560828|P2|Overall Study|Protocol Violation|1
178764|NCT00106028|560829|P1|Overall Study|Protocol Violation|1
178765|NCT00106028|560828|P2|Overall Study|Adverse Event|2
178766|NCT00106028|560829|P1|Overall Study|Adverse Event|3
178767|NCT00106002|560923|P1|Overall Study|Ineligible after Registration|1
178768|NCT00106002|560923|P1|Overall Study|Did not take any study drug|1
178769|NCT00105989|560931|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
178770|NCT00105989|560932|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
178771|NCT00105989|560931|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
178772|NCT00105989|560932|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
178773|NCT00105989|560931|P2|Maintenance - Double-Blind:Week 34-86|Death|0
178774|NCT00105989|560932|P1|Maintenance - Double-Blind:Week 34-86|Death|0
178775|NCT00105989|560931|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
178776|NCT00105989|560932|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
178777|NCT00105989|560931|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
178778|NCT00105989|560932|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
178779|NCT00105989|560931|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
178780|NCT00105989|560932|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
178781|NCT00105989|560931|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
178782|NCT00105989|560932|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
178783|NCT00105989|560931|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
178784|NCT00105989|560932|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
178785|NCT00105989|560931|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
178786|NCT00105989|560932|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
178787|NCT00105989|560931|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
178788|NCT00105989|560932|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
178789|NCT00105989|560931|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
178790|NCT00105989|560932|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
178791|NCT00105989|560931|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
178792|NCT00105989|560932|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
178793|NCT00105989|560931|P2|Continuation - Open Label:Week 10-34|Death|0
178794|NCT00105989|560932|P1|Continuation - Open Label:Week 10-34|Death|0
178795|NCT00105989|560931|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
178796|NCT00105989|560932|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
178797|NCT00105989|560931|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
178798|NCT00105989|560932|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
178799|NCT00105989|560931|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
178800|NCT00105989|560932|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
178801|NCT00105989|560931|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
178802|NCT00105989|560932|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
178803|NCT00105989|560931|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
178804|NCT00105989|560932|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
178805|NCT00105989|560931|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
178806|NCT00105989|560932|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
178807|NCT00105989|560931|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
178808|NCT00105989|560932|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
178809|NCT00105989|560931|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
178810|NCT00105989|560932|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
178811|NCT00105989|560931|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
178812|NCT00105989|560932|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
178813|NCT00105989|560931|P2|Acute - Open Label: Week 0-10|Death|0
178814|NCT00105989|560932|P1|Acute - Open Label: Week 0-10|Death|1
178815|NCT00105989|560931|P2|Acute - Open Label: Week 0-10|Physician Decision|0
178816|NCT00105989|560932|P1|Acute - Open Label: Week 0-10|Physician Decision|0
178817|NCT00105989|560931|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
178818|NCT00105989|560932|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
178819|NCT00105989|560931|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
178820|NCT00105989|560932|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
178821|NCT00105989|560931|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
178822|NCT00105989|560932|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
178823|NCT00105989|560931|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
178824|NCT00105989|560932|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
178825|NCT00105989|560931|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
178826|NCT00105989|560932|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
178827|NCT00105989|560931|P2|Acute - Open Label: Week 0-10|Adverse Event|0
178828|NCT00105989|560932|P1|Acute - Open Label: Week 0-10|Adverse Event|33
178829|NCT00105534|561048|P2|Overall Study|Other Reason|2
178830|NCT00105534|561049|P1|Overall Study|Other Reason|0
178831|NCT00105534|561048|P2|Overall Study|Treatment unmasked|0
178832|NCT00105534|561049|P1|Overall Study|Treatment unmasked|1
178833|NCT00105534|561048|P2|Overall Study|Lack of Efficacy|15
178834|NCT00105534|561049|P1|Overall Study|Lack of Efficacy|7
178835|NCT00105534|561048|P2|Overall Study|Lost to Follow-up|1
178836|NCT00105534|561049|P1|Overall Study|Lost to Follow-up|5
178837|NCT00105534|561048|P2|Overall Study|Withdrawal by Subject|6
178838|NCT00105534|561049|P1|Overall Study|Withdrawal by Subject|6
178839|NCT00105534|561048|P2|Overall Study|Protocol Violation|4
178840|NCT00105534|561049|P1|Overall Study|Protocol Violation|1
178841|NCT00105534|561048|P2|Overall Study|Adverse Event|5
178842|NCT00105534|561049|P1|Overall Study|Adverse Event|2
178843|NCT00105482|561059|P2|Overall Study|Withdrawn by PI|1
178844|NCT00105482|561060|P1|Overall Study|Withdrawn by PI|1
178845|NCT00105482|561059|P2|Overall Study|Scheduling Conflict|3
178846|NCT00105482|561060|P1|Overall Study|Scheduling Conflict|2
178847|NCT00105482|561059|P2|Overall Study|Lost Interest|32
178848|NCT00105482|561060|P1|Overall Study|Lost Interest|29
178849|NCT00105482|561059|P2|Overall Study|Withdrawal by Subject|1
178850|NCT00105482|561060|P1|Overall Study|Withdrawal by Subject|0
178851|NCT00105482|561059|P2|Overall Study|Lost to Follow-up|17
178852|NCT00105482|561060|P1|Overall Study|Lost to Follow-up|26
178853|NCT00105482|561059|P2|Overall Study|Adverse Event|1
178854|NCT00105482|561060|P1|Overall Study|Adverse Event|1
178855|NCT00105469|561076|P2|Overall Study|Other Reason|0
178856|NCT00105469|561077|P1|Overall Study|Other Reason|4
178857|NCT00105469|561076|P2|Overall Study|Lack of Efficacy|0
178858|NCT00105469|561077|P1|Overall Study|Lack of Efficacy|2
178859|NCT00105469|561076|P2|Overall Study|Lost to Follow-up|0
178860|NCT00105469|561077|P1|Overall Study|Lost to Follow-up|1
178861|NCT00105469|561076|P2|Overall Study|Withdrawal by Subject|3
178862|NCT00105469|561077|P1|Overall Study|Withdrawal by Subject|2
178863|NCT00105469|561076|P2|Overall Study|Protocol Violation|0
178864|NCT00105469|561077|P1|Overall Study|Protocol Violation|4
178865|NCT00105469|561076|P2|Overall Study|Adverse Event|8
178866|NCT00105469|561077|P1|Overall Study|Adverse Event|9
178867|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
178868|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
178869|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
178870|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
178871|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
178872|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
178873|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
178874|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
178875|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
178876|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
178877|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
178878|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
178879|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
178880|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
178881|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
178882|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
178883|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
178884|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
178885|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
178886|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
178887|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
178888|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
178889|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
178890|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
178891|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
178892|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
178893|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
178894|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
178895|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
178896|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
178897|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
178898|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
178899|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
178900|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
178901|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
178902|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
178903|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
178904|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
178905|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
178906|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
178907|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
178908|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
178909|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
178910|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
178911|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
178912|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
178913|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
178914|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
178915|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
178916|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
178917|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
178918|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
178919|NCT00105443|561087|P4|Follow-up and/or Open Label Nexavar|Death|4
178920|NCT00105443|561088|P3|Follow-up and/or Open Label Nexavar|Death|219
178921|NCT00105443|561089|P2|Follow-up and/or Open Label Nexavar|Death|7
178922|NCT00105443|561090|P1|Follow-up and/or Open Label Nexavar|Death|180
178923|NCT00105443|561087|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
179173|NCT00104299|561633|P1|Overall Study|To have renal transplant|1
178924|NCT00105443|561088|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
178925|NCT00105443|561089|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
178926|NCT00105443|561090|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
178927|NCT00105443|561087|P4|Double-Blind Treatment|Physician Decision|0
178928|NCT00105443|561088|P3|Double-Blind Treatment|Physician Decision|2
178929|NCT00105443|561089|P2|Double-Blind Treatment|Physician Decision|0
178930|NCT00105443|561090|P1|Double-Blind Treatment|Physician Decision|1
178931|NCT00105443|561087|P4|Double-Blind Treatment|Withdrawal by Subject|0
178932|NCT00105443|561088|P3|Double-Blind Treatment|Withdrawal by Subject|7
178933|NCT00105443|561089|P2|Double-Blind Treatment|Withdrawal by Subject|0
178934|NCT00105443|561090|P1|Double-Blind Treatment|Withdrawal by Subject|8
178935|NCT00105443|561087|P4|Double-Blind Treatment|Lost to Follow-up|0
178936|NCT00105443|561088|P3|Double-Blind Treatment|Lost to Follow-up|1
178937|NCT00105443|561089|P2|Double-Blind Treatment|Lost to Follow-up|0
178938|NCT00105443|561090|P1|Double-Blind Treatment|Lost to Follow-up|0
178939|NCT00105443|561087|P4|Double-Blind Treatment|Adverse Event|0
178940|NCT00105443|561088|P3|Double-Blind Treatment|Adverse Event|0
178941|NCT00105443|561089|P2|Double-Blind Treatment|Adverse Event|0
178942|NCT00105443|561090|P1|Double-Blind Treatment|Adverse Event|1
178943|NCT00105235|561117|P1|Overall Study|Withdrawal by Subject|2
178944|NCT00105235|561117|P1|Overall Study|Physician Decision|1
178945|NCT00105235|561117|P1|Overall Study|Death|4
178946|NCT00105196|561130|P2|Overall Study|Subject became unblinded|1
178947|NCT00105196|561131|P1|Overall Study|Subject became unblinded|0
178948|NCT00105196|561130|P2|Overall Study|marijuana use|1
178949|NCT00105196|561131|P1|Overall Study|marijuana use|0
178950|NCT00105196|561130|P2|Overall Study|pending surgery|1
178951|NCT00105196|561131|P1|Overall Study|pending surgery|0
178952|NCT00105196|561130|P2|Overall Study|Protocol Violation|2
178953|NCT00105196|561131|P1|Overall Study|Protocol Violation|5
178954|NCT00105196|561130|P2|Overall Study|Poor/noncompliance|4
178955|NCT00105196|561131|P1|Overall Study|Poor/noncompliance|3
178956|NCT00105196|561130|P2|Overall Study|Lost to Follow-up|2
178957|NCT00105196|561131|P1|Overall Study|Lost to Follow-up|3
178958|NCT00105196|561130|P2|Overall Study|Withdrawal by Subject|6
178959|NCT00105196|561131|P1|Overall Study|Withdrawal by Subject|6
178960|NCT00105196|561130|P2|Overall Study|Adverse Event|3
178961|NCT00105196|561131|P1|Overall Study|Adverse Event|11
178962|NCT00105196|561130|P2|Overall Study|Lack of Efficacy|3
178963|NCT00105196|561131|P1|Overall Study|Lack of Efficacy|2
178964|NCT00105183|561154|P3|Overall Study|Other reason|0
178965|NCT00105183|561155|P2|Overall Study|Other reason|2
178966|NCT00105183|561156|P1|Overall Study|Other reason|1
178967|NCT00105183|561154|P3|Overall Study|Lost to Follow-up|1
178968|NCT00105183|561155|P2|Overall Study|Lost to Follow-up|1
178969|NCT00105183|561156|P1|Overall Study|Lost to Follow-up|0
178970|NCT00105183|561154|P3|Overall Study|Physician Decision|3
178971|NCT00105183|561155|P2|Overall Study|Physician Decision|2
178972|NCT00105183|561156|P1|Overall Study|Physician Decision|1
178973|NCT00105183|561154|P3|Overall Study|Withdrawal by Subject|4
178974|NCT00105183|561155|P2|Overall Study|Withdrawal by Subject|1
178975|NCT00105183|561156|P1|Overall Study|Withdrawal by Subject|1
178976|NCT00105183|561154|P3|Overall Study|Death|15
178977|NCT00105183|561155|P2|Overall Study|Death|13
178978|NCT00105183|561156|P1|Overall Study|Death|19
178979|NCT00105157|561192|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
178980|NCT00105157|561193|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
178981|NCT00105157|561194|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
178982|NCT00105157|561195|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
178983|NCT00105157|561192|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
178984|NCT00105157|561193|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
178985|NCT00105157|561194|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
178986|NCT00105157|561195|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
178987|NCT00105157|561192|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
178988|NCT00105157|561193|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
178989|NCT00105157|561194|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
178990|NCT00105157|561195|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
178991|NCT00105157|561192|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
178992|NCT00105157|561193|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
178993|NCT00105157|561194|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
178994|NCT00105157|561195|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
178995|NCT00105157|561192|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
178996|NCT00105157|561193|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
178997|NCT00105157|561194|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
178998|NCT00105157|561195|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
178999|NCT00105157|561192|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
179000|NCT00105157|561193|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
179001|NCT00105157|561194|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
179002|NCT00105157|561195|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
179172|NCT00104299|561632|P2|Overall Study|To have renal transplant|0
179003|NCT00105157|561192|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
179004|NCT00105157|561193|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
179005|NCT00105157|561194|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
179006|NCT00105157|561195|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
179007|NCT00105157|561192|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
179008|NCT00105157|561193|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
179009|NCT00105157|561194|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
179010|NCT00105157|561195|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
179011|NCT00105157|561192|P4|Open-Label Continuation of DB|Lost to Follow-up|0
179012|NCT00105157|561193|P3|Open-Label Continuation of DB|Lost to Follow-up|1
179013|NCT00105157|561194|P2|Open-Label Continuation of DB|Lost to Follow-up|1
179014|NCT00105157|561195|P1|Open-Label Continuation of DB|Lost to Follow-up|1
179015|NCT00105157|561192|P4|Open-Label Continuation of DB|Lack of Efficacy|1
179016|NCT00105157|561193|P3|Open-Label Continuation of DB|Lack of Efficacy|3
179017|NCT00105157|561194|P2|Open-Label Continuation of DB|Lack of Efficacy|4
179018|NCT00105157|561195|P1|Open-Label Continuation of DB|Lack of Efficacy|1
179019|NCT00105157|561192|P4|Open-Label Continuation of DB|Adverse Event|0
179020|NCT00105157|561193|P3|Open-Label Continuation of DB|Adverse Event|0
179021|NCT00105157|561194|P2|Open-Label Continuation of DB|Adverse Event|1
179022|NCT00105157|561195|P1|Open-Label Continuation of DB|Adverse Event|3
179023|NCT00105157|561192|P4|Double-Blind (DB)|Lack of Efficacy|38
179024|NCT00105157|561193|P3|Double-Blind (DB)|Lack of Efficacy|11
179025|NCT00105157|561194|P2|Double-Blind (DB)|Lack of Efficacy|14
179026|NCT00105157|561195|P1|Double-Blind (DB)|Lack of Efficacy|11
179027|NCT00105157|561192|P4|Double-Blind (DB)|Adverse Event|1
179028|NCT00105157|561193|P3|Double-Blind (DB)|Adverse Event|1
179029|NCT00105157|561194|P2|Double-Blind (DB)|Adverse Event|0
179030|NCT00105157|561195|P1|Double-Blind (DB)|Adverse Event|2
179031|NCT00105157|561192|P4|Double-Blind (DB)|Never Treated|0
179032|NCT00105157|561193|P3|Double-Blind (DB)|Never Treated|0
179033|NCT00105157|561194|P2|Double-Blind (DB)|Never Treated|0
179034|NCT00105157|561195|P1|Double-Blind (DB)|Never Treated|1
179035|NCT00105079|561389|P2|Overall Study|not specified|1
179036|NCT00105079|561390|P1|Overall Study|not specified|3
179037|NCT00105079|561389|P2|Overall Study|Protocol Violation|0
179038|NCT00105079|561390|P1|Overall Study|Protocol Violation|1
179039|NCT00105079|561389|P2|Overall Study|Violation of selection criteria at entry|2
179040|NCT00105079|561390|P1|Overall Study|Violation of selection criteria at entry|0
179041|NCT00105079|561389|P2|Overall Study|Refused treatment|4
179042|NCT00105079|561390|P1|Overall Study|Refused treatment|6
179043|NCT00105079|561389|P2|Overall Study|Lack of Efficacy|3
179044|NCT00105079|561390|P1|Overall Study|Lack of Efficacy|9
179045|NCT00105079|561389|P2|Overall Study|Lost to Follow-up|12
179046|NCT00105079|561390|P1|Overall Study|Lost to Follow-up|12
179047|NCT00105079|561389|P2|Overall Study|Death|1
179048|NCT00105079|561390|P1|Overall Study|Death|3
179049|NCT00105079|561389|P2|Overall Study|Adverse Event|12
179050|NCT00105079|561390|P1|Overall Study|Adverse Event|5
179051|NCT00105066|561408|P2|Overall Study|Adverse Event|5
179052|NCT00105066|561409|P1|Overall Study|Adverse Event|2
179053|NCT00104884|561469|P1|Overall Study|Disease progression|4
179054|NCT00104871|561473|P1|Overall Study|Not evaluable|1
179055|NCT00104728|561478|P1|Overall Study|screen failures|19
179056|NCT00104650|561486|P3|Follow-up Period|Other|0
179057|NCT00104650|561487|P2|Follow-up Period|Other|1
179058|NCT00104650|561488|P1|Follow-up Period|Other|0
179059|NCT00104650|561486|P3|Follow-up Period|Lost to Follow-up|2
179060|NCT00104650|561487|P2|Follow-up Period|Lost to Follow-up|1
179061|NCT00104650|561488|P1|Follow-up Period|Lost to Follow-up|0
179062|NCT00104650|561486|P3|Follow-up Period|Disease progression|0
179063|NCT00104650|561487|P2|Follow-up Period|Disease progression|1
179064|NCT00104650|561488|P1|Follow-up Period|Disease progression|3
179065|NCT00104650|561486|P3|Follow-up Period|Death|4
179066|NCT00104650|561487|P2|Follow-up Period|Death|6
179067|NCT00104650|561488|P1|Follow-up Period|Death|6
179068|NCT00104650|561486|P3|Follow-up Period|Withdrawal by Subject|3
179069|NCT00104650|561487|P2|Follow-up Period|Withdrawal by Subject|3
179070|NCT00104650|561488|P1|Follow-up Period|Withdrawal by Subject|0
179071|NCT00104650|561486|P3|Follow-up Period|Adverse Event|1
179072|NCT00104650|561487|P2|Follow-up Period|Adverse Event|0
179073|NCT00104650|561488|P1|Follow-up Period|Adverse Event|1
179074|NCT00104650|561486|P3|Follow-up Period|Physician Decision|0
179075|NCT00104650|561487|P2|Follow-up Period|Physician Decision|1
179076|NCT00104650|561488|P1|Follow-up Period|Physician Decision|1
179077|NCT00104650|561486|P3|Treatment Period (25 Weeks)|Protocol deviation|0
179078|NCT00104650|561487|P2|Treatment Period (25 Weeks)|Protocol deviation|1
179079|NCT00104650|561488|P1|Treatment Period (25 Weeks)|Protocol deviation|0
179080|NCT00104650|561486|P3|Treatment Period (25 Weeks)|Other|0
179081|NCT00104650|561487|P2|Treatment Period (25 Weeks)|Other|0
179082|NCT00104650|561488|P1|Treatment Period (25 Weeks)|Other|1
179083|NCT00104650|561486|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
179084|NCT00104650|561487|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
179085|NCT00104650|561488|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
179086|NCT00104650|561486|P3|Treatment Period (25 Weeks)|Disease progression|2
179087|NCT00104650|561487|P2|Treatment Period (25 Weeks)|Disease progression|3
179088|NCT00104650|561488|P1|Treatment Period (25 Weeks)|Disease progression|2
179089|NCT00104650|561486|P3|Treatment Period (25 Weeks)|Death|6
179090|NCT00104650|561487|P2|Treatment Period (25 Weeks)|Death|5
179091|NCT00104650|561488|P1|Treatment Period (25 Weeks)|Death|7
179092|NCT00104650|561486|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
179093|NCT00104650|561487|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
179094|NCT00104650|561488|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
179095|NCT00104650|561486|P3|Treatment Period (25 Weeks)|Physician Decision|1
179096|NCT00104650|561487|P2|Treatment Period (25 Weeks)|Physician Decision|0
179097|NCT00104650|561488|P1|Treatment Period (25 Weeks)|Physician Decision|0
179098|NCT00104637|561520|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
179099|NCT00104637|561521|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
179100|NCT00104572|561550|P3|Overall Study|Withdrawal by Subject|0
179101|NCT00104572|561551|P2|Overall Study|Withdrawal by Subject|3
179102|NCT00104572|561552|P1|Overall Study|Withdrawal by Subject|3
179103|NCT00104520|561562|P2|Overall Study|Other|5
179104|NCT00104520|561563|P1|Overall Study|Other|1
179105|NCT00104520|561562|P2|Overall Study|Personal/administrative|1
179106|NCT00104520|561563|P1|Overall Study|Personal/administrative|1
179107|NCT00104520|561562|P2|Overall Study|Noncompliance|2
179108|NCT00104520|561563|P1|Overall Study|Noncompliance|0
179109|NCT00104520|561562|P2|Overall Study|Lost to Follow-up|0
179110|NCT00104520|561563|P1|Overall Study|Lost to Follow-up|1
179111|NCT00104520|561562|P2|Overall Study|Related adverse event|15
179112|NCT00104520|561563|P1|Overall Study|Related adverse event|13
179113|NCT00104520|561562|P2|Overall Study|Study drug intolerance|1
179114|NCT00104520|561563|P1|Overall Study|Study drug intolerance|0
179115|NCT00104520|561562|P2|Overall Study|Unrelated adverse event|47
179116|NCT00104520|561563|P1|Overall Study|Unrelated adverse event|34
179117|NCT00104416|561583|P5|Continuation Phase|Non-compliance|1
179118|NCT00104416|561584|P4|Continuation Phase|Non-compliance|0
179119|NCT00104416|561585|P3|Continuation Phase|Non-compliance|0
179120|NCT00104416|561586|P2|Continuation Phase|Non-compliance|0
179121|NCT00104416|561587|P1|Continuation Phase|Non-compliance|0
179122|NCT00104416|561583|P5|Continuation Phase|Pregnancy|0
179123|NCT00104416|561584|P4|Continuation Phase|Pregnancy|1
179124|NCT00104416|561585|P3|Continuation Phase|Pregnancy|1
179125|NCT00104416|561586|P2|Continuation Phase|Pregnancy|0
179126|NCT00104416|561587|P1|Continuation Phase|Pregnancy|0
179127|NCT00104416|561583|P5|Continuation Phase|Withdrawal by Subject|1
179128|NCT00104416|561584|P4|Continuation Phase|Withdrawal by Subject|1
179129|NCT00104416|561585|P3|Continuation Phase|Withdrawal by Subject|2
179130|NCT00104416|561586|P2|Continuation Phase|Withdrawal by Subject|0
179131|NCT00104416|561587|P1|Continuation Phase|Withdrawal by Subject|0
179132|NCT00104416|561583|P5|Continuation Phase|Lost to Follow-up|1
179133|NCT00104416|561584|P4|Continuation Phase|Lost to Follow-up|0
179134|NCT00104416|561585|P3|Continuation Phase|Lost to Follow-up|1
179135|NCT00104416|561586|P2|Continuation Phase|Lost to Follow-up|0
179136|NCT00104416|561587|P1|Continuation Phase|Lost to Follow-up|0
179137|NCT00104416|561583|P5|Continuation Phase|Adverse Event|2
179138|NCT00104416|561584|P4|Continuation Phase|Adverse Event|0
179139|NCT00104416|561585|P3|Continuation Phase|Adverse Event|2
179140|NCT00104416|561586|P2|Continuation Phase|Adverse Event|0
179141|NCT00104416|561587|P1|Continuation Phase|Adverse Event|0
179142|NCT00104416|561583|P5|Double-Blind Phase|Participant Did Not Take Drug|0
179143|NCT00104416|561584|P4|Double-Blind Phase|Participant Did Not Take Drug|0
179144|NCT00104416|561585|P3|Double-Blind Phase|Participant Did Not Take Drug|0
179145|NCT00104416|561586|P2|Double-Blind Phase|Participant Did Not Take Drug|4
179146|NCT00104416|561587|P1|Double-Blind Phase|Participant Did Not Take Drug|3
179147|NCT00104416|561583|P5|Double-Blind Phase|Pregnancy|0
179148|NCT00104416|561584|P4|Double-Blind Phase|Pregnancy|0
179149|NCT00104416|561585|P3|Double-Blind Phase|Pregnancy|0
179150|NCT00104416|561586|P2|Double-Blind Phase|Pregnancy|0
179151|NCT00104416|561587|P1|Double-Blind Phase|Pregnancy|1
179152|NCT00104416|561583|P5|Double-Blind Phase|Withdrawal by Subject|0
179153|NCT00104416|561584|P4|Double-Blind Phase|Withdrawal by Subject|0
179154|NCT00104416|561585|P3|Double-Blind Phase|Withdrawal by Subject|0
179155|NCT00104416|561586|P2|Double-Blind Phase|Withdrawal by Subject|3
179156|NCT00104416|561587|P1|Double-Blind Phase|Withdrawal by Subject|2
179157|NCT00104416|561583|P5|Double-Blind Phase|Protocol Violation|0
179158|NCT00104416|561584|P4|Double-Blind Phase|Protocol Violation|0
179159|NCT00104416|561585|P3|Double-Blind Phase|Protocol Violation|0
179160|NCT00104416|561586|P2|Double-Blind Phase|Protocol Violation|1
179161|NCT00104416|561587|P1|Double-Blind Phase|Protocol Violation|0
179162|NCT00104416|561583|P5|Double-Blind Phase|Lost to Follow-up|0
179163|NCT00104416|561584|P4|Double-Blind Phase|Lost to Follow-up|0
179164|NCT00104416|561585|P3|Double-Blind Phase|Lost to Follow-up|0
179165|NCT00104416|561586|P2|Double-Blind Phase|Lost to Follow-up|1
179166|NCT00104416|561587|P1|Double-Blind Phase|Lost to Follow-up|0
179167|NCT00104416|561583|P5|Double-Blind Phase|Adverse Event|0
179168|NCT00104416|561584|P4|Double-Blind Phase|Adverse Event|0
179169|NCT00104416|561585|P3|Double-Blind Phase|Adverse Event|0
179170|NCT00104416|561586|P2|Double-Blind Phase|Adverse Event|1
179171|NCT00104416|561587|P1|Double-Blind Phase|Adverse Event|2
179174|NCT00104299|561632|P2|Overall Study|Physician Decision|1
179175|NCT00104299|561633|P1|Overall Study|Physician Decision|1
179176|NCT00104299|561632|P2|Overall Study|Withdrawal by Subject|6
179177|NCT00104299|561633|P1|Overall Study|Withdrawal by Subject|2
179178|NCT00104299|561632|P2|Overall Study|Death|2
179179|NCT00104299|561633|P1|Overall Study|Death|2
179180|NCT00104299|561632|P2|Overall Study|Adverse Event|1
179181|NCT00104299|561633|P1|Overall Study|Adverse Event|3
179182|NCT00104247|561655|P2|Overall Study|Noncompliant with dosing|1
179183|NCT00104247|561656|P1|Overall Study|Noncompliant with dosing|0
179184|NCT00104247|561655|P2|Overall Study|Withdrawal by Subject|0
179185|NCT00104247|561656|P1|Overall Study|Withdrawal by Subject|1
179186|NCT00104104|561675|P2|Overall Study|Death|6
179187|NCT00104104|561676|P1|Overall Study|Death|9
179188|NCT00104104|561675|P2|Overall Study|Administrative problems|13
179189|NCT00104104|561676|P1|Overall Study|Administrative problems|12
179190|NCT00104104|561675|P2|Overall Study|Lost to Follow-up|7
179191|NCT00104104|561676|P1|Overall Study|Lost to Follow-up|3
179192|NCT00104104|561675|P2|Overall Study|Withdrawal by Subject|15
179193|NCT00104104|561676|P1|Overall Study|Withdrawal by Subject|11
179194|NCT00104104|561675|P2|Overall Study|Protocol Violation|2
179195|NCT00104104|561676|P1|Overall Study|Protocol Violation|5
179196|NCT00104104|561675|P2|Overall Study|Condition no longer requires study drug|4
179197|NCT00104104|561676|P1|Overall Study|Condition no longer requires study drug|7
179198|NCT00104104|561675|P2|Overall Study|Lack of Efficacy|3
179199|NCT00104104|561676|P1|Overall Study|Lack of Efficacy|0
179200|NCT00104104|561675|P2|Overall Study|Abnormal laboratory value(s)|14
179201|NCT00104104|561676|P1|Overall Study|Abnormal laboratory value(s)|20
179202|NCT00104104|561675|P2|Overall Study|Adverse Event|8
179203|NCT00104104|561676|P1|Overall Study|Adverse Event|8
179204|NCT00104052|561690|P1|Overall Study|Discontinuation unrelated to treatment|2
179205|NCT00104052|561690|P1|Overall Study|Lack of Efficacy|26
179206|NCT00104052|561690|P1|Overall Study|Adverse Event|1
179207|NCT00103857|561701|P7|50-Week Extension Study|reason unspecified|0
179208|NCT00103857|561702|P6|50-Week Extension Study|reason unspecified|0
179209|NCT00103857|561703|P5|50-Week Extension Study|reason unspecified|1
179210|NCT00103857|561704|P4|50-Week Extension Study|reason unspecified|0
179211|NCT00103857|561705|P3|50-Week Extension Study|reason unspecified|0
179212|NCT00103857|561706|P2|50-Week Extension Study|reason unspecified|0
179213|NCT00103857|561707|P1|50-Week Extension Study|reason unspecified|0
179214|NCT00103857|561701|P7|50-Week Extension Study|patient scheduled for elective surgery|0
179215|NCT00103857|561702|P6|50-Week Extension Study|patient scheduled for elective surgery|0
179216|NCT00103857|561703|P5|50-Week Extension Study|patient scheduled for elective surgery|0
179217|NCT00103857|561704|P4|50-Week Extension Study|patient scheduled for elective surgery|0
179218|NCT00103857|561705|P3|50-Week Extension Study|patient scheduled for elective surgery|1
179219|NCT00103857|561706|P2|50-Week Extension Study|patient scheduled for elective surgery|0
179220|NCT00103857|561707|P1|50-Week Extension Study|patient scheduled for elective surgery|0
179221|NCT00103857|561701|P7|50-Week Extension Study|patient moved|0
179222|NCT00103857|561702|P6|50-Week Extension Study|patient moved|0
179223|NCT00103857|561703|P5|50-Week Extension Study|patient moved|0
179224|NCT00103857|561704|P4|50-Week Extension Study|patient moved|2
179225|NCT00103857|561705|P3|50-Week Extension Study|patient moved|1
179226|NCT00103857|561706|P2|50-Week Extension Study|patient moved|0
179227|NCT00103857|561707|P1|50-Week Extension Study|patient moved|0
179228|NCT00103857|561701|P7|50-Week Extension Study|non-compliance with study procedures|0
179229|NCT00103857|561702|P6|50-Week Extension Study|non-compliance with study procedures|0
179230|NCT00103857|561703|P5|50-Week Extension Study|non-compliance with study procedures|1
179231|NCT00103857|561704|P4|50-Week Extension Study|non-compliance with study procedures|1
179232|NCT00103857|561705|P3|50-Week Extension Study|non-compliance with study procedures|0
179233|NCT00103857|561706|P2|50-Week Extension Study|non-compliance with study procedures|0
179234|NCT00103857|561707|P1|50-Week Extension Study|non-compliance with study procedures|1
179235|NCT00103857|561701|P7|50-Week Extension Study|protocol discontinuation criteria|0
179236|NCT00103857|561702|P6|50-Week Extension Study|protocol discontinuation criteria|3
179237|NCT00103857|561703|P5|50-Week Extension Study|protocol discontinuation criteria|3
179238|NCT00103857|561704|P4|50-Week Extension Study|protocol discontinuation criteria|2
179239|NCT00103857|561705|P3|50-Week Extension Study|protocol discontinuation criteria|3
179240|NCT00103857|561706|P2|50-Week Extension Study|protocol discontinuation criteria|2
179241|NCT00103857|561707|P1|50-Week Extension Study|protocol discontinuation criteria|2
179242|NCT00103857|561701|P7|50-Week Extension Study|Withdrawal by Subject|0
179243|NCT00103857|561702|P6|50-Week Extension Study|Withdrawal by Subject|3
179244|NCT00103857|561703|P5|50-Week Extension Study|Withdrawal by Subject|3
179245|NCT00103857|561704|P4|50-Week Extension Study|Withdrawal by Subject|8
179246|NCT00103857|561705|P3|50-Week Extension Study|Withdrawal by Subject|2
179247|NCT00103857|561706|P2|50-Week Extension Study|Withdrawal by Subject|5
179248|NCT00103857|561707|P1|50-Week Extension Study|Withdrawal by Subject|2
179249|NCT00103857|561701|P7|50-Week Extension Study|Protocol Violation|0
179250|NCT00103857|561702|P6|50-Week Extension Study|Protocol Violation|1
179251|NCT00103857|561703|P5|50-Week Extension Study|Protocol Violation|0
179252|NCT00103857|561704|P4|50-Week Extension Study|Protocol Violation|2
179253|NCT00103857|561705|P3|50-Week Extension Study|Protocol Violation|1
179254|NCT00103857|561706|P2|50-Week Extension Study|Protocol Violation|1
179255|NCT00103857|561707|P1|50-Week Extension Study|Protocol Violation|1
179256|NCT00103857|561701|P7|50-Week Extension Study|Pregnancy|0
179257|NCT00103857|561702|P6|50-Week Extension Study|Pregnancy|0
179258|NCT00103857|561703|P5|50-Week Extension Study|Pregnancy|1
179259|NCT00103857|561704|P4|50-Week Extension Study|Pregnancy|0
179260|NCT00103857|561705|P3|50-Week Extension Study|Pregnancy|1
179261|NCT00103857|561706|P2|50-Week Extension Study|Pregnancy|0
179262|NCT00103857|561707|P1|50-Week Extension Study|Pregnancy|0
179263|NCT00103857|561701|P7|50-Week Extension Study|Physician Decision|0
179264|NCT00103857|561702|P6|50-Week Extension Study|Physician Decision|0
179265|NCT00103857|561703|P5|50-Week Extension Study|Physician Decision|0
179266|NCT00103857|561704|P4|50-Week Extension Study|Physician Decision|0
179267|NCT00103857|561705|P3|50-Week Extension Study|Physician Decision|1
179268|NCT00103857|561706|P2|50-Week Extension Study|Physician Decision|1
179269|NCT00103857|561707|P1|50-Week Extension Study|Physician Decision|0
179270|NCT00103857|561701|P7|50-Week Extension Study|Lost to Follow-up|0
179271|NCT00103857|561702|P6|50-Week Extension Study|Lost to Follow-up|3
179272|NCT00103857|561703|P5|50-Week Extension Study|Lost to Follow-up|3
179273|NCT00103857|561704|P4|50-Week Extension Study|Lost to Follow-up|4
179274|NCT00103857|561705|P3|50-Week Extension Study|Lost to Follow-up|1
179275|NCT00103857|561706|P2|50-Week Extension Study|Lost to Follow-up|0
179276|NCT00103857|561707|P1|50-Week Extension Study|Lost to Follow-up|4
179277|NCT00103857|561701|P7|50-Week Extension Study|Lack of Efficacy|0
179278|NCT00103857|561702|P6|50-Week Extension Study|Lack of Efficacy|8
179279|NCT00103857|561703|P5|50-Week Extension Study|Lack of Efficacy|8
179280|NCT00103857|561704|P4|50-Week Extension Study|Lack of Efficacy|16
179281|NCT00103857|561705|P3|50-Week Extension Study|Lack of Efficacy|13
179282|NCT00103857|561706|P2|50-Week Extension Study|Lack of Efficacy|15
179283|NCT00103857|561707|P1|50-Week Extension Study|Lack of Efficacy|26
179284|NCT00103857|561701|P7|50-Week Extension Study|Death|0
179285|NCT00103857|561702|P6|50-Week Extension Study|Death|1
179286|NCT00103857|561703|P5|50-Week Extension Study|Death|0
179287|NCT00103857|561704|P4|50-Week Extension Study|Death|1
179288|NCT00103857|561705|P3|50-Week Extension Study|Death|0
179289|NCT00103857|561706|P2|50-Week Extension Study|Death|0
179290|NCT00103857|561707|P1|50-Week Extension Study|Death|0
179291|NCT00103857|561701|P7|50-Week Extension Study|Adverse Event|0
179292|NCT00103857|561702|P6|50-Week Extension Study|Adverse Event|1
179293|NCT00103857|561703|P5|50-Week Extension Study|Adverse Event|1
179294|NCT00103857|561704|P4|50-Week Extension Study|Adverse Event|0
179295|NCT00103857|561705|P3|50-Week Extension Study|Adverse Event|2
179296|NCT00103857|561706|P2|50-Week Extension Study|Adverse Event|3
179297|NCT00103857|561707|P1|50-Week Extension Study|Adverse Event|2
179298|NCT00103857|561701|P7|54-Week Base Study|patient intolerance to rescue therapy|0
179299|NCT00103857|561702|P6|54-Week Base Study|patient intolerance to rescue therapy|0
179300|NCT00103857|561703|P5|54-Week Base Study|patient intolerance to rescue therapy|0
179301|NCT00103857|561704|P4|54-Week Base Study|patient intolerance to rescue therapy|0
179302|NCT00103857|561705|P3|54-Week Base Study|patient intolerance to rescue therapy|0
179303|NCT00103857|561706|P2|54-Week Base Study|patient intolerance to rescue therapy|0
179304|NCT00103857|561707|P1|54-Week Base Study|patient intolerance to rescue therapy|1
179305|NCT00103857|561701|P7|54-Week Base Study|site error|0
179306|NCT00103857|561702|P6|54-Week Base Study|site error|1
179307|NCT00103857|561703|P5|54-Week Base Study|site error|0
179308|NCT00103857|561704|P4|54-Week Base Study|site error|0
179309|NCT00103857|561705|P3|54-Week Base Study|site error|0
179310|NCT00103857|561706|P2|54-Week Base Study|site error|0
179311|NCT00103857|561707|P1|54-Week Base Study|site error|0
179312|NCT00103857|561701|P7|54-Week Base Study|laboratory reporting error|0
179313|NCT00103857|561702|P6|54-Week Base Study|laboratory reporting error|0
179314|NCT00103857|561703|P5|54-Week Base Study|laboratory reporting error|1
179315|NCT00103857|561704|P4|54-Week Base Study|laboratory reporting error|0
179316|NCT00103857|561705|P3|54-Week Base Study|laboratory reporting error|0
179317|NCT00103857|561706|P2|54-Week Base Study|laboratory reporting error|0
179318|NCT00103857|561707|P1|54-Week Base Study|laboratory reporting error|0
179319|NCT00103857|561701|P7|54-Week Base Study|patient incarcerated|0
179320|NCT00103857|561702|P6|54-Week Base Study|patient incarcerated|1
179321|NCT00103857|561703|P5|54-Week Base Study|patient incarcerated|1
179322|NCT00103857|561704|P4|54-Week Base Study|patient incarcerated|0
179323|NCT00103857|561705|P3|54-Week Base Study|patient incarcerated|0
179324|NCT00103857|561706|P2|54-Week Base Study|patient incarcerated|0
179325|NCT00103857|561707|P1|54-Week Base Study|patient incarcerated|0
179326|NCT00103857|561701|P7|54-Week Base Study|non-compliance with study procedures|0
179327|NCT00103857|561702|P6|54-Week Base Study|non-compliance with study procedures|2
179328|NCT00103857|561703|P5|54-Week Base Study|non-compliance with study procedures|0
179329|NCT00103857|561704|P4|54-Week Base Study|non-compliance with study procedures|0
179330|NCT00103857|561705|P3|54-Week Base Study|non-compliance with study procedures|0
179331|NCT00103857|561706|P2|54-Week Base Study|non-compliance with study procedures|2
179332|NCT00103857|561707|P1|54-Week Base Study|non-compliance with study procedures|1
179333|NCT00103857|561701|P7|54-Week Base Study|patient moved|0
179334|NCT00103857|561702|P6|54-Week Base Study|patient moved|1
179335|NCT00103857|561703|P5|54-Week Base Study|patient moved|3
179336|NCT00103857|561704|P4|54-Week Base Study|patient moved|2
179337|NCT00103857|561705|P3|54-Week Base Study|patient moved|1
179338|NCT00103857|561706|P2|54-Week Base Study|patient moved|1
179339|NCT00103857|561707|P1|54-Week Base Study|patient moved|0
179340|NCT00103857|561701|P7|54-Week Base Study|protocol discontinuation criteria|5
179341|NCT00103857|561702|P6|54-Week Base Study|protocol discontinuation criteria|3
179342|NCT00103857|561703|P5|54-Week Base Study|protocol discontinuation criteria|5
179343|NCT00103857|561704|P4|54-Week Base Study|protocol discontinuation criteria|6
179344|NCT00103857|561705|P3|54-Week Base Study|protocol discontinuation criteria|2
179345|NCT00103857|561706|P2|54-Week Base Study|protocol discontinuation criteria|5
179346|NCT00103857|561707|P1|54-Week Base Study|protocol discontinuation criteria|2
179347|NCT00103857|561701|P7|54-Week Base Study|Withdrawal by Subject|4
179348|NCT00103857|561702|P6|54-Week Base Study|Withdrawal by Subject|15
179349|NCT00103857|561703|P5|54-Week Base Study|Withdrawal by Subject|10
179350|NCT00103857|561704|P4|54-Week Base Study|Withdrawal by Subject|15
179351|NCT00103857|561705|P3|54-Week Base Study|Withdrawal by Subject|16
179352|NCT00103857|561706|P2|54-Week Base Study|Withdrawal by Subject|16
179353|NCT00103857|561707|P1|54-Week Base Study|Withdrawal by Subject|17
179354|NCT00103857|561701|P7|54-Week Base Study|Protocol Violation|3
179355|NCT00103857|561702|P6|54-Week Base Study|Protocol Violation|3
179356|NCT00103857|561703|P5|54-Week Base Study|Protocol Violation|0
179357|NCT00103857|561704|P4|54-Week Base Study|Protocol Violation|4
179358|NCT00103857|561705|P3|54-Week Base Study|Protocol Violation|2
179359|NCT00103857|561706|P2|54-Week Base Study|Protocol Violation|4
179360|NCT00103857|561707|P1|54-Week Base Study|Protocol Violation|6
179361|NCT00103857|561701|P7|54-Week Base Study|Pregnancy|1
179362|NCT00103857|561702|P6|54-Week Base Study|Pregnancy|0
179363|NCT00103857|561703|P5|54-Week Base Study|Pregnancy|1
179364|NCT00103857|561704|P4|54-Week Base Study|Pregnancy|0
179365|NCT00103857|561705|P3|54-Week Base Study|Pregnancy|0
179366|NCT00103857|561706|P2|54-Week Base Study|Pregnancy|0
179367|NCT00103857|561707|P1|54-Week Base Study|Pregnancy|1
179368|NCT00103857|561701|P7|54-Week Base Study|Physician Decision|0
179369|NCT00103857|561702|P6|54-Week Base Study|Physician Decision|0
179370|NCT00103857|561703|P5|54-Week Base Study|Physician Decision|1
179371|NCT00103857|561704|P4|54-Week Base Study|Physician Decision|0
179372|NCT00103857|561705|P3|54-Week Base Study|Physician Decision|0
179373|NCT00103857|561706|P2|54-Week Base Study|Physician Decision|1
179374|NCT00103857|561707|P1|54-Week Base Study|Physician Decision|1
179375|NCT00103857|561701|P7|54-Week Base Study|Lost to Follow-up|3
179376|NCT00103857|561702|P6|54-Week Base Study|Lost to Follow-up|9
179377|NCT00103857|561703|P5|54-Week Base Study|Lost to Follow-up|10
179378|NCT00103857|561704|P4|54-Week Base Study|Lost to Follow-up|5
179379|NCT00103857|561705|P3|54-Week Base Study|Lost to Follow-up|7
179380|NCT00103857|561706|P2|54-Week Base Study|Lost to Follow-up|4
179381|NCT00103857|561707|P1|54-Week Base Study|Lost to Follow-up|5
179382|NCT00103857|561701|P7|54-Week Base Study|Lack of Efficacy|19
179383|NCT00103857|561702|P6|54-Week Base Study|Lack of Efficacy|14
179384|NCT00103857|561703|P5|54-Week Base Study|Lack of Efficacy|3
179385|NCT00103857|561704|P4|54-Week Base Study|Lack of Efficacy|4
179386|NCT00103857|561705|P3|54-Week Base Study|Lack of Efficacy|8
179387|NCT00103857|561706|P2|54-Week Base Study|Lack of Efficacy|14
179388|NCT00103857|561707|P1|54-Week Base Study|Lack of Efficacy|11
179389|NCT00103857|561701|P7|54-Week Base Study|Death|0
179390|NCT00103857|561702|P6|54-Week Base Study|Death|1
179391|NCT00103857|561703|P5|54-Week Base Study|Death|1
179392|NCT00103857|561704|P4|54-Week Base Study|Death|0
179393|NCT00103857|561705|P3|54-Week Base Study|Death|0
179394|NCT00103857|561706|P2|54-Week Base Study|Death|0
179395|NCT00103857|561707|P1|54-Week Base Study|Death|0
179396|NCT00103857|561701|P7|54-Week Base Study|Adverse Event|3
179397|NCT00103857|561702|P6|54-Week Base Study|Adverse Event|11
179398|NCT00103857|561703|P5|54-Week Base Study|Adverse Event|5
179399|NCT00103857|561704|P4|54-Week Base Study|Adverse Event|6
179400|NCT00103857|561705|P3|54-Week Base Study|Adverse Event|11
179401|NCT00103857|561706|P2|54-Week Base Study|Adverse Event|9
179402|NCT00103857|561707|P1|54-Week Base Study|Adverse Event|12
179403|NCT00103740|561806|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
179404|NCT00103740|561807|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
179405|NCT00103740|561806|P2|Period 2 - Extended Observation Period|Death|2
179406|NCT00103740|561807|P1|Period 2 - Extended Observation Period|Death|6
179407|NCT00103740|561806|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
179408|NCT00103740|561807|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
179409|NCT00103740|561806|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
179410|NCT00103740|561807|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
179411|NCT00103740|561806|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
179412|NCT00103740|561807|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
179413|NCT00103740|561806|P2|Period 1 - Core|Patient withdrew consent|2
179414|NCT00103740|561807|P1|Period 1 - Core|Patient withdrew consent|3
179415|NCT00103740|561806|P2|Period 1 - Core|Protocol Violation|2
179416|NCT00103740|561807|P1|Period 1 - Core|Protocol Violation|3
179417|NCT00103740|561806|P2|Period 1 - Core|Adverse Event|0
179418|NCT00103740|561807|P1|Period 1 - Core|Adverse Event|1
179419|NCT00103662|561835|P2|Overall Study|Intercurrent illness|0
179420|NCT00103662|561836|P1|Overall Study|Intercurrent illness|1
179421|NCT00103662|561835|P2|Overall Study|Failed mobilization|4
179422|NCT00103662|561836|P1|Overall Study|Failed mobilization|0
179423|NCT00103662|561835|P2|Overall Study|Other|9
179424|NCT00103662|561836|P1|Overall Study|Other|6
179425|NCT00103662|561835|P2|Overall Study|Lost to Follow-up|1
179426|NCT00103662|561836|P1|Overall Study|Lost to Follow-up|0
179427|NCT00103662|561835|P2|Overall Study|Elective Withdrawal|5
179428|NCT00103662|561836|P1|Overall Study|Elective Withdrawal|5
179429|NCT00103662|561835|P2|Overall Study|Death|7
179430|NCT00103662|561836|P1|Overall Study|Death|7
179431|NCT00103662|561835|P2|Overall Study|Entered Rescue Procedure|7
179432|NCT00103662|561836|P1|Overall Study|Entered Rescue Procedure|0
179433|NCT00103610|561862|P2|Overall Study|Noncompliance|1
179434|NCT00103610|561863|P1|Overall Study|Noncompliance|0
179435|NCT00103610|561862|P2|Overall Study|Failed mobilization|5
179436|NCT00103610|561863|P1|Overall Study|Failed mobilization|1
179437|NCT00103610|561862|P2|Overall Study|Other|7
179438|NCT00103610|561863|P1|Overall Study|Other|2
179439|NCT00103610|561862|P2|Overall Study|Adverse Event|2
179440|NCT00103610|561863|P1|Overall Study|Adverse Event|2
179441|NCT00103610|561862|P2|Overall Study|Lost to Follow-up|1
179442|NCT00103610|561863|P1|Overall Study|Lost to Follow-up|3
179443|NCT00103610|561862|P2|Overall Study|Elective Withdrawal|0
179444|NCT00103610|561863|P1|Overall Study|Elective Withdrawal|4
179445|NCT00103610|561862|P2|Overall Study|Death|12
179446|NCT00103610|561863|P1|Overall Study|Death|16
179447|NCT00103610|561862|P2|Overall Study|Entered Rescue Procedure|52
179448|NCT00103610|561863|P1|Overall Study|Entered Rescue Procedure|10
179449|NCT00103506|561887|P2|Overall Study|Withdrawal by Subject|21
179450|NCT00103506|561888|P1|Overall Study|Withdrawal by Subject|18
179451|NCT00103506|561887|P2|Overall Study|Lost to Follow-up|13
179452|NCT00103506|561888|P1|Overall Study|Lost to Follow-up|13
179453|NCT00103506|561887|P2|Overall Study|Death|253
179454|NCT00103506|561888|P1|Overall Study|Death|257
179455|NCT00103506|561887|P2|Overall Study|Study closed by sponsor|37
179456|NCT00103506|561888|P1|Overall Study|Study closed by sponsor|34
179457|NCT00103311|561900|P2|Overall Study|Adverse Event|0
179458|NCT00103311|561901|P1|Overall Study|Adverse Event|1
179459|NCT00103311|561900|P2|Overall Study|Withdrawal by Subject|1
179460|NCT00103311|561901|P1|Overall Study|Withdrawal by Subject|2
179461|NCT00103311|561900|P2|Overall Study|Lost to Follow-up|0
179462|NCT00103311|561901|P1|Overall Study|Lost to Follow-up|1
179463|NCT00103259|561913|P2|Overall Study|ineligible/no protocol therapy|6
179464|NCT00103259|561914|P1|Overall Study|ineligible/no protocol therapy|4
179465|NCT00103259|561913|P2|Overall Study|other (reasons were not specified)|1
179466|NCT00103259|561914|P1|Overall Study|other (reasons were not specified)|2
179467|NCT00103259|561913|P2|Overall Study|alternative therapy|0
179468|NCT00103259|561914|P1|Overall Study|alternative therapy|1
179469|NCT00103259|561913|P2|Overall Study|Withdrawal by Subject|3
179470|NCT00103259|561914|P1|Overall Study|Withdrawal by Subject|2
179471|NCT00103259|561913|P2|Overall Study|Death|2
179472|NCT00103259|561914|P1|Overall Study|Death|3
179473|NCT00103207|561926|P1|Overall Study|Diagnosis of BAC not confirmed|27
179474|NCT00103207|561926|P1|Overall Study|Ineligible|4
179475|NCT00103207|561926|P1|Overall Study|Other complicating disease|1
179476|NCT00103207|561926|P1|Overall Study|Withdrawal by Subject|2
179477|NCT00103207|561926|P1|Overall Study|Death|1
179478|NCT00103207|561926|P1|Overall Study|Adverse Event|3
179479|NCT00103142|561945|P2|Overall Study|Progression of disease|1
179480|NCT00103142|561946|P1|Overall Study|Progression of disease|2
179481|NCT00103142|561945|P2|Overall Study|Adverse Event|0
179482|NCT00103142|561946|P1|Overall Study|Adverse Event|1
179483|NCT00103012|561957|P3|Overall Study|Subject non-compliant with medications|1
179484|NCT00103012|561958|P2|Overall Study|Subject non-compliant with medications|0
179485|NCT00103012|561959|P1|Overall Study|Subject non-compliant with medications|0
179486|NCT00103012|561957|P3|Overall Study|Adverse Event|1
179487|NCT00103012|561958|P2|Overall Study|Adverse Event|0
179488|NCT00103012|561959|P1|Overall Study|Adverse Event|0
179489|NCT00103012|561957|P3|Overall Study|Pregnancy|0
179490|NCT00103012|561958|P2|Overall Study|Pregnancy|0
179491|NCT00103012|561959|P1|Overall Study|Pregnancy|1
179492|NCT00103012|561957|P3|Overall Study|Withdrawal by Subject|2
179493|NCT00103012|561958|P2|Overall Study|Withdrawal by Subject|1
179494|NCT00103012|561959|P1|Overall Study|Withdrawal by Subject|2
179495|NCT00102804|561969|P2|Overall Study|Alive, Receiving Treatment|2
179496|NCT00102804|561970|P1|Overall Study|Alive, Receiving Treatment|7
179497|NCT00102804|561969|P2|Overall Study|Sponsor Decision|0
179498|NCT00102804|561970|P1|Overall Study|Sponsor Decision|1
179499|NCT00102804|561969|P2|Overall Study|Satisfactory Response|0
179500|NCT00102804|561970|P1|Overall Study|Satisfactory Response|2
179501|NCT00102804|561969|P2|Overall Study|Protocol Violation|1
179502|NCT00102804|561970|P1|Overall Study|Protocol Violation|2
179503|NCT00102804|561969|P2|Overall Study|Lost to Follow-up|1
179504|NCT00102804|561970|P1|Overall Study|Lost to Follow-up|4
179505|NCT00102804|561969|P2|Overall Study|Enrollment Criteria Not Met|0
179506|NCT00102804|561970|P1|Overall Study|Enrollment Criteria Not Met|6
179507|NCT00102804|561969|P2|Overall Study|Death|6
179508|NCT00102804|561970|P1|Overall Study|Death|5
179509|NCT00102804|561969|P2|Overall Study|Physician Decision|6
179510|NCT00102804|561970|P1|Overall Study|Physician Decision|24
179511|NCT00102804|561969|P2|Overall Study|Adverse Event|3
179512|NCT00102804|561970|P1|Overall Study|Adverse Event|37
179513|NCT00102804|561969|P2|Overall Study|Withdrawal by Subject|7
179514|NCT00102804|561970|P1|Overall Study|Withdrawal by Subject|46
179515|NCT00102804|561969|P2|Overall Study|Progressive Disease (PD)|196
179516|NCT00102804|561970|P1|Overall Study|Progressive Disease (PD)|307
179517|NCT00102687|561991|P5|Maintenance Period|Death|1
179518|NCT00102687|561992|P4|Maintenance Period|Death|1
179519|NCT00102687|561993|P3|Maintenance Period|Death|0
179520|NCT00102687|561994|P2|Maintenance Period|Death|0
179521|NCT00102687|561995|P1|Maintenance Period|Death|0
179522|NCT00102687|561991|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
179523|NCT00102687|561992|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
179524|NCT00102687|561993|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
179525|NCT00102687|561994|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
179526|NCT00102687|561995|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
179527|NCT00102687|561991|P5|Maintenance Period|Sponsor decision|0
179528|NCT00102687|561992|P4|Maintenance Period|Sponsor decision|0
179529|NCT00102687|561993|P3|Maintenance Period|Sponsor decision|0
179530|NCT00102687|561994|P2|Maintenance Period|Sponsor decision|0
179531|NCT00102687|561995|P1|Maintenance Period|Sponsor decision|0
179532|NCT00102687|561991|P5|Maintenance Period|Physician Decision|4
179533|NCT00102687|561992|P4|Maintenance Period|Physician Decision|0
179534|NCT00102687|561993|P3|Maintenance Period|Physician Decision|3
179535|NCT00102687|561994|P2|Maintenance Period|Physician Decision|2
179536|NCT00102687|561995|P1|Maintenance Period|Physician Decision|1
179537|NCT00102687|561991|P5|Maintenance Period|Protocol Violation|0
179538|NCT00102687|561992|P4|Maintenance Period|Protocol Violation|0
179539|NCT00102687|561993|P3|Maintenance Period|Protocol Violation|0
179540|NCT00102687|561994|P2|Maintenance Period|Protocol Violation|0
179541|NCT00102687|561995|P1|Maintenance Period|Protocol Violation|0
179542|NCT00102687|561991|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
179543|NCT00102687|561992|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
179544|NCT00102687|561993|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
179545|NCT00102687|561994|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
179546|NCT00102687|561995|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
179547|NCT00102687|561991|P5|Maintenance Period|Adverse Event|3
179548|NCT00102687|561992|P4|Maintenance Period|Adverse Event|1
179549|NCT00102687|561993|P3|Maintenance Period|Adverse Event|0
179550|NCT00102687|561994|P2|Maintenance Period|Adverse Event|0
179551|NCT00102687|561995|P1|Maintenance Period|Adverse Event|1
179552|NCT00102687|561991|P5|Maintenance Period|Withdrawal by Subject|1
179553|NCT00102687|561992|P4|Maintenance Period|Withdrawal by Subject|3
179554|NCT00102687|561993|P3|Maintenance Period|Withdrawal by Subject|2
179555|NCT00102687|561994|P2|Maintenance Period|Withdrawal by Subject|0
179556|NCT00102687|561995|P1|Maintenance Period|Withdrawal by Subject|4
179557|NCT00102687|561991|P5|Initial Period|Death|0
179558|NCT00102687|561992|P4|Initial Period|Death|0
179559|NCT00102687|561993|P3|Initial Period|Death|1
179560|NCT00102687|561994|P2|Initial Period|Death|1
179561|NCT00102687|561995|P1|Initial Period|Death|1
179562|NCT00102687|561991|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
179563|NCT00102687|561992|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
179564|NCT00102687|561993|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
179565|NCT00102687|561994|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
179566|NCT00102687|561995|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
179567|NCT00102687|561991|P5|Initial Period|Sponsor's decision|0
179568|NCT00102687|561992|P4|Initial Period|Sponsor's decision|0
179569|NCT00102687|561993|P3|Initial Period|Sponsor's decision|1
179570|NCT00102687|561994|P2|Initial Period|Sponsor's decision|1
179571|NCT00102687|561995|P1|Initial Period|Sponsor's decision|0
179572|NCT00102687|561991|P5|Initial Period|Physician Decision|0
179573|NCT00102687|561992|P4|Initial Period|Physician Decision|0
179574|NCT00102687|561993|P3|Initial Period|Physician Decision|6
179575|NCT00102687|561994|P2|Initial Period|Physician Decision|9
179576|NCT00102687|561995|P1|Initial Period|Physician Decision|2
179577|NCT00102687|561991|P5|Initial Period|Protocol Violation|0
179578|NCT00102687|561992|P4|Initial Period|Protocol Violation|0
179579|NCT00102687|561993|P3|Initial Period|Protocol Violation|2
179580|NCT00102687|561994|P2|Initial Period|Protocol Violation|0
179581|NCT00102687|561995|P1|Initial Period|Protocol Violation|0
179582|NCT00102687|561991|P5|Initial Period|Transformation to AML (blast > 30%)|0
179583|NCT00102687|561992|P4|Initial Period|Transformation to AML (blast > 30%)|0
179584|NCT00102687|561993|P3|Initial Period|Transformation to AML (blast > 30%)|0
179585|NCT00102687|561994|P2|Initial Period|Transformation to AML (blast > 30%)|3
179586|NCT00102687|561995|P1|Initial Period|Transformation to AML (blast > 30%)|1
179587|NCT00102687|561991|P5|Initial Period|Adverse Event|0
179588|NCT00102687|561992|P4|Initial Period|Adverse Event|0
179589|NCT00102687|561993|P3|Initial Period|Adverse Event|9
179590|NCT00102687|561994|P2|Initial Period|Adverse Event|7
179591|NCT00102687|561995|P1|Initial Period|Adverse Event|4
179592|NCT00102687|561991|P5|Initial Period|Withdrawal by Subject|0
179593|NCT00102687|561992|P4|Initial Period|Withdrawal by Subject|0
179594|NCT00102687|561993|P3|Initial Period|Withdrawal by Subject|5
179595|NCT00102687|561994|P2|Initial Period|Withdrawal by Subject|3
179596|NCT00102687|561995|P1|Initial Period|Withdrawal by Subject|6
179597|NCT00102596|562059|P2|Part A|Adverse Event|0
179598|NCT00102596|562060|P1|Part A|Adverse Event|1
179599|NCT00102596|562059|P2|Part A|Screen failures|0
179600|NCT00102596|562060|P1|Part A|Screen failures|6
179601|NCT00101686|562135|P10|Overall Study|Withdrawal by Subject|9
179602|NCT00101686|562136|P9|Overall Study|Withdrawal by Subject|8
179603|NCT00101686|562137|P8|Overall Study|Withdrawal by Subject|7
179604|NCT00101686|562138|P7|Overall Study|Withdrawal by Subject|7
179605|NCT00101686|562139|P6|Overall Study|Withdrawal by Subject|7
179606|NCT00101686|562140|P5|Overall Study|Withdrawal by Subject|8
179607|NCT00101686|562141|P4|Overall Study|Withdrawal by Subject|8
179608|NCT00101686|562142|P3|Overall Study|Withdrawal by Subject|6
179609|NCT00101686|562143|P2|Overall Study|Withdrawal by Subject|8
179610|NCT00101686|562144|P1|Overall Study|Withdrawal by Subject|9
179611|NCT00101686|562135|P10|Overall Study|Other|3
179612|NCT00101686|562136|P9|Overall Study|Other|3
179613|NCT00101686|562137|P8|Overall Study|Other|5
179614|NCT00101686|562138|P7|Overall Study|Other|1
179615|NCT00101686|562139|P6|Overall Study|Other|12
179616|NCT00101686|562140|P5|Overall Study|Other|2
179617|NCT00101686|562141|P4|Overall Study|Other|6
179618|NCT00101686|562142|P3|Overall Study|Other|1
179619|NCT00101686|562143|P2|Overall Study|Other|4
179620|NCT00101686|562144|P1|Overall Study|Other|1
179621|NCT00101686|562135|P10|Overall Study|Physician Decision|1
179622|NCT00101686|562136|P9|Overall Study|Physician Decision|1
179623|NCT00101686|562137|P8|Overall Study|Physician Decision|5
179624|NCT00101686|562138|P7|Overall Study|Physician Decision|5
179625|NCT00101686|562139|P6|Overall Study|Physician Decision|9
179626|NCT00101686|562140|P5|Overall Study|Physician Decision|8
179627|NCT00101686|562141|P4|Overall Study|Physician Decision|7
179628|NCT00101686|562142|P3|Overall Study|Physician Decision|6
179629|NCT00101686|562143|P2|Overall Study|Physician Decision|13
179630|NCT00101686|562144|P1|Overall Study|Physician Decision|10
179631|NCT00101686|562135|P10|Overall Study|intercurrent non-cancer related illness|1
179632|NCT00101686|562136|P9|Overall Study|intercurrent non-cancer related illness|1
179633|NCT00101686|562137|P8|Overall Study|intercurrent non-cancer related illness|0
179634|NCT00101686|562138|P7|Overall Study|intercurrent non-cancer related illness|1
179635|NCT00101686|562139|P6|Overall Study|intercurrent non-cancer related illness|3
179636|NCT00101686|562140|P5|Overall Study|intercurrent non-cancer related illness|1
179637|NCT00101686|562141|P4|Overall Study|intercurrent non-cancer related illness|0
179638|NCT00101686|562142|P3|Overall Study|intercurrent non-cancer related illness|2
179639|NCT00101686|562143|P2|Overall Study|intercurrent non-cancer related illness|0
179640|NCT00101686|562144|P1|Overall Study|intercurrent non-cancer related illness|0
179641|NCT00101686|562135|P10|Overall Study|Randomized but did not receive treament|1
179642|NCT00101686|562136|P9|Overall Study|Randomized but did not receive treament|0
179643|NCT00101686|562137|P8|Overall Study|Randomized but did not receive treament|1
179644|NCT00101686|562138|P7|Overall Study|Randomized but did not receive treament|0
179645|NCT00101686|562139|P6|Overall Study|Randomized but did not receive treament|2
179646|NCT00101686|562140|P5|Overall Study|Randomized but did not receive treament|2
179647|NCT00101686|562141|P4|Overall Study|Randomized but did not receive treament|2
179648|NCT00101686|562142|P3|Overall Study|Randomized but did not receive treament|2
179649|NCT00101686|562143|P2|Overall Study|Randomized but did not receive treament|6
179650|NCT00101686|562144|P1|Overall Study|Randomized but did not receive treament|1
179651|NCT00101686|562135|P10|Overall Study|unacceptable toxicity|4
179652|NCT00101686|562136|P9|Overall Study|unacceptable toxicity|1
179653|NCT00101686|562137|P8|Overall Study|unacceptable toxicity|2
179654|NCT00101686|562138|P7|Overall Study|unacceptable toxicity|4
179655|NCT00101686|562139|P6|Overall Study|unacceptable toxicity|10
179656|NCT00101686|562140|P5|Overall Study|unacceptable toxicity|16
179657|NCT00101686|562141|P4|Overall Study|unacceptable toxicity|6
179658|NCT00101686|562142|P3|Overall Study|unacceptable toxicity|10
179659|NCT00101686|562143|P2|Overall Study|unacceptable toxicity|9
179660|NCT00101686|562144|P1|Overall Study|unacceptable toxicity|3
179661|NCT00101686|562135|P10|Overall Study|>3 week delay treatment due toxicity|0
179662|NCT00101686|562136|P9|Overall Study|>3 week delay treatment due toxicity|3
179663|NCT00101686|562137|P8|Overall Study|>3 week delay treatment due toxicity|1
179664|NCT00101686|562138|P7|Overall Study|>3 week delay treatment due toxicity|2
179665|NCT00101686|562139|P6|Overall Study|>3 week delay treatment due toxicity|3
179666|NCT00101686|562140|P5|Overall Study|>3 week delay treatment due toxicity|7
179667|NCT00101686|562141|P4|Overall Study|>3 week delay treatment due toxicity|2
179668|NCT00101686|562142|P3|Overall Study|>3 week delay treatment due toxicity|1
179669|NCT00101686|562143|P2|Overall Study|>3 week delay treatment due toxicity|2
179670|NCT00101686|562144|P1|Overall Study|>3 week delay treatment due toxicity|6
179671|NCT00101686|562135|P10|Overall Study|initiation other anti-cancer treatment|3
179762|NCT00101868|562444|P2|Overall Study|Protocol Violation|0
179672|NCT00101686|562136|P9|Overall Study|initiation other anti-cancer treatment|3
179673|NCT00101686|562137|P8|Overall Study|initiation other anti-cancer treatment|2
179674|NCT00101686|562138|P7|Overall Study|initiation other anti-cancer treatment|2
179675|NCT00101686|562139|P6|Overall Study|initiation other anti-cancer treatment|1
179676|NCT00101686|562140|P5|Overall Study|initiation other anti-cancer treatment|1
179677|NCT00101686|562141|P4|Overall Study|initiation other anti-cancer treatment|3
179678|NCT00101686|562142|P3|Overall Study|initiation other anti-cancer treatment|4
179679|NCT00101686|562143|P2|Overall Study|initiation other anti-cancer treatment|3
179680|NCT00101686|562144|P1|Overall Study|initiation other anti-cancer treatment|4
179681|NCT00101686|562135|P10|Overall Study|Progressive Disease|8
179682|NCT00101686|562136|P9|Overall Study|Progressive Disease|10
179683|NCT00101686|562137|P8|Overall Study|Progressive Disease|7
179684|NCT00101686|562138|P7|Overall Study|Progressive Disease|5
179685|NCT00101686|562139|P6|Overall Study|Progressive Disease|25
179686|NCT00101686|562140|P5|Overall Study|Progressive Disease|28
179687|NCT00101686|562141|P4|Overall Study|Progressive Disease|38
179688|NCT00101686|562142|P3|Overall Study|Progressive Disease|37
179689|NCT00101686|562143|P2|Overall Study|Progressive Disease|28
179690|NCT00101686|562144|P1|Overall Study|Progressive Disease|37
179691|NCT00101582|562261|P2|Overall Study|Other|1
179692|NCT00101582|562262|P1|Overall Study|Other|0
179693|NCT00101582|562261|P2|Overall Study|Death|5
179694|NCT00101582|562262|P1|Overall Study|Death|3
179695|NCT00101582|562261|P2|Overall Study|Physician Decision|0
179696|NCT00101582|562262|P1|Overall Study|Physician Decision|1
179697|NCT00101582|562261|P2|Overall Study|Withdrawal by Subject|4
179698|NCT00101582|562262|P1|Overall Study|Withdrawal by Subject|6
179699|NCT00101582|562261|P2|Overall Study|Adverse Event|4
179700|NCT00101582|562262|P1|Overall Study|Adverse Event|1
179701|NCT00101582|562261|P2|Overall Study|Ineligibility determined|1
179702|NCT00101582|562262|P1|Overall Study|Ineligibility determined|0
179703|NCT00102440|562285|P3|Overall Study|Protocol Violation|1
179704|NCT00102440|562286|P2|Overall Study|Protocol Violation|2
179705|NCT00102440|562287|P1|Overall Study|Protocol Violation|7
179706|NCT00102440|562285|P3|Overall Study|Other|14
179707|NCT00102440|562286|P2|Overall Study|Other|14
179708|NCT00102440|562287|P1|Overall Study|Other|11
179709|NCT00102440|562285|P3|Overall Study|Personal Reason(s)|13
179710|NCT00102440|562286|P2|Overall Study|Personal Reason(s)|13
179711|NCT00102440|562287|P1|Overall Study|Personal Reason(s)|19
179712|NCT00102440|562285|P3|Overall Study|Gout Flare|9
179713|NCT00102440|562286|P2|Overall Study|Gout Flare|28
179714|NCT00102440|562287|P1|Overall Study|Gout Flare|10
179715|NCT00102440|562285|P3|Overall Study|Adverse Event|8
179716|NCT00102440|562286|P2|Overall Study|Adverse Event|23
179717|NCT00102440|562287|P1|Overall Study|Adverse Event|16
179718|NCT00102440|562285|P3|Overall Study|Lost to Follow-up|21
179719|NCT00102440|562286|P2|Overall Study|Lost to Follow-up|18
179720|NCT00102440|562287|P1|Overall Study|Lost to Follow-up|25
179721|NCT00102063|562337|P3|Overall Study|Protocol Violation|1
179722|NCT00102063|562338|P2|Overall Study|Protocol Violation|1
179723|NCT00102063|562339|P1|Overall Study|Protocol Violation|0
179724|NCT00102063|562337|P3|Overall Study|Lost to Follow-up|1
179725|NCT00102063|562338|P2|Overall Study|Lost to Follow-up|0
179726|NCT00102063|562339|P1|Overall Study|Lost to Follow-up|0
179727|NCT00102063|562337|P3|Overall Study|Withdrawal by Subject|5
179728|NCT00102063|562338|P2|Overall Study|Withdrawal by Subject|12
179729|NCT00102063|562339|P1|Overall Study|Withdrawal by Subject|4
179730|NCT00102063|562337|P3|Overall Study|Adverse Event|2
179731|NCT00102063|562338|P2|Overall Study|Adverse Event|4
179732|NCT00102063|562339|P1|Overall Study|Adverse Event|7
179733|NCT00102063|562337|P3|Overall Study|Lack of Efficacy|1
179734|NCT00102063|562338|P2|Overall Study|Lack of Efficacy|1
179735|NCT00102063|562339|P1|Overall Study|Lack of Efficacy|5
179736|NCT00101907|562397|P6|Overall Study|Withdrawal by Subject|0
179737|NCT00101907|562398|P5|Overall Study|Withdrawal by Subject|1
179738|NCT00101907|562399|P4|Overall Study|Withdrawal by Subject|0
179739|NCT00101907|562400|P3|Overall Study|Withdrawal by Subject|1
179740|NCT00101907|562401|P2|Overall Study|Withdrawal by Subject|0
179741|NCT00101907|562402|P1|Overall Study|Withdrawal by Subject|1
179742|NCT00101907|562397|P6|Overall Study|Physician Decision|0
179743|NCT00101907|562398|P5|Overall Study|Physician Decision|1
179744|NCT00101907|562399|P4|Overall Study|Physician Decision|1
179745|NCT00101907|562400|P3|Overall Study|Physician Decision|0
179746|NCT00101907|562401|P2|Overall Study|Physician Decision|0
179747|NCT00101907|562402|P1|Overall Study|Physician Decision|0
179748|NCT00101907|562397|P6|Overall Study|Death|0
179749|NCT00101907|562398|P5|Overall Study|Death|3
179750|NCT00101907|562399|P4|Overall Study|Death|0
179751|NCT00101907|562400|P3|Overall Study|Death|0
179752|NCT00101907|562401|P2|Overall Study|Death|1
179753|NCT00101907|562402|P1|Overall Study|Death|0
179754|NCT00101907|562397|P6|Overall Study|Adverse Event|0
179755|NCT00101907|562398|P5|Overall Study|Adverse Event|0
179756|NCT00101907|562399|P4|Overall Study|Adverse Event|0
179757|NCT00101907|562400|P3|Overall Study|Adverse Event|0
179758|NCT00101907|562401|P2|Overall Study|Adverse Event|0
179759|NCT00101907|562402|P1|Overall Study|Adverse Event|1
179760|NCT00101868|562444|P2|Overall Study|Lost to Follow-up|13
179761|NCT00101868|562445|P1|Overall Study|Lost to Follow-up|8
179763|NCT00101868|562445|P1|Overall Study|Protocol Violation|3
179764|NCT00101868|562444|P2|Overall Study|Withdrawal by Subject|9
179765|NCT00101868|562445|P1|Overall Study|Withdrawal by Subject|8
179766|NCT00101868|562444|P2|Overall Study|Death|10
179767|NCT00101868|562445|P1|Overall Study|Death|10
179768|NCT00101452|562458|P3|Overall Study|Other|12
179769|NCT00101452|562459|P2|Overall Study|Other|16
179770|NCT00101452|562460|P1|Overall Study|Other|15
179771|NCT00101452|562458|P3|Overall Study|Protocol Violation|3
179772|NCT00101452|562459|P2|Overall Study|Protocol Violation|1
179773|NCT00101452|562460|P1|Overall Study|Protocol Violation|2
179774|NCT00101452|562458|P3|Overall Study|Physician Decision|2
179775|NCT00101452|562459|P2|Overall Study|Physician Decision|3
179776|NCT00101452|562460|P1|Overall Study|Physician Decision|0
179777|NCT00101452|562458|P3|Overall Study|Baseline Fail|2
179778|NCT00101452|562459|P2|Overall Study|Baseline Fail|1
179779|NCT00101452|562460|P1|Overall Study|Baseline Fail|2
179780|NCT00101452|562458|P3|Overall Study|Withdrawal by Subject|9
179781|NCT00101452|562459|P2|Overall Study|Withdrawal by Subject|14
179782|NCT00101452|562460|P1|Overall Study|Withdrawal by Subject|10
179783|NCT00101452|562458|P3|Overall Study|Lost to Follow-up|14
179784|NCT00101452|562459|P2|Overall Study|Lost to Follow-up|8
179785|NCT00101452|562460|P1|Overall Study|Lost to Follow-up|13
179786|NCT00101452|562458|P3|Overall Study|Adverse Event|1
179787|NCT00101452|562459|P2|Overall Study|Adverse Event|0
179788|NCT00101452|562460|P1|Overall Study|Adverse Event|2
179789|NCT00101439|562470|P2|Period 2|Withdrawal by Subject|2
179790|NCT00101439|562471|P1|Period 2|Withdrawal by Subject|0
179791|NCT00101400|562487|P1|Survival Follow-Up|Alive|7
179792|NCT00101283|562507|P2|Overall Study|Prostate Cancer Recurrence|1
179793|NCT00101283|562508|P1|Overall Study|Prostate Cancer Recurrence|0
179794|NCT00101283|562507|P2|Overall Study|Insurance Refusal|1
179795|NCT00101283|562508|P1|Overall Study|Insurance Refusal|0
179796|NCT00101283|562507|P2|Overall Study|Withdrawal by Subject|1
179797|NCT00101283|562508|P1|Overall Study|Withdrawal by Subject|0
179798|NCT00101192|562518|P1|Overall Study|Inevaluable|1
179799|NCT00101192|562518|P1|Overall Study|Ineligible|6
179800|NCT00101166|562522|P1|Overall Study|progressive disease|10
179801|NCT00101101|562530|P1|Overall Study|never received vaccine|20
179802|NCT00100932|562551|P2|Overall Study|Not specified|2
179803|NCT00100932|562552|P1|Overall Study|Not specified|5
179804|NCT00100932|562551|P2|Overall Study|Physician Decision|5
179805|NCT00100932|562552|P1|Overall Study|Physician Decision|7
179806|NCT00100932|562551|P2|Overall Study|Progressive Disease|18
179807|NCT00100932|562552|P1|Overall Study|Progressive Disease|44
179808|NCT00100932|562551|P2|Overall Study|Withdrawal by Subject|0
179809|NCT00100932|562552|P1|Overall Study|Withdrawal by Subject|6
179810|NCT00100932|562551|P2|Overall Study|Adverse Event|2
179811|NCT00100932|562552|P1|Overall Study|Adverse Event|11
179812|NCT00100815|562567|P1|Overall Study|not specified|3
179813|NCT00100815|562567|P1|Overall Study|Death|4
179814|NCT00100815|562567|P1|Overall Study|Adverse Event|18
179815|NCT00100815|562567|P1|Overall Study|Progression|24
179816|NCT00100802|562575|P1|Overall Study|Ineligible|12
179817|NCT00100802|562575|P1|Overall Study|Withdrawal by Subject|5
179818|NCT00100802|562575|P1|Overall Study|Protocol Violation|1
179819|NCT00100802|562575|P1|Overall Study|Physician Decision|5
179820|NCT00100802|562575|P1|Overall Study|Lack of Efficacy|47
179821|NCT00100802|562575|P1|Overall Study|Death|1
179822|NCT00100802|562575|P1|Overall Study|Adverse Event|9
179823|NCT00100789|562580|P1|Overall Study|Never received treatment|1
179824|NCT00100789|562580|P1|Overall Study|Ineligible|3
179825|NCT00100789|562580|P1|Overall Study|Not protocol specified|5
179826|NCT00100789|562580|P1|Overall Study|Death|2
179827|NCT00100789|562580|P1|Overall Study|Progression/relapse|42
179828|NCT00100789|562580|P1|Overall Study|Withdrawal by Subject|1
179829|NCT00100789|562580|P1|Overall Study|Adverse Event|10
179830|NCT00099632|562645|P6|Overall Study|Protocol Violation|1
179831|NCT00099632|562646|P5|Overall Study|Protocol Violation|0
179832|NCT00099632|562647|P4|Overall Study|Protocol Violation|0
179833|NCT00099632|562648|P3|Overall Study|Protocol Violation|0
179834|NCT00099632|562649|P2|Overall Study|Protocol Violation|0
179835|NCT00099632|562650|P1|Overall Study|Protocol Violation|0
179836|NCT00099632|562645|P6|Overall Study|Withdrawal by Subject|1
179837|NCT00099632|562646|P5|Overall Study|Withdrawal by Subject|0
179838|NCT00099632|562647|P4|Overall Study|Withdrawal by Subject|0
179839|NCT00099632|562648|P3|Overall Study|Withdrawal by Subject|0
179840|NCT00099632|562649|P2|Overall Study|Withdrawal by Subject|1
179841|NCT00099632|562650|P1|Overall Study|Withdrawal by Subject|0
179842|NCT00099632|562645|P6|Overall Study|Lost to Follow-up|0
179843|NCT00099632|562646|P5|Overall Study|Lost to Follow-up|1
179844|NCT00099632|562647|P4|Overall Study|Lost to Follow-up|1
179845|NCT00099632|562648|P3|Overall Study|Lost to Follow-up|3
179846|NCT00099632|562649|P2|Overall Study|Lost to Follow-up|0
179847|NCT00099632|562650|P1|Overall Study|Lost to Follow-up|1
179848|NCT00100178|562704|P3|Overall Study|Physician Decision|3
179849|NCT00100178|562705|P2|Overall Study|Physician Decision|1
179850|NCT00100178|562706|P1|Overall Study|Physician Decision|6
179851|NCT00100178|562704|P3|Overall Study|Withdrawal by Subject|1
179852|NCT00100178|562705|P2|Overall Study|Withdrawal by Subject|1
179853|NCT00100178|562706|P1|Overall Study|Withdrawal by Subject|1
179854|NCT00100178|562704|P3|Overall Study|Adverse Event|1
179855|NCT00100178|562705|P2|Overall Study|Adverse Event|2
179856|NCT00100178|562706|P1|Overall Study|Adverse Event|2
179857|NCT00100178|562704|P3|Overall Study|Lost to Follow-up|5
179858|NCT00100178|562705|P2|Overall Study|Lost to Follow-up|6
179859|NCT00100178|562706|P1|Overall Study|Lost to Follow-up|0
179860|NCT00100048|562719|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
179861|NCT00100048|562720|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
179862|NCT00100048|562721|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
179863|NCT00100048|562722|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
179864|NCT00100048|562723|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
179865|NCT00100048|562724|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
179866|NCT00100048|562719|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
179867|NCT00100048|562720|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
179868|NCT00100048|562721|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
179869|NCT00100048|562722|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
179870|NCT00100048|562723|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
179871|NCT00100048|562724|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
179872|NCT00100048|562719|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
179873|NCT00100048|562720|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
179874|NCT00100048|562721|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
179875|NCT00100048|562722|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
179876|NCT00100048|562723|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
179877|NCT00100048|562724|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
179878|NCT00100048|562719|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
179879|NCT00100048|562720|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
179880|NCT00100048|562721|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
179881|NCT00100048|562722|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
179882|NCT00100048|562723|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
179883|NCT00100048|562724|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
179884|NCT00100048|562719|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
179885|NCT00100048|562720|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
179886|NCT00100048|562721|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
179887|NCT00100048|562722|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
179888|NCT00100048|562723|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
179889|NCT00100048|562724|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
179890|NCT00100048|562719|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
179891|NCT00100048|562720|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
179892|NCT00100048|562721|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
179893|NCT00100048|562722|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
179894|NCT00100048|562723|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
179895|NCT00100048|562724|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
179896|NCT00100048|562719|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
179897|NCT00100048|562720|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
179898|NCT00100048|562721|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
179899|NCT00100048|562722|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
179900|NCT00100048|562723|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
179901|NCT00100048|562724|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
179902|NCT00100048|562719|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
179903|NCT00100048|562720|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
179904|NCT00100048|562721|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
179905|NCT00100048|562722|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
179906|NCT00100048|562723|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
179907|NCT00100048|562724|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
179908|NCT00099983|562833|P2|Overall Study|Other issue|0
179909|NCT00099983|562834|P1|Overall Study|Other issue|1
179910|NCT00099983|562833|P2|Overall Study|Intolerant of burden of visits|1
179911|NCT00099983|562834|P1|Overall Study|Intolerant of burden of visits|0
179912|NCT00099983|562833|P2|Overall Study|Incarcerated|1
179913|NCT00099983|562834|P1|Overall Study|Incarcerated|0
179914|NCT00099983|562833|P2|Overall Study|Other psychiatric problem|0
179915|NCT00099983|562834|P1|Overall Study|Other psychiatric problem|1
179916|NCT00099983|562833|P2|Overall Study|Moved|0
179917|NCT00099983|562834|P1|Overall Study|Moved|1
179918|NCT00099983|562833|P2|Overall Study|Unable to return for appointments|1
179919|NCT00099983|562834|P1|Overall Study|Unable to return for appointments|1
179920|NCT00099983|562833|P2|Overall Study|Lack of Efficacy|1
179921|NCT00099983|562834|P1|Overall Study|Lack of Efficacy|0
179922|NCT00099983|562833|P2|Overall Study|Adverse Event|1
179923|NCT00099983|562834|P1|Overall Study|Adverse Event|1
179924|NCT00099983|562833|P2|Overall Study|Withdrawal by Subject|2
179925|NCT00099983|562834|P1|Overall Study|Withdrawal by Subject|3
179926|NCT00099983|562833|P2|Overall Study|Missing Source Documents|15
179927|NCT00099983|562834|P1|Overall Study|Missing Source Documents|14
179928|NCT00099983|562833|P2|Overall Study|Lost to Follow-up|3
179929|NCT00099983|562834|P1|Overall Study|Lost to Follow-up|2
179930|NCT00099437|562842|P2|Overall Study|Ongoing in FU but not on treatment|45
179931|NCT00099437|562843|P1|Overall Study|Ongoing in FU but not on treatment|37
179932|NCT00099437|562842|P2|Overall Study|Withdrawal by Subject|10
179933|NCT00099437|562843|P1|Overall Study|Withdrawal by Subject|6
179934|NCT00099437|562842|P2|Overall Study|Death|261
179935|NCT00099437|562843|P1|Overall Study|Death|293
179936|NCT00099437|562842|P2|Overall Study|Lost to Follow-up|33
179937|NCT00099437|562843|P1|Overall Study|Lost to Follow-up|30
179938|NCT00099359|562866|P3|Overall Study|moved out of area|4
179939|NCT00099359|562867|P2|Overall Study|moved out of area|7
179940|NCT00099359|562868|P1|Overall Study|moved out of area|9
179941|NCT00099359|562866|P3|Overall Study|Lost to Follow-up|24
179942|NCT00099359|562867|P2|Overall Study|Lost to Follow-up|24
179943|NCT00099359|562868|P1|Overall Study|Lost to Follow-up|15
179944|NCT00099359|562866|P3|Overall Study|Withdrawal by Subject|23
179945|NCT00099359|562867|P2|Overall Study|Withdrawal by Subject|19
179946|NCT00099359|562868|P1|Overall Study|Withdrawal by Subject|19
179947|NCT00099359|562866|P3|Overall Study|Death|17
179948|NCT00099359|562867|P2|Overall Study|Death|15
179949|NCT00099359|562868|P1|Overall Study|Death|11
179950|NCT00099268|562891|P2|Overall Study|Death|1
179951|NCT00099268|562892|P1|Overall Study|Death|3
179952|NCT00099268|562891|P2|Overall Study|Administrative problems|4
179953|NCT00099268|562892|P1|Overall Study|Administrative problems|4
179954|NCT00099268|562891|P2|Overall Study|Lack of Efficacy|18
179955|NCT00099268|562892|P1|Overall Study|Lack of Efficacy|5
179956|NCT00099268|562891|P2|Overall Study|Lost to Follow-up|4
179957|NCT00099268|562892|P1|Overall Study|Lost to Follow-up|6
179958|NCT00099268|562891|P2|Overall Study|Protocol Violation|8
179959|NCT00099268|562892|P1|Overall Study|Protocol Violation|9
179960|NCT00099268|562891|P2|Overall Study|Adverse Event|19
179961|NCT00099268|562892|P1|Overall Study|Adverse Event|19
179962|NCT00099268|562891|P2|Overall Study|Withdrawal by Subject|28
179963|NCT00099268|562892|P1|Overall Study|Withdrawal by Subject|46
179964|NCT00098865|562928|P1|Overall Study|Alternative Therapy|1
179965|NCT00098865|562928|P1|Overall Study|Adverse Event|2
179966|NCT00098865|562928|P1|Overall Study|Progressive Disease|6
179967|NCT00098839|562936|P2|Overall Study|Ineligible|0
179968|NCT00098839|562937|P1|Overall Study|Ineligible|2
179969|NCT00098839|562936|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
179970|NCT00098839|562937|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
179971|NCT00098839|562936|P2|Overall Study|Relapse|3
179972|NCT00098839|562937|P1|Overall Study|Relapse|6
179973|NCT00098839|562936|P2|Overall Study|Refusal of further protocol therapy|1
179974|NCT00098839|562937|P1|Overall Study|Refusal of further protocol therapy|3
179975|NCT00098839|562936|P2|Overall Study|Withdrawal by Subject|0
179976|NCT00098839|562937|P1|Overall Study|Withdrawal by Subject|1
179977|NCT00098839|562936|P2|Overall Study|Physician Decision|14
179978|NCT00098839|562937|P1|Overall Study|Physician Decision|4
179979|NCT00098839|562936|P2|Overall Study|Death|2
179980|NCT00098839|562937|P1|Overall Study|Death|1
179981|NCT00098839|562936|P2|Overall Study|Adverse Event|2
179982|NCT00098839|562937|P1|Overall Study|Adverse Event|5
179983|NCT00098813|562947|P1|Overall Study|Reversal of RAI resistance|1
179984|NCT00098813|562947|P1|Overall Study|Other complicating disease|1
179985|NCT00098813|562947|P1|Overall Study|Progression of Disease|1
179986|NCT00098813|562947|P1|Overall Study|Withdrawal by Subject|7
179987|NCT00098813|562947|P1|Overall Study|Protocol Violation|1
179988|NCT00098813|562947|P1|Overall Study|Death|8
179989|NCT00098787|562954|P3|Overall Study|Other|9
179990|NCT00098787|562955|P2|Overall Study|Other|6
179991|NCT00098787|562956|P1|Overall Study|Other|7
179992|NCT00098787|562954|P3|Overall Study|Alternative therapy|13
179993|NCT00098787|562955|P2|Overall Study|Alternative therapy|13
179994|NCT00098787|562956|P1|Overall Study|Alternative therapy|8
179995|NCT00098787|562954|P3|Overall Study|Withdrawal by Subject|6
179996|NCT00098787|562955|P2|Overall Study|Withdrawal by Subject|12
179997|NCT00098787|562956|P1|Overall Study|Withdrawal by Subject|4
179998|NCT00098787|562954|P3|Overall Study|Death|0
179999|NCT00098787|562955|P2|Overall Study|Death|1
180000|NCT00098787|562956|P1|Overall Study|Death|6
180001|NCT00098787|562954|P3|Overall Study|Adverse Event|8
180002|NCT00098787|562955|P2|Overall Study|Adverse Event|17
180003|NCT00098787|562956|P1|Overall Study|Adverse Event|8
180004|NCT00098787|562954|P3|Overall Study|Disease progression|23
180005|NCT00098787|562955|P2|Overall Study|Disease progression|17
180006|NCT00098787|562956|P1|Overall Study|Disease progression|28
180007|NCT00098787|562954|P3|Overall Study|Ineligible|3
180008|NCT00098787|562955|P2|Overall Study|Ineligible|7
180009|NCT00098787|562956|P1|Overall Study|Ineligible|9
180010|NCT00098787|562954|P3|Overall Study|Never started treatment|1
180011|NCT00098787|562955|P2|Overall Study|Never started treatment|2
180012|NCT00098787|562956|P1|Overall Study|Never started treatment|3
180013|NCT00098774|562970|P1|Overall Study|Physician Decision|2
180014|NCT00098774|562970|P1|Overall Study|Failed (to respond) during induction|4
180015|NCT00098774|562970|P1|Overall Study|Withdrawal by Subject|1
180016|NCT00098774|562970|P1|Overall Study|Disease Progression|9
180017|NCT00098774|562970|P1|Overall Study|Adverse Event|2
180018|NCT00098748|562980|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
180019|NCT00098748|562981|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
180020|NCT00098748|562982|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
180021|NCT00098748|562980|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
180022|NCT00098748|562981|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
180023|NCT00098748|562982|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
180024|NCT00098748|562980|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
180025|NCT00098748|562981|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
180026|NCT00098748|562982|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
180027|NCT00098748|562980|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
180028|NCT00098748|562981|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
180029|NCT00098748|562982|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
180030|NCT00098748|562980|P3|Continued on Open-Label Treatment|Adverse Event|0
180031|NCT00098748|562981|P2|Continued on Open-Label Treatment|Adverse Event|1
180032|NCT00098748|562982|P1|Continued on Open-Label Treatment|Adverse Event|0
180033|NCT00098748|562980|P3|Received Study Treatment|Subject defaulted|4
180034|NCT00098748|562981|P2|Received Study Treatment|Subject defaulted|4
180035|NCT00098748|562982|P1|Received Study Treatment|Subject defaulted|3
180036|NCT00098748|562980|P3|Received Study Treatment|Unspecified|6
180037|NCT00098748|562981|P2|Received Study Treatment|Unspecified|2
180038|NCT00098748|562982|P1|Received Study Treatment|Unspecified|2
180039|NCT00098748|562980|P3|Received Study Treatment|Lack of Efficacy|27
180040|NCT00098748|562981|P2|Received Study Treatment|Lack of Efficacy|27
180041|NCT00098748|562982|P1|Received Study Treatment|Lack of Efficacy|40
180042|NCT00098748|562980|P3|Received Study Treatment|Adverse Event|5
180043|NCT00098748|562981|P2|Received Study Treatment|Adverse Event|2
180044|NCT00098748|562982|P1|Received Study Treatment|Adverse Event|1
180045|NCT00098748|562980|P3|Received Study Treatment|Death|2
180046|NCT00098748|562981|P2|Received Study Treatment|Death|1
180047|NCT00098748|562982|P1|Received Study Treatment|Death|2
180048|NCT00098748|562980|P3|Assigned to Study Treatment|Randomized, but not treated|2
180049|NCT00098748|562981|P2|Assigned to Study Treatment|Randomized, but not treated|2
180050|NCT00098748|562982|P1|Assigned to Study Treatment|Randomized, but not treated|0
180051|NCT00098722|563038|P7|Observation Phase|Unspecified|10
180052|NCT00098722|563039|P6|Observation Phase|Unspecified|21
180053|NCT00098722|563040|P5|Observation Phase|Unspecified|0
180054|NCT00098722|563041|P4|Observation Phase|Unspecified|0
180055|NCT00098722|563042|P3|Observation Phase|Unspecified|0
180056|NCT00098722|563043|P2|Observation Phase|Unspecified|0
180057|NCT00098722|563044|P1|Observation Phase|Unspecified|0
180058|NCT00098722|563038|P7|Observation Phase|Participant defaulted|4
180059|NCT00098722|563039|P6|Observation Phase|Participant defaulted|17
180060|NCT00098722|563040|P5|Observation Phase|Participant defaulted|0
180061|NCT00098722|563041|P4|Observation Phase|Participant defaulted|0
180062|NCT00098722|563042|P3|Observation Phase|Participant defaulted|0
180063|NCT00098722|563043|P2|Observation Phase|Participant defaulted|0
180064|NCT00098722|563044|P1|Observation Phase|Participant defaulted|0
180065|NCT00098722|563038|P7|Observation Phase|Lack of Efficacy|0
180066|NCT00098722|563039|P6|Observation Phase|Lack of Efficacy|2
180067|NCT00098722|563040|P5|Observation Phase|Lack of Efficacy|0
180068|NCT00098722|563041|P4|Observation Phase|Lack of Efficacy|0
180069|NCT00098722|563042|P3|Observation Phase|Lack of Efficacy|0
180070|NCT00098722|563043|P2|Observation Phase|Lack of Efficacy|0
180071|NCT00098722|563044|P1|Observation Phase|Lack of Efficacy|0
180072|NCT00098722|563038|P7|Observation Phase|Death|3
180073|NCT00098722|563039|P6|Observation Phase|Death|5
180074|NCT00098722|563040|P5|Observation Phase|Death|0
180075|NCT00098722|563041|P4|Observation Phase|Death|0
180076|NCT00098722|563042|P3|Observation Phase|Death|0
180077|NCT00098722|563043|P2|Observation Phase|Death|0
180078|NCT00098722|563044|P1|Observation Phase|Death|0
180079|NCT00098722|563038|P7|Open Label Phase|Unspecified|0
180080|NCT00098722|563039|P6|Open Label Phase|Unspecified|0
180081|NCT00098722|563040|P5|Open Label Phase|Unspecified|0
180082|NCT00098722|563041|P4|Open Label Phase|Unspecified|18
180083|NCT00098722|563042|P3|Open Label Phase|Unspecified|0
180084|NCT00098722|563043|P2|Open Label Phase|Unspecified|0
180085|NCT00098722|563044|P1|Open Label Phase|Unspecified|0
180086|NCT00098722|563038|P7|Open Label Phase|Ongoing at cut-off date|0
180087|NCT00098722|563039|P6|Open Label Phase|Ongoing at cut-off date|0
180088|NCT00098722|563040|P5|Open Label Phase|Ongoing at cut-off date|50
180089|NCT00098722|563041|P4|Open Label Phase|Ongoing at cut-off date|220
180090|NCT00098722|563042|P3|Open Label Phase|Ongoing at cut-off date|0
180091|NCT00098722|563043|P2|Open Label Phase|Ongoing at cut-off date|0
180092|NCT00098722|563044|P1|Open Label Phase|Ongoing at cut-off date|0
180093|NCT00098722|563038|P7|Open Label Phase|Participant defaulted|0
180094|NCT00098722|563039|P6|Open Label Phase|Participant defaulted|0
180095|NCT00098722|563040|P5|Open Label Phase|Participant defaulted|0
180096|NCT00098722|563041|P4|Open Label Phase|Participant defaulted|18
180097|NCT00098722|563042|P3|Open Label Phase|Participant defaulted|0
180098|NCT00098722|563043|P2|Open Label Phase|Participant defaulted|0
180099|NCT00098722|563044|P1|Open Label Phase|Participant defaulted|0
180100|NCT00098722|563038|P7|Open Label Phase|Pregnancy|0
180101|NCT00098722|563039|P6|Open Label Phase|Pregnancy|0
180102|NCT00098722|563040|P5|Open Label Phase|Pregnancy|0
180103|NCT00098722|563041|P4|Open Label Phase|Pregnancy|1
180104|NCT00098722|563042|P3|Open Label Phase|Pregnancy|0
180105|NCT00098722|563043|P2|Open Label Phase|Pregnancy|0
180106|NCT00098722|563044|P1|Open Label Phase|Pregnancy|0
180107|NCT00098722|563038|P7|Open Label Phase|Lack of Efficacy|0
180108|NCT00098722|563039|P6|Open Label Phase|Lack of Efficacy|0
180109|NCT00098722|563040|P5|Open Label Phase|Lack of Efficacy|0
180110|NCT00098722|563041|P4|Open Label Phase|Lack of Efficacy|8
180111|NCT00098722|563042|P3|Open Label Phase|Lack of Efficacy|0
180112|NCT00098722|563043|P2|Open Label Phase|Lack of Efficacy|0
180113|NCT00098722|563044|P1|Open Label Phase|Lack of Efficacy|0
180114|NCT00098722|563038|P7|Open Label Phase|Death|0
180115|NCT00098722|563039|P6|Open Label Phase|Death|0
180116|NCT00098722|563040|P5|Open Label Phase|Death|0
180117|NCT00098722|563041|P4|Open Label Phase|Death|2
180118|NCT00098722|563042|P3|Open Label Phase|Death|0
180119|NCT00098722|563043|P2|Open Label Phase|Death|0
180120|NCT00098722|563044|P1|Open Label Phase|Death|0
180121|NCT00098722|563038|P7|Open Label Phase|Adverse Event|0
180122|NCT00098722|563039|P6|Open Label Phase|Adverse Event|0
180123|NCT00098722|563040|P5|Open Label Phase|Adverse Event|0
180124|NCT00098722|563041|P4|Open Label Phase|Adverse Event|5
180125|NCT00098722|563042|P3|Open Label Phase|Adverse Event|0
180126|NCT00098722|563043|P2|Open Label Phase|Adverse Event|0
180127|NCT00098722|563044|P1|Open Label Phase|Adverse Event|0
180128|NCT00098722|563038|P7|Double Blind Phase|Unspecified|0
180129|NCT00098722|563039|P6|Double Blind Phase|Unspecified|0
180130|NCT00098722|563040|P5|Double Blind Phase|Unspecified|0
180131|NCT00098722|563041|P4|Double Blind Phase|Unspecified|0
180132|NCT00098722|563042|P3|Double Blind Phase|Unspecified|7
180133|NCT00098722|563043|P2|Double Blind Phase|Unspecified|8
180134|NCT00098722|563044|P1|Double Blind Phase|Unspecified|7
180135|NCT00098722|563038|P7|Double Blind Phase|Ongoing at cut-off date|0
180136|NCT00098722|563039|P6|Double Blind Phase|Ongoing at cut-off date|0
180137|NCT00098722|563040|P5|Double Blind Phase|Ongoing at cut-off date|0
180138|NCT00098722|563041|P4|Double Blind Phase|Ongoing at cut-off date|0
180139|NCT00098722|563042|P3|Double Blind Phase|Ongoing at cut-off date|57
180140|NCT00098722|563043|P2|Double Blind Phase|Ongoing at cut-off date|137
180141|NCT00098722|563044|P1|Double Blind Phase|Ongoing at cut-off date|128
180142|NCT00098722|563038|P7|Double Blind Phase|Randomized, not treated|0
180143|NCT00098722|563039|P6|Double Blind Phase|Randomized, not treated|0
180144|NCT00098722|563040|P5|Double Blind Phase|Randomized, not treated|0
180145|NCT00098722|563041|P4|Double Blind Phase|Randomized, not treated|0
180146|NCT00098722|563042|P3|Double Blind Phase|Randomized, not treated|3
180147|NCT00098722|563043|P2|Double Blind Phase|Randomized, not treated|3
180148|NCT00098722|563044|P1|Double Blind Phase|Randomized, not treated|4
180149|NCT00098722|563038|P7|Double Blind Phase|Pregnancy|0
180150|NCT00098722|563039|P6|Double Blind Phase|Pregnancy|0
180151|NCT00098722|563040|P5|Double Blind Phase|Pregnancy|0
180152|NCT00098722|563041|P4|Double Blind Phase|Pregnancy|0
180153|NCT00098722|563042|P3|Double Blind Phase|Pregnancy|0
180154|NCT00098722|563043|P2|Double Blind Phase|Pregnancy|0
180155|NCT00098722|563044|P1|Double Blind Phase|Pregnancy|1
180156|NCT00098722|563038|P7|Double Blind Phase|Participant defaulted|0
180157|NCT00098722|563039|P6|Double Blind Phase|Participant defaulted|0
180158|NCT00098722|563040|P5|Double Blind Phase|Participant defaulted|0
180159|NCT00098722|563041|P4|Double Blind Phase|Participant defaulted|0
180160|NCT00098722|563042|P3|Double Blind Phase|Participant defaulted|9
180161|NCT00098722|563043|P2|Double Blind Phase|Participant defaulted|11
180162|NCT00098722|563044|P1|Double Blind Phase|Participant defaulted|16
180163|NCT00098722|563038|P7|Double Blind Phase|Lack of Efficacy|0
180164|NCT00098722|563039|P6|Double Blind Phase|Lack of Efficacy|0
180165|NCT00098722|563040|P5|Double Blind Phase|Lack of Efficacy|0
180166|NCT00098722|563041|P4|Double Blind Phase|Lack of Efficacy|0
180167|NCT00098722|563042|P3|Double Blind Phase|Lack of Efficacy|15
180168|NCT00098722|563043|P2|Double Blind Phase|Lack of Efficacy|23
180169|NCT00098722|563044|P1|Double Blind Phase|Lack of Efficacy|21
180170|NCT00098722|563038|P7|Double Blind Phase|Death|0
180171|NCT00098722|563039|P6|Double Blind Phase|Death|0
180172|NCT00098722|563040|P5|Double Blind Phase|Death|0
180173|NCT00098722|563041|P4|Double Blind Phase|Death|0
180174|NCT00098722|563042|P3|Double Blind Phase|Death|0
180175|NCT00098722|563043|P2|Double Blind Phase|Death|5
180176|NCT00098722|563044|P1|Double Blind Phase|Death|2
180177|NCT00098722|563038|P7|Double Blind Phase|Adverse Event|0
180178|NCT00098722|563039|P6|Double Blind Phase|Adverse Event|0
180179|NCT00098722|563040|P5|Double Blind Phase|Adverse Event|0
180180|NCT00098722|563041|P4|Double Blind Phase|Adverse Event|0
180181|NCT00098722|563042|P3|Double Blind Phase|Adverse Event|3
180182|NCT00098722|563043|P2|Double Blind Phase|Adverse Event|7
180183|NCT00098722|563044|P1|Double Blind Phase|Adverse Event|7
180184|NCT00098475|563118|P4|Step 2|Never started treatment|0
180185|NCT00098475|563119|P3|Step 2|Never started treatment|0
180186|NCT00098475|563120|P2|Step 2|Never started treatment|1
180187|NCT00098475|563121|P1|Step 2|Never started treatment|1
180188|NCT00098475|563118|P4|Step 2|Alternative therapy|0
180189|NCT00098475|563119|P3|Step 2|Alternative therapy|0
180190|NCT00098475|563120|P2|Step 2|Alternative therapy|2
180191|NCT00098475|563121|P1|Step 2|Alternative therapy|1
180192|NCT00098475|563118|P4|Step 2|Physician Decision|0
180193|NCT00098475|563119|P3|Step 2|Physician Decision|0
180194|NCT00098475|563120|P2|Step 2|Physician Decision|1
180195|NCT00098475|563121|P1|Step 2|Physician Decision|0
180196|NCT00098475|563118|P4|Step 2|Withdrawal by Subject|0
180197|NCT00098475|563119|P3|Step 2|Withdrawal by Subject|0
180198|NCT00098475|563120|P2|Step 2|Withdrawal by Subject|2
180199|NCT00098475|563121|P1|Step 2|Withdrawal by Subject|0
180200|NCT00098475|563118|P4|Step 2|Adverse Event|0
180201|NCT00098475|563119|P3|Step 2|Adverse Event|0
180202|NCT00098475|563120|P2|Step 2|Adverse Event|0
180203|NCT00098475|563121|P1|Step 2|Adverse Event|2
180204|NCT00098475|563118|P4|Step 2|Disease progression|0
180205|NCT00098475|563119|P3|Step 2|Disease progression|0
180206|NCT00098475|563120|P2|Step 2|Disease progression|4
180207|NCT00098475|563121|P1|Step 2|Disease progression|1
180208|NCT00098475|563118|P4|Step 1|Not documented|0
180209|NCT00098475|563119|P3|Step 1|Not documented|0
180210|NCT00098475|563120|P2|Step 1|Not documented|1
180211|NCT00098475|563121|P1|Step 1|Not documented|0
180212|NCT00098475|563118|P4|Step 1|Patient fell with fracture|0
180213|NCT00098475|563119|P3|Step 1|Patient fell with fracture|0
180214|NCT00098475|563120|P2|Step 1|Patient fell with fracture|0
180215|NCT00098475|563121|P1|Step 1|Patient fell with fracture|1
180216|NCT00098475|563118|P4|Step 1|Misinterpretation of lab data|0
180217|NCT00098475|563119|P3|Step 1|Misinterpretation of lab data|0
180218|NCT00098475|563120|P2|Step 1|Misinterpretation of lab data|1
180219|NCT00098475|563121|P1|Step 1|Misinterpretation of lab data|0
180220|NCT00098475|563118|P4|Step 1|Criteria to continue treatment not met|0
180221|NCT00098475|563119|P3|Step 1|Criteria to continue treatment not met|0
180222|NCT00098475|563120|P2|Step 1|Criteria to continue treatment not met|1
180223|NCT00098475|563121|P1|Step 1|Criteria to continue treatment not met|0
180224|NCT00098475|563118|P4|Step 1|Referred to other physicians|0
180225|NCT00098475|563119|P3|Step 1|Referred to other physicians|0
180226|NCT00098475|563120|P2|Step 1|Referred to other physicians|1
180227|NCT00098475|563121|P1|Step 1|Referred to other physicians|0
180228|NCT00098475|563118|P4|Step 1|Rising paraprotein|0
180229|NCT00098475|563119|P3|Step 1|Rising paraprotein|0
180230|NCT00098475|563120|P2|Step 1|Rising paraprotein|1
180231|NCT00098475|563121|P1|Step 1|Rising paraprotein|0
180232|NCT00098475|563118|P4|Step 1|Insurance issue|0
180233|NCT00098475|563119|P3|Step 1|Insurance issue|0
180234|NCT00098475|563120|P2|Step 1|Insurance issue|1
180235|NCT00098475|563121|P1|Step 1|Insurance issue|0
180236|NCT00098475|563118|P4|Step 1|Declining performance status|0
180237|NCT00098475|563119|P3|Step 1|Declining performance status|0
180238|NCT00098475|563120|P2|Step 1|Declining performance status|1
180239|NCT00098475|563121|P1|Step 1|Declining performance status|0
180240|NCT00098475|563118|P4|Step 1|Off treatment for > specified timeframe|0
180241|NCT00098475|563119|P3|Step 1|Off treatment for > specified timeframe|0
180242|NCT00098475|563120|P2|Step 1|Off treatment for > specified timeframe|1
180243|NCT00098475|563121|P1|Step 1|Off treatment for > specified timeframe|1
180244|NCT00098475|563118|P4|Step 1|Incorrect disease assessment|0
180245|NCT00098475|563119|P3|Step 1|Incorrect disease assessment|0
180246|NCT00098475|563120|P2|Step 1|Incorrect disease assessment|0
180247|NCT00098475|563121|P1|Step 1|Incorrect disease assessment|2
180248|NCT00098475|563118|P4|Step 1|Both patient and physician's decision|0
180249|NCT00098475|563119|P3|Step 1|Both patient and physician's decision|0
180250|NCT00098475|563120|P2|Step 1|Both patient and physician's decision|1
180251|NCT00098475|563121|P1|Step 1|Both patient and physician's decision|2
180252|NCT00098475|563118|P4|Step 1|Cannot comply due to other tx|0
180253|NCT00098475|563119|P3|Step 1|Cannot comply due to other tx|0
180254|NCT00098475|563120|P2|Step 1|Cannot comply due to other tx|1
180255|NCT00098475|563121|P1|Step 1|Cannot comply due to other tx|0
180256|NCT00098475|563118|P4|Step 1|Complications|0
180257|NCT00098475|563119|P3|Step 1|Complications|0
180258|NCT00098475|563120|P2|Step 1|Complications|0
180259|NCT00098475|563121|P1|Step 1|Complications|1
180260|NCT00098475|563118|P4|Step 1|Knee surgery|0
180261|NCT00098475|563119|P3|Step 1|Knee surgery|0
180262|NCT00098475|563120|P2|Step 1|Knee surgery|0
180263|NCT00098475|563121|P1|Step 1|Knee surgery|1
180264|NCT00098475|563118|P4|Step 1|Still on treatment as of this analysis|0
180265|NCT00098475|563119|P3|Step 1|Still on treatment as of this analysis|0
180266|NCT00098475|563120|P2|Step 1|Still on treatment as of this analysis|27
180267|NCT00098475|563121|P1|Step 1|Still on treatment as of this analysis|14
180268|NCT00098475|563118|P4|Step 1|Never started treatment|0
180269|NCT00098475|563119|P3|Step 1|Never started treatment|0
180270|NCT00098475|563120|P2|Step 1|Never started treatment|2
180271|NCT00098475|563121|P1|Step 1|Never started treatment|0
180272|NCT00098475|563118|P4|Step 1|Other disease|0
180273|NCT00098475|563119|P3|Step 1|Other disease|1
180274|NCT00098475|563120|P2|Step 1|Other disease|1
180275|NCT00098475|563121|P1|Step 1|Other disease|2
180276|NCT00098475|563118|P4|Step 1|Alternative therapy|0
180277|NCT00098475|563119|P3|Step 1|Alternative therapy|1
180278|NCT00098475|563120|P2|Step 1|Alternative therapy|43
180279|NCT00098475|563121|P1|Step 1|Alternative therapy|31
180280|NCT00098475|563118|P4|Step 1|Physician Decision|0
180281|NCT00098475|563119|P3|Step 1|Physician Decision|0
180282|NCT00098475|563120|P2|Step 1|Physician Decision|2
180283|NCT00098475|563121|P1|Step 1|Physician Decision|5
180284|NCT00098475|563118|P4|Step 1|Withdrawal by Subject|0
180285|NCT00098475|563119|P3|Step 1|Withdrawal by Subject|0
180286|NCT00098475|563120|P2|Step 1|Withdrawal by Subject|11
180287|NCT00098475|563121|P1|Step 1|Withdrawal by Subject|14
180288|NCT00098475|563118|P4|Step 1|Death|1
180289|NCT00098475|563119|P3|Step 1|Death|0
180290|NCT00098475|563120|P2|Step 1|Death|5
180291|NCT00098475|563121|P1|Step 1|Death|8
180292|NCT00098475|563118|P4|Step 1|Adverse Event|1
180293|NCT00098475|563119|P3|Step 1|Adverse Event|0
180294|NCT00098475|563120|P2|Step 1|Adverse Event|37
180295|NCT00098475|563121|P1|Step 1|Adverse Event|56
180296|NCT00098475|563118|P4|Step 1|Progressive disease|1
180297|NCT00098475|563119|P3|Step 1|Progressive disease|2
180298|NCT00098475|563120|P2|Step 1|Progressive disease|35
180299|NCT00098475|563121|P1|Step 1|Progressive disease|33
180300|NCT00098345|563158|P1|Overall Study|progression|4
180301|NCT00098345|563158|P1|Overall Study|Withdrawal by Subject|2
180302|NCT00098345|563158|P1|Overall Study|Adverse Event|7
180303|NCT00098306|563171|P7|Observational Phase|Un-specified|4
180304|NCT00098306|563172|P6|Observational Phase|Un-specified|7
180305|NCT00098306|563173|P5|Observational Phase|Un-specified|0
180306|NCT00098306|563174|P4|Observational Phase|Un-specified|0
180307|NCT00098306|563175|P3|Observational Phase|Un-specified|0
180308|NCT00098306|563176|P2|Observational Phase|Un-specified|0
180309|NCT00098306|563177|P1|Observational Phase|Un-specified|0
180310|NCT00098306|563171|P7|Observational Phase|Participant defaulted|18
180311|NCT00098306|563172|P6|Observational Phase|Participant defaulted|34
180312|NCT00098306|563173|P5|Observational Phase|Participant defaulted|0
180313|NCT00098306|563174|P4|Observational Phase|Participant defaulted|0
180314|NCT00098306|563175|P3|Observational Phase|Participant defaulted|0
180315|NCT00098306|563176|P2|Observational Phase|Participant defaulted|0
180316|NCT00098306|563177|P1|Observational Phase|Participant defaulted|0
180317|NCT00098306|563171|P7|Observational Phase|Death|4
180318|NCT00098306|563172|P6|Observational Phase|Death|5
180319|NCT00098306|563173|P5|Observational Phase|Death|0
180320|NCT00098306|563174|P4|Observational Phase|Death|0
180321|NCT00098306|563175|P3|Observational Phase|Death|0
180322|NCT00098306|563176|P2|Observational Phase|Death|0
180323|NCT00098306|563177|P1|Observational Phase|Death|0
180324|NCT00098306|563171|P7|Open Label|Ongoing at cut-off date|0
180325|NCT00098306|563172|P6|Open Label|Ongoing at cut-off date|0
180326|NCT00098306|563173|P5|Open Label|Ongoing at cut-off date|62
180327|NCT00098306|563174|P4|Open Label|Ongoing at cut-off date|269
180328|NCT00098306|563175|P3|Open Label|Ongoing at cut-off date|0
180329|NCT00098306|563176|P2|Open Label|Ongoing at cut-off date|0
180330|NCT00098306|563177|P1|Open Label|Ongoing at cut-off date|0
180331|NCT00098306|563171|P7|Open Label|Un-specified|0
180332|NCT00098306|563172|P6|Open Label|Un-specified|0
180333|NCT00098306|563173|P5|Open Label|Un-specified|0
180334|NCT00098306|563174|P4|Open Label|Un-specified|15
180335|NCT00098306|563175|P3|Open Label|Un-specified|0
180336|NCT00098306|563176|P2|Open Label|Un-specified|0
180337|NCT00098306|563177|P1|Open Label|Un-specified|0
180338|NCT00098306|563171|P7|Open Label|Participant defaulted|0
180339|NCT00098306|563172|P6|Open Label|Participant defaulted|0
180340|NCT00098306|563173|P5|Open Label|Participant defaulted|0
180341|NCT00098306|563174|P4|Open Label|Participant defaulted|24
180342|NCT00098306|563175|P3|Open Label|Participant defaulted|0
180343|NCT00098306|563176|P2|Open Label|Participant defaulted|0
180344|NCT00098306|563177|P1|Open Label|Participant defaulted|0
180345|NCT00098306|563171|P7|Open Label|Death|0
180346|NCT00098306|563172|P6|Open Label|Death|0
180347|NCT00098306|563173|P5|Open Label|Death|0
180348|NCT00098306|563174|P4|Open Label|Death|4
180349|NCT00098306|563175|P3|Open Label|Death|0
180350|NCT00098306|563176|P2|Open Label|Death|0
180351|NCT00098306|563177|P1|Open Label|Death|0
180352|NCT00098306|563171|P7|Open Label|Adverse Event|0
180353|NCT00098306|563172|P6|Open Label|Adverse Event|0
180354|NCT00098306|563173|P5|Open Label|Adverse Event|0
180355|NCT00098306|563174|P4|Open Label|Adverse Event|2
180356|NCT00098306|563175|P3|Open Label|Adverse Event|0
180357|NCT00098306|563176|P2|Open Label|Adverse Event|0
180358|NCT00098306|563177|P1|Open Label|Adverse Event|0
180359|NCT00098306|563171|P7|Open Label|Lack of Efficacy|0
180360|NCT00098306|563172|P6|Open Label|Lack of Efficacy|0
180361|NCT00098306|563173|P5|Open Label|Lack of Efficacy|0
180362|NCT00098306|563174|P4|Open Label|Lack of Efficacy|13
180363|NCT00098306|563175|P3|Open Label|Lack of Efficacy|0
180364|NCT00098306|563176|P2|Open Label|Lack of Efficacy|0
180365|NCT00098306|563177|P1|Open Label|Lack of Efficacy|0
180366|NCT00098306|563171|P7|Double Blind|Un-specified|0
180367|NCT00098306|563172|P6|Double Blind|Un-specified|0
180368|NCT00098306|563173|P5|Double Blind|Un-specified|0
180369|NCT00098306|563174|P4|Double Blind|Un-specified|0
180370|NCT00098306|563175|P3|Double Blind|Un-specified|11
180371|NCT00098306|563176|P2|Double Blind|Un-specified|3
180372|NCT00098306|563177|P1|Double Blind|Un-specified|7
180373|NCT00098306|563171|P7|Double Blind|Participant defaulted|0
180374|NCT00098306|563172|P6|Double Blind|Participant defaulted|0
180375|NCT00098306|563173|P5|Double Blind|Participant defaulted|0
180376|NCT00098306|563174|P4|Double Blind|Participant defaulted|0
180377|NCT00098306|563175|P3|Double Blind|Participant defaulted|11
180378|NCT00098306|563176|P2|Double Blind|Participant defaulted|18
180379|NCT00098306|563177|P1|Double Blind|Participant defaulted|19
180380|NCT00098306|563171|P7|Double Blind|Death|0
180381|NCT00098306|563172|P6|Double Blind|Death|0
180382|NCT00098306|563173|P5|Double Blind|Death|0
180383|NCT00098306|563174|P4|Double Blind|Death|0
180384|NCT00098306|563175|P3|Double Blind|Death|1
180385|NCT00098306|563176|P2|Double Blind|Death|4
180386|NCT00098306|563177|P1|Double Blind|Death|1
180387|NCT00098306|563171|P7|Double Blind|Lack of Efficacy|0
180388|NCT00098306|563172|P6|Double Blind|Lack of Efficacy|0
180389|NCT00098306|563173|P5|Double Blind|Lack of Efficacy|0
180390|NCT00098306|563174|P4|Double Blind|Lack of Efficacy|0
180391|NCT00098306|563175|P3|Double Blind|Lack of Efficacy|17
180392|NCT00098306|563176|P2|Double Blind|Lack of Efficacy|34
180393|NCT00098306|563177|P1|Double Blind|Lack of Efficacy|43
180394|NCT00098306|563171|P7|Double Blind|Adverse Event|0
180395|NCT00098306|563172|P6|Double Blind|Adverse Event|0
180396|NCT00098306|563173|P5|Double Blind|Adverse Event|0
180397|NCT00098306|563174|P4|Double Blind|Adverse Event|0
180398|NCT00098306|563175|P3|Double Blind|Adverse Event|6
180399|NCT00098306|563176|P2|Double Blind|Adverse Event|10
180400|NCT00098306|563177|P1|Double Blind|Adverse Event|11
180401|NCT00098306|563171|P7|Double Blind|Ongoing at cut-off date|0
180402|NCT00098306|563172|P6|Double Blind|Ongoing at cut-off date|0
180403|NCT00098306|563173|P5|Double Blind|Ongoing at cut-off date|0
180404|NCT00098306|563174|P4|Double Blind|Ongoing at cut-off date|0
180405|NCT00098306|563175|P3|Double Blind|Ongoing at cut-off date|72
180406|NCT00098306|563176|P2|Double Blind|Ongoing at cut-off date|166
180407|NCT00098306|563177|P1|Double Blind|Ongoing at cut-off date|151
180408|NCT00098306|563171|P7|Double Blind|Randomized, not treated|0
180409|NCT00098306|563172|P6|Double Blind|Randomized, not treated|0
180410|NCT00098306|563173|P5|Double Blind|Randomized, not treated|0
180411|NCT00098306|563174|P4|Double Blind|Randomized, not treated|0
180412|NCT00098306|563175|P3|Double Blind|Randomized, not treated|2
180413|NCT00098306|563176|P2|Double Blind|Randomized, not treated|5
180414|NCT00098306|563177|P1|Double Blind|Randomized, not treated|9
180415|NCT00098293|563243|P5|Supplemental Phase (SP)|Unspecified|22
180416|NCT00098293|563244|P4|Supplemental Phase (SP)|Unspecified|0
180417|NCT00098293|563245|P3|Supplemental Phase (SP)|Unspecified|0
180418|NCT00098293|563246|P2|Supplemental Phase (SP)|Unspecified|0
180419|NCT00098293|563247|P1|Supplemental Phase (SP)|Unspecified|0
180420|NCT00098293|563243|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
180421|NCT00098293|563244|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
180422|NCT00098293|563245|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
180423|NCT00098293|563246|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
180424|NCT00098293|563247|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
180425|NCT00098293|563243|P5|Supplemental Phase (SP)|Lost to Follow-up|2
180426|NCT00098293|563244|P4|Supplemental Phase (SP)|Lost to Follow-up|0
180427|NCT00098293|563245|P3|Supplemental Phase (SP)|Lost to Follow-up|0
180428|NCT00098293|563246|P2|Supplemental Phase (SP)|Lost to Follow-up|0
180429|NCT00098293|563247|P1|Supplemental Phase (SP)|Lost to Follow-up|0
180430|NCT00098293|563243|P5|Supplemental Phase (SP)|Death|1
180431|NCT00098293|563244|P4|Supplemental Phase (SP)|Death|0
180432|NCT00098293|563245|P3|Supplemental Phase (SP)|Death|0
180433|NCT00098293|563246|P2|Supplemental Phase (SP)|Death|0
180434|NCT00098293|563247|P1|Supplemental Phase (SP)|Death|0
180435|NCT00098293|563243|P5|Open-label (OL) Phase|Death|0
180436|NCT00098293|563244|P4|Open-label (OL) Phase|Death|0
180437|NCT00098293|563245|P3|Open-label (OL) Phase|Death|3
180438|NCT00098293|563246|P2|Open-label (OL) Phase|Death|2
180439|NCT00098293|563247|P1|Open-label (OL) Phase|Death|0
180440|NCT00098293|563243|P5|Open-label (OL) Phase|Participant Defaulted|0
180441|NCT00098293|563244|P4|Open-label (OL) Phase|Participant Defaulted|20
180442|NCT00098293|563245|P3|Open-label (OL) Phase|Participant Defaulted|16
180443|NCT00098293|563246|P2|Open-label (OL) Phase|Participant Defaulted|6
180444|NCT00098293|563247|P1|Open-label (OL) Phase|Participant Defaulted|0
180445|NCT00098293|563243|P5|Open-label (OL) Phase|Protocol Violation|0
180446|NCT00098293|563244|P4|Open-label (OL) Phase|Protocol Violation|16
180447|NCT00098293|563245|P3|Open-label (OL) Phase|Protocol Violation|13
180448|NCT00098293|563246|P2|Open-label (OL) Phase|Protocol Violation|6
180449|NCT00098293|563247|P1|Open-label (OL) Phase|Protocol Violation|0
180450|NCT00098293|563243|P5|Open-label (OL) Phase|Pregnancy|0
180451|NCT00098293|563244|P4|Open-label (OL) Phase|Pregnancy|3
180452|NCT00098293|563245|P3|Open-label (OL) Phase|Pregnancy|0
180453|NCT00098293|563246|P2|Open-label (OL) Phase|Pregnancy|1
180454|NCT00098293|563247|P1|Open-label (OL) Phase|Pregnancy|0
180455|NCT00098293|563243|P5|Open-label (OL) Phase|Lack of Efficacy|0
180456|NCT00098293|563244|P4|Open-label (OL) Phase|Lack of Efficacy|20
180457|NCT00098293|563245|P3|Open-label (OL) Phase|Lack of Efficacy|2
180458|NCT00098293|563246|P2|Open-label (OL) Phase|Lack of Efficacy|7
180459|NCT00098293|563247|P1|Open-label (OL) Phase|Lack of Efficacy|0
180460|NCT00098293|563243|P5|Open-label (OL) Phase|Adverse Event|0
180461|NCT00098293|563244|P4|Open-label (OL) Phase|Adverse Event|6
180462|NCT00098293|563245|P3|Open-label (OL) Phase|Adverse Event|7
180463|NCT00098293|563246|P2|Open-label (OL) Phase|Adverse Event|3
180464|NCT00098293|563247|P1|Open-label (OL) Phase|Adverse Event|0
180465|NCT00098293|563243|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
180466|NCT00098293|563244|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
180467|NCT00098293|563245|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
180468|NCT00098293|563246|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
180469|NCT00098293|563247|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
180470|NCT00098293|563243|P5|Double-blind (DB) Phase|Terminated by sponsor|0
180471|NCT00098293|563244|P4|Double-blind (DB) Phase|Terminated by sponsor|0
180472|NCT00098293|563245|P3|Double-blind (DB) Phase|Terminated by sponsor|0
180473|NCT00098293|563246|P2|Double-blind (DB) Phase|Terminated by sponsor|0
180474|NCT00098293|563247|P1|Double-blind (DB) Phase|Terminated by sponsor|135
180475|NCT00098293|563243|P5|Double-blind (DB) Phase|Protocol Violation|0
180476|NCT00098293|563244|P4|Double-blind (DB) Phase|Protocol Violation|0
180477|NCT00098293|563245|P3|Double-blind (DB) Phase|Protocol Violation|22
180478|NCT00098293|563246|P2|Double-blind (DB) Phase|Protocol Violation|18
180479|NCT00098293|563247|P1|Double-blind (DB) Phase|Protocol Violation|2
180480|NCT00098293|563243|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
180481|NCT00098293|563244|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
180482|NCT00098293|563245|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
180483|NCT00098293|563246|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
180484|NCT00098293|563247|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
180485|NCT00098293|563243|P5|Double-blind (DB) Phase|Death|0
180486|NCT00098293|563244|P4|Double-blind (DB) Phase|Death|0
180487|NCT00098293|563245|P3|Double-blind (DB) Phase|Death|2
180488|NCT00098293|563246|P2|Double-blind (DB) Phase|Death|2
180489|NCT00098293|563247|P1|Double-blind (DB) Phase|Death|1
180490|NCT00098293|563243|P5|Double-blind (DB) Phase|Lack of Efficacy|0
180491|NCT00098293|563244|P4|Double-blind (DB) Phase|Lack of Efficacy|0
180492|NCT00098293|563245|P3|Double-blind (DB) Phase|Lack of Efficacy|30
180493|NCT00098293|563246|P2|Double-blind (DB) Phase|Lack of Efficacy|64
180494|NCT00098293|563247|P1|Double-blind (DB) Phase|Lack of Efficacy|11
180495|NCT00098293|563243|P5|Double-blind (DB) Phase|Participant Defaulted|0
180496|NCT00098293|563244|P4|Double-blind (DB) Phase|Participant Defaulted|0
180497|NCT00098293|563245|P3|Double-blind (DB) Phase|Participant Defaulted|36
180498|NCT00098293|563246|P2|Double-blind (DB) Phase|Participant Defaulted|40
180499|NCT00098293|563247|P1|Double-blind (DB) Phase|Participant Defaulted|11
180500|NCT00098293|563243|P5|Double-blind (DB) Phase|Pregnancy|0
180501|NCT00098293|563244|P4|Double-blind (DB) Phase|Pregnancy|0
180502|NCT00098293|563245|P3|Double-blind (DB) Phase|Pregnancy|9
180503|NCT00098293|563246|P2|Double-blind (DB) Phase|Pregnancy|7
180504|NCT00098293|563247|P1|Double-blind (DB) Phase|Pregnancy|0
180505|NCT00098293|563243|P5|Double-blind (DB) Phase|Adverse Event|0
180506|NCT00098293|563244|P4|Double-blind (DB) Phase|Adverse Event|0
180507|NCT00098293|563245|P3|Double-blind (DB) Phase|Adverse Event|60
180508|NCT00098293|563246|P2|Double-blind (DB) Phase|Adverse Event|27
180509|NCT00098293|563247|P1|Double-blind (DB) Phase|Adverse Event|14
180510|NCT00098254|563300|P1|Overall Study|Death|1
180511|NCT00098254|563300|P1|Overall Study|Adverse Event|2
180512|NCT00097370|563319|P1|Stage 3|Lost to Follow-up|1
180513|NCT00097370|563319|P1|Stage 3|Sponsor Terminated Study|52
180514|NCT00097370|563319|P1|Stage 3|Lack of Efficacy|1
180515|NCT00097370|563319|P1|Stage 3|Withdrawal by Subject|3
180516|NCT00097370|563319|P1|Stage 3|Adverse Event|2
180517|NCT00097370|563319|P1|Stage 2|Lost to Follow-up|1
180518|NCT00097370|563319|P1|Stage 2|Sponsor Terminated Study|2
180519|NCT00097370|563319|P1|Stage 2|Pregnancy|1
180520|NCT00097370|563319|P1|Stage 2|Lack of Efficacy|3
180521|NCT00097370|563319|P1|Stage 2|Withdrawal by Subject|1
180522|NCT00097370|563319|P1|Stage 2|Adverse Event|5
180523|NCT00097370|563319|P1|Stage 1|Lack of Efficacy|2
180524|NCT00097370|563319|P1|Stage 1|Withdrawal by Subject|1
180525|NCT00097370|563319|P1|Stage 1|Adverse Event|3
180526|NCT00097981|563400|P2|Overall Study|Other|13
180527|NCT00097981|563401|P1|Overall Study|Other|19
180528|NCT00097981|563400|P2|Overall Study|Transplant planned|27
180529|NCT00097981|563401|P1|Overall Study|Transplant planned|28
180530|NCT00097981|563400|P2|Overall Study|Disease Progression|2
180531|NCT00097981|563401|P1|Overall Study|Disease Progression|8
180532|NCT00097981|563400|P2|Overall Study|Physician Decision|1
180533|NCT00097981|563401|P1|Overall Study|Physician Decision|7
180534|NCT00097981|563400|P2|Overall Study|Death|4
180535|NCT00097981|563401|P1|Overall Study|Death|2
180536|NCT00097981|563400|P2|Overall Study|Protocol Violation|1
180537|NCT00097981|563401|P1|Overall Study|Protocol Violation|1
180538|NCT00097981|563400|P2|Overall Study|Withdrawal by Subject|8
180539|NCT00097981|563401|P1|Overall Study|Withdrawal by Subject|10
180540|NCT00097981|563400|P2|Overall Study|Adverse Event|44
180541|NCT00097981|563401|P1|Overall Study|Adverse Event|31
180542|NCT00097786|563417|P4|Overall Study|lost to follow-up for all-cause death|310
180543|NCT00097786|563418|P3|Overall Study|lost to follow-up for all-cause death|313
180544|NCT00097786|563419|P2|Overall Study|lost to follow-up for all-cause death|292
180545|NCT00097786|563420|P1|Overall Study|lost to follow-up for all-cause death|296
180546|NCT00097773|563442|P4|Overall Study|Other|0
180547|NCT00097773|563443|P3|Overall Study|Other|2
180548|NCT00097773|563444|P2|Overall Study|Other|0
180549|NCT00097773|563445|P1|Overall Study|Other|1
180550|NCT00097773|563442|P4|Overall Study|Adverse Event|0
180551|NCT00097773|563443|P3|Overall Study|Adverse Event|0
180552|NCT00097773|563444|P2|Overall Study|Adverse Event|1
180553|NCT00097773|563445|P1|Overall Study|Adverse Event|0
180554|NCT00097773|563442|P4|Overall Study|Withdrawal by Subject|1
180555|NCT00097773|563443|P3|Overall Study|Withdrawal by Subject|3
180556|NCT00097773|563444|P2|Overall Study|Withdrawal by Subject|3
180557|NCT00097773|563445|P1|Overall Study|Withdrawal by Subject|3
180558|NCT00097773|563442|P4|Overall Study|Physician Decision|1
180559|NCT00097773|563443|P3|Overall Study|Physician Decision|3
180560|NCT00097773|563444|P2|Overall Study|Physician Decision|2
180561|NCT00097773|563445|P1|Overall Study|Physician Decision|2
180562|NCT00097773|563442|P4|Overall Study|Lost to Follow-up|1
180563|NCT00097773|563443|P3|Overall Study|Lost to Follow-up|0
180564|NCT00097773|563444|P2|Overall Study|Lost to Follow-up|2
180565|NCT00097773|563445|P1|Overall Study|Lost to Follow-up|2
180566|NCT00097721|563465|P2|Overall Study|Reason not given|1
180567|NCT00097721|563466|P1|Overall Study|Reason not given|1
180568|NCT00097721|563465|P2|Overall Study|Physician Decision|3
180569|NCT00097721|563466|P1|Overall Study|Physician Decision|1
180570|NCT00097721|563465|P2|Overall Study|Progressive Disease|27
180571|NCT00097721|563466|P1|Overall Study|Progressive Disease|55
180572|NCT00097721|563465|P2|Overall Study|Withdrawal by Subject|1
180573|NCT00097721|563466|P1|Overall Study|Withdrawal by Subject|6
180574|NCT00097721|563465|P2|Overall Study|Adverse Event|1
180575|NCT00097721|563466|P1|Overall Study|Adverse Event|8
180576|NCT00097591|563516|P2|Overall Study|Other|3
180577|NCT00097591|563517|P1|Overall Study|Other|0
180578|NCT00097591|563516|P2|Overall Study|Lost to follow up|10
180579|NCT00097591|563517|P1|Overall Study|Lost to follow up|6
180580|NCT00097591|563516|P2|Overall Study|Unable to attend termination visit|51
180581|NCT00097591|563517|P1|Overall Study|Unable to attend termination visit|53
180582|NCT00097591|563516|P2|Overall Study|Less than 6 months on study drug|7
180583|NCT00097591|563517|P1|Overall Study|Less than 6 months on study drug|9
180584|NCT00097591|563516|P2|Overall Study|Withdrawal of consent|323
180585|NCT00097591|563517|P1|Overall Study|Withdrawal of consent|342
180586|NCT00097539|563540|P7|Overall Study|Reason not Specified|2
180587|NCT00097539|563541|P6|Overall Study|Reason not Specified|40
180588|NCT00097539|563542|P5|Overall Study|Reason not Specified|11
180589|NCT00097539|563543|P4|Overall Study|Reason not Specified|21
180590|NCT00097539|563544|P3|Overall Study|Reason not Specified|53
180591|NCT00097539|563545|P2|Overall Study|Reason not Specified|49
180592|NCT00097539|563546|P1|Overall Study|Reason not Specified|111
180593|NCT00097539|563540|P7|Overall Study|Reasons Other Than Above|34
180594|NCT00097539|563541|P6|Overall Study|Reasons Other Than Above|1244
180595|NCT00097539|563542|P5|Overall Study|Reasons Other Than Above|361
180596|NCT00097539|563543|P4|Overall Study|Reasons Other Than Above|692
180597|NCT00097539|563544|P3|Overall Study|Reasons Other Than Above|1757
180598|NCT00097539|563545|P2|Overall Study|Reasons Other Than Above|1382
180599|NCT00097539|563546|P1|Overall Study|Reasons Other Than Above|3602
180600|NCT00097539|563540|P7|Overall Study|Death|0
180601|NCT00097539|563541|P6|Overall Study|Death|3
180602|NCT00097539|563542|P5|Overall Study|Death|1
180603|NCT00097539|563543|P4|Overall Study|Death|0
180604|NCT00097539|563544|P3|Overall Study|Death|0
180605|NCT00097539|563545|P2|Overall Study|Death|7
180606|NCT00097539|563546|P1|Overall Study|Death|2
180607|NCT00097539|563540|P7|Overall Study|Adverse Event|1
180608|NCT00097539|563541|P6|Overall Study|Adverse Event|59
180609|NCT00097539|563542|P5|Overall Study|Adverse Event|30
180610|NCT00097539|563543|P4|Overall Study|Adverse Event|27
180611|NCT00097539|563544|P3|Overall Study|Adverse Event|37
180612|NCT00097539|563545|P2|Overall Study|Adverse Event|133
180613|NCT00097539|563546|P1|Overall Study|Adverse Event|78
180614|NCT00097539|563540|P7|Overall Study|Lack of Efficacy|5
180615|NCT00097539|563541|P6|Overall Study|Lack of Efficacy|228
180616|NCT00097539|563542|P5|Overall Study|Lack of Efficacy|45
180617|NCT00097539|563543|P4|Overall Study|Lack of Efficacy|105
180618|NCT00097539|563544|P3|Overall Study|Lack of Efficacy|202
180619|NCT00097539|563545|P2|Overall Study|Lack of Efficacy|122
180620|NCT00097539|563546|P1|Overall Study|Lack of Efficacy|249
180621|NCT00097539|563540|P7|Overall Study|Participant Non-compliant|18
180622|NCT00097539|563541|P6|Overall Study|Participant Non-compliant|543
180623|NCT00097539|563542|P5|Overall Study|Participant Non-compliant|136
180624|NCT00097539|563543|P4|Overall Study|Participant Non-compliant|353
180625|NCT00097539|563544|P3|Overall Study|Participant Non-compliant|1067
180626|NCT00097539|563545|P2|Overall Study|Participant Non-compliant|567
180627|NCT00097539|563546|P1|Overall Study|Participant Non-compliant|2140
180628|NCT00097539|563540|P7|Overall Study|Withdrawal by Subject|3
180629|NCT00097539|563541|P6|Overall Study|Withdrawal by Subject|229
180630|NCT00097539|563542|P5|Overall Study|Withdrawal by Subject|68
180631|NCT00097539|563543|P4|Overall Study|Withdrawal by Subject|217
180632|NCT00097539|563544|P3|Overall Study|Withdrawal by Subject|346
180633|NCT00097539|563545|P2|Overall Study|Withdrawal by Subject|323
180634|NCT00097539|563546|P1|Overall Study|Withdrawal by Subject|925
180635|NCT00097539|563540|P7|Overall Study|Status Unknown (Or no final evaluation)|108
180636|NCT00097539|563541|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
180722|NCT00096265|563766|P2|Overall Study|Ineligible|0
180637|NCT00097539|563542|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
180638|NCT00097539|563543|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
180639|NCT00097539|563544|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
180640|NCT00097539|563545|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
180641|NCT00097539|563546|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
180642|NCT00097500|563592|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
180643|NCT00097500|563593|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
180644|NCT00097500|563592|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
180645|NCT00097500|563593|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
180646|NCT00097500|563592|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
180647|NCT00097500|563593|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
180648|NCT00097500|563592|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
180649|NCT00097500|563593|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
180650|NCT00097500|563592|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
180651|NCT00097500|563593|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
180652|NCT00097500|563592|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
180653|NCT00097500|563593|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
180654|NCT00097500|563592|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
180655|NCT00097500|563593|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
180656|NCT00096993|563626|P2|Overall Study|Other unspecified|1
180657|NCT00096993|563627|P1|Overall Study|Other unspecified|1
180658|NCT00096993|563626|P2|Overall Study|Non-compliance|1
180659|NCT00096993|563627|P1|Overall Study|Non-compliance|0
180660|NCT00096993|563626|P2|Overall Study|Physician Decision|1
180661|NCT00096993|563627|P1|Overall Study|Physician Decision|2
180662|NCT00096993|563626|P2|Overall Study|Subject's decision|1
180663|NCT00096993|563627|P1|Overall Study|Subject's decision|3
180664|NCT00096993|563626|P2|Overall Study|Adverse Event|8
180665|NCT00096993|563627|P1|Overall Study|Adverse Event|2
180666|NCT00096993|563626|P2|Overall Study|Disease progression|53
180667|NCT00096993|563627|P1|Overall Study|Disease progression|56
180668|NCT00096993|563626|P2|Overall Study|Death|0
180669|NCT00096993|563627|P1|Overall Study|Death|1
180670|NCT00096954|563643|P2|Overall Study|Lost to Follow-up|5
180671|NCT00096954|563644|P1|Overall Study|Lost to Follow-up|8
180672|NCT00096954|563643|P2|Overall Study|Non-compliance|3
180673|NCT00096954|563644|P1|Overall Study|Non-compliance|0
180674|NCT00096954|563643|P2|Overall Study|Initiation of immunotherapy|0
180675|NCT00096954|563644|P1|Overall Study|Initiation of immunotherapy|1
180676|NCT00096954|563643|P2|Overall Study|Pregnancy|1
180677|NCT00096954|563644|P1|Overall Study|Pregnancy|1
180678|NCT00096954|563643|P2|Overall Study|Sponsors Decision|1
180679|NCT00096954|563644|P1|Overall Study|Sponsors Decision|1
180680|NCT00096954|563643|P2|Overall Study|Physician Decision|1
180681|NCT00096954|563644|P1|Overall Study|Physician Decision|1
180682|NCT00096954|563643|P2|Overall Study|Withdrawal by Subject|8
180683|NCT00096954|563644|P1|Overall Study|Withdrawal by Subject|9
180684|NCT00096954|563643|P2|Overall Study|Adverse Event|1
180685|NCT00096954|563644|P1|Overall Study|Adverse Event|3
180686|NCT00096941|563656|P1|Overall Study|disease progression|3
180687|NCT00096785|563663|P2|Overall Study|Relocated|0
180688|NCT00096785|563664|P1|Overall Study|Relocated|1
180689|NCT00096785|563663|P2|Overall Study|Withdrawal by Subject|1
180690|NCT00096785|563664|P1|Overall Study|Withdrawal by Subject|0
180691|NCT00096785|563663|P2|Overall Study|Lost to Follow-up|0
180692|NCT00096785|563664|P1|Overall Study|Lost to Follow-up|1
180693|NCT00096538|563693|P1|Overall Study|Withdrawal by Subject|1
180694|NCT00096486|563701|P4|Overall Study|Not Treated|1
180695|NCT00096486|563702|P3|Overall Study|Not Treated|1
180696|NCT00096486|563703|P2|Overall Study|Not Treated|0
180697|NCT00096486|563704|P1|Overall Study|Not Treated|0
180698|NCT00096486|563701|P4|Overall Study|Withdrawal by Subject|1
180699|NCT00096486|563702|P3|Overall Study|Withdrawal by Subject|1
180700|NCT00096486|563703|P2|Overall Study|Withdrawal by Subject|0
180701|NCT00096486|563704|P1|Overall Study|Withdrawal by Subject|0
180702|NCT00096447|563723|P1|Overall Study|Never treated|1
180703|NCT00096382|563731|P2|Overall Study|Death during treatment|0
180704|NCT00096382|563732|P1|Overall Study|Death during treatment|1
180705|NCT00096382|563731|P2|Overall Study|Not treated|0
180706|NCT00096382|563732|P1|Overall Study|Not treated|1
180707|NCT00096356|563742|P2|Overall Study|multiple reasons|18
180708|NCT00096356|563743|P1|Overall Study|multiple reasons|10
180709|NCT00096356|563742|P2|Overall Study|Lack of Efficacy|0
180710|NCT00096356|563743|P1|Overall Study|Lack of Efficacy|1
180711|NCT00096356|563742|P2|Overall Study|Withdrawal by Subject|23
180712|NCT00096356|563743|P1|Overall Study|Withdrawal by Subject|17
180713|NCT00096356|563742|P2|Overall Study|Physician Decision|3
180714|NCT00096356|563743|P1|Overall Study|Physician Decision|5
180715|NCT00096356|563742|P2|Overall Study|Adverse Event|9
180716|NCT00096356|563743|P1|Overall Study|Adverse Event|11
180717|NCT00096278|563755|P2|Overall Study|Patient not at risk for primary endpoint|2
180718|NCT00096278|563756|P1|Overall Study|Patient not at risk for primary endpoint|3
180719|NCT00096278|563755|P2|Overall Study|No follow-up data|18
180720|NCT00096278|563756|P1|Overall Study|No follow-up data|15
180721|NCT00096265|563765|P3|Overall Study|Ineligible|0
180723|NCT00096265|563767|P1|Overall Study|Ineligible|1
180724|NCT00096226|563775|P1|Overall Study|Surgery but inadequate nodal sampling|1
180725|NCT00096226|563775|P1|Overall Study|Surgical restaging not performed|13
180726|NCT00096226|563775|P1|Overall Study|Protocol treatment not started|1
180727|NCT00096226|563775|P1|Overall Study|Ineligible|2
180728|NCT00096200|563782|P3|Overall Study|Ineligible pathology|0
180729|NCT00096200|563783|P2|Overall Study|Ineligible pathology|1
180730|NCT00096200|563784|P1|Overall Study|Ineligible pathology|0
180731|NCT00096200|563782|P3|Overall Study|Withdrawal by Subject|0
180732|NCT00096200|563783|P2|Overall Study|Withdrawal by Subject|2
180733|NCT00096200|563784|P1|Overall Study|Withdrawal by Subject|1
180734|NCT00096200|563782|P3|Overall Study|Adverse Event|0
180735|NCT00096200|563783|P2|Overall Study|Adverse Event|4
180736|NCT00096200|563784|P1|Overall Study|Adverse Event|0
180737|NCT00096174|563792|P1|Overall Study|other reason|8
180738|NCT00096174|563792|P1|Overall Study|Ineligible|6
180739|NCT00096174|563792|P1|Overall Study|Not started protocol therapy|3
180740|NCT00096174|563792|P1|Overall Study|Withdrawal by Subject|15
180741|NCT00096174|563792|P1|Overall Study|Death|6
180742|NCT00096174|563792|P1|Overall Study|Adverse Event|15
180743|NCT00096174|563792|P1|Overall Study|Lack of Efficacy|9
180744|NCT00096135|563800|P2|Overall Study|Ineligible|0
180745|NCT00096135|563801|P1|Overall Study|Ineligible|2
180746|NCT00096135|563800|P2|Overall Study|Other, specify|3
180747|NCT00096135|563801|P1|Overall Study|Other, specify|15
180748|NCT00096135|563800|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
180749|NCT00096135|563801|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
180750|NCT00096135|563800|P2|Overall Study|Refusal of further protocol therapy|1
180751|NCT00096135|563801|P1|Overall Study|Refusal of further protocol therapy|4
180752|NCT00096135|563800|P2|Overall Study|Physician Decision|4
180753|NCT00096135|563801|P1|Overall Study|Physician Decision|20
180754|NCT00096031|563817|P1|Overall Study|Not protocol specified|5
180755|NCT00096031|563817|P1|Overall Study|Ineligible|8
180756|NCT00096031|563817|P1|Overall Study|Withdrawal by Subject|1
180757|NCT00096031|563817|P1|Overall Study|Death|4
180758|NCT00096031|563817|P1|Overall Study|Lack of Efficacy|42
180759|NCT00096031|563817|P1|Overall Study|Adverse Event|3
180760|NCT00096018|563825|P2|Overall Study|Miscellaneous|1
180761|NCT00096018|563826|P1|Overall Study|Miscellaneous|2
180762|NCT00096018|563825|P2|Overall Study|Withdrawal by Subject|2
180763|NCT00096018|563826|P1|Overall Study|Withdrawal by Subject|0
180764|NCT00096018|563825|P2|Overall Study|Death|1
180765|NCT00096018|563826|P1|Overall Study|Death|0
180766|NCT00096018|563825|P2|Overall Study|Adverse Event|5
180767|NCT00096018|563826|P1|Overall Study|Adverse Event|0
180768|NCT00096018|563825|P2|Overall Study|Miscellaneous (not treated)|2
180769|NCT00096018|563826|P1|Overall Study|Miscellaneous (not treated)|0
180770|NCT00096018|563825|P2|Overall Study|Became Ineligible (not treated)|3
180771|NCT00096018|563826|P1|Overall Study|Became Ineligible (not treated)|0
180772|NCT00095979|563834|P1|Overall Study|Ineligible: Second primary cancer site|2
180773|NCT00095940|563847|P9|Lapatinib Continuation/Phase II|Adverse Event|0
180774|NCT00095940|563848|P8|Lapatinib Continuation/Phase II|Adverse Event|1
180775|NCT00095940|563849|P7|Lapatinib Continuation/Phase II|Adverse Event|0
180776|NCT00095940|563850|P6|Lapatinib Continuation/Phase II|Adverse Event|0
180777|NCT00095940|563851|P5|Lapatinib Continuation/Phase II|Adverse Event|0
180778|NCT00095940|563852|P4|Lapatinib Continuation/Phase II|Adverse Event|0
180779|NCT00095940|563853|P3|Lapatinib Continuation/Phase II|Adverse Event|0
180780|NCT00095940|563854|P2|Lapatinib Continuation/Phase II|Adverse Event|0
180781|NCT00095940|563855|P1|Lapatinib Continuation/Phase II|Adverse Event|0
180782|NCT00095940|563847|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
180783|NCT00095940|563848|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
180784|NCT00095940|563849|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
180785|NCT00095940|563850|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
180786|NCT00095940|563851|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
180787|NCT00095940|563852|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
180788|NCT00095940|563853|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
180789|NCT00095940|563854|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
180790|NCT00095940|563855|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
180791|NCT00095940|563847|P9|Lapatinib Continuation/Phase II|Disease Progression|12
180792|NCT00095940|563848|P8|Lapatinib Continuation/Phase II|Disease Progression|1
180793|NCT00095940|563849|P7|Lapatinib Continuation/Phase II|Disease Progression|2
180794|NCT00095940|563850|P6|Lapatinib Continuation/Phase II|Disease Progression|13
180795|NCT00095940|563851|P5|Lapatinib Continuation/Phase II|Disease Progression|0
180796|NCT00095940|563852|P4|Lapatinib Continuation/Phase II|Disease Progression|0
180797|NCT00095940|563853|P3|Lapatinib Continuation/Phase II|Disease Progression|15
180798|NCT00095940|563854|P2|Lapatinib Continuation/Phase II|Disease Progression|1
180799|NCT00095940|563855|P1|Lapatinib Continuation/Phase II|Disease Progression|1
180800|NCT00095576|563913|P2|Overall Study|Subject moved|36
180801|NCT00095576|563914|P1|Overall Study|Subject moved|30
180802|NCT00095576|563913|P2|Overall Study|Site terminated|67
180803|NCT00095576|563914|P1|Overall Study|Site terminated|75
180804|NCT00095576|563913|P2|Overall Study|Option to switch to a rollover study|1099
180805|NCT00095576|563914|P1|Overall Study|Option to switch to a rollover study|1097
180806|NCT00095576|563913|P2|Overall Study|Withdrawal by Subject|47
180807|NCT00095576|563914|P1|Overall Study|Withdrawal by Subject|34
180808|NCT00095576|563913|P2|Overall Study|Protocol Violation|0
180809|NCT00095576|563914|P1|Overall Study|Protocol Violation|1
180810|NCT00095576|563913|P2|Overall Study|Lost to Follow-up|229
180811|NCT00095576|563914|P1|Overall Study|Lost to Follow-up|233
180812|NCT00095576|563913|P2|Overall Study|Adverse Event|3
180813|NCT00095576|563914|P1|Overall Study|Adverse Event|5
180814|NCT00095498|563929|P3|Overall Study|Requirement for alternative therapy|2
180815|NCT00095498|563930|P2|Overall Study|Requirement for alternative therapy|0
180816|NCT00095498|563931|P1|Overall Study|Requirement for alternative therapy|1
180817|NCT00095498|563929|P3|Overall Study|Protocol Violation|1
180818|NCT00095498|563930|P2|Overall Study|Protocol Violation|0
180819|NCT00095498|563931|P1|Overall Study|Protocol Violation|0
180820|NCT00095498|563929|P3|Overall Study|Other|6
180821|NCT00095498|563930|P2|Overall Study|Other|7
180822|NCT00095498|563931|P1|Overall Study|Other|6
180823|NCT00095498|563929|P3|Overall Study|Noncompliance|1
180824|NCT00095498|563930|P2|Overall Study|Noncompliance|0
180825|NCT00095498|563931|P1|Overall Study|Noncompliance|1
180826|NCT00095498|563929|P3|Overall Study|Lost to Follow-up|2
180827|NCT00095498|563930|P2|Overall Study|Lost to Follow-up|1
180828|NCT00095498|563931|P1|Overall Study|Lost to Follow-up|1
180829|NCT00095498|563929|P3|Overall Study|Ineligibility determined|2
180830|NCT00095498|563930|P2|Overall Study|Ineligibility determined|0
180831|NCT00095498|563931|P1|Overall Study|Ineligibility determined|3
180832|NCT00095498|563929|P3|Overall Study|Disease progression|1
180833|NCT00095498|563930|P2|Overall Study|Disease progression|1
180834|NCT00095498|563931|P1|Overall Study|Disease progression|0
180835|NCT00095498|563929|P3|Overall Study|Withdrawal by Subject|15
180836|NCT00095498|563930|P2|Overall Study|Withdrawal by Subject|16
180837|NCT00095498|563931|P1|Overall Study|Withdrawal by Subject|15
180838|NCT00095498|563929|P3|Overall Study|Adverse Event|1
180839|NCT00095498|563930|P2|Overall Study|Adverse Event|0
180840|NCT00095498|563931|P1|Overall Study|Adverse Event|1
180841|NCT00095498|563929|P3|Overall Study|Physician Decision|8
180842|NCT00095498|563930|P2|Overall Study|Physician Decision|10
180843|NCT00095498|563931|P1|Overall Study|Physician Decision|9
180844|NCT00095303|564358|P2|Follow Up Study|Lost to Follow-up|58
180845|NCT00095303|564359|P1|Follow Up Study|Lost to Follow-up|59
180846|NCT00095303|564358|P2|Main Study|Lost to Follow-up|87
180847|NCT00095303|564359|P1|Main Study|Lost to Follow-up|91
180848|NCT00095238|564427|P2|Overall Study|Other Reasons|88
180849|NCT00095238|564428|P1|Overall Study|Other Reasons|87
180850|NCT00095238|564427|P2|Overall Study|Missing|0
180851|NCT00095238|564428|P1|Overall Study|Missing|1
180852|NCT00095238|564427|P2|Overall Study|Study terminated by sponsor|1
180853|NCT00095238|564428|P1|Overall Study|Study terminated by sponsor|0
180854|NCT00095238|564427|P2|Overall Study|No longer met study criteria|5
180855|NCT00095238|564428|P1|Overall Study|No longer met study criteria|4
180856|NCT00095238|564427|P2|Overall Study|Noncompliance|45
180857|NCT00095238|564428|P1|Overall Study|Noncompliance|44
180858|NCT00095238|564427|P2|Overall Study|Lost to Follow-up|24
180859|NCT00095238|564428|P1|Overall Study|Lost to Follow-up|19
180860|NCT00095238|564427|P2|Overall Study|Death|170
180861|NCT00095238|564428|P1|Overall Study|Death|154
180862|NCT00095238|564427|P2|Overall Study|Subject Withdrew Consent|223
180863|NCT00095238|564428|P1|Overall Study|Subject Withdrew Consent|208
180864|NCT00095238|564427|P2|Overall Study|Adverse Event|287
180865|NCT00095238|564428|P1|Overall Study|Adverse Event|331
180866|NCT00095238|564427|P2|Overall Study|Lack of Efficacy|9
180867|NCT00095238|564428|P1|Overall Study|Lack of Efficacy|9
180868|NCT00095212|564490|P2|Overall Study|Withdrawal by Subject|3
180869|NCT00095212|564491|P1|Overall Study|Withdrawal by Subject|1
180870|NCT00095199|564521|P4|Overall Study|Data inadvertently lost by site|0
180871|NCT00095199|564522|P3|Overall Study|Data inadvertently lost by site|0
180872|NCT00095199|564523|P2|Overall Study|Data inadvertently lost by site|0
180873|NCT00095199|564524|P1|Overall Study|Data inadvertently lost by site|1
180874|NCT00095199|564521|P4|Overall Study|Primary tumor removed in other surgery|0
180875|NCT00095199|564522|P3|Overall Study|Primary tumor removed in other surgery|0
180876|NCT00095199|564523|P2|Overall Study|Primary tumor removed in other surgery|1
180877|NCT00095199|564524|P1|Overall Study|Primary tumor removed in other surgery|0
180878|NCT00095199|564521|P4|Overall Study|Started radiotherapy regimen|0
180879|NCT00095199|564522|P3|Overall Study|Started radiotherapy regimen|0
180880|NCT00095199|564523|P2|Overall Study|Started radiotherapy regimen|1
180881|NCT00095199|564524|P1|Overall Study|Started radiotherapy regimen|0
180882|NCT00095199|564521|P4|Overall Study|Started Palliative Radiotherapy|0
180883|NCT00095199|564522|P3|Overall Study|Started Palliative Radiotherapy|0
180884|NCT00095199|564523|P2|Overall Study|Started Palliative Radiotherapy|0
180885|NCT00095199|564524|P1|Overall Study|Started Palliative Radiotherapy|1
180886|NCT00095199|564521|P4|Overall Study|Not eligible|1
180887|NCT00095199|564522|P3|Overall Study|Not eligible|0
180888|NCT00095199|564523|P2|Overall Study|Not eligible|7
180889|NCT00095199|564524|P1|Overall Study|Not eligible|1
180890|NCT00095199|564521|P4|Overall Study|Physician Decision|1
180891|NCT00095199|564522|P3|Overall Study|Physician Decision|1
180892|NCT00095199|564523|P2|Overall Study|Physician Decision|6
180893|NCT00095199|564524|P1|Overall Study|Physician Decision|5
180894|NCT00095199|564521|P4|Overall Study|Surgery needed could not start in 7 days|0
180895|NCT00095199|564522|P3|Overall Study|Surgery needed could not start in 7 days|1
180896|NCT00095199|564523|P2|Overall Study|Surgery needed could not start in 7 days|0
180897|NCT00095199|564524|P1|Overall Study|Surgery needed could not start in 7 days|0
180898|NCT00095199|564521|P4|Overall Study|Liver function test results elevated|1
180899|NCT00095199|564522|P3|Overall Study|Liver function test results elevated|1
180900|NCT00095199|564523|P2|Overall Study|Liver function test results elevated|0
180901|NCT00095199|564524|P1|Overall Study|Liver function test results elevated|0
180902|NCT00095199|564521|P4|Overall Study|Protocol Violation|0
180903|NCT00095199|564522|P3|Overall Study|Protocol Violation|2
180904|NCT00095199|564523|P2|Overall Study|Protocol Violation|4
180905|NCT00095199|564524|P1|Overall Study|Protocol Violation|4
180906|NCT00095199|564521|P4|Overall Study|Withdrawal by Subject|22
180907|NCT00095199|564522|P3|Overall Study|Withdrawal by Subject|13
180908|NCT00095199|564523|P2|Overall Study|Withdrawal by Subject|16
180909|NCT00095199|564524|P1|Overall Study|Withdrawal by Subject|21
180910|NCT00095199|564521|P4|Overall Study|Death|9
180911|NCT00095199|564522|P3|Overall Study|Death|11
180912|NCT00095199|564523|P2|Overall Study|Death|6
180913|NCT00095199|564524|P1|Overall Study|Death|10
180914|NCT00095199|564521|P4|Overall Study|Progressive disease|98
180915|NCT00095199|564522|P3|Overall Study|Progressive disease|105
180916|NCT00095199|564523|P2|Overall Study|Progressive disease|179
180917|NCT00095199|564524|P1|Overall Study|Progressive disease|213
180918|NCT00095199|564521|P4|Overall Study|Adverse Event|11
180919|NCT00095199|564522|P3|Overall Study|Adverse Event|26
180920|NCT00095199|564523|P2|Overall Study|Adverse Event|22
180921|NCT00095199|564524|P1|Overall Study|Adverse Event|40
180922|NCT00095173|564562|P6|Open-Label Extension Phase (Period C)|Not Specified|8
180923|NCT00095173|564563|P5|Open-Label Extension Phase (Period C)|Not Specified|6
180924|NCT00095173|564564|P4|Open-Label Extension Phase (Period C)|Not Specified|4
180925|NCT00095173|564565|P3|Open-Label Extension Phase (Period C)|Not Specified|0
180926|NCT00095173|564566|P2|Open-Label Extension Phase (Period C)|Not Specified|0
180927|NCT00095173|564567|P1|Open-Label Extension Phase (Period C)|Not Specified|0
180928|NCT00095173|564562|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
180929|NCT00095173|564563|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
180930|NCT00095173|564564|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
180931|NCT00095173|564565|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
180932|NCT00095173|564566|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
180933|NCT00095173|564567|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
180934|NCT00095173|564562|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
180935|NCT00095173|564563|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
180936|NCT00095173|564564|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
180937|NCT00095173|564565|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
180938|NCT00095173|564566|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
180939|NCT00095173|564567|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
180940|NCT00095173|564562|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
180941|NCT00095173|564563|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
180942|NCT00095173|564564|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
180943|NCT00095173|564565|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
180944|NCT00095173|564566|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
180945|NCT00095173|564567|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
180946|NCT00095173|564562|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
180947|NCT00095173|564563|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
180948|NCT00095173|564564|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
180949|NCT00095173|564565|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
180950|NCT00095173|564566|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
180951|NCT00095173|564567|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
180952|NCT00095173|564562|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
180953|NCT00095173|564563|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
180954|NCT00095173|564564|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
180955|NCT00095173|564565|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
180956|NCT00095173|564566|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
180957|NCT00095173|564567|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
180958|NCT00095173|564562|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
180959|NCT00095173|564563|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
180960|NCT00095173|564564|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
180961|NCT00095173|564565|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
180962|NCT00095173|564566|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
180963|NCT00095173|564567|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
180964|NCT00095173|564562|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
180965|NCT00095173|564563|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
180966|NCT00095173|564564|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
180967|NCT00095173|564565|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
180968|NCT00095173|564566|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
180969|NCT00095173|564567|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
180970|NCT00095173|564562|P6|Open-Label Extension Phase (Period C)|Death|1
180971|NCT00095173|564563|P5|Open-Label Extension Phase (Period C)|Death|0
180972|NCT00095173|564564|P4|Open-Label Extension Phase (Period C)|Death|0
180973|NCT00095173|564565|P3|Open-Label Extension Phase (Period C)|Death|0
180974|NCT00095173|564566|P2|Open-Label Extension Phase (Period C)|Death|0
180975|NCT00095173|564567|P1|Open-Label Extension Phase (Period C)|Death|0
180976|NCT00095173|564562|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
180977|NCT00095173|564563|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
180978|NCT00095173|564564|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
180979|NCT00095173|564565|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
180980|NCT00095173|564566|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
180981|NCT00095173|564567|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
180982|NCT00095173|564562|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
180983|NCT00095173|564563|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
180984|NCT00095173|564564|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
180985|NCT00095173|564565|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
180986|NCT00095173|564566|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
180987|NCT00095173|564567|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
180988|NCT00095173|564562|P6|Open-Label Lead-In Phase (Period A)|Not specified|0
180989|NCT00095173|564563|P5|Open-Label Lead-In Phase (Period A)|Not specified|0
180990|NCT00095173|564564|P4|Open-Label Lead-In Phase (Period A)|Not specified|0
180991|NCT00095173|564565|P3|Open-Label Lead-In Phase (Period A)|Not specified|0
180992|NCT00095173|564566|P2|Open-Label Lead-In Phase (Period A)|Not specified|0
180993|NCT00095173|564567|P1|Open-Label Lead-In Phase (Period A)|Not specified|1
180994|NCT00095173|564562|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
180995|NCT00095173|564563|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
180996|NCT00095173|564564|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
180997|NCT00095173|564565|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
180998|NCT00095173|564566|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
180999|NCT00095173|564567|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
181000|NCT00095173|564562|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
181001|NCT00095173|564563|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
181002|NCT00095173|564564|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
181003|NCT00095173|564565|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
181004|NCT00095173|564566|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
181005|NCT00095173|564567|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
181006|NCT00095173|564562|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
181007|NCT00095173|564563|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
181008|NCT00095173|564564|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
181009|NCT00095173|564565|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
181010|NCT00095173|564566|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
181011|NCT00095173|564567|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
181012|NCT00095147|564605|P5|Long-term Extension Period|Leaving country|1
181013|NCT00095147|564606|P4|Long-term Extension Period|Leaving country|0
181014|NCT00095147|564607|P3|Long-term Extension Period|Leaving country|0
181015|NCT00095147|564608|P2|Long-term Extension Period|Leaving country|0
181016|NCT00095147|564609|P1|Long-term Extension Period|Leaving country|0
181017|NCT00095147|564605|P5|Long-term Extension Period|Participant chose to use Revellex|1
181018|NCT00095147|564606|P4|Long-term Extension Period|Participant chose to use Revellex|0
181019|NCT00095147|564607|P3|Long-term Extension Period|Participant chose to use Revellex|0
181020|NCT00095147|564608|P2|Long-term Extension Period|Participant chose to use Revellex|0
181021|NCT00095147|564609|P1|Long-term Extension Period|Participant chose to use Revellex|0
181022|NCT00095147|564605|P5|Long-term Extension Period|No longer meets study criteria|1
181023|NCT00095147|564606|P4|Long-term Extension Period|No longer meets study criteria|0
181024|NCT00095147|564607|P3|Long-term Extension Period|No longer meets study criteria|0
181025|NCT00095147|564608|P2|Long-term Extension Period|No longer meets study criteria|0
181026|NCT00095147|564609|P1|Long-term Extension Period|No longer meets study criteria|0
181027|NCT00095147|564605|P5|Long-term Extension Period|Pregnancy|1
181028|NCT00095147|564606|P4|Long-term Extension Period|Pregnancy|0
181029|NCT00095147|564607|P3|Long-term Extension Period|Pregnancy|0
181030|NCT00095147|564608|P2|Long-term Extension Period|Pregnancy|0
181031|NCT00095147|564609|P1|Long-term Extension Period|Pregnancy|0
181032|NCT00095147|564605|P5|Long-term Extension Period|Withdrawal of consent|12
181033|NCT00095147|564606|P4|Long-term Extension Period|Withdrawal of consent|0
181034|NCT00095147|564607|P3|Long-term Extension Period|Withdrawal of consent|0
181035|NCT00095147|564608|P2|Long-term Extension Period|Withdrawal of consent|0
181036|NCT00095147|564609|P1|Long-term Extension Period|Withdrawal of consent|0
181037|NCT00095147|564605|P5|Long-term Extension Period|Lost to Follow-up|6
181038|NCT00095147|564606|P4|Long-term Extension Period|Lost to Follow-up|0
181039|NCT00095147|564607|P3|Long-term Extension Period|Lost to Follow-up|0
181040|NCT00095147|564608|P2|Long-term Extension Period|Lost to Follow-up|0
181041|NCT00095147|564609|P1|Long-term Extension Period|Lost to Follow-up|0
181042|NCT00095147|564605|P5|Long-term Extension Period|Lack of Efficacy|9
181043|NCT00095147|564606|P4|Long-term Extension Period|Lack of Efficacy|0
181044|NCT00095147|564607|P3|Long-term Extension Period|Lack of Efficacy|0
181045|NCT00095147|564608|P2|Long-term Extension Period|Lack of Efficacy|0
181046|NCT00095147|564609|P1|Long-term Extension Period|Lack of Efficacy|0
181047|NCT00095147|564605|P5|Long-term Extension Period|Adverse Event|11
181048|NCT00095147|564606|P4|Long-term Extension Period|Adverse Event|0
181049|NCT00095147|564607|P3|Long-term Extension Period|Adverse Event|0
181050|NCT00095147|564608|P2|Long-term Extension Period|Adverse Event|0
181051|NCT00095147|564609|P1|Long-term Extension Period|Adverse Event|0
181052|NCT00095147|564605|P5|Long-term Extension Period|Death|3
181053|NCT00095147|564606|P4|Long-term Extension Period|Death|0
181054|NCT00095147|564607|P3|Long-term Extension Period|Death|0
181055|NCT00095147|564608|P2|Long-term Extension Period|Death|0
181056|NCT00095147|564609|P1|Long-term Extension Period|Death|0
181057|NCT00095147|564605|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
181058|NCT00095147|564606|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
181059|NCT00095147|564607|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
181060|NCT00095147|564608|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
181061|NCT00095147|564609|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
181062|NCT00095147|564605|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
181063|NCT00095147|564606|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
181064|NCT00095147|564607|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
181065|NCT00095147|564608|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
181066|NCT00095147|564609|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
181067|NCT00095147|564605|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
181068|NCT00095147|564606|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
181069|NCT00095147|564607|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
181070|NCT00095147|564608|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
181071|NCT00095147|564609|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
181072|NCT00095147|564605|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
181073|NCT00095147|564606|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
181074|NCT00095147|564607|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
181075|NCT00095147|564608|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
181076|NCT00095147|564609|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
181077|NCT00095147|564605|P5|Double-blind Period 2 (Days 198-365)|Death|0
181078|NCT00095147|564606|P4|Double-blind Period 2 (Days 198-365)|Death|1
181079|NCT00095147|564607|P3|Double-blind Period 2 (Days 198-365)|Death|0
181080|NCT00095147|564608|P2|Double-blind Period 2 (Days 198-365)|Death|1
181081|NCT00095147|564609|P1|Double-blind Period 2 (Days 198-365)|Death|0
181082|NCT00095147|564605|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
181083|NCT00095147|564606|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
181084|NCT00095147|564607|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
181085|NCT00095147|564608|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
181086|NCT00095147|564609|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
181087|NCT00095147|564605|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
181088|NCT00095147|564606|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
181089|NCT00095147|564607|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
181090|NCT00095147|564608|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
181091|NCT00095147|564609|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
181092|NCT00095147|564605|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
181093|NCT00095147|564606|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
181094|NCT00095147|564607|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
181095|NCT00095147|564608|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
181096|NCT00095147|564609|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
181097|NCT00095147|564605|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
181098|NCT00095147|564606|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
181099|NCT00095147|564607|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
181100|NCT00095147|564608|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
181101|NCT00095147|564609|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
181102|NCT00095147|564605|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
181103|NCT00095147|564606|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
181104|NCT00095147|564607|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
181105|NCT00095147|564608|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
181106|NCT00095147|564609|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
181107|NCT00095147|564605|P5|Double-blind Period 1 (Days 1-197)|Death|0
181108|NCT00095147|564606|P4|Double-blind Period 1 (Days 1-197)|Death|0
181109|NCT00095147|564607|P3|Double-blind Period 1 (Days 1-197)|Death|0
181110|NCT00095147|564608|P2|Double-blind Period 1 (Days 1-197)|Death|0
181111|NCT00095147|564609|P1|Double-blind Period 1 (Days 1-197)|Death|1
181112|NCT00095121|564804|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
181113|NCT00095121|564805|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
181114|NCT00095121|564804|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
181115|NCT00095121|564805|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
181116|NCT00095056|564851|P2|Phase B (Weeks 12-54)|Protocol Violation|1
181117|NCT00095056|564852|P1|Phase B (Weeks 12-54)|Protocol Violation|0
181118|NCT00095056|564851|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
181119|NCT00095056|564852|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
181120|NCT00095056|564851|P2|Phase B (Weeks 12-54)|Death|1
181121|NCT00095056|564852|P1|Phase B (Weeks 12-54)|Death|3
181122|NCT00095056|564851|P2|Phase B (Weeks 12-54)|Patient Moved|0
181123|NCT00095056|564852|P1|Phase B (Weeks 12-54)|Patient Moved|1
181124|NCT00095056|564851|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
181125|NCT00095056|564852|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
181126|NCT00095056|564851|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
181127|NCT00095056|564852|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
181128|NCT00095056|564851|P2|Phase B (Weeks 12-54)|Adverse Event|2
181129|NCT00095056|564852|P1|Phase B (Weeks 12-54)|Adverse Event|2
181130|NCT00095056|564851|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
181131|NCT00095056|564852|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
181132|NCT00095056|564851|P2|Phase A (Weeks 0-12)|Death|0
181133|NCT00095056|564852|P1|Phase A (Weeks 0-12)|Death|1
181134|NCT00095056|564851|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
181135|NCT00095056|564852|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
181136|NCT00095056|564851|P2|Phase A (Weeks 0-12)|Adverse Event|1
181137|NCT00095056|564852|P1|Phase A (Weeks 0-12)|Adverse Event|1
181138|NCT00094887|564962|P2|Overall Study|Physician Decision|2
181139|NCT00094887|564963|P1|Overall Study|Physician Decision|2
181140|NCT00094887|564962|P2|Overall Study|Family emergency, Subject noncompliance|4
181141|NCT00094887|564963|P1|Overall Study|Family emergency, Subject noncompliance|3
181142|NCT00094861|564971|P2|Overall Study|Other|0
181143|NCT00094861|564972|P1|Overall Study|Other|3
181144|NCT00094861|564971|P2|Overall Study|Death|2
181145|NCT00094861|564972|P1|Overall Study|Death|4
181146|NCT00094861|564971|P2|Overall Study|Lost to Follow-up|1
181147|NCT00094861|564972|P1|Overall Study|Lost to Follow-up|0
181148|NCT00094861|564971|P2|Overall Study|Physician Decision|1
181149|NCT00094861|564972|P1|Overall Study|Physician Decision|1
181150|NCT00094861|564971|P2|Overall Study|Withdrawal by Subject|3
181151|NCT00094861|564972|P1|Overall Study|Withdrawal by Subject|5
181152|NCT00094861|564971|P2|Overall Study|Adverse Event|2
181153|NCT00094861|564972|P1|Overall Study|Adverse Event|5
181154|NCT00094835|564999|P7|Overall Study|Other|0
181155|NCT00094835|565000|P6|Overall Study|Other|0
181156|NCT00094835|565001|P5|Overall Study|Other|0
181157|NCT00094835|565002|P4|Overall Study|Other|1
181158|NCT00094835|565003|P3|Overall Study|Other|1
181159|NCT00094835|565004|P2|Overall Study|Other|1
181160|NCT00094835|565005|P1|Overall Study|Other|1
181161|NCT00094835|564999|P7|Overall Study|Non-compliance|1
181162|NCT00094835|565000|P6|Overall Study|Non-compliance|2
181163|NCT00094835|565001|P5|Overall Study|Non-compliance|2
181164|NCT00094835|565002|P4|Overall Study|Non-compliance|0
181165|NCT00094835|565003|P3|Overall Study|Non-compliance|2
181166|NCT00094835|565004|P2|Overall Study|Non-compliance|2
181167|NCT00094835|565005|P1|Overall Study|Non-compliance|1
181168|NCT00094835|564999|P7|Overall Study|Death|0
181169|NCT00094835|565000|P6|Overall Study|Death|0
181170|NCT00094835|565001|P5|Overall Study|Death|1
181171|NCT00094835|565002|P4|Overall Study|Death|0
181172|NCT00094835|565003|P3|Overall Study|Death|0
181173|NCT00094835|565004|P2|Overall Study|Death|0
181174|NCT00094835|565005|P1|Overall Study|Death|1
181175|NCT00094835|564999|P7|Overall Study|Lost to Follow-up|0
181176|NCT00094835|565000|P6|Overall Study|Lost to Follow-up|0
181177|NCT00094835|565001|P5|Overall Study|Lost to Follow-up|1
181178|NCT00094835|565002|P4|Overall Study|Lost to Follow-up|0
181179|NCT00094835|565003|P3|Overall Study|Lost to Follow-up|0
181180|NCT00094835|565004|P2|Overall Study|Lost to Follow-up|0
181181|NCT00094835|565005|P1|Overall Study|Lost to Follow-up|0
181182|NCT00094835|564999|P7|Overall Study|Withdrawal by Subject|1
181183|NCT00094835|565000|P6|Overall Study|Withdrawal by Subject|0
181184|NCT00094835|565001|P5|Overall Study|Withdrawal by Subject|0
181185|NCT00094835|565002|P4|Overall Study|Withdrawal by Subject|0
181186|NCT00094835|565003|P3|Overall Study|Withdrawal by Subject|0
181187|NCT00094835|565004|P2|Overall Study|Withdrawal by Subject|0
181188|NCT00094835|565005|P1|Overall Study|Withdrawal by Subject|0
181189|NCT00094835|564999|P7|Overall Study|Physician Decision|0
181190|NCT00094835|565000|P6|Overall Study|Physician Decision|1
181191|NCT00094835|565001|P5|Overall Study|Physician Decision|0
181192|NCT00094835|565002|P4|Overall Study|Physician Decision|0
181193|NCT00094835|565003|P3|Overall Study|Physician Decision|0
181194|NCT00094835|565004|P2|Overall Study|Physician Decision|0
181195|NCT00094835|565005|P1|Overall Study|Physician Decision|1
181196|NCT00094809|565083|P2|Overall Study|Other|1
181197|NCT00094809|565084|P1|Overall Study|Other|1
181198|NCT00094809|565083|P2|Overall Study|Study drug not received|8
181199|NCT00094809|565084|P1|Overall Study|Study drug not received|2
181200|NCT00094809|565083|P2|Overall Study|Informed consent signed after treatment|0
181201|NCT00094809|565084|P1|Overall Study|Informed consent signed after treatment|1
181202|NCT00094809|565083|P2|Overall Study|Other|4
181203|NCT00094809|565084|P1|Overall Study|Other|2
181204|NCT00094809|565083|P2|Overall Study|Protocol-specified criteria|1
181205|NCT00094809|565084|P1|Overall Study|Protocol-specified criteria|1
181206|NCT00094809|565083|P2|Overall Study|Death|25
181207|NCT00094809|565084|P1|Overall Study|Death|19
181208|NCT00094809|565083|P2|Overall Study|Lost to Follow-up|6
181209|NCT00094809|565084|P1|Overall Study|Lost to Follow-up|6
181210|NCT00094809|565083|P2|Overall Study|Physician Decision|5
181211|NCT00094809|565084|P1|Overall Study|Physician Decision|3
181212|NCT00094809|565083|P2|Overall Study|Disease progression|3
181213|NCT00094809|565084|P1|Overall Study|Disease progression|3
181214|NCT00094809|565083|P2|Overall Study|Withdrawal by Subject|9
181215|NCT00094809|565084|P1|Overall Study|Withdrawal by Subject|8
181216|NCT00094809|565083|P2|Overall Study|Adverse Event|1
181217|NCT00094809|565084|P1|Overall Study|Adverse Event|3
181218|NCT00094809|565083|P2|Overall Study|Noncompliance|0
181219|NCT00094809|565084|P1|Overall Study|Noncompliance|1
181220|NCT00094809|565083|P2|Overall Study|Protocol deviation|2
181221|NCT00094809|565084|P1|Overall Study|Protocol deviation|2
181222|NCT00094770|565110|P2|Year 2 (Week 0 to Week 104)|Unspecified|23
181223|NCT00094770|565111|P1|Year 2 (Week 0 to Week 104)|Unspecified|15
181224|NCT00094770|565110|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
181225|NCT00094770|565111|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
181226|NCT00094770|565110|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
181227|NCT00094770|565111|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
181228|NCT00094770|565110|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
181229|NCT00094770|565111|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
181230|NCT00094770|565110|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
181231|NCT00094770|565111|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
181232|NCT00094770|565110|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
181233|NCT00094770|565111|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
181234|NCT00094770|565110|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
181235|NCT00094770|565111|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
181236|NCT00094770|565110|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
181237|NCT00094770|565111|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
181238|NCT00094770|565110|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
181239|NCT00094770|565111|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
181240|NCT00094770|565110|P2|Year 1 ( Week 0 to Week 52)|Unspecified|11
181241|NCT00094770|565111|P1|Year 1 ( Week 0 to Week 52)|Unspecified|10
181242|NCT00094770|565110|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
181243|NCT00094770|565111|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
181244|NCT00094770|565110|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
181245|NCT00094770|565111|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
181246|NCT00094770|565110|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
181247|NCT00094770|565111|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
181248|NCT00094770|565110|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
181249|NCT00094770|565111|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
181250|NCT00094770|565110|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
181251|NCT00094770|565111|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
181252|NCT00094770|565110|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
181253|NCT00094770|565111|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
181254|NCT00094770|565110|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
181255|NCT00094770|565111|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
181256|NCT00094770|565110|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
181257|NCT00094770|565111|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
181258|NCT00094757|565142|P3|Overall Study|Protocol specified discontinuation|0
181259|NCT00094757|565143|P2|Overall Study|Protocol specified discontinuation|3
181260|NCT00094757|565144|P1|Overall Study|Protocol specified discontinuation|1
181261|NCT00094757|565142|P3|Overall Study|Unspecified|1
181262|NCT00094757|565143|P2|Overall Study|Unspecified|3
181263|NCT00094757|565144|P1|Overall Study|Unspecified|3
181264|NCT00094757|565142|P3|Overall Study|Withdrawal by Subject|5
181265|NCT00094757|565143|P2|Overall Study|Withdrawal by Subject|21
181266|NCT00094757|565144|P1|Overall Study|Withdrawal by Subject|14
181267|NCT00094757|565142|P3|Overall Study|Protocol Violation|3
181268|NCT00094757|565143|P2|Overall Study|Protocol Violation|5
181269|NCT00094757|565144|P1|Overall Study|Protocol Violation|8
181270|NCT00094757|565142|P3|Overall Study|Patient Moved|1
181271|NCT00094757|565143|P2|Overall Study|Patient Moved|1
181272|NCT00094757|565144|P1|Overall Study|Patient Moved|2
181273|NCT00094757|565142|P3|Overall Study|Lost to Follow-up|6
181274|NCT00094757|565143|P2|Overall Study|Lost to Follow-up|5
181275|NCT00094757|565144|P1|Overall Study|Lost to Follow-up|3
181276|NCT00094757|565142|P3|Overall Study|Lack of Efficacy|8
181277|NCT00094757|565143|P2|Overall Study|Lack of Efficacy|15
181278|NCT00094757|565144|P1|Overall Study|Lack of Efficacy|11
181279|NCT00094757|565142|P3|Overall Study|Adverse Event|6
181280|NCT00094757|565143|P2|Overall Study|Adverse Event|9
181281|NCT00094757|565144|P1|Overall Study|Adverse Event|11
181282|NCT00094653|565164|P3|Overall Study|Protocol Violation|1
181283|NCT00094653|565165|P2|Overall Study|Protocol Violation|0
181284|NCT00094653|565166|P1|Overall Study|Protocol Violation|0
181285|NCT00094653|565164|P3|Overall Study|Lost to Follow-up|1
181286|NCT00094653|565165|P2|Overall Study|Lost to Follow-up|2
181287|NCT00094653|565166|P1|Overall Study|Lost to Follow-up|3
181288|NCT00094653|565164|P3|Overall Study|Not specified|2
181289|NCT00094653|565165|P2|Overall Study|Not specified|2
181290|NCT00094653|565166|P1|Overall Study|Not specified|2
181291|NCT00094653|565164|P3|Overall Study|Subject Withdrew Consent|3
181292|NCT00094653|565165|P2|Overall Study|Subject Withdrew Consent|2
181293|NCT00094653|565166|P1|Overall Study|Subject Withdrew Consent|10
181294|NCT00094653|565164|P3|Overall Study|Death|119
181295|NCT00094653|565165|P2|Overall Study|Death|100
181296|NCT00094653|565166|P1|Overall Study|Death|306
181297|NCT00094575|565229|P2|Overall Study|Death|146
181298|NCT00094575|565230|P1|Overall Study|Death|146
181299|NCT00094458|565270|P6|OLE: Open-Label Extension|Patient decision|0
181300|NCT00094458|565271|P5|OLE: Open-Label Extension|Patient decision|1
181301|NCT00094458|565272|P4|OLE: Open-Label Extension|Patient decision|0
181302|NCT00094458|565273|P3|OLE: Open-Label Extension|Patient decision|0
181303|NCT00094458|565274|P2|OLE: Open-Label Extension|Patient decision|0
181304|NCT00094458|565275|P1|OLE: Open-Label Extension|Patient decision|0
181305|NCT00094458|565270|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
181306|NCT00094458|565271|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
181307|NCT00094458|565272|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
181308|NCT00094458|565273|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
181309|NCT00094458|565274|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
181310|NCT00094458|565275|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
181311|NCT00094458|565270|P6|OLE: Open-Label Extension|Adverse Event|4
181312|NCT00094458|565271|P5|OLE: Open-Label Extension|Adverse Event|3
181313|NCT00094458|565272|P4|OLE: Open-Label Extension|Adverse Event|0
181314|NCT00094458|565273|P3|OLE: Open-Label Extension|Adverse Event|0
181315|NCT00094458|565274|P2|OLE: Open-Label Extension|Adverse Event|0
181316|NCT00094458|565275|P1|OLE: Open-Label Extension|Adverse Event|0
181317|NCT00094458|565270|P6|Study Extension: Week 30 Through Week 50|Unspecified|0
181318|NCT00094458|565271|P5|Study Extension: Week 30 Through Week 50|Unspecified|0
181319|NCT00094458|565272|P4|Study Extension: Week 30 Through Week 50|Unspecified|0
181320|NCT00094458|565273|P3|Study Extension: Week 30 Through Week 50|Unspecified|3
181321|NCT00094458|565274|P2|Study Extension: Week 30 Through Week 50|Unspecified|2
181322|NCT00094458|565275|P1|Study Extension: Week 30 Through Week 50|Unspecified|1
181323|NCT00094458|565270|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
181324|NCT00094458|565271|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
181325|NCT00094458|565272|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
181326|NCT00094458|565273|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
181327|NCT00094458|565274|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
181328|NCT00094458|565275|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
181329|NCT00094458|565270|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
181330|NCT00094458|565271|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
181331|NCT00094458|565272|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
181332|NCT00094458|565273|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
181333|NCT00094458|565274|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
181334|NCT00094458|565275|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
181335|NCT00094458|565270|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
181336|NCT00094458|565271|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
181337|NCT00094458|565272|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
181338|NCT00094458|565273|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
181339|NCT00094458|565274|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
181340|NCT00094458|565275|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
181341|NCT00094458|565270|P6|Main Study: Through Week 30|Unspecified|0
181342|NCT00094458|565271|P5|Main Study: Through Week 30|Unspecified|0
181343|NCT00094458|565272|P4|Main Study: Through Week 30|Unspecified|0
181344|NCT00094458|565273|P3|Main Study: Through Week 30|Unspecified|9
181345|NCT00094458|565274|P2|Main Study: Through Week 30|Unspecified|16
181346|NCT00094458|565275|P1|Main Study: Through Week 30|Unspecified|19
181347|NCT00094458|565270|P6|Main Study: Through Week 30|Death|0
181348|NCT00094458|565271|P5|Main Study: Through Week 30|Death|0
181349|NCT00094458|565272|P4|Main Study: Through Week 30|Death|0
181350|NCT00094458|565273|P3|Main Study: Through Week 30|Death|0
181351|NCT00094458|565274|P2|Main Study: Through Week 30|Death|0
181352|NCT00094458|565275|P1|Main Study: Through Week 30|Death|1
181353|NCT00094458|565270|P6|Main Study: Through Week 30|Adverse Event|0
181354|NCT00094458|565271|P5|Main Study: Through Week 30|Adverse Event|0
181355|NCT00094458|565272|P4|Main Study: Through Week 30|Adverse Event|0
181356|NCT00094458|565273|P3|Main Study: Through Week 30|Adverse Event|28
181357|NCT00094458|565274|P2|Main Study: Through Week 30|Adverse Event|20
181358|NCT00094458|565275|P1|Main Study: Through Week 30|Adverse Event|38
181359|NCT00094458|565270|P6|Main Study: Through Week 30|Withdrawal by Subject|0
181360|NCT00094458|565271|P5|Main Study: Through Week 30|Withdrawal by Subject|0
181361|NCT00094458|565272|P4|Main Study: Through Week 30|Withdrawal by Subject|0
181362|NCT00094458|565273|P3|Main Study: Through Week 30|Withdrawal by Subject|7
181363|NCT00094458|565274|P2|Main Study: Through Week 30|Withdrawal by Subject|9
181364|NCT00094458|565275|P1|Main Study: Through Week 30|Withdrawal by Subject|18
181365|NCT00094458|565270|P6|Main Study: Through Week 30|Lost to Follow-up|0
181366|NCT00094458|565271|P5|Main Study: Through Week 30|Lost to Follow-up|0
181367|NCT00094458|565272|P4|Main Study: Through Week 30|Lost to Follow-up|0
181368|NCT00094458|565273|P3|Main Study: Through Week 30|Lost to Follow-up|2
181369|NCT00094458|565274|P2|Main Study: Through Week 30|Lost to Follow-up|5
181370|NCT00094458|565275|P1|Main Study: Through Week 30|Lost to Follow-up|5
181371|NCT00094458|565270|P6|Main Study: Through Week 30|Eligibility criteria not met|0
181372|NCT00094458|565271|P5|Main Study: Through Week 30|Eligibility criteria not met|0
181373|NCT00094458|565272|P4|Main Study: Through Week 30|Eligibility criteria not met|0
181374|NCT00094458|565273|P3|Main Study: Through Week 30|Eligibility criteria not met|2
181375|NCT00094458|565274|P2|Main Study: Through Week 30|Eligibility criteria not met|8
181376|NCT00094458|565275|P1|Main Study: Through Week 30|Eligibility criteria not met|3
181377|NCT00094328|565313|P1|Overall Study|Lost to Follow-up|1
181378|NCT00094302|565323|P2|Overall Study|Death|246
181379|NCT00094302|565324|P1|Overall Study|Death|266
181380|NCT00094302|565323|P2|Overall Study|Withdrawal by Subject|111
181381|NCT00094302|565324|P1|Overall Study|Withdrawal by Subject|103
181382|NCT00094302|565323|P2|Overall Study|Physician Decision|8
181383|NCT00094302|565324|P1|Overall Study|Physician Decision|5
181384|NCT00094302|565323|P2|Overall Study|Lost to Follow-up|41
181385|NCT00094302|565324|P1|Overall Study|Lost to Follow-up|43
181386|NCT00094172|565380|P2|Overall Study|Started other MS therapy due to disease|0
181387|NCT00094172|565381|P1|Overall Study|Started other MS therapy due to disease|1
181388|NCT00094172|565380|P2|Overall Study|Primary endpoint met.|0
181389|NCT00094172|565381|P1|Overall Study|Primary endpoint met.|1
181390|NCT00094172|565380|P2|Overall Study|Withdrawal by Subject|5
181391|NCT00094172|565381|P1|Overall Study|Withdrawal by Subject|10
181392|NCT00094172|565380|P2|Overall Study|Protocol Violation|1
181393|NCT00094172|565381|P1|Overall Study|Protocol Violation|0
181394|NCT00094172|565380|P2|Overall Study|Lost to Follow-up|0
181395|NCT00094172|565381|P1|Overall Study|Lost to Follow-up|2
181396|NCT00094172|565380|P2|Overall Study|Adverse Event|1
181397|NCT00094172|565381|P1|Overall Study|Adverse Event|0
181398|NCT00094107|565391|P1|Overall Study|Withdrawal due to Disease Progression|1
181399|NCT00094107|565391|P1|Overall Study|Adverse Event|3
181400|NCT00094107|565391|P1|Overall Study|Death|5
181401|NCT00094107|565391|P1|Overall Study|Lack of Efficacy|23
181402|NCT00094094|565400|P1|Overall Study|Adverse Event|7
181403|NCT00094094|565400|P1|Overall Study|Lack of Efficacy|23
181404|NCT00094094|565400|P1|Overall Study|Death|2
181405|NCT00094055|565409|P1|Overall Study|Withdrawal by Subject|9
181406|NCT00094055|565409|P1|Overall Study|roll-over to another study|14
181407|NCT00094055|565409|P1|Overall Study|clinical progression|1
181408|NCT00094055|565409|P1|Overall Study|progressive disease|2
181409|NCT00094055|565409|P1|Overall Study|Lost to Follow-up|2
181410|NCT00094055|565409|P1|Overall Study|Lack of Efficacy|17
181411|NCT00094055|565409|P1|Overall Study|Death|4
181412|NCT00094055|565409|P1|Overall Study|Adverse Event|11
181413|NCT00093808|565429|P1|Overall Study|Protocol Violation|1
181414|NCT00093808|565429|P1|Overall Study|Cancel|1
181415|NCT00093496|565456|P2|Overall Study|Protocol Violation|3
181416|NCT00093496|565457|P1|Overall Study|Protocol Violation|1
181417|NCT00093470|565470|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
181418|NCT00093470|565471|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
181419|NCT00093470|565470|P2|Overall Study|Never started treatment|0
181420|NCT00093470|565471|P1|Overall Study|Never started treatment|1
181421|NCT00093470|565470|P2|Overall Study|Physician Decision|0
181422|NCT00093470|565471|P1|Overall Study|Physician Decision|2
181423|NCT00093470|565470|P2|Overall Study|Other complicating disease|0
181424|NCT00093470|565471|P1|Overall Study|Other complicating disease|3
181425|NCT00093470|565470|P2|Overall Study|Alternative therapy|0
181426|NCT00093470|565471|P1|Overall Study|Alternative therapy|2
181427|NCT00093470|565470|P2|Overall Study|Withdrawal by Subject|0
181428|NCT00093470|565471|P1|Overall Study|Withdrawal by Subject|8
181429|NCT00093470|565470|P2|Overall Study|Death|0
181430|NCT00093470|565471|P1|Overall Study|Death|2
181431|NCT00093470|565470|P2|Overall Study|Adverse Event|0
181432|NCT00093470|565471|P1|Overall Study|Adverse Event|15
181433|NCT00093470|565470|P2|Overall Study|Disease progression|0
181434|NCT00093470|565471|P1|Overall Study|Disease progression|39
181435|NCT00093145|565485|P1|Overall Study|Other|1
181436|NCT00093145|565485|P1|Overall Study|Withdrawal by Subject|9
181437|NCT00093145|565485|P1|Overall Study|Physician Decision|5
181438|NCT00093145|565485|P1|Overall Study|Unacceptable Toxicity Only|2
181439|NCT00093015|565527|P2|Overall Study|Death|385
181440|NCT00093015|565528|P1|Overall Study|Death|375
181441|NCT00093015|565527|P2|Overall Study|Lost to Follow-up|108
181442|NCT00093015|565528|P1|Overall Study|Lost to Follow-up|96
181443|NCT00093015|565527|P2|Overall Study|Withdrawal by Subject|171
181444|NCT00093015|565528|P1|Overall Study|Withdrawal by Subject|194
181445|NCT00092677|565556|P2|Overall Study|Adminstrative|9
181446|NCT00092677|565557|P1|Overall Study|Adminstrative|5
181447|NCT00092677|565556|P2|Overall Study|Lost to Follow-up|2
181448|NCT00092677|565557|P1|Overall Study|Lost to Follow-up|0
181449|NCT00092547|565601|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
181450|NCT00092547|565602|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
181451|NCT00092547|565603|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
181452|NCT00092547|565601|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
181453|NCT00092547|565602|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
181454|NCT00092547|565603|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
181455|NCT00092547|565601|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
181456|NCT00092547|565602|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
181457|NCT00092547|565603|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
181458|NCT00092547|565601|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
181459|NCT00092547|565602|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
181460|NCT00092547|565603|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
181461|NCT00092547|565601|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
181462|NCT00092547|565602|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
181463|NCT00092547|565603|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
181464|NCT00092547|565601|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
181465|NCT00092547|565602|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
181466|NCT00092547|565603|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
181467|NCT00092547|565601|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
181468|NCT00092547|565602|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
181469|NCT00092547|565603|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
181470|NCT00092547|565601|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
181471|NCT00092547|565602|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
181472|NCT00092547|565603|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
181473|NCT00092547|565601|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
181474|NCT00092547|565602|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
181475|NCT00092547|565603|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
181476|NCT00092547|565601|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
181477|NCT00092547|565602|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
181478|NCT00092547|565603|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
181479|NCT00092547|565601|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
181480|NCT00092547|565602|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
181481|NCT00092547|565603|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
181482|NCT00092547|565601|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
181483|NCT00092547|565602|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
181484|NCT00092547|565603|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
181485|NCT00092547|565601|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
181486|NCT00092547|565602|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
181487|NCT00092547|565603|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
181488|NCT00092547|565601|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
181489|NCT00092547|565602|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
181490|NCT00092547|565603|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
181491|NCT00092547|565601|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
181492|NCT00092547|565602|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
181493|NCT00092547|565603|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
181494|NCT00092547|565601|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
181495|NCT00092547|565602|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
181496|NCT00092547|565603|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
181497|NCT00092547|565601|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
181498|NCT00092547|565602|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
181499|NCT00092547|565603|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
181500|NCT00092547|565601|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
181501|NCT00092547|565602|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
181502|NCT00092547|565603|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
181503|NCT00092547|565601|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
181504|NCT00092547|565602|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
181505|NCT00092547|565603|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
181506|NCT00092547|565601|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
181507|NCT00092547|565602|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
181508|NCT00092547|565603|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
181509|NCT00092547|565601|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
181510|NCT00092547|565602|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
181511|NCT00092547|565603|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
181512|NCT00092534|565647|P3|Extension Study|Protocol Deviation|15
181513|NCT00092534|565648|P2|Extension Study|Protocol Deviation|0
181514|NCT00092534|565649|P1|Extension Study|Protocol Deviation|0
181515|NCT00092534|565647|P3|Extension Study|Study Ended|29
181516|NCT00092534|565648|P2|Extension Study|Study Ended|0
181517|NCT00092534|565649|P1|Extension Study|Study Ended|0
181518|NCT00092534|565647|P3|Extension Study|Site Closed|21
181519|NCT00092534|565648|P2|Extension Study|Site Closed|0
181520|NCT00092534|565649|P1|Extension Study|Site Closed|0
181521|NCT00092534|565647|P3|Extension Study|Travel|2
181522|NCT00092534|565648|P2|Extension Study|Travel|0
181523|NCT00092534|565649|P1|Extension Study|Travel|0
181524|NCT00092534|565647|P3|Extension Study|Moved|6
181525|NCT00092534|565648|P2|Extension Study|Moved|0
181526|NCT00092534|565649|P1|Extension Study|Moved|0
181527|NCT00092534|565647|P3|Extension Study|Withdrawal by Subject|18
181528|NCT00092534|565648|P2|Extension Study|Withdrawal by Subject|0
181529|NCT00092534|565649|P1|Extension Study|Withdrawal by Subject|0
181530|NCT00092534|565647|P3|Extension Study|Pregnancy|12
181531|NCT00092534|565648|P2|Extension Study|Pregnancy|0
181532|NCT00092534|565649|P1|Extension Study|Pregnancy|0
181533|NCT00092534|565647|P3|Extension Study|Physician Decision|1
181534|NCT00092534|565648|P2|Extension Study|Physician Decision|0
181535|NCT00092534|565649|P1|Extension Study|Physician Decision|0
181536|NCT00092534|565647|P3|Extension Study|Lost to Follow-up|41
181537|NCT00092534|565648|P2|Extension Study|Lost to Follow-up|0
181538|NCT00092534|565649|P1|Extension Study|Lost to Follow-up|0
181539|NCT00092534|565647|P3|Base Study Follow Up Period|Subjects in extension|0
181540|NCT00092534|565648|P2|Base Study Follow Up Period|Subjects in extension|371
181541|NCT00092534|565649|P1|Base Study Follow Up Period|Subjects in extension|15
181542|NCT00092534|565647|P3|Base Study Follow Up Period|Subjects continuing|0
181543|NCT00092534|565648|P2|Base Study Follow Up Period|Subjects continuing|31
181544|NCT00092534|565649|P1|Base Study Follow Up Period|Subjects continuing|27
181545|NCT00092534|565647|P3|Base Study Follow Up Period|Site Closed|0
181546|NCT00092534|565648|P2|Base Study Follow Up Period|Site Closed|2
181547|NCT00092534|565649|P1|Base Study Follow Up Period|Site Closed|0
181548|NCT00092534|565647|P3|Base Study Follow Up Period|Travel|0
181549|NCT00092534|565648|P2|Base Study Follow Up Period|Travel|7
181550|NCT00092534|565649|P1|Base Study Follow Up Period|Travel|10
181551|NCT00092534|565647|P3|Base Study Follow Up Period|Moved|0
181552|NCT00092534|565648|P2|Base Study Follow Up Period|Moved|58
181553|NCT00092534|565649|P1|Base Study Follow Up Period|Moved|62
181554|NCT00092534|565647|P3|Base Study Follow Up Period|Withdrawal by Subject|0
181555|NCT00092534|565648|P2|Base Study Follow Up Period|Withdrawal by Subject|62
181556|NCT00092534|565649|P1|Base Study Follow Up Period|Withdrawal by Subject|71
181557|NCT00092534|565647|P3|Base Study Follow Up Period|Protocol Violation|0
181558|NCT00092534|565648|P2|Base Study Follow Up Period|Protocol Violation|2
181559|NCT00092534|565649|P1|Base Study Follow Up Period|Protocol Violation|1
181560|NCT00092534|565647|P3|Base Study Follow Up Period|Pregnancy|0
181561|NCT00092534|565648|P2|Base Study Follow Up Period|Pregnancy|10
181562|NCT00092534|565649|P1|Base Study Follow Up Period|Pregnancy|6
181563|NCT00092534|565647|P3|Base Study Follow Up Period|Lost to Follow-up|0
181564|NCT00092534|565648|P2|Base Study Follow Up Period|Lost to Follow-up|146
181565|NCT00092534|565649|P1|Base Study Follow Up Period|Lost to Follow-up|120
181566|NCT00092534|565647|P3|Base Study Follow Up Period|Death|0
181567|NCT00092534|565648|P2|Base Study Follow Up Period|Death|1
181568|NCT00092534|565649|P1|Base Study Follow Up Period|Death|2
181569|NCT00092534|565647|P3|Base Study Follow Up Period|Adverse Event|0
181570|NCT00092534|565648|P2|Base Study Follow Up Period|Adverse Event|4
181571|NCT00092534|565649|P1|Base Study Follow Up Period|Adverse Event|2
181572|NCT00092534|565647|P3|Base Study Vaccination Period|Site Closed|0
181573|NCT00092534|565648|P2|Base Study Vaccination Period|Site Closed|1
181574|NCT00092534|565649|P1|Base Study Vaccination Period|Site Closed|0
181575|NCT00092534|565647|P3|Base Study Vaccination Period|Travel|0
181576|NCT00092534|565648|P2|Base Study Vaccination Period|Travel|0
181577|NCT00092534|565649|P1|Base Study Vaccination Period|Travel|1
181578|NCT00092534|565647|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
181579|NCT00092534|565648|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
181580|NCT00092534|565649|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
181581|NCT00092534|565647|P3|Base Study Vaccination Period|Moved|0
181582|NCT00092534|565648|P2|Base Study Vaccination Period|Moved|12
181583|NCT00092534|565649|P1|Base Study Vaccination Period|Moved|14
181584|NCT00092534|565647|P3|Base Study Vaccination Period|Withdrawal by Subject|0
181585|NCT00092534|565648|P2|Base Study Vaccination Period|Withdrawal by Subject|58
181586|NCT00092534|565649|P1|Base Study Vaccination Period|Withdrawal by Subject|85
181587|NCT00092534|565647|P3|Base Study Vaccination Period|Protocol Violation|0
181588|NCT00092534|565648|P2|Base Study Vaccination Period|Protocol Violation|1
181589|NCT00092534|565649|P1|Base Study Vaccination Period|Protocol Violation|2
181590|NCT00092534|565647|P3|Base Study Vaccination Period|Pregnancy|0
181591|NCT00092534|565648|P2|Base Study Vaccination Period|Pregnancy|7
181592|NCT00092534|565649|P1|Base Study Vaccination Period|Pregnancy|9
181593|NCT00092534|565647|P3|Base Study Vaccination Period|Physician Decision|0
181594|NCT00092534|565648|P2|Base Study Vaccination Period|Physician Decision|0
181595|NCT00092534|565649|P1|Base Study Vaccination Period|Physician Decision|1
181596|NCT00092534|565647|P3|Base Study Vaccination Period|Lost to Follow-up|0
181597|NCT00092534|565648|P2|Base Study Vaccination Period|Lost to Follow-up|37
181598|NCT00092534|565649|P1|Base Study Vaccination Period|Lost to Follow-up|41
181599|NCT00092534|565647|P3|Base Study Vaccination Period|Death|0
181600|NCT00092534|565648|P2|Base Study Vaccination Period|Death|4
181601|NCT00092534|565649|P1|Base Study Vaccination Period|Death|5
181602|NCT00092534|565647|P3|Base Study Vaccination Period|Adverse Event|0
181603|NCT00092534|565648|P2|Base Study Vaccination Period|Adverse Event|1
181604|NCT00092534|565649|P1|Base Study Vaccination Period|Adverse Event|3
181605|NCT00092534|565647|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
181606|NCT00092534|565648|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
181607|NCT00092534|565649|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
181608|NCT00092521|565667|P4|Extension Study (Group 4)|Unable/unwilling to return|25
181609|NCT00092521|565668|P3|Extension Study (Group 4)|Unable/unwilling to return|0
181610|NCT00092521|565669|P2|Extension Study (Group 4)|Unable/unwilling to return|0
181611|NCT00092521|565670|P1|Extension Study (Group 4)|Unable/unwilling to return|0
181612|NCT00092521|565667|P4|Extension Study (Group 4)|Site Terminated|4
181613|NCT00092521|565668|P3|Extension Study (Group 4)|Site Terminated|0
181614|NCT00092521|565669|P2|Extension Study (Group 4)|Site Terminated|0
181615|NCT00092521|565670|P1|Extension Study (Group 4)|Site Terminated|0
181616|NCT00092521|565667|P4|Extension Study (Group 4)|Moved|16
181617|NCT00092521|565668|P3|Extension Study (Group 4)|Moved|0
181618|NCT00092521|565669|P2|Extension Study (Group 4)|Moved|0
181619|NCT00092521|565670|P1|Extension Study (Group 4)|Moved|0
181620|NCT00092521|565667|P4|Extension Study (Group 4)|Withdrawal by Subject|46
181621|NCT00092521|565668|P3|Extension Study (Group 4)|Withdrawal by Subject|0
181622|NCT00092521|565669|P2|Extension Study (Group 4)|Withdrawal by Subject|0
181623|NCT00092521|565670|P1|Extension Study (Group 4)|Withdrawal by Subject|0
181624|NCT00092521|565667|P4|Extension Study (Group 4)|Protocol Violation|2
181625|NCT00092521|565668|P3|Extension Study (Group 4)|Protocol Violation|0
181626|NCT00092521|565669|P2|Extension Study (Group 4)|Protocol Violation|0
181627|NCT00092521|565670|P1|Extension Study (Group 4)|Protocol Violation|0
181628|NCT00092521|565667|P4|Extension Study (Group 4)|Pregnancy|4
181629|NCT00092521|565668|P3|Extension Study (Group 4)|Pregnancy|0
181630|NCT00092521|565669|P2|Extension Study (Group 4)|Pregnancy|0
181631|NCT00092521|565670|P1|Extension Study (Group 4)|Pregnancy|0
181632|NCT00092521|565667|P4|Extension Study (Group 4)|Lost to Follow-up|87
181633|NCT00092521|565668|P3|Extension Study (Group 4)|Lost to Follow-up|0
181634|NCT00092521|565669|P2|Extension Study (Group 4)|Lost to Follow-up|0
181635|NCT00092521|565670|P1|Extension Study (Group 4)|Lost to Follow-up|0
181636|NCT00092521|565667|P4|Extension Study (Group 4)|Adverse Event|2
181637|NCT00092521|565668|P3|Extension Study (Group 4)|Adverse Event|0
181638|NCT00092521|565669|P2|Extension Study (Group 4)|Adverse Event|0
181639|NCT00092521|565670|P1|Extension Study (Group 4)|Adverse Event|0
181640|NCT00092521|565667|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
181641|NCT00092521|565668|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
181642|NCT00092521|565669|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
181643|NCT00092521|565670|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
181644|NCT00092521|565667|P4|Follow-Up (After Month 7)|Visits Compressed|0
181645|NCT00092521|565668|P3|Follow-Up (After Month 7)|Visits Compressed|5
181646|NCT00092521|565669|P2|Follow-Up (After Month 7)|Visits Compressed|0
181647|NCT00092521|565670|P1|Follow-Up (After Month 7)|Visits Compressed|5
181648|NCT00092521|565667|P4|Follow-Up (After Month 7)|Travel|0
181649|NCT00092521|565668|P3|Follow-Up (After Month 7)|Travel|0
181650|NCT00092521|565669|P2|Follow-Up (After Month 7)|Travel|0
181651|NCT00092521|565670|P1|Follow-Up (After Month 7)|Travel|2
181652|NCT00092521|565667|P4|Follow-Up (After Month 7)|Site Terminated|0
181653|NCT00092521|565668|P3|Follow-Up (After Month 7)|Site Terminated|3
181654|NCT00092521|565669|P2|Follow-Up (After Month 7)|Site Terminated|0
181655|NCT00092521|565670|P1|Follow-Up (After Month 7)|Site Terminated|3
181656|NCT00092521|565667|P4|Follow-Up (After Month 7)|Moved|0
181657|NCT00092521|565668|P3|Follow-Up (After Month 7)|Moved|28
181658|NCT00092521|565669|P2|Follow-Up (After Month 7)|Moved|2
181659|NCT00092521|565670|P1|Follow-Up (After Month 7)|Moved|32
181660|NCT00092521|565667|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
181661|NCT00092521|565668|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
181662|NCT00092521|565669|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
181663|NCT00092521|565670|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
181664|NCT00092521|565667|P4|Follow-Up (After Month 7)|Protocol Violation|0
181665|NCT00092521|565668|P3|Follow-Up (After Month 7)|Protocol Violation|5
181666|NCT00092521|565669|P2|Follow-Up (After Month 7)|Protocol Violation|1
181667|NCT00092521|565670|P1|Follow-Up (After Month 7)|Protocol Violation|1
181668|NCT00092521|565667|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
181669|NCT00092521|565668|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
181670|NCT00092521|565669|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
181671|NCT00092521|565670|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
181672|NCT00092521|565667|P4|Follow-Up (After Month 7)|Death|0
181673|NCT00092521|565668|P3|Follow-Up (After Month 7)|Death|1
181674|NCT00092521|565669|P2|Follow-Up (After Month 7)|Death|0
181675|NCT00092521|565670|P1|Follow-Up (After Month 7)|Death|2
181676|NCT00092521|565667|P4|Follow-Up (After Month 7)|Adverse Event|0
181677|NCT00092521|565668|P3|Follow-Up (After Month 7)|Adverse Event|0
181678|NCT00092521|565669|P2|Follow-Up (After Month 7)|Adverse Event|0
181679|NCT00092521|565670|P1|Follow-Up (After Month 7)|Adverse Event|1
181680|NCT00092521|565667|P4|Follow-Up (After Month 7)|Subjects in Extension|0
181681|NCT00092521|565668|P3|Follow-Up (After Month 7)|Subjects in Extension|412
181682|NCT00092521|565669|P2|Follow-Up (After Month 7)|Subjects in Extension|109
181683|NCT00092521|565670|P1|Follow-Up (After Month 7)|Subjects in Extension|13
181684|NCT00092521|565667|P4|Follow-Up (After Month 7)|Subjects Continuing|0
181685|NCT00092521|565668|P3|Follow-Up (After Month 7)|Subjects Continuing|35
181686|NCT00092521|565669|P2|Follow-Up (After Month 7)|Subjects Continuing|4
181687|NCT00092521|565670|P1|Follow-Up (After Month 7)|Subjects Continuing|34
181688|NCT00092521|565667|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
181689|NCT00092521|565668|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
181690|NCT00092521|565669|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
181691|NCT00092521|565670|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
181692|NCT00092521|565667|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
181693|NCT00092521|565668|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
181694|NCT00092521|565669|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
181695|NCT00092521|565670|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
181696|NCT00092521|565667|P4|Vaccination (Day 1 Through Month 7)|Moved|0
181697|NCT00092521|565668|P3|Vaccination (Day 1 Through Month 7)|Moved|18
181698|NCT00092521|565669|P2|Vaccination (Day 1 Through Month 7)|Moved|1
181699|NCT00092521|565670|P1|Vaccination (Day 1 Through Month 7)|Moved|14
181700|NCT00092521|565667|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
181701|NCT00092521|565668|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
181702|NCT00092521|565669|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
181703|NCT00092521|565670|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
181704|NCT00092521|565667|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
181705|NCT00092521|565668|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
181706|NCT00092521|565669|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
181707|NCT00092521|565670|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
181708|NCT00092521|565667|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
181709|NCT00092521|565668|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
181710|NCT00092521|565669|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
181711|NCT00092521|565670|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
181712|NCT00092521|565667|P4|Vaccination (Day 1 Through Month 7)|Death|0
181713|NCT00092521|565668|P3|Vaccination (Day 1 Through Month 7)|Death|1
181714|NCT00092521|565669|P2|Vaccination (Day 1 Through Month 7)|Death|0
181715|NCT00092521|565670|P1|Vaccination (Day 1 Through Month 7)|Death|0
181716|NCT00092521|565667|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
181717|NCT00092521|565668|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
181718|NCT00092521|565669|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
181719|NCT00092521|565670|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
181720|NCT00092521|565667|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
181721|NCT00092521|565668|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
181722|NCT00092521|565669|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
181723|NCT00092521|565670|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
181724|NCT00092495|565684|P5|Base Study Follow-up Period|Withdrawal by Subject|0
181725|NCT00092495|565685|P4|Base Study Follow-up Period|Withdrawal by Subject|0
181726|NCT00092495|565686|P3|Base Study Follow-up Period|Withdrawal by Subject|0
181727|NCT00092495|565687|P2|Base Study Follow-up Period|Withdrawal by Subject|0
181728|NCT00092495|565688|P1|Base Study Follow-up Period|Withdrawal by Subject|2
181729|NCT00092495|565684|P5|Base Study Follow-up Period|Lost to Follow-up|0
181730|NCT00092495|565685|P4|Base Study Follow-up Period|Lost to Follow-up|12
181731|NCT00092495|565686|P3|Base Study Follow-up Period|Lost to Follow-up|3
181732|NCT00092495|565687|P2|Base Study Follow-up Period|Lost to Follow-up|3
181733|NCT00092495|565688|P1|Base Study Follow-up Period|Lost to Follow-up|1
181734|NCT00092495|565684|P5|Base Study Follow-up Period|Extended|0
181735|NCT00092495|565685|P4|Base Study Follow-up Period|Extended|2
181736|NCT00092495|565686|P3|Base Study Follow-up Period|Extended|1
181737|NCT00092495|565687|P2|Base Study Follow-up Period|Extended|0
181738|NCT00092495|565688|P1|Base Study Follow-up Period|Extended|0
181739|NCT00092495|565684|P5|Base Study Vaccination Period|Withdrawal by Subject|0
181740|NCT00092495|565685|P4|Base Study Vaccination Period|Withdrawal by Subject|25
181741|NCT00092495|565686|P3|Base Study Vaccination Period|Withdrawal by Subject|14
181742|NCT00092495|565687|P2|Base Study Vaccination Period|Withdrawal by Subject|10
181743|NCT00092495|565688|P1|Base Study Vaccination Period|Withdrawal by Subject|9
181744|NCT00092495|565684|P5|Base Study Vaccination Period|Protocol Violation|0
181745|NCT00092495|565685|P4|Base Study Vaccination Period|Protocol Violation|0
181746|NCT00092495|565686|P3|Base Study Vaccination Period|Protocol Violation|0
181747|NCT00092495|565687|P2|Base Study Vaccination Period|Protocol Violation|0
181748|NCT00092495|565688|P1|Base Study Vaccination Period|Protocol Violation|1
181749|NCT00092495|565684|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
181750|NCT00092495|565685|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
181751|NCT00092495|565686|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
181752|NCT00092495|565687|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
181753|NCT00092495|565688|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
181754|NCT00092495|565684|P5|Base Study Vaccination Period|Pregnancy|0
181755|NCT00092495|565685|P4|Base Study Vaccination Period|Pregnancy|0
181756|NCT00092495|565686|P3|Base Study Vaccination Period|Pregnancy|0
181757|NCT00092495|565687|P2|Base Study Vaccination Period|Pregnancy|0
181758|NCT00092495|565688|P1|Base Study Vaccination Period|Pregnancy|2
181759|NCT00092495|565684|P5|Base Study Vaccination Period|Unspecified|0
181760|NCT00092495|565685|P4|Base Study Vaccination Period|Unspecified|2
181761|NCT00092495|565686|P3|Base Study Vaccination Period|Unspecified|0
181762|NCT00092495|565687|P2|Base Study Vaccination Period|Unspecified|1
181763|NCT00092495|565688|P1|Base Study Vaccination Period|Unspecified|1
181764|NCT00092495|565684|P5|Base Study Vaccination Period|Moved|0
181765|NCT00092495|565685|P4|Base Study Vaccination Period|Moved|2
181766|NCT00092495|565686|P3|Base Study Vaccination Period|Moved|2
181767|NCT00092495|565687|P2|Base Study Vaccination Period|Moved|1
181768|NCT00092495|565688|P1|Base Study Vaccination Period|Moved|3
181769|NCT00092495|565684|P5|Base Study Vaccination Period|Lost to Follow-up|0
181770|NCT00092495|565685|P4|Base Study Vaccination Period|Lost to Follow-up|36
181771|NCT00092495|565686|P3|Base Study Vaccination Period|Lost to Follow-up|11
181772|NCT00092495|565687|P2|Base Study Vaccination Period|Lost to Follow-up|6
181773|NCT00092495|565688|P1|Base Study Vaccination Period|Lost to Follow-up|16
181774|NCT00092495|565684|P5|Base Study Vaccination Period|Adverse Event|0
181775|NCT00092495|565685|P4|Base Study Vaccination Period|Adverse Event|3
181776|NCT00092495|565686|P3|Base Study Vaccination Period|Adverse Event|0
181777|NCT00092495|565687|P2|Base Study Vaccination Period|Adverse Event|0
181778|NCT00092495|565688|P1|Base Study Vaccination Period|Adverse Event|1
181779|NCT00092495|565684|P5|Base Study Vaccination Period|*Pregnancy|0
181780|NCT00092495|565685|P4|Base Study Vaccination Period|*Pregnancy|7
181781|NCT00092495|565686|P3|Base Study Vaccination Period|*Pregnancy|5
181782|NCT00092495|565687|P2|Base Study Vaccination Period|*Pregnancy|2
181783|NCT00092495|565688|P1|Base Study Vaccination Period|*Pregnancy|0
181784|NCT00092495|565684|P5|Base Study Vaccination Period|*Other reasons|0
181785|NCT00092495|565685|P4|Base Study Vaccination Period|*Other reasons|1
181786|NCT00092495|565686|P3|Base Study Vaccination Period|*Other reasons|0
181787|NCT00092495|565687|P2|Base Study Vaccination Period|*Other reasons|0
181788|NCT00092495|565688|P1|Base Study Vaccination Period|*Other reasons|1
181789|NCT00092495|565684|P5|Base Study Vaccination Period|*Clinical AE|0
181790|NCT00092495|565685|P4|Base Study Vaccination Period|*Clinical AE|2
181791|NCT00092495|565686|P3|Base Study Vaccination Period|*Clinical AE|1
181792|NCT00092495|565687|P2|Base Study Vaccination Period|*Clinical AE|0
181793|NCT00092495|565688|P1|Base Study Vaccination Period|*Clinical AE|1
181794|NCT00092495|565684|P5|Base Study Vaccination Period|Extended|0
181795|NCT00092495|565685|P4|Base Study Vaccination Period|Extended|1
181796|NCT00092495|565686|P3|Base Study Vaccination Period|Extended|0
181797|NCT00092495|565687|P2|Base Study Vaccination Period|Extended|0
181798|NCT00092495|565688|P1|Base Study Vaccination Period|Extended|0
181799|NCT00092495|565684|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
181800|NCT00092495|565685|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
181801|NCT00092495|565686|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
181802|NCT00092495|565687|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
181803|NCT00092495|565688|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
181804|NCT00092456|565754|P4|Overall Study|Not Specified|0
181805|NCT00092456|565755|P3|Overall Study|Not Specified|3
181806|NCT00092456|565756|P2|Overall Study|Not Specified|2
181807|NCT00092456|565757|P1|Overall Study|Not Specified|4
181808|NCT00092456|565754|P4|Overall Study|Moved|1
181809|NCT00092456|565755|P3|Overall Study|Moved|0
181810|NCT00092456|565756|P2|Overall Study|Moved|1
181811|NCT00092456|565757|P1|Overall Study|Moved|1
181812|NCT00092456|565754|P4|Overall Study|Withdrawal by Subject|6
181813|NCT00092456|565755|P3|Overall Study|Withdrawal by Subject|16
181814|NCT00092456|565756|P2|Overall Study|Withdrawal by Subject|5
181815|NCT00092456|565757|P1|Overall Study|Withdrawal by Subject|13
181816|NCT00092456|565754|P4|Overall Study|Protocol Violation|6
181817|NCT00092456|565755|P3|Overall Study|Protocol Violation|8
181818|NCT00092456|565756|P2|Overall Study|Protocol Violation|7
181819|NCT00092456|565757|P1|Overall Study|Protocol Violation|5
181820|NCT00092456|565754|P4|Overall Study|Lost to Follow-up|2
181821|NCT00092456|565755|P3|Overall Study|Lost to Follow-up|1
181822|NCT00092456|565756|P2|Overall Study|Lost to Follow-up|2
181823|NCT00092456|565757|P1|Overall Study|Lost to Follow-up|2
181824|NCT00092456|565754|P4|Overall Study|Adverse Event|1
181825|NCT00092456|565755|P3|Overall Study|Adverse Event|1
181826|NCT00092456|565756|P2|Overall Study|Adverse Event|0
181827|NCT00092456|565757|P1|Overall Study|Adverse Event|0
181828|NCT00092443|565805|P2|Overall Study|Not Specified|13
181829|NCT00092443|565806|P1|Overall Study|Not Specified|17
181830|NCT00092443|565805|P2|Overall Study|Moved|5
181831|NCT00092443|565806|P1|Overall Study|Moved|5
181832|NCT00092443|565805|P2|Overall Study|Withdrawal by Subject|11
181833|NCT00092443|565806|P1|Overall Study|Withdrawal by Subject|9
181834|NCT00092443|565805|P2|Overall Study|Protocol Violation|9
181835|NCT00092443|565806|P1|Overall Study|Protocol Violation|11
181836|NCT00092443|565805|P2|Overall Study|Lost to Follow-up|3
181837|NCT00092443|565806|P1|Overall Study|Lost to Follow-up|7
181838|NCT00092443|565805|P2|Overall Study|Adverse Event|13
181839|NCT00092443|565806|P1|Overall Study|Adverse Event|9
181840|NCT00092417|565824|P2|Overall Study|Not Specified|0
181841|NCT00092417|565825|P1|Overall Study|Not Specified|1
181842|NCT00092417|565824|P2|Overall Study|Withdrawal by Subject|1
181843|NCT00092417|565825|P1|Overall Study|Withdrawal by Subject|2
181844|NCT00092417|565824|P2|Overall Study|Lost to Follow-up|0
181845|NCT00092417|565825|P1|Overall Study|Lost to Follow-up|2
181846|NCT00092131|565839|P2|Treatment Period II|Adverse Event|1
181847|NCT00092131|565840|P1|Treatment Period II|Adverse Event|0
181848|NCT00092131|565839|P2|Treatment Period I|Adverse Event|0
181849|NCT00092131|565840|P1|Treatment Period I|Adverse Event|1
181850|NCT00092118|565870|P2|Overall Study|Not Specified|5
181851|NCT00092118|565871|P1|Overall Study|Not Specified|6
181852|NCT00092118|565870|P2|Overall Study|Withdrawal by Subject|10
181853|NCT00092118|565871|P1|Overall Study|Withdrawal by Subject|4
181854|NCT00092118|565870|P2|Overall Study|Protocol Violation|25
181855|NCT00092118|565871|P1|Overall Study|Protocol Violation|23
181856|NCT00092118|565870|P2|Overall Study|Lost to Follow-up|3
181857|NCT00092118|565871|P1|Overall Study|Lost to Follow-up|4
181858|NCT00092118|565870|P2|Overall Study|Lack of Efficacy|14
181859|NCT00092118|565871|P1|Overall Study|Lack of Efficacy|12
181860|NCT00092118|565870|P2|Overall Study|Adverse Event|32
181861|NCT00092118|565871|P1|Overall Study|Adverse Event|35
181862|NCT00091949|565905|P2|Overall Study|Lost to Follow-up|41
181863|NCT00091949|565906|P1|Overall Study|Lost to Follow-up|58
181864|NCT00091949|565905|P2|Overall Study|Withdrawal by Subject|110
181865|NCT00091949|565906|P1|Overall Study|Withdrawal by Subject|117
181866|NCT00091832|565930|P6|Overall Study|Protocol Violation|1
181867|NCT00091832|565931|P5|Overall Study|Protocol Violation|0
181868|NCT00091832|565932|P4|Overall Study|Protocol Violation|0
181869|NCT00091832|565933|P3|Overall Study|Protocol Violation|1
181870|NCT00091832|565934|P2|Overall Study|Protocol Violation|0
181871|NCT00091832|565935|P1|Overall Study|Protocol Violation|0
181872|NCT00091832|565930|P6|Overall Study|Other|0
181873|NCT00091832|565931|P5|Overall Study|Other|0
181874|NCT00091832|565932|P4|Overall Study|Other|0
181875|NCT00091832|565933|P3|Overall Study|Other|2
181876|NCT00091832|565934|P2|Overall Study|Other|1
181877|NCT00091832|565935|P1|Overall Study|Other|0
181878|NCT00091832|565930|P6|Overall Study|Noncompliance|0
181879|NCT00091832|565931|P5|Overall Study|Noncompliance|0
181880|NCT00091832|565932|P4|Overall Study|Noncompliance|0
181881|NCT00091832|565933|P3|Overall Study|Noncompliance|0
181882|NCT00091832|565934|P2|Overall Study|Noncompliance|1
181883|NCT00091832|565935|P1|Overall Study|Noncompliance|0
181884|NCT00091832|565930|P6|Overall Study|Lost to Follow-up|1
181885|NCT00091832|565931|P5|Overall Study|Lost to Follow-up|2
181886|NCT00091832|565932|P4|Overall Study|Lost to Follow-up|3
181887|NCT00091832|565933|P3|Overall Study|Lost to Follow-up|3
181888|NCT00091832|565934|P2|Overall Study|Lost to Follow-up|0
181889|NCT00091832|565935|P1|Overall Study|Lost to Follow-up|1
181890|NCT00091832|565930|P6|Overall Study|Ineligibility Determined|0
181891|NCT00091832|565931|P5|Overall Study|Ineligibility Determined|1
181892|NCT00091832|565932|P4|Overall Study|Ineligibility Determined|0
181893|NCT00091832|565933|P3|Overall Study|Ineligibility Determined|1
181894|NCT00091832|565934|P2|Overall Study|Ineligibility Determined|0
181895|NCT00091832|565935|P1|Overall Study|Ineligibility Determined|0
181896|NCT00091832|565930|P6|Overall Study|Disease Progression|2
181897|NCT00091832|565931|P5|Overall Study|Disease Progression|1
181898|NCT00091832|565932|P4|Overall Study|Disease Progression|1
181899|NCT00091832|565933|P3|Overall Study|Disease Progression|0
181900|NCT00091832|565934|P2|Overall Study|Disease Progression|0
181901|NCT00091832|565935|P1|Overall Study|Disease Progression|2
181902|NCT00091832|565930|P6|Overall Study|Death|6
181903|NCT00091832|565931|P5|Overall Study|Death|5
181904|NCT00091832|565932|P4|Overall Study|Death|8
181905|NCT00091832|565933|P3|Overall Study|Death|5
181906|NCT00091832|565934|P2|Overall Study|Death|4
181907|NCT00091832|565935|P1|Overall Study|Death|6
181908|NCT00091832|565930|P6|Overall Study|Withdrawal by Subject|1
181909|NCT00091832|565931|P5|Overall Study|Withdrawal by Subject|3
181910|NCT00091832|565932|P4|Overall Study|Withdrawal by Subject|1
181911|NCT00091832|565933|P3|Overall Study|Withdrawal by Subject|0
181912|NCT00091832|565934|P2|Overall Study|Withdrawal by Subject|5
181913|NCT00091832|565935|P1|Overall Study|Withdrawal by Subject|4
181914|NCT00091832|565930|P6|Overall Study|Adverse Event|0
181915|NCT00091832|565931|P5|Overall Study|Adverse Event|3
181916|NCT00091832|565932|P4|Overall Study|Adverse Event|1
181917|NCT00091832|565933|P3|Overall Study|Adverse Event|0
181918|NCT00091832|565934|P2|Overall Study|Adverse Event|0
181919|NCT00091832|565935|P1|Overall Study|Adverse Event|0
181920|NCT00091832|565930|P6|Overall Study|Physician Decision|0
181921|NCT00091832|565931|P5|Overall Study|Physician Decision|0
181922|NCT00091832|565932|P4|Overall Study|Physician Decision|0
181923|NCT00091832|565933|P3|Overall Study|Physician Decision|0
181924|NCT00091832|565934|P2|Overall Study|Physician Decision|0
181925|NCT00091832|565935|P1|Overall Study|Physician Decision|1
181926|NCT00091819|566053|P2|Overall Study|Never received study treatment|4
181927|NCT00091819|566054|P1|Overall Study|Never received study treatment|3
181928|NCT00091819|566053|P2|Overall Study|Other|3
181929|NCT00091819|566054|P1|Overall Study|Other|2
181930|NCT00091819|566053|P2|Overall Study|Protocol Violation|2
181931|NCT00091819|566054|P1|Overall Study|Protocol Violation|1
181932|NCT00091819|566053|P2|Overall Study|Withdrawal by Subject|8
181933|NCT00091819|566054|P1|Overall Study|Withdrawal by Subject|5
181934|NCT00091819|566053|P2|Overall Study|Lost to Follow-up|23
181935|NCT00091819|566054|P1|Overall Study|Lost to Follow-up|26
181936|NCT00091819|566053|P2|Overall Study|Death|5
181937|NCT00091819|566054|P1|Overall Study|Death|4
181938|NCT00091819|566053|P2|Overall Study|Adverse Event|1
181939|NCT00091819|566054|P1|Overall Study|Adverse Event|1
181940|NCT00091793|566062|P2|Overall Study|Other|0
181941|NCT00091793|566063|P1|Overall Study|Other|2
181942|NCT00091793|566062|P2|Overall Study|Noncompliance|0
181943|NCT00091793|566063|P1|Overall Study|Noncompliance|2
181944|NCT00091793|566062|P2|Overall Study|Lost to Follow-up|5
181945|NCT00091793|566063|P1|Overall Study|Lost to Follow-up|7
181946|NCT00091793|566062|P2|Overall Study|Ineligibility determined|0
181947|NCT00091793|566063|P1|Overall Study|Ineligibility determined|2
181948|NCT00091793|566062|P2|Overall Study|Withdrawal by Subject|15
181949|NCT00091793|566063|P1|Overall Study|Withdrawal by Subject|10
181950|NCT00091793|566062|P2|Overall Study|Adverse Event|2
181951|NCT00091793|566063|P1|Overall Study|Adverse Event|1
181952|NCT00091572|566087|P2|Overall Study|Toxicity (Related AE)|9
181953|NCT00091572|566088|P1|Overall Study|Toxicity (Related AE)|53
181954|NCT00091572|566087|P2|Overall Study|Major Protocol Violation|0
181955|NCT00091572|566088|P1|Overall Study|Major Protocol Violation|2
181956|NCT00091572|566087|P2|Overall Study|Ongoing (still on treatment)|12
181957|NCT00091572|566088|P1|Overall Study|Ongoing (still on treatment)|8
181958|NCT00091572|566087|P2|Overall Study|Other Reason|13
181959|NCT00091572|566088|P1|Overall Study|Other Reason|6
181960|NCT00091572|566087|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
181961|NCT00091572|566088|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
181962|NCT00091572|566087|P2|Overall Study|Death not due to malignancy/toxicity|3
181963|NCT00091572|566088|P1|Overall Study|Death not due to malignancy/toxicity|1
181964|NCT00091572|566087|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
181965|NCT00091572|566088|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
181966|NCT00091572|566087|P2|Overall Study|Lost to Follow-up|1
181967|NCT00091572|566088|P1|Overall Study|Lost to Follow-up|1
181968|NCT00091442|566119|P2|Overall Study|Not Specified|6
181969|NCT00091442|566120|P1|Overall Study|Not Specified|2
181970|NCT00091442|566119|P2|Overall Study|Lost to Follow-up|3
181971|NCT00091442|566120|P1|Overall Study|Lost to Follow-up|1
181972|NCT00091442|566119|P2|Overall Study|Death|7
181973|NCT00091442|566120|P1|Overall Study|Death|9
181974|NCT00091442|566119|P2|Overall Study|2cycles therapy beyond Complete response|16
181975|NCT00091442|566120|P1|Overall Study|2cycles therapy beyond Complete response|9
181976|NCT00091442|566119|P2|Overall Study|Adverse Event|48
181977|NCT00091442|566120|P1|Overall Study|Adverse Event|29
181978|NCT00091442|566119|P2|Overall Study|Withdrawal by Subject|46
181979|NCT00091442|566120|P1|Overall Study|Withdrawal by Subject|38
181980|NCT00091442|566119|P2|Overall Study|Physician Decision|58
181981|NCT00091442|566120|P1|Overall Study|Physician Decision|61
181982|NCT00091442|566119|P2|Overall Study|Progressive Disease|189
181983|NCT00091442|566120|P1|Overall Study|Progressive Disease|220
181984|NCT00091390|566130|P1|Overall Study|Protocol Violation|2
181985|NCT00091390|566130|P1|Overall Study|Withdrawal by Subject|2
181986|NCT00091169|566142|P2|Overall Study|Not start protocol therapy|17
181987|NCT00091169|566143|P1|Overall Study|Not start protocol therapy|26
181988|NCT00091169|566142|P2|Overall Study|Other|4
181989|NCT00091169|566143|P1|Overall Study|Other|3
181990|NCT00091169|566142|P2|Overall Study|Withdrawal by Subject|13
181991|NCT00091169|566143|P1|Overall Study|Withdrawal by Subject|10
181992|NCT00091169|566142|P2|Overall Study|Death|1
181993|NCT00091169|566143|P1|Overall Study|Death|4
181994|NCT00091169|566142|P2|Overall Study|Adverse Event|17
181995|NCT00091169|566143|P1|Overall Study|Adverse Event|11
181996|NCT00091169|566142|P2|Overall Study|Disease progression|1
181997|NCT00091169|566143|P1|Overall Study|Disease progression|3
181998|NCT00091026|566161|P2|Overall Study|Unknown-never received treatment|1
181999|NCT00091026|566162|P1|Overall Study|Unknown-never received treatment|0
182000|NCT00091026|566161|P2|Overall Study|Patient withdrew and never received trea|2
182001|NCT00091026|566162|P1|Overall Study|Patient withdrew and never received trea|0
182002|NCT00091026|566161|P2|Overall Study|Patient deemed non eligible-never receiv|0
182003|NCT00091026|566162|P1|Overall Study|Patient deemed non eligible-never receiv|1
182004|NCT00090987|566172|P1|Overall Study|Incarcerated|1
182005|NCT00090987|566172|P1|Overall Study|Non-compliance|4
182006|NCT00090987|566172|P1|Overall Study|alternative therapy|1
182007|NCT00090987|566172|P1|Overall Study|Withdrawal by Subject|3
182008|NCT00090987|566172|P1|Overall Study|Lack of Efficacy|7
182009|NCT00090987|566172|P1|Overall Study|Adverse Event|5
182010|NCT00090779|566187|P2|Step 3|Off extended study due to study closure|3
182011|NCT00090779|566188|P1|Step 3|Off extended study due to study closure|4
182012|NCT00090779|566187|P2|Step 3|Initiation of ART and off extended study|2
182013|NCT00090779|566188|P1|Step 3|Initiation of ART and off extended study|3
182014|NCT00090779|566187|P2|Step 2|Non-compliance to study requirements|1
182015|NCT00090779|566188|P1|Step 2|Non-compliance to study requirements|0
182016|NCT00090779|566187|P2|Step 2|Subject relocated|1
182017|NCT00090779|566188|P1|Step 2|Subject relocated|0
182018|NCT00090779|566187|P2|Step 2|Off study per study closure|16
182019|NCT00090779|566188|P1|Step 2|Off study per study closure|6
182020|NCT00090779|566187|P2|Step 1|Subject relocated|8
182021|NCT00090779|566188|P1|Step 1|Subject relocated|2
182022|NCT00090779|566187|P2|Step 1|Non-compliance to study requirements|1
182023|NCT00090779|566188|P1|Step 1|Non-compliance to study requirements|0
182024|NCT00090779|566187|P2|Step 1|Pregnancy|0
182025|NCT00090779|566188|P1|Step 1|Pregnancy|1
182026|NCT00090779|566187|P2|Step 1|Physician Decision|0
182027|NCT00090779|566188|P1|Step 1|Physician Decision|1
182028|NCT00090779|566187|P2|Step 1|Death|2
182029|NCT00090779|566188|P1|Step 1|Death|0
182030|NCT00090779|566187|P2|Step 1|Lost to Follow-up|2
182031|NCT00090779|566188|P1|Step 1|Lost to Follow-up|3
182032|NCT00090779|566187|P2|Step 1|Withdrawal by Subject|2
182033|NCT00090779|566188|P1|Step 1|Withdrawal by Subject|4
182034|NCT00090766|566212|P3|Overall Study|Lost to Follow-up|2
182035|NCT00090766|566213|P2|Overall Study|Lost to Follow-up|0
182036|NCT00090766|566214|P1|Overall Study|Lost to Follow-up|2
182037|NCT00090766|566212|P3|Overall Study|Admin|0
182038|NCT00090766|566213|P2|Overall Study|Admin|2
182039|NCT00090766|566214|P1|Overall Study|Admin|0
182040|NCT00090766|566212|P3|Overall Study|Death|0
182041|NCT00090766|566213|P2|Overall Study|Death|0
182042|NCT00090766|566214|P1|Overall Study|Death|1
182043|NCT00090766|566212|P3|Overall Study|Nephrectomy Planned|1
182044|NCT00090766|566213|P2|Overall Study|Nephrectomy Planned|0
182045|NCT00090766|566214|P1|Overall Study|Nephrectomy Planned|0
182046|NCT00090753|566256|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
182047|NCT00090753|566257|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
182048|NCT00090753|566256|P2|Extended Treatment Period|Mircera Commercialization|93
182049|NCT00090753|566257|P1|Extended Treatment Period|Mircera Commercialization|188
182050|NCT00090753|566256|P2|Extended Treatment Period|Renal Transplant|12
182051|NCT00090753|566257|P1|Extended Treatment Period|Renal Transplant|15
182052|NCT00090753|566256|P2|Extended Treatment Period|Lost to Follow-up|1
182053|NCT00090753|566257|P1|Extended Treatment Period|Lost to Follow-up|3
182054|NCT00090753|566256|P2|Extended Treatment Period|Refused Treatment|12
182055|NCT00090753|566257|P1|Extended Treatment Period|Refused Treatment|18
182056|NCT00090753|566256|P2|Extended Treatment Period|Lack of Efficacy|0
182057|NCT00090753|566257|P1|Extended Treatment Period|Lack of Efficacy|1
182058|NCT00090753|566256|P2|Extended Treatment Period|Death|30
182059|NCT00090753|566257|P1|Extended Treatment Period|Death|58
182060|NCT00090753|566256|P2|Extended Treatment Period|Adverse Event|0
182061|NCT00090753|566257|P1|Extended Treatment Period|Adverse Event|11
182062|NCT00090753|566256|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
182063|NCT00090753|566257|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
182064|NCT00090753|566256|P2|First Treatment Period|Mircera Commercialization|0
182065|NCT00090753|566257|P1|First Treatment Period|Mircera Commercialization|1
182066|NCT00090753|566256|P2|First Treatment Period|Renal Transplant|50
182067|NCT00090753|566257|P1|First Treatment Period|Renal Transplant|70
182068|NCT00090753|566256|P2|First Treatment Period|Lost to Follow-up|4
182069|NCT00090753|566257|P1|First Treatment Period|Lost to Follow-up|4
182070|NCT00090753|566256|P2|First Treatment Period|Refused Treatment|25
182071|NCT00090753|566257|P1|First Treatment Period|Refused Treatment|32
182072|NCT00090753|566256|P2|First Treatment Period|Lack of Efficacy|1
182073|NCT00090753|566257|P1|First Treatment Period|Lack of Efficacy|2
182074|NCT00090753|566256|P2|First Treatment Period|Death|62
182075|NCT00090753|566257|P1|First Treatment Period|Death|88
182076|NCT00090753|566256|P2|First Treatment Period|Adverse Event|8
182077|NCT00090753|566257|P1|First Treatment Period|Adverse Event|20
182078|NCT00090610|566267|P2|Overall Study|Withdrawal by Subject|1
182079|NCT00090610|566268|P1|Overall Study|Withdrawal by Subject|1
182080|NCT00090584|566284|P2|Baseline to 8 Months|Lost to Follow-up|41
182081|NCT00090584|566285|P1|Baseline to 8 Months|Lost to Follow-up|44
182082|NCT00090584|566284|P2|Baseline to 10 Weeks|Lost to Follow-up|12
182083|NCT00090584|566285|P1|Baseline to 10 Weeks|Lost to Follow-up|15
182084|NCT00090545|566317|P2|Overall Study|Adverse Event|2
182085|NCT00090545|566318|P1|Overall Study|Adverse Event|0
182086|NCT00090545|566317|P2|Overall Study|Death|1
182087|NCT00090545|566318|P1|Overall Study|Death|0
182088|NCT00090545|566317|P2|Overall Study|Refused further treatment|4
182089|NCT00090545|566318|P1|Overall Study|Refused further treatment|1
182090|NCT00090545|566317|P2|Overall Study|Disease progression on study|17
182091|NCT00090545|566318|P1|Overall Study|Disease progression on study|21
182092|NCT00090519|566328|P2|Overall Study|Sponsor Decision|1
182093|NCT00090519|566329|P1|Overall Study|Sponsor Decision|3
182094|NCT00090519|566328|P2|Overall Study|Physician Decision|3
182095|NCT00090519|566329|P1|Overall Study|Physician Decision|2
182096|NCT00090519|566328|P2|Overall Study|Withdrawal by Subject|29
182097|NCT00090519|566329|P1|Overall Study|Withdrawal by Subject|28
182098|NCT00090519|566328|P2|Overall Study|Lost to Follow-up|29
182099|NCT00090519|566329|P1|Overall Study|Lost to Follow-up|26
182100|NCT00090519|566328|P2|Overall Study|Death|9
182101|NCT00090519|566329|P1|Overall Study|Death|9
182102|NCT00090519|566328|P2|Overall Study|Adverse Event|4
182103|NCT00090519|566329|P1|Overall Study|Adverse Event|5
182104|NCT00090493|566353|P1|Overall Study|Physician Decision|2
182105|NCT00090402|566360|P3|Overall Study|stopped taking study medication|1
182106|NCT00090402|566361|P2|Overall Study|stopped taking study medication|1
182107|NCT00090402|566362|P1|Overall Study|stopped taking study medication|0
182108|NCT00090402|566360|P3|Overall Study|subject moved|0
182109|NCT00090402|566361|P2|Overall Study|subject moved|0
182110|NCT00090402|566362|P1|Overall Study|subject moved|1
182111|NCT00090402|566360|P3|Overall Study|Death|0
182112|NCT00090402|566361|P2|Overall Study|Death|1
182113|NCT00090402|566362|P1|Overall Study|Death|1
182114|NCT00090363|566373|P3|Overall Study|Continuing on study off treatment|16
182115|NCT00090363|566374|P2|Overall Study|Continuing on study off treatment|13
182116|NCT00090363|566375|P1|Overall Study|Continuing on study off treatment|14
182117|NCT00090363|566373|P3|Overall Study|Reasons not specified|1
182118|NCT00090363|566374|P2|Overall Study|Reasons not specified|1
182119|NCT00090363|566375|P1|Overall Study|Reasons not specified|2
182120|NCT00090363|566373|P3|Overall Study|Consent expired|9
182121|NCT00090363|566374|P2|Overall Study|Consent expired|10
182122|NCT00090363|566375|P1|Overall Study|Consent expired|7
182123|NCT00090363|566373|P3|Overall Study|Eligibility criteria not fulfilled|1
182124|NCT00090363|566374|P2|Overall Study|Eligibility criteria not fulfilled|0
182125|NCT00090363|566375|P1|Overall Study|Eligibility criteria not fulfilled|0
182126|NCT00090363|566373|P3|Overall Study|Study-specific discontinuation criteria|62
182127|NCT00090363|566374|P2|Overall Study|Study-specific discontinuation criteria|74
182128|NCT00090363|566375|P1|Overall Study|Study-specific discontinuation criteria|75
182129|NCT00090363|566373|P3|Overall Study|Withdrawal by Subject|6
182130|NCT00090363|566374|P2|Overall Study|Withdrawal by Subject|7
182131|NCT00090363|566375|P1|Overall Study|Withdrawal by Subject|7
182132|NCT00090363|566373|P3|Overall Study|Lost to Follow-up|1
182133|NCT00090363|566374|P2|Overall Study|Lost to Follow-up|2
182134|NCT00090363|566375|P1|Overall Study|Lost to Follow-up|1
182135|NCT00090285|566397|P4|Extension 1|Moved|0
182136|NCT00090285|566398|P3|Extension 1|Moved|3
182137|NCT00090285|566399|P2|Extension 1|Moved|0
182138|NCT00090285|566400|P1|Extension 1|Moved|0
182139|NCT00090285|566397|P4|Extension 1|Other Reason|0
182140|NCT00090285|566398|P3|Extension 1|Other Reason|4
182141|NCT00090285|566399|P2|Extension 1|Other Reason|0
182142|NCT00090285|566400|P1|Extension 1|Other Reason|0
182143|NCT00090285|566397|P4|Extension 1|Withdrawal by Subject|1
182144|NCT00090285|566398|P3|Extension 1|Withdrawal by Subject|13
182145|NCT00090285|566399|P2|Extension 1|Withdrawal by Subject|0
182146|NCT00090285|566400|P1|Extension 1|Withdrawal by Subject|0
182147|NCT00090285|566397|P4|Extension 1|Lost to Follow-up|0
182148|NCT00090285|566398|P3|Extension 1|Lost to Follow-up|35
182149|NCT00090285|566399|P2|Extension 1|Lost to Follow-up|0
182150|NCT00090285|566400|P1|Extension 1|Lost to Follow-up|0
182151|NCT00090285|566397|P4|Extension 1|Adverse Event|0
182152|NCT00090285|566398|P3|Extension 1|Adverse Event|2
182153|NCT00090285|566399|P2|Extension 1|Adverse Event|0
182154|NCT00090285|566400|P1|Extension 1|Adverse Event|0
182155|NCT00090285|566397|P4|Base Study Follow-up Period|Subject Incarcerated|0
182156|NCT00090285|566398|P3|Base Study Follow-up Period|Subject Incarcerated|0
182157|NCT00090285|566399|P2|Base Study Follow-up Period|Subject Incarcerated|2
182158|NCT00090285|566400|P1|Base Study Follow-up Period|Subject Incarcerated|0
182159|NCT00090285|566397|P4|Base Study Follow-up Period|Uncooperative|0
182160|NCT00090285|566398|P3|Base Study Follow-up Period|Uncooperative|0
182161|NCT00090285|566399|P2|Base Study Follow-up Period|Uncooperative|4
182162|NCT00090285|566400|P1|Base Study Follow-up Period|Uncooperative|3
182163|NCT00090285|566397|P4|Base Study Follow-up Period|Protocol Violation|0
182164|NCT00090285|566398|P3|Base Study Follow-up Period|Protocol Violation|0
182165|NCT00090285|566399|P2|Base Study Follow-up Period|Protocol Violation|0
182166|NCT00090285|566400|P1|Base Study Follow-up Period|Protocol Violation|1
182167|NCT00090285|566397|P4|Base Study Follow-up Period|Unspecified|0
182168|NCT00090285|566398|P3|Base Study Follow-up Period|Unspecified|0
182169|NCT00090285|566399|P2|Base Study Follow-up Period|Unspecified|0
182170|NCT00090285|566400|P1|Base Study Follow-up Period|Unspecified|2
182171|NCT00090285|566397|P4|Base Study Follow-up Period|Moved|0
182172|NCT00090285|566398|P3|Base Study Follow-up Period|Moved|0
182173|NCT00090285|566399|P2|Base Study Follow-up Period|Moved|36
182174|NCT00090285|566400|P1|Base Study Follow-up Period|Moved|41
182175|NCT00090285|566397|P4|Base Study Follow-up Period|Withdrawal by Subject|0
182176|NCT00090285|566398|P3|Base Study Follow-up Period|Withdrawal by Subject|0
182177|NCT00090285|566399|P2|Base Study Follow-up Period|Withdrawal by Subject|64
182178|NCT00090285|566400|P1|Base Study Follow-up Period|Withdrawal by Subject|53
182179|NCT00090285|566397|P4|Base Study Follow-up Period|Lost to Follow-up|0
182180|NCT00090285|566398|P3|Base Study Follow-up Period|Lost to Follow-up|0
182181|NCT00090285|566399|P2|Base Study Follow-up Period|Lost to Follow-up|226
182182|NCT00090285|566400|P1|Base Study Follow-up Period|Lost to Follow-up|232
182183|NCT00090285|566397|P4|Base Study Follow-up Period|Adverse Event|0
182184|NCT00090285|566398|P3|Base Study Follow-up Period|Adverse Event|0
182185|NCT00090285|566399|P2|Base Study Follow-up Period|Adverse Event|10
182186|NCT00090285|566400|P1|Base Study Follow-up Period|Adverse Event|3
182187|NCT00090285|566397|P4|Base Study Vaccination Period|HIV positive|0
182188|NCT00090285|566398|P3|Base Study Vaccination Period|HIV positive|0
182189|NCT00090285|566399|P2|Base Study Vaccination Period|HIV positive|1
182190|NCT00090285|566400|P1|Base Study Vaccination Period|HIV positive|1
182191|NCT00090285|566397|P4|Base Study Vaccination Period|Subject Incarcerated|0
182192|NCT00090285|566398|P3|Base Study Vaccination Period|Subject Incarcerated|0
182193|NCT00090285|566399|P2|Base Study Vaccination Period|Subject Incarcerated|2
182194|NCT00090285|566400|P1|Base Study Vaccination Period|Subject Incarcerated|2
182195|NCT00090285|566397|P4|Base Study Vaccination Period|Unspecified|0
182196|NCT00090285|566398|P3|Base Study Vaccination Period|Unspecified|0
182197|NCT00090285|566399|P2|Base Study Vaccination Period|Unspecified|2
182198|NCT00090285|566400|P1|Base Study Vaccination Period|Unspecified|2
182199|NCT00090285|566397|P4|Base Study Vaccination Period|Site Terminated|0
182200|NCT00090285|566398|P3|Base Study Vaccination Period|Site Terminated|0
182201|NCT00090285|566399|P2|Base Study Vaccination Period|Site Terminated|0
182202|NCT00090285|566400|P1|Base Study Vaccination Period|Site Terminated|1
182203|NCT00090285|566397|P4|Base Study Vaccination Period|Moved|0
182204|NCT00090285|566398|P3|Base Study Vaccination Period|Moved|0
182205|NCT00090285|566399|P2|Base Study Vaccination Period|Moved|21
182206|NCT00090285|566400|P1|Base Study Vaccination Period|Moved|20
182207|NCT00090285|566397|P4|Base Study Vaccination Period|Uncooperative|0
182208|NCT00090285|566398|P3|Base Study Vaccination Period|Uncooperative|0
182209|NCT00090285|566399|P2|Base Study Vaccination Period|Uncooperative|2
182210|NCT00090285|566400|P1|Base Study Vaccination Period|Uncooperative|2
182211|NCT00090285|566397|P4|Base Study Vaccination Period|Withdrawal by Subject|0
182212|NCT00090285|566398|P3|Base Study Vaccination Period|Withdrawal by Subject|0
182213|NCT00090285|566399|P2|Base Study Vaccination Period|Withdrawal by Subject|69
182214|NCT00090285|566400|P1|Base Study Vaccination Period|Withdrawal by Subject|64
182215|NCT00090285|566397|P4|Base Study Vaccination Period|Protocol Violation|0
182216|NCT00090285|566398|P3|Base Study Vaccination Period|Protocol Violation|0
182217|NCT00090285|566399|P2|Base Study Vaccination Period|Protocol Violation|3
182218|NCT00090285|566400|P1|Base Study Vaccination Period|Protocol Violation|2
182219|NCT00090285|566397|P4|Base Study Vaccination Period|Lost to Follow-up|0
182220|NCT00090285|566398|P3|Base Study Vaccination Period|Lost to Follow-up|0
182221|NCT00090285|566399|P2|Base Study Vaccination Period|Lost to Follow-up|112
182222|NCT00090285|566400|P1|Base Study Vaccination Period|Lost to Follow-up|111
182223|NCT00090285|566397|P4|Base Study Vaccination Period|Adverse Event|0
182224|NCT00090285|566398|P3|Base Study Vaccination Period|Adverse Event|0
182225|NCT00090285|566399|P2|Base Study Vaccination Period|Adverse Event|4
182226|NCT00090285|566400|P1|Base Study Vaccination Period|Adverse Event|2
182227|NCT00090285|566397|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
182228|NCT00090285|566398|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
182229|NCT00090285|566399|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
182230|NCT00090285|566400|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
182231|NCT00090259|566419|P2|Overall Study|Investigator site closed|7
182232|NCT00090259|566420|P1|Overall Study|Investigator site closed|11
182233|NCT00090259|566419|P2|Overall Study|Withdrawal by Subject|15
182234|NCT00090259|566420|P1|Overall Study|Withdrawal by Subject|21
182235|NCT00090259|566419|P2|Overall Study|Lost to Follow-up|26
182236|NCT00090259|566420|P1|Overall Study|Lost to Follow-up|30
182237|NCT00090233|566436|P2|Overall Study|Data not available at data cut-off point|1563
182238|NCT00090233|566437|P1|Overall Study|Data not available at data cut-off point|1552
182239|NCT00090233|566436|P2|Overall Study|Not Specified|1160
182240|NCT00090233|566437|P1|Overall Study|Not Specified|1211
182241|NCT00090233|566436|P2|Overall Study|Moved|189
182242|NCT00090233|566437|P1|Overall Study|Moved|203
182243|NCT00090233|566436|P2|Overall Study|Withdrawal by Subject|211
182244|NCT00090233|566437|P1|Overall Study|Withdrawal by Subject|182
182245|NCT00090233|566436|P2|Overall Study|Protocol Violation|1022
182246|NCT00090233|566437|P1|Overall Study|Protocol Violation|960
182247|NCT00090233|566436|P2|Overall Study|Lost to Follow-up|95
182248|NCT00090233|566437|P1|Overall Study|Lost to Follow-up|68
182249|NCT00090233|566436|P2|Overall Study|Adverse Event|198
182250|NCT00090233|566437|P1|Overall Study|Adverse Event|214
182251|NCT00090233|566436|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
182252|NCT00090233|566437|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
182253|NCT00090220|566461|P6|Long-term Follow-up (EXT2)|Other|0
182254|NCT00090220|566462|P5|Long-term Follow-up (EXT2)|Other|1
182255|NCT00090220|566463|P4|Long-term Follow-up (EXT2)|Other|0
182256|NCT00090220|566464|P3|Long-term Follow-up (EXT2)|Other|0
182257|NCT00090220|566465|P2|Long-term Follow-up (EXT2)|Other|0
182258|NCT00090220|566466|P1|Long-term Follow-up (EXT2)|Other|0
182259|NCT00090220|566461|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
182260|NCT00090220|566462|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
182261|NCT00090220|566463|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
182262|NCT00090220|566464|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
182263|NCT00090220|566465|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
182264|NCT00090220|566466|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
182265|NCT00090220|566461|P6|Long-term Follow-up (EXT2)|Death|1
182266|NCT00090220|566462|P5|Long-term Follow-up (EXT2)|Death|1
182267|NCT00090220|566463|P4|Long-term Follow-up (EXT2)|Death|0
182268|NCT00090220|566464|P3|Long-term Follow-up (EXT2)|Death|0
182269|NCT00090220|566465|P2|Long-term Follow-up (EXT2)|Death|0
182270|NCT00090220|566466|P1|Long-term Follow-up (EXT2)|Death|0
182271|NCT00090220|566461|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
182272|NCT00090220|566462|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
182273|NCT00090220|566463|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
182274|NCT00090220|566464|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
182275|NCT00090220|566465|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
182276|NCT00090220|566466|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
182277|NCT00090220|566461|P6|Extension 1 (EXT1)|Other reason|0
182278|NCT00090220|566462|P5|Extension 1 (EXT1)|Other reason|0
182279|NCT00090220|566463|P4|Extension 1 (EXT1)|Other reason|0
182280|NCT00090220|566464|P3|Extension 1 (EXT1)|Other reason|2
182281|NCT00090220|566465|P2|Extension 1 (EXT1)|Other reason|0
182282|NCT00090220|566466|P1|Extension 1 (EXT1)|Other reason|0
182283|NCT00090220|566461|P6|Extension 1 (EXT1)|Protocol Violation|0
182284|NCT00090220|566462|P5|Extension 1 (EXT1)|Protocol Violation|0
182285|NCT00090220|566463|P4|Extension 1 (EXT1)|Protocol Violation|1
182286|NCT00090220|566464|P3|Extension 1 (EXT1)|Protocol Violation|0
182287|NCT00090220|566465|P2|Extension 1 (EXT1)|Protocol Violation|0
182288|NCT00090220|566466|P1|Extension 1 (EXT1)|Protocol Violation|0
182289|NCT00090220|566461|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
182290|NCT00090220|566462|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
182291|NCT00090220|566463|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
182292|NCT00090220|566464|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
182293|NCT00090220|566465|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
182294|NCT00090220|566466|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
182295|NCT00090220|566461|P6|Extension 1 (EXT1)|Moved|0
182296|NCT00090220|566462|P5|Extension 1 (EXT1)|Moved|0
182297|NCT00090220|566463|P4|Extension 1 (EXT1)|Moved|1
182298|NCT00090220|566464|P3|Extension 1 (EXT1)|Moved|2
182299|NCT00090220|566465|P2|Extension 1 (EXT1)|Moved|0
182300|NCT00090220|566466|P1|Extension 1 (EXT1)|Moved|0
182301|NCT00090220|566461|P6|Extension 1 (EXT1)|Lost to Follow-up|0
182302|NCT00090220|566462|P5|Extension 1 (EXT1)|Lost to Follow-up|0
182303|NCT00090220|566463|P4|Extension 1 (EXT1)|Lost to Follow-up|0
182304|NCT00090220|566464|P3|Extension 1 (EXT1)|Lost to Follow-up|22
182305|NCT00090220|566465|P2|Extension 1 (EXT1)|Lost to Follow-up|0
182306|NCT00090220|566466|P1|Extension 1 (EXT1)|Lost to Follow-up|0
182307|NCT00090220|566461|P6|Extension 1 (EXT1)|Adverse Event|0
182308|NCT00090220|566462|P5|Extension 1 (EXT1)|Adverse Event|0
182309|NCT00090220|566463|P4|Extension 1 (EXT1)|Adverse Event|0
182310|NCT00090220|566464|P3|Extension 1 (EXT1)|Adverse Event|4
182311|NCT00090220|566465|P2|Extension 1 (EXT1)|Adverse Event|0
182312|NCT00090220|566466|P1|Extension 1 (EXT1)|Adverse Event|0
182313|NCT00090220|566461|P6|Base Study Follow-up Period|Unspecified|0
182314|NCT00090220|566462|P5|Base Study Follow-up Period|Unspecified|0
182315|NCT00090220|566463|P4|Base Study Follow-up Period|Unspecified|0
182316|NCT00090220|566464|P3|Base Study Follow-up Period|Unspecified|0
182317|NCT00090220|566465|P2|Base Study Follow-up Period|Unspecified|21
182318|NCT00090220|566466|P1|Base Study Follow-up Period|Unspecified|19
182319|NCT00090220|566461|P6|Base Study Follow-up Period|Patient Moved|0
182320|NCT00090220|566462|P5|Base Study Follow-up Period|Patient Moved|0
182321|NCT00090220|566463|P4|Base Study Follow-up Period|Patient Moved|0
182322|NCT00090220|566464|P3|Base Study Follow-up Period|Patient Moved|0
182323|NCT00090220|566465|P2|Base Study Follow-up Period|Patient Moved|28
182324|NCT00090220|566466|P1|Base Study Follow-up Period|Patient Moved|20
182325|NCT00090220|566461|P6|Base Study Follow-up Period|Withdrawal by Subject|0
182326|NCT00090220|566462|P5|Base Study Follow-up Period|Withdrawal by Subject|0
182327|NCT00090220|566463|P4|Base Study Follow-up Period|Withdrawal by Subject|0
182328|NCT00090220|566464|P3|Base Study Follow-up Period|Withdrawal by Subject|0
182329|NCT00090220|566465|P2|Base Study Follow-up Period|Withdrawal by Subject|36
182330|NCT00090220|566466|P1|Base Study Follow-up Period|Withdrawal by Subject|27
182331|NCT00090220|566461|P6|Base Study Follow-up Period|Lost to Follow-up|0
182332|NCT00090220|566462|P5|Base Study Follow-up Period|Lost to Follow-up|0
182333|NCT00090220|566463|P4|Base Study Follow-up Period|Lost to Follow-up|0
182334|NCT00090220|566464|P3|Base Study Follow-up Period|Lost to Follow-up|0
182335|NCT00090220|566465|P2|Base Study Follow-up Period|Lost to Follow-up|78
182336|NCT00090220|566466|P1|Base Study Follow-up Period|Lost to Follow-up|88
182337|NCT00090220|566461|P6|Base Study Follow-up Period|Adverse Event|0
182338|NCT00090220|566462|P5|Base Study Follow-up Period|Adverse Event|0
182339|NCT00090220|566463|P4|Base Study Follow-up Period|Adverse Event|0
182340|NCT00090220|566464|P3|Base Study Follow-up Period|Adverse Event|0
182341|NCT00090220|566465|P2|Base Study Follow-up Period|Adverse Event|1
182342|NCT00090220|566466|P1|Base Study Follow-up Period|Adverse Event|6
182343|NCT00090220|566461|P6|Base Study Vaccination Period|Unspecified|0
182344|NCT00090220|566462|P5|Base Study Vaccination Period|Unspecified|0
182345|NCT00090220|566463|P4|Base Study Vaccination Period|Unspecified|0
182346|NCT00090220|566464|P3|Base Study Vaccination Period|Unspecified|0
182347|NCT00090220|566465|P2|Base Study Vaccination Period|Unspecified|4
182348|NCT00090220|566466|P1|Base Study Vaccination Period|Unspecified|4
182349|NCT00090220|566461|P6|Base Study Vaccination Period|Patient Moved|0
182350|NCT00090220|566462|P5|Base Study Vaccination Period|Patient Moved|0
182351|NCT00090220|566463|P4|Base Study Vaccination Period|Patient Moved|0
182352|NCT00090220|566464|P3|Base Study Vaccination Period|Patient Moved|0
182353|NCT00090220|566465|P2|Base Study Vaccination Period|Patient Moved|2
182354|NCT00090220|566466|P1|Base Study Vaccination Period|Patient Moved|6
182355|NCT00090220|566461|P6|Base Study Vaccination Period|Withdrawal by Subject|0
182356|NCT00090220|566462|P5|Base Study Vaccination Period|Withdrawal by Subject|0
182357|NCT00090220|566463|P4|Base Study Vaccination Period|Withdrawal by Subject|0
182358|NCT00090220|566464|P3|Base Study Vaccination Period|Withdrawal by Subject|0
182359|NCT00090220|566465|P2|Base Study Vaccination Period|Withdrawal by Subject|27
182360|NCT00090220|566466|P1|Base Study Vaccination Period|Withdrawal by Subject|23
182361|NCT00090220|566461|P6|Base Study Vaccination Period|Lost to Follow-up|0
182362|NCT00090220|566462|P5|Base Study Vaccination Period|Lost to Follow-up|0
182363|NCT00090220|566463|P4|Base Study Vaccination Period|Lost to Follow-up|0
182364|NCT00090220|566464|P3|Base Study Vaccination Period|Lost to Follow-up|0
182365|NCT00090220|566465|P2|Base Study Vaccination Period|Lost to Follow-up|28
182366|NCT00090220|566466|P1|Base Study Vaccination Period|Lost to Follow-up|24
182367|NCT00090220|566461|P6|Base Study Vaccination Period|Adverse Event|0
182368|NCT00090220|566462|P5|Base Study Vaccination Period|Adverse Event|0
182369|NCT00090220|566463|P4|Base Study Vaccination Period|Adverse Event|0
182370|NCT00090220|566464|P3|Base Study Vaccination Period|Adverse Event|0
182371|NCT00090220|566465|P2|Base Study Vaccination Period|Adverse Event|1
182372|NCT00090220|566466|P1|Base Study Vaccination Period|Adverse Event|6
182373|NCT00090220|566461|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
182374|NCT00090220|566462|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
182375|NCT00090220|566463|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
182376|NCT00090220|566464|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
182377|NCT00090220|566465|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
182378|NCT00090220|566466|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
182379|NCT00090142|566558|P2|Treatment Period II|Not Specified|0
182380|NCT00090142|566559|P1|Treatment Period II|Not Specified|1
182381|NCT00090142|566558|P2|Treatment Period I|Not Specified|1
182382|NCT00090142|566559|P1|Treatment Period I|Not Specified|0
182383|NCT00090142|566558|P2|Treatment Period I|Withdrawal by Subject|0
182384|NCT00090142|566559|P1|Treatment Period I|Withdrawal by Subject|2
182385|NCT00090142|566558|P2|Treatment Period I|Protocol Violation|0
182386|NCT00090142|566559|P1|Treatment Period I|Protocol Violation|2
182387|NCT00090142|566558|P2|Treatment Period I|Lost to Follow-up|2
182388|NCT00090142|566559|P1|Treatment Period I|Lost to Follow-up|1
182389|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Other|0
182390|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Other|1
182391|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Other|0
182392|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Jailed|0
182393|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Jailed|1
182394|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Jailed|0
182395|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
182396|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
182397|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
182398|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Depression|0
182399|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Depression|1
182400|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Depression|0
182401|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
182402|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
182403|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
182404|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
182405|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
182406|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
182407|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Back Pain|0
182408|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Back Pain|1
182409|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Back Pain|0
182410|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
182411|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
182412|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
182413|NCT00090103|566590|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
182414|NCT00090103|566591|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
182415|NCT00090103|566592|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
182416|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
182417|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
182418|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
182419|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Gyneomastia|0
182420|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Gyneomastia|0
182421|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Gyneomastia|1
182422|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Death|1
182423|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Death|0
182424|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Death|1
182425|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
182426|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
182427|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
182428|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Enrollment Error|2
182429|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Enrollment Error|0
182430|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Enrollment Error|1
182431|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Loss of Libido|0
182432|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Loss of Libido|0
182433|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Loss of Libido|1
182434|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
182435|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
182436|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
182437|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
182438|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
182439|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
182440|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
182441|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
182442|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
182443|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
182444|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
182445|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
182446|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Participant relocated|1
182447|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Participant relocated|3
182448|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Participant relocated|2
182449|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
182450|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
182451|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
182452|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Loss of Contact|2
182453|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Loss of Contact|0
182454|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Loss of Contact|4
182455|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
182456|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
182457|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
182458|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
182459|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
182460|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
182461|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Protocol Violation|17
182462|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Protocol Violation|18
182463|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Protocol Violation|18
182464|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
182465|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
182466|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
182467|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
182468|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
182469|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
182470|NCT00090103|566590|P3|16-Week Safety Follow-up Period|Adverse Event|44
182471|NCT00090103|566591|P2|16-Week Safety Follow-up Period|Adverse Event|39
182472|NCT00090103|566592|P1|16-Week Safety Follow-up Period|Adverse Event|34
182473|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
182474|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
182475|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
182476|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
182477|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
182478|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
182479|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
182480|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
182481|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
182482|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
182483|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
182484|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
182485|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
182486|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
182487|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
182488|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
182489|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
182490|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
182491|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
182492|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
182493|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
182494|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
182495|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
182496|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
182497|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
182498|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
182499|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
182500|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
182501|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
182502|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
182503|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
182504|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
182505|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
182506|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
182507|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
182508|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
182509|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
182510|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
182511|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
182512|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
182513|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
182514|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
182515|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
182516|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
182517|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
182518|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
182519|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
182520|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
182521|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
182522|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
182523|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
182524|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
182525|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
182526|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
182527|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
182528|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
182529|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
182530|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
182531|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
182532|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
182533|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
182534|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
182535|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
182536|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
182537|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
182538|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
182539|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
182540|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
182541|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
182542|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
182543|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
182544|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
182545|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
182546|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
182547|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
182548|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
182549|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
182550|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
182551|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
182552|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
182553|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
182554|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
182555|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
182556|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
182557|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
182558|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
182559|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
182560|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
182561|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
182562|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
182563|NCT00090103|566590|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
182564|NCT00090103|566591|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
182565|NCT00090103|566592|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
182566|NCT00089999|566729|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
182567|NCT00089999|566730|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
182568|NCT00089999|566729|P2|Overall Study|Patient Underwent Surgery|0
182569|NCT00089999|566730|P1|Overall Study|Patient Underwent Surgery|2
182570|NCT00089999|566729|P2|Overall Study|Physician Decision|2
182571|NCT00089999|566730|P1|Overall Study|Physician Decision|2
182572|NCT00089999|566729|P2|Overall Study|Clinical Progression|2
182573|NCT00089999|566730|P1|Overall Study|Clinical Progression|1
182574|NCT00089999|566729|P2|Overall Study|Poor General Condition|0
182575|NCT00089999|566730|P1|Overall Study|Poor General Condition|1
182576|NCT00089999|566729|P2|Overall Study|Death|3
182577|NCT00089999|566730|P1|Overall Study|Death|3
182578|NCT00089999|566729|P2|Overall Study|Symptomatic Progression of Cancer|5
182579|NCT00089999|566730|P1|Overall Study|Symptomatic Progression of Cancer|2
182580|NCT00089999|566729|P2|Overall Study|Radiological Progression of Cancer|44
182581|NCT00089999|566730|P1|Overall Study|Radiological Progression of Cancer|52
182582|NCT00089999|566729|P2|Overall Study|Lost to Follow-up|1
182583|NCT00089999|566730|P1|Overall Study|Lost to Follow-up|2
182584|NCT00089999|566729|P2|Overall Study|Withdrawal by Subject|4
182585|NCT00089999|566730|P1|Overall Study|Withdrawal by Subject|0
182586|NCT00089999|566729|P2|Overall Study|Adverse Event|7
182587|NCT00089999|566730|P1|Overall Study|Adverse Event|4
182588|NCT00089895|566752|P2|Overall Study|Missing|2
182589|NCT00089895|566753|P1|Overall Study|Missing|4
182590|NCT00089895|566752|P2|Overall Study|Not otherwise specified|8
182591|NCT00089895|566753|P1|Overall Study|Not otherwise specified|4
182592|NCT00089895|566752|P2|Overall Study|Exclusion criteria met|6
182593|NCT00089895|566753|P1|Overall Study|Exclusion criteria met|6
182594|NCT00089895|566752|P2|Overall Study|Physician Decision|7
182595|NCT00089895|566753|P1|Overall Study|Physician Decision|3
182596|NCT00089895|566752|P2|Overall Study|Bleeding|2
182597|NCT00089895|566753|P1|Overall Study|Bleeding|0
182598|NCT00089895|566752|P2|Overall Study|Surgery|1
182599|NCT00089895|566753|P1|Overall Study|Surgery|0
182600|NCT00089895|566752|P2|Overall Study|Technical reason|2
182601|NCT00089895|566753|P1|Overall Study|Technical reason|7
182602|NCT00089895|566752|P2|Overall Study|Consent Withdrawn|14
182603|NCT00089895|566753|P1|Overall Study|Consent Withdrawn|11
182604|NCT00089843|566765|P4|Overall Study|Physician Decision|1
182605|NCT00089843|566766|P3|Overall Study|Physician Decision|0
182606|NCT00089843|566767|P2|Overall Study|Physician Decision|0
182607|NCT00089843|566768|P1|Overall Study|Physician Decision|1
182608|NCT00089843|566765|P4|Overall Study|Withdrawal by Subject|6
182609|NCT00089843|566766|P3|Overall Study|Withdrawal by Subject|5
182610|NCT00089843|566767|P2|Overall Study|Withdrawal by Subject|4
182611|NCT00089843|566768|P1|Overall Study|Withdrawal by Subject|1
182612|NCT00089791|566780|P2|Overall Study|Requirement for alternative therapy|4
182613|NCT00089791|566781|P1|Overall Study|Requirement for alternative therapy|7
182614|NCT00089791|566780|P2|Overall Study|Protocol deviation|10
182615|NCT00089791|566781|P1|Overall Study|Protocol deviation|12
182616|NCT00089791|566780|P2|Overall Study|Other|32
182617|NCT00089791|566781|P1|Overall Study|Other|20
182618|NCT00089791|566780|P2|Overall Study|Noncompliance|13
182619|NCT00089791|566781|P1|Overall Study|Noncompliance|17
182620|NCT00089791|566780|P2|Overall Study|Lost to Follow-up|57
182621|NCT00089791|566781|P1|Overall Study|Lost to Follow-up|57
182622|NCT00089791|566780|P2|Overall Study|Ineligibility determined|9
182623|NCT00089791|566781|P1|Overall Study|Ineligibility determined|12
182624|NCT00089791|566780|P2|Overall Study|Disease progression|3
182625|NCT00089791|566781|P1|Overall Study|Disease progression|7
182626|NCT00089791|566780|P2|Overall Study|Death|62
182627|NCT00089791|566781|P1|Overall Study|Death|78
182628|NCT00089791|566780|P2|Overall Study|Withdrawal by Subject|344
182629|NCT00089791|566781|P1|Overall Study|Withdrawal by Subject|403
182630|NCT00089791|566780|P2|Overall Study|Adverse Event|93
182631|NCT00089791|566781|P1|Overall Study|Adverse Event|81
182632|NCT00089791|566780|P2|Overall Study|Physician Decision|3
182633|NCT00089791|566781|P1|Overall Study|Physician Decision|6
182634|NCT00089778|566794|P3|Overall Study|Protocol Violation|1
182635|NCT00089778|566795|P2|Overall Study|Protocol Violation|0
182636|NCT00089778|566796|P1|Overall Study|Protocol Violation|0
182637|NCT00089674|566809|P2|Overall Study|Requirement for alternative therapy|4
182638|NCT00089674|566810|P1|Overall Study|Requirement for alternative therapy|14
182639|NCT00089674|566809|P2|Overall Study|Other|9
182640|NCT00089674|566810|P1|Overall Study|Other|5
182641|NCT00089674|566809|P2|Overall Study|Noncompliance|3
182642|NCT00089674|566810|P1|Overall Study|Noncompliance|7
182643|NCT00089674|566809|P2|Overall Study|Lost to Follow-up|17
182644|NCT00089674|566810|P1|Overall Study|Lost to Follow-up|21
182645|NCT00089674|566809|P2|Overall Study|Ineligibility determined|10
182646|NCT00089674|566810|P1|Overall Study|Ineligibility determined|8
182647|NCT00089674|566809|P2|Overall Study|Disease progression|23
182648|NCT00089674|566810|P1|Overall Study|Disease progression|21
182649|NCT00089674|566809|P2|Overall Study|Death|43
182650|NCT00089674|566810|P1|Overall Study|Death|43
182651|NCT00089674|566809|P2|Overall Study|Withdrawal by Subject|127
182652|NCT00089674|566810|P1|Overall Study|Withdrawal by Subject|143
182653|NCT00089674|566809|P2|Overall Study|Adverse Event|29
182654|NCT00089674|566810|P1|Overall Study|Adverse Event|23
182655|NCT00089674|566809|P2|Overall Study|Physician Decision|2
182656|NCT00089674|566810|P1|Overall Study|Physician Decision|4
182657|NCT00089661|566836|P2|Overall Study|Other|1
182658|NCT00089661|566837|P1|Overall Study|Other|2
182659|NCT00089661|566836|P2|Overall Study|Noncompliance|4
182660|NCT00089661|566837|P1|Overall Study|Noncompliance|2
182661|NCT00089661|566836|P2|Overall Study|Ineligibility determined|4
182662|NCT00089661|566837|P1|Overall Study|Ineligibility determined|4
182663|NCT00089661|566836|P2|Overall Study|Disease progression|3
182664|NCT00089661|566837|P1|Overall Study|Disease progression|1
182665|NCT00089661|566836|P2|Overall Study|Withdrawal by Subject|9
182666|NCT00089661|566837|P1|Overall Study|Withdrawal by Subject|11
182667|NCT00089661|566836|P2|Overall Study|Lost to Follow-up|3
182668|NCT00089661|566837|P1|Overall Study|Lost to Follow-up|0
182669|NCT00089661|566836|P2|Overall Study|Death|0
182670|NCT00089661|566837|P1|Overall Study|Death|1
182671|NCT00089661|566836|P2|Overall Study|Adverse Event|2
182672|NCT00089661|566837|P1|Overall Study|Adverse Event|0
182673|NCT00089648|566853|P1|Overall Study|Lack of Efficacy|33
182674|NCT00089648|566853|P1|Overall Study|Withdrawal by Subject|1
182675|NCT00089648|566853|P1|Overall Study|Adverse Event|7
182676|NCT00089635|566869|P1|Overall Study|Not specified|2
182677|NCT00089635|566869|P1|Overall Study|Ineligibility determined|1
182678|NCT00089635|566869|P1|Overall Study|Withdrawal by Subject|6
182679|NCT00089635|566869|P1|Overall Study|Lost to Follow-up|3
182680|NCT00089635|566869|P1|Overall Study|Disease Progression|12
182681|NCT00089635|566869|P1|Overall Study|Death|17
182682|NCT00089635|566869|P1|Overall Study|Adverse Event|2
182683|NCT00089609|566883|P2|Overall Study|Withdrawal by Subject|1
182684|NCT00089609|566884|P1|Overall Study|Withdrawal by Subject|3
182685|NCT00089583|566903|P2|Overall Study|Participant Incarcerated|1
182686|NCT00089583|566904|P1|Overall Study|Participant Incarcerated|0
182687|NCT00089583|566903|P2|Overall Study|Necessity to Use Prohibited Drug|0
182688|NCT00089583|566904|P1|Overall Study|Necessity to Use Prohibited Drug|1
182689|NCT00089583|566903|P2|Overall Study|Start of Disallowed Medication|1
182690|NCT00089583|566904|P1|Overall Study|Start of Disallowed Medication|0
182691|NCT00089583|566903|P2|Overall Study|Principal Investigator Decision|10
182692|NCT00089583|566904|P1|Overall Study|Principal Investigator Decision|0
182693|NCT00089583|566903|P2|Overall Study|Protocol Violation|3
182694|NCT00089583|566904|P1|Overall Study|Protocol Violation|0
182695|NCT00089583|566903|P2|Overall Study|Reason Not Provided|1
182696|NCT00089583|566904|P1|Overall Study|Reason Not Provided|0
182697|NCT00089583|566903|P2|Overall Study|Participant Management Criteria Met|1
182698|NCT00089583|566904|P1|Overall Study|Participant Management Criteria Met|0
182699|NCT00089583|566903|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
182700|NCT00089583|566904|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
182701|NCT00089583|566903|P2|Overall Study|Non-Compliance|4
182702|NCT00089583|566904|P1|Overall Study|Non-Compliance|0
182703|NCT00089583|566903|P2|Overall Study|Participant Refused Study Medication|2
182704|NCT00089583|566904|P1|Overall Study|Participant Refused Study Medication|0
182705|NCT00089583|566903|P2|Overall Study|Participant (Par) Didn't Take Medication|0
182706|NCT00089583|566904|P1|Overall Study|Participant (Par) Didn't Take Medication|1
182707|NCT00089583|566903|P2|Overall Study|Withdrawal by Subject|4
182708|NCT00089583|566904|P1|Overall Study|Withdrawal by Subject|0
182709|NCT00089583|566903|P2|Overall Study|Insufficient Viral Load Response|5
182710|NCT00089583|566904|P1|Overall Study|Insufficient Viral Load Response|5
182711|NCT00089583|566903|P2|Overall Study|Adverse Event|3
182712|NCT00089583|566904|P1|Overall Study|Adverse Event|0
182713|NCT00089544|566998|P2|Overall Study|Ineligible|0
182714|NCT00089544|566999|P1|Overall Study|Ineligible|1
182715|NCT00089505|567013|P4|Overall Study|Protocol Violation|0
182716|NCT00089505|567014|P3|Overall Study|Protocol Violation|1
182717|NCT00089505|567015|P2|Overall Study|Protocol Violation|0
182718|NCT00089505|567016|P1|Overall Study|Protocol Violation|0
182719|NCT00089505|567013|P4|Overall Study|Physician Decision|0
182720|NCT00089505|567014|P3|Overall Study|Physician Decision|0
182721|NCT00089505|567015|P2|Overall Study|Physician Decision|0
182722|NCT00089505|567016|P1|Overall Study|Physician Decision|1
182723|NCT00089505|567013|P4|Overall Study|Lost to Follow-up|7
182724|NCT00089505|567014|P3|Overall Study|Lost to Follow-up|9
182725|NCT00089505|567015|P2|Overall Study|Lost to Follow-up|1
182726|NCT00089505|567016|P1|Overall Study|Lost to Follow-up|1
182727|NCT00089505|567013|P4|Overall Study|Withdrawal by Subject|6
182728|NCT00089505|567014|P3|Overall Study|Withdrawal by Subject|6
182729|NCT00089505|567015|P2|Overall Study|Withdrawal by Subject|0
182730|NCT00089505|567016|P1|Overall Study|Withdrawal by Subject|3
182731|NCT00089505|567013|P4|Overall Study|Death|8
182732|NCT00089505|567014|P3|Overall Study|Death|5
182733|NCT00089505|567015|P2|Overall Study|Death|1
182734|NCT00089505|567016|P1|Overall Study|Death|4
182735|NCT00089479|567060|P2|Overall Study|Lost to Follow-up|107
182736|NCT00089479|567061|P1|Overall Study|Lost to Follow-up|137
182737|NCT00089479|567060|P2|Overall Study|Withdrawal by Subject|107
182738|NCT00089479|567061|P1|Overall Study|Withdrawal by Subject|86
182739|NCT00089479|567060|P2|Overall Study|Death|75
182740|NCT00089479|567061|P1|Overall Study|Death|108
182741|NCT00089297|567104|P1|Overall Study|Non-compliance|1
182742|NCT00089297|567104|P1|Overall Study|IRB approval not ready|1
182743|NCT00089297|567104|P1|Overall Study|Secondary malignancy|1
182744|NCT00089297|567104|P1|Overall Study|Ineligible|11
182745|NCT00089297|567104|P1|Overall Study|Disease progression|2
182746|NCT00089297|567104|P1|Overall Study|Withdrawal by Subject|12
182747|NCT00089297|567104|P1|Overall Study|Death|1
182748|NCT00089297|567104|P1|Overall Study|Adverse Event|9
182749|NCT00089141|567113|P2|Overall Study|Termination of trial|24
182750|NCT00089141|567114|P1|Overall Study|Termination of trial|18
182751|NCT00089076|567136|P1|Overall Study|Progression|7
182752|NCT00089076|567136|P1|Overall Study|Withdrawal by Subject|2
182753|NCT00089076|567136|P1|Overall Study|Alternate Therapy|1
182754|NCT00088907|567158|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
182755|NCT00088907|567159|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
182756|NCT00088907|567158|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
182757|NCT00088907|567159|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
182758|NCT00088907|567158|P2|Single Gefitinib Treatment (Step 2)|Death|0
182759|NCT00088907|567159|P1|Single Gefitinib Treatment (Step 2)|Death|1
182760|NCT00088907|567158|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
182761|NCT00088907|567159|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
182762|NCT00088907|567158|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
182763|NCT00088907|567159|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
182764|NCT00088907|567158|P2|Randomized Study (Step 1)|unknown/not specify|13
182765|NCT00088907|567159|P1|Randomized Study (Step 1)|unknown/not specify|24
182766|NCT00088907|567158|P2|Randomized Study (Step 1)|complicating disease|1
182767|NCT00088907|567159|P1|Randomized Study (Step 1)|complicating disease|3
182768|NCT00088907|567158|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
182769|NCT00088907|567159|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
182770|NCT00088907|567158|P2|Randomized Study (Step 1)|Death|12
182771|NCT00088907|567159|P1|Randomized Study (Step 1)|Death|11
182772|NCT00088907|567158|P2|Randomized Study (Step 1)|Adverse Event|19
182773|NCT00088907|567159|P1|Randomized Study (Step 1)|Adverse Event|14
182774|NCT00088907|567158|P2|Randomized Study (Step 1)|Lack of Efficacy|62
182775|NCT00088907|567159|P1|Randomized Study (Step 1)|Lack of Efficacy|55
182776|NCT00088881|567170|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
182777|NCT00088881|567170|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
182778|NCT00088881|567170|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
182779|NCT00088881|567170|P1|Step 1 - R-CHOP|Physician Decision|1
182780|NCT00088881|567170|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
182781|NCT00088881|567170|P1|Step 1 - R-CHOP|Adverse Event|1
182782|NCT00088881|567170|P1|Step 1 - R-CHOP|Patient ineligible|9
182783|NCT00088595|567198|P1|Overall Study|New Cancer Therapy|2
182784|NCT00088595|567198|P1|Overall Study|Ongoing (After Core)|7
182785|NCT00088595|567198|P1|Overall Study|Withdrawal by Subject|8
182786|NCT00088595|567198|P1|Overall Study|Adverse Event|11
182787|NCT00088465|567214|P1|Overall Study|Death|11
182788|NCT00088465|567214|P1|Overall Study|Protocol Violation|17
182789|NCT00088465|567214|P1|Overall Study|Lack of Efficacy|27
182790|NCT00088465|567214|P1|Overall Study|Sponsor Decision|37
182791|NCT00088465|567214|P1|Overall Study|Physician Decision|45
182792|NCT00088465|567214|P1|Overall Study|Lost to Follow-up|57
182793|NCT00088465|567214|P1|Overall Study|Adverse Event|77
182794|NCT00088465|567214|P1|Overall Study|Withdrawal by Subject|290
182795|NCT00088374|567237|P1|Overall Study|patient received <1 cycle only of 17AAG|1
182796|NCT00088374|567237|P1|Overall Study|patient did not receive any 17AAG|1
182797|NCT00088166|567257|P2|Overall Study|Withdrawal by Subject|5
182798|NCT00088166|567258|P1|Overall Study|Withdrawal by Subject|5
182799|NCT00088166|567257|P2|Overall Study|Patient deterioration|39
182800|NCT00088166|567258|P1|Overall Study|Patient deterioration|29
182801|NCT00088166|567257|P2|Overall Study|Protocol Violation|5
182802|NCT00088166|567258|P1|Overall Study|Protocol Violation|1
182803|NCT00088166|567257|P2|Overall Study|Physician Decision|1
182804|NCT00088166|567258|P1|Overall Study|Physician Decision|4
182805|NCT00088166|567257|P2|Overall Study|Lost to Follow-up|1
182806|NCT00088166|567258|P1|Overall Study|Lost to Follow-up|0
182807|NCT00088166|567257|P2|Overall Study|Death|1
182808|NCT00088166|567258|P1|Overall Study|Death|3
182809|NCT00088166|567257|P2|Overall Study|Adverse Event|9
182810|NCT00088166|567258|P1|Overall Study|Adverse Event|11
182811|NCT00088153|567282|P2|Overall Study|Lost to Follow-up|12
182812|NCT00088153|567283|P1|Overall Study|Lost to Follow-up|11
182813|NCT00088153|567282|P2|Overall Study|Withdrawal by Subject|10
182814|NCT00088153|567283|P1|Overall Study|Withdrawal by Subject|10
182815|NCT00088153|567282|P2|Overall Study|Physician Decision|3
182816|NCT00088153|567283|P1|Overall Study|Physician Decision|3
182817|NCT00087698|567293|P1|Overall Study|Protocol Violation|1
182818|NCT00087698|567293|P1|Overall Study|Death from Study Drug Toxicity|2
182819|NCT00087698|567293|P1|Overall Study|Death from Study Disease|2
182820|NCT00087698|567293|P1|Overall Study|Clinical Relapse|1
182821|NCT00087698|567293|P1|Overall Study|Protocol Entry Criteria Not Met|2
182822|NCT00087698|567293|P1|Overall Study|Lack of Efficacy, Physician Perception|3
182823|NCT00087698|567293|P1|Overall Study|Withdrawal by Subject|4
182824|NCT00087698|567293|P1|Overall Study|Adverse Event|4
182825|NCT00087698|567293|P1|Overall Study|Death from Other Causes|3
182826|NCT00087698|567293|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
182827|NCT00087685|567302|P1|Overall Study|Withdrawal by Subject|3
182828|NCT00087685|567302|P1|Overall Study|Progressive Disease|5
182829|NCT00087685|567302|P1|Overall Study|Non-Compliance|1
182830|NCT00087685|567302|P1|Overall Study|Adverse Event|5
182831|NCT00087646|567315|P4|Overall Study|Violation of Selection Criteria at Entry|1
182832|NCT00087646|567316|P3|Overall Study|Violation of Selection Criteria at Entry|0
182833|NCT00087646|567317|P2|Overall Study|Violation of Selection Criteria at Entry|0
182834|NCT00087646|567318|P1|Overall Study|Violation of Selection Criteria at Entry|1
182835|NCT00087646|567315|P4|Overall Study|Other Protocol Violation|0
182836|NCT00087646|567316|P3|Overall Study|Other Protocol Violation|0
182837|NCT00087646|567317|P2|Overall Study|Other Protocol Violation|1
182838|NCT00087646|567318|P1|Overall Study|Other Protocol Violation|3
182839|NCT00087646|567315|P4|Overall Study|Administrative/Other|2
182840|NCT00087646|567316|P3|Overall Study|Administrative/Other|1
182841|NCT00087646|567317|P2|Overall Study|Administrative/Other|1
182842|NCT00087646|567318|P1|Overall Study|Administrative/Other|6
182843|NCT00087646|567315|P4|Overall Study|Failure to Return|3
182844|NCT00087646|567316|P3|Overall Study|Failure to Return|2
182845|NCT00087646|567317|P2|Overall Study|Failure to Return|2
182846|NCT00087646|567318|P1|Overall Study|Failure to Return|5
182847|NCT00087646|567315|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
182848|NCT00087646|567316|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
182849|NCT00087646|567317|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
182850|NCT00087646|567318|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
182851|NCT00087646|567315|P4|Overall Study|Insufficient therapeutic response|51
182852|NCT00087646|567316|P3|Overall Study|Insufficient therapeutic response|38
182853|NCT00087646|567317|P2|Overall Study|Insufficient therapeutic response|24
182854|NCT00087646|567318|P1|Overall Study|Insufficient therapeutic response|64
182855|NCT00087646|567315|P4|Overall Study|Withdrawal by Subject|2
182856|NCT00087646|567316|P3|Overall Study|Withdrawal by Subject|2
182857|NCT00087646|567317|P2|Overall Study|Withdrawal by Subject|1
182858|NCT00087646|567318|P1|Overall Study|Withdrawal by Subject|6
182859|NCT00087646|567315|P4|Overall Study|Death|0
182860|NCT00087646|567316|P3|Overall Study|Death|0
182861|NCT00087646|567317|P2|Overall Study|Death|1
182862|NCT00087646|567318|P1|Overall Study|Death|0
182863|NCT00087646|567315|P4|Overall Study|Adverse Event|20
182864|NCT00087646|567316|P3|Overall Study|Adverse Event|18
182865|NCT00087646|567317|P2|Overall Study|Adverse Event|6
182866|NCT00087646|567318|P1|Overall Study|Adverse Event|37
182867|NCT00087607|567357|P2|Overall Study|Violation of Selection Criteria at Entry|1
182868|NCT00087607|567358|P1|Overall Study|Violation of Selection Criteria at Entry|0
182869|NCT00087607|567357|P2|Overall Study|Other Protocol Violation|2
182870|NCT00087607|567358|P1|Overall Study|Other Protocol Violation|5
182871|NCT00087607|567357|P2|Overall Study|Refused Treatment|7
182872|NCT00087607|567358|P1|Overall Study|Refused Treatment|5
182873|NCT00087607|567357|P2|Overall Study|Administrative|12
182874|NCT00087607|567358|P1|Overall Study|Administrative|12
182875|NCT00087607|567357|P2|Overall Study|Withdrew Consent|16
182876|NCT00087607|567358|P1|Overall Study|Withdrew Consent|12
182877|NCT00087607|567357|P2|Overall Study|Failure to return|17
182878|NCT00087607|567358|P1|Overall Study|Failure to return|21
182879|NCT00087607|567357|P2|Overall Study|Insufficient Therapeutic Response|42
182880|NCT00087607|567358|P1|Overall Study|Insufficient Therapeutic Response|53
182881|NCT00087607|567357|P2|Overall Study|Death|1
182882|NCT00087607|567358|P1|Overall Study|Death|0
182883|NCT00087607|567357|P2|Overall Study|Adverse Event|24
182884|NCT00087607|567358|P1|Overall Study|Adverse Event|14
182885|NCT00087594|567398|P2|Overall Study|Lack of Efficacy|5
182886|NCT00087594|567399|P1|Overall Study|Lack of Efficacy|2
182887|NCT00087594|567398|P2|Overall Study|Withdrawal by Subject|2
182888|NCT00087594|567399|P1|Overall Study|Withdrawal by Subject|4
182889|NCT00087594|567398|P2|Overall Study|Lost to Follow-up|2
182890|NCT00087594|567399|P1|Overall Study|Lost to Follow-up|0
182891|NCT00087594|567398|P2|Overall Study|Adverse Event|3
182892|NCT00087594|567399|P1|Overall Study|Adverse Event|2
182893|NCT00087568|567433|P2|Overall Study|Lack of Efficacy|1
182894|NCT00087568|567434|P1|Overall Study|Lack of Efficacy|24
182895|NCT00087568|567433|P2|Overall Study|Lost to Follow-up|0
182896|NCT00087568|567434|P1|Overall Study|Lost to Follow-up|1
182897|NCT00087568|567433|P2|Overall Study|Withdrawal by Subject|1
182898|NCT00087568|567434|P1|Overall Study|Withdrawal by Subject|1
182899|NCT00087568|567433|P2|Overall Study|Adverse Event|0
182900|NCT00087568|567434|P1|Overall Study|Adverse Event|4
182901|NCT00087555|567461|P3|Overall Study|Patient wanted to go back on Med|0
182902|NCT00087555|567462|P2|Overall Study|Patient wanted to go back on Med|0
182903|NCT00087555|567463|P1|Overall Study|Patient wanted to go back on Med|1
182904|NCT00087555|567461|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
182905|NCT00087555|567462|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
182906|NCT00087555|567463|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
182907|NCT00087555|567461|P3|Overall Study|Non Compliance|1
182908|NCT00087555|567462|P2|Overall Study|Non Compliance|0
182909|NCT00087555|567463|P1|Overall Study|Non Compliance|0
182910|NCT00087555|567461|P3|Overall Study|Lack of Efficacy|1
182911|NCT00087555|567462|P2|Overall Study|Lack of Efficacy|0
182912|NCT00087555|567463|P1|Overall Study|Lack of Efficacy|2
182913|NCT00087555|567461|P3|Overall Study|Withdrawal by Subject|1
182914|NCT00087555|567462|P2|Overall Study|Withdrawal by Subject|2
182915|NCT00087555|567463|P1|Overall Study|Withdrawal by Subject|3
182916|NCT00087555|567461|P3|Overall Study|Pregnancy|1
182917|NCT00087555|567462|P2|Overall Study|Pregnancy|1
182918|NCT00087555|567463|P1|Overall Study|Pregnancy|0
182919|NCT00087555|567461|P3|Overall Study|Screen Failure|0
182920|NCT00087555|567462|P2|Overall Study|Screen Failure|1
182921|NCT00087555|567463|P1|Overall Study|Screen Failure|1
182922|NCT00087555|567461|P3|Overall Study|Protocol Violation|2
182923|NCT00087555|567462|P2|Overall Study|Protocol Violation|0
182924|NCT00087555|567463|P1|Overall Study|Protocol Violation|0
182925|NCT00087555|567461|P3|Overall Study|Non - Compliance|0
182926|NCT00087555|567462|P2|Overall Study|Non - Compliance|0
182927|NCT00087555|567463|P1|Overall Study|Non - Compliance|1
182928|NCT00087555|567461|P3|Overall Study|Lost to Follow-up|1
182929|NCT00087555|567462|P2|Overall Study|Lost to Follow-up|1
182930|NCT00087555|567463|P1|Overall Study|Lost to Follow-up|0
182931|NCT00087555|567461|P3|Overall Study|Adverse Event|14
182932|NCT00087555|567462|P2|Overall Study|Adverse Event|6
182933|NCT00087555|567463|P1|Overall Study|Adverse Event|3
182934|NCT00087529|567473|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
182935|NCT00087529|567474|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
182936|NCT00087529|567473|P2|Overall Study|Disease Progression|4
182937|NCT00087529|567474|P1|Overall Study|Disease Progression|5
182938|NCT00087529|567473|P2|Overall Study|Participant Noncompliance|1
182939|NCT00087529|567474|P1|Overall Study|Participant Noncompliance|0
182940|NCT00087529|567473|P2|Overall Study|Initiation of Excluded Therapy|1
182941|NCT00087529|567474|P1|Overall Study|Initiation of Excluded Therapy|0
182942|NCT00087529|567473|P2|Overall Study|Physician Decision|8
182943|NCT00087529|567474|P1|Overall Study|Physician Decision|4
182944|NCT00087529|567473|P2|Overall Study|Participant Decision|37
182945|NCT00087529|567474|P1|Overall Study|Participant Decision|14
182946|NCT00087529|567473|P2|Overall Study|Lost to Follow-up|3
182947|NCT00087529|567474|P1|Overall Study|Lost to Follow-up|2
182948|NCT00087529|567473|P2|Overall Study|Pregnancy|1
182949|NCT00087529|567474|P1|Overall Study|Pregnancy|0
182950|NCT00087529|567473|P2|Overall Study|Adverse Event|8
182951|NCT00087529|567474|P1|Overall Study|Adverse Event|0
182952|NCT00087529|567473|P2|Overall Study|Death|0
182953|NCT00087529|567474|P1|Overall Study|Death|1
182954|NCT00087516|567489|P4|Overall Study|Unspecified|0
182955|NCT00087516|567490|P3|Overall Study|Unspecified|1
182956|NCT00087516|567491|P2|Overall Study|Unspecified|0
182957|NCT00087516|567492|P1|Overall Study|Unspecified|0
182958|NCT00087516|567489|P4|Overall Study|Recommendation of Primary Care Physician|1
182959|NCT00087516|567490|P3|Overall Study|Recommendation of Primary Care Physician|0
182960|NCT00087516|567491|P2|Overall Study|Recommendation of Primary Care Physician|0
182961|NCT00087516|567492|P1|Overall Study|Recommendation of Primary Care Physician|0
182962|NCT00087516|567489|P4|Overall Study|Patient was non-compliant|0
182963|NCT00087516|567490|P3|Overall Study|Patient was non-compliant|0
182964|NCT00087516|567491|P2|Overall Study|Patient was non-compliant|1
182965|NCT00087516|567492|P1|Overall Study|Patient was non-compliant|3
182966|NCT00087516|567489|P4|Overall Study|Patient moved|0
182967|NCT00087516|567490|P3|Overall Study|Patient moved|1
182968|NCT00087516|567491|P2|Overall Study|Patient moved|2
182969|NCT00087516|567492|P1|Overall Study|Patient moved|3
182970|NCT00087516|567489|P4|Overall Study|Protocol specified discontinuation|26
182971|NCT00087516|567490|P3|Overall Study|Protocol specified discontinuation|33
182972|NCT00087516|567491|P2|Overall Study|Protocol specified discontinuation|33
182973|NCT00087516|567492|P1|Overall Study|Protocol specified discontinuation|35
182974|NCT00087516|567489|P4|Overall Study|Site terminated|0
182975|NCT00087516|567490|P3|Overall Study|Site terminated|1
182976|NCT00087516|567491|P2|Overall Study|Site terminated|2
182977|NCT00087516|567492|P1|Overall Study|Site terminated|0
182978|NCT00087516|567489|P4|Overall Study|Withdrawal by Subject|12
182979|NCT00087516|567490|P3|Overall Study|Withdrawal by Subject|11
182980|NCT00087516|567491|P2|Overall Study|Withdrawal by Subject|27
182981|NCT00087516|567492|P1|Overall Study|Withdrawal by Subject|16
182982|NCT00087516|567489|P4|Overall Study|Protocol Violation|6
182983|NCT00087516|567490|P3|Overall Study|Protocol Violation|3
182984|NCT00087516|567491|P2|Overall Study|Protocol Violation|8
182985|NCT00087516|567492|P1|Overall Study|Protocol Violation|4
182986|NCT00087516|567489|P4|Overall Study|Lost to Follow-up|5
182987|NCT00087516|567490|P3|Overall Study|Lost to Follow-up|5
182988|NCT00087516|567491|P2|Overall Study|Lost to Follow-up|6
182989|NCT00087516|567492|P1|Overall Study|Lost to Follow-up|8
182990|NCT00087516|567489|P4|Overall Study|Lack of Efficacy|29
182991|NCT00087516|567490|P3|Overall Study|Lack of Efficacy|39
182992|NCT00087516|567491|P2|Overall Study|Lack of Efficacy|80
182993|NCT00087516|567492|P1|Overall Study|Lack of Efficacy|82
182994|NCT00087516|567489|P4|Overall Study|Adverse Event|6
182995|NCT00087516|567490|P3|Overall Study|Adverse Event|3
182996|NCT00087516|567491|P2|Overall Study|Adverse Event|10
182997|NCT00087516|567492|P1|Overall Study|Adverse Event|10
182998|NCT00087490|567521|P2|Overall Study|Randomized but not treated|18
182999|NCT00087490|567522|P1|Overall Study|Randomized but not treated|7
183000|NCT00087490|567521|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
183001|NCT00087490|567522|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
183002|NCT00087490|567521|P2|Overall Study|Protocol Violation or (/) Unspecified|201
183003|NCT00087490|567522|P1|Overall Study|Protocol Violation or (/) Unspecified|214
183004|NCT00087490|567521|P2|Overall Study|Lack of Efficacy|2
183005|NCT00087490|567522|P1|Overall Study|Lack of Efficacy|0
183006|NCT00087490|567521|P2|Overall Study|Adverse Event|8
183007|NCT00087490|567522|P1|Overall Study|Adverse Event|3
183008|NCT00087490|567521|P2|Overall Study|Death|4
183009|NCT00087490|567522|P1|Overall Study|Death|6
183010|NCT00087438|567556|P1|Overall Study|Ineligible / No protocol treatment|4
183011|NCT00087152|567560|P1|Overall Study|Ineligible|6
183012|NCT00087139|567569|P3|Overall Study|Extradural disease|1
183013|NCT00087139|567570|P2|Overall Study|Extradural disease|0
183014|NCT00087139|567571|P1|Overall Study|Extradural disease|0
183015|NCT00087139|567569|P3|Overall Study|Response achieved|0
183016|NCT00087139|567570|P2|Overall Study|Response achieved|1
183017|NCT00087139|567571|P1|Overall Study|Response achieved|0
183018|NCT00087139|567569|P3|Overall Study|Use of coumadin|0
183019|NCT00087139|567570|P2|Overall Study|Use of coumadin|0
183020|NCT00087139|567571|P1|Overall Study|Use of coumadin|1
183021|NCT00087139|567569|P3|Overall Study|Symptomatic deterioration|3
183022|NCT00087139|567570|P2|Overall Study|Symptomatic deterioration|1
183023|NCT00087139|567571|P1|Overall Study|Symptomatic deterioration|1
183024|NCT00087139|567569|P3|Overall Study|Ineligible|4
183025|NCT00087139|567570|P2|Overall Study|Ineligible|7
183026|NCT00087139|567571|P1|Overall Study|Ineligible|4
183027|NCT00087139|567569|P3|Overall Study|Disease progression|12
183028|NCT00087139|567570|P2|Overall Study|Disease progression|19
183029|NCT00087139|567571|P1|Overall Study|Disease progression|9
183030|NCT00087139|567569|P3|Overall Study|Physician Decision|1
183031|NCT00087139|567570|P2|Overall Study|Physician Decision|1
183032|NCT00087139|567571|P1|Overall Study|Physician Decision|1
183033|NCT00087139|567569|P3|Overall Study|Withdrawal by Subject|2
183034|NCT00087139|567570|P2|Overall Study|Withdrawal by Subject|2
183035|NCT00087139|567571|P1|Overall Study|Withdrawal by Subject|3
183036|NCT00087139|567569|P3|Overall Study|Death|0
183037|NCT00087139|567570|P2|Overall Study|Death|1
183038|NCT00087139|567571|P1|Overall Study|Death|2
183039|NCT00087139|567569|P3|Overall Study|Adverse Event|13
183040|NCT00087139|567570|P2|Overall Study|Adverse Event|17
183041|NCT00087139|567571|P1|Overall Study|Adverse Event|18
183042|NCT00086996|567586|P1|Overall Study|not eligible|5
183043|NCT00086996|567586|P1|Overall Study|not specified|6
183044|NCT00086996|567586|P1|Overall Study|Withdrawal by Subject|13
183045|NCT00086996|567586|P1|Overall Study|progression/relapse|7
183046|NCT00086996|567586|P1|Overall Study|Death|4
183047|NCT00086996|567586|P1|Overall Study|Adverse Event|29
183048|NCT00086684|567596|P3|Overall Study|Not specified|3
183049|NCT00086684|567597|P2|Overall Study|Not specified|2
183050|NCT00086684|567598|P1|Overall Study|Not specified|4
183051|NCT00086684|567596|P3|Overall Study|WITHDRAWAL OF CONSENT|5
183052|NCT00086684|567597|P2|Overall Study|WITHDRAWAL OF CONSENT|7
183053|NCT00086684|567598|P1|Overall Study|WITHDRAWAL OF CONSENT|5
183054|NCT00086684|567596|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
183055|NCT00086684|567597|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
183056|NCT00086684|567598|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
183057|NCT00086684|567596|P3|Overall Study|NONCOMPLIANCE|6
183058|NCT00086684|567597|P2|Overall Study|NONCOMPLIANCE|7
183059|NCT00086684|567598|P1|Overall Study|NONCOMPLIANCE|5
183060|NCT00086684|567596|P3|Overall Study|Withdrawal by Subject|10
183061|NCT00086684|567597|P2|Overall Study|Withdrawal by Subject|4
183062|NCT00086684|567598|P1|Overall Study|Withdrawal by Subject|0
183063|NCT00086684|567596|P3|Overall Study|Protocol Violation|0
183064|NCT00086684|567597|P2|Overall Study|Protocol Violation|3
183065|NCT00086684|567598|P1|Overall Study|Protocol Violation|8
183066|NCT00086684|567596|P3|Overall Study|Lost to Follow-up|10
183067|NCT00086684|567597|P2|Overall Study|Lost to Follow-up|8
183068|NCT00086684|567598|P1|Overall Study|Lost to Follow-up|15
183069|NCT00086684|567596|P3|Overall Study|Lack of Efficacy|5
183070|NCT00086684|567597|P2|Overall Study|Lack of Efficacy|6
183071|NCT00086684|567598|P1|Overall Study|Lack of Efficacy|6
183072|NCT00086684|567596|P3|Overall Study|Adverse Event|14
183073|NCT00086684|567597|P2|Overall Study|Adverse Event|17
183074|NCT00086684|567598|P1|Overall Study|Adverse Event|12
183075|NCT00086619|567611|P2|Overall Study|Protocol Violation|1
183076|NCT00086619|567612|P1|Overall Study|Protocol Violation|1
183077|NCT00086619|567611|P2|Overall Study|Adverse Event|10
183078|NCT00086619|567612|P1|Overall Study|Adverse Event|8
183079|NCT00086619|567611|P2|Overall Study|Withdrawal by Subject|6
183080|NCT00086619|567612|P1|Overall Study|Withdrawal by Subject|6
183081|NCT00086580|567622|P2|Observation Period|Not specified|7
183082|NCT00086580|567623|P1|Observation Period|Not specified|8
183083|NCT00086580|567622|P2|Observation Period|Death|55
183084|NCT00086580|567623|P1|Observation Period|Death|33
183085|NCT00086580|567622|P2|Observation Period|Withdrawal by Subject|2
183086|NCT00086580|567623|P1|Observation Period|Withdrawal by Subject|4
183087|NCT00086580|567622|P2|Observation Period|Unable to comply with protocol|1
183088|NCT00086580|567623|P1|Observation Period|Unable to comply with protocol|1
183089|NCT00086580|567622|P2|Follow-up Period|Not specified|6
183090|NCT00086580|567623|P1|Follow-up Period|Not specified|7
183091|NCT00086580|567622|P2|Follow-up Period|Death|7
183092|NCT00086580|567623|P1|Follow-up Period|Death|13
183093|NCT00086580|567622|P2|Follow-up Period|AE - not related|0
183094|NCT00086580|567623|P1|Follow-up Period|AE - not related|1
183095|NCT00086580|567622|P2|Follow-up Period|Physician Decision|1
183096|NCT00086580|567623|P1|Follow-up Period|Physician Decision|0
183097|NCT00086580|567622|P2|Follow-up Period|Withdrawal by Subject|6
183098|NCT00086580|567623|P1|Follow-up Period|Withdrawal by Subject|6
183099|NCT00086580|567622|P2|Follow-up Period|Unable to comply with protocol|0
183100|NCT00086580|567623|P1|Follow-up Period|Unable to comply with protocol|5
183101|NCT00086580|567622|P2|Follow-up Period|Disease progression|99
183102|NCT00086580|567623|P1|Follow-up Period|Disease progression|72
183103|NCT00086580|567622|P2|Treatment Period|Not specified|3
183104|NCT00086580|567623|P1|Treatment Period|Not specified|5
183105|NCT00086580|567622|P2|Treatment Period|Death|7
183106|NCT00086580|567623|P1|Treatment Period|Death|5
183107|NCT00086580|567622|P2|Treatment Period|Anemia or thrombocytopenia|4
183108|NCT00086580|567623|P1|Treatment Period|Anemia or thrombocytopenia|1
183109|NCT00086580|567622|P2|Treatment Period|Toxicity - treatment related|15
183110|NCT00086580|567623|P1|Treatment Period|Toxicity - treatment related|15
183111|NCT00086580|567622|P2|Treatment Period|AE - not treatment related|7
183112|NCT00086580|567623|P1|Treatment Period|AE - not treatment related|7
183113|NCT00086580|567622|P2|Treatment Period|Physician Decision|7
183114|NCT00086580|567623|P1|Treatment Period|Physician Decision|13
183115|NCT00086580|567622|P2|Treatment Period|Withdrawal by Subject|8
183116|NCT00086580|567623|P1|Treatment Period|Withdrawal by Subject|7
183117|NCT00086580|567622|P2|Treatment Period|Unable to comply with protocol|1
183118|NCT00086580|567623|P1|Treatment Period|Unable to comply with protocol|3
183119|NCT00086580|567622|P2|Treatment Period|Disease progression|8
183120|NCT00086580|567623|P1|Treatment Period|Disease progression|9
183121|NCT00086515|567669|P2|Phase B (Weeks 24-104)|Discontinued in error|0
183122|NCT00086515|567670|P1|Phase B (Weeks 24-104)|Discontinued in error|1
183123|NCT00086515|567669|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
183124|NCT00086515|567670|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
183125|NCT00086515|567669|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
183126|NCT00086515|567670|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
183127|NCT00086515|567669|P2|Phase B (Weeks 24-104)|Patient Died|1
183128|NCT00086515|567670|P1|Phase B (Weeks 24-104)|Patient Died|3
183129|NCT00086515|567669|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
183130|NCT00086515|567670|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
183131|NCT00086515|567669|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
183132|NCT00086515|567670|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
183133|NCT00086515|567669|P2|Phase B (Weeks 24-104)|Patient Moved|2
183134|NCT00086515|567670|P1|Phase B (Weeks 24-104)|Patient Moved|2
183135|NCT00086515|567669|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
183136|NCT00086515|567670|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
183137|NCT00086515|567669|P2|Phase B (Weeks 24-104)|Protocol Violation|0
183138|NCT00086515|567670|P1|Phase B (Weeks 24-104)|Protocol Violation|1
183139|NCT00086515|567669|P2|Phase B (Weeks 24-104)|Physician Decision|0
183140|NCT00086515|567670|P1|Phase B (Weeks 24-104)|Physician Decision|3
183141|NCT00086515|567669|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
183142|NCT00086515|567670|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
183143|NCT00086515|567669|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
183144|NCT00086515|567670|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
183145|NCT00086515|567669|P2|Phase B (Weeks 24-104)|Adverse Event|10
183146|NCT00086515|567670|P1|Phase B (Weeks 24-104)|Adverse Event|16
183147|NCT00086515|567669|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
183148|NCT00086515|567670|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
183149|NCT00086515|567669|P2|Phase A to Phase B Transition Period|Poor compliance|0
183150|NCT00086515|567670|P1|Phase A to Phase B Transition Period|Poor compliance|1
183151|NCT00086515|567669|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
183152|NCT00086515|567670|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
183153|NCT00086515|567669|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
183154|NCT00086515|567670|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
183155|NCT00086515|567669|P2|Phase A to Phase B Transition Period|Protocol Violation|1
183156|NCT00086515|567670|P1|Phase A to Phase B Transition Period|Protocol Violation|0
183157|NCT00086515|567669|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
183158|NCT00086515|567670|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
183159|NCT00086515|567669|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
183160|NCT00086515|567670|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
183161|NCT00086515|567669|P2|Phase A to Phase B Transition Period|Adverse Event|1
183162|NCT00086515|567670|P1|Phase A to Phase B Transition Period|Adverse Event|2
183163|NCT00086515|567669|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
183164|NCT00086515|567670|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
183165|NCT00086515|567669|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
183166|NCT00086515|567670|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
183167|NCT00086515|567669|P2|Phase A (Weeks 0-24)|Poor compliance|0
183168|NCT00086515|567670|P1|Phase A (Weeks 0-24)|Poor compliance|1
183169|NCT00086515|567669|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
183170|NCT00086515|567670|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
183171|NCT00086515|567669|P2|Phase A (Weeks 0-24)|Patient Moved|3
183172|NCT00086515|567670|P1|Phase A (Weeks 0-24)|Patient Moved|2
183173|NCT00086515|567669|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
183174|NCT00086515|567670|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
183175|NCT00086515|567669|P2|Phase A (Weeks 0-24)|Protocol Violation|1
183176|NCT00086515|567670|P1|Phase A (Weeks 0-24)|Protocol Violation|3
183177|NCT00086515|567669|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
183178|NCT00086515|567670|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
183179|NCT00086515|567669|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
183180|NCT00086515|567670|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
183181|NCT00086515|567669|P2|Phase A (Weeks 0-24)|Adverse Event|9
183182|NCT00086515|567670|P1|Phase A (Weeks 0-24)|Adverse Event|17
183183|NCT00086502|567682|P2|Overall Study|Patient Accidentally Unblinded|0
183184|NCT00086502|567683|P1|Overall Study|Patient Accidentally Unblinded|1
183185|NCT00086502|567682|P2|Overall Study|Protocol Discontinuation Criteria|3
183186|NCT00086502|567683|P1|Overall Study|Protocol Discontinuation Criteria|1
183187|NCT00086502|567682|P2|Overall Study|Patient Moved|1
183188|NCT00086502|567683|P1|Overall Study|Patient Moved|1
183189|NCT00086502|567682|P2|Overall Study|Withdrawal by Subject|6
183190|NCT00086502|567683|P1|Overall Study|Withdrawal by Subject|5
183191|NCT00086502|567682|P2|Overall Study|Protocol Violation|3
183192|NCT00086502|567683|P1|Overall Study|Protocol Violation|3
183193|NCT00086502|567682|P2|Overall Study|Pregnancy|1
183194|NCT00086502|567683|P1|Overall Study|Pregnancy|0
183195|NCT00086502|567682|P2|Overall Study|Physician Decision|1
183196|NCT00086502|567683|P1|Overall Study|Physician Decision|1
183197|NCT00086502|567682|P2|Overall Study|Lost to Follow-up|1
183198|NCT00086502|567683|P1|Overall Study|Lost to Follow-up|3
183199|NCT00086502|567682|P2|Overall Study|Lack of Efficacy|2
183200|NCT00086502|567683|P1|Overall Study|Lack of Efficacy|0
183201|NCT00086502|567682|P2|Overall Study|Adverse Event|2
183202|NCT00086502|567683|P1|Overall Study|Adverse Event|11
183203|NCT00086411|567710|P4|Overall Study|Lost to Follow-up|12
183204|NCT00086411|567711|P3|Overall Study|Lost to Follow-up|13
183205|NCT00086411|567712|P2|Overall Study|Lost to Follow-up|11
183206|NCT00086411|567713|P1|Overall Study|Lost to Follow-up|11
183207|NCT00086385|567727|P4|Overall Study|Death|1
183208|NCT00086385|567728|P3|Overall Study|Death|1
183209|NCT00086385|567729|P2|Overall Study|Death|2
183210|NCT00086385|567730|P1|Overall Study|Death|2
183211|NCT00086346|567742|P2|Patients Dosed With Test Article|Lack of Efficacy|0
183212|NCT00086346|567743|P1|Patients Dosed With Test Article|Lack of Efficacy|11
183213|NCT00086346|567742|P2|Patients Dosed With Test Article|Protocol Violation|3
183214|NCT00086346|567743|P1|Patients Dosed With Test Article|Protocol Violation|11
183215|NCT00086346|567742|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
183216|NCT00086346|567743|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
183217|NCT00086346|567742|P2|Patients Dosed With Test Article|Nonmedical event|3
183218|NCT00086346|567743|P1|Patients Dosed With Test Article|Nonmedical event|7
183219|NCT00086346|567742|P2|Patients Dosed With Test Article|Lost to Follow-up|3
183220|NCT00086346|567743|P1|Patients Dosed With Test Article|Lost to Follow-up|1
183221|NCT00086346|567742|P2|Patients Dosed With Test Article|Adverse Event|11
183222|NCT00086346|567743|P1|Patients Dosed With Test Article|Adverse Event|94
183223|NCT00086346|567742|P2|Randomization|Did not receive test article|4
183224|NCT00086346|567743|P1|Randomization|Did not receive test article|4
183225|NCT00086307|567758|P3|Overall Study|Withdrawal by Subject|2
183226|NCT00086307|567759|P2|Overall Study|Withdrawal by Subject|0
183227|NCT00086307|567760|P1|Overall Study|Withdrawal by Subject|0
183228|NCT00086307|567758|P3|Overall Study|Fatigue and difficulty falling asleep|1
183229|NCT00086307|567759|P2|Overall Study|Fatigue and difficulty falling asleep|0
183230|NCT00086307|567760|P1|Overall Study|Fatigue and difficulty falling asleep|0
183231|NCT00086307|567758|P3|Overall Study|Suicidal ideation|1
183232|NCT00086307|567759|P2|Overall Study|Suicidal ideation|0
183233|NCT00086307|567760|P1|Overall Study|Suicidal ideation|0
183234|NCT00086307|567758|P3|Overall Study|Constipation and sleepiness|1
183235|NCT00086307|567759|P2|Overall Study|Constipation and sleepiness|0
183236|NCT00086307|567760|P1|Overall Study|Constipation and sleepiness|0
183237|NCT00086307|567758|P3|Overall Study|Nausea and headaches|1
183238|NCT00086307|567759|P2|Overall Study|Nausea and headaches|0
183239|NCT00086307|567760|P1|Overall Study|Nausea and headaches|0
183240|NCT00086307|567758|P3|Overall Study|Shortness of breath and muscle spasms|0
183241|NCT00086307|567759|P2|Overall Study|Shortness of breath and muscle spasms|0
183242|NCT00086307|567760|P1|Overall Study|Shortness of breath and muscle spasms|1
183243|NCT00086307|567758|P3|Overall Study|Lack of Efficacy|2
183244|NCT00086307|567759|P2|Overall Study|Lack of Efficacy|1
183245|NCT00086307|567760|P1|Overall Study|Lack of Efficacy|1
183246|NCT00086281|567783|P15|Phase 2|Adverse Event|0
183247|NCT00086281|567784|P14|Phase 2|Adverse Event|1
183248|NCT00086281|567785|P13|Phase 2|Adverse Event|1
183249|NCT00086281|567786|P12|Phase 2|Adverse Event|0
183250|NCT00086281|567787|P11|Phase 2|Adverse Event|0
183251|NCT00086281|567788|P10|Phase 2|Adverse Event|0
183252|NCT00086281|567789|P9|Phase 2|Adverse Event|0
183253|NCT00086281|567790|P8|Phase 2|Adverse Event|0
183254|NCT00086281|567791|P7|Phase 2|Adverse Event|0
183255|NCT00086281|567792|P6|Phase 2|Adverse Event|0
183256|NCT00086281|567793|P5|Phase 2|Adverse Event|0
183257|NCT00086281|567794|P4|Phase 2|Adverse Event|0
183258|NCT00086281|567795|P3|Phase 2|Adverse Event|0
183259|NCT00086281|567796|P2|Phase 2|Adverse Event|0
183260|NCT00086281|567797|P1|Phase 2|Adverse Event|0
183261|NCT00086281|567783|P15|Phase 1|Serious Adverse Event|1
183262|NCT00086281|567784|P14|Phase 1|Serious Adverse Event|0
183263|NCT00086281|567785|P13|Phase 1|Serious Adverse Event|0
183264|NCT00086281|567786|P12|Phase 1|Serious Adverse Event|0
183265|NCT00086281|567787|P11|Phase 1|Serious Adverse Event|0
183266|NCT00086281|567788|P10|Phase 1|Serious Adverse Event|0
183267|NCT00086281|567789|P9|Phase 1|Serious Adverse Event|0
183268|NCT00086281|567790|P8|Phase 1|Serious Adverse Event|0
183269|NCT00086281|567791|P7|Phase 1|Serious Adverse Event|0
183270|NCT00086281|567792|P6|Phase 1|Serious Adverse Event|0
183271|NCT00086281|567793|P5|Phase 1|Serious Adverse Event|0
183272|NCT00086281|567794|P4|Phase 1|Serious Adverse Event|0
183273|NCT00086281|567795|P3|Phase 1|Serious Adverse Event|0
183274|NCT00086281|567796|P2|Phase 1|Serious Adverse Event|0
183275|NCT00086281|567797|P1|Phase 1|Serious Adverse Event|0
183276|NCT00086281|567783|P15|Phase 1|Protocol Violation|0
183277|NCT00086281|567784|P14|Phase 1|Protocol Violation|0
183278|NCT00086281|567785|P13|Phase 1|Protocol Violation|0
183279|NCT00086281|567786|P12|Phase 1|Protocol Violation|0
183280|NCT00086281|567787|P11|Phase 1|Protocol Violation|1
183281|NCT00086281|567788|P10|Phase 1|Protocol Violation|0
183282|NCT00086281|567789|P9|Phase 1|Protocol Violation|0
183283|NCT00086281|567790|P8|Phase 1|Protocol Violation|0
183284|NCT00086281|567791|P7|Phase 1|Protocol Violation|0
183285|NCT00086281|567792|P6|Phase 1|Protocol Violation|0
183286|NCT00086281|567793|P5|Phase 1|Protocol Violation|0
183287|NCT00086281|567794|P4|Phase 1|Protocol Violation|0
183288|NCT00086281|567795|P3|Phase 1|Protocol Violation|0
183289|NCT00086281|567796|P2|Phase 1|Protocol Violation|0
183290|NCT00086281|567797|P1|Phase 1|Protocol Violation|0
183291|NCT00086281|567783|P15|Phase 1|Adverse Event|2
183292|NCT00086281|567784|P14|Phase 1|Adverse Event|1
183293|NCT00086281|567785|P13|Phase 1|Adverse Event|1
183294|NCT00086281|567786|P12|Phase 1|Adverse Event|1
183295|NCT00086281|567787|P11|Phase 1|Adverse Event|2
183296|NCT00086281|567788|P10|Phase 1|Adverse Event|1
183297|NCT00086281|567789|P9|Phase 1|Adverse Event|0
183298|NCT00086281|567790|P8|Phase 1|Adverse Event|0
183299|NCT00086281|567791|P7|Phase 1|Adverse Event|0
183300|NCT00086281|567792|P6|Phase 1|Adverse Event|0
183301|NCT00086281|567793|P5|Phase 1|Adverse Event|0
183302|NCT00086281|567794|P4|Phase 1|Adverse Event|0
183303|NCT00086281|567795|P3|Phase 1|Adverse Event|0
183304|NCT00086281|567796|P2|Phase 1|Adverse Event|0
183305|NCT00086281|567797|P1|Phase 1|Adverse Event|0
183306|NCT00086190|567810|P3|Overall Study|Worsening depression|2
183307|NCT00086190|567811|P2|Overall Study|Worsening depression|0
183308|NCT00086190|567812|P1|Overall Study|Worsening depression|0
183309|NCT00086190|567810|P3|Overall Study|Moved|0
183310|NCT00086190|567811|P2|Overall Study|Moved|0
183311|NCT00086190|567812|P1|Overall Study|Moved|1
183312|NCT00086190|567810|P3|Overall Study|Protocol Violation|0
183313|NCT00086190|567811|P2|Overall Study|Protocol Violation|0
183314|NCT00086190|567812|P1|Overall Study|Protocol Violation|1
183315|NCT00086190|567810|P3|Overall Study|Withdrawal by Subject|2
183316|NCT00086190|567811|P2|Overall Study|Withdrawal by Subject|2
183317|NCT00086190|567812|P1|Overall Study|Withdrawal by Subject|0
183318|NCT00086190|567810|P3|Overall Study|Adverse Event|2
183319|NCT00086190|567811|P2|Overall Study|Adverse Event|2
183320|NCT00086190|567812|P1|Overall Study|Adverse Event|6
183321|NCT00086047|567870|P2|Overall Study|Physician Decision|1
183322|NCT00086047|567871|P1|Overall Study|Physician Decision|0
183323|NCT00086047|567870|P2|Overall Study|Lost to Follow-up|6
183324|NCT00086047|567871|P1|Overall Study|Lost to Follow-up|7
183325|NCT00085917|567879|P2|Overall Study|Adverse Event|3
183326|NCT00085917|567880|P1|Overall Study|Adverse Event|4
183327|NCT00085709|567905|P2|Overall Study|Withdrawal by Subject|1
183328|NCT00085709|567906|P1|Overall Study|Withdrawal by Subject|2
183329|NCT00085709|567905|P2|Overall Study|Not eligible|19
183330|NCT00085709|567906|P1|Overall Study|Not eligible|19
183331|NCT00085709|567905|P2|Overall Study|Not protocol specified|22
183332|NCT00085709|567906|P1|Overall Study|Not protocol specified|12
183333|NCT00085709|567905|P2|Overall Study|Progression|4
183334|NCT00085709|567906|P1|Overall Study|Progression|3
183335|NCT00085709|567905|P2|Overall Study|Refusal unrelated to adverse events|2
183336|NCT00085709|567906|P1|Overall Study|Refusal unrelated to adverse events|1
183337|NCT00085709|567905|P2|Overall Study|Death|2
183338|NCT00085709|567906|P1|Overall Study|Death|8
183339|NCT00085709|567905|P2|Overall Study|Adverse Event|0
183340|NCT00085709|567906|P1|Overall Study|Adverse Event|8
183341|NCT00085644|567922|P3|Open-Label Period|Personal reason|4
183342|NCT00085644|567923|P2|Open-Label Period|Personal reason|0
183343|NCT00085644|567924|P1|Open-Label Period|Personal reason|0
183344|NCT00085644|567922|P3|Open-Label Period|Protocol Violation|4
183345|NCT00085644|567923|P2|Open-Label Period|Protocol Violation|0
183346|NCT00085644|567924|P1|Open-Label Period|Protocol Violation|0
183347|NCT00085644|567922|P3|Open-Label Period|Contemplating pregnancy|3
183348|NCT00085644|567923|P2|Open-Label Period|Contemplating pregnancy|0
183349|NCT00085644|567924|P1|Open-Label Period|Contemplating pregnancy|0
183350|NCT00085644|567922|P3|Open-Label Period|Pregnancy|3
183351|NCT00085644|567923|P2|Open-Label Period|Pregnancy|0
183352|NCT00085644|567924|P1|Open-Label Period|Pregnancy|0
183353|NCT00085644|567922|P3|Open-Label Period|Lack of Efficacy|15
183354|NCT00085644|567923|P2|Open-Label Period|Lack of Efficacy|0
183355|NCT00085644|567924|P1|Open-Label Period|Lack of Efficacy|0
183356|NCT00085644|567922|P3|Open-Label Period|Lost to Follow-up|13
183357|NCT00085644|567923|P2|Open-Label Period|Lost to Follow-up|0
183358|NCT00085644|567924|P1|Open-Label Period|Lost to Follow-up|0
183359|NCT00085644|567922|P3|Open-Label Period|Withdrawal by Subject|29
183360|NCT00085644|567923|P2|Open-Label Period|Withdrawal by Subject|0
183361|NCT00085644|567924|P1|Open-Label Period|Withdrawal by Subject|0
183362|NCT00085644|567922|P3|Open-Label Period|Adverse Event|38
183363|NCT00085644|567923|P2|Open-Label Period|Adverse Event|0
183364|NCT00085644|567924|P1|Open-Label Period|Adverse Event|0
183365|NCT00085644|567922|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
183366|NCT00085644|567923|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
183367|NCT00085644|567924|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
183368|NCT00085644|567922|P3|Double-Blind Period|Contemplating pregnancy|0
183369|NCT00085644|567923|P2|Double-Blind Period|Contemplating pregnancy|0
183370|NCT00085644|567924|P1|Double-Blind Period|Contemplating pregnancy|1
183371|NCT00085644|567922|P3|Double-Blind Period|Lack/loss of efficacy|0
183372|NCT00085644|567923|P2|Double-Blind Period|Lack/loss of efficacy|2
183373|NCT00085644|567924|P1|Double-Blind Period|Lack/loss of efficacy|2
183374|NCT00085644|567922|P3|Double-Blind Period|Lost to Follow-up|0
183375|NCT00085644|567923|P2|Double-Blind Period|Lost to Follow-up|1
183376|NCT00085644|567924|P1|Double-Blind Period|Lost to Follow-up|2
183377|NCT00085644|567922|P3|Double-Blind Period|Withdrawal by Subject|0
183378|NCT00085644|567923|P2|Double-Blind Period|Withdrawal by Subject|0
183379|NCT00085644|567924|P1|Double-Blind Period|Withdrawal by Subject|3
183380|NCT00085644|567922|P3|Double-Blind Period|Adverse Event|0
183381|NCT00085644|567923|P2|Double-Blind Period|Adverse Event|2
183382|NCT00085644|567924|P1|Double-Blind Period|Adverse Event|5
183383|NCT00085631|567965|P3|Overall Study|Missing Data|7
183384|NCT00085631|567966|P2|Overall Study|Missing Data|11
183385|NCT00085631|567967|P1|Overall Study|Missing Data|4
183386|NCT00085566|567977|P3|Overall Study|Clinical progression|1
183387|NCT00085566|567978|P2|Overall Study|Clinical progression|0
183388|NCT00085566|567979|P1|Overall Study|Clinical progression|0
183389|NCT00085566|567977|P3|Overall Study|Patient Not treated|3
183390|NCT00085566|567978|P2|Overall Study|Patient Not treated|0
183391|NCT00085566|567979|P1|Overall Study|Patient Not treated|0
183392|NCT00085566|567977|P3|Overall Study|Adverse Event|10
183393|NCT00085566|567978|P2|Overall Study|Adverse Event|0
183394|NCT00085566|567979|P1|Overall Study|Adverse Event|0
183395|NCT00085540|567989|P2|Overall Study|Protocol Violation|1
183396|NCT00085540|567990|P1|Overall Study|Protocol Violation|0
183397|NCT00085540|567989|P2|Overall Study|Withdrawal by Subject|1
183398|NCT00085540|567990|P1|Overall Study|Withdrawal by Subject|0
183399|NCT00085423|568001|P1|Overall Study|screen failure|1
183400|NCT00085423|568001|P1|Overall Study|Withdrawal by Subject|1
183401|NCT00085202|568033|P2|Overall Study|Progressive disease|11
183402|NCT00085202|568034|P1|Overall Study|Progressive disease|1
183403|NCT00085202|568033|P2|Overall Study|Physician Decision|1
183404|NCT00085202|568034|P1|Overall Study|Physician Decision|4
183405|NCT00085202|568033|P2|Overall Study|Withdrawal by Subject|1
183406|NCT00085202|568034|P1|Overall Study|Withdrawal by Subject|2
183407|NCT00085202|568033|P2|Overall Study|Non-specified|5
183408|NCT00085202|568034|P1|Overall Study|Non-specified|3
183409|NCT00085202|568033|P2|Overall Study|Excessive toxicity|5
183410|NCT00085202|568034|P1|Overall Study|Excessive toxicity|6
183411|NCT00085202|568033|P2|Overall Study|Bone involvement confirmed by bone scan|1
183412|NCT00085202|568034|P1|Overall Study|Bone involvement confirmed by bone scan|0
183413|NCT00085202|568033|P2|Overall Study|Still on therapy|0
183414|NCT00085202|568034|P1|Overall Study|Still on therapy|2
183415|NCT00085098|568047|P2|Overall Study|Ineligible|1
183416|NCT00085098|568048|P1|Overall Study|Ineligible|1
183417|NCT00085098|568047|P2|Overall Study|Withdrawal by Subject|1
183418|NCT00085098|568048|P1|Overall Study|Withdrawal by Subject|0
183419|NCT00084838|568054|P1|Overall Study|Ineligible|4
183420|NCT00084838|568054|P1|Overall Study|Pt Non-Compliance|1
183421|NCT00084838|568054|P1|Overall Study|Progressive Disease|4
183422|NCT00084838|568054|P1|Overall Study|Withdrawal by Subject|1
183423|NCT00084838|568054|P1|Overall Study|Adverse Event|2
183424|NCT00084838|568054|P1|Overall Study|Death|1
183425|NCT00084747|568076|P1|Overall Study|Withdrawal by Subject|2
183426|NCT00084747|568076|P1|Overall Study|Death|3
183427|NCT00084747|568076|P1|Overall Study|Relapsed|8
183428|NCT00084682|568081|P1|Overall Study|Withdrawal by Subject|1
183429|NCT00084617|568085|P1|Overall Study|Protocol Violation|1
183430|NCT00084617|568085|P1|Overall Study|Lack of Efficacy|1
183431|NCT00084617|568085|P1|Overall Study|Withdrawal by Subject|7
183432|NCT00084487|568091|P1|Overall Study|Death|1
183433|NCT00084318|568137|P2|Overall Study|No protocol treatment|0
183434|NCT00084318|568138|P1|Overall Study|No protocol treatment|2
183435|NCT00084318|568137|P2|Overall Study|Protocol Violation|11
183436|NCT00084318|568138|P1|Overall Study|Protocol Violation|15
183437|NCT00084318|568137|P2|Overall Study|Withdrawal by Subject|2
183438|NCT00084318|568138|P1|Overall Study|Withdrawal by Subject|5
183439|NCT00084266|568156|P2|Overall Study|Randomized not treated|20
183440|NCT00084266|568157|P1|Overall Study|Randomized not treated|21
183441|NCT00084266|568156|P2|Overall Study|Unspecified|344
183442|NCT00084266|568157|P1|Overall Study|Unspecified|360
183443|NCT00084266|568156|P2|Overall Study|Participant not willing to participate|8
183444|NCT00084266|568157|P1|Overall Study|Participant not willing to participate|3
183445|NCT00084266|568156|P2|Overall Study|Lost to Follow-up|3
183446|NCT00084266|568157|P1|Overall Study|Lost to Follow-up|5
183447|NCT00084266|568156|P2|Overall Study|Lack of Efficacy|4
183448|NCT00084266|568157|P1|Overall Study|Lack of Efficacy|2
183449|NCT00084266|568156|P2|Overall Study|Adverse Event|5
183450|NCT00084266|568157|P1|Overall Study|Adverse Event|8
183451|NCT00084266|568156|P2|Overall Study|Death|39
183452|NCT00084266|568157|P1|Overall Study|Death|42
183453|NCT00084136|568194|P3|NRTI Comparison|Not reason above|0
183454|NCT00084136|568195|P2|NRTI Comparison|Not reason above|0
183455|NCT00084136|568196|P1|NRTI Comparison|Not reason above|1
183456|NCT00084136|568194|P3|NRTI Comparison|Clinic site closed|14
183457|NCT00084136|568195|P2|NRTI Comparison|Clinic site closed|0
183458|NCT00084136|568196|P1|NRTI Comparison|Clinic site closed|12
183459|NCT00084136|568194|P3|NRTI Comparison|Withdrawal by Subject|38
183460|NCT00084136|568195|P2|NRTI Comparison|Withdrawal by Subject|0
183461|NCT00084136|568196|P1|NRTI Comparison|Withdrawal by Subject|54
183462|NCT00084136|568194|P3|NRTI Comparison|Lost to Follow-up|12
183463|NCT00084136|568195|P2|NRTI Comparison|Lost to Follow-up|0
183464|NCT00084136|568196|P1|NRTI Comparison|Lost to Follow-up|14
183465|NCT00084136|568194|P3|NRTI Comparison|Death|18
183466|NCT00084136|568195|P2|NRTI Comparison|Death|0
183467|NCT00084136|568196|P1|NRTI Comparison|Death|20
183468|NCT00084136|568194|P3|PI Comparison|Clinic site closed|0
183469|NCT00084136|568195|P2|PI Comparison|Clinic site closed|0
183470|NCT00084136|568196|P1|PI Comparison|Clinic site closed|1
183471|NCT00084136|568194|P3|PI Comparison|Withdrawal by Subject|0
183472|NCT00084136|568195|P2|PI Comparison|Withdrawal by Subject|30
183473|NCT00084136|568196|P1|PI Comparison|Withdrawal by Subject|33
183474|NCT00084136|568194|P3|PI Comparison|Lost to Follow-up|0
183475|NCT00084136|568195|P2|PI Comparison|Lost to Follow-up|8
183476|NCT00084136|568196|P1|PI Comparison|Lost to Follow-up|11
183477|NCT00084136|568194|P3|PI Comparison|Death|0
183478|NCT00084136|568195|P2|PI Comparison|Death|9
183479|NCT00084136|568196|P1|PI Comparison|Death|10
183480|NCT00084084|568255|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
183481|NCT00084084|568255|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
183482|NCT00083915|568265|P2|Overall Study|Insurance issues|1
183483|NCT00083915|568266|P1|Overall Study|Insurance issues|1
183484|NCT00083915|568265|P2|Overall Study|No response|1
183485|NCT00083915|568266|P1|Overall Study|No response|3
183486|NCT00083915|568265|P2|Overall Study|Failure to collect|0
183487|NCT00083915|568266|P1|Overall Study|Failure to collect|3
183488|NCT00083915|568265|P2|Overall Study|disease progression|23
183489|NCT00083915|568266|P1|Overall Study|disease progression|18
183490|NCT00083915|568265|P2|Overall Study|Withdrawal by Subject|3
183491|NCT00083915|568266|P1|Overall Study|Withdrawal by Subject|8
183492|NCT00083915|568265|P2|Overall Study|Physician Decision|6
183493|NCT00083915|568266|P1|Overall Study|Physician Decision|11
183494|NCT00083915|568265|P2|Overall Study|Death|3
183495|NCT00083915|568266|P1|Overall Study|Death|6
183496|NCT00083889|568274|P2|Overall Study|Crossover to SU011248|25
183497|NCT00083889|568275|P1|Overall Study|Crossover to SU011248|0
183498|NCT00083889|568274|P2|Overall Study|Completed on marketed sunitinub|0
183499|NCT00083889|568275|P1|Overall Study|Completed on marketed sunitinub|3
183500|NCT00083889|568274|P2|Overall Study|Randomized: did not take study drug|15
183501|NCT00083889|568275|P1|Overall Study|Randomized: did not take study drug|0
183502|NCT00083889|568274|P2|Overall Study|Decision of sponsor|4
183503|NCT00083889|568275|P1|Overall Study|Decision of sponsor|32
183504|NCT00083889|568274|P2|Overall Study|Lack of Efficacy|219
183505|NCT00083889|568275|P1|Overall Study|Lack of Efficacy|240
183506|NCT00083889|568274|P2|Overall Study|Withdrawal by Subject|24
183507|NCT00083889|568275|P1|Overall Study|Withdrawal by Subject|22
183508|NCT00083889|568274|P2|Overall Study|Protocol Violation|2
183509|NCT00083889|568275|P1|Overall Study|Protocol Violation|2
183510|NCT00083889|568274|P2|Overall Study|Adverse Event|86
183511|NCT00083889|568275|P1|Overall Study|Adverse Event|76
183512|NCT00083759|568326|P2|Overall Study|Other|13
183513|NCT00083759|568327|P1|Overall Study|Other|14
183514|NCT00083759|568326|P2|Overall Study|Sponsor's Discretion|29
183515|NCT00083759|568327|P1|Overall Study|Sponsor's Discretion|28
183516|NCT00083759|568326|P2|Overall Study|Non-Compliance|0
183517|NCT00083759|568327|P1|Overall Study|Non-Compliance|1
183518|NCT00083759|568326|P2|Overall Study|Subject Withdrew Consent|2
183519|NCT00083759|568327|P1|Overall Study|Subject Withdrew Consent|2
183520|NCT00083759|568326|P2|Overall Study|Inadequate Therapeutic Response|35
183521|NCT00083759|568327|P1|Overall Study|Inadequate Therapeutic Response|32
183522|NCT00083759|568326|P2|Overall Study|Death|1
183523|NCT00083759|568327|P1|Overall Study|Death|1
183524|NCT00083759|568326|P2|Overall Study|Lost to Follow-up|0
183525|NCT00083759|568327|P1|Overall Study|Lost to Follow-up|1
183526|NCT00083759|568326|P2|Overall Study|Adverse Event|3
183527|NCT00083759|568327|P1|Overall Study|Adverse Event|5
183528|NCT00083616|568345|P1|Overall Study|Other|6
183529|NCT00083616|568345|P1|Overall Study|Non-compliance|1
183530|NCT00083616|568345|P1|Overall Study|Ineligibility determined|2
183531|NCT00083616|568345|P1|Overall Study|Withdrawal by Subject|3
183532|NCT00083616|568345|P1|Overall Study|Physician Decision|2
183533|NCT00083616|568345|P1|Overall Study|Lost to Follow-up|1
183534|NCT00083616|568345|P1|Overall Study|Disease Progression|16
183535|NCT00083226|568370|P1|Overall Study|ineligible or not receiving treatment|4
183536|NCT00083226|568370|P1|Overall Study|Other|2
183537|NCT00083226|568370|P1|Overall Study|Withdrawal by Subject|4
183538|NCT00083226|568370|P1|Overall Study|Death|4
183539|NCT00083226|568370|P1|Overall Study|Adverse Event|9
183540|NCT00083226|568370|P1|Overall Study|Lack of Efficacy|19
183541|NCT00082888|568409|P1|Overall Study|Still receiving treatment|4
183542|NCT00082888|568409|P1|Overall Study|Other Medical Problems|2
183543|NCT00082888|568409|P1|Overall Study|Alternate Treatment|1
183544|NCT00082888|568409|P1|Overall Study|Withdrawal by Subject|9
183545|NCT00082888|568409|P1|Overall Study|Adverse Event|4
183546|NCT00082888|568409|P1|Overall Study|Death|2
183547|NCT00082810|568413|P1|Overall Study|Withdrawal by Subject|4
183548|NCT00082810|568413|P1|Overall Study|Progressive disease|24
183549|NCT00082810|568413|P1|Overall Study|Adverse Event|3
183550|NCT00082758|568423|P3|Overall Study|Protocol Violation|0
183551|NCT00082758|568424|P2|Overall Study|Protocol Violation|1
183552|NCT00082758|568425|P1|Overall Study|Protocol Violation|0
183553|NCT00082758|568423|P3|Overall Study|Withdrawal by Subject|0
183554|NCT00082758|568424|P2|Overall Study|Withdrawal by Subject|0
183555|NCT00082758|568425|P1|Overall Study|Withdrawal by Subject|3
183556|NCT00082758|568423|P3|Overall Study|Physician Decision|0
183557|NCT00082758|568424|P2|Overall Study|Physician Decision|1
183558|NCT00082758|568425|P1|Overall Study|Physician Decision|0
183559|NCT00082758|568423|P3|Overall Study|Lack of Efficacy|0
183560|NCT00082758|568424|P2|Overall Study|Lack of Efficacy|13
183561|NCT00082758|568425|P1|Overall Study|Lack of Efficacy|12
183562|NCT00082758|568423|P3|Overall Study|Adverse Event|0
183563|NCT00082758|568424|P2|Overall Study|Adverse Event|2
183564|NCT00082758|568425|P1|Overall Study|Adverse Event|0
183565|NCT00082433|568435|P2|Overall Study|Impending surgery|1
183566|NCT00082433|568436|P1|Overall Study|Impending surgery|0
183567|NCT00082433|568435|P2|Overall Study|New primary cancer|0
183568|NCT00082433|568436|P1|Overall Study|New primary cancer|1
183569|NCT00082433|568435|P2|Overall Study|Noncompliance|1
183570|NCT00082433|568436|P1|Overall Study|Noncompliance|2
183571|NCT00082433|568435|P2|Overall Study|Ineligible|1
183572|NCT00082433|568436|P1|Overall Study|Ineligible|2
183573|NCT00082433|568435|P2|Overall Study|Not Treated|11
183574|NCT00082433|568436|P1|Overall Study|Not Treated|12
183575|NCT00082433|568435|P2|Overall Study|Still On Treatment|1
183576|NCT00082433|568436|P1|Overall Study|Still On Treatment|2
183577|NCT00082433|568435|P2|Overall Study|Withdrawal by Subject|30
183578|NCT00082433|568436|P1|Overall Study|Withdrawal by Subject|55
183579|NCT00082433|568435|P2|Overall Study|Study Drug Toxicity|66
183580|NCT00082433|568436|P1|Overall Study|Study Drug Toxicity|179
183581|NCT00082433|568435|P2|Overall Study|Lost to Follow-up|2
183582|NCT00082433|568436|P1|Overall Study|Lost to Follow-up|1
183583|NCT00082433|568435|P2|Overall Study|Physician Decision|61
183584|NCT00082433|568436|P1|Overall Study|Physician Decision|50
183585|NCT00082433|568435|P2|Overall Study|Disease Progression/Relapse|388
183586|NCT00082433|568436|P1|Overall Study|Disease Progression/Relapse|270
183587|NCT00082433|568435|P2|Overall Study|Death|18
183588|NCT00082433|568436|P1|Overall Study|Death|8
183589|NCT00082433|568435|P2|Overall Study|Adverse Event|17
183590|NCT00082433|568436|P1|Overall Study|Adverse Event|12
183591|NCT00082407|568456|P2|Overall Study|Lost to Follow-up|3
183592|NCT00082407|568457|P1|Overall Study|Lost to Follow-up|0
183593|NCT00082407|568456|P2|Overall Study|Death|1
183594|NCT00082407|568457|P1|Overall Study|Death|2
183595|NCT00082407|568456|P2|Overall Study|Loss of Glucose Control|2
183596|NCT00082407|568457|P1|Overall Study|Loss of Glucose Control|2
183597|NCT00082407|568456|P2|Overall Study|Physician Decision|3
183598|NCT00082407|568457|P1|Overall Study|Physician Decision|5
183599|NCT00082407|568456|P2|Overall Study|Patient Decision|6
183600|NCT00082407|568457|P1|Overall Study|Patient Decision|13
183601|NCT00082407|568456|P2|Overall Study|Protocol Violation|12
183602|NCT00082407|568457|P1|Overall Study|Protocol Violation|14
183603|NCT00082407|568456|P2|Overall Study|Adverse Event|0
183604|NCT00082407|568457|P1|Overall Study|Adverse Event|20
183605|NCT00082381|568477|P2|Overall Study|Loss of Glucose Control|0
183606|NCT00082381|568478|P1|Overall Study|Loss of Glucose Control|4
183607|NCT00082381|568477|P2|Overall Study|Protocol Violation|11
183608|NCT00082381|568478|P1|Overall Study|Protocol Violation|10
183609|NCT00082381|568477|P2|Overall Study|Physician Decision|2
183610|NCT00082381|568478|P1|Overall Study|Physician Decision|1
183611|NCT00082381|568477|P2|Overall Study|Patient Decision|4
183612|NCT00082381|568478|P1|Overall Study|Patient Decision|8
183613|NCT00082381|568477|P2|Overall Study|Lost to Follow-up|7
183614|NCT00082381|568478|P1|Overall Study|Lost to Follow-up|5
183615|NCT00082381|568477|P2|Overall Study|Adverse Event|2
183616|NCT00082381|568478|P1|Overall Study|Adverse Event|27
183617|NCT00082368|568496|P1|Overall Study|Not treated-pt had poor IV access|1
183618|NCT00082355|568501|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
183619|NCT00082355|568501|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
183620|NCT00082355|568501|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
183621|NCT00082173|568535|P2|Overall Study|Culture negative or resistant at baselin|6
183622|NCT00082173|568536|P1|Overall Study|Culture negative or resistant at baselin|5
183623|NCT00082173|568535|P2|Overall Study|Adverse Event|0
183624|NCT00082173|568536|P1|Overall Study|Adverse Event|1
183625|NCT00082173|568535|P2|Overall Study|Lost to Follow-up|0
183626|NCT00082173|568536|P1|Overall Study|Lost to Follow-up|1
183627|NCT00082173|568535|P2|Overall Study|Withdrawal by Subject|5
183628|NCT00082173|568536|P1|Overall Study|Withdrawal by Subject|3
183629|NCT00081770|568562|P3|Overall Study|Not Specified|8
183630|NCT00081770|568563|P2|Overall Study|Not Specified|7
183631|NCT00081770|568564|P1|Overall Study|Not Specified|2
183632|NCT00081770|568562|P3|Overall Study|Administrative|1
183633|NCT00081770|568563|P2|Overall Study|Administrative|0
183634|NCT00081770|568564|P1|Overall Study|Administrative|1
183635|NCT00081770|568562|P3|Overall Study|Did not meet protocol eligibility|3
183636|NCT00081770|568563|P2|Overall Study|Did not meet protocol eligibility|0
183637|NCT00081770|568564|P1|Overall Study|Did not meet protocol eligibility|2
183638|NCT00081770|568562|P3|Overall Study|Withdrawal by Subject|42
183639|NCT00081770|568563|P2|Overall Study|Withdrawal by Subject|40
183640|NCT00081770|568564|P1|Overall Study|Withdrawal by Subject|45
183641|NCT00081770|568562|P3|Overall Study|Protocol Violation|10
183642|NCT00081770|568563|P2|Overall Study|Protocol Violation|10
183643|NCT00081770|568564|P1|Overall Study|Protocol Violation|15
183644|NCT00081770|568562|P3|Overall Study|Lost to Follow-up|45
183645|NCT00081770|568563|P2|Overall Study|Lost to Follow-up|34
183646|NCT00081770|568564|P1|Overall Study|Lost to Follow-up|45
183647|NCT00081770|568562|P3|Overall Study|Lack of Efficacy|211
183648|NCT00081770|568563|P2|Overall Study|Lack of Efficacy|357
183649|NCT00081770|568564|P1|Overall Study|Lack of Efficacy|262
183650|NCT00081770|568562|P3|Overall Study|Adverse Event|136
183651|NCT00081770|568563|P2|Overall Study|Adverse Event|98
183652|NCT00081770|568564|P1|Overall Study|Adverse Event|130
183653|NCT00081731|568583|P2|Overall Study|scientific integrity issue|8
183654|NCT00081731|568584|P1|Overall Study|scientific integrity issue|8
183655|NCT00081653|568604|P2|Overall Study|Loss of bone mass|2
183656|NCT00081653|568605|P1|Overall Study|Loss of bone mass|0
183657|NCT00081653|568604|P2|Overall Study|Participant leaving country|0
183658|NCT00081653|568605|P1|Overall Study|Participant leaving country|1
183659|NCT00081653|568604|P2|Overall Study|Bone loss|0
183660|NCT00081653|568605|P1|Overall Study|Bone loss|2
183661|NCT00081653|568604|P2|Overall Study|Low bone mineral density|0
183662|NCT00081653|568605|P1|Overall Study|Low bone mineral density|1
183663|NCT00081653|568604|P2|Overall Study|Refused Treatment|14
183664|NCT00081653|568605|P1|Overall Study|Refused Treatment|18
183665|NCT00081653|568604|P2|Overall Study|Lost to Follow-up|4
183666|NCT00081653|568605|P1|Overall Study|Lost to Follow-up|2
183667|NCT00081653|568604|P2|Overall Study|Adverse Event|17
183668|NCT00081653|568605|P1|Overall Study|Adverse Event|23
183669|NCT00081497|568623|P2|Overall Study|Non-compliance|1
183670|NCT00081497|568624|P1|Overall Study|Non-compliance|0
183671|NCT00081497|568623|P2|Overall Study|Withdrawal by Subject|0
183672|NCT00081497|568624|P1|Overall Study|Withdrawal by Subject|1
183673|NCT00081497|568623|P2|Overall Study|Death|1
183674|NCT00081497|568624|P1|Overall Study|Death|0
183675|NCT00081497|568623|P2|Overall Study|Adverse Event|0
183676|NCT00081497|568624|P1|Overall Study|Adverse Event|2
183677|NCT00081458|568642|P3|Overall Study|Randomized but not dosed|1
183678|NCT00081458|568643|P2|Overall Study|Randomized but not dosed|0
183679|NCT00081458|568644|P1|Overall Study|Randomized but not dosed|0
183680|NCT00081458|568642|P3|Overall Study|Withdrawal by Subject|1
183681|NCT00081458|568643|P2|Overall Study|Withdrawal by Subject|3
183682|NCT00081458|568644|P1|Overall Study|Withdrawal by Subject|0
183683|NCT00081458|568642|P3|Overall Study|Adverse Event|2
183684|NCT00081458|568643|P2|Overall Study|Adverse Event|5
183685|NCT00081458|568644|P1|Overall Study|Adverse Event|1
183686|NCT00081289|568700|P2|Overall Study|Ineligible / no protocol treatment|4
183687|NCT00081289|568701|P1|Overall Study|Ineligible / no protocol treatment|3
183688|NCT00081289|568700|P2|Overall Study|Accrued prior to chemotherapy amendment|17
183689|NCT00081289|568701|P1|Overall Study|Accrued prior to chemotherapy amendment|18
183690|NCT00081159|568709|P2|Overall Study|Lost to Follow-up|1
183691|NCT00081159|568710|P1|Overall Study|Lost to Follow-up|2
183692|NCT00081159|568709|P2|Overall Study|Myelosuppression prior to treatment|1
183693|NCT00081159|568710|P1|Overall Study|Myelosuppression prior to treatment|0
183694|NCT00081159|568709|P2|Overall Study|Withdrawal by Subject|3
183695|NCT00081159|568710|P1|Overall Study|Withdrawal by Subject|0
183696|NCT00080938|568720|P1|Overall Study|Ineligible|4
183697|NCT00080938|568720|P1|Overall Study|Not started protocol therapy|1
183698|NCT00080938|568720|P1|Overall Study|other disease|1
183699|NCT00080938|568720|P1|Overall Study|Lack of Efficacy|7
183700|NCT00080938|568720|P1|Overall Study|Death|2
183701|NCT00080938|568720|P1|Overall Study|Withdrawal by Subject|6
183702|NCT00080938|568720|P1|Overall Study|Adverse Event|3
183703|NCT00080899|568736|P1|Overall Study|Adverse Event|1
183704|NCT00080483|568748|P2|Overall Study|Physician Decision|1
183705|NCT00080483|568749|P1|Overall Study|Physician Decision|1
183706|NCT00080483|568748|P2|Overall Study|Lost to Follow-up|1
183707|NCT00080483|568749|P1|Overall Study|Lost to Follow-up|1
183708|NCT00080301|568768|P2|Overall Study|Still on Treatment as of CSR date|1
183709|NCT00080301|568769|P1|Overall Study|Still on Treatment as of CSR date|0
183710|NCT00080301|568768|P2|Overall Study|Randomized but Never Treated|10
183711|NCT00080301|568769|P1|Overall Study|Randomized but Never Treated|5
183712|NCT00080288|568789|P2|Overall Study|Miscellaneous|11
183713|NCT00080288|568790|P1|Overall Study|Miscellaneous|11
183714|NCT00080288|568789|P2|Overall Study|Withdrawal by Subject|16
183715|NCT00080288|568790|P1|Overall Study|Withdrawal by Subject|3
183716|NCT00080288|568789|P2|Overall Study|Physician Decision|2
183717|NCT00080288|568790|P1|Overall Study|Physician Decision|6
183718|NCT00080288|568789|P2|Overall Study|Lost to Follow-up|5
183719|NCT00080288|568790|P1|Overall Study|Lost to Follow-up|3
183720|NCT00080288|568789|P2|Overall Study|Adverse Event|4
183721|NCT00080288|568790|P1|Overall Study|Adverse Event|7
183722|NCT00080223|568798|P1|Overall Study|Physician Decision|1
183723|NCT00080223|568798|P1|Overall Study|Participant unwilling to continue|2
183724|NCT00080223|568798|P1|Overall Study|Non-compliance With Study Treatment|7
183725|NCT00080223|568798|P1|Overall Study|Lung Transplantation|9
183726|NCT00080223|568798|P1|Overall Study|Withdrawal by Subject|13
183727|NCT00080223|568798|P1|Overall Study|Death|21
183728|NCT00080223|568798|P1|Overall Study|Adverse Event|23
183729|NCT00080119|568810|P4|Overall Study|Lost to Follow-up|14
183730|NCT00080119|568811|P3|Overall Study|Lost to Follow-up|19
183731|NCT00080119|568812|P2|Overall Study|Lost to Follow-up|19
183732|NCT00080119|568813|P1|Overall Study|Lost to Follow-up|16
183733|NCT00080119|568810|P4|Overall Study|Unwilling to adhere to study requirement|1
183734|NCT00080119|568811|P3|Overall Study|Unwilling to adhere to study requirement|5
183735|NCT00080119|568812|P2|Overall Study|Unwilling to adhere to study requirement|2
183736|NCT00080119|568813|P1|Overall Study|Unwilling to adhere to study requirement|3
183737|NCT00080119|568810|P4|Overall Study|Consent withdrawn|6
183738|NCT00080119|568811|P3|Overall Study|Consent withdrawn|4
183739|NCT00080119|568812|P2|Overall Study|Consent withdrawn|17
183740|NCT00080119|568813|P1|Overall Study|Consent withdrawn|13
183741|NCT00080119|568810|P4|Overall Study|Unable to get to clinic|1
183742|NCT00080119|568811|P3|Overall Study|Unable to get to clinic|7
183743|NCT00080119|568812|P2|Overall Study|Unable to get to clinic|24
183744|NCT00080119|568813|P1|Overall Study|Unable to get to clinic|24
183745|NCT00080119|568810|P4|Overall Study|Discontinued because of study closure|141
183746|NCT00080119|568811|P3|Overall Study|Discontinued because of study closure|130
183747|NCT00080119|568812|P2|Overall Study|Discontinued because of study closure|0
183748|NCT00080119|568813|P1|Overall Study|Discontinued because of study closure|0
183749|NCT00079937|568847|P2|Overall Study|Administrative problems|11
183750|NCT00079937|568848|P1|Overall Study|Administrative problems|22
183751|NCT00079937|568847|P2|Overall Study|Lost to Follow-up|5
183752|NCT00079937|568848|P1|Overall Study|Lost to Follow-up|12
183753|NCT00079937|568847|P2|Overall Study|Withdrawal by Subject|7
183754|NCT00079937|568848|P1|Overall Study|Withdrawal by Subject|21
183755|NCT00079937|568847|P2|Overall Study|Protocol Violation|6
183756|NCT00079937|568848|P1|Overall Study|Protocol Violation|8
183757|NCT00079937|568847|P2|Overall Study|Subject no longer requires study drug|0
183758|NCT00079937|568848|P1|Overall Study|Subject no longer requires study drug|3
183759|NCT00079937|568847|P2|Overall Study|Unsatisfactory therapeutic effect|2
183760|NCT00079937|568848|P1|Overall Study|Unsatisfactory therapeutic effect|1
183761|NCT00079937|568847|P2|Overall Study|Adverse Event|1
183762|NCT00079937|568848|P1|Overall Study|Adverse Event|2
183763|NCT00079781|568867|P3|Follow-up Period|Death|1
183764|NCT00079781|568868|P2|Follow-up Period|Death|0
183765|NCT00079781|568869|P1|Follow-up Period|Death|0
183766|NCT00079781|568867|P3|Follow-up Period|Lost to Follow-up|0
183767|NCT00079781|568868|P2|Follow-up Period|Lost to Follow-up|0
183768|NCT00079781|568869|P1|Follow-up Period|Lost to Follow-up|1
183769|NCT00079781|568867|P3|Follow-up Period|Withdrawal by Subject|1
183770|NCT00079781|568868|P2|Follow-up Period|Withdrawal by Subject|0
183771|NCT00079781|568869|P1|Follow-up Period|Withdrawal by Subject|3
183772|NCT00079781|568867|P3|Pre-implant Period|Did not meet I/E criteria|1
183773|NCT00079781|568868|P2|Pre-implant Period|Did not meet I/E criteria|1
183774|NCT00079781|568869|P1|Pre-implant Period|Did not meet I/E criteria|1
183775|NCT00079781|568867|P3|Pre-implant Period|Withdrawal by Subject|0
183776|NCT00079781|568868|P2|Pre-implant Period|Withdrawal by Subject|0
183777|NCT00079781|568869|P1|Pre-implant Period|Withdrawal by Subject|2
183778|NCT00079677|568878|P2|Overall Study|Miscellaneous|0
183779|NCT00079677|568879|P1|Overall Study|Miscellaneous|2
183780|NCT00079677|568878|P2|Overall Study|Withdrawal by Subject|3
183781|NCT00079677|568879|P1|Overall Study|Withdrawal by Subject|5
183782|NCT00079677|568878|P2|Overall Study|Protocol Violation|3
183783|NCT00079677|568879|P1|Overall Study|Protocol Violation|2
183784|NCT00079677|568878|P2|Overall Study|Physician Decision|0
183785|NCT00079677|568879|P1|Overall Study|Physician Decision|3
183786|NCT00079677|568878|P2|Overall Study|Lost to Follow-up|2
183787|NCT00079677|568879|P1|Overall Study|Lost to Follow-up|2
183788|NCT00079677|568878|P2|Overall Study|Lack of Efficacy|0
183789|NCT00079677|568879|P1|Overall Study|Lack of Efficacy|1
183790|NCT00079677|568878|P2|Overall Study|Adverse Event|6
183791|NCT00079677|568879|P1|Overall Study|Adverse Event|5
183792|NCT00079417|568887|P1|Overall Study|ineligible|1
183793|NCT00079417|568887|P1|Overall Study|Tumor requires non-protocol radiotherapy|2
183794|NCT00079417|568887|P1|Overall Study|Tumor requires non-protocol chemotherapy|1
183795|NCT00079417|568887|P1|Overall Study|Physician Decision|5
183796|NCT00079391|568891|P1|Overall Study|Withdrawal by Subject|1
183797|NCT00079339|568903|P3|Overall Study|Disease progression|2
183798|NCT00079339|568904|P2|Overall Study|Disease progression|28
183799|NCT00079339|568905|P1|Overall Study|Disease progression|3
183800|NCT00079339|568903|P3|Overall Study|Withdrawal by Subject|1
183801|NCT00079339|568904|P2|Overall Study|Withdrawal by Subject|4
183802|NCT00079339|568905|P1|Overall Study|Withdrawal by Subject|0
183803|NCT00079339|568903|P3|Overall Study|Non-compliance|1
183804|NCT00079339|568904|P2|Overall Study|Non-compliance|0
183805|NCT00079339|568905|P1|Overall Study|Non-compliance|0
183806|NCT00079339|568903|P3|Overall Study|Death|0
183807|NCT00079339|568904|P2|Overall Study|Death|0
183808|NCT00079339|568905|P1|Overall Study|Death|1
183809|NCT00079339|568903|P3|Overall Study|Adverse Event|2
183810|NCT00079339|568904|P2|Overall Study|Adverse Event|7
183811|NCT00079339|568905|P1|Overall Study|Adverse Event|1
183812|NCT00079274|568936|P7|Overall Study|Not Specified|0
183813|NCT00079274|568937|P6|Overall Study|Not Specified|2
183814|NCT00079274|568938|P5|Overall Study|Not Specified|1
183815|NCT00079274|568939|P4|Overall Study|Not Specified|55
183816|NCT00079274|568940|P3|Overall Study|Not Specified|5
183817|NCT00079274|568941|P2|Overall Study|Not Specified|7
183818|NCT00079274|568942|P1|Overall Study|Not Specified|43
183819|NCT00079274|568936|P7|Overall Study|Cytogenetic resistance|0
183820|NCT00079274|568937|P6|Overall Study|Cytogenetic resistance|0
183821|NCT00079274|568938|P5|Overall Study|Cytogenetic resistance|0
183822|NCT00079274|568939|P4|Overall Study|Cytogenetic resistance|2
183823|NCT00079274|568940|P3|Overall Study|Cytogenetic resistance|0
183824|NCT00079274|568941|P2|Overall Study|Cytogenetic resistance|0
183825|NCT00079274|568942|P1|Overall Study|Cytogenetic resistance|0
183826|NCT00079274|568936|P7|Overall Study|Death|0
183827|NCT00079274|568937|P6|Overall Study|Death|0
183828|NCT00079274|568938|P5|Overall Study|Death|0
183829|NCT00079274|568939|P4|Overall Study|Death|15
183830|NCT00079274|568940|P3|Overall Study|Death|1
183831|NCT00079274|568941|P2|Overall Study|Death|0
183832|NCT00079274|568942|P1|Overall Study|Death|4
183833|NCT00079274|568936|P7|Overall Study|Other Medical Problems|0
183834|NCT00079274|568937|P6|Overall Study|Other Medical Problems|0
183835|NCT00079274|568938|P5|Overall Study|Other Medical Problems|0
183836|NCT00079274|568939|P4|Overall Study|Other Medical Problems|7
183837|NCT00079274|568940|P3|Overall Study|Other Medical Problems|0
183838|NCT00079274|568941|P2|Overall Study|Other Medical Problems|1
183839|NCT00079274|568942|P1|Overall Study|Other Medical Problems|6
183840|NCT00079274|568936|P7|Overall Study|Alternate Treatment|0
183841|NCT00079274|568937|P6|Overall Study|Alternate Treatment|0
183842|NCT00079274|568938|P5|Overall Study|Alternate Treatment|0
183843|NCT00079274|568939|P4|Overall Study|Alternate Treatment|3
183844|NCT00079274|568940|P3|Overall Study|Alternate Treatment|0
183845|NCT00079274|568941|P2|Overall Study|Alternate Treatment|1
183846|NCT00079274|568942|P1|Overall Study|Alternate Treatment|6
183847|NCT00079274|568936|P7|Overall Study|Recurrence|0
183848|NCT00079274|568937|P6|Overall Study|Recurrence|2
183849|NCT00079274|568938|P5|Overall Study|Recurrence|0
183850|NCT00079274|568939|P4|Overall Study|Recurrence|15
183851|NCT00079274|568940|P3|Overall Study|Recurrence|1
183852|NCT00079274|568941|P2|Overall Study|Recurrence|0
183853|NCT00079274|568942|P1|Overall Study|Recurrence|21
183854|NCT00079274|568936|P7|Overall Study|Adverse Event|0
183855|NCT00079274|568937|P6|Overall Study|Adverse Event|8
183856|NCT00079274|568938|P5|Overall Study|Adverse Event|7
183857|NCT00079274|568939|P4|Overall Study|Adverse Event|184
183858|NCT00079274|568940|P3|Overall Study|Adverse Event|8
183859|NCT00079274|568941|P2|Overall Study|Adverse Event|8
183860|NCT00079274|568942|P1|Overall Study|Adverse Event|130
183861|NCT00079274|568936|P7|Overall Study|Withdrawal by Subject|0
183862|NCT00079274|568937|P6|Overall Study|Withdrawal by Subject|8
183863|NCT00079274|568938|P5|Overall Study|Withdrawal by Subject|7
183864|NCT00079274|568939|P4|Overall Study|Withdrawal by Subject|163
183865|NCT00079274|568940|P3|Overall Study|Withdrawal by Subject|12
183866|NCT00079274|568941|P2|Overall Study|Withdrawal by Subject|10
183867|NCT00079274|568942|P1|Overall Study|Withdrawal by Subject|111
183868|NCT00079040|568955|P1|Overall Study|Ineligible|1
183869|NCT00079040|568955|P1|Overall Study|Withdrew before treatment|1
183870|NCT00078949|568978|P4|Maintenance|No treated|3
183871|NCT00078949|568979|P3|Maintenance|No treated|3
183872|NCT00078949|568980|P2|Maintenance|No treated|0
183873|NCT00078949|568981|P1|Maintenance|No treated|0
183874|NCT00078949|568978|P4|Salvage|No treated|0
183875|NCT00078949|568979|P3|Salvage|No treated|0
183876|NCT00078949|568980|P2|Salvage|No treated|5
183877|NCT00078949|568981|P1|Salvage|No treated|4
183878|NCT00078377|569113|P3|Overall Study|Miscellaneous|1
183879|NCT00078377|569114|P2|Overall Study|Miscellaneous|6
183880|NCT00078377|569115|P1|Overall Study|Miscellaneous|2
183881|NCT00078377|569113|P3|Overall Study|Withdrawal by Subject|4
183882|NCT00078377|569114|P2|Overall Study|Withdrawal by Subject|4
183883|NCT00078377|569115|P1|Overall Study|Withdrawal by Subject|3
183884|NCT00078377|569113|P3|Overall Study|Physician Decision|0
183885|NCT00078377|569114|P2|Overall Study|Physician Decision|0
183886|NCT00078377|569115|P1|Overall Study|Physician Decision|2
183887|NCT00078377|569113|P3|Overall Study|Lost to Follow-up|1
183888|NCT00078377|569114|P2|Overall Study|Lost to Follow-up|1
183889|NCT00078377|569115|P1|Overall Study|Lost to Follow-up|0
183890|NCT00078377|569113|P3|Overall Study|Lack of Efficacy|2
183891|NCT00078377|569114|P2|Overall Study|Lack of Efficacy|0
183892|NCT00078377|569115|P1|Overall Study|Lack of Efficacy|2
183893|NCT00078377|569113|P3|Overall Study|Adverse Event|1
183894|NCT00078377|569114|P2|Overall Study|Adverse Event|5
183895|NCT00078377|569115|P1|Overall Study|Adverse Event|2
183896|NCT00078325|569131|P3|Overall Study|Miscellaneous|1
183897|NCT00078325|569132|P2|Overall Study|Miscellaneous|1
183898|NCT00078325|569133|P1|Overall Study|Miscellaneous|1
183899|NCT00078325|569131|P3|Overall Study|Physician Decision|1
183900|NCT00078325|569132|P2|Overall Study|Physician Decision|0
183901|NCT00078325|569133|P1|Overall Study|Physician Decision|2
183902|NCT00078325|569131|P3|Overall Study|Lost to Follow-up|1
183903|NCT00078325|569132|P2|Overall Study|Lost to Follow-up|1
183904|NCT00078325|569133|P1|Overall Study|Lost to Follow-up|0
183905|NCT00078325|569131|P3|Overall Study|Withdrawal by Subject|3
183906|NCT00078325|569132|P2|Overall Study|Withdrawal by Subject|5
183907|NCT00078325|569133|P1|Overall Study|Withdrawal by Subject|1
183908|NCT00078325|569131|P3|Overall Study|Protocol Violation|0
183909|NCT00078325|569132|P2|Overall Study|Protocol Violation|2
183910|NCT00078325|569133|P1|Overall Study|Protocol Violation|2
183911|NCT00078325|569131|P3|Overall Study|Adverse Event|5
183912|NCT00078325|569132|P2|Overall Study|Adverse Event|10
183913|NCT00078325|569133|P1|Overall Study|Adverse Event|15
183914|NCT00078312|569144|P1|Overall Study|Miscellaneous|33
183915|NCT00078312|569144|P1|Overall Study|Withdrawal by Subject|33
183916|NCT00078312|569144|P1|Overall Study|Protocol Violation|3
183917|NCT00078312|569144|P1|Overall Study|Physician Decision|9
183918|NCT00078312|569144|P1|Overall Study|Lost to Follow-up|41
183919|NCT00078312|569144|P1|Overall Study|Lack of Efficacy|15
183920|NCT00078312|569144|P1|Overall Study|Adverse Event|43
183921|NCT00077974|569159|P1|Overall Study|Decision of Sponsor|2
183922|NCT00077974|569159|P1|Overall Study|Lack of Efficacy|76
183923|NCT00077974|569159|P1|Overall Study|Withdrawal by Subject|3
183924|NCT00077974|569159|P1|Overall Study|Protocol Violation|1
183925|NCT00077974|569159|P1|Overall Study|Adverse Event|22
183926|NCT00077857|569181|P2|Overall Study|Other|13
183927|NCT00077857|569182|P1|Overall Study|Other|15
183928|NCT00077857|569181|P2|Overall Study|Failure to return|5
183929|NCT00077857|569182|P1|Overall Study|Failure to return|5
183930|NCT00077857|569181|P2|Overall Study|Refused treatment|21
183931|NCT00077857|569182|P1|Overall Study|Refused treatment|29
183932|NCT00077857|569181|P2|Overall Study|Other protocol violation|1
183933|NCT00077857|569182|P1|Overall Study|Other protocol violation|0
183934|NCT00077857|569181|P2|Overall Study|Violation of selection criteria at entry|1
183935|NCT00077857|569182|P1|Overall Study|Violation of selection criteria at entry|3
183936|NCT00077857|569181|P2|Overall Study|Insufficient therapeutic response|128
183937|NCT00077857|569182|P1|Overall Study|Insufficient therapeutic response|112
183938|NCT00077857|569181|P2|Overall Study|Death|3
183939|NCT00077857|569182|P1|Overall Study|Death|7
183940|NCT00077857|569181|P2|Overall Study|Adverse Event|32
183941|NCT00077857|569182|P1|Overall Study|Adverse Event|30
183942|NCT00077766|569202|P2|Overall Study|Participants Vacation|1
183943|NCT00077766|569203|P1|Overall Study|Participants Vacation|2
183944|NCT00077766|569202|P2|Overall Study|Stop Dialysis|1
183945|NCT00077766|569203|P1|Overall Study|Stop Dialysis|0
183946|NCT00077766|569202|P2|Overall Study|Started Nocturnal Dialysis|1
183947|NCT00077766|569203|P1|Overall Study|Started Nocturnal Dialysis|0
183948|NCT00077766|569202|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
183949|NCT00077766|569203|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
183950|NCT00077766|569202|P2|Overall Study|Dialysis|1
183951|NCT00077766|569203|P1|Overall Study|Dialysis|0
183952|NCT00077766|569202|P2|Overall Study|Dialysis Discontinued|0
183953|NCT00077766|569203|P1|Overall Study|Dialysis Discontinued|1
183954|NCT00077766|569202|P2|Overall Study|Participant's decision|0
183955|NCT00077766|569203|P1|Overall Study|Participant's decision|1
183956|NCT00077766|569202|P2|Overall Study|Investigators Discretion|0
183957|NCT00077766|569203|P1|Overall Study|Investigators Discretion|1
183958|NCT00077766|569202|P2|Overall Study|Transplantation|1
183959|NCT00077766|569203|P1|Overall Study|Transplantation|5
183960|NCT00077766|569202|P2|Overall Study|Kidney Transplantation|5
183961|NCT00077766|569203|P1|Overall Study|Kidney Transplantation|9
183962|NCT00077766|569202|P2|Overall Study|Protocol Violation|0
183963|NCT00077766|569203|P1|Overall Study|Protocol Violation|1
183964|NCT00077766|569202|P2|Overall Study|Lost to Follow-up|0
183965|NCT00077766|569203|P1|Overall Study|Lost to Follow-up|2
183966|NCT00077766|569202|P2|Overall Study|Death|10
183967|NCT00077766|569203|P1|Overall Study|Death|12
183968|NCT00077766|569202|P2|Overall Study|Withdrawal by Subject|3
183969|NCT00077766|569203|P1|Overall Study|Withdrawal by Subject|4
183970|NCT00077766|569202|P2|Overall Study|Adverse Event|1
183971|NCT00077766|569203|P1|Overall Study|Adverse Event|1
183972|NCT00077675|569223|P2|Overall Study|Never received study treatment|3
183973|NCT00077675|569224|P1|Overall Study|Never received study treatment|3
183974|NCT00077675|569223|P2|Overall Study|Other|1
183975|NCT00077675|569224|P1|Overall Study|Other|0
183976|NCT00077675|569223|P2|Overall Study|Withdrawal by Subject|0
183977|NCT00077675|569224|P1|Overall Study|Withdrawal by Subject|1
183978|NCT00077675|569223|P2|Overall Study|Lost to Follow-up|3
183979|NCT00077675|569224|P1|Overall Study|Lost to Follow-up|6
183980|NCT00077675|569223|P2|Overall Study|Adverse Event|2
183981|NCT00077675|569224|P1|Overall Study|Adverse Event|1
183982|NCT00077649|569234|P4|Overall Study|Randomized but never dosed|0
183983|NCT00077649|569235|P3|Overall Study|Randomized but never dosed|0
183984|NCT00077649|569236|P2|Overall Study|Randomized but never dosed|0
183985|NCT00077649|569237|P1|Overall Study|Randomized but never dosed|1
183986|NCT00077649|569234|P4|Overall Study|Abnormality of Laboratory Test|2
183987|NCT00077649|569235|P3|Overall Study|Abnormality of Laboratory Test|1
183988|NCT00077649|569236|P2|Overall Study|Abnormality of Laboratory Test|2
183989|NCT00077649|569237|P1|Overall Study|Abnormality of Laboratory Test|1
183990|NCT00077649|569234|P4|Overall Study|Lost to Follow-up|2
183991|NCT00077649|569235|P3|Overall Study|Lost to Follow-up|3
183992|NCT00077649|569236|P2|Overall Study|Lost to Follow-up|2
183993|NCT00077649|569237|P1|Overall Study|Lost to Follow-up|2
183994|NCT00077649|569234|P4|Overall Study|Withdrawal by Subject|2
183995|NCT00077649|569235|P3|Overall Study|Withdrawal by Subject|1
183996|NCT00077649|569236|P2|Overall Study|Withdrawal by Subject|1
183997|NCT00077649|569237|P1|Overall Study|Withdrawal by Subject|0
183998|NCT00077649|569234|P4|Overall Study|Lack of Efficacy|2
183999|NCT00077649|569235|P3|Overall Study|Lack of Efficacy|3
184000|NCT00077649|569236|P2|Overall Study|Lack of Efficacy|3
184001|NCT00077649|569237|P1|Overall Study|Lack of Efficacy|5
184002|NCT00077649|569234|P4|Overall Study|Adverse Event|9
184003|NCT00077649|569235|P3|Overall Study|Adverse Event|7
184004|NCT00077649|569236|P2|Overall Study|Adverse Event|1
184005|NCT00077649|569237|P1|Overall Study|Adverse Event|5
184006|NCT00077636|569285|P2|Overall Study|Abnormality Of Laboratory Test|2
184007|NCT00077636|569286|P1|Overall Study|Abnormality Of Laboratory Test|3
184008|NCT00077636|569285|P2|Overall Study|Lost to Follow-up|18
184009|NCT00077636|569286|P1|Overall Study|Lost to Follow-up|10
184010|NCT00077636|569285|P2|Overall Study|Protocol Violation|2
184011|NCT00077636|569286|P1|Overall Study|Protocol Violation|0
184012|NCT00077636|569285|P2|Overall Study|Adverse Event|34
184013|NCT00077636|569286|P1|Overall Study|Adverse Event|17
184014|NCT00077636|569285|P2|Overall Study|Withdrawal by Subject|2
184015|NCT00077636|569286|P1|Overall Study|Withdrawal by Subject|2
184016|NCT00077636|569285|P2|Overall Study|Admin|3
184017|NCT00077636|569286|P1|Overall Study|Admin|3
184018|NCT00077636|569285|P2|Overall Study|Refused Treatment|31
184019|NCT00077636|569286|P1|Overall Study|Refused Treatment|9
184020|NCT00077623|569307|P3|Overall Study|Failure to return|0
184021|NCT00077623|569308|P2|Overall Study|Failure to return|0
184022|NCT00077623|569309|P1|Overall Study|Failure to return|1
184023|NCT00077623|569307|P3|Overall Study|Death|11
184024|NCT00077623|569308|P2|Overall Study|Death|18
184025|NCT00077623|569309|P1|Overall Study|Death|12
184026|NCT00077623|569307|P3|Overall Study|Insufficient therapeutic response|0
184027|NCT00077623|569308|P2|Overall Study|Insufficient therapeutic response|0
184028|NCT00077623|569309|P1|Overall Study|Insufficient therapeutic response|2
184029|NCT00077623|569307|P3|Overall Study|Other-Non safety reason|19
184030|NCT00077623|569308|P2|Overall Study|Other-Non safety reason|15
184031|NCT00077623|569309|P1|Overall Study|Other-Non safety reason|18
184032|NCT00077623|569307|P3|Overall Study|Withdrawal by Subject|1
184033|NCT00077623|569308|P2|Overall Study|Withdrawal by Subject|10
184034|NCT00077623|569309|P1|Overall Study|Withdrawal by Subject|2
184035|NCT00077623|569307|P3|Overall Study|Adverse Event|1
184036|NCT00077623|569308|P2|Overall Study|Adverse Event|0
184037|NCT00077623|569309|P1|Overall Study|Adverse Event|1
184038|NCT00077610|569344|P3|Overall Study|Sponsors decision to withdraw|1
184039|NCT00077610|569345|P2|Overall Study|Sponsors decision to withdraw|0
184040|NCT00077610|569346|P1|Overall Study|Sponsors decision to withdraw|0
184041|NCT00077610|569344|P3|Overall Study|Financial issues|0
184042|NCT00077610|569345|P2|Overall Study|Financial issues|1
184043|NCT00077610|569346|P1|Overall Study|Financial issues|0
184044|NCT00077610|569344|P3|Overall Study|Relocation|5
184045|NCT00077610|569345|P2|Overall Study|Relocation|8
184046|NCT00077610|569346|P1|Overall Study|Relocation|0
184047|NCT00077610|569344|P3|Overall Study|Change in dialysis modality|0
184048|NCT00077610|569345|P2|Overall Study|Change in dialysis modality|0
184049|NCT00077610|569346|P1|Overall Study|Change in dialysis modality|1
184050|NCT00077610|569344|P3|Overall Study|Transfer to other center for surgery|0
184051|NCT00077610|569345|P2|Overall Study|Transfer to other center for surgery|0
184052|NCT00077610|569346|P1|Overall Study|Transfer to other center for surgery|1
184053|NCT00077610|569344|P3|Overall Study|Transfer to satellite unit|0
184054|NCT00077610|569345|P2|Overall Study|Transfer to satellite unit|0
184055|NCT00077610|569346|P1|Overall Study|Transfer to satellite unit|1
184056|NCT00077610|569344|P3|Overall Study|Transferred to nursing home|1
184057|NCT00077610|569345|P2|Overall Study|Transferred to nursing home|0
184058|NCT00077610|569346|P1|Overall Study|Transferred to nursing home|0
184059|NCT00077610|569344|P3|Overall Study|Transferred to other unit|1
184060|NCT00077610|569345|P2|Overall Study|Transferred to other unit|0
184061|NCT00077610|569346|P1|Overall Study|Transferred to other unit|0
184062|NCT00077610|569344|P3|Overall Study|Given Epogen in hospital|0
184063|NCT00077610|569345|P2|Overall Study|Given Epogen in hospital|0
184064|NCT00077610|569346|P1|Overall Study|Given Epogen in hospital|1
184065|NCT00077610|569344|P3|Overall Study|Worsening of health condition|0
184066|NCT00077610|569345|P2|Overall Study|Worsening of health condition|1
184067|NCT00077610|569346|P1|Overall Study|Worsening of health condition|1
184068|NCT00077610|569344|P3|Overall Study|Principal Investigator's decision|1
184069|NCT00077610|569345|P2|Overall Study|Principal Investigator's decision|0
184070|NCT00077610|569346|P1|Overall Study|Principal Investigator's decision|1
184071|NCT00077610|569344|P3|Overall Study|Multiple blood transfusions|1
184072|NCT00077610|569345|P2|Overall Study|Multiple blood transfusions|0
184073|NCT00077610|569346|P1|Overall Study|Multiple blood transfusions|0
184074|NCT00077610|569344|P3|Overall Study|Insufficient Therapeutic Response|0
184075|NCT00077610|569345|P2|Overall Study|Insufficient Therapeutic Response|0
184076|NCT00077610|569346|P1|Overall Study|Insufficient Therapeutic Response|1
184077|NCT00077610|569344|P3|Overall Study|Withdrew from dialysis care|3
184078|NCT00077610|569345|P2|Overall Study|Withdrew from dialysis care|0
184079|NCT00077610|569346|P1|Overall Study|Withdrew from dialysis care|5
184080|NCT00077610|569344|P3|Overall Study|Renal transplant|11
184081|NCT00077610|569345|P2|Overall Study|Renal transplant|15
184082|NCT00077610|569346|P1|Overall Study|Renal transplant|12
184083|NCT00077610|569344|P3|Overall Study|Death|13
184084|NCT00077610|569345|P2|Overall Study|Death|13
184085|NCT00077610|569346|P1|Overall Study|Death|17
184086|NCT00077610|569344|P3|Overall Study|Withdrawal by Subject|6
184087|NCT00077610|569345|P2|Overall Study|Withdrawal by Subject|10
184088|NCT00077610|569346|P1|Overall Study|Withdrawal by Subject|4
184089|NCT00077610|569344|P3|Overall Study|Lost to Follow-up|2
184090|NCT00077610|569345|P2|Overall Study|Lost to Follow-up|1
184091|NCT00077610|569346|P1|Overall Study|Lost to Follow-up|0
184092|NCT00077610|569344|P3|Overall Study|Adverse Event|1
184093|NCT00077610|569345|P2|Overall Study|Adverse Event|7
184094|NCT00077610|569346|P1|Overall Study|Adverse Event|9
184095|NCT00077376|569375|P1|Overall Study|Insurance ran out|1
184096|NCT00077376|569375|P1|Overall Study|Surgery|1
184097|NCT00077376|569375|P1|Overall Study|Symptomatic deterioration|1
184098|NCT00077376|569375|P1|Overall Study|Still on treatment|1
184099|NCT00077376|569375|P1|Overall Study|Complicating disease|1
184100|NCT00077376|569375|P1|Overall Study|Alternative therapy|5
184101|NCT00077376|569375|P1|Overall Study|Physician Decision|1
184102|NCT00077376|569375|P1|Overall Study|Death|1
184103|NCT00077376|569375|P1|Overall Study|Withdrawal by Subject|2
184104|NCT00077376|569375|P1|Overall Study|Adverse Event|8
184105|NCT00077207|569386|P1|Overall Study|Ineligible|1
184106|NCT00077207|569386|P1|Overall Study|Withdrawal by Subject|6
184107|NCT00077207|569386|P1|Overall Study|Physician Decision|6
184108|NCT00077207|569386|P1|Overall Study|Lack of Efficacy|12
184109|NCT00077207|569386|P1|Overall Study|Adverse Event|5
184110|NCT00076999|569395|P5|Overall Study|Other reason (not specified)|13
184111|NCT00076999|569396|P4|Overall Study|Other reason (not specified)|1
184112|NCT00076999|569397|P3|Overall Study|Other reason (not specified)|4
184113|NCT00076999|569398|P2|Overall Study|Other reason (not specified)|8
184114|NCT00076999|569399|P1|Overall Study|Other reason (not specified)|8
184115|NCT00076999|569395|P5|Overall Study|Withdrawal by Subject|1
184116|NCT00076999|569396|P4|Overall Study|Withdrawal by Subject|0
184117|NCT00076999|569397|P3|Overall Study|Withdrawal by Subject|3
184118|NCT00076999|569398|P2|Overall Study|Withdrawal by Subject|4
184119|NCT00076999|569399|P1|Overall Study|Withdrawal by Subject|0
184120|NCT00076999|569395|P5|Overall Study|Lost to Follow-up|0
184121|NCT00076999|569396|P4|Overall Study|Lost to Follow-up|0
184122|NCT00076999|569397|P3|Overall Study|Lost to Follow-up|0
184123|NCT00076999|569398|P2|Overall Study|Lost to Follow-up|1
184124|NCT00076999|569399|P1|Overall Study|Lost to Follow-up|2
184125|NCT00076999|569395|P5|Overall Study|Protocol Violation|9
184126|NCT00076999|569396|P4|Overall Study|Protocol Violation|0
184127|NCT00076999|569397|P3|Overall Study|Protocol Violation|4
184128|NCT00076999|569398|P2|Overall Study|Protocol Violation|3
184129|NCT00076999|569399|P1|Overall Study|Protocol Violation|0
184130|NCT00076999|569395|P5|Overall Study|Adverse Event|2
184131|NCT00076999|569396|P4|Overall Study|Adverse Event|0
184132|NCT00076999|569397|P3|Overall Study|Adverse Event|6
184133|NCT00076999|569398|P2|Overall Study|Adverse Event|8
184134|NCT00076999|569399|P1|Overall Study|Adverse Event|2
184135|NCT00076804|569518|P2|Overall Study|Early study Closure|32
184136|NCT00076804|569519|P1|Overall Study|Early study Closure|32
184137|NCT00076804|569518|P2|Overall Study|Withdrawal by Subject|8
184138|NCT00076804|569519|P1|Overall Study|Withdrawal by Subject|10
184139|NCT00076804|569518|P2|Overall Study|Lost to Follow-up|9
184140|NCT00076804|569519|P1|Overall Study|Lost to Follow-up|9
184141|NCT00076804|569518|P2|Overall Study|Death|20
184142|NCT00076804|569519|P1|Overall Study|Death|9
184143|NCT00076752|569531|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
184144|NCT00076752|569531|P1|Overall Study|Death|2
184145|NCT00076570|569560|P2|Overall Study|Drug intolerance|8
184146|NCT00076570|569561|P1|Overall Study|Drug intolerance|8
184147|NCT00075400|569569|P1|Overall Study|Never treated|2
184148|NCT00075400|569569|P1|Overall Study|Ineligible: wrong primary|1
184149|NCT00075270|569577|P2|Overall Study|Missing|13
184150|NCT00075270|569578|P1|Overall Study|Missing|26
184151|NCT00075270|569577|P2|Overall Study|Other/Unknown|5
184152|NCT00075270|569578|P1|Overall Study|Other/Unknown|9
184153|NCT00075270|569577|P2|Overall Study|Death|215
184154|NCT00075270|569578|P1|Overall Study|Death|198
184155|NCT00075270|569577|P2|Overall Study|Protocol Violation|2
184156|NCT00075270|569578|P1|Overall Study|Protocol Violation|0
184157|NCT00075270|569577|P2|Overall Study|Lost to Follow-up|28
184158|NCT00075270|569578|P1|Overall Study|Lost to Follow-up|25
184159|NCT00075270|569577|P2|Overall Study|Withdrawal by Subject|21
184160|NCT00075270|569578|P1|Overall Study|Withdrawal by Subject|28
184161|NCT00076336|569624|P2|Overall Study|Treatment failure|5
184162|NCT00076336|569625|P1|Overall Study|Treatment failure|4
184163|NCT00076336|569624|P2|Overall Study|Virologic Breakthrough|16
184164|NCT00076336|569625|P1|Overall Study|Virologic Breakthrough|14
184165|NCT00076336|569624|P2|Overall Study|Liver Transplantation|3
184166|NCT00076336|569625|P1|Overall Study|Liver Transplantation|3
184167|NCT00076336|569624|P2|Overall Study|Patient, Investigator, Sponsor request|6
184168|NCT00076336|569625|P1|Overall Study|Patient, Investigator, Sponsor request|8
184169|NCT00076336|569624|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
184170|NCT00076336|569625|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
184171|NCT00076336|569624|P2|Overall Study|Non-Compliance|0
184172|NCT00076336|569625|P1|Overall Study|Non-Compliance|2
184173|NCT00076336|569624|P2|Overall Study|Lost to Follow-up|4
184174|NCT00076336|569625|P1|Overall Study|Lost to Follow-up|4
184175|NCT00076336|569624|P2|Overall Study|Adverse Event|4
184176|NCT00076336|569625|P1|Overall Study|Adverse Event|4
184177|NCT00076336|569624|P2|Overall Study|Death|17
184178|NCT00076336|569625|P1|Overall Study|Death|13
184179|NCT00076024|569699|P4|Phase 2, Open-label|Unspecified|2
184180|NCT00076024|569700|P3|Phase 2, Open-label|Unspecified|0
184181|NCT00076024|569701|P2|Phase 2, Open-label|Unspecified|0
184182|NCT00076024|569702|P1|Phase 2, Open-label|Unspecified|0
184183|NCT00076024|569699|P4|Phase 2, Open-label|Withdrawal by Subject|1
184184|NCT00076024|569700|P3|Phase 2, Open-label|Withdrawal by Subject|0
184185|NCT00076024|569701|P2|Phase 2, Open-label|Withdrawal by Subject|0
184186|NCT00076024|569702|P1|Phase 2, Open-label|Withdrawal by Subject|0
184187|NCT00076024|569699|P4|Phase 2, Open-label|Lack of Efficacy|11
184188|NCT00076024|569700|P3|Phase 2, Open-label|Lack of Efficacy|0
184189|NCT00076024|569701|P2|Phase 2, Open-label|Lack of Efficacy|0
184190|NCT00076024|569702|P1|Phase 2, Open-label|Lack of Efficacy|0
184191|NCT00076024|569699|P4|Phase 2, Open-label|Adverse Event|2
184192|NCT00076024|569700|P3|Phase 2, Open-label|Adverse Event|0
184193|NCT00076024|569701|P2|Phase 2, Open-label|Adverse Event|0
184194|NCT00076024|569702|P1|Phase 2, Open-label|Adverse Event|0
184195|NCT00076024|569699|P4|Phase 2, Double-blind|Randomized but not treated|0
184196|NCT00076024|569700|P3|Phase 2, Double-blind|Randomized but not treated|0
184197|NCT00076024|569701|P2|Phase 2, Double-blind|Randomized but not treated|1
184198|NCT00076024|569702|P1|Phase 2, Double-blind|Randomized but not treated|0
184199|NCT00076024|569699|P4|Phase 2, Double-blind|Un-specified|0
184200|NCT00076024|569700|P3|Phase 2, Double-blind|Un-specified|6
184201|NCT00076024|569701|P2|Phase 2, Double-blind|Un-specified|14
184202|NCT00076024|569702|P1|Phase 2, Double-blind|Un-specified|0
184203|NCT00076024|569699|P4|Phase 2, Double-blind|Adverse Event|0
184204|NCT00076024|569700|P3|Phase 2, Double-blind|Adverse Event|6
184205|NCT00076024|569701|P2|Phase 2, Double-blind|Adverse Event|25
184206|NCT00076024|569702|P1|Phase 2, Double-blind|Adverse Event|0
184207|NCT00076024|569699|P4|Phase 2, Double-blind|Withdrawal by Subject|0
184208|NCT00076024|569700|P3|Phase 2, Double-blind|Withdrawal by Subject|4
184209|NCT00076024|569701|P2|Phase 2, Double-blind|Withdrawal by Subject|13
184210|NCT00076024|569702|P1|Phase 2, Double-blind|Withdrawal by Subject|0
184211|NCT00076024|569699|P4|Phase 2, Double-blind|Lack of Efficacy|0
184212|NCT00076024|569700|P3|Phase 2, Double-blind|Lack of Efficacy|40
184213|NCT00076024|569701|P2|Phase 2, Double-blind|Lack of Efficacy|59
184214|NCT00076024|569702|P1|Phase 2, Double-blind|Lack of Efficacy|0
184215|NCT00076024|569699|P4|Phase 1, Lead-in|Clinical progression|0
184216|NCT00076024|569700|P3|Phase 1, Lead-in|Clinical progression|0
184217|NCT00076024|569701|P2|Phase 1, Lead-in|Clinical progression|0
184218|NCT00076024|569702|P1|Phase 1, Lead-in|Clinical progression|1
184219|NCT00076024|569699|P4|Phase 1, Lead-in|Adverse Event|0
184220|NCT00076024|569700|P3|Phase 1, Lead-in|Adverse Event|0
184221|NCT00076024|569701|P2|Phase 1, Lead-in|Adverse Event|0
184222|NCT00076024|569702|P1|Phase 1, Lead-in|Adverse Event|1
184223|NCT00076024|569699|P4|Phase 1, Lead-in|Lack of Efficacy|0
184224|NCT00076024|569700|P3|Phase 1, Lead-in|Lack of Efficacy|0
184225|NCT00076024|569701|P2|Phase 1, Lead-in|Lack of Efficacy|0
184226|NCT00076024|569702|P1|Phase 1, Lead-in|Lack of Efficacy|4
184227|NCT00076011|569716|P1|Overall Study|Ongoing|1
184228|NCT00076011|569716|P1|Overall Study|Unspecified|11
184229|NCT00076011|569716|P1|Overall Study|Study terminated by sponsor|3
184230|NCT00076011|569716|P1|Overall Study|Withdrawal by Subject|1
184231|NCT00076011|569716|P1|Overall Study|Lack of Efficacy|25
184232|NCT00076011|569716|P1|Overall Study|Adverse Event|10
184233|NCT00076011|569716|P1|Overall Study|Death|1
184234|NCT00075946|569728|P5|Overall Study|Other|0
184235|NCT00075946|569729|P4|Overall Study|Other|2
184236|NCT00075946|569730|P3|Overall Study|Other|0
184237|NCT00075946|569731|P2|Overall Study|Other|13
184238|NCT00075946|569732|P1|Overall Study|Other|5
184239|NCT00075946|569728|P5|Overall Study|Time to progression less than 6 months|0
184240|NCT00075946|569729|P4|Overall Study|Time to progression less than 6 months|3
184241|NCT00075946|569730|P3|Overall Study|Time to progression less than 6 months|8
184242|NCT00075946|569731|P2|Overall Study|Time to progression less than 6 months|30
184243|NCT00075946|569732|P1|Overall Study|Time to progression less than 6 months|15
184244|NCT00075946|569728|P5|Overall Study|No response to retreatment|0
184245|NCT00075946|569729|P4|Overall Study|No response to retreatment|0
184246|NCT00075946|569730|P3|Overall Study|No response to retreatment|2
184247|NCT00075946|569731|P2|Overall Study|No response to retreatment|0
184248|NCT00075946|569732|P1|Overall Study|No response to retreatment|23
184249|NCT00075946|569728|P5|Overall Study|Other complicating disease|0
184250|NCT00075946|569729|P4|Overall Study|Other complicating disease|4
184251|NCT00075946|569730|P3|Overall Study|Other complicating disease|1
184252|NCT00075946|569731|P2|Overall Study|Other complicating disease|13
184253|NCT00075946|569732|P1|Overall Study|Other complicating disease|7
184254|NCT00075946|569728|P5|Overall Study|Alternative therapy|0
184255|NCT00075946|569729|P4|Overall Study|Alternative therapy|0
184256|NCT00075946|569730|P3|Overall Study|Alternative therapy|5
184257|NCT00075946|569731|P2|Overall Study|Alternative therapy|2
184258|NCT00075946|569732|P1|Overall Study|Alternative therapy|16
184259|NCT00075946|569728|P5|Overall Study|Withdrawal by Subject|0
184260|NCT00075946|569729|P4|Overall Study|Withdrawal by Subject|9
184261|NCT00075946|569730|P3|Overall Study|Withdrawal by Subject|4
184262|NCT00075946|569731|P2|Overall Study|Withdrawal by Subject|58
184263|NCT00075946|569732|P1|Overall Study|Withdrawal by Subject|23
184264|NCT00075946|569728|P5|Overall Study|Death|0
184265|NCT00075946|569729|P4|Overall Study|Death|0
184266|NCT00075946|569730|P3|Overall Study|Death|0
184267|NCT00075946|569731|P2|Overall Study|Death|1
184268|NCT00075946|569732|P1|Overall Study|Death|0
184269|NCT00075946|569728|P5|Overall Study|Adverse Event|0
184270|NCT00075946|569729|P4|Overall Study|Adverse Event|2
184271|NCT00075946|569730|P3|Overall Study|Adverse Event|0
184272|NCT00075946|569731|P2|Overall Study|Adverse Event|10
184273|NCT00075946|569732|P1|Overall Study|Adverse Event|2
184274|NCT00075946|569728|P5|Overall Study|Still on treatment at time of analysis|0
184275|NCT00075946|569729|P4|Overall Study|Still on treatment at time of analysis|9
184276|NCT00075946|569730|P3|Overall Study|Still on treatment at time of analysis|3
184277|NCT00075946|569731|P2|Overall Study|Still on treatment at time of analysis|19
184278|NCT00075946|569732|P1|Overall Study|Still on treatment at time of analysis|52
184279|NCT00075946|569728|P5|Overall Study|Incorrectly randomized (no response)|0
184280|NCT00075946|569729|P4|Overall Study|Incorrectly randomized (no response)|1
184281|NCT00075946|569730|P3|Overall Study|Incorrectly randomized (no response)|5
184282|NCT00075946|569731|P2|Overall Study|Incorrectly randomized (no response)|5
184283|NCT00075946|569732|P1|Overall Study|Incorrectly randomized (no response)|5
184284|NCT00075946|569728|P5|Overall Study|Did not achieve response after induction|182
184285|NCT00075946|569729|P4|Overall Study|Did not achieve response after induction|0
184286|NCT00075946|569730|P3|Overall Study|Did not achieve response after induction|0
184287|NCT00075946|569731|P2|Overall Study|Did not achieve response after induction|0
184288|NCT00075946|569732|P1|Overall Study|Did not achieve response after induction|0
184289|NCT00075946|569728|P5|Overall Study|Path ineligible: undetermined histology|6
184290|NCT00075946|569729|P4|Overall Study|Path ineligible: undetermined histology|0
184291|NCT00075946|569730|P3|Overall Study|Path ineligible: undetermined histology|0
184292|NCT00075946|569731|P2|Overall Study|Path ineligible: undetermined histology|0
184293|NCT00075946|569732|P1|Overall Study|Path ineligible: undetermined histology|0
184294|NCT00075881|569747|P1|Overall Study|never start protocol therapy|1
184295|NCT00075881|569747|P1|Overall Study|Ineligible|1
184296|NCT00075881|569747|P1|Overall Study|missing data|2
184297|NCT00075881|569747|P1|Overall Study|other|4
184298|NCT00075881|569747|P1|Overall Study|other complicating disease|3
184299|NCT00075881|569747|P1|Overall Study|Protocol Violation|4
184300|NCT00075881|569747|P1|Overall Study|Withdrawal by Subject|2
184301|NCT00075881|569747|P1|Overall Study|Death|1
184302|NCT00075881|569747|P1|Overall Study|Adverse Event|7
184303|NCT00075881|569747|P1|Overall Study|Lack of Efficacy|18
184304|NCT00075816|569791|P2|Overall Study|Did not undergo transplantation|11
184305|NCT00075816|569792|P1|Overall Study|Did not undergo transplantation|14
184306|NCT00075725|569871|P12|Overall Study|Pt incarcerated|0
184307|NCT00075725|569872|P11|Overall Study|Pt incarcerated|0
184308|NCT00075725|569873|P10|Overall Study|Pt incarcerated|0
184309|NCT00075725|569874|P9|Overall Study|Pt incarcerated|0
184310|NCT00075725|569875|P8|Overall Study|Pt incarcerated|1
184311|NCT00075725|569876|P7|Overall Study|Pt incarcerated|0
184312|NCT00075725|569877|P6|Overall Study|Pt incarcerated|0
184313|NCT00075725|569878|P5|Overall Study|Pt incarcerated|0
184314|NCT00075725|569879|P4|Overall Study|Pt incarcerated|0
184315|NCT00075725|569880|P3|Overall Study|Pt incarcerated|0
184316|NCT00075725|569881|P2|Overall Study|Pt incarcerated|0
184317|NCT00075725|569882|P1|Overall Study|Pt incarcerated|0
184318|NCT00075725|569871|P12|Overall Study|Pt care terminated due to pt behavior|0
184319|NCT00075725|569872|P11|Overall Study|Pt care terminated due to pt behavior|0
184320|NCT00075725|569873|P10|Overall Study|Pt care terminated due to pt behavior|0
184321|NCT00075725|569874|P9|Overall Study|Pt care terminated due to pt behavior|0
184322|NCT00075725|569875|P8|Overall Study|Pt care terminated due to pt behavior|1
184323|NCT00075725|569876|P7|Overall Study|Pt care terminated due to pt behavior|0
184324|NCT00075725|569877|P6|Overall Study|Pt care terminated due to pt behavior|0
184325|NCT00075725|569878|P5|Overall Study|Pt care terminated due to pt behavior|0
184326|NCT00075725|569879|P4|Overall Study|Pt care terminated due to pt behavior|0
184327|NCT00075725|569880|P3|Overall Study|Pt care terminated due to pt behavior|0
184328|NCT00075725|569881|P2|Overall Study|Pt care terminated due to pt behavior|0
184329|NCT00075725|569882|P1|Overall Study|Pt care terminated due to pt behavior|0
184330|NCT00075725|569871|P12|Overall Study|Other complications|0
184331|NCT00075725|569872|P11|Overall Study|Other complications|0
184332|NCT00075725|569873|P10|Overall Study|Other complications|0
184333|NCT00075725|569874|P9|Overall Study|Other complications|0
184334|NCT00075725|569875|P8|Overall Study|Other complications|0
184335|NCT00075725|569876|P7|Overall Study|Other complications|0
184336|NCT00075725|569877|P6|Overall Study|Other complications|1
184337|NCT00075725|569878|P5|Overall Study|Other complications|0
184338|NCT00075725|569879|P4|Overall Study|Other complications|0
184339|NCT00075725|569880|P3|Overall Study|Other complications|0
184340|NCT00075725|569881|P2|Overall Study|Other complications|0
184341|NCT00075725|569882|P1|Overall Study|Other complications|0
184342|NCT00075725|569871|P12|Overall Study|Study Closure|0
184343|NCT00075725|569872|P11|Overall Study|Study Closure|0
184344|NCT00075725|569873|P10|Overall Study|Study Closure|0
184345|NCT00075725|569874|P9|Overall Study|Study Closure|0
184346|NCT00075725|569875|P8|Overall Study|Study Closure|1
184347|NCT00075725|569876|P7|Overall Study|Study Closure|0
184348|NCT00075725|569877|P6|Overall Study|Study Closure|3
184349|NCT00075725|569878|P5|Overall Study|Study Closure|1
184350|NCT00075725|569879|P4|Overall Study|Study Closure|0
184351|NCT00075725|569880|P3|Overall Study|Study Closure|0
184352|NCT00075725|569881|P2|Overall Study|Study Closure|0
184353|NCT00075725|569882|P1|Overall Study|Study Closure|1
184354|NCT00075725|569871|P12|Overall Study|Institution Terminated|0
184355|NCT00075725|569872|P11|Overall Study|Institution Terminated|0
184356|NCT00075725|569873|P10|Overall Study|Institution Terminated|0
184357|NCT00075725|569874|P9|Overall Study|Institution Terminated|0
184358|NCT00075725|569875|P8|Overall Study|Institution Terminated|3
184359|NCT00075725|569876|P7|Overall Study|Institution Terminated|0
184360|NCT00075725|569877|P6|Overall Study|Institution Terminated|0
184361|NCT00075725|569878|P5|Overall Study|Institution Terminated|1
184362|NCT00075725|569879|P4|Overall Study|Institution Terminated|0
184363|NCT00075725|569880|P3|Overall Study|Institution Terminated|0
184364|NCT00075725|569881|P2|Overall Study|Institution Terminated|0
184365|NCT00075725|569882|P1|Overall Study|Institution Terminated|0
184366|NCT00075725|569871|P12|Overall Study|Pt relocated|0
184367|NCT00075725|569872|P11|Overall Study|Pt relocated|0
184368|NCT00075725|569873|P10|Overall Study|Pt relocated|0
184369|NCT00075725|569874|P9|Overall Study|Pt relocated|1
184370|NCT00075725|569875|P8|Overall Study|Pt relocated|2
184371|NCT00075725|569876|P7|Overall Study|Pt relocated|1
184372|NCT00075725|569877|P6|Overall Study|Pt relocated|1
184373|NCT00075725|569878|P5|Overall Study|Pt relocated|0
184374|NCT00075725|569879|P4|Overall Study|Pt relocated|2
184375|NCT00075725|569880|P3|Overall Study|Pt relocated|0
184376|NCT00075725|569881|P2|Overall Study|Pt relocated|0
184377|NCT00075725|569882|P1|Overall Study|Pt relocated|0
184378|NCT00075725|569871|P12|Overall Study|Pt received additional steroids|0
184379|NCT00075725|569872|P11|Overall Study|Pt received additional steroids|0
184380|NCT00075725|569873|P10|Overall Study|Pt received additional steroids|0
184381|NCT00075725|569874|P9|Overall Study|Pt received additional steroids|0
184382|NCT00075725|569875|P8|Overall Study|Pt received additional steroids|0
184383|NCT00075725|569876|P7|Overall Study|Pt received additional steroids|0
184384|NCT00075725|569877|P6|Overall Study|Pt received additional steroids|0
184385|NCT00075725|569878|P5|Overall Study|Pt received additional steroids|0
184386|NCT00075725|569879|P4|Overall Study|Pt received additional steroids|1
184387|NCT00075725|569880|P3|Overall Study|Pt received additional steroids|0
184388|NCT00075725|569881|P2|Overall Study|Pt received additional steroids|0
184389|NCT00075725|569882|P1|Overall Study|Pt received additional steroids|0
184390|NCT00075725|569871|P12|Overall Study|Pt went to transplant|0
184391|NCT00075725|569872|P11|Overall Study|Pt went to transplant|0
184392|NCT00075725|569873|P10|Overall Study|Pt went to transplant|0
184393|NCT00075725|569874|P9|Overall Study|Pt went to transplant|0
184394|NCT00075725|569875|P8|Overall Study|Pt went to transplant|0
184395|NCT00075725|569876|P7|Overall Study|Pt went to transplant|0
184396|NCT00075725|569877|P6|Overall Study|Pt went to transplant|1
184397|NCT00075725|569878|P5|Overall Study|Pt went to transplant|0
184398|NCT00075725|569879|P4|Overall Study|Pt went to transplant|1
184399|NCT00075725|569880|P3|Overall Study|Pt went to transplant|0
184400|NCT00075725|569881|P2|Overall Study|Pt went to transplant|0
184401|NCT00075725|569882|P1|Overall Study|Pt went to transplant|0
184402|NCT00075725|569871|P12|Overall Study|specimen(s) not submitted|0
184403|NCT00075725|569872|P11|Overall Study|specimen(s) not submitted|0
184404|NCT00075725|569873|P10|Overall Study|specimen(s) not submitted|0
184405|NCT00075725|569874|P9|Overall Study|specimen(s) not submitted|0
184406|NCT00075725|569875|P8|Overall Study|specimen(s) not submitted|0
184407|NCT00075725|569876|P7|Overall Study|specimen(s) not submitted|0
184408|NCT00075725|569877|P6|Overall Study|specimen(s) not submitted|0
184409|NCT00075725|569878|P5|Overall Study|specimen(s) not submitted|0
184410|NCT00075725|569879|P4|Overall Study|specimen(s) not submitted|0
184411|NCT00075725|569880|P3|Overall Study|specimen(s) not submitted|2
184412|NCT00075725|569881|P2|Overall Study|specimen(s) not submitted|0
184413|NCT00075725|569882|P1|Overall Study|specimen(s) not submitted|0
184414|NCT00075725|569871|P12|Overall Study|Unsuccessful institutional transfer|0
184415|NCT00075725|569872|P11|Overall Study|Unsuccessful institutional transfer|0
184416|NCT00075725|569873|P10|Overall Study|Unsuccessful institutional transfer|1
184417|NCT00075725|569874|P9|Overall Study|Unsuccessful institutional transfer|0
184418|NCT00075725|569875|P8|Overall Study|Unsuccessful institutional transfer|0
184419|NCT00075725|569876|P7|Overall Study|Unsuccessful institutional transfer|0
184420|NCT00075725|569877|P6|Overall Study|Unsuccessful institutional transfer|0
184421|NCT00075725|569878|P5|Overall Study|Unsuccessful institutional transfer|0
184422|NCT00075725|569879|P4|Overall Study|Unsuccessful institutional transfer|0
184423|NCT00075725|569880|P3|Overall Study|Unsuccessful institutional transfer|2
184424|NCT00075725|569881|P2|Overall Study|Unsuccessful institutional transfer|0
184425|NCT00075725|569882|P1|Overall Study|Unsuccessful institutional transfer|0
184426|NCT00075725|569871|P12|Overall Study|Clinic chart lost unable to recreate|0
184427|NCT00075725|569872|P11|Overall Study|Clinic chart lost unable to recreate|0
184428|NCT00075725|569873|P10|Overall Study|Clinic chart lost unable to recreate|0
184429|NCT00075725|569874|P9|Overall Study|Clinic chart lost unable to recreate|0
184430|NCT00075725|569875|P8|Overall Study|Clinic chart lost unable to recreate|0
184431|NCT00075725|569876|P7|Overall Study|Clinic chart lost unable to recreate|0
184432|NCT00075725|569877|P6|Overall Study|Clinic chart lost unable to recreate|0
184433|NCT00075725|569878|P5|Overall Study|Clinic chart lost unable to recreate|0
184434|NCT00075725|569879|P4|Overall Study|Clinic chart lost unable to recreate|0
184435|NCT00075725|569880|P3|Overall Study|Clinic chart lost unable to recreate|1
184436|NCT00075725|569881|P2|Overall Study|Clinic chart lost unable to recreate|0
184437|NCT00075725|569882|P1|Overall Study|Clinic chart lost unable to recreate|0
184438|NCT00075725|569871|P12|Overall Study|Pt trying to find a BM donor|0
184439|NCT00075725|569872|P11|Overall Study|Pt trying to find a BM donor|0
184440|NCT00075725|569873|P10|Overall Study|Pt trying to find a BM donor|0
184441|NCT00075725|569874|P9|Overall Study|Pt trying to find a BM donor|0
184442|NCT00075725|569875|P8|Overall Study|Pt trying to find a BM donor|0
184443|NCT00075725|569876|P7|Overall Study|Pt trying to find a BM donor|0
184444|NCT00075725|569877|P6|Overall Study|Pt trying to find a BM donor|0
184445|NCT00075725|569878|P5|Overall Study|Pt trying to find a BM donor|0
184446|NCT00075725|569879|P4|Overall Study|Pt trying to find a BM donor|0
184447|NCT00075725|569880|P3|Overall Study|Pt trying to find a BM donor|0
184448|NCT00075725|569881|P2|Overall Study|Pt trying to find a BM donor|1
184449|NCT00075725|569882|P1|Overall Study|Pt trying to find a BM donor|0
184450|NCT00075725|569871|P12|Overall Study|Other|3
184451|NCT00075725|569872|P11|Overall Study|Other|0
184452|NCT00075725|569873|P10|Overall Study|Other|1
184453|NCT00075725|569874|P9|Overall Study|Other|2
184454|NCT00075725|569875|P8|Overall Study|Other|9
184455|NCT00075725|569876|P7|Overall Study|Other|2
184456|NCT00075725|569877|P6|Overall Study|Other|4
184457|NCT00075725|569878|P5|Overall Study|Other|1
184458|NCT00075725|569879|P4|Overall Study|Other|1
184459|NCT00075725|569880|P3|Overall Study|Other|1
184460|NCT00075725|569881|P2|Overall Study|Other|2
184461|NCT00075725|569882|P1|Overall Study|Other|4
184462|NCT00075725|569871|P12|Overall Study|Inevaluable|0
184463|NCT00075725|569872|P11|Overall Study|Inevaluable|1
184464|NCT00075725|569873|P10|Overall Study|Inevaluable|0
184465|NCT00075725|569874|P9|Overall Study|Inevaluable|2
184466|NCT00075725|569875|P8|Overall Study|Inevaluable|11
184467|NCT00075725|569876|P7|Overall Study|Inevaluable|1
184468|NCT00075725|569877|P6|Overall Study|Inevaluable|9
184469|NCT00075725|569878|P5|Overall Study|Inevaluable|2
184470|NCT00075725|569879|P4|Overall Study|Inevaluable|2
184471|NCT00075725|569880|P3|Overall Study|Inevaluable|4
184472|NCT00075725|569881|P2|Overall Study|Inevaluable|1
184473|NCT00075725|569882|P1|Overall Study|Inevaluable|1
184474|NCT00075725|569871|P12|Overall Study|Pt has very high risk ALL characteristic|3
184475|NCT00075725|569872|P11|Overall Study|Pt has very high risk ALL characteristic|0
184476|NCT00075725|569873|P10|Overall Study|Pt has very high risk ALL characteristic|1
184477|NCT00075725|569874|P9|Overall Study|Pt has very high risk ALL characteristic|29
184478|NCT00075725|569875|P8|Overall Study|Pt has very high risk ALL characteristic|74
184479|NCT00075725|569876|P7|Overall Study|Pt has very high risk ALL characteristic|23
184480|NCT00075725|569877|P6|Overall Study|Pt has very high risk ALL characteristic|75
184481|NCT00075725|569878|P5|Overall Study|Pt has very high risk ALL characteristic|11
184482|NCT00075725|569879|P4|Overall Study|Pt has very high risk ALL characteristic|18
184483|NCT00075725|569880|P3|Overall Study|Pt has very high risk ALL characteristic|26
184484|NCT00075725|569881|P2|Overall Study|Pt has very high risk ALL characteristic|11
184485|NCT00075725|569882|P1|Overall Study|Pt has very high risk ALL characteristic|15
184486|NCT00075725|569871|P12|Overall Study|MRD positive after extended ind|0
184487|NCT00075725|569872|P11|Overall Study|MRD positive after extended ind|0
184488|NCT00075725|569873|P10|Overall Study|MRD positive after extended ind|0
184489|NCT00075725|569874|P9|Overall Study|MRD positive after extended ind|0
184490|NCT00075725|569875|P8|Overall Study|MRD positive after extended ind|1
184491|NCT00075725|569876|P7|Overall Study|MRD positive after extended ind|0
184492|NCT00075725|569877|P6|Overall Study|MRD positive after extended ind|2
184493|NCT00075725|569878|P5|Overall Study|MRD positive after extended ind|1
184666|NCT00075582|569979|P2|Overall Study|Ineligible for study|16
184494|NCT00075725|569879|P4|Overall Study|MRD positive after extended ind|0
184495|NCT00075725|569880|P3|Overall Study|MRD positive after extended ind|1
184496|NCT00075725|569881|P2|Overall Study|MRD positive after extended ind|1
184497|NCT00075725|569882|P1|Overall Study|MRD positive after extended ind|0
184498|NCT00075725|569871|P12|Overall Study|Insurance issues|0
184499|NCT00075725|569872|P11|Overall Study|Insurance issues|0
184500|NCT00075725|569873|P10|Overall Study|Insurance issues|0
184501|NCT00075725|569874|P9|Overall Study|Insurance issues|0
184502|NCT00075725|569875|P8|Overall Study|Insurance issues|1
184503|NCT00075725|569876|P7|Overall Study|Insurance issues|0
184504|NCT00075725|569877|P6|Overall Study|Insurance issues|1
184505|NCT00075725|569878|P5|Overall Study|Insurance issues|1
184506|NCT00075725|569879|P4|Overall Study|Insurance issues|1
184507|NCT00075725|569880|P3|Overall Study|Insurance issues|0
184508|NCT00075725|569881|P2|Overall Study|Insurance issues|1
184509|NCT00075725|569882|P1|Overall Study|Insurance issues|0
184510|NCT00075725|569871|P12|Overall Study|Pt age out of range for treatment|0
184511|NCT00075725|569872|P11|Overall Study|Pt age out of range for treatment|0
184512|NCT00075725|569873|P10|Overall Study|Pt age out of range for treatment|0
184513|NCT00075725|569874|P9|Overall Study|Pt age out of range for treatment|0
184514|NCT00075725|569875|P8|Overall Study|Pt age out of range for treatment|1
184515|NCT00075725|569876|P7|Overall Study|Pt age out of range for treatment|0
184516|NCT00075725|569877|P6|Overall Study|Pt age out of range for treatment|1
184517|NCT00075725|569878|P5|Overall Study|Pt age out of range for treatment|0
184518|NCT00075725|569879|P4|Overall Study|Pt age out of range for treatment|0
184519|NCT00075725|569880|P3|Overall Study|Pt age out of range for treatment|0
184520|NCT00075725|569881|P2|Overall Study|Pt age out of range for treatment|1
184521|NCT00075725|569882|P1|Overall Study|Pt age out of range for treatment|0
184522|NCT00075725|569871|P12|Overall Study|Pt non compliant with therapy|0
184523|NCT00075725|569872|P11|Overall Study|Pt non compliant with therapy|0
184524|NCT00075725|569873|P10|Overall Study|Pt non compliant with therapy|0
184525|NCT00075725|569874|P9|Overall Study|Pt non compliant with therapy|3
184526|NCT00075725|569875|P8|Overall Study|Pt non compliant with therapy|5
184527|NCT00075725|569876|P7|Overall Study|Pt non compliant with therapy|2
184528|NCT00075725|569877|P6|Overall Study|Pt non compliant with therapy|14
184529|NCT00075725|569878|P5|Overall Study|Pt non compliant with therapy|2
184530|NCT00075725|569879|P4|Overall Study|Pt non compliant with therapy|0
184531|NCT00075725|569880|P3|Overall Study|Pt non compliant with therapy|1
184532|NCT00075725|569881|P2|Overall Study|Pt non compliant with therapy|1
184533|NCT00075725|569882|P1|Overall Study|Pt non compliant with therapy|2
184534|NCT00075725|569871|P12|Overall Study|Pt/Guardian refused RT therapy|0
184535|NCT00075725|569872|P11|Overall Study|Pt/Guardian refused RT therapy|0
184536|NCT00075725|569873|P10|Overall Study|Pt/Guardian refused RT therapy|0
184537|NCT00075725|569874|P9|Overall Study|Pt/Guardian refused RT therapy|0
184538|NCT00075725|569875|P8|Overall Study|Pt/Guardian refused RT therapy|0
184539|NCT00075725|569876|P7|Overall Study|Pt/Guardian refused RT therapy|0
184540|NCT00075725|569877|P6|Overall Study|Pt/Guardian refused RT therapy|0
184541|NCT00075725|569878|P5|Overall Study|Pt/Guardian refused RT therapy|1
184542|NCT00075725|569879|P4|Overall Study|Pt/Guardian refused RT therapy|2
184543|NCT00075725|569880|P3|Overall Study|Pt/Guardian refused RT therapy|1
184544|NCT00075725|569881|P2|Overall Study|Pt/Guardian refused RT therapy|0
184545|NCT00075725|569882|P1|Overall Study|Pt/Guardian refused RT therapy|1
184546|NCT00075725|569871|P12|Overall Study|Ineligible or wrong diagnosis|4
184547|NCT00075725|569872|P11|Overall Study|Ineligible or wrong diagnosis|2
184548|NCT00075725|569873|P10|Overall Study|Ineligible or wrong diagnosis|1
184549|NCT00075725|569874|P9|Overall Study|Ineligible or wrong diagnosis|10
184550|NCT00075725|569875|P8|Overall Study|Ineligible or wrong diagnosis|9
184551|NCT00075725|569876|P7|Overall Study|Ineligible or wrong diagnosis|6
184552|NCT00075725|569877|P6|Overall Study|Ineligible or wrong diagnosis|17
184553|NCT00075725|569878|P5|Overall Study|Ineligible or wrong diagnosis|3
184554|NCT00075725|569879|P4|Overall Study|Ineligible or wrong diagnosis|10
184555|NCT00075725|569880|P3|Overall Study|Ineligible or wrong diagnosis|3
184556|NCT00075725|569881|P2|Overall Study|Ineligible or wrong diagnosis|3
184557|NCT00075725|569882|P1|Overall Study|Ineligible or wrong diagnosis|8
184558|NCT00075725|569871|P12|Overall Study|Patient off treatment|0
184559|NCT00075725|569872|P11|Overall Study|Patient off treatment|0
184560|NCT00075725|569873|P10|Overall Study|Patient off treatment|0
184561|NCT00075725|569874|P9|Overall Study|Patient off treatment|1
184562|NCT00075725|569875|P8|Overall Study|Patient off treatment|2
184563|NCT00075725|569876|P7|Overall Study|Patient off treatment|0
184564|NCT00075725|569877|P6|Overall Study|Patient off treatment|0
184565|NCT00075725|569878|P5|Overall Study|Patient off treatment|1
184566|NCT00075725|569879|P4|Overall Study|Patient off treatment|2
184567|NCT00075725|569880|P3|Overall Study|Patient off treatment|1
184568|NCT00075725|569881|P2|Overall Study|Patient off treatment|0
184569|NCT00075725|569882|P1|Overall Study|Patient off treatment|0
184570|NCT00075725|569871|P12|Overall Study|Disease Progression, all other reasons|5
184571|NCT00075725|569872|P11|Overall Study|Disease Progression, all other reasons|0
184572|NCT00075725|569873|P10|Overall Study|Disease Progression, all other reasons|4
184573|NCT00075725|569874|P9|Overall Study|Disease Progression, all other reasons|21
184574|NCT00075725|569875|P8|Overall Study|Disease Progression, all other reasons|46
184575|NCT00075725|569876|P7|Overall Study|Disease Progression, all other reasons|20
184576|NCT00075725|569877|P6|Overall Study|Disease Progression, all other reasons|59
184577|NCT00075725|569878|P5|Overall Study|Disease Progression, all other reasons|21
184578|NCT00075725|569879|P4|Overall Study|Disease Progression, all other reasons|6
184579|NCT00075725|569880|P3|Overall Study|Disease Progression, all other reasons|33
184580|NCT00075725|569881|P2|Overall Study|Disease Progression, all other reasons|5
184581|NCT00075725|569882|P1|Overall Study|Disease Progression, all other reasons|17
184582|NCT00075725|569871|P12|Overall Study|Withdrawal by Subject|0
184583|NCT00075725|569872|P11|Overall Study|Withdrawal by Subject|0
184584|NCT00075725|569873|P10|Overall Study|Withdrawal by Subject|2
184585|NCT00075725|569874|P9|Overall Study|Withdrawal by Subject|10
184586|NCT00075725|569875|P8|Overall Study|Withdrawal by Subject|31
184587|NCT00075725|569876|P7|Overall Study|Withdrawal by Subject|7
184588|NCT00075725|569877|P6|Overall Study|Withdrawal by Subject|27
184589|NCT00075725|569878|P5|Overall Study|Withdrawal by Subject|6
184590|NCT00075725|569879|P4|Overall Study|Withdrawal by Subject|10
184591|NCT00075725|569880|P3|Overall Study|Withdrawal by Subject|6
184592|NCT00075725|569881|P2|Overall Study|Withdrawal by Subject|3
184593|NCT00075725|569882|P1|Overall Study|Withdrawal by Subject|12
184594|NCT00075725|569871|P12|Overall Study|Protocol Violation|1
184595|NCT00075725|569872|P11|Overall Study|Protocol Violation|0
184596|NCT00075725|569873|P10|Overall Study|Protocol Violation|0
184597|NCT00075725|569874|P9|Overall Study|Protocol Violation|3
184598|NCT00075725|569875|P8|Overall Study|Protocol Violation|2
184599|NCT00075725|569876|P7|Overall Study|Protocol Violation|1
184600|NCT00075725|569877|P6|Overall Study|Protocol Violation|2
184601|NCT00075725|569878|P5|Overall Study|Protocol Violation|3
184602|NCT00075725|569879|P4|Overall Study|Protocol Violation|3
184603|NCT00075725|569880|P3|Overall Study|Protocol Violation|0
184604|NCT00075725|569881|P2|Overall Study|Protocol Violation|1
184605|NCT00075725|569882|P1|Overall Study|Protocol Violation|1
184606|NCT00075725|569871|P12|Overall Study|Pregnancy|0
184607|NCT00075725|569872|P11|Overall Study|Pregnancy|0
184608|NCT00075725|569873|P10|Overall Study|Pregnancy|0
184609|NCT00075725|569874|P9|Overall Study|Pregnancy|0
184610|NCT00075725|569875|P8|Overall Study|Pregnancy|1
184611|NCT00075725|569876|P7|Overall Study|Pregnancy|0
184612|NCT00075725|569877|P6|Overall Study|Pregnancy|1
184613|NCT00075725|569878|P5|Overall Study|Pregnancy|0
184614|NCT00075725|569879|P4|Overall Study|Pregnancy|0
184615|NCT00075725|569880|P3|Overall Study|Pregnancy|0
184616|NCT00075725|569881|P2|Overall Study|Pregnancy|0
184617|NCT00075725|569882|P1|Overall Study|Pregnancy|0
184618|NCT00075725|569871|P12|Overall Study|Physician Decision|0
184619|NCT00075725|569872|P11|Overall Study|Physician Decision|1
184620|NCT00075725|569873|P10|Overall Study|Physician Decision|0
184621|NCT00075725|569874|P9|Overall Study|Physician Decision|5
184622|NCT00075725|569875|P8|Overall Study|Physician Decision|17
184623|NCT00075725|569876|P7|Overall Study|Physician Decision|3
184624|NCT00075725|569877|P6|Overall Study|Physician Decision|19
184625|NCT00075725|569878|P5|Overall Study|Physician Decision|4
184626|NCT00075725|569879|P4|Overall Study|Physician Decision|8
184627|NCT00075725|569880|P3|Overall Study|Physician Decision|5
184628|NCT00075725|569881|P2|Overall Study|Physician Decision|6
184629|NCT00075725|569882|P1|Overall Study|Physician Decision|2
184630|NCT00075725|569871|P12|Overall Study|Lost to Follow-up|0
184631|NCT00075725|569872|P11|Overall Study|Lost to Follow-up|0
184632|NCT00075725|569873|P10|Overall Study|Lost to Follow-up|0
184633|NCT00075725|569874|P9|Overall Study|Lost to Follow-up|1
184634|NCT00075725|569875|P8|Overall Study|Lost to Follow-up|4
184635|NCT00075725|569876|P7|Overall Study|Lost to Follow-up|2
184636|NCT00075725|569877|P6|Overall Study|Lost to Follow-up|13
184637|NCT00075725|569878|P5|Overall Study|Lost to Follow-up|0
184638|NCT00075725|569879|P4|Overall Study|Lost to Follow-up|1
184639|NCT00075725|569880|P3|Overall Study|Lost to Follow-up|4
184640|NCT00075725|569881|P2|Overall Study|Lost to Follow-up|1
184641|NCT00075725|569882|P1|Overall Study|Lost to Follow-up|1
184642|NCT00075725|569871|P12|Overall Study|Death|0
184643|NCT00075725|569872|P11|Overall Study|Death|3
184644|NCT00075725|569873|P10|Overall Study|Death|4
184645|NCT00075725|569874|P9|Overall Study|Death|14
184646|NCT00075725|569875|P8|Overall Study|Death|22
184647|NCT00075725|569876|P7|Overall Study|Death|4
184648|NCT00075725|569877|P6|Overall Study|Death|25
184649|NCT00075725|569878|P5|Overall Study|Death|3
184650|NCT00075725|569879|P4|Overall Study|Death|2
184651|NCT00075725|569880|P3|Overall Study|Death|10
184652|NCT00075725|569881|P2|Overall Study|Death|5
184653|NCT00075725|569882|P1|Overall Study|Death|3
184654|NCT00075725|569871|P12|Overall Study|Adverse Event|2
184655|NCT00075725|569872|P11|Overall Study|Adverse Event|2
184656|NCT00075725|569873|P10|Overall Study|Adverse Event|4
184657|NCT00075725|569874|P9|Overall Study|Adverse Event|15
184658|NCT00075725|569875|P8|Overall Study|Adverse Event|51
184659|NCT00075725|569876|P7|Overall Study|Adverse Event|3
184660|NCT00075725|569877|P6|Overall Study|Adverse Event|38
184661|NCT00075725|569878|P5|Overall Study|Adverse Event|4
184662|NCT00075725|569879|P4|Overall Study|Adverse Event|8
184663|NCT00075725|569880|P3|Overall Study|Adverse Event|20
184664|NCT00075725|569881|P2|Overall Study|Adverse Event|6
184665|NCT00075725|569882|P1|Overall Study|Adverse Event|6
184667|NCT00075582|569980|P1|Overall Study|Ineligible for study|36
184668|NCT00075582|569979|P2|Overall Study|Withdrawal by Subject|2
184669|NCT00075582|569980|P1|Overall Study|Withdrawal by Subject|2
184670|NCT00075582|569979|P2|Overall Study|Physician Decision|8
184671|NCT00075582|569980|P1|Overall Study|Physician Decision|5
184672|NCT00075582|569979|P2|Overall Study|Lack of Efficacy|8
184673|NCT00075582|569980|P1|Overall Study|Lack of Efficacy|4
184674|NCT00075582|569979|P2|Overall Study|Adverse Event|1
184675|NCT00075582|569980|P1|Overall Study|Adverse Event|3
184676|NCT00075504|569990|P2|Overall Study|Withdrawal by Subject|7
184677|NCT00075504|569991|P1|Overall Study|Withdrawal by Subject|9
184678|NCT00075478|570003|P2|Overall Study|Physician Decision|1
184679|NCT00075478|570004|P1|Overall Study|Physician Decision|0
184680|NCT00075478|570003|P2|Overall Study|not eligible|0
184681|NCT00075478|570004|P1|Overall Study|not eligible|1
184682|NCT00075218|570026|P3|Open-Label Treatment|enrolled in a separate continuation|9
184683|NCT00075218|570027|P2|Open-Label Treatment|enrolled in a separate continuation|0
184684|NCT00075218|570028|P1|Open-Label Treatment|enrolled in a separate continuation|0
184685|NCT00075218|570026|P3|Open-Label Treatment|Protocol Violation|1
184686|NCT00075218|570027|P2|Open-Label Treatment|Protocol Violation|0
184687|NCT00075218|570028|P1|Open-Label Treatment|Protocol Violation|0
184688|NCT00075218|570026|P3|Open-Label Treatment|Decision of Sponsor|8
184689|NCT00075218|570027|P2|Open-Label Treatment|Decision of Sponsor|0
184690|NCT00075218|570028|P1|Open-Label Treatment|Decision of Sponsor|0
184691|NCT00075218|570026|P3|Open-Label Treatment|Withdrawal by Subject|12
184692|NCT00075218|570027|P2|Open-Label Treatment|Withdrawal by Subject|0
184693|NCT00075218|570028|P1|Open-Label Treatment|Withdrawal by Subject|0
184694|NCT00075218|570026|P3|Open-Label Treatment|Adverse Event|51
184695|NCT00075218|570027|P2|Open-Label Treatment|Adverse Event|0
184696|NCT00075218|570028|P1|Open-Label Treatment|Adverse Event|0
184697|NCT00075218|570026|P3|Open-Label Treatment|Lack of Efficacy|174
184698|NCT00075218|570027|P2|Open-Label Treatment|Lack of Efficacy|0
184699|NCT00075218|570028|P1|Open-Label Treatment|Lack of Efficacy|0
184700|NCT00075218|570026|P3|Double-Blind Treatment|No study medication taken|0
184701|NCT00075218|570027|P2|Double-Blind Treatment|No study medication taken|0
184702|NCT00075218|570028|P1|Double-Blind Treatment|No study medication taken|2
184703|NCT00075218|570026|P3|Double-Blind Treatment|Decision of Sponsor|0
184704|NCT00075218|570027|P2|Double-Blind Treatment|Decision of Sponsor|1
184705|NCT00075218|570028|P1|Double-Blind Treatment|Decision of Sponsor|0
184706|NCT00075218|570026|P3|Double-Blind Treatment|Lack of Efficacy|0
184707|NCT00075218|570027|P2|Double-Blind Treatment|Lack of Efficacy|6
184708|NCT00075218|570028|P1|Double-Blind Treatment|Lack of Efficacy|58
184709|NCT00075218|570026|P3|Double-Blind Treatment|Lost to Follow-up|0
184710|NCT00075218|570027|P2|Double-Blind Treatment|Lost to Follow-up|0
184711|NCT00075218|570028|P1|Double-Blind Treatment|Lost to Follow-up|1
184712|NCT00075218|570026|P3|Double-Blind Treatment|Withdrawal by Subject|0
184713|NCT00075218|570027|P2|Double-Blind Treatment|Withdrawal by Subject|4
184714|NCT00075218|570028|P1|Double-Blind Treatment|Withdrawal by Subject|7
184715|NCT00075218|570026|P3|Double-Blind Treatment|Adverse Event|0
184716|NCT00075218|570027|P2|Double-Blind Treatment|Adverse Event|4
184717|NCT00075218|570028|P1|Double-Blind Treatment|Adverse Event|23
184718|NCT00075023|570077|P2|Pilot Study|Withdrawal by Subject|0
184719|NCT00075023|570078|P1|Pilot Study|Withdrawal by Subject|1
184720|NCT00075023|570077|P2|Pilot Study|Physician Decision|2
184721|NCT00075023|570078|P1|Pilot Study|Physician Decision|1
184722|NCT00074984|570087|P2|Overall Study|Patient Withdrawn Per Protocol|3
184723|NCT00074984|570088|P1|Overall Study|Patient Withdrawn Per Protocol|0
184724|NCT00074984|570087|P2|Overall Study|Withdrawal by Subject|3
184725|NCT00074984|570088|P1|Overall Study|Withdrawal by Subject|2
184726|NCT00074984|570087|P2|Overall Study|Death|2
184727|NCT00074984|570088|P1|Overall Study|Death|1
184728|NCT00074958|570103|P1|Overall Study|Adverse Event|1
184729|NCT00074711|570123|P2|Overall Study|Participant stopped study drug|6
184730|NCT00074711|570124|P1|Overall Study|Participant stopped study drug|4
184731|NCT00074711|570123|P2|Overall Study|Lost to Follow-up|8
184732|NCT00074711|570124|P1|Overall Study|Lost to Follow-up|10
184733|NCT00074711|570123|P2|Overall Study|Withdrawal by Subject|1
184734|NCT00074711|570124|P1|Overall Study|Withdrawal by Subject|1
184735|NCT00074581|570142|P2|Overall Study|Other|19
184736|NCT00074581|570143|P1|Overall Study|Other|14
184737|NCT00074581|570142|P2|Overall Study|Ended relationship w. index participant|106
184738|NCT00074581|570143|P1|Overall Study|Ended relationship w. index participant|117
184739|NCT00074581|570142|P2|Overall Study|Lost to Follow-up|11
184740|NCT00074581|570143|P1|Overall Study|Lost to Follow-up|16
184741|NCT00074581|570142|P2|Overall Study|Were withdrawn by investigator|2
184742|NCT00074581|570143|P1|Overall Study|Were withdrawn by investigator|5
184743|NCT00074581|570142|P2|Overall Study|Relocated|9
184744|NCT00074581|570143|P1|Overall Study|Relocated|14
184745|NCT00074581|570142|P2|Overall Study|Unable to adhere to visit schedule|14
184746|NCT00074581|570143|P1|Overall Study|Unable to adhere to visit schedule|13
184747|NCT00074581|570142|P2|Overall Study|Withdrawal by Subject|49
184748|NCT00074581|570143|P1|Overall Study|Withdrawal by Subject|50
184749|NCT00074581|570142|P2|Overall Study|Death|16
184750|NCT00074581|570143|P1|Overall Study|Death|15
184751|NCT00074412|570153|P2|Overall Study|Lost to Follow-up|58
184752|NCT00074412|570154|P1|Overall Study|Lost to Follow-up|52
184753|NCT00074412|570153|P2|Overall Study|Death|26
184754|NCT00074412|570154|P1|Overall Study|Death|30
184755|NCT00074152|570179|P2|Overall Study|Lack of Efficacy|24
184756|NCT00074152|570180|P1|Overall Study|Lack of Efficacy|34
184757|NCT00074152|570179|P2|Overall Study|Death|9
184758|NCT00074152|570180|P1|Overall Study|Death|21
184759|NCT00073983|570190|P1|Overall Study|not evaluable|1
184760|NCT00073918|570205|P1|Overall Study|Eligibility requirement not met-low CD20|1
184761|NCT00073918|570205|P1|Overall Study|Rapid disease progression|2
184762|NCT00073918|570205|P1|Overall Study|Eligibility requirement not met - HAMA+|1
184763|NCT00073528|570212|P2|Overall Study|Ongoing|344
184764|NCT00073528|570213|P1|Overall Study|Ongoing|349
184765|NCT00073528|570212|P2|Overall Study|Non-compliance|1
184766|NCT00073528|570213|P1|Overall Study|Non-compliance|0
184767|NCT00073528|570212|P2|Overall Study|Enrolled in Error|1
184768|NCT00073528|570213|P1|Overall Study|Enrolled in Error|0
184769|NCT00073528|570212|P2|Overall Study|Participant Was Unblinded|1
184770|NCT00073528|570213|P1|Overall Study|Participant Was Unblinded|0
184771|NCT00073528|570212|P2|Overall Study|Progressive Disease|1
184772|NCT00073528|570213|P1|Overall Study|Progressive Disease|0
184773|NCT00073528|570212|P2|Overall Study|Randomized in Error; Not Treated|0
184774|NCT00073528|570213|P1|Overall Study|Randomized in Error; Not Treated|2
184775|NCT00073528|570212|P2|Overall Study|Mastectomy Intervention|0
184776|NCT00073528|570213|P1|Overall Study|Mastectomy Intervention|1
184777|NCT00073528|570212|P2|Overall Study|Death|238
184778|NCT00073528|570213|P1|Overall Study|Death|229
184779|NCT00073528|570212|P2|Overall Study|Protocol Violation|5
184780|NCT00073528|570213|P1|Overall Study|Protocol Violation|3
184781|NCT00073528|570212|P2|Overall Study|Lost to Follow-up|22
184782|NCT00073528|570213|P1|Overall Study|Lost to Follow-up|26
184783|NCT00073528|570212|P2|Overall Study|Withdrawal by Subject|29
184784|NCT00073528|570213|P1|Overall Study|Withdrawal by Subject|34
184785|NCT00073307|570302|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
184786|NCT00073307|570303|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
184787|NCT00073307|570304|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
184788|NCT00073307|570302|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
184789|NCT00073307|570303|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
184790|NCT00073307|570304|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
184791|NCT00073307|570302|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
184792|NCT00073307|570303|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
184793|NCT00073307|570304|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
184794|NCT00073307|570302|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
184795|NCT00073307|570303|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
184796|NCT00073307|570304|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
184797|NCT00073307|570302|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
184798|NCT00073307|570303|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
184799|NCT00073307|570304|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
184800|NCT00073307|570302|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
184801|NCT00073307|570303|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
184802|NCT00073307|570304|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
184803|NCT00073307|570302|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
184804|NCT00073307|570303|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
184805|NCT00073307|570304|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
184806|NCT00073307|570302|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
184807|NCT00073307|570303|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
184808|NCT00073307|570304|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
184809|NCT00073307|570302|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
184810|NCT00073307|570303|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
184811|NCT00073307|570304|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
184812|NCT00073307|570302|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
184813|NCT00073307|570303|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
184814|NCT00073307|570304|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
184815|NCT00073307|570302|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
184816|NCT00073307|570303|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
184817|NCT00073307|570304|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
184818|NCT00073307|570302|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
184819|NCT00073307|570303|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
184820|NCT00073307|570304|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
184821|NCT00073307|570302|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
184822|NCT00073307|570303|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
184823|NCT00073307|570304|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
184824|NCT00073307|570302|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
184825|NCT00073307|570303|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
184826|NCT00073307|570304|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
184827|NCT00073307|570302|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
184828|NCT00073307|570303|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
184829|NCT00073307|570304|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
184830|NCT00073307|570302|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
184831|NCT00073307|570303|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
184832|NCT00073307|570304|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
184833|NCT00073307|570302|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
184834|NCT00073307|570303|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
184835|NCT00073307|570304|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
184836|NCT00073307|570302|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
184837|NCT00073307|570303|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
184838|NCT00073307|570304|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
184839|NCT00073307|570302|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
184840|NCT00073307|570303|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
184841|NCT00073307|570304|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
184842|NCT00073021|570335|P2|Overall Study|Lack of Efficacy|5
184843|NCT00073021|570336|P1|Overall Study|Lack of Efficacy|11
184844|NCT00073021|570335|P2|Overall Study|Physician Decision|1
184845|NCT00073021|570336|P1|Overall Study|Physician Decision|3
184846|NCT00073021|570335|P2|Overall Study|Withdrawal by Subject|5
184847|NCT00073021|570336|P1|Overall Study|Withdrawal by Subject|6
184848|NCT00073021|570335|P2|Overall Study|Adverse Event|4
184849|NCT00073021|570336|P1|Overall Study|Adverse Event|4
184850|NCT00073021|570335|P2|Overall Study|Protocol Violation|1
184851|NCT00073021|570336|P1|Overall Study|Protocol Violation|2
184852|NCT00073008|570366|P2|Overall Study|"Other selected on Case Report Form"|5
184853|NCT00073008|570367|P1|Overall Study|"Other selected on Case Report Form"|7
184854|NCT00073008|570366|P2|Overall Study|Death|47
184855|NCT00073008|570367|P1|Overall Study|Death|46
184856|NCT00073008|570366|P2|Overall Study|Lost to Follow-up|3
184857|NCT00073008|570367|P1|Overall Study|Lost to Follow-up|1
184858|NCT00073008|570366|P2|Overall Study|Withdrawal by Subject|2
184859|NCT00073008|570367|P1|Overall Study|Withdrawal by Subject|2
184860|NCT00073008|570366|P2|Overall Study|Missing|6
184861|NCT00073008|570367|P1|Overall Study|Missing|6
184862|NCT00072475|570412|P1|Overall Study|Patient/Investigator Decision|4
184863|NCT00072475|570412|P1|Overall Study|Withdrawal by Subject|46
184864|NCT00072475|570412|P1|Overall Study|Death|3
184865|NCT00072475|570412|P1|Overall Study|Adverse Event|44
184866|NCT00072293|570429|P2|Overall Study|Withdrawal by Subject|1
184867|NCT00072293|570430|P1|Overall Study|Withdrawal by Subject|0
184868|NCT00072293|570429|P2|Overall Study|Lost to Follow-up|1
184869|NCT00072293|570430|P1|Overall Study|Lost to Follow-up|1
184870|NCT00072280|570442|P2|Follow-up|Early termination of study|2
184871|NCT00072280|570443|P1|Follow-up|Early termination of study|2
184872|NCT00072280|570442|P2|Treatment|Found ineligible|2
184873|NCT00072280|570443|P1|Treatment|Found ineligible|1
184874|NCT00072189|570448|P1|Overall Study|Withdrawal by Subject|1
184875|NCT00072176|570456|P2|Overall Study|Protocol Violation|1
184876|NCT00072176|570457|P1|Overall Study|Protocol Violation|0
184877|NCT00072176|570456|P2|Overall Study|Withdrawal by Subject|0
184878|NCT00072176|570457|P1|Overall Study|Withdrawal by Subject|1
184879|NCT00071981|570469|P4|Overall Study|others (not specified in the study)|0
184880|NCT00071981|570470|P3|Overall Study|others (not specified in the study)|2
184881|NCT00071981|570471|P2|Overall Study|others (not specified in the study)|2
184882|NCT00071981|570472|P1|Overall Study|others (not specified in the study)|0
184883|NCT00071981|570469|P4|Overall Study|No protocol therapy|0
184884|NCT00071981|570470|P3|Overall Study|No protocol therapy|1
184885|NCT00071981|570471|P2|Overall Study|No protocol therapy|5
184886|NCT00071981|570472|P1|Overall Study|No protocol therapy|2
184887|NCT00071981|570469|P4|Overall Study|Withdrawal by Subject|0
184888|NCT00071981|570470|P3|Overall Study|Withdrawal by Subject|0
184889|NCT00071981|570471|P2|Overall Study|Withdrawal by Subject|1
184890|NCT00071981|570472|P1|Overall Study|Withdrawal by Subject|3
184891|NCT00071981|570469|P4|Overall Study|Death|1
184892|NCT00071981|570470|P3|Overall Study|Death|1
184893|NCT00071981|570471|P2|Overall Study|Death|0
184894|NCT00071981|570472|P1|Overall Study|Death|0
184895|NCT00071981|570469|P4|Overall Study|Adverse Event|1
184896|NCT00071981|570470|P3|Overall Study|Adverse Event|3
184897|NCT00071981|570471|P2|Overall Study|Adverse Event|4
184898|NCT00071981|570472|P1|Overall Study|Adverse Event|4
184899|NCT00071981|570469|P4|Overall Study|Lack of Efficacy|43
184900|NCT00071981|570470|P3|Overall Study|Lack of Efficacy|30
184901|NCT00071981|570471|P2|Overall Study|Lack of Efficacy|29
184902|NCT00071981|570472|P1|Overall Study|Lack of Efficacy|37
184903|NCT00071812|570515|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
184904|NCT00071812|570516|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
184905|NCT00071812|570517|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
184906|NCT00071812|570518|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
184907|NCT00071812|570515|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
184908|NCT00071812|570516|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
184909|NCT00071812|570517|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
184910|NCT00071812|570518|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
184911|NCT00071812|570515|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
184912|NCT00071812|570516|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
184913|NCT00071812|570517|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
184914|NCT00071812|570518|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
184915|NCT00071812|570515|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
184916|NCT00071812|570516|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
184917|NCT00071812|570517|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
184918|NCT00071812|570518|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
184919|NCT00071812|570515|P4|24-Week Open-Label Extension Period|Adverse Event|7
184920|NCT00071812|570516|P3|24-Week Open-Label Extension Period|Adverse Event|0
184921|NCT00071812|570517|P2|24-Week Open-Label Extension Period|Adverse Event|0
184922|NCT00071812|570518|P1|24-Week Open-Label Extension Period|Adverse Event|0
184923|NCT00071812|570515|P4|24-Week Double-Blind Period|Protocol Violation|1
184924|NCT00071812|570516|P3|24-Week Double-Blind Period|Protocol Violation|0
184925|NCT00071812|570517|P2|24-Week Double-Blind Period|Protocol Violation|0
184926|NCT00071812|570518|P1|24-Week Double-Blind Period|Protocol Violation|0
184927|NCT00071812|570515|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
184928|NCT00071812|570516|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
184929|NCT00071812|570517|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
184930|NCT00071812|570518|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
184931|NCT00071812|570515|P4|24-Week Double-Blind Period|Lost to Follow-up|0
184932|NCT00071812|570516|P3|24-Week Double-Blind Period|Lost to Follow-up|1
184933|NCT00071812|570517|P2|24-Week Double-Blind Period|Lost to Follow-up|1
184934|NCT00071812|570518|P1|24-Week Double-Blind Period|Lost to Follow-up|0
184935|NCT00071812|570515|P4|24-Week Double-Blind Period|Lack of Efficacy|1
184936|NCT00071812|570516|P3|24-Week Double-Blind Period|Lack of Efficacy|2
184937|NCT00071812|570517|P2|24-Week Double-Blind Period|Lack of Efficacy|1
184938|NCT00071812|570518|P1|24-Week Double-Blind Period|Lack of Efficacy|3
184939|NCT00071812|570515|P4|24-Week Double-Blind Period|Adverse Event|4
184940|NCT00071812|570516|P3|24-Week Double-Blind Period|Adverse Event|4
184941|NCT00071812|570517|P2|24-Week Double-Blind Period|Adverse Event|3
184942|NCT00071812|570518|P1|24-Week Double-Blind Period|Adverse Event|2
184943|NCT00071799|570560|P2|Overall Study|Not Documented|2
184944|NCT00071799|570561|P1|Overall Study|Not Documented|0
184945|NCT00071799|570560|P2|Overall Study|Different Central+Local Pathology Review|1
184946|NCT00071799|570561|P1|Overall Study|Different Central+Local Pathology Review|0
184947|NCT00071799|570560|P2|Overall Study|Disease Progression|20
184948|NCT00071799|570561|P1|Overall Study|Disease Progression|23
184949|NCT00071799|570560|P2|Overall Study|Lack of Efficacy|18
184950|NCT00071799|570561|P1|Overall Study|Lack of Efficacy|11
184951|NCT00071799|570560|P2|Overall Study|Physician Decision|2
184952|NCT00071799|570561|P1|Overall Study|Physician Decision|0
184953|NCT00071799|570560|P2|Overall Study|Withdrawal by Subject|37
184954|NCT00071799|570561|P1|Overall Study|Withdrawal by Subject|15
184955|NCT00071799|570560|P2|Overall Study|Lost to Follow-up|1
184956|NCT00071799|570561|P1|Overall Study|Lost to Follow-up|1
184957|NCT00071799|570560|P2|Overall Study|Protocol Violation|7
184958|NCT00071799|570561|P1|Overall Study|Protocol Violation|1
184959|NCT00071799|570560|P2|Overall Study|Adverse Event|10
184960|NCT00071799|570561|P1|Overall Study|Adverse Event|19
184961|NCT00071760|570601|P1|Overall Study|Ongoing|25
184962|NCT00071760|570601|P1|Overall Study|Study Team Rec./Resistance|1
184963|NCT00071760|570601|P1|Overall Study|Investigator's Recommendation (Rec.)|4
184964|NCT00071760|570601|P1|Overall Study|Relocation|1
184965|NCT00071760|570601|P1|Overall Study|Unavailability of RTV|8
184966|NCT00071760|570601|P1|Overall Study|Pulmonary Tuberculosis|1
184967|NCT00071760|570601|P1|Overall Study|Insufficient Viral Load Response|3
184968|NCT00071760|570601|P1|Overall Study|Withdrawal by Subject|3
184969|NCT00071760|570601|P1|Overall Study|Protocol Violation|1
184970|NCT00071760|570601|P1|Overall Study|Lost to Follow-up|4
184971|NCT00071760|570601|P1|Overall Study|Adverse Event|3
184972|NCT00071513|570681|P2|Follow-up Assessment|Withdrawal by Subject|6
184973|NCT00071513|570682|P1|Follow-up Assessment|Withdrawal by Subject|6
184974|NCT00071513|570681|P2|Intervention Component|Withdrawal by Subject|3
184975|NCT00071513|570682|P1|Intervention Component|Withdrawal by Subject|2
184976|NCT00071487|570694|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
184977|NCT00071487|570695|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
184978|NCT00071487|570696|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
184979|NCT00071487|570697|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
184980|NCT00071487|570694|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
184981|NCT00071487|570695|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
184982|NCT00071487|570696|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
184983|NCT00071487|570697|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
184984|NCT00071487|570694|P4|24-Week Open-Label Extension Period|Pregnancy|1
184985|NCT00071487|570695|P3|24-Week Open-Label Extension Period|Pregnancy|0
184986|NCT00071487|570696|P2|24-Week Open-Label Extension Period|Pregnancy|0
184987|NCT00071487|570697|P1|24-Week Open-Label Extension Period|Pregnancy|0
184988|NCT00071487|570694|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
184989|NCT00071487|570695|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
184990|NCT00071487|570696|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
184991|NCT00071487|570697|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
184992|NCT00071487|570694|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
184993|NCT00071487|570695|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
184994|NCT00071487|570696|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
184995|NCT00071487|570697|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
184996|NCT00071487|570694|P4|24-Week Open-Label Extension Period|Adverse Event|6
184997|NCT00071487|570695|P3|24-Week Open-Label Extension Period|Adverse Event|1
184998|NCT00071487|570696|P2|24-Week Open-Label Extension Period|Adverse Event|0
184999|NCT00071487|570697|P1|24-Week Open-Label Extension Period|Adverse Event|0
185000|NCT00071487|570694|P4|52-Week Double-Blind Period|Lack of Compliance|3
185001|NCT00071487|570695|P3|52-Week Double-Blind Period|Lack of Compliance|3
185002|NCT00071487|570696|P2|52-Week Double-Blind Period|Lack of Compliance|3
185003|NCT00071487|570697|P1|52-Week Double-Blind Period|Lack of Compliance|6
185004|NCT00071487|570694|P4|52-Week Double-Blind Period|Death|0
185005|NCT00071487|570695|P3|52-Week Double-Blind Period|Death|0
185006|NCT00071487|570696|P2|52-Week Double-Blind Period|Death|1
185007|NCT00071487|570697|P1|52-Week Double-Blind Period|Death|0
185008|NCT00071487|570694|P4|52-Week Double-Blind Period|Protocol Violation|0
185009|NCT00071487|570695|P3|52-Week Double-Blind Period|Protocol Violation|1
185010|NCT00071487|570696|P2|52-Week Double-Blind Period|Protocol Violation|1
185011|NCT00071487|570697|P1|52-Week Double-Blind Period|Protocol Violation|0
185012|NCT00071487|570694|P4|52-Week Double-Blind Period|Pregnancy|0
185013|NCT00071487|570695|P3|52-Week Double-Blind Period|Pregnancy|0
185014|NCT00071487|570696|P2|52-Week Double-Blind Period|Pregnancy|1
185015|NCT00071487|570697|P1|52-Week Double-Blind Period|Pregnancy|0
185016|NCT00071487|570694|P4|52-Week Double-Blind Period|Lost to Follow-up|2
185017|NCT00071487|570695|P3|52-Week Double-Blind Period|Lost to Follow-up|2
185018|NCT00071487|570696|P2|52-Week Double-Blind Period|Lost to Follow-up|0
185019|NCT00071487|570697|P1|52-Week Double-Blind Period|Lost to Follow-up|0
185020|NCT00071487|570694|P4|52-Week Double-Blind Period|Physician Decision|0
185021|NCT00071487|570695|P3|52-Week Double-Blind Period|Physician Decision|0
185022|NCT00071487|570696|P2|52-Week Double-Blind Period|Physician Decision|0
185023|NCT00071487|570697|P1|52-Week Double-Blind Period|Physician Decision|1
185024|NCT00071487|570694|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
185025|NCT00071487|570695|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
185026|NCT00071487|570696|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
185027|NCT00071487|570697|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
185028|NCT00071487|570694|P4|52-Week Double-Blind Period|Lack of Efficacy|1
185029|NCT00071487|570695|P3|52-Week Double-Blind Period|Lack of Efficacy|0
185030|NCT00071487|570696|P2|52-Week Double-Blind Period|Lack of Efficacy|2
185031|NCT00071487|570697|P1|52-Week Double-Blind Period|Lack of Efficacy|1
185032|NCT00071487|570694|P4|52-Week Double-Blind Period|Adverse Event|8
185033|NCT00071487|570695|P3|52-Week Double-Blind Period|Adverse Event|4
185034|NCT00071487|570696|P2|52-Week Double-Blind Period|Adverse Event|8
185035|NCT00071487|570697|P1|52-Week Double-Blind Period|Adverse Event|5
185036|NCT00071396|570741|P1|Overall Study|Physician Decision|2
185037|NCT00071396|570741|P1|Overall Study|Withdrawal by Subject|1
185038|NCT00071110|570747|P2|Overall Study|Protocol Violation|4
185039|NCT00071110|570748|P1|Overall Study|Protocol Violation|0
185040|NCT00071058|570760|P1|Overall Study|brain tumor-removed from study|1
185041|NCT00071032|570767|P2|Overall Study|Missing Primary Outcome|1
185042|NCT00071032|570768|P1|Overall Study|Missing Primary Outcome|0
185043|NCT00071032|570767|P2|Overall Study|Withdrawal by Subject|6
185044|NCT00071032|570768|P1|Overall Study|Withdrawal by Subject|8
185045|NCT00071032|570767|P2|Overall Study|Lost to Follow-up|1
185046|NCT00071032|570768|P1|Overall Study|Lost to Follow-up|1
185047|NCT00071006|570776|P1|Overall Study|Unspecified|3
185048|NCT00071006|570776|P1|Overall Study|Withdrawal by Subject|1
185049|NCT00071006|570776|P1|Overall Study|Adverse Event|1
185050|NCT00071006|570776|P1|Overall Study|Lack of Efficacy|7
185051|NCT00070941|570789|P3|Overall Study|Adverse Event|4
185052|NCT00070941|570790|P2|Overall Study|Adverse Event|8
185053|NCT00070941|570791|P1|Overall Study|Adverse Event|10
185054|NCT00070499|570803|P4|Overall Study|Not eligible|2
185055|NCT00070499|570804|P3|Overall Study|Not eligible|3
185056|NCT00070499|570805|P2|Overall Study|Not eligible|5
185057|NCT00070499|570806|P1|Overall Study|Not eligible|2
185058|NCT00070499|570803|P4|Overall Study|Did not start treatment|2
185059|NCT00070499|570804|P3|Overall Study|Did not start treatment|0
185060|NCT00070499|570805|P2|Overall Study|Did not start treatment|0
185061|NCT00070499|570806|P1|Overall Study|Did not start treatment|1
185062|NCT00070499|570803|P4|Overall Study|Still on protocol treatment|57
185063|NCT00070499|570804|P3|Overall Study|Still on protocol treatment|79
185064|NCT00070499|570805|P2|Overall Study|Still on protocol treatment|4
185065|NCT00070499|570806|P1|Overall Study|Still on protocol treatment|10
185066|NCT00070499|570803|P4|Overall Study|Other - not protocol specified|20
185067|NCT00070499|570804|P3|Overall Study|Other - not protocol specified|12
185068|NCT00070499|570805|P2|Overall Study|Other - not protocol specified|3
185069|NCT00070499|570806|P1|Overall Study|Other - not protocol specified|7
185070|NCT00070499|570803|P4|Overall Study|Death|2
185071|NCT00070499|570804|P3|Overall Study|Death|1
185072|NCT00070499|570805|P2|Overall Study|Death|1
185073|NCT00070499|570806|P1|Overall Study|Death|1
185074|NCT00070499|570803|P4|Overall Study|Progression/relapse|4
185075|NCT00070499|570804|P3|Overall Study|Progression/relapse|1
185076|NCT00070499|570805|P2|Overall Study|Progression/relapse|2
185077|NCT00070499|570806|P1|Overall Study|Progression/relapse|4
185078|NCT00070499|570803|P4|Overall Study|Refusal unrelated to adverse effects|8
185079|NCT00070499|570804|P3|Overall Study|Refusal unrelated to adverse effects|5
185080|NCT00070499|570805|P2|Overall Study|Refusal unrelated to adverse effects|5
185081|NCT00070499|570806|P1|Overall Study|Refusal unrelated to adverse effects|7
185082|NCT00070499|570803|P4|Overall Study|Adverse Event|15
185083|NCT00070499|570804|P3|Overall Study|Adverse Event|19
185084|NCT00070499|570805|P2|Overall Study|Adverse Event|6
185085|NCT00070499|570806|P1|Overall Study|Adverse Event|6
185086|NCT00070291|570832|P1|Step 2|Adverse Event|1
185087|NCT00070291|570832|P1|Step 1|Adverse Event|1
185088|NCT00070291|570832|P1|Step 1|Withdrawal by Subject|1
185089|NCT00070109|570842|P5|Overall Study|removed from prot thpy prior to chemo|0
185090|NCT00070109|570843|P4|Overall Study|removed from prot thpy prior to chemo|1
185091|NCT00070109|570844|P3|Overall Study|removed from prot thpy prior to chemo|0
185092|NCT00070109|570845|P2|Overall Study|removed from prot thpy prior to chemo|0
185093|NCT00070109|570846|P1|Overall Study|removed from prot thpy prior to chemo|0
185094|NCT00070109|570842|P5|Overall Study|Adverse Event|2
185095|NCT00070109|570843|P4|Overall Study|Adverse Event|4
185096|NCT00070109|570844|P3|Overall Study|Adverse Event|2
185097|NCT00070109|570845|P2|Overall Study|Adverse Event|0
185098|NCT00070109|570846|P1|Overall Study|Adverse Event|0
185099|NCT00070109|570842|P5|Overall Study|Withdrawal by Subject|0
185100|NCT00070109|570843|P4|Overall Study|Withdrawal by Subject|0
185101|NCT00070109|570844|P3|Overall Study|Withdrawal by Subject|1
185102|NCT00070109|570845|P2|Overall Study|Withdrawal by Subject|1
185103|NCT00070109|570846|P1|Overall Study|Withdrawal by Subject|0
185104|NCT00070109|570842|P5|Overall Study|Physician Decision|0
185105|NCT00070109|570843|P4|Overall Study|Physician Decision|0
185106|NCT00070109|570844|P3|Overall Study|Physician Decision|0
185107|NCT00070109|570845|P2|Overall Study|Physician Decision|0
185108|NCT00070109|570846|P1|Overall Study|Physician Decision|1
185109|NCT00070109|570842|P5|Overall Study|Lack of Efficacy|5
185110|NCT00070109|570843|P4|Overall Study|Lack of Efficacy|15
185111|NCT00070109|570844|P3|Overall Study|Lack of Efficacy|5
185112|NCT00070109|570845|P2|Overall Study|Lack of Efficacy|4
185113|NCT00070109|570846|P1|Overall Study|Lack of Efficacy|6
185114|NCT00070109|570842|P5|Overall Study|Death|1
185115|NCT00070109|570843|P4|Overall Study|Death|0
185116|NCT00070109|570844|P3|Overall Study|Death|0
185117|NCT00070109|570845|P2|Overall Study|Death|1
185118|NCT00070109|570846|P1|Overall Study|Death|1
185119|NCT00070018|570859|P1|Overall Study|Withdrawal by Subject|1
185120|NCT00070018|570859|P1|Overall Study|Lack of Efficacy|1
185121|NCT00070018|570859|P1|Overall Study|Adverse Event|2
185122|NCT00069953|570863|P1|Overall Study|Protocol Violation|2
185123|NCT00069823|570869|P2|Overall Study|Did not have follow-up diary cards|3
185124|NCT00069823|570870|P1|Overall Study|Did not have follow-up diary cards|6
185125|NCT00069784|570912|P2|Overall Study|Other|0
185126|NCT00069784|570913|P1|Overall Study|Other|17
185127|NCT00069784|570912|P2|Overall Study|Withdrawal by Subject|0
185128|NCT00069784|570913|P1|Overall Study|Withdrawal by Subject|1090
185129|NCT00069784|570912|P2|Overall Study|Adverse Event|0
185130|NCT00069784|570913|P1|Overall Study|Adverse Event|105
185131|NCT00069641|570934|P3|Overall Study|Death|1
185132|NCT00069641|570935|P2|Overall Study|Death|0
185133|NCT00069641|570936|P1|Overall Study|Death|1
185134|NCT00069277|570985|P1|Overall Study|Physician Decision|2
185135|NCT00069277|570985|P1|Overall Study|Progressive Disease|15
185136|NCT00069277|570985|P1|Overall Study|Withdrawal by Subject|1
185137|NCT00069277|570985|P1|Overall Study|Adverse Event|3
185138|NCT00069264|570989|P1|Overall Study|Discon Therapy|3
185139|NCT00069264|570989|P1|Overall Study|Withdrawal by Subject|3
185140|NCT00069264|570989|P1|Overall Study|Progressive Disease|23
185141|NCT00069264|570989|P1|Overall Study|Adverse Event|3
185142|NCT00069238|570993|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
185143|NCT00069238|570994|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
185144|NCT00069238|570995|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
185145|NCT00069238|570993|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
185146|NCT00069238|570994|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
185147|NCT00069238|570995|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
185148|NCT00069238|570993|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
185149|NCT00069238|570994|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
185150|NCT00069238|570995|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
185151|NCT00069121|571018|P2|Overall Study|Lost to Follow-up|57
185152|NCT00069121|571019|P1|Overall Study|Lost to Follow-up|57
185153|NCT00069121|571018|P2|Overall Study|Withdrawal by Subject|22
185154|NCT00069121|571019|P1|Overall Study|Withdrawal by Subject|20
185155|NCT00069121|571018|P2|Overall Study|Death|197
185156|NCT00069121|571019|P1|Overall Study|Death|225
185157|NCT00069108|571041|P2|Overall Study|Refused treatment|10
185158|NCT00069108|571042|P1|Overall Study|Refused treatment|5
185159|NCT00069108|571041|P2|Overall Study|Violation criteria|4
185160|NCT00069108|571042|P1|Overall Study|Violation criteria|1
185161|NCT00069108|571041|P2|Overall Study|Insufficient therapy|144
185162|NCT00069108|571042|P1|Overall Study|Insufficient therapy|117
185163|NCT00069108|571041|P2|Overall Study|Administration|4
185164|NCT00069108|571042|P1|Overall Study|Administration|15
185165|NCT00069108|571041|P2|Overall Study|Death|6
185166|NCT00069108|571042|P1|Overall Study|Death|6
185167|NCT00069108|571041|P2|Overall Study|Adverse Event|42
185168|NCT00069108|571042|P1|Overall Study|Adverse Event|64
185169|NCT00069108|571041|P2|Overall Study|Withdrawal by Subject|9
185170|NCT00069108|571042|P1|Overall Study|Withdrawal by Subject|5
185171|NCT00069095|571074|P6|Follow-up Phase|Death|101
185172|NCT00069095|571075|P5|Follow-up Phase|Death|92
185173|NCT00069095|571076|P4|Follow-up Phase|Death|112
185174|NCT00069095|571077|P3|Follow-up Phase|Death|120
185175|NCT00069095|571078|P2|Follow-up Phase|Death|206
185176|NCT00069095|571079|P1|Follow-up Phase|Death|174
185177|NCT00069095|571074|P6|Post-study Treatment Phase|Investigator decision|1
185178|NCT00069095|571075|P5|Post-study Treatment Phase|Investigator decision|0
185179|NCT00069095|571076|P4|Post-study Treatment Phase|Investigator decision|0
185180|NCT00069095|571077|P3|Post-study Treatment Phase|Investigator decision|0
185181|NCT00069095|571078|P2|Post-study Treatment Phase|Investigator decision|0
185182|NCT00069095|571079|P1|Post-study Treatment Phase|Investigator decision|0
185183|NCT00069095|571074|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
185184|NCT00069095|571075|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
185185|NCT00069095|571076|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
185186|NCT00069095|571077|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
185187|NCT00069095|571078|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
185188|NCT00069095|571079|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
185189|NCT00069095|571074|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
185190|NCT00069095|571075|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
185191|NCT00069095|571076|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
185192|NCT00069095|571077|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
185193|NCT00069095|571078|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
185194|NCT00069095|571079|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
185195|NCT00069095|571074|P6|Post-study Treatment Phase|Participant had progressive disease|0
185196|NCT00069095|571075|P5|Post-study Treatment Phase|Participant had progressive disease|1
185197|NCT00069095|571076|P4|Post-study Treatment Phase|Participant had progressive disease|0
185198|NCT00069095|571077|P3|Post-study Treatment Phase|Participant had progressive disease|0
185199|NCT00069095|571078|P2|Post-study Treatment Phase|Participant had progressive disease|0
185200|NCT00069095|571079|P1|Post-study Treatment Phase|Participant had progressive disease|0
185201|NCT00069095|571074|P6|Post-study Treatment Phase|Death|0
185202|NCT00069095|571075|P5|Post-study Treatment Phase|Death|1
185203|NCT00069095|571076|P4|Post-study Treatment Phase|Death|0
185204|NCT00069095|571077|P3|Post-study Treatment Phase|Death|0
185205|NCT00069095|571078|P2|Post-study Treatment Phase|Death|0
185206|NCT00069095|571079|P1|Post-study Treatment Phase|Death|0
185207|NCT00069095|571074|P6|Post-study Treatment Phase|Surgery|0
185208|NCT00069095|571075|P5|Post-study Treatment Phase|Surgery|1
185209|NCT00069095|571076|P4|Post-study Treatment Phase|Surgery|1
185210|NCT00069095|571077|P3|Post-study Treatment Phase|Surgery|0
185211|NCT00069095|571078|P2|Post-study Treatment Phase|Surgery|0
185212|NCT00069095|571079|P1|Post-study Treatment Phase|Surgery|0
185213|NCT00069095|571074|P6|Post-study Treatment Phase|Participant completed treatment|0
185214|NCT00069095|571075|P5|Post-study Treatment Phase|Participant completed treatment|0
185215|NCT00069095|571076|P4|Post-study Treatment Phase|Participant completed treatment|1
185216|NCT00069095|571077|P3|Post-study Treatment Phase|Participant completed treatment|0
185217|NCT00069095|571078|P2|Post-study Treatment Phase|Participant completed treatment|0
185218|NCT00069095|571079|P1|Post-study Treatment Phase|Participant completed treatment|0
185219|NCT00069095|571074|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
185220|NCT00069095|571075|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
185221|NCT00069095|571076|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
185222|NCT00069095|571077|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
185223|NCT00069095|571078|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
185224|NCT00069095|571079|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
185225|NCT00069095|571074|P6|Post-study Treatment Phase|Participant will start new treatment|0
185226|NCT00069095|571075|P5|Post-study Treatment Phase|Participant will start new treatment|0
185227|NCT00069095|571076|P4|Post-study Treatment Phase|Participant will start new treatment|0
185228|NCT00069095|571077|P3|Post-study Treatment Phase|Participant will start new treatment|1
185229|NCT00069095|571078|P2|Post-study Treatment Phase|Participant will start new treatment|0
185230|NCT00069095|571079|P1|Post-study Treatment Phase|Participant will start new treatment|0
185231|NCT00069095|571074|P6|Post-study Treatment Phase|Participant withdrew consent|0
185232|NCT00069095|571075|P5|Post-study Treatment Phase|Participant withdrew consent|0
185233|NCT00069095|571076|P4|Post-study Treatment Phase|Participant withdrew consent|0
185234|NCT00069095|571077|P3|Post-study Treatment Phase|Participant withdrew consent|1
185235|NCT00069095|571078|P2|Post-study Treatment Phase|Participant withdrew consent|0
185236|NCT00069095|571079|P1|Post-study Treatment Phase|Participant withdrew consent|0
185237|NCT00069095|571074|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
185238|NCT00069095|571075|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
185239|NCT00069095|571076|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
185240|NCT00069095|571077|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
185241|NCT00069095|571078|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
185242|NCT00069095|571079|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
185243|NCT00069095|571074|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
185244|NCT00069095|571075|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
185245|NCT00069095|571076|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
185246|NCT00069095|571077|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
185247|NCT00069095|571078|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
185248|NCT00069095|571079|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
185249|NCT00069095|571074|P6|Post-study Treatment Phase|Participant had complete response|0
185250|NCT00069095|571075|P5|Post-study Treatment Phase|Participant had complete response|0
185251|NCT00069095|571076|P4|Post-study Treatment Phase|Participant had complete response|0
185252|NCT00069095|571077|P3|Post-study Treatment Phase|Participant had complete response|0
185253|NCT00069095|571078|P2|Post-study Treatment Phase|Participant had complete response|1
185254|NCT00069095|571079|P1|Post-study Treatment Phase|Participant had complete response|1
185255|NCT00069095|571074|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
185256|NCT00069095|571075|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
185257|NCT00069095|571076|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
185258|NCT00069095|571077|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
185259|NCT00069095|571078|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
185260|NCT00069095|571079|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
185261|NCT00069095|571074|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
185262|NCT00069095|571075|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
185263|NCT00069095|571076|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
185264|NCT00069095|571077|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
185265|NCT00069095|571078|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
185266|NCT00069095|571079|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
185267|NCT00069095|571074|P6|Post-study Treatment Phase|Eligible for surgery|0
185268|NCT00069095|571075|P5|Post-study Treatment Phase|Eligible for surgery|0
185269|NCT00069095|571076|P4|Post-study Treatment Phase|Eligible for surgery|0
185270|NCT00069095|571077|P3|Post-study Treatment Phase|Eligible for surgery|0
185271|NCT00069095|571078|P2|Post-study Treatment Phase|Eligible for surgery|0
185272|NCT00069095|571079|P1|Post-study Treatment Phase|Eligible for surgery|2
185273|NCT00069095|571074|P6|Post-study Treatment Phase|Adverse Event|1
185274|NCT00069095|571075|P5|Post-study Treatment Phase|Adverse Event|5
185275|NCT00069095|571076|P4|Post-study Treatment Phase|Adverse Event|0
185276|NCT00069095|571077|P3|Post-study Treatment Phase|Adverse Event|1
185277|NCT00069095|571078|P2|Post-study Treatment Phase|Adverse Event|3
185278|NCT00069095|571079|P1|Post-study Treatment Phase|Adverse Event|2
185279|NCT00069095|571074|P6|Post-study Treatment Phase|Missing reason|17
185280|NCT00069095|571075|P5|Post-study Treatment Phase|Missing reason|18
185281|NCT00069095|571076|P4|Post-study Treatment Phase|Missing reason|8
185282|NCT00069095|571077|P3|Post-study Treatment Phase|Missing reason|12
185283|NCT00069095|571078|P2|Post-study Treatment Phase|Missing reason|3
185284|NCT00069095|571079|P1|Post-study Treatment Phase|Missing reason|1
185285|NCT00069095|571074|P6|Primary Treatment Phase|Violation criteria|5
185286|NCT00069095|571075|P5|Primary Treatment Phase|Violation criteria|1
185287|NCT00069095|571076|P4|Primary Treatment Phase|Violation criteria|3
185288|NCT00069095|571077|P3|Primary Treatment Phase|Violation criteria|4
185289|NCT00069095|571078|P2|Primary Treatment Phase|Violation criteria|2
185290|NCT00069095|571079|P1|Primary Treatment Phase|Violation criteria|0
185291|NCT00069095|571074|P6|Primary Treatment Phase|Other Violation|1
185292|NCT00069095|571075|P5|Primary Treatment Phase|Other Violation|0
185293|NCT00069095|571076|P4|Primary Treatment Phase|Other Violation|1
185294|NCT00069095|571077|P3|Primary Treatment Phase|Other Violation|1
185295|NCT00069095|571078|P2|Primary Treatment Phase|Other Violation|1
185296|NCT00069095|571079|P1|Primary Treatment Phase|Other Violation|0
185297|NCT00069095|571074|P6|Primary Treatment Phase|Withdrew|9
185298|NCT00069095|571075|P5|Primary Treatment Phase|Withdrew|4
185299|NCT00069095|571076|P4|Primary Treatment Phase|Withdrew|2
185300|NCT00069095|571077|P3|Primary Treatment Phase|Withdrew|8
185301|NCT00069095|571078|P2|Primary Treatment Phase|Withdrew|3
185302|NCT00069095|571079|P1|Primary Treatment Phase|Withdrew|2
185303|NCT00069095|571074|P6|Primary Treatment Phase|Refused treatment|27
185304|NCT00069095|571075|P5|Primary Treatment Phase|Refused treatment|24
185305|NCT00069095|571076|P4|Primary Treatment Phase|Refused treatment|31
185306|NCT00069095|571077|P3|Primary Treatment Phase|Refused treatment|17
185307|NCT00069095|571078|P2|Primary Treatment Phase|Refused treatment|26
185308|NCT00069095|571079|P1|Primary Treatment Phase|Refused treatment|15
185309|NCT00069095|571074|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
185310|NCT00069095|571075|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
185311|NCT00069095|571076|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
185312|NCT00069095|571077|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
185313|NCT00069095|571078|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
185314|NCT00069095|571079|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
185315|NCT00069095|571074|P6|Primary Treatment Phase|Failure to return|2
185316|NCT00069095|571075|P5|Primary Treatment Phase|Failure to return|0
185317|NCT00069095|571076|P4|Primary Treatment Phase|Failure to return|0
185318|NCT00069095|571077|P3|Primary Treatment Phase|Failure to return|0
185319|NCT00069095|571078|P2|Primary Treatment Phase|Failure to return|5
185320|NCT00069095|571079|P1|Primary Treatment Phase|Failure to return|5
185321|NCT00069095|571074|P6|Primary Treatment Phase|Death|8
185322|NCT00069095|571075|P5|Primary Treatment Phase|Death|8
185323|NCT00069095|571076|P4|Primary Treatment Phase|Death|5
185324|NCT00069095|571077|P3|Primary Treatment Phase|Death|2
185325|NCT00069095|571078|P2|Primary Treatment Phase|Death|8
185326|NCT00069095|571079|P1|Primary Treatment Phase|Death|14
185327|NCT00069095|571074|P6|Primary Treatment Phase|Adverse Event|101
185328|NCT00069095|571075|P5|Primary Treatment Phase|Adverse Event|109
185329|NCT00069095|571076|P4|Primary Treatment Phase|Adverse Event|72
185330|NCT00069095|571077|P3|Primary Treatment Phase|Adverse Event|71
185331|NCT00069095|571078|P2|Primary Treatment Phase|Adverse Event|92
185332|NCT00069095|571079|P1|Primary Treatment Phase|Adverse Event|99
185333|NCT00069095|571074|P6|Primary Treatment Phase|Admin/Other|42
185334|NCT00069095|571075|P5|Primary Treatment Phase|Admin/Other|48
185335|NCT00069095|571076|P4|Primary Treatment Phase|Admin/Other|45
185336|NCT00069095|571077|P3|Primary Treatment Phase|Admin/Other|31
185337|NCT00069095|571078|P2|Primary Treatment Phase|Admin/Other|38
185338|NCT00069095|571079|P1|Primary Treatment Phase|Admin/Other|29
185339|NCT00069095|571074|P6|Primary Treatment Phase|Ongoing|4
185340|NCT00069095|571075|P5|Primary Treatment Phase|Ongoing|7
185341|NCT00069095|571076|P4|Primary Treatment Phase|Ongoing|7
185342|NCT00069095|571077|P3|Primary Treatment Phase|Ongoing|5
185343|NCT00069095|571078|P2|Primary Treatment Phase|Ongoing|0
185344|NCT00069095|571079|P1|Primary Treatment Phase|Ongoing|0
185345|NCT00068822|571133|P2|First Randomized Intervention|Lost to Follow-up|2
185346|NCT00068822|571134|P1|First Randomized Intervention|Lost to Follow-up|1
185347|NCT00068588|571158|P3|Overall Study|Poor KPS|1
185348|NCT00068588|571159|P2|Overall Study|Poor KPS|0
185349|NCT00068588|571160|P1|Overall Study|Poor KPS|0
185350|NCT00068588|571158|P3|Overall Study|Withdrawal by Subject|1
185351|NCT00068588|571159|P2|Overall Study|Withdrawal by Subject|0
185352|NCT00068588|571160|P1|Overall Study|Withdrawal by Subject|0
185353|NCT00068588|571158|P3|Overall Study|Adverse Event|2
185354|NCT00068588|571159|P2|Overall Study|Adverse Event|0
185355|NCT00068588|571160|P1|Overall Study|Adverse Event|0
185356|NCT00068419|571174|P1|Overall Study|Ineligible|11
185357|NCT00068419|571174|P1|Overall Study|Withdrawal by Subject|14
185358|NCT00068419|571174|P1|Overall Study|Physician Decision|7
185359|NCT00068419|571174|P1|Overall Study|Lost to Follow-up|1
185360|NCT00068419|571174|P1|Overall Study|Lack of Efficacy|24
185361|NCT00068419|571174|P1|Overall Study|Adverse Event|3
185362|NCT00068393|571178|P1|Overall Study|Quality of life worsening|1
185363|NCT00068393|571178|P1|Overall Study|Alternative treatment|1
185364|NCT00068393|571178|P1|Overall Study|Withdrawal by Subject|3
185365|NCT00068393|571178|P1|Overall Study|Death|3
185366|NCT00068393|571178|P1|Overall Study|Adverse Event|2
185367|NCT00068380|571184|P1|Overall Study|Adverse Event|2
185368|NCT00068380|571184|P1|Overall Study|Withdrawal by Subject|3
185369|NCT00068237|571188|P1|Overall Study|No protocol treatment received|2
185370|NCT00068237|571188|P1|Overall Study|Ineligible|3
185371|NCT00068107|571192|P1|Overall Study|Withdrawal by Subject|1
185372|NCT00068107|571192|P1|Overall Study|Death|2
185373|NCT00068107|571192|P1|Overall Study|end-stage renal disease|6
185374|NCT00067470|571218|P2|Overall Study|Withdrawal by Subject|1
185375|NCT00067470|571219|P1|Overall Study|Withdrawal by Subject|0
185376|NCT00066807|571253|P2|Overall Study|Study was terminated early|15
185377|NCT00066807|571254|P1|Overall Study|Study was terminated early|14
185378|NCT00066742|571266|P1|Consolidation Chemotherapy|Ineligible|2
185379|NCT00066742|571266|P1|Consolidation Chemotherapy|not protocol specified|1
185380|NCT00066742|571266|P1|Induction Chemoradiotherapy|Ineligible|3
185381|NCT00066742|571266|P1|Induction Chemoradiotherapy|not protocol specified|2
185382|NCT00066742|571266|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
185383|NCT00066742|571266|P1|Induction Chemoradiotherapy|Adverse Event|21
185384|NCT00066742|571266|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
185385|NCT00066703|571275|P2|Overall Study|Treatment ongoing|311
185386|NCT00066703|571276|P1|Overall Study|Treatment ongoing|346
185387|NCT00066703|571275|P2|Overall Study|Withdrawal by Subject|63
185388|NCT00066703|571276|P1|Overall Study|Withdrawal by Subject|38
185389|NCT00066703|571275|P2|Overall Study|Lost to Follow-up|28
185390|NCT00066703|571276|P1|Overall Study|Lost to Follow-up|31
185391|NCT00066703|571275|P2|Overall Study|Lack of Efficacy|69
185392|NCT00066703|571276|P1|Overall Study|Lack of Efficacy|114
185393|NCT00066703|571275|P2|Overall Study|Death|0
185394|NCT00066703|571276|P1|Overall Study|Death|3
185395|NCT00066703|571275|P2|Overall Study|Adverse Event|111
185396|NCT00066703|571276|P1|Overall Study|Adverse Event|80
185397|NCT00066690|571289|P3|Overall Study|Treatment Ongoing|282
185398|NCT00066690|571290|P2|Overall Study|Treatment Ongoing|278
185399|NCT00066690|571291|P1|Overall Study|Treatment Ongoing|246
185400|NCT00066690|571289|P3|Overall Study|Withdrawal by Subject|49
185401|NCT00066690|571290|P2|Overall Study|Withdrawal by Subject|55
185402|NCT00066690|571291|P1|Overall Study|Withdrawal by Subject|50
185403|NCT00066690|571289|P3|Overall Study|Lost to Follow-up|29
185404|NCT00066690|571290|P2|Overall Study|Lost to Follow-up|21
185405|NCT00066690|571291|P1|Overall Study|Lost to Follow-up|40
185406|NCT00066690|571289|P3|Overall Study|Lack of Efficacy|76
185407|NCT00066690|571290|P2|Overall Study|Lack of Efficacy|110
185408|NCT00066690|571291|P1|Overall Study|Lack of Efficacy|114
185409|NCT00066690|571289|P3|Overall Study|Death|2
185410|NCT00066690|571290|P2|Overall Study|Death|0
185411|NCT00066690|571291|P1|Overall Study|Death|3
185412|NCT00066690|571289|P3|Overall Study|Adverse Event|126
185413|NCT00066690|571290|P2|Overall Study|Adverse Event|58
185414|NCT00066690|571291|P1|Overall Study|Adverse Event|145
185415|NCT00066573|571307|P2|Overall Study|Did not received protocol treatment|28
185416|NCT00066573|571308|P1|Overall Study|Did not received protocol treatment|28
185417|NCT00066469|571314|P1|Overall Study|ineligible|1
185418|NCT00066469|571314|P1|Overall Study|Withdrawal by Subject|1
185419|NCT00066469|571314|P1|Overall Study|Physician Decision|1
185420|NCT00066469|571314|P1|Overall Study|Lost to Follow-up|1
185421|NCT00066469|571314|P1|Overall Study|Lack of Efficacy|9
185422|NCT00066469|571314|P1|Overall Study|Death|3
185423|NCT00066365|571320|P2|Overall Study|Ineligible|2
185424|NCT00066365|571321|P1|Overall Study|Ineligible|4
185425|NCT00066365|571320|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
185426|NCT00066365|571321|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
185427|NCT00066365|571320|P2|Overall Study|Physician Decision|0
185428|NCT00066365|571321|P1|Overall Study|Physician Decision|1
185429|NCT00066365|571320|P2|Overall Study|Lack of Efficacy|12
185430|NCT00066365|571321|P1|Overall Study|Lack of Efficacy|15
185431|NCT00066365|571320|P2|Overall Study|Adverse Event|0
185432|NCT00066365|571321|P1|Overall Study|Adverse Event|1
185433|NCT00066222|571349|P1|Overall Study|No protocol treatment received|1
185434|NCT00066170|571357|P4|Overall Study|Other|0
185435|NCT00066170|571358|P3|Overall Study|Other|2
185436|NCT00066170|571359|P2|Overall Study|Other|5
185437|NCT00066170|571360|P1|Overall Study|Other|1
185438|NCT00066170|571357|P4|Overall Study|Protocol Violation|0
185439|NCT00066170|571358|P3|Overall Study|Protocol Violation|0
185440|NCT00066170|571359|P2|Overall Study|Protocol Violation|0
185441|NCT00066170|571360|P1|Overall Study|Protocol Violation|3
185442|NCT00066170|571357|P4|Overall Study|Non-Compliance with Trial Medicine|1
185443|NCT00066170|571358|P3|Overall Study|Non-Compliance with Trial Medicine|0
185444|NCT00066170|571359|P2|Overall Study|Non-Compliance with Trial Medicine|0
185445|NCT00066170|571360|P1|Overall Study|Non-Compliance with Trial Medicine|1
185446|NCT00066170|571357|P4|Overall Study|Lost to Follow-up|0
185447|NCT00066170|571358|P3|Overall Study|Lost to Follow-up|0
185448|NCT00066170|571359|P2|Overall Study|Lost to Follow-up|1
185449|NCT00066170|571360|P1|Overall Study|Lost to Follow-up|0
185450|NCT00066170|571357|P4|Overall Study|Serious Adverse Event|1
185451|NCT00066170|571358|P3|Overall Study|Serious Adverse Event|1
185452|NCT00066170|571359|P2|Overall Study|Serious Adverse Event|0
185453|NCT00066170|571360|P1|Overall Study|Serious Adverse Event|0
185454|NCT00066170|571357|P4|Overall Study|Adverse Event|7
185455|NCT00066170|571358|P3|Overall Study|Adverse Event|1
185456|NCT00066170|571359|P2|Overall Study|Adverse Event|4
185457|NCT00066170|571360|P1|Overall Study|Adverse Event|2
185458|NCT00066066|571373|P6|Overall Study|Lost to Follow-up|5
185459|NCT00066066|571374|P5|Overall Study|Lost to Follow-up|3
185460|NCT00066066|571375|P4|Overall Study|Lost to Follow-up|4
185461|NCT00066066|571376|P3|Overall Study|Lost to Follow-up|7
185462|NCT00066066|571377|P2|Overall Study|Lost to Follow-up|4
185463|NCT00066066|571378|P1|Overall Study|Lost to Follow-up|6
185464|NCT00065507|571452|P2|Overall Study|Subject No Longer Meets Study Criteria|0
185465|NCT00065507|571453|P1|Overall Study|Subject No Longer Meets Study Criteria|1
185466|NCT00065507|571452|P2|Overall Study|Subject Withdrew Consent|1
185467|NCT00065507|571453|P1|Overall Study|Subject Withdrew Consent|2
185468|NCT00065507|571452|P2|Overall Study|Lost to Follow-up|0
185469|NCT00065507|571453|P1|Overall Study|Lost to Follow-up|3
185470|NCT00065507|571452|P2|Overall Study|Poor/Non-compliance|2
185471|NCT00065507|571453|P1|Overall Study|Poor/Non-compliance|3
185472|NCT00065507|571452|P2|Overall Study|Lack of Efficacy|6
185473|NCT00065507|571453|P1|Overall Study|Lack of Efficacy|0
185474|NCT00065507|571452|P2|Overall Study|Adverse Event|3
185475|NCT00065507|571453|P1|Overall Study|Adverse Event|4
185476|NCT00065507|571452|P2|Overall Study|Death|17
185477|NCT00065507|571453|P1|Overall Study|Death|16
185478|NCT00065468|571518|P3|Overall Study|Unspecified|18
185479|NCT00065468|571519|P2|Overall Study|Unspecified|24
185480|NCT00065468|571520|P1|Overall Study|Unspecified|14
185481|NCT00065468|571518|P3|Overall Study|Disease progression|1
185482|NCT00065468|571519|P2|Overall Study|Disease progression|0
185483|NCT00065468|571520|P1|Overall Study|Disease progression|0
185484|NCT00065468|571518|P3|Overall Study|Discontinuation of study by Sponsor|13
185485|NCT00065468|571519|P2|Overall Study|Discontinuation of study by Sponsor|9
185486|NCT00065468|571520|P1|Overall Study|Discontinuation of study by Sponsor|13
185487|NCT00065468|571518|P3|Overall Study|Lost to Follow-up|2
185488|NCT00065468|571519|P2|Overall Study|Lost to Follow-up|3
185489|NCT00065468|571520|P1|Overall Study|Lost to Follow-up|5
185490|NCT00065468|571518|P3|Overall Study|Withdrawal by Subject|5
185491|NCT00065468|571519|P2|Overall Study|Withdrawal by Subject|4
185492|NCT00065468|571520|P1|Overall Study|Withdrawal by Subject|3
185493|NCT00065468|571518|P3|Overall Study|Death|171
185494|NCT00065468|571519|P2|Overall Study|Death|169
185495|NCT00065468|571520|P1|Overall Study|Death|172
185496|NCT00065442|571551|P2|Overall Study|Withdrawal by Subject|9
185497|NCT00065442|571552|P1|Overall Study|Withdrawal by Subject|3
185498|NCT00065442|571551|P2|Overall Study|Death|210
185499|NCT00065442|571552|P1|Overall Study|Death|121
185500|NCT00065442|571551|P2|Overall Study|Lost to Follow-up|1
185501|NCT00065442|571552|P1|Overall Study|Lost to Follow-up|1
185502|NCT00065429|571567|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
185503|NCT00065429|571568|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
185504|NCT00065429|571569|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
185505|NCT00065429|571570|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
185506|NCT00065429|571571|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
185507|NCT00065429|571572|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
185508|NCT00065429|571573|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
185509|NCT00065429|571567|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
185510|NCT00065429|571568|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
185511|NCT00065429|571569|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
185512|NCT00065429|571570|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
185513|NCT00065429|571571|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
185514|NCT00065429|571572|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
185515|NCT00065429|571573|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
185516|NCT00065429|571567|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
185517|NCT00065429|571568|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
185518|NCT00065429|571569|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
185519|NCT00065429|571570|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
185520|NCT00065429|571571|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
185521|NCT00065429|571572|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
185522|NCT00065429|571573|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
185523|NCT00065429|571567|P7|Phase I - May 2001 - Oct 2002|Death|0
185524|NCT00065429|571568|P6|Phase I - May 2001 - Oct 2002|Death|0
185525|NCT00065429|571569|P5|Phase I - May 2001 - Oct 2002|Death|1
185526|NCT00065429|571570|P4|Phase I - May 2001 - Oct 2002|Death|0
185527|NCT00065429|571571|P3|Phase I - May 2001 - Oct 2002|Death|0
185528|NCT00065429|571572|P2|Phase I - May 2001 - Oct 2002|Death|0
185529|NCT00065429|571573|P1|Phase I - May 2001 - Oct 2002|Death|0
185530|NCT00065429|571567|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
185531|NCT00065429|571568|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
185532|NCT00065429|571569|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
185533|NCT00065429|571570|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
185534|NCT00065429|571571|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
185535|NCT00065429|571572|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
185536|NCT00065429|571573|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
185537|NCT00065429|571567|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
185538|NCT00065429|571568|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
185539|NCT00065429|571569|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
185540|NCT00065429|571570|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
185541|NCT00065429|571571|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
185542|NCT00065429|571572|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
185543|NCT00065429|571573|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
185544|NCT00065429|571567|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
185545|NCT00065429|571568|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
185546|NCT00065429|571569|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
185547|NCT00065429|571570|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
185548|NCT00065429|571571|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
185549|NCT00065429|571572|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
185550|NCT00065429|571573|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
185551|NCT00065260|571587|P2|Overall Study|Death|1
185552|NCT00065260|571588|P1|Overall Study|Death|0
185553|NCT00065156|571594|P1|Overall Study|Secondary Malign Disease|1
185554|NCT00065156|571594|P1|Overall Study|Loss of Response|1
185555|NCT00065156|571594|P1|Overall Study|Non-Compliance|2
185556|NCT00065156|571594|P1|Overall Study|Investigator Decision|2
185557|NCT00065156|571594|P1|Overall Study|Disease Progression|7
185558|NCT00065156|571594|P1|Overall Study|Study Closed by Sponsor|2
185559|NCT00065156|571594|P1|Overall Study|Death|11
185560|NCT00065156|571594|P1|Overall Study|Lost to Follow-up|1
185561|NCT00065156|571594|P1|Overall Study|Withdrawal by Subject|8
185562|NCT00065156|571594|P1|Overall Study|Lack of Efficacy|52
185563|NCT00065156|571594|P1|Overall Study|Adverse Event|37
185564|NCT00065065|571611|P2|Overall Study|Other|2
185565|NCT00065065|571612|P1|Overall Study|Other|2
185566|NCT00065065|571611|P2|Overall Study|Lack of Efficacy|11
185567|NCT00065065|571612|P1|Overall Study|Lack of Efficacy|4
185568|NCT00065065|571611|P2|Overall Study|Withdrawal by Subject|5
185569|NCT00065065|571612|P1|Overall Study|Withdrawal by Subject|1
185570|NCT00065065|571611|P2|Overall Study|Adverse Event|2
185571|NCT00065065|571612|P1|Overall Study|Adverse Event|3
185572|NCT00064792|571633|P2|Overall Study|Adverse Event|0
185573|NCT00064792|571634|P1|Overall Study|Adverse Event|3
185574|NCT00064792|571633|P2|Overall Study|Withdrawal by Subject|0
185575|NCT00064792|571634|P1|Overall Study|Withdrawal by Subject|2
185576|NCT00064753|571644|P2|Overall Study|Lost to Follow-up|235
185577|NCT00064753|571645|P1|Overall Study|Lost to Follow-up|225
185578|NCT00064753|571644|P2|Overall Study|Withdrawal by Subject|171
185579|NCT00064753|571645|P1|Overall Study|Withdrawal by Subject|198
185580|NCT00064753|571644|P2|Overall Study|Death|242
185581|NCT00064753|571645|P1|Overall Study|Death|251
185582|NCT00064701|571676|P3|Clinical Continuation Phase|Patient opted out|1
185583|NCT00064701|571677|P2|Clinical Continuation Phase|Patient opted out|0
185584|NCT00064701|571678|P1|Clinical Continuation Phase|Patient opted out|0
185585|NCT00064701|571676|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
185586|NCT00064701|571677|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
185587|NCT00064701|571678|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
185588|NCT00064701|571676|P3|Clinical Continuation Phase|Discharged to nursing home|0
185589|NCT00064701|571677|P2|Clinical Continuation Phase|Discharged to nursing home|1
185590|NCT00064701|571678|P1|Clinical Continuation Phase|Discharged to nursing home|0
185591|NCT00064701|571676|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
185592|NCT00064701|571677|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
185593|NCT00064701|571678|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
185594|NCT00064701|571676|P3|Clinical Continuation Phase|Pancreas transplant|0
185595|NCT00064701|571677|P2|Clinical Continuation Phase|Pancreas transplant|0
185596|NCT00064701|571678|P1|Clinical Continuation Phase|Pancreas transplant|1
185597|NCT00064701|571676|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
185598|NCT00064701|571677|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
185599|NCT00064701|571678|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
185600|NCT00064701|571676|P3|Clinical Continuation Phase|Physician Decision|0
185601|NCT00064701|571677|P2|Clinical Continuation Phase|Physician Decision|3
185602|NCT00064701|571678|P1|Clinical Continuation Phase|Physician Decision|1
185603|NCT00064701|571676|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
185604|NCT00064701|571677|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
185605|NCT00064701|571678|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
185606|NCT00064701|571676|P3|Clinical Continuation Phase|Sponsor discontinued study|79
185607|NCT00064701|571677|P2|Clinical Continuation Phase|Sponsor discontinued study|129
185608|NCT00064701|571678|P1|Clinical Continuation Phase|Sponsor discontinued study|113
185609|NCT00064701|571676|P3|Clinical Continuation Phase|Rejection|2
185610|NCT00064701|571677|P2|Clinical Continuation Phase|Rejection|2
185611|NCT00064701|571678|P1|Clinical Continuation Phase|Rejection|1
185612|NCT00064701|571676|P3|Clinical Continuation Phase|Graft Failure|2
185613|NCT00064701|571677|P2|Clinical Continuation Phase|Graft Failure|5
185614|NCT00064701|571678|P1|Clinical Continuation Phase|Graft Failure|5
185615|NCT00064701|571676|P3|Clinical Continuation Phase|Lost to Follow-up|6
185616|NCT00064701|571677|P2|Clinical Continuation Phase|Lost to Follow-up|3
185617|NCT00064701|571678|P1|Clinical Continuation Phase|Lost to Follow-up|6
185618|NCT00064701|571676|P3|Clinical Continuation Phase|Withdrawal by Subject|22
185619|NCT00064701|571677|P2|Clinical Continuation Phase|Withdrawal by Subject|3
185620|NCT00064701|571678|P1|Clinical Continuation Phase|Withdrawal by Subject|22
185621|NCT00064701|571676|P3|Clinical Continuation Phase|Non-compliance|7
185622|NCT00064701|571677|P2|Clinical Continuation Phase|Non-compliance|6
185623|NCT00064701|571678|P1|Clinical Continuation Phase|Non-compliance|8
185624|NCT00064701|571676|P3|Clinical Continuation Phase|Adverse Event|14
185625|NCT00064701|571677|P2|Clinical Continuation Phase|Adverse Event|21
185626|NCT00064701|571678|P1|Clinical Continuation Phase|Adverse Event|12
185627|NCT00064701|571676|P3|One Year Post-transplant|Pancreas transplant|1
185628|NCT00064701|571677|P2|One Year Post-transplant|Pancreas transplant|0
185629|NCT00064701|571678|P1|One Year Post-transplant|Pancreas transplant|0
185630|NCT00064701|571676|P3|One Year Post-transplant|Poor absorption|0
185631|NCT00064701|571677|P2|One Year Post-transplant|Poor absorption|1
185632|NCT00064701|571678|P1|One Year Post-transplant|Poor absorption|0
185633|NCT00064701|571676|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
185634|NCT00064701|571677|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
185635|NCT00064701|571678|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
185636|NCT00064701|571676|P3|One Year Post-transplant|Incorrect study drug dispensed|0
185637|NCT00064701|571677|P2|One Year Post-transplant|Incorrect study drug dispensed|1
185638|NCT00064701|571678|P1|One Year Post-transplant|Incorrect study drug dispensed|0
185639|NCT00064701|571676|P3|One Year Post-transplant|Acute tubular necrosis|0
185640|NCT00064701|571677|P2|One Year Post-transplant|Acute tubular necrosis|0
185641|NCT00064701|571678|P1|One Year Post-transplant|Acute tubular necrosis|1
185642|NCT00064701|571676|P3|One Year Post-transplant|Converted to rapamycin|0
185643|NCT00064701|571677|P2|One Year Post-transplant|Converted to rapamycin|0
185644|NCT00064701|571678|P1|One Year Post-transplant|Converted to rapamycin|1
185645|NCT00064701|571676|P3|One Year Post-transplant|Lost to Follow-up|0
185646|NCT00064701|571677|P2|One Year Post-transplant|Lost to Follow-up|0
185647|NCT00064701|571678|P1|One Year Post-transplant|Lost to Follow-up|1
185648|NCT00064701|571676|P3|One Year Post-transplant|Withdrawal by Subject|1
185649|NCT00064701|571677|P2|One Year Post-transplant|Withdrawal by Subject|4
185650|NCT00064701|571678|P1|One Year Post-transplant|Withdrawal by Subject|0
185651|NCT00064701|571676|P3|One Year Post-transplant|Graft Failure|1
185652|NCT00064701|571677|P2|One Year Post-transplant|Graft Failure|2
185653|NCT00064701|571678|P1|One Year Post-transplant|Graft Failure|3
185654|NCT00064701|571676|P3|One Year Post-transplant|Non-compliance|5
185655|NCT00064701|571677|P2|One Year Post-transplant|Non-compliance|2
185656|NCT00064701|571678|P1|One Year Post-transplant|Non-compliance|4
185657|NCT00064701|571676|P3|One Year Post-transplant|Rejection|16
185658|NCT00064701|571677|P2|One Year Post-transplant|Rejection|1
185659|NCT00064701|571678|P1|One Year Post-transplant|Rejection|0
185660|NCT00064701|571676|P3|One Year Post-transplant|Adverse Event|37
185661|NCT00064701|571677|P2|One Year Post-transplant|Adverse Event|19
185662|NCT00064701|571678|P1|One Year Post-transplant|Adverse Event|23
185663|NCT00064701|571676|P3|One Year Post-transplant|Did not receive study drug|11
185664|NCT00064701|571677|P2|One Year Post-transplant|Did not receive study drug|12
185665|NCT00064701|571678|P1|One Year Post-transplant|Did not receive study drug|7
185666|NCT00064662|571730|P2|Overall Study|Administratively withdrawn|2
185667|NCT00064662|571731|P1|Overall Study|Administratively withdrawn|2
185668|NCT00064662|571730|P2|Overall Study|Withdrawal by Subject|14
185669|NCT00064662|571731|P1|Overall Study|Withdrawal by Subject|14
185670|NCT00064662|571730|P2|Overall Study|Lost to Follow-up|44
185671|NCT00064662|571731|P1|Overall Study|Lost to Follow-up|57
185672|NCT00064662|571730|P2|Overall Study|Death|1
185673|NCT00064662|571731|P1|Overall Study|Death|1
185674|NCT00064350|571742|P3|Cross-Over|Other|0
185675|NCT00064350|571743|P2|Cross-Over|Other|2
185676|NCT00064350|571744|P1|Cross-Over|Other|0
185677|NCT00064350|571742|P3|Cross-Over|Ineligible or never started treatment|0
185678|NCT00064350|571743|P2|Cross-Over|Ineligible or never started treatment|6
185679|NCT00064350|571744|P1|Cross-Over|Ineligible or never started treatment|3
185680|NCT00064350|571742|P3|Cross-Over|Withdrawal by Subject|0
185681|NCT00064350|571743|P2|Cross-Over|Withdrawal by Subject|2
185682|NCT00064350|571744|P1|Cross-Over|Withdrawal by Subject|2
185683|NCT00064350|571742|P3|Cross-Over|Death|0
185684|NCT00064350|571743|P2|Cross-Over|Death|3
185685|NCT00064350|571744|P1|Cross-Over|Death|1
185686|NCT00064350|571742|P3|Cross-Over|Adverse Event|0
185687|NCT00064350|571743|P2|Cross-Over|Adverse Event|1
185688|NCT00064350|571744|P1|Cross-Over|Adverse Event|0
185689|NCT00064350|571742|P3|Randomization|Other|0
185690|NCT00064350|571743|P2|Randomization|Other|0
185691|NCT00064350|571744|P1|Randomization|Other|5
185692|NCT00064350|571742|P3|Randomization|Ineligible or never started treatment|0
185693|NCT00064350|571743|P2|Randomization|Ineligible or never started treatment|15
185694|NCT00064350|571744|P1|Randomization|Ineligible or never started treatment|9
185695|NCT00064350|571742|P3|Randomization|Withdrawal by Subject|0
185696|NCT00064350|571743|P2|Randomization|Withdrawal by Subject|0
185697|NCT00064350|571744|P1|Randomization|Withdrawal by Subject|1
185698|NCT00064350|571742|P3|Randomization|Death|0
185699|NCT00064350|571743|P2|Randomization|Death|0
185700|NCT00064350|571744|P1|Randomization|Death|3
185701|NCT00064350|571742|P3|Randomization|Adverse Event|0
185702|NCT00064350|571743|P2|Randomization|Adverse Event|3
185703|NCT00064350|571744|P1|Randomization|Adverse Event|8
185704|NCT00064350|571742|P3|Induction Treatment|Other|13
185705|NCT00064350|571743|P2|Induction Treatment|Other|0
185706|NCT00064350|571744|P1|Induction Treatment|Other|0
185707|NCT00064350|571742|P3|Induction Treatment|Ineligible or never started treatment|34
185708|NCT00064350|571743|P2|Induction Treatment|Ineligible or never started treatment|6
185709|NCT00064350|571744|P1|Induction Treatment|Ineligible or never started treatment|3
185710|NCT00064350|571742|P3|Induction Treatment|Withdrawal by Subject|21
185711|NCT00064350|571743|P2|Induction Treatment|Withdrawal by Subject|0
185712|NCT00064350|571744|P1|Induction Treatment|Withdrawal by Subject|0
185713|NCT00064350|571742|P3|Induction Treatment|Death|9
185714|NCT00064350|571743|P2|Induction Treatment|Death|0
185715|NCT00064350|571744|P1|Induction Treatment|Death|0
185716|NCT00064350|571742|P3|Induction Treatment|Adverse Event|49
185717|NCT00064350|571743|P2|Induction Treatment|Adverse Event|2
185718|NCT00064350|571744|P1|Induction Treatment|Adverse Event|0
185719|NCT00064350|571742|P3|Induction Treatment|Disease Progression|110
185720|NCT00064350|571743|P2|Induction Treatment|Disease Progression|1
185721|NCT00064350|571744|P1|Induction Treatment|Disease Progression|5
185722|NCT00064259|571759|P4|Overall Study|Adverse Event|1
185723|NCT00064259|571760|P3|Overall Study|Adverse Event|0
185724|NCT00064259|571761|P2|Overall Study|Adverse Event|0
185725|NCT00064259|571762|P1|Overall Study|Adverse Event|1
185726|NCT00064025|571780|P1|Overall Study|Inevaluable|3
185727|NCT00064025|571780|P1|Overall Study|Ineligible|4
185728|NCT00063986|571787|P1|Overall Study|Intra-operatively ineligible|4
185729|NCT00063986|571787|P1|Overall Study|Ineligible|1
185730|NCT00063986|571787|P1|Overall Study|Withdrawal by Subject|1
185731|NCT00063934|571799|P1|Overall Study|Ineligible|1
185732|NCT00063258|571904|P2|Overall Study|Lack of Efficacy|0
185733|NCT00063258|571905|P1|Overall Study|Lack of Efficacy|2
185734|NCT00063258|571904|P2|Overall Study|Physician Decision|0
185735|NCT00063258|571905|P1|Overall Study|Physician Decision|2
185736|NCT00063154|571917|P1|Overall Study|Did not receive treatment|8
185737|NCT00063154|571917|P1|Overall Study|Reason unspecified|1
185738|NCT00063154|571917|P1|Overall Study|Death|3
185739|NCT00063154|571917|P1|Overall Study|Physician Decision|10
185740|NCT00063154|571917|P1|Overall Study|Adverse Event|2
185741|NCT00063154|571917|P1|Overall Study|Disease progression|27
185742|NCT00062751|571937|P5|Overall Study|Death|0
185743|NCT00062751|571938|P4|Overall Study|Death|0
185744|NCT00062751|571939|P3|Overall Study|Death|1
185745|NCT00062751|571940|P2|Overall Study|Death|0
185746|NCT00062751|571941|P1|Overall Study|Death|1
185747|NCT00062751|571937|P5|Overall Study|Symptomatic deterioration|1
185748|NCT00062751|571938|P4|Overall Study|Symptomatic deterioration|0
185749|NCT00062751|571939|P3|Overall Study|Symptomatic deterioration|0
185750|NCT00062751|571940|P2|Overall Study|Symptomatic deterioration|1
185751|NCT00062751|571941|P1|Overall Study|Symptomatic deterioration|1
185752|NCT00062751|571937|P5|Overall Study|Withdrawal by Subject|0
185753|NCT00062751|571938|P4|Overall Study|Withdrawal by Subject|1
185754|NCT00062751|571939|P3|Overall Study|Withdrawal by Subject|2
185755|NCT00062751|571940|P2|Overall Study|Withdrawal by Subject|2
185756|NCT00062751|571941|P1|Overall Study|Withdrawal by Subject|1
185757|NCT00062751|571937|P5|Overall Study|Unspecified|1
185758|NCT00062751|571938|P4|Overall Study|Unspecified|0
185759|NCT00062751|571939|P3|Overall Study|Unspecified|1
185760|NCT00062751|571940|P2|Overall Study|Unspecified|3
185761|NCT00062751|571941|P1|Overall Study|Unspecified|2
185762|NCT00062751|571937|P5|Overall Study|Adverse Event|2
185763|NCT00062751|571938|P4|Overall Study|Adverse Event|2
185764|NCT00062751|571939|P3|Overall Study|Adverse Event|2
185765|NCT00062751|571940|P2|Overall Study|Adverse Event|7
185766|NCT00062751|571941|P1|Overall Study|Adverse Event|4
185767|NCT00062751|571937|P5|Overall Study|Disease progression|2
185768|NCT00062751|571938|P4|Overall Study|Disease progression|2
185769|NCT00062751|571939|P3|Overall Study|Disease progression|24
185770|NCT00062751|571940|P2|Overall Study|Disease progression|17
185771|NCT00062751|571941|P1|Overall Study|Disease progression|24
185772|NCT00062647|572027|P2|Overall Study|Never received study treatment|1
185773|NCT00062647|572028|P1|Overall Study|Never received study treatment|1
185774|NCT00062647|572027|P2|Overall Study|Other|4
185775|NCT00062647|572028|P1|Overall Study|Other|4
185776|NCT00062647|572027|P2|Overall Study|Failed continuation criteria|2
185777|NCT00062647|572028|P1|Overall Study|Failed continuation criteria|4
185778|NCT00062647|572027|P2|Overall Study|Lost to Follow-up|2
185779|NCT00062647|572028|P1|Overall Study|Lost to Follow-up|1
185780|NCT00062647|572027|P2|Overall Study|Protocol Violation|0
185781|NCT00062647|572028|P1|Overall Study|Protocol Violation|1
185782|NCT00062647|572027|P2|Overall Study|Withdrawal by Subject|1
185783|NCT00062647|572028|P1|Overall Study|Withdrawal by Subject|2
185784|NCT00062647|572027|P2|Overall Study|Adverse Event|1
185785|NCT00062647|572028|P1|Overall Study|Adverse Event|1
185786|NCT00062647|572027|P2|Overall Study|Death|2
185787|NCT00062647|572028|P1|Overall Study|Death|2
185788|NCT00062439|572034|P1|Consolidation Chemotherapy|Adverse Event|2
185789|NCT00062439|572034|P1|Surgery|Adverse Event|2
185790|NCT00062439|572034|P1|Surgery|Death|1
185791|NCT00062439|572034|P1|Surgery|Physician Decision|4
185792|NCT00062439|572034|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
185793|NCT00062439|572034|P1|Post Chemoradiation Assessment|Physician Decision|1
185794|NCT00062439|572034|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
185795|NCT00062439|572034|P1|Post Chemoradiation Assessment|Disease progression|2
185796|NCT00062439|572034|P1|Post Chemoradiation Assessment|Death|1
185797|NCT00062439|572034|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
185798|NCT00062439|572034|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
185799|NCT00062439|572034|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
185800|NCT00062439|572034|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
185801|NCT00062010|572046|P1|Overall Study|Ineligible|3
185802|NCT00061945|572054|P2|Course IV: Alemtuzumab|Early exits|15
185803|NCT00061945|572055|P1|Course IV: Alemtuzumab|Early exits|6
185804|NCT00061945|572054|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
185805|NCT00061945|572055|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
185806|NCT00061945|572054|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
185807|NCT00061945|572055|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
185808|NCT00061945|572054|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
185809|NCT00061945|572055|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
185810|NCT00061932|572065|P2|Overall Study|Withdrawal by Subject|4
185811|NCT00061932|572066|P1|Overall Study|Withdrawal by Subject|13
185812|NCT00061633|572079|P2|Overall Study|Never received study treatment|2
185813|NCT00061633|572080|P1|Overall Study|Never received study treatment|0
185814|NCT00061633|572079|P2|Overall Study|Other|1
185815|NCT00061633|572080|P1|Overall Study|Other|1
185816|NCT00061633|572079|P2|Overall Study|Lost to Follow-up|4
185817|NCT00061633|572080|P1|Overall Study|Lost to Follow-up|1
185818|NCT00061633|572079|P2|Overall Study|Withdrawal by Subject|2
185819|NCT00061633|572080|P1|Overall Study|Withdrawal by Subject|2
185820|NCT00061633|572079|P2|Overall Study|Adverse Event|2
185821|NCT00061633|572080|P1|Overall Study|Adverse Event|1
185822|NCT00061048|572105|P1|Overall Study|disease progression|20
185823|NCT00061048|572105|P1|Overall Study|Adverse Event|2
185824|NCT00060944|572115|P2|Overall Study|randomized but not treated|4
185825|NCT00060944|572116|P1|Overall Study|randomized but not treated|6
185826|NCT00060944|572115|P2|Overall Study|Not specified|4
185827|NCT00060944|572116|P1|Overall Study|Not specified|2
185828|NCT00060944|572115|P2|Overall Study|Treatment Switch|13
185829|NCT00060944|572116|P1|Overall Study|Treatment Switch|0
185830|NCT00060944|572115|P2|Overall Study|Subject Ineligible To Continue|1
185831|NCT00060944|572116|P1|Overall Study|Subject Ineligible To Continue|2
185832|NCT00060944|572115|P2|Overall Study|Lost to Follow-up|0
185833|NCT00060944|572116|P1|Overall Study|Lost to Follow-up|1
185834|NCT00060944|572115|P2|Overall Study|Disease Progression|94
185835|NCT00060944|572116|P1|Overall Study|Disease Progression|93
185836|NCT00060944|572115|P2|Overall Study|Withdrawal by Subject|5
185837|NCT00060944|572116|P1|Overall Study|Withdrawal by Subject|18
185838|NCT00060944|572115|P2|Overall Study|Death|3
185839|NCT00060944|572116|P1|Overall Study|Death|2
185840|NCT00060944|572115|P2|Overall Study|Adverse Event|10
185841|NCT00060944|572116|P1|Overall Study|Adverse Event|12
185842|NCT00060840|572132|P2|Overall Study|Other|0
185843|NCT00060840|572133|P1|Overall Study|Other|1
185844|NCT00060840|572132|P2|Overall Study|Physician Decision|0
185845|NCT00060840|572133|P1|Overall Study|Physician Decision|1
185846|NCT00060840|572132|P2|Overall Study|Subinvestigator unavailable|1
185847|NCT00060840|572133|P1|Overall Study|Subinvestigator unavailable|0
185848|NCT00060840|572132|P2|Overall Study|Withdrawal by Subject|1
185849|NCT00060840|572133|P1|Overall Study|Withdrawal by Subject|0
185850|NCT00060840|572132|P2|Overall Study|Death|1
185851|NCT00060840|572133|P1|Overall Study|Death|0
185852|NCT00060840|572132|P2|Overall Study|Change in surgical plan|6
185853|NCT00060840|572133|P1|Overall Study|Change in surgical plan|2
185854|NCT00059839|572167|P2|Overall Study|Ineligible|3
185855|NCT00059839|572168|P1|Overall Study|Ineligible|1
185856|NCT00059839|572167|P2|Overall Study|Withdrawal by Subject|6
185857|NCT00059839|572168|P1|Overall Study|Withdrawal by Subject|1
185858|NCT00059839|572167|P2|Overall Study|Physician Decision|2
185859|NCT00059839|572168|P1|Overall Study|Physician Decision|1
185860|NCT00059839|572167|P2|Overall Study|Lost to Follow-up|0
185861|NCT00059839|572168|P1|Overall Study|Lost to Follow-up|2
185862|NCT00059839|572167|P2|Overall Study|Lack of Efficacy|5
185863|NCT00059839|572168|P1|Overall Study|Lack of Efficacy|6
185864|NCT00059839|572167|P2|Overall Study|Death|1
185865|NCT00059839|572168|P1|Overall Study|Death|1
185866|NCT00059787|572174|P1|Overall Study|Other|4
185867|NCT00059787|572174|P1|Overall Study|ineligible|1
185868|NCT00059787|572174|P1|Overall Study|disease progression|2
185869|NCT00059787|572174|P1|Overall Study|Adverse Event|13
185870|NCT00059332|572225|P2|Overall Study|Lost to Follow-up|1
185871|NCT00059332|572226|P1|Overall Study|Lost to Follow-up|1
185872|NCT00059332|572225|P2|Overall Study|Withdrawal by Subject|1
185873|NCT00059332|572226|P1|Overall Study|Withdrawal by Subject|2
185874|NCT00059215|572252|P4|Overall Study|Physician Decision|1
185875|NCT00059215|572253|P3|Overall Study|Physician Decision|1
185876|NCT00059215|572254|P2|Overall Study|Physician Decision|2
185877|NCT00059215|572255|P1|Overall Study|Physician Decision|1
185878|NCT00059215|572252|P4|Overall Study|Protocol entry criteria not met|2
185879|NCT00059215|572253|P3|Overall Study|Protocol entry criteria not met|0
185880|NCT00059215|572254|P2|Overall Study|Protocol entry criteria not met|1
185881|NCT00059215|572255|P1|Overall Study|Protocol entry criteria not met|1
185882|NCT00059215|572252|P4|Overall Study|Protocol Violation|0
185883|NCT00059215|572253|P3|Overall Study|Protocol Violation|1
185884|NCT00059215|572254|P2|Overall Study|Protocol Violation|0
185885|NCT00059215|572255|P1|Overall Study|Protocol Violation|1
185886|NCT00059215|572252|P4|Overall Study|Withdrawal by Subject|3
185887|NCT00059215|572253|P3|Overall Study|Withdrawal by Subject|1
185888|NCT00059215|572254|P2|Overall Study|Withdrawal by Subject|4
185889|NCT00059215|572255|P1|Overall Study|Withdrawal by Subject|4
185890|NCT00059215|572252|P4|Overall Study|Lost to Follow-up|0
185891|NCT00059215|572253|P3|Overall Study|Lost to Follow-up|0
185892|NCT00059215|572254|P2|Overall Study|Lost to Follow-up|2
185893|NCT00059215|572255|P1|Overall Study|Lost to Follow-up|1
185894|NCT00059215|572252|P4|Overall Study|Death|0
185895|NCT00059215|572253|P3|Overall Study|Death|3
185896|NCT00059215|572254|P2|Overall Study|Death|0
185897|NCT00059215|572255|P1|Overall Study|Death|0
185898|NCT00059215|572252|P4|Overall Study|Adverse Event|9
185899|NCT00059215|572253|P3|Overall Study|Adverse Event|9
185900|NCT00059215|572254|P2|Overall Study|Adverse Event|5
185901|NCT00059215|572255|P1|Overall Study|Adverse Event|5
185902|NCT00058825|572281|P1|Overall Study|Death|3
185903|NCT00058825|572281|P1|Overall Study|Graft Failure|5
185904|NCT00058825|572281|P1|Overall Study|Progressive Disease|5
185905|NCT00058825|572281|P1|Overall Study|Relapse|9
185906|NCT00058552|572297|P2|Overall Study|Clinical disease progression|4
185907|NCT00058552|572298|P1|Overall Study|Clinical disease progression|0
185908|NCT00058552|572297|P2|Overall Study|Physician Decision|5
185909|NCT00058552|572298|P1|Overall Study|Physician Decision|2
185910|NCT00058552|572297|P2|Overall Study|Withdrawal by Subject|5
185911|NCT00058552|572298|P1|Overall Study|Withdrawal by Subject|3
185912|NCT00058552|572297|P2|Overall Study|Adverse Event|2
185913|NCT00058552|572298|P1|Overall Study|Adverse Event|4
185914|NCT00058552|572297|P2|Overall Study|Disease progression|44
185915|NCT00058552|572298|P1|Overall Study|Disease progression|52
185916|NCT00058552|572297|P2|Overall Study|Died prior to receiving treatment|2
185917|NCT00058552|572298|P1|Overall Study|Died prior to receiving treatment|4
185918|NCT00058539|572316|P1|Overall Study|Death|1
185919|NCT00058539|572316|P1|Overall Study|Physician Decision|9
185920|NCT00058539|572316|P1|Overall Study|Withdrawal by Subject|5
185921|NCT00058539|572316|P1|Overall Study|Adverse Event|3
185922|NCT00058539|572316|P1|Overall Study|Disease progression|24
185923|NCT00058214|572326|P1|Overall Study|Adverse Event|1
185924|NCT00057954|572347|P1|Overall Study|Disease progression|1
185925|NCT00057954|572347|P1|Overall Study|Death|1
185926|NCT00057941|572355|P2|Overall Study|Ineligible|5
185927|NCT00057941|572356|P1|Overall Study|Ineligible|2
185928|NCT00057941|572355|P2|Overall Study|insurance, symptomatic deterioration|3
185929|NCT00057941|572356|P1|Overall Study|insurance, symptomatic deterioration|1
185930|NCT00057941|572355|P2|Overall Study|still on treatment|1
185931|NCT00057941|572356|P1|Overall Study|still on treatment|3
185932|NCT00057941|572355|P2|Overall Study|Withdrawal by Subject|1
185933|NCT00057941|572356|P1|Overall Study|Withdrawal by Subject|6
185934|NCT00057941|572355|P2|Overall Study|Lack of Efficacy|53
185935|NCT00057941|572356|P1|Overall Study|Lack of Efficacy|54
185936|NCT00057941|572355|P2|Overall Study|Adverse Event|9
185937|NCT00057941|572356|P1|Overall Study|Adverse Event|7
185938|NCT00057941|572355|P2|Overall Study|Death|2
185939|NCT00057941|572356|P1|Overall Study|Death|1
185940|NCT00057876|572364|P2|Overall Study|other complicating disease|0
185941|NCT00057876|572365|P1|Overall Study|other complicating disease|1
185942|NCT00057876|572364|P2|Overall Study|other reason|2
185943|NCT00057876|572365|P1|Overall Study|other reason|2
185944|NCT00057876|572364|P2|Overall Study|Ineligible|2
185945|NCT00057876|572365|P1|Overall Study|Ineligible|1
185946|NCT00057876|572364|P2|Overall Study|Lack of Efficacy|8
185947|NCT00057876|572365|P1|Overall Study|Lack of Efficacy|10
185948|NCT00057876|572364|P2|Overall Study|Withdrawal by Subject|6
185949|NCT00057876|572365|P1|Overall Study|Withdrawal by Subject|5
185950|NCT00057876|572364|P2|Overall Study|Death|1
185951|NCT00057876|572365|P1|Overall Study|Death|2
185952|NCT00057876|572364|P2|Overall Study|Adverse Event|8
185953|NCT00057876|572365|P1|Overall Study|Adverse Event|8
185954|NCT00057863|572375|P1|Overall Study|Withdrawal by Subject|2
185955|NCT00057863|572375|P1|Overall Study|Death|1
185956|NCT00057837|572384|P2|Overall Study|Never started treatment|1
185957|NCT00057837|572385|P1|Overall Study|Never started treatment|1
185958|NCT00057837|572384|P2|Overall Study|Ineligible|3
185959|NCT00057837|572385|P1|Overall Study|Ineligible|3
185960|NCT00057837|572384|P2|Overall Study|Physician Decision|0
185961|NCT00057837|572385|P1|Overall Study|Physician Decision|1
185962|NCT00057837|572384|P2|Overall Study|Other complicating disease|1
185963|NCT00057837|572385|P1|Overall Study|Other complicating disease|2
185964|NCT00057837|572384|P2|Overall Study|Alternative therapy|1
185965|NCT00057837|572385|P1|Overall Study|Alternative therapy|0
185966|NCT00057837|572384|P2|Overall Study|Withdrawal by Subject|3
185967|NCT00057837|572385|P1|Overall Study|Withdrawal by Subject|5
185968|NCT00057837|572384|P2|Overall Study|Death|4
185969|NCT00057837|572385|P1|Overall Study|Death|5
185970|NCT00057837|572384|P2|Overall Study|Adverse Event|12
185971|NCT00057837|572385|P1|Overall Study|Adverse Event|2
185972|NCT00057837|572384|P2|Overall Study|Progression/relapse|14
185973|NCT00057837|572385|P1|Overall Study|Progression/relapse|12
185974|NCT00057811|572397|P2|Overall Study|Inevaluable|2
185975|NCT00057811|572398|P1|Overall Study|Inevaluable|1
185976|NCT00057811|572397|P2|Overall Study|Ineligible|2
185977|NCT00057811|572398|P1|Overall Study|Ineligible|4
185978|NCT00057811|572397|P2|Overall Study|Withdrawal by Subject|4
185979|NCT00057811|572398|P1|Overall Study|Withdrawal by Subject|3
185980|NCT00057811|572397|P2|Overall Study|Physician Decision|0
185981|NCT00057811|572398|P1|Overall Study|Physician Decision|1
185982|NCT00057811|572397|P2|Overall Study|Lack of Efficacy|4
185983|NCT00057811|572398|P1|Overall Study|Lack of Efficacy|1
185984|NCT00057746|572417|P3|Overall Study|Withdrawal by Subject|1
185985|NCT00057746|572418|P2|Overall Study|Withdrawal by Subject|0
185986|NCT00057746|572419|P1|Overall Study|Withdrawal by Subject|0
185987|NCT00057330|572472|P2|Overall Study|Unspecified|206
185988|NCT00057330|572473|P1|Overall Study|Unspecified|260
185989|NCT00057330|572472|P2|Overall Study|Physician Decision|0
185990|NCT00057330|572473|P1|Overall Study|Physician Decision|1
185991|NCT00057330|572472|P2|Overall Study|Lost to Follow-up|617
185992|NCT00057330|572473|P1|Overall Study|Lost to Follow-up|745
185993|NCT00057330|572472|P2|Overall Study|Withdrawal by Subject|84
185994|NCT00057330|572473|P1|Overall Study|Withdrawal by Subject|115
185995|NCT00057330|572472|P2|Overall Study|Protocol Violation|1
185996|NCT00057330|572473|P1|Overall Study|Protocol Violation|1
185997|NCT00057330|572472|P2|Overall Study|Death|0
185998|NCT00057330|572473|P1|Overall Study|Death|1
185999|NCT00057330|572472|P2|Overall Study|Adverse Event|12
186000|NCT00057330|572473|P1|Overall Study|Adverse Event|9
186001|NCT00056862|572503|P2|Overall Study|Protocol Violation|0
186002|NCT00056862|572504|P1|Overall Study|Protocol Violation|1
186003|NCT00056407|572558|P2|Overall Study|Missing|34
186004|NCT00056407|572559|P1|Overall Study|Missing|25
186005|NCT00056407|572558|P2|Overall Study|"Listed as Other on Case Report Form"|60
186006|NCT00056407|572559|P1|Overall Study|"Listed as Other on Case Report Form"|98
186007|NCT00056407|572558|P2|Overall Study|Diagnosed with Prostate Cancer|166
186008|NCT00056407|572559|P1|Overall Study|Diagnosed with Prostate Cancer|202
186009|NCT00056407|572558|P2|Overall Study|Protocol Violation|95
186010|NCT00056407|572559|P1|Overall Study|Protocol Violation|104
186011|NCT00056407|572558|P2|Overall Study|Lost to Follow-up|113
186012|NCT00056407|572559|P1|Overall Study|Lost to Follow-up|123
186013|NCT00056407|572558|P2|Overall Study|Withdrawal by Subject|361
186014|NCT00056407|572559|P1|Overall Study|Withdrawal by Subject|377
186015|NCT00056407|572558|P2|Overall Study|Adverse Event|364
186016|NCT00056407|572559|P1|Overall Study|Adverse Event|282
186017|NCT00056316|572617|P2|Overall Study|Death/NH placement of pt|1
186018|NCT00056316|572618|P1|Overall Study|Death/NH placement of pt|1
186019|NCT00056316|572617|P2|Overall Study|Withdrawal by Subject|2
186020|NCT00056316|572618|P1|Overall Study|Withdrawal by Subject|2
186021|NCT00056160|572632|P2|Final Follow-up|Adverse Event|0
186022|NCT00056160|572633|P1|Final Follow-up|Adverse Event|1
186023|NCT00056160|572632|P2|Final Follow-up|Transferred into RevAssist Program|0
186024|NCT00056160|572633|P1|Final Follow-up|Transferred into RevAssist Program|2
186025|NCT00056160|572632|P2|Final Follow-up|Transferred into expanded access study.|0
186026|NCT00056160|572633|P1|Final Follow-up|Transferred into expanded access study.|3
186027|NCT00056160|572632|P2|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|0
186028|NCT00056160|572633|P1|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|21
186029|NCT00056160|572632|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
186030|NCT00056160|572633|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
186031|NCT00056160|572632|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
186032|NCT00056160|572633|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
186033|NCT00056160|572632|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
186034|NCT00056160|572633|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
186035|NCT00056160|572632|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
186036|NCT00056160|572633|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
186037|NCT00056160|572632|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
186038|NCT00056160|572633|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
186039|NCT00056160|572632|P2|Up to Unblinding (07 Jun 2005)|Not specified|7
186040|NCT00056160|572633|P1|Up to Unblinding (07 Jun 2005)|Not specified|8
186041|NCT00056160|572632|P2|Up to Unblinding (07 Jun 2005)|Death|1
186042|NCT00056160|572633|P1|Up to Unblinding (07 Jun 2005)|Death|2
186043|NCT00056160|572632|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
186044|NCT00056160|572633|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
186045|NCT00056160|572632|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
186046|NCT00056160|572633|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
186047|NCT00056160|572632|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
186048|NCT00056160|572633|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
186049|NCT00056160|572632|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
186050|NCT00056160|572633|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
186051|NCT00055601|572656|P2|Overall Study|No protocol treatment received|1
186052|NCT00055601|572657|P1|Overall Study|No protocol treatment received|1
186053|NCT00055601|572656|P2|Overall Study|Protocol Violation|1
186054|NCT00055601|572657|P1|Overall Study|Protocol Violation|1
186055|NCT00055497|572671|P4|Overall Study|Other|11
186056|NCT00055497|572672|P3|Overall Study|Other|0
186057|NCT00055497|572673|P2|Overall Study|Other|0
186058|NCT00055497|572674|P1|Overall Study|Other|0
186059|NCT00055497|572671|P4|Overall Study|Administrative Reasons|1
186060|NCT00055497|572672|P3|Overall Study|Administrative Reasons|0
186061|NCT00055497|572673|P2|Overall Study|Administrative Reasons|0
186062|NCT00055497|572674|P1|Overall Study|Administrative Reasons|0
186063|NCT00055497|572671|P4|Overall Study|Lack of Efficacy|27
186064|NCT00055497|572672|P3|Overall Study|Lack of Efficacy|0
186065|NCT00055497|572673|P2|Overall Study|Lack of Efficacy|0
186066|NCT00055497|572674|P1|Overall Study|Lack of Efficacy|1
186067|NCT00055497|572671|P4|Overall Study|Protocol Violation|3
186068|NCT00055497|572672|P3|Overall Study|Protocol Violation|0
186069|NCT00055497|572673|P2|Overall Study|Protocol Violation|0
186070|NCT00055497|572674|P1|Overall Study|Protocol Violation|0
186071|NCT00055497|572671|P4|Overall Study|Lost to Follow-up|5
186072|NCT00055497|572672|P3|Overall Study|Lost to Follow-up|0
186073|NCT00055497|572673|P2|Overall Study|Lost to Follow-up|1
186074|NCT00055497|572674|P1|Overall Study|Lost to Follow-up|0
186075|NCT00055497|572671|P4|Overall Study|Withdrawal by Subject|15
186076|NCT00055497|572672|P3|Overall Study|Withdrawal by Subject|1
186077|NCT00055497|572673|P2|Overall Study|Withdrawal by Subject|1
186078|NCT00055497|572674|P1|Overall Study|Withdrawal by Subject|3
186079|NCT00055497|572671|P4|Overall Study|Adverse Event|28
186080|NCT00055497|572672|P3|Overall Study|Adverse Event|1
186081|NCT00055497|572673|P2|Overall Study|Adverse Event|1
186082|NCT00055497|572674|P1|Overall Study|Adverse Event|1
186083|NCT00055471|572719|P3|Period 1: Dose Escalation Period|Disease progression|0
186084|NCT00055471|572720|P2|Period 1: Dose Escalation Period|Disease progression|1
186085|NCT00055471|572721|P1|Period 1: Dose Escalation Period|Disease progression|0
186086|NCT00055471|572719|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
186087|NCT00055471|572720|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
186088|NCT00055471|572721|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
186089|NCT00055471|572719|P3|Period 1: Dose Escalation Period|Adverse Event|2
186090|NCT00055471|572720|P2|Period 1: Dose Escalation Period|Adverse Event|1
186091|NCT00055471|572721|P1|Period 1: Dose Escalation Period|Adverse Event|0
186092|NCT00054717|572772|P2|Overall Study|Other reason not defined above|217
186093|NCT00054717|572773|P1|Overall Study|Other reason not defined above|117
186094|NCT00054717|572772|P2|Overall Study|Withdrawal by Subject|20
186095|NCT00054717|572773|P1|Overall Study|Withdrawal by Subject|32
186096|NCT00054717|572772|P2|Overall Study|Lost to Follow-up|13
186097|NCT00054717|572773|P1|Overall Study|Lost to Follow-up|23
186098|NCT00054717|572772|P2|Overall Study|Protocol Violation|19
186099|NCT00054717|572773|P1|Overall Study|Protocol Violation|18
186100|NCT00054717|572772|P2|Overall Study|Adverse Event|22
186101|NCT00054717|572773|P1|Overall Study|Adverse Event|70
186102|NCT00054717|572772|P2|Overall Study|Randomized but not treated|8
186103|NCT00054717|572773|P1|Overall Study|Randomized but not treated|2
186104|NCT00054704|572961|P2|Overall Study|Lost to Follow-up|0
186105|NCT00054704|572962|P1|Overall Study|Lost to Follow-up|1
186106|NCT00054704|572961|P2|Overall Study|Adverse Event|2
186107|NCT00054704|572962|P1|Overall Study|Adverse Event|3
186108|NCT00054704|572961|P2|Overall Study|Lack of Efficacy|3
186109|NCT00054704|572962|P1|Overall Study|Lack of Efficacy|1
186110|NCT00054691|572968|P1|Overall Study|Noncompliant|1
186111|NCT00054691|572968|P1|Overall Study|Unmeasurable Disease|2
186112|NCT00054639|572982|P1|Overall Study|Physician Decision|1
186113|NCT00054639|572982|P1|Overall Study|Lack of Efficacy|1
186114|NCT00054327|572992|P6|Overall Study|Engraftment failure|0
186115|NCT00054327|572993|P5|Overall Study|Engraftment failure|0
186116|NCT00054327|572994|P4|Overall Study|Engraftment failure|0
186117|NCT00054327|572995|P3|Overall Study|Engraftment failure|0
186118|NCT00054327|572996|P2|Overall Study|Engraftment failure|0
186119|NCT00054327|572997|P1|Overall Study|Engraftment failure|1
186120|NCT00054275|573035|P1|Overall Study|Physician Decision|1
186121|NCT00054275|573035|P1|Overall Study|Progressive disease in cycle 1|1
186122|NCT00054275|573035|P1|Overall Study|Adverse Event|5
186123|NCT00054275|573035|P1|Overall Study|Withdrawal by Subject|4
186124|NCT00053846|573051|P2|Overall Study|Pills too large|1
186125|NCT00053846|573052|P1|Overall Study|Pills too large|0
186126|NCT00053846|573051|P2|Overall Study|Quit due to side effects|3
186127|NCT00053846|573052|P1|Overall Study|Quit due to side effects|1
186128|NCT00053846|573051|P2|Overall Study|Did not return data|2
186129|NCT00053846|573052|P1|Overall Study|Did not return data|1
186130|NCT00053846|573051|P2|Overall Study|Became ineligible|1
186131|NCT00053846|573052|P1|Overall Study|Became ineligible|3
186132|NCT00053846|573051|P2|Overall Study|Expired|0
186133|NCT00053846|573052|P1|Overall Study|Expired|5
186134|NCT00053846|573051|P2|Overall Study|Became too ill|7
186135|NCT00053846|573052|P1|Overall Study|Became too ill|8
186136|NCT00053846|573051|P2|Overall Study|Changed mind|13
186137|NCT00053846|573052|P1|Overall Study|Changed mind|8
186138|NCT00053417|573202|P4|Overall Study|Lost to Follow-up|0
186139|NCT00053417|573203|P3|Overall Study|Lost to Follow-up|0
186140|NCT00053417|573204|P2|Overall Study|Lost to Follow-up|1
186141|NCT00053417|573205|P1|Overall Study|Lost to Follow-up|1
186142|NCT00053417|573202|P4|Overall Study|Withdrawal by Subject|0
186143|NCT00053417|573203|P3|Overall Study|Withdrawal by Subject|0
186144|NCT00053417|573204|P2|Overall Study|Withdrawal by Subject|1
186145|NCT00053417|573205|P1|Overall Study|Withdrawal by Subject|0
186146|NCT00053417|573202|P4|Overall Study|Non-Compliance|1
186147|NCT00053417|573203|P3|Overall Study|Non-Compliance|0
186148|NCT00053417|573204|P2|Overall Study|Non-Compliance|0
186149|NCT00053417|573205|P1|Overall Study|Non-Compliance|0
186150|NCT00053417|573202|P4|Overall Study|Adverse Event|5
186151|NCT00053417|573203|P3|Overall Study|Adverse Event|1
186152|NCT00053417|573204|P2|Overall Study|Adverse Event|0
186153|NCT00053417|573205|P1|Overall Study|Adverse Event|1
186154|NCT00053365|573215|P1|Overall Study|Never treated|4
186155|NCT00053365|573215|P1|Overall Study|Platinum-sensitive interval >12 months|1
186156|NCT00053365|573215|P1|Overall Study|Incorrect cell type|1
186157|NCT00052962|573227|P2|Overall Study|Not randomized/not evaluable|0
186158|NCT00052962|573228|P1|Overall Study|Not randomized/not evaluable|1
186159|NCT00052962|573227|P2|Overall Study|Not evaluable|2
186160|NCT00052962|573228|P1|Overall Study|Not evaluable|0
186161|NCT00051636|573243|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
186162|NCT00051636|573244|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
186163|NCT00051636|573243|P2|Period 2- Extended Observation Period|Death|5
186164|NCT00051636|573244|P1|Period 2- Extended Observation Period|Death|4
186165|NCT00051636|573243|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
186166|NCT00051636|573244|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
186167|NCT00051636|573243|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
186256|NCT00050778|573385|P2|Overall Study|Lack of Efficacy|2
186168|NCT00051636|573244|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
186169|NCT00051636|573243|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
186170|NCT00051636|573244|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
186171|NCT00051636|573243|P2|Period 1 - Core|Lost to Follow-up|2
186172|NCT00051636|573244|P1|Period 1 - Core|Lost to Follow-up|0
186173|NCT00051636|573243|P2|Period 1 - Core|Withdrawal by Subject|2
186174|NCT00051636|573244|P1|Period 1 - Core|Withdrawal by Subject|1
186175|NCT00051636|573243|P2|Period 1 - Core|Protocol Violation|0
186176|NCT00051636|573244|P1|Period 1 - Core|Protocol Violation|1
186177|NCT00051636|573243|P2|Period 1 - Core|Adverse Event|2
186178|NCT00051636|573244|P1|Period 1 - Core|Adverse Event|2
186179|NCT00051558|573272|P2|Overall Study|Physician Decision|0
186180|NCT00051558|573273|P1|Overall Study|Physician Decision|5
186181|NCT00051558|573272|P2|Overall Study|Significant Lab Value|0
186182|NCT00051558|573273|P1|Overall Study|Significant Lab Value|2
186183|NCT00051558|573272|P2|Overall Study|Unspecified|1
186184|NCT00051558|573273|P1|Overall Study|Unspecified|2
186185|NCT00051558|573272|P2|Overall Study|Sponsor Decision|1
186186|NCT00051558|573273|P1|Overall Study|Sponsor Decision|6
186187|NCT00051558|573272|P2|Overall Study|Protocol Entry Criteria Unmet|2
186188|NCT00051558|573273|P1|Overall Study|Protocol Entry Criteria Unmet|1
186189|NCT00051558|573272|P2|Overall Study|Protocol Violation|4
186190|NCT00051558|573273|P1|Overall Study|Protocol Violation|3
186191|NCT00051558|573272|P2|Overall Study|Lost to Follow-up|13
186192|NCT00051558|573273|P1|Overall Study|Lost to Follow-up|4
186193|NCT00051558|573272|P2|Overall Study|Death|15
186194|NCT00051558|573273|P1|Overall Study|Death|9
186195|NCT00051558|573272|P2|Overall Study|Withdrawal by Subject|42
186196|NCT00051558|573273|P1|Overall Study|Withdrawal by Subject|29
186197|NCT00051558|573272|P2|Overall Study|Adverse Event|18
186198|NCT00051558|573273|P1|Overall Study|Adverse Event|30
186199|NCT00051363|573309|P2|Overall Study|Excluded Pre-Randomization|5
186200|NCT00051363|573310|P1|Overall Study|Excluded Pre-Randomization|2
186201|NCT00051363|573309|P2|Overall Study|Death|2
186202|NCT00051363|573310|P1|Overall Study|Death|2
186203|NCT00051363|573309|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
186204|NCT00051363|573310|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
186205|NCT00051363|573309|P2|Overall Study|Dropped Post-Rand for Any Reason|126
186206|NCT00051363|573310|P1|Overall Study|Dropped Post-Rand for Any Reason|102
186207|NCT00050167|573350|P2|Overall Study|not eligible not invasive|1
186208|NCT00050167|573351|P1|Overall Study|not eligible not invasive|1
186209|NCT00051025|573359|P2|Overall Study|Death|1
186210|NCT00051025|573360|P1|Overall Study|Death|0
186211|NCT00051025|573359|P2|Overall Study|Withdrawal by Subject|1
186212|NCT00051025|573360|P1|Overall Study|Withdrawal by Subject|0
186213|NCT00051025|573359|P2|Overall Study|Adverse Event|1
186214|NCT00051025|573360|P1|Overall Study|Adverse Event|1
186215|NCT00051025|573359|P2|Overall Study|Progressive Disease|1
186216|NCT00051025|573360|P1|Overall Study|Progressive Disease|1
186217|NCT00050960|573374|P2|Overall Study|Death|15
186218|NCT00050960|573375|P1|Overall Study|Death|13
186219|NCT00050960|573374|P2|Overall Study|Non-compliance|1
186220|NCT00050960|573375|P1|Overall Study|Non-compliance|3
186221|NCT00050960|573374|P2|Overall Study|Administrative|46
186222|NCT00050960|573375|P1|Overall Study|Administrative|31
186223|NCT00050960|573374|P2|Overall Study|Withdrawal by Subject|18
186224|NCT00050960|573375|P1|Overall Study|Withdrawal by Subject|23
186225|NCT00050960|573374|P2|Overall Study|Lost to Follow-up|1
186226|NCT00050960|573375|P1|Overall Study|Lost to Follow-up|0
186227|NCT00050960|573374|P2|Overall Study|Adverse Event|61
186228|NCT00050960|573375|P1|Overall Study|Adverse Event|62
186229|NCT00050960|573374|P2|Overall Study|Complete Response|2
186230|NCT00050960|573375|P1|Overall Study|Complete Response|0
186231|NCT00050960|573374|P2|Overall Study|Partial Response|19
186232|NCT00050960|573375|P1|Overall Study|Partial Response|14
186233|NCT00050960|573374|P2|Overall Study|Stable Disease|48
186234|NCT00050960|573375|P1|Overall Study|Stable Disease|19
186235|NCT00050960|573374|P2|Overall Study|Progressive Disease|93
186236|NCT00050960|573375|P1|Overall Study|Progressive Disease|137
186237|NCT00050778|573384|P3|Overall Study|Familial and personal reasons|0
186238|NCT00050778|573385|P2|Overall Study|Familial and personal reasons|0
186239|NCT00050778|573386|P1|Overall Study|Familial and personal reasons|1
186240|NCT00050778|573384|P3|Overall Study|Randomized but not treated|2
186241|NCT00050778|573385|P2|Overall Study|Randomized but not treated|5
186242|NCT00050778|573386|P1|Overall Study|Randomized but not treated|4
186243|NCT00050778|573384|P3|Overall Study|Withdrawal by Subject|4
186244|NCT00050778|573385|P2|Overall Study|Withdrawal by Subject|8
186245|NCT00050778|573386|P1|Overall Study|Withdrawal by Subject|6
186246|NCT00050778|573384|P3|Overall Study|Protocol Violation|1
186247|NCT00050778|573385|P2|Overall Study|Protocol Violation|0
186248|NCT00050778|573386|P1|Overall Study|Protocol Violation|2
186249|NCT00050778|573384|P3|Overall Study|Physician Decision|2
186250|NCT00050778|573385|P2|Overall Study|Physician Decision|0
186251|NCT00050778|573386|P1|Overall Study|Physician Decision|3
186252|NCT00050778|573384|P3|Overall Study|Lost to Follow-up|4
186253|NCT00050778|573385|P2|Overall Study|Lost to Follow-up|2
186254|NCT00050778|573386|P1|Overall Study|Lost to Follow-up|0
186255|NCT00050778|573384|P3|Overall Study|Lack of Efficacy|2
186257|NCT00050778|573386|P1|Overall Study|Lack of Efficacy|16
186258|NCT00050778|573384|P3|Overall Study|Death|1
186259|NCT00050778|573385|P2|Overall Study|Death|1
186260|NCT00050778|573386|P1|Overall Study|Death|0
186261|NCT00050778|573384|P3|Overall Study|Adverse Event|2
186262|NCT00050778|573385|P2|Overall Study|Adverse Event|3
186263|NCT00050778|573386|P1|Overall Study|Adverse Event|13
186264|NCT00050622|573412|P1|Overall Study|Adverse Event|1
186265|NCT00050011|573475|P2|Overall Study|Unknown - Reason is missing|2
186266|NCT00050011|573476|P1|Overall Study|Unknown - Reason is missing|0
186267|NCT00050011|573475|P2|Overall Study|Death|4
186268|NCT00050011|573476|P1|Overall Study|Death|7
186269|NCT00050011|573475|P2|Overall Study|Administrative problems|6
186270|NCT00050011|573476|P1|Overall Study|Administrative problems|10
186271|NCT00050011|573475|P2|Overall Study|Lost to Follow-up|9
186272|NCT00050011|573476|P1|Overall Study|Lost to Follow-up|7
186273|NCT00050011|573475|P2|Overall Study|Withdrawal by Subject|26
186274|NCT00050011|573476|P1|Overall Study|Withdrawal by Subject|34
186275|NCT00050011|573475|P2|Overall Study|Protocol Violation|10
186276|NCT00050011|573476|P1|Overall Study|Protocol Violation|4
186277|NCT00050011|573475|P2|Overall Study|Participant condition no longer required|0
186278|NCT00050011|573476|P1|Overall Study|Participant condition no longer required|1
186279|NCT00050011|573475|P2|Overall Study|Lack of Efficacy|21
186280|NCT00050011|573476|P1|Overall Study|Lack of Efficacy|16
186281|NCT00050011|573475|P2|Overall Study|Abnormal test procedure results|1
186282|NCT00050011|573476|P1|Overall Study|Abnormal test procedure results|0
186283|NCT00050011|573475|P2|Overall Study|Abnormal laboratory value(s)|1
186284|NCT00050011|573476|P1|Overall Study|Abnormal laboratory value(s)|1
186285|NCT00050011|573475|P2|Overall Study|Adverse Event|46
186286|NCT00050011|573476|P1|Overall Study|Adverse Event|41
186287|NCT00049842|573498|P2|Follow-up Phase|Not specified|4
186288|NCT00049842|573499|P1|Follow-up Phase|Not specified|1
186289|NCT00049842|573498|P2|Follow-up Phase|Adverse Event|1
186290|NCT00049842|573499|P1|Follow-up Phase|Adverse Event|6
186291|NCT00049842|573498|P2|Treatment Phase|Did not meet protocol eligibility|1
186292|NCT00049842|573499|P1|Treatment Phase|Did not meet protocol eligibility|0
186293|NCT00049842|573498|P2|Treatment Phase|Administrative|3
186294|NCT00049842|573499|P1|Treatment Phase|Administrative|0
186295|NCT00049842|573498|P2|Treatment Phase|Lost to Follow-up|8
186296|NCT00049842|573499|P1|Treatment Phase|Lost to Follow-up|4
186297|NCT00049842|573498|P2|Treatment Phase|Non-compliance with protocol|8
186298|NCT00049842|573499|P1|Treatment Phase|Non-compliance with protocol|7
186299|NCT00049842|573498|P2|Treatment Phase|Withdrawal by Subject|46
186300|NCT00049842|573499|P1|Treatment Phase|Withdrawal by Subject|35
186301|NCT00049842|573498|P2|Treatment Phase|Adverse Event|12
186302|NCT00049842|573499|P1|Treatment Phase|Adverse Event|47
186303|NCT00049543|573517|P2|Overall Study|still on treatment|9
186304|NCT00049543|573518|P1|Overall Study|still on treatment|2
186305|NCT00049530|573528|P1|Overall Study|ineligible|3
186306|NCT00049530|573528|P1|Overall Study|symptomatic deterioration|1
186307|NCT00049530|573528|P1|Overall Study|Death|1
186308|NCT00049530|573528|P1|Overall Study|Adverse Event|2
186309|NCT00049530|573528|P1|Overall Study|Lack of Efficacy|25
186310|NCT00049517|573537|P6|Conditioning/Transplant|Reasons not reported|5
186311|NCT00049517|573538|P5|Conditioning/Transplant|Reasons not reported|5
186312|NCT00049517|573539|P4|Conditioning/Transplant|Reasons not reported|15
186313|NCT00049517|573540|P3|Conditioning/Transplant|Reasons not reported|18
186314|NCT00049517|573541|P2|Conditioning/Transplant|Reasons not reported|31
186315|NCT00049517|573542|P1|Conditioning/Transplant|Reasons not reported|25
186316|NCT00049517|573537|P6|Conditioning/Transplant|Other complicating disease|1
186317|NCT00049517|573538|P5|Conditioning/Transplant|Other complicating disease|0
186318|NCT00049517|573539|P4|Conditioning/Transplant|Other complicating disease|4
186319|NCT00049517|573540|P3|Conditioning/Transplant|Other complicating disease|0
186320|NCT00049517|573541|P2|Conditioning/Transplant|Other complicating disease|0
186321|NCT00049517|573542|P1|Conditioning/Transplant|Other complicating disease|2
186322|NCT00049517|573537|P6|Conditioning/Transplant|Alternative therapy|0
186323|NCT00049517|573538|P5|Conditioning/Transplant|Alternative therapy|1
186324|NCT00049517|573539|P4|Conditioning/Transplant|Alternative therapy|1
186325|NCT00049517|573540|P3|Conditioning/Transplant|Alternative therapy|2
186326|NCT00049517|573541|P2|Conditioning/Transplant|Alternative therapy|4
186327|NCT00049517|573542|P1|Conditioning/Transplant|Alternative therapy|4
186328|NCT00049517|573537|P6|Conditioning/Transplant|Withdrawal by Subject|0
186329|NCT00049517|573538|P5|Conditioning/Transplant|Withdrawal by Subject|0
186330|NCT00049517|573539|P4|Conditioning/Transplant|Withdrawal by Subject|7
186331|NCT00049517|573540|P3|Conditioning/Transplant|Withdrawal by Subject|4
186332|NCT00049517|573541|P2|Conditioning/Transplant|Withdrawal by Subject|8
186333|NCT00049517|573542|P1|Conditioning/Transplant|Withdrawal by Subject|4
186334|NCT00049517|573537|P6|Conditioning/Transplant|Death|0
186335|NCT00049517|573538|P5|Conditioning/Transplant|Death|0
186336|NCT00049517|573539|P4|Conditioning/Transplant|Death|2
186337|NCT00049517|573540|P3|Conditioning/Transplant|Death|0
186338|NCT00049517|573541|P2|Conditioning/Transplant|Death|0
186339|NCT00049517|573542|P1|Conditioning/Transplant|Death|1
186340|NCT00049517|573537|P6|Conditioning/Transplant|Adverse Event|0
186341|NCT00049517|573538|P5|Conditioning/Transplant|Adverse Event|0
186342|NCT00049517|573539|P4|Conditioning/Transplant|Adverse Event|8
186343|NCT00049517|573540|P3|Conditioning/Transplant|Adverse Event|4
186344|NCT00049517|573541|P2|Conditioning/Transplant|Adverse Event|1
186345|NCT00049517|573542|P1|Conditioning/Transplant|Adverse Event|2
186346|NCT00049517|573537|P6|Conditioning/Transplant|Disease progression|0
186347|NCT00049517|573538|P5|Conditioning/Transplant|Disease progression|0
186348|NCT00049517|573539|P4|Conditioning/Transplant|Disease progression|6
186349|NCT00049517|573540|P3|Conditioning/Transplant|Disease progression|10
186350|NCT00049517|573541|P2|Conditioning/Transplant|Disease progression|6
186351|NCT00049517|573542|P1|Conditioning/Transplant|Disease progression|14
186352|NCT00049517|573537|P6|Induction|Reasons not reported|25
186353|NCT00049517|573538|P5|Induction|Reasons not reported|22
186354|NCT00049517|573539|P4|Induction|Reasons not reported|0
186355|NCT00049517|573540|P3|Induction|Reasons not reported|0
186356|NCT00049517|573541|P2|Induction|Reasons not reported|0
186357|NCT00049517|573542|P1|Induction|Reasons not reported|0
186358|NCT00049517|573537|P6|Induction|Other complicating disease|0
186359|NCT00049517|573538|P5|Induction|Other complicating disease|3
186360|NCT00049517|573539|P4|Induction|Other complicating disease|0
186361|NCT00049517|573540|P3|Induction|Other complicating disease|0
186362|NCT00049517|573541|P2|Induction|Other complicating disease|0
186363|NCT00049517|573542|P1|Induction|Other complicating disease|0
186364|NCT00049517|573537|P6|Induction|Alternative therapy|2
186365|NCT00049517|573538|P5|Induction|Alternative therapy|2
186366|NCT00049517|573539|P4|Induction|Alternative therapy|0
186367|NCT00049517|573540|P3|Induction|Alternative therapy|0
186368|NCT00049517|573541|P2|Induction|Alternative therapy|0
186369|NCT00049517|573542|P1|Induction|Alternative therapy|0
186370|NCT00049517|573537|P6|Induction|Withdrawal by Subject|3
186371|NCT00049517|573538|P5|Induction|Withdrawal by Subject|1
186372|NCT00049517|573539|P4|Induction|Withdrawal by Subject|0
186373|NCT00049517|573540|P3|Induction|Withdrawal by Subject|0
186374|NCT00049517|573541|P2|Induction|Withdrawal by Subject|0
186375|NCT00049517|573542|P1|Induction|Withdrawal by Subject|0
186376|NCT00049517|573537|P6|Induction|Death|6
186377|NCT00049517|573538|P5|Induction|Death|9
186378|NCT00049517|573539|P4|Induction|Death|0
186379|NCT00049517|573540|P3|Induction|Death|0
186380|NCT00049517|573541|P2|Induction|Death|0
186381|NCT00049517|573542|P1|Induction|Death|0
186382|NCT00049517|573537|P6|Induction|Adverse Event|7
186383|NCT00049517|573538|P5|Induction|Adverse Event|5
186384|NCT00049517|573539|P4|Induction|Adverse Event|0
186385|NCT00049517|573540|P3|Induction|Adverse Event|0
186386|NCT00049517|573541|P2|Induction|Adverse Event|0
186387|NCT00049517|573542|P1|Induction|Adverse Event|0
186388|NCT00049517|573537|P6|Induction|Disease progression|11
186389|NCT00049517|573538|P5|Induction|Disease progression|18
186390|NCT00049517|573539|P4|Induction|Disease progression|0
186391|NCT00049517|573540|P3|Induction|Disease progression|0
186392|NCT00049517|573541|P2|Induction|Disease progression|0
186393|NCT00049517|573542|P1|Induction|Disease progression|0
186394|NCT00049322|573554|P2|Overall Study|refused angio|3
186395|NCT00049322|573555|P1|Overall Study|refused angio|0
186396|NCT00049322|573554|P2|Overall Study|Adverse Event|0
186397|NCT00049322|573555|P1|Overall Study|Adverse Event|1
186398|NCT00049322|573554|P2|Overall Study|disease burden|3
186399|NCT00049322|573555|P1|Overall Study|disease burden|0
186400|NCT00049257|573567|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
186401|NCT00049257|573567|P1|Carboplatin, Paclitaxel|Death|2
186402|NCT00049257|573567|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
186403|NCT00049257|573567|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
186404|NCT00049127|573579|P5|Overall Study|Withdrawal by Subject|0
186405|NCT00049127|573580|P4|Overall Study|Withdrawal by Subject|0
186406|NCT00049127|573581|P3|Overall Study|Withdrawal by Subject|1
186407|NCT00049127|573582|P2|Overall Study|Withdrawal by Subject|0
186408|NCT00049127|573583|P1|Overall Study|Withdrawal by Subject|0
186409|NCT00048997|573621|P2|Overall Study|Withdrawal by Subject|1
186410|NCT00048997|573622|P1|Overall Study|Withdrawal by Subject|6
186411|NCT00048997|573621|P2|Overall Study|Protocol Violation|2
186412|NCT00048997|573622|P1|Overall Study|Protocol Violation|7
186413|NCT00048932|573629|P3|Open Label Period (OL)|Participant Surgery|1
186414|NCT00048932|573630|P2|Open Label Period (OL)|Participant Surgery|0
186415|NCT00048932|573631|P1|Open Label Period (OL)|Participant Surgery|0
186416|NCT00048932|573629|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
186417|NCT00048932|573630|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
186418|NCT00048932|573631|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
186419|NCT00048932|573629|P3|Open Label Period (OL)|Site Staff Issues|2
186420|NCT00048932|573630|P2|Open Label Period (OL)|Site Staff Issues|0
186421|NCT00048932|573631|P1|Open Label Period (OL)|Site Staff Issues|0
186422|NCT00048932|573629|P3|Open Label Period (OL)|Investigator Decision|4
186423|NCT00048932|573630|P2|Open Label Period (OL)|Investigator Decision|0
186424|NCT00048932|573631|P1|Open Label Period (OL)|Investigator Decision|0
186425|NCT00048932|573629|P3|Open Label Period (OL)|Medication Lost Efficacy|1
186426|NCT00048932|573630|P2|Open Label Period (OL)|Medication Lost Efficacy|0
186427|NCT00048932|573631|P1|Open Label Period (OL)|Medication Lost Efficacy|0
186428|NCT00048932|573629|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
186429|NCT00048932|573630|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
186430|NCT00048932|573631|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
186431|NCT00048932|573629|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
186432|NCT00048932|573630|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
186433|NCT00048932|573631|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
186434|NCT00048932|573629|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
186435|NCT00048932|573630|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
186436|NCT00048932|573631|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
186437|NCT00048932|573629|P3|Open Label Period (OL)|Patient Decision|4
186438|NCT00048932|573630|P2|Open Label Period (OL)|Patient Decision|0
186439|NCT00048932|573631|P1|Open Label Period (OL)|Patient Decision|0
186440|NCT00048932|573629|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
186441|NCT00048932|573630|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
186442|NCT00048932|573631|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
186443|NCT00048932|573629|P3|Open Label Period (OL)|Trial Terminated|1
186444|NCT00048932|573630|P2|Open Label Period (OL)|Trial Terminated|0
186445|NCT00048932|573631|P1|Open Label Period (OL)|Trial Terminated|0
186446|NCT00048932|573629|P3|Open Label Period (OL)|Site Closure|3
186447|NCT00048932|573630|P2|Open Label Period (OL)|Site Closure|0
186448|NCT00048932|573631|P1|Open Label Period (OL)|Site Closure|0
186449|NCT00048932|573629|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
186450|NCT00048932|573630|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
186451|NCT00048932|573631|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
186452|NCT00048932|573629|P3|Open Label Period (OL)|Participant Relocated|6
186453|NCT00048932|573630|P2|Open Label Period (OL)|Participant Relocated|0
186454|NCT00048932|573631|P1|Open Label Period (OL)|Participant Relocated|0
186455|NCT00048932|573629|P3|Open Label Period (OL)|Participant Transportation Issues|1
186456|NCT00048932|573630|P2|Open Label Period (OL)|Participant Transportation Issues|0
186457|NCT00048932|573631|P1|Open Label Period (OL)|Participant Transportation Issues|0
186458|NCT00048932|573629|P3|Open Label Period (OL)|Investigator Retiring|2
186459|NCT00048932|573630|P2|Open Label Period (OL)|Investigator Retiring|0
186460|NCT00048932|573631|P1|Open Label Period (OL)|Investigator Retiring|0
186461|NCT00048932|573629|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
186462|NCT00048932|573630|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
186463|NCT00048932|573631|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
186464|NCT00048932|573629|P3|Open Label Period (OL)|Pregnancy|6
186465|NCT00048932|573630|P2|Open Label Period (OL)|Pregnancy|0
186466|NCT00048932|573631|P1|Open Label Period (OL)|Pregnancy|0
186467|NCT00048932|573629|P3|Open Label Period (OL)|Poor/Non-Compliance|13
186468|NCT00048932|573630|P2|Open Label Period (OL)|Poor/Non-Compliance|0
186469|NCT00048932|573631|P1|Open Label Period (OL)|Poor/Non-Compliance|0
186470|NCT00048932|573629|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
186471|NCT00048932|573630|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
186472|NCT00048932|573631|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
186473|NCT00048932|573629|P3|Open Label Period (OL)|Withdrawal by Subject|117
186474|NCT00048932|573630|P2|Open Label Period (OL)|Withdrawal by Subject|0
186475|NCT00048932|573631|P1|Open Label Period (OL)|Withdrawal by Subject|0
186476|NCT00048932|573629|P3|Open Label Period (OL)|Lost to Follow-up|27
186477|NCT00048932|573630|P2|Open Label Period (OL)|Lost to Follow-up|0
186478|NCT00048932|573631|P1|Open Label Period (OL)|Lost to Follow-up|0
186479|NCT00048932|573629|P3|Open Label Period (OL)|Lack of Efficacy|81
186480|NCT00048932|573630|P2|Open Label Period (OL)|Lack of Efficacy|0
186481|NCT00048932|573631|P1|Open Label Period (OL)|Lack of Efficacy|0
186482|NCT00048932|573629|P3|Open Label Period (OL)|Adverse Event|103
186483|NCT00048932|573630|P2|Open Label Period (OL)|Adverse Event|0
186484|NCT00048932|573631|P1|Open Label Period (OL)|Adverse Event|0
186485|NCT00048932|573629|P3|Open Label Period (OL)|Death|25
186486|NCT00048932|573630|P2|Open Label Period (OL)|Death|0
186487|NCT00048932|573631|P1|Open Label Period (OL)|Death|0
186488|NCT00048932|573629|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
186489|NCT00048932|573630|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
186490|NCT00048932|573631|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
186491|NCT00048932|573629|P3|Double Blind Period (DB)|Withdrawal by Subject|0
186492|NCT00048932|573630|P2|Double Blind Period (DB)|Withdrawal by Subject|10
186493|NCT00048932|573631|P1|Double Blind Period (DB)|Withdrawal by Subject|24
186494|NCT00048932|573629|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
186495|NCT00048932|573630|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
186496|NCT00048932|573631|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
186497|NCT00048932|573629|P3|Double Blind Period (DB)|Pregnancy|0
186498|NCT00048932|573630|P2|Double Blind Period (DB)|Pregnancy|0
186499|NCT00048932|573631|P1|Double Blind Period (DB)|Pregnancy|1
186500|NCT00048932|573629|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
186501|NCT00048932|573630|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
186502|NCT00048932|573631|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
186503|NCT00048932|573629|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
186504|NCT00048932|573630|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
186505|NCT00048932|573631|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
186506|NCT00048932|573629|P3|Double Blind Period (DB)|Relocation|0
186507|NCT00048932|573630|P2|Double Blind Period (DB)|Relocation|0
186508|NCT00048932|573631|P1|Double Blind Period (DB)|Relocation|1
186509|NCT00048932|573629|P3|Double Blind Period (DB)|Lost to Follow-up|0
186510|NCT00048932|573630|P2|Double Blind Period (DB)|Lost to Follow-up|4
186511|NCT00048932|573631|P1|Double Blind Period (DB)|Lost to Follow-up|3
186512|NCT00048932|573629|P3|Double Blind Period (DB)|Lack of Efficacy|0
186513|NCT00048932|573630|P2|Double Blind Period (DB)|Lack of Efficacy|44
186514|NCT00048932|573631|P1|Double Blind Period (DB)|Lack of Efficacy|26
186515|NCT00048932|573629|P3|Double Blind Period (DB)|Death|0
186516|NCT00048932|573630|P2|Double Blind Period (DB)|Death|3
186517|NCT00048932|573631|P1|Double Blind Period (DB)|Death|5
186518|NCT00048932|573629|P3|Double Blind Period (DB)|Adverse Event|0
186519|NCT00048932|573630|P2|Double Blind Period (DB)|Adverse Event|19
186520|NCT00048932|573631|P1|Double Blind Period (DB)|Adverse Event|51
186521|NCT00048932|573629|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
186522|NCT00048932|573630|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
186523|NCT00048932|573631|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
186524|NCT00048724|573672|P2|Overall Study|Administrative|1
186525|NCT00048724|573673|P1|Overall Study|Administrative|1
186526|NCT00048724|573672|P2|Overall Study|Did Not Meet Protocol Eligibility|2
186527|NCT00048724|573673|P1|Overall Study|Did Not Meet Protocol Eligibility|2
186528|NCT00048724|573672|P2|Overall Study|Noncompliance With Protocol|12
186529|NCT00048724|573673|P1|Overall Study|Noncompliance With Protocol|4
186530|NCT00048724|573672|P2|Overall Study|Protocol-defined Clinical Event|32
186531|NCT00048724|573673|P1|Overall Study|Protocol-defined Clinical Event|17
186532|NCT00048724|573672|P2|Overall Study|Lost to Follow-up|5
186533|NCT00048724|573673|P1|Overall Study|Lost to Follow-up|5
186534|NCT00048724|573672|P2|Overall Study|Withdrawal by Subject|54
186535|NCT00048724|573673|P1|Overall Study|Withdrawal by Subject|34
186536|NCT00048724|573672|P2|Overall Study|Adverse Event|12
186537|NCT00048724|573673|P1|Overall Study|Adverse Event|53
186538|NCT00048581|573683|P3|Open-Label Period|Study Ended By Sponsor|1
186539|NCT00048581|573684|P2|Open-Label Period|Study Ended By Sponsor|0
186540|NCT00048581|573685|P1|Open-Label Period|Study Ended By Sponsor|0
186541|NCT00048581|573683|P3|Open-Label Period|Primary Investigator Retired|2
186542|NCT00048581|573684|P2|Open-Label Period|Primary Investigator Retired|0
186543|NCT00048581|573685|P1|Open-Label Period|Primary Investigator Retired|0
186544|NCT00048581|573683|P3|Open-Label Period|Problem With Transportation To Site|1
186545|NCT00048581|573684|P2|Open-Label Period|Problem With Transportation To Site|0
186546|NCT00048581|573685|P1|Open-Label Period|Problem With Transportation To Site|0
186547|NCT00048581|573683|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
186548|NCT00048581|573684|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
186549|NCT00048581|573685|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
186550|NCT00048581|573683|P3|Open-Label Period|Study Site Closure|2
186551|NCT00048581|573684|P2|Open-Label Period|Study Site Closure|0
186552|NCT00048581|573685|P1|Open-Label Period|Study Site Closure|0
186553|NCT00048581|573683|P3|Open-Label Period|Pregnancy|7
186554|NCT00048581|573684|P2|Open-Label Period|Pregnancy|0
186555|NCT00048581|573685|P1|Open-Label Period|Pregnancy|0
186556|NCT00048581|573683|P3|Open-Label Period|Poor/Non-compliance|5
186557|NCT00048581|573684|P2|Open-Label Period|Poor/Non-compliance|0
186558|NCT00048581|573685|P1|Open-Label Period|Poor/Non-compliance|0
186559|NCT00048581|573683|P3|Open-Label Period|No Longer Meets Study Criteria|2
186560|NCT00048581|573684|P2|Open-Label Period|No Longer Meets Study Criteria|0
186561|NCT00048581|573685|P1|Open-Label Period|No Longer Meets Study Criteria|0
186562|NCT00048581|573683|P3|Open-Label Period|Withdrawal by Subject|20
186563|NCT00048581|573684|P2|Open-Label Period|Withdrawal by Subject|0
186564|NCT00048581|573685|P1|Open-Label Period|Withdrawal by Subject|0
186565|NCT00048581|573683|P3|Open-Label Period|Lost to Follow-up|14
186566|NCT00048581|573684|P2|Open-Label Period|Lost to Follow-up|0
186567|NCT00048581|573685|P1|Open-Label Period|Lost to Follow-up|0
186568|NCT00048581|573683|P3|Open-Label Period|Lack of Efficacy|69
186569|NCT00048581|573684|P2|Open-Label Period|Lack of Efficacy|0
186570|NCT00048581|573685|P1|Open-Label Period|Lack of Efficacy|0
186571|NCT00048581|573683|P3|Open-Label Period|Adverse Event|37
186572|NCT00048581|573684|P2|Open-Label Period|Adverse Event|0
186573|NCT00048581|573685|P1|Open-Label Period|Adverse Event|0
186574|NCT00048581|573683|P3|Open-Label Period|Death|4
186575|NCT00048581|573684|P2|Open-Label Period|Death|0
186576|NCT00048581|573685|P1|Open-Label Period|Death|0
186577|NCT00048581|573683|P3|Double-Blind Period|Investigator Decision|0
186578|NCT00048581|573684|P2|Double-Blind Period|Investigator Decision|0
186579|NCT00048581|573685|P1|Double-Blind Period|Investigator Decision|1
186580|NCT00048581|573683|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
186581|NCT00048581|573684|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
186582|NCT00048581|573685|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
186583|NCT00048581|573683|P3|Double-Blind Period|Withdrawal by Subject|0
186584|NCT00048581|573684|P2|Double-Blind Period|Withdrawal by Subject|2
186585|NCT00048581|573685|P1|Double-Blind Period|Withdrawal by Subject|5
186586|NCT00048581|573683|P3|Double-Blind Period|Lost to Follow-up|0
186587|NCT00048581|573684|P2|Double-Blind Period|Lost to Follow-up|0
186588|NCT00048581|573685|P1|Double-Blind Period|Lost to Follow-up|5
186589|NCT00048581|573683|P3|Double-Blind Period|Lack of Efficacy|0
186590|NCT00048581|573684|P2|Double-Blind Period|Lack of Efficacy|27
186591|NCT00048581|573685|P1|Double-Blind Period|Lack of Efficacy|14
186592|NCT00048581|573683|P3|Double-Blind Period|Adverse Event|0
186593|NCT00048581|573684|P2|Double-Blind Period|Adverse Event|5
186594|NCT00048581|573685|P1|Double-Blind Period|Adverse Event|9
186595|NCT00048568|573852|P3|Open-Label Period|Lost to Follow-up|7
186596|NCT00048568|573853|P2|Open-Label Period|Lost to Follow-up|0
186597|NCT00048568|573854|P1|Open-Label Period|Lost to Follow-up|0
186598|NCT00048568|573852|P3|Open-Label Period|Unknown Reasons|25
186599|NCT00048568|573853|P2|Open-Label Period|Unknown Reasons|0
186600|NCT00048568|573854|P1|Open-Label Period|Unknown Reasons|0
186601|NCT00048568|573852|P3|Open-Label Period|Administrative Decision By Sponsor|1
186602|NCT00048568|573853|P2|Open-Label Period|Administrative Decision By Sponsor|0
186603|NCT00048568|573854|P1|Open-Label Period|Administrative Decision By Sponsor|0
186604|NCT00048568|573852|P3|Open-Label Period|No Longer Met Study Criteria|2
186605|NCT00048568|573853|P2|Open-Label Period|No Longer Met Study Criteria|0
186606|NCT00048568|573854|P1|Open-Label Period|No Longer Met Study Criteria|0
186607|NCT00048568|573852|P3|Open-Label Period|Pregnancy|5
186608|NCT00048568|573853|P2|Open-Label Period|Pregnancy|0
186609|NCT00048568|573854|P1|Open-Label Period|Pregnancy|0
186610|NCT00048568|573852|P3|Open-Label Period|Withdrawal by Subject|26
186611|NCT00048568|573853|P2|Open-Label Period|Withdrawal by Subject|0
186612|NCT00048568|573854|P1|Open-Label Period|Withdrawal by Subject|0
186613|NCT00048568|573852|P3|Open-Label Period|Lack of Efficacy|32
186614|NCT00048568|573853|P2|Open-Label Period|Lack of Efficacy|0
186615|NCT00048568|573854|P1|Open-Label Period|Lack of Efficacy|0
186616|NCT00048568|573852|P3|Open-Label Period|Adverse Event|49
186617|NCT00048568|573853|P2|Open-Label Period|Adverse Event|0
186618|NCT00048568|573854|P1|Open-Label Period|Adverse Event|0
186619|NCT00048568|573852|P3|Open-Label Period|Death|13
186620|NCT00048568|573853|P2|Open-Label Period|Death|0
186621|NCT00048568|573854|P1|Open-Label Period|Death|0
186622|NCT00048568|573852|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
186623|NCT00048568|573853|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
186624|NCT00048568|573854|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
186625|NCT00048568|573852|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
186626|NCT00048568|573853|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
186627|NCT00048568|573854|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
186628|NCT00048568|573852|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
186629|NCT00048568|573853|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
186630|NCT00048568|573854|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
186631|NCT00048568|573852|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
186632|NCT00048568|573853|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
186633|NCT00048568|573854|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
186634|NCT00048568|573852|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
186635|NCT00048568|573853|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
186636|NCT00048568|573854|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
186637|NCT00048568|573852|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
186638|NCT00048568|573853|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
186639|NCT00048568|573854|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
186640|NCT00048568|573852|P3|Double-Blind Period Days 170 to 365|Death|0
186641|NCT00048568|573853|P2|Double-Blind Period Days 170 to 365|Death|1
186642|NCT00048568|573854|P1|Double-Blind Period Days 170 to 365|Death|1
186643|NCT00048568|573852|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
186644|NCT00048568|573853|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
186645|NCT00048568|573854|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
186646|NCT00048568|573852|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
186647|NCT00048568|573853|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
186648|NCT00048568|573854|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
186649|NCT00048568|573852|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
186650|NCT00048568|573853|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
186651|NCT00048568|573854|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
186652|NCT00048568|573852|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
186653|NCT00048568|573853|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
186654|NCT00048568|573854|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
186655|NCT00048568|573852|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
186656|NCT00048568|573853|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
186657|NCT00048568|573854|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
186658|NCT00048542|574146|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
186659|NCT00048542|574147|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
186660|NCT00048542|574148|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
186661|NCT00048542|574149|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
186662|NCT00048542|574150|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
186663|NCT00048542|574151|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
186664|NCT00048542|574152|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
186665|NCT00048542|574153|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
186666|NCT00048542|574146|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
186667|NCT00048542|574147|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
186668|NCT00048542|574148|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
186669|NCT00048542|574149|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
186670|NCT00048542|574150|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
186671|NCT00048542|574151|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
186672|NCT00048542|574152|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
186673|NCT00048542|574153|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
186674|NCT00048542|574146|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
186675|NCT00048542|574147|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
186676|NCT00048542|574148|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
186677|NCT00048542|574149|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
186678|NCT00048542|574150|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
186679|NCT00048542|574151|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
186680|NCT00048542|574152|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
186681|NCT00048542|574153|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
186682|NCT00048542|574146|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
186683|NCT00048542|574147|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
186684|NCT00048542|574148|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
186685|NCT00048542|574149|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
186686|NCT00048542|574150|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
186687|NCT00048542|574151|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
186688|NCT00048542|574152|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
186689|NCT00048542|574153|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
186690|NCT00048542|574146|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
186691|NCT00048542|574147|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
186692|NCT00048542|574148|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
186693|NCT00048542|574149|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
186694|NCT00048542|574150|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
186695|NCT00048542|574151|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
186696|NCT00048542|574152|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
186697|NCT00048542|574153|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
186698|NCT00048542|574146|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
186699|NCT00048542|574147|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
186700|NCT00048542|574148|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
186701|NCT00048542|574149|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
186702|NCT00048542|574150|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
186703|NCT00048542|574151|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
186704|NCT00048542|574152|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
186705|NCT00048542|574153|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
186706|NCT00048542|574146|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
186707|NCT00048542|574147|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
186708|NCT00048542|574148|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
186709|NCT00048542|574149|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
186710|NCT00048542|574150|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
186711|NCT00048542|574151|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
186712|NCT00048542|574152|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
186713|NCT00048542|574153|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
186714|NCT00048542|574146|P8|Open-Label Extension BSA Phase|Adverse Event|0
186715|NCT00048542|574147|P7|Open-Label Extension BSA Phase|Adverse Event|0
186716|NCT00048542|574148|P6|Open-Label Extension BSA Phase|Adverse Event|1
186717|NCT00048542|574149|P5|Open-Label Extension BSA Phase|Adverse Event|1
186718|NCT00048542|574150|P4|Open-Label Extension BSA Phase|Adverse Event|0
186719|NCT00048542|574151|P3|Open-Label Extension BSA Phase|Adverse Event|0
186720|NCT00048542|574152|P2|Open-Label Extension BSA Phase|Adverse Event|0
186721|NCT00048542|574153|P1|Open-Label Extension BSA Phase|Adverse Event|0
186722|NCT00048542|574146|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
186723|NCT00048542|574147|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
186724|NCT00048542|574148|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
186725|NCT00048542|574149|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
186726|NCT00048542|574150|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
186727|NCT00048542|574151|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
186728|NCT00048542|574152|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
186729|NCT00048542|574153|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
186730|NCT00048542|574146|P8|Open-Label Extension BSA Phase|Protocol Violation|0
186731|NCT00048542|574147|P7|Open-Label Extension BSA Phase|Protocol Violation|0
186732|NCT00048542|574148|P6|Open-Label Extension BSA Phase|Protocol Violation|1
186733|NCT00048542|574149|P5|Open-Label Extension BSA Phase|Protocol Violation|0
186734|NCT00048542|574150|P4|Open-Label Extension BSA Phase|Protocol Violation|0
186735|NCT00048542|574151|P3|Open-Label Extension BSA Phase|Protocol Violation|0
186736|NCT00048542|574152|P2|Open-Label Extension BSA Phase|Protocol Violation|0
186737|NCT00048542|574153|P1|Open-Label Extension BSA Phase|Protocol Violation|0
186738|NCT00048542|574146|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
186739|NCT00048542|574147|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
186740|NCT00048542|574148|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
186741|NCT00048542|574149|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
186742|NCT00048542|574150|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
186743|NCT00048542|574151|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
186744|NCT00048542|574152|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
186745|NCT00048542|574153|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
186746|NCT00048542|574146|P8|Double-Blind Phase|Randomized in error|0
186747|NCT00048542|574147|P7|Double-Blind Phase|Randomized in error|0
186748|NCT00048542|574148|P6|Double-Blind Phase|Randomized in error|0
186749|NCT00048542|574149|P5|Double-Blind Phase|Randomized in error|0
186750|NCT00048542|574150|P4|Double-Blind Phase|Randomized in error|0
186751|NCT00048542|574151|P3|Double-Blind Phase|Randomized in error|0
186752|NCT00048542|574152|P2|Double-Blind Phase|Randomized in error|0
186753|NCT00048542|574153|P1|Double-Blind Phase|Randomized in error|1
186754|NCT00048542|574146|P8|Double-Blind Phase|Sponsor request or decision|0
186755|NCT00048542|574147|P7|Double-Blind Phase|Sponsor request or decision|0
186756|NCT00048542|574148|P6|Double-Blind Phase|Sponsor request or decision|0
186757|NCT00048542|574149|P5|Double-Blind Phase|Sponsor request or decision|0
186758|NCT00048542|574150|P4|Double-Blind Phase|Sponsor request or decision|0
186759|NCT00048542|574151|P3|Double-Blind Phase|Sponsor request or decision|0
186760|NCT00048542|574152|P2|Double-Blind Phase|Sponsor request or decision|0
186761|NCT00048542|574153|P1|Double-Blind Phase|Sponsor request or decision|2
186762|NCT00048542|574146|P8|Double-Blind Phase|Protocol Violation|0
186763|NCT00048542|574147|P7|Double-Blind Phase|Protocol Violation|0
186764|NCT00048542|574148|P6|Double-Blind Phase|Protocol Violation|0
186765|NCT00048542|574149|P5|Double-Blind Phase|Protocol Violation|0
186766|NCT00048542|574150|P4|Double-Blind Phase|Protocol Violation|0
186767|NCT00048542|574151|P3|Double-Blind Phase|Protocol Violation|1
186768|NCT00048542|574152|P2|Double-Blind Phase|Protocol Violation|0
186769|NCT00048542|574153|P1|Double-Blind Phase|Protocol Violation|0
186770|NCT00048542|574146|P8|Double-Blind Phase|Withdrawal by Subject|0
186771|NCT00048542|574147|P7|Double-Blind Phase|Withdrawal by Subject|0
186772|NCT00048542|574148|P6|Double-Blind Phase|Withdrawal by Subject|0
186773|NCT00048542|574149|P5|Double-Blind Phase|Withdrawal by Subject|0
186774|NCT00048542|574150|P4|Double-Blind Phase|Withdrawal by Subject|0
186775|NCT00048542|574151|P3|Double-Blind Phase|Withdrawal by Subject|0
186776|NCT00048542|574152|P2|Double-Blind Phase|Withdrawal by Subject|1
186777|NCT00048542|574153|P1|Double-Blind Phase|Withdrawal by Subject|0
186778|NCT00048347|574219|P1|Overall Study|Screen failure|2
186779|NCT00048165|574225|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
186780|NCT00048165|574226|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
186781|NCT00048165|574225|P2|Completed 12 Months Study|Death|1
186782|NCT00048165|574226|P1|Completed 12 Months Study|Death|2
186783|NCT00048165|574225|P2|Completed 12 Months Study|Administration/Other|2
186784|NCT00048165|574226|P1|Completed 12 Months Study|Administration/Other|0
186785|NCT00048165|574225|P2|Completed 6 Months Study|Did not receive study drug|6
186786|NCT00048165|574226|P1|Completed 6 Months Study|Did not receive study drug|6
186787|NCT00048165|574225|P2|Completed 6 Months Study|Violation criteria|2
186788|NCT00048165|574226|P1|Completed 6 Months Study|Violation criteria|0
186789|NCT00048165|574225|P2|Completed 6 Months Study|Refused treatment|5
186790|NCT00048165|574226|P1|Completed 6 Months Study|Refused treatment|5
186791|NCT00048165|574225|P2|Completed 6 Months Study|Other violation|6
186792|NCT00048165|574226|P1|Completed 6 Months Study|Other violation|4
186793|NCT00048165|574225|P2|Completed 6 Months Study|Insufficient therapy|4
186794|NCT00048165|574226|P1|Completed 6 Months Study|Insufficient therapy|1
186795|NCT00048165|574225|P2|Completed 6 Months Study|Death|6
186796|NCT00048165|574226|P1|Completed 6 Months Study|Death|12
186797|NCT00048165|574225|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
186798|NCT00048165|574226|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
186799|NCT00048165|574225|P2|Completed 6 Months Study|Abnormality of laboratory test|0
186800|NCT00048165|574226|P1|Completed 6 Months Study|Abnormality of laboratory test|1
186801|NCT00048165|574225|P2|Completed 6 Months Study|Administration/Other|8
186802|NCT00048165|574226|P1|Completed 6 Months Study|Administration/Other|8
186803|NCT00048074|574261|P3|Overall Study|Social reasons|0
186804|NCT00048074|574262|P2|Overall Study|Social reasons|0
186805|NCT00048074|574263|P1|Overall Study|Social reasons|1
186806|NCT00048074|574261|P3|Overall Study|Out of station|1
186807|NCT00048074|574262|P2|Overall Study|Out of station|1
186808|NCT00048074|574263|P1|Overall Study|Out of station|0
186809|NCT00048074|574261|P3|Overall Study|Poor compliance|0
186810|NCT00048074|574262|P2|Overall Study|Poor compliance|1
186811|NCT00048074|574263|P1|Overall Study|Poor compliance|0
186812|NCT00048074|574261|P3|Overall Study|Husband ill|0
186813|NCT00048074|574262|P2|Overall Study|Husband ill|1
186814|NCT00048074|574263|P1|Overall Study|Husband ill|0
186815|NCT00048074|574261|P3|Overall Study|Study participation was terminated|0
186816|NCT00048074|574262|P2|Overall Study|Study participation was terminated|1
186817|NCT00048074|574263|P1|Overall Study|Study participation was terminated|0
186818|NCT00048074|574261|P3|Overall Study|Protocol Violation|0
186819|NCT00048074|574262|P2|Overall Study|Protocol Violation|3
186820|NCT00048074|574263|P1|Overall Study|Protocol Violation|1
186821|NCT00048074|574261|P3|Overall Study|Withdrawal by Subject|35
186822|NCT00048074|574262|P2|Overall Study|Withdrawal by Subject|30
186823|NCT00048074|574263|P1|Overall Study|Withdrawal by Subject|28
186824|NCT00048074|574261|P3|Overall Study|Lost to Follow-up|6
186825|NCT00048074|574262|P2|Overall Study|Lost to Follow-up|6
186826|NCT00048074|574263|P1|Overall Study|Lost to Follow-up|2
186827|NCT00048074|574261|P3|Overall Study|Death|2
186828|NCT00048074|574262|P2|Overall Study|Death|3
186829|NCT00048074|574263|P1|Overall Study|Death|3
186830|NCT00048074|574261|P3|Overall Study|Adverse Event|53
186831|NCT00048074|574262|P2|Overall Study|Adverse Event|41
186832|NCT00048074|574263|P1|Overall Study|Adverse Event|46
186833|NCT00048061|574320|P4|Overall Study|Early improvement|0
186834|NCT00048061|574321|P3|Overall Study|Early improvement|3
186835|NCT00048061|574322|P2|Overall Study|Early improvement|5
186836|NCT00048061|574323|P1|Overall Study|Early improvement|6
186837|NCT00048061|574320|P4|Overall Study|Did not follow-up|5
186838|NCT00048061|574321|P3|Overall Study|Did not follow-up|4
186839|NCT00048061|574322|P2|Overall Study|Did not follow-up|5
186840|NCT00048061|574323|P1|Overall Study|Did not follow-up|5
186841|NCT00048061|574320|P4|Overall Study|Withdrawal by Subject|32
186842|NCT00048061|574321|P3|Overall Study|Withdrawal by Subject|29
186843|NCT00048061|574322|P2|Overall Study|Withdrawal by Subject|29
186844|NCT00048061|574323|P1|Overall Study|Withdrawal by Subject|20
186845|NCT00048061|574320|P4|Overall Study|Lost to Follow-up|5
186846|NCT00048061|574321|P3|Overall Study|Lost to Follow-up|4
186847|NCT00048061|574322|P2|Overall Study|Lost to Follow-up|2
186848|NCT00048061|574323|P1|Overall Study|Lost to Follow-up|3
186849|NCT00048061|574320|P4|Overall Study|Adverse Event|37
186850|NCT00048061|574321|P3|Overall Study|Adverse Event|44
186851|NCT00048061|574322|P2|Overall Study|Adverse Event|32
186852|NCT00048061|574323|P1|Overall Study|Adverse Event|41
186853|NCT00048035|574399|P8|Extension Year 2|Early Withdrawals|3
186854|NCT00048035|574400|P7|Extension Year 2|Early Withdrawals|3
186855|NCT00048035|574401|P6|Extension Year 2|Early Withdrawals|0
186856|NCT00048035|574402|P5|Extension Year 2|Early Withdrawals|0
186857|NCT00048035|574403|P4|Extension Year 2|Early Withdrawals|0
186858|NCT00048035|574404|P3|Extension Year 2|Early Withdrawals|0
186859|NCT00048035|574405|P2|Extension Year 2|Early Withdrawals|0
186860|NCT00048035|574406|P1|Extension Year 2|Early Withdrawals|0
186861|NCT00048035|574399|P8|Extension Year 1|Early Withdrawals|11
186862|NCT00048035|574400|P7|Extension Year 1|Early Withdrawals|11
186863|NCT00048035|574401|P6|Extension Year 1|Early Withdrawals|0
186864|NCT00048035|574402|P5|Extension Year 1|Early Withdrawals|0
186865|NCT00048035|574403|P4|Extension Year 1|Early Withdrawals|0
186866|NCT00048035|574404|P3|Extension Year 1|Early Withdrawals|0
186867|NCT00048035|574405|P2|Extension Year 1|Early Withdrawals|0
186868|NCT00048035|574406|P1|Extension Year 1|Early Withdrawals|0
186869|NCT00048035|574399|P8|Core Period|Early Withdrawals|0
186870|NCT00048035|574400|P7|Core Period|Early Withdrawals|0
186871|NCT00048035|574401|P6|Core Period|Early Withdrawals|1
186872|NCT00048035|574402|P5|Core Period|Early Withdrawals|1
186873|NCT00048035|574403|P4|Core Period|Early Withdrawals|1
186874|NCT00048035|574404|P3|Core Period|Early Withdrawals|1
186875|NCT00048035|574405|P2|Core Period|Early Withdrawals|2
186876|NCT00048035|574406|P1|Core Period|Early Withdrawals|4
186877|NCT00047879|574444|P2|Overall Study|Progressive disease|3
186878|NCT00047879|574445|P1|Overall Study|Progressive disease|4
186879|NCT00047463|574468|P2|Overall Study|Withdrawal by Subject|3
186880|NCT00047463|574469|P1|Overall Study|Withdrawal by Subject|0
186881|NCT00047385|574480|P2|Overall Study|Eligible for screening but had no screen|492
186882|NCT00047385|574481|P1|Overall Study|Eligible for screening but had no screen|260
186883|NCT00047385|574480|P2|Overall Study|Lung Cancer diagnosed before screening|3
186884|NCT00047385|574481|P1|Overall Study|Lung Cancer diagnosed before screening|5
186885|NCT00047385|574480|P2|Overall Study|Death before any screening|5
186886|NCT00047385|574481|P1|Overall Study|Death before any screening|2
186887|NCT00047320|574499|P1|Overall Study|Ineligible|3
186888|NCT00047320|574499|P1|Overall Study|Withdrawal by Subject|6
186889|NCT00047320|574499|P1|Overall Study|Physician Decision|8
186890|NCT00047320|574499|P1|Overall Study|Lost to Follow-up|1
186891|NCT00047320|574499|P1|Overall Study|Lack of Efficacy|10
186892|NCT00047008|574505|P2|Overall Study|Ineligible|8
186893|NCT00047008|574506|P1|Overall Study|Ineligible|9
186894|NCT00047008|574505|P2|Overall Study|Withdrawn consent|3
186895|NCT00047008|574506|P1|Overall Study|Withdrawn consent|2
186896|NCT00046930|574514|P2|Overall Study|Ineligible|4
186897|NCT00046930|574515|P1|Overall Study|Ineligible|12
186898|NCT00046891|574530|P2|Overall Study|Adverse Event|5
186899|NCT00046891|574531|P1|Overall Study|Adverse Event|5
186900|NCT00046891|574530|P2|Overall Study|Withdrawal by Subject|15
186901|NCT00046891|574531|P1|Overall Study|Withdrawal by Subject|18
186902|NCT00046891|574530|P2|Overall Study|Ineligible|1
186903|NCT00046891|574531|P1|Overall Study|Ineligible|1
186904|NCT00046891|574530|P2|Overall Study|Cancels|9
186905|NCT00046891|574531|P1|Overall Study|Cancels|5
186906|NCT00046839|574551|P2|Overall Study|Withdrawal of consent|0
186907|NCT00046839|574552|P1|Overall Study|Withdrawal of consent|1
186908|NCT00046839|574551|P2|Overall Study|Ineligible / No protocol treatment|2
186909|NCT00046839|574552|P1|Overall Study|Ineligible / No protocol treatment|0
186910|NCT00045630|574639|P1|Overall Study|Ineligible|2
186911|NCT00045630|574639|P1|Overall Study|Death|1
186912|NCT00045630|574639|P1|Overall Study|Progression/relapse|1
186913|NCT00045630|574639|P1|Overall Study|Refusal unrelated to adverse event|1
186914|NCT00045630|574639|P1|Overall Study|Adverse Event|1
186915|NCT00045305|574649|P1|Overall Study|site error|2
186916|NCT00045305|574649|P1|Overall Study|Death|3
186917|NCT00045305|574649|P1|Overall Study|Adverse Event|3
186918|NCT00045305|574649|P1|Overall Study|Lack of Efficacy|6
186919|NCT00045162|574660|P2|Overall Study|Not specified|16
186920|NCT00045162|574661|P1|Overall Study|Not specified|21
186921|NCT00045162|574660|P2|Overall Study|Withdrawal by Subject|3
186922|NCT00045162|574661|P1|Overall Study|Withdrawal by Subject|5
186923|NCT00045162|574660|P2|Overall Study|Death|10
186924|NCT00045162|574661|P1|Overall Study|Death|10
186925|NCT00045162|574660|P2|Overall Study|Lack of Efficacy|29
186926|NCT00045162|574661|P1|Overall Study|Lack of Efficacy|32
186927|NCT00045162|574660|P2|Overall Study|Adverse Event|50
186928|NCT00045162|574661|P1|Overall Study|Adverse Event|55
186929|NCT00045162|574660|P2|Overall Study|Not treated|2
186930|NCT00045162|574661|P1|Overall Study|Not treated|7
186931|NCT00045162|574660|P2|Overall Study|Ineligible|8
186932|NCT00045162|574661|P1|Overall Study|Ineligible|12
186933|NCT00044512|574682|P1|Follow Up|Lost to Follow-up|2
186934|NCT00044213|574697|P4|Overall Study|Lost to Follow-up|4
186935|NCT00044213|574698|P3|Overall Study|Lost to Follow-up|5
186936|NCT00044213|574699|P2|Overall Study|Lost to Follow-up|5
186937|NCT00044213|574700|P1|Overall Study|Lost to Follow-up|8
186938|NCT00044213|574697|P4|Overall Study|Death|49
186939|NCT00044213|574698|P3|Overall Study|Death|42
186940|NCT00044213|574699|P2|Overall Study|Death|42
186941|NCT00044213|574700|P1|Overall Study|Death|42
186942|NCT00044213|574697|P4|Overall Study|Withdrawal by Subject|83
186943|NCT00044213|574698|P3|Overall Study|Withdrawal by Subject|91
186944|NCT00044213|574699|P2|Overall Study|Withdrawal by Subject|65
186945|NCT00044213|574700|P1|Overall Study|Withdrawal by Subject|50
186946|NCT00043979|574765|P3|Period 1|recipient with progressive disease|3
186947|NCT00043979|574766|P2|Period 1|recipient with progressive disease|4
186948|NCT00043979|574767|P1|Period 1|recipient with progressive disease|7
186949|NCT00043186|574783|P9|Overall Study|Other|0
186950|NCT00043186|574784|P8|Overall Study|Other|0
186951|NCT00043186|574785|P7|Overall Study|Other|0
186952|NCT00043186|574786|P6|Overall Study|Other|0
186953|NCT00043186|574787|P5|Overall Study|Other|0
186954|NCT00043186|574788|P4|Overall Study|Other|1
186955|NCT00043186|574789|P3|Overall Study|Other|1
186956|NCT00043186|574790|P2|Overall Study|Other|0
186957|NCT00043186|574791|P1|Overall Study|Other|0
186958|NCT00043186|574783|P9|Overall Study|Noncompliance|0
186959|NCT00043186|574784|P8|Overall Study|Noncompliance|0
186960|NCT00043186|574785|P7|Overall Study|Noncompliance|0
186961|NCT00043186|574786|P6|Overall Study|Noncompliance|0
186962|NCT00043186|574787|P5|Overall Study|Noncompliance|0
186963|NCT00043186|574788|P4|Overall Study|Noncompliance|1
186964|NCT00043186|574789|P3|Overall Study|Noncompliance|1
186965|NCT00043186|574790|P2|Overall Study|Noncompliance|0
186966|NCT00043186|574791|P1|Overall Study|Noncompliance|0
186967|NCT00043186|574783|P9|Overall Study|Lost to Follow-up|2
186968|NCT00043186|574784|P8|Overall Study|Lost to Follow-up|1
186969|NCT00043186|574785|P7|Overall Study|Lost to Follow-up|1
186970|NCT00043186|574786|P6|Overall Study|Lost to Follow-up|1
186971|NCT00043186|574787|P5|Overall Study|Lost to Follow-up|1
186972|NCT00043186|574788|P4|Overall Study|Lost to Follow-up|1
186973|NCT00043186|574789|P3|Overall Study|Lost to Follow-up|1
186974|NCT00043186|574790|P2|Overall Study|Lost to Follow-up|5
186975|NCT00043186|574791|P1|Overall Study|Lost to Follow-up|3
186976|NCT00043186|574783|P9|Overall Study|Ineligibility determined|1
186977|NCT00043186|574784|P8|Overall Study|Ineligibility determined|0
186978|NCT00043186|574785|P7|Overall Study|Ineligibility determined|0
186979|NCT00043186|574786|P6|Overall Study|Ineligibility determined|0
186980|NCT00043186|574787|P5|Overall Study|Ineligibility determined|0
186981|NCT00043186|574788|P4|Overall Study|Ineligibility determined|0
186982|NCT00043186|574789|P3|Overall Study|Ineligibility determined|0
186983|NCT00043186|574790|P2|Overall Study|Ineligibility determined|0
186984|NCT00043186|574791|P1|Overall Study|Ineligibility determined|0
186985|NCT00043186|574783|P9|Overall Study|Disease progression|0
186986|NCT00043186|574784|P8|Overall Study|Disease progression|4
186987|NCT00043186|574785|P7|Overall Study|Disease progression|0
186988|NCT00043186|574786|P6|Overall Study|Disease progression|0
186989|NCT00043186|574787|P5|Overall Study|Disease progression|0
186990|NCT00043186|574788|P4|Overall Study|Disease progression|3
186991|NCT00043186|574789|P3|Overall Study|Disease progression|0
186992|NCT00043186|574790|P2|Overall Study|Disease progression|0
186993|NCT00043186|574791|P1|Overall Study|Disease progression|1
186994|NCT00043186|574783|P9|Overall Study|Death|0
186995|NCT00043186|574784|P8|Overall Study|Death|0
186996|NCT00043186|574785|P7|Overall Study|Death|2
186997|NCT00043186|574786|P6|Overall Study|Death|0
186998|NCT00043186|574787|P5|Overall Study|Death|0
186999|NCT00043186|574788|P4|Overall Study|Death|0
187000|NCT00043186|574789|P3|Overall Study|Death|1
187001|NCT00043186|574790|P2|Overall Study|Death|0
187002|NCT00043186|574791|P1|Overall Study|Death|0
187003|NCT00043186|574783|P9|Overall Study|Withdrawal by Subject|10
187004|NCT00043186|574784|P8|Overall Study|Withdrawal by Subject|9
187005|NCT00043186|574785|P7|Overall Study|Withdrawal by Subject|12
187006|NCT00043186|574786|P6|Overall Study|Withdrawal by Subject|6
187007|NCT00043186|574787|P5|Overall Study|Withdrawal by Subject|14
187008|NCT00043186|574788|P4|Overall Study|Withdrawal by Subject|13
187009|NCT00043186|574789|P3|Overall Study|Withdrawal by Subject|11
187010|NCT00043186|574790|P2|Overall Study|Withdrawal by Subject|8
187011|NCT00043186|574791|P1|Overall Study|Withdrawal by Subject|11
187012|NCT00043186|574783|P9|Overall Study|Adverse Event|3
187013|NCT00043186|574784|P8|Overall Study|Adverse Event|1
187014|NCT00043186|574785|P7|Overall Study|Adverse Event|2
187015|NCT00043186|574786|P6|Overall Study|Adverse Event|1
187016|NCT00043186|574787|P5|Overall Study|Adverse Event|2
187017|NCT00043186|574788|P4|Overall Study|Adverse Event|3
187018|NCT00043186|574789|P3|Overall Study|Adverse Event|2
187019|NCT00043186|574790|P2|Overall Study|Adverse Event|2
187020|NCT00043186|574791|P1|Overall Study|Adverse Event|2
187021|NCT00043186|574783|P9|Overall Study|Physician Decision|1
187022|NCT00043186|574784|P8|Overall Study|Physician Decision|1
187023|NCT00043186|574785|P7|Overall Study|Physician Decision|0
187024|NCT00043186|574786|P6|Overall Study|Physician Decision|0
187025|NCT00043186|574787|P5|Overall Study|Physician Decision|1
187026|NCT00043186|574788|P4|Overall Study|Physician Decision|0
187027|NCT00043186|574789|P3|Overall Study|Physician Decision|3
187028|NCT00043186|574790|P2|Overall Study|Physician Decision|0
187029|NCT00043186|574791|P1|Overall Study|Physician Decision|0
187030|NCT00042991|575124|P7|Overall Study|Alternative Therapy|0
187031|NCT00042991|575125|P6|Overall Study|Alternative Therapy|0
187032|NCT00042991|575126|P5|Overall Study|Alternative Therapy|1
187033|NCT00042991|575127|P4|Overall Study|Alternative Therapy|0
187034|NCT00042991|575128|P3|Overall Study|Alternative Therapy|0
187035|NCT00042991|575129|P2|Overall Study|Alternative Therapy|0
187036|NCT00042991|575130|P1|Overall Study|Alternative Therapy|0
187037|NCT00042991|575124|P7|Overall Study|Disease Progression|2
187038|NCT00042991|575125|P6|Overall Study|Disease Progression|4
187039|NCT00042991|575126|P5|Overall Study|Disease Progression|1
187040|NCT00042991|575127|P4|Overall Study|Disease Progression|2
187041|NCT00042991|575128|P3|Overall Study|Disease Progression|2
187042|NCT00042991|575129|P2|Overall Study|Disease Progression|29
187043|NCT00042991|575130|P1|Overall Study|Disease Progression|5
187044|NCT00042991|575124|P7|Overall Study|Withdrawal by Subject|0
187045|NCT00042991|575125|P6|Overall Study|Withdrawal by Subject|0
187046|NCT00042991|575126|P5|Overall Study|Withdrawal by Subject|1
187047|NCT00042991|575127|P4|Overall Study|Withdrawal by Subject|0
187048|NCT00042991|575128|P3|Overall Study|Withdrawal by Subject|2
187049|NCT00042991|575129|P2|Overall Study|Withdrawal by Subject|7
187050|NCT00042991|575130|P1|Overall Study|Withdrawal by Subject|0
187051|NCT00042991|575124|P7|Overall Study|Adverse Event|0
187052|NCT00042991|575125|P6|Overall Study|Adverse Event|1
187053|NCT00042991|575126|P5|Overall Study|Adverse Event|0
187054|NCT00042991|575127|P4|Overall Study|Adverse Event|0
187055|NCT00042991|575128|P3|Overall Study|Adverse Event|2
187056|NCT00042991|575129|P2|Overall Study|Adverse Event|4
187057|NCT00042991|575130|P1|Overall Study|Adverse Event|1
187058|NCT00042939|575173|P2|Overall Study|Did not start treatment|1
187059|NCT00042939|575174|P1|Overall Study|Did not start treatment|2
187060|NCT00042939|575173|P2|Overall Study|Treatment break > 4 weeks|1
187061|NCT00042939|575174|P1|Overall Study|Treatment break > 4 weeks|0
187062|NCT00042939|575173|P2|Overall Study|Still on treatment|0
187063|NCT00042939|575174|P1|Overall Study|Still on treatment|1
187064|NCT00042939|575173|P2|Overall Study|Patient non-compliance|0
187065|NCT00042939|575174|P1|Overall Study|Patient non-compliance|1
187066|NCT00042939|575173|P2|Overall Study|Rising ca 19-9|0
187067|NCT00042939|575174|P1|Overall Study|Rising ca 19-9|1
187068|NCT00042939|575173|P2|Overall Study|QOL diminished|0
187069|NCT00042939|575174|P1|Overall Study|QOL diminished|1
187070|NCT00042939|575173|P2|Overall Study|Deterioration of health|4
187071|NCT00042939|575174|P1|Overall Study|Deterioration of health|3
187072|NCT00042939|575173|P2|Overall Study|Ineligible|2
187073|NCT00042939|575174|P1|Overall Study|Ineligible|2
187074|NCT00042939|575173|P2|Overall Study|Other disease|0
187075|NCT00042939|575174|P1|Overall Study|Other disease|1
187076|NCT00042939|575173|P2|Overall Study|Withdrawal by Subject|4
187077|NCT00042939|575174|P1|Overall Study|Withdrawal by Subject|3
187078|NCT00042939|575173|P2|Overall Study|Death|2
187079|NCT00042939|575174|P1|Overall Study|Death|3
187080|NCT00042939|575173|P2|Overall Study|Adverse Event|7
187081|NCT00042939|575174|P1|Overall Study|Adverse Event|6
187082|NCT00041080|575221|P2|Overall Study|Ineligible|0
187083|NCT00041080|575222|P1|Overall Study|Ineligible|1
187084|NCT00041080|575221|P2|Overall Study|Did not start therapy|1
187085|NCT00041080|575222|P1|Overall Study|Did not start therapy|1
187086|NCT00041080|575221|P2|Overall Study|Concommitant Illness/Other|2
187087|NCT00041080|575222|P1|Overall Study|Concommitant Illness/Other|1
187088|NCT00041080|575221|P2|Overall Study|Withdrawal by Subject|6
187089|NCT00041080|575222|P1|Overall Study|Withdrawal by Subject|6
187090|NCT00041080|575221|P2|Overall Study|Adverse Event|1
187091|NCT00041080|575222|P1|Overall Study|Adverse Event|21
187092|NCT00041067|575228|P1|Overall Study|Ineligible|2
187093|NCT00041067|575228|P1|Overall Study|Other reasons|23
187094|NCT00041067|575228|P1|Overall Study|Patient refusal|12
187095|NCT00041067|575228|P1|Overall Study|Progression|19
187096|NCT00041067|575228|P1|Overall Study|Adverse Event|20
187097|NCT00042432|575244|P2|Overall Study|Other|0
187098|NCT00042432|575245|P1|Overall Study|Other|2
187099|NCT00042432|575244|P2|Overall Study|Initiation of maintenance dialysis|1
187100|NCT00042432|575245|P1|Overall Study|Initiation of maintenance dialysis|1
187101|NCT00042432|575244|P2|Overall Study|Ineligibility determined|0
187102|NCT00042432|575245|P1|Overall Study|Ineligibility determined|1
187103|NCT00042432|575244|P2|Overall Study|Death|2
187104|NCT00042432|575245|P1|Overall Study|Death|0
187105|NCT00042432|575244|P2|Overall Study|Withdrawal by Subject|3
187106|NCT00042432|575245|P1|Overall Study|Withdrawal by Subject|1
187107|NCT00042432|575244|P2|Overall Study|Adverse Event|1
187108|NCT00042432|575245|P1|Overall Study|Adverse Event|4
187109|NCT00041756|575267|P5|Overall Study|Data Monitoring Committee Recommendation|21
187110|NCT00041756|575268|P4|Overall Study|Data Monitoring Committee Recommendation|0
187111|NCT00041756|575269|P3|Overall Study|Data Monitoring Committee Recommendation|0
187112|NCT00041756|575270|P2|Overall Study|Data Monitoring Committee Recommendation|0
187113|NCT00041756|575271|P1|Overall Study|Data Monitoring Committee Recommendation|0
187114|NCT00041756|575267|P5|Overall Study|Unable to meet protocol criteria|1
187115|NCT00041756|575268|P4|Overall Study|Unable to meet protocol criteria|0
187116|NCT00041756|575269|P3|Overall Study|Unable to meet protocol criteria|1
187117|NCT00041756|575270|P2|Overall Study|Unable to meet protocol criteria|0
187118|NCT00041756|575271|P1|Overall Study|Unable to meet protocol criteria|0
187119|NCT00041756|575267|P5|Overall Study|Lost to Follow-up|0
187120|NCT00041756|575268|P4|Overall Study|Lost to Follow-up|1
187121|NCT00041756|575269|P3|Overall Study|Lost to Follow-up|0
187122|NCT00041756|575270|P2|Overall Study|Lost to Follow-up|1
187123|NCT00041756|575271|P1|Overall Study|Lost to Follow-up|0
187124|NCT00041756|575267|P5|Overall Study|Withdrawal by Subject|3
187125|NCT00041756|575268|P4|Overall Study|Withdrawal by Subject|2
187126|NCT00041756|575269|P3|Overall Study|Withdrawal by Subject|4
187127|NCT00041756|575270|P2|Overall Study|Withdrawal by Subject|3
187128|NCT00041756|575271|P1|Overall Study|Withdrawal by Subject|3
187129|NCT00041756|575267|P5|Overall Study|Protocol Violation|1
187130|NCT00041756|575268|P4|Overall Study|Protocol Violation|2
187131|NCT00041756|575269|P3|Overall Study|Protocol Violation|2
187132|NCT00041756|575270|P2|Overall Study|Protocol Violation|1
187133|NCT00041756|575271|P1|Overall Study|Protocol Violation|1
187134|NCT00041756|575267|P5|Overall Study|Adverse Event|34
187135|NCT00041756|575268|P4|Overall Study|Adverse Event|11
187136|NCT00041756|575269|P3|Overall Study|Adverse Event|6
187137|NCT00041756|575270|P2|Overall Study|Adverse Event|10
187138|NCT00041756|575271|P1|Overall Study|Adverse Event|4
187139|NCT00041132|575308|P1|Overall Study|Physician Decision|2
187140|NCT00041132|575308|P1|Overall Study|Withdrawal by Subject|1
187141|NCT00041132|575308|P1|Overall Study|Not Eligible|7
187142|NCT00041132|575308|P1|Overall Study|Death|1
187143|NCT00041132|575308|P1|Overall Study|Adverse Event|19
187144|NCT00040742|575318|P4|Overall Study|Other medical|5
187145|NCT00040742|575319|P3|Overall Study|Other medical|5
187146|NCT00040742|575320|P2|Overall Study|Other medical|5
187147|NCT00040742|575321|P1|Overall Study|Other medical|7
187148|NCT00040742|575318|P4|Overall Study|Incomplete Forms|5
187149|NCT00040742|575319|P3|Overall Study|Incomplete Forms|4
187150|NCT00040742|575320|P2|Overall Study|Incomplete Forms|10
187151|NCT00040742|575321|P1|Overall Study|Incomplete Forms|6
187152|NCT00040742|575318|P4|Overall Study|Chemotoxicity|2
187153|NCT00040742|575319|P3|Overall Study|Chemotoxicity|5
187154|NCT00040742|575320|P2|Overall Study|Chemotoxicity|3
187155|NCT00040742|575321|P1|Overall Study|Chemotoxicity|4
187156|NCT00040742|575318|P4|Overall Study|Withdrawal by Subject|13
187157|NCT00040742|575319|P3|Overall Study|Withdrawal by Subject|10
187158|NCT00040742|575320|P2|Overall Study|Withdrawal by Subject|15
187159|NCT00040742|575321|P1|Overall Study|Withdrawal by Subject|7
187160|NCT00040742|575318|P4|Overall Study|Adverse Event|9
187161|NCT00040742|575319|P3|Overall Study|Adverse Event|21
187162|NCT00040742|575320|P2|Overall Study|Adverse Event|16
187163|NCT00040742|575321|P1|Overall Study|Adverse Event|15
187164|NCT00040742|575318|P4|Overall Study|Death|0
187165|NCT00040742|575319|P3|Overall Study|Death|1
187166|NCT00040742|575320|P2|Overall Study|Death|0
187167|NCT00040742|575321|P1|Overall Study|Death|0
187168|NCT00040664|575335|P4|Overall Study|Non-viability of oral suspension|0
187169|NCT00040664|575336|P3|Overall Study|Non-viability of oral suspension|1
187170|NCT00040664|575337|P2|Overall Study|Non-viability of oral suspension|0
187171|NCT00040664|575338|P1|Overall Study|Non-viability of oral suspension|1
187172|NCT00040664|575335|P4|Overall Study|Change of formulation|0
187173|NCT00040664|575336|P3|Overall Study|Change of formulation|0
187174|NCT00040664|575337|P2|Overall Study|Change of formulation|2
187175|NCT00040664|575338|P1|Overall Study|Change of formulation|2
187176|NCT00040664|575335|P4|Overall Study|Pharmacokinetic target not achieved|1
187177|NCT00040664|575336|P3|Overall Study|Pharmacokinetic target not achieved|0
187178|NCT00040664|575337|P2|Overall Study|Pharmacokinetic target not achieved|1
187179|NCT00040664|575338|P1|Overall Study|Pharmacokinetic target not achieved|2
187180|NCT00040664|575335|P4|Overall Study|Poor taste|0
187181|NCT00040664|575336|P3|Overall Study|Poor taste|2
187182|NCT00040664|575337|P2|Overall Study|Poor taste|0
187183|NCT00040664|575338|P1|Overall Study|Poor taste|2
187184|NCT00040664|575335|P4|Overall Study|Medication adherence/compliance problems|5
187185|NCT00040664|575336|P3|Overall Study|Medication adherence/compliance problems|1
187186|NCT00040664|575337|P2|Overall Study|Medication adherence/compliance problems|2
187187|NCT00040664|575338|P1|Overall Study|Medication adherence/compliance problems|8
187188|NCT00040664|575335|P4|Overall Study|Pregnancy|3
187189|NCT00040664|575336|P3|Overall Study|Pregnancy|0
187190|NCT00040664|575337|P2|Overall Study|Pregnancy|0
187191|NCT00040664|575338|P1|Overall Study|Pregnancy|3
187192|NCT00040664|575335|P4|Overall Study|Withdrawal by Subject|4
187193|NCT00040664|575336|P3|Overall Study|Withdrawal by Subject|3
187194|NCT00040664|575337|P2|Overall Study|Withdrawal by Subject|0
187195|NCT00040664|575338|P1|Overall Study|Withdrawal by Subject|7
187196|NCT00040664|575335|P4|Overall Study|Protocol Violation|1
187197|NCT00040664|575336|P3|Overall Study|Protocol Violation|0
187198|NCT00040664|575337|P2|Overall Study|Protocol Violation|1
187199|NCT00040664|575338|P1|Overall Study|Protocol Violation|2
187200|NCT00040664|575335|P4|Overall Study|Lost to Follow-up|2
187201|NCT00040664|575336|P3|Overall Study|Lost to Follow-up|0
187202|NCT00040664|575337|P2|Overall Study|Lost to Follow-up|2
187203|NCT00040664|575338|P1|Overall Study|Lost to Follow-up|4
187204|NCT00040664|575335|P4|Overall Study|Insufficient CD4 response|0
187205|NCT00040664|575336|P3|Overall Study|Insufficient CD4 response|1
187206|NCT00040664|575337|P2|Overall Study|Insufficient CD4 response|0
187207|NCT00040664|575338|P1|Overall Study|Insufficient CD4 response|1
187208|NCT00040664|575335|P4|Overall Study|Lack of Efficacy|4
187209|NCT00040664|575336|P3|Overall Study|Lack of Efficacy|3
187210|NCT00040664|575337|P2|Overall Study|Lack of Efficacy|2
187211|NCT00040664|575338|P1|Overall Study|Lack of Efficacy|9
187212|NCT00040664|575335|P4|Overall Study|Adverse Event|7
187213|NCT00040664|575336|P3|Overall Study|Adverse Event|2
187214|NCT00040664|575337|P2|Overall Study|Adverse Event|3
187215|NCT00040664|575338|P1|Overall Study|Adverse Event|12
187216|NCT00040365|575386|P1|Overall Study|Lost to Follow-up|3
187217|NCT00040365|575386|P1|Overall Study|Progressive disease|7
187218|NCT00040365|575386|P1|Overall Study|Death|1
187219|NCT00039130|575399|P1|Overall Study|Physician Decision|3
187220|NCT00039130|575399|P1|Overall Study|Subsequent treatment|2
187221|NCT00039130|575399|P1|Overall Study|Progression|2
187222|NCT00039130|575399|P1|Overall Study|Withdrawal by Subject|3
187223|NCT00039130|575399|P1|Overall Study|Death|9
187224|NCT00039130|575399|P1|Overall Study|Adverse Event|11
187225|NCT00039871|575405|P1|Overall Study|Never entered follow-up|7
187226|NCT00039871|575405|P1|Overall Study|Discontinued at Week 12 per protocol|1061
187227|NCT00039871|575405|P1|Overall Study|Administrative|1
187228|NCT00039871|575405|P1|Overall Study|Did not meet eligibility criteria|11
187229|NCT00039871|575405|P1|Overall Study|Withdrawal by Subject|97
187230|NCT00039871|575405|P1|Overall Study|Protocol Violation|24
187231|NCT00039871|575405|P1|Overall Study|Lost to Follow-up|18
187232|NCT00039871|575405|P1|Overall Study|Adverse Event|165
187233|NCT00039741|575415|P4|Overall Study|Missed final visit|2
187234|NCT00039741|575416|P3|Overall Study|Missed final visit|2
187235|NCT00039741|575417|P2|Overall Study|Missed final visit|1
187236|NCT00039741|575418|P1|Overall Study|Missed final visit|2
187237|NCT00039741|575415|P4|Overall Study|Withdrew consent|1
187238|NCT00039741|575416|P3|Overall Study|Withdrew consent|0
187239|NCT00039741|575417|P2|Overall Study|Withdrew consent|5
187240|NCT00039741|575418|P1|Overall Study|Withdrew consent|0
187241|NCT00039741|575415|P4|Overall Study|Non-compliance with protocol|0
187242|NCT00039741|575416|P3|Overall Study|Non-compliance with protocol|1
187243|NCT00039741|575417|P2|Overall Study|Non-compliance with protocol|0
187244|NCT00039741|575418|P1|Overall Study|Non-compliance with protocol|1
187245|NCT00039741|575415|P4|Overall Study|Moved|6
187246|NCT00039741|575416|P3|Overall Study|Moved|3
187247|NCT00039741|575417|P2|Overall Study|Moved|2
187248|NCT00039741|575418|P1|Overall Study|Moved|3
187249|NCT00039741|575415|P4|Overall Study|Not able to get to clinic|3
187250|NCT00039741|575416|P3|Overall Study|Not able to get to clinic|0
187251|NCT00039741|575417|P2|Overall Study|Not able to get to clinic|2
187252|NCT00039741|575418|P1|Overall Study|Not able to get to clinic|5
187253|NCT00039741|575415|P4|Overall Study|Confounding medical condition|0
187254|NCT00039741|575416|P3|Overall Study|Confounding medical condition|0
187255|NCT00039741|575417|P2|Overall Study|Confounding medical condition|0
187256|NCT00039741|575418|P1|Overall Study|Confounding medical condition|1
187257|NCT00039741|575415|P4|Overall Study|Lost to Follow-up|2
187258|NCT00039741|575416|P3|Overall Study|Lost to Follow-up|5
187259|NCT00039741|575417|P2|Overall Study|Lost to Follow-up|1
187260|NCT00039741|575418|P1|Overall Study|Lost to Follow-up|3
187261|NCT00039741|575415|P4|Overall Study|Death|0
187262|NCT00039741|575416|P3|Overall Study|Death|0
187263|NCT00039741|575417|P2|Overall Study|Death|1
187264|NCT00039741|575418|P1|Overall Study|Death|0
187265|NCT00039377|575460|P4|Initial Registration|Withdrawal by Subject|0
187266|NCT00039377|575461|P3|Initial Registration|Withdrawal by Subject|0
187267|NCT00039377|575462|P2|Initial Registration|Withdrawal by Subject|0
187268|NCT00039377|575463|P1|Initial Registration|Withdrawal by Subject|3
187269|NCT00039377|575460|P4|Initial Registration|Received non-protocol therapy|0
187270|NCT00039377|575461|P3|Initial Registration|Received non-protocol therapy|0
187271|NCT00039377|575462|P2|Initial Registration|Received non-protocol therapy|0
187272|NCT00039377|575463|P1|Initial Registration|Received non-protocol therapy|11
187273|NCT00039377|575460|P4|Initial Registration|Relapsed|0
187274|NCT00039377|575461|P3|Initial Registration|Relapsed|0
187275|NCT00039377|575462|P2|Initial Registration|Relapsed|0
187276|NCT00039377|575463|P1|Initial Registration|Relapsed|6
187277|NCT00039377|575460|P4|Initial Registration|Adverse Event|0
187278|NCT00039377|575461|P3|Initial Registration|Adverse Event|0
187279|NCT00039377|575462|P2|Initial Registration|Adverse Event|0
187280|NCT00039377|575463|P1|Initial Registration|Adverse Event|2
187281|NCT00038948|575477|P2|Overall Study|Lack of Efficacy|6
187282|NCT00038948|575478|P1|Overall Study|Lack of Efficacy|3
187283|NCT00038948|575477|P2|Overall Study|Protocol Violation|7
187284|NCT00038948|575478|P1|Overall Study|Protocol Violation|3
187285|NCT00038948|575477|P2|Overall Study|Withdrawal by Subject|10
187286|NCT00038948|575478|P1|Overall Study|Withdrawal by Subject|23
187287|NCT00038948|575477|P2|Overall Study|Nonmedical event|7
187288|NCT00038948|575478|P1|Overall Study|Nonmedical event|5
187289|NCT00038948|575477|P2|Overall Study|Lost to Follow-up|4
187290|NCT00038948|575478|P1|Overall Study|Lost to Follow-up|4
187291|NCT00038948|575477|P2|Overall Study|Adverse Event|43
187292|NCT00038948|575478|P1|Overall Study|Adverse Event|131
187293|NCT00038467|575502|P2|Overall Study|Unspecified|28
187294|NCT00038467|575503|P1|Overall Study|Unspecified|26
187295|NCT00038467|575502|P2|Overall Study|Randomized, but not treated|35
187296|NCT00038467|575503|P1|Overall Study|Randomized, but not treated|31
187297|NCT00038467|575502|P2|Overall Study|Recurrence|179
187298|NCT00038467|575503|P1|Overall Study|Recurrence|109
187299|NCT00038467|575502|P2|Overall Study|Lost to Follow-up|10
187300|NCT00038467|575503|P1|Overall Study|Lost to Follow-up|15
187301|NCT00038467|575502|P2|Overall Study|Death|16
187302|NCT00038467|575503|P1|Overall Study|Death|22
187303|NCT00038467|575502|P2|Overall Study|Protocol Violation|22
187304|NCT00038467|575503|P1|Overall Study|Protocol Violation|19
187305|NCT00038467|575502|P2|Overall Study|Withdrawal by Subject|107
187306|NCT00038467|575503|P1|Overall Study|Withdrawal by Subject|150
187307|NCT00038467|575502|P2|Overall Study|Adverse Event|145
187308|NCT00038467|575503|P1|Overall Study|Adverse Event|170
187309|NCT00038103|575565|P2|Overall Study|Randomized/never treated|0
187310|NCT00038103|575566|P1|Overall Study|Randomized/never treated|2
187311|NCT00038103|575565|P2|Overall Study|Sponsor Decision|1
187312|NCT00038103|575566|P1|Overall Study|Sponsor Decision|0
187313|NCT00038103|575565|P2|Overall Study|Protocol Violation|2
187314|NCT00038103|575566|P1|Overall Study|Protocol Violation|0
187315|NCT00038103|575565|P2|Overall Study|Lost to Follow-up|3
187316|NCT00038103|575566|P1|Overall Study|Lost to Follow-up|0
187317|NCT00038103|575565|P2|Overall Study|Withdrawal by Subject|3
187318|NCT00038103|575566|P1|Overall Study|Withdrawal by Subject|0
187319|NCT00038103|575565|P2|Overall Study|Lack of Efficacy|41
187320|NCT00038103|575566|P1|Overall Study|Lack of Efficacy|48
187321|NCT00038103|575565|P2|Overall Study|Adverse Event|6
187322|NCT00038103|575566|P1|Overall Study|Adverse Event|5
187323|NCT00037830|575589|P3|Overall Study|Unrelated Medical Problem|0
187324|NCT00037830|575590|P2|Overall Study|Unrelated Medical Problem|0
187325|NCT00037830|575591|P1|Overall Study|Unrelated Medical Problem|2
187326|NCT00037830|575589|P3|Overall Study|Protocol Violation|0
187327|NCT00037830|575590|P2|Overall Study|Protocol Violation|2
187328|NCT00037830|575591|P1|Overall Study|Protocol Violation|2
187329|NCT00037830|575589|P3|Overall Study|Withdrawal by Subject|1
187330|NCT00037830|575590|P2|Overall Study|Withdrawal by Subject|5
187331|NCT00037830|575591|P1|Overall Study|Withdrawal by Subject|4
187332|NCT00037830|575589|P3|Overall Study|Adverse Event|0
187333|NCT00037830|575590|P2|Overall Study|Adverse Event|0
187334|NCT00037830|575591|P1|Overall Study|Adverse Event|2
187335|NCT00036270|575623|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
187336|NCT00036270|575624|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
187337|NCT00036270|575623|P2|Study Treatment to 5 Year Report|Too early switch|103
187338|NCT00036270|575624|P1|Study Treatment to 5 Year Report|Too early switch|0
187339|NCT00036270|575623|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
187340|NCT00036270|575624|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
187341|NCT00036270|575623|P2|Study Treatment to 5 Year Report|Protocol Violation|91
187342|NCT00036270|575624|P1|Study Treatment to 5 Year Report|Protocol Violation|23
187343|NCT00036270|575623|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
187344|NCT00036270|575624|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
187345|NCT00036270|575623|P2|Study Treatment to 5 Year Report|Treatment refusal|208
187346|NCT00036270|575624|P1|Study Treatment to 5 Year Report|Treatment refusal|113
187347|NCT00036270|575623|P2|Study Treatment to 5 Year Report|Unspecified|288
187348|NCT00036270|575624|P1|Study Treatment to 5 Year Report|Unspecified|277
187349|NCT00036270|575623|P2|Study Treatment to 5 Year Report|Adverse Event|782
187350|NCT00036270|575624|P1|Study Treatment to 5 Year Report|Adverse Event|501
187351|NCT00036270|575623|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
187352|NCT00036270|575624|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
187353|NCT00036270|575623|P2|Study Treatment to 5 Year Report|Ongoing|736
187354|NCT00036270|575624|P1|Study Treatment to 5 Year Report|Ongoing|1081
187355|NCT00036270|575623|P2|Randomized to Study Treatment|Withdrawal by Subject|7
187356|NCT00036270|575624|P1|Randomized to Study Treatment|Withdrawal by Subject|6
187357|NCT00035932|575643|P3|Overall Study|Lack of Efficacy|28
187358|NCT00035932|575644|P2|Overall Study|Lack of Efficacy|33
187359|NCT00035932|575645|P1|Overall Study|Lack of Efficacy|33
187360|NCT00035932|575643|P3|Overall Study|Study Termination by Sponsor|0
187361|NCT00035932|575644|P2|Overall Study|Study Termination by Sponsor|0
187362|NCT00035932|575645|P1|Overall Study|Study Termination by Sponsor|1
187363|NCT00035932|575643|P3|Overall Study|Withdrawal by Subject|0
187364|NCT00035932|575644|P2|Overall Study|Withdrawal by Subject|5
187365|NCT00035932|575645|P1|Overall Study|Withdrawal by Subject|1
187366|NCT00035932|575643|P3|Overall Study|Protocol Violation While on Study|2
187367|NCT00035932|575644|P2|Overall Study|Protocol Violation While on Study|1
187368|NCT00035932|575645|P1|Overall Study|Protocol Violation While on Study|0
187369|NCT00035932|575643|P3|Overall Study|Noncompliance|6
187370|NCT00035932|575644|P2|Overall Study|Noncompliance|7
187371|NCT00035932|575645|P1|Overall Study|Noncompliance|6
187372|NCT00035932|575643|P3|Overall Study|Lost to Follow-up|3
187373|NCT00035932|575644|P2|Overall Study|Lost to Follow-up|4
187374|NCT00035932|575645|P1|Overall Study|Lost to Follow-up|4
187375|NCT00035932|575643|P3|Overall Study|Disease Progression / Relapse|0
187376|NCT00035932|575644|P2|Overall Study|Disease Progression / Relapse|1
187377|NCT00035932|575645|P1|Overall Study|Disease Progression / Relapse|1
187378|NCT00035932|575643|P3|Overall Study|Death|1
187379|NCT00035932|575644|P2|Overall Study|Death|0
187380|NCT00035932|575645|P1|Overall Study|Death|0
187381|NCT00035932|575643|P3|Overall Study|Adverse Event|9
187382|NCT00035932|575644|P2|Overall Study|Adverse Event|9
187383|NCT00035932|575645|P1|Overall Study|Adverse Event|10
187384|NCT00035815|575771|P2|Overall Study|Withdrawal by Subject|11
187385|NCT00035815|575772|P1|Overall Study|Withdrawal by Subject|17
187386|NCT00035555|575785|P3|Overall Study|Received cyclosporin in error|1
187387|NCT00035555|575786|P2|Overall Study|Received cyclosporin in error|0
187388|NCT00035555|575787|P1|Overall Study|Received cyclosporin in error|0
187389|NCT00035555|575785|P3|Overall Study|Investigator deemed not a good candidate|1
187390|NCT00035555|575786|P2|Overall Study|Investigator deemed not a good candidate|0
187391|NCT00035555|575787|P1|Overall Study|Investigator deemed not a good candidate|0
187392|NCT00035555|575785|P3|Overall Study|Withdrawal by Subject|2
187393|NCT00035555|575786|P2|Overall Study|Withdrawal by Subject|0
187394|NCT00035555|575787|P1|Overall Study|Withdrawal by Subject|2
187395|NCT00035555|575785|P3|Overall Study|Treatment failure/lack of efficacy|3
187396|NCT00035555|575786|P2|Overall Study|Treatment failure/lack of efficacy|5
187397|NCT00035555|575787|P1|Overall Study|Treatment failure/lack of efficacy|7
187398|NCT00035555|575785|P3|Overall Study|Prohibited medication|0
187399|NCT00035555|575786|P2|Overall Study|Prohibited medication|1
187400|NCT00035555|575787|P1|Overall Study|Prohibited medication|1
187401|NCT00035555|575785|P3|Overall Study|Noncompliance|1
187402|NCT00035555|575786|P2|Overall Study|Noncompliance|1
187403|NCT00035555|575787|P1|Overall Study|Noncompliance|0
187404|NCT00035555|575785|P3|Overall Study|Lost to Follow-up|1
187405|NCT00035555|575786|P2|Overall Study|Lost to Follow-up|0
187406|NCT00035555|575787|P1|Overall Study|Lost to Follow-up|0
187407|NCT00035555|575785|P3|Overall Study|Death|2
187408|NCT00035555|575786|P2|Overall Study|Death|0
187409|NCT00035555|575787|P1|Overall Study|Death|0
187410|NCT00035555|575785|P3|Overall Study|Allograft loss|2
187411|NCT00035555|575786|P2|Overall Study|Allograft loss|1
187412|NCT00035555|575787|P1|Overall Study|Allograft loss|1
187413|NCT00035555|575785|P3|Overall Study|Adverse Event|9
187414|NCT00035555|575786|P2|Overall Study|Adverse Event|8
187415|NCT00035555|575787|P1|Overall Study|Adverse Event|5
187416|NCT00033657|575843|P2|Adjuvant Chemotherapy|Other|2
187417|NCT00033657|575844|P1|Adjuvant Chemotherapy|Other|0
187418|NCT00033657|575843|P2|Adjuvant Chemotherapy|alternative therapy|0
187419|NCT00033657|575844|P1|Adjuvant Chemotherapy|alternative therapy|1
187420|NCT00033657|575843|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
187421|NCT00033657|575844|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
187422|NCT00033657|575843|P2|Adjuvant Chemotherapy|Death|1
187423|NCT00033657|575844|P1|Adjuvant Chemotherapy|Death|2
187424|NCT00033657|575843|P2|Adjuvant Chemotherapy|Adverse Event|10
187425|NCT00033657|575844|P1|Adjuvant Chemotherapy|Adverse Event|7
187426|NCT00033657|575843|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
187427|NCT00033657|575844|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
187428|NCT00033657|575843|P2|Surgical Resection|not complete resection|3
187429|NCT00033657|575844|P1|Surgical Resection|not complete resection|0
187430|NCT00033657|575843|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
187431|NCT00033657|575844|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
187432|NCT00033657|575843|P2|Neoadjuvant Chemotherapy|Ineligible|4
187433|NCT00033657|575844|P1|Neoadjuvant Chemotherapy|Ineligible|8
187434|NCT00033657|575843|P2|Neoadjuvant Chemotherapy|other complicating disease|1
187435|NCT00033657|575844|P1|Neoadjuvant Chemotherapy|other complicating disease|0
187436|NCT00033657|575843|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
187437|NCT00033657|575844|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
187438|NCT00033657|575843|P2|Neoadjuvant Chemotherapy|Death|1
187439|NCT00033657|575844|P1|Neoadjuvant Chemotherapy|Death|1
187440|NCT00033657|575843|P2|Neoadjuvant Chemotherapy|Adverse Event|2
187441|NCT00033657|575844|P1|Neoadjuvant Chemotherapy|Adverse Event|0
187442|NCT00033657|575843|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
187443|NCT00033657|575844|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
187444|NCT00033631|575858|P2|Overall Study|Withdrawal by Subject|4
187445|NCT00033631|575859|P1|Overall Study|Withdrawal by Subject|4
187446|NCT00033631|575858|P2|Overall Study|Protocol Violation|11
187447|NCT00033631|575859|P1|Overall Study|Protocol Violation|14
187448|NCT00033540|575877|P1|Overall Study|Never received treatment|2
187449|NCT00033540|575877|P1|Overall Study|Ineligible|3
187450|NCT00033540|575877|P1|Overall Study|Not specified|5
187451|NCT00033540|575877|P1|Overall Study|Withdrawal by Subject|6
187452|NCT00033540|575877|P1|Overall Study|Progression|26
187453|NCT00033540|575877|P1|Overall Study|Death|1
187454|NCT00033540|575877|P1|Overall Study|Adverse Event|14
187455|NCT00033514|575887|P2|Overall Study|Withdrawal by Subject|3
187456|NCT00033514|575888|P1|Overall Study|Withdrawal by Subject|0
187457|NCT00033514|575887|P2|Overall Study|Lost to Follow-up|1
187458|NCT00033514|575888|P1|Overall Study|Lost to Follow-up|1
187459|NCT00033371|575898|P2|Overall Study|Disease Progression|1
187460|NCT00033371|575899|P1|Overall Study|Disease Progression|0
187461|NCT00033371|575898|P2|Overall Study|Withdrawal by Subject|3
187462|NCT00033371|575899|P1|Overall Study|Withdrawal by Subject|3
187463|NCT00033371|575898|P2|Overall Study|Lost to Follow-up|1
187464|NCT00033371|575899|P1|Overall Study|Lost to Follow-up|2
187465|NCT00033371|575898|P2|Overall Study|Adverse Event|5
187466|NCT00033371|575899|P1|Overall Study|Adverse Event|1
187467|NCT00033293|575907|P2|Overall Study|Treatment refused|6
187468|NCT00033293|575908|P1|Overall Study|Treatment refused|0
187469|NCT00033293|575907|P2|Overall Study|Could not be weaned from steroid therapy|1
187470|NCT00033293|575908|P1|Overall Study|Could not be weaned from steroid therapy|1
187471|NCT00033293|575907|P2|Overall Study|Withdrawal by Subject|0
187472|NCT00033293|575908|P1|Overall Study|Withdrawal by Subject|1
187473|NCT00033293|575907|P2|Overall Study|Physician Decision|1
187474|NCT00033293|575908|P1|Overall Study|Physician Decision|3
187475|NCT00033293|575907|P2|Overall Study|Lost to Follow-up|1
187476|NCT00033293|575908|P1|Overall Study|Lost to Follow-up|0
187477|NCT00033293|575907|P2|Overall Study|Lack of Efficacy|8
187478|NCT00033293|575908|P1|Overall Study|Lack of Efficacy|5
187479|NCT00033293|575907|P2|Overall Study|Death|1
187480|NCT00033293|575908|P1|Overall Study|Death|0
187481|NCT00032487|575944|P2|Overall Study|Had other reason|12
187482|NCT00032487|575945|P1|Overall Study|Had other reason|12
187483|NCT00032487|575944|P2|Overall Study|Lost to Follow-up|58
187484|NCT00032487|575945|P1|Overall Study|Lost to Follow-up|57
187485|NCT00032487|575944|P2|Overall Study|Adverse Event|7
187486|NCT00032487|575945|P1|Overall Study|Adverse Event|3
187487|NCT00032487|575944|P2|Overall Study|Withdrawal by Subject|43
187488|NCT00032487|575945|P1|Overall Study|Withdrawal by Subject|67
187489|NCT00031694|575953|P1|Overall Study|Withdrawal by Subject|5
187490|NCT00031694|575953|P1|Overall Study|Death|2
187491|NCT00031694|575953|P1|Overall Study|Adverse Event|12
187492|NCT00031551|575959|P2|Overall Study|Withdrew due to chemotherapy effects|0
187493|NCT00031551|575960|P1|Overall Study|Withdrew due to chemotherapy effects|2
187494|NCT00031486|575972|P2|Overall Study|Unspecified|1
187495|NCT00031486|575973|P1|Overall Study|Unspecified|1
187496|NCT00031486|575972|P2|Overall Study|Did not meet eligibility requirement|1
187497|NCT00031486|575973|P1|Overall Study|Did not meet eligibility requirement|2
187498|NCT00031486|575972|P2|Overall Study|Non-compliant|4
187499|NCT00031486|575973|P1|Overall Study|Non-compliant|0
187500|NCT00031486|575972|P2|Overall Study|Death|3
187501|NCT00031486|575973|P1|Overall Study|Death|0
187502|NCT00031486|575972|P2|Overall Study|Withdrawal by Subject|2
187503|NCT00031486|575973|P1|Overall Study|Withdrawal by Subject|3
187504|NCT00031486|575972|P2|Overall Study|Lost to Follow-up|1
187505|NCT00031486|575973|P1|Overall Study|Lost to Follow-up|0
187506|NCT00031486|575972|P2|Overall Study|Adverse Event|0
187507|NCT00031486|575973|P1|Overall Study|Adverse Event|1
187508|NCT00031460|575999|P2|Overall Study|Confirmed unevaluable|1
187509|NCT00031460|576000|P1|Overall Study|Confirmed unevaluable|0
187510|NCT00031460|575999|P2|Overall Study|Disruption of blinded drug supply|0
187511|NCT00031460|576000|P1|Overall Study|Disruption of blinded drug supply|2
187512|NCT00031460|575999|P2|Overall Study|Reactivation of Disease|9
187513|NCT00031460|576000|P1|Overall Study|Reactivation of Disease|5
187514|NCT00031460|575999|P2|Overall Study|Death|1
187515|NCT00031460|576000|P1|Overall Study|Death|0
187516|NCT00031460|575999|P2|Overall Study|Non-Compliant|1
187517|NCT00031460|576000|P1|Overall Study|Non-Compliant|1
187518|NCT00031460|575999|P2|Overall Study|Withdrawal by Subject|1
187519|NCT00031460|576000|P1|Overall Study|Withdrawal by Subject|1
187520|NCT00031460|575999|P2|Overall Study|Lost to Follow-up|1
187521|NCT00031460|576000|P1|Overall Study|Lost to Follow-up|0
187522|NCT00031447|576014|P2|Overall Study|Disruption of blinded study drug supply|4
187523|NCT00031447|576015|P1|Overall Study|Disruption of blinded study drug supply|7
187524|NCT00031447|576014|P2|Overall Study|Re-activation of Disease|1
187525|NCT00031447|576015|P1|Overall Study|Re-activation of Disease|2
187526|NCT00031447|576014|P2|Overall Study|Non-compliant|1
187527|NCT00031447|576015|P1|Overall Study|Non-compliant|1
187528|NCT00031447|576014|P2|Overall Study|Lost to Follow-up|1
187529|NCT00031447|576015|P1|Overall Study|Lost to Follow-up|0
187530|NCT00030901|576034|P3|Randomization|Ineligible|14
187531|NCT00030901|576035|P2|Randomization|Ineligible|15
187532|NCT00030901|576036|P1|Randomization|Ineligible|0
187533|NCT00030901|576034|P3|Randomization|Other|33
187534|NCT00030901|576035|P2|Randomization|Other|36
187535|NCT00030901|576036|P1|Randomization|Other|0
187536|NCT00030901|576034|P3|Randomization|Death|3
187537|NCT00030901|576035|P2|Randomization|Death|1
187538|NCT00030901|576036|P1|Randomization|Death|0
187539|NCT00030901|576034|P3|Randomization|Progression/Relapse|21
187540|NCT00030901|576035|P2|Randomization|Progression/Relapse|22
187541|NCT00030901|576036|P1|Randomization|Progression/Relapse|0
187542|NCT00030901|576034|P3|Randomization|Refusal Unrelated to Adverse Event|10
187543|NCT00030901|576035|P2|Randomization|Refusal Unrelated to Adverse Event|16
187544|NCT00030901|576036|P1|Randomization|Refusal Unrelated to Adverse Event|0
187545|NCT00030901|576034|P3|Randomization|Adverse Event|7
187546|NCT00030901|576035|P2|Randomization|Adverse Event|11
187547|NCT00030901|576036|P1|Randomization|Adverse Event|0
187548|NCT00030901|576034|P3|Initial Registration|Ineligible|0
187549|NCT00030901|576035|P2|Initial Registration|Ineligible|0
187550|NCT00030901|576036|P1|Initial Registration|Ineligible|167
187551|NCT00030823|576044|P1|Overall Study|Withdrawal by Subject|1
187552|NCT00029146|576075|P2|Overall Study|Lost to Follow-up|1
187553|NCT00029146|576076|P1|Overall Study|Lost to Follow-up|2
187554|NCT00028769|576112|P1|Overall Study|Not Analyzable|1
187555|NCT00028769|576112|P1|Overall Study|Ineligible|5
187556|NCT00028769|576112|P1|Overall Study|Other - Not Protocol Specified|1
187557|NCT00028769|576112|P1|Overall Study|Progression or Death|31
187558|NCT00028769|576112|P1|Overall Study|Refusal Unrelated to Adverse Events|1
187559|NCT00028769|576112|P1|Overall Study|Adverse Event|2
187560|NCT00028002|576131|P1|Overall Study|Ineligible|8
187561|NCT00028002|576131|P1|Overall Study|Withdrawal by Subject|3
187562|NCT00027560|576135|P1|Overall Study|Withdrawal by Subject|1
187563|NCT00027378|576146|P2|Overall Study|Physician Decision|3
187564|NCT00027378|576147|P1|Overall Study|Physician Decision|0
187565|NCT00027027|576160|P5|Overall Study|Withdrawal by Subject|1
187566|NCT00027027|576161|P4|Overall Study|Withdrawal by Subject|0
187567|NCT00027027|576162|P3|Overall Study|Withdrawal by Subject|0
187568|NCT00027027|576163|P2|Overall Study|Withdrawal by Subject|0
187569|NCT00027027|576164|P1|Overall Study|Withdrawal by Subject|0
187570|NCT00027027|576160|P5|Overall Study|Physician Decision Due To PD|5
187571|NCT00027027|576161|P4|Overall Study|Physician Decision Due To PD|3
187572|NCT00027027|576162|P3|Overall Study|Physician Decision Due To PD|2
187573|NCT00027027|576163|P2|Overall Study|Physician Decision Due To PD|3
187574|NCT00027027|576164|P1|Overall Study|Physician Decision Due To PD|2
187575|NCT00027027|576160|P5|Overall Study|PD Requiring Surgery|0
187576|NCT00027027|576161|P4|Overall Study|PD Requiring Surgery|0
187577|NCT00027027|576162|P3|Overall Study|PD Requiring Surgery|1
187578|NCT00027027|576163|P2|Overall Study|PD Requiring Surgery|0
187579|NCT00027027|576164|P1|Overall Study|PD Requiring Surgery|0
187580|NCT00027027|576160|P5|Overall Study|Clinical Symptoms Progression not PD|0
187581|NCT00027027|576161|P4|Overall Study|Clinical Symptoms Progression not PD|0
187582|NCT00027027|576162|P3|Overall Study|Clinical Symptoms Progression not PD|0
187583|NCT00027027|576163|P2|Overall Study|Clinical Symptoms Progression not PD|0
187584|NCT00027027|576164|P1|Overall Study|Clinical Symptoms Progression not PD|1
187585|NCT00027027|576160|P5|Overall Study|Admitted for Signs of PD|1
187586|NCT00027027|576161|P4|Overall Study|Admitted for Signs of PD|0
187587|NCT00027027|576162|P3|Overall Study|Admitted for Signs of PD|0
187588|NCT00027027|576163|P2|Overall Study|Admitted for Signs of PD|0
187589|NCT00027027|576164|P1|Overall Study|Admitted for Signs of PD|0
187590|NCT00027027|576160|P5|Overall Study|Adverse Event|1
187591|NCT00027027|576161|P4|Overall Study|Adverse Event|0
187592|NCT00027027|576162|P3|Overall Study|Adverse Event|1
187593|NCT00027027|576163|P2|Overall Study|Adverse Event|0
187594|NCT00027027|576164|P1|Overall Study|Adverse Event|0
187595|NCT00026494|576213|P4|Overall Study|Clinical progression|0
187596|NCT00026494|576214|P3|Overall Study|Clinical progression|3
187597|NCT00026494|576215|P2|Overall Study|Clinical progression|0
187598|NCT00026494|576216|P1|Overall Study|Clinical progression|0
187599|NCT00026494|576213|P4|Overall Study|Patient not treated|0
187600|NCT00026494|576214|P3|Overall Study|Patient not treated|2
187601|NCT00026494|576215|P2|Overall Study|Patient not treated|0
187602|NCT00026494|576216|P1|Overall Study|Patient not treated|0
187603|NCT00026494|576213|P4|Overall Study|Patient non-compliance|0
187604|NCT00026494|576214|P3|Overall Study|Patient non-compliance|0
187605|NCT00026494|576215|P2|Overall Study|Patient non-compliance|0
187606|NCT00026494|576216|P1|Overall Study|Patient non-compliance|1
187607|NCT00026494|576213|P4|Overall Study|Withdrawal by Subject|0
187608|NCT00026494|576214|P3|Overall Study|Withdrawal by Subject|1
187609|NCT00026494|576215|P2|Overall Study|Withdrawal by Subject|0
187610|NCT00026494|576216|P1|Overall Study|Withdrawal by Subject|1
187611|NCT00025883|576250|P1|Overall Study|didn't reach 6 months of Metreleptin|10
187612|NCT00025883|576250|P1|Overall Study|Adverse Event|1
187613|NCT00025883|576250|P1|Overall Study|Death|1
187614|NCT00025883|576250|P1|Overall Study|no baseline data|1
187615|NCT00025883|576250|P1|Overall Study|had atypical progeriod lipodystrophy|4
187616|NCT00025662|576257|P1|Overall Study|Technical failure of manipulation|1
187617|NCT00025662|576257|P1|Overall Study|Withdrawal by Subject|2
187618|NCT00025506|576265|P1|Overall Study|Never Treated|2
187619|NCT00025506|576265|P1|Overall Study|Ineligible: inadequate pathology|2
187620|NCT00025506|576265|P1|Overall Study|Ineligible: wrong cell type|5
187621|NCT00025506|576265|P1|Overall Study|Ineligible: clerical error|1
187622|NCT00025233|576271|P1|Overall Study|Never treated|1
187623|NCT00025233|576271|P1|Overall Study|Ineligible: improper prior treatment|1
187624|NCT00025233|576271|P1|Overall Study|Ineligible: wrong primary|1
187625|NCT00025233|576271|P1|Overall Study|Ineligible: wrong cell type|1
187626|NCT00025155|576277|P1|Overall Study|Ineligible: Second primary cancer site|1
187627|NCT00025155|576277|P1|Overall Study|Ineligible: Wrong primary cancer site|1
187628|NCT00024258|576283|P1|Overall Study|Disease Progression|8
187629|NCT00024258|576283|P1|Overall Study|Withdrawal by Subject|1
187630|NCT00024167|576290|P2|Overall Study|Death|47
187631|NCT00024167|576291|P1|Overall Study|Death|53
187632|NCT00023764|576315|P1|Overall Study|delay in obtaining staging images|1
187633|NCT00023764|576315|P1|Overall Study|patient received other treatment|1
187634|NCT00023764|576315|P1|Overall Study|Progression of disease|6
187635|NCT00023764|576315|P1|Overall Study|Withdrawal by Subject|1
187636|NCT00023764|576315|P1|Overall Study|Adverse Event|4
187637|NCT00023764|576315|P1|Overall Study|Other|1
187638|NCT00023712|576322|P2|Overall Study|Never treated|1
187639|NCT00023712|576323|P1|Overall Study|Never treated|1
187640|NCT00023712|576322|P2|Overall Study|Not platinum sensitive|0
187641|NCT00023712|576323|P1|Overall Study|Not platinum sensitive|1
187642|NCT00023673|576338|P4|Overall Study|Patient withdrew consent|1
187643|NCT00023673|576339|P3|Overall Study|Patient withdrew consent|0
187644|NCT00023673|576340|P2|Overall Study|Patient withdrew consent|0
187645|NCT00023673|576341|P1|Overall Study|Patient withdrew consent|0
187646|NCT00023673|576338|P4|Overall Study|Ineligible / no protocol treatment|1
187647|NCT00023673|576339|P3|Overall Study|Ineligible / no protocol treatment|0
187648|NCT00023673|576340|P2|Overall Study|Ineligible / no protocol treatment|0
187649|NCT00023673|576341|P1|Overall Study|Ineligible / no protocol treatment|0
187650|NCT00023452|576350|P2|Overall Study|Other|69
187651|NCT00023452|576351|P1|Overall Study|Other|204
187652|NCT00023452|576350|P2|Overall Study|Pregnant|20
187653|NCT00023452|576351|P1|Overall Study|Pregnant|53
187654|NCT00023452|576350|P2|Overall Study|Refused Treatment (continued follow-up)|224
187655|NCT00023452|576351|P1|Overall Study|Refused Treatment (continued follow-up)|225
187656|NCT00023452|576350|P2|Overall Study|Physician Decision|21
187657|NCT00023452|576351|P1|Overall Study|Physician Decision|49
187658|NCT00023452|576350|P2|Overall Study|Lost to Follow-up|60
187659|NCT00023452|576351|P1|Overall Study|Lost to Follow-up|293
187660|NCT00023452|576350|P2|Overall Study|Adverse Event|196
187661|NCT00023452|576351|P1|Overall Study|Adverse Event|139
187662|NCT00023452|576350|P2|Overall Study|Withdrawal by Subject|54
187663|NCT00023452|576351|P1|Overall Study|Withdrawal by Subject|66
187664|NCT00023452|576350|P2|Overall Study|Death|0
187665|NCT00023452|576351|P1|Overall Study|Death|2
187666|NCT00023452|576350|P2|Overall Study|Out of Window|69
187667|NCT00023452|576351|P1|Overall Study|Out of Window|129
187668|NCT00023452|576350|P2|Overall Study|Ineligible for Study|159
187669|NCT00023452|576351|P1|Overall Study|Ineligible for Study|163
187670|NCT00023322|576375|P1|Overall Study|Lost to Follow-up|1
187671|NCT00022763|576399|P2|Overall Study|Admin|2
187672|NCT00022763|576400|P1|Overall Study|Admin|3
187673|NCT00022763|576399|P2|Overall Study|Insufficient Therapy|0
187674|NCT00022763|576400|P1|Overall Study|Insufficient Therapy|1
187675|NCT00022763|576399|P2|Overall Study|Withdrawal by Subject|7
187676|NCT00022763|576400|P1|Overall Study|Withdrawal by Subject|4
187677|NCT00022763|576399|P2|Overall Study|Lost to Follow-up|3
187678|NCT00022763|576400|P1|Overall Study|Lost to Follow-up|0
187679|NCT00022763|576399|P2|Overall Study|Death|1
187680|NCT00022763|576400|P1|Overall Study|Death|0
187681|NCT00022763|576399|P2|Overall Study|Injection Site Reactions|2
187682|NCT00022763|576400|P1|Overall Study|Injection Site Reactions|0
187683|NCT00022763|576399|P2|Overall Study|Adverse Event|2
187684|NCT00022763|576400|P1|Overall Study|Adverse Event|1
187685|NCT00022698|576425|P2|Overall Study|Administrative /other|7
187686|NCT00022698|576426|P1|Overall Study|Administrative /other|1
187687|NCT00022698|576425|P2|Overall Study|Insufficient therapeutic response|14
187688|NCT00022698|576426|P1|Overall Study|Insufficient therapeutic response|2
187689|NCT00022698|576425|P2|Overall Study|Refused treatment|2
187690|NCT00022698|576426|P1|Overall Study|Refused treatment|0
187691|NCT00022698|576425|P2|Overall Study|Failure to return|1
187692|NCT00022698|576426|P1|Overall Study|Failure to return|0
187693|NCT00022698|576425|P2|Overall Study|Death|2
187694|NCT00022698|576426|P1|Overall Study|Death|0
187695|NCT00022698|576425|P2|Overall Study|Adverse Event|9
187696|NCT00022698|576426|P1|Overall Study|Adverse Event|5
187697|NCT00022672|576451|P2|Extension Phase|Other|1
187698|NCT00022672|576452|P1|Extension Phase|Other|1
187699|NCT00022672|576451|P2|Extension Phase|Refused Treatment|2
187700|NCT00022672|576452|P1|Extension Phase|Refused Treatment|0
187701|NCT00022672|576451|P2|Extension Phase|Insufficient Therapeutic Response|44
187702|NCT00022672|576452|P1|Extension Phase|Insufficient Therapeutic Response|1
187703|NCT00022672|576451|P2|Extension Phase|Death|1
187704|NCT00022672|576452|P1|Extension Phase|Death|0
187705|NCT00022672|576451|P2|Extension Phase|Adverse Event|3
187706|NCT00022672|576452|P1|Extension Phase|Adverse Event|1
187707|NCT00022672|576451|P2|Main Phase: 24 Months|Other|0
187708|NCT00022672|576452|P1|Main Phase: 24 Months|Other|1
187709|NCT00022672|576451|P2|Main Phase: 24 Months|Failure to Return|1
187710|NCT00022672|576452|P1|Main Phase: 24 Months|Failure to Return|1
187711|NCT00022672|576451|P2|Main Phase: 24 Months|Refused Treatment|4
187712|NCT00022672|576452|P1|Main Phase: 24 Months|Refused Treatment|3
187713|NCT00022672|576451|P2|Main Phase: 24 Months|Other Protocol Violation|0
187714|NCT00022672|576452|P1|Main Phase: 24 Months|Other Protocol Violation|1
187715|NCT00022672|576451|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
187716|NCT00022672|576452|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
187717|NCT00022672|576451|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
187718|NCT00022672|576452|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
187719|NCT00022672|576451|P2|Main Phase: 24 Months|Death|3
187720|NCT00022672|576452|P1|Main Phase: 24 Months|Death|0
187721|NCT00022672|576451|P2|Main Phase: 24 Months|Adverse Event|0
187722|NCT00022672|576452|P1|Main Phase: 24 Months|Adverse Event|6
187723|NCT00022659|576485|P1|Overall Study|Never treated|1
187724|NCT00022659|576485|P1|Overall Study|Ineligible: wrong primary|1
187725|NCT00022633|576493|P2|Overall Study|Ineligible|0
187726|NCT00022633|576494|P1|Overall Study|Ineligible|4
187727|NCT00022633|576493|P2|Overall Study|Other - not protocol specified|2
187728|NCT00022633|576494|P1|Overall Study|Other - not protocol specified|3
187729|NCT00022633|576493|P2|Overall Study|Death|0
187730|NCT00022633|576494|P1|Overall Study|Death|4
187731|NCT00022633|576493|P2|Overall Study|Progression/relapse|2
187732|NCT00022633|576494|P1|Overall Study|Progression/relapse|9
187733|NCT00022633|576493|P2|Overall Study|Refusal unrelated to adverse event|0
187734|NCT00022633|576494|P1|Overall Study|Refusal unrelated to adverse event|1
187735|NCT00022633|576493|P2|Overall Study|Adverse Event|1
187736|NCT00022633|576494|P1|Overall Study|Adverse Event|11
187737|NCT00022516|576507|P2|Overall Study|Incomplete documentation|27
187738|NCT00022516|576508|P1|Overall Study|Incomplete documentation|0
187739|NCT00022516|576507|P2|Overall Study|Withdrawal by Subject|113
187740|NCT00022516|576508|P1|Overall Study|Withdrawal by Subject|2
187741|NCT00022516|576507|P2|Overall Study|Protocol Violation|3
187742|NCT00022516|576508|P1|Overall Study|Protocol Violation|1
187743|NCT00022516|576507|P2|Overall Study|Physician Decision|1
187744|NCT00022516|576508|P1|Overall Study|Physician Decision|0
187745|NCT00022516|576507|P2|Overall Study|Lack of Efficacy|27
187746|NCT00022516|576508|P1|Overall Study|Lack of Efficacy|0
187747|NCT00022516|576507|P2|Overall Study|Adverse Event|59
187748|NCT00022516|576508|P1|Overall Study|Adverse Event|0
187749|NCT00021541|576526|P2|Period 2-crossover|Pts that did not progress|3
187750|NCT00021541|576527|P1|Period 2-crossover|Pts that did not progress|2
187751|NCT00021541|576526|P2|Period 2-crossover|non-adherence|0
187752|NCT00021541|576527|P1|Period 2-crossover|non-adherence|1
187753|NCT00021541|576526|P2|Period 2-crossover|Adverse Event|2
187754|NCT00021541|576527|P1|Period 2-crossover|Adverse Event|2
187755|NCT00021541|576526|P2|Period 2-crossover|Withdrawal by Subject|4
187756|NCT00021541|576527|P1|Period 2-crossover|Withdrawal by Subject|3
187757|NCT00021541|576526|P2|Period 2-crossover|refused phase B|2
187758|NCT00021541|576527|P1|Period 2-crossover|refused phase B|2
187759|NCT00021541|576526|P2|Period 1-First Treatment|Ineligible|2
187760|NCT00021541|576527|P1|Period 1-First Treatment|Ineligible|0
187761|NCT00021541|576526|P2|Period 1-First Treatment|Pts that did not progress|2
187762|NCT00021541|576527|P1|Period 1-First Treatment|Pts that did not progress|2
187763|NCT00021541|576526|P2|Period 1-First Treatment|Death|0
187764|NCT00021541|576527|P1|Period 1-First Treatment|Death|1
187765|NCT00021541|576526|P2|Period 1-First Treatment|non-adherence|0
187766|NCT00021541|576527|P1|Period 1-First Treatment|non-adherence|3
187767|NCT00021541|576526|P2|Period 1-First Treatment|Adverse Event|1
187768|NCT00021541|576527|P1|Period 1-First Treatment|Adverse Event|2
187769|NCT00021541|576526|P2|Period 1-First Treatment|Withdrawal by Subject|3
187770|NCT00021541|576527|P1|Period 1-First Treatment|Withdrawal by Subject|3
187771|NCT00021255|576536|P3|Overall Study|Randomized but not treated|18
187772|NCT00021255|576537|P2|Overall Study|Randomized but not treated|2
187773|NCT00021255|576538|P1|Overall Study|Randomized but not treated|28
187774|NCT00021255|576536|P3|Overall Study|Missing|13
187775|NCT00021255|576537|P2|Overall Study|Missing|27
187776|NCT00021255|576538|P1|Overall Study|Missing|0
187777|NCT00021255|576536|P3|Overall Study|Other than specified above|19
187778|NCT00021255|576537|P2|Overall Study|Other than specified above|38
187779|NCT00021255|576538|P1|Overall Study|Other than specified above|0
187780|NCT00021255|576536|P3|Overall Study|Protocol Violation|0
187781|NCT00021255|576537|P2|Overall Study|Protocol Violation|2
187782|NCT00021255|576538|P1|Overall Study|Protocol Violation|0
187783|NCT00021255|576536|P3|Overall Study|Adverse Event|18
187784|NCT00021255|576537|P2|Overall Study|Adverse Event|30
187785|NCT00021255|576538|P1|Overall Study|Adverse Event|46
187786|NCT00021255|576536|P3|Overall Study|Herceptin toxicity|6
187787|NCT00021255|576537|P2|Overall Study|Herceptin toxicity|22
187788|NCT00021255|576538|P1|Overall Study|Herceptin toxicity|0
187789|NCT00021255|576536|P3|Overall Study|Cardiac toxicity|32
187790|NCT00021255|576537|P2|Overall Study|Cardiac toxicity|61
187791|NCT00021255|576538|P1|Overall Study|Cardiac toxicity|0
187792|NCT00021255|576536|P3|Overall Study|Lost to Follow-up|3
187793|NCT00021255|576537|P2|Overall Study|Lost to Follow-up|2
187794|NCT00021255|576538|P1|Overall Study|Lost to Follow-up|0
187795|NCT00021255|576536|P3|Overall Study|Withdrawal by Subject|26
187796|NCT00021255|576537|P2|Overall Study|Withdrawal by Subject|64
187797|NCT00021255|576538|P1|Overall Study|Withdrawal by Subject|41
187798|NCT00021255|576536|P3|Overall Study|Second primary malignancy|1
187799|NCT00021255|576537|P2|Overall Study|Second primary malignancy|4
187800|NCT00021255|576538|P1|Overall Study|Second primary malignancy|0
187801|NCT00021255|576536|P3|Overall Study|Breast cancer relapse|11
187802|NCT00021255|576537|P2|Overall Study|Breast cancer relapse|18
187803|NCT00021255|576538|P1|Overall Study|Breast cancer relapse|5
187804|NCT00021255|576536|P3|Overall Study|Death|2
187805|NCT00021255|576537|P2|Overall Study|Death|0
187806|NCT00021255|576538|P1|Overall Study|Death|1
187807|NCT00021229|576555|P3|Overall Study|Punctate hemmorrhage post RT|0
187808|NCT00021229|576556|P2|Overall Study|Punctate hemmorrhage post RT|0
187809|NCT00021229|576557|P1|Overall Study|Punctate hemmorrhage post RT|2
187810|NCT00021229|576555|P3|Overall Study|Physician Decision|1
187811|NCT00021229|576556|P2|Overall Study|Physician Decision|0
187812|NCT00021229|576557|P1|Overall Study|Physician Decision|0
187813|NCT00021229|576555|P3|Overall Study|Protocol Violation|0
187814|NCT00021229|576556|P2|Overall Study|Protocol Violation|1
187815|NCT00021229|576557|P1|Overall Study|Protocol Violation|1
187816|NCT00021229|576555|P3|Overall Study|Progressive Disease|12
187817|NCT00021229|576556|P2|Overall Study|Progressive Disease|19
187818|NCT00021229|576557|P1|Overall Study|Progressive Disease|15
187819|NCT00021229|576555|P3|Overall Study|Withdrawal by Subject|1
187820|NCT00021229|576556|P2|Overall Study|Withdrawal by Subject|7
187821|NCT00021229|576557|P1|Overall Study|Withdrawal by Subject|7
187822|NCT00021229|576555|P3|Overall Study|Death|0
187823|NCT00021229|576556|P2|Overall Study|Death|1
187824|NCT00021229|576557|P1|Overall Study|Death|0
187825|NCT00021229|576555|P3|Overall Study|Adverse Event|2
187826|NCT00021229|576556|P2|Overall Study|Adverse Event|5
187827|NCT00021229|576557|P1|Overall Study|Adverse Event|10
187828|NCT00019604|576597|P1|Overall Study|Details for other not available|4
187829|NCT00019604|576597|P1|Overall Study|Unable to evaluate|1
187830|NCT00019604|576597|P1|Overall Study|Too much disease|1
187831|NCT00019604|576597|P1|Overall Study|Pt going to immunotherapy study|1
187832|NCT00019604|576597|P1|Overall Study|Started new chemo regimen|1
187833|NCT00019604|576597|P1|Overall Study|Resectable disease|1
187834|NCT00019604|576597|P1|Overall Study|Non compliant|1
187835|NCT00019604|576597|P1|Overall Study|Non compliant on systemic CH|1
187836|NCT00019604|576597|P1|Overall Study|Move to a different study|1
187837|NCT00019604|576597|P1|Overall Study|Going to have liver transplant|1
187838|NCT00019604|576597|P1|Overall Study|Carcinoid tumor, not treatable|1
187839|NCT00019604|576597|P1|Overall Study|Refused treatment|1
187840|NCT00019604|576597|P1|Overall Study|Progressive disease|23
187841|NCT00019604|576597|P1|Overall Study|Death|1
187842|NCT00016354|576624|P8|Overall Study|Lack of Efficacy|1
187843|NCT00016354|576625|P7|Overall Study|Lack of Efficacy|0
187844|NCT00016354|576626|P6|Overall Study|Lack of Efficacy|0
187845|NCT00016354|576627|P5|Overall Study|Lack of Efficacy|0
187846|NCT00016354|576628|P4|Overall Study|Lack of Efficacy|0
187847|NCT00016354|576629|P3|Overall Study|Lack of Efficacy|0
187848|NCT00016354|576630|P2|Overall Study|Lack of Efficacy|0
187849|NCT00016354|576631|P1|Overall Study|Lack of Efficacy|0
187850|NCT00014495|576645|P4|Overall Study|Clinical deterioration|1
187851|NCT00014495|576646|P3|Overall Study|Clinical deterioration|0
187852|NCT00014495|576647|P2|Overall Study|Clinical deterioration|0
187853|NCT00014495|576648|P1|Overall Study|Clinical deterioration|0
187854|NCT00014495|576645|P4|Overall Study|Death|0
187855|NCT00014495|576646|P3|Overall Study|Death|1
187856|NCT00014495|576647|P2|Overall Study|Death|0
187857|NCT00014495|576648|P1|Overall Study|Death|0
187858|NCT00015457|576655|P2|Second Intervention|Withdrawal by Subject|0
187859|NCT00015457|576656|P1|Second Intervention|Withdrawal by Subject|1
187860|NCT00015457|576655|P2|First Intervention|Lack of Efficacy|1
187861|NCT00015457|576656|P1|First Intervention|Lack of Efficacy|0
187862|NCT00015457|576655|P2|First Intervention|Adverse Event|2
187863|NCT00015457|576656|P1|First Intervention|Adverse Event|0
187864|NCT00014911|576664|P1|Overall Study|Immunosuppression-related Side Effects|1
187865|NCT00014911|576664|P1|Overall Study|Unknown Reasons|2
187866|NCT00014911|576664|P1|Overall Study|Withdrawal by Subject|6
187867|NCT00014911|576664|P1|Overall Study|Lost to Follow-up|1
187868|NCT00014911|576664|P1|Overall Study|Adverse Event|1
187869|NCT00013611|576679|P2|Overall Study|Lost to Follow-up|100
187870|NCT00013611|576680|P1|Overall Study|Lost to Follow-up|91
187871|NCT00012012|576733|P2|Overall Study|Withdrawal by Subject|2
187872|NCT00012012|576734|P1|Overall Study|Withdrawal by Subject|0
187873|NCT00012012|576733|P2|Overall Study|Protocol Violation|1
187874|NCT00012012|576734|P1|Overall Study|Protocol Violation|1
187875|NCT00010803|576763|P2|Overall Study|Withdrawal by Subject|98
187876|NCT00010803|576764|P1|Overall Study|Withdrawal by Subject|97
187877|NCT00010257|576781|P2|Overall Study|Withdrawal by Subject|0
187878|NCT00010257|576782|P1|Overall Study|Withdrawal by Subject|1
187879|NCT00009737|576792|P2|Overall Study|Administrative/Other Reasons|1
187880|NCT00009737|576793|P1|Overall Study|Administrative/Other Reasons|7
187881|NCT00009737|576792|P2|Overall Study|Lost to Follow-up|1
187882|NCT00009737|576793|P1|Overall Study|Lost to Follow-up|1
187883|NCT00009737|576792|P2|Overall Study|Refused Treatment|16
187884|NCT00009737|576793|P1|Overall Study|Refused Treatment|15
187885|NCT00009737|576792|P2|Overall Study|Other Protocol Violation|0
187886|NCT00009737|576793|P1|Overall Study|Other Protocol Violation|1
187887|NCT00009737|576792|P2|Overall Study|Violation of Selection Criteria at Entry|9
187888|NCT00009737|576793|P1|Overall Study|Violation of Selection Criteria at Entry|13
187889|NCT00009737|576792|P2|Overall Study|Lack of Efficacy|15
187890|NCT00009737|576793|P1|Overall Study|Lack of Efficacy|17
187891|NCT00009737|576792|P2|Overall Study|Death|6
187892|NCT00009737|576793|P1|Overall Study|Death|4
187893|NCT00009737|576792|P2|Overall Study|Adverse Event|75
187894|NCT00009737|576793|P1|Overall Study|Adverse Event|112
187895|NCT00008385|576811|P2|Overall Study|Not start protocol therapy|175
187896|NCT00008385|576812|P1|Overall Study|Not start protocol therapy|44
187897|NCT00008385|576811|P2|Overall Study|Not specified|212
187898|NCT00008385|576812|P1|Overall Study|Not specified|105
187899|NCT00008385|576811|P2|Overall Study|Maximum dose reached|2
187900|NCT00008385|576812|P1|Overall Study|Maximum dose reached|0
187901|NCT00008385|576811|P2|Overall Study|Other complicating disease|30
187902|NCT00008385|576812|P1|Overall Study|Other complicating disease|17
187903|NCT00008385|576811|P2|Overall Study|Start non-protocol therapy|1
187904|NCT00008385|576812|P1|Overall Study|Start non-protocol therapy|3
187905|NCT00008385|576811|P2|Overall Study|Withdrawal by Subject|157
187906|NCT00008385|576812|P1|Overall Study|Withdrawal by Subject|67
187907|NCT00008385|576811|P2|Overall Study|Death|18
187908|NCT00008385|576812|P1|Overall Study|Death|12
187909|NCT00008385|576811|P2|Overall Study|Adverse Event|20
187910|NCT00008385|576812|P1|Overall Study|Adverse Event|8
187911|NCT00008385|576811|P2|Overall Study|Progressive disease|117
187912|NCT00008385|576812|P1|Overall Study|Progressive disease|52
187913|NCT00008385|576811|P2|Overall Study|Off treatment reasons not reported|70
187914|NCT00008385|576812|P1|Overall Study|Off treatment reasons not reported|79
187915|NCT00008138|576822|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
187916|NCT00008138|576822|P1|Post-Cytoreduction Chemotherapy|Progression|1
187917|NCT00008138|576822|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
187918|NCT00008138|576822|P1|Interval Debulking|Withdrawal by Subject|2
187919|NCT00008138|576822|P1|Neoadjuvant Chemotherapy|not protocol specified|8
187920|NCT00008138|576822|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
187921|NCT00008138|576822|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
187922|NCT00008138|576822|P1|Neoadjuvant Chemotherapy|Adverse Event|3
187923|NCT00007475|576840|P4|Overall Study|Adverse Event|0
187924|NCT00007475|576841|P3|Overall Study|Adverse Event|0
187925|NCT00007475|576842|P2|Overall Study|Adverse Event|0
187926|NCT00007475|576843|P1|Overall Study|Adverse Event|3
187927|NCT00007475|576840|P4|Overall Study|Withdrawal by Subject|0
187928|NCT00007475|576841|P3|Overall Study|Withdrawal by Subject|0
187929|NCT00007475|576842|P2|Overall Study|Withdrawal by Subject|0
187930|NCT00007475|576843|P1|Overall Study|Withdrawal by Subject|1
187931|NCT00007345|576865|P2|Overall Study|Death on study|1
187932|NCT00007345|576866|P1|Overall Study|Death on study|1
187933|NCT00007345|576865|P2|Overall Study|Intercurrent illness|0
187934|NCT00007345|576866|P1|Overall Study|Intercurrent illness|1
187935|NCT00007345|576865|P2|Overall Study|Switched to alternative treatment|3
187936|NCT00007345|576866|P1|Overall Study|Switched to alternative treatment|0
187937|NCT00007345|576865|P2|Overall Study|Refused further treatment|7
187938|NCT00007345|576866|P1|Overall Study|Refused further treatment|0
187939|NCT00006916|576876|P1|Overall Study|Complication of device insertion|1
187940|NCT00006916|576876|P1|Overall Study|Device not inserted|4
187941|NCT00006903|576882|P3|Overall Study|Ineligible|2
187942|NCT00006903|576883|P2|Overall Study|Ineligible|1
187943|NCT00006903|576884|P1|Overall Study|Ineligible|10
187944|NCT00006903|576882|P3|Overall Study|Patient never treated|1
187945|NCT00006903|576883|P2|Overall Study|Patient never treated|0
187946|NCT00006903|576884|P1|Overall Study|Patient never treated|0
187947|NCT00006903|576882|P3|Overall Study|Death|0
187948|NCT00006903|576883|P2|Overall Study|Death|1
187949|NCT00006903|576884|P1|Overall Study|Death|0
187950|NCT00006903|576882|P3|Overall Study|Adverse Event|1
187951|NCT00006903|576883|P2|Overall Study|Adverse Event|0
187952|NCT00006903|576884|P1|Overall Study|Adverse Event|0
187953|NCT00006903|576882|P3|Overall Study|Refused further treatment|1
187954|NCT00006903|576883|P2|Overall Study|Refused further treatment|2
187955|NCT00006903|576884|P1|Overall Study|Refused further treatment|0
187956|NCT00006903|576882|P3|Overall Study|Still receiving treatment|1
187957|NCT00006903|576883|P2|Overall Study|Still receiving treatment|0
187958|NCT00006903|576884|P1|Overall Study|Still receiving treatment|0
187959|NCT00006721|576892|P3|Overall Study|Eligible but no Treatment Received|0
187960|NCT00006721|576893|P2|Overall Study|Eligible but no Treatment Received|0
187961|NCT00006721|576894|P1|Overall Study|Eligible but no Treatment Received|1
187962|NCT00006721|576892|P3|Overall Study|Ineligible|10
187963|NCT00006721|576893|P2|Overall Study|Ineligible|12
187964|NCT00006721|576894|P1|Overall Study|Ineligible|2
187965|NCT00006721|576892|P3|Overall Study|Other - Not Protocol Specified|7
187966|NCT00006721|576893|P2|Overall Study|Other - Not Protocol Specified|7
187967|NCT00006721|576894|P1|Overall Study|Other - Not Protocol Specified|0
187968|NCT00006721|576892|P3|Overall Study|Death|2
187969|NCT00006721|576893|P2|Overall Study|Death|1
187970|NCT00006721|576894|P1|Overall Study|Death|0
187971|NCT00006721|576892|P3|Overall Study|Progression/Relapse|2
187972|NCT00006721|576893|P2|Overall Study|Progression/Relapse|1
187973|NCT00006721|576894|P1|Overall Study|Progression/Relapse|0
187974|NCT00006721|576892|P3|Overall Study|Refusal Unrelated to Adverse Event|8
187975|NCT00006721|576893|P2|Overall Study|Refusal Unrelated to Adverse Event|0
187976|NCT00006721|576894|P1|Overall Study|Refusal Unrelated to Adverse Event|1
187977|NCT00006721|576892|P3|Overall Study|Adverse Event|4
187978|NCT00006721|576893|P2|Overall Study|Adverse Event|4
187979|NCT00006721|576894|P1|Overall Study|Adverse Event|0
187980|NCT00006604|576919|P17|Overall Study|Other Reason|0
187981|NCT00006604|576920|P16|Overall Study|Other Reason|0
187982|NCT00006604|576921|P15|Overall Study|Other Reason|0
187983|NCT00006604|576922|P14|Overall Study|Other Reason|0
187984|NCT00006604|576923|P13|Overall Study|Other Reason|0
187985|NCT00006604|576924|P12|Overall Study|Other Reason|0
187986|NCT00006604|576925|P11|Overall Study|Other Reason|0
187987|NCT00006604|576926|P10|Overall Study|Other Reason|1
187988|NCT00006604|576927|P9|Overall Study|Other Reason|0
187989|NCT00006604|576928|P8|Overall Study|Other Reason|0
187990|NCT00006604|576929|P7|Overall Study|Other Reason|0
187991|NCT00006604|576930|P6|Overall Study|Other Reason|1
187992|NCT00006604|576931|P5|Overall Study|Other Reason|0
187993|NCT00006604|576932|P4|Overall Study|Other Reason|0
187994|NCT00006604|576933|P3|Overall Study|Other Reason|0
187995|NCT00006604|576934|P2|Overall Study|Other Reason|0
187996|NCT00006604|576935|P1|Overall Study|Other Reason|0
187997|NCT00006604|576919|P17|Overall Study|Lost to Follow-up|3
187998|NCT00006604|576920|P16|Overall Study|Lost to Follow-up|1
187999|NCT00006604|576921|P15|Overall Study|Lost to Follow-up|0
188000|NCT00006604|576922|P14|Overall Study|Lost to Follow-up|0
188001|NCT00006604|576923|P13|Overall Study|Lost to Follow-up|0
188002|NCT00006604|576924|P12|Overall Study|Lost to Follow-up|0
188003|NCT00006604|576925|P11|Overall Study|Lost to Follow-up|0
188004|NCT00006604|576926|P10|Overall Study|Lost to Follow-up|2
188005|NCT00006604|576927|P9|Overall Study|Lost to Follow-up|0
188006|NCT00006604|576928|P8|Overall Study|Lost to Follow-up|1
188007|NCT00006604|576929|P7|Overall Study|Lost to Follow-up|0
188008|NCT00006604|576930|P6|Overall Study|Lost to Follow-up|0
188009|NCT00006604|576931|P5|Overall Study|Lost to Follow-up|0
188010|NCT00006604|576932|P4|Overall Study|Lost to Follow-up|0
188011|NCT00006604|576933|P3|Overall Study|Lost to Follow-up|0
188012|NCT00006604|576934|P2|Overall Study|Lost to Follow-up|0
188013|NCT00006604|576935|P1|Overall Study|Lost to Follow-up|0
188014|NCT00006604|576919|P17|Overall Study|Subj/parent not willing to adhere to req|4
188015|NCT00006604|576920|P16|Overall Study|Subj/parent not willing to adhere to req|3
188016|NCT00006604|576921|P15|Overall Study|Subj/parent not willing to adhere to req|3
188017|NCT00006604|576922|P14|Overall Study|Subj/parent not willing to adhere to req|2
188018|NCT00006604|576923|P13|Overall Study|Subj/parent not willing to adhere to req|0
188019|NCT00006604|576924|P12|Overall Study|Subj/parent not willing to adhere to req|0
188020|NCT00006604|576925|P11|Overall Study|Subj/parent not willing to adhere to req|3
188021|NCT00006604|576926|P10|Overall Study|Subj/parent not willing to adhere to req|6
188022|NCT00006604|576927|P9|Overall Study|Subj/parent not willing to adhere to req|0
188023|NCT00006604|576928|P8|Overall Study|Subj/parent not willing to adhere to req|1
188024|NCT00006604|576929|P7|Overall Study|Subj/parent not willing to adhere to req|3
188025|NCT00006604|576930|P6|Overall Study|Subj/parent not willing to adhere to req|0
188026|NCT00006604|576931|P5|Overall Study|Subj/parent not willing to adhere to req|0
188027|NCT00006604|576932|P4|Overall Study|Subj/parent not willing to adhere to req|3
188028|NCT00006604|576933|P3|Overall Study|Subj/parent not willing to adhere to req|1
188029|NCT00006604|576934|P2|Overall Study|Subj/parent not willing to adhere to req|0
188030|NCT00006604|576935|P1|Overall Study|Subj/parent not willing to adhere to req|0
188031|NCT00006604|576919|P17|Overall Study|Withdrawal by Subject|1
188032|NCT00006604|576920|P16|Overall Study|Withdrawal by Subject|0
188033|NCT00006604|576921|P15|Overall Study|Withdrawal by Subject|1
188034|NCT00006604|576922|P14|Overall Study|Withdrawal by Subject|2
188035|NCT00006604|576923|P13|Overall Study|Withdrawal by Subject|1
188036|NCT00006604|576924|P12|Overall Study|Withdrawal by Subject|0
188037|NCT00006604|576925|P11|Overall Study|Withdrawal by Subject|2
188038|NCT00006604|576926|P10|Overall Study|Withdrawal by Subject|3
188039|NCT00006604|576927|P9|Overall Study|Withdrawal by Subject|1
188040|NCT00006604|576928|P8|Overall Study|Withdrawal by Subject|0
188041|NCT00006604|576929|P7|Overall Study|Withdrawal by Subject|2
188042|NCT00006604|576930|P6|Overall Study|Withdrawal by Subject|2
188043|NCT00006604|576931|P5|Overall Study|Withdrawal by Subject|1
188044|NCT00006604|576932|P4|Overall Study|Withdrawal by Subject|0
188045|NCT00006604|576933|P3|Overall Study|Withdrawal by Subject|2
188046|NCT00006604|576934|P2|Overall Study|Withdrawal by Subject|0
188047|NCT00006604|576935|P1|Overall Study|Withdrawal by Subject|1
188048|NCT00006604|576919|P17|Overall Study|Site closing|1
188049|NCT00006604|576920|P16|Overall Study|Site closing|0
188050|NCT00006604|576921|P15|Overall Study|Site closing|0
188051|NCT00006604|576922|P14|Overall Study|Site closing|1
188052|NCT00006604|576923|P13|Overall Study|Site closing|1
188053|NCT00006604|576924|P12|Overall Study|Site closing|1
188054|NCT00006604|576925|P11|Overall Study|Site closing|0
188055|NCT00006604|576926|P10|Overall Study|Site closing|0
188056|NCT00006604|576927|P9|Overall Study|Site closing|0
188057|NCT00006604|576928|P8|Overall Study|Site closing|1
188058|NCT00006604|576929|P7|Overall Study|Site closing|0
188059|NCT00006604|576930|P6|Overall Study|Site closing|0
188060|NCT00006604|576931|P5|Overall Study|Site closing|0
188061|NCT00006604|576932|P4|Overall Study|Site closing|1
188062|NCT00006604|576933|P3|Overall Study|Site closing|1
188063|NCT00006604|576934|P2|Overall Study|Site closing|0
188064|NCT00006604|576935|P1|Overall Study|Site closing|0
188065|NCT00006604|576919|P17|Overall Study|Subj/Parent not able to get to clinic|0
188066|NCT00006604|576920|P16|Overall Study|Subj/Parent not able to get to clinic|0
188067|NCT00006604|576921|P15|Overall Study|Subj/Parent not able to get to clinic|3
188068|NCT00006604|576922|P14|Overall Study|Subj/Parent not able to get to clinic|1
188069|NCT00006604|576923|P13|Overall Study|Subj/Parent not able to get to clinic|1
188070|NCT00006604|576924|P12|Overall Study|Subj/Parent not able to get to clinic|1
188071|NCT00006604|576925|P11|Overall Study|Subj/Parent not able to get to clinic|2
188072|NCT00006604|576926|P10|Overall Study|Subj/Parent not able to get to clinic|1
188073|NCT00006604|576927|P9|Overall Study|Subj/Parent not able to get to clinic|0
188074|NCT00006604|576928|P8|Overall Study|Subj/Parent not able to get to clinic|0
188075|NCT00006604|576929|P7|Overall Study|Subj/Parent not able to get to clinic|1
188076|NCT00006604|576930|P6|Overall Study|Subj/Parent not able to get to clinic|0
188077|NCT00006604|576931|P5|Overall Study|Subj/Parent not able to get to clinic|1
188078|NCT00006604|576932|P4|Overall Study|Subj/Parent not able to get to clinic|1
188079|NCT00006604|576933|P3|Overall Study|Subj/Parent not able to get to clinic|0
188080|NCT00006604|576934|P2|Overall Study|Subj/Parent not able to get to clinic|0
188081|NCT00006604|576935|P1|Overall Study|Subj/Parent not able to get to clinic|0
188082|NCT00006604|576919|P17|Overall Study|Severe debilitation, unable to continue|0
188083|NCT00006604|576920|P16|Overall Study|Severe debilitation, unable to continue|0
188084|NCT00006604|576921|P15|Overall Study|Severe debilitation, unable to continue|2
188085|NCT00006604|576922|P14|Overall Study|Severe debilitation, unable to continue|0
188086|NCT00006604|576923|P13|Overall Study|Severe debilitation, unable to continue|1
188087|NCT00006604|576924|P12|Overall Study|Severe debilitation, unable to continue|2
188088|NCT00006604|576925|P11|Overall Study|Severe debilitation, unable to continue|0
188089|NCT00006604|576926|P10|Overall Study|Severe debilitation, unable to continue|5
188090|NCT00006604|576927|P9|Overall Study|Severe debilitation, unable to continue|0
188091|NCT00006604|576928|P8|Overall Study|Severe debilitation, unable to continue|0
188092|NCT00006604|576929|P7|Overall Study|Severe debilitation, unable to continue|3
188093|NCT00006604|576930|P6|Overall Study|Severe debilitation, unable to continue|0
188094|NCT00006604|576931|P5|Overall Study|Severe debilitation, unable to continue|0
188095|NCT00006604|576932|P4|Overall Study|Severe debilitation, unable to continue|0
188096|NCT00006604|576933|P3|Overall Study|Severe debilitation, unable to continue|0
188097|NCT00006604|576934|P2|Overall Study|Severe debilitation, unable to continue|0
188098|NCT00006604|576935|P1|Overall Study|Severe debilitation, unable to continue|0
188099|NCT00006604|576919|P17|Overall Study|Death|0
188100|NCT00006604|576920|P16|Overall Study|Death|0
188101|NCT00006604|576921|P15|Overall Study|Death|0
188102|NCT00006604|576922|P14|Overall Study|Death|0
188103|NCT00006604|576923|P13|Overall Study|Death|0
188104|NCT00006604|576924|P12|Overall Study|Death|1
188105|NCT00006604|576925|P11|Overall Study|Death|1
188106|NCT00006604|576926|P10|Overall Study|Death|1
188107|NCT00006604|576927|P9|Overall Study|Death|0
188108|NCT00006604|576928|P8|Overall Study|Death|0
188109|NCT00006604|576929|P7|Overall Study|Death|0
188110|NCT00006604|576930|P6|Overall Study|Death|0
188111|NCT00006604|576931|P5|Overall Study|Death|0
188112|NCT00006604|576932|P4|Overall Study|Death|0
188113|NCT00006604|576933|P3|Overall Study|Death|0
188114|NCT00006604|576934|P2|Overall Study|Death|0
188115|NCT00006604|576935|P1|Overall Study|Death|0
188116|NCT00006604|576919|P17|Overall Study|Randomization entry error-no RX, no FU|0
188117|NCT00006604|576920|P16|Overall Study|Randomization entry error-no RX, no FU|0
188118|NCT00006604|576921|P15|Overall Study|Randomization entry error-no RX, no FU|0
188119|NCT00006604|576922|P14|Overall Study|Randomization entry error-no RX, no FU|0
188120|NCT00006604|576923|P13|Overall Study|Randomization entry error-no RX, no FU|0
188121|NCT00006604|576924|P12|Overall Study|Randomization entry error-no RX, no FU|1
188122|NCT00006604|576925|P11|Overall Study|Randomization entry error-no RX, no FU|0
188123|NCT00006604|576926|P10|Overall Study|Randomization entry error-no RX, no FU|0
188124|NCT00006604|576927|P9|Overall Study|Randomization entry error-no RX, no FU|0
188125|NCT00006604|576928|P8|Overall Study|Randomization entry error-no RX, no FU|0
188126|NCT00006604|576929|P7|Overall Study|Randomization entry error-no RX, no FU|0
188127|NCT00006604|576930|P6|Overall Study|Randomization entry error-no RX, no FU|0
188128|NCT00006604|576931|P5|Overall Study|Randomization entry error-no RX, no FU|0
188129|NCT00006604|576932|P4|Overall Study|Randomization entry error-no RX, no FU|0
188130|NCT00006604|576933|P3|Overall Study|Randomization entry error-no RX, no FU|0
188131|NCT00006604|576934|P2|Overall Study|Randomization entry error-no RX, no FU|0
188132|NCT00006604|576935|P1|Overall Study|Randomization entry error-no RX, no FU|0
188133|NCT00006604|576919|P17|Overall Study|Met study objective - no further FU|0
188134|NCT00006604|576920|P16|Overall Study|Met study objective - no further FU|1
188135|NCT00006604|576921|P15|Overall Study|Met study objective - no further FU|1
188136|NCT00006604|576922|P14|Overall Study|Met study objective - no further FU|0
188137|NCT00006604|576923|P13|Overall Study|Met study objective - no further FU|0
188138|NCT00006604|576924|P12|Overall Study|Met study objective - no further FU|0
188139|NCT00006604|576925|P11|Overall Study|Met study objective - no further FU|0
188140|NCT00006604|576926|P10|Overall Study|Met study objective - no further FU|0
188141|NCT00006604|576927|P9|Overall Study|Met study objective - no further FU|0
188142|NCT00006604|576928|P8|Overall Study|Met study objective - no further FU|0
188143|NCT00006604|576929|P7|Overall Study|Met study objective - no further FU|0
188144|NCT00006604|576930|P6|Overall Study|Met study objective - no further FU|0
188145|NCT00006604|576931|P5|Overall Study|Met study objective - no further FU|0
188146|NCT00006604|576932|P4|Overall Study|Met study objective - no further FU|0
188147|NCT00006604|576933|P3|Overall Study|Met study objective - no further FU|0
188148|NCT00006604|576934|P2|Overall Study|Met study objective - no further FU|0
188149|NCT00006604|576935|P1|Overall Study|Met study objective - no further FU|1
188150|NCT00006478|577049|P1|Overall Study|Physician Decision|6
188151|NCT00006478|577049|P1|Overall Study|Vaccine could not be produced|1
188152|NCT00006409|577059|P6|Post-3 Year Intervention|Protocol Violation|62
188153|NCT00006409|577060|P5|Post-3 Year Intervention|Protocol Violation|62
188154|NCT00006409|577061|P4|Post-3 Year Intervention|Protocol Violation|0
188155|NCT00006409|577062|P3|Post-3 Year Intervention|Protocol Violation|0
188156|NCT00006409|577063|P2|Post-3 Year Intervention|Protocol Violation|0
188157|NCT00006409|577064|P1|Post-3 Year Intervention|Protocol Violation|0
188158|NCT00006409|577059|P6|Post-2 Year Intervention|Protocol Violation|0
188159|NCT00006409|577060|P5|Post-2 Year Intervention|Protocol Violation|0
188160|NCT00006409|577061|P4|Post-2 Year Intervention|Protocol Violation|168
188161|NCT00006409|577062|P3|Post-2 Year Intervention|Protocol Violation|251
188162|NCT00006409|577063|P2|Post-2 Year Intervention|Protocol Violation|0
188163|NCT00006409|577064|P1|Post-2 Year Intervention|Protocol Violation|0
188164|NCT00006409|577059|P6|Baseline|Protocol Violation|0
188165|NCT00006409|577060|P5|Baseline|Protocol Violation|0
188166|NCT00006409|577061|P4|Baseline|Protocol Violation|0
188167|NCT00006409|577062|P3|Baseline|Protocol Violation|0
188168|NCT00006409|577063|P2|Baseline|Protocol Violation|70
188169|NCT00006409|577064|P1|Baseline|Protocol Violation|48
188170|NCT00006392|577088|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
188171|NCT00006392|577089|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
188172|NCT00006392|577090|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
188173|NCT00006392|577091|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
188174|NCT00006392|577088|P4|Overall Study|Ineligible|5
188175|NCT00006392|577089|P3|Overall Study|Ineligible|5
188176|NCT00006392|577090|P2|Overall Study|Ineligible|3
188177|NCT00006392|577091|P1|Overall Study|Ineligible|11
188178|NCT00006389|577121|P1|Overall Study|Adverse Event|1
188179|NCT00006305|577131|P4|Overall Study|Withdrawal by Subject|14
188180|NCT00006305|577132|P3|Overall Study|Withdrawal by Subject|15
188181|NCT00006305|577133|P2|Overall Study|Withdrawal by Subject|10
188182|NCT00006305|577134|P1|Overall Study|Withdrawal by Subject|17
188183|NCT00006289|577150|P2|Second Intervention (5 Weeks)|Protocol Violation|1
188184|NCT00006289|577151|P1|Second Intervention (5 Weeks)|Protocol Violation|1
188185|NCT00006289|577150|P2|First Intervention (5 Weeks)|Adverse Event|0
188186|NCT00006289|577151|P1|First Intervention (5 Weeks)|Adverse Event|1
188187|NCT00006237|577169|P2|Overall Study|Not protocol specified|5
188188|NCT00006237|577170|P1|Overall Study|Not protocol specified|14
188189|NCT00006237|577169|P2|Overall Study|Withdrawal by Subject|1
188190|NCT00006237|577170|P1|Overall Study|Withdrawal by Subject|0
188191|NCT00006237|577169|P2|Overall Study|Not eligible|20
188192|NCT00006237|577170|P1|Overall Study|Not eligible|9
188193|NCT00006237|577169|P2|Overall Study|Progression/relapse|2
188194|NCT00006237|577170|P1|Overall Study|Progression/relapse|54
188195|NCT00006237|577169|P2|Overall Study|Refusal unrelated to adverse effects|4
188196|NCT00006237|577170|P1|Overall Study|Refusal unrelated to adverse effects|8
188197|NCT00006237|577169|P2|Overall Study|Death|0
188198|NCT00006237|577170|P1|Overall Study|Death|1
188199|NCT00006237|577169|P2|Overall Study|Adverse Event|29
188200|NCT00006237|577170|P1|Overall Study|Adverse Event|39
188201|NCT00006184|577182|P2|Overall Study|Death|0
188202|NCT00006184|577183|P1|Overall Study|Death|1
188203|NCT00006164|577224|P2|Overall Study|Withdrew or lost to follow-up|81
188204|NCT00006164|577225|P1|Overall Study|Withdrew or lost to follow-up|70
188205|NCT00006011|577271|P3|Overall Study|Ineligible|9
188206|NCT00006011|577272|P2|Overall Study|Ineligible|16
188207|NCT00006011|577273|P1|Overall Study|Ineligible|18
188208|NCT00006011|577271|P3|Overall Study|Not specified|5
188209|NCT00006011|577272|P2|Overall Study|Not specified|2
188210|NCT00006011|577273|P1|Overall Study|Not specified|4
188211|NCT00006011|577271|P3|Overall Study|Death|2
188212|NCT00006011|577272|P2|Overall Study|Death|1
188213|NCT00006011|577273|P1|Overall Study|Death|0
188214|NCT00006011|577271|P3|Overall Study|Adverse Event|5
188215|NCT00006011|577272|P2|Overall Study|Adverse Event|39
188216|NCT00006011|577273|P1|Overall Study|Adverse Event|15
188217|NCT00006011|577271|P3|Overall Study|Refused further treatment|26
188218|NCT00006011|577272|P2|Overall Study|Refused further treatment|13
188219|NCT00006011|577273|P1|Overall Study|Refused further treatment|15
188220|NCT00006011|577271|P3|Overall Study|Disease progression|26
188221|NCT00006011|577272|P2|Overall Study|Disease progression|6
188222|NCT00006011|577273|P1|Overall Study|Disease progression|13
188223|NCT00005957|577281|P2|Overall Study|Crossover to the other arm|19
188224|NCT00005957|577282|P1|Overall Study|Crossover to the other arm|5
188225|NCT00005957|577281|P2|Overall Study|No treated|9
188226|NCT00005957|577282|P1|Overall Study|No treated|3
188227|NCT00005947|577292|P2|Overall Study|Site Closure|0
188228|NCT00005947|577293|P1|Overall Study|Site Closure|1
188229|NCT00005947|577292|P2|Overall Study|Patient Refused to Continue|1
188230|NCT00005947|577293|P1|Overall Study|Patient Refused to Continue|2
188231|NCT00005947|577292|P2|Overall Study|Death|40
188232|NCT00005947|577293|P1|Overall Study|Death|54
188233|NCT00005937|577301|P1|Overall Study|Lack of Efficacy|5
188234|NCT00005908|577305|P2|Overall Study|Withdrawal by Subject|0
188235|NCT00005908|577306|P1|Overall Study|Withdrawal by Subject|1
188236|NCT00005906|577315|P1|Overall Study|Lack of Efficacy|3
188237|NCT00004980|577359|P2|Overall Study|Physician Decision|1
188238|NCT00004980|577360|P1|Overall Study|Physician Decision|0
188239|NCT00004980|577359|P2|Overall Study|memory difficulties|1
188240|NCT00004980|577360|P1|Overall Study|memory difficulties|1
188241|NCT00004980|577359|P2|Overall Study|Withdrawal by Subject|0
188242|NCT00004980|577360|P1|Overall Study|Withdrawal by Subject|1
188243|NCT00004978|577374|P2|Overall Study|site closure - not in analysis cohort|20
188244|NCT00004978|577375|P1|Overall Study|site closure - not in analysis cohort|19
188245|NCT00004978|577374|P2|Overall Study|Withdrawal by Subject|26
188246|NCT00004978|577375|P1|Overall Study|Withdrawal by Subject|17
188247|NCT00004978|577374|P2|Overall Study|Lost to Follow-up|108
188248|NCT00004978|577375|P1|Overall Study|Lost to Follow-up|101
188249|NCT00004978|577374|P2|Overall Study|Death|116
188250|NCT00004978|577375|P1|Overall Study|Death|107
188251|NCT00004888|577401|P2|Overall Study|Toxic death|0
188252|NCT00004888|577402|P1|Overall Study|Toxic death|1
188253|NCT00004888|577401|P2|Overall Study|Death without progressive disease|1
188254|NCT00004888|577402|P1|Overall Study|Death without progressive disease|0
188255|NCT00004888|577401|P2|Overall Study|Progressive Disease|9
188256|NCT00004888|577402|P1|Overall Study|Progressive Disease|4
188257|NCT00004888|577401|P2|Overall Study|Physician Decision|1
188258|NCT00004888|577402|P1|Overall Study|Physician Decision|1
188259|NCT00004888|577401|P2|Overall Study|Withdrawal by Subject|3
188260|NCT00004888|577402|P1|Overall Study|Withdrawal by Subject|0
188261|NCT00004888|577401|P2|Overall Study|Adverse Event|10
188262|NCT00004888|577402|P1|Overall Study|Adverse Event|5
188263|NCT00004859|577420|P2|Overall Study|Not specified|21
188264|NCT00004859|577421|P1|Overall Study|Not specified|13
188265|NCT00004859|577420|P2|Overall Study|missing data|11
188266|NCT00004859|577421|P1|Overall Study|missing data|14
188267|NCT00004859|577420|P2|Overall Study|error|1
188268|NCT00004859|577421|P1|Overall Study|error|3
188269|NCT00004859|577420|P2|Overall Study|other disease|3
188270|NCT00004859|577421|P1|Overall Study|other disease|0
188271|NCT00004859|577420|P2|Overall Study|Protocol Violation|2
188272|NCT00004859|577421|P1|Overall Study|Protocol Violation|2
188273|NCT00004859|577420|P2|Overall Study|Withdrawal by Subject|33
188274|NCT00004859|577421|P1|Overall Study|Withdrawal by Subject|7
188275|NCT00004859|577420|P2|Overall Study|Death|5
188276|NCT00004859|577421|P1|Overall Study|Death|5
188277|NCT00004859|577420|P2|Overall Study|Adverse Event|93
188278|NCT00004859|577421|P1|Overall Study|Adverse Event|31
188279|NCT00004859|577420|P2|Overall Study|Lack of Efficacy|113
188280|NCT00004859|577421|P1|Overall Study|Lack of Efficacy|43
188281|NCT00004732|577433|P2|Overall Study|Lost to Follow-up|47
188282|NCT00004732|577434|P1|Overall Study|Lost to Follow-up|33
188283|NCT00004732|577433|P2|Overall Study|Withdrawal by Subject|64
188284|NCT00004732|577434|P1|Overall Study|Withdrawal by Subject|36
188285|NCT00004635|577444|P2|Period Two|discrepancy in data entry|1
188286|NCT00004635|577445|P1|Period Two|discrepancy in data entry|0
188287|NCT00004635|577444|P2|Period Two|Lost to Follow-up|0
188288|NCT00004635|577445|P1|Period Two|Lost to Follow-up|1
188289|NCT00004635|577444|P2|Period Two|secondary malignancy|1
188290|NCT00004635|577445|P1|Period Two|secondary malignancy|1
188291|NCT00004635|577444|P2|Period Two|travel issues|1
188292|NCT00004635|577445|P1|Period Two|travel issues|0
188293|NCT00004635|577444|P2|Period Two|health problem|1
188294|NCT00004635|577445|P1|Period Two|health problem|1
188295|NCT00004635|577444|P2|Period Two|refused|2
188296|NCT00004635|577445|P1|Period Two|refused|0
188297|NCT00004635|577444|P2|Period Two|Adverse Event|0
188298|NCT00004635|577445|P1|Period Two|Adverse Event|1
188299|NCT00004635|577444|P2|Period Two|progression|3
188300|NCT00004635|577445|P1|Period Two|progression|2
188301|NCT00004635|577444|P2|Period One|discrepancy in data entry|1
188302|NCT00004635|577445|P1|Period One|discrepancy in data entry|0
188303|NCT00004635|577444|P2|Period One|health problem|1
188304|NCT00004635|577445|P1|Period One|health problem|0
188305|NCT00004635|577444|P2|Period One|progressed|2
188306|NCT00004635|577445|P1|Period One|progressed|0
188307|NCT00004635|577444|P2|Period One|second malignancy|0
188308|NCT00004635|577445|P1|Period One|second malignancy|1
188309|NCT00004635|577444|P2|Period One|PSA did not go <5 ng/mL|0
188310|NCT00004635|577445|P1|Period One|PSA did not go <5 ng/mL|1
188311|NCT00004635|577444|P2|Period One|Protocol Violation|0
188312|NCT00004635|577445|P1|Period One|Protocol Violation|1
188313|NCT00004635|577444|P2|Period One|Withdrawal by Subject|1
188314|NCT00004635|577445|P1|Period One|Withdrawal by Subject|1
188315|NCT00004635|577444|P2|Period One|refused|1
188316|NCT00004635|577445|P1|Period One|refused|2
188317|NCT00004563|577457|P2|Overall Study|Death|3
188318|NCT00004563|577458|P1|Overall Study|Death|2
188319|NCT00004563|577457|P2|Overall Study|Lack of Efficacy|5
188320|NCT00004563|577458|P1|Overall Study|Lack of Efficacy|3
188321|NCT00004563|577457|P2|Overall Study|Withdrawal by Subject|16
188322|NCT00004563|577458|P1|Overall Study|Withdrawal by Subject|20
188323|NCT00004562|577470|P2|Overall Study|Lost to Follow-up|91
188324|NCT00004562|577471|P1|Overall Study|Lost to Follow-up|102
188325|NCT00004412|577518|P3|Randomized Period|Moved to Crossover Period|0
188326|NCT00004412|577519|P2|Randomized Period|Moved to Crossover Period|0
188327|NCT00004412|577520|P1|Randomized Period|Moved to Crossover Period|3
188328|NCT00004228|577535|P7|Overall Study|ineligible|5
188329|NCT00004228|577536|P6|Overall Study|ineligible|2
188330|NCT00004228|577537|P5|Overall Study|ineligible|1
188331|NCT00004228|577538|P4|Overall Study|ineligible|1
188332|NCT00004228|577539|P3|Overall Study|ineligible|4
188333|NCT00004228|577540|P2|Overall Study|ineligible|2
188334|NCT00004228|577541|P1|Overall Study|ineligible|4
188335|NCT00004228|577535|P7|Overall Study|Other|0
188336|NCT00004228|577536|P6|Overall Study|Other|0
188337|NCT00004228|577537|P5|Overall Study|Other|0
188338|NCT00004228|577538|P4|Overall Study|Other|0
188339|NCT00004228|577539|P3|Overall Study|Other|1
188340|NCT00004228|577540|P2|Overall Study|Other|0
188341|NCT00004228|577541|P1|Overall Study|Other|0
188342|NCT00004228|577535|P7|Overall Study|Withdrawal by Subject|2
188343|NCT00004228|577536|P6|Overall Study|Withdrawal by Subject|1
188344|NCT00004228|577537|P5|Overall Study|Withdrawal by Subject|2
188345|NCT00004228|577538|P4|Overall Study|Withdrawal by Subject|0
188346|NCT00004228|577539|P3|Overall Study|Withdrawal by Subject|1
188347|NCT00004228|577540|P2|Overall Study|Withdrawal by Subject|0
188348|NCT00004228|577541|P1|Overall Study|Withdrawal by Subject|3
188349|NCT00004228|577535|P7|Overall Study|Protocol Violation|0
188350|NCT00004228|577536|P6|Overall Study|Protocol Violation|2
188351|NCT00004228|577537|P5|Overall Study|Protocol Violation|1
188352|NCT00004228|577538|P4|Overall Study|Protocol Violation|1
188353|NCT00004228|577539|P3|Overall Study|Protocol Violation|2
188354|NCT00004228|577540|P2|Overall Study|Protocol Violation|5
188355|NCT00004228|577541|P1|Overall Study|Protocol Violation|0
188356|NCT00004228|577535|P7|Overall Study|Physician Decision|1
188357|NCT00004228|577536|P6|Overall Study|Physician Decision|1
188358|NCT00004228|577537|P5|Overall Study|Physician Decision|1
188359|NCT00004228|577538|P4|Overall Study|Physician Decision|2
188360|NCT00004228|577539|P3|Overall Study|Physician Decision|3
188361|NCT00004228|577540|P2|Overall Study|Physician Decision|0
188362|NCT00004228|577541|P1|Overall Study|Physician Decision|1
188363|NCT00004228|577535|P7|Overall Study|Lost to Follow-up|0
188364|NCT00004228|577536|P6|Overall Study|Lost to Follow-up|0
188365|NCT00004228|577537|P5|Overall Study|Lost to Follow-up|0
188366|NCT00004228|577538|P4|Overall Study|Lost to Follow-up|0
188367|NCT00004228|577539|P3|Overall Study|Lost to Follow-up|1
188368|NCT00004228|577540|P2|Overall Study|Lost to Follow-up|0
188369|NCT00004228|577541|P1|Overall Study|Lost to Follow-up|0
188370|NCT00004228|577535|P7|Overall Study|Lack of Efficacy|4
188371|NCT00004228|577536|P6|Overall Study|Lack of Efficacy|8
188372|NCT00004228|577537|P5|Overall Study|Lack of Efficacy|9
188373|NCT00004228|577538|P4|Overall Study|Lack of Efficacy|3
188374|NCT00004228|577539|P3|Overall Study|Lack of Efficacy|5
188375|NCT00004228|577540|P2|Overall Study|Lack of Efficacy|6
188376|NCT00004228|577541|P1|Overall Study|Lack of Efficacy|1
188377|NCT00004228|577535|P7|Overall Study|Death|0
188378|NCT00004228|577536|P6|Overall Study|Death|0
188379|NCT00004228|577537|P5|Overall Study|Death|1
188380|NCT00004228|577538|P4|Overall Study|Death|0
188381|NCT00004228|577539|P3|Overall Study|Death|2
188382|NCT00004228|577540|P2|Overall Study|Death|1
188383|NCT00004228|577541|P1|Overall Study|Death|0
188384|NCT00004228|577535|P7|Overall Study|Adverse Event|0
188385|NCT00004228|577536|P6|Overall Study|Adverse Event|0
188386|NCT00004228|577537|P5|Overall Study|Adverse Event|1
188387|NCT00004228|577538|P4|Overall Study|Adverse Event|0
188388|NCT00004228|577539|P3|Overall Study|Adverse Event|0
188389|NCT00004228|577540|P2|Overall Study|Adverse Event|1
188390|NCT00004228|577541|P1|Overall Study|Adverse Event|0
188391|NCT00003907|577608|P2|Overall Study|ineligible or not treated|2
188392|NCT00003907|577609|P1|Overall Study|ineligible or not treated|2
188393|NCT00003907|577608|P2|Overall Study|Not specified|3
188394|NCT00003907|577609|P1|Overall Study|Not specified|1
188395|NCT00003907|577608|P2|Overall Study|Complicating disease|0
188396|NCT00003907|577609|P1|Overall Study|Complicating disease|1
188397|NCT00003907|577608|P2|Overall Study|Progressive disease|4
188398|NCT00003907|577609|P1|Overall Study|Progressive disease|4
188399|NCT00003907|577608|P2|Overall Study|Withdrawal by Subject|3
188400|NCT00003907|577609|P1|Overall Study|Withdrawal by Subject|1
188401|NCT00003907|577608|P2|Overall Study|Death|0
188402|NCT00003907|577609|P1|Overall Study|Death|2
188403|NCT00003907|577608|P2|Overall Study|Adverse Event|11
188404|NCT00003907|577609|P1|Overall Study|Adverse Event|2
188405|NCT00003901|577619|P1|Overall Study|Medical problems|6
188406|NCT00003901|577619|P1|Overall Study|Chest X-Ray not done prior registration|1
188407|NCT00003901|577619|P1|Overall Study|CT Scan not within protocol requirement|2
188408|NCT00003901|577619|P1|Overall Study|Ineligible|6
188409|NCT00003901|577619|P1|Overall Study|Withdrawal by Subject|1
188410|NCT00003901|577619|P1|Overall Study|Adverse Event|1
188411|NCT00003896|577630|P1|Overall Study|ineligible|5
188412|NCT00003896|577630|P1|Overall Study|not protocol specified|3
188413|NCT00003896|577630|P1|Overall Study|Death|3
188414|NCT00003896|577630|P1|Overall Study|Lack of Efficacy|1
188415|NCT00003896|577630|P1|Overall Study|Withdrawal by Subject|1
188416|NCT00003896|577630|P1|Overall Study|Adverse Event|16
188417|NCT00003869|577638|P2|Overall Study|Alternative treatmnt, medical problems|4
188418|NCT00003869|577639|P1|Overall Study|Alternative treatmnt, medical problems|5
188419|NCT00003869|577638|P2|Overall Study|Death|2
188420|NCT00003869|577639|P1|Overall Study|Death|1
188421|NCT00003869|577638|P2|Overall Study|Withdrawal by Subject|3
188422|NCT00003869|577639|P1|Overall Study|Withdrawal by Subject|21
188423|NCT00003869|577638|P2|Overall Study|Adverse Event|3
188424|NCT00003869|577639|P1|Overall Study|Adverse Event|14
188425|NCT00003782|577658|P3|Overall Study|No follow up data|26
188426|NCT00003782|577659|P2|Overall Study|No follow up data|31
188427|NCT00003782|577660|P1|Overall Study|No follow up data|30
188428|NCT00003659|577672|P1|Overall Study|Withdrawal by Subject|3
188429|NCT00003641|577680|P2|Overall Study|Never started interferon|12
188430|NCT00003641|577681|P1|Overall Study|Never started interferon|567
188431|NCT00003641|577680|P2|Overall Study|Should not receive interferon therapy|0
188432|NCT00003641|577681|P1|Overall Study|Should not receive interferon therapy|2
188433|NCT00003641|577680|P2|Overall Study|Unknown/missing|22
188434|NCT00003641|577681|P1|Overall Study|Unknown/missing|0
188435|NCT00003641|577680|P2|Overall Study|Disease progression|2
188436|NCT00003641|577681|P1|Overall Study|Disease progression|0
188437|NCT00003641|577680|P2|Overall Study|Adverse Event|38
188438|NCT00003641|577681|P1|Overall Study|Adverse Event|0
188439|NCT00003641|577680|P2|Overall Study|Withdrawal by Subject|100
188440|NCT00003641|577681|P1|Overall Study|Withdrawal by Subject|0
188441|NCT00003631|577692|P3|Overall Study|Evaluable for toxicity only|2
188442|NCT00003631|577693|P2|Overall Study|Evaluable for toxicity only|0
188443|NCT00003631|577694|P1|Overall Study|Evaluable for toxicity only|0
188444|NCT00003631|577692|P3|Overall Study|Death|1
188445|NCT00003631|577693|P2|Overall Study|Death|0
188446|NCT00003631|577694|P1|Overall Study|Death|0
188447|NCT00003631|577692|P3|Overall Study|Adverse Event|5
188448|NCT00003631|577693|P2|Overall Study|Adverse Event|1
188449|NCT00003631|577694|P1|Overall Study|Adverse Event|1
188450|NCT00003631|577692|P3|Overall Study|Protocol Violation|0
188451|NCT00003631|577693|P2|Overall Study|Protocol Violation|0
188452|NCT00003631|577694|P1|Overall Study|Protocol Violation|1
188453|NCT00003631|577692|P3|Overall Study|Patient not treated|1
188454|NCT00003631|577693|P2|Overall Study|Patient not treated|0
188455|NCT00003631|577694|P1|Overall Study|Patient not treated|1
188456|NCT00003590|577702|P1|Overall Study|Physician Decision|1
188457|NCT00003590|577702|P1|Overall Study|Death|1
188458|NCT00003590|577702|P1|Overall Study|Lack of Efficacy|11
188459|NCT00003590|577702|P1|Overall Study|Withdrawal by Subject|1
188460|NCT00003590|577702|P1|Overall Study|Adverse Event|7
188461|NCT00003590|577702|P1|Overall Study|Ineligible Patient|1
188462|NCT00003483|577707|P1|Overall Study|Not evaluable|1
188463|NCT00003479|577712|P1|Overall Study|Not evaluable|3
188464|NCT00003477|577717|P1|Overall Study|Not evalauable|4
188465|NCT00003475|577722|P1|Overall Study|Not evaluable|13
188466|NCT00003473|577727|P1|Overall Study|Three patients were not evaluable.|3
188467|NCT00003470|577732|P1|Overall Study|Not evaluable|6
188468|NCT00003458|577752|P1|Overall Study|Not evaluable|4
188469|NCT00003457|577757|P1|Overall Study|Not evaluable|9
188470|NCT00003389|577764|P2|Overall Study|Ineligible|27
188471|NCT00003389|577765|P1|Overall Study|Ineligible|33
188472|NCT00003389|577764|P2|Overall Study|Off-treatment reason missing|21
188473|NCT00003389|577765|P1|Overall Study|Off-treatment reason missing|31
188474|NCT00003389|577764|P2|Overall Study|Complicating disease|0
188475|NCT00003389|577765|P1|Overall Study|Complicating disease|1
188476|NCT00003389|577764|P2|Overall Study|Alternative therapy|1
188477|NCT00003389|577765|P1|Overall Study|Alternative therapy|2
188478|NCT00003389|577764|P2|Overall Study|Withdrawal by Subject|5
188479|NCT00003389|577765|P1|Overall Study|Withdrawal by Subject|12
188480|NCT00003389|577764|P2|Overall Study|Death|3
188481|NCT00003389|577765|P1|Overall Study|Death|0
188482|NCT00003389|577764|P2|Overall Study|Adverse Event|2
188483|NCT00003389|577765|P1|Overall Study|Adverse Event|13
188484|NCT00003389|577764|P2|Overall Study|Disease progression|1
188485|NCT00003389|577765|P1|Overall Study|Disease progression|6
188486|NCT00003377|577780|P5|Period II|Ureteral stent complications|1
188487|NCT00003377|577781|P4|Period II|Ureteral stent complications|0
188488|NCT00003377|577782|P3|Period II|Ureteral stent complications|0
188489|NCT00003377|577783|P2|Period II|Ureteral stent complications|0
188490|NCT00003377|577784|P1|Period II|Ureteral stent complications|0
188491|NCT00003377|577780|P5|Period I|Dose Limiting Toxicity(DLT)|0
188492|NCT00003377|577781|P4|Period I|Dose Limiting Toxicity(DLT)|1
188493|NCT00003377|577782|P3|Period I|Dose Limiting Toxicity(DLT)|1
188494|NCT00003377|577783|P2|Period I|Dose Limiting Toxicity(DLT)|0
188495|NCT00003377|577784|P1|Period I|Dose Limiting Toxicity(DLT)|0
188496|NCT00003298|577798|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
188497|NCT00003298|577798|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
188498|NCT00003298|577798|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
188499|NCT00003298|577798|P1|Step 2 (Adjuvant Therapy)|Death|1
188500|NCT00003298|577798|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
188501|NCT00003298|577798|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
188502|NCT00003298|577798|P1|Re-register to Step 2 After Surgery|Reason unknown|1
188503|NCT00003298|577798|P1|Re-register to Step 2 After Surgery|Other complications|2
188504|NCT00003298|577798|P1|Re-register to Step 2 After Surgery|Positive margins|5
188505|NCT00003298|577798|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
188506|NCT00003298|577798|P1|Surgery|Unevaluable and off study|2
188507|NCT00003298|577798|P1|Surgery|Progression before surgery|2
188508|NCT00003298|577798|P1|Surgery|Unresectable at surgery|3
188509|NCT00003298|577798|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
188510|NCT00003298|577798|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
188511|NCT00003222|577837|P2|Overall Study|Physician Decision|1
188512|NCT00003222|577838|P1|Overall Study|Physician Decision|0
188513|NCT00003138|577850|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
188514|NCT00003138|577851|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
188515|NCT00003138|577850|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
188516|NCT00003138|577851|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
188517|NCT00003138|577850|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
188518|NCT00003138|577851|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
188519|NCT00003138|577850|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
188520|NCT00003138|577851|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
188521|NCT00003138|577850|P2|Step 1|Never started treatment|0
188522|NCT00003138|577851|P1|Step 1|Never started treatment|1
188523|NCT00003138|577850|P2|Step 1|Reasons off treatment not documented|57
188524|NCT00003138|577851|P1|Step 1|Reasons off treatment not documented|60
188525|NCT00002931|577868|P1|Overall Study|rapidly progressing disease during|2
188526|NCT00002850|577877|P3|Overall Study|Withdrawal by Subject|0
188527|NCT00002850|577878|P2|Overall Study|Withdrawal by Subject|1
188528|NCT00002850|577879|P1|Overall Study|Withdrawal by Subject|0
188529|NCT00002850|577877|P3|Overall Study|Protocol Violation|1
188530|NCT00002850|577878|P2|Overall Study|Protocol Violation|0
188531|NCT00002850|577879|P1|Overall Study|Protocol Violation|1
188532|NCT00002850|577877|P3|Overall Study|Death|3
188533|NCT00002850|577878|P2|Overall Study|Death|1
188534|NCT00002850|577879|P1|Overall Study|Death|4
188535|NCT00002766|577889|P2|Overall Study|Protocol Violation|0
188536|NCT00002766|577890|P1|Overall Study|Protocol Violation|1
188537|NCT00002766|577889|P2|Overall Study|Adverse Event|1
188538|NCT00002766|577890|P1|Overall Study|Adverse Event|1
188539|NCT00002766|577889|P2|Overall Study|Patient Not Treated|2
188540|NCT00002766|577890|P1|Overall Study|Patient Not Treated|1
188541|NCT00002766|577889|P2|Overall Study|Withdrawal by Subject|1
188542|NCT00002766|577890|P1|Overall Study|Withdrawal by Subject|0
188543|NCT00002558|577906|P2|Overall Study|Withdrawal by Subject|1
188544|NCT00002558|577907|P1|Overall Study|Withdrawal by Subject|0
188545|NCT00002540|577915|P2|Overall Study|Refused Screen (Prostate Screening)|2433
188546|NCT00002540|577916|P1|Overall Study|Refused Screen (Prostate Screening)|0
188547|NCT00002540|577915|P2|Overall Study|Refused ASU (Control)|0
188548|NCT00002540|577916|P1|Overall Study|Refused ASU (Control)|597
188549|NCT00002540|577915|P2|Overall Study|Died Before ASU (Control)|0
188550|NCT00002540|577916|P1|Overall Study|Died Before ASU (Control)|202
188551|NCT00002540|577915|P2|Overall Study|Died Before Randomization|6
188552|NCT00002540|577916|P1|Overall Study|Died Before Randomization|2
188553|NCT00002540|577915|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
188554|NCT00002540|577916|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
188555|NCT00002525|577944|P2|Overall Study|Never start protocol therapy|0
188556|NCT00002525|577945|P1|Overall Study|Never start protocol therapy|8
188557|NCT00002525|577944|P2|Overall Study|Other|0
188558|NCT00002525|577945|P1|Overall Study|Other|26
188559|NCT00002525|577944|P2|Overall Study|Error|0
188560|NCT00002525|577945|P1|Overall Study|Error|6
188561|NCT00002525|577944|P2|Overall Study|Duke's A, B1, D disease|0
188562|NCT00002525|577945|P1|Overall Study|Duke's A, B1, D disease|92
188563|NCT00002525|577944|P2|Overall Study|Other complicating disease|0
188564|NCT00002525|577945|P1|Overall Study|Other complicating disease|1
188565|NCT00002525|577944|P2|Overall Study|Start non-protocol therapy|0
188566|NCT00002525|577945|P1|Overall Study|Start non-protocol therapy|1
188567|NCT00002525|577944|P2|Overall Study|Withdrawal by Subject|0
188568|NCT00002525|577945|P1|Overall Study|Withdrawal by Subject|11
188569|NCT00002525|577944|P2|Overall Study|Death|0
188570|NCT00002525|577945|P1|Overall Study|Death|5
188571|NCT00002525|577944|P2|Overall Study|Adverse Event|0
188572|NCT00002525|577945|P1|Overall Study|Adverse Event|36
188573|NCT00001962|577969|P1|Overall Study|Adverse Event|1
188574|NCT00001962|577969|P1|Overall Study|Lost to Follow-up|2
188575|NCT00001962|577969|P1|Overall Study|Death|1
188576|NCT00001962|577969|P1|Overall Study|Lack of Accrual|6
188577|NCT00001962|577969|P1|Overall Study|Lack of Efficacy|18
188578|NCT00001959|577973|P1|Overall Study|non-compliance|1
188579|NCT00001959|577973|P1|Overall Study|disabling sedation|1
188580|NCT00001959|577973|P1|Overall Study|newly diagnosed colon cancer|1
188581|NCT00001941|577979|P5|Overall Study|not treated- rapidly progressing disease|1
188582|NCT00001941|577980|P4|Overall Study|not treated- rapidly progressing disease|0
188583|NCT00001941|577981|P3|Overall Study|not treated- rapidly progressing disease|0
188584|NCT00001941|577982|P2|Overall Study|not treated- rapidly progressing disease|0
188585|NCT00001941|577983|P1|Overall Study|not treated- rapidly progressing disease|0
188586|NCT00001832|578004|P15|Treatment Period|Not treated|0
188587|NCT00001832|578005|P14|Treatment Period|Not treated|0
188588|NCT00001832|578006|P13|Treatment Period|Not treated|0
188589|NCT00001832|578007|P12|Treatment Period|Not treated|0
188590|NCT00001832|578008|P11|Treatment Period|Not treated|0
188591|NCT00001832|578009|P10|Treatment Period|Not treated|0
188592|NCT00001832|578010|P9|Treatment Period|Not treated|0
188593|NCT00001832|578011|P8|Treatment Period|Not treated|1
188594|NCT00001832|578012|P7|Treatment Period|Not treated|0
188595|NCT00001832|578013|P6|Treatment Period|Not treated|0
188596|NCT00001832|578014|P5|Treatment Period|Not treated|0
188597|NCT00001832|578015|P4|Treatment Period|Not treated|0
188598|NCT00001832|578016|P3|Treatment Period|Not treated|0
188599|NCT00001832|578017|P2|Treatment Period|Not treated|0
188600|NCT00001832|578018|P1|Treatment Period|Not treated|0
188601|NCT00001832|578004|P15|Treatment Period|Death during treatment|0
188602|NCT00001832|578005|P14|Treatment Period|Death during treatment|0
188603|NCT00001832|578006|P13|Treatment Period|Death during treatment|0
188604|NCT00001832|578007|P12|Treatment Period|Death during treatment|0
188605|NCT00001832|578008|P11|Treatment Period|Death during treatment|0
188606|NCT00001832|578009|P10|Treatment Period|Death during treatment|0
188607|NCT00001832|578010|P9|Treatment Period|Death during treatment|0
188608|NCT00001832|578011|P8|Treatment Period|Death during treatment|0
188609|NCT00001832|578012|P7|Treatment Period|Death during treatment|0
188610|NCT00001832|578013|P6|Treatment Period|Death during treatment|1
188611|NCT00001832|578014|P5|Treatment Period|Death during treatment|0
188612|NCT00001832|578015|P4|Treatment Period|Death during treatment|0
188613|NCT00001832|578016|P3|Treatment Period|Death during treatment|0
188614|NCT00001832|578017|P2|Treatment Period|Death during treatment|0
188615|NCT00001832|578018|P1|Treatment Period|Death during treatment|0
188616|NCT00001832|578004|P15|Apheresis Period|not able to manufacture treatment cells|0
188617|NCT00001832|578005|P14|Apheresis Period|not able to manufacture treatment cells|0
188618|NCT00001832|578006|P13|Apheresis Period|not able to manufacture treatment cells|0
188619|NCT00001832|578007|P12|Apheresis Period|not able to manufacture treatment cells|0
188620|NCT00001832|578008|P11|Apheresis Period|not able to manufacture treatment cells|0
188621|NCT00001832|578009|P10|Apheresis Period|not able to manufacture treatment cells|0
188622|NCT00001832|578010|P9|Apheresis Period|not able to manufacture treatment cells|0
188623|NCT00001832|578011|P8|Apheresis Period|not able to manufacture treatment cells|0
188624|NCT00001832|578012|P7|Apheresis Period|not able to manufacture treatment cells|0
188625|NCT00001832|578013|P6|Apheresis Period|not able to manufacture treatment cells|0
188626|NCT00001832|578014|P5|Apheresis Period|not able to manufacture treatment cells|0
188627|NCT00001832|578015|P4|Apheresis Period|not able to manufacture treatment cells|0
188628|NCT00001832|578016|P3|Apheresis Period|not able to manufacture treatment cells|0
188629|NCT00001832|578017|P2|Apheresis Period|not able to manufacture treatment cells|0
188630|NCT00001832|578018|P1|Apheresis Period|not able to manufacture treatment cells|60
188631|NCT00001723|578064|P2|Overall Study|medication intolerance|2
188632|NCT00001723|578065|P1|Overall Study|medication intolerance|1
188633|NCT00001723|578064|P2|Overall Study|Lost to Follow-up|2
188634|NCT00001723|578065|P1|Overall Study|Lost to Follow-up|2
188635|NCT00001723|578064|P2|Overall Study|Lack of family interest|5
188636|NCT00001723|578065|P1|Overall Study|Lack of family interest|4
188637|NCT00001723|578064|P2|Overall Study|Lack of Efficacy|7
188638|NCT00001723|578065|P1|Overall Study|Lack of Efficacy|6
188639|NCT00001703|578081|P1|Overall Study|recurrent disease|2
188640|NCT00001703|578081|P1|Overall Study|No evidence of disease|1
188641|NCT00001703|578081|P1|Overall Study|progressed disease|2
188642|NCT00001596|578119|P2|Overall Study|Adverse Event|0
188643|NCT00001596|578120|P1|Overall Study|Adverse Event|1
188644|NCT00001596|578119|P2|Overall Study|Study Termination|9
188645|NCT00001596|578120|P1|Overall Study|Study Termination|12
188646|NCT00001596|578119|P2|Overall Study|Withdrawal by Subject|1
188647|NCT00001596|578120|P1|Overall Study|Withdrawal by Subject|3
188648|NCT00001596|578119|P2|Overall Study|Death|0
188649|NCT00001596|578120|P1|Overall Study|Death|1
188650|NCT00001575|578151|P1|Overall Study|Withdrawn/deaths|23
188651|NCT00001575|578151|P1|Overall Study|Screening failures-Ph I portion|22
188652|NCT00001566|578157|P1|Overall Study|unable to complete initial apheresis|1
188653|NCT00001566|578157|P1|Overall Study|Lost to Follow-up|1
188654|NCT00001566|578157|P1|Overall Study|Death|13
188655|NCT00001566|578157|P1|Overall Study|stopped after C3 due to symptomatic PD|1
188656|NCT00001566|578157|P1|Overall Study|patients' choice to discontinue protocol|3
188657|NCT00001262|578193|P3|Overall Study|Withdrawal by Subject|0
188658|NCT00001262|578194|P2|Overall Study|Withdrawal by Subject|3
188659|NCT00001262|578195|P1|Overall Study|Withdrawal by Subject|0
188660|NCT00001262|578193|P3|Overall Study|Death|0
188661|NCT00001262|578194|P2|Overall Study|Death|11
188662|NCT00001262|578195|P1|Overall Study|Death|10
188663|NCT00001213|578221|P1|Overall Study|Death|18
188664|NCT00000620|578232|P8|Overall Study|missed closeout visit|16
188665|NCT00000620|578233|P7|Overall Study|missed closeout visit|13
188666|NCT00000620|578234|P6|Overall Study|missed closeout visit|28
188667|NCT00000620|578235|P5|Overall Study|missed closeout visit|26
188668|NCT00000620|578236|P4|Overall Study|missed closeout visit|11
188669|NCT00000620|578237|P3|Overall Study|missed closeout visit|16
188670|NCT00000620|578238|P2|Overall Study|missed closeout visit|28
188671|NCT00000620|578239|P1|Overall Study|missed closeout visit|22
188672|NCT00000620|578232|P8|Overall Study|Withdrawal by Subject|21
188673|NCT00000620|578233|P7|Overall Study|Withdrawal by Subject|32
188674|NCT00000620|578234|P6|Overall Study|Withdrawal by Subject|32
188675|NCT00000620|578235|P5|Overall Study|Withdrawal by Subject|30
188676|NCT00000620|578236|P4|Overall Study|Withdrawal by Subject|27
188677|NCT00000620|578237|P3|Overall Study|Withdrawal by Subject|28
188678|NCT00000620|578238|P2|Overall Study|Withdrawal by Subject|27
188679|NCT00000620|578239|P1|Overall Study|Withdrawal by Subject|40
188680|NCT00000620|578232|P8|Overall Study|Lost to Follow-up|14
188681|NCT00000620|578233|P7|Overall Study|Lost to Follow-up|13
188682|NCT00000620|578234|P6|Overall Study|Lost to Follow-up|15
188683|NCT00000620|578235|P5|Overall Study|Lost to Follow-up|15
188684|NCT00000620|578236|P4|Overall Study|Lost to Follow-up|14
188685|NCT00000620|578237|P3|Overall Study|Lost to Follow-up|14
188686|NCT00000620|578238|P2|Overall Study|Lost to Follow-up|14
188687|NCT00000620|578239|P1|Overall Study|Lost to Follow-up|14
188688|NCT00000620|578232|P8|Overall Study|Death|95
188689|NCT00000620|578233|P7|Overall Study|Death|91
188690|NCT00000620|578234|P6|Overall Study|Death|77
188691|NCT00000620|578235|P5|Overall Study|Death|64
188692|NCT00000620|578236|P4|Overall Study|Death|126
188693|NCT00000620|578237|P3|Overall Study|Death|112
188694|NCT00000620|578238|P2|Overall Study|Death|67
188695|NCT00000620|578239|P1|Overall Study|Death|86
188696|NCT00000378|578320|P2|Overall Study|Lack of Efficacy|14
188697|NCT00000378|578321|P1|Overall Study|Lack of Efficacy|16
188698|NCT00000135|578369|P2|Overall Study|Death|14
188699|NCT00000135|578370|P1|Overall Study|Death|27
